PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Huang, SYN; Ghosh, S; Pommier, Y				Huang, Shar-yin Naomi; Ghosh, Sanchari; Pommier, Yves			Topoisomerase I Alone Is Sufficient to Produce Short DNA Deletions and Can Also Reverse Nicks at Ribonucleotide Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACCINIA TOPOISOMERASE; GENOME INTEGRITY; EXCISION-REPAIR; LEADING-STRAND; DUPLEX DNA; COMPLEXES; CLEAVAGE; MECHANISMS; COVALENT; YEAST	Ribonucleotide monophosphates (rNMPs) are among the most frequent form of DNA aberration, as high ratios of ribonucleotide triphosphate: deoxyribonucleotide triphosphate pools result in approximately two misincorporated rNMPs/kb of DNA. The main pathway for the removal of rNMPs is by RNase H2. However, in a RNase H2 knock-out yeast strain, a topoisomerase I (Top1)-dependent mutator effect develops with accumulation of short deletions within tandem repeats. Proposed models for these deletions implicated processing of Top1-generated nicks at rNMP sites and/or sequential Top1 binding, but experimental support has been lacking thus far. Here, we investigated the biochemical mechanism of the Top1-induced short deletions at the rNMP sites by generating nicked DNA substrates bearing 2',3'-cyclic phosphates at the nick sites, mimicking the Top1-induced nicks. We demonstrate that a second Top1 cleavage complex adjacent to the nick and subsequent faulty Top1 religation led to the short deletions. Moreover, when acting on the nicked DNA substrates containing 2',3'-cyclic phosphates, Top1 generated not only the short deletion, but also a full-length religated DNA product. Acatalytically inactive Top1 mutant (Top1-Y723F) also induced the full-length products, indicating that Top1 binding independent of its enzymatic activity promotes the sealing of DNA backbones via nucleophilic attacks by the 5'-hydroxyl on the 2',3'-cyclic phosphate. The resealed DNA would allow renewed attempt for repair by the error-free RNase H2-dependent pathway in vivo. Our results provide direct evidence for the generation of short deletions by sequential Top1 cleavage events and for the promotion of nick religation at rNMP sites by Top1.	[Pommier, Yves] NCI, Dev Therapeut Branch, NIH, Bethesda, MD 20892 USA; NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pommier, Y (corresponding author), NCI, Dev Therapeut Branch, NIH, Bethesda, MD 20892 USA.	pommier@nih.gov			National Institutes of Health from the Center for Cancer Research, NCI [Z01 BC006161]; NATIONAL CANCER INSTITUTE [ZIABC006161] Funding Source: NIH RePORTER	National Institutes of Health from the Center for Cancer Research, NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Intramural Program Grant Z01 BC006161 from the Center for Cancer Research, NCI.	Abaan OD, 2013, CANCER RES, V73, P4372, DOI 10.1158/0008-5472.CAN-12-3342; Antony S, 2007, NUCLEIC ACIDS RES, V35, P4474, DOI 10.1093/nar/gkm463; Chakravarty AK, 2011, J BIOL CHEM, V286, P4117, DOI 10.1074/jbc.M110.196766; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Cho JE, 2013, DNA REPAIR, V12, P205, DOI 10.1016/j.dnarep.2012.12.004; Clausen AR, 2015, NAT STRUCT MOL BIOL, V22, P185, DOI 10.1038/nsmb.2957; Clausen AR, 2013, DNA REPAIR, V12, P121, DOI 10.1016/j.dnarep.2012.11.006; Dexheimer TS, 2008, NAT PROTOC, V3, P1736, DOI 10.1038/nprot.2008.174; HENNINGFELD KA, 1995, BIOCHEMISTRY-US, V34, P6120, DOI 10.1021/bi00018a015; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Interthal H, 2005, J BIOL CHEM, V280, P36518, DOI 10.1074/jbc.M508898200; Interthal H, 2011, BIOCHEM J, V436, P559, DOI 10.1042/BJ20101841; Kim N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003924; Kim N, 2011, SCIENCE, V332, P1561, DOI 10.1126/science.1205016; Koster DA, 2005, NATURE, V434, P671, DOI 10.1038/nature03395; Lazzaro F, 2012, MOL CELL, V45, P99, DOI 10.1016/j.molcel.2011.12.019; Leppard JB, 2005, CHROMOSOMA, V114, P75, DOI 10.1007/s00412-005-0345-5; McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI [10.1038/NCHEMBIO.424, 10.1038/nchembio.424]; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; Meng B, 2014, GYNECOL ONCOL, V134, P15, DOI 10.1016/j.ygyno.2014.05.006; Palles C, 2013, NAT GENET, V45, P136, DOI 10.1038/ng.2503; POMMIER Y, 1994, BIOCHEM BIOPH RES CO, V205, P1601, DOI 10.1006/bbrc.1994.2850; Pommier Y, 1998, BBA-GENE STRUCT EXPR, V1400, P83, DOI 10.1016/S0167-4781(98)00129-8; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Potenski CJ, 2014, NUCLEIC ACIDS RES, V42, P10226, DOI 10.1093/nar/gku773; Potenski CJ, 2014, NATURE, V511, P251, DOI 10.1038/nature13292; Pourquier P, 1997, J BIOL CHEM, V272, P26441, DOI 10.1074/jbc.272.42.26441; Pourquier P, 1999, J BIOL CHEM, V274, P8516, DOI 10.1074/jbc.274.13.8516; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; Reijns MAM, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.011; Sekiguchi J, 1997, MOL CELL, V1, P89, DOI 10.1016/S1097-2765(00)80010-6; Seol Y, 2012, P NATL ACAD SCI USA, V109, P16125, DOI 10.1073/pnas.1206480109; Shen Y, 2012, NAT STRUCT MOL BIOL, V19, P98, DOI 10.1038/nsmb.2176; Shuman S, 1998, MOL CELL, V1, P741, DOI 10.1016/S1097-2765(00)80073-8; SHUMAN S, 1992, J BIOL CHEM, V267, P8620; SHUMAN S, 1993, J BIOL CHEM, V268, P18943; Sousa FG, 2015, DNA REPAIR, V28, P107, DOI 10.1016/j.dnarep.2015.01.011; Sparks J. L., 2015, EMBO J; Sparks JL, 2012, MOL CELL, V47, P980, DOI 10.1016/j.molcel.2012.06.035; Strumberg D, 2000, MOL CELL BIOL, V20, P3977, DOI 10.1128/MCB.20.11.3977-3987.2000; Takahashi T, 2011, P NATL ACAD SCI USA, V108, P692, DOI 10.1073/pnas.1012582108; Tanaka N, 2010, STRUCTURE, V18, P449, DOI 10.1016/j.str.2010.01.016; Tumbale P, 2014, NATURE, V506, P111, DOI 10.1038/nature12824; Vaisman A, 2014, MUTAT RES-FUND MOL M, V761, P21, DOI 10.1016/j.mrfmmm.2014.01.005; Vaisman A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003878; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Williams JS, 2014, DNA REPAIR, V19, P27, DOI 10.1016/j.dnarep.2014.03.029; Williams JS, 2013, MOL CELL, V49, P1010, DOI 10.1016/j.molcel.2012.12.021; Woodfield G, 2000, NUCLEIC ACIDS RES, V28, P3323, DOI 10.1093/nar/28.17.3323; Yang SW, 1996, P NATL ACAD SCI USA, V93, P11534, DOI 10.1073/pnas.93.21.11534	50	44	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					14068	14076		10.1074/jbc.M115.653345	http://dx.doi.org/10.1074/jbc.M115.653345			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25887397	hybrid, Green Published			2022-12-26	WOS:000355313000036
J	El Rahman, MA; Haase, D; Rentzsch, A; Olchvary, J; Schafers, HJ; Henn, W; Wagenpfeil, S; Abdul-Khaliq, H				El Rahman, Mohamed Abd; Haase, Denise; Rentzsch, Axel; Olchvary, Julia; Schaefers, Hans-Joachim; Henn, Wolfram; Wagenpfeil, Stefan; Abdul-Khaliq, Hashim			Left Ventricular Systolic Dysfunction in Asymptomatic Marfan Syndrome Patients Is Related to the Severity of Gene Mutation: Insights from the Novel Three Dimensional Speckle Tracking Echocardiography	PLOS ONE			English	Article							EJECTION FRACTION; STRAIN; ADULTS; HEART; IMPAIRMENT; MECHANICS; CHILDREN; VOLUMES; DISEASE; FBN1	Background In asymptomatic Marfan syndrome (MFS) patients we evaluated the relationship between the types of fibrillin-1 (FBN1) gene mutation and possible altered left ventricular (LV) function as assessed by three-dimensional speckle tracking echocardiography (3D-STE). Methods and Results Forty-five MFS patients (mean age 24 +/- 15 years) and 40 age-matched healthy controls were studied. Genetic evaluation for the FBN1 gene was carried on 32 MFS patients. Gene mutation (n = 15, 47%) was classified as mild when the mutation resulted in nearly normally functioning protein, while mutations resulting in abnormally function protein were considered to be severe (n = 17, 53%). All patients and controls underwent 3D-STE for evaluation of LV function by an echocardiographer blinded to the results of the genetic testing. Compared to controls, MFS patients had significantly lower 3D-STE derived LV ejection fraction (EF, 57.43 +/- 7.51 vs. 62.69 +/- 4.76%, p = 0.0001), global LV longitudinal strain (LS, 14.85 +/- 2.89 vs. 17.90 +/- 2.01%, p = 0.0001), global LV circumferential strain (CS, 13.93 +/- 2.81 vs. 16.82 +/- 2.17%, p = 0.0001) and global LV area strain (AS, 25.76 +/- 4.43 vs. 30.51 +/- 2.61%, p = 0.0001). Apart from the global LV LS all these parameters were significantly lower in patients with severe gene mutation than in those with mild mutation (p<0.05). In the multivariate linear regression analysis only the type of mutation had a significant influence on the 3D-STE derived LVEF (p = 0.017), global CS (p = 0.005) and global AS (p = 0.03). Conclusions In asymptomatic MFS patients latent LV dysfunction can be detected using 3D STE. The LV dysfunction is mainly related to the severity of gene mutation, suggesting possible primary cardiomyopathy in MFS patients.	[El Rahman, Mohamed Abd; Haase, Denise; Rentzsch, Axel; Olchvary, Julia; Abdul-Khaliq, Hashim] Saarland Univ Hosp, Dept Pediat Cardiol, Homburg, Germany; [El Rahman, Mohamed Abd] Cairo Univ, Dept Pediat Cardiol, Cairo, Egypt; [Schaefers, Hans-Joachim] Saarland Univ Hosp, Dept Thorac & Cardiovasc Surg, Homburg, Germany; [Henn, Wolfram] Saarland Univ Hosp, Dept Human Genet, Homburg, Germany; [Wagenpfeil, Stefan] Saarland Univ Hosp, Inst Med Biometry Epidemiol & Med Informat, Homburg, Germany	Universitatsklinikum des Saarlandes; Egyptian Knowledge Bank (EKB); Cairo University; Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes	Abdul-Khaliq, H (corresponding author), Saarland Univ Hosp, Dept Pediat Cardiol, Homburg, Germany.	hashim.abdul-khaliq@uks.eu	Henn, Wolfram/AAU-1608-2020		Competence Network for Congenital Heart Defects - Federal Ministry of Education and Research (BMBF), Germany	Competence Network for Congenital Heart Defects - Federal Ministry of Education and Research (BMBF), Germany	This work was supported by the Competence Network for Congenital Heart Defects funded by the Federal Ministry of Education and Research (BMBF), Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El Rahman M, 2014, CARDIOL YOUNG, P1; Alpendurada F, 2010, EUR J HEART FAIL, V12, P1085, DOI 10.1093/eurjhf/hfq127; Aune E, 2009, EUR J ECHOCARDIOGR, V10, P738, DOI 10.1093/ejechocard/jep054; Cameli M, 2012, CARDIOVASC ULTRASOUN, V10, DOI 10.1186/1476-7120-10-4; Cameli M, 2010, CARDIOVASC ULTRASOUN, V8, DOI 10.1186/1476-7120-8-14; Collod-Beroud G, 2003, HUM MUTAT, V22, P199, DOI 10.1002/humu.10249; Cook JR, 2014, J CLIN INVEST, V124, P1329, DOI 10.1172/JCI71059; Creemers EE, 2011, CARDIOVASC RES, V89, P265, DOI 10.1093/cvr/cvq308; Das BB, 2006, PEDIATR CARDIOL, V27, P256, DOI 10.1007/s00246-005-1139-5; De Backer JF, 2006, INT J CARDIOL, V112, P353, DOI 10.1016/j.ijcard.2005.10.010; de Witte P, 2011, HEART, V97, P2063, DOI 10.1136/heartjnl-2011-300169; DePaepe A, 1996, AM J MED GENET, V62, P417, DOI 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R; DIETZ HC, 1995, HUM MOL GENET, V4, P1799, DOI 10.1093/hmg/4.suppl_1.1799; DIETZ HC, 1991, GENOMICS, V9, P355, DOI 10.1016/0888-7543(91)90264-F; Hansegard J, 2009, CARDIOVASC ULTRASOUN, V7, DOI 10.1186/1476-7120-7-18; HATLE L, 1984, HERZ, V9, P213; Judge DP, 2005, LANCET, V366, P1965, DOI 10.1016/S0140-6736(05)67789-6; Kiotsekoglou A, 2011, ECHOCARDIOGR-J CARD, V28, P416, DOI 10.1111/j.1540-8175.2010.01359.x; Kiotsekoglou A, 2010, HELL J CARDIOL, V51, P501; Kleijn SA, 2012, EUR HEART J-CARD IMG, V13, P159, DOI 10.1093/ejechocard/jer174; Kleijn SA, 2011, J AM SOC ECHOCARDIOG, V24, P314, DOI 10.1016/j.echo.2011.01.014; Li RK, 1997, CIRCULATION, V96, P874; Miyoshi T, 2014, ECHOCARDIOGR-J CARD, V31, P848, DOI 10.1111/echo.12473; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; NISHIMURA RA, 1989, MAYO CLIN PROC, V64, P71, DOI 10.1016/S0025-6196(12)65305-1; Park Jae-Hyeong, 2011, J Cardiovasc Ultrasound, V19, P169, DOI 10.4250/jcu.2011.19.4.169; Pyeritz RE, 2009, HEART, V95, P173, DOI 10.1136/hrt.2008.160515; Riesenkampff E, 2010, AM J PHYSIOL-HEART C, V299, pH364, DOI 10.1152/ajpheart.00264.2010; ROMAN MJ, 1989, AM J CARDIOL, V63, P317, DOI 10.1016/0002-9149(89)90338-X; Rybczynski M, 2007, CLIN CARDIOL, V30, P19, DOI 10.1002/clc.3; SANCHEZQUINTANA D, 1995, ANAT RECORD, V243, P483, DOI 10.1002/ar.1092430411; SAVOLAINEN A, 1994, EUR HEART J, V15, P625, DOI 10.1093/oxfordjournals.eurheartj.a060558; Seguela PE, 2012, ECHOCARDIOGR-J CARD, V29, P492, DOI 10.1111/j.1540-8175.2011.01596.x; SILVERMAN DI, 1995, J AM COLL CARDIOL, V26, P1062, DOI 10.1016/0735-1097(95)00258-0; Tei C, 1995, J Cardiol, V26, P135; Urbano-Moral JA, 2013, EUR HEART J-CARD IMG, V14, P1167, DOI 10.1093/ehjci/jet065; Vahanian A, 2007, EUR HEART J, V28, P230, DOI 10.1093/eurheartj/ehl428; VRACKO R, 1990, J MOL CELL CARDIOL, V22, P749, DOI 10.1016/0022-2828(90)90087-I; Wen HL, 2011, EUR J ECHOCARDIOGR, V12, P910, DOI 10.1093/ejechocard/jer162; Xu TY, 2014, INT J CARDIOL, V176, P360, DOI 10.1016/j.ijcard.2014.07.015; Yetman AT, 2003, J AM COLL CARDIOL, V41, P329, DOI 10.1016/S0735-1097(02)02699-2; Yu HK, 2013, J AM SOC ECHOCARDIOG, V26, P846, DOI 10.1016/j.echo.2013.04.018	42	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124112	10.1371/journal.pone.0124112	http://dx.doi.org/10.1371/journal.pone.0124112			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901601	gold, Green Submitted, Green Published			2022-12-26	WOS:000353331500077
J	Gitter, F; Gross, M; Piller, WE				Gitter, Frank; Gross, Martin; Piller, Werner E.			Sub-Decadal Resolution in Sediments of Late Miocene Lake Pannon Reveals Speciation of Cyprideis (Crustacea, Ostracoda)	PLOS ONE			English	Article							TOROSA CRUSTACEA; FLOCK CRUSTACEA; EVOLUTION; JONES; TANGANYIKA; SALINITY; EUROPE; BASIN; SHAPE	Late Miocene "Lake Pannon" (similar to 11.3 Ma) was a remnant of the Central Paratethyan Sea. Successive freshening and constantly changing environmental conditions, like oxygenation, nutrition and substrate led to a well-documented radiation in molluscs and ostracods. Among ostracods (small crustaceans), Cyprideis is one of the most common genera in "Lake Pannon", as well as in several other ancient lakes, showing numerous adaptations and speciations. Here, we present high-resolution data from an early transgression of "Lake Pannon" in the Eastern Styrian Basin (SE Austria). Mataschen clay pit is in the focus of geologic and paleontologic research since 20 years and its geologic and paleoecologic evolution is well-documented. We drilled five cores covering a similar to 2.3 m long section and completely sampled it in 5-mm thick intervals to reconstruct minute changes in the ostracod fauna over a transgression of a brackish water body. The dominant genus, Cyprideis, is represented by three species C. mataschensis, C. kapfensteinensis and C. ex gr. pannonica. Through morphometric analyses we highlight the variance of each taxon and suggest that there is no direct ecologic control on size or shape. Furthermore, we found a second, cooccurring morphotype of C. kapfensteinensis which is directly related to an elevation of salinities above 13 psu. The presence of two intermediate specimens between the two morphotypes in the sample directly below the first appearance of C. kapfensteinensis B leads us to the conclusion that we are facing a speciation event leading to four sympatric species of Cyprideis.	[Gitter, Frank; Gross, Martin] Universalmuseum Joanneum, Dept Geol & Palaeontol, A-8045 Graz, Austria; [Gitter, Frank; Piller, Werner E.] Graz Univ, Inst Earth Sci, NAWI Graz, A-8010 Graz, Austria	University of Graz	Piller, WE (corresponding author), Graz Univ, Inst Earth Sci, NAWI Graz, Heinrichstr 26, A-8010 Graz, Austria.	werner.piller@uni-graz.at		Gross, Martin/0000-0002-5113-6069; Piller, Werner E./0000-0003-2808-4720	Austrian Science Fund (FWF) [P21748-N21]; Austrian Science Fund (FWF) [P 21748] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work is financed through the Austrian Science Fund (http://www.fwf.ac.at/; FWF-project P21748-N21). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello G, 2007, ACTA PALAEONTOL POL, V52, P563; ALADIN NV, 1993, OSTRACODA IN THE EARTH AND LIFE SCIENCES, P387; Aladin NV, 1996, J COMP PHYSIOL B, V166, P215, DOI 10.1007/BF00263985; Baltanas A, 1998, SEX AND PARTHENOGENESIS, P127; Baltanas A, 2000, HYDROBIOLOGIA, V419, P65, DOI 10.1023/A:1003994209369; Baltanas Angel, 2011, Joannea Geologie und Palaeontologie, V11, P235; BaltanuYs A., 2003, PALEONTOLOGICAL SOC, V9, P101, DOI DOI 10.1017/S1089332600002175; Bassiouni M.A., 1979, Geologisches Jahrbuch Reihe B, V31, P3; Bodergat AM, 1983, DOCUMENTS LAB GEOLOG, V88; Boomer I, 2011, JOANNEA GEOLOGIE PAL, V11, P26; COHEN A S, 1987, Palaios, V2, P426, DOI 10.2307/3514614; Cristescu ME, 2010, MOL ECOL, V19, P4837, DOI 10.1111/j.1365-294X.2010.04832.x; Danielopol Dan L., 2011, Joannea Geologie und Palaeontologie, V11, P273; Danielopol Dan L., 2008, Senckenbergiana Lethaea, V88, P147; Danielopol DL, 2008, CONTRIBUTION GEOMETR, P13; Decima A., 1964, Palaeontographia Italica, V57, P81; Elewa AMT, 2003, PALAEONT ELEC, V6, P11; Frenzel P, 2012, INT REV HYDROBIOL, V97, P314, DOI 10.1002/iroh.201211494; Gamenick I, 1996, MAR ECOL PROG SER, V144, P73, DOI 10.3354/meps144073; Gavrilets S, 2005, P NATL ACAD SCI USA, V102, P18040, DOI 10.1073/pnas.0506330102; Gross M., 2003, OSTERR AKAD WISS SCH, P11; Gross M, 2013, J S AM EARTH SCI, V42, P216, DOI 10.1016/j.jsames.2012.10.002; Gross M, 2011, PALAEOGEOGR PALAEOCL, V312, P181, DOI 10.1016/j.palaeo.2011.10.010; Gross Martin, 2008, Senckenbergiana Lethaea, V88, P161; Gross MD, 2004, PHARM BIOL, V42, P1, DOI 10.1080/13880200490893546; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HEIP C, 1976, OECOLOGIA, V24, P229, DOI 10.1007/BF00345475; Iepure S, 2007, HYDROBIOLOGIA, V585, P159, DOI 10.1007/s10750-007-0636-3; Jahn A, 1996, MAR ECOL PROG SER, V142, P215, DOI 10.3354/meps142215; Jones T.R., 1857, MONOGRAPH PALAEONTOG, V9, P1; Jones T.R., 1850, ANN MAGA ZINE NATURA, V6, P25; Kern AK, 2012, PALAEOGEOGR PALAEOCL, V317, P1, DOI 10.1016/j.palaeo.2011.11.021; Keyser D, 2005, HYDROBIOLOGIA, V538, P95, DOI 10.1007/s10750-004-4940-x; Keyser Dietmar, 2004, Studia Quaternaria, V21, P19; Kollmann K., 1960, Oesterreich Mitt geol Ges Wien, V51, P89; Krstic N., 1968, B MUSEUM HIST NATU A, V23, P153; Krstic N., 1968, B MUS HIST NAT BEL A, V23, P107; Ligios Silvia, 2012, Revue de Micropaleontologie, V55, P171, DOI 10.1016/j.revmic.2012.09.002; Linhart J, 2007, MORPHOMATICA VERSION; Martens K, 1997, TRENDS ECOL EVOL, V12, P177, DOI 10.1016/S0169-5347(97)01039-2; Matz H., 1970, Senckenbergiana Lethaea, V51, P1; Mehes G., 1908, FOLDTANI KOZLONY S, V38, P601; Meisch C, 2000, SUSSWASSERFAUNA MITT, V8, P522; Munoz-Torres FA, 2006, J S AM EARTH SCI, V21, P75, DOI 10.1016/j.jsames.2005.08.005; Namiotko T, 2012, INT REV HYDROBIOL, V97, P356, DOI 10.1002/iroh.201211496; Neubauer W, 2007, THESIS SALZBURG; Pint A, 2012, INT REV HYDROBIOL, V97, P330, DOI 10.1002/iroh.201111495; Reyment RA, 1997, B MATH BIOL, V59, P63; Reyment Richard A., 1993, Revista Espanola de Paleontologia, V8, P125; Rohlf FJ, 2009, TPSDIG DIGITIZE LAND; Rosenfeld A., 1976, ASPECTS ECOLOGY ZOOG, P55; Sames B, 2009, THESIS BERLIN; Sandberg P. A., 1964, Stockholm Contributions in Geology, V12, P1; Schon I, 2012, HYDROBIOLOGIA, V682, P91, DOI 10.1007/s10750-011-0935-6; SCHWEITZER PN, 1990, PALEOBIOLOGY, V16, P107, DOI 10.1017/S0094837300009830; Tanaka G, 2009, BIOL J LINN SOC, V97, P810, DOI 10.1111/j.1095-8312.2009.01222.x; van Harten D, 2000, HYDROBIOLOGIA, V419, P131, DOI 10.1023/A:1003935419364; Van Morkhoven FPCM, 1962, POSTPALAEOZOIC OSTRA, DOI [10.2108/zsj.26.846, DOI 10.2108/ZSJ.26.846]; VANHARTEN D, 1975, PALAEOGEOGR PALAEOCL, V17, P35, DOI 10.1016/0031-0182(75)90028-0; Vesper B., 1972, Mus lnst, V68, P21; Wesselingh Frank P., 2007, V29, P275; Whatley Robin, 1998, Bulletin Centre de Recherches Exploration-Production Elf-Aquitaine Memoire, V20, P231; Wouters K, 2001, HYDROBIOLOGIA, V450, P111, DOI 10.1023/A:1017547523121; Wouters Karel, 2008, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V78, P29	64	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0109360	10.1371/journal.pone.0109360	http://dx.doi.org/10.1371/journal.pone.0109360			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902063	gold, Green Submitted, Green Published			2022-12-26	WOS:000353331500001
J	Gonzalez-Rodriguez, D; Barakat, AI				Gonzalez-Rodriguez, David; Barakat, Abdul I.			Dynamics of Receptor-Mediated Nanoparticle Internalization into Endothelial Cells	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; ATOMIC-FORCE MICROSCOPY; SHEAR-STRESS; VISCOELASTIC PROPERTIES; NONSPHERICAL PARTICLES; MEMBRANE TENSION; ICAM-1; FLOW; ENDOCYTOSIS; SHAPE	Nanoparticles offer a promising medical tool for targeted drug delivery, for example to treat inflamed endothelial cells during the development of atherosclerosis. To inform the design of such therapeutic strategies, we develop a computational model of nanoparticle internalization into endothelial cells, where internalization is driven by receptor-ligand binding and limited by the deformation of the cell membrane and cytoplasm. We specifically consider the case of nanoparticles targeted against ICAM-1 receptors, of relevance for treating atherosclerosis. The model computes the kinetics of the internalization process, the dynamics of binding, and the distribution of stresses exerted between the nanoparticle and the cell membrane. The model predicts the existence of an optimal nanoparticle size for fastest internalization, consistent with experimental observations, as well as the role of bond characteristics, local cell mechanical properties, and external forces in the nanoparticle internalization process.	[Gonzalez-Rodriguez, David; Barakat, Abdul I.] Ecole Polytech, CNRS, UMR 7646, Lab Hydrodynam LadHyX, F-91128 Palaiseau, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Institut Polytechnique de Paris	Gonzalez-Rodriguez, D (corresponding author), Ecole Polytech, CNRS, UMR 7646, Lab Hydrodynam LadHyX, F-91128 Palaiseau, France.	davidgr@alum.mit.edu; barakat@ladhyx.polytechnique.fr	Gonzalez-Rodriguez, David/AAY-7037-2021; Barakat, Abdul I/AAI-3117-2020	Barakat, Abdul I/0000-0002-7551-3631	Fondation pour la Recherche Medicale-France; AXA Research Fund	Fondation pour la Recherche Medicale-France(Fondation pour la Recherche Medicale); AXA Research Fund(AXA Research Fund)	The work was supported by the following: Fondation pour la Recherche Medicale-France (http://www.frm.org/); and AXA Research Fund (http://www.axa-research.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal NJ, 2007, J PHYS CHEM C, V111, P15848, DOI 10.1021/jp074514x; Albanese A, 2012, ANNU REV BIOMED ENG, V14, P1, DOI [10.1146/annurev-bioeng-071811-150124, 10.1146/annurev.bioeng-071811-150124]; Bahrami AH, 2014, ADV COLLOID INTERFAC, V208, P214, DOI 10.1016/j.cis.2014.02.012; Barreiro O, 2008, J CELL BIOL, V183, P527, DOI 10.1083/jcb.200805076; BELL GI, 1984, BIOPHYS J, V45, P1051, DOI 10.1016/S0006-3495(84)84252-6; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Bhowmick T, 2012, J CONTROL RELEASE, V157, P485, DOI 10.1016/j.jconrel.2011.09.067; Boulant S, 2011, NAT CELL BIOL, V13, P1124, DOI 10.1038/ncb2307; Calderon AJ, 2011, J CONTROL RELEASE, V150, P37, DOI 10.1016/j.jconrel.2010.10.025; Calderon AJ, 2009, BIORHEOLOGY, V46, P323, DOI 10.3233/BIR-2009-0544; CASASNOVAS JM, 1995, J BIOL CHEM, V270, P13216, DOI 10.1074/jbc.270.22.13216; Chang KC, 2000, P NATL ACAD SCI USA, V97, P11262, DOI 10.1073/pnas.200240897; Chaudhuri A, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/4/046002; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; Dasgupta S, 2014, NANO LETT, V14, P687, DOI 10.1021/nl403949h; Dasgupta S, 2013, SOFT MATTER, V9, P5473, DOI 10.1039/c3sm50351h; Decuzzi P, 2008, BIOPHYS J, V94, P3790, DOI 10.1529/biophysj.107.120238; DEMBO M, 1988, PROC R SOC SER B-BIO, V234, P55, DOI 10.1098/rspb.1988.0038; Evans E, 2010, BIOPHYS J, V98, P1458, DOI 10.1016/j.bpj.2009.09.067; Fery A, 2003, CR PHYS, V4, P259, DOI 10.1016/S1631-0705(03)00030-6; Gao HJ, 2005, P NATL ACAD SCI USA, V102, P9469, DOI 10.1073/pnas.0503879102; Han JY, 2012, ACS NANO, V6, P8824, DOI 10.1021/nn302687n; Jaskiewicz K, 2012, ACS NANO, V6, P7254, DOI 10.1021/nn302367m; Koay EJ, 2003, J BIOMECH ENG-T ASME, V125, P334, DOI 10.1115/1.1572517; Le Bihan O, 2009, J STRUCT BIOL, V168, P419, DOI 10.1016/j.jsb.2009.07.006; Li XL, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3502489; Liu J, 2010, P NATL ACAD SCI USA, V107, P16530, DOI 10.1073/pnas.1006611107; MacDonald C, 2012, PHARM RES-DORDR, V29, P1270, DOI 10.1007/s11095-011-0663-7; Mathur AB, 2001, J BIOMECH, V34, P1545, DOI 10.1016/S0021-9290(01)00149-X; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Mirigian S, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4813921; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Muro S, 2003, J CELL SCI, V116, P1599, DOI 10.1242/jcs.00367; Muro S, 2008, MOL THER, V16, P1450, DOI 10.1038/mt.2008.127; Muro S, 2006, J PHARMACOL EXP THER, V317, P1161, DOI 10.1124/jpet.105.098970; Muzykantov VR, 2013, ISRN VASC MED, V2013, DOI [10.1155/2013/916254, DOI 10.1155/2013/916254]; Pierres A, 2002, BIOPHYS J, V82, P3214, DOI 10.1016/S0006-3495(02)75664-6; Raatz M, 2014, SOFT MATTER, V10, P3570, DOI 10.1039/c3sm52498a; Raucher D, 2000, J CELL BIOL, V148, P127, DOI 10.1083/jcb.148.1.127; Sato M, 1996, J BIOMECH, V29, P461, DOI 10.1016/0021-9290(95)00069-0; Sato M, 2000, J BIOMECH, V33, P127, DOI 10.1016/S0021-9290(99)00178-5; SATO M, 1990, J BIOMECH ENG-T ASME, V112, P263, DOI 10.1115/1.2891183; Schiavo VL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044070, DOI 10.1371/JOURNAL.PONE.0044070]; Seifert U, 2000, PHYS REV LETT, V84, P2750, DOI 10.1103/PhysRevLett.84.2750; Serrano D, 2012, ARTERIOSCL THROM VAS, V32, P1178, DOI 10.1161/ATVBAHA.111.244186; Verdier C, 2009, J MATH BIOL, V58, P235, DOI 10.1007/s00285-008-0164-4; Yi X, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.098101; Yue TT, 2011, SOFT MATTER, V7, P9104, DOI 10.1039/c1sm05398a; Zhou XM, 2006, MECH AGEING DEV, V127, P779, DOI 10.1016/j.mad.2006.07.003	49	13	13	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0122097	10.1371/journal.pone.0122097	http://dx.doi.org/10.1371/journal.pone.0122097			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901833	gold, Green Published, Green Submitted			2022-12-26	WOS:000353331500015
J	Iacono, MI; Neufeld, E; Akinnagbe, E; Bower, K; Wolf, J; Oikonomidis, IV; Sharma, D; Lloyd, B; Wilm, BJ; Wyss, M; Pruessmann, KP; Jakab, A; Makris, N; Cohen, ED; Kuster, N; Kainz, W; Angelone, LM				Iacono, Maria Ida; Neufeld, Esra; Akinnagbe, Esther; Bower, Kelsey; Wolf, Johanna; Oikonomidis, Ioannis Vogiatzis; Sharma, Deepika; Lloyd, Bryn; Wilm, Bertram J.; Wyss, Michael; Pruessmann, Klaas P.; Jakab, Andras; Makris, Nikos; Cohen, Ethan D.; Kuster, Niels; Kainz, Wolfgang; Angelone, Leonardo M.			MIDA: A Multimodal Imaging-Based Detailed Anatomical Model of the Human Head and Neck	PLOS ONE			English	Article							INDUCED CURRENT DENSITIES; REALISTIC ANTHROPOMORPHIC PHANTOM; MONTE-CARLO CALCULATIONS; ADULT VOXEL PHANTOM; CONVERSION COEFFICIENTS; ABSORBED FRACTIONS; COLOR PHOTOGRAPHS; PREGNANT-WOMEN; RESOLUTION; FIELD	Computational modeling and simulations are increasingly being used to complement experimental testing for analysis of safety and efficacy of medical devices. Multiple voxel- and surface-based whole-and partial-body models have been proposed in the literature, typically with spatial resolution in the range of 1-2 mm and with 10-50 different tissue types resolved. We have developed a multimodal imaging-based detailed anatomical model of the human head and neck, named "MIDA". The model was obtained by integrating three different magnetic resonance imaging (MRI) modalities, the parameters of which were tailored to enhance the signals of specific tissues: i) structural T1- and T2-weighted MRIs; a specific heavily T2-weighted MRI slab with high nerve contrast optimized to enhance the structures of the ear and eye; ii) magnetic resonance angiography (MRA) data to image the vasculature, and iii) diffusion tensor imaging (DTI) to obtain information on anisotropy and fiber orientation. The unique multimodal high-resolution approach allowed resolving 153 structures, including several distinct muscles, bones and skull layers, arteries and veins, nerves, as well as salivary glands. The model offers also a detailed characterization of eyes, ears, and deep brain structures. A special automatic atlas-based segmentation procedure was adopted to include a detailed map of the nuclei of the thalamus and midbrain into the head model. The suitability of the model to simulations involving different numerical methods, discretization approaches, as well as DTI-based tensorial electrical conductivity, was examined in a case-study, in which the electric field was generated by transcranial alternating current stimulation. The voxel- and the surface-based versions of the models are freely available to the scientific community.	[Iacono, Maria Ida; Akinnagbe, Esther; Bower, Kelsey; Cohen, Ethan D.; Kainz, Wolfgang; Angelone, Leonardo M.] US FDA, Ctr Devices & Radiol Hlth, Off Sci & Engn Labs, Div Biomed Phys, Silver Spring, MD 20993 USA; [Neufeld, Esra; Wolf, Johanna; Oikonomidis, Ioannis Vogiatzis; Sharma, Deepika; Lloyd, Bryn; Kuster, Niels] ITIS Fdn Res Informat Technol Soc, Zurich, Switzerland; [Wolf, Johanna; Oikonomidis, Ioannis Vogiatzis; Sharma, Deepika; Kuster, Niels] Swiss Fed Inst Technol, CH-8092 Zurich, Switzerland; [Wilm, Bertram J.; Wyss, Michael; Pruessmann, Klaas P.] Univ Zurich, Inst Biomed Engn, Zurich, Switzerland; [Wilm, Bertram J.; Wyss, Michael; Pruessmann, Klaas P.] Swiss Fed Inst Technol, Zurich, Switzerland; [Jakab, Andras] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Computat Imaging Res Lab, Vienna, Austria; [Jakab, Andras] Swiss Fed Inst Technol, Comp Vision Lab, Zurich, Switzerland; [Makris, Nikos] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Athinoula Martinos Ctr Biomed Imaging,Dept Radiol, Charlestown, MA 02129 USA; [Makris, Nikos] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Morphometr Anal,Dept Psychiat & Neurol, Charlestown, MA 02129 USA	US Food & Drug Administration (FDA); Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Medical University of Vienna; Swiss Federal Institutes of Technology Domain; ETH Zurich; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Angelone, LM (corresponding author), US FDA, Ctr Devices & Radiol Hlth, Off Sci & Engn Labs, Div Biomed Phys, Silver Spring, MD 20993 USA.	Leonardo.angelone@fda.hhs.gov	/AAB-9109-2019; Jakab, András/U-9436-2019; Pruessmann, Klaas P/H-5385-2018	Jakab, András/0000-0001-6291-9889; Pruessmann, Klaas P/0000-0003-0009-8362; COHEN, ETHAN/0000-0001-6365-2266; Kuster, Niels/0000-0002-5827-3728; Angelone, Leonardo/0000-0002-1105-021X; Sharma, Deepika/0000-0001-5445-7274	National Institute of Biomedical Imaging and Bioengineering at the National Institutes of Health [1R21EB016449-01A1]; U.S. Food and Drug Administration; CTI [14930.1 PFLS-LS]; Center for Devices and Radiological Health; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB016449] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); U.S. Food and Drug Administration; CTI; Center for Devices and Radiological Health; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This research was supported in part by the National Institute of Biomedical Imaging and Bioengineering at the National Institutes of Health (1R21EB016449-01A1), in part by the U.S. Food and Drug Administration's Critical Path Initiative, in part by CTI (14930.1 PFLS-LS), and in part by the Research Participation Program at the Center for Devices and Radiological Health administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and the U.S. Food and Drug Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman MJ, 1998, P IEEE, V86, P504, DOI 10.1109/5.662875; ADAIR ER, 1983, MICROWAVES THERMOREG; Bolch WE, 1999, J NUCL MED, V40, p11S; Caon M, 2000, RADIAT PROT DOSIM, V90, P445, DOI 10.1093/oxfordjournals.rpd.a033172; CDRH, 2011, FDA SCI REP; Chen XL, 2010, IEEE INT SYMP ELEC, P702, DOI 10.1109/ISEMC.2010.5711363; Cheng S-W, 2007, ARXIV07121959; Christ A, 2010, PHYS MED BIOL, V55, pN23, DOI 10.1088/0031-9155/55/2/N01; COLEMAN GB, 1979, P IEEE, V67, P773, DOI 10.1109/PROC.1979.11327; Damsgaard M, 2006, SIMUL MODEL PRACT TH, V14, P1100, DOI 10.1016/j.simpat.2006.09.001; Deoni SCL, 2007, NEUROIMAGE, V34, P117, DOI 10.1016/j.neuroimage.2006.09.016; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Dimbylow P, 2005, PHYS MED BIOL, V50, P1047, DOI 10.1088/0031-9155/50/6/002; DIMBYLOW PJ, 1994, PHYS MED BIOL, V39, P1537, DOI 10.1088/0031-9155/39/10/003; Dimbylow PJ, 1997, PHYS MED BIOL, V42, P479, DOI 10.1088/0031-9155/42/3/003; DIMBYLOW PJ, 1991, PHYS MED BIOL, V36, P1075, DOI 10.1088/0031-9155/36/8/004; Dimbylow PJ, 1998, PHYS MED BIOL, V43, P221, DOI 10.1088/0031-9155/43/2/001; DUBUISSON MP, 1994, INT C PATT RECOG, P566, DOI 10.1109/ICPR.1994.576361; ELLETT WH, 1964, BRIT J RADIOL, V37, P45, DOI 10.1259/0007-1285-37-433-45; Fill UA, 2004, HEALTH PHYS, V86, P253, DOI 10.1097/00004032-200403000-00003; Gabriel S, 1996, PHYS MED BIOL, V41, P2251, DOI 10.1088/0031-9155/41/11/002; Gjonaj E, 2002, IEEE T MAGN, V38, P357, DOI 10.1109/20.996096; Gosselin M, 2014, PHYS MED BI IN PRESS; Gullmar D, 2010, NEUROIMAGE, V51, P145, DOI 10.1016/j.neuroimage.2010.02.014; HARALICK RM, 1987, IEEE T PATTERN ANAL, V9, P532, DOI 10.1109/TPAMI.1987.4767941; Hart F, 1988, MODERN BIOELECTRICIT, V281, P343; HENNIG J, 1988, J MAGN RESON, V78, P397, DOI 10.1016/0022-2364(88)90128-X; Iacono MI, 2014, IEEE ENG MED BIO, P6258, DOI 10.1109/EMBC.2014.6945059; Iacono MI, 2013, COMP MATH MATH PHYS, V2013, P12; Irarrazabal P, 1996, MAGNET RESON MED, V35, P278, DOI 10.1002/mrm.1910350221; Jakab A, 2012, AM J NEURORADIOL, V33, P2110, DOI 10.3174/ajnr.A3140; Jezzard P, 1998, MAGNET RESON MED, V39, P801, DOI 10.1002/mrm.1910390518; Jones DG, 1998, RADIAT PROT DOSIM, V79, P411, DOI 10.1093/oxfordjournals.rpd.a032439; Jones DG, 1997, RADIAT PROT DOSIM, V72, P21, DOI 10.1093/oxfordjournals.rpd.a032072; Kainz W, 2003, PHYS MED BIOL, V48, P2551, DOI 10.1088/0031-9155/48/15/319; Kitware Inc, VISUALIZATION TOOLKI; Kramer R, 2004, PHYS MED BIOL, V49, P5203, DOI 10.1088/0031-9155/49/23/001; Kramer R, 2003, PHYS MED BIOL, V48, P1239, DOI 10.1088/0031-9155/48/10/301; Krauth A, 2010, NEUROIMAGE, V49, P2053, DOI 10.1016/j.neuroimage.2009.10.042; Kyriakou A, 2013, INT J HYPERTHER, P1; Laakso I, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/4/046009; Lalys F, 2010, NEUROIMAGE, V49, P345, DOI 10.1016/j.neuroimage.2009.08.007; Lee C, 2004, MED PHYS, V31, P1017, DOI 10.1118/1.1689013; Leng J, 2012, P 20 INT MESH ROUNDT, P347, DOI DOI 10.1007/978-3-642-24734-7_19; LIN JC, 1973, IEEE T MICROW THEORY, VMT21, P791, DOI 10.1109/TMTT.1973.1128133; Makris N, 2008, MED BIOL ENG COMPUT, V46, P1239, DOI 10.1007/s11517-008-0414-z; Margulies S.S., 1987, THESIS; Mason PA, 2000, IEEE T MICROW THEORY, V48, P2050, DOI 10.1109/22.884194; Mattiello J, 1997, MAGNET RESON MED, V37, P292, DOI 10.1002/mrm.1910370226; McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P589, DOI 10.1016/j.clinph.2003.10.033; Mitsuhashi N, 2009, NUCLEIC ACIDS RES, V37, pD782, DOI 10.1093/nar/gkn613; Morel A., 2007, STEREOTACTIC ATLAS H, DOI 10.3109/9781420016796; Nagaoka T, 2004, PHYS MED BIOL, V49, P1, DOI 10.1088/0031-9155/49/1/001; NEUFELD E, 2008, THESIS SWISS FEDERAL; Nikita KS, 2000, IEEE T MICROW THEORY, V48, P2003, DOI 10.1109/22.884189; Nowinski WL, 2011, NEUROIMAGE, V55, P986, DOI 10.1016/j.neuroimage.2010.12.079; Nowinski WL, 2008, ACTA NEUROCHIR, V150, P1, DOI 10.1007/s00701-007-1270-6; Nowinski WL, 2000, IEEE T MED IMAGING, V19, P62, DOI 10.1109/42.832961; Park JS, 2005, IEEE T MED IMAGING, V24, P352, DOI 10.1109/TMI.2004.842454; Paulides MM, 2013, INT J HYPERTHER, V29, P346, DOI 10.3109/02656736.2013.790092; Petoussi-Henss N, 2002, PHYS MED BIOL, V47, P89, DOI 10.1088/0031-9155/47/1/307; Petoussi-Henss N, 1998, RADIAT PROT DOSIM, V79, P415, DOI 10.1093/oxfordjournals.rpd.a032440; Pham DL, 2000, ANNU REV BIOMED ENG, V2, P315, DOI 10.1146/annurev.bioeng.2.1.315; Pluim JPW, 2003, IEEE T MED IMAGING, V22, P986, DOI 10.1109/TMI.2003.815867; Pohle R, 2001, PROC SPIE, V4322, P1337, DOI 10.1117/12.431013; Pommert A, 2001, HIGHLY REALISTIC VOL; Powell S, 2008, NEUROIMAGE, V39, P238, DOI 10.1016/j.neuroimage.2007.05.063; Rao A, 2008, MED IMAGE ANAL, V12, P55, DOI 10.1016/j.media.2007.06.006; RAYA SP, 1990, IEEE T MED IMAGING, V9, P32, DOI 10.1109/42.52980; Rineau L, 2007, COMP GEOM-THEOR APPL, V38, P100, DOI 10.1016/j.comgeo.2006.11.008; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Saito K, 2001, RADIAT ENVIRON BIOPH, V40, P69, DOI 10.1007/s004110000082; Sato K, 2007, RADIAT PROT DOSIM, V123, P337, DOI 10.1093/rpd/ncl101; Sato K, 2009, J NUCL SCI TECHNOL, V46, P907, DOI [10.3327/jnst.46.907, 10.1080/18811248.2009.9711599]; Segars WP, 2010, MED PHYS, V37, P4902, DOI 10.1118/1.3480985; Stabin MG, 2002, HEALTH PHYS, V82, P21, DOI 10.1097/00004032-200201000-00005; Staton RJ, 2003, PHYS MED BIOL, V48, P805, DOI 10.1088/0031-9155/48/7/301; Toga AW, 1997, COMPUT MED IMAG GRAP, V21, P131, DOI 10.1016/S0895-6111(96)00072-9; Tong P, 1989, 12 INT TECHN C SAF V, P617; Tuch DS, 2001, P NATL ACAD SCI USA, V98, P11697, DOI 10.1073/pnas.171473898; Tuch DS, 1997, NEUROIMAGE, V5, pS44; Viola P, 1997, INT J COMPUT VISION, V24, P137, DOI 10.1023/A:1007958904918; Warfield SK, 2004, IEEE T MED IMAGING, V23, P903, DOI 10.1109/TMI.2004.828354; WEIL CM, 1975, IEEE T BIO-MED ENG, V22, P468, DOI 10.1109/TBME.1975.324467; Wu DG, 2007, PHYS MED BIOL, V52, P5735, DOI 10.1088/0031-9155/52/19/001; Wu K-L, 2008, HIGH RESOLUTION ELEC; Wu TN, 2011, PHYS MED BIOL, V56, P2075, DOI 10.1088/0031-9155/56/7/011; Xu XG, 2000, HEALTH PHYS, V78, P476, DOI 10.1097/00004032-200005000-00003; Yelnik J, 2007, NEUROIMAGE, V34, P618, DOI 10.1016/j.neuroimage.2006.09.026; ZANKL M, 1988, RADIAT ENVIRON BIOPH, V27, P153, DOI 10.1007/BF01214605; Zankl M, 2003, RADIAT PROT DOSIM, V105, P539, DOI 10.1093/oxfordjournals.rpd.a006299; Zankl M, 2002, PHYS MED BIOL, V47, P2367, DOI 10.1088/0031-9155/47/14/301; Zankl M, 2001, RADIAT ENVIRON BIOPH, V40, P153, DOI 10.1007/s004110100094; Zhang BQ, 2007, RADIAT PROT DOSIM, V124, P130, DOI 10.1093/rpd/ncm184; Zhang SX, 2004, J ANAT, V204, P165, DOI 10.1111/j.0021-8782.2004.00274.x; ZUBAL IG, 1992, IMAGE VISION COMPUT, V10, P342, DOI 10.1016/0262-8856(92)90020-4; ZUBAL IG, 1994, MED PHYS, V21, P299, DOI 10.1118/1.597290	97	137	141	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124126	10.1371/journal.pone.0124126	http://dx.doi.org/10.1371/journal.pone.0124126			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901747	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000353331500078
J	Jakhetia, R; Verma, NK				Jakhetia, Richa; Verma, Naresh K.			Identification and Molecular Characterisation of a Novel Mu-Like Bacteriophage, SfMu, of Shigella flexneri	PLOS ONE			English	Article							CELL-WALL RECEPTOR; GENOME SEQUENCE; DNA INVERSION; BINDING; PROTEIN; GENES; SITE; RECOMBINATION; TRANSPOSITION; HAEMOPHILUS	S. flexneri is the leading cause of bacillary dysentery in the developing countries. Several temperate phages originating from this host have been characterised. However, all S. flexneri phages known to date are lambdoid phages, which have the ability to confer the O-antigen modification of their host. In this study, we report the isolation and characterisation of a novel Mu-like phage from a serotype 4a strain of S. flexneri. The genome of phage SfMu is composed of 37,146 bp and is predicted to contain 55 open reading frames (orfs). Comparative genome analysis of phage SfMu with Mu and other Mu-like phages revealed that SfMu is closely related to phage Mu, sharing >90% identity with majority of its proteins. Moreover, investigation of phage SfMu receptor on the surface of the host cell revealed that the O-antigen of the host serves as the receptor for the adsorption of phage SfMu. This study also demonstrates pervasiveness of SfMu phage in S. flexneri, by identifying complete SfMu prophage strains of serotype X and Y, and remnants of SfMu in strains belonging to 4 other serotypes, thereby indicating that transposable phages in S. flexneri are not uncommon. The findings of this study contribute an advance in our current knowledge of S. flexneri phages and will also play a key role in understanding the evolution of S. flexneri.	[Jakhetia, Richa; Verma, Naresh K.] Australian Natl Univ, Res Sch Biol, Div Biomed Sci & Biochem, Canberra, ACT 0200, Australia	Australian National University	Verma, NK (corresponding author), Australian Natl Univ, Res Sch Biol, Div Biomed Sci & Biochem, Canberra, ACT 0200, Australia.	naresh.verma@anu.edu.au	Verma, Naresh/C-9161-2009	Verma, Naresh/0000-0001-8109-2215				Adams MM, 2001, MICROBIOL-UK, V147, P851, DOI 10.1099/00221287-147-4-851; AKHVERDIAN VZ, 1984, GENETIKA+, V20, P1612; Allison GE, 2002, J BACTERIOL, V184, P1974, DOI 10.1128/JB.184.7.1974-1987.2002; BRADLEY DE, 1967, BACTERIOL REV, V31, P230, DOI 10.1128/MMBR.31.4.230-314.1967; BUKHARI AI, 1976, NATURE, V264, P580, DOI 10.1038/264580a0; Casjens S, 2004, J MOL BIOL, V339, P379, DOI 10.1016/j.jmb.2004.03.068; Comeau AM, 2007, VIROLOGY, V362, P384, DOI 10.1016/j.virol.2006.12.031; CRAIG NL, 1995, SCIENCE, V270, P253, DOI 10.1126/science.270.5234.253; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Dupont K, 2004, APPL ENVIRON MICROB, V70, P5818, DOI 10.1128/AEM.70.10.5818-5824.2004; FAELEN M, 1976, J MOL BIOL, V104, P525, DOI 10.1016/0022-2836(76)90118-2; Fogg PCM, 2011, VIROLOGY, V421, P211, DOI 10.1016/j.virol.2011.09.028; Gautheret D, 2001, J MOL BIOL, V313, P1003, DOI 10.1006/jmbi.2001.5102; GILL GS, 1981, J VIROL, V37, P420, DOI 10.1128/JVI.37.1.420-430.1981; GIPHARTGASSLER M, 1981, J MOL BIOL, V145, P139, DOI 10.1016/0022-2836(81)90338-7; Goudie AD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-615; GRUNDY FJ, 1985, VIROLOGY, V143, P485, DOI 10.1016/0042-6822(85)90388-5; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Heidelberg JF, 2002, NAT BIOTECHNOL, V20, P1118, DOI 10.1038/nbt749; IIDA S, 1986, CELL, V45, P71, DOI 10.1016/0092-8674(86)90539-8; Jakhetia R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-742; Jakhetia R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-677; KAMP D, 1981, MOL GEN GENET, V184, P564, DOI 10.1007/BF00352543; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Le S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068562; LINDBERG AA, 1988, VACCINE, V6, P146, DOI 10.1016/S0264-410X(88)80018-5; Mavris M, 1997, MOL MICROBIOL, V26, P939, DOI 10.1046/j.1365-2958.1997.6301997.x; MERTENS G, 1984, EMBO J, V3, P2415, DOI 10.1002/j.1460-2075.1984.tb02148.x; MIZUUCHI K, 1992, ANNU REV BIOCHEM, V61, P1011; MONTAG D, 1987, J MOL BIOL, V196, P165, DOI 10.1016/0022-2836(87)90519-5; Morgan GJ, 2002, J MOL BIOL, V317, P337, DOI 10.1006/jmbi.2002.5437; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SANDULACHE R, 1985, FEMS MICROBIOL LETT, V28, P307; SANDULACHE R, 1984, J BACTERIOL, V160, P299, DOI 10.1128/JB.160.1.299-303.1984; Santos SB, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-148; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; SCHMUCKER R, 1986, J GEN VIROL, V67, P1123, DOI 10.1099/0022-1317-67-6-1123; Summer EJ, 2004, J MOL BIOL, V340, P49, DOI 10.1016/j.jmb.2004.04.053; Sun QZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070238; Sun QZ, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-39; Symonds N., 1987, PHAGE MU; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANDEPUTTE P, 1980, NATURE, V286, P218, DOI 10.1038/286218a0; VOGEL JL, 1991, J BACTERIOL, V173, P6568, DOI 10.1128/jb.173.20.6568-6577.1991; Wang J, 2000, J BACTERIOL, V182, P508, DOI 10.1128/JB.182.2.508-512.2000; WANG XH, 1994, MOL MICROBIOL, V12, P665, DOI 10.1111/j.1365-2958.1994.tb01054.x; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; Zehr ES, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-331; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	49	12	12	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124053	10.1371/journal.pone.0124053	http://dx.doi.org/10.1371/journal.pone.0124053			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902138	Green Published, Green Submitted, gold			2022-12-26	WOS:000353331500073
J	Sondermann, W; Griewank, KG; Schilling, B; Livingstone, E; Leyh, JC; Rompoti, N; Cosgarea, I; Schimming, T; Schadendorf, D; Zimmer, L; Hillen, U				Sondermann, Wiebke; Griewank, Klaus G.; Schilling, Bastian; Livingstone, Elisabeth; Leyh, Julia C.; Rompoti, Natalia; Cosgarea, Ioana; Schimming, Tobias; Schadendorf, Dirk; Zimmer, Lisa; Hillen, Uwe			Corticosteroids Augment BRAF Inhibitor Vemurafenib Induced Lymphopenia and Risk of Infection	PLOS ONE			English	Article							LYMPHOCYTE SUBPOPULATIONS; METASTATIC MELANOMA; IPILIMUMAB; SURVIVAL; DABRAFENIB; SAFETY; ANTI-PD-1; THERAPY	We have previously demonstrated an impact of the BRAF inhibitor vemurafenib on patient lymphocyte counts. In the current study, the extent to which concomitant use of corticosteroids in BRAF inhibitor treated patients affects lymphocyte counts and predisposes to infection was investigated. A cohort of 102 patients receiving either the selective BRAF inhibitor vemurafenib or dabrafenib was analyzed. The amount of patients receiving either medication with or without systemic corticosteroids (dexamethasone) was determined and lymphocyte counts before and under therapy assessed. Additionally, the number and severity of infections occurring in these groups was analyzed. Vemurafenib treatment led to a considerable decrease in lymphocyte cell counts, with 62.3% of patients having lymphopenia. Dabrafenib treated patients only rarely demonstrated lymphopenia (12.5%). Dexamethasone co-administration further diminished lymphocyte counts. Lymphopenias were observed in 84.6% of patients receiving vemurafenib and dexamethasone. In our cohort, infections were noted in 9 patients, 4 of these were severe and 2 eventually fatal. All 9 cases with infections demonstrated lymphopenia, 8 of these had received dexamethasone and 7 of these a therapy with vemurafenib. Our findings demonstrate a significant lymphopenia in patients treated with the BRAF inhibitor vemurafenib, which is further augmented by dexamethasone and predisposes to infection. If validated in other studies, risk of infection should be considered when applying corticosteroids in combination with BRAF inhibitors, in particular vemurafenib.	[Griewank, Klaus G.] Univ Duisburg Essen, Univ Hosp Essen, West German Canc Ctr, Dept Dermatol, Essen, Germany; German Canc Consortium DKTK, Essen, Germany	University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ)	Griewank, KG (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, West German Canc Ctr, Dept Dermatol, Essen, Germany.	klaus.griewank@uk-essen.de; uwe.hillen@uk-essen.de	Livingstone, Elisabeth/AHE-9171-2022; Griewank, Klaus G/A-9097-2017; Schilling, Bastian/AAY-8646-2020; Zimmer, Lisa/AAP-8495-2021; Schadendorf, Dirk/AAE-8206-2019	Griewank, Klaus G/0000-0003-3899-9449; Schilling, Bastian/0000-0001-8859-4103; Zimmer, Lisa/0000-0002-3680-3521; 	Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	Wiebke Sondermann has received honoraria from Roche and travel support from Bristol-Myers Squibb. Bastian Schilling has received honoraria from Roche and travel support as well research funding from Bristol-Myers Squibb. Elisabeth Livingstone has received honoraria from Roche, Bristol-Myers Squibb, Amgen, Boehringer Ingelheim, Merck Sharp & Dohme, and Merck, and travel support from Bristol-Myers Squibb. Lisa Zimmer has received honoraria from Roche, Bristol-Myers Squibb, Boehringer Ingelheim and Amgen, and travel support from Merck Sharp & Dohme and Bristol-Myers Squibb. Uwe Hillen has received honoraria from Roche. Dirk Schadendorf is on the advisory board or has received honoraria from Roche, Genentech, Novartis, Amgen, GlaxoSmithKline, Bristol-Myers Squibb, Boehringer Ingelheim, and Merck Sharp & Dohme. The remaining authors have declared no conflicts of interest. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Boni A, 2010, CANCER RES, V70, P5213, DOI 10.1158/0008-5472.CAN-10-0118; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Danielli R, 2012, CANCER IMMUNOL IMMUN, V61, P41, DOI 10.1007/s00262-011-1089-0; Deichmann M, 2000, J EXP CLIN CANC RES, V19, P301; FAUCI AS, 1975, IMMUNOLOGY, V28, P669; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Lipson EJ, 2013, CLIN CANCER RES, V19, P462, DOI 10.1158/1078-0432.CCR-12-2625; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Ribas A, 2013, NEW ENGL J MED, V368, P1365, DOI 10.1056/NEJMc1302338; Robert C, 2015, NEW ENGL J MED, V372, P30, DOI 10.1056/NEJMoa1412690; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Schilling B, 2014, ANN ONCOL, V25, P747, DOI 10.1093/annonc/mdt587; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Siroy AE, 2014, J INVESTIGATIVE DERM; Topalian SL, 2014, J CLIN ONCOL, V32, P1020, DOI 10.1200/JCO.2013.53.0105; Wolchok JD, 2013, ANN ONCOL, V24, P2174, DOI 10.1093/annonc/mdt161; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Yamane H, 2014, J CLIN ONCOL, V32, P607, DOI 10.1200/JCO.2013.53.2226; YU DTY, 1974, J CLIN INVEST, V53, P565, DOI 10.1172/JCI107591	23	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124590	10.1371/journal.pone.0124590	http://dx.doi.org/10.1371/journal.pone.0124590			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897843	Green Published, gold, Green Submitted			2022-12-26	WOS:000353212600075
J	Akgun, J; Schabussova, I; Schwarzer, M; Kozakova, H; Kundi, M; Wiedermann, U				Akguen, Johnnie; Schabussova, Irma; Schwarzer, Martin; Kozakova, Hana; Kundi, Michael; Wiedermann, Ursula			The Role of Alveolar Epithelial Type II-Like Cells in Uptake of Structurally Different Antigens and in Polarisation of Local Immune Responses	PLOS ONE			English	Article							BIRCH POLLEN ALLERGEN; DENDRITIC CELLS; AIRWAY INFLAMMATION; LYMPH-NODES; EXPRESSION; LUNG; INTRANASAL; TRANSDIFFERENTIATION; SUPPRESSION; TOLERANCE	Background Our previous studies on intranasal tolerance induction demonstrated reduction of allergic responses with different allergen constructs. The underlying mechanisms varied depending on their conformation or size. Objective The aim of the present study was to compare the uptake of two structurally different allergen molecules within the respiratory tract following intranasal application. Methods The three-dimensional Bet v 1 (Bv1-Protein) and the T cell epitope peptide of Bet v 1 (Bv1-Peptide) were labelled with 5,6-Carboxyfluorescein (FAM) and their uptake was investigated in lung cells and cells of the nasal associated lymphoid tissue from naive and sensitised BALB/c mice. Phenotypic characterisation of FAM(+) lung cells after antigen incubation in vitro and after intranasal application was performed by flow cytometry. Impact of Bv1-Protein and Bv1-Peptide on cytokine profiles and gene expression in vivo or in an alveolar epithelial type II (ATII) cell line were assessed in mono-and co-cultures with monocytes using ELISA and quantitative real-time PCR. Results Both antigens were taken up preferably by ATII-like cells (ATII-LCs) in naive mice, and by macrophages in sensitised mice. After intranasal application, Bv1-Peptide was taken up faster and more efficiently than Bv1-Protein. In vivo and in vitro experiments revealed that Bv1-Protein induced the transcription of thymic stromal lymphopoietin mRNA while Bv1-Peptide induced the transcription of IL-10 and MCP1 mRNA in ATII-LCs. Conclusion and Clinical Relevance Both tested antigens were taken up by ATII-LCs under steady state conditions and induced different polarisation of the immune responses. These data may have an important impact for the generation of novel and more effective prophylactic or therapeutic tools targeting the respiratory mucosa.	[Akguen, Johnnie; Schabussova, Irma; Wiedermann, Ursula] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Specif Prophylaxis & Trop Med, Vienna, Austria; [Schwarzer, Martin; Kozakova, Hana] Acad Sci Czech Republic, Lab Gnotobiol, Inst Microbiol, Vvi, Novy Hradek, Czech Republic; [Kundi, Michael] Med Univ Vienna, Inst Environm Hlth, Vienna, Austria; [Wiedermann, Ursula] Univ Goteborg, Dept Rheumatol & Inflammat Res, Inst Med, Gothenburg, Sweden	Medical University of Vienna; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Medical University of Vienna; University of Gothenburg	Schabussova, I (corresponding author), Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Specif Prophylaxis & Trop Med, Vienna, Austria.	irma.schabussova@meduniwien.ac.at	Kozakova, Hana/I-1153-2014; Schwarzer, Martin/P-9871-2017	Kozakova, Hana/0000-0001-7352-5922; Schwarzer, Martin/0000-0002-1401-6578; Schabussova, Irma/0000-0002-2109-2640; Wiedermann, Ursula/0000-0002-1302-3223	Austrian Science Found [SFB F46]; OEAD [WTZ CZ16]	Austrian Science Found(Austrian Science Fund (FWF)); OEAD	This work has been supported by grant SFB F46 "Towards prevention and therapy of allergy" from Austrian Science Found and by grant WTZ CZ16 of the OEAD. Furthermore the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam E, 2006, J BIOL CHEM, V281, P6910, DOI 10.1074/jbc.M507140200; Akdis CA, 1998, EUR J IMMUNOL, V28, P914, DOI 10.1002/(SICI)1521-4141(199803)28:03<914::AID-IMMU914>3.0.CO;2-C; Akkoc T, 2011, ALLERGY ASTHMA IMMUN, V3, P11, DOI 10.4168/aair.2011.3.1.11; BECKER S, 1994, AM J PHYSIOL, V266, pL278, DOI 10.1152/ajplung.1994.266.3.L278; Bozza S, 2002, J IMMUNOL, V168, P1362, DOI 10.4049/jimmunol.168.3.1362; Campbell L, 1999, BIOCHEM BIOPH RES CO, V262, P744, DOI 10.1006/bbrc.1999.1280; DANTO SI, 1995, AM J RESP CELL MOL, V12, P497, DOI 10.1165/ajrcmb.12.5.7742013; Driscoll Barbara, 2012, Methods Mol Biol, V879, P109, DOI 10.1007/978-1-61779-815-3_7; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; Galligan C, 2003, CHEM IMMUNOL, V83, P24; Geha RS, 2003, CURR OPIN IMMUNOL, V15, P603, DOI 10.1016/j.coi.2003.09.017; Golias J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037156; Hammad H, 2011, ALLERGY, V66, P579, DOI 10.1111/j.1398-9995.2010.02528.x; Hufnagl K, 2008, CLIN EXP ALLERGY, V38, P1192, DOI 10.1111/j.1365-2222.2008.02992.x; Hufnagl K, 2005, J ALLERGY CLIN IMMUN, V116, P370, DOI 10.1016/j.jaci.2005.04.002; Kolesar L, 2012, IMMUNOL RES, V52, P269, DOI 10.1007/s12026-012-8338-y; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; Lombry C, 2002, J CONTROL RELEASE, V83, P331, DOI 10.1016/S0168-3659(02)00174-8; Maurer M, 2004, INT J BIOCHEM CELL B, V36, P1882, DOI 10.1016/j.biocel.2003.10.019; Olszewska-Pazdrak B, 1998, J VIROL, V72, P4756, DOI 10.1128/JVI.72.6.4756-4764.1998; Ozsoy Y, 2009, MOLECULES, V14, P3754, DOI 10.3390/molecules14093754; Reibman J, 2003, AM J RESP CELL MOL, V28, P648, DOI 10.1165/rcmb.2002-0095OC; Ryan GM, 2013, MOL PHARMACEUT, V10, P2986, DOI 10.1021/mp400091n; Salik E, 1999, AM J RESP CELL MOL, V21, P365, DOI 10.1165/ajrcmb.21.3.3529; Sauty A, 1999, J IMMUNOL, V162, P3549; Schabussova I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067544; Schmiedl A, 2009, INT ARCH ALLERGY IMM, V148, P118, DOI 10.1159/000155742; SINGH G, 1988, AM REV RESPIR DIS, V138, P1261, DOI 10.1164/ajrccm/138.5.1261; Striz I, 2001, INFLAMMATION, V25, P241, DOI 10.1023/A:1010975804179; STRUNK RC, 1988, J CLIN INVEST, V81, P1419, DOI 10.1172/JCI113472; Stumbles PA, 2001, J IMMUNOL, V167, P228, DOI 10.4049/jimmunol.167.1.228; Valenta R, 2011, ALLERGY, V66, P775, DOI 10.1111/j.1398-9995.2011.02565.x; Vermaelen KY, 2001, J EXP MED, V193, P51, DOI 10.1084/jem.193.1.51; Vinhas R, 2011, ALLERGY, V66, P1088, DOI 10.1111/j.1398-9995.2011.02598.x; Wiedermann U, 1999, J ALLERGY CLIN IMMUN, V103, P1202, DOI 10.1016/S0091-6749(99)70200-9; Wills-Karp M, 2001, NAT REV IMMUNOL, V1, P69, DOI 10.1038/35095579; Winkler B, 2002, CLIN EXP ALLERGY, V32, P30, DOI 10.1046/j.0022-0477.2001.01214.x	37	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124777	10.1371/journal.pone.0124777	http://dx.doi.org/10.1371/journal.pone.0124777			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894334	Green Published, gold, Green Submitted			2022-12-26	WOS:000353211700123
J	Farber, C; Wisshak, M; Pyko, I; Bellou, N; Freiwald, A				Faerber, Claudia; Wisshak, Max; Pyko, Ines; Bellou, Nikoleta; Freiwald, Andre			Effects of Water Depth, Seasonal Exposure, and Substrate Orientation on Microbial Bioerosion in the Ionian Sea (Eastern Mediterranean)	PLOS ONE			English	Article							LAGOONS FRENCH-POLYNESIA; GREAT-BARRIER-REEF; HIGH ISLANDS; CORAL-REEFS; CARBONATE; SHELF; COMMUNITIES; RATES	The effects of water depth, seasonal exposure, and substrate orientation on microbioerosion were studied by means of a settlement experiment deployed in 15, 50, 100, and 250 m water depth south-west of the Peloponnese Peninsula (Greece). At each depth, an experimental platform was exposed for a summer period, a winter period, and about an entire year. On the up- and down-facing side of each platform, substrates were fixed to document the succession of bioerosion traces, and to measure variations in bioerosion and accretion rates. In total, 29 different bioerosion traces were recorded revealing a dominance of microborings produced by phototrophic and organotrophic microendoliths, complemented by few macroborings, attachment scars, and grazing traces. The highest bioerosion activity was recorded in 15 m up-facing substrates in the shallow euphotic zone, largely driven by phototrophic cyanobacteria. Towards the chlorophyte-dominated deep euphotic to dysphotic zones and the organotroph-dominated aphotic zone the intensity of bioerosion and the diversity of bioerosion traces strongly decreased. During summer the activity of phototrophs was higher than during winter, which was likely stimulated by enhanced light availability due to more hours of daylight and increased irradiance angles. Stable water column stratification and a resulting nutrient depletion in shallow water led to lower turbidity levels and caused a shift in the photic zonation that was reflected by more phototrophs being active at greater depth. With respect to the subordinate bioerosion activity of organotrophs, fluctuations in temperature and the trophic regime were assumed to be the main seasonal controls. The observed patterns in overall bioeroder distribution and abundance were mirrored by the calculated carbonate budget with bioerosion rates exceeding carbonate accretion rates in shallow water and distinctly higher bioerosion rates at all depths during summer. These findings highlight the relevance of bioerosion and accretion for the carbonate budget of the Ionian Sea.	[Faerber, Claudia; Wisshak, Max; Freiwald, Andre] Abt Meeresforschung, Senckenberg Meer, D-26382 Wilhelmshaven, Germany; [Pyko, Ines] Univ Erlangen Nurnberg, Fachgrp Palaoumwelt, GeoZentrum Nordbayern, D-91054 Erlangen, Germany; [Bellou, Nikoleta] Inst Oceanog, Hellen Ctr Marine Res, Anavyssos 19003, Greece	Senckenberg Gesellschaft fur Naturforschung (SGN); University of Erlangen Nuremberg; Hellenic Centre for Marine Research	Farber, C (corresponding author), Abt Meeresforschung, Senckenberg Meer, Sudstrand 40, D-26382 Wilhelmshaven, Germany.	claudia.faerber@senckenberg.de	Wisshak, Max/A-3418-2011; Bellou, Nikoleta/G-8891-2011; Freiwald, Andre/C-2061-2018	Wisshak, Max/0000-0001-7531-3317; Bellou, Nikoleta/0000-0003-3789-1903; Freiwald, Andre/0000-0002-2335-4042; Pyko, Ines/0000-0001-9227-4604	Deutsche Forschungsgemeinschaft (DFG) [Wi 3754/2]; project KM3NET (EU-FP6) [011937]; POSEIDON II (EFTA & Greek Ministry of National Economy); POSEIDON III [EL0048]; Greek-German cooperation IKYDA - Greek State Scholarship Foundation; German Academic Exchange Service (DAAD)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); project KM3NET (EU-FP6); POSEIDON II (EFTA & Greek Ministry of National Economy); POSEIDON III; Greek-German cooperation IKYDA - Greek State Scholarship Foundation; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This study was funded by the Deutsche Forschungsgemeinschaft (DFG Wi 3754/2). The research cruises were financed by the projects KM3NET (Contract No. 011937; EU-FP6), POSEIDON II (EFTA & Greek Ministry of National Economy), and POSEIDON III (Contract no. EL0048; EEA Grants). The travels were financially supported by the Greek-German cooperation IKYDA 2008-2009, a fellowship for exchanging knowledge among young scientists that was funded by the Greek State Scholarship Foundation (IKY) and the German Academic Exchange Service (DAAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKPAN E B, 1984, Transactions of the Royal Society of Edinburgh Earth Sciences, V75, P1; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Bongiorni L, 2002, AQUAT MICROB ECOL, V30, P49, DOI 10.3354/ame030049; Bornet E, 1889, B SOC BOT FRANCE, V36, P147, DOI [10.1080/00378941.1889.10835893, DOI 10.1080/00378941.1889.10835893, DOI 10.1080/00378941.1889.10830435]; Bornet E, 1888, J BOT, V2, P161; Bromley Richard G., 2007, P518, DOI 10.1016/B978-044452949-7/50158-3; Bromley RG, 1990, B GEOL SOC DENMARK, V38, P85; BUDD DA, 1980, J SEDIMENT PETROL, V50, P881; CHAZOTTES V, 1995, PALAEOGEOGR PALAEOCL, V113, P189, DOI 10.1016/0031-0182(95)00043-L; Chazottes V, 2002, CORAL REEFS, V21, P375, DOI 10.1007/s00338-002-0259-0; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; ERCEGOVI A., 1929, ARCH PROTISTENK, V66, P164; ERCEGOVI ANTE, 1927, ACTA BOT INST UNIV ZAGREB, V2, P78; Ercegovic A., 1932, RAD JUGOSLOVENSKE AK, V244, P129; Fornos JJ, 2006, GEOL SOC SPEC PUBL, V255, P71, DOI 10.1144/GSL.SP.2006.255.01.06; Glaub I., 2001, ICHNOS, V8, P185, DOI [10.1080/10420940109380186, DOI 10.1080/10420940109380186]; Glaub Ingrid, 2007, P368, DOI 10.1016/B978-044452949-7/50147-9; Glaub Ingrid, 1994, Courier Forschungsinstitut Senckenberg, V174, P1; Golubic S, 2005, TRENDS MICROBIOL, V13, P229, DOI 10.1016/j.tim.2005.03.007; Golubic S., 1979, Biogeochemical cycling of mineral-forming elements, P29; Golubic S., 1975, STUDY TRACE FOSSILS, P229; Gorley C.K., 2006, GETTING STARTED PRIM; Gunther A., 1990, Facies, V22, P233, DOI 10.1007/BF02536953; HOSKIN CM, 1986, MAR GEOL, V73, P125, DOI 10.1016/0025-3227(86)90115-5; HUTCHINGS PA, 1986, CORAL REEFS, V4, P239, DOI 10.1007/BF00298083; Khanaev SA, 1992, P 2 NESTOR INT WORKS, P253; KIENE WE, 1994, CORAL REEFS, V13, P91, DOI 10.1007/BF00300767; Krom M, 2014, MEDITERRANEAN SEA: ITS HISTORY AND PRESENT CHALLENGES, P49, DOI 10.1007/978-94-007-6704-1_4; LECAMPIONALSUMARD T, 1979, OCEANOL ACTA, V2, P143; Malanotte-Rizzoli P, 1997, PROG OCEANOGR, V39, P153, DOI 10.1016/S0079-6611(97)00013-X; Mater Group, 2001, MAS3CT960051; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Pari N, 2002, J EXP MAR BIOL ECOL, V276, P109, DOI 10.1016/S0022-0981(02)00243-5; Pari N, 1998, MAR ECOL PROG SER, V166, P119, DOI 10.3354/meps166119; PERKINS RD, 1976, GEOL SOC AM BULL, V87, P1615, DOI 10.1130/0016-7606(1976)87<1615:MIOCSP>2.0.CO;2; Perry CT, 2002, PALAEOGEOGR PALAEOCL, V186, P101, DOI 10.1016/S0031-0182(02)00446-7; Radtke G., 1991, Courier Forschungsinstitut Senckenberg, V138, P1; Ridgwell A, 2005, EARTH PLANET SC LETT, V234, P299, DOI 10.1016/j.epsl.2005.03.006; Sartoretto S, 1998, CR ACAD SCI II A, V327, P839, DOI 10.1016/S1251-8050(99)80059-7; Schlitzer R, 2014, OCEAN DATA VIEW 2014; Schmidt Horst, 1992, Frankfurter Geowissenschaftliche Arbeiten Serie A Geologie-Palaeontologie, V12, P1; Schonberg CHL, 2014, MEDITERRANEAN SEA: ITS HISTORY AND PRESENT CHALLENGES, P449, DOI 10.1007/978-94-007-6704-1_26; Stambler N, 2014, MEDITERRANEAN SEA: ITS HISTORY AND PRESENT CHALLENGES, P113, DOI 10.1007/978-94-007-6704-1_7; Tribollet A, 2005, CORAL REEFS, V24, P422, DOI 10.1007/s00338-005-0003-7; Tribollet Aline, 2011, P117; Trimonis E., 1992, P 2 NESTOR INT WORKS, P321; Vogel K, 2000, LETHAIA, V33, P190; Vogel K., 1995, NEUES JB GEOL PAL, V195, P49; Vogel K., 1996, GOTTINGER ARBEITEN G, V2, P139; Wisshak M, 2006, LECT NOTES EARTH SCI, V109, P1, DOI 10.1007/978-3-540-36849-6; Wisshak M, 2015, MAR BIODIVERS, V45, P87, DOI 10.1007/s12526-014-0231-6; Wisshak M, 2011, GEOBIOLOGY, V9, P492, DOI 10.1111/j.1472-4669.2011.00299.x; Wisshak M, 2010, BIOGEOSCIENCES, V7, P2379, DOI 10.5194/bg-7-2379-2010; Wisshak M., 2012, TRACE FOSSILS INDICA, V64, P213, DOI DOI 10.1016/B978-0-444-53813-0.00008-3; Wisshak Max, 2006, Ichnos, V13, P135, DOI 10.1080/10420940600851255; Wisshak M, 2014, ICHNOS, V21, P111, DOI 10.1080/10420940.2014.907572	56	13	13	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0126495	10.1371/journal.pone.0126495	http://dx.doi.org/10.1371/journal.pone.0126495			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893244	gold, Green Published, Green Submitted			2022-12-26	WOS:000353211700143
J	Ghaley, BB; Sandhu, HS; Porter, JR				Ghaley, Bhim B.; Sandhu, Harpinder S.; Porter, John R.			Relationship between C:N/C:O Stoichiometry and Ecosystem Services in Managed Production Systems	PLOS ONE			English	Article							N-P STOICHIOMETRY; SOIL; AGRICULTURE; QUANTIFICATION; CARBON; AGROECOSYSTEMS; ORGANISMS; VALUATION; BIOMASS; ENERGY	Land use and management intensity can influence provision of ecosystem services (ES). We argue that forest/agroforestry production systems are characterized by relatively higher C:O/C:N and ES value compared to arable production systems. Field investigations on C:N/C:O and 15 ES were determined in three diverse production systems: wheat monoculture (C-wheat), a combined food and energy system (CFE) and a beech forest in Denmark. The C:N/C:O ratios were 194.1/1.68, 94.1/1.57 and 59.5/1.45 for beech forest, CFE and Cwheat, respectively. The economic value of the non-marketed ES was also highest in beech forest (US$ 1089 ha(-1) yr(-1)) followed by CFE (US$ 800 ha(-1) yr(-1)) and Cwheat (US$ 339 ha(-1) yr(-1)). The combined economic value was highest in the CFE (US$ 3143 ha(-1) yr(-1)) as compared to the Cwheat (US$ 2767 ha(-1) yr(-1)) and beech forest (US$ 2365 ha(-1) yr(-1)). We argue that C:N/C:O can be used as a proxy of ES, particularly for the non-marketed ES, such as regulating, supporting and cultural services. These ES play a vital role in the sustainable production of food and energy. Therefore, they should be considered in decision making and developing appropriate policy responses for land use management.	[Ghaley, Bhim B.; Porter, John R.] Univ Copenhagen, Fac Sci, Dept Plant & Environm Sci, DK-2630 Taastrup, Denmark; [Ghaley, Bhim B.] Univ Copenhagen, Fac Sci, Copenhagen Plant Sci Ctr, DK-1871 Frederiksberg C, Denmark; [Sandhu, Harpinder S.] Flinders Univ S Australia, Sch Environm, Adelaide, SA 5001, Australia; [Porter, John R.] Univ Greenwich, Nat Resources Inst, Chatam, Slovakia; [Porter, John R.] Lincoln Univ, Fac Agr & Life Sci, Lincoln 7647, New Zealand	University of Copenhagen; University of Copenhagen; Flinders University South Australia; Lincoln University - New Zealand	Ghaley, BB (corresponding author), Univ Copenhagen, Fac Sci, Dept Plant & Environm Sci, Hojbakkegard Alle 30, DK-2630 Taastrup, Denmark.	bbg@plen.ku.dk	Ghaley, Bhim B/G-5232-2014; Sandhu, Harpinder S/E-9338-2010	Sandhu, Harpinder S/0000-0001-5428-094X; Ghaley, Bhim Bahadur/0000-0002-0864-7613	European Commission [289694]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by European Commission FP7 (FP7-KBBE-2011-5) programme: SmartSOIL project (Soil Management Aimed at Reducing Threats to SOILs under climate change) (Project number: 289694), smartsoil.eu. The funding is received by John R. Porter and Bhim B. Ghaley to carry out research in the University of Copenhagen, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aertsens J, 2013, LAND USE POLICY, V31, P584, DOI 10.1016/j.landusepol.2012.09.003; Als C., 1989, Soil erosion protection measures in Europe, Proceedings of the European Community Workshop, Freising, Germany., P25; [Anonymous], 2000, FLASH 2000 CHNS O AN; [Anonymous], 2010, EC ECOSYSTEMS BIODIV; Bai YF, 2012, J APPL ECOL, V49, P1204, DOI 10.1111/j.1365-2664.2012.02205.x; Boyd J, 2007, ECOL ECON, V63, P616, DOI 10.1016/j.ecolecon.2007.01.002; Cleveland CC, 2007, BIOGEOCHEMISTRY, V85, P235, DOI 10.1007/s10533-007-9132-0; Costanza R, 2008, BIOL CONSERV, V141, P350, DOI 10.1016/j.biocon.2007.12.020; Costanza R, 2014, GLOBAL ENVIRON CHANG, V26, P152, DOI 10.1016/j.gloenvcha.2014.04.002; Daily GC, 1997, NATURES SERVICES SOC, DOI DOI 10.12987/9780300188479-039; Dale VH, 2007, ECOL ECON, V64, P286, DOI 10.1016/j.ecolecon.2007.05.009; Danish Forest Association, 2012, WOOD PRIC STAT DAN F; de la Rosa D, 2000, AGR ECOSYST ENVIRON, V81, P179, DOI 10.1016/S0167-8809(00)00161-4; Dominati E, 2014, ECOL ECON, V100, P119, DOI 10.1016/j.ecolecon.2014.02.008; Drake L., 1992, European Review of Agricultural Economics, V19, P351, DOI 10.1093/erae/19.3.351; Drake L, 1999, INT J SOC ECON, V26, P1042, DOI [DOI 10.1108/03068299910245813, 10.1108/03068299910245813]; Elser JJ, 2010, NEW PHYTOL, V186, P593, DOI 10.1111/j.1469-8137.2010.03214.x; Food and Agriculture Organization of the United Nations, 2011, SAV GROW POL GUID SU; Fountain ED, 2013, ECOSYSTEM SERVICES IN NEW ZEALAND: CONDITIONS AND TRENDS, P115; Ghaley Bhim B., 2014, International Journal of Biodiversity Science Ecosystem Services & Management, V10, P177, DOI 10.1080/21513732.2014.926990; Ghaley BB, 2014, ENVIRON SCI POLICY, V39, P139, DOI 10.1016/j.envsci.2013.08.004; Ghaley BB, 2013, ECOL INDIC, V24, P534, DOI 10.1016/j.ecolind.2012.08.009; Hansen K, 2009, FOREST ECOL MANAG, V257, P2133, DOI 10.1016/j.foreco.2009.02.021; Hogh-Jensen H, 2004, AGR SYST, V82, P181, DOI 10.1016/j.agsy.2003.12.003; Kossoy A, 2010, STATE TRENDS CARBON; Li Y, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2012GB004399; McGroddy ME, 2004, ECOLOGY, V85, P2390, DOI 10.1890/03-0351; Millennium Ecosystem Assessment, 2005, SYNTH REP; Moller C.M.M., 1933, DANSK SKOVFORENINGS, V18, P537; Mulder C, 2011, ADV ECOL RES, V44, P277, DOI 10.1016/B978-0-12-374794-5.00005-5; Ostle NJ, 2009, LAND USE POLICY, V26, pS274, DOI 10.1016/j.landusepol.2009.08.006; Porter J, 2009, AMBIO, V38, P186, DOI 10.1579/0044-7447-38.4.186; Pretty JN, 2000, AGR SYST, V65, P113, DOI 10.1016/S0308-521X(00)00031-7; Ptacnik R, 2005, OIKOS, V109, P52, DOI 10.1111/j.0030-1299.2005.14051.x; Robinson DA, 2014, SOIL SCI SOC AM J, V78, P685, DOI 10.2136/sssaj2014.01.0017; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Sandhu H., 2013, Ecosystem services in agricultural and urban landscapes, P122; Sandhu HS, 2008, ECOL ECON, V64, P835, DOI 10.1016/j.ecolecon.2007.05.007; Sandhu HS, 2012, ECOL ECON, V74, P19, DOI 10.1016/j.ecolecon.2011.12.001; Sandhu HS, 2010, ECOL COMPLEX, V7, P302, DOI 10.1016/j.ecocom.2010.04.006; Sardans J, 2012, PERSPECT PLANT ECOL, V14, P33, DOI 10.1016/j.ppees.2011.08.002; Sistla SA, 2012, NEW PHYTOL, V196, P68, DOI 10.1111/j.1469-8137.2012.04234.x; Skovsgaard JP, 2012, EUR J FOREST RES, V131, P1035, DOI 10.1007/s10342-011-0575-4; Soegaard B., 1954, IUFRO 11 C P 1953 RO, P246; Suadicani K., 2012, SORTIMENTSFORDELINGE, P1; Tian HQ, 2010, BIOGEOCHEMISTRY, V98, P139, DOI 10.1007/s10533-009-9382-0; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Uri V, 2011, ECOL ENG, V37, P920, DOI 10.1016/j.ecoleng.2011.01.016; Vanni MJ, 2011, FRESHWATER BIOL, V56, P791, DOI 10.1111/j.1365-2427.2010.02436.x; VONTORNE E, 1990, PEDOBIOLOGIA, V34, P89; Yang Y.H., 2010, BIOGEOSCI DISCUSS, V7, P1, DOI [10.5194/bgd-7-1-2010, DOI 10.5194/BGD-7-1-2010]; Zhang W, 2007, ECOL ECON, V64, P253, DOI 10.1016/j.ecolecon.2007.02.024; Zheng SX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051750	53	4	4	4	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123869	10.1371/journal.pone.0123869	http://dx.doi.org/10.1371/journal.pone.0123869			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894553	Green Published, Green Submitted, gold			2022-12-26	WOS:000353211700061
J	Li, M; Yang, ZL; Vollmer, LL; Gao, Y; Fu, YY; Liu, C; Chen, XY; Liu, PQ; Vogt, A; Yin, XM				Li, Min; Yang, Zuolong; Vollmer, Laura L.; Gao, Ying; Fu, Yuanyuan; Liu, Cui; Chen, Xiaoyun; Liu, Peiqing; Vogt, Andreas; Yin, Xiao-Ming			AMDE-1 Is a Dual Function Chemical for Autophagy Activation and Inhibition	PLOS ONE			English	Article							MODULATORS; MTOR; DEGRADATION; INDUCTION; INDUCERS; SCREEN; ASSAYS	Autophagy is the process by which cytosolic components and organelles are delivered to the lysosome for degradation. Autophagy plays important roles in cellular homeostasis and disease pathogenesis. Small chemical molecules that can modulate autophagy activity may have pharmacological value for treating diseases. Using a GFP-LC3-based high content screening assay we identified a novel chemical that is able to modulate autophagy at both initiation and degradation levels. This molecule, termed as Autophagy Modulator with Dual Effect-1 (AMDE-1), triggered autophagy in an Atg5-dependent manner, recruiting Atg16 to the pre-autophagosomal site and causing LC3 lipidation. AMDE-1 induced autophagy through the activation of AMPK, which inactivated mTORC1 and activated ULK1. AMDE-1 did not affect MAP kinase, JNK or oxidative stress signaling for autophagy induction. Surprisingly, treatment with AMDE-1 resulted in impairment in autophagic flux and inhibition of long-lived protein degradation. This inhibition was correlated with a reduction in lysosomal degradation capacity but not with autophagosome-lysosome fusion. Further analysis indicated that AMDE-1 caused a reduction in lysosome acidity and lysosomal proteolytic activity, suggesting that it suppressed general lysosome function. AMDE-1 thus also impaired endocytosis-mediated EGF receptor degradation. The dual effects of AMDE-1 on autophagy induction and lysosomal degradation suggested that its net effect would likely lead to autophagic stress and lysosome dysfunction, and therefore cell death. Indeed, AMDE-1 triggered necroptosis and was preferentially cytotoxic to cancer cells. In conclusion, this study identified a new class of autophagy modulators with dual effects, which can be explored for potential uses in cancer therapy.	[Li, Min; Yang, Zuolong; Gao, Ying; Fu, Yuanyuan; Liu, Cui; Liu, Peiqing] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China; [Li, Min; Chen, Xiaoyun; Yin, Xiao-Ming] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Vollmer, Laura L.; Vogt, Andreas] Univ Pittsburgh, Drug Discovery Inst, Pittsburgh, PA USA; [Vogt, Andreas] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA USA	Sun Yat Sen University; Indiana University System; Indiana University Bloomington; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Li, M (corresponding author), Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China.	limin65@mail.sysu.edu.cn; xmyin@iupui.edu		Vogt, Andreas/0000-0001-6846-9292; li, min/0000-0002-5657-8675	Natural Science Foundation of Guangdong Province, China [S2013010015876]; Specialized Research Fund for the Doctoral Program of Higher Education [20130171120049]; Opening Project of Guangdong Provincial Key Laboratory of New Drug Design and Evaluation [2011A060901014]; Key Laboratory of Regenerative Biology, Guangzhou Institute of Biomedicine and Health, CAS [KLRB201307]; National Cancer Institute; National Institute of Mental Health [R03MH083154, R01CA111456, R01CA83817]; National Cancer Institute of the National Institutes of Health [P30CA037904]; NATIONAL CANCER INSTITUTE [P30CA047904, R01CA111456, R01CA083817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH083154] Funding Source: NIH RePORTER	Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Opening Project of Guangdong Provincial Key Laboratory of New Drug Design and Evaluation; Key Laboratory of Regenerative Biology, Guangzhou Institute of Biomedicine and Health, CAS; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Natural Science Foundation of Guangdong Province, China (S2013010015876. to M. L), the Specialized Research Fund for the Doctoral Program of Higher Education (20130171120049, to M.L), the Opening Project of Guangdong Provincial Key Laboratory of New Drug Design and Evaluation (2011A060901014, to ML), Key Laboratory of Regenerative Biology, Guangzhou Institute of Biomedicine and Health, CAS (KLRB201307 to M.L), National Cancer Institute (http://www.cancer.gov/) and National Institute of Mental Health (http://www.nimh.nih.gov/index. shtml) R03MH083154, R01CA111456 and R01CA83817) (to X.-M. Y). This project used the UPCI Chemical Biology facility that is supported in part by National Cancer Institute (http://www.cancer.gov/) of the National Institutes of Health (P30CA037904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alers S, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-7; Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Balgi AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007124; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Beau I, 2011, INT J BIOCHEM CELL B, V43, P460, DOI 10.1016/j.biocel.2011.01.006; Bischoff P, 2012, EXPERT OPIN THER PAT, V22, P1053, DOI 10.1517/13543776.2012.715148; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Choi AMK, 2013, NEW ENGL J MED, V368, P1845, DOI 10.1056/NEJMc1303158; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Ding WX, 2010, GASTROENTEROLOGY, V139, P1740, DOI 10.1053/j.gastro.2010.07.041; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Eng CH, 2011, ONCOGENE, V30, P4687, DOI 10.1038/onc.2011.220; Fleming A, 2011, NAT CHEM BIOL, V7, P9, DOI 10.1038/NCHEMBIO.500; Gonzalez P, 2012, CELL DEATH DIFFER, V19, P1337, DOI 10.1038/cdd.2012.10; Hidvegi T, 2010, SCIENCE, V329, P229, DOI 10.1126/science.1190354; Hundeshagen P, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-38; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Iversen PW, 2004, ASSAY GUIDANCE MANUA; Jiang PD, 2014, CELL RES, V24, P69, DOI 10.1038/cr.2013.161; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kriston-Vizi J, 2010, J BIOMOL SCREEN, V15, P869, DOI 10.1177/1087057110373393; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li M, 2013, J BIOL CHEM, V288, P35769, DOI 10.1074/jbc.M113.511212; Li M, 2012, AUTOPHAGY, V8, P401, DOI 10.4161/auto.18777; Liu JL, 2011, CELL, V147, P223, DOI 10.1016/j.cell.2011.08.037; Rangwala R, 2014, AUTOPHAGY, V10, P1391, DOI 10.4161/auto.29119; Ravikumar B, 2010, NAT CELL BIOL, V12, P747, DOI 10.1038/ncb2078; Sanghee Lee EK, 2013, CHEM SCI, V4, P6; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Shu CW, 2011, J BIOMOL SCREEN, V16, P174, DOI 10.1177/1087057110392996; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Wong CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009996; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	37	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0122083	10.1371/journal.pone.0122083	http://dx.doi.org/10.1371/journal.pone.0122083			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894744	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000353211700012
J	Otomaru, H; Kamigaki, T; Tamaki, R; Opinion, J; Santo, A; Daya, E; Okamoto, M; Saito, M; Tallo, V; Lupisan, S; Suzuki, A; Oshitani, H				Otomaru, Hirono; Kamigaki, Taro; Tamaki, Raita; Opinion, Jamie; Santo, Arlene; Daya, Edgard; Okamoto, Michiko; Saito, Mariko; Tallo, Veronica; Lupisan, Soccoro; Suzuki, Akira; Oshitani, Hitoshi			Influenza and Other Respiratory Viruses Detected by Influenza-Like Illness Surveillance in Leyte Island, the Philippines, 2010-2013	PLOS ONE			English	Article							REAL-TIME PCR; HUMAN METAPNEUMOVIRUS; SYNCYTIAL VIRUS; SENTINEL SURVEILLANCE; MICROPLATE METHOD; VIRAL ETIOLOGY; CHILDREN; INFECTIONS; SEASONS; OUTPATIENTS	This study aimed to determine the role of influenza-like illness (ILI) surveillance conducted on Leyte Island, the Philippines, including involvement of other respiratory viruses, from 2010 to 2013. ILI surveillance was conducted from January 2010 to March 2013 with 3 sentinel sites located in Tacloban city, Palo and Tanauan of Leyte Island. ILI was defined as fever >= 38 degrees C or feverish feeling and either cough or running nose in a patient of any age. Influenza virus and other 5 respiratory viruses were searched. A total of 5,550 ILI cases visited the 3 sites and specimens were collected from 2,031 (36.6%) cases. Among the cases sampled, 1,637 (75.6%) were children aged <5 years. 874 (43.0%) cases were positive for at least one of the respiratory viruses tested. Influenza virus and respiratory syncytial virus (RSV) were predominantly detected (both were 25.7%) followed by human rhinovirus (HRV) (17.5%). The age distributions were significantly different between those who were positive for influenza, HRV, and RSV. ILI cases were reported throughout the year and influenza virus was co-detected with those viruses on approximately half of the weeks of study period (RSV in 60.5% and HRV 47.4%). In terms of clinical manifestations, only the rates of headache and sore throat were significantly higher in influenza positive cases than cases positive to other viruses. In conclusion, syndromic ILI surveillance in this area is difficult to detect the start of influenza epidemic without laboratory confirmation which requires huge resources. Age was an important factor that affected positive rates of influenza and other respiratory viruses. Involvement of older age children may be useful to detect influenza more effectively.	[Otomaru, Hirono; Kamigaki, Taro; Tamaki, Raita; Okamoto, Michiko; Saito, Mariko; Oshitani, Hitoshi] Tohoku Univ, Sch Med, Dept Virol, Sendai, Miyagi 980, Japan; [Opinion, Jamie] Tacloban City Hlth Off, Tacloban City, Philippines; [Santo, Arlene] Tanauan Rural Hlth Unit, Tanauan, Philippines; [Daya, Edgard] Leyte Prov Hlth Off, Palo, Philippines; [Saito, Mariko] Tohoku RITM Res Ctr Emerging & Reemerging Infect, Muntinlupa, Philippines; [Tallo, Veronica; Lupisan, Soccoro] Res Inst Trop Med, Muntinlupa, Philippines; [Suzuki, Akira] Sendai Med Ctr, Virus Res Ctr, Div Clin Res, Sendai, Miyagi, Japan	Tohoku University; Research Institute for Tropical Medicine - Philippines	Kamigaki, T (corresponding author), Tohoku Univ, Sch Med, Dept Virol, Sendai, Miyagi 980, Japan.	kamigakit@med.tohoku.ac.jp	Oshitani, Hitoshi/AAE-4349-2019; Okamoto, Michiko/AAE-4373-2019	Okamoto, Michiko/0000-0002-3505-5939; Suzuki, Akira/0000-0002-8223-0314	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Science and Technology Research Partnership for Sustainable Development (SATREPS) from the Japan Science and Technology Agency (JICA), Japan; JSPS KAKENHI [24249041]	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Science and Technology Research Partnership for Sustainable Development (SATREPS) from the Japan Science and Technology Agency (JICA), Japan; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid from the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; the Science and Technology Research Partnership for Sustainable Development (SATREPS) from the Japan Science and Technology Agency (JICA), Japan; and JSPS KAKENHI Grant number 24249041. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azziz-Baumgartner E, 2012, B WORLD HEALTH ORGAN, V90, P12, DOI 10.2471/BLT.11.090209; Bellau-Pujol S, 2005, J VIROL METHODS, V126, P53, DOI 10.1016/j.jviromet.2005.01.020; Bonroy C, 2007, CLIN MICROBIOL INFEC, V13, P504, DOI 10.1111/j.1469-0691.2007.01682.x; Casas I, 2005, J CLIN MICROBIOL, V43, P6176, DOI 10.1128/JCM.43.12.6176-6182.2005; Chen SY, 2012, AM J EMERG MED, V30, P1796, DOI 10.1016/j.ajem.2012.02.016; Dennis KM, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3693; Furuse Y, 2010, J VIROL METHODS, V168, P94, DOI 10.1016/j.jviromet.2010.04.023; Galindo-Fraga A, 2013, INT J INFECT DIS, V17, pE510, DOI 10.1016/j.ijid.2013.01.006; Hombrouck A, 2012, EUR J CLIN MICROBIOL, V31, P999, DOI 10.1007/s10096-011-1398-4; Huo X, 2012, J MED VIROL, V84, P1980, DOI 10.1002/jmv.23401; Kadjo HA, 2013, INFLUENZA OTHER RESP, V7, P296, DOI 10.1111/j.1750-2659.2012.00389.x; Kiang D, 2008, J CLIN MICROBIOL, V46, P3736, DOI 10.1128/JCM.00674-08; Kono J, 2014, J MED VIROL, V86, P899, DOI 10.1002/jmv.23786; Landes MB, 2013, INFLUENZA OTHER RESP, V7, P1122, DOI 10.1111/irv.12145; Mak GC, 2012, INFLUENZA OTHER RESP, V6, pe6, DOI 10.1111/j.1750-2659.2011.00323.x; Matsuzaki Y, 2009, J CLIN MICROBIOL, V47, P2981, DOI 10.1128/JCM.00321-09; Mizuta K, 2008, JPN J INFECT DIS, V61, P196; Mizuta K, 2013, JPN J INFECT DIS, V66, P140, DOI 10.7883/yoken.66.140; Mizuta Katsumi, 2003, International Journal of Infectious Diseases, V7, P138, DOI 10.1016/S1201-9712(03)90010-5; Mmbaga VM, 2012, J INFECT DIS, V206, pS80, DOI 10.1093/infdis/jis540; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; National Statistical Office, 2010 CENS POP HOUS; Navarro-Mari JM, 2005, J CLIN EPIDEMIOL, V58, P275, DOI 10.1016/j.jclinepi.2004.08.014; Nguyen YT, 2013, VACCINE, V31, P4368, DOI 10.1016/j.vaccine.2013.07.018; Nicholson KG, 2006, VACCINE, V24, P102, DOI 10.1016/j.vaccine.2005.02.004; Nishimura N, 2005, PEDIATR INT, V47, P412, DOI 10.1111/j.1442-200x.2005.02099.x; Njouom R, 2012, J INFECT DIS, V206, pS29, DOI 10.1093/infdis/jis573; NUMAZAKI Y, 1987, MICROBIOL IMMUNOL, V31, P1085, DOI 10.1111/j.1348-0421.1987.tb01340.x; Peltola V, 2005, CLIN INFECT DIS, V41, P1198, DOI 10.1086/444508; Peng JS, 2012, J MED VIROL, V84, P672, DOI 10.1002/jmv.22247; Shafik CF, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-350; Silvennoinen H, 2009, PEDIATR INFECT DIS J, V28, P372, DOI 10.1097/INF.0b013e318191eef7; Suzuki A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-267; Tallo VL, 2014, INFLUENZA OTHER RESP, V8, P159, DOI 10.1111/irv.12223; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; Western Pacific Region Global Influenza Surveillance and Response System Epidemiological and virological characteristics of influenza in the Western Pacific Region of the World Health Organization, 2006, PLOS ONE, V7, DOI [10.1371/journal.pone.0037568, DOI 10.1371/JOURNAL.PONE.0037568]; WHO, 2012, WHO INT GLOB EP SURV; WHO, CDC PROT REALT RTPCR; Wolf DG, 2010, J PEDIATR-US, V156, P115, DOI 10.1016/j.jpeds.2009.07.014; World Health Organization (WHO), WHO REC SURV STAND; Yang TU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084873; Zaman RU, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008452	42	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123755	10.1371/journal.pone.0123755	http://dx.doi.org/10.1371/journal.pone.0123755			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893441	Green Published, Green Submitted, gold			2022-12-26	WOS:000353211700053
J	Saglam, O; Samayoa, E; Somasekar, S; Naccache, S; Iwasaki, A; Chiu, CY				Saglam, Ozlen; Samayoa, Erik; Somasekar, Sneha; Naccache, Samia; Iwasaki, Akiko; Chiu, Charles Y.			No Viral Association Found in a Set of Differentiated Vulvar Intraepithelial Neoplasia Cases by Human Papillomavirus and Pan-Viral Microarray Testing	PLOS ONE			English	Article							IDENTIFICATION; TERMINOLOGY	Vulvar Intraepithelial Neoplasia (VIN) is the precursor lesion of Vulvar Squamous Cell Carcinoma (VSCC), and the differentiated type (dVIN) is more frequently observed in relation to VSCC. In contrast to usual-type VIN (uVIN), which is related to infection by human papillomavirus (HPV), a germline mutation in the p53 gene is thought to be associated with similar to 90% of dVIN cases. To date, no infectious agent has been identified in association with dVIN, and studies investigating this possibility have been hindered by the difficulty in accurately diagnosing dVIN from small biopsies. Here, we used immunostaining for p16(ink4a), a biomarker for HPV infection, to study 14 uVIN high-grade VIN and 14 dVIN cases, and to select 10 dVIN cases to broadly screen for all known viruses using a pan-viral microarray platform (ViroChip). All of the uVIN tissue samples, including 8 warty and 6 basaloid cases, showed positivity with the p16(ink4a) immunostain. The staining pattern was full-thickness for all except two cases in which positive staining was localized in the lower 1/3 of the epidermis. In contrast, immunostaining for p16(ink4a) was negative in all dVIN cases. ViroChip analysis of 10 pure dVIN samples confirmed the absence of human papillomavirus subtypes or any other virus with the exception of a single sample that showed a weak microarray signature to a porcine herpesvirus. Follow-up PCR testing of the sample was negative for herpesvirus, and in-depth metagenomic next-generation sequencing revealed only sequences corresponding to non-pathogenic viral flora and bacterial contamination. In this study, we demonstrated lack of a virus association in 10 dVIN cases. Alternative pathways for carcinogenesis such as the p53 mutation should be considered for investigation of potential treatment options in dVIN.	[Saglam, Ozlen] H Lee Moffitt Canc Ctr & Res Inst, Dept Pathol, Tampa, FL 33612 USA; [Samayoa, Erik; Somasekar, Sneha; Naccache, Samia; Chiu, Charles Y.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Samayoa, Erik; Somasekar, Sneha; Naccache, Samia; Chiu, Charles Y.] UCSF, Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA USA; [Iwasaki, Akiko] Yale Univ, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06511 USA; [Chiu, Charles Y.] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA	H Lee Moffitt Cancer Center & Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; Yale University; University of California System; University of California San Francisco	Saglam, O (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Pathol, Tampa, FL 33612 USA.	ozlen.saglam@moffitt.org	Iwasaki, Akiko/Z-1591-2019	Iwasaki, Akiko/0000-0002-7824-9856; Chiu, Charles/0000-0003-2915-2094	Howard Hughes Medical Institute; National Institutes of Health [HL105704]; Abbott Viral Discovery Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054359] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abbott Viral Discovery Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported in part by the Howard Hughes Medical Institute (AI), an R01 grant HL105704 from the National Institutes of Health (CYC), and an Abbott Viral Discovery Award (CYC). The funders had no role in the data collection, analysis, patient recruitment, or decision to publish.	Bonvicini F, 2005, J MED VIROL, V77, P102, DOI 10.1002/jmv.20420; Camargo M, 2011, J VIROL METHODS, V178, P68, DOI 10.1016/j.jviromet.2011.08.014; Chen EC, 2011, JOVE-J VIS EXP, DOI 10.3791/2536; Chen EC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002155; Chiu CY, 2008, P NATL ACAD SCI USA, V105, P14124, DOI 10.1073/pnas.0805968105; Chiu CY, 2008, J PEDIATR-US, V153, P76, DOI 10.1016/j.jpeds.2007.12.035; del Pino M, 2013, HISTOPATHOLOGY, V62, P161, DOI 10.1111/his.12034; Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fancello L, 2012, VIROLOGY, V434, P162, DOI 10.1016/j.virol.2012.09.025; Grard G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002924; Greninger AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013381; Hart WR, 2001, INT J GYNECOL PATHOL, V20, P16, DOI 10.1097/00004347-200101000-00003; Judson PL, 2006, OBSTET GYNECOL, V107, P1018, DOI 10.1097/01.AOG.0000210268.57527.a1; Kokka F, 2011, INT J GYNECOL CANCER, V21, P1297, DOI 10.1097/IGC.0b013e31822dbe26; Lee D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044954; Naccache SN, 2014, GENOME RES, V24, P1180, DOI 10.1101/gr.171934.113; Naccache SN, 2013, J VIROL, V87, P11966, DOI 10.1128/JVI.02323-13; Pinto AP, 2010, MODERN PATHOL, V23, P404, DOI 10.1038/modpathol.2009.179; Reyes MC, 2014, J CLIN PATHOL, V67, P290, DOI 10.1136/jclinpath-2013-202117; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sideri M, 2005, J REPROD MED, V50, P807; Stern PL, 2012, VACCINE, V30, pF71, DOI 10.1016/j.vaccine.2012.05.091; Terlou A, 2010, ACTA OBSTET GYN SCAN, V89, P741, DOI 10.3109/00016341003739575; Tsoumpou I, 2009, CANCER TREAT REV, V35, P210, DOI 10.1016/j.ctrv.2008.10.005; Ueda Y, 2011, J SKIN CANCER, V2011, DOI 10.1155/2011/951250; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Wilson MR, 2014, NEW ENGL J MED, V370, P2408, DOI 10.1056/NEJMoa1401268; Yang B, 2000, AM J SURG PATHOL, V24, P429, DOI 10.1097/00000478-200003000-00013; Yu GX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049449; Zaharia M, ARXIV201111115572; Zhao YA, 2012, BIOINFORMATICS, V28, P125, DOI 10.1093/bioinformatics/btr595	32	6	6	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0125292	10.1371/journal.pone.0125292	http://dx.doi.org/10.1371/journal.pone.0125292			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894343	gold, Green Published, Green Submitted			2022-12-26	WOS:000353211700137
J	Dale, C; Nuesch, E; Prieto-Merino, D; Choi, M; Amuzu, A; Ebrahim, S; Casas, JP; Davey-Smith, G				Dale, Caroline; Nueesch, Eveline; Prieto-Merino, David; Choi, Minkyoung; Amuzu, Antoinette; Ebrahim, Shah; Casas, Juan P.; Davey-Smith, George			Why Do Thin People Have Elevated All-Cause Mortality? Evidence on Confounding and Reverse Causality in the Association of Adiposity and COPD from the British Women's Heart and Health Study	PLOS ONE			English	Article							BODY-MASS INDEX; OBSTRUCTIVE PULMONARY-DISEASE; WEIGHT CHANGE; OLDER WOMEN; RISK; OBESITY; CANCER; COHORT; DEATH; BMI	Low adiposity has been linked to elevated mortality from several causes including respiratory disease. However, this could arise from confounding or reverse causality. We explore the association between two measures of adiposity (BMI and WHR) with COPD in the British Women's Heart and Health Study including a detailed assessment of the potential for confounding and reverse causality for each adiposity measure. Low BMI was found to be associated with increased COPD risk while low WHR was not (OR = 2.2; 95% CI 1.3-3.1 versus OR = 1.2; 95% CI 0.7-1.6). Potential confounding variables (e.g. smoking) and markers of ill-health (e.g. unintentional weight loss) were found to be higher in low BMI but not in low WHR. Women with low BMI have a detrimental profile across a broad range of health markers compared to women with low WHR, and women with low WHR do not appear to have an elevated COPD risk, lending support to the hypothesis that WHR is a less confounded measure of adiposity than BMI. Low adiposity does not in itself appear to increase the risk of respiratory disease, and the apparent adverse consequences of low BMI may be due to reverse causation and confounding.	[Dale, Caroline; Nueesch, Eveline; Prieto-Merino, David; Choi, Minkyoung; Amuzu, Antoinette; Ebrahim, Shah; Casas, Juan P.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Noncommunicable Dis Epidemiol, London WC1, England; [Casas, Juan P.] UCL, Inst Cardiovasc Sci, London, England; [Davey-Smith, George] Univ Bristol, CAiTE Ctr, Sch Social & Community Med, Bristol, Avon, England	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of Bristol	Dale, C (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Noncommunicable Dis Epidemiol, London WC1, England.	caroline.dale@ishtm.ac.uk	Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314; s, hema/0000-0002-3440-9475; Dale, Caroline/0000-0002-3889-8974; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Prieto-Merino, David/0000-0001-5001-0061	Department of Health Policy Research Programme (England) [0090049]; British Heart Foundation [PG/09/022]; Marie Curie Intra-European Fellowship for Career Development [FP7-PEOPLE-2010-IEF-273673]; MRC [MC_UU_12013/1] Funding Source: UKRI; British Heart Foundation [PG/13/66/30442] Funding Source: researchfish; Medical Research Council [MC_UU_12013/1] Funding Source: researchfish	Department of Health Policy Research Programme (England); British Heart Foundation(British Heart Foundation); Marie Curie Intra-European Fellowship for Career Development; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Department of Health Policy Research Programme (England) [grant 0090049] and the British Heart Foundation [grant PG/09/022]. EN was a recipient of a Marie Curie Intra-European Fellowship for Career Development [grant No FP7-PEOPLE-2010-IEF-273673]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson J, 2004, AGE AGEING, V33, P293, DOI 10.1093/ageing/afh090; Agusti AGN, 2002, PULM PHARMACOL THER, V15, P425, DOI 10.1006/pupt.2002.0385; Alley DE, 2010, AM J EPIDEMIOL, V172, P558, DOI 10.1093/aje/kwq168; Bennett A. E., 1975, QUESTIONNAIRES MED G; Bjorge T, 2008, AM J EPIDEMIOL, V168, P30, DOI 10.1093/aje/kwn096; Boffetta P, 2006, CANCER EPIDEM BIOMAR, V15, P1184, DOI 10.1158/1055-9965.EPI-06-0032; Chen ZM, 2012, INT J EPIDEMIOL, V41, P472, DOI 10.1093/ije/dyr208; Cotes JE, 2006, LUNG FUNCTION PHYSL, P87; de Hollander EL, 2012, INT J EPIDEMIOL, V41, P805, DOI 10.1093/ije/dys008; Ebrahim S, 2008, HUM GENET, V123, P15, DOI 10.1007/s00439-007-0448-6; EuroQol Group, 2009, EQ 5D STAND INSTR US; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Franzosi MG, 2006, LANCET, V368, P624, DOI 10.1016/S0140-6736(06)69222-2; Gaunt TR, 2012, EUR J HUM GENET; Gulland Anne, 2010, BMJ, V341, pc3585, DOI 10.1136/bmj.c3585; Jefferis BJ, 2010, ATHEROSCLEROSIS, V208, P550, DOI 10.1016/j.atherosclerosis.2009.07.044; Lainscak Mitja, 2007, Curr Opin Support Palliat Care, V1, P299, DOI 10.1097/SPC.0b013e3282f31667; Lawlor DA, 2004, BRIT J CANCER, V91, P512, DOI 10.1038/sj.bjc.6601916; Lawlor DA, 2002, J EPIDEMIOL COMMUN H, V56, P473, DOI 10.1136/jech.56.6.473; Lawlor DA, 2005, AM J PUBLIC HEALTH, V95, P91, DOI 10.2105/AJPH.2003.035592; Lawlor DA, 2003, J EPIDEMIOL COMMUN H, V57, P134, DOI 10.1136/jech.57.2.134; Leyland AH, 2010, INT J OBES LOND; Lopez-Jimenez F, 2009, LANCET, V373, P1055, DOI 10.1016/S0140-6736(09)60628-0; Newman AB, 2001, J AM GERIATR SOC, V49, P1309, DOI 10.1046/j.1532-5415.2001.49258.x; Nuesch E, 2012, EUR J EPIDEMIOL, V27, P633, DOI 10.1007/s10654-012-9706-6; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Prescott E, 2002, EUR RESPIR J, V20, P539, DOI 10.1183/09031936.02.00532002; Smith GD, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5043; Stevens J, 2008, INT J OBESITY, V32, pS60, DOI 10.1038/ijo.2008.88; The Emerging Risk Factors Collaboration, 2011, LANCET; University of Cambridge, 2010, EUR PROSP INV CANC; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5	33	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0115446	10.1371/journal.pone.0115446	http://dx.doi.org/10.1371/journal.pone.0115446			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EX	25884834	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000353017000001
J	Lee, E; Jung, DY; Kim, JH; Patel, PR; Hu, XD; Lee, Y; Azuma, Y; Wang, HF; Tsitsilianos, N; Shafiq, U; Kwon, JY; Lee, HJ; Lee, KW; Kim, JK				Lee, Eunjung; Jung, Dae Young; Kim, Jong Hun; Patel, Payal R.; Hu, Xiaodi; Lee, Yongjin; Azuma, Yoshihiro; Wang, Hsun-Fan; Tsitsilianos, Nicholas; Shafiq, Umber; Kwon, Jung Yeon; Lee, Hyong Joo; Lee, Ki Won; Kim, Jason K.			Transient receptor potential vanilloid type-1 channel regulates diet-induced obesity, insulin resistance, and leptin resistance	FASEB JOURNAL			English	Article						capsaicin; hyperinsulinemic-euglycemic clamp; glucose metabolism; aging	IMPAIRED NOCICEPTION; SKELETAL-MUSCLE; PAIN SENSATION; MICE LACKING; CAPSAICIN; CALCIUM; TRPV1; METABOLISM; INTERVENTION; INFLAMMATION	Insulin resistance is a major characteristic of obesity and type 2 diabetes, but the underlying mechanism is unclear. Recent studies have shown a metabolic role of capsaicin that may be mediated via the transient receptor potential vanilloid type-1 (TRPV1) channel. In this study, TRPV1 knockout (KO) and wild-type (WT) mice (as controls) were fed a high-fat diet (HFD), and metabolic studies were performed to measure insulin and leptin action. The TRPV1 KO mice became more obese than the WT mice after HFD, partly attributed to altered energy balance and leptin resistance in the KO mice. The hyperinsulinemic-euglycemic clamp experiment showed that the TRPV1 KO mice were more insulin resistant after HFD because of the similar to 40% reduction inglucose metabolism in the white and brown adipose tissue, compared with that in the WT mice. Leptin treatment failed to suppress food intake, and leptin-mediated hypothalamic signal transducer and activator of transcription (STAT)-3 activity was blunted in the TRPV1 KO mice. We also found that the TRPV1 KO mice were more obese and insulin resistant than the WT mice at 9 mo of age. Taken together, these results indicate that lacking TRPV1 exacerbates the obesity and insulin resistance associated with an HFD and aging, and our findings further suggest that TRPV1 has a major role in regulating glucose metabolism and hypothalamic leptin's effects in obesity.	[Lee, Eunjung; Jung, Dae Young; Kim, Jong Hun; Patel, Payal R.; Hu, Xiaodi; Lee, Yongjin; Azuma, Yoshihiro; Wang, Hsun-Fan; Tsitsilianos, Nicholas; Shafiq, Umber; Kwon, Jung Yeon; Kim, Jason K.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Kim, Jason K.] Univ Massachusetts, Sch Med, Dept Med, Div Endocrinol Metab & Diabet, Worcester, MA 01605 USA; [Lee, Eunjung; Lee, Hyong Joo; Lee, Ki Won; Kim, Jason K.] Seoul Natl Univ, World Class Univ Biomodulat Major, Dept Agr Biotechnol, Seoul, South Korea; [Lee, Eunjung; Lee, Hyong Joo; Lee, Ki Won; Kim, Jason K.] Seoul Natl Univ, Ctr Food & Bioconvergence, Seoul, South Korea; [Lee, Eunjung] Korea Food Res Inst, Tradit Alcohol Beverage Res Team, Songnam, South Korea; [Kim, Jong Hun; Kwon, Jung Yeon; Lee, Ki Won] Seoul Natl Univ, Adv Inst Convergence Technol, Suwon, South Korea	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Seoul National University (SNU); Seoul National University (SNU); Korea Food Research Institute (KFRI); Seoul National University (SNU)	Kim, JK (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 368 Plantat St,AS9-1041, Worcester, MA 01605 USA.	kiwon@snu.ac.kr; jason.kim@umassmed.edu	Lee, Ki Won/M-4114-2018	Kim, Jason/0000-0002-7185-042X	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK080756, U24-DK093000, R24-DK090963]; National Leap Research Program Grant [2010-0029233]; National Research Foundation of Korea - Ministry of Science, Information and Communications Technology, and Future Planning [2012M3A9C4048818]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK090963, U24DK093000, R01DK080756] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Leap Research Program Grant; National Research Foundation of Korea - Ministry of Science, Information and Communications Technology, and Future Planning; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grants R01-DK080756, U24-DK093000, and R24-DK090963 to J.K.K.; National Leap Research Program Grant 2010-0029233 to K.W.L.; and National Research Foundation of Korea Grant 2012M3A9C4048818 to K.W.L. funded by the Ministry of Science, Information and Communications Technology, and Future Planning.	Abramowitz J., 2007, V179, P379; Bjorbaek C, 2000, J BIOL CHEM, V275, P40649, DOI 10.1074/jbc.M007577200; Carruth BR, 2001, INT J OBESITY, V25, P559, DOI 10.1038/sj.ijo.0801562; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Coppari R, 2005, CELL METAB, V1, P63, DOI 10.1016/j.cmet.2004.12.004; Coppari R, 2012, NAT REV DRUG DISCOV, V11, P692, DOI 10.1038/nrd3757; Cummings BP, 2011, P NATL ACAD SCI USA, V108, P14670, DOI 10.1073/pnas.1107163108; Hong EG, 2009, DIABETES, V58, P2525, DOI 10.2337/db08-1261; Huo L, 2009, CELL METAB, V9, P537, DOI 10.1016/j.cmet.2009.05.003; Jung DY, 2013, AM J PHYSIOL-ENDOC M, V304, pE964, DOI 10.1152/ajpendo.00462.2012; Kang JH, 2010, OBESITY, V18, P780, DOI 10.1038/oby.2009.301; Kim HJ, 2004, DIABETES, V53, P1060, DOI 10.2337/diabetes.53.4.1060; Kim JH, 1996, FASEB J, V10, P1646, DOI 10.1096/fasebj.10.14.9002558; Kusudo T, 2012, J APPL PHYSIOL, V112, P1223, DOI 10.1152/japplphysiol.01070.2011; Lee E, 2013, TOXICOL APPL PHARM, V272, P12, DOI 10.1016/j.taap.2013.04.030; Lin YC, 2000, J AM COLL NUTR, V19, P754, DOI 10.1080/07315724.2000.10718075; Mittendorfer B, 2011, DIABETES, V60, P1474, DOI 10.2337/db10-1302; Motter AL, 2008, FEBS LETT, V582, P2257, DOI 10.1016/j.febslet.2008.05.021; Negri L, 2006, J NEUROSCI, V26, P6716, DOI 10.1523/JNEUROSCI.5403-05.2006; Oral EA, 2002, NEW ENGL J MED, V346, P570, DOI 10.1056/NEJMoa012437; Palmer RK, 2013, CURR TOP MED CHEM, V13, P247; Rasouli N, 2008, J CLIN ENDOCR METAB, V93, pS64, DOI 10.1210/jc.2008-1613; Reed AS, 2010, DIABETES, V59, P894, DOI 10.2337/db09-1024; Reinbach HC, 2009, CLIN NUTR, V28, P260, DOI 10.1016/j.clnu.2009.01.010; Ribeiro AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023364; Riera CE, 2014, CELL, V157, P1023, DOI 10.1016/j.cell.2014.03.051; Romanovsky AA, 2009, PHARMACOL REV, V61, P228, DOI 10.1124/pr.109.001263; Shi H, 2001, FASEB J, V15, P291; Wang MY, 2010, P NATL ACAD SCI USA, V107, P4813, DOI 10.1073/pnas.0909422107; Wisse BE, 2004, J AM SOC NEPHROL, V15, P2792, DOI 10.1097/01.ASN.0000141966.69934.21; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Ye L, 2012, CELL, V151, P96, DOI 10.1016/j.cell.2012.08.034; Yu Q, 2012, MOL BIOL REP, V39, P7583, DOI 10.1007/s11033-012-1592-1; Zemel M. B., 2001, J AM COLL NUTR, V20, p440S; Zemel MB, 2000, FASEB J, V14, P1132, DOI 10.1096/fasebj.14.9.1132; Zhang LL, 2007, CIRC RES, V100, P1063, DOI 10.1161/01.RES.0000262653.84850.8b; Zhang ZY, 2012, AM J PHYSIOL-ENDOC M, V302, pE807, DOI 10.1152/ajpendo.00239.2011; Zhu ZM, 2011, PFLUG ARCH EUR J PHY, V461, P211, DOI 10.1007/s00424-010-0902-5	38	90	92	1	24	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3182	3192		10.1096/fj.14-268300	http://dx.doi.org/10.1096/fj.14-268300			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25888600	Green Published			2022-12-26	WOS:000358796900008
J	Chu, C; Zheng, GY; Hu, SG; Zhang, JS; Xie, SS; Ma, WB; Ni, MJ; Tang, CH; Zhou, L; Zhou, YC; Liu, MF; Li, YX; Zhang, YL				Chu, Chen; Zheng, Guangyong; Hu, Shuanggang; Zhang, Jinsong; Xie, Shengsong; Ma, Wubin; Ni, Minjie; Tang, Chunhua; Zhou, Lu; Zhou, Yuchuan; Liu, Mofang; Li, Yixue; Zhang, Yonglian			Epididymal Region-Specific miRNA Expression and DNA Methylation and Their Roles in Controlling Gene Expression in Rats	PLOS ONE			English	Article							MIR-200 FAMILY; MESSENGER-RNA; E-CADHERIN; MESENCHYMAL TRANSITION; MOUSE EPIDIDYMIS; REPRESSORS ZEB1; CANCER-CELLS; STEM-CELLS; MICRORNAS; DIFFERENTIATION	Region-specific gene expression is an intriguing feature of the mammalian epididymis. This unique property is essential for sperm maturation and storage, and it also implicates stringent and multi-level regulations of gene expression. Over the past decade, the androgen-driven activation of epididymal gene transcription has been extensively studied. However, it still remains largely unexplored whether and how other regulatory mechanisms, such as miRNAs and DNA methylation, are involved in controlling regional gene expression in the epididymis. Using microarray-based approaches, we studied the regional miRNA expression and DNA methylation profiles in 4 distinct epididymal regions (initial segment, caput, corpus and cauda) of rats. We found that the miR-200 family members were more expressed in caput, compared with cauda. By GSEA analysis, the differential expression of miR-200 family between caput and cauda was shown to be negatively correlated with their predicted target genes, among which 4 bona fide targets were verified by luciferase reporter assay. Predicted target genes of miR-200 family have enriched functions in anti-apoptosis, cell transportation and development, implying the regional diversity in epididymal functions. On the other hand, we revealed epididymal DNA methylation of 2002 CpG islands and 2771 gene promoters (-3.88-0.97kb), among which 1350 (67.43%) CpG islands and 2095 (75.60%) promoters contained region-specific DNA methylation. We observed significant and distinct functional enrichment in genes with specifically methylated promoters in each epididymal regions, but these DNA methylations did not show significant correlation with repressed gene transcription in the mature epididymis. Conclusively, we investigated the regional miRNA expression and DNA methylation in the rat epididymis and revealed a potential role of miR-200 family in gene expression regulation between caput and cauda. This may contribute to the distinct physiological function in sperm maturation / storage of caput / cauda epididymis.	[Chu, Chen; Hu, Shuanggang; Zhang, Jinsong; Xie, Shengsong; Ma, Wubin; Ni, Minjie; Tang, Chunhua; Zhou, Yuchuan; Liu, Mofang; Zhang, Yonglian] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol,Shanghai Key Lab Mol Andro, Shanghai 200031, Peoples R China; [Zheng, Guangyong] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Shanghai 200031, Peoples R China; [Zhou, Lu; Li, Yixue] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai 200031, Peoples R China; [Chu, Chen; Tang, Chunhua; Zhou, Lu] Chinese Acad Sci, Grad Univ, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, YX (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai 200031, Peoples R China.	yxli@sibs.ac.cn; ylzhang@sibcb.ac.cn	zhou, yuchuan/AAF-6202-2019; Chu, Chen/J-6527-2019; Ma, Wubin/P-3045-2017	Chu, Chen/0000-0001-8084-0867; 	National Basic Research Program [2014CB943103]; National Natural Science Foundation of China [31171115, 31301225]; SA-SIBS scholarship program	National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); SA-SIBS scholarship program	This work was supported by the National Basic Research Program (Grant No. 2014CB943103), National Natural Science Foundation of China (Grant No. 31171115 and Grant No. 31301225). The authors gratefully acknowledge the support of SA-SIBS scholarship program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Belleannee C, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110486; Belleannee C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034996; Bhardwaj A, 2012, MOL ENDOCRINOL, V26, P538, DOI 10.1210/me.2011-1059; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bjorkgren I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038457; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Chabory E, 2009, J CLIN INVEST, V119, P2074, DOI 10.1172/JCI38940; Chauvin TR, 2004, BIOL REPROD, V71, P560, DOI 10.1095/biolreprod.103.026302; Corpe CP, 2010, J CLIN INVEST, V120, P1069, DOI 10.1172/JCI39191; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Feng XL, 2014, CANCER LETT, V344, P166, DOI 10.1016/j.canlet.2013.11.004; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Grimm C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003250; Guerrero JA, 2014, BLOOD, V124, P3624, DOI 10.1182/blood-2014-04-566760; Hamzeh M, 2010, ENDOCRINOLOGY, V151, P4504, DOI 10.1210/en.2010-0023; Hsia N, 2004, BIOL REPROD, V70, P448, DOI 10.1095/biolreprod.103.021493; Hu SG, 2010, MOL ENDOCRINOL, V24, P2392, DOI 10.1210/me.2010-0226; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Ivey KN, 2010, CELL STEM CELL, V7, P36, DOI 10.1016/j.stem.2010.06.012; Jelinsky SA, 2007, BIOL REPROD, V76, P561, DOI 10.1095/biolreprod.106.057323; Jervis KM, 2001, BIOL REPROD, V65, P696, DOI 10.1095/biolreprod65.3.696; Khavari DA, 2010, CELL CYCLE, V9, P3880, DOI 10.4161/cc.9.19.13385; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Li P, 2001, SCIENCE, V291, P1783, DOI 10.1126/science.1056545; Ma WB, 2012, J BIOL CHEM, V287, P10189, DOI 10.1074/jbc.M111.303636; Newell-Price J, 2000, TRENDS ENDOCRIN MET, V11, P142, DOI 10.1016/S1043-2760(00)00248-4; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pellinen T, 2006, J CELL BIOL, V173, P767, DOI 10.1083/jcb.200509019; Robaire B, 2011, J ANDROL, V32, P592, DOI 10.2164/jandrol.111.014266; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Scacheri PC, 2006, METHOD ENZYMOL, V411, P270, DOI 10.1016/S0076-6879(06)11014-9; Simpson JC, 2004, J CELL SCI, V117, P6297, DOI 10.1242/jcs.01560; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tarantino C, 2010, FASEB J, V24, P3255, DOI 10.1096/fj.09-152207; Wang JF, 2010, BIOCHEM BIOPH RES CO, V402, P222, DOI 10.1016/j.bbrc.2010.10.002; Wang JF, 2010, ACTA BIOCH BIOPH SIN, V42, P628, DOI 10.1093/abbs/gmq073; Wu XJ, 2012, ACTA BIOCH BIOPH SIN, V44, P233, DOI 10.1093/abbs/gmr122; Zhang JS, 2010, ACTA BIOCH BIOPH SIN, V42, P145, DOI 10.1093/abbs/gmp116; Zhang SP, 2014, P NATL ACAD SCI USA, V111, P17266, DOI 10.1073/pnas.1419599111; Zhao Y, 2011, CELL MOL LIFE SCI, V68, P697, DOI 10.1007/s00018-010-0478-4; Zheng GY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S6; Zhou YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004106; Zou Q, 2014, COMPUT BIOL MED, V45, P157, DOI 10.1016/j.compbiomed.2013.12.007	52	17	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124450	10.1371/journal.pone.0124450	http://dx.doi.org/10.1371/journal.pone.0124450			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901964	Green Published, gold, Green Submitted			2022-12-26	WOS:000353331500087
J	Lopez-Estepa, M; Arda, A; Savko, M; Round, A; Shepard, WE; Bruix, M; Coll, M; Fernandez, FJ; Jimenez-Barbero, J; Vega, MC				Lopez-Estepa, Miguel; Arda, Ana; Savko, Martin; Round, Adam; Shepard, William E.; Bruix, Marta; Coll, Miquel; Fernandez, Francisco J.; Jimenez-Barbero, Jesus; Cristina Vega, M.			The Crystal Structure and Small-Angle X-Ray Analysis of CsdL/TcdA Reveal a New tRNA Binding Motif in the MoeB/E1 Superfamily	PLOS ONE			English	Article							S CLUSTER BIOGENESIS; BIOLOGICAL MACROMOLECULES; CYSTEINE DESULFURASE; SOLUTION SCATTERING; BIOSYNTHESIS; TRNA(LYS); RESOLUTION; PROTEINS; MODELS; SAXS	Cyclic N-6-threonylcarbamoyladenosine ('cyclic t(6)A', ct(6)A) is a non-thiolated hypermodification found in transfer RNAs (tRNAs) in bacteria, protists, fungi and plants. In bacteria and yeast cells ct(6)A has been shown to enhance translation fidelity and efficiency of ANN codons by improving the faithful discrimination of aminoacylated tRNAs by the ribosome. To further the understanding of ct(6)A biology we have determined the high-resolution crystal structures of CsdL/TcdA in complex with AMP and ATP, an E1-like activating enzyme from Escherichia coli, which catalyzes the ATP-dependent dehydration of t(6)A to form ct(6)A. CsdL/TcdA is a dimer whose structural integrity and dimer interface depend critically on strongly bound K+ and Na+ cations. By using biochemical assays and small-angle X-ray scattering we show that CsdL/TcdA can associate with tRNA with a 1:1 stoichiometry and with the proper position and orientation for the cyclization of t(6)A. Furthermore, we show by nuclear magnetic resonance that CsdL/TcdA engages in transient interactions with CsdA and CsdE, which, in the latter case, involve catalytically important residues. These short-lived interactions may underpin the precise channeling of sulfur atoms from cysteine to CsdL/TcdA as previously characterized. In summary, the combination of structural, biophysical and biochemical methods applied to CsdL/TcdA has afforded a more thorough understanding of how the structure of this E1-like enzyme has been fine tuned to accomplish ct(6)A synthesis on tRNAs while providing support for the notion that CsdA and CsdE are able to functionally interact with CsdL/TcdA.	[Lopez-Estepa, Miguel; Arda, Ana; Fernandez, Francisco J.; Jimenez-Barbero, Jesus; Cristina Vega, M.] CSIC, CIB, Biol Res Ctr, Chem & Phys Biol, Madrid, Spain; [Arda, Ana; Jimenez-Barbero, Jesus] CIC BioGUNE, Struct Biol, Derio Bizkaia, Spain; [Savko, Martin; Shepard, William E.] Synchrotron SOLEIL, Gif Sur Yvette, France; [Round, Adam] European Mol Biol Lab, Grenoble Outstat, F-38042 Grenoble, France; [Round, Adam] Univ Grenoble Alpes, EMBL CNRS, Unit Virus Host Cell Interact, Martyrs, France; [Bruix, Marta] CSIC, IFQR, Inst Phys Chem Rocasolano, Madrid, Spain; [Coll, Miquel] IRB Barcelona, Inst Res Biomed, Barcelona, Spain; [Coll, Miquel] CSIC, IBMB, Inst Biol Mol Barcelona, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); CIC bioGUNE; SOLEIL Synchrotron; European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Vega, MC (corresponding author), CSIC, CIB, Biol Res Ctr, Chem & Phys Biol, Madrid, Spain.	cvega@cib.csic.es	Bruix, Marta/H-4161-2011; Coll, Miquel/L-5999-2014; JIMENEZ-BARBERO, JESUS/D-4431-2014; Vega, M. Cristina/C-3640-2011; Fernandez, Francisco J./C-3647-2011	Bruix, Marta/0000-0002-0096-3558; Coll, Miquel/0000-0003-4471-8674; JIMENEZ-BARBERO, JESUS/0000-0001-5421-8513; Vega, M. Cristina/0000-0003-0628-8378; Fernandez, Francisco J./0000-0002-5015-1849; Shepard, William/0000-0002-5724-1193	Ministerio de Economia y Competitividad [PET2008_0101, BIO2009-11184, BFU2010-22260-C02-02, BFU2008-02372/BMC, CONSOLIDER CSD 2006-23, BFU2011-22588, CTQ2012-32035]; Generalitat de Catalunya [SGR2009-1309]; European Commission [279039, 260644]	Ministerio de Economia y Competitividad(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); European Commission(European CommissionEuropean Commission Joint Research Centre)	Ministerio de Economia y Competitividad (ES) (grants PET2008_0101, BIO2009-11184 and BFU2010-22260-C02-02 to MCV, BFU2008-02372/BMC, CONSOLIDER CSD 2006-23 and BFU2011-22588 to MC, CTQ2012-32035 to JJB), Generalitat de Catalunya (ES) (grant SGR2009-1309 to MC), the European Commission (Framework Programme 7 (FP7) projects ComplexINC No. 279039 to MCV and SILVER-GA No. 260644 to MC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Agris PF, 2007, J MOL BIOL, V366, P1, DOI 10.1016/j.jmb.2006.11.046; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bolstad HM, 2010, J PROTEOME RES, V9, P5358, DOI 10.1021/pr1006087; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cole JL, 2004, METHOD ENZYMOL, V384, P212; El Yacoubi B, 2012, ANNU REV GENET, V46, P69, DOI 10.1146/annurev-genet-110711-155641; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Grosjean H., 2000, DNA RNA MODIFICATION, P1; GRZESIEK S, 1992, J MAGN RESON, V99, P201, DOI 10.1016/0022-2364(92)90169-8; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; Guinier A., 1955, SMALL ANGLE SCATTERI; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim S, 2014, ACTA CRYSTALLOGR F, V70, P1517, DOI 10.1107/S2053230X14020883; Kim S, 2013, J BIOL CHEM, V288, P27172, DOI 10.1074/jbc.M113.480277; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2011, ACTA CRYSTALLOGR D, V67, P376, DOI 10.1107/S0907444911007232; Lake MW, 2001, NATURE, V414, P325, DOI 10.1038/35104586; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lin CA, 2010, MOL CELL BIOL, V30, P354, DOI 10.1128/MCB.00754-09; Liu GH, 2005, PROTEIN SCI, V14, P1597, DOI 10.1110/ps.041322705; Loiseau L, 2005, J BIOL CHEM, V280, P26760, DOI 10.1074/jbc.M504067200; Machnicka Magdalena A, 2013, Nucleic Acids Res, V41, pD262, DOI 10.1093/nar/gks1007; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miyauchi K, 2013, NAT CHEM BIOL, V9, P105, DOI [10.1038/NCHEMBIO.1137, 10.1038/nchembio.1137]; Murphy FV, 2004, NAT STRUCT MOL BIOL, V11, P1186, DOI 10.1038/nsmb861; NIIMI T, 1994, NUCLEOS NUCLEOT NUCL, V13, P1231, DOI 10.1080/15257779408012147; Pernot P, 2013, J SYNCHROTRON RADIAT, V20, P660, DOI 10.1107/S0909049513010431; Phelps SS, 2004, J MOL BIOL, V338, P439, DOI 10.1016/j.jmb.2004.02.070; Porod G., 1982, SMALL ANGLE XRAY SCA, P17, DOI DOI 10.1002/ACTP.1985.010360520; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Round A, 2013, ACTA CRYSTALLOGR D, V69, P2072, DOI 10.1107/S0907444913019276; Schrodinger L., 2020, PYMOL; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SCHWEIZE.MP, 1969, BIOCHEMISTRY-US, V8, P3283, DOI 10.1021/bi00836a023; Stuart JW, 2000, BIOCHEMISTRY-US, V39, P13396, DOI 10.1021/bi0013039; Sundaram M, 2000, BIOCHEMISTRY-US, V39, P15652, DOI 10.1021/bi005120y; Suzuki T, 2005, TOP CURR GENET, V12, P23, DOI 10.1007/b106361; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Svergun DI, 2000, J BIOL CHEM, V275, P14432, DOI 10.1074/jbc.275.19.14432; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Trotter V, 2009, MOL MICROBIOL, V74, P1527, DOI 10.1111/j.1365-2958.2009.06954.x; Ucci JW, 2004, BIOPHYS CHEM, V108, P127, DOI 10.1016/j.bpc.2003.10.033; van de Weert M, 2010, J FLUORESC, V20, P625, DOI 10.1007/s10895-009-0572-x; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wei FY, 2011, J CLIN INVEST, V121, P3598, DOI 10.1172/JCI58056; WEISSENBACH J, 1981, EUR J BIOCHEM, V116, P207, DOI 10.1111/j.1432-1033.1981.tb05320.x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yarian C, 2002, J BIOL CHEM, V277, P16391, DOI 10.1074/jbc.M200253200	56	9	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0118606	10.1371/journal.pone.0118606	http://dx.doi.org/10.1371/journal.pone.0118606			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897750	Green Published, Green Submitted, gold			2022-12-26	WOS:000353212600001
J	Martinez-Cuenca, MR; Quinones, A; Primo-Millo, E; Forner-Giner, MA				Martinez-Cuenca, Mary-Rus; Quinones, Ana; Primo-Millo, Eduardo; Forner-Giner, M. Angeles			Flooding Impairs Fe Uptake and Distribution in Citrus Due to the Strong Down-Regulation of Genes Involved in Strategy I Responses to Fe Deficiency in Roots	PLOS ONE			English	Article							FERRIC-CHELATE REDUCTASE; IRON-DEFICIENCY; PHYSIOLOGICAL-RESPONSES; ANTIOXIDANT DEFENSE; REDUCING CAPACITY; PEACH ROOTSTOCKS; RT-PCR; TOLERANCE; BICARBONATE; SOIL	This work determines the ffects of long-term anoxia conditions-21 days-on Strategy I responses to iron (Fe) deficiency in Citrus and its impact on Fe uptake and distribution. The study was carried out in Citrus aurantium L. seedlings grown under flooding conditions (S) and in both the presence (+Fe) and absence of Fe (-Fe) in nutritive solution. The results revealed a strong down-regulation (more than 65%) of genes HA1 and FRO2 coding for enzymes proton-ATPase and Ferric-Chelate Reductase (FC-R), respectively, in -FeS plants when compared with -Fe ones. H+-extrusion and FC-R activity analyses confirmed the genetic results, indicating that flooding stress markedly repressed acidification and reduction responses to Fe deficiency (3.1- and 2.0-fold, respectively). Waterlogging reduced by half Fe concentration in +FeS roots, which led to 30% up-regulation of Fe transporter IRT1, although this effect was unable to improve Fe absorption. Consequently, flooding inhibited 57Fe uptake in +Fe and -Fe seedlings (29.8 and 66.2%, respectively) and 57Fe distribution to aerial part (30.6 and 72.3%, respectively). This evidences that the synergistic action of both enzymes H+-ATPase and FC-R is the preferential regulator of the Fe acquisition system under flooding conditions and, hence, their inactivation implies a limiting factor of citrus in their Fe-deficiency tolerance in waterlogged soils.	[Martinez-Cuenca, Mary-Rus; Quinones, Ana; Primo-Millo, Eduardo; Forner-Giner, M. Angeles] Valencian Inst Agrarian Res, Dept Citriculture & Vegetal Prod, Moncada, Valencia, Spain		Martinez-Cuenca, MR (corresponding author), Valencian Inst Agrarian Res, Dept Citriculture & Vegetal Prod, Moncada, Valencia, Spain.	martinez_mru@gva.es	Quinones, Ana/E-6229-2014; Forner-Giner, Angeles/D-5306-2014; Primo-Millo, Eduardo/D-8584-2014; Martinez-Cuenca, Mary-Rus/K-7710-2015	Quinones, Ana/0000-0002-6096-734X; Forner-Giner, Angeles/0000-0003-3237-0893; Primo-Millo, Eduardo/0000-0002-2146-0175; Martinez-Cuenca, Mary-Rus/0000-0002-9017-2951	National Institute of Research and Agrarian and Food Technology [RTA2011-00127]; Valencian Generalitat; FEDER funds	National Institute of Research and Agrarian and Food Technology; Valencian Generalitat; FEDER funds(European Commission)	This work was funded by the National Institute of Research and Agrarian and Food Technology (RTA2011-00127), Valencian Generalitat and FEDER funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadia J, 1999, PLANT SOIL, V215, P183, DOI 10.1023/A:1004451728237; Alcantara E, 2000, J PLANT NUTR, V23, P1607, DOI 10.1080/01904160009382127; Arbona V, 2008, J PLANT GROWTH REGUL, V27, P241, DOI 10.1007/s00344-008-9051-x; Arbona V, 2008, PHYSIOL PLANTARUM, V132, P452, DOI 10.1111/j.1399-3054.2007.01029.x; Balakhnina TI, 2010, PLANT SOIL, V327, P293, DOI 10.1007/s11104-009-0054-6; Brait JF, 2002, OXIDATIVE STRESS PLA, P171; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; CHANEY RL, 1972, PLANT PHYSIOL, V50, P208, DOI 10.1104/pp.50.2.208; Chouliaras V, 2004, AGRONOMIE, V24, P1, DOI 10.1051/agro:2003055; Colmer TD, 2009, FUNCT PLANT BIOL, V36, P665, DOI 10.1071/FP09144; Colmer TD, 2003, ANN BOT-LONDON, V91, P301, DOI 10.1093/aob/mcf114; Connolly EL, 2003, PLANT PHYSIOL, V133, P1102, DOI 10.1104/pp.103.025122; Connolly EL, 2002, PLANT CELL, V14, P1347, DOI 10.1105/tpc.001263; de la Guardia MD, 2002, PLANT SOIL, V241, P49, DOI 10.1023/A:1016083512158; De Simone O, 2003, TREES-STRUCT FUNCT, V17, P535, DOI 10.1007/s00468-003-0270-2; Donnini S, 2009, J PLANT PHYSIOL, V166, P1181, DOI 10.1016/j.jplph.2009.01.007; Felle HH, 2005, ANN BOT-LONDON, V96, P519, DOI 10.1093/aob/mci207; Fox TC, 1996, PLANT PHYSIOL, V111, P93, DOI 10.1104/pp.111.1.93; Fukao T, 2003, J EXP BOT, V54, P1421, DOI 10.1093/jxb/erg140; Garcia-Sanchez F, 2007, PHYSIOL PLANTARUM, V130, P532, DOI 10.1111/j.1399-3054.2007.00925.x; Gharsalli M, 2002, J PLANT NUTR, V25, P1139, DOI 10.1081/PLN-120003945; Gimeno V, 2012, HORTSCIENCE, V47, P403, DOI 10.21273/HORTSCI.47.3.403; Gogorcena Y, 2004, J PLANT NUTR, V27, P1701, DOI [10.1081/LPLA-200026406, 10.1081/PLN-200026406]; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Hell R, 2003, PLANTA, V216, P541, DOI 10.1007/s00425-002-0920-4; Hossain Z, 2009, J PLANT PHYSIOL, V166, P1391, DOI 10.1016/j.jplph.2009.02.012; Jelali N, 2010, SCI HORTIC-AMSTERDAM, V124, P116, DOI 10.1016/j.scienta.2009.12.010; Jeong J, 2009, PLANT SCI, V176, P709, DOI 10.1016/j.plantsci.2009.02.011; Kato-Noguchi H, 2000, PHYSIOL PLANTARUM, V109, P28, DOI 10.1034/j.1399-3054.2000.100105.x; Khabaz-Saberi H, 2010, EUPHYTICA, V172, P275, DOI 10.1007/s10681-009-0069-3; Kim SA, 2007, FEBS LETT, V581, P2273, DOI 10.1016/j.febslet.2007.04.043; Kosegarten H, 2001, PHYSIOL PLANTARUM, V113, P515, DOI 10.1034/j.1399-3054.2001.1130410.x; Ksouri R, 2007, PLANT PHYSIOL BIOCH, V45, P315, DOI 10.1016/j.plaphy.2007.03.014; LAAN P, 1991, PLANT SOIL, V136, P153, DOI 10.1007/BF02150046; Ladygin VG, 2004, APPL BIOCHEM MICRO+, V40, P506, DOI 10.1023/B:ABIM.0000040676.09063.6e; LARSON KD, 1991, SOIL SCI, V152, P33, DOI 10.1097/00010694-199107000-00006; Lin KH, 2008, ANN APPL BIOL, V152, P157, DOI 10.1111/j.1744-7348.2007.00211.x; Lucena C, 2007, FUNCT PLANT BIOL, V34, P1002, DOI 10.1071/FP07136; MANTHEY JA, 1994, PLANT PHYSIOL BIOCH, V32, P211; Marschner H., 1995, MINERAL NUTR HIGHER, P651; Martinez-Alcantara B, 2012, J PLANT PHYSIOL, V169, P1150, DOI 10.1016/j.jplph.2012.03.016; Martinez-Cuenca MR, 2013, PLANT SOIL, V373, P943, DOI 10.1007/s11104-013-1861-3; Martinez-Cuenca MR, 2013, SCI HORTIC-AMSTERDAM, V153, P56, DOI 10.1016/j.scienta.2013.01.009; Martinez-Cuenca MR, 2013, ACTA PHYSIOL PLANT, V35, P2853; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Molassiotis A, 2006, J PLANT PHYSIOL, V163, P176, DOI 10.1016/j.jplph.2004.11.016; MORAN R, 1980, PLANT PHYSIOL, V65, P478, DOI 10.1104/pp.65.3.478; Msilini N, 2009, ACTA PHYSIOL PLANT, V31, P849, DOI 10.1007/s11738-009-0318-z; Pestana M, 2005, SCI HORTIC-AMSTERDAM, V104, P25, DOI 10.1016/j.scienta.2004.07.007; Pezeshki SR, 2001, ENVIRON EXP BOT, V46, P299, DOI 10.1016/S0098-8472(01)00107-1; Ponnamperuma F. N., 1984, Flooding and plant growth, P9; Rodriguez-Gamir J, 2011, PLANT PHYSIOL BIOCH, V49, P636, DOI 10.1016/j.plaphy.2011.03.003; RuizSanchez MC, 1996, PLANT SCI, V120, P119, DOI 10.1016/S0168-9452(96)04494-9; Ryser P, 2011, PLANT SOIL, V343, P247, DOI 10.1007/s11104-011-0715-0; Santi S, 2005, PLANT PHYSIOL BIOCH, V43, P287, DOI 10.1016/j.plaphy.2005.02.007; Santi S, 2009, NEW PHYTOL, V183, P1072, DOI 10.1111/j.1469-8137.2009.02908.x; Schaffer B, 2006, HORTSCIENCE, V41, P549, DOI 10.21273/HORTSCI.41.3.549; Schaffer B., 1992, Horticultural Reviews, V13, P257, DOI 10.1002/9780470650509.ch7; SCHMIDT W, 1990, J PLANT PHYSIOL, V136, P51, DOI 10.1016/S0176-1617(11)81614-7; Snowden RED, 1995, NEW PHYTOL, V131, P503, DOI 10.1111/j.1469-8137.1995.tb03087.x; SYVERTSEN JP, 1983, PLANT SOIL, V72, P3, DOI 10.1007/BF02185089; TREEBY M, 1993, Z PFLANZ BODENKUNDE, V156, P75, DOI 10.1002/jpln.19931560112; Unger IM, 2009, AGR ECOSYST ENVIRON, V131, P105, DOI 10.1016/j.agee.2008.09.013; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; Vert G, 2009, PLANTA, V229, P1171, DOI 10.1007/s00425-009-0904-8; Visser EJW, 2000, PLANT CELL ENVIRON, V23, P1237, DOI 10.1046/j.1365-3040.2000.00628.x; VU JCV, 1991, PHYSIOL PLANTARUM, V81, P7, DOI 10.1111/j.1399-3054.1991.tb01705.x; Waters BM, 2002, PLANT PHYSIOL, V129, P85, DOI 10.1104/pp.010829; Wegner LH, 2004, PLANT PHYSIOL, V136, P3469, DOI 10.1104/pp.104.043844; WHITE PF, 1990, PLANT SOIL, V125, P39, DOI 10.1007/BF00010742; Yan JW, 2012, MOL BIOL REP, V39, P1831, DOI 10.1007/s11033-011-0925-9; ZOCCHI G, 1990, PLANT PHYSIOL, V92, P908, DOI 10.1104/pp.92.4.908; Zude-Sasse M., 2000, Proceedings of the Florida State Horticultural Society, V113, P1	73	12	13	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123644	10.1371/journal.pone.0123644	http://dx.doi.org/10.1371/journal.pone.0123644			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897804	Green Submitted, Green Published, gold			2022-12-26	WOS:000353212600038
J	Rutstein, SE; Hosseinipour, MC; Kamwendo, D; Soko, A; Mkandawire, M; Biddle, AK; Miller, WC; Weinberger, M; Wheeler, SB; Sarr, A; Gupta, S; Chimbwandira, F; Mwenda, R; Kamiza, S; Hoffman, I; Mataya, R				Rutstein, Sarah E.; Hosseinipour, Mina C.; Kamwendo, Deborah; Soko, Alice; Mkandawire, Memory; Biddle, Andrea K.; Miller, William C.; Weinberger, Morris; Wheeler, Stephanie B.; Sarr, Abdoulaye; Gupta, Sundeep; Chimbwandira, Frank; Mwenda, Reuben; Kamiza, Steve; Hoffman, Irving; Mataya, Ronald			Dried Blood Spots for Viral Load Monitoring in Malawi: Feasible and Effective	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HIV-1 DRUG-RESISTANCE; TREATMENT FAILURE; IMMUNOLOGICAL CRITERIA; VIROLOGICAL FAILURE; INFECTED ADULTS; HIGH-FREQUENCY; VERSION 2.0; CELL COUNT; PLASMA	Objectives To evaluate the feasibility and effectiveness of dried blood spots (DBS) use for viral load (VL) monitoring, describing patient outcomes and programmatic challenges that are relevant for DBS implementation in sub-Saharan Africa. Methods We recruited adult antiretroviral therapy (ART) patients from five district hospitals in Malawi. Eligibility reflected anticipated Ministry of Health VL monitoring criteria. Testing was conducted at a central laboratory. Virological failure was defined as >5000 copies/ml. Primary outcomes were program feasibility (timely result availability and patient receipt) and effectiveness (second-line therapy initiation). Results We enrolled 1,498 participants; 5.9% were failing at baseline. Median time from enrollment to receipt of results was 42 days; 79.6% of participants received results within 3 months. Among participants with confirmed elevated VL, 92.6% initiated second-line therapy; 90.7% were switched within 365 days of VL testing. Nearly one-third (30.8%) of participants with elevated baseline VL had suppressed (<5,000 copies/ml) on confirmatory testing. Median period between enrollment and specimen testing was 23 days. Adjusting for relevant covariates, participants on ART >4 years were more likely to be failing than participants on therapy 1-4 years (RR 1.7, 95% CI 1.0-2.8); older participants were less likely to be failing (RR 0.95, 95% CI 0.92-0.98). There was no difference in likelihood of failure based on clinical symptoms (RR 1.17, 95% CI 0.65-2.11). Conclusions DBS for VL monitoring is feasible and effective in real-world clinical settings. Centralized DBS testing may increase access to VL monitoring in remote settings. Programmatic outcomes are encouraging, especially proportion of eligible participants switched to secondline therapy.	[Rutstein, Sarah E.; Biddle, Andrea K.; Weinberger, Morris; Wheeler, Stephanie B.] Univ N Carolina, Dept Hlth Policy & Management, Chapel Hill, NC 27514 USA; [Rutstein, Sarah E.; Hosseinipour, Mina C.; Miller, William C.] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Hosseinipour, Mina C.; Kamwendo, Deborah; Soko, Alice] Univ North Carolina Project, Lilongwe, Malawi; [Mkandawire, Memory; Mataya, Ronald] Loma Linda Univ, Sch Publ Hlth, Loma Linda, CA 92350 USA; [Miller, William C.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Sarr, Abdoulaye; Gupta, Sundeep] Ctr Dis Control, Lilongwe, Malawi; [Chimbwandira, Frank; Mwenda, Reuben] Minist Hlth, Lilongwe, Malawi; [Kamiza, Steve] Coll Med, Blantyre, Malawi	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Loma Linda University; University of North Carolina; University of North Carolina Chapel Hill; University of Malawi	Rutstein, SE (corresponding author), Univ N Carolina, Dept Hlth Policy & Management, Chapel Hill, NC 27514 USA.	sarah_rutstein@med.unc.edu	Miller, William C/H-4800-2014	Miller, William C/0000-0002-1934-7827	Public Health Evaluation of use of Dried Blood Spots for Viral Load Monitoring [MW.10.1433];  [F30 MH098731]; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) [U2GPS001965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH098731] Funding Source: NIH RePORTER	Public Health Evaluation of use of Dried Blood Spots for Viral Load Monitoring; ; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	MW.10.1433 (http://www.cdc.gov/globalhealth/countries/malawi/) Public Health Evaluation of use of Dried Blood Spots for Viral Load Monitoring received by RM. The funder assisted in the early stages of study design, and AS and SG were involved in preparation of the manuscript. Funders were not involved in data collection, analysis or decision to publish. F30 MH098731 (http://www.nimh.nih.gov/index.shtml) Fellowship support for SER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	[Anonymous], 2011, CLIN MAN HIV CHILDR; [Anonymous], 2014, HIV AIDS DIAGN TECHN; [Anonymous], 2013, INT HIV PROGR REP JU; [Anonymous], 2014, GLOB AIDS RESP PROGR; Arredondo M, 2012, J CLIN MICROBIOL, V50, P569, DOI 10.1128/JCM.00418-11; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Brambilla D, 2003, J CLIN MICROBIOL, V41, P1888, DOI 10.1128/JCM.41.5.1888-1893.2003; Chaiwarith R, 2007, INT J INFECT DIS, V11, P413, DOI 10.1016/j.ijid.2006.11.003; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; El-Khatib Z, 2011, J AIDS CLIN RES, V2; Estill J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057611; Fajardo E, 2014, J CLIN MICROBIOL, V52, P1343, DOI 10.1128/JCM.03519-13; Fiscus SA, 1998, J CLIN MICROBIOL, V36, P258, DOI 10.1128/JCM.36.1.258-260.1998; Ford N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010460; Fox MP, 2012, JAIDS-J ACQ IMM DEF, V60, P428, DOI 10.1097/QAI.0b013e3182557785; Gsponer T, 2012, AIDS, V26, P57, DOI 10.1097/QAD.0b013e32834e1b5f; Gupta RK, 2014, CLIN INFECT DIS, V58, P1023, DOI 10.1093/cid/cit933; Gupta RK, 2009, LANCET INFECT DIS, V9, P409, DOI 10.1016/S1473-3099(09)70136-7; Hosseinipour MC, 2009, AIDS, V23, P1127, DOI 10.1097/QAD.0b013e32832ac34e; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Johannessen A, 2009, CLIN INFECT DIS, V49, P976, DOI 10.1086/605502; Kamya MR, 2007, JAIDS-J ACQ IMM DEF, V46, P187, DOI 10.1097/QAI.0b013e31814278c0; Keiser O, 2011, AIDS, V25, P1761, DOI 10.1097/QAD.0b013e328349822f; Keiser O, 2010, TROP MED INT HEALTH, V15, P251, DOI 10.1111/j.1365-3156.2009.02445.x; Koyalta D, 2009, CLIN INFECT DIS, V49, P155, DOI 10.1086/599611; Kumarasamy N, 2009, CLIN INFECT DIS, V49, P306, DOI 10.1086/600044; Loutfy MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055747; Maldonado F, 2009, T ROY SOC TROP MED H, V103, P607, DOI 10.1016/j.trstmh.2008.07.014; Marconi VC, 2008, CLIN INFECT DIS, V46, P1589, DOI 10.1086/587109; McMahon JH, 2013, B WORLD HEALTH ORGAN, V91, P377, DOI 10.2471/BLT.12.112946; Mee P, 2008, AIDS, V22, P1971, DOI 10.1097/QAD.0b013e32830e4cd8; Mermin J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6792; Monleau M, 2014, J CLIN MICROBIOL, V52, P578, DOI 10.1128/JCM.02860-13; Moore DM, 2008, JAIDS-J ACQ IMM DEF, V49, P477, DOI 10.1097/QAI.0b013e318186eb18; O'Shea S, 1999, AIDS, V13, P630, DOI 10.1097/00002030-199904010-00019; Orrell C, 2007, ANTIVIR THER, V12, P83; Ouma KN, 2013, J CLIN MICROBIOL, V51, P1208, DOI 10.1128/JCM.03048-12; Pagano M., 2018, PRINCIPLES BIOSTATIS; Pannus P, 2013, JAIDS-J ACQ IMM DEF, V64, P134, DOI 10.1097/QAI.0b013e3182a61e63; Phan V, 2013, JAIDS-J ACQ IMM DEF, V62, P509, DOI 10.1097/QAI.0b013e318285d28c; Rawizza HE, 2011, CLIN INFECT DIS, V53, P1283, DOI 10.1093/cid/cir729; Reynolds SJ, 2009, ANTIVIR THER, V14, P293; Reynolds SJ, 2009, AIDS, V23, P697, DOI 10.1097/QAD.0b013e3283262a78; Rutstein SE, 2014, J CLIN VIROL; Sigaloff KCE, 2011, JAIDS-J ACQ IMM DEF, V58, P23, DOI 10.1097/QAI.0b013e318227fc34; Smit P. W., 2014, PLOS ONE, V9, P6, DOI DOI 10.1371/J0URNAL.P0NE.0086461; UNAIDS, 2013, ACC ANT THER AFR STA; van Oosterhout JJG, 2009, TROP MED INT HEALTH, V14, P856, DOI 10.1111/j.1365-3156.2009.02309.x; van Zyl GU, 2011, JAIDS-J ACQ IMM DEF, V56, P333, DOI 10.1097/QAI.0b013e31820dc0cc; WHO, 2021, HIV AIDS	53	29	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124748	10.1371/journal.pone.0124748	http://dx.doi.org/10.1371/journal.pone.0124748			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898365	Green Published, gold, Green Submitted			2022-12-26	WOS:000353212600082
J	Wagh, D; Terry-Lorenzo, R; Waites, CL; Leal-Ortiz, SA; Maas, C; Reimer, RJ; Garner, CC				Wagh, Dhananjay; Terry-Lorenzo, Ryan; Waites, Clarissa L.; Leal-Ortiz, Sergio A.; Maas, Christoph; Reimer, Richard J.; Garner, Craig C.			Piccolo Directs Activity Dependent F-Actin Assembly from Presynaptic Active Zones via Daam1	PLOS ONE			English	Article							FORMIN DAAM1; SYNAPTIC VESICLES; PROTEIN; ENDOCYTOSIS; PROFILIN; BINDING; ACTIVATION; PLASTICITY; SYNAPSIN; CDC42	The dynamic assembly of filamentous (F) actin plays essential roles in the assembly of presynaptic boutons, the fusion, mobilization and recycling of synaptic vesicles (SVs), and presynaptic forms of plasticity. However, the molecular mechanisms that regulate the temporal and spatial assembly of presynaptic F-actin remain largely unknown. Similar to other F-actin rich membrane specializations, presynaptic boutons contain a set of molecules that respond to cellular cues and trans-synaptic signals to facilitate activity-dependent assembly of F-actin. The presynaptic active zone (AZ) protein Piccolo has recently been identified as a key regulator of neurotransmitter release during SV cycling. It does so by coordinating the activity-dependent assembly of F-Actin and the dynamics of key plasticity molecules including Synapsin1, Profilin and CaMKII. The multidomain structure of Piccolo, its exquisite association with the AZ, and its ability to interact with a number of actin-associated proteins suggest that Piccolo may function as a platform to coordinate the spatial assembly of F-actin. Here we have identified Daam1, a Formin that functions with Profilin to drive F-actin assembly, as a novel Piccolo binding partner. We also found that within cells Daam1 activation promotes Piccolo binding, an interaction that can spatially direct the polymerization of F-Actin. Moreover, similar to Piccolo and Profilin, Daam1 loss of function impairs presynaptic-F-actin assembly in neurons. These data suggest a model in which Piccolo directs the assembly of presynaptic F-Actin from the AZ by scaffolding key actin regulatory proteins including Daam1.	[Wagh, Dhananjay; Terry-Lorenzo, Ryan; Leal-Ortiz, Sergio A.; Maas, Christoph; Garner, Craig C.] Stanford Univ, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Waites, Clarissa L.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Reimer, Richard J.] Stanford Univ, Dept Neurol & Neurol Sci, Palo Alto, CA 94304 USA; [Reimer, Richard J.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; Columbia University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Garner, CC (corresponding author), Stanford Univ, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.	cgarner@stanford.edu		Garner, Craig/0000-0003-1970-5417	NIH [NS39471, NS353862]; United States/Israel Binational Science Foundation [2007425]; German Center for Neurodegenerative Diseases (DZNE); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039471] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States/Israel Binational Science Foundation(US-Israel Binational Science Foundation); German Center for Neurodegenerative Diseases (DZNE)(Helmholtz Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants NS39471 and NS353862, the United States/Israel Binational Science Foundation (2007425) and German Center for Neurodegenerative Diseases (DZNE) to CCG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad-Annuar A, 2006, J CELL BIOL, V174, P127, DOI 10.1083/jcb.200511054; Aspenstrom P, 2006, EXP CELL RES, V312, P2180, DOI 10.1016/j.yexcr.2006.03.013; BANKER G, 1998, CULTURING NERVE CELL; Bloom O, 2003, J CELL BIOL, V161, P737, DOI 10.1083/jcb.200212140; Boyl PP, 2007, EMBO J, V26, P2991, DOI 10.1038/sj.emboj.7601737; Brodin L, 2006, CELL TISSUE RES, V326, P301, DOI 10.1007/s00441-006-0216-2; Bruses JL, 2006, MOL NEUROBIOL, V33, P237, DOI 10.1385/MN:33:3:237; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; CasesLanghoff C, 1996, EUR J CELL BIOL, V69, P214; Chavrier P, 1999, CURR OPIN CELL BIOL, V11, P466, DOI 10.1016/S0955-0674(99)80067-2; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; Colombo A, 2013, DEVELOPMENT, V140, P3997, DOI 10.1242/dev.091934; Darcy KJ, 2006, NAT NEUROSCI, V9, P315, DOI 10.1038/nn1640; Di Nardo A, 2000, J CELL SCI, V113, P3795; Dillon C, 2005, ANNU REV NEUROSCI, V28, P25, DOI 10.1146/annurev.neuro.28.061604.135757; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Evergren E, 2007, J NEUROSCI RES, V85, P2648, DOI 10.1002/jnr.21176; Fenster SD, 2000, NEURON, V25, P203, DOI 10.1016/S0896-6273(00)80883-1; Fujimoto K, 2002, J BIOL CHEM, V277, P50497, DOI 10.1074/jbc.M210146200; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Gareus R, 2006, J BIOL CHEM, V281, P2803, DOI 10.1074/jbc.M503528200; GREENGARD P, 1994, ADV SEC MESS PHOSPH, V29, P31; Gu C, 2003, SCIENCE, V301, P646, DOI 10.1126/science.1086998; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Higashi T, 2008, J BIOL CHEM, V283, P8746, DOI 10.1074/jbc.M707839200; Hilfiker S, 1999, PHILOS T ROY SOC B, V354, P269, DOI 10.1098/rstb.1999.0378; HIROKAWA N, 1989, J CELL BIOL, V108, P111, DOI 10.1083/jcb.108.1.111; Jaiswal R, 2013, CURR BIOL, V23, P1373, DOI 10.1016/j.cub.2013.06.013; Jensen V, 2007, J PHYSIOL-LONDON, V583, P129, DOI 10.1113/jphysiol.2007.131300; Jordan R, 2005, BIOPHYS J, V89, P2091, DOI 10.1529/biophysj.105.061663; Jungling K, 2006, J NEUROSCI, V26, P6968, DOI 10.1523/JNEUROSCI.1013-06.2006; Kim S, 2003, J BIOL CHEM, V278, P6291, DOI 10.1074/jbc.M212287200; LASSING I, 1985, NATURE, V314, P472, DOI 10.1038/314472a0; Leal-Ortiz S, 2008, J CELL BIOL, V181, P831, DOI 10.1083/jcb.200711167; Liu W, 2008, P NATL ACAD SCI USA, V105, P210, DOI 10.1073/pnas.0707277105; Liu YH, 2005, J BIOL CHEM, V280, P8884, DOI 10.1074/jbc.M412200200; Maas C, 2012, J NEUROSCI, V32, P11095, DOI 10.1523/JNEUROSCI.0195-12.2012; Matusek T, 2008, J NEUROSCI, V28, P13310, DOI 10.1523/JNEUROSCI.2727-08.2008; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; Moseley JB, 2006, METHOD ENZYMOL, V406, P215, DOI 10.1016/S0076-6879(06)06016-2; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Qualmann B, 2002, INT REV CYTOL, V220, P93; Rivera GM, 2004, CURR BIOL, V14, P11, DOI 10.1016/j.cub.2003.12.033; Rosenmund C, 2003, CURR OPIN NEUROBIOL, V13, P509, DOI 10.1016/j.conb.2003.09.011; Ryan TA, 1999, J NEUROSCI, V19, P1317; Salomon SN, 2008, NEUROSCI LETT, V447, P62, DOI 10.1016/j.neulet.2008.09.051; Sankaranarayanan S, 2003, NAT NEUROSCI, V6, P127, DOI 10.1038/nn1002; Sato A, 2006, DEVELOPMENT, V133, P4219, DOI 10.1242/dev.02590; Schoch S, 2006, CELL TISSUE RES, V326, P379, DOI 10.1007/s00441-006-0244-y; Schonichen A, 2010, BBA-MOL CELL RES, V1803, P152, DOI 10.1016/j.bbamcr.2010.01.014; Shen WH, 2006, NEURON, V50, P401, DOI 10.1016/j.neuron.2006.03.017; Shupliakov O, 2002, P NATL ACAD SCI USA, V99, P14476, DOI 10.1073/pnas.212381799; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Udo H, 2005, NEURON, V45, P887, DOI 10.1016/j.neuron.2005.01.044; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Waites CL, 2011, J NEUROSCI, V31, P14250, DOI 10.1523/JNEUROSCI.1835-11.2011; Waites CL, 2009, J NEUROSCI, V29, P4332, DOI 10.1523/JNEUROSCI.4431-08.2009; Wang HG, 2005, NEURON, V45, P389, DOI 10.1016/j.neuron.2005.01.011; Wang XL, 1999, J CELL BIOL, V147, P151, DOI 10.1083/jcb.147.1.151; Watanabe S, 2013, NATURE, V504, P242, DOI 10.1038/nature12809; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; Yamashita M, 2007, GENES CELLS, V12, P1255, DOI 10.1111/j.1365-2443.2007.01132.x; Yao J, 2006, J NEUROSCI, V26, P8137, DOI 10.1523/JNEUROSCI.1183-06.2006; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001	69	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0120093	10.1371/journal.pone.0120093	http://dx.doi.org/10.1371/journal.pone.0120093			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897839	Green Published, Green Submitted, gold			2022-12-26	WOS:000353212600003
J	Seuss, B; Wisshak, M; Mapes, RH; Landman, NH				Seuss, Barbara; Wisshak, Max; Mapes, Royal H.; Landman, Neil H.			Syn-Vivo Bioerosion of Nautilus by Endo- and Epilithic Foraminiferans (New Caledonia and Vanuatu)	PLOS ONE			English	Article							MUSSEL PERNA-PERNA; TAPHONOMY; SHELLS; ENDOLITHS; FUNGI	A variety of syn-vivo bioerosion traces produced by foraminiferans is recorded in shells of Nautilus sampled near New Caledonia and Vanuatu. These are two types of attachment scars of epilithic foraminiferans and two forms of previously undescribed microborings, a spiral-shaped and a dendritic one, both most likely being the work of endolithic 'naked' foraminiferans. Scanning electron microscopy of epoxy-resin casts of the latter revealed that these traces occur in clusters of up to many dozen individuals and potentially are substrate-specific. The foraminiferan traces are the sole signs of bioerosion in the studied Nautilus conchs, and neither traces of phototrophic nor other chemotrophic microendoliths were found. While the complete absence of photoautotrophic endoliths would be in good accordance with the life habit of Nautilus, which resides in aphotic deep marine environments and seeks shallower waters in the photic zone for feeding only during night-time, the absence of any microbial bioerosion may also be explained by an effective defence provided by the nautilid periostracum. Following this line of reasoning, the recorded foraminiferan bioerosion traces in turn would identify their trace makers as being specialized in their ability to penetrate the periostracum barrier and to bioerode the shell of modern Nautilus.	[Seuss, Barbara] Univ Erlangen Nurnberg, GeoZentrum Nordbayern Palaoumwelt, D-91054 Erlangen, Germany; [Wisshak, Max] Senckenberg Meer, Marine Res Dept, D-26382 Wilhelmshaven, Germany; [Mapes, Royal H.] North Carolina Museum Nat Sci, Raleigh, NC 27601 USA; [Landman, Neil H.] Amer Museum Nat Hist, New York, NY 10024 USA	University of Erlangen Nuremberg; Senckenberg Gesellschaft fur Naturforschung (SGN); American Museum of Natural History (AMNH)	Seuss, B (corresponding author), Univ Erlangen Nurnberg, GeoZentrum Nordbayern Palaoumwelt, Loewenichstr 28, D-91054 Erlangen, Germany.	barbara.seuss@fau.de	Wisshak, Max/A-3418-2011; Seuss, Barbara/G-5131-2011	Wisshak, Max/0000-0001-7531-3317; Seuss, Barbara/0000-0001-6615-8108	University of Erlangen-Nuremberg; Deutsche Forschungsgemeinschaft; Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)	University of Erlangen-Nuremberg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)	The project was funded by a research grant provided by the University of Erlangen-Nuremberg to the first author ("Bavarian Equal Opportunities Sponsorship - Forderung von Frauen in Forschung und Lehre (FFL) - Promoting Equal Opportunities for Women in Research and Teaching"). The authors acknowledge support by Deutsche Forschungsgemeinschaft and Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing.	Beuck L, 2008, CURRENT DEVELOPMENTS IN BIOEROSION, P329, DOI 10.1007/978-3-540-77598-0_17; Bonacum J, 2011, AM MALACOL BULL, V29, P77, DOI 10.4003/006.029.0221; Bromley RG, 2004, GEOL SOC SPEC PUBL, V228, P455, DOI 10.1144/GSL.SP.2004.228.01.20; Bromley Richard G., 2007, P518, DOI 10.1016/B978-044452949-7/50158-3; Bromley Richard G., 1994, P134; CEDHAGEN T, 1994, SARSIA, V79, P65, DOI 10.1080/00364827.1994.10413549; Che LM, 1996, MAR BIOL, V126, P509; Debenay JP, 2012, GUIDE 1000 FORAMINIF; Freiwald A, 1996, MAR MICROPALEONTOL, V28, P199, DOI 10.1016/0377-8398(96)00002-3; Glaub Ingrid, 2007, P368, DOI 10.1016/B978-044452949-7/50147-9; Golubic S, 2005, TRENDS MICROBIOL, V13, P229, DOI 10.1016/j.tim.2005.03.007; GOLUBIC S, 1970, LETHAIA, V3, P203, DOI 10.1111/j.1502-3931.1970.tb01858.x; GOLUBIC S, 1983, PRAPARATOR, V29, P197; Golubic S., 1975, STUDY TRACE FOSSILS, P229; HOOK JE, 1990, PSZNI MAR ECOL, V11, P239, DOI 10.1111/j.1439-0485.1990.tb00242.x; HOOK JE, 1988, PSZNI MAR ECOL, V9, P347, DOI 10.1111/j.1439-0485.1988.tb00212.x; Kaehler S, 1999, MAR BIOL, V135, P505, DOI 10.1007/s002270050651; Kaehler S, 1999, MAR BIOL, V135, P497, DOI 10.1007/s002270050650; Klug C, 2007, CEPHALOPODS PRESENT AND PAST: NEW INSIGHTS AND FRESH PERSPECTIVES, P205, DOI 10.1007/978-1-4020-6806-5_10; Landman NH, 2010, TOP GEOBIOL, V6, P163; Maeda H, 2003, PALAIOS, V18, P421, DOI 10.1669/0883-1351(2003)018<0421:TFOALP>2.0.CO;2; MAPES R. H., 1996, AMMONOID PALEOBIOLOG, V13, P104; Mapes RH, 2003, PREDATOR PREY INTERA, P77; Mapes RH, 2010, PALAIOS, V25, P597, DOI 10.2110/palo.2009.p09-109r; Mapes RH, 2010, PALAIOS, V25, P656, DOI 10.2110/palo.2010.p10-010r; NEUMANN AC, 1966, LIMNOL OCEANOGR, V11, P92, DOI 10.4319/lo.1966.11.1.0092; Neumann Christian, 2006, Ichnos, V13, P185, DOI 10.1080/10420940600853954; Plewes C.R., 1993, Journal of Micropalaeontology, V12, P83; Ritterbush KA, 2014, J ZOOL, V292, P229, DOI 10.1111/jzo.12118; Saunders W. B., 2009, NAUTILUS BIOL PALEOB; Seuss B, PALAIOS IN PRESS; Seuss B, 2016, ICHNOS, V23, P108, DOI 10.1080/10420940.2015.1030074; TODD RUTH, 1965, DEEP SEA RES, V12, P831, DOI 10.1016/0011-7471(65)90806-5; VENECPEYRE MT, 1987, CORAL REEFS, V5, P205, DOI 10.1007/BF00300966; VenecPeyre MT, 1996, MAR MICROPALEONTOL, V28, P19, DOI 10.1016/0377-8398(95)00037-2; Waite J.H., 1983, P467; Wani R, 2004, LETHAIA, V37, P113, DOI 10.1080/00241160410006420; Wani R, 2007, ACTA PALAEONTOL POL, V52, P77; Warme JE., 1975, STUDY TRACE FOSSILS, P181, DOI DOI 10.1007/978-3-642-65923-2_11; Wilson Mark A., 2007, P356, DOI 10.1016/B978-044452949-7/50146-7; Wisshak M, 2006, FACIES, V52, P1, DOI 10.1007/s10347-005-0033-1; Wisshak M, 2011, GEOBIOLOGY, V9, P492, DOI 10.1111/j.1472-4669.2011.00299.x; Wisshak M., 2012, DEV SEDIMENTOL, V64, P213; Wisshak M, 2008, CURRENT DEVELOPMENTS IN BIOEROSION, P21, DOI 10.1007/978-3-540-77598-0_2; Zapalski MK, 2007, PALAEONTOLOGY, V50, P1375, DOI 10.1111/j.1475-4983.2007.00716.x	45	10	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0125558	10.1371/journal.pone.0125558	http://dx.doi.org/10.1371/journal.pone.0125558			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894584	Green Submitted, gold, Green Published			2022-12-26	WOS:000353211700140
J	Amano, S; Chang, YT; Fukui, Y				Amano, Shigeru; Chang, Yu-Tzu; Fukui, Yasuhisa			ERK5 Activation Is Essential for Osteoclast Differentiation	PLOS ONE			English	Article							DC-STAMP; RANKL; CELLS	The MEK/ERK pathways are critical for controlling cell proliferation and differentiation. In this study, we show that the MEK5/ERK5 pathway participates in osteoclast differentiation. ERK5 was activated by M-CSF, which is one of the essential factors in osteoclast differentiation. Inhibition of MEK5 by BIX02189 or inhibition of ERK5 by XMD 8-92 blocked osteoclast differentiation. MEK5 knockdown inhibited osteoclast differentiation. RAW264.7D clone cells, which are monocytic cells, differentiate into osteoclasts after stimulation with sRANKL. ERK5 was activated without any stimulation in these cells. Inhibition of the MEK5/ERK5 pathway by the inhibitors also blocked the differentiation of RAW264.7D cells into osteoclasts. Moreover, expression of the transcription factor c-Fos, which is indispensable for osteoclast differentiation, was inhibited by treatment with MEK5 or ERK5 inhibitors. Therefore, activation of ERK5 is required for the induction of c-Fos. These events were confirmed in experiments using M-CSF-dependent bone marrow macrophages. Taken together, the present results show that activation of the MEK5/ERK5 pathway with M-CSF is required for osteoclast differentiation, which may induce differentiation through the induction of c-Fos.	[Amano, Shigeru] Meikai Univ, Sch Dent, Div Microbiol & Immunol, Dept Oral Biol & Tissue Engn, Sakado, Saitama, Japan; [Chang, Yu-Tzu; Fukui, Yasuhisa] Natl Hlth Res Inst, Zhunan Town, Miaoli County, Taiwan	Meikai University; National Health Research Institutes - Taiwan	Fukui, Y (corresponding author), Natl Hlth Res Inst, Zhunan Town, Miaoli County, Taiwan.	990412@nhri.org.tw			Ministry of Education, Science, Sports, and Culture of Japan [22592047, 25670799]; Miyata Foundation, Meikai University; National Health Research Institute [01A1-CSPP04-014]; National Science Council Taiwan [101-2300-B-400-015]; Grants-in-Aid for Scientific Research [25670799] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Miyata Foundation, Meikai University; National Health Research Institute(National Health Research Institutes - Taiwan); National Science Council Taiwan(Ministry of Science and Technology, Taiwan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the grants-in-aid from the Ministry of Education, Science, Sports, and Culture of Japan (no. 22592047 and no. 25670799) and a grant from the Miyata Foundation, Meikai University to S.A. and grants from the National Health Research Institute (01A1-CSPP04-014) and the National Science Council Taiwan (101-2300-B-400-015) to Y. F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano S, 2009, J CELL PHYSIOL, V221, P40, DOI 10.1002/jcp.21827; Drew BA, 2012, BBA-REV CANCER, V1825, P37, DOI 10.1016/j.bbcan.2011.10.002; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Hotokezaka H, 2002, J BIOL CHEM, V277, P47366, DOI 10.1074/jbc.M208284200; Kukita T, 2004, J EXP MED, V200, P941, DOI 10.1084/jem.20040518; Meadows NA, 2007, J BIOL CHEM, V282, P1891, DOI 10.1074/jbc.M608572200; Mellis DJ, 2011, J ENDOCRINOL, V211, P131, DOI 10.1530/JOE-11-0212; Nithianandarajah-Jones GN, 2012, CELL SIGNAL, V24, P2187, DOI 10.1016/j.cellsig.2012.07.007; Shinohara M, 2010, GASTROENTEROLOGY, V139, P2050, DOI 10.1053/j.gastro.2010.08.052; Watanabe T, 2004, J ENDOCRINOL, V180, P193, DOI 10.1677/joe.0.1800193; Yagi M, 2006, J BONE MINER METAB, V24, P355, DOI 10.1007/s00774-006-0697-9	11	19	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0125054	10.1371/journal.pone.0125054	http://dx.doi.org/10.1371/journal.pone.0125054			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885811	Green Submitted, Green Published, gold			2022-12-26	WOS:000353017000148
J	Chizimba, R; Christofides, N; Chirwa, T; Singini, I; Ozumba, C; Sikwese, S; Banda, HT; Banda, R; Chimbali, H; Ngwira, B; Munthali, A; Nyasulu, P				Chizimba, Robert; Christofides, Nicola; Chirwa, Tobias; Singini, Isaac; Ozumba, Chineme; Sikwese, Simon; Banda, Hastings T.; Banda, Rhoda; Chimbali, Henry; Ngwira, Bagrey; Munthali, Alister; Nyasulu, Peter			The Association between Multiple Sources of Information and Risk Perceptions of Tuberculosis, Ntcheu District, Malawi	PLOS ONE			English	Article							SOCIAL DETERMINANTS	Background Tuberculosis (TB) is one of the main causes of death in developing countries. Awareness and perception of risk of TB could influence early detection, diagnosis and care seeking at treatment centers. However, perceptions about TB are influenced by sources of information. Aim This study aimed to determine the association between multiple sources of information, and perceptions of risk of TB among adults aged 18-49 years. Methods A cross-sectional study was conducted in Ntcheu district in Malawi. A total of 121 adults were sampled in a three-stage simple random sampling technique. Data were collected using a structured questionnaire. Perceptions of risk were measured using specific statements that reflected common myths and misconceptions. Low risk perception implied a person having strong belief in myths and misconceptions about TB and high risk perception meant a person having no belief in myths or misconceptions and demonstrated understanding of the disease. Results Females were more likely to have low risk perceptions about TB compared to males (67.7% vs. 32.5%, p = 0.01). The higher the household asset index the more likely an individual had higher risk perceptions about TB (p = 0.006). The perception of risk of TB was associated with sources of information (p = 0.03). Use of both interpersonal communication and mass media was 2.8 times more likely to be associated with increased perception of risk of TB (Odds Ratio [OR] = 2.8; 95% Confidence interva1[CI]: 3.1-15. 6; p = 0.01). After adjusting for sex and asset ownership, use of interpersonal communication and mass media were more likely to be associated with higher perception of risk of TB (OR, 2.0; 95% CI: 1.65-10.72; p = 0.003) compared with interpersonal communication only (OR 1.6, 95%; CI: 1.13-8.98, p = 0.027). Conclusion The study found that there was association between multiple sources of information, and higher perceptions of risk of TB among adults aged 18-49 years.	[Chizimba, Robert] Save Children Int, Dept Hlth, Lilongwe, Malawi; [Ozumba, Chineme; Nyasulu, Peter] Sch Hlth Sci, Dept Publ Hlth, Monash, South Africa; [Chizimba, Robert; Christofides, Nicola; Chirwa, Tobias; Sikwese, Simon; Nyasulu, Peter] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa; [Singini, Isaac] Univ Malawi, Johns Hopkins Res Project, Coll Med, Blantyre, Malawi; [Sikwese, Simon] Pakachere Inst Hlth & Dev Commun, Blantyre, Malawi; [Banda, Hastings T.] Res Equ & Community Hlth REACH Trust, Lilongwe, Malawi; [Banda, Rhoda] Minist Hlth, Natl TB Control Program, Community Hlth Sci Unit, Lilongwe, Malawi; [Chimbali, Henry] Minist Hlth, Hlth Promot Serv, Lilongwe, Malawi; [Ngwira, Bagrey] Univ Malawi, Dept Community Hlth, Coll Med, Blantyre, Malawi; [Munthali, Alister] Univ Malawi, Ctr Social Res, Zomba, Malawi	Save the Children; University of Witwatersrand; University of Malawi; University of Malawi; University of Malawi	Nyasulu, P (corresponding author), Sch Hlth Sci, Dept Publ Hlth, Monash, South Africa.	peter.nyasulu@monash.edu	Chirwa, Tobias/AAI-9087-2021					Bacay-Domingo M.C.N., 2009, PEDIAT INFECT DIS SO, V10, P28; Banerjee A, 2000, INT J TUBERC LUNG D, V4, P1047; Banerjee A, 1999, T ROY SOC TROP MED H, V93, P392, DOI 10.1016/S0035-9203(99)90128-1; Fatiregun A. A., 2010, Tanzania Journal of Health Research, V12, punpaginated; Hargreaves JR, 2011, AM J PUBLIC HEALTH, V101, P654, DOI 10.2105/AJPH.2010.199505; Harries AD, 1997, T ROY SOC TROP MED H, V91, P15, DOI 10.1016/S0035-9203(97)90376-X; Hoa N. P., 2008, HLTH POLICY, V90, P8, DOI [DOI 10.1016/J.HEALTHP0L.2008.08.006, 10.1016/j.healthpol.2008.08.006]; Karim F, 2011, PUBLIC HEALTH, V125, P84, DOI 10.1016/j.puhe.2010.10.005; Dias AAL, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-595; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Makesh D., 2011, GLOBAL MEDIA J INDIA, V2; Nyirenda Thomas, 2006, Malawi Med J, V18, P147; Onyeonoro UU, 2013, HEALTH EDUC, V113, P536, DOI 10.1108/HE-10-2012-0050; Simwaka Bertha Nhlema, 2007, Int J Equity Health, V6, P24, DOI 10.1186/1475-9276-6-24; Waisbord S, 2008, SOC IDENT, V14, P505, DOI 10.1080/13504630802212009; WHO, 2012, WHOHTMTB20107; WHO, 2012, MAL COUNTR OFF 2012; World Health Organization, 2010, WHOHTMTB20107; World Health Organization, 2013, WHOHTMTB201311; World Health Organization, 2007, NAT TUB CONTR PROGR; Wu PS, 2009, J FORMOS MED ASSOC, V108, P377, DOI 10.1016/S0929-6646(09)60081-4	21	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0122998	10.1371/journal.pone.0122998	http://dx.doi.org/10.1371/journal.pone.0122998			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EX	25885532	gold, Green Submitted, Green Published			2022-12-26	WOS:000353017000046
J	Downie, LE; Keller, PR				Downie, Laura Elizabeth; Keller, Peter Richard			The Self-Reported Clinical Practice Behaviors of Australian Optometrists as Related to Smoking, Diet and Nutritional Supplementation	PLOS ONE			English	Article							MACULAR DEGENERATION; CIGARETTE-SMOKING; FATTY-ACIDS; GENERAL-PRACTITIONERS; AGE; RISK; CESSATION; OMEGA-3; CARE; CONSUMPTION	Objective The primary aim of this study was to examine the self-reported, routine clinical practice behaviors of Australian optometrists with respect to advice regarding smoking, diet and nutritional supplementation. The study also sought to assess the potential influence of practitioner age, gender, practice location (major city versus regional), therapeutic-endorsement status and personal nutritional supplementation habits upon management practices in these areas. Methods A survey was electronically distributed to Australian optometrists (n = 4,242). Respondents anonymously provided information about their personal demographics and lifestyle behaviors (i.e., age, gender, practice location, therapeutic-endorsement status, smoking status, nutritional supplement intake) and routine patient management practices with respect to advice across three domains: smoking, diet and nutritional supplementation. Multivariate logistic regression analyses were performed to assess for potential effects of the listed factors on practitioner behavior. Results A total of 283 completed surveys were received (completed survey response rate: 6.7%). Fewer than half of respondents indicated routinely asking their patients about smoking status. Younger practitioners were significantly (p < 0.05) less likely to enquire about patients' smoking behaviors, but this did not extend to counseling for smoking cessation. Almost two-thirds of respondents indicated routinely counseling patients about diet. About half of practitioners specified routinely asking their patients about nutritional supplement intake; this form of questioning was significantly more likely if the respondent was female (p < 0.05). Practitioners who recommended nutritional supplements most commonly did so for age-related macular degeneration (91.2%) and dry eye disease (63.9%). The primary source of evidence used to guide practitioners' nutrition-related patient management was reported to be peer-reviewed publications. Conclusions These findings demonstrate that there are no clear predictors of practitioner behavior across the three domains. Overall, this study suggests that there is scope for Australian optometrists to improve their routine engagement by questioning patients, as well as providing evidence-based clinical advice, about smoking status, diet and nutritional supplement behaviors, being key modifiable lifestyle risk factors with long-term implications for eye health.	[Downie, Laura Elizabeth; Keller, Peter Richard] Univ Melbourne, Dept Optometry & Vis Sci, Parkville, Vic 3010, Australia; [Keller, Peter Richard] Ctr Eye Res Australia, Macular Res Unit, East Melbourne, Vic 3002, Australia	University of Melbourne; Centre for Eye Research Australia	Downie, LE (corresponding author), Univ Melbourne, Dept Optometry & Vis Sci, Parkville, Vic 3010, Australia.	ldownie@unimelb.edu.au		Downie, Laura/0000-0002-1596-2259; Keller, Peter/0000-0003-4431-184X				Augood C, 2008, AM J CLIN NUTR, V88, P398, DOI 10.1093/ajcn/88.2.398; Australian Bureau of Statistics, 2010, 1216 0 AUSTR STAND G; Bernstein PS, 2010, VISION RES, V50, P716, DOI 10.1016/j.visres.2009.10.014; Brignole-Baudouin F, 2011, ACTA OPHTHALMOL, V89, pE591, DOI 10.1111/j.1755-3768.2011.02196.x; Brule J, 2012, CLIN EXP OPTOM, V95, P599, DOI 10.1111/j.1444-0938.2012.00748.x; Caban-Martinez AJ, 2011, PREV CHRONIC DIS, V8; Carroll T, 2003, TOB CONTROL, V12, P40; Chew EY, 2013, JAMA-J AM MED ASSOC, V309, P2005, DOI 10.1001/jama.2013.4997; CHRISTEN WG, 1992, JAMA-J AM MED ASSOC, V268, P989; Cockburn David M, 2005, Clin Exp Optom, V88, P2; Coleman HR, 2008, LANCET, V372, P1835, DOI 10.1016/S0140-6736(08)61759-6; Deloitte Access Economics-Macular Disease Foundation, 2011, EYES FUT CLEAR OUTL; Downie LE, 2013, OPTOMETRY VISION SCI, V90, P1385, DOI 10.1097/OPX.0000000000000087; Downie LE, 2014, OPTOMETRY VISION SCI, V91, P821, DOI 10.1097/OPX.0000000000000285; Downie LE, 2015, NUTRITION; Druesne-Pecollo N, 2010, INT J CANCER, V127, P172, DOI 10.1002/ijc.25008; Evans JR, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000254.pub3; Evans JR, 2005, BRIT J OPHTHALMOL, V89, P550, DOI 10.1136/bjo.2004.049726; Galor A, 2011, CURR OPIN OPHTHALMOL, V22, P477, DOI 10.1097/ICU.0b013e32834bbe7a; Handa S, 2011, EYE, V25, P1170, DOI 10.1038/eye.2011.143; HANKINSON SE, 1992, JAMA-J AM MED ASSOC, V268, P994, DOI 10.1001/jama.268.8.994; Health Workforce Australia, 2014, AUSTR HLTH WORKF SER; Jalbert I, 2013, EXP EYE RES, V117, P138, DOI 10.1016/j.exer.2013.08.016; Kangari H, 2013, OPHTHALMOLOGY, V120, P2191, DOI 10.1016/j.ophtha.2013.04.006; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Khan JC, 2006, BRIT J OPHTHALMOL, V90, P75, DOI 10.1136/bjo.2005.073643; Klein ML, 2011, ARCH OPHTHALMOL-CHIC, V129, P1543, DOI 10.1001/archophthalmol.2011.216; KLEIN R, 1993, AM J EPIDEMIOL, V137, P190, DOI 10.1093/oxfordjournals.aje.a116659; Lancaster T, 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD000165.PUB2; Lawrenson JG, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-564; Loo DLS, 2009, CLIN EXP OPTOM, V92, P42, DOI 10.1111/j.1444-0938.2008.00283.x; Merle BMJ, 2013, J NUTR, V143, P505, DOI 10.3945/jn.112.171033; Olenik A, 2013, CLIN INTERV AGING, V8, P1133, DOI 10.2147/CIA.S48955; Optometry Australia, 2014, POS STAT OPT WORKF; Optometry Australia, 2014, REG CHANG FORC 1 DEC; Rotstein NP, 1997, J NEUROCHEM, V69, P504; SanGiovanni JP, 2007, ARCH OPHTHALMOL-CHIC, V125, P1225, DOI 10.1001/archopht.125.9.1225; SanGiovanni JP, 2005, PROG RETIN EYE RES, V24, P87, DOI 10.1016/j.preteyeres.2004.06.002; Seddon JM, 1996, JAMA-J AM MED ASSOC, V276, P1141, DOI 10.1001/jama.276.14.1141; SEDDON JM, 1994, JAMA-J AM MED ASSOC, V272, P1413, DOI 10.1001/jama.272.18.1413; Sheck LHN, 2009, CLIN EXP OPTOM, V92, P75, DOI 10.1111/j.1444-0938.2009.00348.x; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; Swanson MW, 2014, OPTOMETRY VISION SCI, V91, P865, DOI 10.1097/OPX.0000000000000315; Thompson C, 2007, OPHTHAL PHYSL OPT, V27, P389, DOI 10.1111/j.1475-1313.2007.00483.x; Thornton J, 2005, EYE, V19, P935, DOI 10.1038/sj.eye.6701978; U.S. Department of Health and Human Services, 2008, TREATING TOBACCO USE; Unim B, 2013, ANN I SUPER SANITA, V49, P266, DOI 10.4415/ANN_13_03_06; Verbiest MEA, 2014, NICOTINE TOB RES, V16, P1, DOI 10.1093/ntr/ntt100; Wojtowicz JC, 2011, CORNEA, V30, P308, DOI 10.1097/ICO.0b013e3181f22e03	49	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124533	10.1371/journal.pone.0124533	http://dx.doi.org/10.1371/journal.pone.0124533			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886641	Green Published, gold, Green Submitted			2022-12-26	WOS:000353017000135
J	Fan, Y; Liu, Y; Xue, K; Gu, GB; Fan, WM; Xu, YL; Ding, ZD				Fan, Yong; Liu, Yue; Xue, Ke; Gu, Guobao; Fan, Weimin; Xu, Yali; Ding, Zhide			Diet-Induced Obesity in Male C57BL/6 Mice Decreases Fertility as a Consequence of Disrupted Blood-Testis Barrier	PLOS ONE			English	Article							BODY-MASS INDEX; SPERM DNA INTEGRITY; SEMEN QUALITY; ANDROGEN RECEPTOR; INFERTILITY; SERTOLI; TESTOSTERONE; ASSOCIATION; ENDOCYTOSIS; TGF-BETA-3	Obesity is a complex metabolic disease that is a serious detriment to both children and adult health, which induces a variety of diseases, such as cardiovascular disease, type II diabetes, hypertension and cancer. Although adverse effects of obesity on female reproduction or oocyte development have been well recognized, its harmfulness to male fertility is still unclear because of reported conflicting results. The aim of this study was to determine whether diet-induced obesity impairs male fertility and furthermore to uncover its underlying mechanisms. Thus, male C57BL/6 mice fed a high-fat diet (HFD) for 10 weeks served as a model of diet-induced obesity. The results clearly show that the percentage of sperm motility and progressive motility significantly decreased, whereas the proportion of teratozoospermia dramatically increased in HFD mice compared to those in normal diet fed controls. Besides, the sperm acrosome reaction fell accompanied by a decline in testosterone level and an increase in estradiol level in the HFD group. This alteration of sperm function parameters strongly indicated that the fertility of HFD mice was indeed impaired, which was also validated by a low pregnancy rate in their mated normal female. Moreover, testicular morphological analyses revealed that seminiferous epithelia were severely atrophic, and cell adhesions between spermatogenic cells and Sertoli cells were loosely arranged in HFD mice. Meanwhile, the integrity of the blood-testis barrier was severely interrupted consistent with declines in the tight junction related proteins, occludin, ZO-1 and androgen receptor, but instead endocytic vesicle-associated protein, clathrin rose. Taken together, obesity can impair male fertility through declines in the sperm function parameters, sex hormone level, whereas during spermatogenesis damage to the blood-testis barrier (BTB) integrity may be one of the crucial underlying factors accounting for this change.	[Fan, Yong; Liu, Yue; Xue, Ke; Fan, Weimin; Xu, Yali; Ding, Zhide] Shanghai Jiao Tong Univ, Sch Med, Dept Human Anat Histol & Embryol, Shanghai Key Lab Reprod Med, Shanghai 200030, Peoples R China; [Gu, Guobao] Cent Hosp Zhabei Dist, Dept Med Lab Sci, Shanghai, Peoples R China; [Fan, Weimin] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Human Reprod Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Ding, ZD (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Human Anat Histol & Embryol, Shanghai Key Lab Reprod Med, Shanghai 200030, Peoples R China.	zding@shsmu.edu.cn	Liu, Yue/GQP-1774-2022		National Natural Science Foundation of China [81370752]; Shanghai Municipal Education Commission [12ZZ108]; Science and Technology Commission of Shanghai Municipality [12ZR1445900, 14140901600]; Shanghai Leading Academic Discipline Project [S30201]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	Support was provided by the National Natural Science Foundation of China (No. 81370752), Shanghai Municipal Education Commission (no. 12ZZ108), the Science and Technology Commission of Shanghai Municipality (no. 12ZR1445900 and no. 14140901600) and the Shanghai Leading Academic Discipline Project (no. S30201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggerholm AS, 2008, FERTIL STERIL, V90, P619, DOI 10.1016/j.fertnstert.2007.07.1292; Bakos HW, 2011, INT J ANDROL, V34, P402, DOI 10.1111/j.1365-2605.2010.01092.x; Cabler S, 2010, ASIAN J ANDROL, V12, P480, DOI 10.1038/aja.2010.38; Chavarro JE, 2010, FERTIL STERIL, V93, P2222, DOI 10.1016/j.fertnstert.2009.01.100; Cheng CY, 2012, PHARMACOL REV, V64, P16, DOI 10.1124/pr.110.002790; Cheng CY, 2010, NAT REV ENDOCRINOL, V6, P380, DOI 10.1038/nrendo.2010.71; Du Plessis SS, 2010, NAT REV UROL, V7, P153, DOI 10.1038/nrurol.2010.6; Fariello RM, 2012, BJU INT, V110, P863, DOI 10.1111/j.1464-410X.2011.10813.x; Fejes I, 2005, ANDROLOGIA, V37, P155, DOI 10.1111/j.1439-0272.2005.00671.x; Ghanayem BI, 2010, BIOL REPROD, V82, P96, DOI 10.1095/biolreprod.109.078915; GIAGULLI VA, 1994, J CLIN ENDOCR METAB, V79, P997, DOI 10.1210/jc.79.4.997; Hammiche F, 2012, HUM REPROD, V27, P2365, DOI 10.1093/humrep/des177; Hammoud AO, 2008, FERTIL STERIL, V90, P897, DOI 10.1016/j.fertnstert.2008.08.026; Hammoud AO, 2006, J ANDROL, V27, P619, DOI 10.2164/jandrol.106.000125; Hammoud AO, 2008, FERTIL STERIL, V90, P2222, DOI 10.1016/j.fertnstert.2007.10.011; Hofny ERM, 2010, FERTIL STERIL, V94, P581, DOI 10.1016/j.fertnstert.2009.03.085; Jensen TK, 2004, FERTIL STERIL, V82, P863, DOI 10.1016/j.fertnstert.2004.03.056; Kort HI, 2006, J ANDROL, V27, P450, DOI 10.2164/jandrol.05124; Law DCG, 2007, HUM REPROD, V22, P414, DOI 10.1093/humrep/de1400; Li MWM, 2009, INT J BIOCHEM CELL B, V41, P2302, DOI 10.1016/j.biocel.2009.05.016; Liu Y, 2013, ANDROLOGY-US, V1, P75, DOI 10.1111/j.2047-2927.2012.00022.x; Liu Y, 2014, MOL REPROD DEV, V81, P315, DOI 10.1002/mrd.22300; Martini AC, 2010, FERTIL STERIL, V94, P1739, DOI 10.1016/j.fertnstert.2009.11.017; Mayes J S, 2004, Obes Rev, V5, P197, DOI 10.1111/j.1467-789X.2004.00152.x; Mruk DD, 2004, ENDOCR REV, V25, P747, DOI 10.1210/er.2003-0022; Nammi S, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-3; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Paasch U, 2010, FERTIL STERIL, V94, P2898, DOI 10.1016/j.fertnstert.2010.06.047; Pauli EM, 2008, FERTIL STERIL, V90, P346, DOI 10.1016/j.fertnstert.2007.06.046; Ruhayel Y, 2004, HUM REPROD, V19, P2076, DOI 10.1093/humrep/deh349; RUSSELL L, 1977, AM J ANAT, V148, P313, DOI 10.1002/aja.1001480303; Rybar R, 2011, ANDROLOGIA, V43, P286, DOI 10.1111/j.1439-0272.2010.01057.x; SCHNEIDER G, 1979, J CLIN ENDOCR METAB, V48, P633, DOI 10.1210/jcem-48-4-633; Shayeb AG, 2011, REPROD BIOMED ONLINE, V23, P717, DOI 10.1016/j.rbmo.2011.07.018; Su LL, 2010, EXP CELL RES, V316, P2945, DOI 10.1016/j.yexcr.2010.07.018; Tortoriello DV, 2004, ENDOCRINOLOGY, V145, P1238, DOI 10.1210/en.2003-1406; Wang RS, 2006, ENDOCRINOLOGY, V147, P5624, DOI 10.1210/en.2006-0138; Willems A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014168; Wu J, 2013, HEPATOLOGY, V58, P617, DOI 10.1002/hep.26272; Wu RC, 2013, P NATL ACAD SCI USA, V110, P4616, DOI 10.1073/pnas.1218318110; Xia WL, 2009, DEV BIOL, V327, P48, DOI 10.1016/j.ydbio.2008.11.028; Xiao X, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004447; Yan HHN, 2008, FASEB J, V22, P1945, DOI 10.1096/fj.06-070342; Zain MM, 2008, WOMENS HEALTH, V4, P183, DOI 10.2217/17455057.4.2.183	44	112	123	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0120775	10.1371/journal.pone.0120775	http://dx.doi.org/10.1371/journal.pone.0120775			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886196	Green Published, Green Submitted, gold			2022-12-26	WOS:000353017000011
J	Stephan, K; Kavanagh, KL; Koyama, A				Stephan, Kirsten; Kavanagh, Kathleen L.; Koyama, Akihiro			Comparing the Influence of Wildfire and Prescribed Burns on Watershed Nitrogen Biogeochemistry Using N-15 Natural Abundance in Terrestrial and Aquatic Ecosystem Components	PLOS ONE			English	Article							NITRATE REDUCTASE-ACTIVITY; DIFFUSION METHOD; FIRE SEVERITY; CENTRAL IDAHO; DYNAMICS; TRANSFORMATIONS; NITRIFICATION; AVAILABILITY; ADAPTATION; DELTA-N-15	We evaluated differences in the effects of three low-severity spring prescribed burns and four wildfires on nitrogen (N) biogeochemistry in Rocky Mountain headwater watersheds. We compared paired (burned/unburned) watersheds of four wildfires and three spring prescribed burns for three growing seasons post-fire. To better understand fire effects on the entire watershed ecosystem, we measured N concentrations and delta N-15 in both the terrestrial and aquatic ecosystems components, i.e., soil, understory plants in upland and riparian areas, streamwater, and in-stream moss. In addition, we measured nitrate reductase activity in foliage of Spiraea betulifolia, a dominant understory species. We found increases of delta N-15 and N concentrations in both terrestrial and aquatic ecosystem N pools after wildfire, but responses were limited to terrestrial N pools after prescribed burns indicating that N transfer from terrestrial to aquatic ecosystem components did not occur in low-severity prescribed burns. Foliar delta N-15 differed between wildfire and prescribed burn sites; the delta N-15 of foliage of upland plants was enriched by 2.9 parts per thousand (difference between burned and unburned watersheds) in the first two years after wildfire, but only 1.3 parts per thousand after prescribed burns. In-stream moss delta N-15 in wildfire-burned watersheds was enriched by 1.3 parts per thousand, but there was no response by moss in prescription-burned watersheds, mirroring patterns of streamwater nitrate concentrations. S. betulifolia showed significantly higher nitrate reductase activity two years after wildfires relative to corresponding unburned watersheds, but no such difference was found after prescribed burns. These responses are consistent with less altered N biogeochemistry after prescribed burns relative to wildfire. We concluded that delta N-15 values in terrestrial and aquatic plants and streamwater nitrate concentrations after fire can be useful indicators of the magnitude and duration of fire effects and the fate of post-fire available N.	[Stephan, Kirsten; Kavanagh, Kathleen L.; Koyama, Akihiro] Univ Idaho, Forest Rangeland & Fire Sci, Moscow, ID 83843 USA; [Stephan, Kirsten] Lincoln Univ, Dept Life & Phys Sci & Cooperat Res, Jefferson City, MO USA	Idaho; University of Idaho; Lincoln University - Missouri	Stephan, K (corresponding author), Univ Idaho, Forest Rangeland & Fire Sci, Moscow, ID 83843 USA.	stephank@lincolnu.edu	Koyama, Akihiro/E-4868-2019	Koyama, Akihiro/0000-0002-3854-1035	Joint Fire Science Program [04-2-1-97, 05-2-1-41]; McIntire-Stennis Cooperative Forestry Research Program [MOXStephan2]	Joint Fire Science Program; McIntire-Stennis Cooperative Forestry Research Program	This work was supported by Joint Fire Science Program, Project ID: 04-2-1-97, Project ID: 05-2-1-41 (www.firescience.gov) to KLK, and McIntire-Stennis Cooperative Forestry Research Program, Project No.: MOXStephan2 to KS at Lincoln University of Missouri. http://www.csrees.usda.gov/business/awards/formula/mcintire_stennis.html The funders had no role in study design, data collection	Ashkenas LR, 2004, ECOLOGY, V85, P1725, DOI 10.1890/03-0032; Beghin R, 2011, TREES-STRUCT FUNCT, V25, P627, DOI 10.1007/s00468-011-0539-9; Belillas CM, 1998, INT J WILDLAND FIRE, V8, P87, DOI 10.1071/WF9980087; Binkley D., 2012, ECOLOGY MANAGEMENT F, V4th; Chambers C, 2004, OECOLOGIA, V140, P125, DOI 10.1007/s00442-004-1565-8; DAVIDSON EA, 1991, J SOIL SCI, V42, P335, DOI 10.1111/j.1365-2389.1991.tb00413.x; Debano L.F., 1998, FIRE EFFECTS ECOSYST; Dunnette PV, 2014, NEW PHYTOL, V203, P900, DOI 10.1111/nph.12828; Evans RD, 2001, TRENDS PLANT SCI, V6, P121, DOI 10.1016/S1360-1385(01)01889-1; FILNER P, 1966, BIOCHIM BIOPHYS ACTA, V118, P299, DOI 10.1016/S0926-6593(66)80038-3; GARTEN CT, 1994, CAN J FOREST RES, V24, P1636, DOI 10.1139/x94-212; GEBAUER G, 1984, OECOLOGIA, V63, P136, DOI 10.1007/BF00379795; GRIER C C, 1975, Canadian Journal of Forest Research, V5, P599, DOI 10.1139/x75-087; Grogan P, 2000, OECOLOGIA, V122, P537, DOI 10.1007/s004420050977; Hauer FR, 1998, INT J WILDLAND FIRE, V8, P183, DOI 10.1071/WF9980183; Hobbie EA, 2000, OECOLOGIA, V122, P273, DOI 10.1007/PL00008856; Hogberg P, 1997, NEW PHYTOL, V137, P179, DOI 10.1046/j.1469-8137.1997.00808.x; HOGBERG P, 1993, PLANT SOIL, V157, P147, DOI 10.1007/BF02390237; Hogbom L, 2002, FOREST ECOL MANAG, V160, P273, DOI 10.1016/S0378-1127(01)00475-3; Holmes RM, 1998, MAR CHEM, V60, P235, DOI 10.1016/S0304-4203(97)00099-6; Keeley JE, 2009, INT J WILDLAND FIRE, V18, P116, DOI 10.1071/WF07049; Key C., 2006, FIREMON FIRE EFFECTS, pLA1; Koyama A, 2007, THESIS U IDAHO; Koyama A, 2012, INT J WILDLAND FIRE, V21, P69, DOI 10.1071/WF10132; Koyama A, 2010, ECOSYSTEMS, V13, P1112, DOI 10.1007/s10021-010-9377-7; LeDuc SD, 2013, PLANT SOIL, V373, P955, DOI 10.1007/s11104-013-1856-0; Lee J. A., 1979, ADV BOT RES, V6, P1; Lentile LB, 2006, INT J WILDLAND FIRE, V15, P319, DOI 10.1071/WF05097; Michelsen A, 1998, OECOLOGIA, V115, P406, DOI 10.1007/s004420050535; Mulholland PJ, 2000, VERHANDLUNGEN INT VE, V27, P1320, DOI DOI 10.1080/03680770.1998.11901450; Nadelhoffer K, 1996, OECOLOGIA, V107, P386, DOI 10.1007/BF00328456; Nadelhoffer K, 1999, ENVIRON MONIT ASSESS, V55, P187, DOI 10.1023/A:1006190222768; Nakano S, 2001, P NATL ACAD SCI USA, V98, P166, DOI 10.1073/pnas.98.1.166; Pardo LH, 2002, CAN J FOREST RES, V32, P1126, DOI [10.1139/x02-041, 10.1139/X02-041]; Peterson BJ, 2001, SCIENCE, V292, P86, DOI 10.1126/science.1056874; RAISON RJ, 1979, PLANT SOIL, V51, P73, DOI 10.1007/BF02205929; Robinson D, 2001, TRENDS ECOL EVOL, V16, P153, DOI 10.1016/S0169-5347(00)02098-X; Saito L, 2007, J ENVIRON QUAL, V36, P91, DOI 10.2134/jeq2006.0233; Sanzone DM, 2003, OECOLOGIA, V134, P238, DOI 10.1007/s00442-002-1113-3; SCHOCH P, 1986, FOREST ECOL MANAG, V14, P13, DOI 10.1016/0378-1127(86)90049-6; SHEARER G, 1974, SOIL SCI SOC AM J, V38, P315, DOI 10.2136/sssaj1974.03615995003800020030x; Sigman DM, 1997, MAR CHEM, V57, P227, DOI 10.1016/S0304-4203(97)00009-1; Silins U, 2014, ECOHYDROLOGY, V7, P1508, DOI 10.1002/eco.1474; Smithwick EAH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050597; Spencer CN, 2003, FOREST ECOL MANAG, V178, P141, DOI 10.1016/S0378-1127(03)00058-6; Stark JM, 1997, NATURE, V385, P61, DOI 10.1038/385061a0; Stephan K, 2012, FOREST ECOL MANAG, V263, P240, DOI 10.1016/j.foreco.2011.09.013; Stephan K, 2010, FIRE ECOL, V6, P95, DOI 10.4996/fireecology.0601095; Stephan K, 2009, SOIL SCI SOC AM J, V73, P293, DOI 10.2136/sssaj2007.0079; STEWART GR, 1973, NEW PHYTOL, V72, P539, DOI 10.1111/j.1469-8137.1973.tb04405.x; STEWART GR, 1993, PLANT CELL ENVIRON, V16, P351, DOI 10.1111/j.1365-3040.1993.tb00881.x; Templer PH, 2012, ECOLOGY, V93, P1816, DOI 10.1890/11-1146.1; Turner MG, 2011, ECOSYSTEMS, V14, P1081, DOI 10.1007/s10021-011-9465-3; Vallano DM, 2008, NEW PHYTOL, V177, P946, DOI 10.1111/j.1469-8137.2007.02311.x; VanderSchaaf CL, 2004, FOREST ECOL MANAG, V190, P201, DOI 10.1016/j.foreco.2003.10.014; Wallenda T, 1998, NEW PHYTOL, V139, P169, DOI 10.1046/j.1469-8137.1998.00176.x; Wan SQ, 2001, ECOL APPL, V11, P1349, DOI 10.1890/1051-0761(2001)011[1349:FEONPA]2.0.CO;2	57	18	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0119560	10.1371/journal.pone.0119560	http://dx.doi.org/10.1371/journal.pone.0119560			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885257	Green Published, gold			2022-12-26	WOS:000353017000004
J	Varga, Z; Cassoly, E; Li, QY; Oehlschlegel, C; Tapia, C; Lehr, HA; Klingbiel, D; Thurlimann, B; Ruhstaller, T				Varga, Zsuzsanna; Cassoly, Estelle; Li, Qiyu; Oehlschlegel, Christian; Tapia, Coya; Lehr, Hans Anton; Klingbiel, Dirk; Thuerlimann, Beat; Ruhstaller, Thomas			Standardization for Ki-67 Assessment in Moderately Differentiated Breast Cancer. A Retrospective Analysis of the SAKK 28/12 Study	PLOS ONE			English	Article							INTERNATIONAL EXPERT CONSENSUS; PREDICTIVE-VALUE; PRIMARY THERAPY; LABELING INDEX; KI67; PROLIFERATION; REPRODUCIBILITY; HIGHLIGHTS; WOMEN	Background Proliferative activity (Ki-67 Labelling Index) in breast cancer increasingly serves as an additional tool in the decision for or against adjuvant chemotherapy in midrange hormone receptor positive breast cancer. Ki-67 Index has been previously shown to suffer from high inter-observer variability especially in midrange (G2) breast carcinomas. In this study we conducted a systematic approach using different Ki-67 assessments on large tissue sections in order to identify the method with the highest reliability and the lowest variability. Materials and Methods Five breast pathologists retrospectively analyzed proliferative activity of 50 G2 invasive breast carcinomas using large tissue sections by assessing Ki-67 immunohistochemistry. Ki-67-assessments were done on light microscopy and on digital images following these methods: 1) assessing five regions, 2) assessing only darkly stained nuclei and 3) considering only condensed proliferative areas ('hotspots'). An individual review (the first described assessment from 2008) was also performed. The assessments on light microscopy were done by estimating. All measurements were performed three times. Inter-observer and intra-observer reliabilities were calculated using the approach proposed by Eliasziw et al. Clinical cutoffs (14% and 20%) were tested using Fleiss' Kappa. Results There was a good intra-observer reliability in 5 of 7 methods (ICC: 0.76-0.89). The two highest inter-observer reliability was fair to moderate (ICC: 0.71 and 0.74) in 2 methods (region-analysis and individual-review) on light microscopy. Fleiss'-kappa-values (14% cut-off) were the highest (moderate) using the original recommendation on light-microscope (Kappa 0.58). Fleiss' kappa values (20% cut-off) were the highest (Kappa 0.48 each) in analyzing hotspots on light-microscopy and digital-analysis. No methodologies using digital-analysis were superior to the methods on light microscope. Conclusion Our results show that all methods on light-microscopy for Ki-67 assessment in large tissue sections resulted in a good intra-observer reliability. Region analysis and individual review (the original recommendation) on light-microscopy yielded the highest inter-observer reliability. These results show slight improvement to previously published data on poor-reproducibility and thus might be a practical-pragmatic way for routine assessment of Ki-67 Index in G2 breast carcinomas.	[Varga, Zsuzsanna] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Cassoly, Estelle; Li, Qiyu; Klingbiel, Dirk; Thuerlimann, Beat] Swiss Grp Clin Canc Res, Bern, Switzerland; [Oehlschlegel, Christian] Cantonal Hosp St Gallen, Inst Pathol, St Gallen, Switzerland; [Tapia, Coya] Univ Bern, Inst Pathol, Bern, Switzerland; [Lehr, Hans Anton] Inst Pathol, Friedrichshafen, Friedrichshafen, Germany; [Thuerlimann, Beat; Ruhstaller, Thomas] Cantonal Hosp St Gallen, Breast Ctr, St Gallen, Switzerland	University of Zurich; University Zurich Hospital; Swiss Group for Clinical Cancer Research (SAKK); Kantonsspital St. Gallen; University of Bern; Kantonsspital St. Gallen	Varga, Z (corresponding author), Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland.	zsuzsanna.varga@usz.ch		Klingbiel, Dirk/0000-0002-9914-0243	Empiris Foundation Zurich, Switzerland; Swiss Group for Clinical Cancer Research Bern, Switzerland, SAKK [SAKK 28/12]; State Secretariat for Education, Research and Innovation, Switzerland	Empiris Foundation Zurich, Switzerland; Swiss Group for Clinical Cancer Research Bern, Switzerland, SAKK; State Secretariat for Education, Research and Innovation, Switzerland	Empiris Foundation Zurich, Switzerland (funding receiver: ZV and Swiss Group for Clinical Cancer Research). Swiss Group for Clinical Cancer Research Bern, Switzerland, SAKK (funding receiver was the study itself, numbered as SAKK 28/12). State Secretariat for Education, Research and Innovation, Switzerland (funding receiver was the SAKK).	Allison KH, 2012, BREAST CANCER RES TR, V131, P413, DOI 10.1007/s10549-011-1416-3; Christgen M, 2014, PATHOLOGE, V35, P54, DOI 10.1007/s00292-013-1843-5; Cserni G, 2014, BREAST, V23, P259, DOI 10.1016/j.breast.2014.02.003; Denkert C, 2013, ANN ONCOL, V24, P2786, DOI 10.1093/annonc/mdt350; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; ELIASZIW M, 1994, PHYS THER, V74, P777, DOI 10.1093/ptj/74.8.777; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Fasanella S, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-S1-S7; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Gong P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054912; Gudlaugsson E, 2012, HISTOPATHOLOGY, V61, P1134, DOI 10.1111/j.1365-2559.2012.04329.x; Ingoldsby H, 2013, BREAST, V22, P879, DOI 10.1016/j.breast.2013.04.008; Luporsi E, 2012, BREAST CANCER RES TR, V132, P895, DOI 10.1007/s10549-011-1837-z; Obermann EC, 2012, PATHOLOGE, V33, P245, DOI 10.1007/s00292-012-1583-y; Pavlakis K, 2012, BREAST, V21, P529, DOI 10.1016/j.breast.2012.04.004; Polley MYC, 2013, JNCI-J NATL CANCER I, V105, P1897, DOI 10.1093/jnci/djt306; Tuominen VJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2615; Varga Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058483; Varga Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037379; Viale G, 2008, JNCI-J NATL CANCER I, V100, P207, DOI 10.1093/jnci/djm289; Viale G, 2008, J CLIN ONCOL, V26, P5569, DOI 10.1200/JCO.2008.17.0829; Voros A, 2014, PATHOLOGY ONCOLOGY R; Williams DJ, 2011, APPL IMMUNOHISTO M M, V19, P431, DOI 10.1097/PAI.0b013e318206d23d	24	30	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123435	10.1371/journal.pone.0123435	http://dx.doi.org/10.1371/journal.pone.0123435			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885288	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000353017000064
J	Zhou, Z; He, HL; Ma, LP; Yu, XQ; Mi, Q; Pang, JS; Tang, GX; Liu, B				Zhou, Zheng; He, Hongli; Ma, Luping; Yu, Xiaoqian; Mi, Qian; Pang, Jingsong; Tang, Guixiang; Liu, Bao			Overexpression of a GmCnx1 Gene Enhanced Activity of Nitrate Reductase and Aldehyde Oxidase, and Boosted Mosaic Virus Resistance in Soybean	PLOS ONE			English	Article							MOLYBDENUM COFACTOR BIOSYNTHESIS; XANTHINE DEHYDROGENASE; ABSCISIC-ACID; ARABIDOPSIS; ACCUMULATION; MUTANTS; DROUGHT; ENCODES; BIOLOGY; STRESS	Molybdenum cofactor (Moco) is required for the activities of Moco-dependant enzymes. Cofactor for nitrate reductase and xanthine dehydrogenase (Cnx1) is known to be involved in the biosynthesis of Moco in plants. In this work, a soybean (Glycine maxL.) Cnx1-gene (GmCnx1) was transferred into soybean using Agrobacterium tumefaciens-mediated transformation method. Twenty seven positive transgenic soybean plants were identified by coating leaves with phosphinothricin, bar protein quick dip stick and PCR analysis. Moreover, Southern blot analysis was carried out to confirm the insertion of GmCnx1 gene. Furthermore, expression of GmCnx1 gene in leaf and root of all transgenic lines increased 1.04-2.12 and 1.55-3.89 folds, respectively, as compared to wild type with GmCnx1 gene and in line 10, 22 showing the highest expression. The activities of Moco-related enzymes viznitrate reductase (NR) and aldehydeoxidase (AO) of T-1 generation plants revealed that the best line among the GmCnx1 transgenic plants accumulated 4.25 mu g g(-1) h(-1) and30 pmol L-1, respectively (approximately 2.6-fold and 3.9-fold higher than non-transgenic control plants). In addition, overexpression ofGmCnx1boosted the resistance to various strains of soybean mosaic virus (SMV). DAS-ELISA analysis further revealed that infection rate of GmCnx1 transgenic plants were generally lower than those of non-transgenic plants among two different virus strains tested. Taken together, this study showed that overexpression of a GmCnx1 gene enhanced NR and AO activities and SMV resistance, suggesting its important role in soybean genetic improvement.	[Zhou, Zheng; Ma, Luping; Yu, Xiaoqian; Mi, Qian; Tang, Guixiang] Zhejiang Univ, Inst Crop Sci, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China; [He, Hongli; Pang, Jingsong; Liu, Bao] NE Normal Univ, Minist Educ MOE, Mol Epigenetices, Changchun, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Zhejiang University; Northeast Normal University - China	Tang, GX (corresponding author), Zhejiang Univ, Inst Crop Sci, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China.	tanggx@zju.edu.cn		Zhou, Zheng/0000-0002-9614-5751; Liu, Bao/0000-0001-5481-1675; zakaria, seyed moein/0000-0002-0086-1279	National Natural Science Foundation of China [31071443]; National Major Special Project for Transgenic Organisms, Ministry of Agriculture in China [2013ZX08004-004-008, 2014ZX08004-004-008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major Special Project for Transgenic Organisms, Ministry of Agriculture in China	Support was provided by the National Natural Science Foundation of China (no. 31071443), [http://www.nsfc.gov.cn/] and the National Major Special Project for Transgenic Organisms, Ministry of Agriculture in China (nos. 2013ZX08004-004-008 and 2014ZX08004-004-008), [http://www.ny3721.com/url/2805/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bittner F, 2010, PLANT CELL MONOGR, V17, P119, DOI [10.1016/j.bbamcr.2006.03.013, 10.1007/978-3-642-10613-2_6]; Campbell WH, 1999, ANNU REV PLANT PHYS, V50, P277, DOI 10.1146/annurev.arplant.50.1.277; Campbell WH, 2001, CELL MOL LIFE SCI, V58, P194, DOI 10.1007/PL00000847; Crawford Nigel M, 2002, Arabidopsis Book, V1, pe0011, DOI 10.1199/tab.0011; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; He HL, 2011, THESIS NE NORMAL U C; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; HINCHEE MAW, 1988, BIO-TECHNOL, V6, P915, DOI 10.1038/nbt0888-915; Hoagland D.R., 1950, CALIF AES C, V347, P1, DOI DOI 10.1016/S0140-6736(00)73482-9; Kleinhofs A., 1989, Molecular and genetic aspects of nitrate assimilation., P197; Koshiba T, 1996, PLANT PHYSIOL, V110, P781, DOI 10.1104/pp.110.3.781; LeonKloosterziel KM, 1996, PLANT J, V10, P655, DOI 10.1046/j.1365-313X.1996.10040655.x; Li YJ, 2013, PLANT BIOTECHNOL J, V11, P747, DOI 10.1111/pbi.12066; Mauch-Mani B, 2005, CURR OPIN PLANT BIOL, V8, P409, DOI 10.1016/j.pbi.2005.05.015; Mendel RR, 2007, J EXP BOT, V58, P2289, DOI 10.1093/jxb/erm024; Mendel RR, 2011, COORDIN CHEM REV, V255, P1145, DOI 10.1016/j.ccr.2011.01.054; MENDEL RR, 1976, BIOCHEM PHYSIOL PFL, V170, P538; Mendel RR, 2002, MET IONS BIOL SYST, V39, P317; MENDEL RR, 1978, MOL GEN GENET, V161, P77, DOI 10.1007/BF00266617; Mendel RR, 2002, J EXP BOT, V53, P1689, DOI 10.1093/jxb/erf038; Muller A. J., 1989, Molecular and genetic aspects of nitrate assimilation., P166; Paz MM, 2006, PLANT CELL REP, V25, P206, DOI 10.1007/s00299-005-0048-7; ROTHE GM, 1974, PLANT CELL PHYSIOL, V15, P493; Sagi M, 1998, PLANT SCI, V135, P17, DOI 10.1016/S0168-9452(98)00084-3; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwarz G, 2000, PLANT CELL, V12, P2455, DOI 10.1105/tpc.12.12.2455; Schwarz G, 2006, ANNU REV PLANT BIOL, V57, P623, DOI 10.1146/annurev.arplant.57.032905.105437; Seo M, 2002, TRENDS PLANT SCI, V7, P41, DOI 10.1016/S1360-1385(01)02187-2; STALLMEYER B, 1995, PLANT J, V8, P751, DOI 10.1046/j.1365-313X.1995.08050751.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Verslues PE, 2005, BIOCHEM SOC T, V33, P375, DOI 10.1042/BST0330375; WALKERSIMMONS M, 1989, PLANT PHYSIOL, V90, P728, DOI 10.1104/pp.90.2.728; [王晓丹 Wang Xiaodan], 2004, [分子植物育种, Molecular Plant Breeding], V2, P891; Xiong LM, 2001, PLANT CELL, V13, P2063, DOI 10.1105/tpc.13.9.2063; Xue ZG, 2012, MOL BIOL REP, V39, P1411, DOI 10.1007/s11033-011-0875-2; Yang SH, 2003, PLANT CELL PHYSIOL, V44, P1037, DOI 10.1093/pcp/pcg122; Yang XF, 2011, THESIS ZHEJIANG U HA; Yang XiaoFeng, 2013, Acta Agronomica Sinica, V39, P216, DOI 10.3724/SP.J.1006.2013.00216; Yesbergenova Z, 2005, PLANT J, V42, P862, DOI 10.1111/j.1365-313X.2005.02422.x; Zhang ZY, 1999, PLANT CELL TISS ORG, V56, P37, DOI 10.1023/A:1006298622969	40	19	24	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124273	10.1371/journal.pone.0124273	http://dx.doi.org/10.1371/journal.pone.0124273			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886067	Green Published, Green Submitted, gold			2022-12-26	WOS:000353017000110
J	de Laurentiis, A; Hiscott, J; Alcalay, M				de Laurentiis, A.; Hiscott, J.; Alcalay, M.			The TEL-AML1 fusion protein of acute lymphoblastic leukemia modulates IRF3 activity during early B-cell differentiation	ONCOGENE			English	Article							INTERFERON REGULATORY FACTOR-3; ORIGINS; EXPRESSION; RECEPTOR; TARGET; GENES	The t(12;21) translocation is the most common genetic rearrangement in childhood acute lymphoblastic leukemia (ALL) and gives rise to the TEL-AML1 fusion gene. Many studies on TEL-AML1 describe specific properties of the fusion protein, but a thorough understanding of its function is lacking. We exploited a pluripotent hematopoietic stem/progenitor cell line, EML1, and generated a cell line (EML-TA) stably expressing the TEL-AML1 fusion protein. EML1 cells differentiate to mature B-cells following treatment with IL7; whereas EML-TA display an impaired differentiation capacity and remain blocked at an early stage of maturation. Global gene expression profiling of EML1 cells at different stages of B-lymphoid differentiation, compared with EML-TA, identified the interferon (IFN)alpha/beta pathway as a primary target of repression by TEL-AML1. In particular, expression and phosphorylation of interferon-regulatory factor 3 (IRF3) was decreased in EML-TA cells; strikingly, stable expression of IRF3 restored the capacity of EML-TA cells to differentiate into mature B-cells. Similarly, IRF3 silencing in EML1 cells by siRNA was sufficient to block B-lymphoid differentiation. The ability of TEL-AML1 to block B-cell differentiation and downregulate the IRF3-IFN alpha/beta pathway was confirmed in mouse and human primary hematopoietic precursor cells (Lin- and CD34+ cells, respectively), and in a patient-derived cell line expressing TEL-AML1 (REH). Furthermore, treatment of TEL-AML1 expressing cells with IFN alpha/beta was sufficient to overcome the maturation block. Our data provide new insight on TEL-AML1 function and may offer a new therapeutic opportunity for B-ALL.	[de Laurentiis, A.; Alcalay, M.] Ist Europeo Oncol, Dept Expt Oncol, I-20139 Milan, Italy; [Hiscott, J.] Vaccine & Gene Therapy Inst Florida, Port St Lucie, FL USA; [Alcalay, M.] Univ Milan, Dipartimento Sci Salute, Milan, Italy	IRCCS European Institute of Oncology (IEO); Vaccine & Gene Therapy Institute of Florida; University of Milan	de Laurentiis, A (corresponding author), Ist Europeo Oncol, Dept Expt Oncol, Via Adamello 16, I-20139 Milan, Italy.	angela.delaurentiis@ieo.eu	Alcalay, Myriam/AAB-4300-2019; Alcalay, Myriam/B-3182-2016	Alcalay, Myriam/0000-0002-5558-4272; Alcalay, Myriam/0000-0002-5558-4272	Associazione Italiana per la Ricerca sul Cancro (AIRC); Fondazione Umberto Veronesi (FUV); Italian Ministry of Health [PO-RF08]	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Umberto Veronesi (FUV)(Fondazione Umberto Veronesi); Italian Ministry of Health(Ministry of Health, Italy)	We are grateful to Giacomo Iros Barozzi and Stefano Casola for their support and advice, the cell culture staff of the IEO-DEO, the microarray and FACS facilities of the IFOM-IEO Campus for excellent technical assistance and to Elisa Barbieri, Alicja M Gruszka, Marco Saia and Rita de Molfetta for many helpful discussions. We are thankful to S Tsai for the EML1 cell line, A Zelent and AM Ford for TEL-AML1 expression vectors. This work was supported by grants from Associazione Italiana per la Ricerca sul Cancro (AIRC), Fondazione Umberto Veronesi (FUV) and Italian Ministry of Health (PO-RF08) to MA.	Ardekani Ali M., 2011, Avicenna Journal of Medical Biotechnology, V3, P1; Battle TE, 2003, BLOOD, V102, P3016, DOI 10.1182/blood-2002-09-2972; Caraglia M, 2013, PROTEIN PEPTIDE LETT, V20, P412, DOI 10.2174/092986613805290372; Chawla-Sarkar M, 2001, CLIN CANCER RES, V7, P1821; Chessells JM, 1998, BRIT J HAEMATOL, V102, P423, DOI 10.1046/j.1365-2141.1998.00776.x; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; de Lendonck LY, 2014, CELL MOL LIFE SCI, V71, P3873, DOI 10.1007/s00018-014-1653-9; Diakos C, 2007, BLOOD, V109, P2607, DOI 10.1182/blood-2006-04-019612; Dowling RJO, 2010, BBA-PROTEINS PROTEOM, V1804, P433, DOI 10.1016/j.bbapap.2009.12.001; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Fan D, 2015, ONCOGENE, V34, P2083, DOI 10.1038/onc.2014.148; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Ford AM, 1998, P NATL ACAD SCI USA, V95, P4584, DOI 10.1073/pnas.95.8.4584; Fuka G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026348; Gandemer V, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-385; George J, 2009, CLIN CANCER RES, V15, P7186, DOI 10.1158/1078-0432.CCR-09-1425; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Greaves MF, 2003, NAT REV CANCER, V3, P639, DOI 10.1038/nrc1164; Hong DL, 2008, SCIENCE, V319, P336, DOI 10.1126/science.1150648; Li M, 2013, LEUKEMIA, V27, P1570, DOI 10.1038/leu.2013.15; Lin RT, 1999, MOL CELL BIOL, V19, P2465; Linka Y, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.48; Long LY, 2014, IMMUNITY, V40, P515, DOI 10.1016/j.immuni.2014.01.015; Moritz A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000998; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nagasawa T, 2006, NAT REV IMMUNOL, V6, P107, DOI 10.1038/nri1780; ROMANA SP, 1995, BLOOD, V86, P4263, DOI 10.1182/blood.V86.11.4263.bloodjournal86114263; ROSENFELD C, 1977, EUR J CANCER, V13, P377, DOI 10.1016/0014-2964(77)90085-8; Shurtleff SA, 1995, LEUKEMIA, V9, P1985; Tamassia N, 2012, J IMMUNOL, V189, P1500, DOI 10.4049/jimmunol.1102985; Taylor KE, 2013, IMMUNOLOGY, V138, P190, DOI 10.1111/imm.12038; Torrano V, 2011, BLOOD, V118, P4910, DOI 10.1182/blood-2011-05-354266; TSAI S, 1994, GENE DEV, V8, P2831, DOI 10.1101/gad.8.23.2831; van Delft FW, 2011, BLOOD, V117, P6247, DOI 10.1182/blood-2010-10-314674; Zelent A, 2004, ONCOGENE, V23, P4275, DOI 10.1038/sj.onc.1207672; Zhao JW, 2010, MOL IMMUNOL, V48, P294, DOI 10.1016/j.molimm.2010.07.014	36	9	9	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 3	2015	34	49					6018	6028		10.1038/onc.2015.50	http://dx.doi.org/10.1038/onc.2015.50			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CY0RO	25893288				2022-12-26	WOS:000366113500008
J	Binsker, U; Kohler, TP; Krauel, K; Kohler, S; Schwertz, H; Hammerschmidt, S				Binsker, Ulrike; Kohler, Thomas P.; Krauel, Krystin; Kohler, Sylvia; Schwertz, Hansjoerg; Hammerschmidt, Sven			Pneumococcal Adhesins PavB and PspC Are Important for the Interplay with Human Thrombospondin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR ADHERENCE PROTEIN; HEPARIN-BINDING DOMAIN; STREPTOCOCCUS-PNEUMONIAE; HUMAN PLATELETS; NASOPHARYNGEAL COLONIZATION; EPITHELIAL-CELLS; MESSENGER-RNA; STAPHYLOCOCCUS-AUREUS; MATRIX MOLECULES; INTENSIVE-CARE	The human matricellular glycoprotein thrombospondin-1 (hTSP-1) is released by activated platelets and mediates adhesion of Gram-positive bacteria to various host cells. In staphylococci, the adhesins extracellular adherence protein (Eap) and autolysin (Atl), both surface-exposed proteins containing repeating structures, were shown to be involved in the acquisition of hTSP-1 to the bacterial surface. The interaction partner( s) on the pneumococcal surface was hitherto unknown. Here, we demonstrate for the first time that pneumococcal adherence and virulence factor B (PavB) and pneumococcal surface protein C (PspC) are key players for the interaction of Streptococcus pneumoniae with matricellular hTSP-1. PavB and PspC are pneumococcal surface-exposed adhesins and virulence factors exhibiting repetitive sequences in their core structure. Heterologously expressed fragments of PavB and PspC containing repetitive structures exhibit hTSP-1 binding activity as shown by ELISA and surface plasmon resonance studies. Binding of hTSP-1 is charge-dependent and inhibited by heparin. Importantly, the deficiency in PavB and PspC reduces the recruitment of soluble hTSP-1 by pneumococci and decreases hTSP-1-mediated pneumococcal adherence to human epithelial cells. Platelet activation assays suggested that PavB and PspC are not involved in the activation of purified human platelets by pneumococci. In conclusion, this study indicates a pivotal role of PavB and PspC for pneumococcal recruitment of soluble hTSP-1 to the bacterial surface and binding of pneumococci to host cell-bound hTSP-1 during adhesion.	[Binsker, Ulrike; Kohler, Thomas P.; Kohler, Sylvia; Hammerschmidt, Sven] Ernst Moritz Arndt Univ Greifswald, Dept Genet Microorganisms, Interfac Inst Genet & Funct Genom, Friedrich Ludwig Jahn Str 15a, D-17487 Greifswald, Germany; [Krauel, Krystin; Schwertz, Hansjoerg] Univ Med Greifswald, Inst Immunol & Transfus Med, D-17489 Greifswald, Germany	Ernst Moritz Arndt Universitat Greifswald; Greifswald Medical School	Kohler, TP (corresponding author), Ernst Moritz Arndt Univ Greifswald, Dept Genet Microorganisms, Interfac Inst Genet & Funct Genom, Friedrich Ludwig Jahn Str 15a, D-17487 Greifswald, Germany.	kohlert@uni-greifswald.de	Hammerschmidt, Sven/G-2598-2010	Hammerschmidt, Sven/0000-0002-6382-6681; Krauel, Krystin/0000-0002-2030-1332	Deutsche Forschungsgemeinschaft [SFB TRR 34, DFG HA 3125/4-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB TRR 34, Project C10 (to S. H.) and DFG HA 3125/4-2.	Agarwal V, 2009, J BIOL CHEM, V284, P19427, DOI 10.1074/jbc.M109.003442; ASCH AS, 1986, P NATL ACAD SCI USA, V83, P2904, DOI 10.1073/pnas.83.9.2904; Asmat TM, 2012, MICROBIOL-SGM, V158, P771, DOI 10.1099/mic.0.053603-0; Balachandran P, 2002, INFECT IMMUN, V70, P2526, DOI 10.1128/IAI.70.5.2526-2534.2002; BAUGHMAN RP, 1993, CHEST, V104, P1243, DOI 10.1378/chest.104.4.1243; Bertling A, 2012, ARTERIOSCL THROM VAS, V32, P1979, DOI 10.1161/ATVBAHA.112.246249; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; BORNSTEIN P, 1995, J CELL BIOL, V130, P503, DOI 10.1083/jcb.130.3.503; Bumbaca D, 2004, OMICS, V8, P341, DOI 10.1089/omi.2004.8.341; Byrne MF, 2003, GASTROENTEROLOGY, V124, P1846, DOI 10.1016/S0016-5085(03)00397-4; Calzada MJ, 2003, J BIOL CHEM, V278, P40679, DOI 10.1074/jbc.M302014200; Carlson CB, 2008, CELL MOL LIFE SCI, V65, P672, DOI 10.1007/s00018-007-7484-1; Denis MM, 2005, CELL, V122, P379, DOI 10.1016/j.cell.2005.06.015; Dieudonne-Vatran A, 2009, J IMMUNOL, V182, P7865, DOI 10.4049/jimmunol.0802376; Elm C, 2004, J BIOL CHEM, V279, P6296, DOI 10.1074/jbc.M310528200; Fitzgerald JR, 2006, NAT REV MICROBIOL, V4, P445, DOI 10.1038/nrmicro1425; Fitzgerald JR, 2006, MOL MICROBIOL, V59, P212, DOI 10.1111/j.1365-2958.2005.04922.x; Gamez G, 2012, CURR DRUG TARGETS, V13, P323, DOI 10.2174/138945012799424697; Garenne Michel, 1992, World Health Statistics Quarterly, V45, P180; GRAY BM, 1980, J INFECT DIS, V142, P923, DOI 10.1093/infdis/142.6.923; GWALTNEY JM, 1975, J INFECT DIS, V132, P62, DOI 10.1093/infdis/132.1.62; Hammerschmidt S, 2005, INFECT IMMUN, V73, P4653, DOI 10.1128/IAI.73.8.4653-4667.2005; Hammerschmidt S, 2000, MOL MICROBIOL, V36, P726, DOI 10.1046/j.1365-2958.2000.01897.x; Hammerschmidt S, 2007, J IMMUNOL, V178, P5848, DOI 10.4049/jimmunol.178.9.5848; Hernani MD, 2011, FEMS IMMUNOL MED MIC, V62, P263, DOI 10.1111/j.1574-695X.2011.00809.x; Hussain M, 2005, EPIDEMIOL INFECT, V133, P891, DOI 10.1017/S0950268805004012; Hussain M, 2008, INFECT IMMUN, V76, P5615, DOI 10.1128/IAI.00480-08; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Isenberg JS, 2007, J BIOL CHEM, V282, P15404, DOI 10.1074/jbc.M701638200; JAFFE EA, 1985, BLOOD, V65, P79; Jensch I, 2010, MOL MICROBIOL, V77, P22, DOI 10.1111/j.1365-2958.2010.07189.x; Kerrigan SW, 2002, BLOOD, V100, P509, DOI 10.1182/blood.V100.2.509; Kohler TP, 2014, J BIOL CHEM, V289, P4070, DOI 10.1074/jbc.M113.521229; Levi M, 2004, J THROMB HAEMOST, V2, P2094, DOI 10.1111/j.1538-7836.2004.01004.x; Narizhneva NV, 2005, FASEB J, V19, P1158, DOI 10.1096/fj.04-3310fje; Nelson AL, 2007, INFECT IMMUN, V75, P83, DOI 10.1128/IAI.01475-06; Niemann S, 2009, THROMB HAEMOSTASIS, V102, P735, DOI 10.1160/TH09-01-0049; Ogunniyi AD, 2007, INFECT IMMUN, V75, P1843, DOI 10.1128/IAI.01384-06; Orihuela CJ, 2009, J CLIN INVEST, V119, P1638, DOI 10.1172/JCI36759; Panetti TS, 1999, J BIOL CHEM, V274, P430, DOI 10.1074/jbc.274.1.430; Paterson GK, 2010, MOL MICROBIOL, V77, P1, DOI 10.1111/j.1365-2958.2010.07190.x; PREISSNER KT, 1991, ANNU REV CELL BIOL, V7, P275, DOI 10.1146/annurev.cellbio.7.1.275; RAUGI GJ, 1987, AM J PATHOL, V129, P364; RAUGI GJ, 1982, J CELL BIOL, V95, P351, DOI 10.1083/jcb.95.1.351; Rennemeier C, 2007, FASEB J, V21, P3118, DOI 10.1096/fj.06-7992com; Resovi A, 2014, MATRIX BIOL, V37, P83, DOI 10.1016/j.matbio.2014.01.012; Rondina MT, 2011, J THROMB HAEMOST, V9, P748, DOI 10.1111/j.1538-7836.2011.04208.x; Rosenow C, 1997, MOL MICROBIOL, V25, P819, DOI 10.1111/j.1365-2958.1997.mmi494.x; Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026; Schaefer L, 2010, CELL TISSUE RES, V339, P237, DOI 10.1007/s00441-009-0821-y; Schwertz H, 2006, J EXP MED, V203, P2433, DOI 10.1084/jem.20061302; Sharma B, 2007, ANAESTH INTENS CARE, V35, P874, DOI 10.1177/0310057X0703500604; Stephan F, 1999, CHEST, V115, P1363, DOI 10.1378/chest.115.5.1363; Tan K, 2008, J BIOL CHEM, V283, P3932, DOI 10.1074/jbc.M705203200; Tan K, 2009, J CELL COMMUN SIGNAL, V3, P177, DOI 10.1007/s12079-009-0074-2; Tang MX, 2011, MOL CELL BIOCHEM, V346, P49, DOI 10.1007/s11010-010-0590-7; Vanderschueren S, 2000, CRIT CARE MED, V28, P1871, DOI 10.1097/00003246-200006000-00031; Vincent JL, 2002, CRIT CARE MED, V30, pS313, DOI 10.1097/00003246-200205001-00022; VOGEL T, 1993, J CELL BIOCHEM, V53, P74, DOI 10.1002/jcb.240530109; Voss S, 2012, MOL ORAL MICROBIOL, V27, P246, DOI 10.1111/j.2041-1014.2012.00654.x; Voss S, 2013, J BIOL CHEM, V288, P15614, DOI 10.1074/jbc.M112.443507; WEISER JN, 1994, INFECT IMMUN, V62, P2582, DOI 10.1128/IAI.62.6.2582-2589.1994; Weyrich AS, 2007, BLOOD, V109, P1975, DOI 10.1182/blood-2006-08-042192; Yu HN, 2000, ARCH BIOCHEM BIOPHYS, V374, P13, DOI 10.1006/abbi.1999.1597	64	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14542	14555		10.1074/jbc.M114.623876	http://dx.doi.org/10.1074/jbc.M114.623876			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25897078	Green Published, hybrid			2022-12-26	WOS:000355754600026
J	Johnston, C; Bootsma, HJ; Aldridge, C; Manuse, S; Gisch, N; Schwudke, D; Hermans, PWM; Grangeasse, C; Polard, P; Vollmer, W; Claverys, JP				Johnston, Calum; Bootsma, Hester J.; Aldridge, Christine; Manuse, Sylvie; Gisch, Nicolas; Schwudke, Dominik; Hermans, Peter W. M.; Grangeasse, Christophe; Polard, Patrice; Vollmer, Waldemar; Claverys, Jean-Pierre			Co-Inactivation of GlnR and CodY Regulators Impacts Pneumococcal Cell Wall Physiology	PLOS ONE			English	Article							PATHOGEN STREPTOCOCCUS-PNEUMONIAE; GRAM-POSITIVE BACTERIA; BACILLUS-SUBTILIS; LIPOTEICHOIC ACID; ESCHERICHIA-COLI; GLOBAL REGULATOR; IRON TRANSPORT; COMPETENCE; GENE; TRANSFORMATION	CodY, a nutritional regulator highly conserved in low G+C Gram-positive bacteria, is essential in Streptococcus pneumoniae (the pneumococcus). A published codY mutant possessed suppressing mutations inactivating the fatC and amiC genes, respectively belonging to iron (Fat/Fec) and oligopeptide (Ami) ABC permease operons, which are directly repressed by CodY. Here we analyzed two additional published codY mutants to further explore the essentiality of CodY. We show that one, in which the regulator of glutamine/glutamate metabolism glnR had been inactivated by design, had only a suppressor in fecE (a gene in the fat/fecoperon), while the other possessed both fecE and amiC mutations. Independent isolation of three different fat/fec suppressors thus establishes that reduction of iron import is crucial for survival without CodY. We refer to these as primary suppressors, while inactivation of ami, which is not essential for survival of codY mutants and acquired after initial fat/fec inactivation, can be regarded as a secondary suppressor. The availability of codY-ami+ cells allowed us to establish that CodY activates competence for genetic transformation indirectly, presumably by repressing ami which is known to antagonize competence. The glnR codY fecE mutant was then found to be only partially viable on solid medium and hypersensitive to peptidoglycan (PG) targeting agents such as the antibiotic cefotaxime and the muramidase lysozyme. While analysis of PG and teichoic acid composition uncovered no alteration in the glnR codY fecE mutant compared to wildtype, electron microscopy revealed altered ultrastructure of the cell wall in the mutant, establishing that co-inactivation of GlnR and CodY regulators impacts pneumococcal cell wall physiology. In light of rising levels of resistance to PG-targeting antibiotics of natural pneumococcal isolates, GlnR and CodY constitute potential alternative therapeutic targets to combat this debilitating pathogen, as co-inactivation of these regulators renders pneumococci sensitive to iron and PG-targeting agents.	[Johnston, Calum; Polard, Patrice; Claverys, Jean-Pierre] CNRS, LMGM UMR5100, F-31000 Toulouse, France; [Johnston, Calum; Polard, Patrice; Claverys, Jean-Pierre] Univ Toulouse, UPS, Lab Microbiol & Genet Mol, F-31000 Toulouse, France; [Bootsma, Hester J.; Hermans, Peter W. M.] Radboud Univ Nijmegen, Med Ctr, Lab Pediat Infect Dis, NL-6500 HB Nijmegen, Netherlands; [Aldridge, Christine; Vollmer, Waldemar] Newcastle Univ, Ctr Bacterial Cell Biol, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England; [Manuse, Sylvie; Grangeasse, Christophe] Univ Lyon 1, CNRS, IBCP, Bases Mol & Struct Syst Infect,UMR 5086, F-69007 Lyon, France; [Gisch, Nicolas; Schwudke, Dominik] Leibniz Ctr Med & Biosci, Res Ctr Borstel, D-23845 Borstel, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Radboud University Nijmegen; Newcastle University - UK; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Forschungszentrum Borstel	Johnston, C (corresponding author), CNRS, LMGM UMR5100, F-31000 Toulouse, France.	johnston@biotoul.fr; claverys@biotoul.fr	Hermans, Peter W.M./H-8042-2014; Johnston, Calum Harvey Gustave/HHZ-8472-2022; Schwudke, Dominik/B-3478-2013	Johnston, Calum Harvey Gustave/0000-0001-5942-9117; Schwudke, Dominik/0000-0002-1379-9451; Grangeasse, Christophe/0000-0002-5484-4589; Gisch, Nicolas/0000-0003-3260-5269	European Community's Seventh Framework Programme [HEALTH-F3-2009-222983]; CNRS; BBSRC [BB/G015902/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G015902/1] Funding Source: researchfish	European Community's Seventh Framework Programme(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by the European Community's Seventh Framework Programme FP7/2007-2013 under grant agreement number HEALTH-F3-2009-222983 (Pneumopath project) and the CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloing G, 1998, MOL MICROBIOL, V29, P75, DOI 10.1046/j.1365-2958.1998.00904.x; ALLOING G, 1994, J MOL BIOL, V241, P44, DOI 10.1006/jmbi.1994.1472; Brown JS, 2002, INFECT IMMUN, V70, P4389, DOI 10.1128/IAI.70.8.4389-4398.2002; Bui NK, 2012, ANAL BIOCHEM, V421, P657, DOI 10.1016/j.ab.2011.11.026; Caymaris S, 2010, MOL MICROBIOL, V78, P344, DOI 10.1111/j.1365-2958.2010.07339.x; Chastanet A, 2001, J BACTERIOL, V183, P7295, DOI 10.1128/JB.183.24.7295-7307.2001; CHEN JD, 1987, J GEN MICROBIOL, V133, P1959; Claverys JP, 2006, ANNU REV MICROBIOL, V60, P451, DOI 10.1146/annurev.micro.60.080805.142139; CLAVERYS JP, 1986, MICROBIOL REV, V50, P133, DOI 10.1128/MMBR.50.2.133-165.1986; Davis KM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000241; de Jong IG, 2011, JOVE-J VIS EXP, DOI 10.3791/3145; Denapaite D, 2012, MICROB DRUG RESIST, V18, P344, DOI 10.1089/mdr.2012.0026; Draing C, 2006, J BIOL CHEM, V281, P33849, DOI 10.1074/jbc.M602676200; Figueiredo TA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002508; Filipe SR, 2002, P NATL ACAD SCI USA, V99, P1550, DOI 10.1073/pnas.032671699; FISCHER W, 1993, EUR J BIOCHEM, V215, P851, DOI 10.1111/j.1432-1033.1993.tb18102.x; GARCIA P, 1986, GENE, V43, P265, DOI 10.1016/0378-1119(86)90215-5; Garcia P, 1999, MOL MICROBIOL, V31, P1275, DOI 10.1046/j.1365-2958.1999.01238.x; GARCIABUSTOS JF, 1988, J BACTERIOL, V170, P2143, DOI 10.1128/jb.170.5.2143-2147.1988; Gisch N, 2013, J BIOL CHEM, V288, P15654, DOI 10.1074/jbc.M112.446963; Guedon E, 2001, MOL MICROBIOL, V40, P1227, DOI 10.1046/j.1365-2958.2001.02470.x; Guiral S, 2006, MICROBIOL-SGM, V152, P343, DOI 10.1099/mic.0.28433-0; Guiral S, 2005, P NATL ACAD SCI USA, V102, P8710, DOI 10.1073/pnas.0500879102; Hartel T, 2012, J BIOL CHEM, V287, P4260, DOI 10.1074/jbc.M111.304311; HAHN J, 1987, J BACTERIOL, V169, P3104, DOI 10.1128/jb.169.7.3104-3109.1987; Handke LD, 2008, J BACTERIOL, V190, P798, DOI 10.1128/JB.01115-07; Hendriksen WT, 2008, J BACTERIOL, V190, P590, DOI 10.1128/JB.00917-07; HOLTJE JV, 1976, J BIOL CHEM, V251, P4199; Johnston C, 2014, NAT REV MICROBIOL, V12, P181, DOI 10.1038/nrmicro3199; Johnston C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003178; Kloosterman TG, 2006, J BIOL CHEM, V281, P25097, DOI 10.1074/jbc.M601661200; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; Letoffe S, 2006, P NATL ACAD SCI USA, V103, P12891, DOI 10.1073/pnas.0605440103; Molle V, 2003, J BACTERIOL, V185, P1911, DOI 10.1128/JB.185.6.1911-1922.2003; Mortier-Barriere I, 1998, MOL MICROBIOL, V27, P159, DOI 10.1046/j.1365-2958.1998.00668.x; Munch D, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002509; Prudhomme M, 2007, MOL BIOL STREPTOCOCC, P519; Reith J, 2011, APPL MICROBIOL BIOT, V92, P1, DOI 10.1007/s00253-011-3486-x; SALLES C, 1992, NUCLEIC ACIDS RES, V20, P6103, DOI 10.1093/nar/20.22.6103; Serror P, 1996, J BACTERIOL, V178, P5910, DOI 10.1128/jb.178.20.5910-5915.1996; Sliusarenko O, 2011, MOL MICROBIOL, V80, P612, DOI 10.1111/j.1365-2958.2011.07579.x; Smith AM, 2001, ANTIMICROB AGENTS CH, V45, P2393, DOI 10.1128/AAC.45.8.2393-2396.2001; Sonenshein AL, 2007, NAT REV MICROBIOL, V5, P917, DOI 10.1038/nrmicro1772; Sonenshein AL, 2005, CURR OPIN MICROBIOL, V8, P203, DOI 10.1016/j.mib.2005.01.001; Tai SS, 2003, FEMS MICROBIOL LETT, V220, P303, DOI 10.1016/S0378-1097(03)00135-6; TOMASZ A, 1966, J BACTERIOL, V91, P1050, DOI 10.1128/JB.91.3.1050-1061.1966; Ulijasz AT, 2004, J BACTERIOL, V186, P8123, DOI 10.1128/JB.186.23.8123-8136.2004; Zapun A, 2013, ACS CHEM BIOL, V8, P2688, DOI 10.1021/cb400575t	48	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123702	10.1371/journal.pone.0123702	http://dx.doi.org/10.1371/journal.pone.0123702			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901369	Green Published, Green Submitted, gold			2022-12-26	WOS:000353331500060
J	Nandi, M; Selin, C; Brassinga, AKC; Belmonte, MF; Fernando, WGD; Loewen, PC; De Kievit, TR				Nandi, Munmun; Selin, Carrie; Brassinga, Ann Karen C.; Belmonte, Mark F.; Fernando, W. G. Dilantha; Loewen, Peter C.; De Kievit, Teresa R.			Pyrrolnitrin and Hydrogen Cyanide Production by Pseudomonas chlororaphis Strain PA23 Exhibits Nematicidal and Repellent Activity against Caenorhabditis elegans	PLOS ONE			English	Article							SCLEROTINIA-SCLEROTIORUM; STRINGENT RESPONSE; BIOFILM FORMATION; BIOCONTROL; AERUGINOSA; BACTERIA; FLUORESCENS; ANTIBIOTICS; EXPRESSION; PREDATOR	Pseudomonas chlororaphis strain PA23 is a biocontrol agent able to suppress growth of the fungal pathogen Sclerotinia sclerotiorum. This bacterium produces an arsenal of exometa-bolites including pyrrolnitrin (PRN), phenazine (PHZ), hydrogen cyanide (HCN), and degradative enzymes. Production of these compounds is controlled at both the transcriptional and posttranscriptional levels by the Gac-Rsm system, RpoS, PsrA, and the Phz quorum-sensing system. Beyond pathogen-suppression, the success of a biocontrol agent is dependent upon its ability to establish itself in the environment where predation by bacterivorous organisms, including nematodes, may threaten persistence. The focus of this study was to investigate whether PA23 is able to resist grazing by Caenorhabditis elegans and to define the role played by exoproducts in the bacterial-nematode interaction. We discovered that both PRN and HCN contribute to fast- and slow-killing of C. elegans. HCN is well-established as having lethal effects on C. elegans; however, PRN has not been reported to be nematicidal. Exposure of L4 stage nematodes to purified PRN reduced nematode viability in a dose-dependent fashion and led to reduced hatching of eggs laid by gravid adults. Because bacterial metabolites can act as chemoattractants or repellents, we analyzed whether PA23 exhibited attractant or repulsive properties towards C. elegans. Both PRN and HCN were found to be potent repellents. Next we investigated whether the presence of C. elegans would elicit changes in PA23 gene activity. Co-culturing the two organisms increased expression of a number of genes associated with biocontrol, including phzA, hcnA, phzR, phzI, rpoS and gacS. Exoproduct analysis showed that PHZ and autoinducer signals were upregulated, consistent with the gene expression profiles. Collectively, these findings indicate that PA23 is able to sense the presence of C. elegans and it is able to both repel and kill the nematodes, which should facilitate environmental persistence and ultimately biocontrol.	[Nandi, Munmun; Brassinga, Ann Karen C.; Loewen, Peter C.; De Kievit, Teresa R.] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada; [Selin, Carrie; Fernando, W. G. Dilantha] Univ Manitoba, Dept Plant Sci, Winnipeg, MB R3T 2N2, Canada; [Belmonte, Mark F.] Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; University of Manitoba	De Kievit, TR (corresponding author), Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada.	Teresa.Dekievit@ad.umanitoba.ca			Natural Sciences and Engineering Research Council (NSERC); Canada Research Chair Program (PCL); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair Program (PCL); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Financial support was provided through grants from the Natural Sciences and Engineering Research Council (NSERC) Discovery Grants Program (TdK, AKCB, MFB, WGDF, and PCL) and the Canada Research Chair Program (PCL). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alexeyev MF, 1999, BIOTECHNIQUES, V26, P824, DOI 10.2144/99265bm05; Beale E, 2006, APPL ENVIRON MICROB, V72, P5135, DOI 10.1128/AEM.00611-06; Berry CL, 2012, CAN J MICROBIOL, V58, P1027, DOI [10.1139/w2012-079, 10.1139/W2012-079]; BRENNER S, 1974, GENETICS, V77, P71; Burlinson P, 2013, ISME J, V7, P1126, DOI 10.1038/ismej.2013.9; Cezairliyan B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003101; Darby C, 1999, P NATL ACAD SCI USA, V96, P15202, DOI 10.1073/pnas.96.26.15202; Darby C, 2002, NATURE, V417, P243, DOI 10.1038/417243a; Gallagher LA, 2001, J BACTERIOL, V183, P6207, DOI 10.1128/JB.183.21.6207-6214.2001; Girard LR, 2007, NUCLEIC ACIDS RES, V35, pD472, DOI 10.1093/nar/gkl894; Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912; Hughes DT, 2008, NAT REV MICROBIOL, V6, P111, DOI 10.1038/nrmicro1836; Jousset A, 2010, APPL ENVIRON MICROB, V76, P5263, DOI 10.1128/AEM.02941-09; KING EO, 1954, J LAB CLIN MED, V44, P301; Lee JH, 2010, CURR MICROBIOL, DOI [10.1007/s00284-101-9779-y, DOI 10.1007/S00284-101-9779-Y]; Linares JF, 2006, P NATL ACAD SCI USA, V103, P19484, DOI 10.1073/pnas.0608949103; Ling EA, 2009, PLASMID, V62, P16, DOI 10.1016/j.plasmid.2009.02.002; Manuel J, 2012, MICROBIOL-SGM, V158, P207, DOI 10.1099/mic.0.053082-0; Mazzola M, 2009, APPL ENVIRON MICROB, V75, P6804, DOI 10.1128/AEM.01272-09; Meyer SLF, 2009, J NEMATOL, V41, P274; MILLER JH, 1972, EXPT MOL GENETICS, P351; Neidig N, 2011, MICROB ECOL, V61, P853, DOI 10.1007/s00248-011-9821-z; Poritsanos N, 2006, CAN J MICROBIOL, V52, P1177, DOI 10.1139/W06-079; Pradel E, 2007, P NATL ACAD SCI USA, V104, P2295, DOI 10.1073/pnas.0610281104; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Savchuk S, 2004, FEMS MICROBIOL ECOL, V49, P379, DOI 10.1016/j.femsec.2004.04.014; Selin C, 2014, BIOL CONTROL, V69, P24, DOI 10.1016/j.biocontrol.2013.10.015; Selin C, 2012, MICROBIOL-SGM, V158, P896, DOI 10.1099/mic.0.054254-0; Selin C, 2010, FEMS MICROBIOL ECOL, V71, P73, DOI 10.1111/j.1574-6941.2009.00792.x; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Zhang Y, 2006, CAN J MICROBIOL, V52, P476, DOI 10.1139/W05-152	31	52	55	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123184	10.1371/journal.pone.0123184	http://dx.doi.org/10.1371/journal.pone.0123184			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901993	Green Submitted, Green Published, gold			2022-12-26	WOS:000353331500048
J	Roi, GS; Monticone, M; Salvoni, M; Sassi, R; Alberti, G				Roi, Giulio Sergio; Monticone, Marco; Salvoni, Marco; Sassi, Roberto; Alberti, Giampietro			Self-Reported Knee Symptoms Assessed by KOOS Questionnaire in Downhill Runners (Skyrunners)	PLOS ONE			English	Article							OSTEOARTHRITIS OUTCOME SCORE; POSTTRAUMATIC OSTEOARTHRITIS; INJURY; UPHILL; LEVEL; SPORT; POPULATION; ADAPTATION; ACTIVATION; KINETICS	Background The knee is the weight-bearing joint most commonly associated with sports injuries, and therefore is most at risk of developing degenerative changes, including osteoarthritis. Skyrunners can be considered to be at risk of developing symptoms of post-traumatic osteoarthritis due to downhill running. Aim The aim of this study was to analyze the health of the knee joints of a large group of these athletes via a specific self-report questionnaire. Methods This study was carried out by asking the participants of seven official Skyraces (22.4 +/- 3.1 km length; 1596 +/- 393 m elevation) to fill out a questionnaire. Information regarding age, sex, downhill elevation (m) during training and competitions over the last month, and history of previous knee injury was also collected before the participants filled out the Knee injury and Osteoarthritis Outcome Score (KOOS), which is a reliable and validated instrument designed to assess patients' opinions about their knees and associated problems that can result in post-traumatic osteoarthritis. Athletes were divided into six age groups (from 17 to 70 years) and 12 groups based on the downhill gradient they had covered over the last month (from 1,000 to 40,000 m). Results Six hundred twenty-one questionnaires were collected from 45% of the participants in the seven races. Multivariate analysis revealed that self-reported KOOS scores were unrelated to age, sex and monthly downhill gradient. Only 74 (12%) of the participants reported previous knee injuries. Significant differences in the five subscales of the KOOS were found between skyrunners with and without previous knee injuries (P<0.01). Conclusions In the studied population, regular training for downhill running and participation in Skyraces could not be considered risk factors for subjective knee symptoms. Skyrunners with selfreported histories of knee injuries scored worse on all five subscales of the KOOS.	[Roi, Giulio Sergio; Salvoni, Marco] Isokinet Med Grp, Educ & Res Dept, Bologna, Italy; [Roi, Giulio Sergio; Salvoni, Marco] Int Skyrunning Federat, Biella, Italy; [Monticone, Marco] Salvatore Maugeri Fdn IRCCS, Sci Inst Lissone Milan, Inst Care & Res IRCCS, Phys Med & Rehabil Unit, Lissone, Italy; [Sassi, Roberto] Univ Milan, Dept Comp Sci, Milan, Italy; [Alberti, Giampietro] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy	Istituti Clinici Scientifici Maugeri IRCCS; University of Milan; University of Milan	Roi, GS (corresponding author), Isokinet Med Grp, Educ & Res Dept, Bologna, Italy.	gs.roi@isokinetic.com	Theoharides, Theoharis C/E-5596-2010; Alberti, Giampietro/M-4110-2016	Alberti, Giampietro/0000-0002-5464-9644	Isokinetic Medical Group; International Skyrunning Federation	Isokinetic Medical Group; International Skyrunning Federation	Isokinetic Medical Group and International Skyrunning Federation provided support in the form of salaries for authors GSR and MS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bremner-Smith AT, 2004, KNEE, V11, P279, DOI 10.1016/j.knee.2003.06.001; Buckwalter JA, 2003, J ORTHOP SPORT PHYS, V33, P578, DOI 10.2519/jospt.2003.33.10.578; BUCZEK FL, 1990, MED SCI SPORT EXER, V22, P669, DOI 10.1249/00005768-199010000-00019; Chakravarty EF, 2008, AM J PREV MED, V35, P133, DOI 10.1016/j.amepre.2008.03.032; Derrick TR, 1998, MED SCI SPORT EXER, V30, P128, DOI 10.1097/00005768-199801000-00018; DeVita P, 2008, J BIOMECH, V41, P3354, DOI 10.1016/j.jbiomech.2008.09.024; ESTON RG, 1995, BRIT J SPORT MED, V29, P89, DOI 10.1136/bjsm.29.2.89; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Frobell RB, 2008, KNEE SURG SPORT TR A, V16, P713, DOI 10.1007/s00167-008-0509-y; Gottschall JS, 2005, J BIOMECH, V38, P445, DOI 10.1016/j.jbiomech.2004.04.023; Hamann N, 2014, SCAND J MED SCI SPOR, V24, P179, DOI 10.1111/j.1600-0838.2012.01513.x; Hortobagyi T, 2000, J ELECTROMYOGR KINES, V10, P117, DOI 10.1016/S1050-6411(99)00026-7; Hreljac A, 2004, MED SCI SPORT EXER, V36, P845, DOI 10.1249/01.MSS.0000126803.66636.DD; Hurley MV, 1999, RHEUM DIS CLIN N AM, V25, P283, DOI 10.1016/S0889-857X(05)70068-5; Kamibayashi K, 2006, J ELECTROMYOGR KINES, V16, P432, DOI 10.1016/j.jelekin.2005.09.004; KONRADSEN L, 1990, AM J SPORT MED, V18, P379, DOI 10.1177/036354659001800408; Lahr D D, 1996, Md Med J, V45, P641; LaStayo PC, 2003, J ORTHOP SPORT PHYS, V33, P557, DOI 10.2519/jospt.2003.33.10.557; Maffulli N, 2011, BRIT MED BULL, V97, P47, DOI 10.1093/bmb/ldq026; Minetti AE, 2002, J APPL PHYSIOL, V93, P1039, DOI 10.1152/japplphysiol.01177.2001; Molloy MG, 2011, BRIT J SPORT MED, V45, P275, DOI 10.1136/bjsm.2011.083956; Monticone M, 2012, OSTEOARTHR CARTILAGE, V20, P330, DOI 10.1016/j.joca.2012.01.001; Paradowski PT, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-38; PIERRYNOWSKI MR, 1987, EUR J APPL PHYSIOL O, V56, P668, DOI 10.1007/BF00424808; Roi G. S., 1999, Medicine and Science in Sports and Exercise, V31, pS191, DOI 10.1097/00005768-199905001-00859; Roi GS, 2002, MED SPORT, V55, P51; Roos E, 2003, USERS GUIDE KNEE INJ; Roos EM, 1999, OSTEOARTHR CARTILAGE, V7, P216, DOI 10.1053/joca.1998.0153; Roos EM, 1998, J ORTHOP SPORT PHYS, V28, P88, DOI 10.2519/jospt.1998.28.2.88; Roos Ewa M, 2003, Health Qual Life Outcomes, V1, P64, DOI 10.1186/1477-7525-1-64; Shirer I, 2004, BRIT J SPORT MED, V38, P526; Snyder KL, 2012, J EXP BIOL, V215, P2283, DOI 10.1242/jeb.066332; Telhan G, 2010, J ATHL TRAINING, V45, P16, DOI 10.4085/1062-6050-45.1.16; Urquhart DM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2343; Van Ginckel A, 2010, OSTEOARTHR CARTILAGE, V18, P1564, DOI 10.1016/j.joca.2010.10.007; Willick SE, 2010, CLIN SPORT MED, V29, P417, DOI 10.1016/j.csm.2010.03.006	36	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0126382	10.1371/journal.pone.0126382	http://dx.doi.org/10.1371/journal.pone.0126382			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902316	Green Published, gold, Green Submitted			2022-12-26	WOS:000353331500123
J	Whitaker, JW; Boyle, DL; Bartok, B; Ball, ST; Gay, S; Wang, W; Firestein, GS				Whitaker, John W.; Boyle, David L.; Bartok, Beatrix; Ball, Scott T.; Gay, Steffen; Wang, Wei; Firestein, Gary S.			Integrative Omics Analysis of Rheumatoid Arthritis Identifies Non-Obvious Therapeutic Targets	PLOS ONE			English	Article							FIBROBLAST-LIKE SYNOVIOCYTES; GENE-EXPRESSION; ELMO1; CELLS; ASSOCIATION; RECEPTOR; ALPHA; ENGULFMENT; CYTOKINES; INVASION	Identifying novel therapeutic targets for the treatment of disease is challenging. To this end, we developed a genome-wide approach of candidate gene prioritization. We independently collocated sets of genes that were implicated in rheumatoid arthritis (RA) pathogenicity through three genome-wide assays: (i) genome-wide association studies (GWAS), (ii) differentially expression in RA fibroblast-like synoviocytes (FLS), and (iii) differentially methylation in RA FLS. Integrated analysis of these complementary data sets identified a significant enrichment of multi-evidence genes (MEGs) within pathways relating to RA pathogenicity. One MEG is Engulfment and Cell Motility Protein-1 (ELMO1), a gene not previously considered as a therapeutic target in RA FLS. We demonstrated in RA FLS that ELMO1 is: (i) expressed, (ii) promotes cell migration and invasion, and (iii) regulates Rac1 activity. Thus, we created links between ELMO1 and RA pathogenicity, which in turn validates ELMO1 as a potential RA therapeutic target. This study illustrated the power of MEG-based approaches for therapeutic target identification.	[Whitaker, John W.; Wang, Wei] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Whitaker, John W.; Wang, Wei] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Boyle, David L.; Bartok, Beatrix; Firestein, Gary S.] Univ Calif San Diego, Div Rheumatol Allergy & Immunol, La Jolla, CA 92093 USA; [Ball, Scott T.] Univ Calif San Diego, Sch Med, Dept Orthopaed, La Jolla, CA 92093 USA; [Gay, Steffen] Univ Zurich Hosp, Dept Rheumatol, CH-8091 Zurich, Switzerland	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Zurich; University Zurich Hospital	Wang, W (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	wei-wang@ucsd.edu; gfirestein@ucsd.edu		Whitaker, John W./0000-0002-0585-9119	Research Foundation	Research Foundation	This project was supported by a grant from the Research Foundation (GSF).	ALVAROGRACIA JM, 1991, J IMMUNOL, V146, P3365; AREND WP, 1990, ARTHRITIS RHEUM-US, V33, P305, DOI 10.1002/art.1780330302; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bartok B, 2014, J IMMUNOL, V192, P2063, DOI 10.4049/jimmunol.1300950; Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x; Bottini N, 2013, NAT REV RHEUMATOL, V9, P24, DOI 10.1038/nrrheum.2012.190; Boyle DL, 2003, ARTHRITIS RES THER, V5, pR352, DOI 10.1186/ar1004; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Burmester GR, 2011, ANN RHEUM DIS, V70, P1542, DOI 10.1136/ard.2010.146225; Castro F, 2001, ANN RHEUM DIS, V60, P791, DOI 10.1136/ard.60.8.791; Chan A, 2007, MOL MED, V13, P297, DOI 10.2119/2007-00025.Chan; Das S, 2011, P NATL ACAD SCI USA, V108, P2136, DOI 10.1073/pnas.1014775108; Del Rey MJ, 2012, ANN RHEUM DIS, V71, P275, DOI 10.1136/annrheumdis-2011-200281; Ekwall AH, 2015, ARTHRITIS RHEUMATOLO; Elliott MR, 2010, NATURE, V467, P333, DOI 10.1038/nature09356; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Grimsley CM, 2004, J BIOL CHEM, V279, P6087, DOI 10.1074/jbc.M307087200; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hanawa-Suetsugu K, 2012, P NATL ACAD SCI USA, V109, P3305, DOI 10.1073/pnas.1113512109; Hawkins RD, 2010, NAT REV GENET, V11, P476, DOI 10.1038/nrg2795; Hindorff LA, CATALOG PUBLISHED GE; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hinoue T, 2012, GENOME RES, V22, P271, DOI 10.1101/gr.117523.110; Hon GC, 2012, GENOME RES, V22, P246, DOI 10.1101/gr.125872.111; Komander D, 2008, MOL BIOL CELL, V19, P4837, DOI 10.1091/mbc.E08-04-0345; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lee DM, 2007, SCIENCE, V315, P1006, DOI 10.1126/science.1137306; Lefevre S, 2009, NAT MED, V15, P1414, DOI 10.1038/nm.2050; Li HY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2680; Nakano K, 2013, J IMMUNOL, V190, P1297, DOI 10.4049/jimmunol.1202572; Nakano K, 2013, ANN RHEUM DIS, V72, P110, DOI 10.1136/annrheumdis-2012-201526; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Rosengren Sanna, 2007, V135, P365; Simelyte E, 2004, ANN RHEUM DIS, V63, P1695, DOI 10.1136/ard.2003.017210; Sohn C, 2015, ARTHRITIS RHEUMATOL, V67, P86, DOI 10.1002/art.38871; Stahl EA, 2012, NAT GENET, V44, P483, DOI 10.1038/ng.2232; Stevens A, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4559; Stevenson C, 2014, J IMMUNOL, V192, P6062, DOI 10.4049/jimmunol.1303348; Tieri P, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00059; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Whitaker JW, 2015, NAT METHODS, V12, P265, DOI [10.1038/NMETH.3065, 10.1038/nmeth.3065]; Whitaker JW, 2015, METHODS, V72, P86, DOI 10.1016/j.ymeth.2014.10.008; Whitaker JW, 2013, GENOME MED, V5, DOI 10.1186/gm444; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004	47	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124254	10.1371/journal.pone.0124254	http://dx.doi.org/10.1371/journal.pone.0124254			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901943	Green Published, Green Accepted, gold			2022-12-26	WOS:000353331500079
J	Xing, LD; Zhang, JP; Lockley, MG; McCrea, RT; Klein, H; Alcala, L; Buckley, LG; Burns, ME; Kummell, SB; He, Q				Xing, Lida; Zhang, Jianping; Lockley, Martin G.; McCrea, Richard T.; Klein, Hendrik; Alcala, Luis; Buckley, Lisa G.; Burns, Michael E.; Kuemmell, Susanna B.; He, Qing			Hints of the Early Jehol Biota: Important Dinosaur Footprint Assemblages from the Jurassic-Cretaceous Boundary Tuchengzi Formation in Beijing, China	PLOS ONE			English	Article							SAUROPOD TRACKWAYS; HOUCHENG FORMATION; SHANDONG PROVINCE; NORTHERN HEBEI; THEROPOD; GANSU; BASIN; AGES; ASIA	New reports of dinosaur tracksites in the Tuchengzi Formation in the newly established Yanqing Global Geopark, Beijing, China, support previous inferences that the track assemblages from this formation are saurischian-dominated. More specifically, the assemblages appear theropod-dominated, with the majority of well-preserved tracks conforming to the Grallator type (sensus lato), thus representing relatively small trackmakers. Such ichnofaunas supplement the skeletal record from this unit that lacks theropods thus far, proving a larger diversity of dinosaur faunas in that region. Sauropods are represented by medium to large sized and narrow and wide-gauge groups, respectively. The latter correspond with earlier discoveries of titanosauriform skeletons in the same unit. Previous records of ornithischian tracks cannot be positively confirmed. Purported occurrences are re-evaluated here, the trackways and imprints, except of a single possible specimen, re-assigned to theropods. Palecologically the Tuchengzi ichnofauna is characteristic of semi-arid fluvio-lacustrine inland basins with Upper Jurassic-Lower Cretaceous deposits in northern China that all show assemblages with abundant theropod and sauropod tracks and minor components of ornithopod, pterosaur and bird tracks.	[Xing, Lida; Zhang, Jianping; He, Qing] China Univ Geosci, Sch Earth Sci & Resources, Beijing 100083, Peoples R China; [Lockley, Martin G.] Univ Colorado Denver, Dinosaur Trackers Res Grp, Denver, CO 80217 USA; [McCrea, Richard T.; Buckley, Lisa G.] Peace Reg Palaeontol Res Ctr, Tumbler Ridge, BC V0C 2W0, Canada; [Klein, Hendrik] Saurierwelt Palaontol Museum, D-92318 Neumarkt, Germany; [Alcala, Luis] Fdn Conjunto Paleontol Teruel Dinopolis, E-44002 Teruel, Aragon, Spain; [Burns, Michael E.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Kuemmell, Susanna B.] Univ Witten Herdecke, Inst Evolutionary Biol, D-58454 Witten, Germany	China University of Geosciences; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Alberta; Witten Herdecke University	Xing, LD (corresponding author), China Univ Geosci, Sch Earth Sci & Resources, Beijing 100083, Peoples R China.	xinglida@gmail.com	Alcalá, Luis/A-7413-2009; Alcalá, Luis/P-5793-2014; Burns, Michael E/GPC-8311-2022	Alcalá, Luis/0000-0002-6369-6186; Burns, Michael/0000-0002-9587-563X	Yanqing Global Geopark; China University of Geosciences (Beijing), China	Yanqing Global Geopark; China University of Geosciences (Beijing), China	This research project was supported by Yanqing Global Geopark (LX, JZ), and the 2013 support fund for graduate student's science and technology innovation from China University of Geosciences (Beijing), China (LX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1976, NATURE, V261, P129, DOI 10.1038/261129a0; Carrano MT, 2001, PALEOBIOLOGY, V27, P564, DOI 10.1666/0094-8373(2001)027<0564:TDATTT>2.0.CO;2; Castanera D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081830; Dong Zhiming, 2001, P29; DUAN S-Y, 1986, Acta Botanica Sinica, V28, P331; Farlow J.O., 1989, P371; Farlow J.O., 2013, TYRANNOSAURID PALEOB, P88; Farlow James O., 1992, Zubia, V10, P89; Fujita Masato, 2007, Memoir of the Fukui Prefectural Dinosaur Museum, V6, P17; Gaston Robert, 2003, Ichnos, V10, P153, DOI 10.1080/10420940390256258; [张建平 Zhang JianPing], 2012, [科学通报, Chinese Science Bulletin], V57, P144; Gierlinski GD, 2009, ACTA GEOL POL, V59, P221; He Q, 2014, THESIS CHINA U GEOSC; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Ji Q., 2004, MESOZOIC JEHOL BIOTA; Li J., 2011, DINOSAUR TRACKS LOWE; Li RH, 2008, NATURWISSENSCHAFTEN, V95, P185, DOI 10.1007/s00114-007-0310-7; Lim S.-K., 1989, P333; Lockley M, 2006, CRETACEOUS RES, V27, P33, DOI 10.1016/j.cretres.2005.10.007; Lockley M, 2002, CRETACEOUS RES, V23, P363, DOI 10.1006/cres.2002.1005; LOCKLEY M, 1995, DINOSAUR TRACKS OTHE; Lockley M.G., DINOSAUR TR IN PRESS; Lockley Martin, 1998, Modern Geology, V23, P317; Lockley Martin G., 1994, Gaia, V10, P135; Lockley MG, 2013, ACTA GEOL SIN-ENGL, V87, P1, DOI 10.1111/1755-6724.12026; Lockley MG, 2009, GEOL SOC SPEC PUBL, V315, P255, DOI 10.1144/SP315.18; Lockley MG, 2009, GEOL Q, V53, P415; Lull R. S., 1904, Memoirs of the Boston Society, Vv, P461; Marty D, 2008, GEOFOCUS, V21, P1; Marty D, 2010, HIST BIOL, V22, P109, DOI 10.1080/08912960903503345; Marty Daniel, 2006, Hantkeniana, V5, P38; Matsukawa M, 2006, CRETACEOUS RES, V27, P3, DOI 10.1016/j.cretres.2005.10.009; McCrea RT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103613; MEYER CA, 1990, ECLOGAE GEOL HELV, V83, P389; Myers TS, 2009, PALAEOGEOGR PALAEOCL, V274, P96, DOI 10.1016/j.palaeo.2009.01.002; Oh C, 2015, ACTA PALAEONTOL POL, V60, P245, DOI 10.4202/app.2012.0132; Olsen P.E., 1980, P35; Olsen PE, 1998, J VERTEBR PALEONTOL, V18, P586, DOI 10.1080/02724634.1998.10011086; Pan YH, 2013, CRETACEOUS RES, V44, P30, DOI 10.1016/j.cretres.2013.03.007; Santos VF, 2009, ACTA PALAEONTOL POL, V54, P409, DOI 10.4202/app.2008.0049; [邵济安 Shao Jian], 2003, [地质通报, Geological Bulletin of China], V22, P751; Shikama T., 1942, CENTRAL NATURAL MUSE, V3, P21; Sullivan Corwin, 2009, Vertebrata Palasiatica, V47, P35; Swisher CC, 2002, CHINESE SCI BULL, V47, P135; Sze H.C., 1963, FOSSIL PLANTS CHINA, V2; Thulborn RA., 1990, DINOSAUR TRACKS; Tian SG, 1994, CHINESE SCI BULL, V8, P766; Wang Si-en, 2013, Dizhi Tongbao, V32, P1673; Weems R.E., 1992, P 26 FORUM GEOLOGY I, V119, P113; White D., 1929, CARNEGIE I WASHINGTO, V405, P1; Wilson JA, 1999, PALEOBIOLOGY, V25, P252, DOI 10.1017/S0094837300026543; Xing LD, CRETA RES IN PRESS; Xing LD, 2014, PALAEOWORLD, V23, P200, DOI 10.1016/j.palwor.2013.10.002; Xing Li-da, 2014, Acta Palaeontologica Sinica, V53, P381; Xing Li-Da, 2014, Vertebrata Palasiatica, V52, P233; Xing Li-da, 2012, Dizhi Tongbao, V31, P20; Xing Li-Da, 2012, Palaeoworld, V21, P50, DOI 10.1016/j.palwor.2012.02.004; Xing Li-Da, 2011, Vertebrata Palasiatica, V49, P423; Xing Li-da, 2010, Acta Palaeontologica Sinica, V49, P448; Xing Li-da, 2009, Acta Palaeontologica Sinica, V48, P662; Xing LD, 2015, CRETACEOUS RES, V52, P194, DOI 10.1016/j.cretres.2014.10.001; Xing LD, 2013, CRETACEOUS RES, V45, P114, DOI 10.1016/j.cretres.2013.07.009; Xing LD, 2013, ACTA PALAEONTOL POL, V58, P723, DOI 10.4202/app.2011.0115; [Xing Lida 邢立达], 2010, [地质通报, Geological Bulletin of China], V29, P1105; Xing X, 2006, GEOL J, V41, P419, DOI 10.1002/gj.1044; [许欢 Xu Huan], 2014, [地学前缘, Earth Science Frontiers], V21, P203; [许欢 Xu Huan], 2013, [地质通报, Geological Bulletin of China], V32, P502; [许欢 Xu Huan], 2011, [地学前缘, Earth Science Frontiers], V18, P88; Xu K, 2003, STRATIGRAPHIC REGION; Xu X, 2010, CHINESE SCI BULL, V55, P3971, DOI 10.1007/s11434-010-4150-z; Yabe H., 1940, P IMP ACAD JAPAN, V16, P560, DOI [10.2183/pjab1912.16.560, DOI 10.2183/PJAB1912.16.560]; Young C. C., 1966, VERTEBRAT PALASIATIC, V10, P68; YOUNG CHUNG-CHIEN, 1960, VERTEBR PALASIAT [CHINA], V4, P53; Zhang JP, 2006, CRETACEOUS RES, V27, P44, DOI 10.1016/j.cretres.2005.10.006; Zhang W., 2000, CHINESE B BOT, V17, P202; Zhang Yongzhong, 2004, Geological Review (Beijing), V50, P561; Zhao XJ, 2006, ACTA GEOL SIN-ENGL, V80, P467; Zhao XJ, 1999, J VERTEBR PALEONTOL, V19, P681; Zhen S., 1989, P187; Zheng S.L., 2008, FOSSIL WOOD OF CHINA; Zhou ZH, 2010, SCI CHINA EARTH SCI, V53, P1894, DOI 10.1007/s11430-010-4094-9	81	25	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0122715	10.1371/journal.pone.0122715	http://dx.doi.org/10.1371/journal.pone.0122715			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901363	Green Published, gold, Green Submitted			2022-12-26	WOS:000353331500028
J	Chung, BH; Joo, YY; Lee, J; Kim, HD; Kim, JI; Moon, IS; Choi, BS; Oh, EJ; Park, CW; Kim, YS; Yang, CW				Chung, Byung Ha; Joo, Yu Young; Lee, Jaesin; Kim, Hyung Duk; Kim, Ji-Il; Moon, In Sung; Choi, Bum Soon; Oh, Eun-Jee; Park, Cheol Whee; Kim, Yong-Soo; Yang, Chul Woo			Impact of ABO Incompatibility on the Development of Acute Antibody-Mediated Rejection in Kidney Transplant Recipients Presensitized to HLA	PLOS ONE			English	Article							POSITIVE-CROSS-MATCH; SUCCESSFUL RENAL-TRANSPLANTATION; DONOR-SPECIFIC ANTIBODIES; SINGLE ANTIGEN-ASSAY; SENSITIZED PATIENTS; CLASS-I; DESENSITIZATION; RITUXIMAB; TITER; RISK	Whether the coexistence of anti-A/B antibody and donor specific anti-HLA antibody (HLA-DSA) has a synergistic impact on the development of acute antibody-mediated rejection (AAMR) in kidney transplant recipients (KTRs) is unclear. This study includes 92 KTRs who received a kidney from an ABO-incompatible (ABOi) donor or were presensitized to donor HLA (HLAs) and 292 controls (CONT). HLAs was defined as a crossmatch positivity or the presence of HLA-DSA. We compared the incidence of AAMR among ABOi (n = 58), ABOi +HLAs (n = 12), HLAs (n = 22), and CONT (n = 292) groups and evaluated the risk factors and antibody type (anti-A/B vs. HLA-DSA) responsible for AAMR. AAMR developed less frequently in ABOi and CONT than in the ABOi+HLAs or HLAs (P < 0.05 for all); however, there was no difference between the ABOi+HLAs and HLAs groups. AAMR developed more frequently with strong HLA-DSA at baseline; however, high baseline anti-A/B titer did not affect AAMR development. Strong baseline HLA-DSA was an independent predictor for AAMR, however the baseline anti-A/B titer was not. All four AAMR episodes in ABOi+HLAs were positive to HLA-DSA but not to anti-A/B. In conclusion, ABO incompatibility does not increase the risk for AAMR in HLAs KTRs.	[Chung, Byung Ha; Kim, Ji-Il; Moon, In Sung; Choi, Bum Soon; Park, Cheol Whee; Kim, Yong-Soo; Yang, Chul Woo] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Transplant Res Ctr, Seoul, South Korea; [Chung, Byung Ha; Joo, Yu Young; Lee, Jaesin; Kim, Hyung Duk; Choi, Bum Soon; Park, Cheol Whee; Kim, Yong-Soo; Yang, Chul Woo] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Internal Med,Div Nephrol, Seoul, South Korea; [Kim, Ji-Il; Moon, In Sung] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Surg, Seoul, South Korea; [Oh, Eun-Jee] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Lab Med, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital	Yang, CW (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Transplant Res Ctr, Seoul, South Korea.	yangch@catholic.ac.kr	Kim, Hyungduk/CAH-5630-2022	Oh, Eun-Jee/0000-0001-5870-915X	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2013R1A1A1009718]; Catholic Medical Center Research Foundation	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); Catholic Medical Center Research Foundation	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2013R1A1A1009718) and the Catholic Medical Center Research Foundation made in the program year of 2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chung BH, 2013, TRANSPL INFECT DIS, V15, P559, DOI 10.1111/tid.12135; Chung BH, 2013, NEPHRON CLIN PRACT, V124, P79, DOI 10.1159/000355855; Chung BH, 2014, TRANSPL INT, V27, P49, DOI 10.1111/tri.12199; Chung BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042011; Chung BH, 2012, RENAL FAILURE, V34, P974, DOI 10.3109/0886022X.2012.700892; Chung BH, 2012, TRANSPL INT, V25, P687, DOI 10.1111/j.1432-2277.2012.01480.x; Chung BH, 2011, RENAL FAILURE, V33, P150, DOI 10.3109/0886022X.2011.552149; Dean PG, 2005, SURGERY, V137, P269, DOI 10.1016/j.surg.2004.08.002; Everly MJ, 2013, TRANSPLANTATION, V95, P410, DOI 10.1097/TP.0b013e31827d62e3; Gloor JM, 2003, AM J TRANSPLANT, V3, P1017, DOI 10.1034/j.1600-6143.2003.00180.x; Gloor JM, 2003, TRANSPLANTATION, V75, P971, DOI 10.1097/01.TP.0000058226.397.32; Haririan A, 2009, AM J TRANSPLANT, V9, P536, DOI 10.1111/j.1600-6143.2008.02524.x; Hidalgo LG, 2009, AM J TRANSPLANT, V9, P2532, DOI 10.1111/j.1600-6143.2009.02800.x; Huh KH, 2012, INT UROL NEPHROL, V44, P1549, DOI 10.1007/s11255-012-0169-1; Jang JY, 2012, ANN LAB MED, V32, P66, DOI 10.3343/alm.2012.32.1.66; Kim Y, 2010, ANN CLIN LAB SCI, V40, P330; Kong JM, 2013, CLIN TRANSPLANT, V27, P875, DOI 10.1111/ctr.12249; Lobo LJ, 2013, J HEART LUNG TRANSPL, V32, P70, DOI 10.1016/j.healun.2012.10.007; Caro-Oleas JL, 2012, NEPHROL DIAL TRANSPL, V27, P1231, DOI 10.1093/ndt/gfr429; Marfo K, 2011, CLIN J AM SOC NEPHRO, V6, P922, DOI 10.2215/CJN.08140910; Montgomery JR, 2012, TRANSPLANTATION, V93, P603, DOI 10.1097/TP.0b013e318245b2af; Montgomery RA, 2011, NEW ENGL J MED, V365, P318, DOI 10.1056/NEJMoa1012376; Naemi FMA, 2013, TRANSPLANTATION, V96, P258, DOI 10.1097/TP.0b013e3182985504; Padmanabhan A, 2009, TRANSPLANTATION, V87, P1889, DOI 10.1097/TP.0b013e3181a76ae1; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; Stegall MD, 2006, AM J TRANSPLANT, V6, P346, DOI 10.1111/j.1600-6143.2005.01178.x; Takahashi K, 2004, AM J TRANSPLANT, V4, P1089, DOI 10.1111/j.1600-6143.2004.00464.x; Tobian AAR, 2010, AM J TRANSPLANT, V10, P1247, DOI 10.1111/j.1600-6143.2010.03103.x; Toki D, 2009, AM J TRANSPLANT, V9, P567, DOI 10.1111/j.1600-6143.2008.02538.x; Tyden G, 2007, TRANSPLANTATION, V83, P1153, DOI 10.1097/01.tp.0000262570.18117.55; Uchida J, 2010, TRANSPL P, V42, P3998, DOI 10.1016/j.transproceed.2010.09.043; Vieira CA, 2004, TRANSPLANTATION, V77, P542, DOI 10.1097/01.TP.0000112934.12622.2B; Warren DS, 2004, AM J TRANSPLANT, V4, P561, DOI 10.1111/j.1600-6143.2004.00364.x; Wiebe C, 2012, AM J TRANSPLANT, V12, P1157, DOI 10.1111/j.1600-6143.2012.04013.x; Yoon HE, 2009, J KOREAN MED SCI, V24, pS148, DOI 10.3346/jkms.2009.24.S1.S148	35	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123638	10.1371/journal.pone.0123638	http://dx.doi.org/10.1371/journal.pone.0123638			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897756	Green Published, gold, Green Submitted			2022-12-26	WOS:000353212600037
J	Johnson, KR; Hindmarch, CCT; Salinas, YD; Shi, YJ; Greenwood, M; Hoe, SZ; Murphy, D; Gainer, H				Johnson, Kory R.; Hindmarch, C. C. T.; Salinas, Yasmmyn D.; Shi, YiJun; Greenwood, Michael; Hoe, See Ziau; Murphy, David; Gainer, Harold			A RNA-Seq Analysis of the Rat Supraoptic Nucleus Transcriptome: Effects of Salt Loading on Gene Expression	PLOS ONE			English	Article							HYPOTHALAMO-NEUROHYPOPHYSEAL SYSTEM; VASOPRESSIN HETERONUCLEAR RNA; DOMINANT-NEGATIVE INHIBITOR; IMMEDIATE-EARLY GENES; CELL-SIZE CHANGES; MAGNOCELLULAR NEURONS; MESSENGER-RNA; HYPOTHALAMONEUROHYPOPHYSEAL SYSTEM; C-FOS; OXYTOCIN	Magnocellular neurons (MCNs) in the hypothalamo-neurohypophysial system (HNS) are highly specialized to release large amounts of arginine vasopressin (Avp) or oxytocin (Oxt) into the blood stream and play critical roles in the regulation of body fluid homeostasis. The MCNs are osmosensory neurons and are excited by exposure to hypertonic solutions and inhibited by hypotonic solutions. The MCNs respond to systemic hypertonic and hypotonic stimulation with large changes in the expression of their Avp and Oxt genes, and microarray studies have shown that these osmotic perturbations also cause large changes in global gene expression in the HNS. In this paper, we examine gene expression in the rat supraoptic nucleus (SON) under normosmotic and chronic salt-loading SL) conditions by the first time using "new-generation", RNA sequencing (RNA-Seq) methods. We reliably detect 9,709 genes as present in the SON by RNA-Seq, and 552 of these genes were changed in expression as a result of chronic SL. These genes reflect diverse functions, and 42 of these are involved in either transcriptional or translational processes. In addition, we compare the SON transcriptomes resolved by RNA-Seq methods with the SON transcriptomes determined by Affymetrix microarray methods in rats under the same osmotic conditions, and find that there are 6,466 genes present in the SON that are represented in both data sets, although 1,040 of the expressed genes were found only in the microarray data, and 2,762 of the expressed genes are selectively found in the RNA-Seq data and not the microarray data. These data provide the research community a comprehensive view of the transcriptome in the SON under normosmotic conditions and the changes in specific gene expression evoked by salt loading.	[Johnson, Kory R.] NINDS, Bioinformat Sect, Informat Technol & Bioinformat Program, NIH, Bethesda, MD 20892 USA; [Salinas, Yasmmyn D.; Shi, YiJun; Gainer, Harold] NINDS, Neurochem Lab, NIH, Bethesda, MD 20892 USA; [Hindmarch, C. C. T.; Greenwood, Michael; Murphy, David] Univ Bristol, Sch Clin Sci, Bristol BS1 3NY, England; [Hindmarch, C. C. T.; Hoe, See Ziau; Murphy, David] Univ Malaya, Fac Med, Dept Physiol, Kuala Lumpur 50603, Malaysia	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Bristol; Universiti Malaya	Gainer, H (corresponding author), NINDS, Neurochem Lab, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	gainerh@ninds.nih.gov	Hindmarch, Charles/AAM-3385-2021; HOE, SEE ZIAU/B-8637-2010; Murphy, David/C-3967-2012	HOE, SEE ZIAU/0000-0001-6138-1271; Hindmarch, Charles/0000-0002-6036-1292; Murphy, David/0000-0003-2946-0353; Greenwood, Michael/0000-0003-0565-2748	NIH, NINDS; BHF [RG/11/28714]; BBSRC [BB/J005452/1]; High Impact Research Chancellory Grant from the University of Malaya [UM.C/625/1/HIR/MOHE/MED/22 H-20001-E000086]; Biotechnology and Biological Sciences Research Council [BB/J005452/1] Funding Source: researchfish; British Heart Foundation [RG/11/6/28714] Funding Source: researchfish	NIH, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); BHF(British Heart Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); High Impact Research Chancellory Grant from the University of Malaya; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation)	This research was supported by the Intramural Research Program of the NIH, NINDS (KJ, HG), and by funding from the BHF (RG/11/28714, MG, DM), the BBSRC (BB/J005452/1, CH, DM) and a High Impact Research Chancellory Grant (UM.C/625/1/HIR/MOHE/MED/22 H-20001-E000086) from the University of Malaya (SZH, CH, DM).	Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Antunes-Rodrigues J, 2004, PHYSIOL REV, V84, P169, DOI 10.1152/physrev.00017.2003; ARMSTRONG WE, 1977, BRAIN RES BULL, V2, P7, DOI 10.1016/0361-9230(77)90019-3; Armstrong WE, 1995, PROG NEUROBIOL, V47, P291, DOI 10.1016/0301-0082(95)00025-9; Baro DJ, 1997, J NEUROSCI, V17, P6597; BENBARAK Y, 1985, J NEUROSCI, V5, P81; Bourque CW, 2008, NAT REV NEUROSCI, V9, P519, DOI 10.1038/nrn2400; BOURQUE CW, 1989, J PHYSIOL-LONDON, V417, P263, DOI 10.1113/jphysiol.1989.sp017800; Brown CH, 2013, J NEUROENDOCRINOL, V25, P678, DOI 10.1111/jne.12051; BROWNSTEIN MJ, 1980, SCIENCE, V207, P373, DOI 10.1126/science.6153132; Burbach JPH, 2001, PHYSIOL REV, V81, P1197, DOI 10.1152/physrev.2001.81.3.1197; CARTER DA, 1989, BRAIN RES, V487, P350, DOI 10.1016/0006-8993(89)90839-1; Chen H, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00098; Chen Xiao-Ping, 2005, Methods Mol Biol, V293, P285; Fields RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032085; Glasgow E, 2000, AM J PHYSIOL-REG I, V279, pR1239, DOI 10.1152/ajpregu.2000.279.4.R1239; Greenwood M, 2015, AM J PHYSL REGUL INT; Greenwood M, 2014, J NEUROSCI, V34, P3810, DOI 10.1523/JNEUROSCI.4343-13.2014; Grunewald A, 2014, J NEUROSCI METH, V232, P143, DOI 10.1016/j.jneumeth.2014.05.026; Hashimoto H, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00213; Hatton GI, 1997, ANNU REV NEUROSCI, V20, P375, DOI 10.1146/annurev.neuro.20.1.375; HATTON GI, 1990, PROG NEUROBIOL, V34, P437, DOI 10.1016/0301-0082(90)90017-B; HATTON GI, 1973, BRAIN RES, V59, P137, DOI 10.1016/0006-8993(73)90256-4; Hindmarch C, 2006, P NATL ACAD SCI USA, V103, P1609, DOI 10.1073/pnas.0507450103; Hitzemann R, 2014, INT REV NEUROBIOL, V116, P1, DOI 10.1016/B978-0-12-801105-8.00001-1; Humerick M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069407; Iwasaki Y, 1997, ENDOCRINOLOGY, V138, P5266, DOI 10.1210/en.138.12.5266; Kawasaki M, 2005, J NEUROENDOCRINOL, V17, P227, DOI 10.1111/j.1365-2826.2005.01297.x; Kawasaki M, 2009, EXP NEUROL, V219, P212, DOI 10.1016/j.expneurol.2009.05.019; Kuwahara S, 2003, J NEUROSCI, V23, P10231; Landry CF, 1998, J NEUROSCI, V18, P7315; LIGHTMAN SL, 1987, J PHYSIOL-LONDON, V394, P23, DOI 10.1113/jphysiol.1987.sp016858; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Lubelski D, 2012, BRAIN RES, V1429, P18, DOI 10.1016/j.brainres.2011.10.033; Luo L, 1999, NAT MED, V5, P117, DOI 10.1038/4806; MIYATA S, 1994, BRAIN RES BULL, V34, P169, DOI 10.1016/0361-9230(94)90057-4; MURPHY D, 1990, MOL ENDOCRINOL, V4, P1051, DOI 10.1210/mend-4-7-1051; Mutsuga N, 2004, J NEUROSCI, V24, P7174, DOI 10.1523/JNEUROSCI.2022-04.2004; Mutsuga N, 2005, ENDOCRINOLOGY, V146, P1254, DOI 10.1210/en.2004-1202; Nedungadi TP, 2012, EXP NEUROL, V237, P223, DOI 10.1016/j.expneurol.2012.06.017; Ponzio TA, 2007, J NEUROSCI METH, V164, P149, DOI 10.1016/j.jneumeth.2007.04.012; Ponzio TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048860; Qiu J, 2007, J NEUROSCI, V27, P2196, DOI 10.1523/JNEUROSCI.5420-06.2007; Qiu J, 2011, ENDOCRINOLOGY, V152, P3483, DOI 10.1210/en.2011-1044; Qiu Shenfeng, 2012, Frontiers in Genetics, V3, P124, DOI 10.3389/fgene.2012.00124; RHODES CH, 1981, J COMP NEUROL, V198, P45, DOI 10.1002/cne.901980106; Salm AK, 2004, J NEUROENDOCRINOL, V16, P661, DOI 10.1111/j.1365-2826.2004.01219.x; SHERMAN TG, 1986, NEUROENDOCRINOLOGY, V44, P222, DOI 10.1159/000124649; SHERMAN TG, 1988, J NEUROSCI, V8, P3785; Snyder SE, 1998, J COMP NEUROL, V394, P91; STEINBUSCH HWM, 1988, ACTA HISTOCHEM, P85; Stewart L, 2011, J NEUROENDOCRINOL, V23, P177, DOI 10.1111/j.1365-2826.2010.02093.x; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Toledo-Rodriguez M, 2014, METHODS MOL BIOL, V1183, P143, DOI 10.1007/978-1-4939-1096-0_8; Tosic M, 2002, GLIA, V37, P219, DOI 10.1002/glia.10028; TWEEDLE CD, 1976, BRAIN RES BULL, V1, P103, DOI 10.1016/0361-9230(76)90054-X; TWEEDLE CD, 1977, CELL TISSUE RES, V181, P59; Ueta Y, 2005, ENDOCRINOLOGY, V146, P406, DOI 10.1210/en.2004-0830; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WHITNALL MH, 1985, J NEUROSCI, V5, P98; Wichterle H, 2013, SCIENCE, V341, P726, DOI 10.1126/science.1235884; Yamashita M, 2002, ENDOCRINOLOGY, V143, P4464, DOI 10.1210/en.2002-220516; Young LJ, 1999, HORM BEHAV, V36, P212, DOI 10.1006/hbeh.1999.1548; Yue C, 2008, J NEUROENDOCRINOL, V20, P227, DOI 10.1111/j.1365-2826.2007.01640.x; Yue CM, 2006, CELL MOL NEUROBIOL, V26, P959, DOI 10.1007/s10571-006-9017-0; Zhang B, 2001, J NEUROENDOCRINOL, V13, P29, DOI 10.1046/j.1365-2826.2001.00593.x; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zwemer LM, 2014, PRENATAL DIAG, V34, P1006, DOI 10.1002/pd.4417	70	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124523	10.1371/journal.pone.0124523	http://dx.doi.org/10.1371/journal.pone.0124523			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897513	gold, Green Published, Green Submitted			2022-12-26	WOS:000353212600071
J	Lee, H; Kuk, H; Byun, SS; Lee, SE; Hong, SK				Lee, Hakmin; Kuk, Harim; Byun, Seok-Soo; Lee, Sang Eun; Hong, Sung Kyu			Preoperative Glycemic Control Status as a Significant Predictor of Biochemical Recurrence in Prostate Cancer Patients after Radical Prostatectomy	PLOS ONE			English	Article							DIABETES-MELLITUS; COLORECTAL-CANCER; MEN; MORTALITY; METFORMIN; SURVIVAL; TESTOSTERONE; OUTCOMES; GLUCOSE; HBA1C	Background The effect of diabetes mellitus (DM) on prostate cancer (PCa) outcome remains controversial. Thus, we investigated the association of DM history, glycemic control, and metformin use with oncologic outcomes after radical prostatectomy (RP). Methods We reviewed the records of 746 contemporary patients who had hemoglobin A1c (HbA1c) measured within the 6 months preceding RP. The associations between clinical variables and risk of adverse pathological features and biochemical recurrence (BCR) were tested using a multivariate logistic regression and multiple Cox-proportional hazards model, respectively. BCR was defined as prostatic specific antigen (PSA) > 0.2 ng/mL in 2 consecutive tests. Results There were no significant differences in the rates of adverse pathologic features and BCR-free survival between patients with (n = 209) and without (n = 537) a history of DM diagnosis (all p > 0.05). In multivariate analyses, high HbA1c level (>= 6.5%) was significantly related with high pathologic Gleason score (>= 4+3; odds ratio [OR] 1.704, p = 0.019) and BCR-free survival (OR 1.853, p = 0.007). Metformin use was not associated with BCR-free survival (OR 0.662, p = 0.125). Conclusions Poor glycemic control was significantly associated with BCR after RP. Meanwhile, metformin use was not associated with biochemical outcome after RP. Further investigation would be needed to identify exact mechanism underlying the impact of glycemic control on PCa treatment outcome.	[Lee, Hakmin; Kuk, Harim; Byun, Seok-Soo; Lee, Sang Eun; Hong, Sung Kyu] Seoul Natl Univ, Bundang Hosp, Dept Urol, Songnam, South Korea	Seoul National University (SNU)	Hong, SK (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Urol, Songnam, South Korea.	hsk823@chol.com						Barba M, 2012, ANN ONCOL, V23, P1838, DOI 10.1093/annonc/mdr540; Ben Sahra I, 2008, ONCOGENE, V27, P3576, DOI 10.1038/sj.onc.1211024; Bonovas S, 2004, DIABETOLOGIA, V47, P1071, DOI 10.1007/s00125-004-1415-6; *CDCP, 2010, NAT DIAB FACT SHEET; Chan JM, 2005, CANCER CAUSE CONTROL, V16, P789, DOI 10.1007/s10552-005-3301-z; Gapstur SM, 2001, CANCER CAUSE CONTROL, V12, P763, DOI 10.1023/A:1011279907108; Garcia-Cruz E, 2012, BJU INT, V110, pE541, DOI 10.1111/j.1464-410X.2012.11232.x; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; He XX, 2011, ANN ONCOL, V22, P2640, DOI 10.1093/annonc/mdr020; Hong SK, 2009, PROSTATE, V69, P820, DOI 10.1002/pros.20932; Isom-Batz G, 2005, J UROLOGY, V173, P1935, DOI 10.1097/01.ju.0000158040.33531.e7; Jayachandran J, 2010, CANCER EPIDEM BIOMAR, V19, P9, DOI 10.1158/1055-9965.EPI-09-0777; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Kaneda K, 2012, J SURG ONCOL, V105, P606, DOI 10.1002/jso.22137; Kasper JS, 2008, CANCER CAUSE CONTROL, V19, P703, DOI 10.1007/s10552-008-9133-x; Kasper JS, 2006, CANCER EPIDEM BIOMAR, V15, P2056, DOI 10.1158/1055-9965.EPI-06-0410; Kim HS, 2010, PROSTATE, V70, P1540, DOI 10.1002/pros.21189; Krone Cheryl A, 2005, Integr Cancer Ther, V4, P25, DOI 10.1177/1534735404274167; Ma J, 2008, LANCET ONCOL, V9, P1039, DOI 10.1016/S1470-2045(08)70235-3; Merrick GS, 2007, CANCER, V110, P289, DOI 10.1002/cncr.22793; Patel T, 2010, UROLOGY, V76, P1240, DOI 10.1016/j.urology.2010.03.059; Rieken M, 2014, WORLD J UROL, V32, P999, DOI 10.1007/s00345-013-1171-7; Siddiqui AA, 2008, DIGEST DIS SCI, V53, P2486, DOI 10.1007/s10620-008-0264-4; Smith MR, 2008, J CLIN ONCOL, V26, P4333, DOI 10.1200/JCO.2008.16.5845; Spratt DE, 2013, EUR UROL, V63, P709, DOI 10.1016/j.eururo.2012.12.004; Wright JL, 2013, PROSTATE CANCER P D, V16, P204, DOI 10.1038/pcan.2013.5; Wu CW, 2013, BJU INT, V111, pE310, DOI 10.1111/j.1464-410X.2012.11687.x	27	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124761	10.1371/journal.pone.0124761	http://dx.doi.org/10.1371/journal.pone.0124761			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897669	Green Published, Green Submitted, gold			2022-12-26	WOS:000353212600084
J	Moreno, M; Moreno-Navarrete, JM; Serrano, M; Ortega, F; Delgado, E; Sanchez-Ragnarsson, C; Valdes, S; Botas, P; Ricart, W; Fernandez-Real, JM				Moreno, Mara; Maria Moreno-Navarrete, Jose; Serrano, Marta; Ortega, Francisco; Delgado, Elias; Sanchez-Ragnarsson, Cecilia; Valdes, Sergio; Botas, Patricia; Ricart, Wifredo; Manuel Fernandez-Real, Jose			Circulating Irisin Levels Are Positively Associated with Metabolic Risk Factors in Sedentary Subjects	PLOS ONE			English	Article							ADIPOSE-TISSUE; EXERCISE; FAT; OBESITY; MUSCLE; SERUM; EXPRESSION; HUMANS; URBAN; FNDC5	Introduction A physically active life-style plays an independent role in the protection against type 2 diabetes and cardiovascular diseases. Irisin, a novel exercise-induced myokine, activates thermogenesis in rodents through increasing beige fat cells abundance within white fat. We aimed to investigate circulating irisin levels in association with the degree of physical activity and various metabolic parameters in humans. Methods Circulating irisin levels (ELISA) and metabolic parameters were analyzed in 428 subjects (195 men/233 women). Participants were classified according to their self-reported physical activity and to their area of residence. Results Circulating irisin levels were higher in active than in sedentary subjects (p=0.006). Rural inhabitants showed higher circulating irisin levels than urban subjects (p < 0.0001). The increase in irisin levels related to an active lifestyle was only observed in rural citizens (p = 0.014). Among sedentary participants, irisin levels were positively associated with metabolic risk factors (BMI, fasting insulin, HOMA and fasting triglycerides). The area of residence (beta = -0.592, p = < 0.0001) contributed independently to circulating irisin levels variance after controlling for age, gender, BMI, HOMA(IR), triglycerides and physical activity. Conclusions In sedentary participants, circulating irisin levels were positively associated with parameters related to an increased cardiometabolic risk. The present study confirmed that an active lifestyle increases circulating irisin levels, but only among subjects living in a rural environment. Area of residence might be a determinant of irisin levels.	[Moreno, Mara; Maria Moreno-Navarrete, Jose; Serrano, Marta; Ortega, Francisco; Ricart, Wifredo; Manuel Fernandez-Real, Jose] CIBEROBN CB06 03 010, IdIBGi, Dept Diabet Endocrinol & Nutr, Girona, Spain; [Moreno, Mara; Maria Moreno-Navarrete, Jose; Serrano, Marta; Ortega, Francisco; Ricart, Wifredo; Manuel Fernandez-Real, Jose] Inst Salud Carlos III, Girona, Spain; [Delgado, Elias; Sanchez-Ragnarsson, Cecilia] Univ Oviedo, Hosp Cent Asturias, Dept Endocrinol & Nutr, E-33080 Oviedo, Spain; [Valdes, Sergio] CIBERDEM, IBIMA, Hosp Reg Malaga, Endocrinol & Nutr, Barcelona, Spain; [Botas, Patricia] Hosp San Agustin, Dept Med, Aviles, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Instituto de Salud Carlos III; Central University Hospital Asturias; University of Oviedo; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Universidad de Malaga; Hospital San Agustin	Fernandez-Real, JM (corresponding author), CIBEROBN CB06 03 010, IdIBGi, Dept Diabet Endocrinol & Nutr, Girona, Spain.	jmfreal@idibgi.org	Fernández-Real, Jose Manuel/AGH-3599-2022; Moreno-Navarrete, José María/H-9772-2015; Moreno-Navarrete, José María/ABG-5548-2021; Veiras, Oscar/GMW-9525-2022; Ortega, Francisco José J/F-3883-2016; Delgado, Elias/B-2634-2013	Fernández-Real, Jose Manuel/0000-0002-7442-9323; Moreno-Navarrete, José María/0000-0002-2883-511X; Moreno-Navarrete, José María/0000-0002-2883-511X; Ortega, Francisco José J/0000-0003-2111-769X; Delgado, Elias/0000-0001-6114-9712; Ricart, Wifredo/0000-0002-3452-9098; Sanchez Ragnarsson, Cecilia/0000-0003-3649-2636	Spanish Ministry of Health [FIS 2011-00214]; CIBERobn Fisiopatologia de la Obesidad y la Nutricion (CIBERobn)	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); CIBERobn Fisiopatologia de la Obesidad y la Nutricion (CIBERobn)	This study was supported by the Spanish Ministry of Health (FIS 2011-00214), and CIBERobn Fisiopatologia de la Obesidad y la Nutricion (CIBERobn). The CIBER de la Fisiopatologia de la Obesidad y Nutricion (CIBERobn) is an initiative from the Instituto de Salud Carlos III (ISCIII). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adediran Olufemi Sola, 2013, BMC Res Notes, V6, P123, DOI 10.1186/1756-0500-6-123; Ahmed RG, 2013, J ENDOCRINOL, V219, P205, DOI 10.1530/JOE-13-0302; Anastasilakis AD, 2014, J CLIN ENDOCR METAB, V99, P3247, DOI 10.1210/jc.2014-1367; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Broholm C, 2010, EXERC IMMUNOL REV, V16, P77; Choi YK, 2013, DIABETES RES CLIN PR, V100, P96, DOI 10.1016/j.diabres.2013.01.007; DEURENBERG P, 1991, BRIT J NUTR, V65, P105, DOI 10.1079/BJN19910073; Hecksteden A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-235; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Kurdiova T, 2014, J PHYSIOL-LONDON, V592, P1091, DOI 10.1113/jphysiol.2013.264655; Lee P, 2014, CELL METAB, V19, P302, DOI 10.1016/j.cmet.2013.12.017; Lim JE, 2015, ENDOCRINE, V48, P211, DOI 10.1007/s12020-014-0231-0; Liu JJ, 2013, J DIABETES COMPLICAT, V27, P365, DOI 10.1016/j.jdiacomp.2013.03.002; Moreno-Navarrete JM, 2013, J CLIN ENDOCR METAB, V98, pE769, DOI 10.1210/jc.2012-2749; Moreno M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097014; Nielsen AR, 2007, APPL PHYSIOL NUTR ME, V32, P833, DOI 10.1139/H07-054; Panagiotou G, 2014, METABOLISM, V63, P1265, DOI 10.1016/j.metabol.2014.06.001; Pedersen BK, 2009, J PHYSIOL-LONDON, V587, P5559, DOI 10.1113/jphysiol.2009.179515; Pedersen Bente Klarlund, 2011, J Exp Biol, V214, P337, DOI 10.1242/jeb.048074; Polyzos SA, 2013, METABOLISM, V62, P1037, DOI 10.1016/j.metabol.2013.04.008; Roca-Rivada A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060563; Stengel A, 2013, PEPTIDES, V39, P125, DOI 10.1016/j.peptides.2012.11.014; Timmons JA, 2012, NATURE, V488, pE9, DOI 10.1038/nature11364; Valdes S, 2007, DIABETES CARE, V30, P2258, DOI 10.2337/dc06-2461; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yajnik CS, 2013, INT J CARDIOL, V165, P255, DOI 10.1016/j.ijcard.2011.08.053	26	53	56	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124100	10.1371/journal.pone.0124100	http://dx.doi.org/10.1371/journal.pone.0124100			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897751	Green Published, Green Submitted, gold			2022-12-26	WOS:000353212600049
J	Probst, BL; Trevino, I; McCauley, L; Bumeister, R; Dulubova, I; Wigley, WC; Ferguson, DA				Probst, Brandon L.; Trevino, Isaac; McCauley, Lyndsey; Bumeister, Ron; Dulubova, Irina; Wigley, W. Christian; Ferguson, Deborah A.			RTA 408, A Novel Synthetic Triterpenoid with Broad Anticancer and Anti-Inflammatory Activity	PLOS ONE			English	Article							CDDO-METHYL ESTER; NITRIC-OXIDE PRODUCTION; DIRECT INHIBITION; DOWN-REGULATION; ACTIVATES NRF2; 2-CYANO-3,12-DIOXOOLEAN-1,9-DIEN-28-OIC ACID; OLEANANE TRITERPENOIDS; TOPICAL APPLICATION; IMMUNE-RESPONSE; GROWTH ARREST	Semi-synthetic triterpenoids are antioxidant inflammation modulator (AIM) compounds that inhibit tumor cell growth and metastasis. Compounds in the AIM class bind to Keap1 and attenuate Nrf2 degradation. In the nucleus, Nrf2 increases antioxidant gene expression and reduces pro-inflammatory gene expression. By increasing Nrf2 activity, AIMs reduce reactive oxygen species and inflammation in the tumor microenvironment, which reverses tumor-mediated immune evasion and inhibits tumor growth and metastasis. AIMs also directly inhibit tumor cell growth by modulating oncogenic signaling pathways, such as IKK beta/NF-kappa B. Here, we characterized the in vitro antioxidant, anti-inflammatory, and anticancer activities of RTA 408, a novel AIM that is currently being evaluated in patients with advanced malignancies. At low concentrations (<= 25 nM), RTA 408 activated Nrf2 and suppressed nitric oxide and pro-inflammatory cytokine levels in interferon-gamma-stimulated RAW 264.7 macrophage cells. At higher concentrations, RTA 408 inhibited tumor cell growth (GI(50) = 260 +/- 74 nM) and increased caspase activity in tumor cell lines, but not in normal primary human cells. Consistent with the direct effect of AIMs on IKK beta, RTA 408 inhibited NF-kappa B signaling and decreased cyclin D1 levels at the same concentrations that inhibited cell growth and induced apoptosis. RTA 408 also increased CDKN1A (p21) levels and JNK phosphorylation. The in vitro activity profile of RTA 408 is similar to that of bardoxolone methyl, which was well-tolerated by patients at doses that demonstrated target engagement. Taken together, these data support clinical evaluation of RTA 408 for cancer treatment.	[Probst, Brandon L.; Trevino, Isaac; McCauley, Lyndsey; Bumeister, Ron; Dulubova, Irina; Wigley, W. Christian; Ferguson, Deborah A.] Reata Pharmaceut Inc, Irving, TX 75063 USA		Wigley, WC (corresponding author), Reata Pharmaceut Inc, Irving, TX 75063 USA.	chris.wigley@reatapharma.com; deborah.ferguson@reatapharma.com			Reata Pharmaceuticals	Reata Pharmaceuticals	This work was funded by Reata Pharmaceuticals, who had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ahmad R, 2008, CANCER RES, V68, P2920, DOI 10.1158/0008-5472.CAN-07-3036; Ahmad R, 2006, J BIOL CHEM, V281, P35764, DOI 10.1074/jbc.M607160200; Baird L, 2011, ARCH TOXICOL, V85, P241, DOI 10.1007/s00204-011-0674-5; Carrasco RA, 2003, BIOTECHNIQUES, V34, P1064, DOI 10.2144/03345dd02; Chauhan D, 2004, BLOOD, V103, P3158, DOI 10.1182/blood-2003-08-2873; Cleasby A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098896; Dinkova-Kostova AT, 2005, P NATL ACAD SCI USA, V102, P4584, DOI 10.1073/pnas.0500815102; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Hiramoto K, 2014, CANCER PREV RES, V7, P835, DOI 10.1158/1940-6207.CAPR-14-0094; Honda T, 1998, BIOORG MED CHEM LETT, V8, P2711, DOI 10.1016/S0960-894X(98)00479-X; Honda T, 1999, BIOORG MED CHEM LETT, V9, P3429, DOI 10.1016/S0960-894X(99)00623-X; Hong D.S., 2012, CLIN CANC RES; Ikeda T, 2003, CANCER RES, V63, P5551; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Kensler TW, 2010, CARCINOGENESIS, V31, P90, DOI 10.1093/carcin/bgp231; Kim EH, 2011, CANC PREV RES PHILA; Konopleva M, 2006, MOL CANCER THER, V5, P317, DOI 10.1158/1535-7163.MCT-05-0350; Konopleva M, 2002, BLOOD, V99, P326, DOI 10.1182/blood.V99.1.326; Lapillonne H, 2003, CANCER RES, V63, P5926; Lee DF, 2009, MOL CELL, V36, P131, DOI 10.1016/j.molcel.2009.07.025; Liby K, 2006, CLIN CANCER RES, V12, P4288, DOI 10.1158/1078-0432.CCR-06-0215; Liby KT, 2012, PHARMACOL REV, V64, P972, DOI 10.1124/pr.111.004846; Liby KT, 2010, CANCER PREV RES, V3, P1427, DOI 10.1158/1940-6207.CAPR-10-0197; Ling XY, 2007, CANCER RES, V67, P4210, DOI 10.1158/0008-5472.CAN-06-3629; Liu H, 2005, J ETHNOPHARMACOL, V100, P92, DOI 10.1016/j.jep.2005.05.024; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu TY, 2012, CLIN CANCER RES, V18, P4877, DOI 10.1158/1078-0432.CCR-11-2939; Nagaraj S, 2010, CLIN CANCER RES, V16, P1812, DOI 10.1158/1078-0432.CCR-09-3272; Niture SK, 2011, CELL DEATH DIFFER, V18, P439, DOI 10.1038/cdd.2010.114; Ohta T, 2008, CANCER RES, V68, P1303, DOI 10.1158/0008-5472.CAN-07-5003; Rachakonda G, 2010, ONCOGENE, V29, P3703, DOI 10.1038/onc.2010.118; Reisman SA, 2014, ARCH DERMATOL RES, V306, P447, DOI 10.1007/s00403-013-1433-7; Reisman SA, 2014, RADIAT RES, V181, P512, DOI 10.1667/RR13578.1; Reisman SA, 2009, BIOCHEM PHARMACOL, V77, P1273, DOI 10.1016/j.bcp.2008.12.028; Satoh H, 2010, CARCINOGENESIS; Shishodia S, 2006, CLIN CANCER RES, V12, P1828, DOI 10.1158/1078-0432.CCR-05-2044; Singh A, 2010, ANTIOXID REDOX SIGN, V13, P1627, DOI 10.1089/ars.2010.3219; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Slocum SL, 2011, ARCH TOXICOL, V85, P273, DOI 10.1007/s00204-011-0675-4; Sporn MB, 2012, NAT REV CANCER, V12, P564, DOI 10.1038/nrc3278; Suh NJ, 1999, CANCER RES, V59, P336; Thangasamy A, 2011, J BIOL CHEM, V286, P32115, DOI 10.1074/jbc.M111.245746; Thimmulappa RK, 2006, BIOCHEM BIOPH RES CO, V351, P883, DOI 10.1016/j.bbrc.2006.10.102; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; Thu KL, 2011, J THORAC ONCOL, V6, P1521, DOI 10.1097/JTO.0b013e3182289479; Townson JL, 2011, CLIN EXP METASTASIS; Tran K, 2012, CANCER PREV RES, V5, P726, DOI 10.1158/1940-6207.CAPR-11-0404; Vannini N, 2007, MOL CANCER THER, V6, P3139, DOI 10.1158/1535-7163.MCT-07-0451; Wang YY, 2014, MOL CANCER, V13, DOI [10.1186/1476-4598-13-30, 10.1186/s12934-014-0151-y]; Yamamoto T, 2008, MOL CELL BIOL, V28, P2758, DOI 10.1128/MCB.01704-07; Yates MS, 2009, CARCINOGENESIS, V30, P1024, DOI 10.1093/carcin/bgp100; Yore MM, 2006, MOL CANCER THER, V5, P3232, DOI 10.1158/1535-7163.MCT-06-0444; Zou W, 2004, CANCER RES, V64, P7570, DOI 10.1158/0008-5472.CAN-04-1238; Zou W, 2008, CANCER RES, V68, P7484, DOI 10.1158/0008-5472.CAN-08-1318; Zou W, 2007, CANCER BIOL THER, V6, P1614, DOI 10.4161/cbt.6.10.4763	55	50	53	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0122942	10.1371/journal.pone.0122942	http://dx.doi.org/10.1371/journal.pone.0122942			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897966	gold, Green Published, Green Submitted			2022-12-26	WOS:000353212600016
J	Gradwohl, G; Berdugo-Boura, N; Segev, Y; Tarasiuk, A				Gradwohl, Gideon; Berdugo-Boura, Nilly; Segev, Yael; Tarasiuk, Ariel			Sleep/Wake Dynamics Changes during Maturation in Rats	PLOS ONE			English	Article							UPPER AIRWAY-OBSTRUCTION; SLOW-WAVE ACTIVITY; BEHAVIORAL STATES; BRAIN MATURATION; OREXIN; PATTERNS; AGE; CHILDREN; ADENOTONSILLECTOMY; HOMEOSTASIS	Objectives Conventional scoring of sleep provides little information about the process of transitioning between vigilance states. We applied the state space technique (SST) using frequency band ratios to follow normal maturation of different sleep/wake states, velocities of movements, and transitions between states of juvenile (postnatal day 34, P34) and young adult rats (P71). Design 24-h sleep recordings of eight P34 and nine P71 were analyzed using conventional scoring criteria and SST one week following implantation of telemetric transmitter. SST is a non-categorical approach that allows novel quantitative and unbiased examination of vigilance-states dynamics and state transitions. In this approach, behavioral changes are described in a 2-dimensional state space that is derived from spectral characteristics of the electroencephalography. Measurements and Results With maturation sleep intensity declines, the duration of deep slow wave sleep (DSWS) and light slow wave sleep (LSWS) decreases and increases, respectively. Vigilance state determination, as a function of frequency, is not constant; there is a substantial shift to higher ratio 1 in all vigilance states except DSWS. Deep slow wave sleep decreases in adult relative to juvenile animals at all frequencies. P71 animals have 400% more trajectories from Wake to LSWS (p = 0.005) and vice versa (p = 0.005), and 100% more micro-arousals (p = 0.021), while trajectories from LSWS to DSWS (p = 0.047) and vice versa (p = 0.033) were reduced by 60%. In both juvenile and adult animals, no significant changes were found in sleep velocity at all regions of the 2-dimensional state space plot; suggesting that maturation has a partial effect on sleep stability. Conclusions Here, we present novel and original evidence that SST enables visualization of vigilance-state intensity, transitions, and velocities that were not evident by traditional scoring methods. These observations provide new perspectives in sleep state dynamics and highlight the usefulness of this technique in exploring the development of sleep-wake activity.	[Gradwohl, Gideon; Berdugo-Boura, Nilly; Tarasiuk, Ariel] Ben Gurion Univ Negev, Soroka Univ Med Ctr, Sleep Wake Disorders Unit, IL-84105 Beer Sheva, Israel; [Gradwohl, Gideon; Berdugo-Boura, Nilly; Tarasiuk, Ariel] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol, IL-84105 Beer Sheva, Israel; [Berdugo-Boura, Nilly; Segev, Yael] Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol & Immunol, IL-84105 Beer Sheva, Israel; [Gradwohl, Gideon] Jerusalem Coll Technol, Dept Phys, Unit Biomed Engn, Jerusalem, Jerusalem, Israel	Ben Gurion University; Soroka Medical Center; Ben Gurion University; Ben Gurion University	Tarasiuk, A (corresponding author), Ben Gurion Univ Negev, Soroka Univ Med Ctr, Sleep Wake Disorders Unit, IL-84105 Beer Sheva, Israel.	tarasiuk@bgu.ac.il			Israel Science Foundation [31/14]	Israel Science Foundation(Israel Science Foundation)	This work was supported Israel Science Foundation Grant No. 31/14 to A.T. and Y.S. These funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann P, 1998, NEUROSCIENCE, V85, P1195, DOI 10.1016/S0306-4522(97)00692-1; Behn CGD, 2010, SLEEP, V33, P297, DOI 10.1093/sleep/33.3.297; Ben-Israel N, 2011, EUR RESPIR J, V37, P1144, DOI 10.1183/09031936.00106710; Campbell IG, 2009, P NATL ACAD SCI USA, V106, P5177, DOI 10.1073/pnas.0812947106; Dahl RE, 1996, DEV PSYCHOPATHOL, V8, P3, DOI 10.1017/S0954579400006945; DASILVA FL, 1991, ELECTROEN CLIN NEURO, V79, P81, DOI 10.1016/0013-4694(91)90044-5; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; de Vivo L, 2014, SLEEP, V37, P689, DOI 10.5665/sleep.3570; Dzirasa K, 2006, J NEUROSCI, V26, P10577, DOI 10.1523/JNEUROSCI.1767-06.2006; Esser SK, 2007, SLEEP, V30, P1617, DOI 10.1093/sleep/30.12.1617; FEINBERG I, 1974, J PSYCHIATR RES, V10, P283, DOI 10.1016/0022-3956(74)90011-9; Feinberg I, 2006, AM J PHYSIOL-REG I, V291, pR1724, DOI 10.1152/ajpregu.00293.2006; Feinberg I, 2010, BRAIN COGNITION, V72, P56, DOI 10.1016/j.bandc.2009.09.008; Gervasoni D, 2004, J NEUROSCI, V24, P11137, DOI 10.1523/JNEUROSCI.3524-04.2004; Gradwohl G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097111; Hagenauer MH, 2013, HORM BEHAV, V64, P270, DOI 10.1016/j.yhbeh.2013.01.013; Hagenauer MH, 2012, FRONT NEUROENDOCRIN, V33, P211, DOI 10.1016/j.yfrne.2012.04.003; Hunt NJ, 2015, NEUROBIOL AGING, V36, P292, DOI 10.1016/j.neurobiolaging.2014.08.010; Iglowstein I, 2003, PEDIATRICS, V111, P302, DOI 10.1542/peds.111.2.302; Imbach LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048660; Jenni OG, 2004, SLEEP, V27, P774; LI H, 1995, AM J PHYSIOL-REG I, V269, pR208, DOI 10.1152/ajpregu.1995.269.1.R208; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Lin SC, 2007, METHODS NEURAL ENSEM; Maret S, 2011, NAT NEUROSCI, V14, P1418, DOI 10.1038/nn.2934; Mong JA, 2011, J NEUROSCI, V31, P16107, DOI 10.1523/JNEUROSCI.4175-11.2011; Naylor E, 1998, SLEEP, V21, P687, DOI 10.1093/sleep/21.7.687; Nelson AB, 2013, BRAIN SCI, V3, P318, DOI 10.3390/brainsci3010318; OBAL F, 1991, BRAIN RES, V557, P149, DOI 10.1016/0006-8993(91)90128-I; Obal F, 2004, SLEEP MED REV, V8, P367, DOI 10.1016/j.smrv.2004.03.005; Olini N, 2014, J SLEEP RES, V23, P261, DOI 10.1111/jsr.12124; Olini N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072539; Porkka-Heiskanen T, 2013, CURR OPIN NEUROBIOL, V23, P799, DOI 10.1016/j.conb.2013.02.010; Ringli M, 2011, PROG BRAIN RES, V193, P63, DOI 10.1016/B978-0-444-53839-0.00005-3; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Segev Y, 2008, J APPL PHYSIOL, V105, P1602, DOI 10.1152/japplphysiol.90772.2008; Spruyt K, 2005, J SLEEP RES, V14, P163, DOI 10.1111/j.1365-2869.2005.00458.x; Tal A, 2003, CHEST, V124, P948, DOI 10.1378/chest.124.3.948; Tarasiuk A, 2011, EUR RESPIR J, V38, P870, DOI 10.1183/09031936.00197610; Tarasiuk A, 2014, SLEEP, V37, P987, DOI 10.5665/sleep.3676; Terao A, 2002, NEUROSCI LETT, V332, P190, DOI 10.1016/S0304-3940(02)00953-9; Thorleifsdottir B, 2002, J PSYCHOSOM RES, V53, P529, DOI 10.1016/S0022-3999(02)00444-0; Timofeeva OA, 2001, BRAIN RES, V893, P165, DOI 10.1016/S0006-8993(00)03309-6; VANGOOL WA, 1986, SLEEP, V9, P335, DOI 10.1093/sleep/9.2.335; Vyazovskiy VV, 2009, NEURON, V63, P865, DOI 10.1016/j.neuron.2009.08.024; WELSH DK, 1986, J GERONTOL, V41, P579, DOI 10.1093/geronj/41.5.579; Wimmer ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081880; Zamir G, 1998, J RHEUMATOL, V25, P1191	48	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0125509	10.1371/journal.pone.0125509	http://dx.doi.org/10.1371/journal.pone.0125509			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894573	Green Published, gold, Green Submitted			2022-12-26	WOS:000353211700139
J	Ma, SM; Chen, LX; Lin, YF; Yan, H; Lv, JW; Xiong, M; Li, J; Cheng, GQ; Yang, Y; Qiu, ZL; Zhou, WH				Ma, Si-Min; Chen, Long-Xia; Lin, Yi-Feng; Yan, Hu; Lv, Jing-Wen; Xiong, Man; Li, Jin; Cheng, Guo-Qiang; Yang, Yi; Qiu, Zi-Long; Zhou, Wen-Hao			Periostin Promotes Neural Stem Cell Proliferation and Differentiation following Hypoxic-Ischemic Injury	PLOS ONE			English	Article							RAT MODEL; ADULT NEUROGENESIS; BRAIN; REGENERATION; EXPRESSION; MIGRATION; ISCHEMIA/HYPOXIA; FIBROBLASTS; NEURONS	Neural stem cell (NSC) proliferation and differentiation are required to replace neurons damaged or lost after hypoxic-ischemic events and recover brain function. Periostin (POSTN), a novel matricellular protein, plays pivotal roles in the survival, migration, and regeneration of various cell types, but its function in NSCs of neonatal rodent brain is still unknown. The purpose of this study was to investigate the role of POSTN in NSCs following hypoxia-ischemia (HI). We found that POSTN mRNA levels significantly increased in differentiating NSCs. The proliferation and differentiation of NSCs in the hippocampus is compromised in POSTN knockout mice. Moreover, NSC proliferation and differentiation into neurons and astrocytes significantly increased in cultured NSCs treated with recombinant POSTN. Consistently, injection of POSTN into neonatal hypoxic-ischemic rat brains stimulated NSC proliferation and differentiation in the subventricular and subgranular zones after 7 and 14 days of brain injury. Lastly, POSTN treatment significantly improved the spatial learning deficits of rats subjected to HI. These results suggest that POSTN significantly enhances NSC proliferation and differentiation after HI, and provides new insights into therapeutic strategies for the treatment of hypoxic-ischemic encephalopathy.	[Ma, Si-Min; Cheng, Guo-Qiang; Zhou, Wen-Hao] Fudan Univ, Childrens Hosp, Dept Neonatol, Shanghai 200433, Peoples R China; [Chen, Long-Xia; Lin, Yi-Feng] Fudan Univ, Childrens Hosp, Key Lab Birth Defect, Shanghai 200433, Peoples R China; [Ma, Si-Min; Chen, Long-Xia; Lin, Yi-Feng; Yan, Hu; Lv, Jing-Wen; Xiong, Man; Yang, Yi; Zhou, Wen-Hao] Fudan Univ, Childrens Hosp, Key Lab Neonatal Dis, Minist Hlth, Shanghai 200433, Peoples R China; [Qiu, Zi-Long] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai, Peoples R China; [Li, Jin] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University	Zhou, WH (corresponding author), Fudan Univ, Childrens Hosp, Dept Neonatol, Shanghai 200433, Peoples R China.	zwhchfu@126.com	wenhao, zhou/AAA-1505-2020		National Natural Science Foundation of China [81170599, 81300518]; Health Industry Research Project of The Ministry of Health [201002006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Health Industry Research Project of The Ministry of Health	This study was supported by the National Natural Science Foundation of China (NO. 81170599; NO. 81300518) and The Health Industry Research Project of The Ministry of Health (No. 201002006).	Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Aukkarasongsup P, 2013, BIOCHEM BIOPH RES CO, V441, P126, DOI 10.1016/j.bbrc.2013.10.027; Conway SJ, 2014, CELL MOL LIFE SCI, V71, P1279, DOI 10.1007/s00018-013-1494-y; Conway SJ, 2008, CURR GENOMICS, V9, P548, DOI 10.2174/138920208786847917; De Filippis L, 2011, CELL MOL LIFE SCI, V68, P2831, DOI 10.1007/s00018-011-0723-5; Dizon M, 2010, DEV NEUROSCI-BASEL, V32, P173, DOI 10.1159/000313468; Dorn GW, 2007, NEW ENGL J MED, V357, P1552, DOI 10.1056/NEJMcibr074816; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; Gonzalez FF, 2008, PHARMACOL THERAPEUT, V120, P43, DOI 10.1016/j.pharmthera.2008.07.003; Hayashi T, 2005, BRAIN RES, V1038, P41, DOI 10.1016/j.brainres.2004.12.048; Huang ZH, 2009, BRAIN RES, V1301, P100, DOI 10.1016/j.brainres.2009.09.006; Ikeda T, 2005, AM J OBSTET GYNECOL, V193, P849, DOI 10.1016/j.ajog.2005.01.029; Ikeda T, 2008, CELL TISSUE RES, V331, P263, DOI 10.1007/s00441-007-0546-8; Ishikawa K, 2014, FASEB J, V28, P131, DOI 10.1096/fj.13-229740; Iwai M, 2006, NEUROL RES, V28, P461, DOI 10.1179/016164105X49283; Jackson-Boeters L, 2009, J CELL COMMUN SIGNAL, V3, P125, DOI 10.1007/s12079-009-0057-3; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Nishiyama T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018410; Ohira K, 2011, CELL MOL LIFE SCI, V68, P1645, DOI 10.1007/s00018-010-0552-y; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Padial-Molina M, 2014, J PERIODONTAL RES, V49, P405, DOI 10.1111/jre.12120; Pimentel-Coelho PM, 2010, STEM CELLS DEV, V19, P299, DOI 10.1089/scd.2009.0403; Sheldon RA, 1996, BIOL NEONATE, V69, P327; Shih CH, 2014, J NEUROSCI, V34, P2438, DOI 10.1523/JNEUROSCI.2947-13.2014; Shimamura M, 2014, HYPERTENS RES, V37, P494, DOI 10.1038/hr.2014.36; Shimamura M, 2012, STROKE, V43, P1108, DOI 10.1161/STROKEAHA.111.636662; Snider P, 2008, CIRC RES, V102, P752, DOI 10.1161/CIRCRESAHA.107.159517; Stansfield WE, 2009, ANN THORAC SURG, V88, P1916, DOI 10.1016/j.athoracsur.2009.07.038; Sun JQ, 2010, BIOCHEM BIOPH RES CO, V394, P146, DOI 10.1016/j.bbrc.2010.02.132; TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271; Taupin P, 2007, BRAIN RES REV, V53, P198, DOI 10.1016/j.brainresrev.2006.08.002; Vannucci RC, 1999, J NEUROSCI RES, V55, P158, DOI 10.1002/(SICI)1097-4547(19990115)55:2<158::AID-JNR3>3.0.CO;2-1; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wachtel EV, 2011, CURR PROB PEDIATR AD, V41, P132, DOI 10.1016/j.cppeds.2010.12.002; Weiss S, 1996, TRENDS NEUROSCI, V19, P387, DOI 10.1016/S0166-2236(96)10035-7; Xiao ZM, 2013, BIOTECHNOL APPL BIOC, DOI [10.1002/bab.1193.s, DOI 10.1002/BAB.1193.S]; Xiong M, 2008, NEUROBIOL DIS, V32, P433, DOI 10.1016/j.nbd.2008.08.007; Yan H, 2010, BIOCHEM BIOPH RES CO, V391, P1187, DOI 10.1016/j.bbrc.2009.12.015; Zhang Z, 2014, INT J MOL MED, V34, P253, DOI 10.3892/ijmm.2014.1760; Zhou B, 2010, DEV BIOL, V338, P251, DOI 10.1016/j.ydbio.2009.12.007; Zhu SM, 2008, J HISTOCHEM CYTOCHEM, V56, P329, DOI 10.1369/jhc.7A7321.2007; Zhu SM, 2009, J CELL PHYSIOL, V218, P584, DOI 10.1002/jcp.21633	46	12	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123585	10.1371/journal.pone.0123585	http://dx.doi.org/10.1371/journal.pone.0123585			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894199	gold, Green Published, Green Submitted			2022-12-26	WOS:000353211700045
J	Marino, F; Tozzi, M; Schembri, L; Ferraro, S; Tarallo, A; Scanzano, A; Legnaro, M; Castelli, P; Cosentino, M				Marino, Franca; Tozzi, Matteo; Schembri, Laura; Ferraro, Stefania; Tarallo, Antonino; Scanzano, Angela; Legnaro, Massimiliano; Castelli, Patrizio; Cosentino, Marco			Production of IL-8, VEGF and Elastase by Circulating and Intraplaque Neutrophils in Patients with Carotid Atherosclerosis	PLOS ONE			English	Article							TYPE-1 RECEPTOR EXPRESSION; POLYMORPHONUCLEAR NEUTROPHILS; PLAQUE; ARTERY; INFILTRATION; ANGIOGENESIS; INSTABILITY; MECHANISMS; LEUKOCYTES; MEDIATOR	Objectives Polymorphonuclear neutrophils (PMN) in atherosclerotic plaques have been identified only recently, and their contribution to plaque development is not yet fully understood. In this study, production of elastase, interleukin (IL)-8 and vascular endothelial growth factor (VEGF) by PMN was investigated in subjects with carotid stenosis undergoing carotid endarterectomy (CEA). Methods The study enrolled 50 patients (Pts) and 10 healthy subjects (HS). Circulating PMN (cPMN) isolated from venous blood (in both Pts and HS) and from plaques (pPMN, in Pts) were cultured, alone or with 0.1 mu M fMLP. Elastase, IL-8 and VEGF mRNA were analyzed by real-time PCR. In CEA specimens, PMN were localized by immunohistochemistry. Results In both Pts cPMN and pPMN, IL-8 mRNA was higher at rest but lower after fMLP (P<0.01 vs HS), and VEGF mRNA was higher both at rest and after fMLP (P<0.01 vs HS), while elastase mRNA was not significantly different. On the contrary, protein production was always higher in cPMN of HS with respect to values measured in cells of Pts. In CEA specimens, CD66b+ cells localized to areas with massive plaque formation close to neovessels. Pts with soft and mix plaques, as defined by computed tomography, did not differ in cPMN or pPMN IL-8, VEGF or elastase mRNA, or in intraplaque CD66b+ cell density. However, Pts with soft plaques had higher white blood cell count due to increased PMN. Conclusions In Pts with carotid plaques, both circulating and intraplaque PMN produce IL-8, VEGF and elastase, which are crucial for plaque development and progression. These findings suggest mechanistic explanations to the reported correlation between PMN count and cardiovascular mortality in carotid ATH.	[Marino, Franca; Schembri, Laura; Scanzano, Angela; Legnaro, Massimiliano; Cosentino, Marco] Univ Insubria, Ctr Res Med Pharmacol, Varese, Italy; [Tozzi, Matteo; Ferraro, Stefania; Tarallo, Antonino; Castelli, Patrizio] Univ Insubria, Dept Surg & Morphol Sci, Varese, Italy	University of Insubria; University of Insubria	Marino, F (corresponding author), Univ Insubria, Ctr Res Med Pharmacol, Varese, Italy.	franca.marino@uninsubria.it	Cosentino, Marco/A-3848-2010; Tozzi, Matteo/L-1598-2019	Cosentino, Marco/0000-0002-6978-7775; Tozzi, Matteo/0000-0002-7300-8260; Castelli, Patrizio/0000-0002-0709-6936	University of Insubria; PhD Course in Clinical and Experimental Pharmacology, University of Insubria	University of Insubria; PhD Course in Clinical and Experimental Pharmacology, University of Insubria	This work was supported in part by grants from the University of Insubria (FAR 2011-2012) to FM and MT. AS was supported by a fellowship grant from the PhD Course in Clinical and Experimental Pharmacology, University of Insubria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baetta R, 2010, ATHEROSCLEROSIS, V210, P1, DOI 10.1016/j.atherosclerosis.2009.10.028; Baggiolini M, 2001, J INTERN MED, V250, P91, DOI 10.1046/j.1365-2796.2001.00867.x; Benabid R, 2012, J BIOL CHEM, V287, P34883, DOI 10.1074/jbc.M112.361352; Boisvert William A, 2004, Discov Med, V4, P288; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; de Weert TT, 2008, INT J CARDIOVAS IMAG, V24, P751, DOI 10.1007/s10554-008-9309-1; Della Bona R, 2013, INFLAMM RES, V62, P537, DOI 10.1007/s00011-013-0617-0; Dorweiler B, 2008, THROMB HAEMOSTASIS, V99, P373, DOI 10.1160/TH07-06-0387; Drechsler M, 2010, CIRCULATION, V122, P1837, DOI 10.1161/CIRCULATIONAHA.110.961714; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Golledge J, 1997, BRIT J SURG, V84, P1697; Golledge J, 2000, STROKE, V31, P774, DOI 10.1161/01.STR.31.3.774; Guasti L, 2008, EUR HEART J, V29, P1118, DOI 10.1093/eurheartj/ehn138; Guasti L, 2006, J HYPERTENS, V24, P2423, DOI 10.1097/01.hjh.0000251903.62804.77; Guasti L, 2011, THROMB HAEMOSTASIS, V106, P591, DOI 10.1160/TH11-02-0096; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Henriksen PA, 2008, INT J BIOCHEM CELL B, V40, P1095, DOI 10.1016/j.biocel.2008.01.004; Ho-Tin-Noe B, 2011, TRENDS CARDIOVAS MED, V21, P183, DOI 10.1016/j.tcm.2012.05.007; Holm PW, 2009, ANN MED, V41, P257, DOI 10.1080/07853890802516507; Ionita MG, 2010, ARTERIOSCL THROM VAS, V30, P1842, DOI 10.1161/ATVBAHA.110.209296; Khuseyinova N, 2006, CURR OPIN CRIT CARE, V12, P412, DOI 10.1097/01.ccx.0000244119.16377.75; Liapis CD, 2009, EUR J VASC ENDOVASC, V37, pS1, DOI 10.1016/j.ejvs.2008.11.006; Marino F, 2007, J CARDIOVASC PHARM, V49, P299, DOI 10.1097/FJC.0b013e31803d35ce; Marino F, 2009, J CARDIOVASC PHARM, V54, P520, DOI 10.1097/FJC.0b013e3181bfadfd; Mayer FJ, 2013, ATHEROSCLEROSIS, V231, P274, DOI 10.1016/j.atherosclerosis.2013.10.002; Mocsai A, 2013, J EXP MED, V210, P1283, DOI 10.1084/jem.20122220; Moreno PR, 2012, ANN NY ACAD SCI, V1254, P7, DOI 10.1111/j.1749-6632.2012.06497.x; Naruko T, 2002, CIRCULATION, V106, P2894, DOI 10.1161/01.CIR.0000042674.89762.20; Quigley JP, 2012, FUTURE ONCOL, V8, P5, DOI [10.2217/FON.11.133, 10.2217/fon.11.133]; Quinn K, 2008, AM J PHYSIOL-HEART C, V295, pH1817, DOI 10.1152/ajpheart.00472.2008; Rotzius P, 2010, AM J PATHOL, V177, P493, DOI 10.2353/ajpath.2010.090480; Saba L, 2012, AM J NEURORADIOL, V33, P1814, DOI 10.3174/ajnr.A3073; Saba L, 2009, CLIN RADIOL, V64, P767, DOI 10.1016/j.crad.2009.03.009; Simonini A, 2000, CIRCULATION, V101, P1519, DOI 10.1161/01.CIR.101.13.1519; Soehnlein O, 2012, CIRC RES, V110, P875, DOI 10.1161/CIRCRESAHA.111.257535; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Tecchio C, 2014, CHEM IMMUNOL ALLERGY, V99, P123, DOI 10.1159/000353358; van Leeuwen M, 2008, ARTERIOSCL THROM VAS, V28, P84, DOI 10.1161/ATVBAHA.107.154807; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578; Zernecke A, 2008, CIRC RES, V102, P209, DOI 10.1161/CIRCRESAHA.107.160697	42	28	30	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124565	10.1371/journal.pone.0124565	http://dx.doi.org/10.1371/journal.pone.0124565			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893670	Green Published, gold			2022-12-26	WOS:000353211700106
J	Zhan, LJ; Masoudi, FA; Li, X; Hu, S; Venkatesh, AK; Spertus, JA; Lin, ZQ; Desai, NR; Li, J; Krumholz, HM; Jiang, LX				Zhan, Lijuan; Masoudi, Frederick A.; Li, Xi; Hu, Shuang; Venkatesh, Arjun K.; Spertus, John A.; Lin, Zhenqiu; Desai, Nihar R.; Li, Jing; Krumholz, Harlan M.; Jiang, Lixin		China PEACE Collaborative Grp	Trends in Cardiac Biomarker Testing in China for Patients with Acute Myocardial Infarction, 2001 to 2011: China PEACE-Retrospective AMI Study	PLOS ONE			English	Article							3RD UNIVERSAL DEFINITION; ASSOCIATION TASK-FORCE; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; PRACTICE GUIDELINES; AMERICAN-COLLEGE; NATIONAL-ACADEMY; TROPONIN; MANAGEMENT; REFORM	Objectives To describe trends in the availability of biomarker testing in Chinese hospitals and how practice complies with established standards for the diagnosis of acute myocardial infarction (AMI). Background Cardiac biomarker testing is standard in high-income countries, but little is known about the availability and use of cardiac biomarker testing in low-and middle-income countries (LMICs) such as China. Methods Based on a nationally representative sample of Chinese hospitals in 2001, 2006 and 2011, we describe the temporal trends and regional differences in the hospital capability and rates of use of cardiac biomarker testing, as well as the variation in use across hospitals with testing capability, for patients labeled with the diagnosis of AMI. Results We sampled 175 hospitals (162 participated in the study) and 18,631 AMI admissions. 14,370 patients were included in analysis of biomarker use. The proportion of hospitals with biomarker testing capability was 57.4% in 2001 (25.0% troponin and 32.4% creatine kinase MB fraction (CK-MB) only) and 96.3% (81.4% troponin and 14.9% CK-MB only) in 2011. The proportion of hospitals with troponin testing capability in 2011 was significantly higher in urban compared with rural hospitals (96.8% vs. 71.4%, p< 0.001). In 2011, only 55.9% of hospitals with troponin testing capability (71 out of 127 hospitals) used the assay for more than 80% of their patients with AMI. Among hospitals with either biomarker testing capability, there was marked variation in use in both rural (from 7.1% to 100.0% of patients) and urban hospitals (from 57.9% to 100.0% of patients). In 2011, 36.1% of the patients with AMI did not have troponin tested and 4.9% did not have either biomarker measured. Conclusions The recommended biomarker tests for AMI diagnosis are not universally available and the testing is not consistently applied when it is available in China.	[Zhan, Lijuan; Li, Xi; Hu, Shuang; Li, Jing; Jiang, Lixin] Chinese Acad Med Sci, Natl Clin Res Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China; [Zhan, Lijuan; Li, Xi; Hu, Shuang; Li, Jing; Jiang, Lixin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Masoudi, Frederick A.] Univ Colorado, Div Cardiol, Aurora, CO USA; [Venkatesh, Arjun K.; Krumholz, Harlan M.] Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT USA; [Venkatesh, Arjun K.; Desai, Nihar R.; Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Venkatesh, Arjun K.] Yale Univ, Sch Med, Dept Emergency Med, New Haven, CT USA; [Spertus, John A.] Univ Missouri, St Lukes Mid Amer Heart Inst, Kansas City, MO 64110 USA; [Desai, Nihar R.; Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Hlth Policy & Management, New Haven, CT USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Colorado System; University of Colorado Anschutz Medical Campus; Yale University; Yale University; Yale University; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; Yale University; Yale University; Yale University	Jiang, LX (corresponding author), Chinese Acad Med Sci, Natl Clin Res Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China.	jiangl@fwoxford.org	, Harlan/AAI-2875-2020; Spertus, John/ABD-3075-2021	Li, Xi/0000-0003-2249-688X	National Health and Family Planning Commission of China [201202025]; National Heart, Lung, and Blood Institute [U01 HL105270-04]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER	National Health and Family Planning Commission of China; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	1. This project was partly supported by the Research Special Fund for Public Welfare Industry of Health (201202025) from National Health and Family Planning Commission of China. HMK is supported by grant U01 HL105270-04 (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute. 2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn T, 2011, LANCET, V377, P1557, DOI 10.1016/S0140-6736(11)60625-9; Alpert JS, 2000, EUR HEART J, V21, P1502, DOI 10.1053/euhj.2000.2305; Anderson JL, 2007, CIRCULATION, V116, pE148, DOI 10.1161/CIRCULATIONAHA.107.181940; Apple FS, 1997, CLIN CHEM, V43, P2047; China Society of Cardiology of Chinese Medical Association, 2010, Zhonghua Xin Xue Guan Bing Za Zhi, V38, P675; Chinese Society of Cardiology of Chinese Medical Association, 2008, ZHONGHUA XIN XUE GUA, V36, P867; Dharmarajan K, 2013, CIRC-CARDIOVASC QUAL, V6, P732, DOI 10.1161/CIRCOUTCOMES.113.000441; Farsi D, 2013, EUR J EMERG MED, V20, P120, DOI 10.1097/MEJ.0b013e328351360f; Ferguson JL, 2002, HEART, V88, P343, DOI 10.1136/heart.88.4.343; Gerhardt W, 1999, SCAND J CLIN LAB INV, V59, P83; Guo Xiaobi, 2006, Exp Clin Cardiol, V11, P298; Hasdai D, 2003, EUR HEART J, V24, P1189, DOI 10.1016/S0195-668X(03)00204-5; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Huffman MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020821; Jaffe AS, 2012, CLIN CHEM, V58, P1727, DOI 10.1373/clinchem.2012.196832; Jaffe AS, 2000, CIRCULATION, V102, P1216, DOI 10.1161/01.CIR.102.11.1216; Kontos MC, 2010, AM HEART J, V160, P819, DOI 10.1016/j.ahj.2010.07.022; Li J, 2015, LANCET, V385, P441, DOI 10.1016/S0140-6736(14)60921-1; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; Mendis S, 2011, INT J EPIDEMIOL, V40, P139, DOI 10.1093/ije/dyq165; Moran A, 2010, CIRC-CARDIOVASC QUAL, V3, P243, DOI 10.1161/CIRCOUTCOMES.109.910711; O'Gara PT, 2013, CIRCULATION, V127, pE362, DOI 10.1161/CIR.0b013e3182742cf6; Takakuwa KM, 2009, CLIN CARDIOL, V20, P120; Tang WHW, 2007, CIRCULATION, V116, pE99, DOI 10.1161/CIRCULATIONAHA.107.185267; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Wagner GS, 2000, J ELECTROCARDIOL, V33, P57, DOI 10.1054/jelc.2000.20334; White HD, 2002, AM HEART J, V144, P933, DOI 10.1067/mhj.2002.129780; White HD, 2013, HEART; Wu AHB, 1999, CLIN CHEM, V45, P1104; Wu AHB, 2007, CLIN CHEM, V53, P2086, DOI 10.1373/clinchem.2007.095679; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488; Zhang XH, 2008, HEART, V94, P1126, DOI 10.1136/hrt.2007.132423; Zhang Xiao-fei, 2012, Zhonghua Xin Xue Guan Bing Za Zhi, V40, P179	36	8	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0122237	10.1371/journal.pone.0122237	http://dx.doi.org/10.1371/journal.pone.0122237			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893247	Green Published, Green Submitted, gold			2022-12-26	WOS:000353211700013
J	Guo, ZY; Zhang, Q; Li, XG; Jing, ZY				Guo, Ziyi; Zhang, Qiang; Li, Xiaoguang; Jing, Zhengyu			Thermochemical Ablation Therapy of VX2 Tumor Using a Permeable Oil-Packed Liquid Alkali Metal	PLOS ONE			English	Article							SOFT-TISSUE TUMOR; HEPATOCELLULAR-CARCINOMA; ANGIOGENESIS; SYSTEM	Objective Alkali metal appears to be a promising tool in thermochemical ablation, but, it requires additional data on safety is required. The objective of this study was to explore the effectiveness of permeable oil-packed liquid alkali metal in the thermochemical ablation of tumors. Methods Permeable oil-packed sodium-potassium (NaK) was prepared using ultrasonic mixing of different ratios of metal to oil. The thermal effect of the mixture during ablation of muscle tissue ex vivo was evaluated using the Fluke Ti400 Thermal Imager. The thermochemical effect of the NaK-oil mixture on VX2 tumors was evaluated by performing perfusion CT scans both before and after treatment in 10 VX2 rabbit model tumors. VX2 tumors were harvested from two rabbits immediately after treatment to assess their viability using trypan blue and hematoxylin and eosin (H.E.) staining. Results The injection of the NaK-oil mixture resulted in significantly higher heat in the ablation areas. The permeable oil controlled the rate of heat released during the NaK reaction with water in the living tissue. Perfusion computed tomography and its parameter map confirmed that the NaK-oil mixture had curative effects on VX2 tumors. Both trypan blue and H.E. staining showed partial necrosis of the VX2 tumors. Conclusions The NaK-oil mixture may be used successfully to ablate tumor tissue in vivo. With reference to the controlled thermal and chemical lethal injury to tumors, using a liquid alkali in ablation is potentially an effective and safe method to treat malignant tumors.	[Guo, Ziyi; Zhang, Qiang; Li, Xiaoguang; Jing, Zhengyu] Chinese Acad Med Sci, Dept Radiol, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China; [Guo, Ziyi; Zhang, Qiang; Li, Xiaoguang; Jing, Zhengyu] Peking Union Med Coll, Beijing 100021, Peoples R China; [Guo, Ziyi] Cent S Univ, Xiangya Med Sch, Dept Radiol, Haikou Peoples Hosp, Haikou, Hainan, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Central South University	Jing, ZY (corresponding author), Chinese Acad Med Sci, Dept Radiol, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China.	Xglee88@126.com; MRI_learn@163.com			Haikou Municipal Bureau of Industry and Information Bureau of the key projects [2012075]; Hainan Natural Science Foundation [813261]	Haikou Municipal Bureau of Industry and Information Bureau of the key projects; Hainan Natural Science Foundation	This work was supported by the Haikou Municipal Bureau of Industry and Information Bureau of the key projects (contract/grant numbers 2012075) and Hainan Natural Science Foundation Project (contract/grant numbers 813261). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clark TWI, 2002, J VASC INTERV RADIOL, V13, pS245, DOI 10.1016/S1051-0443(07)61792-8; Cressman ENK, 2013, INT J HYPERTHER, V29, P71, DOI 10.3109/02656736.2012.756124; Deng ZS, 2007, MINIM INVASIV THER, V16, P341, DOI 10.1080/13645700701709494; Farnam JL, 2010, J VASC INTERV RADIOL, V21, P1573, DOI 10.1016/j.jvir.2010.06.012; Hines-Peralta A, 2006, J VASC INTERV RADIOL, V17, P351, DOI 10.1097/01.RVI.0000196355.31419.1E; Kitchin D, 2014, INT J HYPERTHER, V30, P299, DOI 10.3109/02656736.2014.936050; MACDONALD DKC, 1956, CAN J PHYS, V34, P389, DOI 10.1139/p56-045; Misselt AJ, 2009, J VASC INTERV RADIOL, V20, P1352, DOI 10.1016/j.jvir.2009.06.027; Nishikawa H, 2013, INT J HYPERTHER, V29, P558, DOI 10.3109/02656736.2013.821528; Purdie TG, 2003, PHYS MED BIOL, V48, P849, DOI 10.1088/0031-9155/48/7/303; Purdie TG, 2001, PHYS MED BIOL, V46, P3161, DOI 10.1088/0031-9155/46/12/307; Rao W, 2008, INT J HYPERTHER, V24, P675, DOI 10.1080/02656730802228465; Rao W, 2008, MINIM INVASIV THER, V17, P43, DOI 10.1080/13645700701803826; Rao W, 2009, MINIM INVASIV THER, V18, P30, DOI 10.1080/13645700802384023; Stewart EE, 2012, RADIOLOGY, V264, P68, DOI 10.1148/radiol.12110674; Versura P, 2001, OPHTHALMOLOGICA, V215, P276, DOI 10.1159/000050874; Vogl TJ, 2004, INT J HYPERTHER, V20, P713, DOI 10.1080/02656730400007212; Wang Y, 2013, INT J HYPERTHER, V29, P683, DOI 10.3109/02656736.2013.840806; Wistuba II, 2011, NAT REV CLIN ONCOL, V8, P135, DOI 10.1038/nrclinonc.2011.2; Zheng B, 2004, ANGEW CHEM INT EDIT, V43, P2508, DOI 10.1002/anie.200453974	20	1	1	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123196	10.1371/journal.pone.0123196	http://dx.doi.org/10.1371/journal.pone.0123196			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885926	Green Submitted, Green Published, gold			2022-12-26	WOS:000353017000049
J	Liu, JCY; Leung, JM; Ngan, DA; Nashta, NF; Guillemi, S; Harris, M; Lima, VD; Um, SJ; Li, YX; Tam, S; Shaipanich, T; Raju, R; Hague, C; Leipsic, JA; Bourbeau, J; Tan, WC; Harrigan, PR; Sin, DD; Montaner, J; Man, SFP				Liu, Joseph C. Y.; Leung, Janice M.; Ngan, David A.; Nashta, Negar F.; Guillemi, Silvia; Harris, Marianne; Lima, Viviane D.; Um, Soo-Jung; Li, Yuexin; Tam, Sheena; Shaipanich, Tawimas; Raju, Rekha; Hague, Cameron; Leipsic, Jonathon A.; Bourbeau, Jean; Tan, Wan C.; Harrigan, P. Richard; Sin, Don D.; Montaner, Julio; Man, S. F. Paul			Absolute Leukocyte Telomere Length in HIV-Infected and Uninfected Individuals: Evidence of Accelerated Cell Senescence in HIV-Associated Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							LUNG-FUNCTION; CIRCULATING LEUKOCYTES; SHORTENED TELOMERES; T-CELL; COPD; AGE; DESIGN; COHORT; CT	Combination antiretroviral therapy (cART) has extended the longevity of human immunodeficiency virus (HIV)-infected individuals. However, this has resulted in greater awareness of age-associated diseases such as chronic obstructive pulmonary disease (COPD). Accelerated cellular senescence may be responsible, but its magnitude as measured by leukocyte telomere length is unknown and its relationship to HIV-associated COPD has not yet been established. We measured absolute telomere length (aTL) in peripheral leukocytes from 231 HIV-infected adults. Comparisons were made to 691 HIV-uninfected individuals from a population-based sample. Subject quartiles of aTL were assessed for relationships with measures of HIV disease severity, airflow obstruction, and emphysema severity on computed tomographic (CT) imaging. Multivariable regression models identified factors associated with shortened aTL. Compared to HIV-uninfected subjects, the mean aTL in HIV-infected patients was markedly shorter by 27 kbp/genome (p<0.001); however, the slopes of aTL vs. age were not different (p=0.469). Patients with longer known durations of HIV infection (p=0.019) and lower nadir CD4 cell counts (p=0.023) had shorter aTL. Shorter aTL were also associated with older age (p=0.026), smoking (p=0.005), reduced forced expiratory volume in one second (p=0.030), and worse CT emphysema severity score (p=0.049). HIV-infected subjects demonstrate advanced cellular aging, yet in a cART-treated cohort, the relationship between aTL and age appears no different from that of HIV-uninfected subjects.	[Liu, Joseph C. Y.; Leung, Janice M.; Ngan, David A.; Li, Yuexin; Tam, Sheena; Tan, Wan C.; Sin, Don D.; Man, S. F. Paul] Ctr Heart Lung Innovat, Vancouver, BC, Canada; [Nashta, Negar F.; Harris, Marianne] St Pauls Hosp, AIDS Res Program, Vancouver, BC V6Z 1Y6, Canada; [Guillemi, Silvia; Harris, Marianne] Univ British Columbia, Fac Med, Dept Family Med, Vancouver, BC, Canada; [Guillemi, Silvia; Harris, Marianne; Montaner, Julio] Univ British Columbia, Dept Med, Div HIV AIDS, Vancouver, BC, Canada; [Guillemi, Silvia; Lima, Viviane D.; Harrigan, P. Richard; Montaner, Julio] St Pauls Hosp, BC Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; [Um, Soo-Jung] Dong A Univ, Dept Med, Div Pulm & Crit Care Med, Busan, South Korea; [Shaipanich, Tawimas; Sin, Don D.; Man, S. F. Paul] St Pauls Hosp, UBC Dept Med, Vancouver, BC V6Z 1Y6, Canada; [Shaipanich, Tawimas; Sin, Don D.; Man, S. F. Paul] St Pauls Hosp, Div Resp Med, Vancouver, BC V6Z 1Y6, Canada; [Raju, Rekha; Hague, Cameron; Leipsic, Jonathon A.] St Pauls Hosp, Dept Radiol & Diagnost Imaging, Vancouver, BC V6Z 1Y6, Canada; [Bourbeau, Jean] McGill Univ, Resp Epidemiol & Clin Res Unit, Montreal Chest Inst, Montreal, PQ, Canada	St. Paul's Hospital; University of Saskatchewan; University of British Columbia; University of British Columbia; B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan; Dong A University; St. Paul's Hospital; University of British Columbia; University of Saskatchewan; St. Paul's Hospital; University of Saskatchewan; St. Paul's Hospital; University of Saskatchewan; McGill University	Man, SFP (corresponding author), Ctr Heart Lung Innovat, Vancouver, BC, Canada.	pman@providencehealth.bc.ca	Shaipanich, Tawimas/AAN-6237-2020; Sin, Don/AAC-2219-2021; Leipsic, Jonathon/ABE-6194-2020		Canadian Institutes of Health Research [DCB 120265]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funding was supplied by the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html). The grant number is DCB 120265. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht E, 2014, EUR RESPIR J, V43, P983, DOI 10.1183/09031936.00046213; Barr RG, 2012, COPD, V9, P151, DOI 10.3109/15412555.2012.654923; Bourbeau J, 2014, COPD, V11, P125, DOI 10.3109/15412555.2012.665520; Cheung NKV, 2012, JAMA-J AM MED ASSOC, V307, P1062, DOI 10.1001/jama.2012.228; Crothers K, 2006, CHEST, V130, P1326, DOI 10.1378/chest.130.5.1326; Crothers K, 2011, AM J RESP CRIT CARE, V183, P388, DOI 10.1164/rccm.201006-0836OC; Dawson D, 1995, GENDER DIFFERENCES A; Deeks SG, 2012, CURR OPIN IMMUNOL, V24, P501, DOI 10.1016/j.coi.2012.05.004; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Effros RB, 1996, AIDS, V10, pF17, DOI 10.1097/00002030-199607000-00001; Fehrer C, 2006, EXP GERONTOL, V41, P648, DOI 10.1016/j.exger.2006.03.016; Fischer BM, 2013, AM J PHYSIOL-LUNG C, V304, pL394, DOI 10.1152/ajplung.00091.2012; Fitzpatrick ME, 2014, AIDS, V28, P2505, DOI 10.1097/QAD.0000000000000471; Gardner M, 2014, EXP GERONTOL, V51, P15, DOI 10.1016/j.exger.2013.12.004; Guaraldi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109027; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hodes RJ, 2002, NAT REV IMMUNOL, V2, P699, DOI 10.1038/nri890; Kazerooni EA, 1997, AM J ROENTGENOL, V169, P977, DOI 10.2214/ajr.169.4.9308447; Lee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035567; Leung JM, 2014, AIDS PATIENT CARE ST, V28, P240, DOI 10.1089/apc.2013.0373; Mayer S, 2006, CYTOGENET GENOME RES, V112, P194, DOI 10.1159/000089870; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; O'Callaghan NJ, 2011, BIOL PROCED ONLINE, V13, DOI 10.1186/1480-9222-13-3; Pathai S, 2013, AIDS, V27, P2375, DOI 10.1097/QAD.0b013e328363bf7f; Ribaudo HJ, 2006, ANTIVIR THER, V11, P751; Rode L, 2013, THORAX, V68, P429, DOI 10.1136/thoraxjnl-2012-202544; Saferali A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095600; Samji H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081355; Savale L, 2009, AM J RESP CRIT CARE, V179, P566, DOI 10.1164/rccm.200809-1398OC; Tan WC, 2011, INT J TUBERC LUNG D, V15, P1691, DOI 10.5588/ijtld.11.0211; Tsuji T, 2006, AM J RESP CRIT CARE, V174, P886, DOI 10.1164/rccm.200509-1374OC; Worm SW, 2010, AIDS, V24, P1537, DOI 10.1097/QAD.0b013e32833a0918; Zanet DL, 2014, CLIN INFECT DIS, V58, P1322, DOI 10.1093/cid/ciu051	33	42	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124426	10.1371/journal.pone.0124426	http://dx.doi.org/10.1371/journal.pone.0124426			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885433	gold, Green Published, Green Submitted			2022-12-26	WOS:000353017000125
J	Zhang, N; Brugger, J; Etschmann, B; Ngothai, Y; Zeng, DW				Zhang, Ning; Brugger, Joel; Etschmann, Barbara; Ngothai, Yung; Zeng, Dewen			Thermodynamic Modeling of Poorly Complexing Metals in Concentrated Electrolyte Solutions: An X-Ray Absorption and UV-Vis Spectroscopic Study of Ni(II) in the NiCl2-MgCl2-H2O System	PLOS ONE			English	Article							PARTIAL MOLAL PROPERTIES; SHARED ION-PAIRS; CHLORIDE COMPLEXES; AQUEOUS-SOLUTION; ACTIVITY-COEFFICIENTS; HIGH-PRESSURES; THEORETICAL PREDICTION; SUPERCRITICAL WATER; ZINC COMPLEXATION; PHASE-EQUILIBRIA	Knowledge of the structure and speciation of aqueous Ni(II)-chloride complexes is important for understanding Ni behavior in hydrometallurgical extraction. The effect of concentration on the first-shell structure of Ni(II) in aqueous NiCl2 and NiCl2-MgCl2 solutions was investigated by Ni K edge X-ray absorption (XAS) and UV-Vis spectroscopy at ambient conditions. Both techniques show that no large structural change (e.g., transition from octahedral to tetrahedral-like configuration) occurs. Both methods confirm that the Ni(II) aqua ion (with six coordinated water molecules at RNi-O = 2.07(2) angstrom) is the dominant species over the whole NiCl2 concentration range. However, XANES, EXAFS and UV-Vis data show subtle changes at high salinity (> 2 mol.kg(-1) NiCl2), which are consistent with the formation of small amounts of the NiCl+ complex (up to 0.44(23) Cl at a Ni-Cl distance of 2.35(2) angstrom in 5.05 mol.kg(-1) NiCl2) in the pure NiCl2 solutions. At high Cl: Ni ratio in the NiCl2-MgCl2-H2O solutions, small amounts of [ NiCl2](0) are also present. We developed a speciation-based mixed-solvent electrolyte (MSE) model to describe activity-composition relationships in NiCl2-MgCl2-H2O solutions, and at the same time predict Ni(II) speciation that is consistent with our XAS and UV-Vis data and with existing literature data up to the solubility limit, resolving a long-standing uncertainty about the role of chloride complexing in this system.	[Zhang, Ning; Zeng, Dewen] Cent South Univ, Coll Chem & Chem Engn, Changsha 410083, Hunan, Peoples R China; [Zhang, Ning; Etschmann, Barbara; Ngothai, Yung] Univ Adelaide, Sch Chem Engn, Adelaide, SA 5000, Australia; [Brugger, Joel; Etschmann, Barbara] S Australian Museum, Div Mineral, Adelaide, SA 5000, Australia; [Zhang, Ning; Brugger, Joel; Etschmann, Barbara] Monash Univ, Sch Geosci, Clayton, Vic 3800, Australia	Central South University; University of Adelaide; Monash University	Brugger, J (corresponding author), S Australian Museum, Div Mineral, Adelaide, SA 5000, Australia.	joel.brugger@monash.edu; dewen_zeng@hotmail.com	Brugger, Joël/C-7113-2008	Brugger, Joël/0000-0003-1510-5764; Etschmann, Barbara/0000-0002-7807-2763; Ngothai, Yung/0000-0002-0199-4225	National Basic Research Program of China [2014CB643401]; National Natural Science Foundation of China [20773036, 51134007, 21463010]; China Scholarship Council [201306370118]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	This research was financially supported by National Basic Research Program of China (No. 2014CB643401), the National Natural Science Foundation of China (Nos: 20773036, 51134007 and 21463010), and the China Scholarship Council (No. 201306370118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS DS, 1975, AICHE J, V21, P116, DOI 10.1002/aic.690210115; Agrawal A, 2009, IND ENG CHEM RES, V48, P6145, DOI 10.1021/ie900135u; ANGELL CA, 1966, J AM CHEM SOC, V88, P5192, DOI 10.1021/ja00974a029; Aparicio JL, 1996, J SOLUTION CHEM, V25, P1055, DOI 10.1007/BF00972921; Atak K, 2013, J PHYS CHEM B, V117, P12613, DOI 10.1021/jp408212u; Azimi G, 2008, FLUID PHASE EQUILIBR, V266, P172, DOI 10.1016/j.fluid.2008.01.027; Aziz EF, 2007, J PHYS CHEM B, V111, P4440, DOI 10.1021/jp070085r; BJERRUM J, 1988, ACTA CHEM SCAND A, V42, P714, DOI 10.3891/acta.chem.scand.42a-0714; Brugger J, 2007, GEOCHIM COSMOCHIM AC, V71, P4920, DOI 10.1016/j.gca.2007.08.003; Brugger J, 2001, GEOCHIM COSMOCHIM AC, V65, P2691, DOI 10.1016/S0016-7037(01)00614-7; Brugger J, 2007, COMPUT GEOSCI-UK, V33, P248, DOI 10.1016/j.cageo.2006.06.011; CLIFFORD AA, 1966, J PHYS CHEM-US, V70, P1536, DOI 10.1021/j100877a032; de Jong P. H. K., 1996, Journal of Chemical Physics, V105, P5155, DOI 10.1063/1.472359; Farges F, 2001, GEOCHIM COSMOCHIM AC, V65, P1665, DOI 10.1016/S0016-7037(00)00625-6; FLORENCE TM, 1966, AUST J CHEM, V19, P1343, DOI 10.1071/CH9661343; FONTANA MP, 1978, J CHEM PHYS, V69, P676, DOI 10.1063/1.436633; Fulton JL, 2003, J PHYS CHEM A, V107, P4688, DOI 10.1021/jp0272264; GOLDBERG RN, 1979, J PHYS CHEM REF DATA, V8, P923, DOI 10.1063/1.555615; Harris DJ, 2003, J PHYS CHEM A, V107, P1050, DOI 10.1021/jp026098g; HARVIE CE, 1984, GEOCHIM COSMOCHIM AC, V48, P723, DOI 10.1016/0016-7037(84)90098-X; [何配华 He Peihua], 2010, [冶金分析, Metallurgical Analysis], V30, P58; HELGESON HC, 1974, AM J SCI, V274, P1199, DOI 10.2475/ajs.274.10.1199; HELGESON HC, 1981, AM J SCI, V281, P1249, DOI 10.2475/ajs.281.10.1249; Helm L, 2005, CHEM REV, V105, P1923, DOI 10.1021/cr030726o; Hoffmann MM, 1999, J PHYS CHEM A, V103, P8471, DOI 10.1021/jp990435c; Iuchi S, 2010, CHEM PHYS LETT, V485, P114, DOI 10.1016/j.cplett.2009.12.039; Kelly SD, 2008, METHODS SOIL ANAL 5, P387, DOI DOI 10.2136/SSSABOOKSER5.5.C14; KLEINBERG R, 1969, J CHEM PHYS, V50, P4690, DOI 10.1063/1.1670957; LAGARDE P, 1980, J CHEM PHYS, V72, P3061, DOI 10.1063/1.439509; Li HX, 2014, J CHEM ENG DATA, V59, P2177, DOI 10.1021/je500097j; LIBUS Z, 1975, J SOLUTION CHEM, V4, P1011, DOI 10.1007/BF01074743; LICHERI G, 1983, J CHEM PHYS, V79, P2168, DOI 10.1063/1.446063; LICHERI G, 1981, CHEM PHYS LETT, V83, P384, DOI 10.1016/0009-2614(81)85484-X; Liu HX, 2006, IND ENG CHEM RES, V45, P39, DOI 10.1021/ie050619f; Liu WH, 2007, AM MINERAL, V92, P761, DOI 10.2138/am.2007.2225; Liu W, 2006, CHEM GEOL, V231, P326, DOI 10.1016/j.chemgeo.2006.02.005; Liu WH, 2012, GEOCHIM COSMOCHIM AC, V94, P276, DOI 10.1016/j.gca.2012.04.055; Liu WH, 2012, CHEM GEOL, V298, P57, DOI 10.1016/j.chemgeo.2011.12.018; Liu WH, 2011, GEOCHIM COSMOCHIM AC, V75, P1227, DOI 10.1016/j.gca.2010.12.002; MAGINI M, 1982, J CHEM PHYS, V76, P1116, DOI 10.1063/1.443079; MAGINI M, 1981, J CHEM PHYS, V74, P2523, DOI 10.1063/1.441322; MAGINI M, 1985, J CHEM PHYS, V83, P5797, DOI 10.1063/1.449659; MALINOWSKI ER, 1977, ANAL CHEM, V49, P612, DOI 10.1021/ac50012a027; Mei Y, 2015, GEOCHIM COSMOCHIM AC, V150, P265, DOI 10.1016/j.gca.2014.09.023; Mei Y, 2013, GEOCHIM COSMOCHIM AC, V102, P45, DOI 10.1016/j.gca.2012.10.027; MILLERO FJ, 1992, MAR CHEM, V40, P19, DOI 10.1016/0304-4203(92)90046-D; MILLERO FJ, 1995, MAR CHEM, V50, P21, DOI 10.1016/0304-4203(95)00024-L; NEILSON GW, 1978, J PHYS C SOLID STATE, V11, pL625, DOI 10.1088/0022-3719/11/15/003; NEWSOME JR, 1981, CHEM PHYS LETT, V82, P399, DOI 10.1016/0009-2614(81)85406-1; OIKOVA T, 1979, ZH NEORG KHIM+, V24, P219; Paatero J, 1971, ACTA ACAD ABO MATH P, V31, P1; PITZER KS, 1980, J AM CHEM SOC, V102, P2902, DOI 10.1021/ja00529a006; PITZER KS, 1973, J PHYS CHEM-US, V77, P268, DOI 10.1021/j100621a026; Pospiech B, 2007, SEP PURIF TECHNOL, V57, P461, DOI 10.1016/j.seppur.2006.07.005; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; Rousseau B, 2000, ACTA CRYSTALLOGR A, V56, P300, DOI 10.1107/S0108767300002853; SANDSTROM DR, 1979, J CHEM PHYS, V71, P2381, DOI 10.1063/1.438643; Santana-Casiano JM, 2008, J SOLUTION CHEM, V37, P749, DOI 10.1007/s10953-008-9274-2; SHARPS JA, 1993, GEOCHIM COSMOCHIM AC, V57, P721, DOI 10.1016/0016-7037(93)90164-R; SOPER AK, 1977, J PHYS C SOLID STATE, V10, P1793, DOI 10.1088/0022-3719/10/11/014; STOKES RH, 1946, J AM CHEM SOC, V68, P333, DOI 10.1021/ja01206a055; Sverjensky DA, 1997, GEOCHIM COSMOCHIM AC, V61, P1359, DOI 10.1016/S0016-7037(97)00009-4; TANGER JC, 1988, AM J SCI, V288, P19, DOI 10.2475/ajs.288.1.19; Tian Y, 2012, CHEM GEOL, V334, P345, DOI 10.1016/j.chemgeo.2012.10.010; Waizumi K, 1999, J SOLUTION CHEM, V28, P83, DOI 10.1023/A:1021741911462; WAKITA H, 1982, B CHEM SOC JPN, V55, P817, DOI 10.1246/bcsj.55.817; Wallen SL, 1998, J CHEM PHYS, V108, P4039, DOI 10.1063/1.475838; Wang P, 2006, J MOL LIQ, V125, P37, DOI 10.1016/j.molliq.2005.11.030; Wang P, 2004, FLUID PHASE EQUILIBR, V222, P11, DOI 10.1016/j.fluid.2004.06.008; Wang PM, 2002, FLUID PHASE EQUILIBR, V203, P141, DOI 10.1016/S0378-3812(02)00178-4; Wang WL, 2012, IND ENG CHEM RES, V51, P5124, DOI 10.1021/ie201721m; Xia FF, 2013, J PHYS CHEM A, V117, P8468, DOI 10.1021/jp405168r; ZABINSKY SI, 1995, PHYS REV B, V52, P2995, DOI 10.1103/PhysRevB.52.2995; Zhang N, 2014, J MOL LIQ, V198, P200, DOI 10.1016/j.molliq.2014.06.025; Zhang N, 2014, J SOLUTION CHEM, V43, P326, DOI 10.1007/s10953-014-0129-8; Zhu Z, 2012, HYDROMETALLURGY, V127, P1, DOI 10.1016/j.hydromet.2012.07.001	76	7	7	6	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0119805	10.1371/journal.pone.0119805	http://dx.doi.org/10.1371/journal.pone.0119805			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885410	Green Published, gold, Green Submitted			2022-12-26	WOS:000353017000005
J	Zhou, AM; Kuang, BQ; Gao, YR; Liang, GW				Zhou, Aiming; Kuang, Beiqing; Gao, Yingrui; Liang, Guangwen			Density-Dependent Benefits in Ant-Hemipteran Mutualism? The Case of the Ghost Ant Tapinoma melanocephalum (Hymenoptera: Formicidae) and the Invasive Mealybug Phenacoccus solenopsis (Hemiptera: Pseudococcidae)	PLOS ONE			English	Article							HONEYDEW SUGAR COMPOSITION; FIRE ANTS; HOMOPTERA PSEUDOCOCCIDAE; MEMBRACID MUTUALISM; UNITED-STATES; APHID; ENCYRTIDAE; TINSLEY; COTTON; PLANT	Although density-dependent benefits to hemipterans from ant tending have been measured many times, few studies have focused on integrated effects such as interactions between ant tending, natural enemy density, and hemipteran density. In this study, we tested whether the invasive mealybug Phenacoccus solenopsis is affected by tending by ghost ants (Tapinoma melanocephalum), the presence of parasitoids, mealybug density, parasitoid density and interactions among these factors. Our results showed that mealybug colony growth rate and percentage parasitism were significantly affected by ant tending, parasitoid presence, and initial mealybug density separately. However, there were no interactions among the independent factors. There were also no significant interactions between ant tending and parasitoid density on either mealybug colony growth rate or percentage parasitism. Mealybug colony growth rate showed a negative linear relationship with initial mealybug density but a positive linear relationship with the level of ant tending. These results suggest that benefits to mealybugs are density-independent and are affected by ant tending level.	[Zhou, Aiming] Huazhong Agr Univ, Coll Plant Sci & Technol, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Peoples R China; [Zhou, Aiming; Kuang, Beiqing; Gao, Yingrui; Liang, Guangwen] South China Agr Univ, Red Imported Fire Ant Res Ctr, Guangzhou 510642, Guangdong, Peoples R China	Huazhong Agricultural University; South China Agricultural University	Zhou, AM (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Peoples R China.	zhouam@mail.hzau.edu.cn			National Natural Science Foundation of China [31401808]; Fundamental Research Funds For the Central Universities [2014QC024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds For the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the National Natural Science Foundation of China (No. 31401808) and the Fundamental Research Funds For the Central Universities (No. 2014QC024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDICOTT JF, 1978, CAN J ZOOL, V56, P2093, DOI 10.1139/z78-283; ADDICOTT JF, 1979, CAN J ZOOL, V57, P558, DOI 10.1139/z79-066; AUGSPURGER CK, 1981, ECOLOGY, V62, P775, DOI 10.2307/1937745; BANKS CJ, 1958, J EXP BIOL, V35, P703; BARTON AM, 1986, ECOLOGY, V67, P495, DOI 10.2307/1938592; BRETON LM, 1992, ECOLOGY, V73, P2175, DOI 10.2307/1941465; BRONSTEIN JL, 1994, TRENDS ECOL EVOL, V9, P214, DOI 10.1016/0169-5347(94)90246-1; Bronstein JL, 2003, AM NAT, V162, pS24, DOI 10.1086/378645; BUCKLEY R, 1987, ADV ECOL RES, V16, P53; Chen Hua-Yan, 2011, Huanjing Kunchong Xuebao, V33, P269; CUSHMAN JH, 1989, ECOLOGY, V70, P1040, DOI 10.2307/1941372; Fand BB, 2010, BIOCONTROL SCI TECHN, V21, P51, DOI 10.1080/09583157.2010.522702; Fischer MK, 2001, FUNCT ECOL, V15, P544, DOI 10.1046/j.0269-8463.2001.00550.x; Flatt T, 2000, ECOLOGY, V81, P3522, DOI 10.1890/0012-9658(2000)081[3522:TEOMAO]2.0.CO;2; FUCHS TW, 1991, SOUTHWEST ENTOMOL, V16, P215; Gilbert LE, 1983, COEVOLUTION MIMICRY; Hayat Mohammad, 2009, Biosystematica, V3, P21; Itioka T, 1996, OECOLOGIA, V106, P448, DOI 10.1007/BF00329700; JOUVENAZ DP, 1977, FLA ENTOMOL, V60, P275, DOI 10.2307/3493922; Kaplan I, 2002, ENVIRON ENTOMOL, V31, P1175, DOI 10.1603/0046-225X-31.6.1175; Kaplan I, 2005, ECOLOGY, V86, P1640, DOI 10.1890/04-0016; Kay AD, 2004, ECOL LETT, V7, P1024, DOI 10.1111/j.1461-0248.2004.00667.x; Kumar Rishi, 2009, Journal of Biological Control, V23, P457; [陆永跃 LU Yong-Yue], 2008, [环境昆虫学报, Journal of Environmental Entomology], V30, P386; MCEVOY P B, 1979, Miscellaneous Publications of the Entomological Society of America, V11, P1; MESSINA FJ, 1981, ECOLOGY, V62, P1433, DOI 10.2307/1941499; Mooney KA, 2008, AM NAT, V171, pE195, DOI 10.1086/587758; Morales MA, 2000, ECOLOGY, V81, P482, DOI 10.2307/177441; Nagrare VS, 2009, B ENTOMOL RES, V99, P537, DOI 10.1017/S0007485308006573; Powell BE, 2010, BIOL CONTROL, V54, P285, DOI 10.1016/j.biocontrol.2010.05.013; Sakata H, 1995, RES POPUL ECOL, V37, P159, DOI 10.1007/BF02515816; SMITH MR, 1965, HOUSE INFESTING ANTS; Stadler B, 1998, J ANIM ECOL, V67, P454, DOI 10.1046/j.1365-2656.1998.00209.x; Stadler B, 2005, ANNU REV ECOL EVOL S, V36, P345, DOI 10.1146/annurev.ecolsys.36.091704.175531; Styrsky JD, 2007, P ROY SOC B-BIOL SCI, V274, P151, DOI 10.1098/rspb.2006.3701; Suroshe S. S., 2014, Indian Journal of Entomology, V76, P224; Suroshe Sachin S., 2013, Journal of Biological Control, V27, P204; Volkl W, 1999, OECOLOGIA, V118, P483, DOI 10.1007/s004420050751; WAY MJ, 1963, ANNU REV ENTOMOL, V8, P307, DOI 10.1146/annurev.en.08.010163.001515; Wheeler W. M., 1910, ANTS THEIR STRUCTURE, V9; Wilder SM, 2011, P NATL ACAD SCI USA, V108, P20639, DOI 10.1073/pnas.1115263108; WOOD TK, 1982, ANN ENTOMOL SOC AM, V75, P649, DOI 10.1093/aesa/75.6.649; Yao I, 2000, OIKOS, V89, P3, DOI 10.1034/j.1600-0706.2000.890101.x; Yao I, 2004, EUR J ENTOMOL, V101, P531, DOI 10.14411/eje.2004.076; Zhou AM, 2014, FLA ENTOMOL, V97, P1474, DOI 10.1653/024.097.0423; Zhou AM, 2013, ENVIRON ENTOMOL, V42, P247, DOI 10.1603/EN12168; Zhou AM, 2012, SOCIOBIOLOGY, V59, P795; Zhou AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041856	48	7	8	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123885	10.1371/journal.pone.0123885	http://dx.doi.org/10.1371/journal.pone.0123885			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886510	Green Submitted, Green Published, gold			2022-12-26	WOS:000353017000093
J	Cieslik, KA; Trial, J; Entman, ML				Cieslik, Katarzyna A.; Trial, JoAnn; Entman, Mark L.			Mesenchymal stem cell-derived inflammatory fibroblasts promote monocyte transition into myeloid fibroblasts via an IL-6-dependent mechanism in the aging mouse heart	FASEB JOURNAL			English	Article						fibrosis; RasGrf1; transendothelial migration	NF-KAPPA-B; MYOCARDIAL-INFARCTION; CARDIAC FIBROSIS; GENE-EXPRESSION; INTERLEUKIN-6; ACTIVATION; DIFFERENTIATION; TRANSCRIPTION; PRECURSORS; ARTHRITIS	Fibrosis in the oldmouse heart arises partly as a result of aberrant mesenchymal fibroblast activation. We have previously shown that endogenous mesenchymal stem cells (MSCs) in the aged heart are markedly resistant to TGF-beta signaling. Fibroblasts originating from these MSCs retain their TGF-beta unresponsiveness and become inflammatory. In current studies, we found that these inflammatory fibroblasts secreted higher levels of IL-6 (3-fold increase, P < 0.05) when compared with fibroblasts derived from the young hearts. Elevated IL-6 levels in fibroblasts derived from old hearts arose from upregulated expression of Ras protein-specific guanine nucleotide releasing factor 1 (RasGrf1), a Ras activator (5-fold, P < 0.01). Knockdown of RasGrf1 by gene silencing or pharmacologic inhibition of farnesyltransferase (FTase) or ERK caused reduction of IL-6 mRNA (more than 65%, P < 0.01) and decreased levels of secreted IL-6 (by 44%, P < 0.01). In vitro, IL-6 markedly increased monocyte chemoattractant protein-1-driven monocyte-to-myeloid fibroblast formation after transendothelial migration (TEM; 3-fold, P < 0.01). In conclusion, abnormal expression of RasGrf1 promoted production of IL-6 by mesenchymal fibroblasts in the old heart. Secreted IL-6 supported conversion of monocyte into myeloid fibroblasts. This process promotes fibrosis and contributes to the diastolic dysfunction in the aging heart.	[Cieslik, Katarzyna A.] Baylor Coll Med, Dept Med, Div Cardiovasc Sci, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, DeBakey Heart Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center	Cieslik, KA (corresponding author), Baylor Coll Med, Dept Med, Div Cardiovasc Sci, One Baylor Plaza,MS BCM620, Houston, TX 77030 USA.	cieslik@bcm.edu	Cieslik, Katarzyna/AAO-1982-2021	Cieslik, Katarzyna/0000-0002-2167-7921; Trial, JoAnn/0000-0001-7145-7786	U.S. National Institutes of Health National Heart, Lung, and Blood Institute [R01HL089792]; Medallion Foundation grant; Hankamer Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089792] Funding Source: NIH RePORTER	U.S. National Institutes of Health National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medallion Foundation grant; Hankamer Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. Jeffrey Crawford for conducting protein array experiment. They also thank Christina Sam and Dorellyn Lee for excellent technical assistance. This work was supported by U.S. National Institutes of Health National Heart, Lung, and Blood Institute Grant R01HL089792 (to M.L.E.), a Medallion Foundation grant (to K.A.C.), and the Hankamer Foundation.	Abreu JRF, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2785; Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; Borras C, 2011, AGING-US, V3, P262, DOI 10.18632/aging.100279; Bujak M, 2008, J AM COLL CARDIOL, V51, P1384, DOI 10.1016/j.jacc.2008.01.011; Burman A, 2005, JOINT BONE SPINE, V72, P10, DOI 10.1016/j.jbspin.2004.03.009; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carlson S, 2011, CARDIOVASC RES, V91, P99, DOI 10.1093/cvr/cvr061; Cieslik KA, 2014, J MOL CELL CARDIOL, V70, P56, DOI 10.1016/j.yjmcc.2013.10.017; Cieslik KA, 2013, FASEB J, V27, P1761, DOI 10.1096/fj.12-220145; Cieslik KA, 2011, AM J PATHOL, V179, P1792, DOI 10.1016/j.ajpath.2011.06.022; Cieslik KA, 2011, J MOL CELL CARDIOL, V50, P248, DOI 10.1016/j.yjmcc.2010.10.019; de Launay D, 2010, AM J PATHOL, V177, P3010, DOI 10.2353/ajpath.2010.091053; de Mora JF, 2003, EMBO J, V22, P3039, DOI 10.1093/emboj/cdg280; El Kasmi KC, 2014, J IMMUNOL, V193, P597, DOI 10.4049/jimmunol.1303048; Feinberg MW, 2004, CIRC RES, V94, P601, DOI 10.1161/01.RES.0000119170.70818.4F; Fernando MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094188; Georganas C, 2000, J IMMUNOL, V165, P7199, DOI 10.4049/jimmunol.165.12.7199; Haudek SB, 2008, P NATL ACAD SCI USA, V105, P10179, DOI 10.1073/pnas.0804910105; Haudek SB, 2006, P NATL ACAD SCI USA, V103, P18284, DOI 10.1073/pnas.0608799103; Haudek SB, 2010, J MOL CELL CARDIOL, V49, P499, DOI 10.1016/j.yjmcc.2010.05.005; Haudek SB, 2009, CARDIOVASC RES, V83, P511, DOI 10.1093/cvr/cvp135; Hogaboam CM, 1998, KIDNEY INT, V54, P2152, DOI 10.1046/j.1523-1755.1998.00176.x; Holt AP, 2009, GASTROENTEROLOGY, V136, P705, DOI 10.1053/j.gastro.2008.10.020; Itier JM, 1998, NATURE, V393, P125, DOI 10.1038/30120; Jones SA, 2002, BBA-MOL CELL RES, V1592, P251, DOI 10.1016/S0167-4889(02)00319-1; Jones SA, 2001, FASEB J, V15, P43, DOI 10.1096/fj.99-1003rev; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Lindsey ML, 2005, CARDIOVASC RES, V66, P410, DOI 10.1016/j.cardiores.2004.11.029; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; McGettrick HM, 2009, EUR J IMMUNOL, V39, P113, DOI 10.1002/eji.200838232; Melendez GC, 2010, HYPERTENSION, V56, P225, DOI 10.1161/HYPERTENSIONAHA.109.148635; Obana M, 2010, CIRCULATION, V121, P684, DOI 10.1161/CIRCULATIONAHA.109.893677; Ogata A, 1997, J IMMUNOL, V159, P2212; Parsonage G, 2003, THROMB HAEMOSTASIS, V90, P688, DOI 10.1160/TH03-04-0208; Plenz G, 2001, EUR J HEART FAIL, V3, P415, DOI 10.1016/S1388-9842(01)00137-4; Ploeger DTA, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-29; Ratajczak MZ, 2011, AGING-US, V3, P692, DOI 10.18632/aging.100354; Sato S, 2001, J DERMATOL SCI, V27, P140, DOI 10.1016/S0923-1811(01)00128-1; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Squires CE, 2005, J MOL CELL CARDIOL, V39, P699, DOI 10.1016/j.yjmcc.2005.07.008; Studebaker AW, 2008, CANCER RES, V68, P9087, DOI 10.1158/0008-5472.CAN-08-0400; Sun L, 2011, AM J PHYSIOL-LUNG C, V300, pL341, DOI 10.1152/ajplung.00122.2010; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Trial JA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00287; Tsutamoto T, 1998, J AM COLL CARDIOL, V31, P391, DOI 10.1016/S0735-1097(97)00494-4; Weigert C, 2007, AM J PHYSIOL-CELL PH, V293, pC1139, DOI 10.1152/ajpcell.00142.2007; Williams SM, 2014, J MOL CELL CARDIOL, V67, P112, DOI 10.1016/j.yjmcc.2013.12.013; Wu L, 2014, J EXP MED, V211, P1441, DOI 10.1084/jem.20132126; Xia YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077493; Yamamoto A, 2003, ARTHRITIS RHEUM, V48, P2682, DOI 10.1002/art.11214	51	20	22	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3160	3170		10.1096/fj.14-268136	http://dx.doi.org/10.1096/fj.14-268136			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25888601	Green Published			2022-12-26	WOS:000358796900006
J	Giustiniani, J; Guillemeau, K; Dounane, O; Sardin, E; Huvent, I; Schmitt, A; Hamdane, M; Buee, L; Landrieu, I; Lippens, G; Baulieu, EE; Chambraud, B				Giustiniani, Julien; Guillemeau, Kevin; Dounane, Omar; Sardin, Elodie; Huvent, Isabelle; Schmitt, Alain; Hamdane, Malika; Buee, Luc; Landrieu, Isabelle; Lippens, Guy; Baulieu, Etienne Emile; Chambraud, Beatrice			The FK506-binding protein FKBP52 in vitro induces aggregation of truncated Tau forms with prion-like behavior	FASEB JOURNAL			English	Article						microtubule; immunophilin; Tau assembly; seeding	PAIRED HELICAL FILAMENTS; ALZHEIMERS-DISEASE; BETA-STRUCTURE; FTDP-17; TUBULIN; BRAIN; MUTATIONS; OLIGOMERS; ISOFORMS; MODEL	Tauopathies, including Alzheimer's disease (AD), are neurodegenerative diseases associated with the pathologic aggregation of human brain Tau protein. Neuronal Tau is involved in microtubule (MT) formation and stabilization. We showed previously that the immunophilin FK506-binding protein of MW similar to 52 kDa (FKBP52) interferes with this function of full-length Tau and provokes aggregation of a disease-related mutant of Tau. To dissect the molecular interaction between recombinant human FKBP52 and Tau, here, we study the effect of FKBP52 on a functional Tau fragment (Tau-F4, Ser(208)-Ser(324)) containing part of the proline-rich region and MT-binding repeats. Therefore, we perform MT assembly and light-scattering assays, blue native PAGE analysis, electron microscopy, and Tau seeding experiments in SH-SY5Y human neuroblastoma cells. We show that FKBP52 (6 mu M) prevents MT formation generated by Tau-F4 (5 mu M) and induces Tau-F4 oligomerization and aggregation. Electron microscopy analyses show granular oligomers and filaments of Tau-F4 after short-time FKBP52 incubation. We demonstrate that the terminal parts of Tau interfere with the effects of FKBP52. Finally, we find that FKBP52-induced Tau-F4 oligomers cannot only generate in vitro, direct conformational changes in full-length Tau and that their uptake into neuronal cells can equally lead to aggregation of wild-type endogenous Tau. This suggests a potential prion-like property of these particular Tau-F4 aggregates. Collectively, our results strengthen the hypothesis of FKBP52 involvement in the Tau pathogenicity process.	[Giustiniani, Julien; Guillemeau, Kevin; Dounane, Omar; Sardin, Elodie; Baulieu, Etienne Emile; Chambraud, Beatrice] Univ Paris 11, INSERM, UMR 1195, Le Kremlin Bicetre, France; [Huvent, Isabelle; Landrieu, Isabelle; Lippens, Guy] Univ Lille 1, CNRS, UMR 8576, F-59655 Villeneuve Dascq, France; [Schmitt, Alain] Inst Cochin, INSERM, U1016, Paris, France; [Schmitt, Alain] CNRS, UMR 8104, Paris, France; [Schmitt, Alain] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Hamdane, Malika; Buee, Luc] Ctr Rech Jean Pierre Aubert, INSERM, UMR 1172, Lille, France; [Hamdane, Malika; Buee, Luc] Univ Lille, Sch Med, Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; Universite de Lille - ISITE; CHU Lille; Universite de Lille	Chambraud, B (corresponding author), Univ Paris 11, INSERM, UMR 1195, Le Kremlin Bicetre, France.	etienne.baulieu@inserm.fr; beatrice.chambraud@inserm.fr	Landrieu, Isabelle/AAF-8495-2019; BUEE, Luc/B-3126-2010	Landrieu, Isabelle/0000-0002-4883-2637; BUEE, Luc/0000-0002-6261-4230; Huvent, Isabelle/0000-0002-7241-0290; Giustiniani, Julien/0000-0003-0373-5857; Hamdane, Malika/0000-0001-7971-8696; Lippens, Guy/0000-0002-8236-0901	Fondation Vivre Longtemps; Institut Merieux; Institut Baulieu; Agence Nationale de la Recherche [ANR] [FKBP52]; Laboratoire d'Excellence Developpement de Strategies Innovantes pour une Approche Transdisciplinaire de la Maladie d'Alzheimer (LABEX DISTALZ) grants	Fondation Vivre Longtemps; Institut Merieux; Institut Baulieu; Agence Nationale de la Recherche [ANR](French National Research Agency (ANR)); Laboratoire d'Excellence Developpement de Strategies Innovantes pour une Approche Transdisciplinaire de la Maladie d'Alzheimer (LABEX DISTALZ) grants	The authors thank Dr. M. Tawk and Dr. G. Meduri (Institut National de la Sante et de la Recherche Medicale, Unite 788, Le Kremlin-Bicetre, France) for critical reading and discussion, E. Bourrin for technical help with confocal imaging and analyses, and A. Kamah (Centre Nationale de la Recherche Scientifique - Universite de Lille 1, Unite Mixte de Reccherche 8576, Villeneuve-d'Ascq, France) for technical help for pilot experiments. The authors also thank Dr. P. Davies (Albert Einstein College of Medicine, Bronx, NY, USA) for the generous gift of MC1 and PHF-1 antibodies. E.S., O.D., and K.G. were funded by Fondation Vivre Longtemps, Institut Merieux, and Institut Baulieu. J.G. is supported by Agence Nationale de la Recherche [ANR; Program Maladie d'Alzheimer et Maladies Apparentees (MALZ): Tau Association with FKBP52 (TAF)]. The work has been supported jointly by ANR and by Laboratoire d'Excellence Developpement de Strategies Innovantes pour une Approche Transdisciplinaire de la Maladie d'Alzheimer (LABEX DISTALZ) grants. The authors declare no competing financial interests.	Berriman J, 2003, P NATL ACAD SCI USA, V100, P9034, DOI 10.1073/pnas.1530287100; BRANDT R, 1993, J BIOL CHEM, V268, P3414; Bretteville A, 2008, J ALZHEIMERS DIS, V14, P431; Bretteville A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004843; CHAMBRAUD B, 1993, BIOCHEM BIOPH RES CO, V196, P160, DOI 10.1006/bbrc.1993.2229; Chambraud B, 2007, FASEB J, V21, P2787, DOI 10.1096/fj.06-7667com; Chambraud B, 2010, P NATL ACAD SCI USA, V107, P2658, DOI 10.1073/pnas.0914957107; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Davies TH, 2005, INT J BIOCHEM CELL B, V37, P42, DOI 10.1016/j.biocel.2004.03.013; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; Fauquant C, 2011, J BIOL CHEM, V286, P33358, DOI 10.1074/jbc.M111.223545; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Garcia-Sierra F, 2008, J ALZHEIMERS DIS, V14, P401; Giustiniani J, 2014, P NATL ACAD SCI USA, V111, P4584, DOI 10.1073/pnas.1402645111; Giustiniani J, 2012, J ALZHEIMERS DIS, V29, P471, DOI 10.3233/JAD-2011-111895; Goedert M, 1999, FEBS LETT, V450, P306, DOI 10.1016/S0014-5793(99)00508-6; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Hanger DP, 2010, BIOCHEM SOC T, V38, P1016, DOI 10.1042/BST0381016; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Huvent I, 2014, BIOCHEM BIOPH RES CO, V445, P299, DOI 10.1016/j.bbrc.2014.01.161; Ikura T, 2013, PROTEIN ENG DES SEL, V26, P539, DOI 10.1093/protein/gzt033; Iqbal K, 2009, ACTA NEUROPATHOL, V118, P53, DOI 10.1007/s00401-009-0486-3; Jeganathan S, 2006, BIOCHEMISTRY-US, V45, P2283, DOI 10.1021/bi0521543; KIDD M, 1963, NATURE, V197, P192, DOI 10.1038/197192b0; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Liu M, 2004, ASSAY DRUG DEV TECHN, V2, P609, DOI 10.1089/adt.2004.2.609; Maeda S, 2006, NEUROSCI RES, V54, P197, DOI 10.1016/j.neures.2005.11.009; Maeda S, 2007, BIOCHEMISTRY-US, V46, P3856, DOI 10.1021/bi061359o; Michel CH, 2014, J BIOL CHEM, V289, P956, DOI 10.1074/jbc.M113.515445; Nacharaju P, 1999, FEBS LETT, V447, P195, DOI 10.1016/S0014-5793(99)00294-X; NIETO A, 1991, BIOCHIM BIOPHYS ACTA, V1096, P197, DOI 10.1016/0925-4439(91)90005-T; Preuss U, 1997, J CELL SCI, V110, P789; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Takashima A, 2013, J ALZHEIMERS DIS, V37, P565, DOI 10.3233/JAD-130653; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Wang YP, 2010, BIOCHEM SOC T, V38, P955, DOI 10.1042/BST0380955; Weaver CL, 2000, NEUROBIOL AGING, V21, P719, DOI 10.1016/S0197-4580(00)00157-3; Wegmann S, 2010, J BIOL CHEM, V285, P27302, DOI 10.1074/jbc.M110.145318; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528; Xu SH, 2010, ALZHEIMERS DEMENT, V6, P110, DOI 10.1016/j.jalz.2009.06.002; Zilka N, 2012, BIOCHEM SOC T, V40, P681, DOI 10.1042/BST20120015	47	25	25	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3171	3181		10.1096/fj.14-268243	http://dx.doi.org/10.1096/fj.14-268243			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25888602				2022-12-26	WOS:000358796900007
J	Nagy-Szakal, D; Mir, SAV; Harris, RA; Dowd, SE; Yamada, T; Lacorazza, HD; Tatevian, N; Smith, CW; de Zoeten, EF; Klein, J; Kellermayer, R				Nagy-Szakal, Dorottya; Mir, Sabina A. V.; Harris, R. Alan; Dowd, Scot E.; Yamada, Takeshi; Lacorazza, H. Daniel; Tatevian, Nina; Smith, C. Wayne; de Zoeten, Edwin F.; Klein, John; Kellermayer, Richard			Loss of n-6 fatty acid induced pediatric obesity protects against acute murine colitis	FASEB JOURNAL			English	Article						diet; inflammatory bowel disease; microbiome; CXCL13	INFLAMMATORY-BOWEL-DISEASE; EUROPEAN PROSPECTIVE COHORT; DEXTRAN SULFATE SODIUM; ULCERATIVE-COLITIS; CROHNS-DISEASE; T-CELLS; GUT MICROBIOTA; COLONIC-MUCOSA; MICE; SUSCEPTIBILITY	Dietary influences may affect microbiome composition and host immune responses, thereby modulating propensity toward inflammatory bowel diseases (IBDs): Crohn disease (CD) and ulcerative colitis (UC). Dietary n-6 fatty acids have been associated with UC in prospective studies. However, the critical developmental period when (n-6) consumption may induce UC is not known. We examined the effects of transiently increased n-6 consumption during pediatric development on subsequent dextran-sulfate-sodium (DSS)-induced acute murine colitis. The animals transiently became obese then rapidly lost this phenotype. Interestingly, mice were protected against DSS colitis 40 days after n-6 consumption. The transient high n-6-induced protection against colitis was fat type-and dietary reversal-dependent and could be transferred to germ-free mice by fecal microbiota transplantation. We also detected decreased numbers of chemokine receptor (Cxcr)5(+) CD4(+) T cells in the mesenteric lymph nodes (MLNs) of transiently n-6-fed mice. Further experiments revealed that anti-chemokine ligand (Cxcl)13 (the ligand of Cxcr5) antibody treatment decreased DSS colitis severity, implicating the importance of the Cxcr5-Cxcl13 pathway in mammalian colitis. Consecutively, we found elevated CXCL13 concentrations (CD: 1.8-fold, P = 0.0077; UC: 1.9-fold, P = 0.056) in the serum of untreated pediatric IBD patients. The human serologic observations supported the translational relevance of our findings.	[Nagy-Szakal, Dorottya; Mir, Sabina A. V.; Kellermayer, Richard] Baylor Coll Med, Texas Children Hosp, Sect Pediat Gastroenterol, Houston, TX 77030 USA; [Nagy-Szakal, Dorottya; Smith, C. Wayne; Kellermayer, Richard] ARS, USDA, Childrens Nutr Res Ctr, Houston, TX USA; [Harris, R. Alan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Dowd, Scot E.] Mol Res LP, Shallowater, TX USA; [Yamada, Takeshi; Lacorazza, H. Daniel] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; Univ Texas Hlth Sci Ctr Houston, Dept Pathol & Lab Med, Houston, TX 77030 USA; [de Zoeten, Edwin F.] Childrens Hosp Colorado, Digest Hlth Inst, Aurora, CO USA; [Klein, John] Univ Texas Hlth Sci Ctr Houston, Sch Dent, Houston, TX 77030 USA	Baylor College of Medicine; United States Department of Agriculture (USDA); Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Children's Hospital Colorado; University of Texas System; University of Texas Health Science Center Houston	Kellermayer, R (corresponding author), Baylor Coll Med, Sect Pediat Gastroenterol Hepatol & Nutr, 6621 Fannin St,CC1010-00, Houston, TX 77030 USA.	kellerma@bcm.edu	Dowd, Scot E/M-5386-2017; Harris, R. Alan/AAI-2784-2020	Dowd, Scot E/0000-0002-6296-1427; Harris, R. Alan/0000-0002-7333-4752; de Zoeten, Edwin/0000-0002-0946-9759	Houston Men of Distinction; U.S. National Institutes of Health [P30 DK56338]; USDA ARS; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER	Houston Men of Distinction; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank the Gutsy Kids Fund, including philanthropic donation from the Karen and Brock Wagner family, and the support of the Houston Men of Distinction. The authors also acknowledge support from the U.S. National Institutes of Health for the Texas Medical Center Digestive Diseases Center (P30 DK56338). Measurements of body composition were performed in the Mouse Metabolic Research Unit at the U.S. Department of Agriculture/Agricultural Research Service (USDA/ARS) Children's Nutrition Research Center, which is supported by funds from the USDA ARS (www.bcm.edu/cnrc/mmru). The authors acknowledge the assistance of the Mouse Metabolic Research Unit (Baylor College of Medicine) staff and faculty in performing these measurements. D.N.S. and R.K. developed the study concept and design; D.N.S., S.A.V.M., R.A.H., S.E.D., T.Y., H.D.L., N.T., E.Z., J.K., and R.K. acquired the data; D.N.S., R.A.H., S.E.D., and R.K. analyzed and interpreted the data; D.N.S. and R.K. drafted the manuscript; H.D.L., N.T., C.W.S., and R.K. critically revised the manuscript for important intellectual content; R.A.H., S.E.D., and R.K. performed statistical analysis; R.K. obtained funding; C.W.S. and R.K. provided material support; and T.Y., H.D.L., and N.T. provided technical support. The authors declare no conflicts of interest.	Abramson O, 2010, J PEDIATR-US, V157, P233, DOI 10.1016/j.jpeds.2010.02.024; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Bailey MT, 2010, BRAIN BEHAV IMMUN, V24, P577, DOI 10.1016/j.bbi.2009.12.010; Barnett M, 2010, MUTAT RES-FUND MOL M, V690, P71, DOI 10.1016/j.mrfmmm.2010.02.006; Benchimol EI, 2009, GUT, V58, P1490, DOI 10.1136/gut.2009.188383; Boland BS, 2014, GASTROENTEROL CLIN N, V43, P603, DOI 10.1016/j.gtc.2014.05.011; Boyle D.L., 2014, ANN RHEUM DIS; Brocker T, 1999, EUR J IMMUNOL, V29, P1610, DOI 10.1002/(SICI)1521-4141(199905)29:05<1610::AID-IMMU1610>3.0.CO;2-8; Chan SSM, 2013, AM J GASTROENTEROL, V108, P575, DOI 10.1038/ajg.2012.453; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cosnes J, 2011, GASTROENTEROLOGY, V140, P1785, DOI 10.1053/j.gastro.2011.01.055; de Zoeten EF, 2011, MOL CELL BIOL, V31, P2066, DOI 10.1128/MCB.05155-11; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Dowd SE, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-93; Fite A, 2013, J CLIN MICROBIOL, V51, P849, DOI 10.1128/JCM.02574-12; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Gruber L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071661; Gunnarsson C, 2012, DIGEST DIS SCI, V57, P3080, DOI 10.1007/s10620-012-2289-y; Gupta N, 2010, INFLAMM BOWEL DIS, V16, P638, DOI 10.1002/ibd.21099; Haberman Y, 2014, J CLIN INVEST, V124, P3617, DOI 10.1172/JCI75436; Halfvarson J, 2011, INFLAMM BOWEL DIS, V17, P6, DOI 10.1002/ibd.21295; Harris RA, 2014, EPIGENETICS-US, V9, P1131, DOI 10.4161/epi.29446; Hou JK, 2011, AM J GASTROENTEROL, V106, P563, DOI 10.1038/ajg.2011.44; Jason K., 2011, TEX MED CTR DIG DIS; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kellermayer R, 2012, CAN J GASTROENTEROL, V26, P909, DOI 10.1155/2012/526408; Kellermayer R, 2010, AM J MED GENET A, V152A, P3022, DOI 10.1002/ajmg.a.33726; Kellermayer R, 2010, HUM MOL GENET, V19, P2168, DOI 10.1093/hmg/ddq095; Kitajima S, 2000, EXP ANIM TOKYO, V49, P9, DOI 10.1538/expanim.49.9; Lepage P, 2011, GASTROENTEROLOGY, V141, P227, DOI 10.1053/j.gastro.2011.04.011; Magyari L, 2014, WORLD J GASTROENTERO, V20, P3208, DOI 10.3748/wjg.v20.i12.3208; Malaty HM, 2010, J PEDIATR GASTR NUTR, V50, P27, DOI 10.1097/MPG.0b013e3181b99baa; Marion-Letellier R, 2013, INFLAMM BOWEL DIS, V19, P205, DOI [10.1097/MIB.0b013e3182810122, 10.1002/ibd.23001]; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Murata K, 2002, J IMMUNOL, V169, P4628, DOI 10.4049/jimmunol.169.8.4628; Nagy-Szakal D, 2013, J PEDIATR GASTR NUTR, V56, P544, DOI 10.1097/MPG.0b013e3182769748; Nishimura M, 2009, ANN NY ACAD SCI, V1173, P350, DOI 10.1111/j.1749-6632.2009.04738.x; Obermeier F, 2003, EUR J IMMUNOL, V33, P3265, DOI 10.1002/eji.200324124; PERRET V, 1977, GUT, V18, P382, DOI 10.1136/gut.18.5.382; Petronis A, 2010, NATURE, V465, P721, DOI 10.1038/nature09230; Sarra M, 2010, INFLAMM BOWEL DIS, V16, P1332, DOI 10.1002/ibd.21238; Sartor RB, 2011, MUCOSAL IMMUNOL, V4, P127, DOI 10.1038/mi.2010.87; Schaefer JS, 2010, J LEUKOCYTE BIOL, V87, P301, DOI 10.1189/jlb.0409238; Schaible TD, 2011, HUM MOL GENET, V20, P1687, DOI 10.1093/hmg/ddr044; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; Steck N, 2011, GASTROENTEROLOGY, V141, P959, DOI 10.1053/j.gastro.2011.05.035; Szigeti R, 2012, ANN CLIN LAB SCI, V42, P401; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Tjonneland A, 2009, GUT, V58, P1606, DOI 10.1136/gut.2008.169078; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Walker LSK, 1999, J EXP MED, V190, P1115, DOI 10.1084/jem.190.8.1115; Walters WA, 2014, FEBS LETT, V588, P4223, DOI 10.1016/j.febslet.2014.09.039; Yamada T, 2009, NAT IMMUNOL, V10, P618, DOI 10.1038/ni.1730	55	13	14	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3151	3159		10.1096/fj.14-267690	http://dx.doi.org/10.1096/fj.14-267690			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25903104	Green Published			2022-12-26	WOS:000358796900005
J	Li, L; Ryoo, JE; Lee, KJ; Choi, BC; Baek, KH				Li, Lan; Ryoo, Ji Eun; Lee, Kyung-Ju; Choi, Bum-Chae; Baek, Kwang-Hyun			Genetic Variation in the Mcp-1 Gene Promoter Associated with the Risk of Polycystic Ovary Syndrome	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; LOW-GRADE INFLAMMATION; INSULIN-RESISTANCE; ADIPOSE-TISSUE; ENDOCRINE ORGAN; POLYMORPHISM; EXPRESSION; OBESITY; PCOS	Monocyte chemoattractant protein-1 (MCP-1) is a pivotal chemokine in the inflammatory response, which plays an important role in recruiting monocytes to sites of injury and infection. However, the exact mechanism of Mcp-1 associated with PCOS risk was unknown. In this study, we explored whether the Mcp-1 -2518G>A polymorphism increases the risk of PCOS. We performed a comparative study of -2518G>A polymorphism of the Mcp-1 gene with PCOS. In addition, luciferase reporter assay was performed to evaluate the Mcp-1 transcriptional activity. A strong association was observed between the -2518G>A polymorphism of Mcp-1 gene and PCOS (p-value = 0.016, odd ratio (OR) = 0.693). A p-value under 0.05 is considered statistically significant. The genotype and allelic frequencies were assumed to be in Hardy-Weinberg equilibrium (HWE). The luciferase assays in 2 cell lines showed that the Mcp-1 -2518G>A substitution can increase the expression of Mcp-1. MCP-1 levels in serum for PCOS group were significantly higher than those in serum for controls (p-value = 0.02). Furthermore, the patients carrying a genotype A/A had significantly increased levels of MCP-1 in serum compared with levels of the MCP-1 of the patients with genotypes G/G and G/A (p-value = 0.031). This is the first study on the genetic variation of the Mcp-1 gene and PCOS. This finding suggests that the Mcp-1 -2518G>A polymorphism is associated with PCOS risk by affecting transcriptional activity, leading to an increased expression level of Mcp-1.	[Li, Lan; Baek, Kwang-Hyun] CHA Univ, Bundang CHA Hosp, Dept Biomed Sci, Gyeonggi Do, South Korea; [Ryoo, Ji Eun] Hankuk Acad Foreign Studies, Yongin, South Korea; [Lee, Kyung-Ju] CHA Univ, CHA Gen Hosp, Dept Gynecol & Obstet, Seoul, South Korea; [Choi, Bum-Chae] CL Womens Hosp, Dept Obstet & Gynecol, Gwangju, South Korea	Pochon Cha University; Pochon Cha University	Baek, KH (corresponding author), CHA Univ, Bundang CHA Hosp, Dept Biomed Sci, Gyeonggi Do, South Korea.	baek@cha.ac.kr		Baek, Kwang-Hyun/0000-0001-7662-7190	Ministry of Education, Republic of Korea	Ministry of Education, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of KoreaMinistry of Education (MOE), Republic of Korea)	This study was supported by a grant from BK21 program of the Ministry of Education, Republic of Korea. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2006, OBESITY, V14, P242, DOI 10.1038/oby.2006.317; Atabekoglu CS, 2011, FERTIL STERIL, V95, P295, DOI 10.1016/j.fertnstert.2010.08.030; Barthelmess Erin K, 2014, Front Biosci (Elite Ed), V6, P104; Caserta D, 2014, GYNECOL ENDOCRINOL, V30, P397, DOI 10.3109/09513590.2014.887673; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Diamanti-Kandarakis E, 2006, ANN NY ACAD SCI, V1092, P175, DOI 10.1196/annals.1365.015; Dragomir E, 2006, VASC PHARMACOL, V44, P440, DOI 10.1016/j.vph.2006.02.006; Duleba AJ, 2012, FERTIL STERIL, V97, P7, DOI 10.1016/j.fertnstert.2011.11.023; Ebejer K, 2013, GYNECOL ENDOCRINOL, V29, P536, DOI 10.3109/09513590.2012.760195; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Evian Annual Reprod EVAR Workshop, 2011, HUM REPROD UPDATE, V17, P829, DOI 10.1093/humupd/dmr033; Ewens KG, 2010, J CLIN ENDOCR METAB, V95, P2306, DOI 10.1210/jc.2009-2703; Glintborg D, 2009, CLIN ENDOCRINOL, V71, P652, DOI 10.1111/j.1365-2265.2009.03523.x; Gonzalez F, 2012, STEROIDS, V77, P300, DOI 10.1016/j.steroids.2011.12.003; Gonzalez F, 2009, METABOLISM, V58, P954, DOI 10.1016/j.metabol.2009.02.022; Guerre-Millo M, 2002, J ENDOCRINOL INVEST, V25, P855, DOI 10.1007/BF03344048; Heilbronn LK, 2008, CURR PHARM DESIGN, V14, P1225, DOI 10.2174/138161208784246153; Hu Wei-hong, 2006, Beijing Da Xue Xue Bao Yi Xue Ban, V38, P487; Hu WH, 2011, EUR J OBSTET GYN R B, V157, P53, DOI 10.1016/j.ejogrb.2011.03.015; Karadeniz M, 2010, ENDOCRINE, V37, P513, DOI 10.1007/s12020-010-9342-4; King J, 2006, J MIDWIFERY WOM HEAL, V51, P415, DOI 10.1016/j.jmwh.2006.01.008; Kolattukudy PE, 2012, CIRC RES, V110, P174, DOI 10.1161/CIRCRESAHA.111.243212; Kruger B, 2002, J AM SOC NEPHROL, V13, P2585, DOI 10.1097/01.ASN.0000031701.53792.54; Kumar PS, 2014, J OBSTET GYNAECOL RE, V40, P1361, DOI 10.1111/jog.12346; Li SX, 2013, GYNECOL ENDOCRINOL, V29, P878, DOI 10.3109/09513590.2013.819081; Moran L, 2009, HUM REPROD UPDATE, V15, P477, DOI 10.1093/humupd/dmp008; Norman RJ, 2007, LANCET, V370, P685, DOI 10.1016/S0140-6736(07)61345-2; Ortega-Gomez A, 2013, EMBO MOL MED, V5, P661, DOI 10.1002/emmm.201202382; Paneni F, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0419-z; Prins JB, 2002, BEST PRACT RES CL EN, V16, P639, DOI 10.1053/beem.2002.0222; Roberson LL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-14; Rovin BH, 1999, BIOCHEM BIOPH RES CO, V259, P344, DOI 10.1006/bbrc.1999.0796; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Sathyapalan T, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/758656; Shang KW, 2012, REPROD SCI, V19, P674, DOI 10.1177/1933719111430993; Shi YY, 2012, NAT GENET, V44, P1020, DOI 10.1038/ng.2384; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Simeoni E, 2004, DIABETOLOGIA, V47, P1574, DOI 10.1007/s00125-004-1494-4; Sirmans SM, 2012, ANN PHARMACOTHER, V46, P403, DOI 10.1345/aph.1Q514; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Traub ML, 2011, WORLD J DIABETES, V2, P33, DOI 10.4239/wjd.v2.i3.33; UEDA A, 1994, J IMMUNOL, V153, P2052; Xing L, 2007, ANTIOXID REDOX SIGN, V9, P1979, DOI 10.1089/ars.2007.1921	43	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123045	10.1371/journal.pone.0123045	http://dx.doi.org/10.1371/journal.pone.0123045			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902044	Green Submitted, gold, Green Published			2022-12-26	WOS:000353331500040
J	Awasthi, S; Nichter, M; Verma, T; Srivastava, NM; Agarwal, M; Singh, JV				Awasthi, Shally; Nichter, Mark; Verma, Tuhina; Srivastava, Neeraj Mohan; Agarwal, Monica; Singh, Jai Vir		CAP-Lucknow Team	Revisiting Community Case Management of Childhood Pneumonia: Perceptions of Caregivers and Grass Root Health Providers in Uttar Pradesh and Bihar, Northern India	PLOS ONE			English	Article							CARE-SEEKING BEHAVIOR; ACUTE RESPIRATORY-INFECTIONS; DANGER SIGNS; URBAN-POOR; DIARRHEA; MORTALITY; ILLNESSES; CHILDREN; LUCKNOW	Background Community-acquired pneumonia (CAP) is the leading cause of under-five mortality globally with almost one-quarter of deaths occurring in India. Objectives To identify predisposing, enabling and service-related factors influencing treatment delay for CAP in rural communities of two states in India. Factors investigated included recognition of danger signs of CAP, health care decision making, self-medication, treatment and referral by local practitioners, and perceptions about quality of care. Methods Qualitative research employing case studies (CS) of care-seeking, key informant interviews (KII), semi-structured interviews (SSI) and focus group discussions (FGD) with both video presentations of CAP signs, and case scenarios. Interviews and FGDs were conducted with parents of under-five children who had suffered CAP, community health workers (CHW), and rural medical practitioners (RMP). Results From September 2013 to January 2014, 30 CS, 43 KIIs, 42 SSIs, and 42 FGDs were conducted. Recognition of danger signs of CAP among caregivers was poor. Fast breathing, an early sign of CAP, was not commonly recognized. Chest in-drawing was recognized as a sign of serious illness, but not commonly monitored by removing a child's clothing. Most cases of mild to moderate CAP were brought to RMP, and more severe cases taken to private clinics in towns. Mothers consulted local RMP directly, but decisions to visit doctors outside the village required consultation with husband or mother-in-law. By the time most cases reached a public tertiary-care hospital, children had been ill for a week and treated by 2-3 providers. Quality of care at government facilities was deemed poor by caregivers. Conclusion To reduce CAP-associated mortality, recognition of its danger signs and the consequences of treatment delay needed to be better recognized by caregivers, and confidence in government facilities increased. The involvement of RMP in community based CAP programs needs to be investigated further given their widespread popularity.	[Awasthi, Shally; Verma, Tuhina] King Georges Med Univ, Dept Pediat, Lucknow, Uttar Pradesh, India; [Nichter, Mark] Univ Arizona, Sch Anthropol, Tucson, AZ USA; [Srivastava, Neeraj Mohan] UNICEFs Off Uttar Pradesh, Lucknow, Uttar Pradesh, India; [Agarwal, Monica; Singh, Jai Vir] King Georges Med Univ, Dept Community Med, Lucknow, Uttar Pradesh, India	King George's Medical University; University of Arizona; King George's Medical University	Awasthi, S (corresponding author), King Georges Med Univ, Dept Pediat, Lucknow, Uttar Pradesh, India.	shally07@gmail.com	Rastogi, Tuhina/K-9856-2019	Rastogi, Tuhina/0000-0001-7426-0110	Bill and Melinda Gates Foundation (BMGF) [OPP1093327]	Bill and Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation)	This study is funded by Bill and Melinda Gates Foundation (BMGF) to SA through the Global Health Grant No: OPP1093327. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, J Health Popul Nutr, V19, pS111; [Anonymous], 2007, DISTRICT LEVEL HOUSE; Awasthi S, 2006, J PEDIATR GASTR NUTR, V42, P300; Awasthi S, 2008, J PERINATOL, V28, pS69, DOI 10.1038/jp.2008.169; Awasthi S, 2006, B WORLD HEALTH ORGAN, V84, P819, DOI 10.2471/BLT.05.029207; Bhattacharyya K., 1997, ANTHR INFECT DIS THE, P211; Bhutta ZA, 2013, LANCET, V381, P1417, DOI 10.1016/S0140-6736(13)60648-0; Bojalil R, 2007, TROP MED INT HEALTH, V12, P1545, DOI 10.1111/j.1365-3156.2007.01963.x; Darmstadt GL, 2006, J HEALTH POPUL NUTR, V24, P380; Das JK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S29; Dongre AR, 2008, INDIAN J PEDIATR, V75, P325, DOI 10.1007/s12098-008-0032-7; Geldsetzer P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093427; Gove S, 1994, Med Anthropol, V15, P409; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hildenwall H, 2007, ACTA TROP, V101, P217, DOI 10.1016/j.actatropica.2007.02.003; HILL Z, 2004, FAMILY COMMUNITY PRA; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Hussain R, 1997, SOC SCI MED, V45, P991, DOI 10.1016/S0277-9536(97)00012-9; IGUN UA, 1979, SOC SCI MED-MED SOC, V13, P445, DOI 10.1016/0160-7979(79)90133-4; Irimu G, 2008, AFR HEALTH SCI, V8, P103; Kallander K, 2008, B WORLD HEALTH ORGAN, V86, P332, DOI 10.2471/BLT.07.049353; KROEGER A, 1983, SOC SCI MED, V17, P147, DOI 10.1016/0277-9536(83)90248-4; Kumar V, 2008, LANCET, V372, P1151, DOI 10.1016/S0140-6736(08)61483-X; Madsen HO, 2009, TROP MED INT HEALTH, V14, P1315, DOI 10.1111/j.1365-3156.2009.02374.x; May C, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-182; Mesko Natasha, 2003, BMC Int Health Hum Rights, V3, P3, DOI 10.1186/1472-698X-3-3; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Mohan P, 2008, J PERINATOL, V28, pS31, DOI 10.1038/jp.2008.167; National Health Mission. Government of Uttar Pradesh, 108 SAM SWASTH SEW U; National Health Mission. Government of Uttar Pradesh, 102 NAT AMB SERV UTT; Nichter M, 1994, Med Anthropol, V15, P353; Pillai R, 2003, SOC SCI MED, V57, P783, DOI 10.1016/S0277-9536(02)00448-3; Registrar General of India, 2011, SAMPL REG SYST SRS 2; Registrar General of India, 2012, ANN HLTH SURV UTT PR; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Ryan G.W., 2003, FIELD METHOD, V15, P85, DOI DOI 10.1177/1525822X02239569; Sreeramareddy Chandrashekhar T, 2006, BMC Int Health Hum Rights, V6, P7, DOI 10.1186/1472-698X-6-7; Srivastava NM, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-61; Srivastava NM, 2008, INDIAN PEDIATR, V45, P229; Taffa N, 2005, TROP MED INT HEALTH, V10, P240, DOI 10.1111/j.1365-3156.2004.01381.x; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Thurmond VA, 2001, J NURS SCHOLARSHIP, V33, P253, DOI 10.1111/j.1547-5069.2001.00253.x; Ukwaja KN, 2012, INT HEALTH, V4, P289, DOI 10.1016/j.inhe.2012.09.001; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Walley J, 2008, LANCET, V372, P1001, DOI 10.1016/S0140-6736(08)61409-9; WHO, 2008, INT MAN CHILDH ILLN; Winch PJ, 2005, LANCET, V366, P478, DOI 10.1016/S0140-6736(05)66836-5; Winch PJ, 2003, FINAL REPORT FORMATI	48	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123135	10.1371/journal.pone.0123135	http://dx.doi.org/10.1371/journal.pone.0123135			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG3XJ	25898211	Green Published, gold, Green Submitted			2022-12-26	WOS:000353212600019
J	Cheng, WP; Wang, BW; Lo, HM; Shyu, KG				Cheng, Wen-Pin; Wang, Bao-Wei; Lo, Huey-Ming; Shyu, Kou-Gi			Mechanical Stretch Induces Apoptosis Regulator TRB3 in Cultured Cardiomyocytes and Volume-Overloaded Heart	PLOS ONE			English	Article							ER STRESS; GENE; TRIBBLES; CHOP; AKT; PHOSPHORYLATION; OVEREXPRESSION; INHIBITION; EXPRESSION; INDUCTION	The expression of TRB3 (tribbles 3), an apoptosis regulated gene, increases during endoplasmic reticulum (ER) stress. How mechanical stress affects the regulation of TRB3 in cardiomyocytes during apoptosis is not fully understood. An in vivo model of aorta-caval shunt in adult rats demonstrated the increased TRB3 protein expression in the myocardium. The tumor necrosis factor-alpha (TNF-alpha) antagonist etanercept reversed the TRB3 protein expression and cardiomyocyte apoptosis induced by AV shunt. An in vitro model of cyclic stretch in neonatal rats was also used to investigate TRB3 expression. We hypothesized that cardiomyocyte apoptosis induced by cyclic stretch is TRB3 dependent. Neonatal rat cardiomyocytes grown on a flexible membrane base were stretched by vacuum to 20% of maximum elongation, at 60 cycles/min. Cyclic stretch significantly increased TRB3 protein and mRNA expression. Addition of c-jun N-terminal kinase (JNK) inhibitor SP600125, TNF-alpha antibody and etanercept 30 min before stretch reversed the induction of TRB3 protein induced by stretch. Cyclic stretch induced the DNA-binding activity of growth arrest and DNA damaged inducible gene-153 (GADD153) by electrophoretic mobility shift assay. SP600125, JNK siRNA, TNF-alpha antibody and etanercept abolished the binding activity induced by stretch. TRB3 promoter activity was enhanced by stretch and TRB3-mut plasmid, SP600125, TNF-alpha antibody and etanercept attenuated TRB3 promoter activity induced by stretch. Exogenous administration of TNF-alpha recombinant protein to the non-stretched cardiomyocytes increased TRB3 protein expression similar to that seen after stretch. Cyclic stretch induced cardiomyocyte apoptosis is inhibited by TRB3 siRNA and etanercept. The stretch-induced TRB3 is mediated by TNF-alpha. JNK and GADD153 pathway. These results indicate that TRB3 plays an important role in stretch-induced cardiomyocyte apoptosis.	[Cheng, Wen-Pin; Wang, Bao-Wei] Shin Kong Wu Ho Mem Hosp, Dept Med Educ & Res, Taipei, Taiwan; [Lo, Huey-Ming; Shyu, Kou-Gi] Shin Kong Wu Ho Mem Hosp, Div Cardiol, Taipei, Taiwan; [Lo, Huey-Ming] Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan; [Shyu, Kou-Gi] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan	Shin Kong Wu Ho Su Memorial Hospital; Shin Kong Wu Ho Su Memorial Hospital; Fu Jen Catholic University; Taipei Medical University	Shyu, KG (corresponding author), Shin Kong Wu Ho Mem Hosp, Div Cardiol, Taipei, Taiwan.	shyukg@ms12.hinet.net			National Science Council, Executive Yuan, Taiwan; Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan	National Science Council, Executive Yuan, Taiwan(Ministry of Science and Technology, Taiwan); Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan	This study was sponsored in part from National Science Council, Executive Yuan, Taiwan and Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwar MA, 2012, J VASC RES, V49, P463, DOI 10.1159/000339151; Avery J, 2010, CIRC RES, V106, P1516, DOI 10.1161/CIRCRESAHA.109.211920; Boltzen U, 2012, J MOL CELL CARDIOL, V52, P1056, DOI 10.1016/j.yjmcc.2012.01.015; Bromati CR, 2011, AM J PHYSIOL-REG I, V300, pR92, DOI 10.1152/ajpregu.00169.2010; Chandar S, 2010, CIRC RES, V106, P573, DOI 10.1161/CIRCRESAHA.109.204388; Chen SY, 2012, FOOD CHEM TOXICOL, V50, P3025, DOI 10.1016/j.fct.2012.06.006; Cheng WP, 2009, EUR J CLIN INVEST, V39, P960, DOI 10.1111/j.1365-2362.2009.02193.x; Cittadini A, 2012, CARDIOVASC RES, V96, P381, DOI 10.1093/cvr/cvs261; De Jong AM, 2013, J CELL MOL MED, V17, P743, DOI 10.1111/jcmm.12064; Ding WY, 2014, EXP MOL PATHOL, V96, P80, DOI 10.1016/j.yexmp.2013.12.003; Fawcett TW, 1996, J BIOL CHEM, V271, P14285, DOI 10.1074/jbc.271.24.14285; Formoso G, 2011, CARDIOVASC RES, V89, P184, DOI 10.1093/cvr/cvq255; Gutkowska J, 2011, J HYPERTENS, V29, P1203, DOI 10.1097/HJH.0b013e3283468392; Hill C, 2013, CARDIOVASC RES, V99, P121, DOI 10.1093/cvr/cvt094; Honsho S, 2009, CIRC RES, V105, P1149, DOI 10.1161/CIRCRESAHA.109.208199; Hua F, 2011, J CELL SCI, V124, P3235, DOI 10.1242/jcs.082875; Izrailit J, 2013, P NATL ACAD SCI USA, V110, P1714, DOI 10.1073/pnas.1214014110; Kiss-Toth E, 2004, J BIOL CHEM, V279, P42703, DOI 10.1074/jbc.M407732200; Koh HJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2851; Kristiansen M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-551; Lee JH, 2013, BIOCHEM BIOPH RES CO, V439, P327, DOI 10.1016/j.bbrc.2013.08.087; Logue SE, 2013, APOPTOSIS, V18, P537, DOI 10.1007/s10495-013-0818-6; Lv XX, 2013, CHIN J INTEGR MED, V19, P424, DOI 10.1007/s11655-011-0856-2; Mihailidou C, 2014, BIOCHIMIE, V99, P19, DOI 10.1016/j.biochi.2013.11.003; Moriya S, 2013, INT J ONCOL, V42, P1541, DOI 10.3892/ijo.2013.1870; Morse E, 2010, AM J PHYSIOL-RENAL, V299, pF965, DOI 10.1152/ajprenal.00236.2010; Muslin AJ, 2011, PEDIATR CARDIOL, V32, P317, DOI 10.1007/s00246-010-9879-2; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Peng W, 2010, CIRC RES, V106, P102, DOI 10.1161/CIRCRESAHA.109.210914; Prudente S, 2009, ACTA DIABETOL, V46, P79, DOI 10.1007/s00592-008-0087-y; Raaz U, 2009, MICROVASC RES, V77, P297, DOI 10.1016/j.mvr.2009.01.012; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Sun WX, 2014, FREE RADICAL BIO MED, V68, P22, DOI 10.1016/j.freeradbiomed.2013.11.015; Thaher F, 2011, INT IMMUNOPHARMACOL, V11, P1724, DOI 10.1016/j.intimp.2011.06.005; Tsoporis JN, 2010, CIRC RES, V106, P93, DOI 10.1161/CIRCRESAHA.109.195834; Wali VB, 2009, APOPTOSIS, V14, P1366, DOI 10.1007/s10495-009-0406-y; Wang ZH, 2012, DIABETES, V61, P463, DOI 10.2337/db11-0518; Wennemers M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2934; Zhang J, 2011, ORAL ONCOL, V47, P934, DOI 10.1016/j.oraloncology.2011.06.512; Zhou XP, 2011, IMMUNOPHARM IMMUNOT, V33, P594, DOI 10.3109/08923973.2010.549135	41	28	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123235	10.1371/journal.pone.0123235	http://dx.doi.org/10.1371/journal.pone.0123235			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898323	Green Published, Green Submitted, gold			2022-12-26	WOS:000353212600021
J	Duchesne, T; Fortin, D; Rivest, LP				Duchesne, Thierry; Fortin, Daniel; Rivest, Louis-Paul			Equivalence between Step Selection Functions and Biased Correlated Random Walks for Statistical Inference on Animal Movement	PLOS ONE			English	Article							CONDITIONAL LOGISTIC-REGRESSION; FINE-SCALE; WOODLAND CARIBOU; MODELS; BEHAVIOR; CONNECTIVITY; MECHANISMS; PATTERNS; ECOLOGY; SHAPES	Animal movement has a fundamental impact on population and community structure and dynamics. Biased correlated random walks (BCRW) and step selection functions (SSF) are commonly used to study movements. Because no studies have contrasted the parameters and the statistical properties of their estimators for models constructed under these two Lagrangian approaches, it remains unclear whether or not they allow for similar inference. First, we used the Weak Law of Large Numbers to demonstrate that the log-likelihood function for estimating the parameters of BCRW models can be approximated by the log-likelihood of SSFs. Second, we illustrated the link between the two approaches by fitting BCRW with maximum likelihood and with SSF to simulated movement data in virtual environments and to the trajectory of bison (Bison bison L.) trails in natural landscapes. Using simulated and empirical data, we found that the parameters of a BCRW estimated directly from maximum likelihood and by fitting an SSF were remarkably similar. Movement analysis is increasingly used as a tool for understanding the influence of landscape properties on animal distribution. In the rapidly developing field of movement ecology, management and conservation biologists must decide which method they should implement to accurately assess the determinants of animal movement. We showed that BCRW and SSF can provide similar insights into the environmental features influencing animal movements. Both techniques have advantages. BCRW has already been extended to allow for multi-state modeling. Unlike BCRW, however, SSF can be estimated using most statistical packages, it can simultaneously evaluate habitat selection and movement biases, and can easily integrate a large number of movement taxes at multiple scales. SSF thus offers a simple, yet effective, statistical technique to identify movement taxis.	[Duchesne, Thierry; Rivest, Louis-Paul] Univ Laval, Dept Math & Stat, Quebec City, PQ G1K 7P4, Canada; [Fortin, Daniel] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada; [Fortin, Daniel] Univ Laval, Ctr Etud Foret, Dept Biol, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University; Laval University	Fortin, D (corresponding author), Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada.	daniel.fortin@bio.ulaval.ca	Fortin, Daniel/ABG-3554-2020; Rivest, Louis-Paul/AAU-9879-2020	Rivest, Louis-Paul/0000-0003-4351-4127; Duchesne, Thierry/0000-0001-9893-604X	Parks Canada; Natural Sciences and Engineering Research Council of Canada; Canadian Foundation for Innovation	Parks Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Foundation for Innovation(Canada Foundation for Innovation)	Funding was provided by Parks Canada (www.pc.gc.ca), the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca), and the Canadian Foundation for Innovation (www.innovation.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, MATH STAT METASTATIS; Barton KA, 2009, OIKOS, V118, P309, DOI 10.1111/j.1600-0706.2008.16936.x; Benhamou S, 2014, ECOL LETT, V17, P261, DOI 10.1111/ele.12225; Cagnacci F, 2010, PHILOS T R SOC B, V365, P2157, DOI 10.1098/rstb.2010.0107; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; Coulon A, 2008, LANDSCAPE ECOL, V23, P603, DOI 10.1007/s10980-008-9220-0; Craiu RV, 2008, BIOMETRICAL J, V50, P97, DOI 10.1002/bimj.200610379; Dancose K, 2011, ECOL APPL, V21, P1871, DOI 10.1890/10-0779.1; Duchesne T, 2010, J ANIM ECOL, V79, P548, DOI 10.1111/j.1365-2656.2010.01670.x; Fagan WF, 2013, ECOL LETT, V16, P1316, DOI 10.1111/ele.12165; Forester JD, 2007, ECOL MONOGR, V77, P285, DOI 10.1890/06-0534; Forester JD, 2009, ECOLOGY, V90, P3554, DOI 10.1890/08-0874.1; Fortin D, 2005, OECOLOGIA, V145, P335, DOI 10.1007/s00442-005-0122-4; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Fortin D, 2009, ANIM BEHAV, V78, P887, DOI 10.1016/j.anbehav.2009.06.026; Fronhofer EA, 2013, OIKOS, V122, P857, DOI 10.1111/j.1600-0706.2012.21021.x; Gillies CS, 2011, ECOL APPL, V21, P944, DOI 10.1890/09-2090.1; Hodson J, 2010, J MAMMAL, V91, P607, DOI 10.1644/09-MAMM-A-289.1; Holyoak M, 2008, P NATL ACAD SCI USA, V105, P19060, DOI 10.1073/pnas.0800483105; Langrock R, 2012, ECOLOGY, V93, P2336, DOI 10.1890/11-2241.1; Latham ADM, 2011, ECOL APPL, V21, P2854, DOI 10.1890/11-0666.1; Latombe G., 2013, THESIS U MONTREAL MO; Latombe G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099938; Latombe G, 2014, J ANIM ECOL, V83, P185, DOI 10.1111/1365-2656.12108; Manly B.F.J., 2002, RESOURCE SELECTION A; Mardia KV, 2000, DIRECTIONAL STAT; McClintock BT, 2012, ECOL MONOGR, V82, P335, DOI 10.1890/11-0326.1; Moorcroft P.R., 2006, MECHANISTIC HOME RAN; Moorcroft PR, 2008, ECOLOGY, V89, P1112, DOI 10.1890/06-1985.1; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Northrup JM, 2012, J APPL ECOL, V49, P1159, DOI 10.1111/j.1365-2664.2012.02180.x; Presnell B, 1998, J AM STAT ASSOC, V93, P1068, DOI 10.2307/2669850; Rivest LP, 1997, BIOMETRIKA, V84, P717, DOI 10.1093/biomet/84.3.717; Schultz CB, 2001, ECOLOGY, V82, P1879, DOI 10.1890/0012-9658(2001)082[1879:EMDBIA]2.0.CO;2; Severns PM, 2013, LANDSCAPE ECOL, V28, P559, DOI 10.1007/s10980-013-9860-6; Turchin Peter, 1998; Vanak AT, 2013, ECOLOGY, V94, P2619, DOI 10.1890/13-0217.1	37	41	41	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0122947	10.1371/journal.pone.0122947	http://dx.doi.org/10.1371/journal.pone.0122947			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898019	Green Published, gold, Green Submitted			2022-12-26	WOS:000353212600017
J	Li, X; Wang, BZ; Liu, WW; Gui, MM; Peng, Z; Meng, SD				Li, Xin; Wang, Baozhong; Liu, Weiwei; Gui, Mingming; Peng, Zheng; Meng, Songdong			Blockage of Conformational Changes of Heat Shock Protein gp96 on Cell Membrane by a alpha-Helix Peptide Inhibits HER2 Dimerization and Signaling in Breast Cancer	PLOS ONE			English	Article							CHAPERONE GP96; THERAPEUTIC-TARGET; GRP94; HOMEOSTASIS; GP96/GRP94; DOMAIN	Cell membrane translocation of heat shock protein gp96 from the endoplasmic reticulum has been observed in multiple tumors and is associated with tumor malignancy. However, the cancer-intrinsic function and the related mechanism of cell membrane gp96 as a pro-on-cogenic chaperone remain further elucidated. In this study, we found that inhibition of gp96 intramolecular conformational changes by a single alpha-helix peptide p37 dramatically increased its binding to HER2, whereas decreased HER2 dimerization, phosphorylation and downstream signaling. Targeting cell membrane gp96 promoted HER2 ubiquitination and subsequent lysosomal degradation, which led to decreased cell growth and increased apoptosis, and inhibited tumor growth in vivo. We also demonstrate that gp96 inhibitory peptide p37 synergized with trastuzumab to suppress cell growth and induce apoptosis. Our work demonstrates that blocking gp96 conformational changes directs HER2 for cellular degradation, and represents a new therapeutic strategy for inhibiting HER2 signaling in cancer.	[Li, Xin; Liu, Weiwei; Gui, Mingming; Meng, Songdong] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Li, Xin; Liu, Weiwei] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Baozhong] Anhui Univ, Sch Life Sci, Hefei 230039, Peoples R China; [Peng, Zheng] Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Anhui University; Chinese People's Liberation Army General Hospital	Peng, Z (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China.	zihpeng@sina.com; mengsd@im.ac.cn			Major State Basic Research Development Program of China (973 Program) [2014CB542602]; National Natural Science Foundation of China [31230026, 81321063, 81102018, 81471960]; Key Projects in the National Science & Technology Program [2013ZX10002001-003-003]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in the National Science & Technology Program	This work was supported by a grant from Major State Basic Research Development Program of China (973 Program, No.2014CB542602), grants from the National Natural Science Foundation of China (31230026, 81321063, 81102018, 81471960), and grants from Key Projects in the National Science & Technology Program (2013ZX10002001-003-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chavany C, 1996, J BIOL CHEM, V271, P4974; Dollins DE, 2007, MOL CELL, V28, P41, DOI 10.1016/j.molcel.2007.08.024; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Ghosh R, 2011, CANCER RES, V71, P1871, DOI 10.1158/0008-5472.CAN-10-1872; Hong F, 2013, J BIOL CHEM, V288, P18243, DOI 10.1074/jbc.M113.468850; Hong RL, 1999, CLIN CANCER RES, V5, P1884; Hua YP, 2013, CLIN CANCER RES, V19, P6242, DOI 10.1158/1078-0432.CCR-13-2083; Kliger Y, 2009, P NATL ACAD SCI USA, V106, P13797, DOI 10.1073/pnas.0906514106; Koo BH, 2010, J BIOL CHEM, V285, P197, DOI 10.1074/jbc.M109.039677; Kropp LE, 2010, J IMMUNOL, V184, P5619, DOI 10.4049/jimmunol.0902368; Li X, 2015, INT J CANCER, V137, P512, DOI 10.1002/ijc.29405; Liu B, 2013, P NATL ACAD SCI USA, V110, P6877, DOI 10.1073/pnas.1302933110; Liu Z, 2009, EUR J IMMUNOL, V39, P3110, DOI 10.1002/eji.200939593; Morales C, 2014, CANCER RES, V74, P446, DOI 10.1158/0008-5472.CAN-13-1677; Patel PD, 2013, NAT CHEM BIOL, V9, P677, DOI [10.1038/NCHEMBIO.1335, 10.1038/nchembio.1335]; Rachidi S, 2015, J HEPATOL, V62, P879, DOI 10.1016/j.jhep.2014.11.010; Rosenbaum M, 2014, GENE DEV, V28, P1165, DOI 10.1101/gad.240762.114; Staron M, 2011, BLOOD, V117, P7136, DOI 10.1182/blood-2011-01-330464; Wu B, 2015, CANCER LETT, V359, P325, DOI 10.1016/j.canlet.2015.01.034; Wu S, 2012, J BIOL CHEM, V287, P19896, DOI 10.1074/jbc.M112.343848; Wu S, 2012, J BIOL CHEM, V287, P6735, DOI 10.1074/jbc.M111.309526	21	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124647	10.1371/journal.pone.0124647	http://dx.doi.org/10.1371/journal.pone.0124647			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898135	Green Published, gold, Green Submitted			2022-12-26	WOS:000353212600078
J	Sedlacek, J; Wheeler, JA; Cortes, AJ; Bossdorf, O; Hoch, G; Lexer, C; Wipf, S; Karrenberg, S; van Kleunen, M; Rixen, C				Sedlacek, Janosch; Wheeler, Julia A.; Cortes, Andres J.; Bossdorf, Oliver; Hoch, Guenter; Lexer, Christian; Wipf, Sonja; Karrenberg, Sophie; van Kleunen, Mark; Rixen, Christian			The Response of the Alpine Dwarf Shrub Salix herbacea to Altered Snowmelt Timing: Lessons from a Multi-Site Transplant Experiment	PLOS ONE			English	Article							HIGH-MOUNTAIN PLANTS; CLIMATE-CHANGE; PHENOTYPIC PLASTICITY; FLOWERING PHENOLOGY; LOCAL ADAPTATION; GENE FLOW; SEXUAL REPRODUCTION; GROWTH; RANGE; ALPS	Climate change is altering spring snowmelt patterns in alpine and arctic ecosystems, and these changes may alter plant phenology, growth and reproduction. To predict how alpine plants respond to shifts in snowmelt timing, we need to understand trait plasticity, its effects on growth and reproduction, and the degree to which plants experience a home-site advantage. We tested how the common, long-lived dwarf shrub Salix herbacea responded to changing spring snowmelt time by reciprocally transplanting turfs of S. herbacea between early-exposure ridge and late-exposure snowbed microhabitats. After the transplant, we monitored phenological, morphological and fitness traits, as well as leaf damage, during two growing seasons. Salix herbacea leafed out earlier, but had a longer development time and produced smaller leaves on ridges relative to snowbeds. Longer phenological development times and smaller leaves were associated with reduced sexual reproduction on ridges. On snowbeds, larger leaves and intermediate development times were associated with increased clonal reproduction. Clonal and sexual reproduction showed no response to altered snowmelt time. We found no home-site advantage in terms of sexual and clonal reproduction. Leaf damage probability depended on snowmelt and thus exposure period, but had no short-term effect on fitness traits. We conclude that the studied populations of S. herbacea can respond to shifts in snowmelt by plastic changes in phenology and leaf size, while maintaining levels of clonal and sexual reproduction. The lack of a home-site advantage suggests that S. herbacea may not be adapted to different microhabitats. The studied populations are thus unlikely to react to climate change by rapid adaptation, but their responses will also not be constrained by small-scale local adaptation. In the short term, snowbed plants may persist due to high stem densities. However, in the long term, reduction in leaf size and flowering, a longer phenological development time and increased exposure to damage may decrease overall performance of S. herbacea under earlier snowmelt.	[Sedlacek, Janosch; van Kleunen, Mark] Univ Konstanz, Dept Biol, Ecol, D-78457 Constance, Germany; [Wheeler, Julia A.; Wipf, Sonja; Rixen, Christian] WSL Inst Snow & Avalanche Res SLF, CH-7260 Davos, Switzerland; [Cortes, Andres J.; Karrenberg, Sophie] Uppsala Univ, Dept Ecol & Genet, S-75236 Uppsala, Sweden; [Bossdorf, Oliver] Univ Tubingen, Inst Evolut & Ecol, Plant Evolutionary Ecol, D-72076 Tubingen, Germany; [Wheeler, Julia A.; Hoch, Guenter] Univ Basel, Inst Bot, CH-4056 Basel, Switzerland; [Lexer, Christian] Univ Fribourg, Dept Biol, Unit Ecol & Evolut, CH-1700 Fribourg, Switzerland	University of Konstanz; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Uppsala University; Eberhard Karls University of Tubingen; University of Basel; University of Fribourg	van Kleunen, M (corresponding author), Univ Konstanz, Dept Biol, Ecol, D-78457 Constance, Germany.	mark.vankleunen@uni-konstanz.de	van Kleunen, Mark/B-3769-2009; Hoch, Guenter/H-1505-2018; Wipf, Sonja/A-5075-2010; Bossdorf, Oliver/A-8328-2008	van Kleunen, Mark/0000-0002-2861-3701; Hoch, Guenter/0000-0003-0985-9746; Wipf, Sonja/0000-0002-3492-1399; Bossdorf, Oliver/0000-0001-7504-6511; Rixen, Christian/0000-0002-2486-9988; Lexer, Christian/0000-0002-7221-7482; Cortes, Andres J./0000-0003-4178-0675	Swiss National Science Foundation [CRSI33_130409/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This project was funded by a Sinergia grant (grant nr. CRSI33_130409/1) provided by the Swiss National Science Foundation (http://www.snf.ch/en/funding/Pages/default. aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; Anderson JT, 2012, P ROY SOC B-BIOL SCI, V279, P3843, DOI 10.1098/rspb.2012.1051; Arft AM, 1999, ECOL MONOGR, V69, P491, DOI 10.1890/0012-9615(1999)069[0491:ROTPTE]2.0.CO;2; Bazzaz F. A., 1996, PLANTS CHANGING ENV; Beerling DJ, 1998, J ECOL, V86, P872, DOI 10.1046/j.1365-2745.1998.8650872.x; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Beniston M, 2003, THEOR APPL CLIMATOL, V76, P125, DOI 10.1007/s00704-003-0016-5; Bennington CC, 2012, J ECOL, V100, P841, DOI 10.1111/j.1365-2745.2012.01984.x; Blanquart F, 2013, ECOL LETT, V16, P1195, DOI 10.1111/ele.12150; Bradshaw WE, 2006, SCIENCE, V312, P1477, DOI 10.1126/science.1127000; Byars SG, 2007, EVOLUTION, V61, P2925, DOI 10.1111/j.1558-5646.2007.00248.x; Castro HF, 2010, APPL ENVIRON MICROB, V76, P999, DOI 10.1128/AEM.02874-09; Cortes AJ, 2014, HEREDITY, V113, P233, DOI 10.1038/hdy.2014.19; Defossez E, 2011, BIOL LETTERS, V7, P699, DOI 10.1098/rsbl.2011.0236; Dullinger S, 2012, NAT CLIM CHANGE, V2, P619, DOI 10.1038/NCLIMATE1514; Franks SJ, 2014, EVOL APPL, V7, P123, DOI 10.1111/eva.12112; Frei ER, 2014, GLOBAL CHANGE BIOL, V20, P441, DOI 10.1111/gcb.12403; GALEN C, 1991, AM J BOT, V78, P978, DOI 10.2307/2445177; GALEN C, 1993, ECOLOGY, V74, P1052, DOI 10.2307/1940475; Gerdol R, 2013, J VEG SCI, V24, P569, DOI 10.1111/j.1654-1103.2012.01472.x; Givnish T., 1979, Topics in plant population biology., P375; Gonzalo-Turpin H, 2009, J ECOL, V97, P742, DOI 10.1111/j.1365-2745.2009.01509.x; GRABHERR G, 1995, ECOL STU AN, V113, P167; Haggberg S, 2014, THESIS U UPPSALA UPP; Hoye TT, 2013, NAT CLIM CHANGE, V3, P759, DOI [10.1038/nclimate1909, 10.1038/NCLIMATE1909]; Hudson JMG, 2011, GLOBAL CHANGE BIOL, V17, P1013, DOI 10.1111/j.1365-2486.2010.02294.x; Huelber K, 2006, ARCT ANTARCT ALP RES, V38, P99, DOI 10.1657/1523-0430(2006)038[0099:PROSST]2.0.CO;2; Hulber K, 2010, FUNCT ECOL, V24, P245, DOI 10.1111/j.1365-2435.2009.01645.x; Inouye DW, 2008, ECOLOGY, V89, P353, DOI 10.1890/06-2128.1; Jump AS, 2005, ECOL LETT, V8, P1010, DOI 10.1111/j.1461-0248.2005.00796.x; Kawai Y, 2011, BOTANY, V89, P361, DOI [10.1139/B11-024, 10.1139/b11-024]; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kim E, 2013, J ECOL, V101, P796, DOI 10.1111/1365-2745.12077; KRAMER K, 1995, PLANT CELL ENVIRON, V18, P93, DOI 10.1111/j.1365-3040.1995.tb00356.x; Kudo G., 1999, POLAR BIOSCI, V12, P100; Ladinig U, 2013, OECOLOGIA, V171, P743, DOI 10.1007/s00442-012-2581-8; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; Little C, 2014, THESIS LUDWIG MAXIMI; Merila J, 2014, EVOL APPL, V7, P1, DOI 10.1111/eva.12137; Midgley GF, 2006, DIVERS DISTRIB, V12, P555, DOI 10.1111/j.1366-9516.2006.00273.x; Molau U, 2005, AM J BOT, V92, P422, DOI 10.3732/ajb.92.3.422; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nicotra AB, 2010, TRENDS PLANT SCI, V15, P684, DOI 10.1016/j.tplants.2010.09.008; R Core Team, 2021, R LANGUAGE ENV STAT; Rasmann S, 2014, FUNCT ECOL, V28, P46, DOI 10.1111/1365-2435.12135; Rixen C, 2012, OIKOS, V121, P1532, DOI 10.1111/j.1600-0706.2011.20031.x; Roy BA, 2004, ECOLOGY, V85, P2570, DOI 10.1890/03-0182; Scheepens JF, 2013, OECOLOGIA, V171, P679, DOI 10.1007/s00442-012-2582-7; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schob C, 2009, PLANT ECOL, V200, P91, DOI 10.1007/s11258-008-9435-9; Schwaegerle KE, 2000, EVOLUTION, V54, P452; Sedlacek JF, 2014, BASIC APPL ECOL, V15, P305, DOI 10.1016/j.baae.2014.05.006; Skelly DK, 2007, CONSERV BIOL, V21, P1353, DOI 10.1111/j.1523-1739.2007.00764.x; SMITH WK, 1979, OECOLOGIA, V41, P109, DOI 10.1007/BF00344841; Stanton ML, 1997, AM NAT, V150, P143, DOI 10.1086/286061; Steger C, 2013, CLIM DYNAM, V41, P735, DOI 10.1007/s00382-012-1545-3; Stinson KA, 2004, AM J BOT, V91, P531, DOI 10.3732/ajb.91.4.531; Theurillat JP, 2001, CLIMATIC CHANGE, V50, P77, DOI 10.1023/A:1010632015572; van der Putten WH, 2013, J ECOL, V101, P265, DOI 10.1111/1365-2745.12054; van Grunsven RHA, 2007, J ECOL, V95, P1050, DOI 10.1111/j.1365-2745.2007.01282.x; van Kleunen M, 2005, NEW PHYTOL, V166, P49, DOI 10.1111/j.1469-8137.2004.01296.x; van Kleunen M, 2001, OIKOS, V94, P515, DOI 10.1034/j.1600-0706.2001.940313.x; WALKER MD, 1995, ECOLOGY, V76, P1067, DOI 10.2307/1940916; Wheeler JA, 2015, BASIC APPL ECOL, V16, P202, DOI 10.1016/j.baae.2015.02.004; Wheeler JA, 2014, OECOLOGIA, V175, P219, DOI 10.1007/s00442-013-2872-8; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325; Wipf S, 2010, PLANT ECOL, V207, P53, DOI 10.1007/s11258-009-9653-9; Wipf S, 2009, CLIMATIC CHANGE, V94, P105, DOI [10.1007/s10584-009-9546-x, 10.1007/s10584-009-9546-X]; Zuur Alain F., 2009, P1	69	54	55	3	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0122395	10.1371/journal.pone.0122395	http://dx.doi.org/10.1371/journal.pone.0122395			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893438	Green Published, gold, Green Submitted			2022-12-26	WOS:000353211700014
J	Toth, A; Fodor, J; Vincze, J; Olah, T; Juhasz, T; Zakany, R; Csernoch, L; Zador, E				Toth, Adrienn; Fodor, Janos; Vincze, Janos; Olah, Tamas; Juhasz, Tamas; Zakany, Roza; Csernoch, Laszlo; Zador, Erno			The Effect of SERCA1b Silencing on the Differentiation and Calcium Homeostasis of C2C12 Skeletal Muscle Cells	PLOS ONE			English	Article							NOTEXIN-INDUCED NECROSIS; MESSENGER-RNA LEVELS; RAT SOLEUS MUSCLE; STROMAL INTERACTION MOLECULE-1; CYCLOSPORINE-A; SARCOPLASMIC-RETICULUM; CA-2+ ATPASE; EXPRESSION; ENTRY; CALCINEURIN	The sarcoplasmic/endoplasmic reticulum Ca2+ ATPases (SERCAs) are the main Ca2+ pumps which decrease the intracellular Ca2+ level by reaccumulating Ca2+ into the sarcoplasmic reticulum. The neonatal SERCA1b is the major Ca2+ pump in myotubes and young muscle fibers. To understand its role during skeletal muscle differentiation its synthesis has been interfered with specific shRNA sequence. Stably transfected clones showing significantly decreased SERCA1b expression (cloneC1) were selected for experiments. The expression of the regulatory proteins of skeletal muscle differentiation was examined either by Western-blot at the protein level for MyoD, STIM1, calsequestrin (CSQ), and calcineurin (CaN) or by RT-PCR for myostatin and MCIP1.4. Quantitative analysis revealed significant alterations in CSQ, STIM1, and CaN expression in cloneC1 as compared to control cells. To examine the functional consequences of the decreased expression of SERCA1b, repeated Ca2+-transients were evoked by applications of 120 mM KCl. The significantly higher [Ca2+]i measured at the 20th and 40th seconds after the beginning of KCl application (112 +/- 3 and 110 +/- 3 nMvs. 150 +/- 7 and 135 +/- 5 nM, in control and in cloneC1 cells, respectively) indicated a decreased Ca2+-uptake capability which was quantified by extracting the maximal pump rate (454 +/- 41 mu M/s vs. 144 +/- 24 mu M/s, in control and in cloneC1 cells). Furthermore, the rate of calcium release from the SR (610 +/- 60 vs. 377 +/- 64 mu M/s) and the amount of calcium released (843 +/- 75 mu M vs. 576 +/- 80 mu M) were also significantly suppressed. These changes were also accompanied by a reduced activity of CaN in cells with decreased SERCA1b. In parallel, cloneC1 cells showed inhibited cell proliferation and decreased myotube nuclear numbers. Moreover, while cyclosporineA treatment suppressed the proliferation of parental cultures it had no effect on cloneC1 cells. SERCA1b is thus considered to play an essential role in the regulation of [Ca2+]i and its ab ovo gene silencing results in decreased skeletal muscle differentiation.	[Toth, Adrienn; Fodor, Janos; Vincze, Janos; Olah, Tamas; Csernoch, Laszlo] Univ Debrecen, Fac Med, Dept Physiol, Debrecen, Hungary; [Juhasz, Tamas; Zakany, Roza] Univ Debrecen, Fac Med, Dept Anat Histol & Embryol, Debrecen, Hungary; [Zador, Erno] Univ Szeged, Fac Med, Dept Biochem, Szeged, Hungary	University of Debrecen; University of Debrecen; Szeged University	Csernoch, L (corresponding author), Univ Debrecen, Fac Med, Dept Physiol, Debrecen, Hungary.	csl@edu.unideb.hu	Juhasz, Tamas/M-6878-2019	Juhasz, Tamas/0000-0003-0489-5676; Olah, Tamas/0000-0002-3834-6272; Csernoch, Laszlo/0000-0002-2446-1456	Bolyai Research Scholarship of the Hungarian Academy of Sciences; TAMOP [4.2.4. A/2-11-1-2012-0001];  [OTKA NN-107765];  [TAMOP-4.2.1/B-09/1/KONV-2010-0007];  [TAMOP-4.2.2/B-10/1-2010-0024]	Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); TAMOP; ; ; 	This work was supported by grants: OTKA NN-107765, TAMOP-4.2.1/B-09/1/KONV-2010-0007 and TAMOP-4.2.2/B-10/1-2010-0024, Bolyai Research Scholarship of the Hungarian Academy of Sciences to JF, TAMOP 4.2.4. A/2-11-1-2012-0001 'National Excellence Program' to TO.	Abbott KL, 1998, MOL BIOL CELL, V9, P2905, DOI 10.1091/mbc.9.10.2905; Aoki MS, 2006, BRAZ J MED BIOL RES, V39, P243, DOI 10.1590/S0100-879X2006000200011; BRANDL CJ, 1986, CELL, V44, P597, DOI 10.1016/0092-8674(86)90269-2; BRANDL CJ, 1987, J BIOL CHEM, V262, P3768; BURK SE, 1989, J BIOL CHEM, V264, P18561; Choi YM, 2014, BIOCHEM BIOPH RES CO, V448, P182, DOI 10.1016/j.bbrc.2014.04.083; Collet C, 2004, BIOPHYS J, V87, P268, DOI 10.1529/biophysj.103.039305; Fenyvesi R, 2004, BIOCHEM BIOPH RES CO, V320, P599, DOI 10.1016/j.bbrc.2004.06.005; Fodor J, 2013, CELL CALCIUM, V54, P1, DOI 10.1016/j.ceca.2013.03.003; Froehlich JP, 2008, BIOCHEMISTRY-US, V47, P13150, DOI 10.1021/bi801925p; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guglielmi V, 2013, MOL GENET METAB, V110, P162, DOI 10.1016/j.ymgme.2013.07.015; GUNTESKIHAMBLIN AM, 1988, J BIOL CHEM, V263, P15032; Gutierrez-Martin Y, 2005, BBA-BIOMEMBRANES, V1711, P33, DOI 10.1016/j.bbamem.2005.02.017; Horsley V, 2002, J CELL BIOL, V156, P771, DOI 10.1083/jcb.200111073; Juhasz T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091541; Kosa M, 2013, MOL BIOTECHNOL, V54, P220, DOI 10.1007/s12033-012-9555-2; Lee KJ, 2014, PFLUG ARCH EUR J PHY, V466, P987, DOI 10.1007/s00424-013-1361-6; Lipskaia L, 2005, CIRC RES, V97, P488, DOI 10.1161/01.RES.0000180663.42594.aa; Lipskaia L, 2009, PFLUG ARCH EUR J PHY, V457, P673, DOI 10.1007/s00424-007-0428-7; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; Mendler L, 1998, J MUSCLE RES CELL M, V19, P777, DOI 10.1023/A:1005499304147; Michalak M, 2009, TRENDS CELL BIOL, V19, P253, DOI 10.1016/j.tcb.2009.03.006; MILLER JB, 1990, J CELL BIOL, V111, P1149, DOI 10.1083/jcb.111.3.1149; Olah T, 2011, CELL CALCIUM, V49, P415, DOI 10.1016/j.ceca.2011.03.012; Pan Y, 2003, J BIOL CHEM, V278, P13367, DOI 10.1074/jbc.M213228200; Porter GA, 2002, J BIOL CHEM, V277, P28942, DOI 10.1074/jbc.M203961200; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Roberts-Wilson TK, 2010, BBA-MOL CELL RES, V1803, P960, DOI 10.1016/j.bbamcr.2010.03.019; Rosenberg P, 2004, P NATL ACAD SCI USA, V101, P9387, DOI 10.1073/pnas.0308179101; Rossi D, 2007, CELL CALCIUM, V41, P573, DOI 10.1016/j.ceca.2006.10.007; Sachewsky N, 2014, DIS MODEL MECH, V7, P953, DOI 10.1242/dmm.014480; Sakuma K, 2005, ACTA NEUROPATHOL, V110, P269, DOI 10.1007/s00401-005-1049-x; Seth M, 2012, DEV DYNAM, V241, P639, DOI 10.1002/dvdy.23760; Stiber J, 2008, NAT CELL BIOL, V10, P688, DOI 10.1038/ncb1731; Stiber JA, 2011, CELL CALCIUM, V49, P341, DOI 10.1016/j.ceca.2010.11.012; Sumbilla C, 1999, AM J PHYSIOL-HEART C, V277, pH2381, DOI 10.1152/ajpheart.1999.277.6.H2381; Szabo A, 2008, J HISTOCHEM CYTOCHEM, V56, P1013, DOI 10.1369/jhc.2008.951632; Szappanos H, 2004, J BIOCHEM BIOPH METH, V59, P89, DOI 10.1016/j.jbbm.2003.12.002; Sztretye M, 2014, 58 ANN M BIOPH SOC B; Sztretye M, 2007, J MUSCLE RES CELL M, V28, P421, DOI 10.1007/s10974-008-9135-z; Tam TTP, 2013, BIOCHEM BIOPH RES CO, V430, P722, DOI 10.1016/j.bbrc.2012.11.082; Trebak M, 2013, MICROCIRCULATION, V20, P330, DOI 10.1111/micc.12042; Vangheluwe P, 2006, BBA-MOL CELL RES, V1763, P1216, DOI 10.1016/j.bbamcr.2006.08.025; Vega AV, 2011, J PHYSIOL-LONDON, V589, P4649, DOI 10.1113/jphysiol.2011.210765; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61; Yeo H, 2007, BONE, V40, P1502, DOI 10.1016/j.bone.2007.02.017; Zador E, 1998, ACTA HISTOCHEM, V100, P355, DOI 10.1016/S0065-1281(98)80033-0; Zador E, 1999, J MUSCLE RES CELL M, V20, P395, DOI 10.1023/A:1005541522599; Zador E, 1996, BIOCHEM J, V320, P107, DOI 10.1042/bj3200107; Zador E, 2007, CELL CALCIUM, V41, P379, DOI 10.1016/j.ceca.2006.08.001; Zador E, 2011, HISTOCHEM CELL BIOL, V135, P11, DOI 10.1007/s00418-010-0766-y; Zakany R, 2005, EXP CELL RES, V305, P190, DOI 10.1016/j.yexcr.2004.12.016; ZHANG M, 1995, DEV DYNAM, V204, P168, DOI 10.1002/aja.1002040207	54	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123583	10.1371/journal.pone.0123583	http://dx.doi.org/10.1371/journal.pone.0123583			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893964	Green Accepted, gold, Green Published			2022-12-26	WOS:000353211700044
J	Wang, YK; Ning, ZY; Hu, Y; Chen, JD; Zhao, R; Chen, H; Ai, NJ; Guo, WZ; Zhang, TZ				Wang, Yangkun; Ning, Zhiyuan; Hu, Yan; Chen, Jiedan; Zhao, Rui; Chen, Hong; Ai, Nijiang; Guo, Wangzhen; Zhang, Tianzhen			Molecular Mapping of Restriction-Site Associated DNA Markers in Allotetraploid Upland Cotton	PLOS ONE			English	Article							VERTICILLIUM WILT; FIBER QUALITY; GENOME; DISCOVERY; RESISTANCE; QTLS	Upland cotton (Gossypium hirsutum L., 2n = 52, AADD) is an allotetraploid, therefore the discovery of single nucleotide polymorphism (SNP) markers is difficult. The recent emergence of genome complexity reduction technologies based on the next-generation sequencing (NGS) platform has greatly expedited SNP discovery in crops with highly repetitive and complex genomes. Here we applied restriction-site associated DNA (RAD) sequencing technology for de novo SNP discovery in allotetraploid cotton. We identified 21,109 SNPs between the two parents and used these for genotyping of 161 recombinant inbred lines (RILs). Finally, a high dense linkage map comprising 4,153 loci over 3500-cM was developed based on the previous result. Using this map quantitative trait locus (QTLs) conferring fiber strength and Verticillium Wilt (VW) resistance were mapped to a more accurate region in comparison to the 1576-cM interval determined using the simple sequence repeat (SSR) genetic map. This suggests that the newly constructed map has more power and resolution than the previous SSR map. It will pave the way for the rapid identification of the marker-assisted selection in cotton breeding and cloning of QTL of interest traits.	[Wang, Yangkun; Ning, Zhiyuan; Hu, Yan; Chen, Jiedan; Zhao, Rui; Guo, Wangzhen; Zhang, Tianzhen] Nanjing Agr Univ, Minist Educ, Natl Key Lab Crop Genet & Germplasm Enhancement, Cotton Hybrid R&D Engn Ctr, Nanjing 210095, Jiangsu, Peoples R China; [Chen, Hong] Xinjiang Acad Agr & Reclamat Sci, Cotton Res Inst, Shihezi 832000, Xinjiang, Peoples R China; [Ai, Nijiang] Shihezi Agr Sci & Tec Res Ctr, Shihezi 832000, Xinjiang, Peoples R China	Nanjing Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Zhang, TZ (corresponding author), Nanjing Agr Univ, Minist Educ, Natl Key Lab Crop Genet & Germplasm Enhancement, Cotton Hybrid R&D Engn Ctr, Nanjing 210095, Jiangsu, Peoples R China.	cotton@njau.edu.cn			Major State Basic Research Development Program of China (973 Program) [2011CB109300]; National High Technology Research and Development Program of China (863 Program) [2011AA10A102]; Jiangsu province [BE2012329]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Jiangsu province	This work was supported by the Major State Basic Research Development Program of China (973 Program) (2011CB109300), the National High Technology Research and Development Program of China (863 Program) (2011AA10A102), and Jiangsu province (BE2012329). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An CF, 2007, MOL GENET GENOMICS, V278, P539, DOI 10.1007/s00438-007-0270-9; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Brubaker CL, 1999, GENOME, V42, P184, DOI 10.1139/gen-42-2-184; Brunner AL, 2009, GENOME RES, V19, P1044, DOI 10.1101/gr.088773.108; Byers RL, 2012, THEOR APPL GENET, V124, P1201, DOI 10.1007/s00122-011-1780-8; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Chen AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096417; Chen H, 2009, THEOR APPL GENET, V119, P605, DOI 10.1007/s00122-009-1070-x; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Emerson KJ, 2010, P NATL ACAD SCI USA, V107, P16196, DOI 10.1073/pnas.1006538107; Flagel LE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-302; Guo WZ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-314; Hansey CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033071; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Jiang F, 2009, SCI CHINA SER C, V52, P872, DOI 10.1007/s11427-009-0110-8; Lacape JM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-132; Lacape JM, 2003, GENOME, V46, P612, DOI [10.1139/G03-050, 10.1139/g03-050]; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liu MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071067; Mammadov J, 2012, INT J PANT PROD; Matsumura H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087138; Ning ZY, 2013, CROP SCI, V53, P2304, DOI 10.2135/cropsci2012.12.0694; Ning ZY, 2014, EUPHYTICA, V195, P143, DOI 10.1007/s10681-013-0990-3; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Pfender WF, 2011, THEOR APPL GENET, V122, P1467, DOI 10.1007/s00122-011-1546-3; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Talukder ZI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098628; Ulloa M., 2000, Journal of Cotton Science, V4, P161; Van Deynze A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-125; van Poecke RMP, 2013, PLANT BIOTECHNOL J, V11, P809, DOI 10.1111/pbi.12072; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; WANG GL, 1995, THEOR APPL GENET, V91, P1153, DOI 10.1007/BF00223934; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang S., WINDOWS QTL CARTOGRA; Wang S, 2012, NAT METHODS, V9, P808, DOI [10.1038/nmeth.2023, 10.1038/NMETH.2023]; Xie SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068510; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang K, 2012, MOL BREEDING, V29, P335, DOI 10.1007/s11032-011-9549-y	40	36	38	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124781	10.1371/journal.pone.0124781	http://dx.doi.org/10.1371/journal.pone.0124781			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894395	Green Published, gold, Green Submitted			2022-12-26	WOS:000353211700124
J	Yilmaz, V; Oflazer, P; Aysal, F; Durmus, H; Poulas, K; Yentur, SP; Gulsen-Parman, Y; Tzartos, S; Marx, A; Tuzun, E; Deymeer, F; Saruhan-Direskeneli, G				Yilmaz, Vuslat; Oflazer, Piraye; Aysal, Fikret; Durmus, Hacer; Poulas, Kostas; Yentur, Sibel P.; Gulsen-Parman, Yesim; Tzartos, Socrates; Marx, Alexander; Tuzun, Erdem; Deymeer, Feza; Saruhan-Direskeneli, Guher			Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTOR ANTIBODY; MESSENGER-RNA EXPRESSION; BLOOD MONONUCLEAR-CELLS; REGULATORY T-CELLS; IGG4 PRODUCTION; SUBPOPULATIONS; AUTOANTIBODIES; SECRETION; RESPONSES; IL-10	Neuromuscular transmission failure in myasthenia gravis (MG) is most commonly elicited by autoantibodies (ab) to the acetylcholine receptor or the muscle-specific kinase, constituting AChR-MG and MuSK-MG. It is controversial whether these MG subtypes arise through different T helper (Th) 1, Th2 or Th17 polarized immune reactions and how these reactions are blunted by immunosuppression. To address these questions, plasma levels of cytokines related to various Th subtypes were determined in patients with AChR-MG, MuSK-MG and healthy controls (CON). Peripheral blood mononuclear cells (PBMC) were activated in vitro by anti-CD3, and cytokines were quantified in supernatants. In purified blood CD4(+) T cells, RNA of various cytokines, Th subtype specific transcription factors and the co-stimulatory molecule, CD40L, were quantified by qRT-PCR. Plasma levels of Th1, Th2 and Th17 related cytokines were overall not significantly different between MG subtypes and CON. By contrast, in vitro stimulated PBMC from MuSK-MG but not AChR-MG patients showed significantly increased secretion of the Th1, Th17 and T follicular helper cell related cytokines, IFN-gamma, IL-17A and IL-21. Stimulated expression of IL-4, IL-6, IL-10 and IL-13 was not significantly different. At the RNA level, expression of CD40L by CD4+ T cells was reduced in both AChR-MG and MuSK-MG patients while expression of Th subset related cytokines and transcription factors were normal. Immunosuppression treatment had two effects: First, it reduced levels of IL12p40 in the plasma of AChR-MG and MuSK-MG patients, leaving other cytokine levels unchanged; second, it reduced spontaneous secretion of IFN-. and increased secretion of IL-6 and IL-10 by cultured PBMC from AChR-MG, but not MuSK-MG patients. We conclude that Th1 and Th17 immune reactions play a role in MuSK-MG. Immunosuppression attenuates the Th1 response in AChR-MG and MuSK-MG, but otherwise modulates immune responses in AChR-MG and MuSK-MG patients differentially.	[Yilmaz, Vuslat; Yentur, Sibel P.; Saruhan-Direskeneli, Guher] Istanbul Univ, Istanbul Fac Med, Dept Physiol, Istanbul, Turkey; [Oflazer, Piraye; Durmus, Hacer; Gulsen-Parman, Yesim; Deymeer, Feza] Istanbul Univ, Istanbul Fac Med, Dept Neurol, Istanbul, Turkey; [Aysal, Fikret] Bakirkoy Res & Training Hosp Psychiat & Neurol Di, Dept Neurol, Istanbul, Turkey; [Poulas, Kostas] Univ Patras, Sch Hlth Sci, Dept Pharm, Patras, Greece; [Tzartos, Socrates] Hellenic Pasteur Inst, Athens, Greece; [Marx, Alexander] Heidelberg Univ, Inst Pathol, Univ Med Ctr Mannheim, Mannheim, Germany; [Tuzun, Erdem] Istanbul Univ, Expt Med Res Inst, Dept Neurosci, Istanbul, Turkey	Istanbul University; Istanbul University; Istanbul Bakirkoy Mental Health & Neurology Training & Research Hospital; University of Patras; Ruprecht Karls University Heidelberg; Istanbul University	Saruhan-Direskeneli, G (corresponding author), Istanbul Univ, Istanbul Fac Med, Dept Physiol, Istanbul, Turkey.	gsaruhan@istanbul.edu.tr	Saruhan-Direskeneli, Guher/AAG-5657-2019; Tuzun, Erdem/AAH-9212-2019; YILMAZ, VUSLAT/AAB-9205-2020; Poulas, Konstantinos/L-4874-2018	Saruhan-Direskeneli, Guher/0000-0002-6903-7173; Poulas, Konstantinos/0000-0002-5397-1543; , Piraye/0000-0001-8202-5313	TUBITAK [106S223, 109S353, 110S297]; BMBF [01DL12027]; Istanbul University Research Fund (UDP and BYP)	TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); BMBF(Federal Ministry of Education & Research (BMBF)); Istanbul University Research Fund (UDP and BYP)(Istanbul University)	The work was supported by the following: TUBITAK (grant #: 106S223, 109S353 and 110S297 to VY ET FD GSD); and BMBF (grant # 01DL12027 to AM) Istanbul University Research Fund (UDP and BYP to VY SPY GSD).	Berrih-Aknin S, 2014, J AUTOIMMUN, V48-49, P143, DOI 10.1016/j.jaut.2014.01.003; deBoer BA, 1997, INFECT IMMUN, V65, P1122, DOI 10.1128/IAI.65.3.1122-1125.1997; Diaz-Manera J, 2012, NEUROLOGY, V78, P189, DOI 10.1212/WNL.0b013e3182407982; DRACHMAN DB, 1978, NEW ENGL J MED, V298, P1116, DOI 10.1056/NEJM197805182982004; DRACHMAN DB, 1994, NEW ENGL J MED, V330, P1797, DOI 10.1056/NEJM199406233302507; Higuchi O, 2011, ANN NEUROL, V69, P418, DOI 10.1002/ana.22312; Hoch W, 2001, NAT MED, V7, P365, DOI 10.1038/85520; Huang WX, 2000, EUR J NEUROL, V7, P195, DOI 10.1046/j.1468-1331.2000.00056.x; Im SH, 2001, J IMMUNOL, V166, P6893, DOI 10.4049/jimmunol.166.11.6893; Jeannin P, 1998, J IMMUNOL, V160, P3555; Leite MI, 2008, BRAIN, V131, P1940, DOI 10.1093/brain/awn092; Li X, 2008, CLIN IMMUNOL, V126, P180, DOI 10.1016/j.clim.2007.10.001; Li Y, 2014, NEUROL SCI, V35, P29, DOI 10.1007/s10072-013-1460-3; LINDSTROM JM, 1976, NEUROLOGY, V26, P1054, DOI 10.1212/WNL.26.11.1054; LINK J, 1994, NEUROLOGY, V44, P728, DOI 10.1212/WNL.44.4.728; Masuda M, 2010, EUR J PHARMACOL, V627, P325, DOI 10.1016/j.ejphar.2009.10.040; Milani M, 2003, ANN NY ACAD SCI, V998, P284, DOI 10.1196/annals.1254.032; Mu LL, 2009, IMMUNOLOGY, V128, pe826, DOI 10.1111/j.1365-2567.2009.03089.x; Neron S, 2005, IMMUNOLOGY, V116, P454, DOI 10.1111/j.1365-2567.2005.02244.x; Pevzner A, 2012, J NEUROL, V259, P427, DOI 10.1007/s00415-011-6194-7; Roche JC, 2011, MUSCLE NERVE, V44, P278, DOI 10.1002/mus.22070; RODGAARD A, 1987, CLIN EXP IMMUNOL, V67, P82; Sanders DB, 2003, NEUROLOGY, V60, P1978, DOI 10.1212/01.WNL.0000065882.63904.53; STEVENS TL, 1988, NATURE, V334, P255, DOI 10.1038/334255a0; Tanaka A, 2012, ARTHRITIS RHEUM-US, V64, P254, DOI 10.1002/art.33320; Teleshova N, 2000, MUSCLE NERVE, V23, P946, DOI 10.1002/(SICI)1097-4598(200006)23:6<946::AID-MUS16>3.0.CO;2-4; Tuzun E, 2011, J AUTOIMMUN, V37, P136, DOI 10.1016/j.jaut.2011.05.006; Ulusoy C, 2014, CLIN IMMUNOL, V151, P155, DOI 10.1016/j.clim.2014.02.012; Uzawa A, 2014, CLIN EXP IMMUNOL, V176, P232, DOI 10.1111/cei.12272; VINCENT A, 1985, J NEUROL NEUROSUR PS, V48, P1246, DOI 10.1136/jnnp.48.12.1246; Vincent A, 2001, LANCET, V357, P2122, DOI 10.1016/S0140-6736(00)05186-2; Vincent Angela, 2002, Adv Neurol, V88, P159; Wang Z, 2012, SCAND J IMMUNOL, V76, P54, DOI 10.1111/j.1365-3083.2012.02703.x; Wood N, 2004, CELL IMMUNOL, V231, P133, DOI 10.1016/j.cellimm.2005.01.001; Yeh JH, 2009, EUR J NEUROL, V16, P1318, DOI 10.1111/j.1468-1331.2009.02729.x; Yi JS, 2014, J AUTOIMMUN, V52, P130, DOI 10.1016/j.jaut.2013.12.005; YI Q, 1994, J NEUROIMMUNOL, V50, P177, DOI 10.1016/0165-5728(94)90044-2; Yilmaz V, 2014, AUTOIMMUNITY, V2014, P1, DOI [10.3109/08916934.2013.856006, DOI 10.3109/08916934.2013.856006]; Yoshikawa H, 2002, J CLIN NEUROSCI, V9, P133, DOI 10.1054/jocn.2001.1028; Zhang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091816; Zhang B, 2012, ARCH NEUROL-CHICAGO, V69, P445, DOI 10.1001/archneurol.2011.2393; Zisimopoulou P, 2014, J AUTOIMMUN, V52, P139, DOI 10.1016/j.jaut.2013.12.004	42	31	31	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123546	10.1371/journal.pone.0123546	http://dx.doi.org/10.1371/journal.pone.0123546			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893403	Green Submitted, gold, Green Published			2022-12-26	WOS:000353211700040
J	Zhang, XY; Song, QB				Zhang, Xueying; Song, Qinbao			A Multi-Label Learning Based Kernel Automatic Recommendation Method for Support Vector Machine	PLOS ONE			English	Article							ALGORITHM SELECTION; PATTERN-RECOGNITION; MODEL SELECTION; CLASSIFICATION; VALIDATION; PREDICTION; ACCURACY	Choosing an appropriate kernel is very important and critical when classifying a new problem with Support Vector Machine. So far, more attention has been paid on constructing new kernels and choosing suitable parameter values for a specific kernel function, but less on kernel selection. Furthermore, most of current kernel selection methods focus on seeking a best kernel with the highest classification accuracy via cross-validation, they are time consuming and ignore the differences among the number of support vectors and the CPU time of SVM with different kernels. Considering the tradeoff between classification success ratio and CPU time, there may be multiple kernel functions performing equally well on the same classification problem. Aiming to automatically select those appropriate kernel functions for a given data set, we propose a multi-label learning based kernel recommendation method built on the data characteristics. For each data set, the meta-knowledge data base is first created by extracting the feature vector of data characteristics and identifying the corresponding applicable kernel set. Then the kernel recommendation model is constructed on the generated meta-knowledge data base with the multi-label classification method. Finally, the appropriate kernel functions are recommended to a new data set by the recommendation model according to the characteristics of the new data set. Extensive experiments over 132 UCI benchmark data sets, with five different types of data set characteristics, eleven typical kernels (Linear, Polynomial, Radial Basis Function, Sigmoidal function, Laplace, Multiquadric, Rational Quadratic, Spherical, Spline, Wave and Circular), and five multi-label classification methods demonstrate that, compared with the existing kernel selection methods and the most widely used RBF kernel function, SVM with the kernel function recommended by our proposed method achieved the highest classification performance.	[Zhang, Xueying; Song, Qinbao] Xi An Jiao Tong Univ, Dept Comp Sci & Technol, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University	Song, QB (corresponding author), Xi An Jiao Tong Univ, Dept Comp Sci & Technol, 28 Xian Ning West Rd, Xian 710049, Shaanxi, Peoples R China.	qbsong@mail.xjtu.edu.cn			National Natural Science Foundation of China [61373046]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is supported by the National Natural Science Foundation of China. The grant number is 61373046 and the URLs of the National Natural Science Foundation of China is http://www.nsfc.gov.cn/. XYZ and QBS received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S., 2005, SUPPORT VECTOR MACHI, V53; Akay MF, 2009, EXPERT SYST APPL, V36, P3240, DOI 10.1016/j.eswa.2008.01.009; Ali S, 2006, APPL SOFT COMPUT, V6, P119, DOI 10.1016/j.asoc.2004.12.002; Ali S, 2006, NEUROCOMPUTING, V70, P173, DOI 10.1016/j.neucom.2006.03.004; ARONSZAJN N, 1950, T AM MATH SOC, V68, P337, DOI 10.1090/s0002-9947-1950-0051437-7; Ayat NE, 2005, PATTERN RECOGN, V38, P1733, DOI 10.1016/j.patcog.2005.03.011; Bach F. R., 2004, P 21 INT C MACH LEAR, P41, DOI 10.1145/ 1015330.1015424; Bensusan H, 2000, LECT NOTES COMPUT<D>, V1910, P325; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Boutell MR, 2004, PATTERN RECOGN, V37, P1757, DOI 10.1016/j.patcog.2004.03.009; Bradford JR, 2005, BIOINFORMATICS, V21, P1487, DOI 10.1093/bioinformatics/bti242; Brazdil P., 1994, Machine Learning: ECML-94. European Conference on Machine Learning. Proceedings, P83; Brazdil PB, 2003, MACH LEARN, V50, P251, DOI 10.1023/A:1021713901879; Brereton RG, 2010, ANALYST, V135, P230, DOI 10.1039/b918972f; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Byun H, 2002, LECT NOTES COMPUT SC, V2388, P213; Castiello C, 2005, LECT NOTES ARTIF INT, V3558, P457; Cawley GC, 2006, IEEE IJCNN, P1661; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Clare A., 2001, EUROPEAN C PRINCIPLE, V2168, P42; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Crammer K, 2003, J MACH LEARN RES, V3, P1025, DOI 10.1162/153244303322533188; Cybenko G., 1989, Mathematics of Control, Signals, and Systems, V2, P303, DOI 10.1007/BF02551274; Demsar J, 2006, J MACH LEARN RES, V7, P1; Duin RPW, 2004, INT C PATT RECOG, P140; Elisseeff A, 2002, ADV NEUR IN, V14, P681; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Friedman M, 1937, J AM STAT ASSOC, V32, P675, DOI 10.2307/2279372; Friedman M, 1940, ANN MATH STAT, V11, P86, DOI 10.1214/aoms/1177731944; Furnkranz J, 2008, MACH LEARN, V73, P133, DOI 10.1007/s10994-008-5064-8; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Genton MG, 2002, J MACH LEARN RES, V2, P299, DOI 10.1162/15324430260185646; Godbole S, 2004, LECT NOTES ARTIF INT, V3056, P22; Gonen M, 2011, J MACH LEARN RES, V12, P2211; Gopal S, 2010, SIGIR 2010: PROCEEDINGS OF THE 33RD ANNUAL INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH DEVELOPMENT IN INFORMATION RETRIEVAL, P315; Heckman N, 2012, STAT SURV, V6, P113, DOI 10.1214/12-SS101; Ho TK, 2002, IEEE T PATTERN ANAL, V24, P289, DOI 10.1109/34.990132; HOLM S, 1979, SCAND J STAT, V6, P65; Howley T, 2005, ARTIF INTELL REV, V24, P379, DOI 10.1007/s10462-005-9009-3; Hsu CW, 2002, IEEE T NEURAL NETWOR, V13, P415, DOI 10.1109/72.991427; Huang J, 2005, IEEE T KNOWL DATA EN, V17, P299, DOI 10.1109/TKDE.2005.50; Jensen DD, 2000, MACH LEARN, V38, P309, DOI 10.1023/A:1007631014630; Kalousis A, 2004, MACH LEARN, V54, P275, DOI 10.1023/B:MACH.0000015882.38031.85; Katakis I, 2008, P ECML PKDD 2008 DIS; KIRA K, 1992, MACHINE LEARNING /, P249; Leopold E, 2002, MACH LEARN, V46, P423, DOI 10.1023/A:1012491419635; Lin CJ, 2010, PRACTICAL GUIDE SUPP; Lindner G, 1999, LECT NOTES ARTIF INT, V1704, P418; Muller KR, 2001, IEEE T NEURAL NETWOR, V12, P181, DOI 10.1109/72.914517; Nakhaeizadeh G., 1997, Proceedings of the Third International Conference on Knowledge Discovery and Data Mining, P37; Nguyen Minh N, 2003, Genome Inform, V14, P218; Partridge M, 2000, NEURAL NETWORKS FOR SIGNAL PROCESSING X, VOLS 1 AND 2, PROCEEDINGS, P289, DOI 10.1109/NNSP.2000.889420; Peng Y., 2002, 2 ECML PKDD INT WORK, P111; Pfahringer Bernhard, 2000, P 17 INT C MACH LEAR, P743, DOI [10.5555/645529.658105, DOI 10.5555/645529.658105]; Qi G.-J., 2007, P 15 INT C MULT, P17, DOI DOI 10.1145/1291233.1291245; Rakotomamonjy A, 2008, J MACH LEARN RES, V9, P2491; Sapankevych NL, 2009, IEEE COMPUT INTELL M, V4, P24, DOI 10.1109/MCI.2009.932254; Schapire RE, 2000, MACH LEARN, V39, P135, DOI 10.1023/A:1007649029923; Shi ZW, 2007, IEEE T NEURAL NETWOR, V18, P359, DOI 10.1109/TNN.2006.885113; Smola AJ, 1998, ALGORITHMICA, V22, P211, DOI 10.1007/PL00013831; Song QB, 2012, PATTERN RECOGN, V45, P2672, DOI 10.1016/j.patcog.2011.12.025; Sonnenburg S, 2006, J MACH LEARN RES, V7, P1531; Staelin C., 2003, HPL2002354R1; Sullivan K, 2007, GECCO 2007: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOL 1 AND 2, P1702; Thabtah FA, 2004, FOURTH IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P217, DOI 10.1109/ICDM.2004.10117; Thadani K, 2007, 2006 INTERNATIONAL CONFERENCE ON ADVANCED COMPUTING AND COMMUNICATIONS, VOLS 1 AND 2, P18; Tong S, 2002, J MACH LEARN RES, V2, P45, DOI 10.1162/153244302760185243; Tsoumakas G., 2009, INT J DATA WAREHOUS, V3, P1, DOI DOI 10.4018/JDWM.2007070101; Tsoumakas G, 2010, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, SECOND EDITION, P667, DOI 10.1007/978-0-387-09823-4_34; Vapnik V, 2000, NEURAL COMPUT, V12, P2013, DOI 10.1162/089976600300015042; Vapnik V., 1998, STAT LEARNING THEORY, V3, DOI DOI 10.1007/978-1-4419-1428-6_5864; Vapnik V.N., 2006, ESTIMATION DEPENDENC, VVolume 40; VAPNIK VN, 1971, THEOR PROBAB APPL+, V16, P264, DOI 10.1137/1116025; Wang GT, 2014, ACM T KNOWL DISCOV D, V9, DOI 10.1145/2629474; Wang WJ, 2008, LECT NOTES ARTIF INT, V5009, P596, DOI 10.1007/978-3-540-79721-0_80; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Wolpert DH, 1998, SUPPORT VECTOR MACHI; Yang S, 2007, IEEE T CIRC SYST VID, V17, P324, DOI 10.1109/TCSVT.2007.890829; Yang Y., 1997, P 14 INT C MACH LEAR, P412, DOI DOI 10.1016/J.ESWA.2008.05.026; Yu K., 2005, SIGIR 2005. Proceedings of the Twenty-Eighth Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P258, DOI 10.1145/1076034.1076080; Zhang DQ, 2006, IEEE DATA MINING, P1178; Zhang DQ, 2006, PATTERN RECOGN, V39, P133, DOI 10.1016/j.patcog.2005.08.001; Zhang ML, 2007, PATTERN RECOGN, V40, P2038, DOI 10.1016/j.patcog.2006.12.019; Zhang ML, 2014, IEEE T KNOWL DATA EN, V26, P1819, DOI 10.1109/TKDE.2013.39; Zhang W, 2008, KNOWL-BASED SYST, V21, P879, DOI 10.1016/j.knosys.2008.03.044; Zhu S., 2005, SIGIR 2005. Proceedings of the Twenty-Eighth Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P274, DOI 10.1145/1076034.1076082; Zien A., 2007, P 24 INT C MACH LEAR, P1191, DOI DOI 10.1145/1273496.1273646	88	12	12	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0120455	10.1371/journal.pone.0120455	http://dx.doi.org/10.1371/journal.pone.0120455			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893896	Green Published, Green Submitted, gold			2022-12-26	WOS:000353211700005
J	Lee, WR; Sacharidou, A; Behling-Kelly, E; Oltmann, SC; Zhu, WF; Ahmed, M; Gerard, RD; Hui, DY; Abe, JI; Shaul, PW; Mineo, C				Lee, Wan Ru; Sacharidou, Anastasia; Behling-Kelly, Erica; Oltmann, Sarah C.; Zhu, Weifei; Ahmed, Mohamed; Gerard, Robert D.; Hui, David Y.; Abe, Jun-ichi; Shaul, Philip W.; Mineo, Chieko			PDZK1 Prevents Neointima Formation via Suppression of Breakpoint Cluster Region Kinase in Vascular Smooth Muscle	PLOS ONE			English	Article							RECEPTOR CLASS-B; ADAPTER PROTEIN PDZK1; TANDEM AFFINITY PURIFICATION; NITRIC-OXIDE SYNTHASE; SR-BI; LIPOPROTEIN METABOLISM; TARGETED DISRUPTION; BCR GENE; IN-VIVO; ATHEROSCLEROSIS	Scavenger receptor class B, type I (SR-BI) and its adaptor protein PDZK1 mediate responses to HDL cholesterol in endothelium. Whether the receptor-adaptor protein tandem serves functions in other vascular cell types is unknown. The current work determined the roles of SR-BI and PDZK1 in vascular smooth muscle (VSM). To evaluate possible VSM functions of SR-BI and PDZK1 in vivo, neointima formation was assessed 21 days post-ligation in the carotid arteries of wild-type, SR-BI-/- or PDZK1(-/-) mice. Whereas neointima development was negligible in wild-type and SR-BI-/-, there was marked neointima formation in PDZK1(-/-) mice. PDZK1 expression was demonstrated in primary mouse VSM cells, and compared to wild-type cells, PDZK1(-/-) VSM displayed exaggerated proliferation and migration in response to platelet derived growth factor (PDGF). Tandem affinity purification-mass spectrometry revealed that PDZK1 interacts with breakpoint cluster region kinase (Bcr), which contains a C-terminal PDZ binding sequence and is known to enhance responses to PDGF in VSM. PDZK1 interaction with Bcr in VSM was demonstrated by pull-down and by coimmunoprecipitation, and the augmented proliferative response to PDGF in PDZK1(-/-) VSM was abrogated by Bcr depletion. Furthermore, compared with wild-type Bcr overexpression, the introduction of a Bcr mutant incapable of PDZK1 binding into VSM cells yielded an exaggerated proliferative response to PDGF. Thus, PDZK1 has novel SR-BI-independent function in VSM that affords protection from neointima formation, and this involves PDZK1 suppression of VSM cell proliferation via an inhibitory interaction with Bcr.	[Lee, Wan Ru; Sacharidou, Anastasia; Behling-Kelly, Erica; Oltmann, Sarah C.; Zhu, Weifei; Ahmed, Mohamed; Shaul, Philip W.; Mineo, Chieko] Univ Texas SW Med Ctr Dallas, Dept Pediat, Ctr Pulm & Vasc Biol, Dallas, TX 75390 USA; [Gerard, Robert D.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Hui, David Y.] Univ Cincinnati, Coll Med, Dept Pathol, Metab Dis Inst, Cincinnati, OH USA; [Abe, Jun-ichi] Univ Rochester, Sch Med & Dent, Dept Med, Rochester, NY 14642 USA; [Abe, Jun-ichi] Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University System of Ohio; University of Cincinnati; University of Rochester; University of Rochester	Shaul, PW (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat, Ctr Pulm & Vasc Biol, Dallas, TX 75390 USA.	Philip.Shaul@utsouthwestern.edu; Chieko.Mineo@utsouthwestern.edu			NIH [HL058888]; Crystal Charity Ball Center for Pediatric Critical Care Research; Associates First Capital Corporation Distinguished Chair in Pediatrics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058888] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crystal Charity Ball Center for Pediatric Critical Care Research; Associates First Capital Corporation Distinguished Chair in Pediatrics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH Grant HL058888 (PWS). Additional support was provided by the Crystal Charity Ball Center for Pediatric Critical Care Research and the Associates First Capital Corporation Distinguished Chair in Pediatrics (PWS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Alexis JD, 2009, CIRC RES, V104, P69, DOI 10.1161/CIRCRESAHA.108.188409; Aoki K, 1999, MOL MED, V5, P224, DOI 10.1007/BF03402119; Assanasen C, 2005, J CLIN INVEST, V115, P969, DOI 10.1172/JCI23858; Basford JE, 2009, ARTERIOSCL THROM VAS, V29, P1772, DOI 10.1161/ATVBAHA.109.194357; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BRASELMANN S, 1995, EMBO J, V14, P4839, DOI 10.1002/j.1460-2075.1995.tb00165.x; Burckstummer T, 2006, NAT METHODS, V3, P1013, DOI 10.1038/nmeth968; Che W, 2001, CIRCULATION, V104, P1399, DOI 10.1161/hc3701.095581; De Meyer G R, 1997, Vasc Med, V2, P179; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Dzau VJ, 2002, NAT MED, V8, P1249, DOI 10.1038/nm1102-1249; Hui DY, 2008, CURR DRUG TARGETS, V9, P251, DOI 10.2174/138945008783755601; Kher N, 2004, SEMIN THROMB HEMOST, V30, P665, DOI 10.1055/s-2004-861509; Kocher O, 1998, LAB INVEST, V78, P117; Kocher O, 2003, J BIOL CHEM, V278, P52820, DOI 10.1074/jbc.M310482200; Kocher O, 2003, MOL CELL BIOL, V23, P1175, DOI 10.1128/MCB.23.4.1175-1180.2003; Kocher O, 2008, BBA-MOL BASIS DIS, V1782, P310, DOI 10.1016/j.bbadis.2008.02.004; Kocher O, 2009, CURR OPIN LIPIDOL, V20, P236, DOI 10.1097/MOL.0b013e32832aee82; Kumar A, 1997, ARTERIOSCL THROM VAS, V17, P2238, DOI 10.1161/01.ATV.17.10.2238; Laurent E, 2001, CANCER RES, V61, P2343; Malmberg EK, 2004, J CELL SCI, V117, P5535, DOI 10.1242/jcs.01472; Mardones P, 2003, J BIOL CHEM, V278, P7884, DOI 10.1074/jbc.M211627200; MARU Y, 1991, CELL, V67, P459, DOI 10.1016/0092-8674(91)90521-Y; Mineo C, 2003, J BIOL CHEM, V278, P9142, DOI 10.1074/jbc.M211394200; Mineo C, 2006, CIRC RES, V98, P1352, DOI 10.1161/01.RES.0000225982.01988.93; Mineo C, 2012, CURR OPIN LIPIDOL, V23, P487, DOI 10.1097/MOL.0b013e328357ba61; Nakamura T, 2005, P NATL ACAD SCI USA, V102, P13404, DOI 10.1073/pnas.0506679102; Niemeier A, 2009, ATHEROSCLEROSIS, V202, P169, DOI 10.1016/j.atherosclerosis.2008.04.018; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Resch ZT, 2006, ENDOCRINOLOGY, V147, P5634, DOI 10.1210/en.2006-0493; Schwartz R, 2007, CIRC RES, V100, P1452, DOI 10.1161/01.RES.0000267745.03488.47; Seetharam D, 2006, CIRC RES, V98, P63, DOI 10.1161/01.RES.0000199272.59432.5b; Tachibana K, 2008, FEBS LETT, V582, P3884, DOI 10.1016/j.febslet.2008.10.027; Walker G, 2007, GYNECOL ONCOL, V106, P461, DOI 10.1016/j.ygyno.2007.05.009; Yesilaltay A, 2005, CURR OPIN LIPIDOL, V16, P147, DOI 10.1097/01.mol.0000162319.54795.e5; Yesilaltay A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008103; Yuhanna IS, 2001, NAT MED, V7, P853, DOI 10.1038/89986; Zeng XY, 2003, INFECT IMMUN, V71, P1306, DOI 10.1128/IAI.71.3.1306-1315.2003; Zhu BH, 2000, AM J PATHOL, V157, P1839, DOI 10.1016/S0002-9440(10)64823-7; Zhu WF, 2008, CIRC RES, V102, P480, DOI 10.1161/CIRCRESAHA.107.159079	42	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124494	10.1371/journal.pone.0124494	http://dx.doi.org/10.1371/journal.pone.0124494			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886360	gold, Green Published, Green Submitted			2022-12-26	WOS:000353017000132
J	McCann, JC; Shigenaga, MK; Mietus-Snyder, ML; Lal, A; Suh, JH; Krauss, RM; Gildengorin, GL; Goldrich, AM; Block, DS; Shenvi, SV; McHugh, TH; Olson, DA; Ames, BN				McCann, Joyce C.; Shigenaga, Mark K.; Mietus-Snyder, Michele L.; Lal, Ashutosh; Suh, Jung H.; Krauss, Ronald M.; Gildengorin, Ginny L.; Goldrich, Alisa M.; Block, Devan S.; Shenvi, Swapna V.; McHugh, Tara H.; Olson, Don A.; Ames, Bruce N.			A multicomponent nutrient bar promotes weight loss and improves dyslipidemia and insulin resistance in the overweight/obese: chronic inflammation blunts these improvements	FASEB JOURNAL			English	Article						cardiovascular; dietary intervention; nutritional supplements; lipid particles; HDL cholesterol	C-REACTIVE PROTEIN; DENSITY-LIPOPROTEIN CHOLESTEROL; LIFE-STYLE INTERVENTION; PUBLIC-HEALTH PRACTICE; DIETARY FIBER INTAKE; BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; GUT MICROBIOTA; INTESTINAL PERMEABILITY	This study determined if twice-daily consumption of a nutrient-dense bar intended to fill gaps in Western diets, without other dietary/lifestyle requirements, favorably shifted metabolic/anthropometric indicators of dysregulation in a healthy direction. Three 8-wk clinical trials in 43 healthy lean and overweight/obese (OW/OB) adults, who served as their own controls, were pooled for analysis. In less inflamed OW/OB [high-sensitivity C-reactive protein (hsCRP) < 1.5], statistically significant decreases occurred in weight (-1.1 +/- 0.5 kg), waist circumference (-3.1 +/- 1.4 cm), diastolic blood pressure (-4.1 +/- 1.6 mmHg), heart rate [HR; -4.0 +/- 1.7 beats per minute (bpm)], triglycerides (-72 +/- 38.2 mg/dl), insulin resistance (homeostatic model of insulin resistance) (-0.72 +/- 0.3), and insulin (-2.8 +/- 1.3 mU/L); an increase in HDL-2b (+303 +/- 116 nM) and realignment of LDL lipid subfractions toward a less atherogenic profile [decreased small LDL IIIb (-44 +/- 23.5 nM), LDL IIIa (-99 +/- 43.7nM), andincreased large LDLI (+66 +/- 28.0 nM)]. In the more inflamed OW/OB (hsCRP >1.5), inflammation was reduced at 2 wk (-0.66 mg/L), and HR at 8 wk (-3.4 +/- 1.3 bpm). The large HDL subfraction (10.5-14.5 nm) increased at 8 wk (+346 +/- 126 nM). Metabolic improvements were also observed in lean participants. Thus, favorable changes in measures of cardiovascular health, insulin resistance, inflammation, and obesity were initiated within 8 wk in the OW/OB by replacing deficiencies in Western diets without requiring other dietary or lifestyle modifications; chronic inflammation blunted most improvements.	[McCann, Joyce C.; Shigenaga, Mark K.; Mietus-Snyder, Michele L.; Lal, Ashutosh; Suh, Jung H.; Krauss, Ronald M.; Gildengorin, Ginny L.; Goldrich, Alisa M.; Block, Devan S.; Shenvi, Swapna V.; Ames, Bruce N.] Childrens Hosp Oakland Res Inst, Nutr & Metab Ctr, Oakland, CA 94609 USA; [Mietus-Snyder, Michele L.] Childrens Natl Med Ctr, Washington, DC 20010 USA; [McHugh, Tara H.; Olson, Don A.] ARS, Proc Foods Res Unit, USDA, Western Reg Res Ctr, Albany, CA USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Children's National Health System; United States Department of Agriculture (USDA)	McCann, JC (corresponding author), Childrens Hosp Oakland Res Inst, Nutr & Metab Ctr, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	jmccann@chori.org; mshigenaga@chori.org		Mietus-Snyder, Michele/0000-0003-2791-9896	Children's Hospital Oakland Research Institute-Ames Foundation; S.D. Bechtel, Jr. Foundation; Quest Diagnostics	Children's Hospital Oakland Research Institute-Ames Foundation; S.D. Bechtel, Jr. Foundation; Quest Diagnostics	The authors thank Kirsten Graves for construction of the formulation table, Darryl Chow for technical assistance with the database and the serum amyloid A and adiponectin analyses, Rachelle Woods for assisting with nutrient bar sensory improvement and bar production, the staff at the Pediatric Clinical Research Center at Children's Hospital Oakland, Teresa Klask for invaluable administrative assistance, and the many volunteers who have assisted in this project over the years. R.M.K. thanks Joe Orr for conducting the lipoprotein subfraction analyses. The authors are grateful to several organizations for their generous donations of bar ingredients: Pharmachem Laboratories (Kearny, NJ, USA) for a vitamin and mineral blend; the U.S. Highbush Blueberry Council (Folsom, CA, USA) for blueberry powder; and Dow Chemical (Midland MI, USA) for hydroxypropylmethylcellulose. The authors are also grateful to Henry H. Wheeler for his generous support of their laboratory. All authors read and approved the final manuscript. This work was supported by the Children's Hospital Oakland Research Institute-Ames Foundation (to J.C.M., M.K.S., A.L., A.M.G., D.S.B., and S.V.S.), S.D. Bechtel, Jr. Foundation (to J.H.S.), and Quest Diagnostics (to R.M.K.).	Aasheim ET, 2008, AM J CLIN NUTR, V87, P362, DOI 10.1093/ajcn/87.2.362; Alhassan S, 2008, INT J OBESITY, V32, P985, DOI 10.1038/ijo.2008.8; Alpers DH, 2000, CURR OPIN GASTROEN, V16, P155, DOI 10.1097/00001574-200003000-00010; Ames BN, 2006, P NATL ACAD SCI USA, V103, P17589, DOI 10.1073/pnas.0608757103; Ames BN, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/725071; Anderson JW, 2009, NUTR REV, V67, P188, DOI 10.1111/j.1753-4887.2009.00189.x; Arts ICW, 2005, AM J CLIN NUTR, V81, p317S, DOI 10.1093/ajcn/81.1.317S; Asztalos BF, 2004, ARTERIOSCL THROM VAS, V24, P2181, DOI 10.1161/01.ATV.0000146325.93749.a8; Baker B, 2014, J BIOL CHEM, V289, P16262, DOI 10.1074/jbc.M114.569210; Basaki M, 2012, BIOL TRACE ELEM RES, V148, P161, DOI 10.1007/s12011-012-9360-6; Bashan N, 2009, PHYSIOL REV, V89, P27, DOI 10.1152/physrev.00014.2008; Beaufrere AM, 2014, J NUTR HEALTH AGING, V18, P814, DOI [10.1007/s12603-014-0554-9, 10.1007/s12603-014-0468-6]; Billington CJ, 2000, ARCH INTERN MED, V160, P898, DOI 10.1001/archinte.160.7.898; Bioletto S, 2000, AM J CLIN NUTR, V71, P443; Blackburn R, 2001, ARTERIOSCL THROM VAS, V21, P1962, DOI 10.1161/hq1201.099433; Bouchoucha M, 2011, DIABETES METAB, V37, P90, DOI 10.1016/j.diabet.2010.11.002; Bremer AA, 2012, PEDIATRICS, V129, P557, DOI 10.1542/peds.2011-2912; Brockman DA, 2014, J NUTR, V144, P1415, DOI 10.3945/jn.114.191577; Camilleri M, 2012, NEUROGASTROENT MOTIL, V24, P503, DOI 10.1111/j.1365-2982.2012.01921.x; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Carrera-Bastos P, 2011, RES REP CLIN CARDIOL, V2, P15, DOI 10.2147/RRCC.S16919; dos Santos RDC, 2010, JPEN-PARENTER ENTER, V34, P408, DOI 10.1177/0148607110362530; Caulfield MP, 2008, CLIN CHEM, V54, P1307, DOI 10.1373/clinchem.2007.100586; Chan DC, 2014, BEST PRACT RES CL EN, V28, P369, DOI 10.1016/j.beem.2013.10.001; Chen HM, 2013, AM J CLIN NUTR, V97, P1044, DOI 10.3945/ajcn.112.046607; CHRCO/CHORI, 2009, Pending U.S. Application, Patent No. [13/877,103, 13877103]; Christou GA, 2013, OBES REV, V14, P939, DOI 10.1111/obr.12064; Chuang CC, 2011, ANNU REV NUTR, V31, P155, DOI 10.1146/annurev-nutr-072610-145149; CORNELL RP, 1985, DIABETES, V34, P1253, DOI 10.2337/diabetes.34.12.1253; Del Rio D, 2013, ANTIOXID REDOX SIGN, V18, P1818, DOI 10.1089/ars.2012.4581; Desroches S, 2006, J NUTR, V136, P1005, DOI 10.1093/jn/136.4.1005; Di Daniele N, 2013, ACTA DIABETOL, V50, P409, DOI 10.1007/s00592-012-0445-7; Eamin EE, 2013, J NUTR, V143, P1872, DOI 10.3945/jn.113.179549; Erlinger TP, 2003, CIRCULATION, V108, P150, DOI 10.1161/01.CIR.0000080288.30567.86; Esmaillzadeh A, 2007, AM J CLIN NUTR, V85, P910, DOI 10.1093/ajcn/85.3.910; Esser N, 2014, DIABETES RES CLIN PR, V105, P141, DOI 10.1016/j.diabres.2014.04.006; Falcao-Pires I, 2012, DRUG DISCOV TODAY, V17, P880, DOI 10.1016/j.drudis.2012.04.007; Fernandez-Sanchez A, 2011, INT J MOL SCI, V12, P3117, DOI 10.3390/ijms12053117; Fisher-Wellman KH, 2012, TRENDS ENDOCRIN MET, V23, P142, DOI 10.1016/j.tem.2011.12.008; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Ghosh A, 2007, EUR J CLIN NUTR, V61, P412, DOI 10.1038/sj.ejcn.1602534; Ghosh A, 2007, FOOD NUTR BULL, V28, P399, DOI 10.1177/156482650702800404; Gigleux I, 2007, BRIT J NUTR, V98, P1229, DOI 10.1017/S0007114507781461; Glaros Trevor G, 2013, Front Biosci (Schol Ed), V5, P754; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Grunfeld C, 1996, J CLIN INVEST, V97, P2152, DOI 10.1172/JCI118653; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Harte AL, 2012, DIABETES CARE, V35, P375, DOI 10.2337/dc11-1593; Heaney RP, 2006, AM J CLIN NUTR, V84, P471, DOI 10.1093/ajcn/84.3.471; Hellerstein M, 2014, CURR OPIN LIPIDOL, V25, P40, DOI 10.1097/MOL.0000000000000050; Henriksen EJ, 2011, FREE RADICAL BIO MED, V51, P993, DOI 10.1016/j.freeradbiomed.2010.12.005; Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371; Hilpert KF, 2005, J NUTR, V135, P1075, DOI 10.1093/jn/135.5.1075; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Hu F, 2011, CELL SIGNAL, V23, P1528, DOI 10.1016/j.cellsig.2011.05.008; Queipo-Ortuno MI, 2012, AM J CLIN NUTR, V95, P1323, DOI 10.3945/ajcn.111.027847; Iyer A, 2010, NAT REV ENDOCRINOL, V6, P71, DOI 10.1038/nrendo.2009.264; Jin R, 2014, INT J HEPATOL, V2014, DOI 10.1155/2014/560620; Kalaria RN, 2010, NUTR REV, V68, pS74, DOI 10.1111/j.1753-4887.2010.00352.x; Kassirer JP, 1998, NEW ENGL J MED, V338, P52, DOI 10.1056/NEJM199801013380109; Kelley DS, 2007, AM J CLIN NUTR, V86, P324, DOI 10.1093/ajcn/86.2.324; Kimmons Joel E, 2006, MedGenMed, V8, P59; King VL, 2011, CURR OPIN LIPIDOL, V22, P302, DOI 10.1097/MOL.0b013e3283488c39; Kishida K, 2014, BEST PRACT RES CL EN, V28, P119, DOI 10.1016/j.beem.2013.08.006; Kong LC, 2013, AM J CLIN NUTR, V98, P1385, DOI 10.3945/ajcn.113.058099; Kranz S, 2012, ADV NUTR, V3, P47, DOI 10.3945/an.111.001362; Krauss RM, 2014, ARTERIOSCL THROM VAS, V34, P959, DOI 10.1161/ATVBAHA.114.303458; Krebs-Smith SM, 2010, J NUTR, V140, P1832, DOI 10.3945/jn.110.124826; Kris-Etherton PM, 2003, ARTERIOSCL THROM VAS, V23, pE20, DOI 10.1161/01.ATV.0000038493.65177.94; Kris-Etherton PM, 2000, AM J CLIN NUTR, V71, p179S, DOI 10.1093/ajcn/71.1.179S; Lambert JC, 2003, J PHARMACOL EXP THER, V305, P880, DOI 10.1124/jpet.102.047852; Lewis K, 2010, INFLAMM BOWEL DIS, V16, P1138, DOI 10.1002/ibd.21177; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Lim S, 2014, ATHEROSCLEROSIS, V233, P721, DOI 10.1016/j.atherosclerosis.2014.01.051; Lipina C, 2013, DIABETES, V62, P3426, DOI 10.2337/db13-0264; Ludwig DS, 2007, NEW ENGL J MED, V357, P2325, DOI 10.1056/NEJMp0706538; Maki KC, 2007, DIABETES CARE, V30, P1039, DOI 10.2337/dc06-2344; Maki KC, 2009, J CLIN LIPIDOL, V3, P159, DOI 10.1016/j.jacl.2009.04.053; Manco M, 2010, ENDOCR REV, V31, P817, DOI 10.1210/er.2009-0030; Martins D, 2008, J NATL MED ASSOC, V100, P565, DOI 10.1016/S0027-9684(15)31304-3; Matsuda M, 2014, REV ENDOCR METAB DIS, V15, P1, DOI 10.1007/s11154-013-9271-7; McCann JC, 2011, FASEB J, V25, P1793, DOI 10.1096/fj.11-180885; McCann JC, 2009, AM J CLIN NUTR, V90, P889, DOI 10.3945/ajcn.2009.27930; McNaughton SA, 2007, J NUTR, V137, P99, DOI 10.1093/jn/137.1.99; Mietus-Snyder M, 2013, J PEDIATR-US, V163, P355, DOI 10.1016/j.jpeds.2013.01.012; Mietus-Snyder ML, 2012, FASEB J, V26, P3515, DOI 10.1096/fj.11-201558; Mosenthal AC, 2002, CRIT CARE MED, V30, P396, DOI 10.1097/00003246-200202000-00022; Mosfegh A., 2009, WHAT WE EAT AM NHANE; Most J, 2014, INT J OBESITY, V38, P698, DOI 10.1038/ijo.2013.231; Munsters MJM, 2014, ANNU REV FOOD SCI T, V5, P39, DOI 10.1146/annurev-food-030212-182557; Musunuru K, 2009, ARTERIOSCL THROM VAS, V29, P1975, DOI 10.1161/ATVBAHA.109.190405; Myers GL, 2004, CIRCULATION, V110, pE545, DOI 10.1161/01.CIR.0000148980.87579.5E; Novotny D, 2012, LIPOPROTEINS - ROLE IN HEALTH AND DISEASES, P677, DOI 10.5772/47754; Ozata M, 2002, CLIN BIOCHEM, V35, P627, DOI 10.1016/S0009-9120(02)00363-6; Parikh SJ, 2004, J CLIN ENDOCR METAB, V89, P1196, DOI 10.1210/jc.2003-031398; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Peng ZL, 2015, SHOCK, V43, P327, DOI 10.1097/SHK.0000000000000297; Pereira MA, 2009, INT J ENV RES PUB HE, V6, P2568, DOI 10.3390/ijerph6102568; Pernicova I, 2014, NAT REV ENDOCRINOL, V10, P143, DOI 10.1038/nrendo.2013.256; Piya MK, 2013, J ENDOCRINOL, V216, pT1, DOI 10.1530/JOE-12-0498; Popkin BM, 2007, SCI AM, V297, P88, DOI 10.1038/scientificamerican0907-88; Qi L, 2006, DIABETES CARE, V29, P207, DOI 10.2337/diacare.29.02.06.dc05-1903; Reinehr T, 2013, NAT REV ENDOCRINOL, V9, P607, DOI 10.1038/nrendo.2013.149; Reinehr T, 2011, P NUTR SOC, V70, P494, DOI 10.1017/S0029665111000577; Ricciardiello L, 2011, NAT REV GASTRO HEPAT, V8, P592, DOI 10.1038/nrgastro.2011.149; Rosenson RS, 2013, CIRCULATION, V128, P1256, DOI 10.1161/CIRCULATIONAHA.113.000962; Sabin MA, 2007, J EVAL CLIN PRACT, V13, P364, DOI 10.1111/j.1365-2753.2006.00706.x; Sarafidis PA, 2008, FUND CLIN PHARMACOL, V22, P247, DOI 10.1111/j.1472-8206.2008.00568.x; Savage DB, 2005, HYPERTENSION, V45, P828, DOI 10.1161/01.HYP.0000163475.04421.e4; SPAETH G, 1995, EUR J SURG, V161, P513; St-Onge MP, 2009, J NUTR, V139, P680, DOI 10.3945/jn.108.098251; St-Onge MP, 2004, DIABETES CARE, V27, P2222, DOI 10.2337/diacare.27.9.2222; Steinberger J, 2003, CIRCULATION, V107, P1448, DOI 10.1161/01.CIR.0000060923.07573.F2; Stone NJ, 2014, ANN INTERN MED, V160, P339, DOI 10.7326/M14-0126; Sturniolo GC, 2002, J LAB CLIN MED, V139, P311, DOI 10.1067/mlc.2002.123624; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Swaid F, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-53; Thuy S, 2008, J NUTR, V138, P1452, DOI 10.1093/jn/138.8.1452; Toledo FGS, 2013, MOL CELL ENDOCRINOL, V379, P30, DOI 10.1016/j.mce.2013.06.018; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; U.S. Department of Agriculture; Agricultural Research Service, 2011, USDA NAT NUTR DAT ST; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; US Department of Agriculture, 2007, USDA DAT FLAV CONT S; van Diepen JA, 2013, ATHEROSCLEROSIS, V228, P306, DOI 10.1016/j.atherosclerosis.2013.02.028; van Duynhoven J, 2013, AM J CLIN NUTR, V98, p1631S, DOI 10.3945/ajcn.113.058263; Vial G, 2011, J HEPATOL, V54, P348, DOI 10.1016/j.jhep.2010.06.044; Wadden TA, 2013, INT J OBESITY, V37, pS3, DOI 10.1038/ijo.2013.90; Weiss EC, 2007, AM J PREV MED, V33, P34, DOI 10.1016/j.amepre.2007.02.040; Wijnhoven TMA, 2013, PEDIATR OBES, V8, P79, DOI 10.1111/j.2047-6310.2012.00090.x; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Wilkinson MJ, 2014, BEST PRACT RES CL EN, V28, P439, DOI 10.1016/j.beem.2014.01.006; Williams L, 2007, INT J OBESITY, V31, P978, DOI 10.1038/sj.ijo.0803550; Williams PT, 2014, ATHEROSCLEROSIS, V233, P713, DOI 10.1016/j.atherosclerosis.2014.01.034; Wu GH, 2004, WORLD J GASTROENTERO, V10, P2592, DOI 10.3748/wjg.v10.i17.2592; Yan LJ, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/137919; Yuzefovych LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054059; Zeino Z, 2010, BEST PRACT RES CL GA, V24, P133, DOI 10.1016/j.bpg.2010.02.008; Zhong W, 2010, AM J PHYSIOL-GASTR L, V298, pG625, DOI 10.1152/ajpgi.00350.2009	139	8	8	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3287	3301		10.1096/fj.15-271833	http://dx.doi.org/10.1096/fj.15-271833			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25900806	Green Submitted			2022-12-26	WOS:000358796900017
J	Chang, CL; Liou, J				Chang, Chi-Lun; Liou, Jen			Phosphatidylinositol 4,5-Bisphosphate Homeostasis Regulated by Nir2 and Nir3 Proteins at Endoplasmic Reticulum-Plasma Membrane Junctions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDIC-ACID; CELL REGULATION; PHOSPHOINOSITIDES; POOLS; GOLGI; PTDINS(4,5)P-2; TRAFFICKING; 4-PHOSPHATE; PI(4,5)P-2; MULTIPLE	Phosphatidylinositol (PI) 4,5-bisphosphate (PIP2) at the plasma membrane (PM) constitutively controls many cellular functions, and its hydrolysis via receptor stimulation governs cell signaling. The PI transfer protein Nir2 is essential for replenishing PM PIP2 following receptor-induced hydrolysis, but key mechanistic aspects of this process remain elusive. Here, we demonstrate that PI at the membrane of the endoplasmic reticulum (ER) is required for the rapid replenishment of PM PIP2 mediated by Nir2. Nir2 detects PIP2 hydrolysis and translocates to ER-PM junctions via binding to phosphatidic acid. With distinct phosphatidic acid binding abilities and PI transfer protein activities, Nir2 and its homolog Nir3 differentially regulate PIP2 homeostasis in cells during intense receptor stimulation and in the resting state, respectively. Our study reveals that Nir2 and Nir3 work in tandem to achieve different levels of feedback based on the consumption of PM PIP2 and function at ER-PM junctions to mediate nonvesicular lipid transport between the ER and the PM.	[Chang, Chi-Lun; Liou, Jen] Univ Texas SW Med Ctr Dallas, Dept Physiol, 6001 Forest Pk Rd, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Liou, J (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	jen.liou@utsouthwestern.edu	Liou, Jen/AAN-1105-2021; Chang, Chi-Lun/Z-1891-2019	Chang, Chi-Lun/0000-0003-0017-2243	Welch Foundation [I-1789]; Howard Hughes Medical Institute Graduate Grant [56006776]	Welch Foundation(The Welch Foundation); Howard Hughes Medical Institute Graduate Grant	This work was supported by Welch Foundation Grant I-1789 and by Howard Hughes Medical Institute Graduate Grant 56006776 (to the Mechanisms of Disease and Translational Science Ph.D. Track).	Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Barylko B, 2001, J BIOL CHEM, V276, P7705, DOI 10.1074/jbc.C000861200; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Carlisle FA, 2013, NEUROSCIENCE, V248, P620, DOI 10.1016/j.neuroscience.2013.06.045; Chang CL, 2013, CELL REP, V5, P813, DOI 10.1016/j.celrep.2013.09.038; Cockcroft S, 2012, CURR TOP MICROBIOL, V362, P185, DOI 10.1007/978-94-007-5025-8_9; CREBA JA, 1983, BIOCHEM J, V212, P733, DOI 10.1042/bj2120733; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dickson EJ, 2014, P NATL ACAD SCI USA, V111, pE2281, DOI 10.1073/pnas.1407133111; Edelstein A., 2010, CURR PROTOC MOL BIOL, P20, DOI [DOI 10.1002/0471142727.MB1420S92, 10.1002/0471142727.mb1420s92]; Garner K, 2012, J BIOL CHEM, V287, P32263, DOI 10.1074/jbc.M112.375840; Hammond GRV, 2014, J CELL BIOL, V205, P113, DOI 10.1083/jcb.201312072; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Hammond GRV, 2009, BIOCHEM J, V422, P23, DOI 10.1042/BJ20090428; Hilgemann D.W., 2001, SCI STKE SIGNAL TRAN, V2001, pre19; Ile KE, 2006, NAT CHEM BIOL, V2, P576, DOI 10.1038/nchembio835; Kim S, 2013, EMBO REP, V14, P891, DOI 10.1038/embor.2013.113; Kim YJ, 2011, DEV CELL, V21, P813, DOI 10.1016/j.devcel.2011.09.005; Lev S, 1999, MOL CELL BIOL, V19, P2278; Lev S, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013300; Levine T, 2004, TRENDS CELL BIOL, V14, P483, DOI 10.1016/j.tcb.2004.07.017; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Lu C, 2001, NEUROSCIENCE, V107, P35, DOI 10.1016/S0306-4522(01)00337-2; Nakatsu F, 2012, J CELL BIOL, V199, P1003, DOI 10.1083/jcb.201206095; Nasuhoglu C, 2002, AM J PHYSIOL-CELL PH, V283, pC223, DOI 10.1152/ajpcell.00486.2001; Shulga YV, 2011, CHEM REV, V111, P6186, DOI 10.1021/cr1004106; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Szentpetery Z, 2010, P NATL ACAD SCI USA, V107, P8225, DOI 10.1073/pnas.1000157107	30	74	79	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14289	14301		10.1074/jbc.M114.621375	http://dx.doi.org/10.1074/jbc.M114.621375			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25887399	Green Published, hybrid			2022-12-26	WOS:000355754600003
J	Qi, SK; Wang, ZQ; Li, PS; Wu, QH; Shi, TL; Li, JW; Wong, JM				Qi, Shankang; Wang, Zhiqiang; Li, Pishun; Wu, Qihan; Shi, Tieliu; Li, Jiwen; Wong, Jiemin			Non-germ Line Restoration of Genomic Imprinting for a Small Subset of Imprinted Genes in Ubiquitin-like PHD and RING Finger Domain-Containing 1 (Uhrf1) Null Mouse Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DE-NOVO METHYLATION; DNA METHYLATION; CONTROL REGIONS; HISTONE H3; CHROMATIN; DNMT1; EXPRESSION; H19; METHYLTRANSFERASE; TRANSCRIPTION	The underlying mechanism for the establishment and maintenance of differential DNA methylation in imprinted genes is largely unknown. Previous studies using Dnmt1 knock-out embryonic stem (ES) cells demonstrated that, although re-expression of DNMT1 restored DNA methylation in the non-imprinted regions, the methylation patterns of imprinted genes could be restored only through germ line passage. Knock-out of Uhrf1, an accessory factor essential for DNMT1-mediated DNA methylation, in mouse ES cells also led to impaired global DNA methylation and loss of genomic imprinting. Here, we demonstrate that, although re-expression of UHRF1 in Uhrf1(-/-) ES cells restored DNA methylation for the bulk genome but not for most of the imprinted genes, it did rescue DNA methylation for the imprinted H19, Nnat, and Dlk1 genes. Analysis of histone modifications at the differential methylated regions of the imprinted genes by ChIP assays revealed that for the imprinted genes whose DNA methylation could be restored upon re-expression of UHRF1, the active histone markers (especially H3K4me3) were maintained at considerably low levels, and low levels were maintained even in Uhrf1(-/-) ES cells. In contrast, for the imprinted genes whose DNA methylation could not be restored upon UHRF1 re-expression, the active histone markers (especially H3K4me3) were relatively high and became even higher in Uhrf1(-/-) ES cells. Our study thus supports a role for histone modifications in determining the establishment of imprinting-related DNA methylation and demonstrates that mouse ES cells can be a valuable model for mechanistic study of the establishment and maintenance of differential DNA methylation in imprinted genes.	[Qi, Shankang; Wang, Zhiqiang; Li, Pishun; Wu, Qihan; Shi, Tieliu; Li, Jiwen; Wong, Jiemin] E China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai 200241, Peoples R China; [Qi, Shankang; Wang, Zhiqiang; Li, Pishun; Wu, Qihan; Shi, Tieliu; Li, Jiwen; Wong, Jiemin] E China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China; [Wong, Jiemin] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Guangdong, Peoples R China	East China Normal University; East China Normal University; Sun Yat Sen University	Li, JW (corresponding author), E China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai 200241, Peoples R China.	jwli@bio.ecnu.edu.cn; jmweng@bio.ecnu.edu.cn		Wong, Jiemin/0000-0002-5311-842X	National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program" of China [2014ZX09507002-005]; Science and Technology Commission of Shanghai Municipality [14XD1401700, 11DZ2260300]; National Natural Science Foundation of China [30871381, 91219302, 81272287, 31371504]	National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program" of China; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grant 2014ZX09507002-005 from the National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program" of China; Grants 14XD1401700 and 11DZ2260300 from the Science and Technology Commission of Shanghai Municipality; and Grants 30871381, 91219302, 81272287, and 31371504 from the National Natural Science Foundation of China.	Bartolomei MS, 2009, GENE DEV, V23, P2124, DOI 10.1101/gad.1841409; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Carr MS, 2007, GENOMICS, V89, P280, DOI 10.1016/j.ygeno.2006.10.005; Choo JH, 2006, HUM MOL GENET, V15, P717, DOI 10.1093/hmg/ddi485; Ciccone DN, 2009, NATURE, V461, P415, DOI 10.1038/nature08315; Cleaton MAM, 2014, ANNU REV GENOM HUM G, V15, P93, DOI 10.1146/annurev-genom-091212-153441; Das R, 2009, MAMM GENOME, V20, P563, DOI 10.1007/s00335-009-9229-y; Delaval K, 2007, EMBO J, V26, P720, DOI 10.1038/sj.emboj.7601513; Ferguson-Smith AC, 2011, NAT REV GENET, V12, P565, DOI 10.1038/nrg3032; FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0; Ferron SR, 2011, NATURE, V475, P381, DOI 10.1038/nature10229; Fournier C, 2002, EMBO J, V21, P6560, DOI 10.1093/emboj/cdf655; Henckel A, 2012, EMBO J, V31, P606, DOI 10.1038/emboj.2011.425; Hirasawa R, 2008, GENE DEV, V22, P1607, DOI 10.1101/gad.1667008; Holm TM, 2005, CANCER CELL, V8, P275, DOI 10.1016/j.ccr.2005.09.007; Hu JL, 2009, P NATL ACAD SCI USA, V106, P22187, DOI 10.1073/pnas.0905767106; John RM, 2010, BRIEF FUNCT GENOMICS, V9, P294, DOI 10.1093/bfgp/elq010; Joseph RM, 2014, GENOMICS, V103, P183, DOI 10.1016/j.ygeno.2013.12.001; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kaneda M, 2010, GENES CELLS, V15, P169, DOI 10.1111/j.1365-2443.2009.01374.x; Kato Y, 2007, HUM MOL GENET, V16, P2272, DOI 10.1093/hmg/ddm179; Kota SK, 2010, DEV CELL, V19, P675, DOI 10.1016/j.devcel.2010.10.009; LEIGHTON PA, 1995, GENE DEV, V9, P2079, DOI 10.1101/gad.9.17.2079; Li BZ, 2011, CELL RES, V21, P1172, DOI 10.1038/cr.2011.92; Li J, 2012, J BIOL CHEM, V287, P10089, DOI 10.1074/jbc.M111.313965; Li XJ, 2008, DEV CELL, V15, P547, DOI 10.1016/j.devcel.2008.08.014; Li YF, 2011, CELL RES, V21, P466, DOI 10.1038/cr.2011.15; Liu XL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2562; McGraw S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003873; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Nakamura T, 2012, NATURE, V486, P415, DOI 10.1038/nature11093; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Plasschaert RN, 2014, DEVELOPMENT, V141, P1805, DOI 10.1242/dev.101428; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Quenneville S, 2011, MOL CELL, V44, P361, DOI 10.1016/j.molcel.2011.08.032; Sasaki H, 1995, DEVELOPMENT, V121, P4195; Sasaki H, 2000, J BIOCHEM, V127, P711, DOI 10.1093/oxfordjournals.jbchem.a022661; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Tucker KL, 1996, GENE DEV, V10, P1008, DOI 10.1101/gad.10.8.1008; Unoki M, 2004, ONCOGENE, V23, P7601, DOI 10.1038/sj.onc.1208053; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Zhang JQ, 2011, CELL RES, V21, P1723, DOI 10.1038/cr.2011.176; Zhou YX, 1997, BIOTECHNIQUES, V22, P850	44	5	6	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					14181	14191		10.1074/jbc.M114.626697	http://dx.doi.org/10.1074/jbc.M114.626697			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25900245	Green Published, hybrid			2022-12-26	WOS:000355313000045
J	Dunning, A; Ghoreyshi, A; Bertucco, M; Sanger, TD				Dunning, Amber; Ghoreyshi, Atiyeh; Bertucco, Matteo; Sanger, Terence D.			The Tuning of Human Motor Response to Risk in a Dynamic Environment Task	PLOS ONE			English	Article							STATISTICAL DECISION-THEORY; UNCERTAINTY; PERCEPTION	The role of motor uncertainty in discrete or static space tasks, such as pointing tasks, has been investigated in many experiments. These studies have shown that humans hold an internal representation of intrinsic and extrinsic motor uncertainty and compensate for this variability when planning movement. The aim of this study was to investigate how humans respond to uncertainties during movement execution in a dynamic environment despite indeterminate knowledge of the outcome of actions. Additionally, the role of errors, or lack thereof, in predicting risk was examined. In the experiment, subjects completed a driving simulation game on a two-lane road. The road contained random curves so that subjects were forced to use sensory feedback to complete the task and could not rely only on motor planning. Risk was manipulated by using horizontal perturbations to create the illusion of driving on a bumpy road, thereby imposing motor uncertainty, and altering the cost function of the road. Results suggest continual responsiveness to cost and uncertainty in a dynamic task and provide evidence that subjects avoid risk even in the absence of errors. The results suggest that humans tune their statistical motor behavior based on cost, taking into account probabilities of possible outcomes in response to environmental uncertainty.	[Dunning, Amber; Ghoreyshi, Atiyeh; Bertucco, Matteo; Sanger, Terence D.] Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA; [Sanger, Terence D.] Univ So Calif, Dept Neurol, Los Angeles, CA USA; [Sanger, Terence D.] Univ So Calif, Dept Biokinesiol, Los Angeles, CA USA; [Sanger, Terence D.] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA	University of Southern California; University of Southern California; University of Southern California; Children's Hospital Los Angeles	Dunning, A (corresponding author), Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA.	dunning@usc.edu			University of Southern California Provost Fellowship; James McDonnell Foundation; National Institutes of Neurological Disorders and Stroke [NS069214]; University of Southern California Department of Biomedical Engineering; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069214] Funding Source: NIH RePORTER	University of Southern California Provost Fellowship; James McDonnell Foundation; National Institutes of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); University of Southern California Department of Biomedical Engineering; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support for this project was provided by the University of Southern California Provost Fellowship, the James McDonnell Foundation, the National Institutes of Neurological Disorders and Stroke (NS069214), and the University of Southern California Department of Biomedical Engineering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braun DA, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00001; Faisal AA, 2009, J NEUROPHYSIOL, V101, P1901, DOI 10.1152/jn.90974.2008; Farin G, 1997, CURVES SURFACES CAGD, P33; KEELE SW, 1968, J EXP PSYCHOL, V77, P155, DOI 10.1037/h0025754; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Kording KP, 2006, TRENDS COGN SCI, V10, P319, DOI 10.1016/j.tics.2006.05.003; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Maloney L.T., 2007, INTEGRATED MODELS CO, P297, DOI [10.1093/acprof:oso/9780195189193.003.0021, DOI 10.1093/ACPROF:OSO/9780195189193.003.0021, https://doi.org/10.1093/acprof:oso/9780195189193.003.0021]; Maloney LT, 2010, VISION RES, V50, P2362, DOI 10.1016/j.visres.2010.09.031; Sanger TD, 2014, NEURAL COMPUT, V26, P2669, DOI 10.1162/NECO_a_00662; Tassinari H, 2006, J NEUROSCI, V26, P10154, DOI 10.1523/JNEUROSCI.2779-06.2006; Trommershauser J, 2005, J NEUROSCI, V25, P7169, DOI 10.1523/JNEUROSCI.1906-05.2005; Trommershauser J, 2003, SPATIAL VISION, V16, P255, DOI 10.1163/156856803322467527; Trommershauser J, 2003, J OPT SOC AM A, V20, P1419, DOI 10.1364/JOSAA.20.001419; VANGALEN GP, 1995, HUM MOVEMENT SCI, V14, P539, DOI 10.1016/0167-9457(95)00027-3; Wei KL, 2009, J NEUROPHYSIOL, V101, P655, DOI 10.1152/jn.90545.2008; Wolpert D, 2012, CURR OPIN NEUROBIOL, V22, P1, DOI [10.1016/j.conb.2012.01.004, DOI 10.1016/J.CONB.2012.01.004]; Zhang H, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00214	18	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0125461	10.1371/journal.pone.0125461	http://dx.doi.org/10.1371/journal.pone.0125461			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG5KV	25901604	Green Published, Green Submitted, gold			2022-12-26	WOS:000353331500117
J	Kang, W; Lee, DS; Jang, JH				Kang, Wonmo; Lee, Dong-Sung; Jang, Jun-Hyeog			Evaluation of Sustained BMP-2 Release Profiles Using a Novel Fluorescence-Based Retention Assay	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-2; GROWTH-FACTORS; VASCULARIZATION; SCAFFOLDS; DELIVERY	The purpose of this study was to develop and characterize a novel fluorescence-based retention assay for the evaluation of the release profile of bone morphogenetic protein-2 (BMP-2) released from bone graft carrier. In this study, we evaluated the binding, release kinetics, and delivery efficacies of BMP-2 incorporated into hydroxyapatite (HA) bone grafts. The evaluation of the release profile of BMP-2 from HA bone grafts using a fluorescence-based retention assay revealed initial burst releases from the HA bone grafts followed by long sustained releases up to 14 weeks. The sustained biological activity of the released BMP-2 from HA bone grafts over the full 14-week period supports a long sustained mechanism via fluorescence-based retention assay. Thus, the results from this study show that BMP-2 could be incorporated into HA bone grafts for sustained release over a prolonged period of time with retention of bioactivity and our fluorescence-based retention assay, which is principally detecting the retention profile of BMP-2 in HA bone grafts, is more accurate than conventionally collecting the released BMP-2 for evaluation of BMP-2 release profiles.	[Kang, Wonmo; Jang, Jun-Hyeog] Inha Univ, Sch Med, Dept Biochem, Inchon, South Korea; [Lee, Dong-Sung] Konkuk Univ, Dept Biomed Chem, Chungju, South Korea	Inha University; Konkuk University	Jang, JH (corresponding author), Inha Univ, Sch Med, Dept Biochem, Inchon, South Korea.	juhjang@inha.ac.kr			Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) [HI14C0522]; Ministry of Health & Welfare, Republic of Korea	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This research was supported by a grant of the Korea Health Technology R&D Project (HI14C0522) through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bessho K, 2000, BRIT J ORAL MAX SURG, V38, P645, DOI 10.1054/bjom.2000.0533; BOTHWELL MA, 1977, J BIOL CHEM, V252, P8532; Brekke JH, 1998, J BIOMED MATER RES, V43, P380, DOI 10.1002/(SICI)1097-4636(199824)43:4<380::AID-JBM6>3.0.CO;2-D; Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023; Draenert FG, 2013, CLIN ORAL IMPLAN RES, V24, P750, DOI 10.1111/j.1600-0501.2012.02481.x; Du P, 2014, J CONTROL RELEASE, V194, P122, DOI 10.1016/j.jconrel.2014.08.026; Fu YC, 2008, BIOTECHNOL BIOENG, V99, P996, DOI 10.1002/bit.21648; Garcia P, 2012, J BONE JOINT SURG AM, V94A, P49, DOI 10.2106/JBJS.J.00795; Hanseler P, 2014, J BIOMED MATER RES A, V2014, P35211; Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24; Jeon O, 2008, BIOCHEM BIOPH RES CO, V369, P774, DOI 10.1016/j.bbrc.2008.02.099; Jones AL, 2006, J BONE JOINT SURG AM, V88A, P1431, DOI 10.2106/JBJS.E.00381; Kim JE, 2012, J BIOMED MATER RES A, V100A, P1488, DOI 10.1002/jbm.a.34089; Knaack S, 2014, J BIOMED MATER RES A, V102, P3500, DOI 10.1002/jbm.a.35020; Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032, DOI 10.2106/00004623-200206000-00022; Matsumoto T, 2004, BIOMATERIALS, V25, P3807, DOI 10.1016/j.biomaterials.2003.10.081; Poldervaart MT, 2014, J CONTROL RELEASE, V184, P58, DOI 10.1016/j.jconrel.2014.04.007; Seeherman H, 2005, CYTOKINE GROWTH F R, V16, P329, DOI 10.1016/j.cytogfr.2005.05.001; SMITH JC, 1982, NATURE, V296, P154, DOI 10.1038/296154a0; Tampieri A, 2005, ANAL BIOANAL CHEM, V381, P568, DOI 10.1007/s00216-004-2943-0	20	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123402	10.1371/journal.pone.0123402	http://dx.doi.org/10.1371/journal.pone.0123402			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901352	Green Submitted, Green Published, gold			2022-12-26	WOS:000353331500052
J	Liu, YF; Sowell, SM; Luo, Y; Chaubey, A; Cameron, RS; Kim, HG; Srivastava, AK				Liu, Ying F.; Sowell, Sarah M.; Luo, Yue; Chaubey, Alka; Cameron, Richard S.; Kim, Hyung-Goo; Srivastava, Anand K.			Autism and Intellectual Disability-Associated KIRREL3 Interacts with Neuronal Proteins MAP1B and MYO16 with Potential Roles in Neurodevelopment	PLOS ONE			English	Article							CELL-ADHESION; SPECTRUM DISORDERS; GENES; BRAIN; CASK; PHENOTYPE; DELETION; MICE; SYNAPTOGENESIS; EXPRESSION	Cell-adhesion molecules of the immunoglobulin superfamily play critical roles in brain development, as well as in maintaining synaptic plasticity, the dysfunction of which is known to cause cognitive impairment. Recently dysfunction of KIRREL3, a synaptic molecule of the immunoglobulin superfamily, has been implicated in several neurodevelopmental conditions including intellectual disability, autism spectrum disorder, and in the neurocognitive delay associated with Jacobsen syndrome. However, the molecular mechanisms of its physiological actions remain largely unknown. Using a yeast two-hybrid screen, we found that the KIRREL3 extracellular domain interacts with brain expressed proteins MAP1B and MYO16 and its intracellular domain can potentially interact with ATP1B1, UFC1, and SHMT2. The interactions were confirmed by co-immunoprecipitation and colocalization analyses of proteins expressed in human embryonic kidney cells, mouse neuronal cells, and rat primary neuronal cells. Furthermore, we show KIRREL3 colocalization with the marker for the Golgi apparatus and synaptic vesicles. Previously, we have shown that KIRREL3 interacts with the X-linked intellectual disability associated synaptic scaffolding protein CASK through its cytoplasmic domain. In addition, we found a genomic deletion encompassing MAP1B in one patient with intellectual disability, microcephaly and seizures and deletions encompassing MYO16 in two unrelated patients with intellectual disability, autism and microcephaly. MAP1B has been previously implicated in synaptogenesis and is involved in the development of the actin-based membrane skeleton. MYO16 is expressed in hippocampal neurons and also indirectly affects actin cytoskeleton through its interaction with WAVE1 complex. We speculate KIRREL3 interacting proteins are potential candidates for intellectual disability and autism spectrum disorder. Moreover, our findings provide further insight into understanding the molecular mechanisms underlying the physiological action of KIRREL3 and its role in neurodevelopment.	[Liu, Ying F.; Sowell, Sarah M.; Luo, Yue; Chaubey, Alka; Srivastava, Anand K.] Greenwood Genet Ctr, JC Self Res Inst Human Genet, Greenwood, SC 29646 USA; [Srivastava, Anand K.] Clemson Univ, Dept Genet & Biochem, Clemson, SC USA; [Cameron, Richard S.] Georgia Regents Univ, Dept Med, Augusta, GA USA; [Kim, Hyung-Goo] Georgia Regents Univ, Dept OB GYN, Inst Mol Med & Genet, Augusta, GA USA	Greenwood Genetic Center; Clemson University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Srivastava, AK (corresponding author), Greenwood Genet Ctr, JC Self Res Inst Human Genet, Greenwood, SC 29646 USA.	anand@ggc.org			Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01-HD039331]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD039331] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01-HD039331 to A.K.S.).	Atasoy D, 2007, P NATL ACAD SCI USA, V104, P2525, DOI 10.1073/pnas.0611003104; Betancur C, 2009, TRENDS NEUROSCI, V32, P402, DOI 10.1016/j.tins.2009.04.003; Bhalla K, 2008, AM J HUM GENET, V83, P703, DOI 10.1016/j.ajhg.2008.10.020; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Chao DL, 2008, MOL CELL NEUROSCI, V39, P248, DOI 10.1016/j.mcn.2008.07.001; Chattopadhyaya B, 2013, J NEUROSCI, V33, P5957, DOI 10.1523/JNEUROSCI.1306-12.2013; Cheng Y, 2013, HUM MOL GENET, V22, P2960, DOI 10.1093/hmg/ddt150; Chia PH, 2014, CELL, V156, P208, DOI 10.1016/j.cell.2013.12.009; Ching MSL, 2010, AM J MED GENET B, V153B, P937, DOI 10.1002/ajmg.b.31063; Cordelieres FP, 2014, METHOD CELL BIOL, V123, P395, DOI [10.1016/B978-0-12.420138-5.00021-S, 10.1016/B978-0-12-420138-5.00021-5]; Ding JQ, 2002, J CELL BIOL, V158, P427, DOI 10.1083/jcb.200202055; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Friedman JM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-526; Froyen G, 2007, HUM MUTAT, V28, P1034, DOI 10.1002/humu.20564; Gerke P, 2006, J COMP NEUROL, V498, P466, DOI 10.1002/cne.21064; Guerin A, 2012, AM J MED GENET A, V158A, P2551, DOI 10.1002/ajmg.a.35621; Henriquez DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053123; Homrich M, 2014, EXP CELL RES, V324, P192, DOI 10.1016/j.yexcr.2014.04.003; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Johar K, 2014, EUR J NEUROSCI, V39, P566, DOI 10.1111/ejn.12415; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Lee GY, 2014, CANCER RES, V74, P3114, DOI 10.1158/0008-5472.CAN-13-2683; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Najm J, 2008, NAT GENET, V40, P1065, DOI 10.1038/ng.194; Nakayama M, 2002, GENOME RES, V12, P1773, DOI 10.1101/gr.406902; Opal P, 2003, J BIOL CHEM, V278, P34691, DOI 10.1074/jbc.M302785200; Pangratz-Fuehrer S, 2005, BEHAV BRAIN RES, V164, P188, DOI 10.1016/j.bbr.2005.06.018; Patel KG, 2001, J NEUROSCI, V21, P7954; Piluso G, 2009, AM J HUM GENET, V84, P162, DOI 10.1016/j.ajhg.2008.12.018; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Srivastava AK, 2014, NEUROSCI BIOBEHAV R, V46, P161, DOI 10.1016/j.neubiorev.2014.02.015; Sun JY, 2014, J ALZHEIMERS DIS, V41, P1039, DOI 10.3233/JAD-140054; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Tamura S, 2005, NEUROSCIENCE, V133, P615, DOI 10.1016/j.neuroscience.2005.03.030; Tucker T, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-25; Vieira GH, 2012, EUR J HUM GENET, V20, P148, DOI 10.1038/ejhg.2011.167; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Yao AY, 2011, HUM MOL GENET, V20, P51, DOI 10.1093/hmg/ddq431; Yokoyama K, 2011, EMBO J, V30, P4739, DOI 10.1038/emboj.2011.348; Zervas M, 2005, J NEUROSCI RES, V82, P83, DOI 10.1002/jnr.20624	40	23	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123106	10.1371/journal.pone.0123106	http://dx.doi.org/10.1371/journal.pone.0123106			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902260	Green Submitted, gold, Green Published			2022-12-26	WOS:000353331500042
J	Zhang, M; Fu, GZ; Lei, T				Zhang, Man; Fu, Guangzhen; Lei, Ting			Two Urinary Peptides Associated Closely With Type 2 Diabetes Mellitus	PLOS ONE			English	Article							MASS-SPECTROMETRY; OXIDANT STRESS; RISK FACTOR; BIOMARKERS; ACTIVATION; FIBRINOGEN; ELECTROPHORESIS; IDENTIFICATION; NEPHROPATHY; PROGRESSION	Objective To monitor of type 2 diabetes more simply, conveniently and noninvasively, we are trying to identify the potential urinary peptides that associated with different stages of glucose control in type 2 diabetes mellitus. Methods Firstly, we collected urine samples from type 2 diabetic patients and normal controls. These type 2 diabetic patients were divided into two groups according to fasting plasma glucose (FPG) and hemoglobin A1c% (HbA1c), respectively. Magnetic beads based weak cation exchange chromatography (MB-WCX) was used to condense urinary peptides. The eluates were then analyzed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS). Subsequently, ClinProt was used to profile and screen the polypeptide patterns based on different methods of grouping in diabetic patients and normal controls. Finally, the amino acid sequences of differentially expressed peptides were identified by nano-liquid chromatography-tandem mass spectrometry and the protein sources of the corresponding peptide were matched in IPI Human database. Results Proteomics analysis found two up-regulated peptide (m/z 2756.1 and m/z 3223.2) representations in diabetic subjects, and the two peptides increased with increases in the amount of glycosylated hemoglobin. Further, the parallelism between m/z 3223.2 and glycosylated hemoglobin was better than the parallelism between m/z 2756.1 and glycosylated hemoglobin. Area under the receiver operating characteristic of the two peptides was 0.722 and 0.661, respectively. The above-mentioned peptide m/z 2756.1 was further identified as fragment of fibrinogen alpha chain precursor and m/z 3223.2 was fragment of prothrombin precusor. Conclusion These results suggested the two urinary biomarkers enable monitor of type 2 diabetes patients with different stages of glucose control.	[Zhang, Man; Fu, Guangzhen; Lei, Ting] Peking Univ, Dept Clin Lab, Sch Clin Med 9, Beijing Shijitan Hosp, Beijing 100871, Peoples R China; [Zhang, Man; Lei, Ting] Capital Med Univ, Beijing Shijitan Hosp, Dept Clin Lab, Beijing, Peoples R China	Peking University; Capital Medical University	Zhang, M (corresponding author), Peking Univ, Dept Clin Lab, Sch Clin Med 9, Beijing Shijitan Hosp, Beijing 100871, Peoples R China.	mzhang99@aliyun.com			Capital Health Research and Development of Special [2011-2008-02]; National Key Technology RD Program [2013BAI12B01-4]	Capital Health Research and Development of Special; National Key Technology RD Program(National Key Technology R&D Program)	The authors' sources of funding that supported the work were Capital Health Research and Development of Special (2011-2008-02) and National Key Technology R&D Program (No. 2013BAI12B01-4). Man Zhang received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carr ME, 2001, J DIABETES COMPLICAT, V15, P44, DOI 10.1016/S1056-8727(00)00132-X; CERIELLO A, 1994, THROMB HAEMOSTASIS, V71, P593; Chu L, 2013, DIABETES RES CLIN PR, V101, P187, DOI 10.1016/j.diabres.2013.05.004; Decramer S, 2008, MOL CELL PROTEOMICS, V7, P1850, DOI 10.1074/mcp.R800001-MCP200; Forsblom CM, 1998, DIABETES CARE, V21, P1932, DOI 10.2337/diacare.21.11.1932; Goodwill AG, 2012, VASC PHARMACOL, V57, P150, DOI 10.1016/j.vph.2012.07.002; IDF. Task Force, 2005, GLOB GUID TYP 2 DIAB, P1; Khechai F, 1997, ARTERIOSCL THROM VAS, V17, P2885, DOI 10.1161/01.ATV.17.11.2885; Kolch W, 2005, MASS SPECTROM REV, V24, P959, DOI 10.1002/mas.20051; Lapolla A, 2005, CLIN CHIM ACTA, V357, P236, DOI 10.1016/j.cccn.2005.03.032; Lei T, 2013, CLIN GENITOURIN CANC, V11, P56, DOI 10.1016/j.clgc.2012.06.003; Matheson A, 2010, DIABETES-METAB RES, V26, P150, DOI 10.1002/dmrr.1068; Omenn GS, 2005, PROTEOMICS, V5, P3226, DOI 10.1002/pmic.200500358; Overgaard AJ, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-4; Padrao AI, 2012, PROTEOM CLIN APPL, V6, P447, DOI 10.1002/prca.201200044; Rao AK, 1999, DIABETES, V48, P1156, DOI 10.2337/diabetes.48.5.1156; Rao PV, 2007, DIABETES CARE, V30, P629, DOI 10.2337/dc06-2056; Rossing K, 2004, KIDNEY INT, V66, P1596, DOI 10.1111/j.1523-1755.2004.00925.x; SCHAFER AI, 1985, ANN INTERN MED, V102, P814, DOI 10.7326/0003-4819-102-6-814; Schaffer SW, 2012, VASC PHARMACOL, V57, P139, DOI 10.1016/j.vph.2012.03.005; Shechter M, 2000, J AM COLL CARDIOL, V35, P300, DOI 10.1016/S0735-1097(99)00545-8; Tilton RG, 2007, PROTEOMICS, V7, P1729, DOI 10.1002/pmic.200700017; Waugh N, 2007, HEALTH TECHNOL ASSES, V11, P1; WILHELMSEN L, 1984, NEW ENGL J MED, V311, P501, DOI 10.1056/NEJM198408233110804; YARNELL JWG, 1991, CIRCULATION, V83, P836, DOI 10.1161/01.CIR.83.3.836	25	14	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0122950	10.1371/journal.pone.0122950	http://dx.doi.org/10.1371/journal.pone.0122950			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902048	Green Published, Green Submitted, gold			2022-12-26	WOS:000353331500032
J	Villalobos-Sambucaro, MJ; Lorenzo-Figueiras, AN; Riccillo, FL; Diambra, LA; Noriega, FG; Ronderos, JR				Jose Villalobos-Sambucaro, Maria; Nieves Lorenzo-Figueiras, Alicia; Luis Riccillo, Fernando; Anibal Diambra, Luis; Gabriel Noriega, Fernando; Rafael Ronderos, Jorge			Allatotropin Modulates Myostimulatory and Cardioacceleratory Activities in Rhodnius prolixus (Stal)	PLOS ONE			English	Article							FUNCTIONAL-CHARACTERIZATION; HOST IMMUNOGLOBULIN; MALPIGHIAN TUBULES; DORSAL VESSEL; HEART-RATE; HEMOLYMPH; PEPTIDE; INSECT; SEROTONIN; RECEPTOR	Haematophagous insects can ingest large quantities of blood in a single meal and eliminate high volumes of urine in the next few hours. This rise in diuresis is possible because the excretory activity of the Malpighian tubules is facilitated by an increase in haemolymph circulation as a result of intensification of aorta contractions combined with an increase of the anterior midgut peristaltic waves. It has been previously described that haemolymph circulation during post-prandial diuresis is stimulated by the synergistic activity of allatotropin (AT) and serotonin in the kissing bug Triatoma infestans; resulting in an increase in aorta contractions. In the same species, AT stimulates anterior midgut and rectum muscle contractions to mix urine and feces and facilitate the voiding of the rectum. Furthermore, levels of AT in midgut and Malpighian tubules increased in the afternoon when insects are getting ready for nocturnal feeding. In the present study we describe the synergistic effect of AT and serotonin increasing the frequency of contractions of the aorta in Rhodnius prolixus. The basal frequency of contractions of the aorta in the afternoon is higher that the observed during the morning, suggesting the existence of a daily rhythmic activity. The AT receptor is expressed in the rectum, midgut and dorsal vessel, three critical organs involved in postprandial diuresis. All together these findings provide evidence that AT plays a role as a myoregulatory and cardioacceleratory peptide in Rhodnius prolixus.	[Jose Villalobos-Sambucaro, Maria; Luis Riccillo, Fernando; Rafael Ronderos, Jorge] FCNyM UNLP, Catedra Histol & Embriol Anim, La Plata, Buenos Aires, Argentina; [Jose Villalobos-Sambucaro, Maria; Luis Riccillo, Fernando; Anibal Diambra, Luis; Rafael Ronderos, Jorge] Ctr Reg Estudios Genom CREG UNLP, La Plata, Buenos Aires, Argentina; [Gabriel Noriega, Fernando] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [Nieves Lorenzo-Figueiras, Alicia] FCEyN UBA, IBBEA, Dept Biodiversidad & Biol Expt, Buenos Aires, DF, Argentina	National University of La Plata; State University System of Florida; Florida International University; University of Buenos Aires	Ronderos, JR (corresponding author), FCNyM UNLP, Catedra Histol & Embriol Anim, La Plata, Buenos Aires, Argentina.	jrondero@museo.fcnym.unlp.edu.ar	L, Diambra/F-6319-2015	L, Diambra/0000-0001-8052-4880; Villalobos-Sambucaro, Maria Jose/0000-0001-9815-7185	Universidad Nacional de La Plata [N559, N673]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045545] Funding Source: NIH RePORTER	Universidad Nacional de La Plata(National University of La Plata); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by Universidad Nacional de La Plata N559 and N673 to JRR.	ALLINGHAM PG, 1992, J INSECT PHYSIOL, V38, P9, DOI 10.1016/0022-1910(92)90017-8; BENYAKIR D, 1989, J MED ENTOMOL, V26, P243, DOI 10.1093/jmedent/26.4.243; BUXTON P. A., 1930, TRANS ENT SOC LONDON, V78, P227; CHIANG RG, 1990, J MORPHOL, V204, P9, DOI 10.1002/jmor.1052040103; CHIANG RG, 1992, EXPERIENTIA, V48, P1122, DOI 10.1007/BF01948003; Dasari S, 2006, J COMP PHYSIOL B, V176, P349, DOI 10.1007/s00360-005-0058-3; Duve H, 1999, J COMP NEUROL, V413, P405, DOI 10.1002/(SICI)1096-9861(19991025)413:3&lt;405::AID-CNE4&gt;3.0.CO;2-R; Duve H, 2000, CELL TISSUE RES, V300, P153, DOI 10.1007/s004410050056; Alzugaray ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077520; Gerould JH, 1933, BIOL BULL-US, V64, P424, DOI 10.2307/1537208; Glenn JD, 2010, J EXP BIOL, V213, P541, DOI 10.1242/jeb.035014; Hernandez-Martinez S, 2005, CELL TISSUE RES, V321, P105, DOI 10.1007/s00441-005-1133-5; Horodyski FM, 2011, INSECT BIOCHEM MOLEC, V41, P804, DOI 10.1016/j.ibmb.2011.06.002; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; KATAOKA H, 1989, SCIENCE, V243, P1481, DOI 10.1126/science.243.4897.1481; Koladich PM, 2002, PEPTIDES, V23, P645, DOI 10.1016/S0196-9781(01)00658-1; Kumari A, 2009, J VECTOR DIS, V46, P255; League GP, 2015, J EXP BIOL, V218, P370, DOI 10.1242/jeb.114942; MADDRELL SH, 1964, J EXP BIOL, V41, P163; MADDRELL SHP, 1978, J EXP BIOL, V75, P133; MADDRELL SHP, 1991, J EXP BIOL, V156, P557; MADDRELL SHP, 1975, J EXP BIOL, V62, P671; Masood M, 2014, PEPTIDES, V53, P159, DOI 10.1016/j.peptides.2013.10.017; Matsushita T, 2002, COMP BIOCHEM PHYS A, V133, P625, DOI 10.1016/S1095-6433(02)00154-X; Nichols R, 2006, PEPTIDES, V27, P1130, DOI 10.1016/j.peptides.2005.07.032; Nouzova M, 2012, PEPTIDES, V34, P201, DOI 10.1016/j.peptides.2011.07.025; NUNEZ JA, 1990, J APPL ENTOMOL, V109, P87, DOI 10.1111/j.1439-0418.1990.tb00023.x; O'Donnell MJ, 2003, BBA-BIOMEMBRANES, V1618, P194, DOI 10.1016/j.bbamem.2003.07.003; Orchard I, 2006, COMP BIOCHEM PHYS A, V144, P316, DOI 10.1016/j.cbpa.2005.11.010; RAMSAY JA, 1952, J EXP BIOL, V29, P110; Riccillo FL, 2010, TISSUE CELL, V42, P355, DOI 10.1016/j.tice.2010.07.011; Rudwall AJ, 2000, J COMP NEUROL, V428, P159, DOI 10.1002/1096-9861(20001204)428:1<159::AID-CNE11>3.0.CO;2-Y; Santini MS, 2007, J EXP BIOL, V210, P1986, DOI 10.1242/jeb.004291; Santini MS, 2009, GEN COMP ENDOCR, V160, P243, DOI 10.1016/j.ygcen.2008.12.002; Santini MS, 2009, BIOL RHYTHM RES, V40, P299, DOI 10.1080/09291010802214583; Steel CGH, 2006, COMP BIOCHEM PHYS A, V144, P351, DOI 10.1016/j.cbpa.2006.02.018; Sterkel M, 2010, COMP BIOCHEM PHYS A, V155, P371, DOI 10.1016/j.cbpa.2009.12.002; Vafopoulou X, 2010, J COMP NEUROL, V518, P1264, DOI 10.1002/cne.22274; VEENSTRA JA, 1994, J EXP BIOL, V188, P347; Voisin T, 2003, CELL MOL LIFE SCI, V60, P72, DOI 10.1007/s000180300005; Vuerinckx K, 2011, INSECT BIOCHEM MOLEC, V41, P815, DOI 10.1016/j.ibmb.2011.06.003; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033	42	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124131	10.1371/journal.pone.0124131	http://dx.doi.org/10.1371/journal.pone.0124131			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897783	Green Published, gold, Green Submitted			2022-12-26	WOS:000353212600050
J	Zhu, XY; He, XY; Wang, W; Zhou, QY; Yu, Z; Dai, Y; Zhu, XF; Yan, QF				Zhu, Xiaoyu; He, Xiangyu; Wang, Wei; Zhou, Qiyin; Yu, Zhe; Dai, Yu; Zhu, Xufen; Yan, Qingfeng			MTO1 Worked as a Modifier in the Aminoglycosides Sensitivity of Yeast Carrying a Mitochondrial 15S rRNA C1477G Mutation	PLOS ONE			English	Article							A1555G MUTATION; PROTEINS MNME; DEAFNESS; GENE; EXPRESSION; PATHOGENESIS; GIDA	MTO1, together with MSS1 and MTO2, is a gene involved in the pathway of encoding a mitochondria- specific RNA-modifying enzyme related to the post-transcriptional modification of mitochondrial tRNAs. We have previously shown that a mutation of the MTO2 or MSS1 gene can suppress the neomycin-sensitive phenotype of yeast carrying a mitochondrial 15S rRNA C1477G mutation. Here we report that a null mutation of MTO1 also can inhibit the aminoglycoside-sensitivity of yeast carrying mitochondrial 15S rRNA C1477G mutation. The C1477G mutation corresponds to the human 12S rRNA A1555G mutation. Yeast with an mtDNA C1477G mutation exhibits hypersensitivity to neomycin and displays mitochondrial function impairment beyond neomycin treatment. When the mto1 null mutation and mitochondrial C1477G mutation coexist, the yeast strain shows growth recovery. The deletion of the nuclear gene MTO1 regulates neomycin sensitivity in yeast carrying the mitochondrial 15S rRNA C1477G mutation. MTO1 deletion causes the expression levels of the key glycolytic genes HXK2, PFK1 and PYK1 to become significantly up-regulated. The energy deficit due to impaired mitochondrial function was partially compensated by the energy generated by glycolysis. Being in the same pathway, the regulation of MTO1, MSS1 and MTO2 to the neomycin-sensitivity of yeast showed difference in the growth activity of strains, mitochondrial function and the expression level of glycolytic genes.	[Zhu, Xiaoyu; He, Xiangyu; Wang, Wei; Zhou, Qiyin; Yu, Zhe; Dai, Yu; Zhu, Xufen; Yan, Qingfeng] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Zhu, XF (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.	xufenzhu@zju.edu.cn; qfyan@zju.edu.cn	yan, qing/GZN-2287-2022	Yu, Zhe/0000-0002-6908-6135	National Basic Research Program of China [2014CB943001, 2012CB966804]; National Natural Science Foundation of China [30971599]; Natural Science Foundation of Zhejiang Province [LY14C060004]; Program for New Century Excellent Talents in University [NCET-06-0526]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by National Basic Research Program of China (2014CB943001, 2012CB966804), National Natural Science Foundation of China (30971599), Natural Science Foundation of Zhejiang Province (LY14C060004), Program for New Century Excellent Talents in University (NCET-06-0526). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bykhovskaya Y, 2004, MOL GENET METAB, V83, P199, DOI 10.1016/j.ymgme.2004.07.009; Cantara WA, 2011, NUCLEIC ACIDS RES, V39, pD195, DOI 10.1093/nar/gkq1028; Colby G, 1998, J BIOL CHEM, V273, P27945, DOI 10.1074/jbc.273.43.27945; DECOSTER E, 1993, J MOL BIOL, V232, P79, DOI 10.1006/jmbi.1993.1371; Estivill X, 1998, AM J HUM GENET, V62, P27, DOI 10.1086/301676; Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011; Guan MX, 2011, MITOCHONDRION, V11, P237, DOI 10.1016/j.mito.2010.10.006; He XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081490; Kim TW, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-502; Li RH, 2003, BBA-GENE STRUCT EXPR, V1629, P53, DOI 10.1016/S0167-4781(03)00160-X; Li XM, 2002, MOL CELL BIOL, V22, P7701, DOI 10.1128/MCB.22.21.7701-7711.2002; Li XM, 2002, J BIOL CHEM, V277, P27256, DOI 10.1074/jbc.M203267200; Meyer S, 2009, J MOL BIOL, V392, P910, DOI 10.1016/j.jmb.2009.07.004; Moukadiri I, 2009, NUCLEIC ACIDS RES, V37, P7177, DOI 10.1093/nar/gkp762; Qian YP, 2009, ANTIMICROB AGENTS CH, V53, P4612, DOI 10.1128/AAC.00965-08; Ryu DH, 2001, BIOORGAN MED CHEM, V9, P2601; Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531; Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200; Vicens Q, 2001, STRUCTURE, V9, P647, DOI 10.1016/S0969-2126(01)00629-3; Wang XJ, 2007, FEBS LETT, V581, P4228, DOI 10.1016/j.febslet.2007.07.067; Wang XJ, 2010, J MOL BIOL, V395, P1038, DOI 10.1016/j.jmb.2009.12.002; Wang XJ, 2009, MITOCHONDRION, V9, P180, DOI 10.1016/j.mito.2009.01.010; Yan QF, 2005, J BIOL CHEM, V280, P29151, DOI 10.1074/jbc.M504247200; Yim L, 2006, NUCLEIC ACIDS RES, V34, P5892, DOI 10.1093/nar/gkl752; Zhao H, 2004, AM J HUM GENET, V74, P139, DOI 10.1086/381133; Zhou QY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090336	26	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124200	10.1371/journal.pone.0124200	http://dx.doi.org/10.1371/journal.pone.0124200			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898254	Green Published, gold, Green Submitted			2022-12-26	WOS:000353212600056
J	Counts, CJ; Ho, PS; Donlin, MJ; Tavis, JE; Chen, CP				Counts, Christopher J.; Ho, P. Shing; Donlin, Maureen J.; Tavis, John E.; Chen, Chaoping			A Functional Interplay between Human Immunodeficiency Virus Type 1 Protease Residues 77 and 93 Involved in Differential Regulation of Precursor Autoprocessing and Mature Protease Activity	PLOS ONE			English	Article							HIV-1 PROTEASE; TRANSFRAME PROTEIN; DRUG-RESISTANCE; REVERSE-TRANSCRIPTASE; COORDINATED EVOLUTION; CORRELATED MUTATIONS; GAGPOL PRECURSOR; SUBTYPES B; P RNA; INHIBITION	HIV-1 protease (PR) is a viral enzyme vital to the production of infectious virions. It is initially synthesized as part of the Gag-Pol polyprotein precursor in the infected cell. The free mature PR is liberated as a result of precursor autoprocessing upon virion release. We previously described a model system to examine autoprocessing in transfected mammalian cells. Here, we report that a covariance analysis of miniprecursor (p6*-PR) sequences derived from drug naive patients identified a series of amino acid pairs that vary together across independent viral isolates. These covariance pairs were used to build the first topology map of the miniprecursor that suggests high levels of interaction between the p6* peptide and the mature PR. Additionally, several PR-PR covariance pairs are located far from each other (> 12 angstrom C alpha to C alpha) relative to their positions in the mature PR structure. Biochemical characterization of one such covariance pair (77-93) revealed that each residue shows distinct preference for one of three alkyl amino acids (V, I, and L) and that a polar or charged amino acid at either of these two positions abolishes precursor autoprocessing. The most commonly observed 77V is preferred by the most commonly observed 93I, but the 77I variant is preferred by other 93 variances (L, V, or M) in supporting precursor autoprocessing. Furthermore, the 77I93V covariant enhanced precursor autoprocessing and Gag polyprotein processing but decreased the mature PR activity. Therefore, both covariance and biochemical analyses support a functional association between residues 77 and 93, which are spatially distant from each other in the mature PR structure. Our data also suggests that these covariance pairs differentially regulate precursor autoprocessing and the mature protease activity.	[Counts, Christopher J.; Ho, P. Shing; Chen, Chaoping] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Donlin, Maureen J.; Tavis, John E.] St Louis Univ, Dept Mol Microbiol & Immunol, Sch Med, St Louis, MO 63103 USA; [Donlin, Maureen J.] St Louis Univ, Dept Biochem & Mol Biol, Sch Med, St Louis, MO 63103 USA; [Donlin, Maureen J.; Tavis, John E.] St Louis Univ, Ctr Liver, Sch Med, St Louis, MO 63103 USA	Colorado State University; Saint Louis University; Saint Louis University; Saint Louis University	Chen, CP (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA.	Chaoping.Chen@colostate.edu	Donlin, Maureen J./M-4709-2019; Ho, Pui/AAF-8838-2020; Ho, Pui S/F-6186-2014	Ho, Pui/0000-0002-8082-4311; Ho, Pui S/0000-0002-8082-4311; Counts, Christopher/0000-0002-6524-4263; Donlin, Maureen/0000-0001-7312-079X; Chen, Chaoping/0000-0001-9387-6252	NIH NIAID [R21A1080351, R03AI108392-01A1]; NIH [CA126807]; NSF [CHE-1152494]; Colorado State University Libraries Open Access Research and Scholarship Fund; NATIONAL CANCER INSTITUTE [R01CA126807] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI108392] Funding Source: NIH RePORTER	NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Colorado State University Libraries Open Access Research and Scholarship Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was in part supported by NIH NIAID R21A1080351 and R03AI108392-01A1 to CC, by NIH CA126807 to MJD and JET, and NSF CHE-1152494 to PSH. Authors acknowledge the Colorado State University Libraries Open Access Research and Scholarship Fund for covering the publication cost. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agniswamy J, 2012, BIOCHEMISTRY-US, V51, P1041, DOI 10.1021/bi201809s; Aurora R, 2009, J CLIN INVEST, V119, P225, DOI 10.1172/JCI37085; Brown JW, 1996, P NATL ACAD SCI USA, V93, P3001, DOI 10.1073/pnas.93.7.3001; Campo DS, 2008, P NATL ACAD SCI USA, V105, P9685, DOI 10.1073/pnas.0801774105; Chang MW, 2011, J MOL BIOL, V410, P756, DOI 10.1016/j.jmb.2011.03.038; Chen CP, 2003, J VIROL, V77, P10280, DOI 10.1128/JVI.77.19.10280-10287.2003; Cherry E, 1998, J MOL BIOL, V284, P43, DOI 10.1006/jmbi.1998.1968; Dautin N, 2003, J VIROL, V77, P8216, DOI 10.1128/JVI.77.15.8216-8226.2003; Davis DA, 2012, ANTIMICROB AGENTS CH, V56, P3620, DOI 10.1128/AAC.00055-12; Donlin MJ, 2012, J VIROL, V86, P3050, DOI 10.1128/JVI.06857-11; Dumans AT, 2009, INFECT GENET EVOL, V9, P62, DOI 10.1016/j.meegid.2008.10.002; Dvali N, 2012, J MED VIROL, V84, P1002, DOI 10.1002/jmv.23269; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eyal E, 2007, PROTEINS, V67, P142, DOI 10.1002/prot.21223; Fabrini R, 2009, BIOCHEMISTRY-US, V48, P10473, DOI 10.1021/bi901238t; Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1; Ghosh AK, 2007, BIOORG MED CHEM; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Harris JK, 2001, RNA, V7, P220, DOI 10.1017/S1355838201001777; Heaslet H, 2006, J MOL BIOL, V356, P967, DOI 10.1016/j.jmb.2005.11.094; Huang LQ, 2013, FUTURE MED CHEM, V5, P1215, DOI 10.4155/fmc.13.89; Huang LQ, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-79; Huang LQ, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-27; Huang LQ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-24; Huang LQ, 2009, J VIROL, V83, P7789, DOI 10.1128/JVI.00473-09; HUANG MJ, 1995, J VIROL, V69, P6810, DOI 10.1128/JVI.69.11.6810-6818.1995; KAPLAN AH, 1993, J VIROL, V67, P4050, DOI 10.1128/JVI.67.7.4050-4055.1993; KARACOSTAS V, 1993, VIROLOGY, V193, P661, DOI 10.1006/viro.1993.1174; Koh Y, 2003, ANTIMICROB AGENTS CH, V47, P3123, DOI 10.1128/AAC.47.10.3123-3129.2003; Koh Y, 2007, J BIOL CHEM, V282, P28709, DOI 10.1074/jbc.M703938200; KOHL NE, 1988, P NATL ACAD SCI USA, V85, P4686, DOI 10.1073/pnas.85.13.4686; Lara James, 2011, In Silico Biology, V11, P213, DOI 10.3233/ISB-2012-0456; Leiherer A, 2009, J VIROL, V83, P7210, DOI 10.1128/JVI.02603-08; Liu Y, 2008, BIOINFORMATICS, V24, P1243, DOI 10.1093/bioinformatics/btn110; LOEB DD, 1989, NATURE, V340, P397, DOI 10.1038/340397a0; Louis J M, 2000, Adv Pharmacol, V49, P111; LOUIS JM, 1994, P NATL ACAD SCI USA, V91, P7970, DOI 10.1073/pnas.91.17.7970; Louis JM, 1999, NAT STRUCT BIOL, V6, P868; Louis JM, 2007, ADV PHARMACOL, V55, P261, DOI 10.1016/S1054-3589(07)55008-8; Louis JM, 2011, P NATL ACAD SCI USA, V108, P9072, DOI 10.1073/pnas.1102278108; Ludwig C, 2008, J VIROL, V82, P4573, DOI 10.1128/JVI.02353-07; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Ohtaka H, 2003, BIOCHEMISTRY-US, V42, P13659, DOI 10.1021/bi0350405; OROSZLAN S, 1990, CURR TOP MICROBIOL, V157, P153; PARTIN K, 1991, P NATL ACAD SCI USA, V88, P4776, DOI 10.1073/pnas.88.11.4776; Pettit SC, 2005, J VIROL, V79, P10601, DOI 10.1128/JVI.79.16.10601-10607.2005; Pettit SC, 2004, J VIROL, V78, P8477, DOI 10.1128/JVI.78.16.8477-8485.2004; Rhee SY, 2007, PLOS COMPUT BIOL, V3, P836, DOI 10.1371/journal.pcbi.0030087; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; ROSE JR, 1993, J BIOL CHEM, V268, P11939; Schvoerer E, 2013, J INFECT DIS, V207, P1306, DOI 10.1093/infdis/jit032; Shafer RW, 2006, J INFECT DIS, V194, pS51, DOI 10.1086/505356; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang C, 2008, NATURE, V455, P693, DOI 10.1038/nature07342; Tessmer U, 1998, J VIROL, V72, P3459, DOI 10.1128/JVI.72.4.3459-3463.1998; Westin MR, 2011, AIDS RES HUM RETROV, V27, P981, DOI 10.1089/aid.2010.0260; Wondrak EM, 1996, J BIOL CHEM, V271, P4477, DOI 10.1074/jbc.271.8.4477; Wu TD, 2003, J VIROL, V77, P4836, DOI 10.1128/JVI.77.8.4836-4847.2003	58	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123561	10.1371/journal.pone.0123561	http://dx.doi.org/10.1371/journal.pone.0123561			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893662	Green Published, gold, Green Submitted			2022-12-26	WOS:000353211700042
J	Gilbert, GS; Briggs, HM; Magarey, R				Gilbert, Gregory S.; Briggs, Heather M.; Magarey, Roger			The Impact of Plant Enemies Shows a Phylogenetic Signal	PLOS ONE			English	Article							HOST PHYLOGENY; TRAITS; TRANSMISSION; SPECIFICITY; SIMILARITY; HERBIVORES; COMPONENTS; RESISTANCE; DIVERSITY; EMERGENCE	The host ranges of plant pathogens and herbivores are phylogenetically constrained, so that closely related plant species are more likely to share pests and pathogens. Here we conducted a reanalysis of data from published experimental studies to test whether the severity of host-enemy interactions follows a similar phylogenetic signal. The impact of herbivores and pathogens on their host plants declined steadily with phylogenetic distance from the most severely affected focal hosts. The steepness of this phylogenetic signal was similar to that previously measured for binary-response host ranges. Enemy behavior and development showed similar, but weaker phylogenetic signal, with oviposition and growth rates declining with evolutionary distance from optimal hosts. Phylogenetic distance is an informative surrogate for estimating the likely impacts of a pest or pathogen on potential plant hosts, and may be particularly useful in early assessing risk from emergent plant pests, where critical decisions must be made with incomplete host records.	[Gilbert, Gregory S.; Briggs, Heather M.] Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA; [Gilbert, Gregory S.] Smithsonian Trop Res Inst, Balboa, Panama; [Magarey, Roger] N Carolina State Univ, Ctr Integrated Pest Management, Raleigh, NC 27695 USA	University of California System; University of California Santa Cruz; Smithsonian Institution; Smithsonian Tropical Research Institute; University of North Carolina; North Carolina State University	Gilbert, GS (corresponding author), Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA.	ggilbert@ucsc.edu		Magarey, Roger/0000-0002-5651-5965	NSF [DEB-0842059, DEB-1136626]; University of California Santa Cruz; Direct For Biological Sciences [1136626] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); University of California Santa Cruz(University of California System); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding for this work was provided by Cooperative Agreement between G. Gilbert and USDA-APHIS-PPQ-CPHST PERAL funded from Section 10201 of the Farm Bill, and by NSF grants DEB-0842059 and DEB-1136626 to G. Gilbert. Additional support was provided by the University of California Santa Cruz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2007, TRENDS ECOL EVOL, V22, P103, DOI 10.1016/j.tree.2006.10.012; Agrawal AA, 2009, NEW PHYTOL, V183, P848, DOI 10.1111/j.1469-8137.2009.02897.x; Agrawal AA, 2009, EVOLUTION, V63, P663, DOI 10.1111/j.1558-5646.2008.00573.x; AMMAR ED, 1995, PLANT PATHOL, V44, P239, DOI 10.1111/j.1365-3059.1995.tb02774.x; Antonovics J, 2013, EVOLUTION, V67, P1, DOI 10.1111/j.1558-5646.2012.01793.x; Bagchi R, 2014, NATURE, V506, P85, DOI 10.1038/nature12911; Barrett LG, 2012, TRENDS PLANT SCI, V17, P282, DOI 10.1016/j.tplants.2012.02.009; Becerra JX, 1997, SCIENCE, V276, P253, DOI 10.1126/science.276.5310.253; Becker BJ, 2007, STAT SCI, V22, P414, DOI 10.1214/07-STS243; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Boller T, ANN REV PLANT BIOL, V602009, P379; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Carmona D, 2011, FUNCT ECOL, V25, P358, DOI 10.1111/j.1365-2435.2010.01794.x; Chazdon RL, 2003, ECOL MONOGR, V73, P331, DOI 10.1890/02-4037; CONNELL J H, 1971, P298; CUNFER BM, 1988, EUPHYTICA, V37, P129, DOI 10.1007/BF00036850; DAS MK, 1993, EUPHYTICA, V68, P99, DOI 10.1007/BF00024159; Davies TJ, 2008, P ROY SOC B-BIOL SCI, V275, P1695, DOI 10.1098/rspb.2008.0284; de Vienne DM, 2009, J EVOLUTION BIOL, V22, P2532, DOI 10.1111/j.1420-9101.2009.01878.x; Desneux N, 2012, ECOL LETT, V15, P453, DOI 10.1111/j.1461-0248.2012.01754.x; Farrell MJ, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/015036; Gilbert GS, 2007, P NATL ACAD SCI USA, V104, P4979, DOI 10.1073/pnas.0607968104; Gilbert Gregory S, 2012, Evol Appl, V5, P869, DOI 10.1111/j.1752-4571.2012.00265.x; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Jonsson AM, 2011, CLIMATIC CHANGE, V109, P695, DOI 10.1007/s10584-011-0038-4; Liu XB, 2012, ECOL LETT, V15, P111, DOI 10.1111/j.1461-0248.2011.01715.x; Loiola PP, 2012, J VEG SCI, V23, P1095, DOI 10.1111/j.1654-1103.2012.01424.x; Magarey RD, 2009, BIOSCIENCE, V59, P875, DOI 10.1525/bio.2009.59.10.9; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; McEvoy PB, 1996, BIOSCIENCE, V46, P401, DOI 10.2307/1312873; Medeiros MCI, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2947; Parker IM, NATURE IN PRESS; Pearse IS, 2013, OIKOS, V122, P1554, DOI 10.1111/j.1600-0706.2013.00527.x; Pearse IS, 2009, P NATL ACAD SCI USA, V106, P18097, DOI 10.1073/pnas.0904867106; Pedersen AB, 2009, ECOHEALTH, V6, P496, DOI 10.1007/s10393-010-0284-3; Perlman SJ, 2003, EVOLUTION, V57, P544, DOI 10.1111/j.0014-3820.2003.tb01546.x; Pichersky E, 2011, ANNU REV PLANT BIOL, V62, P549, DOI 10.1146/annurev-arplant-042110-103814; Ronsted N, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-182; Schweizer D, 2013, FOREST ECOL MANAG, V297, P57, DOI 10.1016/j.foreco.2013.02.012; Sedio BE, 2013, ECOL LETT, V16, P995, DOI 10.1111/ele.12130; Streicker DG, 2010, SCIENCE, V329, P676, DOI 10.1126/science.1188836; Terborgh J, 2012, AM NAT, V179, P303, DOI 10.1086/664183; Vacher C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001740; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Wink M, 2003, PHYTOCHEMISTRY, V64, P3, DOI 10.1016/S0031-9422(03)00300-5; Yguel B, 2011, ECOL LETT, V14, P1117, DOI 10.1111/j.1461-0248.2011.01680.x	46	40	40	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123758	10.1371/journal.pone.0123758	http://dx.doi.org/10.1371/journal.pone.0123758			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893581	gold, Green Published, Green Submitted			2022-12-26	WOS:000353211700054
J	Kim, HR; Kim, KW; Kim, BM; Cho, ML; Lee, SH				Kim, Hae-Rim; Kim, Kyoung-Woon; Kim, Bo-Mi; Cho, Mi-La; Lee, Sang-Heon			The Effect of Vascular Endothelial Growth Factor on Osteoclastogenesis in Rheumatoid Arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; COLONY-STIMULATING FACTOR; SYNOVIAL FIBROBLASTS; INHIBITORY FACTOR; BONE-RESORPTION; KEY REGULATOR; T-LYMPHOCYTES; UP-REGULATION; EXPRESSION; VEGF	Vascular endothelial growth factor (VEGF) has angiogenic, inflammatory, and bone-destructive roles in rheumatoid arthritis (RA). We aimed to determine the unique role of VEGF in osteoclastogenesis in RA. VEGF-induced receptor activator of nuclear factor kappa B ligand (RANKL) expression was determined in RA synovial fibroblasts by real-time PCR, luciferase assays, and ELISA. Osteoclastogenesis in peripheral blood monocytes cultured with VEGF was assessed by determining the numbers of tartrate-resistant acid phosphatase (TRAP)-positive multinucleated cells. Synovial fluid RANKL was correlated with VEGF concentration in the RA patients. VEGF stimulated the expression of RANKL in RA synovial fibroblasts. The RANKL promoter activity was upregulated by VEGF in the synovial fibroblasts transfected with RANKL-reporter plasmids. The VEGF-induced RANKL expression was decreased by the inhibition of both VEGF receptors (VEGFR) 1 and 2, Src, protein kinase C (PKC) and p38 MAPK. VEGF induced osteoclast differentiation from monocytes in the absence of RANKL and this was decreased by the inhibition of VEGFR1 and 2, Src, PKC and p38 MAPK. On coculturing with VEGF-prestimulated RA synovial fibroblasts, the monocytes differentiated into osteoclasts, and the osteoclastogenesis decreased by inhibition of Src and PKC pathways. VEGF plays dual roles on osteoclastogenesis in RA: direct induction of osteoclastogenesis from the precursors and stimulation of RANKL production in synovial fibroblasts, which is mediated by Src and PKC pathways. The axis of VEGF and RANKL could be a potential therapeutic target for RA-associated bone destruction.	[Kim, Hae-Rim; Lee, Sang-Heon] Konkuk Univ, Sch Med, Dept Rheumatol, Res Inst Med Sci, Seoul, South Korea; [Kim, Kyoung-Woon; Kim, Bo-Mi; Cho, Mi-La] Catholic Univ Korea, Conversant Res Consortium Immunol Dis, Seoul St Marys Hosp, Coll Med, Seoul, South Korea; [Kim, Kyoung-Woon; Kim, Bo-Mi; Cho, Mi-La] Catholic Univ Korea, Rheumatism Res Ctr, Catholic Res Inst Med Sci, Seoul, South Korea	Konkuk University; Konkuk University Medical Center; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea	Cho, ML (corresponding author), Catholic Univ Korea, Conversant Res Consortium Immunol Dis, Seoul St Marys Hosp, Coll Med, Seoul, South Korea.	iammila@catholic.ac.kr; shlee@kuh.ac.kr			National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [NRF-2010-0024198, NRF-2013R1A1A1008171]	National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (NRF-2010-0024198 and NRF-2013R1A1A1008171). http://www.nrf.re.kr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge SE, 2005, BRIT J CANCER, V92, P1531, DOI 10.1038/sj.bjc.6602417; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Brentano F, 2005, ARTHRITIS RHEUM-US, V52, P2656, DOI 10.1002/art.21273; Cho CS, 2000, J IMMUNOL, V164, P5055, DOI 10.4049/jimmunol.164.10.5055; Cho ML, 2006, IMMUNOL LETT, V103, P159, DOI 10.1016/j.imlet.2005.10.020; Choi ST, 2009, CLIN RHEUMATOL, V28, P333, DOI 10.1007/s10067-008-1075-x; De Bandt M, 2003, J IMMUNOL, V171, P4853, DOI 10.4049/jimmunol.171.9.4853; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FREEMAN MR, 1995, CANCER RES, V55, P4140; Fujikawa Y, 1996, ANN RHEUM DIS, V55, P816, DOI 10.1136/ard.55.11.816; Fujikawa Y, 2001, BONE, V28, P261, DOI 10.1016/S8756-3282(00)00453-1; Garcia-Gomez A, 2013, INVEST NEW DRUG, V31, P200, DOI 10.1007/s10637-012-9845-3; Gronthos S, 2007, TRENDS ENDOCRIN MET, V18, P108, DOI 10.1016/j.tem.2007.02.002; Harada M, 1998, SCAND J RHEUMATOL, V27, P377; HARRIS ED, 1990, NEW ENGL J MED, V322, P1277, DOI 10.1056/nejm199005033221805; Ikeda M, 2000, J PATHOL, V191, P426; Kasama T, 2000, CLIN EXP IMMUNOL, V121, P533, DOI 10.1046/j.1365-2249.2000.01272.x; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kikuchi K, 1998, BRIT J DERMATOL, V139, P1049; Kim HR, 2007, J RHEUMATOL, V34, P927; Kim HR, 2014, ARTHRITIS RHEUMATOL, V66, P538, DOI 10.1002/art.38286; Kim KW, 2007, ARTHRITIS RHEUM-US, V56, P1076, DOI 10.1002/art.22439; Kim KW, 2012, ARTHRITIS RHEUM-US, V64, P1015, DOI 10.1002/art.33446; Kim W, 2006, NY TIMES BK REV, P1; Koch AE, 1998, ARTHRITIS RHEUM-US, V41, P951, DOI 10.1002/1529-0131(199806)41:6<951::AID-ART2>3.0.CO;2-D; KOCH AE, 1994, J IMMUNOL, V152, P4149; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Konisti S, 2012, NAT REV RHEUMATOL, V8, P153, DOI 10.1038/nrrheum.2011.205; Lee SS, 2001, CLIN EXP RHEUMATOL, V19, P321; Lee TH, 2002, J BIOL CHEM, V277, P10445, DOI 10.1074/jbc.M107348200; Marumo T, 1999, DIABETES, V48, P1131, DOI 10.2337/diabetes.48.5.1131; McLaren J, 1996, J CLIN INVEST, V98, P482, DOI 10.1172/JCI118815; Mould AW, 2003, ARTHRITIS RHEUM-US, V48, P2660, DOI 10.1002/art.11232; Namiki A, 1995, J BIOL CHEM, V270, P31189, DOI 10.1074/jbc.270.52.31189; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Niida S, 1999, J EXP MED, V190, P293, DOI 10.1084/jem.190.2.293; Oura H, 2003, BLOOD, V101, P560, DOI 10.1182/blood-2002-05-1516; PERTOVAARA L, 1994, J BIOL CHEM, V269, P6271; Ryu S, 2006, CLIN RHEUMATOL, V25, P16, DOI 10.1007/s10067-005-1081-1; Sawano A, 2001, BLOOD, V97, P785, DOI 10.1182/blood.V97.3.785; Szekanecz Zoltan, 2005, Current Drug Targets - Inflammation and Allergy, V4, P319, DOI 10.2174/1568010054022187; Takahashi H, 2005, CLIN SCI, V109, P227, DOI 10.1042/CS20040370; Tunyogi-Csapo M, 2008, ARTHRITIS RHEUM-US, V58, P2397, DOI 10.1002/art.23653; Wu YL, 2005, ARTHRITIS RHEUM-US, V52, P3257, DOI 10.1002/art.21354; Yang QL, 2008, MATRIX BIOL, V27, P589, DOI 10.1016/j.matbio.2008.06.005; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yoo SA, 2005, J IMMUNOL, V174, P5846, DOI 10.4049/jimmunol.174.9.5846; Yoo SA, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/129873; Zhou JL, 2009, J ORTHOP SCI, V14, P313, DOI 10.1007/s00776-009-1329-8	50	43	47	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124909	10.1371/journal.pone.0124909	http://dx.doi.org/10.1371/journal.pone.0124909			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894998	Green Published, Green Submitted, gold			2022-12-26	WOS:000353211700129
J	Qiu, YX; Sun, SH; Charkraborty, T; Wu, LM; Sun, LN; Wei, J; Nagahama, Y; Wang, DS; Zhou, LY				Qiu, Yongxiu; Sun, Shaohua; Charkraborty, Tapas; Wu, Limin; Sun, Lina; Wei, Jing; Nagahama, Yoshitaka; Wang, Deshou; Zhou, Linyan			Figla Favors Ovarian Differentiation by Antagonizing Spermatogenesis in a Teleosts, Nile Tilapia (Oreochromis niloticus)	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; SEX DETERMINATION; GENE-EXPRESSION; GERM-CELLS; GONADAL DIFFERENTIATION; MAMMALIAN GONAD; ALPHA; FISH; AROMATASE; FEMALE	Figla (factor in the germ line, alpha), a female germ cell-specific transcription factor, had been shown to activate genetic hierarchies in oocytes. The ectopic expression of Figla was known to repress spermatogenesis-associated genes in male mice. However, the potential role of Figla in other vertebrates remains elusive. The present work was aimed to identify and characterize the functional relevance of Figla in the ovarian development of Nile tilapia (Oreochromis niloticus). Tissue distribution and ontogeny analysis revealed that tilapia Figla gene was dominantly expressed in the ovary from 30 days after hatching. Immunohistochemistry analysis also demonstrated that Figla was expressed in the cytoplasm of early primary oocytes. Intriguingly, over-expression of Figla in XY fish resulted in the disruption of spermatogenesis along with the depletion of meiotic spermatocytes and spermatids in testis. Dramatic decline of sycp3 (synaptonemal complex protein 3) and prm (protamine) expression indicates that meiotic spermatocytes and mature sperm production are impaired. Even though Sertoli cell (dmrt1) and Leydig cell (star and cyp17a1) marker genes remained unaffected, hsd3b1 expression and 11-KT production were enhanced in Figla-transgene testis. Taken together, our data suggest that fish Figla might play an essential role in the ovarian development by antagonizing spermatogenesis.	[Qiu, Yongxiu; Sun, Shaohua; Wu, Limin; Sun, Lina; Wei, Jing; Wang, Deshou; Zhou, Linyan] Southwest Univ, Sch Life Sci, Minist Educ, Key Lab Freshwater Fish Reprod & Dev, Chongqing, Peoples R China; [Charkraborty, Tapas; Nagahama, Yoshitaka] Ehime Univ, South Ehime Fisheries Res Ctr, Ainan, Ehime, Japan	Southwest University - China; Ehime University	Wang, DS (corresponding author), Southwest Univ, Sch Life Sci, Minist Educ, Key Lab Freshwater Fish Reprod & Dev, Chongqing, Peoples R China.	wdeshou@swu.edu.cn; yanlinzhou916@126.com	wei, jing/GXA-1455-2022; Wang, Deshou/ABD-6014-2021; Chakraborty, Tapas/M-5865-2018	Wang, Deshou/0000-0002-4967-524X; Chakraborty, Tapas/0000-0003-1984-234X	National Natural Science Foundation of China [31201986, 91331119, 31201979, 31030063]; Research Foundation of Talent Introduction of Southwest University, China [SWU111003]; Specialized Research Fund for the Doctoral Program of Higher Education of China; Ministry of Education [20110182120003, 20130182130003]; special fund of Chongqing key laboratory (CSTC), Natural Science Foundation Project of Chongqing, China [cstc2012jjA80005, cstc2012jjA80041]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Foundation of Talent Introduction of Southwest University, China; Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Ministry of Education; special fund of Chongqing key laboratory (CSTC), Natural Science Foundation Project of Chongqing, China	This work was supported in part by Grants for Scientific Research from the National Natural Science Foundation of China (31201986, 91331119, 31201979, and 31030063). This work was also supported in part by Research Foundation of Talent Introduction of Southwest University, China (SWU111003). The project was supported by the Specialized Research Fund for the Doctoral Program of Higher Education of China, Ministry of Education (20110182120003 and 20130182130003) and the special fund of Chongqing key laboratory (CSTC), Natural Science Foundation Project of Chongqing, China (cstc2012jjA80005 and cstc2012jjA80041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayne RAL, 2004, MOL HUM REPROD, V10, P373, DOI 10.1093/molehr/gah056; Brennan J, 2004, NAT REV GENET, V5, P509, DOI 10.1038/nrg1381; Capel B, 2000, MECH DEVELOP, V92, P89, DOI 10.1016/S0925-4773(99)00327-5; Chassot AA, 2014, REPRODUCTION, V148, pR97, DOI 10.1530/REP-14-0177; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; Dohle GR, 2003, WORLD J UROL, V21, P341, DOI 10.1007/s00345-003-0365-9; Eggers S, 2014, NAT REV ENDOCRINOL, V10, P673, DOI 10.1038/nrendo.2014.163; Fujimoto T, 2010, P NATL ACAD SCI USA, V107, P17211, DOI 10.1073/pnas.1007032107; GRECO TL, 1994, ENDOCRINOLOGY, V135, P262, DOI 10.1210/en.135.1.262; Guigon CJ, 2006, BIOL REPROD, V74, P450, DOI 10.1095/biolreprod.105.047134; Guigon CJ, 2005, ENDOCRINOLOGY, V146, P2992, DOI 10.1210/en.2005-0045; Hu W, 2010, MOL CELL BIOL, V30, P3661, DOI 10.1128/MCB.00201-10; Huntriss J, 2002, MOL HUM REPROD, V8, P1087, DOI 10.1093/molehr/8.12.1087; Jorgensen A, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-25; Joshi S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-67; Kanamori A, 2000, Tanpakushitsu Kakusan Koso, V45, P2949; Kanamori A, 2008, GENE, V423, P180, DOI 10.1016/j.gene.2008.07.007; Kobayashi T, 2009, SEX DEV, V3, P108, DOI 10.1159/000223076; Kobayashi T, 2008, DEV DYNAM, V237, P297, DOI 10.1002/dvdy.21409; Kurokawa H, 2007, P NATL ACAD SCI USA, V104, P16958, DOI 10.1073/pnas.0609932104; Li MH, 2013, ENDOCRINOLOGY, V154, P4814, DOI 10.1210/en.2013-1451; Li MH, 2014, GENETICS, V197, P591, DOI 10.1534/genetics.114.163667; Liang LF, 1997, DEVELOPMENT, V124, P4939; Liu G, 2014, J MOL ENDOCRINOL, V53, P57, DOI 10.1530/JME-13-0300; Maatouk DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047238; MCLAREN A, 1991, BIOESSAYS, V13, P151, DOI 10.1002/bies.950130402; McLaren A, 2000, MOL CELL ENDOCRINOL, V163, P3, DOI 10.1016/S0303-7207(99)00234-8; Nishimura T, 2014, SEX DEV, V8, P252, DOI 10.1159/000364924; Onichtchouk D, 2003, DEV DYNAM, V228, P393, DOI 10.1002/dvdy.10392; Rodriguez-Mari A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001034; Siegfried KR, 2008, DEV BIOL, V324, P277, DOI 10.1016/j.ydbio.2008.09.025; Slanchev K, 2005, P NATL ACAD SCI USA, V102, P4074, DOI 10.1073/pnas.0407475102; Soyal SM, 2000, DEVELOPMENT, V127, P4645; Swain A, 1999, GENE DEV, V13, P755, DOI 10.1101/gad.13.7.755; Tao WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063604; Thompson WE, 1997, J REPROD FERTIL, V109, P337, DOI 10.1530/jrf.0.1090337; Wang DS, 2007, MOL ENDOCRINOL, V21, P712, DOI 10.1210/me.2006-0248; Wang DS, 2010, ENDOCRINOLOGY, V151, P1331, DOI 10.1210/en.2009-0999; Wu GC, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.104398; Yokoi H, 2002, MOL REPROD DEV, V63, P5, DOI 10.1002/mrd.10169; Yu XG, 2014, MOL CELL ENDOCRINOL, V392, P152, DOI 10.1016/j.mce.2014.05.013; ZAMBONI L, 1983, J EXP ZOOL, V228, P173, DOI 10.1002/jez.1402280204	42	25	29	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123900	10.1371/journal.pone.0123900	http://dx.doi.org/10.1371/journal.pone.0123900			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894586	Green Published, gold, Green Submitted			2022-12-26	WOS:000353211700063
J	Sumbele, IUN; Kimbi, HK; Ndamukong-Nyanga, JL; Nweboh, M; Anchang-Kimbi, JK; Lum, E; Nana, Y; Ndamukong, KKJ; Lehman, LG				Sumbele, Irene Ule Ngole; Kimbi, Helen Kuokuo; Ndamukong-Nyanga, Judith Lum; Nweboh, Malaika; Anchang-Kimbi, Judith Kuoh; Lum, Emmaculate; Nana, Yannick; Ndamukong, Kenneth K. J.; Lehman, Leopold G.			Malarial Anaemia and Anaemia Severity in Apparently Healthy Primary School Children in Urban and Rural Settings in the Mount Cameroon Area: Cross Sectional Survey	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM PARASITEMIA; HEMOGLOBIN CONCENTRATIONS; YOUNG-CHILDREN; WESTERN KENYA; TRANSMISSION; IMPACT; ERYTHROPOIESIS; MORBIDITY; RESPONSES; IMMUNITY	Background This study examines the relative importance of living in an urban versus rural setting and malaria in contributing to the public health problem of malarial anaemia (MA) and anaemia respectively in apparently healthy primary school children. Methods A cross-sectional study was conducted among 727 school children aged between four and 15 years living in an urban (302) and rural (425) settings in the Mount Cameroon area. Blood sample collected from each child was used for the preparation of blood films for detection of malaria parasites and assessment of malaria parasite density as well as full blood count determination using an automated haematology analyzer. Based on haemoglobin (Hb) measurements, children with malaria parasitaemia were stratified into MA (Hb<11g/dL); mild MA (Hb of 8-10.9g/dL); moderate MA (Hb of 6.1-7.9g/dL) and severe MA (Hb <= 6g/dL). Evaluation of potential determinants of MA and anaemia was performed by multinomial logistic-regression analysis and odds ratios used to evaluate risk factors. Results Out of the 727 children examined, 72 (9.9%) had MA. The prevalence of MA and anaemia were significantly higher (chi(2) = 36.5, P < 0.001; chi(2) = 16.19, P < 0.001 respectively) in children in the urban (17.9%; 26.8% respectively) than in the rural area (4.2%; 14.8% respectively). Majority of the MA cases were mild (88.9%), with moderate (5.6%) and severe MA (5.6%) occurring in the urban area only. The age group <= 6years was significantly (P < 0.05) associated with both MA and anaemia. In addition, low parasite density was associated with MA while malaria parasite negative and microcytosis were associated with anaemia. Conclusions Malarial anaemia and anaemia display heterogeneity and complexity that differ with the type of settlement. The presence of severe MA and the contributions of the age group <= 6 years, low parasite density and microcytosis to the public health problem of MA and anaemia are noteworthy.	[Sumbele, Irene Ule Ngole; Kimbi, Helen Kuokuo; Nweboh, Malaika; Anchang-Kimbi, Judith Kuoh; Lum, Emmaculate; Nana, Yannick; Ndamukong, Kenneth K. J.] Univ Buea, Fac Sci, Dept Zool & Anim Physiol, Buea, Cameroon; [Ndamukong-Nyanga, Judith Lum] Univ Yaounde I, Higher Teachers Training Coll, Dept Biol Sci, Yaounde, Cameroon; [Lehman, Leopold G.] Univ Douala, Fac Sci, Dept Biol Sci, Douala, Cameroon	University of Yaounde I	Sumbele, IUN (corresponding author), Univ Buea, Fac Sci, Dept Zool & Anim Physiol, Buea, Cameroon.	sumbelei@yahoo.co.uk	Anchang-Kimbi, Judith/AAE-9802-2020		government of Cameroon	government of Cameroon	This work was supported by the staff development grant and special fund for research and modernization given to authors by the government of Cameroon.	ABDALLA S, 1980, BRIT J HAEMATOL, V46, P171, DOI 10.1111/j.1365-2141.1980.tb05956.x; Achidi EA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-215; ALLEN SJ, 1992, T ROY SOC TROP MED H, V86, P494, DOI 10.1016/0035-9203(92)90083-O; [Anonymous], 2012, J BACTERIOL PARASITO; BEADLE C, 1995, J INFECT DIS, V172, P1047, DOI 10.1093/infdis/172.4.1047; Benichou J, STAT METH MED RES, V110, P195; Bhawna Sethi, 2013, Iranian Journal of Pathology, V8, P1; Biemba G, 2000, TROP MED INT HEALTH, V5, P9, DOI 10.1046/j.1365-3156.2000.00506.x; Bjorkman A, 2002, INT J PARASITOL, V32, P1637, DOI 10.1016/S0020-7519(02)00192-3; Brabin BJ, 2001, J NUTR, V131, p636S; Bryan FJ., 1992, DESIGN ANAL RES STUD; Casals-Pascual C, 2006, BLOOD, V108, P2569, DOI 10.1182/blood-2006-05-018697; Chang KH, 2004, INT J PARASITOL, V34, P1501, DOI 10.1016/j.ijpara.2004.10.008; Cheesbrough M., 2009, DISTRICT LAB PRACT 2; Cheesbrough M, 2009, DISTRICT LAB PRACT 1; Cornet M, 1998, AM J TROP MED HYG, V58, P606, DOI 10.4269/ajtmh.1998.58.606; De Silva PM, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/819563; Desai MR, 2005, AM J TROP MED HYG, V72, P47, DOI 10.4269/ajtmh.2005.72.47; Deshmukh Pradeep R, 2013, Med J Armed Forces India, V69, P213, DOI 10.1016/j.mjafi.2012.10.004; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Ekvall H, 2003, CURR OPIN HEMATOL, V10, P108, DOI 10.1097/00062752-200303000-00002; Ekvall H, 2001, T ROY SOC TROP MED H, V95, P611, DOI 10.1016/S0035-9203(01)90095-1; Fernando SD, 2003, AM J TROP MED HYG, V69, P582, DOI 10.4269/ajtmh.2003.69.582; Fowkes FJI, 2008, PLOS MED, V5, P494, DOI 10.1371/journal.pmed.0050056; Geerligs PDP, 2003, B WORLD HEALTH ORGAN, V81, P205; Ghosh K, 2007, PARASITOL RES, V101, P1463, DOI 10.1007/s00436-007-0742-1; Gudo ES, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-244; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; Kimbi H K, 2006, East Afr Med J, V83, P602; Kimbi HK, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-193; Kitua AY, 1997, TROP MED INT HEALTH, V2, P325; Klinkenberg E, 2006, TROP MED INT HEALTH, V11, P578, DOI 10.1111/j.1365-3156.2006.01609.x; Korenromp EL, 2004, TROP MED INT HEALTH, V9, P1050, DOI 10.1111/j.1365-3156.2004.01317.x; Ladhani S, 2002, BRIT J HAEMATOL, V119, P839, DOI 10.1046/j.1365-2141.2002.03904.x; Lucien K. F. H., 2010, African Journal of Clinical and Experimental Microbiology, V11, P120; Luxemburger C, 1998, T ROY SOC TROP MED H, V92, P45, DOI 10.1016/S0035-9203(98)90950-6; Martorell R, 1992, HUMAN GROWTH BASIC C, P143; MCELROY PD, 1994, AM J TROP MED HYG, V51, P523, DOI 10.4269/ajtmh.1994.51.523; McElroy PD, 2000, AM J TROP MED HYG, V62, P504, DOI 10.4269/ajtmh.2000.62.504; Menendez C, 2000, PARASITOL TODAY, V16, P469, DOI 10.1016/S0169-4758(00)01774-9; Mockenhaupt FP, 1999, J INFECT DIS, V180, P925, DOI 10.1086/314959; Nkuo-Akenji T. K., 2008, African Journal of Food, Agriculture, Nutrition and Development, V8, P252; Novelli EM, 2010, BRIT J HAEMATOL, V149, P711, DOI 10.1111/j.1365-2141.2010.08147.x; Ong'echa JM, 2006, AM J TROP MED HYG, V74, P376, DOI 10.4269/ajtmh.2006.74.376; Perkins DJ, 2011, INT J BIOL SCI, V7, P1427, DOI 10.7150/ijbs.7.1427; Sumbele IUN., 2010, J CLI MED RES, V2, P143; Tatem AJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-133; Vitor-Silva S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-230; Wanji S, 2008, MALARIA J, V7, P9, DOI [10.1186/1475-2875-7-9, DOI 10.1186/1475-2875-7-9]; World Health Organization, WORLD MALARIA REPORT	50	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123549	10.1371/journal.pone.0123549	http://dx.doi.org/10.1371/journal.pone.0123549			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893500	Green Published, gold, Green Submitted			2022-12-26	WOS:000353211700041
J	Zhang, W; Pei, YL; Zhong, L; Wen, BQ; Cao, SY; Han, JY				Zhang, Wei; Pei, Yangli; Zhong, Liang; Wen, Bingqiang; Cao, Suying; Han, Jianyong			Pluripotent and Metabolic Features of Two Types of Porcine iPSCs Derived from Defined Mouse and Human ES Cell Culture Conditions	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; EARLY LINEAGE SEGREGATION; SELF-RENEWAL; EXPRESSION; NAIVE; INDUCTION; EPIBLAST; STATE; FGF; FIBROBLASTS	The domestic pig is an excellent animal model for stem cell research and clinical medicine. There is still no suitable culture condition to generate authentic porcine embryonic stem cells (pESCs) and high quality porcine induced pluripotent stem cells (piPSCs). In this study, we found that culture conditions affected pluripotent and metabolic features of piPSCs. Using defined human embryonic stem cell (hESC) and mouse ESC (mESC) culture conditions, we generated two types of piPSCs, one of which was morphologically similar to hESCs (here called hpiPSCs), the other resembled mESCs (here called mpiPSCs). Transcriptome analysis and signaling pathway inhibition results suggested that mpiPSCs shared more of mESC signaling pathways, such as the BMP pathway and JAK/STAT pathway and hpiPSCs shared more hESC signaling pathways, such as the FGF pathway. Importantly, the mpiPSCs performed embryonic chimera incorporation more efficiently than the hpiPSCs did. In addition, the mpiPSCs showed mitochondrial features of naive ESCs and lipid droplets accumulation. These evidences may facilitate understanding of the gene regulation network and metabolism in piPSCs and promote derivation of bona fide pESCs for translational medicine.	[Zhang, Wei; Pei, Yangli; Zhong, Liang; Wen, Bingqiang; Han, Jianyong] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Cao, Suying] Beijing Agr Univ, Coll Anim Sci & Technol, Beijing 100094, Peoples R China	China Agricultural University; Beijing University of Agriculture	Han, JY (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	hanjy@cau.edu.cn	Zhong, Liang/AAO-1379-2020; Wen, Bingqiang/ABF-4375-2021; zhang, wei/J-1685-2019		China National Basic Research Program [2011CBB01001, 2011CBA01102]; Beijing Natural Science Foundation [6152004]; National Thousand Talents Program of China; Program for New Century Excellent Talents in University [NCET-11-0482]; State Key Laboratory for Agrobiotechnology Foundation [2015SKLAB6-18]	China National Basic Research Program(National Basic Research Program of China); Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Thousand Talents Program of China; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); State Key Laboratory for Agrobiotechnology Foundation	This study was supported by grants from the China National Basic Research Program (2011CBB01001, 2011CBA01102), Beijing Natural Science Foundation (6152004), the National Thousand Talents Program of China and the Program for New Century Excellent Talents in University (NCET-11-0482) and by State Key Laboratory for Agrobiotechnology Foundation (2015SKLAB6-18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Cao SY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-4; Cao ZB, 2014, THERIOGENOLOGY, V81, P496, DOI 10.1016/j.theriogenology.2013.10.025; Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Cheng D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051778; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fujishiro S, 2013, STEM CELLS DEV, V22, P473, DOI 10.1089/scd.2012.0173; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Gu Q, 2014, PROTEIN CELL, V5, P338, DOI 10.1007/s13238-014-0043-2; Hall VJ, 2010, DEV DYNAM, V239, P2911, DOI 10.1002/dvdy.22424; Hall VJ, 2014, STEM CELLS DEV, V23, P2030, DOI 10.1089/scd.2013.0502; Henderson JK, 2002, STEM CELLS, V20, P329, DOI 10.1634/stemcells.20-4-329; Kikuchi K, 2002, ZYGOTE, V10, P355, DOI 10.1017/S0967199402004100; Kuijk EW, 2008, DEV DYNAM, V237, P918, DOI 10.1002/dvdy.21480; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Li ZH, 2014, CURR BIOL, V24, P1485, DOI 10.1016/j.cub.2014.05.022; Li ZH, 2012, CURR BIOL, V22, P2104, DOI 10.1016/j.cub.2012.09.018; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Montserrat N, 2013, CELL STEM CELL, V13, P341, DOI 10.1016/j.stem.2013.06.019; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Park JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052481; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Ruan WM, 2011, SCI CHINA LIFE SCI, V54, P553, DOI 10.1007/s11427-011-4179-5; Shu J, 2013, CELL, V153, P963, DOI 10.1016/j.cell.2013.05.001; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Telugu BPVL, 2010, INT J DEV BIOL, V54, P1703, DOI 10.1387/ijdb.103200bt; Thomson AJ, 2012, CELL REPROGRAM, V14, P112, DOI 10.1089/cell.2011.0078; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Ware CB, 2014, P NATL ACAD SCI USA, V111, P4484, DOI 10.1073/pnas.1319738111; West FD, 2010, STEM CELLS DEV, V19, P1211, DOI 10.1089/scd.2009.0458; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhang Shuangqing, 2014, ScientificWorldJournal, V2014, P217142, DOI 10.1155/2014/217142; Zhou WY, 2012, EMBO J, V31, P2103, DOI 10.1038/emboj.2012.71	45	26	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124562	10.1371/journal.pone.0124562	http://dx.doi.org/10.1371/journal.pone.0124562			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893435	gold, Green Published, Green Submitted			2022-12-26	WOS:000353211700105
J	Hosoda, M; Tokonami, S; Omori, Y; Sahoo, SK; Akiba, S; Sorimachi, A; Ishikawa, T; Nair, RR; Jayalekshmi, PA; Sebastian, P; Iwaoka, K; Akata, N; Kudo, H				Hosoda, Masahiro; Tokonami, Shinji; Omori, Yasutaka; Sahoo, Sarata Kumar; Akiba, Suminori; Sorimachi, Atsuyuki; Ishikawa, Tetsuo; Nair, Raghu Ram; Jayalekshmi, Padmavathy Amma; Sebastian, Paul; Iwaoka, Kazuki; Akata, Naofumi; Kudo, Hiromi			Estimation of External Dose by Car-Borne Survey in Kerala, India	PLOS ONE			English	Article							TERRESTRIAL GAMMA-RADIATION; BACKGROUND-RADIATION	A car-borne survey was carried out in Kerala, India to estimate external dose. Measurements were made with a 3-in x 3-in NaI(Tl) scintillation spectrometer from September 23 to 27, 2013. The routes were selected from 12 Panchayats in Karunagappally Taluk which were classified into high level, mid-level and low level high background radiation (HBR) areas. A heterogeneous distribution of air kerma rates was seen in the dose rate distribution map. The maximum air kerma rate, 2.1 mu Gy/h, was observed on a beach sand surface. Th-232 activity concentration for the beach sand was higher than that for soil and grass surfaces, and the range of activity concentration was estimated to be 0.7-2.3 kBq/kg. The contribution of 232Th to air kerma rate was over 70% at the measurement points with values larger than 0.34 mu Gy/h. The maximum value of the annual effective dose in Karunagappally Taluk was observed around coastal areas, and it was estimated to be 13 mSv/y. More than 30% of all the annual effective doses obtained in this survey exceeded 1 mSv/y.	[Hosoda, Masahiro; Kudo, Hiromi] Hirosaki Univ, Grad Sch Hlth Sci, Aomori, Japan; [Tokonami, Shinji; Iwaoka, Kazuki] Hirosaki Univ, Inst Radiat Emergency Med, Aomori, Japan; [Omori, Yasutaka; Sorimachi, Atsuyuki; Ishikawa, Tetsuo] Fukushima Med Univ, Fukushima, Japan; [Sahoo, Sarata Kumar] Natl Inst Radiol Sci, Chiba 260, Japan; [Akiba, Suminori] Kagoshima Univ, Grad Sch Med & Dent Sci, Kagoshima 890, Japan; [Nair, Raghu Ram; Sebastian, Paul] Reg Canc Ctr, Neendakara, Kerala, India; [Jayalekshmi, Padmavathy Amma] Nat Background Radiat Canc Registry, Neendakara, Kerala, India; [Akata, Naofumi] Natl Inst Fus Sci, Gifu, Japan	Hirosaki University; Hirosaki University; Fukushima Medical University; National Institutes for Quantum Science & Technology; Kagoshima University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Fusion Science (NIFS) - Japan	Tokonami, S (corresponding author), Hirosaki Univ, Inst Radiat Emergency Med, Aomori, Japan.	tokonami@hirosaki-u.ac.jp	Omori, Yasutaka/AAF-8203-2021; Tokonami, Shinji/AAH-6042-2020	Omori, Yasutaka/0000-0003-3629-8761; Tokonami, Shinji/0000-0002-6617-7402	Japanese Ministry of the Environment	Japanese Ministry of the Environment(Ministry of the Environment, Japan)	This work was conducted for the grant-in-aid "Dosimetric Studies of Residents in High Natural Background Radiation Areas in India and China" financially supported from the Japanese Ministry of the Environment.	Akahane K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01670; Beck H.L., 1972, HASL258 US AT EN COM; Beck HL, 1972, HASL262 US AT EN COM; Chougaonkar MP, 2004, J ENVIRON RADIOACTIV, V71, P275, DOI 10.1016/S0265-931X(03)00174-7; Christa EP, 2012, RADIAT PROT DOSIM, V148, P482, DOI 10.1093/rpd/ncr198; Derin MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050468; Hosoda M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02283; Ishikawa T., 2014, RAD EMERGENCY MED, V3, P21; Matsuda H., 1982, Reports of the Government Industrial Research Institute, Nagoya, V31, P132; Matsuda Hideharu, 2002, Radioisotopes, V51, P42; MINATO S, 1970, J NUCL SCI TECHNOL-T, V7, P401, DOI 10.3327/jnst.7.401; Minato S., 2001, Radioisotopes, V50, P463, DOI 10.3769/radioisotopes.50.10_463; MINATO S, 1971, J NUCL SCI TECHNOL-T, V8, P342, DOI 10.3327/jnst.8.342; Minato S., 1995, Reports of the National Industrial Research Institute of Nagoya, V44, P609; Minato S., 1977, Reports of the Government Industrial Research Institute, Nagoya, V26, P190; Minato S, 2012, RAD EMERG MED, V1, P108; Minato S., 1978, REP GOV IND RES I NA, V27, P384; Minato S., 1980, J JPN HLTH PHYS, V15, P19; Moller AP, 2013, BIOL REV, V88, P226, DOI 10.1111/j.1469-185X.2012.00249.x; Nair RRK, 2009, HEALTH PHYS, V96, P55, DOI 10.1097/01.HP.0000327646.54923.11; Nambi KSV, 1986, 130 BHABH AT RES CTR; Tokonami S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00507; United Nations Scientific Committee on the Effects of Atomic Radiation, 2014, UNSCEAR 2013 REP GEN; United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), 2000, SOURC EFF LON RAD; Wessel P, 1991, EOS T AM GEOPHYS UN, V72, P445, DOI [10.1029/90EO00319, DOI 10.1029/90EO00319, DOI 10.1029/90E000319]	25	31	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124433	10.1371/journal.pone.0124433	http://dx.doi.org/10.1371/journal.pone.0124433			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885680	Green Published, gold, Green Submitted			2022-12-26	WOS:000353017000127
J	Nogueira, A; Rey, PJ; Alcantara, JM; Feitosa, RM; Lohmann, LG				Nogueira, Anselmo; Rey, Pedro J.; Alcantara, Julio M.; Feitosa, Rodrigo M.; Lohmann, Lucia G.			Geographic Mosaic of Plant Evolution: Extrafloral Nectary Variation Mediated by Ant and Herbivore Assemblages	PLOS ONE			English	Article							HELLEBORUS-FOETIDUS; BODY-SIZE; CHAMAECRISTA-FASCICULATA; FRUIT-SET; SELECTION; MUTUALISM; DISPERSAL; TRAITS; DISRUPTION; HERB	Herbivory is an ecological process that is known to generate different patterns of selection on defensive plant traits across populations. Studies on this topic could greatly benefit from the general framework of the Geographic Mosaic Theory of Coevolution (GMT). Here, we hypothesize that herbivory represents a strong pressure for extrafloral nectary (EFN) bearing plants, with differences in herbivore and ant visitor assemblages leading to different evolutionary pressures among localities and ultimately to differences in EFN abundance and function. In this study, we investigate this hypothesis by analyzing 10 populations of Anemopaegma album (30 individuals per population) distributed through ca. 600 km of Neotropical savanna and covering most of the geographic range of this plant species. A common garden experiment revealed a phenotypic differentiation in EFN abundance, in which field and experimental plants showed a similar pattern of EFN variation among populations. We also did not find significant correlations between EFN traits and ant abundance, herbivory and plant performance across localities. Instead, a more complex pattern of ant-EFN variation, a geographic mosaic, emerged throughout the geographical range of A. album. We modeled the functional relationship between EFNs and ant traits across ant species and extended this phenotypic interface to characterize local situations of phenotypic matching and mismatching at the population level. Two distinct types of phenotypic matching emerged throughout populations: (1) a population with smaller ants (Crematogaster crinosa) matched with low abundance of EFNs; and (2) seven populations with bigger ants (Camponotus species) matched with higher EFN abundances. Three matched populations showed the highest plant performance and narrower variance of EFN abundance, representing potential plant evolutionary hotspots. Cases of mismatched and matched populations with the lowest performance were associated with abundant and highly detrimental herbivores. Our findings provide insights on the ecology and evolution of plant-ant guarding systems, and suggest new directions to research on facultative mutualistic interactions at wide geographic scales.	[Nogueira, Anselmo; Lohmann, Lucia G.] Univ Sao Paulo, Inst Biociencias, Dept Bot, Sao Paulo, SP, Brazil; [Rey, Pedro J.; Alcantara, Julio M.] Univ Jaen, Dept Biol Anim Biol Vegetal & Ecol, Fac Ciencias Expt, Jaen, Andalucia, Spain; [Feitosa, Rodrigo M.] Univ Fed Parana, Dept Zool, Setor Ciencias Biol, BR-80060000 Curitiba, Parana, Brazil	Universidade de Sao Paulo; Universidad de Jaen; Universidade Federal do Parana	Nogueira, A (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Bot, Sao Paulo, SP, Brazil.	anselmoeco@yahoo.com.br; prey@ujaen.es; jmalcan@ujaen.es; rsmfeitosa@gmail.com; llohmann@usp.br	Lohmann, Lucia G./AAF-7259-2021; Feitosa, Rodrigo Machado/D-2171-2012; Alcantara, Julio M./O-4400-2017; Rey, Pedro J./I-2165-2015; Nogueira, Anselmo/C-3465-2013	Lohmann, Lucia G./0000-0003-4960-0587; Feitosa, Rodrigo Machado/0000-0001-9042-0129; Alcantara, Julio M./0000-0002-8003-7844; Rey, Pedro J./0000-0001-5550-0393; Nogueira, Anselmo/0000-0002-8232-4636	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [AN 2012/02110-5, AN 2013/04591-3]; FAPESP grant [LGL 2007/55433-8]; Pq-1C grant from the CNPq; CAPES/PROEX	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP grant(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Pq-1C grant from the CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES/PROEX(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This project was funded by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP Fellowships to AN 2012/02110-5 and AN 2013/04591-3, and FAPESP grant to LGL 2007/55433-8), a Pq-1C grant from the CNPq to LGL, and CAPES/PROEX.	Alcantara JM, 2007, EVOL ECOL, V21, P411, DOI 10.1007/s10682-006-9110-3; Baker-Meio B, 2012, J ECOL, V100, P242, DOI 10.1111/j.1365-2745.2011.01892.x; Beattie A. J., 1985, EVOLUTIONARY ECOLOGY; Beattie Andrew J., 2002, P211; Benkman CW, 1999, AM NAT, V153, pS75, DOI 10.1086/303213; Bluthgen N, 2004, ECOLOGY, V85, P1479, DOI 10.1890/03-0430; Bronstein JL, 1998, BIOTROPICA, V30, P150, DOI 10.1111/j.1744-7429.1998.tb00050.x; BRONSTEIN JL, 1994, TRENDS ECOL EVOL, V9, P214, DOI 10.1016/0169-5347(94)90246-1; Chamberlain SA, 2009, ECOLOGY, V90, P2384, DOI 10.1890/08-1490.1; Davidson DW, 2004, OECOLOGIA, V139, P255, DOI 10.1007/s00442-004-1508-4; DelClaro K, 1996, J TROP ECOL, V12, P887, DOI 10.1017/S0266467400010142; Denno R.F., 1983, VARIABLE PLANTS HERB; Diaz-Castelazo C, 2005, ANN BOT-LONDON, V96, P1175, DOI 10.1093/aob/mci270; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Elias T. S., 1983, The biology of nectaries, P174; Garrido JL, 2002, J ECOL, V90, P446, DOI 10.1046/j.1365-2745.2002.00675.x; GENTRY AH, 1974, ANN MO BOT GARD, V61, P728, DOI 10.2307/2395026; Godoy BS, 2013, BIOTA NEOTROP, V13, P91, DOI 10.1590/S1676-06032013000100010; Gomez JM, 2009, ECOL MONOGR, V79, P245, DOI 10.1890/08-0511.1; Hanifin CT, 2008, PLOS BIOL, V6, P471, DOI 10.1371/journal.pbio.0060060; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Herrera C.M., 2006, ECOLOGY EVOLUTION FL, P278; Hijmans R. J., 2014, GEOSPHERE SPHERICAL; Hurlbert AH, 2008, ECOL ENTOMOL, V33, P144, DOI 10.1111/j.1365-2311.2007.00962.x; Jones CG, 2007, J VEG SCI, V18, P771; Kersch MF, 2005, ECOLOGY, V86, P2117, DOI 10.1890/04-1916; Korndorfer AP, 2006, BIOTROPICA, V38, P786, DOI 10.1111/j.1744-7429.2006.00200.x; Kostyshak S, 2014, BOOTSTRAP R PACKAGE; Legendre P., 2012, NUMERICAL ECOLOGY; Liere H, 2010, OIKOS, V119, P1394, DOI 10.1111/j.1600-0706.2010.17985.x; Loe G, 2007, OIKOS, V116, P134, DOI 10.1111/j.2006.0030-1299.15022.x; Manly B., 1998, RANDOMIZATION BOOTST; Manzaneda AJ, 2008, ECOGRAPHY, V31, P583, DOI 10.1111/j.0906-7590.2008.05345.x; Manzaneda AJ, 2007, BIOL J LINN SOC, V92, P135, DOI 10.1111/j.1095-8312.2007.00831.x; Manzaneda AJ, 2012, ECOGRAPHY, V35, P322, DOI 10.1111/j.1600-0587.2011.06923.x; Manzaneda AJ, 2009, ECOLOGY, V90, P3009, DOI 10.1890/08-2274.1; Mezquida ET, 2005, J EVOLUTION BIOL, V18, P348, DOI 10.1111/j.1420-9101.2004.00846.x; Mitchell RJ, 2004, ECOLOGY, V85, P1527, DOI 10.1890/03-0388; Mooney KA, 2006, ECOLOGY, V87, P1805, DOI 10.1890/0012-9658(2006)87[1805:TDOAAM]2.0.CO;2; Nascimento EA, 2010, FLORA, V205, P754, DOI 10.1016/j.flora.2009.12.040; Ness JH, 2006, ECOLOGY, V87, P912, DOI 10.1890/0012-9658(2006)87[912:IQAQOM]2.0.CO;2; Ness JH, 2003, OECOLOGIA, V134, P210, DOI 10.1007/s00442-002-1110-6; Nogueira A, 2012, J EVOLUTION BIOL, V25, P2325, DOI 10.1111/j.1420-9101.2012.02615.x; Nogueira A, 2013, ANN BOT-LONDON, V112, P1331, DOI 10.1093/aob/mct201; Nogueira A, 2012, PLANT ECOL, V213, P289, DOI 10.1007/s11258-011-9974-3; Nowbahari E, 1999, AGGRESSIVE BEHAV, V25, P369, DOI 10.1002/(SICI)1098-2337(1999)25:5<369::AID-AB5>3.0.CO;2-C; Oksanen J, 2013, COMMUNITY ECOLOGY PA, V2, P1; Oliveira PS, 1997, FUNCT ECOL, V11, P323, DOI 10.1046/j.1365-2435.1997.00087.x; Oliveira PS, 2004, NATURWISSENSCHAFTEN, V91, P557, DOI 10.1007/s00114-004-0585-x; R Development Core Team, 2014, R LANG ENV STAT COMP; Rey P.J., 2009, CONSERVACION INTERAC, P113; Rey PJ, 2007, J ECOL, V95, P1381, DOI 10.1111/j.1365-2745.2007.01293.x; Rey PJ, 2006, J EVOLUTION BIOL, V19, P21, DOI 10.1111/j.1420-9101.2005.00992.x; Ribas CR, 2002, OECOLOGIA, V131, P606, DOI 10.1007/s00442-002-0912-x; Rico-Gray V, 1998, BIOTROPICA, V30, P190, DOI 10.1111/j.1744-7429.1998.tb00054.x; Rico-Gray V., 2008, ECOLOGY EVOLUTION AN, DOI DOI 10.7208/CHICAGO/9780226713540.001.0001; Rios RS, 2008, OECOLOGIA, V156, P577, DOI 10.1007/s00442-008-1024-z; Rodriguez-Cabal MA, 2012, BIOL INVASIONS, V14, P557, DOI 10.1007/s10530-011-0097-5; Rudgers JA, 2004, P ROY SOC B-BIOL SCI, V271, P2481, DOI 10.1098/rspb.2004.2900; Rudgers JA, 2004, ECOLOGY, V85, P192, DOI 10.1890/02-0625; Rutter MT, 2004, EVOLUTION, V58, P2657, DOI 10.1111/j.0014-3820.2004.tb01619.x; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schoereder Jose H., 2010, Terrestrial Arthropod Reviews, V3, P3, DOI 10.1163/187498310X487785; Sendoya SF, 2009, AM NAT, V174, P134, DOI 10.1086/599302; STEPHENSON AG, 1982, ECOLOGY, V63, P663, DOI 10.2307/1936786; Stinchcombe JR, 2002, P ROY SOC B-BIOL SCI, V269, P1241, DOI 10.1098/rspb.2002.2015; Thompson J., 2013, RELENTLESS EVOLUTION, DOI DOI 10.7208/CHICAGO/9780226018898.001.0001; Thompson J. N., 2005, INTERSPEC INTERACT; Thompson JD., 1994, COEVOLUTIONARY PROCE; Thompson JN, 1997, ECOLOGY, V78, P1619; Thompson JN, 1999, AM NAT, V153, pS1, DOI 10.1086/303208; Weber MG, 2013, ANN BOT-LONDON, V111, P1251, DOI 10.1093/aob/mcs225; Zangerl AR, 2003, EVOLUTION, V57, P806, DOI 10.1111/j.0014-3820.2003.tb00292.x	73	18	18	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123806	10.1371/journal.pone.0123806	http://dx.doi.org/10.1371/journal.pone.0123806			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885221	Green Published, gold, Green Submitted			2022-12-26	WOS:000353017000083
J	Vogelstein, JT; Conroy, JM; Lyzinski, V; Podrazik, LJ; Kratzer, SG; Harley, ET; Fishkind, DE; Vogelstein, RJ; Priebe, CE				Vogelstein, Joshua T.; Conroy, John M.; Lyzinski, Vince; Podrazik, Louis J.; Kratzer, Steven G.; Harley, Eric T.; Fishkind, Donnie E.; Vogelstein, R. Jacob; Priebe, Carey E.			Fast Approximate Quadratic Programming for Graph Matching	PLOS ONE			English	Article							ALGORITHM	Quadratic assignment problems arise in a wide variety of domains, spanning operations research, graph theory, computer vision, and neuroscience, to name a few. The graph matching problem is a special case of the quadratic assignment problem, and graph matching is increasingly important as graph-valued data is becoming more prominent. With the aim of efficiently and accurately matching the large graphs common in big data, we present our graph matching algorithm, the Fast Approximate Quadratic assignment algorithm. We empirically demonstrate that our algorithm is faster and achieves a lower objective value on over 80% of the QAPLIB benchmark library, compared with the previous state-of-the-art. Applying our algorithm to our motivating example, matching C. elegans connectomes (brain-graphs), we find that it efficiently achieves performance.	[Vogelstein, Joshua T.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Conroy, John M.; Podrazik, Louis J.; Kratzer, Steven G.] Inst Def Analyses, Ctr Comp Sci, Bowie, MD USA; [Lyzinski, Vince] Johns Hopkins Univ, Human Language Technol Ctr Excellence, Baltimore, MD USA; [Harley, Eric T.; Fishkind, Donnie E.; Priebe, Carey E.] Johns Hopkins Univ, Dept Appl Math & Stat, Baltimore, MD USA; [Vogelstein, R. Jacob] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory	Vogelstein, JT (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.	jovo@jhu.edu	Vogelstein, Joshua/AAG-5489-2019	Vogelstein, Joshua/0000-0003-2487-6237	Research Program in Applied Neuroscience; National Security Science and Engineering Faculty Fellowship; Johns Hopkins University Human Language Technology Center of Excellence; XDATA program of the Defense Advanced Research Projects Agency; Air Force Research Laboratory [FA8750-12-2-0303]	Research Program in Applied Neuroscience; National Security Science and Engineering Faculty Fellowship; Johns Hopkins University Human Language Technology Center of Excellence; XDATA program of the Defense Advanced Research Projects Agency; Air Force Research Laboratory	This work was partially supported by the Research Program in Applied Neuroscience (JV, RJV, CEP, http://www.jhuapl.edu/ourwork/red/an/), a National Security Science and Engineering Faculty Fellowship (CEP, http://www.acq.osd.mil/rd/basic_research/program_info/nsseff.html), Johns Hopkins University Human Language Technology Center of Excellence (DEF, JV, CEP, VL, http://hltcoe.jhu.edu/), and the XDATA program of the Defense Advanced Research Projects Agency (CEP, http://www.darpa.mil/Our_Work/I2O/Programs/XDATA.aspx) administered through Air Force Research Laboratory contract FA8750-12-2-0303. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstreicher KM, 2001, MATH PROGRAM, V89, P341, DOI 10.1007/PL00011402; Anstreicher KM, 2003, SIAM J OPTIMIZ, V97, P27; Babai L., 1981, Fundamentals of Computation Theory. Proceedings of the 1981 International FCT-Conference, P34; BABAI L, 1980, SIAM J COMPUT, V9, P628, DOI 10.1137/0209047; Bazaraa M.S., 2013, NONLINEAR PROGRAMMIN, Vthird; Boyd S., 2004, CONVEX OPTIMIZATION; Bradley SP, 1977, APPL MATH PROGRAMMIN; Brixius NW, 2000, MANAGEMENT, P1; Burkard R. E., 2013, HDB COMBINATORIAL OP, P2741, DOI DOI 10.1007/978-1-4419-7997-1_22; Burkard RE, 1997, J GLOBAL OPTIM, V10, P391, DOI 10.1023/A:1008293323270; Calhoun Vince D, 2011, Front Psychiatry, V2, P75, DOI 10.3389/fpsyt.2011.00075; CHEN JN, 1994, SIAM J DISCRETE MATH, V7, P614, DOI 10.1137/S0895480191196769; Conte D, 2004, INT J PATTERN RECOGN, V18, P265, DOI 10.1142/S0218001404003228; Csernansky JG, 2004, NEUROIMAGE, V23, pS56, DOI 10.1016/j.neuroimage.2004.07.025; Escolano F, 2011, COMPUTER VISION PATT; Fornito A, 2012, NEUROIMAGE, V62, P2296, DOI 10.1016/j.neuroimage.2011.12.090; Fornito Alex, 2012, Front Psychiatry, V3, P32, DOI 10.3389/fpsyt.2012.00032; Fortin S, 1996, TECHNICAL REPORT; Frank M., 1956, NAV RES LOGIST Q, V3, P95, DOI 10.1002/nav.3800030109; Gold S, 1996, IEEE T PATTERN ANAL, V18, P377, DOI 10.1109/34.491619; Gray Roncal W., 2013, GLOB C SIGN INF PROC; HAGMANN P, 2005, THESIS I TRAITEMENT; Herculano-Houzel S, 2012, P NATL ACAD SCI USA, V109, P10661, DOI 10.1073/pnas.1201895109; JONKER R, 1987, COMPUTING, V38, P325, DOI 10.1007/BF02278710; Kolaczyk ED, 2009, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-88146-1_1; KOOPMANS TC, 1957, ECONOMETRICA, V25, P53, DOI 10.2307/1907742; Kubicki M, 2007, J PSYCHIATR RES, V41, P15, DOI 10.1016/j.jpsychires.2005.05.005; Leordeanu M., 2009, ADV NEURAL INFORM PR, P1114; Liu ZY, 2012, IEEE T PATTERN ANAL, V34, P1451, DOI 10.1109/TPAMI.2012.45; Lyzinski V, 2013, 13101297 ARXIV; Lyzinski V, 2014, J MACHINE L IN PRESS; Lyzinski V, 2014, ARXIV14053133; Papadimitriou C.H., 1998, COMBINATORIAL OPTIMI, VUnabridged edition; Priebe CE, 2013, COMMUN STAT-THEOR M, V42, P3455, DOI 10.1080/03610926.2011.630768; Schellewald C., 2001, Pattern Recognition. 23rd DAGM Symposium. Proceedings (Lecture Notes in Computer Science Vol.2191), P361; Singh R, 2007, LECT NOTES COMPUT SC, V4453, P16; SINKHORN R, 1964, ANN MATH STAT, V35, P876, DOI 10.1214/aoms/1177703591; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; UMEYAMA S, 1988, IEEE T PATTERN ANAL, V10, P695, DOI 10.1109/34.6778; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; Vogelstein JT, 2014, J CLASSIFIC IN PRESS; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zaslavskiy M, 2010, LECT NOTES ARTIF INT, V6323, P515, DOI 10.1007/978-3-642-15939-8_33; Zaslavskiy M, 2009, IEEE T PATTERN ANAL, V31, P2227, DOI 10.1109/TPAMI.2008.245	45	60	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0121002	10.1371/journal.pone.0121002	http://dx.doi.org/10.1371/journal.pone.0121002			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886624	gold, Green Published, Green Submitted			2022-12-26	WOS:000353017000015
J	Satija, YK; Das, S				Satija, Y. K.; Das, S.			Tyr99 phosphorylation determines the regulatory milieu of tumor suppressor p73	ONCOGENE			English	Article							KINASE C-ABL; DNA-DAMAGE; P53 FAMILY; APOPTOTIC RESPONSE; INDUCE APOPTOSIS; DOWN-REGULATION; E3 LIGASE; CANCER; PROTEIN; GENE	p73 is a member of the p53 tumor suppressor family, which mediates genotoxic stress response by triggering cell cycle arrest and apoptosis. Similar to p53, p73 is maintained at very low levels, but it gets rapidly induced upon genotoxic stress. Mounting evidences demonstrate that p73 is primarily regulated posttranslationally. However, the molecular mechanisms which determine its stability and activity discerningly under normal and stress conditions are still not well understood. Here, we employed a proteomics approach to identify differential interactors of p73 under normal and genotoxic stress conditions. We report here that TRIM28, an E3 ligase, interacts with p73 and targets it for proteasomal degradation under normal conditions. Genotoxic stress-induced phosphorylation of p73 at tyrosine 99 residue by c-abl kinase leads to abrogation of this interaction thereby promoting p73 stabilization. Furthermore, the phosphorylated form of p73 specifically interacts with MED15, which serves as a transcriptional coactivator and leads to activation of proarrest, proapoptotic and anti-metastatic genes. RNAi-mediated abrogation of TRIM28 expression facilitates p73-mediated tumor suppression in mouse tumor models, whereas disruption of MED15 expression abrogates p73 tumor suppressor and anti-metastatic functions. These findings provide new insights into the pivotal role of Tyr99 phosphorylation in determining p73 levels and functions.	[Satija, Y. K.; Das, S.] Natl Inst Immunol, Mol Oncol Lab, Aruna Asaf Ali Marg, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Das, S (corresponding author), Natl Inst Immunol, Mol Oncol Lab, Aruna Asaf Ali Marg, New Delhi 110067, India.	sdas@nii.ac.in		Das, Sanjeev/0000-0002-3594-1033	Department of Biotechnology, Government of India [BT/PR7200/BRB/10/1155/2012]; NII Core Fund; Council for Scientific and Industrial Research, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); NII Core Fund; Council for Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	We thank the members of the Molecular Oncology Lab for helpful discussions. This work was supported by a grant from the Department of Biotechnology, Government of India (BT/PR7200/BRB/10/1155/2012). We also acknowledge the financial support received from NII Core Fund. YKS was supported by a fellowship from the Council for Scientific and Industrial Research, Government of India.	Agami R, 1999, NATURE, V399, P809; Allton K, 2009, P NATL ACAD SCI USA, V106, P11612, DOI 10.1073/pnas.0813177106; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Beitzinger M, 2008, EMBO J, V27, P792, DOI 10.1038/emboj.2008.13; Bergamaschi D, 2004, MOL CELL BIOL, V24, P1341, DOI 10.1128/MCB.24.3.1341-1350.2004; Das S, 2006, CANCER BIOL THER, V5, P210, DOI 10.4161/cbt.5.2.2402; Dotsch V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004887; Gong JG, 1999, NATURE, V399, P806; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Han JA, 2002, EMBO J, V21, P5635, DOI 10.1093/emboj/cdf591; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Irwin MS, 2003, CANCER CELL, V3, P403, DOI 10.1016/S1535-6108(03)00078-3; Ishikawa H, 2006, FEBS LETT, V580, P4784, DOI 10.1016/j.febslet.2006.07.066; Jiang WG, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-71; Jing C, 2002, JNCI-J NATL CANCER I, V94, P482; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Kato Y, 2002, NATURE, V418, P641, DOI 10.1038/nature00969; Lapi E, 2006, ONCOGENE, V25, P3628, DOI 10.1038/sj.onc.1209401; Levy D, 2007, CELL DEATH DIFFER, V14, P743, DOI 10.1038/sj.cdd.4402063; Levy D, 2008, MOL CELL, V29, P350, DOI 10.1016/j.molcel.2007.12.022; Liang QM, 2011, J IMMUNOL, V187, P4754, DOI 10.4049/jimmunol.1101704; Melino G, 2002, NAT REV CANCER, V2, P605, DOI 10.1038/nrc861; Melino G, 2008, CELL DEATH DIFFER, V15, P1103, DOI 10.1038/cdd.2008.60; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Naar AM, 1999, NATURE, V398, P828, DOI 10.1038/19789; Noon AT, 2010, NAT CELL BIOL, V12, P177, DOI 10.1038/ncb2017; Oberst A, 2005, BIOCHEM BIOPH RES CO, V331, P707, DOI 10.1016/j.bbrc.2005.03.158; Ozaki T, 2005, CANCER SCI, V96, P729, DOI 10.1111/j.1349-7006.2005.00116.x; Peschiaroli A, 2009, ONCOGENE, V28, P3157, DOI 10.1038/onc.2009.177; Rachez C, 2001, CURR OPIN CELL BIOL, V13, P274, DOI 10.1016/S0955-0674(00)00209-X; Rossi M, 2005, EMBO J, V24, P836, DOI 10.1038/sj.emboj.7600444; Sanchez-Prieto R, 2002, ONCOGENE, V21, P974, DOI 10.1038/sj.onc.1205134; Sasaki Y, 2012, CANCER BIOL THER, V13, P1512, DOI 10.4161/cbt.22280; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Steder M, 2013, CANCER CELL, V24, P512, DOI 10.1016/j.ccr.2013.08.023; Strano S, 2005, MOL CELL, V18, P447, DOI 10.1016/j.molcel.2005.04.008; Suzuki F, 2005, ONCOL REP, V14, P1493; Takai N, 2005, MOL CANCER RES, V3, P261, DOI 10.1158/1541-7786.MCR-04-0110; Tanikawa C, 2012, NEOPLASIA, V14, P141, DOI 10.1593/neo.111700; Wang CG, 2005, EMBO J, V24, P3279, DOI 10.1038/sj.emboj.7600791; Wezensky SJ, 2010, GENE, V452, P22, DOI 10.1016/j.gene.2009.12.003; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942; Yokoe T, 2010, ANN SURG ONCOL, V17, P821, DOI 10.1245/s10434-009-0795-8; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; Zhang JM, 2004, ONCOGENE, V23, P2241, DOI 10.1038/sj.onc.1207328; Zhang S, 2011, ONCOGENE, V30, P4941, DOI 10.1038/onc.2011.199; Zhang X, 2007, HEAD NECK-J SCI SPEC, V29, P236, DOI 10.1002/hed.20511; Zhu JH, 1998, CANCER RES, V58, P5061; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	51	11	11	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 28	2016	35	4					513	527		10.1038/onc.2015.111	http://dx.doi.org/10.1038/onc.2015.111			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DC2OT	25893286				2022-12-26	WOS:000369056700011
J	Ernst, CM; Buddle, CM				Ernst, Crystal M.; Buddle, Christopher M.			Drivers and Patterns of Ground-Dwelling Beetle Biodiversity across Northern Canada	PLOS ONE			English	Article							LATITUDINAL GRADIENTS; SPECIES-RICHNESS; FUNCTIONAL DIVERSITY; DIFFERENT RESPONSES; GLOBAL PATTERNS; ASSEMBLAGES; PHENOLOGY; INSECTS; SCALE; PERMAFROST	Many macroecological patterns of biodiversity, including the relationship between latitude and species richness, are well-described. Data collected in a repeatable, standardized manner can advance the discipline beyond the description of patterns and be used to elucidate underlying mechanisms. Using standardized field methods and a hyper-diverse focal taxon, viz. Coleoptera, we aim to (1) describe large-scale latitudinal patterns of taxonomic diversity, functional diversity, and assemblage structure across northern Canada, and (2) determine which climatic, spatial, and habitat variables best explain these patterns. We collected terrestrial beetles at twelve locations in the three northernmost ecoclimatic zones in North America: north boreal, subarctic, and high arctic (51-81 degrees N, 60-138 degrees W). After identifying beetles and assigning them to a functional group, we assessed latitudinal trends for multiple diversity indices using linear regression and visualized spatial patterns of assemblage structure with multivariate ordinations. We used path analysis to test causal hypotheses for species and functional group richness, and we used a permutational approach to assess relationships between assemblage structure and 20 possible climatic and environmental mechanisms. More than 9,000 beetles were collected, representing 464 species and 18 functional groups. Species and functional diversity have significant negative relationships with latitude, which are likely explained by the mediating effects of temperature, precipitation, and plant height. Assemblages within the same ecoclimatic zone are similar, and there is a significant relationship between assemblage structure and latitude. Species and functional assemblage structure are significantly correlated with many of the same climatic factors, particularly temperature maxima and minima. At a large spatial extent, the diversity and assemblage structure of northern beetles show strong latitudinal gradients due to the mediating effects of climate, particularly temperature. Northern arthropod assemblages present significant opportunities for biodiversity research and conservation efforts, and their sensitivity to climate make them ideal targets for long-term terrestrial diversity monitoring.	[Ernst, Crystal M.; Buddle, Christopher M.] McGill Univ, Dept Nat Resource Sci, Ste Anne De Bellevue, PQ, Canada	McGill University	Ernst, CM (corresponding author), McGill Univ, Dept Nat Resource Sci, Ste Anne De Bellevue, PQ, Canada.	crystal.ernst@mail.mcgill.ca	Ernst, Christopher M./O-8317-2018	Ernst, Christopher M./0000-0002-0257-6252; Buddle, Christopher/0000-0002-7494-9732	National Science and Engineering Research Council of Canada (NCERC); NSERC CGS-D Alexander Graham Bell Canada	National Science and Engineering Research Council of Canada (NCERC); NSERC CGS-D Alexander Graham Bell Canada	This work was supported by a National Science and Engineering Research Council of Canada (NCERC) Strategic Project Grant (Ecological Structure of Northern Arthropods: Adaptation to a Changing Environment) awarded to C. Buddle, T. Wheeler, and D. Currie (University of Toronto), its supporting partners and collaborators, and a NSERC CGS-D Alexander Graham Bell Canada Graduate Scholarship awarded to C. Ernst. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beche LA, 2009, BIODIVERS CONSERV, V18, P3909, DOI 10.1007/s10531-009-9688-1; Beck J, 2012, ECOGRAPHY, V35, P673, DOI 10.1111/j.1600-0587.2012.07364.x; Bolduc E, 2013, CAN ENTOMOL, V145, P155, DOI 10.4039/tce.2013.4; Bowden JJ, 2010, ECOSCIENCE, V17, P287, DOI 10.2980/17-3-3308; Boyero L, 2011, ECOLOGY, V92, P1839, DOI 10.1890/10-2244.1; Braun-Blanquet J., 1964, PFLANZENSOZIOLOGIE G; Buschke FT, 2011, AFR INVERTEBR, V52, P217, DOI 10.5733/afin.052.0112; Cardoso P, 2014, METHODS ECOL EVOL, V5, P452, DOI 10.1111/2041-210X.12173; CHAO A, 1984, SCAND J STAT, V11, P265; Chernov Y.I., 2014, ENTOMOL REV, V94, P438, DOI [10.1134/S0013873814040022, DOI 10.1134/S0013873814040022]; Christensen T, 2013, CAFF MONITORING SERI; Condamine FL, 2012, ECOL LETT, V15, P267, DOI 10.1111/j.1461-0248.2011.01737.x; Danks H. V., 1981, ARCTIC ARTHROPODS RE; DANKS HV, 1992, ARCTIC, V45, P159; Danks HV, 2004, INTEGR COMP BIOL, V44, P85, DOI 10.1093/icb/44.2.85; DANKS HV, 1993, MEM ENTOMOL SOC CAN, P51; Ernst CM, 2013, CAN ENTOMOL, V145, P171, DOI 10.4039/tce.2012.111; Field R, 2009, J BIOGEOGR, V36, P132, DOI 10.1111/j.1365-2699.2008.01963.x; Flynn DFB, 2009, ECOL LETT, V12, P22, DOI 10.1111/j.1461-0248.2008.01255.x; Frouz J, 2004, ENVIRON ENTOMOL, V33, P1282, DOI 10.1603/0046-225X-33.5.1282; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; GASTON KJ, 1992, OECOLOGIA, V90, P417, DOI 10.1007/BF00317700; Hawkins BA, 2004, BASIC APPL ECOL, V5, P1, DOI 10.1078/1439-1791-00214; Heiberger RM, 2014, HH STAT ANAL DATA DI, DOI [10.1186/1687-4153-2014-7, DOI 10.1186/1687-4153-2014-7]; Hilty J, 2000, BIOL CONSERV, V92, P185, DOI 10.1016/S0006-3207(99)00052-X; Hinkel KM, 2000, ADV SOIL S, P197; Hodar JA, 1996, ACTA OECOL, V17, P421; Hooper DU, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P195; Hoye TT, 2008, ADV ECOL RES, V40, P299, DOI 10.1016/S0065-2504(07)00013-X; Hoye Toke T., 2008, BMC Ecology, V8, P8, DOI 10.1186/1472-6785-8-8; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; JAROSIK V, 1989, PEDOBIOLOGIA, V33, P87; KANE DL, 1991, COLD REG SCI TECHNOL, V19, P111, DOI 10.1016/0165-232X(91)90002-X; Keil P, 2008, ECOL ENTOMOL, V33, P748, DOI 10.1111/j.1365-2311.2008.01032.x; Keith SA, 2012, BIOL LETT; Kevan P.G., 1986, P72; Lamanna C, 2014, P NATL ACAD SCI USA, V111, P13745, DOI 10.1073/pnas.1317722111; Lemieux JP, 1999, PEDOBIOLOGIA, V43, P245; Ma M, 2005, OIKOS, V111, P192, DOI 10.1111/j.0030-1299.2005.13049.x; Magurran A.E, 2003, MEASURING BIOL DIVER; Marchetti G. M., 2014, GGM PACKAGE GRAPHICA; McGeoch MA, 1998, BIOL REV, V73, P181, DOI 10.1017/S000632319700515X; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; McGill BJ, 2010, OIKOS, V119, P591, DOI 10.1111/j.1600-0706.2009.17771.x; Missa O, 2009, J INSECT CONSERV, V13, P103, DOI 10.1007/s10841-007-9130-5; Mjaaseth RR, 2005, OECOLOGIA, V145, P53, DOI 10.1007/s00442-005-0089-1; Oksanen J, 2010, VEGEN COMMUNITY ECOL; Peres-Neto PR, 2001, OECOLOGIA, V129, P169, DOI 10.1007/s004420100720; Poyry J, 2006, OIKOS, V115, P401, DOI 10.1111/j.2006.0030-1299.15126.x; QUINN JF, 1983, AM NAT, V122, P602, DOI 10.1086/284161; Rainio J, 2003, BIODIVERS CONSERV, V12, P487, DOI 10.1023/A:1022412617568; Rich ME, 2013, ECOGRAPHY, V36, P994, DOI 10.1111/j.1600-0587.2012.00078.x; ROHDE K, 1992, OIKOS, V65, P514, DOI 10.2307/3545569; Rossi J, 2011, RICH SPECIES RICHNES; Safi K, 2011, PHILOS T R SOC B, V366, P2536, DOI 10.1098/rstb.2011.0024; SERVICE MW, 1980, INT J BIOMETEOROL, V24, P347, DOI 10.1007/BF02250577; Shipley B, 2000, STRUCT EQU MODELING, V7, P206, DOI 10.1207/S15328007SEM0702_4; Shipley B, 2009, ECOLOGY, V90, P363, DOI 10.1890/08-1034.1; Smith SL, 2010, PERMAFROST PERIGLAC, V21, P117, DOI 10.1002/ppp.690; SPENCE JR, 1994, CAN ENTOMOL, V126, P881, DOI 10.4039/Ent126881-3; Stevens RD, 2003, ECOL LETT, V6, P1099, DOI 10.1046/j.1461-0248.2003.00541.x; Stirling G, 2001, AM NAT, V158, P286, DOI 10.1086/321317; Strong W., 1989, ECOCLIMATIC REGIONS; Timms LL, 2013, ECOGRAPHY, V36, P1227, DOI 10.1111/j.1600-0587.2012.00278.x; Timms LL, 2013, INSECT CONSERV DIVER, V6, P453, DOI 10.1111/icad.12004; Voigt W, 2007, GLOBAL CHANGE BIOL, V13, P1710, DOI 10.1111/j.1365-2486.2007.01398.x; Walker MD, 2006, P NATL ACAD SCI USA, V103, P1342, DOI 10.1073/pnas.0503198103; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	69	16	16	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0122163	10.1371/journal.pone.0122163	http://dx.doi.org/10.1371/journal.pone.0122163			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901996	Green Submitted, Green Published, gold			2022-12-26	WOS:000353331500016
J	Jager, S; Jacobs, S; Kroger, J; Stefan, N; Fritsche, A; Weikert, C; Boeing, H; Schulze, MB				Jaeger, Susanne; Jacobs, Simone; Kroeger, Janine; Stefan, Norbert; Fritsche, Andreas; Weikert, Cornelia; Boeing, Heiner; Schulze, Matthias B.			Association between the Fatty Liver Index and Risk of Type 2 Diabetes in the EPIC-Potsdam Study	PLOS ONE			English	Article							BODY-MASS INDEX; INSULIN-RESISTANCE; HEPATIC STEATOSIS; METABOLICALLY BENIGN; EXTERNAL VALIDATION; NATURAL DIRECT; DISEASE; MELLITUS; CANCER; COHORT	The fatty liver index (FLI) predicts fatty liver by using BMI, waist circumference, gamma-glutamyl-transferase and triglycerides. We investigated the association between the FLI and the risk of type 2 diabetes and evaluated to what extent single FLI components contribute to the diabetes risk. We analysed a case-cohort study (random sub-cohort: 1922; incident cases: 563) nested within the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study. The proportion of exposure effect (PEE) explained by single FLI components was evaluated and effect decomposition using inverse probability weighting (IPW) was applied. Women and men with a FLI >= 60 compared to those with a FLI <30 had a multivariable-adjusted Hazard Ratio (HR) of 17.6; 95% confidence interval (CI) 11.1-28.0 and HR: 10.9; 95% CI 6.22-19.2, respectively. Adjustment for BMI or waist circumference attenuated this association in men [PEEBMI(95% CI) = 53.8% (43.9%-65.8%); PEEwaist(95% CI) = 54.8% (44.2%-68.8%)]. In women, adjustment for waist circumference attenuated the association to a lesser degree than in men [PEEwaist(95% CI) = 31.1%; (21.9%-43.1%)] while BMI had no appreciable effect [PEEBMI(95% CI) = 11.0% (2.68%-21.0%)] gamma-glutamyl-transferase and triglycerides showed only a small attenuation in women [PEEGGT(95% CI) = 3.11% (-0.72%-4.48%); PEETG(95% CI) = 6.36% (3.81%-9.92%)] and in men [PEEGGT = 0%; PEETG(95% CI) = 6.23% (2.03%-11.8%)]. In women, the total effect was decomposed into a direct effect and 4 indirect effects (HRBMI= 1.10; HRwaist = 1.28; HRGGT = 0.97 and HRTG= 1.03). In men, the 4 indirect effects were HRBMI= 1.25; HRwaist = 1.29; HRGGT = 0.97 and HRTG= 0.99. These data suggest that the FLI, as a proxy for fatty liver, is associated with risk of type 2 diabetes. This association is only partly explained by standard estimates of overall and abdominal body fatness, particularly among women.	[Jaeger, Susanne; Jacobs, Simone; Kroeger, Janine; Schulze, Matthias B.] German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Epidemiol, Nuthetal, Germany; [Jaeger, Susanne; Jacobs, Simone; Kroeger, Janine; Stefan, Norbert; Fritsche, Andreas; Schulze, Matthias B.] German Ctr Diabet Res DZD, Neuherberg, Germany; [Stefan, Norbert; Fritsche, Andreas] Univ Tubingen Hosp, Dept Internal Med, Div Endocrinol Diabetol Nephrol Vasc Dis & Clin C, Tubingen, Germany; [Weikert, Cornelia] German Inst Human Nutr Potsdam Rehbrucke, Res Grp Cardiovasc Epidemiol, Nuthetal, Germany; [Weikert, Cornelia] Charite Univ Med Ctr, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany; [Boeing, Heiner] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Schulze, MB (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Epidemiol, Nuthetal, Germany.	mschulze@dife.de	Schulze, Matthias B/AAH-6906-2021	Schulze, Matthias B/0000-0002-0830-5277; Kroger, Janine/0000-0002-7496-3665; Stefan, Norbert/0000-0002-2186-9595; Jager, Susanne/0000-0001-6619-0861	Federal Ministry of Science, Germany [01 EA 9401]; European Union [SOC 95201408 05 F02]; German Cancer Aid [70-2488-Ha I]; European Community [SOC 98200769 05 F02]; German Federal Ministry of Education and Research (BMBF)	Federal Ministry of Science, Germany; European Union(European Commission); German Cancer Aid(Deutsche Krebshilfe); European Community(European Commission); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The recruitment phase of the EPIC-Potsdam Study was supported by the Federal Ministry of Science, Germany (grant 01 EA 9401) and the European Union (grant SOC 95201408 05 F02). The follow-up of the EPIC-Potsdam Study is supported by the German Cancer Aid (grant 70-2488-Ha I) and the European Community (grant SOC 98200769 05 F02). This study was supported in part by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkau B, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-56; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Bergmann MM, 2013, INT J EPIDEMIOL, V42, P1772, DOI 10.1093/ije/dyt154; Bergmann MM, 2004, EUR J EPIDEMIOL, V19, P411, DOI 10.1023/B:EJEP.0000027350.85974.47; Boeing H, 1999, ANN NUTR METAB, V43, P205, DOI 10.1159/000012787; Boeing H, 1999, ANN NUTR METAB, V43, P195, DOI 10.1159/000012786; Borman MA, 2013, HEPATOL INT, V7, P592, DOI 10.1007/s12072-012-9401-4; Brandstetter BR, 1999, ANN NUTR METAB, V43, P246, DOI 10.1159/000012791; Chang Y, 2013, AM J GASTROENTEROL, V108, P1861, DOI 10.1038/ajg.2013.349; Choi JH, 2013, ARCH MED RES, V44, P115, DOI 10.1016/j.arcmed.2013.01.007; Enzenbach C, 2011, EUR J NUTR, V50, P625, DOI 10.1007/s00394-011-0169-4; Feller S, 2010, DTSCH ARZTEBL INT, V107, P470, DOI 10.3238/arztebl.2010.0470; Ford ES, 2008, DIABETES CARE, V31, P1138, DOI [10.2337/dc07-2159, 10.2337/dc08-1138]; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gastaldelli A, 2009, HEPATOLOGY, V49, P1537, DOI 10.1002/hep.22845; Hernaez R, 2011, HEPATOLOGY, V54, P1082, DOI 10.1002/hep.24452; Hoffmann K, 2008, AM J EPIDEMIOL, V167, P517, DOI 10.1093/aje/kwm357; Jacobs S, 2014, AM J CLIN NUTR, V100, P891, DOI 10.3945/ajcn.113.080317; Jung CH, 2013, DIABETIC MED, V30, P428, DOI 10.1111/dme.12104; Kahl S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094059; Kantartzis K, 2010, DIABETOLOGIA, V53, P882, DOI 10.1007/s00125-010-1663-6; Kasturiratne A, 2013, J GASTROEN HEPATOL, V28, P142, DOI 10.1111/j.1440-1746.2012.07264.x; Kim CH, 2008, DIABETIC MED, V25, P476, DOI 10.1111/j.1464-5491.2008.02410.x; Kim JH, 2011, LIVER INT, V31, P1600, DOI 10.1111/j.1478-3231.2011.02580.x; KlipsteinGrobusch K, 1997, INT J EPIDEMIOL, V26, pS174, DOI 10.1093/ije/26.suppl_1.S174; Koehler EM, 2013, CLIN GASTROENTEROL H, V11, P1201, DOI 10.1016/j.cgh.2012.12.031; Kotronen A, 2008, DIABETES CARE, V31, P165, DOI 10.2337/dc07-1463; Kroke A, 1999, ANN NUTR METAB, V43, P216, DOI 10.1159/000012788; LaBrecque DR, 2014, J CLIN GASTROENTEROL, V48, P467, DOI 10.1097/MCG.0000000000000116; Lange T, 2014, AM J EPIDEMIOL, V179, P513, DOI 10.1093/aje/kwt270; Lange T, 2012, AM J EPIDEMIOL, V176, P190, DOI 10.1093/aje/kwr525; Langsted A, 2008, CIRCULATION, V118, P2047, DOI 10.1161/CIRCULATIONAHA.108.804146; Lazo M, 2008, SEMIN LIVER DIS, V28, P339, DOI 10.1055/s-0028-1091978; Lazo M, 2013, AM J EPIDEMIOL, V178, P38, DOI 10.1093/aje/kws448; Lin DY, 1997, STAT MED, V16, P1515, DOI 10.1002/(SICI)1097-0258(19970715)16:13<1515::AID-SIM572>3.3.CO;2-T; Meffert PJ, 2014, AM J GASTROENTEROL, V109, P1404, DOI 10.1038/ajg.2014.155; Myers RP, 2012, LIVER INT, V32, P902, DOI 10.1111/j.1478-3231.2012.02781.x; Okamoto M, 2003, J EPIDEMIOL, V13, P15, DOI 10.2188/jea.13.15; Park SK, 2013, HEPATOLOGY, V57, P1378, DOI 10.1002/hep.26183; Pearl J, 2001, P 17 C UNC ART INT S, P411; PICCININO F, 1986, J HEPATOL, V2, P165, DOI 10.1016/S0168-8278(86)80075-7; PRENTICE RL, 1986, BIOMETRIKA, V73, P1; Sahani DV, 2004, ONCOLOGIST, V9, P385, DOI 10.1634/theoncologist.9-4-385; Schienkiewitz A, 2006, AM J CLIN NUTR, V84, P427; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Schwenzer NF, 2009, J HEPATOL, V51, P433, DOI 10.1016/j.jhep.2009.05.023; Shibata M, 2007, DIABETES CARE, V30, P2940, DOI 10.2337/dc07-0792; Siegert S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076813; Stefan N, 2008, DIABETES, V57, P2762, DOI 10.2337/db08-0538; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; Stefan N, 2011, DIABETES, V60, P2011, DOI 10.2337/db11-0231; Strauss S, 2007, AM J ROENTGENOL, V189, pW320, DOI 10.2214/AJR.07.2123; Sung KC, 2013, J CLIN ENDOCR METAB, V98, P3637, DOI 10.1210/jc.2013-1519; Sung KC, 2012, DIABETES CARE, V35, P717, DOI 10.2337/dc11-1853; Sung KC, 2011, J CLIN ENDOCR METAB, V96, P1093, DOI 10.1210/jc.2010-2190; WACHOLDER S, 1989, BIOMETRIKA, V76, P117, DOI 10.1093/biomet/76.1.117; Wieckowska A, 2008, SEMIN LIVER DIS, V28, P386, DOI 10.1055/s-0028-1091983; Yamada T, 2010, J GASTROEN HEPATOL, V25, P352, DOI 10.1111/j.1440-1746.2009.05998.x; Yki-Jarvinen H, 2014, LANCET DIABETES ENDO, V2, P901, DOI 10.1016/S2213-8587(14)70032-4; Zelber-Sagi S, 2013, LIVER INT, V33, P1406, DOI 10.1111/liv.12200	60	37	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124749	10.1371/journal.pone.0124749	http://dx.doi.org/10.1371/journal.pone.0124749			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902304	Green Published, Green Submitted, gold			2022-12-26	WOS:000353331500099
J	Lange, BA; Michel, C; Beckers, JF; Casey, JA; Flores, H; Hatam, I; Meisterhans, G; Niemi, A; Haas, C				Lange, Benjamin A.; Michel, Christine; Beckers, Justin F.; Casey, J. Alec; Flores, Hauke; Hatam, Ido; Meisterhans, Guillaume; Niemi, Andrea; Haas, Christian			Comparing Springtime Ice-Algal Chlorophyll a and Physical Properties of Multi-Year and First-Year Sea Ice from the Lincoln Sea	PLOS ONE			English	Article							SNOW COVER; ARCTIC-OCEAN; GREENLAND SEA; PACK-ICE; BIOMASS; MICROALGAE; MEIOFAUNA; ABUNDANCE; GROWTH; PHYTOPLANKTON	With near-complete replacement of Arctic multi-year ice (MYI) by first-year ice (FYI) predicted to occur within this century, it remains uncertain how the loss of MYI will impact the abundance and distribution of sea ice associated algae. In this study we compare the chlorophyll a (chl a) concentrations and physical properties of MYI and FYI from the Lincoln Sea during 3 spring seasons (2010-2012). Cores were analysed for texture, salinity, and chl a. We identified annual growth layers for 7 of 11 MYI cores and found no significant differences in chl a concentration between the bottom first-year-ice portions of MYI, upper old-ice portions of MYI, and FYI cores. Overall, the maximum chl a concentrations were observed at the bottom of young FYI. However, there were no significant differences in chl a concentrations between MYI and FYI. This suggests little or no change in algal biomass with a shift from MYI to FYI and that the spatial extent and regional variability of refrozen leads and younger FYI will likely be key factors governing future changes in Arctic sea ice algal biomass. Bottom-integrated chl a concentrations showed negative logistic relationships with snow depth and bulk (snow plus ice) integrated extinction coefficients; indicating a strong influence of snow cover in controlling bottom ice algal biomass. The maximum bottom MYI chl a concentration was observed in a hummock, representing the thickest ice with lowest snow depth of this study. Hence, in this and other studies MYI chl a biomass may be under-estimated due to an under-representation of thick MYI (e.g., hummocks), which typically have a relatively thin snowpack allowing for increased light transmission. Therefore, we suggest the on-going loss of MYI in the Arctic Ocean may have a larger impact on ice-associated production than generally assumed.	[Lange, Benjamin A.; Flores, Hauke] Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, Polar Biol Oceanog, Bremerhaven, Germany; [Lange, Benjamin A.; Flores, Hauke] Univ Hamburg, Ctr Nat Hist CeNak, Zool Museum, Bioctr Grindel, Hamburg, Germany; [Lange, Benjamin A.; Beckers, Justin F.; Casey, J. Alec; Haas, Christian] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB, Canada; [Michel, Christine; Meisterhans, Guillaume; Niemi, Andrea] Fisheries & Oceans Canada, Inst Freshwater, Winnipeg, MB R3T 2N6, Canada; [Hatam, Ido] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Haas, Christian] York Univ, Dept Earth & Space Sci & Engn, Toronto, ON M3J 2R7, Canada	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Hamburg; University of Alberta; Fisheries & Oceans Canada; University of Alberta; York University - Canada	Lange, BA (corresponding author), Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, Polar Biol Oceanog, Bremerhaven, Germany.	benjamin.lange@awi.de	Flores, Hauke/ABD-1888-2020; Beckers, Justin/I-2806-2014; Haas, Christian/L-5279-2016; Lange, Benjamin/H-4733-2017	Flores, Hauke/0000-0003-1617-5449; Beckers, Justin/0000-0003-0751-3995; Haas, Christian/0000-0002-7674-3500; Casey, Alec/0000-0001-6011-4112; Lange, Benjamin Allen/0000-0003-4534-8978	Alberta Ingenuity Scholarship program [RN:200700172]; NSERC [356589-08]; Canadian Federal Programme on Energy Research and Development; Polar Continental Shelf Project; Northern Scientific Training Program (NSTP); Circumpolar-Boreal Arctic Research (C-BAR) program; Helmholtz Young Investigators Group "Iceflux" [VH-NG-800]	Alberta Ingenuity Scholarship program; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Federal Programme on Energy Research and Development; Polar Continental Shelf Project(Natural Resources Canada); Northern Scientific Training Program (NSTP); Circumpolar-Boreal Arctic Research (C-BAR) program; Helmholtz Young Investigators Group "Iceflux"	This study was supported by the Alberta Ingenuity Scholarship program (RN:200700172) to CH, NSERC Discovery Grants to CH (356589-08) and CM (http://www.nserc-crsng.gc.ca/index_eng.asp), and the Canadian Federal Programme on Energy Research and Development to CM (http://www.nrcan.gc.ca/energy/funding/current-funding-programs/perd/4993). Some in-kind support was provided by the Polar Continental Shelf Project (PCSP; http://www.nrcan.gc.ca/the-north/polarcontinental-shelf-program). BAL, JB, JAC, and IH were supported by the Northern Scientific Training Program (NSTP) and Circumpolar-Boreal Arctic Research (C-BAR) program. Additional funding was provided to HF and BAL as part of the Helmholtz Young Investigators Group "Iceflux" (VH-NG-800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alou-Font E, 2013, MAR ECOL PROG SER, V474, P89, DOI 10.3354/meps10107; [Anonymous], 2011, SNOW WATER ICE PERMA; Arrigo KR, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007151; Arrigo KR, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035028; ARRIGO KR, 1991, J GEOPHYS RES-OCEANS, V96, P10581, DOI 10.1029/91JC00455; Arrigo KR, 2004, ANTARCT SCI, V16, P471, DOI 10.1017/S0954102004002263; Arrigo KR., 2010, SEA ICE, P283, DOI DOI 10.1002/9781444317145.CH8; BARLOW RG, 1988, MAR ECOL PROG SER, V45, P145, DOI 10.3354/meps045145; Boetius A, 2013, SCIENCE, V339, P1430, DOI 10.1126/science.1231346; Bowman JS, 2011, ISME J, P1, DOI [10.1038/ismej.2011.71, DOI 10.1038/ISMEJ.2011.71]; Budge SM, 2008, OECOLOGIA, V157, P117, DOI 10.1007/s00442-008-1053-7; Campbell K, 2014, J MARINE SY IN PRESS; Cota GF., 1991, J MARINE SYST, V2, P257, DOI [10.1016/0924-7963(91)90036-T, DOI 10.1016/0924-7963(91)90036-T]; COTA GF, 1991, J MARINE SYST, V2, P297, DOI DOI 10.1016/0924-7963(91)90038-V; COX GFN, 1983, J GLACIOL, V29, P306, DOI 10.3189/S0022143000008364; EICKEN H, 1989, J GEOPHYS RES-OCEANS, V94, P8193, DOI 10.1029/JC094iC06p08193; EICKEN H, 1995, J GEOPHYS RES-OCEANS, V100, P22697, DOI 10.1029/95JC02188; GOSSELIN M, 1985, CAN J FISH AQUAT SCI, V42, P999, DOI 10.1139/f85-125; Gosselin M, 1997, DEEP-SEA RES PT II, V44, P1623, DOI 10.1016/S0967-0645(97)00054-4; GOSSELIN M, 1990, J PHYCOL, V26, P220, DOI 10.1111/j.0022-3646.1990.00220.x; GOSSELIN M, 1986, MAR ECOL PROG SER, V29, P289, DOI 10.3354/meps029289; Gradinger R, 1997, POLAR BIOL, V17, P448, DOI 10.1007/s003000050139; Gradinger R, 1999, MAR BIOL, V133, P745, DOI 10.1007/s002270050516; Gradinger R, 2005, POLAR BIOL, V28, P171, DOI 10.1007/s00300-004-0674-5; Gradinger R, 1999, DEEP-SEA RES PT II, V46, P1457, DOI 10.1016/S0967-0645(99)00030-2; Gradinger R, 2010, DEEP-SEA RES PT II, V57, P86, DOI 10.1016/j.dsr2.2009.08.008; Grenfell TC, 1977, J GLACIOL, V18, P445, DOI [DOI 10.3189/S0022143000021122, 10.3189/S0022143000021122]; Haas C, 2006, ANN GLACIOL-SER, V44, P247, DOI 10.3189/172756406781811781; Haas C, 2011, CRYOVEX 2011 ALERT S, P1; Haas C, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042652; Hamre B, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001926; Hatam I, 2014, FEMS MICROBIOLOGY EC, P1; HORNER R, 1982, ARCTIC, V35, P485; Howell SEL, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037681; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Jarvinen O, 2011, J GLACIOL, V57, P861; Jeffries MO, 1988, ANN GLACIOL, V10, P63, DOI DOI 10.3198/1988A0G10-63-67; Kovacs Kit M., 2011, Marine Biodiversity, V41, P181, DOI 10.1007/s12526-010-0061-0; Kwok R, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039035; Kwok R, 2005, GEOPHYS RES LETT; Kwok R, 2010, GEOPHYS RES LETT; Lalande C, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040570; Lange M.A., 1988, ANN GLACIOL, V10, P95; LANGE MA, 1989, ANN GLACIOL, V12, P92, DOI DOI 10.3189/S0260305500007023; Lavoie D, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2005JC002922; Legendre L., 1991, J MARINE SYST, V2, P347, DOI DOI 10.1016/0924-7963(91)90041-R; Leu E, 2011, PROG OCEANOGR, V90, P18, DOI 10.1016/j.pocean.2011.02.004; Light B, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2006JC003977; Lund-Hansen LC, 2014, POLAR BIOL, V37, P471, DOI 10.1007/s00300-013-1444-z; Markus T, 2009, J GEOPHYS RES; Maslanik JA, 2011, GEOPHYS RES LETT; MASSONNET F, 2012, CRYOSPHERE, V6, P1383, DOI [10.5194/tc-6-1383-2012, DOI 10.5194/tc-6-1383-2012]; MAYKUT GA, 1975, LIMNOL OCEANOGR, V20, P554, DOI 10.4319/lo.1975.20.4.0554; MAYKUT GA, 1971, J GEOPHYS RES, V76, P1550, DOI 10.1029/JC076i006p01550; MCROY CP, 1974, OCEANOGRAPHY BERING, P403; Melnikov IA, 2002, DEEP-SEA RES PT I, V49, P1623, DOI 10.1016/S0967-0637(02)00042-0; Michel C, 1996, J GEOPHYS RES-OCEANS, V101, P18345, DOI 10.1029/96JC00045; MICHEL C, 1988, MAR ECOL PROG SER, V50, P177, DOI 10.3354/meps050177; Michel C., 2013, ARCTIC BIODIVERSITY, P486, DOI 10.1201/9780203757222-17.; Mundy CJ, 2011, POLAR BIOL, V34, P1869, DOI 10.1007/s00300-011-0998-x; Mundy CJ, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003683; Newton JL, 1997, J GEOPHYS RES-OCEANS, V102, P3393, DOI 10.1029/96JC03441; Nicolaus M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053738; Nicolaus M, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC006074; Nozais C, 2001, MAR ECOL PROG SER, V217, P235, DOI 10.3354/meps217235; Overland JE, 2013, GEOPHYS RES LETT, V40, P2097, DOI 10.1002/grl.50316; Parkinson CL, 2013, GEOPHYS RES LETT, V40, DOI 10.1002/grl.50349; Parsons T.R., 1989, MANUAL CHEM BIOL MET; Perovich DK, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001079; Perovich DK, 1996, COLD REGIONS RES ENG, P96; R Development Core Team, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; Rampal P, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007110; Riedel A, 2006, AQUAT MICROB ECOL, V45, P195, DOI 10.3354/ame045195; Rigor IG, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019492; Rigor IG, 2002, J CLIMATE, V15, P2648, DOI 10.1175/1520-0442(2002)015<2648:ROSITT>2.0.CO;2; Riihela A, 2013, NAT CLIM CHANGE, V3, P895, DOI [10.1038/NCLIMATE1963, 10.1038/nclimate1963]; Rintala JM, 2014, POLAR BIOL, V37, P1811, DOI 10.1007/s00300-014-1563-1; Rysgaard S, 2008, POLAR BIOL, V31, P527, DOI 10.1007/s00300-007-0384-x; Schunemann H, 2005, MAR BIOL, V146, P1091, DOI 10.1007/s00227-004-1511-7; SCHWARZACHER W, 1959, J GEOPHYS RES, V64, P2357, DOI 10.1029/JZ064i012p02357; Screen JA, 2010, NATURE, V464, P1334, DOI 10.1038/nature09051; SMITH REH, 1990, MAR BIOL, V107, P255, DOI 10.1007/BF01319824; Soreide JE, 2006, PROG OCEANOGR, V71, P59, DOI 10.1016/j.pocean.2006.06.001; Soreide JE, 2013, MAR BIOL RES, V9, P831, DOI 10.1080/17451000.2013.775457; Soreide JE, 2010, GLOBAL CHANGE BIOL, V16, P3154, DOI 10.1111/j.1365-2486.2010.02175.x; Stammerjohn S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL050874; Stroeve JC, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021810; Stroeve JC, 2012, CLIMATIC CHANGE, V110, P1005, DOI 10.1007/s10584-011-0101-1; Stroeve JC, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052676; Sturm M, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2000JC000400; THOMAS DN, 1995, POLAR BIOL, V15, P477; Tremblay JE, 2012, CLIMATIC CHANGE, V115, P161, DOI 10.1007/s10584-012-0496-3; Vancoppenolle M, 2013, QUATERNARY SCI REV, V79, P207, DOI 10.1016/j.quascirev.2013.04.011; Werner I, 2002, MAR BIOL, V140, P317, DOI 10.1007/s00227-001-0709-1	95	24	26	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0122418	10.1371/journal.pone.0122418	http://dx.doi.org/10.1371/journal.pone.0122418			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901605	Green Submitted, gold, Green Published			2022-12-26	WOS:000353331500021
J	Stayte, S; Rentsch, P; Li, KM; Vissel, B				Stayte, Sandy; Rentsch, Peggy; Li, Kong M.; Vissel, Bryce			Activin A Protects Midbrain Neurons in the 6-Hydroxydopamine Mouse Model of Parkinson's Disease	PLOS ONE			English	Article							NIGRAL DOPAMINERGIC-NEURONS; SUBSTANTIA-NIGRA; 6-OHDA LESION; NIGROSTRIATAL PATHWAY; FUNCTIONAL RECOVERY; NEUROTROPHIC FACTOR; TIME-COURSE; RAT MODEL; GDNF; DELIVERY	Parkinson's disease (PD) is a chronic neurodegenerative disease characterized by a significant loss of dopaminergic neurons within the substantia nigra pars compacta (SNpc) and a subsequent loss of dopamine (DA) within the striatum. Despite advances in the development of pharmacological therapies that are effective at alleviating the symptoms of PD, the search for therapeutic treatments that halt or slow the underlying nigral degeneration remains a particular challenge. Activin A, a member of the transforming growth factor beta superfamily, has been shown to play a role in the neuroprotection of midbrain neurons against 6-hydroxydopamine (6-OHDA) in vitro, suggesting that activin A may offer similar neuroprotective effects in in vivo models of PD. Using robust stereological methods, we found that intrastriatal injections of 6-OHDA results in a significant loss of both TH positive and NeuN positive populations in the SNpc at 1, 2, and 3 weeks post-lesioning in drug naive mice. Exogenous application of activin A for 7 days, beginning the day prior to 6-OHDA administration, resulted in a significant survival of both dopaminergic and total neuron numbers in the SNpc against 6-OHDA-induced toxicity. However, we found no corresponding protection of striatal DA or dopamine transporter (DAT) expression levels in animals receiving activin A compared to vehicle controls. These results provide the first evidence that activin A exerts potent neuroprotection in a mouse model of PD, however this neuroprotection may be localized to the midbrain.	[Stayte, Sandy; Rentsch, Peggy; Vissel, Bryce] Garvan Inst Med Res, Neurosci Dept, Sydney, NSW, Australia; [Stayte, Sandy] UNSW Australia, Fac Med, Sydney, NSW, Australia; [Rentsch, Peggy] UNSW Australia, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Li, Kong M.] Univ Sydney, Dept Pharmacol, Bosch Inst, Sydney Med Sch, Sydney, NSW 2006, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney; University of New South Wales Sydney; University of Sydney	Vissel, B (corresponding author), Garvan Inst Med Res, Neurosci Dept, Sydney, NSW, Australia.	brycevissel@gmail.com	Stayte, Sandy/AAC-5457-2019; Li, Kong M./R-4655-2019	Stayte, Sandy/0000-0002-6518-1979; Li, Kong/0000-0003-2709-0344; Rentsch, Peggy/0000-0002-2108-3568; Vissel, Bryce/0000-0001-8860-8050	Parkinson's NSW; Bill Gruy; Boyarsky family; Stanley and John Roth; David Baffsky; Patricia A. Quick Foundation; David King; Doug Battersby; Iain S. Gray Foundation in memory of Kylie; FIVEX in memory of Marko Berger; Tony and Vivian Howland-Rose; Walter and Edith Sheldon in memory of Walter Sheldon; Gleneagle Securities; Geoffrey Towner; Amadeus Energy Ltd.; Nick and Melanie Kell, J. O. and J. R.; Wicking Trust; Mason Foundation and SpinalCure Australia	Parkinson's NSW; Bill Gruy; Boyarsky family; Stanley and John Roth; David Baffsky; Patricia A. Quick Foundation; David King; Doug Battersby; Iain S. Gray Foundation in memory of Kylie; FIVEX in memory of Marko Berger; Tony and Vivian Howland-Rose; Walter and Edith Sheldon in memory of Walter Sheldon; Gleneagle Securities; Geoffrey Towner; Amadeus Energy Ltd.; Nick and Melanie Kell, J. O. and J. R.; Wicking Trust; Mason Foundation and SpinalCure Australia	Funding provided by Parkinson's NSW, Bill Gruy, The Boyarsky family, Stanley and John Roth, David Baffsky, Patricia A. Quick Foundation, David King, Doug Battersby, Iain S. Gray Foundation in memory of Kylie, FIVEX in memory of Marko Berger, Tony and Vivian Howland-Rose, Walter and Edith Sheldon in memory of Walter Sheldon, Gleneagle Securities, Geoffrey Towner, Amadeus Energy Ltd., Nick and Melanie Kell, J. O. and J. R. Wicking Trust and the Mason Foundation and SpinalCure Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdipranoto-Cowley A, 2009, STEM CELLS, V27, P1330, DOI 10.1002/stem.80; Bartus RT, 2013, NEUROLOGY, V80, P1698, DOI 10.1212/WNL.0b013e3182904faa; Bartus RT, 2011, MOVEMENT DISORD, V26, P27, DOI 10.1002/mds.23442; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Bezard E, 2001, J NEUROSCI, V21, P6853, DOI 10.1523/JNEUROSCI.21-17-06853.2001; Cenci MA, 2007, CURR PROTOC NEUROSCI; Eberling JL, 2009, HUM GENE THER, V20, P511, DOI 10.1089/hum.2008.201; Eslamboli A, 2003, EXP NEUROL, V184, P536, DOI 10.1016/j.expneurol.2003.08.007; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Herzog CD, 2013, NEUROBIOL DIS, V58, P38, DOI 10.1016/j.nbd.2013.04.011; Jaber M, 1999, EUR J NEUROSCI, V11, P3499, DOI 10.1046/j.1460-9568.1999.00764.x; JEON BS, 1995, NEURODEGENERATION, V4, P131, DOI 10.1006/neur.1995.0016; Johnston LC, 2009, HUM GENE THER, V20, P497, DOI 10.1089/hum.2008.137; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; Kirik D, 2000, EUR J NEUROSCI, V12, P3871, DOI 10.1046/j.1460-9568.2000.00274.x; Kordower JH, 2013, MOVEMENT DISORD, V28, P96, DOI 10.1002/mds.25344; Kordower JH, 1999, ANN NEUROL, V46, P419, DOI 10.1002/1531-8249(199909)46:3<419::AID-ANA21>3.0.CO;2-Q; KRIEGLSTEIN K, 1995, EMBO J, V14, P736, DOI 10.1002/j.1460-2075.1995.tb07052.x; Kupershmidt L, 2007, J NEUROCHEM, V103, P962, DOI 10.1111/j.1471-4159.2007.04785.x; Lai M, 1996, NEUROSCIENCE, V70, P1013, DOI 10.1016/0306-4522(95)00413-0; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Rosenblad C, 2000, EXP NEUROL, V161, P503, DOI 10.1006/exnr.1999.7296; Rosenblad C, 1999, EUR J NEUROSCI, V11, P1554, DOI 10.1046/j.1460-9568.1999.00566.x; SAUER H, 1994, NEUROSCIENCE, V59, P401, DOI 10.1016/0306-4522(94)90605-X; SAUER H, 1995, P NATL ACAD SCI USA, V92, P8935, DOI 10.1073/pnas.92.19.8935; Stayte S, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00113; Stott SRW, 2014, EUR J NEUROSCI, V39, P1042, DOI 10.1111/ejn.12459; Tretter YP, 2000, NAT MED, V6, P812, DOI 10.1038/77548; Tretter YP, 1996, NEUROREPORT, V7, P1819, DOI 10.1097/00001756-199607290-00026; Vaughan RA, 2013, TRENDS PHARMACOL SCI, V34, P489, DOI 10.1016/j.tips.2013.07.005; Wang L, 2002, GENE THER, V9, P381, DOI 10.1038/sj.gt.3301682; Winkler C, 1996, J NEUROSCI, V16, P7206	32	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124325	10.1371/journal.pone.0124325	http://dx.doi.org/10.1371/journal.pone.0124325			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902062	Green Submitted, gold, Green Published			2022-12-26	WOS:000353331500081
J	Paz-Ferreiro, J; Liang, CF; Fu, SL; Mendez, A; Gasco, G				Paz-Ferreiro, Jorge; Liang, Chenfei; Fu, Shenglei; Mendez, Ana; Gasco, Gabriel			The Effect of Biochar and Its Interaction with the Earthworm Pontoscolex corethrurus on Soil Microbial Community Structure in Tropical Soils	PLOS ONE			English	Article							RICE STRAW; BIOMASS; CARBON; EMISSIONS; BACTERIAL; PROFILES; IMPACTS; N2O; CO2	Biochar effects on soil microbial abundance and community structure are keys for understanding the biogeochemical cycling of nutrients and organic matter turnover, but are poorly understood, in particular in tropical areas. We conducted a greenhouse experiment in which we added biochars produced from four different feedstocks [sewage sludge (B1), deinking sewage sludge (B2), Miscanthus (B3) and pine wood (B4)] at a rate of 3% (w/w) to two tropical soils (an Acrisol and a Ferralsol) planted with proso millet (Panicum milliaceum L.). The interactive effect of the addition of earthworms was also addressed. For this purpose we utilized soil samples from pots with or without the earthworm Pontoscolex corethrurus, which is a ubiquitous earthworm in tropical soils. Phospholipid fatty acid (PLFA) measurements showed that biochar type, soil type and the presence of earthworms significantly affected soil microbial community size and structure. In general, biochar addition affected fungal but not bacterial populations. Overall, biochars rich in ash (B1 and B2) resulted in a marked increase in the fungi to bacteria ratio, while this ratio was unaltered after addition of biochars with a high fixed carbon content (B3 and B4). Our study remarked the contrasting effect that both, biochar prepared from different materials and macrofauna, can have on soil microbial community. Such changes might end up with ecosystem-level effects.	[Paz-Ferreiro, Jorge] RMIT Univ, Sch Civil Environm & Chem Engn, Melbourne, Vic, Australia; [Liang, Chenfei; Fu, Shenglei] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [Liang, Chenfei] Univ Chinese Acad Sci, Beijing, Peoples R China; [Mendez, Ana] Univ Politecn Madrid, ETSI Minas, Dept Ingn Geol & Minera, Madrid, Spain; [Gasco, Gabriel] Univ Politecn Madrid, ETSI Agron, Dept Prod Agr, Madrid, Spain	Royal Melbourne Institute of Technology (RMIT); Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Universidad Politecnica de Madrid; Universidad Politecnica de Madrid	Paz-Ferreiro, J (corresponding author), RMIT Univ, Sch Civil Environm & Chem Engn, Melbourne, Vic, Australia.	jorge.paz-ferreiro@rmit.edu.au	Fu, Shenglei/B-2729-2012; Méndez, Ana María/L-5946-2014; Paz-Ferreiro, Jorge/H-6297-2011	Méndez, Ana María/0000-0001-9642-0875; Paz-Ferreiro, Jorge/0000-0001-8169-4099	Chinese Academy of Sciences (fellowship for Young International Scientists) [2012Y1SA0002]	Chinese Academy of Sciences (fellowship for Young International Scientists)	J. Paz-Ferreiro was sponsored by the Chinese Academy of Sciences (fellowship for Young International Scientists number 2012Y1SA0002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aira M, 2014, J SOIL SEDIMENT, V14, P1335, DOI 10.1007/s11368-014-0889-1; Ameloot N, 2015, GCB BIOENERGY, V7, P135, DOI 10.1111/gcbb.12119; Ameloot N, 2013, SOIL BIOL BIOCHEM, V57, P401, DOI 10.1016/j.soilbio.2012.10.025; Augustenborg CA, 2012, J ENVIRON QUAL, V41, P1203, DOI 10.2134/jeq2011.0119; Bossio DA, 1998, MICROBIAL ECOL, V35, P265, DOI 10.1007/s002489900082; Bougnom BP, 2010, APPL SOIL ECOL, V45, P319, DOI 10.1016/j.apsoil.2010.05.009; BROWN GG, 1995, PLANT SOIL, V170, P209, DOI 10.1007/BF02183068; Case SDC, 2012, SOIL BIOL BIOCHEM, V51, P125, DOI 10.1016/j.soilbio.2012.03.017; Curry JP, 2007, PEDOBIOLOGIA, V50, P463, DOI 10.1016/j.pedobi.2006.09.001; de Vries FT, 2012, NAT CLIM CHANGE, V2, P276, DOI [10.1038/NCLIMATE1368, 10.1038/nclimate1368]; Dominguez J, 2004, EARTHWORM ECOLOGY, P401; Enami Y, 2001, EUR J SOIL BIOL, V37, P269, DOI 10.1016/S1164-5563(01)01096-2; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; Gomez JD, 2014, EUR J SOIL SCI, V65, P28, DOI 10.1111/ejss.12097; Gormsen D, 2004, APPL SOIL ECOL, V27, P211, DOI 10.1016/j.apsoil.2004.06.001; Kim JS, 2007, SOIL BIOL BIOCHEM, V39, P684, DOI 10.1016/j.soilbio.2006.08.010; Kramer C, 2008, SOIL BIOL BIOCHEM, V40, P425, DOI 10.1016/j.soilbio.2007.09.016; Lehmann J, 2011, SOIL BIOL BIOCHEM, V43, P1812, DOI 10.1016/j.soilbio.2011.04.022; Liu L, 2012, SOIL BIOL BIOCHEM, V44, P31, DOI 10.1016/j.soilbio.2011.08.017; Liu XY, 2013, PLANT SOIL, V373, P583, DOI 10.1007/s11104-013-1806-x; Mader P, 2002, SCIENCE, V296, P1694, DOI 10.1126/science.1071148; McCormack SA, 2013, GCB BIOENERGY, V5, P81, DOI 10.1111/gcbb.12046; Mendez A, 2012, CHEMOSPHERE, V89, P1354, DOI 10.1016/j.chemosphere.2012.05.092; Muhammad N, 2014, GEODERMA, V226, P270, DOI 10.1016/j.geoderma.2014.01.023; Noguera D, 2012, SOIL BIOL BIOCHEM, V52, P13, DOI 10.1016/j.soilbio.2012.04.004; Noguera D, 2010, SOIL BIOL BIOCHEM, V42, P1017, DOI 10.1016/j.soilbio.2010.03.001; Olsson PA, 1999, FEMS MICROBIOL ECOL, V29, P303, DOI 10.1111/j.1574-6941.1999.tb00621.x; Paz-Ferreiro J, 2012, BIOL FERT SOILS, V48, P511, DOI 10.1007/s00374-011-0644-3; Paz-Ferreiro J, 2014, J SOIL SEDIMENT, V14, P483, DOI 10.1007/s11368-013-0806-z; Peng X, 2011, SOIL TILL RES, V112, P159, DOI 10.1016/j.still.2011.01.002; Ponge JF, 2006, SOIL BIOL BIOCHEM, V38, P2008, DOI 10.1016/j.soilbio.2005.12.024; Prayogo C, 2014, BIOL FERT SOILS, V50, P695, DOI 10.1007/s00374-013-0884-5; Rousk J, 2010, SOIL BIOL BIOCHEM, V42, P516, DOI 10.1016/j.soilbio.2009.11.026; Sanchez PA, 1992, MYTHS SCI SOILS TROP, P17; Steinbeiss S, 2009, SOIL BIOL BIOCHEM, V41, P1301, DOI 10.1016/j.soilbio.2009.03.016; Van Zwieten L, 2010, PLANT SOIL, V327, P235, DOI 10.1007/s11104-009-0050-x; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Yin YF, 2014, J INTEGR AGR, V13, P491, DOI 10.1016/S2095-3119(13)60704-2	38	39	39	3	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124891	10.1371/journal.pone.0124891	http://dx.doi.org/10.1371/journal.pone.0124891			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898344	Green Published, gold, Green Submitted			2022-12-26	WOS:000353212600093
J	Sonestedt, E; Hellstrand, S; Schulz, CA; Wallstrom, P; Drake, I; Ericson, U; Gullberg, B; Hedblad, B; Orho-Melander, M				Sonestedt, Emily; Hellstrand, Sophie; Schulz, Christina-Alexandra; Wallstrom, Peter; Drake, Isabel; Ericson, Ulrika; Gullberg, Bo; Hedblad, Bo; Orho-Melander, Marju			The Association between Carbohydrate-Rich Foods and Risk of Cardiovascular Disease Is Not Modified by Genetic Susceptibility to Dyslipidemia as Determined by 80 Validated Variants	PLOS ONE			English	Article							WHOLE-GRAIN INTAKE; SWEETENED BEVERAGE CONSUMPTION; CORONARY-HEART-DISEASE; DIET HISTORY METHOD; MALMO DIET; HABIT CHANGE; CANCER; OBESITY; STROKE; CEREAL	Background It is still unclear whether carbohydrate consumption is associated with cardiovascular disease (CVD) risk. Genetic susceptibility might modify the associations between dietary intakes and disease risk. Objectives The aim was to examine the association between the consumption of carbohydrate-rich foods (vegetables, fruits and berries, juice, potatoes, whole grains, refined grains, cookies and cakes, sugar and sweets, and sugar-sweetened beverages) and the risk of incident ischemic CVD (iCVD; coronary events and ischemic stroke), and whether these associations differ depending on genetic susceptibility to dyslipidemia. Methods Among 26,445 individuals (44-74 years; 62% females) from the Malmo Diet and Cancer Study cohort, 2,921 experienced an iCVD event during a mean follow-up time of 14 years. At baseline, dietary data were collected using a modified diet history method, and clinical risk factors were measured in 4,535 subjects. We combined 80 validated genetic variants associated with triglycerides and HDL-C or LDL-C, into genetic risk scores and examined the interactions between dietary intakes and genetic risk scores on the incidence of iCVD. Results Subjects in the highest intake quintile for whole grains had a 13% (95% CI: 3-23%; p-trend: 0.002) lower risk for iCVD compared to the lowest quintile. A higher consumption of foods rich in added sugar (sugar and sweets, and sugar-sweetened beverages) had a significant cross-sectional association with higher triglyceride concentrations and lower HDL-C concentrations. A stronger positive association between a high consumption of sugar and sweets on iCVD risk was observed among those with low genetic risk score for triglycerides (p-interaction=0.05). Conclusion In this prospective cohort study that examined food sources of carbohydrates, individuals with a high consumption of whole grains had a decreased risk of iCVD. No convincing evidence of an interaction between genetic susceptibility for dyslipidemia, measured as genetic risk scores of dyslipidemia-associated variants, and the consumption of carbohydrate-rich foods on iCVD risk was observed.	[Sonestedt, Emily; Hellstrand, Sophie; Schulz, Christina-Alexandra; Ericson, Ulrika; Orho-Melander, Marju] Lund Univ, Dept Clin Sci Malmo, Diabet & Cardiovasc Dis Genet Epidemiol, Malmo, Sweden; [Wallstrom, Peter; Drake, Isabel; Gullberg, Bo] Lund Univ, Dept Clin Sci Malmo, Nutr Epidemiol, Malmo, Sweden; [Hedblad, Bo] Lund Univ, Dept Clin Sci Malmo, Cardiovasc Dis Epidemiol, Malmo, Sweden	Lund University; Lund University; Lund University	Sonestedt, E (corresponding author), Lund Univ, Dept Clin Sci Malmo, Diabet & Cardiovasc Dis Genet Epidemiol, Malmo, Sweden.	Emily.Sonestedt@med.lu.se	Sonestedt, Emily/I-3814-2016	Sonestedt, Emily/0000-0002-0747-4562; Drake, Isabel/0000-0002-6500-6310	Swedish Medical Research Council; Swedish Heart and Lung Foundation; Skane University Hospital; Albert Pahlsson Research Foundation; Crafoord Foundation; Swedish Society for Medical Research; Novo Nordisk Fonden [NNF14OC0011049] Funding Source: researchfish	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Skane University Hospital; Albert Pahlsson Research Foundation; Crafoord Foundation; Swedish Society for Medical Research; Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was supported by the Swedish Medical Research Council, Swedish Society for Medical Research, the Swedish Heart and Lung Foundation, the Skane University Hospital, the Albert Pahlsson Research Foundation, and the Crafoord Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson KE, 2012, MOL NUTR FOOD RES, V56, P1003, DOI 10.1002/mnfr.201100706; [Anonymous], 2000, VARD DIAGN AK HJART; Becker W, 2002, RIKSMATEN 1997 98 KO, DOI [10.1007/s00394-008-0701-3, DOI 10.1007/S00394-008-0701-3]; Bernstein AM, 2012, AM J CLIN NUTR, V95, P1190, DOI 10.3945/ajcn.111.030205; CALLMER E, 1993, J INTERN MED, V233, P53, DOI 10.1111/j.1365-2796.1993.tb00648.x; Costabile A, 2008, BRIT J NUTR, V99, P110, DOI 10.1017/S0007114507793923; de Koning L, 2012, CIRCULATION, V125, P1735, DOI 10.1161/CIRCULATIONAHA.111.067017; Elmstahl S, 1996, EUR J CLIN NUTR, V50, P143; Elmstahl S, 1996, EUR J CLIN NUTR, V50, P134; Eshak ES, 2012, AM J CLIN NUTR, V96, P1390, DOI 10.3945/ajcn.112.037903; Fung TT, 2009, AM J CLIN NUTR, V89, P1037, DOI 10.3945/ajcn.2008.27140; Hellstrand S, 2012, J LIPID RES, V53, P1183, DOI 10.1194/jlr.P023721; Hlebowicz J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071095; Kyro C, 2013, CANCER CAUSE CONTROL, V24, P1363, DOI 10.1007/s10552-013-0215-z; Maersk M, 2012, AM J CLIN NUTR, V95, P283, DOI 10.3945/ajcn.111.022533; Manjer J, 2001, EUR J CANCER PREV, V10, P489, DOI 10.1097/00008469-200112000-00003; Manjer J, 2002, SCAND J PUBLIC HEALT, V30, P103, DOI 10.1080/14034940210133771; Mellen PB, 2008, NUTR METAB CARDIOVAS, V18, P283, DOI 10.1016/j.numecd.2006.12.008; Mente A, 2009, ARCH INTERN MED, V169, P659, DOI 10.1001/archinternmed.2009.38; Nettleton JA, 2010, DIABETES CARE, V33, P2684, DOI 10.2337/dc10-1150; Pollin TI, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002895; Pollin TI, 2011, J CLIN ENDOCR METAB, V96, pE1142, DOI 10.1210/jc.2010-2324; Riboli E, 1997, INT J EPIDEMIOL, V26, pS161, DOI 10.1093/ije/26.suppl_1.S161; Sharma S, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-65; Silbernagel G, 2012, EXP DIABETES RES, DOI 10.1155/2012/361863; Sonestedt E, 2005, PUBLIC HEALTH NUTR, V8, P876, DOI 10.1079/PHN2005736; SONESTEDT E, 2012, HIGH DISACCHARIDE IN, V107, P1062, DOI DOI 10.1017/S0007114511003783; Sonestedt E, 2007, PUBLIC HEALTH NUTR, V10, P769, DOI 10.1017/S1368980007246646; Sonestedt E, 2011, EUR J EPIDEMIOL, V26, P609, DOI 10.1007/s10654-011-9589-y; TESLOVICH TM, 2010, BIOLOGICAL CLIN POPU, V466, P707, DOI DOI 10.1038/NATURE09270; Wallstrom P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031637; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wirfalt E, 2002, NUTR J, V1, DOI 10.1186/1475-2891-1-3; Ye EQ, 2012, J NUTR, V142, P1304, DOI 10.3945/jn.111.155325; Zia E, 2006, CEREBROVASC DIS, V21, P18, DOI 10.1159/000089589	35	25	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0126104	10.1371/journal.pone.0126104	http://dx.doi.org/10.1371/journal.pone.0126104			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898210	Green Published, gold, Green Submitted			2022-12-26	WOS:000353212600103
J	Verdejo-Garcia, A; Moreno-Padilla, M; Garcia-Rios, MC; Lopez-Torrecillas, F; Delgado-Rico, E; Schmidt-Rio-Valle, J; Fernandez-Serrano, MJ				Verdejo-Garcia, Antonio; Moreno-Padilla, Maria; Carmen Garcia-Rios, M.; Lopez-Torrecillas, Francisca; Delgado-Rico, Elena; Schmidt-Rio-Valle, Jacqueline; Fernandez-Serrano, Maria J.			Social Stress Increases Cortisol and Hampers Attention in Adolescents with Excess Weight	PLOS ONE			English	Article							REDUCED OBESE INDIVIDUALS; DECISION-MAKING; PSYCHOSOCIAL STRESS; ANTERIOR CINGULATE; PREFRONTAL CORTEX; PEER REJECTION; GAMBLING TASK; RISK-TAKING; REACTIVITY; RESPONSES	Objective To experimentally examine if adolescents with excess weight are more sensitive to social stress and hence more sensitive to harmful effects of stress in cognition. Design and Methods We conducted an experimental study in 84 adolescents aged 12 to 18 years old classified in two groups based on age adjusted Body Mass Index percentile: Normal weight (n=42) and Excess weight (n=42). Both groups were exposed to social stress as induced by the virtual reality version of the Trier Social Stress Task -participants were requested to give a public speech about positive and negative aspects of their personalities in front of a virtual audience. The outcome measures were salivary cortisol levels and performance in cognitive tests before and after the social stressor. Cognitive tests included the CANTAB Rapid Visual Processing Test (measuring attention response latency and discriminability) and the Iowa Gambling Task (measuring decision-making). Results Adolescents with excess weight compared to healthy weight controls displayed increased cortisol response and less improvement of attentional performance after the social stressor. Decision-making performance decreased after the social stressor in both groups. Conclusion Adolescents who are overweight or obese have increased sensitivity to social stress, which detrimentally impacts attentional skills.	[Verdejo-Garcia, Antonio; Moreno-Padilla, Maria; Lopez-Torrecillas, Francisca; Delgado-Rico, Elena] Univ Granada, Dept Clin Psychol, Granada, Spain; [Verdejo-Garcia, Antonio; Moreno-Padilla, Maria; Lopez-Torrecillas, Francisca; Delgado-Rico, Elena] Univ Granada, Inst Neurosci F Oloriz, Granada, Spain; [Verdejo-Garcia, Antonio] Monash Univ, Sch Psychol Sci, Melbourne, Vic 3004, Australia; [Carmen Garcia-Rios, M.; Schmidt-Rio-Valle, Jacqueline] Univ Granada, Sch Hlth Sci, Granada, Spain; [Fernandez-Serrano, Maria J.] Univ Jaen, Dept Psychol, Jaen, Spain	University of Granada; University of Granada; Monash University; University of Granada; Universidad de Jaen	Verdejo-Garcia, A (corresponding author), Univ Granada, Dept Clin Psychol, Granada, Spain.	antonio.verdejo@monash.edu	Lopez-Torrecillas, Francisca/C-8267-2018; Fernandez-Serrano, Maria Jose/AGA-6711-2022; Serrano, M Josefa Fernández/V-3124-2019; PADILLA, MARÍA M/Z-1050-2018; García-Ríos, María del Carmen/I-3603-2015; del Carmen García-Ríos, María/L-9683-2019; Verdejo-Garcia, Antonio/AAV-1147-2021; Rueda, Maria del Mar/F-9571-2015	Serrano, M Josefa Fernández/0000-0002-6158-237X; García-Ríos, María del Carmen/0000-0003-2913-1410; del Carmen García-Ríos, María/0000-0003-2913-1410; Verdejo-Garcia, Antonio/0000-0001-8874-9339; lopez-torrecillas, francisca/0000-0002-4541-5184; MORENO PADILLA, MARIA/0000-0002-4751-8283; Bauldry, Shawn/0000-0002-6679-3125; Rueda, Maria del Mar/0000-0002-2903-8745; Delgado Rico, Elena/0000-0001-9424-8928	Ministry of Innovation and Science (MICINN) [PSI2010-17290, P-10-HUM-6635]	Ministry of Innovation and Science (MICINN)	This study has been funded by grants PSI2010-17290 (INTEROBE) from the Ministry of Innovation and Science (MICINN), and P-10-HUM-6635 (NEUROECOBE).	Baeken C, 2011, PSYCHONEUROENDOCRINO, V36, P60, DOI 10.1016/j.psyneuen.2010.06.006; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Bechara A, 2007, IOWA GAMBLING TASK; Butler TR, 2014, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00102; Chein J, 2011, DEVELOPMENTAL SCI, V14, pF1, DOI 10.1111/j.1467-7687.2010.01035.x; Chudasama Y, 2003, BEHAV BRAIN RES, V146, P105, DOI 10.1016/j.bbr.2003.09.020; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Davidson RJ, 2012, NAT NEUROSCI, V15, P689, DOI 10.1038/nn.3093; DeSantis AS, 2012, PSYCHONEUROENDOCRINO, V37, P1009, DOI 10.1016/j.psyneuen.2011.11.009; Frazier-Wood AC, OBESITY IN PRESS; Gardner M, 2005, DEV PSYCHOL, V41, P625, DOI 10.1037/0012-1649.41.4.625; Garner DM, 1994, EDI 2 INVENTARIO TRA; Gunnarsdottir T, 2012, J EVAL CLIN PRACT, V18, P465, DOI 10.1111/j.1365-2753.2010.01603.x; Hanson JL, 2012, J NEUROSCI, V32, P7917, DOI 10.1523/JNEUROSCI.0307-12.2012; He Q, 2013, BRAIN STRUCT FUNCT; Jahn AL, 2010, BIOL PSYCHIAT, V67, P175, DOI 10.1016/j.biopsych.2009.07.039; Kelly O, 2007, CYBERPSYCHOL BEHAV, V10, P655, DOI 10.1089/cpb.2007.9973; Kiem SA, 2013, PSYCHONEUROENDOCRINO, V38, P1338, DOI 10.1016/j.psyneuen.2012.11.021; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Kubzansky LD, 2014, JAMA PSYCHIAT, V71, P44, DOI 10.1001/jamapsychiatry.2013.2798; Liang J, 2014, INT J OBESITY, V38, P494, DOI 10.1038/ijo.2013.142; Liu J, 2012, J AM ACAD CHILD PSY, V51, P304, DOI 10.1016/j.jaac.2011.12.014; Lowe C, 1998, NEUROPSYCHOLOGIA, V36, P915, DOI 10.1016/S0028-3932(98)00036-0; Lu QY, 2014, APPETITE, V72, P13, DOI 10.1016/j.appet.2013.09.019; Ludwig DS, 2007, NEW ENGL J MED, V357, P2325, DOI 10.1056/NEJMp0706538; Masten CL, 2013, DEVELOPMENTAL SCI, V16, P743, DOI 10.1111/desc.12056; Masten CL, 2011, DEV PSYCHOPATHOL, V23, P283, DOI 10.1017/S0954579410000799; Moreno-Lopez L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049185; Preston SD, 2007, BEHAV NEUROSCI, V121, P257, DOI 10.1037/0735-7044.121.2.257; Rao U, 2008, BIOL PSYCHIAT, V64, P521, DOI 10.1016/j.biopsych.2008.05.012; Robbins TW, 1998, J INT NEUROPSYCH SOC, V4, P474, DOI 10.1017/s1355617798455073; Root JC, 2009, NEUROREPORT, V20, P429, DOI 10.1097/WNR.0b013e328326a031; Rouach V, 2007, PSYCHONEUROENDOCRINO, V32, P693, DOI 10.1016/j.psyneuen.2007.04.010; Seeyave DM, 2009, ARCH PEDIAT ADOL MED, V163, P303, DOI 10.1001/archpediatrics.2009.12; Slavich GM, 2010, P NATL ACAD SCI USA, V107, P14817, DOI 10.1073/pnas.1009164107; Strauss RS, 2003, ARCH PEDIAT ADOL MED, V157, P746, DOI 10.1001/archpedi.157.8.746; Therrien F, 2007, OBESITY, V15, P377, DOI 10.1038/oby.2007.509; Therrien F, 2010, BIOL PSYCHOL, V84, P325, DOI 10.1016/j.biopsycho.2010.03.013; Thomason ME, 2011, J CHILD PSYCHOL PSYC, V52, P1026, DOI 10.1111/j.1469-7610.2011.02422.x; Tsai SF, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00027; van den Bos R, 2009, PSYCHONEUROENDOCRINO, V34, P1449, DOI 10.1016/j.psyneuen.2009.04.016; van Strien T, 2013, PSYCHONEUROENDOCRINO, V38, P677, DOI 10.1016/j.psyneuen.2012.08.008; VANSTRIEN T, 1986, INT J EAT DISORDER, V5, P295, DOI 10.1002/1098-108X(198602)5:2<295::AID-EAT2260050209>3.0.CO;2-T; Verdejo-Garcia A, 2006, PSYCHOL BELG, V46, P55, DOI 10.5334/pb-46-1-2-55; Verdejo-Garcia A, 2015, HUM BRAIN MAPP, V36, P226, DOI 10.1002/hbm.22625	45	26	27	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123565	10.1371/journal.pone.0123565	http://dx.doi.org/10.1371/journal.pone.0123565			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG3XJ	25898204	Green Published, Green Submitted, gold			2022-12-26	WOS:000353212600031
J	Gabor, CR; Fisher, MC; Bosch, J				Gabor, Caitlin R.; Fisher, Matthew C.; Bosch, Jaime			Elevated Corticosterone Levels and Changes in Amphibian Behavior Are Associated with Batrachochytrium dendrobatidis (Bd) Infection and Bd Lineage	PLOS ONE			English	Article							POPULATION DECLINES; CHYTRIDIOMYCOSIS; STRESS; SUSCEPTIBILITY; TEMPERATURE; PREVALENCE; RESPONSES; DISEASE; GLUCOCORTICOIDS; HORMONE	Few studies have examined the role hormones play in mediating clinical changes associated with infection by the parasite Batrachochytrium dendrobatidis (Bd). Glucocorticoid (GC) hormones such as corticosteroids (CORT) regulate homeostasis and likely play a key role in response to infection in amphibians. We explore the relationship between CORT release rates and Bd infection in tadpoles of the common midwife toad, Alytes obstetricians, using a non-invasive water-borne hormone collection method across seven populations. We further examined whether tadpoles of A. muletensis infected with a hypervirulent lineage of Bd, BdGPL, had greater CORT release rates than those infected with a hypovirulent lineage, BdCAPE. Finally, we examined the relationship between righting reflex and CORT release rates in infected metamorphic toads of A. obstetricans. We found an interaction between elevation and Bd infection status confirming that altitude is associated with the overall severity of infection. In tandem, increasing elevation was associated with increasing CORT release rates. Tadpoles infected with the hypervirulent BdGPL had significantly higher CORT release rates than tadpoles infected with BdCAPE showing that more aggressive infections lead to increased CORT release rates. Infected metamorphs with higher CORT levels had an impaired righting reflex, our defined experimental endpoint. These results provide evidence that CORT is associated with an amphibian's vulnerability to Bd infection, and that CORT is also affected by the aggressiveness of infection by Bd. Together these results indicate that CORT is a viable biomarker of amphibian stress.	[Gabor, Caitlin R.] Texas State Univ, Dept Biol, San Marcos, TX USA; [Fisher, Matthew C.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Bosch, Jaime] CSIC, Museo Nacl Ciencias Nat, E-28006 Madrid, Spain	Texas State University System; Texas State University San Marcos; Imperial College London; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Fisher, MC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, Norfolk Pl, London, England.	matthew.fisher@imperial.ac.uk	Fisher, Matthew/B-9094-2011; Bosch, Jaime/H-3042-2011; Gabor, Caitlin/AAK-8369-2020	Fisher, Matthew/0000-0002-1862-6402; Bosch, Jaime/0000-0002-0099-7934; 	Fundacion General CSIC; Biodiversa Project RACE; UK Natural Environmental Research Council NERC; Banco Santander (Zero Project); NERC [NE/K014455/1] Funding Source: UKRI; Natural Environment Research Council [NE/K014455/1] Funding Source: researchfish	Fundacion General CSIC; Biodiversa Project RACE; UK Natural Environmental Research Council NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Banco Santander (Zero Project); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding was provided by the Fundacion General CSIC and Banco Santander (Zero Project, PI: J. Bosch), the Biodiversa Project RACE (PI: M. C. Fisher) and the UK Natural Environmental Research Council NERC (PI: M. C. Fisher). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Bielby J, 2008, CONSERV LETT, V1, P82, DOI 10.1111/j.1755-263X.2008.00015.x; Blaustein AR, 2012, PHILOS T R SOC B, V367, P1688, DOI 10.1098/rstb.2012.0011; Blaustein AR, 2005, CONSERV BIOL, V19, P1460, DOI 10.1111/j.1523-1739.2005.00195.x; Bosch J, 2001, BIOL CONSERV, V97, P331, DOI 10.1016/S0006-3207(00)00132-4; Bosch J, 2007, P ROY SOC B-BIOL SCI, V274, P253, DOI 10.1098/rspb.2006.3713; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Davis A. K., 2010, Comparative Clinical Pathology, V19, P49, DOI 10.1007/s00580-009-0914-8; Doddington BJ, 2013, ECOLOGY, V94, P1795, DOI 10.1890/12-1270.1; DuRant SE, 2008, GEN COMP ENDOCR, V156, P126, DOI 10.1016/j.ygcen.2007.12.004; Eikenaar C, 2012, AM NAT, V180, P642, DOI 10.1086/667891; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Gabor CR, 2013, AMPHIBIA-REPTILIA, V34, P151, DOI 10.1163/15685381-00002877; Gabor CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056054; Garner TWJ, 2011, GLOBAL CHANGE BIOL, V17, P667, DOI 10.1111/j.1365-2486.2010.02272.x; Garner TWJ, 2009, OIKOS, V118, P783, DOI 10.1111/j.1600-0706.2008.17202.x; Gosner K. L., 1960, Herpetologica, V16, P183; Graham CM, 2013, GEN COMP ENDOCR, V191, P24, DOI 10.1016/j.ygcen.2013.05.012; Homan RN, 2003, GEN COMP ENDOCR, V130, P165, DOI 10.1016/S0016-6480(02)00578-6; Janin A, 2012, CONSERV BIOL, V26, P923, DOI 10.1111/j.1523-1739.2012.01910.x; Janin A, 2011, BIOL CONSERV, V144, P1008, DOI 10.1016/j.biocon.2010.12.009; Kindermann C, 2012, COMP BIOCHEM PHYS A, V162, P171, DOI 10.1016/j.cbpa.2012.02.018; Knapp RA, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00028.1; Kriger KM, 2008, AUSTRAL ECOL, V33, P1022, DOI 10.1111/j.1442-9993.2008.01872.x; Kriger KM, 2007, CONSERV BIOL, V21, P1280, DOI 10.1111/j.1523-1739.2007.00777.x; Landys MM, 2006, GEN COMP ENDOCR, V148, P132, DOI 10.1016/j.ygcen.2006.02.013; Lips KR, 2003, CONSERV BIOL, V17, P1078, DOI 10.1046/j.1523-1739.2003.01623.x; Narayan EJ, 2012, GEN COMP ENDOCR, V178, P301, DOI 10.1016/j.ygcen.2012.06.014; Pearl CA, 2009, ECOHEALTH, V6, P209, DOI 10.1007/s10393-009-0237-x; Peterson JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062146; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Raffel TR, 2006, FUNCT ECOL, V20, P819, DOI 10.1111/j.1365-2435.2006.01159.x; Ribas L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008408; Rollins-Smith LA, 2011, INTEGR COMP BIOL, V51, P552, DOI 10.1093/icb/icr095; Rosenblum EB, 2013, P NATL ACAD SCI USA, V110, P9385, DOI 10.1073/pnas.1300130110; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Sapsford SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082425; Searle CL, 2014, J EXP ZOOL PART A, V321, P243, DOI 10.1002/jez.1855; Tobler U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034667; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Wack CL, 2012, COMP BIOCHEM PHYS A, V161, P153, DOI 10.1016/j.cbpa.2011.10.017; Walker SF, 2010, ECOL LETT, V13, P372, DOI 10.1111/j.1461-0248.2009.01434.x; Warne RW, 2011, FUNCT ECOL, V25, P139, DOI 10.1111/j.1365-2435.2010.01793.x	44	36	36	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0122685	10.1371/journal.pone.0122685	http://dx.doi.org/10.1371/journal.pone.0122685			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893675	Green Published, gold, Green Submitted			2022-12-26	WOS:000353211700015
J	Heroux, ME; Law, TCY; Fitzpatrick, RC; Blouin, JS				Heroux, Martin E.; Law, Tammy C. Y.; Fitzpatrick, Richard C.; Blouin, Jean-Sebastien			Cross-Modal Calibration of Vestibular Afference for Human Balance	PLOS ONE			English	Article							INNERVATING SEMICIRCULAR CANALS; SQUIRREL-MONKEY; HEAD ROTATION; STIMULATION; RESPONSES; REFLEXES; NEURONS; OTOLITH; MOTION; REAFFERENCE	To determine how the vestibular sense controls balance, we used instantaneous head angular velocity to drive a galvanic vestibular stimulus so that afference would signal that head movement was faster or slower than actual. In effect, this changed vestibular afferent gain. This increased sway 4-fold when subjects (N = 8) stood without vision. However, after a 240 s conditioning period with stable balance achieved through reliable visual or somatosensory cues, sway returned to normal. An equivalent galvanic stimulus unrelated to sway (not driven by head motion) was equally destabilising but in this situation the conditioning period of stable balance did not reduce sway. Reflex muscle responses evoked by an independent, higher bandwidth vestibular stimulus were initially reduced in amplitude by the galvanic stimulus but returned to normal levels after the conditioning period, contrary to predictions that they would decrease after adaptation to increased sensory gain and increase after adaptation to decreased sensory gain. We conclude that an erroneous vestibular signal of head motion during standing has profound effects on balance control. If it is unrelated to current head motion, the CNS has no immediate mechanism of ignoring the vestibular signal to reduce its influence on destabilising balance. This result is inconsistent with sensory reweighting based on disturbances. The increase in sway with increased sensory gain is also inconsistent with a simple feedback model of vestibular reflex action. Thus, we propose that recalibration of a forward sensory model best explains the reinterpretation of an altered reafferent signal of head motion during stable balance.	[Heroux, Martin E.; Law, Tammy C. Y.; Blouin, Jean-Sebastien] Univ British Columbia, Sch Kinesiol, Vancouver, BC V5Z 1M9, Canada; [Fitzpatrick, Richard C.] Univ New S Wales, Neurosci Res Australia, Sydney, NSW, Australia; [Fitzpatrick, Richard C.] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Blouin, Jean-Sebastien] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC V5Z 1M9, Canada; [Blouin, Jean-Sebastien] Univ British Columbia, Inst Comp Informat & Cognit Syst, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; Neuroscience Research Australia; University of New South Wales Sydney; University of New South Wales Sydney; University of British Columbia; University of British Columbia	Fitzpatrick, RC (corresponding author), Univ New S Wales, Neurosci Res Australia, Sydney, NSW, Australia.	r.fitzpatrick@neura.edu.au	Heroux, Martin/AAD-7694-2021	Heroux, Martin/0000-0002-3354-7104	Natural Sciences and Engineering Research Council of Canada; Canadian Chiropractic Research Foundation; Michael Smith Foundation for Health Research; National Health and Medical Research Council of Australia; Canadian Institute for Health Research	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Chiropractic Research Foundation; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by a grant to JSB from the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca). JSB received support from the Canadian Chiropractic Research Foundation (www.chiropractic.ca/research-foundation) and the Michael Smith Foundation for Health Research (www.msfhr.org). RCF received support from the National Health and Medical Research Council of Australia (www.nhmrc.gov.au). MEH received a post-doctoral fellowship from the Michael Smith Foundation for Health Research and the Canadian Institute for Health Research (www.cihr-irsc.gc.ca) and support from a Natural Sciences and Engineering Research Council of Canada Discovery Accelerator Supplement awarded to J. Timothy Inglis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allum JHJ, 2001, GAIT POSTURE, V14, P227, DOI 10.1016/S0966-6362(01)00132-1; Bacsi AM, 2005, EXP BRAIN RES, V160, P22, DOI 10.1007/s00221-004-1982-2; Basta D, 2005, HUM MOVEMENT SCI, V24, P268, DOI 10.1016/j.humov.2005.04.002; Brooks JX, 2014, J NEUROPHYSIOL, V111, P2465, DOI 10.1152/jn.00600.2013; Brooks JX, 2013, CURR BIOL, V23, P947, DOI 10.1016/j.cub.2013.04.029; Cathers I, 2005, J PHYSIOL-LONDON, V563, P229, DOI 10.1113/jphysiol.2004.079525; Cenciarini M, 2006, J NEUROPHYSIOL, V95, P2733, DOI 10.1152/jn.00856.2004; Curthoys I S, 1995, J Vestib Res, V5, P67, DOI 10.1016/0957-4271(94)00026-X; Dakin CJ, 2007, J PHYSIOL-LONDON, V583, P1117, DOI 10.1113/jphysiol.2007.133264; Dakin CJ, 2010, J NEUROPHYSIOL, V103, P1048, DOI 10.1152/jn.00881.2009; Day BL, 2005, J PHYSIOL-LONDON, V567, P591, DOI 10.1113/jphysiol.2005.092544; Day BL, 2005, CURR BIOL, V15, P1390, DOI 10.1016/j.cub.2005.06.036; Day BL, 2002, BRAIN, V125, P2081, DOI 10.1093/brain/awf212; Dilda V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112131; FERNANDEZ C, 1971, J NEUROPHYSIOL, V34, P661, DOI 10.1152/jn.1971.34.4.661; Fetsch CR, 2009, J NEUROSCI, V29, P15601, DOI 10.1523/JNEUROSCI.2574-09.2009; Fitzpatrick R, 1996, J NEUROPHYSIOL, V76, P3994, DOI 10.1152/jn.1996.76.6.3994; FITZPATRICK R, 1994, J PHYSIOL-LONDON, V478, P363, DOI 10.1113/jphysiol.1994.sp020257; FITZPATRICK R, 1994, J PHYSIOL-LONDON, V480, P395, DOI 10.1113/jphysiol.1994.sp020369; Fitzpatrick RC, 2004, J APPL PHYSIOL, V96, P2301, DOI 10.1152/japplphysiol.00008.2004; Fitzpatrick RC, 2002, NEUROREPORT, V13, P2379, DOI 10.1097/00001756-200212200-00001; Fitzpatrick RC, 2006, CURR BIOL, V16, P1509, DOI 10.1016/j.cub.2006.05.063; GOLDBERG JM, 1971, J NEUROPHYSIOL, V34, P635, DOI 10.1152/jn.1971.34.4.635; GOLDBERG JM, 1982, BRAIN RES, V252, P156, DOI 10.1016/0006-8993(82)90990-8; Guerraz M, 2005, J COGNITIVE NEUROSCI, V17, P463, DOI 10.1162/0898929053279540; Iwasaki S, 2014, NEUROLOGY, V82, P969, DOI 10.1212/WNL.0000000000000215; JOYCE GC, 1974, J PHYSIOL-LONDON, V240, P351, DOI 10.1113/jphysiol.1974.sp010614; Kim J, 2004, BRAIN RES BULL, V64, P265, DOI 10.1016/j.brainresbull.2004.07.008; Kitazaki M, 2010, PRESENCE-TELEOP VIRT, V19, P544, DOI 10.1162/pres_a_00017; Mian OS, 2010, J PHYSIOL-LONDON, V588, P4441, DOI 10.1113/jphysiol.2010.195222; Oie KS, 2002, COGNITIVE BRAIN RES, V14, P164, DOI 10.1016/S0926-6410(02)00071-X; Pasma JH, 2012, J NEUROPHYSIOL, V108, P1138, DOI 10.1152/jn.01008.2011; Rabbitt RD, 2005, J NEUROPHYSIOL, V93, P424, DOI 10.1152/jn.00426.2004; Reynolds Raymond Francis, 2012, Front Neurol, V3, P104; ROSENBERG JR, 1989, PROG BIOPHYS MOL BIO, V53, P1, DOI 10.1016/0079-6107(89)90004-7; Roy JE, 2004, J NEUROSCI, V24, P2102, DOI 10.1523/JNEUROSCI.3988-03.2004; Roy JE, 2001, J NEUROSCI, V21, P2131, DOI 10.1523/JNEUROSCI.21-06-02131.2001; SCHMIDT RA, 1975, PSYCHOL REV, V82, P225, DOI 10.1037/h0076770; Schneider E, 2002, J NEUROPHYSIOL, V87, P2064, DOI 10.1152/jn.00558.2001; von Holst E, 1959, NATURWISSENSCHAFTEN, V7, P1109; Wardman DL, 2003, J PHYSIOL-LONDON, V547, P293, DOI 10.1113/jphysiol.2002.030767; Wardman DL, 2003, J PHYSIOL-LONDON, V551, P1033, DOI 10.1113/jphysiol.2003.045971; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2	44	17	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124532	10.1371/journal.pone.0124532	http://dx.doi.org/10.1371/journal.pone.0124532			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894558	gold, Green Published			2022-12-26	WOS:000353211700101
J	Kirschner, MMJ; Schemionek, M; Schubert, C; Chatain, N; Sontag, S; Isfort, S; Ortiz-Bruchle, N; Schmitt, K; Kruger, L; Zerres, K; Zenke, M; Brummendorf, TH; Koschmieder, S				Kirschner, Martin M. J.; Schemionek, Mirle; Schubert, Claudia; Chatain, Nicolas; Sontag, Stephanie; Isfort, Susanne; Ortiz-Bruechle, Nadina; Schmitt, Karla; Krueger, Luisa; Zerres, Klaus; Zenke, Martin; Bruemmendorf, Tim H.; Koschmieder, Steffen			Dissecting Genomic Aberrations in Myeloproliferative Neoplasms by Multiplex-PCR and Next Generation Sequencing	PLOS ONE			English	Article							JAK2V617F ALLELE BURDEN; ACUTE MYELOID-LEUKEMIA; 1ST-LINE TREATMENT; SOMATIC MUTATIONS; DNA-BINDING; JAK2; KINASE; CANCER; FLUOROURACIL; LEUCOVORIN	In order to assess the feasibility of amplicon-based parallel next generation sequencing (NGS) for the diagnosis of myeloproliferative neoplasms (MPN), we investigated multiplex-PCR of 212 amplicons covering genomic mutational hotspots in 48 cancer-related genes. Samples from 64 patients with MPN and five controls as well as seven (myeloid) cell lines were analyzed. Healthy donor and reactive erythrocytosis samples showed several frequent single-nucleotide polymorphisms (SNPs) but no known pathogenic mutation. Sequencing of the cell lines confirmed the presence of the known mutations. In the patient samples, JAK2 V617F was present in all PV, 4 of 10 ET, and 16 of 19 MF patients. The JAK2 V617F allele burden was different in the three groups (ET, 33+/-22%; PV 48+/-28% and MF 68+/-29%). Further analysis detected both previously described and undescribed mutations (i.e., G12V NRAS, IDH1 R132H, E255G ABL, and V125G IDH1 mutations). One patient with lymphoid BC/Ph+ALL who harbored a T315I ABL mutation and was treated with ponatinib was found to have developed a newly acquired V216M TP53 mutation (12% of transcripts) when becoming resistant to ponatinib. Ponatinib led to a decrease of ABL T315I positive transcripts from 47% before ponatinib treatment to 16% at the time of ponatinib resistance in this patient, suggesting that both TP53 and ABL mutations were present in the same clone and that the newly acquired TP53 mutation might have caused ponatinib resistance in this patient. In conclusion, amplicon-sequencing-based NGS allows simultaneous analysis of multiple MPN associated genes for diagnosis and during treatment and measurement of the mutant allele burden.	[Kirschner, Martin M. J.; Schemionek, Mirle; Schubert, Claudia; Chatain, Nicolas; Isfort, Susanne; Schmitt, Karla; Krueger, Luisa; Bruemmendorf, Tim H.; Koschmieder, Steffen] Rhein Westfal TH Aachen, Dept Hematol Oncol Hemostaseol & Stem Cell Transp, Fac Med, Aachen, Germany; [Sontag, Stephanie; Zenke, Martin] Rhein Westfal TH Aachen, Inst Biomed Engn Cell Biol, Aachen, Germany; [Ortiz-Bruechle, Nadina; Zerres, Klaus] Rhein Westfal TH Aachen, Fac Med, Inst Human Genet, Aachen, Germany	RWTH Aachen University; RWTH Aachen University; RWTH Aachen University	Koschmieder, S (corresponding author), Rhein Westfal TH Aachen, Dept Hematol Oncol Hemostaseol & Stem Cell Transp, Fac Med, Aachen, Germany.	skoschmieder@ukaachen.de		Koschmieder, Steffen/0000-0002-1011-8171	BILD hilft e.V. "Ein Herz fur Kinder" foundation	BILD hilft e.V. "Ein Herz fur Kinder" foundation	This work was in part supported by a research grant from the BILD hilft e.V. "Ein Herz fur Kinder" foundation (to SK).	Antonioli E, 2007, HAEMATOLOGICA, V93, P41, DOI 10.3324/haematol.11653; Baccarani M, 2013, BLOOD, V122, P872, DOI 10.1182/blood-2013-05-501569; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bokemeyer C, 2011, ANN ONCOL, V22, P1535, DOI 10.1093/annonc/mdq632; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Buzek J, 2002, NUCLEIC ACIDS RES, V30, P2340, DOI 10.1093/nar/30.11.2340; Cammenga J, 2005, BLOOD, V106, P3958, DOI 10.1182/blood-2005-02-0583; Chanock SJ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1637; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; GARDNER AM, 1993, J BIOL CHEM, V268, P17896; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; Guglielmelli P, 2014, BLOOD, V123, P2157, DOI 10.1182/blood-2013-11-536557; Hussein K, 2009, EXP HEMATOL, V37, P1186, DOI 10.1016/j.exphem.2009.07.005; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Janin M, 2014, J CLIN ONCOL, V32, P297, DOI 10.1200/JCO.2013.50.2047; Kittur J, 2007, CANCER-AM CANCER SOC, V109, P2279, DOI 10.1002/cncr.22663; Klampfl T, 2013, NEW ENGL J MED, V369, P2379, DOI 10.1056/NEJMoa1311347; Kurtz Jean-Emmanuel, 2010, Sarcoma, V2010, P458156, DOI 10.1155/2010/458156; Larsen TS, 2008, LEUKEMIA, V22, P194, DOI 10.1038/sj.leu.2404861; Latini A, 2003, EUR J NEUROSCI, V17, P2017, DOI 10.1046/j.1460-9568.2003.02639.x; Lippert E, 2009, HAEMATOL-HEMATOL J, V94, P38, DOI 10.3324/haematol.13486; Lundberg P, 2014, BLOOD, V123, P2220, DOI 10.1182/blood-2013-11-537167; MACDONALD SG, 1993, MOL CELL BIOL, V13, P6615, DOI 10.1128/MCB.13.11.6615; Martinez-Aviles L, 2012, ANN HEMATOL, V91, P533, DOI 10.1007/s00277-011-1330-0; Maxson JE, 2013, NEW ENGL J MED, V368, P1781, DOI 10.1056/NEJMoa1214514; Nangalia J, 2013, NEW ENGL J MED, V369, P2391, DOI 10.1056/NEJMoa1312542; Oh ST, 2010, BLOOD, V116, P988, DOI 10.1182/blood-2010-02-270108; Orouji A, 2014, BR J DERMATOL; PARK SJ, 2013, ASIAN WOMEN, V29, P1, DOI DOI 10.5045/BR.2013.48.2.128; Peeters M, 2010, J CLIN ONCOL, V28, P4706, DOI 10.1200/JCO.2009.27.6055; Piazza R, 2013, NAT GENET, V45, P18, DOI 10.1038/ng.2495; Pietsch EC, 2008, J BIOL CHEM, V283, P21294, DOI 10.1074/jbc.M710539200; Qin Wei, 2013, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V21, P1507, DOI 10.7534/j.issn.1009-2137.2013.06.026; Ross CW, 2007, CLIN CANCER RES, V13, P4777, DOI 10.1158/1078-0432.CCR-07-0456; Schwaab J, 2013, BLOOD, V122, P2460, DOI 10.1182/blood-2013-04-496448; Soverini S, 2013, BLOOD, V122, P1634, DOI 10.1182/blood-2013-03-487728; Tefferi A, 2007, LEUKEMIA, V21, P2074, DOI 10.1038/sj.leu.2404724; Tefferi A, 2010, LEUKEMIA, V24, P1302, DOI 10.1038/leu.2010.113; Tenedini E, 2014, LEUKEMIA, V28, P1052, DOI 10.1038/leu.2013.302; Theocharides A, 2008, HAEMATOL-HEMATOL J, V93, P1890, DOI 10.3324/haematol.13074; Thol F, 2012, GENE CHROMOSOME CANC, V51, P689, DOI 10.1002/gcc.21955; Thornton PD, 2003, ANN HEMATOL, V82, P759, DOI 10.1007/s00277-003-0710-5; Tyner JW, 2009, BLOOD, V113, P1749, DOI 10.1182/blood-2008-04-152157; Vainchenker W, 2011, BLOOD, V118, P1723, DOI 10.1182/blood-2011-02-292102; Vannucchi AM, 2008, LEUKEMIA, V22, pCP5, DOI 10.1038/leu.2008.113; Wang JY, 2013, BLOOD, V121, P5203, DOI 10.1182/blood-2012-12-475863; Wang JY, 2011, CELL CYCLE, V10, P2836, DOI 10.4161/cc.10.17.17195; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Zhao WK, 2012, EXP HEMATOL ONCOL, V1, DOI 10.1186/2162-3619-1-15	50	10	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123476	10.1371/journal.pone.0123476	http://dx.doi.org/10.1371/journal.pone.0123476			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894969	Green Published, gold, Green Submitted			2022-12-26	WOS:000353211700037
J	Leoni, GG; Palmerini, MG; Satta, V; Succu, S; Pasciu, V; Zinellu, A; Carru, C; Macchiarelli, G; Nottola, SA; Naitana, S; Berlinguer, F				Leoni, Giovanni Giuseppe; Palmerini, Maria Grazia; Satta, Valentina; Succu, Sara; Pasciu, Valeria; Zinellu, Angelo; Carru, Ciriaco; Macchiarelli, Guido; Nottola, Stefania Annarita; Naitana, Salvatore; Berlinguer, Fiammetta			Differences in the Kinetic of the First Meiotic Division and in Active Mitochondrial Distribution between Prepubertal and Adult Oocytes Mirror Differences in their Developmental Competence in a Sheep Model	PLOS ONE			English	Article							IN-VITRO MATURATION; PROMOTING FACTOR ACTIVITY; EARLY EMBRYO DEVELOPMENT; BOVINE OOCYTES; MATURE OOCYTES; PREIMPLANTATION EMBRYOS; ADENOSINE-TRIPHOSPHATE; AGGREGATION PATTERNS; PROTEIN-SYNTHESIS; GENE-EXPRESSION	Our aim is to verify if oocyte developmental potential is related to the timing of meiotic progression and to mitochondrial distribution and activity using prepubertal and adult oocytes as models of low and high developmental capacity respectively. Prepubertal and adult oocytes were incorporated in an in vitro maturation system to determine meiotic and developmental competence and to assess at different time points kinetic of meiotic maturation, 2D protein electrophoresis patterns, ATP content and mitochondria distribution. Maturation and fertilization rates did not differ between prepubertal and adult oocytes (95.1% vs 96.7% and 66.73% vs 70.62% respectively for prepubertal and adult oocytes). Compared to adults, prepubertal oocytes showed higher parthenogenesis (17.38% vs 2.08% respectively in prepubertals and adults; P<0.01) and polispermy (14.30% vs 2.21% respectively in prepubertals and adults; P<0.01), lower cleavage rates (60.00% vs 67.08% respectively in prepubertals and adults; P<0.05) and blastocyst output (11.94% vs 34.% respectively in prepubertals and adults; P<0.01). Prepubertal oocytes reached MI stage 1 hr later than adults and this delay grows as the first meiotic division proceeds. Simultaneously, the protein pattern was altered since in prepubertal oocytes it fluctuates, dropping and rising to levels similar to adults only at 24 hrs. In prepubertal oocytes ATP rise is delayed and did not reach levels comparable to adult ones. CLSM observations revealed that at MII, in the majority of prepubertal oocytes, the active mitochondria are homogenously distributed, while in adults they are aggregated in big clusters. Our work demonstrates that mitochondria and their functional aggregation during maturation play an active role to provide energy in terms of ATP. The oocyte ATP content determines the timing of the meiotic cycle and the acquisition of developmental competence. Taken together our data suggest that oocytes with low developmental competence have a slowed down energetic metabolism which delays later development.	[Leoni, Giovanni Giuseppe; Satta, Valentina; Succu, Sara; Pasciu, Valeria; Naitana, Salvatore; Berlinguer, Fiammetta] Univ Sassari, Dept Vet Med, I-07100 Sassari, Italy; [Leoni, Giovanni Giuseppe; Naitana, Salvatore; Berlinguer, Fiammetta] CCBA, Sardinian Anim Biodivers Ctr, Sassari, Italy; [Palmerini, Maria Grazia; Macchiarelli, Guido] Univ Aquila, Dept Life Hlth & Environm Sci, I-67100 Laquila, Italy; [Zinellu, Angelo; Carru, Ciriaco] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy; [Nottola, Stefania Annarita] Univ Roma La Sapienza, Dept Anat Histol Forens Med & Orthopaed, I-00185 Rome, Italy	University of Sassari; University of L'Aquila; University of Sassari; Sapienza University Rome	Leoni, GG (corresponding author), Univ Sassari, Dept Vet Med, I-07100 Sassari, Italy.	gioleoni@uniss.it	Pasciu, Valeria/ABP-1843-2022; Carru, Ciriaco/AAI-9996-2021; Palmerini, Maria Grazia/N-7424-2017; Berlinguer, Fiammetta/Y-1757-2019; Macchiarelli, Guido/N-1771-2016	Palmerini, Maria Grazia/0000-0002-3985-0112; Berlinguer, Fiammetta/0000-0002-2500-8063; Macchiarelli, Guido/0000-0002-9182-0586; Carru, Ciriaco/0000-0002-6985-4907; Zinellu, Angelo/0000-0002-8396-0968	Fondazione Banco di Sardegna; Sardinian Region Council	Fondazione Banco di Sardegna(Fondazione Banco di Sardegna); Sardinian Region Council	This study was supported by the Fondazione Banco di Sardegna (www.fondazionebancodisardegna.it) and the Sardinian Region Council (www.regione.sardegna.it). SS received a grant from the Fondazione Banco di Sardegna (www.fondazionebancodisardegna. it). The Sardinian Region Council (www.regione.sardegna.it) gave a grant to VS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bebbere D, 2009, REPROD FERT DEVELOP, V21, P187, DOI 10.1071/RDv21n1Ab177; Bettegowda A, 2008, REPROD FERT DEVELOP, V20, P45, DOI 10.1071/RD07156; Brevini TAL, 2005, BIOL REPROD, V72, P1218, DOI 10.1095/biolreprod.104.038141; CALARCO PG, 1995, DEV GENET, V16, P36, DOI 10.1002/dvg.1020160108; Catala MG, 2012, FERTIL STERIL, V97, P1004, DOI 10.1016/j.fertnstert.2011.12.043; Dal Canto M, 2012, REPROD BIOMED ONLINE, V25, P474, DOI 10.1016/j.rbmo.2012.07.016; Dang-Nguyen TQ, 2010, J REPROD DEVELOP, V56, P593, DOI 10.1262/jrd.10-038M; De los Reyes M, 2011, THERIOGENOLOGY, V75, P346, DOI 10.1016/j.theriogenology.2010.09.005; Dell'Aquila ME, 2009, FERTIL STERIL, V91, P249, DOI 10.1016/j.fertnstert.2007.10.042; Dominko T, 1997, MOL REPROD DEV, V47, P456, DOI 10.1002/(SICI)1098-2795(199708)47:4&lt;456::AID-MRD13&gt;3.0.CO;2-U; Dumollard R, 2007, CURR TOP DEV BIOL, V77, P21, DOI 10.1016/S0070-2153(06)77002-8; EARL CR, 1998, GAMETES DEV FUNCTION, P115; Eichenlaub-Ritter U, 2004, REPROD BIOMED ONLINE, V8, P45, DOI 10.1016/S1472-6483(10)60497-X; EPPIG JJ, 1982, DEV BIOL, V89, P268, DOI 10.1016/0012-1606(82)90314-1; Escrich L, 2012, FERTIL STERIL, V98, P1147, DOI 10.1016/j.fertnstert.2012.07.1116; Fenwick J, 2002, HUM REPROD, V17, P407, DOI 10.1093/humrep/17.2.407; Ferreira EM, 2009, THERIOGENOLOGY, V71, P836, DOI 10.1016/j.theriogenology.2008.10.023; Gardner DK, 2005, REPROD FERT DEVELOP, V17, P361, DOI 10.1071/RD04103; Catala MG, 2011, REPRODUCTION, V142, P517, DOI 10.1530/REP-10-0528; Khalili MA, 2012, EUR J HISTOCHEM, V56, P236, DOI 10.4081/ejh.2012.e38; Kochhar HPS, 2002, REPROD DOMEST ANIM, V37, P19, DOI 10.1046/j.1439-0531.2002.00326.x; Ledda S, 1997, J REPROD FERTIL, V109, P73, DOI 10.1530/jrf.0.1090073; Ledda S, 1996, ZYGOTE, V4, P343, DOI 10.1017/S0967199400003361; Ledda S, 2001, BIOL REPROD, V65, P247, DOI 10.1095/biolreprod65.1.247; LEDDA S, 1998, GAMETES DEV FUNCTION, P101; Leoni GG, 2007, REPROD DOMEST ANIM, V42, P299, DOI 10.1111/j.1439-0531.2006.00783.x; Leoni GG, 2007, MOL REPROD DEV, V74, P249, DOI 10.1002/mrd.20442; Leoni GG, 2006, ANIM REPROD SCI, V92, P373, DOI 10.1016/j.anireprosci.2005.05.027; Liu S, 2010, FERTIL STERIL, V93, P1550, DOI 10.1016/j.fertnstert.2009.03.050; Lonergan P, 2008, THERIOGENOLOGY, V69, P17, DOI 10.1016/j.theriogenology.2007.09.007; Lonergan P, 2000, MOL REPROD DEV, V57, P146, DOI 10.1002/1098-2795(200010)57:2&lt;146::AID-MRD5&gt;3.0.CO;2-2; Morton KM, 2008, REPROD DOMEST ANIM, V43, P137, DOI 10.1111/j.1439-0531.2008.01153.x; Nagano M, 2006, ZYGOTE, V14, P299, DOI 10.1017/S0967199406003807; Nottola SA, 2009, REPROD BIOMED ONLINE, V19, P17, DOI 10.1016/S1472-6483(10)60280-5; OBrien JK, 1996, REPROD FERT DEVELOP, V8, P1029, DOI 10.1071/RD9961029; Palmerini MG, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-115; Ptak G, 1999, BIOL REPROD, V61, P1568, DOI 10.1095/biolreprod61.6.1568; Ptak G, 2006, HUM REPROD, V21, P2228, DOI 10.1093/humrep/del184; Santos TA, 2006, FERTIL STERIL, V85, P584, DOI 10.1016/j.fertnstert.2005.09.017; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Somfai T, 2010, J REPROD DEVELOP, V56, P200, DOI 10.1262/jrd.09-097A; Stojkovic M, 2001, BIOL REPROD, V64, P904, DOI 10.1095/biolreprod64.3.904; Tarazona AM, 2006, REPROD DOMEST ANIM, V41, P5, DOI 10.1111/j.1439-0531.2006.00615.x; Tomek W, 2002, REPROD DOMEST ANIM, V37, P86, DOI 10.1046/j.1439-0531.2002.00336.x; Torner H, 2007, REPROD DOMEST ANIM, V42, P176, DOI 10.1111/j.1439-0531.2006.00749.x; Torner H, 2004, THERIOGENOLOGY, V61, P1675, DOI 10.1016/j.theriogenology.2003.09.013; Urrego R, 2014, EPIGENETICS, V9, DOI [10.4161/epi.28790, DOI 10.4161/EPI.28790]; Valentini L, 2010, ANIM REPROD SCI, V117, P166, DOI 10.1016/j.anireprosci.2009.03.008; Van Blerkom J, 2008, MOL HUM REPROD, V14, P431, DOI 10.1093/molehr/gan037; Van Blerkom J, 2011, MITOCHONDRION, V11, P797, DOI 10.1016/j.mito.2010.09.012; VANBLERKOM J, 1995, HUM REPROD, V10, P415, DOI 10.1093/oxfordjournals.humrep.a135954; VANBLERKOM J, 1984, AM J ANAT, V171, P335, DOI 10.1002/aja.1001710309; Velilla E, 2006, MOL REPROD DEV, V73, P617, DOI 10.1002/mrd.20426; Wilding M, 2001, HUM REPROD, V16, P909, DOI 10.1093/humrep/16.5.909; Yin H, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-14; Zinellu A, 2010, ANAL BIOANAL CHEM, V398, P2109, DOI 10.1007/s00216-010-4186-6	56	53	54	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124911	10.1371/journal.pone.0124911	http://dx.doi.org/10.1371/journal.pone.0124911			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893245	Green Published, gold, Green Submitted			2022-12-26	WOS:000353211700130
J	Littnerova, S; Kala, P; Jarkovsky, J; Kubkova, L; Prymusova, K; Kubena, P; Tesak, M; Toman, O; Poloczek, M; Spinar, J; Dusek, L; Parenica, J				Littnerova, Simona; Kala, Petr; Jarkovsky, Jiri; Kubkova, Lenka; Prymusova, Krystyna; Kubena, Petr; Tesak, Martin; Toman, Ondrej; Poloczek, Martin; Spinar, Jindrich; Dusek, Ladislav; Parenica, Jiri			GRACE Score among Six Risk Scoring Systems (CADILLAC, PAMI, TIMI, Dynamic TIMI, Zwolle) Demonstrated the Best Predictive Value for Prediction of Long-Term Mortality in Patients with ST-Elevation Myocardial Infarction	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; OUTCOMES; REGISTRY; THERAPY; MODEL	Aim To compare the prognostic accuracy of six scoring models for up to three-year mortality and rates of hospitalisation due to acute decompensated heart failure (ADHF) in STEMI patients. Methods and Results A total of 593 patients treated with primary PCI were evaluated. Prospective follow-up of patients was >= 3 years. Thirty-day, one-year, two-year, and three-year mortality rates were 4.0%, 7.3%, 8.9%, and 10.6%, respectively. Six risk scores-the TIMI score and derived dynamic TIMI, CADILLAC, PAMI, Zwolle, and GRACE-showed a high predictive accuracy for six- and 12-month mortality with area under the receiver operating characteristic curve (AUC) values of 0.73-0.85. The best predictive values for long-term mortality were obtained by GRACE. The next best-performing scores were CADILLAC, Zwolle, and Dynamic TIMI. All risk scores had a lower prediction accuracy for repeat hospitalisation due to ADHF, except Zwolle with the discriminatory capacity for hospitalisation up to two years (AUC, 0.80-0.83). Conclusions All tested models showed a high predictive value for the estimation of one-year mortality, but GRACE appears to be the most suitable for the prediction for a longer follow-up period. The tested models exhibited an ability to predict the risk of ADHF, especially the Zwolle model.	[Littnerova, Simona; Jarkovsky, Jiri; Dusek, Ladislav] Masaryk Univ, Inst Biostat & Anal, Brno, Czech Republic; [Kala, Petr; Kubkova, Lenka; Prymusova, Krystyna; Kubena, Petr; Tesak, Martin; Toman, Ondrej; Poloczek, Martin; Spinar, Jindrich; Parenica, Jiri] Univ Hosp Brno, Dept Cardiol, Brno, Czech Republic; [Kala, Petr; Kubkova, Lenka; Kubena, Petr; Poloczek, Martin; Spinar, Jindrich; Parenica, Jiri] Masaryk Univ, Fac Med, Brno, Czech Republic; [Kubkova, Lenka; Toman, Ondrej; Spinar, Jindrich; Parenica, Jiri] St Annes Univ Hosp, Int Clin Res Ctr, Dept Cardiovasc Dis, Brno, Czech Republic; [Prymusova, Krystyna] Hosp Podlesi AS, Trinec, Czech Republic; [Tesak, Martin] Hosp Trebic, Trebic, Czech Republic	Institute of Biostatistics & Analyses; Masaryk University Brno; University Hospital Brno; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC)	Jarkovsky, J (corresponding author), Masaryk Univ, Inst Biostat & Anal, Brno, Czech Republic.	jarkovsky@iba.muni.cz	Dušek, Ladislav/G-8794-2013; Jarkovsky, Jiri/G-5494-2017	Dusek, Ladislav/0000-0002-8589-4378	MH CZ - DRO (FNBr) [65269705]; European Regional Development Fund - Project FNUSA-ICRC [CZ.1.05/1.1.00/02.0123]; Ministry of Education Youth and Sports of the Czech Republic [MUNI/A/1012/2013]	MH CZ - DRO (FNBr); European Regional Development Fund - Project FNUSA-ICRC; Ministry of Education Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by the MH CZ - DRO (FNBr, 65269705), by the European Regional Development Fund - Project FNUSA-ICRC (CZ.1.05/1.1.00/02.0123), the Grant of Ministry of Education Youth and Sports of the Czech Republic (MUNI/A/1012/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addala S, 2004, AM J CARDIOL, V93, P629, DOI 10.1016/j.amjcard.2003.11.036; Amin ST, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.003269; De Bruyne B, 2012, NEW ENGL J MED, V367, P991, DOI 10.1056/NEJMoa1205361; De Luca G, 2004, CIRCULATION, V109, P2737, DOI 10.1161/01.CIR.0000131765.73959.87; Eagle KA, 2004, JAMA-J AM MED ASSOC, V291, P2727, DOI 10.1001/jama.291.22.2727; Fox KAA, 2006, BMJ-BRIT MED J, V333, P1091, DOI 10.1136/bmj.38985.646481.55; Garg S, 2011, JACC-CARDIOVASC INTE, V4, P66, DOI 10.1016/j.jcin.2010.09.017; Granger CB, 2003, ARCH INTERN MED, V163, P2345, DOI 10.1001/archinte.163.19.2345; Halkin A, 2005, J AM COLL CARDIOL, V45, P1397, DOI 10.1016/j.jacc.2005.01.041; Kozieradzka A, 2011, INT J CARDIOL, V148, P70, DOI 10.1016/j.ijcard.2009.10.026; Lev EI, 2008, AM J CARDIOL, V102, P6, DOI 10.1016/j.amjcard.2008.02.088; Morrow DA, 2000, CIRCULATION, V102, P2031, DOI 10.1161/01.CIR.102.17.2031; Morrow DA, 2001, JAMA-J AM MED ASSOC, V286, P1356, DOI 10.1001/jama.286.11.1356; Stebbins A, 2010, CIRC-CARDIOVASC INTE, V3, P414, DOI 10.1161/CIRCINTERVENTIONS.109.925180; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Widimsky P, 2010, EUR HEART J, V31, P943, DOI 10.1093/eurheartj/ehp492	16	38	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123215	10.1371/journal.pone.0123215	http://dx.doi.org/10.1371/journal.pone.0123215			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893501	Green Submitted, Green Published, gold			2022-12-26	WOS:000353211700028
J	Nishimatsu, H; Suzuki, E; Saito, Y; Niimi, A; Nomiya, A; Fukuhara, H; Kume, H; Homma, Y				Nishimatsu, Hiroaki; Suzuki, Etsu; Saito, Yasuho; Niimi, Aya; Nomiya, Akira; Fukuhara, Hiroshi; Kume, Haruki; Homma, Yukio			Senescent Cells Impair Erectile Function through Induction of Endothelial Dysfunction and Nerve Injury in Mice	PLOS ONE			English	Article							ADIPOSE-TISSUE; GROWTH-FACTOR; NITRIC-OXIDE; DNA-DAMAGE; STEM-CELLS; TNF-ALPHA; ATHEROSCLEROSIS; ADRENOMEDULLIN; ANGIOPOIETIN-1; INFLAMMATION	Erectile dysfunction (ED) is a major health problem, particularly in the elderly population, which is rapidly increasing. It is necessary to elucidate the mechanism by which ED occurs in the elderly. Cellular senescence is commonly detected in old tissues, and it is well known that senescent cells not only withdraw from the cell cycle but also remain viable and actively produce a variety of cytokines. We examined the effect of senescent cells on erectile function after injection of senescent cells into the penises of mice. Human umbilical vein endothelial cells were infected with an adenovirus expressing a constitutively active mutant of Ras to induce senescence, and were injected into the penises of nude mice. These senescent cells expressed proinflammatory cytokines such as interleukin-1 beta (IL-1 beta). Injection of senescent cells impaired erectile function, as assessed by the measurement of intracavernous pressure. Although the structure of the cavernous body did not remarkably change, expression of the catalytically active form of endothelial nitric oxide synthase and that of total neural nitric oxide synthase significantly decreased after injection. The penises injected with the senescent cells expressed human IL-1 beta and subsequently endogenous proinflammatory cytokines such as mouse IL-1 beta and tumor necrosis factor-alpha. These results suggested that senescent cells impaired erectile function through induction of endothelial dysfunction and nerve injury. These effects may be mediated by proinflammatory cytokines produced by senescent cells.	[Nishimatsu, Hiroaki; Saito, Yasuho; Niimi, Aya; Nomiya, Akira; Fukuhara, Hiroshi; Kume, Haruki; Homma, Yukio] Univ Tokyo, Fac Med, Dept Urol, Bunkyo Ku, Tokyo 113, Japan; [Suzuki, Etsu] St Marianna Univ, Sch Med, Inst Med Sci, Miyamae Ku, Kawasaki, Kanagawa, Japan	University of Tokyo; Saint Marianna University	Suzuki, E (corresponding author), St Marianna Univ, Sch Med, Inst Med Sci, Miyamae Ku, Kawasaki, Kanagawa, Japan.	esuzuki-tky@umin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24592422, 24592423]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was funded by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan to AN 24592422 [http://www.jsps.go.jp]; and to HN 24592423 from Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan; [http://www.jsps.go.jp]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson D, 2008, ADV CARDIOL, V45, P1, DOI 10.1159/000115118; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Batten P, 1996, IMMUNOLOGY, V87, P127; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; Branen L, 2004, ARTERIOSCL THROM VAS, V24, P2137, DOI 10.1161/01.ATV.0000143933.20616.1b; BURNETT AL, 1992, SCIENCE, V257, P401, DOI 10.1126/science.1378650; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Du XL, 1999, FREE RADICAL BIO MED, V27, P752, DOI 10.1016/S0891-5849(99)00079-9; Fantuzzi G, 2007, ARTERIOSCL THROM VAS, V27, P996, DOI 10.1161/ATVBAHA.106.131755; Ferrini MG, 2007, BIOL REPROD, V76, P915, DOI 10.1095/biolreprod.106.059642; FLANAGAN SP, 1966, GENET RES, V8, P295, DOI 10.1017/S0016672300010168; Fraga-Silva RA, 2013, J SEX MED, V10, P2430, DOI 10.1111/jsm.12262; GALIS ZS, 1995, ANN NY ACAD SCI, V748, P501; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Hedlund P, 1999, BRIT J PHARMACOL, V127, P349, DOI 10.1038/sj.bjp.0702556; Huang YC, 2010, J SEX MED, V7, P1391, DOI 10.1111/j.1743-6109.2009.01697.x; Khera M, 2011, J SEX MED, V8, P3204, DOI 10.1111/j.1743-6109.2011.02436.x; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; Labazi H, 2013, J SEX MED, V10, P2154, DOI 10.1111/jsm.12245; Luttrell IP, 2008, AM J PHYSIOL-HEART C, V294, pH2204, DOI 10.1152/ajpheart.00027.2008; Matthews C, 2006, CIRC RES, V99, P156, DOI 10.1161/01.RES.0000233315.38086.bc; Minamino T, 2003, CIRCULATION, V108, P2264, DOI 10.1161/01.CIR.0000093274.82929.22; MULLARKEY CJ, 1990, BIOCHEM BIOPH RES CO, V173, P932, DOI 10.1016/S0006-291X(05)80875-7; Nishimatsu H, 2013, J SEX MED, V10, P1707, DOI 10.1111/jsm.12177; Nishimatsu H, 2012, J SEX MED, V9, P482, DOI 10.1111/j.1743-6109.2011.02469.x; Orasanu G, 2009, J AM COLL CARDIOL, V53, pS35, DOI 10.1016/j.jacc.2008.09.055; Orimo M, 2009, ARTERIOSCL THROM VAS, V29, P889, DOI 10.1161/ATVBAHA.109.185694; Pelleitier M, 1975, Methods Achiev Exp Pathol, V7, P149; Qiu XF, 2011, J SEX MED, V8, P427, DOI 10.1111/j.1743-6109.2010.02118.x; Ryu JK, 2006, MOL THER, V13, P705, DOI 10.1016/j.ymthe.2005.10.016; Seftel AD, 2004, J ANDROL, V25, P963; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shirai M, 2002, NIHON RINSHO, V60, P91; Suzuki E, 2002, HYPERTENS RES, V25, P773; Suzuki E, 2000, J BIOL CHEM, V275, P3637, DOI 10.1074/jbc.275.5.3637; Suzuki E, 2013, SCI WORLD J, DOI 10.1155/2013/754735; Taube A, 2012, AM J PHYSIOL-HEART C, V302, pH2148, DOI 10.1152/ajpheart.00907.2011; Yokoi T, 2006, DIABETES, V55, P1660, DOI 10.2337/db05-1607; Zhang HR, 2009, CLIN SCI, V116, P219, DOI 10.1042/CS20080196	42	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124129	10.1371/journal.pone.0124129	http://dx.doi.org/10.1371/journal.pone.0124129			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894557	gold, Green Submitted, Green Published			2022-12-26	WOS:000353211700075
J	Wang, JG; Zheng, R; Bai, SL; Gao, XM; Liu, M; Yan, W				Wang, Jugang; Zheng, Rong; Bai, Shulan; Gao, Xiaomin; Liu, Min; Yan, Wei			Mongolian Almond (Prunus mongolica Maxim): The Morpho-Physiological, Biochemical and Transcriptomic Response to Drought Stress	PLOS ONE			English	Article							GENE-EXPRESSION; WEB TOOL; AQUAPORINS; MEMBRANE; RESISTANCE; DATABASE; FAMILY; IDENTIFICATION; PERSPECTIVE; ANTIOXIDANT	Prunus mongolica Maxim, which is widely established in the Gobi Desert, shows extreme tolerance to drought. However, there is a lack of available transcriptomic resources for this species related to its response to water deficiency. To investigate the mechanisms that allow P. mongolica to maintain growth in extremely arid environments, the response of P. mongolica seedlings to drought stress was analyzed using morphological, physiological, biochemical and high-throughput sequencing approaches. We generated 28,713,735 and 26,650,133 raw reads from no-stress control and drought-stressed P. mongolica seedlings, respectively. In total, we obtained 67,352 transcripts with an average length of 874.44 bp. Compared with the no-stress control, 3,365 transcripts were differentially expressed in the drought-stressed seedlings, including 55.75% (1,876 transcripts) up-regulated and 44.25% (1,489 transcripts) down-regulated transcripts. The photosynthesis response showed a decreasing tendency under drought stress, but the changes in the levels of hormones (auxins, cytokinins and abscisic acid) resulted in the closing of stomata and decreased cell enlargement and division; these changes were effective for promoting P. mongolica survival in Gobi Desert. Next, we analyzed the aquaporin and superoxide dismutase gene families due to their importance in plant resistance to drought stress. We found that all of the plasma membrane intrinsic protein transcripts were down-regulated in the drought-stressed treatment, whereas drought did not affect the expression of nodulin intrinsic protein or small basic intrinsic protein transcripts in P. mongolica seedlings. In addition, activation of iron superoxide dismutase transcription and enhanced transcription of manganese superoxide dismutase were observed in P. mongolica to promote tolerance of drought stress. This study identified drought response genes in P. mongolica seedlings. Our results provide a significant contribution to the understanding of how P. mongolica responds to drought stress at the transcriptome level, which may help to elucidate molecular mechanisms associated with the drought response of almond plants.	[Wang, Jugang; Zheng, Rong; Bai, Shulan; Liu, Min] Inner Mongolia Agr Univ, Coll Forestry, Hohhot, Inner Mongolia, Peoples R China; [Zheng, Rong] Inner Mongolia Normal Univ, Coll Life Sci & Technol, Hohhot, Inner Mongolia, Peoples R China; [Gao, Xiaomin] Inner Mongolia Agr Univ, Coll Agr, Hohhot, Inner Mongolia, Peoples R China; [Yan, Wei] Inst Forestry Sci Ordos, Ordos, Inner Mongolia, Peoples R China	Inner Mongolia Agricultural University; Inner Mongolia Normal University; Inner Mongolia Agricultural University	Bai, SL (corresponding author), Inner Mongolia Agr Univ, Coll Forestry, Hohhot, Inner Mongolia, Peoples R China.	baishulan2004@163.com		Wang, Ju-Gang/0000-0002-4616-8007	National Natural Science Foundation of China [31060110, 30860225]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Nos. 31060110 and 30860225). URL: http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajithkumar IP, 2014, CELL BIOCHEM BIOPHYS, V68, P587, DOI 10.1007/s12013-013-9746-x; Alimohammadi A, 2013, SCI HORTIC-AMSTERDAM, V159, P19, DOI 10.1016/j.scienta.2013.04.023; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarez M, 2009, TREE PHYSIOL; Arias R, 2014, WATER-SUI, V6, P3049, DOI 10.3390/w6103049; Arshad M, 2014, TREES-STRUCT FUNCT, V28, P531, DOI 10.1007/s00468-013-0969-7; Bhoomika K, 2013, PLANT GROWTH REGUL, V71, P235, DOI 10.1007/s10725-013-9824-5; Blankenship R. E., 2014, MOL MECH PHOTOSYNTHE; Chaumont F, 2001, PLANT PHYSIOL, V125, P1206, DOI 10.1104/pp.125.3.1206; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Chen JH, 2013, PLANT MOL BIOL REP, V31, P946, DOI 10.1007/s11105-013-0563-6; Davies P.J., 2004, PLANT HORMONES BIOSY; Dong YP, 2014, INT J MOL SCI, V15, P4583, DOI 10.3390/ijms15034583; Eilmann B, 2013, ANN FOREST SCI, V70, P685, DOI 10.1007/s13595-013-0310-z; Eldem V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050298; Fan XD, 2013, GENE, V512, P392, DOI 10.1016/j.gene.2012.09.100; Gale EM, 2010, INORG CHEM, V49, P7080, DOI 10.1021/ic1009187; Golldack D, 2011, PLANT CELL REP, V30, P1383, DOI 10.1007/s00299-011-1068-0; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gross SM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-563; Gupta S, 2012, FUNCT INTEGR GENOMIC, V12, P543, DOI 10.1007/s10142-012-0277-0; Hancock JT, 2011, PLANT SCI, V181, P555, DOI 10.1016/j.plantsci.2011.03.017; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Ishikawa F, 2005, FEBS LETT, V579, P5814, DOI 10.1016/j.febslet.2005.09.076; Jain M, 2009, PLANT SCI, V176, P702, DOI 10.1016/j.plantsci.2009.02.001; Jang JY, 2004, PLANT MOL BIOL, V54, P713, DOI 10.1023/B:PLAN.0000040900.61345.a6; Jayanthi H, 2013, INT J DISAST RISK RE, V4, P71, DOI 10.1016/j.ijdrr.2013.02.001; Jiang JL, 2013, BIOLOGIA, V68, P231, DOI 10.2478/s11756-013-0003-y; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Keppel-Aleks G, 2014, GLOBAL BIOGEOCHEM CY, V28, P1295, DOI 10.1002/2014GB004890; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Liu TM, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-130; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu TT, 2010, GENOME RES, V20, P1238, DOI 10.1101/gr.106120.110; Manea A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091046; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; Mousavi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104541; Muller T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-673; Mulder NJ, 2003, NUCLEIC ACIDS RES, V31, P315, DOI 10.1093/nar/gkg046; Nadzirin N, 2012, INT J MOL SCI, V13, P12761, DOI 10.3390/ijms131012761; Nakashima K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00170; Nuruzzaman M, 2014, J PLANT PHYSIOL, V171, P2, DOI 10.1016/j.jplph.2013.09.010; Okay S, 2014, MOL GENET GENOMICS, V289, P765, DOI 10.1007/s00438-014-0849-x; Peng SM, 2012, TREE PHYSIOL, V32, P1541, DOI 10.1093/treephys/tps110; Polozov R, 2014, J BIOMOLECULAR STRUC, P1; Pou A, 2013, PLANT CELL ENVIRON, V36, P828, DOI 10.1111/pce.12019; Raney J. A., 2014, American Journal of Plant Sciences, V5, P338; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Sarda X, 1997, PLANT J, V12, P1103, DOI 10.1046/j.1365-313X.1997.12051103.x; SCALABRIN S, 2011, CATALOG MOL DIVERSIT, P169; Shiran B, 2007, SCI HORTIC-AMSTERDAM, V111, P280, DOI 10.1016/j.scienta.2006.10.024; Signorelli S, 2013, PLANT PHYSIOL BIOCH, V70, P195, DOI 10.1016/j.plaphy.2013.05.028; Song LH, 2013, PHYSIOL PLANTARUM, V148, P322, DOI 10.1111/ppl.12013; Tang S, 2013, PLANT MOL BIOL, V83, P539, DOI 10.1007/s11103-013-0107-3; Tarkowska D., 2014, PLANTA, P1; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tian FX, 2013, J EXP BOT, V64, P1509, DOI 10.1093/jxb/ert004; Tripathi P, 2014, PLANTA, V239, P255, DOI 10.1007/s00425-013-1985-y; Utsumi Y, 2012, DNA RES, V19, P335, DOI 10.1093/dnares/dss016; Varshney RK, 2012, J BIOSCIENCES, V37, P811, DOI 10.1007/s12038-012-9228-0; Vencio RZN, 2003, BIOINFORMATICS, V19, P2461, DOI 10.1093/bioinformatics/btg357; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Verkman AS, 2013, CURR BIOL, V23, pR52, DOI 10.1016/j.cub.2012.11.025; Xangsayasane P, 2014, FIELD CROP RES, V156, P281, DOI 10.1016/j.fcr.2013.10.017; Yan F, 2014, GENETICS MOL RES GMR, P13; Yazbek MM, 2014, GENETIC RESOURCES CR, P1; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zadworny M, 2014, FOREST ECOL MANAG, V318, P133, DOI 10.1016/j.foreco.2014.01.017; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhou YJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-266	74	9	14	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124442	10.1371/journal.pone.0124442	http://dx.doi.org/10.1371/journal.pone.0124442			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893685	Green Submitted, Green Published, gold			2022-12-26	WOS:000353211700094
J	Bhawna; Chaduvula, PK; Bonthala, VS; Manjusha, V; Siddiq, EA; Polumetla, AK; Prasad, GMNV				Bhawna; Chaduvula, Pavan K.; Bonthala, Venkata S.; Manjusha, Verma; Siddiq, Ebrahimali A.; Polumetla, Ananda K.; Prasad, Gajula M. N. V.			CmMDb: A Versatile Database for Cucumis melo Microsatellite Markers and Other Horticulture Crop Research	PLOS ONE			English	Article							SSR MARKERS; GENOME; IDENTIFICATION; SEQUENCES	Cucumis melo L. that belongs to Cucurbitaceae family ranks among one of the highest valued horticulture crops being cultivated across the globe. Besides its economical and medicinal importance, Cucumis melo L. is a valuable resource and model system for the evolutionary studies of cucurbit family. However, very limited numbers of molecular markers were reported for Cucumis melo L. so far that limits the pace of functional genomic research in melon and other similar horticulture crops. We developed the first whole genome based microsatellite DNA marker database of Cucumis melo L. and comprehensive web resource that aids in variety identification and physical mapping of Cucurbitaceae family. The Cucumis melo L. microsatellite database (CmMDb: http://65.181.125.102/cmmdb2/index.html) encompasses 39,072 SSR markers along with its motif repeat, motif length, motif sequence, marker ID, motif type and chromosomal locations. The database is featured with novel automated primer designing facility to meet the needs of wet lab researchers. CmMDb is a freely available web resource that facilitates the researchers to select the most appropriate markers for marker-assisted selection in melons and to improve breeding strategies.	[Bhawna; Manjusha, Verma] Natl Bur Plant Genet Resources, Genom Resources Div, New Delhi 12, India; [Chaduvula, Pavan K.] Natl Res Ctr Plant Biotechnol, New Delhi 110012, India; [Bonthala, Venkata S.; Siddiq, Ebrahimali A.; Polumetla, Ananda K.; Prasad, Gajula M. N. V.] PJTSAU, Inst Biotechnol, Hyderabad 500030, Andhra Pradesh, India	Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources; Indian Council of Agricultural Research (ICAR); ICAR - National Institute For Plant Biotechnology (NIPB)	Prasad, GMNV (corresponding author), PJTSAU, Inst Biotechnol, Hyderabad 500030, Andhra Pradesh, India.	gajulaibt@grnail.com	Bonthala, Venkata Suresh/G-9852-2013	Bonthala, Venkata Suresh/0000-0001-6550-1648; Bonthala, Bhawna/0000-0003-2839-1691	Department of Science and Technology, Govt. of India; Ramanujan Fellowship grant [SRN/S2/RJN-22/2011]	Department of Science and Technology, Govt. of India; Ramanujan Fellowship grant	This work was supported by the Department of Science and Technology, Govt. of India; Ramanujan Fellowship grant award no. SRN/S2/RJN-22/2011. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Bhawna, 2014, APPL BIOCH BIOTECHNO; Cavagnaro PF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-569; Clepet C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-252; DELSENY M, 1983, BIOCHEM BIOPH RES CO, V116, P113, DOI 10.1016/0006-291X(83)90388-1; Diaz A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-111; Ferreira ME., 1998, INTRO USE MOL MARKER, V2, P220; Garcia-Mas J, 2012, P NATL ACAD SCI USA, V109, P11872, DOI 10.1073/pnas.1205415109; Gonzalez VM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-339; Gonzalez-Ibeas D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-306; Gupta S, 2012, PLANT CELL REP, V31, P323, DOI 10.1007/s00299-011-1168-x; Harel-Beja R, 2010, THEOR APPL GENET, V121, P511, DOI 10.1007/s00122-010-1327-4; Karakousis A, 2003, AUST J AGR RES, V54, P1197, DOI 10.1071/AR02178; KAWCHUK LM, 1990, MOL PLANT MICROBE IN, V3, P301, DOI 10.1094/MPMI-3-301; Kumari K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067742; Lin HS, 2011, INT J MOL SCI, V12, P7835, DOI 10.3390/ijms12117835; Manigbas N. L., 2004, Philippine Journal of Crop Science, V29, P23; Mascarell-Creus A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-467; MICCOLIS V, 1991, J AM SOC HORTIC SCI, V116, P1025, DOI 10.21273/JASHS.116.6.1025; Nunez-Palenius HG, 2008, CRIT REV BIOTECHNOL, V28, P13, DOI [10.1080/07388550801891111, 10.1080/07388550801891111 ]; Ophir R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-269; Pandey G, 2013, DNA RES, V20, P197, DOI 10.1093/dnares/dst002; Parida SK, 2006, THEOR APPL GENET, V112, P808, DOI 10.1007/s00122-005-0182-1; Parida SK, 2010, GENOME, V53, P55, DOI [10.1139/G09-084, 10.1139/g09-084]; Parida SK, 2009, THEOR APPL GENET, V118, P327, DOI 10.1007/s00122-008-0902-4; Ren Y, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-33; Ritschel Patricia Silva, 2004, BMC Plant Biology, V4, P9, DOI 10.1186/1471-2229-4-9; Shirasawa K, 2013, MOL BREEDING, V31, P101, DOI 10.1007/s11032-012-9774-z; Stagel A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-357; Suresh BV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086387; TAUTZ D, 1984, NUCLEIC ACIDS RES, V12, P4127, DOI 10.1093/nar/12.10.4127; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Venkata SB, 2013, PLOS ONE, V8, DOI [10.1371/journal, DOI 10.1371/JOURNAL]; Youens-Clark K, 2009, BIOINFORMATICS, V25, P3040, DOI 10.1093/bioinformatics/btp458	35	6	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0118630	10.1371/journal.pone.0118630	http://dx.doi.org/10.1371/journal.pone.0118630			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885062	gold, Green Published, Green Submitted			2022-12-26	WOS:000353017000003
J	Rothhammer, F; Fuentes-Guajardo, M; Chakraborty, R; Bermejo, JL; Dittmar, M				Rothhammer, Francisco; Fuentes-Guajardo, Macarena; Chakraborty, Ranajit; Bermejo, Justo Lorenzo; Dittmar, Manuela			Neonatal Variables, Altitude of Residence and Aymara Ancestry in Northern Chile	PLOS ONE			English	Article							GAMMA-GLOBIN-GENE; BIRTH-WEIGHT; PHENOTYPIC PLASTICITY; OXYGEN DELIVERY; ADAPTATION; FETAL; POPULATIONS; REDUCTIONS; DELETION; HYPOXIA	Studies performed in the Andean plateau, one of the highest inhabited areas in the world, have reported that reduced availability of oxygen is associated to fetal growth retardation and lower birth weight, which are established predictors of morbidity and mortality during the first year of life. To test this hypothesis, perinatal variables of neonates born at the Juan Noe Hospital of Arica, Chile, were analyzed in relation to altitude of residence and Aymara ancestry of their mothers. The study population comprised the offspring of 5,295 mothers born between February 2004 and August 2010. Information included birth weight, height, head circumference, gestational age, altitude of residence and socioeconomic status, and was obtained from medical records. Mother's ancestry was assessed based on surnames which were linked to percentages of Aymara admixture estimates relying on 40 selected ancestry informative markers. After correcting for the effect of multicollinearity among predictor variables, neonates born to mothers with an increased component of Aymara ancestry showed significantly higher birth weight and height at sea level, a marginally significant (p-value 0.06) decrease of birth weight and a significant decrease of height with altitude in comparison with the offspring of mothers with low Aymara ancestry. Since observed tendencies are suggestive of a possible genetic adaptation to hypoxia of the Chilean Aymara, we discuss briefly preliminary evidence related to fetal oxygen transport, particularly polymorphisms in the promoters of the HBG1 and HBG2 genes that are modulators of HbF synthesis, obtained in this ethnic group.	[Rothhammer, Francisco] Univ Tarapaca, Inst Alta Invest, Arica, Chile; [Rothhammer, Francisco] Ctr Invest Hombre Desierto CIHDE, Arica, Chile; [Chakraborty, Ranajit] Univ N Texas, Hlth Sci Ctr, Ctr Computat Genom, Inst Appl Genet, Ft Worth, TX USA; [Bermejo, Justo Lorenzo] Heidelberg Univ, Inst Med Biometry & Informat, Heidelberg, Germany; [Dittmar, Manuela] Univ Kiel, Inst Zool, Dept Human Biol, D-24098 Kiel, Germany; [Fuentes-Guajardo, Macarena] Univ Tarapaca, Fac Ciencias Salud, Dept Tecnol Med, Arica, Chile	Universidad de Tarapaca; University of North Texas System; University of North Texas Health Science Center; Ruprecht Karls University Heidelberg; University of Kiel; Universidad de Tarapaca	Rothhammer, F (corresponding author), Univ Tarapaca, Inst Alta Invest, Arica, Chile.	frothham@med.uchile.cl		Lorenzo Bermejo, Justo/0000-0002-6568-5333	University of Tarapaca	University of Tarapaca	Funding was provided by University of Tarapaca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Bennett A, 2008, AM J HUM BIOL, V20, P592, DOI 10.1002/ajhb.20784; Bigham A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001116; Bigham AW, 2014, PHYSIOL GENOMICS, V46, P687, DOI 10.1152/physiolgenomics.00063.2014; Bigham AW, 2013, AM J HUM BIOL, V25, P190, DOI 10.1002/ajhb.22358; Capriles JM, 2013, QUATERN INT, V301, P46, DOI 10.1016/j.quaint.2012.06.012; COLEMAN MB, 1991, BLOOD, V78, P2473; Eichstaedt CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093314; FRISANCHO AR, 1995, AM J PHYS ANTHROPOL, V96, P431, DOI 10.1002/ajpa.1330960408; Fuentes M, 2014, REV MED CHILE, V142, P281, DOI 10.4067/S0034-98872014000300001; GILMAN JG, 1985, BLOOD, V66, P783; GILMAN JG, 1988, BRIT J HAEMATOL, V68, P455; Hammond KA, 2001, J EXP BIOL, V204, P1991; Hartinger S, 2006, INT J GYNECOL OBSTET, V93, P275, DOI 10.1016/j.ijgo.2006.02.023; Huerta-Sanchez E, 2014, NATURE, V512, P194, DOI 10.1038/nature13408; Johnson L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019918; Julian CG, 2007, ARCH DIS CHILD-FETAL, V92, P372, DOI 10.1136/adc.2006.109579; Julian CG, 2011, CLIN CHEST MED, V32, P21, DOI 10.1016/j.ccm.2010.10.008; Julian CG, 2009, AM J HUM BIOL, V21, P614, DOI 10.1002/ajhb.20900; Julian CG, 2009, AM J PHYSIOL-REG I, V296, pR1564, DOI 10.1152/ajpregu.90945.2008; Lomaglio D, 2005, ANTROPOL, V9, P61; MANCA L, 1991, BRIT J HAEMATOL, V78, P105, DOI 10.1111/j.1365-2141.1991.tb04390.x; Manriquez G, 2011, CHUNGARA, V43, P283, DOI 10.4067/S0717-73562011000200009; Mazzi E, 1985, REV SOC BOLIV PEDIAT, V24, P43; McAuliffe F, 2001, BRIT J OBSTET GYNAEC, V108, P980, DOI 10.1111/j.1471-0528.2001.00225.x; Moore LG, 2001, HIGH ALT MED BIOL, V2, P257, DOI 10.1089/152702901750265341; Moraga M, 2005, AM J PHYS ANTHROPOL, V127, P170, DOI 10.1002/ajpa.10438; Moreno S, 2003, OBSERV MEDIOAMB, V6, P161; Munoz I., 1993, ACHA 2 ORIGENES POBL; Peng Y, 2011, MOL BIOL EVOL, V28, P1075, DOI 10.1093/molbev/msq290; Postigo L, 2009, J PHYSIOL-LONDON, V587, P693, DOI 10.1113/jphysiol.2008.163634; Rothhammer F, 2009, ANN HUM GENET, V73, P540, DOI 10.1111/j.1469-1809.2009.00537.x; Rottgardt I, 2010, ANTHROPOL SCI, V118, P41, DOI 10.1537/ase.090402; Rupert JL, 2001, HIGH ALT MED BIOL, V2, P235, DOI 10.1089/152702901750265332; Rupert JL, 2001, J EXP BIOL, V204, P3151; Scheinfeldt LB, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-133; Schull WJ, 1990, AYMARA STRATEGIES HU; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Soria R, 2013, PEDIATR RES, V74, P633, DOI 10.1038/pr.2013.150; Storz JF, 2010, J EXP BIOL, V213, P4125, DOI 10.1242/jeb.048181; Stuber T, 2010, PROG CARDIOVASC DIS, V52, P534, DOI 10.1016/j.pcad.2010.02.009; Wang B, 2011, PLOS ONE, V9; Xu SH, 2011, MOL BIOL EVOL, V28, P1003, DOI 10.1093/molbev/msq277	43	9	9	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0121834	10.1371/journal.pone.0121834	http://dx.doi.org/10.1371/journal.pone.0121834			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885573	Green Submitted, Green Published, gold			2022-12-26	WOS:000353017000026
J	Wang, GQ; Wang, R; Strulovici-Barel, Y; Salit, J; Staudt, MR; Ahmed, J; Tilley, AE; Yee-Levin, J; Hollmann, C; Harvey, BG; Kaner, RJ; Mezey, JG; Sridhar, S; Pillai, SG; Hilton, H; Wolff, G; Bitter, H; Visvanathan, S; Fine, JS; Stevenson, CS; Crystal, RG				Wang, Guoqing; Wang, Rui; Strulovici-Barel, Yael; Salit, Jacqueline; Staudt, Michelle R.; Ahmed, Joumana; Tilley, Ann E.; Yee-Levin, Jenny; Hollmann, Charleen; Harvey, Ben-Gary; Kaner, Robert J.; Mezey, Jason G.; Sridhar, Sriram; Pillai, Sreekumar G.; Hilton, Holly; Wolff, Gerhard; Bitter, Hans; Visvanathan, Sudha; Fine, Jay S.; Stevenson, Christopher S.; Crystal, Ronald G.			Persistence of Smoking-Induced Dysregulation of MiRNA Expression in the Small Airway Epithelium Despite Smoking Cessation	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CIGARETTE-SMOKE; GENE-EXPRESSION; LUNG-FUNCTION; BRONCHIAL EPITHELIUM; MICRORNAS; CANCER; INFLAMMATION; MODULATION; EXPOSURE	Even after quitting smoking, the risk of the development of chronic obstructive pulmonary disease (COPD) and lung cancer remains significantly higher compared to healthy nonsmokers. Based on the knowledge that COPD and most lung cancers start in the small airway epithelium (SAE), we hypothesized that smoking modulates miRNA expression in the SAE linked to the pathogenesis of smoking-induced airway disease, and that some of these changes persist after smoking cessation. SAE was collected from 10th to 12th order bronchi using fiberoptic bronchoscopy. Affymetrix miRNA 2.0 arrays were used to assess miRNA expression in the SAE from 9 healthy nonsmokers and 10 healthy smokers, before and after they quit smoking for 3 months. Smoking status was determined by urine nicotine and cotinine measurement. There were significant differences in the expression of 34 miRNAs between healthy smokers and healthy nonsmokers (p<0.01, fold-change >1.5), with functions associated with lung development, airway epithelium differentiation, inflammation and cancer. After quitting smoking for 3 months, 12 out of the 34 miRNAs did not return to normal levels, with Wnt/beta-catenin signaling pathway being the top identified enriched pathway of the target genes of the persistent dysregulated miRNAs. In the context that many of these persistent smoking-dependent miRNAs are associated with differentiation, inflammatory diseases or lung cancer, it is likely that persistent smoking-related changes in SAE miRNAs play a role in the subsequent development of these disorders.	[Wang, Guoqing; Wang, Rui; Strulovici-Barel, Yael; Salit, Jacqueline; Staudt, Michelle R.; Ahmed, Joumana; Tilley, Ann E.; Yee-Levin, Jenny; Hollmann, Charleen; Harvey, Ben-Gary; Kaner, Robert J.; Mezey, Jason G.; Crystal, Ronald G.] Weill Cornell Med Coll, Dept Med Genet, New York, NY 10065 USA; [Tilley, Ann E.; Harvey, Ben-Gary; Kaner, Robert J.; Crystal, Ronald G.] Weill Cornell Med Coll, Dept Med, Div Pulm & Crit Care Med, New York, NY USA; [Mezey, Jason G.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA; [Sridhar, Sriram; Pillai, Sreekumar G.; Hilton, Holly; Wolff, Gerhard; Bitter, Hans; Visvanathan, Sudha; Fine, Jay S.; Stevenson, Christopher S.] Hoffmann La Roche Inc, Nutley, NJ 07110 USA	Cornell University; Cornell University; Cornell University; Roche Holding	Crystal, RG (corresponding author), Weill Cornell Med Coll, Dept Med Genet, New York, NY 10065 USA.	geneticmedicine@med.cornell.edu		Wolff MD|PhD, Gerhard/0000-0002-4458-0700; Staudt, Michelle/0000-0002-3364-0894	JP Smith Clinical Scholar; Hoffmann-La Roche, Inc, Nutley;  [1R01HL107882];  [P20 HL113443];  [1K23 HL103837];  [UL1-RR024996];  [UL1-RR024143];  [P50 HL084936]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457, UL1TR002384] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143, UL1RR024996] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL084936, P20HL113443, R01HL107882, K23HL103837] Funding Source: NIH RePORTER	JP Smith Clinical Scholar; Hoffmann-La Roche, Inc, Nutley; ; ; ; ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were supported by 1R01HL107882, P20 HL113443, 1K23 HL103837, UL1-RR024996, UL1-RR024143, and P50 HL084936. RJK and BGH were supported in part by "JP Smith Clinical Scholar." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was also supported by Hoffmann-La Roche, Inc, Nutley, who provided support in the form of salaries for authors SS, SGP, HH, GW, HB, SV, JSF, and CSS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Anthonisen NR, 2002, AM J RESP CRIT CARE, V166, P675, DOI 10.1164/rccm.2112096; AUERBACH O, 1961, NEW ENGL J MED, V265, P253, DOI 10.1056/NEJM196108102650601; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beane J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r201; Bhaskaran M, 2009, PHYSIOL GENOMICS, V37, P268, DOI 10.1152/physiolgenomics.90268.2008; Boldin MP, 2012, IMMUNOL REV, V246, P205, DOI 10.1111/j.1600-065X.2011.01089.x; Brody JS, 2011, ANNU REV PHYSIOL, V73, P437, DOI 10.1146/annurev-physiol-012110-142219; Buro-Auriemma LJ, 2013, HUM MOL GENET, V22, P4726, DOI 10.1093/hmg/ddt326; Chari R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-297; Davidson MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012560; Davis-Dusenbery BN, 2011, J BIOL CHEM, V286, P28097, DOI 10.1074/jbc.M111.236950; Dong J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010854; Duan MC, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/350727; Ezzie ME, 2012, THORAX, V67, P122, DOI 10.1136/thoraxjnl-2011-200089; Gillen AE, 2011, BIOCHEM J, V438, P25, DOI 10.1042/BJ20110672; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hackett NR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-82; HALPERN MT, 1993, JNCI-J NATL CANCER I, V85, P457, DOI 10.1093/jnci/85.6.457; Harvey BG, 2007, J MOL MED, V85, P39, DOI 10.1007/s00109-006-0103-z; Hecht SS, 2003, NAT REV CANCER, V3, P733, DOI 10.1038/nrc1190; Heijink IH, 2013, THORAX, V68, P709, DOI 10.1136/thoraxjnl-2012-201667; HOGG JC, 1968, NEW ENGL J MED, V278, P1355, DOI 10.1056/NEJM196806202782501; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Konigshoff M, 2010, AM J RESP CELL MOL, V42, P21, DOI 10.1165/rcmb.2008-0485TR; Lapperre TS, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-85; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Lee YB, 2009, NUCLEIC ACIDS RES, V37, P123, DOI 10.1093/nar/gkn920; Ma XD, 2011, J MOL CELL BIOL, V3, P159, DOI 10.1093/jmcb/mjr007; MacNee W, 2001, EUR J PHARMACOL, V429, P195, DOI 10.1016/S0014-2999(01)01320-6; Marcet B, 2011, NAT CELL BIOL, V13, P693, DOI 10.1038/ncb2241; Milosevic J, 2012, AM J RESP CELL MOL, V47, P879, DOI 10.1165/rcmb.2011-0377OC; Mizuno S, 2012, CHEST, V142, P663, DOI 10.1378/chest.11-2746; Morissette MC, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-49; Nana-Sinkam SP, 2009, AM J RESP CRIT CARE, V179, P4, DOI 10.1164/rccm.200807-1042PP; Nohata N, 2012, ONCOTARGET, V3, P9; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; Punturieri A, 2009, JNCI-J NATL CANCER I, V101, P554, DOI 10.1093/jnci/djp023; Qin W, 2012, ONCOGENE, V31, P4067, DOI 10.1038/onc.2011.561; Rawlins EL, 2008, AM J PHYSIOL-LUNG C, V295, pL231, DOI 10.1152/ajplung.90209.2008; ROSADODECHRISTENSON ML, 1994, RADIOGRAPHICS, V14, P429, DOI 10.1148/radiographics.14.2.8190965; Sato T, 2010, AM J RESP CRIT CARE, V182, P1020, DOI 10.1164/rccm.201001-0055OC; Schembri F, 2009, P NATL ACAD SCI USA, V106, P2319, DOI 10.1073/pnas.0806383106; Solberg OD, 2012, AM J RESP CRIT CARE; Spira A, 2004, P NATL ACAD SCI USA, V101, P10143, DOI 10.1073/pnas.0401422101; Steiling K, 2013, AM J RESP CRIT CARE, V187, P933, DOI 10.1164/rccm.201208-1449OC; Sun XH, 2014, TRENDS CARDIOVAS MED, V24, P105, DOI 10.1016/j.tcm.2013.09.002; Tilley AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022798; Wang XG, 2013, NAT MED, V19, P93, DOI 10.1038/nm.3026; Willemse BWM, 2004, EUR RESPIR J, V23, P464, DOI 10.1183/09031936.04.00012704; Williams AE, 2007, DEV DYNAM, V236, P572, DOI 10.1002/dvdy.21047; Xi SC, 2013, J CLIN INVEST, V123, P1241, DOI 10.1172/JCI61271; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yoshida T, 2007, PHYSIOL REV, V87, P1047, DOI 10.1152/physrev.00048.2006; Zhang Y, 2011, EMBO REP, V12, P811, DOI 10.1038/embor.2011.98	55	53	54	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0120824	10.1371/journal.pone.0120824	http://dx.doi.org/10.1371/journal.pone.0120824			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886353	Green Submitted, Green Published, gold			2022-12-26	WOS:000353017000012
J	Zhe, C; Yu, F; Tian, J; Zheng, SG				Zhe, Cheng; Yu, Fan; Tian, Ju; Zheng, Shuguo			Trps1 Regulates Biliary Epithelial-Mesenchymal Transition and Has Roles during Biliary Fibrosis in Liver Grafts: A Preliminary Study	PLOS ONE			English	Article							COLD PRESERVATION; CANCER; TRANSPLANTATION; EXPRESSION; CELLS; DIFFERENTIATION; FIBROGENESIS; MECHANISMS; ISCHEMIA; KIDNEY	Objectives To investigate the role(s) of Trps1 in non-anastomotic biliary stricture (NABS) following liver transplantation. Methods Immunohistochemical and histological techniques were used to detect Trps1, E-cadherin, CK19, vimentin, alpha-SMA, and collagen deposition. Human intrahepatic biliary epithelial cells (HIBECs) were infected with a Trps1 adenovirus, or transfected with Trps1 short-interfering RNAs (siRNAs). Reverse transcription polymerase chain reaction (RT-PCR) assays and western blotting were used to determine expression levels of epithelial and mesenchymal markers, and Trps1 in HIBECs. Results Expression of Trps1 and epithelial markers was down-regulated or absent in NABS liver samples. Mesenchymal markers were seen in biliary epithelial cells (BECs), with collagen deposited around the bile duct. Trps1 expression positively correlated with epithelial markers. Expression of epithelial marker mRNAs and proteins in HIBECs decreased with prolonged cold preservation (CP), while mesenchymal marker expression increased. A 12-h CP period led to increased Trps1 mRNA and protein levels. Expression of E-cadherin was increased in HIBECs following Trps1 adenovirus infection and CP/reperfusion injury (CPRI), with vimentin expression levels reduced and CPRI-mediated epithelial-mesenchymal transition (EMT) inhibited. Transfection of HIBECs with Trps1 siRNAs in conjunction with CPRI revealed that E-cadherin expression was decreased, vimentin expression was increased, and CPRI-mediated EMT was promoted. Conclusion Trps1 is involved in NABS pathogenesis following liver transplantation and negatively correlates with BEC EMT and biliary fibrosis in liver grafts. Trps1 demonstrates antagonistic effects that could reverse EMT.	[Zhe, Cheng; Yu, Fan; Tian, Ju; Zheng, Shuguo] Third Mil Med Univ, Inst Hepatobiliary Surg, Southwest Hosp, Chongqing 400038, Peoples R China	Army Medical University	Zheng, SG (corresponding author), Third Mil Med Univ, Inst Hepatobiliary Surg, Southwest Hosp, 29 Gaotanyan Rd, Chongqing 400038, Peoples R China.	shuguozh@gmail.com			National Science Foundation of China [30972948]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Science Foundation of China (No: 30972948).	Chen Jie Qing, 2011, Hormones & Cancer, V2, P132, DOI 10.1007/s12672-011-0067-5; Dooley S, 2008, GASTROENTEROLOGY, V135, P642, DOI 10.1053/j.gastro.2008.04.038; Gai ZB, 2011, HISTOL HISTOPATHOL, V26, P915, DOI 10.14670/HH-26.915; Gai ZB, 2010, J AM SOC NEPHROL, V21, P1468, DOI 10.1681/ASN.2009121201; Gai ZB, 2009, J AM SOC NEPHROL, V20, P2403, DOI 10.1681/ASN.2008091020; Hong J, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/454085; Huang Kun, 2012, J 3 MILITARY MED U, V34, P1158; Huang WY, 2009, J BIOL CHEM, V284, P9426, DOI 10.1074/jbc.M900039200; Kim KK, 2009, J CLIN INVEST, V119, P213, DOI 10.1172/JCI36940; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Liang H, 2012, GENOME RES, V22, P2120, DOI 10.1101/gr.137596.112; Lin VC, 2014, ARCH TOXICOL, V88, P901, DOI 10.1007/s00204-014-1196-8; Liu XW, 2012, HEPATOL RES, V42, P1024, DOI 10.1111/j.1872-034X.2012.01011.x; Malik TH, 2002, MOL CELL BIOL, V22, P8592, DOI 10.1128/MCB.22.24.8592-8600.2002; Malik TH, 2001, EMBO J, V20, P1715, DOI 10.1093/emboj/20.7.1715; Park JB, 2008, TRANSPLANTATION, V86, P1536, DOI 10.1097/TP.0b013e31818b2316; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Que XY, 2004, J SURG RES, V116, P262, DOI 10.1016/j.jss.2003.07.005; Rauen U, 1997, FREE RADICAL BIO MED, V23, P392, DOI 10.1016/S0891-5849(96)00618-1; Robertson H, 2007, HEPATOLOGY, V45, P977, DOI 10.1002/hep.21624; Rygiel KA, 2008, LAB INVEST, V88, P112, DOI 10.1038/labinvest.3700704; SANCHEZURDAZPAL L, 1992, HEPATOLOGY, V16, P49, DOI 10.1002/hep.1840160110; Stinson S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002258; Su AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071309; Wendt MK, 2012, CELL TISSUE RES, V347, P85, DOI 10.1007/s00441-011-1199-1; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yanagita M, 2012, NEPHROL DIAL TRANSPL, V27, P3686, DOI 10.1093/ndt/gfs381; Zhao LJ, 2011, J SURG RES, V171, P819, DOI 10.1016/j.jss.2010.04.059; Zheng S, 2008, TRANSPL P, V40, P1629, DOI 10.1016/j.transproceed.2008.01.072	29	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123233	10.1371/journal.pone.0123233	http://dx.doi.org/10.1371/journal.pone.0123233			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886207	gold, Green Submitted, Green Published			2022-12-26	WOS:000353017000051
J	D'Avanzo, C; Sliwinski, C; Wagner, SL; Tanzi, RE; Kim, DY; Kovacs, DM				D'Avanzo, Carla; Sliwinski, Christopher; Wagner, Steven L.; Tanzi, Rudolph E.; Kim, Doo Yeon; Kovacs, Dora M.			gamma-Secretase modulators reduce endogenous amyloid beta(42) levels in human neural progenitor cells without altering neuronal differentiation	FASEB JOURNAL			English	Article						presenilin; Alzheimer's disease; SGSM; Notch; ReNcell VM	ALZHEIMERS-DISEASE; STEM-CELLS; INHIBITOR; ADULT; MODEL; TRIAL; SEMAGACESTAT; MAINTENANCE; PRESENILINS; MECHANISMS	Soluble gamma-secretase modulators (SGSMs) selectively decrease toxic amyloid beta (A beta) peptides (A beta(42)). However, their effect on the physiologic functions of gamma-secretase has not been tested in human model systems. gamma-Secretase regulates fate determination of neural progenitor cells. Thus, we studied the impact of SGSMs on the neuronal differentiation of ReNcell VM (ReN) human neural progenitor cells (hNPCs). Quantitative PCR analysis showed that treatment of neurosphere-like ReN cell aggregate cultures with gamma-secretase inhibitors (GSIs), but not SGSMs, induced a 2- to 4-fold increase in the expression of the neuronal markers Tuj1 and doublecortin. GSI treatment also induced neuronal marker protein expression, as shown by Western blot analysis. In the same conditions, SGSM treatment selectively reduced endogenous A beta(42) levels by similar to 80%. Mechanistically, we found that Notch target gene expressions were selectively inhibited by a GSI, not by SGSM treatment. We can assert, for the first time, that SGSMs do not affect the neuronal differentiation of hNPCs while selectively decreasing endogenous A beta(42) levels in the same conditions. Our results suggest that our hNPC differentiation system can serve as a useful model to test the impact of GSIs and SGSMs on both endogenous A beta levels and gamma-secretase physiologic functions including endogenous Notch signaling.	[D'Avanzo, Carla; Sliwinski, Christopher; Tanzi, Rudolph E.; Kim, Doo Yeon; Kovacs, Dora M.] Harvard Univ, Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Genet & Aging Res Unit,Med Sch, Charlestown, MA USA; [Wagner, Steven L.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Harvard University; Massachusetts General Hospital; University of California System; University of California San Diego	Kim, DY (corresponding author), 114 16th St, Charlestown, MA 02129 USA.	dkim@helix.mgh.harvard.edu; dora_kovacs@hms.harvard.edu	Tanzi, Rudolph/AAE-9622-2019	Tanzi, Rudolph/0000-0002-7032-1454	U.S. National Institutes of Health, National Institute on Aging [5P01AG015379, 1RF1AG048080-01, 2R01AG014713]; Cure Alzheimer's Fund (Cure Alzheimer's Grant Stem Cell Consortium); NATIONAL INSTITUTE ON AGING [RF1AG048080, P50AG005134, R01AG014713, P01AG015379] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Cure Alzheimer's Fund (Cure Alzheimer's Grant Stem Cell Consortium); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Dr. Se Hoon Choi and Ms. Jenna Garr for revising and editing the manuscript. This study was supported by the U.S. National Institutes of Health, National Institute on Aging (Grants 5P01AG015379 and 1RF1AG048080-01 to D.Y.K. and R.E.T., and Grant 2R01AG014713 to D.Y.K.), and from Cure Alzheimer's Fund (Cure Alzheimer's Grant Stem Cell Consortium; to D.Y.K., R.E.T. and S.L.W.). C.D. performed immunochemistry studies, immunofluorescence studies, analyzed data, and wrote the manuscript; C.S. performed quantitative RT-PCR studies, analyzed data, and reviewed the manuscript; S.L.W. and R.E.T. designed the soluble gamma-secretase modulators and tested for their efficacy; and D.Y.K. and D.M.K. designed the study and wrote the manuscript. The authors declare no conflicts of interest.	Ben-Shushan E, 2015, STEM CELLS, V33, P403, DOI 10.1002/stem.1873; Borghese L, 2010, STEM CELLS, V28, P955, DOI 10.1002/stem.408; Chaudhry ZL, 2013, NEUROL RES, V35, P435, DOI 10.1179/1743132812Y.0000000135; Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800; Donato R, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-36; Doody RS, 2013, NEW ENGL J MED, V369, P341, DOI 10.1056/NEJMoa1210951; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Fleisher AS, 2008, ARCH NEUROL-CHICAGO, V65, P1031, DOI 10.1001/archneur.65.8.1031; Gadadhar A, 2011, J NEUROSCI, V31, P2615, DOI 10.1523/JNEUROSCI.4767-10.2011; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Henley DB, 2014, CURR MED RES OPIN, V30, P2021, DOI 10.1185/03007995.2014.939167; Hu YY, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-82; Kim WY, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-2; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; Ledford H, 2010, NATURE, V466, P1031, DOI 10.1038/4661031a; Liao HJ, 2012, TRAFFIC, V13, P1106, DOI 10.1111/j.1600-0854.2012.01371.x; Miljan E. A., 2008, RENCELL HUMAN NEURAL, P1; Morgan PJ, 2009, NEUROREPORT, V20, P1225, DOI 10.1097/WNR.0b013e32832fbf49; Niva C, 2013, EUR J CLIN PHARMACOL, V69, P1247, DOI 10.1007/s00228-012-1459-3; Ogura A, 2013, STEM CELLS DEV, V22, P374, DOI 10.1089/scd.2012.0198; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Sisodia SS, 2001, TRENDS NEUROSCI, V24, pS2, DOI 10.1016/S0166-2236(00)01987-1; Sloane PD, 2002, ANNU REV PUBL HEALTH, V23, P213, DOI 10.1146/annurev.publhealth.23.100901.140525; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tesco G, 2000, ANN NY ACAD SCI, V920, P227; Tesco G, 1998, J BIOL CHEM, V273, P33909, DOI 10.1074/jbc.273.51.33909; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; Veeraraghavalu K, 2010, J NEUROSCI, V30, P6903, DOI 10.1523/JNEUROSCI.0527-10.2010; Wagner SL, 2014, BIOCHEMISTRY-US, V53, P702, DOI 10.1021/bi401537v; Wines-Samuelson M, 2005, NEUROSCIENTIST, V11, P441, DOI 10.1177/1073858405278922	33	7	7	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3335	3341		10.1096/fj.15-271015	http://dx.doi.org/10.1096/fj.15-271015			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25903103	Green Published			2022-12-26	WOS:000358796900021
J	Baban, B; Liu, JY; Qin, X; Weintraub, NL; Mozaffari, MS				Baban, Babak; Liu, Jun Yao; Qin, Xu; Weintraub, Neal L.; Mozaffari, Mahmood S.			Upregulation of Programmed Death-1 and Its Ligand in Cardiac Injury Models: Interaction with GADD153	PLOS ONE			English	Article							GRAFT ARTERIAL-DISEASE; PD-L1; INFLAMMATION; PATHWAY; B7-H1; EXPRESSION; OVEREXPRESSION; MYOCARDITIS; PROGNOSIS; CARCINOMA	Purpose Programmed Death-1 (PD-1) and its ligand, PD-L1, are regulators of immune/inflammatory mechanisms. We explored the potential involvement of PD-1/PD-L1 pathway in the inflammatory response and tissue damage in cardiac injury models. Experimental Design Ischemic-reperfused and cryoinjured hearts were processed for flow cytometry and immunohistochemical studies for determination of cardiac PD-1 and PD-L1 in the context of assessment of the growth arrest-and DNA damage-inducible protein 153 (GADD153) which regulates both inflammation and cell death. Further, we explored the potential ability of injured cardiac cells to influence proliferation of T lymphocytes. Results The isolated ischemic-reperfused hearts displayed marked increases in expression of PD-1 and PD-L1 in cardiomyocytes; however, immunofluorescent studies indicate that PD-1 and PD-L1 are not primarily co-expressed on the same cardiomyocytes. Upregulation of PD-1/PD-L1 was associated with a) marked increases in GADD153 and interleukin (IL)-17 but a mild increase in IL-10 and b) disruption of mitochondrial membrane potential (psi(m)) as well as apoptotic and necrotic cell death. Importantly, while isotype matching treatment did not affect the aforementioned changes, treatment with the PD-L1 blocking antibody reversed those effects in association with marked cardioprotection. Further, ischemic-reperfused cardiac cells reduced proliferation of T lymphocytes, an effect partially reversed by PD-L1 antibody. Subsequent studies using the cryoinjury model of myocardial infarction revealed significant increases in PD-1, PD-L1, GADD153 and IL-17 positive cells in association with significant apoptosis/necrosis. Conclusions The data suggest that upregulation of PD-1/PD-L1 pathway in cardiac injury models mediates tissue damage likely through a paracrine mechanism. Importantly, inhibition of T cell proliferation by ischemic-reperfused cardiac cells is consistent with the negative immunoregulatory role of PD-1/PD-L1 pathway, likely reflecting an endogenous cardiac mechanism to curtail the deleterious impact of infiltrating immune cells to the damaged myocardium. The balance of these countervailing effects determines the extent of cardiac injury.	[Baban, Babak; Liu, Jun Yao; Qin, Xu; Mozaffari, Mahmood S.] Georgia Regents Univ, Coll Dent Med, Dept Oral Biol, Augusta, GA 30912 USA; [Weintraub, Neal L.] Georgia Regents Univ, Dept Med, Cardiol Sect, Augusta, GA 30912 USA; [Weintraub, Neal L.] Georgia Regents Univ, Vasc Biol Ctr, Med Coll Georgia, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Baban, B (corresponding author), Georgia Regents Univ, Coll Dent Med, Dept Oral Biol, Augusta, GA 30912 USA.	bbaban@gru.edu		Weintraub, Neal/0000-0002-5138-3705	Georgia Regents University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112640] Funding Source: NIH RePORTER	Georgia Regents University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Source of funding for supporting all studies in this article is the institutional seed money, Georgia Regents University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baban B, 2014, J EXPT CLIN CARDIOLO, V5, P286; Baban B, 2014, AM J HYPERTENS, V27, P846, DOI 10.1093/ajh/hpt269; Baban B, 2013, HYPERTENSION, V61, P95, DOI 10.1161/HYPERTENSIONAHA.111.00028; Baban B, 2011, J IMMUNOL, V187, P2329, DOI 10.4049/jimmunol.1100276; Baban B, 2009, J IMMUNOL, V183, P2475, DOI 10.4049/jimmunol.0900986; Becher UM, 2011, J MOL CELL CARDIOL, V50, P570, DOI 10.1016/j.yjmcc.2010.11.013; Blackburn SD, 2010, J VIROL, V84, P2078, DOI 10.1128/JVI.01579-09; Bodhankar S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-111; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Bu DX, 2011, ARTERIOSCL THROM VAS, V31, P1100, DOI 10.1161/ATVBAHA.111.224709; Carter LL, 2007, J NEUROIMMUNOL, V182, P124, DOI 10.1016/j.jneuroim.2006.10.006; Chiodi F, 2010, J CLIN INVEST, V120, P3810, DOI 10.1172/JCI44872; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Furukawa Y, 2000, AM J PATHOL, V157, P473, DOI 10.1016/S0002-9440(10)64559-2; Ghebeh H, 2006, NEOPLASIA, V8, P190, DOI 10.1593/neo.05733; Grabie N, 2007, CIRCULATION, V116, P2062, DOI 10.1161/CIRCULATIONAHA.107.709360; Kim KS, 2001, AM J PATHOL, V158, P977, DOI 10.1016/S0002-9440(10)64044-8; Koga N, 2004, ARTERIOSCL THROM VAS, V24, P2057, DOI 10.1161/01.ATV.0000145015.23656.e4; Lucas JA, 2008, J IMMUNOL, V181, P2513, DOI 10.4049/jimmunol.181.4.2513; Miyazaki Y, 2011, ARTERIOSCL THROM VAS, V31, P1124, DOI 10.1161/ATVBAHA.111.224519; Mozaffari MS, 2013, AM J CARDIOVASC DIS, V3, P180; Nakanishi J, 2007, CANCER IMMUNOL IMMUN, V56, P1173, DOI 10.1007/s00262-006-0266-z; Nomi T, 2007, CLIN CANCER RES, V13, P2151, DOI 10.1158/1078-0432.CCR-06-2746; Ozkaynak E, 2002, J IMMUNOL, V169, P6546, DOI 10.4049/jimmunol.169.11.6546; Ren XF, 2011, STROKE, V42, P2578, DOI 10.1161/STROKEAHA.111.613182; ROSE ML, 1986, TRANSPLANTATION, V41, P776, DOI 10.1097/00007890-198606000-00021; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Seko Y, 2007, CARDIOVASC RES, V75, P158, DOI 10.1016/j.cardiores.2007.03.012; Tarrio ML, 2012, J IMMUNOL, V188, P4876, DOI 10.4049/jimmunol.1200389; Thompson RH, 2006, CLIN GENITOURIN CANC, V5, P206, DOI 10.3816/CGC.2006.n.038; Thompson RH, 2006, CANCER RES, V66, P3381, DOI 10.1158/0008-5472.CAN-05-4303; Topalian SL, 2011, J CLIN ONCOL, V29, P4828, DOI 10.1200/JCO.2011.38.0899; van den Bos EJ, 2005, AM J PHYSIOL-HEART C, V289, pH1291, DOI 10.1152/ajpheart.00111.2005; Wang LQ, 2007, EUR J IMMUNOL, V37, P2983, DOI 10.1002/eji.200737583; Wang WG, 2008, TRANSPLANTATION, V86, P836, DOI 10.1097/TP.0b013e3181861932; Zhang Y, 2010, CRIT CARE, V14, DOI 10.1186/cc9354	36	56	61	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124059	10.1371/journal.pone.0124059	http://dx.doi.org/10.1371/journal.pone.0124059			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902191	Green Published, gold, Green Submitted			2022-12-26	WOS:000353331500074
J	Huang, L; Counter, CM				Huang, Lu; Counter, Christopher M.			Reduced HRAS(G12V)-Driven Tumorigenesis of Cell Lines Expressing KRAS(C118S)	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; GUANINE-NUCLEOTIDE EXCHANGE; P21(RAS) S-NITROSYLATION; WILD-TYPE RAS; MUTANT K-RAS; ENDOTHELIAL-CELLS; ACTIVATION; ONCOGENES; PROTEIN; AKT	In many different human cancers, one of the HRAS, NRAS, or KRAS genes in the RAS family of small GTPases acquires an oncogenic mutation that renders the encoded protein constitutively GTP-bound and thereby active, which is well established to promote tumorigenesis. In addition to oncogenic mutations, accumulating evidence suggests that the wild-type isoforms may also be activated and contribute to oncogenic RAS-driven tumorigenesis. In this regard, redox-dependent reactions with cysteine 118 (C118) have been found to promote activation of wild-type HRAS and NRAS. We sought to determine if this residue is also important for the activation of wild-type KRAS and promotion of tumorigenesis. Thus, we mutated C118 to serine (C118S) in wild-type KRAS to block redox-dependent reactions at this site. We now report that this mutation reduced the level of GTP-bound KRAS and impaired RAS signaling stimulated by the growth factor EGF. With regards to tumorigenesis, we also report that oncogenic HRAS-transformed human cells in which endogenous KRAS was knocked down and replaced with KRAS(C118S) exhibited reduced xenograft tumor growth, as did oncogenic HRAS-transformed Kras(C118S/C118S) murine cells in which the C118S mutation was knocked into the endogenous Kras gene. Taken together, these data suggest a role for redox-dependent activation of wild-type KRAS through C118 in oncogenic HRAS-driven tumorigenesis.	[Huang, Lu; Counter, Christopher M.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA; [Counter, Christopher M.] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC USA	Duke University; Duke University	Counter, CM (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA.	count004@mc.duke.edu	Huang, Lu/I-4148-2018	Counter, Christopher M/0000-0003-0748-3079	National Cancer Institute [R01CA123031]; NATIONAL CANCER INSTITUTE [R01CA123031] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant R01CA123031 to CMC from the National Cancer Institute (http://www.cancer.gov/researchandfunding) supported this research. The funding agency had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2004, J BIOL CHEM, V279, P29857, DOI 10.1074/jbc.M313320200; An HJ, 2006, J BIOL CHEM, V281, P33939, DOI 10.1074/jbc.M605819200; Batista WL, 2013, ANTIOXID REDOX SIGN, V18, P221, DOI 10.1089/ars.2011.4455; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Brady DC, 2014, NATURE, V509, P492, DOI 10.1038/nature13180; Clavreul N, 2006, FASEB J, V20, P518, DOI 10.1096/fj.05-4875fje; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Grabocka E, 2014, CANCER CELL, V25, P243, DOI 10.1016/j.ccr.2014.01.005; Heo JY, 2004, BIOCHEMISTRY-US, V43, P2314, DOI 10.1021/bi035275g; Hobbs GA, 2013, FREE RADICAL BIO MED, V57, P221, DOI 10.1016/j.freeradbiomed.2012.10.531; Jeng HH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2173; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kashatus DF, 2011, NAT CELL BIOL, V13, P1108, DOI 10.1038/ncb2310; Lampson BL, 2013, CURR BIOL, V23, P70, DOI 10.1016/j.cub.2012.11.031; Lander HM, 1996, NATURE, V381, P380, DOI 10.1038/381380a0; Lander HM, 1997, J BIOL CHEM, V272, P4323, DOI 10.1074/jbc.272.7.4323; Lim KH, 2008, NATURE, V452, P646, DOI 10.1038/nature06778; Matallanas D, 2011, MOL CELL, V44, P893, DOI 10.1016/j.molcel.2011.10.016; Michell BJ, 1999, CURR BIOL, V9, P845, DOI 10.1016/S0960-9822(99)80371-6; Mott HR, 1997, BIOCHEMISTRY-US, V36, P3640, DOI 10.1021/bi962790o; O'Hayer KM, 2006, METHOD ENZYMOL, V407, P637, DOI 10.1016/S0076-6879(05)07050-3; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Raines KW, 2007, CARDIOVASC RES, V75, P229, DOI 10.1016/j.cardiores.2007.04.013; Raines KW, 2006, BIOCHEM J, V397, P329, DOI 10.1042/BJ20052002; Rajalingam K, 2007, BBA-MOL CELL RES, V1773, P1177, DOI 10.1016/j.bbamcr.2007.01.012; Teng KK, 1999, J BIOL CHEM, V274, P37315, DOI 10.1074/jbc.274.52.37315; To MD, 2013, ONCOGENE, V32, P4028, DOI 10.1038/onc.2012.404; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Williams JG, 2003, P NATL ACAD SCI USA, V100, P6376, DOI 10.1073/pnas.1037299100; Wittinghofer A, 1996, TRENDS BIOCHEM SCI, V21, P488, DOI 10.1016/S0968-0004(96)10064-5; Xu JX, 2014, INT J ADAPT CONTROL, V28, P1, DOI 10.1002/acs.2380; Young A, 2013, CANCER DISCOV, V3, P112, DOI 10.1158/2159-8290.CD-12-0231; Zhang ZQ, 2001, NAT GENET, V29, P25, DOI 10.1038/ng721	36	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123918	10.1371/journal.pone.0123918	http://dx.doi.org/10.1371/journal.pone.0123918			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902334	Green Submitted, Green Published, gold			2022-12-26	WOS:000353331500067
J	Seredin, P; Goloshchapov, D; Prutskij, T; Ippolitov, Y				Seredin, Pavel; Goloshchapov, Dmitry; Prutskij, Tatiana; Ippolitov, Yury			Phase Transformations in a Human Tooth Tissue at the Initial Stage of Caries	PLOS ONE			English	Article							EARLY DENTAL-CARIES; MICRO-RAMAN SPECTROSCOPY; X-RAY-DIFFRACTION; HUMAN ENAMEL; HYDROXYAPATITE; SOLUBILITY	The aim of the paper is to study phase transformations in solid tissues of the human teeth during the development of fissure caries by Raman and fluorescence microspectroscopy. The study of the areas with fissure caries confirmed the assumption of the formation of a weak interaction between phosphate apatite enamel and organic acids (products of microorganisms). The experimental results obtained with by Raman microspectroscopy showed the formation of dicalcium phosphate dihydrate - CaHPO4-2H(2)O in the area of mural demineralization of carious fissure. A comparative analysis of structural and spectroscopic data for the intact and carious enamel shows that emergence of a more soluble phase - carbonate-substituted hydroxyapatite - is typical for the initial stage of caries. It is shown that microareas of dental hard tissues in the carious fissure due to an emerging misorientation of apatite crystals have a higher fluorescence yield than the area of the intact enamel. These areas can be easily detected even prior to a deep demineralization (white spot stage) for the case of irreversibly changed organomineral complex and intensive removal of the mineral component.	[Seredin, Pavel; Goloshchapov, Dmitry] Voronezh State Univ, Dept Solid State Phys & Nanostruct, Voronezh 394693, Russia; [Prutskij, Tatiana] Benemerita Univ Autonoma Puebla, Inst Ciencias, Puebla, Mexico; [Ippolitov, Yury] Voronezh State Univ, Dept Prevent Dent, Voronezh 394693, Russia	Voronezh State University; Benemerita Universidad Autonoma de Puebla; Voronezh State University	Seredin, P (corresponding author), Voronezh State Univ, Dept Solid State Phys & Nanostruct, Voronezh 394693, Russia.	paul@phys.vsu.ru	Seredin, Pavel/M-3682-2014; Goloshchapov, Dmitry/M-5149-2016	Seredin, Pavel/0000-0002-6724-0063; Goloshchapov, Dmitry/0000-0002-1400-2870; Ippolitov, Yury/0000-0001-9922-137X	Russian Foundation for Basic Research (RFBR) [13-02-97500]	Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR))	The work was supported by Russian Foundation for Basic Research (RFBR), project number 13-02-97500. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoba T, 2004, ORAL DIS, V10, P249, DOI 10.1111/j.1601-0825.2004.01030.x; Farlay D, 2010, J BONE MINER METAB, V28, P433, DOI 10.1007/s00774-009-0146-7; Gimenez T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060421; Gross EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047722; Ippolitov Y, 2014, INDIAN J DENT S, V5, P135; Kapolos J, 1999, LANGMUIR, V15, P6557, DOI 10.1021/la981285k; Kashkarov VM, 2011, J SURF INVESTIG, V5, P1162, DOI 10.1134/S1027451011120068; Ko ACT, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1915488; Ko ACT, 2006, OPT EXPRESS, V14, P203, DOI 10.1364/OPEX.14.000203; Ko ACT, 2008, OPT EXPRESS, V16, P6274, DOI 10.1364/OE.16.006274; Kon M, 2002, DENT MATER J, V21, P170, DOI 10.4012/dmj.21.170; Lieber CA, 2003, APPL SPECTROSC, V57, P1363, DOI 10.1366/000370203322554518; Mann S., 2001, BIOMINERALIZATION PR; Margolis HC, 1999, J DENT RES, V78, P1326, DOI 10.1177/00220345990780070701; Markovic M, 2004, J RES NATL INST STAN, V109, P553, DOI 10.6028/jres.109.042; MORENO EC, 1990, J BIOL BUCCALE, V18, P195; Pan HB, 2010, CRYST GROWTH DES, V10, P845, DOI 10.1021/cg901199h; Rey C, 2007, MAT SCI ENG C-BIO S, V27, P198, DOI 10.1016/j.msec.2006.05.015; Reyes-Gasga J, 2013, MAT SCI ENG C-MATER, V33, P4568, DOI 10.1016/j.msec.2013.07.014; Robinson C, 2000, CRIT REV ORAL BIOL M, V11, P481, DOI 10.1177/10454411000110040601; Robinson C., 1995, DENT ENAMEL FORMATIO, P223; Schulze KA, 2004, J BIOMED MATER RES A, V69A, P286, DOI 10.1002/jbm.a.20130; Seredin P, 2013, J SYNCHROTRON RADIAT, V20, P705, DOI 10.1107/S0909049513019444; TSUDA H, 1994, J DENT RES, V73, P1703, DOI 10.1177/00220345940730110501; Tsuda H, 1997, Adv Dent Res, V11, P539; Veresov A.G., 2004, ROSS KHIM ZH, V48, P52; Xue J, 2008, J SYNCHROTRON RADIAT, V15, P235, DOI 10.1107/S0909049508003397; Zavala-Alonso V, 2012, J ORAL SCI, V54, P93, DOI 10.2334/josnusd.54.93	28	37	46	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124008	10.1371/journal.pone.0124008	http://dx.doi.org/10.1371/journal.pone.0124008			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901743	Green Published, gold, Green Submitted			2022-12-26	WOS:000353331500070
J	Tessier, L; Bienzle, D; Williams, LB; Koch, TG				Tessier, Laurence; Bienzle, Dorothee; Williams, Lynn B.; Koch, Thomas G.			Phenotypic and Immunomodulatory Properties of Equine Cord Blood-Derived Mesenchymal Stromal Cells	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; TOLL-LIKE RECEPTORS; STEM-CELLS; BONE-MARROW; ADIPOSE-TISSUE; MARKERS; CULTURE; DIFFERENTIATION; IMMUNOPHENOTYPE; THERAPY	Multipotent mesenchymal stromal cells (MSC) have attracted interest for their cytotherapeutic potential, partly due to their immunomodulatory abilities. The aim of this study was to test the robustness of our equine cord blood (CB) MSC isolation protocol, to characterize the CB-MSC before and after cryopreservation, and to evaluate their immunosuppressive phenotype. We hypothesized that MSC can be consistently isolated from equine CB, have unique and reproducible marker expression and in vitro suppress lymphoproliferation. Preliminary investigation of constitutive cytoplasmic Toll-like receptor (TLR) 3 and 4 expression was also preformed due to their possible association with anti-or pro-inflammatory MSC phenotypes, respectively. Surface markers were assessed for antigen and mRNA expression by flow cytometry and quantitative polymerase chain reaction (qPCR). Immunomodulatory properties were evaluated in mixed lymphocyte reaction assays, and TLR3 and TLR4 expression were measured by qPCR and immunocytochemistry (ICC). CB-MSC were isolated from each off nine cord blood samples. CB-MSC highly expressed CD29, CD44, CD90, and lacked or had low expression of major histocompatibility complex (MHC) class I, MHC-II, CD4, CD8, CD11a/18 and CD73 before and after cryopreservation. CB-MSC suppressed in vitro lymphoproliferation and constitutively expressed TLR4. Our findings confirmed CB as a reliable MSC source, provides an association of surface marker phenotype and mRNA expression and suggest anti-inflammatory properties of CB-MSC. The relationship between TLRs and lymphocyte function warrants further investigation.	[Tessier, Laurence; Koch, Thomas G.] Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada; [Bienzle, Dorothee] Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON N1G 2W1, Canada; [Williams, Lynn B.] Univ Guelph, Ontario Vet Coll, Dept Clin Studies, Guelph, ON N1G 2W1, Canada; [Koch, Thomas G.] Aarhus Univ, Orthopaed Res Lab, Aarhus, Denmark	University of Guelph; University of Guelph; University of Guelph; Aarhus University	Koch, TG (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada.	tkoch@uoguelph.ca	Bienzle, Dorothee/AAY-5009-2020	Bienzle, Dorothee/0000-0002-2301-2931	Danish Agency for Technology, Production and Innovation; Equine Guelph; Department of Biomedical Sciences at the University of Guelph	Danish Agency for Technology, Production and Innovation; Equine Guelph; Department of Biomedical Sciences at the University of Guelph	This project was supported by the Danish Agency for Technology, Production and Innovation, Equine Guelph and the Department of Biomedical Sciences at the University of Guelph. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnhold SJ, 2007, AM J VET RES, V68, P1095, DOI 10.2460/ajvr.68.10.1095; Bieback K, 2004, STEM CELLS, V22, P625, DOI 10.1634/stemcells.22-4-625; Braun J, 2010, AM J VET RES, V71, P1228, DOI 10.2460/ajvr.71.10.1228; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Calloni R, 2013, STEM CELLS DEV, V22, P1455, DOI 10.1089/scd.2012.0637; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Carrade DD, 2012, CELL MED, V4, P1, DOI 10.3727/215517912X647217; Carvalho AD, 2009, VET IMMUNOL IMMUNOP, V132, P303, DOI 10.1016/j.vetimm.2009.06.014; Chagastelles PC, 2011, KIDNEY INT SUPPL, V1, P63, DOI 10.1038/kisup.2011.15; Cyranoski D, 2013, NATURE, V496, P148, DOI 10.1038/496148a; De Schauwer C, 2013, EQUINE VET J, V45, P518, DOI 10.1111/evj.12003; De Schauwer C, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt395; De Schauwer C, 2012, CYTOM PART A, V81A, P312, DOI 10.1002/cyto.a.22026; De Schauwer C, 2011, TISSUE ENG PART C-ME, V17, P1061, DOI 10.1089/ten.tec.2011.0052; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Ferwerda B, 2008, MOL MED, V14, P346, DOI 10.2119/2007-00135.Ferwerda; Figueiredo MD, 2009, VET IMMUNOL IMMUNOP, V131, P65, DOI 10.1016/j.vetimm.2009.03.013; Fortier LA, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt50; Frisbie DD, 2009, J ORTHOP RES, V27, P1675, DOI 10.1002/jor.20933; Frisbie DD, 2005, VET CLIN N AM-EQUINE, V21, P713, DOI 10.1016/j.cveq.2005.07.001; Galipeau J, 2013, CYTOTHERAPY, V15, P2, DOI 10.1016/j.jcyt.2012.10.002; Geng SM, 2013, ARCH DERMATOL RES, V305, P35, DOI 10.1007/s00403-012-1260-2; Guest DJ, 2008, EQUINE VET J, V40, P178, DOI 10.2746/042516408X276942; Haeryfar SMM, 2004, J IMMUNOL, V173, P3581, DOI 10.4049/jimmunol.173.6.3581; Hass R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-12; Iacono E, 2012, REPRODUCTION, V143, P455, DOI 10.1530/REP-10-0408; Kang JG, 2013, J VET SCI, V14, P367, DOI 10.4142/jvs.2013.14.3.367; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Koch TG, 2008, CAN VET J, V49, P1009; Koch TG, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-26; Koch TG, 2009, CAN VET J, V50, P155; Koch TG, 2009, CYTOTHERAPY, V11, P443, DOI 10.1080/14653240902887259; Kogler G, 2006, EXP HEMATOL, V34, P1589, DOI 10.1016/j.exphem.2006.07.011; Lange-Consiglio A, 2013, EQUINE VET J, V45, P737, DOI 10.1111/evj.12052; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x; Li Q, 2013, J MOL HISTOL, V44, P411, DOI 10.1007/s10735-013-9492-9; Liotta F, 2008, STEM CELLS, V26, P279, DOI 10.1634/stemcells.2007-0454; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lovati AB, 2011, VET RES COMMUN, V35, P103, DOI 10.1007/s11259-010-9457-3; Lundberg AM, 2007, BLOOD, V110, P3245, DOI 10.1182/blood-2007-02-072934; Maia L, 2013, MICROSC RES TECHNIQ, V76, P618, DOI 10.1002/jemt.22208; Mohanty N, 2014, IN VITRO CELL DEV-AN, V50, P538, DOI 10.1007/s11626-013-9729-7; Nailis H, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-25; Paebst F, 2014, CYTOM PART A, V85A, P678, DOI 10.1002/cyto.a.22491; Pascucci L, 2011, VET IMMUNOL IMMUNOP, V144, P499, DOI 10.1016/j.vetimm.2011.07.017; Pevsner-Fischer M, 2007, BLOOD, V109, P1422, DOI 10.1182/blood-2006-06-028704; Pigott JH, 2013, VET IMMUNOL IMMUNOP, V156, P99, DOI 10.1016/j.vetimm.2013.09.003; Raabe O, 2011, VET RES COMMUN, V35, P355, DOI 10.1007/s11259-011-9480-z; Radcliffe CH, 2010, STEM CELLS DEV, V19, P269, DOI 10.1089/scd.2009.0091; Radtke CL, 2013, AM J VET RES, V74, P790, DOI 10.2460/ajvr.74.5.790; Raicevic G, 2011, CELL IMMUNOL, V270, P207, DOI 10.1016/j.cellimm.2011.05.010; Ranera B, 2012, EQUINE VET J, V44, P33, DOI 10.1111/j.2042-3306.2010.00353.x; Ranera B, 2011, VET IMMUNOL IMMUNOP, V144, P147, DOI 10.1016/j.vetimm.2011.06.033; Schnabel LV, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt402; Schuh EM, 2009, AM J VET RES, V70, P1526, DOI 10.2460/ajvr.70.12.1526; Singh A, 2014, BONE JOINT RES, V3, P32, DOI 10.1302/2046-3758.32.2000187; Tomchuck SL, 2008, STEM CELLS, V26, P99, DOI 10.1634/stemcells.2007-0563; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verreck FAW, 2006, J LEUKOCYTE BIOL, V79, P285, DOI 10.1189/jlb.0105015; Violini S, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-29; Waterman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010088; Zhang X, 2011, J CELL BIOCHEM, V112, P1206, DOI 10.1002/jcb.23042	63	33	35	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0122954	10.1371/journal.pone.0122954	http://dx.doi.org/10.1371/journal.pone.0122954			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902064	Green Submitted, Green Published, gold			2022-12-26	WOS:000353331500033
J	Vaillant, C; Valdivieso, P; Nuciforo, S; Kool, M; Schwarzentruber-Schauerte, A; Mereau, H; Cabuy, E; Lobrinus, JA; Pfister, S; Zuniga, A; Frank, S; Zeller, R				Vaillant, Catherine; Valdivieso, Paola; Nuciforo, Sandro; Kool, Marcel; Schwarzentruber-Schauerte, Alexandra; Mereau, Helene; Cabuy, Erik; Lobrinus, Johannes A.; Pfister, Stefan; Zuniga, Aimee; Frank, Stephan; Zeller, Rolf			Serpine2/PN-1 Is Required for Proliferative Expansion of Pre-Neoplastic Lesions and Malignant Progression to Medulloblastoma	PLOS ONE			English	Article							SONIC HEDGEHOG; PROTEASE NEXIN-1; MOUSE MODEL; GENETIC PROFILES; MESSENGER-RNA; EXPRESSION; MUTATIONS; SUBGROUPS; TARGET; GROWTH	Background Medulloblastomas are malignant childhood brain tumors that arise due to the aberrant activity of developmental pathways during postnatal cerebellar development and in adult humans. Transcriptome analysis has identified four major medulloblastoma subgroups. One of them, the Sonic hedgehog (SHH) subgroup, is caused by aberrant Hedgehog signal transduction due to mutations in the Patched1 (PTCH1) receptor or downstream effectors. Mice carrying a Patched-1 null allele (Ptch1(Delta/+)) are a good model to study the alterations underlying medulloblastoma development as a consequence of aberrant Hedgehog pathway activity. Results Transcriptome analysis of human medulloblastomas shows that SERPINE2, also called Protease Nexin-1 (PN-1) is overexpressed in most medulloblastomas, in particular in the SHH and WNT subgroups. As siRNA-mediated lowering of SERPINE2/PN-1 in human medulloblastoma DAOY cells reduces cell proliferation, we analyzed its potential involvement in medulloblastoma development using the Ptch1(Delta/+) mouse model. In Ptch1(Delta/+) mice, medulloblastomas arise as a consequence of aberrant Hedgehog pathway activity. Genetic reduction of Serpine2/Pn-1 interferes with medulloblastoma development in Ptch1(Delta/+) mice, as similar to 60% of the pre-neoplastic lesions (PNLs) fail to develop into medulloblastomas and remain as small cerebellar nodules. In particular the transcription factor Atoh1, whose expression is essential for development of SHH subgroup medulloblastomas is lost. Comparative molecular analysis reveals the distinct nature of the PNLs in young Ptch1(Delta/+)Pn-1(Delta/+) mice. The remaining wild-type Ptch1 allele escapes transcriptional silencing in most cases and the aberrant Hedgehog pathway activity is normalized. Furthermore, cell proliferation and the expression of the cell-cycle regulators Mycn and Cdk6 are significantly reduced in PNLs of Ptch1(Delta/+)Pn-1(Delta/+) mice. Conclusions Our analysis provides genetic evidence that aberrant Serpine2/Pn-1 is required for proliferation of human and mouse medulloblastoma cells. In summary, our analysis shows that Serpine2/PN-1 boosts malignant progression of PNLs to medulloblastomas, in which the Hedgehog pathway is activated in a SHH ligand-independent manner.	[Vaillant, Catherine; Valdivieso, Paola; Nuciforo, Sandro; Schwarzentruber-Schauerte, Alexandra; Mereau, Helene; Zuniga, Aimee; Zeller, Rolf] Univ Basel, Dept Biomed, Dev Genet, Basel, Switzerland; [Kool, Marcel; Pfister, Stefan] German Canc Res Ctr, Div Pediat Neurooncol, Heidelberg, Germany; [Cabuy, Erik] Friedrich Miescher Inst, Single Cell Genom, CH-4002 Basel, Switzerland; [Lobrinus, Johannes A.] Univ Hosp Geneva, Dept Clin Pathol, Neuropathol Unit, Geneva, Switzerland; [Frank, Stephan] Univ Basel, Inst Pathol, Div Neuropathol, Basel, Switzerland	University of Basel; Helmholtz Association; German Cancer Research Center (DKFZ); Friedrich Miescher Institute for Biomedical Research; University of Geneva; University of Basel	Zeller, R (corresponding author), Univ Basel, Dept Biomed, Dev Genet, Basel, Switzerland.	rolf.zeller@unibas.ch	Zeller, Rolf/C-2610-2013; Zuniga, Aimée/Q-2692-2018; Zuniga, Aimée/AAG-7335-2020; Pfister, Stefan M/F-6860-2013	Zeller, Rolf/0000-0002-3186-7403; Zuniga, Aimée/0000-0002-9953-3637; Zuniga, Aimée/0000-0002-9953-3637; Pfister, Stefan M/0000-0002-5447-5322; Nuciforo, Sandro/0000-0002-1863-1869; Valdivieso, Paola/0000-0001-9322-4510	Swiss National Science Foundation Marie-Heim Vogtlin fellowship; OncoSuisse research grant; Krebsforschung Schweiz grant; cantons of Basel	Swiss National Science Foundation Marie-Heim Vogtlin fellowship; OncoSuisse research grant; Krebsforschung Schweiz grant; cantons of Basel	This research was supported by a Swiss National Science Foundation Marie-Heim Vogtlin fellowship (to C.V.), an OncoSuisse research grant (to R.Z and S.F), a Krebsforschung Schweiz grant (to R.Z) and the cantons of Basel (to A.Z. and R.Z).	Asuthkar S, 2014, ONCOGENE, V33, P1922, DOI 10.1038/onc.2013.151; Beliveau A, 2010, GENE DEV, V24, P2800, DOI 10.1101/gad.1990410; Benazet JD, 2009, SCIENCE, V323, P1050, DOI 10.1126/science.1168755; Bergeron S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-271; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Buchholz M, 2003, CANCER RES, V63, P4945; Fattet S, 2009, J PATHOL, V218, P86, DOI 10.1002/path.2514; Fayard B, 2009, CANCER RES, V69, P5690, DOI 10.1158/0008-5472.CAN-08-4573; FLOOR E, 1988, J NEUROCHEM, V50, P1597, DOI 10.1111/j.1471-4159.1988.tb03049.x; Flora A, 2009, SCIENCE, V326, P1424, DOI 10.1126/science.1181453; Gao S, 2008, ORAL ONCOL, V44, P309, DOI 10.1016/j.oraloncology.2007.02.009; Garcia-Lopez R, 2013, J CANCER RES THER, V1, P11; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Gotschel F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065403; Goodrich LV, 1999, DEV BIOL, V211, P323, DOI 10.1006/dbio.1999.9311; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Gravendeel LAM, 2009, CANCER RES, V69, P9065, DOI 10.1158/0008-5472.CAN-09-2307; Hallahan AR, 2004, CANCER RES, V64, P7794, DOI 10.1158/0008-5472.CAN-04-1813; Hatten ME, 1997, CURR OPIN NEUROBIOL, V7, P40, DOI 10.1016/S0959-4388(97)80118-3; Heit C, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-22; Hoffman LM, 2014, ACTA NEUROPATHOL, V127, P731, DOI 10.1007/s00401-013-1212-8; Johnson RA, 2010, NATURE, V466, P632, DOI 10.1038/nature09173; Jones DTW, 2013, NAT GENET, V45, P927, DOI 10.1038/ng.2682; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kessler JD, 2009, GENE DEV, V23, P157, DOI 10.1101/gad.1759909; Kool M, 2014, CANCER CELL, V25, P393, DOI 10.1016/j.ccr.2014.02.004; Kool M, 2012, ACTA NEUROPATHOL, V123, P473, DOI 10.1007/s00401-012-0958-8; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Lee EY, 2010, P NATL ACAD SCI USA, V107, P9736, DOI 10.1073/pnas.1004602107; Lee J, 1997, DEVELOPMENT, V124, P2537; Lopez-Rios J, 2012, DEV CELL, V22, P837, DOI 10.1016/j.devcel.2012.01.006; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; Matsuo S, 2013, EXP TOXICOL PATHOL, V65, P863, DOI 10.1016/j.etp.2012.12.005; Mckee CM, 2012, J CLIN INVEST, V122, P4025, DOI 10.1172/JCI59348; Mendrzyk F, 2005, J CLIN ONCOL, V23, P8853, DOI 10.1200/JCO.2005.02.8589; Monje M, 2011, J CLIN ONCOL, V29, P1395, DOI 10.1200/JCO.2010.34.0547; Nagahara A, 2010, BIOCHEM BIOPH RES CO, V391, P1641, DOI 10.1016/j.bbrc.2009.12.105; Northcott PA, 2012, NAT REV NEUROL, V8, P340, DOI 10.1038/nrneurol.2012.78; Oliver TG, 2005, DEVELOPMENT, V132, P2425, DOI 10.1242/dev.01793; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Pfister S, 2009, J CHILD NEUROL, V24, P1375, DOI 10.1177/0883073809339213; Pierson J, 2008, J NEURO-ONCOL, V90, P1, DOI 10.1007/s11060-008-9624-3; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Roth RB, 2006, NEUROGENETICS, V7, P67, DOI 10.1007/s10048-006-0032-6; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Salsano E, 2004, NEUROSCI LETT, V370, P180, DOI 10.1016/j.neulet.2004.08.053; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Swartling FJ, 2010, GENE DEV, V24, P1059, DOI 10.1101/gad.1907510; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Vaillant C, 2007, DEVELOPMENT, V134, P1745, DOI 10.1242/dev.02840; Valiente M, 2014, CELL, V156, P1002, DOI 10.1016/j.cell.2014.01.040; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Wang K, 2015, J CANCER RES CLIN, V141, P805, DOI 10.1007/s00432-014-1858-1; Wang VY, 2005, NEURON, V48, P31, DOI 10.1016/j.neuron.2005.08.024; Xu DM, 2010, CANCER RES, V70, P6988, DOI 10.1158/0008-5472.CAN-10-0242; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681; ZHENG T, 1993, DEV BRAIN RES, V75, P91, DOI 10.1016/0165-3806(93)90068-L	65	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124870	10.1371/journal.pone.0124870	http://dx.doi.org/10.1371/journal.pone.0124870			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901736	Green Published, Green Submitted, gold			2022-12-26	WOS:000353331500102
J	Wang, J; Caccamise, SAL; Woodward, LA; Li, QX				Wang, Jun; Caccamise, Sarah A. L.; Woodward, Lee Ann; Li, Qing X.			Polychlorinated Biphenyls in the Plasma and Preen Oil of Black-Footed Albatross (Diomedea nigripes) Chicks and Adults on Midway Atoll, North Pacific Ocean	PLOS ONE			English	Article							EATING SEA BIRDS; ORGANOCHLORINE PESTICIDES; PHALACROCORAX-CARBO; TISSUE DISTRIBUTION; MOLECULAR-FEATURES; METABOLIC-RATE; PCB ISOMERS; CONGENERS; TOXICITY; EGGS	Polychlorinated biphenyls (PCBs) are ubiquitous in the environment. Midway Atoll, located in the North Pacific Ocean, was occupied by the military during and after World War II. However, Midway Atoll has become a national wildlife refuge and home to many different sea-birds today, including the black-footed albatross (Diomedea nigripes) (BFAL). The profiles and toxic equivalents (TEQ) of PCB congeners in the plasma and preen oil of BFAL chicks and adults were determined in this study. The concentrations of the total PCBs in the plasma samples of chicks and adults collected in Midway Atoll ranged from 2.3 to 223.8 (mean 80.1) and 22.8 to 504.5 (mean 158.6) ng g(-1) (wet weight, ww), respectively. The TEQs ranged from 0.2 to 0.6 (mean 0.4) and 0.4 to 1.6 (mean 0.9) pg g(-1) ww, respectively, in the plasma samples of chicks and adults from Midway Atoll. The major congeners in the plasma samples of chicks and adults included PCBs 31, 87, 97, 99, 118, 138, 153, and 180, accounting for 70% of the total PCBs. The concentrations of the total PCBs in the adult preen oil samples ranged from 1693 to 39404 (mean 10122) ng g(-1) (ww), of which 97% were PCBs 105, 118, 128, 138, 153, 161, 172, and 183.	[Wang, Jun; Caccamise, Sarah A. L.; Li, Qing X.] Univ Hawaii Manoa, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA; [Woodward, Lee Ann] US Fish & Wildlife Serv, Pacific Reefs NWRC, Honolulu, HI 96850 USA	University of Hawaii System; University of Hawaii Manoa; United States Department of the Interior; US Fish & Wildlife Service	Caccamise, SAL (corresponding author), Univ Hawaii Manoa, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA.	qingl@hawaii.edu	Wang, Jun/H-5837-2015; Wang, Jun/AAN-4446-2021; Li, Qing/AAO-3938-2020	Wang, Jun/0000-0002-7574-9468; Caccamise, Sarah/0000-0002-2710-1683				[Anonymous], 1997, ANAL CHEM PCBS; Auman HJ, 1997, ENVIRON TOXICOL CHEM, V16, P498, DOI [10.1897/1551-5028(1997)016&lt;0498:PDDATE&gt;2.3.CO;2, 10.1002/etc.5620160315]; BARRON MG, 1995, COMP BIOCHEM PHYS C, V112, P1, DOI 10.1016/0742-8413(95)00074-7; BORLAKOGLU JT, 1990, COMP BIOCHEM PHYS C, V97, P173, DOI 10.1016/0742-8413(90)90188-F; BORLAKOGLU JT, 1990, COMP BIOCHEM PHYS C, V97, P161, DOI 10.1016/0742-8413(90)90187-E; BRAUNE BM, 1989, ENVIRON TOXICOL CHEM, V8, P957, DOI 10.1002/etc.5620081015; Caccamise SAL, 2012, ECOL INDIC, V20, P75, DOI 10.1016/j.ecolind.2012.01.023; Castello G, 1997, J CHROMATOGR A, V787, P215, DOI 10.1016/S0021-9673(97)00662-6; Cifuentes JM, 2003, ENVIRON POLLUT, V126, P123, DOI 10.1016/S0269-7491(02)00400-1; FALANDYSZ J, 1994, ARCH ENVIRON CON TOX, V26, P13, DOI 10.1007/BF00212788; Ge J, 2013, SCI TOTAL ENVIRON, V452, P421, DOI 10.1016/j.scitotenv.2013.03.015; Geyer H. J., 2000, HDB ENV CHEM; Giesy JP, 1994, DIOXINS HLTH; GONZALEZ MJ, 1991, ARCH ENVIRON CON TOX, V20, P343, DOI 10.1007/BF01064400; Guruge KS, 2001, ENVIRON POLLUT, V114, P389, DOI 10.1016/S0269-7491(00)00234-7; Guruge KS, 2001, MAR ENVIRON RES, V52, P271, DOI 10.1016/S0141-1136(01)00099-X; Guruge KS, 2000, ARCH ENVIRON CON TOX, V38, P509, DOI 10.1007/s002449910067; Hario M, 2004, ENVIRON POLLUT, V127, P411, DOI 10.1016/j.envpol.2003.08.008; Hope B, 1997, MAR POLLUT BULL, V34, P548, DOI 10.1016/S0025-326X(96)00180-4; Jones PD, 1996, ENVIRON TOXICOL CHEM, V15, P1793, DOI 10.1002/etc.5620151021; Kannan K, 2000, HUM ECOL RISK ASSESS, V6, P181, DOI 10.1080/10807030091124491; LEMMETYINEN R, 1982, CHEMOSPHERE, V11, P1059, DOI 10.1016/0045-6535(82)90080-7; Miao XS, 2000, SCI TOTAL ENVIRON, V257, P17, DOI 10.1016/S0048-9697(00)00484-8; Mora MA, 1996, ENVIRON TOXICOL CHEM, V15, P1003, DOI 10.1002/etc.5620150624; Parham FM, 1998, TOXICOL APPL PHARM, V151, P110, DOI 10.1006/taap.1998.8441; Phillips RA, 2003, COMP BIOCHEM PHYS A, V135, P185, DOI 10.1016/S1095-6433(03)00073-4; RICKETTS C, 1984, AUK, V101, P790, DOI 10.2307/4086905; Van den Berg M, 1998, ENVIRON HEALTH PERSP, V106, P775, DOI 10.1289/ehp.98106775; Van den Berg M, 2006, TOXICOL SCI, V93, P223, DOI 10.1093/toxsci/kfl055; Wang DL, 2010, ARCH ENVIRON CON TOX, V58, P478, DOI 10.1007/s00244-009-9396-6; WARHAM J, 1990, PETRELS THEIR ECOLOG; Yang YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086441; Yu LH, 2014, ENVIRON POLLUT, V188, P118, DOI 10.1016/j.envpol.2014.01.023	33	4	4	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123041	10.1371/journal.pone.0123041	http://dx.doi.org/10.1371/journal.pone.0123041			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901941	Green Submitted, gold, Green Published			2022-12-26	WOS:000353331500039
J	Brieno-Enriquez, MA; Garcia-Lopez, J; Cardenas, DB; Guibert, S; Cleroux, E; Ded, L; Hourcade, JD; Peknicova, J; Weber, M; del Mazo, J				Brieno-Enriquez, Miguel A.; Garcia-Lopez, Jesus; Cardenas, David B.; Guibert, Sylvain; Cleroux, Elouan; Ded, Lukas; de Dios Hourcade, Juan; Peknicova, Jana; Weber, Michael; del Mazo, Jesus			Exposure to Endocrine Disruptor Induces Transgenerational Epigenetic Deregulation of MicroRNAs in Primordial Germ Cells	PLOS ONE			English	Article							BINDING PROTEIN LIN28; DNA METHYLATION; IMPRINTED GENES; PRE-MICRORNA; VINCLOZOLIN; EXPRESSION; DYNAMICS; SPECIFICATION; BIOGENESIS; LINEAGE	In mammals, germ cell differentiation is initiated in the Primordial Germ Cells (PGCs) during fetal development. Prenatal exposure to environmental toxicants such as endocrine disruptors may alter PGC differentiation, development of the male germline and induce transgenerational epigenetic disorders. The anti-androgenic compound vinclozolin represents a paradigmatic example of molecule causing transgenerational effects on germ cells. We performed prenatal exposure to vinclozolin in mice and analyzed the phenotypic and molecular changes in three successive generations. A reduction in the number of embryonic PGCs and increased rate of apoptotic cells along with decrease of fertility rate in adult males were observed in F1 to F3 generations. Blimp1 is a crucial regulator of PGC differentiation. We show that prenatal exposure to vinclozolin deregulates specific microRNAs in PGCs, such as miR-23b and miR-21, inducing disequilibrium in the Lin28/let-7/Blimp1 pathway in three successive generations of males. As determined by global maps of cytosine methylation, we found no evidence for prominent changes in DNA methylation in PGCs or mature sperm. Our data suggest that embryonic exposure to environmental endocrine disruptors induces transgenerational epigenetic deregulation of expression of microRNAs affecting key regulatory pathways of germ cells differentiation.	[Brieno-Enriquez, Miguel A.; Garcia-Lopez, Jesus; Cardenas, David B.; de Dios Hourcade, Juan; del Mazo, Jesus] CSIC, Dept Cellular & Mol Biol, Ctr Invest Biol, Madrid, Spain; [Guibert, Sylvain; Cleroux, Elouan; Weber, Michael] Univ Strasbourg, CNRS UMR7242, Biotechnol & Cell Signaling, Strasbourg, France; [Ded, Lukas; Peknicova, Jana] Inst Biotechnol AS CR, Vvi, Prague, Czech Republic	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences	del Mazo, J (corresponding author), CSIC, Dept Cellular & Mol Biol, Ctr Invest Biol, Madrid, Spain.	jdelmazo@cib.csic.es	Weber, Michael/P-1914-2016; Ded, Lukas/G-9543-2014; del Mazo, Jesus/L-3156-2015; Lopez, Jesus Garcia/N-7952-2019	Weber, Michael/0000-0003-3484-5821; Ded, Lukas/0000-0003-1053-4025; del Mazo, Jesus/0000-0003-3269-3895; Lopez, Jesus Garcia/0000-0002-1877-3402; Cardenas Sanjur, David Bolivar/0000-0001-6952-7140; Brieno-Enriquez, Miguel Angel/0000-0002-8806-0918	CONACYT Mexico [165418]; CEFIC-LRi; MEDDTL, France [11-MRES-PNRPE-9-CVS-072]; CSIC [PIE-201020E016]; MINECO, Spain [BFU2013-42164-R]; Grant Agency of the Czech Republic [P503/12/1834]; BIOCEV project from the ERDF [CZ.1.05 / 1.1.00/02.0109]	CONACYT Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CEFIC-LRi; MEDDTL, France; CSIC; MINECO, Spain; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); BIOCEV project from the ERDF	M. A. Brieno-Enriquez was supported by Postdoctoral Grant from CONACYT Mexico (165418). This work was supported by grants from The CEFIC-LRi; MEDDTL, France (11-MRES-PNRPE-9-CVS-072): CSIC, (PIE-201020E016) and MINECO (BFU2013-42164-R), Spain; Grant Agency of the Czech Republic (No. P503/12/1834) and BIOCEV project (CZ.1.05 / 1.1.00/02.0109) from the ERDF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034158, 10.1371/journal.pone.0049576]; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Auclair G, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0545-5; Avissar-Whiting M, 2010, REPROD TOXICOL, V29, P401, DOI 10.1016/j.reprotox.2010.04.004; Barnes NA, 2012, J IMMUNOL, V189, P253, DOI 10.4049/jimmunol.1101563; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Buckley Jill, 2006, Environ Health, V5, P4, DOI 10.1186/1476-069X-5-4; Cao DF, 2011, HUM PATHOL, V42, P710, DOI 10.1016/j.humpath.2010.09.007; Cowin PA, 2010, ENDOCRINOLOGY, V151, P783, DOI 10.1210/en.2009-0982; Del Mazo J, 2013, INT J DEV BIOL, V57, P225, DOI 10.1387/ijdb.130042jd; Elzeinova F, 2008, REPROD TOXICOL, V26, P231, DOI 10.1016/j.reprotox.2008.09.007; Gapp K, 2014, NAT NEUROSCI, V17, P667, DOI 10.1038/nn.3695; GINSBURG M, 1990, DEVELOPMENT, V110, P521; Grandjean V, 2009, DEVELOPMENT, V136, P3647, DOI 10.1242/dev.041061; Guerrero-Bosagna C, 2012, REPROD TOXICOL, V34, P694, DOI 10.1016/j.reprotox.2012.09.005; Guibert S, 2012, GENOME RES, V22, P633, DOI 10.1101/gr.130997.111; Heo I, 2012, CELL, V151, P521, DOI 10.1016/j.cell.2012.09.022; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Hou LF, 2011, MUTAT RES-FUND MOL M, V714, P105, DOI 10.1016/j.mrfmmm.2011.05.004; Ivanova E, 2012, EPIGENETICS-US, V7, P1200, DOI 10.4161/epi.22141; Kelce WR, 1997, TOXICOL APPL PHARM, V142, P192, DOI 10.1006/taap.1996.7966; Kiani J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003498; Kurimoto K, 2008, GENE DEV, V22, P1617, DOI 10.1101/gad.1649908; Liu XL, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-96; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Majid S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067686; Matsuura Ikuo, 2005, Journal of Toxicological Sciences, V30, P163; Matzuk MM, 2009, DEV CELL, V17, P160, DOI 10.1016/j.devcel.2009.07.020; Merlet J, 2007, P NATL ACAD SCI USA, V104, P3615, DOI 10.1073/pnas.0611421104; Nam Y, 2011, CELL, V147, P1080, DOI 10.1016/j.cell.2011.10.020; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Niu ZY, 2011, P NATL ACAD SCI USA, V108, P12740, DOI 10.1073/pnas.1109987108; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Ohinata Y, 2009, CELL, V137, P571, DOI 10.1016/j.cell.2009.03.014; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; PESCE M, 1995, DEV BIOL, V170, P722, DOI 10.1006/dbio.1995.1250; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Radford EJ, 2014, SCIENCE, V345, P785, DOI 10.1126/science.1255903; Radford EJ, 2012, PLOS GENET, V8, P41, DOI 10.1371/journal.pgen.1002605; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Richardson BE, 2010, NAT REV MOL CELL BIO, V11, P37, DOI 10.1038/nrm2815; Rodgers AB, 2013, J NEUROSCI, V33, P9003, DOI 10.1523/JNEUROSCI.0914-13.2013; Romanuik TL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-476; Saitou M, 2012, COLD SPRING HARB PER, V4; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Seki Y, 2007, DEVELOPMENT, V134, P2627, DOI 10.1242/dev.005611; Shinoda G, 2013, STEM CELLS, V31, P1001, DOI 10.1002/stem.1343; Skinner MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066318; Skinner MK, 2011, REPROD TOXICOL, V31, P337, DOI 10.1016/j.reprotox.2010.10.012; Skogen JC., 2012, JRSM SHORT REP, V3, P59, DOI [10.1258/shorts.2012.012048, DOI 10.1258/SHORTS.2012.012048]; Stouder C, 2010, REPRODUCTION, V139, P373, DOI 10.1530/REP-09-0340; Teng Y, 2013, TOXICOL SCI, V131, P71, DOI 10.1093/toxsci/kfs290; van den Bergen JA, 2009, BIOL REPROD, V81, P362, DOI 10.1095/biolreprod.109.076224; Vincent JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028960; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711; Wang KC, 2010, P NATL ACAD SCI USA, V107, P3234, DOI 10.1073/pnas.0914825107; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Xu Z., 2013, ADV DIFFER EQU-NY, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0053146; Xue DB, 2011, HISTOPATHOLOGY, V59, P452, DOI 10.1111/j.1365-2559.2011.03949.x; Zhang HS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1555; Zinchuk V, 2013, SCI REP-UK, V3, DOI 10.1038/srep01365	63	67	74	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124296	10.1371/journal.pone.0124296	http://dx.doi.org/10.1371/journal.pone.0124296			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897752	gold, Green Published, Green Submitted			2022-12-26	WOS:000353212600061
J	Cox, JA; Lukande, RL; Kalungi, S; Van Marck, E; Van de Vijver, K; Kambugu, A; Nelson, AM; Colebunders, R; Manabe, YC				Cox, Janneke A.; Lukande, Robert L.; Kalungi, Sam; Van Marck, Eric; Van de Vijver, Koen; Kambugu, Andrew; Nelson, Ann M.; Colebunders, Robert; Manabe, Yukari C.			Is Urinary Lipoarabinomannan the Result of Renal Tuberculosis? Assessment of the Renal Histology in an Autopsy Cohort of Ugandan HIV-Infected Adults	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; DIAGNOSTIC-ACCURACY; MYCOBACTERIAL LIPOARABINOMANNAN; ANTIRETROVIRAL THERAPY; HOSPITALIZED-PATIENTS; LAM-ELISA; ASSAY; DEATH; ASSOCIATION; MICROSCOPY	Objective The detection of urinary lipoarabinomannan (LAM), a mycobacterial cell wall component, is used to diagnose tuberculosis (TB). How LAM enters the urine is not known. To investigate if urinary LAM-positivity is the result of renal TB infection we correlated the outcomes of urinary LAM-antigen testing to renal histology in an autopsy cohort of hospitalized, Ugandan, HIV-infected adults. Methods We performed a complete autopsy, including renal sampling, in HIV-infected adults that died during hospitalization after written informed consent was obtained from the next of kin. Urine was collected postmortem through post-mortem catheterisation or by bladder puncture and tested for LAM with both a lateral flow assay (LFA) and an ELISA assay. Two pathologists assessed the kidney histology. We correlated the LAM-assay results and the histology findings. Results Of the 13/36 (36%) patients with a positive urinary LAM ELISA and/or LFA, 8/13 (62%) had renal TB. The remaining 5 LAM-positive patients had disseminated TB without renal involvement. Of the 23 LAM-negative patients, 3 had disseminated TB without renal involvement. The remaining LAM-negative patients had no TB infection and died mostly of fungal and bacterial infections. LAM LFA had a sensitivity of 81% and specificity of 100% to diagnose TB at any location, and the LAM ELISA a sensitivity of 63% and a specificity of 100%. 54% (7/13) LAM LFA-positive patients were not on anti-TB treatment at the time of death. Conclusion Renal TB infection explained LAM-positivity in the majority of patients. Patients with disseminated TB without renal involvement can also be diagnosed with LAM. This suggests that other mechanisms that lead to urinary LAM-positivity exist in a minority of patients.	[Cox, Janneke A.; Colebunders, Robert] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Cox, Janneke A.; Kambugu, Andrew; Manabe, Yukari C.] Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda; [Lukande, Robert L.; Kalungi, Sam] Makerere Univ, Coll Hlth Sci, Dept Pathol, Kampala, Uganda; [Kalungi, Sam] Mulago Hosp Complex, Dept Pathol, Kampala, Uganda; [Van Marck, Eric] Univ Antwerp, Univ Antwerp Hosp, Dept Pathol, B-2020 Antwerp, Belgium; [Van de Vijver, Koen] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Diagnost Oncol & Mol Pathol, Amsterdam, Netherlands; [Nelson, Ann M.] Joint Pathol Ctr, Silver Spring, MD USA; [Colebunders, Robert] Univ Antwerp, Dept Epidemiol & Social Med, B-2020 Antwerp, Belgium; [Manabe, Yukari C.] Johns Hopkins Univ, Sch Med, Div Infect Dis, Dept Med, Baltimore, MD 21205 USA	Institute of Tropical Medicine (ITM); Makerere University; Makerere University; Mulago National Referral Hospital; University of Antwerp; Netherlands Cancer Institute; University of Antwerp; Johns Hopkins University	Cox, JA (corresponding author), Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium.	jannekecox@xs4all.nl	Van de Vijver, Koen/N-7895-2019	Van de Vijver, Koen/0000-0002-2026-9790; Colebunders, Robert/0000-0002-1919-1340	Belgium government through the "Fonds Wetenschappelijk Onderzoek" Flanders; Division of Microbiology and Infectious Diseases [HHSN272200900050C]; Division of AIDS, National Institute of Allergy and Infectious Diseases [1P30AI094189]; Fogarty International Center at the National Institutes of Health [1D43TW009771]; FOGARTY INTERNATIONAL CENTER [D43TW009771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER	Belgium government through the "Fonds Wetenschappelijk Onderzoek" Flanders; Division of Microbiology and Infectious Diseases; Division of AIDS, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fogarty International Center at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	JAC received a travel grant from the Belgium government through the "Fonds Wetenschappelijk Onderzoek" Flanders. YCM receives funding support from HHSN272200900050C grant from the Division of Microbiology and Infectious Diseases, 1P30AI094189 grant to the Johns Hopkins University Center for AIDS Research from the Division of AIDS, National Institute of Allergy and Infectious Diseases, and 1D43TW009771 grant from the Fogarty International Center at the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The remaining authors received no specific funding for this work.	Ansari NA, 2002, INT J TUBERC LUNG D, V6, P55; Boehme C, 2005, T ROY SOC TROP MED H, V99, P893, DOI 10.1016/j.trstmh.2005.04.014; Chihota VN, 2010, INT J TUBERC LUNG D, V14, P1024; Cox JA, 2014, JAIDS-J ACQ IMM DEF, V67, P169, DOI 10.1097/QAI.0000000000000290; DACOSTA CTKA, 1993, CLIN EXP IMMUNOL, V91, P25; Dheda K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009848; Fenner L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077697; Gounder CR, 2011, JAIDS-J ACQ IMM DEF, V58, P219, DOI 10.1097/QAI.0b013e31822b75d4; Gupta RK, 2013, INT J TUBERC LUNG D, V17, P1014, DOI 10.5588/ijtld.13.0032; HUNTER SW, 1986, J BIOL CHEM, V261, P2345; Kivihya-Ndugga LEA, 2003, INT J TUBERC LUNG D, V7, P1163; Kroidl I, 2013, SCAND J INFECT DIS, DOI 10.3109/00365548.2013.853133; Lawn SD, 2012, LANCET INFECT DIS, V12, P201, DOI 10.1016/S1473-3099(11)70251-1; Lawn SD, 2009, AIDS, V23, P1875, DOI 10.1097/QAD.0b013e32832e05c8; Martinson NA, 2007, AIDS, V21, P2043, DOI 10.1097/QAD.0b013e3282eea47f; Mishra AK, 2011, FEMS MICROBIOL REV, V35, P1126, DOI 10.1111/j.1574-6976.2011.00276.x; MYERS BD, 1993, AM J NEPHROL, V13, P311, DOI 10.1159/000168645; Nakiyingi L, 2014, JAIDS-J ACQ IMM DEF, V66, P270, DOI 10.1097/QAI.0000000000000151; Patel VB, 2009, FLUIDS BARRIERS CNS, V6, DOI 10.1186/1743-8454-6-13; Peter JG, 2012, EUR RESPIR J, V40, P1211, DOI 10.1183/09031936.00201711; Rana FS, 2000, J ACQ IMMUN DEF SYND, V24, P23; Reither K, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-141; SADA E, 1992, J CLIN MICROBIOL, V30, P2415, DOI 10.1128/JCM.30.9.2415-2418.1992; SCHUBERT GE, 1992, EUR UROL, V21, P216; Shah M, 2010, J CLIN MICROBIOL, V48, P2972, DOI 10.1128/JCM.00363-10; Shah M, 2009, JAIDS-J ACQ IMM DEF, V52, P145, DOI 10.1097/QAI.0b013e3181b98430; Symes J M, 1973, Br J Urol, V45, P432, DOI 10.1111/j.1464-410X.1973.tb12184.x; Tessema TA, 2002, SCAND J INFECT DIS, V34, P97, DOI 10.1080/00365540110077263; Theron G, 2011, AM J RESP CRIT CARE, V184, P132, DOI 10.1164/rccm.201101-0056OC; Trebucq A, 2011, INT J TUBERC LUNG D, V15, P1567, DOI 10.5588/ijtld.11.0392; UNAIDS, 2013, AIDS BY THE NUMB; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2011, POL STAT AUT REAL TI; Wood R, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-47; World Health Organisation, 2015, EST TB MDR TB BURD U	35	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123323	10.1371/journal.pone.0123323	http://dx.doi.org/10.1371/journal.pone.0123323			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897661	Green Published, gold, Green Submitted			2022-12-26	WOS:000353212600024
J	Sawada, I; Tanuma, J; Cuong, DD; Tra, TD; Quynh, PL; Lan, ATN; Tuong, VTV; Tuan, QN; Tsuchiya, N; Shiino, T; Yoshida, LM; Thanh, TTP; Ariyoshi, K; Oka, S				Sawada, Ikumi; Tanuma, Junko; Cuong Duy Do; Tra Thu Doan; Quynh Phuong Luu; Lan Anh Thi Nguyen; Tuong Van Thi Vu; Tuan Quang Nguyen; Tsuchiya, Naho; Shiino, Teiichiro; Yoshida, Lay-Myint; Thanh Thuy Thi Pham; Ariyoshi, Koya; Oka, Shinichi			High Proportion of HIV Serodiscordance among HIV-Affected Married Couples in Northern Vietnam	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HETEROSEXUAL TRANSMISSION; HEPATITIS-B; DISCORDANT COUPLES; SEXUAL PARTNERS; CELL ACTIVATION; DRUG-USERS; VIRAL LOAD; PREVENTION; INFECTION	Introduction Little is known about the state of HIV transmission among married couples in Vietnam. This study aims to clarify HIV serostatus in this group and elucidate risk factors for intra-marital HIV transmission. Methods In 2012, we enrolled a group of HIV-positive married men registered at the HIV outpatient clinic of a referral hospital in northern Vietnam, along with their wives. Sociodemographic, behavioural and clinical data were collected from men and wives. HIV serodiscordant couples were followed until March 2014 to determine seroconversion rate. A phylogenetic analysis was performed based on env V3 sequence to detail cluster formation among men. Results Of the 163 HIV-positive men enrolled in the study, 101 (62.0%) had wives testing HIV-negative. Half of men reported injecting drug use (IDU) as a likely transmission route. Couples reported a high incidence of unprotected sexual intercourse prior to diagnosis; the median (inter quartile range) was 4 (4-8) times per month. Only 17 couples (10.4%) reported using condoms during at least half these instances. Multivariable analysis revealed IDU history among men was independently associated with HIV-negative wives (adjusted OR 0.31; 95% CI 0.10-0.95, p=0.041). Phylogenetic analysis of 80 samples indicated CRF01_AE. Of these, 69 (86.3%) clustered with IDU-associated viruses from Vietnam. No HIV seroconversion was identified during a follow-up of 61 serodiscordant couples, with 126.5 person-years of observation during which HIV-infectedmen were on antiretroviral drug therapy (ART). Conclusion High HIV serodiscordance was observed among HIV-affected married couples in northern Vietnam. A large number of at-risk wives therefore remain HIV-negative and can be protected with measures including proper use of ART if couples are made aware of the serodiscordance through screening.	[Sawada, Ikumi; Tsuchiya, Naho; Ariyoshi, Koya] Nagasaki Univ, Grad Sch Biomed Sci, Inst Trop Med, Dept Clin Trop Med, Nagasaki 852, Japan; [Sawada, Ikumi; Tanuma, Junko; Oka, Shinichi] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan; [Cuong Duy Do; Tra Thu Doan; Tuan Quang Nguyen; Thanh Thuy Thi Pham] Bach Mai Hosp, Dept Infect Dis, Hanoi, Vietnam; [Quynh Phuong Luu; Lan Anh Thi Nguyen] Natl Inst Hyg & Epidemiol, Dept Immunol & Mol Biol, Lab Mol Diagnost, Hanoi, Vietnam; [Tuong Van Thi Vu] BachMai Hosp, Dept Microbiol, Hanoi, Vietnam; [Shiino, Teiichiro] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan; [Yoshida, Lay-Myint] Nagasaki Univ, Inst Trop Med, Dept Pediat Infect Dis, Nagasaki 852, Japan	Nagasaki University; National Center for Global Health & Medicine - Japan; National Institute of Hygiene & Epidemiology (NIHE); National Institute of Infectious Diseases (NIID); Nagasaki University	Ariyoshi, K (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Inst Trop Med, Dept Clin Trop Med, Nagasaki 852, Japan.	kari@nagasaki-u.ac.jp	lan, A/HHZ-6588-2022; Tanuma, Junko/AAE-5395-2020	YOSHIDA, LAYMYINT/0000-0002-7567-3248	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) of Japanese Initiative for Global Research Network on Infectious Diseases (J-GRID)	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) of Japanese Initiative for Global Research Network on Infectious Diseases (J-GRID)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Financial support from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) as a project of the Japanese Initiative for Global Research Network on Infectious Diseases (J-GRID, http://www.crnid.riken.jp/jgrid/en/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Capoulade-Metay C, 2004, AIDS, V18, P2243, DOI 10.1097/00002030-200411190-00004; Chun HM, 2012, J INFECT DIS, V205, P185, DOI 10.1093/infdis/jir720; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Degenhardt L, 2012, LANCET, V379, P55, DOI 10.1016/S0140-6736(11)61138-0; Deschamps MM, 1996, ANN INTERN MED, V125, P324, DOI 10.7326/0003-4819-125-4-199608150-00011; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Go VF, 2006, DRUG ALCOHOL DEPEN, V84, P69, DOI 10.1016/j.drugalcdep.2005.12.006; Gomez-Gonzalo M, 2001, J BIOL CHEM, V276, P35435, DOI 10.1074/jbc.M103020200; Gonzalez Adam, 2011, Curr HIV/AIDS Rep, V8, P223, DOI 10.1007/s11904-011-0093-5; Hammett TM, 2010, AIDS CARE, V22, P1466, DOI 10.1080/09540121003758580; Hien NT, 2004, AIDS EDUC PREV, V16, P137, DOI 10.1521/aeap.16.3.5.137.35527; Hisada M, 2000, J INFECT DIS, V181, P1475, DOI 10.1086/315396; Kaur G, 2009, TISSUE ANTIGENS, V73, P289, DOI 10.1111/j.1399-0039.2009.01220.x; KUNANUSONT C, 1995, LANCET, V345, P1078, DOI 10.1016/S0140-6736(95)90818-8; Liao HA, 2009, VIROLOGY, V391, P51, DOI 10.1016/j.virol.2009.05.023; McGovern RA, 2010, AIDS, V24, P2512, DOI 10.1097/QAD.0b013e32833e6cfb; Ministry of Health, 2009, GUID HIV AIDS DIAGN; MUSICCO M, 1994, ARCH INTERN MED, V154, P1971, DOI 10.1001/archinte.154.17.1971; Nguyen TA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-37; Punpanich W, 2004, AIDS EDUC PREV, V16, P119, DOI 10.1521/aeap.16.3.5.119.35520; Quan VM, 2000, J ACQ IMMUN DEF SYND, V25, P360, DOI 10.1097/00126334-200012010-00011; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Luu QP, 2012, AIDS RES HUM RETROV, V28, P1344, DOI 10.1089/aid.2011.0396; Ravet S, 2007, BLOOD, V109, P4296, DOI 10.1182/blood-2006-08-040238; Raymond S, 2013, J CLIN MICROBIOL, V51, P564, DOI 10.1128/JCM.02328-12; Rojanawiwat A, 2009, JPN J INFECT DIS, V62, P32; Ruxrungtham K, 2004, LANCET, V364, P69, DOI 10.1016/S0140-6736(04)16593-8; Saez-Cirion A, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-81; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tsuchiya N, 2013, EPIDEMIOL INFECT, V141, P1840, DOI 10.1017/S0950268812002397; UNAIDS, 2010, HIV TRANSM MEN WOM I; Vandekerckhove LPR, 2011, LANCET INFECT DIS, V11, P394, DOI 10.1016/S1473-3099(10)70319-4; Venkatesh KK, 2011, AIDS CARE, V23, P722, DOI 10.1080/09540121.2010.525616; Vietnam administratoin of HIV/ AIDS control ( Ministry of Health) & Family Health International, 2009, AIDS ED PREV; Vietnam administratoin of HIV/AIDS control (Ministry of Health) & Family Health International & National Institute for Hygiene and Epidemiology, 2011, RESULTS HIV STI; Wang L, 2012, AIDS CARE, V24, P1059, DOI 10.1080/09540121.2012.661837	38	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0125299	10.1371/journal.pone.0125299	http://dx.doi.org/10.1371/journal.pone.0125299			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898138	gold, Green Published, Green Submitted			2022-12-26	WOS:000353212600102
J	Thomas, JM; Allison, AB; Holmes, EC; Phillips, JE; Bunting, EM; Yabsley, MJ; Brown, JD				Thomas, Jesse M.; Allison, Andrew B.; Holmes, Edward C.; Phillips, Jamie E.; Bunting, Elizabeth M.; Yabsley, Michael J.; Brown, Justin D.			Molecular Surveillance for Lymphoproliferative Disease Virus in Wild Turkeys (Meleagris gallopavo) from the Eastern United States	PLOS ONE			English	Article							MAREKS-DISEASE; AVIAN-LEUKOSIS; RETICULOENDOTHELIOSIS	Lymphoproliferative disease virus (LPDV) is a poorly understood, oncogenic avian retrovirus of domestic turkeys that has historically been restricted to Europe and Israel. However, a recent study reported LPDV in multiple wild turkey diagnostic cases from throughout the eastern United States of America (USA). To better understand the distribution of LPDV in the eastern USA, we surveyed 1,164 reportedly asymptomatic hunter-harvested wild turkeys from 17 states for the presence of LPDV proviral DNA by PCR. In total, 564/1,164 (47%) turkeys were positive for LPDV. Wild turkeys from each state had a relatively high prevalence of LPDV, although statewide prevalence varied from 26 to 83%. Phylogenetic analysis revealed two major clades of LPDV in the USA, although one was at a low frequency suggesting restricted transmission, as well as significant clustering by state of isolation. To determine the best tissue to target for diagnostic purposes, liver, spleen, and bone marrow were tested from a subset of 15 hunter-harvested wild turkeys and 20 wild turkey diagnostic cases. Overall, bone marrow provided the highest level of detection for both hunterharvested turkeys and diagnostic cases. The sensitivity of LPDV detection between tissues was not significantly different for diagnostic cases, but was for hunter-harvested birds. These results indicate that LPDV infection is common and widespread in wild turkey populations throughout the eastern USA, even without overt signs of disease.	[Thomas, Jesse M.; Phillips, Jamie E.; Yabsley, Michael J.; Brown, Justin D.] Univ Georgia, Coll Vet Med, Dept Populat Hlth, Southeastern Cooperat Wildlife Dis Study, Athens, GA 30602 USA; [Thomas, Jesse M.; Yabsley, Michael J.] Univ Georgia, Daniel B Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Allison, Andrew B.] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Baker Inst Anim Hlth, Ithaca, NY 14853 USA; [Holmes, Edward C.] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Charles Perkins Ctr, Sch Biol Sci, Sydney, NSW 2006, Australia; [Holmes, Edward C.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Bunting, Elizabeth M.] Cornell Univ, Coll Vet Med, Anim Hlth Diagnost Ctr, Ithaca, NY 14853 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Cornell University; University of Sydney; University of Sydney; Cornell University	Brown, JD (corresponding author), Univ Georgia, Coll Vet Med, Dept Populat Hlth, Southeastern Cooperat Wildlife Dis Study, 589 D-W Brooks Dr,Wildlife Hlth Bldg, Athens, GA 30602 USA.	judbrow@pa.gov	Holmes, Edward/Y-2789-2019; Holmes, Edward/GVR-9499-2022	Holmes, Edward/0000-0001-9596-3552; Yabsley, Michael/0000-0003-2452-5015; Allison, Andrew B./0000-0003-0971-1215	Southeastern Cooperative Wildlife Disease; Arcadia Wildlife Preserve, Inc.; National Health and Medical Research Council Australia Fellowship [AF30]	Southeastern Cooperative Wildlife Disease; Arcadia Wildlife Preserve, Inc.; National Health and Medical Research Council Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This research was funded through the continued sponsorship of the Southeastern Cooperative Wildlife Disease Study by member states and federal agencies as well as the Arcadia Wildlife Preserve, Inc. Dr. Edward Holmes was funded by a National Health and Medical Research Council Australia Fellowship (AF30).	Allison AB, 2013, VIROLOGY, V450-451, P2, DOI [10.1016/j.virol.2013.12.013, DOI 10.1016/J.VIROL.2013.12.013]; Biggs PM, 1997, DIS POULTRY, P485; BUSCH RH, 1970, AVIAN DIS, V14, P550, DOI 10.2307/1588617; Carlson H C, 1974, Avian Pathol, V3, P169, DOI 10.1080/03079457409353829; CHEN PY, 1987, ARCH VIROL, V93, P233, DOI 10.1007/BF01310977; COTTRAL GE, 1954, POULTRY SCI, V33, P1174, DOI 10.3382/ps.0331174; DAVIDSON WR, 1985, J WILDLIFE DIS, V21, P386, DOI 10.7589/0090-3558-21.4.386; DREN CN, 1983, AVIAN PATHOL, V12, P55, DOI 10.1080/03079458308436149; Drew Mark L., 2007, P216, DOI 10.1002/9780470344668.ch11; Drew ML, 1998, J WILDLIFE DIS, V34, P783, DOI 10.7589/0090-3558-34.4.783; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fadly A, 2008, DIS POULTRY, p[514, 34]; Fadly AM, 2008, DIS POULTRY, P449; Fadly AM, 2008, DIS POULTRY, P568; GAZIT A, 1982, INT J CANCER, V29, P599, DOI 10.1002/ijc.2910290518; Gazit A, 1999, ENCY VIROLOGY, V2nd, P911; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HAYES LE, 1992, J WILDLIFE DIS, V28, P154, DOI 10.7589/0090-3558-28.1.154; IANCONESCU M, 1981, AVIAN PATHOL, V10, P131, DOI 10.1080/03079458108418467; LEY DH, 1989, J WILDLIFE DIS, V25, P262, DOI 10.7589/0090-3558-25.2.262; MCDOUGALL JS, 1978, AVIAN PATHOL, V7, P141, DOI 10.1080/03079457808418266; Miller PE, 1998, J AM VET MED ASSOC, V213, P377; National Wild Turkey Federation, 2009, NAT WILD TURK FED SU; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; Payne LN, 2000, REV SCI TECH OIE, V19, P544, DOI 10.20506/rst.19.2.1226; Payne LN, 1998, POULTRY SCI, V77, P1204, DOI 10.1093/ps/77.8.1204; RUBIN H, 1962, VIROLOGY, V17, P143, DOI 10.1016/0042-6822(62)90091-0; SCHAT KA, 1976, AVIAN DIS, V20, P153, DOI 10.2307/1589484; Schat KA, 2008, DIS POULTRY, P453; SIEGFRIED LM, 1983, AVIAN DIS, V27, P86, DOI 10.2307/1590375; Tapley J.L., 2005, P NATL WILD TURKEY S, V9, P21; Wakeling BF, 1997, WILDLIFE SOC B, V25, P706	33	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0122644	10.1371/journal.pone.0122644	http://dx.doi.org/10.1371/journal.pone.0122644			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897755	Green Published, gold, Green Submitted			2022-12-26	WOS:000353212600013
J	Vaquero, ME; de Eugenio, LI; Martinez, MJ; Barriuso, J				Vaquero, Maria E.; de Eugenio, Laura I.; Martinez, Maria J.; Barriuso, Jorge			A Novel CalB-Type Lipase Discovered by Fungal Genomes Mining	PLOS ONE			English	Article							CANDIDA-ANTARCTICA; INTERFACIAL ACTIVATION; ESTERASES; REDESIGN; SEQUENCE; USTILAGO; SITE	The fungus Pseudozyma antarctica produces a lipase (CalB) with broad substrate specificity, stability, high regio-and enantio-selectivity. It is active in non-aqueous organic solvents and at elevated temperatures. Hence, CalB is a robust biocatalyst for chemical conversions on an industrial scale. Here we report the in silico mining of public metagenomes and fungal genomes to discover novel lipases with high homology to CalB. The candidates were selected taking into account homology and conserved motifs criteria, as well as, phylogeny and 3D model analyses. The most promising candidate (PlicB) presented interesting structural properties. PlicB was expressed in a heterologous host, purified and partially characterized. Further experiments will allow finding novel catalytic properties with biotechnological interest.	[Vaquero, Maria E.; de Eugenio, Laura I.; Martinez, Maria J.; Barriuso, Jorge] CSIC, Ctr Invest Biol, Madrid 28040, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Martinez, MJ (corresponding author), CSIC, Ctr Invest Biol, Ramiro de Maeztu 9, Madrid 28040, Spain.	mjmartinez@cib.csic.es; jbarriuso@cib.csic.es	Martinez, Maria Jesus/F-9147-2015; Vaquero Morales, Maria Eugenia/Y-6304-2018; Barriuso, Jorge/AAF-6118-2020	Martinez, Maria Jesus/0000-0003-2166-1097; Vaquero Morales, Maria Eugenia/0000-0003-3277-5532; Barriuso, Jorge/0000-0003-0916-6560	JAE-DOC CSIC program;  [BIO2012-36372];  [RTC-2014-1777-3];  [S2013/MAE-2907]	JAE-DOC CSIC program; ; ; 	This work was supported by the Spanish projects BIO2012-36372, RTC-2014-1777-3 and S2013/MAE-2907. J. Barriuso thanks the financial support from the JAE-DOC CSIC program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, HDB HYDROCARBON LIPI, DOI [DOI 10.1007/978-3-540-77587-4_247, 10.1007/978-3-540-77587-4_247]; Barriuso J, 2014, J MICROBIOL BIOTECHN, DOI [10.4014/jmb1406.06049, DOI 10.4014/JMB1406.06049]; Barriuso J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-712; Ben Ali Y, 2012, METHODS MOL BIOL, V861, P31, DOI 10.1007/978-1-61779-600-5_2; Besenmatter W, 2013, Patent, Patent No. [WO2013010783 A1, 2013010783]; Brundiek H, 2012, APPL MICROBIOL BIOT, V94, P141, DOI 10.1007/s00253-012-3903-9; Buerth C, 2014, APPL MICROBIOL BIOT, V98, P4963, DOI 10.1007/s00253-013-5493-6; Casas-Godoy L, 2012, METHODS MOL BIOL, V861, P3, DOI 10.1007/978-1-61779-600-5_1; Choi SJ, 2003, J BIOCHEM MOL BIOL, V36, P417; Farias RN, 1997, ANAL BIOCHEM, V252, P186, DOI 10.1006/abio.1997.2240; Ganjalikhany MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040327; Gasser B, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-11; Gordon S, 2014, BIORXIV, DOI [10.1101/012542, DOI 10.1101/012542]; Gutierrez-Fernandez J, 2014, J STRUCT BIOL, V187, P215, DOI 10.1016/j.jsb.2014.07.007; Hibbett D, 2014, SYSTEMATICS EVOLUTIO, P373, DOI DOI 10.1007/978-3-642-55318-9_14; Idris A, 2012, BIOTECHNOL ADV, V30, P550, DOI 10.1016/j.biotechadv.2011.10.002; Magnusson AO, 2005, CHEMBIOCHEM, V6, P1051, DOI 10.1002/cbic.200400410; MARTINELLE M, 1995, BBA-LIPID LIPID MET, V1258, P272, DOI 10.1016/0005-2760(95)00131-U; Naik S, 2010, J MOL CATAL B-ENZYM, V65, P18, DOI 10.1016/j.molcatb.2010.01.002; Pleiss J, 2000, J MOL CATAL B-ENZYM, V10, P491, DOI 10.1016/S1381-1177(00)00092-8; Pleiss J, 1998, CHEM PHYS LIPIDS, V93, P67, DOI 10.1016/S0009-3084(98)00030-9; Qian Z, 2009, J MOL BIOL, V393, P191, DOI 10.1016/j.jmb.2009.08.008; Shivaji S., 2009, YEAST BIOTECHNOLOGY, P3, DOI DOI 10.1007/978-1-4020-8292-4_1; Skjot M, 2009, CHEMBIOCHEM, V10, P520, DOI 10.1002/cbic.200800668; Stoll M, 2003, CAN J BOT, V81, P976, DOI [10.1139/b03-094, 10.1139/B03-094]; UPPENBERG J, 1994, STRUCTURE, V2, P293, DOI 10.1016/S0969-2126(00)00031-9; Valero F, 2012, METHODS MOL BIOL, V861, P161, DOI 10.1007/978-1-61779-600-5_11; Verger R, 1997, TRENDS BIOTECHNOL, V15, P32, DOI 10.1016/S0167-7799(96)10064-0; Wang QM, 2006, INT J SYST EVOL MICR, V56, P289, DOI 10.1099/ijs.0.63827-0; Xie Y, 2014, J BIOL CHEM, V289, P7994, DOI 10.1074/jbc.M113.536045	30	9	12	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124882	10.1371/journal.pone.0124882	http://dx.doi.org/10.1371/journal.pone.0124882			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898146	Green Submitted, Green Published, gold			2022-12-26	WOS:000353212600090
J	Khuperkar, D; Helen, M; Magre, I; Joseph, J				Khuperkar, Deepak; Helen, Mary; Magre, Indrasen; Joseph, Jomon			Inter-Cellular Transport of Ran GTPase	PLOS ONE			English	Article							NUCLEAR EXPORT; INTERCELLULAR TRANSFER; PROTEOMIC ANALYSIS; BINDING PROTEIN; RCC1 PROTEIN; CHROMOSOME; REGULATOR; RECEPTOR; RANGAP1; RNA	Ran, a member of the Ras-GTPase superfamily, has a well-established role in regulating the transport of macromolecules across the nuclear envelope (NE). Ran has also been implicated in mitosis, cell cycle progression, and NE formation. Over-expression of Ran is associated with various cancers, although the molecular mechanism underlying this phenomenon is unclear. Serendipitously, we found that Ran possesses the ability to move from cell-to-cell when transiently expressed in mammalian cells. Moreover, we show that the inter-cellular transport of Ran is GTP-dependent. Importantly, Ran displays a similar distribution pattern in the recipient cells as that in the donor cell and co-localizes with the Ran binding protein Nup358 (also called RanBP2). Interestingly, leptomycin B, an inhibitor of CRM1-mediated export, or siRNA mediated depletion of CRM1, significantly impaired the inter-cellular transport of Ran, suggesting a function for CRM1 in this process. These novel findings indicate a possible role for Ran beyond nucleo-cytoplasmic transport, with potential implications in inter-cellular communication and cancers.	[Khuperkar, Deepak; Helen, Mary; Magre, Indrasen; Joseph, Jomon] Natl Ctr Cell Sci, Pune, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Joseph, J (corresponding author), Natl Ctr Cell Sci, Pune, Maharashtra, India.	josephj@nccs.res.in	Joseph, Jomon/C-1397-2009	Joseph, Jomon/0000-0002-3042-6286	NCCS	NCCS	This work was supported by the Intramural funding from NCCS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2008, INT J CANCER, V122, P2391, DOI 10.1002/ijc.23400; Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Alt JR, 2000, GENE DEV, V14, P3102, DOI 10.1101/gad.854900; Arts GJ, 1998, EMBO J, V17, P7430, DOI 10.1093/emboj/17.24.7430; Azuma K, 2004, CLIN CANCER RES, V10, P6695, DOI 10.1158/1078-0432.CCR-04-0818; Barres V, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-272; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Choi DS, 2007, J PROTEOME RES, V6, P4646, DOI 10.1021/pr070192y; Clarke PR, 2001, TRENDS CELL BIOL, V11, P366, DOI 10.1016/S0962-8924(01)02071-2; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Cullen BR, 2003, J CELL SCI, V116, P587, DOI 10.1242/jcs.00268; DASSO M, 1994, EMBO J, V13, P5732, DOI 10.1002/j.1460-2075.1994.tb06911.x; Dasso M, 2002, CURR BIOL, V12, pR502, DOI 10.1016/S0960-9822(02)00970-3; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Gerdes HH, 2008, CURR OPIN CELL BIOL, V20, P470, DOI 10.1016/j.ceb.2008.03.005; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Grosshans H, 2000, GENE DEV, V14, P830; Guescini M, 2010, EXP CELL RES, V316, P1977, DOI 10.1016/j.yexcr.2010.04.006; Hetzer M, 2002, NAT CELL BIOL, V4, pE177, DOI 10.1038/ncb0702-e177; Huber J, 1998, EMBO J, V17, P4114, DOI 10.1093/emboj/17.14.4114; Hung KE, 2009, CANCER PREV RES, V2, P224, DOI 10.1158/1940-6207.CAPR-08-0153; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; Janowska-Wieczorek A, 2005, INT J CANCER, V113, P752, DOI 10.1002/ijc.20657; Joseph J, 2004, CURR BIOL, V14, P611, DOI 10.1016/j.cub.2004.03.031; Joseph J, 2008, FEBS LETT, V582, P190, DOI 10.1016/j.febslet.2007.11.087; Joseph J, 2006, J CELL SCI, V119, P3481, DOI 10.1242/jcs.03071; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; Koppen T, 2011, PROTEOMICS, V11, P4397, DOI 10.1002/pmic.201000774; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Kurisetty VV, 2008, ONCOGENE, V27, P7139, DOI 10.1038/onc.2008.325; Lounsbury KM, 1996, J BIOL CHEM, V271, P32834, DOI 10.1074/jbc.271.51.32834; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Mears R, 2004, PROTEOMICS, V4, P4019, DOI 10.1002/pmic.200400876; Miguet L, 2006, PROTEOMICS, V6, P153, DOI 10.1002/pmic.200500133; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; MOSER FG, 1975, J CELL BIOL, V66, P676, DOI 10.1083/jcb.66.3.676; Moy TI, 2002, J CELL SCI, V115, P2985; Moy TI, 1999, GENE DEV, V13, P2118, DOI 10.1101/gad.13.16.2118; Muralidharan-Chari V, 2010, J CELL SCI, V123, P1603, DOI 10.1242/jcs.064386; OHTSUBO M, 1989, J CELL BIOL, V109, P1389, DOI 10.1083/jcb.109.4.1389; Pires-daSilva A, 2003, NAT REV GENET, V4, P39, DOI 10.1038/nrg977; Prochiantz A, 2013, CURR GENOMICS, V14, P361, DOI 10.2174/1389202911314060009; Prochiantz A, 2011, METHODS MOL BIOL, V683, P249, DOI 10.1007/978-1-60761-919-2_18; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Sahoo PK, 2012, BIOL OPEN, V1, P109, DOI 10.1242/bio.2011023; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Strom AC, 2001, GENOME BIOL, V2; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209; Xia F, 2008, CANCER RES, V68, P1826, DOI 10.1158/0008-5472.CAN-07-5279; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; YOKOYAMA N, 1995, NATURE, V376, P184, DOI 10.1038/376184a0	62	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0125506	10.1371/journal.pone.0125506	http://dx.doi.org/10.1371/journal.pone.0125506			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894517	Green Submitted, Green Published, gold			2022-12-26	WOS:000353211700138
J	Liao-Chan, S; Daine-Matsuoka, B; Heald, N; Wong, T; Lin, T; Cai, AG; Lai, M; D'Alessio, JA; Theunissen, JW				Liao-Chan, Sindy; Daine-Matsuoka, Barbara; Heald, Nathan; Wong, Tiffany; Lin, Tracey; Cai, Allen G.; Lai, Michelle; D'Alessio, Joseph A.; Theunissen, Jan-Willem			Quantitative Assessment of Antibody Internalization with Novel Monoclonal Antibodies against Alexa Fluorophores	PLOS ONE			English	Article							DRUG CONJUGATE; CANCER THERAPEUTICS; IMAGE-ANALYSIS; IN-VIVO; TRASTUZUMAB; CELLS; SENSITIVITY; ENDOCYTOSIS; EXPRESSION; SURVIVAL	Antibodies against cell surface antigens may be internalized through their specific interactions with these proteins and in some cases may induce or perturb antigen internalization. The anti-cancer efficacy of antibody-drug conjugates is thought to rely on their uptake by cancer cells expressing the surface antigen. Numerous techniques, including microscopy and flow cytometry, have been used to identify antibodies with desired cellular uptake rates. To enable quantitative measurements of internalization of labeled antibodies, an assay based on internalized and quenched fluorescence was developed. For this approach, we generated novel anti-Alexa Fluor monoclonal antibodies (mAbs) that effectively and specifically quench cell surface-bound Alexa Fluor 488 or Alexa Fluor 594 fluorescence. Utilizing Alexa Fluor-labeled mAbs against the EphA2 receptor tyrosine kinase, we showed that the anti-Alexa Fluor reagents could be used to monitor internalization quantitatively over time. The anti-Alexa Fluor mAbs were also validated in a proof of concept dual-label internalization assay with simultaneous exposure of cells to two different mAbs. Importantly, the unique anti-Alexa Fluor mAbs described here may also enable other single-and dual-label experiments, including label detection and signal enhancement in macromolecules, trafficking of proteins and microorganisms, and cell migration and morphology.	[Liao-Chan, Sindy; Daine-Matsuoka, Barbara; Heald, Nathan; Wong, Tiffany; Lin, Tracey; Cai, Allen G.; Lai, Michelle; D'Alessio, Joseph A.; Theunissen, Jan-Willem] Igen Biotherapeut, Dept Discovery Res, Burlingame, CA 94010 USA		Theunissen, JW (corresponding author), Igen Biotherapeut, Dept Discovery Res, Burlingame, CA 94010 USA.	jtheunissen@igenica.com			Igenica Biotherapeutics	Igenica Biotherapeutics	Igenica Biotherapeutics provided support in the form of salaries for authors SLC, BDM, NH, TW, TL, AGC, ML, JAD'A and JWT but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Austin CD, 2004, MOL BIOL CELL, V15, P5268, DOI 10.1091/mbc.E04-07-0591; Blot V, 2006, EMBO J, V25, P5648, DOI 10.1038/sj.emboj.7601462; Chen AK, 2008, ANAL CHEM, V80, P7437, DOI 10.1021/ac8011347; Chen HM, 2010, J AM CHEM SOC, V132, P7244, DOI 10.1021/ja100500k; Coleman RA, 2006, J HISTOCHEM CYTOCHEM, V54, P817, DOI 10.1369/jhc.6A6929.2006; Collinet C, 2010, NATURE, V464, P243, DOI 10.1038/nature08779; de Groot DM, 2009, J IMMUNOL, V183, P4127, DOI 10.4049/jimmunol.0901253; Demichelis VT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055304; FitzGerald DJ, 2011, CANCER RES, V71, P6300, DOI 10.1158/0008-5472.CAN-11-1374; Ford CHJ, 1996, CYTOMETRY, V23, P228; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Ingle GS, 2008, BRIT J HAEMATOL, V140, P46, DOI 10.1111/j.1365-2141.2007.06883.x; Jackson D, 2008, CANCER RES, V68, P9367, DOI 10.1158/0008-5472.CAN-08-1933; Jones SL, 2014, J CELL BIOL, V205, P67, DOI 10.1083/jcb.201401045; Kilpatrick KE, 1997, HYBRIDOMA, V16, P381, DOI 10.1089/hyb.1997.16.381; Kudo T, 2012, J NEUROSCI, V32, P18035, DOI 10.1523/JNEUROSCI.4057-12.2012; Leal M, 2014, ANN NY ACAD SCI, V1321, P41, DOI 10.1111/nyas.12499; Liao-Chan S, 2014, J IMMUNOL METHODS, V405, P1, DOI 10.1016/j.jim.2013.12.007; MAIER LA, 1991, CANCER RES, V51, P5361; McDonagh CF, 2008, MOL CANCER THER, V7, P2913, DOI 10.1158/1535-7163.MCT-08-0295; Metkar SS, 2008, IMMUNITY, V29, P720, DOI 10.1016/j.immuni.2008.08.014; Miksa M, 2009, J IMMUNOL METHODS, V342, P71, DOI 10.1016/j.jim.2008.11.019; Nahta R, 2004, CANCER RES, V64, P2343, DOI 10.1158/0008-5472.CAN-03-3856; Nylandsted J, 2004, J EXP MED, V200, P425, DOI 10.1084/jem.20040531; Ogata K, 2002, NEUROSCIENCE, V113, P221, DOI 10.1016/S0306-4522(02)00041-6; Panchuk-Voloshina N, 1999, J HISTOCHEM CYTOCHEM, V47, P1179, DOI 10.1177/002215549904700910; Peng L, 2011, J MOL BIOL, V413, P390, DOI 10.1016/j.jmb.2011.08.018; Phillips GDL, 2014, CLIN CANCER RES, V20, P456, DOI 10.1158/1078-0432.CCR-13-0358; Rudnick SI, 2011, CANCER RES, V71, P2250, DOI 10.1158/0008-5472.CAN-10-2277; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schrama D, 2006, NAT REV DRUG DISCOV, V5, P147, DOI 10.1038/nrd1957; Sutherland MSK, 2013, BLOOD, V122, P1455, DOI 10.1182/blood-2013-03-491506; van der Horst E, 2009, NEOPLASIA, V11, P355, DOI 10.1593/neo.81536; Wade JB, 2006, P NATL ACAD SCI USA, V103, P8558, DOI 10.1073/pnas.0603109103; Wang IH, 2013, CELL HOST MICROBE, V14, P468, DOI 10.1016/j.chom.2013.09.004	35	20	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124708	10.1371/journal.pone.0124708	http://dx.doi.org/10.1371/journal.pone.0124708			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894652	Green Submitted, Green Published, gold			2022-12-26	WOS:000353211700116
J	Proches, S; Forest, F; Jose, S; De Dominicis, M; Ramdhani, S; Wiggill, T				Proches, Serban; Forest, Felix; Jose, Sarah; De Dominicis, Michela; Ramdhani, Syd; Wiggill, Timothy			How Do Alien Plants Fit in the Space-Phylogeny Matrix?	PLOS ONE			English	Article							SOUTH-AFRICA; MANTEL TEST; COMMUNITIES; RELATEDNESS; INVASIVENESS; EVOLUTION; INVASION; ECOLOGY; PATTERN; SCALES	Recent advances in the field of plant community phylogenetics and invasion phylogenetics are mostly based on plot-level data, which do not take into consideration the spatial arrangement of individual plants within the plot. Here we use within-plot plant coordinates to investigate the link between the physical distance separating plants, and their phylogenetic relatedness. We look at two vegetation types (forest and grassland, similar in species richness and in the proportion of alien invasive plants) in subtropical coastal KwaZulu-Natal, South Africa. The relationship between phylogenetic distance and physical distance is weak in grassland (characterised by higher plant densities and low phylogenetic diversity), and varies substantially in forest vegetation (variable plant density, higher phylogenetic diversity). There is no significant relationship between the proportion of alien plants in the plots and the strength of the physical-phylogenetic distance relationship, suggesting that alien plants are well integrated in the local spatial-phylogenetic landscape.	[Proches, Serban; De Dominicis, Michela; Wiggill, Timothy] Univ KwaZulu Natal, Discipline Geog, Durban, South Africa; [Forest, Felix; Jose, Sarah] Royal Bot Gardens, Jodrell Lab, Richmond TW9 3DS, Surrey, England; [Ramdhani, Syd] Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa	University of Kwazulu Natal; Royal Botanic Gardens, Kew; University of Kwazulu Natal	Proches, S (corresponding author), Univ KwaZulu Natal, Discipline Geog, Westville Campus,Private Bag X54001, Durban, South Africa.	setapion@gmail.com	Procheş, Şerban/A-2044-2008; Ramdhani, Syd/AFQ-0706-2022	Procheş, Şerban/0000-0002-3415-6930; Ramdhani, Syd/0000-0003-1988-5438; Jose, Sarah/0000-0003-2737-6473	National Research Foundation; Royal Botanic Gardens, Kew Phylogenetic analysis	National Research Foundation; Royal Botanic Gardens, Kew Phylogenetic analysis	This work was supported by the following sources of funding: National Research Foundation (http://www.nrf.ac.za/) Incentive Funding for Rated Researchers SP Postdoctoral Grant SR; Royal Botanic Gardens, Kew (http://www.kew.org/) Phylogenetic analysis FF SJ.	[Anonymous], 2010, R LANG ENV STAT COMP; Carvallo GO, 2014, AUSTRAL ECOL, V39, P304, DOI 10.1111/aec.12079; Cavender-Bares J, 2004, AM NAT, V163, P823, DOI 10.1086/386375; Daehler CC, 2001, AM NAT, V158, P324, DOI 10.1086/321316; Dale MRT, 2001, J VEG SCI, V12, P597, DOI 10.2307/3236899; Davies KF, 2011, DIVERS DISTRIB, V17, P35, DOI 10.1111/j.1472-4642.2010.00721.x; Dawson W, 2009, J ECOL, V97, P657, DOI 10.1111/j.1365-2745.2009.01519.x; Diniz JAF, 2013, GENET MOL BIOL, V36, P475, DOI 10.1590/S1415-47572013000400002; Dostal P, 2011, AM NAT, V177, P655, DOI 10.1086/659060; Duncan RP, 2002, NATURE, V417, P608, DOI 10.1038/417608a; Eccles NS, 1999, PLANT ECOL, V142, P71, DOI 10.1023/A:1009857824912; Escobedo VM, 2011, REV CHIL HIST NAT, V84, P543, DOI 10.4067/S0716-078X2011000400007; ESRI, 2008, ARCGIS VERS 9 3; eThekwini Municipality, 2010, FRAM STRAT CONTR INV; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Germishuizen G., 2003, PLANTS SO AFRICA ANN; Gray L, 2009, FOREST ECOL MANAG, V259, P98, DOI 10.1016/j.foreco.2009.09.048; Greene BT, 2012, BIOL INVASIONS, V14, P139, DOI 10.1007/s10530-011-9990-1; Jones EI, 2013, P NATL ACAD SCI USA, V110, P20627, DOI 10.1073/pnas.1310247110; Legendre P, 2010, MOL ECOL RESOUR, V10, P831, DOI 10.1111/j.1755-0998.2010.02866.x; Oksanen J, 2022, COMMUNITY ECOLOGY PA; Padayachi Y, 2014, ARTHROPOD-PLANT INTE, V8, P135, DOI 10.1007/s11829-014-9295-2; Pellock S, 2013, COMMUNITY ECOL, V14, P172, DOI 10.1556/ComEc.14.2013.2.7; Pooley E, 2005, AIELD FUIDE WILD FLO; Pooley E. S., 2003, COMPLETE FIELD GUIDE; Prinzing A, 2001, P ROY SOC LOND B BIO, V268, P1, DOI DOI 10.1098/RSPB.2000.1322; Prinzing A, 2008, ECOL LETT, V11, P809, DOI 10.1111/j.1461-0248.2008.01189.x; Proches S, 2006, P R SOC B, V273, P1143, DOI 10.1098/rspb.2005.3427; Proches S, 2008, GLOBAL ECOL BIOGEOGR, V17, P5, DOI 10.1111/j.1466-8238.2007.00333.x; Pysek Petr, 2007, V193, P97; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Shen GC, 2013, METHODS ECOL EVOL, V4, P1132, DOI 10.1111/2041-210X.12119; Silvertown J, 2006, P ROY SOC B-BIOL SCI, V273, P39, DOI 10.1098/rspb.2005.3288; Slingsby JA, 2006, AM NAT, V168, P14, DOI 10.1086/505158; SOLTIS DE, 1998, MOL SYSTEMATICS PLAN, V2, P1; Strauss SY, 2006, P NATL ACAD SCI USA, V103, P5841, DOI 10.1073/pnas.0508073103; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Thuiller W, 2011, DIVERS DISTRIB, V16, P471; Vila M, 2015, GLOBAL ECOL BIOGEOGR, V24, P139, DOI 10.1111/geb.12249; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Zachariades C, 2000, P 5 INT WORKSH BIOL	41	4	4	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123238	10.1371/journal.pone.0123238	http://dx.doi.org/10.1371/journal.pone.0123238			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893962	Green Submitted, Green Published, gold			2022-12-26	WOS:000353211700031
J	Busconi, M; Colli, L; Sanchez, RA; Santaella, M; Pascual, MD; Santana, O; Roldan, M; Fernandez, JA				Busconi, Matteo; Colli, Licia; Ana Sanchez, Rosa; Santaella, Marcela; De-Los-Mozos Pascual, Marcelino; Santana, Omar; Roldan, Marta; Fernandez, Jose-Antonio			AFLP and MS-AFLP Analysis of the Variation within Saffron Crocus (Crocus sativus L.) Germplasm	PLOS ONE			English	Article							DNA METHYLATION; STRATEGIES; GENOTYPE	The presence and extent of genetic variation in saffron crocus are still debated, as testified by several contradictory articles providing contrasting results about the monomorphism or less of the species. Remarkably, phenotypic variations have been frequently observed in the field, such variations are usually unstable and can change from one growing season to another. Considering that gene expression can be influenced both by genetic and epigenetic changes, epigenetics could be a plausible cause of the alternative phenotypes. In order to obtain new insights into this issue, we carried out a molecular marker analysis of 112 accessions from the World Saffron and Crocus Collection. The accessions were grown for at least three years in the same open field conditions. The same samples were analysed using Amplified Fragment Length Polymorphism (AFLP) and Methyl Sensitive AFLP in order to search for variation at the genetic (DNA sequence) and epigenetic (cytosine methylation) level. While the genetic variability was low (4.23% polymorphic peaks and twelve (12) effective different genotypes), the methyl sensitive analysis showed the presence of high epigenetic variability (33.57% polymorphic peaks and twenty eight (28) different effective epigenotypes). The pattern obtained by Factorial Correspondence Analysis of AFLP and, in particular, of MS-AFLP data was consistent with the geographical provenance of the accessions. Very interestingly, by focusing on Spanish accessions, it was observed that the distribution of the accessions in the Factorial Correspondence Analysis is not random but tends to reflect the geographical origin. Two clearly defined clusters grouping accessions from the West (Toledo and Ciudad Real) and accessions from the East (Cuenca and Teruel) were clearly recognised.	[Busconi, Matteo; Colli, Licia] Univ Cattolica Sacro Cuore, Fac Agr Food & Environm Sci, Piacenza, Italy; [Busconi, Matteo; Colli, Licia] Univ Cattolica Sacro Cuore, BioDNA, Ctr Ric Biodiversita & DNA Ant, Piacenza, Italy; [Ana Sanchez, Rosa; Santaella, Marcela; Roldan, Marta; Fernandez, Jose-Antonio] Univ Castilla La Mancha, IDR Biotechnol, Albacete, Spain; [Santaella, Marcela; De-Los-Mozos Pascual, Marcelino; Santana, Omar] Consejeria Agr Castilla La Mancha, Ctr Invest Agr Albaladejito, Cuenca, Spain	Catholic University of the Sacred Heart; Catholic University of the Sacred Heart; Universidad de Castilla-La Mancha	Busconi, M (corresponding author), Univ Cattolica Sacro Cuore, Fac Agr Food & Environm Sci, Piacenza, Italy.	matteo.busconi@unicatt.it; JoseAntonio.FPerez@uclm.es	Colli, Licia/AAC-2985-2021; Fernández, José Antonio/R-9082-2019	Fernández, José Antonio/0000-0002-9913-4978; SANTANA MERIDAS, OMAR/0000-0003-0352-5921; Busconi, Matteo/0000-0002-7824-3446	Creacion de la coleccion espanola de azafran y especies afines [RF2004-00032]; Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (ES); Coleccion espanola de germoplasma de azafran y especies afines [RF2008-00012]; Avances en la estrategia de conservacion, multiplicacion y caracterizacion de la coleccion espanola de germoplasma de azafran y especies afines [RF2011-00005]; European commission; Genetic resources of saffron and allies [AGRI-2006-0265]; European Cooperation in Science and Technology; Omics technologies for crop improvement, traceability, determination of authenticity, adulteration and origin in saffron, COST action [FA1101]	Creacion de la coleccion espanola de azafran y especies afines; Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (ES); Coleccion espanola de germoplasma de azafran y especies afines; Avances en la estrategia de conservacion, multiplicacion y caracterizacion de la coleccion espanola de germoplasma de azafran y especies afines; European commission(European CommissionEuropean Commission Joint Research Centre); Genetic resources of saffron and allies; European Cooperation in Science and Technology(European Cooperation in Science and Technology (COST)); Omics technologies for crop improvement, traceability, determination of authenticity, adulteration and origin in saffron, COST action	This work was supported by: 1) Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (ES); Creacion de la coleccion espanola de azafran y especies afines, grant number RF2004-00032; URL: http://www.inia.es/IniaPortal/verPresentacion.action; grant holder MDM; 2) Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (ES); Coleccion espanola de germoplasma de azafran y especies afines, grant number RF2008-00012; URL: http://www.inia.es/IniaPortal/verPresentacion.action; grant holder MDM; 3) Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (ES); Avances en la estrategia de conservacion, multiplicacion y caracterizacion de la coleccion espanola de germoplasma de azafran y especies afines, grant number RF2011-00005; URL: http://www.inia.es/IniaPortal/verPresentacion.action; grant holder MDM; 4) European commission; Genetic resources of saffron and allies (crocus spp.): Crocusbank, grant number AGRI-2006-0265; URL: http://ec.europa.eu/; grant holder JAF; 5) European Cooperation in Science and Technology; Omics technologies for crop improvement, traceability, determination of authenticity, adulteration and origin in saffron, COST action FA1101; URL: http://www.cost.eu/; grant holder MR.	Agayev YMO, 2009, EUPHYTICA, V169, P81, DOI 10.1007/s10681-009-9946-z; BELKHIR K., 2004, LOGICIEL WINDOWS GEN; Benjak A, 2006, VITIS, V45, P15; BENZECRI J.-P, 1973, LANALYSE DONNEES; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Brautigam K, 2013, ECOL EVOL, V3, P399, DOI 10.1002/ece3.461; Brandizzi F, 1998, PLANT SYST EVOL, V211, P149, DOI 10.1007/BF00985356; BRIGHTON C A, 1973, Kew Bulletin, V28, P451, DOI 10.2307/4108890; Caiola MG, 2004, ACTA HORTIC, P25; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; De-Los-Mozos-Pascual M, 2010, ACTA HORTIC, V850, P35, DOI 10.17660/ActaHortic.2010.850.3; Erol O, 2014, TURK J BIOL, V38, P48, DOI 10.3906/biy-1305-14; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fernandez JA, 2004, RECENT RES DEV PLANT, V2, P127; Fernandez JA, 2011, GENET RESOUR CROP EV, V58, P125, DOI 10.1007/s10722-010-9601-5; Fluch S, 2010, ACTA HORTIC, V850, P41, DOI 10.17660/ActaHortic.2010.850.4; Herrera CM, 2013, BOT J LINN SOC, V171, P441, DOI 10.1111/boj.12007; Lisch D, 2011, INT REV CEL MOL BIO, V292, P119, DOI 10.1016/B978-0-12-386033-0.00003-7; Lu GY, 2007, J INTEGR PLANT BIOL, V49, P1599, DOI 10.1111/j.1774-7909.2007.00566.x; Luo M, 2012, BBA-GENE REGUL MECH, V1819, P129, DOI 10.1016/j.bbagrm.2011.06.008; Marconi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075597; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Montana G, 2006, BRIEF BIOINFORM, V7, P297, DOI 10.1093/bib/bbl028; Myles S, 2011, P NATL ACAD SCI USA, V108, P3530, DOI 10.1073/pnas.1009363108; Nei M., 1987, MOL EVOLUTIONARY GEN; Nemati Z, 2014, SPAN J AGRIC RES, V12, P753, DOI 10.5424/sjar/2014123-5564; Paszkowski J, 2011, CURR OPIN PLANT BIOL, V14, P195, DOI 10.1016/j.pbi.2011.01.002; Ranieri E, 2013, P 57 IT SOC AGR GEN; Richards EJ, 2011, CURR OPIN PLANT BIOL, V14, P204, DOI 10.1016/j.pbi.2011.03.009; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rubio-Moraga Angela, 2009, BMC Res Notes, V2, P189, DOI 10.1186/1756-0500-2-189; Saze H, 2012, PLANT CELL PHYSIOL, V53, P766, DOI 10.1093/pcp/pcs008; Schmidt T, 1998, TRENDS PLANT SCI, V3, P195, DOI 10.1016/S1360-1385(98)01223-0; Siracusa L, 2013, GENET RESOUR CROP EV, V60, P711, DOI 10.1007/s10722-012-9868-9; Tenaillon MI, 2010, TRENDS PLANT SCI, V15, P471, DOI 10.1016/j.tplants.2010.05.003; Zhang ChangQing, 2013, Plant Breeding and Biotechnology, V1, P307, DOI 10.9787/PBB.2013.1.4.307	38	28	29	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123434	10.1371/journal.pone.0123434	http://dx.doi.org/10.1371/journal.pone.0123434			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885113	Green Submitted, gold, Green Published			2022-12-26	WOS:000353017000063
J	Hua, YJ; Stojanovic, A; Utheim, TP; Chen, XJ; Raeder, S; Huang, JH; Wang, QM				Hua, Yanjun; Stojanovic, Aleksander; Utheim, Tor Paaske; Chen, Xiangjun; Raeder, Sten; Huang, Jinhai; Wang, Qinmei			Keratometric Index Obtained by Fourier-Domain Optical Coherence Tomography	PLOS ONE			English	Article							LENS POWER CALCULATION; CORNEAL POWER; ORBSCAN-II; POSTERIOR SURFACE; ANTERIOR SEGMENT; PENTACAM; CURVATURE; SURGERY; EYES; VIDEOKERATOGRAPHY	Purpose To determine the keratometric indices calculated based on parameters obtained by Fourier-domain optical coherence tomography (FD-OCT). Methods The ratio of anterior corneal curvature to posterior corneal curvature (Ratio) and keratometric index (N) were calculated within central 3 mm zone with the RTVue FD-OCT (RTVue, Optovue, Inc.) in 186 untreated eyes, 60 post-LASIK/PRK eyes, and 39 keratoconus eyes. The total corneal powers were calculated using different keratometric indices: K-cal based on the mean calculated keratometric index, K1.3315 calculated by the keratometric index of 1.3315, and K1.3375 calculated by the keratometric index of 1.3375. In addition, the total corneal powers based on Gaussian optics formula (K-actual) were calculated. Results The means for Ratio in untreated controls, post-LASIK/PRK group and keratoconus group were 1.176 +/- 0.022 (95% confidence interval (CI), 1.172-1.179), 1.314 +/- 0.042 (95% CI, 1.303-1.325) and 1.229 +/- 0.118 (95% CI, 1.191-1.267), respectively. And the mean calculated keratometric index in untreated controls, post-LASIK/PRK group and keratoconus group were 1.3299 +/- 0.00085 (95% CI, 1.3272-1.3308), 1.3242 +/- 0.00171 (95% CI, 1.3238-1.3246) and 1.3277 +/- 0.0046 (95% CI, 1.3263-1.3292), respectively. All the parameters were normally distributed. The differences between Kcal and Kactual, K1.3315 and Kactual, and K1.3375 and Kactual were 0.00 +/- 0.11 D, 0.21 +/- 0.11 D and 0.99 +/- 0.12 D, respectively, in untreated controls; -0.01 +/- 0.20 D, 0.85 +/- 0.18 D and 1.56 +/- 0.16 D, respectively, in postLASIK/PRK group; and 0.03 +/- 0.67 D, 0.56 +/- 0.70 D and 1.40 +/- 0.76 D, respectively, in keratoconus group. Conclusion The calculated keratometric index is negatively related to the ratio of anterior corneal curvature to posterior corneal curvature in untreated, post-LASIK/PRK, and keratoconus eyes, respectively. Using the calculated keratometric index may improve the prediction accuracies of total corneal powers in untreated controls, but not in post-LASIK/PRK and keratoconus eyes.	[Hua, Yanjun] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Ophthalmol, Shanghai 200233, Peoples R China; [Stojanovic, Aleksander] Univ Hosp North Norway, Dept Ophthalmol, Tromso, Norway; [Stojanovic, Aleksander; Chen, Xiangjun; Raeder, Sten] SynsLaser Kirurgi AS, Tromso, Norway; [Utheim, Tor Paaske] Oslo Univ Hosp, Dept Med Biochem, N-0450 Oslo, Norway; [Huang, Jinhai; Wang, Qinmei] Wenzhou Med Univ, Sch Optometry & Ophthalmol, Key Lab Vis Sci, Minist Hlth Peoples Republ China, Wenzhou, Zhejiang, Peoples R China; [Huang, Jinhai; Wang, Qinmei] Wenzhou Med Univ, Hosp Eye, Key Lab Vis Sci, Minist Hlth Peoples Republ China, Wenzhou, Zhejiang, Peoples R China	Shanghai Jiao Tong University; UiT The Arctic University of Tromso; University Hospital of North Norway; University of Oslo; Wenzhou Medical University; Wenzhou Medical University	Huang, JH (corresponding author), Wenzhou Med Univ, Sch Optometry & Ophthalmol, Key Lab Vis Sci, Minist Hlth Peoples Republ China, Wenzhou, Zhejiang, Peoples R China.	1278034009@qq.com; wqm6@mail.eye.ac.en	Huang, Jinhai/ABH-4519-2020	HUA, YANJUN/0000-0001-6461-3576	National Natural Science Foundation of China [81300807]; Foundation of Wenzhou City Science & Technology Bureau [Y20120176, Y20130118]; National Science and Technology Ministry [2012BAI08B04]; Health Bureau of Zhejiang Province [2012KYB135]; Science Research Fund of Zhejiang Provincial Education Department [Y201223147]; SynsLaser Kirurgi AS	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Wenzhou City Science & Technology Bureau; National Science and Technology Ministry; Health Bureau of Zhejiang Province; Science Research Fund of Zhejiang Provincial Education Department; SynsLaser Kirurgi AS	This study was supported in part by the National Natural Science Foundation of China (81300807); Foundation of Wenzhou City Science & Technology Bureau (Y20120176, Y20130118); the National Science and Technology Ministry (2012BAI08B04); the Health Bureau of Zhejiang Province (2012KYB135); and the Science Research Fund of Zhejiang Provincial Education Department (Y201223147). Authors AS, XC and SR are employed by SynsLaser Kirurgi AS. SynsLaser Kirurgi AS provided support in the form of salaries for authors AS, XC and SR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ang M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101483; Arce CG, 2007, J CATARACT REFR SURG, V33, P1348, DOI 10.1016/j.jcrs.2007.03.062; Borasio E, 2006, J CATARACT REFR SURG, V32, P2004, DOI 10.1016/j.jcrs.2006.08.037; Cheng ACK, 2009, J REFRACT SURG, V25, P221, DOI 10.3928/1081597X-20090201-08; Dubbelman M, 2006, VISION RES, V46, P993, DOI 10.1016/j.visres.2005.09.021; Falavarjani KG, 2010, CLIN EXP OPHTHALMOL, V38, P341, DOI 10.1111/j.1442-9071.2010.02286.x; Fam HB, 2007, J CATARACT REFR SURG, V33, P686, DOI 10.1016/j.jcrs.2006.11.023; Garner LF, 1997, OPTOMETRY VISION SCI, V74, P496, DOI 10.1097/00006324-199707000-00016; Goss DA, 2002, INTRO OPTICS EYE, P113; Ho JD, 2008, J CATARACT REFR SURG, V34, P137, DOI 10.1016/j.jcrs.2007.09.033; Hua Y, 2013, CHINESE J OPTOMETRY, V15, P150, DOI [10.1016/j.optom.2013.06.002, DOI 10.1016/J.0PT0M.2013.06.002]; [华焱军 Hua Yanjun], 2013, [中华实验眼科杂志, Chinese Journal of Experimental Ophthalmology], V31, P177; Jin HY, 2012, J CATARACT REFR SURG, V38, P1749, DOI 10.1016/j.jcrs.2012.06.048; Leyland M, 2004, EYE, V18, P357, DOI 10.1038/sj.eye.6700659; Lim KL, 2006, J CATARACT REFR SURG, V32, P1814, DOI 10.1016/j.jcrs.2006.08.022; McAlinden C, 2011, INVEST OPHTH VIS SCI, V52, P7731, DOI 10.1167/iovs.10-7093; OLSEN T, 1986, BRIT J OPHTHALMOL, V70, P152, DOI 10.1136/bjo.70.2.152; Ortiz S, 2011, BIOMED OPT EXPRESS, V2, P3232, DOI 10.1364/BOE.2.003232; Savini G, 2009, J REFRACT SURG, V25, P534, DOI 10.3928/1081597X-20090512-07; Shankar H, 2008, J CATARACT REFR SURG, V34, P103, DOI 10.1016/j.jcrs.2007.09.013; Tang ML, 2006, J CATARACT REFR SURG, V32, P1843, DOI 10.1016/j.jcrs.2006.04.046; Tang ML, 2012, J CATARACT REFR SURG, V38, P589, DOI 10.1016/j.jcrs.2011.11.025; Tang ML, 2010, J CATARACT REFR SURG, V36, P2115, DOI 10.1016/j.jcrs.2010.07.018; Wang L, 2011, INVEST OPHTH VIS SCI, V52, P1716, DOI 10.1167/iovs.09-4982; Wang QM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045607	25	3	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0122441	10.1371/journal.pone.0122441	http://dx.doi.org/10.1371/journal.pone.0122441			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886489	Green Published, gold, Green Submitted			2022-12-26	WOS:000353017000033
J	Stanifer, JW; Maro, V; Egger, J; Karia, F; Thielman, N; Turner, EL; Shimbi, D; Kilaweh, H; Matemu, O; Patel, UD				Stanifer, John W.; Maro, Venance; Egger, Joseph; Karia, Francis; Thielman, Nathan; Turner, Elizabeth L.; Shimbi, Dionis; Kilaweh, Humphrey; Matemu, Oliver; Patel, Uptal D.			The Epidemiology of Chronic Kidney Disease in Northern Tanzania: A Population-Based Survey	PLOS ONE			English	Article							PREVALENCE; BURDEN; ADULTS; RISK	Background In sub-Saharan Africa, kidney failure has a high morbidity and mortality. Despite this, population-based estimates of prevalence, potential etiologies, and awareness are not available. Methods Between January and June 2014, we conducted a household survey of randomly-selected adults in Northern Tanzania. To estimate prevalence we screened for CKD, which was defined as an estimated glomerular filtration rate <= 60 ml/min/1.73m2 and/or persistent albuminuria. We also screened for human immunodeficiency virus (HIV), diabetes, hypertension, obesity, and lifestyle practices including alcohol, tobacco, and traditional medicine use. Awareness was defined as a self-reported disease history and subsequently testing positive. We used population-based age-and gender-weights in estimating prevalence, and we used generalized linear models to explore potential risk factors associated with CKD, including living in an urban environment. Results We enrolled 481 adults from 346 households with a median age of 45 years. The community-based prevalence of CKD was 7.0% (95% CI 3.8-12.3), and awareness was low at 10.5% (4.7-22.0). The urban prevalence of CKD was 15.2% (9.6-23.3) while the rural prevalence was 2.0% (0.5-6.9). Half of the cases of CKD (49.1%) were not associated with any of the measured risk factors of hypertension, diabetes, or HIV. Living in an urban environment had the strongest crude (5.40; 95% CI 2.05-14.2) and adjusted prevalence risk ratio (4.80; 1.70-13.6) for CKD, and the majority (79%) of this increased risk was not explained by demographics, traditional medicine use, socioeconomic status, or co-morbid non-communicable diseases (NCDs). Conclusions We observed a high burden of CKD in Northern Tanzania that was associated with low awareness. Although demographic, lifestyle practices including traditional medicine use, socioeconomic factors, and NCDs accounted for some of the excess CKD risk observed with urban residence, much of the increased urban prevalence remained unexplained and will further study as demographic shifts reshape sub-Saharan Africa.	[Stanifer, John W.; Thielman, Nathan; Patel, Uptal D.] Duke Univ, Dept Med, Durham, NC 27708 USA; [Stanifer, John W.; Egger, Joseph; Thielman, Nathan; Turner, Elizabeth L.] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Maro, Venance; Karia, Francis; Shimbi, Dionis; Kilaweh, Humphrey; Matemu, Oliver] Kilimanjaro Christian Med Coll, Moshi, Tanzania; [Turner, Elizabeth L.] Duke Univ, Dept Biostat & Bioinformat, Durham, NC USA; [Patel, Uptal D.] Duke Univ, Duke Clin Res Inst, Durham, NC USA	Duke University; Duke University; Duke University; Duke University	Stanifer, JW (corresponding author), Duke Univ, Dept Med, Durham, NC 27708 USA.	john.stanifer@duke.edu	Thielman, Nathan/R-5142-2019	Thielman, Nathan/0000-0001-8152-2879	NIH - Fogarty International Center [R25 TW009337]; National Institute of Mental Health; Research and Prevention Grant - International Society of Nephrology Global Outreach Committee; Master's of Science research stipend from Duke Global Health Institute; FOGARTY INTERNATIONAL CENTER [R25TW009337] Funding Source: NIH RePORTER	NIH - Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Research and Prevention Grant - International Society of Nephrology Global Outreach Committee; Master's of Science research stipend from Duke Global Health Institute; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by an NIH Research Training Grant (#R25 TW009337) funded by the Fogarty International Center and the National Institute of Mental Health; a Research and Prevention Grant funded by the International Society of Nephrology Global Outreach Committee; and a Master's of Science research stipend from the Duke Global Health Institute. There was no involvement by the funding source in the design, analysis, or writing of this study. All authors had full access to the data and had final responsibility for the decision to publish.	Agarwal SK, 2005, NEPHROL DIAL TRANSPL, V20, P1638, DOI 10.1093/ndt/gfh855; Agyei-Mensah S, 2010, J URBAN HEALTH, V87, P879, DOI 10.1007/s11524-010-9492-y; Boutayeb Abdesslam, 2005, Int J Equity Health, V4, P2, DOI 10.1186/1475-9276-4-2; Central Census Office and National Bureau of Statistics, 2013, UN REP TANZ 2012 POP; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368; Daar AS, 2007, NATURE, V450, P494, DOI 10.1038/450494a; Demographic and Health Surveys, 2013, UN REP TANZ HIV AIDS; DONNER A, 1980, BIOMETRIKA, V67, P719; Eastwood JB, 2010, NEPHROL DIAL TRANSPL, V25, P2178, DOI 10.1093/ndt/gfp765; Education Sector Development Committee, 2013, UN REP TANZ ED SECT; Fuster V, 2006, NAT CLIN PRACT CARD, V3, P401, DOI 10.1038/ncpcardio0630; Hall V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-564; Hendriks ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032638; Hove M, 2013, STABILITY, V2, DOI 10.5334/sta.ap; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Krenzke T, 2006, P AM SOC ASS SURV RE; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; Naicker S, 2013, KIDNEY INT SUPPL, V3, P161, DOI 10.1038/kisup.2013.4; National AIDS Control Programme, 2005, NAT GUID VOL TEST CO; Seck SM, 2014, IRAN J KIDNEY DIS, V8, P286; Sharma SK, 2010, AM J KIDNEY DIS, V56, P915, DOI 10.1053/j.ajkd.2010.06.022; Singh AK, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-114; Stanifer JW, 2014, LANCET GLOB HEALTH, V2, pE174, DOI 10.1016/S2214-109X(14)70002-6; Sumaili EK, 2009, NEPHROL DIAL TRANSPL, V24, P117, DOI 10.1093/ndt/gfn469; Sumaili EK, 2008, NEPHRON CLIN PRACT, V110, pC220, DOI 10.1159/000167869; United Nations Office of the Secretary General, 2011, REP PREV CONTR NONC; United Nations Programme on HIV/AIDS, 2013, GETTING ZERO HIV E S; Wu S, 2012, CONTEMP CLIN TRIALS, V33, P869, DOI 10.1016/j.cct.2012.05.004; Wyatt CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069601	31	52	52	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124506	10.1371/journal.pone.0124506	http://dx.doi.org/10.1371/journal.pone.0124506			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886472	Green Submitted, Green Published, gold			2022-12-26	WOS:000353017000133
J	Xiang, YX; Yan, H; Zhou, J; Zhang, Q; Hanley, G; Caudle, Y; LeSage, G; Zhang, XM; Yin, DL				Xiang, Yanxiao; Yan, Hui; Zhou, Jun; Zhang, Qi; Hanley, Gregory; Caudle, Yi; LeSage, Gene; Zhang, Xiumei; Yin, Deling			The Role of Toll-Like Receptor 9 in Chronic Stress-Induced Apoptosis in Macrophage	PLOS ONE			English	Article							IN-VIVO; KINASE; EXPRESSION; IMMUNITY; PHOSPHORYLATION; PROGRESSION; INHIBITION; PATHWAYS; MORPHINE; GAMMA	Emerging evidence implied that chronic stress has been exerting detrimental impact on immune system functions in both humans and animals. Toll-like receptors (TLRs) have been shown to play an essential role in modulating immune responses and cell survival. We have recently shown that TLR9 deficiency protects against lymphocyte apoptosis induced by chronic stress. However, the exact role of TLR9 in stress-mediated change of macrophage function remains unclear. The results of the current study showed that when BALB/c mice were treated with restraint stress (12 h daily for 2 days), the number of macrophages recruited to the peritoneal cavity was obviously increased. Results also demonstrated that the sustained effects of stress elevated cytokine IL-1 beta, TNF-alpha and IL-10 production yet diminished IFN-gamma production from macrophage, which led to apoptotic cell death. However, TLR9 deficiency prevented the chronic stress-mediated accumulation of macrophages. In addition, knocking out TLR9 significantly abolished the chronic stress-induced imbalance of cytokine levels and apoptosis in macrophage. TLR9 deficiency was also found to reverse elevation of plasma IL-1 beta, IL-10 and IL-17 levels and decrease of plasma IFN-. level under the condition of chronic stress. These results indicated that TLR9-mediated macrophage responses were required for chronic stress-induced immunosuppression. Further exploration showed that TLR9 deficiency prevented the increment of p38 MAPK phosphorylation and reduction of Akt/Gsk-3 beta phosphorylation; TLR9 deficiency also attenuated the release of mitochondrial cytochrome c into cytoplasm, caused upregulation of Bcl-2/Bax protein ratio, downregulation of cleavage of caspase-3 and PARP, as well as decreased TUNEL-positive cells in macrophage of stressed mice. Collectively, our studies demonstrated that deficiency of TLR9 maintained macrophage function by modulating macrophage accumulation and attenuating macrophage apoptosis, thus preventing immunosuppression in restraint-stressed mice.	[Xiang, Yanxiao; Yan, Hui; Zhang, Qi; Caudle, Yi; LeSage, Gene; Yin, Deling] E Tennessee State Univ, Dept Internal Med, Coll Med, Johnson City, TN 37614 USA; [Xiang, Yanxiao; Zhang, Xiumei] Shandong Univ, Dept Pharmacol, Sch Med, Jinan 250100, Peoples R China; [Zhou, Jun] Shanghai Univ Tradit Chinese Med, Dept Radiol, Shuguang Hosp, Shanghai, Peoples R China; [Hanley, Gregory] E Tennessee State Univ, Coll Med, Lab Anim Resources, Johnson City, TN 37614 USA	East Tennessee State University; Shandong University; Shanghai University of Traditional Chinese Medicine; East Tennessee State University	Zhang, XM (corresponding author), Shandong Univ, Dept Pharmacol, Sch Med, Jinan 250100, Peoples R China.	zhangxm@sdu.edu.cn; yin@etsu.edu		Yan, Hui/0000-0002-6990-2526	NIH [NIGMS94740]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by research grant NIGMS94740 from NIH to D. Yin.	Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Chang CW, 2009, J BIOL CHEM, V284, P33195, DOI 10.1074/jbc.M109.020586; Chen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009205; Cheng MG, 1998, P NATL ACAD SCI USA, V95, P1091, DOI 10.1073/pnas.95.3.1091; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Dhabhar FS, 1997, BRAIN BEHAV IMMUN, V11, P286, DOI 10.1006/brbi.1997.0508; Dominguez-Gerpe L, 2001, BMC Immunol, V2, P7, DOI 10.1186/1471-2172-2-7; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; ELIAS JA, 1985, J IMMUNOL, V135, P3198; Gowda NM, 2012, J IMMUNOL, V188, P5073, DOI 10.4049/jimmunol.1102143; He L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018190; Hu D, 2014, BRAIN BEHAV IMMUN, V36, P118, DOI 10.1016/j.bbi.2013.10.016; Hu D, 2013, CELL IMMUNOL, V283, P18, DOI 10.1016/j.cellimm.2013.05.007; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kour K, 2011, NEUROPHARMACOLOGY, V60, P852, DOI 10.1016/j.neuropharm.2011.01.001; Li H., 2010, MODERN MED J, V3, P003; Li HX, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-143; Li H, 2011, J NEUROIMMUNOL, V233, P73, DOI 10.1016/j.jneuroim.2010.11.015; Liang XQ, 2010, BLOOD, V115, P5041, DOI 10.1182/blood-2009-03-213363; Maes M, 2001, CLIN SCI, V101, P193, DOI 10.1042/CS20010157; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Maus U, 2002, AM J RESP CRIT CARE, V165, P95, DOI 10.1164/ajrccm.165.1.2106148; Moon DO, 2007, ACTA PHARMACOL SIN, V28, P1205, DOI 10.1111/j.1745-7254.2007.00615.x; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nilsson EM, 2010, EXP CELL RES, V316, P800, DOI 10.1016/j.yexcr.2009.11.019; Palermo-Neto J, 2003, BRAIN BEHAV IMMUN, V17, P43, DOI 10.1016/S0889-1591(02)00057-0; Ponferrada A, 2007, GASTROENTEROLOGY, V132, P1791, DOI 10.1053/j.gastro.2007.02.032; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Reiche EMV, 2004, LANCET ONCOL, V5, P617, DOI 10.1016/S1470-2045(04)01597-9; Riquelme P, 2013, MOL THER, V21, P409, DOI 10.1038/mt.2012.168; Ropert C, 2001, J IMMUNOL, V166, P3423, DOI 10.4049/jimmunol.166.5.3423; Sarkar DK, 2012, CANCER RES, V72, P836, DOI 10.1158/0008-5472.CAN-11-3292; Shan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003041; Shi YF, 2003, BRAIN BEHAV IMMUN, V17, pS18; Singhal PC, 2002, J IMMUNOL, V168, P4025, DOI 10.4049/jimmunol.168.8.4025; Sun XM, 1999, J BIOL CHEM, V274, P5053, DOI 10.1074/jbc.274.8.5053; Thirunavukkarasu S, 2013, VET IMMUNOL IMMUNOP, V156, P20, DOI 10.1016/j.vetimm.2013.08.008; Voorhees JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058488; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zhang Y, 2008, J NEUROIMMUNOL, V200, P71, DOI 10.1016/j.jneuroim.2008.06.014; Zhang Y, 2008, J NEUROIMMUNOL, V194, P115, DOI 10.1016/j.jneuroim.2007.12.002; Zhang Y, 2008, J NEUROIMMUNOL, V204, P13, DOI 10.1016/j.jneuroim.2008.08.011	43	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123447	10.1371/journal.pone.0123447	http://dx.doi.org/10.1371/journal.pone.0123447			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885582	Green Submitted, Green Published, gold			2022-12-26	WOS:000353017000066
J	Li, S; Oh, YT; Yue, P; Khuri, FR; Sun, SY				Li, S.; Oh, Y-T; Yue, P.; Khuri, F. R.; Sun, S-Y			Inhibition of mTOR complex 2 induces GSK3/FBXW7-dependent degradation of sterol regulatory element-binding protein 1 (SREBP1) and suppresses lipogenesis in cancer cells	ONCOGENE			English	Article							TRANSCRIPTION FACTORS; KINASE INHIBITORS; MAMMALIAN TARGET; LIPID-METABOLISM; PHOSPHORYLATION; GROWTH; AKT; ACTIVATION; APOPTOSIS; PATHWAY	Cancer cells feature increased de novo lipogenesis. Sterol regulatory element-binding protein 1 (SREBP1), when presented in its mature form (mSREBP1), enhances lipogenesis by increasing transcription of several of its target genes. Mammalian target of rapamycin (mTOR) complexes, mTORC1 and mTORC2, are master regulators of cellular survival, growth and metabolism. A role for mTORC1 in the regulation of SREBP1 activity has been suggested; however, the connection between mTORC2 and SREBP1 has not been clearly established and hence is the focus of this study. mTOR kinase inhibitors (for example, INK128), which inhibit both mTORC1 and mTORC2, decreased mSREBP1 levels in various cancer cell lines. Knockdown of rictor, but not raptor, also decreased mSREBP1. Consistently, reduced mSREBP1 levels were detected in cells deficient in rictor or Sin1 compared with parent or rictor-deficient cells with re-expression of ectopic rictor. Hence it is mTORC2 inhibition that causes mSREBP1 reduction. As a result, expression of the mSREBP1 target genes acetyl-CoA carboxylase and fatty-acid synthase was suppressed, along with suppressed lipogenesis in cells exposed to INK128. Moreover, mSREBP1 stability was reduced in cells treated with INK128 or rictor knockdown. Inhibition of proteasome, GSK3 or the E3 ubiquitin ligase, FBXW7, prevented mSREBP1 reduction induced by mTORC2 inhibition. Thus mTORC2 inhibition clearly facilitates GSK3-dependent, FBXW7-mediated mSREBP1 degradation, leading to mSREBP1 reduction. Accordingly, we conclude that mTORC2 positively regulates mSREBP1 stability and lipogenesis. Our findings reveal a novel biological function of mTORC2 in the regulation of lipogenesis and warrant further study in this direction.	[Li, S.; Oh, Y-T; Yue, P.; Khuri, F. R.; Sun, S-Y] Emory Univ, Sch Med, Dept Hematol & Med Oncol, 1365-C Clifton Rd NE,C3088, Atlanta, GA 30322 USA; [Li, S.; Oh, Y-T; Yue, P.; Khuri, F. R.; Sun, S-Y] Winship Canc Inst, 1365-C Clifton Rd NE,C3088, Atlanta, GA 30322 USA; [Li, S.] Beijing Inst Basic Med Sci, Dept Biochem & Mol Biol, Beijing, Peoples R China	Emory University; Academy of Military Medical Sciences - China	Sun, SY (corresponding author), Emory Univ, Sch Med, Dept Hematol & Med Oncol, 1365-C Clifton Rd NE,C3088, Atlanta, GA 30322 USA.; Sun, SY (corresponding author), Winship Canc Inst, 1365-C Clifton Rd NE,C3088, Atlanta, GA 30322 USA.	ssun@emory.edu	Khuri, Fadlo R./AAU-4942-2020; Xia, Bo/P-9380-2016; LI, SHAOHUA/E-2733-2015	Khuri, Fadlo R./0000-0002-8638-7618; 	NIH/NCI [R01 CA118450, R01 CA160522]; Halpern Research Scholar award; NATIONAL CANCER INSTITUTE [R01CA160522, R01CA118450] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Halpern Research Scholar award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs B Vogelstein, MA Magnuson, B Su, DD Sarbassov and R Schweppes for providing us with some cell lines used in this work. We are also grateful to Dr A Hammond in our department for editing the manuscript. This study was supported by the NIH/NCI R01 CA118450 (SYS) and R01 CA160522 (SYS) and Halpern Research Scholar award (to SYS). FRK and SYS are Georgia Research Alliance Distinguished Cancer Scientists. SYS is a Halpern Research Scholar.	Agarwal NK, 2013, ONCOGENE, V32, P2521, DOI 10.1038/onc.2012.287; Alessi DR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe27; Bakan I, 2012, CURR OPIN LIPIDOL, V23, P226, DOI 10.1097/MOL.0b013e328352dd03; Bengoechea-Alonso MT, 2009, J BIOL CHEM, V284, P5885, DOI 10.1074/jbc.M807906200; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Espenshade PJ, 2006, J CELL SCI, V119, P973, DOI 10.1242/jcs02866; Griffiths B, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-3; Guo DL, 2011, CANCER DISCOV, V1, P442, DOI 10.1158/2159-8290.CD-11-0102; Guo DL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000446; Hagiwara A, 2012, CELL METAB, V15, P725, DOI 10.1016/j.cmet.2012.03.015; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Koo J, 2015, ONCOTARGET; Koo J, 2014, CANCER RES, V74, P2555, DOI 10.1158/0008-5472.CAN-13-2946; Laplante M, 2010, P NATL ACAD SCI USA, V107, P3281, DOI 10.1073/pnas.1000323107; Lewis CA, 2011, BIOCHEM SOC T, V39, P495, DOI 10.1042/BST0390495; Li WH, 2012, CELL CYCLE, V11, P2348, DOI 10.4161/cc.20811; Li XY, 2014, MOL CANCER THER, V13, P855, DOI 10.1158/1535-7163.MCT-13-0797; Liu W, 2011, BREAST CANCER RES TR, V128, P57, DOI 10.1007/s10549-010-1076-8; Ma KL, 2013, CARDIOVASC RES, V100, P450, DOI 10.1093/cvr/cvt203; MEDES G, 1953, CANCER RES, V13, P27; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Porstmann T, 2009, BIOCHEM SOC T, V37, P278, DOI 10.1042/BST0370278; Preuss E, 2013, J BIOL CHEM, V288, P35287, DOI 10.1074/jbc.M113.495986; Punga T, 2006, J BIOL CHEM, V281, P25278, DOI 10.1074/jbc.M604983200; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Santos CR, 2012, FEBS J, V279, P2610, DOI 10.1111/j.1742-4658.2012.08644.x; Shao W, 2012, CELL METAB, V16, P414, DOI 10.1016/j.cmet.2012.09.002; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Sun SY, 2013, CANCER LETT, V340, P1, DOI 10.1016/j.canlet.2013.06.017; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Wang HZ, 2006, REPRODUCTION, V132, P485, DOI 10.1530/rep.1.01213; Williams KJ, 2013, CANCER RES, V73, P2850, DOI 10.1158/0008-5472.CAN-13-0382-T; Yuan MS, 2012, J BIOL CHEM, V287, P29579, DOI 10.1074/jbc.M112.386854; Zhao LQ, 2013, CANCER RES, V73, P1946, DOI 10.1158/0008-5472.CAN-12-3710	36	39	42	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 4	2016	35	5					642	650		10.1038/onc.2015.123	http://dx.doi.org/10.1038/onc.2015.123			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DC9NR	25893295	Green Accepted			2022-12-26	WOS:000369548800011
J	Sengupta, S; Lingnurkar, R; Carey, TS; Pomaville, M; Kar, P; Feig, M; Wilson, CA; Knott, JG; Arnosti, DN; Henry, RW				Sengupta, Satyaki; Lingnurkar, Raj; Carey, Timothy S.; Pomaville, Monica; Kar, Parimal; Feig, Michael; Wilson, Catherine A.; Knott, Jason G.; Arnosti, David N.; Henry, R. William			The Evolutionarily Conserved C-terminal Domains in the Mammalian Retinoblastoma Tumor Suppressor Family Serve as Dual Regulators of Protein Stability and Transcriptional Potency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; CYCLIN-CDK COMPLEXES; RB FAMILY; KINASE-ACTIVITY; IN-VIVO; GENE; E2F; EXPRESSION; PRB; GROWTH	The retinoblastoma (RB) tumor suppressor and related family of proteins play critical roles in development through their regulation of genes involved in cell fate. Multiple regulatory pathways impact RB function, including the ubiquitin-proteasome system with deregulated RB destruction frequently associated with pathogenesis. With the current study we explored the mechanisms connecting proteasome-mediated turnover of the RB family to the regulation of repressor activity. We find that steady state levels of all RB family members, RB, p107, and p130, were diminished during embryonic stem cell differentiation concomitant with their target gene acquisition. Proteasome-dependent turnover of the RB family is mediated by distinct and autonomously acting instability elements (IE) located in their C-terminal regulatory domains in a process that is sensitive to cyclin-dependent kinase (CDK4) perturbation. The IE regions include motifs that contribute to E2F-DP transcription factor interaction, and consistently, p107 and p130 repressor potency was reduced by IE deletion. The juxtaposition of degron sequences and E2F interaction motifs appears to be a conserved feature across the RB family, suggesting the potential for repressor ubiquitination and specific target gene regulation. These findings establish a mechanistic link between regulation of RB family repressor potency and the ubiquitin-proteasome system.	[Sengupta, Satyaki; Lingnurkar, Raj; Carey, Timothy S.; Pomaville, Monica; Kar, Parimal; Feig, Michael; Knott, Jason G.; Arnosti, David N.; Henry, R. William] Michigan State Univ, Dept Biochem & Mol Biol, 603 Wilson Rd, E Lansing, MI 48824 USA; [Sengupta, Satyaki] Michigan State Univ, Grad Program Physiol, E Lansing, MI 48824 USA; [Wilson, Catherine A.; Knott, Jason G.] Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Arnosti, DN (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, 603 Wilson Rd, E Lansing, MI 48824 USA.	arnosti@msu.edu; henryrw@msu.edu	Sengupta, Satyaki/AAD-6065-2022; Feig, Michael/AAI-9540-2021; Regan, Clinton/E-6250-2012	Kar, Parimal/0000-0001-8451-9739	National Institutes of Health [R01GM095347, R01GM079098]; College of Natural Science at Michigan State University; Lyman Briggs College at Michigan State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095347, R01GM079098] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Natural Science at Michigan State University; Lyman Briggs College at Michigan State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM095347 (to J. G. K.) and R01GM079098 (to D. N. A. and R. W. H.).r Supported in part by fellowships from the College of Natural Science at Michigan State University.r Supported in part by an undergraduate research award from the Lyman Briggs College at Michigan State University.	Acharya P, 2012, G3-GENES GENOM GENET, V2, P1459, DOI 10.1534/g3.112.004424; Acharya P, 2010, MOL BIOL CELL, V21, P3890, DOI 10.1091/mbc.E10-06-0520; Ajioka I, 2007, CELL, V131, P378, DOI 10.1016/j.cell.2007.09.036; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BEIJERSBERGEN RL, 1995, GENE DEV, V9, P1340, DOI 10.1101/gad.9.11.1340; Bhattacharya S, 2003, ONCOGENE, V22, P2443, DOI 10.1038/sj.onc.1206339; Black EP, 2003, CANCER RES, V63, P3716; BUCHKOVICH K, 1989, CELL, V58, P1097, DOI 10.1016/0092-8674(89)90508-4; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; Cecchini MJ, 2011, BIOCHEM J, V434, P297, DOI 10.1042/BJ20101210; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; Chestukhin A, 2002, MOL CELL BIOL, V22, P453, DOI 10.1128/MCB.22.2.453-468.2002; Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; Claudio PP, 2000, CANCER RES, V60, P372; Conklin JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2254; DECAPRIO JA, 1989, CELL, V58, P1085, DOI 10.1016/0092-8674(89)90507-2; Dick FA, 2013, NAT REV MOL CELL BIO, V14, P297, DOI 10.1038/nrm3567; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Elenbaas JS, 2015, CELL CYCLE, V14, P589, DOI 10.4161/15384101.2014.991182; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Hilgendorf KI, 2013, GENE DEV, V27, P1003, DOI 10.1101/gad.211326.112; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; Hirsch HA, 2004, MOL CELL BIOL, V24, P5989, DOI 10.1128/MCB.24.13.5989-5999.2004; Hurford RK, 1997, GENE DEV, V11, P1447, DOI 10.1101/gad.11.11.1447; Ianari A, 2009, CANCER CELL, V15, P184, DOI 10.1016/j.ccr.2009.01.026; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Ji P, 2004, MOL CELL, V16, P47, DOI 10.1016/j.molcel.2004.09.029; Julian LM, 2008, ONCOGENE, V27, P1572, DOI 10.1038/sj.onc.1210803; Kim Y, 2009, J BIOL CHEM, V284, P23405, DOI 10.1074/jbc.M109.026088; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; MacPherson D, 2007, EMBO J, V26, P784, DOI 10.1038/sj.emboj.7601515; McConnell BB, 1999, MOL CELL BIOL, V19, P1981; Narasimha AM, 2014, ELIFE, V3, DOI 10.7554/eLife.02872; Philips A, 1998, ONCOGENE, V16, P1373, DOI 10.1038/sj.onc.1201655; Raj N, 2012, J BIOL CHEM, V287, P41835, DOI 10.1074/jbc.M112.422428; Raj N, 2012, CELL CYCLE, V11, P3731, DOI 10.4161/cc.21665; Rivadeneira DB, 2010, GASTROENTEROLOGY, V138, P1920, DOI 10.1053/j.gastro.2010.01.007; Rubin SM, 2005, CELL, V123, P1093, DOI 10.1016/j.cell.2005.09.044; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Sage J, 2012, GENE DEV, V26, P1409, DOI 10.1101/gad.193730.112; Salghetti SE, 2000, P NATL ACAD SCI USA, V97, P3118, DOI 10.1073/pnas.050007597; SAVATIER P, 1994, ONCOGENE, V9, P809; Schaffer BE, 2010, CANCER RES, V70, P3877, DOI 10.1158/0008-5472.CAN-09-4228; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Sdek P, 2004, J BIOL CHEM, V279, P53317, DOI 10.1074/jbc.M406062200; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Stengel KR, 2009, J BIOL CHEM, V284, P19265, DOI 10.1074/jbc.M808740200; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Takahashi Y, 2000, GENE DEV, V14, P804; Tedesco D, 2002, GENE DEV, V16, P2946, DOI 10.1101/gad.1011202; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Uchida CH, 2005, EMBO J, V24, P160, DOI 10.1038/sj.emboj.7600486; Ullah Z, 2007, MOL BIOL CELL, V18, P1179, DOI 10.1091/mbc.E06-09-0790; Wang K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010622; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; White J, 2005, MOL BIOL CELL, V16, P2018, DOI 10.1091/mbc.e04-12-1056; White J, 2005, STEM CELL REV, V1, P131, DOI 10.1385/SCR:1:2:131; Wirbelauer C, 2000, EMBO J, V19, P5362, DOI 10.1093/emboj/19.20.5362; Wirt SE, 2010, J CELL BIOL, V191, P809, DOI 10.1083/jcb.201003048; ZHANG H, 1995, CELL, V82, P915, DOI 10.1016/0092-8674(95)90271-6; Zhang L, 2014, J BIOL CHEM, V289, P24863, DOI 10.1074/jbc.M114.586818; ZHU L, 1995, EMBO J, V14, P1904, DOI 10.1002/j.1460-2075.1995.tb07182.x	67	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14462	14475		10.1074/jbc.M114.599993	http://dx.doi.org/10.1074/jbc.M114.599993			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25903125	hybrid, Green Published			2022-12-26	WOS:000355754600017
J	Casey, CS; Atagi, Y; Yamazaki, Y; Shinohara, M; Tachibana, M; Fu, Y; Bu, GJ; Kanekiyo, T				Casey, Caroline S.; Atagi, Yuka; Yamazaki, Yu; Shinohara, Mitsuru; Tachibana, Masaya; Fu, Yuan; Bu, Guojun; Kanekiyo, Takahisa			Apolipoprotein E Inhibits Cerebrovascular Pericyte Mobility through a RhoA Protein-mediated Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN-1; ALZHEIMERS-DISEASE; CELL MIGRATION; APOE; EXPRESSION; BETA; LIPOPROTEINS; ASTROCYTES; TISSUE; CLEARANCE	Pericytes play a critical role in the cerebrovasculature within the CNS. These small contractile cells produce large quantities of apolipoprotein E (apoE) whose isoforms influence cerebrovascular functions and determine the genetic risk for Alzheimer disease. Despite extensive studies on astrocyte-secreted apoE, which supports synapses by transporting cholesterol to neurons, the biochemical properties and function of apoE secreted by pericytes are not clear. Because pericytes mediate important functions in the CNS, including the initiation of glial scar formation, angiogenesis, and maintenance of the blood-brain barrier, we investigated the potential role of apoE in pericyte mobility. We found that knockdown of apoE expression significantly accelerates pericyte migration, an effect that can be rescued by exogenous apoE3, but not apoE4, a risk factor for Alzheimer disease. ApoE-regulated migration of pericytes also requires the function of the low-density lipoprotein receptor-related protein 1 (LRP1), a major apoE receptor in the brain that is abundantly expressed in pericytes. Because apoE-knockdown also leads to enhanced cell adhesion, we investigated the role of apoE in the regulation of the actin cytoskeleton. Interestingly, we found that the levels of active RhoA are increased significantly in apoE knockdown pericytes and that RhoA inhibitors blocked pericyte migration. Taken together, our results suggest that apoE has an intrinsic role in pericyte mobility, which is vital in maintaining cerebrovascular function. These findings provide novel insights into the role of apoE in the cerebrovascular system.	[Casey, Caroline S.; Atagi, Yuka; Yamazaki, Yu; Shinohara, Mitsuru; Tachibana, Masaya; Fu, Yuan; Bu, Guojun; Kanekiyo, Takahisa] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA	Mayo Clinic	Bu, GJ (corresponding author), Mayo Clin, Dept Neurosci, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	bu.guojun@mayo.edu; kanekiyo.takahisa@mayo.edu	Tachibana, Masaya/AAW-3526-2020; Regan, Clinton/E-6250-2012; Fu, Yuan/AAO-6040-2020	Tachibana, Masaya/0000-0002-6761-7158; Fu, Yuan/0000-0003-2293-814X; Yamazaki, Yu/0000-0002-0806-4960	National Institutes of Health [P50AG016574, R01AG027924, R01AG035355, R01AG046205, P01 NS074969]; Alzheimer's Association; Cure Alzheimer's Fund; Alex Lemonade Stand Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS074969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG046205, P50AG016574, P01AG030128, R01AG046205, R01AG035355, R01AG027924] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Cure Alzheimer's Fund; Alex Lemonade Stand Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants P50AG016574, R01AG027924, R01AG035355, R01AG046205, and P01 NS074969 (to G. B.). This work was also supported by a grant from the Alzheimer's Association and a grant from the Cure Alzheimer's Fund (to G. B.) and a Young Investigator Grant from the Alex Lemonade Stand Foundation (to T. K.).	Bales KR, 2009, J NEUROSCI, V29, P6771, DOI 10.1523/JNEUROSCI.0887-09.2009; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Bu GJ, 2000, TRENDS CARDIOVAS MED, V10, P148, DOI 10.1016/S1050-1738(00)00045-1; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Castoreno AB, 2010, NAT CHEM BIOL, V6, P457, DOI 10.1038/nchembio.363; de la Torre JC, 2002, STROKE, V33, P1152, DOI 10.1161/01.STR.0000014421.15948.67; Dore-Duffy P, 2000, MICROVASC RES, V60, P55, DOI 10.1006/mvre.2000.2244; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fagan AM, 1999, J BIOL CHEM, V274, P30001, DOI 10.1074/jbc.274.42.30001; Fagan AM, 2000, ANN NEUROL, V48, P201, DOI 10.1002/1531-8249(200008)48:2<201::AID-ANA10>3.0.CO;2-X; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fernandez-Lopez D, 2012, J NEUROSCI, V32, P9588, DOI 10.1523/JNEUROSCI.5977-11.2012; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; HUI DY, 1980, J BIOL CHEM, V255, P1775; Iadecola C, 2013, NEURON, V80, P844, DOI 10.1016/j.neuron.2013.10.008; Ishigami M, 1998, J BIOL CHEM, V273, P20156, DOI 10.1074/jbc.273.32.20156; Jha A, 2008, J SPINAL CORD MED, V31, P171, DOI 10.1080/10790268.2008.11760708; Kanekiyo T, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00093; Kanekiyo T, 2014, NEURON, V81, P740, DOI 10.1016/j.neuron.2014.01.045; Kovac A, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-139; KRUL ES, 1988, J LIPID RES, V29, P1309; Li YH, 2003, FEBS LETT, V555, P346, DOI 10.1016/S0014-5793(03)01272-9; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Morikawa M, 2005, NEUROBIOL DIS, V19, P66, DOI 10.1016/j.nbd.2004.11.005; Nishitsuji K, 2011, J BIOL CHEM, V286, P17536, DOI 10.1074/jbc.M111.225532; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Pencheva N, 2012, CELL, V151, P1068, DOI 10.1016/j.cell.2012.10.028; Reiman EM, 2009, P NATL ACAD SCI USA, V106, P6820, DOI 10.1073/pnas.0900345106; Ridley AJ, 2001, J CELL SCI, V114, P2713; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; Seitz A, 2003, J NEUROSCI RES, V71, P417, DOI 10.1002/jnr.10482; Senger DR, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005090; Shinohara M, 2013, ACTA NEUROPATHOL, V125, P535, DOI 10.1007/s00401-013-1086-9; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Song H, 2009, CANCER RES, V69, P879, DOI 10.1158/0008-5472.CAN-08-3379; Stratman AN, 2009, BLOOD, V114, P5091, DOI 10.1182/blood-2009-05-222364; Swertfeger DK, 2002, J BIOL CHEM, V277, P4141, DOI 10.1074/jbc.M109124200; WARSHAWSKY I, 1993, J CLIN INVEST, V92, P937, DOI 10.1172/JCI116669; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wilhelmus MMM, 2005, J NEUROSCI, V25, P3621, DOI 10.1523/JNEUROSCI.4213-04.2005; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Xu Q, 2006, J NEUROSCI, V26, P4985, DOI 10.1523/JNEUROSCI.5476-05.2006; Zhao J, 2014, J BIOL CHEM, V289, P11282, DOI 10.1074/jbc.M113.526095; Zlokovic BV, 2013, JAMA NEUROL, V70, P440, DOI 10.1001/jamaneurol.2013.2152; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	51	39	40	1	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					14208	14217		10.1074/jbc.M114.625251	http://dx.doi.org/10.1074/jbc.M114.625251			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25903128	Green Published, hybrid			2022-12-26	WOS:000355313000047
J	He, J; Lu, YQ; Xia, H; Liang, YJ; Wang, X; Bao, WDN; Yun, SF; Ye, YT; Zheng, CX; Liu, ZH; Shi, SL				He, Jing; Lu, Yuqiu; Xia, Hong; Liang, Yaojun; Wang, Xiao; Bao, Wenduona; Yun, Shifeng; Ye, Yuting; Zheng, Chunxia; Liu, Zhihong; Shi, Shaolin			Circulating Mitochondrial DAMPs Are Not Effective Inducers of Proteinuria and Kidney Injury in Rodents	PLOS ONE			English	Article							INFLAMMATORY RESPONSES; TRANSCRIPTION FACTOR; CELL ACTIVATION; NECROTIC CELLS; DNA LEVELS; IN-VIVO; TRAUMA; PODOCYTE; DISEASE; GLOMERULOSCLEROSIS	Mitochondria in eukaryotic cells are derived from bacteria in evolution. Like bacteria, mitochondria contain DNA with unmethylated CpG motifs and formyl peptides, both of which have recently been shown to be damage associated molecular patterns (DAMPs) and induce immune response and cell injury. Based on the facts that circulating mitochondrial DAMPs (mtDAMPs) are increased in the patients of trauma or burn injury who also have proteinuria, that mtDAMPs can activate immune cells which in turn secrete glomerular permeability factors, that renal intrinsic cells express a variety of DAMP receptors, and that mtDAMPs can directly increase endothelial cell permeability in vitro, we hypothesized that mtDAMPs may be novel circulating factors inducing proteinuria and kidney injury. We tested this hypothesis by directly injecting mtDAMPs into rodents and examining urinary protein and kidney histology. We prepared mtDAMP samples, including mitochondrial DNA (mtDNA) and mitochondrial debris (MTD), from rodent liver. In mice, injection of mtDNA for 20 mu g/ml initial concentration in circulation (much higher than the clinical range), did not cause any renal manifestations. However, an increased dose leading to 45 mu g/ml initial concentration in circulation resulted in a transient, slight increase in urinary albumin. In rats, MTD injection resulting in 450 mu g/ml initial concentration of MTD protein in circulation, which was much higher than the clinical range, caused mild, transient proteinuria and lung lesions. Multiple injections of such large amount of either mtDNA or MTD into rodents on 3 consecutive days also failed in inducing proteinuria and kidney injury. In summary, clinical levels of circulating mtDAMPs do not induce proteinuria and clinically irrelevant high levels of mtDAMPs cause only a transient and slight increase in urinary protein in rodents, suggesting that circulating mtDAMPs may not be responsible for the proteinuria and kidney injury in patients with trauma, burn injury, and other diseases.	[He, Jing; Lu, Yuqiu; Xia, Hong; Liang, Yaojun; Wang, Xiao; Bao, Wenduona; Ye, Yuting; Zheng, Chunxia; Liu, Zhihong; Shi, Shaolin] Nanjing Univ, Sch Med, Jinling Hosp, Natl Clin Res Ctr Kidney Dis, Nanjing 210008, Jiangsu, Peoples R China; [Yun, Shifeng] Nanjing Univ, Sch Med, Jinling Hosp, Dept Comparat Med, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Liu, ZH (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Natl Clin Res Ctr Kidney Dis, Nanjing 210008, Jiangsu, Peoples R China.	liuzhihong@nju.edu.cn; shaolinshi1001@yahoo.com		Shi, Shaolin/0000-0003-2297-6496; Liu, Zhi-Hong/0000-0001-6093-0726	National Natural Science Foundation of China [81370827, 30900686, 81100508]; National Basic Research Program of China 973 Program [2012CB517600/2012CB517606]; Natural Science Foundation of Jiangsu Province [BK20131324]; Jiangsu Innovation Talent Program [2011-32]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China 973 Program(National Basic Research Program of China); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Jiangsu Innovation Talent Program	This work was supported by the grants funded by National Natural Science Foundation of China - No. 81370827 (http://www.nsfc.gov.cn/) to SS, National Basic Research Program of China 973 Program - No. 2012CB517600/2012CB517606 (www.most.gov.cn) to ZL and SS, Natural Science Foundation of Jiangsu Province - BK20131324 (www.jstd.gov.cn) to SS, Jiangsu Innovation Talent Program - No. 2011-32) (http://www.jsrcgz.gov.cn/) to SS, National Natural Science Foundation of China - No. 30900686 (http://www.nsfc.gov.cn/) to CZ (Chunxia Zheng), and National Natural Science Foundation of China - No. 81100508 (http://www.nsfc.gov.cn/) to YL (Yaojun Liang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders HJ, 2007, KIDNEY INT, V72, P1051, DOI 10.1038/sj.ki.5002436; Anders HJ, 2011, J AM SOC NEPHROL, V22, P1007, DOI 10.1681/ASN.2010080798; Axelsson J, 2009, AM J PHYSIOL-RENAL, V297, pF577, DOI 10.1152/ajprenal.00246.2009; BORST P, 1967, BIOCHIM BIOPHYS ACTA, V149, P140, DOI 10.1016/0005-2787(67)90697-1; CARDON LR, 1994, P NATL ACAD SCI USA, V91, P3799, DOI 10.1073/pnas.91.9.3799; Chaung WW, 2012, INT J MOL MED, V30, P199, DOI 10.3892/ijmm.2012.959; Chou CC, 2008, DIGEST SURG, V25, P300, DOI 10.1159/000152846; Collins LV, 2004, J LEUKOCYTE BIOL, V75, P995, DOI 10.1189/jlb.0703328; Crouser ED, 2009, CRIT CARE MED, V37, P2000, DOI 10.1097/CCM.0b013e3181a001ae; De Gaudio AR, 1999, CRIT CARE MED, V27, P2105, DOI 10.1097/00003246-199910000-00004; Futrakul N, 2009, RENAL FAILURE, V31, P140, DOI 10.1080/08860220802595948; Goncalves GM, 2010, SHOCK, V34, P22, DOI 10.1097/SHK.0b013e3181e7e69e; GOSLING P, 1986, ANN CLIN BIOCHEM, V23, P681, DOI 10.1177/000456328602300610; Goulopoulou S, 2012, CLIN SCI, V123, P429, DOI 10.1042/CS20120130; Gu XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072834; Guo JC, 2008, J AM SOC NEPHROL, V19, P961, DOI 10.1681/ASN.2007101109; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Lam NYL, 2004, CLIN CHEM, V50, P213, DOI 10.1373/clinchem.2003.025783; Lang A, 2005, J AM SOC NEPHROL, V16, P383, DOI 10.1681/ASN.2004040276; Little JP, 2014, MOL CELL NEUROSCI, V60, P88, DOI 10.1016/j.mcn.2014.04.003; Mathieson PW, 2003, CLIN EXP IMMUNOL, V134, P1, DOI 10.1046/j.1365-2249.2003.02236.x; Miranda ML, 2013, AM J HYPERTENS, V26, P1377, DOI 10.1093/ajh/hpt187; Nagata T, 2010, ANAL BIOCHEM, V398, P178, DOI 10.1016/j.ab.2009.11.017; Navarro-Gonzalez JF, 2008, J AM SOC NEPHROL, V19, P433, DOI 10.1681/ASN.2007091048; Reiser J, 2004, J CLIN INVEST, V113, P1390, DOI 10.1172/JCI200420402; Ries M, 2013, J LEUKOCYTE BIOL, V94, P123, DOI 10.1189/jlb.0612278; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Schaefer L, 2010, CURR OPIN PHARMACOL, V10, P185, DOI 10.1016/j.coph.2009.11.007; Schlondorff DO, 2008, KIDNEY INT, V74, P860, DOI 10.1038/ki.2008.351; SHAKESPEARE PG, 1981, ANN CLIN BIOCHEM, V18, P353, DOI 10.1177/000456328101800606; Shi SL, 2008, J AM SOC NEPHROL, V19, P2159, DOI 10.1681/ASN.2008030312; Shi SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075572; Shimada M, 2009, NEPHROL DIAL TRANSPL, V24, P2960, DOI 10.1093/ndt/gfp330; Shock LS, 2011, P NATL ACAD SCI USA, V108, P3630, DOI 10.1073/pnas.1012311108; Simmons JD, 2013, ANN SURG, V258, P591, DOI 10.1097/SLA.0b013e3182a4ea46; Sun SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059989; TAMURA K, 1988, BIOCHEM GENET, V26, P815, DOI 10.1007/BF02395525; Wu HL, 2010, J AM SOC NEPHROL, V21, P1878, DOI 10.1681/ASN.2009101048; Yamanouchi S, 2013, J CRIT CARE, V28, P1027, DOI 10.1016/j.jcrc.2013.05.006; Zhang Q, 2010, SHOCK, V34, P55, DOI 10.1097/SHK.0b013e3181cd8c08; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	42	17	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124469	10.1371/journal.pone.0124469	http://dx.doi.org/10.1371/journal.pone.0124469			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902071	Green Published, Green Submitted, gold			2022-12-26	WOS:000353331500089
J	Hu, GH; Chen, B; Fu, WG; Xu, X; Guo, DQ; Jiang, JH; Yang, J; Wang, YQ				Hu, Guohua; Chen, Bin; Fu, Weiguo; Xu, Xin; Guo, Daqiao; Jiang, Junhao; Yang, Jue; Wang, Yuqi			Predictors and Treatments of Proglide-Related Complications in Percutaneous Endovascular Aortic Repair	PLOS ONE			English	Article							ANEURYSM REPAIR; PRECLOSE TECHNIQUE; CLOSURE DEVICES; ACCESS; OUTCOMES; IMPLANTATION; METAANALYSIS; MULTICENTER; EXPERIENCE; SUCCESS	Purpose To investigate the predictors and treatment of the 6-Fr Perclose Proglide-related complications ( PRC) in percutaneous endovascular aortic repair (pEVAR). Methods We retrospectively analyzed the PRC after pEVAR for the treatment of aortic aneurysm or dissection in our center from December 2012 to November 2013. Procedure success was defined as effective functioning of the two devices and local hemostasis. Access-related adverse events included vascular complications and device failures. Operative data and angiographic and computed tomography images were collected to assess the complications and treatment strategy. Results A total of 198 patients with 275 puncture sites underwent pEVAR with the 6-Fr Perclose Proglide. The procedure was successful in 178 patients (89.9%), whereas PRC occurred in 20 cases (10.1%), including 10 device failures and 10 vascular complications. An extra manual ancillary compression was conducted in 7 patients, one more device was used in 8 patients, and surgical repair of the femoral artery was performed in 5 patients. PRC had a tendency to occur in patients with body mass index (BMI)>30 kg/m(2) (p = 0.021), thoracic stent grafts (p = 0.038), common femoral artery (CFA) calcification (p = 0.001), CFA depth>4 cm(p = 0.001), and sheath size>20Fr (p = 0.005). Device failure-related mortality was zero. None of the access sites had complications during the midterm follow-up. Conclusions The pre-close technique with 6-Fr Perclose Proglide devices for pEVAR appears to be safe and effective with low technical failure and complication rates. Careful patient selection and proficiency in device manipulation might reduce the device related complications.	[Hu, Guohua; Chen, Bin; Fu, Weiguo; Xu, Xin; Guo, Daqiao; Jiang, Junhao; Yang, Jue; Wang, Yuqi] Fudan Univ, Zhongshan Hosp, Dept Vasc Surg, Shanghai 200433, Peoples R China	Fudan University	Fu, WG (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Vasc Surg, Shanghai 200433, Peoples R China.	fu.weiguo@zs-hospital.sh.cn						Al-Khatib WK, 2012, ANN VASC SURG, V26, P476, DOI 10.1016/j.avsg.2011.11.026; [Anonymous], 2007, VASC ENDOVASC SURG; Applegate RJ, 2012, JACC-CARDIOVASC INTE, V5, P845, DOI 10.1016/j.jcin.2012.06.006; Bechara CF, 2013, J VASC SURG, V57, P72, DOI 10.1016/j.jvs.2012.07.050; Bensley RP, 2012, J VASC SURG, V55, P1554, DOI 10.1016/j.jvs.2011.12.042; Dosluogiu HH, 2007, J ENDOVASC THER, V14, P184, DOI 10.1583/1545-1550(2007)14[184:TPEROA]2.0.CO;2; Dosluoglu HH, 2014, J VASC SURG, V59, P58, DOI 10.1016/j.jvs.2013.06.076; Eisenack M, 2009, J ENDOVASC THER, V16, P708, DOI 10.1583/08-2622.1; Georgiadis GS, 2011, J ENDOVASC THER, V18, P445, DOI 10.1583/11-342.1; Grenon SM, 2009, CAN J SURG, V52, pE156; Griese DP, 2013, CATHETER CARDIO INTE, V82, pE734, DOI 10.1002/ccd.25053; Haas PC, 1999, J ENDOVASC SURG, V6, P168, DOI 10.1583/1074-6218(1999)006<0168:COLPAS>2.0.CO;2; Harkin DW, 2007, EUR J VASC ENDOVASC, V34, P673, DOI 10.1016/j.ejvs.2007.06.004; Howell M, 2001, J ENDOVASC THER, V8, P68, DOI 10.1583/1545-1550(2001)008<0068:PAACOF>2.0.CO;2; Jabori S, 2013, ANN VASC SURG, V27, P1049, DOI 10.1016/j.avsg.2013.04.008; Jean-Baptiste E, 2008, EUR J VASC ENDOVASC, V35, P422, DOI 10.1016/j.ejvs.2007.10.021; Jonker FHW, 2010, J VASC SURG, V51, P1026, DOI 10.1016/j.jvs.2009.10.103; Kahlert P, 2008, CATHETER CARDIO INTE, V72, P877, DOI 10.1002/ccd.21711; Kim WH, 2013, J ENDOVASC THER, V20, P350, DOI 10.1583/12-4103MR2.1; Krajcer Z, 2011, J CARDIOVASC SURG, V52, P651; Krajcer Z, 2010, J CARDIOVASC SURG, V51, P493; Lee WA, 2008, J VASC SURG, V47, P919, DOI 10.1016/j.jvs.2007.12.029; Lee WA, 2007, J VASC SURG, V45, P1095, DOI 10.1016/j.jvs.2007.01.050; Malkawi AH, 2010, EUR J VASC ENDOVASC, V39, P676, DOI 10.1016/j.ejvs.2010.02.001; Manunga JM, 2013, J VASC SURG, V58, P1208, DOI 10.1016/j.jvs.2013.05.028; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Morasch MD, 2004, J VASC SURG, V40, P12, DOI 10.1016/j.jvs.2004.03.019; Nelson PR, 2014, J VASC SURG, V59, P1181, DOI 10.1016/j.jvs.2013.10.101; Ni ZH, 2011, CHINESE MED J-PEKING, V124, P851, DOI 10.3760/cma.j.issn.0366-6999.2011.06.009; Smith ST, 2009, ANN VASC SURG, V23, P621, DOI 10.1016/j.avsg.2008.09.002; Starnes BW, 2006, J VASC SURG, V43, P270, DOI 10.1016/j.jvs.2005.11.004; Steuer J, 2011, EUR J VASC ENDOVASC, V41, P318, DOI 10.1016/j.ejvs.2010.11.024; Wei Ren, 2012, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V26, P968; Ye Peng, 2014, Nan Fang Yi Ke Da Xue Xue Bao, V34, P747; Zakko J, 2014, J VASC SURG, V60, P921, DOI 10.1016/j.jvs.2014.04.051; Zhang Hong-peng, 2010, Zhonghua Wai Ke Za Zhi, V48, P1855	36	42	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123739	10.1371/journal.pone.0123739	http://dx.doi.org/10.1371/journal.pone.0123739			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901610	Green Published, Green Submitted, gold			2022-12-26	WOS:000353331500061
J	Nakagawa, F; Miners, A; Smith, CJ; Simmons, R; Lodwick, RK; Cambiano, V; Lundgren, JD; Delpech, V; Phillips, AN				Nakagawa, Fumiyo; Miners, Alec; Smith, Colette J.; Simmons, Ruth; Lodwick, Rebecca K.; Cambiano, Valentina; Lundgren, Jens D.; Delpech, Valerie; Phillips, Andrew N.			Projected Lifetime Healthcare Costs Associated with HIV Infection	PLOS ONE			English	Article							ANTIRETROVIRAL TREATMENT; UK; MORTALITY; THERAPY; FAILURE; SUCCESS; PEOPLE; TRENDS; TIME	Objective Estimates of healthcare costs associated with HIV infection would provide valuable insight for evaluating the cost-effectiveness of possible prevention interventions. We evaluate the additional lifetime healthcare cost incurred due to living with HIV. Methods We used a stochastic computer simulation model to project the distribution of lifetime outcomes and costs of men-who-have-sex-with-men (MSM) infected with HIV in 2013 aged 30, over 10,000 simulations. We assumed a resource-rich setting with no loss to follow-up, and that standards and costs of healthcare management remain as now. Results Based on a median (interquartile range) life expectancy of 71.5 (45.0-81.5) years for MSM in such a setting, the estimated mean lifetime cost of treating one person was (sic)360,800 ($567,000 or (sic)480,000). With 3.5% discounting, it was (sic)185,200 ($291,000 or (sic)246,000). The largest proportion (68%) of these costs was attributed to antiretroviral drugs. If patented drugs are replaced by generic versions (at 20% cost of patented prices), estimated mean lifetime costs reduced to (sic)179,000 ($281,000 or (sic)238,000) and (sic)101,200 ($158,900 or (sic)134,600) discounted. Conclusions If 3,000 MSM had been infected in 2013, then future lifetime costs relating to HIV care is likely to be in excess of (sic)1 billion. It is imperative for investment into prevention programmes to be continued or scaled-up in settings with good access to HIV care services. Costs would be reduced considerably with use of generic antiretroviral drugs.	[Nakagawa, Fumiyo; Smith, Colette J.; Cambiano, Valentina; Phillips, Andrew N.] UCL, Res Dept Infect & Populat Hlth, London, England; [Miners, Alec] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1, England; [Simmons, Ruth; Delpech, Valerie] Publ Hlth England, HIV & STI Dept, London, England; [Lodwick, Rebecca K.] UCL, Res Dept Primary Care & Populat Hlth, London, England; [Lundgren, Jens D.] Univ Copenhagen, Rigshosp, Copenhagen HIV Programme CHIP, Dept Infect Dis 8632, DK-2100 Copenhagen, Denmark	University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; Public Health England; University of London; University College London; Rigshospitalet; University of Copenhagen	Nakagawa, F (corresponding author), UCL, Res Dept Infect & Populat Hlth, London, England.	f.nakagawa@ucl.ac.uk	Phillips, Andrew N/B-4427-2008; Lodwick, Rebecca/B-7578-2015; Lundgren, Jens/AAE-6876-2019	Phillips, Andrew N/0000-0003-2384-4807; Lodwick, Rebecca/0000-0003-2558-4762; Lundgren, Jens/0000-0001-8901-7850; Smith, Colette/0000-0003-2847-3355; delpech, valerie/0000-0002-9952-8109; Nakagawa, Fumiyo/0000-0002-6646-8744				Arribas JR, 2012, HIV MED, V13, P398, DOI 10.1111/j.1468-1293.2012.00989.x; Bansi L, 2010, HIV MED, V11, P432, DOI 10.1111/j.1468-1293.2009.00809.x; Beck EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027830; Daskalopoulou M, 2014, LANCET HIV, V1, pE22, DOI 10.1016/S2352-3018(14)70001-3; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Department of Health, 15869 DEP HLTH; Gazzard B, 2012, CLINICOECONOMIC OUTC, V4, P193, DOI 10.2147/CEOR.S12496; Hagger-Johnson G, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002810; Harding R, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-43; Health Protection Agency, 2012, HIV UK 2012 REP; Kanavos P, 2007, CURR MED RES OPIN, V23, P105, DOI 10.1185/030079907X159506; Katlama C, 2010, AIDS, V24, P2365, DOI 10.1097/QAD.0b013e32833dec20; KULLER LH, 1991, PREV MED, V20, P638, DOI 10.1016/0091-7435(91)90060-H; Lampe FC, 2006, ARCH INTERN MED, V166, P521, DOI 10.1001/archinte.166.5.521; Lampe FC, 2007, ARCH INTERN MED, V167, P692, DOI 10.1001/archinte.167.7.692; May M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6016; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Nakagawa F, 2012, AIDS, V26, P335, DOI 10.1097/QAD.0b013e32834dcec9; O'Connor J, 2014, J INT AIDS SOC, V17, P25, DOI 10.7448/IAS.17.4.19527; Office for National Statistics, 2011, DEATHS REG ENGL W DR; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Phillips AN, 2007, HIV MED, V8, P536, DOI 10.1111/j.1468-1293.2007.00507.x; Phillips AN, 2008, AIDS, V22, P2409, DOI 10.1097/QAD.0b013e3283174636; Rao G, 2013, 53 INT C ANT AG CHEM; Sax PE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031591; Schackman BR, 2006, MED CARE, V44, P990, DOI 10.1097/01.mlr.0000228021.89490.2a; Sloan CE, 2012, AIDS, V26, P45, DOI 10.1097/QAD.0b013e32834dce6e; Turner J, 2010, J VIRAL HEPATITIS, V17, P569, DOI 10.1111/j.1365-2893.2009.01215.x; Walensky RP, 2013, ANN INTERN MED, V158, P84, DOI 10.7326/0003-4819-158-2-201301150-00002; Yazdanpanah Y, 2002, ANTIVIR THER, V7, P257; Yin Z, 2014, HIV UK 2014 REPORT D	32	37	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0125018	10.1371/journal.pone.0125018	http://dx.doi.org/10.1371/journal.pone.0125018			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901355	Green Accepted, Green Published, gold			2022-12-26	WOS:000353331500108
J	Swift, BJF; Baneyx, F				Swift, Brian J. F.; Baneyx, Franois			Microbial Uptake, Toxicity, and Fate of Biofabricated ZnS:Mn Nanocrystals	PLOS ONE			English	Article							SEMICONDUCTOR QUANTUM DOTS; ESCHERICHIA-COLI; MEMBRANE; CDSE; CYTOTOXICITY; PROTEINS; CDTE	Despite their importance in nano-environmental health and safety, interactions between engineered nanomaterials and microbial life remain poorly characterized. Here, we used the model organism E. coli to study the penetration requirements, subcellular localization, induction of stress responses, and long-term fate of luminescent Mn-doped ZnS nanocrystals fabricated under "green" processing conditions with a minimized ZnS-binding protein. We find that such protein-coated quantum dots (QDs) are unable to penetrate the envelope of unmodified E. coli but readily translocate to the cytoplasm of cells that have been made competent by chemical treatment. The process is dose-dependent and reminiscent of bacterial transformation. Cells that have internalized up to 0.5 mu g/mL of nanocrystals do not experience a significant activation of the unfolded protein or SOS responses but undergo oxidative stress when exposed to high QD doses (2.5 mu g/mL). Finally, although they are stable in quiescent cells over temperatures ranging from 4 to 42 degrees C, internalized QDs are rapidly diluted by cell division in a process that does not involve TolC-dependent efflux. Taken together, our results suggest that biomimetic QDs based on low toxicity inorganic cores capped by a protein shell are unlikely to cause significant damage to the microbial ecosystem.	[Swift, Brian J. F.; Baneyx, Franois] Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Baneyx, F (corresponding author), Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.	baneyx@uw.edu			National Insitute of Environmental Health Sciences [1U19ES019545-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U19ES019545] Funding Source: NIH RePORTER	National Insitute of Environmental Health Sciences; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Insitute of Environmental Health Sciences 1U19ES019545-01 (subcontract to FB - PI Kavanagh) (http://www.niehs.nih.gov/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anas A, 2008, J PHYS CHEM B, V112, P10005, DOI 10.1021/jp8018606; BAYER ME, 1968, J GEN MICROBIOL, V53, P395, DOI 10.1099/00221287-53-3-395; Bianchi AA, 1999, APPL ENVIRON MICROB, V65, P5023; Biju V, 2008, ANAL BIOANAL CHEM, V391, P2469, DOI 10.1007/s00216-008-2185-7; Bottrill M, 2011, CHEM COMMUN, V47, P7039, DOI 10.1039/c1cc10692a; Derfus AM, 2004, NANO LETT, V4, P11, DOI 10.1021/nl0347334; Dumas EM, 2009, IEEE T NANOBIOSCI, V8, P58, DOI 10.1109/TNB.2009.2017313; Dwarakanath S, 2007, FOLIA MICROBIOL, V52, P31, DOI 10.1007/BF02932134; Frigerio C, 2012, ANAL CHIM ACTA, V735, P9, DOI 10.1016/j.aca.2012.04.042; Gomes SAO, 2011, SENSORS-BASEL, V11, P11664, DOI 10.3390/s111211664; He Y, 2008, ANAL CHEM, V80, P3832, DOI 10.1021/ac800100y; Hoshino A, 2011, ARCH TOXICOL, V85, P707, DOI 10.1007/s00204-011-0695-0; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jamieson T, 2007, BIOMATERIALS, V28, P4717, DOI 10.1016/j.biomaterials.2007.07.014; Kloepfer JA, 2005, APPL ENVIRON MICROB, V71, P2548, DOI 10.1128/AEM.71.5.2548-2557.2005; Kloepfer JA, 2003, APPL ENVIRON MICROB, V69, P4205, DOI 10.1128/AEM.69.7.4205-4213.2003; Koronakis V, 2004, ANNU REV BIOCHEM, V73, P467, DOI 10.1146/annurev.biochem.73.011303.074104; Li WH, 2004, J BIOCHEM BIOPH METH, V58, P59, DOI 10.1016/S0165-022X(03)00154-4; Lu ZS, 2008, LANGMUIR, V24, P5445, DOI 10.1021/la704075r; Mahendra S, 2008, ENVIRON SCI TECHNOL, V42, P9424, DOI 10.1021/es8023385; Medintz IL, 2005, NAT MATER, V4, P435, DOI 10.1038/nmat1390; MINSKY A, 1986, P NATL ACAD SCI USA, V83, P4180, DOI 10.1073/pnas.83.12.4180; Nies DH, 1999, APPL MICROBIOL BIOT, V51, P730, DOI 10.1007/s002530051457; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Nozik AJ, 2010, CHEM REV, V110, P6873, DOI 10.1021/cr900289f; Ostermeier M, 2005, PROTEIN ENG DES SEL, V18, P359, DOI 10.1093/protein/gzi048; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; Schneider R, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/22/225101; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shapiro E, 2002, ANTIMICROB AGENTS CH, V46, P2490, DOI 10.1128/AAC.46.8.2490-2497.2002; Shirasaki Y, 2013, NAT PHOTONICS, V7, P13, DOI 10.1038/nphoton.2012.328; Silhavy T.J., 1984, EXPT GENE FUSIONS; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Smith WE, 2012, ACS NANO, V6, P9475, DOI 10.1021/nn302288r; Sun Q, 2007, NAT PHOTONICS, V1, P717, DOI 10.1038/nphoton.2007.226; Winnik FM, 2013, ACCOUNTS CHEM RES, V46, P672, DOI 10.1021/ar3000585; Yong KT, 2013, CHEM SOC REV, V42, P1236, DOI 10.1039/c2cs35392j; Zhou W, 2015, CHEM COMMUN UNPUB; Zhou WB, 2011, ACS NANO, V5, P8013, DOI 10.1021/nn2024896; Zhou W, 2010, J AM CHEM SOC, V132, P4731, DOI 10.1021/ja909406n; Zrazhevskiy P, 2010, CHEM SOC REV, V39, P4326, DOI 10.1039/b915139g	41	8	8	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124916	10.1371/journal.pone.0124916	http://dx.doi.org/10.1371/journal.pone.0124916			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902065	Green Submitted, Green Published, gold			2022-12-26	WOS:000353331500105
J	Klaver, EJ; Kuijk, LM; Lindhorst, TK; Cummings, RD; van Die, I				Klaver, Elsenoor J.; Kuijk, Loes M.; Lindhorst, Thisbe K.; Cummings, Richard D.; van Die, Irma			Schistosoma mansoni Soluble Egg Antigens Induce Expression of the Negative Regulators SOCS1 and SHP1 in Human Dendritic Cells via Interaction with the Mannose Receptor	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; C-TYPE LECTINS; DC-SIGN; IMMUNE-RESPONSES; TH2 RESPONSES; INFLAMMATORY PHENOTYPE; LEWIS-X; HELMINTH; INFECTION; RECOGNITION	Schistosomiasis is a common debilitating human parasitic disease in (sub) tropical areas, however, schistosome infections can also protect against a variety of inflammatory diseases. This has raised broad interest in the mechanisms by which Schistosoma modulate the immune system into an anti-inflammatory and regulatory state. Human dendritic cells (DCs) show many phenotypic changes upon contact with Schistosoma mansoni soluble egg antigens (SEA). We here show that oxidation of SEA glycans, but not heat-denaturation, abrogates the capacity of SEA to suppress both LPS-induced cytokine secretion and DC proliferation, indicating an important role of SEA glycans in these processes. Remarkably, interaction of SEA glycans with DCs results in a strongly increased expression of Suppressor Of Cytokine Signalling1 (SOCS1) and SH2-containing protein tyrosine Phosphatase-1 (SHP1), important negative regulators of TLR4 signalling. In addition, SEA induces the secretion of transforming growth factor beta (TGF-beta), and the surface expression of the costimulatory molecules Programmed Death Ligand-1 (PD-L1) and OX40 ligand (OX40L), which are known phenotypic markers for the capacity of DCs to polarize naive T cells into Th2/Treg cell subsets. Inhibition of mannose receptor (MR)-mediated internalization of SEA into DCs by blocking with allyl alpha-D-mannoside or anti-MR antibodies, significantly reduced SOCS1 and SHP1 expression. In conclusion, we demonstrate that SEA glycans are essential for induction of enhanced SOCS1 and SHP1 levels in DCs via the MR. Our data provide novel mechanistic evidence for the potential of Schistosoma mansoni SEA glycans to modulate human DCs, which may contribute to the capacity of SEA to down-regulate inflammatory responses.	[Klaver, Elsenoor J.; Kuijk, Loes M.; van Die, Irma] Vrije Univ Amsterdam Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands; [Lindhorst, Thisbe K.] Univ Kiel, Otto Diels Inst Organ Chem, Kiel, Germany; [Cummings, Richard D.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Kiel; Emory University	van Die, I (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands.	im.vandie@vumc.nl		Klaver, Elsenoor/0000-0001-7956-1449	Broad Medical Research Program of The Broad Foundation [IBD-0234R]; National Institute of Health [AI101982]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101982] Funding Source: NIH RePORTER	Broad Medical Research Program of The Broad Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Broad Medical Research Program of The Broad Foundation (http://www.broadmedical.org/), Grant IBD-0234R to IVD, and The National Institute of Health (http://www.nih.gov/), Grant AI101982 to RDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Chen XP, 2002, P NATL ACAD SCI USA, V99, P2175, DOI 10.1073/pnas.042035699; Chieppa M, 2003, J IMMUNOL, V171, P4552, DOI 10.4049/jimmunol.171.9.4552; Christophi GP, 2009, LAB INVEST, V89, P742, DOI 10.1038/labinvest.2009.32; Correale J, 2013, J IMMUNOL, V191, P3827, DOI 10.4049/jimmunol.1301110; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; de Jong EC, 2002, J IMMUNOL, V168, P1704, DOI 10.4049/jimmunol.168.4.1704; Everts B, 2012, J EXP MED, V209, P1753, DOI 10.1084/jem.20111381; Everts B, 2009, J EXP MED, V206, P1673, DOI 10.1084/jem.20082460; Faveeuw C, 2002, J IMMUNOL, V169, P906, DOI 10.4049/jimmunol.169.2.906; Gadina M, 2001, CURR OPIN IMMUNOL, V13, P363, DOI 10.1016/S0952-7915(00)00228-4; Garcia-Vallejo Juan J., 2006, V347, P187; Garcia-Vallejo JJ, 2008, MOL IMMUNOL, V45, P2359, DOI 10.1016/j.molimm.2007.11.001; Gazi U, 2009, IMMUNOBIOLOGY, V214, P554, DOI 10.1016/j.imbio.2008.11.004; Geijtenbeek TBH, 2004, ANNU REV IMMUNOL, V22, P33, DOI 10.1146/annurev.immunol.22.012703.104558; Geijtenbeek TBH, 2002, J BIOL CHEM, V277, P11314, DOI 10.1074/jbc.M111532200; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Gregorieff A, 2000, J BIOL CHEM, V275, P21596, DOI 10.1074/jbc.M910087199; Gringhuis SI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4898; Hamilton CM, 2009, INFECT IMMUN, V77, P2488, DOI 10.1128/IAI.00919-08; HAY G. W., 1965, METHOD CARBOHYD CHEM, V5, P357; Hokke CH, 2007, EXP PARASITOL, V117, P275, DOI 10.1016/j.exppara.2007.06.003; Jang-Lee J, 2007, MOL CELL PROTEOMICS, V6, P1485, DOI 10.1074/mcp.M700004-MCP200; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; Kalinski P, 1999, IMMUNOL TODAY, V20, P561, DOI 10.1016/S0167-5699(99)01547-9; Kapsenberg ML, 1999, IMMUNOL LETT, V69, P5, DOI 10.1016/S0165-2478(99)00096-6; Klaver EJ, 2013, INT J PARASITOL, V43, P191, DOI 10.1016/j.ijpara.2012.10.021; Kuijk LM, 2012, MOL IMMUNOL, V51, P210, DOI 10.1016/j.molimm.2012.03.020; Kuijk LM, 2010, IUBMB LIFE, V62, P303, DOI 10.1002/iub.304; La Flamme AC, 2003, INFECT IMMUN, V71, P4996, DOI 10.1128/IAI.71.9.4996-5004.2003; Mckay DM, 2009, TRENDS PARASITOL, V25, P109, DOI 10.1016/j.pt.2008.11.008; Meevissen MHJ, 2012, INT J PARASITOL, V42, P269, DOI 10.1016/j.ijpara.2012.01.004; Meevissen MHJ, 2010, J PROTEOME RES, V9, P2630, DOI 10.1021/pr100081c; Minoo P, 2004, BLOOD, V103, P1398, DOI 10.1182/blood-2003-07-2617; Moreels TG, 2004, GUT, V53, P99, DOI 10.1136/gut.53.1.99; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Nyame AK, 2003, EXP PARASITOL, V104, P1, DOI 10.1016/S0014-4894(03)00110-3; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Okano M, 1999, J IMMUNOL, V163, P6712; Osada Y, 2009, INT J PARASITOL, V39, P457, DOI 10.1016/j.ijpara.2008.08.007; Paveley RA, 2011, INT J PARASITOL, V41, P1335, DOI 10.1016/j.ijpara.2011.08.005; Pearce EJ, 2004, IMMUNOL REV, V201, P117, DOI 10.1111/j.0105-2896.2004.00187.x; PEREZ JFA, 1982, IMMUNOLOGY, V47, P695; Riella LV, 2012, AM J TRANSPLANT, V12, P2575, DOI 10.1111/j.1600-6143.2012.04224.x; Rutella S, 2006, BLOOD, V108, P1435, DOI 10.1182/blood-2006-03-006403; Schramm G, 2003, J BIOL CHEM, V278, P18384, DOI 10.1074/jbc.M300497200; Schramm G, 2009, MOL BIOCHEM PARASIT, V166, P4, DOI 10.1016/j.molbiopara.2009.02.003; Smith P, 2007, J IMMUNOL, V178, P4557, DOI 10.4049/jimmunol.178.7.4557; Steinfelder S, 2009, J EXP MED, V206, P1681, DOI 10.1084/jem.20082462; TAYLOR ME, 1992, J BIOL CHEM, V267, P1719; van Die I, 2003, GLYCOBIOLOGY, V13, P471, DOI 10.1093/glycob/cwg052; van Liempt E, 2007, MOL IMMUNOL, V44, P2605, DOI 10.1016/j.molimm.2006.12.012; van Liempt E, 2006, FEBS LETT, V580, P6123, DOI 10.1016/j.febslet.2006.10.009; van Stijn CMW, 2010, MOL IMMUNOL, V47, P1544, DOI 10.1016/j.molimm.2010.01.014; van Stijn CMW, 2009, MOL IMMUNOL, V46, P3292, DOI 10.1016/j.molimm.2009.07.026; van Vliet SJ, 2005, INT IMMUNOL, V17, P661, DOI 10.1093/intimm/dxh246; Vazquez N, 2006, J LEUKOCYTE BIOL, V80, P1136, DOI 10.1189/jlb.0306206; Weinstock JV, 2009, INFLAMM BOWEL DIS, V15, P128, DOI 10.1002/ibd.20633; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; WINNIK FM, 1982, CARBOHYD RES, V103, P15, DOI 10.1016/S0008-6215(82)80004-9; Wuhrer M, 2006, FEBS J, V273, P2276, DOI 10.1111/j.1742-4658.2006.05242.x; Yadav A, 2009, VIROLOGY, V385, P126, DOI 10.1016/j.virol.2008.11.039	64	25	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124089	10.1371/journal.pone.0124089	http://dx.doi.org/10.1371/journal.pone.0124089			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897665	Green Submitted, Green Published, gold			2022-12-26	WOS:000353212600048
J	Stupnisek, M; Kokot, A; Drmic, D; Patrlj, MH; Sever, AZ; Kolenc, D; Radic, B; Suran, J; Bojic, D; Vcev, A; Seiwerth, S; Sikiric, P				Stupnisek, Mirjana; Kokot, Antonio; Drmic, Domagoj; Patrlj, Masa Hrelec; Sever, Anita Zenko; Kolenc, Danijela; Radic, Bozo; Suran, Jelena; Bojic, Davor; Vcev, Aleksandar; Seiwerth, Sven; Sikiric, Predrag			Pentadecapeptide BPC 157 Reduces Bleeding and Thrombocytopenia after Amputation in Rats Treated with Heparin, Warfarin, L-NAME and L-Arginine	PLOS ONE			English	Article							NITRIC-OXIDE; PLASMINOGEN-ACTIVATOR; PLATELET ACTIVATION; METHYL-ESTER; INHIBITION; RELEASE; EGR-1; ENDOTHELIN-1; ENHANCEMENT; ANASTOMOSIS	Background BPC 157 is a stable gastric pentadecapeptide recently implicated with a role in hemostasis. While NO is largely implicated in hemostatic mechanisms, in tail-amputation-models under heparin-and warfarin-administration, both the NO-synthase (NOS)-blocker, L-NAME (prothrombotic) and the NOS-substrate L-arginine (antithrombotic), were little investigated. Objective. To investigate the effect of L-NAME and L-arginine on hemostatic parameters, and to reveal the effects of BPC 157 on the L-NAME-and L-arginine-induced hemostatic actions under different pathological condition: tail amputation without or with anticoagulants, heparin or warfarin. Methods Tail amputation, and/or i.v.-heparin (10 mg/kg), i.g.-warfarin (1.5 mu g/kg/day for 3 days) were used in rats. Treatment includes BPC 157, L-NAME, L-arginine, per se and their combination. Results After (tail) amputation, with or without i.v.-heparin or i.g.-warfarin, BPC 157 (10 mu g/kg, 10 ng/kg, i.p., i.v. (heparin), 10 g/kg i.g. (warfarin)) always reduced bleeding time and/or haemorrhage and counteracted thrombocytopenia. As for L-NAME and/or L-arginine, we noted: L-arginine (100 mg/kg i.p.)-rats: more bleeding, less/no thrombocytopenia; L-NAME (5 mg/kg i.p.)-rats: less bleeding (amputation only), but present thrombocytopenia; L-NAME+ L-argininerats also exhibited thrombocytopenia: L-NAME counteracted L-arginine-increased bleeding, L-arginine did not counteract L-NAME-thrombocytopenia. All animals receiving BPC 157 in addition (BPC 157 mu g+ L-NAME; BPC 157 mu g+ L-arginine, BPC 157 mu g+ L-NAME+ L-arginine), exhibited decreased haemorrhage and markedly counteracted thrombocytopenia. Conclusions L-NAME (thrombocytopenia), L-arginine (increased haemorrhage) counteraction and BPC 157 (decreased haemorrhage, counteracted thrombocytopenia) with rescue against two different anticoagulants, implicate a BPC 157 modulatory and balancing role with rescued NO-hemostatic mechanisms.	[Stupnisek, Mirjana; Kokot, Antonio; Vcev, Aleksandar] JJ Strossmayer Univ Osijek, Fac Med, Osijek, Croatia; [Drmic, Domagoj; Patrlj, Masa Hrelec; Radic, Bozo; Suran, Jelena; Bojic, Davor; Sikiric, Predrag] Univ Zagreb, Sch Med, Dept Pharmacol, Zagreb 41001, Croatia; [Sever, Anita Zenko; Kolenc, Danijela; Seiwerth, Sven] Univ Zagreb, Sch Med, Dept Pathol, Zagreb 41001, Croatia	University of JJ Strossmayer Osijek; University of Zagreb; University of Zagreb	Sikiric, P (corresponding author), Univ Zagreb, Sch Med, Dept Pharmacol, Zagreb 41001, Croatia.	sikiric@mef.hr	Stupnisek, Mirjana/A-9884-2015; Kokot, Antonio/O-3111-2019; Suran, Jelena/AAU-8102-2020; Kokot, Antonio/HGB-2080-2022; Kokot, Antonio/B-3276-2017	Stupnisek, Mirjana/0000-0003-2109-2787; Kokot, Antonio/0000-0002-4836-7536; 	Ministry of Science, Education and Sports, Republic of Croatia [108-1083570-3635]	Ministry of Science, Education and Sports, Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia)	The research described in this manuscript was supported by grant 108-1083570-3635, Ministry of Science, Education and Sports, Republic of Croatia.	Ashour M, 2004, EUR J CARDIO-THORAC, V25, P839, DOI 10.1016/j.ejcts.2003.12.010; Balenovic D, 2012, J CLIN EXP CARDIOLOG, V3, P201, DOI [10.4172/2155-9880.1000201, DOI 10.4172/2155-9880.1000201]; Balenovic D, 2009, REGUL PEPTIDES, V156, P83, DOI 10.1016/j.regpep.2009.05.008; Barisic I, 2013, REGUL PEPTIDES, V181, P50, DOI 10.1016/j.regpep.2012.12.007; Boban-Blagaic A, 2006, MED SCI MONITOR, V12, pBR36; Cesarec V, 2013, EUR J PHARMACOL, V701, P203, DOI 10.1016/j.ejphar.2012.11.055; Dambisya YM, 1996, BLOOD COAGUL FIBRIN, V7, P678, DOI 10.1097/00001721-199610000-00003; Diodati JG, 1998, CIRCULATION, V98, P17, DOI 10.1161/01.CIR.98.1.17; Dran GI, 2002, KIDNEY INT, V62, P1338, DOI 10.1046/j.1523-1755.2002.00554.x; Duplancic B, 2014, EUR J PHARMACOL, V727, P75, DOI 10.1016/j.ejphar.2014.01.046; Freedman JE, 1997, J CLIN INVEST, V100, P350, DOI 10.1172/JCI119540; Gozdzikiewicz J, 2014, HEMODIAL INT, V18, P819, DOI 10.1111/hdi.12177; Grabarevic Z, 1997, J PHYSIOLOGY-PARIS, V91, P139, DOI 10.1016/S0928-4257(97)89478-8; HIEBERT LM, 1993, Q J MED, V86, P341; Hrelec M, 2009, J PHYSIOL PHARMACOL, V60, P161; HUNEIDI AHS, 1991, J CARDIOVASC PHARM, V17, pS492; Kalogjera L, 1997, EUR ARCH OTO-RHINO-L, V254, pS9, DOI 10.1007/BF02439711; KESTIN AS, 1993, BLOOD, V82, P107, DOI 10.1182/blood.V82.1.107.bloodjournal821107; Kim SS, 2003, J KOREAN MED SCI, V18, P637, DOI 10.3346/jkms.2003.18.5.637; Kitashoji A, 2013, STROKE, V44, P2862, DOI 10.1161/STROKEAHA.113.001183; Klicek R, 2013, J PHYSIOL PHARMACOL, V64, P597; Klicek R, 2008, J PHARMACOL SCI, V108, P7, DOI 10.1254/jphs.FP0072161; KORBUT R, 1990, LANCET, V335, P669, DOI 10.1016/0140-6736(90)90462-E; KORBUT R, 1995, J PHYSIOL PHARMACOL, V46, P37; LIDBURY PS, 1990, BRIT J PHARMACOL, V101, P527, DOI 10.1111/j.1476-5381.1990.tb14115.x; Lombardini Cristina, 2009, Am J Emerg Med, V27, DOI 10.1016/j.ajem.2009.02.005; Lovric-Bencic M, 2004, J PHARMACOL SCI, V95, P19, DOI 10.1254/jphs.95.19; Lucerna M, 2003, J BIOL CHEM, V278, P11433, DOI 10.1074/jbc.M204937200; Marietta M, 1997, THROMB RES, V88, P229, DOI 10.1016/S0049-3848(97)00233-8; McMahon GS, 2013, THROMB HAEMOSTASIS, V109, P1099, DOI 10.1160/TH12-11-0793; MOLNAR M, 1994, AM J OBSTET GYNECOL, V170, P1458; Noguchi K, 1996, BRIT J PHARMACOL, V118, P941, DOI 10.1111/j.1476-5381.1996.tb15490.x; Sakawi Y, 2000, ANESTHESIOLOGY, V93, P1446, DOI 10.1097/00000542-200012000-00017; Seiwerth S, 2014, CURR PHARM DESIGN, V20, P1121, DOI 10.2174/13816128113199990421; Sikiric P, 2012, CURR MED CHEM, V19, P126, DOI 10.2174/092986712803414015; Sikiric P, 1997, EUR J PHARMACOL, V332, P23, DOI 10.1016/S0014-2999(97)01033-9; Sikiric P, 2014, CURR PHARM DESIGN, V20, P1126, DOI 10.2174/13816128113190990411; Sikiric P, 2013, CURR PHARM DESIGN, V19, P76; Sikiric P, 2011, CURR PHARM DESIGN, V17, P1612, DOI 10.2174/138161211796196954; Sikiric P, 2010, CURR PHARM DESIGN, V16, P1224, DOI 10.2174/138161210790945977; Stupnisek M, 2012, THROMB RES, V129, P652, DOI 10.1016/j.thromres.2011.07.035; Thom SR, 1999, AM J PHYSIOL-HEART C, V276, pH984, DOI 10.1152/ajpheart.1999.276.3.H984; Tkalcevic VI, 2007, EUR J PHARMACOL, V570, P212, DOI 10.1016/j.ejphar.2007.05.072; Upchurch GR, 1997, CIRCULATION, V95, P2115, DOI 10.1161/01.CIR.95.8.2115; VELJACA M, 1995, J PHARMACOL EXP THER, V272, P417; Yan SF, 2000, NAT MED, V6, P1355, DOI 10.1038/82168	47	42	42	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123454	10.1371/journal.pone.0123454	http://dx.doi.org/10.1371/journal.pone.0123454			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897838	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000353212600027
J	Gil-Jimenez, E; Villamuelas, M; Serrano, E; Delibes, M; Fernandez, N				Gil-Jimenez, Esperanza; Villamuelas, Miriam; Serrano, Emmanuel; Delibes, Miguel; Fernandez, Nestor			Fecal Nitrogen Concentration as a Nutritional Quality Indicator for European Rabbit Ecological Studies	PLOS ONE			English	Article							INFRARED REFLECTANCE SPECTROSCOPY; DEER CAPREOLUS-CAPREOLUS; DIET QUALITY; ORYCTOLAGUS-CUNICULUS; MAMMALIAN HERBIVORES; CHEMICAL-COMPOSITION; IBERIAN PENINSULA; STOMACH CONTENTS; COMPOUND FEEDS; NATIONAL-PARK	Measuring the quality of the nutritional resources available to wild herbivores is critical to understanding trophic regulation processes. However, the direct assessment of dietary nutritional characteristics is usually difficult, which hampers monitoring nutritional constraints in natural populations. The feeding ecology of ruminant herbivores has been often assessed by analyzing fecal nitrogen (FN) concentrations, although this method has been less evaluated in other taxa. This study analyzed the suitability of FN as an indicator of ingesta quality in the European rabbit (Oryctolagus cuniculus), which is a keystone lagomorph species in Mediterranean ecosystems and of great conservation interest. Firstly, domestic O. cuniculus were used to evaluate under experimental conditions the accuracy of total FN and the metabolic FN as diet quality indicators of forages with characteristics similar to those available under natural conditions. Secondly, the accuracy of Near-Infrared Spectroscopy (NIRS) to calculate FN was tested using partial least squares regression. Thirdly, a pilot field study was conducted to monitor FN dynamics from wild O. cuniculus in three different habitats during wet and drought periods. A strong association was found between diet type and total FN and metabolic FN (Pseudo-R-2 >= 0.89). It was also found that NIRS calibrations were accurate for depicting nitrogen concentrations (R-2 > 0.98 between NIRS and chemical results). Finally, the seasonal FN dynamics measured in the field were consistent with current knowledge on vegetation dynamics and forage limitations in the three habitats. The results support the use of NIRS methods and FN indices as a reliable and affordable approach to monitoring the nutritional quality of rabbit habitats. Potential applications include the assessment of the mechanistic relationships between resource limitations and population abundance, e.g., in relation to natural drought cycles and to habitat interventions aimed at reinforcing rabbit populations.	[Gil-Jimenez, Esperanza; Delibes, Miguel; Fernandez, Nestor] Spanish Council Sci Res CSIC, Dept Conservat Biol, Estn Biol, Seville, Spain; [Villamuelas, Miriam; Serrano, Emmanuel] Univ Autonoma Barcelona, Dept Med & Cirugia Anim, Serv Ecopatol Fauna Salvatge, Bellaterra, Barcelona, Spain; [Serrano, Emmanuel] Univ Aveiro, CESAM, Dept Biol, P-3800 Aveiro, Portugal	Consejo Superior de Investigaciones Cientificas (CSIC); Autonomous University of Barcelona; Universidade de Aveiro	Fernandez, N (corresponding author), Spanish Council Sci Res CSIC, Dept Conservat Biol, Estn Biol, Seville, Spain.	nestor@ebd.csic.es	Fernández, Néstor/AAA-3523-2020; SERRANO-FERRON, Emmanuel/J-4489-2013; Gil-Jiménez, Esperanza/C-6108-2015; Fernández, Néstor/N-5802-2014; Delibes, Miguel/K-2744-2014	SERRANO-FERRON, Emmanuel/0000-0002-9799-9804; Gil-Jiménez, Esperanza/0000-0002-6808-9967; Fernández, Néstor/0000-0002-9645-8571; Delibes, Miguel/0000-0002-3569-567X	Consejeria de Economia, Innovacion, Ciencia y Empleo of Junta de Andalucia [RNM-6685]; Fundaxao para a Ciencia ea Tecnologia, Portugal [SFRH/BPD/96637/2013]	Consejeria de Economia, Innovacion, Ciencia y Empleo of Junta de Andalucia; Fundaxao para a Ciencia ea Tecnologia, Portugal	Funding was provided by Consejeria de Economia, Innovacion, Ciencia y Empleo of Junta de Andalucia, Excellence Project #RNM-6685; ES was supported by the postdoctoral program (SFRH/BPD/96637/2013) of the Fundaxao para a Ciencia ea Tecnologia, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOAC, 2006, OFFICIAL METHODS ANA; BARNES RJ, 1989, APPL SPECTROSC, V43, P772, DOI 10.1366/0003702894202201; Barton K., 2014, R PACKAGE VERSION; BERGERON JM, 1994, CAN J ZOOL, V72, P183, DOI 10.1139/z94-023; Bjornhag Goran, 1999, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Zoologische Reihe, V75, P275; Blanchard P, 2003, J WILDLIFE MANAGE, V67, P477, DOI 10.2307/3802705; Carneiro M, 2011, MOL BIOL EVOL, V28, P1801, DOI 10.1093/molbev/msr003; Cen HY, 2007, TRENDS FOOD SCI TECH, V18, P72, DOI 10.1016/j.tifs.2006.09.003; Clark JE, 2003, J MAMMAL, V84, P1399, DOI 10.1644/BRG-105; Delibes M., 1979, P WORLD LAGOMORPH C, P614, DOI DOI 10.1007/BF00275171; Delibes-Mateos M, 2008, CONSERV BIOL, V22, P1106, DOI 10.1111/j.1523-1739.2008.00993.x; Delibes-Mateos M, 2009, MAMMAL REV, V39, P124, DOI 10.1111/j.1365-2907.2009.00140.x; Dixon R, 2009, J NEAR INFRARED SPEC, V17, P1, DOI 10.1255/jnirs.822; Duffy JP, 2012, AFR J ECOL, V50, P455, DOI 10.1111/j.1365-2028.2012.01340.x; Etheridge RD, 1998, ANIM FEED SCI TECH, V73, P21, DOI 10.1016/S0377-8401(98)00136-9; Fernandez N, 2005, LANDSCAPE ECOL, V20, P897, DOI 10.1007/s10980-004-3976-7; Fernandez N, 2003, ECOL APPL, V13, P1310, DOI 10.1890/02-5081; Fernandez N, 2010, REMOTE SENS ENVIRON, V114, P211, DOI 10.1016/j.rse.2009.09.001; Ferreira C, 2014, MAMMAL REV, V44, P30, DOI 10.1111/mam.12006; Foley WJ, 1998, OECOLOGIA, V116, P293, DOI 10.1007/s004420050591; Franz R, 2011, J ANIM PHYSIOL AN N, V95, P564, DOI 10.1111/j.1439-0396.2010.01084.x; Galvez- Ceron A, 2013, EUR J WILDLIFE RES, P59; Garel M, 2011, J MAMMAL, V92, P1112, DOI 10.1644/10-MAMM-A-056.1; GELADI P, 1985, APPL SPECTROSC, V39, P491, DOI 10.1366/0003702854248656; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Gislum R, 2004, FIELD CROP RES, V88, P269, DOI 10.1016/j.fcr.2004.01.021; Hirakawa H, 2001, MAMMAL REV, V31, P61, DOI 10.1046/j.1365-2907.2001.00079.x; HOBBS NT, 1987, J WILDLIFE MANAGE, V51, P317, DOI 10.2307/3801008; Hopcraft JGC, 2010, TRENDS ECOL EVOL, V25, P119, DOI 10.1016/j.tree.2009.08.001; Janova E, 2015, EUR J WILDLIFE RES, V61, P57, DOI 10.1007/s10344-014-0873-5; Kamler J, 2005, FOLIA ZOOL, V54, P89; Kamler J, 2004, WILDLIFE BIOL, V10, P235, DOI 10.2981/wlb.2004.021; Leslie DM, 2008, J WILDLIFE MANAGE, V72, P1420, DOI 10.2193/2007-404; LESLIE DM, 1987, J WILDLIFE MANAGE, V51, P321, DOI 10.2307/3801009; Lombardi L, 2003, J MAMMAL, V84, P26, DOI 10.1644/1545-1542(2003)084<0026:HRDIRO>2.0.CO;2; Lombardi L, 2007, BASIC APPL ECOL, V8, P453, DOI 10.1016/j.baae.2006.09.004; Marco A, 2002, TALANTA, V57, P1019, DOI 10.1016/S0039-9140(02)00136-4; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Meineri G, 2009, ITAL J ANIM SCI, V8, P75, DOI 10.4081/ijas.2009.75; Mesochina P, 1998, GRASS FORAGE SCI, V53, P189, DOI 10.1046/j.1365-2494.1998.5320189.x; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nunez-Sanchez N, 2012, LIVEST SCI, V150, P386, DOI 10.1016/j.livsci.2012.07.030; Parker KL, 2009, FUNCT ECOL, V23, P57, DOI 10.1111/j.1365-2435.2009.01528.x; Pettorelli N, 2009, AM NAT, V173, P698, DOI 10.1086/597379; Pinheiro J, 2014, TEAM RC NLME LINEAR; PLUMPTRE AJ, 1995, J ZOOL, V235, P323; R Core Team, 2014, LANG ENV STAT COMP; Robbins C.T., 1983, WILDLIFE FEEDING NUT; ROBBINS CT, 1987, ECOLOGY, V68, P98, DOI 10.2307/1938809; Rothman JM, 2008, AM J PRIMATOL, V70, P690, DOI 10.1002/ajp.20540; Rothman JM, 2006, AM J PRIMATOL, V68, P675, DOI 10.1002/ajp.20243; Sacconi F, 2007, ITAL J ANIM SCI, V6, P862, DOI 10.4081/ijas.2007.1s.862; Sader A. P. O., 2004, Archives of Veterinary Science, V9, P73; Sakaguchi Ei, 2003, Animal Science Journal, V74, P327, DOI 10.1046/j.1344-3941.2003.00124.x; Schwarm A, 2009, J ANIM PHYSIOL AN N, V93, P596, DOI 10.1111/j.1439-0396.2008.00842.x; Shenk J. S., 1995, ROUTINE OPERATION CA; Shenk J.S., 1996, NEAR INFRARED SPECTR, P198; Showers SE, 2006, RANGELAND ECOL MANAG, V59, P300, DOI 10.2111/04-069.1; Stott P, 2008, MAMM BIOL, V73, P276, DOI 10.1016/j.mambio.2007.07.002; Stuth J, 2003, FIELD CROP RES, V84, P45, DOI 10.1016/S0378-4290(03)00140-0; van der Waal C, 2003, S AFR J WILDL RES, V33, P33; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; Verheyden H, 2011, WILDLIFE BIOL, V17, P166, DOI 10.2981/10-111; Villafuerte R, 1997, REV ECOL-TERRE VIE, V52, P345; Vogel KP, 1999, CROP SCI, V39, P276, DOI 10.2135/cropsci1999.0011183X003900010042x; Williams P. C., 2001, NEAR INFRARED TECHNO, V2, P145; Williams PC, 1996, NEAR INFRARED SPECTR, P185; Windley HR, 2013, OECOLOGIA, V173, P203, DOI 10.1007/s00442-013-2616-9; Xiccato G, 1999, ANIM FEED SCI TECH, V77, P201, DOI 10.1016/S0377-8401(98)00253-3; Xiccato G, 2003, ANIM FEED SCI TECH, V104, P153, DOI 10.1016/S0377-8401(02)00294-8	70	8	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0125190	10.1371/journal.pone.0125190	http://dx.doi.org/10.1371/journal.pone.0125190			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893872	Green Published, Green Submitted, gold			2022-12-26	WOS:000353211700134
J	Zimmermann, M; Kugler, SJ; Schulz, A; Nagel, AC				Zimmermann, Mirjam; Kugler, Sabrina J.; Schulz, Adriana; Nagel, Anja C.			Loss of putzig Activity Results in Apoptosis during Wing Imaginal Development in Drosophila	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; COMPENSATORY PROLIFERATION; TRANSCRIPTIONAL REGULATION; DISTINCT MECHANISMS; NOTCH ACTIVITY; TELOMERE LOSS; GENE; DREF; JNK; GROWTH	The Drosophila gene putzig (pzg) encodes a nuclear protein that is an integral component of the Trf2/Dref complex involved in the transcription of proliferation-related genes. Moreover, Pzg is found in a complex together with the nucleosome remodeling factor NURF, where it promotes Notch target gene activation. Here we show that downregulation of pzg activity in the developing wing imaginal discs induces an apoptotic response, accompanied by the induction of the pro-apoptotic gene reaper, repression of Drosophila inhibitor of apoptosis protein accumulation and the activation of the caspases Drice, Caspase3 and Dcp1. As a further consequence 'Apoptosis induced Proliferation' (AiP) and 'Apoptosis induced Apoptosis' (AiA) are triggered. As expected, the activity of the stress kinase Jun N-terminal kinase (JNK), proposed to mediate both processes, is ectopically induced in response to pzg loss. In addition, the expression of the mitogen wingless (wg) but not of decapentaplegic (dpp) is observed. We present evidence that downregulation of Notch activates Dcp1 caspase and JNK signaling, however, neither induces ectopic wg nor dpp expression. In contrast, the consequences of Dref-RNAi were largely indistinguishable from pzg-RNAi with regard to apoptosis induction. Moreover, overexpression of Dref ameliorated the downregulation of pzg compatible with the notion that the two are required together to maintain cell and tissue homeostasis in Drosophila.	[Zimmermann, Mirjam; Kugler, Sabrina J.; Schulz, Adriana; Nagel, Anja C.] Univ Hohenheim, Inst Genet, D-70599 Stuttgart, Germany	University Hohenheim	Nagel, AC (corresponding author), Univ Hohenheim, Inst Genet, D-70599 Stuttgart, Germany.	anja.nagel@uni-hohenheim.de	Nagel, Anja/AAA-4254-2022	Nagel, Anja/0000-0002-2733-3249				Abrams JM, 1999, TRENDS CELL BIOL, V9, P435, DOI 10.1016/S0962-8924(99)01646-3; Ahmad K, 1999, GENETICS, V151, P1041; Andreyeva EN, 2005, J CELL SCI, V118, P5465, DOI 10.1242/jcs.02654; Bergantinos C, 2010, DEVELOPMENT, V137, P1169, DOI 10.1242/dev.045559; Bergmann A, 1998, CELL, V95, P331, DOI 10.1016/S0092-8674(00)81765-1; Bergmann A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3145re8; Berthelet Jean, 2013, Cells, V2, P163, DOI 10.3390/cells2010163; BLACKMAN RK, 1991, DEVELOPMENT, V111, P657; Bosch M, 2005, DEV BIOL, V280, P73, DOI 10.1016/j.ydbio.2005.01.002; Brancolini C, 1997, J CELL BIOL, V139, P759, DOI 10.1083/jcb.139.3.759; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773; CLEM RJ, 1991, SCIENCE, V254, P1388, DOI 10.1126/science.1962198; Colombani J, 2012, SCIENCE, V336, P582, DOI 10.1126/science.1216689; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Djiane A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106211; Djiane A, 2013, EMBO J, V32, P60, DOI 10.1038/emboj.2012.326; Dominguez M, 2014, SEMIN CELL DEV BIOL, V28, P78, DOI 10.1016/j.semcdb.2014.04.012; Fan Y, 2008, TRENDS CELL BIOL, V18, P467, DOI 10.1016/j.tcb.2008.08.001; Fan Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004131; Fujiwara S, 2012, AM J CANCER RES, V2, P36; Garelli A, 2012, SCIENCE, V336, P579, DOI 10.1126/science.1216735; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hay BA, 1997, P NATL ACAD SCI USA, V94, P5195, DOI 10.1073/pnas.94.10.5195; HAY BA, 1994, DEVELOPMENT, V120, P2121; Herrera SC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003446; Hirose F, 2001, MOL CELL BIOL, V21, P7231, DOI 10.1128/MCB.21.21.7231-7242.2001; Hochheimer A, 2002, NATURE, V420, P439, DOI 10.1038/nature01167; Huh JR, 2004, CURR BIOL, V14, P1262, DOI 10.1016/j.cub.2004.06.015; Hyun JY, 2005, MOL CELL BIOL, V25, P5590, DOI 10.1128/MCB.25.13.5590-5598.2005; Igaki T, 2006, CURR BIOL, V16, P1139, DOI 10.1016/j.cub.2006.04.042; Igaki T, 2009, APOPTOSIS, V14, P1021, DOI 10.1007/s10495-009-0361-7; Iyer EPR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072434; Jacobson MD, 1997, CURR BIOL, V7, pR277, DOI 10.1016/S0960-9822(06)00136-9; Kashio S, 2014, DEV GROWTH DIFFER, V56, P368, DOI 10.1111/dgd.12139; Kessler T, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-15; Kondo S, 2006, MOL CELL BIOL, V26, P7258, DOI 10.1128/MCB.00183-06; Kugler SJ, 2007, MOL BIOL CELL, V18, P3733, DOI 10.1091/mbc.E07-03-0263; Kugler SJ, 2011, GENETICS, V188, P127, DOI 10.1534/genetics.111.127795; Kugler SJ, 2010, MOL BIOL CELL, V21, P3443, DOI 10.1091/mbc.E10-03-0212; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; Kurada P, 1998, CELL, V95, P319, DOI 10.1016/S0092-8674(00)81764-X; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Maier D, 2002, P NATL ACAD SCI USA, V99, P15480, DOI 10.1073/pnas.242596699; Martin FA, 2009, INT J DEV BIOL, V53, P1341, DOI 10.1387/ijdb.072447fm; Martin SJ, 2002, CELL, V109, P793, DOI 10.1016/S0092-8674(02)00802-4; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Mason JM, 2008, BIOESSAYS, V30, P25, DOI 10.1002/bies.20688; Matsukage A, 2008, BBA-GENE REGUL MECH, V1779, P81, DOI 10.1016/j.bbagrm.2007.11.011; Mattila J, 2005, INT J DEV BIOL, V49, P391, DOI 10.1387/ijdb.052006jm; McCall K, 1997, TRENDS GENET, V13, P222, DOI 10.1016/S0168-9525(97)01126-8; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; Milan M, 1997, P NATL ACAD SCI USA, V94, P5691, DOI 10.1073/pnas.94.11.5691; Mollereau B, 2013, CELL DEATH DIFFER, V20, P181, DOI 10.1038/cdd.2012.82; Morata G, 2013, ELIFE, V2, DOI 10.7554/eLife.01388; Morata G, 2011, DEV GROWTH DIFFER, V53, P168, DOI 10.1111/j.1440-169X.2010.01225.x; Muller D, 2005, GENETICS, V171, P1137, DOI 10.1534/genetics.105.044453; Nagel AC, 2005, MOL CELL BIOL, V25, P10433, DOI 10.1128/MCB.25.23.10433-10441.2005; Neufeld TP, 1998, CURR OPIN CELL BIOL, V10, P784, DOI 10.1016/S0955-0674(98)80122-1; Nigg EA, 2005, ADV EXPT MED BIOL; Ohler U, 2002, GENOME BIOL, V3, P87, DOI DOI 10.1186/GB-2002-3-12-RESEARCH0087; Perez-Garijo A, 2004, DEVELOPMENT, V131, P5591, DOI 10.1242/dev.01432; Perez-Garijo A, 2013, ELIFE, V2, DOI 10.7554/eLife.01004; Perez-Garijo A, 2009, DEVELOPMENT, V136, P1169, DOI 10.1242/dev.034017; Protzer CE, 2008, J CELL SCI, V121, P3167, DOI 10.1242/jcs.035014; Richardson H, 2002, J IMMUNOL METHODS, V265, P21, DOI 10.1016/S0022-1759(02)00068-6; RING JM, 1993, DEVELOPMENT, P251; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Ryoo HD, 2002, NAT CELL BIOL, V4, P432, DOI 10.1038/ncb795; Ryoo HD, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008797; Ryu JR, 1997, NUCLEIC ACIDS RES, V25, P794, DOI 10.1093/nar/25.4.794; Silva-Sousa R, 2013, MOBILE DNA-UK, V4, DOI 10.1186/1759-8753-4-18; Silva-Sousa R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003153; Smith-Bolton RK, 2009, DEV CELL, V16, P797, DOI 10.1016/j.devcel.2009.04.015; Sogame N, 2003, P NATL ACAD SCI USA, V100, P4696, DOI 10.1073/pnas.0736384100; Stewart SA, 2006, ANNU REV CELL DEV BI, V22, P531, DOI 10.1146/annurev.cellbio.22.010305.104518; Tabata T, 2004, DEVELOPMENT, V131, P703, DOI 10.1242/dev.01043; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Titen SWA, 2008, GENETICS, V180, P1821, DOI 10.1534/genetics.108.093625; Trong-Tue N, 2010, ONCOGENE, V29, P2060, DOI 10.1038/onc.2009.483; Vidal M, 2006, CURR OPIN GENET DEV, V16, P10, DOI 10.1016/j.gde.2005.12.004; Vo N, 2014, SCI REP-UK, V4, DOI 10.1038/srep07196; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; Worley MI, 2012, ANNU REV GENET, V46, P289, DOI 10.1146/annurev-genet-110711-155637; Yoo SJ, 2002, NAT CELL BIOL, V4, P416, DOI 10.1038/ncb793; Yoshida H, 2004, GENES CELLS, V9, P935, DOI 10.1111/j.1365-2443.2004.00775.x; You H, 2013, J CELL SCI, V126, P2718, DOI 10.1242/jcs.122903	92	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124652	10.1371/journal.pone.0124652	http://dx.doi.org/10.1371/journal.pone.0124652			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894556	Green Published, gold, Green Submitted			2022-12-26	WOS:000353211700113
J	Ishino, S; Kawata, Y; Taguchi, H; Kajimura, N; Matsuzaki, K; Hoshino, M				Ishino, So; Kawata, Yasushi; Taguchi, Hideki; Kajimura, Naoko; Matsuzaki, Katsumi; Hoshino, Masaru			Effects of C-terminal Truncation of Chaperonin GroEL on the Yield of In-cage Folding of the Green Fluorescent Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; HYDROPHILIC RESIDUES; STRUCTURAL FEATURES; SUBSTRATE PROTEIN; FUNCTIONAL FORM; REACTION CYCLE; COMPLEX; INTERMEDIATE; POLYPEPTIDE	Chaperonin GroEL from Escherichia coli consists of two heptameric rings stacked back-to-back to form a cagelike structure. It assists in the folding of substrate proteins in concert with the co-chaperonin GroES by incorporating them into its large cavity. The mechanism underlying the incorporation of substrate proteins currently remains unclear. The flexible C-terminal residues of GroEL, which are invisible in the x-ray crystal structure, have recently been suggested to play a key role in the efficient encapsulation of substrates. These C-terminal regions have also been suggested to separate the double rings of GroEL at the bottom of the cavity. To elucidate the role of the C-terminal regions of GroEL on the efficient encapsulation of substrate proteins, we herein investigated the effects of C-terminal truncation on GroE-mediated folding using the green fluorescent protein (GFP) as a substrate. We demonstrated that the yield of in-cage folding mediated by a single ring GroEL (SR1) was markedly decreased by truncation, whereas that mediated by a double ring football-shaped complex was not affected. These results suggest that the C-terminal region of GroEL functions as a barrier between rings, preventing the leakage of GFP through the bottom space of the cage. We also found that once GFP folded into its native conformation within the cavity of SR1 it never escaped even in the absence of the C-terminal tails. This suggests that GFP molecules escaped through the pore only when they adopted a denatured conformation. Therefore, the folding and escape of GFP from C-terminally truncated SR1 center dot GroES appeared to be competing with each other.	[Ishino, So; Matsuzaki, Katsumi; Hoshino, Masaru] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan; [Kawata, Yasushi] Tottori Univ, Grad Sch Engn, Dept Biotechnol, Tottori 6808552, Japan; [Taguchi, Hideki] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Kajimura, Naoko] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	Kyoto University; Tottori University; Tokyo Institute of Technology; Osaka University	Hoshino, M (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, 46-29 Yoshida Shimoadachi, Kyoto 6068501, Japan.	hoshi@pharm.kyoto-u.ac.jp	Kawata, Yasushi/ABA-9608-2021; taguchi, hideki/AAM-2663-2021; Taguchi, Hideki/B-6946-2009; Kajimura, Naoko/R-9267-2019	taguchi, hideki/0000-0002-6612-9339; Taguchi, Hideki/0000-0002-6612-9339; Kawata, Yasushi/0000-0002-2744-1506	Japan Society for the Promotion of Science [23570192]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japan Society for the Promotion of Science Grant-in-aid for Scientific Research (C) 23570192.	Apetri AC, 2008, P NATL ACAD SCI USA, V105, P17351, DOI 10.1073/pnas.0809794105; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; BURNETT BP, 1994, J BACTERIOL, V176, P6980, DOI 10.1128/JB.176.22.6980-6985.1994; Chen DH, 2013, CELL, V153, P1354, DOI 10.1016/j.cell.2013.04.052; CHEN S, 1994, NATURE, V371, P261, DOI 10.1038/371261a0; Doering DS, 1996, BIOCHEMISTRY-US, V35, P12677, DOI 10.1021/bi9615699; Farr GW, 2007, P NATL ACAD SCI USA, V104, P5342, DOI 10.1073/pnas.0700820104; Fei X, 2014, P NATL ACAD SCI USA, V111, P12775, DOI 10.1073/pnas.1412922111; Fujiwara K, 2010, EMBO J, V29, P1552, DOI 10.1038/emboj.2010.52; Gupta AJ, 2014, J MOL BIOL, V426, P2739, DOI 10.1016/j.jmb.2014.04.018; HORWICH AL, 1993, CELL, V74, P909, DOI 10.1016/0092-8674(93)90470-B; Horwich AL, 2009, FEBS LETT, V583, P2654, DOI 10.1016/j.febslet.2009.06.049; Hunt JF, 1996, NATURE, V379, P37, DOI 10.1038/379037a0; Ishino S, 2014, J BIOCHEM, V155, P295, DOI 10.1093/jb/mvu009; Kawata Y, 1999, BIOCHEMISTRY-US, V38, P15731, DOI 10.1021/bi9909750; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Koike-Takeshita A, 2008, J BIOL CHEM, V283, P23774, DOI 10.1074/jbc.M802542200; Koike-Takeshita A, 2014, J BIOL CHEM, V289, P30005, DOI 10.1074/jbc.M114.593822; Koike-Takeshita A, 2014, J MOL BIOL, V426, P3634, DOI 10.1016/j.jmb.2014.08.017; Machida K, 2008, J BIOL CHEM, V283, P6886, DOI 10.1074/jbc.M708002200; MCLENNAN NF, 1994, MOL MICROBIOL, V14, P309, DOI 10.1111/j.1365-2958.1994.tb01292.x; MCLENNAN NF, 1993, MOL MICROBIOL, V7, P49, DOI 10.1111/j.1365-2958.1993.tb01096.x; Motojima F, 2003, J BIOL CHEM, V278, P26648, DOI 10.1074/jbc.M300806200; Motojima F, 2000, BIOCHEM BIOPH RES CO, V267, P842, DOI 10.1006/bbrc.1999.2020; Motojima F, 2010, EMBO J, V29, P4008, DOI 10.1038/emboj.2010.262; Nojima T, 2008, J BIOL CHEM, V283, P18385, DOI 10.1074/jbc.M709825200; Sameshima T, 2008, J BIOL CHEM, V283, P23765, DOI 10.1074/jbc.M802541200; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Suzuki M, 2008, J BIOL CHEM, V283, P23931, DOI 10.1074/jbc.M804090200; Taguchi H, 2004, J BIOL CHEM, V279, P45737, DOI 10.1074/jbc.M406795200; Tanaka S, 2010, BBA-PROTEINS PROTEOM, V1804, P866, DOI 10.1016/j.bbapap.2009.12.016; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Thiyagarajan P, 1996, STRUCTURE, V4, P79, DOI 10.1016/S0969-2126(96)00011-1; Ueno T, 2004, MOL CELL, V14, P423, DOI 10.1016/S1097-2765(04)00261-8; Weaver J, 2014, J BIOL CHEM, V289, P23219, DOI 10.1074/jbc.M114.577205; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Yang D, 2013, P NATL ACAD SCI USA, V110, pE4298, DOI 10.1073/pnas.1318862110	38	10	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15042	15051		10.1074/jbc.M114.633636	http://dx.doi.org/10.1074/jbc.M114.633636			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25887400	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000356177300020
J	Tietz, S; Puthiyaveetil, S; Enlow, HM; Yarbrough, R; Wood, M; Semchonok, DA; Lowry, T; Li, Z; Jahns, P; Boekema, EJ; Lenhert, S; Niyogi, KK; Kirchhoff, H				Tietz, Stefanie; Puthiyaveetil, Sujith; Enlow, Heather M.; Yarbrough, Robert; Wood, Magnus; Semchonok, Dmitry A.; Lowry, Troy; Li, Zhirong; Jahns, Peter; Boekema, Egbert J.; Lenhert, Steven; Niyogi, Krishna K.; Kirchhoff, Helmut			Functional Implications of Photosystem II Crystal Formation in Photosynthetic Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEX; ELECTRON-TRANSPORT; GRANA MEMBRANES; THYLAKOID MEMBRANES; PROTEIN-PHOSPHORYLATION; ARABIDOPSIS DEFICIENT; XANTHOPHYLL-CYCLE; SPINACH-CHLOROPLASTS; ANTENNA PROTEINS; QUALITY-CONTROL	The structural organization of proteins in biological membranes can affect their function. Photosynthetic thylakoid membranes in chloroplasts have the remarkable ability to change their supramolecular organization between disordered and semicrystalline states. Although the change to the semicrystalline state is known to be triggered by abiotic factors, the functional significance of this protein organization has not yet been understood. Taking advantage of an Arabidopsis thaliana fatty acid desaturase mutant (fad5) that constitutively forms semicrystalline arrays, we systematically test the functional implications of protein crystals in photosynthetic membranes. Here, we show that the change into an ordered state facilitates molecular diffusion of photosynthetic components in crowded thylakoid membranes. The increased mobility of small lipophilic molecules like plastoquinone and xanthophylls has implications for diffusion-dependent electron transport and photoprotective energy-dependent quenching. The mobility of the large photosystem II supercomplexes, however, is impaired, leading to retarded repair of damaged proteins. Our results demonstrate that supramolecular changes into more ordered states have differing impacts on photosynthesis that favor either diffusion-dependent electron transport and photoprotection or protein repair processes, thus fine-tuning the photosynthetic energy conversion.	[Tietz, Stefanie; Puthiyaveetil, Sujith; Enlow, Heather M.; Yarbrough, Robert; Wood, Magnus; Kirchhoff, Helmut] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Semchonok, Dmitry A.; Boekema, Egbert J.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Electron Microscopy Grp, NL-9747 AG Groningen, Netherlands; [Lowry, Troy; Lenhert, Steven] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Li, Zhirong; Niyogi, Krishna K.] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Li, Zhirong; Niyogi, Krishna K.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Jahns, Peter] Univ Dusseldorf, Inst Biochem Pflanzen, D-40225 Dusseldorf, Germany	Washington State University; University of Groningen; State University System of Florida; Florida State University; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Heinrich Heine University Dusseldorf	Kirchhoff, H (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	kirchhh@wsu.edu	Semchonok, Dmitry/E-1461-2017; Puthiyaveetil, Sujith/S-3098-2016; Kirchhoff, Helmut/AAN-6695-2020	Puthiyaveetil, Sujith/0000-0001-7505-4511; Kirchhoff, Helmut/0000-0001-5874-3681; Tietz, Stefanie/0000-0003-1293-1163; Semchonok, Dmitry A./0000-0003-1622-9443	National Science Foundation [MCB115871]; United States-Israel Binational Agricultural Research and Development Fund [US-4334-10]; United States Department of Agriculture ARC [WNP00775]; Washington State University; Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, United States Department of Energy, FWP [SISGRKN]	National Science Foundation(National Science Foundation (NSF)); United States-Israel Binational Agricultural Research and Development Fund(US-Israel Binational Science Foundation); United States Department of Agriculture ARC; Washington State University; Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, United States Department of Energy, FWP(United States Department of Energy (DOE))	This work was supported by National Science Foundation Grant MCB115871 (to H. K.), United States-Israel Binational Agricultural Research and Development Fund US-4334-10, United States Department of Agriculture ARC Grant WNP00775, and Washington State University. The immunoblot experiments were supported by a grant from the Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, United States Department of Energy, FWP number SISGRKN (to K. K. N.)	ALLEN JF, 1992, BIOCHIM BIOPHYS ACTA, V1098, P275, DOI 10.1016/S0005-2728(09)91014-3; Arnoux P, 2009, PLANT CELL, V21, P2036, DOI 10.1105/tpc.109.068007; Betterle N, 2009, J BIOL CHEM, V284, P15255, DOI 10.1074/jbc.M808625200; BILGER W, 1988, Z NATURFORSCH C, V43, P877; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cramer WA, 1996, ANNU REV PLANT PHYS, V47, P477, DOI 10.1146/annurev.arplant.47.1.477; Daum B, 2010, PLANT CELL, V22, P1299, DOI 10.1105/tpc.109.071431; de Bianchi S, 2008, PLANT CELL, V20, P1012, DOI 10.1105/tpc.107.055749; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; Demmig-Adams B, 2012, PHOTOSYNTH RES, V113, P75, DOI 10.1007/s11120-012-9761-6; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; Farber A, 1997, PLANT PHYSIOL, V115, P1609, DOI 10.1104/pp.115.4.1609; Frommolt R, 2001, PLANTA, V213, P446, DOI 10.1007/s004250100589; Goral TK, 2012, PLANT J, V69, P289, DOI 10.1111/j.1365-313X.2011.04790.x; Goral TK, 2010, PLANT J, V62, P948, DOI [10.1111/j.1365-313X.2010.04207.x, 10.1111/j.0960-7412.2010.04207.x]; Goss R, 2005, BIOCHEMISTRY-US, V44, P4028, DOI 10.1021/bi047464k; Goss R, 2015, J PLANT PHYSIOL, V172, P13, DOI 10.1016/j.jplph.2014.03.004; HAEHNEL W, 1984, ANNU REV PLANT PHYS, V35, P659, DOI 10.1146/annurev.pp.35.060184.003303; Haferkamp S, 2010, J BIOL CHEM, V285, P17020, DOI 10.1074/jbc.M109.077750; Heilmann I, 2004, PLANT PHYSIOL, V136, P4237, DOI 10.1104/pp.104.052951; Herbstova M, 2012, P NATL ACAD SCI USA, V109, P20130, DOI 10.1073/pnas.1214265109; IZAWA S, 1978, BIOCHEM BIOPH RES CO, V83, P1171, DOI 10.1016/0006-291X(78)91518-8; Jahns P, 2009, BBA-BIOENERGETICS, V1787, P3, DOI 10.1016/j.bbabio.2008.09.013; Jahns P, 2012, BBA-BIOENERGETICS, V1817, P182, DOI 10.1016/j.bbabio.2011.04.012; Johnson MP, 2011, PLANT CELL, V23, P1468, DOI 10.1105/tpc.110.081646; Kereiche S, 2010, FEBS LETT, V584, P759, DOI 10.1016/j.febslet.2009.12.031; Kirchhoff H, 2002, BIOCHEMISTRY-US, V41, P4872, DOI 10.1021/bi011650y; Kirchhoff H, 2000, BBA-BIOENERGETICS, V1459, P148, DOI 10.1016/S0005-2728(00)00143-2; Kirchhoff H, 2004, BBA-BIOENERGETICS, V1659, P63, DOI 10.1016/j.bbabio.2004.08.004; Kirchhoff H, 2008, TRENDS PLANT SCI, V13, P201, DOI 10.1016/j.tplants.2008.03.001; Kirchhoff H, 2008, PLANT PHYSIOL, V146, P1571, DOI 10.1104/pp.107.115170; Kirchhoff H, 2008, BIOCHEMISTRY-US, V47, P431, DOI 10.1021/bi7017877; Kirchhoff H, 2014, BBA-BIOENERGETICS, V1837, P495, DOI 10.1016/j.bbabio.2013.11.003; Kirchhoff H, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23634; Kirchhoff H, 2013, PLANT PHYSIOL, V161, P497, DOI 10.1104/pp.112.207548; Klughammer C, 1998, PHOTOSYNTH RES, V56, P117, DOI 10.1023/A:1005998729041; Kouril R, 2013, BBA-BIOENERGETICS, V1827, P411, DOI 10.1016/j.bbabio.2012.12.003; Kovacs L, 2006, PLANT CELL, V18, P3106, DOI 10.1105/tpc.106.045641; Kramer DM, 2004, PHOTOSYNTH RES, V79, P209, DOI 10.1023/B:PRES.0000015391.99477.0d; Krause G. H., 2003, LIGHT HARVESTING ANT, V13, P373; KUNST L, 1989, PLANT PHYSIOL, V90, P943, DOI 10.1104/pp.90.3.943; KUNST L, 1989, PLANT PHYSIOL, V91, P401, DOI 10.1104/pp.91.1.401; KYLE DJ, 1984, P NATL ACAD SCI-BIOL, V81, P4070, DOI 10.1073/pnas.81.13.4070; Li XP, 2002, FUNCT PLANT BIOL, V29, P1131, DOI 10.1071/FP02065; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Melis A, 1999, TRENDS PLANT SCI, V4, P130, DOI 10.1016/S1360-1385(99)01387-4; Morosinotto T, 2006, FEBS J, V273, P4616, DOI 10.1111/j.1742-4658.2006.05465.x; Mulo P, 2008, PHOTOSYNTH RES, V98, P489, DOI 10.1007/s11120-008-9320-3; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; Nield J, 2006, BBA-BIOENERGETICS, V1757, P353, DOI 10.1016/j.bbabio.2006.03.019; OHAD I, 1984, J CELL BIOL, V99, P481, DOI 10.1083/jcb.99.2.481; Oostergetel GT, 1998, ULTRAMICROSCOPY, V74, P47, DOI 10.1016/S0304-3991(98)00022-9; PARK RB, 1964, SCIENCE, V144, P1009, DOI 10.1126/science.144.3621.1009; Pesaresi P, 2011, BBA-BIOENERGETICS, V1807, P887, DOI 10.1016/j.bbabio.2010.08.002; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Puthiyaveetil S, 2014, P NATL ACAD SCI USA, V111, P15839, DOI 10.1073/pnas.1413739111; Rappaport F, 2007, BBA-BIOENERGETICS, V1767, P56, DOI 10.1016/j.bbabio.2006.10.002; Ruban AV, 2015, J EXP BOT, V66, P7, DOI 10.1093/jxb/eru400; Ruban AV, 2012, BBA-BIOENERGETICS, V1817, P167, DOI 10.1016/j.bbabio.2011.04.007; Schuhmann H, 2012, PHYSIOL PLANTARUM, V145, P224, DOI 10.1111/j.1399-3054.2011.01533.x; SEMENOVA GA, 1995, CAN J BOT, V73, P1676, DOI 10.1139/b95-181; Sznee K, 2011, J BIOL CHEM, V286, P39164, DOI 10.1074/jbc.M111.284844; Tikkanen M, 2012, BBA-BIOENERGETICS, V1817, P232, DOI 10.1016/j.bbabio.2011.05.005; Tremmel IG, 2003, BBA-BIOENERGETICS, V1607, P97, DOI 10.1016/j.bbabio.2003.09.004; TSVETKOVA NM, 1994, BBA-BIOMEMBRANES, V1192, P263, DOI 10.1016/0005-2736(94)90127-9; Tyystjarvi E, 1996, P NATL ACAD SCI USA, V93, P2213, DOI 10.1073/pnas.93.5.2213; Vijayan P, 2002, PLANT PHYSIOL, V129, P876, DOI 10.1104/pp.004341; Wagner R, 2012, PHYSIOL PLANTARUM, V145, P203, DOI 10.1111/j.1399-3054.2011.01548.x; WEBB MS, 1991, BIOCHIM BIOPHYS ACTA, V1060, P133, DOI 10.1016/S0005-2728(09)91002-7; Wu W, 2013, BBA-BIOENERGETICS, V1827, P709, DOI 10.1016/j.bbabio.2013.02.013; YAMAMOTO HY, 1985, METHOD ENZYMOL, V110, P303; Yoshioka-Nishimura M, 2014, PLANT CELL PHYSIOL, V55, P1255, DOI 10.1093/pcp/pcu079; Zhang R, 2011, PHOTOSYNTH RES, V108, P171, DOI 10.1007/s11120-011-9672-y	75	38	38	0	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					14091	14106		10.1074/jbc.M114.619841	http://dx.doi.org/10.1074/jbc.M114.619841			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25897076	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000355313000038
J	Aldaz, G; Shluzas, LA; Pickham, D; Eris, O; Sadler, J; Joshi, S; Leifer, L				Aldaz, Gabriel; Shluzas, Lauren Aquino; Pickham, David; Eris, Ozgur; Sadler, Joel; Joshi, Shantanu; Leifer, Larry			Hands-Free Image Capture, Data Tagging and Transfer Using Google Glass: A Pilot Study for Improved Wound Care Management	PLOS ONE			English	Article							SPEECH RECOGNITION; PRESSURE ULCERS; NAVIGATION; WORDS; ERROR	Chronic wounds, including pressure ulcers, compromise the health of 6.5 million Americans and pose an annual estimated burden of $25 billion to the U.S. health care system. When treating chronic wounds, clinicians must use meticulous documentation to determine wound severity and to monitor healing progress over time. Yet, current wound documentation practices using digital photography are often cumbersome and labor intensive. The process of transferring photos into Electronic Medical Records (EMRs) requires many steps and can take several days. Newer smartphone and tablet-based solutions, such as Epic Haiku, have reduced EMR upload time. However, issues still exist involving patient positioning, image-capture technique, and patient identification. In this paper, we present the development and assessment of the SnapCap System for chronic wound photography. Through leveraging the sensor capabilities of Google Glass, SnapCap enables hands-free digital image capture, and the tagging and transfer of images to a patient's EMR. In a pilot study with wound care nurses at Stanford Hospital (n=16), we (i) examined feature preferences for hands-free digital image capture and documentation, and (ii) compared SnapCap to the state of the art in digital wound care photography, the Epic Haiku application. We used the Wilcoxon Signed-ranks test to evaluate differences in mean ranks between preference options. Preferred hands-free navigation features include barcode scanning for patient identification, Z(15) = -3.873, p < 0.001, r = 0.71, and double-blinking to take photographs, Z(13) = -3.606, p < 0.001, r = 0.71. In the comparison between SnapCap and Epic Haiku, the SnapCap System was preferred for sterile image-capture technique, Z(16) = -3.873, p < 0.001, r = 0.68. Responses were divided with respect to image quality and overall ease of use. The study's results have contributed to the future implementation of new features aimed at enhancing mobile hands-free digital photography for chronic wound care.	[Aldaz, Gabriel; Shluzas, Lauren Aquino; Sadler, Joel; Joshi, Shantanu; Leifer, Larry] Stanford Univ, Ctr Design Res, Stanford, CA 94305 USA; [Pickham, David] Stanford Hlth Care, Stanford, CA USA; [Eris, Ozgur] Delft Univ Technol, Delft, Netherlands	Stanford University; Stanford University; Delft University of Technology	Shluzas, LA (corresponding author), Stanford Univ, Ctr Design Res, Stanford, CA 94305 USA.	lauren.aquino@stanford.edu	Joshi, Sudhanshu/L-2284-2019; Pickham, David/AAD-8301-2021	Joshi, Sudhanshu/0000-0003-4748-5001; 	Hasso Plattner Design Thinking Research Program	Hasso Plattner Design Thinking Research Program	This work was supported by Hasso Plattner Design Thinking Research Program, http://www.hpi.uni-potsdam.de/. Authors who received funding: LAS GA SSJ LJL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Chulhyun, 2008, Adv Skin Wound Care, V21, P85, DOI 10.1097/01.ASW.0000305411.58350.7d; Albrecht UV, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3225; Beard HR, 2014, HEALTHCARE, V2, P22, DOI 10.1016/j.hjdsi.2013.09.009; Bigham J. P., 2010, P 23 ANN ACM S US IN, P333, DOI [DOI 10.1145/1866029.1866080, 10.1145/1866029.1866080?casa_token=eqdciLsaAKsAAAAA:v_iSvCJKVqaa-xY5ls_4fwveOme0IVWxS0hy40kPYpp]; Bizzotto N, 2014, SURG INNOV, V21, P338, DOI 10.1177/1553350613513514; Craig A.B., 2013, UNDERSTANDING AUGMEN, P209; Dixon BJ, 2013, SURG ENDOSC, V27, P454, DOI 10.1007/s00464-012-2457-3; Doherty A, 2013, SENSECAM 13, P60; Glauser W, 2013, CAN MED ASSOC J, V185, P1385, DOI 10.1503/cmaj.109-4607; Goldwater S, 2010, SPEECH COMMUN, V52, P181, DOI 10.1016/j.specom.2009.10.001; Gonzales D, 2011, STANFORD NURSE, V31, P12; Google, GLASS UPD; Google, GOOGL GL; Graves N, 2005, INFECT CONT HOSP EP, V26, P293, DOI 10.1086/502542; Hayes S, 2003, NURSING TIMES, V99, P1; Ishimaru S, 2014, AH 14, P150; Jacob R. J. K., 1990, SIGCHI Bulletin, P11; Jurafsky Dan, 2014, SPEECH LANGUAGE PROC, V3; Krouskop TA, 2002, J REHABIL RES DEV, V39, P337; Lutz BJ, 2013, CHICAGO SURG USE GOO; Lyder CH, 2012, J AM GERIATR SOC, V60, P1603, DOI 10.1111/j.1532-5415.2012.04106.x; Medical Xpress, 2013, 1 US SURG TRANSM LIV; Muensterer OJ, 2014, INT J SURG, V12, P281, DOI 10.1016/j.ijsu.2014.02.003; National Pressure Ulcer Advisory Council, FAQ PHOT PRESS ULC D; NPUAP, PRESS ULC STAG CAT; Perry Baromedical, MAVIS 3; Sears A, 2003, HUM-COMPUT INTERACT, V18, P229, DOI 10.1207/S15327051HCI1803_2; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Shluzas LA, 2014, US Provisional Patent, Patent No. 61968857; Wagner P, 2006, ETRA 2006, P117; Zafar A, 2004, INT J MED INFORM, V73, P719, DOI 10.1016/j.ijmedinf.2004.05.008; ZBar, BARC READ	32	28	28	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0121179	10.1371/journal.pone.0121179	http://dx.doi.org/10.1371/journal.pone.0121179			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902061	Green Submitted, gold, Green Published			2022-12-26	WOS:000353331500009
J	Beissner, F; Brunner, F; Fink, M; Meissner, K; Kaptchuk, TJ; Napadow, V				Beissner, Florian; Bruenner, Franziska; Fink, Maria; Meissner, Karin; Kaptchuk, Ted J.; Napadow, Vitaly			Placebo-Induced Somatic Sensations: A Multi-Modal Study of Three Different Placebo Interventions	PLOS ONE			English	Article							MCGILL PAIN QUESTIONNAIRE; PERSONALITY-TRAIT; NOVELTY SEEKING; MUSCLE PAIN; ACUPUNCTURE; BRAIN; PERCEPTION; MICROSTIMULATION; SYNAESTHESIA; MIGRAINE	Somatic sensations induced by placebos are a frequent phenomenon whose etiology and clinical relevance remains unknown. In this study, we have evaluated the quantitative, qualitative, spatial, and temporal characteristics of placebo-induced somatic sensations in response to three different placebo interventions: (1) placebo irritant solution, (2) placebo laser stimulation, and (3) imagined laser stimulation. The quality and intensity of evoked sensations were assessed using the McGill pain questionnaire and visual analogue scales (VAS), while subjects' sensation drawings processed by a geographic information system (GIS) were used to measure their spatial characteristics. We found that all three interventions are capable of producing robust sensations most frequently described as "tingling" and "warm" that can reach consider-able spatial extent (<= 205mm(2)) and intensity (<= 80/100 VAS). Sensations from placebo stimulation were often referred to areas remote from the stimulation site and exhibit considerable similarity with referred pain. Interestingly, there was considerable similarity of qualitative features as well as spatial patterns across subjects and placebos. However, placebo laser stimulation elicited significantly stronger and more widespread sensations than placebo irritant solution. Finally, novelty seeking, a character trait assessed by the Temperament and Character Inventory and associated with basal dopaminergic activity, was less pronounced in subjects susceptible to report placebo-induced sensations. Our study has shown that placebo-induced sensations are frequent and can reach considerable intensity and extent. As multiple somatosensory subsystems are involved despite the lack of peripheral stimulus, we propose a central etiology for this phenomenon.	[Beissner, Florian] Hannover Med Sch, Somatosensory & Auton Therapy Res, Inst Neuroradiol, D-30625 Hannover, Germany; [Beissner, Florian; Napadow, Vitaly] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol, Boston, MA 02129 USA; [Bruenner, Franziska; Fink, Maria] Jena Univ Hosp, Pain & Auton Integrat Res PAIR, Dept Psychiat & Psychotherapy, D-07743 Jena, Germany; [Meissner, Karin] Univ Munich, Inst Med Psychol, D-80336 Munich, Germany; [Kaptchuk, Ted J.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Program Placebo Studies, Boston, MA 02215 USA; [Napadow, Vitaly] Kyung Hee Univ, Dept Biomed Engn, Yongin, South Korea	Hannover Medical School; Harvard University; Massachusetts General Hospital; Friedrich Schiller University of Jena; University of Munich; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Kyung Hee University	Beissner, F (corresponding author), Hannover Med Sch, Somatosensory & Auton Therapy Res, Inst Neuroradiol, D-30625 Hannover, Germany.	beissner.florian@mh-hannover.de	MEISSNER, Karin/AAS-2483-2021; Beissner, Florian/I-3474-2019	Beissner, Florian/0000-0003-0513-7551; Napadow, Vitaly/0000-0003-1941-1750	Horst Gortz Foundation; German Research Foundation [BE4677/1-1]; Schweizer-Arau Foundation; Theophrastus Foundation; NIH [K24-AT004095, P01-AT006663, R01-AT007550, R01-AR064367]; National Center for Complementary & Integrative Health [K24AT004095, R01AT007550, P01AT006663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064367] Funding Source: NIH RePORTER	Horst Gortz Foundation; German Research Foundation(German Research Foundation (DFG)); Schweizer-Arau Foundation; Theophrastus Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by Horst Gortz Foundation (FBe, FBr), German Research Foundation BE4677/1-1 (FB), Schweizer-Arau Foundation (KM), Theophrastus Foundation (KM) and NIH grants K24-AT004095 (TJK), P01-AT006663 (VN, TJK), R01-AT007550 (VN), and R01-AR064367 (VN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banissy MJ, 2009, EXP BRAIN RES, V198, P261, DOI 10.1007/s00221-009-1810-9; Beissner F, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/591304; Benedetti F, 2011, NEUROPSYCHOPHARMACOL, V36, P339, DOI 10.1038/npp.2010.81; Bryant BP, 1999, BRAIN RES, V842, P452, DOI 10.1016/S0006-8993(99)01878-8; CLONINGER CR, 1987, ARCH GEN PSYCHIAT, V44, P573; CLONINGER CR, 1986, PSYCHIAT DEV, V4, P167; Colloca L, 2009, PAIN, V144, P28, DOI 10.1016/j.pain.2009.01.033; Darragh M, 2014, J PSYCHOSOM RES, V76, P414, DOI 10.1016/j.jpsychores.2014.02.011; De Pascalis V, 2002, PAIN, V96, P393, DOI 10.1016/S0304-3959(01)00485-7; Ebstein RP, 1996, NAT GENET, V12, P78, DOI 10.1038/ng0196-78; Enck P, 2013, NAT REV DRUG DISCOV, V12, P191, DOI 10.1038/nrd3923; FEINSTEIN B, 1954, J BONE JOINT SURG AM, V36-A, P981, DOI 10.2106/00004623-195436050-00007; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Fiorio M, 2012, NEUROSCIENCE, V217, P96, DOI 10.1016/j.neuroscience.2012.04.066; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; GravenNielsen T, 1997, BRAIN RES, V744, P121, DOI 10.1016/S0006-8993(96)01077-3; GravenNielsen T, 1997, J MUSCULOSKELET PAIN, V5, P49, DOI 10.1300/J094v05n01_04; Harrison J, 1997, SYNAESTHESIA INTRO, P281; Head H, 1893, BRAIN, V16, P1, DOI DOI 10.1093/BRAIN/16.1-2.1; Hrobjartsson A, 2011, J CLIN EPIDEMIOL, V64, P1223, DOI 10.1016/j.jclinepi.2011.01.008; Hui Kathleen K S, 2007, BMC Complement Altern Med, V7, P33, DOI 10.1186/1472-6882-7-33; Irnich D, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/neq009; JOHNSON AG, 1994, LANCET, V344, P1140, DOI 10.1016/S0140-6736(94)90637-8; Kaptchuk TJ, 2006, BMJ-BRIT MED J, V332, P391, DOI 10.1136/bmj.38726.603310.55; Kaptchuk TJ, 2000, J CLIN EPIDEMIOL, V53, P786, DOI 10.1016/S0895-4356(00)00206-7; Kerr CE, 2011, CONSCIOUS COGN, V20, P784, DOI 10.1016/j.concog.2010.12.009; Keysers C, 2010, NAT REV NEUROSCI, V11, P417, DOI 10.1038/nrn2833; Kong J, 2007, J ALTERN COMPLEM MED, V13, P1059, DOI 10.1089/acm.2007.0524; Lennertz RC, 2010, J NEUROSCI, V30, P4353, DOI 10.1523/JNEUROSCI.4666-09.2010; LENZ FA, 1993, J NEUROPHYSIOL, V70, P200, DOI 10.1152/jn.1993.70.1.200; Liang ZH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/620671; Linde K, 2010, FORSCH KOMPLEMENTMED, V17, P259, DOI 10.1159/000320374; Longley P.A., 2005, GEOGRAPHIC INFORM SY, V2nd, P536; Lucas MV, 2015, CEREB CORTEX, V25, P2623, DOI 10.1093/cercor/bhu061; Mackenzie J, 1893, BRAIN, V16, P321; MARCHAND S, 1993, PAIN, V54, P99, DOI 10.1016/0304-3959(93)90104-W; MAUGUIERE F, 1978, BRAIN, V101, P307, DOI 10.1093/brain/101.2.307; Meissner K, 2013, JAMA INTERN MED, V173, P1941, DOI 10.1001/jamainternmed.2013.10391; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Michael GA, 2011, CONSCIOUS COGN, V20, P603, DOI 10.1016/j.concog.2010.11.013; Napadow V, 2009, NEUROIMAGE, V47, P1055, DOI 10.1016/j.neuroimage.2009.05.079; NORDIN M, 1984, PAIN, V20, P231, DOI 10.1016/0304-3959(84)90013-7; OCHOA J, 1983, J PHYSIOL-LONDON, V342, P633, DOI 10.1113/jphysiol.1983.sp014873; Park H, 2002, AM J CHINESE MED, V30, P45, DOI 10.1142/S0192415X02000053; Penfield W, 1933, ARCH NEURO PSYCHIATR, V30, P709, DOI 10.1001/archneurpsyc.1933.02240160009001; Ramachandran V, 2001, J CONSCIOUSNESS STUD, V8, P3; Ro T, 2007, ANN NEUROL, V62, P433, DOI 10.1002/ana.21219; ROBERTS AH, 1993, CLIN PSYCHOL REV, V13, P375, DOI 10.1016/0272-7358(93)90010-J; Salih N, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-81; Schmidt TT, 2014, NEUROIMAGE, V98, P216, DOI 10.1016/j.neuroimage.2014.05.014; Schweinhardt P, 2009, J NEUROSCI, V29, P4882, DOI 10.1523/JNEUROSCI.5634-08.2009; SHAPIRO AK, 1968, PSYCHIAT QUART, V42, P653, DOI 10.1007/BF01564309; Sihvonen R, 2013, NEW ENGL J MED, V369, P2515, DOI 10.1056/NEJMoa1305189; STEIN C, 1988, PAIN, V32, P251, DOI 10.1016/0304-3959(88)90074-7; Streitberger K, 1998, LANCET, V352, P364, DOI 10.1016/S0140-6736(97)10471-8; Suhara T, 2001, NEUROIMAGE, V13, P891, DOI 10.1006/nimg.2001.0761; TANSEY MJB, 1993, J NEUROL SCI, V114, P109, DOI 10.1016/0022-510X(93)90057-6; Tracey I, 2010, NAT MED, V16, P1277, DOI 10.1038/nm.2229; Vecchiet, 1999, Curr Rev Pain, V3, P489; Ward J, 2013, ANNU REV PSYCHOL, V64, P49, DOI 10.1146/annurev-psych-113011-143840; Wartolowska K, 2014, BMJ IN PRESS, P348	61	21	21	15	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124808	10.1371/journal.pone.0124808	http://dx.doi.org/10.1371/journal.pone.0124808			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG5KV	25901350	Green Published, Green Submitted, gold			2022-12-26	WOS:000353331500100
J	Bizjak, DA; Brinkmann, C; Bloch, W; Grau, M				Bizjak, Daniel Alexander; Brinkmann, Christian; Bloch, Wilhelm; Grau, Marijke			Increase in Red Blood Cell-Nitric Oxide Synthase Dependent Nitric Oxide Production during Red Blood Cell Aging in Health and Disease: A Study on Age Dependent Changes of Rheologic and Enzymatic Properties in Red Blood Cells	PLOS ONE			English	Article							IN-VIVO; S-NITROSOHEMOGLOBIN; ANALYZER LORCA; PLASMA NITRITE; ARGINASE; HEMOGLOBIN; NO; ERYTHROCYTES; CHEMILUMINESCENCE; DEFORMABILITY	Aim To investigate RBC-NOS dependent NO signaling during in vivo RBC aging in health and disease. Method RBC from fifteen healthy volunteers (HC) and four patients with type 2 diabetes mellitus (DM) were separated in seven subpopulations by Percoll density gradient centrifugation. Results The proportion of old RBC was significantly higher in DM compared to HC. In both groups, in vivo aging was marked by changes in RBC shape and decreased cell volume. RBC nitrite, as marker for NO, was higher in DM and increased in both HC and DM during aging. RBC deformability was lower in DM and significantly decreased in old compared to young RBC in both HC and DM. RBC-NOS Serine(1177) phosphorylation, indicating enzyme activation, increased during aging in both HC and DM. Arginase I activity remained unchanged during aging in HC. In DM, arginase I activity was significantly higher in young RBC compared to HC but decreased during aging. In HC, concentration of L-arginine, the substrate of RBC-NOS and arginase I, significantly dropped from young to old RBC. In DM, L-arginine concentration was significantly higher in young RBC compared to HC and significantly decreased during aging. In blood from healthy subjects, RBC-NOS activation was additionally inhibited by N-5-(1-iminoethyl)-L-Ornithine dihydrochloride which decreased RBC nitrite, and impaired RBC deformability of all but the oldest RBC subpopulation. Conclusion This study first-time showed highest RBC-NOS activation and NO production in old RBC, possibly to counteract the negative impact of cell shrinkage on RBC deformability. This was even more pronounced in DM. It is further suggested that highly produced NO only insufficiently affects cell function of old RBC maybe because of isolated RBC-NOS in old RBC thus decreasing NO bioavailability. Thus, increasing NO availability may improve RBC function and may extend cell life span in old RBC.	[Bizjak, Daniel Alexander; Brinkmann, Christian; Bloch, Wilhelm; Grau, Marijke] German Sport Univ Cologne, Dept Mol & Cellular Sport Med, Cologne, Germany	German Sport University Cologne	Grau, M (corresponding author), German Sport Univ Cologne, Dept Mol & Cellular Sport Med, Cologne, Germany.	m.grau@dshs-koeln.de	Grau, Marijke/AAM-7025-2020	Grau, Dr. Marijke/0000-0003-1980-9195; Bizjak, Daniel/0000-0003-4075-0204; , Christian Brinkmann/0000-0001-8419-7565				Alaarg A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00365; Antonelou MH, 2010, BLOOD TRANSFUS-ITALY, V8, pS39, DOI 10.2450/2010.007S; Bivalacqua TJ, 2001, BIOCHEM BIOPH RES CO, V283, P923, DOI 10.1006/bbrc.2001.4874; Bonnefont-Rousselot D, 2002, CURR OPIN CLIN NUTR, V5, P561, DOI 10.1097/00075197-200209000-00016; Bor-Kucukatay M, 2003, AM J PHYSIOL-HEART C, V284, pH1577, DOI 10.1152/ajpheart.00665.2002; BOSCH FH, 1992, BLOOD, V79, P254; Bosman GJCGM, 2010, J PROTEOMICS, V73, P396, DOI 10.1016/j.jprot.2009.07.010; Bosman GJCGM, 2008, TRANSFUSION MED, V18, P335, DOI 10.1111/j.1365-3148.2008.00892.x; Bruckdorfer Richard, 2005, Molecular Aspects of Medicine, V26, P3, DOI 10.1016/j.mam.2004.09.002; CHANDRAMOULI V, 1975, DIABETES, V24, P257, DOI 10.2337/diabetes.24.3.257; CLARK MR, 1983, BLOOD, V61, P899, DOI 10.1182/blood.V61.5.899.899; CONNOR J, 1994, J BIOL CHEM, V269, P2399; CORRALIZA IM, 1994, J IMMUNOL METHODS, V174, P231, DOI 10.1016/0022-1759(94)90027-2; Durante W, 2007, CLIN EXP PHARMACOL P, V34, P906, DOI 10.1111/j.1440-1681.2007.04638.x; Franco RS, 2009, AM J HEMATOL, V84, P109, DOI 10.1002/ajh.21298; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Gifford SC, 2006, BRIT J HAEMATOL, V135, P395, DOI 10.1111/j.1365-2141.2006.06279.x; Gow AJ, 1998, NATURE, V391, P169, DOI 10.1038/34402; Grau M, 2007, J CHROMATOGR B, V851, P106, DOI 10.1016/j.jchromb.2007.02.002; Grau M, 2015, BRIT J HAEMATOL, V168, P728, DOI 10.1111/bjh.13185; Grau M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056759; Green DJ, 2004, J PHYSIOL-LONDON, V561, P1, DOI 10.1113/jphysiol.2004.068197; Gronros J, 2011, AM J PHYSIOL-HEART C, V300, pH1174, DOI 10.1152/ajpheart.00560.2010; Gupta BL, 2004, J BIOSCIENCES, V29, P73, DOI 10.1007/BF02702564; Handelman GJ, 2010, J RENAL NUTR, V20, pS84, DOI 10.1053/j.jrn.2010.06.007; HARDEMAN MR, 1994, CLIN HEMORHEOL, V14, P605; Hardeman MR, 2001, CLIN HEMORHEOL MICRO, V25, P1; Hayashino Y, 2014, METABOLISM, V63, P431, DOI 10.1016/j.metabol.2013.08.018; Hendgen-Cotta U, 2008, METHOD ENZYMOL, V441, P295, DOI 10.1016/S0076-6879(08)01216-0; Hobbs AJ, 2002, TRENDS PHARMACOL SCI, V23, P406, DOI 10.1016/S0165-6147(02)02067-9; Horn P, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.003764; Huang KT, 2005, J BIOL CHEM, V280, P31126, DOI 10.1074/jbc.M501496200; Huang Z, 2005, J CLIN INVEST, V115, P2099, DOI 10.1172/JCI24650; IGNARRO LJ, 1993, P NATL ACAD SCI USA, V90, P8103, DOI 10.1073/pnas.90.17.8103; IKEMOTO M, 1990, BIOCHEM J, V270, P697, DOI 10.1042/bj2700697; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; Joshi MS, 2002, P NATL ACAD SCI USA, V99, P10341, DOI 10.1073/pnas.152149699; Kelm M, 1999, CARDIOVASC RES, V41, P765, DOI 10.1016/S0008-6363(98)00259-4; Kim-Shapiro DB, 2006, ARTERIOSCL THROM VAS, V26, P697, DOI 10.1161/01.ATV.0000204350.44226.9a; Kleinbongard P, 2006, BLOOD, V107, P2943, DOI 10.1182/blood-2005-10-3992; Kleinbongard P, 2007, THROMB HAEMOSTASIS, V98, P970, DOI 10.1160/TH07-04-0305; KOLLURU GK, 2012, INT J VASC MED, DOI DOI 10.1155/2012/918267; Lauer T, 2001, P NATL ACAD SCI USA, V98, P12814, DOI 10.1073/pnas.221381098; LEDEVEHAT C, 1994, DIABETES METAB, V20, P401; LINDERKAMP O, 1982, BLOOD, V59, P1121; Liu X, J BIOL CHEM, V277, P26194; Liu XP, 1998, J BIOL CHEM, V273, P18709, DOI 10.1074/jbc.273.30.18709; MAZZANTI L, 1992, CLIN BIOCHEM, V25, P41, DOI 10.1016/0009-9120(92)80044-H; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; MOORE EG, 1976, J BIOL CHEM, V251, P2788; Munder M, 2009, BRIT J PHARMACOL, V158, P638, DOI 10.1111/j.1476-5381.2009.00291.x; NASH GB, 1980, BIORHEOLOGY, V17, P479; NASH GB, 1983, BIOPHYS J, V43, P63, DOI 10.1016/S0006-3495(83)84324-0; Owusu BY, 2013, ANTIOXID REDOX SIGN, V19, P1198, DOI 10.1089/ars.2012.4884; Palis J, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00003; Pelletier MM, 2006, FREE RADICAL BIO MED, V41, P541, DOI 10.1016/j.freeradbiomed.2006.05.001; Quinones Manuel J, 2005, Curr Diab Rep, V5, P246, DOI 10.1007/s11892-005-0018-z; Ramirez-Zamora S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066823; Rassaf T, 2007, CIRC RES, V100, P1749, DOI 10.1161/CIRCRESAHA.107.152488; Rifkind JM, 2013, ANTIOXID REDOX SIGN, V18, P2274, DOI 10.1089/ars.2012.4867; Romero MJ, 2008, CIRC RES, V102, P95, DOI 10.1161/CIRCRESAHA.107.155028; Sakai H, 2008, J BIOL CHEM, V283, P1508, DOI 10.1074/jbc.M707660200; Savu O, 2015, ANN CLIN BIOCHEM, V52, P135, DOI 10.1177/0004563214531739; SCHWARTZ RS, 1991, DIABETES, V40, P701, DOI 10.2337/diabetes.40.6.701; SHARMA VS, 1978, J BIOL CHEM, V253, P6467; Shemyakin A, 2012, CIRCULATION, V126, P2943, DOI 10.1161/CIRCULATIONAHA.112.140335; Shiva S, 2013, REDOX BIOL, V1, P40, DOI 10.1016/j.redox.2012.11.005; Simmonds MJ, 2014, BIORHEOLOGY, V51, P121, DOI 10.3233/BIR-140653; Smith JA, 1999, AM J PHYSIOL-HEART C, V276, pH2188, DOI 10.1152/ajpheart.1999.276.6.H2188; Stamler JS, 1997, SCIENCE, V276, P2034, DOI 10.1126/science.276.5321.2034; Subasinghe W, 2008, ANAL CHIM ACTA, V618, P227, DOI 10.1016/j.aca.2008.04.061; Suhr F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045982; Tessari P, 2010, DIABETES, V59, P2152, DOI 10.2337/db09-1772; Totzeck M, 2012, CIRCULATION, V126, P325, DOI 10.1161/CIRCULATIONAHA.111.087155; Vaughn MW, 2001, NITRIC OXIDE-BIOL CH, V5, P18, DOI 10.1006/niox.2000.0328; Virtue MA, 2004, DIABETES CARE, V27, P931, DOI 10.2337/diacare.27.4.931; Witte MB, 2002, METABOLISM, V51, P1269, DOI 10.1053/meta.2002.35185; Yang JN, 2013, P NATL ACAD SCI USA, V110, P15049, DOI 10.1073/pnas.1307058110; Yang ZH, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00149; Zimny S, 2001, DIABETES CARE, V24, P1810, DOI 10.2337/diacare.24.10.1810	80	43	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0125206	10.1371/journal.pone.0125206	http://dx.doi.org/10.1371/journal.pone.0125206			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902315	Green Published, Green Submitted, gold			2022-12-26	WOS:000353331500115
J	Broadway, KJ; Pyron, M; Gammon, JR; Murry, BA				Broadway, Kyle J.; Pyron, Mark; Gammon, James R.; Murry, Brent A.			Shift in a Large River Fish Assemblage: Body-Size and Trophic Structure Dynamics	PLOS ONE			English	Article							REGIME SHIFTS; WABASH RIVER; ECOLOGICAL-SYSTEMS; BERING-SEA; COMMUNITY; RESILIENCE; ABUNDANCE; SPECTRA; THRESHOLDS; ECOSYSTEMS	As the intensity and speed of environmental change increase at both local and global scales it is imperative that we gain a better understanding of the ecological implications of community shifts. While there has been substantial progress toward understanding the drivers and subsequent responses of community change (e.g. lake trophic state), the ecological impacts of food web changes are far less understood. We analyzed Wabash River fish assemblage data collected from 1974-2008, to evaluate temporal variation in body-size structure and functional group composition. Two parameters derived from annual community size-spectra were our major response variables: (1) the regression slope is an index of ecological efficiency and predator-prey biomass ratios, and (2) spectral elevation (regression midpoint height) is a proxy for food web capacity. We detected a large assemblage shift, over at least a seven year period, defined by dramatic changes in abundance (measured as catchper- unit-effort) of the dominant functional feeding groups among two time periods; from an assemblage dominated by planktivore-omnivores to benthic invertivores. There was a concurrent increase in ecological efficiency (slopes increased over time) following the shift associated with an increase in large-bodied low trophic level fish. Food web capacity remained relatively stable with no clear temporal trends. Thus, increased ecological efficiency occurred simultaneous to a compensatory response that shifted biomass among functional feeding groups.	[Broadway, Kyle J.; Murry, Brent A.] Cent Michigan Univ, Dept Biol, Inst Great Lakes Res, Mt Pleasant, MI 48858 USA; [Pyron, Mark] Ball State Univ, Dept Biol, Muncie, IN 47306 USA; [Gammon, James R.] Depauw Univ, Dept Biol, Greencastle, IN 46135 USA	Central Michigan University; Ball State University; DePauw University	Pyron, M (corresponding author), Ball State Univ, Dept Biol, Muncie, IN 47306 USA.	mpyron@bsu.edu	Pyron, Mark/D-4572-2011	Pyron, Mark/0000-0003-0451-7827	Duke Power; Eli Lilly, Inc.	Duke Power; Eli Lilly, Inc.(Eli Lilly)	Pyron field collections were funded by Duke Power and Eli Lilly, Inc. no grant numbers available. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen T, 2009, TRENDS ECOL EVOL, V24, P49, DOI 10.1016/j.tree.2008.07.014; Arim M, 2010, OIKOS, V119, P147, DOI 10.1111/j.1600-0706.2009.17768.x; Benson AJ, 2002, FISH FISH, V3, P95, DOI 10.1046/j.1467-2979.2002.00078.x; Blanchard JL, 2009, J ANIM ECOL, V78, P270, DOI 10.1111/j.1365-2656.2008.01466.x; Boldt JL, 2012, T AM FISH SOC, V141, P327, DOI 10.1080/00028487.2012.662205; Brose U, 2006, ECOLOGY, V87, P2411, DOI 10.1890/0012-9658(2006)87[2411:CBRINF]2.0.CO;2; Brown JL, 2004, J RAPTOR RES, V38, P148; Buishand TA, 1984, J HYDROL, V73, P51069; Carpenter SR, 2011, SCIENCE, V332, P1079, DOI 10.1126/science.1203672; CARPENTER SR, 1989, ECOLOGY, V70, P1142, DOI 10.2307/1941382; Castrale JS, 1983, P INDIANA ACAD SCI, V93, P173; Chapin FS, 1997, SCIENCE, V277, P500, DOI 10.1126/science.277.5325.500; Coulter AA, 2013, FRESHWATER BIOL, V58, P1029, DOI 10.1111/fwb.12106; Daan N, 2005, ICES J MAR SCI, V62, P177, DOI 10.1016/j.icesjms.2004.08.020; Deyoung B, 2008, TRENDS ECOL EVOL, V23, P402, DOI 10.1016/j.tree.2008.03.008; Dossena M, 2012, P ROY SOC B-BIOL SCI, V279, P3011, DOI 10.1098/rspb.2012.0394; DUARTE CM, 1987, OECOLOGIA, V74, P272, DOI 10.1007/BF00379370; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Folke C, 2010, ECOL SOC, V15, DOI 10.5751/es-03610-150420; Frimpong EA, 2009, FISHERIES, V34, P487, DOI 10.1577/1548-8446-34.10.487; GAEDKE U, 1993, LIMNOL OCEANOGR, V38, P112, DOI 10.4319/lo.1993.38.1.0112; Gammon J. R., 1998, WABASH RIVER ECOSYST; Gammon JR, 2000, HYDROBIOLOGIA, V422, P291, DOI 10.1023/A:1017060520873; Gammon JR, 1976, IWRRC TECHNICAL REPO; Hare SR, 2000, PROG OCEANOGR, V47, P103, DOI 10.1016/S0079-6611(00)00033-1; Hastings A, 2010, ECOL LETT, V13, P464, DOI 10.1111/j.1461-0248.2010.01439.x; HAYES DB, 1994, T AM FISH SOC, V123, P204, DOI 10.1577/1548-8659(1994)123<0204:CITCOS>2.3.CO;2; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jennings S, 2003, ECOL LETT, V6, P971, DOI 10.1046/j.1461-0248.2003.00529.x; Jennings S, 2002, MAR ECOL PROG SER, V240, P11, DOI 10.3354/meps240011; Jennings S, 2010, J MARINE SYST, V79, P418, DOI 10.1016/j.jmarsys.2008.12.016; Jung S, 2005, ESTUARIES, V28, P226, DOI 10.1007/BF02732857; Karns Daryl R., 2006, Proceedings of the Indiana Academy of Science, V115, P79; Karr J. R., 1986, SPECIAL PUBLICATION, V5; Kerr S. R., 2001, COM ECO SYS; Kinzig AP, 2006, ECOL SOC, V11; Maxwell TAD, 2006, OECOLOGIA, V150, P282, DOI 10.1007/s00442-006-0520-2; MAY RM, 1977, NATURE, V269, P471, DOI 10.1038/269471a0; Mueller R, 2010, COPEIA, P47, DOI 10.1643/CE-08-154; Murry BA, 2014, FRESHWATER BIOL, V59, P155, DOI 10.1111/fwb.12255; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Paul MJ, 2001, ANNU REV ECOL SYST, V32, P333, DOI 10.1146/annurev.ecolsys.32.081501.114040; Persson L, 2007, SCIENCE, V316, P1743, DOI 10.1126/science.1141412; PETERS RH, 1983, OECOLOGIA, V60, P89, DOI 10.1007/BF00379325; Post DM, 2002, TRENDS ECOL EVOL, V17, P269, DOI 10.1016/S0169-5347(02)02455-2; Pritchett J, 2012, RIVER RES APPL, V28, P1501, DOI 10.1002/rra.1528; Pyron M, 2004, HYDROBIOLOGIA, V525, P203, DOI 10.1023/B:HYDR.0000038867.28271.45; Pyron M, 2008, RIVER RES APPL, V24, P1175, DOI 10.1002/rra.1155; Pyron M, 2008, HYDROBIOLOGIA, V600, P205, DOI 10.1007/s10750-007-9232-9; Pyron M, 2006, FRESHWATER BIOL, V51, P1789, DOI 10.1111/j.1365-2427.2006.01609.x; Pyron Mark, 2011, River Systems, V19, P239, DOI 10.1127/1868-5749/2011/019-0028; Pyron M, 2011, FRESHWATER BIOL, V56, P1579, DOI 10.1111/j.1365-2427.2011.02596.x; Robinson CT, 2008, ECOL APPL, V18, P511, DOI 10.1890/07-0886.1; Rochet MJ, 2012, P ROY SOC B-BIOL SCI, V279, P284, DOI 10.1098/rspb.2011.0893; RODRIGUEZ J, 1990, J PLANKTON RES, V12, P593, DOI 10.1093/plankt/12.3.593; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; SHELDON RW, 1972, LIMNOL OCEANOGR, V17, P327, DOI 10.4319/lo.1972.17.3.0327; Small GE, 2011, ECOLOGY, V92, P386, DOI 10.1890/10-0081.1; SPRULES WG, 1986, CAN J FISH AQUAT SCI, V43, P1789, DOI 10.1139/f86-222; Suding KN, 2009, TRENDS ECOL EVOL, V24, P271, DOI 10.1016/j.tree.2008.11.012; Sweeting CJ, 2009, ICES J MAR SCI, V66, P195, DOI 10.1093/icesjms/fsn203; Tockner K, 2010, FRESHWATER BIOL, V55, P135, DOI 10.1111/j.1365-2427.2009.02371.x; Trebilco R, 2013, TRENDS ECOL EVOL, V28, P423, DOI 10.1016/j.tree.2013.03.008; Vanni MJ, 1997, ECOLOGY, V78, P1; Walker B, 2004, ECOL SOC, V9; Walker B, 2004, ECOL SOC, V9; White EP, 2007, TRENDS ECOL EVOL, V22, P323, DOI 10.1016/j.tree.2007.03.007; Yvon-Durocher G, 2011, OIKOS, V120, P550, DOI 10.1111/j.1600-0706.2010.18863.x	70	18	19	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124954	10.1371/journal.pone.0124954	http://dx.doi.org/10.1371/journal.pone.0124954			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902144	Green Published, gold, Green Submitted			2022-12-26	WOS:000353331500106
J	Sangi, M; Win, KT; Shirvani, F; Namazi-Rad, MR; Shukla, N				Sangi, Mohsen; Win, Khin Than; Shirvani, Farid; Namazi-Rad, Mohammad-Reza; Shukla, Nagesh			Applying a Novel Combination of Techniques to Develop a Predictive Model for Diabetes Complications	PLOS ONE			English	Article							NEURAL-NETWORKS; MANAGEMENT; CLASSIFICATION; CARE; PHYSICIANS	Among the many related issues of diabetes management, its complications constitute the main part of the heavy burden of this disease. The aim of this paper is to develop a risk advisor model to predict the chances of diabetes complications according to the changes in risk factors. As the starting point, an inclusive list of (k) diabetes complications and (n) their correlated predisposing factors are derived from the existing endocrinology text books. A type of data meta-analysis has been done to extract and combine the numeric value of the relationships between these two. The whole n (risk factors) - k (complications) model was broken down into k different (n-1) relationships and these (n-1) dependencies were broken into n (1-1) models. Applying regression analysis (seven patterns) and artificial neural networks (ANN), we created models to show the (1-1) correspondence between factors and complications. Then all 1-1 models related to an individual complication were integrated using the naive Bayes theorem. Finally, a Bayesian belief network was developed to show the influence of all risk factors and complications on each other. We assessed the predictive power of the 1-1 models by R-2, F-ratio and adjusted R-2 equations; sensitivity, specificity and positive predictive value were calculated to evaluate the final model using real patient data. The results suggest that the best fitted regression models outperform the predictive ability of an ANN model, as well as six other regression patterns for all 1-1 models.	[Sangi, Mohsen; Shirvani, Farid; Namazi-Rad, Mohammad-Reza; Shukla, Nagesh] Univ Wollongong, SMART Infrastruct Facil, Wollongong, NSW 2522, Australia; [Sangi, Mohsen; Win, Khin Than] Univ Wollongong, Sch Informat Syst & Technol, Wollongong, NSW 2522, Australia	University of Wollongong; University of Wollongong	Sangi, M (corresponding author), Univ Wollongong, SMART Infrastruct Facil, Wollongong, NSW 2522, Australia.	m64473s@yahoo.com	Win, Khin Than/F-7491-2018; Shukla, Nagesh/X-6556-2019	Win, Khin Than/0000-0002-7810-6388; NAMAZI-RAD, Mohammad-Reza/0000-0003-1941-9445; Shirvani, Fariba/0000-0003-1161-8650; Shukla, Nagesh/0000-0002-8421-3972				[Anonymous], 1996, DIABETES, V45, P1289; [Anonymous], 2010, IBM SPSS STAT; [Anonymous], 2007, PRACTICE NURSE, V33, P6, DOI DOI 10.1578/AM.33.1.2007.6; Balas EA, 1998, J AM MED INFORM ASSN, P295; Balas EA, 2004, MED CARE, V42, P610, DOI 10.1097/01.mlr.0000128008.12117.f8; Boulton A J, 2000, J Fam Pract, V49, pS3; Brierley P, 2011, TIBERIUS DATA MINING; BROWN DE, 1993, PATTERN RECOGN, V26, P953, DOI 10.1016/0031-3203(93)90060-A; Brownlee M, 2011, COMPLICATIONS DIABET; Celler BG, 2003, MED J AUSTRALIA, V179, P242, DOI 10.5694/j.1326-5377.2003.tb05529.x; CURRAM SP, 1994, J OPER RES SOC, V45, P440, DOI 10.2307/2584215; DEUTSCH T, 1989, COMPUT METH PROG BIO, V29, P75, DOI 10.1016/0169-2607(89)90076-X; Dunstan DW, 2002, DIABETES RES CLIN PR, V57, P119, DOI 10.1016/S0168-8227(02)00025-6; Everett J, 2004, PRACTICAL DIABETES I, V21, P173; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Griffith J, 2000, MED DECIS MAKING, V20, P243, DOI 10.1177/0272989X0002000210; Habacher W, 2007, J EVAL CLIN PRACT, V13, P906, DOI 10.1111/j.1365-2753.2006.00770.x; Han J., 2006, DATA MINING CONCEPTS, DOI 10.1016/C2009-0-61819-5; HARRIS MI, 1990, DIABETES CARE, V13, P419, DOI 10.2337/diacare.13.4.419; Hernando ME, 2000, COMPUT METH PROG BIO, V62, P235, DOI 10.1016/S0169-2607(00)00070-5; Hutcheson G. D., 1999, MULTIVARIATE SOCIAL; International Diabetes Federation, 2011, MODULE 2 2B NUTR THE; JACQUES CHM, 1991, DIABETES CARE, V14, P712, DOI 10.2337/diacare.14.8.712; Kapur A, 2007, INDIAN J MED RES, V125, P473; Koleszynska J, 2008, KNOWLEDGE BASED INTE, P789; Koumakis L., 2012, WIRELESS MOBILE COMM, P46; Lagani V, 2013, J DIABETES COMPLICAT, V27, P407, DOI 10.1016/j.jdiacomp.2012.11.003; Lawrence J., 1994, INTRO NEURAL NETWORK; Lim TS, 2000, MACH LEARN, V40, P203, DOI 10.1023/A:1007608224229; Longo DL, 2012, HARRISONS PRINCIPLES; Masharani U, 2013, CURRENT MED DIAGNOSI; Montani S, 2001, Diabetes Technol Ther, V3, P347, DOI 10.1089/15209150152607123; Murphy K, 2002, SOFTWARE PACKAGES GR; PEARL J, 1998, PROBABILISTIC REASON; Pickup John C, 2012, Int J Clin Pract Suppl, P15, DOI 10.1111/j.1742-1241.2011.02849.x; Quinlan J R, 1988, EMPIRICAL COMP GENET, P135; Razi MA, 2005, EXPERT SYST APPL, V29, P65, DOI 10.1016/j.eswa.2005.01.006; RODBARD D, 1988, DIABETES CARE, V11, P54; Sangi M, 2010, KNOWLEDGE BASED RISK, P1798; Schuster MA, 1998, MILBANK Q, V76, P517, DOI 10.1111/1468-0009.00105; SHAVLIK JW, 1991, MACH LEARN, V6, P111, DOI 10.1007/BF00114160; Smith A. E., 1997, Engineering Economist, V42, P137, DOI 10.1080/00137919708903174; Stevens J.P., 2009, APPL MULTIVARIATE ST, V5th ed.; Zikmund W.G., 2010, EXPLORING MARKETING	44	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0121569	10.1371/journal.pone.0121569	http://dx.doi.org/10.1371/journal.pone.0121569			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902317	Green Published, gold, Green Submitted			2022-12-26	WOS:000353331500011
J	Zhang, XM; Li, FP; Guo, L; Hei, HY; Tian, LL; Peng, W; Cai, H				Zhang, Xuemei; Li, Fangping; Guo, Lin; Hei, Hongya; Tian, Lulu; Peng, Wen; Cai, Hui			Forskolin Regulates L-Type Calcium Channel through Interaction between Actinin 4 and beta(3) Subunit in Osteoblasts	PLOS ONE			English	Article							INDUCED BONE-FORMATION; CA2+ CHANNELS; ALPHA-ACTININ; PARATHYROID-HORMONE; KINASE; CYTOSKELETON; MODULATION; REQUIRES; COMPLEX; CELLS	Voltage-dependent L-type calcium channels that permit cellular calcium influx are essential in calcium-mediated modulation of cellular signaling. Although the regulation of voltage-dependent L-type calcium channels is linked to many factors including cAMP-dependent protein kinase A (PKA) activity and actin cytoskeleton, little is known about the detailed mechanisms underlying the regulation in osteoblasts. Our present study investigated the modulation of L-type calcium channel activities through the effects of forskolin on actin reorganization and on its functional interaction with actin binding protein actinin 4. The results showed that forskolin did not significantly affect the trafficking of pore forming alpha(1c) subunit and its interaction with actin binding protein actinin 4, whereas it significantly increased the expression of beta(3) subunit and its interaction with actinin 4 in osteoblast cells as assessed by co-immunoprecipitation, pull-down assay, and immunostaining. Further mapping showed that the ABD and EF domains of actinin 4 were interaction sites. This interaction is independent of PKA phosphorylation. Knockdown of actinin 4 significantly decreased the activities of L-type calcium channels. Our study revealed a new aspect of the mechanisms by which the forskolin activation of adenylyl cyclase - cAMP cascade regulates the L-type calcium channel in osteoblast cells, besides the PKA mediated phosphorylation of the channel subunits. These data provide insight into the important role of interconnection among adenylyl cyclase, cAMP, PKA, the actin cytoskeleton, and the channel proteins in the regulation of voltage-dependent L-type calcium channels in osteoblast cells.	[Zhang, Xuemei; Guo, Lin; Hei, Hongya; Tian, Lulu] Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai 201203, Peoples R China; [Li, Fangping] Fudan Univ, Huashan Hosp, Jingan Dist Ctr Hosp Shanghai, Dept Pharm,Jingan Branch, Shanghai 200040, Peoples R China; [Peng, Wen] Shanghai Univ Tradit Chinese Med, Putuo Hosp, Dept Nephrol, Shanghai 200062, Peoples R China; [Cai, Hui] Emory Univ, Sch Med, Dept Med, Div Renal, Atlanta, GA 30322 USA; [Cai, Hui] Atlanta Veteran Adm Med Ctr, Renal Sect, Decatur, GA 30033 USA	Fudan University; Fudan University; Shanghai University of Traditional Chinese Medicine; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Zhang, XM (corresponding author), Fudan Univ, Sch Pharm, Dept Pharmacol, 826 Zhangheng Rd, Shanghai 201203, Peoples R China.	xuemzhang@fudan.edu.cn; wenpeng@shutcm.edu.cn			National Science Foundation of China [81370979]; Shanghai science and technology innovation [14140903202, 14431905102]; Department of Veteran Affairs [5I01BX000994]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai science and technology innovation; Department of Veteran Affairs(US Department of Veterans Affairs)	This work is supported by the National Science Foundation of China No. 81370979 (X. Zhang), Shanghai science and technology innovation grants 14140903202 and 14431905102 (X. Zhang), and Department of Veteran Affairs MERIT Award 5I01BX000994 (H. Cai).	Ayling LJ, 2012, J CELL SCI, V125, P869, DOI 10.1242/jcs.091090; Bergh JJ, 2003, CALCIFIED TISSUE INT, V73, P502, DOI 10.1007/s00223-002-0016-y; Betanzos A, 2004, EXP CELL RES, V292, P51, DOI 10.1016/j.yexcr.2003.08.007; BLANCHARD A, 1989, J MUSCLE RES CELL M, V10, P280, DOI 10.1007/BF01758424; Broderick MJF, 2005, ADV PROTEIN CHEM, V70, P203, DOI 10.1016/S0065-3233(04)70007-8; Bunemann M, 1999, J BIOL CHEM, V274, P33851, DOI 10.1074/jbc.274.48.33851; Chan YM, 1998, J CELL BIOL, V143, P2033, DOI 10.1083/jcb.143.7.2033; CHIEN AJ, 1995, J BIOL CHEM, V270, P30036; DEWAARD M, 1994, NEURON, V13, P495, DOI 10.1016/0896-6273(94)90363-8; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; Gerits N, 2007, J BIOL CHEM, V282, P37232, DOI 10.1074/jbc.M704873200; GUGGINO SE, 1989, P NATL ACAD SCI USA, V86, P2957, DOI 10.1073/pnas.86.8.2957; Haase H, 1999, FASEB J, V13, P2161, DOI 10.1096/fasebj.13.15.2161; Hall DD, 2013, NEURON, V78, P483, DOI 10.1016/j.neuron.2013.02.032; Hanlon MR, 1999, FEBS LETT, V445, P366, DOI 10.1016/S0014-5793(99)00156-8; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Johnson BD, 2005, P NATL ACAD SCI USA, V102, P4191, DOI 10.1073/pnas.0409695102; Johnson BD, 1999, ADV SEC MESS PHOSPH, V33, P203; Kim JH, 2002, J BIOL CHEM, V277, P23714, DOI 10.1074/jbc.M200835200; Leach RN, 2005, CELL CALCIUM, V38, P515, DOI 10.1016/j.ceca.2005.07.006; Li FP, 2011, J BONE MINER METAB, V29, P515, DOI 10.1007/s00774-010-0252-6; Li J, 2003, ENDOCRINOLOGY, V144, P1226, DOI 10.1210/en.2002-220821; Li JL, 2002, J BONE MINER RES, V17, P1795, DOI 10.1359/jbmr.2002.17.10.1795; Liu RT, 2000, J BIOL CHEM, V275, P8711, DOI 10.1074/jbc.275.12.8711; Lu L, 2007, CIRC RES, V100, P112, DOI 10.1161/01.RES.0000253095.44186.72; Meszaros JG, 1996, J BIOL CHEM, V271, P32981, DOI 10.1074/jbc.271.51.32981; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Radermacher AN, 2008, IMMUNITY, V28, P13, DOI 10.1016/j.immuni.2007.12.009; Rey A, 2007, BONE, V41, P59, DOI 10.1016/j.bone.2007.02.031; RITCHIE CK, 1994, ENDOCRINOLOGY, V135, P996, DOI 10.1210/en.135.3.996; Sadeghi A, 2002, AM J PHYSIOL-CELL PH, V282, pC1502, DOI 10.1152/ajpcell.00435.2001; Scott JD, 2003, BIOCHEM SOC T, V31, P87, DOI 10.1042/bst0310087; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; Takahashi SX, 2004, P NATL ACAD SCI USA, V101, P7193, DOI 10.1073/pnas.0306665101; TETI A, 1989, Bollettino Societa Italiana Biologia Sperimentale, V65, P1115; VADIAKAS GP, 1992, MATRIX, V12, P439, DOI 10.1016/S0934-8832(11)80088-0; Wang Y, 2010, VIRULENCE, V1, P202, DOI 10.4161/viru.1.3.11836; Yamaguchi H, 1998, J BIOL CHEM, V273, P19348, DOI 10.1074/jbc.273.30.19348; Zanello LP, STEROIDS; Zhao PL, 2002, KIDNEY INT, V61, P1393, DOI 10.1046/j.1523-1755.2002.00267.x	42	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124274	10.1371/journal.pone.0124274	http://dx.doi.org/10.1371/journal.pone.0124274			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902045	Green Published, gold, Green Submitted			2022-12-26	WOS:000353331500080
J	Paganin, P; Fiscarelli, EV; Tuccio, V; Chiancianesi, M; Bacci, G; Morelli, P; Dolce, D; Dalmastri, C; De Alessandri, A; Lucidi, V; Taccetti, G; Mengoni, A; Bevivino, A				Paganin, Patrizia; Fiscarelli, Ersilia Vita; Tuccio, Vanessa; Chiancianesi, Manuela; Bacci, Giovanni; Morelli, Patrizia; Dolce, Daniela; Dalmastri, Claudia; De Alessandri, Alessandra; Lucidi, Vincenzina; Taccetti, Giovanni; Mengoni, Alessio; Bevivino, Annamaria			Changes in Cystic Fibrosis Airway Microbial Community Associated with a Severe Decline in Lung Function	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISMS; T-RFLP ANALYSIS; BACTERIAL DIVERSITY; PULMONARY-FUNCTION; SPUTUM SAMPLES; FEV1 DECLINE; INFECTION; 16S; INSIGHTS; IDENTIFICATION	Cystic fibrosis (CF) is a genetic disease resulting in chronic polymicrobial infections of the airways and progressive decline in lung function. To gain insight into the underlying causes of severe lung diseases, we aimed at comparing the airway microbiota detected in sputum of CF patients with stable lung function (S) versus those with a substantial decline in lung function (SD). Microbiota composition was investigated by using culture-based and culture-independent methods, and by performing multivariate and statistical analyses. Culture-based methods identified some microbial species associated with a worse lung function, i.e. Pseudomonas aeruginosa, Rothia mucilaginosa, Streptococcus pneumoniae and Candida albicans, but only the presence of S. pneumoniae and R. mucilaginosa was found to be associated with increased severe decline in forced expiratory volume in 1 second (FEV1). Terminal-Restriction Fragment Length Polymorphism (T-RFLP) analysis revealed a higher bacterial diversity than that detected by culture-based methods. Molecular signatures with a statistically significant odds ratio for SD status were detected, and classified as Pseudomonas, Burkholderia and Shewanella, while for other Terminal Restriction Fragments (T-RFs) no species assignation was achieved. The analysis of T-RFLP data using ecological biodiversity indices showed reduced Evenness in SD patients compared to S ones, suggesting an impaired ecology of the bacterial community in SD patients. Statistically significant differences of the ecological biodiversity indices among the three sub-groups of FEV1 (normal/mild vs moderate vs severe) were also found, suggesting that the patients with moderate lung disease experienced changes in the airway assembly of taxa. Overall, changes in CF airway microbial community associated with a severe lung function decline were detected, allowing us to define some discriminatory species as well as some discriminatory T-RFs that represent good candidates for the development of predictive biomarkers of substantial decline in lung function.	[Paganin, Patrizia; Dalmastri, Claudia; Bevivino, Annamaria] Casaccia Res Ctr, ENEA Italian Natl Agcy New Technol Energy & Susta, Tech Unit Sustainable Dev & Innovat Agroind Syst, Rome, Italy; [Fiscarelli, Ersilia Vita; Tuccio, Vanessa; Lucidi, Vincenzina] Childrens Hosp, Cyst Fibrosis Microbiol & Cyst Fibrosis Ctr, Rome, Italy; [Fiscarelli, Ersilia Vita; Tuccio, Vanessa; Lucidi, Vincenzina] Inst Bambino Gesu, Rome, Italy; [Chiancianesi, Manuela; Bacci, Giovanni; Mengoni, Alessio] Univ Florence, Dept Evolutionary Biol, Florence, Italy; [Morelli, Patrizia; De Alessandri, Alessandra] G Gaslini Inst Children, Cyst Fibrosis Ctr, Dept Pediat, Genoa, Italy; [Dolce, Daniela; Taccetti, Giovanni] Meyer Hosp, Cyst Fibrosis Ctr, Dept Pediat, Florence, Italy	Italian National Agency New Technical Energy & Sustainable Economics Development; University of Florence; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER	Bevivino, A (corresponding author), Casaccia Res Ctr, ENEA Italian Natl Agcy New Technol Energy & Susta, Tech Unit Sustainable Dev & Innovat Agroind Syst, Rome, Italy.	annamaria.bevivino@enea.it	Bevivino, Annamaria/F-4060-2015; Fiscarelli, Ersilia Vita/K-3035-2016; Dalmastri, Claudia/AAD-1627-2021; Mengoni, Alessio/G-5336-2013; Paganin, Patrizia/AAB-9735-2022; Taccetti, Giovanni/K-9519-2016	Fiscarelli, Ersilia Vita/0000-0003-4156-1835; Mengoni, Alessio/0000-0002-1265-8251; Paganin, Patrizia/0000-0002-8993-6651; Dolce, Daniela/0000-0002-8317-9928; Taccetti, Giovanni/0000-0002-9448-5381; Bacci, Giovanni/0000-0003-4406-7816; Lucidi, Vincenzina/0000-0003-3661-607X; Bevivino, Annamaria/0000-0003-4277-7048	Italian Cystic Fibrosis Research Foundation (FCC) [8/2012, 10/2014]; Italian Cystic Fibrosis Research Foundation	Italian Cystic Fibrosis Research Foundation (FCC); Italian Cystic Fibrosis Research Foundation(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation)	This research was supported by grants from the Italian Cystic Fibrosis Research Foundation (FCC) (http://www.fibrosicisticaricerca.it/) to AB [Project FFC #8/2012 (with the contribution of "Delegazione FFC di Latina", "Delegazione FFC di Imola", "Delegazione FFC di Cecina", Associazione Trentina FC onlus in ricordo di Vanessa Weber, and "Associazione Davide e Guido - Insieme - Fibrosi Cistica Trust Online) and Project FFC #10/2014 (with the contribution of "Delegazione FFC di Villa D'Alme - Bergamo", "Gruppo di Sostegno FFC di Reggello Firenze", Gruppo di Sostegno FFC di Lainate", and "Delegazione FFC di Verbania e V.C.O")]. PP, VT, and MC were supported by grants awarded by the Italian Cystic Fibrosis Research Foundation. The funders had no role in study design, data collection, analysis and interpretation of the data, decision to publish, or preparation of the manuscript.	Bevivino A, 2013, CML CYSTIC FIBROSIS, V3, P93; Bittar F, 2010, CLIN MICROBIOL INFEC, V16, P809, DOI 10.1111/j.1469-0691.2010.03236.x; Bittar F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002908; Blackwood CB, 2007, APPL ENVIRON MICROB, V73, P5276, DOI 10.1128/AEM.00514-07; Burns JL, 1998, CLIN INFECT DIS, V27, P158, DOI 10.1086/514631; Cai L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053649; Camarinha-Silva A, 2012, FEMS MICROBIOL ECOL, V79, P98, DOI 10.1111/j.1574-6941.2011.01197.x; Carmody Lisa A, 2013, Ann Am Thorac Soc, V10, P179, DOI 10.1513/AnnalsATS.201211-107OC; Cazzola M, 2008, EUR RESPIR J, V31, P416, DOI 10.1183/09031936.00099306; Chotirmall SH, 2010, CHEST, V138, P1186, DOI 10.1378/chest.09-2996; Del Chierico F, 2012, J PROTEOMICS, V75, P3314, DOI 10.1016/j.jprot.2012.03.048; Ding T, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-1; Emerson J, 2002, PEDIATR PULM, V34, P91, DOI 10.1002/ppul.10127; Farrell PM, 2008, J PEDIATR-US, V153, pS4, DOI 10.1016/j.jpeds.2008.05.005; Filkins LM, 2012, J BACTERIOL, V194, P4709, DOI 10.1128/JB.00566-12; Flume PA, 2009, AM J RESP CRIT CARE, V180, P802, DOI 10.1164/rccm.200812-1845PP; Foweraker J, 2009, BRIT MED BULL, V89, P93, DOI 10.1093/bmb/ldn050; FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003; Guss AM, 2011, ISME J, V5, P20, DOI 10.1038/ismej.2010.88; Hauser AR, 2011, CLIN MICROBIOL REV, V24, P29, DOI 10.1128/CMR.00036-10; Huang YJ, 2011, EXPERT REV RESP MED, V5, P809, DOI [10.1586/ERS.11.76, 10.1586/ers.11.76]; Joo S, 2010, J MICROBIOL METH, V81, P61, DOI 10.1016/j.mimet.2010.01.025; Kerem Eitan, 2005, J Cyst Fibros, V4, P7, DOI 10.1016/j.jcf.2004.12.002; Kerem E, 2014, EUR RESPIR J, V43, P125, DOI 10.1183/09031936.00166412; Konstan MW, 2007, J PEDIATR-US, V151, P134, DOI 10.1016/j.jpeds.2007.03.006; Lim YW, 2014, J CLIN MICROBIOL, V52, P425, DOI 10.1128/JCM.02204-13; Lim YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064285; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Lynch SV, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009738; Maeda Y, 2011, J CYST FIBROS, V10, P133, DOI 10.1016/j.jcf.2010.11.003; Mahenthiralingam E, 2014, PAEDIATR RESPIR REV, V15, P13, DOI 10.1016/j.prrv.2014.04.006; Marsh TL, 2005, METHOD ENZYMOL, V397, P308, DOI 10.1016/S0076-6879(05)97018-3; Maughan H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045791; McCafferty J, 2012, ENV MICROBIOL REP, V4, P556, DOI 10.1111/j.1758-2229.2012.00368.x; Milla CE, 1998, CHEST, V113, P1230, DOI 10.1378/chest.113.5.1230; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Nakano Y, 2010, MICROB ECOL, V60, P364, DOI 10.1007/s00248-010-9703-9; Osborn AM, 2000, ENVIRON MICROBIOL, V2, P39, DOI 10.1046/j.1462-2920.2000.00081.x; R Development Core Team, R LANG ENV STAT COMP; Ramsey BW, 1999, NEW ENGL J MED, V340, P23, DOI 10.1056/NEJM199901073400104; Rogers GB, 2004, J CLIN MICROBIOL, V42, P5176, DOI 10.1128/JCM.42.11.5176-5183.2004; Rogers GB, 2003, J CLIN MICROBIOL, V41, P3548, DOI 10.1128/JCM.41.8.3548-3558.2003; Rogers GB, 2015, THORAX, V70, P74, DOI 10.1136/thoraxjnl-2014-205826; Rogers GB, 2010, J CLIN MICROBIOL, V48, P78, DOI 10.1128/JCM.01324-09; Rosenbluth DB, 2004, CHEST, V126, P412, DOI 10.1378/chest.126.2.412; Saiman L, 2014, INFECT CONT HOSP EP, V35, pS1, DOI 10.1086/676882; Sanders DB, 2010, AM J RESP CRIT CARE, V182, P627, DOI 10.1164/rccm.200909-1421OC; Seng P, 2013, J CLIN MICROBIOL, V51, P2182, DOI 10.1128/JCM.00492-13; Shyu C, 2007, MICROB ECOL, V53, P562, DOI 10.1007/s00248-006-9106-0; Sibley CD, 2009, CURR OPIN INVEST DR, V10, P787; Sibley CD, 2008, P NATL ACAD SCI USA, V105, P15070, DOI 10.1073/pnas.0804326105; Stressmann FA, 2011, J CLIN MICROBIOL, V49, P281, DOI 10.1128/JCM.01650-10; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Taylor-Robinson D, 2012, THORAX, V67, P860, DOI 10.1136/thoraxjnl-2011-200953; Tiquia SM, 2010, METHODS MOL BIOL, V599, P89, DOI 10.1007/978-1-60761-439-5_6; Tunney MM, 2008, AM J RESP CRIT CARE, V177, P995, DOI 10.1164/rccm.200708-1151OC; VandenBranden SL, 2012, PEDIATR PULM, V47, P135, DOI 10.1002/ppul.21526; Zhao JC, 2014, SCI REP-UK, V4, DOI 10.1038/srep04345; Zhao JC, 2012, P NATL ACAD SCI USA, V109, P5809, DOI 10.1073/pnas.1120577109	59	47	48	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124348	10.1371/journal.pone.0124348	http://dx.doi.org/10.1371/journal.pone.0124348			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898134	Green Published, Green Submitted, gold			2022-12-26	WOS:000353212600066
J	Afanasyev, V; Buldyrev, SV; Dunn, MJ; Robst, J; Preston, M; Bremner, SF; Briggs, DR; Brown, R; Adlard, S; Peat, HJ				Afanasyev, Vsevolod; Buldyrev, Sergey V.; Dunn, Michael J.; Robst, Jeremy; Preston, Mark; Bremner, Steve F.; Briggs, Dirk R.; Brown, Ruth; Adlard, Stacey; Peat, Helen J.			Increasing Accuracy: A New Design and Algorithm for Automatically Measuring Weights, Travel Direction and Radio Frequency Identification (RFID) of Penguins	PLOS ONE			English	Article							FORAGING-TRIP DURATION; ADELIE PENGUINS; FLIPPER BANDS; CHINSTRAP PENGUINS; BECHERVAISE-ISLAND; SIGNY ISLAND; SUCCESS; ANTARCTICA; SURVIVAL; CHICKS	A fully automated weighbridge using a new algorithm and mechanics integrated with a Radio Frequency Identification System is described. It is currently in use collecting data on Macaroni penguins (Eudyptes chrysolophus) at Bird Island, South Georgia. The technology allows researchers to collect very large, highly accurate datasets of both penguin weight and direction of their travel into or out of a breeding colony, providing important contributory information to help understand penguin breeding success, reproductive output and availability of prey. Reliable discrimination between single and multiple penguin crossings is demonstrated. Passive radio frequency tags implanted into penguins allow researchers to match weight and trip direction to individual birds. Low unit and operation costs, low maintenance needs, simple operator requirements and accurate time stamping of every record are all important features of this type of weighbridge, as is its proven ability to operate 24 hours a day throughout a breeding season, regardless of temperature or weather conditions. Users are able to define required levels of accuracy by adjusting filters and raw data are automatically recorded and stored allowing for a range of processing options. This paper presents the underlying principles, design specification and system description, provides evidence of the weighbridge's accurate performance and demonstrates how its design is a significant improvement on existing systems.	[Afanasyev, Vsevolod; Dunn, Michael J.; Robst, Jeremy; Preston, Mark; Bremner, Steve F.; Briggs, Dirk R.; Brown, Ruth; Adlard, Stacey; Peat, Helen J.] British Antarctic Survey, NERC, Cambridge CB3 0ET, England; [Buldyrev, Sergey V.] Yeshiva Univ, Dept Phys, New York, NY 10033 USA	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Yeshiva University	Afanasyev, V (corresponding author), British Antarctic Survey, NERC, High Cross,Madingley Rd, Cambridge CB3 0ET, England.	hjpe@bas.ac.uk	Peat, Helen J/E-9666-2015; Buldyrev, Sergey V/I-3933-2015	Buldyrev, Sergey/0000-0002-3008-1070; Dunn, Michael/0000-0003-4633-5466; Peat, Helen/0000-0003-2017-8597	Bernard W. Gamson Computational Science Center at Yeshiva College; Natural Environment Research Council (NERC) British Antarctic Survey core budget; Natural Environment Research Council [bas0100025, bas010011, bas0100035] Funding Source: researchfish; NERC [bas0100025, bas0100035, bas010011] Funding Source: UKRI	Bernard W. Gamson Computational Science Center at Yeshiva College; Natural Environment Research Council (NERC) British Antarctic Survey core budget; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	SVB acknowledges partial support of this research through Bernard W. Gamson Computational Science Center at Yeshiva College. This project is also funded by Natural Environment Research Council (NERC) British Antarctic Survey core budget. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballard G, 2001, CONDOR, V103, P481, DOI 10.1650/0010-5422(2001)103[0481:EOIAAO]2.0.CO;2; Ballard G, 2010, MAR ECOL PROG SER, V405, P287, DOI 10.3354/meps08514; Boersma PD, 2009, J FIELD ORNITHOL, V80, P408, DOI 10.1111/j.1557-9263.2009.00248.x; Bonter DN, 2011, J FIELD ORNITHOL, V82, P1, DOI 10.1111/j.1557-9263.2010.00302.x; Clarke J, 2002, POLAR BIOL, V25, P21, DOI 10.1007/s003000100307; Clarke JR, 2001, POLAR BIOL, V24, P16, DOI 10.1007/s003000000168; Clarke J, 2006, MAR ECOL PROG SER, V310, P247, DOI 10.3354/meps310247; Dehnhard N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079487; Dugger KM, 2006, AUK, V123, P858, DOI 10.1642/0004-8038(2006)123[858:EOFBOF]2.0.CO;2; Gauthier-Clerc M, 2004, P ROY SOC B-BIOL SCI, V271, pS423, DOI 10.1098/rsbl.2004.0201; Green CJ, 2006, POLAR BIOL, V29, P1003, DOI 10.1007/s00300-006-0143-4; Harding AMA, 2011, OECOLOGIA, V167, P49, DOI 10.1007/s00442-011-1971-7; Kerry Knowles, 1993, Proceedings of the NIPR Symposium on Polar Biology, V6, P62; LISHMAN GS, 1985, J ZOOL, V205, P245, DOI 10.1111/j.1469-7998.1985.tb03532.x; Newton I., 1687, MATH PRINCIPLES NATU; Renner Martin, 2000, Notornis, V47, P163; Robinson S, 2005, IBIS, V147, P483, DOI 10.1111/j.1474-919x.2005.00431.x; Takahashi A, 2003, MAR ECOL PROG SER, V250, P279, DOI 10.3354/meps250279; Vertigan C, 2012, ANIM WELFARE, V21, P101, DOI 10.7120/096272812799129493; Waluda CM, 2012, MAR ECOL PROG SER, V466, P261, DOI 10.3354/meps09930; Watanuki Y, 2002, POLAR BIOL, V25, P672, DOI 10.1007/s00300-002-0399-2; Williams T.D., 1995, PENGUINS	22	0	0	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0126292	10.1371/journal.pone.0126292	http://dx.doi.org/10.1371/journal.pone.0126292			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894763	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000353211700142
J	Tagwireyi, P; Sullivan, SMP				Tagwireyi, Paradzayi; Sullivan, S. Mazeika P.			Riverine Landscape Patch Heterogeneity Drives Riparian Ant Assemblages in the Scioto River Basin, USA	PLOS ONE			English	Article							HYMENOPTERA-FORMICIDAE; HABITAT; COMMUNITIES; ECOLOGY; FLOODPLAIN; DIVERSITY; URBANIZATION; FOREST; INVERTEBRATES; BIODIVERSITY	Although the principles of landscape ecology are increasingly extended to include riverine landscapes, explicit applications are few. We investigated associations between patch heterogeneity and riparian ant assemblages at 12 riverine landscapes of the Scioto River, Ohio, USA, that represent urban/developed, agricultural, and mixed (primarily forested, but also wetland, grassland/fallow, and exurban) land-use settings. Using remotely-sensed and ground-collected data, we delineated riverine landscape patch types (crop, grass/herbaceous, gravel, lawn, mudflat, open water, shrub, swamp, and woody vegetation), computed patch metrics (area, density, edge, richness, and shape), and conducted coordinated sampling of surface-active Formicidae assemblages. Ant density and species richness was lower in agricultural riverine landscapes than at mixed or developed reaches (measured using S [total number of species], but not using Menhinick's Index [D-M]), whereas ant diversity (using the Berger-Park Index [D-BP]) was highest in agricultural reaches. We found no differences in ant density, richness, or diversity among internal riverine landscape patches. However, certain characteristics of patches influenced ant communities. Patch shape and density were significant predictors of richness (S: R-2 = 0.72; D-M: R-2 = 0.57). Patch area, edge, and shape emerged as important predictors of D-BP (R-2 = 0.62) whereas patch area, edge, and density were strongly related to ant density (R-2 = 0.65). Non-metric multidimensional scaling and analysis of similarities distinguished ant assemblage composition in grass and swamp patches from crop, gravel, lawn, and shrub as well as ant assemblages in woody vegetation patches from crop, lawn, and gravel (stress = 0.18, R-2 = 0.64). These findings lend insight into the utility of landscape ecology to river science by providing evidence that spatial habitat patterns within riverine landscapes can influence assemblage characteristics of riparian arthropods.	[Tagwireyi, Paradzayi; Sullivan, S. Mazeika P.] Ohio State Univ, Sch Environm & Nat Resources, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Tagwireyi, P (corresponding author), Univ Zimbabwe, Dept Geog & Environm Sci, Geoinformat & Earth Observat Ctr, POB MP 167, Harare, Zimbabwe.	tagwireyi.1@buckeyemail.osu.edu	Sulliván, Mažeika Patricio/C-8261-2012	Sulliván, Mažeika Patricio/0000-0003-2341-5316	Ohio Agricultural Research and Development Center	Ohio Agricultural Research and Development Center	Support for this research was provided by state and federal funds appropriated to The Ohio State University, and The Ohio Agricultural Research and Development Center (SMPS).	Alberts JM, 2013, SCI TOTAL ENVIRON, V463, P42, DOI 10.1016/j.scitotenv.2013.05.065; Andersen A. N., 1997, CONSERV ECOL, V1, P8, DOI DOI 10.5751/ES-00014-010108; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2005, B OHIO BIOL SURV; Ballinger A, 2007, OECOLOGIA, V152, P227, DOI 10.1007/s00442-006-0648-0; BAXTER MJ, 1995, J R STAT SOC C-APPL, V44, P513, DOI 10.2307/2986142; BAYLEY PB, 1995, BIOSCIENCE, V45, P153, DOI 10.2307/1312554; BERGER WH, 1970, SCIENCE, V168, P1345, DOI 10.1126/science.168.3937.1345; BRUDER KW, 1972, ANN ENTOMOL SOC AM, V65, P358, DOI 10.1093/aesa/65.2.358; Buczkowski G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041729; Burt TP, 2005, PROG PHYS GEOG, V29, P297, DOI 10.1191/0309133305pp450ra; Carbonneau P, 2012, GEOMORPHOLOGY, V137, P74, DOI 10.1016/j.geomorph.2010.09.030; Church M, 2002, GEOMORPHOLOGY, V45, P1; Church M, 2002, FRESHWATER BIOL, V47, P541, DOI 10.1046/j.1365-2427.2002.00919.x; Dix NJ, 1995, MOSAIC LANDSCAPES EC, DOI [10.1007/978-94-011-0693-1, DOI 10.1007/978-94-011-0717-4_1]; Elkie P, 1999, PATCH ANAL USERS MAN; Fisher B. L., 2007, ANTS N AM GUIDE GENE; Fletcher RJ, 2007, CAN J ZOOL, V85, P1017, DOI 10.1139/Z07-100; Framenau VW, 2002, AUST J ZOOL, V50, P103, DOI 10.1071/ZO01039; Goebel PC, 2012, WETLANDS, V32, P679, DOI 10.1007/s13157-012-0300-1; Gollan JR, 2011, ECOL INDIC, V11, P1517, DOI 10.1016/j.ecolind.2009.09.007; Gomez C, 2013, ECOGRAPHY, V36, P1193, DOI 10.1111/j.1600-0587.2013.00289.x; Hammond PM, 1998, RIPARIAN FLOODPLAIN, P237; Hering D, 2004, RIVER RES APPL, V20, P445, DOI 10.1002/rra.759; Hering D, 1997, OECOLOGIA, V111, P261, DOI 10.1007/s004420050234; Holmes KL, 2011, J FOREST, V109, P233; Holway DA, 2006, BIOL CONSERV, V127, P319, DOI 10.1016/j.biocon.2005.05.016; Hufkens K, 2009, ECOL RES, V24, P977, DOI 10.1007/s11284-009-0584-7; Ivanov K, 2011, BIOL INVASIONS, V13, P1945, DOI 10.1007/s10530-011-0021-z; Ives CD, 2013, LANDSCAPE URBAN PLAN, V110, P155, DOI 10.1016/j.landurbplan.2012.11.005; Jarolimek I, 1999, BIOLOGIA, V54, P405; Johansen K, 2010, REMOTE SENS ENVIRON, V114, P2679, DOI 10.1016/j.rse.2010.06.004; Johnston CA, 2001, SOIL SCI SOC AM J, V65, P557, DOI 10.2136/sssaj2001.652557x; JUNK W J, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P110; Karl T. R., 1984, HIST CLIMATOLOGY SER, V4-3; Kaspari M, 2000, P ROY SOC B-BIOL SCI, V267, P485, DOI 10.1098/rspb.2000.1026; Kawula R., 2009, FLORIDA LAND COVER C; KIM HH, 1992, INT J REMOTE SENS, V13, P2319, DOI 10.1080/01431169208904271; King JR, 2006, J ANIM ECOL, V75, P1370, DOI 10.1111/j.1365-2656.2006.01161.x; Lambeets K, 2008, J ANIM ECOL, V77, P1162, DOI 10.1111/j.1365-2656.2008.01443.x; Latterell JJ, 2006, FRESHWATER BIOL, V51, P523, DOI 10.1111/j.1365-2427.2006.01513.x; Lessard JP, 2005, CAN ENTOMOL, V137, P215, DOI 10.4039/N04-055; Lude A, 1999, ENTOMOL GEN, V24, P75; MAC ARTHUR ROBERT H., 1967; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; McGarigal K., 2012, TECH REP; McGlynn TP, 1999, J BIOGEOGR, V26, P535, DOI 10.1046/j.1365-2699.1999.00310.x; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Menke SB, 2011, URBAN ECOSYST, V14, P135, DOI 10.1007/s11252-010-0150-7; Menke SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009194; Mitchell CE, 2002, ECOL APPL, V12, P1364, DOI 10.2307/3099977; Muller J, 2009, J APPL ECOL, V46, P897, DOI 10.1111/j.1365-2664.2009.01677.x; NLCD, 2006, NATL LAND COVER DATA; Ohio Division of Geological Survey, 1998, PHYS REG OH; Orrock JL, 2011, LANDSCAPE ECOL, V26, P1361, DOI 10.1007/s10980-011-9656-5; Paetzold A, 2008, J APPL ECOL, V45, P894, DOI 10.1111/j.1365-2664.2008.01463.x; Pecarevic M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013222; Petal J.M., 1976, Polish ecol Stud, V2, P209; Poole GC, 2002, FRESHWATER BIOL, V47, P641, DOI 10.1046/j.1365-2427.2002.00922.x; Rencher A.C., 1995, METHODS MULTIVARIATE; Retana J, 2000, OECOLOGIA, V123, P436, DOI 10.1007/s004420051031; Richards K, 2002, FRESHWATER BIOL, V47, P559, DOI 10.1046/j.1365-2427.2002.00920.x; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; ROGERS JC, 1993, OHIO J SCI, V93, P51; Sadler JP, 2004, BIOL CONSERV, V118, P41, DOI 10.1016/j.biocon.2003.07.007; Sanders NJ, 2003, P NATL ACAD SCI USA, V100, P2474, DOI 10.1073/pnas.0437913100; Scheifer MC, 2002, OHIO B, V47; STAMPS JA, 1987, AM NAT, V129, P533, DOI 10.1086/284656; Steiner FM, 2008, DIVERS DISTRIB, V14, P538, DOI 10.1111/j.1472-4642.2008.00472.x; Sullivan SMP, 2007, LANDSCAPE ECOL, V22, P1169, DOI 10.1007/s10980-007-9097-3; Sullivan SMP, 2008, CAN J FISH AQUAT SCI, V65, P2667, DOI 10.1139/F08-165; Thompson Bill, 2007, Urban Ecosystems, V10, P43, DOI 10.1007/s11252-006-0013-4; Thorp JH, 2014, FRESHWATER BIOL, V59, P200, DOI 10.1111/fwb.12237; Thorp JH, 2006, RIVER RES APPL, V22, P123, DOI 10.1002/rra.901; Underwood EC, 2006, BIOL CONSERV, V132, P166, DOI 10.1016/j.biocon.2006.03.022; US Census Bureau, 2011, GUID STAT LOC CENS G; Vierling KT, 2011, ECOL APPL, V21, P577, DOI 10.1890/09-2155.1; Ward D, 2008, PAC SCI, V62, P473, DOI 10.2984/1534-6188(2008)62[473:EPAIAH]2.0.CO;2; Ward JV, 2001, FRESHWATER BIOL, V46, P807, DOI 10.1046/j.1365-2427.2001.00713.x; Ward JV, 2002, LANDSCAPE ECOL, V17, P35, DOI 10.1023/A:1015277626224; Ward JV, 2002, FRESHWATER BIOL, V47, P517, DOI 10.1046/j.1365-2427.2002.00893.x; Ward JV, 1999, REGUL RIVER, V15, P125, DOI 10.1002/(SICI)1099-1646(199901/06)15:1/3&lt;125::AID-RRR523&gt;3.0.CO;2-E; White D., 2005, RIVERS N AM, P375; Wiens JA, 2002, FRESHWATER BIOL, V47, P501, DOI 10.1046/j.1365-2427.2002.00887.x; Yasuda M, 2009, LANDSCAPE URBAN PLAN, V92, P276, DOI 10.1016/j.landurbplan.2009.05.008	86	15	17	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124807	10.1371/journal.pone.0124807	http://dx.doi.org/10.1371/journal.pone.0124807			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894540	Green Published, gold, Green Submitted			2022-12-26	WOS:000353211700125
J	Greenlee, JE; Clawson, SA; Hill, KE; Wood, B; Clardy, SL; Tsunoda, I; Carlson, NG				Greenlee, John E.; Clawson, Susan A.; Hill, Kenneth E.; Wood, Blair; Clardy, Stacey L.; Tsunoda, Ikuo; Carlson, Noel G.			Anti-Yo Antibody Uptake and Interaction with Its Intracellular Target Antigen Causes Purkinje Cell Death in Rat Cerebellar Slice Cultures: A Possible Mechanism for Paraneoplastic Cerebellar Degeneration in Humans with Gynecological or Breast Cancers	PLOS ONE			English	Article							ULTRASTRUCTURAL-LOCALIZATION; NEUROLOGICAL DISEASE; BINDING SITES; IMMUNOREACTIVITY; DIFFERENTIATION; NEURONS; CLONING; SERA	Anti-Yo antibodies are immunoglobulin G (IgG) autoantibodies reactive with a 62 kDa Purkinje cell cytoplasmic protein. These antibodies are closely associated with paraneoplastic cerebellar degeneration in the setting of gynecological and breast malignancies. We have previously demonstrated that incubation of rat cerebellar slice cultures with patient sera and cerebrospinal fluid containing anti-Yo antibodies resulted in Purkinje cell death. The present study addressed three fundamental questions regarding the role of anti-Yo antibodies in disease pathogenesis: 1) Whether the Purkinje cell cytotoxicity required binding of anti-Yo antibody to its intraneuronal 62 kDa target antigen; 2) whether Purkinje cell death might be initiated by antibody-dependent cellular cytotoxicity rather than intracellular antibody binding; and 3) whether Purkinje cell death might simply be a more general result of intracellular antibody accumulation, rather than of specific antibody-antigen interaction. In our study, incubation of rat cerebellar slice cultures with anti-Yo IgG resulted in intracellular antibody binding, and cell death. Infiltration of the Purkinje cell layer by cells of macrophage/microglia lineage was not observed until extensive cell death was already present. Adsorption of anti-Yo IgG with its 62 kDa target antigen abolished both antibody accumulation and cytotoxicity. Antibodies to other intracellular Purkinje cell proteins were also taken up by Purkinje cells and accumulated intracellularly; these included calbindin, calmodulin, PCP-2, and patient anti-Purkinje cell antibodies not reactive with the 62 kDa Yo antigen. However, intracellular accumulation of these antibodies did not affect Purkinje cell viability. The present study is the first to demonstrate that anti-Yo antibodies cause Purkinje cell death by binding to the intracellular 62 kDa Yo antigen. Anti-Yo antibody cytotoxicity did not involve other antibodies or factors present in patient serum and was not initiated by brain mononuclear cells. Purkinje cell death was not simply due to intraneuronal antibody accumulation.	[Greenlee, John E.; Clardy, Stacey L.] George E Wahlen Vet Affairs Hlth Care Syst, Neurol Serv, Salt Lake City, UT 84148 USA; [Greenlee, John E.; Clawson, Susan A.; Hill, Kenneth E.; Wood, Blair; Clardy, Stacey L.; Carlson, Noel G.] Univ Utah, Sch Med, Dept Neurol, Salt Lake City, UT USA; [Tsunoda, Ikuo] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol & Immunol, CMTV, Shreveport, LA 71105 USA; [Carlson, Noel G.] George E Wahlen Vet Affairs Hlth Care Syst, GRECC, Salt Lake City, UT USA; [Carlson, Noel G.] George E Wahlen Vet Affairs Hlth Care Syst, Res Serv, Salt Lake City, UT USA; [Carlson, Noel G.] Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT USA	US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; US Department of Veterans Affairs; Utah System of Higher Education; University of Utah	Greenlee, JE (corresponding author), George E Wahlen Vet Affairs Hlth Care Syst, Neurol Serv, Salt Lake City, UT 84148 USA.	john.greenlee@hsc.utah.edu	Carlson, Noel/W-2734-2019; Tsunoda, Ikuo/B-4722-2008	Tsunoda, Ikuo/0000-0003-1798-714X; Clardy, Stacey/0000-0001-6600-9428	Merit Review Research Award from the United States Department of Veterans Affairs; Western Institute for Biomedical Research; National Institute of Neurological Disorders and Stroke of the National Institutes of Health [R21NS059724]; COBRE Center from the National Institute of General Medical Sciences of the NIH [8P20GM103433]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110703, P20GM103433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS059724] Funding Source: NIH RePORTER	Merit Review Research Award from the United States Department of Veterans Affairs; Western Institute for Biomedical Research; National Institute of Neurological Disorders and Stroke of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); COBRE Center from the National Institute of General Medical Sciences of the NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by a Merit Review Research Award from the United States Department of Veterans Affairs and by a research award from the Western Institute for Biomedical Research. Dr. Tsunoda is supported by grant R21NS059724 from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health and by COBRE Center grant 8P20GM103433 from the National Institute of General Medical Sciences of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMENTA F, 1994, NEUROSCI LETT, V178, P131, DOI 10.1016/0304-3940(94)90307-7; BERREBI AS, 1992, J CHEM NEUROANAT, V5, P235, DOI 10.1016/0891-0618(92)90048-U; BRASHEAR HR, 1989, NEUROLOGY, V39, P1605, DOI 10.1212/WNL.39.12.1605; Dalmau J, 2008, LANCET NEUROL, V7, P327, DOI 10.1016/S1474-4422(08)70060-7; DROPCHO EJ, 1987, P NATL ACAD SCI USA, V84, P4552, DOI 10.1073/pnas.84.13.4552; FATHALLAHSHAYKH H, 1991, P NATL ACAD SCI USA, V88, P3451, DOI 10.1073/pnas.88.8.3451; FURNEAUX HF, 1990, NEUROLOGY, V40, P1085, DOI 10.1212/WNL.40.7.1085; FURNEAUX HM, 1990, NEW ENGL J MED, V322, P1844, DOI 10.1056/NEJM199006283222604; Graus F, 2010, J NEUROL, V257, P509, DOI 10.1007/s00415-009-5431-9; GREENLEE JE, 1988, J NEUROPATH EXP NEUR, V47, P561, DOI 10.1097/00005072-198809000-00007; GREENLEE JE, 1993, NEUROLOGY, V43, P2049, DOI 10.1212/WNL.43.10.2049; GREENLEE JE, 1983, ANN NEUROL, V14, P609, DOI 10.1002/ana.410140603; Greenlee JE, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0160-0; Greenlee JE, 2010, J NEUROPATH EXP NEUR, V69, P997, DOI 10.1097/NEN.0b013e3181f0c82b; Gu JP, 2013, J BIOL CHEM, V288, P33081, DOI 10.1074/jbc.M113.494922; Guan JZ, 2005, BIOCHEM J, V392, P389, DOI 10.1042/BJ20042102; HENSON RA, 1982, CANCER NERVOUS SYSTE, P346; HIDA C, 1994, ARCH NEUROL-CHICAGO, V51, P555, DOI 10.1001/archneur.1994.00540180033010; Hill KE, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-31; King MA, 2000, J IMMUNOL METHODS, V243, P155, DOI 10.1016/S0022-1759(00)00232-5; LIN CT, 1980, J CELL BIOL, V85, P473, DOI 10.1083/jcb.85.2.473; MOLL JWB, 1995, NEUROLOGY, V45, P1937, DOI 10.1212/WNL.45.10.1937; Nag TC, 1999, J CHEM NEUROANAT, V17, P1, DOI 10.1016/S0891-0618(99)00016-2; RODRIGUEZ M, 1988, NEUROLOGY, V38, P1380, DOI 10.1212/WNL.38.9.1380; ROTHSTEIN JD, 1993, P NATL ACAD SCI USA, V90, P6591, DOI 10.1073/pnas.90.14.6591; Tauer U, 1996, NEUROPATH APPL NEURO, V22, P361, DOI 10.1111/j.1365-2990.1996.tb01115.x	26	35	35	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123446	10.1371/journal.pone.0123446	http://dx.doi.org/10.1371/journal.pone.0123446			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885452	Green Submitted, Green Published, gold			2022-12-26	WOS:000353017000065
J	Mendez, F; de Garay, T; Rodriguez, D; Rodriguez, JF				Mendez, Fernando; de Garay, Tomas; Rodriguez, Dolores; Rodriguez, Jose F.			Infectious Bursal Disease Virus VP5 Polypeptide: A Phosphoinositide-Binding Protein Required for Efficient Cell-to-Cell Virus Dissemination	PLOS ONE			English	Article							TRANSMEMBRANE TOPOLOGY; PLASMA-MEMBRANE; LIPIDS; EXPRESSION; APOPTOSIS; GENE	Infectious bursal disease virus (IBDV), a member of the Birnaviridae family, is a major avian pathogen responsible for an immunosuppressive disease affecting juvenile chickens. The IBDV genome is formed by two dsRNA segments. The largest one harbors two partially overlapping open reading frames encoding a non-structural polypeptide, known as VP5, and a large polyprotein, respectively. VP5 is non-essential for virus replication. However, it plays a major role in IBDV pathogenesis. VP5 accumulates at the plasma membrane (PM) of IBDV-infected cells. We have analyzed the mechanism underlying the VP5 PM targeting. Updated topological prediction algorithm servers fail to identify a transmembrane domain within the VP5 sequence. However, the VP5 polycationic C-terminal region, harboring three closely spaced patches formed by two or three consecutive basic amino acid residues (lysine or arginine), might account for its PM tropism. We have found that mutations, either C-terminal VP5 deletions or replacement of basic amino acids by alanine residues, that reduce the electropositive charge of the VP5 C-terminus abolish PM targeting. Lipid overlay assays performed with an affinity-purified Flag-tagged VP5 (FVP5) protein version show that this polypeptide binds several phosphoinositides (PIP), exhibiting a clear preference for monophosphate species. Experiments performed with FVP5 mutant proteins lacking the polycationic domain demonstrate that this region is essential for PIP binding. Data gathered with IBDV mutants expressing C-terminal deleted VP5 polypeptides generated by reverse genetics demonstrate that the VP5-PIP binding domain is required both for its PM targeting in infected cells, and for efficient virus dissemination. Data presented here lead us to hypothesize that IBDV might use a non-lytic VP5-dependent cell-to-cell spreading mechanism.	[Mendez, Fernando; de Garay, Tomas; Rodriguez, Dolores; Rodriguez, Jose F.] Ctr Nacl Biotecnol CSIC, Dept Mol & Cellular Biol, Madrid 28049, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Rodriguez, JF (corresponding author), Ctr Nacl Biotecnol CSIC, Dept Mol & Cellular Biol, Madrid 28049, Spain.	jfrodrig@cnb.csic.es	Rodríguez, José F/T-8500-2017; Rodriguez, Dolores/ABF-9855-2020	Rodríguez, José F/0000-0001-7944-5341; Rodriguez, Dolores/0000-0001-6365-4501	Spanish Ministry of Economy and Competitiveness [AGL2011-24758, AGL2010-15495]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This study was supported by grant AGL2011-24758, Spanish Ministry of Economy and Competitiveness (http://www.idi.mineco.gob.es/portal/site/MICINN/); grant AGL2010-15495, Spanish Ministry of Economy and Competitiveness (http://www.idi.mineco.gob.es/portal/site/MICINN/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Bird SW, 2014, P NATL ACAD SCI USA, V111, P13081, DOI 10.1073/pnas.1401437111; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Cserzo M, 2002, PROTEIN ENG, V15, P745, DOI 10.1093/protein/15.9.745; Feng ZD, 2013, NATURE, V496, P367, DOI 10.1038/nature12029; Fernandez-Arias A, 1998, J GEN VIROL, V79, P1047, DOI 10.1099/0022-1317-79-5-1047; Goldenberg NM, 2010, CANCER RES, V70, P1277, DOI 10.1158/0008-5472.CAN-09-2905; Harlow E., 1988, ANTIBODIES LAB MANUA; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hernandez M, 2010, VIRUS GENES, V41, P59, DOI 10.1007/s11262-010-0485-4; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Ingrao F, 2013, DEV COMP IMMUNOL, V41, P429, DOI 10.1016/j.dci.2013.03.017; Irigoyen N, 2009, J BIOL CHEM, V284, P8064, DOI 10.1074/jbc.M808942200; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kutateladze TG, 2010, NAT CHEM BIOL, V6, P507, DOI [10.1038/NCHEMBIO.390, 10.1038/nchembio.390]; LEMON SM, 1985, NEW ENGL J MED, V313, P1059, DOI 10.1056/NEJM198510243131706; Li F, 2006, ANNU REV MICROBIOL, V60, P503, DOI 10.1146/annurev.micro.60.080805.142205; Li ZH, 2012, J VIROL, V86, P1328, DOI 10.1128/JVI.06104-11; Liu MH, 2006, J VIROL, V80, P3369, DOI 10.1128/JVI.80.7.3369-3377.2006; Lombardo E, 2000, VIROLOGY, V277, P345, DOI 10.1006/viro.2000.0595; Lorizate M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004820; Luque D, 2009, J MOL BIOL, V386, P891, DOI 10.1016/j.jmb.2008.11.029; Mahgoub HA, 2012, ARCH VIROL, V157, P2047, DOI 10.1007/s00705-012-1377-9; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Meier C, 2006, STRUCTURE, V14, P1157, DOI 10.1016/j.str.2006.05.012; Moss SE, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002839; Mundt E, 1997, J VIROL, V71, P5647, DOI 10.1128/JVI.71.7.5647-5651.1997; MUNDT E, 1995, J GEN VIROL, V76, P437, DOI 10.1099/0022-1317-76-2-437; Paloheimo O, 2011, J VIROL, V85, P6714, DOI 10.1128/JVI.00247-10; Payrastre Bernard, 2012, Subcell Biochem, V59, P363, DOI 10.1007/978-94-007-3015-1_12; Qin LT, 2010, VACCINE, V28, P3735, DOI 10.1016/j.vaccine.2010.02.102; Rancurel C, 2009, J VIROL, V83, P10719, DOI 10.1128/JVI.00595-09; Roussarie JP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001331; Stenmark H, 1999, J CELL SCI, V112, P4175; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Viklund H, 2008, BIOINFORMATICS, V24, P2928, DOI 10.1093/bioinformatics/btn550; WARD GA, 1995, P NATL ACAD SCI USA, V92, P6773, DOI 10.1073/pnas.92.15.6773; Wei L, 2011, VIROLOGY, V417, P211, DOI 10.1016/j.virol.2011.03.003; Wu YP, 2009, ARCH VIROL, V154, P1873, DOI 10.1007/s00705-009-0524-4; Yao K, 1998, J VIROL, V72, P2647, DOI 10.1128/JVI.72.4.2647-2654.1998	41	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123470	10.1371/journal.pone.0123470	http://dx.doi.org/10.1371/journal.pone.0123470			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886023	Green Submitted, Green Published, gold			2022-12-26	WOS:000353017000069
J	Gaudette, BT; Dwivedi, B; Chitta, KS; Poulain, S; Powell, D; Vertino, P; Leleu, X; Lonial, S; Chanan-Khan, AA; Kowalski, J; Boise, LH				Gaudette, B. T.; Dwivedi, B.; Chitta, K. S.; Poulain, S.; Powell, D.; Vertino, P.; Leleu, X.; Lonial, S.; Chanan-Khan, A. A.; Kowalski, J.; Boise, L. H.			Low expression of pro-apoptotic Bcl-2 family proteins sets the apoptotic threshold in Waldenstrom macroglobulinemia	ONCOGENE			English	Article							CELL-DEATH; MITOCHONDRIAL DYSFUNCTION; MYELOMA; LINE; BIM; BAX; ESTABLISHMENT; ACTIVATION; BCL-X(L); SURVIVAL	Waldenstrom macroglobulinemia (WM) is a proliferative disorder of IgM-secreting, lymphoplasmacytoid cells that inhabit the lymph nodes and bone marrow. The disease carries a high prevalence of activating mutations in MyD88 (91%) and CXCR4 (28%). Because signaling through these pathways leads to Bcl-xL induction, we examined Bcl-2 family expression in WM patients and cell lines. Unlike other B-lymphocyte-derived malignancies, which become dependent on expression of anti-apoptotic proteins to counter expression of pro-apoptotic proteins, WM samples expressed both pro-and anti-apoptotic Bcl-2 proteins at low levels similar to their normal B-cell and plasma cell counterparts. Three WM cell lines expressed pro-apoptotic Bcl-2 family members Bim or Bax and Bak at low levels, which determined their sensitivity to inducers of intrinsic apoptosis. In two cell lines, miR-155 upregulation, which is common in WM, was responsible for the inhibition of FOXO3a and Bim expression. Both antagonizing miR-155 to induce Bim and proteasome inhibition increased the sensitivity to ABT-737 in these lines indicating a lowering of the apoptotic threshold. In this manner, treatments that increase pro-apoptotic protein expression increase the efficacy of agents treated in combination in addition to direct killing.	[Gaudette, B. T.; Lonial, S.; Boise, L. H.] Emory Univ, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Gaudette, B. T.; Dwivedi, B.; Powell, D.; Vertino, P.; Lonial, S.; Kowalski, J.; Boise, L. H.] Emory Univ, Winship Canc Inst, 1365C Clifton RD NE,Suite C4012, Atlanta, GA 30322 USA; [Gaudette, B. T.; Boise, L. H.] Emory Univ, Grad Program Immunol & Mol Pathogenesis, Atlanta, GA 30322 USA; [Chitta, K. S.] Mayo Clin, Canc Biol, Jacksonville, FL 32224 USA; [Poulain, S.] Hop Valenciennes, Serv Hematol Immunol Cytogenet, Valenciennes, France; [Vertino, P.] Emory Univ, Dept Radiat Oncol, Atlanta, GA 30322 USA; [Leleu, X.] CHRU Lille, Hop Claude Huriez, Serv Malad Sang, F-59037 Lille, France; [Chanan-Khan, A. A.] Mayo Clin, Hematol & Oncol, Jacksonville, FL 32224 USA; [Boise, L. H.] Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Mayo Clinic; CH de Valenciennes; Emory University; Universite de Lille - ISITE; CHU Lille; Mayo Clinic; Emory University	Boise, LH (corresponding author), Emory Univ, Winship Canc Inst, 1365C Clifton RD NE,Suite C4012, Atlanta, GA 30322 USA.	lboise@emory.edu	Boise, Lawrence/AAD-2314-2019; Poulain, Stéphanie/T-9033-2018	Poulain, Stéphanie/0000-0002-1792-7270; Gaudette, Brian/0000-0001-6627-3085; Boise, Lawrence/0000-0001-9436-8815; Kowalski, Jeanne/0000-0003-3458-3024; Dwivedi, Bhakti/0000-0002-9029-3737	TJ Martell Foundation [R01 CA127910, R01 CA129968]; Leukemia & Lymphoma Society; International Waldenstrom Macroglobulinemia; Comite du Septentrion de la Ligue contre le Cancer; NATIONAL CANCER INSTITUTE [R01CA129968, R01CA127910, P30CA138292] Funding Source: NIH RePORTER	TJ Martell Foundation; Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); International Waldenstrom Macroglobulinemia; Comite du Septentrion de la Ligue contre le Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Stephen Ansell and Kelvin Lee for cell lines and reagents. This work was supported by: R01 CA127910 and R01 CA129968 as well as funding from the TJ Martell Foundation (LHB), the Leukemia & Lymphoma Society (AAC), the International Waldenstrom Macroglobulinemia (AAC), and the Comite du Septentrion de la Ligue contre le Cancer (XL). LHB is a GRA Distinguished Cancer Scientist. ABT-737 and ABT-199 were a generous gift of Abbvie, (North Chicago, IL, USA).	Beverly LJ, 2009, ONCOGENE, V28, P1274, DOI 10.1038/onc.2008.466; Boise LH, 2010, BLOOD, V115, P4007, DOI 10.1182/blood-2010-02-270231; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Chitta KS, 2013, LEUKEMIA LYMPHOMA, V54, P387, DOI 10.3109/10428194.2012.713481; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Gaudette BT, 2014, J BIOL CHEM, V289, P23629, DOI 10.1074/jbc.M114.569376; Gertz MA, 2013, AM J HEMATOL, V88, P703, DOI 10.1002/ajh.23472; Ghobrial IM, 2003, LANCET ONCOL, V4, P679, DOI 10.1016/S1470-2045(03)01246-4; Gutierrez NC, 2007, LEUKEMIA, V21, P541, DOI 10.1038/sj.leu.2404520; HERRINTON LJ, 1993, BLOOD, V82, P3148; Hodge LS, 2011, BLOOD, V117, pE190, DOI 10.1182/blood-2010-12-326868; Kong W, 2010, J BIOL CHEM, V285, P17869, DOI 10.1074/jbc.M110.101055; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Morales AA, 2008, BLOOD, V111, P5152, DOI 10.1182/blood-2007-10-116889; Morales AA, 2011, BLOOD, V118, P1329, DOI 10.1182/blood-2011-01-327197; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Poulain S, 2013, BLOOD, V121, P4504, DOI 10.1182/blood-2012-06-436329; Premkumar DR, 2012, J PHARMACOL EXP THER, V341, P859, DOI 10.1124/jpet.112.191536; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Roccaro AM, 2010, BLOOD, V115, P4051, DOI 10.1182/blood-2009-09-243402; Roccaro AM, 2009, BLOOD, V113, P4391, DOI 10.1182/blood-2008-09-178228; Santos DD, 2007, EXP HEMATOL, V35, P1366, DOI 10.1016/j.exphem.2007.05.022; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; Treon SP, 2014, BLOOD, V124, P503, DOI 10.1182/blood-2014-03-566273; Treon SP, 2012, NEW ENGL J MED, V367, P826, DOI 10.1056/NEJMoa1200710; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Yamanaka Y, 2009, BLOOD, V114, P3265, DOI 10.1182/blood-2009-06-222794; Zhang Y, 2012, BLOOD, V120, P1678, DOI 10.1182/blood-2012-02-410647	31	9	10	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 28	2016	35	4					479	490		10.1038/onc.2015.103	http://dx.doi.org/10.1038/onc.2015.103			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DC2OT	25893290	Green Accepted			2022-12-26	WOS:000369056700008
J	Arya, M; Thrasivoulou, C; Henrique, R; Millar, M; Hamblin, R; Davda, R; Aare, K; Masters, JR; Thomson, C; Muneer, A; Patel, HRH; Ahmed, A				Arya, Manit; Thrasivoulou, Christopher; Henrique, Rui; Millar, Michael; Hamblin, Ruth; Davda, Reena; Aare, Kristina; Masters, John R.; Thomson, Calum; Muneer, Asif; Patel, Hitendra R. H.; Ahmed, Aamir			Targets of Wnt/beta-Catenin Transcription in Penile Carcinoma	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; BETA-CATENIN; CYCLIN D1; MATRIX METALLOPROTEINASE-7; C-MYC; EXPRESSION; WNT; CANCER; OVEREXPRESSION; PROTEIN	Penile squamous cell carcinoma (PeCa) is a rare malignancy and little is known regarding the molecular mechanisms involved in carcinogenesis of PeCa. The Wnt signaling pathway, with the transcription activator beta-catenin as a major transducer, is a key cellular pathway during development and in disease, particularly cancer. We have used PeCa tissue arrays and multi-fluorophore labelled, quantitative, immunohistochemistry to interrogate the expression of WNT4, a Wnt ligand, and three targets of Wnt-beta-catenin transcription activation, namely, MMP7, cyclinD1 (CD1) and c-MYC in 141 penile tissue cores from 101 unique samples. The expression of all Wnt signaling proteins tested was increased by 1.6 to 3 fold in PeCa samples compared to control tissue (normal or cancer adjacent) samples (p<0.01). Expression of all proteins, except CD1, showed a significant decrease in grade II compared to grade I tumors. High magnification, deconvolved confocal images were used to measure differences in co-localization between the four proteins. Significant (p<0.04-0.0001) differences were observed for various permutations of the combinations of proteins and state of the tissue (control, tumor grades I and II). Wnt signaling may play an important role in PeCa and proteins of the Wnt signaling network could be useful targets for diagnosis and prognostic stratification of disease.	[Arya, Manit] Univ Coll London Hosp, Div Surg, London, England; [Arya, Manit] Queen Mary Univ London, Barts Canc Inst, London, England; [Thrasivoulou, Christopher] UCL, Res Dept Cell & Dev Biol, Ctr Cell & Mol Dynam, London, England; [Henrique, Rui] Univ Porto, Dept Pathol, Portuguese Oncol Inst, P-4100 Porto, Portugal; [Henrique, Rui] Univ Porto, Dept Pathol & Mol Immunol, Abel Salazar Inst Biomed Sci, P-4100 Porto, Portugal; [Millar, Michael; Hamblin, Ruth] Univ Edinburgh, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Davda, Reena; Aare, Kristina; Masters, John R.; Ahmed, Aamir] UCL, Prostate Canc Res Ctr, Div Surg, London, England; [Thomson, Calum] Univ Dundee, Dundee Imaging Facil, Coll Life Sci, Dundee, Scotland; [Muneer, Asif] Univ Coll London Hosp, Dept Urol, London, England; [Patel, Hitendra R. H.] Univ Hosp Northern Norway, Div Surg Oncol Urol & Womens Hlth, Tromso, Norway	University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; Queen Mary University London; University of London; University College London; Portuguese Institute of Oncology; Universidade do Porto; Universidade do Porto; University of Edinburgh; University of London; University College London; University of Dundee; University College London Hospitals NHS Foundation Trust; University of London; University College London; UiT The Arctic University of Tromso; University Hospital of North Norway	Ahmed, A (corresponding author), Kings Coll London, Ctr Stem Cells & Regenerat Med, London WC2R 2LS, England.	aamir.ahmed@kcl.ac.uk	Henrique, Rui Manuel Ferreira/I-2757-2013; Thrasivoulou, Christopher/F-7087-2010	Henrique, Rui Manuel Ferreira/0000-0003-3171-4666; Thrasivoulou, Christopher/0000-0001-9425-8624; Ahmed, Aamir/0000-0001-7405-5336	Prostate Cancer Research Centre [1156027]	Prostate Cancer Research Centre	This research was funded by the Prostate Cancer Research Centre charity (registered UK charity no. 1156027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arya M, 2013, CANCER CAUSE CONTROL, V24, P2169, DOI 10.1007/s10552-013-0293-y; Arya M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1149; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Borggrefe T, 2009, CELL MOL LIFE SCI, V66, P1631, DOI 10.1007/s00018-009-8668-7; Brabletz T, 2000, VERH DEUT G, V84, P175; Brabletz T, 1999, AM J PATHOL, V155, P1033, DOI 10.1016/S0002-9440(10)65204-2; Campos RSM, 2006, UROLOGY, V67, P797, DOI 10.1016/j.urology.2005.10.026; Clevers H, 2004, CANCER CELL, V5, P5, DOI 10.1016/S1535-6108(03)00339-8; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cui J, 2001, J CANCER RES CLIN, V127, P577, DOI 10.1007/s004320100259; DAKSIS JI, 1994, ONCOGENE, V9, P3635; de Vicente JC, 2007, J ORAL PATHOL MED, V36, P415, DOI 10.1111/j.1600-0714.2007.00546.x; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Golijanin D, 2004, CLIN CANCER RES, V10, P1024, DOI 10.1158/1078-0432.CCR-1032-3; GOSNEY JR, 1990, ANTICANCER RES, V10, P623; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hofmann BM, 2006, AM J SURG PATHOL, V30, P1595, DOI 10.1097/01.pas.0000213328.64121.12; HUGUET EL, 1994, CANCER RES, V54, P2615; Hung MC, 2011, J CELL SCI, V124, P3381, DOI 10.1242/jcs.089110; KANDA Y, 1994, INT J CANCER, V58, P291, DOI 10.1002/ijc.2910580224; Klein EA, 2008, J CELL SCI, V121, P3853, DOI 10.1242/jcs.039131; Leis PF, 1998, CANCER-AM CANCER SOC, V83, P122, DOI 10.1002/(SICI)1097-0142(19980701)83:1<122::AID-CNCR16>3.0.CO;2-Z; LEW DJ, 1991, CELL, V66, P1197, DOI 10.1016/0092-8674(91)90042-W; Li WP, 2014, J CLIN NEUROSCI, V21, P137, DOI 10.1016/j.jocn.2013.04.034; Liu D, 2007, LUNG CANCER, V58, P384, DOI 10.1016/j.lungcan.2007.07.005; Martins ACP, 2002, J UROLOGY, V167, P89, DOI 10.1016/S0022-5347(05)65389-X; Masferrer E, 2012, J UROLOGY, V188, P1965, DOI 10.1016/j.juro.2012.07.003; Mentrikoski MJ, 2014, AM J SURG PATHOL, V38, P1340, DOI 10.1097/PAS.0000000000000124; Niehrs C, 2012, EMBO J, V31, P2705, DOI 10.1038/emboj.2012.124; Ohashi K, 2000, CANCER-AM CANCER SOC, V88, P2201, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2201::AID-CNCR2>3.3.CO;2-E; Papadopoulos O, 2007, ANTICANCER RES, V27, P2167; Pizzocaro G, 2010, EUR UROL, V57, P1002, DOI 10.1016/j.eururo.2010.01.039; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Polakis P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008052; Polakis P, 2012, EMBO J, V31, P2737, DOI 10.1038/emboj.2012.126; Rauch GJ, 1997, COLD SPRING HARB SYM, V62, P227, DOI 10.1101/SQB.1997.062.01.028; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Symes AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084295; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Thrasivoulou C, 2013, J BIOL CHEM, V288, P35651, DOI 10.1074/jbc.M112.437913; Ting WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056196; Toth ZE, 2007, J HISTOCHEM CYTOCHEM, V55, P545, DOI 10.1369/jhc.6A7134.2007; Vaid M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023000; Veeck J, 2006, ONCOGENE, V25, P3479, DOI 10.1038/sj.onc.1209386; Velazquez EF, 2008, AM J SURG PATHOL, V32, P974, DOI 10.1097/PAS.0b013e3181641365; Wang Q, 2007, ONCOGENE, V26, P6560, DOI 10.1038/sj.onc.1210472; Wang Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010456; YAMAMOTO H, 2010, ONCOGENE; Zeng G, 2006, NEOPLASIA, V8, P279, DOI 10.1593/neo.05607	49	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124395	10.1371/journal.pone.0124395	http://dx.doi.org/10.1371/journal.pone.0124395			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901368	Green Published, gold			2022-12-26	WOS:000353331500084
J	Beller, CJ; Farag, M; Wannaku, S; Seppelt, P; Arif, R; Ruhparwar, A; Karck, M; Weymann, A; Kallenbach, K				Beller, Carsten J.; Farag, Mina; Wannaku, Sepali; Seppelt, Philipp; Arif, Rawa; Ruhparwar, Arjang; Karck, Matthias; Weymann, Alexander; Kallenbach, Klaus			Gender-Specific Differences in Outcome of Ascending Aortic Aneurysm Surgery	PLOS ONE			English	Article							HEART-DISEASE; GUIDELINES; EXPERIENCE; MANAGEMENT; DISSECTION; MORTALITY; STROKE; VALVE; WOMEN; ROOT	Objectives Gender specific differences receive increasing attention and are known to affect the outcome of cardiovascular diseases. We investigated possible risk-factors for gender-specific differences in ascending aortic aneurysm surgery. Methods 548 consecutive patients (male: n = 390, age: 58.3 +/- 14.4 years; female: n = 158, age: 65.3 +/- 12.9 years) with aneurysms of the ascending aorta eligible for cardiac surgery were retrospectively analyzed. Results Women were significantly older when operation was indicated (p<0.001) and presented with significantly more hypertension (p=0.04) and chronic obstructive pulmonary disease (COPD; p = 0.017), whereas men had significantly more previous cardiac operations (p = 0.016). Normalized aortic diameters (diameter / body surface area) were significantly larger in women (3.10 +/- 0.6 cm) vs. (2.75 +/- 0,5 cm, p <= 0.001) in men, without differences in absolute values (5.74 +/- 1.04 cm vs. 5.86 +/- 1.34 cm). The aortic arch was significantly more involved in aneurysm formation in women (p = 0.04). Follow-up was available in 93% of the patients with a mean follow-up time of 3.9 +/- 3.9 (0-17.8) years. 30-day mortality was 3.5% in men (n=12) and 7.9% in women (n=11; p = 0.058). Univariate regression analysis shows gender specific risk factors for 30-day mortality in men to be age: p = 0.028; myocardial infarction: p = 0.0.24 and in women diameter of the ascending aorta: p=0.014; renal insufficiency: p=0.007. Long-term survival was significantly reduced in women (log-rank p = 0.0052). Conclusions The outcome after surgery for ascending aortic aneurysm is less favourable in women with significantly reduced long-term survival and a trend to increased 30-day mortality in this cohort. Larger normalized aortic diameters, higher incidence of involvement of the aortic arch and differences in comorbidities may contribute to gender differences. Women undergo surgery at higher age and more progressed state of aortic disease. Therefore, gender-specific guidelines for ascending replacement may be useful to improve outcome in women.	[Beller, Carsten J.; Farag, Mina; Wannaku, Sepali; Seppelt, Philipp; Arif, Rawa; Ruhparwar, Arjang; Karck, Matthias; Weymann, Alexander; Kallenbach, Klaus] Heidelberg Univ, Heart Ctr Heidelberg, Clin Cardiac Surg, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Beller, CJ (corresponding author), Heidelberg Univ, Heart Ctr Heidelberg, Clin Cardiac Surg, Heidelberg, Germany.	carsten.beller@urz.uni-heidelberg.de	Weymann, Alexander/AAQ-5115-2021		German Research Foundation (DFG) [SFB-TRR 125]; German Heart Foundation	German Research Foundation (DFG)(German Research Foundation (DFG)); German Heart Foundation	This study was supported by the German Research Foundation (DFG), SFB-TRR 125 "Cognition-Guided Surgery" Project R03, and the German Heart Foundation "Dr. Rusche-Forderprojekt 2012". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Etz CD, 2007, J THORAC CARDIOV SUR, V133, P1455, DOI 10.1016/j.jtcvs.2007.01.058; Grubb KJ, 2011, SEMIN THORAC CARDIOV, V23, P124, DOI 10.1053/j.semtcvs.2011.08.009; Guethoff S GL, 2013, THORAC CARDIOVASC SU, V2013; Hannawa KK, 2009, VASCULAR, V17, pS30, DOI 10.2310/6670.2008.00092; Hiratzka LF, 2010, CIRCULATION, V121, pE266, DOI 10.1161/CIR.0b013e3181d4739e; Huynh TTT, 2013, J VASC SURG, V57, p11S, DOI 10.1016/j.jvs.2012.08.126; Kaczmarek I, 2013, THORAC CARDIOV SURG, V61, P29, DOI 10.1055/s-0032-1331467; Kallenbach K, 2013, JACC-CARDIOVASC IMAG, V6, P1321, DOI 10.1016/j.jcmg.2013.08.009; Kallenbach K, 2013, EUR J CARDIO-THORAC, V44, P337, DOI 10.1093/ejcts/ezs661; Katz DJ, 1997, J VASC SURG, V25, P561, DOI 10.1016/S0741-5214(97)70268-4; Laser A, 2014, J SURG RES, V186, P467, DOI 10.1016/j.jss.2013.07.050; Matura LA, 2007, CIRCULATION, V116, P1663, DOI 10.1161/CIRCULATIONAHA.106.685487; McPhee JT, 2007, J VASC SURG, V45, P891, DOI 10.1016/j.jvs.2007.01.043; Nienaber CA, 2004, CIRCULATION, V109, P3014, DOI 10.1161/01.CIR.0000130644.78677.2C; Okita Y, 1998, J THORAC CARDIOV SUR, V115, P129, DOI 10.1016/S0022-5223(98)70451-9; Rylski B, 2014, EUR J CARDIO-THORAC, V45, P805, DOI 10.1093/ejcts/ezt597; Seeburger J, 2013, THORAC CARDIOV SURG, V61, P42, DOI 10.1055/s-0032-1331583; Solimene MC, 2010, CLINICS, V65, P99, DOI 10.1590/S1807-59322010000100015; Vahanian A, 2012, EUR J CARDIO-THORAC, V42, pS1, DOI 10.1093/ejcts/ezs455; Zehr KJ, 2004, CIRCULATION, V110, P1364, DOI 10.1161/01.CIR.0000141593.05085.87	20	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124461	10.1371/journal.pone.0124461	http://dx.doi.org/10.1371/journal.pone.0124461			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902057	Green Published, gold, Green Submitted			2022-12-26	WOS:000353331500088
J	Iida, Y; van't Hof, P; Beenen, H; Mesarich, C; Kubota, M; Stergiopoulos, I; Mehrabi, R; Notsu, A; Fujiwara, K; Bahkali, A; Abd-Elsalam, K; Collemare, J; de Wit, PJGM				Iida, Yuichiro; van't Hof, Pieter; Beenen, Henriek; Mesarich, Carl; Kubota, Masaharu; Stergiopoulos, Ioannis; Mehrabi, Rahim; Notsu, Ayumi; Fujiwara, Kazuki; Bahkali, Ali; Abd-Elsalam, Kamel; Collemare, Jerome; de Wit, Pierre J. G. M.			Novel Mutations Detected in Avirulence Genes Overcoming Tomato Cf Resistance Genes in Isolates of a Japanese Population of Cladosporium fulvum	PLOS ONE			English	Article							LEAF MOLD; CF-4-MEDIATED RESISTANCE; ALLELIC VARIATION; VIRULENCE FACTOR; PASSALORA-FULVA; PLANT-PATHOGEN; EFFECTOR ECP6; BINDING-SITE; AVR4; RECOGNITION	Leaf mold of tomato is caused by the biotrophic fungus Cladosporium fulvum which complies with the gene-for-gene system. The disease was first reported in Japan in the 1920s and has since been frequently observed. Initially only race 0 isolates were reported, but since the consecutive introduction of resistance genes Cf-2, Cf-4, Cf-5 and Cf-9 new races have evolved. Here we first determined the virulence spectrum of 133 C. fulvum isolates collected from 22 prefectures in Japan, and subsequently sequenced the avirulence (Avr) genes Avr2, Avr4, Avr4E, Avr5 and Avr9 to determine the molecular basis of overcoming Cfgenes. Twelve races of C. fulvum with a different virulence spectrum were identified, of which races 9, 2.9, 4.9, 4.5.9 and 4.9.11 occur only in Japan. The Avr genes in many of these races contain unique mutations not observed in races identified elsewhere in the world including (i) frameshift mutations and (ii) transposon insertions in Avr2, (iii) point mutations in Avr4and Avr4E, and (iv) deletions of Avr4E, Avr5 and Avr9. New races have developed by selection pressure imposed by consecutive introductions of Cf-2, Cf-4, Cf-5and Cf-9 genes in commercially grown tomato cultivars. Our study shows that molecular variations to adapt to different Cf genes in an isolated C. fulvum population in Japan are novel but overall follow similar patterns as those observed in populations from other parts of the world. Implications for breeding of more durable C. fulvum resistant varieties are discussed.	[Iida, Yuichiro; Kubota, Masaharu; Fujiwara, Kazuki] Natl Agr & Food Res Org, Tsu, Mie, Japan; [Iida, Yuichiro; van't Hof, Pieter; Beenen, Henriek; Mesarich, Carl; Stergiopoulos, Ioannis; Mehrabi, Rahim; Collemare, Jerome; de Wit, Pierre J. G. M.] Wageningen Univ, Lab Phytopathol, NL-6700 AP Wageningen, Netherlands; [Mehrabi, Rahim] Seed & Plant Improvement Inst, Karaj, Iran; [Notsu, Ayumi] Hokkaido Res Org, Ornamental Plants & Vegetables Res Ctr, Sapporo, Hokkaido, Japan; [Bahkali, Ali; Abd-Elsalam, Kamel] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh 11451, Saudi Arabia; [Abd-Elsalam, Kamel] Agr Res Ctr, Plant Pathol Res Inst, Giza, Egypt; [de Wit, Pierre J. G. M.] Ctr Biosyst Genom, Wageningen, Netherlands	National Agriculture & Food Research Organization - Japan; Wageningen University & Research; King Saud University; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt; Centre for BioSystems Genomics	de Wit, PJGM (corresponding author), Wageningen Univ, Lab Phytopathol, NL-6700 AP Wageningen, Netherlands.	pierre.dewit@wur.nl	Mehrabi, Rahim/S-1800-2016; Mesarich, Carl H/E-4304-2015; Abd-Elsalam, Kamel Ahmed/AAU-4696-2020; Bahkali, Ali/E-3720-2014; Stergiopoulos, Ioannis/N-5430-2014	Mehrabi, Rahim/0000-0002-5098-9123; Mesarich, Carl H/0000-0002-5207-4074; Bahkali, Ali/0000-0003-3936-0436; Stergiopoulos, Ioannis/0000-0002-2368-6119; Collemare, Jerome/0000-0001-8152-6642; Abd-Elsalam, Kamel/0000-0002-4042-4022	Dutch Organization for Advanced Science (NWO) [23780046]; Dutch Organization for Advanced Science (ERA-NET); Royal Netherlands Academy of Sciences; King Saud University, Riyadh, SaudiArabia	Dutch Organization for Advanced Science (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Organization for Advanced Science (ERA-NET); Royal Netherlands Academy of Sciences; King Saud University, Riyadh, SaudiArabia	This work was supported in part by Grant-in-Aid for Young Scientists (23780046 to YI) (http://www.jsps.go.jp/english/e-grants/), grants from the Dutch Organization for Advanced Science (NWO; ERA-NET to IS, RM and JC) (http://www.nwo.nl/en/), grants from the Royal Netherlands Academy of Sciences (to PJGMW)(https://www.knaw.nl/en) and a grant from the King Saud University, Riyadh, SaudiArabia (to PVH)(http://ksu.edu.sa/en/) for study design, data collection, and data analysis. The funders had no role in the decision to publish or in the preparation of the manuscript.	Bolton MD, 2008, MOL MICROBIOL, V69, P119, DOI 10.1111/j.1365-2958.2008.06270.x; Cooke MC, 1883, GREVILLEA, VXII, P32; de Jonge R, 2010, SCIENCE, V329, P953, DOI 10.1126/science.1190859; de Wit PJGM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003088; de Wit PJGM, 2009, MOL PLANT PATHOL, V10, P735, DOI 10.1111/j.1364-3703.2009.00591.x; De Wit PJGM., 2009, PLANT RELATIONSHIPS, P135, DOI DOI 10.1007/978-3-540-87407-2_7; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Dixon MS, 1998, PLANT CELL, V10, P1915, DOI 10.1105/tpc.10.11.1915; Dixon MS, 1996, CELL, V84, P451, DOI 10.1016/S0092-8674(00)81290-8; Enya J, 2009, J GEN PLANT PATHOL, V75, P76, DOI 10.1007/s10327-008-0134-0; Fujimori M, 1980, J JAPAN SOC HORT SCI, V49, P208; HOLIDAY P, 1976, CMI DESCRIPTIONS PAT; Iida Y, 2010, J GEN PLANT PATHOL, V76, P84, DOI 10.1007/s10327-009-0207-8; JONES DA, 1994, SCIENCE, V266, P789, DOI 10.1126/science.7973631; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; JOOSTEN MHAJ, 1994, NATURE, V367, P384, DOI 10.1038/367384a0; Joosten MHAJ, 1997, PLANT CELL, V9, P367; Joosten MHAJ, 1999, ANNU REV PHYTOPATHOL, V37, P335, DOI 10.1146/annurev.phyto.37.1.335; KISHI K., 1962, Annals of the Phytopathological Society of Japan, V27, P189; Kishi K, 1976, JAPANEASE J PHYTOPAT, V42, P497; KOOISTRA E, 1964, EUPHYTICA, V13, P103; Kooman-Gersmann M, 1998, PLANT PHYSIOL, V117, P609, DOI 10.1104/pp.117.2.609; KoomanGersmann M, 1996, PLANT CELL, V8, P929, DOI 10.1105/tpc.8.5.929; Kubota M, 2015, J GEN PLANT PATHOL; Langford AN, 1937, CAN J RES C, V15, P109; Lauge R, 2000, PLANT J, V23, P735, DOI 10.1046/j.1365-313x.2000.00843.x; Lauge R, 1998, P NATL ACAD SCI USA, V95, P9014, DOI 10.1073/pnas.95.15.9014; Lauge R, 1998, FUNGAL GENET BIOL, V24, P285, DOI 10.1006/fgbi.1998.1076; LAZAROVITS G, 1976, CAN J BOT, V54, P235, DOI 10.1139/b76-023; LAZAROVITS G, 1976, CAN J BOT, V54, P224, DOI 10.1139/b76-022; LINDHOUT P, 1989, NETH J PLANT PATHOL, V95, P143, DOI 10.1007/BF01999969; Mesarich CH, 2014, MOL PLANT MICROBE IN, V27, P846, DOI 10.1094/MPMI-02-14-0050-R; Rivas S, 2005, ANNU REV PHYTOPATHOL, V43, P395, DOI 10.1146/annurev.phyto.43.040204.140224; Rooney HCE, 2005, SCIENCE, V308, P1783, DOI 10.1126/science.1111404; Satou Mamoru, 2005, Journal of General Plant Pathology, V71, P436, DOI 10.1007/s10327-005-0223-2; Stergiopoulos I, 2007, MOL PLANT MICROBE IN, V20, P1271, DOI 10.1094/MPMI-20-10-1271; Stergiopoulos I, 2007, FUNGAL GENET BIOL, V44, P415, DOI 10.1016/j.fgb.2006.11.004; Stergiopoulos I, 2010, P NATL ACAD SCI USA, V107, P7610, DOI 10.1073/pnas.1002910107; Stergiopoulos I, 2009, ANNU REV PHYTOPATHOL, V47, P233, DOI 10.1146/annurev.phyto.112408.132637; Sugahara Y, 1965, B HORTICULTURAL RE B, V4, P17; Takken FLW, 1999, PLANT J, V20, P279, DOI 10.1046/j.1365-313X.1999.t01-1-00601.x; Thomas CM, 1997, PLANT CELL, V9, P2209, DOI 10.1105/tpc.9.12.2209; Thomma BPHJ, 2005, MOL PLANT PATHOL, V6, P379, DOI 10.1111/J.1364-3703.2005.00292.X; van den Burg HA, 2004, J BIOL CHEM, V279, P16786, DOI 10.1074/jbc.M312594200; van den Burg HA, 2003, J BIOL CHEM, V278, P27340, DOI 10.1074/jbc.M212196200; van den Burg HA, 2006, MOL PLANT MICROBE IN, V19, P1420, DOI 10.1094/MPMI-19-1420; Van der Hoorn RAL, 2000, MOL PLANT MICROBE IN, V13, P439, DOI 10.1094/MPMI.2000.13.4.439; van Esse HP, 2008, PLANT CELL, V20, P1948, DOI 10.1105/tpc.108.059394; van Esse HP, 2007, MOL PLANT MICROBE IN, V20, P1092, DOI 10.1094/MPMI-20-9-1092; van't Klooster JW, 2011, MOL PLANT PATHOL, V12, P21, DOI 10.1111/j.1364-3703.2010.00647.x; VANDENACKERVEKEN GFJM, 1992, PLANT J, V2, P359, DOI 10.1111/j.1365-313X.1992.00359.x; VANKAN JAL, 1991, MOL PLANT MICROBE IN, V4, P52, DOI 10.1094/MPMI-4-052; Westerink N, 2004, FUNGAL DISEASE RESISTANCE IN PLANTS: BIOCHEMISTRY, MOLECULAR BIOLOGY, AND GENETIC ENGINEERING, P93; Westerink N, 2004, MOL MICROBIOL, V54, P533, DOI 10.1111/j.1365-2958.2004.04288.x; Wit P. J. G. M. de, 1977, Netherlands Journal of Plant Pathology, V83, P109, DOI 10.1007/BF01981556; Yamada K, 2002, JAPANESE J PHYTOPATH, V68, P36	56	26	26	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123271	10.1371/journal.pone.0123271	http://dx.doi.org/10.1371/journal.pone.0123271			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902074	gold, Green Published			2022-12-26	WOS:000353331500050
J	Maetzler, W; Ellerbrock, M; Heger, T; Sass, C; Berg, D; Reilmann, R				Maetzler, Walter; Ellerbrock, Maren; Heger, Tanja; Sass, Christian; Berg, Daniela; Reilmann, Ralf			Digitomotography in Parkinson's Disease: A Cross-Sectional and Longitudinal Study	PLOS ONE			English	Article							SOCIETY-SPONSORED REVISION; SCALE MDS-UPDRS; PROGRESSION; MOVEMENT; ONSET; RELIABILITY; PREMANIFEST; IMPAIRMENT	Motor symptoms in Parkinson's disease (PD) are usually assessed with semi-quantitative tests such as the Unified PD Rating Scale (UPDRS) which are limited by subjectivity, categorical design, and low sensitivity. Particularly bradykinesia as assessed e.g. with speeded index finger tapping exhibits low validity measures. This exploratory study set out to (i) assess whether force transducer-based objective and quantitative analysis of motor coordination in index finger tapping is able to distinguish between PD patients and controls, and (ii) assess longitudinal changes. Sixteen early-stage and 17 mid-stage PD patients as well as 18 controls were included in the cross-sectional part of the study; thirteen, 16 and 16 individuals of the respective groups agreed in a reassessment 12 months later. Frequency, force, rhythmicity, regularity and laterality of speeded and metronome paced tapping were recorded by digitomotography using a quantitative motor system ("Q-Motor"). Analysis of cross-sectional data revealed most consistent differences between PD patients and controls in variability of tap performance across modalities assessed. Among PD patients, variability of taps and the ability to keep a given rhythm were associated with UPDRS motor and finger tapping scores. After 12 months, laterality parameters were reduced but no other parameters changed significantly. This data suggests that digitomotography provides quantitative and objective measures capable to differentiate PD from non-PD in a small cohort, however, the value of the assessment to track PD progression has to be further evaluated in larger cohorts of patients.	[Maetzler, Walter; Ellerbrock, Maren; Heger, Tanja; Berg, Daniela; Reilmann, Ralf] Univ Tubingen, Ctr Neurol, Dept Neurodegenerat, Hertie Inst Clin Brain Res, Tubingen, Germany; [Maetzler, Walter; Heger, Tanja; Berg, Daniela] German Ctr Neurodegenerat Dis, DZNE, Tubingen, Germany; [Ellerbrock, Maren] Clin Ctr Lunenburg, Neurol Clin, Lunenburg, Germany; [Berg, Daniela; Reilmann, Ralf] George Huntington Inst, Munster, Germany; [Berg, Daniela; Reilmann, Ralf] Univ Munster, Dept Radiol, Munster, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munster	Maetzler, W (corresponding author), Univ Tubingen, Ctr Neurol, Dept Neurodegenerat, Hertie Inst Clin Brain Res, Tubingen, Germany.	Walter.maetzler@uni-tuebingen.de; ralf.reilmann@ghi-muenster.de	Maetzler, Walter/A-6796-2011; Maetzler, Walter/AAE-5831-2020; Berg, Daniela/A-8728-2019	Maetzler, Walter/0000-0002-5945-4694; Maetzler, Walter/0000-0002-5945-4694; Berg, Daniela/0000-0001-5796-5442; Reilmann, Ralf/0000-0002-5904-9517	European Union project SENSE-PARK, under Seventh Framework Programme, Cooperation-ICT [288557]; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of Tuebingen University	European Union project SENSE-PARK, under Seventh Framework Programme, Cooperation-ICT; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of Tuebingen University	WM was partly supported by the European Union project SENSE-PARK, funded under the Seventh Framework Programme, Cooperation-ICT (grant agreement no. 288557). The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University. No other external funding was obtained for this study.	Baltadjieva R, 2006, EUR J NEUROSCI, V24, P1815, DOI 10.1111/j.1460-9568.2006.05033.x; Bechtel N, 2010, NEUROLOGY, V75, P2150, DOI 10.1212/WNL.0b013e3182020123; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Costa J, 2010, MOVEMENT DISORD, V25, P2577, DOI 10.1002/mds.23334; Espay AJ, 2009, MOVEMENT DISORD, V24, P1001, DOI 10.1002/mds.22480; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GIBB WRG, 1988, NEUROLOGY, V38, P1402, DOI 10.1212/WNL.38.9.1402; Goetz CG, 2004, MOVEMENT DISORD, V19, P1453, DOI 10.1002/mds.20220; Goetz CG, 2007, MOVEMENT DISORD, V22, P41, DOI 10.1002/mds.21198; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Heldman DA, 2011, MOVEMENT DISORD, V26, P1859, DOI 10.1002/mds.23740; HENDERSON L, 1991, J NEUROL NEUROSUR PS, V54, P18, DOI 10.1136/jnnp.54.1.18; Hobert MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027831; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Kim JW, 2011, MED BIOL ENG COMPUT, V49, P365, DOI 10.1007/s11517-010-0697-8; Louie S, 2009, MOVEMENT DISORD, V24, P1991, DOI 10.1002/mds.22741; Maetzler W, 2013, MOVEMENT DISORD, V28, P1576, DOI 10.1002/mds.25682; Maetzler W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032240; Maetzler W, 2009, LANCET NEUROL, V8, P1158, DOI 10.1016/S1474-4422(09)70291-1; Rascol O, 2009, NEUROLOGY, V72, pS51, DOI 10.1212/WNL.0b013e318199049e; Tabrizi SJ, 2013, LANCET NEUROL, V12, P637, DOI 10.1016/S1474-4422(13)70088-7; Tabrizi SJ, 2009, LANCET NEUROL, V8, P791, DOI 10.1016/S1474-4422(09)70170-X; Uitti RJ, 2005, NEUROLOGY, V64, P1925, DOI 10.1212/01.WNL.0000163993.82388.C8; Yahalom G, 2004, PARKINSONISM RELAT D, V10, P143, DOI 10.1016/j.parkreldis.2003.10.001	24	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123914	10.1371/journal.pone.0123914	http://dx.doi.org/10.1371/journal.pone.0123914			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902182	Green Published, Green Submitted, gold			2022-12-26	WOS:000353331500066
J	Malli, C; Pandit, L; D'Cunha, A; Mustafa, S				Malli, Chaithra; Pandit, Lekha; D'Cunha, Anita; Mustafa, Sharik			Environmental Factors Related to Multiple Sclerosis in Indian Population	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; VITAMIN-D; RISK-FACTORS; ASSOCIATION; DISEASES; SUSCEPTIBILITY; EPIDEMIOLOGY; AUTOIMMUNE; MS	Background Multiple sclerosis (MS) is less prevalent among Indians when compared to white populations. Genetic susceptibility remaining the same it is possible that environmental associations may have a role in determining disease prevalence. Aims To determine whether childhood infections, vaccination status, past infection with Helicobacter pylori (H.pylori), diet, socioeconomic and educational status were associated with MS. Material and Methods 139 patients and 278 matched control subjects were selected. A validated environmental exposure questionnaire was administered. Estimation of serum H.pylori IgG antibody was done by ELISA. Patients and controls were genotyped for HLA-DRB1*15:01. Results In our cohort a significant association was seen with measles (p < 0.007), vegetarian diet (p < 0.001, higher educational status (p < 0.0001) and urban living (p < 0.0001). An inverse relationship was seen with H.Pylori infection and MS (p < 0.001). Measles infection (OR 6.479, CI 1.21-34.668, p < 0.029) and high educational status (OR 3.088, CI 1.212-7.872, p < 0.018) were significant risk factors associated with MS. H. pylori infection was inversely related to MS (OR 0.319, CI 0.144-0.706, p < 0.005). Conclusions Environmental influences may be important in determining MS prevalence.	[Malli, Chaithra; Pandit, Lekha; D'Cunha, Anita; Mustafa, Sharik] Nitte Univ, KS Hegde Med Acad, Ctr Adv Neurol Res, Mangalore, India	NITTE (Deemed to be University); K.S. Hegde Medical Academy	Pandit, L (corresponding author), Nitte Univ, KS Hegde Med Acad, Ctr Adv Neurol Res, Mangalore, India.	panditmng@gmail.com	Malli, Chaithra/AAO-3778-2021; Pandit, Lekha/AAO-3791-2021	malli, Chaithra/0000-0003-1969-034X; Pandit, Lekha/0000-0002-2269-5312	Department of Science and Technology, Government of India [SR/SO/HS/127/2010]	Department of Science and Technology, Government of India(Department of Science & Technology (India))	L.P. received funding from Department of Science and Technology, Government of India (SR/SO/HS/127/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal A N, 2006, Indian J Chest Dis Allied Sci, V48, P13; Amezcua L, 2012, J NEUROL, V259, P2565, DOI 10.1007/s00415-012-6537-z; [Anonymous], 1985, ANN ACAD MED SINGAP; Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Bager P, 2004, BRAIN, V127, P2491, DOI 10.1093/brain/awh283; Cisneros E, 2010, J NEUROIMMUNOL, V225, P143, DOI 10.1016/j.jneuroim.2010.03.019; Cooper GS, 2009, J AUTOIMMUN, V33, P197, DOI 10.1016/j.jaut.2009.09.008; Gale CR, 1995, PROG NEUROBIOL, V47, P425, DOI 10.1016/0301-0082(95)00033-X; Gelfand JM, 2011, NEUROLOGY, V76, P1824, DOI 10.1212/WNL.0b013e31821cccf5; Ghosal Samit, 2013, J Indian Med Assoc, V111, P751; GRAHAM DY, 1991, J GASTROEN HEPATOL, V6, P105, DOI 10.1111/j.1440-1746.1991.tb01448.x; Harinarayan C V, 2009, J Assoc Physicians India, V57, P40; Hunter SF, 2000, NEUROLOGY, V55, P164, DOI 10.1212/WNL.55.2.164; Kankonkar S, 2003, HUM IMMUNOL, V64, P478, DOI 10.1016/S0198-8859(03)00014-4; Kurtzke JF, 1997, NEUROLOGY, V48, P204, DOI 10.1212/WNL.48.1.204; LEIBOWITZ U, 1966, J NEUROL NEUROSUR PS, V29, P60, DOI 10.1136/jnnp.29.1.60; Li W, 2007, J NEUROIMMUNOL, V184, P227, DOI 10.1016/j.jneuroim.2006.12.010; Long YM, 2013, NEUROIMMUNOMODULAT, V20, P107, DOI 10.1159/000345838; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Mohebi N, 2013, NEUROL INT, V5, P31, DOI 10.4081/ni.2013.e10; Norrby E, 1973, ARCH NEUROL-CHICAGO, V127, P467; OLERUP O, 1992, TISSUE ANTIGENS, V39, P225, DOI 10.1111/j.1399-0039.1992.tb01940.x; Pandit L, 2011, AUTOIMMUN DIS, V2011, DOI 10.4061/2011/937586; Pandit L, 2014, MULT SCLER J, V20, P1651, DOI 10.1177/1352458514521503; Pandit L, 2013, MULT SCLER J, V19, P1592, DOI 10.1177/1352458513482375; Pandit L, 2013, J NEUROL SCI, V325, P86, DOI 10.1016/j.jns.2012.12.004; Pandit L, 2012, NEUROL INDIA, V60, P470, DOI 10.4103/0028-3886.103186; Pandit L, 2011, MULT SCLER J, V17, P139, DOI 10.1177/1352458510384011; Prabhu, 2014, INT J RES HLTH SCI, V2, P875; Rosche B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028094; RUSSELL WR, 1971, LANCET, V2, P832; Schmidt H, 2007, AM J EPIDEMIOL, V165, P1097, DOI 10.1093/aje/kwk118; Thirumurthi S, 2012, INDIAN J MED RES, V136, P549; VENKITARAMAN AR, 1986, INT J EPIDEMIOL, V15, P561, DOI 10.1093/ije/15.4.561; Vieira SM, 2014, LUPUS, V23, P518, DOI 10.1177/0961203313501401; Weinstock JV, 2014, J IMMUNOL, V193, P3239, DOI 10.4049/jimmunol.1400927	37	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124064	10.1371/journal.pone.0124064	http://dx.doi.org/10.1371/journal.pone.0124064			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902359	Green Published, gold, Green Submitted			2022-12-26	WOS:000353331500075
J	Qi, DF; Hu, Y; Li, JH; Peng, T; Su, JL; He, Y; Ji, WD				Qi, Defeng; Hu, Yuan; Li, Jinhui; Peng, Tao; Su, Jialin; He, Yun; Ji, Weidong			Hyperthermia Induces Apoptosis of 786-O Cells through Suppressing Ku80 Expression	PLOS ONE			English	Article							DOUBLE-STRAND BREAK; DEPENDENT PROTEIN-KINASE; IONIZING-RADIATION; CATALYTIC SUBUNIT; ANTICANCER DRUGS; GAMMA-H2AX FOCI; DEFICIENT CELLS; DNA-REPAIR; HEAT-SHOCK; CARCINOMA	Hyperthermia as an anticancer method has been paid increasing attention in recent years. Several studies have shown that hyperthermia can kill tumor cells by inducing apoptosis. However, the underlying molecular mechanisms of hyperthermia-induced apoptosis are largely unknown. To investigate the effects and molecular mechanism of hyperthermia on the apoptosis in renal carcinoma 786-O cells, we firstly examined apoptosis and Ku expression in 786-O cell line treated with heat exposure (42 degrees C for 0-4 h). The results showed that hyperthermia induced apoptosis of 786-O cells, and suppressed significantly Ku80 expression, but not Ku70 expression. Next, we knock-down Ku80 in 786-O cells, generating stable cell line 786-O-shKu80, and detected apoptosis, cell survival and cell cycle distribution. Our data showed higher apoptotic rate and lower surviving fraction in the stable cell line 786-O-shKu80 compared with those in control cells, exposed to the same heat stress (42 degrees C for 0-4 h). Moreover, the results also showed suppression of Ku80 led to G2/M phase arrest in the stable cell line 786-O-shKu80 following heat treatment. Together, these findings indicate that Ku80 may play an important role in hyperthermia-induced apoptosis and heat-sensitivity of renal carcinoma cells through influencing the cell cycle distribution.	[Qi, Defeng; Hu, Yuan; Li, Jinhui; Peng, Tao; Su, Jialin] Guangzhou Med Univ, Affiliated Hosp 1, Minimally Invas Surg Ctr, Dept Urol,Guangdong Prov Key Lab Urol, Guangzhou, Guangdong, Peoples R China; [He, Yun] Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China; [Ji, Weidong] Sun Yat Sen Univ, Affiliated Hosp 1, Ctr Translat Med, Guangzhou 510275, Guangdong, Peoples R China	Guangzhou Medical University; Sun Yat Sen University; Sun Yat Sen University	Qi, DF (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Minimally Invas Surg Ctr, Dept Urol,Guangdong Prov Key Lab Urol, Guangzhou, Guangdong, Peoples R China.	qdf70818@tom.com; heyun_jane@163.com; wdji2008@163.com	ji, weidong/AAX-7397-2020	Peng, Tao/0000-0001-5260-7128	National Natural Science Foundation of China [30872142, 81272350, 81472999]; Natural Science Foundation of Guangdong [S2012010008908, 8151012003000011]; University Talent Program of Guangzhou [12A015G]; Science and Technology Program of Guangdong [2010B060900096]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province); University Talent Program of Guangzhou; Science and Technology Program of Guangdong	This work was supported by grants from National Natural Science Foundation of China (No. 30872142, No. 81272350, No. 81472999 to WJ), Natural Science Foundation of Guangdong (No. S2012010008908 to WJ, No. 8151012003000011 to DQ), University Talent Program of Guangzhou (No. 12A015G to WJ) and Science and Technology Program of Guangdong (No. 2010B060900096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRY MA, 1990, BIOCHEM PHARMACOL, V40, P2353, DOI 10.1016/0006-2952(90)90733-2; Basile A, 2008, J CELL BIOCHEM, V103, P212, DOI 10.1002/jcb.21401; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Campbell SC, 2009, J UROLOGY, V182, P1271, DOI 10.1016/j.juro.2009.07.004; Coffey DS, 2006, JAMA-J AM MED ASSOC, V296, P445, DOI 10.1001/jama.296.4.445; Davis AJ, 2013, J BIOL CHEM, V288, P7037, DOI 10.1074/jbc.M112.434498; DIKOMEY E, 1992, INT J RADIAT BIOL, V61, P221, DOI 10.1080/09553009214550851; DYSON JED, 1986, CELL TISSUE KINET, V19, P311, DOI 10.1111/j.1365-2184.1986.tb00683.x; GABAI VL, 1995, FEBS LETT, V375, P21, DOI 10.1016/0014-5793(95)01152-5; Gabai VL, 1998, FEBS LETT, V438, P1, DOI 10.1016/S0014-5793(98)01242-3; HARMON BV, 1991, INT J RADIAT BIOL, V59, P489, DOI 10.1080/09553009114550441; Hildebrandt B, 2002, CRIT REV ONCOL HEMAT, V43, P33, DOI 10.1016/S1040-8428(01)00179-2; Ihara M, 2014, INT J HYPERTHER, V30, P102, DOI 10.3109/02656736.2014.887793; Iliakis G, 2004, CYTOGENET GENOME RES, V104, P14, DOI 10.1159/000077461; Ismail-Zade RS, 2005, PEDIATR BLOOD CANCER, V44, P679, DOI 10.1002/pbc.20299; Jones EL, 2005, J CLIN ONCOL, V23, P3079, DOI 10.1200/JCO.2005.05.520; Kajihara A, 2008, INT J HYPERTHER, V24, P605, DOI 10.1080/02656730802348339; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kim SH, 1999, CANCER RES, V59, P4012; Kim SH, 2000, LEUKEMIA RES, V24, P917, DOI 10.1016/S0145-2126(00)00061-8; Kuhne M, 2004, CANCER RES, V64, P500, DOI 10.1158/0008-5472.CAN-03-2384; Kurimasa A, 1999, P NATL ACAD SCI USA, V96, P1403, DOI 10.1073/pnas.96.4.1403; Li G, 2002, P NATL ACAD SCI USA, V99, P832, DOI 10.1073/pnas.022649699; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; MIKKELSEN RB, 1991, CANCER RES, V51, P359; Moriyama-Gonda N, 2002, BJU INT, V90, P317, DOI 10.1046/j.1464-410X.2002.02810.x; Motzer RJ, 1997, CURR PROB CANCER, V21, P191, DOI 10.1016/S0147-0272(97)80007-4; Munoz P, 1998, MOL CELL BIOL, V18, P5797, DOI 10.1128/MCB.18.10.5797; Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0; Nussenzweig A, 1997, P NATL ACAD SCI USA, V94, P13588, DOI 10.1073/pnas.94.25.13588; Okamoto N, 2011, INT J HYPERTHER, V27, P297, DOI 10.3109/02656736.2010.545365; Omori S, 2002, DNA REPAIR, V1, P299, DOI 10.1016/S1568-7864(02)00006-X; Ouyang H, 1997, J EXP MED, V186, P921, DOI 10.1084/jem.186.6.921; Ponnala S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026191; RADFORD IR, 1983, INT J RADIAT BIOL, V43, P551, DOI 10.1080/09553008314550641; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Takahashi A, 2004, CANCER RES, V64, P8839, DOI 10.1158/0008-5472.CAN-04-1876; Takahashi A, 2008, MUTAT RES-GEN TOX EN, V656, P88, DOI 10.1016/j.mrgentox.2008.07.012; Takahashi A, 2010, J RADIAT RES, V51, P91, DOI [10.1269/jrr.09111, 10.1269/jrr.0911]; VIDAIR CA, 1995, J CELL PHYSIOL, V163, P194, DOI 10.1002/jcp.1041630122; Wang C, 2013, INT J RADIAT ONCOL, V86, P440, DOI 10.1016/j.ijrobp.2013.01.011; Weterings E, 2008, CELL RES, V18, P114, DOI 10.1038/cr.2008.3; Zhuang L, 2011, INT J ONCOL, V39, P443, DOI 10.3892/ijo.2011.1041; Zuo L, 2000, AM J PHYSIOL-CELL PH, V279, pC1058, DOI 10.1152/ajpcell.2000.279.4.C1058	44	16	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0122977	10.1371/journal.pone.0122977	http://dx.doi.org/10.1371/journal.pone.0122977			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902193	Green Published, Green Submitted, gold			2022-12-26	WOS:000353331500035
J	Singh, M; Evans, D; Tan, BS; Nin, CS				Singh, Minerva; Evans, Damian; Tan, Boun Suy; Nin, Chan Samean			Mapping and Characterizing Selected Canopy Tree Species at the Angkor World Heritage Site in Cambodia Using Aerial Data	PLOS ONE			English	Article							FOREST BIOMASS; CROWN DELINEATION; LAND-USE; WATERSHED SEGMENTATION; MULTISCALE TEXTURE; INDIVIDUAL TREES; LIDAR DATA; CLASSIFICATION; IMAGERY; QUICKBIRD	At present, there is very limited information on the ecology, distribution, and structure of Cambodia's tree species to warrant suitable conservation measures. The aim of this study was to assess various methods of analysis of aerial imagery for characterization of the forest mensuration variables (i.e., tree height and crown width) of selected tree species found in the forested region around the temples of Angkor Thom, Cambodia. Object-based image analysis (OBIA) was used (using multiresolution segmentation) to delineate individual tree crowns from very-high-resolution (VHR) aerial imagery and light detection and ranging (LiDAR) data. Crown width and tree height values that were extracted using multiresolution segmentation showed a high level of congruence with field-measured values of the trees (Spearman's rho 0.782 and 0.589, respectively). Individual tree crowns that were delineated from aerial imagery using multiresolution segmentation had a high level of segmentation accuracy (69.22%), whereas tree crowns delineated using watershed segmentation underestimated the field-measured tree crown widths. Both spectral angle mapper (SAM) and maximum likelihood (ML) classifications were applied to the aerial imagery for mapping of selected tree species. The latter was found to be more suitable for tree species classification. Individual tree species were identified with high accuracy. Inclusion of textural information further improved species identification, albeit marginally. Our findings suggest that VHR aerial imagery, in conjunction with OBIA-based segmentation methods (such as multiresolution segmentation) and supervised classification techniques are useful for tree species mapping and for studies of the forest mensuration variables.	[Singh, Minerva] Univ Cambridge, Dept Plant Sci, Cambridge, England; [Evans, Damian] Univ Sydney, Dept Asian Studies, Sydney, NSW 2006, Australia; [Evans, Damian] Univ Sydney, Dept Archaeol, Sydney, NSW 2006, Australia; [Tan, Boun Suy] Angkor Int Res & Documentat Ctr, Siem Reap, Cambodia; [Nin, Chan Samean] APSARA Natl Author, Dept Forestry Management Cultural Landscape & Env, Siem Reap, Cambodia	University of Cambridge; University of Sydney; University of Sydney	Singh, M (corresponding author), Univ Cambridge, Dept Plant Sci, Cambridge, England.	ms2127@cam.ac.uk		Singh, Minerva/0000-0002-7148-0078	APSARA Authority; University of Sydney; Ecole Francaise d'Extreme Orient; Hungarian Southeast Asian Research Institute; Japan-APSARA Safeguarding Angkor; Archaeology and Development Foundation; World Monuments Fund; Societe Concessionaire d'Aeroport	APSARA Authority; University of Sydney(University of Sydney); Ecole Francaise d'Extreme Orient; Hungarian Southeast Asian Research Institute; Japan-APSARA Safeguarding Angkor; Archaeology and Development Foundation; World Monuments Fund; Societe Concessionaire d'Aeroport	We are grateful to the APSARA National Authority for permission to undertake field research in the Angkor Thom area, including Bun Chamrouen and Ley Kimsy for their assistance in the field. So Malay, Martin Polkinghorne, Son Rothaphum, and the Robert Christie Foundation made essential contributions to the logistical and administrative components of the field program. We thank PT McElhanney Indonesia for their contribution to the LiDAR acquisition and acknowledge support and funding from eight institutions of the Khmer Archaeology LiDAR Consortium: the APSARA Authority, the University of Sydney, the Ecole Francaise d'Extreme Orient, Societe Concessionaire d'Aeroport, the Hungarian Southeast Asian Research Institute, Japan-APSARA Safeguarding Angkor, the Archaeology and Development Foundation, and the World Monuments Fund.	Abd Latif Zulkiflee, 2011, 2011 Proceedings of IEEE 7th International Colloquium on Signal Processing & its Applications (CSPA 2011), P354, DOI 10.1109/CSPA.2011.5759902; Anthony G, 2007, 10 INT S PHYS MEAS S; Arasato LS, 2011, AN 15 S BRAS SENS RE, P7628; Benz UC, 2004, ISPRS J PHOTOGRAMM, V58, P239, DOI 10.1016/j.isprsjprs.2003.10.002; Blaschke T, 2010, ISPRS J PHOTOGRAMM, V65, P2, DOI 10.1016/j.isprsjprs.2009.06.004; Campbell MO, 2005, SINGAPORE J TROP GEO, V26, P151, DOI 10.1111/j.0129-7619.2005.00211.x; Carleer AP, 2005, PHOTOGRAMM ENG REM S, V71, P1285, DOI 10.14358/PERS.71.11.1285; Cho M., 2011, P 34 INT S REM SENS, P10; Cho MA, 2012, REMOTE SENS ENVIRON, V125, P214, DOI 10.1016/j.rse.2012.07.010; Clark ML, 2012, REMOTE SENS-BASEL, V4, P1820, DOI 10.3390/rs4061820; Clark ML, 2004, REMOTE SENS ENVIRON, V91, P68, DOI 10.1016/j.rse.2004.02.008; Clinton N., 2008, INT ARCH PHOTOGRAMM, V37, P1189; Coburn CA, 2004, INT J REMOTE SENS, V25, P4287, DOI 10.1080/0143116042000192367; Corlett RT, 2000, SEED DISPERSAL FRUGI, P451; d'Oliveira MVN, 2012, REMOTE SENS ENVIRON, V124, P479, DOI 10.1016/j.rse.2012.05.014; Dey V, 2010, INT ARCH PHOTOGRAMM, V38, P31; Diamond J, 2009, NATURE, V461, P479, DOI 10.1038/461479a; Dupuy S, 2012, 4 INT C GEOGR OBJ B; Eckert S, 2012, REMOTE SENS-BASEL, V4, P810, DOI 10.3390/rs4040810; Edson C, 2011, REMOTE SENS-BASEL, V3, P2494, DOI 10.3390/rs3112494; Englhart S, 2013, REMOTE SENS-BASEL, V5, P2368, DOI 10.3390/rs5052368; Erikson M, 2005, MACH VISION APPL, V16, P258, DOI 10.1007/s00138-005-0180-y; Evans D, 2007, P NATL ACAD SCI USA, V104, P14277, DOI 10.1073/pnas.0702525104; Evans DH, 2013, P NATL ACAD SCI USA, V110, P12595, DOI 10.1073/pnas.1306539110; Fletcher R, 2007, WORLD ARCHAEOL, V39, P385, DOI 10.1080/00438240701465001; Fowler P. J., 2003, WORLD HERITAGE 2002, V7, P16; Franklin SE, 2001, PHOTOGRAMM ENG REM S, V67, P849; Galletti CS, 2014, REMOTE SENS-BASEL, V6, P6089, DOI 10.3390/rs6076089; Gao J, 2009, MULTITEMPORAL IMAGE, P645; Gao Y, 2006, INT J REMOTE SENS, V27, P4039, DOI 10.1080/01431160600702632; Garzon-Lopez CX, 2013, BIOTROPICA, V45, P308, DOI 10.1111/btp.12009; Gaucher J, 2002, MUSEUM INT, V54, P28, DOI 10.1111/1468-0033.00361; Gaucher J, 2003, FISHBONES GLITTERING, P233; Gaughan AE, 2009, APPL GEOGR, V29, P212, DOI 10.1016/j.apgeog.2008.09.007; Gillespie J, 2009, INT J HERIT STUD, V15, P338, DOI 10.1080/13527250902933900; Gomes MF, 2013, SPIE REMOTE SENSING; Gonzalez-Orozco CE, 2010, APPL VEG SCI, V13, P510, DOI 10.1111/j.1654-109X.2010.01090.x; Gougeon FA, 2006, PHOTOGRAMM ENG REM S, V72, P1287, DOI 10.14358/PERS.72.11.1287; Guo QH, 2007, GISCI REMOTE SENS, V44, P24, DOI 10.2747/1548-1603.44.1.24; Hall O, 2004, LANDSCAPE ECOL, V19, P59, DOI 10.1023/B:LAND.0000018371.43447.1f; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hatami F, 2012, CARBON ESTIMATION IN; Heenkenda MK, 2014, REMOTE SENS-BASEL, V6, P6064, DOI 10.3390/rs6076064; Heinzel JN, 2008, P SILVILASER ED UK; Hodgson ME, 2004, PHOTOGRAMM ENG REM S, V70, P331, DOI 10.14358/PERS.70.3.331; Huang HB, 2009, SENSORS-BASEL, V9, P1541, DOI 10.3390/s90301541; Hunter MO, 2013, BIOGEOSCIENCES, V10, P8385, DOI 10.5194/bg-10-8385-2013; Imai Y, 2004, INT SOC PHOTOGRAMMET, V4; Jakubowski MK, 2013, REMOTE SENS-BASEL, V5, P4163, DOI 10.3390/rs5094163; Jansen PA, 2008, ECOGRAPHY, V31, P33, DOI 10.1111/j.2007.0906-7590.05151.x; Jing LH, 2012, ISPRS J PHOTOGRAMM, V70, P88, DOI 10.1016/j.isprsjprs.2012.04.003; Jones H.G., 2010, REMOTE SENSING VEGET; Kakunda CB, 2013, THESIS U TWENTE ENSC; Kanda F, 2004, INT GEOSCI REMOTE SE, P3822; Karegowda AG, 2010, INT J INFORM TECHNOL, V2, P271; Ke YH, 2010, REMOTE SENS ENVIRON, V114, P1141, DOI 10.1016/j.rse.2010.01.002; Kim M, 2009, PHOTOGRAMM ENG REM S, V75, P819, DOI 10.14358/PERS.75.7.819; Koedsin W, 2013, REMOTE SENS-BASEL, V5, P3562, DOI 10.3390/rs5073562; Koh LP, 2012, TROP CONSERV SCI, V5, P121, DOI 10.1177/194008291200500202; Korom A, 2004, IOP C SER EARTH ENV, V18; Kraus K, 1998, ISPRS J PHOTOGRAMM, V53, P193, DOI 10.1016/S0924-2716(98)00009-4; Kulikova M, 2007, EUSIPCO POZN POL, p[2007, 1]; Kumar M, 2012, OSGEO INDIA, P1; Kux HJ, 2012, ISPRS ANN PHOTOGRAMM, V1-4, P95, DOI DOI 10.5194/ISPRSANNALS-I-4-95-2012; Larjavaara M, 2013, METHODS ECOL EVOL, V4, P793, DOI 10.1111/2041-210X.12071; Lemaistre A, 2002, MUSEUM INT, V54, P117, DOI 10.1111/1468-0033.00375; Li Z, 2010, DIGITAL TERRAIN MODE; Liu X, 2007, MODSIM 2007: INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION, P1363; Lizarazo I, 2008, PIXELS GRIXELS UNIFI; Malhi Y, 2012, J ECOL, V100, P65, DOI 10.1111/j.1365-2745.2011.01916.x; Marthews T., 2012, MEASURING TROPICAL F; Martinez-Uso A, 2007, IEEE T GEOSCI REMOTE, V45, P4158, DOI 10.1109/TGRS.2007.904951; Maxwell J. F., 1995, Natural History Bulletin of the Siam Society, V43, P131; Mbaabu PR, 2012, AGB CARBON MAPPING U; McGaughey R. J., 2010, FUSION LDV SOFTWARE; McKay JE, 2014, ORYX, V48, P23, DOI 10.1017/S0030605313001087; Mei C., 2004, INT ARCH PHOTOGRAMME, V36, P218; Michael Spencer and the FREELAND Foundation, 2013, AS MOST PREC WOOD SO; Mikusinski G, 2014, ORYX, V48, P17, DOI 10.1017/S0030605312000993; Miura K., 2005, CONSERV MANAGE ARCHA, V7, P3, DOI [DOI 10.1179/135050305793137602, 10.1179/135050305793137602]; Palace M, 2008, BIOTROPICA, V40, P141, DOI 10.1111/J.1744-7429.2007.00353.x; Phua MH, 2003, CAN J REMOTE SENS, V29, P429, DOI 10.5589/m03-005; Popescu SC, 2003, CAN J REMOTE SENS, V29, P564, DOI 10.5589/m03-027; Primack R., 1998, TIMBER TOURISTS TEMP; Chen Q, 2006, PHOTOGRAMM ENG REM S, V72, P923, DOI 10.14358/PERS.72.8.923; Shafri Helmi Zulhaidi Mohd, 2007, Journal of Computer Sciences, V3, P419, DOI 10.3844/jcssp.2007.419.423; Shendryk I, 2013, THESIS DEP PHYS GEOG; Simard M, 2000, IEEE T GEOSCI REMOTE, V38, P2310, DOI 10.1109/36.868888; Singh M, 2014, J APPL REMOTE SENS, V8, DOI 10.1117/1.JRS.8.083695; Smits I., 2012, BIOSYST INF TECHNOL, V1, P19, DOI [10.11592/bit.121103, DOI 10.11592/BIT.121103, DOI 10.11592/bit.121103]; Steinmetz RG., 2009, THESIS U MINNEAPOLIS; Tan BS, 2012, DETERIORATION STONE, P108; Tinkham WT, 2012, CAN J FOREST RES, V42, P413, DOI [10.1139/X11-193, 10.1139/x11-193]; Tochon G, 2012, INT GEOSCI REMOTE SE, P6368, DOI 10.1109/IGARSS.2012.6352716; Tokola T, 2008, ISPRS C GEORG; Tsendbazar NE, 2011, THESIS U TWENTE ENSC; Turner BL, 2012, P NATL ACAD SCI USA, V109, P13908, DOI 10.1073/pnas.1210106109; Turner BL, 2001, FOREST ECOL MANAG, V154, P353, DOI 10.1016/S0378-1127(01)00508-4; UN-REDD, 2010, CAMB NAT UN REDD NAT; Vadakkenveettil B., 2012, INT J COMPUT SCI ENG, V2, P151, DOI [10.5121/ijcseit.2012.2213, DOI 10.5121/IJCSEIT.2012.2213]; Wales N, 2012, COMBINING REMOTE SEN; Walsh SJ, 2008, REMOTE SENS ENVIRON, V112, P1927, DOI 10.1016/j.rse.2007.06.028; Wang L, 2004, PHOTOGRAMM ENG REM S, V70, P351, DOI 10.14358/PERS.70.3.351; Wang L, 2013, GEOINFORMATICA, V17, P35, DOI 10.1007/s10707-011-0148-1; Whiteside T, 2011, THESIS C DARWIN U ME; Wijaya A, 2007, 5 ISPRS INT S SPAT D; World Agroforestry Centre, 2013, AGR DAT; Yang J, 2014, INT GEOSCI REMOTE SE, P1588, DOI 10.1109/IGARSS.2014.6945949; Zhou JJ, 2013, J APPL REMOTE SENS, V7, DOI 10.1117/1.JRS.7.073484	110	37	37	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0121558	10.1371/journal.pone.0121558	http://dx.doi.org/10.1371/journal.pone.0121558			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902148	Green Published, Green Submitted, gold			2022-12-26	WOS:000353331500010
J	Vieira, MF; de Avelar, IS; Silva, MS; Soares, V; da Costa, PHL				Vieira, Marcus Fraga; de Avelar, Ivan Silveira; Silva, Maria Sebastiana; Soares, Viviane; Lobo da Costa, Paula Hentschel			Effects of Four Days Hiking on Postural Control	PLOS ONE			English	Article							STRENUOUS TREADMILL EXERCISE; TRICEPS SURAE MUSCLES; MUSCULAR FATIGUE; VISUAL CONTRIBUTION; UPRIGHT STANCE; POSITION SENSE; LOCAL FATIGUE; SWAY-DENSITY; QUIET STANCE; BODY SWAY	Hiking is a demanding form of exercise that may cause delayed responses of the postural muscles and a loss of somatosensory information, particularly when repeatedly performed for several days. These effects may negatively influence the postural control of hikers. Therefore, the aim of this study was to investigate the effects of a four-day hike on postural control. Twenty-six adults of both sexes travelled 262 kilometers, stopping for lunch and resting in the early evening each day. Force platforms were used to collect center of pressure (COP) data at 100 Hz for 70 seconds before hiking started and immediately after arriving at the rest station each day. The COP time course data were analyzed according to global stabilometric descriptors, spectral analysis and structural descriptors using sway density curve (SDC) and stabilometric diffusion analysis (SDA). Significant increases were found for global variables in both the anterior-posterior and medial-lateral directions (COP sway area, COP total sway path, COP mean velocity, COP root mean square value and COP range). In the spectral analysis, only the 80% power frequency (F80) in the anterior-posterior direction showed a significant increase, reflecting the increase of the sway frequencies. The SDC revealed a significant increase in the mean distance between peaks (MD) and a significant decrease in the mean peak amplitudes (MP), suggesting that a larger torque amplitude is required for stabilization and that the postural stability is reduced. The SDA revealed a decrease in the long-term slope (Hl) and increases in the short-term (Ks) and the long-term (Kl) intercepts. We considered the likelihood that the presence of local and general fatigue, pain and related neuromuscular adaptations and somatosensory deficits may have contributed to these postural responses. Together, these results demonstrated that four days of hiking increased sway frequencies and deteriorated postural control in the standing position.	[Vieira, Marcus Fraga; de Avelar, Ivan Silveira; Silva, Maria Sebastiana; Soares, Viviane] Univ Fed Goias, Bioengn & Biomech Lab, Goiania, Go, Brazil; [Lobo da Costa, Paula Hentschel] Univ Fed Sao Carlos, Dept Phys Educ, Sao Paulo, Brazil	Universidade Federal de Goias; Universidade Federal de Sao Carlos	Vieira, MF (corresponding author), Univ Fed Goias, Bioengn & Biomech Lab, Goiania, Go, Brazil.	marcus@ufg.br	da Costa, Paula Hentschel Lobo/AAQ-3498-2021; Soares, Viviane/AAE-9771-2020; Vieira, Marcus Fraga/G-4840-2012	da Costa, Paula Hentschel Lobo/0000-0003-2117-0423; Soares, Viviane/0000-0002-1570-6626; Vieira, Marcus Fraga/0000-0001-9096-1603	Capes Foundation, Brazil	Capes Foundation, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Ivan Silveira de Avelar and Viviane Soares were supported by a scholarship provided by Capes Foundation, Brazil.	Amoud H, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-12; Asseman F, 2005, INT J SPORTS MED, V26, P116, DOI 10.1055/s-2004-830529; Baratto L, 2002, MOTOR CONTROL, V6, P246, DOI 10.1123/mcj.6.3.246; BONNARD M, 1994, NEUROSCI LETT, V166, P101, DOI 10.1016/0304-3940(94)90850-8; Bove M, 2007, NEUROSCI LETT, V418, P276, DOI 10.1016/j.neulet.2007.03.036; Burdet C, 2004, SCI SPORT, V19, P308, DOI 10.1016/j.scispo.2004.02.003; Caron O, 2004, NEUROSCI LETT, V363, P18, DOI 10.1016/j.neulet.2004.03.038; Chiari L, 2000, GAIT POSTURE, V12, P225, DOI 10.1016/S0966-6362(00)00086-2; COLLINS JJ, 1993, EXP BRAIN RES, V95, P308, DOI 10.1007/BF00229788; Corbeil P, 2003, GAIT POSTURE, V18, P92, DOI 10.1016/S0966-6362(02)00198-4; Cote JN, 2002, EXP BRAIN RES, V146, P394, DOI 10.1007/s00221-002-1186-6; Degache F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084554; Derave W, 2002, INT J SPORTS MED, V23, P44, DOI 10.1055/s-2002-19374; Enoka RM, 2008, J PHYSIOL-LONDON, V586, P11, DOI 10.1113/jphysiol.2007.139477; Forestier N, 1998, NEUROSCI LETT, V252, P187, DOI 10.1016/S0304-3940(98)00584-9; Forestier N, 2002, MED SCI SPORT EXER, V34, P117, DOI 10.1097/00005768-200201000-00018; Fox ZG, 2008, J ATHL TRAINING, V43, P456, DOI 10.4085/1062-6050-43.5.456; Garland SJ, 1995, ADV EXP MED BIOL, V384, P271; Gauchard GC, 2002, INT J NEUROSCI, V112, P1191, DOI 10.1080/00207450290026157; Gimmon Y, 2011, J ELECTROMYOGR KINES, V21, P922, DOI 10.1016/j.jelekin.2011.08.005; Golomer E, 1999, NEUROSCI LETT, V267, P189, DOI 10.1016/S0304-3940(99)00356-0; Gribble PA, 2004, ARCH PHYS MED REHAB, V85, P589, DOI 10.1016/j.apmr.2003.06.031; Guidetti L, 2011, J SPORT SCI MED, V10, P515; Hayes K C, 1982, Exerc Sport Sci Rev, V10, P363, DOI 10.1249/00003677-198201000-00011; Henriksen M, 2007, J APPL PHYSIOL, V103, P132, DOI 10.1152/japplphysiol.01105.2006; Hodges PW, 2011, PAIN, V152, pS90, DOI 10.1016/j.pain.2010.10.020; Hosseini S, 2012, MIDDLE E J SCI RES, V11, P230; Jacono M, 2004, MOTOR CONTROL, V8, P292, DOI 10.1123/mcj.8.3.292; Lafond D, 2004, ARCH PHYS MED REHAB, V85, P896, DOI 10.1016/j.apmr.2003.08.089; Laughton CA, 2003, GAIT POSTURE, V18, P101, DOI 10.1016/S0966-6362(02)00200-X; Ledin T, 2004, GAIT POSTURE, V19, P184, DOI 10.1016/S0966-6362(03)00061-4; Lepers R, 1997, EUR J APPL PHYSIOL, V76, P55, DOI 10.1007/s004210050212; Lin DD, 2008, GAIT POSTURE, V28, P337, DOI 10.1016/j.gaitpost.2008.01.005; Loram ID, 2001, J PHYSIOL-LONDON, V532, P879, DOI 10.1111/j.1469-7793.2001.0879e.x; Vieira TDM, 2009, J ELECTROMYOGR KINES, V19, pE513, DOI 10.1016/j.jelekin.2008.10.007; McLean L, 2004, EUR J APPL PHYSIOL, V91, P204, DOI 10.1007/s00421-003-0967-3; Mello RG, 2009, ENG MED BIOL SOC 200; Mezzarane RA, 2007, EXP BRAIN RES, V180, P377, DOI 10.1007/s00221-007-0865-8; Nagy E, 2004, EUR J APPL PHYSIOL, V92, P407, DOI 10.1007/s00421-004-1157-7; Nardone A, 1997, ELECTROMYOGR MOTOR C, V105, P309, DOI 10.1016/S0924-980X(97)00040-4; Nardone A, 1998, ARCH PHYS MED REHAB, V79, P920, DOI 10.1016/S0003-9993(98)90088-0; NELSON DL, 1985, MED SCI SPORT EXER, V17, P445, DOI 10.1249/00005768-198508000-00007; Oliveira LF, 1996, PHYSIOL MEAS, V17, P305, DOI 10.1088/0967-3334/17/4/008; Oppenheim U, 1999, DIABETES CARE, V22, P328, DOI 10.2337/diacare.22.2.328; Paillard T, 2012, NEUROSCI BIOBEHAV R, V36, P162, DOI 10.1016/j.neubiorev.2011.05.009; Patel M, 2011, EXP BRAIN RES, V208, P519, DOI 10.1007/s00221-010-2498-6; Pedersen J, 1998, NEUROSCIENCE, V84, P953, DOI 10.1016/S0306-4522(97)00403-X; Pollak KA, 2014, EXP PHYSIOL, V99, P368, DOI 10.1113/expphysiol.2013.075812; Rival C, 2005, NEUROSCI LETT, V376, P133, DOI 10.1016/j.neulet.2004.11.042; Saffer M, 2008, EXP BRAIN RES, V185, P215, DOI 10.1007/s00221-007-1145-3; Schilling R. J., 2011, FUNDAMENTALS DIGITAL; Simoneau G., 1995, GAIT POSTURE, V3, P115, DOI [DOI 10.1016/0966-6362(95)99061-O, 10.1016/0966-6362(95)99061-O]; SKINNER HB, 1986, J ORTHOP RES, V4, P112, DOI 10.1002/jor.1100040115; SOAMES RW, 1982, EUR J APPL PHYSIOL O, V49, P169, DOI 10.1007/BF02334065; Sparto PJ, 1997, SPINE, V22, P2647, DOI 10.1097/00007632-199711150-00013; Springer BK, 2009, GAIT POSTURE, V30, P50, DOI 10.1016/j.gaitpost.2009.02.014; Stolwijk NM, 2010, MED SCI SPORT EXER, V42, P2264, DOI 10.1249/MSS.0b013e3181e305f4; Mello RGT, 2010, GAIT POSTURE, V32, P220, DOI 10.1016/j.gaitpost.2010.04.016; Vieira MF, 2013, P 24 C INT SOC BIOM; Vuillerme N, 2003, ARCH PHYS MED REHAB, V84, P1560, DOI 10.1016/S0003-9993(03)00235-1; Vuillerme N, 2007, EUR J APPL PHYSIOL, V100, P169, DOI 10.1007/s00421-007-0419-6; Winter DA, 1996, J NEUROPHYSIOL, V75, P2334, DOI 10.1152/jn.1996.75.6.2334; Wojcik LA, 2011, HUM MOVEMENT SCI, V30, P574, DOI 10.1016/j.humov.2010.03.008; Yoshino K, 2004, J BIOMECH, V37, P1271, DOI 10.1016/j.jbiomech.2003.11.031	64	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123214	10.1371/journal.pone.0123214	http://dx.doi.org/10.1371/journal.pone.0123214			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902060	gold, Green Published, Green Submitted			2022-12-26	WOS:000353331500049
J	Arner, P; Henjes, F; Schwenk, JM; Darmanis, S; Dahlman, I; Iresjo, BM; Naredi, P; Agustsson, T; Lundholm, K; Nilsson, P; Ryden, M				Arner, Peter; Henjes, Frauke; Schwenk, Jochen M.; Darmanis, Spyros; Dahlman, Ingrid; Iresjo, Britt-Marie; Naredi, Peter; Agustsson, Thorhallur; Lundholm, Kent; Nilsson, Peter; Ryden, Mikael			Circulating Carnosine Dipeptidase 1 Associates with Weight Loss and Poor Prognosis in Gastrointestinal Cancer	PLOS ONE			English	Article							DIABETIC-NEPHROPATHY; PALLIATIVE CARE; CACHEXIA; METABOLISM; TISSUE; SERUM; FAT; ERYTHROPOIETIN; DEFINITION; MECHANISMS	Background Cancer cachexia (CC) is linked to poor prognosis. Although the mechanisms promoting this condition are not known, several circulating proteins have been proposed to contribute. We analyzed the plasma proteome in cancer subjects in order to identify factors associated with cachexia. Design/Subjects Plasma was obtained from a screening cohort of 59 patients, newly diagnosed with suspected gastrointestinal cancer, with (n = 32) or without (n = 27) cachexia. Samples were subjected to proteomic profiling using 760 antibodies (targeting 698 individual proteins) from the Human Protein Atlas project. The main findings were validated in a cohort of 93 patients with verified and advanced pancreas cancer. Results Only six proteins displayed differential plasma levels in the screening cohort. Among these, Carnosine Dipeptidase 1 (CNDP1) was confirmed by sandwich immunoassay to be lower in CC (p = 0.008). In both cohorts, low CNDP1 levels were associated with markers of poor prognosis including weight loss, malnutrition, lipid breakdown, low circulating albumin/IGF1 levels and poor quality of life. Eleven of the subjects in the discovery cohort were finally diagnosed with non-malignant disease but omitting these subjects from the analyses did not have any major influence on the results. Conclusions In gastrointestinal cancer, reduced plasma levels of CNDP1 associate with signs of catabolism and poor outcome. These results, together with recently published data demonstrating lower circulating CNDP1 in subjects with glioblastoma and metastatic prostate cancer, suggest that CNDP1 may constitute a marker of aggressive cancer and CC.	[Arner, Peter; Dahlman, Ingrid; Ryden, Mikael] Karolinska Univ Hosp, Karolinska Inst, Dept Med H7, S-14186 Stockholm, Sweden; [Henjes, Frauke; Schwenk, Jochen M.; Darmanis, Spyros; Nilsson, Peter] Royal Inst Technol, Sch Biotechnol, Affin Prote Sci Life Lab, Solna, Sweden; [Iresjo, Britt-Marie; Naredi, Peter; Lundholm, Kent] Univ Gothenburg, Sahlgrenska Acad, Dept Surg, S-41345 Gothenburg, Sweden; [Agustsson, Thorhallur] CLINTEC, Dept Clin Sci Intervent & Technol, Div Surg, S-11883 Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Royal Institute of Technology; University of Gothenburg	Ryden, M (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Med H7, S-14186 Stockholm, Sweden.	mikael.ryden@ki.se	Schwenk, Jochen/AAS-4164-2021; Schwenk, Jochen M/F-1730-2010; Nilsson, Peter/E-4547-2010; Naredi, Peter/AAG-1504-2019; Darmanis, Spyros/ABG-4670-2020	Schwenk, Jochen/0000-0001-8141-8449; Schwenk, Jochen M/0000-0001-8141-8449; Nilsson, Peter/0000-0002-4657-8532; Darmanis, Spyros/0000-0003-4002-8158; Iresjo, Britt-Marie/0000-0002-7724-0243; Lundholm, Kent/0000-0002-8727-6266; Arner, Peter/0000-0002-6208-6220; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Naredi, Peter/0000-0002-5652-0422; Dahlman, Ingrid/0000-0003-3819-5977	Swedish Heart and Lung Foundation; Swedish Diabetes Association; Novo Nordisk Foundation; Swedish Cancer Foundation; DiabetesWellness; Swedish Medical Association; Swedish Research Council; Strategic Research Programme in Diabetes at the Karolinska Institute; Knut and Alice Wallenberg Foundation; SciLifeLab Stockholm; Novo Nordisk Fonden [NNF14OC0010187, NNF12OC1016371] Funding Source: researchfish	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Diabetes Association; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Cancer Foundation; DiabetesWellness; Swedish Medical Association; Swedish Research Council(Swedish Research CouncilEuropean Commission); Strategic Research Programme in Diabetes at the Karolinska Institute; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); SciLifeLab Stockholm; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by grants from the Swedish Heart and Lung Foundation, the Swedish Diabetes Association, the Novo Nordisk Foundation, the Swedish Cancer Foundation, DiabetesWellness, the Swedish Medical Association, the Swedish Research Council, the Strategic Research Programme in Diabetes at the Karolinska Institute, the Knut and Alice Wallenberg Foundation and SciLifeLab Stockholm. None of the funding sources have taken part in planning, performing, analyzing the data or writing the manuscript.	Adelmann K, 2012, AMINO ACIDS, V43, P143, DOI 10.1007/s00726-012-1244-8; Agustsson T, 2007, CANCER RES, V67, P5531, DOI 10.1158/0008-5472.CAN-06-4585; Ahluwalia TS, 2011, DIABETOLOGIA, V54, P2295, DOI 10.1007/s00125-011-2178-5; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Arner P, 2011, SCIENCE, V333, P163, DOI 10.1126/science.1209418; Barski OA, 2013, ARTERIOSCL THROM VAS, V33, P1162, DOI 10.1161/ATVBAHA.112.300572; Bosaeus I, 2001, INT J CANCER, V93, P380, DOI 10.1002/ijc.1332; Braoudaki M, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-52; Dahlman I, 2010, BRIT J CANCER, V102, P1541, DOI 10.1038/sj.bjc.6605665; Dieplinger H, 2009, CANCER EPIDEM BIOMAR, V18, P1127, DOI 10.1158/1055-9965.EPI-08-0653; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; Fouladiun M, 2005, CANCER-AM CANCER SOC, V103, P2189, DOI 10.1002/cncr.21013; Gaunitz F, 2012, AMINO ACIDS, V43, P135, DOI 10.1007/s00726-012-1271-5; Gautam P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046153; HELLMER J, 1992, J CLIN ENDOCR METAB, V75, P15, DOI 10.1210/jc.75.1.15; Iovine B, 2012, CANCER LETT, V315, P122, DOI 10.1016/j.canlet.2011.07.021; Janssen B, 2005, DIABETES, V54, P2320, DOI 10.2337/diabetes.54.8.2320; Lainscak M, 2008, AM J CARDIOL, V101, p8E, DOI 10.1016/j.amjcard.2008.02.065; Laurencikiene J, 2008, CANCER RES, V68, P9247, DOI 10.1158/0008-5472.CAN-08-1343; LENNEY JF, 1982, CLIN CHIM ACTA, V123, P221, DOI 10.1016/0009-8981(82)90166-8; Li L, 2012, ASIAN PAC J CANCER P, V13, P3265, DOI 10.7314/APJCP.2012.13.7.3265; Lindholm E, 2004, CLIN CANCER RES, V10, P6855, DOI 10.1158/1078-0432.CCR-04-0373; Ljungman D, 2013, WORLD J SURG, V37, P1883, DOI 10.1007/s00268-013-2003-z; Lundholm K, 2004, CANCER-AM CANCER SOC, V100, P1967, DOI 10.1002/cncr.20160; Lundholm K, 2007, CLIN CANCER RES, V13, P2699, DOI 10.1158/1078-0432.CCR-06-2720; Lundholm K, 2010, CANCER-AM CANCER SOC, V116, P2044, DOI 10.1002/cncr.24917; Mong MC, 2011, EUR J PHARMACOL, V653, P82, DOI 10.1016/j.ejphar.2010.12.001; Mooyaart AL, 2010, DIABETES, V59, P1555, DOI 10.2337/db09-1377; Nagai K, 1986, Nihon Seirigaku Zasshi, V48, P741; Ottery FD, 1996, NUTRITION, V12, pS15, DOI 10.1016/0899-9007(95)00067-4; Qundos U, 2014, TRANSL PROTEOMICS, V2, P14; Renner C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-2; Ryden M, 2011, J INTERN MED; Ryden M, 2007, CLIN NUTR, V26, P1, DOI 10.1016/j.clnu.2006.09.009; Schwenk JM, 2010, MOL CELL PROTEOMICS, V9, P2497, DOI 10.1074/mcp.M110.001560; Schwenk JM, 2010, PROTEOMICS, V10, P532, DOI 10.1002/pmic.200900657; Stoevesandt O, 2012, EXPERT REV PROTEOMIC, V9, P401, DOI [10.1586/EPR.12.34, 10.1586/epr.12.34]; Teufel M, 2003, J BIOL CHEM, V278, P6521, DOI 10.1074/jbc.M209764200; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Tisdale MJ, 2003, SUPPORT CARE CANCER, V11, P73, DOI 10.1007/s00520-002-0408-6; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Wallengren O, 2013, SUPPORT CARE CANCER, V21, P1569, DOI 10.1007/s00520-012-1697-z; Zhu JM, 2013, GENET TEST MOL BIOMA, V17, P289, DOI 10.1089/gtmb.2012.0341	44	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123566	10.1371/journal.pone.0123566	http://dx.doi.org/10.1371/journal.pone.0123566			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898255	Green Published, Green Submitted, gold			2022-12-26	WOS:000353212600032
J	Hsu, JC; Hsieh, CY; Yang, YHK; Lu, CY				Hsu, Jason C.; Hsieh, Cheng-Yang; Yang, Yea-Huei Kao; Lu, Christine Y.			Net Clinical Benefit of Oral Anticoagulants: A Multiple Criteria Decision Analysis	PLOS ONE			English	Article							MEDICINES-PART 1; ATRIAL-FIBRILLATION; QUANTITATIVE APPROACH; STROKE PREVENTION; RISK ASSESSMENT; NEW-MODEL; COST-EFFECTIVENESS; ISCHEMIC-STROKE; TASK-FORCE; EFFICACY	Background This study quantitatively evaluated the comparative efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, and apizaban) and warfarin for treatment of nonvalvular atrial fibrillation. We also compared these agents under different scenarios, including population with high risk of stroke and for primary vs. secondary stroke prevention. Methods We used multiple criteria decision analysis (MCDA) to assess the benefit-risk of these medications. Our MCDA models contained criteria for benefits (prevention of ischemic stroke and systemic embolism) and risks (intracranial and extracranial bleeding). We calculated a performance score for each drug accounting for benefits and risks in comparison to treatment alternatives. Results Overall, new agents had higher performance scores than warfarin; in order of performance scores: dabigatran 150 mg (0.529), rivaroxaban (0.462), apixaban (0.426), and warfarin (0.191). For patients at a higher risk of stroke (CHADS(2) score >= 3), apixaban had the highest performance score (0.686); performance scores for other drugs were 0.462 for dabigatran 150 mg, 0.392 for dabigatran 110 mg, 0.271 for rivaroxaban, and 0.116 for warfarin. Dabigatran 150 mg had the highest performance score for primary stroke prevention, while dabigatran 110 mg had the highest performance score for secondary prevention. Conclusions Our results suggest that new oral anticoagulants might be preferred over warfarin. Selecting appropriate medicines according to the patient's condition based on information from an integrated benefit-risk assessment of treatment options is crucial to achieve optimal clinical outcomes.	[Hsu, Jason C.; Hsieh, Cheng-Yang; Yang, Yea-Huei Kao] Natl Cheng Kung Univ, Sch Pharm, Tainan 70101, Taiwan; [Hsu, Jason C.; Hsieh, Cheng-Yang; Yang, Yea-Huei Kao] Natl Cheng Kung Univ, Inst Clin Pharm & Pharmaceut Sci, Tainan 70101, Taiwan; [Hsieh, Cheng-Yang] Tainan Sin Lau Hosp, Stroke Ctr, Tainan, Taiwan; [Hsieh, Cheng-Yang] Tainan Sin Lau Hosp, Dept Neurol, Tainan, Taiwan; [Lu, Christine Y.] Harvard Univ, Sch Med, Dept Populat Med, Cambridge, MA 02138 USA; [Lu, Christine Y.] Harvard Pilgrim Hlth Care Inst, Boston, MA USA	National Cheng Kung University; National Cheng Kung University; Harvard University; Harvard Pilgrim Health Care	Hsu, JC (corresponding author), Natl Cheng Kung Univ, Sch Pharm, Tainan 70101, Taiwan.	jasonhsu@mail.ncku.edu.tw	Hsieh, Cheng-Yang/W-4841-2019	Hsieh, Cheng-Yang/0000-0002-8772-4073	Taiwan National Science Council Fellowship [102-2917-I-564-013]	Taiwan National Science Council Fellowship	Dr. Hsu was supported by the Taiwan National Science Council Fellowship (Fellowship ID 102-2917-I-564-013). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker WL, 2012, CIRC-CARDIOVASC QUAL, V5, P711, DOI 10.1161/CIRCOUTCOMES.112.966572; Cairns JA, 2011, CAN J CARDIOL, V27, P74, DOI 10.1016/j.cjca.2010.11.007; Canestaro WJ, 2013, CIRC-CARDIOVASC QUAL, V6, P724, DOI 10.1161/CIRCOUTCOMES.113.000661; Connolly SJ, 2011, NEW ENGL J MED, V364, P806, DOI 10.1056/NEJMoa1007432; Connolly SJ, 2010, NEW ENGL J MED, V363, P1875, DOI 10.1056/NEJMc1007378; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Feeny D, 2002, MED CARE, V40, P113, DOI 10.1097/00005650-200202000-00006; Gage BF, 2004, CIRCULATION, V110, P2287, DOI 10.1161/01.CIR.0000145172.55640.93; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Guo JJ, 2010, VALUE HEALTH, V13, P657, DOI 10.1111/j.1524-4733.2010.00725.x; Hsu JC, 2014, INT J CLIN PRACTICE; Karasakal E, 2009, OPER RES, V57, P187, DOI 10.1287/opre.1080.0581; Keeney R.L., 1996, VALUE FOCUSED THINKI; Koksalan M.M., 2011, MULTIPLE CRITERIA DE; Lee S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047473; Lip GYH, 2012, J AM COLL CARDIOL, V60, P738, DOI 10.1016/j.jacc.2012.03.019; Marini C, 2005, STROKE, V36, P1115, DOI 10.1161/01.STR.0000166053.83476.4a; Medi C, 2010, STROKE, V41, P2705, DOI 10.1161/STROKEAHA.110.589218; Meenan RT, 2007, MED DECIS MAKING, V27, P161, DOI 10.1177/0272989X06297388; Miller CS, 2012, AM J CARDIOL, V110, P453, DOI 10.1016/j.amjcard.2012.03.049; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Mussen F, 2007, PHARMACOEPIDEM DR S, V16, pS2, DOI 10.1002/pds.1435; Mussen F, 2007, PHARMACOEPIDEM DR S, V16, pS42, DOI 10.1002/pds.1436; Mussen F, 2007, PHARMACOEPIDEM DR S, V16, pS16, DOI 10.1002/pds.1434; O'Brien CL, 2005, JAMA-J AM MED ASSOC, V293, P699, DOI 10.1001/jama.293.6.699; Paciaroni M, 2011, J THROMB HAEMOST, V9, P893, DOI 10.1111/j.1538-7836.2011.04241.x; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Rasmussen LH, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7097; Saaty T.L., 2008, GROUP DECISION MAKIN; SAATY TL, 1990, EUR J OPER RES, V48, P9, DOI 10.1016/0377-2217(90)90057-I; Saaty TL, 2003, EUR J OPER RES, V145, P85, DOI 10.1016/S0377-2217(02)00227-8; Schneeweiss S, 2012, CIRC-CARDIOVASC QUAL, V5, P480, DOI 10.1161/CIRCOUTCOMES.112.965988; Stevens K, 2007, J HEALTH ECON, V26, P992, DOI 10.1016/j.jhealeco.2006.12.007; Turpie AGG, 2008, EUR HEART J, V29, P155, DOI 10.1093/eurheartj/ehm575; Wann LS, 2011, J AM COLL CARDIOL, V57, P1330, DOI 10.1016/j.jacc.2011.01.010; Weinstein MC, 2003, VALUE HEALTH, V6, P9, DOI 10.1046/j.1524-4733.2003.00234.x; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Yip PK, 1997, STROKE, V28, P2507, DOI 10.1161/01.STR.28.12.2507	40	18	19	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124806	10.1371/journal.pone.0124806	http://dx.doi.org/10.1371/journal.pone.0124806			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897861	Green Submitted, Green Published, gold			2022-12-26	WOS:000353212600087
J	Kramer, M; Quickert, S; Sponholz, C; Menzel, U; Huse, K; Platzer, M; Bauer, M; Claus, RA				Kramer, Marcel; Quickert, Stefanie; Sponholz, Christoph; Menzel, Uwe; Huse, Klaus; Platzer, Matthias; Bauer, Michael; Claus, Ralf A.			Alternative Splicing of SMPD1 in Human Sepsis	PLOS ONE			English	Article							HUMAN ACID SPHINGOMYELINASE; ORGAN FAILURE; CERAMIDE	Acid sphingomyelinase (ASM or sphingomyelin phosphodiesterase, SMPD) activity engages a critical role for regulation of immune response and development of organ failure in critically ill patients. Beside genetic variation in the human gene encoding ASM (SMPD1), alternative splicing of the mRNA is involved in regulation of enzymatic activity. Here we show that the patterns of alternatively spliced SMPD1 transcripts are significantly different in patients with systemic inflammatory response syndrome and severe sepsis/septic shock compared to control subjects allowing discrimination of respective disease entity. The different splicing patterns might contribute to the better understanding of the pathophysiology of human sepsis.	[Kramer, Marcel; Quickert, Stefanie; Bauer, Michael; Claus, Ralf A.] Jena Univ Hosp, CSCC, Integrated Res & Treatment Ctr, Jena, Germany; [Kramer, Marcel; Huse, Klaus; Platzer, Matthias] Fritz Lipmann Inst, Leibniz Inst Age Res, Genome Anal, Jena, Germany; [Sponholz, Christoph; Bauer, Michael; Claus, Ralf A.] Jena Univ Hosp, Dept Anesthesiol & Intens Care Therapy, Jena, Germany; [Menzel, Uwe] Leibniz Inst, Hans Knoll Inst Nat Prod Res & Infect Biol, Jena, Germany	Friedrich Schiller University of Jena; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Friedrich Schiller University of Jena; Hans Knoll Institute (HKI)	Claus, RA (corresponding author), Jena Univ Hosp, CSCC, Integrated Res & Treatment Ctr, Jena, Germany.	ralf.claus@med.uni-jena.de	Sponholz, Christoph/I-3585-2019; Quickert, Stefanie/AAD-1412-2020; Claus, Ralf A./Q-4035-2016	Sponholz, Christoph/0000-0002-1746-7024; Bauer, Michael/0000-0002-1521-3514; Huse, Klaus/0000-0003-3854-1884; Claus, Ralf A./0000-0001-7232-4088	Federal Ministry of Education and Research (BMBF, Germany) [FKZ: 01EO1002]; Deutsche Forschungsgemeinschaft (DFG, Germany) [CL173/4-2]	Federal Ministry of Education and Research (BMBF, Germany)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG, Germany)(German Research Foundation (DFG))	This work was supported by the Federal Ministry of Education and Research (BMBF, Germany, FKZ: 01EO1002 to MB) and the Deutsche Forschungsgemeinschaft (DFG, Germany, CL173/4-2 to RAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker Katrin Anne, 2008, V49, P523, DOI 10.1007/978-1-4020-8831-5_20; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bota DP, 2002, INTENS CARE MED, V28, P1619, DOI 10.1007/s00134-002-1491-3; BRADY RO, 1966, P NATL ACAD SCI USA, V55, P366, DOI 10.1073/pnas.55.2.366; Claus RA, 2005, FASEB J, V19, P1719, DOI 10.1096/fj.04-2842fje; Fried E, 2011, CURR OPIN CRIT CARE, V17, P396, DOI 10.1097/MCC.0b013e328348bee2; Jbeily N, 2013, J LIPID RES, V54, P410, DOI 10.1194/jlr.M031625; Jenkins RW, 2010, J BIOL CHEM, V285, P35706, DOI 10.1074/jbc.M110.125609; Jenkins RW, 2009, CELL SIGNAL, V21, P836, DOI 10.1016/j.cellsig.2009.01.026; Kramer M, 2011, GENETICS, V187, P761, DOI 10.1534/genetics.110.125096; Lareau LF, 2007, ADV EXP MED BIOL, V623, P190, DOI 10.1007/978-0-387-77374-2_12; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Martin GS, 2012, EXPERT REV ANTI-INFE, V10, P701, DOI [10.1586/ERI.12.50, 10.1586/eri.12.50]; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Nikolova-Karakashian MN, 2010, ADV EXP MED BIOL, V688, P86; Peters JH, 2011, BIOMARK INSIGHTS, V6, P59, DOI 10.4137/BMI.S7204; QUINTERN LE, 1989, EMBO J, V8, P2469, DOI 10.1002/j.1460-2075.1989.tb08382.x; Rhein C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035467; SCHUCHMAN EH, 1991, J BIOL CHEM, V266, P8531; Simonaro CM, 2002, AM J HUM GENET, V71, P1413, DOI 10.1086/345074; Smith EL, 2008, FASEB J, V22, P3419, DOI 10.1096/fj.08-108043	21	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124503	10.1371/journal.pone.0124503	http://dx.doi.org/10.1371/journal.pone.0124503			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898364	Green Published, gold, Green Submitted			2022-12-26	WOS:000353212600070
J	Lan, KC; Chiu, CY; Kao, CW; Huang, KH; Wang, CC; Huang, KT; Tsai, KS; Sheu, ML; Liu, SH				Lan, Kuo-Cheng; Chiu, Chen-Yuan; Kao, Chia-Wei; Huang, Kuo-How; Wang, Ching-Chia; Huang, Kuo-Tong; Tsai, Keh-Sung; Sheu, Meei-Ling; Liu, Shing Hwa			Advanced Glycation End-Products Induce Apoptosis in Pancreatic Islet Endothelial Cells via NF-kappa B-Activated Cyclooxygenase-2/Prostaglandin E-2 Up-Regulation	PLOS ONE			English	Article							HIGH GLUCOSE; PHENOTYPIC HETEROGENEITY; BETA-CELLS; RECEPTOR; ATHEROSCLEROSIS; DYSFUNCTION; STRESS; AGES; COMPLICATIONS; INHIBITION	Microvascular complications eventually affect nearly all patients with diabetes. Advanced glycation end-products (AGEs) resulting from hyperglycemia are a complex and heterogeneous group of compounds that accumulate in the plasma and tissues in diabetic patients. They are responsible for both endothelial dysfunction and diabetic vasculopathy. The aim of this study was to investigate the cytotoxicity of AGEs on pancreatic islet microvascular endothelial cells. The mechanism underlying the apoptotic effect of AGEs in pancreatic islet endothelial cell line MS1 was explored. The results showed that AGEs significantly decreased MS1 cell viability and induced MS1 cell apoptosis in a dose-dependent manner. AGEs dose-dependently increased the expressions of cleaved caspase-3, and cleaved poly (ADP-ribose) polymerase in MS1 cells. Treatment of MS1 cells with AGEs also resulted in increased nuclear factor (NF)-kappa B-p65 phosphorylation and cyclooxygenase (COX)-2 expression. However, AGEs did not affect the expressions of endoplasmic reticulum (ER) stress-related molecules in MS1 cells. Pretreatment with NS398 (a COX-2 inhibitor) to inhibit prostaglandin E-2 (PGE(2)) production reversed the induction of cleaved caspase-3, cleaved PARP, and MS1 cell viability. Moreover, AGEs significantly increased the receptor for AGEs (RAGE) protein expression in MS1 cells, which could be reversed by RAGE neutralizing antibody. RAGE Neutralizing antibody could also reverse the induction of cleaved caspase-3 and cleaved PARP and decreased cell viability induced by AGEs. These results implicate the involvement of NF-kappa B-activated COX-2/PGE(2) up-regulation in AGEs/RAGE-induced islet endothelial cell apoptosis and cytotoxicity. These findings may provide insight into the pathological processes within the pancreatic islet microvasculature induced by AGEs accumulation.	[Lan, Kuo-Cheng] Triserv Gen Hosp, Natl Def Med Ctr, Dept Emergency Med, Taipei, Taiwan; [Chiu, Chen-Yuan; Kao, Chia-Wei; Huang, Kuo-Tong; Liu, Shing Hwa] Natl Taiwan Univ, Coll Med, Inst Toxicol, Taipei 10764, Taiwan; [Huang, Kuo-How] Natl Taiwan Univ, Coll Med & Hosp, Dept Urol, Taipei 10764, Taiwan; [Wang, Ching-Chia; Liu, Shing Hwa] Natl Taiwan Univ, Coll Med & Hosp, Dept Pediat, Taipei 10764, Taiwan; [Tsai, Keh-Sung] Natl Taiwan Univ, Coll Med & Hosp, Dept Lab Med, Taipei 10764, Taiwan; [Sheu, Meei-Ling] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Liu, Shing Hwa] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Chung Hsing University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Liu, SH (corresponding author), Natl Taiwan Univ, Coll Med, Inst Toxicol, Taipei 10764, Taiwan.	shinghwaliu@ntu.edu.tw	Sheu, Meei-Ling/AAT-3401-2020	Sheu, Meei-Ling/0000-0002-0431-1282; Chiu, Chen-Yuan/0000-0003-4378-993X; WANG, CHING-CHIA/0000-0002-5954-5684; TSAI, KEH-SUNG/0000-0001-8528-1566; LIU, SHING-HWA/0000-0002-9976-1197	National Science Council of Taiwan [NSC100-2314-B-002-084]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the grant from the National Science Council of Taiwan (NSC100-2314-B-002-084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamopoulos C, 2014, CLIN CHEM LAB MED, V52, P151, DOI 10.1515/cclm-2012-0826; Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Basta G, 2004, CARDIOVASC RES, V63, P582, DOI 10.1016/j.cardiores.2004.05.001; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Bucciarelli LG, 2002, CELL MOL LIFE SCI, V59, P1117, DOI 10.1007/s00018-002-8491-x; Chawla D, 2014, MICROVASC RES, V95, P1, DOI 10.1016/j.mvr.2014.06.010; Chen YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066611; Chistiakov DA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/610140; Favaro E, 2008, AM J PATHOL, V173, P442, DOI 10.2353/ajpath.2008.080238; Figarola JL, 2014, APOPTOSIS, V19, P776, DOI 10.1007/s10495-014-0974-3; Gastaldelli A, 2011, DIABETES RES CLIN PR, V93, pS60, DOI 10.1016/S0168-8227(11)70015-8; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Hadi HAR, 2007, VASC HEALTH RISK MAN, V3, P853; Hernandez-Fonseca JP, 2009, EXP DIABETES RES, DOI 10.1155/2009/329632; Ho FM, 2000, CIRCULATION, V101, P2618, DOI 10.1161/01.CIR.101.22.2618; Ido Y, 2002, DIABETES, V51, P159, DOI 10.2337/diabetes.51.1.159; Jakus V, 2004, PHYSIOL RES, V53, P131; Kang YH, 2008, J CELL PHYSIOL, V217, P23, DOI 10.1002/jcp.21470; Konstantinova I, 2004, BIOESSAYS, V26, P1069, DOI 10.1002/bies.20105; Lim M, 2008, ANN NY ACAD SCI, V1150, P311, DOI 10.1196/annals.1447.011; McElroy SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038373; Orasanu G, 2009, J AM COLL CARDIOL, V53, pS35, DOI 10.1016/j.jacc.2008.09.055; Pal PB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107220; Robertson RP, 1998, DIABETES, V47, P1379, DOI 10.2337/diabetes.47.9.1379; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Schmidt AM, 1999, CIRC RES, V84, P489, DOI 10.1161/01.RES.84.5.489; Shanmugam N, 2006, DIABETOLOGIA, V49, P100, DOI 10.1007/s00125-005-0065-7; Shen C, 2010, BIOMED PHARMACOTHER, V64, P35, DOI 10.1016/j.biopha.2009.03.002; Sheu ML, 2005, ARTERIOSCL THROM VAS, V25, P539, DOI 10.1161/01.ATV.0000155462.24263.e4; Shi L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066781; Thomas Merlin C, 2005, Am J Ther, V12, P562, DOI 10.1097/01.mjt.0000178769.52610.69; Tran POT, 1999, J BIOL CHEM, V274, P31245, DOI 10.1074/jbc.274.44.31245; van den Oever IA, 2010, MEDIAT INFLAMM, V2010, DOI [10.1155/2010/792393, DOI 10.1155/2010/792393]; Wada R, 2005, ANN NY ACAD SCI, V1043, P598, DOI 10.1196/annals.1338.067; Xiang Y, 2011, CELL BIOCHEM FUNCT, V29, P149, DOI 10.1002/cbf.1736; Yamagishi S, 2005, CURR DIABETES REV, V1, P93, DOI 10.2174/1573399052952631; Yamagishi S, 2011, EXP GERONTOL, V46, P217, DOI 10.1016/j.exger.2010.11.007; Zanone MM, 2008, CURR DIABETES REV, V4, P1, DOI 10.2174/157339908783502415	42	39	42	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124418	10.1371/journal.pone.0124418	http://dx.doi.org/10.1371/journal.pone.0124418			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898207	Green Published, Green Submitted, gold			2022-12-26	WOS:000353212600067
J	Spitschan, M; Aguirre, GK; Brainard, DH				Spitschan, Manuel; Aguirre, Geoffrey K.; Brainard, David H.			Selective Stimulation of Penumbral Cones Reveals Perception in the Shadow of Retinal Blood Vessels	PLOS ONE			English	Article							ILLUMINATION PUPIL RESPONSE; GANGLION-CELLS; SUBJECTIVE PATTERNS; ENTOPTIC TEST; VISUAL-FIELD; MELANOPSIN; LIGHT; ROD; REPRESENTATION; VASCULATURE	In 1819, Johann Purkinje described how a moving light source that displaces the shadow of the retinal blood vessels to adjacent cones can produce the entopic percept of a branching tree. Here, we describe a novel method for producing a similar percept. We used a device that mixes 56 narrowband primaries under computer control, in conjunction with the method of silent substitution, to present observers with a spectral modulation that selectively targeted penumbral cones in the shadow of the retinal blood vessels. Such a modulation elicits a clear Purkinje-tree percept. We show that the percept is specific to penumbral L and M cone stimulation and is not produced by selective penumbral S cone stimulation. The Purkinje-tree percept was strongest at 16 Hz and fell off at lower (8 Hz) and higher (32 Hz) temporal frequencies. Selective stimulation of open-field cones that are not in shadow, with penumbral cones silenced, also produced the percept, but it was not seen when penumbral and open-field cones were modulated together. This indicates the need for spatial contrast between penumbral and open-field cones to create the Purkinje-tree percept. Our observation provides a new means for studying the response of retinally stabilized images and demonstrates that penumbral cones can support spatial vision. Further, the result illustrates a way in which silent substitution techniques can fail to be silent. We show that inadvertent penumbral cone stimulation can accompany melanopsin-directed modulations that are designed only to silence open-field cones. This in turn can result in visual responses that might be mistaken as melanopsin-driven.	[Spitschan, Manuel; Brainard, David H.] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA; [Aguirre, Geoffrey K.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Aguirre, GK (corresponding author), Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA.	aguirreg@mail.med.upenn.edu; brainard@psych.upenn.edu		Spitschan, Manuel/0000-0002-8572-9268	National Institutes of Health [1 R01 EY020516, R01 EY10016, P30 EY001583]; Deutscher Akademischer Austauschdienst; NATIONAL EYE INSTITUTE [P30EY001583, R01EY020516, R01EY010016] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grant 1 R01 EY020516 (GKA), R01 EY10016 (DHB), P30 EY001583 (Core Grant for Vision Research) and Deutscher Akademischer Austauschdienst (MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DL, 2003, J NEUROSCI, V23, P5984, DOI 10.1523/JNEUROSCI.23-14-05984.2003; Adams DL, 2002, SCIENCE, V298, P572, DOI 10.1126/science.1074887; Adams DL, 2003, J NEUROSCI, V23, P3771; al Enezi J, 2011, J BIOL RHYTHM, V26, P314, DOI 10.1177/0748730411409719; Allefeld C, 2011, CONSCIOUS COGN, V20, P1344, DOI 10.1016/j.concog.2010.10.026; Allen AE, 2014, CURR BIOL, V24, P2481, DOI 10.1016/j.cub.2014.09.015; Applegate RA, 1997, INVEST OPHTH VIS SCI, V38, P783; APPLEGATE RA, 1990, INVEST OPHTH VIS SCI, V31, P2088; ASHTON N, 1957, AM J OPHTHALMOL, V44, P7, DOI 10.1016/0002-9394(57)90426-9; Atchison DA, 1997, CLIN EXPT OPTOMETRY, V80, P49, DOI [10.1111/j.1444-0938.1997.tb04850.x, DOI 10.1111/J.1444-0938.1997.TB04850.X]; Aubert H, 1865, PHYSIOLOGIE NETZHAUT; Bailes HJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2987; Barrionuevo PA, 2014, INVEST OPHTH VIS SCI, V55, P719, DOI 10.1167/iovs.13-13252; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; BIRD AC, 1974, EXP EYE RES, V19, P409, DOI 10.1016/0014-4835(74)90050-5; BOWEN SF, 1963, ARCH OPHTHALMOL-CHIC, V69, P551, DOI 10.1001/archopht.1963.00960040557003; Bradley A, 1998, VISION RES, V38, P2685, DOI 10.1016/S0042-6989(97)00345-3; Brainard D. H, 2010, OPTICAL SOC AM HDB O, VIII; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRODIE SE, 1987, INT OPHTHALMOL CLIN, V27, P153, DOI 10.1097/00004397-198702730-00004; BROWN CR, 1948, J EXP PSYCHOL, V38, P188, DOI 10.1037/h0054433; Brown TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053583; Brown TM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000558; CIE, 2006, 1701 CIE CENTR BUR; COMBERG D, 1971, OPHTHALMOLOGICA, V162, P140, DOI 10.1159/000306255; Coppola D, 1996, P NATL ACAD SCI USA, V93, P8001, DOI 10.1073/pnas.93.15.8001; Cornsweet T., 1970, VISUAL PERCEPTION; Cornsweet TN, 1966, RECENT DEV VISION RE; Deeley RM, 1913, NATURE, V90, P594, DOI 10.1038/090594e0; Ditchburn RW, 1936, NATURE, V137, P661, DOI [10.1038/137661a0, DOI 10.1038/137661A0]; Do MTH, 2009, NATURE, V457, P281, DOI 10.1038/nature07682; DONNER KO, 1959, J PHYSIOL-LONDON, V149, P288, DOI 10.1113/jphysiol.1959.sp006340; Drews LC, 1943, AM J OPHTHALMOL, V26, P1143, DOI [10.1016/s0002-9394(43)90490-8, DOI 10.1016/S0002-9394(43)90490-8]; Drews LC, 1941, AM J OPHTHALMOL, V24, P1403, DOI [10.1016/s0002-9394(14)77452-5, DOI 10.1016/S0002-9394(14)77452-5]; DRYSDALE AE, 1975, VISION RES, V15, P813, DOI 10.1016/0042-6989(75)90259-X; Eber SI, 1922, AM J OPHTHALMOL, V5, P973, DOI [10.1016/s0002-9394(22)90950-x, DOI 10.1016/S0002-9394(22)90950-X]; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; EHRICH W, 1958, Klin Monbl Augenheilkd Augenarztl Fortbild, V133, P396; EHRICH W, 1961, Doc Ophthalmol, V15, P371, DOI 10.1007/BF00234354; Ehrich W, 1961, MED KLIN, V54, P31; ESTEVEZ O, 1982, VISION RES, V22, P681, DOI 10.1016/0042-6989(82)90104-3; Exner S, 1868, ARCH PHYSL, V1, P375, DOI [10.1007/bf01640325, DOI 10.1007/BF01640325]; Exner S, 1884, SITZUNGSBERICHTE MN, V88, P103; Feigl B, 2014, OPTOMETRY VISION SCI, V91, P894, DOI 10.1097/OPX.0000000000000284; Feigl B, 2012, ACTA OPHTHALMOL, V90, pe230, DOI 10.1111/j.1755-3768.2011.02226.x; Friedman B, 1931, ARCH OPHTHALMOL-CHIC, V5, P636, DOI [10.1001/archopht.1931.00820040132010, DOI 10.1001/ARCHOPHT.1931.00820040132010]; Gamlin PDR, 2007, VISION RES, V47, P946, DOI 10.1016/j.visres.2006.12.015; Goebel K, 1922, ARCH AUGENHEILKD, V90, P245, DOI [10.1055/s-0033-1360260, DOI 10.1055/S-0033-1360260]; GOLDMANN H, 1972, AM J OPHTHALMOL, V73, P309; Gooley JJ, 2012, J NEUROSCI, V32, P14242, DOI 10.1523/JNEUROSCI.1321-12.2012; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Gudden B, 1849, ARCH ANAT PHYSL WISS, P522; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hill A.V, 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; Hilmantel G, 1999, OPTOMETRY VISION SCI, V76, P826, DOI 10.1097/00006324-199912000-00017; Horiguchi H, 2013, P NATL ACAD SCI USA, V110, pE260, DOI 10.1073/pnas.1214240110; Ishihara S., 1977, TESTS COLOUR BLINDNE; ISO, 2007, 150042 ISO, DOI [10.1097/HP.0b013e3181f4993d.Retinal, DOI 10.1097/HP.0B013E3181F4993D.RETINAL]; Kahn RH, 1908, FARBIGE SCHATTEN NET, V56, P1; Kaiser P.K, 1996, HUMAN COLOR VISION; Kankipati L, 2010, INVEST OPHTH VIS SCI, V51, P2764, DOI 10.1167/iovs.09-4717; Kardon R, 2009, OPHTHALMOLOGY, V116, P1564, DOI 10.1016/j.ophtha.2009.02.007; KELLY D H, 1964, Doc Ophthalmol, V18, P16, DOI 10.1007/BF00160561; KELLY DH, 1979, J OPT SOC AM, V69, P1340, DOI 10.1364/JOSA.69.001340; KLUXEN G, 1987, DIABETES CARE, V10, P800, DOI 10.2337/diacare.10.6.800; Kolb H., 1995, WEBVISION ORG RETINA; KRAUPA E, 1949, OPHTHALMOLOGICA, V118, P318, DOI 10.1159/000300734; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Lucas RJ, 2014, TRENDS NEUROSCI, V37, P1, DOI 10.1016/j.tins.2013.10.004; M_uller H., 1854, VERHANDLUNGEN PHYSIK, V4, P96; Martin PR, 2014, VISUAL NEUROSCI, V31, P177, DOI 10.1017/S0952523813000631; McDougal DH, 2010, VISION RES, V50, P72, DOI 10.1016/j.visres.2009.10.012; Muller H., 1855, VERHANDLUNGEN PHYSIK, V5, P411; Murillo-Lopez F, 2000, J CATARACT REFR SURG, V26, P260, DOI 10.1016/S0886-3350(99)00341-7; Noseda R, 2011, CURR OPIN NEUROL, V24, P197, DOI 10.1097/WCO.0b013e3283466c8e; Pagenstecher AH, 1903, Z AUGENHEILD, V10, P206, DOI [10.1107/S0108767309007235, DOI 10.1107/S0108767309007235]; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Prahl  S., 1999, OPTICAL ABSORPTION H; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Purkinje J., 1825, NEUE BEITRAGE KENNTN, V2; Purkinje JE, 1819, BEOBACHTUNGEN VERSUC; REMOLE A, 1971, J OPT SOC AM, V61, P1164, DOI 10.1364/JOSA.61.001164; Roecklein K, 2013, PSYCHIAT RES, V210, P150, DOI 10.1016/j.psychres.2013.05.023; Rood ON, 1860, AM J SCI ARTS, V30, P264; RUSHTON WAH, 1968, VISION RES, V8, P617, DOI 10.1016/0042-6989(68)90040-0; Scheerer R, 1924, KLIN MONATSBL AUGENH, V73, P67; SHARPE CR, 1972, J PHYSIOL-LONDON, V222, P113, DOI 10.1113/jphysiol.1972.sp009790; Smithson HE, 2014, VISUAL NEUROSCI, V31, P211, DOI 10.1017/S0952523814000030; SMYTHIES JR, 1957, NATURE, V179, P523, DOI 10.1038/179523a0; SNODDERLY DM, 1992, J NEUROSCI, V12, P1169; Spitschan M, 2014, P NATL ACAD SCI USA, V111, P15568, DOI 10.1073/pnas.1400942111; Steinbuch W, 1813, JB TSCH MD CHIR, V3, P270; Stigler R, 1905, Z PSYCHOL PHYSIOL SI, V39, P332; Stockman A, 2000, VISION RES, V40, P1711, DOI 10.1016/S0042-6989(00)00021-3; Suzuki R, 1941, NIPPON GANKA GAKKAI, V45, P590; TALBOT EM, 1992, EYE, V6, P322, DOI 10.1038/eye.1992.64; Tsujimura S, 2011, OPHTHAL PHYSL OPT, V31, P469, DOI 10.1111/j.1475-1313.2011.00846.x; Tsujimura S, 2010, P ROY SOC B-BIOL SCI, V277, P2485, DOI 10.1098/rspb.2010.0330; Vienot F, 2014, J OPT SOC AM A, V31, pA38, DOI 10.1364/JOSAA.31.000A38; Vienot F, 2012, J OPT SOC AM A, V29, pA366, DOI 10.1364/JOSAA.29.00A366; Vienot F, 2010, OPHTHAL PHYSL OPT, V30, P484, DOI 10.1111/j.1475-1313.2010.00754.x; Vierodt K, 1856, ARCH PHYSL HEILK, V15, P255, DOI [10.1055/s-0033-1360260, DOI 10.1055/S-0033-1360260]; von Helmholtz H., 1867, HDB PHYSL OPTIK, VVol. 9, DOI 10.1007/BF01708548; von Thomsen E, 1919, SKANDINAVISCHES ARCH, V37, P1, DOI [10.1111/j.1748-1716.1919.tb00120.x, DOI 10.1111/J.1748-1716.1919.TB00120.X]; von Zehender W, 1895, KLIN MONATSBL AUGENH, V33, P112; Wade N. J., 2001, PURKINJES VISION DAW; Walker CB, 1940, AM J OPHTHALMOL, V23, P803, DOI [10.1016/S0002-9394(40)92383-2, DOI 10.1016/S0002-9394(40)92383-2]; Watson AB, 2012, J VISION, V12, DOI 10.1167/12.10.12; WEBSTER MA, 1988, J OPT SOC AM A, V5, P1722, DOI 10.1364/JOSAA.5.001722; WYATT HJ, 1978, VISION RES, V18, P875, DOI 10.1016/0042-6989(78)90133-5; Xu J, 1997, J OPT SOC AM A, V14, P953, DOI 10.1364/JOSAA.14.000953; YOUNG RSL, 1975, VISION RES, V15, P1291, DOI 10.1016/0042-6989(75)90177-7	115	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124328	10.1371/journal.pone.0124328	http://dx.doi.org/10.1371/journal.pone.0124328			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897842	Green Published, gold, Green Submitted			2022-12-26	WOS:000353212600063
J	Largeron, C; Mougel, PN; Rabbany, R; Zaiane, OR				Largeron, Christine; Mougel, Pierre-Nicolas; Rabbany, Reihaneh; Zaiane, Osmar R.			Generating Attributed Networks with Communities	PLOS ONE			English	Article							MODEL	In many modern applications data is represented in the form of nodes and their relationships, forming an information network. When nodes are described with a set of attributes we have an attributed network. Nodes and their relationships tend to naturally form into communities or clusters, and discovering these communities is paramount to many applications. Evaluating algorithms or comparing algorithms for automatic discovery of communities requires networks with known structures. Synthetic generators of networks have been proposed for this task but most solely focus on connectivity and their properties and overlook attribute values and the network properties vis-a-vis these attributes. In this paper, we propose a new generator for attributed networks with community structure that dependably follows the properties of real world networks.	[Largeron, Christine; Mougel, Pierre-Nicolas] Univ Lyon, Hubert Curien Lab, St Etienne, France; [Rabbany, Reihaneh; Zaiane, Osmar R.] Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada	University of Alberta	Largeron, C (corresponding author), Univ Lyon, Hubert Curien Lab, St Etienne, France.	Christine.Largeron@univ-st-etienne.fr			Universite Jean Monnet; Natural Sciences and Engineering Research Council of Canada; Alberta Innovates Centre for Machine Learning	Universite Jean Monnet; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Innovates Centre for Machine Learning	Funding provided by Universite Jean Monnet, Natural Sciences and Engineering Research Council of Canada, and Alberta Innovates Centre for Machine Learning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoglu L, 2009, DATA MIN KNOWL DISC, V19, P194, DOI 10.1007/s10618-009-0140-7; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Benson AR, 2014, PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), P1326, DOI 10.1145/2623330.2623718; Dang T. N. L., 2012, THESIS; Easley D, 2010, NETWORKS CROWDS MARK, P85; ERDOS P, 1960, B INT STATIST INST, V38, P343; Fortunato S., 2012, COMPUT COMPLEX THEOR, P490, DOI [10.1007/978-1-4614-1800-9_33, DOI 10.1007/978-1-4614-1800-9_33]; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Goldenberg A, 2010, FOUND TRENDS MACH LE, V2, P129, DOI 10.1561/2200000005; Gustafsson M, 2006, PHYSICA A, V367, P559, DOI 10.1016/j.physa.2005.12.017; Kaufman L., 1987, Statistical Data Analysis Based on the L1-Norm and Related Methods. First International Conference, P405; Kim M, 2010, LECT NOTES COMPUT SC, V6516, P62, DOI 10.1007/978-3-642-18009-5_7; Kolda TG, 2013, CORR; Lancichinetti A., 2013, DYNAMICS COMPLEX NET, V2, P143; Lancichinetti A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056117; Lancichinetti A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016118; Lancichinetti A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046110; Lazarsfeld P. F., 1954, FREEDOM CONTROL MOD, V18, P18, DOI DOI 10.1111/J.1467-8705.2012.02056_3.X; Leskovec J., 2008, P 14 ACM SIGKDD INT, P462, DOI DOI 10.1145/1401890.1401948; Leskovec J., 2005, P 11 ACM SIGKDD INT, P177, DOI 10.1145/1081870.1081893; Leskovec J, 2010, J MACH LEARN RES, V11, P985; Leskovec J, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232727; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; MILGRAM S, 1967, PSYCHOL TODAY, V1, P61; Moussiades L, 2009, INT CONF RES CHAL, P197, DOI 10.1109/RCIS.2009.5089283; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Newman MEJ, 2002, P NATL ACAD SCI USA, V99, P2566, DOI 10.1073/pnas.012582999; Orman Gunce Keziban, 2013, International Journal of Web Based Communities, V9, P349; Orman GK, 2009, LECT NOTES ARTIF INT, V5808, P242, DOI 10.1007/978-3-642-04747-3_20; Orman GK, 2010, 2010 INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM 2010), P301, DOI 10.1109/ASONAM.2010.70; Orman GK, 2011, COMM COM INF SC, V167, P265; Palla G, 2010, P NATL ACAD SCI USA, V107, P7640, DOI 10.1073/pnas.0912983107; Palla K., 2012, P 29 INT C MACH LEAR, P1607; Poncela J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002449; Seshadhri C, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.056109; Vazquez A, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.056104; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wong LH, 2006, PHYSICA A, V360, P99, DOI 10.1016/j.physa.2005.04.029; Yang J, 2013, IEEE DATA MINING, P1151, DOI 10.1109/ICDM.2013.167; Zhou Y., 2009, PVLDB, V2, P718, DOI DOI 10.14778/1687627.1687709	47	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0122777	10.1371/journal.pone.0122777	http://dx.doi.org/10.1371/journal.pone.0122777			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893834	Green Published, gold, Green Submitted			2022-12-26	WOS:000353211700016
J	Deiteren, A; van der Linden, L; de Wit, A; Ceuleers, H; Buckinx, R; Timmermans, JP; Moreels, TG; Pelckmans, PA; De Man, JG; De Winter, BY				Deiteren, Annemie; van der Linden, Laura; de Wit, Anouk; Ceuleers, Hannah; Buckinx, Roeland; Timmermans, Jean-Pierre; Moreels, Tom G.; Pelckmans, Paul A.; De Man, Joris G.; De Winter, Benedicte Y.			P2X(3) Receptors Mediate Visceral Hypersensitivity during Acute Chemically-Induced Colitis and in the Post-Inflammatory Phase via Different Mechanisms of Sensitization	PLOS ONE			English	Article							RAT MODEL; NEUROPATHIC PAIN; MECHANOSENSORY TRANSDUCTION; COLORECTAL DISTENSION; ANTAGONIST; MICE; ATP; HYPERALGESIA; CONSTRICTION; A-317491	Objectives Experiments using P2X(3) knock-out mice or more general P2X receptor antagonists suggest that P2X(3) receptors contribute to visceral hypersensitivity. We aimed to investigate the effect of the selective P2X(3) antagonist A-317491 on visceral sensitivity under physiological conditions, during acute colitis and in the post-inflammatory phase of colitis. Methods Trinitrobenzene sulphonic-acid colitis was monitored by colonoscopy: on day 3 to confirm the presence of colitis and then every 4 days, starting from day 10, to monitor convalescence and determine the exact timepoint of endoscopic healing in each rat. Visceral sensitivity was assessed by quantifying visceromotor responses to colorectal distension in controls, rats with acute colitis and post-colitis rats. A-317491 was administered 30 min prior to visceral sensitivity testing. Expression of P2X(3) receptors (RT-PCR and immunohistochemistry) and the intracellular signalling molecules cdk5, csk and CASK (RT-PCR) were quantified in colonic tissue and dorsal root ganglia. ATP release in response to colorectal distension was measured by luminiscence. Results Rats with acute TNBS-colitis displayed significant visceral hypersensitivity that was dose-dependently, but not fully, reversed by A-317491. Hypersenstivity was accompanied by an increased colonic release of ATP. Post-colitis rats also displayed visceral hypersensitivity that was dose-dependently reduced and fully normalized by A-317491 without increased release of ATP. A-317491 did not modify visceral sensitivity in controls. P2X(3) mRNA and protein expression in the colon and dorsal root ganglia were similar in control, acute colitis and post-colitis groups, while colonic mRNA expression of cdk5, csk and CASK was increased in the post-colitis group only. Conclusions These findings indicate that P2X(3) receptors are not involved in sensory signaling under physiological conditions whereas they modulate visceral hypersensitivity during acute TNBS-colitis and even more so in the post-inflammatory phase, albeit via different mechanisms of sensitization, validating P2X(3) receptors as potential new targets in the treatment of abdominal pain syndromes.	[Deiteren, Annemie; van der Linden, Laura; de Wit, Anouk; Ceuleers, Hannah; Moreels, Tom G.; Pelckmans, Paul A.; De Man, Joris G.; De Winter, Benedicte Y.] Univ Antwerp, Div Gastroenterol, Lab Expt Med & Pediat, B-2020 Antwerp, Belgium; [Buckinx, Roeland; Timmermans, Jean-Pierre] Univ Antwerp, Lab Cell Biol & Histol, B-2020 Antwerp, Belgium; [Moreels, Tom G.; Pelckmans, Paul A.] Univ Antwerp Hosp, Dept Gastroenterol & Hepatol, Antwerp, Belgium	University of Antwerp; University of Antwerp; University of Antwerp	De Winter, BY (corresponding author), Univ Antwerp, Div Gastroenterol, Lab Expt Med & Pediat, B-2020 Antwerp, Belgium.	benedicte.dewinter@uantwerpen.be	Buckinx, Roeland/G-9482-2011; De Winter, Benedicte Y/G-2616-2011; Deiteren, Annemie/J-4487-2014	Buckinx, Roeland/0000-0001-9976-2889; De Winter, Benedicte Y/0000-0003-0327-6304; Deiteren, Annemie/0000-0002-3841-8731; Ceuleers, Hannah/0000-0003-0477-150X; Timmermans, Jean-Pierre/0000-0003-2506-6252	Fund for Scientific Research Flanders [G.0341.13, G.0249.09N]; Fund for Scientific Research Flanders Community "Gastrointestinal regulatory mechanisms"	Fund for Scientific Research Flanders(FWO); Fund for Scientific Research Flanders Community "Gastrointestinal regulatory mechanisms"	AD is an aspirant of the Fund for Scientific Research Flanders (http://www.fwo.be). This work was supported financially by the Fund for Scientific Research Flanders G.0341.13 and G.0249.09N to BYDW and by the Fund for Scientific Research Flanders Community "Gastrointestinal regulatory mechanisms" (BYDW and JPT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad C, 2005, INFLAMM BOWEL DIS, V11, P674, DOI 10.1097/01.MIB.0000171872.70738.58; Bian XC, 2003, J PHYSIOL-LONDON, V551, P309, DOI 10.1113/jphysiol.2003.044172; Burnstock G, 2001, TRENDS PHARMACOL SCI, V22, P182, DOI 10.1016/S0165-6147(00)01643-6; Burnstock Geoffrey, 2009, Handb Exp Pharmacol, P333, DOI 10.1007/978-3-540-79090-7_10; Cauwels A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.70; Cavaliere F, 2007, J PHARMACOL EXP THER, V323, P70, DOI 10.1124/jpet.106.119024; Cockayne DA, 2005, J PHYSIOL-LONDON, V567, P621, DOI 10.1113/jphysiol.2005.088435; De Schepper HU, 2008, ALIMENT PHARM THER, V27, P621, DOI 10.1111/j.1365-2036.2008.03624.x; Deiteren A, 2014, GUT, V63, P1873, DOI 10.1136/gutjnl-2013-305870; Deiteren A, 2014, STRESS, V17, P431, DOI 10.3109/10253890.2014.951034; Ford AP, 2012, PURINERG SIGNAL, V8, pS3, DOI 10.1007/s11302-011-9271-6; Ford APDW, 2006, BRIT J PHARMACOL, V147, pS132, DOI 10.1038/sj.bjp.0706637; Galligan JJ, 2004, BRIT J PHARMACOL, V141, P1294, DOI 10.1038/sj.bjp.0705761; Honore P, 2002, PAIN, V96, P99, DOI 10.1016/S0304-3959(01)00434-1; Hsieh YL, 2012, EXP NEUROL, V235, P316, DOI 10.1016/j.expneurol.2012.02.013; Jarvis MF, 2002, P NATL ACAD SCI USA, V99, P17179, DOI 10.1073/pnas.252537299; Jones RCW, 2005, J NEUROSCI, V25, P10981, DOI 10.1523/JNEUROSCI.0703-05.2005; Kreis ME, 1998, AM J PHYSIOL-GASTR L, V275, pG675, DOI 10.1152/ajpgi.1998.275.4.G675; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Ma B, 2011, PURINERG SIGNAL, V7, P73, DOI 10.1007/s11302-010-9212-9; Matricon J, 2013, NEUROGASTROENT MOTIL, V25, pE740, DOI 10.1111/nmo.12199; NESS TJ, 1988, BRAIN RES, V450, P153, DOI 10.1016/0006-8993(88)91555-7; Noma N, 2013, J DENT RES, V92, P456, DOI 10.1177/0022034513483770; Robinson DR, 2004, NEUROGASTROENT MOTIL, V16, P113, DOI 10.1046/j.1365-2982.2003.00456.x; Rong W, 2009, NEUROGASTROENT MOTIL, V21, DOI 10.1111/j.1365-2982.2008.01259.x; Sharp CJ, 2006, BRIT J PHARMACOL, V148, P845, DOI 10.1038/sj.bjp.0706790; Shinoda M, 2010, J NEUROPHYSIOL, V104, P3113, DOI 10.1152/jn.00560.2010; Shinoda M, 2009, GASTROENTEROLOGY, V137, P2096, DOI 10.1053/j.gastro.2009.06.048; Spiller R, 2009, GASTROENTEROLOGY, V136, P1979, DOI 10.1053/j.gastro.2009.02.074; Van Crombruggen K, 2007, NEUROPHARMACOLOGY, V53, P257, DOI 10.1016/j.neuropharm.2007.05.010; Vermeulen W, 2011, ACTA GASTRO-ENT BELG, V74, P304; Vermeulen W, 2014, WORLD J GASTROENTERO, V20, P1005, DOI 10.3748/wjg.v20.i4.1005; Vermeulen W, 2013, EUR J PHARMACOL, V698, P404, DOI 10.1016/j.ejphar.2012.10.014; Volonte C, 2013, J NEUROCHEM, V126, P1, DOI 10.1111/jnc.12282; WALLACE JL, 1990, AM J PHYSIOL, V258, pG527, DOI 10.1152/ajpgi.1990.258.4.G527; Wu G, 2004, EUR J PHARMACOL, V504, P45, DOI 10.1016/j.ejphar.2004.09.056; Wynn G, 2004, AM J PHYSIOL-GASTR L, V287, pG647, DOI 10.1152/ajpgi.00020.2004; Wynn G, 2003, GASTROENTEROLOGY, V125, P1398, DOI 10.1016/j.gastro.2003.07.008; Wynn Gregory, 2006, Purinergic Signal, V2, P517, DOI 10.1007/s11302-005-5305-2; Xu GY, 2008, GUT, V57, P1230, DOI 10.1136/gut.2007.134221; Yiangou Y, 2001, NEUROGASTROENT MOTIL, V13, P365, DOI 10.1046/j.1365-2982.2001.00276.x; Yiangou YG, 2001, EUR J GASTROEN HEPAT, V13, P891, DOI 10.1097/00042737-200108000-00003	42	40	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123810	10.1371/journal.pone.0123810	http://dx.doi.org/10.1371/journal.pone.0123810			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885345	Green Submitted, Green Published, gold			2022-12-26	WOS:000353017000084
J	Iglesias, V; Krause, TR; Whitlock, C				Iglesias, Virginia; Krause, Teresa R.; Whitlock, Cathy			Complex Response of White Pines to Past Environmental Variability Increases Understanding of Future Vulnerability	PLOS ONE			English	Article							SUB-ALPINE FORESTS; YELLOWSTONE-NATIONAL-PARK; WIND RIVER RANGE; CLIMATE-CHANGE; MODERN POLLEN; VEGETATION; HOLOCENE; RECORDS; CONSERVATION; DISTURBANCE	Ecological niche models predict plant responses to climate change by circumscribing species distributions within a multivariate environmental framework. Most projections based on modern bioclimatic correlations imply that high-elevation species are likely to be extirpated from their current ranges as a result of rising growing-season temperatures in the coming decades. Paleoecological data spanning the last 15,000 years from the Greater Yellow-stone region describe the response of vegetation to past climate variability and suggest that white pines, a taxon of special concern in the region, have been surprisingly resilient to high summer temperature and fire activity in the past. Moreover, the fossil record suggests that winter conditions and biotic interactions have been critical limiting variables for high-elevation conifers in the past and will likely be so in the future. This long-term perspective offers insights on species responses to a broader range of climate and associated ecosystem changes than can be observed at present and should be part of resource management and conservation planning for the future.	[Iglesias, Virginia; Whitlock, Cathy] Montana State Univ, Montana Inst Ecosyst, Bozeman, MT 59717 USA; [Krause, Teresa R.; Whitlock, Cathy] Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Iglesias, V (corresponding author), Montana State Univ, Montana Inst Ecosyst, Bozeman, MT 59717 USA.	virginia.iglesias@msu.montana.edu		Iglesias, Virginia/0000-0001-5732-3714	National Science Foundation [0818467, 0966472]; Yellowstone National Park; United States Geological Survey North-Central Climate Science Center; Office of Integrative Activities [1443108] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Yellowstone National Park; United States Geological Survey North-Central Climate Science Center; Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	Funding for the research came from the National Science Foundation (http://www.nsf.gov, grant numbers 0818467 and 0966472), Yellowstone National Park (http://www.yellowstonenationalpark.com), and United States Geological Survey North-Central Climate Science Center (https://nccwsc.usgs.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Akima H., 1978, ACM Transactions on Mathematical Software, V4, P148, DOI 10.1145/355780.355786; Alder J, 2014, CLIM PAST DISCUSS, V10, P2925; [Anonymous], 2014, R LANG ENV STAT COMP; Arno S, 1986, WEST J APPL FOR, V1, P92, DOI DOI 10.1093/WJAF/1.3.92; Baker R, 1976, 279E US GEOL SURV; Bennett KD, 2001, TRACKING ENV CHANGE, V3, P5, DOI DOI 10.1007/0-306-47668-1_2; BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; Blarquez O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065852; Brunelle A, 2008, FOREST ECOL MANAG, V255, P836, DOI 10.1016/j.foreco.2007.10.008; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Callaway RM, 1998, OIKOS, V82, P561, DOI 10.2307/3546376; Chang T, PLOS ONE; Davis MB, 2000, ANNU REV EARTH PL SC, V28, P1, DOI 10.1146/annurev.earth.28.1.1; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; FALL PL, 1994, ARCTIC ALPINE RES, V26, P383, DOI 10.2307/1551800; Genries A, 2009, ECOSCIENCE, V16, P13, DOI 10.2980/16-1-3180; Greater Yellowstone Coordinating Committee Whitebark Pine Subcommi.ttee, 2011, WHIT PIN STRAT GREAT; Higuera PE, 2014, J ECOL, V102, P1429, DOI 10.1111/1365-2745.12296; Higuera PE, 2011, HOLOCENE, V21, P327, DOI 10.1177/0959683610374882; Huerta MA, 2009, PALAEOGEOGR PALAEOCL, V271, P170, DOI 10.1016/j.palaeo.2008.10.015; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Iglesias V, 2014, P NATL ACAD SCI US; Jewett JT, 2011, FOREST SCI, V57, P320; Johnson K.A., 2001, FIRE EFFECTS INFORM; Keane R.E., 2001, WHITEBARK PINE COMMU, P89; Kendall C, 1995, STATUS TRENDS NATION; Kendall K, 1996, NUTCRACKER NOTES, V7, P23; Krause T, PALAEOGEOG PALAEOCLI; Krause TR, 2013, QUATERNARY RES, V79, P391, DOI 10.1016/j.yqres.2013.01.005; Leung LR, 2004, CLIMATIC CHANGE, V62, P75, DOI 10.1023/B:CLIM.0000013692.50640.55; Logan JA, 1999, ENVIRON ENTOMOL, V28, P924, DOI 10.1093/ee/28.6.924; Logan JA, 2010, ECOL APPL, V20, P895, DOI 10.1890/09-0655.1; Lotan J.E., 1990, SILVICS N AM, V654, P302, DOI DOI 10.2307/j.ctt1ffjhpb.19; Lynch EA, 1998, ECOLOGY, V79, P1320, DOI 10.1890/0012-9658(1998)079[1320:OOAPFV]2.0.CO;2; MARKGRAF V, 1980, Grana, V19, P127; Marlon J. R., 2012, P NATL ACAD SCI USA, V109, P3203; Millspaugh S, 1997, THESIS U OREGON; Minckley TA, 2008, QUATERNARY SCI REV, V27, P1962, DOI 10.1016/j.quascirev.2008.07.006; Minore D, 1979, PNW87 USFS; Mote P, 2013, US NATL CLIMATE ASSE; Mote PW, 2006, J CLIMATE, V19, P6209, DOI 10.1175/JCLI3971.1; Ortu E, 2006, J QUATERNARY SCI, V21, P615, DOI 10.1002/jqs.998; PRENTICE IC, 1985, QUATERNARY RES, V23, P76, DOI 10.1016/0033-5894(85)90073-0; Ryan WBF, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002332; Schrag AM, 2008, J BIOGEOGR, V35, P698, DOI 10.1111/j.1365-2699.2007.01815.x; Steele R, 1990, SILVICS N AM, V1, P699; Swetnam TW, 1998, J CLIMATE, V11, P3128, DOI 10.1175/1520-0442(1998)011<3128:MDAERT>2.0.CO;2; Temperli C, 2013, ECOL MONOGR, V83, P383, DOI 10.1890/12-1503.1; Tomback D. F., 1986, MADRONO, V33, P100; Westerling AL, 2011, P NATL ACAD SCI USA, V108, P13165, DOI 10.1073/pnas.1110199108; WHITLOCK C, 1993, QUATERNARY RES, V39, P231, DOI 10.1006/qres.1993.1026; WHITLOCK C, 1993, ECOL MONOGR, V63, P173, DOI 10.2307/2937179; Whitlock C, 2001, TRACKING ENV CHANGE, P75, DOI DOI 10.1007/0-306-47668-1_5; Whitlock C, 2012, PALAEOGEOGR PALAEOCL, V331, P90, DOI 10.1016/j.palaeo.2012.03.001; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x	56	17	17	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124439	10.1371/journal.pone.0124439	http://dx.doi.org/10.1371/journal.pone.0124439			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885810	gold, Green Published, Green Submitted			2022-12-26	WOS:000353017000128
J	Chua, CY; Liu, Y; Granberg, KJ; Hu, L; Haapasalo, H; Annala, MJ; Cogdell, DE; Verploegen, M; Moore, LM; Fuller, GN; Nykter, M; Cavenee, WK; Zhang, W				Chua, C. Y.; Liu, Y.; Granberg, K. J.; Hu, L.; Haapasalo, H.; Annala, M. J.; Cogdell, D. E.; Verploegen, M.; Moore, L. M.; Fuller, G. N.; Nykter, M.; Cavenee, W. K.; Zhang, W.			IGFBP2 potentiates nuclear EGFR-STAT3 signaling	ONCOGENE			English	Article							EPIDERMAL-GROWTH-FACTOR; FACTOR-BINDING PROTEIN-2; FACTOR RECEPTOR; EGF RECEPTOR; FACTOR-ALPHA; HUMAN GLIOMAS; GLIOBLASTOMA-MULTIFORME; PROGNOSTIC-SIGNIFICANCE; ASTROCYTIC GLIOMAS; MESSENGER-RNA	Insulin-like growth factor binding protein 2 (IGFBP2) is a pleiotropic oncogenic protein that has both extracellular and intracellular functions. Despite a clear causal role in cancer development, the tumor-promoting mechanisms of IGFBP2 are poorly understood. The contributions of intracellular IGFBP2 to tumor development and progression are also unclear. Here we present evidence that both exogenous IGFBP2 treatment and cellular IGEBP2 overexpression lead to aberrant activation of epidermal growth factor receptor (EGFR), which subsequently activates signal transducer and activator of transcription factor 3 (STAT3) signaling. Furthermore, we demonstrate that IGFBP2 augments the nuclear accumulation of EGFR to potentiate STAT3 transactivation activities, via activation of the nuclear EGFR signaling pathway. Nuclear IGFBP2 directly influences the invasive and migratory capacities of human glioblastoma cells, providing a direct link between intracellular (and particularly nuclear) IGFBP2 and cancer hallmarks. These activities are also consistent with the strong association between IGFBP2 and STAT3-activated genes derived from The Cancer Genome Atlas database for human glioma. A high level of all three proteins (IGFBP2, EGFR and STAT3) was strongly correlated with poorer survival in an independent patient data set. These results identify a novel tumor-promoting function for IGFBP2 of activating EGFR/STAT3 signaling and facilitating EGFR accumulation in the nucleus, thereby deregulating EGFR signaling by two distinct mechanisms. As targeting EGFR in glioma has been relatively unsuccessful, this study suggests that IGFBP2 may be a novel therapeutic target.	[Chua, C. Y.; Liu, Y.; Granberg, K. J.; Hu, L.; Annala, M. J.; Cogdell, D. E.; Verploegen, M.; Moore, L. M.; Fuller, G. N.; Zhang, W.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Chua, C. Y.; Fuller, G. N.; Zhang, W.] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX USA; [Liu, Y.; Fuller, G. N.; Zhang, W.] ISB MDA Genome Data Anal Ctr, Canc Genome Atlas, Seattle, WA USA; [Liu, Y.; Fuller, G. N.; Zhang, W.] ISB MDA Genome Data Anal Ctr, Canc Genome Atlas, Houston, TX USA; [Granberg, K. J.; Annala, M. J.] Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland; [Granberg, K. J.; Annala, M. J.; Nykter, M.] Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland; [Haapasalo, H.] Fimlab Labs, Dept Pathol, Tampere, Finland; [Haapasalo, H.] Univ Tampere, FIN-33101 Tampere, Finland; [Verploegen, M.] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6525 ED Nijmegen, Netherlands; [Cavenee, W. K.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; Tampere University; Tampere University; Radboud University Nijmegen; Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Zhang, W (corresponding author), Univ Texas MD Anderson Canc Ctr, Unit 85, Dept Pathol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	wzhang@mdanderson.org	Verploegen, Maartje/GYA-0516-2022	Chua, Corrine Ying Xuan/0000-0002-5724-8715; Rautajoki, Kirsi Johanna/0000-0001-6549-7810; Nykter, Matti/0000-0001-6956-2843; Fuller, Gregory/0000-0001-9447-2647	US National Institutes of Health [CA098503, CA141432, CA143835, U24 CA143835]; Cancer Systems Informatics Center from the National Foundation for Cancer Research; NIH/NCI grant [P30CA016672]; Finnish Funding Agency for Technology and Innovation Finland Distinguished Professor program; Academy of Finland [259038]; NATIONAL CANCER INSTITUTE [R01CA141432, U24CA143835, P30CA016672, R01CA098503] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Systems Informatics Center from the National Foundation for Cancer Research; NIH/NCI grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Finnish Funding Agency for Technology and Innovation Finland Distinguished Professor program; Academy of Finland(Academy of Finland); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Oliver Bogler, Dr Zhimin Lu, Dr Frederick Lang, Dr Paul Chiao and Dr Tapio Visakorpi for their helpful comments and discussions and Kathryn L Hale, Department of Scientific Publications at MD Anderson Cancer Center, for editing the manuscript. We thank Ville Kytola for contributions to the immunohistochemical association analyses. This work was partially supported by grants from the US National Institutes of Health (CA098503, CA141432 and CA143835 to WZ and GNF and U24 CA143835 to WZ), by funding for the Cancer Systems Informatics Center from the National Foundation for Cancer Research (to WZ), by NIH/NCI grant P30CA016672 to MD Anderson Cancer Center supporting the Flow Cytometry and Cellular Imaging Core Facility and by the Finnish Funding Agency for Technology and Innovation Finland Distinguished Professor program and the Academy of Finland (grant 259038 to KG). WKC is a Fellow of the National Foundation for Cancer Research,	Arese M, 1999, MOL BIOL CELL, V10, P1429, DOI 10.1091/mbc.10.5.1429; Azar WJ, 2014, ONCOGENE, V33, P578, DOI 10.1038/onc.2012.630; Azar WJ, 2011, ENDOCRINOLOGY, V152, P3332, DOI 10.1210/en.2011-1121; BAXTER RC, 1993, TRENDS ENDOCRIN MET, V4, P91, DOI 10.1016/1043-2760(93)90085-S; Baxter RC, 2013, J CELL COMMUN SIGNAL, V7, P179, DOI 10.1007/s12079-013-0203-9; Becher OJ, 2008, J CHILD NEUROL, V23, P1205, DOI 10.1177/0883073808321766; Besnard V, 2001, BBA-MOL CELL RES, V1538, P47, DOI 10.1016/S0167-4889(00)00136-1; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Boerner JL, 2004, MOL CELL BIOL, V24, P7059, DOI 10.1128/MCB.24.16.7059-7071.2004; Brand TM, 2011, DISCOV MED, V12, P419; Burke P, 2001, MOL BIOL CELL, V12, P1897, DOI 10.1091/mbc.12.6.1897; Busund LT, 2005, J CLIN PATHOL, V58, P361, DOI 10.1136/jcp.2004.020834; CLEMMONS DR, 1990, TRENDS ENDOCRIN MET, V1, P412, DOI 10.1016/1043-2760(90)90102-9; COFFER PJ, 1995, BIOCHEM BIOPH RES CO, V210, P74, DOI 10.1006/bbrc.1995.1629; Colman H, 2010, NEURO-ONCOLOGY, V12, P49, DOI 10.1093/neuonc/nop007; Demory ML, 2009, J BIOL CHEM, V284, P36592, DOI 10.1074/jbc.M109.000760; Dobrowolski R, 2012, NAT REV MOL CELL BIO, V13, P53, DOI 10.1038/nrm3244; Dunlap SM, 2007, P NATL ACAD SCI USA, V104, P11736, DOI 10.1073/pnas.0703145104; EKSTRAND AJ, 1994, ONCOGENE, V9, P2313; FERRER I, 1995, NEUROSCIENCE, V66, P189, DOI 10.1016/0306-4522(94)00584-R; Fuller GN, 1999, CANCER RES, V59, P4228; Ganesan A, 2012, PROTEIN SCI, V21, P918, DOI 10.1002/pro.2089; Gerrard DE, 1999, J ANIM SCI, V77, P1431; Giannopoulou E, 2006, IN VIVO, V20, P421; GREEN BN, 1994, ENDOCRINOLOGY, V134, P954, DOI 10.1210/en.134.2.954; Haapasalo H, 1996, BRIT J CANCER, V73, P620, DOI 10.1038/bjc.1996.107; Han S, 2014, BRIT J CANCER, V111, P1400, DOI 10.1038/bjc.2014.435; Hara A, 2004, ACTA NEUROPATHOL, V108, P43, DOI 10.1007/s00401-004-0860-0; Haynik DM, 2007, APPL IMMUNOHISTO M M, V15, P56, DOI 10.1097/01.pai.0000213133.09160.da; Heimberger AB, 2005, CLIN CANCER RES, V11, P1462, DOI 10.1158/1078-0432.CCR-04-1737; Herms JW, 1999, SURG NEUROL, V51, P536, DOI 10.1016/S0090-3019(98)00028-7; Hoeflich A, 2004, BIOCHEM BIOPH RES CO, V324, P705, DOI 10.1016/j.bbrc.2004.09.111; Holmes KM, 2012, P NATL ACAD SCI USA, V109, P3475, DOI 10.1073/pnas.1120375109; Hoshino M, 2007, PATHOBIOLOGY, V74, P15, DOI 10.1159/000101047; Housden BE, 2014, TRENDS BIOCHEM SCI, V39, P457, DOI 10.1016/j.tibs.2014.07.008; Hsieh D, 2010, BIOCHEM BIOPH RES CO, V397, P367, DOI 10.1016/j.bbrc.2010.05.145; Huynh H, 2011, BLOOD, V118, P3236, DOI 10.1182/blood-2011-01-331876; Jaganathan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019605; Jahani-Asl A, 2013, CURR MOL MED, V13, P1241, DOI 10.2174/1566524011313080002; Joki T, 2000, CANCER RES, V60, P4926; Joy A, 1997, ONCOGENE, V14, P171, DOI 10.1038/sj.onc.1200823; KASER MR, 1992, MOL BRAIN RES, V16, P316, DOI 10.1016/0169-328X(92)90241-3; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; KUDLOW JE, 1989, J BIOL CHEM, V264, P3880; LAZAR LM, 1992, J NEUROSCI, V12, P1688; LEE WH, 1993, NEUROSCIENCE, V53, P251, DOI 10.1016/0306-4522(93)90303-W; Li X, 2015, ONCOGENE, V34, P1619, DOI 10.1038/onc.2014.98; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lo HW, 2008, CLIN CANCER RES, V14, P6042, DOI 10.1158/1078-0432.CCR-07-4923; Lo HW, 2010, MOL CANCER RES, V8, P232, DOI 10.1158/1541-7786.MCR-09-0391; Lo HW, 2006, BRIT J CANCER, V94, P184, DOI 10.1038/sj.bjc.6602941; Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007; Lo HW, 2005, CANCER RES, V65, P338; McDonald KL, 2007, J NEUROPATH EXP NEUR, V66, P405, DOI 10.1097/nen.0b013e31804567d7; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Mehrian-Shai R, 2007, P NATL ACAD SCI USA, V104, P5563, DOI 10.1073/pnas.0609139104; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Miyako K, 2009, MOL ENDOCRINOL, V23, P169, DOI 10.1210/me.2008-0168; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; ORIAN JM, 1992, BRIT J CANCER, V66, P106, DOI 10.1038/bjc.1992.225; Park OK, 1996, P NATL ACAD SCI USA, V93, P13704, DOI 10.1073/pnas.93.24.13704; Pennock S, 2003, MOL CELL BIOL, V23, P5803, DOI 10.1128/MCB.23.16.5803-5815.2003; Pereira JJ, 2004, CANCER RES, V64, P977, DOI 10.1158/0008-5472.CAN-03-3056; RAKOWICZSZULCZYNSKA EM, 1986, P NATL ACAD SCI USA, V83, P3728, DOI 10.1073/pnas.83.11.3728; Sallinen SL, 2000, CANCER RES, V60, P6617; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Sarfstein R, 2013, ENDOCRINOLOGY, V154, P1672, DOI 10.1210/en.2012-2165; Scharf JG, 1996, HEPATOLOGY, V23, P818, DOI 10.1002/hep.510230424; Schneider MR, 2009, J CELL PHYSIOL, V218, P460, DOI 10.1002/jcp.21635; Scrideli CA, 2007, J NEURO-ONCOL, V83, P233, DOI 10.1007/s11060-007-9328-0; Shao H, 2003, CANCER RES, V63, P3923; Shono T, 2001, CANCER RES, V61, P4375; Smalheiser NR, 1996, MOL BIOL CELL, V7, P1003, DOI 10.1091/mbc.7.7.1003; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Stachowiak MK, 2003, J CELL BIOCHEM, V90, P662, DOI 10.1002/jcb.10606; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swindle CS, 2001, J CELL BIOL, V154, P459, DOI 10.1083/jcb.200103103; Terrien X, 2005, BIOCHEM J, V392, P457, DOI 10.1042/BJ20050517; Tomas A, 2014, TRENDS CELL BIOL, V24, P26, DOI 10.1016/j.tcb.2013.11.002; TORP SH, 1993, EUR J CANCER, V29A, P1604, DOI 10.1016/0959-8049(93)90305-Y; TUZI NL, 1991, BRIT J CANCER, V63, P227, DOI 10.1038/bjc.1991.54; Waage IS, 2013, INT J SURG PATHOL, V21, P573, DOI 10.1177/1066896913492196; Wang GK, 2006, J BIOL CHEM, V281, P14085, DOI 10.1074/jbc.M513686200; Wang H, 2003, CANCER RES, V63, P4315; Wang JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003769; Wang Y, 2002, MOL CELL BIOL, V22, P7279, DOI 10.1128/MCB.22.20.7279-7290.2002; Wiley HS, 2003, EXP CELL RES, V284, P78, DOI 10.1016/S0014-4827(03)00002-8; WOOD TL, 1992, DEVELOPMENT, V114, P59; Xia WY, 2009, MOL CARCINOGEN, V48, P610, DOI 10.1002/mc.20504; Xu KM, 2014, ONCOTARGET, V5, P1241, DOI 10.18632/oncotarget.1370; Yang DI, 2002, ANN NY ACAD SCI, V962, P8, DOI 10.1111/j.1749-6632.2002.tb04052.x; Yazawa T, 2009, AM J PATHOL, V175, P976, DOI 10.2353/ajpath.2009.081004; Zheng XG, 2007, CANCER SCI, V98, P674, DOI 10.1111/j.1349-7006.2007.00440.x; Zhou BBS, 2006, CANCER CELL, V10, P39, DOI 10.1016/j.ccr.2006.05.024	96	50	54	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 11	2016	35	6					738	747		10.1038/onc.2015.131	http://dx.doi.org/10.1038/onc.2015.131			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DE0RF	25893308	Green Accepted			2022-12-26	WOS:000370331300007
J	Wang, W; Liao, P; Shen, M; Chen, T; Chen, Y; Li, Y; Lin, X; Ge, X; Wang, P				Wang, W.; Liao, P.; Shen, M.; Chen, T.; Chen, Y.; Li, Y.; Lin, X.; Ge, X.; Wang, P.			SCP1 regulates c-Myc stability and functions through dephosphorylating c-Myc Ser62	ONCOGENE			English	Article							TERMINAL DOMAIN PHOSPHATASE; PROTEIN-KINASE CK2; GENE-EXPRESSION; BREAST-CANCER; DNA-BINDING; DEGRADATION; CELLS; COMPLEX; ACTIVATION; SUBUNIT	Serine 62 (Ser62) phosphorylation affects the c-Myc protein stability in cancer cells. However, the mechanism for dephosphorylating c-Myc is not well understood. In this study, we identified carboxyl-terminal domain RNA polymerase II polypeptide A small phosphatase 1 (SCP1) as a novel phosphatase specifically dephosphorylating c-Myc Ser62. Ectopically expressed SCP1 strongly dephosphorylated c-Myc Ser62, destabilized c-Myc protein and suppressed c-Myc transcriptional activity. Knockdown of SCP1 increased the c-Myc protein levels in liver cancer cells. SCP1 interacted with c-Myc both in vivo and in vitro. In addition, Ser245 at the C-terminus of SCP1 was essential for its phosphatase activity towards c-Myc. Functionally, SCP1 negatively regulated the cancer cell proliferation. Collectively, our findings indicate that SCP1 is a potential tumor suppressor for liver cancers through dephosphorylating c-Myc Ser62.	[Wang, W.; Liao, P.; Ge, X.; Wang, P.] Tongji Univ, Dept Cent Lab, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China; [Wang, W.; Liao, P.; Shen, M.; Chen, T.; Chen, Y.; Li, Y.; Wang, P.] E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200062, Peoples R China; [Wang, W.; Liao, P.; Shen, M.; Chen, T.; Chen, Y.; Li, Y.; Wang, P.] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China; [Lin, X.] Baylor Coll Med, Dept Surg, Houston, TX 77030 USA; [Wang, P.] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China	Tongji University; East China Normal University; East China Normal University; Baylor College of Medicine; Tongji University	Ge, X; Wang, P (corresponding author), Tongji Univ, Dept Cent Lab, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China.; Wang, P (corresponding author), E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200062, Peoples R China.; Wang, P (corresponding author), E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China.	gexx0019@163.com; pwangecnu@163.com	Liao, Peng/Y-1896-2019	Liao, Peng/0000-0002-8409-5574	National Basic Research Program of China (973 program) [2012CB910404, 2010CB529704]; National Natural Science Foundation of China [30971521, 31171338, 31222037]; Shanghai Municipal Education Commission; Shanghai Education Development Foundation [11SG27]; Shanghai Key Laboratory of Regulatory Biology [11DZ2260300]; Shanghai Rising-Star program [09QA1401900, 13QH1401300]; scholar of the Program for New Century Excellent Talents in University [NCET-10-0387]	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Shanghai Education Development Foundation; Shanghai Key Laboratory of Regulatory Biology; Shanghai Rising-Star program; scholar of the Program for New Century Excellent Talents in University	This work was supported by grants from National Basic Research Program of China (973 program 2012CB910404 and 2010CB529704), National Natural Science Foundation of China (30971521, 31171338 and 31222037), 'Shu Guang' project supported by Shanghai Municipal Education Commission and Shanghai Education Development Foundation (11SG27), Shanghai Key Laboratory of Regulatory Biology (11DZ2260300) and Shanghai Rising-Star program (09QA1401900 and 13QH1401300). PW is a scholar of the Program for New Century Excellent Talents in University (NCET-10-0387).	Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Amati B, 2004, P NATL ACAD SCI USA, V101, P8843, DOI 10.1073/pnas.0403046101; Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; Arnold HK, 2009, EMBO J, V28, P500, DOI 10.1038/emboj.2008.279; Barford D, 1996, TRENDS BIOCHEM SCI, V21, P407, DOI 10.1016/S0968-0004(96)10060-8; Chan CH, 2010, NAT CELL BIOL, V12, P457, DOI 10.1038/ncb2047; Conacci-Sorrell M, 2011, CELL CYCLE, V10, P604, DOI 10.4161/cc.10.4.14794; CROUCH DH, 1993, ONCOGENE, V8, P1849; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Farrell A.S., 2014, COLD SPRING HARB PER, V4; Farrell AS, 2013, MOL CELL BIOL, V33, P2930, DOI 10.1128/MCB.01455-12; Feng XH, 2002, MOL CELL, V9, P133, DOI 10.1016/S1097-2765(01)00430-0; GUPTA S, 1993, P NATL ACAD SCI USA, V90, P3216, DOI 10.1073/pnas.90.8.3216; HSU TY, 1988, CELL, V55, P627, DOI 10.1016/0092-8674(88)90221-8; Janghorban M, 2014, P NATL ACAD SCI USA, V111, P9157, DOI 10.1073/pnas.1317630111; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Kops O, 2002, FEBS LETT, V513, P305, DOI 10.1016/S0014-5793(02)02288-3; Liao P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.536; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Liu LD, 2012, NATURE, V483, P608, DOI 10.1038/nature10927; Liu Lingfeng, 2012, Genes Cancer, V3, P23, DOI 10.1177/1947601912448067; Liu N, 2010, J BIOL CHEM, V285, P18858, DOI 10.1074/jbc.M109.099440; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sears RC, 2004, CELL CYCLE, V3, P1133, DOI 10.4161/cc.3.9.1145; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Song DH, 2000, J BIOL CHEM, V275, P23790, DOI 10.1074/jbc.M909107199; Stolk M, 2005, BIOCHEM J, V386, P281, DOI 10.1042/BJ20041571; Strack S, 1999, FEBS LETT, V460, P462, DOI 10.1016/S0014-5793(99)01377-0; Tan J, 2010, CANCER CELL, V18, P459, DOI 10.1016/j.ccr.2010.10.021; Wang XY, 2011, CANCER RES, V71, P925, DOI 10.1158/0008-5472.CAN-10-1032; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Wrighton KH, 2006, J BIOL CHEM, V281, P38365, DOI 10.1074/jbc.M607246200; Wu YD, 2009, J BIOL CHEM, V284, P640, DOI 10.1074/jbc.M806916200; Xue Y, 2005, NUCLEIC ACIDS RES, V33, pW184, DOI 10.1093/nar/gki393; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Yeo M, 2003, J BIOL CHEM, V278, P26078, DOI 10.1074/jbc.M301791200; Yeo M, 2005, SCIENCE, V307, P596, DOI 10.1126/science.1100801; Zhang MM, 2010, PROTEIN SCI, V19, P974, DOI 10.1002/pro.375; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P2790, DOI 10.1073/pnas.1100764108; Zhang Y, 2006, MOL CELL, V24, P759, DOI 10.1016/j.molcel.2006.10.027	45	20	20	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 28	2016	35	4					491	500		10.1038/onc.2015.106	http://dx.doi.org/10.1038/onc.2015.106			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DC2OT	25893300				2022-12-26	WOS:000369056700009
J	Lodillinsky, C; Infante, E; Guichard, A; Chaligne, R; Fuhrmann, L; Cyrta, J; Irondelle, M; Lagoutte, E; Vacher, S; Bonsang-Kitzis, H; Glukhova, M; Reyal, F; Bieche, I; Vincent-Salomon, A; Chavrier, P				Lodillinsky, C.; Infante, E.; Guichard, A.; Chaligne, R.; Fuhrmann, L.; Cyrta, J.; Irondelle, M.; Lagoutte, E.; Vacher, S.; Bonsang-Kitzis, H.; Glukhova, M.; Reyal, F.; Bieche, I.; Vincent-Salomon, A.; Chavrier, P.			p63/MT1-MMP axis is required for in situ to invasive transition in basal-like breast cancer	ONCOGENE			English	Article							STEM-CELL ACTIVITY; MATRIX-METALLOPROTEINASE; TISSUE LOCALIZATION; TUMOR-CELLS; EXPRESSION; P63; MT1-MMP; IDENTIFICATION; PROGRESSION; METASTASIS	The transition of ductal carcinoma in situ (DCIS) to invasive breast carcinoma requires tumor cells to cross the basement membrane (BM). However, mechanisms underlying BM transmigration are poorly understood. Here, we report that expression of membranetype 1 (MT1)-matrix metalloproteinase (MMP), a key component of the BM invasion program, increases during breast cancer progression at the in situ to invasive breast carcinoma transition. In the intraductal xenograft model, MT1-MMP is required for BM transmigration of MCF10DCIS. com breast adenocarcinoma cells and is overexpressed in cell clusters overlying focal BM disruptions and at the invasive tumor front. Mirrored upregulation of p63 and MT1-MMP is observed at the edge of MCF10DCIS. com xenograft tumors and p63 is required for induction of MT1-MMP-dependent invasive program in response to microenvironmental signals. Immunohistochemistry and analysis of public database reveal that p63 and MT1-MMP are upregulated in human basal-like breast tumors suggesting that p63/MT1-MMP axis contributes to progression of basal-like breast cancers with elevated p63 and MT1-MMP levels.	[Lodillinsky, C.; Infante, E.; Guichard, A.; Fuhrmann, L.; Cyrta, J.; Irondelle, M.; Lagoutte, E.; Chavrier, P.] CNRS, Membrane & Cytoskeleton Dynam Grp, Cell Dynam & Compartmentalizat Unit, Inst Curie,UMR144, 26 Rue Ulm, F-75248 Paris, France; [Chaligne, R.; Vincent-Salomon, A.] Inst Curie, Genet & Dev Biol Unit, Mammalian Dev Epigenet Grp, Paris, France; [Vacher, S.; Bieche, I.] Inst Curie, Dept Genet, Paris, France; [Bonsang-Kitzis, H.; Reyal, F.] Inst Curie, Team RT2Lab, Translat Res Dept, Paris, France; [Glukhova, M.] CNRS, Mol Mech Mammary Gland Dev Grp, Cell Dynam & Compartmentalizat Unit, Inst Curie,UMR144, Paris, France; [Vincent-Salomon, A.] Inst Curie, Pathol Dept, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Lodillinsky, C; Chavrier, P (corresponding author), CNRS, Membrane & Cytoskeleton Dynam Grp, Cell Dynam & Compartmentalizat Unit, Inst Curie,UMR144, 26 Rue Ulm, F-75248 Paris, France.	catalina.lodillinsky@curie.fr; philippe.chavrier@curie.fr	CHAVRIER, Philippe/AAG-2645-2020; Bièche, Ivan/O-7399-2017; CHAVRIER, Philippe/B-4707-2010	CHAVRIER, Philippe/0000-0002-7351-733X; Bièche, Ivan/0000-0002-2430-5429; CHAVRIER, Philippe/0000-0002-7351-733X; Guichard, Alan/0000-0001-8623-9570; Infante, Elvira/0000-0002-9883-8391; VACHER, Sophie/0000-0002-0042-6023	Agence Nationale pour la Recherche; Fondation Pierre-Gilles de Gennes pour la Recherche; Region Ile-de-France; Appel a Projet 'Biologie des Systemes' du Plan cancer (INVADE project); Incentive and Cooperative Research Programme 'Breast cancer: cell Invasion and Motility' of Institut Curie; ARC [SL220100601356, SLR20130607099]; Ligue Nationale contre le Cancer (Comite de Paris); Agence Nationale pour la Recherche [ANR-08-BLAN-0111]; Institut National du Cancer [2012-1-PL BIO-02-IC-1]; Institut Curie; Centre National pour la Recherche Scientifique (CNRS)	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fondation Pierre-Gilles de Gennes pour la Recherche; Region Ile-de-France(Region Ile-de-France); Appel a Projet 'Biologie des Systemes' du Plan cancer (INVADE project); Incentive and Cooperative Research Programme 'Breast cancer: cell Invasion and Motility' of Institut Curie; ARC(Australian Research Council); Ligue Nationale contre le Cancer (Comite de Paris); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Institut National du Cancer(Institut National du Cancer (INCA) France); Institut Curie; Centre National pour la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	We acknowledge the Breast Cancer Study Group and patients of Institut Curie for the breast tumor samples, Dr G Scita for critical reading of the manuscript, the Nikon Imaging Centre @ Institut Curie-CNRS and Cell and Tissue Imaging Facility of Institut Curie for help with image acquisition, V Dangles-Marie and MA Deugnier for help with the intraductal xenograft model, K Lehti, GP Dotto, C Albiges-Rizo and O Destaing for providing reagents, D Gentien for the gift of breast tumor cell line mRNA samples and M Sefta for correlation analysis of MT1-MMP and p63 expression in breast tumor cell lines. CL was supported by grants from Agence Nationale pour la Recherche and Fondation Pierre-Gilles de Gennes pour la Recherche, EI by a grant from Region Ile-de-France, AG by a grant from Appel a Projet 'Biologie des Systemes' 2012 du Plan cancer 2009-2013 (INVADE project) and LF and MI by the Incentive and Cooperative Research Programme 'Breast cancer: cell Invasion and Motility' of Institut Curie. Funding for this work was provided by grants from ARC (SL220100601356 and SLR20130607099), Ligue Nationale contre le Cancer (Comite de Paris), Agence Nationale pour la Recherche (ANR-08-BLAN-0111) and Institut National du Cancer (2012-1-PL BIO-02-IC-1) to PC and by core funding from Institut Curie and Centre National pour la Recherche Scientifique (CNRS).	Allred DC, 2008, CLIN CANCER RES, V14, P370, DOI 10.1158/1078-0432.CCR-07-1127; Awadelkarim KD, 2012, INT J CANCER, V131, P2852, DOI 10.1002/ijc.27600; Balboni AL, 2013, CANCER RES, V73, P1020, DOI 10.1158/0008-5472.CAN-12-2862; Behbod F, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2358; Bisson C, 2003, INT J CANCER, V105, P7, DOI 10.1002/ijc.11012; Buckley NE, 2011, CANCER RES, V71, P1933, DOI 10.1158/0008-5472.CAN-10-2717; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Chalcrabarti R, 2014, NAT CELL BIOL, V16, P1004, DOI 10.1038/ncb3040; Cheung KJ, 2013, CELL, V155, P1639, DOI 10.1016/j.cell.2013.11.029; Cowell CF, 2013, MOL ONCOL, V7, P859, DOI 10.1016/j.molonc.2013.07.005; Hannemann J, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1613; Harmes DC, 2003, ONCOGENE, V22, P7607, DOI 10.1038/sj.onc.1207129; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Hu M, 2008, CANCER CELL, V13, P394, DOI 10.1016/j.ccr.2008.03.007; Jones JL, 1999, J PATHOL, V189, P161, DOI 10.1002/(SICI)1096-9896(199910)189:2<161::AID-PATH406>3.0.CO;2-2; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kouwenhoven EN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001065; Lee S, 2012, CANCER RES, V72, P4574, DOI 10.1158/0008-5472.CAN-12-0636; Lehmann BD, 2014, J PATHOL, V232, P142, DOI 10.1002/path.4280; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lindsay J, 2011, J BIOL CHEM, V286, P3915, DOI 10.1074/jbc.M110.162511; Livasy CA, 2006, MODERN PATHOL, V19, P264, DOI 10.1038/modpathol.3800528; Lohi J, 2000, GENE, V242, P75, DOI 10.1016/S0378-1119(99)00549-1; Martynova E, 2012, ONCOTARGET, V3, P132; Matos I, 2005, VIRCHOWS ARCH, V447, P688, DOI 10.1007/s00428-005-0010-7; McDade SS, 2012, NUCLEIC ACIDS RES, V40, P7190, DOI 10.1093/nar/gks389; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Monteiro P, 2013, J CELL BIOL, V203, P1063, DOI 10.1083/jcb.201306162; Muggerud AA, 2010, MOL ONCOL, V4, P357, DOI 10.1016/j.molonc.2010.06.007; Nakada M, 1999, AM J PATHOL, V154, P417, DOI 10.1016/S0002-9440(10)65288-1; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; OKADA A, 1995, P NATL ACAD SCI USA, V92, P2730, DOI 10.1073/pnas.92.7.2730; Olsen JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062547; Perentes JY, 2011, CANCER RES, V71, P4527, DOI 10.1158/0008-5472.CAN-10-4376; Polyak K, 2005, J MAMMARY GLAND BIOL, V10, P231, DOI 10.1007/s10911-005-9584-6; Prat A, 2013, J CLIN ONCOL, V31, P203, DOI 10.1200/JCO.2012.43.4134; Ribeiro-Silva A, 2005, HISTOPATHOLOGY, V47, P458, DOI 10.1111/j.1365-2559.2005.02249.x; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Sakakibara M, 1999, CANCER, V85, P231, DOI 10.1002/(SICI)1097-0142(19990101)85:1<231::AID-CNCR31>3.0.CO;2-3; Sakurai-Yageta M, 2008, J CELL BIOL, V181, P985, DOI 10.1083/jcb.200709076; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Shekhar MPV, 2013, ONCOTARGET, V4, P231, DOI 10.18632/oncotarget.818; Szabova L, 2008, ONCOGENE, V27, P3274, DOI 10.1038/sj.onc.1210982; Tetu B, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1503; Teuliere J, 2005, DEVELOPMENT, V132, P267, DOI 10.1242/dev.01583; Tsunezuka Y, 1996, CANCER RES, V56, P5678; Tucci P, 2012, P NATL ACAD SCI USA, V109, P15312, DOI 10.1073/pnas.1110977109; Ueno H, 1997, CANCER RES, V57, P2055; Vincent-Salomon A, 2007, BRIT J CANCER, V96, P654, DOI 10.1038/sj.bjc.6603584; Vincent-Salomon A, 2008, CLIN CANCER RES, V14, P1956, DOI 10.1158/1078-0432.CCR-07-1465; Westfall MD, 2003, MOL CELL BIOL, V23, P2264, DOI 10.1128/MCB.23.7.2264-2276.2003; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yu K, 2004, CANCER RES, V64, P2962, DOI 10.1158/0008-5472.CAN-03-2430; Zhai YL, 2005, CANCER RES, V65, P6543, DOI 10.1158/0008-5472.CAN-05-0231	59	59	60	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 21	2016	35	3					344	357		10.1038/onc.2015.87	http://dx.doi.org/10.1038/onc.2015.87			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DC2OF	25893299				2022-12-26	WOS:000369055300008
J	Saitta, ET				Saitta, Evan Thomas			Evidence for Sexual Dimorphism in the Plated Dinosaur Stegosaurus mjosi (Ornithischia, Stegosauria) from the Morrison Formation (Upper Jurassic) of Western USA	PLOS ONE			English	Article							RELATIVE GROWTH; SELECTION; EVOLUTION; PTEROSAURS; HISTOLOGY	Conclusive evidence for sexual dimorphism in non-avian dinosaurs has been elusive. Here it is shown that dimorphism in the shape of the dermal plates of Stegosaurus mjosi (Upper Jurassic, western USA) does not result from non-sex-related individual, interspecific, or ontogenetic variation and is most likely a sexually dimorphic feature. One morph possessed wide, oval plates 45% larger in surface area than the tall, narrow plates of the other morph. Intermediate morphologies are lacking as principal component analysis supports marked size-and shape-based dimorphism. In contrast, many non-sex-related individual variations are expected to show intermediate morphologies. Taphonomy of a new quarry in Montana (JRDI 5ES Quarry) shows that at least five individuals were buried in a single horizon and were not brought together by water or scavenger transportation. This new site demonstrates co-existence, and possibly suggests sociality, between two morphs that only show dimorphism in their plates. Without evidence for niche partitioning, it is unlikely that the two morphs represent different species. Histology of the new specimens in combination with studies on previous specimens indicates that both morphs occur in fully-grown individuals. Therefore, the dimorphism is not a result of ontogenetic change. Furthermore, the two morphs of plates do not simply come from different positions on the back of a single individual. Plates from all positions on the body can be classified as one of the two morphs, and previously discovered, isolated specimens possess only one morph of plates. Based on the seemingly display-oriented morphology of plates, female mate choice was likely the driving evolutionary mechanism rather than male-male competition. Dinosaur ornamentation possibly served similar functions to the ornamentation of modern species. Comparisons to ornamentation involved in sexual selection of extant species, such as the horns of bovids, may be appropriate in predicting the function of some dinosaur ornamentation.	Univ Bristol, Sch Earth Sci, Bristol, Avon, England	University of Bristol	Saitta, ET (corresponding author), Univ Bristol, Sch Earth Sci, Bristol, Avon, England.	evansaitta@gmail.com	Saitta, Evan Thomas/H-6884-2019	Saitta, Evan Thomas/0000-0002-9306-9060	Princeton University's Office of the Dean of the College; Princeton University's Mountlake Field Research Fund; Princeton University's Fred Fox Class	Princeton University's Office of the Dean of the College; Princeton University's Mountlake Field Research Fund; Princeton University's Fred Fox Class	This work was supported by Princeton University's Office of the Dean of the College, Princeton University's Mountlake Field Research Fund, and Princeton University's Fred Fox Class of 1939 Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayer JV., 2000, HOWE RANCH DINOSAURS, P95; Barden HE, 2011, J VERTEBR PALEONTOL, V31, P641, DOI 10.1080/02724634.2011.557112; Bro-Jorgensen J, 2007, EVOLUTION, V61, P1316, DOI 10.1111/j.1558-5646.2007.00111.x; Brusatte S. L., 2012, DINOSAUR PALEOBIOLOG, V2; Carpenter K, 2001, LIFE O PAST, P55; Carpenter K., 1990, P141, DOI 10.1017/CBO9780511608377.013; Carpenter K, 2005, LIFE O PAST, P325; Carpenter Kenneth, 2007, Journal of Paleontological Sciences, VC.07.0001, P1; Carpenter K, 2010, SWISS J GEOSCI, V103, P155, DOI 10.1007/s00015-010-0020-6; Carpenter Kenneth, 1998, Modern Geology, V23, P127; Chapman R.E., 1990, P21, DOI 10.1017/CBO9780511608377.005; Chapman Ralph E., 1997, P83; CHAPMAN RE, 1981, J PALEONTOL, V55, P608; Chinsamy-Turan A., 2005, MICROSTRUCTURE DINOS; Colbert EH., 1989, MUS NORTH ARIZ BULL, V57, P160; Currie, 1990, DINOSAUR SYSTEMATICS, P91; Czerkas S.A., 1987, P82; DEBUFFRENIL V, 1986, PALEOBIOLOGY, V12, P459, DOI 10.1017/S0094837300003171; DODSON P, 1975, SYST ZOOL, V24, P37, DOI 10.2307/2412696; DODSON P, 1976, J PALEONTOL, V50, P929; Escaso F, 2007, NATURWISSENSCHAFTEN, V94, P367, DOI 10.1007/s00114-006-0209-8; Galton P.M., 1982, Geologica et Palaeontologica, V15, P139; Galton P.M., 1991, Geologica et Palaeontologica, V25, P299; GALTON P.M., 2012, COMPLETE DINOSAUR, P482; Galton PM, 2004, DINOSAURIA, 2ND EDITION, P343; Galton Peter M., 2012, P225; Galton PM, 1999, NEUES JAHRB GEOL P-A, V213, P19, DOI 10.1127/njgpa/213/1999/19; Galton PM., 1974, B BRIT MUS NAT HIS A, V25, P1; Gilmore CW, 1914, B US NATN MUS, V89, P1; Hayashi S, 2012, PALAEONTOLOGY, V55, P145, DOI 10.1111/j.1475-4983.2011.01122.x; Hayashi S, 2009, J VERTEBR PALEONTOL, V29, P123, DOI 10.1080/02724634.2009.10010366; Hennig, 1925, PALAEONTOGRAPHICA S, V7, P101; Hone DWE, 2012, LETHAIA, V45, P139, DOI 10.1111/j.1502-3931.2011.00300.x; Horner JR, 2006, P ROY SOC B-BIOL SCI, V273, P2757, DOI 10.1098/rspb.2006.3643; Hunt Rebecca K., 2010, P447; Knell RJ, 2013, TRENDS ECOL EVOL, V28, P38, DOI 10.1016/j.tree.2012.07.015; Lehman T.M., 1990, P211, DOI 10.1017/CBO9780511608377.019; Lu JC, 2011, SCIENCE, V331, P321, DOI 10.1126/science.1197323; Maidment SCR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036904; Maidment SCR, 2008, J SYST PALAEONTOL, V6, P367, DOI 10.1017/S1477201908002459; Main RP, 2005, PALEOBIOLOGY, V31, P291, DOI 10.1666/0094-8373(2005)031[0291:TEAFOT]2.0.CO;2; Main Russell P., 2000, Journal of Vertebrate Paleontology, V20, p56A; Mallison H, 2011, PALAEONTOL ELECTRON, V14; Marsh O.C., 1877, AM J SCI, V3, P513, DOI [10.2475/ajs.s3-14.84.513, DOI 10.2475/AJS.S3-14.84.513]; PACKER C, 1983, SCIENCE, V221, P1191, DOI 10.1126/science.221.4616.1191; Padian K, 2011, J ZOOL, V283, P23, DOI 10.1111/j.1469-7998.2010.00761.x; Padian K, 2011, J ZOOL, V283, P3, DOI 10.1111/j.1469-7998.2010.00719.x; Padian K, 2013, TRENDS ECOL EVOL, V28, P249, DOI 10.1016/j.tree.2013.01.011; Paul GS, 1987, DINOSAURS PAST PRESE, V2, P4; Paul GS, 1992, GARDEN PARK PALEONTO, V3, P1; Prieto-Marquez A, 2007, J VERTEBR PALEONTOL, V27, P603, DOI 10.1671/0272-4634(2007)27[603:NEOPSA]2.0.CO;2; Redelstorff R, 2009, J VERTEBR PALEONTOL, V29, P1087, DOI 10.1671/039.029.0420; Richmond Dean R., 1996, Museum of Northern Arizona Bulletin, V60, P533; Schmude David E., 1996, Museum of Northern Arizona Bulletin, V60, P547; Siber H.-J., 2009, STEGOSAURS SAURIERMU; Stankowich T, 2009, P ROY SOC B-BIOL SCI, V276, P4329, DOI 10.1098/rspb.2009.1256; VOORHIES M R, 1969, Contributions to Geology Special Paper, P1; Wang XL, 2014, CURR BIOL, V24, P1323, DOI 10.1016/j.cub.2014.04.054	58	19	21	113	146	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123503	10.1371/journal.pone.0123503	http://dx.doi.org/10.1371/journal.pone.0123503			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901727	gold, Green Published, Green Submitted			2022-12-26	WOS:000353331500054
J	Shim, H; Chasman, DI; Smith, JD; Mora, S; Ridker, PM; Nickerson, DA; Krauss, RM; Stephens, M				Shim, Heejung; Chasman, Daniel I.; Smith, Joshua D.; Mora, Samia; Ridker, Paul M.; Nickerson, Deborah A.; Krauss, Ronald M.; Stephens, Matthew			A Multivariate Genome-Wide Association Analysis of 10 LDL Subfractions, and Their Response to Statin Treatment, in 1868 Caucasians	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; GENETIC-DETERMINANTS; THERAPY; PLASMA; LOCI; ROSUVASTATIN; TRIAL; MEN	We conducted a genome-wide association analysis of 7 subfractions of low density lipoproteins (LDLs) and 3 subfractions of intermediate density lipoproteins (IDLs) measured by gradient gel electrophoresis, and their response to statin treatment, in 1868 individuals of European ancestry from the Pharmacogenomics and Risk of Cardiovascular Disease study. Our analyses identified four previously-implicated loci (SORT1, APOE, LPA, and CETP) as containing variants that are very strongly associated with lipoprotein subfractions (log(10)Bayes Factor > 15). Subsequent conditional analyses suggest that three of these (APOE, LPA and CETP) likely harbor multiple independently associated SNPs. Further, while different variants typically showed different characteristic patterns of association with combinations of subfractions, the two SNPs in CETP show strikingly similar patterns - both in our original data and in a replication cohort - consistent with a common underlying molecular mechanism. Notably, the CETP variants are very strongly associated with LDL subfractions, despite showing no association with total LDLs in our study, illustrating the potential value of the more detailed phenotypic measurements. In contrast with these strong subfraction associations, genetic association analysis of subfraction response to statins showed much weaker signals (none exceeding log(10)Bayes Factor of 6). However, two SNPs (in APOE and LPA) previously-reported to be associated with LDL statin response do show some modest evidence for association in our data, and the subfraction response proles at the LPA SNP are consistent with the LPA association, with response likely being due primarily to resistance of Lp(a) particles to statin therapy. An additional important feature of our analysis is that, unlike most previous analyses of multiple related phenotypes, we analyzed the subfractions jointly, rather than one at a time. Comparisons of our multivariate analyses with standard univariate analyses demonstrate that multivariate analyses can substantially increase power to detect associations. Software implementing our multivariate analysis methods is available at http://stephenslab.uchicago.edu/software.html.	[Shim, Heejung; Stephens, Matthew] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Chasman, Daniel I.; Mora, Samia; Ridker, Paul M.] Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA 02115 USA; [Chasman, Daniel I.; Mora, Samia; Ridker, Paul M.] Harvard Univ, Sch Med, Boston, MA USA; [Smith, Joshua D.; Nickerson, Deborah A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Krauss, Ronald M.] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA; [Stephens, Matthew] Univ Chicago, Dept Stat, Chicago, IL 60637 USA	University of Chicago; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; University of Chicago	Krauss, RM (corresponding author), Childrens Hosp, Oakland Res Inst, 747 52nd St, Oakland, CA 94609 USA.	RKrauss@chori.org; stephens@galton.uchicago.edu		Mora, Samia/0000-0001-6283-0980; Shim, Heejung/0000-0002-1375-9310; Venkatasubramanian, Siddharth/0000-0002-5860-0768	National Institutes of Health [U19HL069757]; National Heart, Lung, and Blood Institute [HL117861]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117861, U19HL069757] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by National Institutes of Health grant U19HL069757 to RMK and MS. The replication data from JUPITER was supported by National Heart, Lung, and Blood Institute grant HL117861 to SM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MA, 2001, JAMA-J AM MED ASSOC, V286, P64, DOI 10.1001/jama.286.1.64; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Baker Allison R, 2009, BMC Proc, V3 Suppl 7, pS42; Banerjee S, 2008, GENETICS, V179, P2275, DOI 10.1534/genetics.108.088427; Barber MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009763; Berneis KK, 2002, J LIPID RES, V43, P1363, DOI 10.1194/jlr.R200004-JLR200; Campos H, 1996, ARTERIOSCL THROM VAS, V16, P794, DOI 10.1161/01.ATV.16.6.794; Caulfield MP, 2008, CLIN CHEM, V54, P1307, DOI 10.1373/clinchem.2007.100586; Chasman DI, 2012, CIRC-CARDIOVASC GENE, V5, P257, DOI 10.1161/CIRCGENETICS.111.961144; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Deshmukh HA, 2012, J LIPID RES, V53, P1000, DOI 10.1194/jlr.P021113; Dreon DM, 1997, ARTERIOSCL THROM VAS, V17, P707, DOI 10.1161/01.ATV.17.4.707; Ferreira MAR, 2009, BIOINFORMATICS, V25, P132, DOI 10.1093/bioinformatics/btn563; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Hindorff LA, CATALOG PUBLISHED GE; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Kettunen J, 2012, NAT GENET, V44, P269, DOI 10.1038/ng.1073; Kim S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000587; Kim S, 2009, BIOINFORMATICS, V25, pI204, DOI 10.1093/bioinformatics/btp218; Krauss RM, 2012, J LIPID RES, V53, P540, DOI 10.1194/jlr.M018010; Mangravite LM, 2013, NATURE, V502, P377, DOI 10.1038/nature12508; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Musunuru K, 2009, ARTERIOSCL THROM VAS, V29, P1975, DOI 10.1161/ATVBAHA.109.190405; O'Reilly PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034861; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Qi QB, 2012, EUR HEART J, V33, P325, DOI 10.1093/eurheartj/ehr350; Rader DJ, 2014, ANNU REV MED, V65, P385, DOI 10.1146/annurev-med-050311-163305; Rainwater DL, 1999, INT J OBESITY, V23, DOI [10.1038/sj.ijo.0800813, DOI 10.1038/SJ.IJ0.0800813]; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; SAKAI N, 1991, ARTERIOSCLER THROMB, V11, P71, DOI 10.1161/01.ATV.11.1.71; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Simon JA, 2006, AM J CARDIOL, V97, P843, DOI 10.1016/j.amjcard.2005.09.134; Stephens M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065245; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thompson JF, 2009, CIRC-CARDIOVASC GENE, V2, P173, DOI 10.1161/CIRCGENETICS.108.818062; Verzilli CJ, 2005, GENET EPIDEMIOL, V28, P313, DOI 10.1002/gepi.20072; Wakefield J, 2009, GENET EPIDEMIOL, V33, P79, DOI 10.1002/gepi.20359; Williams PT, 2014, ATHEROSCLEROSIS, V233, P713, DOI 10.1016/j.atherosclerosis.2014.01.034; WILLIAMS PT, 1992, J LIPID RES, V33, P765; Zhang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006502	43	146	146	8	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0120758	10.1371/journal.pone.0120758	http://dx.doi.org/10.1371/journal.pone.0120758			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898129	Green Published, Green Submitted, gold			2022-12-26	WOS:000353212600006
J	Webster, FJ; Babcock, RC; Van Keulen, M; Loneragan, NR				Webster, Fiona J.; Babcock, Russell C.; Van Keulen, Mike; Loneragan, Neil R.			Macroalgae Inhibits Larval Settlement and Increases Recruit Mortality at Ningaloo Reef, Western Australia	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CORAL-REEFS; PHASE-SHIFTS; CLIMATE-CHANGE; SCLERACTINIAN CORALS; COMMUNITY STRUCTURE; JUVENILE CORALS; ALGAL TURFS; MARINE PARK; RESILIENCE	Globally, many coral reefs are degraded and demonstrate reduced coral cover and increased macroalgal abundance. While negative correlations between macroalgae and coral recruitment have commonly been documented, the mechanisms by which macroalgae affects recruitment have received little attention. Here we examined the effect of macroalgae on larval settlement and the growth and survival of coral recruits, in a field experiment over nine months. Exclusion treatments were used to manipulate herbivory and macroalgal biomass, while settlement tiles measured coral settlement and survival. After nine months the volume of macroalgae was up to 40 times greater in the caged treatments than in controls and the settlement of coral larvae on the undersides of tiles within caged plots was 93% lower than in the uncaged treatments. The growth and survival of coral recruits was also severely reduced in the presence of macroalgae: survival was 79% lower in caged treatments and corals were up to 58% smaller with 75% fewer polyps. These data indicate that macroalgae has an additive effect on coral recruitment by reducing larval settlement and increasing recruit mortality. This research demonstrates that macroalgae can not only inhibit coral recruitment, but also potentially maintain dominance through a positive feedback system.	[Webster, Fiona J.; Van Keulen, Mike] Murdoch Univ, Sch Biol Sci & Biotechnol, Perth, WA 6849, Australia; [Babcock, Russell C.] CSIRO, Marine & Atmospher Res, Cleveland Marine Labs, Cleveland, Qld 4163, Australia; [Loneragan, Neil R.] Murdoch Univ, Ctr Fish Fisheries & Aquat Ecosyst Res, Perth, WA 6849, Australia	Murdoch University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Murdoch University	Webster, FJ (corresponding author), Murdoch Univ, Sch Biol Sci & Biotechnol, GPO Box S1400, Perth, WA 6849, Australia.	fiwebster001@hotmail.com	Loneragan, Neil/A-3386-2008; van Keulen, Mike/Q-9856-2019; Babcock, Russell C/A-3794-2012	Loneragan, Neil/0000-0003-2536-8656; van Keulen, Mike/0000-0001-6235-5788; Babcock, Russell C/0000-0002-7756-1290	Department of Environment and Conservation (Exmouth branch); North West Research Association; Australian Federation of University Women (Western Australian Branch)	Department of Environment and Conservation (Exmouth branch); North West Research Association; Australian Federation of University Women (Western Australian Branch)	We are deeply grateful to the Department of Environment and Conservation (Exmouth branch) and the North West Research Association for providing financial support and facilities. We also acknowledge the Australian Federation of University Women (Western Australian Branch) for funding. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, GUIDE SOFTWARE STAT; Arnold SN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028681; Arnold SN, 2010, MAR ECOL PROG SER, V414, P91, DOI 10.3354/meps08724; ATKINSON MJ, 1992, LIMNOL OCEANOGR, V37, P273, DOI 10.4319/lo.1992.37.2.0273; BABCOCK RC, 1986, CORAL REEFS, V5, P111, DOI 10.1007/BF00298178; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Birrell CL, 2008, OCEANOGR MAR BIOL, V46, P25; Birrell CL, 2005, MAR POLLUT BULL, V51, P408, DOI 10.1016/j.marpolbul.2004.10.022; Box SJ, 2007, MAR ECOL PROG SER, V342, P139, DOI 10.3354/meps342139; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; Burkepile DE, 2013, SCI REP-UK, V3, DOI 10.1038/srep01493; Clarke K.R, 2006, PRIMER 6; Connell JH, 2004, ECOL MONOGR, V74, P179, DOI 10.1890/02-4043; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Diaz-Pulido G, 2002, MAR ECOL PROG SER, V232, P115, DOI 10.3354/meps232115; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; Doropoulos C, 2013, MAR ECOL PROG SER, V486, P153, DOI 10.3354/meps10325; Doropoulos C, 2012, ECOLOGY, V93, P2131, DOI 10.1890/12-0495.1; Edmunds PJ, 2001, P NATL ACAD SCI USA, V98, P5067, DOI 10.1073/pnas.071524598; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Finelli CM, 2006, CORAL REEFS, V25, P47, DOI 10.1007/s00338-005-0055-8; Foster NL, 2008, MAR ECOL PROG SER, V367, P143, DOI 10.3354/meps07594; Freeman LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082404; Graham EM, 2008, CORAL REEFS, V27, P529, DOI 10.1007/s00338-008-0361-z; Halford A, 2004, ECOLOGY, V85, P1892, DOI 10.1890/03-4017; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoey AS, 2011, ECOL LETT, V14, P267, DOI 10.1111/j.1461-0248.2010.01581.x; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1989, ECOLOGY, V70, P275, DOI 10.2307/1938434; HUGHES TP, 1985, ECOL MONOGR, V55, P141, DOI 10.2307/1942555; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; HUNTER CL, 1995, B MAR SCI, V57, P501; Johansson CL, 2010, MAR ECOL PROG SER, V414, P65, DOI 10.3354/meps08730; Kuffner IB, 2006, MAR ECOL PROG SER, V323, P107, DOI 10.3354/meps323107; Ledlie MH, 2007, CORAL REEFS, V26, P641, DOI 10.1007/s00338-007-0230-1; McClanahan TR, 2001, CORAL REEFS, V19, P380, DOI 10.1007/s003380000133; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; Miller K, 2003, CORAL REEFS, V22, P99, DOI 10.1007/s00338-003-0290-9; Mumby PJ, 2013, CORAL REEFS, V32, P213, DOI 10.1007/s00338-012-0966-0; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Muscatine, 1990, CORAL REEFS, V25, P1; Paul VJ, 2011, MAR ECOL PROG SER, V426, P161, DOI 10.3354/meps09032; Penin L, 2010, MAR ECOL PROG SER, V408, P55, DOI 10.3354/meps08554; Rasher DB, 2010, P NATL ACAD SCI USA, V107, P9683, DOI 10.1073/pnas.0912095107; Ritson-Williams R, 2014, CORAL REEFS, V33, P59, DOI 10.1007/s00338-013-1113-2; Roff G, 2012, TRENDS ECOL EVOL, V27, P404, DOI 10.1016/j.tree.2012.04.007; SAMMARCO PW, 1980, J EXP MAR BIOL ECOL, V45, P245, DOI 10.1016/0022-0981(80)90061-1; Sebens KP, 1997, P 8 INT COR REEF S, P1053; Sheppard CRC, 2003, NATURE, V425, P294, DOI 10.1038/nature01987; Smallwood CB, 2012, FISH RES, V125, P40, DOI 10.1016/j.fishres.2012.01.019; Smallwood CB, 2011, OCEAN COAST MANAGE, V54, P330, DOI 10.1016/j.ocecoaman.2010.11.007; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Steneck RS, 2014, MAR ECOL PROG SER, V506, P115, DOI 10.3354/meps10764; TANNER JE, 1995, J EXP MAR BIOL ECOL, V190, P151, DOI 10.1016/0022-0981(95)00027-O; Trapon ML, 2013, CORAL REEFS, V32, P1051, DOI 10.1007/s00338-013-1059-4; Venera-Ponton DE, 2011, MAR ECOL PROG SER, V421, P109, DOI 10.3354/meps08869; Verges A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017115; Vermeij MJA, 2009, OECOLOGIA, V159, P325, DOI 10.1007/s00442-008-1223-7; Vermeij MJA, 2008, ECOLOGY, V89, P1994, DOI 10.1890/07-1296.1; Vermeij MJA, 2006, CORAL REEFS, V25, P59, DOI 10.1007/s00338-005-0056-7; Vroom PS, 2006, AM SCI, V94, P430, DOI 10.1511/2006.61.1004; Webster FW, 2008, THESIS MURDOCH U; Westera M, 2003, J EXP MAR BIOL ECOL, V294, P145, DOI 10.1016/S0022-0981(03)00268-5; Wismer S, 2009, MAR ECOL PROG SER, V376, P45, DOI 10.3354/meps07790	66	43	43	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124162	10.1371/journal.pone.0124162	http://dx.doi.org/10.1371/journal.pone.0124162			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898011	gold, Green Published, Green Submitted			2022-12-26	WOS:000353212600053
J	Cueto, JA; Rodriguez, C; Vega, IA; Castro-Vazquez, A				Cueto, Juan A.; Rodriguez, Cristian; Vega, Israel A.; Castro-Vazquez, Alfredo			Immune Defenses of the Invasive Apple Snail Pomacea canaliculata (Caenogastropoda, Ampullariidae): Phagocytic Hemocytes in the Circulation and the Kidney	PLOS ONE			English	Article							FRESH-WATER SNAIL; VIVIPARUS-ATER GASTROPODA; ANGIOSTRONGYLUS-CANTONENSIS; BIOMPHALARIA-GLABRATA; MERCENARIA-MERCENARIA; LYMNAEA-STAGNALIS; CELLS; PROSOBRANCHIA; HEMATOPOIESIS; GRANULOCYTES	Hemocytes in the circulation and kidney islets, as well as their phagocytic responses to microorganisms and fluorescent beads, have been studied in Pomacea canaliculata, using flow cytometry, light microscopy (including confocal laser scanning microscopy) and transmission electron microscopy (TEM). Three circulating hemocyte types (hyalinocytes, agranulocytes and granulocytes) were distinguished by phase contrast microscopy of living cells and after light and electron microscopy of fixed material. Also, three different populations of circulating hemocytes were separated by flow cytometry, which corresponded to the three hemocyte types. Hyalinocytes showed a low nucleus/cytoplasm ratio, and no apparent granules in stained material, but showed granules of moderate electron density under TEM (L granules) and at least some L granules appear acidic when labeled with LysoTracker Red. Both phagocytic and non-phagocytic hyalinocytes lose most (if not all) L granules when exposed to microorganisms in vitro. The phagosomes formed differed whether hyalinocytes were exposed to yeasts or to Gram positive or Gram negative bacteria. Agranulocytes showed a large nucleus/cytoplasm ratio and few or no granules. Granulocytes showed a low nucleus/cytoplasm ratio and numerous eosinophilic granules after staining. These granules are electron dense and rod-shaped under TEM (R granules). Granulocytes may show merging of R granules into gigantic ones, particularly when exposed to microorganisms. Fluorescent bead exposure of sorted hemocytes showed phagocytic activity in hyalinocytes, agranulocytes and granulocytes, but the phagocytic index was significantly higher in hyalinocytes. Extensive hemocyte aggregates ('islets') occupy most renal hemocoelic spaces and hyalinocyte-like cells are the most frequent component in them. Presumptive glycogen deposits were observed in most hyalinocytes in renal islets (they also occur in the circulation but less frequently) and may mean that hyalinocytes participate in the storage and circulation of this compound. Injection of microorganisms in the foot results in phagocytosis by hemocytes in the islets, and the different phagosomes formed are similar to those in circulating hyalinocytes. Dispersed hemocytes were obtained after kidney collagenase digestion and cell sorting, and they were able to phagocytize fluorescent beads. A role for the kidney as an immune barrier is proposed for this snail.	[Cueto, Juan A.; Rodriguez, Cristian; Vega, Israel A.; Castro-Vazquez, Alfredo] Univ Nacl Cuyo, Fac Ciencias Med, Inst Fisiol, RA-5500 Mendoza, Argentina; [Cueto, Juan A.; Rodriguez, Cristian; Vega, Israel A.; Castro-Vazquez, Alfredo] Consejo Nacl Invest Cient & Tecn, Inst Histol Embriol Dr Mario H Burgos, Mendoza, Argentina; [Rodriguez, Cristian; Vega, Israel A.; Castro-Vazquez, Alfredo] Univ Nacl Cuyo, Fac Ciencias Exactas & Nat, Area Biol, RA-5500 Mendoza, Argentina	University Nacional Cuyo Mendoza; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza	Castro-Vazquez, A (corresponding author), Univ Nacl Cuyo, Fac Ciencias Med, Inst Fisiol, RA-5500 Mendoza, Argentina.	acastrovazquez@gmail.com		Rodriguez, Cristian/0000-0003-3289-4187	Agencia Nacional de Promocion Cientifica y Tecnologica; Consejo Nacional de Investigaciones Cientificas y Tecnicas; Universidad Nacional de Cuyo; Malacological Society of London	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad Nacional de Cuyo; Malacological Society of London	This paper was funded by grants from Agencia Nacional de Promocion Cientifica y Tecnologica (www.agencia.mincyt.gob.ar), Consejo Nacional de Investigaciones Cientificas y Tecnicas (www.conicet.gov.ar) and Universidad Nacional de Cuyo (www.uncu.edu.ar) to ACV and IAV, and a grant from the Malacological Society of London to JAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accorsi A, 2013, FISH SHELLFISH IMMUN, V34, P1260, DOI 10.1016/j.fsi.2013.02.008; ADEMA CM, 1992, J INVERTEBR PATHOL, V59, P24, DOI 10.1016/0022-2011(92)90107-F; Andrews E. B., 1965, Journal of Zoology London, V146, P70; ANDREWS EB, 1981, J MOLLUS STUD, V47, P248; Bayne C.J., 1983, P407; Cerenius L, 2010, ADV EXP MED BIOL, V708, P239; Cheng T.C., 1981, INVERTEBRATE BLOOD C, V1, P233; CHENG TC, 1975, J INVERTEBR PATHOL, V25, P261, DOI 10.1016/0022-2011(75)90076-2; CHENG TC, 1975, ANN NY ACAD SCI, V266, P343, DOI 10.1111/j.1749-6632.1975.tb35116.x; CHENG TC, 1977, J INVERTEBR PATHOL, V30, P119, DOI 10.1016/0022-2011(77)90052-0; Ciacci C, 2009, COMP BIOCHEM PHYS B, V153, P365, DOI 10.1016/j.cbpb.2009.04.007; Cowie Robert H, 2013, Hawaii J Med Public Health, V72, P3; Crozatier M, 2011, DIS MODEL MECH, V4, P439, DOI 10.1242/dmm.007351; Cueto JA, 2013, FISH SHELLFISH IMMUN, V34, P443, DOI 10.1016/j.fsi.2012.11.035; Cueto JA, 2011, MOLLUSCAN RES, V31, P57; Fisher W.S., 1986, P25; FOLEY DA, 1977, J INVERTEBR PATHOL, V29, P321, DOI 10.1016/S0022-2011(77)80037-2; FRANCHINI A, 1990, J INVERTEBR PATHOL, V55, P28, DOI 10.1016/0022-2011(90)90028-5; Franchini A, 2000, TISSUE CELL, V32, P312, DOI 10.1054/tice.2000.0118; Giraud-Billoud M, 2013, J EXP BIOL, V216, P614, DOI 10.1242/jeb.075655; Giraud-Billoud M, 2011, COMP BIOCHEM PHYS A, V158, P506, DOI 10.1016/j.cbpa.2010.12.012; Godoy A, 1997, MEM I OSWALDO CRUZ, V92, P121, DOI 10.1590/S0074-02761997000100026; Hayes KA, 2008, DIVERS DISTRIB, V14, P701, DOI 10.1111/j.1472-4642.2008.00483.x; Hayes KA, 2012, ZOOL J LINN SOC-LOND, V166, P723, DOI 10.1111/j.1096-3642.2012.00867.x; Hyman L., 1967, INVERTEBRATES; Lemos QT, 2001, MEM I OSWALDO CRUZ, V96, P719, DOI 10.1590/S0074-02762001000500025; Loker ES, 2010, ADV EXP MED BIOL, V708, P17; Lv S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000368; Mahilini HM, 2008, J INVERTEBR PATHOL, V97, P20, DOI 10.1016/j.jip.2007.07.007; Martin GG, 2007, J MOLLUS STUD, V73, P355, DOI 10.1093/mollus/eym032; MOHANDAS A, 1985, J INVERTEBR PATHOL, V46, P189, DOI 10.1016/0022-2011(85)90148-X; Morassutti AL, 2014, MEM I OSWALDO CRUZ, V109, P399, DOI 10.1590/0074-0276140023; Mount AS, 2004, SCIENCE, V304, P297, DOI 10.1126/science.1090506; OTTAVIANI E, 1983, DEV COMP IMMUNOL, V7, P209, DOI 10.1016/0145-305X(83)90002-2; OTTAVIANI E, 1992, CELL MOL NEUROBIOL, V12, P455, DOI 10.1007/BF00711546; Ottaviani E, 1996, PROG NEUROBIOL, V48, P421, DOI 10.1016/0301-0082(95)00049-6; OTTAVIANI E, 1988, ACTA ZOOL-STOCKHOLM, V69, P157, DOI 10.1111/j.1463-6395.1988.tb00912.x; OTTAVIANI E, 1991, TISSUE CELL, V23, P317, DOI 10.1016/0040-8166(91)90049-Y; Pickett JA, 2006, TRAFFIC, V7, P109, DOI 10.1111/j.1600-0854.2005.00372.x; Ray M, 2013, FISH SHELLFISH IMMUN, V34, P244, DOI 10.1016/j.fsi.2012.11.006; Rebelo MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057384; REVEL JP, 1960, J BIOPHYS BIOCHEM CY, V8, P575, DOI 10.1083/jcb.8.3.575; RODRIGUEZ C., 2012, BIOCELL, V36, pA113; SAKHAROV DA, 1989, ACTA BIOL HUNG, V40, P329; Scott M. I. H., 1958, Revista del Museo Argentino de las Ciencias Naturales Zool, V3, P233; SHOZAWA A, 1990, DEV COMP IMMUNOL, V14, P175, DOI 10.1016/0145-305X(90)90089-W; SMINIA T, 1974, CELL TISSUE RES, V153, P307, DOI 10.1007/BF00229161; Sminia T, 1972, CELL TISSUE RES, V130, P497; Sminia T, 1981, INVERTEBRATE BLOOD C, P191; Soderhall I, 2003, DEV COMP IMMUNOL, V27, P661, DOI 10.1016/S0145-305X(03)00039-9; Thiengo Silvana Carvalho, 2013, Hawaii J Med Public Health, V72, P18; Travers MA, 2008, FISH SHELLFISH IMMUN, V24, P400, DOI 10.1016/j.fsi.2007.10.001; YOUSIF F, 1980, Z PARASITENKD, V62, P179, DOI 10.1007/BF00927863	54	40	40	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123964	10.1371/journal.pone.0123964	http://dx.doi.org/10.1371/journal.pone.0123964			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893243	gold, Green Submitted, Green Published			2022-12-26	WOS:000353211700065
J	Li, XT; Li, XQ; Hu, XM; Qiu, XY				Li, Xian-Tao; Li, Xiao-Qing; Hu, Xi-Mu; Qiu, Xiao-Yue			The Inhibitory Effects of Ca2+ Channel Blocker Nifedipine on Rat Kv2.1 Potassium Channels	PLOS ONE			English	Article							SHAKER K+ CHANNEL; DELAYED RECTIFIER; TRANSIENT OUTWARD; VOLTAGE SENSOR; MESSENGER-RNA; HUMAN HEART; CURRENTS; EXPRESSION; INACTIVATION; MECHANISMS	It is well documented that nifedipine, a commonly used dihydropyridine Ca2+ channel blocker, has also significant interactions with voltage-gated K+ (Kv) channels. But to date, little is known whether nifedipine exerted an action on Kv2.1 channels, a member of the Shab subfamily with slow inactivation. In the present study, we explored the effects of nifedipine on rat Kv2.1 channels expressed in HEK293 cells. Data from whole-cell recording showed that nifedipine substantially reduced Kv2.1 currents with the IC50 value of 37.5 +/- 5.7 mu M and delayed the time course of activation without effects on the activation curve. Moreover, this drug also significantly shortened the duration of inactivation and deactivation of Kv2.1 currents in a voltage-dependent manner. Interestingly, the half-maximum inactivation potential (V1/2) of Kv2.1 currents was -11.4 +/- 0.9 mV in control and became -38.5 +/- 0.4 mV after application of 50 mu M nifedipine. The large hyperpolarizing shift (27 mV) of the inactivation curve has not been reported previously and may result in more inactivation for outward delayed rectifier K+ currents mediated by Kv2.1 channels at repolarization phases. The Y380R mutant significantly increased the binding affinity of nifedipine to Kv2.1 channels, suggesting an interaction of nifedipine with the outer mouth region of this channel. The data present here will be helpful to understand the diverse effects exerted by nifedipine on various Kv channels.	[Li, Xian-Tao; Li, Xiao-Qing] South Cent Univ Nationalities, Coll Life Sci, Dept Neurosci, Wuhan, Peoples R China; [Hu, Xi-Mu; Qiu, Xiao-Yue] South Cent Univ Nationalities, Wuhan, Peoples R China	South Central Minzu University; South Central Minzu University	Li, XT (corresponding author), South Cent Univ Nationalities, Coll Life Sci, Dept Neurosci, Wuhan, Peoples R China.	xiantaoli@outlook.com						BARRY DM, 1995, CIRC RES, V77, P361, DOI 10.1161/01.RES.77.2.361; Bett GCL, 2006, BIOCHEM BIOPH RES CO, V340, P1167, DOI 10.1016/j.bbrc.2005.12.135; Bezanilla F, 2002, J GEN PHYSIOL, V120, P465, DOI 10.1085/jgp.20028660; Brahmajothi MV, 1996, CIRC RES, V78, P1083, DOI 10.1161/01.RES.78.6.1083; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; Cheng YM, 2011, BIOPHYS J, V101, P651, DOI 10.1016/j.bpj.2011.06.025; De Leeuw PW, 2002, BLOOD PRESSURE, V11, P71; Dixon JE, 1996, EUR J NEUROSCI, V8, P183, DOI 10.1111/j.1460-9568.1996.tb01179.x; DREWE JA, 1992, J NEUROSCI, V12, P538; Du J, 2000, J PHYSIOL-LONDON, V522, P19, DOI 10.1111/j.1469-7793.2000.t01-2-00019.xm; FEDIDA D, 1993, CIRC RES, V73, P210, DOI 10.1161/01.RES.73.1.210; Feng JL, 1997, J PHARMACOL EXP THER, V281, P384; Frolov RV, 2010, BRIT J PHARMACOL, V159, P405, DOI 10.1111/j.1476-5381.2009.00539.x; Gandhi CS, 2002, J GEN PHYSIOL, V120, P455, DOI 10.1085/jgp.20028678; Gao Z, 2005, BRIT J PHARMACOL, V144, P595, DOI 10.1038/sj.bjp.0706113; GOTOH Y, 1991, AM J PHYSIOL, V260, pH1737, DOI 10.1152/ajpheart.1991.260.5.H1737; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; JACOBS ER, 1990, J PHARMACOL EXP THER, V255, P459; JAHNEL U, 1994, N-S ARCH PHARMACOL, V349, P87; Kerschensteiner D, 2003, J BIOL CHEM, V278, P18154, DOI 10.1074/jbc.M213117200; Klemic KG, 1998, BIOPHYS J, V74, P1779, DOI 10.1016/S0006-3495(98)77888-9; Kodirov SA, 2004, AM J PHYSIOL-HEART C, V286, pH368, DOI 10.1152/ajpheart.00303.2003; Koidl B, 1997, EUR J PHARMACOL, V322, P243, DOI 10.1016/S0014-2999(96)00995-8; Kumar S, 2003, DRUG AGING, V20, P805, DOI 10.2165/00002512-200320110-00002; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Lin S, 2001, AM J PHYSIOL-HEART C, V280, pH1160, DOI 10.1152/ajpheart.2001.280.3.H1160; Malin SA, 2002, J NEUROSCI, V22, P10094; Milligan CJ, 2000, BIOPHYS J, V78, P1852, DOI 10.1016/S0006-3495(00)76734-8; Milnes JT, 2003, FEBS LETT, V547, P20, DOI 10.1016/S0014-5793(03)00662-8; Misonou H, 2005, NEUROTOXICOLOGY, V26, P743, DOI 10.1016/j.neuro.2005.02.003; Mohapatra DP, 2006, J NEUROSCI, V26, P685, DOI 10.1523/JNEUROSCI.4620-05.2006; Nerbonne JM, 2001, CIRC RES, V89, P944, DOI 10.1161/hh2301.100349; Rasmusson RL, 1998, CIRC RES, V82, P739, DOI 10.1161/01.RES.82.7.739; RODEN DM, 1993, AM J CARDIOL, V72, pB44, DOI 10.1016/0002-9149(93)90040-J; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; Scholle A, 2004, BIOPHYS J, V87, P873, DOI 10.1529/biophysj.104.040550; SLAWSKY MT, 1994, J PHARMACOL EXP THER, V269, P66; Starace DM, 1997, NEURON, V19, P1319, DOI 10.1016/S0896-6273(00)80422-5; TAMKUN MM, 1991, FASEB J, V5, P331, DOI 10.1096/fasebj.5.3.2001794; Tammaro P, 2005, EUR BIOPHYS J BIOPHY, V34, P42, DOI 10.1007/s00249-004-0423-2; TRIMMER JS, 1993, FEBS LETT, V324, P205, DOI 10.1016/0014-5793(93)81394-F; UEHARA A, 1985, J GEN PHYSIOL, V85, P621, DOI 10.1085/jgp.85.5.621; VANDONGEN AMJ, 1990, NEURON, V5, P433, DOI 10.1016/0896-6273(90)90082-Q; Vega-Saenz de Miera E, 2004, MOL BRAIN RES, V123, P91, DOI 10.1016/j.molbrainres.2004.01.004; Wang SM, 2003, J PHYSIOL-LONDON, V546, P387, DOI 10.1113/jphysiol.2002.029512; White William B, 2003, Clin Cardiol, V26, pII7; Xu HD, 1999, CIRC RES, V85, P623, DOI 10.1161/01.RES.85.7.623; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; Yi BA, 2001, P NATL ACAD SCI USA, V98, P11016, DOI 10.1073/pnas.191351798; Zhang ST, 1999, CIRC RES, V84, P989, DOI 10.1161/01.RES.84.9.989; Zhang X, 1997, J PHARMACOL EXP THER, V281, P1247; Zhang XL, 2009, NEUROSCIENCE, V161, P184, DOI 10.1016/j.neuroscience.2009.03.012	53	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124602	10.1371/journal.pone.0124602	http://dx.doi.org/10.1371/journal.pone.0124602			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893973	gold, Green Published, Green Submitted			2022-12-26	WOS:000353211700108
J	Speiser, JL; Lee, WM; Karvellas, CJ				Speiser, Jaime Lynn; Lee, William M.; Karvellas, Constantine J.		US Acute Liver Failure Study Grp	Predicting Outcome on Admission and Post-Admission for Acetaminophen-Induced Acute Liver Failure Using Classification and Regression Tree Models	PLOS ONE			English	Article							TRANSPLANTATION; SURVIVAL	Background/Aim Assessing prognosis for acetaminophen-induced acute liver failure (APAP-ALF) patients often presents significant challenges. King's College (KCC) has been validated on hospital admission, but little has been published on later phases of illness. We aimed to improve determinations of prognosis both at the time of and following admission for APAP-ALF using Classification and Regression Tree (CART) models. Methods CART models were applied to US ALFSG registry data to predict 21-day death or liver transplant early (on admission) and post-admission (days 3-7) for 803 APAP-ALF patients enrolled 01/1998-09/2013. Accuracy in prediction of outcome (AC), sensitivity (SN), specificity (SP), and area under receiver-operating curve (AUROC) were compared between 3 models: KCC (INR, creatinine, coma grade, pH), CART analysis using only KCC variables (KCC-CART) and a CART model using new variables (NEW-CART). Results Traditional KCC yielded 69% AC, 90% SP, 27% SN, and 0.58 AUROC on admission, with similar performance post-admission. KCC-CART at admission offered predictive 66% AC, 65% SP, 67% SN, and 0.74 AUROC. Post-admission, KCC-CART had predictive 82% AC, 86% SP, 46% SN and 0.81 AUROC. NEW-CART models using MELD (Model for end stage liver disease), lactate and mechanical ventilation on admission yielded predictive 72% AC, 71% SP, 77% SN and AUROC 0.79. For later stages, NEW-CART (MELD, lactate, coma grade) offered predictive AC 86%, SP 91%, SN 46%, AUROC 0.73. Conclusion CARTs offer simple prognostic models for APAP-ALF patients, which have higher AUROC and SN than KCC, with similar AC and negligibly worse SP. Admission and post-admission predictions were developed.	[Speiser, Jaime Lynn] Med Univ S Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Lee, William M.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Digest & Liver Dis, Dallas, TX 75390 USA; [Karvellas, Constantine J.] Univ Alberta, Div Hepatol & Crit Care Med, Edmonton, AB, Canada	Medical University of South Carolina; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Alberta	Karvellas, CJ (corresponding author), Univ Alberta, Div Hepatol & Crit Care Med, Edmonton, AB, Canada.	dean.karvellas@ualberta.ca		Karvellas, Constantine/0000-0002-1555-1089	National Institutes of Health (from National Institute of Diabetes and Digestive and Kidney Diseases) [U-01 58369]	National Institutes of Health (from National Institute of Diabetes and Digestive and Kidney Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was sponsored by the National Institutes of Health grant U-01 58369 (from National Institute of Diabetes and Digestive and Kidney Diseases). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar FS, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-40; Antoniades CG, 2008, J HEPATOL, V49, P845, DOI 10.1016/j.jhep.2008.08.009; ATTERBURY CE, 1978, AM J DIG DIS, V23, P398, DOI 10.1007/BF01072921; Audimoolam VK, 2014, CRIT CARE MED, V42, P592, DOI 10.1097/01.ccm.0000435666.15070.d5; Bernal W, 2002, LANCET, V359, P558, DOI 10.1016/S0140-6736(02)07743-7; Bernal W, 2010, LANCET, V376, P190, DOI 10.1016/S0140-6736(10)60274-7; Bernuau J, 1990, Rev Prat, V40, P1652; Breiman L, 1984, CLASSIFICATION AND R; Clemmesen JO, 1999, HEPATOLOGY, V29, P648, DOI 10.1002/hep.510290309; Fagan E, 1996, BRIT MED J, V313, P1417, DOI 10.1136/bmj.313.7070.1417; Garzotto M, 2005, J CLIN ONCOL, V23, P4322, DOI 10.1200/JCO.2005.11.136; GORDON L, 1985, CANCER TREAT REP, V69, P1065; Hubbard AE, 2010, EPIDEMIOLOGY, V21, P467, DOI 10.1097/EDE.0b013e3181caeb90; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Karvellas CJ, 2010, LIVER INT, V30, P826, DOI 10.1111/j.1478-3231.2010.02243.x; Koch DG, 2012, HEPATOLOGY, V56, p964A; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; Nakayama N, 2012, J GASTROENTEROL, V47, P664, DOI 10.1007/s00535-012-0529-8; OGRADY JG, 1993, LANCET, V342, P273; OGRADY JG, 1989, GASTROENTEROLOGY, V97, P439, DOI 10.1016/0016-5085(89)90081-4; PAUWELS A, 1993, J HEPATOL, V17, P124, DOI 10.1016/S0168-8278(05)80532-X; Reddy KR, 2012, HEPATOLOGY, V56, p246A; Schmidt LE, 2007, HEPATOLOGY, V45, P789, DOI 10.1002/hep.21503; Schmidt LE, 2002, HEPATOLOGY, V36, P659, DOI 10.1053/jhep.2002.35069; Shakil AO, 2000, LIVER TRANSPLANT, V6, P163, DOI 10.1016/S1527-6465(00)80005-2; Simpson KJ, 2009, LIVER TRANSPLANT, V15, P600, DOI 10.1002/lt.21681; Sing T., 2005, BIOINFORMATICS, V21; Stravitz RT, 2007, CRIT CARE MED, V35, P2498, DOI 10.1097/01.CCM.0000287592.94554.5F; Team RDC, 2019, R LANG ENV STAT COMP; Therneau TM., 2015, INTRO RECURSIVE PART	30	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0122929	10.1371/journal.pone.0122929	http://dx.doi.org/10.1371/journal.pone.0122929			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885260	Green Published, Green Submitted, gold			2022-12-26	WOS:000353017000044
J	Zhang, CJ; Hou, YQ; Hao, QN; Chen, HF; Chen, LM; Yuan, SL; Shan, ZH; Zhang, XJ; Yang, ZL; Qiu, DZ; Zhou, XA; Huang, WJ				Zhang, Chanjuan; Hou, Yuqing; Hao, Qingnan; Chen, Haifeng; Chen, Limiao; Yuan, Songli; Shan, Zhihui; Zhang, Xiaojuan; Yang, Zhonglu; Qiu, Dezhen; Zhou, Xinan; Huang, Wenjun			Genome-Wide Survey of the Soybean GATA Transcription Factor Gene Family and Expression Analysis under Low Nitrogen Stress	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; CHLOROPHYLL BIOSYNTHESIS; MEDIATED TRANSFORMATION; CHLOROPLAST DEVELOPMENT; REGULATORY ELEMENTS; NEUROSPORA-CRASSA; REDUCTASE GENE; ARABIDOPSIS; LIGHT; PATTERNS	GATA transcription factors are transcriptional regulatory proteins that contain a characteristic type-IV zinc finger DNA-binding domain and recognize the conserved GATA motif in the promoter sequence of target genes. Previous studies demonstrated that plant GATA factors possess critical functions in developmental control and responses to the environment. To date, the GATA factors in soybean (Glycine max) have yet to be characterized. Thus, this study identified 64 putative GATA factors from the entire soybean genomic sequence. The chromosomal distributions, gene structures, duplication patterns, phylogenetic tree, tissue expression patterns, and response to low nitrogen stress of the 64 GATA factors in soybean were analyzed to further investigate the functions of these factors. Results indicated that segmental duplication predominantly contributed to the expansion of the GATA factor gene family in soybean. These GATA proteins were phylogenetically clustered into four distinct subfamilies, wherein their gene structure and motif compositions were considerably conserved. A comparative phylogenetic analysis of the GATA factor zinc finger domain sequences in soybean, Arabidopsis (Arabidopsis thaliana), and rice (Oryza sativa) revealed four major classes. The GATA factors in soybean exhibited expression diversity among different tissues; some of these factors showed tissue-specific expression patterns. Numerous GATA factors displayed upregulation or downregulation in soybean leaf in response to low nitrogen stress, and two GATA factors GATA44 and GATA58 were likely to be involved in the regulation of nitrogen metabolism in soybean. Overexpression of GmGATA44 complemented the reduced chlorophyll phenotype of the Arabidopsis ortholog AtGATA21 mutant, implying that GmGATA44 played an important role in modulating chlorophyll biosynthesis. Overall, our study provides useful information for the further analysis of the biological functions of GATA factors in soybean and other crops.	[Zhang, Chanjuan; Hou, Yuqing; Hao, Qingnan; Chen, Haifeng; Chen, Limiao; Yuan, Songli; Shan, Zhihui; Zhang, Xiaojuan; Yang, Zhonglu; Qiu, Dezhen; Zhou, Xinan] Chinese Acad Agr Sci, Key Lab Oil Crop Biol, Minist Agr, Oil Crops Res Inst, Wuhan, Peoples R China; [Huang, Wenjun] Chinese Acad Sci, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan Bot Garden, Wuhan, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Wuhan Botanical Garden, CAS	Zhou, XA (corresponding author), Chinese Acad Agr Sci, Key Lab Oil Crop Biol, Minist Agr, Oil Crops Res Inst, Wuhan, Peoples R China.	zhouxinan@caas.cn; wjhuang@wbgcas.cn	HUANG, WENJUN/GXM-9167-2022	Yuan, Songli/0000-0001-8558-1454	National Transgenic Project [2014ZX08004-005]; Agricultural Science and Technology Innovation Program; National Natural Science Foundation of China [31201153]	National Transgenic Project; Agricultural Science and Technology Innovation Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Transgenic Project (No. 2014ZX08004-005), Agricultural Science and Technology Innovation Program, and National Natural Science Foundation of China (No. 31201153). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasinghe BHRR, 1998, PLANTA, V206, P44, DOI 10.1007/s004250050372; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bi YM, 2005, PLANT J, V44, P680, DOI 10.1111/j.1365-313X.2005.02568.x; BUZBY JS, 1990, PLANT CELL, V2, P805, DOI 10.1105/tpc.2.8.805; Cannon Ethalinda K S, 2011, Int J Plant Genomics, V2011, P373875, DOI 10.1155/2011/373875; Carre IA, 1995, PLANT CELL, V7, P2039, DOI 10.2307/3870149; CASTRESANA C, 1988, EMBO J, V7, P1929, DOI 10.1002/j.1460-2075.1988.tb03030.x; Chiang YH, 2012, PLANT PHYSIOL, V160, P332, DOI 10.1104/pp.112.198705; DANIELVEDELE F, 1993, MOL GEN GENET, V240, P365, DOI 10.1007/BF00280388; Eckhardt U, 2004, PLANT MOL BIOL, V56, P1, DOI 10.1007/s11103-004-2331-3; FU YH, 1990, MOL CELL BIOL, V10, P1056, DOI 10.1128/MCB.10.3.1056; GIULIANO G, 1988, P NATL ACAD SCI USA, V85, P7089, DOI 10.1073/pnas.85.19.7089; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Guo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076809; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Hao QN, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-525; Hudson D, 2013, PLANT PHYSIOL, V162, P132, DOI 10.1104/pp.113.217265; Hudson D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026765; JARAI G, 1992, CURR GENET, V21, P37, DOI 10.1007/BF00318652; Jeong MJ, 2003, BIOCHEM BIOPH RES CO, V300, P555, DOI 10.1016/S0006-291X(02)02892-9; Kereszt A, 2007, NAT PROTOC, V2, P948, DOI 10.1038/nprot.2007.141; Kim S, 2013, PLANT CELL, V25, P4984, DOI 10.1105/tpc.113.119172; Kong H, 2007, PLANT J, V50, P873, DOI 10.1111/j.1365-313X.2007.03097.x; LAM E, 1990, PLANT CELL, V2, P857, DOI 10.1105/tpc.2.9.857; Li XX, 2014, APPL MICROBIOL BIOT, V98, P2805, DOI 10.1007/s00253-013-5240-z; Libault M, 2009, PLANT PHYSIOL, V151, P1207, DOI 10.1104/pp.109.144030; Liu PP, 2005, PLANT J, V44, P960, DOI 10.1111/j.1365-313X.2005.02588.x; Lowry JA, 2000, J MOL EVOL, V50, P103, DOI 10.1007/s002399910012; Luo XM, 2010, DEV CELL, V19, P872, DOI 10.1016/j.devcel.2010.10.023; Manfield IW, 2007, PLANT PHYSIOL, V143, P941, DOI 10.1104/pp.106.090761; Mara CD, 2008, PLANT PHYSIOL, V147, P707, DOI 10.1104/pp.107.115634; Meyer LJ, 2012, PLANT PHYSIOL, V159, P517, DOI 10.1104/pp.111.191700; Nishii A, 2000, BIOSCI BIOTECH BIOCH, V64, P1402, DOI 10.1271/bbb.64.1402; OMICHINSKI JG, 1993, SCIENCE, V261, P438, DOI 10.1126/science.8332909; Ortega JL, 2001, PLANT PHYSIOL, V126, P109, DOI 10.1104/pp.126.1.109; Patient RK, 2002, CURR OPIN GENET DEV, V12, P416, DOI 10.1016/S0959-437X(02)00319-2; Rastogi R, 1997, PLANT MOL BIOL, V34, P465, DOI 10.1023/A:1005842812321; Reyes JC, 2004, PLANT PHYSIOL, V134, P1718, DOI 10.1104/pp.103.037788; Richter R, 2010, GENE DEV, V24, P2093, DOI 10.1101/gad.594910; Robson F, 2001, PLANT J, V28, P619, DOI 10.1046/j.1365-313x.2001.01163.x; Scazzocchio C, 2000, CURR OPIN MICROBIOL, V3, P126, DOI 10.1016/S1369-5274(00)00063-1; Scheible WR, 2004, PLANT PHYSIOL, V136, P2483, DOI 10.1104/pp.104.047019; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Shikata M, 2004, J EXP BOT, V55, P631, DOI 10.1093/jxb/erh078; Shoichet SA, 2000, P NATL ACAD SCI USA, V97, P4076, DOI 10.1073/pnas.97.8.4076; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Teakle GR, 2002, PLANT MOL BIOL, V50, P43, DOI 10.1023/A:1016062325584; Teakle GR, 1995, PLANT MOL BIOL, V29, P1253, DOI 10.1007/BF00020466; Teakle GR, 1998, TRENDS BIOCHEM SCI, V23, P100, DOI 10.1016/S0968-0004(98)01174-8; Vanholme B, 2007, TRENDS PLANT SCI, V12, P239, DOI 10.1016/j.tplants.2007.04.004; Wang LP, 2009, CELL RES, V19, P598, DOI 10.1038/cr.2009.36; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; Wu SC, 1995, PLANT MOL BIOL, V29, P491, DOI 10.1007/BF00020980; YANG WC, 1993, PLANT J, V3, P573, DOI 10.1046/j.1365-313X.1993.03040573.x; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97; Zhao YX, 2004, PLANT CELL, V16, P2586, DOI 10.1105/tpc.104.024869	56	50	50	7	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0125174	10.1371/journal.pone.0125174	http://dx.doi.org/10.1371/journal.pone.0125174			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886477	Green Published, Green Submitted, gold			2022-12-26	WOS:000353017000153
J	Rannversson, H; Wilson, P; Kristensen, KB; Sinning, S; Kristensen, AS; Stromgaard, K; Andersen, J				Rannversson, Hafsteinn; Wilson, Pamela; Kristensen, Kristina Birch; Sinning, Steffen; Kristensen, Anders Skov; Stromgaard, Kristian; Andersen, Jacob			Importance of the Extracellular Loop 4 in the Human Serotonin Transporter for Inhibitor Binding and Substrate Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE DOMAIN-I; CYSTEINE-SCANNING MUTAGENESIS; HIGH-AFFINITY RECOGNITION; NEUROTRANSMITTER TRANSPORTERS; NOREPINEPHRINE TRANSPORTERS; BACTERIAL HOMOLOG; CONFORMATIONAL DYNAMICS; SELECTIVE RECOGNITION; ALLOSTERIC MECHANISM; PERMEATION PATHWAY	The serotonin transporter (SERT) terminates serotonergic neurotransmission by performing reuptake of released serotonin, and SERT is the primary target for antidepressants. SERT mediates the reuptake of serotonin through an alternating access mechanism, implying that a central substrate site is connected to both sides of the membrane by permeation pathways, of which only one is accessible at a time. The coordinated conformational changes in SERT associated with substrate translocation are not fully understood. Here, we have identified a Leu to Glu mutation at position 406 (L406E) in the extracellular loop 4 (EL4) of human SERT, which induced a remarkable gain-of-potency (up to >40-fold) for a range of SERT inhibitors. The effects were highly specific for L406E relative to six other mutations in the same position, including the closely related L406D mutation, showing that the effects induced by L406E are not simply charge-related effects. Leu(406) is located >10 angstrom from the central inhibitor binding in an indirect manner. We found that L406E decreased accessibility to a residue in the cytoplasmic pathway. The shift in equilibrium to favor a more outward-facing conformation of SERT can explain the reduced turnover rate and increased association rate of inhibitor binding we found for L406E. Together, our findings show that EL4 allosterically can modulate inhibitor binding within the central binding site, and substantiates that EL4 has an important role in controlling the conformational equilibrium of human SERT.	[Rannversson, Hafsteinn; Wilson, Pamela; Kristensen, Anders Skov; Stromgaard, Kristian; Andersen, Jacob] Univ Copenhagen, Dept Drug Design & Pharmacol, DK-2100 Copenhagen, Denmark; [Kristensen, Kristina Birch; Sinning, Steffen] Aarhus Univ, Translat Neuropsychiat Unit, Dept Clin Med, DK-8240 Risskov, Denmark	University of Copenhagen; Aarhus University	Andersen, J (corresponding author), Univ Copenhagen, Jagtvej 162, DK-2100 Copenhagen, Denmark.	jaa@sund.ku.dk	Kristensen, Anders Skov/B-4414-2009; Andersen, Jacob/B-7768-2016	Kristensen, Anders Skov/0000-0001-8955-6790; Andersen, Jacob/0000-0002-8067-3074; Sinning, Steffen/0000-0001-6971-6929; Stromgaard, Kristian/0000-0003-2206-4737	Lundbeck Foundation; Lundbeck Foundation [R126-2012-12453, R34-2011-3868, R126-2012-12576] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Lundbeck Foundation.	Andersen J, 2014, MOL PHARMACOL, V85, P703, DOI 10.1124/mol.113.091249; Andersen J, 2011, P NATL ACAD SCI USA, V108, P12137, DOI 10.1073/pnas.1103060108; Andersen J, 2010, J BIOL CHEM, V285, P2051, DOI 10.1074/jbc.M109.072587; Andersen J, 2009, CHEM COMMUN, P3677, DOI 10.1039/b903035m; Andersen J, 2009, J BIOL CHEM, V284, P10276, DOI 10.1074/jbc.M806907200; Apparsundaram S, 2008, J PHARMACOL EXP THER, V327, P982, DOI 10.1124/jpet.108.142315; Barker EL, 1999, J NEUROSCI, V19, P4705; Barker EL, 1998, J BIOL CHEM, V273, P19459, DOI 10.1074/jbc.273.31.19459; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Celik L, 2008, J AM CHEM SOC, V130, P3853, DOI 10.1021/ja076403h; Chen FH, 2005, EUR NEUROPSYCHOPHARM, V15, P193, DOI 10.1016/j.euroneuro.2004.08.008; Chen JG, 1997, BIOCHEMISTRY-US, V36, P1479, DOI 10.1021/bi962256g; Claxton DP, 2010, NAT STRUCT MOL BIOL, V17, P822, DOI 10.1038/nsmb.1854; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; GRAHAM D, 1989, BIOCHEM PHARMACOL, V38, P3819, DOI 10.1016/0006-2952(89)90591-1; Henry LK, 2006, J BIOL CHEM, V281, P2012, DOI 10.1074/jbc.M505055200; Henry LK, 2003, J BIOL CHEM, V278, P37052, DOI 10.1074/jbc.M305514200; Hilwi M, 2014, J BIOL CHEM, V289, P34258, DOI 10.1074/jbc.M114.593061; Jacobs MT, 2007, J BIOL CHEM, V282, P29441, DOI 10.1074/jbc.M704456200; Kazmier K, 2014, NAT STRUCT MOL BIOL, V21, P472, DOI 10.1038/nsmb.2816; KOE BK, 1990, PSYCHOPHARMACOLOGY, V100, P470, DOI 10.1007/BF02243998; Koldso H, 2010, J AM CHEM SOC, V132, P1311, DOI 10.1021/ja906923j; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Malinauskaite L, 2014, NAT STRUCT MOL BIOL, V21, P1006, DOI 10.1038/nsmb.2894; Mitchell SM, 2004, J BIOL CHEM, V279, P24089, DOI 10.1074/jbc.M311173200; Neubauer HA, 2006, MOL PHARMACOL, V69, P1242, DOI 10.1124/mol.105.018507; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Plenge P, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.371765; Raba M, 2014, STRUCTURE, V22, P769, DOI 10.1016/j.str.2014.03.011; Rudnick G, 1998, J BIOENERG BIOMEMBR, V30, P173, DOI 10.1023/A:1020573325823; Sato Y, 2004, J BIOL CHEM, V279, P22926, DOI 10.1074/jbc.M312194200; Severinsen K, 2014, MOL PHARMACOL, V85, P208, DOI 10.1124/mol.113.088922; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Sinning S, 2010, J BIOL CHEM, V285, P8363, DOI 10.1074/jbc.M109.045401; Smicun Y, 1999, J BIOL CHEM, V274, P36058, DOI 10.1074/jbc.274.51.36058; Sorensen L, 2012, J BIOL CHEM, V287, P43694, DOI 10.1074/jbc.M112.342212; Stephan MM, 1997, BIOCHEMISTRY-US, V36, P1322, DOI 10.1021/bi962150l; Tao Z, 2009, J BIOL CHEM, V284, P33807, DOI 10.1074/jbc.M109.071977; Torres-Altoro MI, 2010, J BIOL CHEM, V285, P15369, DOI 10.1074/jbc.M109.088138; Tsuruda PR, 2010, J PHARMACOL TOXICOL, V61, P192, DOI 10.1016/j.vascn.2009.12.003; Wang H, 2013, NATURE, V503, P141, DOI 10.1038/nature12648; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602; Zhu CB, 2004, MOL PHARMACOL, V65, P1462, DOI 10.1124/mol.65.6.1462; Zomot E, 2003, J BIOL CHEM, V278, P42950, DOI 10.1074/jbc.M209307200	51	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14582	14594		10.1074/jbc.M114.629071	http://dx.doi.org/10.1074/jbc.M114.629071			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25903124	hybrid, Green Published			2022-12-26	WOS:000355754600029
J	Chun, YH; Han, K; Park, YG; Yoon, JS; Kim, HH; Kim, JT; Jeong, DC				Chun, Yoon Hong; Han, Kyungdo; Park, Yong-Gyu; Yoon, Jong-Seo; Kim, Hyun Hee; Kim, Jin Tack; Jeong, Dae Chul			Examining Impacts of Allergic Diseases on Psychological Problems and Tobacco Use in Korean Adolescents: The 2008-2011 Korean National Health and Nutrition Examination Survey	PLOS ONE			English	Article							QUALITY-OF-LIFE; ASTHMA OUTCOMES; DEPRESSION; ANXIETY; RISK; ASSOCIATION; PREVALENCE; DISORDERS; SYMPTOMS; GIRLS	Purpose Asthma during adolescence can induce social, psychological, and behavioral problems. We examined the impact of asthma and other allergic diseases on psychological symptoms and health risk behaviors among South Korean adolescents. Methods In this population-based cross-sectional study, 3192 adolescents (10-18 years of age) participating in the 2008-2011 Korean National Health and Nutrition Examination Survey were enrolled. Psychological problems associated with clinically diagnosed asthma, allergic rhinitis, and atopic dermatitis were assessed using questionnaires and surveys. Data was analyzed using logistic regression to determine the association of depression with allergic disease while controlling for age, sex, body mass index, smoking experience, and alcohol use. Results Asthma and atopic dermatitis were associated with a higher prevalence of depression (17.2% and 13%, respectively). After adjusting for the covariates, asthma patients were approximately two times as likely to have depression as non-allergic participants (odds ratio, 1.81; 95% confidence interval, 1.22-2.68). Psychosocial stress significantly increased in the following order: no allergy, any allergy without asthma, asthma only, and asthma with any allergy (p for linear trend = 0.01). The asthma without other allergies group showed the highest prevalence of cigarette smoking (p = 0.007). Conclusions In this study, asthma with or without other allergies was significantly related to increases in depression, psychosocial stress, and smoking experience. Thus, care should be taken to adjust treatment to account for the psychological symptoms and health risk behaviors common among asthmatic adolescents.	[Chun, Yoon Hong] Catholic Univ Korea, Incheon St Marys Hosp, Coll Med, Dept Pediat, Seoul, South Korea; [Han, Kyungdo; Park, Yong-Gyu] Catholic Univ Korea, Dept Biostat, Seoul, South Korea; [Yoon, Jong-Seo; Jeong, Dae Chul] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Pediat, Seoul, South Korea; [Kim, Hyun Hee] Catholic Univ Korea, Bucheon St Marys Hosp, Coll Med, Dept Pediat, Seoul, South Korea; [Kim, Jin Tack] Catholic Univ Korea, Uijeongbu St Marys Hosp, Coll Med, Dept Pediat, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Catholic University of Korea	Jeong, DC (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Pediat, Seoul, South Korea.	dcjeong@catholic.ac.kr		Chun, Yoon Hong/0000-0002-9871-5244; Park, Yong Gyu/0000-0002-8721-3230				[Anonymous], KOR NAT HLTH NUTR EX; Bahreinian S, 2011, CHEST, V140, P1138, DOI 10.1378/chest.11-0219; Chen MH, 2013, J AFFECT DISORDERS, V145, P49, DOI 10.1016/j.jad.2012.07.011; Covaciu C, 2013, J ASTHMA, V50, P522, DOI 10.3109/02770903.2013.789057; Dowdell EB, 2011, NURS RES PRACT, V2011, DOI 10.1155/2011/503201; Feldman JM, 2005, PSYCHOSOM MED, V67, P989, DOI 10.1097/01.psy.0000188556.97979.13; Fonken LK, 2011, MOL PSYCHIATR, V16, P987, DOI 10.1038/mp.2011.76; Hurwitz EL, 1999, AM J EPIDEMIOL, V150, P1107, DOI 10.1093/oxfordjournals.aje.a009936; JUNIPER EF, 1994, J ALLERGY CLIN IMMUN, V93, P413, DOI 10.1016/0091-6749(94)90349-2; Katon W, 2007, J ADOLESCENT HEALTH, V41, P455, DOI 10.1016/j.jadohealth.2007.05.023; Katon W, 2010, AM J PSYCHIAT, V167, P1020, DOI 10.1176/appi.ajp.2010.10050657; Kelsay K, 2005, J PEDIATR PSYCHOL, V30, P522, DOI 10.1093/jpepsy/jsi077; Krauskopf KA, 2013, J ASTHMA, V50, P260, DOI 10.3109/02770903.2012.757779; Lewis-Jones S, 2006, INT J CLIN PRACT, V60, P984, DOI 10.1111/j.1742-1241.2006.01047.x; Liu LY, 2002, AM J RESP CRIT CARE, V165, P1062, DOI 10.1164/ajrccm.165.8.2109065; McCauley E, 2007, GEN HOSP PSYCHIAT, V29, P214, DOI 10.1016/j.genhosppsych.2007.02.003; Pearce N, 2007, THORAX, V62, P758, DOI 10.1136/thx.2006.070169; Richardson LP, 2006, PEDIATRICS, V118, P1042, DOI 10.1542/peds.2006-0249; Thapar A, 2012, LANCET, V379, P1056, DOI 10.1016/S0140-6736(11)60871-4; Thompson PJ, 2013, RESPIROLOGY, V18, P957, DOI 10.1111/resp.12137; Timonen M, 2003, MOL PSYCHIATR, V8, P738, DOI 10.1038/sj.mp.4001274; Timonen M, 2002, BIOL PSYCHIAT, V52, P349, DOI 10.1016/S0006-3223(01)01364-6; Van Lieshout RJ, 2009, PSYCHOSOM MED, V71, P187, DOI 10.1097/PSY.0b013e3181907012; Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x; Whooley MA, 2000, NEW ENGL J MED, V343, P1942, DOI 10.1056/NEJM200012283432607; Yaghmaie P, 2013, J ALLERGY CLIN IMMUN, V131, P428, DOI 10.1016/j.jaci.2012.10.041	26	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0125172	10.1371/journal.pone.0125172	http://dx.doi.org/10.1371/journal.pone.0125172			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG3XJ	25897790	Green Submitted, Green Published, gold			2022-12-26	WOS:000353212600098
J	Conway, DP; Guy, R; Davies, SC; Couldwell, DL; McNulty, A; Smith, DE; Keen, P; Cunningham, P; Holt, M				Conway, Damian P.; Guy, Rebecca; Davies, Stephen C.; Couldwell, Deborah L.; McNulty, Anna; Smith, Don E.; Keen, Phillip; Cunningham, Philip; Holt, Martin		Sydney Rapid HIV Test Study	Rapid HIV Testing Is Highly Acceptable and Preferred among High-Risk Gay And Bisexual Men after Implementation in Sydney Sexual Health Clinics	PLOS ONE			English	Article							INFECTION; PREFERENCES; FREQUENCY; EPIDEMIOLOGY; GUIDELINES; BARRIERS; PROGRAM; PILOT	Background Rapid HIV testing (RHT) is well established in many countries, but it is new in Australia. We assessed the acceptability of RHT and its associations among gay, bisexual and other men who have sex with men (GBM) after implementation of RHT in Sydney sexual health clinics. Methods GBM were invited to complete an acceptability questionnaire before and after provision of the result of finger-prick blood RHT, comparing their experience of RHT with conventional HIV testing (CHT) involving venipuncture. Logistic regression was used to assess associations between patient characteristics and the preference for RHT over CHT next time they tested for HIV. Results Of 1061 GBM who received non-reactive RHT results, 59% found RHT less stressful than CHT and 34% reported no difference, and 61% found RHT more comfortable than CHT and 26% reported no difference. Nearly all men were satisfied with RHT result delivery (99%) and the RHT process overall (99%). Most men (79%) preferred RHT for their next HIV test and this preference was stronger in men who were aged 35-44 years (adjusted odds ratio [AOR] 2.49, p<0.01), reported they would test more often if RHT was available (AOR 1.66, p=0.01), found returning for results annoying (AOR 1.67, p=0.01), and found RHT less stressful (AOR 2.37, p<0.01) and more comfortable (AOR 1.62, p=0.02) than CHT. Men concerned about the reliability of RHT were less than half as likely to prefer RHT for their next HIV test (AOR 0.44, p<0.01). Conclusions Most GBM preferred RHT to CHT next time and this preference was associated with finding RHT more convenient, more comfortable and less stressful than CHT. These findings suggest that in a clinic setting RHT should be considered to improve the patient experience and may potentially increase uptake and frequency of HIV testing.	[Conway, Damian P.; Guy, Rebecca; Keen, Phillip] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Conway, Damian P.] St George Hosp, Short St Sexual Hlth Ctr, Kogarah, NSW, Australia; [Davies, Stephen C.] Royal N Shore Hosp, North Shore Sexual Hlth Serv, St Leonards, NSW 2065, Australia; [Davies, Stephen C.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Couldwell, Deborah L.] Western Sydney Local Hlth Dist, Western Sydney Sexual Hlth Ctr, Sydney, NSW, Australia; [Couldwell, Deborah L.] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia; [McNulty, Anna] Sydney Hosp, Sydney Sexual Hlth Ctr, Sydney, NSW, Australia; [McNulty, Anna; Smith, Don E.] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Smith, Don E.] Albion Ctr, Surry Hills, NSW, Australia; [Cunningham, Philip] Univ New S Wales, St Vincents Ctr Appl Med Res, Sydney, NSW, Australia; [Cunningham, Philip] St Vincents Hosp, NSW State Reference Lab HIV, Darlinghurst, NSW 2010, Australia; [Holt, Martin] Univ New S Wales, Ctr Social Res Hlth, Sydney, NSW, Australia	University of New South Wales Sydney; Kirby Institute; St George Hospital; Royal North Shore Hospital; University of Sydney; University of Sydney; University of New South Wales Sydney; University of New South Wales Sydney; St Vincents Hospital Sydney; University of New South Wales Sydney	Conway, DP (corresponding author), Univ New S Wales, Kirby Inst, Sydney, NSW, Australia.	dconway@kirby.unsw.edu.au	Cunningham, Philip/GZH-1820-2022; Conway, Damian Patrick/F-2789-2012; Holt, Martin/X-6482-2019	Conway, Damian Patrick/0000-0003-3316-2199; Holt, Martin/0000-0002-2586-8274; O'Sullivan, Matthew/0000-0001-8783-5323; Rawlinson, William/0000-0003-0988-7827; Keen, Phillip/0000-0002-2678-0645; Cunningham, Philip/0000-0003-2613-6910; Guy, Rebecca/0000-0002-2929-4634	National Health & Medical Research Council STI Program Grant [568971]; Australian Rotary Health & Sydney CBD Rotary Club	National Health & Medical Research Council STI Program Grant; Australian Rotary Health & Sydney CBD Rotary Club	The Sydney Rapid HIV Test Study was supported by funding from the National Health & Medical Research Council STI Program Grant Application ID 568971 (https://www.nhmrc.gov.au). Australian Rotary Health & Sydney CBD Rotary Club supported a scholarship for DPC (http://www.australianrotaryhealth.org.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alere Medical Co. Ltd, 2011, DET HIV 1 2 AG AB CO; Bavinton BR, 2013, AIDS BEHAV, V17, P2084, DOI 10.1007/s10461-013-0450-z; Beelaert G, 2010, J VIROL METHODS, V168, P218, DOI 10.1016/j.jviromet.2010.06.002; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Bilardi JE, 2013, AIDS BEHAV, V17, P2093, DOI 10.1007/s10461-012-0395-7; Birrell F, 2010, SEX HEALTH, V7, P11, DOI 10.1071/SH09029; Centers for Diease Control and Prevention, 2011, HIV SURV REP, V23; Champenois K, 2012, BMJ OPEN, V2, DOI [10.1136/bmjopen-2011-000693, DOI 10.1136/bmjopen-2011-000693]; Chen MY, 2010, INT J STD AIDS, V21, P428, DOI 10.1258/ijsa.2010.009552; Cohen MS, 2010, CLIN INFECT DIS, V50, pS85, DOI 10.1086/651478; Conway DP, 2015, HIV MED, V16, P280, DOI 10.1111/hiv.12209; Conway DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094062; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; de Wit J, 2014, HIV AIDS HEPATITIS S; Debattista J, 2007, SEX HEALTH, V4, P105, DOI 10.1071/SH07014; European Centre for Disease Prevention and Control/ WHO Regional Office for Europe, 2013, HIV AIDS SURV EUR 20; Fidler S, 2013, NEW ENGL J MED, V368, P207, DOI 10.1056/NEJMoa1110039; Gray RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055449; Guenter D, 2008, AIDS PATIENT CARE ST, V22, P195, DOI 10.1089/apc.2007.0137; Guy R, 2010, SEX TRANSM INFECT, V86, P371, DOI 10.1136/sti.2009.040972; Hull P, 2011, SYDNEY GAY COMMUNITY; Hutchinson AB, 2004, AIDS EDUC PREV, V16, P101, DOI 10.1521/aeap.16.2.101.29394; Le T, 2013, NEW ENGL J MED, V368, P218, DOI 10.1056/NEJMoa1110187; Maartens G, 2014, LANCET, V384, P258, DOI 10.1016/S0140-6736(14)60164-1; MacKellar DA, 2011, SEX TRANSM DIS, V38, P419, DOI 10.1097/OLQ.0b013e31820369dd; Mallitt KA, 2012, SEX HEALTH, V9, P138, DOI 10.1071/SH10141; Masciotra S, 2013, J CLIN VIROL, V58, pE54, DOI 10.1016/j.jcv.2013.07.002; Merchant RC, 2009, AIDS CARE, V21, P490, DOI 10.1080/09540120802270284; New South Wales Centre for Population Health, 2013, HIV NSW DAT PERF MON, P12; Paz-Bailey G, 2013, MMWR-MORBID MORTAL W, V62, P958; Poynten IM, 2010, HIV MED, V11, P635, DOI 10.1111/j.1468-1293.2010.00833.x; Prestage G, 2012, SEX HEALTH, V9, P453, DOI 10.1071/SH12033; Read TRH, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5086; Rosenberg NE, 2012, J INFECT DIS, V205, P528, DOI 10.1093/infdis/jir789; San Antonio-Gaddy M, 2006, JAIDS-J ACQ IMM DEF, V43, P446; Sharma A, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-109; Smith LV, 2006, AIDS PATIENT CARE ST, V20, P693, DOI 10.1089/apc.2006.20.693; Spielberg F, 2003, JAIDS-J ACQ IMM DEF, V32, P318, DOI 10.1097/00126334-200303010-00012; Templeton DJ, 2014, SEX HEALTH, V11, P217, DOI 10.1071/SH14003; The Kirby Institute, 2014, HIV VIR HEP SEX TRAN; Therapeutic Goods Administration, 2014, HIV SELF TESTS AUSTR; Wilson DP, 2009, SEX HEALTH, V6, P19, DOI 10.1071/SH08081; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1	43	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123814	10.1371/journal.pone.0123814	http://dx.doi.org/10.1371/journal.pone.0123814			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG3XJ	25898140	Green Published, gold, Green Submitted			2022-12-26	WOS:000353212600042
J	Nakao, S; Wakabayashi, S; Nakamura, TY				Nakao, Shu; Wakabayashi, Shigeo; Nakamura, Tomoe Y.			Stimulus-Dependent Regulation of Nuclear Ca2+ Signaling in Cardiomyocytes: A Role of Neuronal Calcium Sensor-1	PLOS ONE			English	Article							CARDIAC MYOCYTES; ATRIAL MYOCYTES; RELEASE; MEMORY; MICRODOMAINS; MODULATION; PLASTICITY; RETICULUM; ENVELOPE; RECEPTOR	In cardiomyocytes, intracellular calcium (Ca2+) transients are elicited by electrical and receptor stimulations, leading to muscle contraction and gene expression, respectively. Although such elevations of Ca2+ levels ([Ca2+]) also occur in the nucleus, the precise mechanism of nuclear [Ca2+] regulation during different kinds of stimuli, and its relationship with cytoplasmic [Ca2+] regulation are not fully understood. To address these issues, we used a new region-specific fluorescent protein-based Ca2+ indicator, GECO, together with the conventional probe Fluo-4 AM. We confirmed that nuclear Ca2+ transients were elicited by both electrical and receptor stimulations in neonatal mouse ventricular myocytes. Kinetic analysis revealed that electrical stimulation-elicited nuclear Ca2+ transients are slower than cytoplasmic Ca2+ transients, and chelating cytoplasmic Ca2+ abolished nuclear Ca2+ transients, suggesting that nuclear Ca2+ are mainly derived from the cytoplasm during electrical stimulation. On the other hand, receptor stimulation such as with insulin-like growth factor-1 (IGF-1) preferentially increased nuclear [Ca2+] compared to cytoplasmic [Ca2+]. Experiments using inhibitors revealed that electrical and receptor stimulation-elicited Ca2+ transients were mainly mediated by ryanodine receptors and inositol 1,4,5-trisphosphate receptors (IP3Rs), respectively, suggesting different mechanisms for the two signals. Furthermore, IGF-1-elicited nuclear Ca2+ transient amplitude was significantly lower in myocytes lacking neuronal Ca2+ sensor-1 (NCS-1), a Ca2+ binding protein implicated in IP3R-mediated pathway in the heart. Moreover, IGF-1 strengthened the interaction between NCS-1 and IP3R. These results suggest a novel mechanism for receptor stimulation-induced nuclear [Ca2+] regulation mediated by IP3R and NCS-1 that may further fine-tune cardiac Ca2+ signal regulation.	[Nakao, Shu; Wakabayashi, Shigeo; Nakamura, Tomoe Y.] Natl Cerebral & Cardiovasc Ctr, Dept Mol Physiol, Suita, Osaka, Japan; [Wakabayashi, Shigeo] Natl Cerebral & Cardiovasc Ctr, Dept Cardiac Physiol, Suita, Osaka, Japan	National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan	Nakamura, TY (corresponding author), Natl Cerebral & Cardiovasc Ctr, Dept Mol Physiol, Suita, Osaka, Japan.	tomoen@ri.ncvc.go.jp	Nakao, Shu/L-1796-2019	Nakao, Shu/0000-0001-8990-1179	JSPS KAKENHI [25860174, 24590293]; Naito Science & Engineering Foundation [J004]; Intramural Research Fund for Cardiovascular Disease of the National Cerebral and Cardiovascular Center [22-2-3]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Naito Science & Engineering Foundation; Intramural Research Fund for Cardiovascular Disease of the National Cerebral and Cardiovascular Center	This work was supported by JSPS KAKENHI, Grant-in-Aid for Young Scientists (B) #25860174 (http://www.jsps.go.jp/j-grantsinaid/03_keikaku/download.html) that SN received, Grant-in-Aid for Scientific Research (C) #24590293 (http://www.jsps.go.jp/j-grantsinaid/03_keikaku/download.html) that TYN received, The Naito Science & Engineering Foundation #J004 (https://www.naito-f.or.jp/jp/joseikn/jo_index.php?data = detail&grant_id=KEN) that TYN received, and by Intramural Research Fund for Cardiovascular Disease of the National Cerebral and Cardiovascular Center #22-2-3 that SW received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bare DJ, 2005, J BIOL CHEM, V280, P15912, DOI 10.1074/jbc.M414212200; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Drumond LE, 2012, BRAIN RES BULL, V88, P385, DOI 10.1016/j.brainresbull.2012.04.005; Escobar M, 2011, J MOL CELL CARDIOL, V50, P451, DOI 10.1016/j.yjmcc.2010.11.021; FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; Fox JL, 1997, BIOCHEM J, V326, P491, DOI 10.1042/bj3260491; Gomez M, 2001, NEURON, V30, P241, DOI 10.1016/S0896-6273(01)00276-8; Guatimosim S, 2008, CELL CALCIUM, V44, P230, DOI 10.1016/j.ceca.2007.11.016; Higazi DR, 2009, MOL CELL, V33, P472, DOI 10.1016/j.molcel.2009.02.005; Hui K, 2007, DEVELOPMENT, V134, P4479, DOI 10.1242/dev.008979; Ibarra C, 2013, CIRC RES, V112, P236, DOI 10.1161/CIRCRESAHA.112.273839; Kim JC, 2010, MOL CELLS, V29, P387, DOI 10.1007/s10059-010-0039-6; Kockskamper J, 2008, J CELL SCI, V121, P186, DOI 10.1242/jcs.021386; Koizumi S, 2002, J BIOL CHEM, V277, P30315, DOI 10.1074/jbc.M201132200; Ledeen R, 2007, J NEUROCHEM, V103, P126, DOI 10.1111/j.1471-4159.2007.04722.x; Ljubojevic S, 2011, BIOPHYS J, V100, P2356, DOI 10.1016/j.bpj.2011.03.060; Nakamura TY, 2011, CIRC RES, V109, P512, DOI 10.1161/CIRCRESAHA.111.248864; Nakamura TY, 2006, J CELL BIOL, V172, P1081, DOI 10.1083/jcb.200508156; NAKAMURA TY, 1993, CIRC RES, V73, P758, DOI 10.1161/01.RES.73.4.758; PONGS O, 1993, NEURON, V11, P15, DOI 10.1016/0896-6273(93)90267-U; Saab BJ, 2009, NEURON, V63, P643, DOI 10.1016/j.neuron.2009.08.014; Sippy T, 2003, NAT NEUROSCI, V6, P1031, DOI 10.1038/nn1117; Wu X, 2006, J CLIN INVEST, V116, P675, DOI 10.1172/JCI27374; Wu X, 2006, CIRC RES, V99, P283, DOI 10.1161/01.RES.0000233386.02708.72; Zhang K, 2010, J MOL CELL CARDIOL, V49, P829, DOI 10.1016/j.yjmcc.2010.08.018; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592; Zima AV, 2007, J PHYSIOL-LONDON, V584, P601, DOI 10.1113/jphysiol.2007.140731	30	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0125050	10.1371/journal.pone.0125050	http://dx.doi.org/10.1371/journal.pone.0125050			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897502	gold, Green Published, Green Submitted			2022-12-26	WOS:000353212600095
J	De Souza, DA; Wang, Y; Kaftanoglu, O; De Jong, D; Amdam, GV; Goncalves, LS; Francoy, TM				De Souza, Daiana A.; Wang, Ying; Kaftanoglu, Osman; De Jong, David; Amdam, Gro V.; Goncalves, Lionel S.; Francoy, Tiago M.			Morphometric Identification of Queens, Workers and Intermediates in In Vitro Reared Honey Bees (Apis mellifera)	PLOS ONE			English	Article							JUVENILE-HORMONE; EVOLUTION; LARVAL; NUMBER; BROOD	In vitro rearing is an important and useful tool for honey bee (Apis mellifera L.) studies. However, it often results in intercastes between queens and workers, which are normally are not seen in hive-reared bees, except when larvae older than three days are grafted for queen rearing. Morphological classification (queen versus worker or intercastes) of bees produced by this method can be subjective and generally depends on size differences. Here, we propose an alternative method for caste classification of female honey bees reared in vitro, based on weight at emergence, ovariole number, spermatheca size and size and shape, and features of the head, mandible and basitarsus. Morphological measurements were made with both traditional morphometric and geometric morphometrics techniques. The classifications were performed by principal component analysis, using naturally developed queens and workers as controls. First, the analysis included all the characters. Subsequently, a new analysis was made without the information about ovariole number and spermatheca size. Geometric morphometrics was less dependent on ovariole number and spermatheca information for caste and intercaste identification. This is useful, since acquiring information concerning these reproductive structures requires time-consuming dissection and they are not accessible when abdomens have been removed for molecular assays or in dried specimens. Additionally, geometric morphometrics divided intercastes into more discrete phenotype subsets. We conclude that morphometric geometrics are superior to traditional morphometrics techniques for identification and classification of honey bee castes and intermediates.	[De Souza, Daiana A.; De Jong, David; Francoy, Tiago M.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Genet, BR-14049 Ribeirao Preto, SP, Brazil; [Wang, Ying; Kaftanoglu, Osman; Amdam, Gro V.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Amdam, Gro V.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway; [Goncalves, Lionel S.] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Biol, BR-14049 Ribeirao Preto, SP, Brazil; [Goncalves, Lionel S.] Univ Fed Semiarido, Mossoro, RN, Brazil; [Francoy, Tiago M.] Univ Sao Paulo, Escola Artes Ciencias Humanidades, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Arizona State University; Arizona State University-Tempe; Norwegian University of Life Sciences; Universidade de Sao Paulo; Universidade de Sao Paulo	De Souza, DA (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Genet, BR-14049 Ribeirao Preto, SP, Brazil.	daianasouz@usp.br	De Jong, David/H-4668-2012; Francoy, TIago/AFW-5399-2022	De Jong, David/0000-0003-2131-9988; Francoy, Tiago Mauricio/0000-0002-2413-966X	National Counsel of Technological and Scientific Development [141512/2010-5]; CAPES foundation [9813/11-0]; Sao Paulo Research Foundation [2011/07857-9]	National Counsel of Technological and Scientific Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by 141512/2010-5 to DADS, National Counsel of Technological and Scientific Development, http://www.cnpq.br/; 9813/11-0 to DADS, CAPES foundation, http://sacexterior.capes.gov.br/sacexterior/; 2011/07857-9 to TMF, Sao Paulo Research Foundation, http://www.fapesp.br/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Adams DC, 2013, HYSTRIX, V24, P7, DOI 10.4404/hystrix-24.1-6283; [Anonymous], 2008, TPSDIG VERSION 2 12, DOI DOI 10.1111/ecog.00762; [Anonymous], 1974, SOCIAL BEHAV BEES; ASENCOT M, 1976, LIFE SCI, V18, P693, DOI 10.1016/0024-3205(76)90180-6; Aupinel Merrick, 2007, Redia, V90, P91; BECKER R, 2009, JULIUS KUHN ARCH, V423, P43; Bookstein FL, 1998, ACTA ZOOL ACAD SCI H, V44, P7; Bookstein FL, 1996, B MATH BIOL, V58, P313, DOI 10.1016/0092-8240(95)00329-0; Bridges C.B., 1923, 3 CHROMOSOME GROUP M; Brodschneider R, 2009, APIDOLOGIE, V40, P441, DOI 10.1051/apido/2009006; Crailsheim K, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.05; Dedej S, 1998, J APICULT RES, V37, P183, DOI 10.1080/00218839.1998.11100970; DeGrandi-Hoffman G, 2004, ANN ENTOMOL SOC AM, V97, P1299, DOI 10.1603/0013-8746(2004)097[1299:DOAIBA]2.0.CO;2; Dietrich MR, 2000, AM ZOOL, V40, P738, DOI 10.1668/0003-1569(2000)040[0738:FHMTHE]2.0.CO;2; Eckert JE, 1934, J ECON ENTOMOL, V27, P629, DOI 10.1093/jee/27.3.629; Francoy TM, 2008, APIDOLOGIE, V39, P488, DOI 10.1051/apido:2008028; Francoy TM, 2012, APIDOLOGIE, V43, P609, DOI 10.1007/s13592-012-0132-2; Garcia-Fernandez J, 2005, NAT REV GENET, V6, P881, DOI 10.1038/nrg1723; JAY SC, 1965, CAN J ZOOLOG, V43, P541, DOI 10.1139/z65-053; Kaftanoglu O, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.9601; Laidlaw Jr H. H., 1979, CONT QUEEN REARING; Leimar O, 2012, ECOL EVOL, V2, P3098, DOI 10.1002/ece3.414; Linksvayer TA, 2011, J EVOLUTION BIOL, V24, P1939, DOI 10.1111/j.1420-9101.2011.02331.x; Luna L.G., 1992, HISTOPATHOLOGICAL ME; Maeda RK, 2009, CURR TOP DEV BIOL, V88, P1, DOI 10.1016/S0070-2153(09)88001-0; MICHAEL AS, 1955, J ECON ENTOMOL, V48, P43, DOI 10.1093/jee/48.1.43; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; MORSE RA, 1979, REARING QUEEN HONEY; Mutti NS, 2011, J EXP BIOL, V214, P3977, DOI 10.1242/jeb.061499; Oomen P. A., 1992, Bulletin OEPP, V22, P613, DOI 10.1111/j.1365-2338.1992.tb00546.x; Page RE, 2001, EXP GERONTOL, V36, P695, DOI 10.1016/S0531-5565(00)00236-9; Patel A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000509; PENG YSC, 1992, J INVERTEBR PATHOL, V60, P127, DOI 10.1016/0022-2011(92)90085-I; REMBOLD H, 1974, J INSECT PHYSIOL, V20, P307, DOI 10.1016/0022-1910(74)90063-8; Rembold H., 1983, QUEEN REARING BIOL B; REMBOLD HEINZ, 1965, VITAMINS HORMONES, V23, P359; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; ROHLF FJ, 2007, TPSRELW VERSION 1 45; Schur Andrea, 2003, Bulletin of Insectology, V56, P91; SHUEL RW, 1978, J APICULT RES, V17, P57, DOI 10.1080/00218839.1978.11099904; Snodgrass RE, 1992, HIVE HONEY BEE, P103; STATSOFT INC, 2004, PROGR COMP STAT 7 0; Tarpy DR, 2011, INSECT SOC, V58, P569, DOI 10.1007/s00040-011-0180-z; Von Rhein Werner, 1933, Wilhelm Roux Arch Entwickl Mech Org, V129, P601, DOI 10.1007/BF00656581; Winston M.L., 1991, BIOL HONEY BEE; WITTMANN D, 1981, Z ANGEW ENTOMOL, V92, P165; Wolschin F, 2011, BIOL LETTERS, V7, P112, DOI 10.1098/rsbl.2010.0463	48	23	23	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123663	10.1371/journal.pone.0123663	http://dx.doi.org/10.1371/journal.pone.0123663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894528	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000353211700048
J	Grier, MD; Carson, RP; Lagrange, AH				Grier, Mark D.; Carson, Robert P.; Lagrange, Andre Hollis			Toward a Broader View of Ube3a in a Mouse Model of Angelman Syndrome: Expression in Brain, Spinal Cord, Sciatic Nerve and Glial Cells	PLOS ONE			English	Article							UBIQUITIN LIGASE; WHITE-MATTER; REVEALS; GENE	Angelman Syndrome (AS) is a devastating neurodevelopmental disorder characterized by developmental delay, speech impairment, movement disorder, sleep disorders and refractory epilepsy. AS is caused by loss of the Ube3a protein encoded for by the imprinted Ube3a gene. Ube3a is expressed nearly exclusively from the maternal chromosome in mature neurons. While imprinting in neurons of the brain has been well described, the imprinting and expression of Ube3a in other neural tissues remains relatively unexplored. Moreover, given the overwhelming deficits in brain function in AS patients, the possibility of disrupted Ube3a expression in the infratentorial nervous system and its consequent disability have been largely ignored. We evaluated the imprinting status of Ube3a in the spinal cord and sciatic nerve and show that it is also imprinted in these neural tissues. Furthermore, a growing body of clinical and radiological evidence has suggested that myelin dysfunction may contribute to morbidity in many neurodevelopmental syndromes. However, findings regarding Ube3a expression in non-neuronal cells of the brain have varied. Utilizing enriched primary cultures of oligodendrocytes and astrocytes, we show that Ube3a is expressed, but not imprinted in these cell types. Unlike many other neurodevelopmental disorders, AS symptoms do not become apparent until roughly 6 to 12 months of age. To determine the temporal expression pattern and silencing, we analyzed Ube3a expression in AS mice at several time points. We confirm relaxed imprinting of Ube3a in neurons of the postnatal developing cortex, but not in structures in which neurogenesis and migration are more complete. This furthers the hypothesis that the apparently normal window of development in AS patients is supported by an incompletely silenced paternal allele in developing neurons, resulting in a relative preservation of Ube3a expression during this crucial epoch of early development.	[Grier, Mark D.; Carson, Robert P.; Lagrange, Andre Hollis] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN 37232 USA; [Carson, Robert P.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Lagrange, Andre Hollis] Tennessee Valley Vet Adm, Dept Neurol, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University	Lagrange, AH (corresponding author), Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN 37232 USA.	Andre.H.Lagrange@vanderbilt.edu	Lagrange, Andre/B-1227-2008	Lagrange, Andre/0000-0003-0147-7778	Vanderbilt Kennedy Center [VA 1I01BX001189]; National Institute of Neurological Disorders and Stroke; NIH [5K08NS050484]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS050484, K08NS083710] Funding Source: NIH RePORTER	Vanderbilt Kennedy Center; National Institute of Neurological Disorders and Stroke; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by a Hobbs Discovery Grant from the Vanderbilt Kennedy Center and VA 1I01BX001189 to AHL and the National Institute of Neurological Disorders and Stroke; NIH (5K08NS050484) to RPC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; Castro-Gago M, 2010, EUR J PAEDIATR NEURO, V14, P292, DOI 10.1016/j.ejpn.2009.07.007; Chamberlain SJ, 2010, P NATL ACAD SCI USA, V107, P17668, DOI 10.1073/pnas.1004487107; Corty Megan M, 2013, J Cell Biol, V203, P395, DOI 10.1083/jcb.201306099; Dindot SV, 2008, HUM MOL GENET, V17, P111, DOI 10.1093/hmg/ddm288; Egawa K, 2008, NEUROIMAGE, V39, P593, DOI 10.1016/j.neuroimage.2007.09.006; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Gustin RM, 2010, NEUROBIOL DIS; Harting I, 2009, EUR J PAEDIATR NEURO, V13, P271, DOI 10.1016/j.ejpn.2008.04.005; Heck DH, 2008, HUM MOL GENET, V17, P2181, DOI 10.1093/hmg/ddn117; Huang HS, 2012, NATURE, V481, P185, DOI 10.1038/nature10726; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Judson MC, 2014, J COMP NEUROL, V522, P1874, DOI 10.1002/cne.23507; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Lossie AC, 2001, J MED GENET, V38, P834, DOI 10.1136/jmg.38.12.834; Lu YB, 2009, HUM MOL GENET, V18, P454, DOI 10.1093/hmg/ddn373; Meng LY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004039; Meng LY, 2012, HUM MOL GENET, V21, P3001, DOI 10.1093/hmg/dds130; Nakatani J, 2009, CELL, V137, P1235, DOI 10.1016/j.cell.2009.04.024; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; O'Meara RW, 2011, JOVE-J VIS EXP, DOI 10.3791/3324; Peters SU, 2011, DEV MED CHILD NEUROL, V53, P361, DOI 10.1111/j.1469-8749.2010.03838.x; Sato M, 2010, P NATL ACAD SCI USA, V107, P5611, DOI 10.1073/pnas.1001281107; Simao G, 2010, AM J NEURORADIOL, V31, P1273, DOI 10.3174/ajnr.A2033; Smith A, 1997, J MED GENET, V34, P426, DOI 10.1136/jmg.34.5.426; Smith SEP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002627; Walz NC, 2006, AM J OCCUP THER, V60, P472, DOI 10.5014/ajot.60.4.472; Williams CA, 2006, AM J MED GENET A, V140A, P413, DOI 10.1002/ajmg.a.31074; Williams CA, 2010, GENET MED, V12, P385, DOI 10.1097/GIM.0b013e3181def138; Wolff JJ, 2012, AM J PSYCHIAT, V169, P589, DOI 10.1176/appi.ajp.2011.11091447; Yarnasaki K, 2003, HUM MOL GENET, V12, P837, DOI 10.1093/hmg/ddg106	31	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124649	10.1371/journal.pone.0124649	http://dx.doi.org/10.1371/journal.pone.0124649			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894543	Green Published, Green Submitted, gold			2022-12-26	WOS:000353211700112
J	Hao, RJ; Adoligbe, C; Jiang, BJ; Zhao, XL; Gui, LS; Qu, KX; Wu, S; Zan, LS				Hao, Ruijie; Adoligbe, Camus; Jiang, Bijie; Zhao, Xianlin; Gui, Linsheng; Qu, Kaixing; Wu, Sen; Zan, Linsen			An Optimized Trichloroacetic Acid/Acetone Precipitation Method for Two-Dimensional Gel Electrophoresis Analysis of Qinchuan Cattle Longissimus Dorsi Muscle Containing High Proportion of Marbling	PLOS ONE			English	Article							PROTEIN EXTRACTION; SAMPLE PREPARATION; MASS-SPECTROMETRY; PLANT-TISSUES; PROTEOMICS; RESOLUTION; SOLUBILIZATION; COMPATIBILITY; IMPROVEMENTS; MEMBRANE	Longissimus dorsi muscle (LD) proteomics provides a novel opportunity to reveal the molecular mechanism behind intramuscular fat deposition. Unfortunately, the vast amounts of lipids and nucleic acids in this tissue hampered LD proteomics analysis. Trichloroacetic acid (TCA)/acetone precipitation is a widely used method to remove contaminants from protein samples. However, the high speed centrifugation employed in this method produces hard precipitates, which restrict contaminant elimination and protein re-dissolution. To address the problem, the centrifugation precipitates were first grinded with a glass tissue grinder and then washed with 90% acetone (TCA/acetone-G-W) in the present study. According to our result, the treatment for solid precipitate facilitated non-protein contaminant removal and protein re-dissolution, ultimately improving two-dimensional gel electrophoresis (2-DE) analysis. Additionally, we also evaluated the effect of sample drying on 2-DE profile as well as protein yield. It was found that 30 min air-drying did not result in significant protein loss, but reduced horizontal streaking and smearing on 2-DE gel compared to 10 min. In summary, we developed an optimized TCA/acetone precipitation method for protein extraction of LD, in which the modifications improved the effectiveness of TCA/acetone method.	[Hao, Ruijie; Adoligbe, Camus; Jiang, Bijie; Zhao, Xianlin; Gui, Linsheng; Qu, Kaixing; Wu, Sen; Zan, Linsen] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Zan, Linsen] Northwest A&F Univ, Natl Beef Cattle Improvement Ctr, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Zan, LS (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.	zanlinsen@163.com	开兴, 亐/AAG-4304-2020	Wu, Sen/0000-0001-5244-4293	National 863 Program of China [2013AA102505, 2011AA100307-02]; National Natural Science Foundation [31272411]; National Beef and Yak Industrial Technology System [CARS-38]; National Science-technology Support Plan Projects [2012BAD28B04-03]; Major Projects for New Varieties of Genetically Modified Organisms of China [2011ZX08007-002]; Technical Innovation Engineering Project of Shaanxi Province [2014KTZB02-02-01]	National 863 Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Beef and Yak Industrial Technology System; National Science-technology Support Plan Projects; Major Projects for New Varieties of Genetically Modified Organisms of China; Technical Innovation Engineering Project of Shaanxi Province	This work was supported by National 863 Program of China (#2013AA102505 & #2011AA100307-02) http://www.863.gov.on/, National Natural Science Foundation (#31272411) http://www.nsfc.gov.on/, National Beef and Yak Industrial Technology System (#CARS-38) http://www.moa.gov.on/, National Science-technology Support Plan Projects (#2012BAD28B04-03) http://www.most.gov.on/, Major Projects for New Varieties of Genetically Modified Organisms of China (#2011ZX08007-002) http://www.most.gov.on/kjjh/, and Technical Innovation Engineering Project of Shaanxi Province (#2014KTZB02-02-01) http://www.sninfo.gov.on: 8083/initSnFirstPageList. do?method = initSnFirstPageList. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry R, 2004, PROTEOMICS, V4, P3717, DOI 10.1002/pmic.200300877; Bjarnadottir SG, 2010, J AGR FOOD CHEM, V58, P7408, DOI 10.1021/jf100697h; Bodzon-Kulakowska A, 2007, J CHROMATOGR B, V849, P1, DOI 10.1016/j.jchromb.2006.10.040; Bouley J, 2004, PROTEOMICS, V4, P1811, DOI 10.1002/pmic.200300688; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Canas B, 2007, J CHROMATOGR A, V1153, P235, DOI 10.1016/j.chroma.2007.01.045; Carpentier SC, 2005, PROTEOMICS, V5, P2497, DOI 10.1002/pmic.200401222; Chaze T, 2008, PROTEOMICS, V8, P4236, DOI 10.1002/pmic.200701101; Chromy BA, 2014, PROTEOME SCI, V12, DOI 10.1186/1477-5956-12-10; DAMERVAL C, 1986, ELECTROPHORESIS, V7, P52, DOI 10.1002/elps.1150070108; DESFRANCS CC, 1985, PLANT PHYSIOL, V78, P178, DOI 10.1104/pp.78.1.178; Garbis S, 2005, J CHROMATOGR A, V1077, P1, DOI 10.1016/j.chroma.2005.04.059; Giavalisco P, 2003, ELECTROPHORESIS, V24, P207, DOI 10.1002/elps.200390016; Gorg A, 1998, ELECTROPHORESIS, V19, P1516, DOI 10.1002/elps.1150190850; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; GORG A, 1988, ELECTROPHORESIS, V9, P681, DOI 10.1002/elps.1150091103; Herbert BR, 1998, ELECTROPHORESIS, V19, P845, DOI 10.1002/elps.1150190540; HOCHSTRASSER DF, 1988, ANAL BIOCHEM, V173, P424, DOI 10.1016/0003-2697(88)90209-6; Islam N, 2004, PROTEOMICS, V4, P1903, DOI 10.1002/pmic.200300816; Jiang L, 2004, J CHROMATOGR A, V1023, P317, DOI 10.1016/j.chroma.2003.10.029; KLOSE J, 1995, ELECTROPHORESIS, V16, P1034, DOI 10.1002/elps.11501601175; Lametsch R, 2003, J AGR FOOD CHEM, V51, P6992, DOI 10.1021/jf034083p; Lametsch R, 2001, J AGR FOOD CHEM, V49, P4531, DOI 10.1021/jf010103g; Laville E, 2009, J AGR FOOD CHEM, V57, P10755, DOI 10.1021/jf901949r; Lee H, 2010, FOOD SCI BIOTECHNOL, V19, P1107, DOI 10.1007/s10068-010-0157-0; Li AN, 2013, MAMM GENOME, V24, P72, DOI 10.1007/s00335-012-9440-0; Lin JF, 2008, ANAL BIOANAL CHEM, V390, P1765, DOI 10.1007/s00216-008-1910-6; Liu JS, 2009, J AGR FOOD CHEM, V57, P3808, DOI 10.1021/jf8033144; Luque-Garcia JL, 2007, J CHROMATOGR A, V1153, P259, DOI 10.1016/j.chroma.2006.11.054; MACGILLIVRAY AJ, 1974, EUR J BIOCHEM, V41, P181, DOI 10.1111/j.1432-1033.1974.tb03258.x; Maldonado AM, 2008, J PROTEOMICS, V71, P461, DOI 10.1016/j.jprot.2008.06.012; Marino R, 2013, MEAT SCI, V95, P281, DOI 10.1016/j.meatsci.2013.04.009; Millioni R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030911; Nandakumar MP, 2003, J PROTEOME RES, V2, P89, DOI 10.1021/pr025541x; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Ohlendieck K, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-6; Pomastowski P, 2014, TRAC-TREND ANAL CHEM, V53, P167, DOI 10.1016/j.trac.2013.09.010; Rabilloud T, 1997, ELECTROPHORESIS, V18, P307, DOI 10.1002/elps.1150180303; Rabilloud T, 2011, J PROTEOMICS, V74, P1829, DOI 10.1016/j.jprot.2011.05.040; Rabilloud T, 2010, J PROTEOMICS, V73, P2064, DOI 10.1016/j.jprot.2010.05.016; Rodriguez-Pineiro AM, 2007, J CHROMATOGR B, V849, P251, DOI 10.1016/j.jchromb.2006.09.021; Roe MR, 2006, PROTEOMICS, V6, P4678, DOI 10.1002/pmic.200500876; Ruan YS, 2007, ELECTROPHORESIS, V28, P3333, DOI 10.1002/elps.200700035; Saravanan RS, 2004, PROTEOMICS, V4, P2522, DOI 10.1002/pmic.200300789; Sheoran IS, 2009, PLANT SCI, V176, P99, DOI 10.1016/j.plantsci.2008.09.015; Song YF, 2012, PLANT MOL BIOL REP, V30, P1204, DOI 10.1007/s11105-012-0442-6; Tang SH, 2002, J AGR FOOD CHEM, V50, P7444, DOI 10.1021/jf025771w; Taylor CM, 2003, PROTEOMICS, V3, P1303, DOI 10.1002/pmic.200300451; Wang SB, 2003, J APPL PHYCOL, V15, P485, DOI 10.1023/B:JAPH.0000004324.88897.b2; Wilkins M, 2009, EXPERT REV PROTEOMIC, V6, P599, DOI [10.1586/epr.09.81, 10.1586/EPR.09.81]; Wu BY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097286; Wu XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050497; Wu YP, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-38; Zhang Q, 2010, MEAT SCI, V86, P814, DOI 10.1016/j.meatsci.2010.07.002	54	14	15	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124723	10.1371/journal.pone.0124723	http://dx.doi.org/10.1371/journal.pone.0124723			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893432	Green Published, Green Submitted, gold			2022-12-26	WOS:000353211700118
J	Lin, CY; Li, PZ; Cheng, HG; Ouyang, W				Lin, Chunye; Li, Peizhong; Cheng, Hongguang; Ouyang, Wei			Vertical Distribution of Lead and Mercury in the Wetland Argialbolls of the Sanjiang Plain in Northeastern China	PLOS ONE			English	Article							SOIL PROFILES; DEPTH PROFILE; UPLAND FOREST; HEAVY-METALS; PEAT BOG; CONTAMINATION; DEPOSITION; SPECIATION; FRACTIONS; DOWNWASH	The wetland Argialbolls pedon was chosen to investigate the effects of pedogenic processes and anthropogenic activities on the vertical distribution of lead and mercury concentration and to assess the potential use of soil as an archive of atmospheric Pb and Hg pollution. The soil was sampled from 5 cm from the surface to a depth of 90 cm at two locations in the Sanjiang Plain in northeastern China. The soil was analyzed for pH, soil organic matter (SOM), Fe, Mn, and Al. The results indicate that the SOM concentration gradually decreased with depth, while Fe and Mn were reductively leached from the upper horizons and accumulated significantly in the lower argillic horizons. Atmospheric Pb and Hg deposition and their redistribution during the pedogenic process led to a unique vertical distribution in the wetland Argialbolls. Overall, Pb was leached from the upper horizons and then accumulated in the lower argillic horizons. However, the Hg concentration decreased with depth, following the SOM distribution. The Pb concentration was significantly correlated to the Fe and Mn concentrations in the Argialbolls profiles, while the Hg concentration was significantly correlated with SOM. Post-depositional mobility along the wetland Argialbolls profile is higher for Pb and low for Hg. Therefore, the Argialbolls profile does not provide an accurate reconstruction of atmospheric Pb deposition, but might provide an accurate reconstruction of net atmospheric Hg deposition.	[Lin, Chunye; Li, Peizhong; Cheng, Hongguang; Ouyang, Wei] Beijing Normal Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100875, Peoples R China	Beijing Normal University	Lin, CY (corresponding author), Beijing Normal Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100875, Peoples R China.	c.lin@bnu.edu.cn		wei, ouyang/0000-0002-5851-056X	National Natural Science Foundation of China [41171359]; National Science and Technology Infrastructure Program [2012BAD15B05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Infrastructure Program	This study was supported by the National Natural Science Foundation of China (41171359) (http://www.nsfc.gov.cn/) and National Science and Technology Infrastructure Program (2012BAD15B05) (http://program.most.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENDOR E, 1989, COMMUN SOIL SCI PLAN, V20, P1675, DOI 10.1080/00103628909368175; Bowen H. J. M, 1979, ENV CHEM ELEMENTS; Burns DA, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086855, 10.1371/journal.pone.0090913]; Chi GY, 2010, J SOIL SEDIMENT, V10, P787, DOI 10.1007/s11368-009-0140-7; do Valle CM, 2005, CHEMOSPHERE, V58, P779, DOI 10.1016/j.chemosphere.2004.09.005; Donisa C, 2005, APPL GEOCHEM, V20, P1258, DOI 10.1016/j.apgeochem.2005.03.006; Fu XW, 2010, ENVIRON POLLUT, V158, P2324, DOI 10.1016/j.envpol.2010.01.032; Gong P, 2014, ENVIRON POLLUT, V188, P94, DOI 10.1016/j.envpol.2014.01.020; Gong Z.T., 2007, CHINA SOIL GENETIC T; Grimaldi C, 2008, SCI TOTAL ENVIRON, V401, P121, DOI 10.1016/j.scitotenv.2008.04.001; Grybos M, 2007, J COLLOID INTERF SCI, V314, P490, DOI 10.1016/j.jcis.2007.04.062; Han F.X., 2007, BIOGEOCHEMISTRY TRAC; Han FXX, 2002, NATURWISSENSCHAFTEN, V89, P497, DOI 10.1007/s00114-002-0373-4; Han FXX, 2003, NATURWISSENSCHAFTEN, V90, P395, DOI 10.1007/s00114-003-0451-2; Hansson SV, 2015, SCI TOTAL ENVIRON, V506, P95, DOI 10.1016/j.scitotenv.2014.10.083; Hansson SV, 2014, SCI TOTAL ENVIRON, V493, P170, DOI 10.1016/j.scitotenv.2014.05.088; Hansson SV, 2014, BIOGEOCHEMISTRY, V119, P329, DOI 10.1007/s10533-014-9969-y; Johnson CE, 1998, SOIL SCI SOC AM J, V62, P782, DOI 10.2136/sssaj1998.03615995006200030035x; Karczewska A, 1996, APPL GEOCHEM, V11, P35, DOI 10.1016/0883-2927(95)00063-1; Kaste JM, 2011, GEOCHIM COSMOCHIM AC, V75, P1642, DOI 10.1016/j.gca.2011.01.011; Kylander ME, 2008, ENVIRON SCI TECHNOL, V42, P3177, DOI 10.1021/es702358e; Li ZG, 2011, APPL GEOCHEM, V26, P160, DOI 10.1016/j.apgeochem.2010.11.014; Lin CY, 2008, ENVIRON MONIT ASSESS, V137, P329, DOI 10.1007/s10661-007-9768-1; Liu RH, 2003, ENVIRON POLLUT, V124, P39, DOI 10.1016/S0269-7491(02)00432-3; Liu Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0106787, 10.1371/journal.pone.0098157, 10.1371/journal.pone.0085323]; Martinez-Cortizas A, 1999, SCIENCE, V284, P939, DOI 10.1126/science.284.5416.939; Pingitore NE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005019; Prapaipong P, 2008, APPL GEOCHEM, V23, P2156, DOI 10.1016/j.apgeochem.2008.05.002; Prohaska T, 2005, INT J MASS SPECTROM, V242, P243, DOI 10.1016/j.ijms.2004.11.028; Prohaska T, 2000, J ANAL ATOM SPECTROM, V15, P365, DOI 10.1039/a907203i; Qi YB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097327; Richardson JB, 2013, ENVIRON POLLUT, V182, P127, DOI 10.1016/j.envpol.2013.07.011; Seybold CA, 2002, WETLANDS, V22, P149, DOI 10.1672/0277-5212(2002)022[0149:SRPTAW]2.0.CO;2; Shotyk W., 1998, HIST ATMOSPHERIC LEA, V12, P370; Sipos P, 2005, ENVIRON GEOCHEM HLTH, V27, P1, DOI 10.1007/s10653-004-1581-y; Stumm W., 2012, AQUATIC CHEM CHEM EQ; Wei F.S., 1990, BACKGROUND CONTENTS; Xie P. R., 2010, CHEM MINERAL PROPERT; Yang WJ, 2012, GEODERMA, V189, P207, DOI 10.1016/j.geoderma.2012.06.025; Zheng SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049664	40	3	3	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124294	10.1371/journal.pone.0124294	http://dx.doi.org/10.1371/journal.pone.0124294			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894341	gold, Green Published, Green Submitted			2022-12-26	WOS:000353211700085
J	Pozniak, B; Grabowski, T; Motykiewicz-Pers, K; Bobrek, K; Rak, L; Bobusia, K; Gawel, A; Switala, M				Pozniak, Blazej; Grabowski, Tomasz; Motykiewicz-Pers, Karolina; Bobrek, Kamila; Rak, Lech; Bobusia, Katarzyna; Gawel, Andrzej; Switala, Marcin			Pharmacokinetics of Repeated Sodium Salicylate Administration to Laying Hens: Evidence for Time Dependent Increase in Drug Elimination from Plasma and Eggs	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; DIETARY ACETYLSALICYLIC-ACID; INDUCTION; CHICKENS; ASPIRIN	Salicylates were the first non-steroid anti-inflammatory drugs (NSAIDs) to be used in any species and are still widely used in humans and livestock. However, the data on their pharmacokinetics in animals is limited, especially after repeated administration. Evidence exist that in chickens (Gallus gallus) salicylate (SA) may induce its own elimination. The aim of this study was to investigate salicylate pharmacokinetics and egg residues during repeated administration of sodium salicylate (SS) to laying hens. Pharmacokinetics of SA was assessed during 14 d oral administration of SS at daily doses of 50 mg/kg and 200 mg/kg body weight to laying hens. On the 1st, 7th and 14th d a 24 h-long pharmacokinetic study was carried out, whereas eggs were collected daily. Salicylate concentrations in plasma and eggs were determined using high-performance liquid chromatography with ultraviolet detection and pharmacokinetic variables were calculated using a non-compartmental model. Mean residence time (MRT), minimal plasma concentration (C-min, C-16h) and elimination half-life (T-1/2el) of SA showed gradual decrease in layers administered with a lower dose. Total body clearance (CIB) increased. Layers administered with the higher dose showed a decrease only in the T-1/2el. In the low dose group, SA was found only in the egg white and was low throughout the experiment. Egg whites from the higher dose group showed initially high SA levels which significantly decreased during the experiment. Yolk SA levels were lower and showed longer periods of accumulation and elimination. Repeated administration of SS induces SA elimination, although this effect may differ depending on the dose and production type of a chicken. Decreased plasma drug concentration may have clinical implications during prolonged SS treatment.	[Pozniak, Blazej; Motykiewicz-Pers, Karolina; Switala, Marcin] Wroclaw Univ Environm & Life Sci, Fac Vet Med, Dept Biochem Pharmacol & Toxicol, Wroclaw, Poland; [Grabowski, Tomasz] Polpharma Biol, Gdansk, Poland; [Bobrek, Kamila; Bobusia, Katarzyna; Gawel, Andrzej] Wroclaw Univ Environm & Life Sci, Dept Epizootiol, Fac Vet Med, Wroclaw, Poland; [Bobrek, Kamila; Bobusia, Katarzyna; Gawel, Andrzej] Wroclaw Univ Environm & Life Sci, Clin Birds & Exot Anim, Fac Vet Med, Wroclaw, Poland; [Rak, Lech] Wroclaw Univ Environm & Life Sci, Fac Vet Med, Dept Food Hyg & Consumer Hlth Protect, Wroclaw, Poland	Wroclaw University of Environmental & Life Sciences; Wroclaw University of Environmental & Life Sciences; Wroclaw University of Environmental & Life Sciences; Wroclaw University of Environmental & Life Sciences	Pozniak, B (corresponding author), Wroclaw Univ Environm & Life Sci, Fac Vet Med, Dept Biochem Pharmacol & Toxicol, Wroclaw, Poland.	blazej.pozniak@up.wroc.pl	Świtała, Marcin/ABB-4761-2021; Grabowski, Tomasz/GPT-2033-2022; Grabowski, Tomasz/AAE-6300-2020; Poźniak, Błażej/ABB-4032-2021; Bobrek, Kamila/X-2745-2018	Grabowski, Tomasz/0000-0002-3077-9698; Grabowski, Tomasz/0000-0002-3077-9698; Poźniak, Błażej/0000-0002-5813-1404; Gawel, Andrzej/0000-0002-5595-8852; Switala, Marcin/0000-0001-7356-1333; Bobrek, Kamila/0000-0001-7214-073X	Fundamental Research Fund for the Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Sciences [WdW/ 312/99/2010]; Wroclaw Centre of Biotechnology, programme: the Leading National Research Centre (KNOW); Polpharma Biologics	Fundamental Research Fund for the Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Sciences; Wroclaw Centre of Biotechnology, programme: the Leading National Research Centre (KNOW); Polpharma Biologics	This research was supported by the Fundamental Research Fund for the Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Sciences (WdW/ 312/99/2010). Publication supported by Wroclaw Centre of Biotechnology, programme: the Leading National Research Centre (KNOW) for years 2014-2018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author TG is employed by Polpharma Biologics. Polpharma Biologics provided support in the form of salary for author TG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Baenkler H, 2008, DTSCH ARZTEBL INT, V105, P137, DOI 10.3238/arztebl.2008.0137; Baert K, 2004, J VET PHARMACOL THER, V27, P123, DOI 10.1111/j.1365-2885.2004.00554.x; Baert K, 2003, COMP BIOCHEM PHYS C, V134, P25, DOI 10.1016/S1532-0456(02)00184-9; Baert K, 2002, J VET PHARMACOL THER, V25, P449, DOI 10.1046/j.1365-2885.2002.00441.x; Balog JM, 2000, POULTRY SCI, V79, P1101, DOI 10.1093/ps/79.8.1101; BALOG JM, 1991, POULTRY SCI, V70, P624, DOI 10.3382/ps.0700624; Boulianne M., 1990, Proceedings of the thirty-ninth Western Poultry Disease Conference, March 4-6, 1990, Sacramento, California., P89; Damme B, 1996, TOXICOLOGY, V106, P99, DOI 10.1016/0300-483X(95)03168-F; de Boever S, 2010, J VET PHARMACOL THER, V33, P564, DOI 10.1111/j.1365-2885.2010.01184.x; Donoghue DJ, 2000, BRIT POULTRY SCI, V41, P174, DOI 10.1080/713654912; Dupont I, 1999, DRUG METAB DISPOS, V27, P322; Johnson A.L., 2000, P569, DOI 10.1016/B978-012747605-6/50023-7; JOUGLAR JY, 1992, RECL MED VET, V168, P745; LEES P, 1991, J SMALL ANIM PRACT, V32, P183, DOI 10.1111/j.1748-5827.1991.tb00541.x; Liu JH, 1996, J CHROMATOGR B, V675, P61; Machin KL, 2005, SEMIN AVIAN EXOT PET, V14, P236, DOI 10.1053/j.saep.2005.09.004; MCDANIEL CD, 1993, POULTRY SCI, V72, P1109, DOI 10.3382/ps.0721109; Mohammad FK, 2012, VET MED-CZECH, V57, P121, DOI 10.17221/5851-VETMED; Mohammed A.A., 2010, INT J POULTRY SCI, V9, P382; Nebbia C, 2003, VET J, V165, P53, DOI 10.1016/S1090-0233(02)00174-0; Pozniak B, 2013, BRIT POULTRY SCI, V54, P538, DOI 10.1080/00071668.2013.809403; Pozniak B, 2012, BRIT POULTRY SCI, V53, P777, DOI 10.1080/00071668.2012.745929; Sampson HA, 1999, J ALLERGY CLIN IMMUN, V103, P717, DOI 10.1016/S0091-6749(99)70411-2; Xu CJ, 2005, ARCH PHARM RES, V28, P249, DOI 10.1007/BF02977789	24	8	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123526	10.1371/journal.pone.0123526	http://dx.doi.org/10.1371/journal.pone.0123526			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893240	Green Submitted, Green Published, gold			2022-12-26	WOS:000353211700039
J	Ravichandran, A; Ramachandran, M; Suriyanarayanan, T; Wong, CC; Swarup, S				Ravichandran, Ayshwarya; Ramachandran, Malarmathy; Suriyanarayanan, Tanujaa; Wong, Chui Ching; Swarup, Sanjay			Global Regulator MorA Affects Virulence-Associated Protease Secretion in Pseudomonas aeruginosa PAO1	PLOS ONE			English	Article							C-DI-GMP; QUORUM-SENSING SYSTEMS; II SECRETION; EXTRACELLULAR SECRETION; CYCLIC DIGUANYLATE; BIOFILM FORMATION; OLIGOMERIC RINGS; EPITHELIAL-CELLS; DOMAIN PROTEINS; OUTER-MEMBRANE	Bacterial invasion plays a critical role in the establishment of Pseudomonas aeruginosainfection and is aided by two major virulence factors - surface appendages and secreted proteases. The second messenger cyclic diguanylate (c-di-GMP) is known to affect bacterial attachment to surfaces, biofilm formation and related virulence phenomena. Here we report that MorA, a global regulator with GGDEF and EAL domains that was previously reported to affect virulence factors, negatively regulates protease secretion via the type II secretion system (T2SS) in P. aeruginosa PAO1. Infection assays with mutant strains carrying gene deletion and domain mutants show that host cell invasion is dependent on the active domain function of MorA. Further investigations suggest that the MorA-mediated c-di-GMP signaling affects protease secretion largely at a post-translational level. We thus report c-di-GMP second messenger system as a novel regulator of T2SS function in P. aeruginosa. Given that T2SS is a central and constitutive pump, and the secreted proteases are involved in interactions with the microbial surroundings, our data broadens the significance of c-di-GMP signaling in P. aeruginosa pathogenesis and ecological fitness.	[Ravichandran, Ayshwarya; Ramachandran, Malarmathy; Suriyanarayanan, Tanujaa; Wong, Chui Ching; Swarup, Sanjay] Natl Univ Singapore, Dept Biol Sci, Metabolites Biol Lab, Singapore 117543, Singapore; [Ravichandran, Ayshwarya; Wong, Chui Ching; Swarup, Sanjay] Natl Univ Singapore, Mechanobiol Inst, Singapore 117411, Singapore; [Swarup, Sanjay] Natl Univ Singapore, NUS Environm Res Inst NERI, Singapore 117411, Singapore; [Suriyanarayanan, Tanujaa; Swarup, Sanjay] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore 637551, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Swarup, S (corresponding author), Natl Univ Singapore, Dept Biol Sci, Metabolites Biol Lab, Singapore 117543, Singapore.	sanjay@nus.edu.sg	Swarup, Sanjay/I-1592-2012	Swarup, Sanjay/0000-0001-6391-0624; Wong, Judith Chui Ching/0000-0002-2061-4486	Mechanobiology Institute [R714-010-006-271]	Mechanobiology Institute	This work was supported by the Mechanobiology Institute (www.mbi.nus.edu.sg) grant no: R714-010-006-271. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 2011, MOL CELL, V43, P550, DOI 10.1016/j.molcel.2011.07.018; Albus AM, 1997, J BACTERIOL, V179, P3928, DOI 10.1128/jb.179.12.3928-3935.1997; Ball G, 2002, MOL MICROBIOL, V43, P475, DOI 10.1046/j.1365-2958.2002.02759.x; Bauman SJ, 2006, MICROBES INFECT, V8, P2400, DOI 10.1016/j.micinf.2006.05.001; Bitter W, 1998, MOL MICROBIOL, V27, P209, DOI 10.1046/j.1365-2958.1998.00677.x; Bleves S, 2010, INT J MED MICROBIOL, V300, P534, DOI 10.1016/j.ijmm.2010.08.005; Borlee BR, 2010, MOL MICROBIOL, V75, P827, DOI 10.1111/j.1365-2958.2009.06991.x; Braun P, 1998, J BACTERIOL, V180, P3467, DOI 10.1128/JB.180.13.3467-3469.1998; Brok R, 1999, J MOL BIOL, V294, P1169, DOI 10.1006/jmbi.1999.3340; Cahan R, 2001, J BIOL CHEM, V276, P43645, DOI 10.1074/jbc.M106950200; ChaponHerve V, 1997, MOL MICROBIOL, V24, P1169, DOI 10.1046/j.1365-2958.1997.4271794.x; Choy W, 2006, SERIES ADV BIOINFORM, V8, P123; Choy WK, 2004, J BACTERIOL, V186, P7221, DOI 10.1128/JB.186.21.7221-7228.2004; Christen M, 2010, SCIENCE, V328, P1295, DOI 10.1126/science.1188658; Cianciotto NP, 2014, CURR TOP MICROBIOL, V376, P81, DOI 10.1007/82_2013_339; Cotter PA, 2007, CURR OPIN MICROBIOL, V10, P17, DOI 10.1016/j.mib.2006.12.006; Cowell BA, 2003, MICROBIOL-SGM, V149, P2291, DOI 10.1099/mic.0.26280-0; D'Argenio DA, 2002, J BACTERIOL, V184, P6481, DOI 10.1128/JB.184.23.6481-6489.2002; Dasgupta N, 2003, MOL MICROBIOL, V50, P809, DOI 10.1046/j.1365-2958.2003.03740.x; Douzi B, 2012, PHILOS T R SOC B, V367, P1059, DOI 10.1098/rstb.2011.0204; Engel LS, 1998, J BIOL CHEM, V273, P16792, DOI 10.1074/jbc.273.27.16792; Erickson DL, 2002, INFECT IMMUN, V70, P1783, DOI 10.1128/IAI.70.4.1783-1790.2002; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003; Filloux A, 1998, FEMS MICROBIOL REV, V22, P177, DOI 10.1016/S0168-6445(98)00013-8; Fleiszig SMJ, 2001, INFECT IMMUN, V69, P4931, DOI 10.1128/IAI.69.8.4931-4937.2001; FLEISZIG SMJ, 1995, INFECT IMMUN, V63, P4072, DOI 10.1128/IAI.63.10.4072-4077.1995; Fleiszig SMJ, 1997, INFECT IMMUN, V65, P579, DOI 10.1128/IAI.65.2.579-586.1997; Fleiszig SMJ, 1996, ARVO ABSTR INVESTIG; Folders J, 2000, J BACTERIOL, V182, P1257, DOI 10.1128/JB.182.5.1257-1263.2000; Grande KK, 2007, J BACTERIOL, V189, P3960, DOI 10.1128/JB.01828-06; Guvener ZT, 2007, MOL MICROBIOL, V66, P1459, DOI 10.1111/j.1365-2958.2007.06008.x; Ha UH, 2004, MOL MICROBIOL, V54, P307, DOI 10.1111/j.1365-2958.2004.04282.x; HE SY, 1991, J BACTERIOL, V173, P4310, DOI 10.1128/JB.173.14.4310-4317.1991; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Johnson TL, 2014, J BACTERIOL, V196, P4245, DOI 10.1128/JB.01944-14; Kader A, 2006, MOL MICROBIOL, V60, P602, DOI 10.1111/j.1365-2958.2006.05123.x; Korotkov KV, 2012, NAT REV MICROBIOL, V10, P336, DOI 10.1038/nrmicro2762; Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103; Lee VT, 2007, MOL MICROBIOL, V65, P1474, DOI 10.1111/j.1365-2958.2007.05879.x; Levi A, 2006, J BACTERIOL, V188, P5315, DOI 10.1128/JB.01725-05; Lindenberg S, 2013, EMBO J, V32, P2001, DOI 10.1038/emboj.2013.120; Lu HM, 1996, EMBO J, V15, P429, DOI 10.1002/j.1460-2075.1996.tb00373.x; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Martinez A, 1998, MOL MICROBIOL, V28, P1235, DOI 10.1046/j.1365-2958.1998.00888.x; Massengale ARD, 2000, EXP LUNG RES, V26, P163; Matsumoto K, 2004, BIOL CHEM, V385, P1007, DOI 10.1515/BC.2004.131; McIver KS, 1995, MOL MICROBIOL, V18, P877, DOI 10.1111/j.1365-2958.1995.18050877.x; Meissner A, 2007, ENVIRON MICROBIOL, V9, P2475, DOI 10.1111/j.1462-2920.2007.01366.x; Merritt JH, 2010, MBIO, V1, DOI 10.1128/mBio.00183-10; Michel GPF, 2007, J BACTERIOL, V189, P3776, DOI 10.1128/JB.00205-07; Michel Gerard P. F., 2009, P67; MORIHARA K, 1965, J BIOL CHEM, V240, P3295; Moscoso JA, 2011, ENVIRON MICROBIOL, V13, P3128, DOI 10.1111/j.1462-2920.2011.02595.x; Navarro MVAS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000588; Newell PD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000587; Nivaskumar M, 2014, BBA-MOL CELL RES, V1843, P1568, DOI 10.1016/j.bbamcr.2013.12.020; Nouwens AS, 2003, MICROBIOL-SGM, V149, P1311, DOI 10.1099/mic.0.25967-0; Palomaki T, 2002, MOL MICROBIOL, V43, P585, DOI 10.1046/j.1365-2958.2002.02793.x; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; Perez-Mendoza D, 2011, MOL MICROBIOL, V82, P719, DOI 10.1111/j.1365-2958.2011.07849.x; Phippen CW, 2014, FEBS LETT, V588, P4631, DOI 10.1016/j.febslet.2014.11.002; Pollack M., 2000, PRINCIPLES PRACTICE; Pratt JT, 2007, J BIOL CHEM, V282, P12860, DOI 10.1074/jbc.M611593200; Reichow SL, 2010, NAT STRUCT MOL BIOL, V17, P1226, DOI 10.1038/nsmb.1910; Robert V, 2005, FEMS MICROBIOL LETT, V252, P43, DOI 10.1016/j.femsle.2005.08.029; Robert V, 2005, RES MICROBIOL, V156, P880, DOI 10.1016/j.resmic.2005.04.002; Romling U, 2009, CONTRIB MICROBIOL, V16, P161, DOI 10.1159/000219379; Ryjenkov DA, 2006, J BIOL CHEM, V281, P30310, DOI 10.1074/jbc.C600179200; Saier MH, 2006, J MEMBRANE BIOL, V214, P75, DOI 10.1007/s00232-006-0049-7; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; Sandkvist M, 2001, MOL MICROBIOL, V40, P271, DOI 10.1046/j.1365-2958.2001.02403.x; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Senf F, 2008, MICROBIOL-SGM, V154, P3025, DOI 10.1099/mic.0.2008/018069-0; Sheng LL, 2013, VET MICROBIOL, V162, P652, DOI 10.1016/j.vetmic.2012.09.009; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Smith RS, 2003, CURR OPIN MICROBIOL, V6, P56, DOI 10.1016/S1369-5274(03)00008-0; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Tao F, 2010, J BACTERIOL, V192, P1020, DOI 10.1128/JB.01253-09; Traidej M, 2003, INVEST OPHTH VIS SCI, V44, P190, DOI 10.1167/iovs.02-0458; Tuckerman JR, 2011, J MOL BIOL, V407, P633, DOI 10.1016/j.jmb.2011.02.019; Ueda A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000483; von Tils D, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00160; Voulhoux R, 2001, EMBO J, V20, P6735, DOI 10.1093/emboj/20.23.6735; Wagner VE, 2003, J BACTERIOL, V185, P2080, DOI 10.1128/JB.185.7.2080-2095.2003; Weber H, 2006, MOL MICROBIOL, V62, P1014, DOI 10.1111/j.1365-2958.2006.05440.x; Whiteley M, 1999, P NATL ACAD SCI USA, V96, P13904, DOI 10.1073/pnas.96.24.13904; Wilderman PJ, 2001, INFECT IMMUN, V69, P5385, DOI 10.1128/IAI.69.9.5385-5394.2001	91	10	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123805	10.1371/journal.pone.0123805	http://dx.doi.org/10.1371/journal.pone.0123805			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894344	Green Submitted, Green Published, gold			2022-12-26	WOS:000353211700059
J	Cui, J; Li, XL; Duan, ZG; Xue, WQ; Wang, Z; Lu, S; Lin, RZ; Liu, MF; Zhu, GX; Huang, JD				Cui, Ju; Li, Xiuling; Duan, Zhigang; Xue, Wenqian; Wang, Zai; Lu, Song; Lin, Raozhou; Liu, Mengfei; Zhu, Guixia; Huang, Jian-Dong			Analysis of Kif5b Expression during Mouse Kidney Development	PLOS ONE			English	Article							KINESIN HEAVY-CHAIN; PANCREATIC BETA-CELLS; THICK ASCENDING LIMB; CONVENTIONAL KINESIN; TARGETED DISRUPTION; DISTAL NEPHRON; TRANSPORT; JUNCTIONS; MICE; LOCALIZATION	Recent studies showed that kidney-specific inactivation of Kif3a produces kidney cysts and renal failure, suggesting that kinesin-mediated intracellular transportation is important for the establishement and maintenance of renal epithelial cell polarity and normal nephron functions. Kif5b, one of the most conserved kinesin heavy chain, is the mouse homologue of the human ubiquitous Kinesin Heavy Chain (uKHC). In order to elucidate the role of Kif5b in kidney development and function, it is essential to establish its expression profile within the organ. Therefore, in this study, we examined the expression pattern of Kif5b in mouse kidney. Kidneys from embryonic (E) 12.5-, 16.5-dpc (days post coitus) mouse fetuses, from postnatal (P) day 0, 10, 20 pups and from adult mice were collected. The distribution of Kif5b was analyzed by immunostaining. The possible involvement of Kif5b in kidney development was investigated in conditional mutant mice by using a Cre-LoxP strategy. This study showed that the distribution of Kif5b displayed spatiotemporal changes during postnatal kidney development. In kidneys of new born mice, Kif5b was strongly expressed in all developing tubules and in the ureteric bud, but not in the glomerulus or in other early-developing structures, such as the cap mesenchyme, the comma-shaped body, and the S-shaped body. In kidneys of postnatal day 20 or of older mice, however, Kif5b was localized selectively in the basolateral domain of epithelial cells of the thick ascending loop of Henle, as well as of the distal convoluted tubule, with little expression being observed in the proximal tubule or in the collecting duct. Conditional knock-down of Kif5b in mouse kidney did not result in detectable morphological defects, but it did lead to a decrease in cell proliferation rate and also to a misloalization of Na+/K+/-ATPase, indicating that although Kif5b is non-essential for kidney morphogenesis, it is important for nephron maturation.	[Cui, Ju] Beijing Hosp, Key Lab Geriatr, Beijing, Peoples R China; [Cui, Ju] Minist Hlth, Beijing Inst Geriatr, Beijing, Peoples R China; [Cui, Ju; Li, Xiuling; Xue, Wenqian; Wang, Zai; Lu, Song; Lin, Raozhou; Liu, Mengfei; Zhu, Guixia; Huang, Jian-Dong] Univ Hong Kong, LKS Fac Med, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; [Duan, Zhigang] Univ Hong Kong, LKS Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Wang, Zai] China Japan Friendship Hosp, Inst Clin Med Sci, Beijing, Peoples R China; [Huang, Jian-Dong] Shenzhen Inst Adv Technol, Ctr Synthet Biol Engn Res, Shenzhen, Peoples R China	Beijing Hospital; University of Hong Kong; University of Hong Kong; China-Japan Friendship Hospital; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Cui, J (corresponding author), Beijing Hosp, Key Lab Geriatr, Beijing, Peoples R China.	juzi.cui@gmail.com; jdhuang@hku.hk	Lin, Raozhou/ABG-3533-2021; /C-4277-2009	Lin, Raozhou/0000-0002-1066-8464; /0000-0001-7531-2816	Hong Kong Research Grants Council [HKU 768113M, HKU 767012]; Ph.D. Scientific Research Foundation of Beijing Hospital [BJ-2012-187]; National Natural Science Foundation of China [31400995]	Hong Kong Research Grants Council(Hong Kong Research Grants Council); Ph.D. Scientific Research Foundation of Beijing Hospital; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Hong Kong Research Grants Council (HKU 768113M, HKU 767012) to J.D.H., a Ph.D. Scientific Research Foundation of Beijing Hospital (BJ-2012-187) and a grant from National Natural Science Foundation of China (31400995) to J.C.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann S, 1999, ANAT EMBRYOL, V200, P447, DOI 10.1007/s004290050294; Cardoso CMP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004424; Cebrian C, 2004, DEV DYNAM, V231, P601, DOI 10.1002/dvdy.20143; CHAMBERLIN ME, 1984, AM J PHYSIOL, V247, pF955, DOI 10.1152/ajprenal.1984.247.6.F955; Chen XY, 2003, J CELL BIOL, V163, P547, DOI 10.1083/jcb.200305137; Cho KI, 2007, TRAFFIC, V8, P1722, DOI 10.1111/j.1600-0854.2007.00647.x; Cui J, 2011, DIABETES, V60, P320, DOI 10.2337/db09-1078; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Gamba G, 1999, KIDNEY INT, V56, P1606, DOI 10.1046/j.1523-1755.1999.00712.x; Grigoriev I, 2007, DEV CELL, V13, P305, DOI 10.1016/j.devcel.2007.06.010; Hartman HA, 2007, DEV BIOL, V310, P379, DOI 10.1016/j.ydbio.2007.08.021; Hebert SC, 2004, KIDNEY INT, V66, pS28, DOI 10.1111/j.1523-1755.2004.09105.x; HIROKAWA N, 1989, CELL, V56, P867, DOI 10.1016/0092-8674(89)90691-0; Hirokawa N, 2008, PHYSIOL REV, V88, P1089, DOI 10.1152/physrev.00023.2007; Ichimura T, 2002, BIOCHEMISTRY-US, V41, P5566, DOI 10.1021/bi015946f; Ivanov AI, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-12; Jaulin F, 2007, DEV CELL, V13, P511, DOI 10.1016/j.devcel.2007.08.001; Joost HG, 2001, MOL MEMBR BIOL, V18, P247, DOI 10.1080/09687680110090456; Kanai Y, 2000, J NEUROSCI, V20, P6374, DOI 10.1523/JNEUROSCI.20-17-06374.2000; KATZ AI, 1979, AM J PHYSIOL, V237, pF114, DOI 10.1152/ajprenal.1979.237.2.F114; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; MARPLES D, 1995, AM J PHYSIOL-CELL PH, V269, pC655, DOI 10.1152/ajpcell.1995.269.3.C655; Meng YX, 1997, ENDOCRINOLOGY, V138, P1979, DOI 10.1210/en.138.5.1979; Naesens Maarten, 2004, Nephron Physiol, V96, pp65, DOI 10.1159/000076752; Nekrasova OE, 2011, J CELL BIOL, V195, P1185, DOI 10.1083/jcb.201106057; Noda Y, 2001, J CELL BIOL, V155, P77, DOI 10.1083/jcb.200108042; Ohyama T, 2004, GENESIS, V38, P195, DOI 10.1002/gene.20017; Palm F, 2005, INT J BIOCHEM CELL B, V37, P1554, DOI 10.1016/j.biocel.2005.02.007; Palm F, 2004, DIABETOLOGIA, V47, P1223, DOI 10.1007/s00125-004-1434-3; Palm F, 2003, DIABETOLOGIA, V46, P1153, DOI 10.1007/s00125-003-1155-z; Patel V, 2008, HUM MOL GENET, V17, P1578, DOI 10.1093/hmg/ddn045; SAXEN L, 1987, PEDIATR NEPHROL, V1, P385, DOI 10.1007/BF00849241; Semiz S, 2003, EMBO J, V22, P2387, DOI 10.1093/emboj/cdg237; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Trejo HE, 2010, FASEB J, V24, P374, DOI 10.1096/fj.09-137802; Vainio S, 2002, NAT REV GENET, V3, P533, DOI 10.1038/nrg842; Varadi A, 2002, J CELL SCI, V115, P4177, DOI 10.1242/jcs.00083; Wang Z, 2013, DEVELOPMENT, V140, P617, DOI 10.1242/dev.085969; Xia CH, 2003, J CELL BIOL, V161, P55, DOI 10.1083/jcb.200301026; Xue XX, 2010, J CELL SCI, V123, P1732, DOI 10.1242/jcs.056366	40	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0126002	10.1371/journal.pone.0126002	http://dx.doi.org/10.1371/journal.pone.0126002			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885434	Green Published, gold, Green Submitted			2022-12-26	WOS:000353017000165
J	Parham, GP; Mwanahamuntu, MH; Kapambwe, S; Muwonge, R; Bateman, AC; Blevins, M; Chibwesha, CJ; Pfaendler, KS; Mudenda, V; Shibemba, AL; Chisele, S; Mkumba, G; Vwalika, B; Hicks, ML; Vermund, SH; Chi, BH; Stringer, JSA; Sankaranarayanan, R; Sahasrabuddhe, VV				Parham, Groesbeck P.; Mwanahamuntu, Mulindi H.; Kapambwe, Sharon; Muwonge, Richard; Bateman, Allen C.; Blevins, Meridith; Chibwesha, Carla J.; Pfaendler, Krista S.; Mudenda, Victor; Shibemba, Aaron L.; Chisele, Samson; Mkumba, Gracilia; Vwalika, Bellington; Hicks, Michael L.; Vermund, Sten H.; Chi, Benjamin H.; Stringer, Jeffrey S. A.; Sankaranarayanan, Rengaswamy; Sahasrabuddhe, Vikrant V.			Population-Level Scale-Up of Cervical Cancer Prevention Services in a Low-Resource Setting: Development, Implementation, and Evaluation of the Cervical Cancer Prevention Program in Zambia	PLOS ONE			English	Article							HIV-INFECTED WOMEN; VISUAL INSPECTION; ACETIC-ACID; MORTALITY; INDIA; CARE	Background Very few efforts have been undertaken to scale-up low-cost approaches to cervical cancer prevention in low-resource countries. Methods In a public sector cervical cancer prevention program in Zambia, nurses provided visual-inspection with acetic acid (VIA) and cryotherapy in clinics co-housed with HIV/AIDS programs, and referred women with complex lesions for histopathologic evaluation. Low-cost technological adaptations were deployed for improving VIA detection, facilitating expert physician opinion, and ensuring quality assurance. Key process and outcome indicators were derived by analyzing electronic medical records to evaluate program expansion efforts. Findings Between 2006-2013, screening services were expanded from 2 to 12 clinics in Lusaka, the most-populous province in Zambia, through which 102,942 women were screened. The majority (71.7%) were in the target age-range of 25-49 years; 28% were HIV-positive. Out of 101,867 with evaluable data, 20,419 (20%) were VIA positive, of whom 11,508 (56.4%) were treated with cryotherapy, and 8,911 (43.6%) were referred for histopathologic evaluation. Most women (87%, 86,301 of 98,961 evaluable) received same-day services (including 5% undergoing same-visit cryotherapy and 82% screening VIA-negative). The proportion of women with cervical intraepithelial neoplasia grade 2 and worse (CIN2+) among those referred for histopathologic evaluation was 44.1% (1,735/3,938 with histopathology results). Detection rates for CIN2+ and invasive cervical cancer were 17 and 7 per 1,000 women screened, respectively. Women with HIV were more likely to screen positive, to be referred for histopathologic evaluation, and to have cervical precancer and cancer than HIV-negative women. Interpretation We creatively disrupted the 'no screening' status quo prevailing in Zambia and addressed the heavy burden of cervical disease among previously unscreened women by establishing and scaling-up public-sector screening and treatment services at a population level. Key determinants for successful expansion included leveraging HIV/AIDS program investments, and context-specific information technology applications for quality assurance and filling human resource gaps.	[Parham, Groesbeck P.; Mwanahamuntu, Mulindi H.; Kapambwe, Sharon; Bateman, Allen C.; Chibwesha, Carla J.; Pfaendler, Krista S.; Chi, Benjamin H.; Stringer, Jeffrey S. A.] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Parham, Groesbeck P.; Mwanahamuntu, Mulindi H.; Kapambwe, Sharon; Mudenda, Victor; Shibemba, Aaron L.; Chisele, Samson; Mkumba, Gracilia; Vwalika, Bellington] Univ Zambia, Lusaka, Zambia; [Parham, Groesbeck P.; Bateman, Allen C.; Chibwesha, Carla J.; Chi, Benjamin H.; Stringer, Jeffrey S. A.] Univ N Carolina, Chapel Hill, NC USA; [Parham, Groesbeck P.; Muwonge, Richard; Sankaranarayanan, Rengaswamy] Int Agcy Res Canc, F-69372 Lyon, France; [Blevins, Meridith; Vermund, Sten H.; Sahasrabuddhe, Vikrant V.] Vanderbilt Univ, Nashville, TN 37235 USA; [Hicks, Michael L.] Michigan Canc Inst, Pontiac, MI USA; [Sahasrabuddhe, Vikrant V.] NCI, Bethesda, MD 20892 USA; [Pfaendler, Krista S.] Univ Calif Irvine, Irvine, CA USA	University of Zambia; University of North Carolina; University of North Carolina Chapel Hill; World Health Organization; International Agency for Research on Cancer (IARC); Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California Irvine	Parham, GP (corresponding author), Ctr Infect Dis Res Zambia, Lusaka, Zambia.	professorparham@gmail.com	Stringer, Jeffrey S. A./AAU-2342-2021; Vermund, Sten/AAD-3592-2020; Muwonge, Richard/P-6375-2015	Vermund, Sten/0000-0001-7289-8698; Stringer, Jeffrey/0000-0002-9590-7216	Government of the Republic of Zambia's Ministry of Health; Ministry of Community Development, Mother and Child Health; United States Government through the President's Emergency Plan for AIDS Relief (PEPFAR) program through the United States Centers for Disease Control and Prevention (CDC); United States National Institutes of Health (NIH) [D43CA153784, D43TW001035, R24TW007988]; FOGARTY INTERNATIONAL CENTER [R24TW007988, D43TW001035] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA060396, D43CA153784] Funding Source: NIH RePORTER	Government of the Republic of Zambia's Ministry of Health; Ministry of Community Development, Mother and Child Health; United States Government through the President's Emergency Plan for AIDS Relief (PEPFAR) program through the United States Centers for Disease Control and Prevention (CDC); United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The program was supported by funding from the Government of the Republic of Zambia's Ministry of Health and Ministry of Community Development, Mother and Child Health, as well as from the United States Government through the President's Emergency Plan for AIDS Relief (PEPFAR) program through the United States Centers for Disease Control and Prevention (CDC). Support for technical assistance and training for program personnel was received from the United States National Institutes of Health (NIH) grants to the University of North Carolina at Chapel Hill (grant number D43CA153784) and Vanderbilt University (grant numbers D43TW001035 and R24TW007988). Dr. Groesbeck Parham serves as a Senior Visiting Scientist at the International Agency for Research on Cancer (IARC)-World Health Organization (WHO), which also provided technical assistance for this evaluation. Dr. Parham had full access to all the data in the study and had final responsibility for the decision to submit for publication. The sponsors of this study had no role in study design, data collection, data analysis, data interpretation, writing of the report, or in the decision to submit the report for publication.	[Anonymous], CANC INCIDENCE 5 CON; Arbyn M, 2012, VACCINE, V30, pF88, DOI 10.1016/j.vaccine.2012.06.095; Bendavid E, 2012, JAMA-J AM MED ASSOC, V307, P2060, DOI 10.1001/jama.2012.2001; Chirwa Susan, 2010, Glob Health Promot, V17, P47, DOI 10.1177/1757975910363938; Editorial, 2012, LANCET, V380, P1622, DOI [10.1016/S0140-6736(12)61931-X, DOI 10.1016/S0140-6736(12)61931-X]; Ferlay J, 2012, IARC CANCERBASE; Gaffikin L, 1999, LANCET, V353, P869; Gaffikin L, 2003, LANCET, V361, P814, DOI 10.1016/S0140-6736(03)12707-9; Murillo R, 2008, VACCINE, V26, pL37, DOI 10.1016/j.vaccine.2008.06.013; Muwonge R, 2010, INT J GYNECOL OBSTET, V111, P68, DOI 10.1016/j.ijgo.2010.04.024; Mwanahamuntu MH, 2014, INT J GYNECOL OBSTET, V126, P88, DOI 10.1016/j.ijgo.2014.01.006; Mwanahamuntu MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074607; Mwanahamuntu MH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001032; Mwanahamuntu MH, 2009, AIDS, V23, pN1, DOI 10.1097/QAD.0b013e3283236e11; Ngoma T, 2010, INT J GYNECOL OBSTET, V109, P100, DOI 10.1016/j.ijgo.2009.11.025; Parham GP, 2006, GYNECOL ONCOL, V103, P1017, DOI 10.1016/j.ygyno.2006.06.015; Parham GP, 2010, J LOW GENIT TRACT DI, V14, P167, DOI 10.1097/LGT.0b013e3181cd6d5e; Pfaendler KS, 2008, GYNECOL ONCOL, V110, P402, DOI 10.1016/j.ygyno.2008.04.031; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Sahasrabuddhe VV, 2012, CANCER PREV RES, V5, P11, DOI 10.1158/1940-6207.CAPR-11-0540; Sankaranarayanan R, 2007, LANCET, V370, P398, DOI 10.1016/S0140-6736(07)61195-7; Sankaranarayanan R, 2012, BEST PRACT RES CL OB, V26, P221, DOI 10.1016/j.bpobgyn.2011.08.003; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Sellors J. W., 2003, COLPOSCOPY TREATMENT; Shastri SS, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju009; Szarewski A, 2007, LANCET, V370, P365, DOI 10.1016/S0140-6736(07)61171-4; Ullrich A, 2011, LANCET, V377, P639, DOI 10.1016/S0140-6736(11)60233-X; WHO, 2013, WHO GUID SCREEN TREA	28	92	93	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0122169	10.1371/journal.pone.0122169	http://dx.doi.org/10.1371/journal.pone.0122169			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885821	Green Published, Green Submitted, gold			2022-12-26	WOS:000353017000028
J	Vazquez, AI; Klimentidis, YC; Dhurandhar, EJ; Veturi, YC; Paerez-Rodriguez, P				Vazquez, Ana I.; Klimentidis, Yann C.; Dhurandhar, Emily J.; Veturi, Yogasudha C.; Paerez-Rodriguez, Paulino			Assessment of Whole-Genome Regression for Type II Diabetes	PLOS ONE			English	Article							GENETIC-RELATIONSHIP INFORMATION; MISSING HERITABILITY; SUSCEPTIBILITY LOCI; CLINICAL MASTITIS; PREDICTION; SELECTION; POPULATION; MELLITUS; IMPACT; ARCHITECTURE	Lifestyle and genetic factors play a large role in the development of Type 2 Diabetes (T2D). Despite the important role of genetic factors, genetic information is not incorporated into the clinical assessment of T2D risk. We assessed and compared Whole Genome Regression methods to predict the T2D status of 5,245 subjects from the Framingham Heart Study. For evaluating each method we constructed the following set of regression models: A clinical baseline model (CBM) which included non-genetic covariates only. CBM was extended by adding the first two marker-derived principal components and 65 SNPs identified by a recent GWAS consortium for T2D (M-65SNPs). Subsequently, it was further extended by adding 249,798 genome-wide SNPs from a high-density array. The Bayesian models used to incorporate genome-wide marker information as predictors were: Bayes A, Bayes C Pi, Bayesian LASSO (BL), and the Genomic Best Linear Unbiased Prediction (G-BLUP). Results included estimates of the genetic variance and heritability, genetic scores for T2D, and predictive ability evaluated in a 10-fold cross-validation. The predictive AUC estimates for CBM and M-65SNPs were: 0.668 and 0.684, respectively. We found evidence of contribution of genetic effects in T2D, as reflected in the genomic heritability estimates (0.492 +/- 0.066). The highest predictive AUC among the genome-wide marker Bayesian models was 0.681 for the Bayesian LASSO. Overall, the improvement in predictive ability was moderate and did not differ greatly among models that included genetic information. Approximately 58% of the total number of genetic variants was found to contribute to the overall genetic variation, indicating a complex genetic architecture for T2D. Our results suggest that the Bayes C Pi and the G-BLUP models with a large set of genome-wide markers could be used for predicting risk to T2D, as an alternative to using high-density arrays when selected markers from large consortiums for a given complex trait or disease are unavailable.	[Vazquez, Ana I.] Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA; [Klimentidis, Yann C.] Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Div Epidemiol & Biostat, Tucson, AZ USA; [Dhurandhar, Emily J.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Hlth Behav, Birmingham, AL 35294 USA; [Veturi, Yogasudha C.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Biostat, Birmingham, AL 35294 USA; [Paerez-Rodriguez, Paulino] Colegio Postgrad, Montecillo, Edo De Mexico, Mexico	Michigan State University; University of Arizona; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Colegio de Postgraduados - Mexico	Vazquez, AI (corresponding author), Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA.	avazquez@uab.edu	Klimentidis, Yann/B-2348-2015	Klimentidis, Yann/0000-0002-6065-4044	National Heart, Lung, and Blood Institute (NHLBI); Boston University [N01-HC-25195]; NHLBI [N02-HL-64278]; National Institute of Health grant, from National Institute of Diabetes and Digestive and Kidney [7-R01-DK-062148-10]; NIH [K01DK095032, R01GM099992, R01GM101219]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK062710, R01DK062148, P30DK079626, K01DK095032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099992, R01GM101219] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Boston University; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Health grant, from National Institute of Diabetes and Digestive and Kidney; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Framingham Heart Study is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with Boston University (Contract No. N01-HC-25195). This manuscript was not prepared in collaboration with investigators of the Framingham Heart Study and does not necessarily reflect the opinions or views of the Framingham Heart Study, Boston University, or NHLBI. Funding for SHARe Affymetrix genotyping was provided by NHLBI Contract N02-HL-64278. SHARe Illumina genotyping was provided under an agreement between Illumina and Boston University. AIV acknowledges National Institute of Health grant, from National Institute of Diabetes and Digestive and Kidney, Research Supplement to 7-R01-DK-062148-10, for their financial support. YCK acknowledges support from NIH grant K01DK095032. PPR had financial support from NIH Grants R01GM099992 AND R01GM101219. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Aslibekyan Stella, 2014, BMC Proc, V8, pS102, DOI 10.1186/1753-6561-8-S1-S102; Avendano S, 2010, 9 WORLD C GEN APPL L; Cowie CC, 1995, DIABETES AM, P85; Crossa J, 2010, GENETICS, V186, P713, DOI 10.1534/genetics.110.118521; Daetwyler HD, 2013, GENETICS, V193, P347, DOI 10.1534/genetics.112.147983; Daetwyler HD, 2010, GENETICS, V185, P1021, DOI 10.1534/genetics.110.116855; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; DAWBER TR, 1963, ANN NY ACAD SCI, V107, P539, DOI 10.1111/j.1749-6632.1963.tb13299.x; De los Campos G, 2013, BGLR BAYESIAN GEN LI; de los Campos G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003608; de los Campos G, 2013, GENETICS, V193, P327, DOI 10.1534/genetics.112.143313; de los Campos G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040964; de los Campos G, 2010, NAT REV GENET, V11, P880, DOI 10.1038/nrg2898; de los Campos G, 2009, GENETICS, V182, P375, DOI 10.1534/genetics.109.101501; Drineas P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011892; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; GARCIA MJ, 1974, DIABETES, V23, P105, DOI 10.2337/diab.23.2.105; Gianola D, 2009, GENETICS, V183, P347, DOI 10.1534/genetics.109.103952; Goddard ME, 2007, J ANIM BREED GENET, V124, P323, DOI 10.1111/j.1439-0388.2007.00702.x; Goddard M, 2009, GENETICA, V136, P245, DOI 10.1007/s10709-008-9308-0; Govindaraju DR, 2008, ADV GENET, V62, P33, DOI 10.1016/S0065-2660(08)00602-0; Habier D, 2007, GENETICS, V177, P2389, DOI 10.1534/genetics.107.081190; Habier D, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-5; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Ishwaran H, 2005, ANN STAT, V33, P730, DOI 10.1214/009053604000001147; KAPRIO J, 1992, DIABETOLOGIA, V35, P1060, DOI 10.1007/BF02221682; Klimentidis Yann C., 2013, Frontiers in Genetics, V4, P174, DOI 10.3389/fgene.2013.00174; Kuo L., 1998, SANKHYA, V60, P65, DOI DOI 10.1186/1471-2105-12-186; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Makowsky R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002051; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Meuwissen THE, 2001, GENETICS, V157, P1819; Mills GW, 2004, DIABETOLOGIA, V47, P732, DOI 10.1007/s00125-004-1338-2; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; NEWMAN B, 1987, DIABETOLOGIA, V30, P763; Park T, 2008, J AM STAT ASSOC, V103, P681, DOI 10.1198/016214508000000337; Perez P, 2014, GENETICS, V198, P483, DOI 10.1534/genetics.114.164442; Perez-Cabal M, 2010, P 9 WORLD C GEN APPL, P150; Poulsen P, 1999, DIABETOLOGIA, V42, P139, DOI 10.1007/s001250051131; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; R Development Core Team R Core Team, 2010, R LANG ENV STAT COMP; Resende MDV, 2012, NEW PHYTOL, V194, P116, DOI 10.1111/j.1469-8137.2011.04038.x; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; Vazquez AI, 2010, J DAIRY SCI, V93, P5942, DOI 10.3168/jds.2010-3335; Vazquez AI, 2009, J DAIRY SCI, V92, P5239, DOI 10.3168/jds.2009-2085; Vazquez AI, 2009, J DAIRY SCI, V92, P739, DOI 10.3168/jds.2008-1325; Vazquez AI, 2012, GENETICS, V192, P1493, DOI 10.1534/genetics.112.141705; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zaitlen N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003520; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	60	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123818	10.1371/journal.pone.0123818	http://dx.doi.org/10.1371/journal.pone.0123818			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885636	gold, Green Published, Green Submitted			2022-12-26	WOS:000353017000086
J	Zuo, HD; Jiang, LX; Qu, N; Wang, JH; Cui, XJ; Yao, WW				Zuo, Houdong; Jiang, Lingxia; Qu, Nan; Wang, Jianhua; Cui, Xiaojiang; Yao, Weiwu			The Biomarkers Changes in Serum and the Correlation with Quantitative MRI Markers by Histopathologic Evaluation of the Cartilage in Surgically-Induced Osteoarthritis Rabbit Model	PLOS ONE			English	Article							HUMAN ARTICULAR-CARTILAGE; MATRIX PROTEIN COMP; BONE MORPHOGENETIC PROTEIN-2; C-TELOPEPTIDE LEVELS; URINARY CTX-II; KNEE OSTEOARTHRITIS; 3 T; HYALINE CARTILAGE; SPATIAL VARIATION; SYNOVIAL-FLUID	Purpose To investigate the biomarkers change in serum and the correlation with quantitative MRI markers by histopathologic evaluation of the cartilage in surgically-induced osteoarthritis (OA) rabbit model. Materials and Methods Thirty-six mature New Zealand rabbits were used. Eighteen rabbits were divided into six groups randomly and equally and subjected to surgery using the improved Hulth method. The other eighteen rabbits were also allocated into six groups randomly and equally which served as the control. At multiple time points after surgery, the BMP-2, CTX-II and COMP levels in the serum were analyzed by ELISA, and quantitative MRI was performed. Histopathology was examined with HE, and Mankin scores were assessed. The changes in the biochemical biomarkers and imaging markers in the OA groups were compared with those in the control groups using paired-samples T tests. The correlation of quantitative MRI markers with biomarkers and Mankin scores were analyzed. The analysis of Mankin scores was conducted with non-parametric wilcoxon signed rank tests. Results The BMP-2 levels were increased at various times after surgery, and significant differences were observed between the OA and control groups (all the P values < 0.001). CTX-II levels were significantly elevated at several intervals after surgery, including W2, W8, W12, W16 and W20 (P=0.019, 0.004, 0.007, <0.001 and 0.016 respectively), but not at W4 (P=0.764). Significant differences in the COMP levels from W2 to W20 were observed between the OA and the control groups (P<0.001, <0.001, <0.001, <0.001, =0.002 and =0.004 respectively). The T2 values increased at W8 post-surgery and were significantly different between the OA and control groups (P=0.001, <0.001, <0.001 and <0.001 respectively). T2* values increased from W2 to W20 and were significantly different between the control and OA groups (P=0.002, =0.001, <0.001, <0.001, =0.001 and <0.001 respectively). T2 values had significant correlation with BMP-2 and CTX-II (P<0.001 and =0.014), except COMP (P=0.305)., while the correlation of T2* values with BMP-2, CTX-II and COMP was significant (P=0.043, 0.005 and 0.025 respectively). In addition, a positive correlation of T2 values and Mankin scores was observed (P<0.001). Conclusion With the relevance of the multiple time point analysis of the serum biomarkers and imaging markers compared with histological findings, BMP-2, CTX-II and COMP combined with T2 and T2* can be used to reflect and monitor OA progression potentially.	[Zuo, Houdong; Qu, Nan; Yao, Weiwu] Shanghai Jiao Tong Univ, Dept Radiol, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China; [Jiang, Lingxia] Tongji Univ, Dept Radiol, Peoples Hosp 10, Shanghai 200092, Peoples R China; [Wang, Jianhua] Shanghai Jiao Tong Univ, Sch Med, Dept Orthoped, Xin Hua Hosp, Shanghai 200030, Peoples R China; [Cui, Xiaojiang] Cedars Sinai Med Ctr, Dept Surg, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA	Shanghai Jiao Tong University; Tongji University; Shanghai Jiao Tong University; Cedars Sinai Medical Center	Yao, WW (corresponding author), Shanghai Jiao Tong Univ, Dept Radiol, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China.	Xiaojiang.cui@cshs.org; yaoweiwu@yahoo.com			National Natural Science Foundation of China [81171312]; NATIONAL CANCER INSTITUTE [R01CA151610] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by a grant from the National Natural Science Foundation of China (No. 81171312). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker AC, 2001, OSTEOARTHR CARTILAGE, V9, P128, DOI 10.1053/joca.2000.0368; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Bender AL, 2010, CLIN CHEM LAB MED, V48, P569, DOI 10.1515/CCLM.2010.081; Charni-Ben Tabassi Nadine, 2007, Curr Rheumatol Rep, V9, P16; Chmielewski TL, 2012, OSTEOARTHR CARTILAGE, V20, P1294, DOI 10.1016/j.joca.2012.07.014; Clark AG, 1999, ARTHRITIS RHEUM, V42, P2356, DOI 10.1002/1529-0131(199911)42:11<2356::AID-ANR14>3.0.CO;2-R; Dardzinski BJ, 1997, RADIOLOGY, V205, P546, DOI 10.1148/radiology.205.2.9356643; Davidson ENB, 2006, ANN RHEUM DIS, V65, P1414, DOI 10.1136/ard.2005.045971; Disler DG, 1996, AM J ROENTGENOL, V167, P127, DOI 10.2214/ajr.167.1.8659356; Duclos ME, 2010, OSTEOARTHR CARTILAGE, V18, P1467, DOI 10.1016/j.joca.2010.07.007; EHRLICH MG, 1978, ARTHRITIS RHEUM-US, V21, P761, DOI 10.1002/art.1780210704; El-Arman Mohammed M, 2010, HSS J, V6, P171, DOI 10.1007/s11420-010-9157-0; EYRE DR, 1995, J RHEUMATOL, V22, P82; Freeman TA, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-17; Fukin N, 2003, J BONE JOINT SURG AM, V85, P59; Garnero P, 2003, ANN RHEUM DIS, V62, P939, DOI 10.1136/ard.62.10.939; Gelse K, 2008, OSTEOARTHR CARTILAGE, V16, P1457, DOI 10.1016/j.joca.2008.04.006; Henrotin Y, 2007, CURR OPIN RHEUMATOL, V19, P444, DOI 10.1097/BOR.0b013e32829fb3b5; HULTH A, 1970, ACTA ORTHOP SCAND, V41, P522, DOI 10.3109/17453677008991540; Jordan KM, 2006, ANN RHEUM DIS, V65, P871, DOI 10.1136/ard.2005.042895; Kalai E, 2012, CLIN LAB, V58, P209; Kim T, 2014, SKELETAL RADIOL, V43, P947, DOI 10.1007/s00256-014-1872-z; Lee SY, 2010, ACTA RADIOL, V51, P455, DOI 10.3109/02841851003662772; Li X, 2013, OSTEOARTHR CARTILAGE, V21, P1567, DOI 10.1016/j.joca.2013.06.006; Lindhorst E, 2005, OSTEOARTHR CARTILAGE, V13, P139, DOI 10.1016/j.joca.2004.10.017; Lohmander LS, 2003, ARTHRITIS RHEUM, V48, P3130, DOI 10.1002/art.11326; Mamisch TC, 2012, SKELETAL RADIOL, V41, P287, DOI 10.1007/s00256-011-1171-x; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009; Marik W, 2012, EUR J RADIOL, V81, P923, DOI 10.1016/j.ejrad.2011.01.124; Matyas JR, 2004, ARTHRITIS RHEUM-US, V50, P543, DOI 10.1002/art.20027; Mazzuca SA, 2006, ANN RHEUM DIS, V65, P1055, DOI 10.1136/ard.2005.041582; MILLER AJ, 1993, MAGN RESON IMAGING, V11, P1051, DOI 10.1016/0730-725X(93)90225-3; Mosher TJ, 2000, RADIOLOGY, V214, P259, DOI 10.1148/radiology.214.1.r00ja15259; Murata M, 2003, CLIN ORTHOP RELAT R, P285, DOI 10.1097/01.blo.0000059582.08469.ac; Papathanasiou I, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3805; Peterfy CG, 2004, OSTEOARTHR CARTILAGE, V12, P177, DOI 10.1016/j.joca.2003.11.003; Petersson IF, 1998, OSTEOARTHR CARTILAGE, V6, P33, DOI 10.1053/joca.1997.0090; Petersson IF, 1998, BRIT J RHEUMATOL, V37, P46; Pfitzner T, 2012, KNEE SURG SPORT TR A, V20, P1803, DOI 10.1007/s00167-011-1774-8; Reijman M, 2004, ARTHRITIS RHEUM-US, V50, P2471, DOI 10.1002/art.20332; Reyes R, 2014, J BIOMED MATER RES A, V102, P1110, DOI 10.1002/jbma.34769; Riley EH, 1996, CLIN ORTHOP RELAT R, P39, DOI 10.1097/00003086-199603000-00006; Rogart JN, 1999, OSTEOARTHR CARTILAGE, V7, P539, DOI 10.1053/joca.1999.0258; Salzmanni GM, 2009, OSTEOARTHR CARTILAGE, V17, P1576, DOI 10.1016/j.joca.2009.07.010; Sowers MF, 2009, OSTEOARTHR CARTILAGE, V17, P1609, DOI 10.1016/j.joca.2009.06.001; Thomas E, 2014, RHEUMATOLOGY, V53, P338, DOI 10.1093/rheumatology/ket346; URIST M R, 1965, J Bone Joint Surg Br, V47, P304; Verma P, 2013, J ORTHOP RES, V31, P999, DOI 10.1002/jor.22324; Vilim V, 2002, OSTEOARTHR CARTILAGE, V10, P707, DOI 10.1053/joca.2002.0819; Vos LM, 2013, J ORAL MAXIL SURG, V71, P1659, DOI 10.1016/j.joms.2013.06.201; Welsch GH, 2008, RADIOLOGY, V247, P154, DOI 10.1148/radiol.2471070688; Welsch GH, 2010, EUR RADIOL, V20, P1515, DOI 10.1007/s00330-009-1669-y; Welsch GH, 2010, AM J SPORT MED, V38, P934, DOI 10.1177/0363546509354971	53	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124717	10.1371/journal.pone.0124717	http://dx.doi.org/10.1371/journal.pone.0124717			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884951	Green Published, gold, Green Submitted			2022-12-26	WOS:000353017000142
J	Shabalina, IG; Landreh, L; Edgar, D; Hou, M; Gibanova, N; Atanassova, N; Petrovic, N; Hultenby, K; Soder, O; Nedergaard, J; Svechnikov, K				Shabalina, Irina G.; Landreh, Luise; Edgar, Daniel; Hou, Mi; Gibanova, Natalia; Atanassova, Nina; Petrovic, Natasa; Hultenby, Kjell; Soder, Olle; Nedergaard, Jan; Svechnikov, Konstantin			Leydig cell steroidogenesis unexpectedly escapes mitochondrial dysfunction in prematurely aging mice	FASEB JOURNAL			English	Article						cytochrome b5; reactive oxygen species; respiratory chain deficiency; testosterone synthesis	MTDNA MUTATOR MICE; TESTOSTERONE SYNTHESIS; LIVER-MITOCHONDRIA; ADIPOSE-TISSUE; DNA POLYMERASE; PROTEIN; MEMBRANE; OUTER; RAT; MUTATIONS	Point mutations and deletions of mitochondrial DNA (mtDNA) accumulate in tissues during aging in animals and humans and are the basis for mitochondrial diseases. Testosterone synthesis occurs in the mitochondria of Leydig cells. Mitochondrial dysfunction (as induced here experimentally in mtDNA mutator mice that carry a proofreading-deficient form of mtDNA polymerase gamma, leading to mitochondrial dysfunction in all cells types so far studied) would therefore be expected to lead to low testosterone levels. Although mtDNA mutator mice showed a dramatic reduction in testicle weight (only 15% remaining) and similar decreases in number of spermatozoa, testosterone levels in mt DNA mutator mice were unexpectedly fully unchanged. Leydig cell did not escape mitochondrial damage (only 20% of complex I and complex IV remaining) and did show high levels of reactive oxygen species (ROS) production (>5-fold increased), and permeabilized cells demonstrated absence of normal mitochondrial function. Nevertheless, within intact cells, mitochondrial membrane potential remained high, and testosterone production was maintained. This implies development of a compensatory mechanism. A rescuing mechanism involving electronsfrom the pentose phosphate pathway transferred via a 3-fold up-regulated cytochrome b5 to cytochrome c, allowing for mitochondrial energization, is suggested. Thus, the Leydig cells escape mitochondrial dysfunction via a unique rescue pathway. Such a pathway, bypassing respiratory chain dysfunction, may be of relevance with regard to mitochondrial disease therapy and to managing ageing in general.	[Shabalina, Irina G.; Edgar, Daniel; Gibanova, Natalia; Petrovic, Natasa; Nedergaard, Jan] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, SE-10691 Stockholm, Sweden; [Landreh, Luise; Hou, Mi; Soder, Olle; Svechnikov, Konstantin] Astrid Lindgrens Children Hosp, Pediat Endocrinol Unit, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Edgar, Daniel; Hultenby, Kjell] Karolinska Inst, Dept Lab Med, Huddinge, Sweden; [Atanassova, Nina] Pathol & Anthropol Museum, Inst Expt Morphol, Sofia, Bulgaria	Stockholm University; Karolinska Institutet; Bulgarian Academy of Sciences	Nedergaard, J (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Arrhenius Labs F3, SE-10691 Stockholm, Sweden.	jan.nedergaard@su.se	Nedergaard, Jan/A-1706-2010; Atanassova, Nina/AAH-2722-2021; Nedergaard, Jan/Q-8286-2019; Shabalina, Irina/AAC-3720-2019; Shabalina, Irina G/A-4225-2011	Atanassova, Nina/0000-0002-9032-3588; Shabalina, Irina/0000-0002-2915-6450; Shabalina, Irina G/0000-0002-2915-6450; Nedergaard, Jan/0000-0003-2070-1587	Swedish Research Council; Children's Cancer Fund; European Union; Karolinska Institutet Research Fund; Frimurare Barnhuset Foundation; Olle Engkvist Byggmastare Foundation; Gunvor och Josef Aners Foundation; EU-FP7 collaborative project DIABAT [HEALTH-F2-2011-278373]; Knut and Alice Wallenberg's Foundation; Mitoengineering Research Institute	Swedish Research Council(Swedish Research CouncilEuropean Commission); Children's Cancer Fund; European Union(European Commission); Karolinska Institutet Research Fund; Frimurare Barnhuset Foundation; Olle Engkvist Byggmastare Foundation; Gunvor och Josef Aners Foundation; EU-FP7 collaborative project DIABAT; Knut and Alice Wallenberg's Foundation(Knut & Alice Wallenberg Foundation); Mitoengineering Research Institute	The authors thank Aleksandra Trifunovic for providing the initial breeding pair of mtDNA mutator mice, and Barbara Cannon for stimulating discussions. Financial support was received from the Swedish Research Council, Children's Cancer Fund, the European Union, Karolinska Institutet Research Fund and Frimurare Barnhuset Foundation (to O.S.), Olle Engkvist Byggmastare and Gunvor och Josef Aners Foundations (to K.S.), the Swedish Research Council, the EU-FP7 collaborative project DIABAT (HEALTH-F2-2011-278373), the Knut and Alice Wallenberg's Foundation (to J.N.) and the Mitoengineering Research Institute (to I.G.S. and N.G.).	Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012; Allen JA, 2006, ENDOCRINOLOGY, V147, P3924, DOI 10.1210/en.2005-1204; ARCHAKOV AI, 1974, FEBS LETT, V39, P239, DOI 10.1016/0014-5793(74)80059-1; BARNARD T, 1969, J ULTRA MOL STRUCT R, V29, P311, DOI 10.1016/S0022-5320(69)90109-9; BERNARDI P, 1981, J BIOL CHEM, V256, P7187; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Bodrova ME, 1998, FEBS LETT, V435, P269, DOI 10.1016/S0014-5793(98)01072-2; Chen HL, 2001, EXP GERONTOL, V36, P1361, DOI 10.1016/S0531-5565(01)00118-8; Dai Dao-Fu, 2014, Longev Healthspan, V3, P6, DOI 10.1186/2046-2395-3-6; Dai Y, 2013, MITOCHONDRION, V13, P282, DOI 10.1016/j.mito.2013.03.006; Dillon LM, 2012, HUM MOL GENET, V21, P2288, DOI 10.1093/hmg/dds049; Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010; ERNSTER L, 1981, FEBS LETT, V132, P6, DOI 10.1016/0014-5793(81)80415-2; Fox R, 2011, P NATL ACAD SCI USA, V108, P8779, DOI 10.1073/pnas.1106344108; Hiona A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011468; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Kukat A, 2011, BIOCHEM BIOPH RES CO, V409, P394, DOI 10.1016/j.bbrc.2011.04.145; Logan A, 2014, AGING CELL, V13, P765, DOI 10.1111/acel.12212; Midzak A, 2011, MOL CELL ENDOCRINOL, V336, P70, DOI 10.1016/j.mce.2010.12.007; Midzak AS, 2007, ENDOCRINOLOGY, V148, P2583, DOI 10.1210/en.2006-1488; Mito T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055789; Nieschlag E, 1999, CLIN ENDOCRINOL, V51, P139, DOI 10.1046/j.1365-2265.1999.00846.x; Ogishima T, 2003, J BIOL CHEM, V278, P21204, DOI 10.1074/jbc.M301698200; PAYNE AH, 1980, ENDOCRINOLOGY, V106, P1424, DOI 10.1210/endo-106-5-1424; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Rone MB, 2009, BBA-MOL CELL BIOL L, V1791, P646, DOI 10.1016/j.bbalip.2009.03.001; Ross JM, 2010, P NATL ACAD SCI USA, V107, P20087, DOI 10.1073/pnas.1008189107; Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Sharpe RM, 2000, BIOL REPROD, V62, P1685, DOI 10.1095/biolreprod62.6.1685; SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415; Stocco DM, 2001, ANNU REV PHYSIOL, V63, P193, DOI 10.1146/annurev.physiol.63.1.193; Svechnikov K, 2003, J MOL ENDOCRINOL, V30, P59, DOI 10.1677/jme.0.0300059; Svechnikov KV, 2001, MOL CELL ENDOCRINOL, V182, P193, DOI 10.1016/S0303-7207(01)00554-8; Tan AS, 2000, J IMMUNOL METHODS, V238, P59, DOI 10.1016/S0022-1759(00)00156-3; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; WEIBEL ER, 1978, J CELL BIOL, V77, P584, DOI 10.1083/jcb.77.2.584; Wiley SE, 2007, P NATL ACAD SCI USA, V104, P5318, DOI 10.1073/pnas.0701078104; WREFORD NG, 1995, MICROSC RES TECHNIQ, V32, P423, DOI 10.1002/jemt.1070320505	39	12	15	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3274	3286		10.1096/fj.15-271825	http://dx.doi.org/10.1096/fj.15-271825			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25900807				2022-12-26	WOS:000358796900016
J	Kahn, TB; Fernandez, JM; Perez-Jimenez, R				Kahn, Thomas B.; Fernandez, Julio M.; Perez-Jimenez, Raul			Monitoring Oxidative Folding of a Single Protein Catalyzed by the Disulfide Oxidoreductase DsbA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORMATION IN-VIVO; ESCHERICHIA-COLI; BOND FORMATION; THIOREDOXIN CATALYSIS; SUBSTRATE-SPECIFICITY; SHIGELLA-FLEXNERI; VIRULENCE FACTORS; CRYSTAL-STRUCTURE; OUTER-MEMBRANE; SECRETION	Oxidative folding, the process by which proteins fold and acquire disulfide bonds concurrently, is of critical importance for a wide range of biological processes. Generally, this process is catalyzed by oxidoreductase enzymes that facilitate oxidation and also bear chaperone functionality. Although this process has been well described qualitatively, fine yet important details remain obscured by a limited quantitative perspective, arising from the limitations in the application of bulk biochemical methods to the study of oxidative folding. In this work, we have applied single molecule force spectroscopy techniques to monitor in real time the process of oxidative folding as catalyzed by DsbA, the enzyme solely responsible for the catalysis of oxidative folding in the bacterial periplasm. We provide a quantitative and detailed description of the catalytic mechanism utilized by DsbA that offers insight into the entire sequence of events that occurs in the periplasm from the unfolded-reduced state to the folded-oxidized protein. We have compared our results with those of protein disulfide-isomerase, the eukaryotic counterpart of DsbA, allowing us to devise a general mechanism for oxidative folding that also reflects upon the physiological functions and demands of these enzymes in vivo.	[Kahn, Thomas B.] Columbia Univ, Med Ctr, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Fernandez, Julio M.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Perez-Jimenez, Raul] Ctr Invest Cooperat CIC NanoGUNE, Donostia San Sebastian 20018, Spain; [Perez-Jimenez, Raul] Basque Fdn Sci, Ikerbasque, Bilbao 48013, Spain	Columbia University; Columbia University; Basque Foundation for Science	Perez-Jimenez, R (corresponding author), CIC NanoGUNE, Tolosa Hiribidea 76, San Sebastian 20018, Spain.	r.perezjimenez@nanogune.eu	Perez-Jimenez, Raul/C-3085-2017; Regan, Clinton/E-6250-2012	Perez-Jimenez, Raul/0000-0001-7094-6799; nanoGUNE, CIC/0000-0001-7874-5254	National Institutes of Health [T32GM008281, HL061228]; National Science Foundation [DBI-1252857]; Spanish Ministry of Economy and Competitiveness [BIO2013-46163-R]; European Commission Marie Curie Actions Grant [CIG 631704]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Spanish Ministry of Economy and Competitiveness(Spanish Government); European Commission Marie Curie Actions Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32GM008281 (to T. B. K.) and HL061228 (to J. M. F.). This work was also supported by National Science Foundation Grant DBI-1252857 (to J. M. F.), Spanish Ministry of Economy and Competitiveness Grant BIO2013-46163-R (to R. P.-J.), and European Commission Marie Curie Actions Grant CIG 631704 (to R. P.-J.).	Ainavarapu RK, 2007, BIOPHYS J, V92, P225, DOI 10.1529/biophysj.106.091561; Alegre-Cebollada J, 2011, NAT CHEM, V3, P882, DOI [10.1038/NCHEM.1155, 10.1038/nchem.1155]; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Berkmen M, 2012, PROTEIN EXPRES PURIF, V82, P240, DOI 10.1016/j.pep.2011.10.009; Bringer MA, 2007, J BACTERIOL, V189, P4860, DOI 10.1128/JB.00233-07; CAMACHO CJ, 1995, PROTEINS, V22, P27, DOI 10.1002/prot.340220105; Coulthurst SJ, 2008, J BIOL CHEM, V283, P23739, DOI 10.1074/jbc.M801829200; Crespo MD, 2012, NAT CHEM BIOL, V8, P707, DOI [10.1038/NCHEMBIO.1019, 10.1038/nchembio.1019]; DAILEY FE, 1993, P NATL ACAD SCI USA, V90, P1043, DOI 10.1073/pnas.90.3.1043; Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105; FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C; Grandbois M, 1999, SCIENCE, V283, P1727, DOI 10.1126/science.283.5408.1727; Guddat LW, 1998, STRUCT FOLD DES, V6, P757, DOI 10.1016/S0969-2126(98)00077-X; Ha UH, 2003, INFECT IMMUN, V71, P1590, DOI 10.1128/IAI.71.3.1590-1595.2003; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; Hiniker A, 2004, J BIOL CHEM, V279, P12967, DOI 10.1074/jbc.M311391200; Jackson MW, 1999, J BACTERIOL, V181, P5126, DOI 10.1128/JB.181.16.5126-5130.1999; JACOBDUBUISSON F, 1994, P NATL ACAD SCI USA, V91, P11552, DOI 10.1073/pnas.91.24.11552; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; KOSHLAND D, 1980, CELL, V20, P749, DOI 10.1016/0092-8674(80)90321-9; Kosuri P, 2012, CELL, V151, P794, DOI 10.1016/j.cell.2012.09.036; Kurth F, 2014, J BIOL CHEM, V289, P19810, DOI 10.1074/jbc.M114.552380; LUNDSTROM J, 1993, BIOCHEMISTRY-US, V32, P6649, DOI 10.1021/bi00077a018; LUNDSTROM J, 1990, J BIOL CHEM, V265, P9114; Manting EH, 2000, MOL MICROBIOL, V37, P226, DOI 10.1046/j.1365-2958.2000.01980.x; MARTIN JL, 1993, NATURE, V365, P464, DOI 10.1038/365464a0; Paxman JJ, 2009, J BIOL CHEM, V284, P17835, DOI 10.1074/jbc.M109.011502; Perez-Jimenez R, 2009, NAT STRUCT MOL BIOL, V16, P890, DOI 10.1038/nsmb.1627; Rietsch A, 1996, P NATL ACAD SCI USA, V93, P13048, DOI 10.1073/pnas.93.23.13048; Sezonov G, 2007, J BACTERIOL, V189, P8746, DOI 10.1128/JB.01368-07; Stenson TH, 2002, INFECT IMMUN, V70, P2297, DOI 10.1128/IAI.70.5.2297-2303.2002; Thanassi DG, 2000, CURR OPIN CELL BIOL, V12, P420, DOI 10.1016/S0955-0674(00)00111-3; WATARAI M, 1995, P NATL ACAD SCI USA, V92, P4927, DOI 10.1073/pnas.92.11.4927; Watson WH, 2003, J BIOL CHEM, V278, P33408, DOI 10.1074/jbc.M211107200; Wedemeyer WJ, 2000, BIOCHEMISTRY-US, V39, P4207, DOI 10.1021/bi992922o; Welker E, 2001, BIOCHEMISTRY-US, V40, P9059, DOI 10.1021/bi010409g; Wiita AP, 2007, NATURE, V450, P124, DOI 10.1038/nature06231; Wiita AP, 2006, P NATL ACAD SCI USA, V103, P7222, DOI 10.1073/pnas.0511035103; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; WUNDERLICH M, 1993, PROTEIN SCI, V2, P717, DOI 10.1002/pro.5560020503; Yu J, 1998, INFECT IMMUN, V66, P3909, DOI 10.1128/IAI.66.8.3909-3917.1998	43	19	19	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14518	14527		10.1074/jbc.M115.646000	http://dx.doi.org/10.1074/jbc.M115.646000			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25897077	Green Published, hybrid			2022-12-26	WOS:000355754600023
J	Dong, Q; Ernst, SE; Ostedgaard, LS; Shah, VS; Heul, ARV; Welsh, MJ; Randak, CO				Dong, Qian; Ernst, Sarah E.; Ostedgaard, Lynda S.; Shah, Viral S.; Heul, Amanda R. Ver; Welsh, Michael J.; Randak, Christoph O.			Mutating the Conserved Q-loop Glutamine 1291 Selectively Disrupts Adenylate Kinase-dependent Channel Gating of the ATP-binding Cassette (ABC) Adenylate Kinase Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and Reduces Channel Function in Primary Human Airway Epithelia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CL-CHANNEL; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; CHLORIDE CHANNEL; IN-VITRO; SUBSTRATE-SPECIFICITY; CATALYTIC CYCLE; MOLECULAR-BASIS; P-GLYCOPROTEIN; REQUIRES ATP	The ATP-binding cassette (ABC) transporter cystic fibrosis transmembrane conductance regulator (CFTR) and two other non-membrane-bound ABC proteins, Rad50 and a structural maintenance of chromosome (SMC) protein, exhibit adenylate kinase activity in the presence of physiologic concentrations of ATP and AMP or ADP (ATP + AMP reversible arrow 2 ADP). The crystal structure of the nucleotide-binding domain of an SMC protein in complex with the adenylate kinase bisubstrate inhibitor P-1, P-5-di(adenosine-5') pentaphosphate (Ap(5)A) suggests that AMP binds to the conserved Q-loop glutamine during the adenylate kinase reaction. Therefore, we hypothesized that mutating the corresponding residue in CFTR, Gln-1291, selectively disrupts adenylate kinase-dependent channel gating at physiologic nucleotide concentrations. We found that substituting Gln-1291 with bulky side-chain amino acids abolished the effects of Ap(5)A, AMP, and adenosine 5'-monophosphoramidate on CFTR channel function. 8-Azidoadenosine 5'-monophosphate photolabeling of the AMP-binding site and adenylate kinase activity were disrupted in Q1291F CFTR. The Gln-1291 mutations did not alter the potency of ATP at stimulating current or ATP-dependent gating when ATP was the only nucleotide present. However, when physiologic concentrations of ADP and AMP were added, adenylate kinase-deficient Q1291F channels opened significantly less than wild type. Consistent with this result, we found that Q1291F CFTR displayed significantly reduced Cl- channel function in well differentiated primary human airway epithelia. These results indicate that a highly conserved residue of an ABC transporter plays an important role in adenylate kinase-dependent CFTR gating. Furthermore, the results suggest that adenylate kinase activity is important for normal CFTR channel function in airway epithelia.	[Dong, Qian; Heul, Amanda R. Ver; Randak, Christoph O.] Univ Iowa, Stead Family Dept Pediat, Iowa City, IA 52242 USA; [Ernst, Sarah E.; Ostedgaard, Lynda S.; Welsh, Michael J.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Shah, Viral S.; Welsh, Michael J.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Shah, Viral S.] Univ Iowa, Med Scientist Training Program, Iowa City, IA 52242 USA; [Ernst, Sarah E.; Welsh, Michael J.] Howard Hughes Med Inst, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; Howard Hughes Medical Institute	Randak, CO (corresponding author), Univ Iowa, Stead Family Dept Pediat, 6336 PBDB, Iowa City, IA 52242 USA.	chris-toph-randak@uiowa.edu	Regan, Clinton/E-6250-2012	Welsh, Michael/0000-0002-1646-6206; Ostedgaard, Lynda/0000-0001-7717-3442; Randak, Christoph/0000-0003-3264-4137	National Institutes of Health [K08HL097071, HL51670, HL091842]; Cystic Fibrosis Foundation [RANDAK09Q0]; Harry Shwachman Cystic Fibrosis Clinical Investigator Award; Parker B. Francis Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL097071, P01HL091842, P01HL051670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Harry Shwachman Cystic Fibrosis Clinical Investigator Award; Parker B. Francis Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants K08HL097071 (to C. O. R.) and HL51670 and HL091842 (to M. J. W.). This work was also supported by Cystic Fibrosis Foundation Grant RANDAK09Q0.; Recipient of a Harry Shwachman Cystic Fibrosis Clinical Investigator Award and of a Parker B. Francis Fellowship. To whom correspondence should be addressed: Stead Family Dept. of Pediatrics, University of Iowa, 6336 PBDB, Iowa City, IA 52242. Tel.: 319-335-6540; Fax: 319-335-7623; E-mail: christoph-randak@uiowa.edu.	Aleksandrov AA, 2007, PFLUG ARCH EUR J PHY, V453, P693, DOI 10.1007/s00424-006-0140-z; AMES GF, 1992, ADV ENZYMOL RAMB, V65, P1; ANDERSON MP, 1992, SCIENCE, V257, P1701, DOI 10.1126/science.1382316; ANDERSON MP, 1991, CELL, V67, P775, DOI 10.1016/0092-8674(91)90072-7; Baker MD, 2006, BIOCHEMISTRY-US, V45, P416, DOI 10.1021/bi0518592; Berger AL, 2005, P NATL ACAD SCI USA, V102, P455, DOI 10.1073/pnas.0408575102; Berger AL, 2002, J BIOL CHEM, V277, P2125, DOI 10.1074/jbc.M109539200; BERRY MB, 1994, PROTEINS, V19, P183, DOI 10.1002/prot.340190304; Bhaskara V, 2007, MOL CELL, V25, P647, DOI 10.1016/j.molcel.2007.01.028; Bianchet MA, 1997, J BIOENERG BIOMEMBR, V29, P503, DOI 10.1023/A:1022443209010; Bompadre SG, 2005, J GEN PHYSIOL, V125, P361, DOI 10.1085/jgp.200409227; Boyer P.D, 1973, ENZYMES, P279; BOZZI A, 1994, BIOCHEM MOL BIOL INT, V32, P95; Cant N, 2014, INT J BIOCHEM CELL B, V52, P15, DOI 10.1016/j.biocel.2014.02.004; CARSON MR, 1995, J BIOL CHEM, V270, P1711, DOI 10.1074/jbc.270.4.1711; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Chen JH, 2010, CELL, V143, P911, DOI 10.1016/j.cell.2010.11.029; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cheung JC, 2008, ARCH BIOCHEM BIOPHYS, V476, P95, DOI 10.1016/j.abb.2008.03.033; Cotten JF, 1998, J BIOL CHEM, V273, P31873, DOI 10.1074/jbc.273.48.31873; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Dong Q, 2008, BIOPHYS J, V95, P5178, DOI 10.1529/biophysj.108.140897; Dong Q, 2012, P NATL ACAD SCI USA, V109, P917, DOI 10.1073/pnas.1120065109; DORK T, 1994, HUM GENET, V94, P533; Drakou CE, 2012, PROTEINS, V80, P206, DOI 10.1002/prot.23186; Frederich M, 2002, J BIOL CHEM, V277, P1928, DOI 10.1074/jbc.M107128200; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; GREGORY RJ, 1990, NATURE, V347, P382, DOI 10.1038/347382a0; GUNDERSON KL, 1995, CELL, V82, P231, DOI 10.1016/0092-8674(95)90310-0; GUNDERSON KL, 1994, J BIOL CHEM, V269, P19349; Hanrahan JW, 2003, ABC PROTEINS BACTERI, P589; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; HWANG TC, 1994, P NATL ACAD SCI USA, V91, P4698, DOI 10.1073/pnas.91.11.4698; Hwang TC, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009498; Hwang TC, 2009, J PHYSIOL-LONDON, V587, P2151, DOI 10.1113/jphysiol.2009.171595; Janas E, 2003, J BIOL CHEM, V278, P26862, DOI 10.1074/jbc.M301227200; Karp Philip H, 2002, Methods Mol Biol, V188, P115; Karpowich N, 2001, STRUCTURE, V9, P571, DOI 10.1016/S0969-2126(01)00617-7; KARTNER N, 1992, NAT GENET, V1, P321, DOI 10.1038/ng0892-321; Kennedy HJ, 1999, J BIOL CHEM, V274, P13281, DOI 10.1074/jbc.274.19.13281; Kumar K, 2003, BIOCHEM BIOPH RES CO, V300, P81, DOI 10.1016/S0006-291X(02)02800-0; Lammens A, 2004, CURR BIOL, V14, P1778, DOI 10.1016/j.cub.2004.09.044; Lammens A, 2010, J MOL BIOL, V401, P265, DOI 10.1016/j.jmb.2010.06.029; LIENHARD GE, 1973, J BIOL CHEM, V248, P1121; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Lowe J, 2001, J MOL BIOL, V306, P25, DOI 10.1006/jmbi.2000.4379; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; MALAISSE WJ, 1987, BIOCHIM BIOPHYS ACTA, V927, P190, DOI 10.1016/0167-4889(87)90134-0; Mall M, 2004, GASTROENTEROLOGY, V126, P32, DOI 10.1053/j.gastro.2003.10.049; Mathews CJ, 1998, J MEMBRANE BIOL, V163, P55, DOI 10.1007/s002329900370; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Muanprasat C, 2004, J GEN PHYSIOL, V124, P125, DOI 10.1085/jgp.200409059; MULLER CW, 1992, J MOL BIOL, V224, P159, DOI 10.1016/0022-2836(92)90582-5; MULLERDIECKMANN HJ, 1995, J MOL BIOL, V246, P522; Oldham ML, 2011, P NATL ACAD SCI USA, V108, P15152, DOI 10.1073/pnas.1108858108; Olson LK, 1996, J BIOL CHEM, V271, P16544, DOI 10.1074/jbc.271.28.16544; OSTEDGAARD LS, 1992, J BIOL CHEM, V267, P26142; Ostedgaard LS, 2002, P NATL ACAD SCI USA, V99, P3093, DOI 10.1073/pnas.261714599; Ostedgaard LS, 2007, P NATL ACAD SCI USA, V104, P15370, DOI 10.1073/pnas.0706974104; Polshakov D, 2005, BIOCHEMISTRY-US, V44, P11241, DOI 10.1021/bi050859z; POTTER RL, 1983, METHOD ENZYMOL, V91, P613; Pucar D, 2002, AM J PHYSIOL-HEART C, V283, pH776, DOI 10.1152/ajpheart.00116.2002; Randak C, 2003, CELL, V115, P837, DOI 10.1016/S0092-8674(03)00983-8; Randak CO, 2007, J BIOENERG BIOMEMBR, V39, P473, DOI 10.1007/s10863-007-9119-5; Randak CO, 2013, J BIOL CHEM, V288, P27692, DOI 10.1074/jbc.M113.479675; Randak CO, 2012, J BIOL CHEM, V287, P36105, DOI 10.1074/jbc.M112.408450; Randak CO, 2005, P NATL ACAD SCI USA, V102, P2216, DOI 10.1073/pnas.0409787102; Ren H, 2005, P NATL ACAD SCI USA, V102, P303, DOI 10.1073/pnas.0407459102; Scheffzek K, 1996, BIOCHEMISTRY-US, V35, P9716, DOI 10.1021/bi960642s; SCHULTZ BD, 1995, J GEN PHYSIOL, V105, P329, DOI 10.1085/jgp.105.3.329; SCHULZ GE, 1992, FARADAY DISCUSS, V93, P85, DOI 10.1039/fd9929300085; SHEPPARD DN, 1994, CELL, V76, P1091, DOI 10.1016/0092-8674(94)90385-9; SHYAMALA V, 1991, J BIOL CHEM, V266, P18714; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Urbatsch IL, 2000, BIOCHEMISTRY-US, V39, P11921, DOI 10.1021/bi001220s; Urbatsch IL, 2000, BIOCHEMISTRY-US, V39, P14138, DOI 10.1021/bi001128w; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WARD CL, 1994, J BIOL CHEM, V269, P25710; Weinreich F, 1999, J GEN PHYSIOL, V114, P55, DOI 10.1085/jgp.114.1.55; Yan HG, 1999, ADV ENZYMOL RAMB, V73, P103, DOI 10.1002/9780470123195.ch4; Yang RY, 2011, BBA-BIOMEMBRANES, V1808, P1790, DOI 10.1016/j.bbamem.2011.02.004; Zabner J, 1998, MOL CELL, V2, P397, DOI 10.1016/S1097-2765(00)80284-1; ZELEZNIKAR RJ, 1995, J BIOL CHEM, V270, P7311, DOI 10.1074/jbc.270.13.7311; Zolnerciks JK, 2014, FASEB J, V28, P4335, DOI 10.1096/fj.13-245639	87	10	10	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					14140	14153		10.1074/jbc.M114.611616	http://dx.doi.org/10.1074/jbc.M114.611616			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25887396	hybrid, Green Published			2022-12-26	WOS:000355313000042
J	Burke, AK; Guthrie, LTC; Modise, T; Cormier, G; Jensen, RV; McCarter, LL; Stevens, AM				Burke, Alison Kernell; Guthrie, Leah T. C.; Modise, Thero; Cormier, Guy; Jensen, Roderick V.; McCarter, Linda L.; Stevens, Ann M.			OpaR Controls a Network of Downstream Transcription Factors in Vibrio parahaemolyticus BB22OP	PLOS ONE			English	Article							III SECRETION; CELL COMMUNICATION; UNITED-STATES; BACTERIAL; REGULATORS; HARVEYI; PROTEIN; LUXR; TOOL; RNA	Vibrio parahaemolyticus is an emerging world-wide human pathogen that is associated with food-borne gastroenteritis when raw or undercooked seafood is consumed. Expression of virulence factors in this organism is modulated by the phenomenon known as quorum sensing, which permits differential gene regulation at low versus high cell density. The master regulator of quorum sensing in V. parahaemolyticusis OpaR. OpaR not only controls virulence factor gene expression, but also the colony and cellular morphology associated with growth on a surface and biofilm formation. Whole transcriptome Next Generation sequencing (RNA-Seq) was utilized to determine the OpaR regulon by comparing strains BB22OP (opaR(+), LM5312) and BB22TR (opaR1, LM5674). This work, using the published V. parahaemolyticus BB22OP genome sequence, confirms and expands upon a previous microarray analysis for these two strains that used an Affymetrix GeneChip designed from the closely related V. parahaemolyticus RIMD2210633 genome sequence. Overall there was excellent correlation between the microarray and RNA-Seq data. Eleven transcription factors under OpaR control were identified by both methods and further confirmed by quantitative reverse transcription PCR (qRT-PCR) analysis. Nine of these transcription factors were demonstrated to be direct OpaR targets via in vitro electrophoretic mobility shift assays with purified hexahistidine-tagged OpaR. Identification of the direct and indirect targets of OpaR, including small RNAs, will enable the construction of a network map of regulatory interactions important for the switch between the nonpathogenic and pathogenic states.	[Burke, Alison Kernell; Guthrie, Leah T. C.; Modise, Thero; Jensen, Roderick V.; Stevens, Ann M.] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA; [Cormier, Guy] Univ Georgia, Georgia Adv Comp Resource Ctr, Athens, GA 30602 USA; [McCarter, Linda L.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA	Virginia Polytechnic Institute & State University; University System of Georgia; University of Georgia; University of Iowa	Stevens, AM (corresponding author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.	ams@vt.edu		Stevens, Ann/0000-0002-4942-0124	Fralin Life Sciences Institute; Virginia Bioinformatics Institute; Graduate Research Development Program; Life Sciences I Building Fund; Virginia Tech's Open Access Subvention Fund	Fralin Life Sciences Institute; Virginia Bioinformatics Institute; Graduate Research Development Program; Life Sciences I Building Fund; Virginia Tech's Open Access Subvention Fund	The work was supported by the Fralin Life Sciences Institute, Virginia Bioinformatics Institute, Graduate Research Development Program, and Life Sciences I Building Fund, and its publication was supported by Virginia Tech's Open Access Subvention Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARNQVIST A, 1992, MOL MICROBIOL, V6, P2443; BELAS R, 1986, J BACTERIOL, V167, P210, DOI 10.1128/jb.167.1.210-218.1986; Boles BR, 2002, J BACTERIOL, V184, P5946, DOI 10.1128/JB.184.21.5946-5954.2002; Brutinel ED, 2009, J BACTERIOL, V191, P3811, DOI 10.1128/JB.00002-09; Busenlehner LS, 2003, FEMS MICROBIOL REV, V27, P131, DOI 10.1016/S0168-6445(03)00054-8; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Croucher NJ, 2010, CURR OPIN MICROBIOL, V13, P619, DOI 10.1016/j.mib.2010.09.009; Daniels NA, 2000, J INFECT DIS, V181, P1661, DOI 10.1086/315459; DePaola A, 2010, APPL ENVIRON MICROB, V76, P2754, DOI 10.1128/AEM.02590-09; Enos-Berlage JL, 2005, MOL MICROBIOL, V55, P1160, DOI 10.1111/j.1365-2958.2004.04453.x; Ferreira RBR, 2012, J BACTERIOL, V194, P914, DOI 10.1128/JB.05807-11; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Gode-Potratz CJ, 2011, J BACTERIOL, V193, P4224, DOI 10.1128/JB.00432-11; Gode-Potratz CJ, 2011, MOL MICROBIOL, V79, P240, DOI 10.1111/j.1365-2958.2010.07445.x; Gode-Potratz CJ, 2010, J BACTERIOL, V192, P6025, DOI 10.1128/JB.00654-10; Guvener ZT, 2003, J BACTERIOL, V185, P5431, DOI 10.1128/JB.185.18.5431-5441.2003; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Jaques S, 2006, J BACTERIOL, V188, P2625, DOI 10.1128/JB.188.7.2625-2635.2006; Jensen R.V., 2013, GENOME ANNOUNC, V1; Joint I, 2007, PHILOS T R SOC B, V362, P1115, DOI 10.1098/rstb.2007.2038; Krasteva PV, 2010, SCIENCE, V327, P866, DOI 10.1126/science.1181185; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li L, 2013, NUCLEIC ACIDS RES, V41, pD233, DOI 10.1093/nar/gks1264; Livny Jonathan, 2007, V395, P475; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Mane SP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-264; McCarter LL, 1998, J BACTERIOL, V180, P3166, DOI 10.1128/JB.180.12.3166-3173.1998; McLaughlin JB, 2005, NEW ENGL J MED, V353, P1463, DOI 10.1056/NEJMoa051594; Nair GB, 2007, CLIN MICROBIOL REV, V20, P39, DOI 10.1128/CMR.00025-06; Park KS, 2004, INFECT IMMUN, V72, P6659, DOI 10.1128/IAI.72.11.6659-6665.2004; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pompeani AJ, 2008, MOL MICROBIOL, V70, P76, DOI 10.1111/j.1365-2958.2008.06389.x; Ramachandran R, 2014, APPL ENVIRON MICROB, V80, P5790, DOI 10.1128/AEM.01489-14; Reen FJ, 2006, NAT REV MICROBIOL, V4, P697, DOI 10.1038/nrmicro1476; Salomon D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061086; Stewart BJ, 2003, J BACTERIOL, V185, P4508, DOI 10.1128/JB.185.15.4508-4518.2003; Tu KC, 2008, MOL MICROBIOL, V70, P896, DOI 10.1111/j.1365-2958.2008.06452.x; von Bodman SB, 2008, J BACTERIOL, V190, P4377, DOI 10.1128/JB.00486-08; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Whitehead NA, 2001, FEMS MICROBIOL REV, V25, P365, DOI 10.1111/j.1574-6976.2001.tb00583.x; Zhang YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034622	44	24	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0121863	10.1371/journal.pone.0121863	http://dx.doi.org/10.1371/journal.pone.0121863			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901572	Green Published, gold			2022-12-26	WOS:000353331500013
J	de Oliveira, SHP; Shi, JY; Deane, CM				de Oliveira, Saulo H. P.; Shi, Jiye; Deane, Charlotte M.			Building a Better Fragment Library for De Novo Protein Structure Prediction	PLOS ONE			English	Article							SECONDARY STRUCTURE PREDICTION	Fragment-based approaches are the current standard for de novo protein structure prediction. These approaches rely on accurate and reliable fragment libraries to generate good structural models. In this work, we describe a novel method for structure fragment library generation and its application in fragment-based de novo protein structure prediction. The importance of correct testing procedures in assessing the quality of fragment libraries is demonstrated. In particular, the exclusion of homologs to the target from the libraries to correctly simulate a de novo protein structure prediction scenario, something which surprisingly is not always done. We demonstrate that fragments presenting different predominant predicted secondary structures should be treated differently during the fragment library generation step and that exhaustive and random search strategies should both be used. This information was used to develop a novel method, Flib. On a validation set of 41 structurally diverse proteins, Flib libraries presents both a higher precision and coverage than two of the state-of-the-art methods, NNMake and HHFrag. Flib also achieves better precision and coverage on the set of 275 protein domains used in the two previous experiments of the the Critical Assessment of Structure Prediction (CASP9 and CASP10). We compared Flib libraries against NNMake libraries in a structure prediction context. Of the 13 cases in which a correct answer was generated, Flib models were more accurate than NNMake models for 10. "Flib is available for download at: http://www.stats.ox.ac.uk/research/proteins/resources".	[de Oliveira, Saulo H. P.; Deane, Charlotte M.] Univ Oxford, Dept Stat, Oxford OX1 3TG, Oxon, England; [Shi, Jiye] UCB Pharma, Dept Informat, Slough, Berks, England; [Shi, Jiye] Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai, Peoples R China	University of Oxford; UCB Pharma SA; Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS	de Oliveira, SHP (corresponding author), Univ Oxford, Dept Stat, Oxford OX1 3TG, Oxon, England.	saulo.deoliveira@dtc.ox.ac.uk		Deane, Charlotte/0000-0003-1388-2252	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) - Ciencia Sem Fronteiras [237656/2012-4]; Engineering and Physical Sciences Research Council [EP/G037280/1]; UCB Pharma	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) - Ciencia Sem Fronteiras(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); UCB Pharma(UCB Pharma SA)	SHPO was funded by: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) - Ciencia Sem Fronteiras-Grant Number: 237656/2012-4 (http://www.cienciasemfronteiras.gov.br/web/csf). CMD was funded by: Engineering and Physical Sciences Research Council grant to System Approaches to Biomedical Sciences-Centre for Doctoral Training (http://www.epsrc.ac.uk/) Grant Number: EP/G037280/1. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. UCB Pharma provided support in the form of salaries for authors [JS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	[Anonymous], 2011, PROTEINS, DOI DOI 10.1002/PR0T.23215; [Anonymous], 2011, CASP9 P, V79, P1, DOI [10.1002/prot.23200, DOI 10.1002/PROT.23200]; [Anonymous], 2005, PROTEINS; [Anonymous], 2014, CASP10 P, V82, P1; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Bonneau R, 2002, J MOL BIOL, V322, P65, DOI 10.1016/S0022-2836(02)00698-8; Bonneau R, 2001, PROTEINS, P119; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Choi YS, 2009, PROTEINS, V77, P14, DOI 10.1002/prot.22410; Choi YJ, 2013, PEERJ, V1, DOI 10.7717/peerj.1; Elcock AH, 2006, PLOS COMPUT BIOL, V2, P824, DOI 10.1371/journal.pcbi.0020098; Ellis JJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-172; Faraggi E, 2012, J COMPUT CHEM, V33, P259, DOI 10.1002/jcc.21968; Faraggi E, 2009, STRUCTURE, V17, P1515, DOI 10.1016/j.str.2009.09.006; Griep S, 2010, NUCLEIC ACIDS RES, V38, pD318, DOI 10.1093/nar/gkp786; Gront D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023294; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; Holmes JB, 2004, PROTEIN SCI, V13, P1636, DOI 10.1110/ps.03494504; Jefferys BR, 2010, J MOL BIOL, V397, P1329, DOI 10.1016/j.jmb.2010.01.074; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Jones DT, 2003, PROTEINS, V53, P480, DOI 10.1002/prot.10542; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kalev I, 2011, BIOINFORMATICS, V27, P3110, DOI 10.1093/bioinformatics/btr541; Kolodny R, 2002, J MOL BIOL, V323, P297, DOI 10.1016/S0022-2836(02)00942-7; Kosciolek T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092197; Lee J, 2005, BIOPHYS CHEM, V115, P209, DOI 10.1016/j.bpc.2004.12.046; Li SC, 2008, BIOINFORMATICS, V24, pI182, DOI 10.1093/bioinformatics/btn165; Moult J, 2011, PROTEINS, V79, P1, DOI 10.1002/prot.23200; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Raman S, 2009, PROTEINS, V77, P89, DOI 10.1002/prot.22540; Saunders R, 2010, PROTEINS, V78, P1282, DOI 10.1002/prot.22646; Shen Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080493; Soding J, 2005, BIOINFORMATICS, P21; SRINIVASAN R, 1995, PROTEINS, V22, P81, DOI 10.1002/prot.340220202	36	17	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123998	10.1371/journal.pone.0123998	http://dx.doi.org/10.1371/journal.pone.0123998			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901595	Green Published, Green Submitted, gold			2022-12-26	WOS:000353331500069
J	Di Ianni, F; Merli, E; Burtini, F; Conti, V; Pelizzone, I; Di Lecce, R; Parmigiani, E; Squassino, GP; Del Bue, M; Lucarelli, E; Ramoni, R; Grolli, S				Di Ianni, Francesco; Merli, Elisa; Burtini, Francesca; Conti, Virna; Pelizzone, Igor; Di Lecce, Rosanna; Parmigiani, Enrico; Squassino, Gian Paolo; Del Bue, Maurizio; Lucarelli, Enrico; Ramoni, Roberto; Grolli, Stefano			Preparation and Application of an Innovative Thrombocyte/Leukocyte-Enriched Plasma to Promote Tissue Repair in Chelonians	PLOS ONE			English	Article							PLATELET-RICH PLASMA; GROWTH-FACTORS; REGENERATIVE MEDICINE; PRP; LEUKOCYTES; RELEASE; TENDONS; GEL	Platelet concentrates are widely used in mammalian regenerative medicine to improve tissue healing. Chelonians (Testudines) would benefit from the application of thrombocyte preparations to regenerate damaged tissues, since traumatic injuries are leading causes of morbidity and mortality for both wild-living and domesticated animals. The aim of this study was to establish a protocol that optimized the recovery of the thrombocytes from blood samples and to show the efficacy of thrombocyte-enriched plasma in chelonians. Peripheral blood samples were obtained from Testudo spp. (n = 12) and Trachemys scripta elegans (n = 10). Blood cells were fractionated by sodium diatrizoate-sodium polysucrose density gradient using a two-step centrifugation protocol. Thrombocytes and leukocytes were isolated and resuspended to obtain thrombocyte-leucocyte rich plasma (TLRP). The mean recovery of leukocytes and thrombocytes was 48.9% (+/- 4.0 SEM, n = 22) of the whole blood cell content. No statistically significant difference was observed between blood samples collected from different turtle species. The ability of TLRP to form a gel was evaluated by adding variable concentrations of calcium gluconate at room temperature and at 37 degrees C. A reliable and consistent clotting of the TLRP was obtained in glass tubes and dishes by adding 520% v/v of a 100 mg/ml solution of calcium gluconate. Furthermore, in order to test the clinical efficacy of TLRP, a preliminary evaluation was performed on four turtles (Testudo spp.) with traumatic injuries. In all the four animals, a successful clinical outcome was observed. The results demonstrated that a thrombocyte-enriched plasma, comparable to mammalian platelet rich plasma, can be prepared from chelonian blood samples. Furthermore, although the low number of cases presented does not allow definitive conclusions from a clinical point of view, their outcome suggests that TLRP application could be further investigated to improve the healing process of both soft and hard tissue injuries in chelonians.	[Di Ianni, Francesco; Merli, Elisa; Burtini, Francesca; Conti, Virna; Pelizzone, Igor; Di Lecce, Rosanna; Parmigiani, Enrico; Del Bue, Maurizio; Ramoni, Roberto; Grolli, Stefano] Univ Parma, Dept Vet Sci, I-43126 Parma, Italy; [Squassino, Gian Paolo] Clin Vet Ambulatorio Squassino, Asti, Italy; [Lucarelli, Enrico] Rizzoli Orthopaed Inst, Osteoarticular Regenerat Lab, I-40136 Bologna, Italy	University of Parma; IRCCS Istituto Ortopedico Rizzoli	Grolli, S (corresponding author), Univ Parma, Dept Vet Sci, Via Del Taglio 10, I-43126 Parma, Italy.	stefano.grolli@unipr.it	Lucarelli, Enrico/AAF-1612-2021; Enrico, Lucarelli/G-3588-2015	Lucarelli, Enrico/0000-0002-6681-6374; Enrico, Lucarelli/0000-0002-6681-6374; Grolli, Stefano/0000-0003-4380-5725				Andia I, 2012, OPER TECH ORTHOP, V22, P3, DOI 10.1053/j.oto.2011.09.005; Anitua E, 2012, J CONTROL RELEASE, V157, P29, DOI 10.1016/j.jconrel.2011.07.004; Barten S.L., 2006, REPTILE MED SURG, V2<feminine, P893; Bielecki T, 2012, CURR PHARM BIOTECHNO, V13, P1153, DOI 10.2174/138920112800624373; Bielecki T, 2012, CURR PHARM BIOTECHNO, V13, P1121, DOI 10.2174/138920112800624292; Bosch G, 2010, J ORTHOP RES, V28, P211, DOI 10.1002/jor.20980; Castillo TN, 2011, AM J SPORT MED, V39, P266, DOI 10.1177/0363546510387517; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe51, DOI 10.1016/j.tripleo.2005.07.010; Drago L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107813; Dunkel B, 2012, EQUINE VET J, V44, P346, DOI 10.1111/j.2042-3306.2011.00431.x; Ehrenfest DMD, 2009, TRENDS BIOTECHNOL, V27, P158, DOI 10.1016/j.tibtech.2008.11.009; Everts PA, 2008, EUR SURG RES, V40, P203, DOI 10.1159/000110862; Everts PAM, 2008, J BIOMED MATER RES A, V85A, P1135, DOI 10.1002/jbm.a.31570; Fleming GJ, 2008, J EXOT PET MED, V17, P246, DOI 10.1053/j.jepm.2008.08.001; Giraldo CE, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-29; Graziani F, 2006, CLIN ORAL IMPLAN RES, V17, P212, DOI 10.1111/j.1600-0501.2005.01203.x; Griffin XL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009496.pub2; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Martinez-Zapata MJ, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006899.pub2, 10.1002/14651858.CD006899.pub3]; Kishimori J., 2001, Exotic DVM, V3, P35; Kiwanuka E, 2012, CLIN PLAST SURG, V39, P239, DOI 10.1016/j.cps.2012.04.003; Lucarelli E, 2003, BIOMATERIALS, V24, P3095, DOI 10.1016/S0142-9612(03)00114-5; Mazzucco L, 2009, VOX SANG, V97, P110, DOI 10.1111/j.1423-0410.2009.01188.x; Mitchell Mark A., 2004, Veterinary Clinics of North America Exotic Animal Practice, V7, P123, DOI 10.1016/j.cvex.2003.08.006; Morgan DA, 2009, TISSUE CELL, V41, P299, DOI 10.1016/j.tice.2008.12.004; Nardini Giordano, 2013, Vet Clin North Am Exot Anim Pract, V16, P1, DOI 10.1016/j.cvex.2012.09.001; NATT MP, 1952, POULTRY SCI, V31, P735, DOI 10.3382/ps.0310735; Nurden AT, 2008, FRONT BIOSCI-LANDMRK, V13, DOI 10.2741/2947; Renzi S, 2013, RES VET SCI, V95, P272, DOI 10.1016/j.rvsc.2013.01.017; Tavares-Dias Marcos, 2008, Acta Amaz., V38, P351, DOI 10.1590/S0044-59672008000200020; Tohidnezhad M, 2012, PLATELETS, V23, P217, DOI 10.3109/09537104.2011.610908; Weibrich G, 2005, INT J ORAL MAX IMPL, V20, P118; Werther K, 2002, SCAND J CLIN LAB INV, V62, P343, DOI 10.1080/00365510260296492	34	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0122595	10.1371/journal.pone.0122595	http://dx.doi.org/10.1371/journal.pone.0122595			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901960	gold, Green Published, Green Submitted			2022-12-26	WOS:000353331500023
J	Fernandez-Grandon, GM; Gezan, SA; Armour, JAL; Pickett, JA; Logan, JG				Fernandez-Grandon, G. Mandela; Gezan, Salvador A.; Armour, John A. L.; Pickett, John A.; Logan, James G.			Heritability of Attractiveness to Mosquitoes	PLOS ONE			English	Article							MALARIA; PREFERENCES; HUMANS; WOMEN	Female mosquitoes display preferences for certain individuals over others, which is determined by differences in volatile chemicals produced by the human body and detected by mosquitoes. Body odour can be controlled genetically but the existence of a genetic basis for differential attraction to insects has never been formally demonstrated. This study investigated heritability of attractiveness to mosquitoes by evaluating the response of Aedes aegypti (=Stegomyia aegypti) mosquitoes to odours from the hands of identical and nonidentical twins in a dual-choice assay. Volatiles from individuals in an identical twin pair showed a high correlation in attractiveness to mosquitoes, while non-identical twin pairs showed a significantly lower correlation. Overall, there was a strong narrow-sense heritability of 0.62 (SE 0.124) for relative attraction and 0.67 (0.354) for flight activity based on the average of ten measurements. The results demonstrate an underlying genetic component detectable by mosquitoes through olfaction. Understanding the genetic basis for attractiveness could create a more informed approach to repellent development.	[Fernandez-Grandon, G. Mandela; Logan, James G.] Univ London London Sch Hyg & Trop Med, Dept Dis Control, London WC1E 7HT, England; [Gezan, Salvador A.] Univ Florida, Sch Forest Resources & Conservat, Gainesville, FL 32611 USA; [Armour, John A. L.] Univ Nottingham, Sch Life Sci, Nottingham NG7 2UH, England; [Pickett, John A.] Rothamsted Res, Biol Chem & Crop Protect Dept, Harpenden AL5 2JQ, Herts, England	University of London; London School of Hygiene & Tropical Medicine; State University System of Florida; University of Florida; University of Nottingham; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Logan, JG (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Dis Control, Keppel St, London WC1E 7HT, England.	James.Logan@LSHTM.ac.uk		Fernandez-Grandon, Mandela/0000-0002-2993-390X; Armour, John/0000-0002-8558-8506	Sir Halley Stewart Trust; Biotechnology and Biological Sciences Research Council (BBSRC) of the UK; Wellcome Trust; European Community; National Institute for Health Research (NIHR); Biomedical Research Centre	Sir Halley Stewart Trust; Biotechnology and Biological Sciences Research Council (BBSRC) of the UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Community(European Commission); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Biomedical Research Centre	This study was funded by Sir Halley Stewart Trust. Rothamsted Research receives grant-aided support from the Biotechnology and Biological Sciences Research Council (BBSRC) of the UK. TwinsUK is funded by the Wellcome Trust, European Community's Seventh Framework Programme (FP7/2007-2013) and also receives support from the National Institute for Health Research (NIHR)-funded BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansell J, 2002, T ROY SOC TROP MED H, V96, P113, DOI 10.1016/S0035-9203(02)90271-3; DEJONG R, 1995, EXPERIENTIA, V51, P80, DOI 10.1007/BF01964925; Falconer D. S., 1996, Introduction to quantitative genetics.; Gilmour AR, 2010, AS REML USER GUIDE; Ives AR, 2005, J AM MOSQUITO CONTR, V21, P213, DOI 10.2987/8756-971X(2005)21[213:TVBAAH]2.0.CO;2; Lacroix R, 2005, PLOS BIOL, V3, P1590, DOI 10.1371/journal.pbio.0030298; Lefevre T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009546; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818; Logan JG, 2008, J CHEM ECOL, V34, P308, DOI 10.1007/s10886-008-9436-0; Logan JG, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-239; Logan JG, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-275; Olanga EA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-6; Penn DJ, 1999, AM NAT, V153, P145, DOI 10.1086/303166; Penn Dustin J., 2004, Biologist (London), V51, P207; PORT GR, 1980, B ENTOMOL RES, V70, P133, DOI 10.1017/S0007485300009834; Qiu YT, 2006, MED VET ENTOMOL, V20, P280, DOI 10.1111/j.1365-2915.2006.00627.x; Rajan TV, 2005, MED VET ENTOMOL, V19, P84, DOI 10.1111/j.0269-283X.2005.00544.x; Rebollar Tellez EA, 2005, FOLIA ENTOMOL MEX, V44, P247; Roberts SC, 2005, CHEM SENSES, V30, P651, DOI 10.1093/chemse/bji058; Stulp G, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028991, 10.1371/journal.pone.0020497]; Verhulst NO, 2013, INFECT GENET EVOL, V18, P87, DOI 10.1016/j.meegid.2013.05.009; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Visscher PM, 2004, TWIN RES, V7, P670, DOI 10.1375/1369052042663742; Wedekind C, 1997, P ROY SOC B-BIOL SCI, V264, P1471, DOI 10.1098/rspb.1997.0204; Weisfeld GE, 2003, J EXP CHILD PSYCHOL, V85, P279, DOI 10.1016/S0022-0965(03)00061-4	25	28	29	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0122716	10.1371/journal.pone.0122716	http://dx.doi.org/10.1371/journal.pone.0122716			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901606	Green Accepted, Green Published, gold			2022-12-26	WOS:000353331500029
J	Olesen, J; Boesgaard, T; Iliffe, TM				Olesen, Jorgen; Boesgaard, Tom; Iliffe, Thomas M.			The Unique Dorsal Brood Pouch of Thermosbaenacea (Crustacea, Malacostraca) and Description of an Advanced Developmental Stage of Tulumella unidens from the Yucatan Peninsula (Mexico), with a Discussion of Mouth Part Homologies to Other Malacostraca	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; EXTERNAL MORPHOLOGY; LARVAL DEVELOPMENT; BRANCHIOPODA; PERACARIDA; EPIPODITES; EVOLUTION; GILLS; MYSTACOCARIDA; CONCHOSTRACA	The Thermosbaenacea, a small taxon of crustaceans inhabiting subterranean waters, are unique among malacostracans as they brood their offspring dorsally under the carapace. This habit is of evolutionary interest but the last detailed report on thermosbaenacean development is more than 40 years old. Here we provide new observations on an ovigerous female of Tulumella unidens with advanced developmental stages in its brood chamber collected from an anchialine cave at the Yucatan Peninsula, which is only the third report on developmental stages of Thermosbaenacea and the first for the genus Tulumella. Significant in a wider crustacean context, we report and discuss hitherto unexplored lobate structures inside the brood chamber of the female originating at the first (maxilliped) and second thoracic segments, which are most likely modified epipods, perhaps serving as gills. At the posterior margin of carapace of the female are rows of large spines preventing the developing stages from falling out. The external morphology of the advanced developmental stages is described in much detail, providing information on e.g., carapace formation and early limb morphology. Among the hitherto unknown structures in the advanced developmental stages provided by this study are the presence of an embryonic dorsal organ and rudimentary 'naupliar processes' of the second antennae. Since most hypotheses on crustacean (and malacostracan and peracaridan) relationship rest on external limb morphology, we use early limb bud morphology of Tulumella to better establish thermosbaenacean limb homologies to those of other crustaceans, which is a necessary basis for future morphology based phylogenetic considerations.	[Olesen, Jorgen; Boesgaard, Tom] Univ Copenhagen, Nat Hist Museum, DK-2100 Copenhagen O, Denmark; [Iliffe, Thomas M.] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA	University of Copenhagen; Texas A&M University System	Olesen, J (corresponding author), Univ Copenhagen, Nat Hist Museum, Univ Pk 15, DK-2100 Copenhagen O, Denmark.	jolesen@snm.ku.dk	Olesen, Jørgen/A-3353-2013; Illife, Thomas/R-2252-2017	Olesen, Jørgen/0000-0001-9582-7083; Illife, Thomas/0000-0002-4342-5960; Olesen, Jes/0000-0002-6712-2702	Carlsberg Foundation	Carlsberg Foundation(Carlsberg Foundation)	The Carlsberg Foundation generously supported the collecting trip to the Yucatan Peninsula on which the material was collected. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER D, 1962, Q J MICROSC SCI, V103, P261; Borradaile L. A., 1907, Annals & Magazine of Natural History Series 7, V19; BOWMAN TE, 1988, P BIOL SOC WASH, V101, P221; Boxshall GA, 2004, BIOL REV, V79, P253, DOI 10.1017/S1464793103006274; Boxshall Geoff A., 2009, Arthropod Systematics & Phylogeny, V67, P229; Briggs DEG, 2004, P ROY SOC B-BIOL SCI, V271, P131, DOI 10.1098/rspb.2003.2593; CALS P, 1991, CAH BIOL MAR, V32, P173; Coineau N, 2013, CRUSTACEA REVISED A, V4, P557; Coutiere H, 1905, CR HEBD ACAD SCI, V141, P64; Elofsson R, 2008, ARTHROPOD STRUCT DEV, V37, P522, DOI 10.1016/j.asd.2008.05.002; FRYER G, 1983, PHILOS T ROY SOC B, V303, P229; Fryer G., 1964, EARTH ENV SCI T R SO, V66, P49; Gordon I, 1960, B BRIT MUS NAT HIST, V6, P285; Hansen H.J., 1893, ZOOL ANZ, V16, P193; Haug JT, 2011, J CRUSTACEAN BIOL, V31, P668, DOI 10.1651/11-3481.1; HONG SY, 1988, J NAT HIST, V22, P1005, DOI 10.1080/00222938800770641; Jaume D, 2008, HYDROBIOLOGIA, V595, P219, DOI 10.1007/s10750-007-9017-1; Lankester R., 1909, TREATISE ZOOLOGY 7, P1; Lerosey-Aubril R, 2013, BIOL REV, V88, P406, DOI 10.1111/brv.12011; Maas Andreas, 2009, Arthropod Systematics & Phylogeny, V67, P255; Martin JW, 2014, ATLAS OF CRUSTACEAN LARVAE, P8; Martin JW, 2014, ATLAS OF CRUSTACEAN LARVAE, P1; MARTIN JW, 1992, ACTA ZOOL-STOCKHOLM, V73, P357, DOI 10.1111/j.1463-6395.1992.tb01108.x; Moller OS, 2004, ZOOMORPHOLOGY, V123, P107, DOI 10.1007/s00435-003-0093-0; MULLER KJ, 1988, FOSSILS STRATA, V23, P1; Olesen J, 2005, J MORPHOL, V264, P131, DOI 10.1002/jmor.10202; Olesen J, 1996, HYDROBIOLOGIA, V330, P213, DOI 10.1007/BF00024209; Olesen J, 1999, ACTA ZOOL-STOCKHOLM, V80, P163, DOI 10.1046/j.1463-6395.1999.80220015.x; Olesen J, 1999, J NAT HIST, V33, P1789, DOI 10.1080/002229399299734; Olesen J, 2014, ATLAS OF CRUSTACEAN LARVAE, P58; Olesen J, 2014, ATLAS OF CRUSTACEAN LARVAE, P195; Olesen Jorgen, 2013, P103; Poore GCB, 2005, NAUPLIUS, V13, P1; Por Francis D., 2014, Subterranean Biology, V14, P63, DOI 10.3897/subtbiol.14.7927; Richter S, 2002, ZOOL ANZ, V241, P339, DOI 10.1078/0044-5231-00083; Richter S, 2001, J ZOOL SYST EVOL RES, V39, P113; Sars G.O., 1899, ACCOUNT CRUSTACEA NO, V2; Sars GO, 1895, ACCOUNT CRUSTACEA NO, VI; Sars GO, 1870, MONOGRAPHI NORGES KY, V1; Sars GO, 1885, CHALLENGER REPORT SC; Sars GO, 1899, ACCOUNT CRUSTACEA NO, V3; Siewing R., 1958, ABH MATH PHYS KGL, V7, P195; Stella E, 1955, P I ASS THEOR APPL L, V12, P464; Stella E, 1959, RIV BIOL PERUGIA, V52, P121; Stella E, 1953, HYDROBIOLOGIA, V5, P225; Wagner HP, 2012, CRUSTACEANA, V85, P1571, DOI 10.1163/156854012X651646; Wagner H.P., 1994, ZOOLOGISCHE VERHANDE, V291, P1; Walossek Dieter, 1993, Fossils and Strata, V32, P1; Waloszek D, 2014, PALAEONTOLOGY, V57, P909, DOI 10.1111/pala.12094; Wilson George D. F., 2009, Arthropod Systematics & Phylogeny, V67, P159; Wirkner CS, 2010, CLADISTICS, V26, P143, DOI 10.1111/j.1096-0031.2009.00278.x; Zhang XG, 2007, NATURE, V449, P595, DOI 10.1038/nature06138; ZILCH R, 1972, Internationale Revue der Gesamten Hydrobiologie, V57, P75, DOI 10.1002/iroh.19720570104; Zilch R., 1974, ZOOL JB ANAT, V93, P462; Zilch R., 1975, VERH DTSCH ZOOL GES, P121	55	7	7	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0122463	10.1371/journal.pone.0122463	http://dx.doi.org/10.1371/journal.pone.0122463			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901753	Green Submitted, Green Published, gold			2022-12-26	WOS:000353331500022
J	Perez-Alvarez, MJ; Olavarria, C; Moraga, R; Baker, CS; Hamner, RM; Poulin, E				Jose Perez-Alvarez, Maria; Olavarria, Carlos; Moraga, Rodrigo; Baker, C. Scott; Hamner, Rebecca M.; Poulin, Elie			Microsatellite Markers Reveal Strong Genetic Structure in the Endemic Chilean Dolphin	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; POPULATION-STRUCTURE; HECTORS DOLPHIN; CEPHALORHYNCHUS-COMMERSONII; MOLECULAR-GENETICS; HABITAT SELECTION; COASTAL WATERS; ORCINUS-ORCA; DNA; MITOCHONDRIAL	Understanding genetic differentiation and speciation processes in marine species with high dispersal capabilities is challenging. The Chilean dolphin, Cephalorhynchus eutropia, is the only endemic cetacean of Chile and is found in two different coastal habitats: a northern habitat with exposed coastlines, bays and estuaries from Valparaiso (33 degrees 02'S) to Chiloe (42 degrees 00'S), and a southern habitat with highly fragmented inshore coastline, channels and fjords between Chiloe and Navarino Island (55 degrees 14'S). With the aim of evaluating the potential existence of conservation units for this species, we analyzed the genetic diversity and population structure of the Chilean dolphin along its entire range. We genotyped 21 dinucleotide microsatellites for 53 skin samples collected between 1998 and 2012 (swab: n = 8, biopsy: n = 38, entanglement n = 7). Bayesian clustering and spatial model analyses identified two genetically distinct populations corresponding to the northern and southern habitats. Genetic diversity levels were similar in the two populations (He: 0.42 v/s 0.45 for southern and northern populations, respectively), while effective size population was higher in the southern area (Ne: 101 v/s 39). Genetic differentiation between these two populations was high and significant (F-ST = 0.15 and R-ST = 0.19), indicating little or no current gene flow. Because of the absence of evident geographical barriers between the northern and southern populations, we propose that genetic differentiation may reflect ecological adaptation to the different habitat conditions and resource uses. Therefore, the two genetic populations of this endemic and Near Threatened species should be considered as different conservation units with independent management strategies.	[Jose Perez-Alvarez, Maria; Poulin, Elie] Univ Chile, Fac Ciencias, IEB, Santiago, Chile; [Jose Perez-Alvarez, Maria; Olavarria, Carlos; Moraga, Rodrigo] Ctr Invest Eutropia, Santiago, Chile; [Olavarria, Carlos] Fdn CEQUA, Punta Arenas, Chile; [Baker, C. Scott; Hamner, Rebecca M.] Oregon State Univ, Hatfield Marine Sci Ctr, Marine Mammal Inst, Newport, OR 97365 USA; [Baker, C. Scott; Hamner, Rebecca M.] Oregon State Univ, Hatfield Marine Sci Ctr, Dept Fisheries & Wildlife, Newport, OR 97365 USA	Universidad de Chile; Oregon State University; Oregon State University	Perez-Alvarez, MJ (corresponding author), Univ Chile, Fac Ciencias, IEB, Santiago, Chile.	mjose.perez@eutropia.cl	Poulin, Elie/C-2654-2012	Poulin, Elie/0000-0001-7736-0969; Perez-Alvarez, M.Jose/0000-0003-1440-8966	CONICYT Doctoral Thesis Scholarship [AT-24100074]; CONICYT Postdoctoral FONDECYT Program [3140513]; MECESUP [UCH0803]; INNOVA CORFO project PN Bernardo O'Higgins (Fundacion CEQUA); Aysen Biodiversity Project (Raleigh-CONAF); "Expedicion Fitz Roy" tourist company;  [ICM P05-002];  [PFB 023]	CONICYT Doctoral Thesis Scholarship; CONICYT Postdoctoral FONDECYT Program(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); MECESUP; INNOVA CORFO project PN Bernardo O'Higgins (Fundacion CEQUA)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT Regional/CEQUA); Aysen Biodiversity Project (Raleigh-CONAF); "Expedicion Fitz Roy" tourist company; ; 	This work was financially supported by CONICYT Doctoral Thesis Scholarship AT-24100074, *CONICYT Postdoctoral FONDECYT Program 3140513,* MECESUP UCH0803, Projects ICM P05-002 and PFB 023, INNOVA CORFO project PN Bernardo O'Higgins (Fundacion CEQUA), Aysen Biodiversity Project (Raleigh-CONAF), and the "Expedicion Fitz Roy" tourist company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASEN E, 1990, BIO-TECHNOL, V8, P1279, DOI 10.1038/nbt1290-1279; AGUAYOL A, 1975, J FISH RES BOARD CAN, V32, P1123, DOI 10.1139/f75-134; Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Amaral AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031482; Amaral AR, 2010, SC62SM2 INT WHAL COM; Ansmann IC, 2012, MOL ECOL, V21, P4472, DOI 10.1111/j.1365-294X.2012.05722.x; AVISE JC, 1989, TRENDS ECOL EVOL, V4, P279, DOI 10.1016/0169-5347(89)90203-6; AVISE JC, 1992, OIKOS, V63, P62, DOI 10.2307/3545516; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; AVISE JC, 1995, CONSERV BIOL, V9, P686, DOI 10.1046/j.1523-1739.1995.09030686.x; Baker AN, 2002, J ROY SOC NEW ZEAL, V32, P713, DOI 10.1080/03014223.2002.9517717; Berube M, 2000, MOL ECOL, V9, P2181; Brager S, 2003, MAR BIOL, V143, P233, DOI 10.1007/s00227-003-1068-x; Brager S, 2002, BIOL CONSERV, V108, P281, DOI 10.1016/S0006-3207(02)00124-6; Butler K, 2004, MOL ECOL, V13, P1589, DOI 10.1111/j.1365-294X.2004.02152.x; Caballero S, 2012, ANIM CONSERV, V15, P95, DOI 10.1111/j.1469-1795.2011.00493.x; Caldwell M, 2002, MOL ECOL NOTES, V2, P393, DOI 10.1046/j.1471-8286.2002.00270.x; Camus PA, 2001, REV CHIL HIST NAT, V74, P587, DOI 10.4067/S0716-078X2001000300008; Capella Juan J., 1999, Estudios Oceanologicos, V18, P65; Cardenas JC, 1986, MANUAL IDENTIFICACIO; Chikhi N., 2004, 5000 CNRS UMR U MONT; Cipriano F, 2011, MAR MAMMAL SCI, V27, P701, DOI 10.1111/j.1748-7692.2010.00434.x; Collet A, 1988, REP INT WHAL COMM, P119; Cunha HA, 2007, MOL ECOL NOTES, V7, P1229, DOI 10.1111/j.1471-8286.2007.01839.x; Dawson MN, 2001, J BIOGEOGR, V28, P723, DOI 10.1046/j.1365-2699.2001.00572.x; Dawson S.M., 1988, REPORTS INT WHALING, P315; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Escribano Rubén, 2003, Gayana (Concepc.), V67, P190; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fontaine MC, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-30; Fullard KJ, 2000, MOL ECOL, V9, P949, DOI 10.1046/j.1365-294x.2000.00957.x; Ge XJ, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-1; Gilson A, 1998, CALIF FISH GAME, V84, P159; Goodall R.N.P., 1988, Reports of the International Whaling Commission Special Issue, P3; Goodall R.N.P., 1980, REPORT INT WHALING C, V30, P445; Goodall RNP, 1988, REP INT WHAL COMM, P197; Goodall RNP, 1994, HDB MARINE MAMMALS, P269; Goodall RNP, 1994, HDB MARINE MAMMALS, P269; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Guillot G, 2009, MOL ECOL, V18, P4734, DOI 10.1111/j.1365-294X.2009.04410.x; Hamner RM, 2012, CONSERV GENET, V13, P987, DOI 10.1007/s10592-012-0347-9; Harlin AD, 1999, MAR MAMMAL SCI, V15, P409, DOI 10.1111/j.1748-7692.1999.tb00810.x; Haye PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088613; Heinrich S, 2006, THESIS U ST ANDREWS; Hoelzel AR, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P736; Hoelzel AR, 1998, J HERED, V89, P451, DOI 10.1093/jhered/89.5.451; Hoelzel AR, 1998, J HERED, V89, P121, DOI 10.1093/jhered/89.2.121; Hoelzel AR, 2002, MARINE MAMMAL BIOLOGY: AN EVOLUTIONARY APPROACH, P325; Hoelzel AR, 2002, P ROY SOC B-BIOL SCI, V269, P1467, DOI 10.1098/rspb.2002.2033; IUCN, 2013, IUCN RED LIST THREAT; IUCN, 2006, IUCN RED LIST THREAT; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Krutzen M, 2002, MAR MAMMAL SCI, V18, P863, DOI 10.1111/j.1748-7692.2002.tb01078.x; Krutzen M, 2001, MOL ECOL NOTES, V1, P170, DOI 10.1046/j.1471-8278.2001.00065.x; Lescrauwaet Anne-Catherine, 1994, Reports of the International Whaling Commission Special Issue, V15, P485; Lomolino M.V., 2010, BIOGEOGRAPHY, Vfourth; Mendez M, 2010, MOL ECOL, V19, P2212, DOI 10.1111/j.1365-294X.2010.04647.x; Moller L, 2011, MAR BIOL, V158, P113, DOI 10.1007/s00227-010-1546-x; Moller LM, 2007, MAR FRESHWATER RES, V58, P640, DOI 10.1071/MF06218; Morgenthaler A, 2014, MAR MAMMAL SCI, V30, P782, DOI 10.1111/mms.12052; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Natoli A, 2005, P ROY SOC B-BIOL SCI, V272, P1217, DOI 10.1098/rspb.2005.3076; Natoli A, 2004, J EVOLUTION BIOL, V17, P363, DOI 10.1046/j.1420-9101.2003.00672.x; Neira S, 2004, J EXP MAR BIOL ECOL, V312, P349, DOI 10.1016/j.jembe.2004.07.011; New Zealand Department of Conservation Ministry of Fisheries, 2007, HECT MAUIS DOLPH THR; OBRIEN SJ, 1994, P NATL ACAD SCI USA, V91, P5748, DOI 10.1073/pnas.91.13.5748; Ojeda FP, 2000, REV CHIL HIST NAT, V73, P625; Oporto J, 1988, THESIS U AUSTRAL CHI; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; PALUMBI SR, 1992, TRENDS ECOL EVOL, V7, P114, DOI 10.1016/0169-5347(92)90144-Z; Perez-Alvarez MJ, 2007, NEW ZEAL J MAR FRESH, V41, P405, DOI 10.1080/00288330709509931; Pichler FB, 1998, CONSERV BIOL, V12, P676, DOI 10.1046/j.1523-1739.1998.96390.x; Pichler FB, 2000, P ROY SOC B-BIOL SCI, V267, P97, DOI 10.1098/rspb.2000.0972; Pichler FB, 2001, MOL ECOL, V10, P2215, DOI 10.1046/j.0962-1083.2001.01360.x; PICHLER FB, 2001, THESIS U AUCKLAND; Pichler Franz B., 2001, Revista de Biologia Marina y Oceanografia, V36, P117; PICKARD GL, 1973, OCEANOGRAPHY S PACIF, P95; Pimper LE, 2010, CONSERV GENET, V11, P2157, DOI 10.1007/s10592-010-0102-z; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; PRITCHARD JK, 2007, DOCUMENTATION STRUCT; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Rayment W, 2009, MAR MAMMAL SCI, V25, P537, DOI 10.1111/j.1748-7692.2008.00271.x; REYES J.C, 1997, B MUSEO NACL HIST NA, V46, P95; Ribeiro S, 2007, J MAR BIOL ASSOC UK, V87, P119, DOI 10.1017/S0025315407051594; ROBINEAU D, 1985, BIOL CONSERV, V31, P85, DOI 10.1016/0006-3207(85)90036-9; Robineau D, 2007, MAMMALIA, V71, P172, DOI 10.1515/MAMM.2007.034; Rooney AP, 1999, J MOL EVOL, V49, P682, DOI 10.1007/PL00006589; Rosel PE, 2009, MOL ECOL, V18, P5030, DOI 10.1111/j.1365-294X.2009.04413.x; Rosel PE, 1999, MOL ECOL, V8, pS41, DOI 10.1046/j.1365-294X.1999.00758.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; SLOOTEN E, 1991, CAN J ZOOL, V69, P1701, DOI 10.1139/z91-235; Strub PT, 2005, SEA, P273; Thiel M, 2007, OCEANOGR MAR BIOL, V45, P195; Valsecchi E, 1996, MOL ECOL, V5, P151, DOI 10.1111/j.1365-294X.1996.tb00301.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; van Vuuren BJ, 2002, ANIM CONSERV, V5, P303, DOI 10.1017/S1367943002004055; Viddi FA, 2010, ICES J MAR SCI, V67, P959, DOI 10.1093/icesjms/fsp288; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2010, EVOL APPL, V3, P244, DOI 10.1111/j.1752-4571.2009.00104.x; Webber MA., 1993, FAO SPECIES IDENTIFI; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wilson GA, 2003, GENETICS, V163, P1177; Yanez A. P., 1948, Revista de Biologia Marina Valparaiso, V1, P103	104	22	24	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123956	10.1371/journal.pone.0123956	http://dx.doi.org/10.1371/journal.pone.0123956			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898340	Green Published, gold, Green Submitted			2022-12-26	WOS:000353212600045
J	Mestre-Citrinovitz, AC; Kleff, V; Vallejo, G; Winterhager, E; Saragueta, P				Mestre-Citrinovitz, Ana C.; Kleff, Veronika; Vallejo, Griselda; Winterhager, Elke; Saragueeta, Patricia			A Suppressive Antagonism Evidences Progesterone and Estrogen Receptor Pathway Interaction with Concomitant Regulation of Hand2, Bmp2 and ERK during Early Decidualization	PLOS ONE			English	Article							STROMAL CELL DECIDUALIZATION; ENDOTHELIAL GROWTH-FACTOR; EMBRYO IMPLANTATION; UTERINE RECEPTIVITY; CYCLIN D3; MOUSE; EXPRESSION; PREGNANCY; ANGIOGENESIS; PROTEIN	Progesterone receptor and estrogen receptor participate in growth and differentiation of the different rat decidual regions. Steroid hormone receptor antagonists were used to study steroid regulation of decidualization. Here we describe a suppressive interaction between progesterone receptor (onapristone) and estrogen receptor (ICI182780) antagonists and their relation to a rescue phenomenon with concomitant regulation of Hand2, Bmp2 and p-ERK1/2 during the early decidualization steps. Phenotypes of decidua development produced by antagonist treatments were characterized by morphology, proliferation, differentiation, angiogenesis and expression of signaling molecules. We found that suppression of progesterone receptor activity by onapristone treatment resulted in resorption of the implantation sites with concomitant decrease in progesterone and estrogen receptors, PCNA, KI67 antigen, DESMIN, CCND3, CX43, Prl8a2, and signaling players such as transcription factor Hand2, Bmp2 mRNAs and p-ERK1/2. Moreover, FGF-2 and Vegfa increased as a consequence of onapristone treatment. Implantation sites from antagonist of estrogen receptor treated rats developed all decidual regions, but showed an anomalous blood vessel formation at the mesometrial part of the decidua. The deleterious effect of onapristone was partially counteracted by the impairment of estrogen receptor activity with rescue of expression levels of hormone steroid receptors, proliferation and differentiation markers, and the induction of a probably compensatory increase in signaling molecules Hand2, Bmp2 and ERK1/2 activation compared to oil treated controls. This novel drug interaction during decidualization could be applied to pathological endometrial cell proliferation processes to improve therapies using steroid hormone receptor targets.	[Mestre-Citrinovitz, Ana C.; Vallejo, Griselda; Saragueeta, Patricia] Consejo Nacl Invest Cient & Tecn, IByME, Inst Biol & Med Expt, RA-1033 Buenos Aires, DF, Argentina; [Kleff, Veronika] Univ Klinikum Duisburg Essen, Inst Anat, Essen, Germany; [Winterhager, Elke] Univ Klinikum Duisburg Essen, Inst Mol Biol, Essen, Germany	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Duisburg Essen; University of Duisburg Essen	Saragueta, P (corresponding author), Consejo Nacl Invest Cient & Tecn, IByME, Inst Biol & Med Expt, RA-1033 Buenos Aires, DF, Argentina.	sarag@dna.uba.ar		Mestre, Ana Cecilia/0000-0001-8027-3487	Agencia Nacional de Promocion Cientifica y Tecnologica Argentina [PID 88]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP); DAAD, Germany; SECYT, Argentina exchange program PROALAR	Agencia Nacional de Promocion Cientifica y Tecnologica Argentina(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); DAAD, Germany(Deutscher Akademischer Austausch Dienst (DAAD)); SECYT, Argentina exchange program PROALAR	This work was supported by grants to P.S. from the Agencia Nacional de Promocion Cientifica y Tecnologica (PID 88) Argentina, the Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 2012-2014), and by the DAAD, Germany and SECYT, Argentina exchange program PROALAR. P.S. is an established investigator from the Consejo Nacional de Investigaciones Cientificas y Tecnicas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam SMK, 2007, DEVELOPMENT, V134, P407, DOI 10.1242/dev.02743; Bagchi IC, 2005, SEMIN REPROD MED, V23, P38, DOI 10.1055/s-2005-864032; Das A, 2009, P NATL ACAD SCI USA, V106, P12542, DOI 10.1073/pnas.0901647106; Das SK, 1999, J MOL ENDOCRINOL, V22, P91, DOI 10.1677/jme.0.0220091; DeLisser H M, 1993, Curr Top Microbiol Immunol, V184, P37; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Ferrara N, 1999, J MOL MED, V77, P527, DOI 10.1007/s001099900019; GLASSER SR, 1986, BIOL REPROD, V35, P463, DOI 10.1095/biolreprod35.2.463; Grummer R, 2004, BIOL REPROD, V71, P273, DOI 10.1095/biolreprod.103.024067; Huyen DV, 2011, REPRODUCTION, V142, P353, DOI 10.1530/REP-11-0060; Hyder SM, 1999, MOL ENDOCRINOL, V13, P806, DOI 10.1210/me.13.6.806; Kurihara I, 2007, PLOS GENET, V3, P1053, DOI 10.1371/journal.pgen.0030102; Laws MJ, 2008, DEVELOPMENT, V135, P2659, DOI 10.1242/dev.019810; Lee DK, 2010, MOL ENDOCRINOL, V24, P930, DOI 10.1210/me.2009-0531; Lee KY, 2007, MOL CELL BIOL, V27, P5468, DOI 10.1128/MCB.00342-07; Li QX, 2007, J BIOL CHEM, V282, P31725, DOI 10.1074/jbc.M704723200; Li QX, 2011, SCIENCE, V331, P912, DOI 10.1126/science.1197454; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; MONTESANO R, 1986, P NATL ACAD SCI USA, V83, P7297, DOI 10.1073/pnas.83.19.7297; Paria BC, 2000, SEMIN CELL DEV BIOL, V11, P67, DOI 10.1006/scdb.2000.0153; Ramathal CY, 2010, SEMIN REPROD MED, V28, P17, DOI 10.1055/s-0029-1242989; Rasmussen CA, 1997, BIOL REPROD, V56, P647, DOI 10.1095/biolreprod56.3.647; Srivastava RK, 1998, J MOL ENDOCRINOL, V21, P355, DOI 10.1677/jme.0.0210355; Tan J, 2002, MECH DEVELOP, V111, P99, DOI 10.1016/S0925-4773(01)00614-1; Thienel T, 2002, MOL HUM REPROD, V8, P465, DOI 10.1093/molehr/8.5.465; Tranguch S, 2005, CELL MOL LIFE SCI, V62, P1964, DOI 10.1007/s00018-005-5230-0; Vallejo G, 2011, BIOL REPROD, V84, P1063, DOI 10.1095/biolreprod.110.085928; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Winterhager E, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.111690; Wu JJ, 2013, J CELL PHYSIOL, V228, P903, DOI 10.1002/jcp.24241; Ying Y, 2000, BIOL REPROD, V63, P1781, DOI 10.1095/biolreprod63.6.1781	31	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124756	10.1371/journal.pone.0124756	http://dx.doi.org/10.1371/journal.pone.0124756			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897495	Green Submitted, gold, Green Published			2022-12-26	WOS:000353212600083
J	Montali, A; Truglio, G; Martino, F; Ceci, F; Ferraguti, G; Ciociola, E; Maranghi, M; Gianfagna, F; Iacoviello, L; Strom, R; Lucarelli, M; Arca, M				Montali, Anna; Truglio, Gessica; Martino, Francesco; Ceci, Fabrizio; Ferraguti, Giampiero; Ciociola, Ester; Maranghi, Marianna; Gianfagna, Francesco; Iacoviello, Licia; Strom, Roberto; Lucarelli, Marco; Arca, Marcello			Atherogenic Dyslipidemia in Children: Evaluation of Clinical, Biochemical and Genetic Aspects	PLOS ONE			English	Article							FAMILIAL COMBINED HYPERLIPIDEMIA; DENSITY-LIPOPROTEIN CHOLESTEROL; METABOLIC SYNDROME; CHILDHOOD DETERMINANTS; CARDIOVASCULAR RISK; ADULT HEALTH; YOUNG FINNS; LIPASE; HEART; INSULIN	The precursors of atherogenic dyslipidemia (AD) are not well defined. Therefore, we investigated 62 non-obese, non-diabetic AD and 221 normolipemic children. Anthropometric parameters, blood pressure and biochemical measures were obtained in index children, their parents and all available siblings. The heritability (h(2)) of anthropometric and biochemical traits was estimated by SOLAR. Rare and common variants in APOA1 and LPL genes were screened by re-sequencing. Compared to normolipemic, AD children showed increased body mass index, waist circumference, plasma glucose, insulin, ApoB, HOMA-IR, hs-CRP and lower adiponectin (p<0.001 for all). Metabolic syndrome was present in 40% of AD while absent in controls. All traits (except adiponectin and hs-CRP) showed a strong familial aggregation, with plasma glucose having the highest heritability (89%). Overall, 4 LPLloss-of-function mutations were detected (p.Asp9Asn, p.Ser45Asn, p.Asn291Ser, p.Leu365Val) and their cumulative prevalence was higher in AD than in control children (0.073 vs. 0.026; P=0.038). The LPLp.S447* gain-of-function mutation, resulted to be less frequent in AD than in control children (0.064 vs. 0.126; P=0.082). No variant in the APOA1gene was found. Our data indicate that AD is a rather common dyslipidemia in childhood; it associates with metabolic abnormalities typical of insulin resistant state and shows a strong familial aggregation. LPLvariants may contribute to the development of AD phenotype.	[Montali, Anna; Truglio, Gessica; Ciociola, Ester; Maranghi, Marianna; Arca, Marcello] Univ Roma La Sapienza, Atherosclerosis Unit, Dept Internal Med & Allied Sci, I-00185 Rome, Italy; [Truglio, Gessica; Ceci, Fabrizio; Ferraguti, Giampiero; Strom, Roberto; Lucarelli, Marco] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, I-00185 Rome, Italy; [Martino, Francesco] Univ Roma La Sapienza, Dept Pediat, I-00185 Rome, Italy; [Gianfagna, Francesco] Univ Insubria, Ctr Ric Epidemiol & Med Prevent, Varese, Italy; [Gianfagna, Francesco; Iacoviello, Licia] Ist Neurol Mediterraneo, Ist Ricovero & Cura Carattere Sci, Lab Mol & Nutr Epidemiol, Dept Epidemiol & Prevent, Pozzilli, Italy; [Lucarelli, Marco] Univ Roma La Sapienza, Cenci Bolognetti Fdn, Inst Pasteur, I-00185 Rome, Italy	Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; University of Insubria; IRCCS Neuromed; Fondazione Cenci Bolognetti; Sapienza University Rome	Arca, M (corresponding author), Univ Roma La Sapienza, Atherosclerosis Unit, Dept Internal Med & Allied Sci, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	marcelloarca@libero.it	Lucarelli, Marco/AAC-1667-2019; ARCA, Marcello/AAC-3883-2022; Iacoviello, Licia/AGX-7071-2022; Iacoviello, Licia/K-4676-2016; Gianfagna, Francesco/K-4561-2016; Siani, Alfonso/B-7925-2015	ARCA, Marcello/0000-0003-3786-0883; Iacoviello, Licia/0000-0003-0514-5885; Iacoviello, Licia/0000-0003-0514-5885; Gianfagna, Francesco/0000-0003-4615-0816; MARANGHI, MARIANNA/0000-0002-3117-7488; FERRAGUTI, Giampiero/0000-0001-6129-4071; CECI, Fabrizio/0000-0003-4051-4922; Lucarelli, Marco/0000-0002-5538-2494	Progetto Ateneo University of Rome La Sapienza [C26A042949]; MIUR [COFIN 2004065985_004]	Progetto Ateneo University of Rome La Sapienza; MIUR(Ministry of Education, Universities and Research (MIUR))	The study was supported by research grants from Progetto Ateneo 2004 University of Rome La Sapienza C26A042949 and COFIN 2004065985_004 from MIUR to M.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Barter P, 2007, J CLIN ENDOCR METAB, V92, P2041, DOI 10.1210/jc.2006-2219; Brian W, 2006, TROMB RES, V118, P49; Campagna F, 2008, ATHEROSCLEROSIS, V196, P356, DOI 10.1016/j.atherosclerosis.2006.11.015; Chan DC, 2011, EXPERT OPIN PHARMACO, V12, P13, DOI 10.1517/14656566.2010.502529; DeBruin TWA, 1996, EUR J CLIN INVEST, V26, P631, DOI 10.1111/j.1365-2362.1996.tb02146.x; Fernandez JR, 2004, J PEDIATR-US, V145, P439, DOI 10.1016/j.jpeds.2004.06.044; Fisher RM, 1997, ATHEROSCLEROSIS, V135, P145, DOI 10.1016/S0021-9150(97)00199-8; Goldberg IJ, 1996, J LIPID RES, V37, P693; Goodman E, 2007, CIRCULATION, V115, P2316, DOI 10.1161/CIRCULATIONAHA.106.669994; Grundy Scott M, 2006, Clin Cornerstone, V8 Suppl 1, pS21, DOI 10.1016/S1098-3597(06)80005-0; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Grundy SM, 1997, CIRCULATION, V95, P1, DOI 10.1161/01.CIR.95.1.1; Krauss RM, 2004, MED CLIN N AM, V88, P897, DOI 10.1016/j.mcna.2004.04.004; Krauss RM, 2004, ENDOCRIN METAB CLIN, V33, P405, DOI 10.1016/j.ecl.2004.03.016; Kusunoki M, 2011, EUR J PHARMACOL, V668, P337, DOI 10.1016/j.ejphar.2011.06.040; Lee KE, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S94; Magnussen CG, 2008, CIRCULATION, V117, P32, DOI 10.1161/CIRCULATIONAHA.107.718981; Magnussen CG, 2009, J AM COLL CARDIOL, V53, P860, DOI 10.1016/j.jacc.2008.09.061; Martino F, 2013, INT J CARDIOL, V168, P1108, DOI 10.1016/j.ijcard.2012.11.045; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Menghetti E, 1999, J HYPERTENS, V17, P1363, DOI 10.1097/00004872-199917100-00002; Menotti A, 1995, G Ital Cardiol, V25, P1539; Miller M, 2004, CURR OPIN CARDIOL, V19, P380, DOI 10.1097/01.hco.0000126584.12520.b5; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Reaven GM, 2006, AM J CLIN NUTR, V83, P1237, DOI 10.1093/ajcn/83.6.1237; REYMER PWA, 1995, HUM MOL GENET, V4, P1543, DOI 10.1093/hmg/4.9.1543; Rip J, 2006, ARTERIOSCL THROM VAS, V26, P1236, DOI 10.1161/01.ATV.0000219283.10832.43; Robciuc MR, 2013, ARTERIOSCL THROM VAS, V33, P1706, DOI 10.1161/ATVBAHA.113.301397; Von Eynatten M, 2006, CLIN CHEM, V52, P853, DOI 10.1373/clinchem.2005.060509; Wagner AM, 2002, ACTA DIABETOL, V39, P215, DOI 10.1007/s005920200037; Watts GF, 2003, DIABETES, V52, P803, DOI 10.2337/diabetes.52.3.803; Wyszynski DF, 2005, AM J CARDIOL, V95, P194, DOI 10.1016/j.amjcard.2004.08.091; Feng Y, 2008, OBESITY, V16, P125, DOI 10.1038/oby.2007.22; Yu Y, 2005, J LIPID RES, V46, P2202, DOI 10.1194/jlr.M500137-JLR200	35	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0120099	10.1371/journal.pone.0120099	http://dx.doi.org/10.1371/journal.pone.0120099			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897955	Green Submitted, Green Published, gold			2022-12-26	WOS:000353212600004
J	Bae, JH; Kim, JM				Bae, Jeong Hun; Kim, Joon Mo			The Rate of Helicobacter pylori Seropositivity in a Group of Korean Patients with HLA-B27-Associated Acute Anterior Uveitis	PLOS ONE			English	Article							REACTIVE ARTHRITIS; ANKYLOSING-SPONDYLITIS; HLA-B27; INFECTION; PREVALENCE; ANTIBODIES; CHLAMYDIA; CELLS	Purpose To investigate an association between Helicobacter pylori seropositivity and HLA-B27-positive acute anterior uveitis (AAU) in Korean patients. Methods Retrospective analysis was performed with data from 106 patients previously diagnosed with AAU without clinical evidence of spondyloarthropathy. Serum immunoglobulin G antibodies to H. pylori were measured by enzyme-linked immunosorbent assay, and HLA typing was performed using polymerase chain reaction of DNA amplification. We included 72 non-uveitis patients and 35 age- and sex-matched healthy controls in the study. Results Of the 106 patients with AAU, 41 (38.7%) were HLA-B27-positive, and 45 (42.5%) were seropositive for H. pylori. Patients with HLA-B27-positive AAU had a significantly lower prevalence of H. pylori seropositivity compared to those with HLA-B27-negative AAU and healthy controls (24.4% vs. 53.8%, p = 0.003; 24.4% vs. 57.1%, p = 0.004, respectively). In the non-uveitis group, however, HLA-B27-positive patients exhibited similar H. pylori seropositivity prevalence to HLA-B27-negative patients and healthy controls (45.5% vs. 55.7%, p = 0.529; 45.5% vs. 57.1%, p = 0.497, respectively). In multivariate analysis, a low prevalence of H. pylori seropositivity was significantly associated with HLA-B27-positive AAU (odds ratio = 0.340, 95% confidence interval 0.135-0.855, p = 0.022). Conclusions Our results suggest an inverse association between H. pylori seropositivity and HLA-B27-positive AAU. Further investigation of this association is needed, given the low prevalence of H. pylori seropositivity observed in patients with HLA-B27-positive AAU.	[Bae, Jeong Hun; Kim, Joon Mo] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Ophthalmol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, JM (corresponding author), Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Ophthalmol, Seoul, South Korea.	kjoonmo1@gmail.com						Arnold IC, 2011, J CLIN INVEST, V121, P3088, DOI 10.1172/JCI45041; Blankenberg-Sprenkels SHD, 1998, J RHEUMATOL, V25, P743; BREWERTON DA, 1973, LANCET, V2, P994, DOI 10.1016/S0140-6736(73)91090-8; Chang JH, 2005, SURV OPHTHALMOL, V50, P364, DOI 10.1016/j.survophthal.2005.04.003; Cotticelli L, 2006, EUR J OPHTHALMOL, V16, P274, DOI 10.1177/112067210601600213; El Miedany YM, 2005, JOINT BONE SPINE, V72, P135, DOI 10.1016/j.jbspin.2004.04.005; FELTKAMP TEW, 1995, BRIT J OPHTHALMOL, V79, P718, DOI 10.1136/bjo.79.8.718; HERMANN E, 1993, LANCET, V342, P646, DOI 10.1016/0140-6736(93)91760-J; Huhtinen M, 2002, ANN RHEUM DIS, V61, P1012, DOI 10.1136/ard.61.11.1012; INMAN RD, 1989, J IMMUNOL, V142, P4256; Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057; KAPASI K, 1992, J IMMUNOL, V148, P3554; KEAT A, 1987, LANCET, V1, P72; Khan MA, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0362-y; Kim JM, 2012, EYE, V26, P1504, DOI 10.1038/eye.2012.206; Konno Y, 1999, INVEST OPHTH VIS SCI, V40, P1838; Lin P, 2014, PLOS ONE, V9; LINSSEN A, 1991, INVEST OPHTH VIS SCI, V32, P2568; MARCHETTI M, 1995, SCIENCE, V267, P1655, DOI 10.1126/science.7886456; MATTILA L, 1994, BRIT J RHEUMATOL, V33, P1136; OH JW, 1999, J KOREAN OPHTHALMOL, V40, P104; Onal S, 2006, OCUL IMMUNOL INFLAMM, V14, P293, DOI 10.1080/09273940600977241; Otasevic L, 2007, OPHTHALMOLOGICA, V221, P6, DOI 10.1159/000096515; Reveille JD, 2001, CURR OPIN RHEUMATOL, V13, P265, DOI 10.1097/00002281-200107000-00004; Reveille JD, 2012, ARTHRITIS RHEUM-US, V64, P1407, DOI 10.1002/art.33503; Rudwaleit M, 2011, ANN RHEUM DIS, V70, P25, DOI 10.1136/ard.2010.133645; Sacca SC, 2006, INVEST OPHTH VIS SCI, V47, P501, DOI 10.1167/iovs.05-0323; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; WAKEFIELD D, 1983, CLIN EXP IMMUNOL, V51, P191; WAKEFIELD D, 1990, ARCH OPHTHALMOL-CHIC, V108, P219, DOI 10.1001/archopht.1990.01070040071033; Yim JY, 2007, HELICOBACTER, V12, P333, DOI 10.1111/j.1523-5378.2007.00504.x	31	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123924	10.1371/journal.pone.0123924	http://dx.doi.org/10.1371/journal.pone.0123924			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894610	gold, Green Published, Green Submitted			2022-12-26	WOS:000353211700064
J	Sommerfelt, RM; Feuerherm, AJ; Skuland, T; Johansen, B				Sommerfelt, Randi M.; Feuerherm, Astrid J.; Skuland, Trine; Johansen, Berit			Cytosolic Phospholipase A2 Modulates TLR2 Signaling in Synoviocytes	PLOS ONE			English	Article							FIBROBLAST-LIKE SYNOVIOCYTES; NECROSIS-FACTOR-ALPHA; RHEUMATOID-ARTHRITIS; GROUP-V; SYNOVIAL FIBROBLASTS; ARACHIDONIC-ACID; BACTERIAL PEPTIDOGLYCANS; CHRONIC INFLAMMATION; IMMUNE-RESPONSES; A(2) INHIBITOR	Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic synovitis leading to destruction of cartilage and bone. PLA2 enzymes are key players in inflammation regulating the release of unsaturated fatty acids such as arachidonic acid (AA), a precursor of pro-inflammatory eicosanoids. Several lines of evidence point to toll-like receptors (TLRs) as drivers of synovitis and joint destruction in RA. However, few studies have addressed the implication of PLA2 activity downstream TLR activation in the synovium. Here, we aimed to characterize PLA2 enzyme involvement in TLR2-induced signaling in synovial fibroblast-like cells. TLRs1-7 and a range of sPLA2, iPLA2 and cPLA2 enzymes were found to be transcriptionally expressed in cultured synoviocytes. Activation of TLR2/1 and TLR2/6 led to phosphorylation of cPLA2 alpha at Ser(505), and induced AA release and PGE(2) production; effects that were attenuated by cPLA2 alpha inhibitors. In contrast, sPLA2 inhibitors did not affect AA or PGE(2) release. cPLA2 alpha inhibitors furthermore attenuated TLR-induced expression of IL-6, IL-8 and COX2. COX1/2 inhibitors attenuated TLR2/6-induced IL-6 transcription and protein production comparable to cPLA2 alpha inhibition. Moreover, exogenously PGE(2) added alone induced IL-6 production and completely rescued IL-6 transcription when added simultaneously with FSL-1 in the presence of a cPLA2 alpha inhibitor. Our results demonstrate for the first time that cPLA2 alpha is involved in TLR2/1-and TLR2/6-induced AA release, PGE(2) production and pro-inflammatory cytokine expression in synoviocytes, possibly through COX/PGE(2)-dependent pathways. These findings expand our understanding of cPLA2 alpha as a modulator of inflammatory molecular mechanisms in chronic diseases such as RA.	[Sommerfelt, Randi M.; Feuerherm, Astrid J.; Skuland, Trine; Johansen, Berit] Norwegian Univ Sci & Technol, Lipid Signaling Grp, Dept Biol, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Johansen, B (corresponding author), Norwegian Univ Sci & Technol, Lipid Signaling Grp, Dept Biol, N-7034 Trondheim, Norway.	berit.johansen@ntnu.no	Skuland, Trine/HGC-9078-2022		Norwegian Research Council, BIA program; Health Region Mid-Norway; Avexxin AS	Norwegian Research Council, BIA program; Health Region Mid-Norway; Avexxin AS	This work was supported by the Norwegian Research Council, BIA program; Health Region Mid-Norway and Avexxin AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have read	Alonzi T, 1998, J EXP MED, V187, P461, DOI 10.1084/jem.187.4.461; Anthonsen MW, 2001, J BIOL CHEM, V276, P30527, DOI 10.1074/jbc.M008481200; Anthonsen MW, 2001, J BIOL CHEM, V276, P35344, DOI 10.1074/jbc.M105264200; Antonopoulou G, 2008, BIOORGAN MED CHEM, V16, P10257, DOI 10.1016/j.bmc.2008.10.046; Balsinde J, 1998, P NATL ACAD SCI USA, V95, P7951, DOI 10.1073/pnas.95.14.7951; Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x; Buckley CD, 2011, IMMUNOL LETT, V138, P12, DOI 10.1016/j.imlet.2011.02.010; Chi PL, 2011, ARTHRITIS RHEUM-US, V63, P2905, DOI 10.1002/art.30504; Crofford LJ, 2002, CURR OPIN RHEUMATOL, V14, P225, DOI 10.1097/00002281-200205000-00005; Dayer JM, 2010, RHEUMATOLOGY, V49, P15, DOI 10.1093/rheumatology/kep329; DELEURAN B, 1994, SCAND J RHEUMATOL, V23, P2, DOI 10.3109/03009749409102126; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Dieter P, 2002, CELL SIGNAL, V14, P199, DOI 10.1016/S0898-6568(01)00243-1; Fraser H, 2009, J CARDIOVASC PHARM, V53, P60, DOI 10.1097/FJC.0b013e318195bfbc; Goh FG, 2012, RHEUMATOLOGY, V51, P7, DOI 10.1093/rheumatology/ker257; Harizi H, 2008, TRENDS MOL MED, V14, P461, DOI 10.1016/j.molmed.2008.08.005; Hayashida K, 2001, ARTHRITIS RES, V3, P118, DOI 10.1186/ar149; Hegen M, 2003, J EXP MED, V197, P1297, DOI 10.1084/jem.20030016; Honda T, 2006, J EXP MED, V203, P325, DOI 10.1084/jem.20051310; Huang QQ, 2009, J IMMUNOL, V182, P4965, DOI 10.4049/jimmunol.0801563; HULKOWER KI, 1992, BIOCHEM BIOPH RES CO, V184, P712, DOI 10.1016/0006-291X(92)90648-5; HUSBY G, 1977, ARTHRITIS RHEUM, V20, P785, DOI 10.1002/art.1780200304; Huwiler A, 2012, BRIT J PHARMACOL, V167, P1691, DOI 10.1111/j.1476-5381.2012.02114.x; Inoue H, 2002, BRIT J PHARMACOL, V136, P287, DOI 10.1038/sj.bjp.0704705; Johansen B, 2000, PROSTAG OTH LIPID M, V60, P119, DOI 10.1016/S0090-6980(99)00057-X; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawashima M, 2013, J ORAL PATHOL MED, V42, P499, DOI 10.1111/jop.12045; Kikawada E, 2007, BLOOD, V110, P561, DOI 10.1182/blood-2006-10-052258; Koch AE, 2001, ARTHRITIS RHEUM-US, V44, P31, DOI 10.1002/1529-0131(200101)44:1<31::AID-ANR5>3.0.CO;2-4; Kokotos G, 2014, J MED CHEM, V57, P7523, DOI 10.1021/jm500192s; Kunisch E, 2009, J IMMUNOL, V183, P1328, DOI 10.4049/jimmunol.0900801; Kyburz D, 2003, ARTHRITIS RHEUM-US, V48, P642, DOI 10.1002/art.10848; Levi M, 2013, J CLIN PHARMACOL, V53, P151, DOI [10.1177/0091270012437585, 10.1177/0091270011437585]; Lindner SC, 2009, J LEUKOCYTE BIOL, V86, P389, DOI 10.1189/jlb.1008591; Lio YC, 1998, BBA-LIPID LIPID MET, V1392, P320, DOI 10.1016/S0005-2760(98)00049-6; Ludwig J, 2006, J MED CHEM, V49, P2611, DOI 10.1021/jm051243a; Maini RN, 2006, ARTHRITIS RHEUM-US, V54, P2817, DOI 10.1002/art.22033; Malaviya R, 2006, EUR J PHARMACOL, V539, P195, DOI 10.1016/j.ejphar.2006.03.018; Masuda S, 2005, FEBS J, V272, P655, DOI 10.1111/j.1742-4658.2004.04489.x; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Mosher AA, 2014, REPROD SCI; Murakami M, 2011, EXP ANIM TOKYO, V60, P7, DOI 10.1538/expanim.60.7; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Nagase T, 2000, NAT IMMUNOL, V1, P42, DOI 10.1038/76897; Nagase T, 2002, NAT MED, V8, P480, DOI 10.1038/nm0502-480; Ohto T, 2005, J BIOL CHEM, V280, P24576, DOI 10.1074/jbc.M413711200; Okamoto H, 1997, ARTHRITIS RHEUM, V40, P1096, DOI 10.1002/art.1780400614; Pawliczak R, 2004, J BIOL CHEM, V279, P48550, DOI 10.1074/jbc.M408926200; Philippe L, 2012, J IMMUNOL, V188, P454, DOI 10.4049/jimmunol.1102348; Raichel L, 2008, EUR J IMMUNOL, V38, P2905, DOI 10.1002/eji.200838545; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Ruiperez V, 2009, J IMMUNOL, V182, P3877, DOI 10.4049/jimmunol.0804003; Sacre SM, 2007, AM J PATHOL, V170, P518, DOI 10.2353/ajpath.2007.060657; Sasai M, 1999, ARTHRITIS RHEUM, V42, P1635, DOI 10.1002/1529-0131(199908)42:8<1635::AID-ANR11>3.0.CO;2-Q; Schett G, 1998, J CLIN INVEST, V102, P302, DOI 10.1172/JCI2465; Seibl R, 2003, AM J PATHOL, V162, P1221, DOI 10.1016/S0002-9440(10)63918-1; Singer AG, 2002, J BIOL CHEM, V277, P48535, DOI 10.1074/jbc.M205855200; Snyder DW, 1999, J PHARMACOL EXP THER, V288, P1117; Sommerfelt RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083555; STREET IP, 1993, BIOCHEMISTRY-US, V32, P5935, DOI 10.1021/bi00074a003; SUNDLER R, 1994, BIOCHEM J, V301, P455, DOI 10.1042/bj3010455; Tai N, 2010, INFLAMM RES, V59, P53, DOI 10.1007/s00011-009-0069-8; Takagi N, 1998, ARTHRITIS RHEUM, V41, P2117, DOI 10.1002/1529-0131(199812)41:12<2117::AID-ART6>3.3.CO;2-G; Takahashi Y, 1999, TOHOKU J EXP MED, V188, P75, DOI 10.1620/tjem.188.75; Tamaki Y, 2011, J RHEUMATOL, V38, P810, DOI 10.3899/jrheum.100732; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; Uson J, 1997, J RHEUMATOL, V24, P2069; van der Heijden IM, 2000, ARTHRITIS RHEUM-US, V43, P593, DOI 10.1002/1529-0131(200003)43:3<593::AID-ANR16>3.0.CO;2-1; Varastehpour A, 2006, J CLIN ENDOCR METAB, V91, P248, DOI 10.1210/jc.2005-0873; Winstead MV, 2000, BBA-MOL CELL BIOL L, V1488, P28, DOI 10.1016/S1388-1981(00)00107-4	72	19	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0119088	10.1371/journal.pone.0119088	http://dx.doi.org/10.1371/journal.pone.0119088			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893499	Green Submitted, Green Published, gold			2022-12-26	WOS:000353211700002
J	Werner, S; van Aken, BC; Hulst, T; Frens, MA; van der Geest, JN; Struder, HK; Donchin, O				Werner, Susen; van Aken, Bernice C.; Hulst, Thomas; Frens, Maarten A.; van der Geest, Jos N.; Strueder, Heiko K.; Donchin, Opher			Awareness of Sensorimotor Adaptation to Visual Rotations of Different Size	PLOS ONE			English	Article							VISUOMOTOR ADAPTATION; EXPLICIT STRATEGY; INTERLIMB TRANSFER; PRISM ADAPTATION; IMPLICIT; CEREBELLAR; YOUNGER; SYSTEMS; MEMORY; ERROR	Previous studies on sensorimotor adaptation revealed no awareness of the nature of the perturbation after adaptation to an abrupt 30 degrees rotation of visual feedback or after adaptation to gradually introduced perturbations. Whether the degree of awareness depends on the magnitude of the perturbation, though, has as yet not been tested. Instead of using questionnaires, as was often done in previous work, the present study used a process dissociation procedure to measure awareness and unawareness. A naive, implicit group and a group of subjects using explicit strategies adapted to 20 degrees, 40 degrees and 60 degrees cursor rotations in different adaptation blocks that were each followed by determination of awareness and unawareness indices. The awareness index differed between groups and increased from 20 degrees to 60 degrees adaptation. In contrast, there was no group difference for the unawareness index, but it also depended on the size of the rotation. Early adaptation varied between groups and correlated with awareness: The more awareness a participant had developed the more the person adapted in the beginning of the adaptation block. In addition, there was a significant group difference for savings but it did not correlate with awareness. Our findings suggest that awareness depends on perturbation size and that aware and strategic processes are differentially involved during adaptation and savings. Moreover, the use of the process dissociation procedure opens the opportunity to determine awareness and unawareness indices in future sensorimotor adaptation research.	[Werner, Susen; Strueder, Heiko K.] German Sport Univ Cologne, Inst Movement & Neurosci, Cologne, Germany; [van Aken, Bernice C.; Hulst, Thomas; Frens, Maarten A.; van der Geest, Jos N.; Donchin, Opher] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; [Frens, Maarten A.] Erasmus Univ Coll, Rotterdam, Netherlands; [Donchin, Opher] Ben Gurion Univ Negev, Dept Biomed Engn, IL-84105 Beer Sheva, Israel	German Sport University Cologne; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Ben Gurion University	Werner, S (corresponding author), German Sport Univ Cologne, Inst Movement & Neurosci, Cologne, Germany.	werner@dshs-koeln.de	Donchin, Opher/A-4389-2008; Werner, Susen/AAN-6219-2021	Donchin, Opher/0000-0003-0963-4467; Hulst, Thomas/0000-0002-2952-0654; Werner, Susen/0000-0001-9664-4617; van Aken, Bernice/0000-0002-4135-7423; van der Geest, J/0000-0002-2870-4208	TC2N Interreg initiative award; C7 Marie Curie ITN award; Israel-Lower Saxony fund; Helmsley ABC Robotics Initiative of Ben-Gurion University	TC2N Interreg initiative award; C7 Marie Curie ITN award; Israel-Lower Saxony fund; Helmsley ABC Robotics Initiative of Ben-Gurion University	This work was supported by the TC2N Interreg initiative awarded to MAF and JNG, the C7 Marie Curie ITN awarded to MAF and by the Israel-Lower Saxony fund and the Helmsley ABC Robotics Initiative of Ben-Gurion University both awarded to OD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen BB, 2003, J COMP NEUROL, V466, P356, DOI 10.1002/cne.10884; Benson BL, 2011, J NEUROPHYSIOL, V105, P2843, DOI 10.1152/jn.00002.2011; Bergerbest D, 2002, MEM COGNITION, V30, P1252, DOI 10.3758/BF03213407; Bock O, 2006, EXP BRAIN RES, V169, P400, DOI 10.1007/s00221-005-0153-4; Bock O, 2005, EXP BRAIN RES, V160, P259, DOI 10.1007/s00221-004-2133-5; Bock O, 2001, EXP BRAIN RES, V138, P359, DOI 10.1007/s002210100704; Buch ER, 2003, LEARN MEMORY, V10, P55, DOI 10.1101/lm.50303; Cleeremans A., 1993, MECH IMPLICIT LEARNI; Cleeremans A, 2008, PROG BRAIN RES, V168, P19, DOI 10.1016/S0079-6123(07)68003-0; Criscimagna-Hemminger SE, 2010, J NEUROPHYSIOL, V103, P2275, DOI 10.1152/jn.00822.2009; de Xivry JJO, 2011, CEREB CORTEX, V21, P1475, DOI 10.1093/cercor/bhq192; Destrebecqz A, 2005, PROG BRAIN RES, V150, P69, DOI 10.1016/S0079-6123(05)50006-2; Destrebecqz A, 2001, PSYCHON B REV, V8, P343, DOI 10.3758/BF03196171; Destrebecqz A, 2003, COGNITIVE BRAIN RES, V16, P391, DOI 10.1016/S0926-6410(03)00053-3; Dimitrova A, 2008, BRAIN RES, V1198, P73, DOI 10.1016/j.brainres.2008.01.034; ERIKSEN CW, 1960, PSYCHOL REV, V67, P279, DOI 10.1037/h0041622; Fernandez-Ruiz J, 2000, COGNITIVE BRAIN RES, V9, P223, DOI 10.1016/S0926-6410(99)00057-9; FRENSCH PA, 1994, J EXP PSYCHOL LEARN, V20, P567, DOI 10.1037/0278-7393.20.3.567; Fu QF, 2008, CONSCIOUS COGN, V17, P185, DOI 10.1016/j.concog.2007.01.007; Galea JM, 2010, EXP BRAIN RES, V202, P473, DOI 10.1007/s00221-010-2158-x; Hatada Y, 2006, EXP BRAIN RES, V169, P417, DOI 10.1007/s00221-005-0159-y; Hegele M, 2013, PSYCHOL AGING, V28, P333, DOI 10.1037/a0031914; Hegele M, 2010, CONSCIOUS COGN, V19, P906, DOI 10.1016/j.concog.2010.05.005; Heuer H, 2008, PSYCHOL AGING, V23, P190, DOI 10.1037/0882-7974.23.1.190; Heuer H, 2011, J NEUROPHYSIOL, V106, P2078, DOI 10.1152/jn.00043.2011; Heuer H, 2011, EXP BRAIN RES, V211, P97, DOI 10.1007/s00221-011-2656-5; Hinder MR, 2008, BRAIN RES, V1197, P123, DOI 10.1016/j.brainres.2007.12.067; Huang VS, 2009, J NEUROPHYSIOL, V102, P931, DOI 10.1152/jn.00237.2009; Hussain SJ, 2014, J NEUROPHYSIOL, V111, P2414, DOI 10.1152/jn.00570.2013; Hwang EJ, 2006, EXP BRAIN RES, V173, P425, DOI 10.1007/s00221-006-0391-0; Ingram HA, 2000, EXP BRAIN RES, V132, P114, DOI 10.1007/s002219900322; Izawa J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002012; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; JAKOBSON LS, 1989, EXP BRAIN RES, V78, P575; Jimenez L, 1996, J EXP PSYCHOL LEARN, V22, P948, DOI 10.1037/0278-7393.22.4.948; JOHNSTON WA, 1991, J EXP PSYCHOL LEARN, V17, P210, DOI 10.1037/0278-7393.17.2.210; Kagerer FA, 1997, EXP BRAIN RES, V115, P557, DOI 10.1007/PL00005727; Kane KA, 2000, COGNITIVE BRAIN RES, V10, P19, DOI 10.1016/S0926-6410(00)00018-5; Karabanov A, 2008, J NEUROPHYSIOL, V100, P733, DOI 10.1152/jn.01303.2007; Kitago Tomoko, 2013, Handb Clin Neurol, V110, P93, DOI 10.1016/B978-0-444-52901-5.00008-3; Klassen J, 2005, EXP BRAIN RES, V164, P250, DOI 10.1007/s00221-005-2247-4; Krakauer JW, 2000, J NEUROSCI, V20, P8916, DOI 10.1523/jneurosci.20-23-08916.2000; Malfait N, 2004, J NEUROSCI, V24, P8084, DOI 10.1523/JNEUROSCI.1742-04.2004; MANDLER G, 1980, PSYCHOL REV, V87, P252, DOI 10.1037/0033-295X.87.3.252; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; McNay EC, 1998, LEARN MEMORY, V4, P411, DOI 10.1101/lm.4.5.411; Michel C, 2007, J COGNITIVE NEUROSCI, V19, P341, DOI 10.1162/jocn.2007.19.2.341; Morehead JR, 2013, TRANSLATIONAL COMPUT; Nisbett RE, 1977, PSYCHOL REV; Norman E, 2006, CONSCIOUS COGN, V15, P723, DOI 10.1016/j.concog.2005.06.003; Peled A, 2012, J MOTOR BEHAV, V44, P185, DOI 10.1080/00222895.2012.672349; REBER PJ, 1994, LEARN MEMORY, V1, P217; REINGOLD EM, 1990, MIND LANG, V5, P9, DOI DOI 10.1111/J.1468-0017.1990.TB00150.X; Schween R, 2014, EXP BRAIN RES, V232, P3007, DOI 10.1007/s00221-014-3992-z; Shabbott BA, 2010, EXP BRAIN RES, V203, P75, DOI 10.1007/s00221-010-2209-3; Shanks DR, 2005, PSYCHOL RES-PSYCH FO, V69, P369, DOI 10.1007/s00426-004-0211-8; SHANKS DR, 1994, BEHAV BRAIN SCI, V17, P367, DOI 10.1017/S0140525X00035032; Slachevsky A, 2001, J COGNITIVE NEUROSCI, V13, P332, DOI 10.1162/08989290151137386; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Sulzenbruck S, 2009, CONSCIOUS COGN, V18, P145, DOI 10.1016/j.concog.2008.12.001; Taylor JA, 2014, PROG BRAIN RES, V210, P217, DOI 10.1016/B978-0-444-63356-9.00009-1; Taylor JA, 2011, J NEUROPHYSIOL, V106, P3157, DOI 10.1152/jn.01008.2010; Taylor JA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001096; Taylor JA, 2010, CEREBELLUM, V9, P580, DOI 10.1007/s12311-010-0201-x; TORVIK A, 1986, J NEUROL SCI, V76, P283, DOI 10.1016/0022-510X(86)90176-0; Venkatakrishnan A, 2011, HUM MOVEMENT SCI, V30, P760, DOI 10.1016/j.humov.2010.08.020; Wang JS, 2011, J NEUROPHYSIOL, V106, P259, DOI 10.1152/jn.00254.2011; Werner S, 2007, EXP BRAIN RES, V178, P554, DOI 10.1007/s00221-007-0925-0; Werner S, 2014, EXP BRAIN RES, V232, P1145, DOI 10.1007/s00221-014-3824-1; Wilkinson L, 2004, J EXP PSYCHOL LEARN, V30, P354, DOI 10.1037/0278-7393.30.2.354; Willingham DB, 2002, J NEUROPHYSIOL, V88, P1451, DOI 10.1152/jn.2002.88.3.1451; WILLINGHAM DB, 1989, J EXP PSYCHOL LEARN, V15, P1047, DOI 10.1037/0278-7393.15.6.1047; Wong AL, 2011, NEUROSCI LETT, V500, P207, DOI 10.1016/j.neulet.2011.06.039; Woodruff-Pak DS, 2001, NEUROBIOL LEARN MEM, V76, P342, DOI 10.1006/nlme.2001.4026	74	53	53	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123321	10.1371/journal.pone.0123321	http://dx.doi.org/10.1371/journal.pone.0123321			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG3XA	25894396	Green Published, Green Submitted, gold			2022-12-26	WOS:000353211700034
J	Ahronian, LG; Driscoll, DR; Klimstra, DS; Lewis, BC				Ahronian, Leanne G.; Driscoll, David R.; Klimstra, David S.; Lewis, Brian C.			The p53(R172H) Mutant Does Not Enhance Hepatocellular Carcinoma Development and Progression	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; MOUSE MODEL; P53 GAIN; P73; MUTATION; METASTASIS; EXPRESSION; TP53; P63; TRANSCRIPTION	Hepatocellular carcinoma is a highly deadly malignancy, accounting for approximately 800,000 deaths worldwide every year. Mutation of the p53 tumor suppressor gene is a common genetic change in HCC, present in 30% of cases. p53(R175H) (corresponding to p53(R172H) in mice) is a hotspot for mutation that demonstrates "prometastatic" gain-of-function in other cancer models. Since the frequency of p53 mutation increases with tumor grade in HCC, we hypothesized that p53(R172H) is a gain-of-function mutation in HCC that contributes to a decrease in tumor-free survival and an increase in metastasis. In an HCC mouse model, we found that p53(R172H/flox) mice do not have decreased survival, increased tumor incidence, or increased metastasis, relative to p53(flox/flox) littermates. Analysis of cell lines derived from both genotypes indicated that there are no differences in anchorage-independent growth and cell migration. However, shRNA-mediated knockdown of mutant p53 in p53(R172H)-expressing HCC cell lines resulted in decreased cell migration and anchorage-independent growth. Thus, although p53 mutant-expressing cells and tumors do not have enhanced properties relative to their p53 null counterparts, p53(R172H)-expressing HCC cells depend on this mutant for their transformation. p53 mutants have been previously shown to bind and inhibit the p53 family proteins p63 and p73. Interestingly, we find that the levels of p63 and p73 target genes are similar in p53 mutant and p53 null HCC cells. These data suggest that pathways regulated by these p53 family members are similarly impacted by p53(R172H) in mutant expressing cells, and by alternate mechanisms in p53 null cells, resulting in equivalent phenotypes. Consistent with this, we find that p53 null HCC cell lines display lower levels of the TA isoforms of p63 and p73 and higher levels of Delta Np63. Taken together these data point to the importance of p63 and p73 in constraining HCC progression.	[Ahronian, Leanne G.; Driscoll, David R.; Lewis, Brian C.] Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA 01605 USA; [Klimstra, David S.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Lewis, Brian C.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA; [Lewis, Brian C.] Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; Memorial Sloan Kettering Cancer Center; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Lewis, BC (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA 01605 USA.	Brian.Lewis@umassmed.edu			National Institutes of Health [R01CA121171]; NATIONAL CANCER INSTITUTE [R01CA121171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by National Institutes of Health grant R01CA121171 to BCL [http://www.nih.gov/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benard J, 2003, HUM MUTAT, V21, P182, DOI 10.1002/humu.10172; Buendia MA, 2000, SEMIN CANCER BIOL, V10, P185; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Chen YW, 2007, CANCER RES, V67, P7589, DOI 10.1158/0008-5472.CAN-07-0381; Cucchetti A, 2012, WORLD J GASTROENTERO, V18, P6398, DOI 10.3748/wjg.v18.i44.6398; Cucchetti A, 2011, ANN SURG ONCOL, V18, P1630, DOI 10.1245/s10434-010-1463-8; de Vries A, 2002, P NATL ACAD SCI USA, V99, P2948, DOI 10.1073/pnas.052713099; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Gouas DA, 2010, CARCINOGENESIS, V31, P1475, DOI 10.1093/carcin/bgq118; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; Herath NI, 2000, HEPATOLOGY, V31, P601, DOI 10.1002/hep.510310309; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lee MK, 2012, CANCER CELL, V22, P751, DOI 10.1016/j.ccr.2012.10.022; Lewis BC, 2005, MOL CELL BIOL, V25, P1228, DOI 10.1128/MCB.25.4.1228-1237.2005; Li Y, 2007, ONCOGENE, V26, P2220, DOI 10.1038/sj.onc.1210311; Lin YL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000680; Liu G, 2000, P NATL ACAD SCI USA, V97, P4174, DOI 10.1073/pnas.97.8.4174; Liu JB, 2012, EUR J CANCER, V48, P2328, DOI 10.1016/j.ejca.2012.03.001; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet Josep M, 2004, Liver Transpl, V10, pS115, DOI 10.1002/lt.20034; Lu X, 2012, ONCOGENE; Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107; ODA T, 1992, CANCER RES, V52, P6358; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; ORY K, 1994, EMBO J, V13, P3496, DOI 10.1002/j.1460-2075.1994.tb06656.x; Pan HC, 2002, ACTA ONCOL, V41, P550; Petitjean A, 2005, ONCOGENE, V24, P512, DOI 10.1038/sj.onc.1208215; Sayan AE, 2001, ONCOGENE, V20, P5111, DOI 10.1038/sj.onc.1204669; Schilling T, 2010, BIOCHEM BIOPH RES CO, V394, P817, DOI 10.1016/j.bbrc.2010.03.082; Sigal A, 2000, CANCER RES, V60, P6788; Stiewe T, 2004, CLIN CANCER RES, V10, P626, DOI 10.1158/1078-0432.CCR-0153-03; Tannapfel A, 1999, J NATL CANCER I, V91, P1154, DOI 10.1093/jnci/91.13.1154; Tannapfel A, 2008, CARCINOGENESIS, V29, P211, DOI 10.1093/carcin/bgm236; UNGER T, 1992, EMBO J, V11, P1383, DOI 10.1002/j.1460-2075.1992.tb05183.x; Venkatanarayan A, 2014, NATURE; Wijnhoven SWP, 2007, CANCER RES, V67, P4648, DOI 10.1158/0008-5472.CAN-06-4681; Woo HG, 2011, GASTROENTEROLOGY, V140, P1063, DOI 10.1053/j.gastro.2010.11.034	41	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123816	10.1371/journal.pone.0123816	http://dx.doi.org/10.1371/journal.pone.0123816			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885474	Green Published, Green Submitted, gold			2022-12-26	WOS:000353017000085
J	Capela, NA; Lemaire, ED; Baddour, N				Capela, Nicole A.; Lemaire, Edward D.; Baddour, Natalie			Feature Selection for Wearable Smartphone-Based Human Activity Recognition with Able bodied, Elderly, and Stroke Patients	PLOS ONE			English	Article							CLASSIFICATION; ACCELEROMETRY; POSTURES; SENSORS; PEOPLE	Human activity recognition (HAR), using wearable sensors, is a growing area with the potential to provide valuable information on patient mobility to rehabilitation specialists. Smartphones with accelerometer and gyroscope sensors are a convenient, minimally invasive, and low cost approach for mobility monitoring. HAR systems typically pre-process raw signals, segment the signals, and then extract features to be used in a classifier. Feature selection is a crucial step in the process to reduce potentially large data dimensionality and provide viable parameters to enable activity classification. Most HAR systems are customized to an individual research group, including a unique data set, classes, algorithms, and signal features. These data sets are obtained predominantly from able-bodied participants. In this paper, smartphone accelerometer and gyroscope sensor data were collected from populations that can benefit from human activity recognition: able-bodied, elderly, and stroke patients. Data from a consecutive sequence of 41 mobility tasks (18 different tasks) were collected for a total of 44 participants. Seventy-six signal features were calculated and subsets of these features were selected using three filter-based, classifier-independent, feature selection methods (Relief-F, Correlation-based Feature Selection, Fast Correlation Based Filter). The feature subsets were then evaluated using three generic classifiers (Naive Bayes, Support Vector Machine, j48 Decision Tree). Common features were identified for all three populations, although the stroke population subset had some differences from both able-bodied and elderly sets. Evaluation with the three classifiers showed that the feature subsets produced similar or better accuracies than classification with the entire feature set. Therefore, since these feature subsets are classifier-independent, they should be useful for developing and improving HAR systems across and within populations.	[Capela, Nicole A.; Lemaire, Edward D.] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Lemaire, Edward D.] Univ Ottawa, Fac Med, Ottawa, ON, Canada; [Capela, Nicole A.; Baddour, Natalie] Univ Ottawa, Dept Mech Engn, Ottawa, ON K1N 6N5, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa	Capela, NA (corresponding author), Ottawa Hosp, Res Inst, Ottawa, ON, Canada.	ncape055@uottawa.ca	Baddour, Natalie/A-4018-2008	Baddour, Natalie/0000-0002-7025-7501; Lemaire, Edward/0000-0003-4693-2623	Natural Sciences and Engineering Research Council of Canada; BlackBerry [CRDPJ 408109]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); BlackBerry	This project was funded by the Natural Sciences and Engineering Research Council of Canada Collaborative Research and Development Grants and BlackBerry (formerly Research in Motion) (CRDPJ 408109, www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen FR, 2006, PHYSIOL MEAS, V27, P935, DOI 10.1088/0967-3334/27/10/001; Atallah L., 2010, BODY SENSOR NETWORKS, DOI DOI 10.1109/BSN.2010.23; Avci A., 2010, 23 INT C ARCH COMP S; Barra J, 2009, NEUROLOGY, V72, P1582, DOI 10.1212/WNL.0b013e3181a4123a; Bidargaddi N, 2007, PROCEEDINGS OF THE 2007 INTERNATIONAL CONFERENCE ON INTELLIGENT SENSORS, SENSOR NETWORKS AND INFORMATION PROCESSING, P555; Cheung VH, 2011, ARCH PHYS MED REHAB, V92, P998, DOI 10.1016/j.apmr.2010.12.040; Del Rosario MB, 2014, PHYSIOL MEAS, V35, P2269, DOI 10.1088/0967-3334/35/11/2269; Dijkstra B, 2010, AGE AGEING, V39, P259, DOI 10.1093/ageing/afp249; Feng YQ, 2003, 2003 INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND CYBERNETICS, VOLS 1-5, PROCEEDINGS, P2085, DOI 10.1109/ICMLC.2003.1259848; Fish B, 2012, INT CONF ACOUST SPEE, P1729, DOI 10.1109/ICASSP.2012.6288232; Fulk GD, 2011, TOP STROKE REHABIL, V18, P746, DOI 10.1310/tsr1806-746; Hache G, 2011, IEEE T INSTRUM MEAS, V60, P3153, DOI 10.1109/TIM.2011.2122490; Hristijan Gjoreski SK, 2014, USING MULTIPLE CONTE, DOI [10.3233/978-1-61499-419-0-1015, DOI 10.3233/978-1-61499-419-0-1015]; Incel OD, 2013, BIONANOSCIENCE, V3, P145, DOI 10.1007/s12668-013-0088-3; Khan AM, 2014, INT J DISTRIB SENS N, DOI 10.1155/2014/503291; Kozina S, 2013, J MED BIOL ENG, V33, P406, DOI 10.5405/jmbe.1321; Lau S.L., 2010, P FUT NETW MOB SUMM, P1; Liu H, 2008, CH CRC DATA MIN KNOW, P3; Mark A, 1999, FEATURE SELECTION FO, P235; Maurer U, 2006, BSN 2006: INTERNATIONAL WORKSHOP ON WEARABLE AND IMPLANTABLE BODY SENSOR NETWORKS, PROCEEDINGS, P113; Mizuike C, 2009, GAIT POSTURE, V30, P60, DOI 10.1016/j.gaitpost.2009.02.017; Nicole A, 2014, 36 ANN INT C IEEE EN; Nuno Cruz Silva JMM, 2013, FEATURES SELECTION H; Pantelopoulos A, 2010, IEEE T SYST MAN CY C, V40, P1, DOI 10.1109/TSMCC.2009.2032660; Patel S, 2010, P IEEE, V98, P450, DOI 10.1109/JPROC.2009.2038727; Ravi N., 2005, P 17 C INN APPL ART, P1541, DOI DOI 10.1007/978-3-642-02481-8_120; Steele BC, 2003, J REHABIL RES DEV, V40, P45, DOI 10.1682/JRRD.2003.10.0045; Tundo MD, 2013, IEEE INT SYM MED MEA, P58, DOI 10.1109/MeMeA.2013.6549706; Zhang M., 2011, BODYNETS, P92; Zhang M, 2012, UBICOMP'12: PROCEEDINGS OF THE 2012 ACM INTERNATIONAL CONFERENCE ON UBIQUITOUS COMPUTING, P1036; Zhao Z., ADV FEATURE SELECTIO	31	100	103	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124414	10.1371/journal.pone.0124414	http://dx.doi.org/10.1371/journal.pone.0124414			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885272	Green Published, gold, Green Submitted			2022-12-26	WOS:000353017000124
J	Ernst, JB; Becker, T; Kuhn, J; Gummert, JF; Zittermann, A				Ernst, Jana B.; Becker, Tobias; Kuhn, Joachim; Gummert, Jan F.; Zittermann, Armin			Independent Association of Circulating Vitamin D Metabolites with Anemia Risk in Patients Scheduled for Cardiac Surgery	PLOS ONE			English	Article							CORONARY-ARTERY-BYPASS; CHRONIC KIDNEY-DISEASE; RED-BLOOD-CELL; HEMODIALYSIS-PATIENTS; PREOPERATIVE ANEMIA; D DEFICIENCY; INTRAVENOUS CALCITRIOL; D SUPPLEMENTATION; HEMOGLOBIN LEVEL; TRANSFUSION	Background Preoperative anemia is considered an independent risk factor of poor clinical outcome in cardiac surgical patients. Low vitamin D status may increase anemia risk. Methods We investigated 3,615 consecutive patients scheduled for cardiac surgery to determine the association between preoperative anemia (hemoglobin [Hb] < 12.5 g/dL) and circulating levels of the vitamin D metabolites 25-hydroxyvitamin D (25OHD) and 1,25-dihydroxyvitamin D (1,25[OH](2)D). Results Of the study cohort, 27.8% met the criteria for anemia. In patients with deficient 25OHD levels (<30 nmol/l) mean Hb concentrations were 0.5 g/dL lower than in patients with adequate 25OHD levels (50.0-125 nmol/l; P<0.001). Regarding 1,25(OH)(2)D, mean Hb concentrations were 1.2 g/dL lower in the lowest 1,25(OH)(2)D category (<40 pmol/l) than in the highest 1,25(OH)(2)D category (>70 pmol/l; P<0.001). In multivariable-adjusted logistic regression analyses, the odds ratios for anemia of the lowest categories of 25OHD and 1,25(OH)(2)D were 1.48 (95% CI: 1.19-1.83) and 2.35 (95% CI: 1.86-2.97), compared with patients who had adequate 25OHD levels and 1,25(OH)(2)D values in the highest category, respectively. Anemia risk was greatest in patients with dual deficiency of 25OHD and 1,25(OH)(2)D (multivariable-adjusted OR = 3.60 (95% CI: 2.40-5.40). Prevalence of deficient 25OHD levels was highest in anemia of nutrient deficiency, whereas low 1,25(OH)(2)D levels were most frequent in anemia of chronic kidney disease. Conclusion This cross-sectional study demonstrates an independent inverse association between vitamin D status and anemia risk. If confirmed in clinical trials, preoperative administration of vitamin D or activated vitamin D (in case of chronic kidney disease) would be a promising strategy to prevent anemia in patients scheduled for cardiac surgery.	[Ernst, Jana B.; Becker, Tobias; Gummert, Jan F.; Zittermann, Armin] Ruhr Univ Bochum, Clin Thorac & Cardiovasc Surg, Heart & Diabet Ctr North Rhine Westphalia, Bad Oeynhausen, Germany; [Kuhn, Joachim] Ruhr Univ Bochum, Inst Lab & Transfus Med, Heart & Diabet Ctr North Rhine Westphalia, Bad Oeynhausen, Germany	Ruhr University Bochum; Ruhr University Bochum	Zittermann, A (corresponding author), Ruhr Univ Bochum, Clin Thorac & Cardiovasc Surg, Heart & Diabet Ctr North Rhine Westphalia, Bad Oeynhausen, Germany.	azittermann@hdz-nrw.de						Atkinson MA, 2014, J PEDIATR-US, V164, P153, DOI 10.1016/j.jpeds.2013.08.060; Aucella F, 2003, NEPHRON CLIN PRACT, V95, pC121, DOI 10.1159/000074837; Baron DM, 2014, BRIT J ANAESTH, V113, P416, DOI 10.1093/bja/aeu098; Ben Alon D, 2002, EXP HEMATOL, V30, P403, DOI 10.1016/S0301-472X(02)00789-0; Bilgin YM, 2004, CIRCULATION, V109, P2755, DOI 10.1161/01.CIR.0000130162.11925.21; Blanco-Rojo R, 2013, EUR J NUTR, V52, P695, DOI 10.1007/s00394-012-0375-8; Carrascal Y, 2010, INTERACT CARDIOV TH, V10, P249, DOI 10.1510/icvts.2009.220160; Eloranta JJ, 2009, MOL PHARMACOL, V76, P1062, DOI 10.1124/mol.109.055392; Engoren M, 2014, ANN THORAC SURG, V97, P514, DOI 10.1016/j.athoracsur.2013.09.019; Galas FRBG, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-54; Goicoechea M, 1998, NEPHRON, V78, P23, DOI 10.1159/000044877; Harskamp RE, 2014, ANN THORAC SURG, V97, P824, DOI 10.1016/j.athoracsur.2013.09.099; Healthcare Cost and Utilization Project, 2013, MOST FREQ PROC PERF; Hung M, 2011, ANAESTHESIA, V66, P812, DOI 10.1111/j.1365-2044.2011.06819.x; Jean G, 2009, NEPHROL DIAL TRANSPL, V24, P3799, DOI 10.1093/ndt/gfp370; Jones G, 1998, PHYSIOL REV, V78, P1193, DOI 10.1152/physrev.1998.78.4.1193; Karkouti K, 2008, CIRCULATION, V117, P478, DOI 10.1161/CIRCULATIONAHA.107.718353; Kendrick J, 2009, AM J NEPHROL, V30, P64, DOI 10.1159/000202632; Kim C, 2014, PERFUSION IN PRESS; Kiss Z, 2011, NEPHRON CLIN PRACT, V117, pC373, DOI 10.1159/000321521; Koch CG, 2006, CRIT CARE MED, V34, P1608, DOI 10.1097/01.CCM.0000217920.48559.D8; Koch CG, 2008, NEW ENGL J MED, V358, P1229, DOI 10.1056/NEJMoa070403; Kumar VA, 2011, J NEPHROL, V24, P98, DOI 10.5301/JN.2010.1830; Lac PT, 2010, CLIN NEPHROL, V74, P25; Lawson M, 1999, BRIT MED J, V318, P28, DOI 10.1136/bmj.318.7175.28; Leal-Noval SM, 2001, CHEST, V119, P1461, DOI 10.1378/chest.119.5.1461; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; MASUHARA T, 1963, J NUTR, V80, P332, DOI 10.1093/jn/80.3.332; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Mehta S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008770; Murphy GJ, 2007, CIRCULATION, V116, P2544, DOI 10.1161/CIRCULATIONAHA.107.698977; Nazem A. K., 1997, International Urology and Nephrology, V29, P119, DOI 10.1007/BF02551427; Neumeister B, 2009, KLINIKLEITFADEN LABO; Neves PL, 2006, INT UROL NEPHROL, V38, P175, DOI 10.1007/s11255-004-1563-0; Paone G, 2014, ANN THORAC SURG, V97, P87, DOI 10.1016/j.athoracsur.2013.07.020; Patel NM, 2010, KIDNEY INT, V77, P715, DOI 10.1038/ki.2009.551; Perlstein TS, 2011, BLOOD, V117, P2800, DOI 10.1182/blood-2010-09-309708; Petkovich M, 2011, CURR OPIN NEPHROL HY, V20, P337, DOI 10.1097/MNH.0b013e3283477a7b; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Saab G, 2007, NEPHRON CLIN PRACT, V105, P132, DOI 10.1159/000098645; Shavit L, 2014, CLIN J AM SOC NEPHRO, V9, P1536, DOI 10.2215/CJN.00110114; Shin JY, 2013, CLIN CHIM ACTA, V421, P177, DOI 10.1016/j.cca.2013.02.025; Sim JJ, 2010, ANN HEMATOL, V89, P447, DOI 10.1007/s00277-009-0850-3; Spahn DR, 2013, LANCET, V381, P1855, DOI 10.1016/S0140-6736(13)60808-9; Surgenor SD, 2009, ANESTH ANALG, V108, P1741, DOI 10.1213/ane.0b013e3181a2a696; Whitson BA, 2010, J SURG RES, V158, P20, DOI 10.1016/j.jss.2008.10.015; Williams ML, 2013, ANN THORAC SURG, V96, P1628, DOI 10.1016/j.athoracsur.2013.06.030; Zittermann A, 2013, INT J LAB H IN PRESS; Zittermann A, 2015, J CLIN ENDOCR METAB, V100, P72, DOI 10.1210/jc.2014-3013; Zittermann A, 2011, CLIN RES CARDIOL, V100, P781, DOI 10.1007/s00392-011-0312-5; Zittermann A, 2009, CLIN CHEM, V55, P1163, DOI 10.1373/clinchem.2008.120006	51	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124751	10.1371/journal.pone.0124751	http://dx.doi.org/10.1371/journal.pone.0124751			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885271	Green Submitted, gold, Green Published			2022-12-26	WOS:000353017000144
J	Gibaja, V; Shen, F; Harari, J; Korn, J; Ruddy, D; Saenz-Vash, V; Zhai, H; Rejtar, T; Paris, CG; Yu, Z; Lira, M; King, D; Qi, W; Keen, N; Hassan, AQ; Chan, HM				Gibaja, V.; Shen, F.; Harari, J.; Korn, J.; Ruddy, D.; Saenz-Vash, V.; Zhai, H.; Rejtar, T.; Paris, C. G.; Yu, Z.; Lira, M.; King, D.; Qi, W.; Keen, N.; Hassan, A. Q.; Chan, H. M.			Development of secondary mutations in wild-type and mutant EZH2 alleles cooperates to confer resistance to EZH2 inhibitors	ONCOGENE			English	Article							EMBRYONIC STEM-CELLS; SELECTIVE-INHIBITION; LYSINE 27; LYMPHOMA; METHYLTRANSFERASE; METHYLATION; POLYCOMB; CANCER; EPIGENETICS; REGULATORS	The histone methyltransferase Enhancer of Zeste Homolog 2 (EZH2) is frequently dysregulated in cancers, and gain-of-function (GOF) EZH2 mutations have been identified in non-Hodgkin lymphomas. Small-molecule inhibitors against EZH2 demonstrated anti-tumor activity in EZH2-mutated lymphomas and entered clinical trials. Here, we developed models of acquired resistance to EZH2 inhibitor EI1 with EZH2-mutated lymphoma cells. Resistance was generated by secondary mutations in both wild-type (WT) and GOF Y641N EZH2 alleles. These EZH2 mutants retained the substrate specificity of their predecessor complexes but became refractory to biochemical inhibition by EZH2 inhibitors. Resistant cells were able to maintain a high level of H3K27Me3 in the presence of inhibitors. Interestingly, mutation of EZH2 WT alone generated an intermediate resistance phenotype, which is consistent with a previously proposed model of cooperation between EZH2 WT and Y641N mutants to promote tumorigenesis. In addition, the findings presented here have implications for the clinical translation of EZH2 inhibitors and underscore the need to develop novel EZH2 inhibitors to target potential resistance emerging in clinical settings.	[Gibaja, V.; Shen, F.; Harari, J.; Korn, J.; Ruddy, D.; Saenz-Vash, V.; Zhai, H.; Rejtar, T.; Paris, C. G.; Lira, M.; King, D.; Keen, N.; Hassan, A. Q.; Chan, H. M.] Novartis Inst BioMed Res, 250 Mass Ave, Cambridge, MA 02139 USA; [Yu, Z.; Qi, W.] China Novartis Inst BioMed Res, Shanghai, Peoples R China	Novartis; Novartis	Hassan, AQ; Chan, HM (corresponding author), Novartis Inst BioMed Res, 250 Mass Ave, Cambridge, MA 02139 USA.	quamrul.hassan@novartis.com; homan.chan@novartis.com		Qi, Wei/0000-0003-0813-5316				Antonysamy S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084147; Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Beguelin W, 2013, CANCER CELL, V23, P677, DOI 10.1016/j.ccr.2013.04.011; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Emery CM, 2009, P NATL ACAD SCI USA, V106, P20411, DOI 10.1073/pnas.0905833106; Ferguson AD, 2011, STRUCTURE, V19, P1262, DOI 10.1016/j.str.2011.06.011; Garapaty-Rao S, 2013, CHEM BIOL, V20, P1329, DOI 10.1016/j.chembiol.2013.09.013; Helin K, 2013, NATURE, V502, P480, DOI 10.1038/nature12751; Hoffman GR, 2014, P NATL ACAD SCI USA, V111, P3128, DOI 10.1073/pnas.1316793111; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Jaffe JD, 2013, NAT GENET, V45, P1386, DOI 10.1038/ng.2777; Kim W, 2013, NAT CHEM BIOL, V9, P643, DOI [10.1038/NCHEMBIO.1331, 10.1038/nchembio.1331]; Kipp DR, 2013, BIOCHEMISTRY-US, V52, P6866, DOI 10.1021/bi400805w; Knutson SK, 2014, MOL CANCER THER, V13, P842, DOI 10.1158/1535-7163.MCT-13-0773; Knutson SK, 2013, P NATL ACAD SCI USA, V110, P7922, DOI 10.1073/pnas.1303800110; Knutson SK, 2012, NAT CHEM BIOL, V8, P890, DOI [10.1038/NCHEMBIO.1084, 10.1038/nchembio.1084]; Korpal M, 2013, CANCER DISCOV, V3, P1030, DOI 10.1158/2159-8290.CD-13-0142; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Mack SC, 2014, NATURE, V506, P445, DOI 10.1038/nature13108; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Qi W, 2012, P NATL ACAD SCI USA, V109, P21360, DOI 10.1073/pnas.1210371110; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Vedadi M, 2011, NAT CHEM BIOL, V7, P566, DOI [10.1038/NCHEMBIO.599, 10.1038/nchembio.599]; Wehrle J, 2014, RECENT RESULTS CANC, V201, P99, DOI 10.1007/978-3-642-54490-3_5; Wu HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013316; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208	31	96	100	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 4	2016	35	5					558	566		10.1038/onc.2015.114	http://dx.doi.org/10.1038/onc.2015.114			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DC9NR	25893294	Green Published, hybrid			2022-12-26	WOS:000369548800003
J	Vashisht, AA; Yu, CC; Sharma, T; Ro, K; Wohlschlegel, JA				Vashisht, Ajay A.; Yu, Clarissa C.; Sharma, Tanu; Ro, Kevin; Wohlschlegel, James A.			The Association of the Xeroderma Pigmentosum Group D DNA Helicase (XPD) with Transcription Factor IIH Is Regulated by the Cytosolic Iron-Sulfur Cluster Assembly Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN IDENTIFICATION TECHNOLOGY; REPAIR; GENE; HOMEOSTASIS; METABOLISM; CANCER; CELLS	Xeroderma pigmentosum groupD(XPD) helicase is a component of the transcription factor IIH (TFIIH) transcription complex and plays essential roles in transcription and nucleotide excision repair. Although iron-sulfur (Fe-S) cluster binding by XPD is required for activity, the process mediating Fe-S cluster assembly remains poorly understood. We recently identified a cytoplasmic Fe-S cluster assembly (CIA) targeting complex composed of MMS19, CIAO1, and FAM96B that is required for the biogenesis of extramitochondrial Fe-S proteins including XPD. Here, we use XPD as a prototypical Fe-S protein to further characterize how Fe-S assembly is facilitated by the CIA targeting complex. Multiple lines of evidence indicate that this process occurs in a stepwise fashion in which XPD acquires a Fe-S cluster from the CIA targeting complex before assembling into TFIIH. First, XPD was found to associate in a mutually exclusive fashion with either TFIIH or the CIA targeting complex. Second, disrupting Fe-S cluster assembly on XPD by either 1) depleting cellular iron levels or 2) utilizing XPD mutants defective in either Fe-S cluster or CIA targeting complex binding blocks Fe-S cluster assembly and prevents XPD incorporation into TFIIH. Finally, subcellular fractionation studies indicate that the association of XPD with the CIA targeting complex occurs in the cytoplasm, whereas its association with TFIIH occurs largely in the nucleus where TFIIH functions. Together, these data establish a sequential assembly process for Fe-S assembly on XPD and highlight the existence of quality control mechanisms that prevent the incorporation of immature apoproteins into their cellular complexes.	[Vashisht, Ajay A.; Yu, Clarissa C.; Sharma, Tanu; Ro, Kevin; Wohlschlegel, James A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Wohlschlegel, JA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.	jwohl@mednet.ucla.edu	Regan, Clinton/E-6250-2012; Ro, Clarissa/M-7638-2017		National Institutes of Health [GM089778]; University of California Cancer Research Coordinating Committee; Jonsson Cancer Center at UCLA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089778] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Cancer Research Coordinating Committee(University of California System); Jonsson Cancer Center at UCLA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM089778 (to J.A.W.). This work was also supported by the University of California Cancer Research Coordinating Committee (to J.A.W.) and the Jonsson Cancer Center at UCLA (to J.A.W.).	Dubaele S, 2003, MOL CELL, V11, P1635, DOI 10.1016/S1097-2765(03)00182-5; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Friedberg EC, 2001, NAT REV CANCER, V1, P22, DOI 10.1038/35094000; Gari K, 2012, SCIENCE, V337, P243, DOI 10.1126/science.1219664; GOZUKARA EM, 1994, CANCER RES, V54, P3837; GUO B, 1995, J BIOL CHEM, V270, P16529, DOI 10.1074/jbc.270.28.16529; Lamond, 2006, CELL BIOL LAB HDB, P103, DOI [10.1016/b978-012164730-8/50087-3, DOI 10.1016/B978-012164730-8/50087-3]; Lehmann AR, 2001, GENE DEV, V15, P15, DOI 10.1101/gad.859501; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Liu H, 2008, CELL, V133, P801, DOI 10.1016/j.cell.2008.04.029; Maio N, 2014, CELL METAB, V19, P445, DOI 10.1016/j.cmet.2014.01.015; Netz DJA, 2014, TRENDS CELL BIOL, V24, P303, DOI 10.1016/j.tcb.2013.11.005; PROTICSABLJIC M, 1986, PHOTOCHEM PHOTOBIOL, V43, P509, DOI 10.1111/j.1751-1097.1986.tb09528.x; Pugh RA, 2008, J BIOL CHEM, V283, P1732, DOI 10.1074/jbc.M707064200; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Stehling O, 2012, SCIENCE, V337, P195, DOI 10.1126/science.1219723; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wohlschlegel James A., 2009, V497, P33, DOI 10.1007/978-1-59745-566-4_3; Wolski SC, 2008, PLOS BIOL, V6, P1332, DOI 10.1371/journal.pbio.0060149; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Ye H., 2010, ADV HEMATOL, V2010, DOI DOI 10.1155/2010/329394; Ye H, 2010, BIOCHEMISTRY-US, V49, P4945, DOI 10.1021/bi1004798	23	29	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					14218	14225		10.1074/jbc.M115.650762	http://dx.doi.org/10.1074/jbc.M115.650762			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25897079	hybrid, Green Published			2022-12-26	WOS:000355313000048
J	Ferreira, CEL; Luiz, OJ; Floeter, SR; Lucena, MB; Barbosa, MC; Rocha, CR; Rocha, LA				Ferreira, Carlos E. L.; Luiz, Osmar J.; Floeter, Sergio R.; Lucena, Marcos B.; Barbosa, Moyses C.; Rocha, Claudia R.; Rocha, Luiz A.			First Record of Invasive Lionfish (Pterois volitans) for the Brazilian Coast	PLOS ONE			English	Article							WESTERN ATLANTIC; FISH; SPP.; PATTERNS; INSIGHTS	The invasion of the northwestern Atlantic by the Indo-Pacific lionfish has developed extraordinarily fast, and is expected to cause one of the most negative ecological impacts among all marine invasions. In less than 30 years, lionfish have dramatically expanded their distribution range to an area encompassing the eastern coast of the USA, Bermuda, the entire Caribbean region and the Gulf of Mexico. The rapidity of the lionfish spread has raised concerns in other parts of the Atlantic that may be under the reach of the invasion. Despite the anticipation that lionfish would eventually extend their range throughout most of the eastern coast of South America, it had not been recorded in Brazil until now. Here we report the first lionfish appearance for the Brazilian coast and show that the individual collected by us is genetically linked to the invasive Caribbean population. Since small-range endemics are found in several locations in Brazil and are among the species that are most vulnerable to extinction, we recommend urgent control, management and education measures aimed at minimizing the effects of this impending invasion.	[Ferreira, Carlos E. L.; Lucena, Marcos B.; Barbosa, Moyses C.] Univ Fed Fluminense, Dept Biol Marinha, Niteroi, RJ, Brazil; [Luiz, Osmar J.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Floeter, Sergio R.] Univ Fed Santa Catarina, Dept Ecol & Zool, Florianopolis, SC, Brazil; [Rocha, Claudia R.; Rocha, Luiz A.] Calif Acad Sci, San Francisco, CA 94118 USA; [Rocha, Luiz A.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA	Universidade Federal Fluminense; Macquarie University; Universidade Federal de Santa Catarina (UFSC); California Academy of Sciences; University of California System; University of California Santa Cruz	Rocha, LA (corresponding author), Calif Acad Sci, San Francisco, CA 94118 USA.	LRocha@calacademy.org	Rocha, Luiz/T-6326-2019; Floeter, S. R./B-1438-2012; Barbosa, Moysés/AAA-9096-2022	Floeter, S. R./0000-0002-3201-6504; Barbosa, Moysés/0000-0001-8842-2619; Rocha, Luiz/0000-0003-4011-569X; Ferreira, Carlos Eduardo/0000-0002-4311-0491	California Academy of Sciences; CNPQ (Brazilian National Research Agency); FAPERJ (Rio de Janeiro State research funding agency); ECOHUB (Brazilian ecological research funding agency)	California Academy of Sciences; CNPQ (Brazilian National Research Agency)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ (Rio de Janeiro State research funding agency)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); ECOHUB (Brazilian ecological research funding agency)	Financial support was provided by the California Academy of Sciences, CNPQ (Brazilian National Research Agency), FAPERJ (Rio de Janeiro State research funding agency) and ECOHUB (Brazilian ecological research funding agency).	Albins MA, 2013, ENVIRON BIOL FISH, V96, P1151, DOI 10.1007/s10641-011-9795-1; Betancur-R R, 2011, J BIOGEOGR, V38, P1281, DOI 10.1111/j.1365-2699.2011.02496.x; Claydon JAB, 2012, MAR ECOL PROG SER, V448, P119, DOI 10.3354/meps09534; Cote IM, 2014, PEERJ PREPRINTS, V2, DOI [DOI 10.7287/PEERJ.PREPRINTS.398V1, 10.7287/peerj.preprints.398v1]; Cote IM, 2013, BIOL CONSERV, V164, P50, DOI 10.1016/j.biocon.2013.04.014; de Leon R, 2013, ENDANGER SPECIES RES, V22, P175, DOI 10.3354/esr00542; Sampaio FDF, 2013, MAR POLICY, V42, P280, DOI 10.1016/j.marpol.2013.03.009; Frazer TK, 2012, REV FISH SCI, V20, P185, DOI 10.1080/10641262.2012.700655; Halpern BS, 2008, MAR ECOL PROG SER, V364, P147, DOI 10.3354/meps07553; Hamner RM, 2007, J FISH BIOL, V71, P214, DOI 10.1111/j.1095-8649.2007.01575.x; Jud ZR, 2015, ENVIRON BIOL FISH, V98, P135, DOI 10.1007/s10641-014-0242-y; Jud ZR, 2012, J EXP MAR BIOL ECOL, V414, P69, DOI 10.1016/j.jembe.2012.01.015; Kulbicki M, 2012, MAR ECOL PROG SER, V446, P189, DOI 10.3354/meps09442; Luiz OJ, 2013, MAR ECOL PROG SER, V485, P1, DOI 10.3354/meps10383; Rocha LA, 2003, J BIOGEOGR, V30, P1161, DOI 10.1046/j.1365-2699.2003.00900.x; Schofield PJ, 2010, AQUAT INVASIONS, V5, pS117, DOI 10.3391/ai.2010.5.S1.024; Valdez-Moreno M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036636	17	93	96	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123002	10.1371/journal.pone.0123002	http://dx.doi.org/10.1371/journal.pone.0123002			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901361	Green Submitted, Green Published, gold			2022-12-26	WOS:000353331500036
J	Iikura, M; Hojo, M; Koketsu, R; Watanabe, S; Sato, A; Chino, H; Ro, S; Masaki, H; Hirashima, J; Ishii, S; Naka, G; Takasaki, J; Izumi, S; Kobayashi, N; Yamaguchi, S; Nakae, S; Sugiyama, H				Iikura, Motoyasu; Hojo, Masayuki; Koketsu, Rikiya; Watanabe, Sho; Sato, Ayano; Chino, Haruka; Ro, Shoki; Masaki, Haruna; Hirashima, Junko; Ishii, Satoru; Naka, Go; Takasaki, Jin; Izumi, Shinyu; Kobayashi, Nobuyuki; Yamaguchi, Sachiko; Nakae, Susumu; Sugiyama, Haruhito			The Importance of Bacterial and Viral Infections Associated with Adult Asthma Exacerbations in Clinical Practice	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; TOLL-LIKE RECEPTOR-4; BRONCHIAL-ASTHMA; LUNG-DISEASES; RHINOVIRUS; RISK; ACTIVATION; EXPRESSION; CHILDREN; CELLS	Background Viral infection is one of the risk factors for asthma exacerbation. However, which pathogens are related to asthma exacerbation in adults remains unclear. Objective The relation between various infections and adult asthma exacerbations was investigated in clinical practice. Methods The study subjects included 50 adult inpatients due to asthma exacerbations and 20 stable outpatients for comparison. The pathogens from a nasopharyngeal swab were measured by multiplex PCR analysis. Results Asthma exacerbations occurred after a common cold in 48 inpatients. The numbers of patients with viral, bacterial, or both infections were 16, 9, and 9, respectively. The dominant viruses were rhinoviruses, respiratory syncytial virus, influenza virus, and metapneumovirus. The major bacteria were S. pneumoniae and H. influenzae. Compared to pathogen-free patients, the patients with pathogens were older and non-atopic and had later onset of disease, lower FeNO levels, lower IgE titers, and a higher incidence of comorbid sinusitis, COPD, or pneumonia. Compared to stable outpatients, asthma exacerbation inpatients had a higher incidence of smoking and comorbid sinusitis, COPD, or pneumonia. Viruses were detected in 50% of stable outpatients, but a higher incidence of rhinovirus, respiratory syncytial virus, and metapneumovirus infections was observed in asthma exacerbation inpatients. H. influenzae was observed in stable asthmatic patients. Other bacteria, especially S. pneumoniae, were important in asthma exacerbation inpatients. Conclusion Viral or bacterial infections were observed in 70% of inpatients with an asthma exacerbation in clinical practice. Infection with S. pneumoniae was related to adult asthma exacerbation.	[Iikura, Motoyasu; Hojo, Masayuki; Koketsu, Rikiya; Watanabe, Sho; Sato, Ayano; Chino, Haruka; Ro, Shoki; Masaki, Haruna; Hirashima, Junko; Ishii, Satoru; Naka, Go; Takasaki, Jin; Izumi, Shinyu; Kobayashi, Nobuyuki; Sugiyama, Haruhito] Natl Ctr Global Hlth & Med, Dept Resp Med, Tokyo, Japan; [Yamaguchi, Sachiko; Nakae, Susumu] Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Lab Syst Biol, Tokyo, Japan; [Nakae, Susumu] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Saitama, Japan	National Center for Global Health & Medicine - Japan; University of Tokyo; Japan Science & Technology Agency (JST)	Iikura, M (corresponding author), Natl Ctr Global Hlth & Med, Dept Resp Med, Tokyo, Japan.	iikura-tky@umin.ac.jp		Kitazawa, Haruna/0000-0001-7234-1275	National Center for Global Health and Medicine [22-120]; Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency	National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by a grant from the National Center for Global Health and Medicine (22-120 MI) and Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency (SN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, THORAX, V69, P1; Barnes PJ, 2005, EUR RESPIR J, V25, P552, DOI 10.1183/09031936.05.00117504; Beale J, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009124; Busse WW, 2010, LANCET, V376, P826, DOI 10.1016/S0140-6736(10)61380-3; Busse WW, 2007, EXPERT PANEL REPORT; Denlinger LC, 2011, AM J RESP CRIT CARE, V184, P1007, DOI 10.1164/rccm.201103-0585OC; Dickson RP, 2014, LANCET, V384, P691, DOI 10.1016/S0140-6736(14)61136-3; Drake Matthew G., 2012, Inflammation & Allergy Drug Targets, V11, P484; FitzGerald M, 2012, GLOBAL STRATEGY ASTH; HAHN DL, 1991, JAMA-J AM MED ASSOC, V266, P225, DOI 10.1001/jama.266.2.225; Hakonarson H, 1998, J CLIN INVEST, V102, P1732, DOI 10.1172/JCI4141; Iikura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068290; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Kusel MMH, 2007, J ALLERGY CLIN IMMUN, V119, P1105, DOI 10.1016/j.jaci.2006.12.669; Kvarnhammar AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068701; Legatzki A, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0466-0; Lieberman D, 2003, AM J RESP CRIT CARE, V167, P406, DOI 10.1164/rccm.200209-996OC; Matsumoto K, 2014, RESPIR INVESTIG, V52, P92, DOI 10.1016/j.resinv.2013.08.005; Mukhopadhyay S, 2014, RESPIROLOGY, V19, P508, DOI 10.1111/resp.12285; Nagase H, 2003, J IMMUNOL, V171, P3977, DOI 10.4049/jimmunol.171.8.3977; Ohta K, 2014, ALLERGOL INT, V63, P293, DOI 10.2332/allergolint.14-RAI-0766; Okimoto N, 2005, INTERNAL MED, V44, P79, DOI 10.2169/internalmedicine.44.79; Okumura S, 2003, BLOOD, V102, P2547, DOI 10.1182/blood-2002-12-3929; Papadopoulos NG, 2011, ALLERGY, V66, P458, DOI 10.1111/j.1398-9995.2010.02505.x; Papi A, 2000, J ALLERGY CLIN IMMUN, V105, P318, DOI 10.1016/S0091-6749(00)90082-4; Sigurs N, 2005, AM J RESP CRIT CARE, V171, P137, DOI 10.1164/rccm.200406-730OC; Soto-Quiros M, 2012, J ALLERGY CLIN IMMUN, V129, P1499, DOI 10.1016/j.jaci.2012.03.040; Tal G, 2004, J INFECT DIS, V189, P2057, DOI 10.1086/420830; Thomson NC, 2004, EUR RESPIR J, V24, P822, DOI 10.1183/09031936.04.00039004; Wark PAB, 2002, EUR RESPIR J, V19, P68, DOI 10.1183/09031936.02.00226302	30	55	57	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123584	10.1371/journal.pone.0123584	http://dx.doi.org/10.1371/journal.pone.0123584			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901797	Green Published, Green Submitted, gold			2022-12-26	WOS:000353331500055
J	Raby, GD; Clark, TD; Farrell, AP; Patterson, DA; Bett, NN; Wilson, SM; Willmore, WG; Suski, CD; Hinch, SG; Cooke, SJ				Raby, Graham D.; Clark, Timothy D.; Farrell, Anthony P.; Patterson, David A.; Bett, Nolan N.; Wilson, Samantha M.; Willmore, William G.; Suski, Cory D.; Hinch, Scott G.; Cooke, Steven J.			Facing the River Gauntlet: Understanding the Effects of Fisheries Capture and Water Temperature on the Physiology of Coho Salmon	PLOS ONE			English	Article							RELEASE ANGLING TOURNAMENTS; TROUT ONCORHYNCHUS-MYKISS; ADULT SOCKEYE-SALMON; BRIEF AIR EXPOSURE; EXHAUSTIVE EXERCISE; PACIFIC SALMON; RAINBOW-TROUT; ATLANTIC SALMON; LARGEMOUTH BASS; CLIMATE-CHANGE	An improved understanding of bycatchmortality can be achieved by complementing field studies with laboratory experiments that use physiological assessments. This study examined the effects of water temperature and the duration of net entanglement on physiological disturbance and recovery in coho salmon (Oncorhynchus kisutch) after release from a simulated beach seine capture. Heart rate was monitored using implanted electrocardiogram biologgers that allowed fish to swim freely before and after release. A subset of fish was recovered in respirometers to monitor metabolic recovery, and separate groups of fish were sacrificed at different times to assess blood and white muscle biochemistry. One hour after release, fish had elevated lactate in muscle and blood plasma, depleted tissue energy stores, and altered osmoregulatory status, particularly in warmer (15 vs. 10 degrees C) and longer (15 vs. 2 min) capture treatments. A significant effect of entanglement duration on blood and muscle metabolites remained after 4 h. Oxygen consumption rate recovered to baseline within 7-10 h. However, recovery of heart rate to routine levels was longer and more variable, with most fish taking over 10 h, and 33% of fish failing to recover within 24 h. There were no significant treatment effects on either oxygen consumption or heart rate recovery. Our results indicate that fishers should minimize handling time for bycatch and maximize oxygen supply during crowding, especially when temperatures are elevated. Physiological data, such as those presented here, can be used to understand mechanisms that underlie bycatch impairment and mortality, and thus inform best practices that ensure the welfare and conservation of affected species.	[Raby, Graham D.; Wilson, Samantha M.; Cooke, Steven J.] Carleton Univ, Dept Biol, Fish Ecol & Conservat Physiol Lab, Ottawa, ON K1S 5B6, Canada; [Raby, Graham D.; Wilson, Samantha M.; Cooke, Steven J.] Carleton Univ, Inst Environm Sci, Ottawa, ON K1S 5B6, Canada; [Clark, Timothy D.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Farrell, Anthony P.] Univ British Columbia, Dept Zool, Vancouver, BC V5Z 1M9, Canada; [Patterson, David A.] Simon Fraser Univ, Sch Resource & Environm Management, Cooperat Resource Management Inst, Fisheries & Oceans Canada,Sci Branch,Pacific Reg, Burnaby, BC V5A 1S6, Canada; [Bett, Nolan N.; Hinch, Scott G.] Univ British Columbia, Dept Forest & Conservat Sci, Pacific Salmon Ecol & Conservat Lab, Vancouver, BC V5Z 1M9, Canada; [Willmore, William G.] Carleton Univ, Inst Biochem, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Suski, Cory D.] Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL 61801 USA	Carleton University; Carleton University; Australian Institute of Marine Science; University of British Columbia; Fisheries & Oceans Canada; Simon Fraser University; University of British Columbia; Carleton University; University of Illinois System; University of Illinois Urbana-Champaign	Raby, GD (corresponding author), Carleton Univ, Dept Biol, Fish Ecol & Conservat Physiol Lab, Ottawa, ON K1S 5B6, Canada.	graham.d.raby@gmail.com	Clark, Timothy Darren/K-7129-2012; Cooke, Steven J/F-4193-2010	Clark, Timothy Darren/0000-0001-8738-3347; Cooke, Steven J/0000-0002-5407-0659; Suski, Cory/0000-0001-8280-873X; Raby, Graham/0000-0002-0549-4017	Natural Sciences and Engineering Research Council of Canada; Ocean Tracking Network Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ocean Tracking Network Canada	Research funding was provided by a Natural Sciences and Engineering Research Council of Canada Strategic Grant ( to SJC, SGH, WGW, and APF) and the Ocean Tracking Network Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson WG, 1998, HYDROBIOLOGIA, V372, P233; Baker MR, 2009, J APPL ECOL, V46, P752, DOI 10.1111/j.1365-2664.2009.01673.x; Bradford MJ, 2010, CAN J FISH AQUAT SCI, V67, P673, DOI 10.1139/F10-017; Brett J.R., 1995, PHYSL ECOLOGY PACIFI, P3; Buchanan S, 2002, N AM J FISH MANAGE, V22, P1270, DOI 10.1577/1548-8675(2002)022<1270:RGNMOI>2.0.CO;2; Careau V, 2012, PHYSIOL BIOCHEM ZOOL, V85, P543, DOI 10.1086/666970; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Chopin FS, 1996, FISH RES, V28, P277, DOI 10.1016/0165-7836(96)00512-7; Clark TD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039079; Clark TD, 2011, J EXP BIOL, V214, P3074, DOI 10.1242/jeb.060517; Clark TD, 2009, J COMP PHYSIOL B, V179, P663, DOI 10.1007/s00360-009-0349-1; Colotelo AH, 2013, FISH RES, V137, P41, DOI 10.1016/j.fishres.2012.08.019; Cook KV, 2014, GEN COMP ENDOCR, V202, P44, DOI 10.1016/j.ygcen.2014.04.008; Cooke SJ, 2013, FISHERIES MANAG ECOL, V20, P268, DOI 10.1111/j.1365-2400.2012.00867.x; Cooke SJ, 2005, BIODIVERS CONSERV, V14, P1195, DOI 10.1007/s10531-004-7845-0; Cooke SJ, 2001, N AM J FISH MANAGE, V21, P333, DOI 10.1577/1548-8675(2000)020&lt;1033:EORGOT&gt;2.0.CO;2; Cooke SJ, 2003, T AM FISH SOC, V132, P1154, DOI 10.1577/T02-059; Cooke SJ, 2004, J APPL ICHTHYOL, V20, P28, DOI 10.1111/j.1439-0426.2004.00494.x; Cooke SJ, 2010, CONSERV LETT, V3, P159, DOI 10.1111/j.1755-263X.2010.00109.x; Crozier LG, 2008, EVOL APPL, V1, P252, DOI 10.1111/j.1752-4571.2008.00033.x; Davies RWD, 2009, MAR POLICY, V33, P661, DOI 10.1016/j.marpol.2009.01.003; Davis MW, 2002, CAN J FISH AQUAT SCI, V59, P1834, DOI 10.1139/F02-139; DFO, 2001, POL SEL FISH CAN PAC; Diggles BK, 2011, REV FISH BIOL FISHER, V21, P739, DOI 10.1007/s11160-011-9206-x; Donaldson MR, 2013, CAN J FISH AQUAT SCI, V70, P90, DOI 10.1139/cjfas-2012-0218; Donaldson MR, 2010, PHYSIOL BIOCHEM ZOOL, V83, P973, DOI 10.1086/656336; Donaldson MR, 2014, COMP BIOCHEM PHYS A, V173, P7, DOI 10.1016/j.cbpa.2014.02.019; Farrell AP, 2008, PHYSIOL BIOCHEM ZOOL, V81, P697, DOI 10.1086/592057; Farrell AP, 2001, CAN J FISH AQUAT SCI, V58, P2319, DOI 10.1139/cjfas-58-12-2319; Farrell AP, 2001, CAN J FISH AQUAT SCI, V58, P1932, DOI 10.1139/cjfas-58-10-1932; FERGUSON RA, 1992, CAN J FISH AQUAT SCI, V49, P1157, DOI 10.1139/f92-129; Ferrari MR, 2007, J HYDROL, V342, P336, DOI 10.1016/j.jhydrol.2007.06.002; Field A., 2012, DISCOVERING STAT USI; Gale MK, 2013, FISH FISH, V14, P1, DOI 10.1111/j.1467-2979.2011.00441.x; Gale MK, 2011, FISH RES, V112, P85, DOI 10.1016/j.fishres.2011.08.014; Galloway BJ, 2003, PHYSIOL BIOCHEM ZOOL, V76, P652, DOI 10.1086/376921; Hague MJ, 2011, GLOBAL CHANGE BIOL, V17, P87, DOI 10.1111/j.1365-2486.2010.02225.x; Hinch SG, 2012, J FISH BIOL, V81, P576, DOI 10.1111/j.1095-8649.2012.03360.x; Jain KE, 2003, J EXP BIOL, V206, P3569, DOI 10.1242/jeb.00588; Jeffries KM, 2012, PHYSIOL BIOCHEM ZOOL, V85, P62, DOI 10.1086/663770; Kelleher K., 2005, FAO FISH TECH PAP; Kieffer JD, 2010, COMP BIOCHEM PHYS A, V156, P163, DOI 10.1016/j.cbpa.2010.02.009; Kieffer JD, 2000, COMP BIOCHEM PHYS A, V126, P161, DOI 10.1016/S1095-6433(00)00202-6; Killen SS, 2006, T AM FISH SOC, V135, P557, DOI 10.1577/T05-168.1; Lewison RL, 2004, ECOL LETT, V7, P221, DOI 10.1111/j.1461-0248.2004.00573.x; Macdonald J., 2000, IMPRINT VARIES, P131; Marcalo A, 2006, MAR BIOL, V149, P1509, DOI 10.1007/s00227-006-0277-5; Martins EG, 2012, CAN J FISH AQUAT SCI, V69, P330, DOI 10.1139/F2011-154; Meka JM, 2005, FISH RES, V72, P311, DOI 10.1016/j.fishres.2004.10.006; Miller KM, 2014, EVOL APPL; Milligan CL, 1996, COMP BIOCHEM PHYS A, V113, P51, DOI 10.1016/0300-9629(95)02060-8; O'Connor CM, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00388.1; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Peterman RM, 2010, TECHNICAL REPORT; Piovano S, 2010, BIOL CONSERV, V143, P261, DOI 10.1016/j.biocon.2009.10.001; Raby GD, 2014, ECOL APPL, V24, P1803, DOI 10.1890/13-1885.1; Raby GD, 2012, J APPL ECOL, V49, P90, DOI 10.1111/j.1365-2664.2011.02073.x; Raby GD, 2011, BIOSCIENCE, V61, P271, DOI 10.1525/bio.2011.61.4.7; Robinson KA, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot015; Romero LM, 2001, P NATL ACAD SCI USA, V98, P7366, DOI 10.1073/pnas.131091498; Schreer JF, 2001, T AM FISH SOC, V130, P783, DOI 10.1577/1548-8659(2001)130<0783:CRTVFE>2.0.CO;2; Shultz AD, 2011, J EXP MAR BIOL ECOL, V402, P19, DOI 10.1016/j.jembe.2011.03.009; Suski CD, 2006, J FISH BIOL, V68, P120, DOI 10.1111/j.0022-1112.2006.00882.x; Suski CD, 2007, COMP BIOCHEM PHYS A, V148, P664, DOI 10.1016/j.cbpa.2007.08.018; Wilkie MP, 1997, CAN J FISH AQUAT SCI, V54, P503, DOI 10.1139/cjfas-54-3-503; Wilson SM, 2014, BIOL CONSERV, V171, P61, DOI 10.1016/j.biocon.2014.01.020; WOOD CM, 1983, J FISH BIOL, V22, P189, DOI 10.1111/j.1095-8649.1983.tb04739.x; WOOD CM, 1991, J EXP BIOL, V160, P285	68	29	29	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124023	10.1371/journal.pone.0124023	http://dx.doi.org/10.1371/journal.pone.0124023			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901952	Green Submitted, gold, Green Published			2022-12-26	WOS:000353331500071
J	Zheng, C; Zhao, L; Wang, Y; Shen, JZ; Zhang, YF; Jia, SS; Li, YS; Ding, ZT				Zheng, Chao; Zhao, Lei; Wang, Yu; Shen, Jiazhi; Zhang, Yinfei; Jia, Sisi; Li, Yusheng; Ding, Zhaotang			Integrated RNA-Seq and sRNA-Seq Analysis Identifies Chilling and Freezing Responsive Key Molecular Players and Pathways in Tea Plant (Camellia sinensis)	PLOS ONE			English	Article							FALSE DISCOVERY RATE; COLD-ACCLIMATION; LOW-TEMPERATURE; ABIOTIC STRESS; TRANSCRIPTION FACTORS; GENE-EXPRESSION; GENOME-WIDE; MICRORNAS; ARABIDOPSIS; TOLERANCE	Tea [Camellia sinensis (L) O. Kuntze, Theaceae] is one of the most popular non-alcoholic beverages worldwide. Cold stress is one of the most severe abiotic stresses that limit tea plants' growth, survival and geographical distribution. However, the genetic regulatory network and signaling pathways involved in cold stress responses in tea plants remain unearthed. Using RNA-Seq, DGE and sRNA-Seq technologies, we performed an integrative analysis of miRNA and mRNA expression profiling and their regulatory network of tea plants under chilling (4 degrees C) and freezing (-5 degrees C) stress. Differentially expressed (DE) miRNA and mRNA profiles were obtained based on fold change analysis, miRNAs and target mRNAs were found to show both coherent and incoherent relationships in the regulatory network. Furthermore, we compared several key pathways (e.g., 'Photosynthesis'), GO terms (e.g., ` response to karrikin') and transcriptional factors (TFs, e.g., DREB1b/CBF1) which were identified as involved in the early chilling and/or freezing response of tea plants. Intriguingly, we found that karrikins, a new group of plant growth regulators, and beta-primeverosidase (BPR), a key enzyme functionally relevant with the formation of tea aroma might play an important role in both early chilling and freezing response of tea plants. Quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) analysis further confirmed the results from RNA-Seq and sRNA-Seq analysis. This is the first study to simultaneously profile the expression patterns of both miRNAs and mRNAs on a genome-wide scale to elucidate the molecular mechanisms of early responses of tea plants to cold stress. In addition to gaining a deeper insight into the cold resistant characteristics of tea plants, we provide a good case study to analyse mRNA/miRNA expression and profiling of non-model plant species using next-generation sequencing technology.	[Zheng, Chao; Zhao, Lei; Wang, Yu; Shen, Jiazhi; Zhang, Yinfei; Jia, Sisi; Ding, Zhaotang] Qingdao Agr Univ, Tea Res Inst, Qingdao, Shandong, Peoples R China; [Zheng, Chao; Zhao, Lei; Wang, Yu; Shen, Jiazhi; Zhang, Yinfei; Jia, Sisi; Ding, Zhaotang] Key Lab Genet Improvement & Breeding Hort Plants, Qingdao, Shandong, Peoples R China; [Li, Yusheng] Fruit & Tea Technol Extens Stn, Jinan, Shandong, Peoples R China	Qingdao Agricultural University	Ding, ZT (corresponding author), Qingdao Agr Univ, Tea Res Inst, Qingdao, Shandong, Peoples R China.	dzttea@163.com		Zheng, Chao/0000-0002-0290-2177	National Natural Science Foundation of China [31470027]; School Fund Project of Qingdao Agricultural University [631412]; Livelihood Project of Qingdao City [13-1-3-85-nsh]; Breeding Project of Shandong Province [2012LZ12-03, 2013LZ12-03, 2014LZ12-03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); School Fund Project of Qingdao Agricultural University; Livelihood Project of Qingdao City; Breeding Project of Shandong Province	This research was supported by the National Natural Science Foundation of China (No. 31470027 to ZD), (School Fund Project of Qingdao Agricultural University, 631412, the Livelihood Project of Qingdao City (No. 13-1-3-85-nsh to ZD) and the Breeding Project of Shandong Province (No. 2012LZ12-03, 2013LZ12-03, 2014LZ12-03 to ZD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad P, 2008, J PLANT BIOL, V51, P167, DOI 10.1007/BF03030694; Akan Das, 2010, American Journal of Plant Sciences, V1, P77, DOI 10.4236/ajps.2010.12010; Barakat A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-481; Barrero-Gil J, 2013, PLANT SCI, V205, P48, DOI 10.1016/j.plantsci.2013.01.008; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhardwaj AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092456; Catala R, 2011, P NATL ACAD SCI USA, V108, P16475, DOI 10.1073/pnas.1107161108; Chen JH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-326; Chen L, 2007, EUPHYTICA, V154, P239, DOI 10.1007/s10681-006-9292-3; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Chinnusamy V, 2004, J EXP BOT, V55, P225, DOI 10.1093/jxb/erh005; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Chitnis VR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087543; Cook D, 2004, P NATL ACAD SCI USA, V101, P15243, DOI 10.1073/pnas.0406069101; Curaba J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-120; Dong JX, 2003, PLANT MOL BIOL, V51, P21, DOI 10.1023/A:1020780022549; Du H, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00397; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Fan GQ, 2014, BIOCHIMIE, V102, P68, DOI 10.1016/j.biochi.2014.02.008; Fang YJ, 2014, J EXP BOT, V65, P2119, DOI 10.1093/jxb/eru072; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Gilmour SJ, 1998, PLANT J, V16, P433, DOI 10.1046/j.1365-313x.1998.00310.x; Gomez-Anduro G, 2011, PLANT MOL BIOL, V77, P159, DOI 10.1007/s11103-011-9800-2; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Griffith M, 2004, TRENDS PLANT SCI, V9, P399, DOI 10.1016/j.tplants.2004.06.007; Guan QM, 2013, PLANT J, V74, P840, DOI 10.1111/tpj.12169; Haas BJ, 2010, NAT BIOTECHNOL, V28, P421, DOI 10.1038/nbt0510-421; Hare PD, 1998, PLANT CELL ENVIRON, V21, P535, DOI 10.1046/j.1365-3040.1998.00309.x; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Heim MA, 2003, MOL BIOL EVOL, V20, P735, DOI 10.1093/molbev/msg088; Huang LB, 2005, ANN BOT-LONDON, V96, P755, DOI 10.1093/aob/mci228; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jain M, 2009, FEBS J, V276, P3148, DOI 10.1111/j.1742-4658.2009.07033.x; Jeon J, 2010, J BIOL CHEM, V285, P23369, DOI 10.1074/jbc.M109.096644; Jeong DH, 2013, J PLANT BIOL, V56, P187, DOI 10.1007/s12374-013-0213-4; Jeyaraj A, 2014, PLANT CELL REP, V33, P1053, DOI 10.1007/s00299-014-1589-4; Kaplan F, 2004, PLANT PHYSIOL, V135, P1674, DOI 10.1104/pp.104.040808; Kim JH, 2009, SCIENCE, V323, P1053, DOI 10.1126/science.1166386; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kuo HF, 2011, PLANT PHYSIOL, V156, P1016, DOI 10.1104/pp.111.175265; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le TD, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-92; Lee BH, 2005, PLANT CELL, V17, P3155, DOI 10.1105/tpc.105.035568; Li BS, 2011, J EXP BOT, V62, P3765, DOI 10.1093/jxb/err051; Li XW, 2010, BIOCHEM BIOPH RES CO, V394, P354, DOI 10.1016/j.bbrc.2010.03.011; Li XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039650; Ligterink W, 2001, INT REV CYTOL, V201, P209, DOI 10.1016/S0074-7696(01)01004-X; Lim CW, 2012, PLANT SCI, V187, P83, DOI 10.1016/j.plantsci.2012.01.013; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu SF, 2008, PLANT J, V55, P131, DOI 10.1111/j.1365-313X.2008.03497.x; LYNCH DV, 1987, PLANT PHYSIOL, V83, P761, DOI 10.1104/pp.83.4.761; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Mizutani M, 2002, PLANT PHYSIOL, V130, P2164, DOI 10.1104/pp.102.011023; Mohanpuria P, 2012, MOL BIOL REP, V39, P3977, DOI 10.1007/s11033-011-1178-3; Monroy AF, 1998, PLANT J, V13, P653, DOI 10.1046/j.1365-313X.1998.00070.x; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Narusaka Y, 2004, PLANT MOL BIOL, V55, P327, DOI 10.1007/s11103-004-0685-1; Nelson DC, 2010, P NATL ACAD SCI USA, V107, P7095, DOI 10.1073/pnas.0911635107; Nuruzzaman M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00248; Pang T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-488; Peleg Z, 2011, CURR OPIN PLANT BIOL, V14, P290, DOI 10.1016/j.pbi.2011.02.001; Pennycooke JC, 2005, ENVIRON EXP BOT, V53, P225, DOI 10.1016/j.envexpbot.2004.04.002; Poldervaart MT, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0072610, 10.1371/journal.pone.0082817]; Prabu G. R., 2010, Genomics Proteomics & Bioinformatics, V8, P113, DOI 10.1016/S1672-0229(10)60012-5; Provart NJ, 2003, PLANT PHYSIOL, V132, P893, DOI 10.1104/pp.103.021261; Rae L, 2011, PLANTA, V234, P429, DOI 10.1007/s00425-011-1414-z; Ramsay NA, 2005, TRENDS PLANT SCI, V10, P63, DOI 10.1016/j.tplants.2004.12.011; Ren LP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-844; Renaut J, 2004, PLANT BIOLOGY, V6, P81, DOI 10.1055/s-2004-815733; Smekalova V, 2014, BIOTECHNOL ADV, V32, P2, DOI 10.1016/j.biotechadv.2013.07.009; Smith SM, 2014, CURR OPIN PLANT BIOL, V21, P23, DOI 10.1016/j.pbi.2014.06.003; Song YP, 2013, PLANT CELL REP, V32, P1407, DOI 10.1007/s00299-013-1454-x; Soos V, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-236; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Suzuki N, 2006, PHYSIOL PLANTARUM, V126, P45, DOI 10.1111/j.0031-9317.2005.00582.x; Svensson JT, 2006, PLANT PHYSIOL, V141, P257, DOI 10.1104/pp.105.072645; Taoka K, 2004, PLANT J, V40, P462, DOI 10.1111/j.1365-313X.2004.02238.x; Thomashow MF, 1998, PLANT PHYSIOL, V118, P1, DOI 10.1104/pp.118.1.1; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Tian DQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-827; Vasudevan S, 2012, WIRES RNA, V3, P311, DOI 10.1002/wrna.121; Vaucheret H, 2006, MOL CELL, V22, P129, DOI 10.1016/j.molcel.2006.03.011; Vogel JT, 2005, PLANT J, V41, P195, DOI 10.1111/j.1365-313X.2004.02288.x; Wang C, 2011, PHYSIOL PLANTARUM, V143, P64, DOI 10.1111/j.1399-3054.2011.01481.x; Wang L, 2009, PLANT MOL BIOL REP, V27, P257, DOI 10.1007/s11105-008-0079-7; Wang XC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-415; Wang Y, 2012, PLANT CELL REP, V31, P27, DOI 10.1007/s00299-011-1136-5; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wen M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-140; Wu HJ, 2012, NUCLEIC ACIDS RES, V40, pW22, DOI 10.1093/nar/gks554; Wu MF, 2006, DEVELOPMENT, V133, P4211, DOI 10.1242/dev.02602; Xia J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-634; Yang CH, 2013, PLANT CELL ENVIRON, V36, P2207, DOI 10.1111/pce.12130; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Ye HY, 2009, PLANT MOL BIOL, V71, P291, DOI 10.1007/s11103-009-9524-8; Zeeman SC, 2004, PLANT PHYSIOL, V135, P849, DOI 10.1104/pp.103.032631; Zhao ZG, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-222; Zhu QW, 2013, J ZHEJIANG UNIV-SC B, V14, P916, DOI 10.1631/jzus.B1300006; Zou CS, 2010, J PLANT BIOL, V53, P400, DOI 10.1007/s12374-010-9129-4	106	64	70	6	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0125031	10.1371/journal.pone.0125031	http://dx.doi.org/10.1371/journal.pone.0125031			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901577	Green Submitted, gold, Green Published			2022-12-26	WOS:000353331500109
J	Ma, CX; Shan, GG; Liu, S				Ma, Changxing; Shan, Guogen; Liu, Song			Homogeneity Test for Correlated Binary Data	PLOS ONE			English	Article							STATISTICAL-METHODS; TRIALS; OPHTHALMOLOGY; PROPORTIONS; EQUALITY	In ophthalmologic studies, measurements obtained from both eyes of an individual are often highly correlated. Ignoring the correlation could lead to incorrect inferences. An asymptotic method was proposed by Tang and others (2008) for testing equality of proportions between two groups under Rosner's model. In this article, we investigate three testing procedures for general g >= 2 groups. Our simulation results show the score testing procedure usually produces satisfactory type I error control and has reasonable power. The three test procedures get closer when sample size becomes larger. Examples from ophthalmologic studies are used to illustrate our proposed methods.	[Ma, Changxing] SUNY Buffalo, Dept Biostat, Buffalo, NY 14214 USA; [Shan, Guogen] Univ Nevada, Sch Community Hlth Sci, Dept Environm & Occupat Hlth, Las Vegas, NV 89154 USA; [Liu, Song] Roswell Pk Canc Inst, Dept Biostat & Bioinformat, Buffalo, NY 14203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Roswell Park Cancer Institute	Ma, CX (corresponding author), SUNY Buffalo, Dept Biostat, Buffalo, NY 14214 USA.	cxma@buffalo.edu	Shan, Guogen/GQI-3293-2022					BODIAN CA, 1994, BIOMETRICS, V50, P183, DOI 10.2307/2533208; DALLAL GE, 1988, BIOMETRICS, V44, P253, DOI 10.2307/2531913; DONNER A, 1989, BIOMETRICS, V45, P605, DOI 10.2307/2531501; DONNER A, 1994, J STAT PLAN INFER, V42, P37, DOI 10.1016/0378-3758(94)90188-0; Rajavi Z, 2011, OPHTHALMOLOGY, V118, P1812, DOI 10.1016/j.ophtha.2011.01.049; ROSNER B, 1982, BIOMETRICS, V38, P105, DOI 10.2307/2530293; ROSNER B, 1988, BIOMETRICS, V44, P505, DOI 10.2307/2531863; Shan GG, 2014, STAT BIOPHARM RES, V6, P115, DOI 10.1080/19466315.2013.861767; SIMON R, 1985, CANCER TREAT REP, V69, P1375; Tang ML, 2006, STAT MED, V25, P2771, DOI 10.1002/sim.2425; Tang NS, 2008, COMPUT STAT DATA AN, V52, P3719, DOI 10.1016/j.csda.2007.12.017; Wilding GE, 2011, CONT CLIN TRIALS	12	17	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124337	10.1371/journal.pone.0124337	http://dx.doi.org/10.1371/journal.pone.0124337			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897962	Green Published, Green Submitted, gold			2022-12-26	WOS:000353212600064
J	Andrew, EVW; Pell, C; Angwin, A; Auwun, A; Daniels, J; Mueller, I; Phuanukoonnon, S; Pool, R				Andrew, Erin V. W.; Pell, Christopher; Angwin, Angeline; Auwun, Alma; Daniels, Job; Mueller, Ivo; Phuanukoonnon, Suparat; Pool, Robert			Knowledge, Attitudes, and Practices Concerning Malaria in Pregnancy: Results from a Qualitative Study in Madang, Papua New Guinea	PLOS ONE			English	Article							EAST SEPIK PROVINCE; MUKONO DISTRICT; VACCINE TRIALS; ANTENATAL CARE; VIVAX MALARIA; WOSERA AREA; RURAL WOMEN; EPIDEMIOLOGY; HEALTH; PERCEPTIONS	Background Malaria is the leading cause of illness and death in Papua New Guinea (PNG). Infection during pregnancy with falciparum or vivax malaria, as occurs in PNG, has health implications for mother and child, causing complications such as maternal anemia, low birth weight and miscarriage. This article explores knowledge, attitudes and practices concerning malaria during pregnancy and it's prevention in Madang, PNG, a high prevalence area. Methods As part of a qualitative study in Madang, exploring MiP, participatory techniques (free-listing and sorting) were conducted along with focus group discussions, in-depth interviews (with pregnant women, health staff and other community members) and observations in the local community and health facilities. Results The main themes explored were attitudes towards and knowledge of MiP, its risks, and prevention. Although there was a general awareness of the term "malaria", it was often conflated with general sickness or with pregnancy-related symptoms. Moreover, many preventive methods for MiP were related to practices of general healthy living. Indeed, varied messages from health staff about the risks of MiP were observed. In addition to ideas about the seriousness and risk of MiP, other factors influenced the uptake of interventions: availability and perceived comfort of sleeping under insecticide-treated mosquito nets were important determinants of usage, and women's heavy workload influenced Chloroquine adherence. Conclusion The non-specific symptoms of MiP and its resultant conflation with symptoms of pregnancy that are perceived as normal have implications for MiP prevention and control. However, in Madang, PNG, this was compounded by the inadequacy of health staff's message about MiP.	[Andrew, Erin V. W.; Pell, Christopher; Mueller, Ivo; Pool, Robert] Univ Barcelona, Hosp Clin, CRESIB, Barcelona Ctr Int Hlth Res, Barcelona, Spain; [Andrew, Erin V. W.] San Francisco Dept Publ Hlth, Bridge HIV, San Francisco, CA USA; [Pell, Christopher; Pool, Robert] Univ Amsterdam, Ctr Social Sci & Global Hlth, Amsterdam, Netherlands; [Angwin, Angeline; Auwun, Alma; Daniels, Job; Mueller, Ivo; Phuanukoonnon, Suparat] Papua New Guinea Inst Med Res, Madang, Papua N Guinea; [Mueller, Ivo] Walter & Eliza Hall Inst Med Res, Infect & Immun Div, Parkville, Vic, Australia	ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; San Francisco Department of Public Health; University of Amsterdam; PNG Institute Of Medical Research; Walter & Eliza Hall Institute	Andrew, EVW (corresponding author), Univ Barcelona, Hosp Clin, CRESIB, Barcelona Ctr Int Hlth Res, Barcelona, Spain.	erinvwandrew@gmail.com		Pell, Christopher/0000-0001-9405-5851	Malaria in Pregnancy (MiP) Consortium - Bill and Melinda Gates Foundation [OPP46099]	Malaria in Pregnancy (MiP) Consortium - Bill and Melinda Gates Foundation	This research was supported and endorsed by the Malaria in Pregnancy (MiP) Consortium, which is funded by a grant from the Bill and Melinda Gates Foundation (www.gatesfoundation.org), Grant OPP46099. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikins AD, 2005, BMJ-BRIT MED J, V331, P737, DOI 10.1136/bmj.331.7519.737; Allen SJ, 1998, ARCH DIS CHILD-FETAL, V79, pF135, DOI 10.1136/fn.79.2.F135; [Anonymous], 2009, WHO WORLD MAL REP; Anya Samuel E, 2008, BMC Pregnancy Childbirth, V8, P9, DOI 10.1186/1471-2393-8-9; Benet A, 2006, AM J TROP MED HYG, V75, P597, DOI 10.4269/ajtmh.2006.75.597; BRABIN BJ, 1990, ANN TROP MED PARASIT, V84, P1; CATTANI JA, 1986, AM J TROP MED HYG, V35, P3, DOI 10.4269/ajtmh.1986.35.3; Cochran PAL, 2008, AM J PUBLIC HEALTH, V98, P22, DOI 10.2105/AJPH.2006.093641; Davy C, 2009, PRIMARY HLTH CARE KN; Davy CP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-268; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Department of Health Papua New Guinea, 2007, NAT POL TRAD MED, P17; Erhun W, 2006, AFRICAN J BIOMEDICAL, V8, P25; GENTON B, 1995, ANN TROP MED PARASIT, V89, P377, DOI 10.1080/00034983.1995.11812966; GENTON B, 1995, ANN TROP MED PARASIT, V89, P359, DOI 10.1080/00034983.1995.11812965; Government of Papua New Guinea, 2010, NAT HLTH PLAN 2011 2; Heggenhougen K, 2003, TDRSTRSEBVOL031 UNDP; Hill Z, 2007, PUBLIC HEALTH NUTR, V10, P827, DOI 10.1017/S1368980007382554; Hinton R, 2011, ASIA PAC VIEWP, V52, P178, DOI 10.1111/j.1467-8373.2011.01449.x; Hinton R, 2010, HEALTH SOCIOL REV, V19, P5, DOI 10.5172/hesr.2010.19.1.005; Hinton R, 2010, WOMEN STUD INT FORUM, V33, P180, DOI 10.1016/j.wsif.2009.12.006; Jahn A, 2000, TROP MED INT HEALTH, V5, P657, DOI 10.1046/j.1365-3156.2000.00611.x; Kazura JW, 2012, ACTA TROP, V121, P274, DOI 10.1016/j.actatropica.2011.08.002; KENGEYAKAYONDO JF, 1994, ACTA TROP, V58, P267, DOI 10.1016/0001-706X(94)90020-5; Launiala A, 2006, ACTA TROP, V98, P111, DOI 10.1016/j.actatropica.2005.12.008; Mbonye AK, 2006, J BIOSOC SCI, V38, P221, DOI 10.1017/S0021932005007108; Mbonye AK, 2006, HEALTH POLICY PLANN, V21, P17, DOI 10.1093/heapol/czj002; McGready R, 2012, LANCET INFECT DIS, V12, P388, DOI 10.1016/S1473-3099(11)70339-5; Menaca A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-257; Menendez C, 2000, J INFECT DIS, V181, P1740, DOI 10.1086/315449; Muela SH, 2002, SOC SCI MED, V55, P403; Mueller Ivo, 2008, Papua New Guinea Medical Journal, V51, P12; Muller I, 2003, TRENDS PARASITOL, V19, P253, DOI 10.1016/S1471-4922(03)00091-6; Ndyomugyenyi R, 1998, HEALTH POLICY PLANN, V13, P94, DOI 10.1093/heapol/13.1.94; Nosten F, 2004, TRENDS PARASITOL, V20, P425, DOI 10.1016/j.pt.2004.06.007; Nosten F, 1999, LANCET, V354, P546, DOI 10.1016/S0140-6736(98)09247-2; Pell C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022452; Pell C, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-369; Pulford J, 2012, SOCIAL SCI MED; Reilley B, 2002, TROP MED INT HEALTH, V7, P744, DOI 10.1046/j.1365-3156.2002.00919.x; Rijken MJ, 2012, LANCET INFECT DIS, V12, P75, DOI 10.1016/S1473-3099(11)70315-2; Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1; Schlagenhauf P, 2011, MALARIA J, V10; Shulman CE, 1999, LANCET, V353, P632, DOI 10.1016/S0140-6736(98)07318-8; Strauss A, 1997, GROUNDED THEORY PRAC; Telfer Michelle L, 2002, Afr J Reprod Health, V6, P74, DOI 10.2307/3583148; Villar J, 2001, LANCET, V357, P1551, DOI 10.1016/S0140-6736(00)04722-X; Welsch RL, 1983, ANTHR MED CULTURE ME, P32; Winch PJ, 1996, SOC SCI MED, V42, P1057, DOI 10.1016/0277-9536(95)00293-6; Wood J W, 1985, J Biosoc Sci Suppl, V9, P159; World Health Organization, 2002, ANT CAR RAND TRIAL M; World Health Organization, 2005, WHO PAP NEW GUIN COU	52	16	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0119077	10.1371/journal.pone.0119077	http://dx.doi.org/10.1371/journal.pone.0119077			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG3XA	25893405	Green Published, gold			2022-12-26	WOS:000353211700001
J	Kim, H; Song, KD; Kim, HJ; Park, W; Kim, J; Lee, T; Shin, DH; Kwak, W; Kwon, YJ; Sung, S; Moon, S; Lee, KT; Kim, N; Hong, JK; Eo, KY; Seo, KS; Kim, G; Park, S; Yun, CH; Kim, H; Choi, K; Kim, J; Lee, WK; Kim, DK; Oh, JD; Kim, ES; Ch, S; Lee, HK; Kim, TH; Kim, H				Kim, Hyeongmin; Song, Ki Duk; Kim, Hyeon Jeong; Park, WonCheoul; Kim, Jaemin; Lee, Taeheon; Shin, Dong-Hyun; Kwak, Woori; Kwon, Young-jun; Sung, Samsun; Moon, Sunjin; Lee, Kyung-Tai; Kim, Namshin; Hong, Joon Ki; Eo, Kyung Yeon; Seo, Kang Seok; Kim, Girak; Park, Sungmoo; Yun, Cheol-Heui; Kim, Hyunil; Choi, Kimyung; Kim, Jiho; Lee, Woon Kyu; Kim, Duk-Kyung; Oh, Jae-Don; Kim, Eui-Soo; Ch, Seoae; Lee, Hak-Kyo; Kim, Tae-Hun; Kim, Heebal			Exploring the Genetic Signature of Body Size in Yucatan Miniature Pig	PLOS ONE			English	Article							RECENT POSITIVE SELECTION; GENOME; LECTIN; BETA; ASSOCIATIONS; FRAMEWORK; FORMAT; SWEEPS; DUROC; SWINE	Since being domesticated about 10,000-12,000 years ago, domestic pigs (Sus scrofa domesticus) have been selected for traits of economic importance, in particular large body size. However, Yucatan miniature pigs have been selected for small body size to withstand high temperature environment and for laboratory use. This renders the Yucatan miniature pig a valuable model for understanding the evolution of body size. We investigate the genetic signature for selection of body size in the Yucatan miniature pig. Phylogenetic distance of Yucatan miniature pig was compared to other large swine breeds (Yorkshire, Landrace, Duroc and wild boar). By estimating the XP-EHH statistic using re-sequencing data derived from 70 pigs, we were able to unravel the signatures of selection of body size. We found that both selections at the level of organism, and at the cellular level have occurred. Selection at the higher levels include feed intake, regulation of body weight and increase in mass while selection at the molecular level includes cell cycle and cell proliferation. Positively selected genes probed by XP-EHH may provide insight into the docile character and innate immunity as well as body size of Yucatan miniature pig.	[Kim, Hyeongmin; Park, WonCheoul; Lee, Taeheon; Shin, Dong-Hyun; Moon, Sunjin; Kim, Girak; Park, Sungmoo; Yun, Cheol-Heui; Kim, Heebal] Seoul Natl Univ, Dept Agr Biotechnol, Anim Biotechnol Major, Seoul 151921, South Korea; [Kim, Hyeongmin; Park, WonCheoul; Lee, Taeheon; Shin, Dong-Hyun; Moon, Sunjin; Kim, Girak; Park, Sungmoo; Yun, Cheol-Heui; Kim, Heebal] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 151921, South Korea; [Song, Ki Duk; Kim, Duk-Kyung; Oh, Jae-Don; Lee, Hak-Kyo] Hankyong Natl Univ, Genom Informat Ctr, Ansong 456749, South Korea; [Kim, Hyeon Jeong; Sung, Samsun; Ch, Seoae; Kim, Heebal] Seoul Natl Univ, CHO & KIM Genom, Seoul 151919, South Korea; [Kim, Jaemin; Kwak, Woori; Kwon, Young-jun] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul 151742, South Korea; [Lee, Kyung-Tai; Kim, Tae-Hun] Natl Inst Anim Sci, RDA, Suwon 441706, South Korea; [Kim, Namshin] Korea Res Inst Biosci & Biotechnol, Korean Bioinformat Ctr, Taejon 305806, South Korea; [Hong, Joon Ki] Natl Inst Anim Sci, RDA, Swine Sci Div, Cheonan 331801, South Korea; [Eo, Kyung Yeon] Seoul Zoo, Anim Res Div, Seoul 427702, South Korea; [Seo, Kang Seok] Sunchon Natl Univ, Dept Anim Sci & Technol, Coll Life Sci & Nat Resources, Sunchon 540950, South Korea; [Kim, Hyunil; Choi, Kimyung; Kim, Jiho] Optipharm Inc, Chengwon Gun 363954, Chungcheongbuk, South Korea; [Lee, Woon Kyu] Inha Univ, Coll Med, Lab Dev Genet, Inchon 400103, South Korea; [Kim, Eui-Soo] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA	Seoul National University (SNU); Seoul National University (SNU); Hankyong National University; Seoul National University (SNU); Seoul National University (SNU); National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Korea Research Institute of Bioscience & Biotechnology (KRIBB); National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Sunchon National University; Inha University; Iowa State University	Lee, HK (corresponding author), Hankyong Natl Univ, Genom Informat Ctr, Ansong 456749, South Korea.	breedlee@empas.com; thkim63@korea.kr; heebal@snu.ac.kr	Kim, Heebal/A-8889-2016; YUN, Cheol-Heui/AAR-2775-2020; Kim, Namshin/Q-6491-2017; Sung, Samsun/AAP-1325-2020	Kim, Heebal/0000-0003-3064-1303; YUN, Cheol-Heui/0000-0002-0041-2887; Kim, Namshin/0000-0001-6361-274X; KIM, Girak/0000-0003-2613-1140; Park, WonCheoul/0000-0003-3140-5628; Moon, Sunjin/0000-0002-3803-6354	Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ01104401, PJ01110901, PJ00811602]; Optipharm, Inc	Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea; Optipharm, Inc	This work was supported by a grant from the Next-Generation BioGreen 21 Program [No. PJ01104401, PJ01110901 and PJ00811602], Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Optipharm, Inc provided support in the form of salaries for authors [Hyunil Kim, KC and Jiho Kim], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adachi Y, 2004, INFECT IMMUN, V72, P4159, DOI 10.1128/IAI.72.7.4159-4171.2004; Alterovitz G., 2011, KNOWL BAS BIOINF AN; Andersson L, 2012, J INTERN MED, V271, P1, DOI 10.1111/j.1365-2796.2011.02450.x; [Anonymous], 1991, MICROLIVESTOCK LITTL; Barbosa MTP, 2007, FASEB J, V21, P3629, DOI 10.1096/fj.07-8290com; Browning BL, 2009, AM J HUM GENET, V85, P847, DOI 10.1016/j.ajhg.2009.11.004; Chakrama FZ, 2010, AUTOPHAGY, V6, P495, DOI 10.4161/auto.6.4.11819; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Delneste Y, 2002, IMMUNITY, V17, P353, DOI 10.1016/S1074-7613(02)00388-6; Deng CJ, 2010, GENET MOL BIOL, V33, P266, DOI 10.1590/S1415-47572010005000034; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Fan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014726; Fang XD, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-16; Galione A, 2000, SCI STKE, V2000, ppe1; Granka JM, 2012, GENETICS, V192, P1049, DOI 10.1534/genetics.112.144071; HAENSLY WE, 1968, J GERONTOL, V23, P53, DOI 10.1093/geronj/23.1.53; Hayashida K, 2002, FEBS LETT, V511, P133, DOI 10.1016/S0014-5793(01)03297-5; Hogan A, 2004, J BIOL CHEM, V279, P53717, DOI 10.1074/jbc.M410654200; HORTON GMJ, 1991, CAN J ANIM SCI, V71, P607, DOI 10.4141/cjas91-075; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Kim TH, 2005, J ANIM SCI, V83, P2255; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Lawrence DA, 1996, EUR CYTOKINE NETW, V7, P363; Lee H-J, 2014, GENOME BIOL EVOLUTIO, pevu102; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; Magowan E, 2009, EFFECT SIRE LINE BRE, P1; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miah SMS, 2004, GENES CELLS, V9, P993, DOI 10.1111/j.1365-2443.2004.00784.x; PANEPINTO LM, 1986, LAB ANIM SCI, V36, P344; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rambaut A, 2012, FIGTREE; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Smith DM, 2005, XENOTRANSPLANTATION, V12, P481, DOI 10.1111/j.1399-3089.2005.00252.x; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Sola-Oriol D, 2009, J ANIM SCI, V87, P562, DOI 10.2527/jas.2008-0949; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Suzuki K, 2005, J ANIM SCI, V83, P2058; Suzuki K, 2003, MEAT SCI, V64, P35, DOI 10.1016/S0309-1740(02)00134-1; Tang K, 2007, PLOS BIOL, V5, P1587, DOI 10.1371/journal.pbio.0050171; Teshima KM, 2006, GENOME RES, V16, P702, DOI 10.1101/gr.5105206; Tsuji S, 2001, J BIOL CHEM, V276, P23456, DOI 10.1074/jbc.M103162200; van Heemst D, 2005, AGING CELL, V4, P79, DOI 10.1111/j.1474-9728.2005.00148.x; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Walsh S, 2007, J APPL PHYSIOL, V102, P2142, DOI 10.1152/japplphysiol.01322.2006; Wang J, 1999, ENDOCRINOLOGY, V140, P3391, DOI 10.1210/en.140.7.3391; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	55	26	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0121732	10.1371/journal.pone.0121732	http://dx.doi.org/10.1371/journal.pone.0121732			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885114	Green Published, gold, Green Submitted			2022-12-26	WOS:000353017000023
J	Hwangbo, C; Tae, N; Lee, S; Kim, O; Park, OK; Kim, J; Kwon, SH; Lee, JH				Hwangbo, C.; Tae, N.; Lee, S.; Kim, O.; Park, O. K.; Kim, J.; Kwon, S-H; Lee, J-H			Syntenin regulates TGF-beta 1-induced Smad activation and the epithelial-to-mesenchymal transition by inhibiting caveolin-mediated TGF-beta type I receptor internalization	ONCOGENE			English	Article							HUMAN-MELANOMA CELLS; ADAPTER PROTEIN; SIGNAL-TRANSDUCTION; PDZ TANDEM; MDA-9/SYNTENIN; CANCER; DEGRADATION; METASTASIS; PATHWAYS; REQUIREMENTS	Syntenin, a tandem PDZ domain containing scaffold protein, functions as a positive regulator of cancer cell progression in several human cancers. We report here that syntenin positively regulates transforming growth factor (TGF)-beta 1-mediated Smad activation and the epithelial-to-mesenchymal transition (EMT) by preventing caveolin-1-mediated internalization of TGF-beta type I receptor (T beta RI). Knockdown of syntenin suppressed TGF-beta 1-mediated cell migration, transcriptional responses and Smad2/3 activation in various types of cells; however, overexpression of syntenin facilitated TGF-beta 1-mediated responses. In particular, syntenin knockdown abolished both the basal and TGF-beta 1-mediated repression of E-cadherin expression, as well as induction of vimentin expression along with Snail and Slug upregulation; thus, blocking the TGF-beta 1-induced EMT in A549 cells. In contrast, overexpression of syntenin exhibited the opposite effect. Knockdown of syntenin-induced ubiquitination and degradation of T beta RI, but not TGF-beta type II receptor, leading to decreased T beta RI expression at the plasma membrane. Syntenin associated with T beta RI at its C-terminal domain and a syntenin mutant lacking C-terminal domain failed to increase TGF-beta 1-induced responses. Biochemical analyzes revealed that syntenin inhibited the interaction between caveolin-1 and T beta RI and knockdown of syntenin induced a massive internalization of T beta RI and caveolin-1 from lipid rafts, indicating that syntenin may increase TGF-beta signaling by inhibiting caveolin-1-dependent internalization of T beta RI. Moreover, a positive correlation between syntenin expression and phospho-Smad2 levels is observed in human lung tumors. Taken together, these findings demonstrate that syntenin may act as an important positive regulator of TGF-beta signaling by regulating caveolin-1-mediated internalization of T beta RI; thus, providing a novel function for syntenin that is linked to cancer progression.	[Hwangbo, C.; Tae, N.; Lee, S.; Kim, O.; Kim, J.; Lee, J-H] Kangwon Natl Univ, Coll Nat Sci, Dept Biochem, Chunchon 200701, Gangwon Do, South Korea; [Park, O. K.; Kwon, S-H] Korea Basic Sci Inst, Chuncheon Ctr, Div Bioimaging, Chunchon, Gangwon Do, South Korea	Kangwon National University; Korea Basic Science Institute (KBSI)	Lee, JH (corresponding author), Kangwon Natl Univ, Coll Nat Sci, Dept Biochem, Chunchon 200701, Gangwon Do, South Korea.	jhlee36@kangwon.ac.kr			Korean Health Technology RD Project [A111311]; Ministry of Health and Welfare, Republic of Korea; National Research Foundation of Korea (NRF) [2013R1A1A2009026]	Korean Health Technology RD Project; Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	This work was supported by grants from the Korean Health Technology R&D Project (A111311), Ministry of Health and Welfare, Republic of Korea and the National Research Foundation of Korea (NRF, 2013R1A1A2009026).	Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Beekman JM, 2008, J CELL SCI, V121, P1349, DOI 10.1242/jcs.026401; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Boukerche H, 2008, P NATL ACAD SCI USA, V105, P15914, DOI 10.1073/pnas.0808171105; Boukerche H, 2007, CANCER RES, V67, P1812, DOI 10.1158/0008-5472.CAN-06-3875; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Chen YG, 2009, CELL RES, V19, P58, DOI 10.1038/cr.2008.315; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Dasgupta S, 2013, CLIN CANCER RES, V19, P4621, DOI 10.1158/1078-0432.CCR-13-0585; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Grembecka J, 2006, BIOCHEMISTRY-US, V45, P3674, DOI 10.1021/bi052225y; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Hwangbo C, 2010, CANCER RES, V70, P1645, DOI 10.1158/0008-5472.CAN-09-2447; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Kang BS, 2003, STRUCTURE, V11, P459, DOI 10.1016/S0969-2126(03)00052-2; Kang JS, 2009, TRENDS CELL BIOL, V19, P385, DOI 10.1016/j.tcb.2009.05.008; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kegelman TP, 2014, NEURO-ONCOLOGY, V16, P50, DOI 10.1093/neuonc/not157; Koo TH, 2002, ONCOGENE, V21, P4080, DOI 10.1038/sj.onc.1205514; Koroll M, 2001, J BIOL CHEM, V276, P10646, DOI 10.1074/jbc.M010647200; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lonn P, 2009, CELL RES, V19, P21, DOI 10.1038/cr.2008.308; Penheiter SG, 2002, MOL CELL BIOL, V22, P4750, DOI 10.1128/MCB.22.13.4750-4759.2002; Razani B, 2001, J BIOL CHEM, V276, P6727, DOI 10.1074/jbc.M008340200; Sarkar D, 2008, CANCER RES, V68, P3087, DOI 10.1158/0008-5472.CAN-07-6210; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Shi J, 2009, CANCER RES, V69, P7180, DOI 10.1158/0008-5472.CAN-08-4470; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; van Rheenen J, 2005, EMBO J, V24, P1664, DOI 10.1038/sj.emboj.7600655; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yang Y, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3442; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhao B, 2012, CELL RES, V22, P1467, DOI 10.1038/cr.2012.92; Zimmermann P, 2002, MOL CELL, V9, P1215, DOI 10.1016/S1097-2765(02)00549-X	43	58	66	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 21	2016	35	3					389	401		10.1038/onc.2015.100	http://dx.doi.org/10.1038/onc.2015.100			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DC2OF	25893292				2022-12-26	WOS:000369055300012
J	Chang, YH; Korkola, J; Amin, DN; Moasser, MM; Carmena, JM; Gray, JW; Tomlin, CJ				Chang, Young Hwan; Korkola, James; Amin, Dhara N.; Moasser, Mark M.; Carmena, Jose M.; Gray, Joe W.; Tomlin, Claire J.			Disentangling Multidimensional Spatio-Temporal Data into Their Common and Aberrant Responses	PLOS ONE			English	Article							EXPRESSION; CHALLENGES; NETWORKS; AKT	With the advent of high-throughput measurement techniques, scientists and engineers are starting to grapple with massive data sets and encountering challenges with how to organize, process and extract information into meaningful structures. Multidimensional spatio-temporal biological data sets such as time series gene expression with various perturbations over different cell lines, or neural spike trains across many experimental trials, have the potential to acquire insight about the dynamic behavior of the system. For this potential to be realized, we need a suitable representation to understand the data. A general question is how to organize the observed data into meaningful structures and how to find an appropriate similarity measure. A natural way of viewing these complex high dimensional data sets is to examine and analyze the large-scale features and then to focus on the interesting details. Since the wide range of experiments and unknown complexity of the underlying system contribute to the heterogeneity of biological data, we develop a new method by proposing an extension of Robust Principal Component Analysis (RPCA), which models common variations across multiple experiments as the lowrank component and anomalies across these experiments as the sparse component. We show that the proposed method is able to find distinct subtypes and classify data sets in a robust way without any prior knowledge by separating these common responses and abnormal responses. Thus, the proposed method provides us a new representation of these data sets which has the potential to help users acquire new insight from data.	[Chang, Young Hwan; Tomlin, Claire J.] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Korkola, James; Gray, Joe W.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA; [Korkola, James; Gray, Joe W.] Oregon Hlth & Sci Univ, Ctr Spatial Syst Biomed, Portland, OR 97201 USA; [Amin, Dhara N.; Moasser, Mark M.] Univ Calif San Francisco, Dept Med, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA; [Carmena, Jose M.] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Carmena, Jose M.] UCB UCSF Grad Program Bioengn, San Francisco, CA USA; [Tomlin, Claire J.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Fac Scientist, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Oregon Health & Science University; Oregon Health & Science University; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Tomlin, CJ (corresponding author), Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA.	tomlin@eecs.berkeley.edu	Gray, Joe/AAX-9549-2020	, James/0000-0002-0030-6216; Chang, Young Hwan/0000-0001-8764-1959	National Institutes of Health National Cancer Institute [5U54CA112970-08]; Stand Up To Cancer-American Association for Cancer Research Dream Team Translational Cancer Research Grant [SU2C-AACR-DT0408]; NIGMS; NSF [EFRI 1137267]; NATIONAL CANCER INSTITUTE [U54CA112970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107615] Funding Source: NIH RePORTER	National Institutes of Health National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Stand Up To Cancer-American Association for Cancer Research Dream Team Translational Cancer Research Grant; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Institutes of Health National Cancer Institute under the ICBP and PS-OC programs (5U54CA112970-08), by the Stand Up To Cancer-American Association for Cancer Research Dream Team Translational Cancer Research Grant SU2C-AACR-DT0408 to JWG, and by the NIGMS and by the NSF under grant EFRI 1137267. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin DN, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000389; Androulakis IP, 2007, ANNU REV BIOMED ENG, V9, P205, DOI 10.1146/annurev.bioeng.9.060906.151904; Baraniuk RG, 2009, FOUND COMPUT MATH, V9, P51, DOI 10.1007/s10208-007-9011-z; Bingham E., 2001, KDD-2001. Proceedings of the Seventh ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, P245, DOI 10.1145/502512.502546; Brognard J, 2008, TRENDS ENDOCRIN MET, V19, P223, DOI 10.1016/j.tem.2008.04.001; Candes EJ, 2011, J ACM, V58, DOI 10.1145/1970392.1970395; Chang YH, 2013, IEEE DECIS CONTR P, P2544, DOI 10.1109/CDC.2013.6760263; Chipman H, 2003, CLUSTERING MICROARRA; Churchland MM, 2007, J NEUROPHYSIOL, V97, P4235, DOI 10.1152/jn.00095.2007; Churchland MM, 2012, NATURE, V487, P51, DOI 10.1038/nature11129; Dasgupta S., 2000, UNCERTAINTY ARTIFICI, P143; Deegalla S, 2006, ICMLA 2006: 5TH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS, PROCEEDINGS, P245; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; Gymnopoulos M, 2007, P NATL ACAD SCI USA, V104, P5569, DOI 10.1073/pnas.0701005104; Heiser LM, 2012, P NATL ACAD SCI USA, V109, P2724, DOI 10.1073/pnas.1018854108; Hennessy Bryan T, 2010, Clin Proteomics, V6, P129, DOI 10.1007/s12014-010-9055-y; Liu JX, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S8-S3; Long MA, 2010, NATURE, V468, P394, DOI 10.1038/nature09514; Marx V, 2013, NATURE, V496, P253, DOI 10.1038/498255a; Moasser M, 2012, UNDERSTANDING NETWOR; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Roy S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003252; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Shiraishi Y, 2010, BIOINFORMATICS, V26, P1073, DOI 10.1093/bioinformatics/btq094; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Yadong Mu, 2011, 2011 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P2609, DOI 10.1109/CVPR.2011.5995369; Yu BM, 2009, J NEUROPHYSIOL, V102, P614, DOI 10.1152/jn.90941.2008; Zhou T, 2011, ARXIV111252152011	30	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0121607	10.1371/journal.pone.0121607	http://dx.doi.org/10.1371/journal.pone.0121607			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901353	Green Submitted, Green Published, gold			2022-12-26	WOS:000353331500012
J	Qiang, HP; Chen, ZH; Zhang, ZL; Wang, XM; Gao, HW; Wang, Z				Qiang, Haiping; Chen, Zhihong; Zhang, Zhengli; Wang, Xuemin; Gao, Hongwen; Wang, Zan			Molecular Diversity and Population Structure of a Worldwide Collection of Cultivated Tetraploid Alfalfa (Medicago sativa subsp sativa L.) Germplasm as Revealed by Microsatellite Markers	PLOS ONE			English	Article							GENETIC DIVERSITY; LINKAGE DISEQUILIBRIUM; FORAGE YIELD; PROGRAM	Information on genetic diversity and population structure of a tetraploid alfalfa collection might be valuable in effective use of the genetic resources. A set of 336 worldwide genotypes of tetraploid alfalfa (Medicago sativa subsp. sativa L.) was genotyped using 85 genome-wide distributed SSR markers to reveal the genetic diversity and population structure in the alfalfa. Genetic diversity analysis identified a total of 1056 alleles across 85 marker loci. The average expected heterozygosity and polymorphism information content values were 0.677 and 0.638, respectively, showing high levels of genetic diversity in the cultivated tetraploid alfalfa germplasm. Comparison of genetic characteristics across chromosomes indicated regions of chromosomes 2 and 3 had the highest genetic diversity. A higher genetic diversity was detected in alfalfa landraces than that of wild materials and cultivars. Two populations were identified by the model-based population structure, principal coordinate and neighbor-joining analyses, corresponding to China and other parts of the world. However, lack of strictly correlation between clustering and geographic origins suggested extensive germplasm exchanges of alfalfa germplasm across diverse geographic regions. The quantitative analysis of the genetic diversity and population structure in this study could be useful for genetic and genomic analysis and utilization of the genetic variation in alfalfa breeding.	[Qiang, Haiping; Zhang, Zhengli; Wang, Xuemin; Gao, Hongwen; Wang, Zan] Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China; [Chen, Zhihong] Minist Agr, Natl Anim Husb Serv, Beijing 100125, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Ministry of Agriculture & Rural Affairs	Gao, HW (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China.	hongwengao@hotmail.com; wangzan@caas.cn			National Natural Science Foundation of China [31272495]; Agricultural Science and Technology Innovation Program of China [ASTIP-IAS10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agricultural Science and Technology Innovation Program of China	1 National Natural Science Foundation of China (No. 31272495) http://www.nsfc.gov.cn/, ZW. 2 Agricultural Science and Technology Innovation Program (ASTIP-IAS10) of China http://www.caas.cn/en/research/research_program/index.shtml, HWG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG JM, 1954, CAN J BOT, V32, P531, DOI 10.1139/b54-050; Bagavathiannan MV, 2010, EUPHYTICA, V173, P419, DOI 10.1007/s10681-010-0156-5; Bhandari HS, 2011, CROP SCI, V51, P1110, DOI 10.2135/cropsci2010.08.0492; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Brazauskas G, 2011, PLANT SCI, V181, P412, DOI 10.1016/j.plantsci.2011.06.013; Carelli M, 2009, PLANT BREEDING, V128, P271, DOI 10.1111/j.1439-0523.2008.01573.x; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Esselink GD, 2004, THEOR APPL GENET, V109, P402, DOI 10.1007/s00122-004-1645-5; Eujayl I, 2004, THEOR APPL GENET, V108, P414, DOI 10.1007/s00122-003-1450-6; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Flajoulot S, 2005, THEOR APPL GENET, V111, P1420, DOI 10.1007/s00122-005-0074-4; Hong FZ., 2009, ALFALFA SCI; Jia GQ, 2013, J EXP BOT, V64, P3645, DOI 10.1093/jxb/ert198; Jin L, 2010, THEOR APPL GENET, V121, P475, DOI 10.1007/s00122-010-1324-7; Lamb JFS, 2006, CROP SCI, V46, P902, DOI 10.2135/cropsci2005.08-0236; Li XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084329; Li XH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-568; Li XH, 2011, PLANT GENOME-US, V4, P24, DOI 10.3835/plantgenome2010.09.0022; Lv J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046919; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Riday H, 2002, CROP SCI, V42, P716, DOI 10.2135/cropsci2002.0716; Robins JG, 2007, CROP SCI, V47, P1, DOI 10.2135/cropsci2005.11.0401; Sakiroglu M, 2010, THEOR APPL GENET, V121, P403, DOI 10.1007/s00122-010-1319-4; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Thrall PH, 2000, J HERED, V91, P348, DOI 10.1093/jhered/91.4.348; Tucak M, 2010, RUSS J GENET+, V46, P1314, DOI 10.1134/S1022795410110062; Tyagi P, 2014, THEOR APPL GENET, V127, P283, DOI 10.1007/s00122-013-2217-3; Wang CF, 2012, G3-GENES GENOM GENET, V2, P769, DOI 10.1534/g3.112.002907; Zhang DD, 2010, PLANT GENOME-US, V3, P117, DOI 10.3835/plantgenome2010.03.0004; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089; [No title captured]	35	28	31	4	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124592	10.1371/journal.pone.0124592	http://dx.doi.org/10.1371/journal.pone.0124592			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901573	gold, Green Submitted, Green Published			2022-12-26	WOS:000353331500093
J	Temereva, EN; Tsitrin, EB				Temereva, Elena N.; Tsitrin, Eugeni B.			Modern Data on the Innervation of the Lophophore in Lingula anatina (Brachiopoda) Support the Monophyly of the Lophophorates	PLOS ONE			English	Article							NERVOUS-SYSTEM; PHORONIDA; ULTRASTRUCTURE; TENTACLES	Evolutionary relationships among members of the Lophophorata remain unclear. Traditionally, the Lophophorata included three phyla: Brachiopoda, Bryozoa or Ectoprocta, and Phoronida. All species in these phyla have a lophophore, which is regarded as a homologous structure of the lophophorates. Because the organization of the nervous system has been traditionally used to establish relationships among groups of animals, information on the organization of the nervous system in the lophophore of phoronids, brachiopods, and bryozoans may help clarify relationships among the lophophorates. In the current study, the innervation of the lophophore of the inarticulate brachiopod Lingula anatina is investigated by modern methods. The lophophore of L. anatina contains three brachial nerves: the main, accessory, and lower brachial nerves. The main brachial nerve is located at the base of the dorsal side of the brachial fold and gives rise to the cross neurite bundles, which pass through the connective tissue and connect the main and accessory brachial nerves. Nerves emanating from the accessory brachial nerve account for most of the tentacle innervation and comprise the frontal, latero-frontal, and latero-abfrontal neurite bundles. The lower brachial nerve gives rise to the abfrontal neurite bundles of the outer tentacles. Comparative analysis revealed the presence of many similar features in the organization of the lophophore nervous system in phoronids, brachiopods, and bryozoans. The main brachial nerve of L. anatina is similar to the dorsal ganglion of phoronids and the cerebral ganglion of bryozoans. The accessory brachial nerve of L. anatina is similar to the minor nerve ring of phoronids and the circumoral nerve ring of bryozoans. All lophophorates have intertentacular neurite bundles, which innervate adjacent tentacles. The presence of similar nerve elements in the lophophore of phoronids, brachiopods, and bryozoans supports the homology of the lophophore and the monophyly of the lophophorates.	[Temereva, Elena N.] Moscow MV Lomonosov State Univ, Fac Biol, Dept Invertebrate Zool, Moscow 119992, Russia; [Tsitrin, Eugeni B.] Russian Acad Sci, Inst Dev Biol, Moscow 117808, Russia	Lomonosov Moscow State University; Russian Academy of Sciences; Koltzov Institute of Developmental Biology of the Russian Academy of Sciences	Temereva, EN (corresponding author), Moscow MV Lomonosov State Univ, Fac Biol, Dept Invertebrate Zool, Moscow 119992, Russia.	temereva@mail.ru	Temereva, Elena/J-2814-2012	Temereva, Elena/0000-0001-7791-0553	Russian Foundation of Basic Research [14-04-00238, 15-34-20045]; Russian Scientific Fund [14-50-00029, 14-04-262];  [MD-5812.2015.4]	Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Scientific Fund(Russian Science Foundation (RSF)); 	This research was supported in part by several grants. The collection of material was done with support from the Russian Foundation of Basic Research (#14-04-00238, #15-34-20045), the TEM studies are conducted with support from the Russian Scientific Fund (14-50-00029). Innunocytochemical and 3-D investigations were done with support from the Russian Scientific Fund (#14-04-262), and the processing of the paper was supported by Grants of the President of Russia (#MD-5812.2015.4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1977, BIOL BRYOZOANS; Beklemishev V. N., 1944, PRINCIPLES COMP ANAT; Blochmann F., 1892, UNTERSUCHUNGEN BAU B, P1; Blochmann F, 1900, UNTERSUCHUNGEN BAU B, P1; Bullock H., 1965, STRUCTURE FUNCTION N, V1; Caldwell WH, 1882, P R SOC, V34, P371, DOI [10.1098/rspl.1882.0051, DOI 10.1098/RSPL.1882.0051]; Cohen BL, 2013, ZOOL J LINN SOC-LOND, V167, P82, DOI 10.1111/j.1096-3642.2012.00869.x; Emig C. C., 1976, Z ZOOLOGISCHE SYSEMT, V14, P1; EMIG CC, 1976, ZOOL SCR, V5, P133, DOI 10.1111/j.1463-6409.1976.tb00690.x; EMIG CC, 1977, B SOC ZOOL FR, V102, P341; Fernandez I, 1996, J MORPHOL, V230, P265, DOI 10.1002/(SICI)1097-4687(199612)230:3<265::AID-JMOR2>3.0.CO;2-D; Gerwerzhagen A., 1913, BEITRAGE KENNTNIS BR; GILMOUR THJ, 1978, CAN J ZOOL, V56, P2142, DOI 10.1139/z78-290; GILMOUR THJ, 1981, CAN J ZOOL, V59, P1539, DOI 10.1139/z81-209; GORDON DP, 1974, MAR BIOL, V27, P147; HALANYCH KM, 1995, SCIENCE, V267, P1641, DOI 10.1126/science.7886451; Hancock A., 1858, PHILOS T R SOC LONDO, V148, P791, DOI [10.1098/rstl.1858.0034, DOI 10.1098/RSTL.1858.0034]; Hatschek B., 1888, LEHRBUCH ZOOLOGIE; Hausdorf B, 2010, MOL PHYLOGENET EVOL, V55, P1121, DOI 10.1016/j.ympev.2009.12.022; Helmkampf M, 2008, MOL PHYLOGENET EVOL, V46, P206, DOI 10.1016/j.ympev.2007.09.004; Hyman LH., 1959, INVERTEBRATES, P516; JAMES MA, 1992, ADV MAR BIOL, V28, P175, DOI 10.1016/S0065-2881(08)60040-1; James MA, 1997, MICROSCOPIC ANATOMY, V13, P297; Malakhov V, 1998, VESTIMENTIFERANS GUT; Malakhov VV., 2007, PALEONTOL J, V5, P1, DOI [10.1017/S1477201906001957, DOI 10.1017/S1477201906001957]; Nesnidal MP, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-253; Nielsen C, 1998, MAR ECOL PROG SER, V168, P163, DOI 10.3354/meps168163; NIELSEN C, 1987, ACTA ZOOL-STOCKHOLM, V68, P205, DOI 10.1111/j.1463-6395.1987.tb00892.x; Nielsen C, 2002, INVERTEBR BIOL, V121, P255; PARDOS F, 1991, ACTA ZOOL-STOCKHOLM, V72, P81, DOI 10.1111/j.1463-6395.1991.tb00320.x; PARDOS F, 1993, CAN J ZOOL, V71, P1861, DOI 10.1139/z93-265; REED CG, 1977, CELL TISSUE RES, V185, P17; Santagata S, 2009, ZOOL J LINN SOC-LOND, V157, P34, DOI 10.1111/j.1096-3642.2009.00531.x; Schwaha T, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-23; Shunkina KV, 2015, FRONTIERS Z IN PRESS, DOI [10.1186/s12983-015-0098-9, DOI 10.1186/S12983-015-0098-9]; SILEN LARS, 1954, ARKIV ZOOL, V6, P1; Storch V., 1976, Zoologische Jb (Anat), V96, P225; Sutton MD, 2011, BIOL LETTERS, V7, P146, DOI 10.1098/rsbl.2010.0540; Temereva EN, 2010, RUSS J MAR BIOL+, V36, P109, DOI 10.1134/S1063074010020057; Temereva E. N., 2009, BIOLOGIYA MORYA-MARINE BIOLOGY, V35, P425; Temereva EN, 2009, RUSS J MAR BIOL+, V35, P388, DOI 10.1134/S1063074009050046; Temereva EN, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-35; Temereva EN, 2015, J ZOOLOGY IN PRESS, V295; Van Bemmelen JFV., 1883, JENA Z NATURW, V16, P88; Wang H, 2014, OLDEST GLOSSELLINE L, DOI [10.1080/11035897.2014.914969, DOI 10.1080/11035897.2014.914969]; Weber AV, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0089-2; Williams Alwyn, 1997, P7	47	34	35	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123040	10.1371/journal.pone.0123040	http://dx.doi.org/10.1371/journal.pone.0123040			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901745	gold, Green Published, Green Submitted			2022-12-26	WOS:000353331500038
J	Flood-Nichols, SK; Tinnemore, D; Huang, RR; Napolitano, PG; Ippolito, DL				Flood-Nichols, Shannon K.; Tinnemore, Deborah; Huang, Raywin R.; Napolitano, Peter G.; Ippolito, Danielle L.			Vitamin D Deficiency in Early Pregnancy	PLOS ONE			English	Article							25-HYDROXYVITAMIN D CONCENTRATIONS; GESTATIONAL DIABETES-MELLITUS; D SUPPLEMENTATION; MICRONUTRIENT SUPPLEMENTATION; RISK; PREECLAMPSIA; BIRTH; WOMEN; TIME; AGE	Objective Vitamin D deficiency is a common problem in reproductive-aged women in the United States. The effect of vitamin D deficiency in pregnancy is unknown, but has been associated with adverse pregnancy outcomes. The objective of this study was to analyze the relationship between vitamin D deficiency in the first trimester and subsequent clinical outcomes. Study Design This is a retrospective cohort study. Plasma was collected in the first trimester from 310 nulliparous women with singleton gestations without significant medical problems. Competitive enzymatic vitamin D assays were performed on banked plasma specimens and pregnancy outcomes were collected after delivery. Logistic regression was performed on patients stratified by plasma vitamin D concentration and the following combined clinical outcomes: preeclampsia, preterm delivery, intrauterine growth restriction, gestational diabetes, and spontaneous abortion. Results Vitamin D concentrations were obtained from 235 patients (mean age 24.3 years, range 18-40 years). Seventy percent of our study population was vitamin D insufficient with a serum concentration less than 30 ng/mL (mean serum concentration 27.6 ng/mL, range 13-71.6 ng/mL). Logistic regression was performed adjusting for age, race, body mass index, tobacco use, and time of year. Adverse pregnancy outcomes included preeclampsia, growth restriction, preterm delivery, gestational diabetes, and spontaneous abortion. There was no association between vitamin D deficiency and composite adverse pregnancy outcomes with an adjusted odds ratio of 1.01 (p value 0.738, 95% confidence intervals 0.961-1.057). Conclusion Vitamin D deficiency did not associate with adverse pregnancy outcomes in this study population. However, the high percentage of affected individuals highlights the prevalence of vitamin D deficiency in young, reproductive-aged women.	[Flood-Nichols, Shannon K.; Napolitano, Peter G.] Madigan Army Med Ctr, Div Maternal Fetal Med, Joint Base Lewis McChord, Tacoma, WA 98431 USA; [Tinnemore, Deborah; Huang, Raywin R.; Ippolito, Danielle L.] Madigan Army Med Ctr, Dept Clin Invest, Joint Base Lewis McChord, Tacoma, WA 98431 USA	Madigan Army Medical Center; Madigan Army Medical Center	Flood-Nichols, SK (corresponding author), Madigan Army Med Ctr, Div Maternal Fetal Med, Joint Base Lewis McChord, Tacoma, WA 98431 USA.	Shannon.Flood@us.army.mil						Abouzeid M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005394; Albrecht SS, 2010, DIABETES CARE, V33, P768, DOI 10.2337/dc09-1801; American College of Obstetricians and Gynecologists, 2011, OBSTET GYNECOL, V118, P197, DOI [DOI 10.1097/A0G.0B013E318227F06B, 10.1097/aog.0b013e318227f06b]; Ananth Cande V, 2013, BMJ, V347, pf6564, DOI 10.1136/bmj.f6564; Anna V, 2008, DIABETES CARE, V31, P2288, DOI 10.2337/dc08-1038; [Anonymous], 2010, Obstet Gynecol, V116, P1241, DOI 10.1097/AOG.0b013e3182004fcd; [Anonymous], 2009, Obstet Gynecol, V113, P748, DOI 10.1097/AOG.0b013e31819e9ee2; [Anonymous], 2002, INT J GYNECOL OBSTET, V78, P179; [Anonymous], 2012, OBSTET GYNECOL, V120, P964; Ashoor G, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.029; Azar M, 2011, DIABETES CARE, V34, P1258, DOI 10.2337/dc10-2145; Baker AM, 2012, DIABETES-METAB RES, V28, P164, DOI 10.1002/dmrr.1282; Baker AM, 2011, AM J PERINAT, V28, P667, DOI 10.1055/s-0031-1276731; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Bodnar LM, 2007, J CLIN ENDOCR METAB, V92, P3517, DOI 10.1210/jc.2007-0718; Bodnar LM, 2010, OBSTET GYNECOL SURV, V65, P273, DOI 10.1097/OGX.0b013e3181dbc55b; Bodnar LM, 2010, J NUTR, V140, P999, DOI 10.3945/jn.109.119636; BROOKE OG, 1980, BMJ-BRIT MED J, V280, P751, DOI 10.1136/bmj.280.6216.751; Brough L, 2010, BRIT J NUTR, V104, P437, DOI 10.1017/S0007114510000747; Burris HH, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-013-0451-3; Burris HH, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.022; Burris HH, 2012, ANN EPIDEMIOL, V22, P581, DOI 10.1016/j.annepidem.2012.04.015; Christesen HT, 2012, ACTA OBSTET GYN SCAN, V91, P1357, DOI 10.1111/aogs.12000; Christian P, 2003, AM J CLIN NUTR, V78, P1194, DOI 10.1093/ajcn/78.6.1194; Clifton-Bligh RJ, 2008, DIABETIC MED, V25, P678, DOI 10.1111/j.1464-5491.2008.02422.x; Committee on Practice Bulletins-obstetrics, 2013, OBSTET GYNECOL, V131, P49, DOI DOI 10.1097/01.AOG.0000433006.09219.F1; Dabelea D, 2005, DIABETES CARE, V28, P579, DOI 10.2337/diacare.28.3.579; DELVIN EE, 1986, J PEDIATR-US, V109, P328, DOI 10.1016/S0022-3476(86)80396-1; DeSisto CL, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130415; Dolea C, 2003, EVIDENCE INFORM PILI, P1; Dunlop AL, 2012, REPROD SCI, V19, P939, DOI 10.1177/1933719112438442; Farrant HJW, 2009, EUR J CLIN NUTR, V63, P646, DOI 10.1038/ejcn.2008.14; Fernandez-Alonso AM, 2012, INT J GYNECOL OBSTET, V116, P6, DOI 10.1016/j.ijgo.2011.07.029; Gernand AD, 2013, J CLIN ENDOCR METAB, V98, P398, DOI 10.1210/jc.2012-3275; Getahun D, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.11.017; Ginde AA, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.11.036; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P176, DOI 10.1016/j.diabres.2013.11.003; Halhali A, 2000, J CLIN ENDOCR METAB, V85, P1828, DOI 10.1210/jc.85.5.1828; Haugen M, 2009, EPIDEMIOLOGY, V20, P720, DOI 10.1097/EDE.0b013e3181a70f08; Holick Michael F, 2011, J Clin Endocrinol Metab, V96, P1; Hollis BW, 2013, CALCIFIED TISSUE INT, V92, P128, DOI 10.1007/s00223-012-9607-4; Hollis BW, 2011, J BONE MINER RES, V26, P2341, DOI 10.1002/jbmr.463; Hossein-nezhad A, 2013, MAYO CLIN PROC, V88, P720, DOI 10.1016/j.mayocp.2013.05.011; Hypponen E, 2007, EUR J CLIN NUTR, V61, P1136, DOI 10.1038/sj.ejcn.1602625; Johnson DD, 2011, AM J PERINAT, V28, P7, DOI 10.1055/s-0030-1262505; Katon J, 2014, J WOMENS HEALTH, V23, P792, DOI 10.1089/jwh.2013.4681; Kolusari A, 2008, J INT MED RES, V36, P1335, DOI 10.1177/147323000803600622; LABRIJIMESTAGHANMI H, 1988, J ENDOCRINOL INVEST, V11, P577, DOI 10.1007/BF03350185; Leffelaar ER, 2010, BRIT J NUTR, V104, P108, DOI 10.1017/S000711451000022X; Lifshitz F, 2007, PEDIAT ENDOCRINOLOGY, P1; Looker AC, 2008, AM J CLIN NUTR, V88, P1519, DOI 10.3945/ajcn.2008.26182; Maghbooli Z, 2008, DIABETES-METAB RES, V24, P27, DOI 10.1002/dmrr.737; Makgoba M, 2011, DIABETES CARE, V34, P1091, DOI 10.2337/dc10-2264; Martin JA, 2014, NCHS DATA BRIEF, P1; McCullough ML, 2009, J AM COLL NUTR, V28, P678, DOI 10.1080/07315724.2009.10719801; Merewood A, 2009, J CLIN ENDOCR METAB, V94, P940, DOI 10.1210/jc.2008-1217; Ness RB, 1996, AM J OBSTET GYNECOL, V175, P1365, DOI 10.1016/S0002-9378(96)70056-X; Pawley N, 2004, AM J CLIN NUTR, V80, p1748S, DOI 10.1093/ajcn/80.6.1748S; Powe CE, 2010, HYPERTENSION, V56, P758, DOI 10.1161/HYPERTENSIONAHA.110.158238; Roberts CL, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000101; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Robinson Christopher J, 2011, Am J Obstet Gynecol, V204, DOI 10.1016/j.ajog.2011.03.022; Romo Agustin, 2009, Pediatr Endocrinol Rev, V6 Suppl 3, P332; Rosen CJ, 2011, NEW ENGL J MED, V364, P248, DOI 10.1056/NEJMcp1009570; Ross AC, 2011, DIETARY REFERENCE INTAKES FOR CALCIUM AND VITAMIN D, P35; Samadi AR, 1996, OBSTET GYNECOL, V87, P557, DOI 10.1016/0029-7844(95)00480-7; Sibai BM, 2003, SEMIN PERINATOL, V27, P239, DOI 10.1016/S0146-0005(03)00022-3; Wallis AB, 2008, AM J HYPERTENS, V21, P521, DOI 10.1038/ajh.2008.20; Wang XB, 2003, FERTIL STERIL, V79, P577, DOI 10.1016/S0015-0282(02)04694-0; WEBB AR, 1988, J CLIN ENDOCR METAB, V67, P373, DOI 10.1210/jcem-67-2-373; Wei SQ, 2013, J MATERN-FETAL NEO M, V26, P889, DOI 10.3109/14767058.2013.765849; Wilcox AJ, 1999, NEW ENGL J MED, V340, P1796, DOI 10.1056/NEJM199906103402304; Yetley EA, 2008, AM J CLIN NUTR, V88, p558S, DOI 10.1093/ajcn/88.2.558S; Zhang CL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003753	75	56	60	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123763	10.1371/journal.pone.0123763	http://dx.doi.org/10.1371/journal.pone.0123763			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898021	Green Published, gold, Green Submitted			2022-12-26	WOS:000353212600041
J	Ho, MH; Chen, CH; Goodwin, JS; Wang, BY; Xie, H				Ho, Meng-Hsuan; Chen, Chin-Ho; Goodwin, J. Shawn; Wang, Bing-Yan; Xie, Hua			Functional Advantages of Porphyromonas gingivalis Vesicles	PLOS ONE			English	Article							OUTER-MEMBRANE VESICLES; EPITHELIAL-CELLS; PERIODONTAL PATHOGENS; BACTERIAL INVASION; FIMBRIAE; PROTEIN; DNA; BIOGENESIS; VIRULENCE; DISEASE	Porphyromonas gingivalis is a keystone pathogen of periodontitis. Outer membrane vesicles (OMVs) have been considered as both offense and defense components of this bacterium. Previous studies indicated that like their originating cells, P. gingivalis vesicles, are able to invade oral epithelial cells and gingival fibroblasts, in order to promote aggregation of some specific oral bacteria and to induce host immune responses. In the present study, we investigated the invasive efficiency of P. gingivalis OMVs and compared results with that of the originating cells. Results revealed that 70-90% of human primary oral epithelial cells, gingival fibroblasts, and human umbilical vein endothelial cells carried vesicles from P. gingivalis 33277 after being exposed to the vesicles for 1 h, while 20-50% of the host cells had internalized P. gingivalis cells. We also detected vesicle-associated DNA and RNA and a vesicle-mediated horizontal gene transfer in P. gingivalis strains, which represents a novel mechanism for gene transfer between P. gingivalis strains. Moreover, purified vesicles of P. gingivalis appear to have a negative impact on biofilm formation and the maintenance of Streptococcus gordonii. Our results suggest that vesicles are likely the best offence weapon of P. gingivalis for bacterial survival in the oral cavity and for induction of periodontitis.	[Ho, Meng-Hsuan; Xie, Hua] Meharry Med Coll, Sch Dent, Nashville, TN 37208 USA; [Chen, Chin-Ho] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Goodwin, J. Shawn] Meharry Med Coll, Dept Biochem & Canc Biol, Nashville, TN 37208 USA; [Wang, Bing-Yan] Univ Texas Houston, Dept Periodont, Sch Dent, Hlth Sci Ctr Houston, Houston, TX USA	Meharry Medical College; Duke University; Meharry Medical College; University of Texas System; University of Texas Health Science Center Houston	Xie, H (corresponding author), Meharry Med Coll, Sch Dent, Nashville, TN 37208 USA.	hxie@mmc.edu			Public Health Service grant from NIDCR [DE020915, DE022428]; NIMHD [MD007593, MD007586]; National Center for Research Resources [UL1 RR024975-01]; National Center for Advancing Translational Sciences [2 UL1 TR000445-06]; NATIONAL CANCER INSTITUTE [U54CA163069] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975, S10RR025497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE022428, R21DE020915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R24DA036420] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007586, U54MD007593] Funding Source: NIH RePORTER	Public Health Service grant from NIDCR; NIMHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by Public Health Service grant DE020915 and DE022428 (HX) from NIDCR and by MD007593 and MD007586 from NIMHD. The project described was also supported by the National Center for Research Resources, grant UL1 RR024975-01, which is now mediated by the National Center for Advancing Translational Sciences under another agency number (grant 2 UL1 TR000445-06).	Beck J, 1996, J PERIODONTOL, V67, P1123, DOI 10.1902/jop.1996.67.10s.1123; Berleman J, 2013, ENVIRON MICROBIOL, V15, P347, DOI 10.1111/1462-2920.12048; Biller SJ, 2014, SCIENCE, V343, P183, DOI 10.1126/science.1243457; Bonnington KE, 2013, BIOCH BIOPHYS ACTA; Daep CA, 2008, INFECT IMMUN, V76, P3273, DOI 10.1128/IAI.00366-08; Daep CA, 2010, PEPTIDES, V31, P2173, DOI 10.1016/j.peptides.2010.08.014; Deatherage BL, 2009, MOL MICROBIOL, V72, P1395, DOI 10.1111/j.1365-2958.2009.06731.x; Elkaim R, 2008, J PERIODONTAL RES, V43, P224, DOI 10.1111/j.1600-0765.2007.01018.x; Furuta N, 2009, INFECT IMMUN, V77, P4187, DOI 10.1128/IAI.00009-09; GRENIER D, 1987, INFECT IMMUN, V55, P111, DOI 10.1128/IAI.55.1.111-117.1987; Grenier D, 2003, INFECT IMMUN, V71, P4742, DOI 10.1128/IAI.71.8.4742-4748.2003; Grenier D, 2013, INT J DENT, V2013, DOI 10.1155/2013/305476; Hajishengallis G, 2014, EUR J IMMUNOL, V44, P328, DOI 10.1002/eji.201344202; HANDLEY PS, 1986, ARCH ORAL BIOL, V31, P325, DOI 10.1016/0003-9969(86)90047-6; Haraszthy VI, 2000, J PERIODONTOL, V71, P1554, DOI 10.1902/jop.2000.71.10.1554; Inagaki S, 2006, INFECT IMMUN, V74, P5023, DOI 10.1128/IAI.00062-06; Kadurugamuwa JL, 1996, J BACTERIOL, V178, P2767, DOI 10.1128/jb.178.10.2767-2774.1996; Kamaguchi A, 2003, CURR MICROBIOL, V47, P485, DOI 10.1007/s00284-003-4069-6; Kerr JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091696; Klieve AV, 2005, APPL ENVIRON MICROB, V71, P4248, DOI 10.1128/AEM.71.8.4248-4253.2005; Kolling GL, 1999, APPL ENVIRON MICROB, V65, P1843; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Kozarov E, 2006, MICROBES INFECT, V8, P687, DOI 10.1016/j.micinf.2005.09.004; Kozarov EV, 2005, ARTERIOSCL THROM VAS, V25, pE17, DOI 10.1161/01.ATV.0000155018.67835.1a; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Lamont RJ, 2002, PERIODONTOL 2000, V30, P61, DOI 10.1034/j.1600-0757.2002.03006.x; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lin XH, 2006, INFECT IMMUN, V74, P6011, DOI 10.1128/IAI.00797-06; LOSTORTO S, 1992, J PERIODONTAL RES, V27, P161; Maeda K, 2004, MICROBES INFECT, V6, P1163, DOI 10.1016/j.micinf.2004.06.005; Mantri CK, 2014, MICROBIOLOGYOPEN; Mashburn LM, 2005, NATURE, V437, P422, DOI 10.1038/nature03925; Nakao R, 2014, MICROBES INFECT, V16, P6, DOI 10.1016/j.micinf.2013.10.005; Nakao R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026163; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Park Y, 2005, INFECT IMMUN, V73, P3983, DOI 10.1128/IAI.73.7.3983-3989.2005; Qi MS, 2003, MICROB PATHOGENESIS, V35, P259, DOI 10.1016/j.micpath.2003.07.002; Rafferty B, 2011, J INTERN MED, V270, P273, DOI 10.1111/j.1365-2796.2011.02373.x; Reyes L, 2013, J PERIODONTOL, V84, pS30, DOI [10.1902/jop.2013.1340012, 10.1111/jcpe.12079]; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rumbo C, 2011, ANTIMICROB AGENTS CH, V55, P3084, DOI 10.1128/AAC.00929-10; Silverman RJ, 2010, INFECT IMMUN, V78, P4644, DOI 10.1128/IAI.00685-10; Tashiro Y, 2010, APPL ENVIRON MICROB, V76, P3732, DOI 10.1128/AEM.02794-09; Tribble GD, 2007, J BACTERIOL, V189, P6382, DOI 10.1128/JB.00460-07; Tribble GD, 2012, MBIO, V3, DOI 10.1128/mBio.00231-11; Tribble GD, 2010, PERIODONTOL 2000, V52, P68, DOI 10.1111/j.1600-0757.2009.00323.x; Veith PD, 2014, J PROTEOME RES; Velimirov Branko, 2011, Mob Genet Elements, V1, P80; Weinberg A, 1997, INFECT IMMUN, V65, P313, DOI 10.1128/IAI.65.1.313-316.1997; Yilmaz O, 2002, CELL MICROBIOL, V4, P305, DOI 10.1046/j.1462-5822.2002.00192.x; Zheng C, 2011, MOL ORAL MICROBIOL, V26, P388, DOI 10.1111/j.2041-1014.2011.00626.x	51	74	81	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123448	10.1371/journal.pone.0123448	http://dx.doi.org/10.1371/journal.pone.0123448			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897780	Green Published, gold, Green Submitted			2022-12-26	WOS:000353212600026
J	Khawaja, SG; Mushtaq, MH; Khan, SA; Akram, MU; Jamal, HU				Khawaja, Sajid Gul; Mushtaq, Mian Hamza; Khan, Shoab A.; Akram, M. Usman; Jamal, Habib Ullah			Designing Area Optimized Application-Specific Network-On-Chip Architectures while Providing Hard QoS Guarantees	PLOS ONE			English	Article							SYSTEMS	With the increase of transistors' density, popularity of System on Chip (SoC) has increased exponentially. As a communication module for SoC, Network on Chip (NoC) framework has been adapted as its backbone. In this paper, we propose a methodology for designing area-optimized application specific NoC while providing hard Quality of Service (QoS) guarantees for real time flows. The novelty of the proposed system lies in derivation of a Mixed Integer Linear Programming model which is then used to generate a resource optimal Network on Chip (NoC) topology and architecture while considering traffic and QoS requirements. We also present the micro-architectural design features used for enabling traffic and latency guarantees and discuss how the solution adapts for dynamic variations in the application traffic. The paper highlights the effectiveness of proposed method by generating resource efficient NoC solutions for both industrial and benchmark applications. The area-optimized results are generated in few seconds by proposed technique, without resorting to heuristics, even for an application with 48 traffic flows.	[Khawaja, Sajid Gul; Mushtaq, Mian Hamza; Khan, Shoab A.; Akram, M. Usman] Natl Univ Sci & Technol, Dept Comp Engn, Islamabad, Pakistan; [Jamal, Habib Ullah] Ghulam Ishaq Khan Inst, Topi, Pakistan	National University of Sciences & Technology - Pakistan; GIK Institute Engineering Science & Technology	Akram, MU (corresponding author), Natl Univ Sci & Technol, Dept Comp Engn, Islamabad, Pakistan.	usman.akram@ceme.nust.edu.pk	Akram, Muhammad Usman/AAD-7343-2020	Akram, Muhammad Usman/0000-0002-6208-7231; Khawaja, Sajid/0000-0002-2409-3470				Abderazek B. A., 2007, MATH MODEL MULTIOBJE, V36; Angiolini F., 2011, EMBEDDED SYSTEMS, P127; Atienza D, 2008, INTEGRATION, V41, P340, DOI 10.1016/j.vlsi.2007.12.002; Bjerregaard T, 2005, INT SYMP ASYNCHRON C, P34, DOI 10.1109/ASYNC.2005.7; Chan Jeremy, 2008, 13th Asia and South Pacific Design Automation Conference ASP-DAC 2008, P265; Goossens K, 2005, IEEE DES TEST COMPUT, V22, P414, DOI 10.1109/MDT.2005.99; Hansson A, 2009, IET COMPUT DIGIT TEC, V3, P398, DOI 10.1049/iet-cdt.2008.0093; Hansson A, 2011, DES AUTOM EMBED SYST, V15, P159, DOI 10.1007/s10617-011-9073-7; Melonit P., 2006, AREA POWER MODELING, P1; Minje Jun, 2008, 13th Asia and South Pacific Design Automation Conference ASP-DAC 2008, P583; Murali S, 2009, ASIA S PACIF DES AUT, P242, DOI 10.1109/ASPDAC.2009.4796487; Rahmati D., 2009, METHOD CALCULATING H, P579; Schmitt J. B., 2008, DELAY BOUNDS ARBITRA, P1669; Srinivasan K, 2004, PR IEEE COMP DESIGN, P422, DOI 10.1109/ICCD.2004.1347957; Srinivasan K, 2006, ISQED 2006: PROCEEDINGS OF THE 7TH INTERNATIONAL SYMPOSIUM ON QUALITY ELECTRONIC DESIGN, P352; Tino A, 2011, MICROPROCESS MICROSY, V35, P523, DOI 10.1016/j.micpro.2011.05.002; Wang XH, 2010, ACM T ARCHIT CODE OP, V7, DOI 10.1145/1736065.1736066; Wiggers M. H., 2009, APERIODIC MULTIPROCE	18	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0125230	10.1371/journal.pone.0125230	http://dx.doi.org/10.1371/journal.pone.0125230			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898016	Green Submitted, Green Published, gold			2022-12-26	WOS:000353212600101
J	Brinkworth, AJ; Hammer, CH; Olano, LR; Kobayashi, SD; Chen, L; Kreiswirth, BN; Deleo, FR				Brinkworth, Amanda J.; Hammer, Carl H.; Olano, L. Renee; Kobayashi, Scott D.; Chen, Liang; Kreiswirth, Barry N.; DeLeo, Frank R.			Identification of Outer Membrane and Exoproteins of Carbapenem-Resistant Multilocus Sequence Type 258 Klebsiella pneumoniae	PLOS ONE			English	Article							IRON-ACQUISITION-SYSTEMS; BETA-LACTAMASE; ESCHERICHIA-COLI; UNITED-STATES; PROTEIN; IMPACT; COMBINATION; INFECTIONS; EPIDEMIOLOGY; PREVALENCE	Carbapenem-resistant Klebsiella pneumoniae strains have emerged as a cause of life-threatening infections in susceptible individuals (e.g., transplant recipients and critically ill patients). Strains classified as multilocus sequence type (ST) 258 are among the most prominent causes of carbapenem-resistant K. pneumoniae infections worldwide, but the basis for the success of this lineage remains incompletely determined. To gain a more comprehensive view of the molecules potentially involved in the success of ST258, we used a proteomics approach to identify surface-associated and culture supernatant proteins produced by ST258. Protein samples were prepared from varied culture conditions in vitro, and were analyzed by a combination of two-dimensional electrophoresis and liquid chromatography followed by tandem mass spectrometry (LC-MS/MS). We identified a total of 193 proteins in outer membrane preparations from bacteria cultured in Luria-Bertani broth (LB) or RPMI 1640 tissue culture media (RPMI). Compared with LB, several iron-acquisition proteins, including IutA, HmuR, HmuS, CirA, FepA, FitA, FoxA, FhuD, and YfeX, were more highly expressed in RPMI. Of the 177 proteins identified in spent media, only the fimbrial subunit, MrkA, was predicted to be extracellular, a finding that suggests few proteins (or a limited quantity) are freely secreted by ST258. Notably, we discovered 203 proteins not reported in previous K. pneumoniaeproteome studies. In silico modeling of proteins with unknown function revealed several proteins with beta-barrel transmembrane structures typical of porins, as well as possible host-interacting proteins. Taken together, these findings contribute several new targets for the mechanistic study of drug-resistance and pathogenesis by ST258 K. pneumoniaeisolates.	[Brinkworth, Amanda J.; Kobayashi, Scott D.; DeLeo, Frank R.] NIAID, Rocky Mt Lab, Lab Human Bacterial Pathogens, NIH, Hamilton, MT 59840 USA; [Hammer, Carl H.; Olano, L. Renee] NIAID, Res Technol Branch, NIH, Bethesda, MD 20892 USA; [Chen, Liang; Kreiswirth, Barry N.] Rutgers State Univ, New Jersey Med Sch, Publ Hlth Res Inst TB Ctr, Newark, NJ 07102 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Deleo, FR (corresponding author), NIAID, Rocky Mt Lab, Lab Human Bacterial Pathogens, NIH, Hamilton, MT 59840 USA.	fdeleo@niaid.nih.gov	Chen, Liang/Q-5337-2019	Chen, Liang/0000-0001-5845-2235; Kobayashi, Scott/0000-0002-5705-1381; Brinkworth, Amanda/0000-0003-3340-8494; DeLeo, Frank/0000-0003-3150-2516	Intramural Research Program of the National Institute of Allergy and Infectious Diseases; National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001195, ZICAI001051] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported in part by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.	Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Chong Y, 2011, INFECT GENET EVOL, V11, P1499, DOI 10.1016/j.meegid.2011.06.001; Clancy CJ, 2013, ANTIMICROB AGENTS CH, V57, P5258, DOI 10.1128/AAC.01069-13; Climent N, 1997, RES MICROBIOL, V148, P133, DOI 10.1016/S0923-2508(97)87644-9; Cuzon G, 2010, EMERG INFECT DIS, V16, P1349, DOI 10.3201/eid1609.091389; Deleo FR, 2014, P NATL ACAD SCI USA, V111, P4988, DOI 10.1073/pnas.1321364111; DELORENZO V, 1984, J GEN MICROBIOL, V130, P391; Endimiani A, 2009, J ANTIMICROB CHEMOTH, V64, P1102, DOI 10.1093/jac/dkp327; Frirdich E, 2005, J BIOL CHEM, V280, P27604, DOI 10.1074/jbc.M504987200; Gona F, 2014, CLIN MICROBIOL INFEC, V20, pO633, DOI 10.1111/1469-0691.12577; Hong JH, 2013, ANTIMICROB AGENTS CH, V57, P2147, DOI 10.1128/AAC.02411-12; Hsieh PF, 2008, J INFECT DIS, V197, P1717, DOI 10.1086/588383; Huang SH, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-148; Jacob JT, 2013, MMWR-MORBID MORTAL W, V62, P165; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kitchel B, 2009, ANTIMICROB AGENTS CH, V53, P3365, DOI 10.1128/AAC.00126-09; Kurupati P, 2006, PROTEOMICS, V6, P836, DOI 10.1002/pmic.200500214; Larrie-Bagha SM, 2013, IRAN J MICROBIOL, V5, P113; Lee CH, 1999, ANAL BIOCHEM, V267, P161, DOI 10.1006/abio.1998.2961; Lee GC, 2012, ANN CLIN MICROB ANTI, V11, DOI 10.1186/1476-0711-11-32; Lee JC, 2012, FEMS MICROBIOL LETT, V331, P17, DOI 10.1111/j.1574-6968.2012.02549.x; Lin CT, 2011, MICROBIOL-SGM, V157, P419, DOI 10.1099/mic.0.044065-0; Lundberg U, 2013, HUM VACC IMMUNOTHER, V9, P497, DOI 10.4161/hv.23225; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; MartinezMartinez L, 1996, ANTIMICROB AGENTS CH, V40, P342, DOI 10.1128/AAC.40.2.342; Mathers AJ, 2011, MBIO, V2, DOI 10.1128/mBio.00204-11; Molloy MP, 2000, EUR J BIOCHEM, V267, P2871, DOI 10.1046/j.1432-1327.2000.01296.x; Molloy MP, 2001, ELECTROPHORESIS, V22, P1686, DOI 10.1002/1522-2683(200105)22:9<1686::AID-ELPS1686>3.0.CO;2-L; Munoz-Price LS, 2013, LANCET INFECT DIS, V13, P785, DOI 10.1016/S1473-3099(13)70190-7; Patel G, 2008, INFECT CONT HOSP EP, V29, P1099, DOI 10.1086/592412; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; PUGSLEY AP, 1986, J BACTERIOL, V166, P1083, DOI 10.1128/jb.166.3.1083-1088.1986; Qureshi ZA, 2012, ANTIMICROB AGENTS CH, V56, P2108, DOI 10.1128/AAC.06268-11; Rey S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-162; Russo TA, 2014, INFECT IMMUN, V82, P2356, DOI 10.1128/IAI.01667-13; SADER HS, 1994, DIAGN MICR INFEC DIS, V20, P203, DOI 10.1016/0732-8893(94)90004-3; Satheshkumar PS, 2013, J VIROL, V87, P10710, DOI 10.1128/JVI.01261-13; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Trishin A. V., 2005, Vestnik Rossiiskoi Akademii Meditsinskikh Nauk, P43; Trishin A. V., 2008, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P46; Tumbarello M, 2012, CLIN INFECT DIS, V55, P943, DOI 10.1093/cid/cis588; Tusnady GE, 2005, BIOINFORMATICS, V21, P1276, DOI 10.1093/bioinformatics/bti121; Wang Wei, 2003, Proteome Sci, V1, P6, DOI 10.1186/1477-5956-1-6; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wright MS, 2014, ANTIMICROB AGENTS CH, V58, P4961, DOI 10.1128/AAC.00125-14; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001; Zarkotou O, 2011, CLIN MICROBIOL INFEC, V17, P1798, DOI 10.1111/j.1469-0691.2011.03514.x	47	15	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123219	10.1371/journal.pone.0123219	http://dx.doi.org/10.1371/journal.pone.0123219			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893665	Green Published, gold, Green Submitted			2022-12-26	WOS:000353211700029
J	Choi, H; Gillespie, DL; Berg, S; Rice, C; Couldwell, S; Gu, J; Colman, H; Jensen, RL; Huang, LE				Choi, Hyunsung; Gillespie, David L.; Berg, Shauna; Rice, Christopher; Couldwell, Sandrine; Gu, Jie; Colman, Howard; Jensen, Randy L.; Huang, L. Eric			Intermittent Induction of HIF-1 alpha Produces Lasting Effects on Malignant Progression Independent of Its Continued Expression	PLOS ONE			English	Article							INDUCIBLE FACTOR-I; HIF-ALPHA; C-MYC; HYPOXIA; CELL; ACTIVATION; CANCER; GROWTH; STABILIZATION; HIF-2-ALPHA	Dysregulation of hypoxia-inducible transcription factors HIF-1 alpha and HIF-2 alpha correlates with poor prognosis in human cancers; yet, divergent and sometimes opposing activities of these factors in cancer biology have been observed. Adding to this complexity is that HIF-1 alpha apparently possesses tumor-suppressing activities, as indicated by the loss-of-function mutations or even homozygous deletion of HIF1A in certain human cancers. As a step towards understanding this complexity, we employed 8-week intermittent induction of a stable HIF-1 alpha variant, HIF1 alpha(PP), in various cancer cell lines and examined the effects on malignant progression in xenografts of immunocompromised mice in comparison to those of HIF2 alpha(PP). Although 8-week treatment led to eventual loss of HIF1 alpha(PP) expression, treated osteosarcoma U-2 OS cells acquired tumorigenicity in the subcutaneous tissue. Furthermore, the prior treatment resulted in widespread invasion of malignant glioma U-87 MG cells in the mouse brain and sustained growth of U-118 MG glioma cells. The lasting effects of HIF-1 alpha on malignant progression are specific because neither HIF2 alpha(PP) nor beta-galactosidase yielded similar effects. By contrast, transient expression of HIF1 alpha(PP) in U-87MG cells or constitutive expression of HIF1 alpha(PP) but not HIF2 alpha(PP) in a patient-derived glioma sphere culture inhibited tumor growth and spread. Our results indicate that intermittent induction of HIF-1 alpha produces lasting effects on malignant progression even at its own expense.	[Choi, Hyunsung; Gillespie, David L.; Berg, Shauna; Rice, Christopher; Couldwell, Sandrine; Gu, Jie; Colman, Howard; Jensen, Randy L.; Huang, L. Eric] Univ Utah, Clin Neurosci Ctr, Dept Neurosurg, Salt Lake City, UT 84112 USA; [Huang, L. Eric] Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Choi, H (corresponding author), Univ Utah, Clin Neurosci Ctr, Dept Neurosurg, Salt Lake City, UT 84112 USA.	eric.huang@hsc.utah.edu	Colman, Howard/L-5433-2019; Couldwell, Sandrine/GNH-4078-2022	Gillespie, David/0000-0002-7375-0262; Huang, Eric/0000-0002-6444-1708	NIH Grant from the National Cancer Institute [CA084563]; Department of Neurosurgery at the University of Utah; NATIONAL CANCER INSTITUTE [K22CA084563] Funding Source: NIH RePORTER	NIH Grant from the National Cancer Institute; Department of Neurosurgery at the University of Utah; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by an NIH Grant CA084563 from the National Cancer Institute and by the Department of Neurosurgery at the University of Utah. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker T, 2005, CANCER CELL, V8, P131, DOI 10.1016/j.ccr.2005.07.003; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Bhat KPL, 2011, GENE DEV, V25, P2594, DOI 10.1101/gad.176800.111; Cairns RA, 2001, CANCER RES, V61, P8903; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Dayan F, 2006, CANCER RES, V66, P3688, DOI 10.1158/0008-5472.CAN-05-4564; Ema M, 1999, EMBO J, V18, P1905, DOI 10.1093/emboj/18.7.1905; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Giaccia A, 2003, NAT REV DRUG DISCOV, V2, P803, DOI 10.1038/nrd1199; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hayashi M, 2011, CELL CYCLE, V10, P2364, DOI 10.4161/cc.10.14.16313; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Huang LE, 2008, CELL DEATH DIFFER, V15, P672, DOI 10.1038/sj.cdd.4402302; Huang LE, 2013, SCIENCE, V339, P1285, DOI 10.1126/science.1236966; Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253; Huang LE, 2004, DRUG DISCOV TODAY, V9, P869, DOI 10.1016/S1359-6446(04)03227-1; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Hubbi ME, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003417; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jensen RL, 2006, NEUROSURG FOCUS, V20, pE24, DOI DOI 10.3171/foc.2006.20.4.16; Kaelin WG, 2007, ANNU REV PATHOL-MECH, V2, P145, DOI 10.1146/annurev.pathol.2.010506.092049; Kageyama Y, 2004, FASEB J, V18, P1028, DOI 10.1096/fj.03-1233fje; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Koshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196; Ku BM, 2011, INT J CANCER, V128, P1316, DOI 10.1002/ijc.25466; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Louis DN, 2006, ANNU REV PATHOL-MECH, V1, P97, DOI 10.1146/annurev.pathol.1.110304.100043; Mack FA, 2005, MOL CELL BIOL, V25, P4565, DOI 10.1128/MCB.25.11.4565-4578.2005; Martinive P, 2006, CANCER RES, V66, P11736, DOI 10.1158/0008-5472.CAN-06-2056; Maxwell PH, 2001, CURR OPIN GENET DEV, V11, P293, DOI 10.1016/S0959-437X(00)00193-3; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mazumdar J, 2010, P NATL ACAD SCI USA, V107, P14182, DOI 10.1073/pnas.1001296107; Mazure NM, 1996, CANCER RES, V56, P3436; Nigro JM, 2005, CANCER RES, V65, P1678, DOI 10.1158/0008-5472.CAN-04-2921; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Pugh CW, 1997, J BIOL CHEM, V272, P11205; Purdue MP, 2011, NAT GENET, V43, P60, DOI 10.1038/ng.723; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Rapisarda A, 2012, NAT REV CLIN ONCOL, V9, P378, DOI 10.1038/nrclinonc.2012.64; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Rice Christopher, 2010, Cancer Manag Res, V3, P9, DOI 10.2147/CMR.S14812; Rofstad EK, 1999, BRIT J CANCER, V80, P1697, DOI 10.1038/sj.bjc.6690586; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; SEMENZA GL, 1991, P NATL ACAD SCI USA, V88, P5680, DOI 10.1073/pnas.88.13.5680; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shen C, 2011, CANCER DISCOV, V1, P222, DOI 10.1158/2159-8290.CD-11-0098; Sun HX, 2013, HEPATOLOGY, V57, P1088, DOI 10.1002/hep.26188; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Tiburcio PD, 2014, HYPOXIA, V2, P59, DOI 10.2147/HP.S50651; Toffoli S, 2008, FEBS J, V275, P2991, DOI 10.1111/j.1742-4658.2008.06454.x; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang V, 2005, CANCER RES, V65, P3299, DOI 10.1158/0008-5472.CAN-04-4130; Young RM, 2012, NAT MED, V18, P1024, DOI 10.1038/nm.2865; YOUNG SD, 1988, P NATL ACAD SCI USA, V85, P9533, DOI 10.1073/pnas.85.24.9533; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Zhuang ZP, 2012, NEW ENGL J MED, V367, P922, DOI 10.1056/NEJMoa1205119	64	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0125125	10.1371/journal.pone.0125125	http://dx.doi.org/10.1371/journal.pone.0125125			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893706	Green Published, gold, Green Submitted			2022-12-26	WOS:000353211700133
J	Lu, L; Cheng, HG; Liu, XL; Xie, J; Li, Q; Zhou, T				Lu, Lu; Cheng, Hongguang; Liu, Xuelian; Xie, Jing; Li, Qian; Zhou, Tan			Assessment of Regional Human Health Risks from Lead Contamination in Yunnan Province, Southwestern China	PLOS ONE			English	Article							MODEL; EMISSIONS; EXPOSURE	Identification and management the 'critical risk areas' where hotspot lead exposures are a potential risk to human health, become a major focus of public health efforts in China. But the knowledge of health risk assessment of lead pollution at regional and national scales is still limited in China. In this paper, under the guidance of 'sources-pathways-receptors' framework, regional human health risk assessment model for lead contamination was developed to calculate the population health risk in Yunnan province. And the cluster and AHP (analytic hierarchy process) analysis was taken to classify and calculate regional health risk and the decomposition of the regional health risk in the greatest health risk region, respectively. The results showed that Yunnan province can be divided into three areas. The highest health risk levels, located in northeastern Yunnan, including Kunming, Qujing, Zhaotong region. In those regions, lead is present at high levels in air, food, water and soil, and high population density which pose a high potential population risk to the public. The current study also reveals that most regional health risk was derived from the child receptors (age above 3 years) 4.3 times than the child receptors (age under 3years), and ingestion of lead-contaminated rice was found to be the most significant contributor to the health risk (accounting for more than 49% health risk of total). This study can provide a framework for regional risk assessment in China and highlighted some indicators and uncertainties.	[Lu, Lu; Cheng, Hongguang; Liu, Xuelian; Xie, Jing] Beijing Normal Univ, Sch Environm, Beijing 100875, Peoples R China; [Li, Qian] Standardizat Tech Res Ctr, Shandong Inst Standardizat, Jinan, Shandong, Peoples R China; [Zhou, Tan] Texas A&M Univ, Spatial Sci Lab, College Stn, TX USA	Beijing Normal University; Texas A&M University System; Texas A&M University College Station	Cheng, HG (corresponding author), Beijing Normal Univ, Sch Environm, Beijing 100875, Peoples R China.	chg@bnu.edu.cn	Zhou, Tan/U-3953-2019	Zhou, Tan/0000-0002-9193-5113	National Natural Science Foundation of China [40930740, 41171384]; Special Environmental Research Funds for Public Welfare [2010467046]; program of the "Twelfth Five-year Plan" for Sci & Tech Research of China [2012BAD15B05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Environmental Research Funds for Public Welfare; program of the "Twelfth Five-year Plan" for Sci & Tech Research of China	This research work was funded by the National Natural Science Foundation of China (key project 40930740 and general project 41171384) and Special Environmental Research Funds for Public Welfare (No. 2010467046). The authors are also grateful for financial support from the program of the "Twelfth Five-year Plan" for Sci & Tech Research of China (2012BAD15B05). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	BOGEN KT, 1987, RISK ANAL, V7, P427, DOI 10.1111/j.1539-6924.1987.tb00480.x; Caudeville J, 2012, SCI TOTAL ENVIRON, V432, P297, DOI 10.1016/j.scitotenv.2012.06.001; Chen JM, 2005, ATMOS ENVIRON, V39, P1245, DOI 10.1016/j.atmosenv.2004.10.041; Cheng SY, 2012, ATMOS ENVIRON, V60, P613, DOI 10.1016/j.atmosenv.2012.07.056; Cohen JE, 2012, HLTH HUMAN RIGHTS IN, V14; Dong ZM, 2012, ENVIRON SCI TECHNOL, V46, P1144, DOI 10.1021/es202800z; Duzgoren-Aydin NS, 2007, SCI TOTAL ENVIRON, V385, P182, DOI 10.1016/j.scitotenv.2007.06.047; Feng JF, 2011, J ENVIRON SCI-CHINA, V23, P1158, DOI 10.1016/S1001-0742(10)60529-3; Gumus AT, 2009, EXPERT SYST APPL, V36, P4067, DOI 10.1016/j.eswa.2008.03.013; He KM, 2009, SCI TOTAL ENVIRON, V407, P3986, DOI 10.1016/j.scitotenv.2009.03.018; Kayal T, 2011, TECHNOL ECON DEV ECO, V17, P313, DOI 10.3846/20294913.2011.583727; LEGGETT RW, 1993, ENVIRON HEALTH PERSP, V101, P598, DOI 10.2307/3431645; Li Q, 2012, ATMOSPHERIC ENV; Ma HW, 2012, ENVIRON SCI TECHNOL, V46, P1104, DOI 10.1021/es203036r; Mickle MH, 1998, ENVIRON HEALTH PERSP, V106, P1531, DOI 10.1289/ehp.98106s61531; Niisoe T, 2011, ENVIRON SCI TECHNOL, V45, P2856, DOI 10.1021/es103666e; Pennington DW, 2005, ENVIRON SCI TECHNOL, V39, P1119, DOI 10.1021/es034598x; Qu CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046793; Roper W.L., 1991, PREVENTING LEAD POIS; US-EPA, 2010, INT EXP UPT BIOK MOD; USEPA, 2005, EPA530R05006 US EPA; World Health Organization, 1995, ENV HLTH CRIT; Xu DC, 2013, ECOTOX ENVIRON SAFE, V90, P103, DOI 10.1016/j.ecoenv.2012.12.018; Xu XG, 2004, J ENVIRON MANAGE, V70, P253, DOI 10.1016/j.jenvman.2003.12.001; Ye XB, 2006, REGUL TOXICOL PHARM, V46, P157, DOI 10.1016/j.yrtph.2006.04.003	25	10	10	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0119562	10.1371/journal.pone.0119562	http://dx.doi.org/10.1371/journal.pone.0119562			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893826	Green Published, Green Submitted, gold			2022-12-26	WOS:000353211700004
J	Yamane, T; Goenaga, J; Ronn, JL; Arnqvist, G				Yamane, Takashi; Goenaga, Julieta; Ronn, Johanna Liljestrand; Arnqvist, Goran			Male Seminal Fluid Substances Affect Sperm Competition Success and Female Reproductive Behavior in a Seed Beetle	PLOS ONE			English	Article							PROTEASE INHIBITOR; COLEOPTERA; PROTEINS; PEPTIDE; RECEPTIVITY; ALLOCATION; POLYANDRY; VIABILITY; EVOLUTION; FECUNDITY	Male seminal fluid proteins are known to affect female reproductive behavior and physiology by reducing mating receptivity and by increasing egg production rates. Such substances are also though to increase the competitive fertilization success of males, but the empirical foundation for this tenet is restricted. Here, we examined the effects of injections of size-fractioned protein extracts from male reproductive organs on both male competitive fertilization success (i.e., P2 in double mating experiments) and female reproduction in the seed beetle Callosobruchus maculatus. We found that extracts of male seminal vesicles and ejaculatory ducts increased competitive fertilization success when males mated with females 1 day after the females' initial mating, while extracts from accessory glands and testes increased competitive fertilization success when males mated with females 2 days after the females' initial mating. Moreover, different size fractions of seminal fluid proteins had distinct and partly antagonistic effects on male competitive fertilization success. Collectively, our experiments show that several different seminal fluid proteins, deriving from different parts in the male reproductive tract and of different molecular weight, affect male competitive fertilization success in C. maculatus. Our results highlight the diverse effects of seminal fluid proteins and show that the function of such proteins can be contingent upon female mating status. We also document effects of different size fractions on female mating receptivity and egg laying rates, which can serve as a basis for future efforts to identify the molecular identity of seminal fluid proteins and their function in this model species.	[Goenaga, Julieta] Aarhus Univ, Aarhus Inst Adv Studies, Aarhus, Denmark; [Ronn, Johanna Liljestrand; Arnqvist, Goran] Uppsala Univ, Dept Ecol & Genet, Anim Ecol, Uppsala, Sweden	Aarhus University; Uppsala University	Arnqvist, G (corresponding author), Uppsala Univ, Dept Ecol & Genet, Anim Ecol, Uppsala, Sweden.	Goran.Arnqvist@ebc.uu.se	Arnqvist, Göran/E-6782-2015; Goenaga, Julieta/O-4643-2016	Arnqvist, Göran/0000-0002-3501-3376; Goenaga, Julieta/0000-0002-2894-1166; Goenaga, Julieta/0000-0002-9822-5800	Japan Society for the Promotion of Science [233967]; Wenner-Gren Foundation; European Research Council [GENCON AdG-29433]; Swedish Research Council [621-2010-5266]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Wenner-Gren Foundation; European Research Council(European Research Council (ERC)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was financially supported by Research Fellowships for Young Scientists (Japan Society for the Promotion of Science 233967, to TY), by the Wenner-Gren Foundation (to JG), by the European Research Council (GENCON AdG-294333, to GA) and by the Swedish Research Council (621-2010-5266, to GA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Arnqvist Goran, 2005, pUnpaginated; Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823; BAUMANN H, 1974, J INSECT PHYSIOL, V20, P2347, DOI 10.1016/0022-1910(74)90022-5; Birkhead T, 2000, PROMISCUITY EVOLUTIO; Chapman T, 2000, P ROY SOC B-BIOL SCI, V267, P1097, DOI 10.1098/rspb.2000.1114; Chapman T, 2004, PEPTIDES, V25, P1477, DOI 10.1016/j.peptides.2003.10.023; CHEN PS, 1988, CELL, V54, P291, DOI 10.1016/0092-8674(88)90192-4; CLARK AG, 1995, GENETICS, V139, P189; DAS AK, 1980, EXPERIENTIA, V36, P918, DOI 10.1007/BF01953792; DelBarco-Trillo J, 2011, J EVOLUTION BIOL, V24, P1706, DOI 10.1111/j.1420-9101.2011.02293.x; den Boer SPA, 2008, BEHAV ECOL SOCIOBIOL, V62, P1843, DOI 10.1007/s00265-008-0613-5; EADY PE, 1991, ECOL ENTOMOL, V16, P45, DOI 10.1111/j.1365-2311.1991.tb00191.x; EADY PE, 1995, BEHAV ECOL SOCIOBIOL, V36, P25, DOI 10.1007/BF00175725; Fiumera AC, 2005, GENETICS, V169, P243, DOI 10.1534/genetics.104.032870; Fiumera AC, 2007, GENETICS, V176, P1245, DOI 10.1534/genetics.106.064915; Fricke C, 2010, J EVOLUTION BIOL, V23, P157, DOI 10.1111/j.1420-9101.2009.01882.x; Fricke C, 2009, J EVOLUTION BIOL, V22, P275, DOI 10.1111/j.1420-9101.2008.01638.x; FUCHS MS, 1970, J INSECT PHYSIOL, V16, P931, DOI 10.1016/0022-1910(70)90223-4; Garcia-Gonzalez F, 2005, CURR BIOL, V15, P271, DOI 10.1016/j.cub.2005.01.032; Gay L, 2009, J EVOLUTION BIOL, V22, P1143, DOI 10.1111/j.1420-9101.2009.01724.x; Gillott C, 2003, ANNU REV ENTOMOL, V48, P163, DOI 10.1146/annurev.ento.48.091801.112657; Hayashi N, 2014, PHYSIOL ENTOMOL, V39, P12, DOI 10.1111/phen.12042; HOLM S, 1979, SCAND J STAT, V6, P65; Holman L, 2009, FUNCT ECOL, V23, P180, DOI 10.1111/j.1365-2435.2008.01509.x; Hotzy C, 2012, CURR BIOL, V22, P2258, DOI 10.1016/j.cub.2012.10.009; Hotzy C, 2009, CURR BIOL, V19, P404, DOI 10.1016/j.cub.2009.01.045; Imamura M, 1998, INSECT BIOCHEM MOLEC, V28, P365, DOI 10.1016/S0965-1748(98)00004-6; Katvala M, 2008, J EVOLUTION BIOL, V21, P471, DOI 10.1111/j.1420-9101.2007.01494.x; KINGAN TG, 1993, J EXP BIOL, V183, P61; Kvarnemo C, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0042; LEAHY MG, 1967, J INSECT PHYSIOL, V13, P1283, DOI 10.1016/0022-1910(67)90100-X; Lung O, 2002, GENETICS, V160, P211; Maklakov AA, 2009, CURR BIOL, V19, P1903, DOI 10.1016/j.cub.2009.08.058; Mueller JL, 2008, GENETICS, V178, P1605, DOI 10.1534/genetics.107.083766; Neubaum DM, 1999, GENETICS, V153, P845; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Perry JC, 2013, TRENDS ECOL EVOL, V28, P414, DOI 10.1016/j.tree.2013.03.005; Poiani A, 2006, BEHAV ECOL SOCIOBIOL, V60, P289, DOI 10.1007/s00265-006-0178-0; RIDLEY M, 1988, BIOL REV, V63, P509, DOI 10.1111/j.1469-185X.1988.tb00669.x; Roenn JL, 2008, J EVOLUTION BIOL, V21, P461, DOI 10.1111/j.1420-9101.2007.01493.x; Ronn J, 2007, P NATL ACAD SCI USA, V104, P10921, DOI 10.1073/pnas.0701170104; SAS Institute, 2007, JMP7; Saudan P, 2002, EUR J BIOCHEM, V269, P989, DOI 10.1046/j.0014-2956.2001.02733.x; Savalli UM, 1999, FUNCT ECOL, V13, P169, DOI 10.1046/j.1365-2435.1999.00287.x; Simmons L. W., 2001, MG BEH ECOL; Sirot LK, 2011, P NATL ACAD SCI USA, V108, P9922, DOI 10.1073/pnas.1100905108; Snook RR, 2005, TRENDS ECOL EVOL, V20, P46, DOI 10.1016/j.tree.2004.10.011; Thornhill R., 1983, pi; Wedell N, 2005, J EXP BIOL, V208, P3433, DOI 10.1242/jeb.01774; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8; Wigby S, 2005, CURR BIOL, V15, P316, DOI 10.1016/j.cub.2005.01.051; Wilson N, 1997, P ROY SOC B-BIOL SCI, V264, P1491, DOI 10.1098/rspb.1997.0206; Wolfner MF, 2002, HEREDITY, V88, P85, DOI 10.1038/sj.hdy.6800017; Yamane T, 2008, J ETHOL, V26, P225, DOI 10.1007/s10164-007-0051-2; Yamane T, 2013, ANN ENTOMOL SOC AM, V106, P258, DOI 10.1603/AN12079; Yamane T, 2013, EVOL BIOL, V40, P133, DOI 10.1007/s11692-012-9193-4; Yamane T, 2012, BEHAV ECOL, V23, P715, DOI 10.1093/beheco/ars017	58	54	56	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123770	10.1371/journal.pone.0123770	http://dx.doi.org/10.1371/journal.pone.0123770			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893888	Green Published, gold, Green Submitted			2022-12-26	WOS:000353211700056
J	Barrado, MJG; Osma, MCI; Blanco, EJ; Hernandez, MC; Robledo, VS; Iniesta, LC; Carrero, S; Carretero, J				Garcia Barrado, Maria Jose; Iglesias Osma, Maria Carmen; Blanco, Enrique J.; Carretero Hernandez, Marta; Sanchez Robledo, Virginia; Catalano Iniesta, Leonardo; Carrero, Sixto; Carretero, Jose			Dopamine Modulates Insulin Release and Is Involved in the Survival of Rat Pancreatic Beta Cells	PLOS ONE			English	Article							IN-VITRO; PARKINSONS-DISEASE; KNOCKOUT MICE; SECRETION; INHIBITION; APOPTOSIS; GLUCOSE; TYPE-2; ACTIVATION; RECEPTORS	The local synthesis of dopamine and its effects on insulin release have been described in isolated islets. Thus, it may be accepted that dopamine exerts an auto-paracrine regulation of insulin secretion from pancreatic beta cells. The aim of the present study is to analyze whether dopamine is a regulator of the proliferation and apoptosis of rat pancreatic beta cells after glucose-stimulated insulin secretion. Glucose stimulated pancreatic islets obtained from male Wistar rats were cultured with 1 or 10 mu M dopamine from 1 to 12 h. Insulin secretion was analyzed by RIA. The cellular proliferation rate of pancreatic islets and beta cells was studied with immunocytochemical double labelling for both insulin and PCNA (proliferating cell nuclear antigen), and active caspase-3 was detected to evaluate apoptosis. The secretion of insulin from isolated islets was significantly inhibited (p<0.01), by treatment with 1 and 10 mu M dopamine, with no differences between either dose as early as 1 h after treatment. The percentage of insulin-positive cells in the islets decreased significantly (p< 0.01) after 1 h of treatment up to 12 h. The proliferation rate of insulin-positive cells in the islets decreased significantly (p< 0.01) following treatment with dopamine. Apoptosis in pancreatic islets and beta cells was increased by treatment with 1 and 10 mu M dopamine along 12 h. In conclusion, these results suggest that dopamine could modulate the proliferation and apoptosis of pancreatic beta cells and that dopamine may be involved in the maintenance of pancreatic islets.	[Garcia Barrado, Maria Jose; Iglesias Osma, Maria Carmen; Sanchez Robledo, Virginia; Catalano Iniesta, Leonardo] Univ Salamanca, Dept Physiol & Pharmacol, Fac Med, E-37008 Salamanca, Spain; [Blanco, Enrique J.; Carretero Hernandez, Marta; Carretero, Jose] Univ Salamanca, Dept Human Anat & Histol, Fac Med, E-37008 Salamanca, Spain; [Garcia Barrado, Maria Jose; Iglesias Osma, Maria Carmen; Blanco, Enrique J.; Carrero, Sixto; Carretero, Jose] Univ Salamanca, Neuroendocrinol Lab, Inst Neurosci Castilla & Leon, E-37008 Salamanca, Spain; [Garcia Barrado, Maria Jose; Iglesias Osma, Maria Carmen; Blanco, Enrique J.; Carrero, Sixto; Carretero, Jose] Univ Salamanca, Lab Neuroendocrinol & Obes IBSAL, E-37008 Salamanca, Spain	University of Salamanca; University of Salamanca; University of Salamanca; University of Salamanca	Carretero, J (corresponding author), Univ Salamanca, Dept Human Anat & Histol, Fac Med, E-37008 Salamanca, Spain.	jcar@usal.es	Iglesias-Osma, Maria Carmen/B-1641-2013; Blanco, Enrique J/B-2243-2017; Catalano-Iniesta, Leonardo/U-7583-2019; Carretero, José J/L-6930-2014; Barrado, Maria Jose Garcia/L-4852-2014	Iglesias-Osma, Maria Carmen/0000-0002-2206-9119; Blanco, Enrique J/0000-0002-5332-4282; Catalano-Iniesta, Leonardo/0000-0003-1957-1762; Carretero, José J/0000-0003-3143-6512; Barrado, Maria Jose Garcia/0000-0003-2552-5973; Carrero Garcia, Sixto/0000-0002-1006-6615	Junta de Castilla y Leon [BIO103/SA18/11]	Junta de Castilla y Leon(Junta de Castilla y Leon)	This work was supported by Junta de Castilla y Leon grant BIO103/SA18/11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHREN B, 1985, PHARMACOLOGY, V30, P71, DOI 10.1159/000138053; ARNERIC SP, 1983, J PHARMACOL EXP THER, V224, P161; Bensellam M, 2012, MOL CELL ENDOCRINOL, V364, P1, DOI 10.1016/j.mce.2012.08.003; Radl DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018097; Bonner-Weir S, 2000, TRENDS ENDOCRIN MET, V11, P375, DOI 10.1016/S1043-2760(00)00305-2; Borelli Maria I, 2003, BMC Endocr Disord, V3, P2, DOI 10.1186/1472-6823-3-2; Borelli Maria I, 2001, BMC Endocr Disord, V1, P1, DOI 10.1186/1472-6823-1-1; Butler AE, 2003, DIABETES, V52, P2304, DOI 10.2337/diabetes.52.9.2304; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Callier S, 2003, BIOL CELL, V95, P489, DOI 10.1016/S0248-4900(03)00089-3; Carretero J, 2006, ANAT EMBRYOL, V211, P11, DOI 10.1007/s00429-005-0058-9; CARRETERO J, 1994, NEUROPEPTIDES, V27, P1, DOI 10.1016/0143-4179(94)90009-4; Chen Y, 2014, CELL TISSUE RES, V357, P597, DOI 10.1007/s00441-014-1894-9; Choi D, 2010, AM J PHYSIOL-ENDOC M, V298, pE735, DOI 10.1152/ajpendo.00696.2009; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; DEBUYSER A, 1991, MOL CELL ENDOCRINOL, V78, P179, DOI 10.1016/0303-7207(91)90121-8; DRIVER JA, 2008, DIABETES CARE, V31, P2003, DOI [DOI 10.2337/DC08-0688, DOI 10.2337/dc08-0688]; ERICSON LE, 1977, DIABETOLOGIA, V13, P117, DOI 10.1007/BF00745138; Fleenor DE, 2001, ENDOCRINOLOGY, V142, P2805, DOI 10.1210/en.142.7.2805; Garcia-Barrado MJ, 2001, ENDOCRINOLOGY, V142, P299, DOI 10.1210/en.142.1.299; Garcia-Tornadu I, 2010, NEUROENDOCRINOLOGY, V92, P207, DOI 10.1159/000321395; Garcia-Tornadu I, 2010, ENDOCRINOLOGY, V151, P1441, DOI 10.1210/en.2009-0996; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Iwatsubo K, 2007, AM J PHYSIOL-CELL PH, V293, pC1498, DOI 10.1152/ajpcell.00088.2007; Jetton TL, 2001, METABOLISM, V50, P1377, DOI 10.1053/meta.2001.26741; Jiang JL, 2007, J NEUROIMMUNOL, V192, P79, DOI 10.1016/j.jneuroim.2007.09.012; Jonas JC, 1999, J BIOL CHEM, V274, P14112, DOI 10.1074/jbc.274.20.14112; Kitamura T, 1999, MOL CELL BIOL, V19, P6286; Kvist-Reimer M, 2002, CELL TISSUE RES, V307, P203, DOI 10.1007/s00441-001-0496-5; Los M, 1999, IMMUNITY, V10, P629, DOI 10.1016/S1074-7613(00)80062-X; MILBURN JL, 1995, J BIOL CHEM, V270, P1295, DOI 10.1074/jbc.270.3.1295; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Peterhoff M, 2003, EUR J ENDOCRINOL, V149, P343, DOI 10.1530/eje.0.1490343; Putinski C, 2013, P NATL ACAD SCI USA, V110, pE4079, DOI 10.1073/pnas.1315587110; Raffo A, 2008, J ENDOCRINOL, V198, P41, DOI 10.1677/JOE-07-0632; ROSATI G, 1976, EUR NEUROL, V14, P229, DOI 10.1159/000114744; Rubi B, 2005, J BIOL CHEM, V280, P36824, DOI 10.1074/jbc.M505560200; RUFFOLO RR, 1991, LIFE SCI, V49, P171, DOI 10.1016/0024-3205(91)90001-R; Sakano D, 2014, NAT CHEM BIOL, V10, P141, DOI 10.1038/nchembio.1410; Shankar E, 2006, IUBMB LIFE, V58, P157, DOI 10.1080/15216540600687993; Simpson N, 2012, MOL ENDOCRINOL, V26, P1757, DOI 10.1210/me.2012-1101; Szollosi A, 2010, BRIT J PHARMACOL, V159, P669, DOI 10.1111/j.1476-5381.2009.00588.x; Ustione A, 2013, MOL ENDOCRINOL, V27, P1198, DOI 10.1210/me.2013-1083; Ustione A, 2012, MOL ENDOCRINOL, V26, P1928, DOI 10.1210/me.2012-1226; Van de Casteele M, 2003, BIOCHEM BIOPH RES CO, V312, P937, DOI 10.1016/j.bbrc.2003.11.013; van Weenen JED, 2010, BIOCHEM PHARMACOL, V79, P1827, DOI 10.1016/j.bcp.2010.01.029; Vazquez P, 2014, DIABETOLOGIA, V57, P2339, DOI 10.1007/s00125-014-3341-6; Weir GC, 2009, DIABETES OBES METAB, V11, P82, DOI 10.1111/j.1463-1326.2009.01113.x; ZERN RT, 1980, DIABETOLOGIA, V18, P341	49	20	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123197	10.1371/journal.pone.0123197	http://dx.doi.org/10.1371/journal.pone.0123197			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886074	Green Published, gold, Green Submitted			2022-12-26	WOS:000353017000050
J	Vieira, AR; Gibson, CW; Deeley, K; Xue, H; Li, Y				Vieira, Alexandre R.; Gibson, Carolyn W.; Deeley, Kathleen; Xue, Hui; Li, Yong			Weaker Dental Enamel Explains Dental Decay	PLOS ONE			English	Article							HIGH CARIES EXPERIENCE; AMELOGENIN; ASSOCIATION; RELEASE; ABSCESS; RESCUE; GENES; AMELX; MICE	Dental caries continues to be the most prevalent bacteria-mediated non-contagious disease of humankind. Dental professionals assert the disease can be explained by poor oral hygiene and a diet rich in sugars but this does not account for caries free individuals exposed to the same risk factors. In order to test the hypothesis that amount of amelogenin during enamel development can influence caries susceptibility, we generated multiple strains of mice with varying levels of available amelogenin during dental development. Mechanical tests showed that dental enamel developed with less amelogenin is "weaker" while the dental enamel of animals over-expressing amelogenin appears to be more resistant to acid dissolution.	[Vieira, Alexandre R.; Deeley, Kathleen] Univ Pittsburgh, Sch Dent Med, Dept Oral Biol, Pittsburgh, PA 15260 USA; [Gibson, Carolyn W.; Xue, Hui; Li, Yong] Univ Penn, Sch Dent Med, Dept Anat & Cell Biol, Philadelphia, PA 19104 USA; [Xue, Hui] Fourth Mil Med Univ, Sch Stomatol, Dept Orthodont, Xian 710032, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Pennsylvania; Air Force Military Medical University	Vieira, AR (corresponding author), Univ Pittsburgh, Sch Dent Med, Dept Oral Biol, Pittsburgh, PA 15260 USA.	arv11@pitt.edu			NIH/National Institute of Dental and Craniofacial Research [R01-DE18914]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018914] Funding Source: NIH RePORTER	NIH/National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Support was provided by the NIH/National Institute of Dental and Craniofacial Research R01-DE18914. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahovuo-Saloranta A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001830.pub4; ALDOUS JA, 1987, J AM DENT ASSOC, V115, P861, DOI 10.1016/S0002-8177(87)56011-1; BADDOUR HM, 1979, ORAL SURG ORAL MED O, V47, P303, DOI 10.1016/0030-4220(79)90250-0; BORAAS JC, 1988, J DENT RES, V67, P1150, DOI 10.1177/00220345880670090201; Chaussain C, 2014, J DENT RES, V93, P360, DOI 10.1177/0022034514522060; CONRY JP, 1993, ARCH ORAL BIOL, V38, P937, DOI 10.1016/0003-9969(93)90106-V; Deeley K, 2008, CARIES RES, V42, P8, DOI 10.1159/000111744; FERNANDO IN, 1988, BRIT DENT J, V165, P220, DOI 10.1038/sj.bdj.4806573; Fukushima K, 2012, INTERNAL MED, V51, P3073, DOI 10.2169/internalmedicine.51.7962; Gasse B, 2013, J DENT RES, V92, P418, DOI 10.1177/0022034513482941; Gibson CW, 2007, J DENT RES, V86, P331, DOI 10.1177/154405910708600406; Gibson CW, 2011, EUR J ORAL SCI, V119, P70, DOI 10.1111/j.1600-0722.2011.00882.x; Gibson CW, 2001, J BIOL CHEM, V276, P31871, DOI 10.1074/jbc.M104624200; Hunt H. R., 1944, JOUR DENTAL RES, V23, P385, DOI 10.1177/00220345440230051101; Jackson SL, 2011, AM J PUBLIC HEALTH, V101, P1900, DOI 10.2105/AJPH.2010.200915; Jeremias F, 2013, ARCH ORAL BIOL, V58, P1434, DOI 10.1016/j.archoralbio.2013.05.005; Kang SW, 2011, ORAL DIS, V17, P399, DOI 10.1111/j.1601-0825.2010.01766.x; Klein H, 1940, MILBANK MEML FUND Q, V18, P67, DOI 10.2307/3347653; Li Y, 2008, J BIOL CHEM, V283, P15056, DOI 10.1074/jbc.M707992200; Meyer-Lueckel H, 2012, CARIES RES, V46, P544, DOI 10.1159/000341807; Modesto A, 1997, AM J DENT, V10, P123; Moynihan PJ, 2014, J DENT RES, V93, P8, DOI 10.1177/0022034513508954; Nariyama M, 2004, CARIES RES, V38, P79, DOI 10.1159/000075929; Page LAF, 2013, EUR J ORAL SCI, V121, P182, DOI 10.1111/eos.12034; Patir A, 2008, CARIES RES, V42, P394, DOI 10.1159/000154785; Queiroz Celso Silva, 2008, Braz. Dent. J., V19, P21, DOI 10.1590/S0103-64402008000100004; Shanmugam KT, 2013, J CLIN DIAGN RES, V7, P1250, DOI 10.7860/JCDR/2013/5246.3053; Shimizu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045022; Silva KG, 2010, ACTA ODONTOL SCAND, V68, P11, DOI 10.3109/00016350903260264; Slade GD, 2013, J DENT RES, V92, P376, DOI 10.1177/0022034513481190; Slayton RL, 2005, J DENT RES, V84, P711, DOI 10.1177/154405910508400805; VALLEE L, 1994, ARCH PEDIATRIE, V1, P166; Vieira AR, 1999, AM J DENT, V12, P14; Vieira AR, 1999, REV ODONTOL U S PAUL, V13, P321; WHO, 2003, WHO TECH REP SER, V916, P1; Wright JT, 2006, AM J MED GENET A, V140A, P2547, DOI 10.1002/ajmg.a.31358; Yee R, 2002, INT DENT J, V52, P1; Zachariades N, 2005, ORAL SURG ORAL MED O, V100, P70, DOI DOI 10.1016/J.TRIPLE0.2005.02.062.PMID:16182155	38	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124236	10.1371/journal.pone.0124236	http://dx.doi.org/10.1371/journal.pone.0124236			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885796	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000353017000108
J	Min, KW; Liggett, JL; Silva, G; Wu, WW; Wang, R; Shen, RF; Eling, TE; Baek, SJ				Min, K-W; Liggett, J. L.; Silva, G.; Wu, W. W.; Wang, R.; Shen, R-F; Eling, T. E.; Baek, S. J.			NAG-1/GDF15 accumulates in the nucleus and modulates transcriptional regulation of the Smad pathway	ONCOGENE			English	Article							BETA SUPERFAMILY MEMBER; GROWTH-FACTOR-BETA; ACTIVATED GENE NAG-1; CELL-GROWTH; MOUSE MODEL; EXPRESSION; RECEPTOR; LOCALIZATION; APOPTOSIS; PROTEINS	Protein dynamics, modifications and trafficking are all processes that can modulate protein activity. Accumulating evidence strongly suggests that many proteins have distinctive roles dependent on cellular location. Nonsteroidal anti-inflammatory drug-activated gene-1 (NAG-1) is a transforming growth factor-beta (TGF-beta) superfamily protein that has a role in cancer, obesity and inflammation. NAG-1 is synthesized and cleaved into a mature peptide, which is ultimately secreted into the extracellular matrix (ECM). In this study, we have found that full-length NAG-1 is expressed in not only the cytoplasm and ECM, but also in the nucleus. NAG-1 is dynamically moved to the nucleus, exported into cytoplasm and further transported into the ECM. We have also found that nuclear NAG-1 contributes to inhibition of the Smad pathway by interrupting the Smad complex. Overall, our study indicates that NAG-1 is localized in the nucleus and provides new evidence that NAG-1 controls transcriptional regulation in the Smad pathway.	[Min, K-W; Liggett, J. L.; Silva, G.; Baek, S. J.] Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, 2407 River Dr, Knoxville, TN 37996 USA; [Wu, W. W.; Wang, R.; Shen, R-F] US FDA, CBER, Facil Biotechnol Resources, Bethesda, MD 20014 USA; [Eling, T. E.] NIEHS, Mol Carcinogenesis Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Min, K-W] Med Univ S Carolina, Dept Cell & Mol Pharmacol, Charleston, SC 29425 USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Medical University of South Carolina	Baek, SJ (corresponding author), Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, 2407 River Dr, Knoxville, TN 37996 USA.	sbaek2@utk.edu	Silva, Gabriel/D-7731-2017	Silva, Gabriel/0000-0002-5660-9769; Min, Kyung-Won/0000-0002-8718-3588	National Institutes of Health [R01CA108975]; Center of Excellence in Livestock Diseases and Human Health, University of Tennessee; CAPES Foundation, Brazil [BEX 3159/14-0]; NIH, NIEHS Intramural Research Program [Z01-ES010016-14]; NATIONAL CANCER INSTITUTE [R01CA108975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES010016] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center of Excellence in Livestock Diseases and Human Health, University of Tennessee; CAPES Foundation, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NIH, NIEHS Intramural Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Dr Xingya Wang (College of Pharmaceutical Science, Zhejiang Chinese Medical University, China) and Ms Misty Bailey (University of Tennessee) for their critical reading of the manuscript. We also thank Dr John Dunlap (Advanced Microscopy and Imaging Center at The University of Tennessee) for providing technical help on confocal microscopy. This work was supported by the National Institutes of Health (R01CA108975), and the Center of Excellence in Livestock Diseases and Human Health, University of Tennessee, to SJB and a grant (BEX 3159/14-0) from the CAPES Foundation, Brazil (GS). This research was also supported, in part, by the NIH, NIEHS Intramural Research Program (TEE) Z01-ES010016-14.	Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Albertoni M, 2002, ONCOGENE, V21, P4212, DOI 10.1038/sj.onc.1205610; Baek SJ, 2006, GASTROENTEROLOGY, V131, P1553, DOI 10.1053/j.gastro.2006.09.015; Baek SJ, 2006, PROG LIPID RES, V45, P1, DOI 10.1016/j.plipres.2005.10.001; Baek SJ, 2004, CARCINOGENESIS, V25, P2425, DOI 10.1093/carcin/bgh255; Baek SJ, 2004, J BIOL CHEM, V279, P6883, DOI 10.1074/jbc.M305295200; Baek SJ, 2003, J BIOL CHEM, V278, P5845, DOI 10.1074/jbc.M208394200; Baek SJ, 2002, J PHARMACOL EXP THER, V301, P1126, DOI 10.1124/jpet.301.3.1126; Baek SJ, 2002, CARCINOGENESIS, V23, P425, DOI 10.1093/carcin/23.3.425; Baek SJ, 2001, J BIOL CHEM, V276, P33384, DOI 10.1074/jbc.M101814200; Baek SJ, 2001, MOL PHARMACOL, V59, P901, DOI 10.1124/mol.59.4.901; Baron V, 2006, CANCER GENE THER, V13, P115, DOI 10.1038/sj.cgt.7700896; Bauskin AR, 2005, CANCER RES, V65, P2330, DOI 10.1158/0008-5472.CAN-04-3827; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Bottner M, 1999, GENE, V237, P105, DOI 10.1016/S0378-1119(99)00309-1; Cekanova M, 2009, CANCER PREV RES, V2, P450, DOI 10.1158/1940-6207.CAPR-09-0057; Chan CP, 2010, J CELL SCI, V123, P1438, DOI 10.1242/jcs.067819; Chintharlapalli S, 2005, MOL PHARMACOL, V68, P1782, DOI 10.1124/mol.105.017046; Chrysovergis K, 2014, INT J OBESITY, V38, P1555, DOI 10.1038/ijo.2014.27; Felin JE, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-20; Gitenay D, 2009, FUTURE ONCOL, V5, P993, DOI 10.2217/FON.09.67; Hromas R, 1997, BBA-GENE STRUCT EXPR, V1354, P40, DOI 10.1016/S0167-4781(97)00122-X; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Inui M, 2011, NAT CELL BIOL, V13, P1368, DOI 10.1038/ncb2346; Janknecht R, 1998, GENE DEV, V12, P2114, DOI 10.1101/gad.12.14.2114; Johnen H, 2012, CARDIOVASC PATHOL, V21, P499, DOI 10.1016/j.carpath.2012.02.003; Joshi JP, 2011, BIOCHEM PHARMACOL, V82, P1090, DOI 10.1016/j.bcp.2011.07.082; Kim JM, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/641851; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kuo TF, 2011, FEBS J, V278, P4756, DOI 10.1111/j.1742-4658.2011.08409.x; L/nn P, 2010, MOL CELL, V40, P521; Lee HK, 2010, J CELL BIOCHEM, V111, P755, DOI 10.1002/jcb.22766; Lee SH, 2008, MOL CARCINOGEN, V47, P197, DOI 10.1002/mc.20374; Lee SH, 2008, MOL CANCER THER, V7, P3739, DOI 10.1158/1535-7163.MCT-08-0548; Lee SH, 2006, CARCINOGENESIS, V27, P972, DOI 10.1093/carcin/bgi268; Lee SH, 2005, BIOCHEM BIOPH RES CO, V328, P63, DOI 10.1016/j.bbrc.2004.12.138; Li PX, 2000, J BIOL CHEM, V275, P20127, DOI 10.1074/jbc.M909580199; Lindeman GJ, 1997, P NATL ACAD SCI USA, V94, P5095, DOI 10.1073/pnas.94.10.5095; Macia L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034868; Marchant DJ, 2014, NAT MED, V20, P497, DOI 10.1038/nm.3508; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Min KW, 2012, TOXICOL APPL PHARM, V263, P225, DOI 10.1016/j.taap.2012.06.014; Nguyen BA, 2009, BMC BIOINFORMATICS, V10, P202, DOI [10.1186/1471-2105-10-202, DOI 10.1186/1471-2105-10-202]; Paralkar VM, 1998, J BIOL CHEM, V273, P13760, DOI 10.1074/jbc.273.22.13760; Pierreux CE, 2000, MOL CELL BIOL, V20, P9041, DOI 10.1128/MCB.20.23.9041-9054.2000; Planque Nathalie, 2006, Cell Commun Signal, V4, P7, DOI 10.1186/1478-811X-4-7; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Shappell SB, 2003, CANCER RES, V63, P2256; Sharma M, 2012, J BIOL CHEM, V287, P819, DOI 10.1074/jbc.M111.299099; Shim M, 2005, J BIOL CHEM, V280, P18636, DOI 10.1074/jbc.M414613200; Shureiqi I, 2001, CANCER RES, V61, P6307; Sirover MA, 2012, J CELL BIOCHEM, V113, P2193, DOI 10.1002/jcb.24113; Tan MJ, 2000, P NATL ACAD SCI USA, V97, P109, DOI 10.1073/pnas.97.1.109; Theodore M, 2008, J BIOL CHEM, V283, P8984, DOI 10.1074/jbc.M709040200; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Turner JG, 2012, BIOCHEM PHARMACOL, V83, P1021, DOI 10.1016/j.bcp.2011.12.016; Waldmann I, 2007, J BIOL CHEM, V282, P27685, DOI 10.1074/jbc.M703301200; Wang XY, 2013, BIOCHEM PHARMACOL, V85, P597, DOI 10.1016/j.bcp.2012.11.025; Wang YN, 2010, J BIOL CHEM, V285, P38720, DOI 10.1074/jbc.M110.158659; Xu J, 2006, CIRC RES, V98, P342, DOI 10.1161/01.RES.0000202804.84885.d0; Yamaguchi K, 2004, J BIOL CHEM, V279, P49617, DOI 10.1074/jbc.M408796200; Yamaguchi K, 2008, MOL CANCER THER, V7, P2779, DOI 10.1158/1535-7163.MCT-08-0173; Yang MH, 2014, LIFE SCI, V100, P75, DOI 10.1016/j.lfs.2014.01.075; Zimmers TA, 2005, SHOCK, V23, P543, DOI 10.1097/01.shk.0000163393.55350.70; Zimmers TA, 2010, J CANCER RES CLIN, V136, P571, DOI 10.1007/s00432-009-0691-4	68	49	50	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 21	2016	35	3					377	388		10.1038/onc.2015.95	http://dx.doi.org/10.1038/onc.2015.95			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DC2OF	25893289	Green Accepted			2022-12-26	WOS:000369055300011
J	Hernandez-Guillamon, M; Mawhirt, S; Blais, S; Montaner, J; Neubert, TA; Rostagno, A; Ghiso, J				Hernandez-Guillamon, Mar; Mawhirt, Stephanie; Blais, Steven; Montaner, Joan; Neubert, Thomas A.; Rostagno, Agueda; Ghiso, Jorge			Sequential Amyloid-beta Degradation by the Matrix Metalloproteases MMP-2 and MMP-9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-BRAIN-BARRIER; SPONTANEOUS INTRACEREBRAL HEMORRHAGE; ALZHEIMERS-DISEASE; A-BETA; DEGRADING ENZYMES; MASS-SPECTROMETRY; FIBRIL FORMATION; COMPACT PLAQUES; MATRIX-METALLOPROTEINASE-9; PEPTIDE	Matrix metalloproteases (MMPs) MMP-2 and MMP-9 have been implicated in the physiological catabolism of Alzheimer's amyloid-beta (A beta). Conversely, their association with vascular amyloid deposits, blood-brain barrier disruption, and hemorrhagic transformations after ischemic stroke also highlights their involvement in pathological processes. To better understand this dichotomy, recombinant human (rh) MMP-2 and MMP-9 were incubated with A beta 40 and A beta 42, and the resulting proteolytic fragments were assessed via immunoprecipitation and quantitative mass spectrometry. Both MMPs generated A beta fragments truncated only at the C terminus, ending at positions 34, 30, and 16. Using deuterated homologues as internal standards, we observed limited and relatively slow degradation of A beta 42 by rhMMP-2, although the enzyme cleaved >80% of A beta 40 during the 1st h of incubation. rhMMP-9 was significantly less effective, particularly in degrading A beta(1-42), although the targeted peptide bonds were identical. Using A beta(1-34) and A beta(1-30), we demonstrated that these peptides are also substrates for both MMPs, cleaving A beta(1-34) to produce A beta(1-30) first and A beta(1-16) subsequently. Consistent with the kinetics observed with full-length A beta, rhMMP-9 degraded only a minute fraction of A beta(1-34) and was even less effective in producing A beta(1-16). Further degradation of A beta(1-16) by either MMP-2 or MMP-9 was not observed even after prolonged incubation times. Notably, all MMP-generated C-terminally truncated A beta fragments were highly soluble and did not exhibit fibrillogenic properties or induce cytotoxicity in human cerebral microvascular endothelial or neuronal cells supporting the notion that these truncated A beta species are associated with clearance mechanisms rather than being key elements in the fibrillogenesis process.	[Hernandez-Guillamon, Mar; Mawhirt, Stephanie; Rostagno, Agueda; Ghiso, Jorge] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Ghiso, Jorge] NYU, Sch Med, Dept Psychiat, New York, NY 10016 USA; [Blais, Steven; Neubert, Thomas A.] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA; [Hernandez-Guillamon, Mar; Montaner, Joan] Inst Recerca, Neurovasc Res Lab, Barcelona 08035, Spain; [Blais, Steven; Neubert, Thomas A.] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA; [Montaner, Joan] Univ Autonoma Barcelona, Vall dHebron Hosp, Neurol & Med Dept, Neurovasc Unit, Barcelona 08035, Spain	New York University; New York University; New York University; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); New York University; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron	Ghiso, J (corresponding author), NYU, Sch Med, 550 First Ave,MSB 556, New York, NY 10016 USA.	jorge.ghiso@nyumc.org	Regan, Clinton/E-6250-2012; Montaner, Joan/D-3063-2015	Montaner, Joan/0000-0003-4845-2279; Rostagno, Agueda/0000-0002-6817-2074; Hernandez Guillamon, Maria Mar/0000-0001-8844-0091; neubert, Thomas/0000-0001-7049-2088	National Institutes of Health [AG030539, NS051715, P30 NS050276, U24 CA126485]; Alzheimer's Association; NATIONAL CANCER INSTITUTE [U24CA126485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS050276, R01NS051715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG030539, NS051715, P30 NS050276, and U24 CA126485. This work was also supported by the Alzheimer's Association.	Abilleira S, 2003, J NEUROSURG, V99, P65, DOI 10.3171/jns.2003.99.1.0065; Alvarez-Sabin J, 2004, STROKE, V35, P1316, DOI 10.1161/01.STR.0000126827.69286.90; Aureli L, 2008, CURR MED CHEM, V15, P2192, DOI 10.2174/092986708785747490; Backstrom JR, 1996, J NEUROSCI, V16, P7910; Randall JB, 2006, NAT MED, V12, P856, DOI 10.1038/nm1438; Calero M, 2012, METHODS MOL BIOL, V849, P213, DOI 10.1007/978-1-61779-551-0_15; Chen EI, 2002, J BIOL CHEM, V277, P4485, DOI 10.1074/jbc.M109469200; Crouch PJ, 2009, J NEUROCHEM, V108, P1198, DOI 10.1111/j.1471-4159.2009.05870.x; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; Deb S, 2003, BRAIN RES, V970, P205, DOI 10.1016/S0006-8993(03)02344-8; Deb S, 1996, J NEUROCHEM, V66, P1641; Endres K, 2012, EXP BRAIN RES, V217, P343, DOI 10.1007/s00221-011-2885-7; Fossati S, 2010, FASEB J, V24, P229, DOI 10.1096/fj.09-139584; Fossati S, 2013, BIOCHEM J, V456, P347, DOI 10.1042/BJ20130652; Ghiso J, 2002, ADV DRUG DELIVER REV, V54, P1539, DOI 10.1016/S0169-409X(02)00149-7; Ghiso JA, 2001, J BIOL CHEM, V276, P43909, DOI 10.1074/jbc.M105956200; Gorbenko GP, 2006, CHEM PHYS LIPIDS, V141, P72, DOI 10.1016/j.chemphyslip.2006.02.006; Hampel H, 2010, EXP NEUROL, V223, P334, DOI 10.1016/j.expneurol.2009.09.024; Hernandez-Guillamon M, 2012, BRAIN PATHOL, V22, P133, DOI 10.1111/j.1750-3639.2011.00512.x; Hernandez-Guillamon M, 2010, J BIOL CHEM, V285, P27144, DOI 10.1074/jbc.M110.135228; Kheterpal I, 2006, J MOL BIOL, V361, P785, DOI 10.1016/j.jmb.2006.06.066; KNIGHT CG, 1992, FEBS LETT, V296, P263, DOI 10.1016/0014-5793(92)80300-6; Kridel SJ, 2001, J BIOL CHEM, V276, P20572, DOI 10.1074/jbc.M100900200; Lee JM, 2005, J NEUROL SCI, V229, P249, DOI 10.1016/j.jns.2004.11.041; Liu J, 2012, J NEUROSCI, V32, P3044, DOI 10.1523/JNEUROSCI.6409-11.2012; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; McLaurin J, 2000, J STRUCT BIOL, V130, P259, DOI 10.1006/jsbi.2000.4289; Miners JS, 2008, BRAIN PATHOL, V18, P240, DOI 10.1111/j.1750-3639.2008.00132.x; Miners JS, 2011, J NEUROPATH EXP NEUR, V70, P944, DOI 10.1097/NEN.0b013e3182345e46; Montaner J, 2003, CIRCULATION, V107, P598, DOI 10.1161/01.CIR.0000046451.38849.90; Morelli L, 2002, NEUROCHEM RES, V27, P1387, DOI 10.1023/A:1021679817756; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Obici L, 2005, ANN NEUROL, V58, P639, DOI 10.1002/ana.20571; Portelius E, 2006, J PROTEOME RES, V5, P1010, DOI 10.1021/pr050475v; Portelius E, 2008, EXPERT REV PROTEOMIC, V5, P225, DOI 10.1586/14789450.5.2.225; ROHER AE, 1994, BIOCHEM BIOPH RES CO, V205, P1755, DOI 10.1006/bbrc.1994.2872; ROSENBERG GA, 1993, NEUROSCI LETT, V160, P117, DOI 10.1016/0304-3940(93)90927-D; ROSENBERG GA, 1990, STROKE, V21, P801, DOI 10.1161/01.STR.21.5.801; ROSENBERG GA, 1992, BRAIN RES, V576, P203, DOI 10.1016/0006-8993(92)90681-X; Rosenberg GA, 1995, BRAIN RES, V703, P151, DOI 10.1016/0006-8993(95)01089-0; Rosenberg GA, 2009, LANCET NEUROL, V8, P205, DOI 10.1016/S1474-4422(09)70016-X; Rostagno A, 2010, CELL MOL LIFE SCI, V67, P581, DOI 10.1007/s00018-009-0182-4; Rostagno A., 2009, CURR PROTOC CELL BIO, V3; Sbardella D, 2012, MOL ASPECTS MED, V33, P119, DOI 10.1016/j.mam.2011.10.015; Sekhon BS, 2010, RES REP BIOL, V1, P1, DOI 10.2147/RRB.S12043; Tomidokoro Y, 2005, J BIOL CHEM, V280, P36883, DOI 10.1074/jbc.M504038200; Tomidokoro Y, 2010, AM J PATHOL, V176, P1841, DOI 10.2353/ajpath.2010.090636; Vardy ERLC, 2005, TRENDS MOL MED, V11, P464, DOI 10.1016/j.molmed.2005.08.004; Wang YJ, 2006, DRUG DISCOV TODAY, V11, P931, DOI 10.1016/j.drudis.2006.08.004; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Yan P, 2006, J BIOL CHEM, V281, P24566, DOI 10.1074/jbc.M602440200; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Yin KJ, 2006, J NEUROSCI, V26, P10939, DOI 10.1523/JNEUROSCI.2085-06.2006	53	74	76	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15078	15091		10.1074/jbc.M114.610931	http://dx.doi.org/10.1074/jbc.M114.610931			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25897080	hybrid, Green Published			2022-12-26	WOS:000356177300023
J	Alvarez-Clare, S; Mack, MC				Alvarez-Clare, Silvia; Mack, Michelle C.			Do Foliar, Litter, and Root Nitrogen and Phosphorus Concentrations Reflect Nutrient Limitation in a Lowland Tropical Wet Forest?	PLOS ONE			English	Article							NET PRIMARY PRODUCTIVITY; N-P STOICHIOMETRY; RAIN-FOREST; AMAZONIAN FORESTS; GROWTH; AVAILABILITY; RESPONSES; PATTERNS; RESORPTION; RATIOS	Understanding nutrient limitation of net primary productivity (NPP) is critical to predict how plant communities will respond to environmental change. Foliar nutrients, especially nitrogen and phosphorus concentrations ([N] and [P]) and their ratio, have been used widely as indicators of plant nutritional status and have been linked directly to nutrient limitation of NPP. In tropical systems, however, a high number of confounding factors can limit the ability to predict nutrient limitation-as defined mechanistically by NPP responses to fertilization-based on the stoichiometric signal of the plant community. We used a long-term full factorial N and P fertilization experiment in a lowland tropical wet forest in Costa Rica to explore how tissue (foliar, litter and root) [N] and [P] changed with fertilization, how different tree size classes and taxa influenced the community response, and how tissue nutrients related to NPP. Consistent with NPP responses to fertilization, there were no changes in community-wide foliar [N] and [P], two years after fertilization. Nevertheless, litterfall [N] increased with N additions and root [P] increased with P additions. The most common tree species (Pentaclethra macroloba) had 9% higher mean foliar [N] with NP additions and the most common palm species (Socratea exohrriza) had 15% and 19% higher mean foliar [P] with P and NP additions, respectively. Moreover, N:P ratios were not indicative of NPP responses to fertilization, either at the community or at the taxa level. Our study suggests that in these diverse tropical forests, tissue [N] and [P] are driven by the interaction of multiple factors and are not always indicative of the nutritional status of the plant community.	[Alvarez-Clare, Silvia; Mack, Michelle C.] Univ Florida, Sch Nat Resources & Environm, Dept Biol, Gainesville, FL USA	State University System of Florida; University of Florida	Alvarez-Clare, S (corresponding author), North Cent Coll, Dept Biol, Naperville, IL 60540 USA.	smalvarezclare@noctrl.edu			Doctoral Dissertation Enhancement Project grant from the National Science Foundation [0840298]	Doctoral Dissertation Enhancement Project grant from the National Science Foundation	This study was funded by a Doctoral Dissertation Enhancement Project grant (#0840298) from the National Science Foundation to MCM and SAC which was received between 2008 and 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren GI, 2004, ECOL LETT, V7, P185, DOI 10.1111/j.1461-0248.2004.00567.x; Agren GI, 2008, ANNU REV ECOL EVOL S, V39, P153, DOI 10.1146/annurev.ecolsys.39.110707.173515; Alvarez Clare S, 2012, THESIS U FLORIDA GAI; Alvarez-Clare S, 2013, ECOLOGY, V94, P1540, DOI 10.1890/12-2128.1; Andersen KM, 2010, FUNCT ECOL, V24, P1171, DOI 10.1111/j.1365-2435.2010.01731.x; Bonan GB, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042430; Campo J, 2003, J TROP ECOL, V19, P525, DOI 10.1017/S0266467403003572; CHAPIN FS, 1986, AM NAT, V127, P48, DOI 10.1086/284466; Clark DA, 2001, ECOL APPL, V11, P356, DOI 10.1890/1051-0761(2001)011[0356:MNPPIF]2.0.CO;2; Cleveland CC, 2011, ECOL LETT, V14, P939, DOI 10.1111/j.1461-0248.2011.01658.x; CUEVAS E, 1988, OECOLOGIA, V76, P222, DOI 10.1007/BF00379956; Davidson EA, 2004, ECOL APPL, V14, pS150; Davidson EA, 2007, NATURE, V447, P995, DOI 10.1038/nature05900; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; GENTRY AH, 1988, ANN MO BOT GARD, V75, P1, DOI 10.2307/2399464; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Hattenschwiler S, 2008, NEW PHYTOL, V179, P165, DOI 10.1111/j.1469-8137.2008.02438.x; Harrington RA, 2001, ECOSYSTEMS, V4, P646, DOI 10.1007/s10021-001-0034-z; Hartshorn G, 1983, COSTA RICAN NATURAL; Hartshorn G.S., 1994, SELVA ECOLOGY NATURA; Hedin LO, 2004, P NATL ACAD SCI USA, V101, P10849, DOI 10.1073/pnas.0404222101; HENDERSON A, 1995, FIELD GUIDE PALMS AM; HERBERT DA, 1995, BIOGEOCHEMISTRY, V29, P223, DOI 10.1007/BF02186049; Hidaka A, 2011, J ECOL, V99, P849, DOI 10.1111/j.1365-2745.2011.01805.x; Huberty AF, 2006, OECOLOGIA, V149, P444, DOI 10.1007/s00442-006-0462-8; Jones JB, 1996, METHODS SOIL ANAL 3, P389; Kaspari M, 2008, ECOL LETT, V11, P35, DOI 10.1111/j.1461-0248.2007.01124.x; Kerkhoff AJ, 2006, AM NAT, V168, pE103, DOI 10.1086/507879; Kobe RK, 2005, ECOLOGY, V86, P2780, DOI 10.1890/04-1830; Koerselman W, 1996, J APPL ECOL, V33, P1441, DOI 10.2307/2404783; Kuo S, 1996, METHODS SOIL ANAL PA, V5, P869, DOI [10.2136/sssabookser5.3.c32, DOI 10.2136/SSSABOOKSER5.3.C32]; Lambers H., 2008, PLANT PHYSL ECOLOGY, DOI DOI 10.1007/978-0-387-78341-3_9; Mayor JR, 2014, J ECOL, V102, P36, DOI 10.1111/1365-2745.12190; MCDADE L. A., 1994, SELVA ECOLOGY NATURA; McGroddy ME, 2004, ECOLOGY, V85, P2390, DOI 10.1890/03-0351; MELILLO JM, 1993, NATURE, V363, P234, DOI 10.1038/363234a0; Mirmanto E, 1999, PHILOS T ROY SOC B, V354, P1825, DOI 10.1098/rstb.1999.0524; Ostertag R, 2001, ECOLOGY, V82, P485, DOI 10.1890/0012-9658(2001)082[0485:EONAPA]2.0.CO;2; Ostertag R, 2010, PLANT SOIL, V334, P85, DOI 10.1007/s11104-010-0281-x; Reed SC, 2011, BIOGEOCHEMISTRY, V106, P323, DOI 10.1007/s10533-010-9522-6; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; Reich PB, 2008, ECOL LETT, V11, P793, DOI 10.1111/j.1461-0248.2008.01185.x; Sancho F, 1990, ESTUDIO SUELOS FINCA; Santiago LS, 2012, J ECOL, V100, P309, DOI 10.1111/j.1365-2745.2011.01904.x; Schreeg LA, 2014, ECOLOGY, V95, P2062, DOI 10.1890/13-1671.1; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Sullivan BW, 2014, ECOLOGY, V95, P668, DOI 10.1890/13-0825.1; Tanner EVJ, 1998, ECOLOGY, V79, P10, DOI 10.1890/0012-9658(1998)079[0010:EIONLO]2.0.CO;2; Thornton PE, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002868; Townsend AR, 2007, ECOLOGY, V88, P107, DOI 10.1890/0012-9658(2007)88[107:COFNRI]2.0.CO;2; Tully KL, 2013, ECOLOGY, V94, P930, DOI 10.1890/12-0781.1; van der Ploeg RR, 1999, SOIL SCI SOC AM J, V63, P1055, DOI 10.2136/sssaj1999.6351055x; Vergutz L, 2012, ECOL MONOGR, V82, P205, DOI 10.1890/11-0416.1; Vitousek, 2004, NUTR CYCLING LIMITAT; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; Vitousek PM, 1997, BIOGEOCHEMISTRY, V37, P63, DOI 10.1023/A:1005757218475; Wood TE, 2009, ECOLOGY, V90, P109, DOI 10.1890/07-1146.1; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright SJ, 2011, ECOLOGY, V92, P1616, DOI 10.1890/10-1558.1; Yuan ZY, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1346; Zar J. H., 1996, BIOSTATISTICAL ANAL	62	25	28	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123796	10.1371/journal.pone.0123796	http://dx.doi.org/10.1371/journal.pone.0123796			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901750	Green Submitted, Green Published, gold			2022-12-26	WOS:000353331500062
J	Morel, B; Rouffet, DM; Saboul, D; Rota, S; Clemencon, M; Hautier, CA				Morel, Baptiste; Rouffet, David M.; Saboul, Damien; Rota, Samuel; Clemencon, Michel; Hautier, Christophe A.			Peak Torque and Rate of Torque Development Influence on Repeated Maximal Exercise Performance: Contractile and Neural Contributions	PLOS ONE			English	Article							ELECTRICAL-STIMULATION; SHORTENING VELOCITY; PERIPHERAL FATIGUE; MUSCLE; COACTIVATION; INTERMITTENT; RESISTANCE; FREQUENCY; EXTENSION; BEHAVIOR	Rapid force production is critical to improve performance and prevent injuries. However, changes in rate of force/torque development caused by the repetition of maximal contractions have received little attention. The aim of this study was to determine the relative influence of rate of torque development (RTD) and peak torque (Tpeak) on the overall performance (i.e. mean torque, T-mean) decrease during repeated maximal contractions and to investigate the contribution of contractile and neural mechanisms to the alteration of the various mechanical variables. Eleven well-trained men performed 20 sets of 6-s isokinetic maximal knee extensions at 240 degrees.s(-1), beginning every 30 seconds. RTD, T-peak and T-mean as well as the Rate of EMG Rise (RER), peak EMG (EMG(peak)) and mean EMG (EMGmean) of the vastus lateralis were monitored for each contraction. A wavelet transform was also performed on raw EMG signal for instant mean frequency (if(mean)) calculation. A neuromuscular testing procedure was carried out before and immediately after the fatiguing protocol including evoked RTD (eRTD) and maximal evoked torque (eT(peak)) induced by high frequency doublet (100 Hz). T-mean decrease was correlated to RTD and T-peak decrease (R-2 =0.62; p<0.001; respectively beta=0.62 and beta=0.19). RER, eRTD and initial if(mean) (0-225 ms) decreased after 20 sets (respectively -21.1 +/- 14.1, -25 +/- 13%, and similar to 20%). RTD decrease was correlated to RER decrease (R-2 =0.36; p<0.05). The eT(peak) decreased significantly after 20 sets (24 +/- 5%; p<0.05) contrary to EMG(peak) (-3.2 +/- 19.5 %; p=0.71). Our results show that reductions of RTD explained part of the alterations of the overall performance during repeated moderate velocity maximal exercise. The reductions of RTD were associated to an impairment of the ability of the central nervous system to maximally activate the muscle in the first milliseconds of the contraction.	[Morel, Baptiste; Saboul, Damien; Rota, Samuel; Clemencon, Michel; Hautier, Christophe A.] Univ Lyon 1, Ctr Res & Innovat Sport, F-69622 Villeurbanne, France; [Rouffet, David M.] Victoria Univ, Inst Sport Exercise & Act Living, Melbourne, Vic 8001, Australia; [Saboul, Damien] Almerys, Clermont Ferrand, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Victoria University	Morel, B (corresponding author), Univ Lyon 1, Ctr Res & Innovat Sport, F-69622 Villeurbanne, France.	baptiste.morel@gmail.com	Morel, Baptiste/GNM-6701-2022; Rouffet, David/GLR-6007-2022	Rouffet, David/0000-0003-1105-2992; Morel, Baptiste/0000-0002-2872-6423; Clemencon, Michel/0000-0001-9495-0602; Saboul, Damien/0000-0003-1891-9077				Aagaard P, 2003, EXERC SPORT SCI REV, V31, P61, DOI 10.1097/00003677-200304000-00002; Aagaard P, 2002, J APPL PHYSIOL, V93, P1318, DOI 10.1152/japplphysiol.00283.2002; Amann M, 2013, J APPL PHYSIOL, V115, P355, DOI 10.1152/japplphysiol.00049.2013; Babault N, 2006, J APPL PHYSIOL, V100, P780, DOI 10.1152/japplphysiol.00737.2005; BIGLANDRITCHIE B, 1984, MUSCLE NERVE, V7, P691, DOI 10.1002/mus.880070902; Buckthorpe MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057549; Cairns SP, 2005, EXERC SPORT SCI REV, V33, P9; Cheng AJ, 2005, J APPL PHYSIOL, V99, P1446, DOI 10.1152/japplphysiol.00452.2005; Cheng AJ, 2010, MED SCI SPORT EXER, V42, P1651, DOI 10.1249/MSS.0b013e3181d6c5b5; Christian RJ, 2014, J APPL PHYSIOL, V117, P1063, DOI 10.1152/japplphysiol.00988.2013; Dalton BH, 2012, EXP GERONTOL, V47, P85, DOI 10.1016/j.exger.2011.10.010; Debold EP, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00151; DRAGANICH LF, 1989, J BONE JOINT SURG AM, V71A, P1075, DOI 10.2106/00004623-198971070-00015; Frere J, 2012, COMPUT METHOD BIOMEC, V15, P111, DOI 10.1080/10255842.2010.517199; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Girard O, 2013, EUR J APPL PHYSIOL, V113, P359, DOI 10.1007/s00421-012-2444-3; Girard O, 2011, SPORTS MED, V41, P673, DOI 10.2165/11590550-000000000-00000; Glaister M, 2005, SPORTS MED, V35, P757, DOI 10.2165/00007256-200535090-00003; Harwood B, 2012, J APPL PHYSIOL, V113, P1821, DOI 10.1152/japplphysiol.00879.2012; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Johnson ST, 2015, SCAND J MED SCI SPOR, V25, P623, DOI 10.1111/sms.12283; Lanza IR, 2004, J APPL PHYSIOL, V97, P967, DOI 10.1152/japplphysiol.01351.2003; Maciejewski H, 2013, SCAND J MED SCI SPOR, V23, P585, DOI 10.1111/j.1600-0838.2011.01423.x; MATHIASSEN SE, 1989, EUR J APPL PHYSIOL O, V59, P80, DOI 10.1007/BF02396584; Miller M, 1999, MUSCLE NERVE, V22, P1038, DOI 10.1002/(SICI)1097-4598(199908)22:8<1038::AID-MUS5>3.0.CO;2-R; Millet GY, 2012, NEUROMUSCULAR DISORD, V22, pS181, DOI 10.1016/j.nmd.2012.10.007; Minshull C, 2007, EUR J APPL PHYSIOL, V100, P469, DOI 10.1007/s00421-007-0448-1; Morel B, 2015, SCAND J MED SCI SPOR, V25, pE432, DOI 10.1111/sms.12358; PSEK JA, 1993, J APPL PHYSIOL, V74, P170, DOI 10.1152/jappl.1993.74.1.170; Racinais S, 2007, MED SCI SPORT EXER, V39, P268, DOI 10.1249/01.mss.0000251775.46460.cb; Taylor JL, 2000, J APPL PHYSIOL, V89, P305, DOI 10.1152/jappl.2000.89.1.305; Thorlund JB, 2008, SCAND J MED SCI SPOR, V18, P462, DOI 10.1111/j.1600-0838.2007.00710.x; Thorlund JB, 2009, INT J SPORTS MED, V30, P273, DOI 10.1055/s-0028-1104587; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Van Cutsem M, 1998, J PHYSIOL-LONDON, V513, P295, DOI 10.1111/j.1469-7793.1998.295by.x; von Tscharner V, 2000, J ELECTROMYOGR KINES, V10, P433, DOI 10.1016/S1050-6411(00)00030-4; Wakeling JM, 2009, J ELECTROMYOGR KINES, V19, P199, DOI 10.1016/j.jelekin.2007.09.006; Weir JP, 1998, EUR J APPL PHYSIOL O, V78, P555, DOI 10.1007/s004210050460	38	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0119719	10.1371/journal.pone.0119719	http://dx.doi.org/10.1371/journal.pone.0119719			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901576	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000353331500005
J	Ntui, VO; Kong, K; Khan, RS; Igawa, T; Janavi, GJ; Rabindran, R; Nakamura, I; Mii, M				Ntui, Valentine Otang; Kong, Kynet; Khan, Raham Sher; Igawa, Tomoko; Janavi, Gnanaguru Janaky; Rabindran, Ramalingam; Nakamura, Ikuo; Mii, Masahiro			Resistance to Sri Lankan Cassava Mosaic Virus (SLCMV) in Genetically Engineered Cassava cv. KU50 through RNA Silencing	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; WHITEFLY-TRANSMITTED GEMINIVIRUSES; PLUM-POX-VIRUS; MEDIATED RESISTANCE; TRANSGENIC CASSAVA; MESSENGER-RNA; COAT PROTEIN; SHOOT ORGANOGENESIS; ANTISENSE RNA; AV2 PRECOAT	Cassava ranks fifth among the starch producing crops of the world, its annual bioethanol yield is higher than for any other crop. Cassava cultivar KU50, the most widely grown cultivar for non-food purposes is susceptible to Sri Lankan cassava mosaic virus (SLCMV). The objective of this work was to engineer resistance to SLCMV by RNA interference (RNAi) in order to increase biomass yield, an important aspect for bioethanol production. Here, we produced transgenic KU50 lines expressing dsRNA homologous to the region between the AV2 and AV1 of DNA A of SLCMV. High level expression of dsRNA of SLCMV did not induce any growth abnormality in the transgenic plants. Transgenic lines displayed high levels of resistance to SLCMV compared to the wild-type plants and no virus load could be detected in uninoculated new leaves of the infected resistant lines after PCR amplification and RT-PCR analysis. The agronomic performance of the transgenic lines was unimpaired after inoculation with the virus as the plants presented similar growth when compared to the mock inoculated control plants and revealed no apparent reduction in the amount and weight of tubers produced. We show that the resistance is correlated with post-transcriptional gene silencing because of the production of transgene specific siRNA. The results demonstrate that transgenic lines exhibited high levels of resistance to SLCMV. This resistance coupled with the desirable yield components in the transgenic lines makes them better candidates for exploitation in the production of biomass as well as bioethanol.	[Ntui, Valentine Otang; Kong, Kynet; Khan, Raham Sher; Igawa, Tomoko; Nakamura, Ikuo; Mii, Masahiro] Chiba Univ, Lab Plant Cell Technol, Grad Sch Hort, Chiba, Japan; [Ntui, Valentine Otang] Univ Calabar, Fac Sci, Dept Genet Biotechnol, Calabar, Nigeria; [Kong, Kynet] Cambodia Agr Res & Dev Inst, Phnom Penh, Cambodia; [Khan, Raham Sher] Abdul Wali Khan Univ, Dept Biotechnol, Mardan, Pakistan; [Janavi, Gnanaguru Janaky; Rabindran, Ramalingam] Tamil Nadu Agr Univ, Hort Coll & Res Inst, Coimbatore 641003, Tamil Nadu, India	Chiba University; University of Calabar; Abdul Wali Khan University; Tamil Nadu Agricultural University	Ntui, VO (corresponding author), King Abdullah Univ Sci Technol, Ctr Desert Agr, Thuwal, Saudi Arabia.	ntuival@yahoo.com	Igawa, Tomoko/N-1578-2015; Khan, Raham S/A-5272-2015	Igawa, Tomoko/0000-0003-1829-6076; Mii, Masahiro/0000-0002-8312-3430; Ntui, Valentine/0000-0003-4709-8087	Japan Society for the Promotion of Science (JSPS); JSPS; Grants-in-Aid for Scientific Research [25840113] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work was supported by Japan Society for the Promotion of Science (JSPS). V. O. Ntui is a recipient of JSPS fellowship.	Alabi O. J., 2011, CASSAVA MOSAIC DIS C, DOI DOI 10.1094/APSNETFEATURE-2011-0701; BENADA J, 1981, ROST VYROBA, V27, P131; Bonfim K, 2007, MOL PLANT MICROBE IN, V20, P717, DOI 10.1094/MPMI-20-6-0717; Bull SE, 2009, NAT PROTOC, V4, P1845, DOI 10.1038/nprot.2009.208; Bull SE, 2007, J GEN VIROL, V88, P1624, DOI 10.1099/vir.0.82662-0; Chellappan P, 2004, PLANT MOL BIOL, V56, P601, DOI 10.1007/s11103-004-0147-9; DEHAAN P, 1992, BIO-TECHNOL, V10, P1133, DOI 10.1038/nbt1092-1133; DENG D, 1994, ANN APPL BIOL, V125, P327, DOI 10.1111/j.1744-7348.1994.tb04973.x; Dutt N, 2005, ARCH VIROL, V150, P2101, DOI 10.1007/s00705-005-0579-9; FARGETTE D, 1988, TROP PEST MANAGE, V34, P89; FAUQUET C, 1990, PLANT DIS, V74, P404, DOI 10.1094/PD-74-0404; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hankoua BB, 2005, PLANT CELL TISS ORG, V82, P221, DOI 10.1007/s11240-005-0514-5; Hily JM, 2004, TRANSGENIC RES, V13, P427, DOI 10.1007/s11248-004-8702-3; HONG YG, 1993, J GEN VIROL, V74, P2437, DOI 10.1099/0022-1317-74-11-2437; Jansson C, 2009, APPL ENERG, V86, pS95, DOI 10.1016/j.apenergy.2009.05.011; Kalantidis K, 2002, MOL PLANT MICROBE IN, V15, P826, DOI 10.1094/MPMI.2002.15.8.826; Kasschau KD, 1998, CELL, V95, P461, DOI 10.1016/S0092-8674(00)81614-1; Klas FE, 2006, TRANSGENIC RES, V15, P527, DOI 10.1007/s11248-006-9001-y; KRAPP A, 1993, PLANT J, V3, P817, DOI 10.1111/j.1365-313X.1993.00817.x; Krubphachaya P, 2007, J BIOCHEM MOL BIOL, V40, P404; Kundu JK, 2008, VIRUS GENES, V36, P215, DOI 10.1007/s11262-007-0176-y; Missiou A, 2004, MOL BREEDING, V14, P185, DOI 10.1023/B:MOLB.0000038006.32812.52; Mittal D, 2008, ARCH VIROL, V153, P2149, DOI 10.1007/s00705-008-0238-z; Mubin M, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-10; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nguyen TLT, 2007, ENVIRON SCI TECHNOL, V41, P4135, DOI 10.1021/es0620641; Ntui VO, 2013, TRANSGENIC RES, V22, P1191, DOI 10.1007/s11248-013-9721-8; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Padidam M, 1996, VIROLOGY, V224, P390, DOI 10.1006/viro.1996.0546; Patil BL, 2007, VIRUS RES, V124, P59, DOI 10.1016/j.virusres.2006.10.003; Patil BL, 2011, MOL PLANT PATHOL, V12, P31, DOI 10.1111/j.1364-3703.2010.00650.x; Robinson J, 2013, STANDING PANEL IMPAC, P1; Rogers SO, 1988, PLANT MOL BIOL MAN A, VA6, P1, DOI DOI 10.1007/978-94-017-5294-7_; Rothenstein D, 2007, VIROLOGY, V359, P137, DOI 10.1016/j.virol.2006.09.014; SAELIM L, 2006, GLOBAL J BIOTECHNOL, V1, P7; Sambrook J., 2001, MOL CLONING LAB MANU; Saunders K, 2002, VIROLOGY, V293, P63, DOI 10.1006/viro.2001.1251; Smith Neil A, 2012, Methods Mol Biol, V894, P155, DOI 10.1007/978-1-61779-882-5_11; STAMP JA, 1987, PLANT CELL TISS ORG, V10, P227, DOI 10.1007/BF00037307; TABLER M, 1993, NATO ADV SCI INST SE, V253, P237; TANAKA A, 1990, NUCLEIC ACIDS RES, V18, P6767, DOI 10.1093/nar/18.23.6767; Taylor N, 2004, PLANT MOL BIOL, V56, P671, DOI 10.1007/s11103-004-4872-x; Thomas PE, 2000, VIRUS RES, V71, P49, DOI 10.1016/S0168-1702(00)00187-8; Thresh JM, 1988, REV PLANT PATHOL, V77, P935; Vu TV, 2013, VIRUS RES, V172, P35, DOI 10.1016/j.virusres.2012.12.008; TRICOLI DM, 1995, BIO-TECHNOL, V13, P1458, DOI 10.1038/nbt1295-1458; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Vanderschuren H, 2007, PLANT MOL BIOL, V64, P549, DOI 10.1007/s11103-007-9175-6; Vanderschuren H, 2007, PLANT BIOTECHNOL J, V5, P207, DOI 10.1111/j.1467-7652.2006.00217.x; Vanderschuren H, 2009, PLANT MOL BIOL, V70, P265, DOI 10.1007/s11103-009-9472-3; Vanitharani R, 2004, J VIROL, V78, P9487, DOI 10.1128/JVI.78.17.9487-9498.2004; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Wang W, 2002, CASSAVA RES DEV ASIA; Waterhouse PM, 2001, NATURE, V411, P834, DOI 10.1038/35081168; Yadav JS, 2011, MOL PLANT PATHOL, V12, P677, DOI 10.1111/J.1364-3703.2010.00700.X; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zhang P, 2005, PLANT BIOTECHNOL J, V3, P385, DOI 10.1111/j.1467-7652.2005.00132.x; Zhang P, 2001, PLANT CELL TISS ORG, V67, P47, DOI 10.1023/A:1011654128198	60	23	25	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0120551	10.1371/journal.pone.0120551	http://dx.doi.org/10.1371/journal.pone.0120551			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901740	Green Published, gold, Green Submitted			2022-12-26	WOS:000353331500006
J	Periyakoil, VS; Neri, E; Kraemer, H				Periyakoil, Vyjeyanthi S.; Neri, Eric; Kraemer, Helena			No Easy Talk: A Mixed Methods Study of Doctor Reported Barriers to Conducting Effective End-of-Life Conversations with Diverse Patients	PLOS ONE			English	Article							AFRICAN-AMERICAN PHYSICIANS; ETHNIC-DIFFERENCES; ORGANIZED MEDICINE; CARE; PERCEPTIONS; TRUST; RACE	Objective Though most patients wish to discuss end-of-life (EOL) issues, doctors are reluctant to conduct end-of-life conversations. Little is known about the barriers doctors face in conducting effective EOL conversations with diverse patients. This mixed methods study was undertaken to empirically identify barriers faced by doctors (if any) in conducting effective EOL conversations with diverse patients and to determine if the doctors' age, gender, ethnicity and medical sub-specialty influenced the barriers reported. Design Mixed-methods study of multi-specialty doctors caring for diverse, seriously ill patients in two large academic medical centers at the end of the training; data were collected from 2010 to 2012. Outcomes Doctor-reported barriers to EOL conversations with diverse patients. Results 1040 of 1234 potential subjects (84.3%) participated. 29 participants were designated as the development cohort for coding and grounded theory analyses to identify primary barriers. The codes were validated by analyses of responses from 50 randomly drawn subjects from the validation cohort (n=996 doctors). Qualitative responses from the validation cohort were coded and analyzed using quantitative methods. Only 0.01% doctors reported no barriers to conducting EOL conversations with patients. 99.99% doctors reported barriers with 85.7% finding it very challenging to conduct EOL conversations with all patients and especially so with patients whose ethnicity was different than their own. Asian-American doctors reported the most struggles (91.3%), followed by African Americans (85.3%), Caucasians (83.5%) and Hispanic Americans (79.3%) in conducting EOL conversations with their patients. The biggest doctor-reported barriers to effective EOL conversations are (i) language and medical interpretation issues, (ii) patient/family religio-spiritual beliefs about death and dying, (iii) doctors' ignorance of patients' cultural beliefs, values and practices, (iv) patient/family's cultural differences in truth handling and decision making, (v) patients' limited health literacy and (vi) patients' mistrust of doctors and the health care system. The doctors' ethnicity (Chi-Square = 12.77, DF = 4, p = 0.0125) and medical subspecialty (Chi-Square = 19.33, DF = 10, p = 0.036) influenced their reported barriers. Friedman's test used to examine participants relative ranking of the barriers across sub-groups identified significant differences by age group (F statistic = 303.5, DF = 5, p < 0.0001) and medical sub-specialty (F statistic = 163.7, DF = 5, p < 0.0001). Conclusions and Relevance Doctors report struggles with conducting effective EOL conversations with all patients and especially with those whose ethnicity is different from their own. It is vital to identify strategies to mitigate barriers doctors encounter in conducting effective EOL conversations with seriously ill patients and their families.	[Periyakoil, Vyjeyanthi S.; Neri, Eric; Kraemer, Helena] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA; [Periyakoil, Vyjeyanthi S.] VA Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Periyakoil, VS (corresponding author), Stanford Univ, Sch Med, Palo Alto, CA 94304 USA.	periyakoil@stanford.edu			NIH [NIHMD/NIH: R25 MD006857]; Department of Veterans Affairs; Stanford University School of Medicine; NATIONAL CANCER INSTITUTE [R25CA115562] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R25MD006857] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Stanford University School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Dr. Periyakoil's work is funded by the NIH (NIHMD/NIH: R25 MD006857), the Department of Veterans Affairs and Stanford University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Medical Association website, CURR PROC TERM COD B; ANDERSON JL, 1979, RHEUMATOL REHABIL, V18, P18, DOI 10.1093/rheumatology/18.1.18; Baker RB, 2008, JAMA-J AM MED ASSOC, V300, P306, DOI 10.1001/jama.300.3.306; Barnato AE, 2009, J GEN INTERN MED, V24, P695, DOI 10.1007/s11606-009-0952-6; Boulware LE, 2003, PUBLIC HEALTH REP, V118, P358, DOI 10.1016/S0033-3549(04)50262-5; Buss MK, 2011, CANCER-AM CANCER SOC, V117, P4304, DOI 10.1002/cncr.25952; Buss Mary K, 2007, J Support Oncol, V5, P237; Caracelli V.J, 1997, ADV MIXED METHOD EVA, DOI DOI 10.1002/EV.1069; Centers for Disease Control and Prevention, 2007, STAT AG HLTH AM 2007; Creswell J.W., 2018, QUAL INQ, V4; Creswell J.W., 2010, BEST PRACTICES MIXED; Friedman M, 1937, J AM STAT ASSOC, V32, P675, DOI 10.2307/2279372; Friedman M, 1940, ANN MATH STAT, V11, P86, DOI 10.1214/aoms/1177731944; Givens JL, 2010, ARCH INTERN MED, V170, P427, DOI 10.1001/archinternmed.2009.547; Goodman D. C., 2010, QUALITY END OF LIFE; Gordon HS, 2006, J CLIN ONCOL, V24, P904, DOI 10.1200/JCO.2005.03.1955; Greiner KA, 2003, J AM GERIATR SOC, V51, P970, DOI 10.1046/j.1365-2389.2003.51310.x; Hanchate A, 2009, ARCH INTERN MED, V169, P493, DOI 10.1001/archinternmed.2008.616; Hopp FP, 2000, J AM GERIATR SOC, V48, P658, DOI 10.1111/j.1532-5415.2000.tb04724.x; Kessels RPC, 2003, J ROY SOC MED, V96, P219, DOI 10.1258/jrsm.96.5.219; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Organization for Economic Cooperation and Development (OECD), COUNTR STAT PROF US; Peek ME, 2009, J GEN INTERN MED, V24, P1135, DOI 10.1007/s11606-009-1047-0; Periyakoil VS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098246; Periyakoil VS, 2013, J AM GERIATR SOC, V61, P440, DOI 10.1111/jgs.12145; Periyakoil VS, 2010, J PALLIAT MED, V13, P495, DOI 10.1089/jpm.2009.0279; Periyakoil VS, 2009, J PALLIAT MED, V12, P1125, DOI 10.1089/jpm.2009.0123; Schillinger D, 2003, ARCH INTERN MED, V163, P83, DOI 10.1001/archinte.163.1.83; Strauss A, 1990, BASICS QUALITATIVE R, DOI [10.1111/j.1365-2702.2009.02908.x, DOI 10.1111/J.1365-2702.2009.02908.X]; Tong A, INT J QUALITY HLTH C, V19, P349; Washington HA, 2009, J NATL MED ASSOC, V101, P513, DOI 10.1016/S0027-9684(15)30936-6; Welch LC, 2005, J AM GERIATR SOC, V53, P1145, DOI 10.1111/j.1532-5415.2005.53357.x; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Yu W, HLTH SERVICES RES DE; Zhang BH, 2009, ARCH INTERN MED, V169, P480, DOI 10.1001/archinternmed.2008.587	36	76	78	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0122321	10.1371/journal.pone.0122321	http://dx.doi.org/10.1371/journal.pone.0122321			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG5KV	25902309	Green Submitted, gold, Green Published			2022-12-26	WOS:000353331500019
J	Renault, R; Sukenik, N; Descroix, S; Malaquin, L; Viovy, JL; Peyrin, JM; Bottani, S; Monceau, P; Moses, E; Vignes, M				Renault, Renaud; Sukenik, Nirit; Descroix, Stephanie; Malaquin, Laurent; Viovy, Jean-Louis; Peyrin, Jean-Michel; Bottani, Samuel; Monceau, Pascal; Moses, Elisha; Vignes, Maeva			Combining Microfluidics, Optogenetics and Calcium Imaging to Study Neuronal Communication In Vitro	PLOS ONE			English	Article							2-PHOTON EXCITATION; CORTICAL NETWORKS; POPULATIONS; ACTIVATION; PLASTICITY; PATTERNS; POLARITY	In this paper we report the combination of microfluidics, optogenetics and calcium imaging as a cheap and convenient platform to study synaptic communication between neuronal populations in vitro. We first show that Calcium Orange indicator is compatible in vitro with a commonly used Channelrhodopsine-2 (ChR2) variant, as standard calcium imaging conditions did not alter significantly the activity of transduced cultures of rodent primary neurons. A fast, robust and scalable process for micro-chip fabrication was developed in parallel to build micro-compartmented cultures. Coupling optical fibers to each micro-compartment allowed for the independent control of ChR2 activation in the different populations without crosstalk. By analyzing the post-stimuli activity across the different populations, we finally show how this platform can be used to evaluate quantitatively the effective connectivity between connected neuronal populations.	[Renault, Renaud; Bottani, Samuel; Monceau, Pascal] Univ Paris Diderot, CNRS UMR 7057, MSC, F-75013 Paris, France; [Renault, Renaud; Descroix, Stephanie; Malaquin, Laurent; Viovy, Jean-Louis; Vignes, Maeva] UPMC, CNRS UMR 168, Inst Curie, Physicochim Curie,Ctr Rech, F-75248 Paris 05, France; [Renault, Renaud; Sukenik, Nirit; Moses, Elisha] Weizmann Inst Sci, Dept Complex Syst, Rehovot, Israel; [Peyrin, Jean-Michel; Vignes, Maeva] CNRS, UMR 8256, Biol Adaptat & Ageing, F-75005 Paris, France; [Peyrin, Jean-Michel; Vignes, Maeva] Univ Paris 06, Sorbonne Univ, UMR 8256, B2A,Inst Biol Paris Seine, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Weizmann Institute of Science; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Vignes, M (corresponding author), Univ Copenhagen, Nanosci Ctr, Univ Pk 5, DK-2100 Copenhagen, Denmark.	maeva.vignes@gmail.com	DESCROIX, Stephanie/AAN-8875-2021; MALAQUIN, LAURENT/B-4852-2016; Maeva, VIGNES L/Q-9495-2016	MALAQUIN, LAURENT/0000-0003-4791-3352; Maeva, VIGNES L/0000-0002-4768-9648; Peyrin, Jean-Michel/0000-0002-0108-1266; Peyrin, Jean-Michel/0000-0002-8705-8672; Viovy, Jean-Louis/0000-0002-8223-4040	European Commission; European Research Commission [321107]	European Commission(European CommissionEuropean Commission Joint Research Centre); European Research Commission(European CommissionEuropean Commission Joint Research Centre)	Funding was provided by a grant of the European Commission: MicroDEG, ERA-NET Neuron JTC2012 "Novel Methods", http://www.neuron-eranet.eu/en/317.php, JMP; and a European Research Commission advanced grant: CellO, Nbr: 321107, JLV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselmi F, 2011, P NATL ACAD SCI USA, V108, P19504, DOI 10.1073/pnas.1109111108; Baruchi I, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.050901; Bernardinelli Y, 2011, J NEUROSCI, V31, P8905, DOI 10.1523/JNEUROSCI.6341-10.2011; Bernstein JG, 2011, TRENDS COGN SCI, V15, P592, DOI 10.1016/j.tics.2011.10.003; Bonifazi P, 2005, EUR J NEUROSCI, V22, P2953, DOI 10.1111/j.1460-9568.2005.04464.x; Breskin I, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.188102; Brunello CA, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-11; Chao ZC, 2007, J NEURAL ENG, V4, P294, DOI 10.1088/1741-2560/4/3/015; Chiappalone M, 2006, BRAIN RES, V1093, P41, DOI 10.1016/j.brainres.2006.03.049; Cohen O, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/18008; Dranias MR, 2013, J NEUROSCI, V33, P1940, DOI 10.1523/JNEUROSCI.2718-12.2013; Feinerman O, 2005, J NEUROPHYSIOL, V94, P3406, DOI 10.1152/jn.00264.2005; Feinerman O, 2008, NAT PHYS, V4, P967, DOI 10.1038/nphys1099; Gobel W, 2007, PHYSIOLOGY, V22, P358, DOI 10.1152/physiol.00032.2007; Goldin M, 2001, J NEUROSCI, V21, P186, DOI 10.1523/JNEUROSCI.21-01-00186.2001; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Hallstrom W, 2009, LANGMUIR, V25, P4343, DOI 10.1021/la900436e; Hattori S, 2010, ELECTR COMMUN JPN, V93, P17, DOI 10.1002/ecj.10240; Hinard V, 2012, J NEUROSCI, V32, P12506, DOI 10.1523/JNEUROSCI.2306-12.2012; Kanagasabapathi Thirukumaran T, 2011, Front Neuroeng, V4, P13, DOI 10.3389/fneng.2011.00013; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Marconi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034648; Marx V, 2014, NAT METHODS, V11, P1099, DOI 10.1038/nmeth.3149; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Mohanty SK, 2008, BIOPHYS J, V95, P3916, DOI 10.1529/biophysj.108.130187; Morin F, 2006, BIOSENS BIOELECTRON, V21, P1093, DOI 10.1016/j.bios.2005.04.020; Nathanson JL, 2009, NEUROSCIENCE, V161, P441, DOI 10.1016/j.neuroscience.2009.03.032; Odawara A, 2013, LAB CHIP, V13, P2040, DOI 10.1039/c3lc00036b; Orlandi JG, 2013, NAT PHYS, V9, P582, DOI [10.1038/NPHYS2686, 10.1038/nphys2686]; Pan LB, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046031; Papagiakoumou E, 2010, NAT METHODS, V7, P848, DOI [10.1038/NMETH.1505, 10.1038/nmeth.1505]; Park JW, 2013, LAB CHIP, V13, P509, DOI 10.1039/c2lc41081h; Pautot S, 2008, NAT METHODS, V5, P735, DOI 10.1038/nmeth.1236; Peyrin JM, 2011, LAB CHIP, V11, P3663, DOI 10.1039/c1lc20014c; Roth S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033623; Roth S, 2012, SMALL, V8, P671, DOI 10.1002/smll.201102325; Smetters D, 1999, METHODS, V18, P215, DOI 10.1006/meth.1999.0774; Stenger DA, 1998, J NEUROSCI METH, V82, P167, DOI 10.1016/S0165-0270(98)00047-8; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Taylor AM, 2010, NEURON, V66, P57, DOI 10.1016/j.neuron.2010.03.022; Teller S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003796; Valley M, 2011, JOVE-J VIS EXP, P2; Vogt AK, 2004, J NEUROSCI METH, V134, P191, DOI 10.1016/j.jneumeth.2003.11.004; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11; Yang IH, 2011, J BIOMED MATER RES A, V97A, P451, DOI 10.1002/jbm.a.33082; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Yuste R, 2011, COLD SPRING HARBOR P; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	49	47	46	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0120680	10.1371/journal.pone.0120680	http://dx.doi.org/10.1371/journal.pone.0120680			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901914	Green Published, Green Submitted, gold			2022-12-26	WOS:000353331500007
J	Tan, JYL; Habib, NA; Chuah, YW; Yau, YH; Geifman-Shochat, S; Chen, WN				Tan, Jane Yi Lin; Habib, Nagy A.; Chuah, York Wieo; Yau, Yin Hoe; Geifman-Shochat, Susana; Chen, Wei Ning			Identification of Cellular Targets of MicroRNA-181a in HepG2 Cells: A New Approach for Functional Analysis of MicroRNAs	PLOS ONE			English	Article							CANCER; BIOGENESIS; EXPRESSION; ROLES	MicroRNAs (miRNAs) are known to play a part in regulating important cellular processes. They generally perform their regulatory function through their binding with mRNAs, ultimately leading to a repression of target protein expression levels. However, their roles in cellular processes are poorly understood due to the limited understanding of their specific cellular targets. Aberrant levels of miRNAs have been found in hepatocellular carcinoma (HCC) including miR-181a. Using bioinformatics analysis, cyclin-dependent kinase inhibitor 1B (CDKN1 beta) and transcriptional factor E2F7 were identified as potential targets of miR-181a. Validation analysis using surface plasmon resonance (SPR) showed a positive binding between miR-181a and the 3 ' UTRs of these two potential mRNA targets. In vivo luciferase assay further confirmed the positive miR-181a: mRNA bindings, where a significant decrease in luciferase activity was detected when HepG2 cells were co-transfected with the 3 ' UTR-containing reporter plasmids and miR-181a. The potential impact of miR-181a binding to its specific targets on the general cellular behavior was further investigated. Results showed that miR-181a significantly activated the MAPK/JNK pathway which regulates cell proliferation, supporting our recently reported findings. Inhibition of miR-181a, on the other hand, abolished the observed activation. Our findings open up a new approach in designing targeted functional analysis of miRNAs in cellular processes, through the identification of their cellular targets.	[Tan, Jane Yi Lin; Chen, Wei Ning] Nanyang Technol Univ, Coll Engn, Sch Chem & Biomed Engn, Singapore 639798, Singapore; [Habib, Nagy A.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Surg & Canc, London, England; [Chuah, York Wieo; Yau, Yin Hoe; Geifman-Shochat, Susana] Nanyang Technol Univ, Sch Biol Sci, Div Struct Biol & Biochem, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Imperial College London; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Chen, WN (corresponding author), Nanyang Technol Univ, Coll Engn, Sch Chem & Biomed Engn, Singapore 639798, Singapore.	WNChen@ntu.edu.sg	Hoe, YAU Yin/A-2817-2011	Hoe, YAU Yin/0000-0001-8136-2393; , Yang/0000-0002-6620-8897				Abdulhalim I, 2008, ELECTROMAGNETICS, V28, DOI 10.1080/02726340801921650; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; de Bruin A, 2003, J BIOL CHEM, V278, P42041, DOI 10.1074/jbc.M308105200; de Caestecker MP, 2000, JNCI-J NATL CANCER I, V92, P1388, DOI 10.1093/jnci/92.17.1388; Gramantieri L, 2007, LIVER INT, V27, P997, DOI 10.1111/j.1478-3231.2007.01544.x; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Huang SL, 2010, NUCLEIC ACIDS RES, V38, P7211, DOI 10.1093/nar/gkq564; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ji JF, 2009, HEPATOLOGY, V50, P472, DOI 10.1002/hep.22989; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kato M, 2008, BIOL CELL, V100, P71, DOI 10.1042/BC20070078; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Leong KG, 2002, MOL CELL BIOL, V22, P2830, DOI 10.1128/MCB.22.8.2830-2841.2002; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lobry C, 2011, J EXP MED, V208, P1931, DOI 10.1084/jem.20111855; MacFarlane LA, 2010, CURR GENOMICS, V11, P537, DOI 10.2174/138920210793175895; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Tan YLJ, 2012, CURR PROTEOMICS, V9, P262; Wang V, 2009, BIODRUGS, V23, P15, DOI 10.2165/00063030-200923010-00002; West J, 2010, ADV EXP MED BIOL, V661, P265, DOI 10.1007/978-1-60761-500-2_17	22	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123167	10.1371/journal.pone.0123167	http://dx.doi.org/10.1371/journal.pone.0123167			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901570	Green Published, gold			2022-12-26	WOS:000353331500045
J	De Cobelli, F; Pezzetti, G; Margari, S; Esposito, A; Giganti, F; Agostini, G; Del Maschio, A				De Cobelli, Francesco; Pezzetti, Giulio; Margari, Sergio; Esposito, Antonio; Giganti, Francesco; Agostini, Giulia; Del Maschio, Alessandro			New Insights in Abdominal Pain in Paroxysmal Nocturnal Hemoglobinuria (PNH): A MRI Study	PLOS ONE			English	Article							COMPLEMENT INHIBITOR ECULIZUMAB; CHRONIC MESENTERIC ISCHEMIA; INTESTINAL INFARCTION; DIAGNOSIS; FLOW; MANAGEMENT; THROMBOSIS; HEMOLYSIS; CELLS	Introduction Abdominal pain in PNH has never been investigated by in-vivo imaging studies. With MRI, we aimed to assess mesenteric vessels flow and small bowel wall perfusion to investigate the ischemic origin of abdominal pain. Materials and Methods Six PNH patients with (AP) and six without (NOP) abdominal pain underwent MRI. In a blinded fashion, mean flow (MF, quantity of blood moving through a vessel within a second, in mL.s(-1)) and stroke volume (SV, volume of blood pumped out at each heart contraction, in mL) of Superior Mesenteric Vein (SMV) and Artery (SMA), areas under the curve at 60 (AUC(60)) and 90 seconds (AUC(90)) and K-trans were assessed by two operators. Results Mean total perfusion and flow parameters were lower in AP than in NOP group. AUC(60): 84.81 +/- 11.75 vs. 131.73 +/- 18.89 (P<0.001); AUC(90): 102.33 +/- 14.16 vs. 152.58 +/- 22.70 (P<0.001); K-trans: 0.0346 min(-1) +/- 0.0019 vs. 0.0521 +/- 0.0015 (P = 0.093 duodenum, 0.009 jejunum/ileum). SMV: MF 4.67 ml/s +/- 0.85 vs. 8.32 +/- 2.14 (P = 0.002); SV 3.85 ml +/- 0.76 vs. 6.55 +/- 1.57 (P = 0.02). SMA: MF 6.95 +/- 2.61 vs. 11.2 +/- 2.32 (P = 0.07); SV 6.52 +/- 2.19 vs. 8.78 +/- 1.63 (P = 0.07). We found a significant correlation between MF and SV of SMV and AUC(60) (MF: rho = 0.88, P<0.001; SV: rho = 0.644, P = 0.024), AUC(90) (MF: rho = 0.874, P<0.001; SV: rho = 0.774, P = 0.003) and K-trans (MF: rho = 0.734, P = 0.007; SV: rho = 0.581, P = 0.047). Conclusions Perfusion and flow MRI findings suggest that the impairment of small bowel blood supply is significantly associated with abdominal pain in PNH.	[De Cobelli, Francesco] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Dept Radiol, Milan, Italy; Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Ctr Expt Imaging, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	De Cobelli, F (corresponding author), Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Dept Radiol, Milan, Italy.	decobelli.francesco@hsr.it	Esposito, Antonio/AAZ-7967-2020; Esposito, Antonio/K-5088-2018; DE COBELLI, Francesco/AAC-6488-2022	Esposito, Antonio/0000-0002-1170-6266; Esposito, Antonio/0000-0002-1170-6266; DE COBELLI, Francesco/0000-0003-4014-3711; Giganti, Francesco/0000-0001-5218-6431	Alexion Pharmaceuticals Inc.	Alexion Pharmaceuticals Inc.	Alexion Pharmaceuticals Inc. provided financial support in the form of a grant. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. Alexion Pharmaceuticals Inc. had no involvement in the study design, the collection and the analysis of the data and results.	Adams T, 2002, DIGEST DIS SCI, V47, P58, DOI 10.1023/A:1013207318697; Audebert HJ, 2005, J NEUROL, V252, P1379, DOI 10.1007/s00415-005-0871-3; Barnes Stephanie L, 2012, Pharmaceutics, V4, P442, DOI 10.3390/pharmaceutics4030442; Barrett T, 2007, J MAGN RESON IMAGING, V26, P235, DOI 10.1002/jmri.20991; BLUM SF, 1966, NEW ENGL J MED, V274, P1137, DOI 10.1056/NEJM196605192742008; Borowitz MJ, 2010, CYTOM PART B-CLIN CY, V78B, P211, DOI 10.1002/cyto.b.20525; BURKART DJ, 1995, RADIOLOGY, V194, P801, DOI 10.1148/radiology.194.3.7862982; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; CROSBY WH, 1951, BLOOD, V6, P270, DOI 10.1182/blood.V6.3.270.270; de Latour RP, 2008, BLOOD, V112, P3099, DOI 10.1182/blood-2008-01-133918; Dolezel Z, 2004, PEDIATR NEPHROL, V19, P1177, DOI 10.1007/s00467-004-1563-4; DOUKAS MA, 1984, AM J HEMATOL, V16, P75, DOI 10.1002/ajh.2830160110; Evelhoch JL, 1999, JMRI-J MAGN RESON IM, V10, P254, DOI 10.1002/(SICI)1522-2586(199909)10:3<254::AID-JMRI5>3.0.CO;2-9; Giusti S, 2010, ABDOM IMAGING, V35, P646, DOI 10.1007/s00261-010-9624-6; GRALNICK HR, 1995, BRIT J HAEMATOL, V91, P697, DOI 10.1111/j.1365-2141.1995.tb05371.x; Grand DJ, 2013, RADIOL CLIN N AM, V51, P99, DOI 10.1016/j.rcl.2012.09.007; Haroon HA, 2004, J MAGN RESON IMAGING, V19, P527, DOI 10.1002/jmri.20045; Hernandez-Campo PM, 2006, CYTOM PART B-CLIN CY, V70B, P71, DOI 10.1002/cyto.b.20087; Hill A, 2013, BLOOD, V121, P4985, DOI 10.1182/blood-2012-09-311381; Hillmen P, 2004, NEW ENGL J MED, V350, P552, DOI 10.1056/NEJMoa031688; Hillmen P, 2007, BLOOD, V110, P4123, DOI 10.1182/blood-2007-06-095646; Hillmen P, 2006, NEW ENGL J MED, V355, P1233, DOI 10.1056/NEJMoa061648; Holers VM, 2008, IMMUNOL REV, V223, P300, DOI 10.1111/j.1600-065X.2008.00641.x; Lauenstein TC, 2005, RADIOLOGY, V234, P569, DOI 10.1148/radiol.2342031002; Lee JW, 2013, INT J HEMATOL, V97, P749, DOI 10.1007/s12185-013-1346-4; LI KCP, 1995, RADIOLOGY, V194, P327, DOI 10.1148/radiology.194.2.7824706; LI KCP, 1994, RADIOLOGY, V190, P175, DOI 10.1148/radiology.190.1.8259400; MATHIEU D, 1995, BLOOD, V85, P3283, DOI 10.1182/blood.V85.11.3283.bloodjournal85113283; Naganawa S, 1994, Radiat Med, V12, P213; O'Connor JPB, 2011, BRIT J RADIOL, V84, pS112, DOI 10.1259/bjr/55166688; Parker C, 2005, BLOOD, V106, P3699, DOI 10.1182/blood-2005-04-1717; Richards SJ, 2007, CYTOM PART B-CLIN CY, V72B, P291, DOI 10.1002/cyto.b.20358; Socie G, 1996, LANCET, V348, P573, DOI 10.1016/S0140-6736(95)12360-1; Turkbey B, 2009, AM J ROENTGENOL, V193, P304, DOI 10.2214/AJR.09.2869; Wang HB, 2002, BLOOD, V100, P3897, DOI 10.1182/blood-2002-03-0799; Young NS, 2006, BLOOD, V108, p290A	36	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0122832	10.1371/journal.pone.0122832	http://dx.doi.org/10.1371/journal.pone.0122832			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897796	Green Submitted, gold, Green Published			2022-12-26	WOS:000353212600014
J	Huang, CC; Yang, H; Li, YM; Zou, J; Zhang, YM; Chen, X; Mi, Y; Zhang, ML				Huang, Changchun; Yang, Hao; Li, Yunmei; Zou, Jun; Zhang, YiMing; Chen, Xia; Mi, Yin; Zhang, Mingli			Investigating Changes in Land Use Cover and Associated Environmental Parameters in Taihu Lake in Recent Decades Using Remote Sensing and Geochemistry	PLOS ONE			English	Article							C-ORG/N RATIOS; ORGANIC-MATTER; EUTROPHICATION; RIVER; IMPACT; PHOSPHORUS; CLIMATE; CARBON; MODEL; DEFORESTATION	Humans have had a significant impact on the terrestrial pedosphere through activities such as agriculture and urbanization. The effects of human activities on land use and the related environmental changes were investigated through point and areal studies surrounding Meiliang Bay, which is an open area of extreme eutrophication in Taihu Lake, China. This study used remote sensing and environmental-tracer profiles [total nitrogen (TN), total phosphorus (TP), total organic carbon (TOC), grain size, and geochemical parameters] to determine the causes of changes in land use and the associated environmental parameters. The results of LUCCs (Land use/cover changes) indicate that over the past three decades, total farmland decreased by 862.49 km(2), with an annual decrement rate of 28.75 km(2)/year, and total urbanized land increased by 859.71 km(2), with an annual growth rate of 28.66 km(2)/year. The geochemical results indicate that the trophic state of Taihu Lake was persistently intensifying and that the TN, TP, and TOC concentrations increased twofold, threefold, and twofold, respectively, from 1949 to 2010. The sources of TN, TP, and TOC were highly similar after 1975. However, before 1974, TN and TP originated from different sources than TOC. The grassland and woodland around the lake retain nutrients and sand from the land of study area. The increase in urbanized land and tertiary industries significantly increased the sediment concentrations of TN, TP, and TOC after 1980.	[Huang, Changchun; Li, Yunmei] Nanjing Normal Univ, Jiangsu Ctr Collaborat Innovat Geog Informat Reso, Nanjing, Jiangsu, Peoples R China; [Huang, Changchun; Yang, Hao; Li, Yunmei; Zou, Jun; Zhang, YiMing; Chen, Xia; Mi, Yin; Zhang, Mingli] Nanjing Normal Univ, Sch Geog Sci, Nanjing, Jiangsu, Peoples R China; [Huang, Changchun; Yang, Hao] Nanjing Normal Univ, Jiangsu Prov Key Lab Mat Cycling & Pollut Control, Nanjing, Jiangsu, Peoples R China; [Huang, Changchun] Nanjing Normal Univ, Key Lab Virtual Geog Environm, Minist Educ, Nanjing, Jiangsu, Peoples R China	Nanjing Normal University; Nanjing Normal University; Nanjing Normal University; Nanjing Normal University	Zhang, YM (corresponding author), Nanjing Normal Univ, Sch Geog Sci, Nanjing, Jiangsu, Peoples R China.	zhangyiming@njnu.edu.cn	huang, changchun/E-6580-2016; huang, changchun/E-6580-2016	huang, changchun/0000-0002-9833-5663; huang, changchun/0000-0002-4704-548X	National Natural Science Foundation of China [41201325, 41271343, 41030751]; Natural Science Funds of Provincial Universities [12KJB170005]; Ph.D. Program Foundation of the Ministry of Education of China [20123207120017]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Funds of Provincial Universities; Ph.D. Program Foundation of the Ministry of Education of China(Ministry of Education, China); Priority Academic Program Development of Jiangsu Higher Education Institutions	This study was supported by the National Natural Science Foundation of China (Grant Nos. 41201325, 41271343, and 41030751), the Natural Science Funds of Provincial Universities (Grant No. 12KJB170005), the Ph.D. Program Foundation of the Ministry of Education of China (Grant No. 20123207120017), and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Bala G, 2007, P NATL ACAD SCI USA, V104, P6550, DOI 10.1073/pnas.0608998104; Bengtsson J, 2011, OECOLOGIA, V165, P225, DOI 10.1007/s00442-010-1753-7; Bennett EM, 2001, BIOSCIENCE, V51, P227, DOI 10.1641/0006-3568(2001)051[0227:HIOEPA]2.0.CO;2; Berhe AA, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001790; Berthon V, 2013, J LIMNOL, V72, P417, DOI 10.4081/jlimnol.2013.e34; BONAN GB, 1992, NATURE, V359, P716, DOI 10.1038/359716a0; Costa MH, 2003, J HYDROL, V283, P206, DOI 10.1016/S0022-1694(03)00267-1; Davin EL, 2010, J CLIMATE, V23, P97, DOI 10.1175/2009JCLI3102.1; Digerfeldt G, 2000, PALAEOGEOGR PALAEOCL, V158, P65, DOI 10.1016/S0031-0182(00)00029-8; Dong XH, 2008, J PALEOLIMNOL, V40, P413, DOI 10.1007/s10933-007-9170-6; Feddema JJ, 2005, SCIENCE, V310, P1674, DOI 10.1126/science.1118160; Findlay S, 2013, ECOLOGY, V94, P117, DOI 10.1890/12-0464.1; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Galford GL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0171; Gooday AJ, 2009, BIOGEOSCIENCES, V6, P1707, DOI 10.5194/bg-6-1707-2009; Griffiths P, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/045024; Gusewell S, 2006, PLANT SOIL, V287, P131, DOI 10.1007/s11104-006-9050-2; Guo L, 2007, SCIENCE, V317, P1166, DOI 10.1126/science.317.5842.1166; Guzman G, 2013, J SOIL SEDIMENT, V13, P816, DOI 10.1007/s11368-013-0659-5; Hasler N, 2009, J CLIMATE, V22, P1124, DOI 10.1175/2008JCLI2157.1; Hua WJ, 2013, ADV CLIM CHANG RES, V4, P166, DOI 10.3724/SP.J.1248.2013.166; JACOBS M, 1988, TROPICAL RAIN FOREST; Kendall C, 2001, HYDROL PROCESS, V15, P1301, DOI 10.1002/hyp.216; Knibbs LD, 2014, ENVIRON RES, V135, P204, DOI 10.1016/j.envres.2014.09.011; Kunz MJ, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001538; Lambin EF, 2001, GLOBAL ENVIRON CHANG, V11, P261, DOI 10.1016/S0959-3780(01)00007-3; Lambin EF, 2003, ENVIRONMENT, V45, P22, DOI 10.1080/00139157.2003.10544695; Lawrence PJ, 2012, J CLIMATE, V25, P3071, DOI 10.1175/JCLI-D-11-00256.1; Matthews MW, 2012, REMOTE SENS ENVIRON, V124, P637, DOI 10.1016/j.rse.2012.05.032; Meisel S, 2011, FOSS REC, V14, P141, DOI 10.1002/mmng.201100004; Mizugaki S, 2006, CATENA, V68, P25, DOI 10.1016/j.catena.2006.03.014; Muller A, 1999, PALAEOGEOGR PALAEOCL, V145, P1, DOI 10.1016/S0031-0182(98)00094-7; Nadeu E, 2012, BIOGEOSCIENCES, V9, P1099, DOI 10.5194/bg-9-1099-2012; O'Reilly J, 2011, J ENVIRON RADIOACTIV, V102, P495, DOI 10.1016/j.jenvrad.2010.09.003; Olofsson P, 2013, REMOTE SENS ENVIRON, V129, P122, DOI 10.1016/j.rse.2012.10.031; PETERJOHN WT, 1984, ECOLOGY, V65, P1466, DOI 10.2307/1939127; Piao SL, 2007, P NATL ACAD SCI USA, V104, P15242, DOI 10.1073/pnas.0707213104; Pielke RA, 2005, SCIENCE, V310, P1625, DOI 10.1126/science.1120529; Polyakov VO, 2004, SOIL SCI, V169, P590, DOI 10.1097/01.ss.0000138414.84427.40; Qin B, 2008, LAKE TAIHU CHINA DYN; Rabalais NN, 2009, ICES J MAR SCI, V66, P1528, DOI 10.1093/icesjms/fsp047; Rose NL, 2004, J PALEOLIMNOL, V32, P41, DOI 10.1023/B:JOPL.0000025282.06961.42; Schelske CL, 2006, LIMNOL OCEANOGR, V51, P728, DOI 10.4319/lo.2006.51.1_part_2.0728; Sherbinin A., 2002, LAND USE LAND COVER; SHUKLA J, 1990, SCIENCE, V247, P1322, DOI 10.1126/science.247.4948.1322; Snyder PK, 2004, CLIM DYNAM, V23, P279, DOI 10.1007/s00382-004-0430-0; Sundquist ET, 2011, APPL GEOCHEM, V26, pS259, DOI 10.1016/j.apgeochem.2011.03.118; Thomas AD, 1999, CATENA, V36, P283, DOI 10.1016/S0341-8162(99)00051-X; Townsend AR, 2003, FRONT ECOL ENVIRON, V1, P240, DOI 10.2307/3868011; Tu J, 2008, SCI TOTAL ENVIRON, V407, P358, DOI 10.1016/j.scitotenv.2008.09.031; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wang M., 2011, EOS T AM GEOPHYS UN, V89, P201, DOI [DOI 10.1029/2008EO220001, 10.1029/2008EO220001]; Wang M, 2012, ENVIRON SCI TECHNOL, V46, P4481, DOI 10.1021/es204183v; Wilkinson BH, 2007, GEOL SOC AM BULL, V119, P140, DOI 10.1130/B25899.1; Wu JL, 2006, HYDROBIOLOGIA, V563, P19, DOI 10.1007/s10750-005-9133-8; Xian G, 2009, REMOTE SENS ENVIRON, V113, P1133, DOI 10.1016/j.rse.2009.02.004; Xie HL, 2014, INT J ENV RES PUB HE, V11, P583, DOI 10.3390/ijerph110100583; [殷立琼 Yin Liqiong], 2005, [湖泊科学, Scientia Limnologica Sinica], V17, P139; Yu WH, 2011, APPL GEOGR, V31, P600, DOI 10.1016/j.apgeog.2010.11.019; Zhan CS, 2011, J PLANT ECOL, V4, P61, DOI 10.1093/jpe/rtr003; Zhang EL, 2010, J LIMNOL, V69, P235, DOI 10.4081/jlimnol.2010.235; Zhang H, 2008, ENVIRON SCI TECHNOL, V42, P2328, DOI 10.1021/es0720208; Zhou WH, 2014, ENVIRON RES, V135, P81, DOI 10.1016/j.envres.2014.08.025	63	7	7	7	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0120319	10.1371/journal.pone.0120319	http://dx.doi.org/10.1371/journal.pone.0120319			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898010	Green Published, gold, Green Submitted			2022-12-26	WOS:000353212600005
J	Kim, CK; Seol, YJ; Shin, Y; Lim, HM; Lee, GS; Kim, AR; Lee, TH; Lee, JH; Park, DS; Yoo, S; Kim, YH; Kim, YK				Kim, Chang-Kug; Seol, Young-Joo; Shin, Younhee; Lim, Hye-Min; Lee, Gang-Seob; Kim, A-Ram; Lee, Tae-Ho; Lee, Jae-Hee; Park, Dong-Suk; Yoo, Seungil; Kim, Yong-Hwan; Kim, Yong-Kab			Whole-Genome Resequencing and Transcriptomic Analysis to Identify Genes Involved in Leaf-Color Diversity in Ornamental Rice Plants	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; ANTHOCYANINS; SEQUENCE; IDENTIFICATION; BIOSYNTHESIS; DEFICIENCY; METABOLISM; GENERATION; ALIGNMENT; FAMILY	Rice field art is a large-scale art form in which people design rice fields using various kinds of ornamental rice plants with different leaf colors. Leaf color-related genes play an important role in the study of chlorophyll biosynthesis, chloroplast structure and function, and anthocyanin biosynthesis. Despite the role of different metabolites in the traditional relationship between leaf and color, comprehensive color-specific metabolite studies of ornamental rice have been limited. We performed whole-genome resequencing and transcriptomic analysis of regulatory patterns and genetic diversity among different rice cultivars to discover new genetic mechanisms that promote enhanced levels of various leaf colors. We resequenced the genomes of 10 rice leaf-color accessions to an average of 40x reads depth and >95% coverage and performed 30 RNA-seq experiments using the 10 rice accessions sampled at three developmental stages. The sequencing results yielded a total of 1,814 x 106 reads and identified an average of 713,114 SNPs per rice accession. Based on our analysis of the DNA variation and gene expression, we selected 47 candidate genes. We used an integrated analysis of the whole-genome resequencing data and the RNA-seq data to divide the candidate genes into two groups: genes related to macronutrient (i.e., magnesium and sulfur) transport and genes related to flavonoid pathways, including anthocyanidin biosynthesis. We verified the candidate genes with quantitative real-time PCR using transgenic T-DNA insertion mutants. Our study demonstrates the potential of integrated screening methods combined with genetic-variation and transcriptomic data to isolate genes involved in complex biosynthetic networks and pathways.	[Kim, Chang-Kug; Seol, Young-Joo; Lee, Tae-Ho; Lee, Jae-Hee; Park, Dong-Suk] Rural Dev Adm, NAAS, Genom Div, Jeonju, South Korea; [Shin, Younhee; Yoo, Seungil] Insilicogen Inc, Codes Div, Suwon, Gyeonggi Do, South Korea; [Lim, Hye-Min; Lee, Gang-Seob; Kim, A-Ram] RDA, NAAS, Biosafety Div, Jeonju, South Korea; [Kim, Yong-Hwan] Korea Inst Planning & Evaluat Technol Food Agr Fo, Policy Dev Off, Anyang, South Korea; [Kim, Yong-Kab] Wonkwang Univ, Sch Elect Informat Commun Engn, Iksan, South Korea	Rural Development Administration (RDA); Rural Development Administration (RDA); Wonkwang University	Kim, YK (corresponding author), Wonkwang Univ, Sch Elect Informat Commun Engn, Iksan, South Korea.	ykim@wonkwang.ac.kr			Research Program for Agricultural Science and Technology Development of the National Academy of Agricultural Science [PJ010112]; Next-Generation BioGreen 21 Program (SSAC), Rural Development Administration, Republic of Korea [PJ009614]; Insilicogen Inc.	Research Program for Agricultural Science and Technology Development of the National Academy of Agricultural Science; Next-Generation BioGreen 21 Program (SSAC), Rural Development Administration, Republic of Korea; Insilicogen Inc.	This study was conducted with support from the Research Program for Agricultural Science and Technology Development (Project No. PJ010112) of the National Academy of Agricultural Science, and the Next-Generation BioGreen 21 Program (SSAC, Grant No PJ009614), Rural Development Administration, Republic of Korea. Co-authors YS and SY are employed by Insilicogen Inc. Insilicogen Inc. provided support in the form of salaries for authors YS and SY, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Davidian JC, 2010, MOL PLANT, V3, P314, DOI 10.1093/mp/ssq001; Deng XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099564; Ding YC, 2008, PEDOSPHERE, V18, P316, DOI 10.1016/S1002-0160(08)60021-1; Droux M, 2003, PLANT PHYSIOL BIOCH, V41, P619, DOI 10.1016/S0981-9428(03)00083-4; Gebert M, 2009, PLANT CELL, V21, P4018, DOI 10.1105/tpc.109.070557; Guigo R, 1998, J COMPUT BIOL, V5, P681, DOI 10.1089/cmb.1998.5.681; Jeong DH, 2006, PLANT J, V45, P123, DOI 10.1111/j.1365-313X.2005.02610.x; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Kim CK, 2011, J APPL GENET, V52, P161, DOI 10.1007/s13353-011-0027-3; Kim CK, 2014, EVOL BIOINFORM, V10, DOI 10.4137/EBO.S14823; Kim C, 2010, BIOCHIP J, V4, P247, DOI 10.1007/s13206-010-4313-7; Kobayashi NI, 2013, PHYSIOL PLANTARUM, V148, P490, DOI 10.1111/ppl.12003; Kong JM, 2003, PHYTOCHEMISTRY, V64, P923, DOI 10.1016/S0031-9422(03)00438-2; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kumar S, 2011, FUNCT INTEGR GENOMIC, V11, P259, DOI 10.1007/s10142-010-0207-y; Li YH, 2012, RICE SCI, V19, P79, DOI 10.1016/S1672-6308(12)60025-0; Peng CL, 2006, SCI CHINA SER C, V49, P543, DOI 10.1007/s11427-006-2022-1; Sakuraba Y, 2013, PLANT J, V74, P122, DOI 10.1111/tpj.12110; Springob K, 2003, NAT PROD REP, V20, P288, DOI 10.1039/b109542k; Tanaka A, 2006, CURR OPIN PLANT BIOL, V9, P248, DOI 10.1016/j.pbi.2006.03.011; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Tanner GJ, 2003, J BIOL CHEM, V278, P31647, DOI 10.1074/jbc.M302783200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Unno H, 2007, J BIOL CHEM, V282, P15812, DOI 10.1074/jbc.M700638200; Varinderpal-Singh, 2010, NUTR CYCL AGROECOSYS, V88, P361, DOI 10.1007/s10705-010-9363-7; Xie DY, 2004, ARCH BIOCHEM BIOPHYS, V422, P91, DOI 10.1016/j.abb.2003.12.011; Xu HX, 2007, RUSS J PLANT PHYSL+, V54, P741, DOI 10.1134/S1021443707060040; Xu JM, 2013, PLANT PHYSIOL, V161, P2036, DOI 10.1104/pp.112.210831; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang FT, 2013, RICE, V6, DOI 10.1186/1939-8433-6-7	33	9	10	7	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124071	10.1371/journal.pone.0124071	http://dx.doi.org/10.1371/journal.pone.0124071			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897514	Green Published, Green Submitted, gold			2022-12-26	WOS:000353212600047
J	Weddell, JC; Kwack, J; Imoukhuede, PI; Masud, A				Weddell, Jared C.; Kwack, JaeHyuk; Imoukhuede, P. I.; Masud, Arif			Hemodynamic Analysis in an Idealized Artery Tree: Differences in Wall Shear Stress between Newtonian and Non-Newtonian Blood Models	PLOS ONE			English	Article							FLUID-STRUCTURE INTERACTION; FINITE-ELEMENT-METHOD; ABDOMINAL AORTIC-ANEURYSMS; CORONARY-ARTERY; ISOGEOMETRIC ANALYSIS; CEREBRAL ANEURYSMS; FLOW; PROGRESSION; EXERCISE; RISK	Development of many conditions and disorders, such as atherosclerosis and stroke, are dependent upon hemodynamic forces. To accurately predict and prevent these conditions and disorders hemodynamic forces must be properly mapped. Here we compare a shear-rate dependent fluid (SDF) constitutive model, based on the works by Yasuda et al in 1981, against a Newtonian model of blood. We verify our stabilized finite element numerical method with the benchmark lid-driven cavity flow problem. Numerical simulations show that the Newtonian model gives similar velocity profiles in the 2-dimensional cavity given different height and width dimensions, given the same Reynolds number. Conversely, the SDF model gave dissimilar velocity profiles, differing from the Newtonian velocity profiles by up to 25% in velocity magnitudes. This difference can affect estimation in platelet distribution within blood vessels or magnetic nanoparticle delivery. Wall shear stress (WSS) is an important quantity involved in vascular remodeling through integrin and adhesion molecule mechanotransduction. The SDF model gave a 7.3-fold greater WSS than the Newtonian model at the top of the 3-dimensional cavity. The SDF model gave a 37.7-fold greater WSS than the Newtonian model at artery walls located immediately after bifurcations in the idealized femoral artery tree. The pressure drop across arteries reveals arterial sections highly resistive to flow which correlates with stenosis formation. Numerical simulations give the pressure drop across the idealized femoral artery tree with the SDF model which is approximately 2.3-fold higher than with the Newtonian model. In atherosclerotic lesion models, the SDF model gives over 1 Pa higher WSS than the Newtonian model, a difference correlated with over twice as many adherent monocytes to endothelial cells from the Newtonian model compared to the SDF model.	[Weddell, Jared C.; Imoukhuede, P. I.] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA; [Kwack, JaeHyuk; Masud, Arif] Univ Illinois, Dept Civil Engn, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Weddell, JC (corresponding author), Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA.	Jwedde3@illinois.edu	Imoukhuede, P I/T-7580-2017; Stefanadis, Christodoulos/ABH-2232-2020	Imoukhuede, P I/0000-0002-4257-1085; Stefanadis, Christodoulos/0000-0001-5974-6454	American Cancer Society, Illinois Division Basic Research Grant; National Science Foundation [OCI-0725070, ACI-1238993]; state of Illinois	American Cancer Society, Illinois Division Basic Research Grant(American Cancer Society); National Science Foundation(National Science Foundation (NSF)); state of Illinois	The authors would like to acknowledge the American Cancer Society, Illinois Division Basic Research Grant for funding support. This research is part of the Blue Waters sustained-petascale computing project, which is supported by the National Science Foundation (awards OCI-0725070 and ACI-1238993) and the state of Illinois. Blue Waters is a joint effort of the University of Illinois at Urbana-Champaign and its National Center for Supercomputing Applications. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Anand M, 2013, INT J ENG SCI, V72, P78, DOI 10.1016/j.ijengsci.2013.06.009; Argiento P, 2010, EUR RESPIR J, V35, P1273, DOI 10.1183/09031936.00076009; Argiento P, 2012, CHEST, V142, P1158, DOI 10.1378/chest.12-0071; Bazilevs Y, 2009, COMPUT METHOD APPL M, V198, P3534, DOI 10.1016/j.cma.2009.04.015; Birchall D, 2006, EUR RADIOL, V16, P1074, DOI 10.1007/s00330-005-0048-6; Boussel L, 2008, STROKE, V39, P2997, DOI 10.1161/STROKEAHA.108.521617; Boyd J, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2772250; BROOKS AN, 1982, COMPUT METHOD APPL M, V32, P199, DOI 10.1016/0045-7825(82)90071-8; Calderer R, 2010, COMPUT MECH, V46, P185, DOI 10.1007/s00466-010-0487-z; Cebral JR, 2005, AM J NEURORADIOL, V26, P2550; Cherry EM, 2010, MED PHYS, V37, P175, DOI 10.1118/1.3271344; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; Chung B. J., 2004, THESIS U PITTSBURGH; COKELET GR, 1963, T SOC RHEOL, V7, P303, DOI 10.1122/1.548959; Cutri E, 2013, BIOMECH MODEL MECHAN, V12, P657, DOI 10.1007/s10237-012-0432-5; Darton NJ, 2008, NANOMED-NANOTECHNOL, V4, P19, DOI 10.1016/j.nano.2007.11.001; Ethier CR, 2002, ANN BIOMED ENG, V30, P461, DOI 10.1114/1.1468890; Filipovic N, 2011, J SERB SOC COMPUT ME, V5, P129; Fillinger MF, 2003, J VASC SURG, V37, P724, DOI 10.1067/mva.2003.213; Finley SD, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-193; Gerszten RE, 1998, CIRC RES, V82, P871; GHIA U, 1982, J COMPUT PHYS, V48, P387, DOI 10.1016/0021-9991(82)90058-4; GIBSON CM, 1993, ARTERIOSCLER THROMB, V13, P310, DOI 10.1161/01.ATV.13.2.310; Gijsen FJH, 1999, J BIOMECH, V32, P705, DOI 10.1016/S0021-9290(99)00014-7; Gitz E, 2013, HAEMATOLOGICA, V98, P1810, DOI 10.3324/haematol.2013.087221; Gnasso A, 1997, STROKE, V28, P993, DOI 10.1161/01.STR.28.5.993; Grundy SM, 1999, CIRCULATION, V100, P1481, DOI 10.1161/01.CIR.100.13.1481; HAYNES RH, 1959, AM J PHYSIOL, V197, P943, DOI 10.1152/ajplegacy.1959.197.5.943; Hoi YM, 2011, ANN BIOMED ENG, V39, P1414, DOI 10.1007/s10439-011-0255-z; Hossain SS, 2013, NANOMEDICINE-UK, V8, P343, DOI [10.2217/NNM.12.124, 10.2217/nnm.12.124]; Hossain SS, 2012, COMPUT MECH, V49, P213, DOI 10.1007/s00466-011-0633-2; HUGHES TJR, 1989, COMPUT METHOD APPL M, V73, P173, DOI 10.1016/0045-7825(89)90111-4; Johnston BM, 2004, J BIOMECH, V37, P709, DOI 10.1016/j.jbiomech.2003.09.016; Karmonik Christof, 2008, Technol Health Care, V16, P343; Kennedy JW, 1999, DIABETES, V48, P1192, DOI 10.2337/diabetes.48.5.1192; Kim S, 2011, ASME JSME KSME JOINT; Kim S., 2002, THESIS DREXEL U; Kornet L, 1999, ARTERIOSCL THROM VAS, V19, P2933, DOI 10.1161/01.ATV.19.12.2933; Kornet L, 2000, J VASC RES, V37, P112, DOI 10.1159/000025722; Ku DN, 1997, ANNU REV FLUID MECH, V29, P399, DOI 10.1146/annurev.fluid.29.1.399; Kwack J, 2014, COMPUT MECH, V53, P751, DOI 10.1007/s00466-013-0928-6; Kwack J, 2010, INT J ENG SCI, V48, P1413, DOI 10.1016/j.ijengsci.2010.09.007; Leung JH, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-33; LEWIS P, 1986, ULTRASOUND MED BIOL, V12, P777, DOI 10.1016/0301-5629(86)90075-X; LEWIS P, 1990, BRIT J SURG, V77, P183, DOI 10.1002/bjs.1800770220; Liu Biyue, 2011, Molecular & Cellular Biomechanics, V8, P73, DOI 10.3970/mcb.2011.008.073; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Martin D, 2009, BRIT J RADIOL, V82, pS33, DOI 10.1259/bjr/59367266; Masud A, 2006, COMPUT METHOD APPL M, V195, P1750, DOI 10.1016/j.cma.2005.05.048; Masud A, 2011, COMPUT METHOD APPL M, V200, P577, DOI 10.1016/j.cma.2010.08.012; Masud A, 2009, COMPUT MECH, V44, P145, DOI 10.1007/s00466-008-0362-3; MERRILL EW, 1967, J APPL PHYSIOL, V23, P178, DOI 10.1152/jappl.1967.23.2.178; Mihalef V, 2010, I S BIOMED IMAGING, P504, DOI 10.1109/ISBI.2010.5490298; Milde F, 2008, BIOPHYS J, V95, P3146, DOI 10.1529/biophysj.107.124511; Molla MM, 2012, MED ENG PHYS, V34, P1079, DOI 10.1016/j.medengphy.2011.11.013; Mugii N, 2009, RHEUMATOLOGY, V48, P696, DOI 10.1093/rheumatology/kep066; Naeije R, 2012, COMPR PHYSIOL, V2, P711, DOI 10.1002/cphy.c100091; Nixon AM, 2010, J NEUROSURG, V112, P1240, DOI 10.3171/2009.10.JNS09759; OLESEN SP, 1988, NATURE, V331, P168, DOI 10.1038/331168a0; Olgac U, 2009, AM J PHYSIOL-HEART C, V296, pH1969, DOI 10.1152/ajpheart.01182.2008; Owens RG, 2006, J NON-NEWTON FLUID, V140, P57, DOI 10.1016/j.jnnfm.2006.01.015; Papaioannou Theodoros G, 2005, Hellenic J Cardiol, V46, P9; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Rajagopal K.R., 1993, PITMAN RES NOTES MAT, V291, P129; Samady H, 2011, CIRCULATION, V124, P779, DOI 10.1161/CIRCULATIONAHA.111.021824; SCHMIDSCHONBEIN H, 1969, J APPL PHYSIOL, V26, P674, DOI 10.1152/jappl.1969.26.5.674; Scotti CM, 2005, BIOMED ENG ONLINE, V4, DOI 10.1186/1475-925X-4-64; Sequeira A., 2007, PORTRAIT STATE OF TH, P65; Shojima M, 2004, STROKE, V35, P2500, DOI 10.1161/01.STR.0000144648.89172.0f; Sigal RJ, 2004, DIABETES CARE, V27, P2518, DOI 10.2337/diacare.27.10.2518; Skyba DM, 1998, CIRCULATION, V98, P290, DOI 10.1161/01.CIR.98.4.290; SLIFE DM, 1990, AM J PHYSIOL, V258, pH1823, DOI 10.1152/ajpheart.1990.258.6.H1823; Steinman DA, 2003, J VASC SURG, V37, P1118, DOI 10.1067/mva.2003.122; Stone PH, 2003, CIRCULATION, V108, P438, DOI 10.1161/01.CIR.0000080882.35274.AD; TANGELDER GJ, 1986, CIRC RES, V59, P505, DOI 10.1161/01.RES.59.5.505; Tateshima S, 2003, STROKE, V34, P187, DOI 10.1161/01.STR.0000046456.26587.8B; Tian FB, 2013, COMPUT BIOL MED, V43, P1098, DOI 10.1016/j.compbiomed.2013.05.023; van Royen N, 2001, CARDIOVASC RES, V49, P543, DOI 10.1016/S0008-6363(00)00206-6; Vimmr J, 2010, MATH COMPUT SIMULAT, V80, P1324, DOI 10.1016/j.matcom.2009.01.004; WELLS RE, 1961, SCIENCE, V133, P763, DOI 10.1126/science.133.3455.763; Whaley M H, 1997, J Cardiopulm Rehabil, V17, P37, DOI 10.1097/00008483-199701000-00005; Wolters BJBM, 2005, MED ENG PHYS, V27, P871, DOI 10.1016/j.medengphy.2005.06.008; Yang C, 2007, CMES-COMP MODEL ENG, V19, P233; YASUDA K, 1981, RHEOL ACTA, V20, P163, DOI 10.1007/BF01513059; YOUNG DF, 1975, CIRC RES, V36, P735, DOI 10.1161/01.RES.36.6.735; Zhang YJ, 2007, COMPUT METHOD APPL M, V196, P2943, DOI 10.1016/j.cma.2007.02.009	88	24	24	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124575	10.1371/journal.pone.0124575	http://dx.doi.org/10.1371/journal.pone.0124575			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897758	Green Published, gold, Green Submitted			2022-12-26	WOS:000353212600073
J	Feng, Y; Wratten, S; Sandhu, H; Keller, M				Feng, Yi; Wratten, Steve; Sandhu, Harpinder; Keller, Michael			Host Plants Affect the Foraging Success of Two Parasitoids that Attack Light Brown Apple Moth Epiphyas postvittana (Walker) (Lepidoptera: Tortricidae)	PLOS ONE			English	Article							TRICHOGRAMMA-NUBILALE HYMENOPTERA; CORN-BORER LEPIDOPTERA; BIOLOGICAL-CONTROL; COTESIA-GLOMERATA; NATURAL ENEMIES; BEHAVIOR; VOLATILES; RESPONSES; LARVAE; RUBECULA	The light brown apple moth, Epiphyas postvittana is a key pest of wine grapes in Australia. Two parasitoids, Dolichogenidea tasmanica and Therophilus unimaculatus, attack the larval stage of this pest. D. tasmanica is dominant in vineyards, whereas T. unimaculatus is mainly active in native vegetation. We sought to understand why they differ in their use of habitats. Plants are a major component of habitats of parasitoids, and herbivore-infested plants influence parasitoid foraging efficiency by their architecture and emission of volatile chemicals. We investigated how different plant species infested by E. postvittana could affect the foraging success of the two parasitoid species in both laboratory and field experiments. Four common host-plant species were selected for this study. In paired-choice experiments to determine the innate foraging preferences for plants, both parasitoid species showed differences in innate search preferences among plant species. The plant preference of D. tasmanica was altered by oviposition experience with hosts that were feeding on other plant species. In a behavioral assay, the two parasitoid species allocated their times engaged in various types of behavior differently when foraging on different plant species. For both parasitoids, parasitism on Hardenbergia violacea was the highest of the four plant species. Significantly more larvae dropped from Myoporum insulare when attacked than from the other three host-plant species, which indicates that parasitism is also affected by interactions between plants and host insects. In vineyards, parasitism by D. tasmanica was significantly lower on M. insulare than on the other three host-plant species, but the parasitism rates were similar among the other three plant species. Our results indicate that plants play a role in the habitat preferences of these two parasitoid species by influencing their foraging behavior, and are likely to contribute to their distributions among habitats.	[Feng, Yi; Keller, Michael] Univ Adelaide, Sch Agr Food & Wine, Adelaide, SA, Australia; [Wratten, Steve] Lincoln Univ, Bioprotect Res Ctr, Lincoln, NE, New Zealand; [Sandhu, Harpinder] Flinders Univ S Australia, Sch Environm, Adelaide, SA 5001, Australia	University of Adelaide; Lincoln University - New Zealand; Flinders University South Australia	Feng, Y (corresponding author), Univ Adelaide, Sch Agr Food & Wine, Adelaide, SA, Australia.	yi.feng@adelaide.edu.au	Sandhu, Harpinder S/E-9338-2010; Keller, Michael A/A-8371-2008; Wratten, Steve D/J-3467-2013	Sandhu, Harpinder S/0000-0001-5428-094X; Keller, Michael A/0000-0003-0721-9753; Wratten, Steve D/0000-0002-5168-8277	Chinese Scholarship Council (CSC) [2010630004]; Grape and Wine Research and Development Corporation (GWRDC) [PH1007]	Chinese Scholarship Council (CSC)(China Scholarship Council); Grape and Wine Research and Development Corporation (GWRDC)(Australian Grape and Wine Authority)	The following sources of funding have supported the work: Chinese Scholarship Council (CSC) scholarship Grant Number: 2010630004 and Grape and Wine Research and Development Corporation (GWRDC) PhD Research Scholarship, Grant Number: PH1007 to Yi Feng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABLES J R, 1980, Southwestern Entomologist, V5, P261; ANDOW DA, 1990, OECOLOGIA, V82, P162, DOI 10.1007/BF00323530; BELCHER DW, 1982, ENVIRON ENTOMOL, V11, P91, DOI 10.1093/ee/11.1.91; Bergman J.M., 1979, Bulletin of the Entomological Society of America, V25, P275; BIGLER F, 1986, J APPL ENTOMOL, V102, P303, DOI 10.1111/j.1439-0418.1986.tb00926.x; BOND AB, 1983, ANIM BEHAV, V31, P990, DOI 10.1016/S0003-3472(83)80004-9; BURBUTIS PP, 1981, J ECON ENTOMOL, V74, P246, DOI 10.1093/jee/74.2.246; CARTER MC, 1984, OECOLOGIA, V63, P394, DOI 10.1007/BF00390671; Charles JG, 1996, NEW ZEAL J CROP HORT, V24, P123, DOI 10.1080/01140671.1996.9513944; Cortesero AM, 2000, BIOL CONTROL, V17, P35, DOI 10.1006/bcon.1999.0777; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; DUMBLETON L. J., 1935, NEW ZEALAND JOUR SCI AND TECHNOL, V17, P572; Feng Y, 2015, B ENTOMOL RES, V105, P426, DOI 10.1017/S0007485314000923; Fountain ED, 2013, ECOSYSTEM SERVICES IN NEW ZEALAND: CONDITIONS AND TRENDS, P115; Geervliet JBF, 1997, J CHEM ECOL, V23, P2935, DOI 10.1023/A:1022583515142; GEERVLIET JBF, 1994, ENTOMOL EXP APPL, V73, P289, DOI 10.1007/BF02382480; Geervliet JBF, 1996, J INSECT BEHAV, V9, P525, DOI 10.1007/BF02213877; Geervliet JBF, 1998, ENTOMOL EXP APPL, V86, P241, DOI 10.1023/A:1003186706517; Geitzenauer HL, 1996, ECOL ENTOMOL, V21, P227, DOI 10.1046/j.1365-2311.1996.t01-1-00006.x; Gingras D, 2002, ENVIRON ENTOMOL, V31, P1153, DOI 10.1603/0046-225X-31.6.1153; Gingras D, 2002, OECOLOGIA, V130, P396, DOI 10.1007/s00442-001-0819-y; Girling RD, 2011, P ROY SOC B-BIOL SCI, V278, P2646, DOI 10.1098/rspb.2010.2725; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; GREVSTAD FS, 1992, OECOLOGIA, V92, P399, DOI 10.1007/BF00317466; Gurr G., 2004, ECOLOGICAL ENG PEST; HERARD F, 1988, J CHEM ECOL, V14, P1583, DOI 10.1007/BF01012524; Ishii Y, 2010, POPUL ECOL, V52, P27, DOI 10.1007/s10144-009-0185-x; KANOUR WW, 1984, J ECON ENTOMOL, V77, P103, DOI 10.1093/jee/77.1.103; KAREIVA P, 1990, NATURE, V345, P433, DOI 10.1038/345433a0; KAUFFMAN WC, 1989, ENVIRON ENTOMOL, V18, P698, DOI 10.1093/ee/18.4.698; KELLER MA, 1987, ENTOMOL EXP APPL, V43, P55, DOI 10.1007/BF00350375; KELLER MA, 1990, ENTOMOL EXP APPL, V57, P243, DOI 10.1007/BF00355023; LETOURNEAU DK, 1990, ECOL ENTOMOL, V15, P63, DOI 10.1111/j.1365-2311.1990.tb00784.x; LEWIS WJ, 1990, NATURE, V348, P635, DOI 10.1038/348635a0; Lill JT, 2002, NATURE, V417, P170, DOI 10.1038/417170a; LUCK RF, 1990, TRENDS ECOL EVOL, V5, P196, DOI 10.1016/0169-5347(90)90210-5; MACKAUER M, 1993, OECOLOGIA, V94, P339, DOI 10.1007/BF00317107; Matkin O, 1957, U C SYSTEM PRODUCING, P332; PAPAJ DR, 1990, J CHEM ECOL, V16, P3137, DOI 10.1007/BF00979616; Paull C, 2006, AUST J ENTOMOL, V45, P142, DOI 10.1111/j.1440-6055.2006.00524.x; Paull C, 2013, B ENTOMOL RES, V104, P1; Paull C., 2007, THESIS U ADELAIDE; Paull CA, 2012, BASIC APPL ECOL, V13, P542, DOI 10.1016/j.baae.2012.08.003; Poelman EH, 2009, FUNCT ECOL, V23, P951, DOI 10.1111/j.1365-2435.2009.01570.x; PRICE PW, 1980, ANNU REV ECOL SYST, V11, P41, DOI 10.1146/annurev.es.11.110180.000353; Scholefield P, 2010, 0804 GWR; Stevens NB, 2011, ZOOTAXA, P1; Suckling DM, 2010, ANNU REV ENTOMOL, V55, P285, DOI 10.1146/annurev-ento-112408-085311; Suckling DM, 1998, NEW ZEAL J CROP HORT, V26, P193, DOI 10.1080/01140671.1998.9514055; VET LEM, 1985, OIKOS, V44, P478, DOI 10.2307/3565789; VET LEM, 1992, ANNU REV ENTOMOL, V37, P141, DOI 10.1146/annurev.en.37.010192.001041; VET LEM, 1995, CHEM ECOLOGY INSECTS; VINSON SB, 1976, ANNU REV ENTOMOL, V21, P109, DOI 10.1146/annurev.en.21.010176.000545; WACKERS FL, 1994, BIOL CONTROL, V4, P105, DOI 10.1006/bcon.1994.1018; Yazdani M, 2015, AUSTRAL ENTOMOL, V54, P325, DOI 10.1111/aen.12130; Zar JH, 1999, BIOSTATISTICAL ANAL	56	13	13	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124773	10.1371/journal.pone.0124773	http://dx.doi.org/10.1371/journal.pone.0124773			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893966	Green Published, gold			2022-12-26	WOS:000353211700121
J	Johansson, H; Bjelkenkrantz, K; Darlin, L; Dilllner, J; Forslund, O				Johansson, Hanna; Bjelkenkrantz, Kaj; Darlin, Lotten; Dilllner, Joakim; Forslund, Ola			Presence of High-Risk HPV mRNA in Relation to Future High-Grade Lesions among High-Risk HPV DNA Positive Women with Minor Cytological Abnormalities	PLOS ONE			English	Article							ATYPICAL SQUAMOUS-CELLS; UNDETERMINED SIGNIFICANCE; FOLLOW-UP; DIAGNOSIS; CLASSIFICATION; MANAGEMENT; SAMPLES	Objective Continuous expression of E6- and E7-oncogenes of high-risk human papillomavirus (HPV) types is necessary for the development and maintenance of the dysplastic phenotype. The aim of the study was to determine the sensitivity and specificity of the APTIMA HPV mRNA assay (Hologic) in predicting future development of high-grade cervical intraepithelial neoplasia (CIN) among high-risk HPV-DNA-positive women with atypical squamous cells of undetermined significance (ASCUS) or low-grade squamous epithelial lesion (LSIL) cytology. Methods Archived SurePath cervical samples of women >= 35 years of age with high-risk HPV DNA-positive ASCUS (n = 211) or LSIL, (n = 131) were tested for the presence of high-risk HPV E6/E7 mRNA using the APTIMA HPV assay, and the women were monitored for development of histopathologically verified CIN2+. Results Twenty-nine percent (61/211) of the women in the ASCUS group, and 34.3%(45/131) in the LSIL group developed CIN2+ within 4.5 years of follow-up. The prevalence of HPV mRNA was 90.0%(95% CI 85.9-94.0) among women with ASCUS and 95.4% (95% CI 91.8-99.0) among women with LSIL. The presence of HPV E6/E7 mRNA was associated with future development of CIN2+ among women with ASCUS and LSIL (p=0.02). The mRNA assay demonstrated high sensitivity in predicting future CIN2+ and CIN3 for index ASCUS (96.7%; 95% CI 87.6-99.4 and 100%; 95% CI 82.2-100, respectively) and LSIL (97.8%, 95% CI 86.8-99.9 and 100%, 95% CI 79.9-100, respectively). The corresponding specificity was low, 12.7% (95% CI 7.9-19.3) and 5.8%(95% CI 2.2-13.6), for future CIN2+, respectively. The negative predictive value of the HPV mRNA assay for detecting future CIN3 was 100%, since no mRNA-negative woman developed CIN3 (0/27) as compared to 13.6%(43/315) of the mRNA-positive women (p = 0.03). Conclusion The APTIMA mRNA assay demonstrated high sensitivity but low specificity in predicting future CIN2+ among women with minor cytological abnormalities. The assay had high negative predictive value for future CIN3, indicating that HPV-mRNA-negative women are at low risk of progression to high grade CIN.	[Johansson, Hanna; Forslund, Ola] Lund Univ, Dept Lab Med Med Microbiol, Malmo, Sweden; [Bjelkenkrantz, Kaj] Reg Canc Ctr South, Lund, Sweden; [Darlin, Lotten] Skane Univ Hosp, Dept Obstet & Gynecol, Lund, Sweden; [Dilllner, Joakim] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	Lund University; Lund University; Skane University Hospital; Karolinska Institutet	Forslund, O (corresponding author), Lund Univ, Dept Lab Med Med Microbiol, Malmo, Sweden.	ola.forslund@med.lu.se			BioCARE, a strategic research program of Lund University	BioCARE, a strategic research program of Lund University	This work was supported by BioCARE, a strategic research program of Lund University. The APTIMA reagents were provided free of charge by Hologic, but had no influence on the study design or interpretation of results.	Alanen KW, 1998, CANCER CYTOPATHOL, V84, P5, DOI 10.1002/(SICI)1097-0142(19980225)84:1<5::AID-CNCR2>3.0.CO;2-Q; Arbyn M, 2012, VACCINE, V30, pF88, DOI 10.1016/j.vaccine.2012.06.095; Arbyn M, 2009, J CELL MOL MED, V13, P648, DOI 10.1111/j.1582-4934.2008.00631.x; Broccolo F, 2013, J MED VIROL, V85, P472, DOI 10.1002/jmv.23487; Bzhalava D, 2013, VIROLOGY, V445, P224, DOI 10.1016/j.virol.2013.07.015; Carreon JD, 2007, INT J GYNECOL PATHOL, V26, P441, DOI 10.1097/pgp.0b013e31805152ab; Cuschieri K, 2008, CANCER EPIDEM BIOMAR, V17, P2536, DOI 10.1158/1055-9965.EPI-08-0306; Cuzick J, 2008, VACCINE, V26, pK29, DOI 10.1016/j.vaccine.2008.06.019; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; Elfstrom KM, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g130; Gage JC, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju153; Jeantet D, 2009, J CLIN VIROL, V45, pS29, DOI 10.1016/S1386-6532(09)70006-X; Kirii Y, 1998, VIRUS GENES, V17, P117, DOI 10.1023/A:1008002905588; Lindqvist PG, 2008, EUR J OBSTET GYN R B, V137, P77, DOI 10.1016/j.ejogrb.2006.12.005; Molden T, 2007, J VIROL METHODS, V142, P204, DOI 10.1016/j.jviromet.2007.01.036; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Persson M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090023; Plummer M, 2007, J INFECT DIS, V195, P1582, DOI 10.1086/516784; Safaeian M, 2007, OBSTET GYNECOL, V109, P1325, DOI 10.1097/01.AOG.0000263461.71732.40; Schmitt M, 2006, J CLIN MICROBIOL, V44, P504, DOI 10.1128/JCM.44.2.504-512.2006; Soederlund-Strand A, 2009, J CLIN MICROBIOL, V47, P541, DOI 10.1128/JCM.02007-08; Solomon D, 2004, THE BETHESDA SYSTEM; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Waldstrom M, 2012, CYTOPATHOLOGY, V23, P389, DOI 10.1111/j.1365-2303.2011.00923.x; Waldstrom M, 2011, ARCH PATHOL LAB MED, V135, P1052, DOI 10.5858/2010-0411-OAR	25	23	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124460	10.1371/journal.pone.0124460	http://dx.doi.org/10.1371/journal.pone.0124460			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893988	Green Published, Green Submitted, gold			2022-12-26	WOS:000353211700096
J	Pfefferbaum, A; Zahr, NM; Mayer, D; Rohlfing, T; Sullivan, EV				Pfefferbaum, Adolf; Zahr, Natalie M.; Mayer, Dirk; Rohlfing, Torsten; Sullivan, Edith V.			Dynamic Responses of Selective Brain White Matter Fiber Tracts to Binge Alcohol and Recovery in the Rat	PLOS ONE			English	Article							TRAUMATIC AXONAL INJURY; DIFFUSION-TENSOR MRI; CORPUS-CALLOSUM; IN-VIVO; MICROSTRUCTURAL RECOVERY; PHYSICAL-DEPENDENCE; UNITED-STATES; ETHANOL; ANISOTROPY; DISRUPTION	To determine the dynamics of white matter vulnerability to excessive alcohol consumption, diffusion tensor imaging (DTI) was used in an animal model of alcohol exposure. Quantitative, in vivo fiber tracking results are presented from rats with DTI conducted at 3 time points: baseline; after 4 days of intragastric alcohol to blood alcohol levels of similar to 250mg/dL; and after one week of recovery. Binge alcohol followed by a week of sobriety resulted in rapidly reversible decreases in fractional anisotropy (FA), a measure of the coherence of fiber tracts, in callosal genu and fimbria-fornix but not splenium; and increases in mean diffusivity (MD), an index of freely diffusing water in tissue, selective to the fimbria-fornix. These effects were confirmed with tract-based spatial statistics (TBSS). The directionality of changes in DTI metrics reproduce those observed in human alcoholism. That a single exposure to binge alcohol can cause substantial transient changes detectable in DTI metrics demonstrates the potential for rapid neuroplasticity.	[Pfefferbaum, Adolf; Zahr, Natalie M.; Mayer, Dirk; Rohlfing, Torsten] SRI Int, Neurosci Program, Menlo Pk, CA 94025 USA; [Pfefferbaum, Adolf; Zahr, Natalie M.; Sullivan, Edith V.] Stanford Univ, Dept Psychiat & Behav Sci, Sch Med, Stanford, CA 94305 USA; [Mayer, Dirk] Univ Maryland, Dept Diagnost Radiol, Sch Med, Baltimore, MD 21201 USA	SRI International; Stanford University; University System of Maryland; University of Maryland Baltimore	Zahr, NM (corresponding author), SRI Int, Neurosci Program, 333 Ravenswood Ave, Menlo Pk, CA 94025 USA.	nzahr@stanford.edu	Mayer, Dirk/AAJ-5906-2020; Zahr, Natalie/W-5292-2019; Sullivan, Edith V/ABD-5684-2021	Mayer, Dirk/0000-0001-7557-9019; Sullivan, Edith V/0000-0001-6739-3716	National Institute on Alcohol Abuse and Alcoholism: Integrative Neuroscience Initiative on Neuroscience (INIA) [AA005965, AA012388, AA017168, AA013521]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K05AA017168, R01AA012388, U01AA013521, R37AA005965, R01AA005965] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism: Integrative Neuroscience Initiative on Neuroscience (INIA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	National Institute on Alcohol Abuse and Alcoholism: AA005965, AA012388, AA017168, AA013521-Integrative Neuroscience Initiative on Neuroscience (INIA). SRI International is a nonprofit center (http://www.sri.com/about). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adalsteinsson E, 2004, NEUROIMAGE, V22, P381, DOI 10.1016/j.neuroimage.2003.12.046; Alhassoon OM, 2012, ALCOHOL CLIN EXP RES, V36, P1922, DOI 10.1111/j.1530-0277.2012.01808.x; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Bell RL, 2006, ALCOHOL, V40, P3, DOI 10.1016/j.alcohol.2006.10.001; Bodammer N, 2004, MAGNET RESON MED, V51, P188, DOI 10.1002/mrm.10690; Chanraud S, 2010, NEUROPSYCHOL REV, V20, P209, DOI 10.1007/s11065-010-9129-7; Chanraud S, 2009, NEUROPSYCHOPHARMACOL, V34, P1223, DOI 10.1038/npp.2008.101; Chen CM, 2004, ALCOHOL RES HEALTH, V28, P269; Choe AS, 2012, NMR BIOMED, V25, P900, DOI 10.1002/nbm.1810; Chronik BA, 2000, MAGNET RESON MED, V44, P955, DOI 10.1002/1522-2594(200012)44:6<955::AID-MRM18>3.0.CO;2-1; Chronik B, 2000, MAGN RESON MATER PHY, V10, P131; DELAMONTE SM, 1988, ARCH NEUROL-CHICAGO, V45, P990, DOI 10.1001/archneur.1988.00520330076013; Dodero L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076655; Faingold Carl L, 2008, Curr Protoc Neurosci, VChapter 9, DOI 10.1002/0471142301.ns0928s44; Gozzi A, 2013, NEUROIMAGE, V69, P112, DOI 10.1016/j.neuroimage.2012.12.015; Grant BF, 2004, DRUG ALCOHOL DEPEN, V74, P223, DOI 10.1016/j.drugalcdep.2004.02.004; Grant KA, 2003, PHARMACOL THERAPEUT, V100, P235, DOI 10.1016/j.pharmthera.2003.08.004; HARPER C, 1985, J NEUROL NEUROSUR PS, V48, P211, DOI 10.1136/jnnp.48.3.211; HARPER CG, 1988, BRIT J ADDICT, V83, P577; Harsan LA, 2007, J NEUROSCI RES, V85, P935, DOI 10.1002/jnr.21201; Hofstetter S, 2013, J NEUROSCI, V33, P12844, DOI 10.1523/JNEUROSCI.4520-12.2013; HUNT WA, 1977, J PHARMACOL EXP THER, V201, P103; Jenkinson M, 2003, MAGNET RESON MED, V49, P193, DOI 10.1002/mrm.10354; Jones DK, 2010, DIFFUSION MRI THEORY; Kelso ML, 2011, NEUROSCIENCE, V197, P381, DOI 10.1016/j.neuroscience.2011.09.019; Kong LM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/798261; Konrad A, 2012, ALCOHOL ALCOHOLISM, V47, P118, DOI 10.1093/alcalc/agr157; Kril JJ, 1997, HEPATOLOGY, V26, P837, DOI 10.1053/jhep.1997.v26.pm0009328301; Li T K, 1987, Alcohol Alcohol Suppl, V1, P91; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; MAJCHROWICZ E, 1975, PSYCHOPHARMACOLOGIA, V43, P245, DOI 10.1007/BF00429258; MAJCHROWICZ E, 1976, PSYCHOPHARMACOLOGY, V50, P107, DOI 10.1007/BF00430477; Martin-Fardon R, 2013, CURR TOP BEHAV NEURO, V13, P403, DOI 10.1007/7854_2012_202; Mayer D, 2007, NEUROIMAGE, V35, P1077, DOI 10.1016/j.neuroimage.2007.01.006; McBride WJ, 2010, ALCOHOL, V44, P171, DOI 10.1016/j.alcohol.2009.12.001; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Mori S, 1999, P 7 ISMRM PHIL, P320; NEEMAN M, 1991, MAGNET RESON MED, V21, P138, DOI 10.1002/mrm.1910210117; Neighbors C, 2006, INT J DRUG POLICY, V17, P304, DOI 10.1016/j.drugpo.2006.05.004; O'Brien CP, 2009, ALCOHOLISM DANA GUID; Oster SM, 2006, ALCOHOL, V38, P155, DOI 10.1016/j.alcohol.2006.06.001; PAULABARBOSA MM, 1985, BRAIN RES, V339, P195, DOI 10.1016/0006-8993(85)90645-6; Pfefferbaum A, 2000, MAGNET RESON MED, V44, P259, DOI 10.1002/1522-2594(200008)44:2<259::AID-MRM13>3.0.CO;2-6; Pfefferbaum A, 2003, MAGNET RESON MED, V49, P953, DOI 10.1002/mrm.10452; Pfefferbaum A, 2005, NEUROPSYCHOPHARMACOL, V30, P423, DOI 10.1038/sj.npp.1300623; Pfefferbaum A, 2004, J MAGN RESON IMAGING, V20, P779, DOI 10.1002/jmri.20181; Pfefferbaum A, 2002, NEUROIMAGE, V15, P708, DOI 10.1006/nimg.2001.1018; Pfefferbaum A, 2001, NEUROREPORT, V12, P1677, DOI 10.1097/00001756-200106130-00032; Pfefferbaum A, 2006, NEUROBIOL AGING, V27, P994, DOI 10.1016/j.neurobiolaging.2005.05.007; Pfefferbaum A, 2007, BRAIN, V130, P48, DOI 10.1093/brain/awl242; Pfefferbaum A, 2014, LANCET PSYCHIAT, V1, P202, DOI 10.1016/S2215-0366(14)70301-3; Pfefferbaum A, 2009, BIOL PSYCHIAT, V65, P680, DOI 10.1016/j.biopsych.2008.10.039; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Putzke J, 1998, MOL BRAIN RES, V62, P196, DOI 10.1016/S0169-328X(98)00253-8; Rodd ZA, 2004, PHARMACOL BIOCHEM BE, V79, P439, DOI 10.1016/j.pbb.2004.08.018; Rodd ZA, 2009, ADDICT BIOL, V14, P152, DOI 10.1111/j.1369-1600.2008.00140.x; Rohlfing T, 2003, IEEE T INF TECHNOL B, V7, P16, DOI 10.1109/TITB.2003.808506; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Rutledge PC, 2008, J CONSULT CLIN PSYCH, V76, P511, DOI 10.1037/0022-006X.76.3.511; Sagi Y, 2012, NEURON, V73, P1195, DOI 10.1016/j.neuron.2012.01.025; Satriotomo I, 2000, BRAIN RES, V879, P55, DOI 10.1016/S0006-8993(00)02729-3; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Sorg SF, 2012, BIOL PSYCHIAT, V71, P262, DOI 10.1016/j.biopsych.2011.09.022; Sullivan EV, 2006, CEREB CORTEX, V16, P1030, DOI 10.1093/cercor/bhj045; Sullivan EV, 2011, NEUROIMAGE, V57, P214, DOI 10.1016/j.neuroimage.2011.04.003; Sullivan EV, 2013, NEUROBIOLOG IN PRESS; TARNOWSKADZIDUSZKO E, 1995, FOLIA NEUROPATHOL, V33, P25; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Touquet R, 2008, EMERG MED J, V25, P752, DOI 10.1136/emj.2008.062711; URSO T, 1981, LIFE SCI, V28, P1053, DOI 10.1016/0024-3205(81)90752-9; USDHHS, 2006, ROL BIOM TREATM ALC; Xu DR, 2002, NEUROIMAGE, V17, P1131, DOI 10.1006/nimg.2002.1285; Yeh PH, 2009, PSYCHIAT RES-NEUROIM, V173, P22, DOI 10.1016/j.pscychresns.2008.07.012; Zahr NM, 2013, NEUROPSYCHOPHARMACOL, V38, P1121, DOI 10.1038/npp.2013.11; Zhai GH, 2003, RADIOLOGY, V229, P673, DOI 10.1148/radiol.2293021462	80	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124885	10.1371/journal.pone.0124885	http://dx.doi.org/10.1371/journal.pone.0124885			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894968	Green Published, Green Submitted, gold			2022-12-26	WOS:000353211700127
J	Rocke, E; Pachiadaki, MG; Cobban, A; Kujawinski, EB; Edgcomb, VP				Rocke, Emma; Pachiadaki, Maria G.; Cobban, Alec; Kujawinski, Elizabeth B.; Edgcomb, Virginia P.			Protist Community Grazing on Prokaryotic Prey in Deep Ocean Water Masses	PLOS ONE			English	Article							FLUORESCENTLY LABELED BACTERIA; NW MEDITERRANEAN SEA; PHAGOTROPHIC PROTISTS; MICROBIAL PROCESSES; AMINO-ACIDS; MARINE; PARTICLES; SELECTION; RATES; BACTERIOPLANKTON	Oceanic protist grazing at mesopelagic and bathypelagic depths, and their subsequent effects on trophic links between eukaryotes and prokaryotes, are not well constrained. Recent studies show evidence of higher than expected grazing activity by protists down to mesopelagic depths. This study provides the first exploration of protist grazing in the bathypelagic North Atlantic Deep Water (NADW). Grazing was measured throughout the water column at three stations in the South Atlantic using fluorescently-labeled prey analogues. Grazing in the deep Antarctic Intermediate water (AAIW) and NADW at all three stations removed 3.79% +/- 1.72% to 31.14% +/- 8.24% of the standing prokaryote stock. These results imply that protist grazing may be a significant source of labile organic carbon at certain meso- and bathypelagic depths.	[Rocke, Emma] Hong Kong Univ Sci & Technol, Dept Life Sci, Hong Kong, Hong Kong, Peoples R China; [Pachiadaki, Maria G.; Cobban, Alec; Edgcomb, Virginia P.] Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA; [Cobban, Alec] Falmouth Acad, Falmouth Acad Internship Program, Falmouth, MA USA; [Kujawinski, Elizabeth B.] Woods Hole Oceanog Inst, Marine Chem & Geochem Dept, Woods Hole, MA 02543 USA	Hong Kong University of Science & Technology; Woods Hole Oceanographic Institution; Woods Hole Oceanographic Institution	Edgcomb, VP (corresponding author), Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA.	vedgcomb@whoi.edu	Edgcomb, Virginia/Q-2434-2019; Pachiadaki, Maria/AAW-2640-2021	Pachiadaki, Maria/0000-0003-2684-7501; Rocke, Emma/0000-0001-9514-9788; Edgcomb, Virginia/0000-0001-6805-381X; Cobban, Alec/0000-0001-9296-8147	National Science Foundation [OCE-1154320]; Woods Hole Oceanographic Institution; Ocean Life Institute; Deep Ocean Exploration Institute	National Science Foundation(National Science Foundation (NSF)); Woods Hole Oceanographic Institution; Ocean Life Institute; Deep Ocean Exploration Institute	Funding for the cruise was provided by the National Science Foundation (OCE-1154320) to EBK. Funding for the laboratory work was provided by contributions from the Woods Hole Oceanographic Institution Director of Research, Ocean Life Institute, and Deep Ocean Exploration Institute to VE. No individuals employed or contracted by the funders played any role in this study.	Aristegui J, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021863; Aristegui J, 2009, LIMNOL OCEANOGR, V54, P1501, DOI 10.4319/lo.2009.54.5.1501; Baker BJ, 2004, APPL ENVIRON MICROB, V70, P6264, DOI 10.1128/AEM.70.10.6264-6271.2004; Bochdansky AB, 2010, P NATL ACAD SCI USA, V107, P8287, DOI 10.1073/pnas.0913744107; Brenner R., 2002, BIOGEOCHEMISTRY MARI; Calbet A, 2004, LIMNOL OCEANOGR, V49, P51, DOI 10.4319/lo.2004.49.1.0051; Carlson CA, 2004, LIMNOL OCEANOGR, V49, P1073, DOI 10.4319/lo.2004.49.4.1073; Caron D.A, 1990, ECOLOGY MARINE PROTO; Cho BC, 2000, MAR ECOL PROG SER, V206, P23, DOI 10.3354/meps206023; CHO BC, 1988, NATURE, V332, P441, DOI 10.1038/332441a0; CULLEN JJ, 1982, CAN J FISH AQUAT SCI, V39, P791, DOI 10.1139/f82-108; del Giorgio PA, 2002, NATURE, V420, P379, DOI 10.1038/nature01165; Dolan JR, 1997, MAR GEOL, V139, P109, DOI 10.1016/S0025-3227(96)00106-5; FENCHEL T, 1980, LIMNOL OCEANOGR, V25, P733, DOI 10.4319/lo.1980.25.4.0733; Fenchel T, 1999, PROTIST, V150, P325, DOI 10.1016/S1434-4610(99)70033-7; FENCHEL T, 1982, MAR ECOL PROG SER, V8, P211, DOI 10.3354/meps008211; Fenchel T., 1986, Progress in Protistology, V1, P65; Ferrier-Pages C, 1998, OCEANOL ACTA, V21, P485, DOI 10.1016/S0399-1784(98)80032-7; FOWLER SW, 1986, PROG OCEANOGR, V16, P147, DOI 10.1016/0079-6611(86)90032-7; Fukuda H, 2007, AQUAT MICROB ECOL, V46, P203, DOI 10.3354/ame046203; GONZALEZ JM, 1990, APPL ENVIRON MICROB, V56, P583, DOI 10.1128/AEM.56.3.583-589.1990; Hammer A, 1999, PROTIST, V150, P375, DOI 10.1016/S1434-4610(99)70039-8; Hansell DA, 1998, NATURE, V395, P263, DOI 10.1038/26200; Jezbera J, 2005, FEMS MICROBIOL ECOL, V52, P351, DOI 10.1016/j.femsec.2004.12.001; Jurgens K., 2008, MICROB ECOL OCEAN, P383, DOI [DOI 10.1002/9780470281840.CH11, 10.1002/9780470281840.ch11]; LIGHTHILL J, 1976, SIAM REV, V18, P161, DOI 10.1137/1018040; Matz C, 2005, APPL ENVIRON MICROB, V71, P921, DOI 10.1128/AEM.71.2.921-929.2005; Matz C, 2001, APPL ENVIRON MICROB, V67, P814, DOI 10.1128/AEM.67.2.814-820.2001; Monger BC, 1999, LIMNOL OCEANOGR, V44, P1917, DOI 10.4319/lo.1999.44.8.1917; Morgan-Smith D, 2011, AQUAT MICROB ECOL, V65, P103, DOI 10.3354/ame01536; Nagata T, 2000, LIMNOL OCEANOGR, V45, P426, DOI 10.4319/lo.2000.45.2.0426; NAGATA T, 1991, LIMNOL OCEANOGR, V36, P433, DOI 10.4319/lo.1991.36.3.0433; Nagata T., 2000, MICROBIAL ECOLOGY OC, P121; Nagata T, 2010, DEEP-SEA RES PT II, V57, P1519, DOI 10.1016/j.dsr2.2010.02.019; Pachiadaki M, 2014, DEEP SEA RE IN PRESS; Pernice MC, 2014, ISME J; Reinthaler T, 2006, LIMNOL OCEANOGR, V51, P1262, DOI 10.4319/lo.2006.51.3.1262; SALAT J, 1994, MAR ECOL PROG SER, V104, P205, DOI 10.3354/meps104205; SANDERS RW, 1992, MAR ECOL PROG SER, V86, P1, DOI 10.3354/meps086001; SHERR BF, 1987, APPL ENVIRON MICROB, V53, P958, DOI 10.1128/AEM.53.5.958-965.1987; Sherr EB, 2002, ANTON LEEUW INT J G, V81, P293, DOI 10.1023/A:1020591307260; SHERR EB, 1987, NATURE, V325, P710, DOI 10.1038/325710a0; SHERR EB, 1994, MICROBIAL ECOL, V28, P223, DOI 10.1007/BF00166812; Strom SL, 1997, LIMNOL OCEANOGR, V42, P1364, DOI 10.4319/lo.1997.42.6.1364; Tanaka T, 2004, DEEP-SEA RES PT I, V51, P531, DOI 10.1016/j.dsr.2003.12.001; Tanaka T, 2002, DEEP-SEA RES PT II, V49, P2093, DOI 10.1016/S0967-0645(02)00029-2; TANAKA T, 2004, BIOGEOSCI DISCUSS, V1, P413; Unrein F, 2007, LIMNOL OCEANOGR, V52, P456, DOI 10.4319/lo.2007.52.1.0456; VAQUE D, 1994, MAR ECOL PROG SER, V109, P263, DOI 10.3354/meps109263; Verdugo P, 2010, DEEP-SEA RES PT II, V57, P1486, DOI 10.1016/j.dsr2.2010.03.002	50	16	18	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124505	10.1371/journal.pone.0124505	http://dx.doi.org/10.1371/journal.pone.0124505			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894547	Green Published, gold, Green Submitted			2022-12-26	WOS:000353211700100
J	Tsuji, PA; Carlson, BA; Yoo, MH; Naranjo-Suarez, S; Xu, XM; He, YW; Asaki, E; Seifried, HE; Reinhold, WC; Davis, CD; Gladyshev, VN; Hatfield, DL				Tsuji, Petra A.; Carlson, Bradley A.; Yoo, Min-Hyuk; Naranjo-Suarez, Salvador; Xu, Xue-Ming; He, Yiwen; Asaki, Esther; Seifried, Harold E.; Reinhold, William C.; Davis, Cindy D.; Gladyshev, Vadim N.; Hatfield, Dolph L.			The 15kDa Selenoprotein and Thioredoxin Reductase 1 Promote Colon Cancer by Different Pathways	PLOS ONE			English	Article							SELENIUM SUPPLEMENTATION; NUTRITIONAL PREVENTION; 15-KDA SELENOPROTEIN; CELL-GROWTH; SEP15; EXPRESSION; CARCINOMA; TRIAL; RISK; GENE	Selenoproteins mediate much of the cancer-preventive properties of the essential nutrient selenium, but some of these proteins have been shown to also have cancer-promoting effects. We examined the contributions of the 15kDa selenoprotein (Sep15) and thioredoxin reductase 1 (TR1) to cancer development. Targeted down-regulation of either gene inhibited anchorage-dependent and anchorage-independent growth and formation of experimental metastases of mouse colon carcinoma CT26 cells. Surprisingly, combined deficiency of Sep15 and TR1 reversed the anti-cancer effects observed with down-regulation of each single gene. We found that inflammation-related genes regulated by Stat-1, especially interferon-gamma-regulated guanylate-binding proteins, were highly elevated in Sep15-deficient, but not in TR1-deficient cells. Interestingly, components of the Wnt/beta-catenin signaling pathway were up-regulated in cells lacking both TR1 and Sep15. These results suggest that Sep15 and TR1 participate in interfering regulatory pathways in colon cancer cells. Considering the variable expression levels of Sep15 and TR1 found within the human population, our results provide insights into new roles of selenoproteins in cancer.	[Tsuji, Petra A.] Towson Univ, Dept Biol Sci, Towson, MD 21252 USA; [Carlson, Bradley A.; Yoo, Min-Hyuk; Naranjo-Suarez, Salvador; Xu, Xue-Ming; Hatfield, Dolph L.] NIH, Mol Biol Selenium Sect, Mouse Canc Genet Program, Bethesda, MD 20892 USA; [He, Yiwen; Asaki, Esther] NIH, Ctr Informat Technol, Bethesda, MD 20892 USA; [Seifried, Harold E.] NIH, Nutr Sci Res Grp, Rockville, MD USA; [Reinhold, William C.] NIH, Genom & Informat Grp, Mol Pharmacol Lab, Bethesda, MD 20892 USA; [Davis, Cindy D.] NIH, Off Dietary Supplements, Rockville, MD USA; [Gladyshev, Vadim N.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA	University System of Maryland; Towson University; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Tsuji, PA (corresponding author), Towson Univ, Dept Biol Sci, Towson, MD 21252 USA.	ptsuji@towson.edu	Suarez, Salvador Naranjo/K-8450-2017; Reinhold, William/J-6704-2017	Suarez, Salvador Naranjo/0000-0002-7038-0753; Reinhold, William/0000-0001-5513-9323; Gladyshev, Vadim/0000-0002-0372-7016	Towson University's Fisher College of Science and Mathematics; National Cancer Institute Intramural support; National Cancer Institute Cancer Prevention Fellowship Program; National Institutes of Health [CA080946, GM065204]; NATIONAL CANCER INSTITUTE [R01CA080946, ZIABC011620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065204, R37GM065204] Funding Source: NIH RePORTER	Towson University's Fisher College of Science and Mathematics; National Cancer Institute Intramural support; National Cancer Institute Cancer Prevention Fellowship Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by Towson University's Fisher College of Science and Mathematics (Endowed Chair, PAT), National Cancer Institute Intramural support, the National Cancer Institute Cancer Prevention Fellowship Program (PAT), and National Institutes of Health grants (CA080946, GM065204 to VNG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2013, CANC FACTS FIGURES 2; Apostolou S, 2004, ONCOGENE, V23, P5032, DOI 10.1038/sj.onc.1207683; Arner ESJ, 2006, SEMIN CANCER BIOL, V16, P420, DOI 10.1016/j.semcancer.2006.10.009; Brigelius-Flohe Regina, 2012, Int J Cell Biol, V2012, P486147, DOI 10.1155/2012/486147; Carlson BA, 2012, CARCINOGENESIS, V33, P1806, DOI 10.1093/carcin/bgs230; Chan JY, 2008, CANCER BIOL THER, V7, P1305, DOI 10.4161/cbt.7.8.6302; Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957; Collier J, 1998, HEPATOLOGY, V27, P273, DOI 10.1002/hep.510270140; Almondes KGD, 2010, REV ASSOC MED BRAS, V56, P484, DOI 10.1590/S0104-42302010000400025; Duffield-Lillico AJ, 2002, CANCER EPIDEM BIOMAR, V11, P630; Duffield-Lillico AJ, 2003, BJU INT, V91, P608, DOI 10.1046/j.1464-410X.2003.04167.x; Fodde R, 2002, EUR J CANCER, V38, P867, DOI 10.1016/S0959-8049(02)00040-0; GASDASKA JR, 1995, CELL GROWTH DIFFER, V6, P1643; Hatfield DL, 2014, TRENDS BIOCHEM SCI, V39, P112, DOI 10.1016/j.tibs.2013.12.007; Hatfield DL, 2009, MOL INTERV, V9, P18, DOI 10.1124/mi.9.1.6; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; Hsieh CM, 1996, J BIOL CHEM, V271, P17354, DOI 10.1074/jbc.271.29.17354; Irons R, 2006, J NUTR, V136, P1311, DOI 10.1093/jn/136.5.1311; Irons R, 2010, CANCER PREV RES, V3, P630, DOI 10.1158/1940-6207.CAPR-10-0003; Jablonska E, 2008, EUR J NUTR, V47, P47, DOI 10.1007/s00394-008-0696-9; Jao SW, 1996, DIS COLON RECTUM, V39, P628, DOI 10.1007/BF02056940; Juuti A, 2004, J CLIN PATHOL, V57, P1151, DOI 10.1136/jcp.2003.015818; Kasaikina MV, 2012, BBA-MOL CELL RES, V1823, P1633, DOI 10.1016/j.bbamcr.2012.02.018; Kasaikina MV, 2011, J BIOL CHEM, V286, P33203, DOI 10.1074/jbc.M111.259218; Kipp A, 2009, MOL NUTR FOOD RES, V53, P1561, DOI 10.1002/mnfr.200900105; Korotkov KV, 2001, J BIOL CHEM, V276, P15330, DOI 10.1074/jbc.M009861200; Kressner U, 1997, BRIT J CANCER, V76, P526, DOI 10.1038/bjc.1997.419; Kumaraswamy E, 2002, METHOD ENZYMOL, V347, P187; Labunskyy VM, 2014, PHYSIOL REV, V94, P739, DOI 10.1152/physrev.00039.2013; Lee SC, 2006, PROTEOMICS, V6, P2386, DOI 10.1002/pmic.200500366; Lippman SM, 2009, JAMA-J AM MED ASSOC, P1; Ma XR, 2002, J BIOL CHEM, V277, P22460, DOI 10.1074/jbc.M202286200; Moos PJ, 2003, J BIOL CHEM, V278, P745, DOI 10.1074/jbc.M211134200; Patterson AD, 2013, CHEM RES TOXICOL, V26, P1088, DOI 10.1021/tx4001013; Pensa S, 2009, JAK STAT PATHWAY DIS; Peters U, 2008, CANCER EPIDEM BIOMAR, V17, P1144, DOI 10.1158/1055-9965.EPI-07-2947; Reinhold WC, 2012, CANCER RES, V72, P3499, DOI 10.1158/0008-5472.CAN-12-1370; Santin I, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.158; Suvorova ES, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006158; Tsuji PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050574; Tsuji PA, 2011, NUTRIENTS, V3, P805, DOI 10.3390/nu3090805; Villanueva A, 2012, GASTROENTEROLOGY, V143, P1660, DOI 10.1053/j.gastro.2012.09.002; Wang JW, 2006, NEUROSCI RES, V56, P80, DOI 10.1016/j.neures.2006.05.011; Wang XY, 2008, MOL CELL BIOL, V28, P3589, DOI 10.1128/MCB.00040-08; Wright ME, 2012, SELENIUM ITS MOL BIO; Xu XM, 2009, NAT PROTOC, V4, P1338, DOI 10.1038/nprot.2009.145; Yoo MH, 2006, J BIOL CHEM, V281, P13005, DOI 10.1074/jbc.C600012200; Yoo MH, 2012, SELENIUM ITS MOL BIO; Yoo MH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001112; Yoo MH, 2010, METHOD ENZYMOL, V474, P255, DOI 10.1016/S0076-6879(10)74015-5	50	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124487	10.1371/journal.pone.0124487	http://dx.doi.org/10.1371/journal.pone.0124487			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886253	Green Submitted, Green Published, gold			2022-12-26	WOS:000353017000131
J	Tyler, CJ; Reeve, T; Cheung, SS				Tyler, Christopher James; Reeve, Tom; Cheung, Stephen S.			Cold-Induced Vasodilation during Single Digit Immersion in 0 degrees C and 8 degrees C Water in Men and Women	PLOS ONE			English	Article							HEALTHY-SUBJECTS; FINGERS; SKIN; TRAINABILITY; TEMPERATURE; RESPONSES; EXERCISE; HUMANS; HAND; AGE	The present study compared the thermal responses of the finger to 0 and 8 degrees C water immersion, two commonly used temperatures for cold-induced vasodilation (CIVD) research. On two separate and counterbalanced occasions 15 male and 15 female participants immersed their index finger in 20 degrees C water for 5 min followed by either 0 or 8 degrees C water for 30 min. Skin temperature, cardiovascular and perceptual data were recorded. Secondary analyses were performed between sexes and comparing 0.5, 1 and 4 degrees C CIVD amplitude thresholds. With a 0.5 degrees C threshold, CIVD waves were more prevalent in 8 degrees C (2 (1 -3) than in 0 degrees C (1.5 (0 3)), but the amplitude was lower (4.0 +/- 2.3 v 9.2 +/- 4.0 degrees C). Mean, minimum and maximum finger temperatures were lower in 0 degrees C during the 30 min immersion, and CIVD onset and peak time occurred later in 0 degrees C. Thermal sensation was lower and pain sensation was higher in 0 degrees C. There were no differences between males and females in any of the physiological or CIVD data with the exception of SBP, which was higher in males. Females reported feeling higher thermal sensations in 8 degrees C and lower pain sensations in 0 degrees C and 8 degrees C compared to males. Fewer CIVD responses were observed when using a 4 degrees C (1 (0 -3)) threshold to quantify a CIVD wave compared to using a 1 degrees C (2 (0 -3)) or 0.5 degrees C (2 (0 -3)) amplitude. In conclusion, both 0 and 8 degrees C can elicit CIVD but 8 degrees C may be more suitable when looking to optimise the number of CIVD waves while minimising participant discomfort. The CIVD response to water immersion does not appear to be influenced by sex. Researchers should consider the amplitude threshold that was used to determine a CIVD wave when interpreting previous data.	[Tyler, Christopher James; Reeve, Tom] Univ Roehampton, Dept Life Sci, London, England; [Cheung, Stephen S.] Brock Univ, Dept Kinesiol, St Catharines, ON L2S 3A1, Canada	Roehampton University; Brock University	Tyler, CJ (corresponding author), Univ Roehampton, Dept Life Sci, London, England.	chris.tyler@roehampton.ac.uk	Cheung, Stephen/AAE-9136-2020; Cheung, Stephen/HGU-6191-2022; Tyler, Chris/AAG-1087-2020	Cheung, Stephen/0000-0002-6149-4978; Tyler, Christopher/0000-0002-3233-0771	Canada Research Chair	Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	S.S. Cheung is supported by a Canada Research Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTELINK ML, 1993, J APPL PHYSIOL, V74, P727, DOI 10.1152/jappl.1993.74.2.727; Birnie KA, 2012, J PAIN, V13, P817, DOI 10.1016/j.jpain.2012.06.005; Cheung SS, 2007, EUR J APPL PHYSIOL, V99, P701, DOI 10.1007/s00421-006-0383-6; Cheung SS, 2012, MICROCIRCULATION, V19, P65, DOI 10.1111/j.1549-8719.2011.00126.x; Cohen J., 1988, STAT POWER ANAL BEHA, P543; COOKE JP, 1990, CIRCULATION, V82, P1607, DOI 10.1161/01.CIR.82.5.1607; Costello JT, 2014, EUR J SPORT SCI, V14, P847, DOI 10.1080/17461391.2014.911354; Daanen H A, 2000, High Alt Med Biol, V1, P323, DOI 10.1089/15270290050502390; Daanen HAM, 2005, AVIAT SPACE ENVIR MD, V76, P1119; Daanen HAM, 2003, EUR J APPL PHYSIOL, V89, P411, DOI 10.1007/s00421-003-0818-2; Daanen HAM, 2012, EUR J APPL PHYSIOL, V112, P2595, DOI 10.1007/s00421-011-2233-4; Flouris AD, 2006, J APPL PHYSIOL, V101, P802, DOI 10.1152/japplphysiol.00197.2006; Flouris AD, 2008, EUR J APPL PHYSIOL, V104, P491, DOI 10.1007/s00421-008-0798-3; Geurts CLM, 2006, APPL PHYSIOL NUTR ME, V31, P717, DOI [10.1139/H06-076, 10.1139/h06-076]; KREGEL KC, 1992, J PHYSIOL-LONDON, V454, P359, DOI 10.1113/jphysiol.1992.sp019268; Lewis T, 1930, HEART-J STUD CIRC, V15, P177; Mekjavic IB, 2008, EUR J APPL PHYSIOL, V104, P193, DOI 10.1007/s00421-008-0727-5; Mekjavic IB, 2013, APPL PHYSIOL NUTR ME, V38, P14, DOI 10.1139/apnm-2012-0118; NELMS JD, 1962, J APPL PHYS, V17, P444; Nes BM, 2013, SCAND J MED SCI SPOR, V23, P697, DOI 10.1111/j.1600-0838.2012.01445.x; O'Brien C, 2005, J APPL PHYSIOL, V98, P1334, DOI 10.1152/japplphysiol.00859.2004; Sendowski I, 1997, EUR J APPL PHYSIOL O, V75, P471, DOI 10.1007/s004210050191; SPURR GB, 1955, AM HEART J, V50, P551, DOI 10.1016/0002-8703(55)90300-8; WOLFF HH, 1949, CLIN SCI, V8, P145; YOUNG AJ, 1987, J APPL PHYSIOL, V63, P1218, DOI 10.1152/jappl.1987.63.3.1218	25	10	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0122592	10.1371/journal.pone.0122592	http://dx.doi.org/10.1371/journal.pone.0122592			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886576	gold, Green Published, Green Submitted			2022-12-26	WOS:000353017000034
J	Zou, MC; Dong, HM; Meng, XJ; Cai, CQ; Li, CZ; Cai, SX; Xue, YM				Zou, Mengchen; Dong, Hangming; Meng, Xiaojing; Cai, Chunqing; Li, Chenzhong; Cai, Shaoxi; Xue, Yaoming			Store-Operated Ca2+ Entry Plays a Role in HMGB1-Induced Vascular Endothelial Cell Hyperpermeability	PLOS ONE			English	Article							INCREASED SERUM HMGB1; VE-CADHERIN; CALCIUM-ENTRY; ACTIVATION; STIM1; ORAI1; PERMEABILITY; RELEASE; DISEASE; CRAC	Aims Endothelial dysfunction, including increased endothelial permeability, is considered an early marker for atherosclerosis. High-mobility group box 1 protein (HMGB1) and extracellular Ca2+ entry, primarily mediated through store-operated Ca2+ entry (SOCE), are known to be involved in increasing endothelial permeability. The aim of this study was to clarify how HMGB1 could lead to endothelia hyperpermeability. Methods and Results We have shown that human vascular endothelial cell permeability is increased, while transendothelial electrical resistance and VE-cadherin expression were reduced by HMGB1 treatment. Two SOCE inhibitors and knockdown of stromal interaction molecule 1 (STIM1), a Ca2+ sensor mediating SOCE, inhibited the HMGB1-induced influx of Ca2+ and Src activation followed by significant suppression of endothelial permeability. Moreover, knockdown of Orai1, an essential pore-subunit of SOCE channels, decreased HMGB1-induced endothelial hyperpermeability. Conclusions These data suggest that SOCE, acting via STIM1, might be the predominant mechanism of Ca2+ entry in the modulation of endothelial cell permeability. STIM1 may thus represent a possible new therapeutic target against atherosclerosis.	[Zou, Mengchen; Li, Chenzhong; Xue, Yaoming] Southern Med Univ, Dept Endocrinol & Metab, Nanfang Hosp, Guangzhou 510515, Guangdong, Peoples R China; [Dong, Hangming; Cai, Shaoxi] Southern Med Univ, Dept Resp & Crit Care Med, Chron Airways Dis Lab, Nanfang Hosp, Guangzhou 510515, Guangdong, Peoples R China; [Meng, Xiaojing; Cai, Chunqing] Southern Med Univ, Dept Occupat Hlth & Occupat Med, Sch Publ Hlth & Trop Med, Guangzhou 510515, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Cai, SX (corresponding author), Southern Med Univ, Dept Resp & Crit Care Med, Chron Airways Dis Lab, Nanfang Hosp, Guangzhou 510515, Guangdong, Peoples R China.	cai_shaoxi@163.com; xue_yaoming@163.com			National Natural Science Foundation of China [81270087]; President Foundation of Nanfang Hospital, Southern Medical University [2013C008, 2012C001]; Scientific Research Initiative of Southern Medical University [PY2013N027]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); President Foundation of Nanfang Hospital, Southern Medical University; Scientific Research Initiative of Southern Medical University	This study was supported by National Natural Science Foundation of China (81270087); President Foundation of Nanfang Hospital, Southern Medical University (2013C008,2012C001); Scientific Research Initiative of Southern Medical University (PY2013N027).	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Alexander JS, 2000, INFLAMMATION, V24, P99, DOI 10.1023/A:1007025325451; Ambudkar IS, 2007, CELL CALCIUM, V42, P213, DOI 10.1016/j.ceca.2007.01.013; Andersson U, 2002, J LEUKOCYTE BIOL, V72, P1084; Davignon J., 2004, CIRCULATION, V109, P11127; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Dellis Olivier, 2011, BMC Pharmacology, V11, P1, DOI 10.1186/1471-2210-11-1; Ding HS, 2010, SAUDI MED J, V31, P486; Faxon DP, 2004, CIRCULATION, V109, P2595, DOI 10.1161/01.CIR.0000128517.52533.DB; Fedida-Metula S, 2012, CARCINOGENESIS, V33, P740, DOI 10.1093/carcin/bgs021; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Gilio K, 2010, J BIOL CHEM, V285, P23629, DOI 10.1074/jbc.M110.108696; Harper MT, 2006, J THROMB HAEMOST, V4, P2695, DOI 10.1111/j.1538-7836.2006.02207.x; Hirata Y, 2013, ATHEROSCLEROSIS, V231, P227, DOI 10.1016/j.atherosclerosis.2013.09.010; Hu XR, 2009, CLIN CHIM ACTA, V406, P139, DOI 10.1016/j.cca.2009.06.016; Huang WC, 2012, INFLAMMATION, V35, P350, DOI 10.1007/s10753-011-9325-5; Ichiki T, 2013, PEPTIDES, V48, P21, DOI 10.1016/j.peptides.2013.07.020; Kalinina N, 2004, ARTERIOSCL THROM VAS, V24, P2320, DOI 10.1161/01.ATV.0000145573.36113.8a; Kanellakis P, 2011, ARTERIOSCL THROM VAS, V31, P313, DOI 10.1161/ATVBAHA.110.218669; Kawahara KI, 2008, INT J MOL MED, V22, P639, DOI 10.3892/ijmm_00000066; Li W, 2006, CURR OPIN PHARMACOL, V6, P130, DOI 10.1016/j.coph.2005.10.010; Luo Y, 2013, BIOCHEM BIOPH RES CO, V438, P732, DOI 10.1016/j.bbrc.2013.07.098; McCarron JG, 2002, J CELL SCI, V115, P2207; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Miyazaki T, 2011, CIRCULATION, V124, P2522, DOI 10.1161/CIRCULATIONAHA.111.021675; Moore TM, 2000, AM J PHYSIOL-LUNG C, V279, pL691, DOI 10.1152/ajplung.2000.279.4.L691; Norwood N, 2000, AM J PHYSIOL-LUNG C, V279, pL815, DOI 10.1152/ajplung.2000.279.5.L815; Numaga-Tomita T, 2013, J CELL SCI, V126, P605, DOI 10.1242/jcs.115980; Okutani D, 2006, AM J PHYSIOL-LUNG C, V291, pL129, DOI 10.1152/ajplung.00261.2005; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sandoval R, 2001, J PHYSIOL-LONDON, V533, P433, DOI 10.1111/j.1469-7793.2001.0433a.x; Scott J, 2002, J NEURAL TRANSM-SUPP, P1; Shinde AV, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003425; Soeki T, 2004, CIRC J, V68, P1, DOI 10.1253/circj.68.1; SoRelle R, 1999, CIRCULATION, V99, P3, DOI 10.1161/01.CIR.99.1.3; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Tiruppathi C, 2006, MICROCIRCULATION, V13, P693, DOI 10.1080/10739680600930347; Townsley MI, 2006, MICROCIRCULATION, V13, P725, DOI 10.1080/10739680600930362; Trebak M, 2009, CIRC RES, V104, pE56, DOI 10.1161/CIRCRESAHA.109.196105; Tsung A, 2007, J EXP MED, V204, P2913, DOI 10.1084/jem.20070247; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; West DJ, 2007, CURR PHARM DESIGN, V13, P2428; Wolfson RK, 2011, MICROVASC RES, V81, P189, DOI 10.1016/j.mvr.2010.11.010; Yan XX, 2009, ATHEROSCLEROSIS, V205, P544, DOI 10.1016/j.atherosclerosis.2008.12.016; Yuan SY, 2002, VASC PHARMACOL, V39, P213, DOI 10.1016/S1537-1891(03)00010-7; Zhou Y, 2013, J OPTIMIZ THEORY APP, V156, P1, DOI 10.1007/s10957-013-0271-2; Zou WY, 2012, CELL PHYSIOL BIOCHEM, V30, P221, DOI 10.1159/000339059	49	16	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123432	10.1371/journal.pone.0123432	http://dx.doi.org/10.1371/journal.pone.0123432			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884983	Green Submitted, Green Published, gold			2022-12-26	WOS:000353017000062
J	Lee, SH; Luong, R; Johnson, DT; Cunha, GR; Rivina, L; Gonzalgo, ML; Sun, Z				Lee, S. H.; Luong, R.; Johnson, D. T.; Cunha, G. R.; Rivina, L.; Gonzalgo, M. L.; Sun, Z.			Androgen signaling is a confounding factor for beta-catenin-mediated prostate tumorigenesis	ONCOGENE			English	Article							INTRAEPITHELIAL NEOPLASIA; TUMOR-SUPPRESSOR; MURINE PROSTATE; RECEPTOR; CANCER; CELL; APC; RESISTANCE; REGENERATION; ACTIVATION	Emerging evidence has demonstrated the critical roles for both androgen and Wnt pathways in prostate tumorigenesis. A recent integrative genomic analysis of human prostate cancers (PCas) has revealed a unique enrichment of androgen and Wnt signaling in early-onset PCas, implying their clinical significance in the disease. Additionally, interaction between the androgen receptor (AR) and P-catenin has long been detected in PCa cells. However, the consequence of this interaction in prostate tumorigenesis is still unknown. Because mutations in adenomatous polyposis coli, P-catenin and other components of the destruction complex are generally rare in PCas, other mechanisms of aberrant Wnt signaling activation have been speculated. To address these critical questions, we developed Ctnnb1(L(ex3)/1) /R26hAR(L/+):PB-Cre4 mice, in which transgenic AR and stabilized beta-catenin are co-expressed in prostatic epithelial cells. We observed accelerated tumor development, aggressive tumor invasion and a decreased survival rate in Ctnnb1(L(ex3)/+) /R26hAR(L/+):PB-Cre4 compound mice compared with age-matched Ctnnb1(L(ex3)/+):PB-Cre4 littermate controls, which only have stabilized P-catenin expression in the prostate. Castration of the above transgenic mice resulted in significant tumor regression, implying an essential role of androgen signaling in tumor growth and maintenance. Implantation of the prostatic epithelial cells isolated from the transgenic mice regenerated prostate intraepithelial neoplasias and prostatic adenocarcinoma lesions. Microarray analyses of transcriptional profiles showed more robust enrichment of known tumor-and metastasis-promoting genes: Spp1, Egr1, c-Myc, Sp5, and Sp6 genes, in samples isolated from Ctnnb1(L(ex3)/+)/R26hAR(L/1) :PR-Cre4 compound mice than those from Ctnnb1(L(ex3)/+):PB-Cre4 and R26hAR(L/+) :PB-Cre4 littermate controls. Together, these data demonstrate a confounding role of androgen signaling in P-catenin-initiated oncogenic transformation in prostate tumorigenesis.	[Lee, S. H.; Johnson, D. T.; Rivina, L.; Gonzalgo, M. L.; Sun, Z.] Stanford Univ, Sch Med, Dept Urol, S221,Grant Bldg,300 Pasteur Dr, Stanford, CA 94305 USA; [Luong, R.] Stanford Univ, Sch Med, Dept Comparat Med, Stanford, CA 94305 USA; [Cunha, G. R.] Univ Calif San Francisco, Sch Med, Dept Urol, San Francisco, CA 94143 USA	Stanford University; Stanford University; University of California System; University of California San Francisco	Sun, Z (corresponding author), Stanford Univ, Sch Med, Dept Urol, S221,Grant Bldg,300 Pasteur Dr, Stanford, CA 94305 USA.	zsun@stanford.edu			NIH [R01-CA070297, R01-CA151623, U01-CA166894, R21-CA190021]; NATIONAL CANCER INSTITUTE [R01CA166894, R01CA151623, U01CA166894, R21CA190021, R01CA070297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104941] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr William Tu and Dr Chunfang Zhu for their technical assistance. This work was supported by the NIH grants R01-CA070297, R01-CA151623, U01-CA166894 and R21-CA190021.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Balk SP, 2002, UROLOGY, V60, P132, DOI 10.1016/S0090-4295(02)01593-5; Bierie B, 2003, ONCOGENE, V22, P3875, DOI 10.1038/sj.onc.1206426; Bruxvoort KJ, 2007, CANCER RES, V67, P2490, DOI 10.1158/0008-5472.CAN-06-3028; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen Y, 2013, EUR J HUM GENET, V21, P929, DOI 10.1038/ejhg.2012.281; Chesire DR, 2003, ENDOCR-RELAT CANCER, V10, P537, DOI 10.1677/erc.0.0100537; Chesire DR, 2002, ONCOGENE, V21, P2679, DOI 10.1038/sj.onc.1205352; Chesire DR, 2000, PROSTATE, V45, P323, DOI 10.1002/1097-0045(20001201)45:4<323::AID-PROS7>3.0.CO;2-W; de Ronde JJ, 2013, BREAST CANCER RES TR, V137, P213, DOI 10.1007/s10549-012-2340-x; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Gerstein AV, 2002, GENE CHROMOSOME CANC, V34, P9, DOI 10.1002/gcc.10037; Gounari F, 2002, ONCOGENE, V21, P4099, DOI 10.1038/sj.onc.1205562; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Heinlein CA, 2002, ENDOCR REV, V23, P175, DOI 10.1210/er.23.2.175; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Henrique R, 2007, CLIN CANCER RES, V13, P6122, DOI 10.1158/1078-0432.CCR-07-1042; HOHAUS S, 1995, MOL CELL BIOL, V15, P5830; Huggins C, 2002, J UROLOGY, V168, P9, DOI 10.1016/S0022-5347(05)64820-3; Ibarretxe G, 2012, CELL TISSUE RES, V350, P95, DOI 10.1007/s00441-012-1459-8; Ittmann M, 2013, CANCER RES, V73, P2718, DOI 10.1158/0008-5472.CAN-12-4213; Johnson DT, 2013, J BIOL CHEM, V288, P3727, DOI 10.1074/jbc.M112.417568; Koivisto P, 1997, CANCER RES, V57, P314; Kwak MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053476; KYPRIANOU N, 1988, ENDOCRINOLOGY, V122, P552, DOI 10.1210/endo-122-2-552; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Lee J, 2007, NUCLEIC ACIDS RES, V35, P4523, DOI 10.1093/nar/gkm476; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahmoudi T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000539; Matusik RJ, 2008, DIFFERENTIATION, V76, P682, DOI 10.1111/j.1432-0436.2008.00276.x; Mulholland DJ, 2002, J BIOL CHEM, V277, P17933, DOI 10.1074/jbc.M200135200; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Pearson HB, 2009, CANCER RES, V69, P94, DOI 10.1158/0008-5472.CAN-08-2895; Sauer L, 2010, ONCOGENE, V29, P2628, DOI 10.1038/onc.2010.24; Stanbrough M, 2001, P NATL ACAD SCI USA, V98, P10823, DOI 10.1073/pnas.191235898; SUGIMURA Y, 1986, BIOL REPROD, V34, P973, DOI 10.1095/biolreprod34.5.973; Sun Y, 2012, NAT MED, V18, P1359, DOI 10.1038/nm.2890; Truica CI, 2000, CANCER RES, V60, P4709; Verras M, 2006, CANCER LETT, V237, P22, DOI 10.1016/j.canlet.2005.06.004; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wang YZ, 2005, PROSTATE, V64, P149, DOI 10.1002/pros.20225; Weischenfeldt J, 2013, CANCER CELL, V23, P159, DOI 10.1016/j.ccr.2013.01.002; Wissmann C, 2003, J PATHOL, V201, P204, DOI 10.1002/path.1449; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Xin L, 2003, P NATL ACAD SCI USA, V100, P11896, DOI 10.1073/pnas.1734139100; Yang FJ, 2002, J BIOL CHEM, V277, P11336, DOI 10.1074/jbc.M111962200; Zhu CF, 2011, J BIOL CHEM, V286, P33478, DOI 10.1074/jbc.M111.269894	53	19	19	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 11	2016	35	6					702	714		10.1038/onc.2015.117	http://dx.doi.org/10.1038/onc.2015.117			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DE0RF	25893287	Green Accepted			2022-12-26	WOS:000370331300004
J	Potze, L; Di Franco, S; Grandela, C; Pras-Raves, ML; Picavet, DI; van Veen, HA; van Lenthe, H; Mullauer, FB; van der Wel, NN; Luyf, A; van Kampen, AHC; Kemp, S; Everts, V; Kessler, JH; Vaz, FM; Medema, JP				Potze, L.; Di Franco, S.; Grandela, C.; Pras-Raves, M. L.; Picavet, D. I.; van Veen, H. A.; van Lenthe, H.; Mullauer, F. B.; van der Wel, N. N.; Luyf, A.; van Kampen, A. H. C.; Kemp, S.; Everts, V.; Kessler, J. H.; Vaz, F. M.; Medema, J. P.			Betulinic acid induces a novel cell death pathway that depends on cardiolipin modification	ONCOGENE			English	Article							STEAROYL-COA DESATURASE; CYTOCHROME-C RELEASE; PERMEABILITY TRANSITION PORE; GENE-EXPRESSION CHANGES; ATP CITRATE LYASE; CANCER-CELLS; FATTY-ACIDS; MASS-SPECTROMETRY; PROSTATE-CANCER; BARTH SYNDROME	Cancer is associated with strong changes in lipid metabolism. For instance, normal cells take up fatty acids (FAs) from the circulation, while tumour cells generate their own and become dependent on de novo FA synthesis, which could provide a vulnerability to target tumour cells. Betulinic acid (BetA) is a natural compound that selectively kills tumour cells through an ill-defined mechanism that is independent of BAX and BAK, but depends on mitochondrial permeability transition-pore opening. Here we unravel this pathway and show that BetA inhibits the activity of steroyl-CoA-desaturase (SCD-1). This enzyme is overexpressed in tumour cells and critically important for cells that utilize de novo FA synthesis as it converts newly synthesized saturated FAs to unsaturated FAs. Intriguingly, we find that inhibition of SCD-1 by BetA or, alternatively, with a specific SCD-1 inhibitor directly and rapidly impacts on the saturation level of cardiolipin (CL), a mitochondrial lipid that has important structural and metabolic functions and at the same time regulates mitochondria-dependent cell death. As a result of the enhanced CL saturation mitochondria of cancer cells, but not normal cells that do not depend on de novo FA synthesis, undergo ultrastructural changes, release cytochrome c and quickly induce cell death. Importantly, addition of unsaturated FAs circumvented the need for SCD-1 activity and thereby prevented BetA-induced CL saturation and subsequent cytotoxicity, supporting the importance of this novel pathway in the cytotoxicity induced by BetA.	[Potze, L.; Di Franco, S.; Grandela, C.; Mullauer, F. B.; Kessler, J. H.; Medema, J. P.] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, Lab Expt Oncol & radiobiol LEXOR, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Di Franco, S.] Univ Palermo, Cellular & Mol Pathophysiol Lab, Dept Surg & Oncol Sci, Palermo, Italy; [Pras-Raves, M. L.; Luyf, A.; van Kampen, A. H. C.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Bioinformat Lab, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Picavet, D. I.; van Veen, H. A.; van der Wel, N. N.; Everts, V.] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, Core Facil Cellular Imaging, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [van Lenthe, H.; Kemp, S.; Vaz, F. M.] Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, Lab Genet Metab Dis, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; University of Palermo; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Medema, JP (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, Lab Expt Oncol & radiobiol LEXOR, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.p.medema@amc.uva.nl	Kemp, Stephan/A-3935-2008; Van Der Wel, Nicole/AAE-7569-2020; Di Franco, Simone/AAD-4391-2019; Di Franco, Simone/J-4874-2016; di franco, simone/M-3714-2019	Kemp, Stephan/0000-0003-2023-064X; Di Franco, Simone/0000-0002-6217-2161; di franco, simone/0000-0002-6217-2161; Vaz, Frederic/0000-0002-9048-1041; Medema, Jan Paul/0000-0003-3045-2924	Stichting Nationaal Fonds tegen Kanker (SNFK), Amsterdam, The Netherlands	Stichting Nationaal Fonds tegen Kanker (SNFK), Amsterdam, The Netherlands(Netherlands Government)	We thank Inge Dijkstra, Rob Ofman, Femke Beers-Stet for technical assistance and Louis Vermeulen for his valuable scientific input and helpful discussions. This work was supported by a grant of the Stichting Nationaal Fonds tegen Kanker (SNFK), Amsterdam, The Netherlands (LP).	Acehan D, 2011, BIOPHYS J, V100, P2184, DOI 10.1016/j.bpj.2011.03.031; Alavian KN, 2014, P NATL ACAD SCI USA, V111, P10580, DOI 10.1073/pnas.1401591111; BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5; Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773; BOUGNOUX P, 1992, BREAST CANCER RES TR, V20, P185; Clarke SLN, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-23; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; DeBerardinis RJ, 2012, CELL, V148, P1132, DOI 10.1016/j.cell.2012.02.032; Engelen M, 2008, BBA-MOL CELL BIOL L, V1781, P105, DOI 10.1016/j.bbalip.2007.12.003; Fritz V, 2010, MOL CANCER THER, V9, P1740, DOI 10.1158/1535-7163.MCT-09-1064; FRY M, 1981, J BIOL CHEM, V256, P1874; Fulda S, 1997, CANCER RES, V57, P4956; Fulda S, 1998, CANCER RES, V58, P4453; Gonzalvez F, 2007, APOPTOSIS, V12, P877, DOI 10.1007/s10495-007-0718-8; Gonzalvez F, 2008, J CELL BIOL, V183, P681, DOI 10.1083/jcb.200803129; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Houtkooper RH, 2008, CELL MOL LIFE SCI, V65, P2493, DOI 10.1007/s00018-008-8030-5; Houtkooper RH, 2009, ANAL BIOCHEM, V387, P230, DOI 10.1016/j.ab.2009.01.032; Huttemann M, 2011, MITOCHONDRION, V11, P369, DOI 10.1016/j.mito.2011.01.010; Igal RA, 2010, CARCINOGENESIS, V31, P1509, DOI 10.1093/carcin/bgq131; Jourdain A, 2009, INT J BIOCHEM CELL B, V41, P1884, DOI 10.1016/j.biocel.2009.05.001; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kessler JH, 2007, CANCER LETT, V251, P132, DOI 10.1016/j.canlet.2006.11.003; Kiebish MA, 2008, J LIPID RES, V49, P2545, DOI 10.1194/jlr.M800319-JLR200; Kumar-Sinha C, 2003, CANCER RES, V63, P132; Landes T, 2011, BBA-MOL CELL RES, V1813, P540, DOI 10.1016/j.bbamcr.2011.01.021; LI J, 1994, INT J CANCER, V57, P348, DOI 10.1002/ijc.2910570310; Li JN, 2000, EXP CELL RES, V261, P159, DOI 10.1006/excr.2000.5054; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Lu JX, 1997, MOL CARCINOGEN, V20, P204, DOI 10.1002/(SICI)1098-2744(199710)20:2<204::AID-MC7>3.0.CO;2-M; Martinou JC, 2006, CELL DEATH DIFFER, V13, P1291, DOI 10.1038/sj.cdd.4401985; MEDES G, 1953, CANCER RES, V13, P27; Morgan-Lappe SE, 2007, CANCER RES, V67, P4390, DOI 10.1158/0008-5472.CAN-06-4132; Mullauer FB, 2011, ANTI-CANCER DRUG, V22, P223, DOI 10.1097/CAD.0b013e3283421035; Mullauer FB, 2010, ANTI-CANCER DRUG, V21, P215, DOI 10.1097/CAD.0b013e3283357c62; Mullauer FB, 2009, APOPTOSIS, V14, P191, DOI 10.1007/s10495-008-0290-x; Nogueira V, 2013, CLIN CANCER RES, V19, P4309, DOI 10.1158/1078-0432.CCR-12-1424; OOKHTENS M, 1984, AM J PHYSIOL, V247, pR146, DOI 10.1152/ajpregu.1984.247.1.R146; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Paradies G, 2014, BBA-BIOENERGETICS, V1837, P408, DOI 10.1016/j.bbabio.2013.10.006; Patil VA, 2013, ADV EXP MED BIOL, V991, P195, DOI 10.1007/978-94-007-6331-9_11; Paton CM, 2009, AM J PHYSIOL-ENDOC M, V297, pE28, DOI 10.1152/ajpendo.90897.2008; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Pellegrini L, 2007, CELL DEATH DIFFER, V14, P1275, DOI 10.1038/sj.cdd.4402145; Potze L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.139; Ren MD, 2014, PROG LIPID RES, V55, P1, DOI 10.1016/j.plipres.2014.04.001; Roongta UV, 2011, MOL CANCER RES, V9, P1551, DOI 10.1158/1541-7786.MCR-11-0126; RUGGIERI S, 1979, J LIPID RES, V20, P772; Rzeski W, 2006, N-S ARCH PHARMACOL, V374, P11, DOI 10.1007/s00210-006-0090-1; Santos CR, 2012, FEBS J, V279, P2610, DOI 10.1111/j.1742-4658.2012.08644.x; Scaglia N, 2005, J BIOL CHEM, V280, P25339, DOI 10.1074/jbc.M501159200; Scaglia N, 2005, BBA-MOL CELL BIOL L, V1687, P141, DOI 10.1016/j.bbalip.2004.11.015; Scaglia N, 2008, INT J ONCOL, V33, P839, DOI 10.3892/ijo_00000072; Scaglia N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006812; Schug ZT, 2009, BBA-BIOMEMBRANES, V1788, P2022, DOI 10.1016/j.bbamem.2009.05.004; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Swinnen JV, 2006, CURR OPIN CLIN NUTR, V9, P358, DOI 10.1097/01.mco.0000232894.28674.30; Swinnen JV, 2000, INT J CANCER, V88, P176, DOI 10.1002/1097-0215(20001015)88:2<176::AID-IJC5>3.0.CO;2-3; Thai SF, 2001, CARCINOGENESIS, V22, P1317, DOI 10.1093/carcin/22.8.1317; Tuominen EKJ, 2002, J BIOL CHEM, V277, P8822, DOI 10.1074/jbc.M200056200; Valianpour F, 2003, MOL GENET METAB, V79, P189, DOI 10.1016/S1096-7192(03)00098-2; WARBURG O, 1956, SCIENCE, V124, P269; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Waterhouse NJ, 2003, CELL DEATH DIFFER, V10, P853, DOI 10.1038/sj.cdd.4401263; Yahagi N, 2005, EUR J CANCER, V41, P1316, DOI 10.1016/j.ejca.2004.12.037; Zhang TJ, 2013, BBA-MOL CELL BIOL L, V1831, P1542, DOI 10.1016/j.bbalip.2013.03.001; Zuco V, 2002, CANCER LETT, V175, P17, DOI 10.1016/S0304-3835(01)00718-2	70	46	46	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 28	2016	35	4					427	437		10.1038/onc.2015.102	http://dx.doi.org/10.1038/onc.2015.102			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DC2OT	25893306				2022-12-26	WOS:000369056700003
J	Ho, KM; Rao, S; Burrell, M; Weeramanthri, TS				Ho, Kwok M.; Rao, Sudhakar; Burrell, Maxine; Weeramanthri, Tarun S.			The Journey from Traffic Offender to Severe Road Trauma Victim: Destiny or Preventive Opportunity?	PLOS ONE			English	Article							TIME-SERIES; INJURIES; OFFENSES; ALCOHOL	Background Road trauma is a leading cause of death and injury in young people. Traffic offences are common, but their importance as a risk indicator for subsequent road trauma is unknown. This cohort study assessed whether severe road trauma could be predicted by a history of prior traffic offences. Methodology and Principal Findings Clinical data of all adult road trauma patients admitted to the Western Australia (WA) State Trauma Centre between 1998 and 2013 were linked to traffic offences records at the WA Department of Transport. The primary outcomes were alcohol exposure prior to road trauma, severe trauma (defined by Injury Severity Score > 15), and intensive care admission (ICU) or death, analyzed by logistic regression. Traffic offences directly leading to the road trauma admissions were excluded. Of the 10,330 patients included (median age 34 years-old, 78% male), 1955 (18.9%) had alcohol-exposure before road trauma, 2415 (23.4%) had severe trauma, 1360 (13.2%) required ICU admission, and 267 (2.6%) died. Prior traffic offences were recorded in 6269 (60.7%) patients. The number of prior traffic offences was significantly associated with alcohol-related road trauma (odds ratio [OR] per offence 1.03, 95% confidence interval [CI] 1.02-1.05), severe trauma (OR 1.13, 95% CI 1.14-1.15), and ICU admission or death (OR 1.10, 95% CI 1.08-1.11). Drink-drinking, seat-belt, and use of handheld electronic device offences were specific offences strongly associated with road trauma leading to ICU admission or death-all in a 'dose-related' fashion. For those who recovered from road trauma after an ICU admission, there was a significant reduction in subsequent traffic offences (mean difference 1.8, 95% CI 1.5 to 2.0) and demerit points (mean difference 7.0, 95% CI 6.5 to 7.6) compared to before the trauma event. Significance Previous traffic offences were a significant risk factor for alcohol-related road trauma and severe road trauma leading to ICU admission or death.	[Ho, Kwok M.] Royal Perth Hosp, Dept Intens Care Med, Perth, WA 6001, Australia; [Ho, Kwok M.] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia; [Ho, Kwok M.] Murdoch Univ, Perth, WA, Australia; [Rao, Sudhakar; Burrell, Maxine] Royal Perth Hosp, State Trauma Unit, Perth, WA 6001, Australia; [Weeramanthri, Tarun S.] Western Australia Dept Hlth, Publ Hlth & Clin Serv Div, Perth, WA, Australia	Royal Perth Hospital; University of Western Australia; Murdoch University; Royal Perth Hospital	Ho, KM (corresponding author), Royal Perth Hosp, Dept Intens Care Med, Perth, WA 6001, Australia.	kwok.ho@health.wa.gov.au	Ho, Kwok M./E-3546-2010	Ho, Kwok M./0000-0002-6705-6004				[Anonymous], 2007, LANCET, V369, P1319; Banfield JM, 2011, J TRAUMA, V70, P732, DOI 10.1097/TA.0b013e31820783a3; Boufous S, 2010, INJURY PREV, V16, P275, DOI 10.1136/ip.2009.024877; Butler JS, 2007, LANCET, V369, P2160, DOI 10.1016/S0140-6736(07)61012-5; Butler JS, 2006, IRISH J MED SCI, V175, P20, DOI 10.1007/BF03168994; Gargett S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-270; Ho KM, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-279; Ho KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031776; Ho KM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003226; Novoa AM, 2011, B WORLD HEALTH ORGAN, V89, P422, DOI 10.2471/BLT.10.082180; Novoa AM, 2010, AM J PUBLIC HEALTH, V100, P2220, DOI 10.2105/AJPH.2010.192104; Schermer CR, 2008, J TRAUMA, V65, P1000, DOI 10.1097/TA.0b013e318182f76b; Schermer CR, 2006, J TRAUMA, V60, P29, DOI 10.1097/01.ta.0000199420.12322.5d; Summala H, 2014, ACCIDENT ANAL PREV, V73, P27, DOI 10.1016/j.aap.2014.08.008; Toroyan T, 2013, LANCET, V381, P977, DOI 10.1016/S0140-6736(13)60606-6; World Health Organization, 2009, GLOB STAT REP ROAD S	16	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0122652	10.1371/journal.pone.0122652	http://dx.doi.org/10.1371/journal.pone.0122652			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902197	Green Published, Green Submitted, gold			2022-12-26	WOS:000353331500026
J	Le Cabec, A; Tang, N; Tafforeau, P				Le Cabec, Adeline; Tang, Nancy; Tafforeau, Paul			Accessing Developmental Information of Fossil Hominin Teeth Using New Synchrotron Microtomography-Based Visualization Techniques of Dental Surfaces and Interfaces	PLOS ONE			English	Article							MODERN HUMANS; LIFE-HISTORY; HISTOLOGICAL RECONSTRUCTION; AUSTRALOPITHECUS-SEDIBA; DEVELOPING DENTITION; ENAMEL HYPOPLASIA; CROSS-STRIATIONS; GROWTH; AGE; STRESS	Quantification of dental long-period growth lines (Retzius lines in enamel and Andresen lines in dentine) and matching of stress patterns (internal accentuated lines and hypoplasias) are used in determining crown formation time and age at death in juvenile fossil hominins. They yield the chronology employed for inferences of life history. Synchrotron virtual histology has been demonstrated as a non-destructive alternative to conventional invasive approaches. Nevertheless, fossil teeth are sometimes poorly preserved or physically inaccessible, preventing observation of the external expression of incremental lines (perikymata and periradicular bands). Here we present a new approach combining synchrotron virtual histology and high quality three-dimensional rendering of dental surfaces and internal interfaces. We illustrate this approach with seventeen permanent fossil hominin teeth. The outer enamel surface and enamel-dentine junction (EDJ) were segmented by capturing the phase contrast fringes at the structural interfaces. Three-dimensional models were rendered with Phong's algorithm, and a combination of directional colored lights to enhance surface topography and the pattern of subtle variations in tissue density. The process reveals perikymata and linear enamel hypoplasias on the entire crown surface, including unerupted teeth. Using this method, highly detailed stress patterns at the EDJ allow precise matching of teeth within an individual's dentition when virtual histology is not sufficient. We highlight that taphonomical altered enamel can in particular cases yield artificial subdivisions of perikymata when imaged using X-ray microtomography with insufficient resolution. This may complicate assessments of developmental time, although this can be circumvented by a careful analysis of external and internal structures in parallel. We further present new crown formation times for two unerupted canines from South African Australopiths, which were found to form over a rather surprisingly long time (>4.5 years). This approach provides tools for maximizing the recovery of developmental information in teeth, especially in the most difficult cases.	[Le Cabec, Adeline; Tafforeau, Paul] ESRF, F-38043 Grenoble 9, France; [Le Cabec, Adeline; Tang, Nancy] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Le Cabec, Adeline] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany; [Tang, Nancy] Icahn Sch Med Mt Sinai, Exposure Biol Lab, Dept Prevent Med, New York, NY 10029 USA	European Synchrotron Radiation Facility (ESRF); Harvard University; Max Planck Society; Icahn School of Medicine at Mount Sinai	Le Cabec, A (corresponding author), ESRF, 71 Ave Martyrs,CS 40220, F-38043 Grenoble 9, France.	adeline.le-cabec@esrf.fr; paul.tafforeau@esrf.fr	LE CABEC, Adeline/I-1661-2019	LE CABEC, Adeline/0000-0001-6948-4726; Tafforeau, Paul/0000-0002-5962-1683	NSF [BCS 1126470]; Harvard University; European Synchrotron Radiation Facility [Ec697]; Direct For Social, Behav & Economic Scie [1126470] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Harvard University; European Synchrotron Radiation Facility; Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This research was funded by NSF Grant BCS 1126470, Harvard University, and the European Synchrotron Radiation Facility (Ec697). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel RL, 2012, PALAEONTOL ELECTRON, V15; Antoine D, 2000, EVALUATING PERIODICI; Antoine D, 2009, J ANAT, V214, P45, DOI 10.1111/j.1469-7580.2008.01010.x; Asper H, 1916, SCHWEIZ VJSCHR ZAHNH, V26, P275; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; Betz O, 2007, J MICROSC-OXFORD, V227, P51, DOI 10.1111/j.1365-2818.2007.01785.x; BEYNON AD, 1991, AM J PHYS ANTHROPOL, V86, P189, DOI 10.1002/ajpa.1330860208; Bocaege E, 2010, AM J PHYS ANTHROPOL, V141, P498, DOI 10.1002/ajpa.21233; BOYDE A, 1990, MG PRIMATOL, V14, P229; Boyde A, 1963, 3 INT M FOR IMM MED, P36; BROMAGE TG, 1985, NATURE, V317, P525, DOI 10.1038/317525a0; Bronnikov AV, 2002, J OPT SOC AM A, V19, P472, DOI 10.1364/JOSAA.19.000472; Bronnikov AV, 2006, P EUR C COMP VIS GRA; Dean C, 2001, NATURE, V414, P628, DOI 10.1038/414628a; Dean Christopher, 1999, Cambridge Studies in Biological and Evolutionary Anthropology, V25, P111; Dean MC, 2006, P ROY SOC B-BIOL SCI, V273, P2799, DOI 10.1098/rspb.2006.3583; Dean MC, 2014, ANN HUM BIOL, V41, P358, DOI 10.3109/03014460.2014.923047; Dean MC, 2010, PHILOS T R SOC B, V365, P3397, DOI 10.1098/rstb.2010.0052; DEAN MC, 1986, AM J PHYS ANTHROPOL, V70, P301, DOI 10.1002/ajpa.1330700305; DEAN MC, 1993, AM J PHYS ANTHROPOL, V91, P401, DOI 10.1002/ajpa.1330910402; Dean MC, 1996, ARCH ORAL BIOL, V41, P233, DOI 10.1016/0003-9969(95)00137-9; Dean MC, 1998, J HUM EVOL, V35, P401, DOI 10.1006/jhev.1998.0243; DEAN MC, 1989, FOLIA PRIMATOL, V53, P160; Dean MC., 1995, STRUCTURE FUNCTION E, P239; Dean MC., 1993, INT J OSTEOARCHAEOL, V3, P249, DOI [10.1002/oa.1390030404, DOI 10.1002/OA.1390030404]; Dirks W, 2002, AM J PHYS ANTHROPOL, V118, P239, DOI 10.1002/ajpa.10089; Elhechmi I, 2013, BIOMED OPT EXPRESS, V4, P2124, DOI 10.1364/BOE.4.002124; FitzGerald C. M., 1995, THESIS U CAMBRIDGE; Fitzgerald Charles M., 2000, BIOL ANTHR HUMAN SKE, P237; FitzGerald CM, 1998, J HUM EVOL, V35, P371, DOI 10.1006/jhev.1998.0232; GOODMAN AH, 1990, YEARB PHYS ANTHROPOL, V33, P59; Guatelli-Steinberg D, 2001, EVOL ANTHROPOL, V10, P138, DOI 10.1002/evan.1027; Gysi A., 1939, DENT DIG, V37, P661; Hassett BR, 2014, AM J PHYS ANTHROPOL, V153, P463, DOI 10.1002/ajpa.22445; Hillson S, 1997, AM J PHYS ANTHROPOL, V104, P89, DOI 10.1002/(SICI)1096-8644(199709)104:1<89::AID-AJPA6>3.0.CO;2-8; Hogg RT, 2010, THESIS CIRY U NEW YO; Huda T, 1994, INT J OSTEOARCHAEOL, V4, P49; KAWASAKI K, 1979, ARCH ORAL BIOL, V24, P939, DOI 10.1016/0003-9969(79)90221-8; Kolliker A, 1854, MIKROSKOPISCHE ANATO; Le Cabec A, 2014, AM J PHYS ANTHROPOL, V153, P166; LECABEC A, 2014, P EUR SOC STUD DRUG, V3, P103; Mahoney P, 2012, AM J PHYS ANTHROPOL, V147, P637, DOI 10.1002/ajpa.22029; Moggi-Cecchi J, 1998, AM J PHYS ANTHROPOL, V106, P425, DOI 10.1002/(SICI)1096-8644(199808)106:4<425::AID-AJPA2>3.0.CO;2-I; NEWMAN HN, 1974, ARCH ORAL BIOL, V19, P1135, DOI 10.1016/0003-9969(74)90242-8; NEWMAN HN, 1993, J ROY SOC MED, V86, P61; Pantke H, 1957, STOMA, V10, P32; PHONG BT, 1975, COMMUN ACM, V18, P311, DOI 10.1145/360825.360839; Pickerill H.P., 1913, DENT COSMOS, V55, P969; Preiswerk G, 1895, THESIS U BASEL; Reid DJ, 1998, J HUM EVOL, V35, P463, DOI 10.1006/jhev.1998.0233; Reid DJ, 2000, AM J PHYS ANTHROPOL, V113, P135; Retzius A., 1837, ARCH ANAT PHYSL, V1837, P486; Richards GD, 2012, AM J PHYS ANTHROPOL, V149, P172, DOI 10.1002/ajpa.22103; RISNES S, 1984, SCAND J DENT RES, V92, P1; Risnes S, 1998, J HUM EVOL, V35, P331, DOI 10.1006/jhev.1998.0229; RISNES S, 1990, ANAT RECORD, V226, P135, DOI 10.1002/ar.1092260203; ROSE JC, 1977, AM J PHYS ANTHROPOL, V46, P439, DOI 10.1002/ajpa.1330460309; ROSE JC, 1978, AM J PHYS ANTHROPOL, V49, P511, DOI 10.1002/ajpa.1330490411; ROSE JC, 1979, HUM BIOL, V51, P139; Rozzi FR, 1998, J HUM EVOL, V35, P543, DOI 10.1006/jhev.1998.0250; Schwartz GT, 2006, INT J PRIMATOL, V27, P1201, DOI 10.1007/s10764-006-9051-2; Schwartz GT, 2012, CURR ANTHROPOL, V53, pS395, DOI 10.1086/667591; Schwartz GT, 2001, INT J PRIMATOL, V22, P837, DOI 10.1023/A:1012073601808; Schwartz GT, 2001, AM J PHYS ANTHROPOL, V115, P269, DOI 10.1002/ajpa.1081; SKINNER M, 1991, J FORENSIC SCI, V36, P939; Skinner MF, 2012, AM J PHYS ANTHROPOL, V149, P468, DOI 10.1002/ajpa.22145; Smith BH, 1994, YEARB PHYS ANTHROPOL, V37, P177, DOI DOI 10.1002/AJPA.1330370608; Smith TM, 2008, EVOL ANTHROPOL, V17, P213, DOI 10.1002/evan.20176; Smith TM, 2007, P NATL ACAD SCI USA, V104, P20220, DOI 10.1073/pnas.0707051104; Smith TM, 2008, J HUM EVOL, V54, P205, DOI 10.1016/j.jhevol.2007.09.020; Smith TM, 2007, P NATL ACAD SCI USA, V104, P6128, DOI 10.1073/pnas.0700747104; Smith TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118118; Smith TM, 2014, AM J PHYS ANTHROPOL, V153, P243; Smith TM, 2010, P NATL ACAD SCI USA, V107, P20923, DOI 10.1073/pnas.1010906107; Smith TM, 2009, FRONT ORAL BIOL, V13, P86, DOI 10.1159/000242397; Smith TM., 2004, THESIS STONY BROOK U; Suwa G, 2009, SCIENCE, V326, P94, DOI 10.1126/science.1175824; Tafforeau P, 2006, APPL PHYS A-MATER, V83, P195, DOI 10.1007/s00339-006-3507-2; Tafforeau P, 2013, P EUR SOC STUD DRUG, V2, P224; Tafforeau P, 2008, J HUM EVOL, V54, P272, DOI 10.1016/j.jhevol.2007.09.018; Tafforeau P, 2007, PALAEOGEOGR PALAEOCL, V246, P206, DOI 10.1016/j.palaeo.2006.10.001; Tafforeau P, 2012, J HUM EVOL, V62, P424, DOI 10.1016/j.jhevol.2012.01.001; Wilkins SW, 1996, NATURE, V384, P335, DOI 10.1038/384335a0; YAMASHITA Y, 1983, MECHANISMS TOOTH ENA, P91	84	39	39	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123019	10.1371/journal.pone.0123019	http://dx.doi.org/10.1371/journal.pone.0123019			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901602	Green Submitted, Green Published, gold			2022-12-26	WOS:000353331500037
J	Ma, HY; Yang, HY; Liang, ZW; Ooi, MKJ				Ma, Hongyuan; Yang, Haoyu; Liang, Zhengwei; Ooi, Mark K. J.			Effects of 10-Year Management Regimes on the Soil Seed Bank in Saline-Alkaline Grassland	PLOS ONE			English	Article							SONGNEN PLAIN; ENVIRONMENTAL-FACTORS; BIODIVERSITY LOSS; SODIC SOIL; VEGETATION; RESTORATION; DYNAMICS; DISTURBANCE; LAND; SUCCESSION	Background Management regimes for vegetation restoration of degraded grasslands can significantly affect the process of ecological succession. However, few studies have focused on variation in the soil seed bank during vegetation restoration under different management regimes, especially in saline-alkaline grassland habitats. Our aim was to provide insights into the ecological effects of grassland management regimes on soil seed bank composition and vegetation establishment in mown, fenced, transplanted and natural grassland sites, all dominated by the perennial rhizomatous grass Leymus chinensis. Methodology We studied species composition and diversity in both the soil seed bank and aboveground vegetation in differently managed grasslands in Northeast China. An NMDS (nonmetric multidimensional scaling) was used to evaluate the relationship between species composition, soil seed banks, aboveground vegetation and soil properties. Principal Findings Fenced and mown grassland sites had high density and species richness in both the soil seed bank and aboveground vegetation. The Transplanted treatment exhibited the highest vegetation growth and seed production of the target species L. chinensis. Seeds of L. chinensis in the soil occurred only in transplanted and natural grassland. Based on the NMDS analysis, the number of species in both the soil seed bank and aboveground vegetation were significantly related to soil Na+, Cl-, RSC (residual sodium carbonate), alkalinity, ESP (exchangeable sodium percentage) and AP (available phosphorus). Conclusions Soil seed bank composition and diversity in the saline-alkaline grassland were significantly affected by the management regimes implemented, and were also significantly related to the aboveground vegetation and several soil properties. Based on vegetative growth, reproductive output and maintenance of soil seed bank, the transplanting was identified as the most effective method for relatively rapid restoration of the target species L. chinensis. This approach could be beneficial for the restoration of dominant species in a wide range of degraded grassland ecosystems.	[Ma, Hongyuan; Yang, Haoyu; Liang, Zhengwei] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Changchun, Peoples R China; [Ma, Hongyuan; Yang, Haoyu; Liang, Zhengwei] DaanSod Land Expt Stn China, Daan, Peoples R China; [Ooi, Mark K. J.] Univ Wollongong, Inst Conservat Biol, Sch Biol Sci, Wollongong, NSW, Australia	Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; University of Wollongong	Liang, ZW (corresponding author), Chinese Acad Sci, Northeast Inst Geog & Agroecol, Changchun, Peoples R China.	liangzhengwei@neigae.ac.cn	Ooi, Mark K J/A-4779-2012	Ooi, Mark K J/0000-0002-3046-0417	National Natural Science Foundation of China [41371260]; National Basic Research Program of China [2015CB150802]; Australian Research Council Linkage Project [LP110100527]; Program of Science and Technology development of Jilin province [20140204050SF]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Australian Research Council Linkage Project(Australian Research Council); Program of Science and Technology development of Jilin province	This work was financed by the National Natural Science Foundation of China (41371260), the National Basic Research Program of China (Grant No. 2015CB150802), Australian Research Council Linkage Project grant (LP110100527) and Program of Science and Technology development of Jilin province (20140204050SF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, ACTA ECOL SIN, DOI DOI 10.1016/J.CHNAES.2009.04.004; Aradottir AL, 2012, J APPL ECOL, V49, P439, DOI 10.1111/j.1365-2664.2012.02123.x; Bakker JP, 1996, J VEG SCI, V7, P165, DOI 10.2307/3236316; Begon M, 1986, ECOLOGY INDIVIDUALS; Bologna PAX, 2012, J COASTAL RES, V28, P99, DOI 10.2112/JCOASTRES-D-10-00062.1; Bossuyt B, 2008, J VEG SCI, V19, P875, DOI 10.3170/2008-8-18462; Brys R, 2004, J APPL ECOL, V41, P1080, DOI 10.1111/j.0021-8901.2004.00981.x; Budelsky RA, 2004, PLANT ECOL, V175, P91, DOI 10.1023/B:VEGE.0000048102.72101.50; Busso CA, 2009, ENVIRON EXP BOT, V67, P188, DOI 10.1016/j.envexpbot.2009.01.003; Cooper EJ, 2003, ARCT ANTARCT ALP RES, V35, P369, DOI 10.1657/1523-0430(2003)035[0369:FHODOB]2.0.CO;2; De Steven D, 2007, WETLANDS, V27, P972, DOI 10.1672/0277-5212(2007)27[972:TNDPTF]2.0.CO;2; Deng W, 2006, REGIONAL ECOENVIRONM; Erfanzadeh R, 2010, PLANT ECOL, V206, P335, DOI 10.1007/s11258-009-9646-8; Fenner M., 2005, ECOLOGY SEEDS; Frieswyk CB, 2006, CAN J BOT, V84, P1882, DOI 10.1139/B06-100; Fu PY, 1995, KEYS PLANTS NE CHINA; Gokalp Z, 2010, AFR J AGR RES, V5, P1127; Gonzalez-Alday J, 2009, ECOL ENG, V35, P1062, DOI 10.1016/j.ecoleng.2009.03.007; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; Hopfensperger KN, 2007, OIKOS, V116, P1438, DOI [10.1111/j.2007.0030-1299.15818.x, 10.1111/j.0030-1299.2007.15818.x]; Jacquemyn H, 2003, BIOL CONSERV, V111, P137, DOI 10.1016/S0006-3207(02)00256-2; Jacquemyn H, 2011, BIOL CONSERV, V144, P416, DOI 10.1016/j.biocon.2010.09.020; Janssens F, 1998, PLANT SOIL, V202, P69, DOI 10.1023/A:1004389614865; Jiang SC, 2010, APPL VEG SCI, V13, P47, DOI 10.1111/j.1654-109X.2009.01048.x; Kalamees R, 2002, ECOLOGY, V83, P1017, DOI 10.1890/0012-9658(2002)083[1017:TROTSB]2.0.CO;2; Koch MA, 2011, FLORA, V206, P52, DOI 10.1016/j.flora.2010.01.010; Krauss J, 2010, ECOL LETT, V13, P597, DOI 10.1111/j.1461-0248.2010.01457.x; Le Stradic S, 2014, APPL VEG SCI, V17, P109, DOI 10.1111/avsc.12058; Lee KS, 2008, MAR POLLUT BULL, V56, P1015, DOI 10.1016/j.marpolbul.2008.02.010; Liang ZhengWei, 2008, Journal of Jilin Agricultural University, V30, P517; Luzuriaga AL, 2005, ACTA OECOL, V27, P57, DOI 10.1016/j.actao.2004.09.003; Ma HY, 2014, PAK J BOT, V46, P1147; Ma MJ, 2013, PLANT SOIL, V369, P283, DOI 10.1007/s11104-012-1560-5; Ma MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101458; Ma MJ, 2010, FLORA, V205, P128, DOI 10.1016/j.flora.2009.02.006; Martins AM, 2007, ECOL ENG, V31, P165, DOI 10.1016/j.ecoleng.2007.05.008; Matus G, 2005, FLORA, V200, P296, DOI 10.1016/j.flora.2004.12.002; MILBERG P, 1995, OIKOS, V72, P3, DOI 10.2307/3546031; Mitlacher K, 2009, J VEG SCI, V5, P63; Oksanen J, 2012, MULTIVARIATE ANAL EC; Orth RJ, 1999, AQUAT BOT, V64, P77, DOI 10.1016/S0304-3770(99)00007-8; Pakeman RJ, 2005, J VEG SCI, V16, P121, DOI 10.1111/j.1654-1103.2005.tb02345.x; Renton M, 2011, ANN BOT-LONDON, V108, P1213, DOI 10.1093/aob/mcr131; Schmiede R, 2009, BIOL CONSERV, V142, P404, DOI 10.1016/j.biocon.2008.11.001; Shang ZH, 2008, LAND DEGRAD DEV, V19, P554, DOI 10.1002/ldr.861; Shen YX, 2007, SEED SCI RES, V17, P99, DOI 10.1017/S0960258507708139; Smith SE, 2000, J RANGE MANAGE, V53, P550, DOI 10.2307/4003657; Solomon TB, 2006, S AFR J BOT, V72, P263, DOI 10.1016/j.sajb.2005.09.003; Sternberg M, 2003, J VEG SCI, V14, P375, DOI 10.1658/1100-9233(2003)014[0375:EOGOSS]2.0.CO;2; Stroh M, 2002, PHYTOCOENOLOGIA, V32, P595, DOI 10.1127/0340-269X/2002/0032-0595; Szabo Andras, 2011, Ecological Questions, V14, P65, DOI 10.12775/v10090-011-0019-2; TerHeerdt GNJ, 1996, FUNCT ECOL, V10, P144, DOI 10.2307/2390273; Valko O, 2014, AGR ECOSYST ENVIRON, V182, P80, DOI 10.1016/j.agee.2013.06.012; Vecrin MP, 2007, J NAT CONSERV, V15, P59, DOI 10.1016/j.jnc.2006.10.001; Wang GD, 2013, RESTOR ECOL, V21, P801, DOI 10.1111/rec.12015; Yang F, 2011, INT J ENV RES PUB HE, V8, P374, DOI 10.3390/ijerph8020374; Yu JB, 2010, CLEAN-SOIL AIR WATER, V38, P1010, DOI 10.1002/clen.201000276; ZEDLER JB, 1990, AUST J ECOL, V15, P57, DOI 10.1111/j.1442-9993.1990.tb01021.x; Zedler JB, 2003, PLANT SOIL, V253, P259, DOI 10.1023/A:1024599203741; Zedler JB, 2008, RESTOR ECOL, V16, P249, DOI 10.1111/j.1526-100X.2007.00268.x; Zeiter M, 2013, AGR ECOSYST ENVIRON, V171, P55, DOI 10.1016/j.agee.2013.03.009; Zhan X, 2007, J ARID ENVIRON, V68, P298, DOI 10.1016/j.jaridenv.2006.05.012	62	10	16	5	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0122319	10.1371/journal.pone.0122319	http://dx.doi.org/10.1371/journal.pone.0122319			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902145	Green Published, gold, Green Submitted			2022-12-26	WOS:000353331500018
J	Qiu, TY; Xiao, H; Zhang, QC; Qiu, JX; Yang, YY; Wu, DF; Cao, ZW; Zhu, RX				Qiu, Tianyi; Xiao, Han; Zhang, Qingchen; Qiu, Jingxuan; Yang, Yiyan; Wu, Dingfeng; Cao, Zhiwei; Zhu, Ruixin			Proteochemometric Modeling of the Antigen-Antibody Interaction: New Fingerprints for Antigen, Antibody and Epitope-Paratope Interaction	PLOS ONE			English	Article							PROTEIN-BINDING SITES; CRYSTAL-STRUCTURE; SPACE; RECOGNITION; PREDICTION; INHIBITORS; INTERFACE; ALIGNMENT; PATTERNS; SURFACES	Despite the high specificity between antigen and antibody binding, similar epitopes can be recognized or cross-neutralized by paratopes of antibody with different binding affinities. How to accurately characterize this slight variation which may or may not change the antigen-antibody binding affinity is a key issue in this area. In this report, by combining cylinder model with shell structure model, a new fingerprint was introduced to describe both the structural and physical-chemical features of the antigen and antibody protein. Furthermore, beside the description of individual protein, the specific epitope-paratope interaction fingerprint (EPIF) was developed to reflect the bond and the environment of the antigen-antibody interface. Finally, Proteochemometric Modeling of the antigen-antibody interaction was established and evaluated on 429 antigen-antibody complexes. By using only protein descriptors, our model achieved the best performance (R-2 = 0: 91; Q(test)(2) = 0: 68) among peers. Further, together with EPIF as a new cross-term, our model (R-2 = 0: 92; Q(2) test = 0: 74) can significantly outperform peers with multiplication of ligand and protein descriptors as a cross-term (R2 <= 0.81; Q(test)(2) <= 0: 44). Results illustrated that: 1) our newly designed protein fingerprints and EPIF can better describe the antigen-antibody interaction; 2) EPIF is a better and specific cross-term in Proteochemometric Modeling for antigen-antibody interaction. The fingerprints designed in this study will provide assistance to the description of antigen-antibody binding, and in future, it may be valuable help for the high-throughput antibody screening. The algorithm is freely available on request.	[Qiu, Tianyi; Zhang, Qingchen; Qiu, Jingxuan; Yang, Yiyan; Wu, Dingfeng; Cao, Zhiwei; Zhu, Ruixin] Tongji Univ, Sch Life Sci & Technol, Dept Bioinformat, Shanghai 200092, Peoples R China; [Xiao, Han] Univ Helsinki, Dept Comp Sci, FI-00014 Helsinki, Finland; [Cao, Zhiwei] Shanghai Ctr Bioinformat Technol, Shanghai 201203, Peoples R China; [Zhu, Ruixin] Liaoning Univ Tradit Chinese Med, Sch Pharm, Dalian 116600, Liaoning, Peoples R China	Tongji University; University of Helsinki; Chinese Academy of Sciences; Liaoning University of Traditional Chinese Medicine	Cao, ZW (corresponding author), Tongji Univ, Sch Life Sci & Technol, Dept Bioinformat, Shanghai 200092, Peoples R China.	zwcao@tongji.edu.cn; rxzhu@tongji.edu.cn	, 金石为开/AFU-9737-2022	Zhu, Ruixin/0000-0002-5070-6453	National Natural Science Foundation of China [31200986, 31171272]; Ministry of Science and Technology China [2010CB833601]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology China(Ministry of Science and Technology, ChinaMinistry of Science, ICT & Future Planning, Republic of Korea)	This work was supported in part by grants from National Natural Science Foundation of China (31200986, 31171272) and Ministry of Science and Technology China (2010CB833601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bock ME, 2007, J COMPUT BIOL, V14, P285, DOI 10.1089/cmb.2006.0145; Chen Y, 1999, J MOL BIOL, V293, P865, DOI 10.1006/jmbi.1999.3192; Corti D, 2013, ANNU REV IMMUNOL, V31, P705, DOI 10.1146/annurev-immunol-032712-095916; Georgiev IS, 2013, SCIENCE, V340, P751, DOI 10.1126/science.1233989; Goldsby, 2003, IMM, P57; Hoffmann B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-99; Huang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041698; Ivanciuc O, 2002, BIOINFORMATICS, V18, P1358, DOI 10.1093/bioinformatics/18.10.1358; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Konc J, 2010, BIOINFORMATICS, V26, P1160, DOI 10.1093/bioinformatics/btq100; Lapins M, 2009, J CHEM INF MODEL, V49, P1202, DOI 10.1021/ci800453k; Lapins M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-181; Lapinsh M, 2005, BIOINFORMATICS, V21, P4289, DOI 10.1093/bioinformatics/bti703; Lapinsh M, 2003, J MED CHEM, V46, P2572, DOI 10.1021/jm020945m; Lapinsh M, 2002, MOL PHARMACOL, V61, P1465, DOI 10.1124/mol.61.6.1465; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Macindoe G, 2010, NUCLEIC ACIDS RES, V38, pW445, DOI 10.1093/nar/gkq311; Mordalski S, 2011, BIOORG MED CHEM LETT, V21, P6816, DOI 10.1016/j.bmcl.2011.09.027; Muller KR, 2005, J CHEM INF MODEL, V45, P249, DOI 10.1021/ci049737o; Muller YA, 1998, STRUCTURE, V6, P1153, DOI 10.1016/S0969-2126(98)00116-6; Nisius B, 2012, J BIOTECHNOL, V159, P123, DOI 10.1016/j.jbiotec.2011.12.005; Roitt I., 2001, IMMUNOLOGY; Schalon C, 2008, PROTEINS, V71, P1755, DOI 10.1002/prot.21858; Shulman-Peleg A, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-43; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Stroembergsson H, 2008, J CHEM INF MODEL, V48, P2278, DOI 10.1021/ci800200e; Sun J, 2011, IMMUNOME RES, V7, P1; Sun J, 2009, NUCLEIC ACIDS RES, V37, pW612, DOI 10.1093/nar/gkp417; Tharakaraman K, 2013, CELL, V153, P1475, DOI 10.1016/j.cell.2013.05.035; Tian C, 2014, CHEM BIOL DRUG DES, V83, P610, DOI 10.1111/cbdd.12274; van Westen GJP, 2011, MEDCHEMCOMM, V2, P16, DOI 10.1039/c0md00165a; Weill N, 2010, J CHEM INF MODEL, V50, P123, DOI 10.1021/ci900349y; Wu Di, 2010, Immunome Res, V6 Suppl 1, pS1, DOI 10.1186/1745-7580-6-S1-S1; Wu DF, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-212; Xie L, 2008, P NATL ACAD SCI USA, V105, P5441, DOI 10.1073/pnas.0704422105; Xue WW, 2012, J COMPUT CHEM, V33, P527, DOI 10.1002/jcc.22887; Yao XJ, 2004, J CHEM INF COMP SCI, V44, P1257, DOI 10.1021/ci049965i; Yin SY, 2009, P NATL ACAD SCI USA, V106, P16622, DOI 10.1073/pnas.0906146106; YSERN X, 1994, J MOL BIOL, V238, P496	40	12	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0122416	10.1371/journal.pone.0122416	http://dx.doi.org/10.1371/journal.pone.0122416			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901362	gold, Green Submitted, Green Published			2022-12-26	WOS:000353331500020
J	Yu, ZL; Li, W; Hou, DR; Zhou, L; Deng, YY; Tian, M; Feng, XL				Yu, Zhuling; Li, Wei; Hou, Deren; Zhou, Lin; Deng, Yanyao; Tian, Mi; Feng, Xialu			Relationship between Adiponectin Gene Polymorphisms and Late-Onset Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; TYPE-2 DIABETES-MELLITUS; LINKAGE DISEQUILIBRIUM; INSULIN-RESISTANCE; METABOLIC SYNDROME; SERUM ADIPONECTIN; ASSOCIATION; VARIANTS; OBESITY; TRAITS	In recent years, researchers have found that adiponectin (ANP) plays an important role in the pathogenesis of Alzheimer's disease (AD), and low serum concentrations of ANP are associated with AD. Higher plasma ANP level have a protective effect against the development of cognitive decline, suggesting that ANP may affect AD onset. Meanwhile, accumulating evidence supports the crucial role of ANP in the pathogenesis of AD. To study the relationship between ANP gene polymorphisms (rs266729, -11377C>G and rs1501299, G276T) and late-onset AD (LOAD), we carried out a case-control study that included 201 LOAD patients and 257 healthy control subjects. Statistically significant differences were detected in the genotype and allelotype frequency distributions of rs266729 and rs1501299 between the LOAD group and the control group, with a noticeable increase in the G and T allelotype frequency distributions in the LOAD group (P < 0.05). Logistic regression analysis using recessive model and additive model revealed that the rs266729 GG and rs1501299 TT genotypes are associated with a greater risk of LOAD. Haplotype analysis identified four haplotypes: CG, CT, GG, and GT. The frequencies of the CT and GG haplotypes were not significantly different (P > 0.05) between the LOAD group and control group, whereas the CG and GT haplotypes were significantly different (P < 0.05), suggesting a negative correlation between the CG haplotype and LOAD onset (OR = 0.74, 95% CI = 0.57-0.96, P = 0.022), and a positive correlation between the GT haplotype and LOAD onset (OR = 2.29, 95% CI = 1.42-3.68, P = 0.005). Therefore, we speculated that the rs266729 and rs1501299 of ANP gene polymorphisms and the GT and CG haplotypes were associated with LOAD.	[Yu, Zhuling; Li, Wei; Hou, Deren; Deng, Yanyao; Tian, Mi; Feng, Xialu] Cent S Univ, Dept Neurol, Xiangya Hosp 3, Changsha, Hunan, Peoples R China; [Li, Wei] First Hosp Changsha, Dept Nerve Med Ctr, Changsha, Peoples R China; [Zhou, Lin] Cent S Univ, Dept Geriatr Neurol, Xiangya Hosp, Changsha, Hunan, Peoples R China	Central South University; Central South University	Hou, DR (corresponding author), Cent S Univ, Dept Neurol, Xiangya Hosp 3, Changsha, Hunan, Peoples R China.	hou0718@126.com			Science and Technology Project of the Science and Technology Agency, Hunan Province, China [2014SK3090]; Specialized research funds for the Health care program of Hunan Province, China [A2013-01]	Science and Technology Project of the Science and Technology Agency, Hunan Province, China; Specialized research funds for the Health care program of Hunan Province, China	The study was supported by the Science and Technology Project of the Science and Technology Agency, Hunan Province, China (No. 2014SK3090) and the Specialized research funds for the Health care program of Hunan Province, China (No. A2013-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052354; Chu HY, 2013, DIABETES-METAB RES, V29, P532, DOI 10.1002/dmrr.2424; Gulcelik NE, 2013, MINERVA ENDOCRINOL, V38, P203; Jeon BT, 2009, BRAIN RES REV, V61, P81, DOI 10.1016/j.brainresrev.2009.05.002; Kamogawa K, 2010, DEMENT GERIATR COGN, V30, P432, DOI 10.1159/000321985; Li FYL, 2011, ACTA PHYSIOL, V203, P167, DOI 10.1111/j.1748-1716.2010.02216.x; Lin CH, 2012, CHINESE J PHYSIOL, V55, P405, DOI [10.4077/CJP.2011.AMM081, 10.4077/CJP.2012.BAA081]; Liu ML, 2012, DIABETES, V61, P2776, DOI 10.2337/db12-0169; Masaki T, 2012, METABOLISM, V61, P1197, DOI 10.1016/j.metabol.2012.01.016; Mtiraoui N, 2012, DIABETES RES CLIN PR, V97, P290, DOI 10.1016/j.diabres.2012.02.015; Pakaski M, 2014, J ALZHEIMERS DIS, V38, P371, DOI 10.3233/JAD-131139; Pei HF, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0373-x; Psilopanagioti A, 2009, NEUROENDOCRINOLOGY, V89, P38, DOI 10.1159/000151396; Qiu G, 2011, AGE, V33, P155, DOI 10.1007/s11357-010-9173-5; Ramya K, 2013, GENE, V532, P253, DOI 10.1016/j.gene.2013.09.012; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Teixeira AL, 2013, NEUROMOL MED, V15, P115, DOI 10.1007/s12017-012-8201-2; Tong GX, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-67; van Echten-Deckert G, 2012, PROG LIPID RES, V51, P378, DOI 10.1016/j.plipres.2012.07.001; Weiss KM, 2002, TRENDS GENET, V18, P19, DOI 10.1016/S0168-9525(01)02550-1; Zadjali F, 2013, GENE, V527, P663, DOI 10.1016/j.gene.2013.06.057; Ziemke F, 2010, AM J CLIN NUTR, V91, p258S, DOI 10.3945/ajcn.2009.28449C	22	12	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0125186	10.1371/journal.pone.0125186	http://dx.doi.org/10.1371/journal.pone.0125186			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902149	Green Submitted, Green Published, gold			2022-12-26	WOS:000353331500114
J	Belay, M; Legesse, M; Mihret, A; Bekele, Y; Ottenhoff, THM; Franken, KLMC; Bjune, G; Abebe, F				Belay, Mulugeta; Legesse, Mengistu; Mihret, Adane; Bekele, Yonas; Ottenhoff, Tom H. M.; Franken, Kees L. M. C.; Bjune, Gunnar; Abebe, Fekadu			Pro- and Anti-Inflammatory Cytokines against Rv2031 Are Elevated during Latent Tuberculosis: A Study in Cohorts of Tuberculosis Patients, Household Contacts and Community Controls in an Endemic Setting	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; INTERFERON-GAMMA; DORMANCY REGULON; HSPX PROTEIN; RESPONSES; ANTIGENS; CONVERSIONS; RECOGNITION; VACCINATION; PERSISTENCE	Tuberculosis (TB) is among the leading causes of morbidity and mortality. The causative agent, Mycobacterium tuberculosis (Mtb), has evolved virulent factors for entry, survival, multiplication and immune evasion. Rv2031 (also called alpha crystallin, hspX, 16-kDa antigen), one of the most immunogenic latency antigens, is believed to play a key role in long-term viability of Mtb. Here, we report the dynamics of pro-inflammatory (IFN-gamma, TNF-alpha) and anti-inflammatory (IL-10) cytokines against Rv2031 using whole blood assay in human cohorts in a TB endemic setting. Cytokine responses to ESAT-6-CFP-10 were also measured for comparison. Blood samples were collected from smear positive pulmonary TB patients and their contacts at baseline, 6 and 12 months, and from community controls at entry. At baseline, 54.4% of controls and 73.2% of contacts were QFT-GIT test positive. Baseline IFN-gamma, TNF-alpha and IL-10 responses to Rv2031 were significantly higher in controls compared to contacts and untreated patients (p<0.001). Furthermore, untreated patients had significantly higher TNF-alpha and IL-10 responses to Rv2031 compared to contacts (p<0.001). In contacts and treated patients, IFN-gamma, TNF-alpha and IL-10 responses to Rv2031 significantly increased over 12 months (p<0.0001) and became comparable with the corresponding levels in controls. There was a positive and significant correlation between Rv2031 and ESAT-6-CFP-10 specific cytokine responses in each study group. The fact that the levels of IFN-gamma, TNF-alpha and IL-10 against Rv2031 were highest during latent TB infection may indicate their potential as markers of protection against TB. Taken together, the findings of this study suggest the potential of IFN-gamma, TNF-alpha and IL-10 against Rv2031 as biomarkers of the host response to Mtb during convalescence from, and the absence of, active tuberculosis.	[Belay, Mulugeta; Legesse, Mengistu] Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia; [Belay, Mulugeta; Bjune, Gunnar; Abebe, Fekadu] Univ Oslo, Inst Hlth & Soc, Dept Community Med, Oslo, Norway; [Mihret, Adane; Bekele, Yonas] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Ottenhoff, Tom H. M.; Franken, Kees L. M. C.] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands	Addis Ababa University; University of Oslo; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Belay, M (corresponding author), Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia.	mulg2002@yahoo.com	Franken, Kees/ABA-7095-2021; Bekele, Yonas/AAN-6710-2021	Franken, Kees/0000-0002-4747-6060; Mihret, Adane/0000-0003-3183-4772	Research Council of Norway	Research Council of Norway(Research Council of Norway)	This study was funded by the Research Council of Norway (http://www.forskningsradet.no/en/The_Research_Council/1138785832539). FA and GB received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe F, 2012, CLIN EXP IMMUNOL, V169, P213, DOI 10.1111/j.1365-2249.2012.04614.x; Belay M, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0654-5; Bentrup KHZ, 2001, TRENDS MICROBIOL, V9, P597, DOI 10.1016/S0966-842X(01)02238-7; Chauhan P, 2013, SCI REP-UK, V3, DOI 10.1038/srep01821; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; del Corral H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008257; Demissie A, 2006, CLIN VACCINE IMMUNOL, V13, P179, DOI 10.1128/CVI.13.2.179-186.2006; Dey B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023360; Dey B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018773; Geluk A, 2007, INFECT IMMUN, V75, P2914, DOI 10.1128/IAI.01990-06; Jeon BY, 2011, MICROBES INFECT, V13, P284, DOI 10.1016/j.micinf.2010.11.002; Leyten EMS, 2006, MICROBES INFECT, V8, P2052, DOI 10.1016/j.micinf.2006.03.018; Mamo Gezahegne, 2014, Ethiop Med J, VSuppl 1, P15; Manabe YC, 2000, NAT MED, V6, P1327, DOI 10.1038/82139; MOH, 2007, GUID HIV COUNS TEST; MOH, 2012, GUID CLIN PROGR MAN; Cavalcanti YVN, 2012, PULM MED, V2012, DOI 10.1155/2012/745483; Pai M, 2009, INT J TUBERC LUNG D, V13, P84; Population and Census Commission, 2007, SUMM STAT REP 2007 P; Raja A, 2004, INDIAN J MED RES, V120, P213; Ringshausen FC, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-220; Roupie V, 2007, INFECT IMMUN, V75, P941, DOI 10.1128/IAI.01137-06; Shi CW, 2010, VACCINE, V28, P5237, DOI 10.1016/j.vaccine.2010.05.063; Shi LB, 2003, P NATL ACAD SCI USA, V100, P241, DOI 10.1073/pnas.0136863100; Vekemans J, 2004, INFECT IMMUN, V72, P381, DOI 10.1128/IAI.72.1.381-388.2004; WHO, 2014, GLOB TUB REP 2014; Wilkinson RJ, 1998, SCAND J IMMUNOL, V48, P403; Ying YA, 1996, J BACTERIOL, V178, P4484, DOI 10.1128/jb.178.15.4484-4492.1996; Yuan Y, 1998, P NATL ACAD SCI USA, V95, P9578, DOI 10.1073/pnas.95.16.9578	29	27	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124134	10.1371/journal.pone.0124134	http://dx.doi.org/10.1371/journal.pone.0124134			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897840	Green Submitted, gold, Green Published			2022-12-26	WOS:000353212600051
J	Sasai, T; Morino, K; Tanaka, G; Almendral, JA; Aihara, K				Sasai, Takeyuki; Morino, Kai; Tanaka, Gouhei; Almendral, Juan A.; Aihara, Kazuyuki			Robustness of Oscillatory Behavior in Correlated Networks	PLOS ONE			English	Article							SCALE-FREE NETWORKS; ART.; SYNCHRONIZATION; GRAPHS	Understanding network robustness against failures of network units is useful for preventing large-scale breakdowns and damages in real-world networked systems. The tolerance of networked systems whose functions are maintained by collective dynamical behavior of the network units has recently been analyzed in the framework called dynamical robustness of complex networks. The effect of network structure on the dynamical robustness has been examined with various types of network topology, but the role of network assortativity, or degree- degree correlations, is still unclear. Here we study the dynamical robustness of correlated (assortative and disassortative) networks consisting of diffusively coupled oscillators. Numerical analyses for the correlated networks with Poisson and power-law degree distributions show that network assortativity enhances the dynamical robustness of the oscillator networks but the impact of network disassortativity depends on the detailed network connectivity. Furthermore, we theoretically analyze the dynamical robustness of correlated bimodal networks with two-peak degree distributions and show the positive impact of the network assortativity.	[Sasai, Takeyuki; Morino, Kai; Tanaka, Gouhei; Aihara, Kazuyuki] Univ Tokyo, Grad Sch Informat Sci & Technol, Tokyo 1138656, Japan; [Tanaka, Gouhei; Aihara, Kazuyuki] Univ Tokyo, Grad Sch Engn, Tokyo 1138656, Japan; [Tanaka, Gouhei; Aihara, Kazuyuki] Univ Tokyo, Inst Ind Sci, Tokyo 1538505, Japan; [Almendral, Juan A.] Univ Rey Juan Carlos, Complex Syst Grp, Madrid 28933, Spain; [Almendral, Juan A.] Univ Politecn Madrid, Ctr Biomed Technol, Madrid 28223, Spain	University of Tokyo; University of Tokyo; University of Tokyo; Universidad Rey Juan Carlos; Universidad Politecnica de Madrid; Centro de Tecnologia Biomedica (CTB)	Tanaka, G (corresponding author), Univ Tokyo, Grad Sch Engn, Tokyo 1138656, Japan.	gouhei@sat.t.u-tokyo.ac.jp	Almendral, Juan/ABC-8025-2021; Tanaka, Gouhei/Y-3230-2019	Almendral, Juan/0000-0003-1100-7446; Tanaka, Gouhei/0000-0002-6223-4406	JSPS KAKENHI [24700222, 26730127]; Aihara Innovative Mathematical Modelling Project; Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)"	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Aihara Innovative Mathematical Modelling Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)"(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was partially supported by JSPS KAKENHI Grant No. 24700222 (GT) and 26730127 (KM) as well as the Aihara Innovative Mathematical Modelling Project, the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)," initiated by the Council for Science and Technology Policy (CSTP) (GT, KM, and KA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrat A, 2008, DYNAMICAL PROCESSES, V1; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Boguna M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.028701; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Callaway DS, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.041902; Cohen R., 2010, COMPLEX NETWORKS STR; D'Agostino G, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/68006; Daido H, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.104101; Daido H, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/10002; Daido H, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.052907; Daido H, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016215; ERDOS P, 1960, B INT STATIST INST, V38, P343; Filatrella G, 2008, EUR PHYS J B, V61, P485, DOI 10.1140/epjb/e2008-00098-8; Goltsev AV, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.051105; Guckenheimer J, 2013, APPL MATH SCI, V42; Hasegawa T, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042809; He ZW, 2013, PHYSICA A, V392, P4181, DOI 10.1016/j.physa.2013.05.005; Huang WW, 2014, CHAOS, V24, DOI 10.1063/1.4881215; Kruse K, 2005, CURR OPIN CELL BIOL, V17, P20, DOI 10.1016/j.ceb.2004.12.007; Markovic R, 2014, CHAOS SOLITON FRACT, V69, P14, DOI 10.1016/j.chaos.2014.08.008; McGraw PN, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.015101; Morino K, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.032909; Morino K, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.056208; Nagata M, 2014, EUR PHYS J-SPEC TOP, V223, P2549, DOI 10.1140/epjst/e2014-02215-x; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Noh JD, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026116; Pazo D, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.055202; Shiraki Y, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.036101; Sorrentino F, 2006, PHYSICA D, V224, P123, DOI 10.1016/j.physd.2006.09.030; Tanaka G, 2014, SCI REP-UK, V4, DOI 10.1038/srep05522; Tanaka G, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.052906; Tanaka G, 2012, SCI REP-UK, V2, DOI 10.1038/srep00232; Tanaka G, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.035202; Tanaka Gouhei, 2015, MATH APPROACHES BIOL, P29; Tanizawa T, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.047101; Thakur B, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.042904; Valdez LD, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/38001; Vazquez A, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.015101; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Winfree A. T., 2001, GEOMETRY BIOL TIME, V12; Xulvi-Brunet R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066102	48	20	20	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123722	10.1371/journal.pone.0123722	http://dx.doi.org/10.1371/journal.pone.0123722			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894574	Green Accepted, Green Published, gold			2022-12-26	WOS:000353211700051
J	Wang, Y; Shaulsky, G				Wang, Yue; Shaulsky, Gad			TgrC1 Has Distinct Functions in Dictyostelium Development and Allorecognition	PLOS ONE			English	Article							CELL-CELL ADHESION; DISCOIDEUM; DIFFERENTIATION; LAGC; GENE; AGGREGATION; EXPRESSION; BINDING; GP150; DNA	The cell adhesion glycoproteins, TgrB1 and TgrC1, are essential for Dictyostelium development and allorecognition, but it has been impossible to determine whether their pleiotropic roles are due to one common function or to distinct functions in separate pathways. Mutations in the respective genes, tgrB1 and tgrC1, abrogate both development and allorecognition and the defects cannot be suppressed by activation of the cyclic AMP dependent protein kinase PKA, a central regulator of Dictyostelium development. Here we report that mutations in genes outside the known PKA pathway partially suppress the tgrC1-null developmental defect. We separated the pleiotropic roles of tgrC1 by testing the effects of a suppression mutation, stc(ins)A under different conditions. stcA(ins) modified only the developmental defect of tgrC1(-) but not the allorecognition defect, suggesting that the two functions are separable. The suppressor mutant phenotype also revealed that tgrC1 regulates stalk differentiation in a cell-autonomous manner and spore differentiation in a non-cell-autonomous manner. Moreover, stcA(ins) did not modify the developmental defect of tgrB1(-), but the less robust phenotype of tgrB1(-) obscures the possible role of stcA relative to tgrB1.	[Wang, Yue; Shaulsky, Gad] Baylor Coll Med, Grad Program Struct Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Shaulsky, Gad] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Shaulsky, G (corresponding author), Baylor Coll Med, Grad Program Struct Computat Biol & Mol Biophys, Houston, TX 77030 USA.	gadi@bcm.edu		Shaulsky, Gad/0000-0002-0532-0551	National Institute of General Medical Sciences [R01 GM084992]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084992] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by grant number R01 GM084992 from the National Institute of General Medical Sciences (http://www.nigms.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjard C, 1998, DEV BIOL, V193, P146, DOI 10.1006/dbio.1997.8804; Anjard C, 2011, EUKARYOT CELL, V10, P956, DOI 10.1128/EC.05053-11; Benabentos R, 2009, CURR BIOL, V19, P567, DOI 10.1016/j.cub.2009.02.037; Chen G, 2013, BIOCHEM J, V452, P259, DOI 10.1042/BJ20121674; DYNES JL, 1994, GENE DEV, V8, P948, DOI 10.1101/gad.8.8.948; GAO EN, 1992, J BIOL CHEM, V267, P9409; GELTOSKY JE, 1979, CELL, V18, P391, DOI 10.1016/0092-8674(79)90058-8; HARWOOD AJ, 1993, DEVELOPMENT, V118, P1041; Hirose S, 2011, SCIENCE, V333, P467, DOI 10.1126/science.1203903; Huang EY, 2006, DEVELOPMENT, V133, P449, DOI 10.1242/dev.02240; Iranfar N, 2006, DEV BIOL, V290, P460, DOI 10.1016/j.ydbio.2005.11.035; Katoh M, 2006, EUKARYOT CELL, V5, P18, DOI 10.1128/EC.5.1.18-25.2006; KAY RR, 1983, NATURE, V303, P242, DOI 10.1038/303242a0; Kibler K, 2003, DEV BIOL, V264, P506, DOI 10.1016/j.ydbio.2003.08.025; KUSPA A, 1989, P NATL ACAD SCI USA, V86, P8917, DOI 10.1073/pnas.86.22.8917; Ostrowski EA, 2008, PLOS BIOL, V6, P2376, DOI 10.1371/journal.pbio.0060287; SHAULSKY G, 1993, DEV BIOL, V160, P85, DOI 10.1006/dbio.1993.1288; Shaulsky G, 1996, P NATL ACAD SCI USA, V93, P15260, DOI 10.1073/pnas.93.26.15260; SHAULSKY G, 1995, GENE DEV, V9, P1111, DOI 10.1101/gad.9.9.1111; Siu CH, 2004, SEMIN CELL DEV BIOL, V15, P633, DOI 10.1016/j.semcdb.2004.09.004; Thompson CRL, 2000, MOL CELL, V6, P1509, DOI 10.1016/S1097-2765(00)00147-7; VOLLRATH D, 1988, P NATL ACAD SCI USA, V85, P6027, DOI 10.1073/pnas.85.16.6027; Wang B, 1997, SCIENCE, V277, P251, DOI 10.1126/science.277.5323.251; Wang J, 2000, DEV BIOL, V227, P734, DOI 10.1006/dbio.2000.9881	24	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124270	10.1371/journal.pone.0124270	http://dx.doi.org/10.1371/journal.pone.0124270			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894230	gold, Green Published, Green Submitted			2022-12-26	WOS:000353211700084
J	Chang, X; Li, J; Guo, YR; Wei, Z; Mentch, FD; Hou, CP; Zhao, Y; Qiu, HJ; Kim, C; Sleiman, PMA; Hakonarson, H				Chang, Xiao; Li, Jin; Guo, Yiran; Wei, Zhi; Mentch, Frank D.; Hou, Cuiping; Zhao, Yan; Qiu, Haijun; Kim, Cecilia; Sleiman, Patrick M. A.; Hakonarson, Hakon			Genome-Wide Association Study of Serum Minerals Levels in Children of Different Ethnic Background	PLOS ONE			English	Article							GENE; DATABASE; PLASMA	Calcium, magnesium, potassium, sodium, chloride and phosphorus are the major dietary minerals involved in various biological functions and are commonly measured in the blood serum. Sufficient mineral intake is especially important for children due to their rapid growth. Currently, the genetic mechanisms influencing serum mineral levels are poorly understood, especially for children. We carried out a genome-wide association (GWA) study on 5,602 European-American children and 4,706 African-American children who had mineral measures available in their electronic medical records (EMR). While no locus met the criteria for genome-wide significant association, our results demonstrated a nominal association of total serum calcium levels with a missense variant in the calcium -sensing receptor (CASR) gene on 3q13 (rs1801725, P = 1.96 x 10(-3)) in the African-American pediatric cohort, a locus previously reported in Caucasians. We also confirmed the association result in our pediatric European-American cohort (P = 1.38 x 10(-4)). We further replicated two other loci associated with serum calcium levels in the European-American cohort (rs780094, GCKR, P = 4.26 x 10(-3); rs10491003, GATA3, P = 0.02). In addition, we replicated a previously reported locus on 1q21, demonstrating association of serum magnesium levels with MUC1 (rs4072037, P = 2.04 x 10(-6)). Moreover, in an extended gene-based association analysis we uncovered evidence for association of calcium levels with the previously reported gene locus DGKD in both European-American children and African-American children. Taken together, our results support a role for CASR and DGKD mediated calcium regulation in both African-American and European-American children, and corroborate the association of calcium levels with GCKR and GATA3, and the association of magnesium levels with MUC1 in the European-American children.	[Chang, Xiao; Li, Jin; Guo, Yiran; Mentch, Frank D.; Hou, Cuiping; Zhao, Yan; Qiu, Haijun; Kim, Cecilia; Sleiman, Patrick M. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Wei, Zhi] New Jersey Inst Technol, Dept Comp Sci, Newark, NJ 07102 USA; [Sleiman, Patrick M. A.; Hakonarson, Hakon] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Sleiman, Patrick M. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; New Jersey Institute of Technology; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Sleiman, PMA (corresponding author), Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA.	patricksleiman@me.com; hakonarson@email.chop.edu	Xiao, Chang/AAO-9713-2020; Guo, Yiran/H-4120-2011; , AndyWei/H-4415-2012	Wei, Zhi/0000-0001-6059-4267	Institutional Development Fund from The Children's Hospital of Philadelphia; Kubert Estate Family; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	Institutional Development Fund from The Children's Hospital of Philadelphia; Kubert Estate Family; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The study was funded by an Institutional Development Fund from The Children's Hospital of Philadelphia and by a donation from the Kubert Estate Family. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranzini SE, 2013, AM J HUM GENET, V92, P854, DOI 10.1016/j.ajhg.2013.04.019; Chang X, 2013, SCI REP-UK, V3, DOI 10.1038/srep01691; Cole DEC, 2000, J AM SOC NEPHROL, V11, P1937, DOI 10.1681/ASN.V11101937; D'Souza-Li Lília, 2006, Arq Bras Endocrinol Metab, V50, P628, DOI 10.1590/S0004-27302006000400008; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Hunter DJ, 2002, CLIN SCI, V103, P259, DOI 10.1042/cs1030259; Kapur K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001035; Li J, 2013, HUM MOL GENET, V22, P1457, DOI 10.1093/hmg/dds534; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Meyer TE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001045; O'Seaghdha CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003796; O'Seaghdha CM, 2010, HUM MOL GENET, V19, P4296, DOI 10.1093/hmg/ddq342; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Razick S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-405; WHITFIELD JB, 1984, ANN CLIN BIOCHEM, V21, P176, DOI 10.1177/000456328402100303; WILLIAMS PD, 1992, CLIN SCI, V82, P493, DOI 10.1042/cs0820493	17	17	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123499	10.1371/journal.pone.0123499	http://dx.doi.org/10.1371/journal.pone.0123499			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886283	Green Published, gold, Green Submitted			2022-12-26	WOS:000353017000071
J	Lei, ZJ; Wang, J; Xiao, HL; Guo, Y; Wang, T; Li, Q; Liu, L; Luo, X; Fan, LL; Lin, L; Mao, CY; Wang, SN; Wei, YL; Lan, CH; Jiang, J; Yang, XJ; Liu, PD; Chen, DF; Wang, B				Lei, Z-J; Wang, J.; Xiao, H-L; Guo, Y.; Wang, T.; Li, Q.; Liu, L.; Luo, X.; Fan, L-L; Lin, L.; Mao, C-Y; Wang, S-N; Wei, Y-L; Lan, C-H; Jiang, J.; Yang, X-J; Liu, P-D; Chen, D-F; Wang, B.			Lysine-specific demethylase 1 promotes the stemness and chemoresistance of Lgr5(+) liver cancer initiating cells by suppressing negative regulators of beta-catenin signaling	ONCOGENE			English	Article							COUPLED RECEPTOR 5; DRIVE SELF-RENEWAL; THERAPEUTIC TARGET; LSD1; METASTASIS; COLON; DIFFERENTIATION; IDENTIFICATION; CONTRIBUTES; INHIBITION	Cancer initiating cells (CICs) are responsible for the unrestrained cell growth and chemoresistance of malignant tumors. Histone demethylation has been shown to be crucial for self-renewal/differentiation of stem cells, but it remains elusive whether lysine-specific demethylase 1 (LSD1) regulates the stemness properties of CICs. Here we report that the abundant expression of leucinerich repeat-containing G-protein-coupled receptor 5 (Lgr5) is associated with the progression of hepatocellular carcinoma (HCC). Lgr5(+) HCC cells behave similarly to CICs and are highly tumorigenic and resistant to chemotherapeutic agents. Importantly, Lgr5(+) cells express higher levels of LSD1, which in turn regulates Lgr5 expression and promotes the self-renewal and drug resistance of Lgr5(+) CICs. Mechanistically, LSD1 promotes beta-catenin activation by inhibiting the expression of several suppressors of beta-catenin signaling, especially Prickle1 and APC in Lgr5(+) CICs, by directly regulating the levels of mono- and di-methylation of histone H3 lysine-4 at the promoters of these genes. Furthermore, LSD1-associated activation of the beta-catenin signaling is essential for maintaining the activity of Lgr5(+) CICs. Together, our findings unravel the LSD1/Prickle1/APC/beta-catenin signaling axis as a novel molecular circuit regulating the stemness and chemoresistance of hepatic Lgr5(+) CICs and provide potential targets to improve chemotherapeutic efficacies against HCC.	[Lei, Z-J; Wang, J.; Guo, Y.; Wang, T.; Li, Q.; Liu, L.; Luo, X.; Fan, L-L; Wei, Y-L; Lan, C-H; Chen, D-F; Wang, B.] Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept Gastroenterol, Chongqing 400042, Peoples R China; [Xiao, H-L; Lin, L.; Mao, C-Y] Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept Pathol, Chongqing 400042, Peoples R China; [Wang, S-N] Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept Radiol, Chongqing 400042, Peoples R China; [Jiang, J.] Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept Urol, Chongqing 400042, Peoples R China; [Yang, X-J] Shantou Univ, Coll Med, Ctr Neurosci, Shantou, Peoples R China; [Liu, P-D] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA	Army Medical University; Army Medical University; Army Medical University; Army Medical University; Shantou University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Chen, DF (corresponding author), Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept Gastroenterol, Chongqing 400042, Peoples R China.	chendongfeng1981@126.com; wb_tmmu@126.com	Wang, Bin/W-9917-2019; 黄, 梦茜/AAE-9495-2020	Wang, Bin/0000-0001-5574-1760; 	National Natural Science Foundation of China (NSFC) [81472294, 81201949, 81372558]; Natural Science Foundation Project of CQ CSTC [CSTC2012JJA10124]; Science Foundation of Third Military Medical University [2012XJQ22]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of CQ CSTC(Natural Science Foundation Project of CQ CSTC); Science Foundation of Third Military Medical University	We are indebted to Prof Xiang Xu (Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing, China) for his technical assistance. We are grateful to Miss Chunhua Quan, Ya Li and Qing Li (Department of Gastroenterology, Institute of Surgery Research, Daping Hospital, Third Military Medical University, Chongqing, China) for their help in collecting clinical data. This work was supported by the grants from the National Natural Science Foundation of China (NSFC Nos. 81472294, 81201949, and 81372558), the Natural Science Foundation Project of CQ CSTC (No. CSTC2012JJA10124), and the Science Foundation of Third Military Medical University (No. 2012XJQ22).	Adamo A, 2011, NAT CELL BIOL, V13, P652, DOI 10.1038/ncb2246; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; Chan DW, 2006, GASTROENTEROLOGY, V131, P1218, DOI 10.1053/j.gastro.2006.07.020; Ding J, 2013, BRIT J CANCER, V109, P994, DOI 10.1038/bjc.2013.364; Flesken-Nikitin A, 2013, NATURE, V495, P241, DOI 10.1038/nature11979; Fukuma M, 2013, EXP CELL RES, V319, P113, DOI 10.1016/j.yexcr.2012.10.011; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Gil-Sanchis C, 2013, MOL HUM REPROD, V19, P407, DOI 10.1093/molehr/gat014; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Haraguchi N, 2010, J CLIN INVEST, V120, P3326, DOI 10.1172/JCI42550; Harris WJ, 2012, CANCER CELL, V21, P473, DOI 10.1016/j.ccr.2012.03.014; Hayami S, 2011, INT J CANCER, V128, P574, DOI 10.1002/ijc.25349; Hirsch D, 2014, CARCINOGENESIS, V35, P849, DOI 10.1093/carcin/bgt377; Hu M, 2007, GASTROENTEROLOGY, V133, P1579, DOI 10.1053/j.gastro.2007.08.036; Huang ZB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0070077, 10.1371/journal.pone.0075007]; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Kemper K, 2012, STEM CELLS, V30, P2378, DOI 10.1002/stem.1233; Kreso A, 2014, NAT MED, V20, P29, DOI 10.1038/nm.3418; Lee TKW, 2011, CELL STEM CELL, V9, P50, DOI 10.1016/j.stem.2011.06.005; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; O'Brien CA, 2012, CANCER CELL, V21, P777, DOI 10.1016/j.ccr.2012.04.036; Plaks V, 2013, CELL REP, V3, P70, DOI 10.1016/j.celrep.2012.12.017; Qin Y, 2014, CANCER LETT, V347, P225, DOI 10.1016/j.canlet.2014.02.013; Qiu W, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.125; Schenk T, 2012, NAT MED, V18, P605, DOI 10.1038/nm.2661; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Shan JJ, 2012, HEPATOLOGY, V56, P1004, DOI 10.1002/hep.25745; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Suva ML, 2014, CELL, V157, P580, DOI 10.1016/j.cell.2014.02.030; Wang B, 2014, CANCER RES, V74, P5746, DOI 10.1158/0008-5472.CAN-13-2563; Wang B, 2013, J GASTROENTEROL, V48, P798, DOI 10.1007/s00535-012-0711-z; Wang B, 2011, STEM CELL REV REP, V7, P458, DOI 10.1007/s12015-010-9175-9; Wang J, 2011, CANCER RES, V71, P7238, DOI 10.1158/0008-5472.CAN-11-0896; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Wang Z, 2015, ONCOGENE, V34, P1407, DOI 10.1038/onc.2014.75; Wu YD, 2013, CELL REP, V5, P224, DOI 10.1016/j.celrep.2013.08.030; Xi HQ, 2014, BRIT J CANCER, V110, P2011, DOI 10.1038/bjc.2014.112; Yamashita T, 2013, J CLIN INVEST, V123, P1911, DOI 10.1172/JCI66024; Yamashita T, 2013, HEPATOLOGY, V57, P1484, DOI 10.1002/hep.26168; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Yang W, 2008, CANCER RES, V68, P4287, DOI 10.1158/0008-5472.CAN-07-6691; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Yu YY, 2013, BIOCHEM BIOPH RES CO, V437, P192, DOI 10.1016/j.bbrc.2013.05.123; Zhang XM, 2013, CELL REP, V5, P445, DOI 10.1016/j.celrep.2013.09.018; Zhao ZK, 2013, TUMOR BIOL, V34, P173, DOI 10.1007/s13277-012-0525-x	50	63	66	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 11	2015	34	24					3188	3198		10.1038/onc.2015.129	http://dx.doi.org/10.1038/onc.2015.129			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CK3FD	25893304				2022-12-26	WOS:000356101100010
J	Desmond, MJ; Pritchard, DW; Hepburn, CD				Desmond, Matthew J.; Pritchard, Daniel W.; Hepburn, Christopher D.			Light Limitation within Southern New Zealand Kelp Forest Communities	PLOS ONE			English	Article							MACROCYSTIS-PYRIFERA; GIANT-KELP; MARINE MACROALGAE; PHOTOSYNTHETIC PERFORMANCE; HOLOCENE VEGETATION; DEPTH ZONATION; STEWART ISLAND; WATER-MOVEMENT; GROWTH-RATE; NITROGEN	Light is the fundamental driver of primary productivity in the marine environment. Reduced light availability has the potential to alter the distribution, community composition, and productivity of key benthic primary producers, potentially reducing habitat and energy provision to coastal food webs. We compared the underwater light environment of macroalgal dominated shallow subtidal rocky reef habitats on a coastline modified by human activities with a coastline of forested catchments. Key metrics describing the availability of photosynthetically active radiation (PAR) were determined over 295 days and were related to macroalgal depth distribution, community composition, and standing biomass patterns, which were recorded seasonally. Light attenuation was more than twice as high in shallow subtidal zones along the modified coast. Macroalgal biomass was 2-5 times greater within forested sites, and even in shallow water (2m) a significant difference in biomass was observed. Longterm light dose provided the best explanation for differences in observed biomass between modified and forested coasts, with light availability over the study period differing by 60 and 90 mol photons m(-2) at 2 and 10 metres, respectively. Higher biomass on the forested coast was driven by the presence of larger individuals rather than species diversity or density. This study suggests that commonly used metrics such as species diversity and density are not as sensitive as direct measures of biomass when detecting the effects of light limitation within macroalgal communities.	[Desmond, Matthew J.; Pritchard, Daniel W.; Hepburn, Christopher D.] Univ Otago, Dept Marine Sci, Dunedin, New Zealand	University of Otago	Desmond, MJ (corresponding author), Univ Otago, Dept Marine Sci, Dunedin, New Zealand.	matthew.j.desmond@gmail.com		Pritchard, Daniel/0000-0001-8335-5971	Tertiary Education Commission; University of Otago	Tertiary Education Commission; University of Otago	This study was funded in part by a Tertiary Education Commission scholarship to MJD. All additional funding was provided by the University of Otago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2003, OCEANOGR MAR BIOL, V41, P161; Anthony KRN, 2004, LIMNOL OCEANOGR, V49, P2201, DOI 10.4319/lo.2004.49.6.2201; Aumack CF, 2007, J PHYCOL, V43, P853, DOI 10.1111/j.1529-8817.2007.00383.x; Borum J, 1996, OIKOS, V76, P406, DOI 10.2307/3546213; Bruno JF, 2005, ECOL LETT, V8, P1165, DOI 10.1111/j.1461-0248.2005.00823.x; Brzezinski MA, 2013, OCEANOGRAPHY, V26, P114, DOI 10.5670/oceanog.2013.53; Casas G, 2004, BIOL INVASIONS, V6, P411, DOI 10.1023/B:BINV.0000041555.29305.41; Chadderton WL, 2000, NEW ZEAL J MAR FRESH, V34, P487, DOI 10.1080/00288330.2000.9516951; Collings GJ, 1998, AUST J BOT, V46, P657; Colombo-Pallotta MF, 2006, J PHYCOL, V42, P1225, DOI 10.1111/j.1529-8817.2006.00287.x; Connell SD, 2005, MAR ECOL PROG SER, V289, P53, DOI 10.3354/meps289053; Connell SD, 2008, MAR ECOL PROG SER, V360, P63, DOI 10.3354/meps07526; DAYTON PK, 1985, ANNU REV ECOL SYST, V16, P215, DOI 10.1146/annurev.es.16.110185.001243; Dayton PK, 1998, ECOL APPL, V8, P309, DOI 10.1890/1051-0761(1998)008[0309:SBGARE]2.0.CO;2; DAYTON PK, 1984, ECOL MONOGR, V54, P253, DOI 10.2307/1942498; Dean PR, 2007, J PHYCOL, V43, P1138, DOI 10.1111/j.1529-8817.2007.00416.x; DUGGINS DO, 1989, SCIENCE, V245, P170, DOI 10.1126/science.245.4914.170; Fairhead VA, 2004, MAR BIOL, V145, P415, DOI 10.1007/s00227-004-1330-x; Gattuso JP, 2006, BIOGEOSCIENCES, V3, P489, DOI 10.5194/bg-3-489-2006; GERARD VA, 1988, MAR BIOL, V97, P25, DOI 10.1007/BF00391242; Gorgula SK, 2004, MAR BIOL, V145, P613, DOI 10.1007/s00227-004-1335-5; Hader DP, 1997, PHOTOCHEM PHOTOBIOL, V66, P1, DOI 10.1111/j.1751-1097.1997.tb03132.x; HANELT D, 1993, MAR ECOL PROG SER, V97, P31, DOI 10.3354/meps097031; Hepburn CD, 2011, GLOBAL CHANGE BIOL, V17, P2488, DOI 10.1111/j.1365-2486.2011.02411.x; Hepburn CD, 2006, HYDROBIOLOGIA, V560, P373, DOI 10.1007/s10750-005-1573-7; Hepburn CD, 2007, MAR ECOL PROG SER, V339, P99, DOI 10.3354/meps339099; Hurd CL, 2004, PHYCOL RES, V52, P80, DOI 10.1111/j.1440-183.2004.00331.x; Johansson G, 2002, MAR ECOL PROG SER, V244, P63, DOI 10.3354/meps244063; Kerswell AP, 2006, ECOLOGY, V87, P2479, DOI 10.1890/0012-9658(2006)87[2479:GBPOBM]2.0.CO;2; Koch EM, 2001, ESTUARIES, V24, P1, DOI 10.2307/1352808; Konar B, 2009, MAR ECOL-EVOL PERSP, V30, P63, DOI 10.1111/j.1439-0485.2008.00259.x; Krause-Jensen D, 1998, LIMNOL OCEANOGR, V43, P396, DOI 10.4319/lo.1998.43.3.0396; Levin PS, 2002, ECOLOGY, V83, P3182, DOI 10.2307/3071852; Ling SD, 2008, OECOLOGIA, V156, P883, DOI 10.1007/s00442-008-1043-9; Long MH, 2012, LIMNOL OCEANOGR-METH, V10, P416, DOI 10.4319/lom.2012.10.416; LUNING K, 1979, HELGOLAND WISS MEER, V32, P403, DOI 10.1007/BF02277985; Madsen JD, 2001, HYDROBIOLOGIA, V444, P71, DOI 10.1023/A:1017520800568; MARKAGER S, 1992, MAR ECOL PROG SER, V88, P83, DOI 10.3354/meps088083; MCGLONE MS, 1995, J ROY SOC NEW ZEAL, V25, P1, DOI 10.1080/03014223.1995.9517480; McGlone MS, 1996, NEW ZEAL J BOT, V34, P369; Miller RJ, 2011, LIMNOL OCEANOGR, V56, P119, DOI 10.4319/lo.2011.56.1.0119; Neto AI, 2001, HELGOLAND MAR RES, V55, P101, DOI 10.1007/s101520100074; Oigman-Pszczol SS, 2004, MAR ECOL-P S Z N I, V25, P173, DOI 10.1111/j.1439-0485.2004.00018.x; Palumbi SR, 2009, FRONT ECOL ENVIRON, V7, P204, DOI 10.1890/070135; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pritchard DW, 2014, REV, P1; Pritchard DW, 2013, J PHYCOL, V13, P1; RAMUS J, 1977, MAR BIOL, V42, P293, DOI 10.1007/BF00402191; RAMUS J, 1976, MAR BIOL, V37, P223, DOI 10.1007/BF00387607; Raven JA, 2000, J MAR BIOL ASSOC UK, V80, P1, DOI 10.1017/S0025315499001526; Reed DC, 2008, ECOLOGY, V89, P2493, DOI 10.1890/07-1106.1; Reed DC, 2011, ECOLOGY, V92, P2108, DOI 10.1890/11-0377.1; Ruffin KK, 1998, ESTUAR COAST SHELF S, V47, P579, DOI 10.1006/ecss.1998.0366; SCHIEL DR, 1990, HYDROBIOLOGIA, V192, P59, DOI 10.1007/BF00006227; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Stephens TA, 2014, MAR ECOL PROG SER, V515, P97, DOI 10.3354/meps10974; Van Duin EHS, 2001, HYDROBIOLOGIA, V444, P25, DOI 10.1023/A:1017512614680; Walling DE, 2006, GEOMORPHOLOGY, V79, P192, DOI 10.1016/j.geomorph.2006.06.019; Wang R, 2012, NATURE, V492, P419, DOI 10.1038/nature11655; Wernberg T, 2003, DIVERS DISTRIB, V9, P427, DOI 10.1046/j.1472-4642.2003.00048.x; Wernberg T, 2011, CURR BIOL, V21, P1828, DOI 10.1016/j.cub.2011.09.028; Wernberg T, 2008, ESTUAR COAST SHELF S, V76, P265, DOI 10.1016/j.ecss.2007.07.008	62	37	37	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123676	10.1371/journal.pone.0123676	http://dx.doi.org/10.1371/journal.pone.0123676			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902185	gold, Green Published, Green Submitted			2022-12-26	WOS:000353331500059
J	Peng, Y; Yang, WQ; Li, J; Wang, B; Zhang, C; Yue, K; Wu, FZ				Peng, Yan; Yang, Wanqin; Li, Jun; Wang, Bin; Zhang, Chuan; Yue, Kai; Wu, Fuzhong			Contribution of Soil Fauna to Foliar Litter-Mass Loss in Winter in an Ecotone between Dry Valley and Montane Forest in the Upper Reaches of the Minjiang River	PLOS ONE			English	Article							SNOW COVER; DECOMPOSITION; CLIMATE; TEMPERATURE; STRESS; QUALITY; TRAITS; GROWTH; CARBON; TUNDRA	Litter decomposition during winter can provide essential nutrients for plant growth in the subsequent growing season, which plays important role in preventing the expansion of dry areas and maintaining the stability of ecotone ecosystems. However, limited information is currently available on the contributions of soil fauna to litter decomposition during winter in such ecosystems. Therefore, a field experiment that included litterbags with two different mesh sizes (0.04 mm and 3 mm) was conducted to investigate the contribution of soil fauna to the loss of foliar litter mass in winter from November 2013 to April 2014 along the upper reaches of the Minjiang River. Two litter types of the dominant species were selected in each ecosystem: cypress (Cupressus chengiana) and oak (Quercus baronii) in ecotone; cypress (Cupressus chengiana) and clovershrub (Campylotropis macrocarpa) in dry valley; and fir (Abies faxoniana) and birch (Betula albosinensis) in montane forest. Over one winter incubation, foliar litter lost 6.0%-16.1%, 11.4%-26.0%, and 6.4%-8.5% of initial mass in the ecotone, dry valley and montane forest, respectively. Soil fauna showed obvious contributions to the loss of foliar litter mass in all of the ecosystems. The highest contribution (48.5%-56.8%) was observed in the ecotone, and the lowest contribution (0.4%-25.8%) was observed in the montane forest. Compared with other winter periods, thawing period exhibited higher soil fauna contributions to litter mass loss in ecotone and dry valley, but both thawing period and freezing period displayed higher soil fauna contributions in montane forest. Statistical analysis demonstrated that the contribution of soil fauna was significantly correlated with temperature and soil moisture during the winter-long incubation. These results suggest that temperature might be the primary control factor in foliar litter decomposition, but more active soil fauna in the ecotone could contribute more in litter decomposition and its related ecological processes in this region.	[Peng, Yan; Yang, Wanqin; Li, Jun; Wang, Bin; Zhang, Chuan; Yue, Kai; Wu, Fuzhong] Sichuan Agr Univ, Long Term Res Stn Alpine Forest Ecosyst, Key Lab Ecol Forestry Engn, Inst Ecol & Forestry, Chengdu 611130, Sichuan, Peoples R China	Sichuan Agricultural University	Wu, FZ (corresponding author), Sichuan Agr Univ, Long Term Res Stn Alpine Forest Ecosyst, Key Lab Ecol Forestry Engn, Inst Ecol & Forestry, Chengdu 611130, Sichuan, Peoples R China.	wufzchina@163.com	Yue, Kai/N-6962-2017; Li, Jun/GWR-0996-2022	Yue, Kai/0000-0002-7709-8523; Li, Jun/0000-0001-6459-4117	National Natural Science Foundation of China [31270498, 31170423]; National Key Technologies R D of China [2011BAC09B05]; Sichuan Youth Sci-tech Foundation [2012JQ0008, 2012JQ0059]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technologies R D of China(National Key Technology R&D Program); Sichuan Youth Sci-tech Foundation	This research was financially supported by the National Natural Science Foundation of China (31270498 and 31170423), National Key Technologies R & D of China (2011BAC09B05), and Sichuan Youth Sci-tech Foundation (2012JQ0008 and 2012JQ0059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey RG, 2004, ENVIRON MANAGE, V34, pS14, DOI 10.1007/s00267-003-0163-6; Banon S, 2004, SCI HORTIC-AMSTERDAM, V101, P333, DOI 10.1016/j.scienta.2003.11.007; Baptist F, 2010, PLANT SOIL, V328, P397, DOI 10.1007/s11104-009-0119-6; Berg B., 2014, PLANT ECOL, V3; Bhunia A, 2013, S ASIAN J MANAG, V20, P154; Bo Tan, 2010, Acta Ecologica Sinica, V30, P93; Bokhorst S, 2010, SOIL BIOL BIOCHEM, V42, P611, DOI 10.1016/j.soilbio.2009.12.011; Brandt LA, 2010, ECOSYSTEMS, V13, P765, DOI 10.1007/s10021-010-9353-2; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; David JF, 2014, SOIL BIOL BIOCHEM, V76, P109, DOI 10.1016/j.soilbio.2014.05.009; Edwards AC, 2007, QUATERN INT, V162, P172, DOI 10.1016/j.quaint.2006.10.027; Flora Ebo S, 1999, FLORA EBOS FLORA SIC; Garcia-Palacios P, 2013, ECOL LETT, V16, P1045, DOI 10.1111/ele.12137; Gonzalez G, 2001, ECOLOGY, V82, P955, DOI 10.1890/0012-9658(2001)082[0955:SFAPLD]2.0.CO;2; Gracas M. A., 2005, METHODS STUDY LITTER; Haimi J, 2005, APPL SOIL ECOL, V30, P104, DOI 10.1016/j.apsoil.2005.02.006; Heemsbergen DA, 2004, SCIENCE, V306, P1019, DOI 10.1126/science.1101865; Hunter MD, 2003, PEDOBIOLOGIA, V47, P101, DOI 10.1078/0031-4056-00174; Kage H, 2004, EUR J AGRON, V20, P379, DOI 10.1016/S1161-0301(03)00061-3; Li X., 2014, Acta Ecologica Sinica - International Journal, V34, P290, DOI 10.1016/j.chnaes.2014.09.001; Liu B, 2001, SHENG TAI XUE BAO, V31, P58; [刘彬 Liu Bin], 2012, [水土保持学报, Journal of Soil and Water Conservation], V26, P121; Lu R.K, 1999, SOIL ARGROCHEMISTRY; Maestre FT, 2005, J ECOL, V93, P748, DOI 10.1111/j.1365-2745.2005.01017.x; Makkonen M, 2012, ECOL LETT, V15, P1033, DOI 10.1111/j.1461-0248.2012.01826.x; Meyer III WM, 2001, SOIL BIOL BIOCHEM, V43, P206; Odum E., 2004, FUNDAMENTALS ECOLOGY, V5th; Prescott CE, 2010, BIOGEOCHEMISTRY, V101, P133, DOI 10.1007/s10533-010-9439-0; Schneider T, 2012, ISME J, V6, P1749, DOI 10.1038/ismej.2012.11; Shaw MR, 2001, ECOL APPL, V11, P1206, DOI 10.2307/3061022; Sjogersten S, 2004, PLANT SOIL, V262, P215, DOI 10.1023/B:PLSO.0000037044.63113.fe; Song XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068858; Sponseller RA, 2006, ECOSYSTEMS, V9, P344, DOI 10.1007/s10021-005-0167-6; Swift M.J., 1979, DECOMPOSITION TERRES, V5; TAKEDA H, 1988, PEDOBIOLOGIA, V32, P221; [唐家良 TANG Jialiang], 2009, [山地学报, Journal of Mountain Science], V27, P531; TAYLOR BR, 1988, SOIL BIOL BIOCHEM, V20, P657, DOI 10.1016/0038-0717(88)90150-2; Tourna M, 2008, ENVIRON MICROBIOL, V10, P1357, DOI 10.1111/j.1462-2920.2007.01563.x; WALSH JE, 1985, MON WEATHER REV, V113, P756, DOI 10.1175/1520-0493(1985)113<0756:IOSCAS>2.0.CO;2; Wang Q, 1997, CHINESE BIODIVERSITY, V5, P126; Wang SJ, 2010, ECOL RES, V25, P1113, DOI 10.1007/s11284-010-0736-9; Ward SE, 2015, ECOLOGY, V96, P113, DOI 10.1890/14-0292.1; Wu F, 2014, BIOGEOSCIENCES, V11, P6871, DOI 10.5194/bg-11-6871-2014; Wu FZ, 2009, J ARID ENVIRON, V73, P1067, DOI 10.1016/j.jaridenv.2009.06.007; Wu FZ, 2010, ACTA OECOL, V36, P135, DOI 10.1016/j.actao.2009.11.002; Xin WD, 2012, J ARID ENVIRON, V77, P90, DOI 10.1016/j.jaridenv.2011.10.001; Yang QP, 2014, PLANT SOIL, V374, P449, DOI 10.1007/s11104-013-1882-y; Yang WQ, 2005, PEDOSPHERE, V15, P653; Yang XD, 2009, SOIL BIOL BIOCHEM, V41, P910, DOI 10.1016/j.soilbio.2008.12.028; Zhu JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062073; Zhu JX, 2012, SCAND J FOREST RES, V27, P586, DOI 10.1080/02827581.2012.670726; Zwahlen C, 2007, PLANT SOIL, V300, P245, DOI 10.1007/s11104-007-9410-6	52	7	12	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124605	10.1371/journal.pone.0124605	http://dx.doi.org/10.1371/journal.pone.0124605			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901894	Green Submitted, gold, Green Published			2022-12-26	WOS:000353331500095
J	Al Kayal, T; Panetta, D; Canciani, B; Losi, P; Tripodi, M; Burchielli, S; Ottoni, P; Salvadori, PA; Soldani, G				Al Kayal, Tamer; Panetta, Daniele; Canciani, Barbara; Losi, Paola; Tripodi, Maria; Burchielli, Silvia; Ottoni, Priscilla; Salvadori, Piero Antonio; Soldani, Giorgio			Evaluation of the Effect of a Gamma Irradiated DBM-Pluronic F127 Composite on Bone Regeneration in Wistar Rat	PLOS ONE			English	Article							DRUG-DELIVERY; BLOCK-COPOLYMERS; FIBRIN SEALANT; MATRIX; STERILIZATION; SUBSTITUTES; MARROW; GRAFTS; DEFECT; OSTEOINDUCTIVITY	Demineralized bone matrix (DBM) is widely used for bone regeneration. Since DBM is prepared in powder form its handling properties are not optimal and limit the clinical use of this material. Various synthetic and biological carriers have been used to enhance the DBM handling. In this study we evaluated the effect of gamma irradiation on the physical-chemical properties of Pluronic and on bone morphogenetic proteins (BMPs) amount in DBM samples. In vivo studies were carried out to investigate the effect on bone regeneration of a gamma irradiated DBM-Pluronic F127 (DBM-PF127) composite implanted in the femur of rats. Gamma irradiation effects (25 kGy) on physical-chemical properties of Pluronic F127 were investigated by rheological and infrared analysis. The BMP-2/BMP-7 amount after DBM irradiation was evaluated by ELISA. Bone regeneration capacity of DBM-PF127 containing 40% (w/w) of DBM was investigated in transcortical holes created in the femoral diaphysis of Wistar rat. Bone porosity, repaired bone volume and tissue organization were evaluated at 15, 30 and (0 days by Micro-CT and histological analysis. The results showed that gamma irradiation did not induce significant modification on physical-chemical properties of Pluronic, while a decrease in BMP-2/BMP-7 amount was evidenced in sterilized DBM. Micro-CT and histological evaluation at day 15 post-implantation revealed an interconnected trabeculae network in medullar cavity and cellular infiltration and vascularization of DBM-PF127 residue. In contrast a large rate of not connected trabeculae was observed in Pluronic filled and unfilled defects. At 30 and 90 days the DBM-PF127 samples shown comparable results in term of density and thickness of the new formed tissue respect to unfilled defect. In conclusion a gamma irradiated DBM-PF127 composite, although it may have undergone a significant decrease in the concentration of BMPs, was able to maintains bone regeneration capability.	[Al Kayal, Tamer; Panetta, Daniele; Losi, Paola; Tripodi, Maria; Ottoni, Priscilla; Salvadori, Piero Antonio; Soldani, Giorgio] CNR, Inst Clin Physiol, I-56100 Pisa, Italy; [Canciani, Barbara] Univ & IRCCS AOU San Martino IST, Natl Inst Canc Res, DIMES, Genoa, Italy; [Burchielli, Silvia] CNR, Tuscany G Monasterio Fdn, I-56100 Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); University of Genoa; IRCCS AOU San Martino IST; Consiglio Nazionale delle Ricerche (CNR)	Al Kayal, T (corresponding author), CNR, Inst Clin Physiol, I-56100 Pisa, Italy.	alkayal.tamer@ifc.cnr.it	Panetta, Daniele/A-8580-2013; Salvadori, Piero A/B-2342-2012; Canciani, Barbara/AAJ-6943-2020	Panetta, Daniele/0000-0002-4184-0175; Salvadori, Piero A/0000-0001-6114-1059; Canciani, Barbara/0000-0003-1942-1174; Al Kayal, Tamer/0000-0002-5700-5326				Angle SR, 2012, J MUSCULOSKEL NEURON, V12, P28; [Anonymous], [No title captured]; Araujo MVF, 2010, CLIN ORAL IMPLAN RES, V21, P632, DOI 10.1111/j.1600-0501.2009.01864.x; Bano I, 2014, INT J BIOL MACROMOL, V65, P81, DOI 10.1016/j.ijbiomac.2014.01.015; Barbieri D, 2011, ACTA BIOMATER, V7, P2007, DOI 10.1016/j.actbio.2011.01.017; Batrakova EV, 2008, J CONTROL RELEASE, V130, P98, DOI 10.1016/j.jconrel.2008.04.013; Clokie CML, 2002, J CRANIOFAC SURG, V13, P111, DOI 10.1097/00001665-200201000-00026; Cory E, 2010, J BIOMECH, V43, P953, DOI 10.1016/j.jbiomech.2009.10.047; Di Bella C, 2010, CLIN ORTHOP RELAT R, V468, P3047, DOI 10.1007/s11999-010-1430-5; Dorati R, 2008, AAPS PHARMSCITECH, V9, P718, DOI 10.1208/s12249-008-9103-3; DORPEMA JW, 1990, RADIAT PHYS CHEM, V35, P357; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; Dumortier G, 2006, PHARM RES-DORDR, V23, P2709, DOI 10.1007/s11095-006-9104-4; Dziedzic-Goclawska Anna, 2005, Cell and Tissue Banking, V6, P201, DOI 10.1007/s10561-005-0338-x; El-Bagory I.M., 2010, AUST J BASIC APPL SC, V4, P4490; Elluru M, 2013, POLYMER, V54, P2088, DOI 10.1016/j.polymer.2013.02.017; Escobar-Chavez JJ, 2006, J PHARM PHARM SCI, V9, P339; Gertzman AA, 2005, STERILISATION TISSUE, P151; Groeneveld EHJ, 1999, J BIOMED MATER RES, V48, P393, DOI 10.1002/(SICI)1097-4636(1999)48:4<393::AID-JBM1>3.0.CO;2-C; HABAL MB, 1994, CLIN PLAST SURG, V21, P525; HALLFELDT KKJ, 1992, UNFALLCHIRURG, V95, P313; Han B, 2008, J ORTHOP RES, V26, P75, DOI 10.1002/jor.20478; Hayzlett M, 2005, STERILISATION TISSUE, P117; Jayasuriya AC, 2009, J MATER SCI-MATER M, V20, P1637, DOI 10.1007/s10856-009-3738-9; Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3; Katz JM, 2009, J BIOMED MATER RES B, V89B, P127, DOI 10.1002/jbm.b.31195; Keles H, 2014, VIB SPECTROSC, V71, P76, DOI 10.1016/j.vibspec.2014.01.012; Klouda L, 2008, EUR J PHARM BIOPHARM, V68, P34, DOI 10.1016/j.ejpb.2007.02.025; LASA C, 1995, PLAST RECONSTR SURG, V96, P1409, DOI 10.1097/00006534-199511000-00027; Lelovas PP, 2008, COMPARATIVE MED, V58, P424; Li XD, 2006, BIOMATERIALS, V27, P2426, DOI 10.1016/j.biomaterials.2005.11.040; Li YY, 2013, MAT SCI ENG C-MATER, V33, P2698, DOI 10.1016/j.msec.2013.02.036; Lippens E, 2010, TISSUE ENG PT A, V16, P617, DOI [10.1089/ten.tea.2009.0418, 10.1089/ten.TEA.2009.0418]; Ma WD, 2008, DRUG DEV IND PHARM, V34, P258, DOI 10.1080/03639040701580622 ; Panetta D, 2012, PHYS MEDICA, V28, P166, DOI 10.1016/j.ejmp.2011.03.006; Pekkarinen T, 2004, INT ORTHOP, V28, P97, DOI 10.1007/s00264-003-0524-z; Qiu QQ, 2008, J BIOMED MATER RES A, V87A, P373, DOI 10.1002/jbm.a.31790; Qiu QQ, 2007, J BIOMED MATER RES B, V81B, P516, DOI 10.1002/jbm.b.30692; Russel W. M. S., 1959, PRINC HUM EXP TECH; Sandhu HS, 1999, ORTHOP CLIN N AM, V30, P685, DOI 10.1016/S0030-5898(05)70120-6; Schwartz Z, 2008, CLIN ORAL IMPLAN RES, V19, P1233, DOI 10.1111/j.1600-0501.2008.01582.x; Schwartz Z, 2007, CLIN ORAL IMPLAN RES, V18, P204, DOI 10.1111/j.1600-0501.2006.01303.x; SCHWARZ N, 1989, CLIN ORTHOP RELAT R, P282; Takikawa S, 2003, J BIOMED MATER RES A, V65A, P37, DOI 10.1002/jbm.a.10345; Tian M, 2012, ACTA BIOMATER, V8, P753, DOI 10.1016/j.actbio.2011.10.030; Trojani C, 2006, BIOMATERIALS, V27, P3256, DOI 10.1016/j.biomaterials.2006.01.057; Wildemann B., 2007, Cell and Tissue Banking, V8, P107, DOI 10.1007/s10561-006-9021-0; Zhou AJJ, 2007, J CRANIOFAC SURG, V18, P1264, DOI 10.1097/scs.0b013e318158cb1a; Ziran Bruce, 2005, Am J Orthop (Belle Mead NJ), V34, P329	49	18	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0125110	10.1371/journal.pone.0125110	http://dx.doi.org/10.1371/journal.pone.0125110			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897753	Green Submitted, Green Published, gold			2022-12-26	WOS:000353212600097
J	Lindwall, F; Faubert, P; Rinnan, R				Lindwall, Frida; Faubert, Patrick; Rinnan, Riikka			Diel Variation of Biogenic Volatile Organic Compound Emissions- A field Study in the Sub, Low and High Arctic on the Effect of Temperature and Light	PLOS ONE			English	Article							MONOTERPENE EMISSIONS; ISOPRENE EMISSION; PLANT VOLATILES; INNER-MONGOLIA; SCOTS PINE; VEGETATION; VOC; TUNDRA; BIOSYNTHESIS; EXCHANGE	Many hours of sunlight in the midnight sun period suggest that significant amounts of biogenic volatile organic compounds (BVOCs) may be released from arctic ecosystems during night-time. However, the emissions from these ecosystems are rarely studied and limited to point measurements during daytime. We measured BVOC emissions during 24-hour periods in the field using a push-pull chamber technique and collection of volatiles in adsorbent cartridges followed by analysis with gas chromatography-mass spectrometry. Five different arctic vegetation communities were examined: high arctic heaths dominated by Salix arctica and Cassiope tetragona, low arctic heaths dominated by Salix glauca and Betula nana and a subarctic peatland dominated by the moss Warnstorfia exannulata and the sedge Eriophorum russeolum. We also addressed how climate warming affects the 24-hour emission and how the daytime emissions respond to sudden darkness. The emissions from the high arctic sites were lowest and had a strong diel variation with almost no emissions during night-time. The low arctic sites as well as the subarctic site had a more stable release of BVOCs during the 24-hour period with night-time emissions in the same range as those during the day. These results warn against overlooking the night period when considering arctic emissions. During the day, the quantity of BVOCs and the number of different compounds emitted was higher under ambient light than in darkness. The monoterpenes alpha-fenchene, alpha -phellandrene, 3-carene and alpha-terpinene as well as isoprene were absent in dark measurements during the day. Warming by open top chambers increased the emission rates both in the high and low arctic sites, forewarning higher emissions in a future warmer climate in the Arctic.	[Lindwall, Frida; Rinnan, Riikka] Univ Copenhagen, Dept Biol, Terr Ecol sect, Copenhagen, Denmark; [Lindwall, Frida; Rinnan, Riikka] Univ Copenhagen, Ctr Permafrost, Dept Geosci & Nat Resource Management, Copenhagen, Denmark; [Faubert, Patrick] Univ Quebec Chicoutimi, Dept Sci Fondamentales, Chaire Ecoconseil, Chicoutimi, PQ, Canada	University of Copenhagen; University of Copenhagen; University of Quebec; University of Quebec Chicoutimi	Lindwall, F (corresponding author), Univ Copenhagen, Dept Biol, Terr Ecol sect, Copenhagen, Denmark.	frida.lindwall@bio.ku.dk	Rinnan, Riikka/AAB-8552-2019; Faubert, Patrick/L-2555-2019; Rinnan, Riikka/C-9771-2010	Rinnan, Riikka/0000-0001-7222-700X; Rinnan, Riikka/0000-0001-7222-700X; Faubert, Patrick/0000-0003-0237-3188; lindstein, frida/0000-0002-3981-5966	Villum foundation; Emil Aaltonen Foundation; Danish Council for Independent Research \ Natural Sciences; Danish National Research Foundation [CENPERM DNRF100]; Villum Fonden [00007189] Funding Source: researchfish	Villum foundation(Villum Fonden); Emil Aaltonen Foundation; Danish Council for Independent Research \ Natural Sciences(Det Frie Forskningsrad (DFF)); Danish National Research Foundation(Danmarks Grundforskningsfond); Villum Fonden(Villum Fonden)	Financial support was given to RR by the Villum foundation, the Emil Aaltonen Foundation and the Danish Council for Independent Research vertical bar Natural Sciences. The Danish National Research Foundation supported the activities within the Center for Permafrost (CENPERM DNRF100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen H, 2011, AGR FOREST METEOROL, V151, P682, DOI 10.1016/j.agrformet.2010.12.010; Agelopoulos NG, 2000, J CHEM ECOL, V26, P497, DOI 10.1023/A:1005473825335; Ammann C, 2004, INT J MASS SPECTROM, V239, P87, DOI 10.1016/j.ijms.2004.08.012; AREY J, 1995, ATMOS ENVIRON, V29, P2977, DOI 10.1016/1352-2310(95)00137-N; Atkinson R, 2000, ATMOS ENVIRON, V34, P2063, DOI 10.1016/S1352-2310(99)00460-4; Bai JH, 2006, ATMOS ENVIRON, V40, P5753, DOI 10.1016/j.atmosenv.2006.05.019; Bokhorst S, 2013, GLOBAL CHANGE BIOL, V19, P64, DOI 10.1111/gcb.12028; Chapin FS, 2000, GLOBAL CHANGE BIOL, V6, P211, DOI 10.1046/j.1365-2486.2000.06022.x; Ciccioli P, 1999, J GEOPHYS RES-ATMOS, V104, P8077, DOI 10.1029/1998JD100026; De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; Dudareva N, 2005, P NATL ACAD SCI USA, V102, P933, DOI 10.1073/pnas.0407360102; Duhl TR, 2008, BIOGEOSCIENCES, V5, P761, DOI 10.5194/bg-5-761-2008; Ehn M, 2014, NATURE, V506, P476, DOI 10.1038/nature13032; Ekberg A, 2009, BIOGEOSCIENCES, V6, P601, DOI 10.5194/bg-6-601-2009; Ellebjerg SM, 2008, ADV ECOL RES, V40, P249, DOI 10.1016/S0065-2504(07)00011-6; Fares S, 2013, ENVIRON SCI TECHNOL, V47, P11073, DOI 10.1021/es4022156; Faubert P, 2012, PLANT SOIL, V352, P199, DOI 10.1007/s11104-011-0989-2; Faubert P, 2010, ATMOS ENVIRON, V44, P4432, DOI 10.1016/j.atmosenv.2010.07.039; Faubert P, 2010, ECOSYSTEMS, V13, P860, DOI 10.1007/s10021-010-9362-1; Faubert P, 2010, NEW PHYTOL, V187, P199, DOI 10.1111/j.1469-8137.2010.03270.x; Funk JL, 2004, PLANT CELL ENVIRON, V27, P747, DOI 10.1111/j.1365-3040.2004.01177.x; GUENTHER A, 1995, J GEOPHYS RES-ATMOS, V100, P8873, DOI 10.1029/94JD02950; Hakola H, 2012, ATMOS CHEM PHYS, V12, P11665, DOI 10.5194/acp-12-11665-2012; Hakola H, 2003, ATMOS ENVIRON, V37, P1623, DOI 10.1016/S1352-2310(03)00014-1; Hakola H, 2001, BOREAL ENVIRON RES, V6, P237; Harley P, 2013, BIOL CONTROLS MODELS, V5, P181; He NP, 2005, J INTEGR PLANT BIOL, V47, P13, DOI 10.1111/j.1744-7909.2005.00004.x; Hillel D., 1982, INTRO SOIL PHYS; Hudson JMG, 2011, GLOBAL CHANGE BIOL, V17, P1013, DOI 10.1111/j.1365-2486.2010.02294.x; Insam H, 2010, BIOL FERT SOILS, V46, P199, DOI 10.1007/s00374-010-0442-3; Kesselmeier J, 1999, J ATMOS CHEM, V33, P23, DOI 10.1023/A:1006127516791; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Laothawornkitkul J, 2009, NEW PHYTOL, V183, P27, DOI 10.1111/j.1469-8137.2009.02859.x; Leff JW, 2008, SOIL BIOL BIOCHEM, V40, P1629, DOI 10.1016/j.soilbio.2008.01.018; Liu XY, 2004, ANALYST, V129, P55, DOI 10.1039/b311998j; Loivamaki M, 2007, PLANT PHYSIOL, V143, P540, DOI 10.1104/pp.106.092759; McBean G, 2005, ARCTIC CLIMATE IMPAC; McKinney KA, 2011, ATMOS CHEM PHYS, V11, P4807, DOI 10.5194/acp-11-4807-2011; Myhre G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P659; Niinemets U, 2004, TRENDS PLANT SCI, V9, P180, DOI 10.1016/j.tplants.2004.02.006; Niinemets U, 2014, PLANT CELL ENVIRON, V37, P1790, DOI 10.1111/pce.12322; Patankar R, 2013, ECOL EVOL, V3, P375, DOI 10.1002/ece3.467; Penuelas J, 2003, TRENDS PLANT SCI, V8, P105, DOI 10.1016/S1360-1385(03)00008-6; Penuelas J, 2014, PLANT CELL ENVIRON, V37, P1866, DOI 10.1111/pce.12340; Petron G, 2001, GEOPHYS RES LETT, V28, P1707, DOI 10.1029/2000GL011583; Pressley S, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005523; Rinnan R, 2014, PLANT CELL ENVIRON, V37, P1776, DOI 10.1111/pce.12320; Rinne J, 2005, BOREAL ENVIRON RES, V10, P425; Ruuskanen TM, 2005, BOREAL ENVIRON RES, V10, P553; Schollert M, 2014, POLAR BIOL, V37, P237, DOI 10.1007/s00300-013-1427-0; Starr G, 2003, ECOLOGY, V84, P1415, DOI 10.1890/02-3154; Svenningsson B, 2008, TELLUS B, V60, P353, DOI [10.1111/j.1600-0889.2008.00351.x, 10.3402/tellusb.v60i3.16929]; Taipale R, 2011, BIOGEOSCIENCES, V8, P2247, DOI 10.5194/bg-8-2247-2011; Tiiva P, 2008, NEW PHYTOL, V180, P853, DOI 10.1111/j.1469-8137.2008.02587.x; Walker DA, 2005, J VEG SCI, V16, P267, DOI 10.1111/j.1654-1103.2005.tb02365.x; Wiberley AE, 2009, PLANT CELL ENVIRON, V32, P939, DOI 10.1111/j.1365-3040.2009.01980.x; Zini CA, 2001, ANAL CHEM, V73, P4729, DOI 10.1021/ac0103219	59	24	24	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123610	10.1371/journal.pone.0123610	http://dx.doi.org/10.1371/journal.pone.0123610			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897519	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000353212600035
J	Zhu, QD; Song, YL; Zhang, GS; Ju, L; Zhang, JG; Yu, YG; Niu, N; Wang, JW; Ma, SC				Zhu, Qidi; Song, Yulong; Zhang, Gaisheng; Ju, Lan; Zhang, Jiao; Yu, Yongang; Niu, Na; Wang, Junwei; Ma, Shoucai			De Novo Assembly and Transcriptome Analysis of Wheat with Male Sterility Induced by the Chemical Hybridizing Agent SQ-1	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; CLOFENCET; RICE; HETEROSIS; GENE; TOOL; IMPROVEMENT; EXPRESSION; RESOLUTION; PROTEINS	Wheat (Triticum aestivum L.), one of the world's most important food crops, is a strictly autogamous (self-pollinating) species with exclusively perfect flowers. Male sterility induced by chemical hybridizing agents has increasingly attracted attention as a tool for hybrid seed production in wheat; however, the molecular mechanisms of male sterility induced by the agent SQ-1 remain poorly understood due to limited whole transcriptome data. Therefore, a comparative analysis of wheat anther transcriptomes for male fertile wheat and SQ-1-induced male sterile wheat was carried out using next-generation sequencing technology. In all, 42,634,123 sequence reads were generated and were assembled into 82,356 high-quality unigenes with an average length of 724 bp. Of these, 1,088 unigenes were significantly differentially expressed in the fertile and sterile wheat anthers, including 643 up-regulated unigenes and 445 down-regulated unigenes. The differentially expressed unigenes with functional annotations were mapped onto 60 pathways using the Kyoto Encyclopedia of Genes and Genomes database. They were mainly involved in coding for the components of ribosomes, photosynthesis, respiration, purine and pyrimidine metabolism, amino acid metabolism, glutathione metabolism, RNA transport and signal transduction, reactive oxygen species metabolism, mRNA surveillance pathways, protein processing in the endoplasmic reticulum, protein export, and ubiquitin-mediated proteolysis. This study is the first to provide a systematic overview comparing wheat anther transcriptomes of male fertile wheat with those of SQ-1-induced male sterile wheat and is a valuable source of data for future research in SQ-1-induced wheat male sterility.	[Zhu, Qidi; Song, Yulong; Zhang, Gaisheng; Ju, Lan; Zhang, Jiao; Yu, Yongang; Niu, Na; Wang, Junwei; Ma, Shoucai] Northwest A&F Univ, Natl Yangling Agr Biotechnol & Breeding Ctr, Yangling Branch State,Wheat Improvement Ctr, Wheat Breeding Engn Res Ctr,Minist Educ,Key Lab C, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Zhang, GS (corresponding author), Northwest A&F Univ, Natl Yangling Agr Biotechnol & Breeding Ctr, Yangling Branch State,Wheat Improvement Ctr, Wheat Breeding Engn Res Ctr,Minist Educ,Key Lab C, Yangling, Shaanxi, Peoples R China.	zhanggsh58@aliyun.com			National High Tech Research and Development Program of China (863 Program) [2011AA10A106]; National Natural Science Foundation of China [31171611, 31371697]; Key Scientific and Technological Innovation Special Projects of Shaanxi province [2014KTZB02-01-02, 2011KTZB02-01-01]	National High Tech Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Scientific and Technological Innovation Special Projects of Shaanxi province	This work was supported by National High Tech Research and Development Program of China (863 Program) (No. 2011AA10A106), National Natural Science Foundation of China (No. 31171611, 31371697), the Key Scientific and Technological Innovation Special Projects of Shaanxi province (No. 2014KTZB02-01-02, 2011KTZB02-01-01).	Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bushuk W, 1998, EUPHYTICA, V100, P137, DOI 10.1023/A:1018368316547; Cardoso-Silva CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088462; Chakraborty K, 2005, J AGR FOOD CHEM, V53, P7899, DOI 10.1021/jf051458t; Chakraborty K, 2005, J AGR FOOD CHEM, V53, P3468, DOI 10.1021/jf050187j; Chen XiaoWen, 2011, Journal of Triticeae Crops, V31, P630; Chen ZJ, 2010, TRENDS PLANT SCI, V15, P57, DOI 10.1016/j.tplants.2009.12.003; Clark JD, 2004, ORG PROCESS RES DEV, V8, P176, DOI 10.1021/op034123q; Couee I, 2006, J EXP BOT, V57, P449, DOI 10.1093/jxb/erj027; [邓泱泱 DENG Yangyang], 2006, [计算机工程, Computer Engineering], V32, P71; Dong Jian, 2013, Zhongguo Shengwu Huaxue yu Fenzi Shengwu Xuebao, V29, P948; Dong X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072178; Fu DH, 2014, EUPHYTICA, V197, P161, DOI 10.1007/s10681-014-1103-7; Fu N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057686; Goff SA, 2013, CURR OPIN PLANT BIOL, V16, P221, DOI 10.1016/j.pbi.2013.03.009; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hansey CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033071; Havey MJ, 2004, MOLECULAR BIOLOGY AND BIOTECHNOLOGY OF PLANT ORGANELLES: CHLOROPLASTS AND MITOCHONDRIA, P623, DOI 10.1007/978-1-4020-3166-3_23; Horgan FG, 2013, ENTOMOL EXP APPL, V148, P1, DOI 10.1111/eea.12080; Huang MD, 2009, PLANT PHYSIOL, V149, P694, DOI 10.1104/pp.108.131128; Hwa CM, 2008, EUPHYTICA, V160, P287, DOI 10.1007/s10681-007-9621-1; Jiao WB, 2013, PLANT J, V75, P954, DOI 10.1111/tpj.12254; Kamran A, 2014, EUPHYTICA, V197, P1, DOI 10.1007/s10681-014-1075-7; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kempe K, 2014, P NATL ACAD SCI USA, V111, P9097, DOI 10.1073/pnas.1402836111; Kempe K, 2011, MOL BREEDING, V27, P417, DOI 10.1007/s11032-011-9555-0; Kindred DR, 2005, EUPHYTICA, V142, P149, DOI 10.1007/s10681-005-1250-y; Lal R, 2007, ADV AGRON, V93, P69, DOI 10.1016/S0065-2113(06)93002-8; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Liu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065209; [刘宏伟 Liu Hongwei], 2003, [西北农林科技大学学报. 自然科学版, Journal of northwest sci-tech university of agriculture and forestry], V31, P15; Liu HZ, 2014, ACTA PHYSIOL PLANT, V36, P1473, DOI 10.1007/s11738-014-1525-9; Longin CFH, 2013, THEOR APPL GENET, V126, P2791, DOI 10.1007/s00122-013-2172-z; Lu TT, 2010, GENOME RES, V20, P1238, DOI 10.1101/gr.106120.110; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Parodi PC, 2009, CIENC INVESTIG AGRAR, V36, P267; Pauly A, 2013, COMPR REV FOOD SCI F, V12, P413, DOI 10.1111/1541-4337.12019; Pompella A, 2003, BIOCHEM PHARMACOL, V66, P1499, DOI 10.1016/S0006-2952(03)00504-5; Sheng Ying, 2011, Scientia Agricultura Sinica, V44, P3937; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Vasil IK, 2007, PLANT CELL REP, V26, P1133, DOI 10.1007/s00299-007-0338-3; Wang JG, 2010, MAGNETIC FRINGE FIELDS AND INTERFERENCE IN HIGH INTENSITY ACCELERATORS, P1; Wang Jun-sheng, 2009, Xibei Zhiwu Xuebao, V29, P1351; Wang JunWei, 2005, Journal of Triticeae Crops, V25, P37; [王振华 Wang Zhenhua], 2003, [西北农林科技大学学报. 自然科学版, Journal of northwest sci-tech university of agriculture and forestry], V31, P43; Wei MingMing, 2009, Molecular Plant Breeding, V7, P679; Wong MML, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-342; Wu SW, 2010, CHINESE SCI BULL, V55, P1463, DOI 10.1007/s11434-010-3106-7; Zhai LL, 2014, MOL BREEDING, V33, P611, DOI 10.1007/s11032-013-9978-x; Zhang LongYu, 2011, Acta Agronomica Sinica, V37, P620; Zhang Ming-Zhu, 2010, Zhongguo Shengwu Huaxue yu Fenzi Shengwu Xuebao, V26, P740; Zhou Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091740; Zhu QD, 2013, CHINESE J ANAL CHEM, V41, P565, DOI 10.3724/SP.J.1096.2013.21026; Zhu QD, 2012, CHINESE J ANAL CHEM, V40, P462, DOI 10.3724/SP.J.1096.2012.10820	56	14	18	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123556	10.1371/journal.pone.0123556	http://dx.doi.org/10.1371/journal.pone.0123556			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898130	Green Submitted, Green Published, gold			2022-12-26	WOS:000353212600030
J	Adela, R; Nethi, SK; Bagul, PK; Barui, AK; Mattapally, S; Kuncha, M; Patra, CR; Reddy, PNC; Banerjee, SK				Adela, Ramu; Nethi, Susheel Kumar; Bagul, Pankaj K.; Barui, Ayan K.; Mattapally, Saidulu; Kuncha, Madhusudan; Patra, Chitta R.; Reddy, P. Naveen Chander; Banerjee, Sanjay K.			Hyperglycaemia Enhances Nitric Oxide Production in Diabetes: A Study from South Indian Patients	PLOS ONE			English	Article							HIGH GLUCOSE; SYNTHASE ACTIVITY; SUPEROXIDE; INDIVIDUALS; ENDOTHELIUM; DYSFUNCTION; EXPRESSION; LIVER	Background We have previously reported that increased glucose levels were associated with higher serum nitric oxide (NO) levels in fructose-fed insulin resistant rats. However, the relationship between hyperglycemia and serum NO level was not clear. Therefore, the present study was designed to find the association between hyperglycemia and serum NO levels in Type 2 diabetic (T2DM) patients and T2DM with cardiovascular complication. Methods Endothelial cells (HUVEC) were treated with of D-glucose (10-100mM), and NO levels and NOS gene expression was measured. Hyperglycaemia was induced in Sprague-Dawley rats, and serum NO levels were measured after 8 weeks. For clinical evaluation, five groups of patients were recruited: Control (CT, n=48), Type 2 diabetes (T2DM, n=26), T2DM with hypertension (DMHT, n=46), Coronary artery diseases (CAD, n=29) and T2DM with coronary artery diseases (DMCD, n=38). NO (nitrite + nitrate) levels were measured from human serum. Results We found a significant (p<0.05) and dose-dependent increase in NO levels in HUVEC cells after 4 hours of high glucose exposure. eNOS and iNOS gene expression was increased in HUVEC cells after different concentrations and time periods of glucose treatment. We also observed significant (149.1 +/- 25 mu M, p<0.01) increase in serum NO levels in hyperglycaemic rats compared to control (76.6 +/- 13.2 mu M). Serum NO level was significantly higher in T2DM (111.8 mu M (81.7-122.4), p<0.001) and DMCD patients ((129.4 mu M (121.2-143.5), p<0.001) but not in CAD patients (76.4 mu M (70.5-87)), as compared to control (68.2 mu M (56.4-82.3)). We found significantly lower NO levels (83.5 mu M (60.5-122.9)) in subjects suffering from diabetes since more than 5 years, compared to subjects (115.3 mu M (75.2-127.1), p<0.001) with less than 5 years. Conclusion In conclusion, high NO levels were observed in South Indian diabetic patients. Higher glucose levels in serum might be responsible for activation of endothelial cells to enhance NO levels.	[Adela, Ramu; Bagul, Pankaj K.; Mattapally, Saidulu; Kuncha, Madhusudan; Banerjee, Sanjay K.] CSIR, IICT, Div Med Chem & Pharmacol, Hyderabad 500007, Andhra Pradesh, India; [Reddy, P. Naveen Chander] Mediciti Hosp, Div Cardiol, Hyderabad 500063, Andhra Pradesh, India; CSIR, IICT, Lipid Sci & Technol Div, Biomat Grp, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT)	Banerjee, SK (corresponding author), THSTI, Drug Discovery Res Ctr, Translat Hlth Sci, Faridabad 121001, India.	banerjees74@hotmail.com	Nethi, Susheel/GLN-2719-2022; Dr. Pankaj K. Bagul, M.S Pharm/I-3867-2012; Nethi, Susheel Kumar/S-9324-2019; Saidulu, Mattapally/J-5811-2018; Barui, Ayan Kumar/E-5408-2012	Nethi, Susheel/0000-0002-4138-1618; Nethi, Susheel Kumar/0000-0002-4138-1618; Saidulu, Mattapally/0000-0002-2788-3187; Barui, Ayan Kumar/0000-0003-4475-1183; Adela, Ramu/0000-0003-0909-2557; Banerjee, Sanjay k/0000-0002-0044-0984; Banerjee, Sanjay/0000-0002-0008-0480	Department of Biotechnology (DBT) [BT/HRD/35/02/2006]; Department of Science and Technology (DST), New Delhi [SR/S2/RJN-04/2010, GAP0305]; DST, New Delhi;  [D43 TW 009078]; FOGARTY INTERNATIONAL CENTER [D43TW009078] Funding Source: NIH RePORTER	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Department of Science and Technology (DST), New Delhi(Department of Science & Technology (India)); DST, New Delhi(Department of Science & Technology (India)); ; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	SKB is grateful to Department of Biotechnology (DBT) for providing Ramalingaswami Fellowship (BT/HRD/35/02/2006). CRP is grateful to Department of Science and Technology (DST), New Delhi for 'Ramanujan Fellowship grant'(SR/S2/RJN-04/2010; GAP0305). RA is a scholar in the Fogarty International Center of the National Institutes of Health training program under Award Number D43 TW 009078. SKN is thankful to DST, New Delhi for supporting with junior research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktug H, 2012, TURK J MED SCI, V42, P830, DOI 10.3906/sag-1104-38; American Diabetes Association, 2012, DIABETES CARE, V35, P564; American Heart Association-Metabolic Syndrome, 2011, MET SYNDR; Amrita G, 2011, INT J APPL BASIC MED, V1, P31, DOI [10.4103/ 2229- 516X. 81977, DOI 10.4103/2229-516X.81977]; Avogaro A, 2011, DIABETES CARE, V34, pS285, DOI 10.2337/dc11-s239; Barui AK, 2012, NANOSCALE, V4, P7861, DOI 10.1039/c2nr32369a; Cai SJ, 2005, CARDIOVASC RES, V65, P823, DOI 10.1016/j.cardiores.2004.10.040; Camilletti A, 2001, AM J HYPERTENS, V14, P382, DOI 10.1016/S0895-7061(00)01297-8; Chandra M, 2003, Indian J Clin Biochem, V18, P150, DOI 10.1007/BF02867381; Chien WY, 2005, DIABETES METAB, V31, P63, DOI 10.1016/S1262-3636(07)70168-4; Cosentino F, 1997, CIRCULATION, V96, P25; Das L, 2014, J TRANSL INTERN MED, V2, P36, DOI 10.4103/2224-4018.129503; DOMINICZAK AF, 1995, HYPERTENSION, V25, P1202, DOI 10.1161/01.HYP.25.6.1202; Donmez G, 2002, JPN J PHYSIOL, V52, P435, DOI 10.2170/jjphysiol.52.435; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; FAJANS SS, 1990, DIABETES CARE, V13, P49, DOI 10.2337/diacare.13.1.49; Fujimoto M, 2005, DIABETES, V54, P1340, DOI 10.2337/diabetes.54.5.1340; GRUNFELD S, 1995, HYPERTENSION, V26, P854, DOI 10.1161/01.HYP.26.6.854; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Higashino H, 2007, CLIN EXP PHARMACOL P, V34, P725, DOI 10.1111/j.1440-1681.2007.04617.x; Hoshiyama M, 2003, NEPHRON EXP NEPHROL, V95, pE62, DOI 10.1159/000073673; Ishii N, 2001, J AM SOC NEPHROL, V12, P1630, DOI 10.1681/ASN.V1281630; Kassab A, 2012, BIOCHIMIE, V94, P1837, DOI 10.1016/j.biochi.2012.01.020; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Kwok W, 2009, AM J PHYSIOL-GASTR L, V297, pG930, DOI 10.1152/ajpgi.00106.2009; LERMAN A, 1992, CIRCULATION, V86, P12; Liu XJ, 2013, EXP THER MED, V6, P361, DOI 10.3892/etm.2013.1166; Madhumitha H, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-1; Maejima K, 2001, J DIABETES COMPLICAT, V15, P135, DOI 10.1016/S1056-8727(01)00144-1; Mason RP, 2012, BRIT J CLIN PHARMACO, V74, P141, DOI 10.1111/j.1365-2125.2012.04189.x; Michael JF, 2008, CLIN DIABETES, V26, P277; Monti LD, 2003, DIABETES, V52, P1270, DOI 10.2337/diabetes.52.5.1270; Node K, 1997, HYPERTENSION, V30, P405, DOI 10.1161/01.HYP.30.3.405; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Padiya R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094228; Patra CR, 2011, NANO LETT, V11, P4932, DOI 10.1021/nl2028766; Pieper GM, 1998, HYPERTENSION, V31, P1047, DOI 10.1161/01.HYP.31.5.1047; Pietroa ND, 2013, ATHEROSCLEROSIS, V226, P88, DOI [10.1016/j.atherosclerosis.2012.10.062, DOI 10.1016/J.ATHER0SCLER0SIS.2012.10.062]; SAGAR S, 1992, MOL CELL BIOCHEM, V111, P103; Shiekh Gazalla Ayub, 2011, J Cardiovasc Dis Res, V2, P172, DOI 10.4103/0975-3583.85264; Sugita H, 2002, AM J PHYSIOL-ENDOC M, V282, pE386, DOI 10.1152/ajpendo.00087.2001; Tanaka J, 2009, DIABETES, V58, P2344, DOI 10.2337/db09-0167; Tessari P, 2010, DIABETES, V59, P2152, DOI 10.2337/db09-1772; Tschudi MR, 1996, HYPERTENSION, V27, P32, DOI 10.1161/01.HYP.27.1.32; Versari D, 2009, DIABETES CARE, V32, pS314, DOI 10.2337/dc09-S330; Yang PX, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.05.003; Zangeneh Farhad, 2006, Endocr Pract, V12, P388; Zhang X, 2014, NITRIC OXIDE-BIOL CH, V40, P10, DOI 10.1016/j.niox.2014.05.001	49	61	64	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0125270	10.1371/journal.pone.0125270	http://dx.doi.org/10.1371/journal.pone.0125270			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894234	Green Published, gold, Green Submitted			2022-12-26	WOS:000353211700136
J	Hernandez, MO; Mantis, NJ				Hernandez, Maria Olga; Mantis, Nicholas J.			Phenotypic Analysis of a Population of IgA(+) Cells in the Follicle-Associated Epithelium of Mouse Peyer's Patches	PLOS ONE			English	Article							DENDRITIC CELLS; T-CELLS; B-CELLS; SUBEPITHELIAL DOME; CHOLERA-TOXIN; SECRETORY IGA; MURINE; TRANSPORT; BACTERIA; MIGRATION	The follicle-associated epithelium (FAE) selectively transports prions, viruses, pathogenic bacteria, commensal microflora, and even secretory IgA (SIgA)-immune complexes from the intestinal lumen to underlying gut-associated lymphoid tissues like Peyer's patches. The FAE consists of a single layer of columnar epithelial cells that includes enterocytes and M (microfold) cells, intermingled with dendritic cells (DCs), macrophages, and naive and memory B and T lymphocytes. In this report we describe a population of IgA(+) cells that reside within and immediately below the FAE in mouse Peyer's patches. Immunofluorescence microscopy analysis indicated that the FAE-associated IgA(+) cells were negative for surface antigen markers specific for B cells (B220), T cells (CD3), DCs (CD11c), and plasma cells (CD138). The IgA(+) cells were also negative Ki-67 and IRF4, indicating that they are not mature B cells or plasma cells. The IgA(+) cells were, however, often found in close proximity to DCs, leading us to speculate that the population of IgA(+) cells in the FAE constitutes an atypical subset of B cells involved in mucosal antigen surveillance and/or immune recall.	[Hernandez, Maria Olga; Mantis, Nicholas J.] New York State Dept Hlth, Wadsworth Ctr, Div Infect Dis, Albany, NY 12208 USA; [Mantis, Nicholas J.] SUNY Albany, Dept Biomed Sci, Albany, NY 12208 USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Mantis, NJ (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Div Infect Dis, Albany, NY 12208 USA.	nicholas.mantis@health.ny.gov		Mantis, Nicholas/0000-0002-5083-8640	National Institutes of Health from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [R01HD061916]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061916] Funding Source: NIH RePORTER	National Institutes of Health from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the National Institutes of Health grant R01HD061916 (to NJM) from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD; https://www.nichd.nih.gov/Pages/index.aspx). MOH was the recipient of Supplement to Support Diversity in Science under the auspices of R01HD061916. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlawat S, 2014, MICROSC MICROANAL, V20, P198, DOI 10.1017/S1431927613013640; Anosova NG, 2008, MUCOSAL IMMUNOL, V1, P59, DOI 10.1038/mi.2007.7; Beier R, 1998, AM J PHYSIOL-GASTR L, V275, pG130, DOI 10.1152/ajpgi.1998.275.1.G130; Bergmann B, 2013, SCAND J IMMUNOL, V78, P149, DOI 10.1111/sji.12073; Brandtzaeg P, 2005, IMMUNOL REV, V206, P32, DOI 10.1111/j.0105-2896.2005.00283.x; Brandtzaeg P, 1999, IMMUNOL TODAY, V20, P141, DOI 10.1016/S0167-5699(98)01413-3; Chabot S, 2006, J IMMUNOL, V176, P4275, DOI 10.4049/jimmunol.176.7.4275; De Jesus M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091002; De Jesus M, 2013, JOVE-J VIS EXP, DOI 10.3791/50167; ERMAK TH, 1990, IMMUNOLOGY, V71, P530; FARSTAD IN, 1994, IMMUNOLOGY, V83, P457; Gohda M, 2008, J IMMUNOL, V180, P5335, DOI 10.4049/jimmunol.180.8.5335; Gonzalez-Hernandez MB, 2013, J VIROL, V87, P12685, DOI 10.1128/JVI.02378-13; Hopkins SA, 2000, CELL MICROBIOL, V2, P59; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Johansen FE, 1999, J EXP MED, V190, P915, DOI 10.1084/jem.190.7.915; Johansen FE, 2001, J IMMUNOL, V167, P5185, DOI 10.4049/jimmunol.167.9.5185; Kelsall BL, 1996, J EXP MED, V183, P237, DOI 10.1084/jem.183.1.237; Kujala P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002449; Kunisawa J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2718; Lelouard H, 2012, GASTROENTEROLOGY, V142, P592, DOI 10.1053/j.gastro.2011.11.039; Lelouard H, 2010, GASTROENTEROLOGY, V138, P173, DOI 10.1053/j.gastro.2009.09.051; Mantis N., 1999, Immunology Letters, V69, P42; Mantis NJ, 2011, MUCOSAL IMMUNOL, V4, P603, DOI 10.1038/mi.2011.41; Mantis NJ, 2010, IMMUNOL INVEST, V39, P383, DOI 10.3109/08820131003622635; Nakato G, 2009, DNA RES, V16, P227, DOI 10.1093/dnares/dsp013; Neutra MR, 1999, SEMIN IMMUNOL, V11, P171, DOI 10.1006/smim.1999.0173; Neutra MR, 2001, NAT IMMUNOL, V2, P1004, DOI 10.1038/ni1101-1004; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Rey J, 2004, J IMMUNOL, V172, P3026, DOI 10.4049/jimmunol.172.5.3026; Ruedl C, 1996, EUR J IMMUNOL, V26, P1801, DOI 10.1002/eji.1830260821; Schmidt TH, 2013, J EXP MED, V210, P1099, DOI 10.1084/jem.20122574; Shreedhar VK, 2003, INFECT IMMUN, V71, P504, DOI 10.1128/IAI.71.1.504-509.2003; Takakura I, 2011, AM J PATHOL, V179, P1301, DOI 10.1016/j.ajpath.2011.05.058; Tomayko MM, 2010, J IMMUNOL, V185, P7146, DOI 10.4049/jimmunol.1002163; Tonry JH, 2013, MICROBES INFECT, V15, P37, DOI 10.1016/j.micinf.2012.10.004; Willis SN, 2014, J IMMUNOL, V192, P3200, DOI 10.4049/jimmunol.1303216; WOLF JL, 1981, SCIENCE, V212, P471, DOI 10.1126/science.6259737; Yamanaka T., 1999, Immunology Letters, V69, P42; Yamanaka T, 2003, J IMMUNOL, V170, P816, DOI 10.4049/jimmunol.170.2.816; Yamanaka T, 2001, EUR J IMMUNOL, V31, P107, DOI 10.1002/1521-4141(200101)31:1<107::AID-IMMU107>3.0.CO;2-4; Zuccarino-Catania GV, 2014, NAT IMMUNOL, V15, P631, DOI 10.1038/ni.2914	43	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124111	10.1371/journal.pone.0124111	http://dx.doi.org/10.1371/journal.pone.0124111			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894545	Green Published, Green Submitted, gold			2022-12-26	WOS:000353211700074
J	Kao, J; Gold, KD; Zarrili, G; Copel, E; Silverman, AJ; Ramsaran, SS; Yens, D; Ryu, S				Kao, Johnny; Gold, Kenneth D.; Zarrili, Gina; Copel, Emily; Silverman, Andrew J.; Ramsaran, Shanata S.; Yens, David; Ryu, Samuel			Clinical Predictors of Survival for Patients with Stage IV Cancer Referred to Radiation Oncology	PLOS ONE			English	Article							STEREOTACTIC BODY RADIOTHERAPY; PALLIATIVE RADIOTHERAPY; PROGNOSTIC-FACTORS; EXTRACRANIAL OLIGOMETASTASES; HOSPITALIZED-PATIENTS; CONCURRENT SUNITINIB; PERFORMANCE STATUS; LIFE EXPECTANCY; THERAPY; MODEL	Background There is an urgent need for a robust, clinically useful predictive model for survival in a heterogeneous group of patients with metastatic cancer referred to radiation oncology. Methods From May 2012 to August 2013, 143 consecutive patients with stage IV cancer were prospectively evaluated by a single radiation oncologist. We retrospectively analyzed the effect of 29 patient, laboratory and tumor-related prognostic factors on overall survival using univariate analysis. Variables that were statistically significant on univariate analysis were entered into a multivariable Cox regression to identify independent predictors of overall survival. Results The median overall survival was 5.5 months. Four prognostic factors significantly predicted survival on multivariable analysis including ECOG performance status (0-1 vs. 2 vs. 3-4), number of active tumors (1 to 5 vs. >= 6), albumin levels (>= 3.4 vs. 2.4 to 3.3 vs. <2.4 and primary tumor site (Breast, Kidney or Prostate vs. Other). Risk group stratification was performed by assigning points for adverse prognostic factors resulting in very low, low, intermediate and high risk groups. The median survival was >31.4 months for very low risk patients compared to 14.5 months for low risk, 4.1 months for intermediate risk and 1.2 months for high risk (p<0.001). Conclusions These data suggest that a model that considers performance status, extent of disease, primary tumor site and serum albumin represents a simple model to accurately predict survival for patients with stage IV cancer who are potential candidates for radiation therapy.	[Kao, Johnny; Silverman, Andrew J.; Ramsaran, Shanata S.] Good Samaritan Hosp Med Ctr, Dept Radiat Oncol, New York, NY 10022 USA; [Gold, Kenneth D.] Good Samaritan Hosp Med Ctr, Div Hematol & Med Oncol, New York, NY USA; [Zarrili, Gina; Copel, Emily] Good Samaritan Hosp Med Ctr, Div Palliat Med, New York, NY USA; [Yens, David] New York Coll Osteopath Med, Dept Educ Dev & Assessment, Old Westbury, NY USA; [Ryu, Samuel] Stony Brook Univ Med, Dept Radiat Oncol, Stony Brook, NY USA	New York Institute Technology; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital	Kao, J (corresponding author), Good Samaritan Hosp Med Ctr, Dept Radiat Oncol, New York, NY 10022 USA.	Johnny.kao@chsli.org						Anderson F, 1996, J PALLIAT CARE, V12, P5, DOI 10.1177/082585979601200102; Barbot AC, 2008, J CLIN ONCOL, V26, P2538, DOI 10.1200/JCO.2007.14.9518; Chow E, 2002, INT J RADIAT ONCOL, V53, P1291, DOI 10.1016/S0360-3016(02)02832-8; Chow E, 2008, J CLIN ONCOL, V26, P5863, DOI 10.1200/JCO.2008.17.1363; Christakis NA, 1996, NEW ENGL J MED, V335, P172, DOI 10.1056/NEJM199607183350306; Christakis NA, 2000, BRIT MED J, V320, P469, DOI 10.1136/bmj.320.7233.469; Corbin KS, 2013, J CLIN ONCOL, V31, P1384, DOI 10.1200/JCO.2012.45.9651; Feliu J, 2011, JNCI-J NATL CANCER I, V103, P1613, DOI 10.1093/jnci/djr388; Glare P, 2003, BRIT MED J, V327, P195, DOI 10.1136/bmj.327.7408.195; Glare PA, 2004, J CLIN ONCOL, V22, P4823, DOI 10.1200/JCO.2004.12.056; Glare Paul, 2005, J Support Oncol, V3, P331; GRABOWSKI CM, 1992, RADIOLOGY, V184, P329, DOI 10.1148/radiology.184.2.1377829; Gripp S, 2010, CANCER-AM CANCER SOC, V116, P3251, DOI 10.1002/cncr.25112; Guadagnolo BA, 2013, J CLIN ONCOL, V31, P80, DOI 10.1200/JCO.2012.45.0585; JANISCH L, 1994, CANCER-AM CANCER SOC, V74, P1965, DOI 10.1002/1097-0142(19941001)74:7<1965::AID-CNCR2820740723>3.0.CO;2-1; Kao J, 2015, TECHNOL CANCER RES T, V14, P547, DOI 10.7785/tcrt.2012.500426; Kao J, 2014, TARGET ONCOL, V9, P145, DOI 10.1007/s11523-013-0280-y; Kao J, 2009, CANCER-AM CANCER SOC, V115, P3571, DOI 10.1002/cncr.24412; Krishnan MS, 2014, CANCER-AM CANCER SOC, V120, P134, DOI 10.1002/cncr.28408; Lamont EB, 2003, JAMA-J AM MED ASSOC, V290, P98, DOI 10.1001/jama.290.1.98; Ma C, 2010, EUR J CANCER, V46, P3175, DOI 10.1016/j.ejca.2010.06.126; MALTONI M, 1994, EUR J CANCER, V30A, P764, DOI 10.1016/0959-8049(94)90289-5; Maltoni M, 2005, J CLIN ONCOL, V23, P6240, DOI 10.1200/JCO.2005.06.866; Milano MT, 2008, CANCER-AM CANCER SOC, V112, P650, DOI 10.1002/cncr.23209; Morita T, 1999, SUPPORT CARE CANCER, V7, P128, DOI 10.1007/s005200050242; Rades D, 2005, J CLIN ONCOL, V23, P3366, DOI 10.1200/JCO.2005.04.754; REUBEN DB, 1988, ARCH INTERN MED, V148, P1586, DOI 10.1001/archinte.148.7.1586; Rosenthal Mark A., 1993, Palliative Medicine, V7, P199, DOI 10.1177/026921639300700306; Salama JK, 2012, CANCER-AM CANCER SOC, V118, P2962, DOI 10.1002/cncr.26611; Tree AC, 2013, LANCET ONCOL, V14, pE28, DOI 10.1016/S1470-2045(12)70510-7; Weichselbaum RR, 2011, NAT REV CLIN ONCOL, V8, P378, DOI 10.1038/nrclinonc.2011.44	31	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124329	10.1371/journal.pone.0124329	http://dx.doi.org/10.1371/journal.pone.0124329			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894552	gold, Green Published, Green Submitted			2022-12-26	WOS:000353211700087
J	Nataraj, V; Pang, PC; Haslam, SM; Veerapen, N; Minnikin, DE; Dell, A; Besra, GS; Bhatt, A				Nataraj, Vijayashankar; Pang, Poh-choo; Haslam, Stuart M.; Veerapen, Natacha; Minnikin, David E.; Dell, Anne; Besra, Gurdyal S.; Bhatt, Apoorva			MKAN27435 Is Required for the Biosynthesis of Higher Subclasses of Lipooligosaccharides in Mycobacterium kansasii	PLOS ONE			English	Article							TREHALOSE-CONTAINING LIPOOLIGOSACCHARIDES; MARINUM; TUBERCULOSIS; INFECTION; PULMONARY; ANTIGENS; ENVELOPE; BCG	Lipooligosaccharides are glycolipids found in the cell wall of many mycobacterial species including the opportunistic pathogen Mycobacterium kansasii. The genome of M. kansasii ATCC12478 contains a cluster with genes orthologous to Mycobacterium marinum LOS biosynthesis genes. To initiate a genetic dissection of this cluster and demonstrate its role in LOS biosynthesis in M. kansasii, we chose MKAN27435, a gene encoding a putative glycosyltransferase. Using Specialized Transduction, a phage-based gene knockout tool previously used to generate null mutants in other mycobacteria, we generated a MKAN27435 null mutant. The mutant strain was found to be defective in the biosynthesis of higher LOS subspecies, viz LOS-IV, LOS-V, LOS-VI and LOS-VII. Additionally, a range of low abundance species were detected in the mutant strain and mass spectroscopic analysis indicated that these were shunt products generated from LOS-III by the addition of up to six molecules of a pentose.	[Nataraj, Vijayashankar; Veerapen, Natacha; Minnikin, David E.; Besra, Gurdyal S.; Bhatt, Apoorva] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Nataraj, Vijayashankar; Veerapen, Natacha; Minnikin, David E.; Besra, Gurdyal S.; Bhatt, Apoorva] Univ Birmingham, Inst Microbiol & Infect, Birmingham B15 2TT, W Midlands, England; [Pang, Poh-choo; Haslam, Stuart M.; Dell, Anne] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England	University of Birmingham; University of Birmingham; Imperial College London	Bhatt, A (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.	a.bhatt@bham.ac.uk		Dell, Anne/0000-0003-1380-2347; Besra, Gurdyal/0000-0002-5605-0395	Medical Research Council (UK); Biotechnology and Biological Sciences Research Council [BB/K016164/1] Funding Source: researchfish; Medical Research Council [MR/K012118/1, G0600105] Funding Source: researchfish; BBSRC [BB/K016164/1] Funding Source: UKRI; MRC [MR/K012118/1, G0600105] Funding Source: UKRI	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by grants from the Medical Research Council (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibaud L, 2014, J BIOL CHEM, V289, P215, DOI 10.1074/jbc.M113.525550; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Bardarov S, 1997, P NATL ACAD SCI USA, V94, P10961, DOI 10.1073/pnas.94.20.10961; BELISLE JT, 1989, J BACTERIOL, V171, P3465, DOI 10.1128/jb.171.6.3465-3470.1989; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Burguiere A, 2005, J BIOL CHEM, V280, P42124, DOI 10.1074/jbc.M507500200; COLLINS FM, 1981, INFECT IMMUN, V32, P614, DOI 10.1128/IAI.32.2.614-624.1981; DAFFE M, 1991, BIOCHEMISTRY-US, V30, P378, DOI 10.1021/bi00216a011; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Dobson G., 1985, CHEM METHODS BACTERI, P237; Evans SA, 1996, THORAX, V51, P1248, DOI 10.1136/thx.51.12.1248; HUNTER SW, 1984, J BIOL CHEM, V259, P9729; HUNTER SW, 1985, BIOCHEMISTRY-US, V24, P2798, DOI 10.1021/bi00332a030; HUNTER SW, 1983, J BIOL CHEM, V258, P481; Larsen Michelle H, 2007, Curr Protoc Microbiol, VChapter 10, DOI 10.1002/9780471729259.mc10a02s6; LILLO M, 1990, REV INFECT DIS, V12, P760; Minnikin D E, 1989, Acta Leprol, V7 Suppl 1, P51; Picardeau M, 1997, J CLIN MICROBIOL, V35, P25, DOI 10.1128/JCM.35.1.25-32.1997; Ren HP, 2007, MOL MICROBIOL, V63, P1345, DOI 10.1111/j.1365-2958.2007.05603.x; Rombouts Y, 2010, J AM CHEM SOC, V132, P16073, DOI 10.1021/ja105807s; Rombouts Y, 2009, J BIOL CHEM, V284, P20975, DOI 10.1074/jbc.M109.011429; Sarkar D, 2011, J BACTERIOL, V193, P2336, DOI 10.1128/JB.00065-11; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Tompkins JC, 2007, INT J TUBERC LUNG D, V11, P331; van der Woude AD, 2012, J BIOL CHEM, V287, P20417, DOI 10.1074/jbc.M111.336461	26	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0122804	10.1371/journal.pone.0122804	http://dx.doi.org/10.1371/journal.pone.0122804			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893968	Green Submitted, Green Published, gold			2022-12-26	WOS:000353211700017
J	Periasamy, M; Schafleitner, R; Muthukalingan, K; Ramasamy, S				Periasamy, Malini; Schafleitner, Roland; Muthukalingan, Krishnan; Ramasamy, Srinivasan			Phylogeographical Structure in Mitochondrial DNA of Legume Pod Borer (Maruca vitrata) Population in Tropical Asia and Sub-Saharan Africa	PLOS ONE			English	Article							COII GENE-SEQUENCES; CORN-BORER; TESTULALIS LEPIDOPTERA; OSTRINIA-FURNACALIS; SEX-PHEROMONE; IDENTIFICATION; DIFFERENTIATION; HAPLOTYPES; NUBILALIS; PYRALIDAE	This study was undertaken to assess the genetic diversity and host plant races of M. vitrata population in South and Southeast Asia and sub-Saharan Africa. The cytochrome c oxidase subunit 1 (cox1) gene was used to understand the phylogenetic relationship of geographically different M. vitrata population, but previous studies did not include population from Southeast Asia, the probable center of origin for Maruca, and from east Africa. Extensive sampling was done from different host plant species in target countries. Reference populations from Oceania and Latin America were used. An amplicon of 658 bp was produced by polymerase chain reaction, and 64 haplotypes were identified in 686 M. vitrata individuals. Phylogenetic analysis showed no difference among the M. vitrata population from different host plants. However, the results suggested that M. vitrata has formed two putative subspecies (which cannot be differentiated based on morphological characters) in Asia and sub-Saharan Africa, as indicated by the high pairwise F-ST values (0.44-0.85). The extremely high F-ST values (>= 0.93) of Maruca population in Latin America and Oceania compared to Asian and African population seem to indicate a different species. On the continental or larger geographical region basis, the genetic differentiation is significantly correlated with the geographical distance. In addition, two putative species of Maruca, including M. vitrata occur in Australia, Indonesia and Papua New Guinea. The negative Tajima's D and Fu's F-S values showed the recent demographic expansion of Maruca population. The haplotype network and Automatic Barcode Gap Discovery analyses confirmed the results of phylogenetic analysis. Thus, this study confirmed the presence of three putative Maruca species, including one in Latin America, one in Oceania (including Indonesia) and M. vitrata in Asia, Africa and Oceania. Hence, the genetic differences in Maruca population should be carefully considered while designing the pest management strategies in different regions.	[Periasamy, Malini; Schafleitner, Roland; Ramasamy, Srinivasan] World Vegetable Ctr, Asian Vegetable Res & Dev Ctr, Tainan 74199, Taiwan; [Periasamy, Malini; Muthukalingan, Krishnan] Bharathidasan Univ, Dept Environm Biotechnol, Tiruchirappalli 620024, Tamil Nadu, India	Bharathidasan University	Ramasamy, S (corresponding author), World Vegetable Ctr, Asian Vegetable Res & Dev Ctr, POB 42, Tainan 74199, Taiwan.	srini.ramasamy@worldveg.org	Ramasamy, Srinivasan/N-1686-2019; Periasamy, Malini/AAX-6478-2021	Ramasamy, Srinivasan/0000-0002-8454-7331; Schafleitner, Roland/0000-0003-3637-7603	Federal Ministry for Economic Cooperation and Development (BMZ) through Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ) GmbH. GIZ Project [09.7860.1-001.00. SR]	Federal Ministry for Economic Cooperation and Development (BMZ) through Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ) GmbH. GIZ Project	Funded by Federal Ministry for Economic Cooperation and Development (BMZ) through Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ) GmbH. GIZ Project No: 09.7860.1-001.00. SR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adati T, 1999, J CHEM ECOL, V25, P105, DOI 10.1023/A:1020841217376; AFUN JVK, 1991, CROP PROT, V10, P363, DOI 10.1016/S0261-2194(06)80025-6; Agunbiade TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092072; [Anonymous], 2014, BARCODE INDEX NUMBER; Arodokoun D. Y., 2003, Insect Science and its Application, V23, P103; BayScience Foundation, 2012, MAR GEN; CAB International, 2005, CROP PROT COMP; Chang JC, 2013, ANN ENTOMOL SOC AM, V106, P359, DOI 10.1603/AN12136; Chang JC, 2016, MITOCHONDRIAL DNA A, V27, P198, DOI [10.3109/19401736.2014.880890, 10.1155/2014/454156]; Coates BS, 2005, INT J BIOL SCI, V1, P13; Coates BS, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.35; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Downham MCA, 2004, ENTOMOL EXP APPL, V110, P151, DOI 10.1111/j.0013-8703.2004.00128.x; Downham MCA, 2003, J CHEM ECOL, V29, P989, DOI 10.1023/A:1022996103147; DREYER H, 1994, INT J PEST MANAGE, V40, P252, DOI 10.1080/09670879409371893; EXCOFFIER L, 1992, GENETICS, V131, P479; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FU YX, 1995, THEOR POPUL BIOL, V48, P172, DOI 10.1006/tpbi.1995.1025; Fu YX, 1997, GENETICS, V147, P915; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; Graves JL., 2010, REV BLACK POLIT ECON, V37, P43; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hassan MN, 2007, THESIS U GREENWICH, P244; Herbison-Evans D, 1787, MARUCA VITRATA; Hoshizaki S, 2008, B ENTOMOL RES, V98, P519, DOI 10.1017/S0007485308005841; Huang C. C., 2004, Plant Protection Bulletin (Taichung), V46, P81; JACKAI LEN, 1981, ANN ENTOMOL SOC AM, V74, P402, DOI 10.1093/aesa/74.4.402; Jaramillo C, 2001, MEM I OSWALDO CRUZ, V96, P1043, DOI 10.1590/S0074-02762001000800003; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Kadirvel P, 2013, J ECON ENTOMOL, V106, P408, DOI 10.1603/EC12119; KAREL AK, 1985, J ECON ENTOMOL, V78, P1323, DOI 10.1093/jee/78.6.1323; Kim CG, 1999, APPL ENTOMOL ZOOL, V34, P405, DOI 10.1303/aez.34.405; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kirti Jagbir Singh, 2005, Zoos Print Journal, V20, P1930; Liao PC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-124; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Long Khuat Dang, 2012, Tap Chi Sinh Hoc, V34, P48; Malini P, 2014, FORM ENTOMOL, V33, P356; Margam VM, 2011, MOL BIOL REP, V38, P893, DOI 10.1007/s11033-010-0182-3; NEI M, 1981, GENETICS, V97, P145; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Ohno S, 2006, B ENTOMOL RES, V96, P243, DOI 10.1079/BER2006418; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Rathore Y. S., 1998, Indian Journal of Pulses Research, V11, P152; ROSE HS, 1989, J ADV ZOOL, V10, P99; Schlager S, 2012, GESUNDE PFLANZ, V64, P183, DOI 10.1007/s10343-012-0287-9; SCHNEIDER S, 1997, ARLEQUIN VERSION 1 1; Sharma HC, 1998, CROP PROT, V17, P373, DOI 10.1016/S0261-2194(98)00045-3; Singh SR, 1990, INSECT PESTS TROPICA, P43; Smith Hobart M., 1997, Herpetological Review, V28, P13; Srinivasan R., 2013, Proceedings SEAVEG 2012, Chiang Mai, Thailand, 24-26 January 2012. High value vegetables in Southeast Asia: production, supply and demand, P76; Srinivasan R, 2013, CURR SCI INDIA, V105, P6; TAJIMA F, 1989, GENETICS, V123, P585; Tamo M., 1997, Advances in cowpea research, P259; Tamo M, 2002, CHALLENGES OPPORTUNI, P81; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor T. A., 1967, Journal of the West African Science Association, V12, P111; Templeton AR, 1998, AM ANTHROPOL, V100, P632, DOI 10.1525/aa.1998.100.3.632; Ulrichs C, 2004, J APPL ENTOMOL, V128, P426, DOI 10.1111/j.1439-0418.2004.00867.x; van Achterberg C, 2010, ZOOKEYS, P1, DOI 10.3897/zookeys.54.475	61	24	28	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124057	10.1371/journal.pone.0124057	http://dx.doi.org/10.1371/journal.pone.0124057			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893977	Green Submitted, Green Published, gold			2022-12-26	WOS:000353211700070
J	Raggi, L; Bitocchi, E; Russi, L; Marconi, G; Sharbel, TF; Veronesi, F; Albertini, E				Raggi, Lorenzo; Bitocchi, Elena; Russi, Luigi; Marconi, Gianpiero; Sharbel, Timothy F.; Veronesi, Fabio; Albertini, Emidio			Understanding Genetic Diversity and Population Structure of a Poa pratensis Worldwide Collection through Morphological, Nuclear and Chloroplast Diversity Analysis	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; KENTUCKY BLUEGRASS; DNA-CONTENT; CULTIVARS; MARKERS; L.; INFERENCE; APOMIXIS; TRAITS; NUMBER	Poa pratensis L. is a forage and turf grass species well adapted to a wide range of mesic to moist habitats. Due to its genome complexity little is known regarding evolution, genome composition and intraspecific phylogenetic relationships of this species. In the present study we investigated the morphological and genetic diversity of 33 P. pratensis accessions from 23 different countries using both nuclear and chloroplast molecular markers as well as flow cytometry of somatic tissues. This with the aim of shedding light on the genetic diversity and phylogenetic relationships of the collection that includes both cultivated and wild materials. Morphological characterization showed that the most relevant traits able to distinguish cultivated from wild forms were spring growth habit and leaf colour. The genome size analysis revealed high variability both within and between accessions in both wild and cultivated materials. The sequence analysis of the trnL-F chloroplast region revealed a low polymorphism level that could be the result of the complex mode of reproduction of this species. In addition, a strong reduction of chloroplast SSR variability was detected in cultivated materials, where only two alleles were conserved out of the four present in wild accessions. Contrarily, at nuclear level, high variability exist in the collection where the analysis of 11 SSR loci allowed the detection of a total of 91 different alleles. A Bayesian analysis performed on nuclear SSR data revealed that studied materials belong to two main clusters. While wild materials are equally represented in both clusters, the domesticated forms are mostly belonging to cluster P2 which is characterized by lower genetic diversity compared to the cluster P1. In the Neighbour Joining tree no clear distinction was found between accessions with the exception of those from China and Mongolia that were clearly separated from all the others.	[Raggi, Lorenzo; Russi, Luigi; Marconi, Gianpiero; Veronesi, Fabio; Albertini, Emidio] Univ Perugia, Dipartimento Sci Agr Alimentari & Ambiental, I-06100 Perugia, Italy; [Bitocchi, Elena] Univ Politecn Marche, Dipartimento Sci Agrarie Alimentari & Ambientali, Ancona, Italy; [Sharbel, Timothy F.] Leibniz Inst Plant Genet & Crop Plant Res IPK, Dept Cytogenet & Genome Anal, Apomixis Res Grp, Gatersleben, Germany	University of Perugia; Marche Polytechnic University; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung	Albertini, E (corresponding author), Univ Perugia, Dipartimento Sci Agr Alimentari & Ambiental, I-06100 Perugia, Italy.	emidio.albertini@unipg.it	Raggi, Lorenzo/G-5645-2013; Russi, Luigi/AAE-8230-2020; Bitocchi, Elena/J-7996-2019; Albertini, Emidio/F-7393-2014; Sharbel, Timothy/AAV-9578-2020	Raggi, Lorenzo/0000-0003-0484-8669; Russi, Luigi/0000-0002-7521-2126; Bitocchi, Elena/0000-0002-2152-4634; Sharbel, Timothy/0000-0002-3450-2733; Veronesi, Fabio/0000-0001-7884-6987; Albertini, Emidio/0000-0003-2585-5649; MARCONI, GIANPIERO/0000-0003-2669-0399	Italian Ministry of Education and Scientific Research (MIUR); Dipartimento di Scienze Agrarie Alimentari e Ambientali of Universita degli Studi di Perugia	Italian Ministry of Education and Scientific Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Dipartimento di Scienze Agrarie Alimentari e Ambientali of Universita degli Studi di Perugia	The research was funded by the Italian Ministry of Education and Scientific Research (MIUR) "Genetic aspects of seed production: genomic and functional characterization of candidate genes for apomictic reproduction" and by the Dipartimento di Scienze Agrarie Alimentari e Ambientali of Universita degli Studi di Perugia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerberg E, 1939, HEREDITAS, V25, P359; Arumuganathan K, 1999, CROP SCI, V39, P1518; Bashaw E., 1987, PRINCIPLES CULTIVAR, P40; BENNETT MD, 1995, ANN BOT-LONDON, V76, P113, DOI 10.1006/anbo.1995.1085; Caceres ME, 1998, THEOR APPL GENET, V96, P559, DOI 10.1007/s001220050774; Carrier L., 1916, AGRON J, V8, P256, DOI [10.2134/agronj1916.00021962000800040007x, DOI 10.2134/AGRONJ1916.00021962000800040007X]; Casler MD, 2006, J AGR SCI-CAMBRIDGE, V144, P189, DOI 10.1017/S0021859606006137; Cidade FW, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-50; CLAUSEN J, 1961, EUPHYTICA, V10, P87, DOI 10.1007/BF00037208; CRONQUIST A, 1977, INTERMOUNTAIN FLORA, V6; Curley J, 2004, CROP SCI, V44, P1299, DOI 10.2135/cropsci2004.1299; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Duell R. W., 1985, Forages: the science of grassland agriculture, P188; Eaton TD, 2004, CROP SCI, V44, P2168, DOI 10.2135/cropsci2004.2168; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fard JR, 2012, HORTIC ENVIRON BIOTE, V53, P298, DOI 10.1007/s13580-012-0120-5; FELSENSTEIN J, 1993, PHYLOGENY INFERENCE; Goldman JJ, 2008, PLANT BREEDING, V127, P644, DOI 10.1111/j.1439-0523.2008.01526.x; Harlan JR, 1992, CROPS MAN, V2nd; HARTLEY W., 1961, AUSTRALIAN JOUR BOT, V9, P152, DOI 10.1071/BT9610152; Heslop-Harrison J. S., 1995, Probe. Newsletter of the USDA Plant Genome Research Program, V5, P14; Holt SDS, 2005, PLANT SOIL ENVIRON, V51, P94, DOI 10.17221/3561-PSE; Honig JA, 2012, HORTSCIENCE, V47, P1356, DOI 10.21273/HORTSCI.47.9.1356; Honig JA, 2010, HORTSCIENCE, V45, P1759, DOI 10.21273/HORTSCI.45.11.1759; Huff D.R., 2003, TURFGRASS BIOL GENET, P27; HUFF DR, 1993, THEOR APPL GENET, V87, P201, DOI 10.1007/BF00223765; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Johnson RC, 2002, GENET RESOUR CROP EV, V49, P349, DOI 10.1023/A:1020662108929; Jungmann L, 2010, GENOME, V53, P698, DOI [10.1139/G10-055, 10.1139/g10-055]; Kellog E., 1990, SYST BOT, V15, P112; Krauss SL, 2000, MOL ECOL, V9, P1241, DOI 10.1046/j.1365-294x.2000.01001.x; Lo EYY, 2009, MOL ECOL, V18, P1145, DOI 10.1111/j.1365-294X.2009.04091.x; LOVE A, 1952, HEREDITAS, V38, P11; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Majesky L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041868; Matzk F, 2000, PLANT J, V21, P97, DOI 10.1046/j.1365-313x.2000.00647.x; MOWFORTH MA, 1989, FUNCT ECOL, V3, P289, DOI 10.2307/2389368; Muntzing A, 1940, HEREDITAS, V26, P115; Murovec J, 2009, ACTA BIOL CRACOV BOT, V51, P45; NEI M, 1974, GENETICS, V76, P379; Patterson JT, 2005, GENOME, V48, P76, DOI 10.1139/G04-102; Porceddu A, 2002, THEOR APPL GENET, V104, P273, DOI 10.1007/s001220100659; Pritchard JK, 2000, GENETICS, V155, P945; RAYBURN AL, 1989, J EXP BOT, V40, P1179, DOI 10.1093/jxb/40.11.1179; Rozen S, 2000, Methods Mol Biol, V132, P365; Sokal RR, 2012, BIOMETRY THE PRINCIP; SORENG RJ, 1985, GREAT BASIN NAT, V45, P395; SORENG RJ, 1990, AM J BOT, V77, P1383, DOI 10.2307/2444749; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; UPOV (Union Internationale Pour La Protection Des Obtentions Vegetales), 1990, GUIDELINES FOR THE C; Vekemans X., 2002, LABORATOIRE DE GENET; Vigna B. B. Z., 2011, Tropical Plant Biology, V4, P157, DOI 10.1007/s12042-011-9078-1; Wedin W, 1996, COOL SEASON FORAGE G; Welsh S, 1987, GREAT BASIN NATURALI; Wieners RR, 2006, GENET RESOUR CROP EV, V53, P1531, DOI 10.1007/s10722-005-7766-0; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x	59	16	17	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124709	10.1371/journal.pone.0124709	http://dx.doi.org/10.1371/journal.pone.0124709			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893249	Green Submitted, Green Published, gold			2022-12-26	WOS:000353211700117
J	Wang, QD; Zhang, M; Xu, M; Gu, WQ; Xi, Y; Qi, L; Li, B; Wang, WQ				Wang, Qidi; Zhang, Min; Xu, Min; Gu, Weiqiong; Xi, Yun; Qi, Lu; Li, Biao; Wang, Weiqing			Brown Adipose Tissue Activation Is Inversely Related to Central Obesity and Metabolic Parameters in Adult Human	PLOS ONE			English	Article							DIET-INDUCED OBESITY; CARDIOVASCULAR-DISEASE; VISCERAL ADIPOSITY; BODY FATNESS; FAT; SUSCEPTIBILITY; THERMOGENESIS; TEMPERATURE; PREVALENCE; ABLATION	Background Recent studies have shown that adult human possess active brown adipose tissue (BAT), which might be important in affecting obesity. However, the supporting evidence on the relationship between BAT and central obesity and metabolic profile in large population based studies is sparse. Methodology/Principal Findings We studied 4011 (2688 males and 1323 females) tumor-free Chinese adults aged 18-89 for BAT activities, visceral/subcutaneous fat areas (VFA/SFA), waist circumferences (WC) and metabolic parameters. We found that the prevalence of BAT was around 2.7% in our study participants, with a significant sexual difference (5.5% in the females vs. 1.3% in the males; p<0.0001). BAT detection was increased in low temperature and declined in elderly subjects. The BAT positive subjects had lower BMI (P<0.0001), less SFA (P<0.01), VFA (P<0.0001), WC (P<0.0001), lower fasting glucose and triglyceride levels (both P<0.01) and increased HDL cholesterol concentrations (P<0.0001), compared with the BAT negative subjects. Robust logistic regression revealed that after adjustment for covariates (including age, sex, BMI, VFA, SFA and WC), age and BMI in the males (0.92 [95% CI, 0.88-0.96] and 0.84 [95% CI, 0.75-0.96], both P <= 0.008) while age and VFA in the females (0.87 [95% CI, 0.83-0.91] and 0.98 [95% CI, 0.97-0.99], respectively, P<0.05) were independently associated with detectable BAT. Conclusions/Significance Our data suggest that decreased amount of active BAT might be associated with accumulation of visceral fat content and unfavorable metabolic outcomes.	[Wang, Qidi; Xu, Min; Gu, Weiqiong; Wang, Weiqing] Shanghai Jiao Tong Univ, Rui Jin Hosp, Shanghai Key Lab Endocrine Tumors, Sch Med, Shanghai 200030, Peoples R China; [Wang, Qidi; Xu, Min; Gu, Weiqiong; Wang, Weiqing] Shanghai Jiao Tong Univ, Rui Jin Hosp, Shanghai Clin Ctr Endocrine & Metab Dis, Dept Endocrine & Metab Dis,Sch Med, Shanghai 200030, Peoples R China; [Zhang, Min; Xi, Yun; Li, Biao] Shanghai Jiao Tong Univ, Rui Jin Hosp, Dept Nucl Med, Sch Med, Shanghai 200030, Peoples R China; [Qi, Lu] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Harvard University; Harvard T.H. Chan School of Public Health	Wang, WQ (corresponding author), Shanghai Jiao Tong Univ, Rui Jin Hosp, Shanghai Key Lab Endocrine Tumors, Sch Med, Shanghai 200030, Peoples R China.	wqingw@hotmail.com		Zhang, Min/0000-0001-5812-9518	National Natural Science Foundation of China [81370875]; National Leading Clinical Discipline Project (Medical Imaging); Discipline Leaders Climbing Project of Ruijin Hosptial	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Leading Clinical Discipline Project (Medical Imaging); Discipline Leaders Climbing Project of Ruijin Hosptial	This study was supported by grants from the National Natural Science Foundation of China (No. 81370875), National Leading Clinical Discipline Project (Medical Imaging) and Discipline Leaders Climbing Project of Ruijin Hosptial. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, VOLUME VIEWER 2 USER, V2, P399; Au-Yong ITH, 2009, DIABETES, V58, P2583, DOI 10.2337/db09-0833; Bakker LEH, 2014, LANCET DIABETES ENDO, V2, P210, DOI 10.1016/S2213-8587(13)70156-6; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Boyko EJ, 2000, DIABETES CARE, V23, P465, DOI 10.2337/diacare.23.4.465; Bray GA, 2006, J MED CHEM, V49, P4001, DOI 10.1021/jm0680124; Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; COPPACK SW, 1994, J LIPID RES, V35, P177; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; DESPRES JP, 1988, J CLIN EPIDEMIOL, V41, P889, DOI 10.1016/0895-4356(88)90106-0; DONAHUE RP, 1987, LANCET, V2, P1215; DULLOO AG, 1984, CAN J PHYSIOL PHARM, V62, P235, DOI 10.1139/y84-035; Espeland MA, 1997, J CLIN ENDOCR METAB, V82, P1549, DOI 10.1210/jc.82.5.1549; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; HAARBO J, 1991, METABOLISM, V40, P1323, DOI 10.1016/0026-0495(91)90037-W; Hamann A, 1996, ENDOCRINOLOGY, V137, P21, DOI 10.1210/en.137.1.21; Hany TF, 2002, EUR J NUCL MED MOL I, V29, P1393, DOI 10.1007/s00259-002-0902-6; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Kanaya AM, 2004, DIABETES CARE, V27, P1375, DOI 10.2337/diacare.27.6.1375; Kontani Y, 2005, AGING CELL, V4, P147, DOI 10.1111/j.1474-9726.2005.00157.x; Kozak LP, 2010, CELL METAB, V11, P263, DOI 10.1016/j.cmet.2010.03.009; LARSSON B, 1984, BRIT MED J, V288, P1401, DOI 10.1136/bmj.288.6428.1401; Lee P, 2014, DIABETES, V63, P3686, DOI 10.2337/db14-0513; Lee P, 2010, AM J PHYSIOL-ENDOC M, V299, pE601, DOI 10.1152/ajpendo.00298.2010; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; de Morentin PBM, 2014, CELL METAB, V20, P41, DOI 10.1016/j.cmet.2014.03.031; Matsushita M, 2014, INT J OBESITY, V38, P812, DOI 10.1038/ijo.2013.206; Nakayama K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074720; Nedergaard J, 2010, ANN NY ACAD SCI, V1212, pE20, DOI 10.1111/j.1749-6632.2010.05905.x; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Spiegelman BM, 2013, DIABETES, V62, P1774, DOI 10.2337/db12-1665; Stefan N, 2009, NEW ENGL J MED, V361, P416; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang QD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021006, 10.1371/journal.pone.0028114]; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yoneshiro T, 2015, ANN MED, V47, P133, DOI 10.3109/07853890.2014.911595; Yoneshiro T, 2011, OBESITY, V19, P1755, DOI 10.1038/oby.2011.125; Yoshizumi T, 1999, RADIOLOGY, V211, P283, DOI 10.1148/radiology.211.1.r99ap15283; Zhang QY, 2013, WIEN KLIN WOCHENSCHR, V125, P687, DOI 10.1007/s00508-013-0431-2; Zhang ZY, 2014, EUR J ENDOCRINOL, V170, P359, DOI 10.1530/EJE-13-0712; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546; Zukotynski KA, 2010, EUR J NUCL MED MOL I, V37, P1854, DOI 10.1007/s00259-010-1485-2	50	77	79	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123795	10.1371/journal.pone.0123795	http://dx.doi.org/10.1371/journal.pone.0123795			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894250	Green Published, gold, Green Submitted			2022-12-26	WOS:000353211700058
J	Brown, RE; Ghannoum, MA; Mukherjee, PK; Gillevet, PM; Sikaroodi, M				Brown, Robert E.; Ghannoum, Mahmoud A.; Mukherjee, Pranab K.; Gillevet, Patrick M.; Sikaroodi, Masoumeh			Quorum-Sensing Dysbiotic Shifts in the HIV-Infected Oral Metabiome	PLOS ONE			English	Article							NETWORKS; BIOFILMS	We implemented a Systems Biology approach using Correlation Difference Probability Network (CDPN) analysis to provide insights into the statistically significant functional differences between HIV-infected patients and uninfected individuals. The analysis correlates bacterial microbiome ("bacteriome"), fungal microbiome ("mycobiome"), and metabolome data to model the underlying biological processes comprising the Human Oral Metabiome. CDPN highlights the taxa-metabolite-taxa differences between the cohorts that frequently capture quorum-sensing modifications that reflect communication disruptions in the dysbiotic HIV cohort. The results also highlight the significant role of cyclic mono and dipeptides as quorum-sensing (QS) mediators between oral bacteria and fungal genus. The developed CDPN approach allowed us to model the interactions of taxa and key metabolites, and hypothesize their possible contribution to the etiology of Oral Candidiasis (OC).	[Brown, Robert E.] George Mason Univ, Sch Syst Biol, Fairfax, VA 22030 USA; [Ghannoum, Mahmoud A.; Mukherjee, Pranab K.] Case Western Reserve Univ, Ctr Med Mycol, Cleveland, OH 44106 USA; [Ghannoum, Mahmoud A.; Mukherjee, Pranab K.] Univ Hosp Cleveland, Case Med Ctr, Cleveland, OH 44106 USA; [Gillevet, Patrick M.; Sikaroodi, Masoumeh] George Mason Univ, Dept Environm Sci & Policy, Microbiome Anal Ctr, Fairfax, VA 22030 USA	George Mason University; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; George Mason University	Brown, RE (corresponding author), George Mason Univ, Sch Syst Biol, Fairfax, VA 22030 USA.	RBrownF@gmu.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036219] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Atkinson S, 2009, J R SOC INTERFACE, V6, P959, DOI 10.1098/rsif.2009.0203; Campbell J, 2009, ACS CHEM BIOL, V4, P1051, DOI 10.1021/cb900165y; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; Filoche SK, 2007, ORAL MICROBIOL IMMUN, V22, P73, DOI 10.1111/j.1399-302X.2007.00323.x; Ghannoum M. A., 2011, PLOS PATHOLOGY; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Han TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071364; Henrik Christensen MFB, 2011, CLASSIFICATION PASTE; Jang WS, 2010, MOL MICROBIOL, V77, P354, DOI 10.1111/j.1365-2958.2010.07210.x; Kapfhammer D, 2005, APPL ENVIRON MICROB, V71, P3840, DOI 10.1128/AEM.71.7.3840-3847.2005; Meyer HW, 2005, INDOOR AIR, V15, P73, DOI 10.1111/j.1600-0668.2005.00351.x; Morgenthal K, 2006, BIOSYSTEMS, V83, P108, DOI 10.1016/j.biosystems.2005.05.017; Mukherjee PK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003996; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shiboski CH, 2002, ORAL DIS, V8, P44, DOI 10.1034/j.1601-0825.2002.00011.x; Shiboski CH, 2001, J ADOLESCENT HEALTH, V29, P109, DOI 10.1016/S1054-139X(01)00280-4; Somers E, 2005, APPL ENVIRON MICROB, V71, P1803, DOI 10.1128/AEM.71.4.1803-1810.2005; Thompson GR, 2010, ORAL SURG ORAL MED O, V109, P488, DOI 10.1016/j.tripleo.2009.11.026; Toivari M, 2012, METAB ENG, V14, P427, DOI 10.1016/j.ymben.2012.03.002; Yarwood JM, 2004, J BACTERIOL, V186, P1838, DOI 10.1128/JB.186.6.1838-1850.2004	20	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123880	10.1371/journal.pone.0123880	http://dx.doi.org/10.1371/journal.pone.0123880			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886290	Green Submitted, Green Published, gold			2022-12-26	WOS:000353017000091
J	Datta, S; Mukhopadhyay, S				Datta, Sutapa; Mukhopadhyay, Subhasis			A Grammar Inference Approach for Predicting Kinase Specific Phosphorylation Sites	PLOS ONE			English	Article							CONTEXT-FREE GRAMMARS; PROTEIN SEQUENCES; RNA; LANGUAGE; MODEL; TOOL; GPS; DESIGN; SERVER	Kinase mediated phosphorylation site detection is the key mechanism of post translational mechanism that plays an important role in regulating various cellular processes and phenotypes. Many diseases, like cancer are related with the signaling defects which are associated with protein phosphorylation. Characterizing the protein kinases and their substrates enhances our ability to understand the mechanism of protein phosphorylation and extends our knowledge of signaling network; thereby helping us to treat such diseases. Experimental methods for predicting phosphorylation sites are labour intensive and expensive. Also, manifold increase of protein sequences in the databanks over the years necessitates the improvement of high speed and accurate computational methods for predicting phosphorylation sites in protein sequences. Till date, a number of computational methods have been proposed by various researchers in predicting phosphorylation sites, but there remains much scope of improvement. In this communication, we present a simple and novel method based on Grammatical Inference (GI) approach to automate the prediction of kinase specific phosphorylation sites. In this regard, we have used a popular GI algorithm Alergia to infer Deterministic Stochastic Finite State Automata (DSFA) which equally represents the regular grammar corresponding to the phosphorylation sites. Extensive experiments on several datasets generated by us reveal that, our inferred grammar successfully predicts phosphorylation sites in a kinase specific manner. It performs significantly better when compared with the other existing phosphorylation site prediction methods. We have also compared our inferred DSFA with two other GI inference algorithms. The DSFA generated by our method performs superior which indicates that our method is robust and has a potential for predicting the phosphorylation sites in a kinase specific manner.	[Datta, Sutapa] Univ Calcutta, Dept Biophys Mol Biol & Bioinformat, Kolkata, W Bengal, India; Univ Calcutta, Distributed Informat Ctr Bioinformat, Kolkata, W Bengal, India	University of Calcutta; University of Calcutta	Datta, S (corresponding author), Univ Calcutta, Dept Biophys Mol Biol & Bioinformat, Kolkata, W Bengal, India.	sutapadatta2005@gmail.com			Department of Biotechnology, India [BT/BI/04/026/93, BT/BI/010/019/99]	Department of Biotechnology, India(Department of Biotechnology (DBT) India)	This work was supported by BT/BI/04/026/93 and BT/BI/010/019/99, Department of Biotechnology, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Cai Y, 2007, BIOINFORMATICS, V23, P2760, DOI 10.1093/bioinformatics/btm446; Carrasco R. C., 1994, GRAMMATICAL INFERENC, V862, P139; Chen YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020025; COLLADOVIDES J, 1992, P NATL ACAD SCI USA, V89, P9405, DOI 10.1073/pnas.89.20.9405; Datta S, 2014, INT J NANOMED, V9, P2225, DOI 10.2147/IJN.S57526; Datta S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054843; Dinkel H, 2011, NUCLEIC ACIDS RES, V39, pD261, DOI 10.1093/nar/gkq1104; Dupont P., 1994, Grammatical Inference and Applications. Second International Colloquium, ICGI-94 Proceedings, P25; Dupont P., 1996, Grammatical Inference: Learning Syntax from Sentences. Third International Colloquium, ICGI-96 Proceedings, P222, DOI 10.1007/BFb0033357; Dyrka W, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-323; Gao JJ, 2010, MOL CELL PROTEOMICS, V9, P2586, DOI 10.1074/mcp.M110.001388; Horn H, 2014, NAT METHODS, V11, P603, DOI 10.1038/nmeth.2968; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pW226, DOI 10.1093/nar/gki471; Jung I, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S10; Knudsen B, 2003, NUCLEIC ACIDS RES, V31, P3423, DOI 10.1093/nar/gkg614; Knudsen B, 1999, BIOINFORMATICS, V15, P446, DOI 10.1093/bioinformatics/15.6.446; Kobayashi K, 2003, J NEUROL SCI, V208, P17, DOI 10.1016/S0022-510X(02)00410-0; Lee TY, 2011, NUCLEIC ACIDS RES, V39, pD777, DOI 10.1093/nar/gkq970; Leung SW, 2001, BIOINFORMATICS, V17, P226, DOI 10.1093/bioinformatics/17.3.226; LI L, 2003, P NATL ACAD SCI USA, V100, P4463, DOI DOI 10.1073/PNAS.0737647100; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Loose C, 2006, NATURE, V443, P867, DOI 10.1038/nature05233; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MATTHEWS HR, 1995, PHARMACOL THERAPEUT, V67, P323, DOI 10.1016/0163-7258(95)00020-8; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; ONCINA J, 1992, S MACH PERC, V1, P49; Peris P, 2006, LECT NOTES ARTIF INT, V4201, P175; Peris P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-367; Pinna LA, 1996, BBA-MOL CELL RES, V1314, P191, DOI 10.1016/S0167-4889(96)00083-3; Plewczynski D, 2008, J MOL MODEL, V14, P69, DOI 10.1007/s00894-007-0250-3; Plewczynski D, 2012, AMINO ACIDS, V43, P573, DOI 10.1007/s00726-012-1290-2; Rivas E, 2000, BIOINFORMATICS, V16, P334, DOI 10.1093/bioinformatics/16.4.334; Sakakibara Y, 2005, IEEE T PATTERN ANAL, V27, P1051, DOI 10.1109/TPAMI.2005.140; SAKAKIBARA Y, 1994, NUCLEIC ACIDS RES, V22, P5112, DOI 10.1093/nar/22.23.5112; Salway J.G., 2017, METABOLISM GLANCE; Searls DB, 1997, COMPUT APPL BIOSCI, V13, P333; Searls DB, 2002, NATURE, V420, P211, DOI 10.1038/nature01255; Su MG, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S16-S2; Suo SB, 2014, SCI REP-UK, V4, DOI 10.1038/srep04524; Trost B, 2011, BIOINFORMATICS, V27, P2927, DOI 10.1093/bioinformatics/btr525; Tsafnat G, 2011, BIOINFORMATICS, V27, P791, DOI 10.1093/bioinformatics/btr036; Wan J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm848; Xue Y, 2005, NUCLEIC ACIDS RES, V33, pW184, DOI 10.1093/nar/gki393; Xue Y, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-163; Xue YK, 2010, CLIM DYNAM, V35, P1, DOI 10.1007/s00382-010-0831-1; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yu ZW, 2010, IEEE T NANOBIOSCI, V9, P132, DOI 10.1109/TNB.2010.2043682; Zhou FF, 2004, BIOCHEM BIOPH RES CO, V325, P1443, DOI 10.1016/j.bbrc.2004.11.001	49	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0122294	10.1371/journal.pone.0122294	http://dx.doi.org/10.1371/journal.pone.0122294			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886273	gold, Green Published, Green Submitted			2022-12-26	WOS:000353017000031
J	Wang, TD; Yang, S; Wang, L; Feng, HL				Wang, Tianda; Yang, Sheng; Wang, Lei; Feng, Hailan			Use of Poly (Amidoamine) Dendrimer for Dentinal Tubule Occlusion: A Preliminary Study	PLOS ONE			English	Article							CALCIUM-PHOSPHATE PRECIPITATION; PAMAM DENDRIMERS; AMMONIUM HEXAFLUOROSILICATE; CARBONATED APATITE; IN-VITRO; HYDROXYAPATITE; SURFACE; FLUORIDE; OXALATE; SEM	The occlusion of dentinal tubules is an effective method to alleviate the symptoms caused by dentin hypersensitivity, a significant health problem in dentistry and daily life. The in situ mineralization within dentinal tubules is a promising treatment for dentin hypersensitivity as it induces the formation of mineral on the sensitive regions and occludes the dentinal tubules. This study was carried out to evaluate the in vitro effect of a whole generation poly (amidoamine) (PAMAM) dendrimer (G3.0) on dentinal tubule occlusion by inducing mineralization within dentinal tubules. Dentin discs were treated with PAMAM dendrimers using two methods, followed by the in vitro characterization using Attenuated total reflection Fourier-transform infrared spectroscopy (ATR-FTIR), X-ray diffraction (XRD), Field emission scanning electron microscopy (FE-SEM) and Energy-Dispersive X-ray Spectroscopy (EDS). These results showed that G3.0 PAMAM dendrimers coated on dentin surface and infiltrated in dentinal tubules could induce hydroxyapatite formation and resulted in effective dentinal tubule occlusion. Moreover, crosslinked PAMAM dendrimers could induce the remineralization of demineralized dentin and thus had the potential in dentinal tubule occlusion. In this in vitro study, dentinal tubules occlusion could be achieved by using PAMAM dendrimers. This could lead to the development of a new therapeutic technique for the treatment of dentin hypersensitivity.	[Wang, Tianda; Yang, Sheng; Wang, Lei; Feng, Hailan] Peking Univ, Dept Prosthodont, Sch & Hosp Stomatol, Beijing 100871, Peoples R China; [Yang, Sheng] Chongqing Med Univ, Coll Stomatol, Chongqing Key Lab Oral Dis & Biomed Sci, Chongqing, Peoples R China	Peking University; Chongqing Medical University	Feng, HL (corresponding author), Peking Univ, Dept Prosthodont, Sch & Hosp Stomatol, Beijing 100871, Peoples R China.	Kqfenghl@bjmu.edu.cn	Wang, Tianda/AAV-9811-2020		Specialized Research Fund for the Doctoral Program of Higher Education of China [20100001110092]	Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was supported by the Specialized Research Fund for the Doctoral Program of Higher Education of China (No. 20100001110092). [http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedran-Russo AKB, 2007, J BIOMED MATER RES B, V80B, P268, DOI 10.1002/jbm.b.30593; BRANNSTR.M, 1968, J DENT RES, V47, P679, DOI 10.1177/00220345680470050201; BRANNSTROM M, 1966, ORAL SURG ORAL MED O, V21, P517, DOI 10.1016/0030-4220(66)90411-7; Canadian Advisory Board on Dentin Hypersensitivity, 2002, J CAN DENT ASSOC, V69, P221; Chang MC, 2002, BIOMATERIALS, V23, P4811, DOI 10.1016/S0142-9612(02)00232-6; Chiang YC, 2010, J DENT RES, V89, P236, DOI 10.1177/0022034509357148; Damen JJM, 1998, CARIES RES, V32, P435, DOI 10.1159/000016484; Davies M, 2011, EUR J ORAL SCI, V119, P497, DOI 10.1111/j.1600-0722.2011.00872.x; Duncan R, 2005, ADV DRUG DELIVER REV, V57, P2215, DOI 10.1016/j.addr.2005.09.019; Esfand R, 2001, DRUG DISCOV TODAY, V6, P427, DOI 10.1016/S1359-6446(01)01757-3; Gillam DG, 2004, J ORAL REHABIL, V31, P245, DOI 10.1046/j.0305-182X.2003.01230.x; Gillam DG, 2001, J ORAL REHABIL, V28, P1037, DOI 10.1046/j.1365-2842.2001.00775.x; GOLDBERG M, 1993, HISTOCHEM J, V25, P781; Grossman LI, 1935, J AM DENT ASSOC, V22, P592, DOI [DOI 10.14219/JADA.ARCHIVE.1935.0110, 10.14219/jada.archive.1935.0110]; Habelitz S, 2002, J STRUCT BIOL, V138, P227, DOI 10.1016/S1047-8477(02)00029-1; He G, 2005, J BIOL CHEM, V280, P33109, DOI 10.1074/jbc.M500159200; ISHIKAWA K, 1994, J DENT RES, V73, P1197, DOI 10.1177/00220345940730061101; Kim YK, 2010, J DENT RES, V89, P230, DOI 10.1177/0022034509357172; Kolker Justine L, 2002, J Adhes Dent, V4, P211; Liu Y, 2011, J DENT RES, V90, P953, DOI 10.1177/0022034510391799; Liu Y, 2011, ACTA BIOMATER, V7, P1742, DOI 10.1016/j.actbio.2010.11.028; Lynch E, 2012, DENT MATER, V28, P168, DOI 10.1016/j.dental.2011.11.021; Markowitz K, 2007, J DENT RES, V86, P292, DOI 10.1177/154405910708600401; Mitra T, 2014, J CHEM SCI, V126, P127, DOI 10.1007/s12039-013-0543-2; Morris MF, 1999, AM J DENT, V12, P72; Nancollas GH, 2000, J CRYST GROWTH, V211, P137, DOI 10.1016/S0022-0248(99)00816-7; Niederberger M, 2006, PHYS CHEM CHEM PHYS, V8, P3271, DOI 10.1039/b604589h; Orchardson R, 2006, J AM DENT ASSOC, V137, P990, DOI 10.14219/jada.archive.2006.0321; Pereira JC, 2005, DENT MATER, V21, P129, DOI 10.1016/j.dental.2004.02.007; Pillon FL, 2004, J PERIODONTOL, V75, P1461, DOI 10.1902/jop.2004.75.11.1461; Qia YP, 2012, ACTA BIOMATER, V8, P836, DOI 10.1016/j.actbio.2011.10.033; Rehman I, 1997, J MATER SCI-MATER M, V8, P1, DOI 10.1023/A:1018570213546; Sevenson S, 2012, ADV DRUG DELIVER REV, V64, P102, DOI 10.1016/j.addr.2012.09.030; Shetty S, 2010, J PERIODONTOL, V81, P1781, DOI 10.1902/jop.2010.100172; Suge T, 1995, J DENT RES, V74, P1709, DOI 10.1177/00220345950740101301; SUGE T, 1995, J DENT RES, V74, P1079, DOI 10.1177/00220345950740040801; Suge T, 2008, DENT MATER, V24, P192, DOI 10.1016/j.dental.2007.03.009; Suge T, 2006, AM J DENT, V19, P248; Tanahashi M, 1997, J BIOMED MATER RES, V34, P305; Tay FR, 2008, BIOMATERIALS, V29, P1127, DOI 10.1016/j.biomaterials.2007.11.001; Tian LL, 2014, DENT MATER J, V33, P125, DOI 10.4012/dmj.2013-215; Tirapelli Camila, 2010, Braz. oral res., V24, P381, DOI 10.1590/S1806-83242010000400002; Tomalia DA, 2005, PROG POLYM SCI, V30, P294, DOI 10.1016/j.progpolymsci.2005.01.007; Toworfe GK, 2006, BIOMATERIALS, V27, P631, DOI 10.1016/j.biomaterials.2005.06.017; Wang RZ, 1998, CONNECT TISSUE RES, V39, P269, DOI 10.3109/03008209809021502; Wang TD, 2015, RSC ADV, V5, P11136, DOI 10.1039/c4ra14744h; Wang ZJ, 2010, J DENT, V38, P400, DOI 10.1016/j.jdent.2010.01.007; Wenk HR, 1999, BONE, V24, P361, DOI 10.1016/S8756-3282(98)00192-6; Wong Tak-Sing, 2009, Molecular & Cellular Biomechanics, V6, P1; Xie LB, 2011, POLYM BULL, V66, P119, DOI 10.1007/s00289-010-0350-6; Xu Z, 2011, J BIOMED MATER RES B, V98B, P150, DOI 10.1002/jbm.b.31844; Yan SJ, MAT CHEM, V2; Yang S, 2011, CHEM COMMUN, V47, P10100, DOI 10.1039/c1cc13661e; Zhang Q, 2013, ACS APPL MATER INTER, V5, P1907, DOI 10.1021/am400155b; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874; Zhang X, 2012, J MATER SCI-MATER M, V23, P733, DOI 10.1007/s10856-012-4550-5; Zhou ZH, 2007, MATER RES BULL, V42, P1611, DOI 10.1016/j.materresbull.2006.11.041	57	6	8	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124735	10.1371/journal.pone.0124735	http://dx.doi.org/10.1371/journal.pone.0124735			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885090	gold, Green Submitted, Green Published			2022-12-26	WOS:000353017000143
J	Lin, WC; Chang, WT; Chang, TY; Shin, JW				Lin, Wei-Chen; Chang, Wei-Ting; Chang, Tsuey-Yu; Shin, Jyh-Wei			The Pathogenesis of Human Cervical Epithelium Cells Induced by Interacting with Trichomonas vaginalis	PLOS ONE			English	Article							NF-KAPPA-B; ENTAMOEBA-HISTOLYTICA; TRITRICHOMONAS-FETUS; SECRETORY PRODUCTS; IL-8 PRODUCTION; INFECTION; NEUTROPHILS; INTERLEUKIN-8; EXPRESSION; CYTOTOXICITY	Background Trichomonas vaginalis is a protozoan parasite that occurs in the urogenital-vaginal tract and is the primary causative agent of trichomoniasis, a common sexually transmitted disease in humans. The aggregation of this protozoan tends to destroy epithelial cells and induce pathogenesis. Principal Findings This study cultured T. vaginalis and human cervical epithelial cells (Z172) under the same conditions in the experiments. Following co-culturing for ten hours, the protozoans became attached to Z172, such that the cells presented a round shape and underwent shrinkage. Time-lapse recording and flow cytometry on interacted Z172 revealed that 70% had been disrupted, 18% presented a necrosis-like morphology and 8% showed signs of apoptosis. Gene expression profiling revealed in the seven inflammatory Z172 genes as well as in T. vaginalis genes that code for adhesion proteins 65 and 65-1. Significance These results suggest that cytopathogenic effects progress while Z172 is in contact with T. vaginalis, and the resulting morphological changes can be categorized as disruption.	[Lin, Wei-Chen; Chang, Wei-Ting; Chang, Tsuey-Yu; Shin, Jyh-Wei] Natl Cheng Kung Univ, Dept Parasitol, Tainan 70101, Taiwan	National Cheng Kung University	Shin, JW (corresponding author), Natl Cheng Kung Univ, Dept Parasitol, Tainan 70101, Taiwan.	hippo@mail.ncku.edu.tw	Shin, Jerry/AAO-2515-2021; Lin, Wei-Chen/Y-6149-2019	Lin, Wei-Chen/0000-0001-7223-5931	Ministry of Education, Taiwan, R. O. C.	Ministry of Education, Taiwan, R. O. C.(Ministry of Education, Taiwan)	This research was supported by the Ministry of Education, Taiwan, R. O. C. The Aim for the Top University Project to the National Cheng Kung University (NCKU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira Shizuo, 2002, Arerugi, V51, P352; Al-Sadi RM, 2007, J IMMUNOL, V178, P4641, DOI 10.4049/jimmunol.178.7.4641; Alvarez-Sanchez ME, 2000, MICROB PATHOGENESIS, V28, P193, DOI 10.1006/mpat.1999.0336; ARROYO R, 1992, MOL MICROBIOL, V6, P853, DOI 10.1111/j.1365-2958.1992.tb01536.x; BENCHIMOL M, 1990, J SUBMICR CYTOL PATH, V22, P39; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Crouch ML, 1999, MICROBIOL-SGM, V145, P2835, DOI 10.1099/00221287-145-10-2835; Danesh Irving S., 1995, Journal of Emergency Medicine, V13, P51, DOI 10.1016/0736-4679(94)00112-X; DIAMOND LS, 1995, J EUKARYOT MICROBIOL, V42, P277, DOI 10.1111/j.1550-7408.1995.tb01579.x; ECKMANN L, 1995, J CLIN INVEST, V96, P1269, DOI 10.1172/JCI118161; Fichorova RN, 2006, INFECT IMMUN, V74, P5773, DOI 10.1128/IAI.00631-06; Fiori PL, 1997, INFECT IMMUN, V65, P5142, DOI 10.1128/IAI.65.12.5142-5148.1997; Fiori PL, 1996, MICROB PATHOGENESIS, V20, P109, DOI 10.1006/mpat.1996.0010; Garcia AF, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-116; Guenthner PC, 2005, INFECT IMMUN, V73, P4155, DOI 10.1128/IAI.73.7.4155-4160.2005; Hardwick JCH, 2004, GASTROENTEROLOGY, V126, P111, DOI 10.1053/j.gastro.2003.10.067; HEATH JP, 1981, BRIT J VENER DIS, V57, P106; Kerekes A, 2000, Orv Hetil, V141, P1821; Koch S, 2009, ANN NY ACAD SCI, V1165, P220, DOI 10.1111/j.1749-6632.2009.04025.x; KRIEGER JN, 1985, INFECT IMMUN, V50, P778, DOI 10.1128/IAI.50.3.778-786.1985; Kucknoor A, 2005, CELL MICROBIOL, V7, P887, DOI 10.1111/j.1462-5822.2005.00522.x; Kucknoor AS, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-5; Kucknoor AS, 2005, INFECT IMMUN, V73, P6472, DOI 10.1128/IAI.73.10.6472-6478.2005; Kucknoor AS, 2007, CELL MICROBIOL, V9, P2586, DOI 10.1111/j.1462-5822.2007.00979.x; Lin WC, 2009, GENOMICS, V93, P487, DOI 10.1016/j.ygeno.2009.01.004; Lustig G, 2013, INFECT IMMUN, V81, P1411, DOI 10.1128/IAI.01244-12; Madico G, 1998, J CLIN MICROBIOL, V36, P3205, DOI 10.1128/JCM.36.11.3205-3210.1998; Mason PR, 2005, EPIDEMIOL INFECT, V133, P315, DOI 10.1017/S0950268804003127; Mavedzenge SN, 2010, SEX TRANSM DIS, V37, P460, DOI 10.1097/OLQ.0b013e3181cfcc4b; McClelland RS, 2007, J INFECT DIS, V195, P698, DOI 10.1086/511278; Nam YH, 2011, MICROBES INFECT, V13, P1211, DOI 10.1016/j.micinf.2011.07.006; Okumura CYM, 2008, CELL MICROBIOL, V10, P2078, DOI 10.1111/j.1462-5822.2008.01190.x; Ong SJ, 2006, EUKARYOT CELL, V5, P391, DOI 10.1128/EC.5.2.391-399.2006; PINDAK FF, 1993, GENITOURIN MED, V69, P35; Ryu JS, 2004, INFECT IMMUN, V72, P1326, DOI 10.1128/IAI.72.3.1326-1332.2004; Schwebke JR, 2004, CLIN MICROBIOL REV, V17, P794, DOI 10.1128/CMR.17.4.794-803.2004; SHAIO MF, 1994, J INFECT DIS, V170, P1638, DOI 10.1093/infdis/170.6.1638; SHAIO MF, 1992, INFECT IMMUN, V60, P4475, DOI 10.1128/IAI.60.11.4475-4482.1992; SHAIO MF, 1995, PARASITE IMMUNOL, V17, P127, DOI 10.1111/j.1365-3024.1995.tb01014.x; SHAIO MF, 1995, INFECT IMMUN, V63, P3864, DOI 10.1128/IAI.63.10.3864-3870.1995; Silva FCE, 1998, EXP PARASITOL, V88, P240, DOI 10.1006/expr.1998.4227; Trintis J, 2010, INT J STD AIDS, V21, P606, DOI 10.1258/ijsa.2010.010174; Twu O, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003482; Van Der Pol B, 2008, J INFECT DIS, V197, P548, DOI 10.1086/526496; Nam YH, 2011, KOREAN J PARASITOL, V49, P291, DOI 10.3347/kjp.2011.49.3.291	45	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124087	10.1371/journal.pone.0124087	http://dx.doi.org/10.1371/journal.pone.0124087			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901354	gold, Green Submitted, Green Published			2022-12-26	WOS:000353331500076
J	Trombley, MP; Post, DMB; Rinker, SD; Reinders, LM; Fortney, KR; Zwickl, BW; Janowicz, DM; Baye, FM; Katz, BP; Spinola, SM; Bauer, ME				Trombley, Michael P.; Post, Deborah M. B.; Rinker, Sherri D.; Reinders, Lorri M.; Fortney, Kate R.; Zwickl, Beth W.; Janowicz, Diane M.; Baye, Fitsum M.; Katz, Barry P.; Spinola, Stanley M.; Bauer, Margaret E.			Phosphoethanolamine Transferase LptA in Haemophilus ducreyi Modifies Lipid A and Contributes to Human Defensin Resistance In Vitro	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; NEISSERIA-GONORRHOEAE; CATHELICIDIN RESISTANCE; PERIPLASMIC GLUCANS; SERUM RESISTANCE; HUMAN-MODEL; LIPOPOLYSACCHARIDE; IDENTIFICATION; INFECTION; DELETION	Haemophilus ducreyi resists the cytotoxic effects of human antimicrobial peptides (APs), including alpha-defensins, beta-defensins, and the cathelicidin LL-37. Resistance to LL-37, mediated by the sensitive to antimicrobial peptide (Sap) transporter, is required for H. ducreyi virulence in humans. Cationic APs are attracted to the negatively charged bacterial cell surface. In other gram-negative bacteria, modification of lipopolysaccharide or lipooligosaccharide (LOS) by the addition of positively charged moieties, such as phosphoethanolamine (PEA), confers AP resistance by means of electrostatic repulsion. H. ducreyi LOS has PEA modifications at two sites, and we identified three genes (lptA, ptdA, and ptdB) in H. ducreyi with homology to a family of bacterial PEA transferases. We generated non-polar, unmarked mutants with deletions in one, two, or all three putative PEA transferase genes. The triple mutant was significantly more susceptible to both alpha-and beta-defensins; complementation of all three genes restored parental levels of AP resistance. Deletion of all three PEA transferase genes also resulted in a significant increase in the negativity of the mutant cell surface. Mass spectrometric analysis revealed that LptA was required for PEA modification of lipid A; PtdA and PtdB did not affect PEA modification of LOS. In human inoculation experiments, the triple mutant was as virulent as its parent strain. While this is the first identified mechanism of resistance to alpha-defensins in H. ducreyi, our in vivo data suggest that resistance to cathelicidin LL-37 may be more important than defensin resistance to H. ducreyi pathogenesis.	[Trombley, Michael P.; Rinker, Sherri D.; Fortney, Kate R.; Spinola, Stanley M.; Bauer, Margaret E.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Post, Deborah M. B.; Reinders, Lorri M.] Buck Inst Res Aging, Novato, CA USA; [Zwickl, Beth W.; Janowicz, Diane M.; Spinola, Stanley M.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Baye, Fitsum M.; Katz, Barry P.] Indiana Univ Sch Med, Dept Biostat, Indianapolis, IN 46202 USA; [Baye, Fitsum M.; Katz, Barry P.] Richard M Fairbanks Sch Publ Hlth, Dept Biostat, Indianapolis, IN USA; [Spinola, Stanley M.] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Spinola, Stanley M.] Indiana Univ Sch Med, Ctr Immunobiol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Buck Institute for Research on Aging; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Bauer, ME (corresponding author), Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.	mebauer@iupui.edu			Public Health Service [R21 AI096056]; National Institutes of Health; Indiana University-Purdue University at Indianapolis; Research Support Funds Grant; National Institutes of Health [R01 AI024616, 1S10RR029446, R01 AI027863, UL RR052761]; Indiana Clinical and Translational Sciences Institute; Indiana Clinical Research Center; Indiana University Immunology and Infectious Disease Training Program, National Institutes of Health [T32 AI060519]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002529, UL1TR001108] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI027863, R21AI096056, R01AI024616, T32AI060519] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana University-Purdue University at Indianapolis; Research Support Funds Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana Clinical and Translational Sciences Institute; Indiana Clinical Research Center; Indiana University Immunology and Infectious Disease Training Program, National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grant R21 AI096056 (to M.E.B.) from the National Institutes of Health (www.nih.gov) and an Indiana University-Purdue University at Indianapolis (www.iupui.edu) Research Support Funds Grant (to M.E.B.). Work by D.M.P and L.M.R. was supported by National Institutes of Health (www.nih.gov) grant R01 AI024616. Mass spectrometric instrumentation for this study was provided by the mass spectrometry core at the Buck Institute for Research on Aging (www.buckinstitute.org) and at the University of California-San Francisco (www.ucsf.edu) Sandler-Moore mass spectrometry core facility. The Waters Synapt mass spectrometer was purchased with funds from National Institutes of Health (www.nih.gov) shared instrumentation grant 1S10RR029446. The human challenge experiments were supported by National Institutes of Health (www.nih.gov) grant R01 AI027863 (to S.M.S.), the Indiana Clinical and Translational Sciences Institute (www.indianactsi.org), and the Indiana Clinical Research Center (www.indianactsi.org/programs/icrc), National Institutes of Health (www.nih.gov) grant UL RR052761. M.P.T. was supported by the Indiana University Immunology and Infectious Disease Training Program, National Institutes of Health (www.nih.gov) grant T32 AI060519. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas FE, 2006, J BIOL CHEM, V281, P27712, DOI 10.1074/jbc.M604324200; Al-Tawfiq JA, 2000, J INFECT DIS, V181, P1049, DOI 10.1086/315309; Al-Tawfiq JA, 1998, J INFECT DIS, V178, P1684, DOI 10.1086/314483; Al-Tawfiq JA, 1999, J INFECT DIS, V179, P1283, DOI 10.1086/314732; Al-Tawfiq JA, 2000, SEX TRANSM DIS, V27, P111, DOI 10.1097/00007435-200002000-00009; Allen S, 2005, INFECT IMMUN, V73, P5291, DOI 10.1128/IAI.73.9.5291-5300.2005; Annan Naa Torshie, 2005, Expert Rev Anti Infect Ther, V3, P295, DOI 10.1586/14787210.3.2.295; Apicella Michael A., 2008, V431, P3; Bauer ME, 2006, MICROBES INFECT, V8, P2465, DOI 10.1016/j.micinf.2006.06.001; Bauer ME, 2000, INFECT IMMUN, V68, P2309, DOI 10.1128/IAI.68.4.2309-2314.2000; Bauer ME, 2001, INFECT IMMUN, V69, P2549, DOI 10.1128/IAI.69.4.2549-2557.2001; Bohin JP, 2000, FEMS MICROBIOL LETT, V186, P11, DOI 10.1016/S0378-1097(00)00110-5; Bontemps-Gallo S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/371429; Bozue JA, 1998, FEMS MICROBIOL LETT, V164, P269, DOI 10.1111/j.1574-6968.1998.tb13097.x; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Cox AD, 2003, J BACTERIOL, V185, P3270, DOI 10.1128/JB.185.11.3270-3277.2003; Cullen TW, 2013, INFECT IMMUN, V81, P430, DOI 10.1128/IAI.01046-12; Cullen TW, 2012, J BIOL CHEM, V287, P3326, DOI 10.1074/jbc.M111.321737; Elkins C, 2000, INFECT IMMUN, V68, P1608, DOI 10.1128/IAI.68.3.1608-1619.2000; Gunn JS, 2001, J ENDOTOXIN RES, V7, P57, DOI 10.1177/09680519010070011001; Gunn JS, 1998, MOL MICROBIOL, V27, P1171, DOI 10.1046/j.1365-2958.1998.00757.x; Hiltke TJ, 1999, MICROB PATHOGENESIS, V26, P93, DOI 10.1006/mpat.1998.0250; Hobbs MM, 2013, MBIO, V4, DOI 10.1128/mBio.00892-13; Kim SH, 2006, MICROBIOL-SGM, V152, P657, DOI 10.1099/mic.0.28692-0; Kregiel D, 2012, J IND MICROBIOL BIOT, V39, P1881, DOI 10.1007/s10295-012-1193-y; Leduc I, 2004, INFECT IMMUN, V72, P3418, DOI 10.1128/IAI.72.6.3418-3428.2004; Lee H, 2004, J BACTERIOL, V186, P4124, DOI 10.1128/JB.186.13.4124-4133.2004; Lee S, 2009, BMB REP, V42, P769, DOI 10.5483/BMBRep.2009.42.12.769; Lewis LA, 2009, INFECT IMMUN, V77, P1112, DOI 10.1128/IAI.01280-08; Mackinnon FG, 2002, MOL MICROBIOL, V43, P931, DOI 10.1046/j.1365-2958.2002.02754.x; McBride WJH, 2008, AUSTRALAS J DERMATOL, V49, P98, DOI 10.1111/j.1440-0960.2008.00439.x; MELAUGH W, 1994, BIOCHEMISTRY-US, V33, P13070, DOI 10.1021/bi00248a016; Mitja O, 2014, LANCET GLOB HEALTH, V2, pE235, DOI 10.1016/S2214-109X(14)70019-1; Mount KLB, 2007, ANTIMICROB AGENTS CH, V51, P3391, DOI 10.1128/AAC.00473-07; Mount KLB, 2010, INFECT IMMUN, V78, P1176, DOI 10.1128/IAI.01014-09; Packiam M, 2014, INFECT IMMUN, V82, P2170, DOI 10.1128/IAI.01504-14; Post DAB, 2007, INFECT IMMUN, V75, P113, DOI 10.1128/IAI.01016-06; Reynolds CM, 2005, J BIOL CHEM, V280, P21202, DOI 10.1074/jbc.M500964200; Rinker SD, 2012, J INFECT DIS, V206, P1407, DOI 10.1093/infdis/jis525; Rinker SD, 2011, INFECT IMMUN, V79, P2324, DOI 10.1128/IAI.01316-10; Spinola SM, 2002, INFECT IMMUN, V70, P1667, DOI 10.1128/IAI.70.4.1667-1676.2002; SPINOLA SM, 1994, J INFECT DIS, V169, P1146, DOI 10.1093/infdis/169.5.1146; Spinola SM, 1996, J INFECT DIS, V173, P394, DOI 10.1093/infdis/173.2.394; Spinola SM, 2010, INFECT IMMUN, V78, P3898, DOI 10.1128/IAI.00432-10; Tamayo R, 2005, J BACTERIOL, V187, P3391, DOI 10.1128/JB.187.10.3391-3399.2005; Tracy E, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-101; TREES DL, 1995, CLIN MICROBIOL REV, V8, P357, DOI 10.1128/CMR.8.3.357; Tzeng YL, 2005, J BACTERIOL, V187, P5387, DOI 10.1128/JB.187.15.5387-5396.2005; Ussher JE, 2007, CLIN INFECT DIS, V44, pE85, DOI 10.1086/515404; vd Winkel J G, 1987, Nephrol Dial Transplant, V2, P280; Wood GE, 1999, INFECT IMMUN, V67, P3740, DOI 10.1128/IAI.67.8.3740-3749.1999	51	18	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124373	10.1371/journal.pone.0124373	http://dx.doi.org/10.1371/journal.pone.0124373			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902140	Green Published, gold, Green Submitted			2022-12-26	WOS:000353331500082
J	van Gurp, J; van Selm, M; Vissers, K; van Leeuwen, E; Hasselaar, J				van Gurp, Jelle; van Selm, Martine; Vissers, Kris; van Leeuwen, Evert; Hasselaar, Jeroen			How Outpatient Palliative Care Teleconsultation Facilitates Empathic Patient-Professional Relationships: A Qualitative Study	PLOS ONE			English	Article							CANCER-PATIENTS; MEDICALISATION; COMMUNICATION	Objective The problems and needs of advanced cancer patients and proxies normally increase as the disease progresses. Home-based advanced cancer patients and their proxies benefit from collaborations between primary care physicians and hospital-based palliative care specialists when confronted with complex problems in the last phase of life. Telemedicine might facilitate direct, patient-centered communication between patients and proxies, primary care physicians, and specialist palliative care teams (SPCTs). This study focuses on the impact of teleconsultation technologies on the relationships between home-based palliative care patients and hospital-based palliative care specialists. Methods This work consists of a qualitative study among patients, family members, and caregivers that utilizes long-term direct observations, semi-structured interviews, and open interviews following the observations. Results The analysis of the empirical data resulted in three key concepts that describe the impact of teleconsultation on the patient-professional relationship in palliative homecare: transcending the institutional walls of home and hospital; transparency of teleconsultation technology; and technologized, intimate patient-professional relationships. Teleconsultation offers (1) condensed encounters between home-based palliative care patients and distant professionals, (2) a unique insight into the patients' daily lives for palliative care specialists, and (3) long-term interaction that results in trustful relationships and experiences of intimacy and relief. Conclusions Teleconsultation fits the practice of home-based palliative care. Teleconsultation can, if well applied, facilitate computer-mediated but empathic patient-palliative care specialist relationships, which enable professional care attuned to the patient's context as well as patient involvement. This article proposes a teleconsultation implementation guide for optimal use of teleconsultation in daily palliative care practice.	[van Gurp, Jelle; Vissers, Kris; Hasselaar, Jeroen] Radboud Univ Nijmegen, Med Ctr, Dept Anesthesiol Pain & Palliat Med, NL-6525 ED Nijmegen, Netherlands; [van Selm, Martine] Univ Amsterdam, Amsterdam Sch Commun Res, Amsterdam, Netherlands; [van Leeuwen, Evert] Radboud Univ Nijmegen, Med Ctr, Dept IQ Healthcare Ethics Sect, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; University of Amsterdam; Radboud University Nijmegen	van Gurp, J (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Anesthesiol Pain & Palliat Med, NL-6525 ED Nijmegen, Netherlands.	Jelle.vanGurp@radboudumc.nl	Vissers, Kris C.P./D-3569-2009; van Gurp, Jelle/P-6169-2015; Vissers, Kris/H-8110-2014; Leeuwen, E./H-8068-2014; Hasselaar, Jeroen/C-9446-2011; van Selm, Martine/AAY-3721-2021; van Gurp, Jelle/AAW-9371-2021	Vissers, Kris C.P./0000-0002-2919-6356; van Gurp, Jelle/0000-0002-9904-2571; Vissers, Kris/0000-0002-2919-6356; Leeuwen, E./0000-0001-6356-3917; van Selm, Martine/0000-0001-9188-4021; van Gurp, Jelle/0000-0002-9904-2571	Netherlands Organisation for Scientific Research (NWO) [313-99-120]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by Netherlands Organisation for Scientific Research (NWO). File number 313-99-120. URL: http://www.nwo.nl/en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarshi E, 2011, J PAIN SYMPTOM MANAG, V41, P436, DOI 10.1016/j.jpainsymman.2010.04.016; Bruera E, 2012, ONCOLOGIST, V17, P267, DOI 10.1634/theoncologist.2011-0219; Charmaz K., 2014, INTRO QUALITATIVE ME, V2nd ed.; Clark D, 2002, BRIT MED J, V324, P905, DOI 10.1136/bmj.324.7342.905; COLLIS E, 2013, BMJ-BRIT MED J, V347, P23993, DOI DOI 10.1136/BMJ.F4085; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Demiris George, 2006, Nurs Adm Q, V30, P56; Downie, 2006, PHILOS PALLIATIVE CA; Esterle L, 2013, INT J MED INFORM, V82, P684, DOI 10.1016/j.ijmedinf.2013.04.006; Floriani CA, 2012, PALLIAT SUPPORT CARE, V10, P295, DOI 10.1017/S1478951511001039; Frank AW, 2001, QUAL HEALTH RES, V11, P353, DOI 10.1177/104973201129119154; GOLDCOPD.org, GLOB STRAT DIAGN MAN; GUBA EG, 1981, ECTJ-EDUC COMMUN TEC, V29, P75; Gysels Marjolein, 2008, BMC Med Ethics, V9, P7, DOI 10.1186/1472-6939-9-7; Ihde D, 1979, TECHNIQUES PRAXIS PH; Karnofsky DA, 1949, EVALUATION CHEMOTHER, P191; KENDALL M, 2009, BMJ-BRIT MED J, V339, DOI DOI 10.1136/BMJ.B4122; Kendall M, 2006, FAM PRACT, V23, P644, DOI 10.1093/fampra/cml035; Kidd L, 2010, J TELEMED TELECARE, V16, P394, DOI 10.1258/jtt.2010.091108; Kroenke K, 2010, JAMA-J AM MED ASSOC, V304, P163, DOI 10.1001/jama.2010.944; Lopez D, 2009, SOCIOL REV, V56, P181, DOI 10.1111/j.1467-954X.2009.00822.x; Matusitz J, 2007, HEALTH COMMUN, V21, P73, DOI 10.1080/10410230701283439; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; Murray SA, 2005, BMJ-BRIT MED J, V330, P1007, DOI 10.1136/bmj.330.7498.1007; Murray SA, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3702; Peterson Mark Allen, 2003, ANTHR MASS COMMUNICA; Pivodic L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084440; Pols J., 2012, CARE DISTANCE CLOSEN; Pols J, 2011, SCI TECHNOL HUM VAL, V36, P451, DOI 10.1177/0162243910366134; Quill TE, 2013, NEW ENGL J MED, V368, P1173, DOI 10.1056/NEJMp1215620; Sandman L., 2005, GOOD DEATH VALUE DEA; Seymour JE, 1999, SOC SCI MED, V49, P691, DOI 10.1016/S0277-9536(99)00170-7; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476; Turkle S., 2012, ALONE TOGETHER WHY W; van Gurp J, 2013, PATIENT EDUC COUNS, V93, P504, DOI 10.1016/j.pec.2013.07.002; van Gurp J, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-12; Watanabe SM, 2013, SUPPORT CARE CANCER, V21, P1201, DOI 10.1007/s00520-012-1649-7; Whitten Pamela, 2004, Am J Hosp Palliat Care, V21, P191, DOI 10.1177/104990910402100307; Worldwide Palliative Care Alliance, GLOB ATL PALL CAR EN	39	37	37	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124387	10.1371/journal.pone.0124387	http://dx.doi.org/10.1371/journal.pone.0124387			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG5KV	25902263	gold, Green Published, Green Submitted			2022-12-26	WOS:000353331500083
J	Zhang, GQ; Li, MH; Su, YY; Chen, LJ; Lan, SR; Liu, ZJ				Zhang, Guo-Qiang; Li, Ming-He; Su, Yong-Yu; Chen, Li-Jun; Lan, Si-Ren; Liu, Zhong-Jian			A New Myco-Heterotrophic Genus, Yunorchis, and the Molecular Phylogenetic Relationships of the Tribe Calypsoeae (Epidendroideae, Orchidaceae) Inferred from Plastid and Nuclear DNA Sequences	PLOS ONE			English	Article							RECIRCUMSCRIPTION; CORALLORHIZA; INCONGRUENCE; EVOLUTION; UTILITY; NUMBER; PLANTS; MATK	We identified a new holomycotrophic orchid that is related to the myco-heterotrophic Calypsoeae. Because chloroplast genes are primarily lacking or are highly divergent, key morphological characters are either reduced or lost from many myco-heterotrophs, and the phylogenetic relationships of weakly supported paraphyletic Calypsoeae within Epidendroideae have been poorly understood in previous molecular systematic studies. Using chloroplast rbcL, psaB, and matK and nuclear Xdh and ITS sequences, we determined the circumscription and systematic positions of the new orchid and the tribe. The results indicate that the epidendroid taxa include most of the clades that are successively sister to the grade of clades representing previously recognized tribes. Calypsoeae comprising four well-supported clades with 12 genera (except for the previous temporarily placed Wullschlaegelia) is supported as a monophyletic and sister clade to Epidendreae (excluding Coeliinae). The new orchid is nested in Calypsoeae and is a sister to Dactylostalix and/or Calypso. This new holomycotrophic orchid presents a subumbel inflorescence that grows underground, and flower with a long pedicel reputing the ground to open and two fragments at the base of the hook, which are obviously morphologically different from those of Calypsoeae. To accommodate this species in the current generic circumscription, a new genus Yunorchis was created.	[Zhang, Guo-Qiang; Su, Yong-Yu; Chen, Li-Jun; Liu, Zhong-Jian] Natl Orchid Conservat Ctr China, Shenzhen Key Lab Orchid Conservat & Utilizat, Shenzhen, Peoples R China; [Zhang, Guo-Qiang; Su, Yong-Yu; Chen, Li-Jun; Liu, Zhong-Jian] Orchid Conservat & Res Ctr Shenzhen, Shenzhen, Peoples R China; [Zhang, Guo-Qiang; Li, Ming-He; Lan, Si-Ren; Liu, Zhong-Jian] Fujian Agr & Forestry Univ, Coll Forestry, Fuzhou, Fujian, Peoples R China; [Su, Yong-Yu; Liu, Zhong-Jian] South China Agr Univ, Coll Forestry, Guangzhou, Guangdong, Peoples R China; [Zhang, Guo-Qiang; Li, Ming-He; Lan, Si-Ren] Fujian Agr & Forestry Univ, Orchid Conservat & Res Ctr, Fuzhou, Fujian, Peoples R China	Fujian Agriculture & Forestry University; South China Agricultural University; Fujian Agriculture & Forestry University	Lan, SR (corresponding author), Fujian Agr & Forestry Univ, Coll Forestry, Fuzhou, Fujian, Peoples R China.	lkzx@fafu.edu.cn; liuzj@sinicaorchid.org	Zhang, Guo-Qiang/AAG-6817-2019	Zhang, Guo-Qiang/0000-0001-6439-019X	Science and Technology Project of Guangdong [2011B060400011]; Scientific Research Foundation of the Graduate School of Fujian Agriculture and Forestry University [1122yb006]	Science and Technology Project of Guangdong; Scientific Research Foundation of the Graduate School of Fujian Agriculture and Forestry University	Funds were provided by the Science and Technology Project of Guangdong (Grant No. 2011B060400011) and the Scientific Research Foundation of the Graduate School of Fujian Agriculture and Forestry University (Grant No. 1122yb006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bidartondo MI, 2005, NEW PHYTOL, V167, P335, DOI 10.1111/j.1469-8137.2005.01429.x; Cameron KM, 2004, MOL PHYLOGENET EVOL, V31, P1157, DOI 10.1016/j.ympev.2003.10.010; Cameron KM, 2003, BRITTONIA, V55, P214, DOI 10.1663/0007-196X(2003)055[0214:ROTMFP]2.0.CO;2; Carlsward BS, 2006, AM J BOT, V93, P770, DOI 10.3732/ajb.93.5.770; Chase M.W., 2003, ORCHID CONSERV, P69; Chen SC, 1999, FLORA REIPUBLIC POPU, P18; Cunningham CW, 1997, MOL BIOL EVOL, V14, P733, DOI 10.1093/oxfordjournals.molbev.a025813; Delannoy E, 2011, MOL BIOL EVOL, V28, P2077, DOI 10.1093/molbev/msr028; Dressler RL, 1993, PHYLOGENY CLASSIFICA; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; Freudenstein JV, 2004, AM J BOT, V91, P149, DOI 10.3732/ajb.91.1.149; FREUDENSTEIN JV, 1994, AM J BOT, V81, P1449, DOI 10.2307/2445318; Freudenstein JV, 1996, AM J BOT, V83, P813, DOI 10.2307/2446258; Freudensteinia JV, 2008, AM J BOT, V95, P498, DOI 10.3732/ajb.95.4.498; Gorniak M, 2010, MOL PHYLOGENET EVOL, V56, P784, DOI 10.1016/j.ympev.2010.03.003; Guo YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038788; LEAKE JR, 1994, NEW PHYTOL, V127, P171, DOI 10.1111/j.1469-8137.1994.tb04272.x; Martos F, 2009, NEW PHYTOL, V184, P668, DOI 10.1111/j.1469-8137.2009.02987.x; Merckx V, 2008, P ROY SOC B-BIOL SCI, V275, P1029, DOI 10.1098/rspb.2007.1622; Merckx V, 2009, ANN BOT-LONDON, V104, P1255, DOI 10.1093/aob/mcp235; Merckx V, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-178; Neubig KM, 2009, PLANT SYST EVOL, V277, P75, DOI 10.1007/s00606-008-0105-0; Pridgeon A.M., 2014, GENERA ORCHIDACEARUM, V6; Pridgeon AM, 2005, GENERA ORCHIDACEARUM, V4, P89; Pridgeon AM, 2009, GENERA ORCHIDACEARUM, V5; Rokas A, 2005, MOL BIOL EVOL, V22, P1337, DOI 10.1093/molbev/msi121; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stern WL, 2008, LANKESTERIANA, V8, P105, DOI DOI 10.15517/LANK.V8I1.3201; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Szlachetko DL, 1995, FRAGM FLOR GEOBOT S3; van den Berg C, 2005, AM J BOT, V92, P613, DOI 10.3732/ajb.92.4.613; Xiang XG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087625; Zhai JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060371; Zhang GQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060097	35	10	11	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123382	10.1371/journal.pone.0123382	http://dx.doi.org/10.1371/journal.pone.0123382			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902264	Green Published, Green Submitted, gold			2022-12-26	WOS:000353331500051
J	Zhang, JZ; Li, C; Tang, XF; Lu, QP; Sa, RN; Zhang, HF				Zhang, Jize; Li, Cong; Tang, Xiangfang; Lu, Qingping; Sa, Renna; Zhang, Hongfu			High Concentrations of Atmospheric Ammonia Induce Alterations in the Hepatic Proteome of Broilers (Gallus gallus): An iTRAQ-Based Quantitative Proteomic Analysis	PLOS ONE			English	Article							GENE-EXPRESSION; LIVER; ACID; APOPTOSIS; PATHWAYS; INJURY; ATP	With the development of the poultry industry, ammonia, as a main contaminant in the air, is causing increasing problems with broiler health. To date, most studies of ammonia toxicity have focused on the nervous system and the gastrointestinal tract in mammals. However, few detailed studies have been conducted on the hepatic response to ammonia toxicity in poultry. The molecular mechanisms that underlie these effects remain unclear. In the present study, our group applied isobaric tags for relative and absolute quantitation (iTRAQ)based quantitative proteomic analysis to investigate changes in the protein profile change in hepatic tissue of broilers exposed to high concentrations of atmospheric ammonia, with the goal of characterizing the molecular mechanisms of chronic liver injury from exposure to high ambient levels of ammonia. Overall, 30 differentially expressed proteins that are involved in nutrient metabolism (energy, lipid, and amino acid), immune response, transcriptional and translational regulation, stress response, and detoxification were identified. In particular, two of these proteins, beta-1 galactosidase (GLB1) and a kinase (PRKA) anchor protein 8-like (AKAP8 L), were previously suggested to be potential biomarkers of chronic liver injury. In addition to the changes in the protein profile, serum parameters and histochemical analyses of hepatic tissue also showed extensive hepatic damage in ammoniaexposed broilers. Altogether, these findings suggest that longtime exposure to high concentrations of atmospheric ammonia can trigger chronic hepatic injury in broilers via different mechanisms, providing new information that can be used for intervention using nutritional strategies in the future.	[Zhang, Jize; Li, Cong; Tang, Xiangfang; Lu, Qingping; Sa, Renna; Zhang, Hongfu] Chinese Acad Agr Sci, Inst Anim Sci, State Key Lab Anim Nutr, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS	Zhang, HF (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, State Key Lab Anim Nutr, Beijing 100193, Peoples R China.	zhanghf6565@vip.sina.com			Chinese National Science and Technology Pillar Program [2012BAD39B0]; Special Fund for Innovation Team of the Chinese Academy of Agricultural Sciences [ASTTP-IAS07]	Chinese National Science and Technology Pillar Program; Special Fund for Innovation Team of the Chinese Academy of Agricultural Sciences	This research was supported by the Chinese National Science and Technology Pillar Program (No: 2012BAD39B0) and the Special Fund for Innovation Team of the Chinese Academy of Agricultural Sciences (No: ASTTP-IAS07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astle J, 2007, J NUTR, V137, P2787, DOI 10.1093/jn/137.12.2787; Bertrand FE, 1996, J IMMUNOL, V156, P4240; Bobermin LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052164; Chaika NV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032996; Chen JY, 2013, J NUTR BIOCHEM, V24, P1889, DOI 10.1016/j.jnutbio.2013.05.006; Choi Hee Young, 2009, Cancer Genomics & Proteomics, V6, P263; DANIELLO A, 1993, J BIOL CHEM, V268, P26941; Desert C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-611; Dixit SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023677; Diz AP, 2009, ELECTROPHORESIS, V30, P2967, DOI 10.1002/elps.200900210; Esbaugh AJ, 2006, RESP PHYSIOL NEUROBI, V154, P185, DOI 10.1016/j.resp.2006.03.007; Flowers MT, 2009, CLIN CHEM, V55, P2071, DOI 10.1373/clinchem.2009.135152; GEBHARDT R, 1992, PHARMACOL THERAPEUT, V53, P275, DOI 10.1016/0163-7258(92)90055-5; Hakimov HA, 2009, PROTEOMICS, V9, P4000, DOI 10.1002/pmic.200900049; Huang JB, 2013, J AGR FOOD CHEM, V61, P8565, DOI 10.1021/jf402004x; Jagannathan M, 2012, J CELL SCI, V125, P133, DOI 10.1242/jcs.089938; Jia B, 2014, LIVER INT, V34, P748, DOI 10.1111/liv.12365; Ke Q, 2012, J ZHEJIANG UNIV-SC B, V13, P695, DOI 10.1631/jzus.B1100362; Kleinman MT, 2008, TOXICOL LETT, V178, P127, DOI 10.1016/j.toxlet.2008.03.001; Luo JJ, 2013, J PROTEOMICS, V91, P226, DOI 10.1016/j.jprot.2013.07.017; Maier KG, 2010, J VASC SURG, V51, P1238, DOI 10.1016/j.jvs.2009.11.073; Matsumoto T, 2012, J BIOCHEM, V151, P541, DOI 10.1093/jb/mvs023; Miles DM, 2004, POULTRY SCI, V83, P1650, DOI 10.1093/ps/83.10.1650; Modrego J, 2013, EUR J NUTR, V52, P847, DOI 10.1007/s00394-012-0392-7; Nakagawa H., 2012, PATHOL RES INT, V2012; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; Nemeth E, 2009, SEMIN IMMUNOPATHOL, V31, P333, DOI 10.1007/s00281-009-0173-4; Newman DR, 2000, RNA, V6, P861, DOI 10.1017/S1355838200992446; Nikam A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066094; Nishikawa T, 2014, J HEPATOL, V60, P1203, DOI 10.1016/j.jhep.2014.02.014; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pogorelova TN, 2011, B EXP BIOL MED+, V151, P567; Polyzos S, 2012, IMMUNO GASTROENTEROL, V1, P119; Ramadoss J, 2012, REPROD TOXICOL, V34, P538, DOI 10.1016/j.reprotox.2012.08.008; REINITZ E, 1986, ANN RHEUM DIS, V45, P431, DOI 10.1136/ard.45.5.431; Saller E, 1999, EMBO J, V18, P4424, DOI 10.1093/emboj/18.16.4424; Scheri RC, 2009, TOXICOL LETT, V191, P20, DOI 10.1016/j.toxlet.2009.07.029; Serra MP, 2014, INT J RADIAT BIOL, V90, P876, DOI 10.3109/09553002.2014.922714; Shao CX, 2010, MOL CELL PROTEOMICS, V9, P313, DOI 10.1074/mcp.M900260-MCP200; Shawcross DL, 2007, METAB BRAIN DIS, V22, P125, DOI 10.1007/s11011-006-9042-1; Sherlock L, 2012, BRIT POULTRY SCI, V53, P439, DOI 10.1080/00071668.2012.707310; Skowronska M, 2013, NEUROCHEM INT, V62, P731, DOI 10.1016/j.neuint.2012.10.013; St Peter SD, 2002, LIVER TRANSPLANT, V8, P21, DOI 10.1053/jlts.2002.30344; Su LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054237; Trauner M, 1998, NEW ENGL J MED, V339, P1217, DOI 10.1056/NEJM199810223391707; Varki A., 2009, ESSENTIALS GLYCOBIOL; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang JJ, 2006, J NUTR, V136, P1759, DOI 10.1093/jn/136.7.1759; Wei FX, 2012, J ANIM VET ADV, V11, P3641; Witkowska D., 2006, Archiv fur Tierzucht, V49, P249; Yahav S, 2004, ANIM RES, V53, P289, DOI 10.1051/animres:2004015; Yamada J, 2005, AMINO ACIDS, V28, P273, DOI 10.1007/s00726-005-0181-1; Yang L, 2010, COMP BIOCHEM PHYS C, V151, P204, DOI 10.1016/j.cbpc.2009.10.010; Yang X, 2012, ONCOL REP, V28, P283, DOI 10.3892/or.2012.1767; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yoo Dong Ryeol, 2009, Cancer Genomics & Proteomics, V6, P269; Young TA, 2006, ALCOHOL ALCOHOLISM, V41, P254, DOI 10.1093/alcalc/agl017; Zhang JZ, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-22; Zi J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074229	59	28	35	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123596	10.1371/journal.pone.0123596	http://dx.doi.org/10.1371/journal.pone.0123596			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901992	Green Submitted, Green Published, gold			2022-12-26	WOS:000353331500056
J	Reix, CE; Dikshit, AK; Hockenhull, J; Parker, RMA; Banerjee, A; Burn, CC; Pritchard, JC; Whay, HR				Reix, Christine E.; Dikshit, Amit K.; Hockenhull, Jo; Parker, Richard M. A.; Banerjee, Anindo; Burn, Charlotte C.; Pritchard, Joy C.; Whay, Helen R.			A Two-Year Participatory Intervention Project with Owners to Reduce Lameness and Limb Abnormalities in Working Horses in Jaipur, India	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; DEVELOPING-COUNTRIES; HEALTH; DONKEYS; WELFARE; MULES	Background Participatory methods are increasingly used in international human development, but scientific evaluation of their efficacy versus a control group is rare. Working horses support families in impoverished communities. Lameness and limb abnormalities are highly prevalent in these animals and a cause for welfare concern. We aimed to stimulate and evaluate improvements in lameness and limb abnormalities in horses whose owners took part in a 2-year participatory intervention project to reduce lameness (PI) versus a control group (C) in Jaipur, India. Methodology/Principal Findings In total, 439 owners of 862 horses participated in the study. PI group owners from 21 communities were encouraged to meet regularly to discuss management and work practices influencing lameness and poor welfare and to track their own progress in improving these. Lameness examinations (41 parameters) were conducted at the start of the study (Baseline), and after 1 year and 2 years. Results were compared with control horses from a further 21 communities outside the intervention. Of the 149 horses assessed on all three occasions, PI horses showed significantly (P<0.05) greater improvement than C horses in 20 parameters, most notably overall lameness score, measures of sole pain and range of movement on limb flexion. Control horses showed slight but significantly greater improvements in four parameters, including frog quality in fore and hindlimbs. Conclusions/Significance This participatory intervention succeeded in improving lameness and some limb abnormalities in working horses, by encouraging changes in management and work practices which were feasible within owners' socioeconomic and environmental constraints. Demonstration of the potentially sustainable improvements achieved here should encourage further development of participatory intervention approaches to benefit humans and animals in other contexts.	[Reix, Christine E.; Hockenhull, Jo; Parker, Richard M. A.; Whay, Helen R.] Univ Bristol, Sch Vet Sci, North Somerset, England; [Dikshit, Amit K.] Maharani Farm, Help Suffering, Jaipur, Rajasthan, India; [Banerjee, Anindo] Praxis Inst Participatory Practices, New Delhi, India; [Burn, Charlotte C.] Univ London Royal Vet Coll, Dept Vet Clin Sci, Ctr Anim Welf, London NW1 0TU, Herts, England; [Pritchard, Joy C.] Anim Int Dev, Banwell, North Somerset, England; [Pritchard, Joy C.] Brooke, London, England	University of Bristol; University of London; University of London Royal Veterinary College	Whay, HR (corresponding author), Univ Bristol, Sch Vet Sci, Langford House, North Somerset, England.	bec.whay@bristol.ac.uk	Banerjee, Anindo/GVT-8729-2022	Hockenhull, Jo/0000-0002-9224-7304; Burn, Charlotte/0000-0002-8734-8610; Parker, Richard/0000-0002-3933-9728	Brooke	Brooke	The study was funded by The Brooke (www.thebrooke.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAIR JG, 1984, J APPL PSYCHOL, V69, P334, DOI 10.1037/0021-9010.69.2.334; Ashley FH, 2005, EQUINE VET J, V37, P565, DOI 10.2746/042516405775314826; Broster CE, 2009, EQUINE VET J, V41, P474, DOI 10.2746/042516409X373907; Broster CE, 2010, P 6 INT C WORK EQ NE, P9; Burn CC, 2010, VET J, V186, P385, DOI 10.1016/j.tvjl.2009.09.016; FAOSTAT Food and Agricultural Organisation Statistical Database, 2010, FAOSTAT FOOD AGR ORG; Fidiel MM, 2006, P 5 INT C WORK EQ 30, P360; Fuller CJ, 2006, VET J, V171, P281, DOI 10.1016/j.tvjl.2004.10.012; Geor RJ, 2008, J EQUINE VET SCI, V28, P753, DOI 10.1016/j.jevs.2008.10.016; Guha K, 2010, P 6 INT C WORK EQ NE, P5; Hagmann J, 1999, 94 ODI AGR RES EXT N; KUMAR S., 2002, METHODS COMMUNITY PA, P23; Landsberger HA, 1958, HAWTHORNE REVISITED; Main DCJ, 2012, J DAIRY SCI, V95, P2946, DOI 10.3168/jds.2011-4678; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; Murthy K.S., 2006, P 5 INT C WORK EQ FU, P445; Nutbeam D, 1998, HEALTH PROMOT INT, V13, P27, DOI 10.1093/heapro/13.1.27; Pradhan SK, 2006, P 6 INT C WORK EQ 29, P44; Pritchard J, 2011, SHARING LOAD GUIDE I; Pritchard JC, 2005, PREV VET MED, V69, P265, DOI 10.1016/j.prevetmed.2005.02.002; Rasbash J, 2009, USERS GUIDE MLWIN V2, V2, P10; Rasbash J., 2010, MLWIN VERSION 2 22; Rodriguez PAV, 2006, P 5 INT C WORK EQ 30, P407; Steele F, 2008, J R STAT SOC A STAT, V171, P5; Tsutsumi A, 2009, J OCCUP ENVIRON MED, V51, P554, DOI 10.1097/JOM.0b013e3181a24d28; Upjohn MM, 2013, PREV VET MED, V108, P313, DOI 10.1016/j.prevetmed.2012.11.008; Upjohn MM, 2014, VET J, V199, P210, DOI 10.1016/j.tvjl.2013.09.065; Whay HR, 2007, ANIM WELFARE, V16, P117; Whay HR, 2010, IMPROVING ANIMAL WEL, P227	29	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124342	10.1371/journal.pone.0124342	http://dx.doi.org/10.1371/journal.pone.0124342			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898014	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000353212600065
J	Vicente, CSL; Ikuyo, Y; Shinya, R; Mota, M; Hasegawa, K				Vicente, Claudia S. L.; Ikuyo, Yoriko; Shinya, Ryoji; Mota, Manuel; Hasegawa, Koichi			Catalases Induction in High Virulence Pinewood Nematode Bursaphelenchus xylophilus under Hydrogen Peroxide-Induced Stress	PLOS ONE			English	Article							WOOD NEMATODE; HAEMONCHUS-CONTORTUS; ANTIOXIDANT ENZYMES; APHELENCHOIDIDAE; PEROXIREDOXIN; POPULATIONS; EXPRESSION; RESISTANCE; INFECTION; DISEASE	Considered an EPPO A2 quarantine pest, Bursaphelenchus xylophilus is the causal agent of the pine wilt disease and the most devastating plant parasitic nematode attacking coniferous trees in the world. In the early stages of invasion, this nematode has to manage host defence mechanisms, such as strong oxidative stress. Only successful, virulent nematodes are able to tolerate the basal plant defences, and furthermore migrate and proliferate inside of the host tree. In this work, our main objective was to understand to what extent B. xylophilus catalases are involved in their tolerance to oxidative stress and virulence, using as oxidant agent the reactive oxygen species hydrogen peroxide (H2O2). After 24 hours of exposure, high virulence isolates of B. xylophilus could withstand higher H2O2 concentrations in comparison with low virulence B. xylophilus and B. mucronatus, corroborating our observation of Bxy-ctl-1 and Bxy-ctl-2 catalase up-regulation under the same experimental conditions. Both catalases are expressed throughout the nematode intestine. In addition, transgenic strains of Caenorhabditis elegans overexpressing B. xylophilus catalases were constructed and evaluated for survival under similar conditions as previously. Our results suggest that catalases of high virulence B. xylophilus were crucial for nematode survival under prolonged exposure to in vitro oxidative stress, highlighting their adaptive response, which could contribute to their success in host conditions.	[Vicente, Claudia S. L.; Ikuyo, Yoriko; Shinya, Ryoji; Hasegawa, Koichi] Chubu Univ, Coll Biosci & Biotechnol, Dept Environm Biol, Kasugai, Aichi 487, Japan; [Vicente, Claudia S. L.; Mota, Manuel] Univ Evora, Dept Biol, Inst Ciencias Agr & Ambientais Mediterran, Evora, Portugal; [Shinya, Ryoji] CALTECH, HHMI, Pasadena, CA 91125 USA; [Shinya, Ryoji] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	Chubu University; University of Evora; California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Hasegawa, K (corresponding author), Chubu Univ, Coll Biosci & Biotechnol, Dept Environm Biol, Kasugai, Aichi 487, Japan.	koichihasegawa@isc.chubu.ac.jp	Vicente, Cláudia SL/X-5058-2019; Vicente, Claudia/C-6226-2019; Mota, Manuel/G-6031-2019	Vicente, Cláudia SL/0000-0002-3865-5358; Vicente, Claudia/0000-0002-3865-5358; Mota, Manuel/0000-0002-4145-5031; Shinya, Ryoji/0000-0002-2450-3054	Japan Society for Science Promotion (JSPS) [P14394]; Heiwa Nakajima Foundation; FEDER Funds through the Operational Programme for Competitiveness Factors - COMPETE and National Funds through FCT - Foundation for Science and Technology [C/AGR/UI0115/2011]; EU Plant Health policy, European Union [FP7-KBBE-2010-4]; Grants-in-Aid for Scientific Research [26450204] Funding Source: KAKEN	Japan Society for Science Promotion (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Heiwa Nakajima Foundation; FEDER Funds through the Operational Programme for Competitiveness Factors - COMPETE and National Funds through FCT - Foundation for Science and Technology; EU Plant Health policy, European Union; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for Science Promotion (JSPS - reference P14394) postdoctoral fellowship to CSLV; the Heiwa Nakajima Foundation, international joint research grant; the European Project REPHRAME - Development of improved methods for detection, control and eradication of pine wood nematode in support of EU Plant Health policy, European Union Seventh Framework Programme FP7-KBBE-2010-4; and FEDER Funds through the Operational Programme for Competitiveness Factors - COMPETE and National Funds through FCT - Foundation for Science and Technology under the Strategic Project PEst-C/AGR/UI0115/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa T, 2003, ENVIRON ENTOMOL, V32, P96, DOI 10.1603/0046-225X-32.1.96; Aikawa T, 2007, NEMATOLOGY, V9, P371, DOI 10.1163/156854107781352007; Asai E, 2005, FOREST PATHOL, V35, P135, DOI 10.1111/j.1439-0329.2004.00396.x; Bellafiore S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000192; BRENNER S, 1974, GENETICS, V77, P71; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; de Boer JM, 1998, J NEMATOL, V30, P309; Dubreuil G, 2011, INT J PARASITOL, V41, P385, DOI 10.1016/j.ijpara.2010.10.008; Futai K, 2013, ANNU REV PHYTOPATHOL, V51, P61, DOI 10.1146/annurev-phyto-081211-172910; Guo M, 2012, J BACTERIOL, V194, P5054, DOI 10.1128/JB.00999-12; He L, 2010, J NANJING U NATUR SC, V06; Henkle-Duhrsen K, 2001, MOL BIOCHEM PARASIT, V114, P129, DOI 10.1016/S0166-6851(01)00252-3; Hirao T, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-13; Kikuchi T, 2004, FEBS LETT, V572, P201, DOI 10.1016/j.febslet.2004.07.039; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; KIYOHARA T, 1990, FOREST SCI, V36, P1061; Kotze AC, 2003, INT J PARASITOL, V33, P393, DOI 10.1016/S0020-7519(03)00012-2; Kotze AC, 2001, INT J PARASITOL, V31, P1563, DOI 10.1016/S0020-7519(01)00303-4; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Molinari S, 1997, J NEMATOL, V29, P153; Molinari S, 2005, NEMATROPICA, V35, P88; Molinari S, 2009, NEMATOLOGY, V11, P689, DOI 10.1163/156854108X399317; Mota M., 2008, PINE WILT DIS WORLDW; Olahova M, 2008, P NATL ACAD SCI USA, V105, P19839, DOI 10.1073/pnas.0805507105; OU XU, 1995, EXP PARASITOL, V80, P530, DOI 10.1006/expr.1995.1065; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Petriv OI, 2004, J BIOL CHEM, V279, P19996, DOI 10.1074/jbc.M400207200; Quan LJ, 2008, J INTEGR PLANT BIOL, V50, P2, DOI 10.1111/j.1744-7909.2007.00599.x; Robertson L, 2000, MOL BIOCHEM PARASIT, V111, P41, DOI 10.1016/S0166-6851(00)00295-4; Rozen S, 2000, BIOINFORMATICS METHO; SANTOS CSS, 2012, EUR J PLANT PATHOL, V0132, P00407, DOI DOI 10.1007/s10658-011-9886-z; Shinya R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067377; Shinya R, 2012, APPL ENTOMOL ZOOL, V47, P341, DOI 10.1007/s13355-012-0124-8; Shinya R, 2010, PHYTOPATHOLOGY, V100, P1289, DOI 10.1094/PHYTO-04-10-0109; Takemoto S, 2008, PINE WILT DIS; Vicente C, 2012, EUR J PLANT PATHOL, V133, P89, DOI 10.1007/s10658-011-9924-x; Vicente CSL, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-299	38	26	29	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123839	10.1371/journal.pone.0123839	http://dx.doi.org/10.1371/journal.pone.0123839			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894519	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000353211700060
J	Dare, S; Mackay, DF; Pell, JP				Dare, Shadrach; Mackay, Daniel F.; Pell, Jill P.			Relationship between Smoking and Obesity: A Cross-Sectional Study of 499,504 Middle-Aged Adults in the UK General Population	PLOS ONE			English	Article							BODY-MASS INDEX; SOCIOECONOMIC-STATUS; LONGITUDINAL CHANGES; WEIGHT-GAIN; CESSATION; SMOKERS; CONSEQUENCES	Background There is a general perception that smoking protects against weight gain and this may influence commencement and continuation of smoking, especially among young women. Methods A cross-sectional study was conducted using baseline data from UK Biobank. Logistic regression analyses were used to explore the association between smoking and obesity; defined as body mass index (BMI) > 30kg/m(2). Smoking was examined in terms of smoking status, amount smoked, duration of smoking and time since quitting and we adjusted for the potential confounding effects of age, sex, socioeconomic deprivation, physical activity, alcohol consumption, hypertension and diabetes. Results The study comprised 499,504 adults aged 31 to 69 years. Overall, current smokers were less likely to be obese than never smokers (adjusted OR 0.83 95% CI 0.81-0.86). However, there was no significant association in the youngest sub-group (<= 40 years). Former smokers were more likely to be obese than both current smokers (adjusted OR 1.33 95% CI 1.30-1.37) and never smokers (adjusted OR 1.14 95% CI 1.12-1.15). Among smokers, the risk of obesity increased with the amount smoked and former heavy smokers were more likely to be obese than former light smokers (adjusted OR 1.60, 95% 1.56-1.64, p< 0.001). Risk of obesity fell with time from quitting. After 30 years, former smokers still had higher risk of obesity than current smokers but the same risk as never smokers. Conclusion Beliefs that smoking protects against obesity may be over-simplistic; especially among younger and heavier smokers. Quitting smoking may be associated with temporary weight gain. Therefore, smoking cessation interventions should include weight management support.	[Dare, Shadrach; Mackay, Daniel F.; Pell, Jill P.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Dare, Shadrach] Univ Cape Coast, Sch Nursing, Coll Hlth & Allied Sci, Cape Coast, Ghana	University of Glasgow; University of Cape Coast	Pell, JP (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland.	jill.pell@glasgow.ac.uk	Matsuo, Keitaro/H-6758-2019	Matsuo, Keitaro/0000-0003-1761-6314; Pell, Jill/0000-0002-8898-7035; Dare, Shadrach/0000-0002-2528-5263	Commonwealth Scholarship Commission in the United Kingdom; Medical Research Council [MC_qA137853] Funding Source: researchfish	Commonwealth Scholarship Commission in the United Kingdom; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Shadrach Dare (SD) is funded by Commonwealth Scholarship Commission in the United Kingdom http://cscuk.dfid.gov.uk/.	Allen N, 2012, HEALTH POLICY TECHN, V1, P123, DOI 10.1016/j.hlpt.2012.07.003; Aubin HJ, 2009, INT J ENV RES PUB HE, V6, P943, DOI 10.3390/ijerph6030943; Bakhshi E, 2008, J PUBLIC HEALTH-UK, V30, P429, DOI 10.1093/pubmed/fdn024; Berlin I, 2009, CURR MED RES OPIN, V25, P527, DOI 10.1185/03007990802707626; Cabanac M, 2002, PHYSIOL BEHAV, V76, P539, DOI 10.1016/S0031-9384(02)00783-7; Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Dvorak RD, 2009, J HEALTH PSYCHOL, V14, P919, DOI 10.1177/1359105309341005; Eisenberg D, 2006, HEALTH SERV RES, V41, P2255, DOI 10.1111/j.1475-6773.2006.00594.x; Farley CA, 2012, BMJ, V345; HELLIWELL PS, 1994, ANN RHEUM DIS, V53, P726, DOI 10.1136/ard.53.11.726; Hughes JR, 2003, J GEN INTERN MED, V18, P1053, DOI 10.1111/j.1525-1497.2003.20640.x; Basterra-Gortari FJ, 2010, REV ESP CARDIOL, V63, P20, DOI 10.1016/S0300-8932(10)70005-1; Jitnarin Nattinee, 2008, Journal of the Medical Association of Thailand, V91, P1109; Kadonaga Y, 2009, PREV MED, V48, P567, DOI 10.1016/j.ypmed.2009.03.018; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Kim J., 2012, PLOS ONE, V7; KLESGES RC, 1989, PSYCHOL BULL, V106, P204, DOI 10.1037/0033-2909.106.2.204; Laaksonen M, 2005, EUR J PUBLIC HEALTH, V15, P262, DOI 10.1093/eurpub/cki115; Macera CA, 2011, NICOTINE TOB RES, V13, P965, DOI 10.1093/ntr/ntr104; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Meyers AW, 1997, J CONSULT CLIN PSYCH, V65, P448, DOI 10.1037/0022-006X.65.3.448; Morgenstern Matthis, 2010, Przegl Lek, V67, P826; Munafo MR, 2009, NICOTINE TOB RES, V11, P765, DOI 10.1093/ntr/ntp062; Niedhammer I, 2000, INT J OBESITY, V24, P1111, DOI 10.1038/sj.ijo.0801375; Paccaud F, 2001, REV EPIDEMIOL SANTE, V49, P33; Peeters A, 2003, ANN INTERN MED, V138, P24, DOI 10.7326/0003-4819-138-1-200301070-00008; Potter BK, 2004, NICOTINE TOB RES, V6, P397, DOI 10.1080/14622200410001696529; Reas DL, 2009, SCAND J PUBLIC HEALT, V37, P774, DOI 10.1177/1403494809344654; Rigotti NA, 2002, NEW ENGLAND J MED; Shah NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033308; Sneve M, 2008, SCAND J PUBLIC HEALT, V36, P397, DOI 10.1177/1403494807088453; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Stavropoulos-Kalinoglou A, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2429; Townsend PP., 1988, HLTH DEPRIVATION INE; Travier N, 2012, PREV MED, V54, P183, DOI 10.1016/j.ypmed.2011.09.003; UKBiobank, 2007, UK BIOB PROT LARG SC; USDHHS, 1990, HLTH BEN SMOK CESS R; WACK JT, 1982, AM J CLIN NUTR, V35, P366, DOI 10.1093/ajcn/35.2.366; World Health Organisation, 2013, OB FACT SHEET; YOUNGHWAN J, 2012, J NEUROBIOL, V53, P618; Zbikowski SM, 2011, NICOTINE TOB RES, V13, P319, DOI 10.1093/ntr/ntq257; Zhang LH, 2001, SURGERY, V130, P133, DOI 10.1067/msy.2001.115513	43	150	156	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123579	10.1371/journal.pone.0123579	http://dx.doi.org/10.1371/journal.pone.0123579			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EX	25886648	Green Accepted, Green Published, gold			2022-12-26	WOS:000353017000075
J	Liang, Z; Shi, XM; Liu, LF; Chen, XP; Shanl, ZL; Lin, K; Li, J; Chen, FK; Li, YG; Guo, HY; Wang, YT				Liang, Zhuo; Shi, Xiang-min; Liu, Li-feng; Chen, Xin-pei; Shan, Zhao-liang; Lin, Kun; Li, Jian; Chen, Fu-kun; Li, Yan-guang; Guo, Hong-yang; Wang, Yu-tang			Renal Denervation Suppresses Atrial Fibrillation in a Model of Renal Impairment	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SYMPATHETIC DENERVATION; ACTIVATION; SYSTEM	Background A close association exists between renal impairment (RI) and atrial fibrillation (AF) occurrence. Increased activity of the sympathetic nervous system (SNS) may contribute to the development of AF associated with RI. Renal denervation (RDN) decreases central sympathetic activity. Objective The main objective of the study was to explore the effects of RDN on AF occurrence and its possible mechanisms in beagles with RI. Methods Unilateral RI was induced in beagles by embolization of small branches of the renal artery in the right kidney using gelatin sponge granules in Model (n = 6) and RDN group (n = 6). The Sham group (n = 6) underwent the same procedure, except for embolization. Then animals in RDN group underwent radiofrequency ablation of the renal sympathetic nerve. Cardiac electrophysiological parameters, blood pressure, left ventricular end-diastolic pressure, and AF inducibility were investigated. The activity of the SNS, renin-angiotensin-aldosterone system (RAAS), inflammation and atrial interstitial fibrosis were measured. Results Embolization of small branches of the renal artery in the right kidney led to ischemic RI. Heart rate, P wave duration and BP were increased by RI, which were prevented or attenuated by RDN. Atrial effective refractory period was shortened and AF inducibility was increased by RI, which were prevented by RDN. Antegrade Wenckebach point was shortened, atrial and ventricular rates during AF were increased by RI, which were attenuated or prevented by RDN. Levels of norepinephrine, renin and aldosterone in plasma, norepinephrine, angiotensin II, aldosterone, interleukin-6 and high sensitivity C-reactive protein in atrial tissue were elevated, and atrial interstitial fibrosis was enhanced by RI, which were attenuated by RDN. Conclusions RDN significantly reduced AF inducibility, prevented the atrial electrophysiological changes in a model of RI by combined reduction of sympathetic drive and RAAS activity, and inhibition of inflammation activity and fibrotic pathway in atrial tissue.	[Liang, Zhuo; Shi, Xiang-min; Liu, Li-feng; Shan, Zhao-liang; Lin, Kun; Chen, Fu-kun; Li, Yan-guang; Guo, Hong-yang] Chinese Peoples Liberat Army Gen Hosp, Dept Cardiol, Beijing 100853, Peoples R China; [Chen, Xin-pei] Tsinghua Univ, Beijing Tsinghua Changgeng Hosp Med Ctr, Dept Emergency, Beijing 100084, Peoples R China; [Li, Jian; Wang, Yu-tang] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing 100853, Peoples R China	Chinese People's Liberation Army General Hospital; Tsinghua University; Chinese People's Liberation Army General Hospital	Wang, YT (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing 100853, Peoples R China.	wyt301@sina.com	, Fred/B-8158-2013; Chen, Xinpei/AAO-1879-2021	, Fred/0000-0003-2809-9930; 	Military Key Project of Health [11BJZ10]	Military Key Project of Health	The present study is supported by the Military Key Project of Health Grant number: 11BJZ10.	Alonso A, 2011, CIRCULATION, V123, P2946, DOI 10.1161/CIRCULATIONAHA.111.020982; Bianchi S, 2009, HEART RHYTHM, V6, P1282, DOI 10.1016/j.hrthm.2009.05.011; Chen LY, 2007, HEART RHYTHM, V4, pS1, DOI 10.1016/j.hrthm.2006.12.018; Everett TH, 2007, HEART RHYTHM, V4, pS24, DOI 10.1016/j.hrthm.2006.12.040; Ewen S, 2013, CURR HYPERTENS REP, V15, P370, DOI 10.1007/s11906-013-0365-0; Fukunaga N, 2012, HEART RHYTHM, V9, P2023, DOI 10.1016/j.hrthm.2012.08.019; Hou YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078218; Liang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105974; Linz D, 2013, HYPERTENSION, V62, P767, DOI 10.1161/HYPERTENSIONAHA.113.01728; Linz D, 2013, HYPERTENSION, V61, P225, DOI 10.1161/HYPERTENSIONAHA.111.00182; Linz D, 2012, HYPERTENSION, V60, P172, DOI 10.1161/HYPERTENSIONAHA.112.191965; Mayyas F, 2013, INT J CARDIOL, V168, P5135, DOI 10.1016/j.ijcard.2013.08.022; Ogawa M, 2009, HEART RHYTHM, V6, P1772, DOI 10.1016/j.hrthm.2009.08.011; Park HW, 2012, CURR OPIN CARDIOL, V27, P24, DOI 10.1097/HCO.0b013e32834dc4e8; Redpath CJ, 2006, J MOL CELL CARDIOL, V40, P717, DOI 10.1016/j.yjmcc.2006.01.012; Savelieva I, 2011, EUROPACE, V13, P610, DOI 10.1093/europace/eur023; Schlaich MP, 2009, J AM SOC NEPHROL, V20, P933, DOI 10.1681/ASN.2008040402; Siragy HM, 2010, AM J NEPHROL, V31, P541, DOI 10.1159/000313363; Soliman EZ, 2010, AM HEART J, V159, P1102, DOI 10.1016/j.ahj.2010.03.027; Watanabe T, 2007, J VET MED SCI, V69, P1015, DOI 10.1292/jvms.69.1015; Wienemann H, 2014, MINERVA CARDIOANGIOL, V62, P235; Ye SH, 2002, AM J HYPERTENS, V15, P717, DOI 10.1016/S0895-7061(02)02959-X; Zhao QY, 2013, INT J CARDIOL, V168, P1672, DOI 10.1016/j.ijcard.2013.03.091; Zhao QY, 2012, J INTERV CARD ELECTR, V35, P119, DOI 10.1007/s10840-012-9717-y; Zimmerman D, 2012, NEPHROL DIAL TRANSPL, V27, P3816, DOI 10.1093/ndt/gfs416	25	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124123	10.1371/journal.pone.0124123	http://dx.doi.org/10.1371/journal.pone.0124123			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884946	Green Submitted, Green Published, gold			2022-12-26	WOS:000353017000102
J	Pantano, F; Santoni, M; Procopio, G; Rizzo, M; Lacovelli, R; Porta, C; Conti, A; Lugini, A; Milella, M; Galli, L; Ortega, C; Guida, FM; Silletta, M; Schinzari, G; Verzoni, E; Modica, D; Crucitti, P; Rauco, A; Felici, A; Ballatore, V; Cascinu, S; Tonini, G; Carteni, G; Russo, A; Santini, D				Pantano, Francesco; Santoni, Matteo; Procopio, Giuseppe; Rizzo, Mimma; Lacovelli, Roberto; Porta, Camillo; Conti, Alessandro; Lugini, Antonio; Milella, Michele; Galli, Luca; Ortega, Cinzia; Guida, Francesco Maria; Silletta, Marianna; Schinzari, Giovanni; Verzoni, Elena; Modica, Daniela; Crucitti, Pierfilippo; Rauco, Annamaria; Felici, Alessandra; Ballatore, Valentina; Cascinu, Stefano; Tonini, Giuseppe; Carteni, Giacomo; Russo, Antonio; Santini, Daniele			The Changes of Lipid Metabolism in Advanced Renal Cell Carcinoma Patients Treated with Everolimus: A New Pharmacodynamic Marker?	PLOS ONE			English	Article							MAMMALIAN TARGET; THERAPEUTIC STRATEGIES; MTOR; CHOLESTEROL; RAPAMYCIN; EXPRESSION; CANCER; TRIAL	Background Everolimus is a mammalian target of rapamycin (mTOR) inhibitor approved for the treatment of metastatic renal cell carcinoma (mRCC). We aimed to assess the association between the baseline values and treatmentrelated modifications of total serum cholesterol (C), triglycerides (T), body mass index (BMI), fasting blood glucose level (FBG) and blood pressure (BP) levels and the outcome of patients treated with everolimus for mRCC. Methods 177 patients were included in this retrospective analysis. Time to progression (TTP), clinical benefit (CB) and overall survival (OS) were evaluated. Results Basal BMI was significantly higher in patients who experienced a CB (p=0,0145). C, T and C+T raises were significantly associated with baseline BMI (p=0.0412, 0.0283 and 0.0001). Median TTP was significantly longer in patients with T raise compared to patients without T (10 vs 6, p=0.030), C (8 vs 5, p=0.042) and C+T raise (10.9 vs 5.0, p=0.003). At the mu analysis, only C+T increase was associated with improved TTP (p=0.005). T raise (21.0 vs 14.0, p=0.002) and C+T increase (21.0 vs 14.0, p=0.006) were correlated with improved OS but were not significant at multivariate analysis. Conclusion C+T raise is an early predictor for everolimus efficacy for patients with mRCC.	[Pantano, Francesco; Guida, Francesco Maria; Silletta, Marianna; Tonini, Giuseppe; Santini, Daniele] Campus Biomed Univ Rome, Dept Med Oncol, I-00128 Rome, Italy; [Santoni, Matteo; Cascinu, Stefano] Univ Politecn Marche, AOU Osped Riuniti, Dept Med Oncol, I-60121 Ancona, Italy; [Procopio, Giuseppe; Verzoni, Elena] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, I-20133 Milan, Italy; [Rizzo, Mimma; Carteni, Giacomo] Cardarelli Hosp, Dept Med Oncol, I-80131 Naples, Italy; [Lacovelli, Roberto; Modica, Daniela] Univ Roma La Sapienza, Dept Oncol, Oncol Unit B, I-00185 Rome, Italy; [Porta, Camillo] IRCCS San Matteo Univ Hosp Fdn, Dept Med Oncol, I-27100 Pavia, Italy; [Conti, Alessandro] Univ Politecn Marche, Dept Clin & Specialist Sci, Urol, I-60121 Ancona, Italy; [Lugini, Antonio; Rauco, Annamaria] San Camillo De Lellis Hosp, Dept Med Oncol, I-02100 Rieti, Italy; [Milella, Michele; Felici, Alessandra] Regina Elena Inst Canc Res, Dept Med Oncol, Med Oncol A, I-00128 Rome, Italy; [Galli, Luca] Azienda Osped Univ Pisana, Dept Med Oncol, I-56126 Pisa, Italy; [Ortega, Cinzia; Ballatore, Valentina] Inst Canc Res & Treatment IRCC, Dept Med Oncol, I-10060 Turin, Italy; [Schinzari, Giovanni] Univ Cattolica Sacro Cuore, Dept Med Oncol, I-00168 Rome, Italy; [Crucitti, Pierfilippo] Campus Biomed Univ Rome, Dept Surg, I-00128 Rome, Italy; [Russo, Antonio] Univ Palermo, Dept Surg Oncol & Oral Sci, Palermo, Italy	University Campus Bio-Medico - Rome Italy; Marche Polytechnic University; Fondazione IRCCS Istituto Nazionale Tumori Milan; Antonio Cardarelli Hospital; Sapienza University Rome; IRCCS Fondazione San Matteo; Marche Polytechnic University; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; University of Pisa; Azienda Ospedaliero Universitaria Pisana; IRCCS Fondazione del Piemonte per l'Oncologia; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University Campus Bio-Medico - Rome Italy; University of Palermo	Santini, D (corresponding author), Campus Biomed Univ Rome, Dept Med Oncol, Via Alvaro del Fortino 200, I-00128 Rome, Italy.	d.santini@unicampus.it	Iacovelli, Roberto/AAB-9850-2019; Cascinu, Stefano/AAN-1923-2020; Verzoni, Elena/K-6025-2016; Porta, Camillo/AAB-9482-2020; Schinzari, Giovanni/AAC-1547-2019; Pantano, Francesco/D-8459-2012; Cascinu, Stefano/G-2399-2017; Procopio, Giuseppe/K-2072-2016; GIACOMO, CARTENI/K-5810-2016; Rizzo, Mimma/AAB-6677-2022; rizzo, mimma/AAB-9892-2020	Iacovelli, Roberto/0000-0002-1750-2117; Verzoni, Elena/0000-0001-9756-6112; Pantano, Francesco/0000-0002-2894-9686; Cascinu, Stefano/0000-0003-2215-0731; Procopio, Giuseppe/0000-0002-2498-402X; GIACOMO, CARTENI/0000-0003-1441-6376; rizzo, mimma/0000-0001-7743-741X; Galli, Luca/0000-0001-6008-0266; Tonini, Giuseppe/0000-0003-4442-8677; Porta, Camillo/0000-0003-2412-1563; Santini, Daniele/0000-0002-9118-3337; Conti, Alessandro/0000-0002-7322-9880; Crucitti, Pierfilippo/0000-0003-1509-6714; Santoni, Matteo/0000-0001-7340-6173				Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Bronte F, 2014, CURR MED CHEM, V21, P966, DOI 10.2174/09298673113209990234; Brugarolas JB, 2003, CANCER CELL, V4, P147, DOI 10.1016/S1535-6108(03)00187-9; Cho DC, 2012, CLIN CANCER RES, V18, P2999, DOI 10.1158/1078-0432.CCR-12-0953; Ciuffreda L, 2010, CURR CANCER DRUG TAR, V10, P484, DOI 10.2174/156800910791517172; Drabkin HA, 2010, ADV CANCER RES, V107, P39, DOI 10.1016/S0065-230X(10)07002-8; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Figlin RA, 2011, J CLIN ONCOL S7, V29; Fujita S, 2007, J PHYSIOL-LONDON, V582, P813, DOI 10.1113/jphysiol.2007.134593; GEBHARD RL, 1987, J LIPID RES, V28, P1177; Gueguen Y, 2007, BASIC CLIN PHARMACOL, V100, P392, DOI 10.1111/j.1742-7843.2007.00066.x; Hartford CM, 2009, CLIN CANCER RES, V15, P1428, DOI 10.1158/1078-0432.CCR-08-2076; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Jellinger Paul S, 2012, Endocr Pract, V18 Suppl 1, P1; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kaelin WG, 2004, CLIN CANCER RES, V10, p6290S, DOI 10.1158/1078-0432.CCR-sup-040025; Kasiske BL, 2008, AM J TRANSPLANT, V8, P1384, DOI 10.1111/j.1600-6143.2008.02272.x; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Lee CK, 2012, CLIN CANCER RES, V18, P3188, DOI 10.1158/1078-0432.CCR-11-3137; Linehan WM, 2010, NAT REV UROL, V7, P277, DOI 10.1038/nrurol.2010.47; Luyimbazi D, 2010, MOL CANCER THER, V9, P2770, DOI 10.1158/1535-7163.MCT-09-0980; Ma KL, 2010, AM J PHYSIOL-HEART C, V298, pH1646, DOI 10.1152/ajpheart.00492.2009; Michaelson MD, 2013, SEMIN ONCOL, V40, P459, DOI 10.1053/j.seminoncol.2013.05.001; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Motzer RJ, 2010, CANCER-AM CANCER SOC, V116, P4256, DOI 10.1002/cncr.25219; Mueller MA, 2008, ATHEROSCLEROSIS, V198, P39, DOI 10.1016/j.atherosclerosis.2007.09.019; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Rolfo C, 2014, EXPERT REV GASTROENT, V8, P875, DOI 10.1586/17474124.2014.922870; Rolfo C, 2014, CANCER TREAT REV, V40, P990, DOI 10.1016/j.ctrv.2014.05.009; Sharpe LJ, 2008, BIOCHEM BIOPH RES CO, V373, P670, DOI 10.1016/j.bbrc.2008.06.108; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Singer EA, 2012, CURR OPIN ONCOL, V24, P284, DOI 10.1097/CCO.0b013e328351c646; Soliman GA, 2011, CELL CYCLE, V10, P861, DOI 10.4161/cc.10.6.14930; Tee AR, 2005, SEMIN CELL DEV BIOL, V16, P29, DOI 10.1016/j.semcdb.2004.11.005; Tokunaga C, 2004, BIOCHEM BIOPH RES CO, V313, P443, DOI 10.1016/j.bbrc.2003.07.019; Wang BT, 2011, P NATL ACAD SCI USA, V108, P15201, DOI 10.1073/pnas.1103746108; WHO CRITERIA, 2000, THE INTERNATIONAL CL; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhang C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054465, 10.1371/journal.pone.0059840, 10.1371/journal.pone.0059796, 10.1371/journal.pone.0066382]	40	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0120427	10.1371/journal.pone.0120427	http://dx.doi.org/10.1371/journal.pone.0120427			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885920	Green Published, gold, Green Submitted			2022-12-26	WOS:000353017000009
J	Rivera-Pagan, AF; Rivera-Aponte, DE; Melnik-Martinez, KV; Zayas-Santiago, A; Kucheryavykh, LY; Martins, AH; Cubano, LA; Skatchkov, SN; Eaton, MJ				Rivera-Pagan, Aixa F.; Rivera-Aponte, David E.; Melnik-Martinez, Katya V.; Zayas-Santiago, Astrid; Kucheryavykh, Lilia Y.; Martins, Antonio H.; Cubano, Luis A.; Skatchkov, Serguei N.; Eaton, Misty J.			Up-Regulation of TREK-2 Potassium Channels in Cultured Astrocytes Requires De Novo Protein Synthesis: Relevance to Localization of TREK-2 Channels in Astrocytes after Transient Cerebral Ischemia	PLOS ONE			English	Article							MESSENGER-RNA TRANSLATION; K+ CHANNEL; P-BODIES; CORTICAL ASTROCYTES; GLUTAMATE UPTAKE; BRAIN ISCHEMIA; GLIAL-CELLS; EXPRESSION; DEGRADATION; KIR4.1	Excitotoxicity due to glutamate receptor over-activation is one of the key mediators of neuronal death after an ischemic insult. Therefore, a major function of astrocytes is to maintain low extracellular levels of glutamate. The ability of astrocytic glutamate transporters to regulate the extracellular glutamate concentration depends upon the hyperpolarized membrane potential of astrocytes conferred by the presence of K+ channels in their membranes. We have previously shown that TREK-2 potassium channels in cultured astrocytes are up-regulated by ischemia and may support glutamate clearance by astrocytes during ischemia. Thus, herein we determine the mechanism leading to this up-regulation and assess the localization of TREK-2 channels in astrocytes after transient middle cerebral artery occlusion. By using a cell surface biotinylation assay we confirmed that functional TREK-2 protein is up-regulated in the astrocytic membrane after ischemic conditions. Using real time RTPCR, we determined that the levels of TREK-2 mRNA were not increased in response to ischemic conditions. By using Western blot and a variety of protein synthesis inhibitors, we demonstrated that the increase of TREK-2 protein expression requires De novo protein synthesis, while protein degradation pathways do not contribute to TREK-2 up-regulation after ischemic conditions. Immunohistochemical studies revealed TREK-2 localization in astrocytes together with increased expression of the selective glial marker, glial fibrillary acidic protein, in brain 24 hours after transient middle cerebral occlusion. Our data indicate that functional TREK-2 channels are up-regulated in the astrocytic membrane during ischemia through a mechanism requiring De novo protein synthesis. This study provides important information about the mechanisms underlying TREK-2 regulation, which has profound implications in neurological diseases such as ischemia where astrocytes play an important role.	[Rivera-Pagan, Aixa F.; Rivera-Aponte, David E.; Melnik-Martinez, Katya V.; Kucheryavykh, Lilia Y.; Martins, Antonio H.; Skatchkov, Serguei N.; Eaton, Misty J.] Univ Cent Caribe, Dept Biochem, Bayamon, PR 00960 USA; [Cubano, Luis A.] Univ Cent Caribe, Dept Anat, Bayamon, PR USA; [Cubano, Luis A.] Univ Cent Caribe, Dept Cell Biol, Bayamon, PR USA; [Zayas-Santiago, Astrid; Skatchkov, Serguei N.] Univ Cent Caribe, Dept Physiol, Bayamon, PR USA		Rivera-Pagan, AF (corresponding author), Univ Cent Caribe, Dept Biochem, Bayamon, PR 00960 USA.	aixafernanda@gmail.com; serguei.skatchkov@uccaribe.edu		Zayas-Santiago, Astrid/0000-0003-4028-0564	National Institute of General Medical Sciences [SC1-GM088019]; National Institute of Neurological Disorders and Stroke [R01-NS065201]; National Institute of Minority Health and Health Disparities [G12-MD007583]; Office of the Associate Dean for Research and Graduate Studies (OADRGS) Predoctoral Scholarship; US Department of Education [P031M105050]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM110513, SC1GM088019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065201] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007583] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Office of the Associate Dean for Research and Graduate Studies (OADRGS) Predoctoral Scholarship; US Department of Education(US Department of Education); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Support was provided by: National Institute of General Medical Sciences: SC1-GM088019 (to MJE); National Institute of Neurological Disorders and Stroke: R01-NS065201 (to SNS); National Institute of Minority Health and Health Disparities: G12-MD007583 (for core facilities); Office of the Associate Dean for Research and Graduate Studies (OADRGS) Predoctoral Scholarship (to AFRP); Title V Promoting Postbaccalaureate Opportunities for Hispanic Americans (PPOHA) grant number P031M105050 from the US Department of Education (to LAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang H, 2000, J BIOL CHEM, V275, P17412, DOI 10.1074/jbc.M000445200; BURTRUM D, 1994, EXP NEUROL, V126, P112, DOI 10.1006/exnr.1994.1047; CHUA B, 1979, J BIOL CHEM, V254, P6617; Doerr A, 2011, NAT METHODS, V8, P711, DOI 10.1038/nmeth.1686; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Ferroni S, 2003, J NEUROSCI RES, V72, P363, DOI 10.1002/jnr.10580; Ford G, 2006, BRAIN RES, V1071, P226, DOI 10.1016/j.brainres.2005.11.090; Gnatenco C, 2002, BRAIN RES, V931, P56, DOI 10.1016/S0006-8993(02)02261-8; Huang DY, 2008, MED HYPOTHESES, V70, P618, DOI 10.1016/j.mehy.2007.06.016; KEMPSKI O, 1991, ANN NY ACAD SCI, V633, P306; Kim D, 2003, TRENDS PHARMACOL SCI, V24, P648, DOI 10.1016/j.tips.2003.10.008; Kucheryavykh Lilia Y, 2009, Open Neurosci J, V3, P40; Kucheryavykh YV, 2007, GLIA, V55, P274, DOI 10.1002/glia.20455; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Lent R, 2012, EUR J NEUROSCI, V35, P1, DOI 10.1111/j.1460-9568.2011.07923.x; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; Li ZB, 2005, BIOCHEM BIOPH RES CO, V327, P1163, DOI 10.1016/j.bbrc.2004.12.124; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Marx J, 2005, SCIENCE, V310, P764, DOI 10.1126/science.310.5749.764; Matsuyama N, 2000, CIRCULATION S3, V102; NEDERGAARD M, 1993, J CEREBR BLOOD F MET, V13, P568, DOI 10.1038/jcbfm.1993.74; Neusch C, 2006, J NEUROPHYSIOL, V95, P1843, DOI 10.1152/jn.00996.2005; Olsen ML, 2007, J NEUROPHYSIOL, V98, P786, DOI 10.1152/jn.00340.2007; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pivonkova H, 2010, NEUROCHEM INT, V57, P783, DOI 10.1016/j.neuint.2010.08.016; Plesnila N, 1999, J NEUROTRAUM, V16, P831, DOI 10.1089/neu.1999.16.831; REHNCRONA S, 1982, J NEUROCHEM, V38, P84, DOI 10.1111/j.1471-4159.1982.tb10857.x; Seifert G, 2009, J NEUROSCI, V29, P7474, DOI 10.1523/JNEUROSCI.3790-08.2009; Skatchkov SN, 2006, GLIA, V53, P266, DOI 10.1002/glia.20280; Stanimirovic DB, 1997, GLIA, V19, P123, DOI 10.1002/(SICI)1098-1136(199702)19:2<123::AID-GLIA4>3.0.CO;2-1; Taylor MH, 2002, FEBS LETT, V514, P199, DOI 10.1016/S0014-5793(02)02364-5; Thomzig A, 2001, MOL CELL NEUROSCI, V18, P671, DOI 10.1006/mcne.2001.1048; Valenzuela SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056948; Whitfield J., 2003, NATURE REV MOL CELL, V3, P112; Wilkie GS, 2003, TRENDS BIOCHEM SCI, V28, P182, DOI 10.1016/S0968-0004(03)00051-3; Wu X, 2013, J MOL NEUROSCI, V49, P499, DOI 10.1007/s12031-012-9875-5; Xu XH, 2004, MOL BRAIN RES, V120, P205, DOI 10.1016/j.molbrainres.2003.09.020; YOSHIKAWA M, 1978, PLANT PHYSIOL, V61, P314, DOI 10.1104/pp.61.3.314; Zayas-Santiago A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097155	39	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0125195	10.1371/journal.pone.0125195	http://dx.doi.org/10.1371/journal.pone.0125195			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886567	Green Submitted, gold, Green Published			2022-12-26	WOS:000353017000154
J	Gong, C; Liu, BD; Yao, YD; Qu, SH; Luo, W; Tan, WG; Liu, Q; Yao, HR; Zou, L; Su, FX; Song, EW				Gong, Chang; Liu, Bodu; Yao, Yandan; Qu, Shaohua; Luo, Wei; Tan, Weige; Liu, Qiang; Yao, Herui; Zou, Lee; Su, Fengxi; Song, Erwei			Potentiated DNA Damage Response in Circulating Breast Tumor Cells Confers Resistance to Chemotherapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TRIPLE-NEGATIVE BREAST; CANCER-PATIENTS; SURVIVAL; REPAIR; COMBINATION; METASTASIS; MECHANISMS; EXPRESSION; INHIBITORS	Circulating tumor cells (CTCs) are seeds for cancer metastasis and are predictive of poor prognosis in breast cancer patients. Whether CTCs and primary tumor cells (PTCs) respond to chemotherapy differently is not known. Here, we show that CTCs of breast cancer are more resistant to chemotherapy than PTCs because of potentiated DNA repair. Surprisingly, the chemoresistance of CTCs was recapitulated in PTCs when they were detached from the extracellular matrix. Detachment of PTCs increased the levels of reactive oxygen species and partially activated the DNA damage checkpoint, converting PTCs to a CTC-like state. Inhibition of checkpoint kinases Chk1 and Chk2 in CTCs reduces the basal checkpoint response and sensitizes CTCs to DNA damage in vitro and in mouse xenografts. Our results suggest that DNA damage checkpoint inhibitors may benefit the chemotherapy of breast cancer patients by sup-pressing the chemoresistance of CTCs and reducing the risk of cancer metastasis.	[Gong, Chang; Liu, Bodu; Yao, Yandan; Qu, Shaohua; Luo, Wei; Tan, Weige; Liu, Qiang; Song, Erwei] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou 510120, Guangdong, Peoples R China; [Gong, Chang; Liu, Bodu; Yao, Yandan; Qu, Shaohua; Luo, Wei; Tan, Weige; Liu, Qiang; Su, Fengxi; Song, Erwei] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Breast Tumor Ctr, Guangzhou 510120, Guangdong, Peoples R China; [Yao, Herui] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Med Oncol, Guangzhou 510120, Guangdong, Peoples R China; [Zou, Lee] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Harvard University; Massachusetts General Hospital	Su, FX (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Breast Tumor Ctr, 107 Yanjiang West Rd, Guangzhou 510120, Guangdong, Peoples R China.	fengxisu@vip.163.com; songerwei02@aliyun.com	Liu, Bodu/G-5222-2016; Liu, Qiang/HHZ-3181-2022; Liu, Bodu/AAR-9402-2021	Liu, Bodu/0000-0003-2097-725X; Liu, Bodu/0000-0003-2097-725X; Liu, Qiang/0000-0002-5451-4862	Ministry of Science and Technology of China [2011CB504203]; Natural Science Foundation of China [81172524, 81230060, 81261140373, 81272893, 81102023, 81372819, 81372817, 81272894, 81272897, 81472466, 81490751, 81442009]; Specialized Research Fund for the Doctoral Program of Higher Education Grant [20120171110075]; Program for New Century Excellent Talents in University [NCET-12-0565]; National Science Foundation of Guangdong Province [2011A080300002, 2014A03036003, S2012030006287, 2014A030310378]; Guangdong Department of Science and Technology Translational Medicine Center [2011A080300002]; Guangzhou Science and Technology Bureau [2012J2200092, 2014J4100170]; Sun Yat-sen University Training Project [12ykpy32, 13ykzd14]; Special Project on New Drug Innovation of Sun Yat-sen University; Elite Young Scholars Program of Sun Yat-sen Memorial Hospital [Y201401]; Yat-Sen Scholarship for Young Scientist and Translational Medicine Public Platform of Guangdong Province [4202037]; Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes [KLB09001]; Sun Yat-Sen University; Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology [(2013)163]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education Grant; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Guangdong Department of Science and Technology Translational Medicine Center; Guangzhou Science and Technology Bureau; Sun Yat-sen University Training Project; Special Project on New Drug Innovation of Sun Yat-sen University; Elite Young Scholars Program of Sun Yat-sen Memorial Hospital; Yat-Sen Scholarship for Young Scientist and Translational Medicine Public Platform of Guangdong Province; Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes; Sun Yat-Sen University; Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology	This work was supported by 973 Grant 2011CB504203 from Projects from Ministry of Science and Technology of China; Natural Science Foundation of China Grants 81172524, 81230060, 81261140373, 81272893, 81102023, 81372819, 81372817, 81272894, 81272897, 81472466, 81490751, and 81442009; Specialized Research Fund for the Doctoral Program of Higher Education Grant 20120171110075; Program for New Century Excellent Talents in University Grant NCET-12-0565; National Science Foundation of Guangdong Province Grants 2011A080300002, 2014A03036003, S2012030006287, and 2014A030310378; Guangdong Department of Science and Technology Translational Medicine Center Grant 2011A080300002; Guangzhou Science and Technology Bureau Grants 2012J2200092 and 2014J4100170; Sun Yat-sen University Training Project Grants 12ykpy32 and 13ykzd14; Special Project on New Drug Innovation of Sun Yat-sen University; Elite Young Scholars Program of Sun Yat-sen Memorial Hospital Grant Y201401; Yat-Sen Scholarship for Young Scientist and Translational Medicine Public Platform of Guangdong Province Grant 4202037; Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes Grant KLB09001; Sun Yat-Sen University; and Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology Grant (2013)163.	Al-Ejeh F, 2010, ONCOGENE, V29, P6085, DOI 10.1038/onc.2010.407; Alagoz M, 2012, CURR MED CHEM, V19, P3874, DOI 10.2174/092986712802002590; Alix-Panabieres C, 2008, CLIN CANCER RES, V14, P5013, DOI 10.1158/1078-0432.CCR-07-5125; Ashwell S, 2008, EXPERT OPIN INV DRUG, V17, P1331, DOI [10.1517/13543784.17.9.1331, 10.1517/13543784.17.9.1331 ]; Avivar-Valderas A, 2011, MOL CELL BIOL, V31, P3616, DOI 10.1128/MCB.05164-11; Barbazan J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040476; Bi HS, 2013, BBA-GEN SUBJECTS, V1830, P4899, DOI 10.1016/j.bbagen.2013.06.026; Boldin MP, 2012, IMMUNOL REV, V246, P205, DOI 10.1111/j.1600-065X.2011.01089.x; Bryant C, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-570; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Dai Y, 2010, CLIN CANCER RES, V16, P376, DOI 10.1158/1078-0432.CCR-09-1029; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; De Giorgi U, 2009, J CLIN ONCOL, V27, P3303, DOI 10.1200/JCO.2008.19.4423; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Gingery A, 2003, J CELL BIOCHEM, V89, P165, DOI 10.1002/jcb.10503; Hayashi N, 2012, INT J CLIN ONCOL, V17, P96, DOI 10.1007/s10147-011-0260-0; Helleday T, 2010, CARCINOGENESIS, V31, P955, DOI 10.1093/carcin/bgq064; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Hong JP, 2013, ANN PLAS SURG, V71, P380, DOI 10.1097/SAP.0b013e3182503ac5; Howard EW, 2008, CLIN EXP METASTAS, V25, P497, DOI 10.1007/s10585-008-9157-3; Iwatsuki M, 2013, BRIT J CANCER, V109, P2829, DOI 10.1038/bjc.2013.680; Kasimir-Bauer S, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3099; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Krebs MG, 2011, J CLIN ONCOL, V29, P1556, DOI 10.1200/JCO.2010.28.7045; Ksiazkiewicz M, 2012, PATHOBIOLOGY, V79, P195, DOI 10.1159/000337106; Ma CX, 2013, BREAST CANCER RES TR, V137, P483, DOI 10.1007/s10549-012-2378-9; Maheswaran S, 2010, CURR OPIN GENET DEV, V20, P96, DOI 10.1016/j.gde.2009.12.002; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Negin BP, 2010, CURR TREAT OPTION ON, V11, P1, DOI 10.1007/s11864-010-0115-3; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Ozkumur E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005616; Park YY, 2012, CARCINOGENESIS, V33, P1843, DOI 10.1093/carcin/bgs167; Pilati P, 2012, ANN SURG ONCOL, V19, P402, DOI 10.1245/s10434-011-2132-2; Poehlmann A, 2010, PATHOL RES PRACT, V206, P591, DOI 10.1016/j.prp.2010.06.006; Rack B, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju066; Rai P, 2010, MUTAT RES-GEN TOX EN, V703, P71, DOI 10.1016/j.mrgentox.2010.07.010; Ravid A, 1999, CANCER RES, V59, P862; Rossi E, 2012, BRIT J CANCER, V107, P1286, DOI 10.1038/bjc.2012.388; Sausville E, 2014, CANCER CHEMOTH PHARM, V73, P539, DOI 10.1007/s00280-014-2380-5; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Sherman MH, 2011, TRENDS CELL BIOL, V21, P312, DOI 10.1016/j.tcb.2011.01.004; Tobin LA, 2012, MOL CANCER RES, V10, P96, DOI 10.1158/1541-7786.MCR-11-0255; Wan Y, 2010, CELL CYCLE, V9, P3391, DOI 10.4161/cc.9.17.13122; Wang MW, 2013, APOPTOSIS, V18, P238, DOI 10.1007/s10495-012-0788-0; Xu Y, 2011, CELL CYCLE, V10, P261, DOI 10.4161/cc.10.2.14543; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu M, 2014, SCIENCE, V345, P216, DOI 10.1126/science.1253533; Zhong XL, 2012, CELL SIGNAL, V24, P393, DOI 10.1016/j.cellsig.2011.10.005	48	28	29	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					14811	14825		10.1074/jbc.M115.652628	http://dx.doi.org/10.1074/jbc.M115.652628			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25897074	Green Published, hybrid			2022-12-26	WOS:000356177300002
J	Wang, YJ; Thorin, E; Luo, HY; Tremblay, J; Lavoie, JL; Wu, ZH; Peng, JZ; Qi, SJ; Wu, JP				Wang, Yujia; Thorin, Eric; Luo, Hongyu; Tremblay, Johanne; Lavoie, Julie L.; Wu, Zenghui; Peng, Junzheng; Qi, Shijie; Wu, Jiangping			EPHB4 Protein Expression in Vascular Smooth Muscle Cells Regulates Their Contractility, and EPHB4 Deletion Leads to Hypotension in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-PRESSURE; SIGNAL-TRANSDUCTION; TRANSGENIC MICE; EPHRINB LIGANDS; CROSS-LINKING; RECEPTORS; NEOVASCULARIZATION; PHOSPHORYLATION; COSTIMULATION; ANGIOGENESIS	EPH kinases are the largest family of receptor tyrosine kinases, and their ligands, ephrins (EFNs), are also cell surface molecules. This work presents evidence that EPHB4 on vascular smooth muscle cells (VSMCs) is involved in blood pressure regulation. We generated gene KO mice with smooth muscle cell-specific deletion of EPHB4. Male KO mice, but not female KO mice, were hypotensive. VSMCs from male KO mice showed reduced contractility when compared with their WT counterparts. Signaling both from EFNBs to EPHB4 (forward signaling) and from EPHB4 to EFNB2 (reverse signaling) modulated VSMC contractility. At the molecular level, the absence of EPHB4 in VSMCs resulted in compromised signaling from Ca2+/calmodulin-dependent protein kinase II (CaMKII) to myosin light chain kinase (MLCK) to myosin light chain, the last of which controls the contraction force of motor molecule myosin. Near the cell membrane, an adaptor protein GRIP1, which can associate with EFNB2, was found to be essential in mediating EPHB4-to-EFNB reverse signaling, which regulated VSMC contractility, based on siRNA gene knockdown studies. Our research indicates that EPHB4 plays an essential role in regulating small artery contractility and blood pressure.	[Wang, Yujia; Luo, Hongyu; Tremblay, Johanne; Lavoie, Julie L.; Wu, Zenghui; Peng, Junzheng; Qi, Shijie; Wu, Jiangping] Ctr Hosp Univ Montreal CRCHUM, Res Ctr, Montreal, PQ H2X 0A9, Canada; [Thorin, Eric] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Lavoie, Julie L.] Univ Montreal, Dept Kinesiol, Montreal, PQ H3T 1J4, Canada; [Wu, Jiangping] CHUM, Serv Nephrol, Montreal, PQ H2L 4M1, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Wu, JP (corresponding author), CRCHUM, 900 Rue St Denis,Rm R12-428, Montreal, PQ H2X 0A9, Canada.	jianping.wu@umontreal.ca	Cossette, Suzanne/I-8008-2016; Thorin, Eric/K-3978-2013; Lavoie, Julie/F-2288-2013	Thorin, Eric/0000-0001-5827-8935; Lavoie, Julie/0000-0001-6316-2769	Canadian Institutes of Health Research [MOP57697, MOP69089, MOP123389, MOP97829, MOP14496, ISO106797]; Heart and Stroke Foundation of Quebec; Natural Sciences and Engineering Research Council of Canada [203906-2012]; Juvenile Diabetes Research Foundation [17-2013-440]; J.-Louis Levesque Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Quebec; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); J.-Louis Levesque Foundation	This work was supported by Canadian Institutes of Health Research Grants MOP57697, MOP69089, and MOP123389 (to J. W.), MOP97829 (to H. L.), MOP14496, (to E. T.) and ISO106797 (to J. T.). This work was also funded by grants from the Heart and Stroke Foundation of Quebec, the Natural Sciences and Engineering Research Council of Canada (203906-2012), the Juvenile Diabetes Research Foundation (17-2013-440), and the J.-Louis Levesque Foundation (to J. W.).	Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Bruckner K, 1999, NEURON, V22, P511, DOI 10.1016/S0896-6273(00)80706-0; Cheng N, 2002, CYTOKINE GROWTH F R, V13, P75, DOI 10.1016/S1359-6101(01)00031-4; Dravis C, 2007, HEARING RES, V223, P93, DOI 10.1016/j.heares.2006.10.007; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Flanagan JG, 1997, CELL, V90, P403; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Gale NW, 2001, DEV BIOL, V230, P151, DOI 10.1006/dbio.2000.0112; Golovina VA, 2006, NAT PROTOC, V1, P2681, DOI 10.1038/nprot.2006.425; Hashimoto T, 2007, KIDNEY INT, V72, P954, DOI 10.1038/sj.ki.5002454; Konstantinova I, 2007, CELL, V129, P359, DOI 10.1016/j.cell.2007.02.044; Lavoie JL, 2004, AM J PHYSIOL-RENAL, V286, pF965, DOI 10.1152/ajprenal.00402.2003; Luo HY, 2012, J BIOL CHEM, V287, P6819, DOI 10.1074/jbc.M111.293365; Luo HY, 2011, J BIOL CHEM, V286, P44976, DOI 10.1074/jbc.M111.316414; Luo HY, 2011, J BIOL CHEM, V286, P41135, DOI 10.1074/jbc.M111.302596; Luo HY, 2001, J IMMUNOL, V167, P1362, DOI 10.4049/jimmunol.167.3.1362; Luo HY, 2002, J CLIN INVEST, V110, P1141, DOI 10.1172/JCI200215883; Luo HY, 2004, J CLIN INVEST, V114, P1762, DOI 10.1172/JCI200421846; Martiny-Baron G, 2010, ANGIOGENESIS, V13, P259, DOI 10.1007/s10456-010-9183-z; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pfitzer G, 2001, J APPL PHYSIOL, V91, P497, DOI 10.1152/jappl.2001.91.1.497; Rogatsky I, 2003, P NATL ACAD SCI USA, V100, P13845, DOI 10.1073/pnas.2336092100; Sallstrom J, 2013, AM J PHYSIOL-RENAL, V305, pF71, DOI 10.1152/ajprenal.00694.2012; Salvucci O, 2006, BLOOD, V108, P2914, DOI 10.1182/blood-2006-05-023341; Salvucci O, 2012, ADV CANCER RES, V114, P21, DOI 10.1016/B978-0-12-386503-8.00002-8; Shin D, 2001, DEV BIOL, V230, P139, DOI 10.1006/dbio.2000.9957; TANSEY MG, 1992, J BIOL CHEM, V267, P12511; Wnuk M, 2012, KIDNEY INT, V81, P1212, DOI 10.1038/ki.2012.17; Wu J., 2014, European Patent Office, application, Patent No. [EP14183830, 14183830]; Wu Jiangping, 2005, Curr Opin Hematol, V12, P292, DOI 10.1097/01.moh.0000166497.26397.9f; Wu ZH, 2012, J BIOL CHEM, V287, P15557, DOI 10.1074/jbc.M112.340869; Xin HB, 2002, PHYSIOL GENOMICS, V10, P211, DOI 10.1152/physiolgenomics.00054.2002; Yu G, 2006, J BIOL CHEM, V281, P10222, DOI 10.1074/jbc.M510320200; Yu G, 2003, J IMMUNOL, V171, P106, DOI 10.4049/jimmunol.171.1.106; Yu G, 2004, J BIOL CHEM, V279, P55531, DOI 10.1074/jbc.M410814200; Yu G, 2003, J BIOL CHEM, V278, P47209, DOI 10.1074/jbc.M306659200	36	25	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					14235	14244		10.1074/jbc.M114.621615	http://dx.doi.org/10.1074/jbc.M114.621615			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25903126	Green Published, hybrid			2022-12-26	WOS:000355313000050
J	Brady, RA; Bruno, VM; Burns, DL				Brady, Rebecca A.; Bruno, Vincent M.; Burns, Drusilla L.			RNA-Seq Analysis of the Host Response to Staphylococcus aureus Skin and Soft Tissue Infection in a Mouse Model	PLOS ONE			English	Article							REGULATES INNATE IMMUNITY; UNITED-STATES; KERATIN 1; INFLAMMATION; EXPRESSION; NEUTROPHILS; ACTIVATION; MECHANISMS; GAMMA	Staphylococcus aureus is a leading cause of skin and soft tissue infections (SSTI), which are primarily self-limiting. We conducted a comprehensive analysis of the host transcriptome during a S. aureus SSTI to provide insight on the protective mechanisms that thwart these infections. We utilized a murine SSTI model in which one ear is epicutaneously challenged while the other is not. We then harvested these infected and uninfected ears, as well as ears from naive mice, at one, four, and seven days post-challenge, and performed RNA sequencing (RNA-seq) using the Illumina platform. RNA-seq data demonstrated a robust response at the site of infection. Comparison of gene expression profiles between infected ears and the non-infected ears of challenged mice defined the local response to infection, while comparisons of expression profiles of non-infected ears from challenged mice to ears of naive mice revealed changes in gene expression levels away from the site indicative of a systemic response. Over 1000 genes exhibited increased expression locally at all tested time points. The local response was more robust than the systemic response. Through evaluation of the RNA-seq data using the Upstream Regulator Analytic as part of the Ingenuity Pathway Analysis software package, we found that changes in the activation and inhibition of regulatory pathways happen first locally, and lag behind systemically. The activated pathways are highly similar at all three time points during SSTI, suggesting a stable global response over time. Transcript increases and pathway activation involve pro- and anti-inflammatory mediators, chemotaxis, cell signaling, keratins, and TH1/TH17 cytokines. Transcript decreases and pathway inhibition demonstrate that metabolic genes and anti-inflammatory pathways are repressed. These data provide insight on the host responses that may aid in resolution of this self-limited S. aureus infection, and may shed light on potential immune correlates of protection for staphylococcal SSTI.	[Brady, Rebecca A.; Burns, Drusilla L.] US FDA, Div Bacterial Parasit & Allergen Prod, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Bruno, Vincent M.] Univ Maryland, Inst Genome Sci, Baltimore, MD 21201 USA	US Food & Drug Administration (FDA); University System of Maryland; University of Maryland Baltimore	Brady, RA (corresponding author), US FDA, Div Bacterial Parasit & Allergen Prod, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	Rebecca.Brady@fda.hhs.gov			Intramural Research Program of the Center for Biologics Evaluation and Research, Food and Drug Administration; National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH); Department of Health and Human Services [HHSN272200900009C]	Intramural Research Program of the Center for Biologics Evaluation and Research, Food and Drug Administration; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services	This work was supported by the Intramural Research Program of the Center for Biologics Evaluation and Research, Food and Drug Administration. The sequencing for this project was funded by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), and Department of Health and Human Services under contract number HHSN272200900009C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Anand PK, 2012, NATURE, V488, P389, DOI 10.1038/nature11250; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bixel G, 2004, BLOOD, V104, P3205, DOI 10.1182/blood-2004-03-1184; Bolling MC, 2010, BRIT J DERMATOL, V162, P875, DOI 10.1111/j.1365-2133.2009.09617.x; Brady BL, 2013, IMMUNOL CELL BIOL, V91, P331, DOI 10.1038/icb.2013.19; Brady RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063040; Bratke K, 2005, EUR J IMMUNOL, V35, P2608, DOI 10.1002/eji.200526122; Brownlie RJ, 2013, NAT REV IMMUNOL, V13, P257, DOI 10.1038/nri3403; Carow B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00058; Cho JS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003047; Cho JS, 2011, J INVEST DERMATOL, V131, P907, DOI 10.1038/jid.2010.417; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Cogen AL, 2010, J INVEST DERMATOL, V130, P192, DOI 10.1038/jid.2009.243; DePianto D, 2010, NAT GENET, V42, P910, DOI 10.1038/ng.665; Gasiorowski RE, 2013, IMMUNOL LETT, V149, P93, DOI 10.1016/j.imlet.2012.10.005; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Haim M, 2010, MICROBIOL-SGM, V156, P3710, DOI 10.1099/mic.0.034413-0; Hunold K, 2012, IMMUNOBIOLOGY, V217, P982, DOI 10.1016/j.imbio.2012.01.013; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Krespi YP, 2012, AM J OTOLARYNG, V33, P572, DOI 10.1016/j.amjoto.2012.02.002; Kuijpers TW, 2010, J CLIN INVEST, V120, P214, DOI 10.1172/JCI40231; Lacotte S, 2009, ANN NY ACAD SCI, V1173, P310, DOI 10.1111/j.1749-6632.2009.04813.x; Lessard JC, 2013, P NATL ACAD SCI USA, V110, P19537, DOI 10.1073/pnas.1309576110; Li YK, 2013, J BIOL CHEM, V288, P16225, DOI 10.1074/jbc.M113.454538; Liu WL, 2010, P NATL ACAD SCI USA, V107, P11056, DOI 10.1073/pnas.1001269107; Mocca CP, 2014, CLIN VACCINE IMMUNOL; Molne L, 2000, INFECT IMMUN, V68, P6162, DOI 10.1128/IAI.68.11.6162-6167.2000; Montgomery CP, 2014, INFECT IMMUN, V82, P2125, DOI 10.1128/IAI.01491-14; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Nakahira M, 2002, J IMMUNOL, V168, P1146, DOI 10.4049/jimmunol.168.3.1146; Nippe N, 2011, J INVEST DERMATOL, V131, P125, DOI 10.1038/jid.2010.282; Nold MF, 2010, NAT IMMUNOL, V11, P1014, DOI 10.1038/ni.1944; Pasparakis M, 2014, NAT REV IMMUNOL, V14, P289, DOI 10.1038/nri3646; Plaut RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059232; Prabhakara R, 2013, INFECT IMMUN, V81, P1306, DOI 10.1128/IAI.01304-12; Roth W, 2012, J CELL SCI, V125, P5269, DOI 10.1242/jcs.116574; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; Thorn CF, 2002, J IMMUNOL, V169, P399, DOI 10.4049/jimmunol.169.1.399; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Walker JA, 2008, IMMUNOLOGY, V123, P314, DOI 10.1111/j.1365-2567.2007.02752.x; Zaki MH, 2011, CANCER CELL, V20, P649, DOI 10.1016/j.ccr.2011.10.022; Zetola N, 2005, LANCET INFECT DIS, V5, P275, DOI 10.1016/S1473-3099(05)70112-2; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644	47	18	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124877	10.1371/journal.pone.0124877	http://dx.doi.org/10.1371/journal.pone.0124877			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901897	Green Submitted, Green Published, gold			2022-12-26	WOS:000353331500103
J	Clennin, MN; Payne, JPW; Rienzi, EG; Lavie, CJ; Blair, SN; Pate, RR; Sui, XM				Clennin, Morgan N.; Payne, Jonathan P. W.; Rienzi, Edgardo G.; Lavie, Carl J.; Blair, Steven N.; Pate, Russell R.; Sui, Xuemei			Association between Cardiorespiratory Fitness and Health-Related Quality of Life among Patients at Risk for Cardiovascular Disease in Uruguay	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; CLINICAL CARDIOLOGY; PUBLIC-HEALTH; MENTAL-HEALTH; EXERCISE; INACTIVITY; STATEMENT; ADULTS; REHABILITATION; PERCEPTIONS	To date, few studies have examined the relationship between cardiorespiratory fitness (CRF) and health-related quality of life (HRQoL) in populations at high risk for developing cardiovascular disease (CVD). Purpose To examine the association between objectively measured CRF and physical and mental components of HRQoL in a Uruguayan cohort at risk for developing CVD. Methods Patient data records from 2002-2012 at the Calidad de Vida Center were examined. To assess CRF, participants performed a submaximal exercise test. During the evaluation, participants also completed the SF-36, a HRQoL measure comprised of eight dimensions that are summarized by physical and mental component scores (PCS and MCS, respectively). ANCOVA was used to examine the relationship between HRQoL dimensions and CRF. Logistic regression was then used to compare the odds of having a HRQoL component score above the norm across CRF. All analyses were performed separately for males and females with additional stratified analyses across age and BMI conducted among significant trends. Results A total of 2,302 subjects were included in the analysis. Among females, a significant relationship was observed between CRF and vitality, physical functioning, physical role, bodily pain, and general health dimensions. However, for males the only dimension found to be significantly associated with CRF was physical health. After adjusting for potential con-founders, a significant linear trend (p<0.001) for PCS scores above the norm across CRF levels was observed for females only. Conclusion Among females with one or more risk factors for developing CVD, higher levels of CRF were positively associated with the vitality and physical dimensions of HRQoL, as well as the overall PCS. However, among males the only dimension associated with CRF was physical functioning. Future studies should examine this relationship among populations at risk for developing CVD in more detail and over time.	[Clennin, Morgan N.; Payne, Jonathan P. W.; Blair, Steven N.; Pate, Russell R.; Sui, Xuemei] Univ S Carolina, Arnold Sch Publ Hlth, Dept Exercise Sci, Columbia, SC 29208 USA; [Rienzi, Edgardo G.] Asociac Espanola, Ctr Calidad Vida, Especialista Med Deporte, Montevideo, Uruguay; [Lavie, Carl J.] Univ Queensland, Sch Med, Ochsner Clin School, John Ochsner Heart & Vasc Inst,Dept Cardiovasc Di, New Orleans, LA USA; [Lavie, Carl J.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Dept Prevent Med, Baton Rouge, LA USA; [Blair, Steven N.] Univ S Carolina, Arnold Sch Publ Hlth, Dept Epidemiol & Biostat, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Ochsner Health System; University of Queensland; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Sui, XM (corresponding author), Univ S Carolina, Arnold Sch Publ Hlth, Dept Exercise Sci, Columbia, SC 29208 USA.	msui@mailbox.sc.edu	Lavie, Carl J/A-6014-2011		La Banca Company in Uruguay	La Banca Company in Uruguay	Funding for this project was provided through an unrestricted grant from the La Banca Company in Uruguay. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Sports Medicine, 2003, ACSMS GUID EX TEST P; Annoni I, 2013, SPORT SCI HLTH S, V9, P73; [Anonymous], 2007, CIRCULATION, DOI DOI 10.1161/CIRCULATIONAHA.107.185649; Bennett WL, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-110; Beyler N, 2008, P SURV RES METH SECT, P3282; Bize R, 2007, PREV MED, V45, P401, DOI 10.1016/j.ypmed.2007.07.017; Blair SN, 2001, MED SCI SPORT EXER, V33, pS379, DOI 10.1097/00005768-200106001-00007; Blair SN, 2009, BRIT J SPORT MED, V43, P1; Bouchard C, 1999, J APPL PHYSIOL, V87, P1003, DOI 10.1152/jappl.1999.87.3.1003; Bouchard C, 1998, MED SCI SPORT EXER, V30, P252, DOI 10.1097/00005768-199802000-00013; Brand R, 2006, SOZ PRAVENTIV MED, V51, P14, DOI 10.1007/s00038-005-0002-z; Chai WW, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-83; Chodzko-Zajko W, 2009, AM J LIFESTYLE MED, V3, P20, DOI 10.1177/1559827608325456; Deaton C, 2011, EUR J CARDIOVASC NUR, V10, pS5, DOI 10.1016/S1474-5151(11)00111-3; Eriksen L, 2013, PREV MED, V57, P900, DOI 10.1016/j.ypmed.2013.09.024; Fletcher GF, 1996, CIRCULATION, V94, P857, DOI 10.1161/01.CIR.94.4.857; Galper DI, 2006, MED SCI SPORT EXER, V38, P173, DOI 10.1249/01.mss.0000180883.32116.28; Gillison FB, 2006, HEALTH EDUC RES, V21, P836, DOI 10.1093/her/cyl139; Hakkinen A, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-15; Hamer M, 2009, BRIT J SPORT MED, V43, P1111, DOI 10.1136/bjsm.2008.046243; Hays RD, 2001, ANN MED, V33, P350, DOI 10.3109/07853890109002089; Lavie C J, 2000, J Cardiopulm Rehabil, V20, P235, DOI 10.1097/00008483-200007000-00004; Lee DC, 2010, BRIT J SPORT MED, V10, P684; Lindholm E, 2003, QUAL LIFE RES, V12, P575, DOI 10.1023/A:1025034919526; Martin CK, 2009, ARCH INTERN MED, V169, P269, DOI 10.1001/archinternmed.2008.545; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; Mendis S., 2011, GLOBAL ATLAS CARDIOV, P1, DOI [10.1016/S0022-3476(51)80275-0., DOI 10.1016/S0022-3476(51)80275-0.]; O'Donovan G, 2010, J SPORT SCI, V28, P573, DOI 10.1080/02640411003671212; Olivares PR, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-117; Perales F, 2014, QUAL LIFE RES, P1; Petrou S, 2008, HEALTH ECON, V17, P127, DOI 10.1002/hec.1242; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Rejeski WJ, 2006, OBESITY, V14, P870, DOI 10.1038/oby.2006.101; Sanchez-Villegas A, 2012, BRIT J SPORT MED, V46, P443, DOI 10.1136/bjsm.2010.081836; Shibata A, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-64; Sloan RA, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-47; Strijk JE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-684; Takata Y, 2010, ARCH GERONTOL GERIAT, V50, P272, DOI 10.1016/j.archger.2009.04.005; Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; Wanderley FAC, 2011, QUAL LIFE RES, V20, P1371, DOI 10.1007/s11136-011-9875-x; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P1167, DOI 10.1016/S0895-4356(98)00108-5; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008; Ware JE, 2001, SF 36 PHYS MENTAL HL; World Health Organization (WHO), 2009, GLOB HLTH RISK MORT	47	11	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123989	10.1371/journal.pone.0123989	http://dx.doi.org/10.1371/journal.pone.0123989			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG5KV	25901358	Green Published, Green Submitted, gold			2022-12-26	WOS:000353331500068
J	De Decker, S; Lam, R; Packer, RMA; Gielen, IMVL; Volk, HA				De Decker, Steven; Lam, Richard; Packer, Rowena M. A.; Gielen, Ingrid M. V. L.; Volk, Holger A.			Thoracic and Lumbar Vertebral Bone Mineral Density Changes in a Natural Occurring Dog Model of Diffuse Idiopathic Skeletal Hyperostosis	PLOS ONE			English	Article							ANKYLOSING-SPONDYLITIS; COMPUTED-TOMOGRAPHY; RISK-FACTORS; OSTEOPOROSIS; FRACTURES; FEATURES; CT	Ankylosing spinal disorders can be associated with alterations in vertebral bone mineral density (BMD). There is however controversy about vertebral BMD in patients wuse idiopathic skeletal hyperostosis (DISH). DISH in Boxer dogs has been considered a natural occurring disease model for DISH in people. The purpose of this study was to compare vertebral BMD between Boxers with and without DISH. Fifty-nine Boxers with (n=30) or without (n=29) DISH that underwent computed tomography were included. Vertebral BMD was calculated for each thoracic and lumbar vertebra by using an earlier reported and validated protocol. For each vertebral body, a region of interest was drawn on the axial computed tomographic images at three separate locations: immediately inferior to the superior end plate, in the middle of the vertebral body, and superior to the inferior end plate. Values from the three axial slices were averaged to give a mean Hounsfield Unit value for each vertebral body. Univariate statistical analysis was performed to identify factors to be included in a multivariate model. The multivariate model including all dogs demonstrated that vertebral DISH status (Coefficient 24.63; 95% CI 16.07 to 33.19; p < 0.001), lumbar vertebrae (Coefficient -17.25; 95% CI -23.42 to -11.09; p < 0.01), and to a lesser extent higher age (Coefficient -0.56; 95% CI -1.07 to -0.05; p = 0.03) were significant predictors for vertebral BMD. When the multivariate model was repeated using only dogs with DISH, vertebral DISH status (Coefficient 20.67; 95% CI, 10.98 to 30.37; p < 0.001) and lumbar anatomical region (Coefficient -38.24; 95% CI, -47.75 to -28.73; p < 0.001) were again predictors for vertebral BMD but age was not. The results of this study indicate that DISH can be associated with decreased vertebral BMD. Further studies are necessary to evaluate the clinical importance and pathophysiology of this finding.	[De Decker, Steven; Lam, Richard; Packer, Rowena M. A.; Volk, Holger A.] Univ London, Royal Vet Coll, Dept Clin Sci & Serv, Hatfield AL9 7TA, Herts, England; [Gielen, Ingrid M. V. L.] Univ Ghent, Fac Vet Med, Dept Vet Med Imaging & Small Anim Orthopaed, B-9820 Ghent, Belgium	University of London; University of London Royal Veterinary College; Ghent University	De Decker, S (corresponding author), Univ London, Royal Vet Coll, Dept Clin Sci & Serv, Hawkshead Lane, Hatfield AL9 7TA, Herts, England.	sdedecker@rvc.ac.uk	Volk, Holger Andreas/B-9965-2011	Volk, Holger Andreas/0000-0002-7312-638X; Packer, Rowena/0000-0002-9988-9828				Baskan BM, 2010, RHEUMATOL INT, V30, P375, DOI 10.1007/s00296-009-0975-7; Berthelot JM, 2013, JOINT BONE SPINE, V80, P592, DOI 10.1016/j.jbspin.2013.03.013; Caron T, 2010, SPINE, V35, pE458, DOI 10.1097/BRS.0b013e3181cc764f; De Decker S, 2014, VET REC, V174, DOI 10.1136/vr.102492; Di Franco M, 2000, CLIN RHEUMATOL, V19, P188, DOI 10.1007/s100670050153; Diederichs G, 2011, OSTEOPOROSIS INT, V22, P1789, DOI 10.1007/s00198-010-1409-9; El Maghraoui A, 1999, J RHEUMATOL, V26, P2205; Engelke K, 2008, J CLIN DENSITOM, V11, P123, DOI 10.1016/j.jocd.2007.12.010; Eser P, 2010, RHEUMATOLOGY, V49, P977, DOI 10.1093/rheumatology/keq014; GRATACOS J, 1994, BRIT J RHEUMATOL, V33, P927; Holton KF, 2011, SEMIN ARTHRITIS RHEU, V41, P131, DOI 10.1016/j.semarthrit.2011.01.001; Jun JB, 2006, J RHEUMATOL, V33, P1637; Klingberg E, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3833; Kranenburg HJC, 2014, ILAR J, V55, P150, DOI 10.1093/ilar/ilu012; Kranenburg Hendrik-Jan C, 2011, Vet J, V190, pe84, DOI 10.1016/j.tvjl.2011.04.008; Lau RYC, 2011, J OSTEOPOROS, V2011, DOI 10.4061/2011/293808; Lee S, 2013, J KOREAN NEUROSURG S, V54, P384, DOI 10.3340/jkns.2013.54.5.384; Liu WG, 2012, J VASC INTERV RADIOL, V23, P1143, DOI 10.1016/j.jvir.2012.06.019; Lubberts E, 2003, J IMMUNOL, V170, P2655, DOI 10.4049/jimmunol.170.5.2655; Mader R, 2013, NAT REV RHEUMATOL, V9, P741, DOI 10.1038/nrrheum.2013.165; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; Maruotti N, 2014, REUMATISMO, V66, P125, DOI 10.4081/reumatismo.2014.785; Meredith DS, 2013, SPINE, V38, P415, DOI 10.1097/BRS.0b013e31826ff084; Mosekilde L, 2000, NEURON, V1, P2; Ortega M, 2012, VET RADIOL ULTRASOUN, V53, P128, DOI 10.1111/j.1740-8261.2011.01891.x; Pickhardt PJ, 2013, ANN INTERN MED, V158, P588, DOI 10.7326/0003-4819-158-8-201304160-00003; Pickhardt PJ, 2011, J BONE MINER RES, V26, P2194, DOI 10.1002/jbmr.428; RESNICK D, 1976, RADIOLOGY, V119, P559, DOI 10.1148/119.3.559; RIGGS BL, 1981, J CLIN INVEST, V67, P328, DOI 10.1172/JCI110039; Rutherford O., 1990, PHYSIOTHERAPY, V76, P522; Sahin G, 2002, J WOMEN HEALTH GEN-B, V11, P801, DOI 10.1089/15409990260430945; Sambrook PN, 2012, THER ADV MUSCULOSKEL, V4, P287, DOI 10.1177/1759720X12441276; Schoenfeld AJ, 2011, SPINE J, V11, P257, DOI 10.1016/j.spinee.2011.01.018; Schreiber JJ, 2014, FOCUS, P37, DOI 10.3171/2014_5.FOCUS1483; Schreiber JJ, 2011, J BONE JOINT SURG AM, V93A, P1057, DOI 10.2106/JBJS.J.00160; Takata Shinjiro, 2001, Journal of Medical Investigation, V48, P147; UEBELHART D, 1995, PARAPLEGIA, V33, P669, DOI 10.1038/sc.1995.140; Unnanuntana A, 2010, J BONE JOINT SURG AM, V92A, P743, DOI 10.2106/JBJS.I.00919; Westerveld LA, 2014, SPINE J, V14, P729, DOI 10.1016/j.spinee.2013.06.038; Westerveld LA, 2009, EUR SPINE J, V18, P145, DOI 10.1007/s00586-008-0764-0; Westerveld LA, 2009, RHEUMATOLOGY, V48, P1133, DOI 10.1093/rheumatology/kep177	41	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124166	10.1371/journal.pone.0124166	http://dx.doi.org/10.1371/journal.pone.0124166			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898128	Green Published, gold			2022-12-26	WOS:000353212600054
J	Kim, SH; Kim, SH; Joung, JY; Lee, GK; Hong, EK; Kang, KM; Yu, A; Nam, BH; Chung, J; Seo, HK; Park, WS; Lee, KH				Kim, Sung Han; Kim, Soo Hee; Joung, Jae Young; Lee, Geon Kook; Hong, Eun Kyung; Kang, Kyung Min; Yu, Ami; Nam, Byung Ho; Chung, Jinsoo; Seo, Ho Kyung; Park, Weon Seo; Lee, Kang Hyun			Overexpression of ERG and Wild-Type PTEN Are Associated with Favorable Clinical Prognosis and Low Biochemical Recurrence in Prostate Cancer	PLOS ONE			English	Article							ANTIBODY-BASED DETECTION; PSA RECURRENCE; RADICAL PROSTATECTOMY; FUSION; EXPRESSION; PROGRESSION; IMMUNOHISTOCHEMISTRY; REARRANGEMENTS; ONCOPROTEIN; MORTALITY	Objectives The aim of this study was to investigate the expression of two commonly altered genes ERG and PTEN in prostate cancer (PC) and evaluate their prognostic significance. Despite conflicting published results, TMPRSS2-ERG gene fusion and PTEN loss are generally considered unfavorable markers for PC progression. Materials and Methods Of the 762 prostatic adenocarcinoma specimens obtained from radical prostatectomy, 613 without neoadjuvant hormone therapy were included in tissue microarrays for quantitatively assessment of ERG and PTEN expression via immunohistochemistry. Statistical analysis of the association between such expression and clinicopathological parameters, including clinical prognosis, was performed with a p-value of <0.05 considered significant. Results During a median follow-up period of 44.0 months, 132 (21.5%) patients developed biochemical recurrence (BCR). ERG overexpression and PTEN loss were observed in 145 (23.7%) and 253 (41.3%) cases, respectively. BCR-free survival was significantly better in patients with ERG overexpression (p=0.005), but unfavorable among those with PTEN loss (p=0.142). Sub-group analysis revealed that patients with PTEN loss and negative ERG expression had the worst BCR-free survival outcome (p=0.021). Furthermore, multivariate analysis identified prostate-specific antigen level (>= 10 ng/mL), Gleason score (>6), pathologic T stage (>= T3), positive surgical margin, and extraprostatic capsule extension as significant risk factors for BCR (p<0.05). Conclusions Our results indicated that ERG overexpression was associated with favorable BCR-free survival after radical prostatectomy for PC, whereas PTEN loss was with unfavorable outcomes.	[Kim, Sung Han; Joung, Jae Young; Chung, Jinsoo; Seo, Ho Kyung; Park, Weon Seo; Lee, Kang Hyun] Res Inst, Ctr Prostate Canc, Dept Urol, Goyang, Gyeonggi Do, South Korea; [Kim, Sung Han; Joung, Jae Young; Lee, Geon Kook; Hong, Eun Kyung; Chung, Jinsoo; Seo, Ho Kyung; Park, Weon Seo; Lee, Kang Hyun] Natl Canc Ctr Hosp, Goyang, Gyeonggi Do, South Korea; [Kim, Soo Hee] Yonsei Univ, Severance Hosp, Dept Pathol, Seoul 120749, South Korea; [Lee, Geon Kook; Hong, Eun Kyung; Park, Weon Seo] Res Inst, Ctr Prostate Canc, Dept Pathol, Goyang, Gyeonggi Do, South Korea; [Kang, Kyung Min; Yu, Ami] Natl Canc Ctr, Biometr Res Branch, Goyang, Gyeonggi Do, South Korea; [Nam, Byung Ho] Natl Canc Ctr, Grad Sch Canc Sci & Policy, Dept Canc Control & Policy, Goyang, Gyeonggi Do, South Korea	National Cancer Center - Korea (NCC); Yonsei University; Yonsei University Health System; National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Park, WS (corresponding author), Res Inst, Ctr Prostate Canc, Dept Urol, Goyang, Gyeonggi Do, South Korea.	thymus@ncc.re.kr; uroonco@ncc.re.kr		KIM, Sung Han/0000-0002-1689-5203	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [20110010731]; Korean National Cancer Center Grant [1210110, 1310330]	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); Korean National Cancer Center Grant	This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (20110010731) and by the Korean National Cancer Center Grants (nos. 1210110 and 1310330).	Al Bashir S, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-21; Antonarakis ES, 2012, CANCER-AM CANCER SOC, V118, P6063, DOI 10.1002/cncr.27689; Attard G, 2008, ONCOGENE, V27, P253, DOI 10.1038/sj.onc.1210640; Bismar TA, 2012, EUR J CANCER, V48, P538, DOI 10.1016/j.ejca.2012.01.001; Carver BS, 2009, NATURE, V457, pE1, DOI 10.1038/nature07738; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Chaux A, 2011, AM J SURG PATHOL, V35, P1014, DOI 10.1097/PAS.0b013e31821e8761; Cookson MS, 2007, J UROLOGY, V177, P540, DOI 10.1016/j.juro.2006.10.097; Demichelis F, 2007, ONCOGENE, V26, P4596, DOI 10.1038/sj.onc.1210237; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Falzarano SM, 2011, J UROLOGY, V185, P489, DOI 10.1016/j.juro.2010.09.093; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Furusato B, 2011, PATHOL INT, V61, P409, DOI 10.1111/j.1440-1827.2011.02675.x; Gronberg H, 2003, LANCET, V361, P859, DOI 10.1016/S0140-6736(03)12713-4; Grupp K, 2013, EXP MOL PATHOL, V95, P227, DOI 10.1016/j.yexmp.2013.08.002; Han B, 2009, MODERN PATHOL, V22, P1083, DOI 10.1038/modpathol.2009.69; Hoogland AM, 2012, MODERN PATHOL, V25, P471, DOI 10.1038/modpathol.2011.176; Kim J, 2012, BBA-REV CANCER, V1825, P186, DOI 10.1016/j.bbcan.2011.12.003; Kimura T, 2012, PATHOL INT, V62, P742, DOI 10.1111/pin.12006; Krohn A, 2012, AM J PATHOL, V181, P401, DOI 10.1016/j.ajpath.2012.04.026; Leinonen KA, 2013, CANC EPIDEMIOLO 1127; Magi-Galluzzi C, 2011, PROSTATE, V71, P489, DOI 10.1002/pros.21265; Mao XY, 2010, CANCER RES, V70, P5207, DOI 10.1158/0008-5472.CAN-09-4074; Minner S, 2011, CLIN CANCER RES, V17, P5878, DOI 10.1158/1078-0432.CCR-11-1251; Mosquera JM, 2009, CLIN CANCER RES, V15, P4706, DOI 10.1158/1078-0432.CCR-08-2927; Nagle RB, 2013, PROSTATE, V73, P1233, DOI 10.1002/pros.22675; Park K, 2010, NEOPLASIA, V12, P590, DOI 10.1593/neo.10726; Perner S, 2007, AM J SURG PATHOL, V31, P882, DOI 10.1097/01.pas.0000213424.38503.aa; Petrovics G, 2005, ONCOGENE, V24, P3847, DOI 10.1038/sj.onc.1208518; Reid AHM, 2012, MODERN PATHOL, V25, P902, DOI 10.1038/modpathol.2011.207; Rubin MA, 2011, J CLIN ONCOL, V29, P3659, DOI 10.1200/JCO.2011.35.1916; Saramaki OR, 2008, CLIN CANCER RES, V14, P3395, DOI 10.1158/1078-0432.CCR-07-2051; Sim HG, 2005, EUR J CANCER, V41, P834, DOI 10.1016/j.ejca.2004.12.033; Spencer ES, 2013, PROSTATE, V73, P905, DOI 10.1002/pros.22636; Sreenath Taduru L, 2011, J Carcinog, V10, P37, DOI 10.4103/1477-3163.91122; Suh JH, 2012, KOREAN J PATHOL, V46, P423, DOI 10.4132/KoreanJPathol.2012.46.5.423; Tomlins SA, 2012, ARCH PATHOL LAB MED, V136, P935, DOI 10.5858/arpa.2011-0424-OA; van Leenders GJLH, 2011, MODERN PATHOL, V24, P1128, DOI 10.1038/modpathol.2011.65; Verdu M, 2013, VIRCHOWS ARCH, V462, P639, DOI 10.1007/s00428-013-1415-3; Vogel UF, 2006, AM J CLIN PATHOL, V126, P342, DOI 10.1309/F2Q38DXN1V1V4GQM; Yoshimoto M, 2008, MODERN PATHOL, V21, P1451, DOI 10.1038/modpathol.2008.96	41	37	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0122498	10.1371/journal.pone.0122498	http://dx.doi.org/10.1371/journal.pone.0122498			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897494	gold, Green Submitted, Green Published			2022-12-26	WOS:000353212600011
J	Rathore, DK; Nair, D; Raza, S; Saini, S; Singh, R; Kumar, A; Tripathi, R; Ramji, S; Batra, A; Aggarwal, KC; Chellani, HK; Arya, S; Bhatla, N; Paul, VK; Aggarwal, R; Agarwal, N; Mehta, U; Sopory, S; Natchu, UCM; Bhatnagar, S; Bal, V; Rath, S; Wadhwa, N				Rathore, Deepak K.; Nair, Deepa; Raza, Saimah; Saini, Savita; Singh, Reeta; Kumar, Amit; Tripathi, Reva; Ramji, Siddarth; Batra, Aruna; Aggarwal, Kailash C.; Chellani, Harish K.; Arya, Sugandha; Bhatla, Neerja; Paul, Vinod K.; Aggarwal, Ramesh; Agarwal, Nidhi; Mehta, Umesh; Sopory, Shailaja; Natchu, Uma Chandra Mouli; Bhatnagar, Shinjini; Bal, Vineeta; Rath, Satyajit; Wadhwa, Nitya			Underweight Full-Term Indian Neonates Show Differences in Umbilical Cord Blood Leukocyte Phenotype: A Cross-Sectional Study	PLOS ONE			English	Article							TRANSITIONAL B-CELLS; BIRTH-WEIGHT; LYMPHOCYTE SUBPOPULATIONS; INTRAUTERINE GROWTH; IMMUNE-RESPONSE; PRETERM INFANTS; INFECTION; ASSOCIATION; ZINC; VACCINATION	Background While infections are a major cause of neonatal mortality in India even in full-term neonates, this is an especial problem in the large proportion (similar to 20%) of neonates born underweight (or small-for-gestational-age; SGA). One potential contributory factor for this susceptibility is the possibility that immune system maturation may be affected along with intrauterine growth retardation. Methods In order to examine the possibility that differences in immune status may underlie the susceptibility of SGA neonates to infections, we enumerated the frequencies and concentrations of 22 leukocyte subset populations as well as IgM and IgA levels in umbilical cord blood from full-term SGA neonates and compared them with values from normal-weight (or appropriate-for-gestational-age; AGA) full-term neonates. We eliminated most SGA-associated risk factors in the exclusion criteria so as to ensure that AGA-SGA differences, if any, would be more likely to be associated with the underweight status itself. Results An analysis of 502 such samples, including 50 from SGA neonates, showed that SGA neonates have significantly fewer plasmacytoid dendritic cells (pDCs), a higher myeloid DC (mDC) to pDC ratio, more natural killer (NK) cells, and higher IgM levels in cord blood in comparison with AGA neonates. Other differences were also observed such as tendencies to lower CD4:CD8 ratios and greater prominence of inflammatory monocytes, mDCs and neutrophils, but while some of them had substantial differences, they did not quite reach the standard level of statistical significance. Conclusions These differences in cellular lineages of the immune system possibly reflect stress responses in utero associated with growth restriction. Increased susceptibility to infections may thus be linked to complex immune system dysregulation rather than simply retarded immune system maturation.	[Rathore, Deepak K.; Nair, Deepa; Raza, Saimah; Singh, Reeta; Kumar, Amit; Sopory, Shailaja; Natchu, Uma Chandra Mouli; Bhatnagar, Shinjini; Bal, Vineeta; Rath, Satyajit; Wadhwa, Nitya] Translat Hlth Sci & Technol Inst, Pediat Biol Ctr, Gurgaon, Haryana, India; [Saini, Savita; Paul, Vinod K.; Aggarwal, Ramesh] All India Inst Med Sci, Dept Pediat, New Delhi, India; [Tripathi, Reva] Maulana Azad Med Coll, Dept Obstet & Gynecol, New Delhi, India; [Ramji, Siddarth] Maulana Azad Med Coll, Dept Neonatol, New Delhi, India; [Batra, Aruna] Vardhman Mahavir Med Coll & Safdarjung Hosp, Dept Obstet & Gynecol, New Delhi, India; [Aggarwal, Kailash C.; Chellani, Harish K.; Arya, Sugandha] Vardhman Mahavir Med Coll & Safdarjung Hosp, Dept Pediat, New Delhi, India; [Bhatla, Neerja] All India Inst Med Sci, Dept Obstet & Gynecol, New Delhi, India; [Agarwal, Nidhi] Gen Hosp, Dept Obstet & Gynecol, Gurgaon, Haryana, India; [Mehta, Umesh] Gen Hosp, Dept Pediat, Gurgaon, Haryana, India; [Bal, Vineeta; Rath, Satyajit] Natl Inst Immunol, New Delhi 110067, India	Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI); All India Institute of Medical Sciences (AIIMS) New Delhi; Maulana Azad Medical College; Maulana Azad Medical College; Vardhman Mahavir Medical College & Safdarjung Hospital; Vardhman Mahavir Medical College & Safdarjung Hospital; All India Institute of Medical Sciences (AIIMS) New Delhi; Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Wadhwa, N (corresponding author), Translat Hlth Sci & Technol Inst, Pediat Biol Ctr, Gurgaon, Haryana, India.	nitya.wadhwa@thsti.res.in		bhatnagar, shinjini/0000-0003-1703-5296; Bhatla, Neerja/0000-0002-3894-2795	Translational Health Science and Technology Institute, Gurgaon, Haryana, India	Translational Health Science and Technology Institute, Gurgaon, Haryana, India	The study was supported by Translational Health Science and Technology Institute, Gurgaon, Haryana, India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Perin MCAA, 2012, VACCINE, V30, P6521, DOI 10.1016/j.vaccine.2012.08.056; Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Altman M, 2012, BMJ OPEN, P2, DOI [10.1136/bmjopen-2012-001152, DOI 10.1136/BMJ0PEN-2012-001152]; Amarilyo G, 2011, J PERINATOL, V31, P30, DOI 10.1038/jp.2010.53; [Anonymous], 1967, PEDIATRICS, V39, P935; [Anonymous], NAT NEON FOR IND SAV; [Anonymous], NAT FAM HLTH SURV NF; [Anonymous], 2013, 2013 STAT SNAPSH CHI; [Anonymous], IMPR NEWB SURV IND; AVRECH OM, 1994, INT ARCH ALLERGY IMM, V103, P160, DOI 10.1159/000236622; Bao SY, 2010, AM J PHYSIOL-LUNG C, V298, pL744, DOI 10.1152/ajplung.00368.2009; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; Bassani DG, 2010, LANCET, V376, P1853, DOI 10.1016/S0140-6736(10)61461-4; Baxter D, 2010, HUM VACCINES, V6, P494, DOI 10.4161/hv.6.6.12008; Belnoue E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085302; Bhatnagar S, 2012, LANCET, V379, P2072, DOI 10.1016/S0140-6736(12)60477-2; BOERSMA ER, 1981, ARCH DIS CHILD, V56, P31, DOI 10.1136/adc.56.1.31; Bonnelykke K, 2010, J ALLERGY CLIN IMMUN, V126, P657, DOI 10.1016/j.jaci.2010.06.027; Brocklehurst P, 1998, BRIT J OBSTET GYNAEC, V105, P836, DOI 10.1111/j.1471-0528.1998.tb10227.x; Cekmez F, 2011, VACCINE, V29, P3096, DOI 10.1016/j.vaccine.2011.02.073; Chatrath R, 1997, J TROP PEDIATRICS, V43, P345, DOI 10.1093/tropej/43.6.345; Chung JB, 2003, TRENDS IMMUNOL, V24, P343, DOI 10.1016/S1471-4906(03)00119-4; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; Correa-Rocha R, 2012, PEDIATR RES, V71, P590, DOI 10.1038/pr.2012.6; Covens K, 2013, BLOOD, V121, P5176, DOI 10.1182/blood-2012-12-471953; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Cuss AK, 2006, J IMMUNOL, V176, P1506, DOI 10.4049/jimmunol.176.3.1506; D'Angio CT, 2007, PEDIATRICS, V119, pE574, DOI 10.1542/peds.2006-2241; D'Arena G, 1998, HAEMATOLOGICA, V83, P197; Egan JFX, 2011, PRENATAL DIAG, V31, P560, DOI 10.1002/pd.2747; Elghetany MT, 2002, BLOOD CELL MOL DIS, V28, P260, DOI 10.1006/bcmd.2002.0513; Faridi MMA, 2009, HUM VACCINES, V5, P690, DOI 10.4161/hv.5.10.9317; GOOD RA, 1964, ADV IMMUNOL, V4, P1, DOI 10.1016/S0065-2776(08)60706-3; Griffin DO, 2011, J EXP MED, V208, P67, DOI 10.1084/jem.20101499; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; HAMBIDGE KM, 1990, J TRACE ELEM ELECT H, V4, P229; Hou L, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0372-4; Huang L, 2010, INT REV IMMUNOL, V29, P133, DOI 10.3109/08830180903349669; Indian Council of Medical Re- search & UNICEF, 2014, IMPR NEWB SURV IND; Jourdan M, 2011, J IMMUNOL, V187, P3931, DOI 10.4049/jimmunol.1101230; Kumar A, 2014, EUR J PEDIATR, V173, P1083, DOI 10.1007/s00431-014-2293-7; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Li JR, 2013, CELL MOL IMMUNOL, V10, P437, DOI 10.1038/cmi.2013.31; LUBCHENCO LO, 1963, PEDIATRICS, V32, P793; MacDonald KPA, 2002, BLOOD, V100, P4512, DOI 10.1182/blood-2001-11-0097; Malik S, 2007, PEDIATRICS, V119, pE976, DOI 10.1542/peds.2006-2742; Maloney KF, 2012, FETAL PEDIATR PATHOL, V31, P319, DOI 10.3109/15513815.2012.659391; Marr N, 2014, J IMMUNOL, V192, P948, DOI 10.4049/jimmunol.1302007; Mazor-Dray E, 2009, J MATERN-FETAL NEO M, V22, P124, DOI 10.1080/14767050802488246; Mollah A H, 2012, Mymensingh Med J, V21, P109; Montoya CJ, 2007, IMMUNOLOGY, V122, P1, DOI 10.1111/j.1365-2567.2007.02647.x; Moore SE, 2008, VACCINE, V26, P158, DOI 10.1016/j.vaccine.2007.11.007; Nicholson JKA, 1996, CYTOMETRY, V26, P16; Peoples JD, 2009, AM J PERINAT, V26, P647, DOI 10.1055/s-0029-1220788; PrabhuDas M, 2011, NAT IMMUNOL, V12, P189, DOI 10.1038/ni0311-189; Schuller SS, 2013, J LEUKOCYTE BIOL, V93, P781, DOI 10.1189/jlb.1011525; Shankar AH, 1998, AM J CLIN NUTR, V68, p447S, DOI 10.1093/ajcn/68.2.447S; Sharma AA, 2012, CLIN IMMUNOL, V145, P61, DOI 10.1016/j.clim.2012.08.006; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Simchen MJ, 2000, AM J PERINAT, V17, P187, DOI 10.1055/s-2000-9423; Simister NE, 2003, VACCINE, V21, P3365, DOI 10.1016/S0264-410X(03)00334-7; Sims GP, 2005, BLOOD, V105, P4390, DOI 10.1182/blood-2004-11-4284; Troger B, 2013, NEONATOLOGY, V103, P199, DOI 10.1159/000343260; Vedmedovska N, 2010, GYNECOL OBSTET INVES, V70, P291, DOI 10.1159/000314020; Vermeulen F, 2010, CLIN VACCINE IMMUNOL, V17, P258, DOI 10.1128/CVI.00328-09; Vuorte J, 2001, CYTOMETRY, V43, P290, DOI 10.1002/1097-0320(20010401)43:4<290::AID-CYTO1061>3.0.CO;2-X; Walker JC, 2011, SCAND J IMMUNOL, V73, P53, DOI 10.1111/j.1365-3083.2010.02473.x; Wilson K, 2011, VACCINE, V29, P8267, DOI 10.1016/j.vaccine.2011.08.107; Xiong F, 2012, J MATERN-FETAL NEO M, V25, P2773, DOI 10.3109/14767058.2012.715219; Yagi H, 2004, INT IMMUNOL, V16, P1643, DOI 10.1093/intimm/dxh165	71	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123589	10.1371/journal.pone.0123589	http://dx.doi.org/10.1371/journal.pone.0123589			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898362	Green Submitted, gold, Green Published			2022-12-26	WOS:000353212600034
J	Almquist, J; Bendrioua, L; Adiels, CB; Goksor, M; Hohmann, S; Jirstrand, M				Almquist, Joachim; Bendrioua, Loubna; Adiels, Caroline Beck; Goksor, Mattias; Hohmann, Stefan; Jirstrand, Mats			A Nonlinear Mixed Effects Approach for Modeling the Cell-To-Cell Variability of Mig1 Dynamics in Yeast	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; IDENTIFIABILITY ANALYSIS; SNF1 KINASE; KINETICS; HETEROGENEITY; DISTRIBUTIONS; ADAPTATION; REPRESSION; INFERENCE	The last decade has seen a rapid development of experimental techniques that allow data collection from individual cells. These techniques have enabled the discovery and characterization of variability within a population of genetically identical cells. Nonlinear mixed effects (NLME) modeling is an established framework for studying variability between individuals in a population, frequently used in pharmacokinetics and pharmacodynamics, but its potential for studies of cell-to-cell variability in molecular cell biology is yet to be exploited. Here we take advantage of this novel application of NLME modeling to study cell-to-cell variability in the dynamic behavior of the yeast transcription repressor Mig1. In particular, we investigate a recently discovered phenomenon where Mig1 during a short and transient period exits the nucleus when cells experience a shift from high to intermediate levels of extracellular glucose. A phenomenological model based on ordinary differential equations describing the transient dynamics of nuclear Mig1 is introduced, and according to the NLME methodology the parameters of this model are in turn modeled by a multivariate probability distribution. Using time-lapse microscopy data from nearly 200 cells, we estimate this parameter distribution according to the approach of maximizing the population likelihood. Based on the estimated distribution, parameter values for individual cells are furthermore characterized and the resulting Mig1 dynamics are compared to the single cell times-series data. The proposed NLME framework is also compared to the intuitive but limited standard two-stage (STS) approach. We demonstrate that the latter may overestimate variabilities by up to almost five fold. Finally, Monte Carlo simulations of the inferred population model are used to predict the distribution of key characteristics of the Mig1 transient response. We find that with decreasing levels of post-shift glucose, the transient response of Mig1 tend to be faster, more extended, and displays an increased cell-to-cell variability.	[Almquist, Joachim; Jirstrand, Mats] Fraunhofer Chalmers Ctr, Gothenburg, Sweden; [Almquist, Joachim] Chalmers Univ Technol, Syst & Synthet Biol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden; [Bendrioua, Loubna; Hohmann, Stefan] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden; [Bendrioua, Loubna; Adiels, Caroline Beck; Goksor, Mattias] Univ Gothenburg, Dept Phys, Gothenburg, Sweden	Chalmers University of Technology; Fraunhofer-Chalmers Research Centre for Industrial Mathematics; Chalmers University of Technology; University of Gothenburg; University of Gothenburg	Almquist, J (corresponding author), Fraunhofer Chalmers Ctr, Chalmers Sci Pk, Gothenburg, Sweden.	joachim.almquist@fcc.chalmers.se	Hohmann, Stefan/K-9895-2013; Almquist, Joachim/U-8894-2019	Hohmann, Stefan/0000-0002-0809-1985; Almquist, Joachim/0000-0002-4745-9332; Jirstrand, Mats/0000-0002-6612-8037; Beck Adiels, Caroline/0000-0002-2403-2213	Swedish Foundation for Strategic Research; Swedish Research Council (VR); European Commission FP7 through the UNICELLSYS project [201142]; European Commission FP7 through ISOLATE project [289995]	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council (VR)(Swedish Research Council); European Commission FP7 through the UNICELLSYS project; European Commission FP7 through ISOLATE project	This work has been supported by funds from the Swedish Foundation for Strategic Research (SSF, to MJ), the Swedish Research Council (VR, to SH) as well as the European Commission FP7 through the UNICELLSYS project (grant 201142, to SH, MG and MJ) and the ISOLATE project (grant 289995, to SH and MG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almquist J., 2008, 9 INT C SYST BIOL; Almquist J, 2015, J PHARMACOKINET PHAR, V42, P191, DOI 10.1007/s10928-015-9409-1; Almquist J, 2014, METAB ENG, V24, P38, DOI 10.1016/j.ymben.2014.03.007; Babazadeh R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080901; Bendrioua L, 2014, J BIOL CHEM, V289, P12863, DOI 10.1074/jbc.M114.547976; Berglund M, 2012, MATH MED BIOL, V29, P361, DOI 10.1093/imammb/dqr021; Bodvard K, 2011, BBA-MOL CELL RES, V1813, P358, DOI 10.1016/j.bbamcr.2010.12.004; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; CARLSON M, 1981, GENETICS, V98, P25; Chen WW, 2010, GENE DEV, V24, P1861, DOI 10.1101/gad.1945410; Cheong R, 2010, WIRES SYST BIOL MED, V2, P34, DOI 10.1002/wsbm.49; Cohen-Saidon C, 2009, MOL CELL, V36, P885, DOI 10.1016/j.molcel.2009.11.025; Davidian M, 2003, J AGR BIOL ENVIR ST, V8, P387, DOI 10.1198/1085711032697; DeVit MJ, 1999, CURR BIOL, V9, P1231, DOI 10.1016/S0960-9822(99)80503-X; DeVit MJ, 1997, MOL BIOL CELL, V8, P1603, DOI 10.1091/mbc.8.8.1603; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Feinerman O, 2008, SCIENCE, V321, P1081, DOI 10.1126/science.1158013; Frey S, 2011, MOL BIOSYST, V7, P215, DOI 10.1039/c005305h; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; Garcia-Salcedo R, 2014, FEBS J, V281, P1901, DOI 10.1111/febs.12753; Gaudet S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002482; Gonzalez AM, 2013, EUR CONTR C 2013; Hasenauer J, 2010, PROCEDIA COMPUT SCI, V1, P1649, DOI 10.1016/j.procs.2010.04.185; Hasenauer J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-125; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Janzen D., 2012, STANDARD 2 STAGE NON; Jeschke M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003357; Kalita MK, 2011, J BIOL CHEM, V286, P37741, DOI 10.1074/jbc.M111.280925; Kallenberger SM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004738; Kaltenbach HM, 2009, FEBS LETT, V583, P3923, DOI 10.1016/j.febslet.2009.10.074; Karlsson J., 2012, IFAC PROC VOL, V45, P941, DOI 10.3182/20120711-3-BE-2027.00381; Klim S, 2009, COMPUT METH PROG BIO, V94, P279, DOI 10.1016/j.cmpb.2009.02.001; Koeppl H, 2012, INT J ROBUST NONLIN, V22, P1103, DOI 10.1002/rnc.2804; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; Kristensen NR, 2005, J PHARMACOKINET PHAR, V32, P109, DOI 10.1007/s10928-005-2105-9; Leander J, 2015, AAPS J, V17, P586, DOI 10.1208/s12248-015-9718-8; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; Limpert E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021403; Losev E, 2006, NATURE, V441, P1002, DOI 10.1038/nature04717; Love KR, 2010, BIOTECHNOL BIOENG, V106, P319, DOI 10.1002/bit.22688; McCartney RR, 2001, J BIOL CHEM, V276, P36460, DOI 10.1074/jbc.M104418200; Mettetal JT, 2008, SCIENCE, V319, P482, DOI 10.1126/science.1151582; Meyer R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00451; Muzzey D, 2009, CELL, V138, P160, DOI 10.1016/j.cell.2009.04.047; Nath N, 2003, MOL CELL BIOL, V23, P3909, DOI 10.1128/MCB.23.11.3909-3917.2003; Niepel M, 2009, CURR OPIN CHEM BIOL, V13, P556, DOI 10.1016/j.cbpa.2009.09.015; Papamichos-Chronakis M, 2004, EMBO REP, V5, P368, DOI 10.1038/sj.embor.7400120; Ramsey SA, 2006, NAT GENET, V38, P1082, DOI 10.1038/ng1869; Raue A, 2009, BIOINFORMATICS, V25, P1923, DOI 10.1093/bioinformatics/btp358; Raue A, 2014, BIOINFORMATICS, V30, P1440, DOI 10.1093/bioinformatics/btu006; Sanz P, 2000, MOL CELL BIOL, V20, P1321, DOI 10.1128/MCB.20.4.1321-1328.2000; Savic RM, 2009, AAPS J, V11, P558, DOI 10.1208/s12248-009-9133-0; Schaber J, 2009, IET SYST BIOL, V3, P1, DOI 10.1049/iet-syb:20070042; Schaber J, 2011, CURR OPIN BIOTECH, V22, P109, DOI 10.1016/j.copbio.2010.09.014; Schliemann M, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-204; SHEINER LB, 1983, J PHARMACOKINET BIOP, V11, P303, DOI 10.1007/BF01061870; Sutherland CM, 2003, CURR BIOL, V13, P1299, DOI 10.1016/S0960-9822(03)00459-7; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; VanKampen NG, 2007, NORTH-HOLL PERS LIBR, P1; Wang YN, 2007, J PHARMACOKINET PHAR, V34, P575, DOI 10.1007/s10928-007-9060-6; Wilkinson DJ, 2009, NAT REV GENET, V10, P122, DOI 10.1038/nrg2509; Woodcock DJ, 2013, BIOINFORMATICS, V29, P1519, DOI 10.1093/bioinformatics/btt201; Wright S, 1999, NUMERICAL OPTIMIZATI, V35, P7; Zechner C, 2014, NAT METHODS, V11, P197, DOI [10.1038/NMETH.2794, 10.1038/nmeth.2794]; Zechner C, 2012, P NATL ACAD SCI USA, V109, P8340, DOI 10.1073/pnas.1200161109	66	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124050	10.1371/journal.pone.0124050	http://dx.doi.org/10.1371/journal.pone.0124050			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893847	Green Submitted, gold, Green Published			2022-12-26	WOS:000353211700069
J	Cabiddu, R; Trimer, R; Borghi-Silva, A; Migliorini, M; Mendes, RG; Oliveira, AD; Costa, FSM; Bianchi, AM				Cabiddu, Ramona; Trimer, Renata; Borghi-Silva, Audrey; Migliorini, Matteo; Mendes, Renata G.; Oliveira, Antonio D., Jr.; Costa, Fernando S. M.; Bianchi, Anna M.			Are Complexity Metrics Reliable in Assessing HRV Control in Obese Patients During Sleep?	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; AIRWAY PRESSURE TREATMENTS; NERVOUS-SYSTEM ACTIVITY; DYNAMICS; ENTROPY; APNEA	Obesity is associated with cardiovascular mortality. Linear methods, including time domain and frequency domain analysis, are normally applied on the heart rate variability (HRV) signal to investigate autonomic cardiovascular control, whose imbalance might promote cardiovascular disease in these patients. However, given the cardiac activity non-linearities, non-linear methods might provide better insight. HRV complexity was hereby analyzed during wakefulness and different sleep stages in healthy and obese subjects. Given the short duration of each sleep stage, complexity measures, normally extracted from long-period signals, needed be calculated on short-term signals. Sample entropy, Lempel-Ziv complexity and detrended fluctuation analysis were evaluated and results showed no significant differences among the values calculated over ten-minute signals and longer durations, confirming the reliability of such analysis when performed on short-term signals. Complexity parameters were extracted from ten-minute signal portions selected during wakefulness and different sleep stages on HRV signals obtained from eighteen obese patients and twenty controls. The obese group presented significantly reduced complexity during light and deep sleep, suggesting a deficiency in the control mechanisms integration during these sleep stages. To our knowledge, this study reports for the first time on how the HRV complexity changes in obesity during wakefulness and sleep. Further investigation is needed to quantify altered HRV impact on cardiovascular mortality in obesity.	[Cabiddu, Ramona; Migliorini, Matteo; Bianchi, Anna M.] Politecn Milan, DEIB, I-20133 Milan, Italy; [Trimer, Renata; Borghi-Silva, Audrey; Mendes, Renata G.] Univ Fed Sao Carlos, Cardiopulmonary Physiotherapy Lab, BR-13560 Sao Carlos, SP, Brazil; [Oliveira, Antonio D., Jr.; Costa, Fernando S. M.] Sleep Inst Sao Carlos, Sao Paulo, Brazil	Polytechnic University of Milan; Universidade Federal de Sao Carlos	Cabiddu, R (corresponding author), Politecn Milan, DEIB, I-20133 Milan, Italy.	ramona.cabiddu@gmail.com	Mendes, Renata Gonçalves/E-9284-2013; Cabiddu, Ramona/A-7723-2015; Borghi-Silva, Audrey/F-5702-2012; Bianchi, Anna M./AAA-4258-2020	Mendes, Renata Gonçalves/0000-0003-4683-2657; Borghi-Silva, Audrey/0000-0002-3891-6941; Bianchi, Anna M./0000-0002-8290-7460				Austin MA, 1998, AM J CARDIOL, V81, p7B, DOI 10.1016/S0002-9149(98)00031-9; Bianchi AM, 2010, METHOD INFORM MED, V49, P479, DOI 10.3414/ME09-02-0037; Bunde A, 2000, PHYS REV LETT, V85, P3736, DOI 10.1103/PhysRevLett.85.3736; Cabiddu R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00045; Camm AJ, 1996, CIRCULATION, V93, P1043; Caples SM, 2007, SLEEP, V30, P291, DOI 10.1093/sleep/30.3.291; Chhabra L, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/856793; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Curtis BM, 2002, MAYO CLIN PROC, V77, P45, DOI 10.4065/77.1.45; Davy KP, 1997, CLIN PHYSIOL, V17, P31, DOI 10.1046/j.1365-2281.1997.01010.x; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Gans F, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.098701; Gastaldelli A, 1999, ANN NY ACAD SCI, V879, P249, DOI 10.1111/j.1749-6632.1999.tb10427.x; Gomes RM, 2013, CELL PHYSIOL BIOCHEM, V32, P310, DOI 10.1159/000354439; Guzzetti S, 2000, AUTON NEUROSCI-BASIC, V86, P114, DOI 10.1016/S1566-0702(00)00239-3; Hu J, 2006, IEEE T BIO-MED ENG, V53, P2606, DOI 10.1109/TBME.2006.883825; Iber C, 2007, AASM MANUAL SCORING; Jiang Jieying, 2013, Prev Med, V57, P60, DOI 10.1016/j.ypmed.2013.04.014; KAPLAN DT, 1991, BIOPHYS J, V59, P945, DOI 10.1016/S0006-3495(91)82309-8; KAY SM, 1981, P IEEE, V69, P1380, DOI 10.1109/PROC.1981.12184; Kufoy E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033769; Lips MA, 2013, EUR J ENDOCRINOL, V169, P383, DOI 10.1530/EJE-13-0506; Malliani A, 1998, CIRCULATION, V98, P2640; Nemati S, 2013, RESP PHYSIOL NEUROBI, V189, P27, DOI 10.1016/j.resp.2013.06.016; Nielsen JDJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065764; PAN J, 1985, IEEE T BIO-MED ENG, V32, P230, DOI 10.1109/TBME.1985.325532; Patruno V, 2007, CHEST, V131, P1393, DOI 10.1378/chest.06-2192; Patruno V, 2014, EUR J INTERN MED, V25, P164, DOI 10.1016/j.ejim.2013.11.009; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Perakakis P, 2009, BIOL PSYCHOL, V82, P82, DOI 10.1016/j.biopsycho.2009.06.004; Porta A, 2007, CHAOS, V17, DOI 10.1063/1.2404630; Porta A, 2007, J APPL PHYSIOL, V103, P1143, DOI 10.1152/japplphysiol.00293.2007; Ravesloot MJL, 2012, EUR ARCH OTO-RHINO-L, V269, P1865, DOI 10.1007/s00405-012-1948-0; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Ruehland WR, 2009, SLEEP, V32, P150, DOI 10.1093/sleep/32.2.150; Saul JP., 1987, COMPUT CARDIOL, P419; Schumann AY, 2010, SLEEP, V33, P943, DOI 10.1093/sleep/33.7.943; Silber MH, 2007, J CLIN SLEEP MED, V3, P121; Silva LEV, 2012, CHAOS, V22, DOI 10.1063/1.4758815; Trunkvalterova Z, 2008, PHYSIOL MEAS, V29, P817, DOI 10.1088/0967-3334/29/7/010; Vigo DE, 2010, AUTON NEUROSCI-BASIC, V154, P84, DOI 10.1016/j.autneu.2009.10.007; Viola AU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019002; Virtanen I, 2007, AUTON NEUROSCI-BASIC, V134, P74, DOI 10.1016/j.autneu.2007.01.010	43	6	6	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124458	10.1371/journal.pone.0124458	http://dx.doi.org/10.1371/journal.pone.0124458			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893856	Green Published, gold, Green Submitted			2022-12-26	WOS:000353211700095
J	Darfour-Oduro, KA; Megens, HJ; Roca, AL; Groenen, MAM; Schook, LB				Darfour-Oduro, Kwame A.; Megens, Hendrik-Jan; Roca, Alfred L.; Groenen, Martien A. M.; Schook, Lawrence B.			Adaptive Evolution of Toll-Like Receptors (TLRs) in the Family Suidae	PLOS ONE			English	Article							INNATE IMMUNE-SYSTEM; AMINO-ACID SITES; PHYLOGENETIC ANALYSIS; PATTERN-RECOGNITION; CRYSTAL-STRUCTURE; SELECTION; GENES; SUBSTITUTION; COMPLEX; BINDING	Members of the family Suidae have diverged over extended evolutionary periods in diverse environments, suggesting that adaptation in response to endemic infectious agents may have occurred. Toll-like receptors (TLRs) comprise a multigene family that acts as the first line of defense against infectious microbes at the host-environment interface. We hypothesized that across the Suidae, positive selection mediated by infectious agents has contributed to the evolution of TLR diversity. Thus, we analyzed Sus scrofa, Sus barbatus, Sus verrucosus, Sus celebensis, Sus scebifrons, Babyrousa babyrussa, Potamochoerus larvatus, Potamochoerus porcus and Phacochoerus africanus genomes. Specifically, analyses were performed to identify evidence of positive selection using Maximum likelihood (ML) methods within a phylogenetic framework for bacterial and viral sensing Suidae TLR extracellular domains. Our analyses did not reveal evidence of positive selection for TLR3 and TLR7, suggesting strong functional conservation among these two genes for members of the Suidae. Positive selection was inferred for Suidae TLR1, TLR2, TLR6 and TLR8 evolution. ML methods identified amino acid sites of the bacterial sensing TLR1, TLR2, TLR6 and the viral sensing TLR8 to be under persistent positive selection. Some of these sites are in close proximity to functionally relevant sites, further strengthening the case for pathogen mediated selection for these sites. The branch leading to the genus Sus demonstrated evidence of episodic positive selection for TLR1, indicating selection mediated by infectious agents encountered within the specific geographic origin of the Sus. These results indicate that species of the Suidae have positively selected residues within functional domains of TLRs reflective of prior infections. Thus, TLR genes represent candidates for experimental validation to determine their functional role in antibacterial and antiviral activity within members of the Suidae.	[Darfour-Oduro, Kwame A.; Roca, Alfred L.; Schook, Lawrence B.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Megens, Hendrik-Jan; Groenen, Martien A. M.] Wageningen Univ, Anim Breeding & Genom Ctr, NL-6700 AP Wageningen, Netherlands	University of Illinois System; University of Illinois Urbana-Champaign; Wageningen University & Research	Schook, LB (corresponding author), Univ Illinois, Dept Anim Sci, 328 Mumford Hall, Urbana, IL 61801 USA.	schook@uillinois.edu	Groenen, Martien/D-8408-2012; Megens, Hendrik-Jan/E-9676-2010; Megens, Hendrik-Jan/M-5300-2019	Groenen, Martien/0000-0003-0484-4545; Megens, Hendrik-Jan/0000-0002-3619-7533; Megens, Hendrik-Jan/0000-0002-3619-7533; Schook, Lawrence/0000-0002-6580-8364; Roca, Alfred/0000-0001-9217-5593	U.S. Department of Agriculture (USDA) Agriculture Research Service (ARS) [USDA/ARS 58-5438-2-307]	U.S. Department of Agriculture (USDA) Agriculture Research Service (ARS)	This work was funded by the U.S. Department of Agriculture (USDA) Agriculture Research Service (ARS) grant USDA/ARS 58-5438-2-307 to LBS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguileta G, 2010, MOL ECOL, V19, P292, DOI 10.1111/j.1365-294X.2009.04454.x; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alcaide M, 2011, MOL BIOL EVOL, V28, P1703, DOI 10.1093/molbev/msq351; Areal H, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-368; Barreiro LB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000562; Ben-Ali M, 2011, HUM MUTAT, V32, P643, DOI 10.1002/humu.21486; Bosse M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003100; Dawson HD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-332; de Matos AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081864; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Ferrer-Admetlla A, 2008, J IMMUNOL, V181, P1315, DOI 10.4049/jimmunol.181.2.1315; Fornuskova A, 2014, ECOL EVOL, V4, P2931, DOI 10.1002/ece3.1137; Fornuskova A, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-194; Fowler ME, 1996, REV SCI TECH OIE, V15, P141, DOI 10.20506/rst.15.1.913; Frantz LAF, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r107; Govindaraj RG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025118; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Grubb P, 2005, MAMMAL SPECIES WORLD, P637; Grueber CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089632; Hajjar AM, 2001, J IMMUNOL, V166, P15, DOI 10.4049/jimmunol.166.1.15; Jepson A, 1997, INFECT IMMUN, V65, P872, DOI 10.1128/IAI.65.3.872-876.1997; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kingdon J, 2011, KINGDON FIELD GUIDE, V4th; Klein J, 2000, NEW ENGL J MED, V343, P702, DOI 10.1056/NEJM200009073431006; Lipscomb LA, 1998, PROTEIN SCI, V7, P765, DOI 10.1002/pro.5560070326; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Morgan CC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-39; Mukherjee S, 2009, P NATL ACAD SCI USA, V106, P7073, DOI 10.1073/pnas.0811357106; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Nielsen R, 1998, GENETICS, V148, P929; Niknafs N, 2013, HUM GENET, V132, P1235, DOI 10.1007/s00439-013-1325-0; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Patel MR, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001282; Pedersen A, 2007, CONSERVATION BIOL; Pond SLK, 2011, MOL BIOL EVOL, V28, P3033, DOI 10.1093/molbev/msr125; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Rietsch A, 1998, ANNU REV GENET, V32, P163, DOI 10.1146/annurev.genet.32.1.163; Rothenburg S, 2009, NAT STRUCT MOL BIOL, V16, P63, DOI 10.1038/nsmb.1529; Shinkai H, 2006, IMMUNOGENETICS, V58, P324, DOI 10.1007/s00251-005-0068-z; Smith NGC, 2003, J MOL EVOL, V57, P467, DOI 10.1007/s00239-003-2500-z; Tanji H, 2013, SCIENCE, V339, P1426, DOI 10.1126/science.1229159; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Weber ANR, 2004, J BIOL CHEM, V279, P34589, DOI 10.1074/jbc.M403830200; Wei TD, 2009, PROTEIN SCI, V18, P1684, DOI 10.1002/pro.186; Werling D, 2003, VET IMMUNOL IMMUNOP, V91, P1, DOI 10.1016/S0165-2427(02)00228-3; Wlasiuk G, 2010, MOL BIOL EVOL, V27, P2172, DOI 10.1093/molbev/msq104; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	52	21	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124069	10.1371/journal.pone.0124069	http://dx.doi.org/10.1371/journal.pone.0124069			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894218	gold, Green Published, Green Submitted			2022-12-26	WOS:000353211700071
J	Dasgupta, T; Coram, RJ; Stillwagon, SJ; Ladd, AN				Dasgupta, Twishasri; Coram, Ryan J.; Stillwagon, Samantha J.; Ladd, Andrea N.			Gene Expression Analyses during Spontaneous Reversal of Cardiomyopathy in Mice with Repressed Nuclear CUG-BP, Elav-Like Family (CELF) Activity in Heart Muscle	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; PHOSPHOLAMBAN GENE; DILATED CARDIOMYOPATHY; CARDIAC-FUNCTION; BINDING PROTEIN; MOUSE; CONTRACTILITY; OVEREXPRESSION; HYPERTROPHY; MODULATION	CUG-BP, Elav-like family (CELF) proteins regulate cell type-and developmental stage-specific alternative splicing in the heart. Repression of CELF-mediated splicing activity via expression of a nuclear dominant negative CELF protein in heart muscle was previously shown to induce dysregulation of alternative splicing, cardiac dysfunction, cardiac hypertrophy, and dilated cardiomyopathy in MHC-CELF Delta transgenic mice. A "mild" line of MHC-CELF Delta mice that expresses a lower level of the dominant negative protein exhibits cardiac dysfunction and myopathy at a young age, but spontaneously recovers normal cardiac function and heart size with age despite the persistence of splicing defects. To the best of our knowledge, this was the first example of a genetically induced cardiomyopathy that spontaneously recovers without intervention. In this study, we explored the basis for this recovery. We examined whether a transcriptional program regulated by serum response factor (SRF) that is dysregulated in juvenile MHC-CELF Delta mice is restored in the mild line with age, and evaluated global changes in gene expression by microarray analyses. We found that differences in gene expression between the mild line and wild type hearts are greatly reduced in older animals, including a partial recovery of SRF target gene expression. We did not find evidence of a new compensatory pathway being activated in the mild line with age, and propose that recovery may occur due to developmental stage-specific compatibility of CELF-dependent splice variants with the cellular environment of the cardiomyocyte.	[Dasgupta, Twishasri; Coram, Ryan J.; Stillwagon, Samantha J.; Ladd, Andrea N.] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Ladd, AN (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44106 USA.	ladda@ccf.org			National Institutes of Health [1R01HL089376]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089376] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant to ANL from the National Institutes of Health (1R01HL089376). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balza RO, 2006, J BIOL CHEM, V281, P6498, DOI 10.1074/jbc.M509487200; Belevych AE, 2013, CARDIOVASC RES, V98, P240, DOI 10.1093/cvr/cvt024; Bround MJ, 2012, CARDIOVASC RES, V96, P372, DOI 10.1093/cvr/cvs260; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Chen F, 2002, CELL, V110, P713, DOI 10.1016/S0092-8674(02)00932-7; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Dasgupta T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056590; Dasgupta T, 2012, WIRES RNA, V3, P104, DOI 10.1002/wrna.107; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Haghighi K, 2003, J CLIN INVEST, V111, P869, DOI 10.1172/JCI200317892; Haghighi K, 2012, J MOL CELL CARDIOL, V52, P773, DOI 10.1016/j.yjmcc.2011.11.012; Harrell MD, 2007, PHYSIOL GENOMICS, V28, P273, DOI 10.1152/physiolgenomics.00163.2006; Ho TH, 2005, HUM MOL GENET, V14, P1539, DOI 10.1093/hmg/ddi162; HOIT BD, 1995, CIRC RES, V77, P632, DOI 10.1161/01.RES.77.3.632; Hossain GS, 2003, J BIOL CHEM, V278, P30317, DOI 10.1074/jbc.M212897200; IZUMO S, 1988, P NATL ACAD SCI USA, V85, P339, DOI 10.1073/pnas.85.2.339; Kalsotra A, 2008, P NATL ACAD SCI USA, V105, P20333, DOI 10.1073/pnas.0809045105; KIM WS, 1991, FEBS LETT, V293, P142, DOI 10.1016/0014-5793(91)81171-4; Kodde IF, 2007, COMP BIOCHEM PHYS A, V146, P26, DOI 10.1016/j.cbpa.2006.09.014; KOMURO I, 1988, CIRC RES, V62, P1075, DOI 10.1161/01.RES.62.6.1075; Koshelev M, 2010, HUM MOL GENET, V19, P1066, DOI 10.1093/hmg/ddp570; Kranias EG, 2012, CIRC RES, V110, P1646, DOI 10.1161/CIRCRESAHA.111.259754; Ladd AN, 2005, DEV DYNAM, V233, P783, DOI 10.1002/dvdy.20382; Ladd AN, 2005, MOL CELL BIOL, V25, P6267, DOI 10.1128/MCB.25.14.6267-6278.2005; Lorita J, 2010, J PHYSIOL BIOCHEM, V66, P55, DOI 10.1007/s13105-010-0009-7; Lorita J, 2009, GROWTH FACTORS, V27, P203, DOI 10.1080/08977190902913731; Luo WS, 1996, CIRC RES, V78, P839, DOI 10.1161/01.RES.78.5.839; LUO WS, 1994, CIRC RES, V75, P401, DOI 10.1161/01.RES.75.3.401; Medin M, 2007, EUR J HEART FAIL, V9, P37, DOI 10.1016/j.ejheart.2006.04.007; Montgomery RL, 2011, CIRCULATION, V124, P1537, DOI 10.1161/CIRCULATIONAHA.111.030932; Nelson TJ, 2005, J MOL CELL CARDIOL, V39, P479, DOI 10.1016/j.yjmcc.2005.05.004; Palmer BM, 2005, HEART FAIL REV, V10, P187, DOI 10.1007/s10741-005-5249-1; Parlakian A, 2004, MOL CELL BIOL, V24, P5281, DOI 10.1128/MCB.24.12.5281-5289.2004; Philippar U, 2004, MOL CELL, V16, P867, DOI 10.1016/j.molcel.2004.11.039; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Razafsky D, 2009, J CELL BIOL, V186, P461, DOI 10.1083/jcb.200906068; ROZICH JD, 1995, J MOL CELL CARDIOL, V27, P485, DOI 10.1016/S0022-2828(08)80044-2; Sayer G, 2014, CARDIOL CLIN, V32, P21, DOI 10.1016/j.ccl.2013.09.002; Shieh JTC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019481; Shin CH, 2002, CELL, V110, P725, DOI 10.1016/S0092-8674(02)00933-9; Siedner S, 2003, J PHYSIOL-LONDON, V548, P493, DOI 10.1113/JPHYSIOL.2002.036509; Terenzi F, 2009, J MOL CELL CARDIOL, V46, P395, DOI 10.1016/j.yjmcc.2008.10.030; Verma SK, 2013, J BIOL CHEM, V288, P35372, DOI 10.1074/jbc.M113.507426; Wang GS, 2007, J CLIN INVEST, V117, P2802, DOI 10.1172/JCI32308; Warkman AS, 2012, CYTOSKELETON, V69, P324, DOI 10.1002/cm.21029; Zhang XM, 2003, AM J PHYSIOL-REG I, V285, pR552, DOI 10.1152/ajpregu.00631.2002; Zou YZ, 2011, HYPERTENSION, V58, P1099, DOI 10.1161/HYPERTENSIONAHA.111.173500	47	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124462	10.1371/journal.pone.0124462	http://dx.doi.org/10.1371/journal.pone.0124462			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894229	Green Submitted, Green Published, gold			2022-12-26	WOS:000353211700097
J	de Munnik, SM; Kooistra, AJ; van Offenbeek, J; Nijmeijer, S; de Graaf, C; Smit, MJ; Leurs, R; Vischer, HF				de Munnik, Sabrina M.; Kooistra, Albert J.; van Offenbeek, Jody; Nijmeijer, Saskia; de Graaf, Chris; Smit, Martine J.; Leurs, Rob; Vischer, Henry F.			The Viral G Protein-Coupled Receptor ORF74 Hijacks beta-Arrestins for Endocytic Trafficking in Response to Human Chemokines	PLOS ONE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; 5 CCR5 PHOSPHORYLATION; INVERSE AGONISTS; HIV ENTRY; LIGAND; DESENSITIZATION; INHIBITION; EXPRESSION; RESIDUES; HELIX-8	Kaposi's sarcoma-associated herpesvirus-infected cells express the virally encoded G protein-coupled receptor ORF74. Although ORF74 is constitutively active, it binds human CXC chemokines that modulate this basal activity. ORF74-induced signaling has been demonstrated to underlie the development of the angioproliferative tumor Kaposi's sarcoma. Whereas G protein-dependent signaling of ORF74 has been the subject of several studies, the interaction of this viral GPCR with beta-arrestins has hitherto not been investigated. Bioluminescence resonance energy transfer experiments demonstrate that ORF74 recruits beta-arrestins and subsequently internalizes in response to human CXCL1 and CXCL8, but not CXCL10. Internalized ORF74 traffics via early endosomes to recycling and late endosomes. Site-directed mutagenesis and homology modeling identified four serine and threonine residues at the distal end of the intracellular carboxyl-terminal of ORF74 that are required for beta-arrestin recruitment and subsequent endocytic trafficking. Hijacking of the human endocytic trafficking machinery is a previously unrecognized action of ORF74.	[de Munnik, Sabrina M.; Kooistra, Albert J.; van Offenbeek, Jody; Nijmeijer, Saskia; de Graaf, Chris; Smit, Martine J.; Leurs, Rob; Vischer, Henry F.] Vrije Univ Amsterdam, AIMMS, Dept Chem & Pharmaceut Sci, Div Med Chem, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Vischer, HF (corresponding author), Vrije Univ Amsterdam, AIMMS, Dept Chem & Pharmaceut Sci, Div Med Chem, Amsterdam, Netherlands.	h.f.vischer@vu.nl	Kooistra, Albert J./H-1135-2016; Leurs, Rob/AAC-8508-2022; Leurs, Rob/ABB-4299-2021; de Graaf, Chris/J-8549-2017	Kooistra, Albert J./0000-0001-5514-6021; Leurs, Rob/0000-0003-1354-2848; de Graaf, Chris/0000-0002-1226-2150; Nijmeijer, Saskia/0000-0001-8037-4659; Smit, Martine/0000-0003-2713-0238	ECHO Grant from Netherlands Organization for Scientific Research (NWO) [700.58.008]	ECHO Grant from Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by ECHO Grant 700.58.008 from the Netherlands Organization for Scientific Research (NWO) (www.nwo.nl). RL and HFV received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KH, 2010, BIOCHEMISTRY-US, V49, P502, DOI 10.1021/bi901619r; [Anonymous], 2012, 1010; Arvanitakis L, 1997, NATURE, V385, P347, DOI 10.1038/385347a0; Azzi S, 2014, ONCOGENE, V33, P5609, DOI 10.1038/onc.2013.503; Azzi SG, 2014, RECEPTORS CLIN INVES, V1, P149; Bais C, 1998, NATURE, V391, P86, DOI 10.1038/34193; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bamberg CE, 2010, J BIOL CHEM, V285, P7633, DOI 10.1074/jbc.M109.092106; Berchiche YA, 2011, MOL PHARMACOL, V79, P488, DOI 10.1124/mol.110.068486; Bhave G, 2002, NEURON, V35, P721, DOI 10.1016/S0896-6273(02)00802-4; Brandt SM, 2002, J BIOL CHEM, V277, P17291, DOI 10.1074/jbc.M108232200; Canals M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034192; Chaisuparat R, 2008, CANCER RES, V68, P8361, DOI 10.1158/0008-5472.CAN-08-0878; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chiou CJ, 2002, J VIROL, V76, P3421, DOI 10.1128/JVI.76.7.3421-3439.2002; Dahl ME, 2008, J PHARMACOL EXP THER, V327, P926, DOI 10.1124/jpet.108.142695; Fan H, 2013, INNATE IMMUNITY; Feng H, 2010, J VIROL, V84, P3351, DOI 10.1128/JVI.01939-09; Fox JM, 2011, BLOOD, V117, P1851, DOI 10.1182/blood-2010-05-287474; Geras-Raaka E, 1998, J EXP MED, V187, P801, DOI 10.1084/jem.187.5.801; Gimenez LE, 2012, J BIOL CHEM, V287, P9028, DOI 10.1074/jbc.M111.311803; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Gurevich VV, 2013, PROG MOL BIOL TRANSL, V118, P57, DOI 10.1016/B978-0-12-394440-5.00003-6; Ho HH, 2001, J BIOL CHEM, V276, P1376, DOI 10.1074/jbc.M007885200; Holst PJ, 2001, J CLIN INVEST, V108, P1789, DOI 10.1172/JCI13622; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hu SS, 2013, MOL BIOL REP, V40, P1065, DOI 10.1007/s11033-012-2148-0; Huttenrauch F, 2002, J BIOL CHEM, V277, P30769, DOI 10.1074/jbc.M204033200; Innamorati G, 1998, P NATL ACAD SCI USA, V95, P2222, DOI 10.1073/pnas.95.5.2222; Jensen DD, 2013, J BIOL CHEM, V288, P22942, DOI 10.1074/jbc.M113.455774; Kang DS, 2014, CURR OPIN CELL BIOL, V27, P63, DOI 10.1016/j.ceb.2013.11.005; Katragadda M, 2004, BBA-BIOMEMBRANES, V1663, P74, DOI 10.1016/j.bbamem.2004.01.012; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Krishna AG, 2002, BIOCHEMISTRY-US, V41, P8298, DOI 10.1021/bi025534m; Lagos D, 2008, CELL HOST MICROBE, V4, P470, DOI 10.1016/j.chom.2008.09.012; Lan TH, 2012, TRAFFIC, V13, P1450, DOI 10.1111/j.1600-0854.2012.01401.x; Lan TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017361; London N, 2011, NUCLEIC ACIDS RES, V39, pW249, DOI 10.1093/nar/gkr431; Luttrell LM, 2002, J CELL SCI, V115, P455; Luttrell LM, 2010, PHARMACOL REV, V62, P305, DOI 10.1124/pr.109.002436; MACIEJEWSKI PM, 1995, J BIOL CHEM, V270, P27661, DOI 10.1074/jbc.270.46.27661; Marchese A, 2014, CURR OPIN CELL BIOL, V27, P72, DOI 10.1016/j.ceb.2013.11.011; McLean KA, 2004, VIROLOGY, V325, P241, DOI 10.1016/j.virol.2004.04.027; Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+; Mueller SG, 1997, J BIOL CHEM, V272, P8207, DOI 10.1074/jbc.272.13.8207; Nakajima K, 2012, MOL PHARMACOL, V82, P575, DOI 10.1124/mol.112.080358; Nijmeijer S, 2010, J BIOL CHEM, V285, P29632, DOI 10.1074/jbc.M110.115618; Oppermann M, 1999, J BIOL CHEM, V274, P8875, DOI 10.1074/jbc.274.13.8875; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; Pollok-Kopp B, 2003, J BIOL CHEM, V278, P2190, DOI 10.1074/jbc.M209844200; Qanbar R, 2003, PHARMACOL THERAPEUT, V97, P1, DOI 10.1016/S0163-7258(02)00300-5; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Raveh B, 2010, PROTEINS, V78, P2029, DOI 10.1002/prot.22716; Rosenkilde MM, 1999, J BIOL CHEM, V274, P956, DOI 10.1074/jbc.274.2.956; Rosenkilde MM, 2000, MOL PHARMACOL, V57, P602, DOI 10.1124/mol.57.3.602; Rosethorne EM, 2011, MOL PHARMACOL, V79, P749, DOI 10.1124/mol.110.068395; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Salahpour Ali, 2012, Front Endocrinol (Lausanne), V3, P105, DOI 10.3389/fendo.2012.00105; Scholten DJ, 2012, BRIT J PHARMACOL, V166, P898, DOI 10.1111/j.1476-5381.2011.01648.x; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Shukla AK, 2013, NATURE, V497, P137, DOI 10.1038/nature12120; Smit MJ, 2002, J VIROL, V76, P1744, DOI 10.1128/JVI.76.4.1744-1752.2002; Sodhi A, 2000, CANCER RES, V60, P4873; Sodhi A, 2004, P NATL ACAD SCI USA, V101, P4821, DOI 10.1073/pnas.0400835101; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Tobin AB, 2008, BRIT J PHARMACOL, V153, pS167, DOI 10.1038/sj.bjp.0707662; Unal H, 2012, TRENDS PHARMACOL SCI, V33, P79, DOI 10.1016/j.tips.2011.09.007; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Verzijl D, 2006, J BIOL CHEM, V281, P35327, DOI 10.1074/jbc.M606877200; Vischer HF, 2014, NAT REV DRUG DISCOV, V13, P123, DOI 10.1038/nrd4189; Waldhoer M, 2003, J BIOL CHEM, V278, P19473, DOI 10.1074/jbc.M213179200; Watts AO, 2013, J BIOL CHEM, V288, P7169, DOI 10.1074/jbc.M112.406108; Yeatman HR, 2014, J BIOL CHEM, V289, P15856, DOI 10.1074/jbc.M113.536672; Zhan XZ, 2011, J MOL BIOL, V406, P467, DOI 10.1016/j.jmb.2010.12.034	74	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124486	10.1371/journal.pone.0124486	http://dx.doi.org/10.1371/journal.pone.0124486			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894435	Green Published, gold, Green Submitted			2022-12-26	WOS:000353211700099
J	Egnatios, J; Kaushal, K; Kalmaz, D; Zarrinpar, A				Egnatios, Jeremy; Kaushal, Khushboo; Kalmaz, Denise; Zarrinpar, Amir			Video Capsule Endoscopy in Patients with Chronic Abdominal Pain with or without Associated Symptoms: A Retrospective Study	PLOS ONE			English	Article							BOWEL CROHNS-DISEASE; DIAGNOSTIC YIELD; CLINICAL-PRACTICE; CT ENTEROGRAPHY; UNITED-STATES; MULTICENTER; DIARRHEA; APPROPRIATENESS; METAANALYSIS; PREVALENCE	Background Chronic abdominal pain (CAP) is a common indication for gastroenterology referrals. More insidious causes of CAP isolated to the small bowel, such as malignancies and Crohn's disease, are rising in incidence and causing more gastroenterologists to evaluate their patients with video capsule endoscopy (VCE). However, the role of VCE in patients with CAP is still unclear. Aims We assessed the efficacy of VCE in patients with CAP and whether it led to findings that contributed to disease management and meaningful interventions. Methods This retrospective study evaluated 607 capsule endoscopy studies at an open referral endoscopy unit. Ninety of the studies were for CAP. These studies were compared to those performed for other indications to compare diagnostic yield. In addition, we investigated whether VCE led to an intervention that improved clinical outcomes. Results Overall, the number of abnormal findings in CAP patients was significantly lower than VCE performed for other indications (24.4% vs 39.0%, respectively p = 0.009). When patients with CAP presented with other pertinent clinical findings (e.g. nausea, weight loss, anemia, history of in inflammatory bowel disease, etc.), the likelihood of an abnormal finding increased to a level that was not different from those who received VCE for other indications (27.1%, p = 0.10). The findings from VCE lead to changed management and improved outcomes in 16.2% of CAP patients with associated symptoms. However, the subgroup that benefited the most were those who had a prior history of Crohn's disease. Patients with CAP who did not have any associated symptoms continued to have a significantly lower abnormal finding rate compared to those who received VCE for other indications (19.4%, p = 0.03) and VCE rarely led to a change in management that would improve outcomes (5.6%). Conclusions VCE for CAP has a lower rate of abnormal findings than other indications. However, VCE is a useful diagnostic tool that can help provide a possible etiology of CAP in patients with associated symptoms. However, a change in management from VCE is likely to be limited to those with a history of Crohn's disease.	[Egnatios, Jeremy; Kaushal, Khushboo; Kalmaz, Denise; Zarrinpar, Amir] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Kaushal, Khushboo; Kalmaz, Denise; Zarrinpar, Amir] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Kalmaz, Denise; Zarrinpar, Amir] Univ Calif San Diego, Div Gastroenterol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Zarrinpar, A (corresponding author), Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA.	azarrinpar@ucsd.edu	Zarrinpar, Amir/L-4077-2019; , Amir/AAJ-6732-2020	Zarrinpar, Amir/0000-0001-6423-5982; Egnatios, Jeremy/0000-0003-4292-7392	National Institute of Health T32 Training Grant [DK07202]; American Association for the Study of Liver Diseases Liver Scholar Award; National Institute of Health R25 Training Grant [MH71544]; University of California, San Diego Sam and Rose Stein Institute for Research on Aging; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH071544] Funding Source: NIH RePORTER	National Institute of Health T32 Training Grant; American Association for the Study of Liver Diseases Liver Scholar Award; National Institute of Health R25 Training Grant; University of California, San Diego Sam and Rose Stein Institute for Research on Aging; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	AZ was supported by National Institute of Health T32 Training Grant (DK07202) and American Association for the Study of Liver Diseases Liver Scholar Award. JE was supported by National Institute of Health R25 Training Grant (MH71544) and University of California, San Diego Sam and Rose Stein Institute for Research on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burri E, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-57; Cheifetz AS, 2006, J CLIN GASTROENTEROL, V40, P688, DOI 10.1097/00004836-200609000-00005; Dionisio PM, 2010, AM J GASTROENTEROL, V105, P1240, DOI 10.1038/ajg.2009.713; Esaki M, 2010, DIGEST DIS SCI, V55, P2294, DOI 10.1007/s10620-009-1036-5; Fry LC, 2006, ENDOSCOPY, V38, P498, DOI 10.1055/s-2006-925340; Goldfarb Neil I, 2004, Dis Manag, V7, P292, DOI 10.1089/dis.2004.7.292; Hamilton Matthew J, 2012, Diagn Ther Endosc, V2012, P467979, DOI 10.1155/2012/467979; Hara AK, 2006, RADIOLOGY, V238, P128, DOI 10.1148/radiol.2381050296; Heo HM, 2012, EUR RADIOL, V22, P1159, DOI 10.1007/s00330-011-2374-1; Hulisz Darrell, 2004, J Manag Care Pharm, V10, P299; Jensen MD, 2011, CLIN GASTROENTEROL H, V9, P124, DOI 10.1016/j.cgh.2010.10.019; Jewell DM, 2006, CHALLENGES INFLAMATO; Katsinelos P, 2011, MED PRIN PRACT, V20, P362, DOI 10.1159/000324548; Katsinelos P, 2011, EUR J INTERN MED, V22, pE63, DOI 10.1016/j.ejim.2011.06.012; Kopylov U, 2014, WORLD J GASTROENTERO, V20, P1155, DOI 10.3748/wjg.v20.i5.1155; Lai LH, 2006, AM J GASTROENTEROL, V101, P1224, DOI 10.1111/j.1572-0241.2006.00565.x; Leighton Jonathan A, 2006, Gastrointest Endosc Clin N Am, V16, P229, DOI 10.1016/j.giec.2006.03.004; Long MD, 2011, INFLAMM BOWEL DIS, V17, P1855, DOI 10.1002/ibd.21571; Makins R, 2006, ALIMENT PHARM THERAP, V24, P293, DOI 10.1111/j.1365-2036.2006.02991.x; May A, 2007, ENDOSCOPY, V39, P606, DOI 10.1055/s-2007-966640; Middleton Kimberly R, 2006, Adv Data, P1; Morini S, 2001, GASTROINTEST ENDOSC, V54, P175, DOI 10.1067/mge.2001.116565; Myer PA, 2013, AM J GASTROENTEROL, V108, P1496, DOI 10.1038/ajg.2013.199; Ng Siew C, 2013, Gastroenterol Hepatol (N Y), V9, P28; Quigley EMM, 2006, ALIMENT PHARM THER, V24, P411, DOI 10.1111/j.1365-2036.2006.02989.x; Qvigstad G, 2006, SCAND J GASTROENTERO, V41, P614, DOI 10.1080/00365520500335159; Raju Gottumukkala S, 2007, Gastroenterology, V133, P1697, DOI 10.1053/j.gastro.2007.06.007; Rondonotti E, 2010, EUR J GASTROEN HEPAT, V22, P1380, DOI 10.1097/MEG.0b013e3283352ced; Sandler RS, 2000, DIGEST DIS SCI, V45, P1166, DOI 10.1023/A:1005554103531; Santhakumar Cositha, 2014, World J Gastrointest Pathophysiol, V5, P479, DOI 10.4291/wjgp.v5.i4.479; Santillan CS, 2014, MAGN RESON IMAGING C, V22, P1, DOI 10.1016/j.mric.2013.07.004; Shim KN, 2006, SCAND J GASTROENTERO, V41, P983, DOI 10.1080/00365520600548974; Solem CA, 2008, GASTROINTEST ENDOSC, V68, P255, DOI 10.1016/j.gie.2008.02.017; Spada C, 2006, DIGEST LIVER DIS, V38, P696, DOI 10.1016/j.dld.2006.05.011; Swain P, 2005, GUT, V54, P323, DOI 10.1136/gut.2004.047282; Townsend CO, 2005, J PAIN, V6, P75, DOI 10.1016/j.jpain.2004.10.009; Triester SL, 2006, AM J GASTROENTEROL, V101, P954, DOI 10.1111/j.1572-0241.2006.00506.x; Xue M, 2015, GASTROINTEST ENDOSC, V81, P186, DOI 10.1016/j.gie.2014.04.062; Yamagami H, 2013, CLIN ENDOSC, V46, P321, DOI 10.5946/ce.2013.46.4.321; Yang LP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087396; Zamboni Giulia A, 2010, Gastrointest Endosc Clin N Am, V20, P347, DOI 10.1016/j.giec.2010.02.017	41	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0126509	10.1371/journal.pone.0126509	http://dx.doi.org/10.1371/journal.pone.0126509			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893440	Green Published, Green Submitted, gold			2022-12-26	WOS:000353211700144
J	Kaur, K; Helgesen, KO; Bakke, MJ; Horsberg, TE				Kaur, Kiranpreet; Helgesen, Kari Olli; Bakke, Marit Jorgensen; Horsberg, Tor Einar			Mechanism behind Resistance against the Organophosphate Azamethiphos in Salmon Lice (Lepeophtheirus salmonis)	PLOS ONE			English	Article							AMINO-ACID SUBSTITUTION; HUMAN ACETYLCHOLINESTERASE; INSECTICIDE-INSENSITIVITY; CULEX-TRITAENIORHYNCHUS; TETRANYCHUS-URTICAE; ACTIVE-CENTER; SEA LICE; CHOLINESTERASES; MUTATIONS; RESIDUES	Acetylcholinesterase (AChE) is the primary target for organophosphates (OP). Several mutations have been reported in AChE to be associated with the reduced sensitivity against OP in various arthropods. However, to the best of our knowledge, no such reports are available for Lepeophtheirus salmonis. Hence, in the present study, we aimed to determine the association of AChE(s) gene(s) with resistance against OP. We screened the AChE genes (L. salmonis ace1a and ace1b) in two salmon lice populations: one sensitive (n=5) and the other resistant (n=5) for azamethiphos, a commonly used OP in salmon farming. The screening led to the identification of a missense mutation Phe362Tyr in L. salmonis ace1a, (corresponding to Phe331 in Torpedo californica AChE) in all the samples of the resistant population. We confirmed the potential role of the mutation, with reduced sensitivity against azamethiphos in L. salmonis, by screening for Phe362Tyr in 2 sensitive and 5 resistant strains. The significantly higher frequency of the mutant allele (362Tyr) in the resistant strains clearly indicated the possible association of Phe362Tyrmutation in L. salmonis ace1a with resistance towards azamethiphos. The 3D modelling, short term survival experiments and enzymatic assays further supported the imperative role of Phe362Tyrin reduced sensitivity of L. salmonis for azamethiphos. Based on all these observations, the present study, for the first time, presents the mechanism of resistance in L. salmonisagainst azamethiphos. In addition, we developed a rapid diagnostic tool for the high throughput screening of Phe362Tyr mutation using High Resolution Melt analysis.	[Kaur, Kiranpreet; Helgesen, Kari Olli; Bakke, Marit Jorgensen; Horsberg, Tor Einar] NMBU, Sch Vet Sci, Sea Lice Res Ctr, NO-0033 Oslo, Norway	Norwegian University of Life Sciences	Kaur, K (corresponding author), NMBU, Sch Vet Sci, Sea Lice Res Ctr, POB 8146 Dept, NO-0033 Oslo, Norway.	kiran.kaur@nmbu.no	Kaur, Kiran/R-3535-2018	Kaur, Kiran/0000-0002-7285-5513	Norwegian Research Council [NFR 203513/O30, NFR 199778/S40]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	The study was financially supported by the Norwegian Research Council through the Centre for Innovation Sea Lice Research Centre, grant number NFR 203513/O30 and the project PrevenT, grant number NFR 199778/S40. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRIDGE WN, 1950, BIOCHEM J, V46, P451, DOI 10.1042/bj0460451; Alon M, 2008, INSECT BIOCHEM MOLEC, V38, P940, DOI 10.1016/j.ibmb.2008.07.007; Anazawa Y, 2003, INSECT BIOCHEM MOLEC, V33, P509, DOI 10.1016/S0965-1748(03)00025-0; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bar-On P, 2002, BIOCHEMISTRY-US, V41, P3555, DOI 10.1021/bi020016x; Benting J, 2004, PEST MANAG SCI, V60, P1051, DOI 10.1002/ps.971; Boublik Y, 2002, PROTEIN ENG, V15, P43, DOI 10.1093/protein/15.1.43; Denholm I, 2002, PEST MANAG SCI, V58, P528, DOI 10.1002/ps.482; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; FOURNIER D, 1994, COMP BIOCHEM PHYS C, V108, P19, DOI 10.1016/1367-8280(94)90084-1; Grave K, 2004, DIS AQUAT ORGAN, V60, P123, DOI 10.3354/dao060123; Grontvedt R. N., 2014, SURVEILLANCE PROGRAM; Hamre LA, 2009, PARASITOL INT, V58, P451, DOI 10.1016/j.parint.2009.08.009; Harel M, 2000, PROTEIN SCI, V9, P1063, DOI 10.1110/ps.9.6.1063; Helgesen KO, 2014, J FISH DIS, V37, P877, DOI 10.1111/jfd.12223; Helgesen KO, 2013, J FISH DIS, V36, P261, DOI 10.1111/jfd.12053; HOSEA NA, 1995, BIOCHEMISTRY-US, V34, P11528, DOI 10.1021/bi00036a028; Hotelier T, 2010, J PESTIC SCI, V35, P315, DOI 10.1584/jpestics.R10-10; Kaur K., 2015, PLOS ONE IN PRESS; Kwon DH, 2012, INSECT BIOCHEM MOLEC, V42, P212, DOI 10.1016/j.ibmb.2011.12.003; Low VL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079928; Muhammet MA, 2014, TURKIYE PARAZITOL DE, V38, P111, DOI [10.5152/tpd.2014.3388, DOI 10.5152/TPD.2014.3388]; Nabeshima T, 2004, BIOCHEM BIOPH RES CO, V313, P794, DOI 10.1016/j.bbrc.2003.11.141; Nabeshima T, 2003, BIOCHEM BIOPH RES CO, V307, P15, DOI 10.1016/S0006-291X(03)01101-X; Oh SH, 2006, PESTIC BIOCHEM PHYS, V85, P46, DOI 10.1016/j.pestbp.2005.10.003; Ordentlich A, 1999, BIOCHEMISTRY-US, V38, P3055, DOI 10.1021/bi982261f; Reed GH, 2007, PHARMACOGENOMICS, V8, P597, DOI 10.2217/14622416.8.6.597; Riaz MA, 2013, AQUAT TOXICOL, V126, P326, DOI 10.1016/j.aquatox.2012.09.010; Shafferman A, 1996, BIOCHEM J, V318, P833, DOI 10.1042/bj3180833; SHAFFERMAN A, 1992, EMBO J, V11, P3561, DOI 10.1002/j.1460-2075.1992.tb05439.x; Shi MA, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-5; Surendran SN, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-34; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torrissen O, J FISH DIS, V213, P171; World Health Organization, 1998, WHOCDSCPCMAL98	35	34	34	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124220	10.1371/journal.pone.0124220	http://dx.doi.org/10.1371/journal.pone.0124220			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893248	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000353211700078
J	Kilembe, W; Wall, KM; Mokgoro, M; Mwaanga, A; Dissen, E; Kamusoko, M; Phiri, H; Sakulanda, J; Davitte, J; Reddy, T; Brockman, M; Ndung'u, T; Allen, S				Kilembe, William; Wall, Kristin M.; Mokgoro, Mammekwa; Mwaanga, Annie; Dissen, Elisabeth; Kamusoko, Miriam; Phiri, Hilda; Sakulanda, Jean; Davitte, Jonathan; Reddy, Tarylee; Brockman, Mark; Ndung'u, Thumbi; Allen, Susan			Knowledge of HIV Serodiscordance, Transmission, and Prevention among Couples in Durban, South Africa	PLOS ONE			English	Article							DISCORDANT COUPLES; SEXUAL-BEHAVIOR; ZAMBIA; LUSAKA; SEROCONVERSION; INFECTIONS; PREVALENCE; ENROLLMENT; RWANDA	Objective Couples' voluntary HIV counseling and testing (CVCT) significantly decreases HIV transmission within couples, the largest risk group in sub-Saharan Africa, but it is not currently offered in most HIV testing facilities. To roll out such an intervention, understanding locale-specific knowledge barriers is critical. In this study, we measured knowledge of HIV serodiscordance, transmission, and prevention before and after receipt of CVCT services in Durban. Design Pre- and post-CVCT knowledge surveys were administered to a selection of individuals seeking CVCT services. Methods Changes in knowledge scores were assessed with McNemar Chi-square tests for balanced data and generalized estimating equation methods for unbalanced data. Results The survey included 317 heterosexual black couples (634 individuals) who were primarily Zulu (87%), unemployed (47%), and had at least a secondary level education (78%). 28% of couples proved to be discordant. Only 30% of individuals thought serodiscordance between couples was possible pre-CVCT compared to 95% post-CVCT. One-third thought there was at least one benefit of CVCT pre-CVCT, increasing to 96% post-CVCT. Overall, there were positive changes in knowledge about HIV transmission and prevention. However, many respondents thought all HIV positive mothers give birth to babies with AIDS (64% pre-CVCT, 59% post-CVCT) and that male circumcision does not protect negative men against HIV (70% pre-CVCT, 67% post-CVCT). Conclusions CVCT was well received and was followed by improvements in understanding of discordance, the benefits of joint testing, and HIV transmission. Country-level health messaging would benefit from targeting gaps in knowledge about serodiscordance, vertical transmission, and male circumcision.	[Kilembe, William; Wall, Kristin M.; Mwaanga, Annie; Dissen, Elisabeth; Phiri, Hilda; Sakulanda, Jean; Davitte, Jonathan; Allen, Susan] Emory Univ, Sch Med, Dept Pathol & Lab Med, Rwanda Zambia HIV Res Grp, Atlanta, GA 30322 USA; [Kilembe, William; Wall, Kristin M.; Mwaanga, Annie; Dissen, Elisabeth; Phiri, Hilda; Sakulanda, Jean; Davitte, Jonathan; Allen, Susan] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Wall, Kristin M.] Emory Univ, Laney Grad Sch, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Mokgoro, Mammekwa; Kamusoko, Miriam; Ndung'u, Thumbi] Univ KwaZulu Natal, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Durban, South Africa; [Reddy, Tarylee] MRC, Biostat Unit, Durban, South Africa; [Brockman, Mark] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Brockman, Mark] Simon Fraser Univ, Fac Sci, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Ndung'u, Thumbi] Univ KwaZulu Natal, KwaZulu Natal Res Inst TB & HIV K RITH, Durban, South Africa	Emory University; Emory University; Rollins School Public Health; Emory University; Rollins School Public Health; University of Kwazulu Natal; Simon Fraser University; Simon Fraser University; University of Kwazulu Natal	Wall, KM (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Rwanda Zambia HIV Res Grp, Atlanta, GA 30322 USA.	kmwall@emory.edu	; Brockman, Mark/D-1669-2016	Ndung'u, Thumbi/0000-0003-2962-3992; Reddy, Tarylee/0000-0002-9521-2692; Brockman, Mark/0000-0001-6432-1426	Canadian Global Health Research Initiative (GHRI) International Development Research Centre [107017-001]; Emory Center for AIDS Research [P30 AI050409]; AIDS International Training and Research Program Fogarty International Center [D43 TW001042]; FOGARTY INTERNATIONAL CENTER [D43TW001042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409] Funding Source: NIH RePORTER	Canadian Global Health Research Initiative (GHRI) International Development Research Centre; Emory Center for AIDS Research; AIDS International Training and Research Program Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Canadian Global Health Research Initiative (GHRI) International Development Research Centre (Project Number: 107017-001), the Emory Center for AIDS Research (P30 AI050409), and the AIDS International Training and Research Program Fogarty International Center (D43 TW001042).	Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; ALLEN S, 1992, BRIT MED J, V304, P1605, DOI 10.1136/bmj.304.6842.1605; Allen S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-349; Becker S, 2010, AIDS BEHAV, V14, P558, DOI 10.1007/s10461-009-9607-1; Boeras DI, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-18; Castle S, 2003, HEALTH POLICY PLANN, V18, P146, DOI 10.1093/heapol/czg019; CDC, 2011, COUPL HIV COUNS TEST; Chemaitelly H, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18765; Chomba E, 2008, JAIDS-J ACQ IMM DEF, V47, P108, DOI 10.1097/QAI.0b013e31815b2d67; Delate R, 2010, 2 NAT HIV COMM SURV; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Guthrie BL, 2007, CURR HIV RES, V5, P416, DOI 10.2174/157016207781023992; HIRA SK, 1990, J ACQ IMMUN DEF SYND, V3, P83; Human Sciences Research Council, 2009, S AFR NAT HIV PREV I; KAMENGA M, 1991, AIDS, V5, P61, DOI 10.1097/00002030-199101000-00009; Kelley AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019573; Kempf MC, 2008, JAIDS-J ACQ IMM DEF, V47, P116, DOI 10.1097/QAI.0b013e31815d2f3f; King R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-801; Lingappa JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001411; Matthews LT, 2013, AIDS BEHAV, V17, P461, DOI 10.1007/s10461-011-0068-y; Parker L, 2014, CULTURE HLTH SEXUALI, P1; Peltzer K, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-174; Relief TPsEPfA, 2013, NEXT GEN IND REF GUI; Salaam- Blyther T., 2006, GLOBAL FUND FIGHT AI; Tabana H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066390; Tanser F, 2011, LANCET, V378, P247, DOI 10.1016/S0140-6736(11)60779-4; The Global Fund to Fight AIDS TaM, 2014, COR LIST IND; UNAIDS, 2012, HIV AIDS EST 2012; Wall K, 2012, AIDS, V26, P217, DOI 10.1097/QAD.0b013e32834dc593; Wall KM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001171; WHO, 2014, GEND IN HIV WHO; World Health Organization, 2012, GUID OR PREEXP PROPH	33	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124548	10.1371/journal.pone.0124548	http://dx.doi.org/10.1371/journal.pone.0124548			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894583	gold, Green Submitted, Green Published			2022-12-26	WOS:000353211700103
J	Kuster, DJ; Liu, CY; Fang, Z; Ponder, JW; Marshall, GR				Kuster, Daniel J.; Liu, Chengyu; Fang, Zheng; Ponder, Jay W.; Marshall, Garland R.			High-Resolution Crystal Structures of Protein Helices Reconciled with Three-Centered Hydrogen Bonds and Multipole Electrostatics	PLOS ONE			English	Article							HYDRATION FREE-ENERGIES; ALPHA-HELIX; MOLECULAR-DYNAMICS; ATOMIC MULTIPOLE; CONFORMATIONAL-ANALYSIS; REFINEMENT APPLICATION; FORCE-FIELDS; PEPTIDE; CRYSTALLOGRAPHY; DIPOLE	Theoretical and experimental evidence for non-linear hydrogen bonds in protein helices is ubiquitous. In particular, amide three-centered hydrogen bonds are common features of helices in high-resolution crystal structures of proteins. These high-resolution structures (1.0 to 1.5 angstrom nominal crystallographic resolution) position backbone atoms without significant bias from modeling constraints and identify Phi = -62 degrees, Psi = -43 as the consensus backbone torsional angles of protein helices. These torsional angles preserve the atomic positions of alpha-beta carbons of the classic Pauling alpha-helix while allowing the amide carbonyls to form bifurcated hydrogen bonds as first suggested by Nemethy et al. in 1967. Molecular dynamics simulations of a capped 12-residue oligoalanine in water with AMOEBA (Atomic Multipole Optimized Energetics for Biomolecular Applications), a second-generation force field that includes multipole electrostatics and polarizability, reproduces the experimentally observed high-resolution helical conformation and correctly reorients the amide-bond carbonyls into bifurcated hydrogen bonds. This simple modification of backbone torsional angles reconciles experimental and theoretical views to provide a unified view of amide three-centered hydrogen bonds as crucial components of protein helices. The reason why they have been overlooked by structural biologists depends on the small crankshaft-like changes in orientation of the amide bond that allows maintenance of the overall helical parameters (helix pitch (p) and residues per turn (n)). The Pauling 3.6(13) alpha-helix fits the high-resolution experimental data with the minor exception of the amide-carbonyl electron density, but the previously associated backbone torsional angles (Phi, Psi) needed slight modification to be reconciled with three-atom centered H-bonds and multipole electrostatics. Thus, a new standard helix, the 3.6(13/10)-, Nemethy- or N-helix, is proposed. Due to the use of constraints from monopole force fields and assumed secondary structures used in low-resolution refinement of electron density of proteins, such structures in the PDB often show linear hydrogen bonding.	[Kuster, Daniel J.; Fang, Zheng] Washington Univ, Dept Biomed Engn, St Louis, MO USA; [Liu, Chengyu; Ponder, Jay W.] Washington Univ, Dept Chem, St Louis, MO 63130 USA; [Marshall, Garland R.] Washington Univ, Dept Biochem & Mol Biophys, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Marshall, GR (corresponding author), Washington Univ, Dept Biochem & Mol Biophys, St Louis, MO 63130 USA.	garlandm@gmail.com		Fang, Zheng/0000-0003-2372-0839; Marshall, Garland/0000-0002-3098-0332	National Institutes of Health (NIH) [R01-GM068460]; Department of Defense [HDTRA1-09-CHEM-BIO-BAA]; Ewing Marion Kauffman Foundation; Department of Biomedical Engineering at Washington University; NSF [CHE-0535675]; NIH [R01-GM6955302]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069553, R01GM068460, R01GM106974] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Ewing Marion Kauffman Foundation; Department of Biomedical Engineering at Washington University; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	GRM acknowledges support from National Institutes of Health (NIH) (R01-GM068460) and the Department of Defense (HDTRA1-09-CHEM-BIO-BAA. DJK acknowledges fellowship support from the Ewing Marion Kauffman Foundation and the Department of Biomedical Engineering at Washington University. JWP acknowledges support from the NSF (CHE-0535675) and NIH (R01-GM6955302). The funders had no role in study design, data collection	Aravinda S, 2008, CHEM BIODIVERS, V5, P1238, DOI 10.1002/cbdv.200890112; ARNOTT S, 1966, J MOL BIOL, V21, P371, DOI 10.1016/0022-2836(66)90105-7; ARNOTT S, 1967, J MOL BIOL, V30, P209, DOI 10.1016/0022-2836(67)90253-7; BAUR WH, 1965, ACTA CRYSTALLOGR, V19, P909, DOI 10.1107/S0365110X65004632; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Best RB, 2008, BIOPHYS J, V95, pL7, DOI 10.1529/biophysj.108.132696; BLUNDELL T, 1983, NATURE, V306, P281, DOI 10.1038/306281a0; Bour P, 2002, BIOPOLYMERS, V65, P45, DOI 10.1002/bip.10224; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Cardamone S, 2014, PHYS CHEM CHEM PHYS, V16, P10367, DOI 10.1039/c3cp54829e; Choudhary A, 2011, PROTEIN SCI, V20, P1077, DOI 10.1002/pro.627; DONOHUE J, 1953, P NATL ACAD SCI USA, V39, P470, DOI 10.1073/pnas.39.6.470; Eisenberg D, 2003, P NATL ACAD SCI USA, V100, P11207, DOI 10.1073/pnas.2034522100; Fain A. V., 2001, Biophysics, V46, P921; Fain A. V., 2008, Biophysics, V53, P125, DOI 10.1134/S0006350908020024; Feldblum ES, 2014, P NATL ACAD SCI USA, V111, P4085, DOI 10.1073/pnas.1319827111; Felder CE, 2007, NUCLEIC ACIDS RES, V35, pW512, DOI 10.1093/nar/gkm307; Fenn TD, 2011, STRUCTURE, V19, P523, DOI 10.1016/j.str.2011.01.015; Fenn TD, 2010, BIOPHYS J, V98, P2984, DOI 10.1016/j.bpj.2010.02.057; HODGKIN EE, 1990, BIOPOLYMERS, V30, P533, DOI 10.1002/bip.360300506; HOL WGJ, 1985, PROG BIOPHYS MOL BIO, V45, P149, DOI 10.1016/0079-6107(85)90001-X; Hollingsworth SA, 2009, PROTEIN SCI, V18, P1321, DOI 10.1002/pro.133; Hovmoller S, 2002, ACTA CRYSTALLOGR D, V58, P768, DOI 10.1107/S0907444902003359; Hunt NT, 2007, J AM CHEM SOC, V129, P3168, DOI 10.1021/ja066289n; IUPAC-IUB, 1970, BIOCHEMISTRY-US, V9, P3471; Jeffrey G.A., 2012, HYDROGEN BONDING BIO; Jelsch C, 2000, P NATL ACAD SCI USA, V97, P3171, DOI 10.1073/pnas.97.7.3171; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KARLE IL, 1989, P NATL ACAD SCI USA, V86, P765, DOI 10.1073/pnas.86.3.765; KARLE IL, 1989, BIOCHEMISTRY-US, V28, P6696, DOI 10.1021/bi00442a024; KARLE IL, 1994, PROTEIN SCI, V3, P1547, DOI 10.1002/pro.5560030920; KARLE IL, 1993, BIOPOLYMERS, V33, P827, DOI 10.1002/bip.360330511; KENDREW JC, 1959, FED PROC, V18, P740; Kuster DJ, 2009, UNIFYING MODEL HELIC; Liu C, 2014, PROTEINS IN PRESS; MARSHALL GR, 1972, CIRC RES, V31, pI143; MARSHALL GR, 1990, P NATL ACAD SCI USA, V87, P487, DOI 10.1073/pnas.87.1.487; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; MIYAZAWA T, 1961, J POLYM SCI, V55, P215, DOI 10.1002/pol.1961.1205516121; Morozov AV, 2004, P NATL ACAD SCI USA, V101, P6946, DOI 10.1073/pnas.0307578101; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; NEMETHY G, 1967, NATURE, V214, P363, DOI 10.1038/214363a0; Nicholls RA, 2012, ACTA CRYSTALLOGR D, V68, P404, DOI 10.1107/S090744491105606X; Panman MR, 2013, NAT CHEM, V5, P929, DOI [10.1038/NCHEM.1744, 10.1038/nchem.1744]; Parra RD, 2001, CHEM-EUR J, V7, P4352, DOI 10.1002/1521-3765(20011015)7:20<4352::AID-CHEM4352>3.0.CO;2-L; PATERSON Y, 1981, J AM CHEM SOC, V103, P2947, DOI 10.1021/ja00401a007; Patriksson A, 2008, PHYS CHEM CHEM PHYS, V10, P2073, DOI 10.1039/b716554d; PAULING L, 1950, J AM CHEM SOC, V72, P5349, DOI 10.1021/ja01167a545; PAULING L, 1951, P NATL ACAD SCI USA, V37, P282, DOI 10.1073/pnas.37.5.282; PAULING L, 1951, P NATL ACAD SCI USA, V37, P205, DOI 10.1073/pnas.37.4.205; Penev ES, 2009, COMPUT PHYS COMMUN, V180, P2013, DOI 10.1016/j.cpc.2009.06.005; PERUTZ M F, 1960, Brookhaven Symp Biol, V13, P165; PERUTZ MF, 1951, NATURE, V167, P1053, DOI 10.1038/1671053a0; Ponder J.W, 2014, TINKER SOFTWARE TOOL; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Ponder JW, 2010, J PHYS CHEM IN PRESS; PREISSNER R, 1991, FEBS LETT, V288, P192, DOI 10.1016/0014-5793(91)81032-4; Quine JR, 1999, J MOL STRUC-THEOCHEM, V460, P53, DOI 10.1016/S0166-1280(98)00306-6; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Ren PY, 2011, J CHEM THEORY COMPUT, V7, P3143, DOI 10.1021/ct200304d; Ren PY, 2003, J PHYS CHEM B, V107, P5933, DOI 10.1021/jp027815+; Ripoll DR, 2005, P NATL ACAD SCI USA, V102, P7559, DOI 10.1073/pnas.0502754102; Rozas I, 1998, J PHYS CHEM A, V102, P9925, DOI 10.1021/jp9824813; SCHERAGA HA, 1985, P NATL ACAD SCI USA, V82, P5585, DOI 10.1073/pnas.82.17.5585; Schmidt A, 2011, ACTA CRYSTALLOGR F, V67, P424, DOI 10.1107/S1744309110052607; Schnieders MJ, 2009, ACTA CRYSTALLOGR D, V65, P952, DOI 10.1107/S0907444909022707; Sengupta D, 2005, STRUCTURE, V13, P849, DOI 10.1016/j.str.2005.03.010; SHAMALA N, 1978, J CHEM SOC CHEM COMM, P996, DOI 10.1039/c39780000996; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Shimizu K, 2005, J PHYS CHEM A, V109, P11322, DOI 10.1021/jp054673l; SHOEMAKER KR, 1985, P NATL ACAD SCI USA, V82, P2349, DOI 10.1073/pnas.82.8.2349; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; SMYTHE ML, 1993, J AM CHEM SOC, V115, P11594, DOI 10.1021/ja00077a067; SMYTHE ML, 1995, J AM CHEM SOC, V117, P5445, DOI 10.1021/ja00125a003; STICKLE DF, 1992, J MOL BIOL, V226, P1143, DOI 10.1016/0022-2836(92)91058-W; Stockmayer WH, 1967, PURE APPL CHEM, V15; Stone AJ, 2005, J CHEM THEORY COMPUT, V1, P1128, DOI 10.1021/ct050190+; STONE AJ, 1981, CHEM PHYS LETT, V83, P233, DOI 10.1016/0009-2614(81)85452-8; Stone AJ, 2008, SCIENCE, V321, P787, DOI 10.1126/science.1158006; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; TUCKERMAN ME, 1991, J CHEM PHYS, V94, P1465, DOI 10.1063/1.460004; Welsh E, 2004, SET COMPUTATIONAL TO; WIBERG KB, 1994, J ORG CHEM, V59, P6817, DOI 10.1021/jo00101a050; Wieczorek R, 2004, J AM CHEM SOC, V126, P14198, DOI 10.1021/ja048831i; Williams D.E., 2007, REV COMPUT CHEM, V2, P219; WILLIAMS DE, 1988, J COMPUT CHEM, V9, P745, DOI 10.1002/jcc.540090705; Wlodawer A, 2008, FEBS J, V275, P1, DOI 10.1111/j.1742-4658.2007.06178.x; Yang JH, 1999, ORG LETT, V1, P11, DOI 10.1021/ol9900010; Yuan YN, 2014, J COMPUT CHEM, V35, P343, DOI 10.1002/jcc.23469; Zheng XG, 2012, J AM CHEM SOC, V134, P15970, DOI 10.1021/ja306803v	92	22	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123146	10.1371/journal.pone.0123146	http://dx.doi.org/10.1371/journal.pone.0123146			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894612	Green Submitted, Green Published, gold			2022-12-26	WOS:000353211700023
J	Graichen, U; Eichardt, R; Fiedler, P; Strohmeier, D; Zanow, F; Haueisen, J				Graichen, Uwe; Eichardt, Roland; Fiedler, Patrique; Strohmeier, Daniel; Zanow, Frank; Haueisen, Jens			SPHARA - A Generalized Spatial Fourier Analysis for Multi-Sensor Systems with Non-Uniformly Arranged Sensors: Application to EEG	PLOS ONE			English	Article							COMPONENT ANALYSIS; MATCHING PURSUIT; REPRESENTATIONS; DECOMPOSITION; LOCALIZATION; LAPLACIANS; ALGORITHMS	Important requirements for the analysis of multichannel EEG data are efficient techniques for signal enhancement, signal decomposition, feature extraction, and dimensionality reduction. We propose a new approach for spatial harmonic analysis (SPHARA) that extends the classical spatial Fourier analysis to EEG sensors positioned non-uniformly on the surface of the head. The proposed method is based on the eigenanalysis of the discrete Laplace-Beltrami operator defined on a triangular mesh. We present several ways to discretize the continuous Laplace-Beltrami operator and compare the properties of the resulting basis functions computed using these discretization methods. We apply SPHARA to somatosensory evoked potential data from eleven volunteers and demonstrate the ability of the method for spatial data decomposition, dimensionality reduction and noise suppression. When employing SPHARA for dimensionality reduction, a significantly more compact representation can be achieved using the FEM approach, compared to the other discretization methods. Using FEM, to recover 95% and 99% of the total energy of the EEG data, on average only 35% and 58% of the coefficients are necessary. The capability of SPHARA for noise suppression is shown using artificial data. We conclude that SPHARA can be used for spatial harmonic analysis of multi-sensor data at arbitrary positions and can be utilized in a variety of other applications.	[Graichen, Uwe; Eichardt, Roland; Fiedler, Patrique; Strohmeier, Daniel; Haueisen, Jens] Tech Univ Ilmenau, Fac Comp Sci & Automat, Inst Biomed Engn & Informat, Ilmenau, Germany; [Zanow, Frank] Eemagine GmbH, Berlin, Germany; [Haueisen, Jens] Univ Clin Jena, Biomagnet Ctr, Dept Neurol, Jena, Germany	Technische Universitat Ilmenau; Friedrich Schiller University of Jena	Graichen, U (corresponding author), Tech Univ Ilmenau, Fac Comp Sci & Automat, Inst Biomed Engn & Informat, Ilmenau, Germany.	uwe.graichen@tu-ilmenau.de	Fiedler, Patrique/J-6173-2012; Graichen, Uwe/B-8275-2015; Graichen, Uwe/GPX-1634-2022; Haueisen, Jens/B-7183-2011	Fiedler, Patrique/0000-0001-9196-0717; Graichen, Uwe/0000-0003-2144-4682; Haueisen, Jens/0000-0003-3871-2890	German Federal Ministry for Economic Affairs and Energy [KF2250111ED2]; German Federal Ministry of Education and Research [03IP605A]; German Research Foundation [Ha2899/14-1]; European Union [FP7-PEOPLE Marie Curie IAPP project 610950]; eemagine GmbH	German Federal Ministry for Economic Affairs and Energy; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG)); European Union(European Commission); eemagine GmbH	This work was supported by the following: German Federal Ministry for Economic Affairs and Energy, Grant-No: KF2250111ED2, http://www.bmwi.de/EN/root.html, funding a research position; German Federal Ministry of Education and Research, Grant-No: 03IP605A, http://www.bmbf.de/en/, funding a research position; German Research Foundation, Grant-No: Ha2899/14-1, http://www.dfg.de/en/, funding a research position; and European Union, Grant-No: FP7-PEOPLE Marie Curie IAPP project 610950, http://ec.europa.eu/research/mariecurieactions/, funding two research positions. The eemagine GmbH provided support in the form of salaries for author FZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the "author contributions" section.	Anderson E., 1999, LAPACK USERS GUIDE, V3rd; Bashashati A, 2007, J NEURAL ENG, V4, pR32, DOI 10.1088/1741-2560/4/2/R03; Bayliss JD, 2000, IEEE T REHABIL ENG, V8, P188, DOI 10.1109/86.847811; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bradshaw LA, 2001, ANN BIOMED ENG, V29, P202, DOI 10.1114/1.1352642; Brunner C, 2007, PATTERN RECOGN LETT, V28, P957, DOI 10.1016/j.patrec.2007.01.002; Chavel I, 1984, EIGENVALUES RIEMANNI, V115; Chung F. R. K., 1997, CBMS REGIONAL C SERI, V92; Cichocki A, 2008, COMPUTER, V41, P34, DOI 10.1109/MC.2008.431; Cruccu G, 2008, CLIN NEUROPHYSIOL, V119, P1705, DOI 10.1016/j.clinph.2008.03.016; De Lucia M, 2010, BRAIN TOPOGR, V23, P119, DOI 10.1007/s10548-010-0145-y; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DESANTIS A, 1991, GEOPHYS J INT, V106, P253, DOI 10.1111/j.1365-246X.1991.tb04615.x; Dhillon IS, 2004, LINEAR ALGEBRA APPL, V387, P1, DOI 10.1016/j.laa.2003.12.028; Durka PJ, 2005, J NEUROSCI METH, V148, P49, DOI 10.1016/j.jneumeth.2005.04.001; DURKA PJ, 1995, ANN BIOMED ENG, V23, P608, DOI 10.1007/BF02584459; Dyer R., 2007, INVESTIGATION SPECTR; FUJIWARA K, 1995, P AM MATH SOC, V123, P2585, DOI 10.2307/2161293; Golub GH., 2013, MATRIX COMPUTATIONS; Graichen U., 2011, Proceedings of the 2011 8th International Symposium on Noninvasive Functional Source Imaging of the Brain and Heart and the 2011 8th International Conference on Bioelectromagnetism (NFSI and ICBEM), P18, DOI 10.1109/NFSI.2011.5936811; Gramfort Alexandre, 2007, 2007 Joint Meeting of the 6th International Symposium on Noninvasive Functional Source Imaging of the Brain and Heart and the International Conference on Functional Biomedical Imaging, P169, DOI 10.1109/NFSI-ICFBI.2007.4387717; Gratkowski M, 2008, METHOD INFORM MED, V47, P26, DOI 10.3414/ME0355; Gratkowski M, 2007, PRZ ELEKTROTECHNICZN, V83, P138; HAINES GV, 1988, COMPUT GEOSCI, V14, P413, DOI 10.1016/0098-3004(88)90027-1; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Jung TP, 2001, HUM BRAIN MAPP, V14, P166, DOI 10.1002/hbm.1050; KOLES ZJ, 1995, ELECTROEN CLIN NEURO, V95, P219, DOI 10.1016/0013-4694(95)00083-B; Lagerlund TD, 1997, J CLIN NEUROPHYSIOL, V14, P73, DOI 10.1097/00004691-199701000-00007; Mauguiere F, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P79; Max Wardetzky, 2007, S GEOMETRY PROCESSIN, P33, DOI [DOI 10.2312/SGP/SGP07/033-037, 10.2312/SGP/SGP07/033-037]; Meyer M., 2002, VISUALIZATION MATH, V3, P52, DOI DOI 10.1007/978-3-662-05105-4_2; Miwakeichi F, 2004, NEUROIMAGE, V22, P1035, DOI 10.1016/j.neuroimage.2004.03.039; Morup M, 2006, NEUROIMAGE, V29, P938, DOI 10.1016/j.neuroimage.2005.08.005; Neymeyr K., 2003, NUMERICAL METHODS SC, P74; Nunez Paul L., 1994, Brain Topography, V6, P221, DOI 10.1007/BF01187712; NUNEZ PL, 1994, ELECTROEN CLIN NEURO, V90, P40, DOI 10.1016/0013-4694(94)90112-0; Pinkall U., 1993, EXP MATH, V2, P15, DOI DOI 10.1080/10586458.1993.10504266; Polthier K., 2002, P CLAY SUMM SCH GLOB; Pourtois G, 2008, BRAIN TOPOGR, V20, P265, DOI 10.1007/s10548-008-0053-6; Ramirez-Velez M, 2006, I S BIOMED IMAGING, P956; Rao KR, 2010, SIGNALS COMMUN TECHN, P1, DOI 10.1007/978-1-4020-6629-0; Reuter M, 2006, COMPUT AIDED DESIGN, V38, P342, DOI 10.1016/j.cad.2005.10.011; Rosenberg S, 1997, LONDON MATH SOC STUD, V31; Serby H, 2005, IEEE T NEUR SYS REH, V13, P89, DOI 10.1109/TNSRE.2004.841878; SOONG ACK, 1995, IEEE T BIO-MED ENG, V42, P59, DOI 10.1109/10.362918; Sorkine O, 2006, COMPUT GRAPH FORUM, V25, P789, DOI 10.1111/j.1467-8659.2006.00999.x; Taubin G, 1995, P 22 ANN C COMPUTER, P351, DOI [DOI 10.1145/218380.218473, 10.1145/218380.218473]; Taubin G, 2000, STAR P EUR 2000 EUR; Vallet B, 2007, INRIA00186931 U NANC; Wingeier BM, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051916; Zhang H, 2010, COMPUT GRAPH FORUM, V29, P1865, DOI 10.1111/j.1467-8659.2010.01655.x; Zhang H, 2007, P EUR STAT OF THE AR, P1, DOI DOI 10.1109/IPDPS.2007.370248	54	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0121741	10.1371/journal.pone.0121741	http://dx.doi.org/10.1371/journal.pone.0121741			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885290	Green Submitted, Green Published, gold			2022-12-26	WOS:000353017000024
J	Maxfield-Taylor, SA; Mujic, AB; Rao, S				Maxfield-Taylor, Sarah A.; Mujic, Alija B.; Rao, Sujaya			First Detection of the Larval Chalkbrood Disease Pathogen Ascosphaera apis (Ascomycota: Eurotiomycetes: Ascosphaerales) in Adult Bumble Bees	PLOS ONE			English	Article							AGRI-ENVIRONMENT SCHEMES; MEGACHILE-ROTUNDATA; WILD POLLINATORS; DNA-SEQUENCES; MIXED MODELS; SOLITARY BEE; DECLINE; FUNGUS; CONSERVATION; HYMENOPTERA	Fungi in the genus Ascosphaera (Ascomycota: Eurotiomycetes: Ascosphaerales) cause chalkbrood disease in larvae of bees. Here, we report the first-ever detection of the fungus in adult bumble bees that were raised in captivity for studies on colony development. Wild queens of Bombus griseocollis, B. nevadensis and B. vosnesenskii were collected and maintained for establishment of nests. Queens that died during rearing or that did not lay eggs within one month of capture were dissected, and tissues were examined microscopically for the presence of pathogens. Filamentous fungi that were detected were plated on artificial media containing broad spectrum antibiotics for isolation and identification. Based on morphological characters, the fungus was identified as Ascosphaera apis (Maasen ex Claussen) Olive and Spiltoir, a species that has been reported earlier only from larvae of the European honey bee, Apis mellifera, the Asian honey bee, Apis cerana, and the carpenter bee Xylocopa californica arizonensis. The identity of the fungus was confirmed using molecular markers and phylogenetic analysis. Ascosphaera apis was detected in queens of all three bumble bee species examined. Of 150 queens dissected, 12 (8%) contained vegetative and reproductive stages of the fungus. Both fungal stages were also detected in two workers collected from colonies with Ascosphaera-infected B. nevadensis queens. In this study, wild bees could have been infected prior to capture for rearing, or, the A. apis infection could have originated via contaminated European honey bee pollen fed to the bumble bees in captivity. Thus, the discovery of A. apis in adult bumble bees in the current study has important implications for commercial production of bumble bee colonies and highlights potential risks to native bees via pathogen spillover from infected bees and infected pollen.	[Maxfield-Taylor, Sarah A.; Rao, Sujaya] Oregon State Univ, Dept Crop & Soil Sci, Corvallis, OR 97331 USA; [Mujic, Alija B.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Rao, S (corresponding author), Oregon State Univ, Dept Crop & Soil Sci, Corvallis, OR 97331 USA.	sujaya@oregonstate.edu			Agricultural Research Foundation; Oregon State University [3958]	Agricultural Research Foundation; Oregon State University	This work was supported by the Agricultural Research Foundation (http://agresearchfoundation.oregonstate.edu/), Oregon State University, Grant # 3958 received by SR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DL, 1998, MYCOL RES, V102, P541, DOI 10.1017/S0953756297005261; [Anonymous], EC CHALL POS DECL PO; Aronstein KA, 2010, J INVERTEBR PATHOL, V103, pS20, DOI 10.1016/j.jip.2009.06.018; Beekman M, 1998, P ROY SOC B-BIOL SCI, V265, P1535, DOI 10.1098/rspb.1998.0469; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; BISSETT J, 1988, CAN J BOT, V66, P2541, DOI [10.1139/b88-346, 10.1139/b88-057]; Carvell C, 2007, J APPL ECOL, V44, P29, DOI 10.1111/j.1365-2664.2006.01249.x; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Evison SEF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030641; Flores JM, 2005, MYCOLOGIA, V97, P1171, DOI 10.3852/mycologia.97.6.1171; Furst MA, 2014, NATURE, V506, P364, DOI 10.1038/nature12977; GILLIAM M, 1994, J INVERTEBR PATHOL, V63, P307, DOI 10.1006/jipa.1994.1057; Gilliam M, 1997, HONEY BEE PESTS PRED, P81; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Goulson D, 2003, BUMBLEBEES THEIR BEH; Graystock P, 2013, J APPL ECOL, V50, P1207, DOI 10.1111/1365-2664.12134; Grixti JC, 2009, BIOL CONSERV, V142, P75, DOI 10.1016/j.biocon.2008.09.027; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HEATH LAF, 1987, J APICULT RES, V26, P243, DOI 10.1080/00218839.1987.11100768; Jensen AB, 2012, FEMS MICROBIOL LETT, V330, P17, DOI 10.1111/j.1574-6968.2012.02515.x; KISH LP, 1988, MYCOLOGIA, V80, P312, DOI 10.2307/3807627; Kleijn D, 2006, ECOL LETT, V9, P243, DOI 10.1111/j.1461-0248.2005.00869.x; Koch J, 2012, USDA PUBLICATION; Murray TE, 2013, BIOL CONSERV, V159, P269, DOI 10.1016/j.biocon.2012.10.021; Oregon Department of Agriculture, OR APPR INS LIST; Otterstatter MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002771; Pitts-Singer TL, 2011, ANNU REV ENTOMOL, V56, P221, DOI 10.1146/annurev-ento-120709-144836; PLOWRIGHT R C, 1966, Journal of Apicultural Research, V5, P155; POMEROY N, 1980, CAN ENTOMOL, V112, P321, DOI 10.4039/Ent112321-3; Pridal A, 1997, ACTA U AGR SILVIC ME, V3-4, P59; Pridal A, 2001, ACTA U AGR SILVIC ME, V5, P41; Qin X, 2006, INSECT MOL BIOL, V15, P715, DOI 10.1111/j.1365-2583.2006.00694.x; Rao S., 2010, PSYCHE, DOI [10.1155/2010/354072, DOI 10.1155/2010/354072]; Rao S, 2007, PAN-PAC ENTOMOL, V83, P360, DOI 10.3956/2007-10.1; Rehner SA, 2009, MOL ECOL RESOUR, V9, P855, DOI 10.1111/j.1755-0998.2008.02455.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Singh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014357; Skou JP., 1986, APIMONDIA, V30, P260; Smith KM, 2013, ECOHEALTH, V10, P434, DOI 10.1007/s10393-013-0870-2; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stephen WP, 1957, ORE STATE U AGR EXP, V40; Stephen WP, 1981, ORE STATE U AGR EXP, V653; Thorp Robbin W., 2003, P21; Vanengelsdorp D, 2012, J APICULT RES, V51, P115, DOI 10.3896/IBRA.1.51.1.14; Velthuis HHW, 2006, APIDOLOGIE, V37, P421, DOI 10.1051/apido:2006019; White T. J, 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Williams PH, 2009, APIDOLOGIE, V40, P367, DOI 10.1051/apido/2009025; Wubie AJ, 2013, J FOOD AGRIC ENVIRON, V11, P2190; Wynns AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073419; Wynns AA, 2012, MYCOLOGIA, V104, P108, DOI 10.3852/10-047	51	29	39	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124868	10.1371/journal.pone.0124868	http://dx.doi.org/10.1371/journal.pone.0124868			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885679	Green Published, gold, Green Submitted			2022-12-26	WOS:000353017000147
J	Steinbacher, P; Feichtinger, RG; Kedenko, L; Kedenko, I; Reinhardt, S; Schonauer, AL; Leitner, I; Sanger, AM; Stoiber, W; Kofler, B; Forster, H; Paulweber, B; Ring-Dimitriou, S				Steinbacher, Peter; Feichtinger, Rene G.; Kedenko, Lyudmyla; Kedenko, Igor; Reinhardt, Sandra; Schoenauer, Anna-Lena; Leitner, Isabella; Saenger, Alexandra M.; Stoiber, Walter; Kofler, Barbara; Foerster, Holger; Paulweber, Bernhard; Ring-Dimitriou, Susanne			The Single Nucleotide Polymorphism Gly482Ser in the PGC-1 alpha Gene Impairs Exercise-Induced Slow-Twitch Muscle Fibre Transformation in Humans	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; RECEPTOR-GAMMA COACTIVATOR-1-ALPHA; INDUCED MITOCHONDRIAL BIOGENESIS; LIFE-STYLE INTERVENTION; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; 1-ALPHA PGC-1-ALPHA; METABOLIC SYNDROME; DIABETES-MELLITUS	PGC-1 alpha (peroxisome proliferator-activated receptor. co-activator 1 alpha) is an important regulator of mitochondrial biogenesis and a master regulator of enzymes involved in oxidative phosphorylation. Recent evidence demonstrated that the Gly482Ser single nucleotide polymorphism (SNP) in the PGC-1 alpha gene affects insulin sensitivity, blood lipid metabolism and binding to myocyte enhancer factor 2 (MEF2). Individuals carrying this SNP were shown to have a reduced cardiorespiratory fitness and a higher risk to develop type 2 diabetes. Here, we investigated the responses of untrained men with the Gly482Ser SNP to a 10 week programme of endurance training (cycling, 3 x 60 min/week, heart rate at 70-90% VO2peak). Quantitative data from analysis of biopsies from vastus lateralis muscle revealed that the SNP group, in contrast to the control group, lacked a training-induced increase in content of slow contracting oxidative fibres. Capillary supply, mitochondrial density, mitochondrial enzyme activities and intramyocellular lipid content increased similarly in both groups. These results indicate that the impaired binding of MEF2 to PGC-1 alpha in humans with this SNP impedes exercise-induced fast-to-slow muscle fibre transformation.	[Steinbacher, Peter; Reinhardt, Sandra; Schoenauer, Anna-Lena; Leitner, Isabella; Saenger, Alexandra M.; Stoiber, Walter] Paris Lodron Univ Salzburg, Dept Cell Biol, Salzburg, Austria; [Feichtinger, Rene G.; Kofler, Barbara] Paracelsus Med Univ Salzburg, Dept Pedicatr, Res Program Receptor Biochem & Tumor Metab, Salzburg, Austria; [Kedenko, Lyudmyla; Kedenko, Igor; Paulweber, Bernhard] Paracelsus Med Univ Salzburg, Dept Internal Med 1, Salzburg, Austria; [Foerster, Holger] Med Off Pediat & Sports Med, Salzburg, Austria; [Ring-Dimitriou, Susanne] Paris Lodron Univ Salzburg, Dept Sport Sci & Kinesiol, Paris, Austria	Salzburg University; Paracelsus Private Medical University; Paracelsus Private Medical University	Steinbacher, P (corresponding author), Paris Lodron Univ Salzburg, Dept Cell Biol, Salzburg, Austria.	peter.steinbacher@sbg.ac.at	Ring-Dimitriou, Susanne/AAG-4323-2020	Ring-Dimitriou, Susanne/0000-0002-5317-3891; Kofler, Barbara/0000-0002-1198-4776; Steinbacher, Peter/0000-0001-8033-5190	Austrian National Bank [J14156]	Austrian National Bank	This work was sponsored by the Austrian National Bank (www.oenb.at) (Grant: J14156). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmetov II, 2009, HUM GENET, V126, P751, DOI 10.1007/s00439-009-0728-4; Amati F, 2011, DIABETES, V60, P2588, DOI 10.2337/db10-1221; ANDERSEN P, 1977, J PHYSIOL-LONDON, V270, P677, DOI 10.1113/jphysiol.1977.sp011975; Andrulionyte L, 2006, DIABETES, V55, P2148, DOI 10.2337/db05-1629; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Berger A, 2003, ACTA NEUROPATHOL, V105, P245, DOI 10.1007/s00401-002-0638-1; BERGSTROM J, 1975, SCAND J CLIN LAB INV, V35, P606, DOI 10.3109/00365517509095787; BUCHFUHRER MJ, 1983, J APPL PHYSIOL, V55, P1558, DOI 10.1152/jappl.1983.55.5.1558; Chen CJ, 1999, FLORA CHINA, V4, P1; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; Choi YS, 2006, BIOCHEM BIOPH RES CO, V344, P708, DOI 10.1016/j.bbrc.2006.03.193; Cobley JN, 2012, BIOGERONTOLOGY, V13, P621, DOI 10.1007/s10522-012-9408-1; COGGAN AR, 1992, J APPL PHYSIOL, V72, P1780, DOI 10.1152/jappl.1992.72.5.1780; Dube JJ, 2008, AM J PHYSIOL-ENDOC M, V294, pE882, DOI 10.1152/ajpendo.00769.2007; Dumke CL, 2009, EUR J APPL PHYSIOL, V107, P419, DOI 10.1007/s00421-009-1143-1; Ek J, 2001, DIABETOLOGIA, V44, P2220, DOI 10.1007/s001250100032; Feichtinger Rene G, 2011, Front Biosci (Elite Ed), V3, P194, DOI 10.2741/e233; Feichtinger RG, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-149; Fitts RH, 2001, J EXP BIOL, V204, P3201; Geng TY, 2010, AM J PHYSIOL-CELL PH, V298, pC572, DOI 10.1152/ajpcell.00481.2009; Gibala MJ, 2006, J PHYSIOL-LONDON, V575, P901, DOI 10.1113/jphysiol.2006.112094; Goodpaster BH, 2002, OBES RES, V10, P575, DOI 10.1038/oby.2002.78; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Hakim AA, 1999, CIRCULATION, V100, P9, DOI 10.1161/01.CIR.100.1.9; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Hara K, 2002, DIABETOLOGIA, V45, P740, DOI 10.1007/s00125-002-0803-z; Holloszy JO, 2008, J PHYSIOL PHARMACOL, V59, P5; HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278; Holloszy JO, 2003, AM J PHYSIOL-ENDOC M, V284, pE453, DOI 10.1152/ajpendo.00463.2002; HOWALD H, 1985, PFLUG ARCH EUR J PHY, V403, P369, DOI 10.1007/BF00589248; INGJER F, 1979, J PHYSIOL-LONDON, V294, P419, DOI 10.1113/jphysiol.1979.sp012938; Irrcher I, 2003, AM J PHYSIOL-CELL PH, V284, pC1669, DOI 10.1152/ajpcell.00409.2002; JANSSON E, 1978, ACTA PHYSIOL SCAND, V104, P235, DOI 10.1111/j.1748-1716.1978.tb06272.x; Kang CH, 2013, J SPORT HEALTH SCI, V2, P81, DOI 10.1016/j.jshs.2013.03.005; Kelley DE, 2000, DIABETES, V49, P677, DOI 10.2337/diabetes.49.5.677; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Koves TR, 2013, J LIPID RES, V54, P522, DOI 10.1194/jlr.P028910; Koves TR, 2005, J BIOL CHEM, V280, P33588, DOI 10.1074/jbc.M507621200; Kramer DK, 2006, ACTA PHYSIOL, V188, P207, DOI 10.1111/j.1748-1716.2006.01620.x; Laaksonen DE, 2005, DIABETES, V54, P158, DOI 10.2337/diabetes.54.1.158; LEAN MEJ, 1995, BRIT MED J, V311, P158, DOI 10.1136/bmj.311.6998.158; Leick L, 2009, AM J PHYSIOL-ENDOC M, V297, pE92, DOI 10.1152/ajpendo.00076.2009; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Little JP, 2011, AM J PHYSIOL-REG I, V300, pR1303, DOI 10.1152/ajpregu.00538.2010; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Lucia A, 2005, J APPL PHYSIOL, V99, P344, DOI 10.1152/japplphysiol.00037.2005; Mathai AS, 2008, J APPL PHYSIOL, V105, P1098, DOI 10.1152/japplphysiol.00847.2007; McGee SL, 2006, FASEB J, V20, P348, DOI 10.1096/fj.05-4671fje; Meierhofer D, 2004, CARCINOGENESIS, V25, P1005, DOI 10.1093/carcin/bgh104; Mora S, 2000, J BIOL CHEM, V275, P16323, DOI 10.1074/jbc.M910259199; Oberkofler H, 2003, BIOCHEM J, V371, P89, DOI 10.1042/BJ20021665; Olesen J, 2010, PFLUG ARCH EUR J PHY, V460, P153, DOI 10.1007/s00424-010-0834-0; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Pilegaard H, 2005, METABOLISM, V54, P1048, DOI 10.1016/j.metabol.2005.03.008; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Putman CT, 2004, EUR J APPL PHYSIOL, V92, P376, DOI 10.1007/s00421-004-1104-7; Rasbach KA, 2010, P NATL ACAD SCI USA, V107, P21866, DOI 10.1073/pnas.1016089107; Ring-Dimitriou S., 2014, J EXERC PHYSL ONLINE, V17, P1, DOI 10.1519/JSC.0b013e3181874564; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Sandhofer A, 2007, EUR J CLIN INVEST, V37, P109, DOI 10.1111/j.1365-2362.2007.01751.x; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; Scheuermann BW, 1998, RESP PHYSIOL, V114, P227, DOI 10.1016/S0034-5687(98)00097-8; Schiaffino S, 2010, ACTA PHYSIOL, V199, P451, DOI 10.1111/j.1748-1716.2010.02130.x; Shaw CS, 2008, HISTOCHEM CELL BIOL, V129, P65, DOI 10.1007/s00418-007-0349-8; Shono N, 2002, J ATHEROSCLER THROMB, V9, P1; Stefan N, 2007, J CLIN ENDOCR METAB, V92, P1827, DOI 10.1210/jc.2006-1785; Steinbacher P, 2010, TISSUE CELL, V42, P37, DOI 10.1016/j.tice.2009.07.001; Summermatter S, 2010, J BIOL CHEM, V285, P32793, DOI 10.1074/jbc.M110.145995; Tarnopolsky MA, 2007, AM J PHYSIOL-REG I, V292, pR1271, DOI 10.1152/ajpregu.00472.2006; Thayer R, 2000, J SPORT MED PHYS FIT, V40, P284; Timmons JA, 2006, GENOMICS, V87, P165, DOI 10.1016/j.ygeno.2005.09.007; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; van Loon LJC, 2006, PFLUG ARCH EUR J PHY, V451, P606, DOI 10.1007/s00424-005-1509-0; Vohl MC, 2005, MOL GENET METAB, V86, P300, DOI 10.1016/j.ymgme.2005.07.002; WASSERMAN K, 1964, AM J CARDIOL, V14, P844, DOI 10.1016/0002-9149(64)90012-8; Wasserman K, 2005, PRINCIPLES EXERCISE; Wright DC, 2007, J BIOL CHEM, V282, P194, DOI 10.1074/jbc.M606116200; Wu H, 2000, EMBO J, V19, P1963, DOI 10.1093/emboj/19.9.1963; Yan Z, 2011, J APPL PHYSIOL, V110, P264, DOI 10.1152/japplphysiol.00993.2010; Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008; Zhang SL, 2007, CHINESE MED J-PEKING, V120, P1878, DOI 10.1097/00029330-200711010-00005	87	18	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123881	10.1371/journal.pone.0123881	http://dx.doi.org/10.1371/journal.pone.0123881			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886402	Green Published, Green Submitted, gold			2022-12-26	WOS:000353017000092
J	Zhu, JF; Jin, YY; Wang, K; Zhou, YM; Feng, Y; Yu, MH; Jin, XQ				Zhu, Jianfang; Jin, Yuanyuan; Wang, Kai; Zhou, Yumiao; Feng, Yue; Yu, Maihong; Jin, Xiaoqing			Frequency-Dependent Changes in the Regional Amplitude and Synchronization of Resting-State Functional MRI in Stroke	PLOS ONE			English	Article							BRAIN ACTIVITY; FMRI; CONNECTIVITY; MOVEMENT; VARIABILITY; CHILDREN; RECOVERY	Resting-state functional magnetic resonance imaging (R-fMRI) has been intensively used to assess alterations of inter-regional functional connectivity in patients with stroke, but the regional properties of brain activity in stroke have not yet been fully investigated. Additionally, no study has examined a frequency effect on such regional properties in stroke patients, although this effect has been shown to play important roles in both normal brain functioning and functional abnormalities. Here we utilized R-fMRI to measure the amplitude of low-frequency fluctuations (ALFF) and regional homogeneity (ReHo), two major methods for characterizing the regional properties of R-fMRI, in three different frequency bands (slow-5: 0.01-0.027 Hz; slow-4: 0.027-0.73 Hz; and typical band: 0.01-0.1 Hz) in 19 stroke patients and 15 healthy controls. Both the ALFF and ReHo analyses revealed changes in brain activity in a number of brain regions, particularly the parietal cortex, in stroke patients compared with healthy controls. Remarkably, the regions with changed activity as detected by the slow-5 band data were more extensive, and this finding was true for both the ALFF and ReHo analyses. These results not only confirm previous studies showing abnormality in the parietal cortex in patients with stroke, but also suggest that R-fMRI studies of stroke should take frequency effects into account when measuring intrinsic brain activity.	[Zhu, Jianfang; Jin, Yuanyuan; Wang, Kai; Yu, Maihong; Jin, Xiaoqing] Zhejiang Hosp, Dept Acupuncture & Moxibust, Hangzhou, Zhejiang, Peoples R China; [Zhou, Yumiao] Zhejiang Hosp, Dept Neurol, Hangzhou, Zhejiang, Peoples R China; [Feng, Yue] Zhejiang Hosp, Dept Radiol, Hangzhou, Zhejiang, Peoples R China		Jin, XQ (corresponding author), Zhejiang Hosp, Dept Acupuncture & Moxibust, 12 Lingyin Rd, Hangzhou, Zhejiang, Peoples R China.	zjyyjxq@163.com			Zhejiang Provincial Natural Science Foundation [LY12H27001]; Zhejiang Provincial administration of Traditional Chinese Medicine [2011ZA009]	Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial administration of Traditional Chinese Medicine	This work was supported by Zhejiang Provincial Natural Science Foundation (LY12H27001) and Zhejiang Provincial administration of Traditional Chinese Medicine (2011ZA009). XQJ received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamura C, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-151; Anderson JS, 2011, AM J NEURORADIOL, V32, P548, DOI 10.3174/ajnr.A2330; Baria AT, 2011, J NEUROSCI, V31, P7910, DOI 10.1523/JNEUROSCI.1296-11.2011; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cho SY, 2013, CHIN J INTEGR MED, V19, P269, DOI 10.1007/s11655-013-1436-4; Daly JJ, 2008, J NEUROSCI METH, V175, P133, DOI 10.1016/j.jneumeth.2008.07.025; Dechaumont-Palacin S, 2008, NEUROREHAB NEURAL RE, V22, P154, DOI 10.1177/1545968307307118; Di Martino A, 2008, BIOL PSYCHIAT, V64, P607, DOI 10.1016/j.biopsych.2008.03.008; Fair DA, 2013, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00080; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Garrett DD, 2010, J NEUROSCI, V30, P4914, DOI 10.1523/JNEUROSCI.5166-09.2010; Golestani AM, 2013, NEUROREHAB NEURAL RE, V27, P153, DOI 10.1177/1545968312457827; Han Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028664; Han Y, 2011, NEUROIMAGE, V55, P287, DOI 10.1016/j.neuroimage.2010.11.059; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Hoptman MJ, 2010, SCHIZOPHR RES, V117, P13, DOI 10.1016/j.schres.2009.09.030; Inman CS, 2012, NEUROIMAGE, V59, P227, DOI 10.1016/j.neuroimage.2011.07.083; Jung TD, 2013, J REHABIL MED, V45, P546, DOI 10.2340/16501977-1165; Ledberg A, 1998, NEUROIMAGE, V8, P113, DOI 10.1006/nimg.1998.0336; Li ZJ, 2012, J MAGN RESON IMAGING, V36, P344, DOI 10.1002/jmri.23670; Nunn CL, 1998, AM NAT, V152, P82, DOI 10.1086/286151; Raichle ME, 2006, SCIENCE, V314, P1249, DOI 10.1126/science.1134405; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rongjun Y, 2012, HUMAN BRAIN MAPPING, V0000, P00; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Smits M, 2012, ARCH PHYS MED REHAB, V93, pS4, DOI 10.1016/j.apmr.2011.02.023; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; van Oers CAMM, 2010, NEUROIMAGE, V49, P885, DOI 10.1016/j.neuroimage.2009.08.057; Varkuti B, 2013, NEUROREHAB NEURAL RE, V27, P53, DOI 10.1177/1545968312445910; Wang ZQ, 2011, HUM BRAIN MAPP, V32, P1720, DOI 10.1002/hbm.21140; Wang ZT, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0097907, 10.1371/journal.pone.0114792, 10.1371/journal.pone.0103645, 10.1371/journal.pone.0089948, 10.1371/journal.pone.0087381, 10.1371/journal.pone.0091755, 10.1371/journal.pone.0109571, 10.1371/journal.pone.0104657]; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Yin D, 2013, NEURORADIOLOGY, V17, P19, DOI [10.1186/1687-9856-2013-17, DOI 10.1186/1687-9856-2013-17]; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	36	22	24	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123850	10.1371/journal.pone.0123850	http://dx.doi.org/10.1371/journal.pone.0123850			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885897	Green Submitted, Green Published, gold			2022-12-26	WOS:000353017000088
J	Fan, H; Zhang, H; Pascuzzi, PE; Andrisani, O				Fan, H.; Zhang, H.; Pascuzzi, P. E.; Andrisani, O.			Hepatitis B virus X protein induces EpCAM expression via active DNA demethylation directed by RelA in complex with EZH2 and TET2	ONCOGENE			English	Article							NF-KAPPA-B; POSITIVE HEPATOCELLULAR-CARCINOMA; LIVER-CANCER PROGRESSION; HEPATOCYTE CELL-LINES; GENE-EXPRESSION; TARGET GENES; TRANSGENIC MICE; MAMMALIAN DNA; ANTIGEN EPCAM; EP-CAM	Chronic hepatitis B virus (HBV) infection is a major risk factor for developing hepatocellular carcinoma (HCC), and HBV X protein (HBx) acts as cofactor in hepatocarcinogenesis. In liver tumors from animals modeling HBx- and HBV-mediated hepatocarcinogenesis, downregulation of chromatin regulating proteins SUZ12 and ZNF198 induces expression of several genes, including epithelial cell adhesion molecule (EpCAM). EpCAM upregulation occurs in HBV-mediated HCCs and hepatic cancer stem cells, by a mechanism not understood. Herein we demonstrate HBx induces EpCAM expression via active DNA demethylation. In hepatocytes, EpCAM is silenced by polycomb repressive complex 2 (PRC2) and ZNF198/LSD1/Co-REST/HDAC1 chromatin-modifying complexes. Cells with stable knockdown of SUZ12, an essential PRC2 subunit, upon HBx expression demethylate a CpG dinucleotide located adjacent to NF-kappa B/RelA half-site. This NF-kappa B/RelA site is in a CpG island downstream from EpCAM transcriptional start site (-155). Chromatin immunoprecipitation (ChIP) assays demonstrate HBx-dependent RelA occupancy of NF-kappa B half-site, whereas RelA knockdown suppresses CpG demethylation and EpCAM expression. Tumor necrosis factor-alpha activates RelA, propagating demethylation to nearby CpG sites, shown by sodium bisulfite sequencing. ReIA-dependent demethylation occurring upon HBx expression requires methyltrasferase EZH2, TET2 a key factor in cytosine demethylation and inactive DNMT3L, shown by knockdown assays and sodium bisulfite sequencing. Co-immunoprecipitations and sequential ChIP assays demonstrate that RelA in the presence of HBx forms a complex with EZH2, TET2 and DNMT3L, although the role of DNMT3L remains to be understood. Interestingly, the human EpCAM gene also has a CpG island downstream from its TSS, and a NF-kappa B-binding site flanked by CpGs. HepG2 cells derived from human HCC exhibit demethylation of these NF-kappa B-flanking CpG sites, and HBV replication propagates demethylation to nearby CpG sites. DLK1, another PRC2 target gene, also upregulated in HBV-mediated HCCs, is demethylated in liver tumors at CpG dinucleotides flanking the NF-kappa B-binding sequence, supporting that this active DNA demethylation mechanism functions during oncogenic transformation.	[Fan, H.; Zhang, H.; Andrisani, O.] Purdue Univ, Dept Basic Med Sci, 205A Hansen Bldg,201 South Univ St, W Lafayette, IN 47907 USA; [Fan, H.; Zhang, H.; Andrisani, O.] Purdue Univ, Dept Purdue, Ctr Canc Res, W Lafayette, IN 47907 USA; [Pascuzzi, P. E.] Purdue Univ, Purdue Univ Lib, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Andrisani, O (corresponding author), Purdue Univ, Dept Basic Med Sci, 205A Hansen Bldg,201 South Univ St, W Lafayette, IN 47907 USA.	andrisao@purdue.edu	Pascuzzi, Pete/T-5378-2019	Andrisani, Ourania/0000-0002-6230-0303; Pascuzzi, Pete/0000-0002-9316-4404	NIH [DK044533, P30CA023168]; NATIONAL CANCER INSTITUTE [P30CA023168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK044533, R01DK044533] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grant DK044533 to OA. Shared Resources (flow cytometry and DNA sequencing) are supported by NIH grant P30CA023168 to Purdue Cancer Research Center. The authors thank Dr R Hullinger for critical review of the manuscript.	Andrisani OM, 1999, INT J ONCOL, V15, P373; [Anonymous], 2014, R LANG ENV STAT COMP; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; BEASLEY RP, 1981, LANCET, V2, P1129; Bouchard MJ, 2004, J VIROL, V78, P12725, DOI 10.1128/JVI.78.23.12725-12734.2004; Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Cartron Pierre-Francois, 2013, Genes Cancer, V4, P235, DOI 10.1177/1947601913489020; Chang CJ, 2012, BRIT J CANCER, V106, P243, DOI 10.1038/bjc.2011.551; Chaves-Perez A, 2013, ONCOGENE, V32, P641, DOI 10.1038/onc.2012.75; Chen YQ, 1998, NAT STRUCT BIOL, V5, P67, DOI 10.1038/nsb0198-67; Chen YQ, 2000, STRUCT FOLD DES, V8, P419, DOI 10.1016/S0969-2126(00)00123-4; de Boer CJ, 1999, J PATHOL, V188, P201, DOI 10.1002/(SICI)1096-9896(199906)188:2<201::AID-PATH339>3.0.CO;2-8; de la Rica L, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r99; Delatte B, 2014, EMBO J, V33, P1198, DOI 10.15252/embj.201488290; Denis H, 2011, EMBO REP, V12, P647, DOI 10.1038/embor.2011.110; Fujiki K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3262; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gocke CB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003255; Hachmeister M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071836; Haring M, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-11; Kim E, 2013, CANCER CELL, V23, P839, DOI 10.1016/j.ccr.2013.04.008; Ko M, 2013, NATURE, V497, P122, DOI 10.1038/nature12052; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Ladner SK, 1997, ANTIMICROB AGENTS CH, V41, P1715, DOI 10.1128/AAC.41.8.1715; Lee HJ, 2014, CELL STEM CELL, V14, P710, DOI 10.1016/j.stem.2014.05.008; Lee ST, 2011, MOL CELL, V43, P798, DOI 10.1016/j.molcel.2011.08.011; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu T, 2013, P NATL ACAD SCI USA, V110, P13510, DOI 10.1073/pnas.1311770110; Madden CR, 2001, J VIROL, V75, P3851, DOI 10.1128/JVI.75.8.3851-3858.2001; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Meissner A, 2011, CELL STEM CELL, V9, P388, DOI 10.1016/j.stem.2011.10.014; Munz M, 2004, ONCOGENE, V23, P5748, DOI 10.1038/sj.onc.1207610; Munz M, 2009, CANCER RES, V69, P5627, DOI 10.1158/0008-5472.CAN-09-0654; Nakamoto Y, 1997, J IMMUNOL, V158, P5692; Neri F, 2013, CELL, V155, P121, DOI 10.1016/j.cell.2013.08.056; Ning BF, 2014, HEPATOLOGY, V60, P1607, DOI 10.1002/hep.27177; Schmelzer E, 2007, J EXP MED, V204, P1973, DOI 10.1084/jem.20061603; Schnell U, 2013, BBA-BIOMEMBRANES, V1828, P1989, DOI 10.1016/j.bbamem.2013.04.018; Studach L, 2010, J BIOL CHEM, V285, P30282, DOI 10.1074/jbc.M109.093963; Studach LL, 2012, HEPATOLOGY, V56, P1240, DOI 10.1002/hep.25781; Studach LL, 2009, HEPATOLOGY, V50, P414, DOI 10.1002/hep.22996; Su F, 1996, J VIROL, V70, P4558, DOI 10.1128/JVI.70.7.4558-4566.1996; Sun L, 2013, STEM CELLS, V31, P1454, DOI 10.1002/stem.1394; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tanaka M, 2009, MECH DEVELOP, V126, P665, DOI 10.1016/j.mod.2009.06.939; Tarn C, 1999, J BIOL CHEM, V274, P2327, DOI 10.1074/jbc.274.4.2327; Terradillos O, 1997, ONCOGENE, V14, P395, DOI 10.1038/sj.onc.1200850; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; van der Gun BTF, 2011, BRIT J CANCER, V105, P312, DOI 10.1038/bjc.2011.231; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wang VYF, 2012, CELL REP, V2, P824, DOI 10.1016/j.celrep.2012.08.042; Wang WH, 2011, HEPATOLOGY, V53, P1137, DOI 10.1002/hep.24163; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Went P, 2006, BRIT J CANCER, V94, P128, DOI 10.1038/sj.bjc.6602924; WU JC, 1994, P NATL ACAD SCI USA, V91, P674, DOI 10.1073/pnas.91.2.674; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Zeng SS, 2014, J HEPATOL, V60, P127, DOI 10.1016/j.jhep.2013.08.024; Zhang H, CANC RES IN PRESS; ZOULIM F, 1994, J VIROL, V68, P2026, DOI 10.1128/JVI.68.3.2026-2030.1994	63	31	35	2	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 11	2016	35	6					715	726		10.1038/onc.2015.122	http://dx.doi.org/10.1038/onc.2015.122			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DE0RF	25893293	Green Accepted			2022-12-26	WOS:000370331300005
J	Haeger, SM; Thompson, JJ; Kalra, S; Cleaver, TG; Merrick, D; Wang, XJ; Malkoski, SP				Haeger, S. M.; Thompson, J. J.; Kalra, S.; Cleaver, T. G.; Merrick, D.; Wang, X-J; Malkoski, S. P.			Smad4 loss promotes lung cancer formation but increases sensitivity to DNA topoisomerase inhibitors	ONCOGENE			English	Article							SQUAMOUS-CELL CARCINOMA; BASAL-CELLS; STEM-CELLS; REPAIR; ADENOCARCINOMA; MOUSE; EXPRESSION; PTEN; DISRUPTION; ACTIVATION	Non-small-cell lung cancer (NSCLC) is a common malignancy with a poor prognosis. Despite progress targeting oncogenic drivers, there are no therapies targeting tumor-suppressor loss. Smad4 is an established tumor suppressor in pancreatic and colon cancer; however, the consequences of Smad4 loss in lung cancer are largely unknown. We evaluated Smad4 expression in human NSCLC samples and examined Smad4 alterations in large NSCLC data sets and found that reduced Smad4 expression is common in human NSCLC and occurs through a variety of mechanisms, including mutation, homozygous deletion and heterozygous loss. We modeled Smad4 loss in lung cancer by deleting Smad4 in airway epithelial cells and found that Smad4 deletion both initiates and promotes lung tumor development. Interestingly, both Smad4(-/-) mouse tumors and human NSCLC samples with reduced Smad4 expression demonstrated increased DNA damage, whereas Smad4 knockdown in lung cancer cells reduced DNA repair and increased apoptosis after DNA damage. In addition, Smad4-deficient NSCLC cells demonstrated increased sensitivity to both chemotherapeutics that inhibit DNA topoisomerase and drugs that block double-strand DNA break repair by non-homologous end joining. In sum, these studies establish Smad4 as a lung tumor suppressor and suggest that the defective DNA repair phenotype of Smad4-deficient tumors can be exploited by specific therapeutic strategies.	[Haeger, S. M.; Thompson, J. J.; Kalra, S.; Cleaver, T. G.; Malkoski, S. P.] Univ Colorado, Div Pulm Sci & Crit Care Med, Denver Anschutz Med Campus,12700 E 19th Ave,RC2,R, Aurora, CO 80045 USA; [Merrick, D.; Wang, X-J; Malkoski, S. P.] Univ Colorado, Dept Pathol, Denver Anschutz Med Campus, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Malkoski, SP (corresponding author), Univ Colorado, Div Pulm Sci & Crit Care Med, Denver Anschutz Med Campus,12700 E 19th Ave,RC2,R, Aurora, CO 80045 USA.	Stephen.Malkoski@ucdenver.edu			NIH/NCI [K08 CA131483]; NIH/NIDCR [R01 DE015953]; National Lung Cancer Partnership; Colorado Lung Cancer SPORE [P50 CA058187]; American Cancer Society Institutional Research Grant [ACS IRG 57-001-53];  [P30 CA069533];  [P30 CA046934]; NATIONAL CANCER INSTITUTE [P30CA046934, P50CA058187, R21CA194662, K08CA131483, P30CA069533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007635] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Lung Cancer Partnership; Colorado Lung Cancer SPORE; American Cancer Society Institutional Research Grant(American Cancer Society); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH/NCI (K08 CA131483 to SPM) and NIH/NIDCR (R01 DE015953 to XJW). SPM was also supported by the National Lung Cancer Partnership and a Career Development Award from the Colorado Lung Cancer SPORE (P50 CA058187) and an American Cancer Society Institutional Research Grant (ACS IRG 57-001-53). The OHSU BioLibrary is supported by P30 CA069533. The Colorado Lung Cancer SPORE Tissue Bank is supported by P30 CA046934 and P50 CA058187. We thank OHSU BioLibrary staff for their assistance with patient samples. We also thank Jerry Haney, Christina Nall, Marina Lewis and Wilbur Franklin at the Colorado Lung SPORE for assistance acquiring patient samples and data.	Achanta G, 2001, CANCER RES, V61, P8723; Adachi N, 2004, J BIOL CHEM, V279, P37343, DOI 10.1074/jbc.M313910200; Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; Bargonetti J, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/698960; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Berton TR, 2000, GENESIS, V26, P160, DOI 10.1002/(SICI)1526-968X(200002)26:2<160::AID-GENE20>3.0.CO;2-#; Bornstein S, 2009, J CLIN INVEST, V119, P3408, DOI 10.1172/JCI38854; Caulin C, 2004, CANCER RES, V64, P5054, DOI 10.1158/0008-5472.CAN-04-1488; Crul M, 2003, BIOCHEM PHARMACOL, V65, P275, DOI 10.1016/S0006-2952(02)01508-3; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; Gemma A, 2001, EUR J CANCER, V37, P1554, DOI 10.1016/S0959-8049(01)00154-X; Glick AB, 1997, CANCER RES, V57, P2079; Goldstraw P, 2011, LANCET, V378, P1727, DOI 10.1016/S0140-6736(10)62101-0; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hong KU, 2004, AM J PATHOL, V164, P577, DOI 10.1016/S0002-9440(10)63147-1; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Izeradjene K, 2007, CANCER CELL, V11, P229, DOI 10.1016/j.ccr.2007.01.017; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jalal S, CLIN CANC RES, V17, P6973; Jazag A, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni130; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jin SF, 1998, CARCINOGENESIS, V19, P965, DOI 10.1093/carcin/19.6.965; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kass EM, 2010, FEBS LETT, V584, P3703, DOI 10.1016/j.febslet.2010.07.057; Ke Z, 2008, NEOPLASMA, V55, P323; Kirshner J, 2006, CANCER RES, V66, P10861, DOI 10.1158/0008-5472.CAN-06-2565; Kojima K, 2007, CANCER RES, V67, P8121, DOI 10.1158/0008-5472.CAN-06-4167; Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001; Li WM, 2003, DEVELOPMENT, V130, P6143, DOI 10.1242/dev.00820; Malkoski SP, 2014, MOL CARCINOGEN, V53, P841, DOI 10.1002/mc.22030; Malkoski SP, 2012, FEBS LETT, V586, P1984, DOI 10.1016/j.febslet.2012.01.054; Malkoski SP, 2012, CLIN CANCER RES, V18, P2173, DOI 10.1158/1078-0432.CCR-11-2557; Malkoski SP, 2010, INT J BIOL SCI, V6, P68; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Nagatake M, 1996, CANCER RES, V56, P2718; Neal JA, 2011, MUTAT RES-FUND MOL M, V711, P73, DOI 10.1016/j.mrfmmm.2011.02.010; Nikitin AY, 2004, CANCER RES, V64, P2307, DOI 10.1158/0008-5472.CAN-03-3376; Papageorgis P, 2011, CANCER RES, V71, P998, DOI 10.1158/0008-5472.CAN-09-3269; Qiao W, 2006, ONCOGENE, V25, P207, DOI 10.1038/sj.onc.1209029; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Teng Y, 2006, CANCER RES, V66, P6972, DOI 10.1158/0008-5472.CAN-06-0507; Treszezamsky AD, 2007, CANCER RES, V67, P7078, DOI 10.1158/0008-5472.CAN-07-0601; Wachters FM, 2003, INT J RADIAT ONCOL, V57, P553, DOI 10.1016/s0360-3016(03)00503-0; Woods D, 2013, CANCER BIOL THER, V14, P379, DOI 10.4161/cbt.23761; Wunderlich FT, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.10.e47; Wyatt MD, 2009, CELL MOL LIFE SCI, V66, P788, DOI 10.1007/s00018-008-8557-5; Xu X, 2010, ONCOGENE, V29, P674, DOI 10.1038/onc.2009.375; Xu XL, 2006, J CLIN INVEST, V116, P1843, DOI 10.1172/JCI27282; Yanagisawa K, 2000, ONCOGENE, V19, P2305, DOI 10.1038/sj.onc.1203591; Yang LL, 2005, CANCER RES, V65, P8671, DOI 10.1158/0008-5472.CAN-05-0800; Yu SL, 2013, ONCOL REP, V30, P1293, DOI 10.3892/or.2013.2578	52	34	35	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 4	2016	35	5					577	586		10.1038/onc.2015.112	http://dx.doi.org/10.1038/onc.2015.112			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DC9NR	25893305	Green Accepted			2022-12-26	WOS:000369548800005
J	Chabowska-Kita, A; Trabczynska, A; Korytko, A; Kaczmarek, MM; Kozak, LP				Chabowska-Kita, Agnieszka; Trabczynska, Anna; Korytko, Agnieszka; Kaczmarek, Monika M.; Kozak, Leslie P.			Low ambient temperature during early postnatal development fails to cause a permanent induction of brown adipocytes	FASEB JOURNAL			English	Article						sympathetic activity; diet-induced obesity; recombinant inbred mice; brown adipocyte involution; microarray gene expression	WHITE ADIPOSE-TISSUE; DIET-INDUCED OBESITY; MITOCHONDRIAL UNCOUPLING PROTEIN; GENE-EXPRESSION; BODY-WEIGHT; NERVOUS-SYSTEM; ENERGY-BALANCE; MUS-MUSCULUS; FAT DEPOTS; MICE	The brown adipocyte phenotype (BAP) in white adipose tissue (WAT) is transiently induced in adult mammals in response to reduced ambient temperature. Since it is unknown whether a cold challenge can permanently induce brown adipocytes (BAs), we reared C57BL/6J (B6) and AxB8/PgJ (AxB8) mice at 17 or 29 degrees C from birth to weaning, to assess the BAP in young and adult mice. Energy balance measurements showed that 17 degrees C reduced fat mass in the preweaning mice by increasing energy expenditure and suppressed diet-induced obesity in adults. Microarray analysis of global gene expression of inguinal fat (ING) from 10-day-old (D) mice indicates that expression at 17 degrees C vs. 29 degrees C was not different. Between 10 and 21 days of age, the BAP was induced coincident with morphologic remodeling of ING and marked changes in expression of neural development genes (e.g., Akap 12 and Ngfr). Analyses of Ucp1 mRNA and protein showed that 17 degrees C transiently increased the BAP in ING from 21D mice; however, BAs were unexpectedly present in mice reared at 29 degrees C. The involution of the BAP in WAT occurred after weaning inmice reared at 23 degrees C. Therefore, the capacity to stimulate thermogenically competent BAs in WAT is set by a temperature-independent, genetically controlled program between birth and weaning.	[Chabowska-Kita, Agnieszka; Trabczynska, Anna; Korytko, Agnieszka; Kaczmarek, Monika M.; Kozak, Leslie P.] Polish Acad Sci, Inst Anim Reprod & Food Res, PL-10748 Olsztyn, Poland	Polish Academy of Sciences; Institute of Animal Reproduction & Food Research of the Polish Academy of Sciences	Kozak, LP (corresponding author), Polish Acad Sci, Ul Tuwima 10, PL-10748 Olsztyn, Poland.	l.kozak@pan.olsztyn.pl	Korytko, Agnieszka/H-7200-2017; KACZMAREK, Monika Marzena/AAS-2271-2020; Kaczmarek, Monika/N-4892-2015; Caly, Anna/C-5611-2019	Korytko, Agnieszka/0000-0002-0137-7649; KACZMAREK, Monika Marzena/0000-0002-8213-4381; Kaczmarek, Monika/0000-0002-8213-4381; Caly, Anna/0000-0002-7687-4471; Chabowska-Kita, Agnieszka/0000-0003-3884-579X	Foundation for Polish Science; Programme WELCOME [WELCOME/2010-4/3]; EU Structural Funds in Poland within the Innovative Economy Programme and REFRESH project [FP7-REGPOT-2010-1-264103]	Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); Programme WELCOME; EU Structural Funds in Poland within the Innovative Economy Programme and REFRESH project	This work was supported by grants from the Foundation for Polish Science; Programme WELCOME (WELCOME/2010-4/3, Nutrition and ambient temperature during early development can reduce susceptibility to obesity); and EU Structural Funds in Poland within the Innovative Economy Programme and REFRESH project (FP7-REGPOT-2010-1-264103) (all to L.P.K.).	Amorim BS, 2009, J ENDOCRINOL, V203, P291, DOI 10.1677/JOE-08-0539; Bal N. C., 2012, NAT MED, V18, P1857; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; Bartness TJ, 2010, INT J OBESITY, V34, pS36, DOI 10.1038/ijo.2010.182; Bartness TJ, 2010, MOL CELL ENDOCRINOL, V318, P34, DOI 10.1016/j.mce.2009.08.031; Bartness TJ, 1998, AM J PHYSIOL-REG I, V275, pR1399, DOI 10.1152/ajpregu.1998.275.5.R1399; BATCHELDER P, 1983, PHYSIOL BEHAV, V31, P97, DOI 10.1016/0031-9384(83)90102-6; Bowers RR, 2004, AM J PHYSIOL-REG I, V286, pR1167, DOI 10.1152/ajpregu.00558.2003; BUKOWIECKI L, 1982, AM J PHYSIOL, V242, pE353, DOI 10.1152/ajpendo.1982.242.6.E353; Cannon B, 2009, P NUTR SOC, V68, P401, DOI 10.1017/S0029665109990255; Chau YY, 2014, NAT CELL BIOL, V16, P367, DOI 10.1038/ncb2922; Chen KY, 2013, J CLIN ENDOCR METAB, V98, pE1218, DOI 10.1210/jc.2012-4213; Clarke KJ, 2012, BBA-BIOENERGETICS, V1817, P1759, DOI 10.1016/j.bbabio.2012.03.035; Clevers H, 2014, SCIENCE, V346, P54, DOI 10.1126/science.1248012; Collins S, 1997, ENDOCRINOLOGY, V138, P405, DOI 10.1210/en.138.1.405; Contreras GA, 2014, AM J PHYSIOL-ENDOC M, V307, pE793, DOI 10.1152/ajpendo.00033.2014; COUSIN B, 1992, J CELL SCI, V103, P931; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; GIRALT M, 1990, EUR J BIOCHEM, V193, P297, DOI 10.1111/j.1432-1033.1990.tb19336.x; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Hall KD, 2012, AM J CLIN NUTR, V95, P989, DOI 10.3945/ajcn.112.036350; Han J, 2011, DEVELOPMENT, V138, P5027, DOI 10.1242/dev.067686; Harshaw C, 2012, PHYSIOL BEHAV, V106, P670, DOI 10.1016/j.physbeh.2012.05.002; Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670; JACOBSSON A, 1994, AM J PHYSIOL-REG I, V267, pR999, DOI 10.1152/ajpregu.1994.267.4.R999; Jimenez-Chillaron JC, 2006, DIABETOLOGIA, V49, P1974, DOI 10.1007/s00125-006-0311-7; Jin SH, 2004, J COMP NEUROL, V477, P300, DOI 10.1002/cne.20263; Johnson MS, 2001, J EXP BIOL, V204, P1967; Klein R, 2014, CURR OPIN NEUROBIOL, V27, P16, DOI 10.1016/j.conb.2014.02.006; Koza RA, 2000, J BIOL CHEM, V275, P34486, DOI 10.1074/jbc.M002136200; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; Kozak LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030392; Kozak LP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011015; Lasar D, 2013, BBA-MOL CELL BIOL L, V1831, P960, DOI 10.1016/j.bbalip.2013.01.016; Lee YH, 2015, FASEB J, V29, P286, DOI 10.1096/fj.14-263038; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Liu XT, 2003, J CLIN INVEST, V111, P399, DOI 10.1172/JCI200315737; Mori H, 2012, J CLIN INVEST, V122, P2405, DOI 10.1172/JCI63604; Morrison SF, 2000, J NEUROSCI, V20, P9264; Ozanne SE, 2004, NATURE, V427, P411, DOI 10.1038/427411b; Ozanne SE, 2004, CLIN SCI, V106, P141, DOI 10.1042/CS20030278; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Piontek J, 2003, J BIOL CHEM, V278, P38970, DOI 10.1074/jbc.M306749200; Pope M, 2014, ACTA PHYSIOL, V210, P20, DOI 10.1111/apha.12053; Ravussin Y, 2013, INT J OBESITY, V37, P399, DOI 10.1038/ijo.2012.105; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; ROTHWELL NJ, 1984, J PHYSIOL-LONDON, V355, P457, DOI 10.1113/jphysiol.1984.sp015431; Schmidt M, 2003, INT J DEV NEUROSCI, V21, P125, DOI 10.1016/S0736-5748(03)00030-3; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; SILVERMAN J, 1992, LAB ANIM, V26, P127, DOI 10.1258/002367792780745832; Tang XL, 2008, NAT CELL BIOL, V10, P698, DOI 10.1038/ncb1732; Thomas SA, 1997, NATURE, V387, P94, DOI 10.1038/387094a0; Voigt A, 2013, MOL NUTR FOOD RES, V57, P1423, DOI 10.1002/mnfr.201200671; Walden TB, 2010, BIOCHEM BIOPH RES CO, V397, P146, DOI 10.1016/j.bbrc.2010.05.053; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Whittle A, 2013, TRENDS PHARMACOL SCI, V34, P347, DOI 10.1016/j.tips.2013.04.004; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200; Xue BZ, 2005, MOL CELL BIOL, V25, P8311, DOI 10.1128/MCB.25.18.8311-8322.2005	60	16	18	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3238	3252		10.1096/fj.15-271395	http://dx.doi.org/10.1096/fj.15-271395			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25896784	Green Published			2022-12-26	WOS:000358796900013
J	Borlak, J; Singh, PK; Rittelmeyer, I				Borlak, Juergen; Singh, Prafull Kumar; Rittelmeyer, Ina			Regulation of Liver Enriched Transcription Factors in Rat Hepatocytes Cultures on Collagen and EHS Sarcoma Matrices	PLOS ONE			English	Article							ALVEOLAR EPITHELIAL-CELLS; DISEASE CANDIDATE GENES; IN-VITRO; SANDWICH CONFIGURATION; HEPATOMA-CELL; EXPRESSION; INDUCTION; HEPATOTOXICITY; DIFFERENTIATION; PROGRESSION	Liver-enriched transcription factors (LETF) play a crucial role in the control of liver-specific gene expression and for hepatocytes to retain their molecular and cellular functions complex interactions with extra cellular matrix (ECM) are required However, during cell isolation ECM interactions are disrupted and for hepatocytes to regain metabolic competency cells are cultured on ECM substrata. The regulation of LETFs in hepatocytes cultured on different ECM has not been studied in detail. We therefore compared two common sources of ECM and evaluated cellular morphology and hepatocyte differentiation by investigating DNA binding activity of LETFs at gene specific promoters and marker genes of hepatic metabolism. Furthermore, we studied testosterone metabolism and albumin synthesis to assess the metabolic competence of cell cultures. Despite significant difference in morphological appearance and except for HNF1 beta (p<0.001) most LETFs and several of their target genes did not differ in transcript expression after Bonferroni adjustment when cultured on collagen or Matrigel. Nonetheless, Western blotting revealed HNF1 beta, HNF3 alpha, HNF3 gamma, HNF4 alpha, HNF6 and the smaller subunits of C/EBP alpha and C/EBP beta to be more abundant on Matrigel cultured cells. Likewise, DNA binding activity of HNF3 alpha, HNF3 beta, HNF4 alpha, HNF6 and gene expression of hepatic lineage markers were increased on Matrigel cultured hepatocytes. To further investigate hepatic gene regulation, the effects of Aroclor 1254 treatment, e.g. a potent inducer of xenobiotic defense were studied in vivo and in vitro. The gene expression of C/EBP-alpha increased in rat liver and hepatocytes cultured on collagen and this treatment induced DNA binding activity of HNF4 alpha, C/EBP alpha and C/EBP beta and gene expression of CYP1A1 and CYP1A2 in vivo and in vitro. Taken collectively, two sources of ECM greatly affected hepatocyte morphology, activity of liver enriched transcription factors, hepatic gene expression and metabolic competency that should be considered when used in cell biology studies and drug toxicity testing.	[Borlak, Juergen; Singh, Prafull Kumar; Rittelmeyer, Ina] Hannover Med Sch, Ctr Pharmacol & Toxicol, Hannover, Germany	Hannover Medical School	Borlak, J (corresponding author), Hannover Med Sch, Ctr Pharmacol & Toxicol, Hannover, Germany.	Borlak.Juergen@mh-hannover.de			Virtual Liver Network of the German Federal Ministry of Education and Research (BMBF) [0316154]	Virtual Liver Network of the German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The authors' gratefully acknowledge support from The Virtual Liver Network (grant 031 6154) of the German Federal Ministry of Education and Research (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson N, 2008, PHARMACOL REV, V60, P311, DOI 10.1124/pr.108.00001; Benton G, 2011, INT J CANCER, V128, P1751, DOI 10.1002/ijc.25781; Berthiaume F, 1996, FASEB J, V10, P1471, DOI 10.1096/fasebj.10.13.8940293; Bierwolf J, 2011, BIOTECHNOL BIOENG, V108, P141, DOI 10.1002/bit.22924; BISSELL MJ, 1982, J THEOR BIOL, V99, P31, DOI 10.1016/0022-5193(82)90388-5; Borlak J, 2005, DRUG METAB DISPOS, V33, P1108, DOI 10.1124/dmd.105.003723; Borlak J, 2004, XENOBIOTICA, V34, P935, DOI 10.1080/00498250400008363; Borlak J, 2003, XENOBIOTICA, V33, P655, DOI 10.1080/0049825031000093600; Borlak J, 2001, BIOCHEM PHARMACOL, V61, P145, DOI 10.1016/S0006-2952(00)00537-2; Borlak R, 2003, TOXICOL APPL PHARM, V188, P81, DOI 10.1016/S0041-008X(02)00075-3; BOROK Z, 1995, AM J RESP CELL MOL, V12, P50, DOI 10.1165/ajrcmb.12.1.7811470; CARON JM, 1990, MOL CELL BIOL, V10, P1239, DOI 10.1128/MCB.10.3.1239; DIPERSIO CM, 1991, MOL CELL BIOL, V11, P4405, DOI 10.1128/MCB.11.9.4405; DUNN JCY, 1989, FASEB J, V3, P174, DOI 10.1096/fasebj.3.2.2914628; ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626; Garaguso I, 2008, PROTEOMICS, V8, P2583, DOI 10.1002/pmic.200701147; Godoy P, 2013, ARCH TOXICOL, V87, P1315, DOI 10.1007/s00204-013-1078-5; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; Harris AJ, 2004, TOXICOL MECH METHOD, V14, P257, DOI 10.1080/15376520490434629; Hartung T, 2012, ALTEX-ALTERN ANIM EX, V29, P119, DOI 10.14573/altex.2012.2.119; Hayashi Y, 1999, J CLIN PATHOL-MOL PA, V52, P19; Hewitt NJ, 2007, DRUG METAB REV, V39, P159, DOI 10.1080/03602530601093489; Iwahori T, 2003, HEPATOLOGY, V37, P665, DOI 10.1053/jhep.2003.50094; Kel AE, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r36; Kheolamai P, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-35; Nguyen-Ngoc KV, 2012, P NATL ACAD SCI USA, V109, pE2595, DOI 10.1073/pnas.1212834109; Laurent T, 2012, BIOL OPEN, V1, P958, DOI 10.1242/bio.20121438; Lazarevich N, 2004, HEPATOLOGY, V39, P1038, DOI 10.1002/hep.20155; Lazarevich N. L., 2010, Experimental Oncology, V32, P167; LeBleu VS, 2007, EXP BIOL MED, V232, P1121, DOI 10.3181/0703-MR-72; LeCluyse EL, 2012, CRIT REV TOXICOL, V42, P501, DOI 10.3109/10408444.2012.682115; LIU JK, 1991, MOL CELL BIOL, V11, P773, DOI 10.1128/MCB.11.2.773; Luhe A, 2005, MUTAT RES-FUND MOL M, V575, P102, DOI 10.1016/j.mrfmmm.2005.02.009; Meredith C, 2003, XENOBIOTICA, V33, P511, DOI 10.1080/0049825031000085960; Mitaka T, 1998, INT J EXP PATHOL, V79, P393, DOI 10.1046/j.1365-2613.1998.00083.x; Moghe PV, 1996, BIOMATERIALS, V17, P373, DOI 10.1016/0142-9612(96)85576-1; Niehof M, 2005, MOL PHARMACOL, V67, P604, DOI 10.1124/mol.104.008672; Niehof M, 2008, DIABETES, V57, P1069, DOI 10.2337/db07-1065; Niehof M, 2008, GASTROENTEROLOGY, V134, P1191, DOI 10.1053/j.gastro.2008.01.027; Niehof M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016319; Niehof M, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-68; NISHIYORI A, 1994, J BIOL CHEM, V269, P1323; ODA H, 1995, BIOCHEM BIOPH RES CO, V212, P800, DOI 10.1006/bbrc.1995.2039; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Olsavsky KM, 2007, TOXICOL APPL PHARM, V222, P42, DOI 10.1016/j.taap.2007.03.032; Sakai Y, 2010, CELLS TISSUES ORGANS, V191, P281, DOI 10.1159/000272316; Santangelo L, 2011, HEPATOLOGY, V53, P2063, DOI 10.1002/hep.24280; Schrem H, 2004, PHARMACOL REV, V56, P291, DOI 10.1124/pr.56.2.5; Schrem H, 2002, PHARMACOL REV, V54, P129, DOI 10.1124/pr.54.1.129; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Shulman Maria, 2013, Methods Mol Biol, V945, P287, DOI 10.1007/978-1-62703-125-7_17; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Soldatow VY, 2013, TOXICOL RES-UK, V2, P23, DOI 10.1039/c2tx20051a; Swift B, 2010, DRUG METAB REV, V42, P446, DOI 10.3109/03602530903491881; Thum T, 2008, ARCH TOXICOL, V82, P89, DOI 10.1007/s00204-007-0234-1; Tuschl G, 2006, TOXICOLOGY, V218, P205, DOI 10.1016/j.tox.2005.10.017; Ukairo O, 2013, J BIOCHEM MOL TOXIC, V27, P204, DOI 10.1002/jbt.21469; Wang S, 2008, TISSUE ENG PT A, V14, P227, DOI 10.1089/tea.2007.0143; Weltmeier F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021667; Xu CJ, 2005, ARCH PHARM RES, V28, P249, DOI 10.1007/BF02977789; Xu G, 2001, Zhonghua Wai Ke Za Zhi, V39, P948	61	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124867	10.1371/journal.pone.0124867	http://dx.doi.org/10.1371/journal.pone.0124867			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901575	gold, Green Published, Green Submitted			2022-12-26	WOS:000353331500101
J	Brendel, C; Teichler, S; Millahn, A; Stiewe, T; Krause, M; Stabla, K; Ross, P; Huynh, M; Illmer, T; Mernberger, M; Barckhausen, C; Neubauer, A				Brendel, Cornelia; Teichler, Sabine; Millahn, Axel; Stiewe, Thorsten; Krause, Michael; Stabla, Kathleen; Ross, Petra; Huynh, Minh; Illmer, Thomas; Mernberger, Marco; Barckhausen, Christina; Neubauer, Andreas			Oncogenic NRAS Primes Primary Acute Myeloid Leukemia Cells for Differentiation	PLOS ONE			English	Article							N-RAS GENE; HEMATOPOIETIC PROGENITOR CELLS; HIGH-DOSE CYTARABINE; MYELODYSPLASTIC SYNDROME; ACTIVATING MUTATIONS; SENSITIVE DETECTION; EXPRESSION PROFILE; POOR-PROGNOSIS; DNA-DAMAGE; FLT3	RAS mutations are frequently found among acute myeloid leukemia patients (AML), generating a constitutively active signaling protein changing cellular proliferation, differentiation and apoptosis. We have previously shown that treatment of AML patients with high-dose cytarabine is preferentially beneficial for those harboring oncogenic RAS. On the basis of a murine AML cell culture model, we ascribed this effect to a RAS-driven, p53-dependent induction of differentiation. Hence, in this study we sought to confirm the correlation between RAS status and differentiation of primary blasts obtained from AML patients. The gene expression signature of AML blasts with oncogenic NRAS indeed corresponded to a more mature profile compared to blasts with wildtype RAS, as demonstrated by gene set enrichment analysis (GSEA) and real-time PCR analysis of myeloid ecotropic viral integration site 1 homolog (MEIS1) in a unique cohort of AML patients. In addition, in vitro cell culture experiments with established cell lines and a second set of primary AML cells showed that oncogenic NRAS mutations predisposed cells to cytarabine (AraC) driven differentiation. Taken together, our findings show that AML with inv(16) and NRAS mutation have a differentiation gene signature, supporting the notion that NRAS mutation may predispose leukemic cells to AraC induced differentiation. We therefore suggest that promotion of differentiation pathways by specific genetic alterations could explain the superior treatment outcome after therapy in some AML patient subgroups. Whether a differentiation gene expression status may generally predict for a superior treatment outcome in AML needs to be addressed in future studies.	[Brendel, Cornelia; Teichler, Sabine; Millahn, Axel; Stabla, Kathleen; Ross, Petra; Huynh, Minh; Barckhausen, Christina; Neubauer, Andreas] Univ Marburg, Dept Hematol Oncol & Immunol, Marburg, Germany; [Brendel, Cornelia; Teichler, Sabine; Millahn, Axel; Stabla, Kathleen; Ross, Petra; Huynh, Minh; Barckhausen, Christina; Neubauer, Andreas] Univ Clin Giessen & Marburg, Marburg, Germany; [Stiewe, Thorsten; Krause, Michael; Mernberger, Marco] Univ Marburg, Mol Oncol, Marburg, Germany; [Illmer, Thomas] Tech Univ Dresden, Univ Clin, Med Clin 1, D-01062 Dresden, Germany	Philipps University Marburg; University Hospital of Giessen & Marburg; Philipps University Marburg; Technische Universitat Dresden	Neubauer, A (corresponding author), Univ Marburg, Dept Hematol Oncol & Immunol, Marburg, Germany.	neubauer@mailer.uni-marburg.de	Brendel, Cornelia/U-5901-2019	Brendel, Cornelia/0000-0003-1612-9557; Stiewe, Thorsten/0000-0003-0134-7826	von Behring-Rontgen Foundation [51-0057]; Deutsche Forschungsgemeinschaft [DFG SFB TRR17, KFO210]; German Carreras Leukemia Foundation [AH 06-01, AR08/05v, RO6/31]; Bundesministerium fur Bildung und Forschung [NGFNplus PKL-01GS0880-11]; European Research Council	von Behring-Rontgen Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Carreras Leukemia Foundation; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); European Research Council(European Research Council (ERC)European Commission)	The study was supported by the von Behring-Rontgen Foundation, grant no. 51-0057 to AN, Deutsche Forschungsgemeinschaft, grant no. DFG SFB TRR17 to AN, KFO210 to C. Brendel and AN; German Carreras Leukemia Foundation, grant no. AH 06-01 und AR08/05v to AN and RO6/31 to C. Brendel; Bundesministerium fur Bildung und Forschung, grant no. NGFNplus PKL-01GS0880-11 to AN and ST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. TS acknowledges support by the European Research Council.	Bacher U, 2006, BLOOD, V107, P3847, DOI 10.1182/blood-2005-08-3522; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; BENE MC, 1995, LEUKEMIA, V9, P1783; Bowen DT, 2005, BLOOD, V106, P2113, DOI 10.1182/blood-2005-03-0867; Bowen DT, 2003, BLOOD, V101, P2770, DOI 10.1182/blood-2002-01-0228; Brendel C, 2005, GENE EXPRESSION, V12, P245, DOI 10.3727/000000005783992043; Chan IT, 2004, CELL CYCLE, V3, P536; Chung E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028350; COGHLAN DW, 1994, LEUKEMIA, V8, P1682; Croonquist PA, 2003, BLOOD, V102, P2581, DOI 10.1182/blood-2003-04-1227; DeMelo MB, 1997, LEUKEMIA LYMPHOMA, V24, P309, DOI 10.3109/10428199709039018; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Ewald B, 2008, ONCOGENE, V27, P6522, DOI 10.1038/onc.2008.316; Fikaris AJ, 2006, J BIOL CHEM, V281, P34759, DOI 10.1074/jbc.M606737200; Garcia-Orti L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047717; Illmer T, 2005, CLIN CANCER RES, V11, P3217, DOI 10.1158/1078-0432.CCR-04-2232; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jaatinen T, 2006, STEM CELLS, V24, P631, DOI 10.1634/stemcells.2005-0185; Kiyoi H, 1999, BLOOD, V93, P3074; Krypuy M, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-295; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Meshinchi S, 2003, BLOOD, V102, P1474, DOI 10.1182/blood-2003-01-0137; Meyer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007768; Moriya K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037892; NEUBAUER A, 1994, BLOOD, V83, P1603; Neubauer A, 2008, J CLIN ONCOL, V26, P4603, DOI 10.1200/JCO.2007.14.0418; PAQUETTE RL, 1993, BLOOD, V82, P590, DOI 10.1182/blood.V82.2.590.bloodjournal822590; Pineault N, 2002, EXP HEMATOL, V30, P49, DOI 10.1016/S0301-472X(01)00757-3; Ritter M, 2006, LEUKEMIA, V20, P437, DOI 10.1038/sj.leu.2404093; Ritter M, 1997, BRIT J HAEMATOL, V98, P969, DOI 10.1046/j.1365-2141.1997.2933107.x; Schaich M, 2001, BRIT J HAEMATOL, V112, P300, DOI 10.1046/j.1365-2141.2001.02562.x; Schaich M, 2013, J CLIN ONCOL, V31, P2094, DOI 10.1200/JCO.2012.46.4743; Scholl C, 2008, SEMIN ONCOL, V35, P336, DOI 10.1053/j.seminoncol.2008.04.004; Shen SW, 2004, EXP HEMATOL, V32, P852, DOI 10.1016/j.exphem.2004.06.001; Shen S, 2007, EXP HEMATOL, V35, P908, DOI 10.1016/j.exphem.2007.02.011; Shih LY, 2004, LEUKEMIA, V18, P466, DOI 10.1038/sj.leu.2403274; Stirewalt DL, 2001, BLOOD, V97, P3589, DOI 10.1182/blood.V97.11.3589; Thiede C, 1996, NUCLEIC ACIDS RES, V24, P983, DOI 10.1093/nar/24.5.983; Valk PJM, 2004, HAEMATOLOGICA, V89, P106; Weisberg E, 2009, DRUG RESIST UPDATE, V12, P81, DOI 10.1016/j.drup.2009.04.001	40	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123181	10.1371/journal.pone.0123181	http://dx.doi.org/10.1371/journal.pone.0123181			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901794	gold, Green Published, Green Submitted			2022-12-26	WOS:000353331500047
J	Pascolutti, M; Campitelli, M; Nguyen, B; Pham, N; Gorse, AD; Quinn, RJ				Pascolutti, Mauro; Campitelli, Marc; Bao Nguyen; Ngoc Pham; Gorse, Alain-Dominique; Quinn, Ronald J.			Capturing Nature's Diversity	PLOS ONE			English	Article							DRUG DISCOVERY; CHEMICAL SPACE; PRODUCTS; CHEMISTRY; DESIGN; LIBRARIES; FRAGMENTS	Natural products are universally recognized to contribute valuable chemical diversity to the design of molecular screening libraries. The analysis undertaken in this work, provides a foundation for the generation of fragment screening libraries that capture the diverse range of molecular recognition building blocks embedded within natural products. Physicochemical properties were used to select fragment-sized natural products from a database of known natural products (Dictionary of Natural Products). PCA analysis was used to illustrate the positioning of the fragment subset within the property space of the non-fragment sized natural products in the dataset. Structural diversity was analysed by three distinct methods: atom function analysis, using pharmacophore fingerprints, atom type analysis, using radial fingerprints, and scaffold analysis. Small pharmacophore triplets, representing the range of chemical features present in natural products that are capable of engaging in molecular interactions with small, contiguous areas of protein binding surfaces, were analysed. We demonstrate that fragment-sized natural products capture more than half of the small pharmacophore triplet diversity observed in non fragment-sized natural product datasets. Atom type analysis using radial fingerprints was represented by a self-organizing map. We examined the structural diversity of non-flat fragment-sized natural product scaffolds, rich in sp3 configured centres. From these results we demonstrate that 2-ring fragment-sized natural products effectively balance the opposing characteristics of minimal complexity and broad structural diversity when compared to the larger, more complex fragment-like natural products. These naturally-derived fragments could be used as the starting point for the generation of a highly diverse library with the scope for further medicinal chemistry elaboration due to their minimal structural complexity. This study highlights the possibility to capture a high proportion of the individual molecular interaction motifs embedded within natural products using a fragment screening library spanning 422 structural clusters and comprised of approximately 2800 natural products.	[Pascolutti, Mauro; Campitelli, Marc; Bao Nguyen; Ngoc Pham; Gorse, Alain-Dominique; Quinn, Ronald J.] Griffith Univ, Eskitis Inst Drug Discovery, Brisbane, Qld 4111, Australia; [Gorse, Alain-Dominique] Univ Queensland, QFAB Bioinformat, Brisbane, Qld, Australia	Griffith University; University of Queensland	Quinn, RJ (corresponding author), Griffith Univ, Eskitis Inst Drug Discovery, Brisbane, Qld 4111, Australia.	r.quinn@griffith.edu.au	Gorse, Alain-Dominique JP/G-2444-2010; Gorse, Dominique/GRJ-6993-2022; Quinn, Ronald J/A-7931-2008	Quinn, Ronald J/0000-0002-4022-2623; Gorse, Alain-Dominique/0000-0003-1230-4194	Bill & Melinda Gates Foundation [OPP100837, POO1035218]; ARC [LP120100485]; Chemi-Biology Computational Platform for Lead Discovery in Infectious Disease [LE120100071]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); ARC(Australian Research Council); Chemi-Biology Computational Platform for Lead Discovery in Infectious Disease	The authors acknowledge financial support from Bill & Melinda Gates Foundation Grand Challenges Explorations Grant (OPP100837 and POO1035218), ARC Linkage LE (LP120100485) and Chemi-Biology Computational Platform for Lead Discovery in Infectious Disease (LE120100071).	Bohacek RS, 1996, MED RES REV, V16, P3, DOI 10.1002/(SICI)1098-1128(199601)16:1<3::AID-MED1>3.0.CO;2-6; Chen HM, 2012, MEDCHEMCOMM, V3, P312, DOI 10.1039/c2md00238h; Congreve M, 2003, DRUG DISCOV TODAY, V8, P876, DOI 10.1016/S1359-6446(03)02831-9; Congreve M, 2008, J MED CHEM, V51, P3661, DOI 10.1021/jm8000373; Erlanson DA, 2004, J MED CHEM, V47, P3463, DOI 10.1021/jm040031v; FARNSWORTH NR, 1985, B WORLD HEALTH ORGAN, V63, P965; Feher M, 2003, J CHEM INF COMP SCI, V43, P218, DOI 10.1021/ci0200467; Ganesan A, 2008, CURR OPIN CHEM BIOL, V12, P306, DOI 10.1016/j.cbpa.2008.03.016; Glen RC, 2006, IDRUGS, V9, P199; Grabowski K, 2007, CURR CHEM BIOL, V1, P115, DOI DOI 10.2174/187231307779814066; Hajduk PJ, 2007, NAT REV DRUG DISCOV, V6, P211, DOI 10.1038/nrd2220; Vu H, 2013, ACS CHEM BIOL, V8, P2654, DOI 10.1021/cb400582b; Hung AW, 2011, P NATL ACAD SCI USA, V108, P6799, DOI 10.1073/pnas.1015271108; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Langdon SR, 2011, J CHEM INF MODEL, V51, P2174, DOI 10.1021/ci2001428; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Lopez-Vallejo F, 2012, DRUG DISCOV TODAY, V17, P718, DOI 10.1016/j.drudis.2012.04.001; Lovering F, 2009, J MED CHEM, V52, P6752, DOI 10.1021/jm901241e; McGregor MJ, 1999, J CHEM INF COMP SCI, V39, P569, DOI 10.1021/ci980159j; Murray CW, 2009, NAT CHEM, V1, P187, DOI [10.1038/NCHEM.217, 10.1038/nchem.217]; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Over B, 2013, NAT CHEM, V5, P21, DOI [10.1038/NCHEM.1506, 10.1038/nchem.1506]; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Schuffenhauer A, 2007, J CHEM INF MODEL, V47, P47, DOI 10.1021/ci600338x; Tajabadi F., 2013, SPRINGER SCI REV, V1, P141; Tian S, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-5; Wetzel S, 2007, CHIMIA, V61, P355, DOI 10.2533/chimia.2007.355	29	32	35	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0120942	10.1371/journal.pone.0120942	http://dx.doi.org/10.1371/journal.pone.0120942			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902039	gold, Green Published, Green Submitted			2022-12-26	WOS:000353331500008
J	Carpenter, JS; Robillard, R; Lee, RSC; Hermens, DF; Naismith, SL; White, D; Whitwell, B; Scott, EM; Hickie, IB				Carpenter, Joanne S.; Robillard, Rebecca; Lee, Rico S. C.; Hermens, Daniel F.; Naismith, Sharon L.; White, Django; Whitwell, Bradley; Scott, Elizabeth M.; Hickie, Ian B.			The Relationship between Sleep-Wake Cycle and Cognitive Functioning in Young People with Affective Disorders	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; OBSESSIVE-COMPULSIVE DISORDER; MENTAL-HEALTH-SERVICES; REST-ACTIVITY PATTERNS; CIRCADIAN-RHYTHMS; BIPOLAR DISORDER; ANXIETY DISORDERS; PSYCHIATRIC-DISORDERS; EARLY-ONSET; MEMORY	Although early-stage affective disorders are associated with both cognitive dysfunction and sleep-wake disruptions, relationships between these factors have not been specifically examined in young adults. Sleep and circadian rhythm disturbances in those with affective disorders are considerably heterogeneous, and may not relate to cognitive dysfunction in a simple linear fashion. This study aimed to characterise profiles of sleep and circadian disturbance in young people with affective disorders and examine associations between these profiles and cognitive performance. Actigraphy monitoring was completed in 152 young people (16-30 years; 66% female) with primary diagnoses of affective disorders, and 69 healthy controls (18-30 years; 57% female). Patients also underwent detailed neuropsychological assessment. Actigraphy data were processed to estimate both sleep and circadian parameters. Overall neuropsychological performance in patients was poor on tasks relating to mental flexibility and visual memory. Two hierarchical cluster analyses identified three distinct patient groups based on sleep variables and three based on circadian variables. Sleep clusters included a 'long sleep' cluster, a 'disrupted sleep' cluster, and a 'delayed and disrupted sleep' cluster. Circadian clusters included a 'strong circadian' cluster, a 'weak circadian' cluster, and a 'delayed circadian' cluster. Medication use differed between clusters. The 'long sleep' cluster displayed significantly worse visual memory performance compared to the 'disrupted sleep' cluster. No other cognitive functions differed between clusters. These results highlight the heterogeneity of sleep and circadian profiles in young people with affective disorders, and provide preliminary evidence in support of a relationship between sleep and visual memory, which may be mediated by use of antipsychotic medication. These findings have implications for the personalisation of treatments and improvement of functioning in young adults early in the course of affective illness.	[Carpenter, Joanne S.; Robillard, Rebecca; Lee, Rico S. C.; Hermens, Daniel F.; Naismith, Sharon L.; White, Django; Whitwell, Bradley; Scott, Elizabeth M.; Hickie, Ian B.] Univ Sydney, Clin Res Unit, Brain & Mind Res Inst, Camperdown, NSW, Australia	University of Sydney	Hickie, IB (corresponding author), Univ Sydney, Clin Res Unit, Brain & Mind Res Inst, Camperdown, NSW, Australia.	ian.hickie@sydney.edu.au	Stevens, David/F-4683-2015; Robillard, Rebecca/G-9045-2017; Hickie, Ian B/K-8975-2015	Hickie, Ian B/0000-0001-8832-9895; Hermens, Daniel/0000-0002-8570-2663; Naismith, Sharon/0000-0001-9076-2778; Carpenter, Joanne/0000-0002-9766-6700	National Health and Medical Research Council Program Grant [566529]; Australian Fellowship [464914]; NSW Health Mental Health and Drug Alcohol Office; National Health and Medical Research Council Clinical Development Award [1008117]; Fonds de la recherche en sante du Quebec; NHMRC Centre of Research Excellence in Optimising Early Interventions for Young People with Emerging Mood Disorders [1061043]	National Health and Medical Research Council Program Grant(National Health and Medical Research Council (NHMRC) of Australia); Australian Fellowship; NSW Health Mental Health and Drug Alcohol Office; National Health and Medical Research Council Clinical Development Award; Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); NHMRC Centre of Research Excellence in Optimising Early Interventions for Young People with Emerging Mood Disorders(National Health and Medical Research Council (NHMRC) of Australia)	IBH was funded by a National Health and Medical Research Council Program Grant (No. 566529) and Australian Fellowship (No. 464914). DFH was supported by a grant from NSW Health Mental Health and Drug & Alcohol Office. SLN was funded by a National Health and Medical Research Council Clinical Development Award (No. 1008117). RR received a postdoctoral training award from the Fonds de la recherche en sante du Quebec. RSCL and JSC were supported by the NHMRC Centre of Research Excellence in Optimising Early Interventions for Young People with Emerging Mood Disorders (No. 1061043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen E, 2005, J PSYCHIAT RES, V39, P207, DOI 10.1016/j.jpsychires.2004.06.001; Ankers D, 2009, J CLIN PSYCHOL, V65, P1071, DOI 10.1002/jclp.20608; APA, 1980, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890423349, DOI 10.1176/APPI.BOOKS.9780890423349]; Arico D, 2010, SLEEP MED, V11, P791, DOI 10.1016/j.sleep.2010.02.009; Armitage R, 2004, J AM ACAD CHILD PSY, V43, P761, DOI 10.1097/01.chi.0000122731.72597.4e; Arts B, 2011, ACTA PSYCHIAT SCAND, V123, P190, DOI 10.1111/j.1600-0447.2010.01601.x; Astill RG, 2012, PSYCHOL BULL, V138, P1109, DOI 10.1037/a0028204; Augustinavicius JLS, 2014, J AFFECT DISORDERS, V158, P11, DOI 10.1016/j.jad.2013.12.009; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Bearden CE, 2006, PSYCHIAT RES, V142, P139, DOI 10.1016/j.psychres.2005.08.010; BENCA RM, 1992, ARCH GEN PSYCHIAT, V49, P651; Benitez A, 2012, CLIN NEUROPSYCHOL, V26, P214, DOI 10.1080/13854046.2012.658439; Blatter K, 2007, PHYSIOL BEHAV, V90, P196, DOI 10.1016/j.physbeh.2006.09.009; BORGEN FH, 1987, J COUNS PSYCHOL, V34, P456, DOI 10.1037/0022-0167.34.4.456; Rocha PMB, 2013, COMPR PSYCHIAT, V54, P1003, DOI 10.1016/j.comppsych.2013.04.006; Breslau N, 1996, BIOL PSYCHIAT, V39, P411, DOI 10.1016/0006-3223(95)00188-3; Bruni O, 2012, SLEEP, V35, P649, DOI 10.5665/sleep.1824; BURKE KC, 1990, ARCH GEN PSYCHIAT, V47, P511; Cajochen C, 2003, J NEUROENDOCRINOL, V15, P432, DOI 10.1046/j.1365-2826.2003.00989.x; Castaneda AE, 2008, J AFFECT DISORDERS, V106, P1, DOI 10.1016/j.jad.2007.06.006; Chase RM, 2011, BEHAV SLEEP MED, V9, P224, DOI 10.1080/15402002.2011.606768; Couyoumdjian A, 2010, J SLEEP RES, V19, P64, DOI 10.1111/j.1365-2869.2009.00774.x; Depp CA, 2012, BIPOLAR DISORD, V14, P217, DOI 10.1111/j.1399-5618.2012.01011.x; Dewald JF, 2010, SLEEP MED REV, V14, P179, DOI 10.1016/j.smrv.2009.10.004; Dittmann S, 2008, BIPOLAR DISORD, V10, P877, DOI 10.1111/j.1399-5618.2008.00640.x; Dolsen MR, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0471-y; Donaldson S, 2003, J CLIN PSYCHIAT, V64, P86, DOI 10.4088/JCP.v64n0116; Fortier-Brochu E, 2012, SLEEP MED REV, V16, P83, DOI 10.1016/j.smrv.2011.03.008; Geiger A, 2012, NEUROREPORT, V23, P93, DOI 10.1097/WNR.0b013e32834e7e8f; Geoffroy PA, 2014, J AFFECT DISORDERS, V158, P1, DOI 10.1016/j.jad.2014.01.012; Glozier N, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-33; Goder R, 2007, NEUROPSYCHOBIOLOGY, V55, P36, DOI 10.1159/000103574; Goder R, 2011, J SLEEP RES, V20, P544, DOI 10.1111/j.1365-2869.2011.00914.x; GOLDMAN HH, 1992, AM J PSYCHIAT, V149, P1148; Gonzalez R, 2014, J CLIN PSYCHIAT, V75, pE317, DOI 10.4088/JCP.13m08506; Gruber J, 2011, J AFFECT DISORDERS, V134, P416, DOI 10.1016/j.jad.2011.05.016; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; Harvey AG, 2011, CLIN PSYCHOL REV, V31, P225, DOI 10.1016/j.cpr.2010.04.003; Harvey AG, 2009, CLIN PSYCHOL-SCI PR, V16, P256, DOI 10.1111/j.1468-2850.2009.01164.x; Hasler BP, 2010, PSYCHIAT RES, V178, P205, DOI 10.1016/j.psychres.2010.04.027; Hermens DF, 2010, EARLY INTERV PSYCHIA, V4, P227, DOI 10.1111/j.1751-7893.2010.00194.x; Hickie I, 2005, BRIT J PSYCHIAT, V186, P197, DOI 10.1192/bjp.186.3.197; Hickie IB, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-125; Houthoofd SAMK, 2008, CLIN THER, V30, P1565, DOI 10.1016/j.clinthera.2008.09.014; Hsiao FH, 2010, PSYCHONEUROENDOCRINO, V35, P503, DOI 10.1016/j.psyneuen.2009.08.019; Huang YL, 2002, PHYSIOL BEHAV, V76, P597, DOI 10.1016/S0031-9384(02)00733-3; Jamrozinski K, 2009, ACTA PSYCHIAT SCAND, V119, P365, DOI 10.1111/j.1600-0447.2008.01320.x; Kelly Y, 2013, J EPIDEMIOL COMMUN H, V67, P926, DOI 10.1136/jech-2012-202024; Kessler RC, 2007, WORLD PSYCHIATRY, V6, P168; Lee J., 2006, PSYCHIAT INVEST, V3, P55; Lee RSC, 2014, J PSYCHIATR RES, V57, P1, DOI 10.1016/j.jpsychires.2014.06.019; Lee RSC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058176; Lee RSC, 2012, J AFFECT DISORDERS, V140, P113, DOI 10.1016/j.jad.2011.10.023; Leistedt SJ, 2013, EUR NEUROPSYCHOPHARM, V23, P55, DOI 10.1016/j.euroneuro.2012.10.011; Li SX, 2012, SLEEP, V35, P1153, DOI 10.5665/sleep.2008; Li SX, 2013, PSYCHONEUROENDOCRINO, V38, P2789, DOI 10.1016/j.psyneuen.2013.07.009; Lim ASP, 2012, SLEEP, V35, P633, DOI 10.5665/sleep.1820; Manglick M, 2013, AUST NZ J PSYCHIAT, V47, P556, DOI 10.1177/0004867413481630; Mann-Wrobel MC, 2011, BIPOLAR DISORD, V13, P334, DOI 10.1111/j.1399-5618.2011.00935.x; Marler MR, 2006, STAT MED, V25, P3893, DOI 10.1002/sim.2466; Maziade M, 2011, SCHIZOPHRENIA BULL, V37, P1218, DOI 10.1093/schbul/sbq026; Meyers J. E., 1995, REY COMPLEX FIGURE T; MONTELEONE P, 1994, ACTA PSYCHIAT SCAND, V89, P411, DOI 10.1111/j.1600-0447.1994.tb01538.x; Monti JM, 2004, SLEEP MED REV, V8, P133, DOI 10.1016/S1087-0792(02)00158-2; Muller J, 2005, J ANXIETY DISORD, V19, P1, DOI 10.1016/j.janxdis.2003.12.001; NAIR NPV, 1984, PROG NEURO-PSYCHOPH, V8, P715, DOI 10.1016/0278-5846(84)90044-7; Naismith SL, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.47; Naismith SL, 2011, J AFFECT DISORDERS, V132, P139, DOI 10.1016/j.jad.2011.02.027; Naismith SL, 2009, J AFFECT DISORDERS, V116, P139, DOI 10.1016/j.jad.2008.11.017; Nandi A, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-31; Nota JA, 2015, NEUROSCI BIOBEHAV R, V51, P100, DOI 10.1016/j.neubiorev.2015.01.002; Olley A, 2007, J AFFECT DISORDERS, V104, P15, DOI 10.1016/j.jad.2007.02.023; Ong SH, 2006, J AFFECT DISORDERS, V96, P1, DOI 10.1016/j.jad.2006.05.025; Oosterman JM, 2009, J SLEEP RES, V18, P129, DOI 10.1111/j.1365-2869.2008.00704.x; Paelecke-Habermann Y, 2005, J AFFECT DISORDERS, V89, P125, DOI 10.1016/j.jad.2005.09.006; Papadimitriou GN, 2005, INT REV PSYCHIATR, V17, P229, DOI 10.1080/09540260500104524; Perlman CA, 2006, BIPOLAR DISORD, V8, P271, DOI 10.1111/j.1399-5618.2006.00330.x; Plante DT, 2012, PSYCHIAT RES-NEUROIM, V201, P240, DOI 10.1016/j.pscychresns.2012.03.001; Purcell R, 1997, PSYCHOL MED, V27, P1277, DOI 10.1017/S0033291797005448; Rajaratnam SMW, 2004, J PHYSIOL-LONDON, V561, P339, DOI 10.1113/jphysiol.2004.073742; Rickert P, 1998, WMS 3 LIST LEARNING; Robillard R, 2013, EUR PSYCHIAT, V28, P412, DOI 10.1016/j.eurpsy.2013.04.001; Robillard R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087763; Robillard R, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0402-3; Robillard R, 2013, J AFFECT DISORDERS, V145, P260, DOI 10.1016/j.jad.2012.06.006; Rock P, 2014, CHRONOBIOL INT, V31, P290, DOI 10.3109/07420528.2013.843542; Rouch I, 2005, ERGONOMICS, V48, P1282, DOI 10.1080/00140130500241670; RUBIN RT, 1992, ARCH GEN PSYCHIAT, V49, P558; SAHAKIAN BJ, 1992, J ROY SOC MED, V85, P399; Schabus M, 2006, EUR J NEUROSCI, V23, P1738, DOI 10.1111/j.1460-9568.2006.04694.x; Schmidt C, 2007, COGN NEUROPSYCHOL, V24, P755, DOI 10.1080/02643290701754158; Scott E, 2009, AUSTRALAS PSYCHIATRY, V17, P189, DOI 10.1080/10398560802657322; Scott EM, 2012, MED J AUSTRALIA, V196, P136, DOI 10.5694/mja11.10481; Snyder HR, 2013, PSYCHOL BULL, V139, P81, DOI 10.1037/a0028727; Srinivasan V, 2012, J NEUROPSYCH CLIN N, V24, P290, DOI 10.1176/appi.neuropsych.11090216; Strauss E., 2006, COMPENDIUM NEUROPSYC; Sutter C, 2012, NEUROPSYCHOLOGY, V26, P768, DOI 10.1037/a0030033; Sylvia LG, 2012, J PSYCHOPHARMACOL, V26, P1108, DOI 10.1177/0269881111421973; Tombaugh TN., 1998, COMPENDIUM NEUROPSYC; Tucker AM, 2010, SLEEP, V33, P47, DOI 10.1093/sleep/33.1.47; Turner Jo, 2007, World Psychiatry, V6, P108; Valdez P., 2012, CHRONOPHYSIOLOGY THE, V2, P12, DOI [10.2147/cpt.s32586, DOI 10.2147/CPT.S32586]; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; van Mill JG, 2010, J CLIN PSYCHIAT, V71, P239, DOI 10.4088/JCP.09m05218gry; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wechsler D., 2001, WECHSLER TEST ADULT; Weiland-Fiedler P, 2004, J AFFECT DISORDERS, V82, P253, DOI 10.1016/j.jad.2003.10.009; Wichniak A, 2013, INT REV PSYCHIATR, V25, P632, DOI 10.3109/09540261.2013.812067; Withall A, 2009, PSYCHOL MED, V39, P393, DOI 10.1017/S0033291708003620; Woodward ND, 2005, INT J NEUROPSYCHOPH, V8, P457, DOI 10.1017/S146114570500516X; Wulff K, 2010, NAT REV NEUROSCI, V11, P589, DOI 10.1038/nrn2868; Wulff K, 2009, CURR OPIN GENET DEV, V19, P237, DOI 10.1016/j.gde.2009.03.007; Xu GY, 2012, J AFFECT DISORDERS, V136, P328, DOI 10.1016/j.jad.2011.11.029; Zalta AK, 2013, DEPRESS ANXIETY, V30, P1114, DOI 10.1002/da.22170	115	10	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124710	10.1371/journal.pone.0124710	http://dx.doi.org/10.1371/journal.pone.0124710			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG3XJ	25898321	Green Submitted, Green Published, gold			2022-12-26	WOS:000353212600081
J	Lee, PS; Sing, KW; Wilson, JJ				Lee, Ping-Shin; Sing, Kong-Wah; Wilson, John-James			Reading Mammal Diversity from Flies: The Persistence Period of Amplifiable Mammal mtDNA in Blowfly Guts (Chrysomya megacephala) and a New DNA Mini-Barcode Target	PLOS ONE			English	Article							MOLECULAR METHODS; TRAP; PCR; IDENTIFICATION; AMPLIFICATION; MALAYSIA; PRIMERS; ENHANCE; CLIMATE; CARRION	Most tropical mammal species are threatened or data-deficient. Data collection is impeded by the traditional monitoring approaches which can be laborious, expensive and struggle to detect cryptic diversity. Monitoring approaches using mammal DNA derived from invertebrates are emerging as cost- and time-effective alternatives. As a step towards development of blowfly-derived DNA as an effective method for mammal monitoring in the biodiversity hotspot of Peninsular Malaysia, our objectives were (i) to determine the persistence period of amplifiable mammal mtDNA in blowfly guts through a laboratory feeding experiment (ii) to design and test primers that can selectively amplify mammal COI DNA mini-barcodes in the presence of high concentrations of blowfly DNA. The persistence period of amplifiable mammal mtDNA in blowfly guts was 24 h to 96 h post-feeding indicating the need for collecting flies within 24 h of capture to detect mammal mtDNA of sufficient quantity and quality. We designed a new primer combination for a COI DNA mini-barcode that did not amplify blowfly DNA and showed 89% amplification success for a dataset of mammals from Peninsular Malaysia. The short (205 bp) DNA mini-barcode could distinguish most mammal species (including separating dark taxa) and is of suitable length for high-throughput sequencing. Our new DNA mini-barcode target and a standardized trapping protocol with retrieval of blowflies every 24 h could point the way forward in the development of blowfly-derived DNA as an effective method for mammal monitoring.	[Lee, Ping-Shin; Sing, Kong-Wah; Wilson, John-James] Univ Malaya, Fac Sci, Inst Biol Sci, Museum Zool, Kuala Lumpur 50603, Malaysia; [Lee, Ping-Shin; Sing, Kong-Wah; Wilson, John-James] Univ Malaya, Fac Sci, Inst Biol Sci, Ecol & Biodivers Program, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Universiti Malaya	Lee, PS (corresponding author), Univ Malaya, Fac Sci, Inst Biol Sci, Museum Zool, Kuala Lumpur 50603, Malaysia.	pingshin@um.edu.my; johnwilson@um.edu.my	Wilson, John-James/C-4656-2012; Lee, Ping Shin/G-4378-2014	Wilson, John-James/0000-0002-3583-3550; 	Nagao Natural Environment Foundation Japan; Ministry of Higher Education Fundamental Research Grant Scheme [FP042-2014A]	Nagao Natural Environment Foundation Japan; Ministry of Higher Education Fundamental Research Grant Scheme	This study was supported by grants from the Nagao Natural Environment Foundation Japan to LPS and the Ministry of Higher Education Fundamental Research Grant Scheme (FP042-2014A) to JJW and Yong Kien Thai (UM). The funding bodies had no role in the design, in the collection, analysis, and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication.	Abbasi I, 2009, VECTOR-BORNE ZOONOT, V9, P79, DOI 10.1089/vbz.2008.0064; Akbarzadeh K, 2012, J ARTHROPOD-BORNE DI, V6, P119; Amat Eduardo, 2010, Acta Amaz., V40, P397, DOI 10.1590/S0044-59672010000200018; Arif IA, 2011, GENET MOL RES, V10, P3559, DOI 10.4238/2011.October.31.3; Azwandi A, 2013, TROP BIOMED, V30, P481; Bataille A, 2012, INFECT GENET EVOL, V12, P1831, DOI 10.1016/j.meegid.2012.07.019; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Brodie JF, 2009, SCIENCE, V326, P364, DOI 10.1126/science.326_364b; Calvignac-Spencer S, 2013, BIOESSAYS, V35, P1004, DOI 10.1002/bies.201300060; Calvignac-Spencer S, 2013, MOL ECOL, V22, P915, DOI 10.1111/mec.12183; Campbell G, 2011, BIOL LETTERS, V7, P723, DOI 10.1098/rsbl.2011.0155; Campobasso CP, 2005, AM J FOREN MED PATH, V26, P161, DOI 10.1097/01.pag.0000163832.05939.59; Carew ME, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-45; Ceballos G, 2009, P NATL ACAD SCI USA, V106, P3841, DOI 10.1073/pnas.0812419106; Davison A, 2002, J ZOOL, V257, P141, DOI 10.1017/S0952836902000730; Davison GWH, 2007, P SEM WORKSH STAT BI, P3; Ficetola GF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-434; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fonturbel FE, 2010, MAMM BIOL, V75, P294, DOI 10.1016/j.mambio.2009.03.012; Francis CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012575; Gariepy TD, 2012, MOL ECOL RESOUR, V12, P646, DOI 10.1111/j.1755-0998.2012.03140.x; Hanner R., 2009, DATA STANDARDS BARCO; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hobson RP, 1932, J EXP BIOL, V9, P128; Ivanova Natalia V, 2012, Methods Mol Biol, V858, P153, DOI 10.1007/978-1-61779-591-6_8; Jansen PA, 2010, SCIENCE, V327, P30, DOI 10.1126/science.327.5961.30-a; Kent RJ, 2009, MOL ECOL RESOUR, V9, P4, DOI 10.1111/j.1755-0998.2008.02469.x; Lambert TD, 2005, J MAMMAL, V86, P982, DOI 10.1644/1545-1542(2005)86[982:VISMSR]2.0.CO;2; Lyimo IN, 2009, TRENDS PARASITOL, V25, P189, DOI 10.1016/j.pt.2009.01.005; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Mumma MA, 2014, MOL ECOL RESOUR, V14, P100, DOI 10.1111/1755-0998.12153; Muturi CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017284; NORRIS KR, 1965, ANNU REV ENTOMOL, V10, P47, DOI 10.1146/annurev.en.10.010165.000403; Pinol J, 2014, MOL ECOL RESOUR, V14, P18, DOI 10.1111/1755-0998.12156; Powell RA, 2003, ILAR J, V44, P259, DOI 10.1093/ilar.44.4.259; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Schnell IB, 2012, CURR BIOL, V22, pR262, DOI 10.1016/j.cub.2012.02.058; Scholtz AJ, 2000, J S AFR VET ASSOC, V71, P148; Shen YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057125; Shokralla S, 2014, MOL ECOL RESOUR, V14, P892, DOI 10.1111/1755-0998.12236; Sing KW, 2013, RAFFLES B ZOOL, P211; Stadhouders R, 2010, J MOL DIAGN, V12, P109, DOI 10.2353/jmoldx.2010.090035; Stein ED, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095525; Stenglein JL, 2010, MOL ECOL RESOUR, V10, P109, DOI 10.1111/j.1755-0998.2009.02670.x; Syaripuddin K, 2014, ECOTOXICOLOGY, V23, P1164, DOI 10.1007/s10646-014-1258-y; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanabe S, 2007, BIOSCI BIOTECH BIOCH, V71, P3131, DOI 10.1271/bbb.70683; Torre I, 2010, HYSTRIX, V21, P147, DOI 10.4404/hystrix-21.2-4462; Vestheim H, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-12; VOGT W G, 1974, Journal of the Australian Entomological Society, V13, P249; Whitworth T, 2010, ZOOTAXA, P1; Wilson JJ, 2014, GENET MOL RES, V13, P920, DOI 10.4238/2014.February.19.2; Wilson John James, 2012, Methods Mol Biol, V858, P17, DOI 10.1007/978-1-61779-591-6_3	56	28	29	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123871	10.1371/journal.pone.0123871	http://dx.doi.org/10.1371/journal.pone.0123871			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898278	gold, Green Published, Green Submitted			2022-12-26	WOS:000353212600044
J	Smith, MC; Gomulkiewicz, R; Mack, RN				Smith, Melissa C.; Gomulkiewicz, Richard; Mack, Richard N.			Potential Role of Masting by Introduced Bamboos in Deer Mice (Peromyscus maniculatus) Population Irruptions Holds Public Health Consequences	PLOS ONE			English	Article							SIN-NOMBRE-VIRUS; BIOLOGICAL-CONTROL AGENTS; IXODES-PACIFICUS; SEED PRODUCTION; EXTRA FOOD; RODENT; LONG; HANTAVIRUS; INVASIONS; PATTERNS	We hypothesized that the ongoing naturalization of frost/shade tolerant Asian bamboos in North America could cause environmental consequences involving introduced bamboos, native rodents and ultimately humans. More specifically, we asked whether the eventual masting by an abundant leptomorphic ("running") bamboo within Pacific Northwest coniferous forests could produce a temporary surfeit of food capable of driving a population irruption of a common native seed predator, the deer mouse (Peromyscus maniculatus), a hantavirus carrier. Single-choice and cafeteria-style feeding trials were conducted for deer mice with seeds of two bamboo species (Bambusa distegia and Yushania brevipaniculata), wheat, Pinus ponderosa, and native mixed diets compared to rodent laboratory feed. Adult deer mice consumed bamboo seeds as readily as they consumed native seeds. In the cafeteria-style feeding trials, Y. brevipaniculata seeds were consumed at the same rate as native seeds but more frequently than wheat seeds or rodent laboratory feed. Females produced a median litter of 4 pups on a bamboo diet. Given the ability of deer mice to reproduce frequently whenever food is abundant, we employed our feeding trial results in a modified Rosenzweig-MacArthur consumer-resource model to project the population-level response of deer mice to a suddenly available/rapidly depleted supply of bamboo seeds. The simulations predict rodent population irruptions and declines similar to reported cycles involving Asian and South American rodents but unprecedented in deer mice. Following depletion of a mast seed supply, the incidence of Sin Nombre Virus (SNV) transmission to humans could subsequently rise with dispersal of the peridomestic deer mice into nearby human settlements seeking food.	[Smith, Melissa C.] USDA ARS, Invas Plant Res Lab, Ft Lauderdale, FL 33314 USA; [Gomulkiewicz, Richard; Mack, Richard N.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA	United States Department of Agriculture (USDA); Washington State University	Smith, MC (corresponding author), USDA ARS, Invas Plant Res Lab, 3225 Coll Ave, Ft Lauderdale, FL 33314 USA.	Melissa.Smith@ars.usda.gov			USDA-APHIS contract [1081001205CA]; National Science Foundation [DMS 0540524, DEB 1354264]; Direct For Biological Sciences [1354264] Funding Source: National Science Foundation	USDA-APHIS contract; National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by USDA-APHIS contract #1081001205CA to Washington State University and greatly facilitated by A.V. Tasker. RG was supported in part by National Science Foundation grants DMS 0540524 and DEB 1354264. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, ORNAMENTAL BAMBOOS; [Anonymous], 1980, SOIL SURVEY WHITMAN; [Anonymous], SOIL SURVEY LATAH CO; Aplin K, 2010, RODENT OUTBREAKS ECO, P13; Bartolomucci A, 2003, PSYCHONEUROENDOCRINO, V28, P540, DOI 10.1016/S0306-4530(02)00039-2; Belmain S. R., 2010, RODENT OUTBREAKS ECO, P49; BERRYMAN AA, 1992, ECOLOGY, V73, P1530, DOI 10.2307/1940005; Biggs JR, 2000, J MAMMAL, V81, P676, DOI 10.1644/1545-1542(2000)081<0676:ROEVTS>2.3.CO;2; Blackwell GL, 2003, OIKOS, V100, P601, DOI 10.1034/j.1600-0706.2003.11026.x; Botten J, 2001, COMPARATIVE MED, V51, P314; BURGDORFER W, 1985, AM J TROP MED HYG, V34, P925, DOI 10.4269/ajtmh.1985.34.925; Calisher CH, 2002, CROAT MED J, V43, P330; Calisher CH, 2007, J WILDLIFE DIS, V43, P1, DOI 10.7589/0090-3558-43.1.1; CHAMBERS JC, 1994, ANNU REV ECOL SYST, V25, P263, DOI 10.1146/annurev.es.25.110194.001403; CLARE FRANK H., 1938, JOUR MAMMAL, V19, P230, DOI 10.2307/1374620; Clotfelter ED, 2007, OECOLOGIA, V154, P493, DOI 10.1007/s00442-007-0859-z; Curran JM, 2013, HOTELLING; DAUBENMIRE R., 1970, Technical Bulletin. Washington Agricultural Experiment Station; Daubenmire R, 1968, FOREST VEGETATION WA; Dizney L, 2010, J WILDLIFE DIS, V46, P433, DOI 10.7589/0090-3558-46.2.433; Douangboupha B, 2003, ACIAR MONOGRAPH, V96, P103; Douglass RJ, 2006, J WILDLIFE DIS, V42, P813, DOI 10.7589/0090-3558-42.4.813; DOYLE AT, 1990, J MAMMAL, V71, P14, DOI 10.2307/1381312; Engelthaler DM, 1999, EMERG INFECT DIS, V5, P87, DOI 10.3201/eid0501.990110; Everett R., 1990, Proceedings of the Vertebrate Pest Conference, V14, P186; Fan D, 2000, SCI SILVAE SIN, V36, P57; Franklin DC, 2004, J BIOGEOGR, V31, P773, DOI 10.1111/j.1365-2699.2003.01057.x; FRANKLIN J. F., 1973, NATURAL VEGETATION O; FRENCH NR, 1968, ECOLOGY, V49, P1172, DOI 10.2307/1934507; GASHWILER JS, 1979, AM MIDL NAT, V102, P95, DOI 10.2307/2425070; GILBERT BS, 1981, OECOLOGIA, V51, P326, DOI 10.1007/BF00540901; Gratani L, 2008, FLORA, V203, P77, DOI 10.1016/j.flora.2007.11.002; GUNTHER PM, 1983, NORTHWEST SCI, V57, P32; Hiltbrunner E, 2014, OECOLOGIA, V176, P11, DOI 10.1007/s00442-014-2991-x; Horne BV, 1982, ECOLOGY, V63, P992, DOI [10.2307/1937239, DOI 10.2307/1937239]; Jaksic FM, 2003, AUSTRAL ECOL, V28, P237, DOI 10.1046/j.1442-9993.2003.01271.x; JAMESON EW, 1953, J MAMMAL, V34, P44, DOI 10.2307/1375943; JAMESON EW, 1952, J MAMMAL, V33, P50, DOI 10.2307/1375640; JANZEN DH, 1976, ANNU REV ECOL SYST, V7, P347, DOI 10.1146/annurev.es.07.110176.002023; Johnson DR, 1961, NW SCI, V61, P37; Johnson DR, 1987, NW SCI US; Kelly D, 2002, ANNU REV ECOL SYST, V33, P427, DOI 10.1146/annurev.ecolsys.33.020602.095433; Kelly D, 1997, OIKOS, V78, P143, DOI 10.2307/3545810; Kitzberger T, 2007, ECOLOGY, V88, P2541, DOI 10.1890/06-1587.1; Kon H, 2005, J ECOL, V93, P1148, DOI 10.1111/j.1365-2745.2005.01040.x; Krannitz Pamela G., 2004, Western North American Naturalist, V64, P208; Lalnunmawia F., 2005, Journal of Bamboo and Rattan, V4, P317, DOI 10.1163/156915905775008390; LANE RS, 1991, ANNU REV ENTOMOL, V36, P587, DOI 10.1146/annurev.en.36.010191.003103; Li Zhao-hua, 2006, Journal of Forestry Research (Harbin), V17, P293, DOI 10.1007/s11676-006-0067-4; Liebhold A, 2004, OIKOS, V104, P156, DOI 10.1111/j.0030-1299.2004.12722.x; Liebhold AM, 2012, FRONT ECOL ENVIRON, V10, P135, DOI 10.1890/110198; Lockwood JR, 1998, OECOLOGIA, V116, P475, DOI 10.1007/s004420050612; Luis AD, 2010, J ANIM ECOL, V79, P462, DOI 10.1111/j.1365-2656.2009.01646.x; Mack Richard N., 2011, NeoBiota, V9, P13, DOI 10.3897/neobiota.9.1156; Mack RN, 2003, INT J PLANT SCI, V164, pS185, DOI 10.1086/368399; MAKITA A, 1993, ECOL RES, V8, P215, DOI 10.1007/BF02348534; MANLY BFJ, 1993, OECOLOGIA, V93, P149, DOI 10.1007/BF00321205; Maron JL, 2010, ECOLOGY, V91, P3719, DOI 10.1890/10-0160.1; Maser C, 1981, 133 USDA PNW FOR SER, P496; Mills James N., 2002, Morbidity and Mortality Weekly Report, V51, P1; Minton MS, 2010, OECOLOGIA, V164, P399, DOI 10.1007/s00442-010-1667-4; Morrison ML, 1998, SOUTHWEST NAT, V43, P123; Murua R., 1996, Boletin de la Sociedad de Biologia de Concepcion, V67, P37; Nag S, 1999, Environ Hist Camb, V5, P245, DOI 10.3197/096734099779568317; Ohrnberger D, 1999, BAMBOOS WORLD ANNOTA; Orrock JL, 2011, AM NAT, V177, P691, DOI 10.1086/659632; Ortega YK, 2004, ECOL APPL, V14, P241, DOI 10.1890/02-5276; Oshima Y., 1961, Bot. Mag., V74, P280; Ostfeld R, 2000, CAN J ZOOL, V78, P2061, DOI 10.1139/cjz-78-12-2061; PATTON BD, 1988, J RANGE MANAGE, V41, P232, DOI 10.2307/3899174; Pearson DE, 2006, ECOL LETT, V9, P443, DOI 10.1111/j.1461-0248.2006.00896.x; Pearson DE, 2008, ECOL APPL, V18, P321, DOI 10.1890/07-0766.1; PEAVEY CA, 1995, J PARASITOL, V81, P175, DOI 10.2307/3283916; R Development Core Team, 2014, R LANG ENV STAT COMP; REAL LA, 1979, ECOLOGY, V60, P481, DOI 10.2307/1936067; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; ROSENZWEIG ML, 1963, AM NAT, V97, P209, DOI 10.1086/282272; Rundel PW, 2014, BIOL INVASIONS, V16, P663, DOI 10.1007/s10530-013-0614-9; Ruscoe WA, 2004, NEW ZEAL J ECOL, V28, P259; SIEG CH, 1986, NORTHWEST SCI, V60, P81; Simberloff D, 2005, TRENDS ECOL EVOL, V20, P216, DOI 10.1016/j.tree.2005.02.008; Smith AL, 2014, BIOL INVASIONS, V16, P1325, DOI 10.1007/s10530-013-0585-x; Smith MC, 2013, BIOL INVASIONS, V15, P2081, DOI 10.1007/s10530-013-0434-y; SULLIVAN TP, 1979, CAN J ZOOL, V57, P1636, DOI 10.1139/z79-215; TAITT MJ, 1981, J ANIM ECOL, V50, P111, DOI 10.2307/4035; Tallmon DA, 2003, ECOL APPL, V13, P1193, DOI 10.1890/02-5111; TAYLOR AH, 1988, AM J BOT, V75, P1065, DOI 10.2307/2443774; Timm RM, 1994, PREVENTION CONTROL W, pB47; TISDALE EW, 1947, ECOLOGY, V28, P346, DOI 10.2307/1931227; Tsuyuzaki S, 1996, AM J BOT, V83, P1422, DOI 10.2307/2446097; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; UEMURA S, 1989, VEGETATIO, V82, P127, DOI 10.1007/BF00045026; Vandermeer J, 2010, SCI ED KNOWL, V3, P15; VITOUSEK PM, 1987, SCIENCE, V238, P802, DOI 10.1126/science.238.4828.802; Witmer G, 2007, INTEGR ZOOL, V2, P154, DOI 10.1111/j.1749-4877.2007.00058.x; Wobeser G, 2007, J WILDLIFE DIS, V43, P23, DOI 10.7589/0090-3558-43.1.23; Wolff JO, 1996, J MAMMAL, V77, P850, DOI 10.2307/1382690; WOLFF JO, 1985, CAN J ZOOL, V63, P1548, DOI 10.1139/z85-230; Yunger JA, 2002, J MAMMAL, V83, P267, DOI 10.1644/1545-1542(2002)083<0267:ROTLDP>2.0.CO;2	99	6	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124419	10.1371/journal.pone.0124419	http://dx.doi.org/10.1371/journal.pone.0124419			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898267	Green Published, Green Submitted, gold			2022-12-26	WOS:000353212600068
J	Suresh, RV; Ma, Z; Sunagar, R; Bhatty, V; Banik, S; Catlett, SV; Gosselin, EJ; Malik, M; Bakshi, CS				Suresh, Ragavan Varadharajan; Ma, Zhuo; Sunagar, Raju; Bhatty, Vivek; Banik, Sukalyani; Catlett, Sally V.; Gosselin, Edmund J.; Malik, Meenakshi; Bakshi, Chandra Shekhar			Preclinical Testing of a Vaccine Candidate against Tularemia	PLOS ONE			English	Article							SUBSPECIES TULARENSIS STRAIN; FRANCISELLA-TULARENSIS; SCHU S4; INTRAMACROPHAGE SURVIVAL; MICROBIAL ANTIOXIDANTS; RESPIRATORY TULAREMIA; AEROSOL CHALLENGE; OXIDATIVE STRESS; PURINE AUXOTROPH; DELETION MUTANTS	Tularemia is caused by a gram-negative, intracellular bacterial pathogen, Francisella tularensis (Ft). The history weaponization of Ft in the past has elevated concerns that it could be used as a bioweapon or an agent of bioterrorism. Since the discovery of Ft, three broad approaches adopted for tularemia vaccine development have included inactivated, live attenuated, or subunit vaccines. Shortcomings in each of these approaches have hampered the development of a suitable vaccine for prevention of tularemia. Recently, we reported an oxidant sensitive mutant of Ft LVS in putative EmrA1 (FTL_0687) secretion protein. The emrA1 mutant is highly sensitive to oxidants, attenuated for intramacrophage growth and virulence in mice. We reported that EmrA1 contributes to oxidant resistance by affecting the secretion of antioxidant enzymes SodB and KatG. This study investigated the vaccine potential of the emrA1 mutant in prevention of respiratory tularemia caused by Ft LVS and the virulent SchuS4 strain in C57BL/6 mice. We report that emrA1 mutant is safe and can be used at an intranasal (i.n.) immunization dose as high as 1x10(6) CFU without causing any adverse effects in immunized mice. The emrA1 mutant is cleared by vaccinated mice by day 14-21 post-immunization, induces minimal histopathological lesions in lungs, liver and spleen and a strong humoral immune response. The emrA1 mutant vaccinated mice are protected against 1000-10,000LD(100) doses of i.n. Ft LVS challenge. Such a high degree of protection has not been reported earlier against respiratory challenge with Ft LVS using a single immunization dose with an attenuated mutant generated on Ft LVS background. The emrA1 mutant also provides partial protection against i.n. challenge with virulent Ft SchuS4 strain in vaccinated C57BL/6 mice. Collectively, our results further support the notion that antioxidants of Ft may serve as potential targets for development of effective vaccines for prevention of tularemia.	[Suresh, Ragavan Varadharajan; Bhatty, Vivek; Banik, Sukalyani; Bakshi, Chandra Shekhar] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA; [Ma, Zhuo; Catlett, Sally V.; Malik, Meenakshi] Albany Coll Pharm & Hlth Sci, Albany, NY 12208 USA; [Sunagar, Raju; Gosselin, Edmund J.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA	New York Medical College; Albany College of Pharmacy & Health Sciences; Albany Medical College	Malik, M (corresponding author), Albany Coll Pharm & Hlth Sci, Albany, NY 12208 USA.	Meenakshi.Malik@acphs.edu; Shekhar_Bakshi@nymc.edu	Malik, Meenakshi/F-1501-2015	Malik, Meenakshi/0000-0003-0051-4485; Ma, Zhuo/0000-0002-9766-8239	National Institutes of Health [P01AI056320, R56AI101109-01, R15AI107698-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056320, R15AI107698, R56AI101109] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in whole or in part, by National Institutes of Health Grants P01AI056320 (CSB, EJG), R56AI101109-01 (CSB), and R15AI107698-01 (MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson H, 2006, J MED MICROBIOL, V55, P263, DOI 10.1099/jmm.0.46313-0; ANTHONY LSD, 1987, MICROB PATHOGENESIS, V2, P3, DOI 10.1016/0882-4010(87)90110-0; Ashtekar AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050460; Bakshi CS, 2008, VACCINE, V26, P5276, DOI 10.1016/j.vaccine.2008.07.051; Bakshi CS, 2006, J BACTERIOL, V188, P6443, DOI 10.1128/JB.00266-06; Baron SD, 2007, INFECT IMMUN, V75, P2152, DOI 10.1128/IAI.01606-06; BELYI YF, 1995, APMIS, V103, P107, DOI 10.1111/j.1699-0463.1995.tb01085.x; Broussard LA, 2001, MOL DIAGN, V6, P323, DOI 10.1054/modi.2001.29155; BURKE DS, 1977, J INFECT DIS, V135, P55, DOI 10.1093/infdis/135.1.55; Chu P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004439; Conlan JW, 2007, ANN NY ACAD SCI, V1105, P325, DOI 10.1196/annals.1409.012; Conlan JW, 2010, VACCINE, V28, P1824, DOI 10.1016/j.vaccine.2009.12.001; De Pascalis Roberto, 2012, PLoS Pathog, V8, pe1002494, DOI 10.1371/journal.ppat.1002494; Dotson RJ, 2013, J BIOL CHEM, V288, P23844, DOI 10.1074/jbc.M113.490086; Edwards KM, 2001, AM J RESP CRIT CARE, V164, P2213, DOI 10.1164/ajrccm.164.12.2106093; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Eneslatt K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032367; Eyles JE, 2008, MICROB PATHOGENESIS, V44, P164, DOI 10.1016/j.micpath.2007.08.009; Forslund AL, 2006, MOL MICROBIOL, V59, P1818, DOI 10.1111/j.1365-2958.2006.05061.x; FORTIER AH, 1991, INFECT IMMUN, V59, P2922, DOI 10.1128/IAI.59.9.2922-2928.1991; Fulop M, 1996, FEMS IMMUNOL MED MIC, V13, P245, DOI 10.1111/j.1574-695X.1996.tb00245.x; Gallagher-Smith Melissa, 2004, Clin Lab Sci, V17, P35; Hornick R, 2001, NEW ENGL J MED, V345, P1637, DOI 10.1056/NEJM200111293452211; HORNICK RB, 1966, BACTERIOL REV, V30, P532, DOI 10.1128/MMBR.30.3.532-538.1966; Kernodle DS, 2010, CLIN INFECT DIS, V51, P177, DOI 10.1086/653533; Lamps LW, 2004, MODERN PATHOL, V17, P489, DOI 10.1038/modpathol.3800087; Lavine CL, 2007, EUR J IMMUNOL, V37, P3007, DOI 10.1002/eji.200737620; Li J, 2007, MICROBIOL-SGM, V153, P3141, DOI 10.1099/mic.0.2007/006460-0; Ma Z, 2014, MOL MICROBIOL, V91, P976, DOI 10.1111/mmi.12509; Mahawar M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061539; Mahawar M, 2012, J BIOL CHEM, V287, P25216, DOI 10.1074/jbc.M112.367672; Melillo AA, 2010, J BIOL CHEM, V285, P27553, DOI 10.1074/jbc.M110.144394; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Pechous R, 2006, INFECT IMMUN, V74, P4452, DOI 10.1128/IAI.00666-06; Pechous RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002487; Qin AP, 2009, INFECT IMMUN, V77, P152, DOI 10.1128/IAI.01113-08; Rawool DB, 2008, J IMMUNOL, V180, P5548, DOI 10.4049/jimmunol.180.8.5548; Rockx-Brouwer D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037752; Ryden P, 2013, MOL IMMUNOL, V54, P58, DOI 10.1016/j.molimm.2012.10.043; Sadagopal S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005531; Salomonsson E, 2009, INFECT IMMUN, V77, P3424, DOI 10.1128/IAI.00196-09; Sammons-Jackson WL, 2008, DNA CELL BIOL, V27, P387, DOI 10.1089/dna.2007.0687; SASLAW S, 1961, ARCH INTERN MED, V107, P702, DOI 10.1001/archinte.1961.03620050068007; Tempel R, 2006, INFECT IMMUN, V74, P5095, DOI 10.1128/IAI.00598-06; Twine S, 2005, INFECT IMMUN, V73, P8345, DOI 10.1128/IAI.73.12.8345-8352.2005; Vogel G, 2003, SCIENCE, V302, P222, DOI 10.1126/science.302.5643.222	46	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124326	10.1371/journal.pone.0124326	http://dx.doi.org/10.1371/journal.pone.0124326			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897786	gold, Green Submitted, Green Published			2022-12-26	WOS:000353212600062
J	Bausch-Fluck, D; Hofmann, A; Bock, T; Frei, AP; Cerciello, F; Jacobs, A; Moest, H; Omasit, U; Gundry, RL; Yoon, C; Schiess, R; Schmidt, A; Mirkowska, P; Hartlova, A; Van Eyk, JE; Bourquin, JP; Aebersold, R; Boheler, KR; Zandstra, P; Wollscheid, B				Bausch-Fluck, Damaris; Hofmann, Andreas; Bock, Thomas; Frei, Andreas P.; Cerciello, Ferdinando; Jacobs, Andrea; Moest, Hansjoerg; Omasit, Ulrich; Gundry, Rebekah L.; Yoon, Charles; Schiess, Ralph; Schmidt, Alexander; Mirkowska, Paulina; Haertlova, Anetta; Van Eyk, Jennifer E.; Bourquin, Jean-Pierre; Aebersold, Ruedi; Boheler, Kenneth R.; Zandstra, Peter; Wollscheid, Bernd			A Mass Spectrometric-Derived Cell Surface Protein Atlas	PLOS ONE			English	Article							PLASMA-MEMBRANE PROTEOMICS; MONOCLONAL-ANTIBODY; ANALYSIS REVEALS; STEM-CELLS; IDENTIFICATION; DATABASE; MARKERS; DISEASE; QUANTIFICATION; PREDICTION	Cell surface proteins are major targets of biomedical research due to their utility as cellular markers and their extracellular accessibility for pharmacological intervention. However, information about the cell surface protein repertoire (the surfaceome) of individual cells is only sparsely available. Here, we applied the Cell Surface Capture (CSC) technology to 41 human and 31 mouse cell types to generate a mass-spectrometry derived Cell Surface Protein Atlas (CSPA) providing cellular surfaceome snapshots at high resolution. The CSPA is presented in form of an easy-to-navigate interactive database, a downloadable data matrix and with tools for targeted surfaceome rediscovery (http://wlab.ethz.ch/cspa). The cellular surfaceome snapshots of different cell types, including cancer cells, resulted in a combined dataset of 1492 human and 1296 mouse cell surface glycoproteins, providing experimental evidence for their cell surface expression on different cell types, including 136 G-protein coupled receptors and 75 membrane receptor tyrosine-protein kinases. Integrated analysis of the CSPA reveals that the concerted biological function of individual cell types is mainly guided by quantitative rather than qualitative surfaceome differences. The CSPA will be useful for the evaluation of drug targets, for the improved classification of cell types and for a better understanding of the surfaceome and its concerted biological functions in complex signaling microenvironments.	[Bausch-Fluck, Damaris; Hofmann, Andreas; Bock, Thomas; Frei, Andreas P.; Cerciello, Ferdinando; Jacobs, Andrea; Moest, Hansjoerg; Omasit, Ulrich; Schiess, Ralph; Schmidt, Alexander; Mirkowska, Paulina; Aebersold, Ruedi; Wollscheid, Bernd] ETH, Inst Mol Syst Biol, Zurich, Switzerland; [Cerciello, Ferdinando] Univ Zurich Hosp, Mol Oncol Lab, CH-8091 Zurich, Switzerland; [Gundry, Rebekah L.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Yoon, Charles; Zandstra, Peter] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Mirkowska, Paulina; Bourquin, Jean-Pierre] Univ Children Hosp Zurich, Oncol Res Lab, Zurich, Switzerland; [Haertlova, Anetta] Univ Def, Fac Mil Hlth Sci, Ctr Adv Studies, Hradec Kralove, Czech Republic; [Van Eyk, Jennifer E.] Johns Hopkins Univ, Sch Med, Dept Med Biol Chem & Biomed Engn, Baltimore, MD USA; [Aebersold, Ruedi] Ctr Syst Physiol & Metab Dis, Zurich, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, Zurich, Switzerland; [Boheler, Kenneth R.] Univ Hong Kong, LKS Fac Med, SCRMC, Hong Kong, Hong Kong, Peoples R China; [Boheler, Kenneth R.] Johns Hopkins Univ, Sch Med, Div Cardiol, Baltimore, MD USA; [Wollscheid, Bernd] ETH, BMPP, Dept Hlth Sci & Technol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University Zurich Hospital; Medical College of Wisconsin; University of Toronto; University Children's Hospital Zurich; University of Defence - Czech Republic; Johns Hopkins University; University of Zurich; University of Hong Kong; Johns Hopkins University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Wollscheid, B (corresponding author), ETH, Inst Mol Syst Biol, Zurich, Switzerland.	wbernd@ethz.ch	Bourquin, Jean-Pierre/C-2802-2011; Gundry, Rebekah/K-6080-2019; Wollscheid, Bernd/E-8909-2010	Bourquin, Jean-Pierre/0000-0001-6571-6227; Wollscheid, Bernd/0000-0002-3923-1610; Cerciello, Ferdinando/0000-0001-8987-5732; Bock, Thomas Klaus Christian/0000-0002-9314-5318; Hartlova, Anetta/0000-0002-8152-4361; Gundry, Rebekah L./0000-0002-9263-833X	National Center of Competence in Research Neural Plasticity and Repair of the Swiss National Science Foundation; Center for Proteomics; InfectX; BIP project within the Swiss Initiative in Systems Biology; Ph.D. Program in Molecular Life Sciences in Zurich; Neuroscience Center Zurich Fellowship; Interdisciplinary PhD Project of SystemsX.ch; Swiss Initiative of Systems Biology; MD-PhD fellowship of the Swiss National Science Foundation; Advanced European Research Council [233226]; Swiss National Science Foundation [3100A0-107679]; National Institutes of Health (NIH) [U01CA152813]; NATIONAL CANCER INSTITUTE [U01CA152813] Funding Source: NIH RePORTER	National Center of Competence in Research Neural Plasticity and Repair of the Swiss National Science Foundation(Swiss National Science Foundation (SNSF)); Center for Proteomics; InfectX; BIP project within the Swiss Initiative in Systems Biology; Ph.D. Program in Molecular Life Sciences in Zurich; Neuroscience Center Zurich Fellowship; Interdisciplinary PhD Project of SystemsX.ch; Swiss Initiative of Systems Biology; MD-PhD fellowship of the Swiss National Science Foundation(Swiss National Science Foundation (SNSF)); Advanced European Research Council(European Research Council (ERC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Center of Competence in Research Neural Plasticity and Repair of the Swiss National Science Foundation, Center for Proteomics, http://www.nccr-neuro.uzh.ch (BW); InfectX and BIP project within the Swiss Initiative in Systems Biology, http://www.systemsx.ch/projects/research-technology-and-development-projects/completed-rtd-projects/infectx-2010-201 (BW); Mueller Fellowship from the Ph.D. Program in Molecular Life Sciences in Zurich (AH); Neuroscience Center Zurich Fellowship, http://www.neuroscience.ethz.ch/education/grant_applications (TB); Interdisciplinary PhD Project of SystemsX.ch, the Swiss Initiative of Systems Biology, Project 2 2009, http://www.systemsx.ch/projects/interdisciplinary-phd-projects/iphd-projects-2009/(HM); MD-PhD fellowship of the Swiss National Science Foundation, http://www.snf.ch/en/funding/careers/md-phd-programme/Pages/default.aspx (FC); Advanced European Research Council grant #233226, http://erc.europa.eu/funding-and-grants (RA); Swiss National Science Foundation (grant #3100A0-107679), http://www.snf.ch/en/funding/(RA); National Institutes of Health (NIH Grant #U01CA152813), http://grants.nih.gov/grants/oer. htm (RA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2008, PROTEOMICS, V8, P4946, DOI 10.1002/pmic.200800312; Andersson O, 2005, J PROTEOME RES, V4, P758, DOI 10.1021/pr049776f; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Autelitano F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110316; Bandura DR, 2009, ANAL CHEM, V81, P6813, DOI 10.1021/ac901049w; Baselga J, 1999, SEMIN ONCOL, V26, P78; Beck M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.82; Belov L, 2001, CANCER RES, V61, P4483; Berg JV, 2013, J EXP MED, V210, P2803, DOI 10.1084/jem.20130678; Bock T, 2011, FRONTIERS BIOSCIENCE; Bock T, 2012, J PROTEOME RES, V11, P4885, DOI 10.1021/pr300360a; Bodenmiller B, 2008, NAT BIOTECHNOL, V26, P1339, DOI 10.1038/nbt1208-1339; Boheler KR, 2014, STEM CELL REP, V3, DOI 10.1016/j.stemcr.2014.05.002; Boysen G, 2012, NEOPLASIA, V14, P535, DOI 10.1596/neo.12130; CHUANG W, 1990, DEV BIOL, V137, P219, DOI 10.1016/0012-1606(90)90249-I; Clough T, 2009, J PROTEOME RES, V8, P5275, DOI 10.1021/pr900610q; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; Conn EM, 2008, J BIOL CHEM, V283, P26518, DOI 10.1074/jbc.M803337200; da Cunha JPC, 2009, P NATL ACAD SCI USA, V106, P16752, DOI 10.1073/pnas.0907939106; Deeb SJ, 2014, MOL CELL PROTEOMICS, V13, P240, DOI 10.1074/mcp.M113.033977; Deutsch EW, 2010, PROTEOMICS, V10, P1150, DOI 10.1002/pmic.200900375; Dormeyer W, 2008, J PROTEOME RES, V7, P2936, DOI 10.1021/pr800056j; Dubois NC, 2011, NAT BIOTECHNOL, V29, P1011, DOI 10.1038/nbt.2005; Elschenbroich S, 2010, EXPERT REV PROTEOMIC, V7, P141, DOI 10.1586/EPR.09.97; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Freitas RA, 2005, NANOMED-NANOTECHNOL, V1, P2, DOI 10.1016/j.nano.2004.11.003; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Gundry RL, 2008, PROTEOM CLIN APPL, V2, P892, DOI 10.1002/prca.200780122; Gundry RL, 2009, MOL CELL PROTEOMICS, V8, P2555, DOI 10.1074/mcp.M900195-MCP200; Hartmann J, 2012, J BIOL CHEM, V287, P31527, DOI 10.1074/jbc.M111.304238; Hofmann A, 2010, BLOOD, V116, pE26, DOI 10.1182/blood-2010-02-271270; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Ikeda Masami, 2002, In Silico Biology, V2, P19; Josic D, 2007, PROTEOMICS, V7, P3010, DOI 10.1002/pmic.200700139; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kandasamy K, 2009, NUCLEIC ACIDS RES, V37, pD773, DOI 10.1093/nar/gkn701; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Kim Y, 2011, METHODS MOL BIOL, V748, P227, DOI 10.1007/978-1-61779-139-0_16; Lam H, 2008, NAT METHODS, V5, P873, DOI 10.1038/NMETH.1254; Leth-Larsen R, 2010, MOL CELL PROTEOMICS, V9, P1369, DOI 10.1074/mcp.R900006-MCP200; Lewandrowski U, 2009, BLOOD, V114, pE10, DOI 10.1182/blood-2009-02-203828; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Mirkowska P, 2013, BLOOD, V121, pE149, DOI 10.1182/blood-2012-11-468702; Moest H, 2013, BBA-MOL CELL BIOL L, V1831, P1208, DOI 10.1016/j.bbalip.2013.04.001; Obermair FJ, 2010, STEM CELL RES, V5, P131, DOI 10.1016/j.scr.2010.05.001; Omasits U, 2013, BIOINFORMATICS; Peirce MJ, 2004, MOL CELL PROTEOMICS, V3, P56, DOI 10.1074/mcp.M300064-MCP200; Picotti P, 2010, NAT METHODS, V7, P43, DOI [10.1038/NMETH.1408, 10.1038/nmeth.1408]; Prior MJ, 2011, J PROTEOME RES, V10, P4970, DOI 10.1021/pr200446r; Roesli C, 2006, NAT PROTOC, V1, P192, DOI 10.1038/nprot.2006.29; Rugg-Gunn PJ, 2012, DEV CELL, V22, P887, DOI 10.1016/j.devcel.2012.01.005; Savas JN, 2011, TRENDS BIOCH SCI; Schmidt A, 2008, MOL CELL PROTEOMICS, V7, P2138, DOI 10.1074/mcp.M700498-MCP200; SCHWAB U, 1982, NATURE, V299, P65, DOI 10.1038/299065a0; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Schwartz SM, 1999, CIRC RES, V84, P1234, DOI 10.1161/01.RES.84.10.1234; Scott SD, 1998, CANCER PRACT, V6, P195, DOI 10.1046/j.1523-5394.1998.006003195.x; Siuti N, 2007, NAT METHODS, V4, P817, DOI 10.1038/NMETH1097; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; Stahl-Zeng J, 2007, MOL CELL PROTEOMICS, V6, P1809, DOI 10.1074/mcp.M700132-MCP200; Sun Y, 2012, ANAL BIOCHEM, V424, P45, DOI 10.1016/j.ab.2012.01.034; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Wollscheid B, 2009, NAT BIOTECHNOL, V27, P378, DOI 10.1038/nbt.1532; Ziegler A, 2011, LUNG CANC IN PRESS; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012; Zola H, 2006, MOL MED, V12, P312, DOI 10.2119/2006-00081.Zola	70	200	202	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0121314	10.1371/journal.pone.0121314	http://dx.doi.org/10.1371/journal.pone.0121314			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894527	Green Published, gold, Green Accepted			2022-12-26	WOS:000353211700009
J	Hattenrath-Lehmann, TK; Marcoval, MA; Mittlesdorf, H; Goleski, JA; Wang, ZH; Haynes, B; Morton, SL; Gobler, CJ				Hattenrath-Lehmann, Theresa K.; Marcoval, Maria A.; Mittlesdorf, Heidi; Goleski, Jennifer A.; Wang, Zhihong; Haynes, Bennie; Morton, Steve L.; Gobler, Christopher J.			Nitrogenous Nutrients Promote the Growth and Toxicity of Dinophysis acuminata during Estuarine Bloom Events	PLOS ONE			English	Article							HARMFUL ALGAL BLOOMS; PROROCENTRUM-LIMA DINOPHYCEAE; DIARRHETIC SHELLFISH TOXINS; OKADAIC ACID; LONG-ISLAND; NEW-YORK; AUREOCOCCUS-ANOPHAGEFFERENS; COCHLODINIUM-POLYKRIKOIDES; PHYTOPLANKTON COMMUNITIES; ALEXANDRIUM-CATENELLA	Diarrhetic Shellfish Poisoning (DSP) is a globally significant human health syndrome most commonly caused by dinoflagellates within the genus Dinophysis. While blooms of harmful algae have frequently been linked to excessive nutrient loading, Dinophysis is a mixotrophic alga whose growth is typically associated with prey availability. Consequently, field studies of Dinophysis and nutrients have been rare. Here, the temporal dynamics of Dinophysis acuminata blooms, DSP toxins, and nutrients (nitrate, ammonium, phosphate, silicate, organic compounds) were examined over four years within two New York estuaries (Meeting-house Creek and Northport Bay). Further, changes in the abundance and toxicity of D. acuminata were assessed during a series of nutrient amendment experiments performed over a three year period. During the study, Dinophysis acuminata blooms exceeding one million cells L-1 were observed in both estuaries. Highly significant (p<0.001) forward step-wise multivariate regression models of ecosystem observations demonstrated that D. acuminata abundances were positively dependent on multiple environmental parameters including ammonium (p = 0.007) while cellular toxin content was positively dependent on ammonium (p = 0.002) but negatively dependent on nitrate (p<0.001). Nitrogen- (N) and phosphorus- (P) containing inorganic and organic nutrients significantly enhanced D. acuminata densities in nearly all (13 of 14) experiments performed. Ammonium significantly increased cell densities in 10 of 11 experiments, while glutamine significantly enhanced cellular DSP content in 4 of 5 experiments examining this compound. Nutrients may have directly or indirectly enhanced D. acuminata abundances as densities of this mixotroph during experiments were significantly correlated with multiple members of the planktonic community (phytoflagellates and Mesodinium). Collectively, this study demonstrates that nutrient loading and more specifically N-loading promotes the growth and toxicity of D. acuminata populations in coastal zones.	[Hattenrath-Lehmann, Theresa K.; Marcoval, Maria A.; Mittlesdorf, Heidi; Goleski, Jennifer A.; Gobler, Christopher J.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Southampton, NY 11794 USA; [Wang, Zhihong; Haynes, Bennie; Morton, Steve L.] NOAA, Natl Ocean Serv, Marine Biotoxins Program, Charleston, SC USA; [Marcoval, Maria A.] Univ Nacl Mar del Plata, Estac Costera JJ Nagera, Dept Ciencias Marinas FCEyN, Mar Del Plata, Buenos Aires, Argentina; [Marcoval, Maria A.] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National University of Mar del Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Gobler, CJ (corresponding author), SUNY Stony Brook, Sch Marine & Atmospher Sci, Southampton, NY 11794 USA.	christopher.gobler@stonybrook.edu			New York State Department of Environmental Conservation, New York Sea Grant [R/CMB-38-NYCT]; NOAA's Monitoring and Event Response to Harmful Algal Blooms (MERHAB) program [NA11NOS4780027]	New York State Department of Environmental Conservation, New York Sea Grant; NOAA's Monitoring and Event Response to Harmful Algal Blooms (MERHAB) program	The authors gratefully acknowledge support from the New York State Department of Environmental Conservation, New York Sea Grant (R/CMB-38-NYCT) and NOAA's Monitoring and Event Response to Harmful Algal Blooms (MERHAB) program (NA11NOS4780027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DM, 2002, ESTUARIES, V25, P704, DOI 10.1007/BF02804901; Anderson DM, 2012, ANNU REV MAR SCI, V4, P143, DOI 10.1146/annurev-marine-120308-081121; Anderson DM, 2008, HARMFUL ALGAE, V8, P39, DOI 10.1016/j.hal.2008.08.017; BOYNTON WR, 1985, MAR ECOL PROG SER, V23, P45, DOI 10.3354/meps023045; BOYNTON WR, 1995, ESTUARIES, V18, P285, DOI 10.2307/1352640; BRZEZINSKI MA, 1985, J PHYCOL, V21, P347; Burgess V, 2001, ENVIRON INT, V27, P275, DOI 10.1016/S0160-4120(01)00058-7; Burkholder JM, 2008, HARMFUL ALGAE, V8, P77, DOI 10.1016/j.hal.2008.08.010; Campbell L, 2010, J PHYCOL, V46, P66, DOI 10.1111/j.1529-8817.2009.00791.x; Collos Y, 2007, HARMFUL ALGAE, V6, P781, DOI 10.1016/j.hal.2007.04.003; Davidson K, 2012, ESTUAR COAST SHELF S, V115, P399, DOI 10.1016/j.ecss.2012.09.019; Deeds JR, 2010, TOXICON, V55, P1138, DOI 10.1016/j.toxicon.2010.01.003; DELMAS D, 1992, MAR ECOL PROG SER, V89, P53, DOI 10.3354/meps089053; DICKEY RW, 1992, TOXICON, V30, P355, DOI 10.1016/0041-0101(92)90877-8; DORTCH Q, 1990, MAR ECOL PROG SER, V61, P183, DOI 10.3354/meps061183; Dyhrman ST, 2003, LIMNOL OCEANOGR, V48, P647, DOI 10.4319/lo.2003.48.2.0647; Freudenthal A, 1988, J SHELLFISH RES, V7, P157; Fux E, 2011, TOXICON, V57, P275, DOI 10.1016/j.toxicon.2010.12.002; Gayoso AM, 2002, J SHELLFISH RES, V21, P461; Gerssen A, 2009, J CHROMATOGR A, V1216, P1421, DOI 10.1016/j.chroma.2008.12.099; GIACOBBE MG, 1995, AQUAT MICROB ECOL, V9, P63, DOI 10.3354/ame009063; Glibert PM, 2006, ECOL STU AN, V189, P163, DOI 10.1007/978-3-540-32210-8_13; Glibert Patricia M., 2005, Oceanography, V18, P136; Glibert PM, 2006, BIOGEOCHEMISTRY, V77, P441, DOI 10.1007/s10533-005-3070-5; Gobler CJ, 2012, HARMFUL ALGAE, V17, P64, DOI 10.1016/j.hal.2012.03.001; Gobler CJ, 2006, ESTUAR COAST SHELF S, V68, P127, DOI 10.1016/j.ecss.2006.02.001; Gobler CJ, 2004, HARMFUL ALGAE, V3, P471, DOI 10.1016/j.hal.2004.06.013; Gobler CJ, 2003, LIMNOL OCEANOGR, V48, P2314, DOI 10.4319/lo.2003.48.6.2314; Gobler CJ, 2001, MAR ECOL PROG SER, V217, P299, DOI 10.3354/meps217299; HALLEGRAEFF GM, 1993, PHYCOLOGIA, V32, P79, DOI 10.2216/i0031-8884-32-2-79.1; Hansen PJ, 2013, HARMFUL ALGAE, V28, P126, DOI 10.1016/j.hal.2013.06.004; Hattenrath TK, 2010, HARMFUL ALGAE, V9, P402, DOI 10.1016/j.hal.2010.02.003; Hattenrath-Lehmann TK, 2013, HARMFUL ALGAE, V26, P33, DOI 10.1016/j.hal.2013.03.005; Heisler J, 2008, HARMFUL ALGAE, V8, P3, DOI 10.1016/j.hal.2008.08.006; Horner RA, 1997, LIMNOL OCEANOGR, V42, P1076, DOI 10.4319/lo.1997.42.5_part_2.1076; Jeong HJ, 2005, AQUAT MICROB ECOL, V40, P133, DOI 10.3354/ame040133; Jin D, 2008, HARMFUL ALGAE, V7, P772, DOI 10.1016/j.hal.2008.03.002; Jin D, 2008, OCEAN COAST MANAGE, V51, P420, DOI 10.1016/j.ocecoaman.2008.01.004; Johansson N, 1996, 7 INT C TOX PHYT; JONES MN, 1984, WATER RES, V18, P643, DOI 10.1016/0043-1354(84)90215-X; Kalaitzis JA, 2010, TOXICON, V56, P244, DOI 10.1016/j.toxicon.2009.09.001; Koch F, 2014, HARMFUL ALGAE, V33, P41, DOI 10.1016/j.hal.2014.01.003; Koch F, 2013, LIMNOL OCEANOGR, V58, P1761, DOI 10.4319/lo.2013.58.5.1761; Koch F, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00363; Koukaras K, 2004, J PLANKTON RES, V26, P445, DOI 10.1093/plankt/fbh042; Lee JS, 1989, J APPL PHYCOL, V1, P147, DOI 10.1007/BF00003877; Maranda L, 2007, HARMFUL ALGAE, V6, P632, DOI 10.1016/j.hal.2006.12.006; Mulholland MR, 2002, LIMNOL OCEANOGR, V47, P1094, DOI 10.4319/lo.2002.47.4.1094; Nagai S, 2011, J PHYCOL, V47, P1326, DOI 10.1111/j.1529-8817.2011.01076.x; Nielsen LT, 2013, HARMFUL ALGAE, V23, P34, DOI 10.1016/j.hal.2012.12.004; Nielsen LT, 2012, MAR ECOL PROG SER, V471, P37, DOI 10.3354/meps10027; Park MG, 2006, AQUAT MICROB ECOL, V45, P101, DOI 10.3354/ame045101; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Quilliam MA, 1991, P 2 CAN WORKSH HARMF; RAO DVS, 1993, MAR ECOL PROG SER, V97, P117; Reguera B, 2014, MAR DRUGS, V12, P394, DOI 10.3390/md12010394; Reguera B, 2012, HARMFUL ALGAE, V14, P87, DOI 10.1016/j.hal.2011.10.016; Seeyave S, 2009, MAR ECOL PROG SER, V379, P91, DOI 10.3354/meps07898; Sjoqvist CO, 2011, J EUKARYOT MICROBIOL, V58, P365, DOI 10.1111/j.1550-7408.2011.00559.x; SMAYDA TJ, 1990, TOXIC MARINE PHYTOPLANKTON, P29; Smith JL, 2012, HARMFUL ALGAE, V19, P125, DOI 10.1016/j.hal.2012.06.008; Souto ML, 2001, TOXICON, V39, P659, DOI 10.1016/S0041-0101(00)00190-2; STEENHUIS TS, 1985, J HYDROL, V79, P145, DOI 10.1016/0022-1694(85)90190-8; Stoecker D, 2006, ECOL STU AN, V189, P177, DOI 10.1007/978-3-540-32210-8_14; Suzuki T, 2003, J CHROMATOGR A, V992, P141, DOI 10.1016/S0021-9673(03)00324-8; Suzuki T, 2011, ANAL SCI, V27, P571, DOI 10.2116/analsci.27.571; Swanson KM, 2010, HARMFUL ALGAE, V9, P190, DOI 10.1016/j.hal.2009.10.001; Tang YZ, 2010, P NATL ACAD SCI USA, V107, P20756, DOI 10.1073/pnas.1009566107; Tango P., 2004, HARMFUL ALGAE 2002, P358; Todd ECD, 1997, REV SCI TECH OIE, V16, P661, DOI 10.20506/rst.16.2.1058; Tong MM, 2011, HARMFUL ALGAE, V10, P254, DOI 10.1016/j.hal.2010.10.005; Townsend DW, 2005, DEEP-SEA RES PT II, V52, P2593, DOI 10.1016/j.dsr2.2005.06.027; Trainer VL, 2013, MAR DRUGS, V11, P1815, DOI 10.3390/md11061815; VALDERRAMA JC, 1981, MAR CHEM, V10, P109, DOI 10.1016/0304-4203(81)90027-X; Van Dolah FM, 2000, ENVIRON HEALTH PERSP, V108, P133, DOI 10.1289/ehp.00108s1133; Vanucci S, 2010, HARMFUL ALGAE, V9, P590, DOI 10.1016/j.hal.2010.04.009; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; Xu J, 2012, HARMFUL ALGAE, V16, P89, DOI 10.1016/j.hal.2012.02.006; Young C, 2013, HYDROGEOL J, V21, P1773, DOI 10.1007/s10040-013-1038-4	79	35	36	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124148	10.1371/journal.pone.0124148	http://dx.doi.org/10.1371/journal.pone.0124148			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894567	gold, Green Published, Green Submitted			2022-12-26	WOS:000353211700076
J	Raczkowska, A; Trzos, J; Lewandowska, O; Nieckarz, M; Brzostek, K				Raczkowska, Adrianna; Trzos, Joanna; Lewandowska, Olga; Nieckarz, Marta; Brzostek, Katarzyna			Expression of the AcrAB Components of the AcrAB-TolC Multidrug Efflux Pump of Yersinia enterocolitica Is Subject to Dual Regulation by OmpR	PLOS ONE			English	Article							MULTIPLE ANTIBIOTIC-RESISTANCE; ESCHERICHIA-COLI; SALMONELLA-ENTERICA; SIGNAL-TRANSDUCTION; SYSTEM; PROTEIN; GENES; TYPHIMURIUM; RAMA; IDENTIFICATION	OmpR is a transcriptional regulator implicated in the control of various cellular processes and functions in Enterobacteriaceae. This study was undertaken to identify genes comprising the OmpR regulon in the human gastrointestinal pathogen Yersinia enterocolitica. Derivatives of an ompR-negative strain with random transposon insertions creating transcriptional fusions with the reporter gene lacZ were isolated. These were supplied with the wild-type ompR allele in trans and then screened for OmpR-dependent changes in beta-galactosidase activity. Using this strategy, five insertions in genes/operons positively regulated by OmpR and two insertions in genes negatively regulated by this protein were identified. Genetic analysis of one of these fusion strains revealed that the gene acrR, encoding transcriptional repressor AcrR is negatively regulated by OmpR. Differential analysis of membrane proteins by SDS-PAGE followed by mass spectrometry identified the protein AcrB, a component of the AcrAB-TolC multidrug efflux pump, as being positively regulated by OmpR. Analysis of the activity of the acrR and acrAB promoters using gfp fusions confirmed their OmpR-dependent repression and activation, respectively. The identification of putative OmpR-binding sites and electrophoretic mobility shift assays confirmed that this regulator binds specifically to both promoter regions with different affinity. Examination of the activity of the acrR and acrAB promoters after the exposure of cells to different chemicals showed that bile salts can act as an OmpR-independent inducer. Taken together, our findings suggest that OmpR positively controls the expression of the AcrAB-TolC efflux pump involved in the adaptive response of Y. enterocolitica O:9 to different chemical stressors, thus conferring an advantage in particular ecological niches.	[Raczkowska, Adrianna; Trzos, Joanna; Lewandowska, Olga; Nieckarz, Marta; Brzostek, Katarzyna] Univ Warsaw, Fac Biol, Inst Microbiol, Dept Appl Microbiol, Warsaw, Poland	University of Warsaw	Raczkowska, A (corresponding author), Univ Warsaw, Fac Biol, Inst Microbiol, Dept Appl Microbiol, Warsaw, Poland.	araczko@biol.uw.edu.pl	Raczkowska, Adrianna/AAJ-2244-2020; Raczkowska, Adrianna/ABD-8025-2020	Raczkowska, Adrianna/0000-0002-4311-1689; Brzostek, Katarzyna/0000-0002-7464-1228; Nieckarz, Marta/0000-0002-3813-4923	National Science Center, Poland [2011/01/B/NZ6/01845]	National Science Center, Poland(National Science Centre, Poland)	This research was supported by a grant from the National Science Center, Poland (grant 2011/01/B/NZ6/01845). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRIGHT LM, 1989, ANNU REV GENET, V23, P311, DOI 10.1146/annurev.ge.23.120189.001523; Bailey AM, 2008, ANTIMICROB AGENTS CH, V52, P3604, DOI 10.1128/AAC.00661-08; Bang IS, 2002, MOL MICROBIOL, V44, P1235, DOI 10.1046/j.1365-2958.2002.02937.x; BERNARDINI ML, 1990, J BACTERIOL, V172, P6274, DOI 10.1128/jb.172.11.6274-6281.1990; Blair JMA, 2009, CURR OPIN MICROBIOL, V12, P512, DOI 10.1016/j.mib.2009.07.003; Bottone EJ, 1997, CLIN MICROBIOL REV, V10, P257, DOI 10.1128/CMR.10.2.257; Brzostek K, 2007, FOLIA MICROBIOL, V52, P73, DOI 10.1007/BF02932142; Brzostek K, 2003, FEMS MICROBIOL LETT, V228, P265, DOI 10.1016/S0378-1097(03)00779-1; Brzostkowska M, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00153; Cameron ADS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002615; Clarke EJ, 2011, BIOTECHNOL BIOENG, V108, P666, DOI 10.1002/bit.22966; DORMAN CJ, 1989, INFECT IMMUN, V57, P2136, DOI 10.1128/IAI.57.7.2136-2140.1989; Dupont M, 2007, ANTIMICROB AGENTS CH, V51, P3190, DOI 10.1128/AAC.01481-06; Egger LA, 1997, GENES CELLS, V2, P167, DOI 10.1046/j.1365-2443.1997.d01-311.x; Fabrega A, 2010, INT J MED MICROBIOL, V300, P457, DOI 10.1016/j.ijmm.2010.02.003; Flamez C, 2008, INT J MED MICROBIOL, V298, P193, DOI 10.1016/j.ijmm.2007.05.005; FORST SA, 1994, RES MICROBIOL, V145, P363, DOI 10.1016/0923-2508(94)90083-3; GALAN JE, 1990, INFECT IMMUN, V58, P1879; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Gueguen E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066615; Huang KJ, 1996, J MOL BIOL, V262, P615, DOI 10.1006/jmbi.1996.0540; Jair KW, 1996, J BACTERIOL, V178, P2507, DOI 10.1128/jb.178.9.2507-2513.1996; Kenney LJ, 2002, CURR OPIN MICROBIOL, V5, P135, DOI 10.1016/S1369-5274(02)00310-7; Lee AK, 2000, J BACTERIOL, V182, P771, DOI 10.1128/JB.182.3.771-781.2000; Li XZ, 2004, DRUGS, V64, P159, DOI 10.2165/00003495-200464020-00004; Ma D, 1996, MOL MICROBIOL, V19, P101, DOI 10.1046/j.1365-2958.1996.357881.x; Miller JH., 1972, EXPT MOL GENETICS; MILLER PF, 1994, ANTIMICROB AGENTS CH, V38, P1773, DOI 10.1128/AAC.38.8.1773; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Nikaido E, 2008, J BIOL CHEM, V283, P24245, DOI 10.1074/jbc.M804544200; Nikaido E, 2011, MICROBIOL-SGM, V157, P648, DOI 10.1099/mic.0.045757-0; Nikaido H, 1996, J BACTERIOL, V178, P5853, DOI 10.1128/jb.178.20.5853-5859.1996; O Croinin T, 2006, MOL MICROBIOL, V62, P869, DOI 10.1111/j.1365-2958.2006.05416.x; PAN WB, 1994, MOL MICROBIOL, V11, P769, DOI 10.1111/j.1365-2958.1994.tb00354.x; Pott AS, 1998, MICROBIOL-SGM, V144, P1881, DOI 10.1099/00221287-144-7-1881; PRATT LA, 1995, MOL MICROBIOL, V17, P565, DOI 10.1111/j.1365-2958.1995.mmi_17030565.x; Putman M, 2000, MICROBIOL MOL BIOL R, V64, P672, DOI 10.1128/MMBR.64.4.672-693.2000; Raczkowska A, 2011, FOLIA MICROBIOL, V56, P313, DOI 10.1007/s12223-011-0054-9; Raczkowska Adrianna, 2004, Polish Journal of Microbiology, V53, P11; Raczkowska A, 2011, FEMS MICROBIOL LETT, V321, P43, DOI 10.1111/j.1574-6968.2011.02308.x; Raczkowska A, 2011, ANTON LEEUW INT J G, V99, P381, DOI 10.1007/s10482-010-9503-8; Randall LP, 2002, RES VET SCI, V72, P87, DOI 10.1053/rvsc.2001.0537; Rentschler AE, 2013, MICROBIOL-SGM, V159, P316, DOI 10.1099/mic.0.059386-0; Robleto EA, 2003, J BACTERIOL, V185, P453, DOI 10.1128/JB.185.2.453-460.2003; Rosenberg EY, 2003, MOL MICROBIOL, V48, P1609, DOI 10.1046/j.1365-2958.2003.03531.x; Rosner BM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-337; RUSSO FD, 1991, J MOL BIOL, V222, P567, DOI 10.1016/0022-2836(91)90497-T; Sambrook J., 2001, MOL CLONING LAB MANU; Schneiders T, 2003, ANTIMICROB AGENTS CH, V47, P2831, DOI 10.1128/AAC.47.9.2831-2837.2003; Schuldiner S, 2006, NATURE, V443, P156, DOI 10.1038/443156b; SIMON R, 1989, GENE, V80, P161, DOI 10.1016/0378-1119(89)90262-X; Skorek K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079525; Stincone A, 2011, NUCLEIC ACIDS RES, V39, P7512, DOI 10.1093/nar/gkr338; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; STRALEY SC, 1995, TRENDS MICROBIOL, V3, P310, DOI 10.1016/S0966-842X(00)88960-X; Udani RA, 2006, ANTIMICROB AGENTS CH, V50, P2971, DOI 10.1128/AAC.00015-06; Zhang WP, 2013, ENVIRON MICROBIOL, V15, P557, DOI 10.1111/1462-2920.12005	59	18	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124248	10.1371/journal.pone.0124248	http://dx.doi.org/10.1371/journal.pone.0124248			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893523	gold, Green Published, Green Submitted			2022-12-26	WOS:000353211700080
J	Rogovskyy, AS; Casselli, T; Tourand, Y; Jones, CR; Owen, JP; Mason, KL; Scoles, GA; Bankhead, T				Rogovskyy, Artem S.; Casselli, Timothy; Tourand, Yvonne; Jones, Cami R.; Owen, Jeb P.; Mason, Kathleen L.; Scoles, Glen A.; Bankhead, Troy			Evaluation of the Importance of VlsE Antigenic Variation for the Enzootic Cycle of Borrelia burgdorferi	PLOS ONE			English	Article							WHITE-FOOTED MICE; LYME-DISEASE SPIROCHETE; OUTER-SURFACE PROTEIN; IXODES-SCAPULARIS TICKS; GENETIC-VARIATION; RESERVOIR COMPETENCE; PROTECTIVE IMMUNITY; LINEAR PLASMID-25; ANTIBODY-RESPONSE; ANIMAL-MODELS	Efficient acquisition and transmission of Borrelia burgdorferi by the tick vector, and the ability to persistently infect both vector and host, are important elements for the life cycle of the Lyme disease pathogen. Previous work has provided strong evidence implicating the significance of the vls locus for B. burgdorferi persistence. However, studies involving vls mutant clones have thus far only utilized in vitro-grown or host-adapted spirochetes and laboratory strains of mice. Additionally, the effects of vls mutation on tick acquisition and transmission has not yet been tested. Thus, the importance of VlsE antigenic variation for persistent infection of the natural reservoir host, and for the B. burgdorferi enzootic life cycle in general, has not been examined to date. In the current work, Ixodes scapularis and Peromyscus maniculatus were infected with different vls mutant clones to study the importance of the vls locus for the enzootic cycle of the Lyme disease pathogen. The findings highlight the significance of the vls system for long-term infection of the natural reservoir host, and show that VlsE antigenic variability is advantageous for efficient tick acquisition of B. burgdorferi from the mammalian reservoir. The data also indicate that the adaptation state of infecting spirochetes influences B. burgdorferi avoidance from host antibodies, which may be in part due to its respective VlsE expression levels. Overall, the current findings provide the most direct evidence on the importance of VlsE for the enzootic cycle of Lyme disease spirochetes, and underscore the significance of VlsE antigenic variation for maintaining B. burgdorferi in nature.	[Rogovskyy, Artem S.; Casselli, Timothy; Tourand, Yvonne; Bankhead, Troy] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Jones, Cami R.; Owen, Jeb P.] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA; [Mason, Kathleen L.; Scoles, Glen A.] Washington State Univ, USDA ARS, Anim Dis Res Unit, Pullman, WA 99164 USA; [Bankhead, Troy] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA	Washington State University; Washington State University; United States Department of Agriculture (USDA); Washington State University; Washington State University	Bankhead, T (corresponding author), Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA.	tbankhead@vetmed.wsu.edu	Bankhead, Troy/V-9033-2019	Bankhead, Troy/0000-0002-4336-0298; Casselli, Timothy/0000-0003-1954-2443; Owen, Jeb/0000-0002-2042-0526	National Institute of Allergy and Infectious Diseases, National Institutes of Health [1R01AI108704]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI108704] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institute of Allergy and Infectious Diseases, National Institutes of Health, grant number 1R01AI108704 to TB (http://www.niaid.nih.gov/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins DR, 1998, J CLIN INVEST, V101, P2240, DOI 10.1172/JCI2325; Alghaferi MY, 2005, J CLIN MICROBIOL, V43, P1879, DOI 10.1128/JCM.43.4.1879-1884.2005; Anderson J F, 1989, Conn Med, V53, P343; ANDERSON JF, 1987, J CLIN MICROBIOL, V25, P1564, DOI 10.1128/JCM.25.8.1564-1566.1987; ANDERSON JF, 1986, ZBL BAKT-INT J MED M, V263, P34; Bankhead T, 2007, MOL MICROBIOL, V65, P1547, DOI 10.1111/j.1365-2958.2007.05895.x; BARTHOLD SW, 1993, INFECT IMMUN, V61, P4955, DOI 10.1128/IAI.61.12.4955-4961.1993; BARTHOLD SW, 1993, INFECT IMMUN, V61, P4696, DOI 10.1128/IAI.61.11.4696-4702.1993; BARTHOLD SW, 1995, LAB INVEST, V72, P127; Baum E, 2012, MBIO, V3, DOI 10.1128/mBio.00434-12; Brisson D, 2004, GENETICS, V168, P713, DOI 10.1534/genetics.104.028738; Brisson D, 2012, ANNU REV GENET, V46, P515, DOI 10.1146/annurev-genet-011112-112140; Bunikis J, 1999, INFECT IMMUN, V67, P2874, DOI 10.1128/IAI.67.6.2874-2883.1999; Coutte L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000293; Crother TR, 2003, INFECT IMMUN, V71, P3419, DOI 10.1128/IAI.71.6.3419-3428.2003; de Silva AM, 1998, J INFECT DIS, V177, P395, DOI 10.1086/514200; DONAHUE JG, 1987, AM J TROP MED HYG, V36, P92, DOI 10.4269/ajtmh.1987.36.92; Elias AF, 2002, INFECT IMMUN, V70, P2139, DOI 10.1128/IAI.70.4.2139-2150.2002; Embers ME, 2012, PATHOGENIC SPIROCHET, P113; FIKRIG E, 1993, PARASITOL TODAY, V9, P129, DOI 10.1016/0169-4758(93)90176-G; Frohlich M, 1986, Arch Geschwulstforsch, V56, P125; Golde WT, 1998, J CLIN MICROBIOL, V36, P1015, DOI 10.1128/JCM.36.4.1015-1019.1998; Grimm D, 2005, J MED ENTOMOL, V42, P676, DOI 10.1603/0022-2585(2005)042[0676:DPRBBB]2.0.CO;2; Grimm D, 2004, INFECT IMMUN, V72, P5938, DOI 10.1128/IAI.72.10.5938-5946.2004; Grimm D, 2004, P NATL ACAD SCI USA, V101, P3142, DOI 10.1073/pnas.0306845101; Guttman DS, 1996, J CLIN MICROBIOL, V34, P652, DOI 10.1128/JCM.34.3.652-656.1996; Herrmann Jean Louis, 1995, Clin Microbiol Infect, V1, P72, DOI 10.1111/j.1469-0691.1995.tb00448.x; Hofmeister EK, 1999, INFECT IMMUN, V67, P5709, DOI 10.1128/IAI.67.11.5709-5716.1999; Hove PR, 2014, INFECT IMMUN, V82, P43, DOI 10.1128/IAI.01061-13; Hovius JW, 2008, J INFECT DIS, V198, P1189, DOI 10.1086/591917; HUGHES CAN, 1992, J CLIN MICROBIOL, V30, P698, DOI 10.1128/JCM.30.3.698-703.1992; Indest KJ, 2001, INFECT IMMUN, V69, P7083, DOI 10.1128/IAI.69.11.7083-7090.2001; JONSSON M, 1995, MICROB PATHOGENESIS, V18, P109, DOI 10.1016/S0882-4010(95)90101-9; Krause PJ, 2006, AM J TROP MED HYG, V75, P1090, DOI 10.4269/ajtmh.2006.75.1090; Kung F, 2013, FUTURE MICROBIOL, V8, P41, DOI [10.2217/FMB.12.121, 10.2217/fmb.12.121]; Labandeira-Rey M, 2001, INFECT IMMUN, V69, P446, DOI 10.1128/IAI.69.1.446-455.2001; Labandeira-Rey M, 2003, INFECT IMMUN, V71, P4608, DOI 10.1128/IAI.71.8.4608-4613.2003; LANE RS, 1991, J MED ENTOMOL, V28, P719, DOI 10.1093/jmedent/28.5.719; Lawrenz MB, 2004, INFECT IMMUN, V72, P6577, DOI 10.1128/IAI.72.11.6577-6585.2004; Liang FT, 2004, INFECT IMMUN, V72, P5759, DOI 10.1128/IAI.72.10.5759-5767.2004; Liang FT, 2002, J EXP MED, V195, P415, DOI 10.1084/jem.20011870; Liveris D, 1999, J CLIN MICROBIOL, V37, P565, DOI 10.1128/JCM.37.3.565-569.1999; Margos G, 2008, P NATL ACAD SCI USA, V105, P8730, DOI 10.1073/pnas.0800323105; Martin F, 2001, CURR OPIN IMMUNOL, V13, P195, DOI 10.1016/S0952-7915(00)00204-1; McDowell JV, 2002, INFECT IMMUN, V70, P4196, DOI 10.1128/IAI.70.8.4196-4203.2002; McKisic MD, 2000, INFECT IMMUN, V68, P5190, DOI 10.1128/IAI.68.9.5190-5197.2000; Nadelman RB, 2007, CLIN INFECT DIS, V45, P1032, DOI 10.1086/521256; Norris SJ, 2006, MOL MICROBIOL, V60, P1319, DOI 10.1111/j.1365-2958.2006.05204.x; Nowakowski J, 1997, ANN INTERN MED, V127, P130, DOI 10.7326/0003-4819-127-2-199707150-00006; Nowakowski J, 2003, AM J MED, V115, P91, DOI 10.1016/S0002-9343(03)00308-5; Ohnishi J, 2003, J BACTERIOL, V185, P4432, DOI 10.1128/JB.185.15.4432-4441.2003; Pal U, 2004, J CLIN INVEST, V113, P220, DOI 10.1172/JCI200419894; PEAVEY CA, 1995, J PARASITOL, V81, P175, DOI 10.2307/3283916; Philipp Mario T., 1994, Trends in Microbiology, V2, P431, DOI 10.1016/0966-842X(94)90800-1; Philipp MT, 2001, J INFECT DIS, V184, P870, DOI 10.1086/323392; Purser JE, 2003, MOL MICROBIOL, V48, P753, DOI 10.1046/j.1365-2958.2003.03452.x; Purser JE, 2000, P NATL ACAD SCI USA, V97, P13865, DOI 10.1073/pnas.97.25.13865; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; RAND PW, 1993, J MED ENTOMOL, V30, P614, DOI 10.1093/jmedent/30.3.614; Rogovskyy AS, 2014, INFECT IMMUN, V82, P4542, DOI 10.1128/IAI.01817-14; Rogovskyy AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061226; SALAZAR JC, 1993, J PEDIATR-US, V122, P591, DOI 10.1016/S0022-3476(05)83541-3; SCHWAN TG, 1989, INFECT IMMUN, V57, P3445, DOI 10.1128/IAI.57.11.3445-3451.1989; Smith RP, 2002, ANN INTERN MED, V136, P421, DOI 10.7326/0003-4819-136-6-200203190-00005; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; Stewart PE, 2006, INFECT IMMUN, V74, P3547, DOI 10.1128/IAI.00158-06; Strother KO, 2005, VECTOR-BORNE ZOONOT, V5, P237, DOI 10.1089/vbz.2005.5.237; Strother KO, 2005, J BACTERIOL, V187, P5776, DOI 10.1128/JB.187.16.5776-5781.2005; Tilly K, 2006, INFECT IMMUN, V74, P3554, DOI 10.1128/IAI.01950-05; Tsao JI, 2009, VET RES, V40, DOI 10.1051/vetres/2009019; Tsao K, 2013, APPL ENVIRON MICROB, V79, P958, DOI 10.1128/AEM.03106-12; Wang GQ, 2003, APPL ENVIRON MICROB, V69, P4561, DOI 10.1128/AEM.69.8.4561-4565.2003; Wang IN, 1999, GENETICS, V151, P15; WEBER K, 1986, INFECTION, V14, P32, DOI 10.1007/BF01644807; WILSKE B, 1993, INFECT IMMUN, V61, P2182, DOI 10.1128/IAI.61.5.2182-2191.1993; Wormser GP, 2003, ANN INTERN MED, V138, P697, DOI 10.7326/0003-4819-138-9-200305060-00005; Xu QL, 2006, INFECT IMMUN, V74, P5177, DOI 10.1128/IAI.00713-06; Zhang JR, 1997, CELL, V89, P275, DOI 10.1016/S0092-8674(00)80206-8; Zhang JR, 1998, INFECT IMMUN, V66, P3689, DOI 10.1128/IAI.66.8.3689-3697.1998; Zhang JR, 1998, INFECT IMMUN, V66, P3698, DOI 10.1128/IAI.66.8.3698-3704.1998	80	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124268	10.1371/journal.pone.0124268	http://dx.doi.org/10.1371/journal.pone.0124268			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893989	Green Submitted, gold, Green Published			2022-12-26	WOS:000353211700083
J	Xu, BS; Xu, HW; Wu, YH; Li, XL; Zhang, Y; Ma, XL; Yang, Q				Xu, Baoshan; Xu, Haiwei; Wu, Yaohong; Li, Xiulan; Zhang, Yang; Ma, Xinlong; Yang, Qiang			Intervertebral Disc Tissue Engineering with Natural Extracellular Matrix-Derived Biphasic Composite Scaffolds	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ANNULUS FIBROSUS CELLS; HUMAN NUCLEUS PULPOSUS; REGENERATION; HYDROGEL; REPLACEMENT; MODEL; TRANSPLANTATION; DEGENERATION	Tissue engineering has provided an alternative therapeutic possibility for degenerative disc diseases. However, we lack an ideal scaffold for IVD tissue engineering. The goal of this study is to fabricate a novel biomimetic biphasic scaffold for IVD tissue engineering and evaluate the feasibility of developing tissue-engineered IVD in vitro and in vivo. In present study we developed a novel integrated biphasic IVD scaffold using a simple freeze-drying and cross-linking technique of pig bone matrix gelatin (BMG) for the outer annulus fibrosus (AF) phase and pig acellular cartilage ECM (ACECM) for the inner nucleus pulposus (NP) phase. Histology and SEM results indicated no residual cells remaining in the scaffold that featured an interconnected porous microstructure (pore size of AF and NP phase 401.4 +/- 13.1 mu m and 231.6 +/- 57.2 mu m, respectively). PKH26-labeled AF and NP cells were seeded into the scaffold and cultured in vitro. SEM confirmed that seeded cells could anchor onto the scaffold. Live/dead staining showed that live cells (green fluorescence) were distributed in the scaffold, with no dead cells (red fluorescence) being found. The cell-scaffold constructs were implanted subcutaneously into nude mice and cultured for 6 weeks in vivo. IVD-like tissue formed in nude mice as confirmed by histology. Cells in hybrid constructs originated from PKH26-labeled cells, as confirmed by in vivo fluorescence imaging system. In conclusion, the study demonstrates the feasibility of developing a tissue-engineered IVD in vivo with a BMG- and ACECM-derived integrated AF-NP biphasic scaffold. As well, PKH26 fluorescent labeling with in vivo fluorescent imaging can be used to track cells and analyse cell-scaffold constructs in vivo.	[Xu, Baoshan; Xu, Haiwei; Wu, Yaohong; Ma, Xinlong; Yang, Qiang] Tianjin Hosp, Dept Minimally Invas Spine Surg, Tianjin 300211, Peoples R China; [Xu, Haiwei; Wu, Yaohong; Yang, Qiang] Tianjin Med Univ, Tianjin 300070, Peoples R China; [Li, Xiulan; Zhang, Yang] Tianjin Hosp, Cell Engn Lab Orthopaed Inst, Tianjin 300211, Peoples R China	Tianjin Medical University	Ma, XL (corresponding author), Tianjin Hosp, Dept Minimally Invas Spine Surg, 406 Jie Fang Nan Rd, Tianjin 300211, Peoples R China.	maxinlong8686@sina.com; yangqiang1980@126.com	yang, qiang/GYJ-0971-2022		National Natural Science Foundation of China [31300798, 31000432, 81272046]; China Postdoctoral Science Foundation [2011M500530, 2012T50235]; Research Foundation of the Tianjin Health Bureau [2013KR16, 2012KY24]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Research Foundation of the Tianjin Health Bureau	This study was supported by the National Natural Science Foundation of China (Nos. 31300798, 31000432 and 81272046), China Postdoctoral Science Foundation funded project (Nos. 2011M500530 and 2012T50235), and the Research Foundation of the Tianjin Health Bureau (Nos. 2013KR16 and 2012KY24). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alini M, 2003, SPINE, V28, P446, DOI 10.1097/00007632-200303010-00007; Blanquer SBG, 2012, J APPL BIOMATER FUNC, V10, P177, DOI 10.5301/JABFM.2012.10354; CASSIDY JJ, 1989, CONNECT TISSUE RES, V23, P75, DOI 10.3109/03008208909103905; Chan LKY, 2013, ACTA BIOMATER, V9, P5262, DOI 10.1016/j.actbio.2012.09.005; Chang G, 2007, EUR SPINE J, V16, P1848, DOI 10.1007/s00586-007-0364-4; Dang JM, 2006, BIOMATERIALS, V27, P406, DOI 10.1016/j.biomaterials.2005.07.033; Devereaux M, 2009, MED CLIN N AM, V93, P477, DOI 10.1016/j.mcna.2008.09.013; Foss BL, 2014, J MECH BEHAV BIOMED, V29, P56, DOI 10.1016/j.jmbbm.2013.08.020; Francisco AT, 2014, ACTA BIOMATER, V10, P1102, DOI 10.1016/j.actbio.2013.11.013; Frith JE, 2013, BIOMATERIALS, V34, P9430, DOI 10.1016/j.biomaterials.2013.08.072; Gorapalli D, 2012, LIFE SCI, V91, P1328, DOI 10.1016/j.lfs.2012.10.014; Gruber Helen E, 2004, Spine J, V4, P44, DOI 10.1016/S1529-9430(03)00425-X; Kim SH, 2011, J BIOMATER SCI POLYM, V29, P31; Lazebnik M, 2011, J TISSUE ENG REGEN M, V5, pE179, DOI 10.1002/term.412; Le Visage C, 2006, SPINE, V31, P2423, DOI 10.1097/01.brs.0000238684.04792.eb; Leone G, 2008, J BIOMED MATER RES A, V84A, P391, DOI 10.1002/jbm.a.31334; Li XD, 2006, BIOMATERIALS, V27, P2426, DOI 10.1016/j.biomaterials.2005.11.040; Mercuri JJ, 2011, J BIOMED MATER RES A, V96A, P422, DOI 10.1002/jbm.a.33001; Mizuno H, 2004, SPINE, V29, P1290, DOI 10.1097/01.BRS.0000128264.46510.27; OEGEMA TR, 1993, CLIN SPORT MED, V12, P419; Park SH, 2012, TISSUE ENG PT A, V18, P447, DOI [10.1089/ten.tea.2011.0195, 10.1089/ten.TEA.2011.0195]; Richardson SM, 2006, BIOMATERIALS, V27, P4069, DOI 10.1016/j.biomaterials.2006.03.017; Saad L, 2004, J BIOMED MATER RES A, V71A, P233, DOI 10.1002/jbm.a.30150; Sakai D, 2003, BIOMATERIALS, V24, P3531, DOI 10.1016/S0142-9612(03)00222-9; Seguin CA, 2004, SPINE, V29, P1299, DOI 10.1097/01.BRS.0000127183.43765.AF; Serigano K, 2010, J ORTHOP RES, V28, P1267, DOI 10.1002/jor.21147; Shao XX, 2007, J BIOMED MATER RES A, V82A, P701, DOI 10.1002/jbm.a.31030; Smith LJ, 2011, DIS MODEL MECH, V4, P31, DOI 10.1242/dmm.006403; Wan YQ, 2008, BIOMATERIALS, V29, P643, DOI 10.1016/j.biomaterials.2007.10.031; Wilke HJ, 2006, EUR SPINE J, V15, pS433, DOI 10.1007/s00586-006-0177-x; Wiltsey C, 2013, J MATER SCI-MATER M, V24, P837, DOI 10.1007/s10856-013-4857-x; Yang Q, 2008, BIOMATERIALS, V29, P2378, DOI 10.1016/j.biomaterials.2008.01.037; Zeng C, 2014, MAT SCI ENG C-MATER, V37, P232, DOI 10.1016/j.msec.2014.01.012; Zhang RY, 2004, MACROMOL BIOSCI, V4, P100, DOI 10.1002/mabi.200300017; Zhuang Y, 2011, BIOCHEM BIOPH RES CO, V407, P327, DOI 10.1016/j.bbrc.2011.03.015	35	25	30	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124774	10.1371/journal.pone.0124774	http://dx.doi.org/10.1371/journal.pone.0124774			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894203	Green Submitted, gold, Green Published			2022-12-26	WOS:000353211700122
J	Zhang, P; Zhong, ZH; Yu, HT; Liu, B				Zhang, Ping; Zhong, Zhi-Hong; Yu, Hao-Tao; Liu, Bin			Significance of Increased Leptin Expression in Osteoarthritis Patients	PLOS ONE			English	Article							RADIOGRAPHIC KNEE OSTEOARTHRITIS; ADIPOKINE LEVELS; SYNOVIAL-FLUID; ASSOCIATION; ADIPONECTIN; PLASMA; HIP; HETEROGENEITY; CARTILAGE; RECEPTOR	Objective Alterations in leptin expression contributes to the progression of various diseases, including cancers. This meta-analysis investigated the clinical significance of leptin levels in osteoarthritis (OA) patients, with the goal of building a leptin-based diagnostic criterion for OA. Method Multiple scientific databases in English and Chinese languages, such as the Cochrane Library Database, CINAHL, Chinese Biomedical (CBM), EMBASE, PubMed, and Web of Science, were exhaustively searched, without any language restrictions, to identify high-quality studies relevant to leptin and OA. Version 12.0 STATA software was used for data analysis. We used odds ratios (OR) and 95% confidence intervals (CI) to test the correlation between serum leptin levels and OA progression. Results A total of 11 clinical studies were finally selected for their high quality and relevance to the topic in this meta-analysis. The 11 case-control studies contained a combined total of 3,625 subjects. The meta-analysis results showed that leptin expression was significantly increased in OA patients, compared with the controls (SMD = 0.87, 95% CI: 0.72-1.02, P < 0.001), and there was also a strong association between leptin expression levels and gender (SMD = 8.55, 95% CI: 4.74-12.35, P < 0.001). In ethnicity-stratified subgroup analysis, all the study populations, irrespective of ethnicity, showed remarkably high leptin expression levels in females and in OA patients (all P < 0.05), compared to their respective counterparts. Conclusion The present study revealed that increased leptin expression levels are associated with disease severity in OA patients, especially among the female OA patients. Based on our results, we propose that leptin level may be a useful biomarker for the assessment of the clinical status in OA patients.	[Zhang, Ping; Zhong, Zhi-Hong; Yu, Hao-Tao] Guangzhou Med Univ, Affiliated Hosp 3, Dept Orthoped, Guangzhou 510000, Guangdong, Peoples R China; [Liu, Bin] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Orthoped, Guangzhou 510000, Guangdong, Peoples R China	Guangzhou Medical University; Sun Yat Sen University	Liu, B (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Orthoped, Guangzhou 510000, Guangdong, Peoples R China.	liubin_1216@126.com						ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Attur M, 2013, CURR OPIN RHEUMATOL, V25, P136, DOI 10.1097/BOR.0b013e32835a9381; Bao JP, 2010, MOL BIOL REP, V37, P3265, DOI 10.1007/s11033-009-9911-x; Bartell SM, 2011, J BONE MINER RES, V26, P1710, DOI 10.1002/jbmr.406; Beekhuizen M, 2013, OSTEOARTHR CARTILAGE, V21, P918, DOI 10.1016/j.joca.2013.04.002; Bohler H, 2010, FERTIL STERIL, V94, P795, DOI 10.1016/j.fertnstert.2009.03.079; Chaganti RK, 2011, CURR REV MUSCULOSKE, V4, P99, DOI 10.1007/s12178-011-9088-5; de Boer TN, 2012, OSTEOARTHR CARTILAGE, V20, P846, DOI 10.1016/j.joca.2012.05.002; Dumond H, 2003, ARTHRITIS RHEUM, V48, P3118, DOI 10.1002/art.11303; Gandhi R, 2010, J ORTHOP RES, V28, P329, DOI 10.1002/jor.21000; Gegout PP, 2008, JOINT BONE SPINE, V75, P669, DOI 10.1016/j.jbspin.2008.07.008; Honsawek S, 2010, ARCH MED RES, V41, P593, DOI 10.1016/j.arcmed.2010.11.007; Issa RI, 2012, PATHOBIOL AGING AGE, V9, DOI DOI 10.3402/PBA.V2I0.17470; Jackson D, 2012, STAT MED, V31, P3805, DOI 10.1002/sim.5453; Jarde T, 2011, EUR J CANCER, V47, P33, DOI 10.1016/j.ejca.2010.09.005; Kajikawa Y, 2011, INT HEART J, V52, P17, DOI 10.1536/ihj.52.17; Karvonen-Gutierrez CA, 2012, OSTEOARTHR CARTILAGE, V20, P614, DOI 10.1016/j.joca.2012.02.644; Karvonen-Gutierrez CA, 2013, ARTHRIT CARE RES, V65, P936, DOI 10.1002/acr.21922; Ku JH, 2009, CLIN RHEUMATOL, V28, P1431, DOI 10.1007/s10067-009-1242-8; Massengale M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047860; Massengale M, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3864; Mutabaruka MS, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2925; Perruccio AV, 2014, J RHEUMATOL, V41, P334, DOI 10.3899/jrheum.130709; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Qin JH, 2010, J HUM GENET, V55, P704, DOI 10.1038/jhg.2010.86; Roemmich JN, 1998, AM J PHYSIOL-ENDOC M, V275, pE543, DOI 10.1152/ajpendo.1998.275.3.E543; Simopoulou T, 2007, OSTEOARTHR CARTILAGE, V15, P872, DOI 10.1016/j.joca.2007.01.018; Sowers MR, 2010, CURR OPIN RHEUMATOL, V22, P533, DOI 10.1097/BOR.0b013e32833b4682; Staikos C, 2013, RHEUMATOLOGY, V52, P1077, DOI 10.1093/rheumatology/kes422; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stannus OP, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3022; Tong KM, 2008, CELL SIGNAL, V20, P1478, DOI 10.1016/j.cellsig.2008.04.003; Vuolteenaho K, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/345838; Wang ZH, 2007, MED INFORM, V20, P1222; Zintzaras E, 2005, BIOINFORMATICS, V21, P3672, DOI 10.1093/bioinformatics/bti536	35	21	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123224	10.1371/journal.pone.0123224	http://dx.doi.org/10.1371/journal.pone.0123224			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893833	Green Published, gold, Green Submitted			2022-12-26	WOS:000353211700030
J	Bai, Y; Zhu, XJ; Chao, J; Zhang, Y; Qian, C; Li, PC; Liu, DF; Han, B; Zhao, L; Zhang, JQ; Buch, S; Teng, GJ; Hu, G; Yao, HH				Bai, Ying; Zhu, Xinjian; Chao, Jie; Zhang, Yuan; Qian, Cheng; Li, Peicheng; Liu, Dongfang; Han, Bing; Zhao, Lei; Zhang, Jianqiong; Buch, Shilpa; Teng, Gaojun; Hu, Gang; Yao, Honghong			Pericytes Contribute to the Disruption of the Cerebral Endothelial Barrier via Increasing VEGF Expression: Implications for Stroke	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; GROWTH-FACTOR; MICROVASCULAR PERICYTES; LEUCINE-ENKEPHALIN; UP-REGULATION; CELLS; INDUCTION; ANGIOGENESIS; RECEPTOR; LEAKAGE	Disruption of the blood-brain barrier (BBB) integrity occurring during the early onset of stroke is not only a consequence of, but also contributes to the further progression of stroke. Although it has been well documented that brain microvascular endothelial cells and astrocytes play a critical role in the maintenance of BBB integrity, pericytes, sandwiched between endothelial cells and astrocytes, remain poorly studied in the pathogenesis of stroke. Our findings demonstrated that treatment of human brain microvascular pericytes with sodium cyanide (NaCN) and glucose deprivation resulted in increased expression of vascular endothelial growth factor (VEGF) via the activation of tyrosine kinase Src, with downstream activation of mitogen activated protein kinase and PI3K/Akt pathways and subsequent translocation of NF-kappa B into the nucleus. Conditioned medium from NaCN-treated pericytes led to increased permeability of endothelial cells, and this effect was significantly inhibited by VEGF-neutralizing antibody. The in vivo relevance of these findings was further corroborated in the stroke model of mice wherein the mice, demonstrated disruption of the BBB integrity and concomitant increase in the expression of VEGF in the brain tissue as well as in the isolated microvessel. These findings thus suggest the role of pericyte-derived VEGF in modulating increased permeability of BBB during stroke. Understanding the regulation of VEGF expression could open new avenues for the development of potential therapeutic targets for stroke and other neurological disease.	[Bai, Ying; Zhu, Xinjian; Zhang, Yuan; Han, Bing; Zhao, Lei] Southeast Univ, Sch Med, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China; [Chao, Jie] Southeast Univ, Dept Physiol, Sch Med, Nanjing, Jiangsu, Peoples R China; [Qian, Cheng; Li, Peicheng; Liu, Dongfang; Teng, Gaojun] Southeast Univ, Dept Radiol, Sch Med, Nanjing, Jiangsu, Peoples R China; [Zhang, Jianqiong] Southeast Univ, Dept Immunol, Sch Med, Nanjing, Jiangsu, Peoples R China; [Buch, Shilpa] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA; [Hu, Gang] Nanjing Med Univ, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China; Southeast University - China; Southeast University - China; University of Nebraska System; University of Nebraska Medical Center; Nanjing Medical University		yaohh@seu.edu.cn	Jie, Chao/J-1004-2019	Jie, Chao/0000-0002-7800-3557; Buch, Shilpa/0000-0002-3103-6685	National Natural Science Foundation of China [81322048]; Award for Jiangsu Specially-Appointed Professor; Major State Basic Research Development Program of China (973 Program) [2013CB733800, 2013CB733803]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062261] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Award for Jiangsu Specially-Appointed Professor; Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the National Natural Science Foundation of China (no. 81322048), Award for Jiangsu Specially-Appointed Professor and the Major State Basic Research Development Program of China (973 Program) (2013CB733800, 2013CB733803). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abumiya T, 1999, J CEREBR BLOOD F MET, V19, P1038, DOI 10.1097/00004647-199909000-00012; Argaw AT, 2012, J CLIN INVEST, V122, P2454, DOI 10.1172/JCI60842; Argaw AT, 2009, P NATL ACAD SCI USA, V106, P1977, DOI 10.1073/pnas.0808698106; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Arumugam TV, 2006, NAT MED, V12, P621, DOI 10.1038/nm1403; Bauer AT, 2010, J CEREBR BLOOD F MET, V30, P837, DOI 10.1038/jcbfm.2009.248; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Chen F, 2007, EUR J RADIOL, V63, P68, DOI 10.1016/j.ejrad.2007.01.005; Cheung WM, 2000, CHINESE J PHYSIOL, V43, P119; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Dohgu S, 2005, BRAIN RES, V1038, P208, DOI 10.1016/j.brainres.2005.01.027; Dore-Duffy P, 2006, J CEREBR BLOOD F MET, V26, P613, DOI 10.1038/sj.jcbfm.9600272; Duan PF, 2014, PHARMAZIE, V69, P70, DOI 10.1691/ph.2014.3655; Engelhardt S, 2014, BRIT J PHARMACOL, V171, P1210, DOI 10.1111/bph.12489; Fernandez-Klett F, 2013, J CEREBR BLOOD F MET, V33, P428, DOI 10.1038/jcbfm.2012.187; Gauberti M, 2013, STROKE, V44, P1988, DOI 10.1161/STROKEAHA.111.000544; Huang YH, 2014, ANGIOGENESIS, V17, P407, DOI 10.1007/s10456-013-9386-1; Kovac A, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-139; Li YN, 2014, J NEUROCHEM, V129, P120, DOI 10.1111/jnc.12611; Liu DF, 2014, NANOSCALE, V6, P15161, DOI 10.1039/c4nr03942d; McColl BW, 2010, J CEREBR BLOOD F MET, V30, P267, DOI 10.1038/jcbfm.2009.217; Melgar MA, 2005, NEUROSURGERY, V56, P571, DOI 10.1227/01.NEU.0000154702.23664.3D; MEYER J, 1991, J NEUROCHEM, V57, P1971, DOI 10.1111/j.1471-4159.1991.tb06411.x; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; Neuhaus W, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00352; Omar HA, 2013, TOXICOL APPL PHARM, V272, P616, DOI 10.1016/j.taap.2013.07.014; Persidsky Y, 2006, J NEUROIMMUNE PHARM, V1, P223, DOI 10.1007/s11481-006-9025-3; Plate KH, 1999, J NEUROPATH EXP NEUR, V58, P654, DOI 10.1097/00005072-199906000-00010; Rose K, 2005, J CELL PHYSIOL, V204, P131, DOI 10.1002/jcp.20283; Shibuya M, 2009, FEBS J, V276, P4636, DOI 10.1111/j.1742-4658.2009.07175.x; Takata F, 2007, CELL MOL NEUROBIOL, V27, P317, DOI 10.1007/s10571-006-9125-x; Takata F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-106; Tang YB, 2014, BRIT J PHARMACOL, V171, P2440, DOI 10.1111/bph.12611; Hernandez-Hernandez OT, 2012, J STEROID BIOCHEM, V132, P127, DOI 10.1016/j.jsbmb.2012.04.005; Thanabalasundaram G, 2011, INT J BIOCHEM CELL B, V43, P1284, DOI 10.1016/j.biocel.2011.05.002; Thanabalasundaram G, 2010, BRAIN RES, V1347, P1, DOI 10.1016/j.brainres.2010.05.096; UMEMURA K, 1993, STROKE, V24, P1077, DOI 10.1161/01.STR.24.7.1077; van Vliet EA, 2007, BRAIN, V130, P521, DOI 10.1093/brain/awl318; Wardlaw JM, 2009, ANN NEUROL, V65, P194, DOI 10.1002/ana.21549; Witmer AN, 2004, J HISTOCHEM CYTOCHEM, V52, P39, DOI 10.1177/002215540405200105; Yao H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5386; Yao HH, 2011, J NEUROSCI, V31, P12449, DOI 10.1523/JNEUROSCI.2330-11.2011; Yao HH, 2011, J NEUROSCI, V31, P5942, DOI 10.1523/JNEUROSCI.5618-10.2011; Yao HH, 2010, BLOOD, V115, P4951, DOI 10.1182/blood-2010-01-266221; Yao Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4413; Yi HW, 2014, J NEUROIMMUNE PHARM, V9, P629, DOI 10.1007/s11481-014-9553-1; Zan L, 2014, NEUROSCIENCE, V262, P118, DOI 10.1016/j.neuroscience.2013.12.060; Zhang YQ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031849, 10.1371/journal.pone.0030262]; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zipser BD, 2007, NEUROBIOL AGING, V28, P977, DOI 10.1016/j.neurobiolaging.2006.05.016; ZLOKOVIC BV, 1989, J NEUROCHEM, V53, P1333, DOI 10.1111/j.1471-4159.1989.tb08522.x; ZLOKOVIC BV, 1987, J NEUROCHEM, V49, P310, DOI 10.1111/j.1471-4159.1987.tb03431.x; ZLOKOVIC BV, 1990, BIOCHIM BIOPHYS ACTA, V1025, P191, DOI 10.1016/0005-2736(90)90097-8; ZLOKOVIC BV, 1995, PHARM RES-DORDR, V12, P1395, DOI 10.1023/A:1016254514167; Zlokovic BV, 1997, NEUROSURGERY, V40, P789, DOI 10.1097/00006123-199704000-00027; ZLOKOVIC BV, 1985, BRAIN RES, V336, P125, DOI 10.1016/0006-8993(85)90423-8	57	57	59	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124362	10.1371/journal.pone.0124362	http://dx.doi.org/10.1371/journal.pone.0124362			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884837	Green Submitted, gold, Green Published			2022-12-26	WOS:000353017000121
J	Grode, KD; Rogers, SL				Grode, Kyle D.; Rogers, Stephen L.			The Non-Catalytic Domains of Drosophila Katanin Regulate Its Abundance and Microtubule-Disassembly Activity	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; SPASTIC PARAPLEGIA; SEVERING PROTEIN; SPINDLE; DYNAMICS; ENZYMES; MOTORS; LIGASE; ATPASE; MEL-26	Microtubule severing is a biochemical reaction that generates an internal break in a microtubule and regulation of microtubule severing is critical for cellular processes such as ciliogenesis, morphogenesis, and meiosis and mitosis. Katanin is a conserved heterodimeric ATPase that severs and disassembles microtubules, but the molecular determinants for regulation of microtubule severing by katanin remain poorly defined. Here we show that the non-catalytic domains of Drosophila katanin regulate its abundance and activity in living cells. Our data indicate that the microtubule-interacting and trafficking (MIT) domain and adjacent linker region of the Drosophila katanin catalytic subunit Kat60 cooperate to regulate microtubule severing in two distinct ways. First, the MIT domain and linker region of Kat60 decrease its abundance by enhancing its proteasome-dependent degradation. The Drosophila katanin regulatory subunit Kat80, which is required to stabilize Kat60 in cells, conversely reduces the proteasome-dependent degradation of Kat60. Second, the MIT domain and linker region of Kat60 augment its microtubule-disassembly activity by enhancing its association with microtubules. On the basis of our data, we propose that the non-catalytic domains of Drosophila katanin serve as the principal sites of integration of regulatory inputs, thereby controlling its ability to sever and disassemble microtubules.	[Grode, Kyle D.; Rogers, Stephen L.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Rogers, Stephen L.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Rogers, Stephen L.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Rogers, SL (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.	srogers@bio.unc.edu			National Institutes of Health (NIH) training grant [T32-HD04639-05]; American Heart Association predoctoral fellowship [11PRE6240000]; NIH [R01-GM081645]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081645] Funding Source: NIH RePORTER	National Institutes of Health (NIH) training grant; American Heart Association predoctoral fellowship(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Institutes of Health (NIH) training grant (T32-HD04639-05) to KDG, by an American Heart Association predoctoral fellowship (11PRE6240000) to KDG, and by a NIH grant (R01-GM081645) to SLR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buster D, 2002, J CELL SCI, V115, P1083; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cox GA, 2000, NAT GENET, V26, P198, DOI 10.1038/79923; Cummings CM, 2009, J BIOL CHEM, V284, P11663, DOI 10.1074/jbc.M809374200; Currie JD, 2011, MOL BIOL CELL, V22, P4343, DOI 10.1091/mbc.E11-06-0520; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Diaz-Valencia JD, 2011, BIOPHYS J, V100, P2440, DOI 10.1016/j.bpj.2011.03.062; Eckert T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050161; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Hartman JJ, 1998, CELL, V93, P277, DOI 10.1016/S0092-8674(00)81578-0; Hartman JJ, 1999, SCIENCE, V286, P782, DOI 10.1126/science.286.5440.782; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Iwaya N, 2010, J BIOL CHEM, V285, P16822, DOI 10.1074/jbc.M110.108365; Loughlin R, 2011, CELL, V147, P1397, DOI 10.1016/j.cell.2011.11.014; Maddika S, 2009, NAT CELL BIOL, V11, P409, DOI 10.1038/ncb1848; Mao CX, 2014, DEVELOPMENT, V141, P1064, DOI 10.1242/dev.097774; MCNALLY FJ, 1993, CELL, V75, P419, DOI 10.1016/0092-8674(93)90377-3; McNally K, 2014, MOL BIOL CELL, V25, P1037, DOI 10.1091/mbc.E13-12-0764; McNally KP, 2011, MOL BIOL CELL, V22, P1550, DOI 10.1091/mbc.E10-12-0951; McNally KP, 2000, J CELL SCI, V113, P1623; Muller-Reichert T, 2010, CELL MOL LIFE SCI, V67, P2195, DOI 10.1007/s00018-010-0324-8; O'Donnell L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002698; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Roll-Mecak A, 2008, NATURE, V451, P363, DOI 10.1038/nature06482; Roll-Mecak A, 2010, CURR OPIN CELL BIOL, V22, P96, DOI 10.1016/j.ceb.2009.11.001; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Sharp DJ, 2012, J CELL SCI, V125, P2561, DOI 10.1242/jcs.101139; Siegrist SE, 2007, GENE DEV, V21, P483, DOI 10.1101/gad.1511207; Smith LB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002697; Srayko M, 2000, GENE DEV, V14, P1072; Stitzel ML, 2006, CURR BIOL, V16, P56, DOI 10.1016/j.cub.2005.11.063; Stoppin-Mellet V, 2007, PLANT PHYSIOL BIOCH, V45, P867, DOI 10.1016/j.plaphy.2007.09.005; TAYLOR J, 2012, ANTIOCH REV, V70, P179, DOI DOI 10.1016/J.JSB.2012.03.002; Whitehead E, 2013, J MOL BIOL, V425, P214, DOI 10.1016/j.jmb.2012.11.022; Wilson KJ, 2012, MOL BIOL CELL, V23, P2623, DOI 10.1091/mbc.E12-01-0055; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; Yang SW, 2013, J NEUROSCI, V33, P12728, DOI 10.1523/JNEUROSCI.0698-13.2013; Yu WQ, 2005, J NEUROSCI, V25, P5573, DOI 10.1523/JNEUROSCI.0834-05.2005; Zhang D, 2007, J CELL BIOL, V177, P231, DOI 10.1083/jcb.200612011; Zhang D, 2011, NAT CELL BIOL, V13, P361, DOI 10.1038/ncb2206	42	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123912	10.1371/journal.pone.0123912	http://dx.doi.org/10.1371/journal.pone.0123912			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886649	Green Published, gold, Green Submitted			2022-12-26	WOS:000353017000095
J	Wolcott, DM; Reitz, RL; Weckerly, FW				Wolcott, Daniel M.; Reitz, Ryan L.; Weckerly, Floyd W.			Biological and Environmental Influences on Parturition Date and Birth Mass of a Seasonal Breeder	PLOS ONE			English	Article							SENSITIVE REPRODUCTIVE ALLOCATION; WHITE-TAILED DEER; BODY-MASS; FITNESS COMPONENTS; CLIMATE-CHANGE; SYNCHRONY; GESTATION; SURVIVAL; SENESCENCE; DYNAMICS	Natal features (e.g. Julian birth date and birth mass) often have fitness consequences and can be influenced by endogenous responses by the mother to seasonal fluctuations in nutritional quality and photoperiodic cues. We sought to further understand the biological and environmental factors that influence the natal features of a polytocous species in an environment with constant nutritional resources and limited seasonal variation. During a 36-year study we assessed the influence of biological factors (maternal age and litter type [ i.e., litter size and sexual composition]) and environmental factors (total precipitation and mean maximum temperature during months encompassing conception, the last trimester of gestation, and the entire length of gestation) on Julian birth date and birth mass using linear-mixed effects models. Linear and quadratic functions of maternal age influenced both natal features with earliest Julian birth dates and heaviest birth masses occurring at prime-age and older individuals, which ranged from 5-9 years of age. Litter type influenced Julian birth date and birth mass. Interestingly, environmental factors affected Julian birth date and birth mass even though mothers were continuously allowed access to a high-quality diet. Random effects revealed considerable variation among mothers and years. This study demonstrates that, in long-lived polytocous species, environmental factors may have a greater influence on natal features than previously supposed and the influence from biological factors is also complex. The documented responses to environmental influences provide unique insights into how mammalian seasonal reproductive dynamics may respond to current changes in climate.	[Wolcott, Daniel M.; Weckerly, Floyd W.] Texas State Univ, Dept Biol, San Marcos, TX 78666 USA; [Reitz, Ryan L.] Texas Parks & Wildlife Dept, Kerr Wildlife Management Area, Hunt, TX USA	Texas State University System; Texas State University San Marcos	Wolcott, DM (corresponding author), Texas State Univ, Dept Biol, San Marcos, TX 78666 USA.	dmw5@txstate.edu			Texas Parks and Wildlife Department; Kerr Wildlife Management Area	Texas Parks and Wildlife Department; Kerr Wildlife Management Area	We thank the Texas Parks and Wildlife Department and Kerr Wildlife Management Area for establishing the Donnie E. Harmel White-tailed Deer Research Facility and for continued funding and support of research at the Kerr Wildlife Management Area. Specifically, we thank Donnie Harmel and Donnie Frels for providing the dataset for these analyses. We also thank the many Texas Parks and Wildlife Department employees, technicians, and volunteers who aided in the collection of this data. We appreciate R. T. Bowyer's and Paul L. Leberg's review of an earlier draft of the manuscript.	Ahrestani FS, 2012, OIKOS, V121, P1300, DOI 10.1111/j.1600-0706.2011.20244.x; Aiken MRE, 2014, CAN J ZOOL, V92, P637, DOI 10.1139/cjz-2013-0232; Bardsen BJ, 2008, ECOLOGY, V89, P829, DOI 10.1890/07-0414.1; Bardsen BJ, 2010, OECOLOGIA, V162, P627, DOI 10.1007/s00442-009-1537-0; Bartoskewitz ML, 2003, WILDLIFE SOC B, V31, P1218; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beier P., 1990, Wildlife Monographs; BERGER J, 1992, ECOLOGY, V73, P323, DOI 10.2307/1938743; Bowyer RT, 1998, J MAMMAL, V79, P1332, DOI 10.2307/1383025; Bronson FH, 2009, PHILOS T R SOC B, V364, P3331, DOI 10.1098/rstb.2009.0140; Bunnell FL, 1982, CAN J ZOOL, V58, P1027; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Churkina G, 1998, ECOSYSTEMS, V1, P206, DOI 10.1007/s100219900016; Clements MN, 2011, FUNCT ECOL, V25, P691, DOI 10.1111/j.1365-2435.2010.01812.x; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; CLUTTONBROCK TH, 1984, AM NAT, V123, P212, DOI 10.1086/284198; CLUTTONBROCK TH, 1983, J ANIM ECOL, V52, P367, DOI 10.2307/4560; Cook JG, 2004, WILDLIFE MONOGR, P1; Cote SD, 2001, OECOLOGIA, V127, P230, DOI 10.1007/s004420000584; Ditchkoff SS, 2011, BIOLOGY AND MANAGEMENT OF WHITE-TAILED DEER, P43; Dye MP, 2012, WILDLIFE SOC B, V36, P107, DOI 10.1002/wsb.98; Festa-Bianchet M, 1996, CAN J ZOOL, V75, P1372; FESTABIANCHET M, 1988, J ZOOL, V214, P653, DOI 10.1111/j.1469-7998.1988.tb03764.x; FestaBianchet M, 1996, CAN J ZOOL, V74, P330, DOI 10.1139/z96-041; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; GAILLARD JM, 1993, J ANIM ECOL, V62, P778; Gilbert BA, 2004, J WILDLIFE MANAGE, V68, P120, DOI 10.2193/0022-541X(2004)068[0120:RDOBDI]2.0.CO;2; GUINNESS FE, 1978, J ANIM ECOL, V47, P817, DOI 10.2307/3673; GUINNESS FE, 1978, J REPROD FERTIL, V54, P325, DOI 10.1530/jrf.0.0540325; Hamel S, 2009, J ANIM ECOL, V78, P143, DOI 10.1111/j.1365-2656.2008.01459.x; Haskell SP, 2008, J MAMMAL, V89, P448, DOI 10.1644/07-MAMM-A-127R.1; Hewison AJM, 2001, J ANIM ECOL, V70, P600, DOI 10.1046/j.1365-2656.2001.00528.x; Holand O, 2004, BEHAV ECOL SOCIOBIOL, V57, P69, DOI 10.1007/s00265-004-0827-0; Korsten P, 2009, BIOL LETTERS, V5, P663, DOI 10.1098/rsbl.2009.0366; Kuhl A, 2007, P ROY SOC B-BIOL SCI, V274, P1293, DOI 10.1098/rspb.2007.0038; Langvatn R, 2004, AM NAT, V163, P763, DOI 10.1086/383594; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Lockwood MA, 2007, J WILDLIFE MANAGE, V71, P2732, DOI 10.2193/2005-517; Loison A, 2005, BEHAV ECOL, V16, P624, DOI 10.1093/beheco/ari037; Mazerolle MJ, 2014, R PACKAGE VERSION 2; Monteith KL, 2014, WILDLIFE MONOGR, V186, P1, DOI 10.1002/wmon.1011; Monteith KL, 2013, J ANIM ECOL, V82, P377, DOI 10.1111/1365-2656.12016; Mysterud A, 2009, J ANIM ECOL, V78, P1002, DOI 10.1111/j.1365-2656.2009.01553.x; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nilsen EB, 2004, J ANIM ECOL, V73, P44, DOI 10.1111/j.1365-2656.2004.00790.x; Nussey DH, 2006, ECOL LETT, V9, P1342, DOI 10.1111/j.1461-0248.2006.00989.x; Nussey DH, 2011, ECOLOGY, V92, P1936, DOI 10.1890/11-0308.1; Parra CA, 2014, CAN J ZOOL, V92, P273, DOI 10.1139/cjz-2013-0201; Pekins PJ, 1998, CAN J ZOOL, V76, P1091, DOI 10.1139/cjz-76-6-1091; Pinheiro J, 2000, MIXED EFFECTS MODELS; Post E, 2003, CAN J ZOOL, V81, P1709, DOI 10.1139/Z03-172; Post E, 2008, PHILOS T R SOC B, V363, P2369, DOI 10.1098/rstb.2007.2207; R Core Team, 2021, R LANGUAGE ENV STAT; RACHLOW JL, 1991, J MAMMAL, V72, P487, DOI 10.2307/1382131; ROBBINS CT, 1975, J WILDLIFE MANAGE, V39, P355, DOI 10.2307/3799914; ROBBINS CT, 1979, AM NAT, V114, P101, DOI 10.1086/283456; ROBINETTE WL, 1973, J WILDLIFE MANAGE, V37, P312, DOI 10.2307/3800121; RUTBERG AT, 1984, J MAMMAL, V65, P418, DOI 10.2307/1381088; Ryan BC, 2002, NEUROSCI BIOBEHAV R, V26, P665, DOI 10.1016/S0149-7634(02)00038-6; Stewart KM, 2005, OECOLOGIA, V143, P85, DOI 10.1007/s00442-004-1785-y; VERME LJ, 1989, J MAMMAL, V70, P438, DOI 10.2307/1381538; VERME LOUIS J., 1965, J WILDLIFE MANAGE, V29, P74, DOI 10.2307/3798633; Weladji RB, 2006, P ROY SOC B-BIOL SCI, V273, P1239, DOI 10.1098/rspb.2005.3393; Weladji RB, 2010, OECOLOGIA, V162, P261, DOI 10.1007/s00442-009-1443-5; Wolcott DM, 2014, J WILDLIFE MANAGE, V78, P1335, DOI 10.1002/jwmg.777; Zerbe P, 2012, BIOL REV, V87, P965, DOI 10.1111/j.1469-185X.2012.00238.x	66	17	17	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124431	10.1371/journal.pone.0124431	http://dx.doi.org/10.1371/journal.pone.0124431			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885545	Green Published, gold, Green Submitted			2022-12-26	WOS:000353017000126
J	He, Y; Wu, AC; Harrington, BS; Davies, CM; Wallace, SJ; Adams, MN; Palmer, JS; Roche, DK; Hollier, BG; Westbrook, TF; Hamidi, H; Konecny, G; Winterhoff, B; Chetty, NP; Crandon, AJ; Oliveira, NB; Shannon, CM; Tinker, AV; Gilks, CB; Coward, JI; Lumley, JW; Perrin, LC; Armes, JE; Hooper, JD				He, Y.; Wu, A. C.; Harrington, B. S.; Davies, C. M.; Wallace, S. J.; Adams, M. N.; Palmer, J. S.; Roche, D. K.; Hollier, B. G.; Westbrook, T. F.; Hamidi, H.; Konecny, G. E.; Winterhoff, B.; Chetty, N. P.; Crandon, A. J.; Oliveira, N. B.; Shannon, C. M.; Tinker, A. V.; Gilks, C. B.; Coward, J. I.; Lumley, J. W.; Perrin, L. C.; Armes, J. E.; Hooper, J. D.			Elevated CDCP1 predicts poor patient outcome and mediates ovarian clear cell carcinoma by promoting tumor spheroid formation, cell migration and chemoresistance	ONCOGENE			English	Article							DOMAIN-CONTAINING PROTEIN-1; SURFACE GLYCOPROTEIN CDCP1; CUB-DOMAIN; ANOIKIS RESISTANCE; SURVIVAL; PROGNOSIS; SRC; IDENTIFICATION; METASTASIS; MECHANISMS	Hematogenous metastases are rarely present at diagnosis of ovarian clear cell carcinoma (OCC). Instead dissemination of these tumors is characteristically via direct extension of the primary tumor into nearby organs and the spread of exfoliated tumor cells throughout the peritoneum, initially via the peritoneal fluid, and later via ascites that accumulates as a result of disruption of the lymphatic system. The molecular mechanisms orchestrating these processes are uncertain. In particular, the signaling pathways used by malignant cells to survive the stresses of anchorage-free growth in peritoneal fluid and ascites, and to colonize remote sites, are poorly defined. We demonstrate that the transmembrane glycoprotein CUB-domain-containing protein 1 (CDCP1) has important and inhibitable roles in these processes. In vitro assays indicate that CDCP1 mediates formation and survival of OCC spheroids, as well as cell migration and chemoresistance. Disruption of CDCP1 via silencing and antibody-mediated inhibition markedly reduce the ability of TOV21G OCC cells to form intraperitoneal tumors and induce accumulation of ascites in mice. Mechanistically our data suggest that CDCP1 effects are mediated via a novel mechanism of protein kinase B (Akt) activation. Immunohistochemical analysis also suggested that CDCP1 is functionally important in OCC, with its expression elevated in 90% of 198 OCC tumors and increased CDCP1 expression correlating with poor patient disease-free and overall survival. This analysis also showed that CDCP1 is largely restricted to the surface of malignant cells where it is accessible to therapeutic antibodies. Importantly, antibody-mediated blockade of CDCP1 in vivo significantly increased the anti-tumor efficacy of carboplatin, the chemotherapy most commonly used to treat OCC. In summary, our data indicate that CDCP1 is important in the progression of OCC and that targeting pathways mediated by this protein may be useful for the management of OCC, potentially in combination with chemotherapies and agents targeting the Akt pathway.	[He, Y.; Wu, A. C.; Harrington, B. S.; Davies, C. M.; Adams, M. N.; Palmer, J. S.; Roche, D. K.; Coward, J. I.; Armes, J. E.; Hooper, J. D.] Univ Queensland, Translat Res Inst, Mater Res Inst, Woolloongabba, Qld, Australia; [Davies, C. M.; Wallace, S. J.; Chetty, N. P.; Crandon, A. J.; Oliveira, N. B.; Shannon, C. M.; Coward, J. I.; Perrin, L. C.; Armes, J. E.] Mater Hlth Serv, South Brisbane, Qld, Australia; [Hollier, B. G.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Woolloongabba, Qld, Australia; [Westbrook, T. F.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Hamidi, H.; Konecny, G. E.] Univ Calif Los Angeles, Los Angeles, CA USA; [Winterhoff, B.] Mayo Clin, Rochester, MN USA; [Tinker, A. V.] British Columbia Canc Agcy, Div Med Oncol, Vancouver Ctr, Vancouver, BC V5Z 4E6, Canada; [Tinker, A. V.] British Columbia Canc Agcy, Cheryl Brown Ovarian Canc Outcomes Unit, Vancouver, BC V5Z 4E6, Canada; [Gilks, C. B.] Univ British Columbia, Vancouver Gen Hosp, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Lumley, J. W.] Wesley Hosp, Auchenflower, Qld, Australia	Mater Research; University of Queensland; Mater Health Services; Queensland University of Technology (QUT); Baylor College of Medicine; University of California System; University of California Los Angeles; Mayo Clinic; British Columbia Cancer Agency; British Columbia Cancer Agency; University of British Columbia; Wesley Hospital	Hooper, JD (corresponding author), Univ Queensland, Translat Res Inst, Canc Biol & Management, Mater Res Inst, 37 Kent St, Woolloongabba, Qld 4102, Australia.	john.hooper@mater.uq.edu.au	Coward, Jermaine/F-2903-2016; Adams, Mark/AAE-1209-2021; Harrington, Brittney/Z-5941-2019; Hooper, John/C-1481-2016; Hamidi, Habib/H-8030-2016; Harrington, Brittney/P-1687-2016; OLIVEIRA, Niara/Y-3471-2018	Coward, Jermaine/0000-0002-2309-9379; Adams, Mark/0000-0003-1906-5018; Harrington, Brittney/0000-0001-7083-069X; Hooper, John/0000-0003-1054-8486; Hamidi, Habib/0000-0003-0196-9852; Harrington, Brittney/0000-0001-7083-069X; Wu, Andy C/0000-0002-0864-4447; Perrin, Lewis/0000-0002-6119-8458; OLIVEIRA, Niara/0000-0001-7103-2200; Davies, Claire/0000-0001-8651-0914; HE, Yaowu/0000-0002-7828-263X; Chetty, Naven/0000-0002-7158-7123	Cancer Council Queensland [614205, 1021827]; Wesley Research Institute grant [2008/06]; MNA; BSH received Australian Post-Graduate Awards; BGH holds a Queensland Government Smart Futures Fund Fellowship; JDH holds Australian Research Council Future Fellowship [FT120100917]	Cancer Council Queensland(Cancer Council Queensland); Wesley Research Institute grant; MNA; BSH received Australian Post-Graduate Awards; BGH holds a Queensland Government Smart Futures Fund Fellowship; JDH holds Australian Research Council Future Fellowship	This work was supported by Cancer Council Queensland grants 614205 and 1021827 and Wesley Research Institute grant 2008/06 to JDH. MNA and BSH received Australian Post-Graduate Awards. BGH holds a Queensland Government Smart Futures Fund Fellowship. JDH holds Australian Research Council Future Fellowship FT120100917.	Adams MN, 2015, ONCOGENE, V34, P1375, DOI 10.1038/onc.2014.88; Al-Barrak J, 2011, GYNECOL ONCOL, V122, P107, DOI 10.1016/j.ygyno.2011.03.011; Alvares SM, 2008, BBA-GEN SUBJECTS, V1780, P486, DOI 10.1016/j.bbagen.2008.01.010; Awakura Y, 2008, J CANCER RES CLIN, V134, P1363, DOI 10.1007/s00432-008-0412-4; Carduner L, 2014, EXP CELL RES, V320, P329, DOI 10.1016/j.yexcr.2013.11.011; Casar B, 2014, ONCOGENE, V33, P255, DOI 10.1038/onc.2012.547; Casar B, 2012, ONCOGENE, V31, P3924, DOI 10.1038/onc.2011.555; Casey RC, 2001, AM J PATHOL, V159, P2071, DOI 10.1016/S0002-9440(10)63058-1; Chan JK, 2008, GYNECOL ONCOL, V109, P370, DOI 10.1016/j.ygyno.2008.02.006; Deryugina EI, 2009, MOL CANCER RES, V7, P1197, DOI 10.1158/1541-7786.MCR-09-0100; Dong Y, 2012, J BIOL CHEM, V287, P9792, DOI 10.1074/jbc.M111.335448; Emerling BM, 2013, P NATL ACAD SCI USA, V110, P3483, DOI 10.1073/pnas.1222435110; Gao WC, 2013, GASTROENTEROLOGY, V145, P636, DOI 10.1053/j.gastro.2013.05.049; Hooper JD, 2003, ONCOGENE, V22, P1783, DOI 10.1038/sj.onc.1206220; Hoskins PJ, 2012, J CLIN ONCOL, V30, P1656, DOI 10.1200/JCO.2011.40.1646; Huang RYJ, 2012, CURR DRUG TARGETS, V13, P1649; Ikeda JI, 2009, CANCER SCI, V100, P429, DOI 10.1111/j.1349-7006.2008.01066.x; Itamochi H, 2002, JPN J CANCER RES, V93, P723, DOI 10.1111/j.1349-7006.2002.tb01312.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kemp Z, 2013, INT J WOMENS HEALTH, V5, P45, DOI 10.2147/IJWH.S30231; Kollmorgen G, 2013, MOL ONCOL, V7, P1142, DOI 10.1016/j.molonc.2013.08.009; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Liu H, 2011, P NATL ACAD SCI USA, V108, P1379, DOI 10.1073/pnas.1017228108; McGovern JA, 2013, BRIT J DERMATOL, V168, P496, DOI 10.1111/bjd.12119; Miyazawa Y, 2010, CANCER RES, V70, P5136, DOI 10.1158/0008-5472.CAN-10-0220; Razorenova OV, 2011, P NATL ACAD SCI USA, V108, P1931, DOI 10.1073/pnas.1011777108; Saga Y, 2008, ONCOL REP, V20, P1299, DOI 10.3892/or_00000144; Siva AC, 2008, CANCER RES, V68, P3759, DOI 10.1158/0008-5472.CAN-07-1657; Smith JA, 2005, GYNECOL ONCOL, V98, P141, DOI 10.1016/j.ygyno.2005.02.006; Spassov DS, 2013, CANCER RES, V73, P1168, DOI 10.1158/0008-5472.CAN-12-2496; Sugiyama T, 2000, CANCER, V88, P2584, DOI 10.1002/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5; Tan DSP, 2013, BRIT J CANCER, V108, P1553, DOI 10.1038/bjc.2013.126; Tan DSP, 2006, LANCET ONCOL, V7, P925, DOI 10.1016/S1470-2045(06)70939-1; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Uekita T, 2007, MOL CELL BIOL, V27, P7649, DOI 10.1128/MCB.01246-07; Wong CH, 2009, CLIN CANCER RES, V15, P2311, DOI 10.1158/1078-0432.CCR-08-2533; Wortmann A, 2011, J BIOL CHEM, V286, P42303, DOI 10.1074/jbc.M111.227462; Wortmann A, 2009, IUBMB LIFE, V61, P723, DOI 10.1002/iub.198; Yu XH, 2008, CANCER SCI, V99, P543, DOI 10.1111/j.1349-7006.2007.00722.x	39	35	36	0	10	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 28	2016	35	4					468	478		10.1038/onc.2015.101	http://dx.doi.org/10.1038/onc.2015.101			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DC2OT	25893298	Green Published, hybrid			2022-12-26	WOS:000369056700007
J	Jochems, A; Yoshida, M				Jochems, Arthur; Yoshida, Motoharu			A Robust In Vivo-Like Persistent Firing Supported by a Hybrid of Intracellular and Synaptic Mechanisms	PLOS ONE			English	Article							SHORT-TERM-MEMORY; HIPPOCAMPAL ACETYLCHOLINE-RELEASE; ANTERIOR CINGULATE CORTEX; SPATIAL WORKING-MEMORY; CA3 PYRAMIDAL CELLS; PREFRONTAL CORTEX; ENTORHINAL CORTEX; CHOLINERGIC MODULATION; AUTOASSOCIATIVE MEMORY; NEURAL ACTIVITY	Persistent firing is believed to support short-term information retention in the brain. Established hypotheses make use of the recurrent synaptic connectivity to support persistent firing. However, this mechanism is known to suffer from a lack of robustness. On the other hand, persistent firing can be supported by an intrinsic cellular mechanism in multiple brain areas. However, the consequences of having both the intrinsic and the synaptic mechanisms (a hybrid model) on persistent firing remain largely unknown. The goal of this study is to investigate whether a hybrid neural network model with these two mechanisms has advantages over a conventional recurrent network based model. Our computer simulations were based on in vitro recordings obtained from hippocampal CA3 pyramidal cells under cholinergic receptor activation. Calcium activated non-specific cationic (CAN) current supported persistent firing in the Hodgkin-Huxley style cellular models. Our results suggest that the hybrid model supports persistent firing within a physiological frequency range over a wide range of different parameters, eliminating parameter sensitivity issues generally recognized in network based persistent firing. In addition, persistent firing in the hybrid model is substantially more robust against distracting inputs, can coexist with theta frequency oscillations, and supports pattern completion.	[Jochems, Arthur; Yoshida, Motoharu] Ruhr Univ Bochum, Int Grad Sch Neurosci, Bochum, Germany; [Yoshida, Motoharu] Ruhr Univ Bochum, Fac Psychol, Mercator Res Grp Struct Memory, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Yoshida, M (corresponding author), Ruhr Univ Bochum, Int Grad Sch Neurosci, Bochum, Germany.	motoharu.yoshida@rub.de			German Research Foundation (DFG) [YO177/4-1]; International Graduate School of Neuroscience at Ruhr-University Bochum	German Research Foundation (DFG)(German Research Foundation (DFG)); International Graduate School of Neuroscience at Ruhr-University Bochum	This work was supported by the German Research Foundation (DFG) project YO177/4-1 and the International Graduate School of Neuroscience at Ruhr-University Bochum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron GB, 2001, SYNAPSE, V42, P199, DOI 10.1002/syn.10004; Acquas E, 1996, J NEUROSCI, V16, P3089; Anagnostaras SG, 2003, NAT NEUROSCI, V6, P51, DOI 10.1038/nn992; [Anonymous], 1998, NEURAL NETWORKS BRAI; Arnold DB, 1997, EXP BRAIN RES, V113, P57, DOI 10.1007/BF02454142; Axmacher N, 2007, J NEUROSCI, V27, P7807, DOI 10.1523/JNEUROSCI.0962-07.2007; Bang SJ, 2009, J NEUROSCI, V29, P4346, DOI 10.1523/JNEUROSCI.0069-09.2009; BENNETT MR, 1994, PHILOS T R SOC B, V343, P167, DOI 10.1098/rstb.1994.0019; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Camperi M, 1998, J COMPUT NEUROSCI, V5, P383, DOI 10.1023/A:1008837311948; COLOMBO M, 1994, BEHAV NEUROSCI, V108, P443, DOI 10.1037/0735-7044.108.3.443; Croxson PL, 2011, NAT NEUROSCI, V14, P1510, DOI 10.1038/nn.2971; DESTEXHE A, 1994, J NEUROPHYSIOL, V72, P803, DOI 10.1152/jn.1994.72.2.803; Disterhoft JF, 1999, LIFE SCI, V64, P541, DOI 10.1016/S0024-3205(98)00599-2; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; Fadda F, 1996, EUR J PHARMACOL, V307, pR1, DOI 10.1016/0014-2999(96)00289-0; Fall CP, 2006, J COMPUT NEUROSCI, V20, P97, DOI 10.1007/s10827-006-4791-8; Farovik A, 2010, LEARN MEMORY, V17, P801, DOI 10.1101/lm.1616209; Fransen E, 2002, J NEUROSCI, V22, P1081, DOI 10.1523/JNEUROSCI.22-03-01081.2002; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; GALIANA HL, 1984, J NEUROPHYSIOL, V51, P210, DOI 10.1152/jn.1984.51.2.210; Gold AE, 2005, HIPPOCAMPUS, V15, P808, DOI 10.1002/hipo.20103; Goldman MS, 2003, CEREB CORTEX, V13, P1185, DOI 10.1093/cercor/bhg095; Griffin AL, 2004, BEHAV NEUROSCI, V118, P403, DOI 10.1037/0735-7044.118.2.403; Griffin AL, 2004, LEARN MEMORY, V11, P604, DOI 10.1101/lm.78404; Gutkin BS, 2001, J COMPUT NEUROSCI, V11, P121, DOI 10.1023/A:1012837415096; Hampson RE, 2004, P NATL ACAD SCI USA, V101, P3184, DOI 10.1073/pnas.0400162101; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; HASSELMO ME, 1995, J NEUROSCI, V15, P5249; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hironaka N, 2001, BRAIN RES, V901, P143, DOI 10.1016/S0006-8993(01)02338-1; Hsieh LT, 2011, J NEUROSCI, V31, P10803, DOI 10.1523/JNEUROSCI.0828-11.2011; Jensen O, 2005, TRENDS NEUROSCI, V28, P67, DOI 10.1016/j.tins.2004.12.001; Jensen O, 1996, LEARN MEMORY, V3, P243, DOI 10.1101/lm.3.2-3.243; Jensen O, 1996, LEARN MEMORY, V3, P257, DOI 10.1101/lm.3.2-3.257; Jochems A, 2013, EUR J NEUROSCI, V38, P2250, DOI 10.1111/ejn.12236; Kinoshita-Kawada M, 2005, PFLUG ARCH EUR J PHY, V450, P345, DOI 10.1007/s00424-005-1419-1; Knauer B, 2013, HIPPOCAMPUS, V23, P820, DOI 10.1002/hipo.22136; Koene RA, 2008, BRAIN RES, V1202, P54, DOI 10.1016/j.brainres.2007.06.067; Koene RA, 2007, CEREB CORTEX, V17, P1766, DOI 10.1093/cercor/bhl088; Kremin T, 2007, NEUROSCIENCE, V149, P760, DOI 10.1016/j.neuroscience.2007.07.007; Kubota K, 1971, J NEUROPHYSIOL; Kuzmiski JB, 2001, J NEUROSCI, V21, P8707, DOI 10.1523/JNEUROSCI.21-22-08707.2001; Lee I, 2002, NAT NEUROSCI, V5, P162, DOI 10.1038/nn790; Leutgeb S, 2007, LEARN MEMORY, V14, P745, DOI 10.1101/lm.703907; Magistretti J, 2004, J NEUROPHYSIOL, V92, P1644, DOI 10.1152/jn.00036.2004; Major G, 2004, CURR OPIN NEUROBIOL, V14, P675, DOI 10.1016/j.conb.2004.10.017; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; McEchron MD, 2003, J NEUROSCI, V23, P1535, DOI 10.1523/JNEUROSCI.23-04-01535.2003; McEchron MD, 2001, J NEUROPHYSIOL, V86, P1839, DOI 10.1152/jn.2001.86.4.1839; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Meyer JJ, 1996, PHYSIOL BEHAV, V60, P1199, DOI 10.1016/S0031-9384(96)00211-9; MILES R, 1986, J PHYSIOL-LONDON, V373, P397, DOI 10.1113/jphysiol.1986.sp016055; Miller EK, 1996, J NEUROSCI, V16, P5154; MIYASHITA Y, 1988, NATURE, V335, P817, DOI 10.1038/335817a0; Navaroli VL, 2012, HIPPOCAMPUS, V22, P1392, DOI 10.1002/hipo.20975; OKANE D, 1992, J PHYS A-MATH GEN, V25, P5055, DOI 10.1088/0305-4470/25/19/018; Papoutsi A, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00161; Phelan KD, 2013, MOL PHARMACOL, V83, P429, DOI 10.1124/mol.112.082271; Pospischil M, 2008, BIOL CYBERN, V99, P427, DOI 10.1007/s00422-008-0263-8; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; Reboreda A, 2011, ADV EXP MED BIOL, V704, P595, DOI 10.1007/978-94-007-0265-3_32; Renart A, 2003, NEURON, V38, P473, DOI 10.1016/S0896-6273(03)00255-1; Schon K, 2004, J NEUROSCI, V24, P11088, DOI 10.1523/JNEUROSCI.3807-04.2004; Schwabedal JTC, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.022715; Seung HS, 1996, P NATL ACAD SCI USA, V93, P13339, DOI 10.1073/pnas.93.23.13339; Seung HS, 2000, NEURON, V26, P259, DOI 10.1016/S0896-6273(00)81155-1; SOLOMON PR, 1986, BEHAV NEUROSCI, V100, P729, DOI 10.1037/0735-7044.100.5.729; Suzuki WA, 1997, J NEUROPHYSIOL, V78, P1062, DOI 10.1152/jn.1997.78.2.1062; Symes A, 2009, NEURAL NETWORKS, V22, P1079, DOI 10.1016/j.neunet.2009.07.017; Tahvildari B, 2007, HIPPOCAMPUS, V17, P257, DOI 10.1002/hipo.20270; Tegner J, 2002, BIOL CYBERN, V87, P471, DOI 10.1007/s00422-002-0363-9; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; Vogt KE, 2001, J NEUROSCI, V21, P75, DOI 10.1523/JNEUROSCI.21-01-00075.2001; Wallenstein GV, 1998, TRENDS NEUROSCI, V21, P317, DOI 10.1016/S0166-2236(97)01220-4; Wang M, 2013, NEURON, V77, P736, DOI 10.1016/j.neuron.2012.12.032; Wang XJ, 1999, J NEUROSCI, V19, P9587; WATANABE T, 1985, BRAIN RES, V325, P241, DOI 10.1016/0006-8993(85)90320-8; Weiss C, 1996, HIPPOCAMPUS, V6, P192, DOI 10.1002/(SICI)1098-1063(1996)6:2<192::AID-HIPO9>3.0.CO;2-R; Wiebe SP, 1997, HIPPOCAMPUS, V7, P656, DOI 10.1002/(SICI)1098-1063(1997)7:6<656::AID-HIPO7>3.0.CO;2-C; WILLSHAW DJ, 1990, PHILOS T R SOC B, V329, P205, DOI 10.1098/rstb.1990.0165; Yoshida M, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00010; Young BJ, 1997, J NEUROSCI, V17, P5183; Zhang ZZ, 2011, HIPPOCAMPUS, V21, P386, DOI 10.1002/hipo.20755; Zhang ZZ, 2010, CEREB CORTEX, V20, P2948, DOI 10.1093/cercor/bhq043; Zhu MX, 2005, PFLUG ARCH EUR J PHY, V451, P105, DOI 10.1007/s00424-005-1427-1	86	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123799	10.1371/journal.pone.0123799	http://dx.doi.org/10.1371/journal.pone.0123799			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901969	gold, Green Published, Green Submitted			2022-12-26	WOS:000353331500063
J	Nakajima, R; Yamamoto, H; Kawagucci, S; Takaya, Y; Nozaki, T; Chen, C; Fujikura, K; Miwa, T; Takai, K				Nakajima, Ryota; Yamamoto, Hiroyuki; Kawagucci, Shinsuke; Takaya, Yutaro; Nozaki, Tatsuo; Chen, Chong; Fujikura, Katsunori; Miwa, Tetsuya; Takai, Ken			Post-Drilling Changes in Seabed Landscape and Megabenthos in a Deep-Sea Hydrothermal System, the Iheya North Field, Okinawa Trough	PLOS ONE			English	Article							FAROE-SHETLAND CHANNEL; HYDRAULIC CONDUCTIVITY; BENTHIC COMMUNITIES; VENTS; ASSEMBLAGES; DISTURBANCE; CHEMISTRY; ECOSYSTEM; IMPACTS; ECOLOGY	There has been an increasing interest in seafloor exploitation such as mineral mining in deep-sea hydrothermal fields, but the environmental impact of anthropogenic disturbance to the seafloor is poorly known. In this study, the effect of such anthropogenic disturbance by scientific drilling operations (IODP Expedition 331) on seabed landscape and megafaunal habitation was surveyed for over 3 years using remotely operated vehicle video observation in a deep-sea hydrothermal field, the Iheya North field, in the Okinawa Trough. We focused on observations from a particular drilling site (Site C0014) where the most dynamic change of landscape and megafaunal habitation was observed among the drilling sites of IODP Exp. 331. No visible hydrothermal fluid discharge had been observed at the sedimentary seafloor at Site C0014, where Calyptogena clam colonies were known for more than 10 years, before the drilling event. After drilling commenced, the original Calyptogena colonies were completely buried by the drilling deposits. Several months after the drilling, diffusing high-temperature hydrothermal fluid began to discharge from the sedimentary subseafloor in the area of over 20 m from the drill holes, 'artificially' creating a new hydrothermal vent habitat. Widespread microbial mats developed on the seafloor with the diffusing hydrothermal fluids and the galatheid crab Shinkaia crosnieri endemic to vents dominated the new vent community. The previously soft, sedimentary seafloor was hardened probably due to barite/gypsum mineralization or silicification, becoming rough and undulated with many fissures after the drilling operation. Although the effects of the drilling operation on seabed landscape and megafaunal composition are probably confined to an area of maximally 30 m from the drill holes, the newly established hydrothermal vent ecosystem has already lasted 2 years and is like to continue to exist until the fluid discharge ceases and thus the ecosystem in the area has been altered for long-term.	[Nakajima, Ryota; Fujikura, Katsunori] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Dept Marine Biodivers Res, Yokosuka, Kanagawa 2370061, Japan; [Yamamoto, Hiroyuki; Kawagucci, Shinsuke; Takaya, Yutaro; Nozaki, Tatsuo; Miwa, Tetsuya; Takai, Ken] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Res & Dev Ctr Submarine Resources, Yokosuka, Kanagawa 2370061, Japan; [Kawagucci, Shinsuke; Takai, Ken] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Lab Ocean Earth Life Evolut Res OELE, Yokosuka, Kanagawa 2370061, Japan; [Kawagucci, Shinsuke; Takai, Ken] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Dept Subsurface Geobiol Anal & Res D SUGAR, Yokosuka, Kanagawa 2370061, Japan; [Nozaki, Tatsuo] Univ Tokyo, Sch Engn, Dept Syst Innovat, Bunkyo Ku, Tokyo 1138656, Japan; [Chen, Chong] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Miwa, Tetsuya] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Marine Technol & Engn Ctr MARITEC, Yokosuka, Kanagawa 2370061, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of Tokyo; University of Oxford; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Nakajima, R (corresponding author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Dept Marine Biodivers Res, 2-15 Natsushima, Yokosuka, Kanagawa 2370061, Japan.	nakajimar@jamstec.go.jp	kawagucci, shinsuke/H-6047-2013; Kawagucci, Shinsuke/O-7813-2019; Chen, Chong/F-7489-2019	kawagucci, shinsuke/0000-0002-7807-024X; Chen, Chong/0000-0002-5035-4021; Nozaki, Tatsuo/0000-0001-6523-6231; Takaya, Yutaro/0000-0003-4046-6780	Environment Research and Technology Development Fund (S9) of the Ministry of the Environment, Japan	Environment Research and Technology Development Fund (S9) of the Ministry of the Environment, Japan	RN acknowledges the Environment Research and Technology Development Fund (S9) of the Ministry of the Environment, Japan (http://s9.conservationecology.asia). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEELE W V, 1986, Nuclear and Chemical Waste Management, V6, P81, DOI 10.1016/0191-815X(86)90091-4; Arellano SM, 2010, MAR ECOL PROG SER, V414, P131, DOI 10.3354/meps08717; BLOUNT CW, 1969, GEOCHIM COSMOCHIM AC, V33, P227, DOI 10.1016/0016-7037(69)90140-9; BLOUNT CW, 1977, AM MINERAL, V62, P942; Boschen RE, 2013, OCEAN COAST MANAGE, V84, P54, DOI 10.1016/j.ocecoaman.2013.07.005; Copley JTP, 1999, MAR ECOL-P S Z N I, V20, P291, DOI 10.1046/j.1439-0485.1999.2034076.x; Currie DR, 2005, MAR ENVIRON RES, V59, P217, DOI 10.1016/j.marenvres.2004.05.001; Dattagupta S, 2004, LIMNOL OCEANOGR, V49, P1144, DOI 10.4319/lo.2004.49.4.1144; Dumas P, 2009, J EXP MAR BIOL ECOL, V368, P161, DOI 10.1016/j.jembe.2008.10.002; Fujikura K., 2008, DEEP SEA LIFE BIOL O; Gates AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044114; Glover AG, 2003, ENVIRON CONSERV, V30, P219, DOI 10.1017/S0376892903000225; Jannasch H.W., 1995, GEOPHYS MONOGR SER, V91, P273, DOI DOI 10.1029/GM091P0273; Jones DOB, 2007, MAR BIOL, V151, P1731, DOI 10.1007/s00227-007-0606-3; Jones DOB, 2007, DEEP-SEA RES PT I, V54, P1111, DOI 10.1016/j.dsr.2007.04.001; Jones DOB, 2012, MAR ECOL PROG SER, V461, P71, DOI 10.3354/meps09827; Jones DOB, 2012, J MAR BIOL ASSOC UK, V92, P245, DOI 10.1017/S0025315411001123; Kawagucci S, 2013, GEOCHEM GEOPHY GEOSY, V14, P4774, DOI 10.1002/2013GC004895; Kawagucci S, 2011, GEOCHEM J, V45, P109; KENNEY TC, 1992, CAN GEOTECH J, V29, P364, DOI 10.1139/t92-042; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Mengerink KJ, 2014, SCIENCE, V344, P696, DOI 10.1126/science.1251458; MOHAMEDEEN H, 1989, J EXP MAR BIOL ECOL, V134, P1, DOI 10.1016/0022-0981(90)90053-F; Nakagawa S, 2005, FEMS MICROBIOL ECOL, V54, P141, DOI 10.1016/j.femsec.2005.03.007; Nakajima R, 2014, JAMSTEC REP RES DVE, V19, P59, DOI DOI 10.5918/JAMSTECR.19.59; Nakajima R, 2014, DIVERS DISTRIB, V20, P1160, DOI 10.1111/ddi.12204; Okoshi Kenji, 2003, Japanese Journal of Benthology, V58, P77; Rogers AD, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001234; Shank TM, 1998, DEEP-SEA RES PT II, V45, P465, DOI 10.1016/S0967-0645(97)00089-1; Sivapullaiah PV, 2000, CAN GEOTECH J, V37, P406, DOI 10.1139/cgj-37-2-406; Smith W. F., 2006, FDN MAT SCI ENG; Takai K., 2011, P IODP, DOI [10.2204/iodp.proc.331.2011, DOI 10.2204/IODP.PROC.331.2011]; Takai K, 2012, SCI DRILL, V13, P19, DOI 10.5194/sd-13-19-2012; Tokeshi M, 2011, J OCEANOGR, V67, P651, DOI 10.1007/s10872-011-0065-9; Trannum HC, 2010, J EXP MAR BIOL ECOL, V383, P111, DOI 10.1016/j.jembe.2009.12.004; Tsuji T, 2012, J VOLCANOL GEOTH RES, V213, P41, DOI 10.1016/j.jvolgeores.2011.11.007; TUNNICLIFFE V, 1992, AM SCI, V80, P336; TUNNICLIFFE V, 1991, OCEANOGR MAR BIOL, V29, P319; Ueno H, 2003, JAMSTEC J DEEP SEA R, V22, P49; Van Dover C., 2011, ENV MANAGEMENT DEEP; Van Dover CL, 2012, MAR POLICY, V36, P378, DOI 10.1016/j.marpol.2011.07.002; Van Dover CL, 2014, MAR ENVIRON RES, V102, P59, DOI 10.1016/j.marenvres.2014.03.008; Watanabe H, 2010, TOP GEOBIOL, V33, P379, DOI 10.1007/978-90-481-9572-5_12	43	28	28	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123095	10.1371/journal.pone.0123095	http://dx.doi.org/10.1371/journal.pone.0123095			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902075	Green Submitted, Green Published, gold			2022-12-26	WOS:000353331500041
J	Xu, Y; Furutani, S; Ihara, M; Ling, Y; Yang, XY; Kai, K; Hayashi, H; Matsuda, K				Xu, Yan; Furutani, Shogo; Ihara, Makoto; Ling, Yun; Yang, Xinling; Kai, Kenji; Hayashi, Hideo; Matsuda, Kazuhiko			Meroterpenoid Chrodrimanins Are Selective and Potent Blockers of Insect GABA-Gated Chloride Channels	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; TALAROMYCES SP; RECEPTOR; RESISTANCE; DIELDRIN; NEONICOTINOIDS; IDENTIFICATION; OOCYTES; YO-2	Meroterpenoid chrodrimanins, produced from Talaromyces sp. YO-2, are known to paralyze silkworm (Bombyx mori) larvae, but their target is unknown. We have investigated the actions of chrodrimanin B on ligand-gated ion channels of silkworm larval neurons using patch-clamp electrophysiology. Chrodrimanin B had no effect on membrane currents when tested alone at 1 mu M. However, it completely blocked the.-aminobutyric acid (GABA)-induced current and showed less pronounced actions on acetylcholine-and L-glutamate-induced currents, when delivered at 1 mu M for 1 min prior to co-application with transmitter GABA. Thus, chrodrimanins were also tested on a wild-type isoform of the B. mori GABA receptor (GABAR) RDL using two-electrode voltage-clamp electrophysiology. Chrodrimanin B attenuated the peak current amplitude of the GABA response of RDL with an IC50 of 1.66 nM. The order of the GABAR-blocking potency of chrodrimanins B > D > A was in accordance with their reported insecticidal potency. Chrodrimanin B had no open channel blocking action when tested at 3 nM on the GABA response of RDL. Co-application with 3 nM chrodrimanin B shifted the GABA concentration response curve to a higher concentration and further increase of chrodrimanin B concentration to10 nM; it reduced maximum current amplitude of the GABA response, pointing to a high-affinity competitive action and a lower affinity non-competitive action. The A282S; T286V double mutation of RDL, which impairs the actions of fipronil, hardly affected the blocking action of chrodrimanin B, indicating a binding site of chrodrimanin B distinct from that of fipronil. Chrodrimanin B showed approximately 1,000-fold lower blocking action on human alpha 1 beta 2 gamma 2 GABAR compared to RDL and thus is a selective blocker of insect GABARs.	[Xu, Yan; Ling, Yun; Yang, Xinling] China Agr Univ, Coll Sci, Dept Appl Chem, Beijing 100193, Peoples R China; [Furutani, Shogo; Ihara, Makoto; Matsuda, Kazuhiko] Kinki Univ, Fac Agr, Dept Appl Biol Chem, Nara 6318505, Japan; [Kai, Kenji; Hayashi, Hideo] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Naka Ku, Sakai, Osaka 5998531, Japan	China Agricultural University; Kindai University (Kinki University); Osaka Metropolitan University	Matsuda, K (corresponding author), Kinki Univ, Fac Agr, Dept Appl Biol Chem, 3327-204 Nakamachi, Nara 6318505, Japan.	kmatsuda@nara.kindai.ac.jp	Matsuda, Kazuhiko/AAX-4926-2020; Yang, xinling/HHC-1621-2022; Hayashi, Hideo/AAI-1910-2020; Ihara, Makoto/Q-7204-2016	Kai, Kenji/0000-0002-4036-9959; Ihara, Makoto/0000-0002-6403-0781	JSPS [21310147, 26292031]; MEXT [S1101035]; China Scholarship Council [201206350101]; National Natural Science Foundation of China [21272266]; Grants-in-Aid for Scientific Research [26292031] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); China Scholarship Council(China Scholarship Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	KM was supported in part by JSPS KAKENHI Grant Numbers 21310147, 26292031 and MEXT Strategic Project to Support the Formation of Research Bases at Private Universities: Matching Fund Subsidy Grant Number S1101035. YX was supported by the China Scholarship Council File Number 201206350101. YL was supported by the National Natural Science Foundation of China Grant Number 21272266.	AKAIKE N, 1985, EXPERIENTIA, V41, P70; CHYB S, 1995, J CHEM ECOL, V21, P313, DOI 10.1007/BF02036720; FFRENCHCONSTANT RH, 1993, NATURE, V363, P449, DOI 10.1038/363449a0; FFRENCHCONSTANT RH, 1991, P NATL ACAD SCI USA, V88, P7209, DOI 10.1073/pnas.88.16.7209; Gisselmann G, 2002, NAT NEUROSCI, V5, P11, DOI 10.1038/nn787; HARDIE RC, 1989, NATURE, V339, P704, DOI 10.1038/339704a0; Hayashi H, 2012, BIOSCI BIOTECH BIOCH, V76, P1765, DOI 10.1271/bbb.120365; Hayashi H, 2012, BIOSCI BIOTECH BIOCH, V76, P745, DOI 10.1271/bbb.110858; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hirata K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018354; Hosie AM, 1996, BRIT J PHARMACOL, V119, P1577, DOI 10.1111/j.1476-5381.1996.tb16075.x; HOSIE AM, 1995, BRAIN RES, V693, P257, DOI 10.1016/0006-8993(95)00605-P; Ihara M, 2003, NEUROPHARMACOLOGY, V45, P133, DOI 10.1016/S0028-3908(03)00134-5; Kuriyama T, 2005, PESTIC BIOCHEM PHYS, V81, P176, DOI 10.1016/j.pestbp.2004.11.008; Kuriyama T, 2002, BIOORGAN MED CHEM, V10, P1873, DOI 10.1016/S0968-0896(02)00011-1; Liu GY, 2014, BIOORGAN MED CHEM, V22, P4637, DOI 10.1016/j.bmc.2014.07.021; Matsuda K, 1999, BRIT J PHARMACOL, V127, P1305, DOI 10.1038/sj.bjp.0702663; NAGATA K, 1994, J PHARMACOL EXP THER, V269, P164; Nakao T, 2013, INSECT BIOCHEM MOLEC, V43, P366, DOI 10.1016/j.ibmb.2013.02.002; Schnizler K, 2005, J BIOL CHEM, V280, P16254, DOI 10.1074/jbc.M411759200; Shimomura M, 2006, MOL PHARMACOL, V70, P1255, DOI 10.1124/mol.106.026815; SHIRAI Y, 1995, NEUROSCI LETT, V189, P1, DOI 10.1016/0304-3940(95)11432-V; Zheng YC, 2002, J BIOL CHEM, V277, P2000, DOI 10.1074/jbc.M107635200	24	21	31	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0122629	10.1371/journal.pone.0122629	http://dx.doi.org/10.1371/journal.pone.0122629			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902139	Green Published, gold, Green Submitted			2022-12-26	WOS:000353331500025
J	Kizil, C; Iltzsche, A; Thomas, AK; Bhattarai, P; Zhang, YX; Brand, M				Kizil, Caghan; Iltzsche, Anne; Thomas, Alvin Kuriakose; Bhattarai, Prabesh; Zhang, Yixin; Brand, Michael			Efficient Cargo Delivery into Adult Brain Tissue Using Short Cell-Penetrating Peptides	PLOS ONE			English	Article							END-RULE PEPTIDES; NEUROGENESIS; PROTEIN; MECHANISMS; EXPRESSION; BINDING; SIRNA; RNA	Zebrafish brains can regenerate lost neurons upon neurogenic activity of the radial glial progenitor cells (RGCs) that reside at the ventricular region. Understanding the molecular events underlying this ability is of great interest for translational studies of regenerative medicine. Therefore, functional analyses of gene function in RGCs and neurons are essential. Using cerebroventricular microinjection (CVMI), RGCs can be targeted efficiently but the penetration capacity of the injected molecules reduces dramatically in deeper parts of the brain tissue, such as the parenchymal regions that contain the neurons. In this report, we tested the penetration efficiency of five known cell-penetrating peptides (CPPs) and identified two-polyR and Trans - that efficiently penetrate the brain tissue without overt toxicity in a dose-dependent manner as determined by TUNEL staining and L-Plastin immunohistochemistry. We also found that polyR peptide can help carry plasmid DNA several cell diameters into the brain tissue after a series of coupling reactions using DBCO-PEG4-maleimide-based Michael's addition and azide-mediated copper-free click reaction. Combined with the advantages of CVMI, such as rapidness, reproducibility, and ability to be used in adult animals, CPPs improve the applicability of the CVMI technique to deeper parts of the central nervous system tissues.	[Kizil, Caghan; Bhattarai, Prabesh] German Ctr Neurodegenerat Dis DZNE Dresden Helmho, D-01307 Dresden, Germany; [Kizil, Caghan; Iltzsche, Anne; Brand, Michael] Tech Univ Dresden, DFG Ctr Regenerat Therapies Dresden CRTD Cluster, D-01307 Dresden, Germany; [Thomas, Alvin Kuriakose; Zhang, Yixin] Tech Univ Dresden, Ctr Mol Bioengn, B CUBE, D-01307 Dresden, Germany; [Brand, Michael] Tech Univ Dresden, Ctr Biotechnol, D-01307 Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden	Brand, M (corresponding author), Tech Univ Dresden, DFG Ctr Regenerat Therapies Dresden CRTD Cluster, Fetscherstr 105, D-01307 Dresden, Germany.	michael.brand@biotec.tu-dresden.de	Kizil, Caghan/AFG-2073-2022; Kizil, Caghan/J-6923-2015; Brand, Michael/A-5509-2010; Thomas, Alvin Kuriakose/I-7638-2018	Kizil, Caghan/0000-0002-8164-9762; Kizil, Caghan/0000-0002-8164-9762; Brand, Michael/0000-0001-5711-6512; Thomas, Alvin Kuriakose/0000-0002-8544-4983; Bhattarai, Prabesh/0000-0003-2991-5514	Deutsche Forschungsgemeinschaft [SFB-655-A3]; European Union (Zf-Health); Technische Universitat Dresden; German Centre for Neurodegenerative Diseases (DZNE) within Helmholtz Association; Leibniz Association [SAW-2011-IPF-2]; BMBF BioLithoMorphie project [03Z2E511]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union (Zf-Health); Technische Universitat Dresden; German Centre for Neurodegenerative Diseases (DZNE) within Helmholtz Association; Leibniz Association; BMBF BioLithoMorphie project(Federal Ministry of Education & Research (BMBF))	This work was supported by Deutsche Forschungsgemeinschaft (SFB-655-A3), The European Union (Zf-Health), and Technische Universitat Dresden (AI, CK, MB), German Centre for Neurodegenerative Diseases (DZNE) within Helmholtz Association (CK), and Leibniz Association (SAW-2011-IPF-2 project) and BMBF BioLithoMorphie project 03Z2E511 (AKT, YZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolf B, 2006, DEV BIOL, V295, P278, DOI 10.1016/j.ydbio.2006.03.023; Brand Michael, 2002, P7; Cardozo AK, 2007, BBA-BIOMEMBRANES, V1768, P2222, DOI 10.1016/j.bbamem.2007.06.003; Chapouton P, 2010, METHOD CELL BIOL, V100, P73, DOI 10.1016/B978-0-12-384892-5.00004-9; Dietz GPH, 2004, MOL CELL NEUROSCI, V27, P85, DOI 10.1016/j.mcn.2004.03.005; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Gros E, 2006, BBA-BIOMEMBRANES, V1758, P384, DOI 10.1016/j.bbamem.2006.02.006; Hans S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004640; Heitz F, 2009, BRIT J PHARMACOL, V157, P195, DOI 10.1111/j.1476-5381.2009.00057.x; Jarver P, 2013, MOL THER-NUCL ACIDS, V1, pe27; Jewett JC, 2010, CHEM SOC REV, V39, P1272, DOI 10.1039/b901970g; Jones SW, 2005, BRIT J PHARMACOL, V145, P1093, DOI 10.1038/sj.bjp.0706279; Juliano R, 2008, NUCLEIC ACIDS RES, V36, P4158, DOI 10.1093/nar/gkn342; Kizil C, 2013, JOVE-J VIS EXP, DOI 10.3791/50415; Kizil C, 2012, DEV CELL, V23, P1230, DOI 10.1016/j.devcel.2012.10.014; Kizil C, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-27; Kizil C, 2012, DEV NEUROBIOL, V72, P429, DOI 10.1002/dneu.20918; Kizil C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027395; Knopf F, 2010, P NATL ACAD SCI USA, V107, P19933, DOI 10.1073/pnas.1007799107; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X; Kyritsis N, 2012, SCIENCE, V338, P1353, DOI 10.1126/science.1228773; Lindgren M, 2011, METHODS MOL BIOL, V683, P3, DOI 10.1007/978-1-60761-919-2_1; Malesevic M, 2010, ANGEW CHEM INT EDIT, V49, P213, DOI 10.1002/anie.200904529; Mende F, 2011, ANGEW CHEM INT EDIT, V50, P1232, DOI 10.1002/anie.201005180; Muratovska A, 2004, FEBS LETT, V558, P63, DOI 10.1016/S0014-5793(03)01505-9; Nitin N, 2004, J BIOL INORG CHEM, V9, P706, DOI 10.1007/s00775-004-0560-1; Pantos A, 2008, BBA-BIOMEMBRANES, V1778, P811, DOI 10.1016/j.bbamem.2007.12.003; Rothenaigner I, 2011, DEVELOPMENT, V138, P1459, DOI 10.1242/dev.058156; ROY S, 1990, GENE DEV, V4, P1365, DOI 10.1101/gad.4.8.1365; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Snyder Eric L, 2005, Expert Opin Drug Deliv, V2, P43, DOI 10.1517/17425247.2.1.43; Strassberger V, 2010, PROTEOMICS, V10, P3544, DOI 10.1002/pmic.201000308; Teesalu T, 2009, P NATL ACAD SCI USA, V106, P16157, DOI 10.1073/pnas.0908201106; Torchilin VP, 2008, BIOPOLYMERS, V90, P604, DOI 10.1002/bip.20989; Torchilin VP, 2008, ADV DRUG DELIVER REV, V60, P548, DOI 10.1016/j.addr.2007.10.008; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; Wieduwild R, 2013, J AM CHEM SOC, V135, P2919, DOI 10.1021/ja312022u; Zanuy D, 2013, J STRUCT BIOL, V182, P78, DOI 10.1016/j.jsb.2013.02.006; Zatsepin TS, 2005, CURR PHARM DESIGN, V11, P3639, DOI 10.2174/138161205774580769; Zhang YX, 2002, BIOCHEMISTRY-US, V41, P11868, DOI 10.1021/bi0262395	43	17	18	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124073	10.1371/journal.pone.0124073	http://dx.doi.org/10.1371/journal.pone.0124073			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894337	Green Submitted, Green Published, gold			2022-12-26	WOS:000353211700072
J	Lin, CY; Huang, Z; Wen, W; Wu, A; Wang, CZ; Niu, L				Lin, Chi-Yen; Huang, Zhen; Wen, Wei; Wu, Andrew; Wang, Congzhou; Niu, Li			Enhancing Protein Expression in HEK-293 Cells by Lowering Culture Temperature	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY PRODUCTION; INTERFERON-GAMMA PRODUCTION; HIGH-LEVEL EXPRESSION; HYPOTHERMIC GROWTH; MAMMALIAN-CELLS; AMPA RECEPTOR; CHO-CELLS; PRODUCTIVITY; KINETICS; MOUSE	Animal cells and cell lines, such as HEK-293 cells, are commonly cultured at 37 degrees C. These cells are often used to express recombinant proteins. Having a higher expression level or a higher protein yield is generally desirable. As we demonstrate in this study, dropping culture temperature to 33 degrees C, but not lower, 24 hours after transient transfection in HEK-293S cells will give rise to similar to 1.5-fold higher expression of green fluorescent protein (GFP) and a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors. By following the time course of the GFP-expressing cells growing at 37 degrees C and 33 degrees C from 24 hours after transfection (including 19 hours recovery at 37 degrees C in the normal growth medium), we found that a mild hypothermia (i.e., 33 degrees C) reduces the growth rate of HEK-293S cells, while increasing cellular productivity of recombinant proteins. As a result, green cells remain undivided in a longer period of time. Not surprisingly, the property of a recombinant protein expressed in the cells grown at 33 degrees C is unaffected, as shown by the use of AMPA receptors. We further demonstrate with the use of PC12 cells that this method may be especially useful when a recombinant protein is difficult to express using a chemical-based, transient transfection method.	[Niu, Li] SUNY Albany, Dept Chem, Albany, NY 12222 USA; SUNY Albany, Ctr Neurosci Res, Albany, NY 12222 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Niu, L (corresponding author), SUNY Albany, Dept Chem, Albany, NY 12222 USA.	lniu@albany.edu		Wen, Wei/0000-0003-1422-856X	National Institutes of Health/National Institute of Neurological Disorders and Stroke [RO1 NS060812]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060812] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Institutes of Health/National Institute of Neurological Disorders and Stroke RO1 NS060812 to Li Niu.	Ali SH, 2001, SEMIN CANCER BIOL, V11, P15, DOI 10.1006/scbi.2000.0342; ALRUBEAI M, 1990, J BIOTECHNOL, V16, P67, DOI 10.1016/0168-1656(90)90066-K; BARNABE N, 1994, BIOTECHNOL BIOENG, V44, P1235, DOI 10.1002/bit.260441011; BERG DT, 1993, BIOTECHNIQUES, V14, P972; BLOEMKOLK JW, 1992, BIOTECHNOL BIOENG, V40, P427, DOI 10.1002/bit.260400312; BORTH N, 1992, J BIOTECHNOL, V25, P319, DOI 10.1016/0168-1656(92)90164-5; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Dingledine R, 1999, PHARMACOL REV, V51, P7; Ducommun P, 2002, BIOTECHNOL BIOENG, V77, P838, DOI 10.1002/bit.10185; Fox SR, 2005, BIOTECHNOL APPL BIOC, V41, P265, DOI 10.1042/BA20040067; Fox SR, 2004, BIOTECHNOL BIOENG, V85, P177, DOI 10.1002/bit.10861; Furukawa K, 1998, CYTOTECHNOLOGY, V26, P153, DOI 10.1023/A:1007934216507; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Grau Cristina Malagelada, 2012, Methods Mol Biol, V846, P201, DOI 10.1007/978-1-61779-536-7_18; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Gruswitz F, 2010, P NATL ACAD SCI USA, V107, P9638, DOI 10.1073/pnas.1003587107; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Huang Z, 2005, J NEUROSCI METH, V142, P159, DOI 10.1016/j.jneumeth.2004.09.009; Kaufmann H, 1999, BIOTECHNOL BIOENG, V63, P573, DOI 10.1002/(SICI)1097-0290(19990605)63:5<573::AID-BIT7>3.0.CO;2-Y; Kim JY, 2012, APPL MICROBIOL BIOT, V93, P917, DOI 10.1007/s00253-011-3758-5; Lee JH, 2008, J TISSUE ENG REGEN M, V2, P288, DOI 10.1002/term.94; Li G, 2003, BIOCHEMISTRY-US, V42, P12358, DOI 10.1021/bi0347961; Pei WM, 2007, BIOCHEMISTRY-US, V46, P2027, DOI 10.1021/bi062213s; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; RAO PN, 1965, SCIENCE, V148, P1092, DOI 10.1126/science.148.3673.1092; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; REUVENY S, 1986, J IMMUNOL METHODS, V86, P53, DOI 10.1016/0022-1759(86)90264-4; Rieder CL, 2002, CELL CYCLE, V1, P169, DOI 10.4161/cc.1.3.119; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; Standfuss J, 2007, J MOL BIOL, V372, P1179, DOI 10.1016/j.jmb.2007.03.007; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; STEINMAN RM, 1983, J CELL BIOL, V96, P1, DOI 10.1083/jcb.96.1.1; STILLMAN BW, 1985, MOL CELL BIOL, V5, P2051, DOI 10.1128/MCB.5.8.2051; Sunley K, 2008, BIOTECHNOL PROGR, V24, P898, DOI 10.1021/bp.9; Sunley K, 2010, BIOTECHNOL ADV, V28, P385, DOI 10.1016/j.biotechadv.2010.02.003; SURESHKUMAR GK, 1991, BIOTECHNOL BIOENG, V37, P292, DOI 10.1002/bit.260370313; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Trummer E, 2006, BIOTECHNOL BIOENG, V94, P1045, DOI 10.1002/bit.20958; UDGAONKAR JB, 1987, P NATL ACAD SCI USA, V84, P8758, DOI 10.1073/pnas.84.24.8758; Wang CZ, 2011, BIOCHEMISTRY-US, V50, P7284, DOI 10.1021/bi2007977; WATANABE I, 1967, J CELL BIOL, V32, P309, DOI 10.1083/jcb.32.2.309; WEIDEMANN R, 1994, CYTOTECHNOLOGY, V15, P111, DOI 10.1007/BF00762385; Yoon SK, 2003, BIOTECHNOL BIOENG, V82, P289, DOI 10.1002/bit.10566	47	37	38	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123562	10.1371/journal.pone.0123562	http://dx.doi.org/10.1371/journal.pone.0123562			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893827	Green Submitted, Green Published, gold			2022-12-26	WOS:000353211700043
J	Song, LL; Zeng, W; Wu, AM; Picard, K; Lampugnani, ER; Cheetamun, R; Beahan, C; Cassin, A; Lonsdale, A; Doblin, MS; Bacic, A				Song, Lili; Zeng, Wei; Wu, Aimin; Picard, Kelsey; Lampugnani, Edwin R.; Cheetamun, Roshan; Beahan, Cherie; Cassin, Andrew; Lonsdale, Andrew; Doblin, Monika S.; Bacic, Antony			Asparagus Spears as a Model to Study Heteroxylan Biosynthesis during Secondary Wall Development	PLOS ONE			English	Article							PLANT-CELL WALLS; GLUCURONOXYLAN BIOSYNTHESIS; XYLAN BIOSYNTHESIS; ARABIDOPSIS-THALIANA; MUTANTS REVEALS; STORAGE; WHEAT; OFFICINALIS; PROTEINS; SEQUENCE	Garden asparagus (Asparagus officinalis L.) is a commercially important crop species utilized for its excellent source of vitamins, minerals and dietary fiber. However, after harvest the tissue hardens and its quality rapidly deteriorates because spear cell walls become rigidified due to lignification and substantial increases in heteroxylan content. This latter observation prompted us to investigate the in vitro xylan xylosyltransferase (XylT) activity in asparagus. The current model system for studying heteroxylan biosynthesis, Arabidopsis, whilst a powerful genetic system, displays relatively low xylan XylT activity in in vitro microsomal preparations compared with garden asparagus therefore hampering our ability to study the molecular mechanism(s) of heteroxylan assembly. Here, we analyzed physiological and biochemical changes of garden asparagus spears stored at 4 degrees C after harvest and detected a high level of xylan XylT activity that accounts for this increased heteroxylan. The xylan XylT catalytic activity is at least thirteen-fold higher than that reported for previously published species, including Arabidopsis and grasses. A biochemical assay was optimized and up to seven successive Xyl residues were incorporated to extend the xylotetraose (Xyl(4)) acceptor backbone. To further elucidate the xylan biosynthesis mechanism, we used RNA-seq to generate an Asparagus reference transcriptome and identified five putative xylan biosynthetic genes (AoIRX9, AoIRX9-L, AoIRX10, AoIRX14_A, AoIRX14_B) with AoIRX9 having an expression profile that is distinct from the other genes. We propose that Asparagus provides an ideal biochemical system to investigate the biochemical aspects of heteroxylan biosynthesis and also offers the additional benefit of being able to study the lignification process during plant stem maturation.	[Song, Lili] Zhejiang A&F Univ, Nurturing Stn State Key Lab Subtrop Silviculture, Hangzhou 311300, Zhejiang, Peoples R China; [Song, Lili; Zeng, Wei; Picard, Kelsey; Lampugnani, Edwin R.; Cheetamun, Roshan; Beahan, Cherie; Cassin, Andrew; Lonsdale, Andrew; Doblin, Monika S.; Bacic, Antony] Univ Melbourne, Sch Bot, ARC Ctr Excellence Plant Cell Walls, Parkville, Vic 3010, Australia; [Wu, Aimin] South China Agr Univ, Coll Forestry, Guangzhou 510642, Guangdong, Peoples R China; [Bacic, Antony] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia	Zhejiang A&F University; University of Melbourne; South China Agricultural University; University of Melbourne	Song, LL (corresponding author), Zhejiang A&F Univ, Nurturing Stn State Key Lab Subtrop Silviculture, Hangzhou 311300, Zhejiang, Peoples R China.	lilis2013@163.com; msdoblin@unimelb.edu.au; abacic@unimelb.edu.au	Wu, Aimin/AAG-9747-2020; Doblin, Monika/AAO-6801-2021; Lampugnani, Edwin/AAF-4238-2019; Zeng, Wei/AAZ-7073-2021	Wu, Aimin/0000-0001-8322-8833; Lampugnani, Edwin/0000-0002-3666-7240; Zeng, Wei/0000-0001-6898-1210; Bacic, Tony/0000-0001-7483-8605; Lonsdale, Andrew/0000-0002-0292-2880; Picard, Kelsey/0000-0001-8341-3545	Australia Research Council [CE110001007]; ARC [DP110100410]; Victorian Life Sciences Computation Initiative (VLSCI) [VR0191]; National Natural Science Foundation of China [31170165]	Australia Research Council(Australian Research Council); ARC(Australian Research Council); Victorian Life Sciences Computation Initiative (VLSCI); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by a grant from the Australia Research Council to the ARC Centre of Excellence in Plant Cell Walls (WZ, KP, EL, CB, AC, AL, MSD and AB) (CE110001007); ARC DP110100410 (EL and AB), the Victorian Life Sciences Computation Initiative (VLSCI) grant number VR0191 on its Peak Computing Facility at the University of Melbourne, an initiative of the Victorian Government, Australia and the National Natural Science Foundation of China (LS) (grant no. 31170165). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwael H, 2011, ANAL METHODS-UK, V3, P62, DOI 10.1039/c0ay00516a; BACIC A, 1980, CARBOHYD RES, V82, P372, DOI 10.1016/S0008-6215(00)85713-4; BAILEY RW, 1966, P NATL ACAD SCI USA, V56, P1586, DOI 10.1073/pnas.56.5.1586; Brown DM, 2007, PLANT J, V52, P1154, DOI 10.1111/j.1365-313X.2007.03307.x; Brown DM, 2009, PLANT J, V57, P732, DOI 10.1111/j.1365-313X.2008.03729.x; Busse-Wicher M, 2014, PLANT J, V79, P492, DOI 10.1111/tpj.12575; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Chen XW, 2013, MOL PLANT, V6, P570, DOI 10.1093/mp/sss135; Chiniquy D, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00083; DALESSANDRO G, 1981, PLANTA, V151, P61, DOI 10.1007/BF00384238; Doblin MS, 2010, FUNCT PLANT BIOL, V37, P357, DOI 10.1071/FP09279; Ebringerova A, 2000, MACROMOL RAPID COMM, V21, P542; Faik A, 2010, PLANT PHYSIOL, V153, P396, DOI 10.1104/pp.110.154237; FEINGOLD DS, 1959, J BIOL CHEM, V234, P488; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; HAARD NF, 1974, J FOOD SCI, V39, P452, DOI 10.1111/j.1365-2621.1974.tb02923.x; Hao ZY, 2014, CRIT REV BIOCHEM MOL, V49, P212, DOI 10.3109/10409238.2014.889651; Hornblad E, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-3; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Ishikawa M, 2000, PLANTA, V210, P782, DOI 10.1007/s004250050680; Jensen JK, 2014, PLANT J, V80, P207, DOI 10.1111/tpj.12641; JOHANSSON MH, 1977, WOOD SCI TECHNOL, V11, P251, DOI 10.1007/BF00356924; Johnson MTJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050226; Kuhl JC, 2005, GENOME, V48, P1052, DOI 10.1139/G05-073; Kuhl JC, 2004, PLANT CELL, V16, P114, DOI 10.1105/tpc.017202; Kuroyama H, 2001, PLANTA, V213, P231, DOI 10.1007/s004250000499; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee CH, 2007, PLANT CELL PHYSIOL, V48, P1659, DOI 10.1093/pcp/pcm155; Lee CH, 2007, PLANT CELL PHYSIOL, V48, P1624, DOI 10.1093/pcp/pcm135; Lee C, 2012, PLANT CELL PHYSIOL, V53, P1934, DOI 10.1093/pcp/pcs138; Lee C, 2012, PLANT CELL PHYSIOL, V53, P135, DOI 10.1093/pcp/pcr158; Lee C, 2010, PLANT PHYSIOL, V153, P526, DOI 10.1104/pp.110.155309; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Luo ZS, 2008, EUR FOOD RES TECHNOL, V226, P635, DOI 10.1007/s00217-007-0595-y; Malm E, 2010, CARBOHYD RES, V345, P97, DOI 10.1016/j.carres.2009.10.020; Mazumder K, 2010, CARBOHYD RES, V345, P2183, DOI 10.1016/j.carres.2010.07.034; Mortimer JC, 2010, P NATL ACAD SCI USA, V107, P17409, DOI 10.1073/pnas.1005456107; Oikawa A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015481; Papadopoulou PP, 2002, ACTA HORTIC, P647, DOI 10.17660/ActaHortic.2002.579.114; Pena MJ, 2007, PLANT CELL, V19, P549, DOI 10.1105/tpc.106.049320; Pettolino FA, 2012, NAT PROTOC, V7, P1590, DOI 10.1038/nprot.2012.081; Piston F, 2010, PLANTA, V231, P677, DOI 10.1007/s00425-009-1077-1; Rasmussen S, 1999, PLANT CELL, V11, P1537, DOI 10.1105/tpc.11.8.1537; Ratnayake S, 2014, CARBOHYD RES, V386, P23, DOI 10.1016/j.carres.2013.12.013; Ren YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105014; Rennie EA, 2014, CURR OPIN BIOTECH, V26, P100, DOI 10.1016/j.copbio.2013.11.013; Rodriguez R, 1999, J AGR FOOD CHEM, V47, P3551, DOI 10.1021/jf981295r; SUZUKI K, 1991, PLANT CELL PHYSIOL, V32, P303, DOI 10.1093/oxfordjournals.pcp.a078079; Tzoumaki MV, 2009, FOOD CHEM, V117, P55, DOI 10.1016/j.foodchem.2009.03.076; Urbanowicz BR, 2014, PLANT J, V80, P197, DOI 10.1111/tpj.12643; Villanueva-Suarez MJ, 1999, J AGR FOOD CHEM, V47, P3832, DOI 10.1021/jf980888z; WALDRON KW, 1992, PHYTOCHEMISTRY, V31, P1931, DOI 10.1016/0031-9422(92)80336-D; WALDRON KW, 1990, PHYSIOL PLANTARUM, V80, P576, DOI [10.1034/j.1399-3054.1990.800413.x, 10.1111/j.1399-3054.1990.tb05681.x]; WALDRON KW, 1983, BIOCHEM J, V213, P115, DOI 10.1042/bj2130115; Wu AM, 2010, PLANT PHYSIOL, V153, P542, DOI 10.1104/pp.110.154971; Wu AM, 2009, PLANT J, V57, P718, DOI 10.1111/j.1365-313X.2008.03724.x; Xiong GY, 2013, MOL PLANT, V6, P1373, DOI 10.1093/mp/sst014; Yokoyama R, 2004, PLANT CELL PHYSIOL, V45, P1111, DOI 10.1093/pcp/pch151; Zeng W, 2008, PLANT PHYSIOL, V147, P78, DOI 10.1104/pp.107.115576; Zeng W, 2010, PLANT PHYSIOL, V154, P78, DOI 10.1104/pp.110.159749; Zhong RQ, 2005, PLANT CELL, V17, P3390, DOI 10.1105/tpc.105.035501; Zhong RQ, 2006, PLANT CELL, V18, P3158, DOI 10.1105/tpc.106.047399	63	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123878	10.1371/journal.pone.0123878	http://dx.doi.org/10.1371/journal.pone.0123878			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894575	Green Published, gold			2022-12-26	WOS:000353211700062
J	Fleisig, HB; Hukezalie, KR; Thompson, CAH; Au-Yeung, TTT; Ludlow, AT; Zhao, CR; Wong, JMY				Fleisig, H. B.; Hukezalie, K. R.; Thompson, C. A. H.; Au-Yeung, T. T. T.; Ludlow, A. T.; Zhao, C. R.; Wong, J. M. Y.			Telomerase reverse transcriptase expression protects transformed human cells against DNA-damaging agents, and increases tolerance to chromosomal instability	ONCOGENE			English	Article							CATALYTIC SUBUNIT; HTERT; LENGTH; MAINTENANCE; BIOGENESIS; VARIANT; APOPTOSIS; CHROMATIN; TARGET; CANCER	Reactivation of telomerase reverse transcriptase (TERT) expression is found in more than 85% of human cancers. The remaining cancers rely on the alternative lengthening of telomeres (ALT), a recombination-based mechanism for telomere-length maintenance. Prevalence of TERT reactivation over the ALT mechanism was linked to secondary TERT function unrelated to telomere length maintenance. To characterize this non-canonical function, we created a panel of ALT cells with recombinant expression of TERT and TERT variants: TERT-positive ALT cells showed higher tolerance to genotoxic insults compared with their TERT-negative counterparts. We identified telomere synthesis-defective TERT variants that bestowed similar genotoxic stress tolerance, indicating that telomere synthesis activity is dispensable for this survival phenotype. TERT expression improved the kinetics of double-strand chromosome break repair and reduced DNA damage-related nuclear division abnormalities, a phenotype associated with ALT tumors. Despite this reduction in cytological abnormalities, surviving TERT-positive ALT cells were found to have gross chromosomal instabilities. We sorted TERT-positive cells with cytogenetic changes and followed their growth. We found that the chromosome-number changes persisted, and TERT-positive ALT cells surviving genotoxic events propagated through subsequent generations with new chromosome numbers. Our data confirm that telomerase expression protects against doublestrand DNA (dsDNA)-damaging events, and show that this protective function is uncoupled from its role in telomere synthesis. TERT expression promotes oncogene-transformed cell growth by reducing the inhibitory effects of cell-intrinsic (telomere attrition) and cell-extrinsic (chemical-or metabolism-induced genotoxic stress) challenges. These data provide the impetus to develop new therapeutic interventions for telomerase-positive cancers through simultaneous targeting of multiple telomerase activities.	[Fleisig, H. B.; Hukezalie, K. R.; Thompson, C. A. H.; Au-Yeung, T. T. T.; Zhao, C. R.; Wong, J. M. Y.] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC V6T 1Z3, Canada; [Ludlow, A. T.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA	University of British Columbia; University of Texas System; University of Texas Southwestern Medical Center Dallas	Wong, JMY (corresponding author), Univ British Columbia, Fac Pharmaceut Sci, 2405 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	judy.wong@ubc.ca	Wong, Judy/AAG-1868-2021	Wong, Judy/0000-0001-5572-4143	Canadian Cancer Society Research Institute [019250]; Research Reinvestment Funds from the Faculty of Pharmaceutical Sciences at UBC; Michael Smith Foundation for Health Research Career Development program	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Research Reinvestment Funds from the Faculty of Pharmaceutical Sciences at UBC; Michael Smith Foundation for Health Research Career Development program	We thank members of Judy Wong's laboratory for providing helpful insights. Kathleen Collins and Bill Hahn kindly provided reagents. Shirley Yeung, Irene Iu and Arthur Chan assisted with method development. Nigel O'Neil assisted with optimization of the chromosomal healing assay. Andy Johnson from the UBC Flow-Cytometry Facility provided expertise with FACS procedures. We thank them for their assistance. Financial support for this work was provided by the Canadian Cancer Society Research Institute (operating grant #019250), and Research Reinvestment Funds from the Faculty of Pharmaceutical Sciences at UBC. JMYW is supported by the Michael Smith Foundation for Health Research Career Development program.	Armbruster BN, 2003, MOL CELL BIOL, V23, P3237, DOI 10.1128/MCB.23.9.3237-3246.2003; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Bryant Helen E, 2012, Methods Mol Biol, V920, P315, DOI 10.1007/978-1-61779-998-3_22; Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002; Egan ED, 2012, RNA, V18, P1747, DOI 10.1261/rna.034629.112; Fasching CL, 2005, CANCER RES, V65, P2722, DOI 10.1158/0008-5472.CAN-04-2881; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Fleisig HB, 2012, ONCOGENE, V31, P954, DOI 10.1038/onc.2011.292; Fleisig HB, 2007, EXP GERONTOL, V42, P102, DOI 10.1016/j.exger.2006.05.011; Fu D, 2007, MOL CELL, V28, P773, DOI 10.1016/j.molcel.2007.09.023; Gorbunova V, 2002, J BIOL CHEM, V277, P38540, DOI 10.1074/jbc.M202671200; Hukezalie KR, 2013, FEBS J, V280, P3194, DOI 10.1111/febs.12272; Lincz LF, 2008, NEOPLASIA, V10, P1131, DOI 10.1593/neo.08644; Listerman I, 2013, CANCER RES, V73, P2817, DOI 10.1158/0008-5472.CAN-12-3082; Lovejoy CA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002772; Martinez P, 2011, NAT REV CANCER, V11, P161, DOI 10.1038/nrc3025; Masutomi K, 2005, P NATL ACAD SCI USA, V102, P8222, DOI 10.1073/pnas.0503095102; Okamoto N, 2011, P NATL ACAD SCI USA, V108, P20388, DOI 10.1073/pnas.1015171108; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Perrem K, 2001, MOL CELL BIOL, V21, P3862, DOI 10.1128/MCB.21.12.3862-3875.2001; Poon SSS, 2001, METHOD CELL BIOL, V64, P69; Robin JD, 2014, GENE DEV, V28, P2464, DOI 10.1101/gad.251041.114; Sharma GG, 2003, ONCOGENE, V22, P131, DOI 10.1038/sj.onc.1206063; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Tamakawa RA, 2010, CANCER RES, V70, P8684, DOI 10.1158/0008-5472.CAN-10-2227; Ulaner GA, 1998, CANCER RES, V58, P4168; Wong JMY, 2003, LANCET, V362, P983, DOI 10.1016/S0140-6736(03)14369-3; Wright WE, 1996, DEV GENET, V18, P173; Yi XM, 2000, NEOPLASIA, V2, P433, DOI 10.1038/sj.neo.7900113	30	23	23	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 14	2016	35	2					218	227		10.1038/onc.2015.75	http://dx.doi.org/10.1038/onc.2015.75			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DB0JH	25893297				2022-12-26	WOS:000368193900008
J	Chen, X; Bosques, L; Sung, P; Kupfer, GM				Chen, X.; Bosques, L.; Sung, P.; Kupfer, G. M.			A novel role for non-ubiquitinated FANCD2 in response to hydroxyurea-induced DNA damage	ONCOGENE			English	Article							FANCONI-ANEMIA PATHWAY; CROSS-LINK REPAIR; HOMOLOGOUS RECOMBINATION; REPLICATION FORK; TRANSLESION SYNTHESIS; PHYSICAL INTERACTION; POLYMERASE SWITCH; PCNA; ACTIVATION; MUTAGENESIS	Fanconi anemia (FA) is a genetic disease of bone marrow failure, cancer susceptibility, and sensitivity to DNA crosslinking agents. FANCD2, the central protein of the FA pathway, is monoubiquitinated upon DNA damage, such as crosslinkers and replication blockers such as hydroxyurea (HU). Even though FA cells demonstrate unequivocal sensitivity to crosslinkers, such as mitomycin C (MMC), we find that they are largely resistant to HU, except for cells absent for expression of FANCD2. FANCD2, RAD51 and RAD18 form a complex, which is enhanced upon HU exposure. Surprisingly, although FANCD2 is required for this enhanced interaction, its monoubiquitination is not. Similarly, non-ubiquitinated FANCD2 can still support proliferation cell nuclear antigen (PCNA) monoubiquitination. RAD51, but not BRCA2, is also required for PCNA monoubiquitination in response to HU, suggesting that this function is independent of homologous recombination (HR). We further show that translesion (TLS) polymerase PolH chromatin localization is decreased in FANCD2 deficient cells, FANCD2 siRNA knockdown cells and RAD51 siRNA knockdown cells, and PolH knockdown results in HU sensitivity only. Our data suggest that FANCD2 and RAD51 have an important role in PCNA monoubiquitination and TLS in a FANCD2 monoubiquitination and HR-independent manner in response to HU. This effect is not observed with MMC treatment, suggesting a non-canonical function for the FA pathway in response to different types of DNA damage.	[Chen, X.; Bosques, L.; Kupfer, G. M.] Yale Univ, Sch Med, Yale Canc Ctr, Dept Pediat,Sect Hematol Oncol, New Haven, CT 06520 USA; [Chen, X.; Bosques, L.; Kupfer, G. M.] Yale Univ, Sch Med, Yale Canc Ctr, Dept Pathol,Sect Hematol Oncol, New Haven, CT 06520 USA; [Sung, P.] Yale Univ, Sch Med, Yale Canc Ctr, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Kupfer, GM (corresponding author), Yale Univ, Sch Med, Yale Canc Ctr, Dept Pediat,Sect Hematol Oncol, LMP2073,333 Cedar St, New Haven, CT 06520 USA.	gary.kupfer@yale.edu			NATIONAL CANCER INSTITUTE [R01CA168635] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA168635] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alpi AF, 2009, DNA REPAIR, V8, P430, DOI 10.1016/j.dnarep.2009.01.019; Bagby GC, 2006, SEMIN HEMATOL, V43, P147, DOI 10.1053/j.seminhematol.2006.04.005; Bindra RS, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt255; Brown S, 2009, CELL CYCLE, V8, P689, DOI 10.4161/cc.8.5.7707; Chang DJ, 2009, NAT CHEM BIOL, V5, P82, DOI 10.1038/nchembio.139; Chaudhury I, 2013, NUCLEIC ACIDS RES, V41, P6444, DOI 10.1093/nar/gkt348; Chen JJ, 2011, CELL BIOCHEM BIOPHYS, V60, P47, DOI 10.1007/s12013-011-9187-3; Dunn J, 2006, CANCER RES, V66, P11140, DOI 10.1158/0008-5472.CAN-06-0563; Fu DC, 2013, CELL CYCLE, V12, P803, DOI 10.4161/cc.23755; Garaycoechea JI, 2014, BLOOD, V123, P26, DOI 10.1182/blood-2013-09-427740; Green AM, 2009, HEMATOL ONCOL CLIN N, V23, P193, DOI 10.1016/j.hoc.2009.01.008; Hirano S, 2005, EMBO J, V24, P418, DOI 10.1038/sj.emboj.7600534; Ho V, 2010, ENVIRON MOL MUTAGEN, V51, P552, DOI 10.1002/em.20573; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Holloman WK, 2011, NAT STRUCT MOL BIOL, V18, P748, DOI 10.1038/nsmb.2096; Howlett NG, 2005, HUM MOL GENET, V14, P693, DOI 10.1093/hmg/ddi065; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Howlett NG, 2009, J BIOL CHEM, V284, P28935, DOI 10.1074/jbc.M109.016352; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Hussain S, 2004, HUM MOL GENET, V13, P1241, DOI 10.1093/hmg/ddh135; Johnstone P, 1997, SOMAT CELL MOLEC GEN, V23, P371, DOI 10.1007/BF02673747; Kannouche PL, 2004, CELL CYCLE, V3, P1011; Kim H, 2012, GENE DEV, V26, P1393, DOI 10.1101/gad.195248.112; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Koc A, 2004, J BIOL CHEM, V279, P223, DOI 10.1074/jbc.M303952200; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; Lin JR, 2011, MOL CELL, V42, P237, DOI 10.1016/j.molcel.2011.02.026; Lossaint G, 2013, MOL CELL, V51, P678, DOI 10.1016/j.molcel.2013.07.023; MAURERSCHULTZE B, 1988, EXP CELL RES, V174, P230, DOI 10.1016/0014-4827(88)90157-7; McCabe KM, 2008, MOL GENET METAB, V95, P66, DOI 10.1016/j.ymgme.2008.06.009; Mirchandani KD, 2008, DNA REPAIR, V7, P902, DOI 10.1016/j.dnarep.2008.03.001; Miyase S, 2005, J BIOL CHEM, V280, P515, DOI 10.1074/jbc.M409219200; Moldovan GL, 2012, MOL CELL, V45, P75, DOI 10.1016/j.molcel.2011.11.010; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Palle K, 2011, CELL CYCLE, V10, P1625, DOI 10.4161/cc.10.10.15617; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Pickering A, 2013, CANCER BIOL THER, V14, P1089, DOI 10.4161/cbt.26380; Qiao FY, 2001, J BIOL CHEM, V276, P23391, DOI 10.1074/jbc.M101855200; Reliene R, 2010, CANCER RES, V70, P9703, DOI 10.1158/0008-5472.CAN-09-1022; Schlacher K, 2012, CANCER CELL, V22, P106, DOI 10.1016/j.ccr.2012.05.015; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Suhasini AN, 2011, EMBO J, V30, P692, DOI 10.1038/emboj.2010.362; Tanaka T, 2007, CYTOM PART A, V71A, P648, DOI 10.1002/cyto.a.20426; Terai K, 2010, MOL CELL, V37, P143, DOI 10.1016/j.molcel.2009.12.018; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Williams SA, 2011, HUM MOL GENET, V20, P4395, DOI 10.1093/hmg/ddr366; Williams SA, 2011, BLOOD, V117, P5078, DOI 10.1182/blood-2010-10-311761; Zeman MK, 2014, J CELL BIOL, V206, P183, DOI 10.1083/jcb.201311063	50	33	33	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 7	2016	35	1					22	34		10.1038/onc.2015.68	http://dx.doi.org/10.1038/onc.2015.68			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DA4ZT	25893307	Green Accepted			2022-12-26	WOS:000367812400003
J	Wang, N; Docherty, F; Brown, HK; Reeves, K; Fowles, A; Lawson, M; Ottewell, PD; Holen, I; Croucher, PI; Eaton, CL				Wang, Ning; Docherty, Freyja; Brown, Hannah K.; Reeves, Kim; Fowles, Anne; Lawson, Michelle; Ottewell, Penelope D.; Holen, Ingunn; Croucher, Peter I.; Eaton, Colby L.			Mitotic quiescence, but not unique "stemness," marks the phenotype of bone metastasis-initiating cells in prostate cancer	FASEB JOURNAL			English	Article						cell quiescence; CXCR4; metastatic niche	EXPRESSION; PROLIFERATION; PROGRESSION; INVASION; ANTIGEN; TISSUE; NICHE; CD133	This study aimed to identify subpopulations of prostate cancer cells that are responsible for the initiation of bone metastases. Using rapidly dividing human prostate cancer cell lines, we identified mitotically quiescent subpopulations (<1%), which we compared with the rapidly dividing populations for patterns of gene expression and for their ability to migrate to the skeletons of athymicmice. The study used 2-photon microscopy to map the presence/distribution of fluorescently labeled, quiescent cells and luciferase expression to determine the presence of growing bone metastases. We showed that the mitotically quiescent cells were very significantly more tumorigenic in forming bone metastases than fast-growing cells (55 vs. 15%) and had a unique gene expression profile. The quiescent cells were not uniquely stem cell like, with no expression of CD133 but had the same level expression of other putative prostate stem cell markers (CD44 and integrins alpha 2/beta 1), when compared to the rapidly proliferating population. In addition, mitotic quiescence was associated with very high levels of C-X-C chemokine receptor type 4 (CXCR4) production. Inhibition of CXCR4 activity altered the homing of quiescent tumor cells to bone. Our studies suggest that mitotic dormancy is a unique phenotype that facilitates tumor cell colonization of the skeleton in prostate cancer.	[Wang, Ning; Docherty, Freyja; Brown, Hannah K.; Fowles, Anne; Eaton, Colby L.] Univ Sheffield, Sch Med, Dept Human Metab, Sheffield S10 2RX, S Yorkshire, England; [Reeves, Kim] Paterson Inst Canc Res, Breakthrough Breast Canc Res Unit, Manchester M20 9BX, Lancs, England; [Lawson, Michelle; Ottewell, Penelope D.; Holen, Ingunn] Univ Sheffield, Sch Med, Dept Oncol, Sheffield S10 2RX, S Yorkshire, England; [Croucher, Peter I.] Garvan Inst Med Res, Bone Biol Div, Sydney, NSW, Australia	University of Sheffield; Paterson Institute for Cancer Research; University of Sheffield; Garvan Institute of Medical Research	Eaton, CL (corresponding author), Univ Sheffield, Sch Med, Dept Human Metab, Acad Unit Bone Biol, D Floor,Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England.	c.l.eaton@sheffield.ac.uk	Lawson, Michelle/M-6095-2019	Lawson, Michelle/0000-0002-5446-923X; Ottewell, Penelope/0000-0002-4826-0771; Holen, Ingunn/0000-0002-8759-6913; WANG, NING/0000-0002-2663-7515; Croucher, Peter/0000-0002-7102-2413	Cancer Research UK; Yorkshire Cancer Research; Mrs. Janice Gibson and the Ernest Heine Family Foundation; Cancer Research UK [11991] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Yorkshire Cancer Research; Mrs. Janice Gibson and the Ernest Heine Family Foundation; Cancer Research UK(Cancer Research UK)	The authors thank Cancer Research UK for its generous financial support and Yorkshire Cancer Research for funding in vivo imaging equipment (IVIS). The authors are grateful to the following for technical support: Miss Orla Gallagher, Mr. Darren Lath, Susan Clark, and Kay Hopkins. P.I.C. is supported by Mrs. Janice Gibson and the Ernest Heine Family Foundation. The authors declare no conflicts of interest.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Colombel M, 2012, PROSTATE, V72, P713, DOI 10.1002/pros.21473; Cooper CR, 2002, NEOPLASIA, V4, P191, DOI 10.1038/sj.neo.7900224; Draffin JE, 2004, CANCER RES, V64, P5702, DOI 10.1158/0008-5472.CAN-04-0389; Dutta A, 2014, CANCER RES, V74, P1598, DOI 10.1158/0008-5472.CAN-13-1796; Eaton CL, 2010, PROSTATE, V70, P875, DOI 10.1002/pros.21121; Germann M, 2012, STEM CELLS, V30, P1076, DOI 10.1002/stem.1087; Gu Z, 2000, ONCOGENE, V19, P1288, DOI 10.1038/sj.onc.1203426; Guzman-Ramirez N, 2009, PROSTATE, V69, P1683, DOI 10.1002/pros.21018; Jung K, 1997, INT J CANCER, V74, P220, DOI 10.1002/(SICI)1097-0215(19970422)74:2<220::AID-IJC14>3.0.CO;2-H; Nemeth JA, 2002, J NATL CANCER I, V94, P17; Nie YC, 2008, J EXP MED, V205, P777, DOI 10.1084/jem.20072513; Nutter F, 2014, ENDOCR-RELAT CANCER, V21, P327, DOI 10.1530/ERC-13-0158; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Pellacani D, 2013, ADV EXP MED BIOL, V777, P167, DOI 10.1007/978-1-4614-5894-4_11; Pellacani D, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-94; Pola C, 2013, CANCER RES, V73, P4571, DOI 10.1158/0008-5472.CAN-13-0218; Polson ES, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2627; Reinertsen T, 2012, APMIS, V120, P558, DOI 10.1111/j.1600-0463.2011.02865.x; Reiter RE, 1998, P NATL ACAD SCI USA, V95, P1735, DOI 10.1073/pnas.95.4.1735; Sheng X, 2013, ONCOL LETT, V5, P787, DOI 10.3892/ol.2012.1090; Shiozawa Y, 2011, CLIN CANCER RES, V17, P5553, DOI 10.1158/1078-0432.CCR-10-2505; Singh S, 2004, LAB INVEST, V84, P1666, DOI 10.1038/labinvest.3700181; Wang N, 2014, J BONE MINER RES, V29, P2688, DOI 10.1002/jbmr.2300; Williams LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083991; Williamson SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048944; Yumoto K, 2014, CYTOM PART A, V85A, P548, DOI 10.1002/cyto.a.22434; Zhang L, 2010, CANCER GENE THER, V17, P171, DOI 10.1038/cgt.2009.59	29	37	37	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3141	3150		10.1096/fj.14-266379	http://dx.doi.org/10.1096/fj.14-266379			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25888599	Green Published			2022-12-26	WOS:000358796900004
J	Fan, GF; Aleem, S; Yang, M; Miller, WT; Tonks, NK				Fan, Gaofeng; Aleem, Saadat; Yang, Ming; Miller, W. Todd; Tonks, Nicholas K.			Protein-tyrosine Phosphatase and Kinase Specificity in Regulation of SRC and Breast Tumor Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphorylation; phosphotyrosine; Src; tyrosine-protein kinase (tyrosine kinase); tyrosine-protein phosphatase (tyrosine phosphatase); PTP1B; SRC; BRK; CSK; and CBP; PAG	FAMILY KINASE; INSULIN-RECEPTOR; GROWTH-FACTOR; SUBSTRATE RECOGNITION; ADAPTER PROTEIN; LIPID RAFTS; SH3 DOMAIN; 1B; ACTIVATION; BRK	Background: The view that, unlike kinases, phosphatases are nonspecific pervades the field. Results: PTP1B inhibited BRK by dephosphorylating Tyr-342, but activated SRC by antagonizing PAG-dependent inhibition by CSK. Conclusion: Signaling is regulated by combinatorial effects of PTKs and PTPs, with both enzyme classes displaying exquisite specificity. Significance: Defining phosphatase substrate specificity will reveal new, more effective strategies for therapeutic intervention in major human diseases. Despite significant evidence to the contrary, the view that phosphatases are nonspecific still pervades the field. Systems biology approaches to defining how signal transduction pathways are integrated at the level of whole organisms also often downplay the contribution of phosphatases, defining them as erasers that serve merely to restore the system to its basal state. Here, we present a study that counteracts the idea of nonspecific phosphatases. We have characterized two structurally similar and functionally related kinases, BRK and SRC, which are regulated by combinations of activating autophosphorylation and inhibitory C-terminal sites of tyrosine phosphorylation. We demonstrated specificity at the level of the kinases in that SRMS phosphorylated the C terminus of BRK, but not SRC; in contrast, CSK is the kinase responsible for C-terminal phosphorylation of SRC, but not BRK. For the phosphatases, we observed that RNAi-mediated suppression of PTP1B resulted in opposing effects on the activity of BRK and SRC and have defined the mechanisms underlying this specificity. PTP1B inhibited BRK by directly dephosphorylating the Tyr-342 autophosphorylation site. In contrast, PTP1B potentiated SRC activity, but not by dephosphorylating SRC itself directly; instead, PTP1B regulated the interaction between CBP/PAG and CSK. SRC associated with, and phosphorylated, the transmembrane protein CBP/PAG at Tyr-317, resulting in CSK recruitment. We identified PAG as a substrate of PTP1B, and dephosphorylation abolished recruitment of the inhibitory kinase CSK. Overall, these findings illustrate how the combinatorial effects of PTKs and PTPs may be integrated to regulate signaling, with both classes of enzymes displaying exquisite specificity.	[Fan, Gaofeng; Yang, Ming; Tonks, Nicholas K.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Aleem, Saadat; Miller, W. Todd] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Miller, WT (corresponding author), SUNY Stony Brook, Basic Sci Tower,T-5,Rm 133, Stony Brook, NY 11794 USA.	Todd.Miller@stonybrook.edu; tonks@cshl.edu	Regan, Clinton/E-6250-2012; Fan, Gaofeng/H-2996-2013	Fan, Gaofeng/0000-0002-6729-2867	NIH [CA53840, CA58530]; CSHL Cancer Centre Support Grant [CA45508]; Gladowsky Breast Cancer Foundation; Don Monti Memorial Research Foundation; Hansen Memorial Foundation; West Islip Breast Cancer Coalition for Long Island; Glen Cove CARES; Find a Cure Today (FACT); Constance Silveri; Robertson Research Fund; Masthead Cove Yacht Club Carol Marcincuk Fund; NATIONAL CANCER INSTITUTE [R37CA053840, R01CA058530, R01CA053840, P30CA045508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079710, R01MH083711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033485, R01DA016672, T32DA007290] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CSHL Cancer Centre Support Grant; Gladowsky Breast Cancer Foundation; Don Monti Memorial Research Foundation; Hansen Memorial Foundation; West Islip Breast Cancer Coalition for Long Island; Glen Cove CARES; Find a Cure Today (FACT); Constance Silveri; Robertson Research Fund; Masthead Cove Yacht Club Carol Marcincuk Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research by NIH Grants CA53840 (N. K. T.) and CA58530 (W. T. M) and the CSHL Cancer Centre Support Grant CA45508 (N. K. T.). N. K. T. is also grateful for the support from the following foundations: The Gladowsky Breast Cancer Foundation, The Don Monti Memorial Research Foundation, Hansen Memorial Foundation, West Islip Breast Cancer Coalition for Long Island, Glen Cove CARES, Find a Cure Today (FACT), Constance Silveri, Robertson Research Fund and the Masthead Cove Yacht Club Carol Marcincuk Fund.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Andersen JN, 2004, FASEB J, V18, P8, DOI 10.1096/fj.02-1212rev; BARKER SC, 1995, BIOCHEMISTRY-US, V34, P14843, DOI 10.1021/bi00045a027; Bentires-Alj M, 2007, CANCER RES, V67, P2420, DOI 10.1158/0008-5472.CAN-06-4610; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; CASNELLIE JE, 1991, METHOD ENZYMOL, V200, P115; DANFORTH WH, 1962, P NATL ACAD SCI USA, V48, P1191, DOI 10.1073/pnas.48.7.1191; Dube N, 2004, P NATL ACAD SCI USA, V101, P1834, DOI 10.1073/pnas.0304242101; Fan GF, 2013, J BIOL CHEM, V288, P24923, DOI 10.1074/jbc.M113.482737; Garton AJ, 1997, ONCOGENE, V15, P877, DOI 10.1038/sj.onc.1201279; Goel RK, 2013, FEBS J, V280, P4539, DOI 10.1111/febs.12420; Goldstein BJ, 2000, J BIOL CHEM, V275, P4283, DOI 10.1074/jbc.275.6.4283; Hayashi K, 1999, J CELL SCI, V112, P1149; Hrdinka M, 2014, ONCOGENE, V33, P4881, DOI 10.1038/onc.2013.485; Julien SG, 2007, NAT GENET, V39, P338, DOI 10.1038/ng1963; Kamalati T, 1996, J BIOL CHEM, V271, P30956, DOI 10.1074/jbc.271.48.30956; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; KOHMURA N, 1994, MOL CELL BIOL, V14, P6915, DOI 10.1128/MCB.14.10.6915; Krishnan N, 2014, NAT CHEM BIOL, V10, P558, DOI [10.1038/NCHEMBIO.1528, 10.1038/nchembio.1528]; Lantz KA, 2010, OBESITY, V18, P1516, DOI 10.1038/oby.2009.444; Lim WA, 2010, CELL, V142, P661, DOI 10.1016/j.cell.2010.08.023; MITCHELL PJ, 1994, ONCOGENE, V9, P2383; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; Okada M, 2012, INT J BIOL SCI, V8, P1385, DOI 10.7150/ijbs.5141; Park SH, 1997, CYTOGENET CELL GENET, V77, P271, DOI 10.1159/000134595; Pellicena P, 1998, J BIOL CHEM, V273, P15325, DOI 10.1074/jbc.273.25.15325; Pulido R, 1998, EMBO J, V17, P7337, DOI 10.1093/emboj/17.24.7337; Qiu HQ, 2005, ONCOGENE, V24, P5656, DOI 10.1038/sj.onc.1208721; Qiu HQ, 2004, ONCOGENE, V23, P2216, DOI 10.1038/sj.onc.1207339; Qiu HQ, 2002, J BIOL CHEM, V277, P34634, DOI 10.1074/jbc.M203877200; Ren LG, 2011, BIOCHEMISTRY-US, V50, P2339, DOI 10.1021/bi1014453; Salmeen A, 2000, MOL CELL, V6, P1401, DOI 10.1016/S1097-2765(00)00137-4; Shima T, 2003, P NATL ACAD SCI USA, V100, P14897, DOI 10.1073/pnas.2432139100; Solheim SA, 2008, J BIOL CHEM, V283, P2773, DOI 10.1074/jbc.M705215200; Sondhi D, 1998, BIOCHEMISTRY-US, V37, P165, DOI 10.1021/bi9722960; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2013, FEBS J, V280, P346, DOI 10.1111/febs.12077; Wang YM, 2014, MOL CELL, V53, P752, DOI 10.1016/j.molcel.2014.01.020; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4; ZHENG XM, 1992, NATURE, V359, P336, DOI 10.1038/359336a0	46	31	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					15934	15947		10.1074/jbc.M115.651703	http://dx.doi.org/10.1074/jbc.M115.651703			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25897081	Green Published, hybrid			2022-12-26	WOS:000356930100004
J	Courtois, EA; Gaucher, P; Chave, J; Schmeller, DS				Courtois, Elodie A.; Gaucher, Philippe; Chave, Jerome; Schmeller, Dirk S.			Widespread Occurrence of Bd in French Guiana, South America	PLOS ONE			English	Article							FUNGUS BATRACHOCHYTRIUM-DENDROBATIDIS; POPULATION DECLINES; AMPHIBIAN DECLINES; CHYTRIDIOMYCOSIS; PATHOGEN; DYNAMICS; EXTINCTIONS; PREVALENCE; AUSTRALIA; INFECTION	The amphibian chytrid fungus Batrachochytrium dendrobatidis (Bd) is a purported agent of decline and extinction of many amphibian populations worldwide. Its occurrence remains poorly documented in many tropical regions, including the Guiana Shield, despite the area's high amphibian diversity. We conducted a comprehensive assessment of Bd in French Guiana in order to (1) determine its geographical distribution, (2) test variation of Bd prevalence among species in French Guiana and compare it to earlier reported values in other South American anuran species (http://www.bd-maps.net; 123 species from 15 genera) to define sentinel species for future work, (3) track changes in prevalence through time and (4) determine if Bd presence had a negative effect on one selected species. We tested the presence of Bd in 14 species at 11 sites for a total of 1053 samples (306 in 2009 and 747 in 2012). At least one Bd-positive individual was found at eight out of 11 sites, suggesting a wide distribution of Bd in French Guiana. The pathogen was not uniformly distributed among the studied amphibian hosts, with Dendrobatidae species displaying the highest prevalence (12.4%) as compared to Bufonidae (2.6%) and Hylidae (1.5%). In contrast to earlier reported values, we found highest prevalence for three Dendrobatidae species and two of them displayed an increase in Bd prevalence from 2009 to 2012. Those three species might be the sentinel species of choice for French Guiana. For Dendrobates tinctorius, of key conservation value in the Guiana Shield, smaller female individuals were more likely to be infected, suggesting either that frogs can outgrow their chytrid infections or that the disease induces developmental stress limiting growth. Generally, our study supports the idea that Bd is more widespread than previously thought and occurs at remote places in the lowland forest of the Guiana shield.	[Courtois, Elodie A.] Ctr Natl Rech Sci CNRS Moulis, Stn Ecol Expt, Unite Serv & Rech USR 2936, St Girons, France; [Courtois, Elodie A.; Gaucher, Philippe] Ctr Natl Rech Sci Guyane, Unite Serv & Rech USR 3456, Cayenne, French Guiana; [Chave, Jerome] Unite Mixte Rech UMR 5174, Lab Ecol & Diversite Biol, Toulouse, France; [Schmeller, Dirk S.] Helmholtz Ctr Environm Res, Dept Conservat Biol, Leipzig, Germany; [Schmeller, Dirk S.] Univ Toulouse, Lab Ecol Fonct & Environm Ecolab, Toulouse, France; [Schmeller, Dirk S.] CNRS, EcoLab, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Courtois, EA (corresponding author), Ctr Natl Rech Sci CNRS Moulis, Stn Ecol Expt, Unite Serv & Rech USR 2936, St Girons, France.	courtoiselodie@gmail.com	Schmeller, Dirk S/F-4324-2010; Schmeller, Dirk S./S-6431-2019	Schmeller, Dirk S/0000-0002-3860-9933; Schmeller, Dirk S./0000-0002-3860-9933	Investissement d'Avenir (CEBA) [ANR-10-LABX-25-01]; Investissement d'Avenir (TULIP) [ANR-10-LABX-0041]; BioDiversa-project RACE (Risk Assessment of Chytridiomycosis to European amphibian biodiversity); AMAZONIE research program	Investissement d'Avenir (CEBA)(French National Research Agency (ANR)); Investissement d'Avenir (TULIP)(French National Research Agency (ANR)); BioDiversa-project RACE (Risk Assessment of Chytridiomycosis to European amphibian biodiversity); AMAZONIE research program	This work has benefited from two "Investissement d'Avenir" grants managed by the Agence Nationale de la Recherche (CEBA, ref. ANR-10-LABX-25-01 and TULIP, ref. ANR-10-LABX-0041) and benefitted through the use of the Nouragues station of material and technical support from USR 3456 and AnaEE-S infrastructure (ANR-11-INBS-0001). This work was financially supported by a grant from the AMAZONIE research program and from the BioDiversa-project RACE (Risk Assessment of Chytridiomycosis to European amphibian biodiversity) to DSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, BIOL CONSERV; Bancila RI, 2010, AMPHIBIA-REPTILIA, V31, P558, DOI 10.1163/017353710X518405; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Bielby J, 2008, CONSERV LETT, V1, P82, DOI 10.1111/j.1755-263X.2008.00015.x; Bletz MC, 2015, SCI REP-UK, V5, DOI 10.1038/srep08633; BONGERS F, 2001, NOURAGUES DYNAMICS P; Bourke J, 2010, DIS AQUAT ORGAN, V92, P217, DOI 10.3354/dao02239; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Buck JC, 2011, BIODIVERS CONSERV, V20, P3549, DOI 10.1007/s10531-011-0147-4; Collins JP, 2003, DIVERS DISTRIB, V9, P89, DOI 10.1046/j.1472-4642.2003.00012.x; Courtois EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067486; Courtois Elodie A., 2012, PHYLLOMEDUSA, V11, P63; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Fouquet A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001109; Geiger CC, 2011, AMPHIBIA-REPTILIA, V32, P276, DOI 10.1163/017353711X556970; Gower DJ, 2013, ECOHEALTH, V10, P173, DOI 10.1007/s10393-013-0831-9; Hero JM, 2004, HERPETOL J, V14, P175; Herrera RA, 2005, DIS AQUAT ORGAN, V64, P247, DOI 10.3354/dao064247; Houlahan JE, 2000, NATURE, V404, P752, DOI 10.1038/35008052; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Johnson ML, 2003, EMERG INFECT DIS, V9, P922; Kilburn VL, 2010, ECOHEALTH, V7, P537, DOI 10.1007/s10393-010-0634-1; Kosch Tiffany A., 2012, Herpetological Review, V43, P288; Kriger KM, 2008, AUSTRAL ECOL, V33, P1022, DOI 10.1111/j.1442-9993.2008.01872.x; Kriger KM, 2007, DIVERS DISTRIB, V13, P781, DOI 10.1111/j.1472-4642.2007.00394.x; Lamirande EW, 2002, P 6 INT S PATH REPT, P3; Lampo Margarita, 2008, Herpetological Review, V39, P449; Lescure J., 2001, ATLAS AMPHIBIENS GUY; Lips KR, 2005, BIOTROPICA, V37, P163, DOI 10.1111/j.1744-7429.2005.00023.x; Lips KR, 2003, CONSERV BIOL, V17, P1078, DOI 10.1046/j.1523-1739.2003.01623.x; Lotters S., 2007, POISON FROGS BIOL SP; Luger M, 2008, STUD NEOTROP FAUNA E, V43, P177, DOI 10.1080/01650520802239531; Mazzoni R, 2003, EMERG INFECT DIS, V9, P1188; McCracken Shawn, 2009, Herpetological Review, V40, P190; Carnaval ACOD, 2006, ECOHEALTH, V3, P41, DOI 10.1007/s10393-005-0008-2; Olson DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056802; Parris MJ, 2004, ECOLOGY, V85, P3385, DOI 10.1890/04-0383; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Pistoni Juliana, 2010, South American Journal of Herpetology, V5, P51, DOI 10.2994/057.005.0106; Rebollar EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095484; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Ringler M, 2009, BEHAV ECOL SOCIOBIOL, V63, P1281, DOI 10.1007/s00265-009-0793-7; RON SR, 2000, FROGLOG, V42, P2; Schmeller DS, 2014, CURR BIOL, V24, P176, DOI 10.1016/j.cub.2013.11.032; Skerratt LF, 2008, DIS AQUAT ORGAN, V80, P85, DOI 10.3354/dao01923; Solis R, 2010, BIOL INVASIONS, V12, P1641, DOI 10.1007/s10530-009-9577-2; Spitzen-van der Sluijs A, 2011, AMPHIBIA-REPTILIA, V32, P419, DOI 10.1163/017353711X579830; Stevenson LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073830; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tobler U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010927; Flechas SV, 2012, ECOHEALTH, V9, P298, DOI 10.1007/s10393-012-0771-9; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Walker SF, 2010, ECOL LETT, V13, P372, DOI 10.1111/j.1461-0248.2009.01434.x; Woodhams DC, 2005, CONSERV BIOL, V19, P1449, DOI 10.1111/j.1523-1739.2005.004403.x	56	14	16	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0125128	10.1371/journal.pone.0125128	http://dx.doi.org/10.1371/journal.pone.0125128			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902035	Green Published, gold, Green Submitted			2022-12-26	WOS:000353331500112
J	Li, X; Yang, YC; Gao, B; Zhang, M				Li, Xuan; Yang, Yuechao; Gao, Bin; Zhang, Min			Stimulation of Peanut Seedling Development and Growth by Zero-Valent Iron Nanoparticles at Low Concentrations	PLOS ONE			English	Article							REMEDIATION; DEFICIENCY; PLANTS; PARTICLES; REDUCTION; EXPOSURE; STRESS; NZVI	Because of its strong pollutant degradation ability, nanoscale zerovalent iron (NZVI) has been introduced to soils and groundwater for remediation purposes, but its impacts on plants are still not very clear. In this work, the effects of low concentration (10-320 mu mol/L) NZVI particles on seed germination and growth of peanut plants were evaluated. The exposure of peanut seeds to NZVI at all the tested concentrations altered the seed germination activity, especially the development of seedlings. In comparison with the deionized water treated controls (CK), all of the NZVI treatments had significantly larger average lengths. Further investigations with transmission electron microscopy (TEM) and thermogravimetric analysis (TGA) suggested that NZVI particles may penetrate the peanut seed coats to increase the water uptake to stimulate seed germination. The growth experiments showed that although NZVI at a relatively high concentration (320 mu mol/L) showed phytotoxicity to the peanut plants, the lower concentrations of NZVI particles stimulated the growth and root development of the plants. At certain concentrations (e.g., 40 and 80 mu mol/L), the NZVI treated samples were even better than the ethylenediaminetetraacetate-iron (EDTA-Fe) solution, a commonly used iron nutrient solution, in stimulating the plant growth. This positive effect was probably due to the uptake of NZVI by the plants, as indicated in the TEM analyses. Because low concentrations of NZVI particles stimulated both the seedling development and growth of peanut, they might be used to benefit the growth of peanuts in large-scale agricultural settings.	[Li, Xuan; Yang, Yuechao; Zhang, Min] Shandong Agr Univ, Natl Engn Lab Efficient Utilizat Soil & Fertilize, Natl Engn & Technol Res Ctr Slow & Controlled Rel, Coll Resources & Environm, Tai An 271018, Shandong, Peoples R China; [Yang, Yuechao] Univ Florida, Dept Soil & Water Sci, Trop Res & Educ Ctr, Homestead, FL USA; [Gao, Bin] Univ Florida, Dept Agr & Biol Engn, Gainesville, FL USA	Shandong Agricultural University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Yang, YC (corresponding author), Shandong Agr Univ, Natl Engn Lab Efficient Utilizat Soil & Fertilize, Natl Engn & Technol Res Ctr Slow & Controlled Rel, Coll Resources & Environm, Tai An 271018, Shandong, Peoples R China.	yangyuechao2010@163.com	Gao, Bin/B-8027-2010	Gao, Bin/0000-0003-3769-0191; Yang, Yuechao/0000-0003-4045-0252	major agricultural application technology innovation projects of Shandong Province; Science Tackles Key Problems of Shandong Province [2009GG10006002]; Natural Science Foundation of Shandong Province [Y2008.D29]; Key Projects in the National Science & Technology Pillar Program [2011BAD11B01, 2011BAD11B02]; Key Projects in the National "948" Program [2011-G30]	major agricultural application technology innovation projects of Shandong Province; Science Tackles Key Problems of Shandong Province; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Key Projects in the National Science & Technology Pillar Program; Key Projects in the National "948" Program	This work was partially supported by the major agricultural application technology innovation projects of Shandong Province, the Science Tackles Key Problems of Shandong Province (Grant No. 2009GG10006002), the Natural Science Foundation of Shandong Province (Grant No. Y2008.D29), the Key Projects in the National Science & Technology Pillar Program (2011BAD11B01,2011BAD11B02), and the Key Projects in the National "948" Program (Grant No. 2011-G30).	Adeleye AS, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1418-7; Barnes RJ, 2010, J HAZARD MATER, V184, P73, DOI 10.1016/j.jhazmat.2010.08.006; delaGuardia MD, 1996, J EXP BOT, V47, P669, DOI 10.1093/jxb/47.5.669; Diao MH, 2009, WATER RES, V43, P5243, DOI 10.1016/j.watres.2009.08.051; Ding H, 2009, PHYSIOL PLANTARUM, V136, P274, DOI 10.1111/j.1399-3054.2009.01219.x; El-Temsah YS, 2012, CHEMOSPHERE, V89, P76, DOI 10.1016/j.chemosphere.2012.04.020; El-Temsah YS, 2012, ENVIRON TOXICOL, V27, P42, DOI 10.1002/tox.20610; FAGERIA NK, 1990, PESQUI AGROPECU BRAS, V25, P553; HOAGLAND DR, 1950, AGR EXP STN CIRC, V347, P1036; Huber DL, 2005, SMALL, V1, P482, DOI 10.1002/smll.200500006; Josko I, 2013, CRIT REV ENV SCI TEC, V43, P2581, DOI 10.1080/10643389.2012.694329; Karn B, 2011, CIENC SAUDE COLETIVA, V16, P165, DOI 10.1590/S1413-81232011000100020; Karn B, 2009, ENVIRON HEALTH PERSP, V117, P1823, DOI 10.1289/ehp.0900793; Khodakovskaya M, 2009, ACS NANO, V3, P3221, DOI 10.1021/nn900887m; Khodakovskaya MV, 2012, ACS NANO, V6, P2128, DOI 10.1021/nn204643g; Kim JH, 2014, ENVIRON SCI TECHNOL, V48, P3477, DOI 10.1021/es4043462; Lee C, 2008, ENVIRON SCI TECHNOL, V42, P4927, DOI 10.1021/es800408u; Lin SJ, 2009, SMALL, V5, P1128, DOI 10.1002/smll.200801556; Sacca ML, 2013, MICROB ECOL, V66, P806, DOI 10.1007/s00248-013-0269-1; Ma XM, 2013, SCI TOTAL ENVIRON, V443, P844, DOI 10.1016/j.scitotenv.2012.11.073; Nurmi JT, 2005, ENVIRON SCI TECHNOL, V39, P1221, DOI 10.1021/es049190u; Ponder SM, 2000, ENVIRON SCI TECHNOL, V34, P2564, DOI 10.1021/es9911420; Tang SCN, 2013, WATER RES, V47, P2613, DOI 10.1016/j.watres.2013.02.039; Teja AS, 2009, PROG CRYST GROWTH CH, V55, P22, DOI 10.1016/j.pcrysgrow.2008.08.003; Tosco T, 2014, J CLEAN PROD, V77, P10, DOI 10.1016/j.jclepro.2013.12.026; Trujillo-Reyes J, 2014, J HAZARD MATER, V267, P255, DOI 10.1016/j.jhazmat.2013.11.067; VANWONTERGHEM J, 1986, NATURE, V322, P622, DOI 10.1038/322622a0; Watanabe T, 2009, J PLANT NUTR, V32, P1164, DOI 10.1080/01904160902943189; Wulandari C, 2014, J PLANT NUTR, V37, P50, DOI 10.1080/01904167.2013.837178; Yan WL, 2013, ENVIRON SCI-PROC IMP, V15, P63, DOI [10.1039/c2em30691c, 10.1039]; Ylivainio K, 2004, J PLANT NUTR SOIL SC, V167, P602, DOI 10.1002/jpln.200420412; Zhang WX, 2003, J NANOPART RES, V5, P323, DOI 10.1023/A:1025520116015; Zhou DX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037363	33	83	90	6	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0122884	10.1371/journal.pone.0122884	http://dx.doi.org/10.1371/journal.pone.0122884			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901959	gold, Green Published, Green Submitted			2022-12-26	WOS:000353331500031
J	Regland, B; Forsmark, S; Halaouate, L; Matousek, M; Peilot, B; Zachrisson, O; Gottfries, CG				Regland, Bjorn; Forsmark, Sara; Halaouate, Lena; Matousek, Michael; Peilot, Birgitta; Zachrisson, Olof; Gottfries, Carl-Gerhard			Response to Vitamin B12 and Folic Acid in Myalgic Encephalomyelitis and Fibromyalgia	PLOS ONE			English	Article							CHRONIC-FATIGUE-SYNDROME; NMDA RECEPTOR; MEGALIN; HOMOCYSTEINE; CLASSIFICATION	Background Patients with myalgic encephalomyelitis (ME, also called chronic fatigue syndrome) may respond most favorably to frequent vitamin B12 injections, in vital combination with oral folic acid. However, there is no established algorithm for individualized optimal dosages, and rate of improvement may differ considerably between responders. Objective To evaluate clinical data from patients with ME, with or without fibromyalgia, who had been on B12 injections at least once a week for six months and up to several years. Methods 38 patients were included in a cross-sectional survey. Based on a validated observer's rating scale, they were divided into Good (n = 15) and Mild (n = 23) responders, and the two groups were compared from various clinical aspects. Results Good responders had used significantly more frequent injections (p<0.03) and higher doses of B12 (p < 0.03) for a longer time (p<0.0005), higher daily amounts of oral folic acid (p<0.003) in good relation with the individual MTHFR genotype, more often thyroid hormones (p<0.02), and no strong analgesics at all, while 70% of Mild responders (p<0.0005) used analgesics such as opioids, duloxetine or pregabalin on a daily basis. In addition to ME, the higher number of patients with fibromyalgia among Mild responders was bordering on significance (p<0.09). Good responders rated themselves as "very much" or "much" improved, while Mild responders rated "much" or "minimally" improved. Conclusions Dose-response relationship and long-lasting effects of B12/folic acid support a true positive response in the studied group of patients with ME/fibromyalgia. It's important to be alert on co-existing thyroid dysfunction, and we suspect a risk of counteracting interference between B12/folic acid and certain opioid analgesics and other drugs that have to be demethylated as part of their metabolism. These issues should be considered when controlled trials for ME and fibromyalgia are to be designed.	[Regland, Bjorn; Forsmark, Sara; Halaouate, Lena; Matousek, Michael; Peilot, Birgitta; Zachrisson, Olof; Gottfries, Carl-Gerhard] Gothenburg Univ, Gottfries Clin, Inst Neurosci & Physiol, Gothenburg, Sweden	University of Gothenburg	Regland, B (corresponding author), Gothenburg Univ, Gottfries Clin, Inst Neurosci & Physiol, Gothenburg, Sweden.	bjorn.regland@neuro.gu.se						Bickel MH, 1963, LIFE SCI, V2, P247; Birch CS, 2009, FREE RADICAL BIO MED, V47, P184, DOI 10.1016/j.freeradbiomed.2009.04.023; Birn H, 2005, FEBS J, V272, P4423, DOI 10.1111/j.1742-4658.2005.04857.x; Bizzaro N, 2014, AUTOIMMUN REV, V13, P565, DOI 10.1016/j.autrev.2014.01.042; Brenu EW, 2014, J CLIN CELL IMMUNOL, V5, P228, DOI [10.4172/2155-9899.1000228, DOI 10.4172/2155-9899.1000228]; Carruthers BM, 2003, J CHRONIC FATIGUE SY, V11, P7, DOI [DOI 10.1300/J092V11N01_02, 10.1300/J092v11n01_02]; Chango A, 2000, BRIT J NUTR, V83, P593, DOI 10.1017/S0007114500000751; de Vega WC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104757; DICKENSON AH, 1987, NEUROPHARMACOLOGY, V26, P1235, DOI 10.1016/0028-3908(87)90275-9; Elfaitouri A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081155; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Gena P, 2010, ENVIRON HEALTH PERSP, V118, P1551, DOI 10.1289/ehp.0901874; Grond S, 2004, CLIN PHARMACOKINET, V43, P879, DOI 10.2165/00003088-200443130-00004; Lipton SA, 1997, P NATL ACAD SCI USA, V94, P5923, DOI 10.1073/pnas.94.11.5923; Marzolo MP, 2011, BIOL RES, V44, P89, DOI 10.4067/S0716-97602011000100012; Massoudi Mehran S., 1995, Annals of Epidemiology, V5, P229, DOI 10.1016/1047-2797(94)00110-F; Moestrup SK, 1996, P NATL ACAD SCI USA, V93, P8612, DOI 10.1073/pnas.93.16.8612; Nijs J, 2012, EUR J CLIN INVEST, V42, P203, DOI 10.1111/j.1365-2362.2011.02575.x; Ogino S, 2003, J HUM GENET, V48, P1, DOI 10.1007/s100380300000; OLNEY JW, 1987, BRAIN RES BULL, V19, P597, DOI 10.1016/0361-9230(87)90077-3; PARDRIDGE WM, 1976, J NEUROCHEM, V27, P333, DOI 10.1111/j.1471-4159.1976.tb01595.x; Regland B, 1997, SCAND J RHEUMATOL, V26, P301, DOI 10.3109/03009749709105320; Rietsema WJ, 2014, J AM GERIATR SOC, V62, P1611, DOI 10.1111/jgs.12966; Sousa MM, 2000, J BIOL CHEM, V275, P38176, DOI 10.1074/jbc.M002886200; Suarez-Moreira E, 2009, J AM CHEM SOC, V131, P15078, DOI 10.1021/ja904670x; Vollset SE, 2013, LANCET, V381, P1029, DOI 10.1016/S0140-6736(12)62001-7; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Zachrisson O, 2002, J PSYCHOSOM RES, V52, P501, DOI 10.1016/S0022-3999(01)00315-4	28	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124648	10.1371/journal.pone.0124648	http://dx.doi.org/10.1371/journal.pone.0124648			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902009	Green Submitted, Green Published, gold			2022-12-26	WOS:000353331500096
J	Singh, S; Chand, S; Singh, NK; Sharma, TR				Singh, Sangeeta; Chand, Suresh; Singh, N. K.; Sharma, Tilak Raj			Genome-Wide Distribution, Organisation and Functional Characterization of Disease Resistance and Defence Response Genes across Rice Species	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; ARABIDOPSIS-THALIANA; EXPRESSION ANALYSIS; MILDEW RESISTANCE; ENCODING GENES; REPEAT GENES; EVOLUTION; IDENTIFICATION; ANALOGS; DIVERSITY	The resistance (R) genes and defense response (DR) genes have become very important resources for the development of disease resistant cultivars. In the present investigation, genome-wide identification, expression, phylogenetic and synteny analysis was done for R and DR-genes across three species of rice viz: Oryza sativa ssp indica cv 93-11, Oryza sativa ssp japonica and wild rice species, Oryza brachyantha. We used the in silico approach to identify and map 786 R-genes and 167 DR-genes, 672 R-genes and 142 DR-genes, 251 R-genes and 86 DR-genes in the japonica, indica and O. brachyanth a genomes, respectively. Our analysis showed that 60.5% and 55.6% of the R-genes are tandemly repeated within clusters and distributed over all the rice chromosomes in indica and japonica genomes, respectively. The phylogenetic analysis along with motif distribution shows high degree of conservation of R- and DR-genes in clusters. In silico expression analysis of R-genes and DR-genes showed more than 85% were expressed genes showing corresponding EST matches in the databases. This study gave special emphasis on mechanisms of gene evolution and duplication for R and DR genes across species. Analysis of paralogs across rice species indicated 17% and 4.38% R-genes, 29% and 11.63% DR-genes duplication in indica and Oryza brachyantha, as compared to 20% and 26% duplication of R-genes and DR-genes in japonica respectively. We found that during the course of duplication only 9.5% of R- and DR-genes changed their function and rest of the genes have maintained their identity. Syntenic relationship across three genomes inferred that more orthology is shared between indica and japonica genomes as compared to brachyantha genome. Genome wide identification of R-genes and DR-genes in the rice genome will help in allele mining and functional validation of these genes, and to understand molecular mechanism of disease resistance and their evolution in rice and related species.	[Singh, Sangeeta; Singh, N. K.; Sharma, Tilak Raj] Natl Res Ctr Plant Biotechnol, New Delhi 110012, India; [Singh, Sangeeta; Chand, Suresh] Devi Ahilya Univ, Sch Life Sci, Indore 452017, Madhya Pradesh, India	Indian Council of Agricultural Research (ICAR); ICAR - National Institute For Plant Biotechnology (NIPB); Devi Ahilya University	Sharma, TR (corresponding author), Natl Res Ctr Plant Biotechnol, Pusa Campus, New Delhi 110012, India.	trsharma@nrcpb.org	Singh, Nouratan/N-9377-2017	Singh, Nouratan/0000-0002-8063-8375; SINGH, SANGEETA/0000-0003-3600-9982	Indian Council of Agricultural Research (ICAR, NPTC Project); Department of Biotechnology, Government of India	Indian Council of Agricultural Research (ICAR, NPTC Project); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	Financial support to TRS for this project was provided by Indian Council of Agricultural Research (ICAR, NPTC Project), http://www.icar.org.in/, and the Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameline-Torregrosa C, 2008, PLANT PHYSIOL, V146, P5, DOI 10.1104/pp.107.104588; [Anonymous], 2005, BMC BIOL, V3, P1; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Bai JF, 2002, GENOME RES, V12, P1871, DOI 10.1101/gr.454902; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Baker B, 1997, SCIENCE, V276, P726, DOI 10.1126/science.276.5313.726; Barbosa-Da-Silva A, 2005, GENET MOL BIOL, V28, P562, DOI 10.1590/S1415-47572005000400011; Baumgarten A, 2003, GENETICS, V165, P309; Benko-Iseppon AM, 2003, THEOR APPL GENET, V107, P379, DOI 10.1007/s00122-003-1260-x; Bittner-Eddy PD, 2000, PLANT J, V21, P177, DOI 10.1046/j.1365-313x.2000.00664.x; Botella MA, 1997, PLANT J, V12, P1197, DOI 10.1046/j.1365-313X.1997.12051197.x; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Channamallikarjuna V, 2010, MOL BREEDING, V25, P155, DOI 10.1007/s11032-009-9316-5; Chen G, 2007, J BIOSCIENCES, V32, P713, DOI 10.1007/s12038-007-0071-7; Chen JF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2596; Chen QH, 2010, J MOL EVOL, V70, P137, DOI 10.1007/s00239-009-9316-4; Cheng XA, 2010, GENET MOL BIOL, V33, P292, DOI 10.1590/S1415-47572010005000036; Cordero JC, 2002, THEOR APPL GENET, V104, P1283, DOI 10.1007/s00122-001-0821-0; Dai LY, 2007, J INTEGR PLANT BIOL, V49, P112, DOI 10.1111/j.1744-7909.2006.00413.x; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Ellis J, 2000, CURR OPIN PLANT BIOL, V3, P278, DOI 10.1016/S1369-5266(00)00080-7; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Ghazi IA, 2009, J BIOSCIENCES, V34, P251, DOI 10.1007/s12038-009-0029-z; Glynn NC, 2008, PEST MANAG SCI, V64, P48, DOI 10.1002/ps.1469; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HammondKosack KE, 1997, ANNU REV PLANT PHYS, V48, P575, DOI 10.1146/annurev.arplant.48.1.575; Jinling Liu, 2007, Journal of Genetics and Genomics, V34, P765, DOI 10.1016/S1673-8527(07)60087-3; Jones JDG, 2001, CURR OPIN PLANT BIOL, V4, P281, DOI 10.1016/S1369-5266(00)00174-6; Kikuchi S, 2003, SCIENCE, V301, P376, DOI 10.1126/science.1081288; KOBE B, 1995, NATURE, V374, P183, DOI 10.1038/374183a0; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Kohler A, 2008, PLANT MOL BIOL, V66, P619, DOI 10.1007/s11103-008-9293-9; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Ku HM, 2000, P NATL ACAD SCI USA, V97, P9121, DOI 10.1073/pnas.160271297; Kuang H, 2004, PLANT CELL, V16, P2870, DOI 10.1105/tpc.104.025502; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Lin HN, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-18; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Meyers BC, 1999, PLANT J, V20, P317, DOI 10.1046/j.1365-313X.1999.t01-1-00606.x; Meyers BC, 1998, PLANT CELL, V10, P1817, DOI 10.1105/tpc.10.11.1817; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Monosi B, 2004, THEOR APPL GENET, V109, P1434, DOI 10.1007/s00122-004-1758-x; Mun JH, 2009, MOL GENET GENOMICS, V282, P617, DOI 10.1007/s00438-009-0492-0; NEI M, 1986, MOL BIOL EVOL, V3, P418; Ohtsuki A, 2006, J THEOR BIOL, V238, P780, DOI 10.1016/j.jtbi.2005.06.030; Ou S. H, 1985, RICE DIS; Palomino C, 2006, GENOME, V49, P1227, DOI 10.1139/G06-071; Pryor T, 1993, ADV PLANT PATHOL, V10, P281; Radwan O, 2008, MOL GENET GENOMICS, V280, P111, DOI 10.1007/s00438-008-0346-1; Rawal HC, 2013, INT J GENOMICS, V2013, DOI 10.1155/2013/678969; Richly E, 2002, MOL BIOL EVOL, V19, P76, DOI 10.1093/oxfordjournals.molbev.a003984; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Singh NK, 2012, J PLANT BIOCHEM BIOT, V21, P98, DOI 10.1007/s13562-011-0088-8; Soriano JM, 2005, THEOR APPL GENET, V110, P980, DOI 10.1007/s00122-005-1920-0; Sun Q, 2001, GENETICS, V158, P423; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan XP, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-56; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Throude M, 2009, NUCLEIC ACIDS RES, V37, P1248, DOI 10.1093/nar/gkn1048; Wanderley-Nogueira AC, 2007, GENET MOL RES, V6, P866; Wang XY, 2007, GENETICS, V177, P1753, DOI 10.1534/genetics.107.073197; Wei FS, 2002, PLANT CELL, V14, P1903, DOI 10.1105/tpc.002238; Winter P, 2000, THEOR APPL GENET, V101, P1155, DOI 10.1007/s001220051592; WOLFE KH, 1989, P NATL ACAD SCI USA, V86, P6201, DOI 10.1073/pnas.86.16.6201; Xu Q, 2008, GENETICS, V178, P2081, DOI 10.1534/genetics.107.086421; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Yang SH, 2008, MOL GENET GENOMICS, V280, P187, DOI 10.1007/s00438-008-0355-0; Yang SH, 2008, THEOR APPL GENET, V116, P165, DOI 10.1007/s00122-007-0656-4; Zhou T, 2004, MOL GENET GENOMICS, V271, P402, DOI 10.1007/s00438-004-0990-z	71	26	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0125964	10.1371/journal.pone.0125964	http://dx.doi.org/10.1371/journal.pone.0125964			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902056	Green Published, Green Submitted, gold			2022-12-26	WOS:000353331500120
J	Lee, JW; Park, HS; Park, SA; Ryu, SH; Meng, W; Jurgensmeier, JM; Kurie, JM; Hong, WK; Boyer, JL; Herbst, RS; Koo, JS				Lee, Jong Woo; Park, Hee Sun; Park, Sin-Aye; Ryu, Seung-Hee; Meng, Wuyi; Juergensmeier, Juliane M.; Kurie, Jonathan M.; Hong, Waun Ki; Boyer, Julie L.; Herbst, Roy S.; Koo, Ja Seok			A Novel Small-Molecule Inhibitor Targeting CREB-CBP Complex Possesses Anti-Cancer Effects along with Cell Cycle Regulation, Autophagy Suppression and Endoplasmic Reticulum Stress	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; MUCIN GENE-EXPRESSION; RETINOIC ACID; IDENTIFICATION; ACTIVATOR; DISEASE	Lung adenocarcinoma, the most common subtype of lung cancer, is the leading cause of cancer death worldwide. Despite attempts for the treatment of lung cancer which have been accumulating, promising new therapies are still needed. Here, we found that cyclic-AMP response element-binding protein (CREB)-CREB binding protein (CBP) transcription factors complex inhibitor, Naphthol AS-TR phosphate (NASTRp), is a potential therapeutic agent for lung cancer. We show that NASTRp inhibited oncogenic cell properties through cell cycle arrest with concomitant suppression of tumor-promoting autophagy with down-regulations of Atg5-12 and Atg7, and accumulation of p62 in human lung cancer cell lines. In addition, NASTRp induced expression of endoplasmic reticulum stress markers such as DDIT3/CHOP, and led to apoptosis along with Bim induction. These findings suggest that transcription factor/co-activator complex, CREB-CBP, can be a potential therapeutic target and its inhibition could be a novel therapeutic strategy for lung cancer.	[Lee, Jong Woo; Park, Hee Sun; Park, Sin-Aye; Juergensmeier, Juliane M.; Boyer, Julie L.; Herbst, Roy S.; Koo, Ja Seok] Yale Univ, Sch Med, Yale Comprehens Canc Ctr, Sect Med Oncol,Dept Internal Med, New Haven, CT 06520 USA; [Ryu, Seung-Hee] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiat Oncol, Seoul, South Korea; [Meng, Wuyi] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Kurie, Jonathan M.; Hong, Waun Ki] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Herbst, Roy S.; Koo, Ja Seok] Yale Comprehens Canc Ctr, Translat Res Program, New Haven, CT 06520 USA	Yale University; University of Ulsan; Asan Medical Center; Yale University; University of Texas System; UTMD Anderson Cancer Center; Yale University	Koo, JS (corresponding author), Yale Univ, Sch Med, Yale Comprehens Canc Ctr, Sect Med Oncol,Dept Internal Med, New Haven, CT 06520 USA.	jpeter.koo@yale.edu	Koo, J Peter/AAE-6700-2019; Park, Sin-Aye/E-2303-2019	Park, Hee Sun/0000-0002-9730-8524; Park, Sin-Aye/0000-0003-2456-3572	National Cancer Institute [R01-CA126801]; Yale Comprehensive Cancer Center; National Cancer Institute Cancer Center [CA-16359]; NATIONAL CANCER INSTITUTE [P30CA016359, R01CA126801] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Yale Comprehensive Cancer Center; National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute grant R01-CA126801 (JSK), a Pilot Grant from the Yale Comprehensive Cancer Center (JSK), and National Cancer Institute Cancer Center Support Grant CA-16359 (to Yale Comprehensive Cancer Center).	Aggarwal S, 2008, CANCER RES, V68, P981, DOI 10.1158/0008-5472.CAN-06-0249; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Baumeister P, 2005, MOL CELL BIOL, V25, P4529, DOI 10.1128/MCB.25.11.4529-4540.2005; Baurin N, 2004, J CHEM INF COMP SCI, V44, P643, DOI 10.1021/ci034260m; Beier F, 1999, P NATL ACAD SCI USA, V96, P1433, DOI 10.1073/pnas.96.4.1433; Best JL, 2004, P NATL ACAD SCI USA, V101, P17622, DOI 10.1073/pnas.0406374101; Cheng JC, 2008, BLOOD, V111, P1182, DOI 10.1182/blood-blood-2007-04-083600; Conkright MD, 2005, TRENDS CELL BIOL, V15, P457, DOI 10.1016/j.tcb.2005.07.007; DALBY A, 1992, J CHEM INF COMP SCI, V32, P244, DOI 10.1021/ci00007a012; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Guo JY, 2013, GENE DEV, V27, P1447, DOI 10.1101/gad.219642.113; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Kasper LH, 2010, EMBO J, V29, P3660, DOI 10.1038/emboj.2010.235; Kim SW, 2007, MOL CELL BIOL, V27, P6933, DOI 10.1128/MCB.02385-06; Kim SW, 2007, CANCER RES, V67, P6565, DOI 10.1158/0008-5472.CAN-06-2783; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Koo JS, 1999, BIOCHEM J, V338, P351, DOI 10.1042/0264-6021:3380351; Lee J, 2011, CANCER PREV RES, V4, P1306, DOI 10.1158/1940-6207.CAPR-10-0364; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Moreno CS, 1999, IMMUNITY, V10, P143, DOI 10.1016/S1074-7613(00)80015-1; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Parker D, 1996, MOL CELL BIOL, V16, P694; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Ritchie DW, 2010, BIOINFORMATICS, V26, P2398, DOI 10.1093/bioinformatics/btq444; Seo HS, 2008, CANCER RES, V68, P6065, DOI 10.1158/0008-5472.CAN-07-5376; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sun HX, 2008, CANCER PREV RES, V1, P316, DOI 10.1158/1940-6207.CAPR-07-0002; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5	36	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0122628	10.1371/journal.pone.0122628	http://dx.doi.org/10.1371/journal.pone.0122628			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897662	Green Published, Green Submitted, gold			2022-12-26	WOS:000353212600012
J	Lin, MB; Sun, W; Gong, W; Zhou, ZY; Ding, YS; Hou, Q				Lin, Mingbao; Sun, Wei; Gong, Wan; Zhou, Zhiyu; Ding, Yasi; Hou, Qi			Methylophiopogonanone A Protects against Cerebral Ischemia/Reperfusion Injury and Attenuates Blood-Brain Barrier Disruption In Vitro	PLOS ONE			English	Article							ARTERY OCCLUSION; ISCHEMIA; STROKE; EDEMA; MODEL; HOMOISOFLAVONOIDS; EXPRESSION; TRIALS	Methylophiopogonanone A (MO-A), an active homoisoflavonoid of the Chinese herb Ophiopogon japonicus which has been shown to have protective effects on cerebral ischemia/reperfusion (I/R) injury, has been demonstrated to have anti-inflammatory and anti-oxidative properties. However, little is known about its role in cerebral I/R injury. Therefore, in this study, by using a middle cerebral artery occlusion (MCAO) and reperfusion rat model, the effect of MO-A on cerebral I/R injury was examined. The results showed that MO-A treatment reduced infarct volume and brain edema, improved neurological deficit scores, reversed animal body weight decreases, and increased animal survival time in the stroke groups. Western blotting showed that MO-A suppressed MMP-9, but restored the expression of claudin-3 and claudin-5. Furthermore, transmission electron microscopy were monitored to determine the blood-brain barrier (BBB) alterations in vitro. The results showed that MO-A markedly attenuated BBB damage in vitro. Additionally, MO-A inhibited ROS production in ECs and MMP-9 release in differentiated THP-1 cells in vitro, and suppressed ICAM-1 and VCAM-1 expression in ECs and leukocyte/EC adhesion. In conclusion, our data indicate that MO-A has therapeutic potential against cerebral I/R injury through its ability to attenuate BBB disruption by regulating the expression of MMP-9 and tight junction proteins.	[Lin, Mingbao; Ding, Yasi; Hou, Qi] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100730, Peoples R China; [Lin, Mingbao; Ding, Yasi; Hou, Qi] Peking Union Med Coll, Beijing 100021, Peoples R China; [Sun, Wei] Capital Med Univ, Beijing Friendship Hosp, Clin Lab Ctr, Beijing, Peoples R China; [Gong, Wan] Zhejiang Chinese Med Univ, Coll Basic Med Sci, Hangzhou, Zhejiang, Peoples R China; [Zhou, Zhiyu] Jiangxi Univ Tradit Chinese Med, Coll Basic Med Sci, Nanchang, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Medical University; Zhejiang Chinese Medical University; Jiangxi University of Traditional Chinese Medicine	Hou, Q (corresponding author), Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100730, Peoples R China.	houq@imm.ac.cn			National Twelfth-Five Year Research Program of China [2012ZX09301002001002]; National Natural Science Foundation of China [81473398]; scientific research foundation of Beijing Friendship Hospital [Z20140512030022]	National Twelfth-Five Year Research Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); scientific research foundation of Beijing Friendship Hospital	The current study was supported by research grants from the National Twelfth-Five Year Research Program of China (2012ZX09301002001002), the National Natural Science Foundation of China (Grant No. 81473398) and the scientific research foundation of Beijing Friendship Hospital (Z20140512030022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; Cheng Yu Dennis, 2004, NeuroRx, V1, P36, DOI 10.1007/BF03206566; Chopp M, 1996, J CEREBR BLOOD F MET, V16, P578, DOI 10.1097/00004647-199607000-00007; Curry SH, 2003, ANN NY ACAD SCI, V993, P69, DOI 10.1111/j.1749-6632.2003.tb07512.x; Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015; Gasche Y, 2001, J CEREBR BLOOD F MET, V21, P1393, DOI 10.1097/00004647-200112000-00003; Gladstone DJ, 2002, STROKE, V33, P2123, DOI 10.1161/01.STR.0000025518.34157.51; Gu JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061641; Guan T, 2013, EUR J PHARMACOL, V714, P303, DOI 10.1016/j.ejphar.2013.07.036; Jin G, 2008, STROKE, V39, P2538, DOI 10.1161/STROKEAHA.108.514927; Khatri R, 2012, NEUROLOGY, V79, pS52, DOI 10.1212/WNL.0b013e3182697e70; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Li LH, 2013, CHIN J NAT MEDICINES, V11, P222, DOI [10.1016/S1875-5364(13)60020-5, 10.3724/SP.J.1009.2013.00222]; Li N, 2012, FITOTERAPIA, V83, P1042, DOI 10.1016/j.fitote.2012.05.011; Lijnen HR, 2001, THROMB HAEMOSTASIS, V86, P324; Lin YN, 2010, J PHARMACEUT BIOMED, V52, P757, DOI 10.1016/j.jpba.2010.02.016; Liu FD, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/464701; Liu Y, 2014, BRAIN RES, V1544, P45, DOI 10.1016/j.brainres.2013.11.031; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Miyazaki T, 2011, STROKE, V42, P1097, DOI 10.1161/STROKEAHA.110.598359; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; Rubin LL, 1999, ANNU REV NEUROSCI, V22, P11, DOI 10.1146/annurev.neuro.22.1.11; Sasaki Masanori, 2009, V549, P187, DOI 10.1007/978-1-60327-931-4_13; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Strbian D, 2008, NEUROSCIENCE, V153, P175, DOI 10.1016/j.neuroscience.2008.02.012; Wang Q, 2009, STROKE, V40, P2157, DOI 10.1161/STROKEAHA.108.541490; Wang ZF, 2011, J CEREBR BLOOD F MET, V31, P52, DOI 10.1038/jcbfm.2010.195; Wardlaw JM, 2009, ANN NEUROL, V65, P194, DOI 10.1002/ana.21549; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Zehendner CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082823; Zhang RL, 1999, STROKE, V30, P624, DOI 10.1161/01.STR.30.3.624; Zhou Yi-Feng, 2008, Chinese Journal of Natural Medicines, V6, P201, DOI 10.3724/SP.J.1009.2008.00201; Zhu HR, 2010, NEUROPHARMACOLOGY, V59, P70, DOI 10.1016/j.neuropharm.2010.03.017	35	33	37	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124558	10.1371/journal.pone.0124558	http://dx.doi.org/10.1371/journal.pone.0124558			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897666	Green Published, gold, Green Submitted			2022-12-26	WOS:000353212600072
J	Rocco, ML; Balzamino, BO; Passeri, PP; Micera, A; Aloe, L				Rocco, Maria Luisa; Balzamino, Bijorn Omar; Passeri, Pamela Petrocchi; Micera, Alessandra; Aloe, Luigi			Effect of Purified Murine NGF on Isolated Photoreceptors of a Rodent Developing Retinitis Pigmentosa	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; RETINAL GANGLION-CELLS; ROYAL-COLLEGE; SURGEONS RAT; ANIMAL-MODEL; DEGENERATION; NEUROTROPHINS; EYE; EXPRESSION; P75	A number of different studies have shown that neurotrophins, including nerve growth factor (NGF) support the survival of retinal ganglion neurons during a variety if insults. Recently, we have reported that that eye NGF administration can protect also photoreceptor degeneration in a mice and rat with inherited retinitis pigmentosa. However, the evidence that NGF acts directly on photoreceptors and that other retinal cells mediate the NGF effect could not be excluded. In the present study we have isolated retinal cells from rats with inherited retinitis pigmentosa (RP) during the post-natal stage of photoreceptor degenerative. In presence of NGF, these cells are characterized by enhanced expression of NGF-receptors and rhodopsin, the specific marker of photoreceptor and better cell survival, as well as neuritis outgrowth. Together these observations support the hypothesis that NGF that NGF acts directly on photoreceptors survival and prevents photoreceptor degeneration as previously suggested by in vivo studies.	[Rocco, Maria Luisa; Passeri, Pamela Petrocchi; Aloe, Luigi] CNR, Inst Cell Biol & Neurobiol, Rome, Italy; [Balzamino, Bijorn Omar; Micera, Alessandra] IRCCS, GB Bietti Fdn, Rome, Italy; [Passeri, Pamela Petrocchi] Univ Roma Tor Vergata, Dept Med Syst, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR); IRCCS - Fondazione "G.B. Bietti" per lo Studio e la Ricerca in Oftalmologia; University of Rome Tor Vergata	Aloe, L (corresponding author), CNR, Inst Cell Biol & Neurobiol, Rome, Italy.	luigi.aloe@cnr.it	Micera, Alessandra/J-3373-2013; balzamino, bijorn omar/A-4433-2013	balzamino, bijorn omar/0000-0002-2254-1647	project "NGF on Retinitis Pigmentosa" [RF-2010-2318561]; Italian Ministry of Health and Fondazione Roma (Italy)	project "NGF on Retinitis Pigmentosa"; Italian Ministry of Health and Fondazione Roma (Italy)(Fondazione Roma)	This study was partially supported by the project "NGF on Retinitis Pigmentosa" (RF-2010-2318561) to L. Aloe and M.L. Rocco. The findings of this study are part of the PhD program of M.L.R (University Tor Vergata, Rome, Italy). B.O. Balzamino and A. Micera were supported by the Italian Ministry of Health and Fondazione Roma (Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amendola T, 2003, NEUROSCI LETT, V345, P37, DOI 10.1016/S0304-3940(03)00491-9; Amendola T, 2002, ARCH ITAL BIOL, V140, P81; Angelucci C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050804; BARDE Y-A, 1990, Progress in Growth Factor Research, V2, P237, DOI 10.1016/0955-2235(90)90021-B; BOCCHINI V, 1969, P NATL ACAD SCI USA, V64, P787, DOI 10.1073/pnas.64.2.787; Bourne M C, 1938, Br J Ophthalmol, V22, P613, DOI 10.1136/bjo.22.10.613; CARMIGNOTO G, 1989, J NEUROSCI, V9, P1263; CHAN KY, 1981, J NEUROSCI, V1, P1155; CHAO MV, 1995, TRENDS NEUROSCI, V18, P321, DOI 10.1016/0166-2236(95)93922-K; Chen Q, 2015, GROWTH FACTORS, V24, P1; Coassin M, 2008, GRAEF ARCH CLIN EXP, V246, P1743, DOI 10.1007/s00417-008-0913-5; Colafrancesco V, 2011, ANN I SUPER SANITA, V47, P284, DOI 10.4415/ANN_11_03_08; DUNAIEF JL, 1995, HUM GENE THER, V6, P1225, DOI 10.1089/hum.1995.6.9-1225; el-Hifnawi E, 1989, Prog Clin Biol Res, V314, P343; FAKTOROVICH EG, 1990, NATURE, V347, P83, DOI 10.1038/347083a0; FISCHER W, 1987, NATURE, V329, P65, DOI 10.1038/329065a0; Frade JM, 1999, MICROSC RES TECHNIQ, V45, P243, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<243::AID-JEMT8>3.0.CO;2-S; Gouras P, 1999, INVEST OPHTH VIS SCI, V32, P1704; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Katai N, 2006, JPN J OPHTHALMOL, V50, P121, DOI 10.1007/s10384-005-0296-7; Lambiase A, 1996, GRAEF ARCH CLIN EXP, V234, pS96, DOI 10.1007/BF02343055; Lambiase A, 2009, ANN I SUPER SANITA, V45, P439; Lambiase A, 2009, P NATL ACAD SCI USA, V106, P13469, DOI 10.1073/pnas.0906678106; LAVAIL MM, 1992, P NATL ACAD SCI USA, V89, P11249, DOI 10.1073/pnas.89.23.11249; Lenzi L, 2005, VISION RES, V45, P1491, DOI 10.1016/j.visres.2004.12.020; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LI L, 1993, NAT GENET, V5, P413, DOI 10.1038/ng1293-413; Little CW, 1996, INVEST OPHTH VIS SCI, V37, P204; Lohr HR, 2006, EXP EYE RES, V83, P380, DOI 10.1016/j.exer.2006.01.014; LOPEZ R, 1989, INVEST OPHTH VIS SCI, V30, P586; Mantelli F, 2014, EUR J OPHTHALMOL, V24, P247, DOI 10.5301/ejo.5000359; McAllister AK, 2001, CELL MOL LIFE SCI, V58, P1054, DOI 10.1007/PL00000920; MEAKIN SO, 1992, TRENDS NEUROSCI, V15, P323, DOI 10.1016/0166-2236(92)90047-C; Micera A, 2004, CYTOKINE GROWTH F R, V15, P411, DOI 10.1016/j.cytogfr.2004.09.003; Micera A, 2007, CYTOKINE GROWTH F R, V18, P245, DOI 10.1016/j.cytogfr.2007.04.004; Micera A, 2006, EXP EYE RES, V83, P747, DOI 10.1016/j.exer.2006.03.010; Musarella MA, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/753547; PERRY J, 1995, CURR EYE RES, V14, P585, DOI 10.3109/02713689508998406; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Sancho-Pelluz J, 2008, MOL NEUROBIOL, V38, P253, DOI 10.1007/s12035-008-8045-9; SILIPRANDI R, 1993, INVEST OPHTH VIS SCI, V34, P3232; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; STOECKEL K, 1975, BRAIN RES, V89, P1, DOI 10.1016/0006-8993(75)90129-8; Strauss O, 1998, ACTA ANAT, V162, P101; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239; von Bartheld CS, 1998, HISTOL HISTOPATHOL, V13, P437, DOI 10.14670/HH-13.437; Zaccaro MC, 2001, J BIOL CHEM, V276, P31023, DOI 10.1074/jbc.M104630200	47	20	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124810	10.1371/journal.pone.0124810	http://dx.doi.org/10.1371/journal.pone.0124810			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897972	Green Published, Green Submitted, gold			2022-12-26	WOS:000353212600088
J	Tsutsui, I; Miyoshi, T; Sukchai, H; Pinphoo, P; Aueumneoy, D; Meeanan, C; Songphatkaew, J; Klomkling, S; Yamaguchi, I; Ganmanee, M; Sudo, H; Hamano, K				Tsutsui, Isao; Miyoshi, Tatsuo; Sukchai, Halethichanok; Pinphoo, Piyarat; Aueumneoy, Dusit; Meeanan, Chonlada; Songphatkaew, Jaruwan; Klomkling, Sirimas; Yamaguchi, Iori; Ganmanee, Monthon; Sudo, Hiroyuki; Hamano, Kaoru			Ecological and Morphological Profile of Floating Spherical Cladophora socialis Aggregations in Central Thailand	PLOS ONE			English	Article							RNA GENE-SEQUENCES; CHLOROPHYTA; ULTRASTRUCTURE; PHYLOGENY	The unique beauty of spherical aggregation forming algae has attracted much attention from both the scientific and lay communities. Several aegagropilous seaweeds have been identified to date, including the plants of genus Cladophora and Chaetomorpha. However, this phenomenon remains poorly understood. In July 2013, a mass occurrence of spherical Cladophora aggregations was observed in a salt field reservoir in Central Thailand. The aims of the present study were to describe the habitat of the spherical aggregations and confirm the species. We performed a field survey, internal and external morphological observations, pyrenoid ultrastructure observations, and molecular sequence analysis. Floating spherical Cladophora aggregations (1-8 cm in diameter) were observed in an area similar to 560 m(2), on the downwind side of the reservoir where there was water movement. Individual filaments in the aggregations were entangled in each other; consequently, branches growing in different directions were observed within a clump. We suggest that water movement and morphological characteristics promote the formation of spherical aggregations in this species. The molecular sequencing results revealed that the study species was highly homologous to both Cladophora socialis and C. coelothrix. However, the diameter of the apical cells in the study species was less than that of C. coelothrix. The pyrenoid ultrastructure was more consistent with that of Cladophora socialis. We conclude that the study species is Cladophora socialis. This first record of spherical aggregations in this species advances our understanding of these formations. However, further detailed physical measurements are required to fully elucidate the mechanism behind these spherical formations.	[Tsutsui, Isao; Sudo, Hiroyuki] JIRCAS, Div Fisheries, Tsukuba, Ibaraki, Japan; [Miyoshi, Tatsuo; Hamano, Kaoru] Natl Res Inst Fisheries & Environm Inland Sea, Res Ctr Marine Invertebrates, Onomichi, Hiroshima, Japan; [Sukchai, Halethichanok; Meeanan, Chonlada; Klomkling, Sirimas] KMITL, SCORL, Bangkok, Thailand; [Tsutsui, Isao; Pinphoo, Piyarat; Aueumneoy, Dusit; Songphatkaew, Jaruwan; Ganmanee, Monthon] KMITL, Dept Anim Prod & Fisheries, Bangkok, Thailand; [Yamaguchi, Iori] Fukuoka Inst Technol, Dept Life Environm & Mat Sci, Fukuoka, Japan	Japan International Research Center for Agricultural Sciences; Japan Fisheries Research & Education Agency (FRA); King Mongkuts Institute of Technology Ladkrabang; King Mongkuts Institute of Technology Ladkrabang; Fukuoka Institute of Technology	Tsutsui, I (corresponding author), JIRCAS, Div Fisheries, Tsukuba, Ibaraki, Japan.	cong@affrc.go.jp			international research project "Development of aquaculture technologies for suitable and equitable production of aquatic products in tropical coastal areas"	international research project "Development of aquaculture technologies for suitable and equitable production of aquatic products in tropical coastal areas"	This study was funded and performed as part of the international research project "Development of aquaculture technologies for suitable and equitable production of aquatic products in tropical coastal areas" conducted by the Faculty of Agricultural Technology, KMITL and the Fisheries Division, JIRCAS. The funding bodies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott IA, 2004, BISHOP MUSEUM B BOT, V4, P260; ArthurC.Mathieson, 2002, ALGAE, V17, P283; BACH SD, 1978, MAR POLLUT BULL, V9, P34, DOI 10.1016/0025-326X(78)90529-5; BAKKER FT, 1994, MOL PHYLOGENET EVOL, V3, P365, DOI 10.1006/mpev.1994.1043; Berry S, 2014, YAHOO NEWS      0929; Boedeker C, 2012, J PHYCOL, V48, P808, DOI 10.1111/j.1529-8817.2012.01145.x; Boedeker C, 2010, BIOSCIENCE, V60, P187, DOI 10.1525/bio.2010.60.3.5; Boedeker C, 2010, AQUAT BOT, V92, P75, DOI 10.1016/j.aquabot.2009.10.006; Boedeker C, 2009, AQUAT ECOL, V43, P891, DOI 10.1007/s10452-009-9231-1; Burrows, 1991, SEAWEEDS BRIT ISLES; CHAN K, 1978, PHYCOLOGIA, V17, P419, DOI 10.2216/i0031-8884-17-4-419.1; Cocquyt E, 2010, MOL BIOL EVOL, V27, P2052, DOI 10.1093/molbev/msq091; Dawes C., 2008, SEAWEEDS FLORIDA, V1; GIBBS SP, 1962, J ULTRA MOL STRUCT R, V7, P262, DOI 10.1016/S0022-5320(62)90022-9; Guiry MD, 2014, ALGAEBASE; Hanyuda T, 2002, J PHYCOL, V38, P564, DOI 10.1046/j.1529-8817.2002.01151.x; Hasegawa Y, 1978, OCCURRENCE SEAWATER, V19, P5; Hori T, 1967, SCI REPT TOKYO KYO B, V12, P225; Ichihara K, 2013, PHYCOLOGIA, V52, P398, DOI 10.2216/12-102.1; KUROGI M, 1980, Japanese Journal of Phycology, V28, P168; Leliaert F, 2003, EUR J PHYCOL, V38, P233, DOI 10.1080/1364253031000136376; Leliaert F, 2003, NOVA HEDWIGIA, V76, P45, DOI 10.1127/0029-5035/2003/0076-0045; Leliaert F., 2007, GREEN SEAWEEDS BRITA, P131; Leliaert F, 2007, MOL PHYLOGENET EVOL, V44, P1237, DOI 10.1016/j.ympev.2007.04.016; Lewin J., 1966, PHYCOLOGIA, V6, P1, DOI [10.2216/i0031-8884-6-1-1.1, DOI 10.2216/I0031-8884-6-1-1.1]; Littler D.S., 1989, MARINE PLANTS CARIBB; Mathieson AC, 2000, RHODORA, V102, P202; Matsuyama K, 2000, MEM NATN SCI MUS TOK, V34, P139; Matsuyama Kazuyo, 1998, Journal of Japanese Botany, V73, P279; Matsuyama-Serisawa K, 2009, MOUNT FUJI RES, V3, P13; Miyaji K, 1999, PHYCOLOGIA, V38, P267, DOI 10.2216/i0031-8884-38-4-267.1; NIIYAMA Y, 1989, PHYCOLOGIA, V28, P70, DOI 10.2216/i0031-8884-28-1-70.1; Niiyama Y, 1986, JAP J PHYCOL, V34, P216; Provasoli L, 1966, CULTURES COLLECTIONS, P63; Sakai Y, 1964, SCI PAPERS I ALGALOG; Sano O, 1994, MARIMO RES, V3, P26; SCOTT JL, 1976, CAN J BOT, V54, P1546, DOI 10.1139/b76-169; Thai Meteorological Department, 2014, CLIM DAT PER 2 UNPUB; Thiamdao S, 2012, CHIANG MAI J SCI, V39, P300; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Togashi T, 2014, SCI REP, V4, P1; van den Hoek C, 2000, NAT SCI MUS MONOGRAP, V19; VANDENHOEK C, 1984, PHYCOLOGIA, V23, P39, DOI 10.2216/i0031-8884-23-1-39.1; Wang XY, 1989, JAPANEE J PHYCOLGY, V37, P57; WITTMANN W, 1965, STAIN TECHNOL, V40, P161, DOI 10.3109/10520296509116398	45	7	7	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124997	10.1371/journal.pone.0124997	http://dx.doi.org/10.1371/journal.pone.0124997			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898393	Green Submitted, Green Published, gold			2022-12-26	WOS:000353212600094
J	Blaen, PJ; Jia, L; Peh, KSH; Field, RH; Balmford, A; MacDonald, MA; Bradbury, RB				Blaen, Phillip J.; Jia, Li; Peh, Kelvin S. -H.; Field, Rob H.; Balmford, Andrew; MacDonald, Michael A.; Bradbury, Richard B.			Rapid Assessment of Ecosystem Services Provided by Two Mineral Extraction Sites Restored for Nature Conservation in an Agricultural Landscape in Eastern England	PLOS ONE			English	Article							BENEFITS	Despite growing recognition that mineral sites restored for nature conservation can enhance local biodiversity, the wider societal benefits provided by this type of restoration relative to alternative options are not well understood. This study addresses this research gap by quantifying differences in ecosystem services provision under two common mineral site after-uses: nature conservation and agriculture. Using a combination of site-specific primary field data, benefits transfer and modelling, we show that for our sites restoration for nature conservation provides a more diverse array of ecosystem services than would be delivered under an agricultural restoration scenario. We also explore the effects of addressing different conservation targets, which we find alter the provision of ecosystem services on a service- specific basis. Highly species-focused intervention areas are associated with increased carbon storage and livestock grazing provision, whereas non-intervention areas are important for carbon sequestration, fishing, recreation and flood risk mitigation. The results of this study highlight the wider societal importance of restored mineral sites and may help conservation managers and planners to develop future restoration strategies that provide benefits for both biodiversity and human well-being.	[Blaen, Phillip J.; Field, Rob H.; MacDonald, Michael A.; Bradbury, Richard B.] RSPB, RSPB Ctr Conservat Sci, Sandy SG19 2DL, Beds, England; [Blaen, Phillip J.] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham B15 2TT, W Midlands, England; [Jia, Li] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Peh, Kelvin S. -H.; Balmford, Andrew] Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge CB2 3EJ, England; [Peh, Kelvin S. -H.] Univ Southampton, Inst Life Sci, Southampton SO17 1BJ, Hants, England	Royal Society for Protection of Birds; University of Birmingham; University of Hong Kong; University of Cambridge; University of Southampton	Blaen, PJ (corresponding author), RSPB, RSPB Ctr Conservat Sci, Sandy SG19 2DL, Beds, England.	p.j.blaen@bham.ac.uk	Peh, Kelvin/C-3408-2013; field, rob/M-4442-2019	Peh, Kelvin/0000-0002-2921-1341; field, rob/0000-0002-0194-6872; Blaen, Phillip/0000-0001-5748-3072; Bradbury, Richard/0000-0002-1245-2763; Balmford, Andrew/0000-0002-0144-3589	INTERREG North-West Europe programme - EU European Regional Development Fund [293J RESTORE]	INTERREG North-West Europe programme - EU European Regional Development Fund	PJB was supported by: INTERREG North-West Europe programme (financed by the EU European Regional Development Fund). www.nweurope.eu. Grant code: 293J RESTORE. All other authors received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard V, 2007, AGR ECOSYST ENVIRON, V121, P47, DOI 10.1016/j.agee.2006.12.004; Alonso I, 2012, NATURAL ENGLAND RES; Anderson-Teixeira KJ, 2011, GLOBAL CHANGE BIOL, V17, P425, DOI 10.1111/j.1365-2486.2010.02220.x; [Anonymous], 2007, CLIMATE CHANGE 2007; Arnberger A, 2011, LANDSCAPE RES, V36, P19, DOI 10.1080/01426397.2010.536204; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Bateman IJ, 2011, ENVIRON RESOUR ECON, V48, P177, DOI 10.1007/s10640-010-9418-x; Benes J, 2003, CONSERV BIOL, V17, P1058, DOI 10.1046/j.1523-1739.2003.02092.x; Bide T, 2013, UK MINERALS YB 2013; Birch JC, 2010, P NATL ACAD SCI USA, V107, P21925, DOI 10.1073/pnas.1003369107; Burkhard B, 2012, ECOL INDIC, V21, P17, DOI 10.1016/j.ecolind.2011.06.019; Couwenberg J., 2011, Mires and Peat, V8, P2; Couwenberg J., 2008, EMISSION REDUCTIONS; Davies A. M., 2006, NATURE MINERALS MINE; De Groot RS, 2013, CONSERV BIOL, V27, P1286, DOI 10.1111/cobi.12158; DEFRA, STRUCT AGR IND ENGL; DEFRA, 2014, AGR UK; DEFRA, 2010, FERT MAN RB209; Environment Agency England, 2014, GREAT OUS RIV DISCH; Fischer J, 2008, FRONT ECOL ENVIRON, V6, P382, DOI 10.1890/070019; Fisher B, 2011, BIODIVERS CONSERV, V20, P2461, DOI 10.1007/s10531-011-9998-y; Forster P., 2007, CLIMATE CHANGE 2007, DOI DOI 10.1103/PHYSREVB.77.220407; HAWKE CJ, 1996, REEDBED MANAGEMENT C; Hudson C., 2008, RSPB OUSE FEN MANAGE; Humphries Rowell Associates Ltd. Needingworth Environmental Statement Section, 1999, NEED QUARR WETL HA 2; Intergovernmental Panel on Climate Change, GUIDELINES NATL GREE, V4; Johnson AI, 1967, SPECIFIC YIELD COMPI; Kaltenborn BP, 2002, LANDSCAPE URBAN PLAN, V59, P1, DOI 10.1016/S0169-2046(01)00243-2; Kangas K, 2010, ECOL APPL, V20, P1775, DOI 10.1890/09-0399.1; Kareiva P, 2012, BIOSCIENCE, V62, P962, DOI 10.1525/bio.2012.62.11.5; King H., 2013, INTRO ECOSYSTEM SERV; Lal R, 2004, ENVIRON INT, V30, P981, DOI 10.1016/j.envint.2004.03.005; Lang B, 2012, FARM BUSINESS SURVEY; Lienhoop N, 2009, WATER RESOUR MANAG, V23, P965, DOI 10.1007/s11269-008-9309-x; Metzger MJ, 2006, AGR ECOSYST ENVIRON, V114, P69, DOI 10.1016/j.agee.2005.11.025; Miller SM, 2013, P NATL ACAD SCI USA, V110, P20018, DOI 10.1073/pnas.1314392110; Morey E, 2008, ECOL ECON, V68, P536, DOI 10.1016/j.ecolecon.2008.05.015; Morison J., 2012, UNDERSTANDING CARBON, P1; Office for National Statistics, 2011, 2011 CENS POP AN; Peh KSH, 2013, ECOSYST SERV, V5, pE51, DOI 10.1016/j.ecoser.2013.06.003; Peh KSH, 2014, ECOL EVOL, V4, P3875, DOI 10.1002/ece3.1248; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; Plummer ML, 2009, FRONT ECOL ENVIRON, V7, P38, DOI 10.1890/080091; Posthumus H, 2010, ECOL ECON, V69, P1510, DOI 10.1016/j.ecolecon.2010.02.011; Pretty JN, 2006, ENVIRON SCI TECHNOL, V40, P1114, DOI 10.1021/es051670d; RATCLIFFE DA, 1974, PROC R SOC LON SER-A, V339, P355, DOI 10.1098/rspa.1974.0126; Raudsepp-Hearne C, 2010, P NATL ACAD SCI USA, V107, P5242, DOI 10.1073/pnas.0907284107; Benayas JMR, 2009, SCIENCE, V325, P1121, DOI 10.1126/science.1172460; Santoul F, 2004, BIODIVERS CONSERV, V13, P1231, DOI 10.1023/B:BIOC.0000018154.02096.4b; Seppelt R, 2011, J APPL ECOL, V48, P630, DOI 10.1111/j.1365-2664.2010.01952.x; Thomas MV, 2011, BIOGEOSCIENCES, V8, P1595, DOI 10.5194/bg-8-1595-2011; Wells M.P., 1997, EC PERSPECTIVES NATU	52	66	68	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0121010	10.1371/journal.pone.0121010	http://dx.doi.org/10.1371/journal.pone.0121010			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894293	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000353211700007
J	Hiyoshi, Y; Schetter, AJ; Okayama, H; Inamura, K; Anami, K; Nguyen, GH; Horikawa, I; Hawkes, JE; Bowman, ED; Leung, SY; Harris, CC				Hiyoshi, Yukiharu; Schetter, Aaron J.; Okayama, Hirokazu; Inamura, Kentaro; Anami, Katsuhiro; Nguyen, Giang H.; Horikawa, Izumi; Hawkes, Jason E.; Bowman, Elise D.; Leung, Suet Yi; Harris, Curtis C.			Increased MicroRNA-34b and-34c Predominantly Expressed in Stromal Tissues Is Associated with Poor Prognosis in Human Colon Cancer	PLOS ONE			English	Article							MIR-34A; IDENTIFICATION; METHYLATION; SURVIVAL; MIRNAS; LOOP	The microRNA-34 family (miR-34a, -34b and -34c) have been reported to be tumor suppressor microRNAs (miRNAs) that are regulated by the TP53 and DNA hypermethylation. However, the expression, regulation, and prognostic value of the miR-34 family have not been systematically studied in colon cancer. To elucidate the roles of miR-34 family in colon carcinogenesis, miR-34a/b/c were measured in tumors and adjacent noncancerous tissues from 159 American and 113 Chinese colon cancer patients using quantitative RT-PCR, and we examined associations between miR-34a/b/c expression with TNM staging, cancer-specific mortality, TP53 mutation status and Affymetrix microarray data. All miR-34 family members were significantly increased in colon tumors, counter to the proposed tumor suppressor role for these miRNAs. Increased miR-34b/c were observed in more advanced tumors in two independent cohorts and increased expression of miR-34b/c was associated with poor cancer-specific mortality. While the expression of miR-34 family was not associated with TP53 mutation status, TP53 transcriptional activity was associated with miR-34a/b/c expression that is consistent with the proposed regulation of miR-34a/b/c by TP53. To examine where the miR-34 family is expressed, the expression of miR-34 family was compared between epitheliums and stromal tissues using laser microdissection technique. The expression of miR-34b/c was increased significantly in stromal tissues, especially in cancer stroma, compared with epithelial tissue. In conclusion, increased miR-34b/c predominantly expressed in stromal tissues is associated with poor prognosis in colon cancer. MiR-34 may contribute to cancer-stromal interaction associated with colon cancer progression.	[Hiyoshi, Yukiharu; Schetter, Aaron J.; Okayama, Hirokazu; Inamura, Kentaro; Anami, Katsuhiro; Nguyen, Giang H.; Horikawa, Izumi; Hawkes, Jason E.; Bowman, Elise D.; Leung, Suet Yi; Harris, Curtis C.] NCI, Human Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Harris, CC (corresponding author), NCI, Human Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	curtis_harris@nih.gov	Inamura, Kentaro/G-4229-2018; Leung, Suet Yi/C-4340-2009; Leung, Suet Yi/T-9620-2019	Inamura, Kentaro/0000-0001-6444-3861; Okayama, Hirokazu/0000-0003-0966-4746; Leung, Suet Yi/0000-0001-8614-4619; Hawkes, Jason E./0000-0001-5870-181X	NATIONAL CANCER INSTITUTE [ZIABC011492] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Bu PC, 2013, CELL STEM CELL, V12, P602, DOI 10.1016/j.stem.2013.03.002; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Concepcion CP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002797; COSTA A, 1995, J PATHOL, V176, P45, DOI 10.1002/path.1711760108; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gao W, 2011, J CANCER RES CLIN, V137, P557, DOI 10.1007/s00432-010-0918-4; Hagman Z, 2010, INT J CANCER, V127, P2768, DOI 10.1002/ijc.25269; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Jamieson NB, 2012, CLIN CANCER RES, V18, P534, DOI 10.1158/1078-0432.CCR-11-0679; Juan D, 2010, UROLOGY, V75, P835, DOI 10.1016/j.urology.2009.10.033; Jung M, 2009, J CELL MOL MED, V13, P3918, DOI 10.1111/j.1582-4934.2009.00705.x; Katada T, 2009, INT J ONCOL, V34, P537, DOI 10.3892/ijo_00000179; Lee CH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007314; Liu W, 2007, WORLD J GASTROENTERO, V13, P497, DOI 10.3748/wjg.v13.i4.497; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mathe E, 2012, INT J CANCER, V131, P760, DOI 10.1002/ijc.26403; Merkel O, 2010, P NATL ACAD SCI USA, V107, P16228, DOI 10.1073/pnas.1009719107; Nakatani F, 2012, J PATHOL, V226, P796, DOI 10.1002/path.3007; Nishida N, 2012, CLIN CANCER RES, V18, P3054, DOI 10.1158/1078-0432.CCR-11-1078; Roy S, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-58; Siemens H, 2011, CELL CYCLE, V10, P4256, DOI 10.4161/cc.10.24.18552; Svoboda M, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-31; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Toyota M, 2008, CANCER RES, V68, P4123, DOI 10.1158/0008-5472.CAN-08-0325; Vogt M, 2011, VIRCHOWS ARCH, V458, P313, DOI 10.1007/s00428-010-1030-5; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang MJ, 2012, MED ONCOL, V29, P3113, DOI 10.1007/s12032-012-0241-9; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wu JM, 2012, CARCINOGENESIS, V33, P519, DOI 10.1093/carcin/bgr304; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Zhang H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007826	38	40	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124899	10.1371/journal.pone.0124899	http://dx.doi.org/10.1371/journal.pone.0124899			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894979	gold, Green Submitted, Green Published			2022-12-26	WOS:000353211700128
J	Kitts-Morgan, SE; Caires, KC; Bohannon, LA; Parsons, EI; Hilburn, KA				Kitts-Morgan, Susanna E.; Caires, Kyle C.; Bohannon, Lisa A.; Parsons, Elizabeth I.; Hilburn, Katharine A.			Free-Ranging Farm Cats: Home Range Size and Predation on a Livestock Unit In Northwest Georgia	PLOS ONE			English	Article							FELIS-CATUS; FERAL CATS; ACTIVITY PATTERNS; DOMESTIC CATS; HOUSE CATS; PREY; AUSTRALIA; MOVEMENTS; BEHAVIOR; ECOLOGY	This study's objective was to determine seasonal and diurnal vs. nocturnal home range size, as well as predation for free-ranging farm cats at a livestock unit in Northwest Georgia. Seven adult cats were tracked with attached GPS units for up to two weeks for one spring and two summer seasons from May 2010 through August 2011. Three and five cats were tracked for up to two weeks during the fall and winter seasons, respectively. Feline scat was collected during this entire period. Cats were fed a commercial cat food daily. There was no seasonal effect (P > 0.05) on overall (95% KDE and 90% KDE) or core home range size (50% KDE). Male cats tended (P = 0.08) to have larger diurnal and nocturnal core home ranges (1.09 ha) compared to female cats (0.64 ha). Reproductively intact cats (n = 2) had larger (P < 0.0001) diurnal and nocturnal home ranges as compared to altered cats. Feline scat processing separated scat into prey parts, and of the 210 feline scats collected during the study, 75.24% contained hair. Of these 158 scat samples, 86 contained non-cat hair and 72 contained only cat hair. Other prey components included fragments of bone in 21.43% of scat and teeth in 12.86% of scat. Teeth were used to identify mammalian prey hunted by these cats, of which the Hispid cotton rat (Sigmodon hispidus) was the primary rodent. Other targeted mammals were Peromyscus sp., Sylvilagus sp. and Microtus sp. Invertebrates and birds were less important as prey, but all mammalian prey identified in this study consisted of native animals. While the free-ranging farm cats in this study did not adjust their home range seasonally, sex and reproductive status did increase diurnal and nocturnal home range size. Ultimately, larger home ranges of free-ranging cats could negatively impact native wildlife.	[Kitts-Morgan, Susanna E.; Caires, Kyle C.; Bohannon, Lisa A.; Hilburn, Katharine A.] Berry Coll, Dept Anim Sci, Mt Berry, GA 30149 USA; [Parsons, Elizabeth I.] Berry Coll, Dept Biol, Mt Berry, GA USA		Kitts-Morgan, SE (corresponding author), Berry Coll, Dept Anim Sci, Mt Berry, GA 30149 USA.	skittsmorgan@berry.edu		Kitts-Morgan, Susanna/0000-0001-5032-4693; Calvo-Amodio, Javier/0000-0002-0332-8752				ADAMEC RE, 1976, BEHAV BIOL, V18, P263, DOI 10.1016/S0091-6773(76)92166-0; [Anonymous], 2010, ARCGIS GIS SOFTWARE; Banko P.C., 1992, Wildfowl, V43, P99; Barratt DG, 1997, ECOGRAPHY, V20, P271, DOI 10.1111/j.1600-0587.1997.tb00371.x; Barratt DG, 1997, WILDLIFE RES, V24, P263, DOI 10.1071/WR96020; Beck R.A., 1992, Virginia Journal of Science, V43, P197; Blottner S, 2007, REPROD DOMEST ANIM, V42, P536, DOI 10.1111/j.1439-0531.2006.00817.x; Brown JL, 2006, THERIOGENOLOGY, V66, P25, DOI 10.1016/j.theriogenology.2006.03.011; DAY MG, 1966, J ZOOL, V148, P201, DOI 10.1111/j.1469-7998.1966.tb02948.x; Dowding JE, 2001, BIOL CONSERV, V99, P47, DOI 10.1016/S0006-3207(00)00187-7; Elton C. S., 1953, British Journal of Animal Behaviour, V1, P151, DOI 10.1016/S0950-5601(53)80015-8; Gehrt SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075718; Geospatial Modelling Environment, 2012, GEOSP MOD ENV VERS 0; Gibbons J., 1984, Oryx, V18, P82; Gillies C, 2003, J ZOOL, V259, P309, DOI 10.1017/S095283690200328X; Golley F. B., 1962, MAMMALS GEORGIA STUD; Guttilla DA, 2010, J MAMMAL, V91, P482, DOI 10.1644/09-MAMM-A-111.1; Hawkins CC, 1998, THESIS TEXAS A M U; Hess Steven C., 2004, Proceedings of the Vertebrate Pest Conference, V21, P21; Horn JA, 2011, J WILDLIFE MANAGE, V75, P1177, DOI 10.1002/jwmg.145; KIRKPATRICK RD, 1986, BIOTROPICA, V18, P72, DOI 10.2307/2388365; KONECNY MJ, 1987, OIKOS, V50, P17, DOI 10.2307/3565397; Langton SD, 2001, J APPL ECOL, V38, P699, DOI 10.1046/j.1365-2664.2001.00631.x; Lepczyk CA, 2008, 126 STAT M AM ORN UN; Loss SR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2380; Loyd KAT, 2013, BIOL CONSERV, V160, P183, DOI 10.1016/j.biocon.2013.01.008; Molsher R, 1999, WILDLIFE RES, V26, P593, DOI 10.1071/WR98058; PANAMAN R, 1981, Z TIERPSYCHOL, V56, P59; PRESNALL CLIFFORD C., 1958, JOUR WILDLIFE MANAGEMENT, V22, P45, DOI 10.2307/3797296; R Core Team, 2021, R LANGUAGE ENV STAT; REYNOLDS JC, 1991, MAMMAL REV, V21, P97, DOI 10.1111/j.1365-2907.1991.tb00113.x; ROBINSON R, 1970, Laboratory Animals (London), V4, P99, DOI 10.1258/002367770781036616; SAMUEL MD, 1985, J ANIM ECOL, V54, P711, DOI 10.2307/4373; SCOTT P P, 1955, Proc Soc Study Fertil, V7, P123; Singleton GR, 2005, BIOL J LINN SOC, V84, P617, DOI 10.1111/j.1095-8312.2005.00458.x; Smith David G., 2002, Pacific Science, V56, P451, DOI 10.1353/psc.2002.0044; Tennent J, 2008, AFR ZOOL, V43, P218, DOI 10.3377/1562-7020-43.2.218; TURNER DC, 1986, BEHAVIOUR, V99, P22, DOI 10.1163/156853986X00397; TURNER DC, 1988, DOMESTIC CAT BIOL IT; WARNER RE, 1985, J WILDLIFE MANAGE, V49, P340, DOI 10.2307/3801527; Weber JM, 1998, J ZOOL, V245, P234, DOI 10.1111/j.1469-7998.1998.tb00096.x	41	21	22	1	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0120513	10.1371/journal.pone.0120513	http://dx.doi.org/10.1371/journal.pone.0120513			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894078	gold, Green Published, Green Submitted			2022-12-26	WOS:000353211700006
J	Ortiz, D; Guiguemde, WA; Johnson, A; Elya, C; Anderson, J; Clark, J; Connelly, M; Yang, L; Min, J; Sato, Y; Guy, RK; Landfear, SM				Ortiz, Diana; Guiguemde, W. Armand; Johnson, Alex; Elya, Carolyn; Anderson, Johanna; Clark, Julie; Connelly, Michele; Yang, Lei; Min, Jaeki; Sato, Yuko; Guy, R. Kiplin; Landfear, Scott M.			Identification of Selective Inhibitors of the Plasmodium falciparum Hexose Transporter PfHT by Screening Focused Libraries of Anti-Malarial Compounds	PLOS ONE			English	Article							MALARIA PARASITE; VALIDATION; ARTEMISININ; RESISTANCE	Development of resistance against current antimalarial drugs necessitates the search for novel drugs that interact with different targets and have distinct mechanisms of action. Malaria parasites depend upon high levels of glucose uptake followed by inefficient metabolic utilization via the glycolytic pathway, and the Plasmodium falciparum hexose transporter PfHT, which mediates uptake of glucose, has thus been recognized as a promising drug target. This transporter is highly divergent from mammalian hexose transporters, and it appears to be a permease that is essential for parasite viability in intra-erythrocytic, mosquito, and liver stages of the parasite life cycle. An assay was developed that is appropriate for high throughput screening against PfHT based upon heterologous expression of PfHT in Leishmania mexicana parasites that are null mutants for their endogenous hexose transporters. Screening of two focused libraries of antimalarial compounds identified two such compounds that are high potency selective inhibitors of PfHT compared to human GLUT1. Additionally, 7 other compounds were identified that are lower potency and lower specificity PfHT inhibitors but might nonetheless serve as starting points for identification of analogs with more selective properties. These results further support the potential of PfHT as a novel drug target.	[Ortiz, Diana; Johnson, Alex; Elya, Carolyn; Anderson, Johanna; Sato, Yuko; Landfear, Scott M.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA; [Guiguemde, W. Armand; Clark, Julie; Connelly, Michele; Yang, Lei; Min, Jaeki; Guy, R. Kiplin] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA	Oregon Health & Science University; St Jude Children's Research Hospital	Landfear, SM (corresponding author), Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA.	landfear@ohsu.edu	Guy, Rodney/J-7107-2013	Guy, Rodney/0000-0002-9638-2060; Elya, Carolyn/0000-0002-9634-0303; Sato, Yuko/0000-0002-2177-5820; Min, Jaeki/0000-0002-0083-3198; Johnson, Alexander/0000-0002-4040-9797	National Institutes of Health [1 R01 AI079092, 5 UL1 RR024140 05]; Department of Defense [W81XWH-09-1-0429]; SML Medicines for Malaria Venture [MMV12-0038]; Lebanese Syrian Associated Charities; St. Jude Children's Research Hospital; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); SML Medicines for Malaria Venture; Lebanese Syrian Associated Charities; St. Jude Children's Research Hospital; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institutes of Health, 1 R01 AI079092, SML; National Institutes of Health, 5 UL1 RR024140 05, SML, URL: http://www.ohsu.edu/xd/research/centers-institutes/octri/; Department of Defense, W81XWH-09-1-0429, SML Medicines for Malaria Venture, MMV12-0038, SML, URL: http://www.mmv.org/; Lebanese Syrian Associated Charities and St. Jude Children's Research Hospital, RKG, URL: www.stjude.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIDON GL, 1995, PHARMACEUT RES, V12, P413, DOI 10.1023/A:1016212804288; Blume M, 2011, FASEB J, V25, P1218, DOI 10.1096/fj.10-173278; Cammack N, 2011, SCIENCE, V333, P705, DOI 10.1126/science.1210875; Cornish-Bowden A., 1995, FUNDAMENTALS ENZYME; DAVIES B, 1993, PHARMACEUT RES, V10, P1093, DOI 10.1023/A:1018943613122; Delves M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001169; Di L, 2006, INT J PHARMACEUT, V317, P54, DOI 10.1016/j.ijpharm.2006.03.007; Dondorp AM, 2010, NAT REV MICROBIOL, V8, P272, DOI 10.1038/nrmicro2331; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Feistel T, 2008, MOL BIOCHEM PARASIT, V162, P71, DOI 10.1016/j.molbiopara.2008.07.005; Foth BJ, 2005, MOL MICROBIOL, V55, P39, DOI 10.1111/j.1365-2958.2004.04407.x; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; Goktug AN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049386; Guiguemde WA, 2010, NATURE, V465, P311, DOI 10.1038/nature09099; IOVANNISCI DM, 1984, MOL CELL BIOL, V4, P1013, DOI 10.1128/MCB.4.6.1013; Joet T, 2003, P NATL ACAD SCI USA, V100, P7476, DOI 10.1073/pnas.1330865100; Lang-Unnasch N, 1998, ANNU REV MICROBIOL, V52, P561, DOI 10.1146/annurev.micro.52.1.561; Lu C, 2006, DRUG METAB DISPOS, V34, P1600, DOI 10.1124/dmd.106.010793; Mahindroo N, 2010, BIOORGAN MED CHEM, V18, P4801, DOI 10.1016/j.bmc.2010.05.001; Mueckler M, 2013, MOL ASPECTS MED, V34, P121, DOI 10.1016/j.mam.2012.07.001; Patel Asha Parbhu, 2008, Travel Med Infect Dis, V6, P58, DOI 10.1016/j.tmaid.2008.01.005; Plowe CV, 2007, CLIN INFECT DIS, V44, P1075, DOI 10.1086/512743; Rakesh, 2012, BIOORGAN MED CHEM, V20, P6063, DOI 10.1016/j.bmc.2012.08.023; Ritz C, 2005, J STAT SOFTW, V12, P1; Seyfang A, 2000, J BIOL CHEM, V275, P5687, DOI 10.1074/jbc.275.8.5687; Slavic K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-165; Slavic K, 2011, ANTIMICROB AGENTS CH, V55, P2824, DOI 10.1128/AAC.01739-10; Slavic K, 2010, MOL MICROBIOL, V75, P1402, DOI 10.1111/j.1365-2958.2010.07060.x; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Spangenberg T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062906; Staines HM, 2010, TRENDS PARASITOL, V26, P284, DOI 10.1016/j.pt.2010.03.004; TERKUILE BH, 1992, J PROTOZOOL, V39, P555; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; Woodrow CJ, 1999, J BIOL CHEM, V274, P7272, DOI 10.1074/jbc.274.11.7272; Yu YJ, 2011, J VIROL, V85, P1573, DOI 10.1128/JVI.01967-10; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang YQ, 2010, BIOORGAN MED CHEM, V18, P2756, DOI 10.1016/j.bmc.2010.02.013	38	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123598	10.1371/journal.pone.0123598	http://dx.doi.org/10.1371/journal.pone.0123598			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894322	Green Submitted, gold, Green Published			2022-12-26	WOS:000353211700046
J	Chen, WB; Liu, CX; Xiao, YT; Zhang, DD; Zhang, YD; Li, XC; Tabashnik, BE; Wu, KM				Chen, Wenbo; Liu, Chenxi; Xiao, Yutao; Zhang, Dandan; Zhang, Yongdong; Li, Xianchun; Tabashnik, Bruce E.; Wu, Kongming			A Toxin-Binding Alkaline Phosphatase Fragment Synergizes Bt Toxin Cry1Ac against Susceptible and Resistant Helicoverpa armigera	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS TOXINS; MOSQUITO ANOPHELES-GAMBIAE; FIELD-EVOLVED RESISTANCE; INSECT RESISTANCE; MANDUCA-SEXTA; LEPIDOPTERA-NOCTUIDAE; SPODOPTERA-EXIGUA; AMINOPEPTIDASE-N; PINK-BOLLWORM; HELIOTHIS-VIRESCENS	Evolution of resistance by insects threatens the continued success of pest control using insecticidal crystal (Cry) proteins from the bacterium Bacillus thuringiensis (Bt) in sprays and transgenic plants. In this study, laboratory selection with Cry1Ac yielded five strains of cotton bollworm, Helicoverpa armigera, with resistance ratios at the median lethal concentration (LC50) of activated Cry1Ac ranging from 22 to 1700. Reduced activity and reduced transcription of an alkaline phosphatase protein that binds Cry1Ac was associated with resistance to Cry1Ac in the four most resistant strains. A Cry1Ac-binding fragment of alkaline phosphatase from H. armigera (HaALP1f) was not toxic by itself, but it increased mortality caused by Cry1Ac in a susceptible strain and in all five resistant strains. Although synergism of Bt toxins against susceptible insects by toxin-binding fragments of cadherin and aminopeptidase N has been reported previously, the results here provide the first evidence of synergism of a Bt toxin by a toxin-binding fragment of alkaline phosphatase. The results here also provide the first evidence of synergism of a Bt toxin by any toxin-binding peptide against resistant insects.	[Chen, Wenbo; Liu, Chenxi; Xiao, Yutao; Zhang, Dandan; Zhang, Yongdong; Wu, Kongming] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China; [Li, Xianchun; Tabashnik, Bruce E.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; University of Arizona	Wu, KM (corresponding author), Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, West Yuanmingyuan Rd, Beijing 100193, Peoples R China.	kmwu@ippcaas.cn			Key Project for Breeding Genetic Modified Organisms [2011ZX08012-004]; National Natural Science Foundation of China [31210103921, 31201525, 31321004]	Key Project for Breeding Genetic Modified Organisms; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Key Project for Breeding Genetic Modified Organisms (2011ZX08012-004) and the National Natural Science Foundation of China (Grant No. 31210103921, No. 31201525 and No. 31321004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah MAF, 2009, PEST MANAG SCI, V65, P1097, DOI 10.1002/ps.1798; ADANG MJ, 1985, GENE, V36, P289, DOI 10.1016/0378-1119(85)90184-2; Alcantara E, 2011, CROP PROT, V30, P554, DOI 10.1016/j.cropro.2010.12.019; Alvi AHK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047309; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caccia S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009975; Cao GC, 2014, SCI REP-UK, V4, DOI 10.1038/srep05629; Cao GC, 2013, J ECON ENTOMOL, V106, P2514, DOI 10.1603/EC13301; Chen J, 2007, P NATL ACAD SCI USA, V104, P13901, DOI 10.1073/pnas.0706011104; Dhurua S, 2011, PEST MANAG SCI, V67, P898, DOI 10.1002/ps.2127; Dorsch JA, 2002, INSECT BIOCHEM MOLEC, V32, P1025, DOI 10.1016/S0965-1748(02)00040-1; Downes S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012567; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; Flores-Escobar B, 2013, APPL ENVIRON MICROB, V79, P4543, DOI 10.1128/AEM.01062-13; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Gao YL, 2011, PEST MANAG SCI, V67, P1076, DOI 10.1002/ps.2149; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gilroy T. E., 1992, US Patent, Patent No. [5,128,130, 5128130]; Gunning RV, 2005, APPL ENVIRON MICROB, V71, P2558, DOI 10.1128/AEM.71.5.2558-2563.2005; Heckel DG, 2007, J INVERTEBR PATHOL, V95, P192, DOI 10.1016/j.jip.2007.03.008; Herrero S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-96; Hua G, 2008, BIOCHEMISTRY-US, V47, P5101, DOI 10.1021/bi7023578; Hua G, 2014, INSECT BIOCHEM MOLEC, V45, P11, DOI 10.1016/j.ibmb.2013.10.007; Hua G, 2013, INSECT BIOCHEM MOLEC, V43, P153, DOI 10.1016/j.ibmb.2012.11.007; Hua G, 2009, BIOCHEMISTRY-US, V48, P9785, DOI 10.1021/bi9014538; Huang Fangneng, 2012, GM Crops Food, V3, P245, DOI 10.4161/gmcr.20539; Janmaat AF, 2003, P ROY SOC B-BIOL SCI, V270, P2263, DOI 10.1098/rspb.2003.2497; Jin L, 2015, NAT BIOTECHNOL, V33, P169, DOI 10.1038/nbt.3100; Jurat-Fuentes JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017606; Li Y, 2012, SYST RES BEHAV SCI, V29, P101, DOI 10.1002/sres.2099; Liang GM, 2008, J INVERTEBR PATHOL, V97, P142, DOI 10.1016/j.jip.2007.09.007; Liang GeMei, 2000, Scientia Agricultura Sinica, V33, P46; Liang GeMei, 1999, Plant Protection, V25, P15; Liu CX, 2014, SCI REP-UK, V4, DOI 10.1038/srep07219; Liu CX, 2009, J INSECT PHYSIOL, V55, P686, DOI 10.1016/j.jinsphys.2009.05.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu Q, 2012, J INTEGR AGR, V11, P628, DOI 10.1016/S2095-3119(12)60050-1; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Luttrell R., 2004, P 2004 BELTW COTT C, V2004, P1373; Ma G, 2005, INSECT BIOCHEM MOLEC, V35, P729, DOI 10.1016/j.ibmb.2005.02.011; Mendelsohn M, 2003, NAT BIOTECHNOL, V21, P1003, DOI 10.1038/nbt0903-1003; Morin S, 2003, P NATL ACAD SCI USA, V100, P5004, DOI 10.1073/pnas.0831036100; Ning CM, 2010, J INSECT PHYSIOL, V56, P666, DOI 10.1016/j.jinsphys.2010.02.003; Pacheco S, 2009, PEPTIDES, V30, P583, DOI 10.1016/j.peptides.2008.08.006; Pardo-Lopez L, 2013, FEMS MICROBIOL REV, V37, P3, DOI 10.1111/j.1574-6976.2012.00341.x; Park Y, 2009, APPL ENVIRON MICROB, V75, P7280, DOI 10.1128/AEM.01870-09; Park Y, 2009, APPL ENVIRON MICROB, V75, P3086, DOI 10.1128/AEM.00268-09; Peng DH, 2010, RES MICROBIOL, V161, P383, DOI 10.1016/j.resmic.2010.04.004; Peng DH, 2010, APPL MICROBIOL BIOT, V85, P1033, DOI 10.1007/s00253-009-2142-1; Rahman K, 2012, APPL ENVIRON MICROB, V78, P354, DOI 10.1128/AEM.06212-11; Rajagopal R, 2009, BIOCHEM J, V419, P309, DOI 10.1042/BJ20081152; Rodriguez-Almazan C, 2012, BIOCHEM J, V443, P711, DOI 10.1042/BJ20111579; RUSSELL R M, 1977, Bulletin of the Entomological Society of America, V23, P209; Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x; Sarjan M, 2009, J ILMU DASAR, V10, P77; *SAS I, 1998, SAS STAT US GUID REL; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; TABASHNIK BE, 1994, ANNU REV ENTOMOL, V39, P47, DOI 10.1146/annurev.en.39.010194.000403; TABASHNIK BE, 1990, J ECON ENTOMOL, V83, P1671, DOI 10.1093/jee/83.5.1671; Tabashnik BE, 2002, J ECON ENTOMOL, V95, P1018, DOI 10.1603/0022-0493-95.5.1018; TABASHNIK BE, 1992, APPL ENVIRON MICROB, V58, P3343, DOI 10.1128/AEM.58.10.3343-3346.1992; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080496; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Fernandez-Luna MT, 2010, J INVERTEBR PATHOL, V104, P231, DOI 10.1016/j.jip.2010.03.007; Thammasittirong A, 2011, APPL ENVIRON MICROB, V77, P6836, DOI 10.1128/AEM.05775-11; van Rensburg J. B. J., 2007, South African Journal of Plant and Soil, V24, P147; Wan P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029975; WOLFERSBERGER M, 1987, COMP BIOCHEM PHYS A, V86, P301, DOI 10.1016/0300-9629(87)90334-3; Wu KM, 2005, ANNU REV ENTOMOL, V50, P31, DOI 10.1146/annurev.ento.50.071803.130349; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Wu YD, 2014, ADV INSECT PHYSIOL, V47, P297, DOI 10.1016/B978-0-12-800197-4.00006-3; Xiao YT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06184; Xie RY, 2005, J BIOL CHEM, V280, P8416, DOI 10.1074/jbc.M408403200; Xu XJ, 2005, APPL ENVIRON MICROB, V71, P948, DOI 10.1128/AEM.71.2.948-954.2005; Zhang HN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053418; Zhang HN, 2012, P NATL ACAD SCI USA, V109, P10275, DOI 10.1073/pnas.1200156109; Zhang HN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022874; Zhang R, 2008, BIOCHEMISTRY-US, V47, P11263, DOI 10.1021/bi801181g; Zhang R, 2010, BIOCHEMISTRY-US, V49, P8512, DOI 10.1021/bi1009908; Zhang SP, 2009, INSECT BIOCHEM MOLEC, V39, P421, DOI 10.1016/j.ibmb.2009.04.003	82	15	19	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0126288	10.1371/journal.pone.0126288	http://dx.doi.org/10.1371/journal.pone.0126288			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885820	Green Submitted, gold, Green Published			2022-12-26	WOS:000353017000168
J	Jensen, MK; Vogt, JK; Bressendorff, S; Seguin-Orlando, A; Petersen, M; Sicheritz-Ponten, T; Mundy, J				Jensen, Michael Krogh; Vogt, Josef Korbinian; Bressendorff, Simon; Seguin-Orlando, Andaine; Petersen, Morten; Sicheritz-Ponten, Thomas; Mundy, John			Transcriptome and Genome Size Analysis of the Venus Flytrap	PLOS ONE			English	Article							CARNIVOROUS PLANT; BLADDERWORT UTRICULARIA; RNA-SEQ; EVOLUTION; DNA; LENTIBULARIACEAE; ARABIDOPSIS; PHYLOGENY; SEQUENCES; SARRACENIA	The insectivorous Venus flytrap (Dionaea muscipula) is renowned from Darwin's studies of plant carnivory and the origins of species. To provide tools to analyze the evolution and functional genomics of D. muscipula, we sequenced a normalized cDNA library synthesized from mRNA isolated from D. muscipula flowers and traps. Using the Oases transcriptome assembler 79,165,657 quality trimmed reads were assembled into 80,806 cDNA contigs, with an average length of 679 bp and an N50 length of 1,051 bp. A total of 17,047 unique proteins were identified, and assigned to Gene Ontology (GO) and classified into functional categories. A total of 15,547 full-length cDNA sequences were identified, from which open reading frames were detected in 10,941. Comparative GO analyses revealed that D. muscipula is highly represented in molecular functions related to catalytic, antioxidant, and electron carrier activities. Also, using a single copy sequence PCR-based method, we estimated that the genome size of D. muscipula is approx. 3 Gb. Our genome size estimate and transcriptome analyses will contribute to future research on this fascinating, monotypic species and its heterotrophic adaptations.	[Jensen, Michael Krogh; Bressendorff, Simon; Petersen, Morten; Mundy, John] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Vogt, Josef Korbinian; Sicheritz-Ponten, Thomas] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Seguin-Orlando, Andaine] Natl High Throughput DNA Sequencing Ctr, Copenhagen, Denmark	University of Copenhagen; Technical University of Denmark	Sicheritz-Ponten, T (corresponding author), Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark.	thomas@cbs.dtu.dk; mundy@bio.ku.dk	mundy, john/A-2361-2013; Petersen, Morten/J-5023-2014; Sicheritz-Ponten, Thomas/A-4325-2017	mundy, john/0000-0001-7490-4588; Petersen, Morten/0000-0002-3035-5991; Bressendorff, Simon/0000-0002-1093-2114; Sicheritz-Ponten, Thomas/0000-0001-6615-1141; Jensen, Michael Krogh/0000-0001-7574-4707; Vogt, Josef Korbinian/0000-0002-6472-381X	Danish Research Council [DFF-1323-00267]	Danish Research Council(Det Frie Forskningsrad (DFF))	This work was supported by a grant to JM from the Danish Research Council (#DFF-1323-00267; http://ufm.dk/forskning-og-innovation/rad-og-udvalg/det-frie-forskningsrad/radet/dff-natur-og-univers). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMEC L, 1995, FOLIA GEOBOT PHYTOTX, V30, P53, DOI 10.1007/BF02813219; ALBERT VA, 1992, SCIENCE, V257, P1491, DOI 10.1126/science.1523408; Albert VA, 2010, J EXP BOT, V61, P5, DOI 10.1093/jxb/erp349; Bekesiova I, 1999, PLANT MOL BIOL REP, V17, P269, DOI 10.1023/A:1007627509824; Bennett MD, 2003, ANN BOT-LONDON, V91, P547, DOI 10.1093/aob/mcg057; Britt AB, 1996, ANNU REV PLANT PHYS, V47, P75, DOI 10.1146/annurev.arplant.47.1.75; Cameron KM, 2002, AM J BOT, V89, P1503, DOI 10.3732/ajb.89.9.1503; Darwin C., 1875, INSECTIVOROUS PLANTS; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; Ellison AM, 2009, J EXP BOT, V60, P19, DOI 10.1093/jxb/ern179; Friedman WE, 2009, AM J BOT, V96, P5, DOI 10.3732/ajb.0800150; Gibson TC, 2009, NEW PHYTOL, V183, P575, DOI 10.1111/j.1469-8137.2009.02935.x; Greilhuber J, 2006, PLANT BIOLOGY, V8, P770, DOI 10.1055/s-2006-924101; Hoshi Yoshikazu, 1998, Cytologia (Tokyo), V63, P329; Ibarra-Laclette E, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-101; Jobson RW, 2004, P NATL ACAD SCI USA, V101, P18064, DOI 10.1073/pnas.0408092101; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Meimberg H, 2000, PLANT BIOLOGY, V2, P218, DOI 10.1055/s-2000-9460; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW669, DOI 10.1093/nar/gki436; Muller KF, 2006, PLANT BIOLOGY, V8, P748, DOI 10.1055/s-2006-924706; Pellicer J, 2010, BOT J LINN SOC, V164, P10, DOI 10.1111/j.1095-8339.2010.01072.x; Poppinga S, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24685; Renner T, 2012, MOL BIOL EVOL, V29, P2971, DOI 10.1093/molbev/mss106; Rivadavia F, 2003, AM J BOT, V90, P123, DOI 10.3732/ajb.90.1.123; Rogers WL, 2010, CONSERV GENET RESOUR, V2, P75, DOI 10.1007/s12686-009-9165-x; Rozen S, 2000, Methods Mol Biol, V132, P365; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Schulze WX, 2012, MOL CELL PROTEOMICS, V11, P1306, DOI 10.1074/mcp.M112.021006; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Sirova D, 2010, J EXP BOT, V61, P99, DOI 10.1093/jxb/erp286; Srivastava A, 2011, DNA RES, V18, P253, DOI 10.1093/dnares/dsr014; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; Wilhelm J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gkg056; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031; Zwickl DJ, 2002, SYST BIOL, V51, P588, DOI 10.1080/10635150290102339	37	11	11	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123887	10.1371/journal.pone.0123887	http://dx.doi.org/10.1371/journal.pone.0123887			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886597	Green Published, gold			2022-12-26	WOS:000353017000094
J	Tan, YW; Ye, Y; Zhou, XB; Chen, L; Wen, DF				Tan, Youwen; Ye, Yun; Zhou, Xinbei; Chen, Li; Wen, Danfeng			Age as a Predictor of Significant Fibrosis Features in HBeAg-Negative Chronic Hepatitis B Virus Infection with Persistently Normal Alanine Aminotransferase	PLOS ONE			English	Article							HBV-DNA LEVELS; NORMAL ALT; PEGINTERFERON ALPHA-2A; LAMIVUDINE TREATMENT; LIVER-DISEASE; C PATIENTS; FOLLOW-UP; CARRIERS; COMBINATION; HISTOLOGY	Background Although alanine aminotransferase (ALT) levels reflect the degree of liver damage, not all patients with chronic hepatitis B virus (HBV) infection exhibit persistently elevated ALT levels. In the present study, we aimed to comprehensively evaluate the characteristics of histological abnormalities in a large population of Chinese patients with chronic HBV and persistently normal ALT levels. Methods In total, 2303 consecutive patients who underwent liver biopsy were screened. Of these patients, 273 were categorized as having persistently normal ALT levels (PNALT), whereas 618 were categorized as having persistently or intermittently elevated ALT levels (PIALT). All these patients had at least three ALT values recorded in the year prior to the baseline liver biopsy. Results Significant necroinflammation was observed in 9.7% (11/113) patients with PNALT, 23.3% (42/180) patients with PIALT (ALT 1-2x upper limit of normal [ULN]), and 27.8%(42/151) patients with PIALT (ALT > 2x ULN), whereas significant fibrosis was observed in 8.8% (10/113) patients with PNALT, 27.8% (42/151) patients with PIALT (ALT 1-2x ULN), and 21.2% (32/151) patients with PIALT (ALT > 2x ULN). Multiple logistic regression analysis indicated that age parameters were associated with significant histological abnormalities in patients with PNALT. The area under the curve showed that age was associated with significant fibrosis characteristics in patients with hepatitis B extracellular antigen (HBeAg)-negative PNALT. Conclusion Significant histological abnormalities are not often observed in Chinese patients with PNALT. Interestingly, age appears to be a predictor of significant fibrosis in patients with HBeAg-negative PNALT.	[Tan, Youwen] Soochow Univ, Dept Infect Dis, Affiliated Hosp 1, Suzhou, Peoples R China; [Tan, Youwen; Ye, Yun; Zhou, Xinbei; Chen, Li; Wen, Danfeng] Jiangsu Univ, Dept Hepatosis, Hosp Zhenjiang Affiliated 3, Zhenjiang, Peoples R China	Soochow University - China; Jiangsu University	Tan, YW (corresponding author), Soochow Univ, Dept Infect Dis, Affiliated Hosp 1, Suzhou, Peoples R China.	tyw915@sina.com	Zhou, Xinbei/HGC-1253-2022		Natural Science Foundation of Jiangsu Province, China [BK2011515]; Medical Project of Health Department, Jiangsu Province [H201248]; Preventive medicine research projects, Jiangsu Province [Y2012016]; Social Development Project of Zhenjiang City [SH2013056]	Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); Medical Project of Health Department, Jiangsu Province; Preventive medicine research projects, Jiangsu Province; Social Development Project of Zhenjiang City	This work was supported by the Natural Science Foundation of Jiangsu Province, China (BK2011515) (http://www.jstd.gov.cn/), Medical Project of Health Department, Jiangsu Province (H201248) (http://www.jswst.gov.cn/), Preventive medicine research projects, Jiangsu Province (Y2012016) (http://www.jswst.gov.cn/), and the Social Development Project of Zhenjiang City (SH2013056) (http://kjj.zhenjiang.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreani T, 2007, CLIN GASTROENTEROL H, V5, P636, DOI 10.1016/j.cgh.2007.01.005; Arora S, 2006, J GASTROEN HEPATOL, V21, P406, DOI 10.1111/j.1440-1746.2005.04059.x; Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; Chan WK, 2014, J GASTROEN HEPATOL, V29, P1470, DOI 10.1111/jgh.12557; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Dai CY, 2009, HEPATOLOGY, V49, P704, DOI 10.1002/hep.22723; Hui CK, 2007, ALIMENT PHARM THER, V25, P1283, DOI 10.1111/j.1365-2036.2007.03318.x; Kim WR, 2008, HEPATOLOGY, V47, P1363, DOI 10.1002/hep.22109; Kirschberg O, 2004, J CLIN VIROL, V29, P39, DOI 10.1016/S1386-6532(03)00084-2; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; Kumar M, 2008, GASTROENTEROLOGY, V134, P1376, DOI 10.1053/j.gastro.2008.02.075; Lai M, 2007, J HEPATOL, V47, P760, DOI 10.1016/j.jhep.2007.07.022; Lau GKK, 2005, NEW ENGL J MED, V352, P2682, DOI 10.1056/NEJMoa043470; Lesmana CRA, 2011, J DIGEST DIS, V12, P476, DOI 10.1111/j.1751-2980.2011.00540.x; Liao BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078672; Lin CL, 2007, HEPATOLOGY, V45, P1193, DOI 10.1002/hep.21585; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Manesis EK, 2002, GASTROENTEROLOGY, V122, P2092, DOI 10.1053/gast.2002.34021; Marcellin P, 2013, LANCET, V381, P468, DOI 10.1016/S0140-6736(12)61425-1; Martinot-Peignoux M, 2002, J HEPATOL, V36, P543, DOI 10.1016/S0168-8278(02)00004-1; McMahon BJ, 2004, SEMIN LIVER DIS, V24, P17, DOI 10.1055/s-2004-828674; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Papatheodoridis GV, 2008, HEPATOLOGY, V48, P1451, DOI 10.1002/hep.22518; Papatheodoridis GV, 2012, J HEPATOL, V57, P196, DOI 10.1016/j.jhep.2011.11.030; Park JY, 2008, J VIRAL HEPATITIS, V15, P615, DOI 10.1111/j.1365-2893.2008.00989.x; Perrillo RP, 2002, HEPATOLOGY, V36, P186, DOI 10.1053/jhep.2002.34294; Seto WK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032622; ter Borg F, 2000, J CLIN PATHOL, V53, P541, DOI 10.1136/jcp.53.7.541; Tseng KC, 2014, ANTIVIR THER, V19, P755, DOI 10.3851/IMP2754; Wang H, 2013, J VIRAL HEPATITIS, V20, pe3, DOI 10.1111/jvh.12010; Wang H, 2013, PROTEIN CELL, V4, P643, DOI 10.1007/s13238-013-3048-3; Wong GLH, 2009, CLIN GASTROENTEROL H, V7, P227, DOI 10.1016/j.cgh.2008.10.023; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049; Yuen MF, 2007, HEPATOLOGY, V46, P1695, DOI 10.1002/hep.21939; Yuen MF, 2005, GUT, V54, P1610, DOI 10.1136/gut.2005.065136; Zacharakis G, 2008, J HEPATOL, V49, P884, DOI 10.1016/j.jhep.2008.06.009; Zoulim F, 2012, GUT, V61, P333, DOI 10.1136/gutjnl-2011-300937	37	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123452	10.1371/journal.pone.0123452	http://dx.doi.org/10.1371/journal.pone.0123452			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885705	Green Published, gold, Green Submitted			2022-12-26	WOS:000353017000067
J	Giotopoulos, G; Chan, WI; Horton, SJ; Ruau, D; Gallipoli, P; Fowler, A; Crawley, C; Papaemmanuil, E; Campbell, PJ; Gottgens, B; Van Deursen, JM; Cole, PA; Huntly, BJP				Giotopoulos, G.; Chan, W-I; Horton, S. J.; Ruau, D.; Gallipoli, P.; Fowler, A.; Crawley, C.; Papaemmanuil, E.; Campbell, P. J.; Goettgens, B.; Van Deursen, J. M.; Cole, P. A.; Huntly, B. J. P.			The epigenetic regulators CBP and p300 facilitate leukemogenesis and represent therapeutic targets in acute myeloid leukemia	ONCOGENE			English	Article							CREB-BINDING-PROTEIN; MUTATIONS; GENE; RECRUITMENT; MECHANISMS; INTERACTS; CHROMATIN; REQUIRES	Growing evidence links abnormal epigenetic control to the development of hematological malignancies. Accordingly, inhibition of epigenetic regulators is emerging as a promising therapeutic strategy. The acetylation status of lysine residues in histone tails is one of a number of epigenetic post-translational modifications that alter DNA-templated processes, such as transcription, to facilitate malignant transformation. Although histone deacetylases are already being clinically targeted, the role of histone lysine acetyltransferases (KAT) in malignancy is less well characterized. We chose to study this question in the context of acute myeloid leukemia (AML), where, using in vitro and in vivo genetic ablation and knockdown experiments in murine models, we demonstrate a role for the epigenetic regulators CBP and p300 in the induction and maintenance of AML. Furthermore, using selective small molecule inhibitors of their lysine acetyltransferase activity, we validate CBP/p300 as therapeutic targets in vitro across a wide range of human AML subtypes. We proceed to show that growth retardation occurs through the induction of transcriptional changes that induce apoptosis and cell-cycle arrest in leukemia cells and finally demonstrate the efficacy of the KAT inhibitors in decreasing clonogenic growth of primary AML patient samples. Taken together, these data suggest that CBP/p300 are promising therapeutic targets across multiple subtypes in AML.	[Giotopoulos, G.; Chan, W-I; Horton, S. J.; Ruau, D.; Gallipoli, P.; Fowler, A.; Crawley, C.; Campbell, P. J.; Goettgens, B.; Huntly, B. J. P.] Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Hills Rd, Cambridge CB2 2XY, England; [Giotopoulos, G.; Chan, W-I; Horton, S. J.; Ruau, D.; Gallipoli, P.; Fowler, A.; Crawley, C.; Campbell, P. J.; Goettgens, B.; Huntly, B. J. P.] Univ Cambridge, Addenbrookes Hosp, Cambridge CB2 2QQ, England; [Giotopoulos, G.; Chan, W-I; Horton, S. J.; Ruau, D.; Gallipoli, P.; Goettgens, B.; Huntly, B. J. P.] Wellcome Trust Res Labs, Med Res Council, Cambridge Stem Cell Inst, Cambridge, England; [Chan, W-I] Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Taipa, Macau, Peoples R China; [Papaemmanuil, E.; Campbell, P. J.] Wellcome Trust Sanger Inst, Hinxton, England; [Van Deursen, J. M.] Mayo Clin, Dept Pediat & Adolescent Med, Coll Med, Rochester, MN USA; [Cole, P. A.] Johns Hopkins Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD USA	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; Wellcome Trust Sanger Institute; Macau University of Science & Technology; Wellcome Trust Sanger Institute; Mayo Clinic; Johns Hopkins University; Johns Hopkins Medicine	Huntly, BJP (corresponding author), Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Hills Rd, Cambridge CB2 2XY, England.	bjph2@cam.ac.uk	Gallipoli, Paolo/AAA-7094-2019; huntly, brian/E-6725-2014	Gallipoli, Paolo/0000-0001-7254-2253; Gottgens, Berthold/0000-0001-6302-5705; huntly, brian/0000-0003-0312-161X; Giotopoulos, George/0000-0003-1390-6592	Cancer Research UK; Leukemia Lymphoma Research; Kay Kendal Leukemia Fund; Leukemia lymphoma Society of America; Wellcome Trust; Medical Research Council; NIHR Cambridge Biomedical Research Centre grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062437, R01GM062437] Funding Source: NIH RePORTER; BBSRC [BB/I00050X/1] Funding Source: UKRI; MRC [MR/M010392/1] Funding Source: UKRI; Academy of Medical Sciences (AMS) [AMS-SGCL10-Gallipoli] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/I00050X/1] Funding Source: researchfish; Cancer Research UK [12765] Funding Source: researchfish; Medical Research Council [MR/M010392/1, MC_PC_12009] Funding Source: researchfish; Worldwide Cancer Research [14-1069] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Leukemia Lymphoma Research; Kay Kendal Leukemia Fund; Leukemia lymphoma Society of America(Leukemia and Lymphoma Society); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Cambridge Biomedical Research Centre grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Worldwide Cancer Research	Funding in the Huntly laboratory comes from Cancer Research UK, Leukemia Lymphoma Research, the Kay Kendal Leukemia Fund, the Leukemia lymphoma Society of America, the Wellcome Trust, The Medical Research Council and an NIHR Cambridge Biomedical Research Centre grant. Patient samples were processed in the Cambridge Blood and Stem Cell Biobank.	Allard S, 2004, BBA-GENE STRUCT EXPR, V1677, P158, DOI 10.1016/j.bbaexp.2003.10.016; Baljeyic M, 2011, HEMATOL ONCOL CLIN N, V25, P1215, DOI 10.1016/j.hoc.2011.10.002; Bayly R, 2004, J BIOL CHEM, V279, P55362, DOI 10.1074/jbc.M408654200; Bedford DC, 2010, EPIGENETICS-US, V5, P9, DOI 10.4161/epi.5.1.10449; Blobel GA, 2000, BLOOD, V95, P745, DOI 10.1182/blood.V95.3.745.003k05_745_755; Bowers EM, 2010, CHEM BIOL, V17, P471, DOI 10.1016/j.chembiol.2010.03.006; Cao G., 2014, EVID-BASED COMPL ALT, V2014, P1, DOI DOI 10.1109/WCSP.2013.6677085; Chan WI, 2011, MOL CELL BIOL, V31, P5046, DOI 10.1128/MCB.05830-11; Dawson MA, 2012, NEW ENGL J MED, V367, P647, DOI 10.1056/NEJMra1112635; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Deguchi K, 2003, CANCER CELL, V3, P259, DOI 10.1016/S1535-6108(03)00051-5; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Gang EJ, 2014, ONCOGENE, V33, P2169, DOI 10.1038/onc.2013.169; Grunwald MR, 2013, INT J HEMATOL, V97, P683, DOI 10.1007/s12185-013-1334-8; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Holmfeldt L, 2013, NAT GENET, V45, P242, DOI 10.1038/ng.2532; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Ida K, 1997, BLOOD, V90, P4699, DOI 10.1182/blood.V90.12.4699.4699_4699_4704; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kasper LH, 1999, MOL CELL BIOL, V19, P764; Kimbrel EA, 2009, BLOOD, V114, P4804, DOI 10.1182/blood-2009-04-217794; Kung AL, 2000, GENE DEV, V14, P272; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Mullighan CG, 2011, NATURE, V471, P235, DOI 10.1038/nature09727; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Oki Y, 2010, CANCER TREAT RES, V145, P19, DOI 10.1007/978-0-387-69259-3_2; Papaemmanuil E, 2013, BLOOD, V122, P3616, DOI 10.1182/blood-2013-08-518886; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Payne SR, 2005, CARCINOGENESIS, V26, P2031, DOI 10.1093/carcin/bgi223; Rebel VI, 2002, P NATL ACAD SCI USA, V99, P14789, DOI 10.1073/pnas.232568499; Roelfsema Jeroen H., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000415; So CW, 2002, MOL CELL BIOL, V22, P6542, DOI 10.1128/MCB.22.18.6542-6552.2002; Taki T, 1997, BLOOD, V89, P3945, DOI 10.1182/blood.V89.11.3945; Walter RB, 2012, BLOOD, V119, P6198, DOI 10.1182/blood-2011-11-325050; Wang L, 2011, SCIENCE, V333, P765, DOI 10.1126/science.1201662	36	42	45	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 21	2016	35	3					279	289		10.1038/onc.2015.92	http://dx.doi.org/10.1038/onc.2015.92			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DC2OF	25893291	Green Accepted			2022-12-26	WOS:000369055300002
J	Morton, JJ; Bird, G; Keysar, SB; Astling, DP; Lyons, TR; Anderson, RT; Glogowska, MJ; Estes, P; Eagles, JR; Le, PN; Gan, G; McGettigan, B; Fernandez, P; Padilla-Just, N; Varella-Garcia, M; Song, JI; Bowles, DW; Schedin, P; Tan, AC; Roop, DR; Wang, XJ; Refaeli, Y; Jimeno, A				Morton, J. J.; Bird, G.; Keysar, S. B.; Astling, D. P.; Lyons, T. R.; Anderson, R. T.; Glogowska, M. J.; Estes, P.; Eagles, J. R.; Le, P. N.; Gan, G.; McGettigan, B.; Fernandez, P.; Padilla-Just, N.; Varella-Garcia, M.; Song, J. I.; Bowles, D. W.; Schedin, P.; Tan, A-C; Roop, D. R.; Wang, X-J; Refaeli, Y.; Jimeno, A.			XactMice: humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer	ONCOGENE			English	Article							SQUAMOUS-CELL CARCINOMA; LARGE GENE LISTS; PANCREATIC-CANCER; STEM-CELLS; NUDE-MICE; RNA-SEQ; TUMOR; RECEPTOR; THERAPY; LYMPHANGIOGENESIS	The limitations of cancer cell lines have led to the development of direct patient-derived xenograft models. However, the interplay between the implanted human cancer cells and recruited mouse stromal and immune cells alters the tumor microenvironment and limits the value of these models. To overcome these constraints, we have developed a technique to expand human hematopoietic stem and progenitor cells (HSPCs) and use them to reconstitute the radiation-depleted bone marrow of a NOD/SCID/IL2rg(-/-) (NSG) mouse on which a patient's tumor is then transplanted (XactMice). The human HSPCs produce immune cells that home into the tumor and help replicate its natural microenvironment. Despite previous passage on nude mice, the expression of epithelial, stromal and immune genes in XactMice tumors aligns more closely to that of the patient tumor than to those grown in nonhumanized mice-an effect partially facilitated by human cytokines expressed by both the HSPC progeny and the tumor cells. The human immune and stromal cells produced in the XactMice can help recapitulate the microenvironment of an implanted xenograft, reverse the initial genetic drift seen after passage on non-humanized mice and provide a more accurate tumor model to guide patient treatment.	[Morton, J. J.; Keysar, S. B.; Astling, D. P.; Lyons, T. R.; Anderson, R. T.; Glogowska, M. J.; Eagles, J. R.; Le, P. N.; McGettigan, B.; Padilla-Just, N.; Varella-Garcia, M.; Bowles, D. W.; Schedin, P.; Tan, A-C; Jimeno, A.] Univ Colorado, Sch Med, Div Med Oncol, Dept Med, Aurora, CO USA; [Bird, G.; Estes, P.; Roop, D. R.; Refaeli, Y.] Univ Colorado, Sch Med, Dept Dermatol, 12800 E 19th Ave,MS-8320, Aurora, CO 80045 USA; [Astling, D. P.; Tan, A-C] Univ Colorado, Sch Med, Dept Biostat & Informat, Aurora, CO USA; [Gan, G.] Univ Colorado, Sch Med, Dept Radiat Oncol, Aurora, CO USA; [Fernandez, P.; Wang, X-J] Univ Colorado, Sch Med, Dept Pathol, Aurora, CO USA; [Song, J. I.; Jimeno, A.] Univ Colorado, Sch Med, Dept Otolaryngol, Aurora, CO USA; [Roop, D. R.; Wang, X-J; Refaeli, Y.; Jimeno, A.] Univ Colorado, Sch Med, Charles C Gates Ctr Regenerat Med & Stem Cell Bio, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Refaeli, Y (corresponding author), Univ Colorado, Sch Med, Dept Dermatol, 12800 E 19th Ave,MS-8320, Aurora, CO 80045 USA.; Jimeno, A (corresponding author), Univ Colorado, Sch Med, Dept Med Oncol & Otolaryngol, 12801 E 17th Ave,MS-8117, Aurora, CO 80045 USA.	Yosef.Refaeli@ucdenver.edu; Antonio.Jimeno@ucdenver.edu	McGettigan, Brett/AAT-2828-2021; Schedin, Pepper/C-2532-2009; Tan, Aik Choon/A-3135-2011	Tan, Aik Choon/0000-0003-2955-8369; Astling, David/0000-0001-8179-0304	Department of Defense Award [W81XWN-10-1-0798]; Charles C Gates Center for Regenerative Medicine and Stem Cell Biology; National Institutes of Health Cancer Center [P30 CA046934]; NIH [R21 DE019712, R01 CA149456, R01 CA117802-06, P30 AR057212-02, P01 AI022295-24, T32 CA174648]; Janet Mordecai Foundation; Peter and Rhonda Grant Foundation; Translational Research Award from the Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [R01CA117802, R01CA149456, P30CA046934, R21CA156114, T32CA174648] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057212] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE024371, R01DE015953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE019712] Funding Source: NIH RePORTER	Department of Defense Award(United States Department of Defense); Charles C Gates Center for Regenerative Medicine and Stem Cell Biology; National Institutes of Health Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Janet Mordecai Foundation; Peter and Rhonda Grant Foundation; Translational Research Award from the Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank the patients and normal subjects for their time and generous tissue and blood donations. This work was primarily supported by Department of Defense Award W81XWN-10-1-0798 (principal investigator AJ; co-investigator YR), the Charles C Gates Center for Regenerative Medicine and Stem Cell Biology, and National Institutes of Health Cancer Center Support Grant P30 CA046934 (AJ, YR). Additionally supported by NIH R21 DE019712 (AJ), NIH R01 CA149456 (AJ), the Janet Mordecai Foundation (AJ), the Peter and Rhonda Grant Foundation (AJ), NIH R01 CA117802-06 (YR), NIH P30 AR057212-02 (YR), NIH P01 AI022295-24 (YR), NIH T32 CA174648 (principal investigator XJW; co-investigator PNL) and a Translational Research Award from the Leukemia and Lymphoma Society (YR).	Abate-Daga D, 2014, HUM GENE THER, V25, P1003, DOI 10.1089/hum.2013.209; Al-Lazikani B, 2012, NAT BIOTECHNOL, V30, P679, DOI 10.1038/nbt.2284; Bankert RB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024420; Bird GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105525; Christiansen Ailsa, 2011, Genes Cancer, V2, P1146, DOI 10.1177/1947601911423028; Dadras SS, 2003, AM J PATHOL, V162, P1951, DOI 10.1016/S0002-9440(10)64328-3; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; ENGELHOLM SA, 1985, EUR J CANCER CLIN ON, V21, P815, DOI 10.1016/0277-5379(85)90221-4; Fullar A, 2012, EXP CELL RES, V318, P1517, DOI 10.1016/j.yexcr.2012.03.023; Garrido-Laguna I, 2011, CLIN CANCER RES, V17, P5793, DOI 10.1158/1078-0432.CCR-11-0341; Geary SM, 2008, EXP CELL RES, V314, P2165, DOI 10.1016/j.yexcr.2008.04.011; Gomes FG, 2013, LIFE SCI, V92, P101, DOI 10.1016/j.lfs.2012.10.008; Hausser HJ, 2005, BIOCHEM BIOPH RES CO, V333, P216, DOI 10.1016/j.bbrc.2005.05.097; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Iorns E, 2012, BREAST CANCER RES TR, V131, P321, DOI 10.1007/s10549-011-1784-8; Jackson DG, 2003, TRENDS CARDIOVAS MED, V13, P1, DOI 10.1016/S1050-1738(02)00189-5; Keysar SB, 2013, MOL ONCOL, V7, P776, DOI 10.1016/j.molonc.2013.03.004; Keysar SB, 2013, CANCER RES, V73, P3381, DOI 10.1158/0008-5472.CAN-12-4047; Kidd S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030563; Kimple RJ, 2013, CLIN CANCER RES, V19, P855, DOI 10.1158/1078-0432.CCR-12-2746; Lan P, 2006, BLOOD, V108, P487, DOI 10.1182/blood-2005-11-4388; Lee HJ, 2009, ARTHRITIS RHEUM-US, V60, P2325, DOI 10.1002/art.24786; Leskov I, 2013, ONCOGENE, V32, P1066, DOI 10.1038/onc.2012.117; Lui VWY, 2013, CANCER DISCOV, V3, P761, DOI 10.1158/2159-8290.CD-13-0103; McBride WH, 2004, RADIAT RES, V162, P1, DOI 10.1667/RR3196; Ozer H, 2000, J CLIN ONCOL, V18, P3558, DOI 10.1200/JCO.2000.18.20.3558; Pallasch CP, 2014, CELL, V156, P590, DOI 10.1016/j.cell.2013.12.041; Redon Richard, 2009, V529, P267, DOI 10.1007/978-1-59745-538-1_17; Rong ZL, 2014, CELL STEM CELL, V14, P121, DOI 10.1016/j.stem.2013.11.014; Rongvaux A, 2014, NAT BIOTECHNOL, V32, P364, DOI 10.1038/nbt.2858; Ruitberg CM, 2001, NUCLEIC ACIDS RES, V29, P320, DOI 10.1093/nar/29.1.320; Suggitt M, 2005, CLIN CANCER RES, V11, P971; Tawada M, 2012, J GASTROENTEROL, V47, P1057, DOI 10.1007/s00535-012-0638-4; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; THOMAS ML, 1989, ANNU REV IMMUNOL, V7, P339, DOI 10.1146/annurev.immunol.7.1.339; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsuyada A, 2012, CANCER RES, V72, P2768, DOI 10.1158/0008-5472.CAN-11-3567; Wege AK, 2011, INT J CANCER, V129, P2194, DOI 10.1002/ijc.26159; Wels J, 2008, GENE DEV, V22, P559, DOI 10.1101/gad.1636908; WENNERBERG J, 1983, ACTA OTO-LARYNGOL, V95, P183, DOI 10.3109/00016488309130933; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; Zhou QJ, 2014, CANCER LETT, V344, P13, DOI 10.1016/j.canlet.2013.10.015	45	84	90	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 21	2016	35	3					290	300		10.1038/onc.2015.94	http://dx.doi.org/10.1038/onc.2015.94			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DC2OF	25893296	Green Accepted			2022-12-26	WOS:000369055300003
J	Dong, H; Zhang, L; Qian, ZL; Zhu, XH; Zhu, GS; Chen, YQ; Xie, XY; Ye, QH; Zang, J; Ren, ZG; Ji, QS				Dong, Hua; Zhang, Lan; Qian, Ziliang; Zhu, Xuehua; Zhu, Guanshan; Chen, Yunqin; Xie, Xiaoying; Ye, Qinghai; Zang, Jie; Ren, Zhenggang; Ji, Qunsheng			Identification of HBV-MLL4 Integration and Its Molecular Basis in Chinese Hepatocellular Carcinoma	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; LIVER-CANCER; INFECTION; GENE; EPIDEMIOLOGY; PREVENTION; MUTATIONS; RISK; MLL2	To gain molecular insights of HBV integration that may contribute to HCC tumorigenesis, we performed whole transcriptome sequencing and whole genome copy number profiling of hepatocellular carcinoma (HCC) samples from 50 Chinese patients. We identified a total of 33 HBV-human integration sites in 16 of 44 HBV-positive HCC tissues, which were enriched in HBV genotype C-infected patients. In addition, significantly recurrent HBV-MLL4 integration (18%; 8/44) was found in this cohort of patients. Using long-range PCR and Sanger sequencing, we comprehensively characterized gDNA and cDNA sequences that encode for the HBV-MLL4 transcripts, and we revealed that HBV integration into MLL4 exons led to much higher mRNA expression of MLL4 than the integration into MLL4 introns due to an alternative splicing mechanism. Moreover, the HBV-MLL4 integration occurred almost exclusively in CTNNB1 and TP53 wild-type patients. The integration was also associated with a distinct gene expression profile. In conclusion, this is the first report on the molecular basis of the MLL4 integration driving MLL4 over-expression. HBV-MLL4 integration occurred frequently in Chinese HCC patients, representing a unique molecular segment for HCC with HBV infection.	[Dong, Hua; Qian, Ziliang; Zhu, Xuehua; Zhu, Guanshan; Zang, Jie; Ji, Qunsheng] AstraZeneca Asian & Emerging Market iMed, Shanghai, Peoples R China; [Zhang, Lan; Xie, Xiaoying; Ye, Qinghai; Ren, Zhenggang] Fudan Univ, Minist Educ, Liver Canc Inst, Zhongshan Hosp,Key Lab Carcinogenesis & Canc Inva, Shanghai 200433, Peoples R China; [Chen, Yunqin] AstraZeneca, R&D Informat, Shanghai, Peoples R China	Fudan University; AstraZeneca	Ren, ZG (corresponding author), Fudan Univ, Minist Educ, Liver Canc Inst, Zhongshan Hosp,Key Lab Carcinogenesis & Canc Inva, Shanghai 200433, Peoples R China.	ren.zhenggang@zs-hospital.sh.cn; qsji18@yahoo.com			AstraZeneca	AstraZeneca(AstraZeneca)	This study was sponsored by AstraZeneca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for authors [HD, ZQ, XZ, GZ, YC, JZ and QJ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ansari KI, 2012, BRIT J CANCER, V107, P315, DOI 10.1038/bjc.2012.263; Aspinall EJ, 2011, OCCUP MED-OXFORD, V61, P531, DOI 10.1093/occmed/kqr136; Chu CM, 2000, J GASTROEN HEPATOL, V15, pE25, DOI 10.1046/j.1440-1746.2000.02097.x; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Farinati F, 2006, AM J GASTROENTEROL, V101, P524, DOI 10.1111/j.1572-0241.2006.00443.x; Ge HY, 2011, BIOINFORMATICS, V27, P1922, DOI 10.1093/bioinformatics/btr310; Glaser S, 2006, DEVELOPMENT, V133, P1423, DOI 10.1242/dev.02302; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Huang J, 2012, NAT GENET, V44, P1117, DOI 10.1038/ng.2391; Huntsman DG, 1999, ONCOGENE, V18, P7975, DOI 10.1038/sj.onc.1203291; Ji X, 2012, MOL CELL, V45, P433, DOI 10.1016/j.molcel.2012.02.003; Jiang ZS, 2012, GENOME RES, V22, P593, DOI 10.1101/gr.133926.111; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; KRaC WH, 1998, HEPATITIS B VIRUS; Kremsdorf D, 2006, ONCOGENE, V25, P3823, DOI 10.1038/sj.onc.1209559; Lau CC, 2014, CANCER CELL, V25, P335, DOI 10.1016/j.ccr.2014.01.030; Lu T, 2013, WORLD J GASTROENTERO, V19, P8887, DOI 10.3748/wjg.v19.i47.8887; McGlynn KA, 2011, CLIN LIVER DIS, V15, P223, DOI 10.1016/j.cld.2011.03.006; Merican I, 2000, J GASTROEN HEPATOL, V15, P1356, DOI 10.1046/j.1440-1746.2000.0150121356.x; Moolla N, 2002, J VIRAL HEPATITIS, V9, P323, DOI 10.1046/j.1365-2893.2002.00381.x; Paraskevis D, 2013, HEPATOLOGY, V57, P908, DOI 10.1002/hep.26079; Saigo K, 2008, HUM MUTAT, V29, P703, DOI 10.1002/humu.20701; Sherman M, 2010, SEMIN LIVER DIS, V30, P3, DOI 10.1055/s-0030-1247128; Sung WK, 2012, NAT GENET, V44, P765, DOI 10.1038/ng.2295; Szymanska K, 2009, CANCER EPIDEM BIOMAR, V18, P1638, DOI 10.1158/1055-9965.EPI-08-1102; Toh ST, 2013, CARCINOGENESIS, V34, P787, DOI 10.1093/carcin/bgs406; Voronkov A, 2013, CURR PHARM DESIGN, V19, P634, DOI 10.2174/138161213804581837; Wang Z, 2010, TRANSL ONCOL, V3, P1, DOI 10.1593/tlo.09250; Welzel TM, 2011, HEPATOLOGY, V54, P463, DOI 10.1002/hep.24397; Zhang XC, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-168	30	38	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123175	10.1371/journal.pone.0123175	http://dx.doi.org/10.1371/journal.pone.0123175			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901726	Green Submitted, Green Published, gold			2022-12-26	WOS:000353331500046
J	Haile, LA; Puig, M; Kelley-Baker, L; Verthelyi, D				Haile, Lydia Asrat; Puig, Montserrat; Kelley-Baker, Logan; Verthelyi, Daniela			Detection of Innate Immune Response Modulating Impurities in Therapeutic Proteins	PLOS ONE			English	Article							AMEBOCYTE LYSATE ASSAY; VITRO PYROGEN TEST; WHOLE-BLOOD; MONONUCLEAR-CELLS; RABBIT PYROGEN; IMMUNOGENICITY; ENDOTOXIN; LIPOPOLYSACCHARIDE; ACTIVATION; INDICATORS	Therapeutic proteins can contain multiple impurities, some of which are variants of the product, while others are derived from the cell substrate and the manufacturing process. Such impurities, even when present at trace levels, have the potential to activate innate immune cells in peripheral blood or embedded in tissues causing expression of cytokines and chemokines, increasing antigen uptake, facilitating processing and presentation by antigen presenting cells, and fostering product immunogenicity. Currently, while products are tested for host cell protein content, assays to control innate immune response modulating impurities (IIRMIs) in products are focused mainly on endotoxin and nucleic acids, however, depending on the cell substrate and the manufacturing process, numerous other IIRMI could be present. In these studies we assess two approaches that allow for the detection of a broader subset of IIRMIs. In the first, we use commercial cell lines transfected with Toll like receptors (TLR) to detect receptor-specific agonists. This method is sensitive to trace levels of IIRMI and provides information of the type of IIRMIs present but is limited by the availability of stably transfected cell lines and requires pre-existing knowledge of the IIRMIs likely to be present in the product. Alternatively, the use of a combination of macrophage cell lines of human and mouse origin allows for the detection of a broader spectrum of impurities, but does not identify the source of the activation. Importantly, for either system the lower limit of detection (LLOD) of impurities was similar to that of PBMC and it was not modified by the therapeutic protein tested, even in settings where the product had inherent immune modulatory properties. Together these data indicate that a cell-based assay approach could be used to screen products for the presence of IIRMIs and inform immunogenicity risk assessments, particularly in the context of comparability exercises.	[Haile, Lydia Asrat; Puig, Montserrat; Kelley-Baker, Logan; Verthelyi, Daniela] US FDA, Immunol Lab, Div Biotechnol Review & Res 3, Off Biotechnol Prod,Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Verthelyi, D (corresponding author), US FDA, Immunol Lab, Div Biotechnol Review & Res 3, Off Biotechnol Prod,Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA.	daniela.verthelyi@fda.hhs.gov			Food and Drug Administration	Food and Drug Administration(United States Department of Health & Human Services)	The work was funded by the Food and Drug Administration. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alving CR, 2002, VACCINE, V20, pS56, DOI 10.1016/S0264-410X(02)00174-3; Baker Matthew P, 2010, Self Nonself, V1, P314, DOI 10.4161/self.1.4.13904; Brennan TV, 2012, BLOOD, V120, P2899, DOI 10.1182/blood-2011-07-368720; Chen L, 2013, J PHARMACEUT BIOMED, V80, P180, DOI 10.1016/j.jpba.2013.03.011; Chirmule N, 2012, AAPS J, V14, P296, DOI 10.1208/s12248-012-9340-y; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Daneshian M, 2006, J IMMUNOL METHODS, V313, P169, DOI 10.1016/j.jim.2006.04.009; Eperon S, 1996, J IMMUNOL METHODS, V194, P121, DOI 10.1016/0022-1759(96)00073-7; Eperon S, 1997, J IMMUNOL METHODS, V207, P135, DOI 10.1016/S0022-1759(97)00112-9; Gao JJ, 2001, J IMMUNOL, V166, P6855, DOI 10.4049/jimmunol.166.11.6855; Hasiwa N, 2013, ALTEX-ALTERN ANIM EX, V30, P169, DOI 10.14573/altex.2013.2.169; Huang LY, 2009, J CLIN MICROBIOL, V47, P3427, DOI 10.1128/JCM.00373-09; Jounai N, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2012.00168; Kikkert R, 2008, J IMMUNOL METHODS, V336, P45, DOI 10.1016/j.jim.2008.03.010; Klinman DM, 2004, IMMUNOL REV, V199, P201, DOI 10.1111/j.0105-2896.2004.00148.x; Koyama S, 2009, EXPERT REV VACCINES, V8, P1099, DOI 10.1586/ERV.09.57; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Lai CY, 2014, VACCINE, V32, P5593, DOI 10.1016/j.vaccine.2014.07.104; Lee S, 2013, NAT BIOTECHNOL, V31, P220, DOI 10.1038/nbt.2528; Li N, 2015, SCI REPORTS IN PRESS; Moesby L, 1999, INT J PHARM, V191, P141, DOI 10.1016/S0378-5173(99)00294-X; Moura-Alves P, 2014, NATURE, V512, P387, DOI 10.1038/nature13684; Nakagawa Y, 2002, CLIN DIAGN LAB IMMUN, V9, P588, DOI 10.1128/CDLI.9.3.588-597.2002; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; Peters M, 2012, INNATE IMMUN-LONDON, V18, P694, DOI 10.1177/1753425912436590; Poole S, 1988, Dev Biol Stand, V69, P121; Sato S, 2002, INT IMMUNOL, V14, P783, DOI 10.1093/intimm/dxf046; Schellekens H, 2002, NAT REV DRUG DISCOV, V1, P457, DOI 10.1038/nrd818; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Singh SK, 2011, J PHARM SCI-US, V100, P354, DOI 10.1002/jps.22276; Swanson Steven J, 2006, J Immunotoxicol, V3, P165, DOI 10.1080/15476910600908852; Tallant T, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-33; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Verthelyi D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015252; Zaitseva M, 2012, VACCINE, V30, P4859, DOI 10.1016/j.vaccine.2012.05.002; ZIEGLERHEITBROCK HWL, 1988, INT J CANCER, V41, P456, DOI 10.1002/ijc.2910410324	38	46	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0125078	10.1371/journal.pone.0125078	http://dx.doi.org/10.1371/journal.pone.0125078			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901912	gold, Green Published, Green Submitted			2022-12-26	WOS:000353331500111
J	Baltich, J; Maurer, C; Nigg, BM				Baltich, Jennifer; Maurer, Christian; Nigg, Benno M.			Increased Vertical Impact Forces and Altered Running Mechanics with Softer Midsole Shoes	PLOS ONE			English	Article							GROUND REACTION FORCES; CRUCIATE LIGAMENT INJURY; TIBIAL STRESS-FRACTURE; JOINT STIFFNESS; LEG STIFFNESS; GENDER-DIFFERENCES; ANKLE JOINT; KNEE; KINEMATICS; FOOTWEAR	To date it has been thought that shoe midsole hardness does not affect vertical impact peak forces during running. This conclusion is based partially on results from experimental data using homogeneous samples of participants that found no difference in vertical impact peaks when running in shoes with different midsole properties. However, it is currently unknown how apparent joint stiffness is affected by shoe midsole hardness. An increase in apparent joint stiffness could result in a harder landing, which should result in increased vertical impact peaks during running. The purpose of this study was to quantify the effect of shoe midsole hardness on apparent ankle and knee joint stiffness and the associated vertical ground reaction force for age and sex subgroups during heel-toe running. 93 runners (male and female) aged 16-75 years ran at 3.33 +/- 0.15 m/s on a 30 m-long runway with soft, medium and hard midsole shoes. The vertical impact peak increased as the shoe midsole hardness decreased (mean(SE); soft: 1.70BW(0.03), medium: 1.64BW(0.03), hard: 1.54BW(0.03)). Similar results were found for the apparent ankle joint stiffness where apparent stiffness increased as the shoe midsole hardness decreased (soft: 2.08BWm/degrees x 100 (0.05), medium: 1.92 BWm/degrees x 100 (0.05), hard: 1.85 BWm/degrees x 100 (0.05)). Apparent knee joint stiffness increased for soft (1.06BWm/degrees x 100 (0.04)) midsole compared to the medium (0.95BWm/degrees x 100 (0.04)) and hard (0.96BWm/degrees x 100 (0.04)) midsoles for female participants. The results from this study confirm that shoe midsole hardness can have an effect on vertical impact force peaks and that this may be connected to the hardness of the landing. The results from this study may provide useful information regarding the development of cushioning guidelines for running shoes.	[Baltich, Jennifer; Maurer, Christian; Nigg, Benno M.] Univ Calgary, Fac Kinesiol, HPL, Calgary, AB, Canada	University of Calgary	Baltich, J (corresponding author), Univ Calgary, Fac Kinesiol, HPL, Calgary, AB, Canada.	jbaltich@ucalgary.ca	Maurer, Christian/AAS-9688-2020	Maurer, Christian/0000-0002-8426-813X	Decathlon (Oxylane Group, France)	Decathlon (Oxylane Group, France)	This study was part of a project sponsored by Decathlon (now Oxylane Group, France). This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. The funders had a role in the study design. They did not have a role in the data analysis, decision to publish, or preparation of this manuscript.	Bennell K, 2004, MED SCI SPORT EXER, V36, P397, DOI 10.1249/01.MSS.0000117116.90297.E1; Bishop M, 2006, J ATHL TRAINING, V41, P387; Chambon N, 2014, GAIT POSTURE, V40, P58, DOI 10.1016/j.gaitpost.2014.02.005; Chumanov ES, 2008, CLIN BIOMECH, V23, P1260, DOI 10.1016/j.clinbiomech.2008.07.011; CLARKE TE, 1983, INT J SPORTS MED, V4, P247, DOI 10.1055/s-2008-1026043; Creaby MW, 2008, MED SCI SPORT EXER, V40, P1669, DOI 10.1249/MSS.0b013e31817571ae; Crossley K, 1999, MED SCI SPORT EXER, V31, P1088, DOI 10.1097/00005768-199908000-00002; Denoth J., 1986, BIOMECHANICS RUNNING, P63; Derrick TR, 1998, MED SCI SPORT EXER, V30, P128, DOI 10.1097/00005768-199801000-00018; Dixon SJ, 2006, CLIN BIOMECH, V21, P412, DOI 10.1016/j.clinbiomech.2005.11.009; Farley CT, 1998, J APPL PHYSIOL, V85, P1044, DOI 10.1152/jappl.1998.85.3.1044; Ferris DP, 1999, J BIOMECH, V32, P787, DOI 10.1016/S0021-9290(99)00078-0; Ford KR, 2011, J APPL BIOMECH, V27, P215, DOI 10.1123/jab.27.3.215; Fukuchi R, 2008, J SPORT SCI, V26, P1447, DOI 10.1080/02640410802209018; Gabriel RC, 2008, PHYS THER SPORT, V9, P16, DOI 10.1016/j.ptsp.2007.08.002; GRIMSTON SK, 1991, INT J SPORT BIOMECH, V7, P293, DOI 10.1123/ijsb.7.3.293; Grimston Susan K., 1994, Journal of Biomechanics, V27, P668, DOI 10.1016/0021-9290(94)90983-0; Hamill J, 2014, EUR J SPORT SCI, V14, P130, DOI 10.1080/17461391.2012.728249; Hamill J, 2011, FOOTWEAR SCI, V3, P33, DOI 10.1080/19424280.2010.542187; Hardin EC, 2004, MED SCI SPORT EXER, V36, P838, DOI 10.1249/01.MSS.0000126605.65966.40; Hardin EC, 2002, RES Q EXERCISE SPORT, V73, P125, DOI 10.1080/02701367.2002.10609001; Heiderscheit BC, 2011, MED SCI SPORT EXER, V43, P296, DOI 10.1249/MSS.0b013e3181ebedf4; Hewett TE, 2000, SPORTS MED, V29, P313, DOI 10.2165/00007256-200029050-00003; LATASH ML, 1993, HUM MOVEMENT SCI, V12, P653, DOI 10.1016/0167-9457(93)90010-M; Lephart SM, 2002, CLIN ORTHOP RELAT R, P162; Mercer JA, 2005, J SPORT SCI MED, V4, P144; Milner CE, 2006, MED SCI SPORT EXER, V38, P323, DOI 10.1249/01.mss.0000183477.75808.92; Myer GD, 2009, CLIN J SPORT MED, V19, P3, DOI 10.1097/JSM.0b013e318190bddb; NIGG BM, 1987, J BIOMECH, V20, P951, DOI 10.1016/0021-9290(87)90324-1; NIGG BM, 1988, AM J SPORT MED, V16, P70, DOI 10.1177/036354658801600113; Nigg BM, 1983, BIOMECHANICS, P1041; Queen RM, 2009, AM J SPORT MED, V37, P390, DOI 10.1177/0363546508324967; Rozzi SL, 1999, AM J SPORT MED, V27, P312, DOI 10.1177/03635465990270030801; Sell TC, 2006, AM J SPORT MED, V34, P43, DOI 10.1177/0363546505278696; Sell TC, 2012, ACL INJURIES FEMALE, P109; Stefanyshyn DJ, 1998, J APPL BIOMECH, V14, P292, DOI 10.1123/jab.14.3.292; Sutton K, 2013, J AM ACAD ORTHOP SUR, V21, P3, DOI [10.5435/JAAOS-21-01-3, DOI 10.5435/JAAOS-21-01-3]; VANDERVOORT AA, 1986, J APPL PHYSIOL, V61, P361, DOI 10.1152/jappl.1986.61.1.361; Von Tscharner V, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054063, DOI 10.1371/JOURNAL.PONE.0054063]; Zifchock RA, 2006, J BIOMECH, V39, P2792, DOI 10.1016/j.jbiomech.2005.10.003	40	61	62	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0125196	10.1371/journal.pone.0125196	http://dx.doi.org/10.1371/journal.pone.0125196			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897963	Green Submitted, gold, Green Published			2022-12-26	WOS:000353212600100
J	Goossens, D; Buck, BJ; Teng, YX; McLaurin, BT				Goossens, Dirk; Buck, Brenda J.; Teng, Yuanxin; McLaurin, Brett T.			Surface and Airborne Arsenic Concentrations in a Recreational Site near Las Vegas, Nevada, USA	PLOS ONE			English	Article							DUST EMISSIONS; NELLIS DUNES; AREA	Elevated concentrations of arsenic, up to 7058 mu g g(-1) in topsoil and bedrock, and more than 0.03 mu g m(-3) in air on a 2-week basis, were measured in the Nellis Dunes Recreation Area (NDRA), a very popular off-road area near Las Vegas, Nevada, USA. The elevated arsenic concentrations in the topsoil and bedrock are correlated to outcrops of yellow sandstone belonging to the Muddy Creek Formation (approximate to 10 to 4 Ma) and to faults crossing the area. Mineralized fluids moved to the surface through the faults and deposited the arsenic. A technique was developed to calculate airborne arsenic concentrations from the arsenic content in the topsoil. The technique was tested by comparing calculated with measured concentrations at 34 locations in the NDRA, for 3 periods of 2 weeks each. We then applied it to calculate airborne arsenic concentrations for more than 500 locations all over the NDRA. The highest airborne arsenic concentrations occur over sand dunes and other zones with a surficial layer of aeolian sand. Ironically these areas show the lowest levels of arsenic in the topsoil. However, they are highly susceptible to wind erosion and emit very large amounts of sand and dust during episodes of strong winds, thereby also emitting much arsenic. Elsewhere in the NDRA, in areas not or only very slightly affected by wind erosion, airborne arsenic levels equal the background level for airborne arsenic in the USA, approximately 0.0004 mu gm(-3). The results of this study are important because the NDRA is visited by more than 300,000 people annually.	[Goossens, Dirk; Buck, Brenda J.; Teng, Yuanxin] Univ Nevada, Dept Geosci, Las Vegas, NV 89154 USA; [Goossens, Dirk] Katholieke Univ Leuven, Dept Earth & Environm Sci, Geog Res Grp, Leuven, Belgium; [McLaurin, Brett T.] Bloomsburg Univ Penn, Dept Environm Geog & Geol Sci, Bloomsburg, PA 17815 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; KU Leuven; Pennsylvania State System of Higher Education (PASSHE); Bloomsburg University of Pennsylvania	Goossens, D (corresponding author), Univ Nevada, Dept Geosci, Las Vegas, NV 89154 USA.	Dirk.Goossens@ees.kuleuven.be	Buck, Brenda J/G-5200-2011		Bureau of Land Management [L11AC20058]	Bureau of Land Management	This project was funded by the Bureau of Land Management (URL: http://www.blm.gov/nv/st/en/fo/lvfo.html), Grant number: L11AC20058, Grant awarded to BB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALL AL, 1983, AM IND HYG ASSOC J, V44, P341, DOI 10.1080/15298668391404941; Beard L.S., 2007, 20071010 US GEOL SUR; BLM, 2004, LAS VEG VALL DISP BO; Briggs P.H., 2002, ANAL METHODS CHEM AN; Buck BJ, 2014, NELLIS DUNES RECREAT, P101; Castor SB, 2001, COLORADO RIVER ORIGI, V12, P77; Derbyshire E, 2007, AMBIO, V36, P73, DOI 10.1579/0044-7447(2007)36[73:NMDAHH]2.0.CO;2; Dolgilevich MJ, 2001, P INT S WORKSH WIND, P6; FRYREAR DW, 1986, J SOIL WATER CONSERV, V41, P117; Goossens D, 2012, J ARID ENVIRON, V78, P80, DOI 10.1016/j.jaridenv.2011.10.015; Goossens D, 2011, ASSESSMENT DUST EMIS; Goossens D, 2012, AEOLIAN RES, V5, P43, DOI 10.1016/j.aeolia.2012.03.002; Goossens D, 2011, EARTH SURF PROC LAND, V36, P610, DOI 10.1002/esp.2080; Goossens D, 2009, J ENVIRON MANAGE, V90, P3458, DOI 10.1016/j.jenvman.2009.05.031; Goossens D, 2009, GEOMORPHOLOGY, V107, P118, DOI 10.1016/j.geomorph.2008.12.001; Kabata-Pendias Alina, 2010, P1; McDowell MA., 2008, NATL HLTH STAT REPOR; McLaurin BT, 2011, GEOSPHERE, V7, P260, DOI 10.1130/GES00593.1; Morman SA, 2013, AEOLIAN RES, V9, P203, DOI 10.1016/j.aeolia.2012.12.001; Reimann C, 2009, APPL GEOCHEM, V24, P1147, DOI 10.1016/j.apgeochem.2009.03.013; Soukup D, 2012, AEOLIAN RES, V5, P77, DOI 10.1016/j.aeolia.2011.11.001; Spivey S., 2008, LAS VEGAS REV J 0317; Sultan B, 2005, PLOS MED, V2, P43, DOI 10.1371/journal.pmed.0020006; Suta B.E., 1978, 50 CRESS; USEPA, 2007, 6020A USEPA; Van Pelt RS, 2007, ENVIRON MONIT ASSESS, V130, P3, DOI 10.1007/s10661-006-9446-8	26	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124271	10.1371/journal.pone.0124271	http://dx.doi.org/10.1371/journal.pone.0124271			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897667	Green Published, Green Submitted, gold			2022-12-26	WOS:000353212600060
J	Kipfmueller, F; Schneider, J; Prusseit, J; Dimitriou, I; Zur, B; Franz, AR; Bartmann, P; Mueller, A				Kipfmueller, Florian; Schneider, Jessica; Prusseit, Julia; Dimitriou, Ioanna; Zur, Berndt; Franz, Axel R.; Bartmann, Peter; Mueller, Andreas			Role of Neutrophil CD64 Index as a Screening Marker for Late-Onset Sepsis in Very Low Birth Weight Infants	PLOS ONE			English	Article							C-REACTIVE PROTEIN; UNNECESSARY ANTIBIOTIC-THERAPY; SENSITIVE DIAGNOSTIC MARKER; NEONATAL SEPSIS; NEWBORN-INFANTS; NECROTIZING ENTEROCOLITIS; NOSOCOMIAL INFECTION; OXIDATIVE STRESS; BRAIN-INJURY; PRETERM	Introduction The role of CD64 in late onset sepsis (LOS) in preterm infants has been described in several studies. Aim of this study was to investigate whether CD64 expression is increased in the days before clinical manifestation of LOS. Methods Patients with birth weight below 1,500g were eligible for study participation. During routine blood sampling CD64 index was determined between day of life 4 and 28. Patients were allocated to one of four groups: (1) blood-culture positive sepsis, (2) clinical sepsis, (3) symptoms of infection without biochemical evidence of infection, or (4) patients without suspected infection. Kinetics of CD64 expression were compared during a period before and after the day of infection in the respective groups. Results 50 infants were prospectively enrolled and allocated to each group as follows: group (1) n = 7; group (2) n = 10; group (3) n = 8; and group (4) n = 25. CD64 index was elevated in 57% of patients in group (1) at least two days before infection. In contrast only 20% in the clinical sepsis group and 0% in group (3) had an elevated CD64 index in the days before infection. 10 of the 25 patients in the control group (4) presented increased CD64 index values during the study period. Conclusions The CD64 index might be a promising marker to detect LOS before infants demonstrate signs or symptoms of infection. However, larger prospective studies are needed to define optimal cut-off values and to investigate the role of non-infectious inflammation in this patient group.	[Kipfmueller, Florian; Schneider, Jessica; Prusseit, Julia; Franz, Axel R.; Bartmann, Peter; Mueller, Andreas] Univ Childrens Hosp Bonn, Dept Neonatol & Pediat Crit Care, Bonn, Germany; [Dimitriou, Ioanna] Univ Hosp Bonn, Dept Med Biometry Informat & Epidemiol, Bonn, Germany; [Zur, Berndt] Univ Hosp Bonn, Inst Clin Chem & Clin Pharmacol, Bonn, Germany	University of Bonn; University of Bonn; University of Bonn	Kipfmueller, F (corresponding author), Univ Childrens Hosp Bonn, Dept Neonatol & Pediat Crit Care, Bonn, Germany.	florian.kipfmueller@ukb.uni-bonn.de	Franz, Axel/AAC-8067-2022	Franz, Axel/0000-0001-5066-0857				Adams-Chapman I, 2006, CURR OPIN INFECT DIS, V19, P290, DOI 10.1097/01.qco.0000224825.57976.87; Bartels DB, 2007, ARCH DIS CHILD-FETAL, V92, P449; Been JV, 2011, BJOG-INT J OBSTET GY, V118, P113, DOI 10.1111/j.1471-0528.2010.02751.x; Bekhof J, 2013, EUR J PEDIATR, V172, P501, DOI 10.1007/s00431-012-1910-6; Bhandari V, 2008, PEDIATRICS, V121, P129, DOI 10.1542/peds.2007-1308; Bohrer B, 2010, J PEDIATR-US, V156, P16, DOI 10.1016/j.jpeds.2009.07.027; Cai ZW, 2004, PEDIATR RES, V56, P377, DOI 10.1203/01.PDR.0000134249.92944.14; Dimoula A, 2014, CLIN INFECT DIS, V58, P820, DOI 10.1093/cid/cit936; Du JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102647; Elawady S, 2014, J INVEST MED, V62, P644, DOI 10.2310/JIM.0000000000000060; ERBE DV, 1990, MOL IMMUNOL, V27, P57, DOI 10.1016/0161-5890(90)90060-D; Fjaertoft G, 2005, ACTA PAEDIATR, V94, P295, DOI 10.1111/j.1651-2227.2005.tb03072.x; Fjaertoft G, 1999, PEDIATR RES, V45, P871, DOI 10.1203/00006450-199906000-00016; Franz AR, 2004, PEDIATRICS, V114, P1, DOI 10.1542/peds.114.1.1; Franz AR, 1999, PEDIATRICS, V104, P447, DOI 10.1542/peds.104.3.447; Groselj-Grenc M, 2009, INTENS CARE MED, V35, P1950, DOI 10.1007/s00134-009-1637-7; Groselj-Grenc M, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/202646; Hoffmann JJML, 2011, BIOCHEM MEDICA, V21, P282; Hornik CP, 2012, EARLY HUM DEV, V88, pS69, DOI 10.1016/S0378-3782(12)70019-1; HUIZINGA TWJ, 1991, BLOOD, V77, P2088; Icardi M, 2009, J CLIN MICROBIOL, V47, P3914, DOI 10.1128/JCM.00628-09; KERST JM, 1993, BLOOD, V81, P1457; Kramer BW, 2004, PEDIATR RES, V55, P764, DOI 10.1203/01.PDR.0000120678.72485.19; Kuster H, 1998, LANCET, V352, P1271, DOI 10.1016/S0140-6736(98)08148-3; Kuypers E, 2012, AM J PHYSIOL-LUNG C, V302, pL380, DOI 10.1152/ajplung.00338.2011; Lam HS, 2013, CLIN CHEM, V59, P1753, DOI 10.1373/clinchem.2013.209536; Lavoie PM, 2010, PEDIATR RES, V68, P248, DOI 10.1203/00006450-201011001-00485; Layseca-Espinosa E, 2002, PEDIAT ALLERG IMM-UK, V13, P319, DOI 10.1034/j.1399-3038.2002.01064.x; Leistner R, 2013, KLIN PADIATR, V225, P75, DOI 10.1055/s-0033-1334886; Levy O, 2000, BLOOD, V96, P2664; Mazzucchelli I, 2013, PEDIATR CRIT CARE ME, V14, P178, DOI 10.1097/PCC.0b013e31826e726d; Mestan K, 2009, J MATERN-FETAL NEO M, V22, P379, DOI 10.1080/14767050802609759; Morsy Amal A, 2008, Egypt J Immunol, V15, P53; Ng PC, 2006, CURR OPIN PEDIATR, V18, P125, DOI 10.1097/01.mop.0000193293.87022.4c; Ng PC, 2010, CLIN PERINATOL, V37, P599, DOI 10.1016/j.clp.2010.05.005; Ng PC, 2004, PEDIATR RES, V56, P796, DOI 10.1203/01.PDR.0000142586.47798.5E; Ng PC, 1997, ARCH DIS CHILD-FETAL, V77, pF221, DOI 10.1136/fn.77.3.F221; Ng PC, 2002, PEDIATR RES, V51, P296, DOI 10.1203/00006450-200203000-00006; RODWELL RL, 1988, J PEDIATR-US, V112, P761, DOI 10.1016/S0022-3476(88)80699-1; Schrag SJ, 2006, PEDIATR INFECT DIS J, V25, P939, DOI 10.1097/01.inf.0000239267.42561.06; Schrag SJ, 2006, PEDIATRICS, V118, P570, DOI 10.1542/peds.2005-3083; Soni S, 2013, PEDIATR INFECT DIS J, V32, pE33, DOI 10.1097/INF.0b013e31826faede; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; Stoll BJ, 1996, J PEDIATR-US, V129, P63, DOI 10.1016/S0022-3476(96)70191-9; Streimish I, 2012, PEDIATR INFECT DIS J, V31, P777, DOI 10.1097/INF.0b013e318256fb07; Streimish I, 2014, AM J PERINAT, V31, P21, DOI 10.1055/s-0033-1334453; Strunk T, 2014, LANCET INFECT DIS, V14, P751, DOI 10.1016/S1473-3099(14)70710-8; Vento M, 2009, PEDIATRICS, V124, pE439, DOI 10.1542/peds.2009-0434; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; WALSH MC, 1986, PEDIATR CLIN N AM, V33, P179, DOI 10.1016/s0031-3955(16)34975-6; Wang K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082700; Yeung MY, 2006, ACTA PAEDIATR, V95, P153, DOI 10.1080/08035250500301133	52	16	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124634	10.1371/journal.pone.0124634	http://dx.doi.org/10.1371/journal.pone.0124634			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894336	Green Published, gold, Green Submitted			2022-12-26	WOS:000353211700110
J	Wan, SG; Wu, YS; Zhou, XC; Chen, YB; An, JZ; Yu, XH; Zhang, HQ; Yang, HS; Xing, JL				Wan, Shaogui; Wu, Yousheng; Zhou, Xingchun; Chen, Yibing; An, Jiaze; Yu, Xiaohe; Zhang, Huiqing; Yang, Hushan; Xing, Jinliang			Polymorphisms in Genes of Tricarboxylic Acid Cycle Key Enzymes Are Associated with Early Recurrence of Hepatocellular Carcinoma	PLOS ONE			English	Article							INTRAHEPATIC RECURRENCE; RISK-FACTORS; SDHD GENE; MUTATIONS; CANCER; RESECTION; METABOLISM; EXPRESSION; MANAGEMENT	Alterations of activity and expression in tricarboxylic acid (TCA) cycle key enzymes have been indicated in several malignancies, including hepatocellular carcinoma (HCC). They play an important role in the progression of cancer. However, the impact of single nucleotide polymorphisms (SNPs) in genes encoding these key enzymes on the recurrence of HCC has not been investigated. In this study, we genotyped 17 SNPs in genes encoding TCA cycle key enzymes and analyzed their association with recurrence-free survival (RFS) in a cohort of 492 Chinese HCC patients by Cox proportional hazard model and survival tree analysis. We identified 7 SNPs in SDHC, SDHD, FH, and IDH2 genes to be significantly associated with the RFS of HCC patients. Moreover, all these SNPs were associated with the early recurrence (within 2 years after surgery) risk of diseases. Cumulative effect analysis showed that these SNPs exhibited a dose-dependent effect on the overall and early recurrence. Further stratified analysis suggested that number of risk genotypes modified the protective effect on HCC recurrence conferred by transcatheter arterial chemoembolization treatment. Finally, the survival tree analysis revealed that SNP rs10789859 in SDHD gene was the primary factor contributing to HCC recurrence in our population. To the best of our knowledge, we for the first time observed the association between SNPs in genes encoding TCA cycle key enzymes and HCC recurrence risk. Further observational and functional studies are needed to validate our findings and generalize its clinical usage.	[Wan, Shaogui] Henan Univ, Pharmaceut Coll, Inst Pharm, Kaifeng, Henan, Peoples R China; [Wu, Yousheng; Zhou, Xingchun; Chen, Yibing; Xing, Jinliang] Fourth Mil Med Univ, Expt Teaching Ctr Basic Med, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China; [An, Jiaze] Fourth Mil Med Univ, Xijing Hosp, Dept Hepatobiliary Surg, Xian 710032, Shaanxi, Peoples R China; [Yu, Xiaohe] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Intervent Radiol, Shanghai, Peoples R China; [Zhang, Huiqing] Fourth Mil Med Univ, Tangdu Hosp, Dept Pain Treatment, Xian 710032, Peoples R China; [Yang, Hushan] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Med Oncol, Div Populat Sci, Philadelphia, PA 19107 USA	Henan University; Air Force Military Medical University; Air Force Military Medical University; Naval Medical University; Air Force Military Medical University; Jefferson University	Yang, HS (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Med Oncol, Div Populat Sci, Philadelphia, PA 19107 USA.	hushan.yang@jefferson.edu; xingjinliang@163.com			Program for New Century Excellent Talents in University of China; National Natural Science Foundation [81171966]; National Key Technologies R&D Program of China [2011ZX09307-001-04]; NATIONAL CANCER INSTITUTE [R03CA153099, R21CA159047, P30CA056036] Funding Source: NIH RePORTER	Program for New Century Excellent Talents in University of China(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Technologies R&D Program of China(National Key Technology R&D Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Program for New Century Excellent Talents in University of China, National Natural Science Foundation (No. 81171966) and National Key Technologies R&D Program of China (No. 2011ZX09307-001-04) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardella C, 2011, BBA-BIOENERGETICS, V1807, P1432, DOI 10.1016/j.bbabio.2011.07.003; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; BELGHITI J, 1991, ANN SURG, V214, P114, DOI 10.1097/00000658-199108000-00004; Cardaci Simone, 2012, Int J Cell Biol, V2012, P161837, DOI 10.1155/2012/161837; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Fukuda H, 2002, CARCINOGENESIS, V23, P2019, DOI 10.1093/carcin/23.12.2019; Habano W, 2003, ONCOL REP, V10, P1375; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hirawake H, 1999, BBA-BIOENERGETICS, V1412, P295, DOI 10.1016/S0005-2728(99)00071-7; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Imamura H, 2003, J HEPATOL, V38, P200, DOI 10.1016/S0168-8278(02)00360-4; Ishizawa T, 2008, GASTROENTEROLOGY, V134, P1908, DOI 10.1053/j.gastro.2008.02.091; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; Marrero JA, 2005, HEPATOLOGY, V41, P707, DOI 10.1002/hep.20636; Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735; Poon RTP, 2000, ANN SURG, V232, P10, DOI 10.1097/00000658-200007000-00003; Rahbari NN, 2011, ANN SURG, V253, P453, DOI 10.1097/SLA.0b013e31820d944f; Raimundo N, 2011, TRENDS MOL MED, V17, P641, DOI 10.1016/j.molmed.2011.06.001; Roayaie S, 2009, GASTROENTEROLOGY, V137, P850, DOI 10.1053/j.gastro.2009.06.003; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Ulrich CM, 2003, NAT REV CANCER, V3, P912, DOI 10.1038/nrc1233; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yang M, 2013, J CLIN INVEST, V123, P3652, DOI 10.1172/JCI67228; Yen KE, 2010, ONCOGENE, V29, P6409, DOI 10.1038/onc.2010.444; Yu XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093416; Yuan P, 2014, CANCER SCI, V105, P825, DOI 10.1111/cas.12428	30	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124471	10.1371/journal.pone.0124471	http://dx.doi.org/10.1371/journal.pone.0124471			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894340	Green Published, gold, Green Submitted			2022-12-26	WOS:000353211700098
J	Yakoub, AM; Shukla, D				Yakoub, Abraam M.; Shukla, Deepak			Herpes Simplex Virus-1 Fine-Tunes Host's Autophagic Response to Infection: A Comprehensive Analysis in Productive Infection Models	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; MONITORING AUTOPHAGY; CELLULAR AUTOPHAGY; ANTIVIRAL DEFENSE; HSV-1 INFECTION; REPLICATION; ENTRY; LC3; HERPESVIRUSES; SEQUENCE	Herpes simplex virus-1 (HSV-1) infection causes severe conditions, with serious complications, including corneal blindness from uncontrolled ocular infections. An important cellular defense mechanism against HSV-1 infection is autophagy. The autophagic response of the host cell was suggested to be regulated by HSV-1. In this study, we performed a detailed analysis of autophagy in multiple HSV-1-targeted cell types, and under various infection conditions that recapitulate a productive infection model. We found that autophagy was slightly inhibited in one cell type, while in other cell types autophagy maintained its basal levels mostly unchanged during productive infection. This study refines the concept of HSV-1-mediated autophagy regulation to imply either inhibition, or prevention of activation, of the innate immune pathway.	[Yakoub, Abraam M.; Shukla, Deepak] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA; [Yakoub, Abraam M.; Shukla, Deepak] Univ Illinois, Med Ctr, Dept Ophthalmol & Visual Sci, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Shukla, D (corresponding author), Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA.	dshukla@uic.edu		Shukla, Deepak/0000-0002-3039-6953	NIH [EY023058];  [EY01792]; NATIONAL EYE INSTITUTE [R21EY023058, P30EY001792] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by a NIH grant (EY023058) to DS and a core grant (EY01792). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar J, 2009, FEBS J, V276, P7228, DOI 10.1111/j.1742-4658.2009.07402.x; Alexander DE, 2007, J VIROL, V81, P12128, DOI 10.1128/JVI.01356-07; Aoun P, 2003, INVEST OPHTH VIS SCI, V44, P2999, DOI 10.1167/iovs.02-1060; ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614; Banatvala JE, 2011, LANCET INFECT DIS, V11, P80, DOI 10.1016/S1473-3099(11)70012-3; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Cavignac Y, 2010, VIRUSES-BASEL, V2, P314, DOI 10.3390/v2010314; Choi J, 2005, INVEST OPHTH VIS SCI, V46, P214, DOI 10.1167/iovs.04-0765; CHOU J, 1990, J VIROL, V64, P1014, DOI 10.1128/JVI.64.3.1014-1020.1990; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Eng KE, 2010, AUTOPHAGY, V6, P634, DOI 10.4161/auto.6.5.12112; English L, 2009, NAT IMMUNOL, V10, P480, DOI 10.1038/ni.1720; Gobeil PAM, 2012, MBIO, V3, DOI 10.1128/mBio.00267-12; Jaishankar D, 2015, J VIROL, V89, P1932, DOI 10.1128/JVI.02979-14; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kuballa P, 2012, ANNU REV IMMUNOL, V30, P611, DOI 10.1146/annurev-immunol-020711-074948; Kudchodkar SB, 2009, REV MED VIROL, V19, P359, DOI 10.1002/rmv.630; Kundu M, 2008, ANNU REV PATHOL-MECH, V3, P427, DOI 10.1146/annurev.pathmechdis.2.010506.091842; Le Sage V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042636; Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016; McFarlane S, 2011, J VIROL, V85, P4212, DOI 10.1128/JVI.02435-10; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Nakashima A, 2006, VIROLOGY, V349, P254, DOI 10.1016/j.virol.2006.03.029; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Prentice E, 2004, J BIOL CHEM, V279, P10136, DOI 10.1074/jbc.M306124200; Rasmussen SB, 2011, J IMMUNOL, V187, P5268, DOI 10.4049/jimmunol.1100949; Reggiori F, 2005, CURR OPIN CELL BIOL, V17, P415, DOI 10.1016/j.ceb.2005.06.007; Roizman B, 2013, ANNU REV MICROBIOL, V67, P355, DOI 10.1146/annurev-micro-092412-155654; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866; Szpara ML, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002282; Szpara ML, 2010, J VIROL, V84, P5303, DOI 10.1128/JVI.00312-10; Talloczy Z, 2006, AUTOPHAGY, V2, P24, DOI 10.4161/auto.2176; Tanida I, 2008, AUTOPHAGY, V4, P131, DOI 10.4161/auto.5233; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Tiwari V, 2015, MOLECULES, V20, P2707, DOI 10.3390/molecules20022707; Tumbarello DA, 2012, NAT CELL BIOL, V14, P1024, DOI 10.1038/ncb2589; Wan GH, 2008, J BIOL CHEM, V283, P21540, DOI 10.1074/jbc.M800214200; Watson G, 2012, VIROLOGY, V433, P528, DOI 10.1016/j.virol.2012.08.043; Whitley RJ, 2001, LANCET, V357, P1513, DOI 10.1016/S0140-6736(00)04638-9; Yakoub AM, 2014, J VIROL, V88, P12915, DOI 10.1128/JVI.02071-14; Ying HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047307; Yordy B, 2013, AUTOPHAGY, V9, P236, DOI 10.4161/auto.22506; Yordy B, 2012, CELL HOST MICROBE, V12, P334, DOI 10.1016/j.chom.2012.07.013; Zhou Z, 2009, AUTOPHAGY, V5, P321, DOI 10.4161/auto.5.3.7406	50	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124646	10.1371/journal.pone.0124646	http://dx.doi.org/10.1371/journal.pone.0124646			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894397	Green Published, Green Submitted, gold			2022-12-26	WOS:000353211700111
J	Hou, J; Wang, F; Kong, PZ; Yu, PKN; Wang, HZ; Han, W				Hou, Jue; Wang, Fan; Kong, Peizhong; Yu, Peter K. N.; Wang, Hongzhi; Han, Wei			Gene Profiling Characteristics of Radioadaptive Response in AG01522 Normal Human Fibroblasts	PLOS ONE			English	Article							INDUCED ADAPTIVE RESPONSE; LOW-DOSE-RATE; IONIZING-RADIATION; GERM-CELLS; MICROARRAY ANALYSIS; TRAIL RESISTANCE; CYTOSCAPE PLUGIN; STRESS GENES; NITRIC-OXIDE; IN-VITRO	Radioadaptive response (RAR) in mammalian cells refers to the phenomenon where a low-dose ionizing irradiation alters the gene expression profiles, and protects the cells from the detrimental effects of a subsequent high dose exposure. Despite the completion of numerous experimental studies on RAR, the underlying mechanism has remained unclear. In this study, we aimed to have a comprehensive investigation on the RAR induced in the AG01522 human fibroblasts first exposed to 5 cGy (priming dose) and then followed by 2 Gy (challenge dose) of X-ray through comparisons to those cells that had only received a single 2 Gy dose. We studied how the priming dose affected the expression of gene transcripts, and to identify transcripts or pathways that were associated with the reduced chromosomal damages (in terms of the number of micronuclei) after application of the challenging dose. Through the mRNA and microRNA microarray analyses, the transcriptome alteration in AG01522 cells was examined, and the significantly altered genes were identified for different irradiation procedures using bioinformatics approaches. We observed that a low-dose X-ray exposure produced an alert, triggering and altering cellular responses to defend against subsequent high dose-induced damages, and accelerating the cell repair process. Moreover, the p53 signaling pathway was found to play critial roles in regulating DNA damage responses at the early stage after application of the challenging dose, particularly in the RAR group. Furthermore, microRNA analyses also revealed that cell communication and intercellular signaling transduction played important roles after low-dose irradiation. We conclude that RAR benefits from the alarm mechanisms triggered by a low-dose priming radation dose.	[Hou, Jue; Kong, Peizhong; Wang, Hongzhi; Han, Wei] Chinese Acad Sci, Ctr Med Phys & Technol, Hefei Inst Phys Sci, Hefei, Peoples R China; [Yu, Peter K. N.] City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon Tong, Hong Kong, Peoples R China; [Wang, Fan] Anhui Med Univ, Dept Radiat Oncol, Affiliated Hosp 1, Hefei, Peoples R China; [Wang, Hongzhi; Han, Wei] Chinese Acad Sci, Canc Hosp, Hefei Inst Phys Sci, Hefei, Peoples R China	Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; City University of Hong Kong; Anhui Medical University; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS	Han, W (corresponding author), Chinese Acad Sci, Ctr Med Phys & Technol, Hefei Inst Phys Sci, Hefei, Peoples R China.	hanw@hfcas.ac.cn	Hou, Jue/S-8184-2017; Yu, Peter K.N./C-7051-2013	Hou, Jue/0000-0001-9913-8365; Yu, Peter K.N./0000-0003-1669-5348	National Natural Science Foundation of China [81172602]; "Hundred Talents Program" of the Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Hundred Talents Program" of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was funded by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) under Grant No. 81172602, and "Hundred Talents Program" of the Chinese Academy of Sciences (http://www.cas.cn/ggzy/rcpy/brjh/). Wei Han as grants funder played roles in the study design, decision to publish, and preparation of the manuscript.	Amundson SA, 1999, RADIAT RES, V152, P225, DOI 10.2307/3580321; Amundson SA, 2003, MOL CANCER RES, V1, P445; AZZAM EI, 1994, RADIAT RES, V138, pS28, DOI 10.2307/3578755; Bindea G, 2013, BIOINFORMATICS, V29, P661, DOI 10.1093/bioinformatics/btt019; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Boothman DA, 1996, MUTAT RES-FUND MOL M, V358, P143, DOI 10.1016/S0027-5107(96)00115-7; CAI L, 1995, MUTAGENESIS, V10, P95, DOI 10.1093/mutage/10.2.95; CAI L, 1993, MUTAT RES, V303, P157, DOI 10.1016/0165-7992(93)90017-P; CAI L, 1990, INT J RADIAT BIOL, V58, P187, DOI 10.1080/09553009014551541; Chen SL, 1999, TOXICOL LETT, V105, P141, DOI 10.1016/S0378-4274(98)00393-2; Choi VWY, 2013, J RADIOL PROT, V33, P91, DOI 10.1088/0952-4746/33/1/91; Choi VWY, 2011, RADIAT MEAS, V46, P1795, DOI 10.1016/j.radmeas.2011.06.052; Choi VWY, 2010, ENVIRON SCI TECHNOL, V44, P8829, DOI 10.1021/es101535f; Choi VWY, 2010, NUCL INSTRUM METH B, V268, P651, DOI 10.1016/j.nimb.2009.12.002; Choi V. W. Y., 2014, J RADIAT RES, V55, pi114, DOI [10. 1093/ jrr/ rru004, DOI 10.1093/JRR/RRU004]; Choi V.W.Y., 2014, J RADIAT RES, V55, pI115, DOI [10.1093/jrr/rrt165, DOI 10.1093/JRR/RRT165]; Choi VWY, 2010, J RADIAT RES, V51, P657, DOI 10.1269/jrr.10054; Coleman MA, 2005, RADIAT RES, V164, P369, DOI 10.1667/RR3356.1; COOPER GP, 1968, AM J PHYSIOL, V215, P803, DOI 10.1152/ajplegacy.1968.215.4.803; Corpas FJ, 2004, PLANT PHYSIOL, V136, P2722, DOI 10.1104/pp.104.042812; Corpas FJ, 2001, TRENDS PLANT SCI, V6, P145, DOI 10.1016/S1360-1385(01)01898-2; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; de Toledo SM, 1998, CELL GROWTH DIFFER, V9, P887; Ding LH, 2005, RADIAT RES, V164, P17, DOI 10.1667/RR3354; Emmert-Streib F, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002053; FAROOQI Z, 1993, MUTAT RES, V302, P83, DOI 10.1016/0165-7992(93)90008-J; Feinendegen LE, 1999, HUM EXP TOXICOL, V18, P426, DOI 10.1191/096032799678840309; FUKS Z, 1993, RADIAT ONCOL INVEST, V1, P81; Garofalo M, 2008, ONCOGENE, V27, P3845, DOI 10.1038/onc.2008.6; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Ghandhi SA, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-63; Ghosh S, 1996, J BIOL CHEM, V271, P8472, DOI 10.1074/jbc.271.14.8472; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo HT, 2006, BIOCHEM J, V394, P379, DOI 10.1042/BJ20051730; IKUSHIMA T, 1989, MUTAT RES, V227, P241, DOI 10.1016/0165-7992(89)90104-8; Jen KY, 2005, CANCER RES, V65, P7666, DOI 10.1158/0008-5472.CAN-05-1039; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kalanxhi E, 2012, RADIAT RES, V177, P35, DOI 10.1667/RR2694.1; Kandasamy K, 2002, CANCER RES, V62, P4929; Kis E, 2006, INT J RADIAT ONCOL, V66, P1506, DOI 10.1016/j.ijrobp.2006.08.004; Lee JK, 2008, NEUROBIOL DIS, V30, P174, DOI 10.1016/j.nbd.2008.01.004; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liu ZG, 1996, NATURE, V384, P273, DOI 10.1038/384273a0; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mehrara BJ, 2010, FASEB J, V24, P4877, DOI 10.1096/fj.10-155762; Mezentsev A, 2011, RADIAT RES, V175, P677, DOI 10.1667/RR2483.1; Mosse I, 2000, RADIAT ENVIRON BIOPH, V39, P47, DOI 10.1007/PL00007685; Nagata K, 1998, EMBO J, V17, P149, DOI 10.1093/emboj/17.1.149; OLIVIERI G, 1984, SCIENCE, V223, P594, DOI 10.1126/science.6695170; Park WY, 2002, ONCOGENE, V21, P8521, DOI 10.1038/sj.onc.1205977; SAGAR SM, 1991, INT J RADIAT ONCOL, V20, P771, DOI 10.1016/0360-3016(91)90021-U; Sandberg R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-48; Seong Jinsil, 1994, Yonsei Medical Journal, V35, P77; Smith ML, 1996, MUTAT RES-REV GENET, V340, P109, DOI 10.1016/S0165-1110(96)90043-3; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sorensen KJ, 2002, MUTAT RES-GEN TOX EN, V519, P15, DOI 10.1016/S1383-5718(02)00110-9; Stecca C, 1998, BIOCHEM PHARMACOL, V55, P941, DOI 10.1016/S0006-2952(97)00448-6; Streffer C, 2004, MUTAT RES-FUND MOL M, V568, P79, DOI 10.1016/j.mrfmmm.2004.07.014; Tapio S, 2007, RADIAT ENVIRON BIOPH, V46, P1, DOI 10.1007/s00411-006-0078-8; Turtoi A, 2010, RADIAT RES, V174, P125, DOI 10.1667/RR1659.1; Venkat S, 2001, J Environ Pathol Toxicol Oncol, V20, P165; Wang B, 2004, RADIAT RES, V161, P264, DOI 10.1667/RR3141; Wolff S, 1996, MUTAT RES-FUND MOL M, V358, P135, DOI 10.1016/S0027-5107(96)00114-5; Yin E, 2003, INT J RADIAT BIOL, V79, P759, DOI 10.1080/09553000310001610961; YOSHIDA N, 1993, J RADIAT RES, V34, P269, DOI 10.1269/jrr.34.269; Yu Wenru, 1995, Chinese Medical Sciences Journal, V10, P50; Yunis R, 2012, J RADIAT RES, V53, P860, DOI 10.1093/jrr/rrs063; Zaichkina S I, 1999, Radiats Biol Radioecol, V39, P404; Zasukhina G D, 1999, Radiats Biol Radioecol, V39, P58	71	20	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123316	10.1371/journal.pone.0123316	http://dx.doi.org/10.1371/journal.pone.0123316			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886619	Green Published, gold, Green Submitted			2022-12-26	WOS:000353017000055
J	Jelsone-Swain, L; Persad, C; Burkard, D; Welsh, RC				Jelsone-Swain, Laura; Persad, Carol; Burkard, David; Welsh, Robert C.			Action Processing and Mirror Neuron Function in Patients with Amyotrophic Lateral Sclerosis: An fMRI Study	PLOS ONE			English	Article							COGNITIVE IMPAIRMENT; ALE METAANALYSIS; SCREENING TOOL; MOTOR; BRAIN; RECOGNITION; SIMULATION; PLASTICITY; DEFICITS; SYSTEM	Amyotrophic lateral sclerosis (ALS) is a highly debilitating and rapidly fatal neurodegenerative disease. It has been suggested that social cognition may be affected, such as impairment in theory of mind (ToM) ability. Despite these findings, research in this area is scarce and the investigation of neural mechanisms behind such impairment is absent. Nineteen patients with ALS and eighteen healthy controls participated in this study. Because the mirror neuron system (MNS) is thought to be involved in theory of mind, we first implemented a straightforward action-execution and observation task to assess basic MNS function. Second, we examined the social-cognitive ability to understand actions of others, which is a component of ToM. We used fMRI to assess BOLD activity differences between groups during both experiments. Theory of mind was also measured behaviorally using the Reading the Mind in the Eyes test (RME). ALS patients displayed greater BOLD activity during the action-execution and observation task, especially throughout right anterior cortical regions. These areas included the right inferior operculum, premotor and primary motor regions, and left inferior parietal lobe. A conjunction analysis showed significantly more co-activated voxels during both the observation and action-execution conditions in the patient group throughout MNS regions. These results support a compensatory response in the MNS during action processing. In the action understanding experiment, healthy controls performed better behaviorally and subsequently recruited greater regions of activity throughout the prefrontal cortex and middle temporal gyrus. Lastly, action understanding performance was able to cluster patients with ALS into high and lower performing groups, which then differentiated RME performance. Collectively, these data suggest that social cognition, particularly theory of mind, may be affected in a subset of patients with ALS. This impairment may be related to functioning of the MNS and other regions related to action processing and understanding. Implications for future research are discussed.	[Jelsone-Swain, Laura] Univ South Carolina Aiken, Dept Psychol, Aiken, SC 29801 USA; [Jelsone-Swain, Laura; Burkard, David; Welsh, Robert C.] Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA; [Persad, Carol; Welsh, Robert C.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Jelsone-Swain, L (corresponding author), Univ South Carolina Aiken, Dept Psychol, Aiken, SC 29801 USA.	laurasw@usca.edu	Welsh, Robert/ABH-3526-2021	Jelsone-Swain, Laura/0000-0002-9179-8884	National Center for Advancing Translational Sciences (NCATS) through the National Institutes of Health (NIH) [2UL1TR000433]; NIH/NINDS [R01 NS052514-01A1]; University of Michigan Functional Magnetic Resonance Laboratory [2UL1TR000433]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052514] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences (NCATS) through the National Institutes of Health (NIH); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); University of Michigan Functional Magnetic Resonance Laboratory; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by grant numbers 2UL1TR000433 from the National Center for Advancing Translational Sciences (NCATS) through the National Institutes of Health (NIH) and the grant NIH/NINDS R01 NS052514-01A1 (RCW). University of Michigan Functional Magnetic Resonance Laboratory (LJS) also helped fund this work, and the translational grant number is 2UL1TR000433. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, PERFORMANCE AMYOTROP, V152, pS1; [Anonymous], 2014, VERBAL FLUENCY INDEX, V15, P388; [Anonymous], 2000, VERBAL FLUENCY EXECU, V38, P734; [Anonymous], 2010, DETECTING FRONTOTEMP, V11, P303; [Anonymous], 2012, ARCH REV, V10, P3, DOI [DOI 10.5121/IJAIA.2012.3412161,(19), DOI 10.2151/JMSJ.2012-A02]; Babiloni C, 2009, NEUROIMAGE, V45, P512, DOI 10.1016/j.neuroimage.2008.11.035; Bak TH, 2012, CORTEX, V48, P936, DOI 10.1016/j.cortex.2011.07.008; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Buccino G, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0185; Caspers S, 2010, NEUROIMAGE, V50, P1148, DOI 10.1016/j.neuroimage.2009.12.112; Cattaneo L, 2009, J NEUROSCI, V29, P11134, DOI 10.1523/JNEUROSCI.2605-09.2009; Cattaneo L, 2009, ARCH NEUROL-CHICAGO, V66, P557, DOI 10.1001/archneurol.2009.41; Cavallo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025948; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Eisen A, 2014, MUSCLE NERVE, V49, P469, DOI 10.1002/mus.24132; Fabbri-Destro M, 2008, PHYSIOLOGY, V23, P171, DOI 10.1152/physiol.00004.2008; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Filimon F, 2007, NEUROIMAGE, V37, P1315, DOI 10.1016/j.neuroimage.2007.06.008; Fiori F, 2013, EXP BRAIN RES, V226, P537, DOI 10.1007/s00221-013-3465-9; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gibbons ZC, 2007, NEUROPSYCHOLOGIA, V45, P1196, DOI 10.1016/j.neuropsychologia.2006.10.008; Giordana MT, 2011, NEUROL SCI, V32, P9, DOI 10.1007/s10072-010-0439-6; Girardi A, 2011, NEUROPSYCHOLOGY, V25, P53, DOI 10.1037/a0020357; Gobbini MI, 2007, J COGNITIVE NEUROSCI, V19, P1803, DOI 10.1162/jocn.2007.19.11.1803; Grace GM, 2011, CAN J NEUROL SCI, V38, P88; Grossman M, 2008, NEUROLOGY, V71, P1396, DOI 10.1212/01.wnl.0000319701.50168.8c; Hanagasi HA, 2002, COGNITIVE BRAIN RES, V14, P234, DOI 10.1016/S0926-6410(02)00110-6; Hesslow G, 2002, TRENDS COGN SCI, V6, P242, DOI 10.1016/S1364-6613(02)01913-7; Higuchi S, 2012, NEUROIMAGE, V59, P1668, DOI 10.1016/j.neuroimage.2011.09.021; Hillis AE, 2004, ANN NEUROL, V55, P268, DOI 10.1002/ana.10812; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Jelsone-Swain L, 2012, MIRROR NEURON FUNCTI; Kelly AMC, 2005, CEREB CORTEX, V15, P1089, DOI 10.1093/cercor/bhi005; KEW JJM, 1993, BRAIN, V116, P655, DOI 10.1093/brain/116.3.655; Keysers C, 2010, CURR BIOL, V20, pR353, DOI 10.1016/j.cub.2010.03.013; Kilner JM, 2011, TRENDS COGN SCI, V15, P352, DOI 10.1016/j.tics.2011.06.005; Kollewe K, 2011, J NEUROL, V258, P804, DOI 10.1007/s00415-010-5842-7; Konrad C, 2002, EXP BRAIN RES, V143, P51, DOI 10.1007/s00221-001-0981-9; Lule D, 2007, NEUROREHAB NEURAL RE, V21, P518, DOI 10.1177/1545968307300698; Lule D, 2007, J NEUROL, V254, P519, DOI 10.1007/s00415-006-0409-3; Lule D, 2010, J NEUROL NEUROSUR PS, V81, P899, DOI 10.1136/jnnp.2009.192260; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Meiri H, 2012, NEUROSCI LETT, V510, P43, DOI 10.1016/j.neulet.2011.12.066; Merrilees J, 2010, AMYOTROPH LATERAL SC, V11, P298, DOI 10.3109/17482961003605788; Mohammadi B, 2011, HUM BRAIN MAPP, V32, P750, DOI 10.1002/hbm.21064; Molenberghs P, 2012, NEUROIMAGE, V59, P608, DOI 10.1016/j.neuroimage.2011.07.080; Montgomery KJ, 2007, SOC COGN AFFECT NEUR, V2, P114, DOI 10.1093/scan/nsm004; Montuschi A, 2014, J NEUROLOGY NEUROSUR; Murphy JM, 2007, ARCH NEUROL-CHICAGO, V64, P530, DOI 10.1001/archneur.64.4.530; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Newsom-Davis IC, 1999, J NEUROL SCI, V169, P22, DOI 10.1016/S0022-510X(99)00211-7; Palmieri A, 2014, J NEUROLOGY NEUROSUR; Phukan J, 2012, J NEUROL NEUROSUR PS, V83, P102, DOI 10.1136/jnnp-2011-300188; Pineda JA, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-47; Poujois A, 2013, HUM BRAIN MAPP, V34, P2391, DOI 10.1002/hbm.22070; Raaphorst J, 2012, NEUROLOGY, V79, P1377, DOI 10.1212/WNL.0b013e31826c1aa1; Rizzolatti G, 2005, ANAT EMBRYOL, V210, P419, DOI 10.1007/s00429-005-0039-z; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Rizzolatti G, 2009, NAT CLIN PRACT NEURO, V5, P24, DOI 10.1038/ncpneuro0990; Rusina R, 2010, EUR J NEUROL, V17, P23, DOI 10.1111/j.1468-1331.2009.02717.x; Schmolck H, 2007, NEUROLOGY, V69, P2232, DOI 10.1212/01.wnl.0000296001.16603.b3; Schoenfeld MA, 2005, J NEUROL, V252, P944, DOI 10.1007/s00415-005-0787-y; Sirigu A, 1999, BRAIN, V122, P1867, DOI 10.1093/brain/122.10.1867; Stoppel CM, 2014, NEUROIMAGE-CLIN, V5, P277, DOI 10.1016/j.nicl.2014.07.007; Strong MJ, 2009, AMYOTROPH LATERAL SC, V10, P131, DOI 10.1080/17482960802654364; Terada T, 2011, J NEUROL SCI, V309, P136, DOI 10.1016/j.jns.2011.06.049; Tessitore A, 2006, BRAIN RES BULL, V69, P489, DOI 10.1016/j.brainresbull.2006.01.013; van Veluw SJ, 2014, BRAIN IMAGING BEHAV, V8, P24, DOI 10.1007/s11682-013-9266-8; Vogt S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00807; Weschler IS, 1932, ARCH NEUROLOGY PSYCH, P858; Witgert M, 2010, EUR J NEUROL, V17, P103, DOI 10.1111/j.1468-1331.2009.02801.x; Woolley SC, 2010, AMYOTROPH LATERAL SC, V11, P303, DOI 10.3109/17482961003727954; YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709; York C, 2014, J NEUROL, V261, P1073, DOI 10.1007/s00415-014-7314-y; Zimmerman EK, 2007, COGN BEHAV NEUROL, V20, P79, DOI 10.1097/WNN.0b013e31804c700b	80	23	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0119862	10.1371/journal.pone.0119862	http://dx.doi.org/10.1371/journal.pone.0119862			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885533	Green Published, gold, Green Submitted			2022-12-26	WOS:000353017000006
J	Kessel, L; Larsen, M				Kessel, Line; Larsen, Michael			Action Spectrum for Photobleaching of Human Lenses by Short Wavelength Visible Irradiation	PLOS ONE			English	Article							CATARACT-SURGERY; OCULAR MEDIA; PROTEINS; AGE; GLYCATION; UV; PHOTOOXIDATION; ARGPYRIMIDINE; TRANSMISSION; CHROMOPHORES	Purpose Cataract is the world-leading cause of blindness. In search for a new treatment of cataract we have found that the yellow discolouration of aged human lenses can be photobleached using a non-invasive, infra-red, femtosecond laser treatment. These results were presented in an earlier PlosOne publication. The objective of the study was to characterize the single-photon photobleaching action spectrum of the aged human lens in vitro. Methods Ninety-one human donor lenses were irradiated with continuous wave laser light at 375, 405, 420, 445, 457 or 473 nm. Photobleaching was monitored by photography and transmission measurements. Results The action spectrum peaked at 420 nm followed by, in order of decreasing effect, 445, 457, 473, 405 and 375 nm. Younger and less absorbent lenses showed smaller changes than older and more absorbent lenses. There was a dose-dependent increase in lens transmission with increasing laser irradiation. Conclusions For a 75 year old lens an effect corresponding to elimination of 15 years or more of optical ageing was obtained. This study of the spectral characteristics and intensity needed to bleach the human lens with single-photon laser effects found an action-spectrum peak at 420 nm tailing gradually off toward longer wavelengths and more steeply toward shorter wavelengths. The results may be used to guide experiments with two-photon bleaching.	[Kessel, Line; Larsen, Michael] Glostrup Cty Hosp, Dept Ophthalmol, Glostrup, Denmark; [Larsen, Michael] Univ Copenhagen, Dept Clin Med, Fac Hlth Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Kessel, L (corresponding author), Glostrup Cty Hosp, Dept Ophthalmol, Glostrup, Denmark.	line.kessel@dadlnet.dk	Larsen, Michael/E-9620-2010	Larsen, Michael/0000-0002-5172-5891; Kessel, Line/0000-0002-9375-1510	Danish Medical Research Council (Det Frie Forskningsrad); National Danish Advanced Science Foundation; CIP (Competitiveness and Innovation framework programme) [621088]; Foundation of June 15 (15. Juni Fonden)	Danish Medical Research Council (Det Frie Forskningsrad); National Danish Advanced Science Foundation; CIP (Competitiveness and Innovation framework programme); Foundation of June 15 (15. Juni Fonden)	The study received financial support from the Danish Medical Research Council (Det Frie Forskningsrad), the National Danish Advanced Science Foundation, CIP (Competitiveness and Innovation framework programme 2007-2013) grant number 621088 and the Foundation of June 15 (15. Juni Fonden). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algvere PV, 2006, ACTA OPHTHALMOL SCAN, V84, P4, DOI 10.1111/j.1600-0420.2005.00627.x; ANDLEY UP, 1994, INVEST OPHTH VIS SCI, V35, P367; Balasubramanian D, 2005, PHOTOCHEM PHOTOBIOL, V81, P498, DOI 10.1562/2004-11-01-RA-354.1; Barbazetto IA, 2004, EXP EYE RES, V78, P917, DOI 10.1016/j.exer.2004.01.003; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Bockelbrink A, 2008, SURV OPHTHALMOL, V53, P359, DOI 10.1016/j.survophthal.2008.04.001; BOETTNER EA, 1962, INVEST OPHTH VISUAL, V1, P776; Davies MJ, 2001, J PHOTOCH PHOTOBIO B, V63, P114, DOI 10.1016/S1011-1344(01)00208-1; FOSTER A, 1991, LANCET, V337, P1267, DOI 10.1016/0140-6736(91)92929-V; GORGELS TGMF, 1995, INVEST OPHTH VIS SCI, V36, P851; He L, 2010, CURR OPIN OPHTHALMOL; Holm Thomas, 2015, BMC Res Notes, V8, P5, DOI 10.1186/s13104-015-0977-3; JACQUES SL, 1992, SURG CLIN N AM, V72, P531; Kessel L, 2005, ACTA OPHTHALMOL SCAN, V83, P221, DOI 10.1111/j.1600-0420.2005.00388.x; Kessel L, 2011, ACTA OPHTHALMOL, V89, pe289, DOI 10.1111/j.1755-3768.2009.01839.x; Kessel L, 2010, J CATARACT REFR SURG, V36, P308, DOI 10.1016/j.jcrs.2009.08.035; Kessel L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009711; McNulty R, 2004, J PHYSIOL-LONDON, V559, P883, DOI 10.1113/jphysiol.2004.068619; MONNIER VM, 1981, SCIENCE, V211, P491, DOI 10.1126/science.6779377; Oriowo OM, 2001, INVEST OPHTH VIS SCI, V42, P2596; Ortwerth BJ, 1997, PHOTOCHEM PHOTOBIOL, V65, P666, DOI 10.1111/j.1751-1097.1997.tb01909.x; Ortwerth BJ, 2002, EXP EYE RES, V74, P217, DOI 10.1006/exer.2001.1114; Padayatti PS, 2001, INVEST OPHTH VIS SCI, V42, P1299; PIRIE A, 1971, BIOCHEM J, V125, P203, DOI 10.1042/bj1250203; Ponce A, 2006, MOL VIS, V12, P879; Regini JW, 2004, J MOL BIOL, V336, P1185, DOI 10.1016/S0022-2836(03)00814-3; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Roberts JE, 2001, PHOTOCHEM PHOTOBIOL, V74, P740, DOI 10.1562/0031-8655(2001)074<0740:POLPWX>2.0.CO;2; Tuulonen A, 2009, ACTA OPHTHALMOL; Ulrich P, 2001, RECENT PROG HORM RES, V56, P1, DOI 10.1210/rp.56.1.1; van de Kraats J, 2007, J OPT SOC AM A, V24, P1842, DOI 10.1364/JOSAA.24.001842; Vogel A, 2005, APPL PHYS B-LASERS O, V81, P1015, DOI 10.1007/s00340-005-2036-6; WEALE RA, 1988, J PHYSIOL-LONDON, V395, P577, DOI 10.1113/jphysiol.1988.sp016935	33	0	0	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123732	10.1371/journal.pone.0123732	http://dx.doi.org/10.1371/journal.pone.0123732			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884924	gold, Green Published, Green Submitted			2022-12-26	WOS:000353017000081
J	Vulliez-Le Normand, B; Faber, BW; Saul, FA; van der Eijk, M; Thomas, AW; Singh, B; Kocken, CHM; Bentley, GA				Vulliez-Le Normand, Brigitte; Faber, Bart W.; Saul, Frederick A.; van der Eijk, Marjolein; Thomas, Alan W.; Singh, Balbir; Kocken, Clemens H. M.; Bentley, Graham A.			Crystal Structure of Plasmodium knowlesi Apical Membrane Antigen 1 and Its Complex with an Invasion-Inhibitory Monoclonal Antibody	PLOS ONE			English	Article							MALARIA VACCINE CANDIDATE; BLOOD-STAGE VACCINE; HOST-CELL INVASION; POPULATION-STRUCTURE; NATURAL-SELECTION; MOVING JUNCTION; PROTEIN; AMA1; VIVAX; IMMUNIZATION	The malaria parasite Plasmodium knowlesi, previously associated only with infection of macaques, is now known to infect humans as well and has become a significant public health problemin Southeast Asia. This species should therefore be targeted in vaccine and therapeutic strategies against human malaria. Apical Membrane Antigen 1 (AMA1), which plays a role in Plasmodium merozoite invasion of the erythrocyte, is currently being pursued in human vaccine trials against P. falciparum. Recent vaccine trials in macaques using the P. knowlesi orthologue PkAMA1 have shown that it protects against infection by this parasite species and thus should be developed for human vaccination as well. Here, we present the crystal structure of Domains 1 and 2 of the PkAMA1 ectodomain, and of its complex with the invasion-inhibitory monoclonal antibody R31C2. The Domain 2 (D2) loop, which is displaced upon binding the Rhoptry Neck Protein 2 (RON2) receptor, makes significant contacts with the antibody. R31C2 inhibits binding of the Rhoptry Neck Protein 2 (RON2) receptor by steric blocking of the hydrophobic groove and by preventing the displacement of the D2 loop which is essential for exposing the complete binding site on AMA1. R31C2 recognizes a non-polymorphic epitope and should thus be cross-strain reactive. PkAMA1 is much less polymorphic than the P. falciparum and P. vivax orthologues. Unlike these two latter species, there are no polymorphic sites close to the RON2-binding site of PkAMA1, suggesting that P. knowlesi has not developed a mechanism of immune escape from the host's humoral response to AMA1.	[Vulliez-Le Normand, Brigitte; Saul, Frederick A.; Bentley, Graham A.] Inst Pasteur, Unite Immunol Struct, Dept Biol Struct & Chim, Paris, France; [Vulliez-Le Normand, Brigitte; Saul, Frederick A.; Bentley, Graham A.] CNRS, URA 2185, Paris, France; [Faber, Bart W.; van der Eijk, Marjolein; Thomas, Alan W.; Kocken, Clemens H. M.] Biomed Primate Res Ctr, Dept Parasitol, Rijswijk, Netherlands; [Singh, Balbir] Univ Malaysia Sarawak, Malaria Res Ctr, Fac Med & Hlth Sci, Kuching, Sarawak, Malaysia	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); University of Malaysia Sarawak	Vulliez-Le Normand, B (corresponding author), Univ Paris Diderot, Unite Microbiol Struct, Dept Biol Struct & Chim, Inst Pasteur,CNRS,UMR 3528,Sorbonne Paris Cite,Mi, Paris, France.	bvulliez@pasteur.fr; faber@bprc.nl	Singh, Balbir/A-3610-2009	Singh, Balbir/0000-0002-9143-3965; Faber, Bart/0000-0001-6808-1204; Kocken, Clemens/0000-0002-4784-1734	European Commission (EUROMALVAV2) [QLK2- CT-2002-01197]; European Commission (EviMalaR); European Commission (E(M)VI); European Commission (EMVDA) [LSHP-CT-2007-037506]; Pasteur Institute; Centre National de la Recherche Scientifique; Biomedical Primate Research Centre; Universiti Malaysia Sarawak [01 (TD03)/1003/2013(01), E14054/F05/54/PKI/09/2012(01)]	European Commission (EUROMALVAV2); European Commission (EviMalaR)(European CommissionEuropean Commission Joint Research Centre); European Commission (E(M)VI); European Commission (EMVDA); Pasteur Institute; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Biomedical Primate Research Centre; Universiti Malaysia Sarawak	This work was funded by the European Commission (EUROMALVAV2 contract QLK2- CT-2002-01197, EviMalaR, E(M)VI and EMVDA grant LSHP-CT-2007-037506), the Pasteur Institute, the Centre National de la Recherche Scientifique, the Biomedical Primate Research Centre and the Universiti Malaysia Sarawak (grant numbers 01 (TD03)/1003/2013(01) and E14054/F05/54/PKI/09/2012(01)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DL, 2006, EUKARYOT CELL, V5, P1169, DOI 10.1128/EC.00040-06; Alexander DL, 2005, PLOS PATHOG, V1, P137, DOI 10.1371/journal.ppat.0010017; Anders RF, 1998, VACCINE, V16, P240, DOI 10.1016/S0264-410X(97)88331-4; Arnott A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002506; Bai T, 2005, P NATL ACAD SCI USA, V102, P12736, DOI 10.1073/pnas.0501808102; Bannister LH, 2003, J CELL SCI, V116, P3825, DOI 10.1242/jcs.00665; Bargieri D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004273; Besteiro S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000309; Bricogne G, 2011, BUSTER VERSIONS 2 9; Cao J, 2009, PARASITOL INT, V58, P29, DOI 10.1016/j.parint.2008.09.005; Chesne-Seck ML, 2005, MOL BIOCHEM PARASIT, V144, P55, DOI 10.1016/j.molbiopara.2005.07.007; Coley AM, 2007, PLOS PATHOG, V3, P1308, DOI 10.1371/journal.ppat.0030138; Collins CR, 2007, J BIOL CHEM, V282, P7431, DOI 10.1074/jbc.M610562200; Cox-Singh J, 2008, CLIN INFECT DIS, V46, P165, DOI 10.1086/524888; Crawford J, 2010, J BIOL CHEM, V285, P15644, DOI 10.1074/jbc.M109.092619; Daneshvar C, 2009, CLIN INFECT DIS, V49, P852, DOI 10.1086/605439; De Lano W, 2015, PYMOL MOL GRAPHICS S; DEANS JA, 1982, CLIN EXP IMMUNOL, V49, P297; DEANS JA, 1988, PARASITE IMMUNOL, V10, P535, DOI 10.1111/j.1365-3024.1988.tb00241.x; Diederichs K, 2013, ACTA CRYSTALLOGR D, V69, P1215, DOI 10.1107/S0907444913001121; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Faber BW, 2015, GENE; Figtree M, 2000, MOL BIOCHEM PARASIT, V108, P53, DOI 10.1016/S0166-6851(00)00204-8; Gaffar FR, 2004, INFECT IMMUN, V72, P2947, DOI 10.1128/IAI.72.5.2947-2955.2004; Giovannini D, 2011, CELL HOST MICROBE, V10, P591, DOI 10.1016/j.chom.2011.10.012; Hamid MMA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020547; Harvey KL, 2014, INT J PARASITOL, V44, P853, DOI 10.1016/j.ijpara.2014.08.001; Hehl AB, 2000, INFECT IMMUN, V68, P7078, DOI 10.1128/IAI.68.12.7078-7086.2000; Henderson KA, 2007, STRUCTURE, V15, P1452, DOI 10.1016/j.str.2007.09.011; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kocken CHM, 2002, INFECT IMMUN, V70, P4471, DOI 10.1128/IAI.70.8.4471-4476.2002; Lamarque M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001276; Lamarque MH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5098; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lebrun M, 2005, CELL MICROBIOL, V7, P1823, DOI 10.1111/j.1462-5822.2005.00646.x; Lefranc MP, 2015, NUCLEIC ACIDS RES, V43, pD413, DOI 10.1093/nar/gku1056; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; Marshall VM, 1996, MOL BIOCHEM PARASIT, V77, P109, DOI 10.1016/0166-6851(96)02583-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mitchell GH, 2004, INFECT IMMUN, V72, P154, DOI 10.1128/IAI.72.1.154-158.2004; Moon SU, 2010, ACTA TROP, V114, P71, DOI 10.1016/j.actatropica.2010.01.006; Narum DL, 2000, INFECT IMMUN, V68, P2899, DOI 10.1128/IAI.68.5.2899-2906.2000; Oliveira DA, 1996, MOL BIOCHEM PARASIT, V76, P333, DOI 10.1016/0166-6851(95)02548-0; Pizarro JC, 2005, SCIENCE, V308, P408, DOI 10.1126/science.1107449; Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Singh B, 2013, CLIN MICROBIOL REV, V26, P165, DOI 10.1128/CMR.00079-12; Srinivasan P, 2001, P NATL ACAD SCI USA, V108, P13275; Stowers AW, 2002, INFECT IMMUN, V70, P6961, DOI 10.1128/IAI.70.12.6961-6967.2002; Thakur A, 2008, GENE, V419, P35, DOI 10.1016/j.gene.2008.04.012; Thera MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001465; THOMAS AW, 1984, MOL BIOCHEM PARASIT, V13, P187, DOI 10.1016/0166-6851(84)90112-9; Tonkin ML, 2013, PROTEIN SCI, V22, P114, DOI 10.1002/pro.2193; Tonkin ML, 2011, SCIENCE, V333, P463, DOI 10.1126/science.1204988; Vulliez-Le Normand B, 2004, ACTA CRYSTALLOGR D, V60, P2040, DOI 10.1107/S090744490402116X; Vulliez-Le Normand B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002755; WATERS AP, 1990, J BIOL CHEM, V265, P17974; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	58	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123567	10.1371/journal.pone.0123567	http://dx.doi.org/10.1371/journal.pone.0123567			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886591	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000353017000074
J	Crow, M; Khovanov, N; Kelleher, JH; Sharma, S; Grant, AD; Bogdanov, Y; Wood, JN; McMahon, SB; Denk, F				Crow, Megan; Khovanov, Nikita; Kelleher, Jayne H.; Sharma, Simone; Grant, Andrew D.; Bogdanov, Yury; Wood, John N.; McMahon, Stephen B.; Denk, Franziska			HDAC4 is required for inflammation-associated thermal hypersensitivity	FASEB JOURNAL			English	Article						epigenetics; pain; nerve growth factor; transcription	HISTONE DEACETYLASE 4; NEUROPATHIC PAIN; TRANSCRIPTION FACTOR; SYNAPTIC PLASTICITY; AXON REGENERATION; MEMORY FORMATION; GENE DELETION; HYPERALGESIA; MICROARRAY; GROWTH	Transcriptional alterations are characteristic of persistent pain states, but the key regulators remain elusive. HDAC4 is a transcriptional corepressor that has been linked to synaptic plasticity and neuronal excitability, mechanisms that may be involved in peripheral and central sensitization. Using a conditional knockout (cKO) strategy in mice, we sought to determine whether the loss of HDAC4 would have implications for sensory neuron transcription and nociception. HDAC4 was found to be largely unnecessary for transcriptional regulation of naive sensory neurons but was essential for appropriate transcriptional responses after injury, with Calca and Trpv1 expression consistently down-regulated in HDAC4 cKO compared to levels in the littermate controls (0.2-0.44-fold change, n = 4 in 2 separate experiments). This down-regulation corresponded to reduced sensitivity to 100 nM capsaicin in vitro (IC50 = 230 +/- 20 nM, 76 +/- 4.4% wild-type capsaicin responders vs. 56.9 +/- 4.7% HDAC4 cKO responders) and to reduced thermal hypersensitivity in the complete Freund's adjuvant (CFA) model of inflammatory pain (1.3-1.4-fold improvement over wild-type controls; n = 5-12, in 2 separate experiments). These data indicate that HDAC4 is a novel inflammatory pain mediator and may be a good therapeutic target, capable of orchestrating the regulation of multiple downstream effectors.	[Crow, Megan; Khovanov, Nikita; Kelleher, Jayne H.; Grant, Andrew D.; McMahon, Stephen B.; Denk, Franziska] Kings Coll London, Wolfson Ctr Age Related Dis, London SE1 1UL, England; [Sharma, Simone] UCL Genom, London, England; [Bogdanov, Yury; Wood, John N.] UCL, Wolfson Inst Biomed Res, Mol Nocicept Grp, London, England	University of London; King's College London; University of London; University College London; University of London; University College London	Crow, M (corresponding author), Kings Coll London, Wolfson CARD, Neurorestorat Grp, Guys Campus,18-20 Newcomen St, London SE1 1UL, England.	megan.crow@kcl.ac.uk	Denk, Franziska/A-4212-2010; Grant, Andrew/A-8819-2008	Denk, Franziska/0000-0003-4883-4234; McMahon, Stephen/0000-0003-4656-5536; Grant, Andrew/0000-0002-7032-3716; Bogdanov, Yury/0000-0003-4667-5890	Medical Research Council [G0901905] Funding Source: Medline; Wellcome Trust [101054, 102645, 097903] Funding Source: Medline; MRC [G0901905] Funding Source: UKRI; Wellcome Trust [101054/Z/13/Z] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Bai GA, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-51; BENBASSAT J, 1959, ARCH INT PHARMACOD T, V122, P434; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; BRIDGE PM, 1994, EXP NEUROL, V127, P284, DOI 10.1006/exnr.1994.1104; Callahan BL, 2008, J PAIN, V9, P174, DOI 10.1016/j.jpain.2007.10.011; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chauchereau A, 2004, ONCOGENE, V23, P8777, DOI 10.1038/sj.onc.1208128; Chiechio S, 2009, MOL PHARMACOL, V75, P1014, DOI 10.1124/mol.108.054346; Cho Y, 2013, CELL, V155, P894, DOI 10.1016/j.cell.2013.10.004; Cho Y, 2012, EMBO J, V31, P3063, DOI 10.1038/emboj.2012.160; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; Denk F, 2013, PAIN, V154, P1668, DOI 10.1016/j.pain.2013.05.021; Denk F, 2012, NEURON, V73, P435, DOI 10.1016/j.neuron.2012.01.012; DIXON WJ, 1965, J AM STAT ASSOC, V60, P967, DOI 10.2307/2283398; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ji RR, 2002, NEURON, V36, P57, DOI 10.1016/S0896-6273(02)00908-X; Kim MS, 2012, J NEUROSCI, V32, P10879, DOI 10.1523/JNEUROSCI.2089-12.2012; LaCroix-Fralish ML, 2011, PAIN, V152, P1888, DOI 10.1016/j.pain.2011.04.014; Lau J, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-100; Li JL, 2012, NAT MED, V18, P783, DOI 10.1038/nm.2709; Liu MH, 2012, REPROD SCI, V19, P360, DOI 10.1177/1933719111424453; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu JW, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-438; Ma CHE, 2011, J CLIN INVEST, V121, P4332, DOI 10.1172/JCI58675; Metzger D, 2001, METHODS, V24, P71, DOI 10.1006/meth.2001.1159; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; Rajan I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006612; Ren GL, 2009, INT J BIOCHEM CELL B, V41, P1094, DOI 10.1016/j.biocel.2008.10.015; Ren Ke, 1999, ILAR J, V40, P111; Samad OA, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-45; Sando R, 2012, CELL, V151, P821, DOI 10.1016/j.cell.2012.09.037; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stirling LC, 2005, PAIN, V113, P27, DOI 10.1016/j.pain.2004.08.015; Thakur M, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00087; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Wang WH, 2011, ANAT REC, V294, P1025, DOI 10.1002/ar.21389; Zhang Z, 2011, NAT MED, V17, P1448, DOI 10.1038/nm.2442	40	25	25	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3370	3378		10.1096/fj.14-264440	http://dx.doi.org/10.1096/fj.14-264440			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25903105	Green Published			2022-12-26	WOS:000358796900024
J	van Dijk, IA; Nazmi, K; Bolscher, JGM; Veerman, ECI; Stap, J				van Dijk, Irene A.; Nazmi, Kamran; Bolscher, Jan G. M.; Veerman, Enno C. I.; Stap, Jan			Histatin-1, a histidine-rich peptide in human saliva, promotes cell-substrate and cell-cell adhesion	FASEB JOURNAL			English	Article						cell spreading; transepithelial resistance; barrier function	CANDIDA-ALBICANS; PROTEINS; DISEASE; LINE; POLYPEPTIDES; ANTIFUNGAL; INTEGRINS; BINDING; CACO-2; FAMILY	Histatins (Hsts) are histidine-rich peptides exclusively present in the saliva of higher primates. In this study, we explored the effects ofHsts on cell-substrate and cell-cell adhesion. Histatin (Hst)-1 caused a significant (>2-fold) increase (EC50 = 1 mu M) in the ability of human adherent cells to attach and spread, even in conditions that impaired cell spreading. Other tested Hsts did not stimulate cell spreading, indicating a specific effect of Hst1. The effect of Hst1 on cell-cell adhesion was investigated by using transepithelial resistance (TER) measurements in the human cell line Caco-2, a widely used model for the epithelial layer. We found that 10 mM Hst1 caused a 20% increase in TER compared to the negative control, indicating a function for Hst1 in intercellular cell adhesion and epithelial integrity. A role for Hst1 in both cellsubstrate and cell-cell adhesion is highly conceivable, because these 2 modes of adhesion are closely related via shared components and connected signaling pathways.	[van Dijk, Irene A.; Nazmi, Kamran; Bolscher, Jan G. M.; Veerman, Enno C. I.] Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Oral Biochem, NL-1100 DE Amsterdam, Netherlands; [van Dijk, Irene A.; Nazmi, Kamran; Bolscher, Jan G. M.; Veerman, Enno C. I.] Vrije Univ Amsterdam, Amsterdam, Netherlands; [van Dijk, Irene A.; Stap, Jan] Univ Amsterdam, Acad Med Ctr, Van Leeuwenhoek Ctr Adv Microscopy, Core Facil Cellular Imaging, NL-1100 DE Amsterdam, Netherlands	Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Stap, J (corresponding author), Univ Amsterdam, Acad Med Ctr, Meibergdreef 15,POB 22700, NL-1100 DE Amsterdam, Netherlands.	j.stap@amc.uva.nl	Bolscher, Jan/ABF-6102-2021	Bolscher, Jan/0000-0001-5669-6164	Dutch Organization for Scientific Research (NWO) [ALW2PJ/09070]; University of Amsterdam	Dutch Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); University of Amsterdam	The authors thank the Department of Virology, Academic Medical Center (AMC), University of Amsterdam, The Netherlands, for providing the Caco-2 cell line; and the following people, also affiliated with the AMC: Ing. Ilse Vogels, for helping to set up the ARPE-19 experiments; Dr. Laura Ferrando, for introducing the Caco-2 transepithelial barrier model and for many helpful suggestions; Dr. Ron Hoebe, for providing the TimelapseAnalyse software for analysis of the time-lapse movies; Prof. Wouter de Jonge and Francisca van Leeuwen-Hilbers, for providing the xCELLigence system and helping to set up the experiments; and Shawn Meyers, M.Sc., for proofreading the manuscript. This work was supported by Grant ALW2PJ/09070 from the Dutch Organization for Scientific Research (NWO) and by a grant from the University of Amsterdam for research into the focal point of oral infections and inflammation.	Avery JK, 2002, ORAL DEV HISTOLOGY; Balzac F, 2005, J CELL SCI, V118, P4765, DOI 10.1242/jcs.02584; Bolscher JGM, 2011, FASEB J, V25, P2650, DOI 10.1096/fj.11-182212; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Campese M, 2009, ARCH ORAL BIOL, V54, P345, DOI 10.1016/j.archoralbio.2008.11.010; Chen X, 2006, CURR OPIN CELL BIOL, V18, P572, DOI 10.1016/j.ceb.2006.07.002; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Helmerhorst EJ, 1997, BIOCHEM J, V326, P39, DOI 10.1042/bj3260039; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; HILGERS AR, 1990, PHARMACEUT RES, V7, P902, DOI 10.1023/A:1015937605100; Huang SH, 1999, J CELL BIOCHEM, V75, P327, DOI 10.1002/(SICI)1097-4644(19991101)75:2<327::AID-JCB14>3.3.CO;2-7; Johnson DA, 2000, ARCH ORAL BIOL, V45, P731, DOI 10.1016/S0003-9969(00)00047-9; LAL K, 1992, J ACQ IMMUN DEF SYND, V5, P904; Larjava H, 2011, J DENT RES, V90, P1367, DOI 10.1177/0022034511402207; LARJAVA H, 1990, J CELL BIOL, V110, P803, DOI 10.1083/jcb.110.3.803; MACKAY BJ, 1984, INFECT IMMUN, V44, P695, DOI 10.1128/IAI.44.3.695-701.1984; Marchiando AM, 2010, ANNU REV PATHOL-MECH, V5, P119, DOI 10.1146/annurev.pathol.4.110807.092135; Naurato N, 1999, J AGR FOOD CHEM, V47, P2229, DOI 10.1021/jf981044i; OPPENHEIM FG, 1988, J BIOL CHEM, V263, P7472; Oudhoff MJ, 2008, FASEB J, V22, P3805, DOI 10.1096/fj.08-112003; Oudhoff MJ, 2009, FASEB J, V23, P3928, DOI 10.1096/fj.09-137588; POLLOCK JJ, 1984, INFECT IMMUN, V44, P702, DOI 10.1128/IAI.44.3.702-707.1984; Presland RB, 2000, CRIT REV ORAL BIOL M, V11, P383, DOI 10.1177/10454411000110040101; Punna S, 2005, BIOCONJUGATE CHEM, V16, P1536, DOI 10.1021/bc0501496; Luque-Ortega JR, 2008, FASEB J, V22, P1817, DOI 10.1096/fj.07-096081; SABATINI LM, 1989, BIOCHEM BIOPH RES CO, V160, P495, DOI 10.1016/0006-291X(89)92460-1; Schambony A, 2004, DIFFERENTIATION, V72, P307, DOI 10.1111/j.1432-0436.2004.07207002.x; STEELE JG, 1992, J BIOMED MATER RES, V26, P861, DOI 10.1002/jbm.820260704; STOKER M, 1968, INT J CANCER, V3, P683, DOI 10.1002/ijc.2910030517; Sun XL, 2009, FASEB J, V23, P2691, DOI 10.1096/fj.09-131045; VANDERSPEK JC, 1990, ARCH ORAL BIOL, V35, P137, DOI 10.1016/0003-9969(90)90175-A; VANDERSPEK JC, 1989, AM J HUM GENET, V45, P381; Weber GF, 2011, J CELL SCI, V124, P1183, DOI 10.1242/jcs.064618; Wetzel F, 2011, EUR BIOPHYS J BIOPHY, V40, P1109, DOI 10.1007/s00249-011-0723-2; XU L, 1992, ORAL MICROBIOL IMMUN, V7, P127, DOI 10.1111/j.1399-302X.1992.tb00524.x; YAN QY, 1995, BIOCHEM J, V311, P341, DOI 10.1042/bj3110341	39	26	28	2	34	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3124	3132		10.1096/fj.14-266825	http://dx.doi.org/10.1096/fj.14-266825			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25903106				2022-12-26	WOS:000358796900002
J	Priyamvada, S; Anbazhagan, AN; Gujral, T; Borthakur, A; Saksena, S; Gill, RK; Alrefai, WA; Dudeja, PK				Priyamvada, Shubha; Anbazhagan, Arivarasu N.; Gujral, Tarunmeet; Borthakur, Alip; Saksena, Seema; Gill, Ravinder K.; Alrefai, Waddah A.; Dudeja, Pradeep K.			All-trans-retinoic Acid Increases SLC26A3 DRA (Down-regulated in Adenoma) Expression in Intestinal Epithelial Cells via HNF-1 beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL CHLORIDE DIARRHEA; VITAMIN-A SUPPLEMENTATION; CL-/OH-EXCHANGE; RECEPTOR-BETA; GENE-EXPRESSION; DECREASED EXPRESSION; GUT INTEGRITY; CACO-2 CELLS; CANCER; MECHANISM	All-trans-retinoic acid (ATRA) is an active vitamin A derivative known to modulate a number of physiological processes, including growth and development, differentiation, and gene transcription. The protective effect of ATRA in gut inflammation and diarrheal diseases has been documented. In this regard, down-regulated in adenoma (DRA, a key luminal membrane Cl- transporter involved in NaCl absorption) has been shown to be suppressed in intestinal inflammation. This suppression of DRA is associated with diarrheal phenotype. Therefore, current studies were undertaken to examine the effects of ATRA on DRA expression. DRA mRNA levels were significantly elevated (similar to 4-fold) in response to ATRA with induction starting as early as 8 h of incubation. Similarly, ATRA increased DRA protein expression by similar to 50%. Furthermore, DRA promoter activity was significantly increased in response to ATRA indicating transcriptional activation. ATRA effects on DRA expression appeared to be mediated via the RAR-beta receptor subtype, as ATRA remarkably induced RAR-beta mRNA levels, whereas RAR-beta knockdown substantially attenuated the ability of ATRA to increase DRA expression. Results obtained from agonist (CH-55) and antagonist (LE-135) studies further confirmed that ATRA exerts its effects through RAR-beta. Furthermore, ATRA treatment resulted in a significant increase in HNF-1 beta mRNA levels. The ability of ATRA to induce DRA expression was inhibited in the presence of HNF-1 beta siRNA indicative of its involvement in ATRA-induced effects on DRA expression. In conclusion, ATRA may act as an antidiarrheal agent by increasing DRA expression via the RAR-beta/HNF-1 beta-dependent pathway.	[Alrefai, Waddah A.; Dudeja, Pradeep K.] Univ Illinois, Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA; [Priyamvada, Shubha; Anbazhagan, Arivarasu N.; Gujral, Tarunmeet; Borthakur, Alip; Saksena, Seema; Gill, Ravinder K.; Alrefai, Waddah A.; Dudeja, Pradeep K.] Univ Illinois, Dept Med, Div Gastroenterol & Hepatol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Dudeja, PK (corresponding author), Jesse Brown Vet Affairs Med Ctr, Med Res Serv 600 151, 820 South Damen Ave, Chicago, IL 60612 USA.	pkdudeja@uic.edu		Priyamvada, Shubha/0000-0002-7241-569X	National Institutes of Health from the NIDDK, Department of Veteran Affairs [DK54016, DK81858, DK92441, DK71596, DK96254, RO3 DK 096258, BX002011, BX000152]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054016, R01DK081858, R56DK071596, R01DK092441, R01DK071596, R21DK096254, R03DK096258] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000152, I01BX002011] Funding Source: NIH RePORTER	National Institutes of Health from the NIDDK, Department of Veteran Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants DK54016, DK81858, and DK92441 (to P. K. D.), DK71596 (to W. A. A.), DK96254 (to S. S.), and RO3 DK 096258 (to R. K. G.) from the NIDDK, Department of Veteran Affairs Grants BX002011 and a senior research career scientist award (to P. K. D.) and Grant BX000152 (to W. A. A.).	Alrefai WA, 2007, AM J PHYSIOL-GASTR L, V293, pG923, DOI 10.1152/ajpgi.00029.2007; Altucci L, 2007, NAT REV DRUG DISCOV, V6, P793, DOI 10.1038/nrd2397; Bai AP, 2010, J INTERF CYTOK RES, V30, P399, DOI 10.1089/jir.2009.0028; Bai AP, 2009, J LEUKOCYTE BIOL, V86, P959, DOI 10.1189/jlb.0109006; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Baltes S, 2004, DEV GROWTH DIFFER, V46, P503; BIEBERDO.FA, 1972, J CLIN INVEST, V51, P1958, DOI 10.1172/JCI107002; Borenshtein D, 2009, INFECT IMMUN, V77, P3639, DOI 10.1128/IAI.00225-09; Borthakur A, 2008, J NUTR, V138, P1355, DOI 10.1093/jn/138.7.1355; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen K, 2013, NUTRITION, V29, P1197, DOI 10.1016/j.nut.2013.03.025; DAVIS KD, 1993, ENDOCRINOLOGY, V132, P1469, DOI 10.1210/en.132.4.1469; DUDEJA PK, 2003, COLONIC DIS, P3; Duggan C, 2002, AM J CLIN NUTR, V75, P789, DOI 10.1093/ajcn/75.5.789; Filteau SM, 2001, J PEDIATR GASTR NUTR, V32, P464, DOI 10.1097/00005176-200104000-00014; Geisen C, 1997, CANCER RES, V57, P1460; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Ghana VAST study Team, 1993, LANCET, V342, P7; Gill R. K., 2003, Recent Research Developments in Physiology, Vol. 1, Part II, P643; Gill RK, 2007, J CLIN INVEST, V117, P428, DOI 10.1172/JCI29625; Humphreys EH, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008563; Kiela PR, 2003, J BIOL CHEM, V278, P5659, DOI 10.1074/jbc.M209473200; Lampen A, 2000, J PHARMACOL EXP THER, V295, P979; Lee MO, 2000, BIOCHEM PHARMACOL, V59, P485, DOI 10.1016/S0006-2952(99)00355-X; Lee-Kwon W, 2003, J BIOL CHEM, V278, P16494, DOI 10.1074/jbc.M300580200; Liu Y, 1996, MOL CELL BIOL, V16, P1138; Magee TR, 1998, J BIOL CHEM, V273, P30024, DOI 10.1074/jbc.273.45.30024; Makela S, 2002, HUM MUTAT, V20, P425, DOI 10.1002/humu.10139; McCormack SA, 1996, IN VITRO CELL DEV-AN, V32, P53; Miano JM, 2000, CIRC RES, V87, P355; Mouchel N, 2004, BIOCHEM J, V378, P909, DOI 10.1042/BJ20031157; Ozdemir R, 2013, NEONATOLOGY, V104, P22, DOI 10.1159/000350510; Raheja G, 2010, AM J PHYSIOL-GASTR L, V298, pG395, DOI 10.1152/ajpgi.00465.2009; Saksena S, 2010, AM J PHYSIOL-GASTR L, V298, pG159, DOI 10.1152/ajpgi.00374.2009; Schweinfest CW, 2006, J BIOL CHEM, V281, P37962, DOI 10.1074/jbc.M607527200; Sempertegui F, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.1.e1; Singh V, 2012, AM J PHYSIOL-GASTR L, V303, pG1393, DOI 10.1152/ajpgi.00345.2012; Singla A, 2012, AM J PHYSIOL-GASTR L, V302, pG618, DOI 10.1152/ajpgi.00172.2011; Singla A, 2010, AM J PHYSIOL-GASTR L, V298, pG182, DOI 10.1152/ajpgi.00345.2009; Sporn M. B., 1994, RETINOIDS; Sun SY, 2002, CRIT REV ONCOL HEMAT, V41, P41, DOI 10.1016/S1040-8428(01)00144-5; Talbot C, 2010, AM J PHYSIOL-GASTR L, V299, pG358, DOI 10.1152/ajpgi.00151.2010; Thurnham DI, 2000, J INFECT DIS, V182, pS23, DOI 10.1086/315912; Veldhoen M, 2012, NAT REV IMMUNOL, V12, P696, DOI 10.1038/nri3299; Villamor E, 2000, J INFECT DIS, V182, pS122, DOI 10.1086/315921; Wan Y, 2012, BIOCHEM GENET, V50, P495, DOI 10.1007/s10528-011-9494-9; Wan YJY, 1998, EXP CELL RES, V238, P241, DOI 10.1006/excr.1997.3851; Wang ZH, 2005, AM J PHYSIOL-CELL PH, V288, pC957, DOI 10.1152/ajpcell.00505.2004; Yang HY, 1998, AM J PHYSIOL-GASTR L, V275, pG1445, DOI 10.1152/ajpgi.1998.275.6.G1445	49	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15066	15077		10.1074/jbc.M114.566356	http://dx.doi.org/10.1074/jbc.M114.566356			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25887398	hybrid, Green Published			2022-12-26	WOS:000356177300022
J	Swarts, DC; Koehorst, JJ; Westra, ER; Schaap, PJ; van der Oost, J				Swarts, Daan C.; Koehorst, Jasper J.; Westra, Edze R.; Schaap, Peter J.; van der Oost, John			Effects of Argonaute on Gene Expression in Thermus thermophilus	PLOS ONE			English	Article							CRISPR-CAS SYSTEMS; SILENCING COMPLEX; ADAPTIVE IMMUNITY; PROTEINS; DNA; INTERFERENCE; EVOLUTION; TRANSCRIPTOME; CLEAVAGE; GENOME	Background Eukaryotic Argonaute proteins mediate RNA-guided RNA interference, allowing both regulation of host gene expression and defense against invading mobile genetic elements. Recently, it has become evident that prokaryotic Argonaute homologs mediate DNA-guided DNA interference, and play a role in host defense. Argonaute of the bacterium Thermus thermophilus (TtAgo) targets invading plasmid DNA during and after transformation. Using small interfering DNA guides, TtAgo can cleave single and double stranded DNAs. Although TtAgo additionally has been demonstrated to cleave RNA targets complementary to its DNA guide in vitro, RNA targeting by TtAgo has not been demonstrated in vivo. Methods To investigate if TtAgo also has the potential to control RNA levels, we analyzed RNA-seq data derived from cultures of four T. thermophilus strain HB27 variants: wild type, TtAgo knockout (Delta ago), and either strain transformed with a plasmid. Additionally we determined the effect of TtAgo on expression of plasmid-encoded RNA and plasmid DNA levels. Results In the absence of exogenous DNA (plasmid), TtAgo presence or absence had no effect on gene expression levels. When plasmid DNA is present, TtAgo reduces plasmid DNA levels 4-fold, and a corresponding reduction of plasmid gene transcript levels was observed. We therefore conclude that TtAgo interferes with plasmid DNA, but not with plasmid-encoded RNA. Interestingly, TtAgo presence stimulates expression of specific endogenous genes, but only when exogenous plasmid DNA was present. Specifically, the presence of TtAgo directly or indirectly stimulates expression of CRISPR loci and associated genes, some of which are involved in CRISPR adaptation. This suggests that TtAgo-mediated interference with plasmid DNA stimulates CRISPR adaptation.	[Swarts, Daan C.; Westra, Edze R.; van der Oost, John] Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands; [Koehorst, Jasper J.; Schaap, Peter J.] Wageningen Univ, Lab Syst & Synthet Biol, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	van der Oost, J (corresponding author), Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands.	john.vanderoost@wur.nl	Swarts, Daan/Z-6262-2019; van+der+Oost, John/Y-2548-2019; Koehorst, Jasper Jan/Z-1697-2019	Swarts, Daan/0000-0003-4412-9191; Koehorst, Jasper Jan/0000-0001-8172-8981; Schaap, Peter/0000-0002-4346-6084	TOP grant from the Netherlands Organisation for Scientific Research (NWO) [NWO-TOP 854.10.003]	TOP grant from the Netherlands Organisation for Scientific Research (NWO)	This study was financially supported by a TOP grant from the Netherlands Organisation for Scientific Research (NWO) to John van der Oost (NWO-TOP 854.10.003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agari Y, 2010, J MOL BIOL, V395, P270, DOI 10.1016/j.jmb.2009.10.057; Best A, 2013, ECOL EVOL, V3, P2223, DOI 10.1002/ece3.611; Blesa A, 2015, J BACTERIOL, V197, P138, DOI 10.1128/JB.02113-14; Bronkhorst AW, 2014, CURR OPIN VIROL, V7, P19, DOI 10.1016/j.coviro.2014.03.010; Bruggemann H, 2006, J BIOTECHNOL, V124, P654, DOI 10.1016/j.jbiotec.2006.03.043; Cava F, 2008, ENVIRON MICROBIOL, V10, P605, DOI 10.1111/j.1462-2920.2007.01482.x; Cerutti L, 2000, TRENDS BIOCHEM SCI, V25, P481, DOI 10.1016/S0968-0004(00)01641-8; Copeland A, 2012, SIGMA; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Dupuis ME, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3087; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Harrison E, 2012, TRENDS MICROBIOL, V20, P262, DOI 10.1016/j.tim.2012.04.003; Heler R, 2014, MOL MICROBIOL, V93, P1, DOI 10.1111/mmi.12640; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Kawamata T, 2010, TRENDS BIOCHEM SCI, V35, P368, DOI 10.1016/j.tibs.2010.03.009; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Makarova KS, 2009, BIOLOGY DIRECT, V4; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Ohyama H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-386; Olovnikov I, 2013, MOL CELL, V51, P594, DOI 10.1016/j.molcel.2013.08.014; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Plagens A, 2012, J BACTERIOL, V194, P2491, DOI 10.1128/JB.00206-12; Shabalina SA, 2008, TRENDS ECOL EVOL, V23, P578, DOI 10.1016/j.tree.2008.06.005; Sheng G, 2014, P NATL ACAD SCI USA, V111, P652, DOI 10.1073/pnas.1321032111; Swarts DC, 2014, NAT STRUCT MOL BIOL, V21, P743, DOI 10.1038/nsmb.2879; Swarts DC, 2014, NATURE, V507, P258, DOI 10.1038/nature12971; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Westra ER, 2014, NAT REV MICROBIOL, V12, P317, DOI 10.1038/nrmicro3241; Westra ER, 2012, ANNU REV GENET, V46, P311, DOI 10.1146/annurev-genet-110711-155447; Westra ER, 2015, CURRENT BIOLOGY IN P; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216	37	27	27	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124880	10.1371/journal.pone.0124880	http://dx.doi.org/10.1371/journal.pone.0124880			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902012	Green Published, Green Submitted, gold			2022-12-26	WOS:000353331500104
J	Woo, HM; Lee, JM; Yim, S; Jeong, YJ				Woo, Hye-Min; Lee, Jin-Moo; Yim, Sanggyu; Jeong, Yong-Joo			Isolation of Single-Stranded DNA Aptamers That Distinguish Influenza Virus Hemagglutinin Subtype H1 from H5	PLOS ONE			English	Article							REVERSE TRANSCRIPTION-PCR; MEDIATED MEMBRANE-FUSION; AVIAN INFLUENZA; RNA APTAMER; NUCLEOTIDE-SEQUENCES; RECEPTOR-BINDING; WEB SERVER; PROTEIN; QUADRUPLEX; POLYMERASE	Surface protein hemagglutinin (HA) mediates the binding of influenza virus to host cell receptors containing sialic acid, facilitating the entry of the virus into host cells. Therefore, the HA protein is regarded as a suitable target for the development of influenza virus detection devices. In this study, we isolated single-stranded DNA (ssDNA) aptamers binding to the HA1 subunit of subtype H1 (H1-HA1), but not to the HA1 subunit of subtype H5 (H5-HA1), using a counter-systematic evolution of ligands by exponential enrichment (counterSELEX) procedure. Enzyme-linked immunosorbent assay and surface plasmon resonance studies showed that the selected aptamers bind tightly to H1-HA1 with dissociation constants in the nanomolar range. Western blot analysis demonstrated that the aptamers were binding to H1-HA1 in a concentration-dependent manner, yet were not binding to H5-HA1. Interestingly, the selected aptamers contained G-rich sequences in the central random nucleotides region. Further biophysical analysis showed that the G-rich sequences formed a G-quadruplex structure, which is a distinctive structure compared to the starting ssDNA library. Using flow cytometry analysis, we found that the aptamers did not bind to the receptor- binding site of H1-HA1. These results indicate that the selected aptamers that distinguish H1-HA1 from H5-HA1 can be developed as unique probes for the detection of the H1 subtype of influenza virus.	[Woo, Hye-Min; Lee, Jin-Moo; Yim, Sanggyu; Jeong, Yong-Joo] Kookmin Univ, Dept Bio & Nanochem, Seoul 136702, South Korea	Kookmin University	Jeong, YJ (corresponding author), Kookmin Univ, Dept Bio & Nanochem, Seoul 136702, South Korea.	jeongyj@kookmin.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A1A2A10061193]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	YJJ was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2013R1A1A2A10061193).	ALEXANDER DJ, 1995, J COMP PATHOL, V112, P105, DOI 10.1016/S0021-9975(05)80054-4; Brody E N, 2000, J Biotechnol, V74, P5, DOI 10.1016/S1389-0352(99)00004-5; Bunka DHJ, 2010, CURR OPIN PHARMACOL, V10, P557, DOI 10.1016/j.coph.2010.06.009; Cheng CS, 2008, BIOCHEM BIOPH RES CO, V366, P670, DOI 10.1016/j.bbrc.2007.11.183; Chizmadzhev YA, 2004, BIOELECTROCHEMISTRY, V63, P129, DOI 10.1016/j.bioelechem.2003.10.016; Cho SJ, 2011, J BIOSCI BIOENG, V112, P535, DOI 10.1016/j.jbiosc.2011.08.014; Fukuda H, 2005, GENES CELLS, V10, P953, DOI 10.1111/j.1365-2443.2005.00896.x; Gamblin SJ, 2010, J BIOL CHEM, V285, P28403, DOI 10.1074/jbc.R110.129809; Gopinath SCB, 2006, J GEN VIROL, V87, P479, DOI 10.1099/vir.0.81508-0; Gopinath SCB, 2006, J BIOCHEM, V140, P667, DOI 10.1093/jb/mvj203; Hamilton BS, 2012, VIRUSES-BASEL, V4, P1144, DOI 10.3390/v4071144; HARDIN CC, 1992, BIOCHEMISTRY-US, V31, P833, DOI 10.1021/bi00118a028; HIGUCHI RG, 1989, NUCLEIC ACIDS RES, V17, P5865, DOI 10.1093/nar/17.14.5865; JENISON RD, 1994, SCIENCE, V263, P1425, DOI 10.1126/science.7510417; Jeon SH, 2004, J BIOL CHEM, V279, P48410, DOI 10.1074/jbc.M409059200; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; Kwon HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097574; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee MS, 2001, J VIROL METHODS, V97, P13, DOI 10.1016/S0166-0934(01)00301-9; Luo GX, 1996, VIROLOGY, V226, P66, DOI 10.1006/viro.1996.0628; Menendez C, 2012, NUCLEIC ACIDS RES, V40, pW96, DOI 10.1093/nar/gks422; Munch M, 2001, ARCH VIROL, V146, P87, DOI 10.1007/s007050170193; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nicholls JM, 2008, TRENDS MICROBIOL, V16, P149, DOI 10.1016/j.tim.2008.01.008; Ozalp VC, 2015, ANAL CHIM ACTA, V853, P533, DOI 10.1016/j.aca.2014.10.010; PALESE P., 2007, FIELDS VIROLOGY, V2, P1647, DOI DOI 10.1371/JOURNAL.PPAT.1003019; Park SY, 2011, NUCLEIC ACID THER, V21, P395, DOI 10.1089/nat.2011.0321; Samji Tasleem, 2009, Yale Journal of Biology and Medicine, V82, P153; Shum KT, 2008, CHEMBIOCHEM, V9, P3037, DOI 10.1002/cbic.200800491; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Song SP, 2008, TRAC-TREND ANAL CHEM, V27, P108, DOI 10.1016/j.trac.2007.12.004; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Starick E, 2000, J VET MED B, V47, P295, DOI 10.1046/j.1439-0450.2000.00386.x; Stoltenburg R, 2007, BIOMOL ENG, V24, P381, DOI 10.1016/j.bioeng.2007.06.001; Suenaga E, 2014, ACTA BIOMATER, V10, P1314, DOI 10.1016/j.actbio.2013.12.034; Theis MG, 2004, P NATL ACAD SCI USA, V101, P11221, DOI 10.1073/pnas.0402901101; Todd AK, 2005, NUCLEIC ACIDS RES, V33, P2901, DOI 10.1093/nar/gki553; Tombelli S, 2005, BIOELECTROCHEMISTRY, V67, P135, DOI 10.1016/j.bioelechem.2004.04.011; Tombelli S, 2007, BIOMOL ENG, V24, P191, DOI 10.1016/j.bioeng.2007.03.003; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vairamani M, 2003, J AM CHEM SOC, V125, P42, DOI 10.1021/ja0284299; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; Woo HM, 2013, ANTIVIR RES, V100, P337, DOI 10.1016/j.antiviral.2013.09.004; Wu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046393; Zhao FL, 2015, BIOSENS BIOELECTRON, V66, P238, DOI 10.1016/j.bios.2014.11.024; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	47	18	19	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0125060	10.1371/journal.pone.0125060	http://dx.doi.org/10.1371/journal.pone.0125060			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901739	gold, Green Published, Green Submitted			2022-12-26	WOS:000353331500110
J	Ding, YQ; Yang, YJ; Yang, XX; Zhang, TH; Qiu, XH; He, X; Wang, WB; Wang, L; Sui, H				Ding, Yongqing; Yang, Yanjie; Yang, Xiuxian; Zhang, Tiehui; Qiu, Xiaohui; He, Xin; Wang, Wenbo; Wang, Lin; Sui, Hong			The Mediating Role of Coping Style in the Relationship between Psychological Capital and Burnout among Chinese Nurses	PLOS ONE			English	Article							STRESS; MODERATOR; CONFLICT; SUPPORT	Background Burnout is recognized as an occupational hazard, and nursing has a high risk of burnout. This study aims to explore the relationship between psychological capital (PsyCap) and burnout among Chinese nurses and the mediating role of coping style in this relationship. Methods A total of 1,496 nurses (effective response rate: 80.11%) from two large general hospitals in Daqing City of China were selected as participants. Data were collected via the Chinese Maslach Burnout Inventory (CMBI), the psychological capital questionnaire (PCQ-24), the Chinese Trait Coping Style Questionnaire (TCSQ) and demographic and caregiver-patient relationship. Hierarchical linear regression analyses were performed to explore the mediating role of positive coping and negative coping, and we used the Bootstrap method to confirm the mediating effect. Results Self-efficacy, hope, resilience and optimism of nurses were all negatively related with emotional exhaustion, depersonalization and reduced personal accomplishment among Chinese nurses. Positive coping partially mediated the relationship between hope/optimism and emotional exhaustion and between self-efficacy/optimism and reduced personal accomplishment. Negative coping fully mediated the relationship between self-efficacy and emotional exhaustion, and in the regression model self-efficacy was positively correlated with emotional exhaustion. And negative coping also partially mediated the relationship between hope/optimism and emotional exhaustion and between optimism and depersonalization. Conclusion PsyCap had effects on burnout and coping style was a mediator in this relationship among Chinese nurses. Nurses who had a strong sense of self-efficacy adopted more negative coping style, which in turn would lead to higher levels of emotional exhaustion. These findings shed light on the influence of negative coping on burnout, and positive coping was a positive resource for fighting against nurses' burnout. Hence, in order to avoid negative coping style, improve skill of coping and enhance PsyCap of nurses, active interventions should be developed in the future.	[Ding, Yongqing; Yang, Yanjie; Yang, Xiuxian; Qiu, Xiaohui; Wang, Wenbo; Wang, Lin] Harbin Med Univ, Coll Publ Hlth, Dept Psychol, Harbin, Peoples R China; [Ding, Yongqing] Harbin Med Univ, Affiliated Hosp 1, Daqing, Heilongjiang Pr, Peoples R China; [Zhang, Tiehui] Harbin Med Univ, Affiliated Hosp 1, Dept Surg, Daqing, Heilongjiang Pr, Peoples R China; [He, Xin] Harbin Med Univ, Affiliated Hosp 1, Dept Pediat, Daqing, Heilongjiang Pr, Peoples R China; [Sui, Hong] Harbin Med Univ, Coll Publ Hlth, Dept Hlth Stat, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University	Yang, YJ (corresponding author), Harbin Med Univ, Coll Publ Hlth, Dept Psychol, Harbin, Peoples R China.	yanjie1965@163.com			National Natural Science Foundation of China [81473054, 81202213]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (81473054) to Prof. Yanjie Yang and the National Natural Science Foundation of China (81202213) to Xiuxian Yang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahola K, 2009, J AFFECT DISORDERS, V115, P150, DOI 10.1016/j.jad.2008.09.021; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Cardenas V, 2013, SCHIZOPHRENIA BULL, V39, P908, DOI 10.1093/schbul/sbs004; Carmona C, 2006, J OCCUP ORGAN PSYCH, V79, P85, DOI 10.1348/096317905X40808; Carod-Artal F. J., 2013, BURNOUT SYNDROME INT, P15; Carver CS, 2010, ANNU REV PSYCHOL, V61, P679, DOI 10.1146/annurev.psych.093008.100352; Chen R, 2013, BEIJ 2013 JMS 10 ANN; [成颢 Cheng Hao], 2012, [中华行为医学与脑科学杂志, Chinese Journal of Behavioral Medicine and Brain Science], V21, P262; Cheung F, 2011, INT J STRESS MANAGE, V18, P348, DOI 10.1037/a0025787; Cohen J., 2003, APPL MULTIPLE REGRES; Dasgupta P, 2012, J HEALTH MANAG, V14, P513, DOI 10.1177/0972063412468980; Devereux J, 2009, J APPL RES INTELLECT, V22, P561, DOI 10.1111/j.1468-3148.2009.00509.x; Dong Y.H ., 2010, STUDIES PSYCHOL BEHA, V8, P58, DOI DOI 10.3969/J.ISSN.1672-0628.2010.01.011; Duygun T, 2003, TURK PSIKOL DERG, V18, P37; Eccles JS, 2002, ANNU REV PSYCHOL, V53, P109, DOI 10.1146/annurev.psych.53.100901.135153; Folkman S, 2004, ANNU REV PSYCHOL, V55, P745, DOI 10.1146/annurev.psych.55.090902.141456; Garcia-Campayo J, 2014, PLOS ONE, V9; Garrosa E., 2013, BURNOUT EXPERTS PREV, P201, DOI [DOI 10.1007/978-1-4614-4391-9_13, 10.1007/978-1-4614-4391-9_13]; Honkonen T, 2006, J PSYCHOSOM RES, V61, P59, DOI 10.1016/j.jpsychores.2005.10.002; Isaksson KE, 2013, BMC PUBLIC HEALTH, V10, P213; Kurz AS, 2014, RES DEV DISABIL, V35, P2359, DOI 10.1016/j.ridd.2014.06.003; Laschinger HKS, 2012, INT J NURS STUD, V49, P282, DOI 10.1016/j.ijnurstu.2011.09.004; LAZARUS RS, 1993, ANNU REV PSYCHOL, V44, P1, DOI 10.1146/annurev.ps.44.020193.000245; Li J, 2008, CHINESE MENTAL HLTH, V16, P1406; Li L, 2011, PROCEEDINGS OF 2011 INTERNATIONAL SYMPOSIUM - THE FEMALE SURVIVAL AND DEVELOPMENT, P221; Li Y.X., 2005, PSYCHOL EXPLORATION, V25, P70, DOI DOI 10.3969/j.issn.1003-5184.2005.04.015; Li Yan-ping, 2007, Yaoxue Xuebao, V42, P392; Lievens I, 2014, J ADV NURS, V70, P651, DOI 10.1111/jan.12229; Luthans F, 2004, ORGAN DYN, V33, P143, DOI 10.1016/j.orgdyn.2004.01.003; Luthans F., 2007, PSYCHOL CAPITAL DEV; Luthans F., 2004, BUS HORIZONS, V47, P45, DOI [10.1016/j.bushor.2003.11.007, DOI 10.1016/J.BUSHOR.2003.11.007]; Luthans KW, 2005, J NURS ADMIN, V35, P304; MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205; Ning ZS, 2014, CHINESE J CONT NEURO, V14, P117, DOI DOI 10.3969/j.issn.1672-6731.2014.02.009; Peng JX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0084193, 10.1371/journal.pone.0082465]; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Ribeiro Vivian F, 2014, Int Arch Med, V7, P22, DOI 10.1186/1755-7682-7-22; Schwarzer R, 2003, POSITIVE PSYCHOLOGICAL ASSESSMENT: HANDBOOK OF MODELS AND MEASURES, P393, DOI 10.1037/10612-025; Tennant C, 2001, J PSYCHOSOM RES, V51, P697, DOI 10.1016/S0022-3999(01)00255-0; Toker S, 2012, PSYCHOSOM MED, V74, P840, DOI 10.1097/PSY.0b013e31826c3174; Wang XM, 2012, PROCEEDINGS OF THE FIRST INTERNATIONAL SYMPOSIUM ON PUBLIC HUMAN RESOURCE MANAGEMENT, P33; Wang Y, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-915; Wang Y, 2012, J OCCUP HEALTH, V54, P232, DOI 10.1539/joh.11-0243-OA; Wu H, 2010, J ADV NURS, V66, P627, DOI 10.1111/j.1365-2648.2009.05203.x; Zhang TT, 2011, 2011 SECOND INTERNATIONAL CONFERENCE ON EDUCATION AND SPORTS EDUCATION (ESE 2011), VOL I, P31	45	143	155	5	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0122128	10.1371/journal.pone.0122128	http://dx.doi.org/10.1371/journal.pone.0122128			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG3XJ	25898257	Green Published, Green Submitted, gold			2022-12-26	WOS:000353212600008
J	Lood, C; Tyden, H; Gullstrand, B; Klint, C; Wenglen, C; Nielsen, CT; Heegaard, NHH; Jonsen, A; Kahn, R; Bengtsson, AA				Lood, Christian; Tyden, Helena; Gullstrand, Birgitta; Klint, Cecilia; Wenglen, Christina; Nielsen, Christoffer T.; Heegaard, Niels H. H.; Jonsen, Andreas; Kahn, Robin; Bengtsson, Anders A.			Type I Interferon-Mediated Skewing of the Serotonin Synthesis Is Associated with Severe Disease in Systemic Lupus Erythematosus	PLOS ONE			English	Article							PLATELET SEROTONIN; INDOLEAMINE 2,3-DIOXYGENASE; PLASMA SEROTONIN; HUMAN MONOCYTES; ACTIVATION; 5-HYDROXYTRYPTAMINE; MICROPARTICLES; PATHOGENESIS; INFLAMMATION; EXPRESSION	Serotonin, a highly pro-inflammatory molecule released by activated platelets, is formed by tryptophan. Tryptophan is also needed in the production of kynurenine, a process mediated by the type I interferon (IFN)-regulated rate-limiting enzyme indoleamine 2,3-dioxygenase (IDO). The aim of this study was to investigate levels of serotonin in patients with the autoimmune disease systemic lupus erythematosus (SLE), association to clinical phenotype and possible involvement of IDO in regulation of serotonin synthesis. Serotonin levels were measured in serum and plasma from patients with SLE (n=148) and healthy volunteers (n=79) by liquid chromatography and ELISA, as well as intracellularly in platelets by flow cytometry. We found that SLE patients had decreased serotonin levels in serum (p=0.01) and platelets (p<0.0001) as compared to healthy individuals. SLE patients with ongoing type I IFN activity, as determined by an in- house reporter assay, had decreased serum levels of serotonin (p=0.0008) as well as increased IDO activity (p<0.0001), as determined by the kynurenine/tryptophan ratio measured by liquid chromatography. Furthermore, SLE sera induced IDO expression in WISH cells in a type I IFN-dependent manner (p=0.008). Also platelet activation contributed to reduce overall availability of serotonin levels in platelets and serum (p<0.05). Decreased serum serotonin levels were associated with severe SLE with presence of anti-dsDNA antibodies and nephritis. In all, reduced serum serotonin levels in SLE patients were related to severe disease phenotype, including nephritis, suggesting involvement of important immunopathological processes. Further, our data suggest that type I IFNs, present in SLE sera, are able to up-regulate IDO expression, which may lead to decreased serum serotonin levels.	[Lood, Christian; Tyden, Helena; Jonsen, Andreas; Bengtsson, Anders A.] Lund Univ, Dept Clin Sci Lund, Rheumatol Sect, Lund, Sweden; [Lood, Christian; Tyden, Helena; Jonsen, Andreas; Bengtsson, Anders A.] Skane Univ Hosp, Lund, Sweden; [Gullstrand, Birgitta] Lund Univ, Dept Lab Med Lund, Microbiol Sect, Sect Microbiol Immunol & Glycobiol, Lund, Sweden; [Klint, Cecilia; Wenglen, Christina] AnaMar AB, Lund, Sweden; [Nielsen, Christoffer T.; Heegaard, Niels H. H.] Statens Serum Inst, Dept Clin Biochem Immunol & Genet, DK-2300 Copenhagen, Denmark; [Kahn, Robin] Lund Univ, Dept Pediat, Clin Sci Lund, Lund, Sweden	Lund University; Lund University; Skane University Hospital; Lund University; Statens Serum Institut; Lund University	Lood, C (corresponding author), Lund Univ, Dept Clin Sci Lund, Rheumatol Sect, Lund, Sweden.	loodc@uw.edu	Lood, Christian/H-5670-2019	Lood, Christian/0000-0002-6171-1952	Medical Faculty at Lund University; Crafoord Foundation; Greta and Johan Kock's Foundation; King Gustaf V's 80th Birthday Foundation; Lund University Hospital; Swedish Rheumatism Association; Swedish Society of Medicine; Foundation of the National Board of Health and Welfare; Osterlund's Foundation	Medical Faculty at Lund University; Crafoord Foundation; Greta and Johan Kock's Foundation; King Gustaf V's 80th Birthday Foundation; Lund University Hospital; Swedish Rheumatism Association; Swedish Society of Medicine; Foundation of the National Board of Health and Welfare; Osterlund's Foundation	The study was supported by grants from the Medical Faculty at Lund University, The Crafoord Foundation, Greta and Johan Kock's Foundation, King Gustaf V's 80th Birthday Foundation, Lund University Hospital, the Swedish Rheumatism Association, Swedish Society of Medicine, the Foundation of the National Board of Health and Welfare and Osterlund's Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. CKL, CWE contributed to the design of the study and to the preparation of the manuscript. The collaboration was purely scientific and focused on basic science related to disease mechanisms. AnaMar did not provide support in the form of salaries for authors others then its employees (CKL and CWE). The specific roles of these authors are articulated in the 'author contributions' section. There were no AnaMar compounds involved in the study and AnaMar has no current interest in SLE.	Bengtsson AA, 2000, LUPUS, V9, P664, DOI 10.1191/096120300674499064; Bengtsson AA, 2012, ARTHRITIS RHEUM-US, V64, P1579, DOI 10.1002/art.33493; Boilard E, 2012, NAT REV RHEUMATOL, V8, P534, DOI 10.1038/nrrheum.2012.118; Campbell BM, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00012; Cloutier N, 2012, BLOOD, V120, P1334, DOI 10.1182/blood-2012-02-413047; Crispin JC, 2010, TRENDS MOL MED, V16, P47, DOI 10.1016/j.molmed.2009.12.005; Crow MK, 2003, ARTHRITIS RES THER, V5, P279, DOI 10.1186/ar1015; de las Casas-Engel M, 2013, J IMMUNOL, V190, P2301, DOI 10.4049/jimmunol.1201133; Duerschmied D, 2013, BLOOD, V121, P1008, DOI 10.1182/blood-2012-06-437392; Durk T, 2005, INT IMMUNOL, V17, P599, DOI 10.1093/intimm/dxh242; Eloranta ML, 2009, ARTHRITIS RHEUM-US, V60, P2418, DOI 10.1002/art.24686; FUKAMI MH, 1978, J CELL BIOL, V77, P389, DOI 10.1083/jcb.77.2.389; Furuzawa-Carballeda J, 2011, EUR J CLIN INVEST, V41, P1037, DOI 10.1111/j.1365-2362.2011.02491.x; Gladman DD, 2002, J RHEUMATOL, V29, P288; Hua J, 2006, ARTHRITIS RHEUM-US, V54, P1906, DOI 10.1002/art.21890; Ito T, 2000, CIRCULATION, V102, P2522, DOI 10.1161/01.CIR.102.20.2522; Iversen LV, 2013, J IMMUNOL METHODS, V388, P49, DOI 10.1016/j.jim.2012.12.001; KANAI H, 1989, J MED, V20, P371; Kim JJ, 2013, J IMMUNOL, V190, P4795, DOI 10.4049/jimmunol.1201887; Krishnadas Rajeev, 2011, J Med Case Rep, V5, P112, DOI 10.1186/1752-1947-5-112; Leffler J, 2012, J IMMUNOL, V188, P3522, DOI 10.4049/jimmunol.1102404; Leon-Ponte M, 2007, BLOOD, V109, P3139, DOI 10.1182/blood-2006-10-052787; Li N, 1997, BLOOD COAGUL FIBRIN, V8, P517, DOI 10.1097/00001721-199711000-00006; Lood C, 2012, LUPUS, V21, P1423, DOI 10.1177/0961203312457210; Lood C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099386; Lood C, 2010, BLOOD, V116, P1951, DOI 10.1182/blood-2010-03-274605; MEYERHOFF J, 1981, ARTHRITIS RHEUM, V24, P1495, DOI 10.1002/art.1780241207; Nau F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075426; Ni W, 2006, CLIN EXP PHARMACOL P, V33, P575, DOI 10.1111/j.1440-1681.2006.04410.x; Nielsen CT, 2011, ARTHRITIS RHEUM-US, V63, P3067, DOI 10.1002/art.30499; Ostergaard O, 2012, J PROTEOME RES, V11, P2154, DOI 10.1021/pr200901p; PARBTANI A, 1980, CLIN NEPHROL, V14, P164; PARBTANI A, 1980, CLIN NEPHROL, V14, P112; Perez-De La Cruz Veronica, 2007, CNS & Neurological Disorders-Drug Targets, V6, P398; Pertovaara M, 2007, CLIN EXP IMMUNOL, V150, P274, DOI 10.1111/j.1365-2249.2007.03480.x; Ronnblom L, 2008, LUPUS, V17, P394, DOI 10.1177/0961203308090020; Ronnblom L, 2013, CURR OPIN RHEUMATOL, V25, P248, DOI 10.1097/BOR.0b013e32835c7e32; Ronnblom L, 2011, UPSALA J MED SCI, V116, P227, DOI 10.3109/03009734.2011.624649; Sarac H, 2012, J NEUROIMMUNOL, V251, P87, DOI 10.1016/j.jneuroim.2012.06.011; Schafer A, 2010, J HEPATOL, V52, P10, DOI 10.1016/j.jhep.2009.10.007; Shajib MS, 2015, ACTA PHYSIOL, V213, P561, DOI 10.1111/apha.12430; Shajib MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072774; SHIMIZU T, 1978, J BIOL CHEM, V253, P4700; Soga F, 2007, J INVEST DERMATOL, V127, P1947, DOI 10.1038/sj.jid.5700824; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Thevandavakkam MA, 2010, CNS NEUROL DISORD-DR, V9, P791; Vanhoutte PM, 2009, ACTA PHYSIOL, V196, P193, DOI 10.1111/j.1748-1716.2009.01964.x; Widner B, 2000, IMMUNOBIOLOGY, V201, P621, DOI 10.1016/S0171-2985(00)80079-0; Yu BN, 2008, J PHARMACOL EXP THER, V327, P316, DOI 10.1124/jpet.108.143461; ZELLER J, 1983, ARTHRITIS RHEUM, V26, P532, DOI 10.1002/art.1780260413	50	36	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0125109	10.1371/journal.pone.0125109	http://dx.doi.org/10.1371/journal.pone.0125109			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897671	Green Published, Green Submitted, gold			2022-12-26	WOS:000353212600096
J	Rajamuthiah, R; Fuchs, BB; Conery, AL; Kim, W; Jayamani, E; Kwon, B; Ausubel, FM; Mylonakis, E				Rajamuthiah, Rajmohan; Fuchs, Beth Burgwyn; Conery, Annie L.; Kim, Wooseong; Jayamani, Elamparithi; Kwon, Bumsup; Ausubel, Frederick M.; Mylonakis, Eleftherios			Repurposing Salicylanilide Anthelmintic Drugs to Combat Drug Resistant Staphylococcus aureus	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; PSEUDOMONAS-AERUGINOSA; VIRULENCE FACTORS; MODEL HOST; INTRINSIC RESISTANCE; EFFLUX PUMP(S); INHIBITORS; EVOLUTION; MRSA; IDENTIFICATION	Staphylococcus aureus is a Gram-positive bacterium that has become the leading cause of hospital acquired infections in the US. Repurposing Food and Drug Administration (FDA) approved drugs for antimicrobial therapy involves lower risks and costs compared to de novo development of novel antimicrobial agents. In this study, we examined the antimicrobial properties of two commercially available anthelmintic drugs. The FDA approved drug niclosamide and the veterinary drug oxyclozanide displayed strong in vivo and in vitro activity against methicillin resistant S. aureus (minimum inhibitory concentration (MIC): 0.125 and 0.5 mu g/ml respectively; minimum effective concentration: <= 0.78 mu g/ml for both drugs). The two drugs were also effective against another Gram-positive bacteria Enterococcus faecium (MIC 0.25 and 2 mu g/ml respectively), but not against the Gram-negative species Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter aerogenes. The in vitro antimicrobial activity of niclosamide and oxyclozanide were determined against methicillin, vancomycin, linezolid or daptomycin resistant S. aureus clinical isolates, with MICs at 0.0625-0.5 and 0.125-2 mu g/ml for niclosamide and oxyclozanide respectively. A time-kill study demonstrated that niclosamide is bacteriostatic, whereas oxyclozanide is bactericidal. Interestingly, oxyclozanide permeabilized the bacterial membrane but neither of the anthelmintic drugs exhibited demonstrable toxicity to sheep erythrocytes. Oxyclozanide was non-toxic to HepG2 human liver carcinoma cells within the range of its in vitro MICs but niclosamide displayed toxicity even at low concentrations. These data show that the salicylanilide anthelmintic drugs niclosamide and oxyclozanide are suitable candidates for mechanism of action studies and further clinical evaluation for treatment of staphylococcal infections.	[Rajamuthiah, Rajmohan; Fuchs, Beth Burgwyn; Kim, Wooseong; Jayamani, Elamparithi; Mylonakis, Eleftherios] Brown Univ, Alpert Med Sch, Rhode Isl Hosp, Div Infect Dis, Providence, RI 02912 USA; [Kwon, Bumsup] Brown Univ, Alpert Med Sch, Rhode Isl Hosp, Div Neurol, Providence, RI 02912 USA; [Rajamuthiah, Rajmohan; Conery, Annie L.; Jayamani, Elamparithi; Ausubel, Frederick M.; Mylonakis, Eleftherios] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Mylonakis, E (corresponding author), Brown Univ, Alpert Med Sch, Rhode Isl Hosp, Div Infect Dis, Providence, RI 02912 USA.	emylonakis@lifespan.org	Kim, Wooseong/A-9256-2017; Kim, Wooseong/AAQ-3221-2020	Kim, Wooseong/0000-0002-4597-8374; Kim, Wooseong/0000-0002-4597-8374	National Institutes of Health [P01 AI083214, R01 AI085581]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058510] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI083214] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health grant P01 AI083214 to EM and FMA and National Institutes of Health grant R01 AI085581 to FMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS P, 1982, PHARMACOL THERAPEUT, V19, P245, DOI 10.1016/0163-7258(82)90064-X; [Anonymous], 2003, REP WHO EXP COMM, P0512; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Begun J, 2005, INFECT IMMUN, V73, P872, DOI 10.1128/IAI.73.2.872-877.2005; Benfield T, 2007, CLIN MICROBIOL INFEC, V13, P257, DOI 10.1111/j.1469-0691.2006.01589.x; Boneca IG, 2003, EXPERT OPIN THER TAR, V7, P311, DOI 10.1517/14728222.7.3.311; Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590; CAMPBELL WC, 1986, J PARASITOL, V72, P45, DOI 10.2307/3281795; Carlson-Banning KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069646; (CDC) CfDCaP, 2011, REP EM INF PROGR NET; Cheng TJR, 2010, BIOORGAN MED CHEM, V18, P8512, DOI 10.1016/j.bmc.2010.10.036; Chopra S, 2010, J ANTIMICROB CHEMOTH, V65, P2598, DOI 10.1093/jac/dkq353; Cuddy Suzanne M, 2008, Plast Surg Nurs, V28, P168, DOI 10.1097/PSN.0b013e31818ea7ca; Day SR, 2012, VIRULENCE, V3, P576, DOI 10.4161/viru.22120; Desalermos A, 2014, J INFECT DIS; Desalermos A, 2011, EXPERT OPIN DRUG DIS, V6, P645, DOI 10.1517/17460441.2011.573781; Ewbank JJ, 2011, DIS MODEL MECH, V4, P300, DOI 10.1242/dmm.006684; Feng Y, 2008, FEMS MICROBIOL REV, V32, P23, DOI 10.1111/j.1574-6976.2007.00086.x; French GL, 2006, J ANTIMICROB CHEMOTH, V58, P1107, DOI 10.1093/jac/dkl393; FROYD G, 1968, BRIT VET J, V124, P116, DOI 10.1016/S0007-1935(17)39505-2; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Gottlieb GS, 2000, J AM COLL SURGEONS, V190, P50, DOI 10.1016/S1072-7515(99)00211-2; Haste NM, 2011, ANTIMICROB AGENTS CH, V55, P3305, DOI 10.1128/AAC.01211-10; Hilliard JJ, 1999, ANTIMICROB AGENTS CH, V43, P1693, DOI 10.1128/AAC.43.7.1693; Hu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070702; Irazoqui JE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000982; Isnansetyo A, 2003, ANTIMICROB AGENTS CH, V47, P480, DOI 10.1128/AAC.47.2.480-488.2003; Jayamani E, 2015, ANTIMICROB AGENTS CH, V59, P1733, DOI 10.1128/AAC.04198-14; Jones RN, 2003, SEMIN RESP CRIT CARE, V24, P121, DOI 10.1055/s-2003-37923; Jorgensen JH, 2009, CLIN INFECT DIS, V49, P1749, DOI 10.1086/647952; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Kirienko NV, 2013, CELL HOST MICROBE, V13, P406, DOI 10.1016/j.chom.2013.03.003; Koh JJ, 2013, BBA-BIOMEMBRANES, V1828, P834, DOI 10.1016/j.bbamem.2012.09.004; Kratky M, 2015, BIOORGAN MED CHEM, V23, P868, DOI 10.1016/j.bmc.2014.12.019; Kratky M, 2013, MOLECULES, V18, P3674, DOI 10.3390/molecules18043674; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Kwon B, 2014, HUM MOL GENET, V23, P3681, DOI 10.1093/hmg/ddu077; LI XZ, 1994, ANTIMICROB AGENTS CH, V38, P1732, DOI 10.1128/AAC.38.8.1732; LI XZ, 1994, ANTIMICROB AGENTS CH, V38, P1742, DOI 10.1128/AAC.38.8.1742; Lindsay JA, 2010, INT J MED MICROBIOL, V300, P98, DOI 10.1016/j.ijmm.2009.08.013; Lu WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029290; Macielag MJ, 1998, J MED CHEM, V41, P2939, DOI 10.1021/jm9803572; MACK D, 1994, INFECT IMMUN, V62, P3244, DOI 10.1128/IAI.62.8.3244-3253.1994; Martin RJ, 1997, VET J, V154, P11, DOI 10.1016/S1090-0233(05)80005-X; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Moy TI, 2009, ACS CHEM BIOL, V4, P527, DOI 10.1021/cb900084v; Mylonakis E, 2007, PLOS PATHOG, V3, P859, DOI 10.1371/journal.ppat.0030101; Nair D, 2011, J BACTERIOL, V193, P2332, DOI 10.1128/JB.00027-11; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; Pauk K, 2013, BIOORGAN MED CHEM, V21, P6574, DOI 10.1016/j.bmc.2013.08.029; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Rajamuthiah R, 2014, VIRULENCE, V5, P697, DOI 10.4161/viru.29091; Rajamuthiah R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089189; Rice LB, 2010, INFECT CONT HOSP EP, V31, pS7, DOI 10.1086/655995; Rosch JW, 2010, J CLIN INVEST, V120, P627, DOI 10.1172/JCI39843; ROY R M, 1971, Tropical Animal Health and Production, V3, P26, DOI 10.1007/BF02356681; Schaberle TF, 2014, TRENDS MICROBIOL, V22, P165, DOI 10.1016/j.tim.2013.12.007; Sifri CD, 2005, TRENDS MICROBIOL, V13, P119, DOI 10.1016/j.tim.2005.01.003; Sifri CD, 2006, INFECT IMMUN, V74, P1091, DOI 10.1128/IAI.74.2.1091-1096.2006; Sifri CD, 2003, INFECT IMMUN, V71, P2208, DOI 10.1128/IAI.71.4.2208-2217.2003; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; Swan GE, 1999, J S AFR VET ASSOC, V70, P61; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Tanaka-Hino M, 2002, EMBO REP, V3, P56, DOI 10.1093/embo-reports/kvf001; Tao HL, 2014, NAT MED, V20, P1263, DOI 10.1038/nm.3699; Tomizawa M, 2013, ONCOTARGETS THER, V6, P1685, DOI 10.2147/OTT.S50065; VANDENBOSSCHE H, 1979, ARCH INT PHYSIOL BIO, V87, P851; Weaver AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097742; Wu KY, 2012, CAN J INFECT DIS MED, V23, P130, DOI 10.1155/2012/543817; Ye TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085887; Zhu ZW, 2011, J ENZYM INHIB MED CH, V26, P37, DOI 10.3109/14756361003671060	72	99	104	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124595	10.1371/journal.pone.0124595	http://dx.doi.org/10.1371/journal.pone.0124595			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897961	Green Published, Green Submitted, gold			2022-12-26	WOS:000353212600076
J	Dickey, AM; Kumar, V; Hoddle, MS; Funderburk, JE; Morgan, JK; Jara-Cavieres, A; Shatters, RGJ; Osborne, LS; McKenzie, CL				Dickey, Aaron M.; Kumar, Vivek; Hoddle, Mark S.; Funderburk, Joe E.; Morgan, J. Kent; Jara-Cavieres, Antonella; Shatters, Robert G. Jr.; Osborne, Lance S.; McKenzie, Cindy L.			The Scirtothrips dorsalis Species Complex: Endemism and Invasion in a Global Pest	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; MITOCHONDRIAL-DNA; THYSANOPTERA THRIPIDAE; POPULATION-GROWTH; MOLECULAR CHARACTERIZATION; STATISTICAL TESTS; SPOT VIRUS; HOOD; IDENTIFICATION; NEUTRALITY	Invasive arthropods pose unique management challenges in various environments, the first of which is correct identification. This apparently mundane task is particularly difficult if multiple species are morphologically indistinguishable but accurate identification can be determined with DNA barcoding provided an adequate reference set is available. Scirtothrips dorsalis is a highly polyphagous plant pest with a rapidly expanding global distribution and this species, as currently recognized, may be comprised of cryptic species. Here we report the development of a comprehensive DNA barcode library for S. dorsalis and seven nuclear markers via next-generation sequencing for identification use within the complex. We also report the delimitation of nine cryptic species and two morphologically distinguishable species comprising the S. dorsalis species complex using histogram analysis of DNA barcodes, Bayesian phylogenetics, and the multi-species coalescent. One member of the complex, here designated the South Asia 1 cryptic species, is highly invasive, polyphagous, and likely the species implicated in tospovirus transmission. Two other species, South Asia 2, and East Asia 1 are also highly polyphagous and appear to be at an earlier stage of global invasion. The remaining members of the complex are regionally endemic, varying in their pest status and degree of polyphagy. In addition to patterns of invasion and endemism, our results provide a framework both for identifying members of the complex based on their DNA barcode, and for future species delimiting efforts.	[Dickey, Aaron M.; Kumar, Vivek; Osborne, Lance S.] Univ Florida, Mid Florida Res & Educ Ctr, Apopka, FL USA; [Dickey, Aaron M.; Kumar, Vivek; Morgan, J. Kent; Jara-Cavieres, Antonella; Shatters, Robert G. Jr.; McKenzie, Cindy L.] US Hort Res Lab, Ft Pierce, FL 34945 USA; [Hoddle, Mark S.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Hoddle, Mark S.] Univ Calif Riverside, Ctr Invas Species Res, Riverside, CA 92521 USA; [Funderburk, Joe E.] Univ Florida, North Florida Res & Educ Ctr, Quincy, FL USA; [Morgan, J. Kent; Shatters, Robert G. Jr.; McKenzie, Cindy L.] USDA ARS, Ft Pierce, FL USA; [Jara-Cavieres, Antonella] Univ Florida, Indian River Res & Educ Ctr, Ft Pierce, FL USA	State University System of Florida; University of Florida; University of California System; University of California Riverside; University of California System; University of California Riverside; State University System of Florida; University of Florida; United States Department of Agriculture (USDA); State University System of Florida; University of Florida	McKenzie, CL (corresponding author), US Hort Res Lab, Ft Pierce, FL 34945 USA.	Cindy.McKenzie@ars.usda.gov	Kumar, Vivek/B-8500-2011	Kumar, Vivek/0000-0003-1988-2536; Dickey, Aaron/0000-0003-1250-1390; Shatters, Robert/0000-0002-3903-772X	Floriculture and Nursery Research Initiative [402626]; USDA	Floriculture and Nursery Research Initiative; USDA(United States Department of Agriculture (USDA))	This research was partially funded by the Floriculture and Nursery Research Initiative, http:// www.ars.usda.gov/research/projects/projects.htm?ACCN_NO=402626. Additional funding was provided internally by the USDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIN PW, 1981, PLANT DIS, V65, P663, DOI 10.1094/PD-65-663; [Anonymous], 2012, EVOL BIOINFORM, V8, P1, DOI 10.4137/EBO.S8532; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; CABI, 2013, INV SPEC COMP; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Campbell B., 2000, P59; Carolan JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029251; Chiemsombat P, 2008, ARCH VIROL, V153, P571, DOI 10.1007/s00705-007-0024-3; Chu FH, 2001, PHYTOPATHOLOGY, V91, P856, DOI 10.1094/PHYTO.2001.91.9.856; Cognato AI, 2005, AGR FOREST ENTOMOL, V7, P87, DOI 10.1111/j.1461-9555.2005.00243.x; Condamine FL, 2013, CLADISTICS, V29, P88, DOI 10.1111/j.1096-0031.2012.00412.x; Dickey AM, 2014, FLA ENTOMOL, V97, P362, DOI 10.1653/024.097.0204; Dickey AM, 2012, FLA ENTOMOL, V95, P790, DOI 10.1653/024.095.0336; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Dowton M, 2014, SYST BIOL, V63, P639, DOI 10.1093/sysbio/syu028; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Farris RE, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.2601; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; GILBERT MJ, 1986, J ENTOMOL SOC S AFR, V49, P159; Gopal K., 2010, Archives of Phytopathology and Plant Protection, V43, P421, DOI 10.1080/03235400701850920; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hoddle MS, 2008, ANN ENTOMOL SOC AM, V101, P491, DOI 10.1603/0013-8746(2008)101[491:RASOST]2.0.CO;2; Hoddle MS, 2008, FLA ENTOMOL, V91, P16, DOI 10.1653/0015-4040(2008)091[0016:SOFSST]2.0.CO;2; Hoddle MS, 2003, ZOOTAXA, V268, P1, DOI DOI 10.11646/ZOOTAXA.268.1.1; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jinbo U, 2011, ENTOMOL SCI, V14, P107, DOI 10.1111/j.1479-8298.2011.00449.x; Kadirvel P, 2013, J ECON ENTOMOL, V106, P408, DOI 10.1603/EC12119; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kittler R, 2003, CURR BIOL, V13, P1414, DOI 10.1016/S0960-9822(03)00507-4; Kumar V, 2013, WEED PEST CONTROL CO, DOI [10.5772/55045, DOI 10.5772/55045]; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Leache AD, 2010, P ROY SOC B-BIOL SCI, V277, P3071, DOI 10.1098/rspb.2010.0662; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lombaert E, 2011, MOL ECOL, V20, P4654, DOI 10.1111/j.1365-294X.2011.05322.x; MADDISON W.P., 2001, MESQUITE MODULAR SYS; Magnacca KN, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-174; Meissner H, 2005, EVALUATION POSSIBLE; Minamikawa J, 1960, TEA RES J, V16, P23; Morse JG, 2006, ANNU REV ENTOMOL, V51, P67, DOI 10.1146/annurev.ento.51.110104.151044; Mound LA, 2010, ZOOTAXA, P59; MOUND LA, 1981, B ENTOMOL RES, V71, P467, DOI 10.1017/S0007485300008488; Mound Laurence A., 2011, Zootaxa, V2786, P51; Nietschke BS, 2008, FLA ENTOMOL, V91, P79, DOI 10.1653/0015-4040(2008)091[0079:CPFSDT]2.0.CO;2; O Foighil D, 1998, MAR BIOL, V131, P497, DOI 10.1007/s002270050341; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P7495, DOI 10.1073/pnas.0811117106; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2007, TRACER VERSION 1 6; Rambaut A., 2007, FIGTREE GRAPHICAL VI; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Rannala B, 2013, GENETICS, V194, P245, DOI 10.1534/genetics.112.149039; Rebijith KB, 2012, ENTOMOL NEWS, V122, P201, DOI 10.3157/021.122.0301; Riley DG, 2011, J INTEGR PEST MANAG, V2, DOI 10.1603/IPM10020; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rozen S, 2000, Methods Mol Biol, V132, P365; Rubinoff D, 2006, CONSERV BIOL, V20, P1548, DOI 10.1111/j.1523-1739.2006.00542.x; Rugman-Jones PF, 2006, J ECON ENTOMOL, V99, P1813, DOI 10.1603/0022-0493-99.5.1813; Rugman-Jones PF, J EC ENTOMOL, V103, P877; Schenekar T, 2011, HEREDITY, V107, P511, DOI 10.1038/hdy.2011.48; Seal DR, 2006, CROP PROT, V25, P949, DOI 10.1016/j.cropro.2005.12.008; Seal DR, 2010, ENVIRON ENTOMOL, V39, P1389, DOI 10.1603/EN09236; Shao RF, 2003, MOL BIOL EVOL, V20, P1612, DOI 10.1093/molbev/msg176; Shao RF, 2003, MOL BIOL EVOL, V20, P362, DOI 10.1093/molbev/msg045; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; Smith MA, 2007, P NATL ACAD SCI USA, V104, P4967, DOI 10.1073/pnas.0700050104; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Stanke M, 2005, NUCLEIC ACIDS RES, V33, pW465, DOI 10.1093/nar/gki458; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Swofford DL., 2003, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toda S, 2002, B ENTOMOL RES, V92, P359, DOI 10.1079/BER2002177; Toda S, 2014, APPL ENTOMOL ZOOL, V49, P231, DOI 10.1007/s13355-013-0241-z; Venette RC, 2004, MINIRISK ASSESSMENT; Worner SP, 2006, J APPL ECOL, V43, P858, DOI 10.1111/j.1365-2664.2006.01202.x; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; Xie WG, 2011, SYST BIOL, V60, P150, DOI 10.1093/sysbio/syq085; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107	86	38	43	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123747	10.1371/journal.pone.0123747	http://dx.doi.org/10.1371/journal.pone.0123747			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893251	Green Submitted, gold, Green Published			2022-12-26	WOS:000353211700052
J	Boivin, N; Baillargeon, J; Doss, PMIA; Roy, AP; Rangachari, M				Boivin, Nicolas; Baillargeon, Joanie; Doss, Prenitha Mercy Ignatius Arokia; Roy, Andree-Pascale; Rangachari, Manu			Interferon-beta Suppresses Murine Th1 Cell Function in the Absence of Antigen-Presenting Cells	PLOS ONE			English	Article							CHRONIC VIRAL-INFECTION; T-HELPER TYPE-1; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; RELAPSING MULTIPLE-SCLEROSIS; CENTRAL-NERVOUS-SYSTEM; IFN-BETA; TRANSCRIPTION FACTOR; GLATIRAMER ACETATE; TIM-3 EXPRESSION; I INTERFERON	Interferon (IFN)-beta is a front-line therapy for the treatment of the relapsing-remitting form of multiple sclerosis. However, its immunosuppressive mechanism of function remains incompletely understood. While it has been proposed that IFN-beta suppresses the function of inflammatory myelin antigen-reactive T cells by promoting the release of immunomodulatory cytokines such as IL-27 from antigen-presenting cells (APCs), its direct effects on inflammatory CD4(+) Th1 cells are less clear. Here, we establish that IFN-beta inhibits mouse IFN-gamma(+) Th1 cell function in the absence of APCs. CD4(+) T cells express the type I interferon receptor, and IFN-beta can suppress Th1 cell proliferation under APC-free stimulation conditions. IFN-beta-treated myelin antigen-specific Th1 cells are impaired in their ability to induce severe experimental autoimmune encephalomyelitis (EAE) upon transfer to lymphocyte-deficient Rag1(-/-) mice. Polarized Th1 cells downregulate IFN-gamma and IL-2, and upregulate the negative regulatory receptor Tim-3, when treated with IFN-beta in the absence of APCs. Further, IFN-beta treatment of Th1 cells upregulates phosphorylation of Stat1, and downregulates phosphorylation of Stat4. Our data indicate that IFN-gamma-producing Th1 cells are directly responsive to IFN-beta and point to a novel mechanism of IFN-beta-mediated T cell suppression that is independent of APC-derived signals.	[Boivin, Nicolas; Baillargeon, Joanie; Doss, Prenitha Mercy Ignatius Arokia; Roy, Andree-Pascale; Rangachari, Manu] Univ Laval, CHU Quebec, Ctr Rech, Dept Neurosci, Quebec City, PQ G1V 4G2, Canada; [Doss, Prenitha Mercy Ignatius Arokia; Roy, Andree-Pascale] Univ Laval, Fac Med, Grad Programme Microbiol & Immunol, Quebec City, PQ G1V 0A6, Canada; [Rangachari, Manu] Univ Laval, Fac Med, Dept Mol Med, Quebec City, PQ G1V 0A6, Canada	Laval University; Laval University; Laval University	Rangachari, M (corresponding author), Univ Laval, CHU Quebec, Ctr Rech, Dept Neurosci, Quebec City, PQ G1V 4G2, Canada.	manu.rangachari@crchudequebec.ulaval.ca			Universite Laval; EMD Serono, Canada; MS Research and Training Network Transitional Career Development Award from MS Society of Canada; Multiple Sclerosis Scientific Research Foundation; Junior-1 Research Scholar Career Award from the Fonds de Recherche Sante-Quebec (FRQS); John R. Evans Leaders Fund Award from the Canada Foundation for Innovation (CFI); CHU de Quebec-Universite Laval	Universite Laval; EMD Serono, Canada; MS Research and Training Network Transitional Career Development Award from MS Society of Canada; Multiple Sclerosis Scientific Research Foundation; Junior-1 Research Scholar Career Award from the Fonds de Recherche Sante-Quebec (FRQS); John R. Evans Leaders Fund Award from the Canada Foundation for Innovation (CFI); CHU de Quebec-Universite Laval	P.M.I.A.D. and A.P.R. are supported by funds from Universite Laval. M.R. is supported by the EMD Serono, Canada and MS Research and Training Network Transitional Career Development Award from the MS Society of Canada and the Multiple Sclerosis Scientific Research Foundation; by a Junior-1 Research Scholar Career Award from the Fonds de Recherche Sante-Quebec (FRQS); by a John R. Evans Leaders Fund Award from the Canada Foundation for Innovation (CFI); and by funds from the CHU de Quebec-Universite Laval. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnello D, 2003, J CLIN IMMUNOL, V23, P147, DOI 10.1023/A:1023381027062; Anderson AC, 2010, EUR J IMMUNOL, V40, P859, DOI 10.1002/eji.200939842; Arnason BGW, 1999, ANNU REV MED, V50, P291; Ascherio A, 2013, EXPERT REV NEUROTHER, V13, P3, DOI 10.1586/14737175.2013.865866; Avolio C, 2003, BRAIN RES BULL, V61, P357, DOI 10.1016/S0361-9230(03)00098-4; Axtell RC, 2013, CLIN REV ALLERG IMMU, V44, P114, DOI 10.1007/s12016-011-8296-5; Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Beck CA, 2005, MULT SCLER J, V11, P516, DOI 10.1191/1352458505ms1192oa; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Brod SA, 1997, INT J NEUROSCI, V90, P135, DOI 10.3109/00207459709000633; Burks Jack, 2005, Expert Rev Neurother, V5, P153, DOI 10.1586/14737175.5.2.153; Chitnis T, 2001, J CLIN INVEST, V108, P739, DOI 10.1172/JCI200112563; Clerico M, 2007, EXPERT OPIN BIOL TH, V7, P535, DOI 10.1517/14712598.7.4.535; Deonarain R, 2003, P NATL ACAD SCI USA, V100, P13453, DOI 10.1073/pnas.2230460100; El-behi M, 2010, J NEUROIMMUNE PHARM, V5, P189, DOI 10.1007/s11481-009-9188-9; George PM, 2012, PHARMACOL THERAPEUT, V135, P44, DOI 10.1016/j.pharmthera.2012.03.006; Guo BC, 2008, J CLIN INVEST, V118, P1680, DOI 10.1172/JCI33342; Huber JP, 2011, IMMUNOLOGY, V132, P466, DOI 10.1111/j.1365-2567.2011.03412.x; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Inoges S, 1999, CLIN EXP IMMUNOL, V115, P521; JACOBS L, 1994, ARCH NEUROL-CHICAGO, V51, P1245, DOI 10.1001/archneur.1994.00540240089022; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Kamiya S, 2004, J IMMUNOL, V173, P3871, DOI 10.4049/jimmunol.173.6.3871; Karp CL, 2001, CURR OPIN NEUROL, V14, P361, DOI 10.1097/00019052-200106000-00016; Kieseier BC, 2011, CNS DRUGS, V25, P491, DOI 10.2165/11591110-000000000-00000; Kimura A, 2007, P NATL ACAD SCI USA, V104, P12099, DOI 10.1073/pnas.0705268104; Koguchi K, 2006, J EXP MED, V203, P1413, DOI 10.1084/jem.20060210; Kraus J, 2006, DRUG DISCOV TODAY, V11, P755, DOI 10.1016/j.drudis.2006.06.008; Liu YW, 2014, NAT MED, V20, P272, DOI 10.1038/nm.3485; Liu ZG, 2001, J NEUROIMMUNOL, V112, P153, DOI 10.1016/S0165-5728(00)00403-3; Lombardi G, 2000, J IMMUNOL, V165, P3782, DOI 10.4049/jimmunol.165.7.3782; Luca ME, 1999, J NEUROIMMUNOL, V100, P190, DOI 10.1016/S0165-5728(99)00198-8; McMahan RH, 2010, J CLIN INVEST, V120, P4546, DOI 10.1172/JCI43127; McRae BL, 1997, EUR J IMMUNOL, V27, P2650, DOI 10.1002/eji.1830271026; McRae BL, 1998, J IMMUNOL, V160, P4298; Melo A, 2008, ARQ NEURO-PSIQUIAT, V66, P8, DOI 10.1590/S0004-282X2008000100003; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; NORONHA A, 1993, J NEUROIMMUNOL, V46, P145, DOI 10.1016/0165-5728(93)90244-S; NYLAND H, 1982, NEUROPATH APPL NEURO, V8, P403, DOI 10.1111/j.1365-2990.1982.tb00308.x; Pennell LM, 2014, J INTERF CYTOK RES, V34, P330, DOI 10.1089/jir.2013.0088; Petermann F, 2011, FEBS LETT, V585, P3747, DOI 10.1016/j.febslet.2011.03.064; Peters A, 2011, IMMUNITY, V35, P986, DOI 10.1016/j.immuni.2011.10.015; Polman CH, 2003, LANCET NEUROL, V2, P563, DOI 10.1016/S1474-4422(03)00505-2; Pozzilli C, 2006, NEUROL SCI, V27, pS369, DOI 10.1007/s10072-006-0697-5; Prinz M, 2008, IMMUNITY, V28, P675, DOI 10.1016/j.immuni.2008.03.011; Ramgolam VS, 2009, J IMMUNOL, V183, P5418, DOI 10.4049/jimmunol.0803227; Rangachari M, 2013, J AUTOIMMUN, V45, P31, DOI 10.1016/j.jaut.2013.06.008; Rangachari M, 2012, NAT MED, V18, P1394, DOI 10.1038/nm.2871; Rep MHG, 1996, J NEUROIMMUNOL, V67, P111; Rio J, 2006, ANN NEUROL, V59, P344, DOI 10.1002/ana.20740; Rudick RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019262; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; SHATA MT, 1995, J INTERF CYTOK RES, V15, P291, DOI 10.1089/jir.1995.15.291; Shinohara ML, 2008, IMMUNITY, V29, P68, DOI 10.1016/j.immuni.2008.05.008; Sprent J, 2000, PHILOS T R SOC B, V355, P317, DOI 10.1098/rstb.2000.0568; Starossom SC, 2012, IMMUNITY, V37, P249, DOI 10.1016/j.immuni.2012.05.023; Sweeney CM, 2011, BRAIN BEHAV IMMUN, V25, P1170, DOI 10.1016/j.bbi.2011.03.007; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tigno-Aranjuez JT, 2009, J IMMUNOL, V183, P5654, DOI 10.4049/jimmunol.0900645; Usui T, 2006, J EXP MED, V203, P755, DOI 10.1084/jem.20052165; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Visconti R, 2000, BLOOD, V96, P1844, DOI 10.1182/blood.V96.5.1844.h8001844_1844_1852; Weber MS, 2007, NEUROTHERAPEUTICS, V4, P647, DOI 10.1016/j.nurt.2007.08.002; Yang L, 2008, J IMMUNOL, V180, P4409, DOI 10.4049/jimmunol.180.7.4409; Zhang JW, 2002, CLIN THER, V24, P1998, DOI 10.1016/S0149-2918(02)80094-7; Zhou Q, 2011, BLOOD, V117, P4501, DOI 10.1182/blood-2010-10-310425; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271; Zhu C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7072	77	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124802	10.1371/journal.pone.0124802	http://dx.doi.org/10.1371/journal.pone.0124802			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885435	Green Published, Green Submitted, gold			2022-12-26	WOS:000353017000145
J	Kashojiya, S; Okajima, K; Shimada, T; Tokutomi, S				Kashojiya, Sachiko; Okajima, Koji; Shimada, Takashi; Tokutomi, Satoru			Essential Role of the A 'alpha/A beta Gap in the N-Terminal Upstream of LOV2 for the Blue Light Signaling from LOV2 to Kinase in Arabidopsis Photototropin1, a Plant Blue Light Receptor	PLOS ONE			English	Article							STRUCTURAL BASIS; PHOTOTROPIN 1; CONFORMATIONAL-CHANGES; PHOTORECEPTOR DOMAIN; MUTATIONAL ANALYSIS; BINDING DOMAINS; PRIMARY STEP; INSIGHTS; OXYGEN; NPL1	Phototropin (phot) is a blue light (BL) receptor in plants and is involved in phototropism, chloroplast movement, stomata opening, etc. A phot molecule has two photo-receptive domains named LOV (Light-Oxygen-Voltage) 1 and 2 in its N-terminal region and a serine/threonine kinase (STK) in its C-terminal region. STK activity is regulated mainly by LOV2, which has a cyclic photoreaction, including the transient formation of a flavin mononucleotide (FMN)-cysteinyl adduct (S390). One of the key events for the propagation of the BL signal from LOV2 to STK is conformational changes in a J alpha-helix residing downstream of the LOV2 C-terminus. In contrast, we focused on the role of the A'alpha-helix, which is located upstream of the LOV2 N-terminus and interacts with the Ja-helix. Using LOV2-STK polypeptides from Arabidopsis thaliana phot1, we found that truncation of the A'alpha-helix and amino acid substitutions at Glu474 and Lys475 in the gap between the A'alpha and the A beta strand of LOV2 (A'alpha/A beta gap) to Ala impaired the BL-induced activation of the STK, although they did not affect S390 formation. Trypsin digested the LOV2-STK at Lys603 and Lys475 in a light-dependent manner indicating BL-induced structural changes in both the Ja-helix and the gap. The digestion at Lys603 is faster than at Lys475. These BL-induced structural changes were observed with the Glu474Ala and the Lys475Ala substitutes, indicating that the BL signal reached the Ja-helix as well as the A'alpha/A beta gap but could not activate STK. The amino acid residues, Glu474 and Lys475, in the gap are conserved among the phots of higher plants and may act as a joint to connect the structural changes in the Ja-helix with the activation of STK.	[Kashojiya, Sachiko; Okajima, Koji; Tokutomi, Satoru] Osaka Prefecture Univ, Dept Biol Sci, Sakai, Osaka 591, Japan; [Shimada, Takashi] Shimadzu Co Ltd, Life Sci Res Ctr, Tokyo, Japan	Osaka Metropolitan University; Shimadzu Corporation	Okajima, K (corresponding author), Osaka Prefecture Univ, Dept Biol Sci, Sakai, Osaka 591, Japan.	okajima@b.s.osakafu-u.ac.jp			MEXT Japan [17084008]; JSPS Japan [22120005, 23657105]	MEXT Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid from the MEXT Japan to S.T. (No. 17084008) and from the JSPS Japan to S.T. (No. 22120005 and No. 23657105).	Aihara Y, 2012, J BIOL CHEM, V287, P9901, DOI 10.1074/jbc.M111.324723; Bogre L, 2003, TRENDS PLANT SCI, V8, P424, DOI 10.1016/S1360-1385(03)00188-2; Briggs WR, 2002, TRENDS PLANT SCI, V7, P204, DOI 10.1016/S1360-1385(02)02245-8; Christie JM, 2002, PLANT J, V32, P205, DOI 10.1046/j.1365-313X.2002.01415.x; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; Christie JM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001076; Circolone F, 2012, J MOL BIOL, V417, P362, DOI 10.1016/j.jmb.2012.01.056; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; Crosson S, 2002, PLANT CELL, V14, P1067, DOI 10.1105/tpc.010475; Demarsy E, 2012, EMBO J, V31, P3457, DOI 10.1038/emboj.2012.186; Eitoku T, 2007, J MOL BIOL, V371, P1290, DOI 10.1016/j.jmb.2007.06.035; Freddolino PL, 2013, PHOTOCH PHOTOBIO SCI, V12, P1158, DOI 10.1039/c3pp25400c; Halavaty AS, 2007, BIOCHEMISTRY-US, V46, P14001, DOI 10.1021/bi701543e; Halavaty AS, 2013, ACTA CRYSTALLOGR F, V69, P1316, DOI 10.1107/S1744309113029199; Harper SM, 2004, BIOCHEMISTRY-US, V43, P16184, DOI 10.1021/bi048092i; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Harper SM, 2004, J AM CHEM SOC, V126, P3390, DOI 10.1021/ja038224f; Inoue S, 2008, P NATL ACAD SCI USA, V105, P5626, DOI 10.1073/pnas.0709189105; Jarillo JA, 2001, NATURE, V410, P952, DOI 10.1038/35073622; Jones MA, 2007, J BIOL CHEM, V282, P6405, DOI 10.1074/jbc.M605969200; Kagawa T, 2001, SCIENCE, V291, P2138, DOI 10.1126/science.291.5511.2138; Kasahara M, 2002, PLANT PHYSIOL, V129, P762, DOI 10.1104/pp.002410; Katsura H, 2009, FEBS LETT, V583, P526, DOI 10.1016/j.febslet.2009.01.019; Kinoshita T, 2001, NATURE, V414, P656, DOI 10.1038/414656a; Mitre D, 2012, STRUCTURE, V20, P698, DOI 10.1016/j.str.2012.02.016; Moglich A, 2007, J MOL BIOL, V373, P112, DOI 10.1016/j.jmb.2007.07.039; Moglich A, 2010, ANNU REV PLANT BIOL, V61, P21, DOI 10.1146/annurev-arplant-042809-112259; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Nakasako M, 2004, BIOCHEMISTRY-US, V43, P14881, DOI 10.1021/bi0485530; Nakasako M, 2008, J MOL BIOL, V381, P718, DOI 10.1016/j.jmb.2008.06.033; Nash AI, 2011, P NATL ACAD SCI USA, V108, P9449, DOI 10.1073/pnas.1100262108; Nash AI, 2008, BIOCHEMISTRY-US, V47, P13842, DOI 10.1021/bi801430e; Nozaki D, 2004, BIOCHEMISTRY-US, V43, P8373, DOI 10.1021/bi0494727; Okajima K, 2012, J BIOL CHEM, V287, P40972, DOI 10.1074/jbc.M112.406512; Okajima K, 2011, FEBS LETT, V585, P3391, DOI 10.1016/j.febslet.2011.10.003; Quail PH, 2002, CURR OPIN CELL BIOL, V14, P180, DOI 10.1016/S0955-0674(02)00309-5; Rinaldi J, 2012, J MOL BIOL, V420, P112, DOI 10.1016/j.jmb.2012.04.006; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Sharma S, 2014, PLANT PHYSIOL, V164, P2030, DOI 10.1104/pp.113.232306; Song SH, 2011, BIOCHEMISTRY-US, V50, P2411, DOI 10.1021/bi200198x; Sullivan S, 2008, MOL PLANT, V1, P178, DOI 10.1093/mp/ssm017; Swartz TE, 2001, J BIOL CHEM, V276, P36493, DOI 10.1074/jbc.M103114200; Takayama Y, 2011, BIOCHEMISTRY-US, V50, P1174, DOI 10.1021/bi101689b; Takeda K, 2013, J PHYS CHEM B, V117, P15606, DOI 10.1021/jp406109j; Takemiya A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3094; Zayner JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087074; Zayner JP, 2012, J MOL BIOL, V419, P61, DOI 10.1016/j.jmb.2012.02.037	49	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124284	10.1371/journal.pone.0124284	http://dx.doi.org/10.1371/journal.pone.0124284			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886203	Green Submitted, Green Published, gold			2022-12-26	WOS:000353017000111
J	Liu, JH; Zhang, J; Hu, W; Miao, HX; Zhang, JB; Jia, CH; Wang, Z; Xu, BY; Jin, ZQ				Liu, Juhua; Zhang, Jing; Hu, Wei; Miao, Hongxia; Zhang, Jianbin; Jia, Caihong; Wang, Zhuo; Xu, Biyu; Jin, Zhiqiang			Banana Ovate Family Protein MaOFP1 and MADS-Box Protein MuMADS1 Antagonistically Regulated Banana Fruit Ripening	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; ETHYLENE BIOSYNTHESIS; GENE FAMILY; SUBCELLULAR-LOCALIZATION; ARABIDOPSIS-THALIANA; TOMATO FRUIT; LAND PLANTS; IN-VITRO; EVOLUTION; COMPLEXES	The ovate family protein named MaOFP1 was identified in banana (Musa acuminata L. AAA) fruit by a yeast two-hybrid (Y2H) method using the banana MADS-box gene MuMADS1 as bait and a 2 day postharvest (DPH) banana fruit cDNA library as prey. The interaction between MuMADS1 and MaOFP1 was further confirmed by Y2H and Bimolecular Fluorescence Complementation (BiFC) methods, which showed that the MuMADS1 K domain interacted with MaOFP1. Real-time quantitative PCR evaluation of MuMADS1 and MaOFP1 expression patterns in banana showed that they are highly expressed in 0 DPH fruit, but present in low levels in the stem, which suggests that simultaneous but different expression patterns exist for both MuMADS1 and MaOFP1 in different tissues and developing fruits. Meanwhile, MuMADS1 and MaOFP1 expression was highly stimulated and greatly suppressed, respectively, by exogenous ethylene. In contrast, MaOFP1 expression was highly stimulated while MuMADS1 was greatly suppressed by the ethylene competitor 1-methylcyclopropene (1-MCP). These results indicate that MuMADS1 and MaOFP1 are antagonistically regulated by ethylene and might play important roles in postharvest banana fruit ripening.	[Liu, Juhua; Zhang, Jing; Hu, Wei; Miao, Hongxia; Zhang, Jianbin; Jia, Caihong; Wang, Zhuo; Xu, Biyu; Jin, Zhiqiang] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Minist Agr, Key Lab Trop Crop Biotechnol, Haikou, Hainan, Peoples R China; [Jin, Zhiqiang] Chinese Acad Trop Agr Sci, Haikou Expt Stn, Haikou, Hainan, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Chinese Academy of Tropical Agricultural Sciences	Xu, BY (corresponding author), Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Minist Agr, Key Lab Trop Crop Biotechnol, Haikou, Hainan, Peoples R China.	xubiyu@itbb.org.cn; jinzhiqiang@itbb.org.cn			National Natural Science Foundation of China (NNSFC) [31471924]; 973 program earlier research project [2014CB160314]; Ministry of Science and Technology of the People's Republic of China [2011AA10020605]; earmarked fund for Modern Agro-industry Technology Research System [CARS-32]	National Natural Science Foundation of China (NNSFC)(National Natural Science Foundation of China (NSFC)); 973 program earlier research project(National Basic Research Program of China); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); earmarked fund for Modern Agro-industry Technology Research System	The work is financially supported by the National Natural Science Foundation of China (NNSFC) (Grant No. 31471924), the 973 program earlier research project (2014CB160314), the Ministry of Science and Technology of the People's Republic of China (No. 2011AA10020605), and by the earmarked fund for Modern Agro-industry Technology Research System (CARS-32). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benlloch R, 2009, PLANT J, V60, P102, DOI 10.1111/j.1365-313X.2009.03939.x; Brambilla V, 2007, PLANT CELL, V19, P2544, DOI 10.1105/tpc.107.051797; Citovsky V, 2006, J MOL BIOL, V362, P1120, DOI 10.1016/j.jmb.2006.08.017; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; Davies B, 1996, EMBO J, V15, P4330, DOI 10.1002/j.1460-2075.1996.tb00807.x; de Folter S, 2005, PLANT CELL, V17, P1424, DOI 10.1105/tpc.105.031831; Dreni L, 2014, NEW PHYTOL, V201, P717, DOI 10.1111/nph.12555; Elitzur T, 2010, J EXP BOT, V61, P1523, DOI 10.1093/jxb/erq017; Fan HY, 1997, PLANT J, V12, P999, DOI 10.1046/j.1365-313X.1997.12050999.x; Ferrario S, 2006, PLANT PHYSIOL, V140, P890, DOI 10.1104/pp.105.072660; Ferrario S, 2003, PLANT CELL, V15, P914, DOI 10.1105/tpc.010280; Hackbusch J, 2005, P NATL ACAD SCI USA, V102, P4908, DOI 10.1073/pnas.0501181102; Hake S, 2004, ANNU REV CELL DEV BI, V20, P125, DOI 10.1146/annurev.cellbio.20.031803.093824; Hamant O, 2010, CR BIOL, V333, P371, DOI 10.1016/j.crvi.2010.01.015; Inaba A, 2007, J EXP BOT, V58, P1047, DOI 10.1093/jxb/erl265; Ito Y, 2008, PLANT J, V55, P212, DOI 10.1111/j.1365-313X.2008.03491.x; Kaufmann K, 2005, GENE, V347, P183, DOI 10.1016/j.gene.2004.12.014; Kaufmann K, 2009, PLOS BIOL, V7, P854, DOI 10.1371/journal.pbio.1000090; Li EY, 2011, PLANT J, V67, P328, DOI 10.1111/j.1365-313X.2011.04595.x; Liu DM, 2014, PLANT J, V77, P284, DOI 10.1111/tpj.12387; Liu D, 2014, ANN BOT-LONDON, V113, P1219, DOI 10.1093/aob/mcu061; Liu JP, 2002, P NATL ACAD SCI USA, V99, P13302, DOI 10.1073/pnas.162485999; Liu JH, 2013, POSTHARVEST BIOL TEC, V84, P43, DOI 10.1016/j.postharvbio.2013.04.005; Liu JH, 2013, PLANT CELL REP, V32, P129, DOI 10.1007/s00299-012-1347-4; Liu JH, 2009, PLANT CELL REP, V28, P103, DOI 10.1007/s00299-008-0613-y; Liu XJ, 1999, PLANT PHYSIOL, V121, P1257, DOI 10.1104/pp.121.4.1257; MA H, 1991, GENE DEV, V5, P484, DOI 10.1101/gad.5.3.484; Mara CD, 2008, PLANT PHYSIOL, V147, P707, DOI 10.1104/pp.107.115634; Masiero S, 2002, J BIOL CHEM, V277, P26429, DOI 10.1074/jbc.M202546200; Melzer R, 2009, NUCLEIC ACIDS RES, V37, P144, DOI 10.1093/nar/gkn900; Melzer R, 2009, NUCLEIC ACIDS RES, V37, P2723, DOI 10.1093/nar/gkp129; Pagnussat GC, 2007, PLANT CELL, V19, P3578, DOI 10.1105/tpc.107.054890; PNUELI L, 1991, PLANT J, V1, P255, DOI 10.1111/j.1365-313X.1991.00255.x; Seymour GB, 2011, J EXP BOT, V62, P1179, DOI 10.1093/jxb/erq360; Shima Y, 2014, BIOSCI BIOTECH BIOCH, V78, P231, DOI 10.1080/09168451.2014.878221; Smaczniak C, 2012, DEVELOPMENT, V139, P3081, DOI 10.1242/dev.074674; Smaczniak C, 2012, P NATL ACAD SCI USA, V109, P1560, DOI 10.1073/pnas.1112871109; Sridhar VV, 2006, DEVELOPMENT, V133, P3159, DOI 10.1242/dev.02498; Tadiello A, 2009, J EXP BOT, V60, P651, DOI 10.1093/jxb/ern313; Theissen G, 1996, J MOL EVOL, V43, P484, DOI 10.1007/PL00006110; Tonaco IAN, 2006, J EXP BOT, V57, P33, DOI 10.1093/jxb/erj011; Tsaballa A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-46; Vandenbussche M, 2003, PLANT CELL, V15, P2680, DOI 10.1105/tpc.017376; Vrebalov J, 2002, SCIENCE, V296, P343, DOI 10.1126/science.1068181; WAN CY, 1994, ANAL BIOCHEM, V223, P7, DOI 10.1006/abio.1994.1538; Wang S, 2011, PLOS ONE, V6; Wang S, 2007, PLANT J, V50, P858, DOI 10.1111/j.1365-313X.2007.03096.x; Wang SF, 2014, J EXP BOT, V65, P3005, DOI 10.1093/jxb/eru137; Wang YA, 2010, J PLANT PHYSIOL, V167, P989, DOI 10.1016/j.jplph.2009.11.019; Yang ZR, 2014, MOL GENET GENOMICS, V289, P873, DOI 10.1007/s00438-014-0856-y; Yap YK, 2005, PLANT PHYSIOL, V139, P127, DOI 10.1104/pp.105.065656	51	11	22	6	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123870	10.1371/journal.pone.0123870	http://dx.doi.org/10.1371/journal.pone.0123870			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886169	Green Submitted, Green Published, gold			2022-12-26	WOS:000353017000090
J	Song, YX; An, XP; Zhang, L; Fu, MZ; Peng, JY; Han, P; Hou, JX; Zhou, ZQ; Cao, BY				Song, Yuxuan; An, Xiaopeng; Zhang, Lei; Fu, Mingzhe; Peng, Jiayin; Han, Peng; Hou, Jingxing; Zhou, Zhanqin; Cao, Bingyun			Identification and Profiling of microRNAs in Goat Endometrium during Embryo Implantation	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; CAPRA-HIRCUS; EXPRESSION; MIR-449A; TARGET; PROGESTERONE; UTERUS; TRANSCRIPTION; BIOGENESIS; MIR-216A	Background MicroRNAs (miRNAs) are short, highly conserved small noncoding RNAs that had fundamental roles in post-transcriptional gene expression, and they are crucial for proper control of biological processes and known to participate in embryo implantation. However, miRNA expression profiles in the pre-receptive and receptive phases of the goat endometrium during embryo implantation are unknown. Results A total of 1,069 and 847 miRNAs were expressed in receptive (R) and pre-receptive (P) goat endometrium, and 632 miRNAs were co-expressed in both phases. We identified 545 (50.98%) known miRNAs in the R library and 522 (61.63%) in the P library. There were 110 up-expressed miRNAs and 33 down-expressed miRNAs in receptive endometrium compared with the pre-receptive endometrium meeting the criteria of P-values<0.05. Moreover, GO and KEGG analysis of the target genes of the differentially expressed miRNAs revealed some candidate miRNAs, genes and pathways that may involve in the formation of the receptive endometrium. Based on stem-loop RT-qPCR, 15 miRNAs were detected and the results suggested that the majority of the miRNA expression data measured by Solexa deep sequencing could represent actual miRNA expression levels. Conclusions Our data revealed the first miRNA profile related to the biology of the goat receptive endometrium during embryo implantation, and the results suggested that a subset of miRNAs might play important roles in the formation of endometrial receptivity. Thus, elucidating the physiological roles of endometrial miRNAs will help us better understand the genetic control of embryo implantation in goats.	[Song, Yuxuan; An, Xiaopeng; Zhang, Lei; Fu, Mingzhe; Peng, Jiayin; Han, Peng; Hou, Jingxing; Zhou, Zhanqin; Cao, Bingyun] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China	Cao, BY (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China.	binyun_cao@163.com			National Support Program of China [2011BAD28B05-3]; Science and Technology Innovation Project of Shaanxi Province [2011KTCL02-09]	National Support Program of China; Science and Technology Innovation Project of Shaanxi Province	This study was supported by the National Support Program of China (2011BAD28B05-3) and Science and Technology Innovation Project of Shaanxi Province (2011KTCL02-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Caiment F, 2010, GENOME RES, V20, P1651, DOI 10.1101/gr.108787.110; Carletti MZ, 2009, J ANIM SCI, V87, pE29, DOI 10.2527/jas.2008-1331; Chakrabarty A, 2007, P NATL ACAD SCI USA, V104, P15144, DOI 10.1073/pnas.0705917104; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031426; Chen H, 2012, CANCER LETT, V320, P40, DOI 10.1016/j.canlet.2012.01.027; Chen PJ, 2012, HEPATOLOGY, V56, P632, DOI 10.1002/hep.25695; Chen SH, 2014, ONCOL LETT, V7, P568, DOI 10.3892/ol.2013.1737; Chen X, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r78; Chitwood DH, 2007, NAT GENET, V39, P935, DOI 10.1038/ng0807-935; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Dey SK, 1996, REPROD ENDOCRINOLOGY, V1, P421; Egashira Mahiro, 2013, Reproductive Medicine and Biology, V12, P127, DOI 10.1007/s12522-013-0153-1; Estella C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041080; Flores-Jasso CF, 2009, ACTA PHARMACOL SIN, V30, P1177, DOI 10.1038/aps.2009.108; Guo Y, 2013, CELL PHYSIOL BIOCHEM, V32, P581, DOI 10.1159/000354462; Gupta A, 2012, BIOCHEM SOC T, V40, P752, DOI 10.1042/BST20110763; Hackl M, 2011, J BIOTECHNOL, V153, P62, DOI 10.1016/j.jbiotec.2011.02.011; Hao DC, 2012, PHYSIOL PLANTARUM, V146, P388, DOI 10.1111/j.1399-3054.2012.01668.x; Hu JH, 2014, DIGEST DIS SCI, V59, P336, DOI 10.1007/s10620-013-2923-3; Hu SJ, 2008, J BIOL CHEM, V283, P23473, DOI 10.1074/jbc.M800406200; Igwebuike UM, 2009, ANIM REPROD SCI, V112, P1, DOI 10.1016/j.anireprosci.2008.12.010; Ji ZB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049463; Jiao Y, 2014, MAR BIOTECHNOL, V16, P54, DOI 10.1007/s10126-013-9528-x; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kato M, 2010, J BIOL CHEM, V285, P34004, DOI 10.1074/jbc.M110.165027; Khanum SA, 2007, ANIM REPROD SCI, V102, P267, DOI 10.1016/j.anireprosci.2006.11.010; Koler M, 2009, HUM REPROD, V24, P2541, DOI 10.1093/humrep/dep193; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kuokkanen S, 2010, BIOL REPROD, V82, P791, DOI 10.1095/biolreprod.109.081059; Lee H, 2012, MODERN PATHOL, V25, P1508, DOI 10.1038/modpathol.2012.111; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li MZ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015168, 10.1371/journal.pone.0011541]; Li ZM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041658, 10.1371/journal.pone.0053176]; Lian L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051003; Lim HJ, 1999, MOL ENDOCRINOL, V13, P1005, DOI 10.1210/me.13.6.1005; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Ling YH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-339; Lize M, 2010, CELL DEATH DIFFER, V17, P452, DOI 10.1038/cdd.2009.188; Matsumoto H, 2002, DEV BIOL, V245, P280, DOI 10.1006/dbio.2002.0645; Menghini R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.556; Mi X, 2014, COMP BIOCHEM PHYS D, V10, P1, DOI 10.1016/j.cbd.2014.01.001; Munro SK, 2010, MOL HUM REPROD, V16, P297, DOI 10.1093/molehr/gaq010; Noonan EJ, 2009, ONCOGENE, V28, P1714, DOI 10.1038/onc.2009.19; Paik S, 2012, STEM CELLS DEV, V21, P3298, DOI 10.1089/scd.2011.0732; Paria BC, 2002, SCIENCE, V296, P2185, DOI 10.1126/science.1071601; Perrier D'hauterive S, 2002, J Gynecol Obstet Biol Reprod (Paris), V31, P440; Ratner ES, 2010, GYNECOL ONCOL, V118, P251, DOI 10.1016/j.ygyno.2010.05.010; Revel A, 2011, HUM REPROD, V26, P2830, DOI 10.1093/humrep/der255; Su LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087867; Su RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015513; Sun JJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-42; Tranguch S, 2014, INT J DEV BIOL, V58, P79, DOI 10.1387/ijdb.130332st; Ura S, 2009, HEPATOLOGY, V49, P1098, DOI 10.1002/hep.22749; Wang CQF, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0025832, 10.1371/journal.pone.0018907]; Wessels JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072264; Wheeler G, 2006, FEBS LETT, V580, P2195, DOI 10.1016/j.febslet.2006.03.019; Wu D, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00035; Wu WG, 2009, EUR J CANCER PREV, V18, P50, DOI 10.1097/CEJ.0b013e328305a07a; Xia HF, 2014, FEBS J, V281, P1872, DOI 10.1111/febs.12751; Xia HF, 2010, INT J MOL SCI, V11, P719, DOI 10.3390/ijms11020719; Xie SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016235; Yang CX, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.096669; Yang H, 2014, GENE, V536, P308, DOI 10.1016/j.gene.2013.12.006; Yang XJ, 2009, GENE DEV, V23, P2388, DOI 10.1101/gad.1819009; Yuan C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-511; Yun KW, 2014, PEDIATR CARDIOL, V35, P745, DOI 10.1007/s00246-013-0846-6; Zhang BH, 2009, GENE, V443, P100, DOI 10.1016/j.gene.2009.04.027; Zhang CY, 2009, LIVEST SCI, V125, P60, DOI 10.1016/j.livsci.2009.03.002; Zhang XD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-157; Zhang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081076; Zhao YD, 2008, CANCER INFORM, V6, P9	75	35	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0122202	10.1371/journal.pone.0122202	http://dx.doi.org/10.1371/journal.pone.0122202			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886011	Green Published, Green Submitted, gold			2022-12-26	WOS:000353017000029
J	Mirbaha, H; Holmes, BB; Sanders, DW; Bieschke, J; Diamond, MI				Mirbaha, Hilda; Holmes, Brandon B.; Sanders, David W.; Bieschke, Jan; Diamond, Marc I.			Tau Trimers Are the Minimal Propagation Unit Spontaneously Internalized to Seed Intracellular Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; ALZHEIMERS-DISEASE; PROTEIN; OLIGOMERS; TRANSMISSION; TAUOPATHIES; LUCIFERASE; CELLS; PERMEABILIZATION; DEGENERATION	Tau amyloid assemblies propagate aggregation from the outside to the inside of a cell, which may mediate progression of the tauopathies. The critical size of Tau assemblies, or "seeds," responsible for this activity is currently unknown, but this could be important for the design of effective therapies. We studied recombinant Tau repeat domain (RD) and Tau assemblies purified from Alzheimer disease (AD) brain composed largely of full-length Tau. Large RD fibrils were first sonicated to create a range of assembly sizes. We confirmed our ability to resolve stable assemblies ranging from n = 1 to > 100 units of Tau using size exclusion chromatography, fluorescence correlation spectroscopy, cross-linking followed by Western blot, and mass spectrometry. All recombinant Tau assemblies bound heparan sulfate proteoglycans on the cell surface, which are required for Tau uptake and seeding, because they were equivalently sensitive to inhibition by heparin and chlorate. However, cells only internalized RD assemblies of n >= 3 units. We next analyzed Tau assemblies from AD or control brains. AD brains contained aggregated species, whereas normal brains had predominantly monomer, and no evidence of large assemblies. HEK293 cells and primary neurons spontaneously internalized Tau of n >= 3 units from AD brain in a heparin-and chlorate-sensitive manner. Only n >= 3-unit assemblies from AD brain spontaneously seeded intracellular Tau aggregation in HEK293 cells. These results indicate that a clear minimum size (n = 3) of Tau seed exists for spontaneous propagation of Tau aggregation from the outside to the inside of a cell, whereas many larger sizes of soluble aggregates trigger uptake and seeding.	[Mirbaha, Hilda; Holmes, Brandon B.; Sanders, David W.; Diamond, Marc I.] Univ Texas SW Med Ctr Dallas, Ctr Alzheimers & Neurodegenerat Dis, Dallas, TX 75390 USA; [Bieschke, Jan] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Washington University (WUSTL)	Diamond, MI (corresponding author), Univ Texas SW Med Ctr Dallas, Ctr Alzheimers & Neurodegenerat Dis, 6000 Harry Hines Blvd,NL10-120, Dallas, TX 75390 USA.	Marc.Diamond@UTSouthwestern.edu	Regan, Clinton/E-6250-2012; Bieschke, Jan/AAG-2705-2019	Holmes, Brandon/0000-0002-1153-840X; Sanders, David/0000-0002-1835-6895; Bieschke, Jan/0000-0002-3485-9767	National Institutes of Health [P50AG005681, P01AG003991]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS086251, R01NS071835, F31NS079039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG003991, P50AG005681] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Hong Jiang and David Holtzman for providing the Tau monoclonal antibodies utilized in this study, Kenneth M. Pryse for help in performing FCS, David Piwnica-Worms for plasmids, and Paul Seidler for help with the cross-linking procedure. We are grateful to Nigel Cairns, Erin Householder, the technical support of the Betty Martz Laboratory for Neurodegenerative Research, and the Knight Alzheimer's Disease Research Center at Washington University in St. Louis for brain tissue, supported by the following National Institutes of Health grants: P50AG005681 (Knight Alzheimer's Disease Research Center) and P01AG003991 (Healthy Aging and Senile Dementia). We thank Ning Wang, Larisa Belaygorod, Suzanne Schindler, and Sarah Kaufman for recombinant Tau preparation. We thank Suzanne Schindler, Jennifer Furman, Kristen Funk, and Sarah Kaufman for helpful comments on the manuscript.	Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; BELLINGERKAWAHARA CG, 1988, VIROLOGY, V164, P537, DOI 10.1016/0042-6822(88)90569-7; Bugiani O, 1999, J NEUROPATH EXP NEUR, V58, P667, DOI 10.1097/00005072-199906000-00011; Buschmann V, 2003, BIOCONJUGATE CHEM, V14, P195, DOI 10.1021/bc025600x; Chattopadhyay K, 2002, P NATL ACAD SCI USA, V99, P14171, DOI 10.1073/pnas.172524899; Clavaguera F, 2013, BRAIN PATHOL, V23, P342, DOI 10.1111/bpa.12044; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Fadoulogiou VE, 2008, ANAL BIOCHEM, V373, P404, DOI 10.1016/j.ab.2007.10.027; Flach K, 2012, J BIOL CHEM, V287, P43223, DOI 10.1074/jbc.M112.396176; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Frost B, 2009, J BIOL CHEM, V284, P3546, DOI 10.1074/jbc.M805627200; Funke SA, 2007, BIOCHEM BIOPH RES CO, V364, P902, DOI 10.1016/j.bbrc.2007.10.085; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Guo JL, 2014, NAT MED, V20, P130, DOI 10.1038/nm.3457; Hashimoto T, 2011, J BIOL CHEM, V286, P27081, DOI 10.1074/jbc.M111.257378; Haustein E, 2007, ANNU REV BIOPH BIOM, V36, P151, DOI 10.1146/annurev.biophys.36.040306.132612; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Iba M, 2013, J NEUROSCI, V33, P1024, DOI 10.1523/JNEUROSCI.2642-12.2013; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Lasagna-Reeves CA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00700; Lasagna-Reeves CA, 2012, FASEB J, V26, P1946, DOI 10.1096/fj.11-199851; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Patterson KR, 2011, J BIOL CHEM, V286, P23063, DOI 10.1074/jbc.M111.237974; Relini A, 2004, J MOL BIOL, V338, P943, DOI 10.1016/j.jmb.2004.03.054; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; RUBEN GC, 1991, J BIOL CHEM, V266, P22019; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Tian H., 2013, INT J CELL BIOL; Villalobos V, 2010, CHEM BIOL, V17, P1018, DOI 10.1016/j.chembiol.2010.06.018; Wadia JS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003314; WILLE H, 1992, J CELL BIOL, V118, P573, DOI 10.1083/jcb.118.3.573; Wille H, 2009, P NATL ACAD SCI USA, V106, P16990, DOI 10.1073/pnas.0909006106; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528	36	139	142	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					14893	14903		10.1074/jbc.M115.652693	http://dx.doi.org/10.1074/jbc.M115.652693			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25887395	Green Published, hybrid			2022-12-26	WOS:000356177300009
J	Kadimpati, S; Zale, EL; Hooten, MW; Ditre, JW; Warner, DO				Kadimpati, Sandeep; Zale, Emily L.; Hooten, Michael W.; Ditre, Joseph W.; Warner, David O.			Associations between Neuroticism and Depression in Relation to Catastrophizing and Pain-Related Anxiety in Chronic Pain Patients	PLOS ONE			English	Article							FEAR-AVOIDANCE MODEL; OPIOID USE STATUS; LOW-BACK-PAIN; PERSONALITY-TRAITS; TREATMENT OUTCOMES; MAJOR DEPRESSION; ANALGESIC MEDICATION; MUSCULOSKELETAL PAIN; 1ST ONSET; REHABILITATION	Several cognitive-affective constructs, including pain catastrophizing and pain-related anxiety, have been implicated in the onset and progression of chronic pain, and both constructs have been identified as key targets for multidisciplinary pain treatment. Both neuroticism and depression have been linked to these constructs (and to each other), but how each may contribute to the pain experience is unknown. This study tested associations between neuroticism, depression, and indices of catastrophizing and pain-related anxiety among persons seeking treatment for chronic non-malignant pain. We hypothesized, as a higher-order personality trait, neuroticism would remain uniquely associated with both pain catastrophizing and pain-related anxiety, even after accounting for current symptoms of depression. A retrospective study design assessed depression (as measured by the Centers for Epidemiologic Studies-Depression scale), neuroticism (measured with the Neuroticism-Extraversion-Openness Personality Inventory), the Pain Catastrophizing Scale, and the Pain Anxiety Symptom Score in a consecutive series of patients (n=595) admitted to a 3-week outpatient pain treatment program from March 2009 through January 2011. Hierarchical regression indicated that neuroticism was independently associated with greater pain catastrophizing and pain-related anxiety, above-and-beyond the contributions of sociodemographic characteristics, pain severity, and depression. A depression by neuroticism interaction was not observed, suggesting that associations between neuroticism and cognitive-affective pain constructs remained stable across varying levels of current depression. These findings represent an early but important step towards the clarification of complex associations between trait neuroticism, current depression, and tendencies toward catastrophic and anxiety-provoking appraisals of pain among persons seeking treatment for chronic pain.	[Kadimpati, Sandeep; Hooten, Michael W.; Warner, David O.] Mayo Clin, Dept Anesthesiol, Coll Med, Rochester, MN 55905 USA; [Zale, Emily L.; Ditre, Joseph W.] Syracuse Univ, Dept Psychol, Syracuse, NY USA	Mayo Clinic; Syracuse University	Warner, DO (corresponding author), Mayo Clin, Dept Anesthesiol, Coll Med, Rochester, MN 55905 USA.	warner.david@mayo.edu	Zale, Emily L./L-6585-2019					Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Castro M, 2009, ARQ NEURO-PSIQUIAT, V67, P982, DOI 10.1590/S0004-282X2009000600004; Chittka T, 2010, BEHAV RES THER, V48, P7; Costa PT, 1997, J PERS ASSESS, V68, P86, DOI 10.1207/s15327752jpa6801_7; Crisostomo RA, 2008, AM J PHYS MED REHAB, V87, P527, DOI 10.1097/PHM.0b013e31817c124f; Crombez G, 2004, PAIN, V107, P8; Currie SR, 2004, PAIN, V107, P54, DOI 10.1016/j.pain.2003.09.015; Currie SR, 2005, PSYCHOL MED, V35, P1275, DOI 10.1017/S0033291705004952; Cvijetic S, 2013, APPL RES IN QUAL LIF, P1; Evers AWM, 2001, PAIN, V93, P139, DOI 10.1016/S0304-3959(01)00303-7; Geisser ME, 1997, CLIN J PAIN, V13, P163, DOI 10.1097/00002508-199706000-00011; Goubert L, 2004, PAIN, V107, P234, DOI 10.1016/j.pain.2003.11.005; HARKINS SW, 1989, PAIN, V36, P209, DOI 10.1016/0304-3959(89)90025-0; HIRSCHFELD RMA, 1989, ARCH GEN PSYCHIAT, V46, P345; Hooten WM, 2007, PAIN MED, V8, P624, DOI 10.1111/j.1526-4637.2006.00202.x; Hooten WM, 2007, PAIN MED, V8, P8, DOI 10.1111/j.1526-4637.2007.00253.x; Hooten WM, 2009, PAIN MED, V10, P1416, DOI 10.1111/j.1526-4637.2009.00702.x; Hooten WM, 2009, ANESTH ANALG, V108, P308, DOI 10.1213/ane.0b013e31818c7b99; Kendler KS, 2006, ARCH GEN PSYCHIAT, V63, P1113, DOI 10.1001/archpsyc.63.10.1113; Kotov R, 2010, PSYCHOL BULL, V136, P768, DOI 10.1037/a0020327; Krueger RF, 1996, J ABNORM PSYCHOL, V105, P299, DOI 10.1037/0021-843X.105.3.299; Kumari V, 2007, BEHAV NEUROSCI, V121, P643, DOI 10.1037/0735-7044.121.4.643; Leeuw M, 2007, J BEHAV MED, V30, P77, DOI 10.1007/s10865-006-9085-0; Lewis S, 2012, MANUAL THER, V17, P27, DOI 10.1016/j.math.2011.08.001; McCracken Lance M, 2002, Pain Res Manag, V7, P45; MCCRACKEN LM, 1992, PAIN, V50, P67, DOI 10.1016/0304-3959(92)90113-P; McCracken LM, 2000, PAIN RES MANAG, V7, P45; McCrae R.R., 2008, HDB PERSONALITY THEO, P159; McCrae RR, 1997, AM PSYCHOL, V52, P509, DOI 10.1037/0003-066X.52.5.509; MCCRAE RR, 1991, J PERS ASSESS, V57, P399, DOI 10.1207/s15327752jpa5703_2; Muris P, 2007, J ADOLESCENCE, V30, P1035, DOI 10.1016/j.adolescence.2007.03.003; Ohayon MM, 2003, ARCH GEN PSYCHIAT, V60, P39, DOI 10.1001/archpsyc.60.1.39; Osborne TL, 2007, PAIN, V127, P52, DOI 10.1016/j.pain.2006.07.017; Osman A, 1997, J BEHAV MED, V20, P589, DOI 10.1023/A:1025570508954; Ozer DJ, 2006, ANNU REV PSYCHOL, V57, P401, DOI 10.1146/annurev.psych.57.102904.190127; Martinez MP, 2011, J CLIN PSYCHOL MED S, V18, P380, DOI 10.1007/s10880-011-9263-2; Quartana PJ, 2009, EXPERT REV NEUROTHER, V9, P745, DOI 10.1586/ERN.09.34; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ramirez-Maestre C, 2004, J BEHAV MED, V27, P147, DOI 10.1023/B:JOBM.0000019849.21524.70; Richardson EJ, 2009, PAIN, V147, P147, DOI 10.1016/j.pain.2009.08.030; Rome JD, 2004, MAYO CLIN PROC, V79, P759; Rudy TE, 2009, MULTIAXIAL ASSESSMEN; Smarr KL, 2011, ARTHRIT CARE RES, V63, pS454, DOI 10.1002/acr.20556; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Swinkels-Meewisse IEJ, 2006, PAIN, V120, P36, DOI 10.1016/j.pain.2005.10.005; Tennant F, 2000, WESTERN J MED, V173, P306, DOI 10.1136/ewjm.173.5.306; Tennen H, 2006, HEALTH PSYCHOL, V25, P370, DOI 10.1037/0278-6133.25.3.370; Torelli P, 2006, NEUROL SCI, V27, pS73, DOI 10.1007/s10072-006-0574-2; Townsend CO, 2008, PAIN, V140, P177, DOI 10.1016/j.pain.2008.08.005; TURK DC, 1994, BEHAV RES THER, V32, P9, DOI 10.1016/0005-7967(94)90078-7; Turner JA, 2002, PAIN, V98, P127, DOI 10.1016/S0304-3959(02)00045-3; Van Damme S, 2002, PAIN, V96, P319, DOI 10.1016/S0304-3959(01)00463-8; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; WEISSMAN MM, 1977, AM J EPIDEMIOL, V106, P203, DOI 10.1093/oxfordjournals.aje.a112455; Xu JS, 2012, NEUROIMAGE, V59, P800, DOI 10.1016/j.neuroimage.2011.07.040	55	34	38	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0126351	10.1371/journal.pone.0126351	http://dx.doi.org/10.1371/journal.pone.0126351			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG5KV	25902153	Green Submitted, Green Published, gold			2022-12-26	WOS:000353331500122
J	Liu, YZ; Qiu, XM; Zhang, X; Yu, TX				Liu, Yuzhe; Qiu, Xinming; Zhang, Xiong; Yu, T. X.			Response of Woodpecker's Head during Pecking Process Simulated by Material Point Method	PLOS ONE			English	Article							BRAIN-INJURY; MECHANICAL-PROPERTIES; ALUMINUM FOAM; IMPACT	Prevention of brain injury in woodpeckers under high deceleration during the pecking process has been an intriguing biomechanical problem for a long time. Several studies have provided different explanations, but the function of the hyoid bone, one of the more interesting skeletal features of a woodpecker, still has not been fully explored. This paper studies the relationship between a woodpecker head's response to impact and the hyoid bone. Based on micro-CT scanning images, the material point method (MPM) is employed to simulate woodpecker's pecking process. The maximum shear stress in the brainstem (SSS) is adopted as an indicator of brain injury. The motion and deformation of the first cervical vertebra is found to be the main reason of the shear stress of the brain. Our study found that the existence of the hyoid bone reduces the SSS level, enhances the rigidity of the head, and suppresses the oscillation of the endoskeleton after impact. The mechanism is explained by a brief mechanical analysis while the influence of the material properties of the muscle is also discussed.	[Liu, Yuzhe; Qiu, Xinming; Zhang, Xiong] Tsinghua Univ, Dept Engn Mech, Beijing 100084, Peoples R China; [Yu, T. X.] Hong Kong Univ Sci & Technol, Dept Mech & Aerosp Engn, Kowloon, Hong Kong, Peoples R China; [Yu, T. X.] Ningbo Univ, Ningbo 315211, Zhejiang, Peoples R China	Tsinghua University; Hong Kong University of Science & Technology; Ningbo University	Qiu, XM (corresponding author), Tsinghua Univ, Dept Engn Mech, Beijing 100084, Peoples R China.	qxm@tsinghua.edu.cn	Zhang, Xiong/B-6733-2012	Zhang, Xiong/0000-0001-9905-281X; Qiu, Xinming/0000-0003-2187-6696	National Natural Science Foundation of China [11372163]; National Fundamental Research Program of China [2010CB832701, 2011CB610305]; NSFC [11032001]; Directorate For Geosciences [1258878] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Fundamental Research Program of China; NSFC(National Natural Science Foundation of China (NSFC)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The authors gratefully acknowledge the support from the National Natural Science Foundation of China No. 11372163, the National Fundamental Research Program of China through Grant No. 2010CB832701 and 2011CB610305. The 4th author (T.X. Yu) thanks the support from the NSFC Key Project No. 11032001.	BOCK WJ, 1964, J MORPHOL, V114, P1, DOI 10.1002/jmor.1051140102; Bock WJ, 1999, OSTRICH, V70, P23, DOI 10.1080/00306525.1999.9639746; BOCK WJ, 1966, AUK, V83, P10, DOI 10.2307/4082976; Gadd C.W, 1966, USE WEIGHTED IMPULSE; Gibson LJ, 2006, J ZOOL, V270, P462, DOI 10.1111/j.1469-7998.2006.00166.x; Gong WW, 2012, CMES-COMP MODEL ENG, V83, P527; Gong WW, 2011, CMES-COMP MODEL ENG, V82, P195; HILL AV, 1953, PROC R SOC SER B-BIO, V141, P104, DOI 10.1098/rspb.1953.0027; Hirschman A., 1976, LANCET, V307, P454, DOI [10.1016/s0140-6736(76)91477-x, DOI 10.1016/S0140-6736(76)91477-X]; Hutchinson J, 1998, APPL MATH COMPUT, V96, P1, DOI 10.1016/S0096-3003(97)10106-0; Lee N, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0274; LISSNER HR, 1960, SURG GYNECOL OBSTET, V111, P329; Ma S, 2009, CMES-COMP MODEL ENG, V39, P101; Ma ZT, 2010, CMES-COMP MODEL ENG, V55, P61; MAY PRA, 1979, ARCH NEUROL-CHICAGO, V36, P370, DOI 10.1001/archneur.1979.00500420080011; Newman JA., 2000, STAPP CAR CRASH J, V44, P215, DOI DOI 10.4271/2000-01-SC16; Oda J, 2006, JSME INT J A-SOLID M, V49, P390, DOI 10.1299/jsmea.49.390; Pan XF, 2008, COMMUN THEOR PHYS, V49, P1129, DOI 10.1088/0253-6102/49/5/09; Shang M, 2006, EXPLOSION SHOCK WAVE, V3; SULSKY D, 1994, COMPUT METHOD APPL M, V118, P179, DOI 10.1016/0045-7825(94)00033-6; SULSKY D, 1995, COMPUT PHYS COMMUN, V87, P236, DOI 10.1016/0010-4655(94)00170-7; Versace J, 1971, REV SEVERITY INDEX; Wang LZ, 2011, SCI CHINA LIFE SCI, V54, P1036, DOI 10.1007/s11427-011-4242-2; Wang LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026490; Whittaker E. T., 1952, ANAL DYNAMICS PARTIC; Wu JS, 2000, J APPL POLYM SCI, V76, P1000, DOI 10.1002/(SICI)1097-4628(20000516)76:7<1000::AID-APP3>3.0.CO;2-X; Yoon SH, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/1/016003; Yoon SH, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/3/035501; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhou P, 2009, J BIONIC ENG, V6, P214, DOI 10.1016/S1672-6529(08)60126-2; Zhou S, 2013, INT J COMPUTATIONAL, V10; Zhu ZD, 2012, AIP ADV, V2, DOI 10.1063/1.4770305; Zhu ZD, 2014, J BIONIC ENG, V11, P282, DOI 10.1016/S1672-6529(14)60045-7	33	17	21	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0122677	10.1371/journal.pone.0122677	http://dx.doi.org/10.1371/journal.pone.0122677			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902356	Green Published, Green Submitted, gold			2022-12-26	WOS:000353331500027
J	Mesfin, F; Berhane, Y; Worku, A				Mesfin, Firehiwot; Berhane, Yemane; Worku, Alemayehu			Anemia among Primary School Children in Eastern Ethiopia	PLOS ONE			English	Article							PARASITIC INFECTIONS; RISK-FACTORS; SCHOOLCHILDREN; MALNUTRITION; EDUCATION; HEALTH	Background Anemia during childhood impairs physical growth, cognitive development and school performance. Identifying the causes of anemia in specific contexts can help efforts to prevent negative consequences of anemia among children. The objective of this study was to assess prevalence and identify correlates of anemia among school children in Eastern Ethiopia. Methods A cross sectional study was conducted from January 2012 to February 2012 in Kersa, Eastern Ethiopia. The study included randomly selected primary school students. Hemoglobin concentration was measured using a Hemocue haemoglobinometer. A child was identified as anemic if the hemoglobin concentration was < 11.5 g/dl for children (5-11 yrs) and < 12 g/dl for child older than 12 years age. Poisson regression model with robust variance was used to calculate prevalence ratios. Result The overall prevalence of anemia was 27.1% (95% CI: 24.98, 29.14): 13.8% had mild, 10.8% moderate, and 2.3% severe anemia. Children with in the age group of 5-9 years (APR, 1.083; 95% CI, 1.044-1.124) were at higher risk for anemia. Paternal education (Illiterate, 1.109; 1.044 -1.178) was positively associated with anemia. Children who had irregular legume consumption (APR, 1.069; 95% CI, 1.022 -1.118) were at higher risk for anemia. Conclusion About a quarter of school children suffer from anemia and their educational potential is likely to be affected especially for those with moderate and severe anemia. Child age, irregular legume consumption, and low paternal schooling were associated with anemia. Intervention programmes aimed to reduce anemia among school children are crucial to ensure proper growth and development of children.	[Mesfin, Firehiwot] Haramaya Univ, Coll Hlth & Med Sci, Harar, Ethiopia; [Berhane, Yemane; Worku, Alemayehu] Addis Continental Inst Publ Hlth, Addis Ababa, Ethiopia; [Worku, Alemayehu] Univ Addis Ababa, Sch Publ Hlth, Addis Ababa, Ethiopia	Haramaya University; Addis Continental Institute of Public Health; Addis Ababa University	Mesfin, F (corresponding author), Haramaya Univ, Coll Hlth & Med Sci, Harar, Ethiopia.	mfirehiwotm@gmail.com	Berhane, Yemane/ABB-8154-2020	Berhane, Yemane/0000-0002-2527-1339	Haramaya University	Haramaya University	This study was financially supported by grants from Haramaya University of PhD program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeredolu I. A., 2011, Food and Nutrition Sciences, V2, P1063, DOI 10.4236/fns.2011.210142; Amare B, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-108; Amare B, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-752; [Anonymous], 2001, WHO TECHN REP SER; [Anonymous], 2008, WORLDW PREV AN 1993; Ashton R, 2009, SCH BASED SURVEYS MA, DOI [10.1186/1475-2875-10-25, DOI 10.1186/1475-2875-10-25]; Assefa Selomon, 2014, BMC Hematol, V14, P3, DOI 10.1186/2052-1839-14-3; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Barugahara EI, 2013, AFRICAN J FOOD AGR N, V13; Barugahara El, 2013, AFRICAN J FOOD AGR N, V13, P3; Belachew T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057643; Bobonis G, 2004, J HUM RESOURCES; Bundy Donald, 2005, Food and Nutrition Bulletin, V26, pS186; Children's Hospital & Research Center Oakland, 2012, NOV IR SOURC NEWL ID; Choi HJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-870; Coutinho LMS, 2008, REV SAUDE PUBL, V42; Djokic D, 2010, HIPPOKRATIA, V14, P252; EDHS, 2011, ETH DEM HLTH SURV 20; El Hioui M, 2008, East Afr J Public Health, V5, P62; Gari MA, 2008, MED SCI, V15, P63; Government of Federal Democratic Republic of Ethiopia, 2013, NAT NUTR PROGR; Haidar J, 2010, J HEALTH POPUL NUTR, V28, P359; Hall A, 2008, TROP MED INT HEALTH, V13, P1518, DOI 10.1111/j.1365-3156.2008.02168.x; Koukounari A, 2008, INT J PARASITOL, V38, P1663, DOI 10.1016/j.ijpara.2008.05.013; Liao X, 2013, STRUCTURE FUNCTION N, DOI [10.1080/10408398.2011.635914, DOI 10.1080/10408398.2011.635914]; Mahmud MA, 2013, PATHOG GLOB HEALTH, V107, P58, DOI 10.1179/2047773213Y.0000000074; Mekasha Amha, 2009, Ethiop Med J, V47, P129; Ministry of Education, 2012, SCH HLTH NUTR STRAT; Muhammad Ramzan, 2009, Pakistan Journal of Nutrition, V8, P259, DOI 10.3923/pjn.2009.259.263; Mulugeta A, 2010, J FEDERATION AM SOC; Onimawo I, 2010, ASSESSMENT ANAEMIA I; Prema A., 2011, INT J NUTR PHARM NEU, V1, P184, DOI [10.4103/2231-0738.84212, DOI 10.4103/2231-0738.84212]; Reji P, 2011, AFR J PRIM HEALTH CA, V3, DOI 10.4102/phcfm.v3i1.198; Semba RD, 2008, LANCET, V371, P322, DOI 10.1016/S0140-6736(08)60169-5; Tatala S R, 2008, Tanzan J Health Res, V10, P189; Tengco LW, 2008, J AM COLL NUTR, V27, P229, DOI 10.1080/07315724.2008.10719695; Theil EC, 2004, ANNU REV NUTR, V24, P327, DOI 10.1146/annurev.nutr.24.012003.132212; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Villanova PA, 1994, REFERENCE SELECTED P; VONSCHENCK H, 1986, CLIN CHEM, V32, P526; Webb P., 2003, NUTR KNOWLEDGE PAREN; WHO, 2011, WHONMHNHDMNM111; Zhao GH, 2010, BBA-GEN SUBJECTS, V1800, P815, DOI 10.1016/j.bbagen.2010.01.009	43	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123615	10.1371/journal.pone.0123615	http://dx.doi.org/10.1371/journal.pone.0123615			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902055	Green Submitted, Green Published, gold			2022-12-26	WOS:000353331500057
J	Mytnik-Ejsmont, J; Szlachetko, DL; Baranow, P; Jolliffe, K; Gorniak, M				Mytnik-Ejsmont, Joanna; Szlachetko, Dariusz L.; Baranow, Przemyslaw; Jolliffe, Kevin; Gorniak, Marcin			Phylogenetic Placement and Taxonomy of the Genus Hederorkis (Orchidaceae)	PLOS ONE			English	Article							MOLECULAR PHYLOGENETICS; SEQUENCE ALIGNMENT; DNA-SEQUENCES; TORTOISE; TOOLS	Three plastid regions, matK, rpl32-trnL and rpl16 intron and the ITS1-5.8S-ITS2 nuclear ribosomal DNA were used to demonstrate a phylogenetic placement of the genus Hederorkis (Orchidaceae) for the first time. The taxonomic position of this genus has been unclear thus far. The phylogenetic and morphological relations of Hederorkis to the most closely related genera Sirhookera, Adrorhizon, Bromheadia and Polystachya are also discussed. A hypothesis concerning an origin and evolution of Hederorkis is proposed. Hederorkis is an epiphytic two-leaved orchid genus with lateral inflorescence, non-resupinate flowers, elongate gynostemium and rudimentary column foot. It is native to the Indian Ocean Islands. Two species of Hederorkis are recognized worldwide, H. scandens endemic to Mauritius and Reunion and H. seychellensis endemic to Seychelles. For each of the species treated a full synonymy, detailed description and illustration are included. The distribution map and dichotomous keys to the species have also been provided.	[Mytnik-Ejsmont, Joanna; Szlachetko, Dariusz L.; Baranow, Przemyslaw] Univ Gdansk, Dept Plant Taxon & Nat Conservat, PL-80308 Gdansk, Poland; [Jolliffe, Kevin] Conservat Dept, Cousine Isl, Seychelles; [Gorniak, Marcin] Univ Gdansk, Dept Mol Evolut, PL-80308 Gdansk, Poland	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; University of Gdansk	Mytnik-Ejsmont, J (corresponding author), Univ Gdansk, Dept Plant Taxon & Nat Conservat, Wita Stwosza 59, PL-80308 Gdansk, Poland.	dokjom@univ.gda.pl	Górniak, Marcin/HGB-0473-2022; Baranow, Przemyslaw/G-3416-2013	Górniak, Marcin/0000-0002-7568-7818; Baranow, Przemyslaw/0000-0003-1907-7211; Mytnik, Joanna/0000-0003-4921-4950	Ministry of Science and Higher Education of Poland [N N303 343735, N N303 812440]; Seychelles Bureau of Standards [A0347]	Ministry of Science and Higher Education of Poland(Ministry of Science and Higher Education, Poland); Seychelles Bureau of Standards	1. N N303 343735, grant from the Ministry of Science and Higher Education of Poland, www.nauka.gov.pl. JME received the funding. 2. N N303 812440, grant from the Ministry of Science and Higher Education of Poland, www.nauka.gov.pl. DLS received the funding. 3. Grant from the Seychelles Bureau of Standards (A0347).	BOSSER J, 1976, Adansonia, V16, P225; Burns-Balogh P., 1986, SMITHSON CONTRIB BOT, P1, DOI [10.5479/SI.0081024X.61, DOI 10.5479/SI.0081024X.61]; Carnevali G, 2013, SYST BOT, V38, P46, DOI 10.1600/036364413X661926; Chase M.W., 2003, ORCHID CONSERV, P69; CHASE MW, 1991, TAXON, V40, P215, DOI 10.2307/1222975; Cribb PJ, 2014, GENERA ORCHIDACEAR 3, V6; Cuenoud P, 2002, AM J BOT, V89, P132, DOI 10.3732/ajb.89.1.132; Douzery EJP, 1999, AM J BOT, V86, P887, DOI 10.2307/2656709; Dressler R.L., 1990, ORCHIDS NATURAL HIST; Dressler R.L., 1981, ORCHIDS NATURAL HIST; Dressler RL, 1993, PHYLOGENY CLASSIFICA; du Petit Thouars A, 1809, NOUVEAU B SCI PUBLIE, V1, P314; du Petit Thouars A, 1822, HIST PARTICULIERE PL; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Freudenstein JV, 2004, AM J BOT, V91, P149, DOI 10.3732/ajb.91.1.149; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gerlach J, 1997, SEYCHELLES RED DATA; Gorniak M, 2010, MOL PHYLOGENET EVOL, V56, P784, DOI 10.1016/j.ympev.2010.03.003; HUNT P F, 1968, Kew Bulletin, V22, P489, DOI 10.2307/4108359; MOLVRAY M, 2000, MONOCOTS SYSTEMATICS, P441, DOI DOI 10.1002/ECE3.752; Mytnik-Ejsmont J, 2011, BIODIV RES CONSERV, V23, P17; Pridgeon Alec M., 1997, Lindleyana, V12, P89; RASMUSSEN FN, 1979, BOT NOTISER, V132, P385; Robertson SA., 1989, FLOWERING PLANTS SEY; SCHLECTER R., 1926, NOTIZBL BOT GART U MUS BERLIN DAHLEM, V9, P563, DOI 10.2307/3994326; Senghas K, 1990, ORCHIDEEN; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; SUN Y, 1994, THEOR APPL GENET, V89, P26, DOI 10.1007/BF00226978; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Szlachetko D. L., 1995, FRAGMENTA FLORISTICA, V3, P1; Thiers B., 2022, INDEX HERBARIORUM GL; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Whitten WM, 2000, AM J BOT, V87, P1842, DOI 10.2307/2656837; Wise R, 1998, FRAGILE EDEN PORTRAI	36	3	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0122306	10.1371/journal.pone.0122306	http://dx.doi.org/10.1371/journal.pone.0122306			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902058	gold, Green Published, Green Submitted			2022-12-26	WOS:000353331500017
J	He, Q; Ma, ZG; Dang, XQ; Xu, JS; Zhou, ZY				He, Qiang; Ma, Zhenggang; Dang, Xiaoqun; Xu, Jinshan; Zhou, Zeyang			Identification, Diversity and Evolution of MITEs in the Genomes of Microsporidian Nosema Parasites	PLOS ONE			English	Article							REPEAT TRANSPOSABLE ELEMENTS; DOMESTICATED SILKWORM; GENE; FAMILY; SEQUENCE; TRANSPOSITION; AMPLIFICATION; STOWAWAY; REVEAL; RICE	Miniature inverted-repeat transposable elements (MITEs) are short, non-autonomous DNA transposons, which are widespread in most eukaryotic genomes. However, genome-wide identification, origin and evolution of MITEs remain largely obscure in microsporidia. In this study, we investigated structural features for de novo identification of MITEs in genomes of silkworm microsporidia Nosema bombycis and Nosema antheraeae, as well as a honeybee microsporidia Nosema ceranae. A total of 1490, 149 and 83 MITE-related sequences from 89, 17 and five families, respectively, were found in the genomes of the above-mentioned species. Species-specific MITEs are predominant in each genome of microsporidian Nosema, with the exception of three MITE families that were shared by N. bombycis and N. antheraeae. One or multiple rounds of amplification occurred for MITEs in N. bombycis after divergence between N. bombycis and the other two species, suggesting that the more abundant families in N. bombycis could be attributed to the recent amplification of new MITEs. Significantly, some MITEs that inserted into the homologous protein-coding region of N. bombycis were recruited as introns, indicating that gene expansion occurred during the evolution of microsporidia. NbS31and NbS24had polymorphisms in different geographical strains of N. bombycis, indicating that they could still be active. In addition, several small RNAs in the MITEs in N. bombycis are mainly produced from both ends of the MITEs sequence.	[He, Qiang; Ma, Zhenggang; Dang, Xiaoqun; Xu, Jinshan; Zhou, Zeyang] Chongqing Normal Univ, Coll Life Sci, Chongqing, Peoples R China; [Zhou, Zeyang] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China	Chongqing Normal University; Southwest University - China	Xu, JS (corresponding author), Chongqing Normal Univ, Coll Life Sci, Chongqing, Peoples R China.	xujinshan2003@aliyun.com	He, Qiang/AAP-5896-2021		National High-tech R&D Program (863 Program) [2013AA102507]; National Natural Science Foundation of China [31001037]; Natural Science Foundation Project of Chongqing Science&technology Commission [cstc2012jjA80006, cstc2014jcyjA80039]; Key Project of Ministry of Education of China [210180]; Science and Technology Project of Chongqing Municipal Education Commission [KJ110611, KJ10627, KJ090813]	National High-tech R&D Program (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of Chongqing Science&technology Commission; Key Project of Ministry of Education of China(Ministry of Education, China); Science and Technology Project of Chongqing Municipal Education Commission	This study is supported by National High-tech R&D Program (863 Program, No. 2013AA102507), National Natural Science Foundation of China (No. 31001037), Natural Science Foundation Project of Chongqing Science&technology Commission (No. cstc2012jjA80006 and No. cstc2014jcyjA80039), Key Project of Ministry of Education of China (No. 210180), Science and Technology Project of Chongqing Municipal Education Commission (No. KJ110611, KJ10627 and KJ090813). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUREAU TE, 1992, PLANT CELL, V4, P1283, DOI 10.1105/tpc.4.10.1283; Cai YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036599; Campbell SE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003676; Chen YP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-451; Cornman RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000466; Corradi N, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r106; Cuomo CA, 2012, GENOME RES, V22, P2478, DOI 10.1101/gr.142802.112; DESPORTES I, 1985, J PROTOZOOL, V32, P250; Dong HT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-135; Dufresne M, 2007, GENETICS, V175, P441, DOI 10.1534/genetics.106.064360; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; El Amrani A, 2002, MOL GENET GENOMICS, V267, P459, DOI 10.1007/s00438-002-0675-4; Fattash I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064135; Feschotte C, 2002, NAT REV GENET, V3, P329, DOI 10.1038/nrg793; Guo XZ, 2014, SCI REP-UK, V4, DOI 10.1038/srep05119; Han MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-520; Han YJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq862; Heinz E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002979; Higes M, 2006, J INVERTEBR PATHOL, V92, P93, DOI 10.1016/j.jip.2006.02.005; Jiang N, 2003, NATURE, V421, P163, DOI 10.1038/nature01214; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Kuang HH, 2009, GENOME RES, V19, P42, DOI [10.1101/gr.07816.108, 10.1101/gr.078196.108]; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Liu HD, 2013, PARASITOL RES, V112, P1011, DOI 10.1007/s00436-012-3223-0; Lu C, 2012, MOL BIOL EVOL, V29, P1005, DOI 10.1093/molbev/msr282; Lyons M, 2008, MOL GENET GENOMICS, V280, P275, DOI 10.1007/s00438-008-0363-0; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Miskey C, 2007, MOL CELL BIOL, V27, P4589, DOI 10.1128/MCB.02027-06; Momose M, 2010, GENETICS, V186, P59, DOI 10.1534/genetics.110.117606; Naito K, 2006, P NATL ACAD SCI USA, V103, P17620, DOI 10.1073/pnas.0605421103; Naito K, 2009, NATURE, V461, P1130, DOI 10.1038/nature08479; Ngezahayo F, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-91; Oki N, 2008, GENES GENETIC SYSTEM, V83; Pan GQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-186; Peyretaillade E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2156; Sampath P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094499; Sampath P, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-56; Santiago N, 2002, MOL BIOL EVOL, V19, P2285, DOI 10.1093/oxfordjournals.molbev.a004052; Snowden KF, 2004, WORLD CL PARASITES, V9, P123; Sun W, 2014, MOL BIOL EVOL, V31, P3302, DOI 10.1093/molbev/msu261; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tu ZJ, 2001, P NATL ACAD SCI USA, V98, P1699, DOI 10.1073/pnas.041593198; Williams BAP, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-200; Xu JS, 2006, INT J PARASITOL, V36, P1049, DOI [10.1016/j.ijpara.2006.04.010, 10.1016/j.ijpara.2006.09.010]; Xu JS, 2010, AFR J BIOTECHNOL, V9, P7900; Yaakov B, 2012, THEOR APPL GENET, V124, P1365, DOI 10.1007/s00122-012-1793-y; Yang GJ, 2005, PLANT CELL, V17, P1559, DOI 10.1105/tpc.104.030528; Yang GJ, 2009, SCIENCE, V325, P1391, DOI 10.1126/science.1175688	50	6	8	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123170	10.1371/journal.pone.0123170	http://dx.doi.org/10.1371/journal.pone.0123170			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898273	gold, Green Published, Green Submitted			2022-12-26	WOS:000353212600020
J	Henriksen, DP; Pottegard, A; Laursen, CB; Jensen, TG; Hallas, J; Pedersen, C; Lassen, AT				Henriksen, Daniel Pilsgaard; Pottegard, Anton; Laursen, Christian B.; Jensen, Thoger Gorm; Hallas, Jesper; Pedersen, Court; Lassen, Annmarie Touborg			Risk Factors for Hospitalization Due to Community-Acquired Sepsis - A Population-Based Case-Control Study	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT VISITS; UNITED-STATES; EPIDEMIOLOGY; INFECTION; HEALTH; COMORBIDITY; DISPARITIES; MORTALITY; OUTCOMES; THERAPY	Background The aim of the study was to estimate risk factors for hospitalization due to sepsis and to determine whether these risk factors vary by age and gender. Methods We performed a population-based case-control study of all adult patients admitted to a medical ED from September 2010 to August 2011. Controls were sampled within the hospital catchment-area. All potential cases were manually validated using a structured protocol. Vital signs and laboratory values measured at arrival were registered to define systemic inflammatory response syndrome and organ dysfunction. Multivariable logistic regression was used to elucidate which predefined risk factors were associated with an increased or decreased risk hospitalization due to sepsis. Results A total of 1713 patients were admitted with sepsis of any severity. The median age was 72 years (interquartile range: 57-81 years) and 793 (46.3%) were male. 621 (36.3%) patients were admitted with sepsis, 1071 (62.5%) with severe sepsis and 21 (1.2%) with septic shock. Episodes with sepsis of any severity were associated with older age (85+ years adjusted OR 6.02 [95% CI: 5.09-7.12]), immunosuppression (4.41 [3.83-5.09]), alcoholism-related conditions (2.90 [2.41-3.50]), and certain comorbidities: psychotic disorder (1.90 [1.58-2.27]), neurological (1.98 [1.73-2.26]), respiratory (3.58 [3.16-4.06]), cardiovascular (1.62 [1.41-1.85]), diabetes (1.82 [1.57-2.12]), cancer (1.44 [1.22-1.68]), gastrointestinal (1.71 [1.44-2.05]) and renal (1.46 [1.13-1.89]). The strength of the observed associations for comorbid factors was strongest among younger individuals. Conclusions Hospitalization due to sepsis of any severity was associated with several independent risk factors, including age and comorbid factors.	[Henriksen, Daniel Pilsgaard; Lassen, Annmarie Touborg] Odense Univ Hosp, Dept Emergency Med, DK-5000 Odense C, Denmark; [Pottegard, Anton; Hallas, Jesper] Univ Southern Denmark, Dept Publ Hlth, Clin Pharmacol, DK-5000 Odense C, Denmark; [Laursen, Christian B.] Odense Univ Hosp, Dept Resp Med, DK-5000 Odense C, Denmark; [Jensen, Thoger Gorm] Odense Univ Hosp, Dept Clin Microbiol, DK-5000 Odense C, Denmark; [Hallas, Jesper] Odense Univ Hosp, Dept Clin Chem & Pharmacol, DK-5000 Odense C, Denmark; [Pedersen, Court] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense C, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital	Henriksen, DP (corresponding author), Odense Univ Hosp, Dept Emergency Med, DK-5000 Odense C, Denmark.	dphenriksen@health.sdu.dk	Lassen, Annmarie/AAA-5816-2019	Pottegard, Anton/0000-0001-9314-5679; Jensen, Thoger Gorm/0000-0002-3889-0016; Lassen, Annmarie/0000-0003-4942-6152; Laursen, Christian Borbjerg/0000-0001-6382-9906; Henriksen, Daniel Pilsgaard/0000-0003-1303-6195	Faculty of Health Sciences, Odense University Hospital; Research Foundation of Odense University Hospital, University of Southern Denmark; private philanthropic fund TrygFonden	Faculty of Health Sciences, Odense University Hospital; Research Foundation of Odense University Hospital, University of Southern Denmark; private philanthropic fund TrygFonden	The study was supported by a stipend for PhD students from the Faculty of Health Sciences, Odense University Hospital, as well as a stipend from the Research Foundation of Odense University Hospital, University of Southern Denmark. ATL received an unrestricted grant from the private philanthropic fund TrygFonden given to the University of Southern Denmark.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P241; Esper AM, 2006, CRIT CARE MED, V34, P2576, DOI 10.1097/01.CCM.0000239114.50519.0E; Fielding JE, 1999, ANNU REV PUBL HEALTH, V20, pXIII, DOI 10.1146/annurev.publhealth.20.1.0; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; Ginde AA, 2013, J CRIT CARE, V28, P606, DOI 10.1016/j.jcrc.2013.03.018; Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562; Hallas J, 2001, PHARMACOEPIDEM DR S, V10, P619, DOI 10.1002/pds.638; Harrington R D, 2000, J Gend Specif Med, V3, P27; Henriksen DP, 2015, CRIT CARE MED, V43, P13, DOI 10.1097/CCM.0000000000000611; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Martin GS, 2006, CRIT CARE MED, V34, P15, DOI 10.1097/01.CCM.0000194535.82812.BA; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mayr FB, 2010, JAMA-J AM MED ASSOC, V303, P2495, DOI 10.1001/jama.2010.851; Moss M, 2005, CLIN INFECT DIS, V41, pS490, DOI 10.1086/432003; O'Brien JM, 2007, CRIT CARE MED, V35, P345, DOI 10.1097/01.CCM.0000254340.91644.B2; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Poutsiaka DD, 2009, SCAND J INFECT DIS, V41, P469, DOI 10.1080/00365540902962756; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Seymour CW, 2010, CHEST, V137, P1289, DOI 10.1378/chest.09-2661; Soto GJ, 2013, CRIT CARE MED, V41, P2784, DOI 10.1097/CCM.0b013e3182a84a43; Storgaard M, 2013, SCAND J INFECT DIS, V45, P577, DOI 10.3109/00365548.2013.786836; Strehlow MC, 2006, ANN EMERG MED, V48, P326, DOI 10.1016/j.annemergmed.2006.05.003; Sundararajan V, 2005, CRIT CARE MED, V33, P71, DOI 10.1097/01.CCM.0000150027.98160.80; Thomsen RW, 2011, RESP MED, V105, P1063, DOI 10.1016/j.rmed.2011.01.012; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; Trifiro G, 2010, ANN INTERN MED, V152, P418, DOI 10.7326/0003-4819-152-7-201004060-00006; Wang HE, 2007, CRIT CARE MED, V35, P1928, DOI 10.1097/01.CCM.0000277043.85378.C1; Wang HE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048307; Wang HE, 2011, AM J NEPHROL, V34, P330, DOI 10.1159/000330673	36	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124838	10.1371/journal.pone.0124838	http://dx.doi.org/10.1371/journal.pone.0124838			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898024	Green Published, gold			2022-12-26	WOS:000353212600089
J	Sakamoto, A; Terui, Y; Yoshida, T; Yamamoto, T; Suzuki, H; Yamamoto, K; Ishihama, A; Igarashi, K; Kashiwagi, K				Sakamoto, Akihiko; Terui, Yusuke; Yoshida, Taketo; Yamamoto, Taku; Suzuki, Hideyuki; Yamamoto, Kaneyoshi; Ishihama, Akira; Igarashi, Kazuei; Kashiwagi, Keiko			Three Members of Polyamine Modulon under Oxidative Stress Conditions: Two Transcription Factors (SoxR and EmrR) and a Glutathione Synthetic Enzyme (GshA)	PLOS ONE			English	Article							SUPEROXIDE RESPONSE REGULON; ESCHERICHIA-COLI; CELL VIABILITY; MOLECULAR-MECHANISMS; PROTEIN-SYNTHESIS; RNA-POLYMERASE; GENES; STIMULATION; EXPRESSION; GROWTH	Members of polyamine modulon whose synthesis is enhanced at the level of translation were looked for under oxidative stress conditions caused by 0.6 mu M K2TeO3. When an Escherichia coli polyamine-requiring mutant MA261 was cultured in the presence of K2TeO3, the degree of polyamine stimulation of cell growth was greater than in cells cultured in the absence of K2TeO3. Under these conditions, synthesis of SoxR, a transcriptional factor for expression of the superoxide response regulon, EmrR, a negative transcriptional factor for expression of the genes for drug excretion proteins, EmrA and EmrB, and of GshA, gamma-glutamylcysteine synthetase necessary for glutathione (GSH) synthesis, were stimulated by polyamines at the level of translation. Polyamine stimulation of SoxR and EmrR synthesis was dependent on the existence of an unusually located Shine-Dalgarno (SD) sequence in soxR and emrR mRNAs. Polyamine stimulation of GshA synthesis was due to the existence of the inefficient initiation codon UUG instead of AUG. Polyamine stimulation of the synthesis of EmrR was mainly observed at the logarithmic phase of growth, while that of the synthesis of SoxR and GshA was at the stationary phase. These results strongly suggest that polyamines are involved in easing of oxidative stress through stimulation of synthesis of SoxR, EmrR and GshA together with RpoS, previously found as a member of polyamine modulon at the stationary phase.	[Sakamoto, Akihiko; Terui, Yusuke; Yoshida, Taketo; Yamamoto, Taku; Kashiwagi, Keiko] Chiba Inst Sci, Fac Pharm, Choshi, Chiba, Japan; [Suzuki, Hideyuki] Kyoto Inst Technol, Grad Sch Sci & Technol, Kyoto, Kyoto, Japan; [Yamamoto, Kaneyoshi; Ishihama, Akira] Hosei Univ, Dept Frontier Biosci, Koganei, Tokyo 184, Japan; [Igarashi, Kazuei] Chiba Univ, Grad Sch Pharmaceut Sci, Chiba, Chiba, Japan; [Igarashi, Kazuei] Chiba Univ, Amine Pharma Res Inst, Chiba, Chiba, Japan	Kyoto Institute of Technology; Hosei University; Chiba University; Chiba University	Kashiwagi, K (corresponding author), Chiba Inst Sci, Fac Pharm, Choshi, Chiba, Japan.	kkashiwagi@cis.ac.jp		Igarashi, Kazuei/0000-0003-3751-3187	Ministry of Education, Culture, Sports, Science and Technology, Japan; Futaba Electronics Memorial Foundation; Grants-in-Aid for Scientific Research [25430173] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Futaba Electronics Memorial Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan. T. Yoshida was supported by the Futaba Electronics Memorial Foundation.	AMABILECUEVAS CF, 1991, NUCLEIC ACIDS RES, V19, P4479, DOI 10.1093/nar/19.16.4479; Arenas FA, 2010, BIOCHEM BIOPH RES CO, V398, P690, DOI 10.1016/j.bbrc.2010.07.002; ATKINS JF, 1975, J BIOL CHEM, V250, P5688; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chasteen TG, 2009, FEMS MICROBIOL REV, V33, P820, DOI 10.1111/j.1574-6976.2009.00177.x; Chattopadhyay MK, 2003, P NATL ACAD SCI USA, V100, P2261, DOI 10.1073/pnas.2627990100; Chiang SM, 2012, ARCH BIOCHEM BIOPHYS, V525, P161, DOI 10.1016/j.abb.2012.02.007; CHRISTMAN MF, 1989, P NATL ACAD SCI USA, V86, P3484, DOI 10.1073/pnas.86.10.3484; Contreras ND, 2010, ARCH MICROBIOL, V192, P969, DOI 10.1007/s00203-010-0624-2; CUNNINGHAMRUNDLES S, 1975, J BACTERIOL, V124, P791, DOI 10.1128/JB.124.2.791-799.1975; ECHANDI G, 1975, BIOCHEM BIOPH RES CO, V67, P1185, DOI 10.1016/0006-291X(75)90798-6; EMORY SA, 1990, J BACTERIOL, V172, P4472, DOI 10.1128/jb.172.8.4472-4481.1990; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Igarashi K, 2006, J BIOCHEM, V139, P11, DOI 10.1093/jb/mvj020; IGARASHI K, 1986, J BACTERIOL, V166, P128, DOI 10.1128/jb.166.1.128-134.1986; IGARASHI K, 1979, BIOCHEM BIOPH RES CO, V91, P440, DOI 10.1016/0006-291X(79)91541-9; IGARASHI K, 1979, EUR J BIOCHEM, V93, P345, DOI 10.1111/j.1432-1033.1979.tb12829.x; IGARASHI K, 1974, EUR J BIOCHEM, V48, P495, DOI 10.1111/j.1432-1033.1974.tb03790.x; Igarashi K., 2015, POLYAMINES UNIVERSAL, P131, DOI [10.1007/978-4-431-55212-3_11, DOI 10.1007/978-4-431-55212-3_11]; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; JELENC PC, 1979, P NATL ACAD SCI USA, V76, P3174, DOI 10.1073/pnas.76.7.3174; Jishage M, 1998, P NATL ACAD SCI USA, V95, P4953, DOI 10.1073/pnas.95.9.4953; Kanai T, 2006, J BIOCHEM, V140, P703, DOI 10.1093/jb/mvj199; KASHIWAGI K, 1994, BIOCHEM BIOPH RES CO, V200, P591, DOI 10.1006/bbrc.1994.1489; LOMOVSKAYA O, 1995, J BACTERIOL, V177, P2328, DOI 10.1128/jb.177.9.2328-2334.1995; MIYAMOTO S, 1993, ARCH BIOCHEM BIOPHYS, V300, P63, DOI 10.1006/abbi.1993.1009; NIELSEN PJ, 1982, J BIOL CHEM, V257, P2316; NUNOSHIBA T, 1992, J BACTERIOL, V174, P6054, DOI 10.1128/JB.174.19.6054-6060.1992; Ogasawara H, 2010, MICROBIOL-SGM, V156, P2470, DOI 10.1099/mic.0.039131-0; Rider JE, 2007, AMINO ACIDS, V33, P231, DOI 10.1007/s00726-007-0513-4; Sakamoto A, 2012, INT J BIOCHEM CELL B, V44, P1877, DOI 10.1016/j.biocel.2012.07.010; Sambrook J., 2001, MOL CLONING LAB MANU; SCHELLHORN HE, 1988, J BACTERIOL, V170, P4286, DOI 10.1128/jb.170.9.4286-4292.1988; SHAPIRA SK, 1983, GENE, V25, P71, DOI 10.1016/0378-1119(83)90169-5; Terui Y, 2012, INT J BIOCHEM CELL B, V44, P412, DOI 10.1016/j.biocel.2011.11.017; Terui Y, 2010, J BIOL CHEM, V285, P28698, DOI 10.1074/jbc.M110.111195; WATANABE K, 1986, NUCLEIC ACIDS RES, V14, P4393, DOI 10.1093/nar/14.11.4393; WATANABE S, 1991, J BIOL CHEM, V266, P20803; Wilson K., 2001, CURR PROTOC MOL BIOL, V56, P2, DOI [10.1002/0471142727.mb0204s56, DOI 10.1002/0471142727.MB0204S56]; WU J, 1992, J BACTERIOL, V174, P3915, DOI 10.1128/jb.174.12.3915-3920.1992; WU J, 1991, J BACTERIOL, V173, P2864, DOI 10.1128/JB.173.9.2864-2871.1991; Yoshida M, 2002, J BIOL CHEM, V277, P37139, DOI 10.1074/jbc.M206668200	45	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124883	10.1371/journal.pone.0124883	http://dx.doi.org/10.1371/journal.pone.0124883			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898225	Green Submitted, gold, Green Published			2022-12-26	WOS:000353212600091
J	Zhu, SH; Hu, XS; Yu, ZB; Peng, YZ; Zhu, JG; Liu, XH; Li, MM; Han, SP; Zhu, C				Zhu, Shasha; Hu, Xiaoshan; Yu, Zhangbin; Peng, Yuzhu; Zhu, Jingai; Liu, Xuehua; Li, Mengmeng; Han, Shuping; Zhu, Chun			Effect of miR-20b on Apoptosis, Differentiation, the BMP Signaling Pathway and Mitochondrial Function in the P19 Cell Model of Cardiac Differentiation In Vitro	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; CONGENITAL HEART-DISEASE; CARDIOMYOCYTE DIFFERENTIATION; EMBRYONIC-DEVELOPMENT; MICRORNA SPONGES; MAMMALIAN-CELLS; GENE-EXPRESSION; DEFECTS; MOUSE; OVEREXPRESSION	Objective To explore the effect of miR-20b on apoptosis, differentiation, the BMP signaling pathway and mitochondrial function in the P19 cell model of cardiac differentiation in vitro. Methods A miR-20b over-expression vector, a miR-20b silencing vector and their corresponding empty vectors were constructed and transfected into P19 cells, separately. Stably miR-20b overexpressing and silenced P19 cell lines were successfully selected by blasticidin and puromycin, separately. The cells were induced to undergo apoptosis in FBS-free-alpha-MEM. The induced cells were examined by flow cytometry and measurement of their caspase-3 activities. Quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) was used to evaluate the relative expression of marker genes of cardiomyocytes during differentiation, such as cTnT, GATA4 and ANP. QRT-PCR was also used to detect the mitochondrial DNA (mtDNA) copy number. We investigated the cellular ATP production using a luciferase-based luminescence assay. The reactive oxygen species (ROS) was determined by DCFDA (2', 7'-Dichlorofluorescein diacetate) and the mitochondrial membrane potential (MMP) was elucidated by a JC-1 fluorescent probe, both using fluorescence microscopy and flow cytometer. The expression of BMP signaling pathway-related proteins were analyzed by Western blotting. Results Stably miR-20b overexpressing and silenced P19 cell lines were successfully obtained. MiR-20b overexpression increased apoptosis and promoted differentiation in P19 cells by promoting the activation of the BMP signaling pathway. In addition, miR-20b overexpression induced mitochondrial impairment in P19 cells during differentiation, which was characterized by lower MMP, raised ATP synthesis and increased ROS levels. The effects of miR-20b silencing were the exact opposite to those of overexpression. Conclusion Collectively, these results suggested that miR-20b was very important in apoptosis, differentiation and mitochondrial function of P19 cells. MiR-20b may represent a new therapeutic target for congenital heart diseases and provide new insights into the mechanisms of cardiac diseases.	[Zhu, Shasha] Soochow Univ, Dept Cardiol, Affiliated Hosp 1, Suzhou 215006, Peoples R China; [Hu, Xiaoshan; Yu, Zhangbin; Peng, Yuzhu; Zhu, Jingai; Liu, Xuehua; Li, Mengmeng; Han, Shuping; Zhu, Chun] Nanjing Med Univ, Nanjing Matern & Child Hlth Care Hosp, State Key Lab Reprod Med, Dept Pediat, Nanjing 210004, Jiangsu, Peoples R China	Soochow University - China; Nanjing Medical University	Han, SP (corresponding author), Nanjing Med Univ, Nanjing Matern & Child Hlth Care Hosp, State Key Lab Reprod Med, Dept Pediat, Nanjing 210004, Jiangsu, Peoples R China.	shupinghan@126.com; zhifangxibao@163.com			National Natural Science Foundation of China [81200126]; Key Medical Personnel Foundation of Jiangsu Province [RC2011021]; Nanjing Medical Science and Technique Development Foundation [QRX11107]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Medical Personnel Foundation of Jiangsu Province; Nanjing Medical Science and Technique Development Foundation	This work was supported by grants from the National Natural Science Foundation of China (Grant No. 81200126), the Key Medical Personnel Foundation of Jiangsu Province (Grant No. RC2011021), the Nanjing Medical Science and Technique Development Foundation (QRX11107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HW, 2010, MOL HUM REPROD, V16, P463, DOI 10.1093/molehr/gaq017; Allan L, 2000, HEART, V83, P367, DOI 10.1136/heart.83.3.367; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bajolle F, 2009, ARCH CARDIOVASC DIS, V102, P59, DOI 10.1016/j.acvd.2008.06.020; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Callis TE, 2005, CIRC RES, V97, P992, DOI 10.1161/01.RES.0000190670.92879.7d; Cascio S, 2010, J CELL PHYSIOL, V224, P242, DOI 10.1002/jcp.22126; Cataluccia D, 2008, ANN NY ACAD SCI, V1123, P20, DOI 10.1196/annals.1420.004; Chen JQ, 2007, GENESIS, V45, P482, DOI 10.1002/dvg.20320; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; de Pater E, 2012, CIRC RES, V110, P578, DOI 10.1161/CIRCRESAHA.111.261172; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Ebert MS, 2010, RNA, V16, P2043, DOI 10.1261/rna.2414110; Eleftheriades M, 2012, J MATERN-FETAL NEO M, V25, P2546, DOI 10.3109/14767058.2012.703716; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garzon R, 2007, ONCOGENE, V26, P4148, DOI 10.1038/sj.onc.1210186; Gazzerro E, 2006, REV ENDOCR METAB DIS, V7, P51, DOI 10.1007/s11154-006-9000-6; Harada M, 2014, CIRC RES, V114, P689, DOI 10.1161/CIRCRESAHA.114.301798; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015; Kaaman M, 2007, DIABETOLOGIA, V50, P2526, DOI 10.1007/s00125-007-0818-6; Kang D, 2002, CURR GENET, V41, P311, DOI 10.1007/s00294-002-0312-0; Kehat I, 2002, CIRC RES, V91, P659, DOI 10.1161/01.RES.0000039084.30342.9B; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Ku PM, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-57; Lesnefsky EJ, 2008, BBA-BIOENERGETICS, V1777, P1020, DOI 10.1016/j.bbabio.2008.05.444; Li JY, 2012, ASIAN PAC J CANCER P, V13, P1901, DOI 10.7314/APJCP.2012.13.5.1901; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Mack GS, 2007, NAT BIOTECHNOL, V25, P631, DOI 10.1038/nbt0607-631; MARRE M, 1994, DIABETES, V43, P384, DOI 10.2337/diabetes.43.3.384; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Matsusaka T, 1997, ANNU REV PHYSIOL, V59, P395, DOI 10.1146/annurev.physiol.59.1.395; Maxwell DP, 1999, P NATL ACAD SCI USA, V96, P8271, DOI 10.1073/pnas.96.14.8271; Meberg A, 2005, ACTA PAEDIATR, V94, P1060, DOI 10.1080/08035250410025618; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Monzen K, 1999, MOL CELL BIOL, V19, P7096; Morton SU, 2008, P NATL ACAD SCI USA, V105, P17830, DOI 10.1073/pnas.0804673105; Nabialek E, 2013, MINERVA CARDIOANGIOL, V61, P627; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; Qin DN, 2013, CELL BIOCHEM BIOPHYS, V66, P709, DOI 10.1007/s12013-013-9516-9; ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316; Schultheiss TM, 1997, GENE DEV, V11, P451, DOI 10.1101/gad.11.4.451; Shen YH, 2012, J BIOENERG BIOMEMBR, V44, P317, DOI 10.1007/s10863-012-9439-y; Shi CM, 2013, CELL BIOCHEM BIOPHYS, V66, P489, DOI 10.1007/s12013-012-9496-1; Thum T, 2008, CARDIOVASC RES, V79, P562, DOI 10.1093/cvr/cvn137; Trojnarska O, 2009, CARDIOL J, V16, P341; Ugarte-Uribe B, 2014, BIOL CHEM, V395, P297, DOI 10.1515/hsz-2013-0234; van der Heyden MAG, 2003, CARDIOVASC RES, V58, P410, DOI 10.1016/S0008-6363(03)00247-5; van der Heyden MAG, 2003, CARDIOVASC RES, V58, P292, DOI 10.1016/S0008-6363(02)00771-X; Wang J, 2011, BIRTH DEFECTS RES A, V91, P441, DOI 10.1002/bdra.20785; Wen JY, 2007, J CELL BIOCHEM, V102, P149, DOI 10.1002/jcb.21285; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Zaffran S, 2002, CIRC RES, V91, P457, DOI 10.1161/01.RES.0000034152.74523.A8; Zhang HB, 1996, DEVELOPMENT, V122, P2977; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030; Zhu JJ, 2014, HUM IMMUNOL, V75, P348, DOI 10.1016/j.humimm.2014.01.006; Zhu SS, 2013, CLIN CHIM ACTA, V424, P66, DOI 10.1016/j.cca.2013.05.010	60	16	17	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123519	10.1371/journal.pone.0123519	http://dx.doi.org/10.1371/journal.pone.0123519			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898012	Green Submitted, Green Published, gold			2022-12-26	WOS:000353212600029
J	Arighi, C; Shamovsky, V; Masci, AM; Ruttenberg, A; Smith, B; Natale, DA; Wu, C; D'Eustachio, P				Arighi, Cecilia; Shamovsky, Veronica; Masci, Anna Maria; Ruttenberg, Alan; Smith, Barry; Natale, Darren A.; Wu, Cathy; D'Eustachio, Peter			Toll-Like Receptor Signaling in Vertebrates: Testing the Integration of Protein, Complex, and Pathway Data in the Protein Ontology Framework	PLOS ONE			English	Article							RECOGNITION RECEPTORS; PATHOGEN RECOGNITION; ACTIVATION; INNATE; CD14; DROSOPHILA; GENE; TRANSDUCTION; ENDOCYTOSIS; EVOLUTION	The Protein Ontology (PRO) provides terms for and supports annotation of species-specific protein complexes in an ontology framework that relates them both to their components and to species-independent families of complexes. Comprehensive curation of experimentally known forms and annotations thereof is expected to expose discrepancies, differences, and gaps in our knowledge. We have annotated the early events of innate immune signaling mediated by Toll-Like Receptor 3 and 4 complexes in human, mouse, and chicken. The resulting ontology and annotation data set has allowed us to identify species-specific gaps in experimental data and possible functional differences between species, and to employ inferred structural and functional relationships to suggest plausible resolutions of these discrepancies and gaps.	[Arighi, Cecilia; Wu, Cathy] Univ Delaware, Ctr Bioinformat & Computat Biol, Newark, DC USA; [Shamovsky, Veronica; D'Eustachio, Peter] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10012 USA; [Masci, Anna Maria] Duke Univ, Dept Immunol, Durham, NC USA; [Ruttenberg, Alan] SUNY Buffalo, Sch Dent Med, Buffalo, NY 14260 USA; [Smith, Barry] SUNY Buffalo, Dept Philosophy, Buffalo, NY 14260 USA; [Smith, Barry] SUNY Buffalo, Ctr Excellence Bioinformat & Life Sci, Buffalo, NY 14260 USA; [Natale, Darren A.; Wu, Cathy] Georgetown Univ, Med Ctr, Dept Biochem & Mol & Cellular Biol, Prot Informat Resource, Washington, DC 20007 USA	University of Delaware; New York University; Duke University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Georgetown University	D'Eustachio, P (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10012 USA.	deustp01@med.nyu.edu	Natale, Darren A/AAE-9303-2019; Smith, Barry/A-9525-2011; Arighi, Cecilia N/J-2381-2015	Natale, Darren A/0000-0001-5809-9523; Smith, Barry/0000-0003-1384-116X; Arighi, Cecilia N/0000-0002-0803-4817; Masci, Anna Maria/0000-0003-1940-6740; Wu, Cathy/0000-0001-6379-8601; D'Eustachio, Peter/0000-0002-5494-626X; Ruttenberg, Alan/0000-0002-1604-3078	National Institutes of Health [5R01GM080646-09]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080646] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The project is supported by the National Institutes of Health grant 5R01GM080646-09 (www.nih.gov). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelsadik A, 2011, HUM IMMUNOL, V72, P1188, DOI 10.1016/j.humimm.2011.08.015; Akashi S, 2003, J EXP MED, V198, P1035, DOI 10.1084/jem.20031076; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Arighi C., PRO ONTOLOGY MANUAL; Arighi CN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S5-S3; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Blake JA, 2014, NUCLEIC ACIDS RES, V42, pD810, DOI 10.1093/nar/gkt1225; Bult CJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-371; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Correia JD, 2001, J BIOL CHEM, V276, P21129, DOI 10.1074/jbc.M009164200; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Esnault E, 2011, VIRUS RES, V159, P32, DOI 10.1016/j.virusres.2011.04.022; Gillespie M, 2011, MAMM GENOME, V22, P130, DOI 10.1007/s00335-010-9296-0; Haddadi S, 2013, VET IMMUNOL IMMUNOP, V155, P270, DOI 10.1016/j.vetimm.2013.08.005; HASHIMOTO C, 1988, CELL, V52, P269, DOI 10.1016/0092-8674(88)90516-8; Hastings J, 2013, NUCLEIC ACIDS RES, V41, pD456, DOI 10.1093/nar/gks1146; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Janssens S, 2002, CURR BIOL, V12, P467, DOI 10.1016/S0960-9822(02)00712-1; Jiang QQ, 2000, J IMMUNOL, V165, P3541, DOI 10.4049/jimmunol.165.7.3541; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Jupe S, 2008, DATABASE; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Keestra AM, 2008, J IMMUNOL, V181, P4354, DOI 10.4049/jimmunol.181.6.4354; Kim D, 2014, MOL IMMUNOL, V57, P210, DOI 10.1016/j.molimm.2013.09.009; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Masci AM, 2011, ICBO INT C BIOM ONT; Matsuo A, 2008, J IMMUNOL, V181, P3474, DOI 10.4049/jimmunol.181.5.3474; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Natale DA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S9-S1; Natale DA, 2014, NUCLEIC ACIDS RES, V42, pD415, DOI 10.1093/nar/gkt1173; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Qian C, 2013, ANN NY ACAD SCI, V1283, P67, DOI 10.1111/j.1749-6632.2012.06786.x; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Roach JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054156; Roy S, 2014, J BIOL CHEM, V289, P1174, DOI 10.1074/jbc.M113.523167; Sasai M, 2013, INT REV IMMUNOL, V32, P116, DOI 10.3109/08830185.2013.774391; Smith B, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r46; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Teghanemt A, 2007, J BIOL CHEM, V282, P36250, DOI 10.1074/jbc.M705995200; Tsukamoto H, 2010, INT IMMUNOL, V22, P271, DOI 10.1093/intimm/dxq005; Vaure C, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00316; Wu ZG, 2009, DEV COMP IMMUNOL, V33, P97, DOI 10.1016/j.dci.2008.07.008; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Zhang Q, 2010, IMMUNOGENETICS, V62, P263, DOI 10.1007/s00251-010-0428-1	49	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0122978	10.1371/journal.pone.0122978	http://dx.doi.org/10.1371/journal.pone.0122978			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894391	Green Published, Green Submitted, gold			2022-12-26	WOS:000353211700020
J	Giollo, M; Minervini, G; Scalzotto, M; Leonardi, E; Ferrari, C; Tosatto, SCE				Giollo, Manuel; Minervini, Giovanni; Scalzotto, Marta; Leonardi, Emanuela; Ferrari, Carlo; Tosatto, Silvio C. E.			BOOGIE: Predicting Blood Groups from High Throughput Sequencing Data	PLOS ONE			English	Article							GENOTYPING REPLACE SEROLOGY; FUTURE; IDENTIFICATION; TRANSFUSION; ASSOCIATION; VARIANTS; MEDICINE; ALLELES; PROJECT; COMMON	Over the last decade, we have witnessed an incredible growth in the amount of available genotype data due to high throughput sequencing (HTS) techniques. This information may be used to predict phenotypes of medical relevance, and pave the way towards personalized medicine. Blood phenotypes (e.g. ABO and Rh) are a purely genetic trait that has been extensively studied for decades, with currently over thirty known blood groups. Given the public availability of blood group data, it is of interest to predict these phenotypes from HTS data which may translate into more accurate blood typing in clinical practice. Here we propose BOOGIE, a fast predictor for the inference of blood groups from single nucleotide variant (SNV) databases. We focus on the prediction of thirty blood groups ranging from the well known ABO and Rh, to the less studied Junior or Diego. BOOGIE correctly predicted the blood group with 94% accuracy for the Personal Genome Project whole genome profiles where good quality SNV annotation was available. Additionally, our tool produces a high quality haplotype phase, which is of interest in the context of ethnicity-specific polymorphisms or traits. The versatility and simplicity of the analysis make it easily interpretable and allow easy extension of the protocol towards other phenotypes. BOOGIE can be down-loaded from URL http://protein.bio.unipd.it/download/.	[Giollo, Manuel; Minervini, Giovanni; Scalzotto, Marta; Tosatto, Silvio C. E.] Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy; [Giollo, Manuel; Ferrari, Carlo] Univ Padua, Dept Informat Engn, I-35121 Padua, Italy; [Leonardi, Emanuela] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy	University of Padua; University of Padua; University of Padua	Tosatto, SCE (corresponding author), Univ Padua, Dept Biomed Sci, Viale G Colombo 3, I-35131 Padua, Italy.	silvio.tosatto@unipd.it	Minervini, Giovanni/D-1200-2013; Tosatto, Silvio/B-2840-2009; leonardi, emanuela/AAN-2392-2020; Ferrari, Carlo/AAU-8107-2021	Minervini, Giovanni/0000-0001-7013-5785; Tosatto, Silvio/0000-0003-4525-7793; leonardi, emanuela/0000-0001-8486-8461; FERRARI, CARLO/0000-0003-3665-0446	Italian Ministry of Health [GR-2011-02346845]; FIRB Futuro in Ricerca [RBFR08ZSXY]; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Italian Ministry of Health(Ministry of Health, Italy); FIRB Futuro in Ricerca(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	GM is an AIRC research fellow. This work was also supported by Italian Ministry of Health grant GR-2011-02346845 and FIRB Futuro in Ricerca grant RBFR08ZSXY to ST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Amado M, 2000, VOX SANG, V79, P219, DOI 10.1046/j.1423-0410.2000.7940219.x; Anstee DJ, 2009, BLOOD, V114, P248, DOI 10.1182/blood-2008-11-146860; Avent ND, 2009, TRANSFUS MED HEMOTH, V36, P162, DOI 10.1159/000218192; Ball MP, 2012, P NATL ACAD SCI USA, V109, P11920, DOI 10.1073/pnas.1201904109; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Bugert P, 2009, TRANSFUSION, V49, P1793, DOI 10.1111/j.1537-2995.2009.02220.x; Burke W, 2007, JAMA-J AM MED ASSOC, V298, P1682, DOI 10.1001/jama.298.14.1682; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Church GM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100040; COLIN Y, 1986, J BIOL CHEM, V261, P229; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; Denomme GA, 2011, TRANSFUS APHER SCI, V44, P53, DOI 10.1016/j.transci.2010.12.010; Doscher A, 2009, TRANSFUSION, V49, P1803, DOI 10.1111/j.1537-2995.2009.02221.x; Flegel WA, 2011, TRANSFUS APHER SCI, V44, P81, DOI 10.1016/j.transci.2010.12.013; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Giardine B, 2007, HUM MUTAT, V28, P554, DOI 10.1002/humu.20484; Goodnough LT, 2013, LANCET, V381, P1845, DOI 10.1016/S0140-6736(13)60650-9; Goodnough LT, 1999, NEW ENGL J MED, V340, P438, DOI 10.1056/NEJM199902113400606; Gubin AN, 2000, BLOOD, V96, P2621; Helias V, 2012, NAT GENET, V44, P170, DOI 10.1038/ng.1069; Horaitis O, 2007, NAT GENET, V39, P425, DOI 10.1038/ng0407-425; Huang CH, 1999, TRANSFUSION, V39, P1259, DOI 10.1046/j.1537-2995.1999.39111259.x; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kasprzyk A, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar049; Kauppi L, 2004, NAT REV GENET, V5, P413, DOI 10.1038/nrg1346; Legler TJ, 1999, TRANSFUSION, V39, P852, DOI 10.1046/j.1537-2995.1999.39080852.x; Lublin DM, 2000, TRANSFUSION, V40, P208, DOI 10.1046/j.1537-2995.2000.40020208.x; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Patnaik SK, 2012, NUCLEIC ACIDS RES, V40, pD1023, DOI 10.1093/nar/gkr958; Rentas FJ, 1999, MIL MED, V164, P785, DOI 10.1093/milmed/164.11.785; Saison C, 2012, NAT GENET, V44, P174, DOI 10.1038/ng.1070; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Storry JR, 2009, TRANSFUS MED HEMOTH, V36, P232, DOI 10.1159/000214939; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Telen MJ, 1996, J BIOL CHEM, V271, P7147, DOI 10.1074/jbc.271.12.7147; Thorisson GA, 2005, GENOME RES, V15, P1592, DOI 10.1101/gr.4413105; van de Pas NCA, 2012, J LIPID RES, V53, P2734, DOI 10.1194/jlr.M031930; van der Schoot CE, 2009, TRANSFUS MED HEMOTH, V36, P234, DOI 10.1159/000214840; von Bubnoff A, 2008, CELL, V132, P721, DOI 10.1016/j.cell.2008.02.028; Yip SP, 2002, ANN HUM GENET, V66, P1, DOI 10.1017/S0003480001008995	42	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124579	10.1371/journal.pone.0124579	http://dx.doi.org/10.1371/journal.pone.0124579			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893845	Green Published, gold, Green Submitted			2022-12-26	WOS:000353211700107
J	Naqvi, AAT; Shahbaaz, M; Ahmad, F; Hassan, MI				Naqvi, Ahmad Abu Turab; Shahbaaz, Mohd; Ahmad, Faizan; Hassan, Md. Imtaiyaz			Identification of Functional Candidates amongst Hypothetical Proteins of Treponema pallidum ssp. pallidum	PLOS ONE			English	Article							C-DI-GMP; TARGETING VIRULENCE; CRYSTAL-STRUCTURE; GENE-EXPRESSION; GENOME SEQUENCE; PILZ DOMAIN; SYPHILIS; MEMBRANE; PATHWAY; DESIGN	Syphilis is a globally occurring venereal disease, and its infection is propagated through sexual contact. The causative agent of syphilis, Treponema pallidum ssp. pallidum, a Gram-negative sphirochaete, is an obligate human parasite. Genome of T. pallidum ssp. pallidum SS14 strain (RefSeq NC_010741.1) encodes 1,027 proteins, of which 444 proteins are known as hypothetical proteins (HPs), i.e., proteins of unknown functions. Here, we performed functional annotation of HPs of T. pallidum ssp. pallidum using various database, domain architecture predictors, protein function annotators and clustering tools. We have analyzed the sequences of 444 HPs of T. pallidum ssp. pallidum and subsequently predicted the function of 207 HPs with a high level of confidence. However, functions of 237 HPs are predicted with less accuracy. We found various enzymes, transporters, binding proteins in the annotated group of HPs that may be possible molecular targets, facilitating for the survival of pathogen. Our comprehensive analysis helps to understand the mechanism of pathogenesis to provide many novel potential therapeutic interventions.	[Naqvi, Ahmad Abu Turab; Shahbaaz, Mohd] Jamia Millia Islamia, Dept Comp Sci, New Delhi 110025, India; [Ahmad, Faizan; Hassan, Md. Imtaiyaz] Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India	Jamia Millia Islamia; Jamia Millia Islamia	Hassan, MI (corresponding author), Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India.	mihassan@jmi.ac.in	Shahbaaz, Mohd/ABG-4269-2020; Hassan, Md Imtaiyaz/G-7072-2017; Abu Turab Naqvi, Ahmad/AAX-8854-2020; Ahmad, Faizan/AGH-4493-2022; Hassan, Imtaiyaz/ABF-6485-2020; Hassan, Mohammad/GZA-7507-2022	Shahbaaz, Mohd/0000-0001-8901-7113; Hassan, Md Imtaiyaz/0000-0002-3663-4940; Abu Turab Naqvi, Ahmad/0000-0002-4991-1599; Ahmad, Faizan/0000-0001-7021-7502; Hassan, Imtaiyaz/0000-0002-3663-4940; Hassan, Mohammad/0000-0002-1712-0004	Indian Council of Medical Research [BIC/12(04)/2012]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	The authors sincerely thank the Indian Council of Medical Research for financial assistance (Project No. BIC/12(04)/2012).	ABELL E, 1975, BRIT J DERMATOL, V93, P53, DOI 10.1111/j.1365-2133.1975.tb06476.x; Ahmad F, 2013, THROMB HAEMOSTASIS, V109, P39, DOI 10.1160/TH12-07-0475; Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739; Anantharaman V, 2012, MOL BIOSYST, V8, P3142, DOI 10.1039/c2mb25239b; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Cerveny L, 2013, INFECT IMMUN, V81, P629, DOI 10.1128/IAI.01035-12; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; COLOMBATTI A, 1993, MATRIX, V13, P297, DOI 10.1016/S0934-8832(11)80025-9; Desler C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-289; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Franke K, 2006, MICROBIOL-SGM, V152, P3111, DOI 10.1099/mic.0.29115-0; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Galperin Michael Y., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P303; Garg A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-62; Hase CC, 1999, P NATL ACAD SCI USA, V96, P3183, DOI 10.1073/pnas.96.6.3183; Hassan MI, 2007, J PEPT SCI, V13, P849, DOI 10.1002/psc.911; Hassan MI, 2007, CHEM BIOL DRUG DES, V70, P261, DOI 10.1111/j.1747-0285.2007.00553.x; Hassan MI, 2012, BLOOD COAGUL FIBRIN, V23, P11, DOI 10.1097/MBC.0b013e32834cb35d; Hattori M, 2007, NATURE, V448, P1072, DOI 10.1038/nature06093; Hertel M, 2014, J ORAL MAXIL SURG, V72, P338, DOI 10.1016/j.joms.2013.07.015; Jaktaji RP, 2012, IRAN J PHARM RES, V11, P595; JORIS B, 1992, FEMS MICROBIOL LETT, V91, P257; Kishida H, 2003, ACTA CRYSTALLOGR D, V59, P23, DOI 10.1107/S0907444902017705; Kumar K, 2014, 3BIOTECH IN PRESS, V3; Kumar K, 2014, GENE, V543, P93, DOI 10.1016/j.gene.2014.03.060; Liepinsh E, 1997, NAT STRUCT BIOL, V4, P975, DOI 10.1038/nsb1297-975; Lin HT, 2009, J BIOL CHEM, V284, P1145, DOI 10.1074/jbc.M806964200; Livorsi DJ, 2011, CONTRIB MICROBIOL, V17, P31, DOI 10.1159/000324008; MACINTYRE S, 1990, BIOCHIMIE, V72, P157, DOI 10.1016/0300-9084(90)90141-3; Marra Andrea, 2006, Drugs R D, V7, P1, DOI 10.2165/00126839-200607010-00001; Matejkova P, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-76; Mazandu GK, 2012, INT J MOL SCI, V13, P7283, DOI 10.3390/ijms13067283; McGill MA, 2010, INFECT IMMUN, V78, P2631, DOI 10.1128/IAI.00173-10; McKevitt M, 2005, INFECT IMMUN, V73, P4445, DOI 10.1128/IAI.73.7.4445-4450.2005; Naismith JH, 2012, ANNU REV BIOPHYS, V41, P157, DOI 10.1146/annurev-biophys-101211-113227; Ninio S, 2001, J BIOL CHEM, V276, P48250, DOI 10.1074/jbc.M108231200; Obmolova G, 2001, J STRUCT BIOL, V136, P119, DOI 10.1006/jsbi.2001.4428; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Paster BJ, 2000, J MOL MICROB BIOTECH, V2, P341; Peeling RW, 2006, J PATHOL, V208, P224, DOI 10.1002/path.1903; Petrosova H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074319; Petrosova H, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001832; Rappas M, 2004, CURR PROTEIN PEPT SC, V5, P89, DOI 10.2174/1389203043486874; RUGGERI ZM, 1993, FASEB J, V7, P308, DOI 10.1096/fasebj.7.2.8440408; Ryjenkov DA, 2006, J BIOL CHEM, V281, P30310, DOI 10.1074/jbc.C600179200; Saha Sudipto, 2006, Genomics Proteomics & Bioinformatics, V4, P42, DOI 10.1016/S1672-0229(06)60015-6; Shahbaaz M, 2015, 3 BIOTECH, V5, P317, DOI 10.1007/s13205-014-0231-z; Shahbaaz M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084263; Singer HM, 2014, J BACTERIOL, V196, P1448, DOI 10.1128/JB.01438-13; Singh AE, 1999, CLIN MICROBIOL REV, V12, P187, DOI 10.1128/CMR.12.2.187; Sinha A, 2014, LETT DRUG D IN PRESS; Sinha A, 2015, LETT DRUG DES DISCOV, V12, P46; Smajs D, 2005, J BACTERIOL, V187, P1866, DOI 10.1128/JB.187.5.1866-1874.2005; STAMM LV, 1983, INFECT IMMUN, V41, P709, DOI 10.1128/IAI.41.2.709-721.1983; Stewart V, 2014, MOL MICROBIOL, V91, P853, DOI 10.1111/mmi.12516; Thakur P, 2013, J NAT SCI BIOL MED; Thakur PK, 2014, LETT DRUG DES DISCOV, V11, P363, DOI 10.2174/15701808113106660088; Thakur Prasoon Kumar, 2011, International Journal of Computational Biology and Drug Design, V4, P373, DOI 10.1504/IJCBDD.2011.044404; Titz B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002292; Vetrivel Umashankar, 2011, Hugo J, V5, P25, DOI 10.1007/s11568-011-9152-7; YANG CC, 1984, J BACTERIOL, V158, P757, DOI 10.1128/JB.158.2.757-759.1984; Yeats C, 2002, TRENDS BIOCHEM SCI, V27, P438, DOI 10.1016/S0968-0004(02)02164-3; Zheng LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042517	64	29	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124177	10.1371/journal.pone.0124177	http://dx.doi.org/10.1371/journal.pone.0124177			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894582	gold, Green Published, Green Submitted			2022-12-26	WOS:000353211700077
J	Otto, GP; Hurtado-Oliveros, J; Chung, HY; Knoll, K; Neumann, T; Mueller, HJ; Herbsleb, M; Kohl, M; Busch, M; Sossdorf, M; Claus, RA				Otto, Gordon P.; Hurtado-Oliveros, Jorge; Chung, Ha-Yeun; Knoll, Kristin; Neumann, Thomas; Mueller, Hans J.; Herbsleb, Marco; Kohl, Matthias; Busch, Martin; Sossdorf, Maik; Claus, Ralf A.			Plasma Neutrophil Gelatinase-Associated Lipocalin Is Primarily Related to Inflammation during Sepsis: A Translational Approach	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; INTRACELLULAR IRON; IDENTIFICATION; BIOMARKER; NGAL; ADMISSION; INFECTION; PROTEINS; PREDICTS; IL-10	Acute kidney injury (AKI) during sepsis is common and underestimated. Plasma neutrophil gelatinase-associated lipocalin (plasma-NGAL) is discussed as new biomarker for AKI diagnosis, but during inflammation its function and diagnostic impact remain unclear. The association between plasma-NGAL and inflammatory markers in septic patients, but also in healthy controls and patients with chronic inflammation before and after either maximum exercise test or treatment with an anti-TNF therapy were investigated. In-vitro blood stimulations with IL-6, lipopolysaccharide, NGAL or its combinations were performed to investigate cause-effect-relationship. Plasma-NGAL levels were stronger associated with inflammation markers including IL-6 (Sepsis: r=0.785 P<0.001; chronic inflammation after anti-TNF: r=0.558 P<0.001), IL-8 (Sepsis: r=0.714 P<0.004; healthy controls after exercise r=0.786 P<0.028; chronic inflammation before anti-TNF: r=0.429 P<0.041) and IL-10 (healthy controls before exercise: r=0.791 P<0.028) than with kidney injury or function. Correlation to kidney injury or function was found only in septic patients (for creatinine: r=0.906 P<0.001; for eGFR: r=-0.686 P=0.005) and in patients with rheumatic disease after anti-TNF therapy (for creatinine: r=0.466 P<0.025). In stimulation assays with IL-6 and lipopolysaccharide plasma-NGAL was increased. Co-stimulation of lipopolysaccharide with plasma-NGAL decreased cellular injury (P<0.05) and in trend IL-10 levels (P=0.057). Septic mice demonstrated a significantly improved survival rate after NGAL treatment (P<0.01). Plasma-NGAL seams to be strongly involved in inflammation. For clinical relevance, it might not only be useful for AKI detection during severe inflammation - indeed it has to be interpreted carefully within this setting - but additionally might offer therapeutic potential.	[Otto, Gordon P.; Hurtado-Oliveros, Jorge; Chung, Ha-Yeun; Sossdorf, Maik; Claus, Ralf A.] Jena Univ Hosp, Ctr Sepsis Control & Care, Jena, Germany; [Otto, Gordon P.; Sossdorf, Maik; Claus, Ralf A.] Jena Univ Hosp, Clin Anesthesiol & Intens Care, Jena, Germany; [Knoll, Kristin; Neumann, Thomas] Jena Univ Hosp, Clin Internal Med Rheumatol KIM 3, Jena, Germany; [Mueller, Hans J.; Herbsleb, Marco] Univ Jena, Dept Sports Med & Hlth Promot, Jena, Germany; [Kohl, Matthias] Furtwangen Univ, Dept Med & Life Sci, Villingen Schwenningen, Germany; [Busch, Martin] Jena Univ Hosp, Clin Internal Med Nephrol KIM 3, Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Otto, GP (corresponding author), Jena Univ Hosp, Ctr Sepsis Control & Care, Jena, Germany.	gordonpotto@googlemail.com	Kohl, Matthias/R-6096-2019; Neumann, Thomas/F-2116-2016; Claus, Ralf A./Q-4035-2016	Kohl, Matthias/0000-0001-9514-8910; Neumann, Thomas/0000-0001-6810-6889; Claus, Ralf A./0000-0001-7232-4088	Federal Ministry of Education and Research (BMBF) [FKZ 01EO1002, D1.21]	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This publication was funded by research funding from the Federal Ministry of Education and Research (BMBF, FKZ 01EO1002) to the Center of Sepsis Control and Care (to GPO, project number D1.21). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arena A, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/613937; Bagshaw SM, 2010, INTENS CARE MED, V36, P452, DOI 10.1007/s00134-009-1724-9; Bao GH, 2010, NAT CHEM BIOL, V6, P602, DOI [10.1038/nchembio.402, 10.1038/NCHEMBIO.402]; BAUD L, 1989, KIDNEY INT, V35, P1111, DOI 10.1038/ki.1989.98; Bellmann-Weiler R, 2013, IMMUNOBIOLOGY, V218, P969, DOI 10.1016/j.imbio.2012.11.004; Berger T, 2006, P NATL ACAD SCI USA, V103, P1834, DOI 10.1073/pnas.0510847103; Bihorac A, 2013, J TRAUMA ACUTE CARE, V74, P1005, DOI 10.1097/TA.0b013e31828586ec; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Clerico A, 2012, CLIN CHEM LAB MED, V50, P1505, DOI 10.1515/cclm-2011-0814; Cowland JB, 2006, J IMMUNOL, V176, P5559, DOI 10.4049/jimmunol.176.9.5559; Cowland JB, 1997, GENOMICS, V45, P17, DOI 10.1006/geno.1997.4896; Cowland JB, 2003, J IMMUNOL, V171, P6630, DOI 10.4049/jimmunol.171.12.6630; Cunningham PN, 2002, J IMMUNOL, V168, P5817, DOI 10.4049/jimmunol.168.11.5817; Darmon M, 2011, AM J RESP CRIT CARE, V184, P142, DOI 10.1164/ajrccm.184.1.142a; de Geus HRH, 2013, BIOMARK MED, V7, P415, DOI [10.2217/BMM.13.5, 10.2217/bmm.13.5]; de Geus HRH, 2011, AM J RESP CRIT CARE, V183, P907, DOI 10.1164/rccm.200908-1214OC; Eichacker PQ, 2002, AM J RESP CRIT CARE, V166, P1197, DOI 10.1164/rccm.200204-302OC; Eller K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067693; Esposito BP, 2003, BLOOD, V102, P2670, DOI 10.1182/blood-2003-03-0807; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Haase M, 2012, AM J RESP CRIT CARE, V185, P343, DOI 10.1164/ajrccm.185.3.343a; Han M, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-25; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Huang HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082250; Katagiri D, 2013, J CRIT CARE, V28, P564, DOI 10.1016/j.jcrc.2013.01.009; Kjeldsen L, 2000, BBA-PROTEIN STRUCT M, V1482, P272, DOI 10.1016/S0167-4838(00)00152-7; KJELDSEN L, 1994, BLOOD, V83, P799; Landro L, 2008, CLIN EXP IMMUNOL, V152, P57, DOI 10.1111/j.1365-2249.2008.03592.x; Langenberg C, 2007, INTENS CARE MED, V33, P1614, DOI 10.1007/s00134-007-0734-8; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Li JY, 2004, AM J PHYSIOL-CELL PH, V287, pC1547, DOI 10.1152/ajpcell.00260.2004; LIU QS, 1995, J BIOL CHEM, V270, P22565, DOI 10.1074/jbc.270.38.22565; MEHEUS LA, 1993, J IMMUNOL, V151, P1535; Mellor A, 2013, DIS MARKERS, V2013, P537, DOI 10.1155/2013/601214; Mishra J, 2004, J AM SOC NEPHROL, V15, P3073, DOI 10.1097/01.ASN.0000145013.44578.45; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Mori K, 2005, J CLIN INVEST, V115, P610, DOI 10.1172/JCI200523056; Nairz M, 2009, BLOOD, V114, P3642, DOI 10.1182/blood-2009-05-223354; Oikonomou KA, 2012, J GASTROENTEROL, V47, P519, DOI 10.1007/s00535-011-0516-5; Otto GP, 2013, CRIT CARE, V17, DOI 10.1186/cc12540; Otto GP, 2012, CRIT CARE, V16, DOI 10.1186/cc11205; Otto GP, 2015, NEPHRON; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Roudkenar MH, 2011, FREE RADICAL RES, V45, P810, DOI 10.3109/10715762.2011.581279; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schmidt-Ott KM, 2007, J AM SOC NEPHROL, V18, P407, DOI 10.1681/ASN.2006080882; Tilg H, 2002, J IMMUNOL, V169, P2204, DOI 10.4049/jimmunol.169.4.2204; Wan Li, 2003, Curr Opin Crit Care, V9, P496, DOI 10.1097/00075198-200312000-00006	49	29	29	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124429	10.1371/journal.pone.0124429	http://dx.doi.org/10.1371/journal.pone.0124429			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893429	Green Submitted, gold, Green Published			2022-12-26	WOS:000353211700092
J	Gao, J; Roan, E; Williams, JL				Gao, Jie; Roan, Esra; Williams, John L.			Regional Variations in Growth Plate Chondrocyte Deformation as Predicted By Three-Dimensional Multi-Scale Simulations	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; ARTICULAR-CARTILAGE; TISSUE STRAIN; ION CHANNELS; CELL; BEHAVIOR; INDENTATION; CARTERS; STRESS	The physis, or growth plate, is a complex disc-shaped cartilage structure that is responsible for longitudinal bone growth. In this study, a multi-scale computational approach was undertaken to better understand how physiological loads are experienced by chondrocytes embedded inside chondrons when subjected to moderate strain under instantaneous compressive loading of the growth plate. Models of representative samples of compressed bone/growth-plate/bone from a 0.67mm thick 4-month old bovine proximal tibial physis were subjected to a prescribed displacement equal to 20% of the growth plate thickness. At the macroscale level, the applied compressive deformation resulted in an overall compressive strain across the proliferative-hypertrophic zone of 17%. The microscale model predicted that chondrocytes sustained compressive height strains of 12% and 6% in the proliferative and hypertrophic zones, respectively, in the interior regions of the plate. This pattern was reversed within the outer 300 mu m region at the free surface where cells were compressed by 10% in the proliferative and 26% in the hypertrophic zones, in agreement with experimental observations. This work provides a new approach to study growth plate behavior under compression and illustrates the need for combining computational and experimental methods to better understand the chondrocyte mechanics in the growth plate cartilage. While the current model is relevant to fast dynamic events, such as heel strike in walking, we believe this approach provides new insight into the mechanical factors that regulate bone growth at the cell level and provides a basis for developing models to help interpret experimental results at varying time scales.	[Gao, Jie] Univ Memphis, Dept Mech Engn, Memphis, TN 38152 USA; [Roan, Esra; Williams, John L.] Univ Memphis, Dept Biomed Engn, Memphis, TN 38152 USA	University of Memphis; University of Memphis	Roan, E (corresponding author), Univ Memphis, Dept Biomed Engn, Memphis, TN 38152 USA.	erean@memphis.edu	Williams, John Leicester/B-9452-2008	Williams, John Leicester/0000-0001-8251-4176				ABAQUS, ABAQUS 6 12 DOC; Allen DM, 2004, J STRUCTURAL BIOL, V145; Amini S, 2010, J BIOMECHANICS, V43; Amini S, 2011, STRESS RELAXATION GR; Amini S, 2013, BIOMECH MODEL MECHAN, V12, P67, DOI 10.1007/s10237-012-0382-y; Appelman TP, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003314; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; CARTER DR, 1988, J ORTHOPAED RES, V6, P804, DOI 10.1002/jor.1100060604; Carter DR, 2003, PHILOS T ROYAL SOC B, V358; Chahine NO, 2007, EUR CELLS MATER, V13, P100, DOI 10.22203/eCM.v013a11; Choi JB, 2007, J BIOMECHANICS, V40; COHEN B, 1994, J ORTHOP RES, V12, P804, DOI 10.1002/jor.1100120608; Cohen B, 1998, J BIOMECHANICAL ENG, V120; Destrade M, 2012, INT J NUMER METH ENG, V90, P403, DOI 10.1002/nme.3326; EGGLI PS, 1985, ANAT REC, V211, P246, DOI 10.1002/ar.1092110304; FROST HM, 1990, ANAT RECORD, V226, P423, DOI 10.1002/ar.1092260404; Frost HM, 1997, BONE, V20, P385, DOI 10.1016/S8756-3282(97)00019-7; Gao J., 2014, OPEN J BIOPHYS, V4, P13, DOI [DOI 10.4236/OJBIPHY.2014.41003, 10.4236/ojbiphy.2014.41003]; GUILAK F, 1995, J ORTHOP RES, V13, P410, DOI 10.1002/jor.1100130315; Guilak F, 2000, J BIOMECH, V33, P1663, DOI 10.1016/S0021-9290(00)00105-6; HORI RY, 1976, J BIOMECH, V9, P259, DOI 10.1016/0021-9290(76)90012-9; Hueter C, 1862, VIRKOWS ARCH PATH AN, V25, P28; Hui TH, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.118101; Jiang HY, 2013, BIOPHYS J, V105, P609, DOI 10.1016/j.bpj.2013.06.021; Jin H, 2004, J BIOMECH ENG-T ASME, V126, P138, DOI 10.1115/1.1688772; Koay EJ, 2003, J BIOMECH ENG-T ASME, V125, P334, DOI 10.1115/1.1572517; Lai VK, 2013, J BIOMECHANICAL ENG, V135; Leipzig ND, 2005, J BIOMECH, V38, P77, DOI 10.1016/j.jbiomech.2004.03.013; Lerner AL, 1997, J ORTHOP RES, V15, P353, DOI 10.1002/jor.1100150307; Lerner AL, 1998, J BIOMECH, V31, P327, DOI 10.1016/S0021-9290(98)00015-3; LIPPIELLO L, 1989, J ORTHOPAED RES, V7, P868, DOI 10.1002/jor.1100070613; Madden R, 2013, J BIOMECH, V46, P554, DOI 10.1016/j.jbiomech.2012.09.021; Mao JJ, 2004, AM J ORTHOD DENTOFAC, V125, P676, DOI 10.1016/j.ajodo.2003.08.024; Mobasheri A, 2002, CELL BIOL INT, V26, P1, DOI 10.1006/cbir.2001.0826; Moeendarbary E, 2013, NAT MATER, V12, P253, DOI [10.1038/NMAT3517, 10.1038/nmat3517]; Moo EK, 2014, J BIOMECH, V47, P1004, DOI 10.1016/j.jbiomech.2014.01.003; Nguyen BV, 2010, J ROYAL SOC INTERFAC, V7; Ofek G, 2009, BIOPHYS J, V97, P1873, DOI 10.1016/j.bpj.2009.07.050; PAUWELS F, 1960, Z Anat Entwicklungsgesch, V121, P478, DOI 10.1007/BF00523401; Piszczatowski S, 2012, ACTA BIOENG BIOMECH, V14, P93; Piszczatowski S, 2011, ACTA BIOENG BIOMECH, V13, P3; Radhakrishnan P, 2004, ANNALS OF BIOMEDICAL, V32; Rieppo J, 2001, 47 ANN M ORTH RES SO, P0440; SACHS F, 1991, MOL CELL BIOCHEM, V104, P57; Sergerie K, 2009, J BIOMECHANICS, V42; Shieh AC, 2006, J BIOMECH, V39, P1595, DOI 10.1016/j.jbiomech.2005.05.002; Stokes I. A. F., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P277; Trickey WR, 2000, J ORTHOPAED RES, V18, P891, DOI 10.1002/jor.1100180607; Tutorino JC, 2001, 47 ANN M ORTH RES SO; Verbruggen SW, 2012, J R SOC INTERFACE, V9, P2735, DOI 10.1098/rsif.2012.0286; Villemure I, 2007, J BIOMECHANICS, V40; Villemure I, 2009, J BIOMECHANICS, V42; Volkmann R., 1882, HDB ALLGEMEINEN SPEC; WATSON PA, 1991, FASEB J, V5, P2013, DOI 10.1096/fasebj.5.7.1707019; Wosu R, 2012, BIOMECH MODEL MECHAN, V11, P303, DOI 10.1007/s10237-011-0310-6; Zhou EH, 2009, P NATL ACAD SCI USA, V106, P10632, DOI 10.1073/pnas.0901462106	56	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124862	10.1371/journal.pone.0124862	http://dx.doi.org/10.1371/journal.pone.0124862			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885547	gold, Green Published, Green Submitted			2022-12-26	WOS:000353017000146
J	Li, ZY; Wang, N; Dong, L; Bai, H; Quan, JZ; Liu, L; Dong, ZP				Li, Zhi Yong; Wang, Nan; Dong, Li; Bai, Hui; Quan, Jian Zhang; Liu, Lei; Dong, Zhi-Ping			Differential Gene Expression in Foxtail Millet during Incompatible Interaction with Uromyces setariae-italicae	PLOS ONE			English	Article							CONFERS RESISTANCE; PROTEIN-KINASE; PLANT; IDENTIFICATION; PATHOGEN; DEFENSE; STRESS; RUST; SGT1; RNA	Foxtail millet (Setaria italica) is an important food and fodder grain crop that is grown for human consumption. Production of this species is affected by several plant diseases, such as rust. The cultivar Shilixiang has been identified as resistant to the foxtail millet rust pathogen, Uromyces setariae-italicae. In order to identify signaling pathways and genes related to the plant's defense mechanisms against rust, the Shilixiang cultivar was used to construct a digital gene expression (DGE) library during the interaction of foxtail millet with U. setariae-italicae. In this study, we determined the most abundant differentially expressed signaling pathways of up-regulated genes in foxtail millet and identified significantly up-regulated genes. Finally, quantitative real-time polymerase chain reaction (qRT-PCR) analysis was used to analyze the expression of nine selected genes, and the patterns observed agreed well with DGE analysis. Expression levels of the genes were also compared between a resistant cultivar Shilixiang and a susceptible cultivar Yugu-1, and the result indicated that expression level of Shilixiang is higher than that of Yugu-1. This study reveals the relatively comprehensive mechanisms of rust-responsive transcription in foxtail millet.	[Li, Zhi Yong; Wang, Nan; Dong, Li; Bai, Hui; Quan, Jian Zhang; Liu, Lei; Dong, Zhi-Ping] Hebei Acad Agr & Forestry Sci, Dept Plant Protect, Minor Cereal Crops Lab Hebei Prov, Natl Foxtail Millet Improvement Ctr,Millet Inst, Shijiazhuang, Peoples R China; [Wang, Nan] Hebei Normal Univ, Coll Life Sci, Shijiazhuang, Peoples R China	Hebei Academy of Agricultural & Forestry Sciences; Hebei Normal University	Dong, ZP (corresponding author), Hebei Acad Agr & Forestry Sci, Dept Plant Protect, Minor Cereal Crops Lab Hebei Prov, Natl Foxtail Millet Improvement Ctr,Millet Inst, Shijiazhuang, Peoples R China.	dzping001@163.corn		li, zhiyong/0000-0001-6668-3009	National Natural Science Foundation of China [31271787, 31101163]; Natural Science Foundation of China of Hebei [C2013301037, C2014301028]; Special Project for Key Basic Research of 973 Program [2014CB160305]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of China of Hebei; Special Project for Key Basic Research of 973 Program	This work was supported by the National Natural Science Foundation of China (31271787, 31101163), the Natural Science Foundation of China of Hebei (C2013301037, C2014301028), and Special Project for Key Basic Research of 973 Program (2014CB160305). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin MJ, 2002, SCIENCE, V295, P2077, DOI 10.1126/science.1067747; Azevedo C, 2002, SCIENCE, V295, P2073, DOI 10.1126/science.1067554; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Bravo JM, 2003, PLANT MOL BIOL, V52, P745, DOI 10.1023/A:1025016416951; Cai GH, 2014, PLANT SCI, V214, P57, DOI 10.1016/j.plantsci.2013.09.014; Chi YJ, 2013, MOL PLANT, V6, P287, DOI 10.1093/mp/sst026; Crampton BG, 2009, MOL PLANT PATHOL, V10, P291, DOI 10.1111/j.1364-3703.2008.00532.x; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; de Wit PJGM, 2007, CELL MOL LIFE SCI, V64, P2726, DOI 10.1007/s00018-007-7284-7; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; FOFANA B, 2007, INT J PLANT GENOMICS, P1, DOI DOI 10.1155/2007/17542; Gomez-Vasquez R, 2004, ANN BOT-LONDON, V94, P87, DOI 10.1093/aob/mch107; Goodman R. N., 1994, HYPERSENSITIVE REACT; Jia GQ, 2013, NAT GENET, V45, P957, DOI 10.1038/ng.2673; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kobayashi M, 2012, NEW PHYTOL, V196, P223, DOI 10.1111/j.1469-8137.2012.04226.x; Kumar KRR, 2011, PLANT MOL BIOL, V75, P497, DOI 10.1007/s11103-011-9747-3; Lata C, 2013, CRIT REV BIOTECHNOL, V33, P328, DOI 10.3109/07388551.2012.716809; Li YG, 2011, AGR SCI CHINA, V10, P902, DOI 10.1016/S1671-2927(11)60075-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ludwig AA, 2005, P NATL ACAD SCI USA, V102, P10736, DOI 10.1073/pnas.0502954102; Macho AP, 2014, MOL CELL, V54, P263, DOI 10.1016/j.molcel.2014.03.028; Martin GB, 2003, ANNU REV PLANT BIOL, V54, P23, DOI 10.1146/annurev.arplant.54.031902.135035; Menke FLH, 2005, MOL PLANT MICROBE IN, V18, P1027, DOI 10.1094/MPMI-18-1027; Muthamilarasan M, 2015, THEOR APPL GENET, V128, P1, DOI 10.1007/s00122-014-2399-3; Muthamilarasan M, 2013, J BIOSCIENCES, V38, P433, DOI 10.1007/s12038-013-9302-2; NARASIMHAN MJ, 1964, MYCOLOGIA, V56, P555, DOI 10.2307/3756360; Qi XH, 2012, GENOMICS, V99, P160, DOI 10.1016/j.ygeno.2011.12.008; Rep M, 2002, PLANT PHYSIOL, V130, P904, DOI 10.1104/pp.007427; Sekhon RS, 2006, PHYSIOL MOL PLANT P, V69, P109, DOI 10.1016/j.pmpp.2007.02.004; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tang Q, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-343; Tian DQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-827; Xiao SQ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-544; Yang YO, 1997, GENE DEV, V11, P1621, DOI 10.1101/gad.11.13.1621; Zhao LiQiang, 2010, Scientia Agricultura Sinica, V43, P4349; Zhou J, 2014, MOL PLANT PATHOL, V15, P637, DOI 10.1111/mpp.12118	37	8	8	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123825	10.1371/journal.pone.0123825	http://dx.doi.org/10.1371/journal.pone.0123825			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885767	Green Published, gold, Green Submitted			2022-12-26	WOS:000353017000087
J	Xu, XB; Tan, Y; Chen, S; Yang, GS; Su, WZ				Xu, Xibao; Tan, Yan; Chen, Shuang; Yang, Guishan; Su, Weizhong			Urban Household Carbon Emission and Contributing Factors in the Yangtze River Delta, China	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; DIOXIDE EMISSIONS; CO2 EMISSIONS; LIFE-STYLE; ENERGY USE; IMPACT; CONSUMPTION; TRANSPORT; BEHAVIOR; FRANCE	Carbon reduction at the household level is an integral part of carbon mitigation. This study analyses the characteristics, effects, contributing factors and policies for urban household carbon emissions in the Yangtze River Delta of China. Primary data was collected through structured questionnaire surveys in three cities in the region - Nanjing, Ningbo, and Changzhou in 2011. The survey data was first used to estimate the magnitude of household carbon emissions in different urban contexts. It then examined how, and to what extent, each set of demographic, economic, behavioral/cognitive and spatial factors influence carbon emissions at the household level. The average of urban household carbon emissions in the region was estimated to be 5.96 tonnes CO2 in 2010. Energy consumption, daily commuting, garbage disposal and long-distance travel accounted for 51.2%, 21.3%, 16.0% and 11.5% of the total emission, respectively. Regulating rapidly growing car-holdings of urban households, stabilizing population growth, and transiting residents' low-carbon awareness to household behavior in energy saving and other spheres of consumption in the context of rapid population aging and the growing middle income class are suggested as critical measures for carbon mitigation among urban households in the Yangtze River Delta.	[Xu, Xibao; Chen, Shuang; Yang, Guishan; Su, Weizhong] Chinese Acad Sci, Nanjing Inst Geog & Limnol, Key Lab Watershed Geog Sci, Nanjing, Jiangsu, Peoples R China; [Tan, Yan] Univ Adelaide, Dept Geog Environm & Populat, Adelaide, SA, Australia	Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; University of Adelaide	Xu, XB (corresponding author), Chinese Acad Sci, Nanjing Inst Geog & Limnol, Key Lab Watershed Geog Sci, Nanjing, Jiangsu, Peoples R China.	xbxu@niglas.ac.cn		Tan, Yan/0000-0002-4013-1713	Knowledge Innovation Project of the Chinese Academy of Sciences [KZCX2-EW-315]; National Natural Science Foundation of China [41030745, 41101565, 41371532]; Interdisciplinary Frontier Project of NIGLAS [NIGLAS2012135019]; Australian Research Council Discovery project [DP110105522]	Knowledge Innovation Project of the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Interdisciplinary Frontier Project of NIGLAS; Australian Research Council Discovery project(Australian Research Council)	This work was supported by the Knowledge Innovation Project of the Chinese Academy of Sciences (KZCX2-EW-315) (http://www.cas.cn/), supporting study design, data collection and analysis; National Natural Science Foundation of China (41030745; 41101565; 41371532) (http://www.nsfc.gov.cn/), supporting data collection and analysis, preparation of the manuscript; Interdisciplinary Frontier Project of NIGLAS (NIGLAS2012135019) (http://www.niglas.ac.cn/), supporting data collection and analysis, and preparation of the manuscript; and Australian Research Council Discovery project (DP110105522) (http://www.arc.gov.au/ncgp/dp/dp_default.htm), supporting preparation of the manuscript.	Baiocchi G, 2010, J IND ECOL, V14, P50, DOI 10.1111/j.1530-9290.2009.00216.x; Bin S, 2005, ENERG POLICY, V33, P197, DOI 10.1016/S0301-4215(03)00210-6; Boussauw K, 2009, TRANSPORT RES A-POL, V43, P580, DOI 10.1016/j.tra.2009.02.005; Buchs M, 2013, ECOL ECON, V90, P114, DOI 10.1016/j.ecolecon.2013.03.007; Chancel L, 2014, ECOL ECON, V100, P195, DOI 10.1016/j.ecolecon.2014.02.009; Dalton M, 2008, ENERG ECON, V30, P642, DOI 10.1016/j.eneco.2006.07.002; Davis J, 2010, FOOD RES INT, V43, P1874, DOI 10.1016/j.foodres.2009.08.017; Dietz T, 2009, P NATL ACAD SCI USA, V106, P18452, DOI 10.1073/pnas.0908738106; Druckman A, 2012, ECOL ECON, V84, P153, DOI 10.1016/j.ecolecon.2012.09.008; Duffy A, 2013, TRANSPORT RES D-TR E, V19, P13, DOI 10.1016/j.trd.2012.09.005; Editorial Committee of Annual Report on Development of Small and Medium-Sized Cities in China, 2010, ANN REP DEV SMALL ME; EHRLICH PR, 1971, SCIENCE, V171, P1212, DOI 10.1126/science.171.3977.1212; Fan JL, 2013, APPL ENERG, V101, P323, DOI 10.1016/j.apenergy.2012.01.020; Feng KS, 2009, ECOL ECON, V69, P145, DOI 10.1016/j.ecolecon.2009.08.007; Feng ZH, 2011, ENERGY, V36, P656, DOI 10.1016/j.energy.2010.09.049; Golley J, 2012, ENERG ECON, V34, P1864, DOI 10.1016/j.eneco.2012.07.025; Gu ZH, 2013, SUSTAIN CITIES SOC, V7, P52, DOI 10.1016/j.scs.2012.11.004; Guan D, 2008, GLOBAL ENVIRON CHANG, V18, P626, DOI 10.1016/j.gloenvcha.2008.08.001; International Energy Agency, 2013, CO2 EM FUEL COMB 201; IPCC, 2006, 2006 IPCC GUIDELINES; IPCC, 2014, CLIM CHANG 2014 SYNT; Jin RL, 2010, INT J NONLINEAR SCI, V10, P259; Kim T, 2013, HABITAT INT, V38, P192, DOI 10.1016/j.habitatint.2012.06.006; Kok R, 2006, ENERG POLICY, V34, P2744, DOI 10.1016/j.enpol.2005.04.006; Lin T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055642; Lu L, 2010, SCI TECHNOLOGY INFOR, V27, P253; Meier T, 2012, INT J LIFE CYCLE ASS, V17, P550, DOI 10.1007/s11367-012-0387-x; National Development and Reform Commission, 2010, REG PLAN YANGTZ RIV; National People's Congress, 2013, REP URB DEV; Olivier JGJ, 2013, TRENDS GLOBAL CO2 EM; Qi Y., 2012, ANN REV LOW CARBON D; Social Development Squad of the Ministry of Science and Technology, 2007, HDB EN SAV EM RED; Tian GJ, 2011, ECOL MODEL, V222, P865, DOI 10.1016/j.ecolmodel.2010.09.036; Vieux F, 2012, ECOL ECON, V75, P91, DOI 10.1016/j.ecolecon.2012.01.003; Wang Hai-kun, 2011, China Environmental Science, V31, P1029; Wang Z, 2012, THESIS U SCI TECHNOL; Weber CL, 2008, ECOL ECON, V66, P379, DOI 10.1016/j.ecolecon.2007.09.021; Wei YM, 2007, ENERG POLICY, V35, P247, DOI 10.1016/j.enpol.2005.11.020; White House, 2014, US CHIN JOINT ANN CL; Wright LA, 2011, CARBON MANAG, V2, P61, DOI 10.4155/CMT.10.39; [谢鸿宇 XIE Hongyu], 2011, [生态学报, Acta Ecologica Sinica], V31, P3551; Xinhuanet, 2014, CHIN URB PLAN 2014 2; Xinhuanet, 2013, CHIN EAS ON CHILD PO; [杨选梅 Yang Xuanmei], 2010, [中国人口·资源与环境, China Population·Resources and Environment], V20, P35; [翟石艳 Zhai Shiyan], 2013, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V22, P94; Zhang Q., 2012, CHINA POPULATION ENV, V22, P35; 张涛, 2012, [环境污染与防治, Environmental Pollution & Control], V34, P102	47	35	36	11	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0121604	10.1371/journal.pone.0121604	http://dx.doi.org/10.1371/journal.pone.0121604			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EX	25884853	gold, Green Published, Green Submitted			2022-12-26	WOS:000353017000021
J	Alfano, L; Costa, C; Caporaso, A; Altieri, A; Indovina, P; Macaluso, M; Giordano, A; Pentimalli, F				Alfano, L.; Costa, C.; Caporaso, A.; Altieri, A.; Indovina, P.; Macaluso, M.; Giordano, A.; Pentimalli, F.			NONO regulates the intra-S-phase checkpoint in response to UV radiation	ONCOGENE			English	Article							DNA-DAMAGE RESPONSE; STRAND BREAK REPAIR; SPLICING-FACTOR; MESSENGER-RNA; CHK1 ACTIVATION; ATR ACTIVATION; RPA-SSDNA; PROTEIN; PHOSPHORYLATION; REPLICATION	The main risk factor for skin cancer is ultraviolet (UV) exposure, which causes DNA damage. Cells respond to UV-induced DNA damage by activating the intra-S-phase checkpoint, which prevents replication fork collapse, late origin firing and stabilizes fragile sites. Recently, the 54-kDa multifunctional protein NONO was found to be involved in the non-homologous end-joining DNA repair process and in poly ADP-ribose polymerase 1 activation. Interestingly, NONO is mutated in several tumour types and emerged as a crucial factor underlying both melanoma development and progression. Therefore, we set out to evaluate whether NONO could be involved in the DNA-damage response to UV radiations. We generated NONO-silenced HeLa cell clones and found that lack of NONO decreased cell growth rate. Then, we challenged NONO-silenced cells with exposure to UV radiations and found that NONO-silenced cells, compared with control cells, continued to synthesize DNA, failed to block new origin firing and impaired CHK1S345 phosphorylation showing a defective checkpoint activation. Consistently, NONO is present at the sites of UV-induced DNA damage where it localizes to RAD9 foci. To position NONO in the DNA-damage response cascade, we analysed the loading onto chromatin of various intra-S-phase checkpoint mediators and found that NONO favours the loading of topoisomerase II-binding protein 1 acting upstream of the ATM and Rad3-related kinase activity. Strikingly, re-expression of NONO, through an sh-resistant mRNA, rescued CHK1S345 phosphorylation in NONO-silenced cells. Interestingly, NONO silencing affected cell response to UV radiations also in a melanoma cell line. Overall, our data uncover a new role for NONO in mediating the cellular response to UV-induced DNA damage.	[Alfano, L.; Costa, C.; Altieri, A.; Pentimalli, F.] IRCCS, Ist Nazl Tumori Fdn G Pascale, CROM, Naples, Italy; [Caporaso, A.; Indovina, P.; Giordano, A.] Univ Siena, Dept Med Surg & Neurosci, Via Laterina 8, I-53100 Siena, Italy; [Caporaso, A.; Indovina, P.; Giordano, A.] ITT, Siena, Italy; [Indovina, P.; Macaluso, M.; Giordano, A.] Temple Univ, Sbarro Inst Canc Res & Mol Med, Coll Sci & Technol, BioLife Sci Bldg,Suite 333,1900N 12th St, Philadelphia, PA 19122 USA; [Indovina, P.; Macaluso, M.; Giordano, A.] Temple Univ, Coll Sci & Technol, Ctr Biotechnol, BioLife Sci Bldg,Suite 333,1900N 12th St, Philadelphia, PA 19122 USA	IRCCS Fondazione Pascale; University of Siena; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Giordano, A (corresponding author), Temple Univ, Sbarro Inst Canc Res & Mol Med, Coll Sci & Technol, BioLife Sci Bldg,Suite 333,1900N 12th St, Philadelphia, PA 19122 USA.; Giordano, A (corresponding author), Temple Univ, Coll Sci & Technol, Ctr Biotechnol, BioLife Sci Bldg,Suite 333,1900N 12th St, Philadelphia, PA 19122 USA.; Pentimalli, F (corresponding author), IRCCS, Ist Nazl Per Lo Studio E La Cura Dei Tumori Fdn G, Oncol Res Ctr Mercogliano CROM, Via Ammiraglio Bianco, I-83013 Avellino, Italy.	giordano@temple.edu; f.pentimalli@istitutotumori.na.it	Giordano, Antonio/F-1927-2010; Giordano, Antonio/AAU-1201-2020; Alfano, Luigi/B-8330-2015; Costa, Caterina/N-1742-2019; Costa, Caterina/ABE-2452-2020; Pentimalli, Francesca/K-4936-2014	Giordano, Antonio/0000-0002-5959-016X; Giordano, Antonio/0000-0002-5959-016X; Alfano, Luigi/0000-0002-4516-9956; Costa, Caterina/0000-0003-0909-7366; Pentimalli, Francesca/0000-0003-4740-6801; Indovina, Paola/0000-0001-8416-435X	Sbarro Health Research Organization; Human Health Foundation; Commonwealth of Pennsylvania; Associazione Italiana per la Ricerca sul Cancro [AIRC IG 15690]	Sbarro Health Research Organization; Human Health Foundation; Commonwealth of Pennsylvania; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	We are thankful to the Sbarro Health Research Organization (http://www.shro.org), the Human Health Foundation (http://www.hhfonlus.org), the Commonwealth of Pennsylvania and the Associazione Italiana per la Ricerca sul Cancro (AIRC IG 15690) for their support. We are grateful to Pasquale Barba and Laura Pisapia (Consiglio Nazionale delle Ricerche-Institute of Genetics and Biophysics, Naples, Italy) for the FACS analyses. We also thank Larry M Karnitz, Division of Oncology Research, Mayo Clinic, Rochester, MN, USA for his help in sharing reagents and Marco G Paggi, Regina Elena National Cancer Institute, Rome, Italy for the M14 cell line. Prof Giordano is the director of research line 3 at CROM, Istituto Nazionale Tumori 'Fondazione G. Pascale'-IRCCS, Naples, Italy.	Adamson B, 2012, NAT CELL BIOL, V14, P318, DOI 10.1038/ncb2426; Banck MS, 2013, J CLIN INVEST, V123, P2502, DOI 10.1172/JCI67963; Bao SD, 2001, NATURE, V411, P969, DOI 10.1038/35082110; Bladen CL, 2005, J BIOL CHEM, V280, P5205, DOI 10.1074/jbc.M412758200; Branzei D, 2009, DNA REPAIR, V8, P1038, DOI 10.1016/j.dnarep.2009.04.014; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Clark J, 1997, ONCOGENE, V15, P2233, DOI 10.1038/sj.onc.1201394; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; DONG BH, 1993, NUCLEIC ACIDS RES, V21, P4085, DOI 10.1093/nar/21.17.4085; Duursma AM, 2013, MOL CELL, V50, P116, DOI 10.1016/j.molcel.2013.03.006; Ellison V, 2003, PLOS BIOL, V1, P231, DOI 10.1371/journal.pbio.0000033; Flynn RL, 2011, TRENDS BIOCHEM SCI, V36, P133, DOI 10.1016/j.tibs.2010.09.005; Furuya K, 2004, GENE DEV, V18, P1154, DOI 10.1101/gad.291104; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Ishiguro H, 2003, INT J CANCER, V105, P26, DOI 10.1002/ijc.11021; Ishii T, 2010, J BIOL CHEM, V285, P41993, DOI 10.1074/jbc.M110.161661; Kaufmann WK, 2010, CARCINOGENESIS, V31, P751, DOI 10.1093/carcin/bgp230; Kowalska E, 2013, P NATL ACAD SCI USA, V110, P1592, DOI 10.1073/pnas.1213317110; Krietsch J, 2012, NUCLEIC ACIDS RES, V40, P10287, DOI 10.1093/nar/gks798; Kuhnert A, 2012, J CELL BIOCHEM, V113, P1744, DOI 10.1002/jcb.24045; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Lee J, 2010, MOL BIOL CELL, V21, P926, DOI 10.1091/mbc.E09-11-0958; Li SY, 2014, NUCLEIC ACIDS RES, V42, P9771, DOI 10.1093/nar/gku650; Li SY, 2009, NUCLEIC ACIDS RES, V37, P6746, DOI 10.1093/nar/gkp741; Liu QH, 2000, GENE DEV, V14, P1448; Liu SQ, 2012, NUCLEIC ACIDS RES, V40, P10780, DOI 10.1093/nar/gks849; Liu S, 2006, MOL CELL BIOL, V26, P6056, DOI 10.1128/MCB.00492-06; Liu SZ, 2011, MOL CELL, V43, P192, DOI 10.1016/j.molcel.2011.06.019; Ma HT, 2011, METHODS MOL BIOL, V761, P151, DOI 10.1007/978-1-61779-182-6_10; Marechal A, 2014, MOL CELL, V53, P235, DOI 10.1016/j.molcel.2013.11.002; Martinez-Ramos I, 2005, J CELL BIOCHEM, V96, P79, DOI 10.1002/jcb.20428; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Medhurst AL, 2008, J CELL SCI, V121, P3933, DOI 10.1242/jcs.033688; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; Nelson LD, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-38; Oakley GG, 2010, FRONT BIOSCI-LANDMRK, V15, P883, DOI 10.2741/3652; Parrilla-Castellar ER, 2004, DNA REPAIR, V3, P1009, DOI 10.1016/j.dnarep.2004.03.032; Paulsen RD, 2009, MOL CELL, V35, P228, DOI 10.1016/j.molcel.2009.06.021; Pavao M, 2001, BMC CANCER, V1, DOI 10.1186/1471-2407-1-15; Rajesh C, 2011, NUCLEIC ACIDS RES, V39, P132, DOI 10.1093/nar/gkq738; Rappas M, 2011, NUCLEIC ACIDS RES, V39, P313, DOI 10.1093/nar/gkq743; Rosonina E, 2005, MOL CELL BIOL, V25, P6734, DOI 10.1128/MCB.25.15.6734-6746.2005; Salton M, 2010, CELL CYCLE, V9, P1568, DOI 10.4161/cc.9.8.11298; Schiffnery S, 2011, CARCINOGENESIS, V32, P1176, DOI 10.1093/carcin/bgr103; Shav-Tal Y, 2002, FEBS LETT, V531, P109, DOI 10.1016/S0014-5793(02)03447-6; Sievers C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012735; Skalsky YM, 2001, ONCOGENE, V20, P178, DOI 10.1038/sj.onc.1204056; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Straub T, 2000, BIOCHEMISTRY-US, V39, P7552, DOI 10.1021/bi992898e; Swift LH, 2014, INT J MOL SCI, V15, P3403, DOI 10.3390/ijms15033403; Talman V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020053; Wang X, 2006, MOL CELL, V23, P331, DOI 10.1016/j.molcel.2006.06.022; Willis N, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-13; Zhang Z, 2001, CELL, V106, P465, DOI 10.1016/S0092-8674(01)00466-4; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302; Zou L, 2003, P NATL ACAD SCI USA, V100, P13827, DOI 10.1073/pnas.2336100100; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	59	21	21	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 4	2016	35	5					567	576		10.1038/onc.2015.107	http://dx.doi.org/10.1038/onc.2015.107			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DC9NR	25893301				2022-12-26	WOS:000369548800004
J	Koo, J; Wu, XY; Mao, ZX; Khuri, FR; Sun, SY				Koo, Junghui; Wu, Xiaoyun; Mao, Zixu; Khuri, Fadlo R.; Sun, Shi-Yong			Rictor Undergoes Glycogen Synthase Kinase 3 (GSK3)-dependent, FBXW7-mediated Ubiquitination and Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MTOR COMPLEX 2; LUNG-CANCER CELLS; TUMOR-SUPPRESSOR; C-MYC; DEPENDENT DEGRADATION; PHOSPHORYLATION; FBW7; AKT; APOPTOSIS; DIFFERENTIATION	Rictor, an essential component of mTOR complex 2 (mTORC2), plays a pivotal role in regulating mTOR signaling and other biological functions. Posttranslational regulation of rictor (e.g. via degradation) and its underlying mechanism are largely undefined and thus are the focus of this study. Chemical inhibition of the proteasome increased rictor ubiquitination and levels. Consistently, inhibition of FBXW7 with various genetic means including knockdown, knock-out, and enforced expression of a dominant-negative mutant inhibited rictor ubiquitination and increased rictor levels, whereas enforced expression of FBXW7 decreased rictor stability and levels. Moreover, we detected an interaction between FBXW7 and rictor. Hence, rictor is degraded through an FBXW7-mediated ubiquitination/proteasome mechanism. We show that this process is dependent on glycogen synthase kinase 3 (GSK3): GSK3 was associated with rictor and directly phosphorylated the Thr-1695 site in a putative CDC4 phospho-degron motif of rictor; mutation of this site impaired the interaction between rictor and FBXW7, decreased rictor ubiquitination, and increased rictor stability. Finally, enforced activation of Akt enhanced rictor levels and increasedmTORC2activity as evidenced by increased formation of mTORC2 and elevated phosphorylation of Akt, SGK1, and PKC alpha. Hence we suggest that PI3K/Akt signaling may positively regulate mTORC2 signaling, likely through suppressing GSK3-dependent rictor degradation.	[Koo, Junghui; Wu, Xiaoyun; Khuri, Fadlo R.; Sun, Shi-Yong] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Mao, Zixu] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Mao, Zixu] Winship Canc Inst, Atlanta, GA 30322 USA	Emory University; Emory University	Sun, SY (corresponding author), Emory Univ, Sch Med, 1365-C Clifton Rd NE,C3088, Atlanta, GA 30322 USA.	ssun@emory.edu	Khuri, Fadlo R./AAU-4942-2020; Regan, Clinton/E-6250-2012	Khuri, Fadlo R./0000-0002-8638-7618; 	National Institutes of Health [R01 CA118450, R01 CA160522]; NATIONAL CANCER INSTITUTE [R01CA160522, R01CA118450] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant R01 CA118450 ( to S.-Y. S.) and R01 CA160522 ( to S.-Y. S.).	Chen CH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001731; Chen SZ, 2011, CANCER RES, V71, P6270, DOI 10.1158/0008-5472.CAN-11-0838; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Elrod HA, 2007, MOL CANCER THER, V6, P2029, DOI 10.1158/1535-7163.MCT-07-0004; Fu L, 2009, CANCER RES, V69, P8967, DOI 10.1158/0008-5472.CAN-09-2190; Gao DM, 2010, MOL CELL, V39, P797, DOI 10.1016/j.molcel.2010.08.016; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; Guo Z, 2012, BIOCHEM BIOPH RES CO, V418, P426, DOI 10.1016/j.bbrc.2012.01.054; Hagan GN, 2008, MOL CELL BIOL, V28, P4215, DOI 10.1128/MCB.00867-07; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Kanei-Ishii C, 2008, J BIOL CHEM, V283, P30540, DOI 10.1074/jbc.M804340200; Kitagawa K, 2009, ONCOGENE, V28, P2393, DOI 10.1038/onc.2009.111; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lee K, 2012, J EXP MED, V209, P713, DOI 10.1084/jem.20111470; Liu XG, 2004, JNCI-J NATL CANCER I, V96, P1769, DOI 10.1093/jnci/djh322; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Mao JH, 2008, SCIENCE, V321, P1499, DOI 10.1126/science.1162981; McDonald PC, 2008, CANCER RES, V68, P1618, DOI 10.1158/0008-5472.CAN-07-5869; Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586; Roulin D, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-57; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Soucy Teresa A, 2010, Genes Cancer, V1, P708, DOI 10.1177/1947601910382898; Sparks CA, 2010, ONCOGENE, V29, P3733, DOI 10.1038/onc.2010.139; Sun SY, 1999, ONCOGENE, V18, P2357, DOI 10.1038/sj.onc.1202543; Treins C, 2010, ONCOGENE, V29, P1003, DOI 10.1038/onc.2009.401; Wang ZW, 2012, FEBS LETT, V586, P1409, DOI 10.1016/j.febslet.2012.03.017; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217	31	48	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					14120	14129		10.1074/jbc.M114.633057	http://dx.doi.org/10.1074/jbc.M114.633057			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25897075	Green Published, hybrid			2022-12-26	WOS:000355313000040
J	Leithner, K; Naderer, A; Hartung, D; Abrahamowicz, C; Alexopoulos, J; Walch, K; Wenzl, R; Hilger, E				Leithner, Katharina; Naderer, Andrea; Hartung, Dorothee; Abrahamowicz, Clara; Alexopoulos, Johanna; Walch, Katharina; Wenzl, Rene; Hilger, Eva			Sexual and Psychosocial Functioning in Women with MRKHS after Neovaginoplasty According to Wharton-Sheares-George: A Case Control Study	PLOS ONE			English	Article							KUSTER-HAUSER-SYNDROME; MOTHER-DAUGHTER RELATIONSHIP; VAGINAL AGENESIS; LAPAROSCOPIC DAVYDOV; BONDING INSTRUMENT; INDEX FSFI; VAGINOPLASTY; CREATION; OUTCOMES; UTILITY	Background Mayer-Rokitansky-Kuster-Hauser syndrome (MRKHS) has a major impact on a woman's psychological and sexual well-being. In most of the studies that addressed treatment techniques, postoperative sexual function was reported to be satisfactory; however, comparatively few studies have additionally provided an accurate analysis of psychosocial functions in MRKHS patients following different kinds of neovaginal treatment. This study is to evaluate sexual and psychosocial functioning after creation of a neovagina according to Wharton-Sheares-George in women with MRKHS. Methods We performed a case-control-study using multiple measures to assess sexual and psychosocial functioning. Ten MRKHS patients and 20 controls of a University hospital and tertiary center for pediatric and adolescent gynecology were assessed. The follow-up assessment comprised 6 standardized questionnaires (Female Sexuality Function Index, FSFI; Patient Health Questionnaire, PHQ; Brief Symptom Inventory, BSI; World Health Organization Quality of Life Assessment, WHOQoL-BREF; Parental Bonding Instrument, PBI; and a German questionnaire on body image). The main outcome measures were sexual function, psychological status, quality of life, body image, and parental bonding styles. Findings Sexual function, psychological status (including depressive and somatic symptoms), quality of life, and own-body experience were at least as good in operated MRKHS patients as in controls. In some measures (FSFI, PHQ-15, psychological domain of the WHOQoL-BREF, and BSI Positive Symptom Total), patients scored significantly better than controls. The results of the PBI indicated a close and sustainable mother-daughter-relationship in MRKHS patients. Conclusions We found no evidence for an impairment of sexual or psychosocial functioning in patients after neovaginoplasty according to Wharton-Sheares-George. MRKHS may not necessarily compromise sexual and psychological well-being, provided that the syndrome is properly managed by a multidisciplinary team of health professionals.	[Leithner, Katharina; Naderer, Andrea; Hartung, Dorothee; Abrahamowicz, Clara; Alexopoulos, Johanna] Med Univ Vienna, Dept Psychoanal & Psychotherapy, Vienna, Austria; [Walch, Katharina; Wenzl, Rene] Med Univ Vienna, Dept Obstet & Gynaecol, Div Gynaecol & Gynaecol Oncol, Vienna, Austria; [Hilger, Eva] Med Univ Vienna, Dept Neurol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Leithner, K (corresponding author), Med Univ Vienna, Dept Psychoanal & Psychotherapy, Vienna, Austria.	katharina.leithner@meduniwien.ac.at		Leithner-Dziubas, Katharina/0000-0002-4982-3783				ACOG, 2013, OBSTET GYNECOL, V121, P1134, DOI DOI 10.1097/01.AOG.0000429659.93470; Allen LM, 2010, FERTIL STERIL, V94, P2272, DOI 10.1016/j.fertnstert.2010.02.008; Angermeyer M, 2000, WHOQOL 100 WHOQOL BR; Bean EJ, 2009, J PEDIATR ADOL GYNEC, V22, P339, DOI 10.1016/j.jpag.2008.11.006; Berner MM, 2004, GEBURTSH FRAUENHEILK, V64, P293; Brun JL, 2002, EUR J OBSTET GYN R B, V103, P168, DOI 10.1016/S0301-2115(02)00031-3; Carrard C, 2012, FERTIL STERIL, V97, P691, DOI 10.1016/j.fertnstert.2011.12.015; Communal PH, 2003, FERTIL STERIL, V80, P600, DOI 10.1016/S0015-0282(03)00796-9; Csermely T, 2011, J PEDIATR ADOL GYNEC, V24, P147, DOI 10.1016/j.jpag.2010.12.008; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Edmonds DK, 2012, FERTIL STERIL, V97, P686, DOI 10.1016/j.fertnstert.2011.12.038; Fedele L, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.10.807; Fliegner M, 2014, J SEX MED, V11, P729, DOI 10.1111/jsm.12321; Fotopoulou C, 2010, FERTIL STERIL, V94, P317, DOI 10.1016/j.fertnstert.2009.01.154; Franke GH, 2000, BRIEFF S INV; Gatti C, 2010, J UROLOGY, V184, P1799, DOI 10.1016/j.juro.2010.03.078; Giannesi A, 2005, HUM REPROD, V20, P2954, DOI 10.1093/humrep/dei152; Gueniche K, 2014, B MENNINGER CLIN, V78, P57, DOI 10.1521/bumc.2014.78.1.57; HECKER BR, 1977, AM J OBSTET GYNECOL, V129, P543; Heller-Boersma JG, 2009, PSYCHOSOMATICS, V50, P277, DOI 10.1176/appi.psy.50.3.277; HERRMAN H, 1993, QUAL LIFE RES, V2, P153; Holt Re, 2003, Psychol Health Med, V8, P19, DOI 10.1080/1354850021000059232; Kimberley N, 2011, FERTIL STERIL, V95, P238, DOI 10.1016/j.fertnstert.2010.05.061; Klingele CJ, 2003, AM J OBSTET GYNECOL, V189, P1569, DOI 10.1016/S0002-9378(03)00938-4; Labus LD, 2011, SEX HEALTH, V8, P427, DOI 10.1071/SH10105; Langer M, 1990, ACTA OBSTET GYN SCAN, V69, P343, DOI 10.3109/00016349009036159; Laufer MR, 2002, CURR OPIN OBSTET GYN, V14, P441, DOI 10.1097/00001703-200210000-00001; Liao LM, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.013; Liu XS, 2009, J MINIM INVAS GYN, V16, P720, DOI 10.1016/j.jmig.2009.07.018; Loeser E, 2002, GEBURTSH FRAUENHEILK, V62, P1193, DOI 10.1055/s-2002-36371; Lowe BP, 2001, GESUNDHEITSFRAGENBOG; Mobus VJ, 1996, AM J OBSTET GYNECOL, V175, P617; Morcel K, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-13; Morgan EM, 2006, ARCH SEX BEHAV, V35, P607, DOI 10.1007/s10508-006-9054-2; PARKER G, 1990, SOC PSYCH PSYCH EPID, V25, P281, DOI 10.1007/BF00782881; Reck C, 2006, ARCH WOMEN MENT HLTH, V9, P265, DOI 10.1007/s00737-006-0144-x; Rosen R, 2000, J SEX MARITAL THER, V26, P191, DOI 10.1080/009262300278597; Schatz T, 2005, FERTIL STERIL, V83, P437, DOI 10.1016/j.fertnstert.2004.06.079; SHEARES BH, 1960, J OBSTET GYNAECOL, V67, P24; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Strauss B, 1996, FRAGEBOGEN BEURTELLI; Walch K, 2011, FERTIL STERIL, V96, P492, DOI 10.1016/j.fertnstert.2011.06.004; Zhu L, 2013, J SEX MED, V10, P1652, DOI 10.1111/jsm.12143	44	10	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124604	10.1371/journal.pone.0124604	http://dx.doi.org/10.1371/journal.pone.0124604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG5KV	25901735	Green Submitted, Green Published, gold			2022-12-26	WOS:000353331500094
J	Lyberopoulou, A; Aravantinos, G; Efstathopoulos, EP; Nikiteas, N; Bouziotis, P; Isaakidou, A; Papalois, A; Marinos, E; Gazouli, M				Lyberopoulou, Anna; Aravantinos, Gerasimos; Efstathopoulos, Efstathios P.; Nikiteas, Nikolaos; Bouziotis, Penelope; Isaakidou, Athina; Papalois, Apostolos; Marinos, Evangelos; Gazouli, Maria			Mutational Analysis of Circulating Tumor Cells from Colorectal Cancer Patients and Correlation with Primary Tumor Tissue	PLOS ONE			English	Article							PERIPHERAL-BLOOD; STEM-CELLS; MESENCHYMAL TRANSITION; KRAS; CARCINOMA; THERAPY; BRAF; CHEMOTHERAPY; METASTASES; RESISTANCE	Circulating tumor cells (CTCs) provide a non-invasive accessible source of tumor material from patients with cancer. The cellular heterogeneity within CTC populations is of great clinical importance regarding the increasing number of adjuvant treatment options for patients with metastatic carcinomas, in order to eliminate residual disease. Moreover, the molecular profiling of these rare cells might lead to insight on disease progression and therapeutic strategies than simple CTCs counting. In the present study we investigated the feasibility to detect KRAS, BRAF, CD133 and Plastin3 (PLS3) mutations in an enriched CTCs cell suspension from patients with colorectal cancer, with the hypothesis that these genes mutations are of great importance regarding the generation of CTCs subpopulations. Subsequently, we compared CTCs mutational status with that of the corresponding primary tumor, in order to access the possibility of tumor cells characterization without biopsy. CTCs were detected and isolated from blood drawn from 52 colorectal cancer (CRC) patients using a quantum-dot-labelled magnetic immunoassay method. Mutations were detected by PCR-RFLP or allele-specific PCR and confirmed by direct sequencing. In 52 patients, discordance between primary tumor and CTCs was 5.77% for KRAS, 3.85% for BRAF, 11.54% for CD133 rs3130, 7.69% for CD133 rs2286455 and 11.54% for PLS3 rs6643869 mutations. Our results support that DNA mutational analysis of CTCs may enable non-invasive, specific biomarker diagnostics and expand the scope of personalized medicine for cancer patients.	[Lyberopoulou, Anna; Marinos, Evangelos; Gazouli, Maria] Univ Athens, Sch Med, Dept Basic Med Sci, Biol Lab, GR-11527 Athens, Greece; [Aravantinos, Gerasimos; Isaakidou, Athina] Agioi Anargiroi Canc Hosp, Dept Med Oncol 2, Athens, Greece; [Efstathopoulos, Efstathios P.; Gazouli, Maria] Univ Athens, Sch Med, Dept Radiol 2, GR-11527 Athens, Greece; [Nikiteas, Nikolaos] Univ Athens, Sch Med, Laiko Gen Hosp, Dept Propedeut Surg 2, GR-11527 Athens, Greece; [Bouziotis, Penelope] NCSR Demokritos, Inst Nucl & Radiol Sci & Technol, Energy & Safety, Athens, Greece; [Papalois, Apostolos] ELPEN Pharmaceut, Exprerimental Res Ctr, Attiki, Greece	Athens Medical School; National & Kapodistrian University of Athens; Athens Medical School; National & Kapodistrian University of Athens; Athens Medical School; Laiko General Hospital; National & Kapodistrian University of Athens; National Centre of Scientific Research "Demokritos"	Gazouli, M (corresponding author), Univ Athens, Sch Med, Dept Basic Med Sci, Biol Lab, GR-11527 Athens, Greece.	mgazouli@med.uoa.gr	Gazouli, Maria/I-2572-2018; Nikiteas, Nikolaos I/A-3165-2009; Gazouli, Maria/W-6245-2019	Gazouli, Maria/0000-0002-3295-6811; Nikiteas, Nikolaos I/0000-0002-3996-1584; Gazouli, Maria/0000-0002-3295-6811; Aravantinos, Gerasimos/0000-0002-2106-1713	Experimental Research Center ELPEN Pharmaceuticals (E.R.C.E); Hellenic Society for Gastrointestinal Oncology (H.S.G.O.); non-profit organization of Greek Society of Cancer Biomarkers and Targeted Therapy	Experimental Research Center ELPEN Pharmaceuticals (E.R.C.E); Hellenic Society for Gastrointestinal Oncology (H.S.G.O.); non-profit organization of Greek Society of Cancer Biomarkers and Targeted Therapy	This study was funded by Scholarship-Grant by the Experimental Research Center ELPEN Pharmaceuticals (E.R.C.E), the Hellenic Society for Gastrointestinal Oncology (H.S.G.O.), and a non-profit organization of Greek Society of Cancer Biomarkers and Targeted Therapy. AP is employed by Experimental Research Center ELPEN Pharmaceuticals. Experimental Research Center ELPEN Pharmaceuticals provided support in the form of salary for author AP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Alamgeer M, 2013, RESPIROLOGY, V18, P757, DOI 10.1111/resp.12094; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Alunni-Fabbroni M, 2010, METHODS, V50, P289, DOI 10.1016/j.ymeth.2010.01.027; Andrea C, 2014, WORLD J GASTROENTERO, V20, P8921, DOI 10.3748/wjg.v20.i27.8921; Baas JM, 2011, ONCOLOGIST, V16, P1239, DOI 10.1634/theoncologist.2011-0024; Baldus SE, 2010, CLIN CANCER RES, V16, P790, DOI 10.1158/1078-0432.CCR-09-2446; Barault L, 2008, INT J CANCER, V122, P2255, DOI 10.1002/ijc.23388; Bonnomet A, 2010, J MAMMARY GLAND BIOL, V15, P261, DOI 10.1007/s10911-010-9174-0; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Ciombor KK, 2014, PHARMACOGEN PERS MED, V7, P137, DOI 10.2147/PGPM.S47582; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; De Roock W, 2011, LANCET ONCOL, V12, P594, DOI 10.1016/S1470-2045(10)70209-6; Devriese LA, 2011, CANCER TREAT REV, V37, P579, DOI 10.1016/j.ctrv.2011.04.006; European Medicine Agency, COMM MED PROD HUM US; Frederick BA, 2007, MOL CANCER THER, V6, P1683, DOI 10.1158/1535-7163.MCT-07-0138; Gazouli M, 2012, WORLD J GASTROENTERO, V18, P4419, DOI 10.3748/wjg.v18.i32.4419; Goutas N, 2008, ANTICANCER RES, V28, P305; Gutierrez C, 2013, ONCOL LETT, V6, P1343, DOI 10.3892/ol.2013.1544; Hatzaki A, 2001, MOL CELL PROBE, V15, P243, DOI 10.1006/mcpr.2001.0367; Hayes DF, 2006, CLIN CANCER RES, V12, P4218, DOI 10.1158/1078-0432.CCR-05-2821; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Joosse SA, 2013, CANCER RES, V73, P8, DOI 10.1158/0008-5472.CAN-12-3422; Kaiser J, 2010, SCIENCE, V327, P1072, DOI 10.1126/science.327.5969.1074; Kalikaki A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104902; Konigsberg R, 2011, ACTA ONCOL, V50, P700, DOI 10.3109/0284186X.2010.549151; Krebs MG, 2011, J CLIN ONCOL, V29, P1556, DOI 10.1200/JCO.2010.28.7045; Maheswaran S, 2010, CURR OPIN GENET DEV, V20, P96, DOI 10.1016/j.gde.2009.12.002; Melin C, 2012, ANAL CHEM, V84, P1549, DOI 10.1021/ac202797z; Meregalli M, 2010, EXPERT OPIN BIOL TH, V10, P1521, DOI 10.1517/14712598.2010.528386; Mostert B, 2013, INT J CANCER, V133, P130, DOI 10.1002/ijc.27987; Ning Y, 2014, MOL CANCER THER, V13, P528, DOI 10.1158/1535-7163.MCT-13-0646; Pawlik TM, 2007, J GASTROINTEST SURG, V11, P1057, DOI 10.1007/s11605-006-0061-3; Pinard R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-216; Pohl A, 2013, PHARMACOGENOMICS J, V13, P173, DOI 10.1038/tpj.2011.61; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Ren F, 2013, WORLD J GASTROENTERO, V19, P2603, DOI 10.3748/wjg.v19.i17.2603; Sastre J, 2012, ONCOLOGIST, V17, P947, DOI 10.1634/theoncologist.2012-0048; Satelli A, 2015, CLIN CHEM, V61, P259, DOI 10.1373/clinchem.2014.228122; Shah MM, 2014, GYNECOL ONCOL, V132, P483, DOI 10.1016/j.ygyno.2013.12.001; Sinha N, 2013, ORAL ONCOL, V49, P854, DOI 10.1016/j.oraloncology.2013.06.010; Sugimachi K, 2013, ANN SURG ONCOL; Tanase CP, 2014, WORLD J GASTROENTERO, V20, P10790, DOI 10.3748/wjg.v20.i31.10790; Theodoropoulos PA, 2010, CANCER LETT, V288, P99, DOI 10.1016/j.canlet.2009.06.027; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Wicha MS, 2011, J CLIN ONCOL, V29, P1508, DOI 10.1200/JCO.2010.34.0026; Xenidis N, 2006, J CLIN ONCOL, V24, P3756, DOI 10.1200/JCO.2005.04.5948; Xia T, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/420364; Yokobori T, 2013, CANCER RES, V73, P2059, DOI 10.1158/0008-5472.CAN-12-0326	52	39	41	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123902	10.1371/journal.pone.0123902	http://dx.doi.org/10.1371/journal.pone.0123902			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902072	Green Published, gold, Green Submitted			2022-12-26	WOS:000353331500065
J	Kapella, MC; Berger, BE; Vern, BA; Vispute, S; Prasad, B; Carley, DW				Kapella, Mary C.; Berger, Barbara E.; Vern, Boris A.; Vispute, Sachin; Prasad, Bharati; Carley, David W.			Health-Related Stigma as a Determinant of Functioning in Young Adults with Narcolepsy	PLOS ONE			English	Article							QUALITY-OF-LIFE; HOSPITAL ANXIETY; DAYTIME SLEEPINESS; DEPRESSION SCALE; IMPACT; PEOPLE; CATAPLEXY; EPILEPSY; VALIDITY; SELF	Symptoms of narcolepsy tend to arise during adolescence or young adulthood, a formative time in human development during which people are usually completing their education and launching a career. Little is known about the impact of narcolepsy on the social aspects of health-related quality of life in young adults. The purpose of this study was to examine relationships between health-related stigma, mood (anxiety and depression) and daytime functioning in young adults with narcolepsy compared to those without narcolepsy. Young adults (age 18-35) with narcolepsy (N = 122) and without narcolepsy (N = 93) were mailed a packet that included questionnaires and a self-addressed postage paid envelope. The questionnaire included demographic information and a composite of instruments including the SF 36, Functional Outcomes of Sleep Questionnaire (FOSQ), Fife Stigma Scale (FSS), Epworth Sleepiness Scale (ESS) and Hospital Anxiety and Depression Scale (HADS). Variable associations were assessed using descriptive statistics, ANOVA, Mann-Whitney U Test, correlations, stepwise multiple regression and path analysis. Young adults with narcolepsy perceived significantly more stigma and lower mood and health-related quality of life than young adults without narcolepsy (p<0.01). Health-related stigma was directly and indirectly associated with lower functioning through depressed mood. Fifty-two percent of the variance in functioning was explained by the final model in the young adults with narcolepsy. Health-related stigma in young adults with narcolepsy is at a level consistent with other chronic medical illnesses. Health-related stigma may be an important determinant of functioning in young adults with narcolepsy. Future work is indicated toward further characterizing stigma and developing interventions that address various domains of stigma in people with narcolepsy.	[Kapella, Mary C.; Berger, Barbara E.; Vern, Boris A.; Vispute, Sachin; Carley, David W.] Univ Illinois, Coll Nursing, Ctr Narcolepsy Sleep & Hlth Res, Dept Biobehav Hlth Sci, Chicago, IL 60612 USA; [Vern, Boris A.; Prasad, Bharati] Univ Illinois, Coll Med, Dept Pulm Crit Care Sleep & Allergy, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Kapella, MC (corresponding author), Univ Illinois, Coll Nursing, Ctr Narcolepsy Sleep & Hlth Res, Dept Biobehav Hlth Sci, Chicago, IL 60612 USA.	mkapel1@uic.edu	Vispute, Sachin/ABA-4299-2021; Prasad, Bharati/AAX-4823-2020	Prasad, Bharati/0000-0003-4280-996X	NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR013937] Funding Source: NIH RePORTER; NINR NIH HHS [R01 NR013937] Funding Source: Medline	NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		Baker GA, 2008, EPILEPSY BEHAV, V12, P395, DOI 10.1016/j.yebeh.2007.11.001; Balfe M, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-25; Bassetti C, 2007, NARCOLEPSY HYPERSOMN; Berger BE, 2001, RES NURS HEALTH, V24, P518, DOI 10.1002/nur.10011; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; BROUGHTON R, 1981, CAN J NEUROL SCI, V8, P299, DOI 10.1017/S0317167100043419; BROUGHTON RJ, 1984, EPILEPSIA, V25, P423, DOI 10.1111/j.1528-1157.1984.tb03438.x; BROUGHTON WA, 1994, SLEEP, V17, pS45, DOI 10.1093/sleep/17.suppl_8.S45; Browne JL, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005625; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carpenter JS, 1998, J PSYCHOSOM RES, V45, P5, DOI 10.1016/S0022-3999(97)00298-5; Chama S, 2015, AIDS CARE, V27, P789, DOI 10.1080/09540121.2014.989807; Crawford JR, 2001, BRIT J CLIN PSYCHOL, V40, P429, DOI 10.1348/014466501163904; Culbertson HBD, 2005, E J APPL PSYCHOL, V1, P14, DOI [10. 7790/ ejap. v1i1. 5, DOI 10.7790/EJAP.V1I1.5]; Daniels E, 2001, J SLEEP RES, V10, P75, DOI 10.1046/j.1365-2869.2001.00234.x; Dauvilliers Y, 2009, J NEUROL NEUROSUR PS, V80, P636, DOI 10.1136/jnnp.2008.161588; Dauvilliers Y, 2001, NEUROLOGY, V57, P2029, DOI 10.1212/WNL.57.11.2029; David A, 2012, SLEEP MED, V13, P273, DOI 10.1016/j.sleep.2011.06.021; Dodel R, 2007, SLEEP MED, V8, P733, DOI 10.1016/j.sleep.2006.10.010; Earnshaw VA, 2012, CHRONIC ILLN, V8, P79, DOI 10.1177/1742395311429393; Ervik S, 2006, ACTA NEUROL SCAND, V114, P198, DOI 10.1111/j.1600-0404.2006.00594.x; Fife BL, 2000, J HEALTH SOC BEHAV, V41, P50, DOI 10.2307/2676360; Gauffin H, 2010, EPILEPSY BEHAV, V17, P520, DOI 10.1016/j.yebeh.2010.01.167; Gerlinger G, 2013, WORLD PSYCHIATRY, V12, P155, DOI 10.1002/wps.20040; Grytten N, 2006, CHRONIC ILLN, V2, P195, DOI 10.1179/174592006X129482; Hatzenbuehler ML, 2013, AM J PUBLIC HEALTH, V103, P813, DOI 10.2105/AJPH.2012.301069; Ingravallo F, 2012, SLEEP MED, V13, P1293, DOI 10.1016/j.sleep.2012.08.002; Jennum P, 2012, SLEEP MED, V13, P1086, DOI 10.1016/j.sleep.2012.06.006; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Logie C, 2009, AIDS CARE, V21, P742, DOI 10.1080/09540120802511877; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Merritt SL, 2004, SLEEP, V27, P240; Merritt SL, 1992, PSYCHOSOCIAL ASPECTS, V5, P53, DOI [10. 1300/ J132v05n03_ 06, DOI 10.1300/J132V05N03_]; Mittal D, 2012, PSYCHIAT SERV, V63, P974, DOI 10.1176/appi.ps.201100459; Morrison AP, 2013, BRIT J PSYCHIAT, V203, P140, DOI 10.1192/bjp.bp.112.123703; Ozaki A, 2012, SLEEP MED, V13, P200, DOI 10.1016/j.sleep.2011.07.014; Ozaki A, 2008, J CLIN SLEEP MED, V4, P572; Plazzi G, 2008, SLEEP MED REV, V12, P109, DOI 10.1016/j.smrv.2007.08.010; SNAITH RP, 1986, BRIT MED J, V292, P344, DOI 10.1136/bmj.292.6516.344; Snead K, 2004, EPILEPSY BEHAV, V5, P547, DOI 10.1016/j.yebeh.2004.04.012; Stangl AL, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18734; Vignatelli L, 2011, SLEEP MED, V12, P19, DOI 10.1016/j.sleep.2010.07.008; Viteva E, 2013, SEIZURE-EUR J EPILEP, V22, P64, DOI 10.1016/j.seizure.2012.10.010; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1042, DOI 10.1093/oxfordjournals.aje.a116398; Weaver TE, 2001, SLEEP MED REV, V5, P103, DOI 10.1053/smrv.2001.0152; Weaver TE, 1997, SLEEP, V20, P835; Weiss Mitchell G, 2006, Psychol Health Med, V11, P277; Whatley AD, 2010, HEALTH EDUC RES, V25, P575, DOI 10.1093/her/cyq001; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	50	37	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0122478	10.1371/journal.pone.0122478	http://dx.doi.org/10.1371/journal.pone.0122478			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG3XJ	25898361	Green Published, Green Submitted, gold			2022-12-26	WOS:000353212600010
J	Martin-Rodriguez, AJ; Babarro, JMF; Lahoz, F; Sanson, M; Martin, VS; Norte, M; Fernandez, JJ				Martin-Rodriguez, Alberto J.; Babarro, Jose M. F.; Lahoz, Fernando; Sanson, Marta; Martin, Victor S.; Norte, Manuel; Fernandez, Jose J.			From Broad-Spectrum Biocides to Quorum Sensing Disruptors and Mussel Repellents: Antifouling Profile of Alkyl Triphenylphosphonium Salts	PLOS ONE			English	Article							QUATERNARY PHOSPHONIUM SALT; ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; IN-VITRO; CHROMOBACTERIUM-VIOLACEUM; CYTOTOXIC ACTIVITY; RELEASE COATINGS; DNA RECOGNITION; IONIC LIQUIDS; AMMONIUM	'Onium' compounds, including ammonium and phosphonium salts, have been employed as antiseptics and disinfectants. These cationic biocides have been incorporated into multiple materials, principally to avoid bacterial attachment. In this work, we selected 20 alkyl-triphenylphosphonium salts, differing mainly in the length and functionalization of their alkyl chains, in fulfilment of two main objectives: 1) to provide a comprehensive evaluation of the antifouling profile of these molecules with relevant marine fouling organisms; and 2) to shed new light on their potential applications, beyond their classic use as broad-spectrum biocides. In this regard, we demonstrate for the first time that these compounds are also able to act as non-toxic quorum sensing disruptors in two different bacterial models (Chromobacterium violaceum and Vibrio harveyi) as well as repellents in the mussel Mytilus galloprovincialis. In addition, their inhibitory activity on a fouling-relevant enzymatic model (tyrosinase) is characterized. An analysis of the structure-activity relationships of these compounds for antifouling purposes is provided, which may result useful in the design of targeted antifouling solutions with these molecules. Altogether, the findings reported herein provide a different perspective on the biological activities of phosphonium compounds that is particularly focused on, but, as the reader will realize, is not limited to their use as antifouling agents.	[Martin-Rodriguez, Alberto J.; Martin, Victor S.; Norte, Manuel; Fernandez, Jose J.] Univ La Laguna, Ctr Biomed Res Canary Islands CIBICAN, Inst Bioorgan Chem Antonio Gonzalez, San Cristobal la Laguna 38206, Tenerife, Spain; [Martin-Rodriguez, Alberto J.] Ocean Platform Canary Islands PLOCAN, Telde 35214, Gran Canaria, Spain; [Babarro, Jose M. F.] CSIC, Inst Investigac Marinas, Dept Biotechnol & Aquaculture, Vigo 36208, Spain; [Lahoz, Fernando] Univ La Laguna, Fac Sci, Dept Fundamental & Expt Phys, San Cristobal la Laguna 38206, Tenerife, Spain; [Sanson, Marta] Univ La Laguna, Fac Sci, Dept Bot Ecol & Plant Physiol, San Cristobal la Laguna 38206, Tenerife, Spain	Universidad de la Laguna; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); Universidad de la Laguna; Universidad de la Laguna	Fernandez, JJ (corresponding author), Univ La Laguna, Ctr Biomed Res Canary Islands CIBICAN, Inst Bioorgan Chem Antonio Gonzalez, Av Astrofis Francisco Sanchez 2, San Cristobal la Laguna 38206, Tenerife, Spain.	ajmartinr@ull.es; jjfercas@ull.es	Fernández, José Javier/AAA-3439-2019; Martín-Rodríguez, Alberto J./AAL-2520-2021; Martin, Victor/K-1760-2014; Fernandez, Jose/L-3343-2014; Sansón, Marta/F-9070-2016; Lahoz, Fernando/S-1251-2017; Babarro, Jose MF/F-1175-2016	Fernández, José Javier/0000-0002-0805-8317; Martín-Rodríguez, Alberto J./0000-0003-2422-129X; Martin, Victor/0000-0003-0300-9636; Fernandez, Jose/0000-0002-0805-8317; Lahoz, Fernando/0000-0001-8008-1696; Babarro, Jose/0000-0001-6352-1944; Norte, Manuel/0000-0003-2603-0796	Spanish Ministry of Economy and Competitiveness [SAF2011-28883-C03-01, CTQ2011-28417-C02-01/BQU, AGL2010-16464, MAT2013-40852-R]; Spanish Ministry of Education, Culture and Sport [CEI 10/00018]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Ministry of Education, Culture and Sport(Spanish Government)	This study was supported by the Spanish Ministry of Economy and Competitiveness (http://www.mineco.gob.es/), SAF2011-28883-C03-01 (JJF), CTQ2011-28417-C02-01/BQU (VSM), AGL2010-16464 (JMFB), MAT2013-40852-R (FL); Spanish Ministry of Education, Culture and Sport (http://www.mecd.gob.es/portada-mecd/), CEI 10/00018 (MN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EB, 2010, THESIS VIRGINIA POLY; Anthierens T, 2012, INNOV FOOD SCI EMERG, V15, P81, DOI 10.1016/j.ifset.2012.02.010; Arendrup MC, 2014, EDEF92 ESCMID AFST E; ATKINSON S, 2007, BIOFILM MODE LIFE ME, P95; Bachowska B, 2012, CHEMISTRYOPEN, V1, P33, DOI 10.1002/open.201100003; Bandara N, 2013, J ADHES SCI TECHNOL, V27, P1; Bansal R, 2012, J MATER CHEM, V22, P25427, DOI 10.1039/c2jm35243e; BEAUMONT AR, 1984, MAR POLLUT BULL, V15, P402, DOI 10.1016/0025-326X(84)90256-X; Belikova NA, 2009, FEBS LETT, V583, P1945, DOI 10.1016/j.febslet.2009.04.050; Biswas S, 2012, BIOMATERIALS, V33, P4773, DOI 10.1016/j.biomaterials.2012.03.032; Bridier A, 2011, BIOFOULING, V27, P1017, DOI 10.1080/08927014.2011.626899; Brumaghim JL, 2004, EUR J ORG CHEM, V2004, P4552, DOI 10.1002/ejoc.200400428; Burgess JG, 2003, BIOFOULING, V19, P197, DOI 10.1080/0892701031000061778; Busscher HJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002440; Cai X, 2013, LANGMUIR, V29, P5279, DOI 10.1021/la400824f; Callow ME, 1997, J PHYCOL, V33, P938, DOI 10.1111/j.0022-3646.1997.00938.x; Chambers LD, 2011, INT BIODETER BIODEGR, V65, P939, DOI 10.1016/j.ibiod.2011.07.002; Chang HI, 2010, REACT FUNCT POLYM, V70, P944, DOI 10.1016/j.reactfunctpolym.2010.09.005; Clinical and Laboratory Standards Institute, 2012, METH DIL ANT SUSC TE, V32; Dahms HU, 2009, WOODHEAD PUBL MATER, P275, DOI 10.1533/9781845696313.2.275; Decker JT, 2013, LANGMUIR, V29, P13023, DOI 10.1021/la402952u; Defoirdt T, 2007, TRENDS BIOTECHNOL, V25, P472, DOI 10.1016/j.tibtech.2007.08.001; Dobretsov S, 2007, FEMS MICROBIOL ECOL, V60, P177, DOI 10.1111/j.1574-6941.2007.00285.x; Dobretsov S, 2011, BIOFOULING, V27, P869, DOI 10.1080/08927014.2011.607233; FLETCHER RL, 1989, INT BIODETERIOR, V25, P407, DOI 10.1016/0265-3036(89)90067-5; Fusetani N, 2011, NAT PROD REP, V28, P400, DOI 10.1039/c0np00034e; Garcia-Arguelles S, 2013, LANGMUIR, V29, P9525, DOI 10.1021/la401353r; Garcia-Borron JC, 2002, PIGM CELL RES, V15, P162, DOI 10.1034/j.1600-0749.2002.02012.x; Gilbert P, 2005, J APPL MICROBIOL, V99, P703, DOI 10.1111/j.1365-2672.2005.02664.x; GREENBERG EP, 1979, ARCH MICROBIOL, V120, P87, DOI 10.1007/BF00409093; Hatakeyama ES, 2009, J MEMBRANE SCI, V330, P104, DOI 10.1016/j.memsci.2008.12.049; Hayashi Y., 1996, J MAR BIOTECHNOL, V4, P127; Hemp ST, 2013, MACROMOL CHEM PHYS, V214, P2099, DOI 10.1002/macp.201300322; Hertiani T, 2010, BIOORGAN MED CHEM, V18, P1297, DOI 10.1016/j.bmc.2009.12.028; Huang YL, 2007, APPL ENVIRON MICROB, V73, P6284, DOI 10.1128/AEM.00578-07; Huang YL, 2007, MICROB ECOL, V54, P384, DOI 10.1007/s00248-007-9210-9; Jellali R, 2013, PROG ORG COAT, V76, P1203, DOI 10.1016/j.porgcoat.2013.03.028; Jung K, 2011, NAT CHEM BIOL, V7, P502, DOI 10.1038/nchembio.618; KANAZAWA A, 1993, J POLYM SCI POL CHEM, V31, P335, DOI 10.1002/pola.1993.080310205; KANAZAWA A, 1994, ANTIMICROB AGENTS CH, V38, P945, DOI 10.1128/AAC.38.5.945; Kanazawa A, 2000, ANGEW CHEM INT EDIT, V39, P612, DOI 10.1002/(SICI)1521-3773(20000204)39:3<612::AID-ANIE612>3.0.CO;2-F; Kenawy ER, 2006, REACT FUNCT POLYM, V66, P419, DOI 10.1016/j.reactfunctpolym.2005.09.002; Kim D, 2006, J AGR FOOD CHEM, V54, P935, DOI 10.1021/jf0521855; Kumar V, 2009, BIOORG MED CHEM LETT, V19, P4643, DOI 10.1016/j.bmcl.2009.06.086; Lai JQ, 2011, GREEN CHEM, V13, P1860, DOI 10.1039/c1gc15140a; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, V3rd; Lejars M, 2012, CHEM REV, V112, P4347, DOI 10.1021/cr200350v; Li C, 2013, MATER LETT, V93, P145, DOI 10.1016/j.matlet.2012.11.045; Long CJ, 2010, BIOFOULING, V26, P941, DOI 10.1080/08927014.2010.531390; Maguire R.J., 1987, Applied Organometallic Chemistry, V1, P475, DOI 10.1002/aoc.590010602; Majumdar P, 2008, BIOFOULING, V24, P185, DOI 10.1080/08927010801894660; Manetta A, 1996, GYNECOL ONCOL, V60, P203, DOI 10.1006/gyno.1996.0026; Martin-Rodriguez AJ, 2014, MAR DRUGS, V12, P5503, DOI 10.3390/md12115503; Martinelli D, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-25; Millard M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013131; Moore LE, 2008, APPL ENVIRON MICROB, V74, P4825, DOI 10.1128/AEM.00573-08; Olsen SM, 2010, PROG ORG COAT, V68, P248, DOI 10.1016/j.porgcoat.2010.01.003; Parsek MR, 2005, TRENDS MICROBIOL, V13, P27, DOI 10.1016/j.tim.2004.11.007; Peach KC, 2011, MOL BIOSYST, V7, P1176, DOI 10.1039/c0mb00276c; Pellizzari F, 2013, BOT MAR, V56, P197, DOI 10.1515/bot-2012-0197; Pompeani AJ, 2008, MOL MICROBIOL, V70, P76, DOI 10.1111/j.1365-2958.2008.06389.x; Prasad M, 2004, J PHYS CHEM B, V108, P355, DOI 10.1021/jp036358+; Qian PY, 2007, MAR BIOTECHNOL, V9, P399, DOI 10.1007/s10126-007-9001-9; Qian P.-Y., 2012, HDB MARINE NATURAL P, P749; Qian PY, 2013, BIOFOULING, V29, P381, DOI 10.1080/08927014.2013.776546; Rambali B, 2001, J ANTIMICROB CHEMOTH, V48, P163, DOI 10.1093/jac/48.2.163; Regina VR, 2012, ACS APPL MATER INTER, V4, P5915, DOI 10.1021/am301554m; Rutherford ST, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012427; Sanchez-Amat A, 2010, MAR DRUGS, V8, P519, DOI 10.3390/md8030519; Shrout JD, 2011, MRS BULL, V36, P367, DOI 10.1557/mrs.2011.67; Siedenbiedel F, 2012, POLYMERS-BASEL, V4, P46, DOI 10.3390/polym4010046; Silverman HG, 2007, MAR BIOTECHNOL, V9, P661, DOI 10.1007/s10126-007-9053-x; Smith RAJ, 2003, P NATL ACAD SCI USA, V100, P5407, DOI 10.1073/pnas.0931245100; Smith RAJ, 2012, TRENDS PHARMACOL SCI, V33, P341, DOI 10.1016/j.tips.2012.03.010; Solomon MA, 2013, MITOCHONDRION, V13, P464, DOI 10.1016/j.mito.2012.10.013; Soulere L, 2010, BIOORG MED CHEM LETT, V20, P4355, DOI 10.1016/j.bmcl.2010.06.081; Souza PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048589; Stauff DL, 2011, J BACTERIOL, V193, P3871, DOI 10.1128/JB.05125-11; Thalmann CR, 2002, EUR FOOD RES TECHNOL, V214, P276, DOI 10.1007/s00217-001-0455-0; Twigg MS, 2014, ENVIRON MICROBIOL, V16, P445, DOI 10.1111/1462-2920.12203; Uraguchi D, 2011, ANGEW CHEM INT EDIT, V50, P3681, DOI 10.1002/anie.201007752; VALKIRS AO, 1987, CHEMOSPHERE, V16, P201, DOI 10.1016/0045-6535(87)90124-X; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Vandeputte OM, 2010, APPL ENVIRON MICROB, V76, P243, DOI 10.1128/AEM.01059-09; Wahl M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00292; Wang K, 2012, DESALINATION, V292, P119, DOI 10.1016/j.desal.2012.02.016; Warren CR, 2008, J PLANT NUTR, V31, P1321, DOI 10.1080/01904160802135092; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; Wu T, 2011, COLLOID SURFACE B, V86, P232, DOI 10.1016/j.colsurfb.2011.04.009; Yang ZC, 2012, J ORG CHEM, V77, P3191, DOI 10.1021/jo202642a; Yebra DM, 2004, PROG ORG COAT, V50, P75, DOI 10.1016/j.porgcoat.2003.06.001	91	30	31	5	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123652	10.1371/journal.pone.0123652	http://dx.doi.org/10.1371/journal.pone.0123652			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897858	Green Published, gold			2022-12-26	WOS:000353212600039
J	Tripathi, S; Chabtini, L; Dakle, PJ; Smith, B; Akiba, H; Yagita, H; Guleria, I				Tripathi, Sudipta; Chabtini, Lola; Dakle, Pranal J.; Smith, Brian; Akiba, Hisaya; Yagita, Hideo; Guleria, Indira			Effect of TIM-3 Blockade on the Immunophenotype and Cytokine Profile of Murine Uterine NK Cells	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; METRIAL GLAND-CELLS; INNATE IMMUNE CELLS; CHRONIC HEPATITIS-B; SUPPRESSOR-CELLS; RECEPTORS; PREGNANCY; DIFFERENTIATION; REPERTOIRE; MICE	NK cells are the most abundant lymphocyte population in the feto-maternal interface during gestation. The uterine NK cells (uNK) are transient, have a unique immunophenotype and produce a number of cytokines. These cytokines play an important role in establishment and maintenance of vascular remodeling and tolerance associated with successful pregnancy. The uNK cells also express TIM-3 during gestation and blockade of TIM-3 expression results in fetal loss in mice. In this study we determined the effect of TIM-3 blockade on uNK cells. Specifically we observed surface receptor phenotype and cytokine production by uNK cells following TIM-3 blockade. Our results show that TIM-3 plays a role in regulating the uNK cells and contributes to the maintenance of tolerance at the feto-maternal interface.	[Tripathi, Sudipta; Chabtini, Lola; Dakle, Pranal J.; Smith, Brian; Guleria, Indira] Harvard Univ, Sch Med, Div Renal, Childrens Hosp Boston, Boston, MA 02163 USA; [Akiba, Hisaya; Yagita, Hideo] Juntendo Univ, Dept Immunol, Tokyo, Japan	Harvard University; Boston Children's Hospital; Harvard Medical School; Juntendo University	Guleria, I (corresponding author), Harvard Univ, Sch Med, Div Renal, Childrens Hosp Boston, Boston, MA 02163 USA.	Indira.Guleria@childrens.harvard.edu			National Institutes of Health [RO1 AI84756-01A2, R21AI076794]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076794, R01AI084756] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [25461503] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by research grants from the National Institutes of Health (RO1 AI84756-01A2 and R21AI076794 to I.G.).	Anderson AC, 2012, CURR OPIN IMMUNOL, V24, P213, DOI 10.1016/j.coi.2011.12.005; Ashkar AA, 2003, J IMMUNOL, V171, P2937, DOI 10.4049/jimmunol.171.6.2937; Barber EM, 2003, J IMMUNOL, V171, P37, DOI 10.4049/jimmunol.171.1.37; Carlyle JR, 2006, J IMMUNOL, V176, P7511, DOI 10.4049/jimmunol.176.12.7511; Chabtini L, 2013, J IMMUNOL, V190, P88, DOI 10.4049/jimmunol.1202176; Chazara O, 2011, J LEUKOCYTE BIOL, V90, P703, DOI 10.1189/jlb.0511227; Christiansen OB, 2013, MOL IMMUNOL, V55, P8, DOI 10.1016/j.molimm.2012.08.025; Croy BA, 2006, IMMUNOL REV, V214, P161; Croy BA, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102830; DAMJANOV A, 1992, J REPROD FERTIL, V95, P679; Dardalhon V, 2010, J IMMUNOL, V185, P1383, DOI 10.4049/jimmunol.0903275; Freeman GJ, 2010, IMMUNOL REV, V235, P172, DOI 10.1111/j.0105-2896.2010.00903.x; Fu BQ, 2013, P NATL ACAD SCI USA, V110, pE231, DOI 10.1073/pnas.1206322110; Gleason MK, 2012, BLOOD, V119, P3064, DOI 10.1182/blood-2011-06-360321; Han GC, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00449; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Ju Y, 2010, J HEPATOL, V52, P322, DOI 10.1016/j.jhep.2009.12.005; Karimi K, 2012, J MOL MED, V90, P1047, DOI 10.1007/s00109-012-0872-5; Manaster I, 2010, AM J REPROD IMMUNOL, V63, P434, DOI 10.1111/j.1600-0897.2009.00794.x; Murphy SP, 2005, J IMMUNOL, V175, P4084, DOI 10.4049/jimmunol.175.6.4084; MURPHY SP, 2009, AM J OBSTET GYNECOL, V200, P308, DOI DOI 10.1016/J.AJ0G.2008.10.043; Ndhlovu LC, 2012, BLOOD, V119, P3734, DOI 10.1182/blood-2011-11-392951; Paffaro VA, 2003, PLACENTA, V24, P479, DOI 10.1053/plac.2002.0919; Park YJ, 2013, CANCER RES, V73, P5669, DOI 10.1158/0008-5472.CAN-13-0545; Patel J, 2012, IMMUNOTHERAPY-UK, V4, P1795, DOI [10.2217/IMT.12.126, 10.2217/imt.12.126]; Rahim MMA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00145; Raulet DH, 2013, ANNU REV IMMUNOL, V31, P413, DOI 10.1146/annurev-immunol-032712-095951; Robertson SA, 2007, BIOL REPROD, V76, P738, DOI 10.1095/biolreprod.106.056143; Sheppard S, 2013, BLOOD, V121, P5025, DOI 10.1182/blood-2012-12-471607; Sinha P, 2008, J IMMUNOL, V181, P4666, DOI 10.4049/jimmunol.181.7.4666; Tang ZH, 2013, J IMMUNOL, V190, P1788, DOI 10.4049/jimmunol.1202814; Varla-Leftherioti M, 2005, HUM IMMUNOL, V66, P65, DOI 10.1016/j.humimm.2004.10.005; Varla-Leftherioti M, 2003, AM J REPROD IMMUNOL, V49, P183, DOI 10.1034/j.1600-0897.2003.00018.x; Walzer T, 2007, P NATL ACAD SCI USA, V104, P3384, DOI 10.1073/pnas.0609692104; Wang CL, 2003, MICROSC RES TECHNIQ, V60, P420, DOI 10.1002/jemt.10280; Wu W, 2012, EUR J IMMUNOL, V42, P1180, DOI 10.1002/eji.201141852; Yadi H, 2008, J IMMUNOL, V181, P6140, DOI 10.4049/jimmunol.181.9.6140; Ye WG, 1996, J EXP MED, V184, P2405, DOI 10.1084/jem.184.6.2405; Yeung MY, 2011, AM J TRANSPLANT, V11, P2012, DOI 10.1111/j.1600-6143.2011.03727.x; Zhang JH, 2005, CELL MOL IMMUNOL, V2, P123; Zhao J, 2009, J IMMUNOL, V182, P6618, DOI 10.4049/jimmunol.0803876	41	10	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123439	10.1371/journal.pone.0123439	http://dx.doi.org/10.1371/journal.pone.0123439			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897749	Green Published, gold, Green Submitted			2022-12-26	WOS:000353212600025
J	Dedukh, D; Litvinchuk, S; Rosanov, J; Mazepa, G; Saifitdinova, A; Shabanov, D; Krasikova, A				Dedukh, Dmitry; Litvinchuk, Spartak; Rosanov, Juriy; Mazepa, Glib; Saifitdinova, Alsu; Shabanov, Dmitry; Krasikova, Alla			Optional Endoreplication and Selective Elimination of Parental Genomes during Oogenesis in Diploid and Triploid Hybrid European Water Frogs	PLOS ONE			English	Article							RANA-ESCULENTA; LAMPBRUSH CHROMOSOMES; GYNOGENESIS; TELEOSTEI; EXCLUSION; LOACH	Incompatibilities between parental genomes decrease viability of interspecific hybrids; however, deviations from canonical gametogenesis such as genome endoreplication and elimination can rescue hybrid organisms. To evaluate frequency and regularity of genome elimination and endoreplication during gametogenesis in hybrid animals with different ploidy, we examined genome composition in oocytes of di- and triploid hybrid frogs of the Pelophylax esculentus complex. Obtained results allowed us to suggest that during oogenesis the endoreplication involves all genomes occurring before the selective genome elimination. We accepted the hypothesis that only elimination of one copied genome occurs premeiotically in most of triploid hybrid females. At the same time, we rejected the hypothesis stating that the genome of parental species hybrid frogs co-exist with is always eliminated during oogenesis in diploid hybrids. Diploid hybrid frogs demonstrate an enlarged frequency of deviations in oogenesis comparatively to triploid hybrids. Typical for hybrid frogs deviations in gametogenesis increase variability of produced gametes and provide a mechanism for appearance of different forms of hybrids.	[Dedukh, Dmitry; Saifitdinova, Alsu; Krasikova, Alla] St Petersburg State Univ, St Petersburg 199034, Russia; [Litvinchuk, Spartak; Rosanov, Juriy] Russian Acad Sci, Inst Cytol, St Petersburg 196140, Russia; [Mazepa, Glib] Uppsala Univ, Evolutionary Biol Ctr, Dept Ecol & Genet, Uppsala, Sweden; [Mazepa, Glib; Shabanov, Dmitry] Kharkov Natl Univ, Kharkiv, Ukraine	Saint Petersburg State University; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS; Uppsala University; Ministry of Education & Science of Ukraine; VN Karazin Kharkiv National University	Krasikova, A (corresponding author), St Petersburg State Univ, St Petersburg 199034, Russia.	alla.krasikova@gmail.com	Dedukh, Dmitrij/H-8403-2013; Shabanov, Dmitry/N-3128-2019; Krasikova, Alla/E-4767-2011; Rozanov, Yuriy M./K-2158-2018; Dedukh, Dmitrij/AAE-8994-2022; Litvinchuk, Spartak N/F-1929-2017; Saifitdinova, Alsu F/C-1104-2011; Shabanov, Dmitry A./J-5370-2014	Dedukh, Dmitrij/0000-0002-1152-813X; Shabanov, Dmitry/0000-0003-3247-6882; Krasikova, Alla/0000-0002-6571-5328; Dedukh, Dmitrij/0000-0002-1152-813X; Saifitdinova, Alsu F/0000-0002-1221-479X; Shabanov, Dmitry A./0000-0003-3247-6882; Litvinchuk, Spartak/0000-0001-7447-6691; Mazepa, Glib/0000-0001-6555-1434	Russian Foundation for Basic Research [12-04-01277]; President of Russia [NS-3553.2014.4, JC-3609.2014.4]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); President of Russia	This work was funded in part by the Russian Foundation for Basic Research (http://www.rfbr.ru/rffi/eng) grant 12-04-01277 to SL and JR and by the grants of the President of Russia (https://grants.extech.ru/) NS-3553.2014.4 to AK, DD and AS and JC-3609.2014.4 to AK and DD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves MJ, 1998, MOL BIOL EVOL, V15, P1233, DOI 10.1093/oxfordjournals.molbev.a025852; ARNOLD ML, 1995, TRENDS ECOL EVOL, V10, P67, DOI 10.1016/S0169-5347(00)88979-X; Berger L, 1970, ANN ZOOL FENN, V27, P374; Bogart JP, 2007, GENOME, V50, P119, DOI 10.1139/G06-152; Borkin LJ, 2004, RUSS J HERPETOL, V11, P194; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brown JD, 2010, ANNU REV GENOM HUM G, V11, P291, DOI 10.1146/annurev-genom-082509-141554; BUCCI S, 1990, J EXP ZOOL, V255, P37, DOI 10.1002/jez.1402550107; Callan H G, 1986, Mol Biol Biochem Biophys, V36, P1; Chapman MA, 2007, EVOLUTION, V61, P1773, DOI 10.1111/j.1558-5646.2007.00134.x; Christiansen DG, 2009, EVOLUTION, V63, P1754, DOI 10.1111/j.1558-5646.2009.00673.x; CIMINO MC, 1972, EVOLUTION, V26, P294, DOI 10.1111/j.1558-5646.1972.tb00195.x; Dedukh D, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-26; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; GALL JG, 1991, METHOD CELL BIOL, V36, P149; Gernand D, 2005, PLANT CELL, V17, P2431, DOI 10.1105/tpc.105.034249; GIORGI F, 1972, CARYOLOGIA, V25, P107, DOI 10.1080/00087114.1972.10796470; GRAF JD, 1979, EXPERIENTIA, V35, P1574, DOI 10.1007/BF01953200; Graf Jean-Daniel, 1989, New York State Museum Bulletin, V466, P289; Herrick Glenn, 1999, Results and Problems in Cell Differentiation, V25, P41; Itono M, 2006, J EXP ZOOL PART A, V305A, P513, DOI 10.1002/jez.a.283; Kearney M, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P447, DOI 10.1007/978-90-481-2770-2_21; Korshunov AV, 2009, KHARKOV NAT U J, V8, P48; Krasikova A, 2004, CHROMOSOMA, V113, P316, DOI 10.1007/s00412-004-0321-5; Krasikova A, 2012, CHROMOSOME RES, V20, P979, DOI 10.1007/s10577-012-9327-7; Lamatsch DK, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P399, DOI 10.1007/978-90-481-2770-2_19; Litvinchuk Spartak N., 2004, Asiatic Herpetological Research, V10, P282; Lutes AA, 2010, NATURE, V464, P283, DOI 10.1038/nature08818; MACGREGOR HC, 1990, J EVOLUTION BIOL, V3, P329, DOI 10.1046/j.1420-9101.1990.3050329.x; MACGREGOR HC, 1964, SCIENCE, V143, P1043, DOI 10.1126/science.143.3610.1043; Neaves WB, 2011, TRENDS GENET, V27, P81, DOI 10.1016/j.tig.2010.12.002; Ogielska M., 1994, ZOOL POLONIAE, V39, P461; Plotner J., 2005, W PALEARCTIC WATER F, P1; Pruvost NBM, 2013, ECOL EVOL, V3, P2933, DOI 10.1002/ece3.687; Shabanov DA, 2006, KHARKOV NAT U J, V3, P208; Stenberg P, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P63, DOI 10.1007/978-90-481-2770-2_4; Stock M, 2012, P ROY SOC B-BIOL SCI, V279, P1293, DOI 10.1098/rspb.2011.1738; TUNNER HG, 1981, NATURWISSENSCHAFTEN, V68, P207, DOI 10.1007/BF01047207; TUNNER HG, 1991, NATURWISSENSCHAFTEN, V78, P32, DOI 10.1007/BF01134041; TUNNER HG, 1973, NATURWISSENSCHAFTEN, V60, P481; Uzzell T., 1979, Mitteilungen aus dem Zoologischen Museum in Berlin, V55, P13; VINOGRADOV AE, 1990, GENOME, V33, P619, DOI 10.1139/g90-092; VINOGRADOV AE, 1991, HEREDITAS, V114, P245, DOI 10.1111/j.1601-5223.1991.tb00331.x; YAMASHITA M, 1993, DEV GROWTH DIFFER, V35, P631; Zalesna A, 2011, CYTOGENET GENOME RES, V134, P206, DOI 10.1159/000327716; Zhang QQ, 1998, J EXP ZOOL, V281, P608, DOI 10.1002/(SICI)1097-010X(19980815)281:6&lt;608::AID-JEZ9&gt;3.0.CO;2-R	46	23	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123304	10.1371/journal.pone.0123304	http://dx.doi.org/10.1371/journal.pone.0123304			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894314	Green Published, Green Submitted, gold			2022-12-26	WOS:000353211700033
J	Dutta, DK; Potnis, PA; Rhodes, K; Wood, SC				Dutta, Debargh K.; Potnis, Pushya A.; Rhodes, Kelly; Wood, Steven C.			Wear Particles Derived from Metal Hip Implants Induce the Generation of Multinucleated Giant Cells in a 3-Dimensional Peripheral Tissue-Equivalent Model	PLOS ONE			English	Article							TOTAL JOINT ARTHROPLASTIES; COBALT-ALLOY PARTICLES; ACID-PHOSPHATASE TRAP; IN-VITRO; OSTEOCLAST DIFFERENTIATION; ORTHOPEDIC IMPLANTS; ENDOTHELIAL-CELLS; BONE; MACROPHAGES; EXPRESSION	Multinucleate giant cells (MGCs) are formed by the fusion of 5 to 15 monocytes or macrophages. MGCs can be generated by hip implants at the site where the metal surface of the device is in close contact with tissue. MGCs play a critical role in the inflammatory processes associated with adverse events such as aseptic loosening of the prosthetic joints and bone degeneration process called osteolysis. Upon interaction with metal wear particles, endothelial cells upregulate pro-inflammatory cytokines and other factors that enhance a localized immune response. However, the role of endothelial cells in the generation of MGCs has not been completely investigated. We developed a three-dimensional peripheral tissue-equivalent model (PTE) consisting of collagen gel, supporting a monolayer of endothelial cells and human peripheral blood mononuclear cells (PBMCs) on top, which mimics peripheral tissue under normal physiological conditions. The cultures were incubated for 14 days with Cobalt chromium alloy (CoCr ASTM F75, 1-5 micron) wear particles. PBMC were allowed to transit the endothelium and harvested cells were analyzed for MGC generation via flow cytometry. An increase in forward scatter (cell size) and in the propidium iodide (PI) uptake (DNA intercalating dye) was used to identify MGCs. Our results show that endothelial cells induce the generation of MGCs to a level 4 fold higher in 3-dimentional PTE system as compared to traditional 2-dimensional culture plates. Further characterization of MGCs showed upregulated expression of tartrate resistant alkaline phosphatase (TRAP) and dendritic cell specific transmembrane protein, (DC-STAMP), which are markers of bone degrading cells called osteoclasts. In sum, we have established a robust and relevant model to examine MGC and osteoclast formation in a tissue like environment using flow cytometry and RT-PCR. With endothelial cells help, we observed a consistent generation of metal wear particle-induced MGCs, which heralds metal on metal hip failures.	[Dutta, Debargh K.; Potnis, Pushya A.; Rhodes, Kelly; Wood, Steven C.] FDA, CDRH, Dept Biol Chem & Mat Sci, Off Sci & Engn Labs, Silver Spring, MD 20993 USA; [Dutta, Debargh K.] Uniformed Serv Univ Hlth Sci, Dept Med, Bethesda, MD 20814 USA; [Rhodes, Kelly] Univ Maryland, College Pk, MD 20742 USA	US Food & Drug Administration (FDA); Uniformed Services University of the Health Sciences - USA; University System of Maryland; University of Maryland College Park	Dutta, DK (corresponding author), FDA, CDRH, Dept Biol Chem & Mat Sci, Off Sci & Engn Labs, Silver Spring, MD 20993 USA.	debargh.dutta@gmail.com	Dutta, Debargh/J-6086-2015	Dutta, Debargh/0000-0003-1517-0670	Office of Women's Health [14-01-0009-SW]; Food and Drug Administration	Office of Women's Health; Food and Drug Administration(United States Department of Health & Human Services)	This work was supported by Office of Women's Health, grant number#14-01-0009-SW; intramural funding from the Food and Drug Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSAFFAR N, 1994, J MATER SCI-MATER M, V5, P813, DOI 10.1007/BF00213140; Archibeck M J, 2001, Instr Course Lect, V50, P185; Campbell P, 2010, CLIN ORTHOP RELAT R, V468, P2321, DOI 10.1007/s11999-010-1372-y; Carli A, 2011, BULL HOSP JT DIS, V69, pS47; Choi J, 2013, CELL SIGNAL, V25, P1222, DOI 10.1016/j.cellsig.2013.02.015; Clarke SA, 2001, J BIOMED MATER RES, V57, P84, DOI 10.1002/1097-4636(200110)57:1<84::AID-JBM1145>3.0.CO;2-5; Cuckler JM, 2005, CLIN ORTHOP RELAT R, P132, DOI 10.1097/01.blo.0000193809.85587.f8; Dalal A, 2012, J BIOMED MATER RES A, V100A, P2147, DOI 10.1002/jbm.a.34122; Graves Stephen E, 2011, J Bone Joint Surg Am, V93 Suppl 3, P43, DOI 10.2106/JBJS.K.01220; Hayman AR, 2008, AUTOIMMUNITY, V41, P218, DOI 10.1080/08916930701694667; Jacobs JJ, 2001, CLIN ORTHOP RELAT R, P71; Kadoya Y, 1997, CLIN ORTHOP RELAT R, P118, DOI 10.1097/00003086-199707000-00016; Kadoya Y, 1996, J ORTHOP RES, V14, P473, DOI 10.1002/jor.1100140318; Knight Stephen Richard, 2011, Orthop Rev (Pavia), V3, pe16, DOI 10.4081/or.2011.e16; Kohara H, 2011, IMMUNOL LETT, V137, P53, DOI 10.1016/j.imlet.2011.02.017; Kondo Y, 2009, CLIN EXP IMMUNOL, V158, P84, DOI 10.1111/j.1365-2249.2009.03990.x; Kukita T, 2004, J EXP MED, V200, P941, DOI 10.1084/jem.20040518; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; LINDUNGER A, 1990, BONE MINER, V10, P109, DOI 10.1016/0169-6009(90)90086-U; McFarlane T, 2004, J MATER SCI-MATER M, V15, P315, DOI 10.1023/B:JMSM.0000021094.50889.5c; Mensah KA, 2010, J CELL PHYSIOL, V223, P76, DOI 10.1002/jcp.22012; Miyamoto Takeshi, 2006, Mod Rheumatol, V16, P341; Miyamoto Takeshi, 2011, Keio Journal of Medicine, V60, P101; Miyazaki T, 2011, ANAL BIOCHEM, V410, P7, DOI 10.1016/j.ab.2010.11.014; Morita Y, 2010, CALCIFIED TISSUE INT, V86, P242, DOI 10.1007/s00223-010-9335-6; Nakano K, 2007, RHEUMATOLOGY, V46, P597, DOI 10.1093/rheumatology/kel356; Ninomiya JT, 2013, J ORTHOP RES, V31, P1484, DOI 10.1002/jor.22377; Ohtsuji M, 2014, MOD RHEUMATOL, P1; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Potnis PA, 2013, CELL IMMUNOL, V282, P53, DOI 10.1016/j.cellimm.2013.04.003; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; Revell PA, 2008, J R SOC INTERFACE, V5, P1263, DOI 10.1098/rsif.2008.0142; Robinson E, 2014, ACTA ORTHOP, P1; Suuronen EJ, 2005, INT REV CYTOL, V244, P137, DOI 10.1016/S0074-7696(05)44004-8; Taylor RM, 2012, LAB INVEST, V92, P1398, DOI 10.1038/labinvest.2012.108; Wunschmann S, 2000, J CLIN MICROBIOL, V38, P3055; Yadav Jessica, 2013, Open Orthop J, V7, P605, DOI 10.2174/1874325001307010605; Yoshimatsu M, 2009, BONE, V45, P1010, DOI 10.1016/j.bone.2009.07.079	38	5	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124389	10.1371/journal.pone.0124389	http://dx.doi.org/10.1371/journal.pone.0124389			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894745	Green Published, Green Submitted, gold			2022-12-26	WOS:000353211700090
J	Liu, S; Sun, W; Chu, J; Huang, XF; Wu, ZX; Yan, MX; Zhang, Q; Zhao, P; Igietseme, JU; Black, CM; He, C; Li, YQ				Liu, Shanshan; Sun, Wei; Chu, Jun; Huang, Xiufen; Wu, Zongxue; Yan, Minxin; Zhang, Qiang; Zhao, Peng; Igietseme, Joseph U.; Black, Carolyn M.; He, Cheng; Li, Yongqing			Construction of Recombinant HVT Expressing PmpD, and Immunological Evaluation against Chlamydia psittaci and Marek's Disease Virus	PLOS ONE			English	Article							CHLAMYDOPHILA-PSITTACI; DNA VACCINATION; INFECTIONS; TURKEYS; PROTECTION; HERPESVIRUS; CHALLENGE; CHICKENS; ADJUVANT	Chlamydia psittaci (C. psittaci) is an obligate intracellular zoonotic pathogen that can be transmitted to humans from birds. No efficacious commercial vaccine is available for clearing chlamydial infection due to lack of potential vaccine candidates and effective delivery vehicles. Herpesvirus of turkeys (HVT) is an efficacious commercially available vaccine against Marek's Disease virus (MDV). In this study, a recombinant HVT-delivered vaccine against C. psittaci and Marek's disease was developed and examined. The 5'-terminus of pmpD gene (pmpD-N) encoding the N-terminal fragment of polymorphic membrane protein D of C. psittaci was inserted into a nonessential region of HVT genome using reverse genetics based on an infectious bacterial artificial chromosome (BAC) clone of HVT. The recombinant virus (rHVT-pmpD-N) was recovered from primary chicken embryo fibroblast (CEF) cells by transfection of modified HVT BAC DNA containing the pmpD-N gene. The rHVT-pmpD-N construct was confirmed to express PmpD-N by immunoblot and immunofluorescence. The rHVT-pmpD-N was stable during 20 passages in vitro. The growth kinetics of rHVT-pmpD-N was comparable to that of parental HVT in vitro and in vivo. One-day-old SPF chickens inoculated subcutaneously with rHVT-pmpD-N displayed increased PmpD-specific antibody levels and a vigorous PmpD-specific lymphocyte proliferation response using HVT vector or CEF cells as control. Furthermore, the percentage of CD4+ cells was significantly elevated in rHVT-pmpD-N-immunized birds as compared to the parental HVT. All chickens vaccinated with rHVT-pmpD-N or parental HVT were protected completely against challenge with a very virulent strain of Marek's Disease virus (MDV) RB-1B. Post challenge with C. psittaci CB7 strain, a significant decrease in respiratory distress, lesions and Chlamydia load was found in the rHVT-pmpD-N-vaccinated group compared to the parental HVT. In conclusion, our study suggests that the rHVT-pmpD-N live vaccine may be viable as a candidate dual vaccine that provides protection against both very virulent MDV and C. psittaci.	[Liu, Shanshan; Chu, Jun; Wu, Zongxue; Zhang, Qiang; Zhao, Peng; He, Cheng] China Agr Univ, Coll Vet Med, Key Lab Anim Epidemiol & Zoonosis, Minist Agr, Beijing 100193, Peoples R China; [Liu, Shanshan; Sun, Wei; Huang, Xiufen; Yan, Minxin; Li, Yongqing] Beijing Acad Agr & Forestry Sci, Inst Anim Husb & Vet Med, Beijing 100097, Peoples R China; [Igietseme, Joseph U.; Black, Carolyn M.] CDC, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA	China Agricultural University; Ministry of Agriculture & Rural Affairs; Beijing Academy of Agriculture & Forestry; Centers for Disease Control & Prevention - USA	He, C (corresponding author), China Agr Univ, Coll Vet Med, Key Lab Anim Epidemiol & Zoonosis, Minist Agr, Beijing 100193, Peoples R China.	hecheng@cau.edu.cn; liyngqng@yahoo.com	Zhao, Peng/HDO-7507-2022		Beijing Municipal Science and Technology Project [Z121100001212001]; National Natural Science Foundation of China [31172305, 31372420]; Ministry of Science and Technology (MoST) [2012BAD31B05]; Beijing Natural Science Foundation [6122018]	Beijing Municipal Science and Technology Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology (MoST)(Ministry of Science and Technology, China); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by Beijing Municipal Science and Technology Project (Grant No. Z121100001212001), the National Natural Science Foundation of China (Grant No. 31172305 and 31372420) Ministry of Science and Technology (MoST) (Grant No. 2012BAD31B05) and Beijing Natural Science Foundation (Grant No. 6122018). All of the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen AA, 1997, J VET DIAGN INVEST, V9, P159, DOI 10.1177/104063879700900209; Baigent SJ, 2006, J GEN VIROL, V87, P769, DOI 10.1099/vir.0.81498-0; BARRON AL, 1970, ARCH GES VIRUSFORSCH, V32, P389, DOI 10.1007/BF01250067; Chu J, 2014, GENOMEA, V2; Crane DD, 2006, P NATL ACAD SCI USA, V103, P1894, DOI 10.1073/pnas.0508983103; Dickx V, 2010, J CLIN MICROBIOL, V48, P3244, DOI 10.1128/JCM.00698-10; Farris CM, 2011, INFECT IMMUN, V79, P986, DOI 10.1128/IAI.00881-10; Gaede W, 2008, ZOONOSES PUBLIC HLTH, V55, P184, DOI 10.1111/j.1863-2378.2008.01108.x; Gerdts V, 2006, VET RES, V37, P487, DOI 10.1051/vetres:2006012; Harkinezhad T, 2009, VET RES, V40, DOI 10.1051/vetres/2009044; Iqbal M, 2012, BIOENGINEERED, V3, P222, DOI 10.4161/bioe.20476; Islam A, 2004, J VIROL METHODS, V119, P103, DOI 10.1016/j.jviromet.2004.03.006; Lagae S, 2014, J MED MICROBIOL, V63, P399, DOI 10.1099/jmm.0.064675-0; Laroucau K, 2009, INFECT GENET EVOL, V9, P1240, DOI 10.1016/j.meegid.2009.08.005; Le Gros FX, 2009, VACCINE, V27, P592, DOI 10.1016/j.vaccine.2008.10.094; Li YQ, 2011, VACCINE, V29, P8257, DOI 10.1016/j.vaccine.2011.08.115; Longbottom D, 2006, VET J, V171, P263, DOI 10.1016/j.tvjl.2004.09.006; Loots K, 2006, VACCINE, V24, P4598, DOI 10.1016/j.vaccine.2005.08.042; Ou CB, 2013, INT IMMUNOPHARMACOL, V16, P505, DOI 10.1016/j.intimp.2013.04.027; Petherbridge L, 2004, J VIROL, V78, P13376, DOI 10.1128/JVI.78.23.13376-13380.2004; Robertson T, 2010, VET MICROBIOL, V145, P373, DOI 10.1016/j.vetmic.2010.04.007; Rodolakis A, 2010, VET MICROBIOL, V140, P382, DOI 10.1016/j.vetmic.2009.03.014; SCHAT KA, 1978, JNCI-J NATL CANCER I, V60, P1075, DOI 10.1093/jnci/60.5.1075; Vanrompay D, 1999, CLIN EXP IMMUNOL, V118, P49; VANROMPAY D, 1995, VET MICROBIOL, V45, P93, DOI 10.1016/0378-1135(95)00033-7; Vanrompay D, 1999, VACCINE, V17, P2628, DOI 10.1016/S0264-410X(99)00053-5; Verminnen K, 2005, VACCINE, V23, P4509, DOI 10.1016/j.vaccine.2005.04.014; Verminnen K, 2010, VACCINE, V28, P3095, DOI 10.1016/j.vaccine.2010.02.064; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Wehrl W, 2004, MOL MICROBIOL, V51, P319, DOI 10.1046/j.1365-2958.2003.03838.x; Wheelhouse NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049190; Wu ZX, 2013, NOVEL MODEL AVIAN CH; Yang JJ, 2011, AVIAN DIS, V55, P76, DOI 10.1637/9419-060710-Reg.1; Yin LZ, 2013, VET MICROBIOL, V162, P740, DOI 10.1016/j.vetmic.2012.09.026; Yuan JL, 2013, EVALUATION IMMUNE RE; Zhang FM, 2008, AVIAN DIS, V52, P74, DOI 10.1637/8019-051207-Reg; Zhao XJ, 2011, VACCINE, V29, P9611, DOI 10.1016/j.vaccine.2011.10.053; Zhou JZ, 2007, VACCINE, V25, P6367, DOI 10.1016/j.vaccine.2007.06.031	39	12	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124992	10.1371/journal.pone.0124992	http://dx.doi.org/10.1371/journal.pone.0124992			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893439	Green Published, Green Submitted, gold			2022-12-26	WOS:000353211700131
J	Lynch, CJ; Xu, YP; Hajnal, A; Salzberg, AC; Kawasawa, YI				Lynch, Christopher J.; Xu, Yuping; Hajnal, Andras; Salzberg, Anna C.; Kawasawa, Yuka Imamura			RNA Sequencing Reveals a Slow to Fast Muscle Fiber Type Transition after Olanzapine Infusion in Rats	PLOS ONE			English	Article							OXIDATIVE ENZYME-ACTIVITY; HUMAN SKELETAL-MUSCLE; SARCOMERIC M-BAND; INSULIN-RESISTANCE; SARCOPLASMIC-RETICULUM; MESSENGER-RNA; FAST-TWITCH; 2ND-GENERATION ANTIPSYCHOTICS; GENE-EXPRESSION; ALPHA	Second generation antipsychotics (SGAs), like olanzapine, exhibit acute metabolic side effects leading to metabolic inflexibility, hyperglycemia, adiposity and diabetes. Understanding how SGAs affect the skeletal muscle transcriptome could elucidate approaches for mitigating these side effects. Male Sprague-Dawley rats were infused intravenously with vehicle or olanzapine for 24h using a dose leading to a mild hyperglycemia. RNA-Seq was performed on gastrocnemius muscle, followed by alignment of the data with the Rat Genome Assembly 5.0. Olanzapine altered expression of 1347 out of 26407 genes. Genes encoding skeletal muscle fiber-type specific sarcomeric, ion channel, glycolytic, O-2- and Ca2+-handling, TCA cycle, vascularization and lipid oxidation proteins and pathways, along with NADH shuttles and LDH isoforms were affected. Bioinformatics analyses indicate that olanzapine decreased the expression of slower and more oxidative fiber type genes (e.g., type 1), while up regulating those for the most glycolytic and least metabolically flexible, fast twitch fiber type, IIb. Protein turnover genes, necessary to bring about transition, were also up regulated. Potential upstream regulators were also identified. Olanzapine appears to be rapidly affecting the muscle transcriptome to bring about a change to a fast-glycolytic fiber type. Such fiber types are more susceptible than slow muscle to atrophy, and such transitions are observed in chronic metabolic diseases. Thus these effects could contribute to the altered body composition and metabolic disease olanzapine causes. A potential interventional strategy is implicated because aerobic exercise, in contrast to resistance exercise, can oppose such slow to fast fiber transitions.	[Lynch, Christopher J.; Xu, Yuping] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Hajnal, Andras] Penn State Univ, Dept Neural & Behav Sci, Coll Med, Hershey, PA 17033 USA; [Salzberg, Anna C.] Penn State Univ, Dept Publ Hlth Sci, Coll Med, Hershey, PA 17033 USA; [Kawasawa, Yuka Imamura] Penn State Univ, Dept Pharmacol, Coll Med, Hershey, PA 17033 USA; [Kawasawa, Yuka Imamura] Penn State Univ, Dept Biochem & Mol Biol, Coll Med, Hershey, PA 17033 USA; [Kawasawa, Yuka Imamura] Penn State Univ, Inst Personalized Med, Coll Med, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Lynch, CJ (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA.	clynch@hmc.psu.edu			National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK084428]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084428] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was funded by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK: http://www.niddk.nih.gov/Pages/default.aspx) grant DK084428. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann MA, 2009, MOL BIOL CELL, V20, P2963, DOI 10.1091/mbc.E08-12-1251; Ader M, 2005, DIABETES, V54, P862, DOI 10.2337/diabetes.54.3.862; Agarkova I, 2004, EUR J CELL BIOL, V83, P193, DOI 10.1078/0171-9335-00383; Albaugh VL, 2011, MOL PSYCHIATR, V16, P569, DOI 10.1038/mp.2010.33; Albaugh VL, 2006, OBESITY, V14, P36, DOI 10.1038/oby.2006.6; Albaugh VL, 2012, SCHIZOPHRENIA BULL, V38, P153, DOI 10.1093/schbul/sbq053; Albaugh VL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022662; Almon RR, 2007, PHYSIOL GENOMICS, V30, P282, DOI 10.1152/physiolgenomics.00242.2006; Arikawa E, 2007, DIABETES, V56, P1410, DOI 10.2337/db06-0655; Assie MB, 2008, EUR J PHARMACOL, V592, P160, DOI 10.1016/j.ejphar.2008.06.105; Bamford JA, 2003, CAN J PHYSIOL PHARM, V81, P1072, DOI 10.1139/Y03-110; Beha A, 2006, AM J PHYSIOL-ENDOC M, V290, pE989, DOI 10.1152/ajpendo.00459.2005; Burniston JG, 2013, PHYSIOL GENOMICS, V45, P228, DOI 10.1152/physiolgenomics.00149.2012; Carroll SL, 1997, J PHYSIOL-LONDON, V501, P573, DOI 10.1111/j.1469-7793.1997.573bm.x; Chauvigne F, 2005, DEV DYNAM, V233, P659, DOI 10.1002/dvdy.20371; Chemello F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016807; Chen LN, 2013, INT J MOL MED, V32, P892, DOI 10.3892/ijmm.2013.1453; Chintoh AF, 2008, J CLIN PSYCHOPHARM, V28, P494, DOI 10.1097/JCP.0b013e318184b4c5; Cottle DL, 2007, J CELL SCI, V120, P1423, DOI 10.1242/jcs.004739; de Leon J, 2007, SCHIZOPHR RES, V92, P95, DOI 10.1016/j.schres.2007.01.015; Deng C, 2013, ENDOCRIN METAB CLIN, V42, P545, DOI 10.1016/j.ecl.2013.05.006; eder-Ischia Ursula, 2005, Essent Psychopharmacol, V6, P112; Fertuzinhos S, 2014, CELL REP, V6, P938, DOI 10.1016/j.celrep.2014.01.036; Frey N, 2008, J CLIN INVEST, V118, P3598, DOI 10.1172/JCI36277; Friedman RA, 2012, NY TIMES, pD6; Fujita Naoto, 2012, ScientificWorldJournal, V2012, P637978, DOI 10.1100/2012/637978; Hahn MK, 2013, J CLIN PSYCHOPHARM, V33, P740, DOI 10.1097/JCP.0b013e31829e8333; Hasnain M, 2012, POSTGRAD MED, V124, P154, DOI 10.3810/pgm.2012.07.2577; He J, 2001, DIABETES, V50, P817, DOI 10.2337/diabetes.50.4.817; HEIZMANN CW, 1982, P NATL ACAD SCI-BIOL, V79, P7243, DOI 10.1073/pnas.79.23.7243; Kaddurah-Daouk R, 2007, MOL PSYCHIATR, V12, P934, DOI 10.1038/sj.mp.4002000; Kelleher AR, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.246; Kim JW, 2007, DIFFERENTIATION, V75, P147, DOI 10.1111/j.1432-0436.2006.00118.x; Klingerman CM, 2014, SCHIZOPHRENIA BULL, V40, P327, DOI 10.1093/schbul/sbs196; Kyriazis IA, 2006, J CLIN PSYCHOPHARM, V26, P92, DOI 10.1097/01.jcp.0000196116.78129.86; Laimer M, 2005, J CLIN PSYCHOPHARM, V25, P183, DOI 10.1097/01.jcp.0000155827.05327.88; Laing NG, 2008, LANDES BIOSCIENCE, pxxii; Lynch CJ, 2014, NAT REV ENDOCRINOL, V10, P723, DOI 10.1038/nrendo.2014.171; MacArthur DG, 2004, BIOESSAYS, V26, P786, DOI 10.1002/bies.20061; MacIntosh BR, 2006, SKELETAL MUSCLE FORM, pviii; Maher Alicia R, 2012, J Manag Care Pharm, V18, pS1; McGrath MJ, 2006, J BIOL CHEM, V281, P7666, DOI 10.1074/jbc.M512552200; Mogensen M, 2007, DIABETES, V56, P1592, DOI 10.2337/db06-0981; Mullen AJ, 2000, GENE, V242, P313, DOI 10.1016/S0378-1119(99)00519-3; Nagatomo F, 2011, ACTA HISTOCHEM CYTOC, V44, P73, DOI 10.1267/ahc.10041; Newcomer JW, 2007, J CLIN PSYCHIAT, V68, P20; Norman B, 2009, J APPL PHYSIOL, V106, P959, DOI 10.1152/japplphysiol.91435.2008; Oberbach A, 2006, DIABETES CARE, V29, P895, DOI 10.2337/diacare.29.04.06.dc05-1854; Olfson M, 2006, AM J PSYCHIAT, V163, P1821, DOI 10.1176/appi.ajp.163.10.1821; Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8; SCHANTZ PG, 1986, ACTA PHYSIOL SCAND, V128, P397, DOI 10.1111/j.1748-1716.1986.tb07993.x; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Simoneau JA, 1997, J APPL PHYSIOL, V83, P166, DOI 10.1152/jappl.1997.83.1.166; SMERDU V, 1994, AM J PHYSIOL-CELL PH, V267, pC1723, DOI 10.1152/ajpcell.1994.267.6.C1723; Stevens L, 2000, AM J PHYSIOL-CELL PH, V279, pC1558, DOI 10.1152/ajpcell.2000.279.5.C1558; Summermatter S, 2013, P NATL ACAD SCI USA, V110, P8738, DOI 10.1073/pnas.1212976110; Tajsharghi H, 2004, J NEUROL, V251, P179, DOI 10.1007/s00415-004-0295-5; Talmadge RJ, 2007, BBA-GEN SUBJECTS, V1770, P1187, DOI 10.1016/j.bbagen.2007.03.013; Thompson CB, 1996, J BIOL CHEM, V271, P32653, DOI 10.1074/jbc.271.51.32653; Tiffin N, 2006, NUCLEIC ACIDS RES, V34, P3067, DOI 10.1093/nar/gkl381; Tiso N, 1997, BIOCHEM BIOPH RES CO, V230, P347, DOI 10.1006/bbrc.1996.5958; Towbin KE, 2006, AM J PSYCHIAT, V163, P2034, DOI 10.1176/appi.ajp.163.12.2034; Vary TC, 2008, AM J PHYSIOL-REG I, V294, pR1777, DOI 10.1152/ajpregu.00056.2008; Vidarsdottir S, 2010, J CLIN ENDOCR METAB, V95, P118, DOI 10.1210/jc.2008-1815; Wang YC, 2013, CURR OPIN CLIN NUTR, V16, P243, DOI 10.1097/MCO.0b013e328360272d; Wang ZC, 2003, BIOCHEM BIOPH RES CO, V305, P244, DOI 10.1016/S0006-291X(03)00730-7; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WU KD, 1993, AM J PHYSIOL, V264, pC333, DOI 10.1152/ajpcell.1993.264.2.C333; Yang N, 2009, MED SPORT SCI, V54, P88, DOI 10.1159/000235698; YANO K, 1994, MOL CELL BIOCHEM, V135, P61, DOI 10.1007/BF00925961; Zhang YL, 1995, GENOMICS, V30, P415, DOI 10.1006/geno.1995.1259	71	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123966	10.1371/journal.pone.0123966	http://dx.doi.org/10.1371/journal.pone.0123966			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893406	Green Published, gold, Green Submitted			2022-12-26	WOS:000353211700066
J	Zhao, CM; Peng, LY; Li, L; Liu, XY; Wang, J; Zhang, XL; Yuan, F; Li, RG; Qiu, XB; Yang, YQ				Zhao, Cui-Mei; Peng, Lu-Ying; Li, Li; Liu, Xing-Yuan; Wang, Juan; Zhang, Xian-Ling; Yuan, Fang; Li, Ruo-Gu; Qiu, Xing-Biao; Yang, Yi-Qing			PITX2 Loss-of-Function Mutation Contributes to Congenital Endocardial Cushion Defect and Axenfeld-Rieger Syndrome	PLOS ONE			English	Article							LEFT-RIGHT ASYMMETRY; HEART-DISEASE; SPORADIC TETRALOGY; CHINESE PATIENTS; GENE-EXPRESSION; GATA5 MUTATIONS; ADULT PATIENTS; NKX2-5 GENE; SPECTRUM; PREVALENCE	Congenital heart disease (CHD), the most common type of birth defect, is still the leading non-infectious cause of infant morbidity and mortality in humans. Aggregating evidence demonstrates that genetic defects are involved in the pathogenesis of CHD. However, CHD is genetically heterogeneous and the genetic components underpinning CHD in an overwhelming majority of patients remain unclear. In the present study, the coding exons and flanking introns of the PITX2 gene, which encodes a paired-like homeodomain transcription factor 2essential for cardiovascular morphogenesis as well as maxillary facial development, was sequenced in 196 unrelated patients with CHD and subsequently in the mutation carrier's family members available. As a result, a novel heterozygous PITX2 mutation, p.Q102X for PITX2a, or p.Q148X for PITX2b, or p.Q155X for PITX2c, was identified in a family with endocardial cushion defect (ECD) and Axenfeld-Rieger syndrome (ARS). Genetic analysis of the pedigree showed that the nonsense mutation co-segregated with ECD and ARS transmitted in an autosomal dominant pattern with complete penetrance. The mutation was absent in 800 control chromosomes from an ethnically matched population. Functional analysis by using a dual-luciferase reporter assay system revealed that the mutant PITX2 had no transcriptional activity and that the mutation eliminated synergistic transcriptional activation between PITX2 and NKX2.5, another transcription factor pivotal for cardiogenesis. To our knowledge, this is the first report on the association of PITX2 loss-of-function mutation with increased susceptibility to ECD and ARS. The findings provide novel insight into the molecular mechanisms underpinning ECD and ARS, suggesting the potential implications for the antenatal prophylaxis and personalized treatment of CHD and ARS.	[Zhao, Cui-Mei; Wang, Juan] Tongji Univ, Sch Med, Dept Cardiol, Shanghai 200092, Peoples R China; [Zhao, Cui-Mei; Peng, Lu-Ying; Li, Li] Tongji Univ, Sch Med, Div Med Genet, Shanghai 200092, Peoples R China; [Liu, Xing-Yuan] Tongji Univ, Tongji Hosp, Sch Med, Dept Pediat, Shanghai 200092, Peoples R China; [Zhang, Xian-Ling] Tongji Univ, Sch Med, Shanghai Tenth Peoples Hosp, Dept Cardiol, Shanghai 200092, Peoples R China; [Yuan, Fang; Li, Ruo-Gu; Qiu, Xing-Biao; Yang, Yi-Qing] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Cardiol, Shanghai 200030, Peoples R China; [Yang, Yi-Qing] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Cardiovasc Res Lab, Shanghai 200030, Peoples R China; [Yang, Yi-Qing] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Cent Lab, Shanghai 200030, Peoples R China	Tongji University; Tongji University; Tongji University; Tongji University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhao, CM (corresponding author), Tongji Univ, Sch Med, Dept Cardiol, Shanghai 200092, Peoples R China.	cuimeizhao@sina.com; luying_peng@163.com; dryyq@tongji.edu.cn			National Natural Science Fund of China [81270161, 81270231, 81370298]; National Basic Research Program of China [2012CB9668003]; key basic research program of Shanghai, China [14JC1405500]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); key basic research program of Shanghai, China(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by grants from the National Natural Science Fund of China (81270161, 81270231, and 81370298), the National Basic Research Program of China (2012CB9668003), and the key basic research program of Shanghai, China (14JC1405500).	Ai D, 2006, DEV BIOL, V296, P437, DOI 10.1016/j.ydbio.2006.06.009; Al Turki S, 2014, AM J HUM GENET, V94, P574, DOI 10.1016/j.ajhg.2014.03.007; Alonso-Gonzalez R, 2013, CIRCULATION, V127, P882, DOI 10.1161/CIRCULATIONAHA.112.126755; Banerjee-Basu S, 1999, HUM MUTAT, V14, P312, DOI 10.1002/(SICI)1098-1004(199910)14:4<312::AID-HUMU6>3.0.CO;2-S; Bansal V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085375; Cai BX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089609; Campbell AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035822; Carter DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095253; Chang SW, 2013, HUM MUTAT, V34, P1226, DOI 10.1002/humu.22366; Chen DF, 2013, GENE, V512, P185, DOI 10.1016/j.gene.2012.10.066; Costa MW, 2013, CIRC-CARDIOVASC GENE, V6, P238, DOI 10.1161/CIRCGENETICS.113.000057; Cowan J, 2014, HUM MUTAT, V35, P66, DOI 10.1002/humu.22457; Cox CJ, 2002, J BIOL CHEM, V277, P25001, DOI 10.1074/jbc.M201737200; Dagle JM, 2003, DEV BIOL, V262, P268, DOI 10.1016/S0012-1606(03)00389-0; de Lange FJ, 2004, CIRC RES, V95, P645, DOI 10.1161/01.RES.0000141429.13560.cb; Dimopoulos K, 2014, EUR HEART J, V35, P691, DOI 10.1093/eurheartj/eht437; Doward W, 1999, J MED GENET, V36, P152; Fahed AC, 2014, HEART FAIL CLIN, V10, P219, DOI 10.1016/j.hfc.2013.09.017; Furtado MB, 2011, DEV DYNAM, V240, P195, DOI 10.1002/dvdy.22492; Galli D, 2008, DEVELOPMENT, V135, P1157, DOI 10.1242/dev.014563; Ganga M, 2003, J BIOL CHEM, V278, P22437, DOI 10.1074/jbc.M210163200; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Gong XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076314; Hjalt TA, 2001, J CELL BIOL, V152, P545, DOI 10.1083/jcb.152.3.545; Hjalt Tord A., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405010082; Hoffmann A, 2010, HEART, V96, P1223, DOI 10.1136/hrt.2010.196147; Hsu J, 2012, CIRC-CARDIOVASC GENE, V5, P327, DOI 10.1161/CIRCGENETICS.111.961631; Huang RT, 2014, INT J MOL MED, V33, P1227, DOI 10.3892/ijmm.2014.1674; Huang RT, 2013, INT J MOL MED, V31, P1119, DOI 10.3892/ijmm.2013.1316; Huang RT, 2013, INT J MOL MED, V31, P51, DOI 10.3892/ijmm.2012.1188; Huang WH, 2013, GENE, V524, P152, DOI 10.1016/j.gene.2013.04.043; Hunter RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059734; Jiang JQ, 2013, INT J CARDIOL, V165, P570, DOI 10.1016/j.ijcard.2012.09.039; Kahr PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026389; Kirchhof P, 2011, CIRC-CARDIOVASC GENE, V4, P123, DOI 10.1161/CIRCGENETICS.110.958058; Kitamura K, 1999, DEVELOPMENT, V126, P5749; Kobayashi J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102796; Kroonstrom LA, 2014, INT J CARDIOL, V170, P358, DOI 10.1016/j.ijcard.2013.11.014; Lahm H, 2013, EUR J MED GENET, V56, P591, DOI 10.1016/j.ejmg.2013.09.001; Lalani SR, 2014, EUR J MED GENET, V57, P402, DOI 10.1016/j.ejmg.2014.04.010; Li J, 2014, GENE, V548, P174, DOI 10.1016/j.gene.2014.07.022; Li RG, 2013, BIOCHEM BIOPH RES CO, V439, P591, DOI 10.1016/j.bbrc.2013.09.023; Liang DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103097; Lin B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090215; Liu APY, 2014, EUR J MED GENET, V57, P306, DOI 10.1016/j.ejmg.2014.03.014; Liu CY, 2002, DEVELOPMENT, V129, P5081; Liu CY, 2001, DEVELOPMENT, V128, P2039; Liu Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0106787, 10.1371/journal.pone.0098157, 10.1371/journal.pone.0085323]; Long F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072515; Lozano-Velasco E, 2011, CELLS TISSUES ORGANS, V194, P349, DOI 10.1159/000323533; Lozic Bernarda, 2014, Med Sci Monit, V20, P1531, DOI 10.12659/MSM.890916; Lukasz A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066861; Martinez-Quintana E, 2013, PEDIATR CARDIOL, V34, P912, DOI 10.1007/s00246-012-0571-6; McCulley DJ, 2012, CURR TOP DEV BIOL, V100, P253, DOI 10.1016/B978-0-12-387786-4.00008-7; Moutafi AC, 2014, INT J CARDIOL, V173, P566, DOI 10.1016/j.ijcard.2014.03.120; Muller J, 2012, INT J CARDIOL, V154, P265, DOI 10.1016/j.ijcard.2010.09.029; Mulkey SB, 2013, PEDIATR CARDIOL, V34, P1772, DOI 10.1007/s00246-013-0712-6; Ohuchi H, 2009, AM HEART J, V158, P30, DOI 10.1016/j.ahj.2009.04.021; Perry JC, 2012, PEDIATR CARDIOL, V33, P484, DOI 10.1007/s00246-012-0171-5; Qiu XB, 2014, CLINICS, V69, P15, DOI 10.6061/clinics/2014(01)03; Rajagopal SK, 2007, J MOL CELL CARDIOL, V43, P677, DOI 10.1016/j.yjmcc.2007.06.004; Reamon-Buettner SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083295; Reamon-Buettner SM, 2010, HUM MUTAT, V31, P1185, DOI 10.1002/humu.21345; Rushani D, 2013, CIRCULATION, V128, P1412, DOI 10.1161/CIRCULATIONAHA.113.001827; Sanchez-Castro M, 2013, HUM MUTAT, V34, P1628, DOI 10.1002/humu.22449; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Schweickert A, 2000, MECH DEVELOP, V90, P41, DOI 10.1016/S0925-4773(99)00227-0; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Shi LM, 2014, INT J MOL MED, V33, P1219, DOI 10.3892/ijmm.2014.1700; Simard A, 2009, DEV DYNAM, V238, P2459, DOI 10.1002/dvdy.22062; Topf A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095453; Torrado M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090561; Tumer Z, 2009, EUR J HUM GENET, V17, P1527, DOI 10.1038/ejhg.2009.93; Tutarel O, 2014, EUR HEART J, V35, P725, DOI 10.1093/eurheartj/eht257; Wang C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065120, 10.1371/journal.pone.0068807]; Wang EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072423; Wang E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062138; Wang J, 2013, DNA CELL BIOL, V32, P708, DOI 10.1089/dna.2013.2185; Wang J, 2014, INT J MOL MED, V34, P1581, DOI 10.3892/ijmm.2014.1971; Wang J, 2014, EUR J MED GENET, V57, P25, DOI 10.1016/j.ejmg.2013.11.004; Wang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058041; Wang ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070979; Wei D, 2014, INT J MOL MED, V33, P1201, DOI 10.3892/ijmm.2014.1689; Wu M, 2013, INT J MOL MED, V31, P899, DOI 10.3892/ijmm.2013.1275; Xia K, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.022434; Xiang R, 2014, GENE, V534, P320, DOI 10.1016/j.gene.2013.10.028; Xu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089636; Xu L, 2014, INT J MOL MED, V34, P1315, DOI 10.3892/ijmm.2014.1896; Yang YQ, 2013, ARCH MED SCI, V9, P976, DOI 10.5114/aoms.2013.39788; Yang YQ, 2013, HUM MUTAT, V34, P1662, DOI 10.1002/humu.22434; Yang YQ, 2013, INT J CARDIOL, V168, P2873, DOI 10.1016/j.ijcard.2013.03.141; Yu H, 2014, INT J MED SCI, V11, P554, DOI 10.7150/ijms.8407; Yuan F, 2013, INT J MED SCI, V10, P1422, DOI 10.7150/ijms.6809; Zaidi S, 2013, NATURE, V498, P220, DOI 10.1038/nature12141; Zhao L, 2014, EUR J MED GENET, V57, P579, DOI 10.1016/j.ejmg.2014.08.005; Zhou YM, 2013, INT J MOL MED, V32, P827, DOI 10.3892/ijmm.2013.1463; Zhu XM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087437	98	19	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124409	10.1371/journal.pone.0124409	http://dx.doi.org/10.1371/journal.pone.0124409			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893250	Green Submitted, Green Published, gold			2022-12-26	WOS:000353211700091
J	Kong, FC; Zhang, Y; Chen, H				Kong, Fanchang; Zhang, Yan; Chen, Hong			Inhibition Ability of Food Cues between Successful and Unsuccessful Restrained Eaters: A Two-Choice Oddball Task	PLOS ONE			English	Article							EATING BEHAVIOR; SELF-CONTROL; RESPONSE-INHIBITION; MODEL; DEPLETION; P300	Background Previous studies have presented mixed findings on the inhibition ability in restrained eaters (REs) due to the limited amount of neural evidence and limitations of behavioral measures. The current study explores the neural correlations of the specific inhibition ability among successful restrained eaters (S-REs), unsuccessful restrained eaters (US-REs), and unrestrained eaters (UREs). Methodology and Principal Findings Three groups of females (with 13 participants in each group) completed a two-choice Odd-ball task, while the event-related potentials (ERPs) are recorded synchronously. Results indicate that S-REs showed inhibition deficit in processing high-energy food cues whereas US-REs show inhibition deficit in processing both low-and high-energy food cues. Conclusion Results indicate that S-REs and US-REs differ in terms of specific inhibition ability and that enhanced inhibition is essential to a successful diet.	[Kong, Fanchang] Cent China Normal Univ, Minist Educ, Key Lab Adolescent CyberPsychol & Behav, Wuhan, Peoples R China; [Kong, Fanchang] Cent China Normal Univ, Sch Psychol, Wuhan, Peoples R China; [Kong, Fanchang; Chen, Hong] Southwest Univ, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China; [Kong, Fanchang; Chen, Hong] Southwest Univ, Fac Psychol, Chongqing, Peoples R China; [Zhang, Yan] Huazhong Univ Sci & Technol, Acad Educ Sci, Wuhan 430074, Peoples R China	Central China Normal University; Central China Normal University; Southwest University - China; Southwest University - China; Huazhong University of Science & Technology	Chen, H (corresponding author), Southwest Univ, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China.	kfcpsy@sina.com	Kong, Fanchang/AIE-1078-2022	Kong, Fanchang/0000-0002-0340-8445	Chinese National Natural Science Foundation [31170981, 31200787]; Postgraduate Innovation Foundation of Science and Technology in Southwest University [kb2010014]; China Postdoctoral Science Foundation funded project [2013M531712]; Ministry of Education-China Mobile Foundation [MCM20130601]; Fundamental Research Funds for the Central Universities, China [CCNU13A03011]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Postgraduate Innovation Foundation of Science and Technology in Southwest University(Southwest University - China); China Postdoctoral Science Foundation funded project(China Postdoctoral Science Foundation); Ministry of Education-China Mobile Foundation; Fundamental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities)	This research was supported and granted by Chinese National Natural Science Foundation (31170981 & 31200787), Postgraduate Innovation Foundation of Science and Technology in Southwest University (kb2010014), China Postdoctoral Science Foundation funded project (2013M531712), The Ministry of Education-China Mobile Foundation (MCM20130601), and Fundamental Research Funds for the Central Universities, China (CCNU13A03011). The funders had no role in study design, data	ALEXANDER JE, 1995, COGNITIVE BRAIN RES, V2, P277, DOI 10.1016/0926-6410(95)90019-5; Babiloni C, 2011, CLIN NEUROPHYSIOL, V122, P1348, DOI 10.1016/j.clinph.2010.12.001; BAKER RC, 1993, BEHAV THER, V24, P377, DOI 10.1016/S0005-7894(05)80212-6; Beaver JD, 2006, J NEUROSCI, V26, P5160, DOI 10.1523/JNEUROSCI.0350-06.2006; Blechert J, 2010, APPETITE, V54, P262, DOI 10.1016/j.appet.2009.11.007; Choo V, 2002, LANCET, V360, P235, DOI 10.1016/S0140-6736(02)09512-0; Danhauer SC, 2004, PREV MED, V39, P783, DOI 10.1016/j.ypmed.2004.03.003; Donkers FCL, 2004, BRAIN COGNITION, V56, P165, DOI 10.1016/j.bandc.2004.04.005; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; Graziano PA, 2009, INT J OBE, V4, P633; Guerrieri R, 2012, APPETITE, V59, P96, DOI 10.1016/j.appet.2012.04.006; Hachl P, 2003, INT J PSYCHOPHYSIOL, V49, P111, DOI 10.1016/S0167-8760(03)00099-0; Hagger MS, 2010, PSYCHOL BULL, V136, P495, DOI 10.1037/a0019486; HERMAN CP, 1987, J ABNORM PSYCHOL, V96, P264, DOI 10.1037/0021-843X.96.3.264; Jansen A, 2009, BEHAV RES THER, V47, P105, DOI 10.1016/j.brat.2008.10.016; Kong F. C., 2012, THESIS SW U CHINA; Kuijer R, 2008, APPETITE, V51, P506, DOI 10.1016/j.appet.2008.03.014; Leitch MA, 2013, APPETITE, V69, P54, DOI 10.1016/j.appet.2013.05.007; LOWE MR, 1993, PSYCHOL BULL, V114, P100, DOI 10.1037/0033-2909.114.1.100; Meule A, 2014, APPETITE, V79, P174, DOI 10.1016/j.appet.2014.04.014; Meule A, 2012, APPETITE, V58, P638, DOI 10.1016/j.appet.2011.11.023; Meule A, 2011, APPETITE, V57, P582, DOI 10.1016/j.appet.2011.07.013; Meule A, 2011, EAT BEHAV, V12, P152, DOI 10.1016/j.eatbeh.2011.01.006; Muraven M, 2000, PSYCHOL BULL, V126, P247, DOI 10.1037/0033-2909.126.2.247; Musso F, 2011, NEUROIMAGE, V9, P269; Nederkoorn C, 2004, PERS INDIV DIFFER, V37, P1651, DOI 10.1016/j.paid.2004.02.020; Nederkoorn C, 2010, HEALTH PSYCHOL, V29, P389, DOI 10.1037/a0019921; Nordgren LF, 2009, PSYCHOL SCI, V20, P1523, DOI 10.1111/j.1467-9280.2009.02468.x; Ouwehand C, 2010, APPETITE, V55, P56, DOI 10.1016/j.appet.2010.04.009; Papies EK, 2008, J EXP SOC PSYCHOL, V44, P1283, DOI 10.1016/j.jesp.2008.04.008; Polich J, 2000, INT J PSYCHOPHYSIOL, V38, P3, DOI 10.1016/S0167-8760(00)00127-6; Stroebe W, 2008, J EXP SOC PSYCHOL, V44, P26, DOI 10.1016/j.jesp.2007.01.005; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; van Koningsbruggen GM, 2013, APPETITE, V60, P81, DOI 10.1016/j.appet.2012.09.016; Van Strien T, 2000, INT J EAT DISORDER, V28, P333, DOI 10.1002/1098-108X(200011)28:3&lt;333::AID-EAT11&gt;3.0.CO;2-#; Watson TD, 2013, APPETITE, V71, P40, DOI 10.1016/j.appet.2013.07.007; Yuan JJ, 2008, PSYCHOPHYSIOLOGY, V45, P986, DOI 10.1111/j.1469-8986.2008.00693.x	37	23	25	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0120522	10.1371/journal.pone.0120522	http://dx.doi.org/10.1371/journal.pone.0120522			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EX	25886063	Green Published, gold, Green Submitted			2022-12-26	WOS:000353017000010
J	Andersson, DA; Filipovic, MR; Gentry, C; Eberhardt, M; Vastani, N; Leffler, A; Reeh, P; Bevan, S				Andersson, David A.; Filipovic, Milos R.; Gentry, Clive; Eberhardt, Mirjam; Vastani, Nisha; Leffler, Andreas; Reeh, Peter; Bevan, Stuart			Streptozotocin Stimulates the Ion Channel TRPA1 Directly INVOLVEMENT OF PEROXYNITRITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATE TRPA1; NITRIC-OXIDE; SENSORY NEUROPATHY; PANCREATIC-ISLETS; GENERATION; COLD; HYPERALGESIA; CONTRIBUTES; MECHANISMS; RECEPTOR	Streptozotocin (STZ)-induced diabetes is the most commonly used animal model of diabetes. Here, we have demonstrated that intraplantar injections of low dose STZ evoked acute polymodal hypersensitivities in mice. These hypersensitivities were inhibited by a TRPA1 antagonist and were absent in TRPA1-null mice. In wild type mice, systemic STZ treatment (180 mg/kg) evoked a loss of cold and mechanical sensitivity within an hour of injection, which lasted for at least 10 days. In contrast, Trpa1(-/-) mice developed mechanical, cold, and heat hypersensitivity 24 h after STZ. The TRPA1-dependent sensory loss produced by STZ occurs before the onset of diabetes and may thus not be readily distinguished from the similar sensory abnormalities produced by the ensuing diabetic neuropathy. In vitro, STZ activated TRPA1 in isolated sensory neurons, TRPA1 cell lines, and membrane patches. Mass spectrometry studies revealed that STZ oxidizes TRPA1 cysteines to disulfides and sulfenic acids. Furthermore, incubation of tyrosine with STZ resulted in formation of dityrosine, suggesting formation of peroxynitrite. Functional analysis of TRPA1 mutants showed that cysteine residues that were oxidized by STZ were important for TRPA1 responsiveness to STZ. Our results have identified oxidation of TRPA1 cysteine residues, most likely by peroxynitrite, as a novel mechanism of action of STZ. Direct stimulation of TRPA1 complicates the interpretation of results from STZ models of diabetic sensory neuropathy and strongly argues that more refined models of diabetic neuropathy should replace the use of STZ.	[Andersson, David A.; Gentry, Clive; Vastani, Nisha; Bevan, Stuart] Kings Coll London, Wolfson Ctr Agerelated Dis, London SE1 1UL, England; [Filipovic, Milos R.] Univ Erlangen Nurnberg, Dept Chem & Pharm, Bioinorgan Chem Div, D-91058 Erlangen, Germany; [Eberhardt, Mirjam; Leffler, Andreas] Hannover Med Sch, Dept Anesthesiol & Intens Care, D-30625 Hannover, Germany; [Reeh, Peter] Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, D-91054 Erlangen, Germany	University of London; King's College London; University of Erlangen Nuremberg; Hannover Medical School; University of Erlangen Nuremberg	Andersson, DA (corresponding author), Kings Coll London, Wolfson Ctr Agerelated Dis, Hodgkin Bldg,Guys Campus, London SE1 1UL, England.	david.andersson@kcl.ac.uk	Reeh, Peter W./J-8981-2012; Bevan, Stuart/A-8821-2008; Andersson, David A/C-3435-2008; Filipovic, Milos/D-5482-2014	Reeh, Peter W./0000-0002-4367-094X; Andersson, David A/0000-0001-7451-8548; Filipovic, Milos/0000-0003-0060-0041	Diabetes UK Alec and Beryl Warren Award BDA [13/0004649]; FAU Erlangen-Nuremberg (EFI-MRIC); Diabetes UK [13/0004649] Funding Source: researchfish	Diabetes UK Alec and Beryl Warren Award BDA(Diabetes UK); FAU Erlangen-Nuremberg (EFI-MRIC); Diabetes UK(Diabetes UK)	This work was supported in part by the Diabetes UK Alec and Beryl Warren Award BDA 13/0004649 (to D. A. A. and S. B.).; Supported by FAU Erlangen-Nuremberg (EFI-MRIC).	Alvarez B, 1999, J BIOL CHEM, V274, P842, DOI 10.1074/jbc.274.2.842; Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Andersson DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077986; Andersson DA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1559; Andersson DA, 2009, P NATL ACAD SCI USA, V106, P8374, DOI 10.1073/pnas.0812675106; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bessac BF, 2008, J CLIN INVEST, V118, P1899, DOI 10.1172/JCI34192; BEVAN S, 1995, J NEUROSCI, V15, P4918; Bierhaus A, 2012, NAT MED, V18, P926, DOI 10.1038/nm.2750; Bishnoi M, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-52; Cao DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038005; Cunha JM, 2009, BRAZ J MED BIOL RES, V42, P197, DOI 10.1590/S0100-879X2009000200008; Dai Y, 2007, J CLIN INVEST, V117, P1979, DOI 10.1172/JCI30951; Day BJ, 1997, ARCH BIOCHEM BIOPHYS, V347, P256, DOI 10.1006/abbi.1997.0341; Drel VR, 2007, EUR J PHARMACOL, V569, P48, DOI 10.1016/j.ejphar.2007.05.055; Dworkin RH, 2007, PAIN, V132, P237, DOI 10.1016/j.pain.2007.08.033; Eberhardt M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5381; Eberhardt MJ, 2012, J BIOL CHEM, V287, P28291, DOI 10.1074/jbc.M111.328674; Edwards JL, 2008, PHARMACOL THERAPEUT, V120, P1, DOI 10.1016/j.pharmthera.2008.05.005; Eid SR, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-48; EIZIRIK DL, 1988, DIABETOLOGIA, V31, P168, DOI 10.1007/BF00276851; Engel MA, 2011, GASTROENTEROLOGY, V141, P1346, DOI 10.1053/j.gastro.2011.07.002; Filipovic MR, 2007, FREE RADICAL RES, V41, P62, DOI 10.1080/10715760600944296; Fleming T, 2012, DIABETOLOGIA, V55, P1151, DOI 10.1007/s00125-012-2452-1; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Friedel FC, 2012, J INORG BIOCHEM, V109, P26, DOI 10.1016/j.jinorgbio.2011.12.008; Gentry C, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-4; Hill K, 2009, CELL CALCIUM, V45, P155, DOI 10.1016/j.ceca.2008.08.001; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Jack MM, 2012, EXP NEUROL, V234, P62, DOI 10.1016/j.expneurol.2011.12.015; JANCSO N, 1967, BRIT J PHARM CHEMOTH, V31, P138, DOI 10.1111/j.1476-5381.1967.tb01984.x; Jeffry JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007021; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kissner R, 1997, CHEM RES TOXICOL, V10, P1285, DOI 10.1021/tx970160x; Koivisto A, 2012, PHARMACOL RES, V65, P149, DOI 10.1016/j.phrs.2011.10.006; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; KWON NS, 1994, FASEB J, V8, P529, DOI 10.1096/fasebj.8.8.8181671; Lancaster JR, 2006, CHEM RES TOXICOL, V19, P1160, DOI 10.1021/tx060061w; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Moparthi L, 2014, P NATL ACAD SCI USA, V111, P16901, DOI 10.1073/pnas.1412689111; Nagai R, 2002, DIABETES, V51, P2833, DOI 10.2337/diabetes.51.9.2833; NUKATSUKA M, 1988, FEBS LETT, V239, P295, DOI 10.1016/0014-5793(88)80938-4; Obata K, 2005, J CLIN INVEST, V115, P2393, DOI 10.1172/JCI23437; Obrosova IG, 2009, NEUROTHERAPEUTICS, V6, P638, DOI 10.1016/j.nurt.2009.07.004; Petrus M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-40; PIPELEERS D, 1986, P NATL ACAD SCI USA, V83, P5267, DOI 10.1073/pnas.83.14.5267; Raza H, 2012, INT J MOL SCI, V13, P5751, DOI 10.3390/ijms13055751; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Sugimoto K, 2008, CURR PHARM DESIGN, V14, P953, DOI 10.2174/138161208784139774; Szolcsanyi J, 2004, NEUROPEPTIDES, V38, P377, DOI 10.1016/j.npep.2004.07.005; Takahashi N, 2008, CHANNELS, V2, P287, DOI 10.4161/chan.2.4.6745; TAKASU N, 1991, DIABETES, V40, P1141, DOI 10.2337/diabetes.40.9.1141; Tomlinson DR, 2008, NAT REV NEUROSCI, V9, P36, DOI 10.1038/nrn2294; Vincent AM, 2011, NAT REV NEUROL, V7, P573, DOI 10.1038/nrneurol.2011.137; Wang S, 2008, BRAIN, V131, P1241, DOI 10.1093/brain/awn060; Wei H, 2009, ANESTHESIOLOGY, V111, P147, DOI 10.1097/ALN.0b013e3181a1642b; Willis WD, 2006, PROG NEUROBIOL, V78, P189, DOI 10.1016/j.pneurobio.2006.02.007; WINK DA, 1994, CHEM RES TOXICOL, V7, P519, DOI 10.1021/tx00040a007; Wrigglesworth R, 1996, J MED CHEM, V39, P4942, DOI 10.1021/jm960512h; Zygmunt PM, 2014, HANDB EXP PHARMACOL, V222, P583, DOI 10.1007/978-3-642-54215-2_23	62	53	54	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15185	15196		10.1074/jbc.M115.644476	http://dx.doi.org/10.1074/jbc.M115.644476			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25903127	Green Published, hybrid			2022-12-26	WOS:000356177300032
J	Chung, DY; Cho, KS; Lee, DH; Han, JH; Kang, DH; Do Jung, H; Kown, JK; Ham, WS; Choi, YD; Lee, JY				Chung, Doo Yong; Cho, Kang Su; Lee, Dae Hun; Han, Jang Hee; Kang, Dong Hyuk; Do Jung, Hae; Kown, Jong Kyou; Ham, Won Sik; Choi, Young Deuk; Lee, Joo Yong			Impact of Colic Pain as a Significant Factor for Predicting the Stone Free Rate of One-Session Shock Wave Lithotripsy for Treating Ureter Stones: A Bayesian Logistic Regression Model Analysis	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; PROPENSITY SCORES; CLINICAL-EXPERIENCE; HOUNSFIELD UNITS; MEDICAL-RESEARCH; SUCCESS; CALCULI; PRINCIPLES; PATIENT	Purpose This study was conducted to evaluate colic pain as a prognostic pretreatment factor that can influence ureter stone clearance and to estimate the probability of stone-free status in shock wave lithotripsy (SWL) patients with a ureter stone. Materials and Methods We retrospectively reviewed the medical records of 1,418 patients who underwent their first SWL between 2005 and 2013. Among these patients, 551 had a ureter stone measuring 4-20 mm and were thus eligible for our analyses. The colic pain as the chief complaint was defined as either subjective flank pain during history taking and physical examination. Propensity-scores for established for colic pain was calculated for each patient using multivariate logistic regression based upon the following covariates: age, maximal stone length (MSL), and mean stone density (MSD). Each factor was evaluated as predictor for stone-free status by Bayesian and non-Bayesian logistic regression model. Results After propensity-score matching, 217 patients were extracted in each group from the total patient cohort. There were no statistical differences in variables used in propensity-score matching. One-session success and stone-free rate were also higher in the painful group (73.7% and 71.0%, respectively) than in the painless group (63.6% and 60.4%, respectively). In multivariate non-Bayesian and Bayesian logistic regression models, a painful stone, shorter MSL, and lower MSD were significant factors for one-session stone-free status in patients who underwent SWL. Conclusions Colic pain in patients with ureter calculi was one of the significant predicting factors including MSL and MSD for one-session stone-free status of SWL.	[Chung, Doo Yong; Han, Jang Hee; Do Jung, Hae; Ham, Won Sik; Choi, Young Deuk; Lee, Joo Yong] Yonsei Univ, Coll Med, Severance Hosp, Urol Sci Inst,Dept Urol, Seoul, South Korea; [Cho, Kang Su] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Urol Sci Inst,Dept Urol, Seoul, South Korea; [Lee, Dae Hun] Yonsei Univ Hlth Syst, Severance Check Up, Dept Urol, Seoul, South Korea; [Kang, Dong Hyuk] Yangpyeong Hlth Ctr, Dept Urol, Yangpyeong, South Korea; [Kown, Jong Kyou] Inje Univ, Haeundae Paik Hosp, Coll Med, Dept Urol, Busan, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Inje University	Lee, JY (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Urol Sci Inst,Dept Urol, Seoul, South Korea.	joouro@yuhs.ac	; Lee, Joo Yong/C-3851-2013	Choi, Young Deuk/0000-0002-8545-5797; Lee, Joo Yong/0000-0002-3470-1767; Cho, Kang Su/0000-0002-3500-8833; Ham, Won Sik/0000-0003-2246-8838				Bandi G, 2009, BJU INT, V103, P524, DOI 10.1111/j.1464-410X.2008.08069.x; Berry DA, 2006, NAT REV DRUG DISCOV, V5, P27, DOI 10.1038/nrd1927; BORGHI L, 1994, J UROLOGY, V152, P1095, DOI 10.1016/S0022-5347(17)32511-9; Cakiroglu B, 2014, INT J CLIN EXP MED, V7, P1276; CHAUSSY C, 1982, J UROLOGY, V127, P417, DOI 10.1016/S0022-5347(17)53841-0; Choi JW, 2012, KOREAN J UROL, V53, P424, DOI 10.4111/kju.2012.53.6.424; Cooper JT, 2000, UROLOGY, V56, P575, DOI 10.1016/S0090-4295(00)00658-0; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; El-Nahas AR, 2007, EUR UROL, V51, P1688, DOI 10.1016/j.eururo.2006.11.048; Elganainy Ehab, 2009, Int Arch Med, V2, P13, DOI 10.1186/1755-7682-2-13; ERTURK E, 1993, J UROLOGY, V149, P1425, DOI 10.1016/S0022-5347(17)36405-4; Hay KE, 2014, PREV VET MED; Jacobs BL, 2008, J ENDOUROL, V22, P1623, DOI 10.1089/end.2008.0169; Jee JY, 2013, KOREAN J UROL, V54, P865, DOI 10.4111/kju.2013.54.12.865; Lee JY, 2013, INT J UROL, V20, P1169, DOI 10.1111/iju.12144; Matlaga BR, 2009, J UROLOGY, V181, P2152, DOI 10.1016/j.juro.2009.01.023; MUELLER SC, 1986, J UROLOGY, V135, P831, DOI 10.1016/S0022-5347(17)45870-8; Musa AAK, 2008, INT UROL NEPHROL, V40, P19, DOI 10.1007/s11255-006-9030-8; Pareek G, 2005, UROLOGY, V65, P33, DOI 10.1016/j.urology.2004.08.004; Pareek G, 2003, J UROLOGY, V169, P1679, DOI 10.1097/01.ju.0000055608.92069.3a; Park J, 2013, WORLD J UROL, V31, P1569, DOI 10.1007/s00345-012-0966-2; Ringden I, 2007, SCAND J UROL NEPHROL, V41, P316, DOI 10.1080/00365590601154551; Rubin DB, 1996, BIOMETRICS, V52, P249, DOI 10.2307/2533160; Rubin DB, 2004, PHARMACOEPIDEM DR S, V13, P855, DOI 10.1002/pds.968; Sackett D.L., 1985, CLIN EPIDEMIOLOGY BA; Sarica K, 2014, UROLITHIASIS; Seitz C, 2007, EUR UROL, V52, P1223, DOI 10.1016/j.eururo.2007.02.001; Seitz C, 2006, EUR UROL, V49, P1099, DOI 10.1016/j.eururo.2005.12.003; Tanaka M, 2013, KOREAN J UROL, V54, P454, DOI 10.4111/kju.2013.54.7.454; Tombal B, 2005, EUR UROL, V47, P855, DOI 10.1016/j.eururo.2005.03.006; Weitzen S, 2004, PHARMACOEPIDEM DR S, V13, P841, DOI 10.1002/pds.969; Weld KJ, 2007, UROLOGY, V70, P1043, DOI 10.1016/j.urology.2007.07.074	32	51	57	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123800	10.1371/journal.pone.0123800	http://dx.doi.org/10.1371/journal.pone.0123800			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902059	Green Published, Green Submitted, gold			2022-12-26	WOS:000353331500064
J	E, ZG; Zhang, YP; Li, TT; Wang, L; Zhao, HM				E, Zhiguo; Zhang, Yuping; Li, Tingting; Wang, Lei; Zhao, Heming			Characterization of the Ubiquitin-Conjugating Enzyme Gene Family in Rice and Evaluation of Expression Profiles under Abiotic Stresses and Hormone Treatments	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; PROTEASOME SYSTEM; E2; PROTEIN; MECHANISMS; PHOSPHATE; CLASSIFICATION; EXTENSION; SOFTWARE; LIGASE	Ubiquitin-conjugating enzyme E2s (UBCs), which catalyze the transfer of ubiquitin to substrate or E3 ligases, are key enzymes in ubiquitination modifications of target proteins. However, little is known about the knowledge of UBC gene family in rice. In this study, a total of 39 UBC encoding genes, which all contained an UBC domain with a cysteine active site, were identified in the rice genome. These were classified into fifteen distinct subfamilies based upon their sequence similarity and phylogenetic relationships. A subset of 19 OsUBC genes exhibited chromosomal duplication; 4 and 15 OsUBC genes were tandemly and segmentally duplicated, respectively. Comprehensive analyses were performed to investigate the expression profiles of OsUBC genes in various stages of vegetative and reproductive development using data from EST, Microarrays, MPSS, and real-time PCR. Many OsUBC genes exhibited abundant and tissue-specific expression patterns. Moreover, 14 OsUBCs were found to be differentially expressed under treatments with drought, or salt stresses. The expression analysis after treatments with IAA, 6-BA, GA and ABA indicated that almost all OsUBC genes were responsive to at least two of the four hormones. Several genes were significantly down-regulated under all of the hormone treatments, and most of the genes reduced by 6-BA were also reduced by GA. This study will facilitate further studies of the OsUBC gene family and provide useful clues for functional validation of OsUBCs in rice.	[E, Zhiguo; Zhang, Yuping; Li, Tingting; Wang, Lei] China Natl Rice Res Inst, Hangzhou 310006, Zhejiang, Peoples R China; [Zhao, Heming] Fujian Agr & Forestry Univ, Ctr Genom & Biotechnol, Fuzhou 350002, Fujian Province, Peoples R China	Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Fujian Agriculture & Forestry University	Wang, L (corresponding author), China Natl Rice Res Inst, 359 Tiyuchang Rd, Hangzhou 310006, Zhejiang, Peoples R China.	wanglei05@caas.cn; zhaoheming@whu.edu.cn			special fund for Agro-Scientific Research in the Public Interest [201203031, 201203029, 201003016]; Special Foundation for Basic Research and the Development of Central Level Scientific Research Institutes in China [2012RG006]; Life Science and Technology Center, China National Seed Group Co., Ltd.	special fund for Agro-Scientific Research in the Public Interest; Special Foundation for Basic Research and the Development of Central Level Scientific Research Institutes in China; Life Science and Technology Center, China National Seed Group Co., Ltd.	This research was supported by the special fund for Agro-Scientific Research in the Public Interest (201203031, 201203029, 201003016) and the Special Foundation for Basic Research and the Development of Central Level Scientific Research Institutes in China (2012RG006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Heming Zhao is employed by Life Science and Technology Center, China National Seed Group Co., Ltd. Life Science and Technology Center, China National Seed Group Co., Ltd. provided support in the form of salary for author HZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arrigoni A, 2012, J STRUCT BIOL, V178, P245, DOI 10.1016/j.jsb.2012.04.003; Aung K, 2006, PLANT PHYSIOL, V141, P1000, DOI 10.1104/pp.106.078063; Bae H, 2014, BIOCHEM BIOPH RES CO, V444, P575, DOI 10.1016/j.bbrc.2014.01.098; Bae H, 2013, BIOCHEM BIOPH RES CO, V433, P266, DOI 10.1016/j.bbrc.2013.03.005; Baloglu MC, 2014, BIOCHEM GENET, V52, P90, DOI 10.1007/s10528-013-9630-9; Biasini Marco, 2014, Nucleic Acids Res, V42, pW252, DOI 10.1093/nar/gku340; Chung E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066056; Cooper B, 2003, P NATL ACAD SCI USA, V100, P4945, DOI 10.1073/pnas.0737574100; Criqui MC, 2002, PLANT PHYSIOL, V130, P1230, DOI 10.1104/pp.011353; Cui F, 2012, PLANT CELL, V24, P233, DOI 10.1105/tpc.111.093062; Dong B, 1998, PLANTA, V205, P251, DOI 10.1007/s004250050318; Dreher K, 2007, ANN BOT-LONDON, V99, P787, DOI 10.1093/aob/mcl255; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jeon EH, 2012, BIOCHEM BIOPH RES CO, V427, P309, DOI 10.1016/j.bbrc.2012.09.048; Jones S, 2001, GENOME BIOL, V2; Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750; Kong H, 2007, PLANT J, V50, P873, DOI 10.1111/j.1365-313X.2007.03097.x; Kraft E, 2005, PLANT PHYSIOL, V139, P1597, DOI 10.1104/pp.105.067983; Li WF, 2010, PLANT J, V62, P330, DOI 10.1111/j.1365-313X.2010.04150.x; Lin WY, 2009, J EXP BOT, V60, P1427, DOI 10.1093/jxb/ern303; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Ma HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025184; Ma HL, 2010, J EXP BOT, V61, P2647, DOI 10.1093/jxb/erq104; Michelle C, 2009, J MOL EVOL, V68, P616, DOI 10.1007/s00239-009-9225-6; Papaleo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040786; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Sadanandom A, 2012, NEW PHYTOL, V196, P13, DOI 10.1111/j.1469-8137.2012.04266.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schumacher FR, 2013, J MOL BIOL, V425, P4099, DOI 10.1016/j.jmb.2013.06.039; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Takai R, 2002, PLANT J, V30, P447, DOI 10.1046/j.1365-313X.2002.01299.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; Vierstra RD, 1996, PLANT MOL BIOL, V32, P275, DOI 10.1007/BF00039386; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wan XR, 2011, J BIOSCI BIOENG, V111, P478, DOI 10.1016/j.jbiosc.2010.11.021; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Wen R, 2006, PLANT MOL BIOL, V61, P241, DOI 10.1007/s11103-006-0007-x; Xu L, 2009, PLANT J, V57, P279, DOI 10.1111/j.1365-313X.2008.03684.x; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Zhang XW, 2013, GENE, V530, P185, DOI 10.1016/j.gene.2013.08.048; Zhao HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049210; Zhou GA, 2010, PLANT MOL BIOL, V72, P357, DOI 10.1007/s11103-009-9575-x	47	35	39	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0122621	10.1371/journal.pone.0122621	http://dx.doi.org/10.1371/journal.pone.0122621			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902049	Green Published, gold, Green Submitted			2022-12-26	WOS:000353331500024
J	Kierny, MR; Cunningham, TD; Bouhenni, RA; Edward, DP; Kay, BK				Kierny, Michael R.; Cunningham, Thomas D.; Bouhenni, Rachida A.; Edward, Deepak P.; Kay, Brian K.			Generating Recombinant Antibodies against Putative Biomarkers of Retinal Injury	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; HUMAN PLASMA; LASER; ANTIGENS; CANCER; PHAGE; SERUM; EXPRESSION; PEPTIDES; PROTEINS	Candidate biomarkers, indicative of disease or injury, are beginning to overwhelm the process of validation through immunological means. Recombinant antibodies developed through phage-display offer an alternative means of generating monoclonal antibodies faster than traditional immunization of animals. Peptide segments of putative biomarkers of laser induced injury in the rabbit, discovered through mass spectrometry, were used as targets for a selection against a library of phage-displayed human single-chain variable fragment (scFv) antibodies. Highly specific antibodies were isolated to four of these unique peptide sequences. One antibody against the retinal protein, Guanine Nucleotide-Binding Protein Beta 5 (GBB5), had a dissociation constant similar to 300 nM and recognized the full-length endogenous protein in retinal homogenates of three different animal species by western blot. Alanine scanning of the peptide target identified three charged and one hydrophobic amino acid as the critical binding residues for two different scFvs. To enhance the utility of the reagent, one scFv was dimerized through a Fragment-crystallizable hinge region (i.e., Fc) and expressed in HEK-293 cells. This dimeric reagent yielded a 25-fold lower detection limit in western blots.	[Kierny, Michael R.; Cunningham, Thomas D.; Bouhenni, Rachida A.; Edward, Deepak P.; Kay, Brian K.] Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Kay, BK (corresponding author), Univ Illinois, Dept Biol Sci, 845 W Taylor St,3240 SES-MC 066, Chicago, IL 60607 USA.	bkay@uic.edu		Kierny, Michael/0000-0002-5409-0991	US Air Force Grant [FA014-07-C-0047]; Common Fund at the National Institutes of Health [U54 DK093444]	US Air Force Grant; Common Fund at the National Institutes of Health	This work was funded by grants from the US Air Force Grant (FA014-07-C-0047) and the Common Fund at the National Institutes of Health (U54 DK093444). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NL, 2004, J PROTEOME RES, V3, P235, DOI 10.1021/pr034086h; [Anonymous], 2004, DOTFAAAM049; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Bordeaux J, 2010, BIOTECHNIQUES, V48, P197, DOI 10.2144/000113382; Cheever ML, 2008, NAT STRUCT MOL BIOL, V15, P155, DOI 10.1038/nsmb.1377; Corzo J, 2006, BIOCHEM MOL BIOL EDU, V34, P413, DOI 10.1002/bmb.2006.494034062678; Cunningham BT, 2004, J BIOMOL SCREEN, V9, P481, DOI 10.1177/1087057104267604; de Andrade EV, 2000, J BIOCHEM-TOKYO, V128, P891, DOI 10.1093/oxfordjournals.jbchem.a022838; Devarajan P, 2010, NEPHROLOGY, V15, P419, DOI 10.1111/j.1440-1797.2010.01317.x; Dyson MR, 2011, ANAL BIOCHEM, V417, P25, DOI 10.1016/j.ab.2011.05.005; EINHORN N, 1992, OBSTET GYNECOL, V80, P14; Falk R, 2012, METHODS, V58, P69, DOI 10.1016/j.ymeth.2012.07.008; GOLD P, 1965, J EXP MED, V121, P439, DOI 10.1084/jem.121.3.439; Gould LH, 2005, J VIROL, V79, P14606, DOI 10.1128/JVI.79.23.14606-14613.2005; Gutman S, 2006, NAT REV CANCER, V6, P565, DOI 10.1038/nrc1911; Haidaris CG, 2001, J IMMUNOL METHODS, V257, P185, DOI 10.1016/S0022-1759(01)00463-X; Kehoe JW, 2005, CHEM REV, V105, P4056; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Lam TT, 1996, RETINA-J RET VIT DIS, V16, P42, DOI 10.1097/00006982-199616010-00008; Mainster MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P1210, DOI 10.1001/archopht.122.8.1210; MARSHALL J, 1970, INVEST OPHTH VISUAL, V9, P97; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Nakagawara RWM V.B., 2003, DOTFAAAM0312; Nakagawara Van B, 2008, Optometry, V79, P518, DOI 10.1016/j.optm.2007.08.022; Pershad K, 2011, ANAL BIOCHEM, V412, P210, DOI 10.1016/j.ab.2011.02.006; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Prensner JR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003180; Rusling JF, 2010, ANALYST, V135, P2496, DOI 10.1039/c0an00204f; Schmitz U, 2000, PLACENTA, V21, pS106, DOI 10.1053/plac.1999.0511; Scott SE, 2012, INVEST OPHTH VIS SCI, V53, P1764, DOI 10.1167/iovs.11-7685; Simmons LC, 2002, J IMMUNOL METHODS, V263, P133, DOI 10.1016/S0022-1759(02)00036-4; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Smith RA, 2014, CA-CANCER J CLIN, V64, P31, DOI 10.3322/caac.21212; STAMEY TA, 1987, NEW ENGL J MED, V317, P909, DOI 10.1056/NEJM198710083171501; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011; Veenstra TD, 2005, MOL CELL PROTEOMICS, V4, P409, DOI 10.1074/mcp.M500006-MCP200; Whiteaker JR, 2014, J PROTEOME RES, V13, P2187, DOI 10.1021/pr4009404; Yi JZ, 2007, J PROTEOME RES, V6, P1768, DOI 10.1021/pr060550h; Yi JZ, 2008, J PROTEOME RES, V7, P5112, DOI 10.1021/pr800396c	40	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124492	10.1371/journal.pone.0124492	http://dx.doi.org/10.1371/journal.pone.0124492			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902199	Green Published, gold, Green Submitted			2022-12-26	WOS:000353331500090
J	Liao, YJ; Zeng, ZW; Lu, F; Dong, ZQ; Chang, Q; Gao, JH				Liao, Yunjun; Zeng, Zhaowei; Lu, Feng; Dong, Ziqing; Chang, Qiang; Gao, Jianhua			In Vivo Dedifferentiation of Adult Adipose Cells	PLOS ONE			English	Article							DFAT CELLS; FAT-CELLS; STEM-CELL; TISSUE; ADIPOCYTES; TRANSDIFFERENTIATION; DIFFERENTIATION; TRANSPLANTATION; ADIPOGENESIS; REPAIR	Introduction Adipocytes can dedifferentiate into fibroblast-like cells in vitro and thereby acquire proliferation and multipotent capacities to participate in the repair of various organs and tissues. Whether dedifferentiation occurs under physiological or pathological conditions in vivo is unknown. Methods A tissue expander was placed under the inguinal fat pads of rats and gradually expanded by injection of water. Samples were collected at various time points, and morphological, histological, cytological, ultrastructural, and gene expression analyses were conducted. In a separate experiment, purified green fluorescent protein+ adipocytes were transplanted into C57 mice and collected at various time points. The transplanted adipocytes were assessed by bioluminescence imaging and whole-mount staining. Results The expanded fat pad was obviously thinner than the untreated fat pad on the opposite side. It was also tougher in texture and with more blood vessels attached. Hematoxylin and eosin staining and transmission electron microscopy indicated there were fewer monolocular adipocytes in the expanded fat pad and the morphology of these cells was altered, most notably their lipid content was discarded. Immunohistochemistry showed that the expanded fat pad contained an increased number of proliferative cells, which may have been derived from adipocytes. Following removal of the tissue expander, many small adipocytes were observed. Bioluminescence imaging suggested that some adipocytes survived when transplanted into an ischemic-hypoxic environment. Whole-mount staining revealed that surviving adipocytes underwent a process similar to adipocyte dedifferentiation in vitro. Monolocular adipocytes became multilocular adipocytes and then fibroblast-like cells. Conclusions Mature adipocytes may be able to dedifferentiate in vivo, and this may be an adipose tissue self-repair mechanism. The capacity of adipocytes to dedifferentiate into stem cell-like cells may also have a more general role in the regeneration of many tissues, notably in fat grafting.	[Liao, Yunjun; Zeng, Zhaowei; Lu, Feng; Dong, Ziqing; Chang, Qiang; Gao, Jianhua] Southern Med Univ, Dept Plast & Cosmet Surg, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Liao, YJ (corresponding author), Southern Med Univ, Dept Plast & Cosmet Surg, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China.	573233820@qq.com; gaopsnf@163.com			National Nature Science Foundation of China [81471881, 81372083, 81171834, 81201482]; Key Clinical Specialty Discipline Construction Program; Health Collaborative Innovation major projects of Guangzhou [7414275040815]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Clinical Specialty Discipline Construction Program; Health Collaborative Innovation major projects of Guangzhou	This work was supported by National Nature Science Foundation of China (81471881, 81372083, 81171834 and 81201482), Key Clinical Specialty Discipline Construction Program, Health Collaborative Innovation major projects of Guangzhou (7414275040815). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avram MM, 2007, J AM ACAD DERMATOL, V56, P472, DOI 10.1016/j.jaad.2006.06.022; Barroca V, 2009, NAT CELL BIOL, V11, P190, DOI 10.1038/ncb1826; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; Choi M, 2013, PLAST RECONSTR SURG, V131, P185, DOI 10.1097/PRS.0b013e3182789b13; Cinti S, 2000, METH MOL B, V155, P21; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; De Matteis R, 2009, STEM CELLS, V27, P2761, DOI 10.1002/stem.197; Dodson Michael V, 2011, Int J Stem Cells, V4, P76; Eguizabal C, 2013, SEMIN REPROD MED, V31, P82, DOI 10.1055/s-0032-1331802; Eto H, 2012, PLAST RECONSTR SURG, V129, P1081, DOI 10.1097/PRS.0b013e31824a2b19; Eto H, 2009, PLAST RECONSTR SURG, V124, P1087, DOI 10.1097/PRS.0b013e3181b5a3f1; Fan Y, 2008, TRENDS CELL BIOL, V18, P467, DOI 10.1016/j.tcb.2008.08.001; Gao Q, 2012, MOL BIOL REP, V39, P5791, DOI 10.1007/s11033-011-1371-4; Hausman Gary J, 2013, J Genomics, V1, P56, DOI 10.7150/jgen.3813; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jopling C, 2011, NAT REV MOL CELL BIO, V12, P79, DOI 10.1038/nrm3043; Jumabay M, 2012, J MOL CELL CARDIOL, V53, P790, DOI 10.1016/j.yjmcc.2012.09.005; Jumabay M, 2009, J MOL CELL CARDIOL, V47, P565, DOI 10.1016/j.yjmcc.2009.08.004; Knopf F, 2011, DEV CELL, V20, P713, DOI 10.1016/j.devcel.2011.04.014; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McGown C, 2014, CLIN LIVER DIS, V18, P41, DOI 10.1016/j.cld.2013.09.012; Nishimura S, 2007, DIABETES, V56, P1517, DOI 10.2337/db06-1749; Obinata D, 2011, INT J UROL, V18, P827, DOI 10.1111/j.1442-2042.2011.02865.x; Ohta Y, 2008, CELL TRANSPLANT, V17, P877, DOI 10.3727/096368908786576516; Ono H, 2011, BIOCHEM BIOPH RES CO, V407, P562, DOI 10.1016/j.bbrc.2011.03.063; Piccolo S, 2013, DIFFERENTIATION, V86, P75, DOI 10.1016/j.diff.2013.08.001; Poloni A, 2012, STEM CELLS, V30, P965, DOI 10.1002/stem.1067; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Shoshani O, 2011, STEM CELL REV REP, V7, P488, DOI 10.1007/s12015-011-9231-0; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Suga H, 2010, PLAST RECONSTR SURG, V126, P1911, DOI 10.1097/PRS.0b013e3181f4468b; Suga H, 2009, STEM CELLS, V27, P238, DOI 10.1634/stemcells.2008-0261; SUGIHARA H, 1986, DIFFERENTIATION, V31, P42, DOI 10.1111/j.1432-0436.1986.tb00381.x; Ullah M, 2013, DIFFERENTIATION, V85, P78, DOI 10.1016/j.diff.2013.02.001; von Heimburg D, 2005, RESP PHYSIOL NEUROBI, V146, P107, DOI 10.1016/j.resp.2004.12.013; VONHEIMBURG D, 1994, BRIT J PLAST SURG, V47, P470, DOI 10.1016/0007-1226(94)90029-9; Yoshimura Kotaro, 2011, Regen Med, V6, P33, DOI 10.2217/rme.11.62	39	20	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0125254	10.1371/journal.pone.0125254	http://dx.doi.org/10.1371/journal.pone.0125254			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901360	Green Published, Green Submitted, gold			2022-12-26	WOS:000353331500116
J	Mowls, DS; McCaffree, DR; Beebe, LA				Mowls, Dana S.; McCaffree, D. Robert; Beebe, Laura A.			Trends in Lung Cancer Incidence Rates, Oklahoma 2005-2010	PLOS ONE			English	Article							TOBACCO CONTROL PROGRAMS; UNITED-STATES; SMOKING; EPIDEMIOLOGY; ADULTS; IMPACT	Purpose Lung cancer is the second most frequently diagnosed cancer among men and women in the United States. With cigarette smoking causing the majority of cases, patterns in lung cancer are often monitored to understand the impact of anti-tobacco efforts. The purpose of this research was to investigate trends in lung cancer incidence rates for the period 2005-2010 in Oklahoma. Methods Data on Oklahoma's incident cases of lung cancer (2005-2010) were obtained from the Centers for Disease Control and Prevention WONDER system. Annual percent change (APC) was calculated by linear regression to characterize trends in lung cancer incidence rates over time for the overall population, by gender, by age group, and by age group within gender. Rates were considered to increase or decrease if the p-value for trend was <0.05. Results From 2005 through 2010, lung cancer incidence rates declined from 81.96 to 68.19 per 100,000 population, with an APC of -3.58% (p-value: 0.0220). When subgroups were examined, declines were observed among all males (APC: -4.25%; p-value: 0.0270), males <65 years (APC: -5.32%; p-value: 0.0008), females <65 years (APC: -4.85%; p-value: 0.0044), and persons aged 55-64 years (APC: -6.38%; p-value: 0.0017). Conclusions Declines in lung cancer incidence rates occurred during 2005-2010 among the overall population and within select demographic groups in Oklahoma. Although trends were stable for several demographic groups, rates of lung cancer incidence were lower in 2010 compared to 2005. Continued evidence-based tobacco control efforts are needed to ensure further reductions in lung cancer incidence rates in the state of Oklahoma.	[Mowls, Dana S.; Beebe, Laura A.] Univ Oklahoma, Coll Publ Hlth, Hlth Sci Ctr, Dept Biostat & Epidemiol, Oklahoma City, OK 73104 USA; [McCaffree, D. Robert; Beebe, Laura A.] Oklahoma Tobacco Res Ctr, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Beebe, LA (corresponding author), Univ Oklahoma, Coll Publ Hlth, Hlth Sci Ctr, Dept Biostat & Epidemiol, Oklahoma City, OK 73104 USA.	Laura-Beebe@ouhsc.edu		Beebe, Laura/0000-0002-5784-9203	Oklahoma Tobacco Settlement Endowment Trust	Oklahoma Tobacco Settlement Endowment Trust	This study was funded by the Oklahoma Tobacco Settlement Endowment Trust. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberg AJ, 2003, CHEST, V123, p21S, DOI 10.1378/chest.123.1_suppl.21S; Beebe LA, 2011, TRENDS CIGARETTE SMO; Clegg LX, 2009, STAT MED, V28, P3670, DOI 10.1002/sim.3733; Durkin S, 2012, TOB CONTROL, V21, P127, DOI 10.1136/tobaccocontrol-2011-050345; Farrelly MC, 2008, AM J PUBLIC HEALTH, V98, P304, DOI 10.2105/AJPH.2006.106377; Farrelly MC, 2003, J HEALTH ECON, V22, P843, DOI 10.1016/S0167-6296(03)00057-2; Fichtenberg CM, 2000, NEW ENGL J MED, V343, P1772, DOI 10.1056/NEJM200012143432406; Henley SJ, 2014, MMWR-MORBID MORTAL W, V63, P1; Jemal A, 2003, CANCER CAUSE CONTROL, V14, P579, DOI 10.1023/A:1024891201329; Jemal A, 2013, JNCI-J NATL CANCER I, V105, P175, DOI 10.1093/jnci/djs491; Mariotto AB, 2011, JNCI-J NATL CANCER I, V103, P117, DOI 10.1093/jnci/djq495; Orzechowski B, 2012, TAX BURDEN TOBACCO H; Rhoades RR, 2015, AM J PREV MED, V48, pS21, DOI 10.1016/j.amepre.2014.10.002; Toh Chee-Keong, 2009, V472, P397, DOI 10.1007/978-1-60327-492-0_19; US Cancer Statistics Working Group, 2014, US CANC STAT 1999 20; US Department of Health Human Services, 2014, HLTH CONSMOK 50 YE, P17, DOI DOI 10.1037/E510072014-001; Wakefield M, 2000, TOB CONTROL, V9, P177, DOI 10.1136/tc.9.2.177	17	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0119251	10.1371/journal.pone.0119251	http://dx.doi.org/10.1371/journal.pone.0119251			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG5KV	25901351	gold, Green Submitted, Green Published			2022-12-26	WOS:000353331500004
J	Haraka, F; Glass, TR; Sikalengo, G; Gamell, A; Ntamatungiro, A; Hatz, C; Tanner, M; Furrer, H; Battegay, M; Letang, E				Haraka, Frederick; Glass, Tracy R.; Sikalengo, George; Gamell, Anna; Ntamatungiro, Alex; Hatz, Christoph; Tanner, Marcel; Furrer, Hansjakob; Battegay, Manuel; Letang, Emilio			A Bundle of Services Increased Ascertainment of Tuberculosis among HIV-Infected Individuals Enrolled in a HIV Cohort in Rural Sub-Saharan Africa	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; CARE; PREVALENCE; FEASIBILITY; MULTICENTER; INTEGRATION; PREDICTORS; RESISTANCE; ACCURACY; LESSONS	Objectives To report on trends of tuberculosis ascertainment among HIV patients in a rural HIV cohort in Tanzania, and assessing the impact of a bundle of services implemented in December 2012, consisting of three components:(i) integration of HIV and tuberculosis services; (ii) GeneXpert for tuberculosis diagnosis; and (iii) electronic data collection. Design Retrospective cohort study of patients enrolled in the Kilombero Ulanga Antiretroviral Cohort (KIULARCO), Tanzania.) Methods HIV patients without prior history of tuberculosis enrolled in the KIULARCO cohort between 2005 and 2013 were included. Cox proportional hazard models were used to estimate rates and predictors of tuberculosis ascertainment Results Of 7114 HIV positive patients enrolled, 5123(72%) had no history of tuberculosis. Of these, 66% were female, median age was 38 years, median baseline CD4+ cell count was 243 cells/mu l, and 43% had WHO clinical stage 3 or 4. During follow-up, 421 incident tuberculosis cases were notified with an estimated incidence of 3.6 per 100 person-years(p-y)[95% confidence interval(CI) 3.26-3.97]. The incidence rate varied over time and increased significantly from 2.96 to 43.98 cases per 100 p-y after the introduction of the bundle of services in December 2012. Four independent predictors of tuberculosis ascertainment were identified: poor clinical condition at baseline (Hazard Ratio (HR) 3.89, 95% CI 2.87-5.28), WHO clinical stage 3 or 4 (HR 2.48, 95% CI 1.88-3.26), being antiretroviralnaive (HR 2.97, 95% CI 2.25-3.94), and registration in 2013(HR 6.07, 95% CI 4.39-8.38). Conclusion The integration of tuberculosis and HIV services together with comprehensive electronic data collection and use of GeneXpert increased dramatically the ascertainment of tuberculosis in this rural African HIV cohort.	[Haraka, Frederick] Bagamoyo Res & Training Ctr, Ifakara Hlth Inst, Bagamoyo, Tanzania; [Glass, Tracy R.; Gamell, Anna; Hatz, Christoph; Tanner, Marcel; Letang, Emilio] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Glass, Tracy R.; Battegay, Manuel] Univ Basel, Basel, Switzerland; [Sikalengo, George; Gamell, Anna; Ntamatungiro, Alex; Letang, Emilio] Ifakara Hlth Inst, Ifakara, Tanzania; [Furrer, Hansjakob] Univ Hosp Bern, Dept Infect Dis, CH-3010 Bern, Switzerland; [Furrer, Hansjakob] Univ Bern, CH-3010 Bern, Switzerland; [Battegay, Manuel] Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, Dept Med & Clin Res, CH-4031 Basel, Switzerland; [Letang, Emilio] Univ Barcelona, Hosp Clin, ISGlobal, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain	Ifakara Health Institute; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Ifakara Health Institute; University of Bern; University Hospital of Bern; University of Bern; University of Basel; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona	Letang, E (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.	emili.letang@unibas.ch	Furrer, Hansjakob/G-6768-2013; Glass, Tracy R/D-5046-2017	Furrer, Hansjakob/0000-0002-1375-3146; Glass, Tracy R/0000-0001-7075-9803; Ntamatungiro, Alex/0000-0002-3134-3992; Sikalengo, George/0000-0002-6749-7109	Government of the Canton of Basel	Government of the Canton of Basel	KIULARCO receives funds from the Government of the Canton of Basel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WG, 2003, PEDIATRICS, V111, P626, DOI 10.1542/peds.111.3.626; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Costagliola D, 2005, CLIN INFECT DIS, V41, P1772, DOI 10.1086/498315; del Amo J, 2012, CLIN INFECT DIS, V54, P1364, DOI 10.1093/cid/cis203; Elzi L, 2007, CLIN INFECT DIS, V44, P94, DOI 10.1086/510080; Gasana M, 2008, INT J TUBERC LUNG D, V12, pS39; Harris JB, 2008, INT J TUBERC LUNG D, V12, P773; Hillestad R, 2005, HEALTH AFFAIR, V24, P1103, DOI 10.1377/hlthaff.24.5.1103; Hoog van't A, 2013, SYSTEMATIC REV SENSI; Howard AA, 2010, CLIN INFECT DIS, V50, pS238, DOI 10.1086/651497; Iliyasu Z, 2009, J EPIDEMIOL, V19, P81, DOI 10.2188/jea.JE20080026; Kapata N, 2011, TROP MED INT HEALTH, V16, P1404, DOI 10.1111/j.1365-3156.2011.02849.x; Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067; Lawn SD, 2010, AIDS, V24, P1323, DOI 10.1097/QAD.0b013e3283390dd1; Legido-Quigley H, 2013, TROP MED INT HEALTH, V18, P199, DOI 10.1111/tmi.12029; Li N, 2013, AIDS, V27, P1273, DOI 10.1097/QAD.0b013e32835ecb24; Lodi S, 2013, THORAX, V68, P207, DOI 10.1136/thoraxjnl-2012-201740; Marlowe EM, 2011, J CLIN MICROBIOL, V49, P1621, DOI 10.1128/JCM.02214-10; Masimba P, 2013, AIDS RES HUM RETROV, V29, P1229, DOI [10.1089/AID.2011.0367, 10.1089/aid.2011.0367]; Meyer-Rath G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036966; Middelkoop K, 2011, JAIDS-J ACQ IMM DEF, V56, P263, DOI 10.1097/QAI.0b013e31820413b3; Miranda A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000826; Mossdorf E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-98; Muller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8; Ngowi BJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-341; Pape Jean William, 2004, Top HIV Med, V12, P144; Scott LE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001061; Siika AM, 2005, INT J MED INFORM, V74, P345, DOI 10.1016/j.ijmedinf.2005.03.002; Tanzania Ministry of Health and Social Welfare, 2008, NAT POL GUID COLL TB; Tanzania Ministry of Health and Social Welfare, 2013, 1 TUB PREV SURV UN R; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; Venkatesh PA, 2005, INT J TUBERC LUNG D, V9, P1105; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2012, INC TUB PER 100000 P; Williams Faustine, 2008, Inform Prim Care, V16, P139; World Health Organization, 2013, SYST SCREEN ACT TUB	37	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123275	10.1371/journal.pone.0123275	http://dx.doi.org/10.1371/journal.pone.0123275			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897491	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000353212600023
J	Liu, PJ; Hsin, MC; Huang, YH; Fan, TY; Meng, PJ; Lu, CC; Lin, HJ				Liu, Pi-Jen; Hsin, Min-Chieh; Huang, Yen-Hsun; Fan, Tung-Yung; Meng, Pei-Jie; Lu, Chung-Cheng; Lin, Hsing-Juh			Nutrient Enrichment Coupled with Sedimentation Favors Sea Anemones over Corals	PLOS ONE			English	Article							REEF-BUILDING CORAL; GREAT-BARRIER-REEF; SOUTHERN TAIWAN; SCLERACTINIAN CORALS; NATURAL-WATERS; LONG-TERM; PHOSPHORUS; AVAILABILITY; TEMPERATURE; MACROALGAE	Fine sediments, which account for the majority of total fluvial sediment flux, have been suggested to degrade coral reefs on a global scale. Furthermore, sediment impacts can be exacerbated by extreme rainfall events associated with global climate change and anthropogenic nutrient enrichment. We report the findings from a series of mesocosm experiments exploring the effects of short-term sedimentation and nutrient enrichment on the interactions between the hard coral Acropora muricata, the sea anemone Mesactinia ganesis, and the green macroalga Codium edule. Mesocosms were manipulated to simulate either unimpacted reefs or reefs exposed to elevated levels of fine sediments for 10 or 14 days to simulate the effects of heavy rainfall. The first and second experiments were aimed to examine the effects of inorganic and organic sediments, respectively. The third experiment was designed to examine the interactive effects of nutrient enrichment and elevated sediment loads. Neither inorganic nor organic sediment loadings significantly affected the physiological performance of the coral, but, importantly, did reduce its ability to compete with other organisms. Photosynthetic efficiencies of both the green macroalga and the sea anemone increased in response to both sediment loadings when they were simultaneously exposed to nutrient enrichment. While organic sediment loading increased the nitrogen content of the green macroalga in the first experiment, inorganic sediment loading increased its phosphorus content in the second experiment. The coral mortality due to sea anemones attack was significantly greater upon exposure to enriched levels of organic sediments and nutrients. Our findings suggest that the combined effects of short-term sedimentation and nutrient enrichment could cause replacement of corals by sea anemones on certain coral reefs.	[Liu, Pi-Jen; Fan, Tung-Yung; Meng, Pei-Jie] Natl Dong Hwa Univ, Grad Inst Marine Biol, Pingtung 944, Taiwan; [Liu, Pi-Jen; Fan, Tung-Yung; Meng, Pei-Jie] Natl Museum Marine Biol & Aquarium, Pingtung 944, Taiwan; [Hsin, Min-Chieh; Huang, Yen-Hsun; Lu, Chung-Cheng; Lin, Hsing-Juh] Natl Chung Hsing Univ, Dept Life Sci, Taichung 402, Taiwan; [Hsin, Min-Chieh; Huang, Yen-Hsun; Lu, Chung-Cheng; Lin, Hsing-Juh] Natl Chung Hsing Univ, Res Ctr Global Change Biol, Taichung 402, Taiwan; [Lin, Hsing-Juh] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan	National Dong Hwa University; National Museum of Marine Biology & Aquarium; National Chung Hsing University; National Chung Hsing University; Academia Sinica - Taiwan	Liu, PJ (corresponding author), Natl Dong Hwa Univ, Grad Inst Marine Biol, Pingtung 944, Taiwan.	pijenliu@hotmail.com; hjlin@dragon.nchu.edu.tw	Meng, PJ/AAC-3677-2021; Liu, Pi-Jen/ABC-6596-2021		National Science Council [NSC 97-2621-B-005-001]	National Science Council(Ministry of Science and Technology, Taiwan)	The funding for this study was provided by the National Science Council under grant number NSC 97-2621-B-005-001.	Anthony KRN, 2004, LIMNOL OCEANOGR, V49, P2201, DOI 10.4319/lo.2004.49.6.2201; BAK RPM, 1976, MAR BIOL, V37, P105, DOI 10.1007/BF00389121; Birrell CL, 2005, MAR POLLUT BULL, V51, P408, DOI 10.1016/j.marpolbul.2004.10.022; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brodie J, 2001, WATER SCI TECHNOL, V43, P203, DOI 10.2166/wst.2001.0540; Chadwick-Furman NE, 2000, INVERTEBR BIOL, V119, P351; Chen CA, 2004, CORAL REEFS, V23, P508, DOI 10.1007/s00338-004-0423-9; Chen CC, 2005, MAR ECOL PROG SER, V304, P91, DOI 10.3354/meps304091; Cooke WJ, 1976, COELENTERATE ECOLOGY, P281; D'Angelo C, 2014, CURR OPIN ENV SUST, V7, P82, DOI 10.1016/j.cosust.2013.11.029; Dai C-F, 1998, J NATL PARK, V8, P79; Dai CF, 1999, J NATL PARK, V9, P111; Dai CF, 1993, MAR ECOL, V42, P185; Dai CF, 1997, STATUS CORAL REEFS P, P123; Devlin MJ, 2005, MAR POLLUT BULL, V51, P9, DOI 10.1016/j.marpolbul.2004.10.037; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Gilmour JP, 2002, MAR FRESHWATER RES, V53, P805, DOI 10.1071/MF01219; Golbuu Y, 2003, ESTUAR COAST SHELF S, V57, P941, DOI 10.1016/S0272-7714(02)00424-9; Jeffery SW, 1975, BIOCH PHYSL PFLANZEN, V167, P191; Ketterings QM, 2002, AGR ECOSYST ENVIRON, V92, P37, DOI 10.1016/S0167-8809(01)00287-0; Lin HJ, 1998, BOT BULL ACAD SINICA, V39, P191; Lin HJ, 2004, MAR BIOL, V144, P653, DOI 10.1007/s00227-003-1231-4; Lin HJ, 2007, MAR ECOL PROG SER, V335, P95, DOI 10.3354/meps335095; Linton D, 2002, STATUS CORAL REEFS W, P277; Liu PJ, 2012, MAR POLLUT BULL, V64, P1129, DOI 10.1016/j.marpolbul.2012.03.031; Liu PJ, 2009, LIMNOL OCEANOGR, V54, P1167, DOI 10.4319/lo.2009.54.4.1167; Mayfield AB, 2013, CORAL REEFS, V32, P909, DOI 10.1007/s00338-013-1067-4; Mayfield AB, 2012, J EXP BIOL, V215, P4183, DOI 10.1242/jeb.071688; McGlathery KJ, 1997, AQUAT BOT, V59, P99, DOI 10.1016/S0304-3770(97)00026-0; Meng PJ, 2004, J NATL PARK, V14, P43; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; PAI SC, 1990, ANAL CHIM ACTA, V232, P345, DOI 10.1016/S0003-2670(00)81252-0; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Philipp E, 2003, J EXP MAR BIOL ECOL, V287, P57, DOI 10.1016/S0022-0981(02)00495-1; RICHARDSON CJ, 1986, ECOL MONOGR, V56, P279, DOI 10.2307/1942548; Ridzwan AR, 1993, THESIS; RIEGL B, 1995, J EXP MAR BIOL ECOL, V186, P259, DOI 10.1016/0022-0981(94)00164-9; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; SOLORZANO L, 1980, LIMNOL OCEANOGR, V25, P754, DOI 10.4319/lo.1980.25.4.0754; STAFFORDSMITH MG, 1993, MAR BIOL, V115, P229, DOI 10.1007/BF00346340; Stimson J, 1991, J EXP MAR BIOL ECOL, V153, P3; Strickland JDH, 1972, B FISH RES BD CAN, V167; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Syvitski JPM, 2005, SCIENCE, V308, P376, DOI 10.1126/science.1109454; SZMANT AM, 1990, CORAL REEFS, V8, P217, DOI 10.1007/BF00265014; Tkachenko KS, 2007, MAR BIOL, V151, P185, DOI 10.1007/s00227-006-0467-1; Wiedenmann J, 2007, J MAR BIOL ASSOC UK, V87, P851, DOI 10.1017/S0025315407057050; Wiedenmann J, 2013, NAT CLIM CHANGE, V3, P160, DOI 10.1038/NCLIMATE1661	48	13	13	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0125175	10.1371/journal.pone.0125175	http://dx.doi.org/10.1371/journal.pone.0125175			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897844	Green Published, Green Submitted, gold			2022-12-26	WOS:000353212600099
J	Lv, J; Chen, W; Sun, DJY; Li, SX; Millwood, IY; Smith, M; Guo, Y; Bian, Z; Yu, CQ; Zhou, HY; Tan, YL; Chen, JS; Chen, ZM; Li, LM				Lv, Jun; Chen, Wei; Sun, Dianjianyi; Li, Shengxu; Millwood, Iona Y.; Smith, Margaret; Guo, Yu; Bian, Zheng; Yu, Canqing; Zhou, Huiyan; Tan, Yunlong; Chen, Junshi; Chen, Zhengming; Li, Liming		China Kadoorie Biobank Collaborati	Gender-Specific Association between Tobacco Smoking and Central Obesity among 0.5 Million Chinese People: The China Kadoorie Biobank Study	PLOS ONE			English	Article							BODY-MASS INDEX; METABOLIC SYNDROME; RISK-FACTORS; CIGARETTE-SMOKING; FAT DISTRIBUTION; BIRTH-WEIGHT; HIP RATIO; ADULTS; MEN; OVERWEIGHT	Objectives Lifestyle factors are well-known important modifiable risk factors for obesity; the association between tobacco smoking and central obesity, however, is largely unknown in the Chinese population. This study examined the relationship between smoking and central obesity in 0.5 million Chinese adults, a population with a low prevalence of general obesity, but a high prevalence of central obesity. Subjects A total of 487,527 adults (200,564 males and 286,963 females), aged 30-79 years, were enrolled in the baseline survey of the China Kadoorie Biobank (CKB) Study conducted during 2004-2008. Waist circumference (WC) and WC/height ratio (WHtR) were used as measures of central obesity. Results The prevalence of regular smokers was significantly higher among males (60.6%) than among females (2.2%). The prevalence of central obesity increased with age and BMI levels, with a significant gender difference (females>males). Of note, almost all obese adults (99.4%) were centrally obese regardless of gender. In multivariable regression analyses, adjusting for age, education, physical activity, alcohol use and survey site, regular smoking was inversely associated with BMI in males (standardized regression coefficients, beta= -0.093, p<0.001) and females (beta= -0.025, p<0.001). Of interest, in the BMI stratification analyses in 18 groups, all beta s of regular smoking for WHtR were positive in both genders; the beta s showed a significantly greater increasing trend with increasing BMI in males than in females. In the analyses with model adjustment for BMI, the positive associations between regular smoking and WHtR were stronger in males (beta= 0.021, p<0.001) than in females (beta= 0.008, p<0.001) (p<0.001 for gender difference). WC showed considerably consistent results. Conclusions The data indicate that tobacco smoking is an important risk factor for central obesity, but the association is gender-specific and depends on the adjustment for general obesity.	[Lv, Jun; Chen, Wei; Sun, Dianjianyi; Li, Shengxu; Yu, Canqing; Li, Liming] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100871, Peoples R China; [Chen, Wei; Sun, Dianjianyi; Li, Shengxu] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70118 USA; [Millwood, Iona Y.; Smith, Margaret; Chen, Zhengming] Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford OX1 2JD, England; [Millwood, Iona Y.; Smith, Margaret; Chen, Zhengming] Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit CTSU, Oxford OX1 2JD, England; [Guo, Yu; Bian, Zheng; Zhou, Huiyan; Tan, Yunlong; Li, Liming] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Chen, Junshi] China Natl Ctr Food Safety Risk Assessment, Beijing, Peoples R China	Peking University; Tulane University; University of Oxford; University of Oxford; Chinese Academy of Medical Sciences - Peking Union Medical College	Chen, ZM (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford OX1 2JD, England.	zhengming.chen@ctsu.ox.ac.uk; lmlee@vip.163.com	Lv, Jun/O-4746-2019	Lv, Jun/0000-0001-7916-3870; Sun, Dianjianyi/0000-0003-3651-6693; Chen, Zhengming/0000-0001-6423-105X	CKB baseline survey; Kadoorie Charitable Foundation in Hong Kong; Wellcome Trust in the UK [088158/Z/09/Z]; National Key Technologies Research and Development Program, Chinese Ministry of Science and Technology [2011BAI09B01]; National Natural Science Foundation of China [81390541]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043451] Funding Source: NIH RePORTER; Medical Research Council [MC_U137686851] Funding Source: researchfish; MRC [MC_U137686851] Funding Source: UKRI	CKB baseline survey; Kadoorie Charitable Foundation in Hong Kong; Wellcome Trust in the UK(Instituto de Salud Carlos IIIWellcome Trust); National Key Technologies Research and Development Program, Chinese Ministry of Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the CKB baseline survey and the first re-survey were supported by the Kadoorie Charitable Foundation in Hong Kong. The long-term follow-up of the project during 2009-14 is supported by the Wellcome Trust in the UK [088158/Z/09/Z] and the National Key Technologies Research and Development Program in the 12th Five-year Plan, Chinese Ministry of Science and Technology [2011BAI09B01, 2012-14]. Support for this analysis is provided by the National Natural Science Foundation of China [No. 81390541]. The sponsors had no role in the design, analysis, interpretation or drafting of this manuscript.	Audrain-McGovern J, 2011, CLIN PHARMACOL THER, V90, P164, DOI 10.1038/clpt.2011.105; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Benowitz NL, 2010, NEW ENGL J MED, V362, P2295, DOI 10.1056/NEJMra0809890; Bjorntorp P, 1993, Obes Res, V1, P206; Cameron AJ, 2008, OBESITY, V16, P2707, DOI 10.1038/oby.2008.412; Canoy D, 2005, OBES RES, V13, P1466, DOI 10.1038/oby.2005.177; Chen ZM, 2011, INT J EPIDEMIOL, V40, P1652, DOI 10.1093/ije/dyr120; Cheng TO, 2004, INT J CARDIOL, V96, P425, DOI 10.1016/j.ijcard.2003.10.011; Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Du H, 2013, AM J CLIN NUTR, V97, P487, DOI DOI 10.3945/AJCN.112.046854; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Hebden L, 2012, OBES REV, V13, P692, DOI 10.1111/j.1467-789X.2012.00990.x; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Hernandez-Diaz S, 2006, AM J EPIDEMIOL, V164, P1115, DOI 10.1093/aje/kwj275; Hsieh SD, 2006, PREV MED, V42, P135, DOI 10.1016/j.ypmed.2005.08.007; Hsieh SD, 2005, PREV MED, V40, P216, DOI 10.1016/j.ypmed.2004.05.025; Jee SH, 2002, OBES RES, V10, P891, DOI 10.1038/oby.2002.122; Kanter R, 2012, ADV NUTR, V3, P491, DOI 10.3945/an.112.002063; Kim JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045815; Li Li-ming, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P249; Liu CT, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003681; Lizcano F, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/757461; Low S, 2009, ANN ACAD MED SINGAP, V38, P66; Malik VS, 2013, NAT REV ENDOCRINOL, V9, P13, DOI 10.1038/nrendo.2012.199; Misra A, 2013, NUTRIENTS, V5, P2708, DOI 10.3390/nu5072708; Molarius A, 1997, J EPIDEMIOL COMMUN H, V51, P252, DOI 10.1136/jech.51.3.252; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Ramachandran A, 2012, DIABETES-METAB RES, V28, P47, DOI 10.1002/dmrr.2353; Reynolds K, 2007, OBESITY, V15, P10, DOI 10.1038/oby.2007.527; SHIMOKATA H, 1989, JAMA-J AM MED ASSOC, V261, P1169, DOI 10.1001/jama.261.8.1169; Srinivasan SR, 2009, AM J CARDIOL, V104, P721, DOI 10.1016/j.amjcard.2009.04.037; Tu YK, 2005, AM J EPIDEMIOL, V161, P27, DOI 10.1093/aje/kwi002; Wadden TA, 2012, CIRCULATION, V125, P1157, DOI 10.1161/CIRCULATIONAHA.111.039453; Wakabayashi I, 2014, METAB SYNDR RELAT D, V12, P70, DOI 10.1089/met.2013.0110; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wietlisbach V, 2013, NUTR METAB CARDIOVAS, V23, P432, DOI 10.1016/j.numecd.2011.09.002; Wildman RP, 2008, OBESITY, V16, P1448, DOI 10.1038/oby.2008.208; WILLIAMSON DF, 1991, NEW ENGL J MED, V324, P739, DOI 10.1056/NEJM199103143241106; Xi B, 2012, OBES REV, V13, P287, DOI 10.1111/j.1467-789X.2011.00944.x; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	43	27	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124586	10.1371/journal.pone.0124586	http://dx.doi.org/10.1371/journal.pone.0124586			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897789	Green Published, gold, Green Submitted			2022-12-26	WOS:000353212600074
J	Sato, T; Mori, S; Sakamoto, M; Arai, Y; Kodama, T				Sato, Takuma; Mori, Shiro; Sakamoto, Maya; Arai, Yoichi; Kodama, Tetsuya			Direct Delivery of a Cytotoxic Anticancer Agent into the Metastatic Lymph Node Using Nano/Microbubbles and Ultrasound	PLOS ONE			English	Article							DRUG-DELIVERY; APOPTOSIS; CHEMOTHERAPY	Direct injection of an anticancer agent into a metastatic lymph node (LN) has not been used as a standard treatment because evidence concerning the efficacy of local administration of a drug into a metastatic LN has not been established. Here we show that the combination of intralymphatic drug delivery with nano/microbubbles (NMBs) and ultrasound has the potential to improve the chemotherapeutic effect. We delivered cis-diamminedichloroplatinum (II) (CDDP) into breast carcinoma cells in vitro and found that apoptotic processes were involved in the antitumor action. Next, we investigated the antitumor effect of intralymphatic chemotherapy with NMBs and ultrasound in an experimental model of LN metastasis using MXH10/Mo-lpr/lpr mice exhibiting lymphadenopathy. The combination of intralymphatic chemotherapy with NMBs and ultrasound has the potential to improve the delivery of CDDP into target LNs without damage to the surrounding normal tissues. The present study indicates that intralymphatic drug delivery with NMBs and ultrasound will potentially be of great benefit in the clinical setting.	[Sato, Takuma; Mori, Shiro; Kodama, Tetsuya] Tohoku Univ, Grad Sch Biomed Engn, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Mori, Shiro] Tohoku Univ Hosp, Dept Oral & Maxillofacial Surg, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Sakamoto, Maya] Tohoku Univ Hosp, Dept Oral Diag, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Sato, Takuma; Arai, Yoichi] Tohoku Univ, Grad Sch Med, Dept Urol, Aoba Ku, Sendai, Miyagi 9808575, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University	Kodama, T (corresponding author), Tohoku Univ, Grad Sch Biomed Engn, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	kodama@bme.tohoku.ac.jp	Kodama, Tetsuya/T-2246-2019	Kodama, Tetsuya/0000-0003-4727-9558	JSPS KAKENHI [26293425, 26670856, 25293382, 24659834, 26242051, 24650286]; Grants-in-Aid for Scientific Research [26293425] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by JSPS KAKENHI grant numbers 26293425 (SM), 26670856 (SM), 25293382 (MS), 24659834 (MS), 26242051 (TK) and 24650286 (TK). The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833; de Jong JS, 2000, HISTOPATHOLOGY, V36, P306; DORR RT, 1990, BLOOD REV, V4, P41, DOI 10.1016/0268-960X(90)90015-K; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Furusawa Y, 2010, CANCER LETT, V288, P107, DOI 10.1016/j.canlet.2009.06.029; Gonzalez VM, 2001, MOL PHARMACOL, V59, P657, DOI 10.1124/mol.59.4.657; Johansen P, 2005, EUR J IMMUNOL, V35, P568, DOI 10.1002/eji.200425599; Klerk CPW, 2007, BIOTECHNIQUES, V43, P7, DOI 10.2144/000112515; Kodama T, 2010, ULTRASOUND MED BIOL, V36, P1196, DOI 10.1016/j.ultrasmedbio.2010.04.016; Kodama T, 2010, J ELECTRON MICROSC, V59, P187, DOI 10.1093/jmicro/dfp056; Li L, 2013, CANCER RES, V73, P2082, DOI 10.1158/0008-5472.CAN-12-4200; Li L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055797; Margaris KN, 2012, J R SOC INTERFACE, V9, P601, DOI 10.1098/rsif.2011.0751; Martinez-Gomez JM, 2009, INT ARCH ALLERGY IMM, V150, P59, DOI 10.1159/000210381; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Okamura M, 2004, ANTICANCER RES, V24, P655; Osaki T, 1997, Oral Dis, V3, P247; Ross MH, 2003, HISTOLOGY TEXT ALTAS; Sato T, 2014, ULTRASOUND MED BIOL, V40, P1237, DOI 10.1016/j.ultrasmedbio.2013.12.012; Shao L, 2013, J IMMUNOL METHODS, V389, P69, DOI 10.1016/j.jim.2013.01.004; TIMMERBOSSCHA H, 1992, BRIT J CANCER, V66, P227, DOI 10.1038/bjc.1992.249; Toriyabe Y, 1997, CLIN RADIOL, V52, P927, DOI 10.1016/S0009-9260(97)80226-7; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; Watanabe Y, 2008, CANCER SCI, V99, P2525, DOI 10.1111/j.1349-7006.2008.00989.x; Xie YM, 2009, EXPERT OPIN DRUG DEL, V6, P785, DOI 10.1517/17425240903085128; Zhong WJ, 2011, ULTRASOUND MED BIOL, V37, P2149, DOI 10.1016/j.ultrasmedbio.2011.09.012	26	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123619	10.1371/journal.pone.0123619	http://dx.doi.org/10.1371/journal.pone.0123619			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897663	Green Published, Green Submitted, gold			2022-12-26	WOS:000353212600036
J	Steichen, AL; Simonson, TJ; Salmon, SL; Metzger, DW; Mishra, BB; Sharma, J				Steichen, Anthony L.; Simonson, Tanner J.; Salmon, Sharon L.; Metzger, Dennis W.; Mishra, Bibhuti B.; Sharma, Jyotika			Alarmin Function of Galectin-9 in Murine Respiratory Tularemia	PLOS ONE			English	Article							FRANCISELLA-TULARENSIS; MOLECULAR-MECHANISMS; NEUTROPHIL MIGRATION; PULMONARY INFECTION; INNATE IMMUNITY; MACROPHAGES; ACTIVATION; CELLS; TIM-3; HMGB1	Sepsis is a complex immune disorder that is characterized by systemic hyperinflammation. Alarmins, which are multifunctional endogenous factors, have been implicated in exacerbation of inflammation in many immune disorders including sepsis. Here we show that Galectin-9, a host endogenous beta-galactoside binding lectin, functions as an alarmin capable of mediating inflammatory response during sepsis resulting from pulmonary infection with Francisella novicida, a Gram negative bacterial pathogen. Our results show that this galectin is upregulated and is likely released during tissue damage in the lungs of F. novicida infected septic mice. In vitro, purified recombinant galectin-9 exacerbated F. novicida-induced production of the inflammatory mediators by macrophages and neutrophils. Concomitantly, Galectin-9 deficient (Gal-9(-/-)) mice exhibited improved lung pathology, reduced cell death and reduced leukocyte infiltration, particularly neutrophils, in their lungs. This positively correlated with overall improved survival of F. novicida infected Gal-9(-/-) mice as compared to their wild-type counterparts. Collectively, these findings suggest that galectin-9 functions as a novel alarmin by augmenting the inflammatory response in sepsis development during pulmonary F. novicida infection.	[Steichen, Anthony L.; Simonson, Tanner J.; Mishra, Bibhuti B.; Sharma, Jyotika] Univ N Dakota, Sch Med & Hlth Sci, Dept Basic Sci, Grand Forks, ND 58201 USA; [Salmon, Sharon L.; Metzger, Dennis W.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA	University of North Dakota Grand Forks; Albany Medical College	Sharma, J (corresponding author), Univ N Dakota, Sch Med & Hlth Sci, Dept Basic Sci, Grand Forks, ND 58201 USA.	jyotika.sharma@med.und.edu	Metzger, Dennis W/I-2771-2019	Metzger, Dennis W/0000-0002-8000-9907	American Heart Association [10BGIA4300041]; NIH [1R21AI101644-01, P01AI56320]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101644, P01AI056320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103329] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Heart Association grant (10BGIA4300041) and NIH 1R21AI101644-01 to JS and P01AI56320 to DWM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Balamayooran G, 2012, J IMMUNOL, V189, P5849, DOI 10.4049/jimmunol.1200585; Berthelot F, 2012, J INNATE IMMUN, V4, P41, DOI 10.1159/000328798; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Brett ME, 2014, CLIN INFECT DIS, V59, P826, DOI 10.1093/cid/ciu430; Broz P, 2011, IMMUNOL REV, V243, P174, DOI 10.1111/j.1600-065X.2011.01041.x; Cerliani JP, 2011, J CLIN IMMUNOL, V31, P10, DOI 10.1007/s10875-010-9494-2; Fink MP, 2014, CRIT CARE, V18, DOI 10.1186/cc13810; Foell D, 2008, J PATHOL, V216, P183, DOI 10.1002/path.2394; Gieseke F, 2013, EUR J IMMUNOL, V43, P2741, DOI 10.1002/eji.201343335; Gundra UM, 2011, INFECT IMMUN, V79, P2586, DOI 10.1128/IAI.00920-10; Hall JD, 2009, CLIN EXP IMMUNOL, V156, P278, DOI 10.1111/j.1365-2249.2009.03882.x; Hall JD, 2008, INFECT IMMUN, V76, P5843, DOI 10.1128/IAI.01176-08; Harris HE, 2012, NAT REV RHEUMATOL, V8, P195, DOI 10.1038/nrrheum.2011.222; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Hreggvidsdottir HS, 2009, J LEUKOCYTE BIOL, V86, P655, DOI 10.1189/jlb.0908548; Jayaraman P, 2013, J IMMUNOL, V190, P4196, DOI 10.4049/jimmunol.1202688; Jayaraman P, 2010, J EXP MED, V207, P2343, DOI 10.1084/jem.20100687; Katoh S, 2010, INT ARCH ALLERGY IMM, V153, P294, DOI 10.1159/000314371; Li X, 2012, EXPERT OPIN THER TAR, V16, P1145, DOI 10.1517/14728222.2012.726616; Liu FT, 2002, BBA-GEN SUBJECTS, V1572, P263, DOI 10.1016/S0304-4165(02)00313-6; Liu FT, 2010, ANN NY ACAD SCI, V1183, P158, DOI 10.1111/j.1749-6632.2009.05131.x; Mares CA, 2011, IMMUNOL CELL BIOL, V89, P167, DOI 10.1038/icb.2010.81; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Mengshol JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009504; Milovanovic M, 2012, IMMUNOL RES, V52, P89, DOI 10.1007/s12026-012-8283-9; Mishra BB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059616; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Parmely MJ, 2009, FEMS MICROBIOL LETT, V301, P1, DOI 10.1111/j.1574-6968.2009.01791.x; Rabinovich GA, 2002, CELL DEATH DIFFER, V9, P661, DOI 10.1038/sj.cdd.4401009; Rabinovich GA, 2002, TRENDS IMMUNOL, V23, P313, DOI 10.1016/S1471-4906(02)02232-9; Rabinovich GA, 2012, ANN NY ACAD SCI, V1253, P1, DOI 10.1111/j.1749-6632.2012.06492.x; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Sada-Ovalle I, 2012, J IMMUNOL, V189, P5896, DOI 10.4049/jimmunol.1200990; Sakai K, 2011, EUR J IMMUNOL, V41, P67, DOI 10.1002/eji.200939931; Sangiuliano B, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/821043; Sato S, 2002, GLYCOCONJUGATE J, V19, P583, DOI 10.1023/B:GLYC.0000014089.17121.cc; Sato S, 2002, J IMMUNOL, V168, P1813, DOI 10.4049/jimmunol.168.4.1813; Sato S, 2009, IMMUNOL REV, V230, P172, DOI 10.1111/j.1600-065X.2009.00790.x; Sharma J, 2011, MICROB PATHOGENESIS, V51, P39, DOI 10.1016/j.micpath.2011.03.007; Sharma J, 2009, INFECT IMMUN, V77, P4314, DOI 10.1128/IAI.00654-09; Sharma J, 2009, J LEUKOCYTE BIOL, V86, P491, DOI 10.1189/jlb.1208728; Sharma J, 2009, CELL IMMUNOL, V257, P1, DOI 10.1016/j.cellimm.2009.03.011; Steelman AJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0144-0; Tsai SY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003848; Vandal K, 2003, J IMMUNOL, V171, P2602, DOI 10.4049/jimmunol.171.5.2602; Vega-Carrascal I, 2014, J IMMUNOL, V192, P2418, DOI 10.4049/jimmunol.1300711; Vega-Carrascal I, 2011, J IMMUNOL, V186, P2897, DOI 10.4049/jimmunol.1003187; Wheeler DS, 2007, INFLAMM RES, V56, P216, DOI 10.1007/s00011-007-6108-4; Wickstrum JR, 2009, INFECT IMMUN, V77, P4827, DOI 10.1128/IAI.00246-09; Yang D, 2007, J LEUKOCYTE BIOL, V81, P59, DOI 10.1189/jlb.0306180; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	53	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123573	10.1371/journal.pone.0123573	http://dx.doi.org/10.1371/journal.pone.0123573			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898318	Green Published, gold, Green Submitted			2022-12-26	WOS:000353212600033
J	Jang, JW; Kim, YW; Lee, SW; Kwon, JH; Nam, SW; Bae, SH; Choi, JY; Yoon, SK; Chung, KW				Jang, Jeong Won; Kim, Young Woon; Lee, Sung Won; Kwon, Jung Hyun; Nam, Soon Woo; Bae, Si Hyun; Choi, Jong Young; Yoon, Seung Kew; Chung, Kyu Won			Reactivation of Hepatitis B Virus in HBsAg-Negative Patients with Hepatocellular Carcinoma	PLOS ONE			English	Article							HBV REACTIVATION; RISK; CHEMOEMBOLIZATION; CHEMOTHERAPY; MANAGEMENT; LYMPHOMA	Background & Aims Despite increasing attention to hepatitis B virus (HBV) reactivation in hematologic settings, information on reactivation in hepatitis B surface (HBsAg)-negative patients with hepatocellular carcinoma (HCC) remains unknown. This study aimed to determine the incidence and risk factors of HBV reactivation in HBsAg-negative patients undergoing transarterial chemoembolization (TACE). Methods A total of 109 HBsAg-negative patients with HCC were consecutively recruited for this study and treated with either mono-(n = 75), combination-drug TACE (n = 20), or combination-drug TACE plus radiotherapy (n = 14). With serial monitoring of virological markers every 2-3 months, patients were observed for HBV reactivation (defined as the reappearance of HBV DNA or sero-reversion of HBsAg) in comparison with control subjects with HBsAg-negative cirrhosis (n = 16) or HBsAg loss (n = 46). Results During the study period, HBV reactivation occurred in 12 (11.0%) and 1 (1.6%) patients in the TACE and control groups, respectively. The median level of HBV DNA at reactivation was 5,174 copies/ml (range: 216-116,058). Of the 12 patients with HBV reactivation, four (33.3%) developed clinical hepatitis, including one patient who suffered from decompensation. All antiviral-treated patients achieved undetectable HBV DNA or HBsAg loss after commencement of antiviral drugs. TACE was significantly correlated with a high incidence of HBV reactivation, with increasing risk of reactivation with intensive treatment. On multivariate analysis, treatment intensity and a prior history of chronic hepatitis B remained independently predictive of reactivation. Conclusions TACE can reactivate HBV replication in HBsAg-negative patients, with a dose-risk relationship between treatment intensity and reactivation. Patients with prior chronic HBV infection who are to undergo intensive TACE should be closely monitored, with an alternative approach of antiviral prophylaxis against HBV reactivation.	[Jang, Jeong Won; Bae, Si Hyun; Choi, Jong Young; Yoon, Seung Kew] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Internal Med, Seoul, South Korea; [Kim, Young Woon; Lee, Sung Won; Kwon, Jung Hyun; Nam, Soon Woo; Chung, Kyu Won] Catholic Univ Korea, Incheon St Marys Hosp, Dept Internal Med, Incheon, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea	Nam, SW (corresponding author), Catholic Univ Korea, Incheon St Marys Hosp, Dept Internal Med, Incheon, South Korea.	drswnam@hanmail.net			College of Medicine, the Catholic University of Korea	College of Medicine, the Catholic University of Korea	This work was supported by a Sabbatical researcher fund from College of Medicine, the Catholic University of Korea (2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dong HJ, 2013, J CLIN VIROL, V57, P209, DOI 10.1016/j.jcv.2013.03.010; Hoofnagle JH, 2009, HEPATOLOGY, V49, pS156, DOI 10.1002/hep.22945; Huang G, 2013, ANN SURG, V257, P490, DOI 10.1097/SLA.0b013e318262b218; Huang YH, 2013, J CLIN ONCOL, V31, P2765, DOI 10.1200/JCO.2012.48.5938; Hui CK, 2006, GASTROENTEROLOGY, V131, P59, DOI 10.1053/j.gastro.2006.04.015; Hung HH, 2010, J HEPATOL, V52, P463, DOI 10.1016/j.jhep.2009.11.023; Jang JW, 2014, WORLD J GASTROENTERO, V20, P7675, DOI 10.3748/wjg.v20.i24.7675; Jang JW, 2011, ANTIVIR THER, V16, P969, DOI 10.3851/IMP1840; Jang JW, 2006, HEPATOLOGY, V43, P233, DOI 10.1002/hep.21024; Kusumoto S, 2009, INT J HEMATOL, V90, P13, DOI 10.1007/s12185-009-0359-5; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Peng JW, 2012, ASIA-PAC J CLIN ONCO, V8, P356, DOI 10.1111/j.1743-7563.2012.01534.x; Yeo W, 2006, HEPATOLOGY, V43, P209, DOI 10.1002/hep.21051; Yeo WN, 2009, J CLIN ONCOL, V27, P605, DOI 10.1200/JCO.2008.18.0182; Yu SJ, 2013, RADIOLOGY, V267, P638, DOI 10.1148/radiol.13121498	17	21	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0122041	10.1371/journal.pone.0122041	http://dx.doi.org/10.1371/journal.pone.0122041			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894607	Green Published, gold, Green Submitted			2022-12-26	WOS:000353211700011
J	Wagner, M; Ashby, DR; Kurtz, C; Alam, A; Busbridge, M; Raff, U; Zimmermann, J; Heuschmann, PU; Wanner, C; Schramm, L				Wagner, Martin; Ashby, Damien R.; Kurtz, Caroline; Alam, Ahsan; Busbridge, Mark; Raff, Ulrike; Zimmermann, Josef; Heuschmann, Peter U.; Wanner, Christoph; Schramm, Lothar			Hepcidin-25 in Diabetic Chronic Kidney Disease Is Predictive for Mortality and Progression to End Stage Renal Disease	PLOS ONE			English	Article							INTRAINDIVIDUAL VARIABILITY; CARDIOVASCULAR EVENTS; SERUM HEPCIDIN-25; ANEMIA; ERYTHROPOIETIN; INFLAMMATION; IMMUNOASSAY; HYPOXIA; PROTEIN	Background Anemia is common and is associated with impaired clinical outcomes in diabetic chronic kidney disease (CKD). It may be explained by reduced erythropoietin (EPO) synthesis, but recent data suggest that EPO-resistance and diminished iron availability due to inflammation contribute significantly. In this cohort study, we evaluated the impact of hepcidin-25-the key hormone of iron-metabolism-on clinical outcomes in diabetic patients with CKD along with endogenous EPO levels. Methods 249 diabetic patients with CKD of any stage, excluding end-stage renal disease (ESRD), were enrolled (2003-2005), if they were not on EPO-stimulating agent and iron therapy. Hepcidin-25 levels were measured by radioimmunoassay. The association of hepcidin-25 at baseline with clinical variables was investigated using linear regression models. All-cause mortality and a composite endpoint of CKD progression (ESRD or doubling of serum creatinine) were analyzed by Cox proportional hazards models. Results Patients (age 67 yrs, 53% male, GFR 51 ml/min, hemoglobin 131 g/L, EPO 13.5 U/L, hepcidin-25 62.0 ng/ml) were followed for a median time of 4.2 yrs. Forty-nine patients died (19.7%) and forty (16.1%) patients reached the composite endpoint. Elevated hepcidin levels were independently associated with higher ferritin-levels, lower EPO-levels and impaired kidney function (all p<0.05). Hepcidin was related to mortality, along with its interaction with EPO, older age, greater proteinuria and elevated CRP (all p<0.05). Hepcidin was also predictive for progression of CKD, aside from baseline GFR, proteinuria, low albumin-and hemoglobin-levels and a history of CVD (all p<0.05). Conclusions We found hepcidin-25 to be associated with EPO and impaired kidney function in diabetic CKD. Elevated hepcidin-25 and EPO-levels were independent predictors of mortality, while hepcidin-25 was also predictive for progression of CKD. Both hepcidin-25 and EPO may represent important prognostic factors of clinical outcome and have the potential to further define "high risk" populations in CKD.	[Wagner, Martin; Kurtz, Caroline; Zimmermann, Josef; Wanner, Christoph; Schramm, Lothar] Univ Hosp Wurzburg, Dept Med 1, Div Nephrol, Wurzburg, Germany; [Wagner, Martin; Heuschmann, Peter U.] Unin Wurzburg, Inst Clin Epidemiol & Biometry, Wurzburg, Germany; [Wagner, Martin; Heuschmann, Peter U.] Unin Wurzburg, Comprehens Heart Failure Ctr, Wurzburg, Germany; [Ashby, Damien R.] Univ London Imperial Coll Sci Technol & Med, Kidney & Transplant Inst, London, England; [Alam, Ahsan] McGill Univ, Div Nephrol, Montreal, PQ, Canada; [Busbridge, Mark] Univ London Imperial Coll Sci Technol & Med, Dept Clin Chem, London, England; [Raff, Ulrike] Univ Erlangen Nurnberg, Dept Internal Med 4, Div Nephrol & Hypertens, Erlangen, Germany; [Heuschmann, Peter U.] Univ Hosp Wurzburg, Clin Trial Unit, Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg; Imperial College London; McGill University; Imperial College London; University of Erlangen Nuremberg; University of Wurzburg	Wagner, M (corresponding author), Univ Hosp Wurzburg, Dept Med 1, Div Nephrol, Wurzburg, Germany.	wagner_m@ukw.de			Roche, Germany	Roche, Germany(Roche Holding)	The study was funded by the participating institutions. Furthermore, data collection, measurement of EPO and hepcidin levels were supported by Roche, Germany. Roche, Germany, had no influence on the conduct of the study, data analysis, and interpretation. The data are owned by the authors.	Abdel-Khalek MA, 2011, J RHEUMATOL, V38, P2153, DOI 10.3899/jrheum.110339; Ashby DR, 2010, HAEMATOL-HEMATOL J, V95, P505, DOI 10.3324/haematol.2009.013136; Ashby DR, 2009, KIDNEY INT, V75, P976, DOI 10.1038/ki.2009.21; Bassi R, 2012, EXP DIABETES RES, DOI 10.1155/2012/916560; Belesley D. A., 1980, REGRESSION DIAGNOSTI; Busbridge M, 2009, BRIT J BIOMED SCI, V66, P150, DOI 10.1080/09674845.2009.11730263; Cullis J, 2013, CLIN MED, V13, P193, DOI 10.7861/clinmedicine.13-2-193; Doria A, 2012, SEMIN NEPHROL, V32, P437, DOI 10.1016/j.semnephrol.2012.07.006; El-Achkar TM, 2005, KIDNEY INT, V67, P1483, DOI 10.1111/j.1523-1755.2005.00226.x; Ferrucci L, 2007, BRIT J HAEMATOL, V136, P849, DOI 10.1111/j.1365-2141.2007.06502.x; Fiorina P, 2014, J AM SOC NEPHROL, V25, P1415, DOI 10.1681/ASN.2013050518; Ford BA, 2010, KIDNEY INT, V78, P769, DOI 10.1038/ki.2010.254; Freund R.J., 2000, SAS SYSTEM REGRESSIO, DOI 10.1002/9780470057339.vas007; Ganz T, 2008, BLOOD, V112, P4292, DOI 10.1182/blood-2008-02-139915; Ganz T, 2007, J AM SOC NEPHROL, V18, P394, DOI 10.1681/ASN.2006070802; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Ganz T, 2011, ANNU REV MED, V62, P347, DOI 10.1146/annurev-med-050109-142444; Lee P, 2005, P NATL ACAD SCI USA, V102, P1906, DOI 10.1073/pnas.0409808102; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mast AE, 1998, CLIN CHEM, V44, P45; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; McGill JB, 2006, J DIABETES COMPLICAT, V20, P262, DOI 10.1016/j.jdiacomp.2005.08.001; McMurray J., 2012, KIDNEY INT SUPPL, V2, P279, DOI [10.1038/kisup.2012.37, DOI 10.1038/KISUP.2012.37]; MEANS RT, 1992, BLOOD, V80, P1639; Mohanram A, 2004, KIDNEY INT, V66, P1131, DOI 10.1111/j.1523-1755.2004.00863.x; Mostovaya IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084587; Nakanishi T, 2011, NEPHROL DIAL TRANSPL, V26, P3092, DOI 10.1093/ndt/gfr410; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nemeth E, 2009, ACTA HAEMATOL-BASEL, V122, P78, DOI 10.1159/000243791; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Niewczas MA, 2012, J AM SOC NEPHROL, V23, P507, DOI 10.1681/ASN.2011060627; Niihata K, 2012, NEPHROL DIAL TRANSPL, V27, P4378, DOI 10.1093/ndt/gfs322; Peters HPE, 2012, NEPHROL DIAL TRANSPL, V27, P3923, DOI 10.1093/ndt/gfs164; Ritz E, 2005, EUR J CLIN INVEST, V35, P66, DOI 10.1111/j.1365-2362.2005.01544.x; Roy CN, 2007, BLOOD, V109, P4038, DOI 10.1182/blood-2006-10-051755; Smith TG, 2010, ANTIOXID REDOX SIGN, V12, P431, DOI 10.1089/ars.2009.2901; Solomon SD, 2010, NEW ENGL J MED, V363, P1146, DOI 10.1056/NEJMoa1005109; Soriano S, 2007, CLIN NEPHROL, V67, P352; Stockmann C, 2006, CLIN EXP PHARMACOL P, V33, P968, DOI 10.1111/j.1440-1681.2006.04474.x; Tangri N, 2011, JAMA-J AM MED ASSOC, V305, P1553, DOI 10.1001/jama.2011.451; Thomas MC, 2006, DIABETIC MED, V23, P502, DOI 10.1111/j.1464-5491.2006.01829.x; van der Weerd NC, 2013, NEPHROL DIAL TRANSPL, V28, P3062, DOI 10.1093/ndt/gfs488; Vlagopoulos PT, 2005, J AM SOC NEPHROL, V16, P3403, DOI 10.1681/ASN.2005030226; Wagner M, 2013, NEPHROL DIAL TRANSPL, V28, P2936, DOI 10.1093/ndt/gft330; Wagner M, 2011, CLIN J AM SOC NEPHRO, V6, P1573, DOI 10.2215/CJN.00380111; Wang LJ, 2012, INFLAMM BOWEL DIS, V18, P112, DOI 10.1002/ibd.21675; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Zhao NN, 2013, J CLIN INVEST, V123, P2337, DOI 10.1172/JCI67225	49	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123072	10.1371/journal.pone.0123072	http://dx.doi.org/10.1371/journal.pone.0123072			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894587	gold, Green Published, Green Submitted			2022-12-26	WOS:000353211700022
J	Yamana, S; Tokiyama, A; Mizutani, K; Hirata, K; Takai, Y; Rikitake, Y				Yamana, Shota; Tokiyama, Amina; Mizutani, Kiyohito; Hirata, Ken-ichi; Takai, Yoshimi; Rikitake, Yoshiyuki			The Cell Adhesion Molecule Necl-4/CADM4 Serves as a Novel Regulator for Contact Inhibition of Cell Movement and Proliferation	PLOS ONE			English	Article							VASCULAR ENDOTHELIAL CADHERIN; ACTIN STRESS FIBERS; SMALL G-PROTEINS; GROWTH-FACTOR; TUMOR-SUPPRESSOR; IN-VITRO; ADHERENS JUNCTIONS; SIGNALING-PATHWAY; FOCAL ADHESIONS; BETA-CATENIN	Contact inhibition of cell movement and proliferation is critical for proper organogenesis and tissue remodeling. We show here a novel regulatory mechanism for this contact inhibition using cultured vascular endothelial cells. When the cells were confluently cultured, Necl-4 was up-regulated and localized at cell-cell contact sites where it cis-interacted with the vascular endothelial growth factor (VEGF) receptor. This interaction inhibited the tyrosine-phosphorylation of the VEGF receptor through protein-tyrosine phosphatase, non-receptor type 13 (PTPN13), eventually reducing cell movement and proliferation. When the cells were sparsely cultured, Necl-4 was down-regulated but accumulated at leading edges where it inhibited the activation of Rho-associated protein kinase through PTPN13, eventually facilitating the VEGF-induced activation of Rac1 and enhancing cell movement. Necl-4 further facilitated the activation of extracellular signal-regulated kinase 1/2, eventually enhancing cell proliferation. Thus, Necl-4 serves as a novel regulator for contact inhibition of cell movement and proliferation cooperatively with the VEGF receptor and PTPN13.	[Yamana, Shota; Hirata, Ken-ichi; Rikitake, Yoshiyuki] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc Med, Kobe, Hyogo 657, Japan; [Tokiyama, Amina; Rikitake, Yoshiyuki] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Signal Transduct, Kobe, Hyogo 657, Japan; [Mizutani, Kiyohito; Takai, Yoshimi; Rikitake, Yoshiyuki] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Biol, Kobe, Hyogo 657, Japan; [Takai, Yoshimi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Pathogenet Signaling, Kobe, Hyogo 657, Japan	Kobe University; Kobe University; Kobe University; Kobe University	Rikitake, Y (corresponding author), Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc Med, Kobe, Hyogo 657, Japan.	rikitake@med.kobe-u.ac.jp	Mizutani, Kiyohito/L-8474-2019		Japan Society for the Promotion of Science [21227005, 25461128]; Global Center of Excellence; Takeda Science Foundation; Naito Foundation; SENSHIN Medical Research Foundation; Grants-in-Aid for Scientific Research [24790284, 26860190] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global Center of Excellence(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/e-grants) (to YT (21227005) and YR (25461128)) and by grants from the Global Center of Excellence (http://www.jsps.go.jp/english/e-globalcoe) (to SY, KH, YR), the Takeda Science Foundation (http://www.takeda-sci.or.jp), the Naito Foundation (https://www.naito-f.or.jp), and the SENSHIN Medical Research Foundation (http://www.mt-pharma.co.jp/zaidan) (to YR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Astin JW, 2010, NAT CELL BIOL, V12, P1194, DOI 10.1038/ncb2122; Biederer T, 2006, GENOMICS, V87, P139, DOI 10.1016/j.ygeno.2005.08.017; Cascone I, 2003, J BIOL CHEM, V278, P50702, DOI 10.1074/jbc.M307234200; Coleman SK, 2003, J NEUROSCI, V23, P798; Cooper J, 2014, FEBS LETT, V588, P2743, DOI 10.1016/j.febslet.2014.04.001; Copits BA, 2013, J BIOL CHEM, V288, P8952, DOI 10.1074/jbc.M112.440719; Fagotto F, 1996, DEV BIOL, V180, P445, DOI 10.1006/dbio.1996.0318; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FOLKMAN J, 1980, NATURE, V288, P551, DOI 10.1038/288551a0; Fujita H, 2005, J BIOL CHEM, V280, P5022, DOI 10.1074/jbc.M409701200; Fujito T, 2005, J CELL BIOL, V171, P165, DOI 10.1083/jcb.200501090; Fukuhara H, 2001, ONCOGENE, V20, P5401, DOI 10.1038/sj.onc.1204696; Gourlaouen M, 2013, J BIOL CHEM, V288, P7467, DOI 10.1074/jbc.M112.446401; Guilluy C, 2011, TRENDS CELL BIOL, V21, P718, DOI 10.1016/j.tcb.2011.08.002; Gumbiner BM, 2014, J CELL SCI, V127, P709, DOI 10.1242/jcs.140103; Halbleib JM, 2007, MOL BIOL CELL, V18, P4261, DOI 10.1091/mbc.E07-04-0308; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Ikeda W, 2003, J BIOL CHEM, V278, P28167, DOI 10.1074/jbc.M303586200; Kajita M, 2007, GENES CELLS, V12, P345, DOI 10.1111/j.1365-2443.2007.01062.x; Kakunaga S, 2005, J CELL SCI, V118, P1267, DOI 10.1242/jcs.01656; Kawano S, 2009, J BIOL CHEM, V284, P23793, DOI 10.1074/jbc.M109.025155; Kim NG, 2011, P NATL ACAD SCI USA, V108, P11930, DOI 10.1073/pnas.1103345108; Kinugasa M, 2012, CIRC RES, V110, P716, DOI 10.1161/CIRCRESAHA.111.256834; Kitt KN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017841; Koch AW, 1997, BIOCHEMISTRY-US, V36, P7697, DOI 10.1021/bi9705624; Lai YJ, 2007, J BIOL CHEM, V282, P24381, DOI 10.1074/jbc.M701499200; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Lampugnani MG, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; LAMPUGNANI MG, 1995, J CELL BIOL, V129, P203, DOI 10.1083/jcb.129.1.203; Lee HH, 2008, J CELL BIOL, V181, P999, DOI 10.1083/jcb.200710187; Li W, 2012, EMBO REP, V13, P204, DOI 10.1038/embor.2012.11; Matsumoto T, 2001, Sci STKE, V2001, pre21, DOI 10.1126/stke.2001.112.re21; Mayor R, 2010, TRENDS CELL BIOL, V20, P319, DOI 10.1016/j.tcb.2010.03.005; McClatchey AI, 2012, CURR OPIN CELL BIOL, V24, P685, DOI 10.1016/j.ceb.2012.06.009; Miyata M, 2009, J BIOL CHEM, V284, P24595, DOI 10.1074/jbc.M109.016436; Moleirinho S, 2014, FEBS LETT, V588, P2693, DOI 10.1016/j.febslet.2014.02.006; Murphy JG, 2014, CELL REP, V7, P1577, DOI 10.1016/j.celrep.2014.04.027; Nagata M, 2012, INT J CANCER, V130, P1329, DOI 10.1002/ijc.26160; Nakashima A, 2013, CELL, V154, P1314, DOI 10.1016/j.cell.2013.08.033; Perrais M, 2007, MOL BIOL CELL, V18, P2013, DOI 10.1091/mbc.E06-04-0348; Reymond N, 2004, J EXP MED, V199, P1331, DOI 10.1084/jem.20032206; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rikitake Y, 2005, CIRCULATION, V111, P3261, DOI 10.1161/CIRCULATIONAHA.105.534024; Rikitake Y, 2011, INT REV CEL MOL BIO, V287, P97, DOI 10.1016/B978-0-12-386043-9.00003-7; Sato T, 2006, J BIOL CHEM, V281, P5288, DOI 10.1074/jbc.M510070200; Shingai T, 2003, J BIOL CHEM, V278, P35421, DOI 10.1074/jbc.M305387200; Soga N, 2001, EXP CELL RES, V269, P73, DOI 10.1006/excr.2001.5295; Sugiyama H, 2013, GENES CELLS, V18, P519, DOI 10.1111/gtc.12056; Takahashi T, 1999, ONCOGENE, V18, P2221, DOI 10.1038/sj.onc.1202527; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Taliana L, 2005, INVEST OPHTH VIS SCI, V46, P96, DOI 10.1167/iovs.04-0145; Tan WF, 2008, FASEB J, V22, P1829, DOI 10.1096/fj.07-096438; Tawa H, 2010, CIRC RES, V106, P1731, DOI 10.1161/CIRCRESAHA.110.216747; Vinals F, 1999, MOL CELL BIOL, V19, P2763; Williams YN, 2006, ONCOGENE, V25, P1446, DOI 10.1038/sj.onc.1209192; Yamada A, 2013, MOL CELL NEUROSCI, V56, P234, DOI 10.1016/j.mcn.2013.06.003	58	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124259	10.1371/journal.pone.0124259	http://dx.doi.org/10.1371/journal.pone.0124259			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893857	Green Published, gold, Green Submitted			2022-12-26	WOS:000353211700082
J	Adu-Gyasi, D; Asante, KP; Newton, S; Dosoo, D; Amoako, S; Adjei, G; Amoako, N; Ankrah, L; Tchum, SK; Mahama, E; Agyemang, V; Kayan, K; Owusu-Agyei, S				Adu-Gyasi, Dennis; Asante, Kwaku Poku; Newton, Sam; Dosoo, David; Amoako, Sabastina; Adjei, George; Amoako, Nicholas; Ankrah, Love; Tchum, Samuel Kofi; Mahama, Emmanuel; Agyemang, Veronica; Kayan, Kingsley; Owusu-Agyei, Seth			Evaluation of the Diagnostic Accuracy of CareStart G6PD Deficiency Rapid Diagnostic Test (RDT) in a Malaria Endemic Area in Ghana, Africa	PLOS ONE			English	Article							GLUCOSE-6-PHOSPHATE DEHYDROGENASE; CHILDREN; INFANTS; VIVAX	Background Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most widespread enzyme defect that can result in red cell breakdown under oxidative stress when exposed to certain medicines including antimalarials. We evaluated the diagnostic accuracy of CareStart G6PD deficiency Rapid Diagnostic Test (RDT) as a point-of-care tool for screening G6PD deficiency. Methods A cross-sectional study was conducted among 206 randomly selected and consented participants from a group with known G6PD deficiency status between February 2013 and June 2013. A maximum of 1.6ml of capillary blood samples were used for G6PD deficiency screening using CareStart G6PD RDT and Trinity qualitative with Trinity quantitative methods as the "gold standard". Samples were also screened for the presence of malaria parasites. Data entry and analysis were done using Microsoft Access 2010 and Stata Software version 12. Kintampo Health Research Centre Institutional Ethics Committee granted ethical approval. Results The sensitivity (SE) and specificity (SP) of CareStart G6PD deficiency RDT was 100% and 72.1% compared to Trinity quantitative method respectively and was 98.9% and 96.2% compared to Trinity qualitative method. Malaria infection status had no significant (P= 0.199) change on the performance of the G6PD RDT test kit compared to the "gold standard". Conclusions The outcome of this study suggests that the diagnostic performance of the CareStart G6PD deficiency RDT kit was high and it is acceptable at determining the G6PD deficiency status in a high malaria endemic area in Ghana. The RDT kit presents as an attractive tool for point-of-care G6PD deficiency for rapid testing in areas with high temperatures and less expertise. The CareStart G6PD deficiency RDT kit could be used to screen malaria patients before administration of the fixed dose primaquine with artemisinin-based combination therapy.	[Adu-Gyasi, Dennis; Asante, Kwaku Poku; Newton, Sam; Dosoo, David; Amoako, Sabastina; Adjei, George; Amoako, Nicholas; Ankrah, Love; Tchum, Samuel Kofi; Mahama, Emmanuel; Agyemang, Veronica; Kayan, Kingsley; Owusu-Agyei, Seth] Kintampo Hlth Res Ctr, Kintampo, Brong Ahafo, Ghana	Kintampo Health Research Centre	Adu-Gyasi, D (corresponding author), Kintampo Hlth Res Ctr, POB 200, Kintampo, Brong Ahafo, Ghana.	adugyasidennis@yahoo.co.uk		Adu-Gyasi, Dennis/0000-0002-9449-2565; Owusu-Agyei, Seth/0000-0002-0807-1781	KHRC	KHRC	The study team wish to thank the participants involved in this study. Our appreciation also goes to the staff of Kintampo Health Research Centre (KHRC), especially those who assisted in this work. We are also grateful to the scientific team in KHRC who helped shape the scientific content as well as the institutional ethics committee. We also appreciate KHRC who also funded this study.	Adu-Gyasi D, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-238; Amoako N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112868; Asante KP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-211; Asante KP, 2013, J INFECT DIS, V208, P1504, DOI 10.1093/infdis/jit366; Baird JK, 2002, AM J TROP MED HYG, V66, P280, DOI 10.4269/ajtmh.2002.66.280; Baird JK, 2014, TRANSLATIONAL RES; Bancone G, 2015, AM J TROP MED HYG, P14; Beutler E, 2007, AM J TROP MED HYG, V77, P779, DOI 10.4269/ajtmh.2007.77.779; Carter N, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-241; Culleton RL, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-174; Domingo GJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-391; Dosoo DK, 2014, AM J TROP MED HYG, V90, P767, DOI 10.4269/ajtmh.13-0098; Dosoo DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036308; Goo YK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097390; Kim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028357; KORNBERG A, 1955, METHOD ENZYMOL, V1, P323, DOI 10.1016/0076-6879(55)01046-X; Kotea R, 1999, BRIT J HAEMATOL, V104, P849, DOI 10.1046/j.1365-2141.1999.01230.x; LOHR GW, 1974, METHOD ENZYMAT AN, P636; Meissner PE, 2005, BRIT J HAEMATOL, V131, P395, DOI 10.1111/j.1365-2141.2005.05778.x; Ministry of Health/Ghana Health Service G, 2010, STAND TREATM GUID IN, P376; Osorio L, 2015, AM J TROP MED HYG, V92, P22, DOI 10.4269/ajtmh.14-0298; Owusu-Agyei S, 2012, GLOBAL HLTH ACTION, V5; Owusu-Agyei S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-220; Pamba A, 2012, BLOOD, V120, P4123, DOI 10.1182/blood-2012-03-416032; Roca-Feltrer A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116143; Tinley KE, 2010, AM J TROP MED HYG, V82, P210, DOI 10.4269/ajtmh.2010.09-0416; von Fricken ME, 2014, AM J TROP MED HYG, P14; VULLIAMY TJ, 1991, P NATL ACAD SCI USA, V88, P8568, DOI 10.1073/pnas.88.19.8568; W.H.O, 2012, WHO SINGL DOS PRIM G; White NJ, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-418; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Winstanley P, 2001, Lancet Infect Dis, V1, P242, DOI 10.1016/S1473-3099(01)00119-0	32	27	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0125796	10.1371/journal.pone.0125796	http://dx.doi.org/10.1371/journal.pone.0125796			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885097	gold, Green Published, Green Submitted			2022-12-26	WOS:000353017000163
J	Lee, RF				Lee, Ray F.			Dual Logic and Cerebral Coordinates for Reciprocal Interaction in Eye Contact	PLOS ONE			English	Article							SOCIAL COGNITIVE NEUROSCIENCE; NEURAL MECHANISMS; CINGULATE CORTEX; EXCLUSIVE-OR; BRAIN; CORE; INFORMATION; JUDGMENT; NETWORK; HUMANS	In order to scientifically study the human brain's response to face-to-face social interaction, the scientific method itself needs to be reconsidered so that both quantitative observation and symbolic reasoning can be adapted to the situation where the observer is also observed. In light of the recent development of dyadic fMRI which can directly observe dyadic brain interacting in one MRI scanner, this paper aims to establish a new form of logic, dual logic, which provides a theoretical platform for deductive reasoning in a complementary dual system with emergence mechanism. Applying the dual logic in the dfMRI experimental design and data analysis, the exogenous and endogenous dual systems in the BOLD responses can be identified; the non-reciprocal responses in the dual system can be suppressed; a cerebral coordinate for reciprocal interaction can be generated. Elucidated by dual logic deductions, the cerebral coordinate for reciprocal interaction suggests: the exogenous and endogenous systems consist of the empathy network and the mentalization network respectively; the default-mode network emerges from the resting state to activation in the endogenous system during reciprocal interaction; the cingulate plays an essential role in the emergence from the exogenous system to the endogenous system. Overall, the dual logic deductions are supported by the dfMRI experimental results and are consistent with current literature. Both the theoretical framework and experimental method set the stage to formally apply the scientific method in studying complex social interaction.	Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA	Princeton University	Lee, RF (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	raylee@princeton.edu			Princeton University	Princeton University(Princeton University)	This work is fully funded by the author's startup fund and author's director discretionary account, both are from the Princeton University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Anders S, 2011, NEUROIMAGE, V54, P439, DOI 10.1016/j.neuroimage.2010.07.004; ARON A, 1992, J PERS SOC PSYCHOL, V63, P596, DOI 10.1037/0022-3514.63.4.596; Aziz-Zadeh L, 2006, J NEUROSCI, V26, P2964, DOI 10.1523/JNEUROSCI.2921-05.2006; Baess P, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00083; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Chen S, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P73; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dumas G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012166; Evans JSBT, 2008, ANNU REV PSYCHOL, V59, P255, DOI 10.1146/annurev.psych.59.103006.093629; Gindikin SG, 1985, ALGEBRAIC LOGIC, Vxviii; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hasson U, 2012, TRENDS COGN SCI, V16, P114, DOI 10.1016/j.tics.2011.12.007; Hooker CI, 2003, COGNITIVE BRAIN RES, V17, P406, DOI 10.1016/S0926-6410(03)00143-5; Iacoboni M, 2005, CURR OPIN NEUROBIOL, V15, P632, DOI 10.1016/j.conb.2005.10.010; Itier RJ, 2009, NEUROSCI BIOBEHAV R, V33, P843, DOI 10.1016/j.neubiorev.2009.02.004; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; Keysers C, 2007, TRENDS COGN SCI, V11, P194, DOI 10.1016/j.tics.2007.02.002; Klemm K, 2000, PHYS REV LETT, V84, P3013, DOI 10.1103/PhysRevLett.84.3013; Lee RF, 2012, MAGN RESON MED, V68, P1087, DOI 10.1002/mrm.23313; Lee RF, 2013, DYADIC INTERACTION I, P667; Leech R, 2012, J NEUROSCI, V32, P215, DOI 10.1523/JNEUROSCI.3689-11.2012; Lieberman MD, 2007, ANNU REV PSYCHOL, V58, P259, DOI 10.1146/annurev.psych.58.110405.085654; Lieberman MD, 2002, ADV EXP SOC PSYCHOL, V34, P199, DOI 10.1016/S0065-2601(02)80006-5; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; Montague PR, 2002, NEUROIMAGE, V16, P1159, DOI 10.1006/nimg.2002.1150; Ochsner KN, 2008, BIOL PSYCHIAT, V64, P48, DOI 10.1016/j.biopsych.2008.04.024; Redcay E, 2010, NEUROIMAGE, V50, P1639, DOI 10.1016/j.neuroimage.2010.01.052; Schilbach L, 2006, NEUROPSYCHOLOGIA, V44, P718, DOI 10.1016/j.neuropsychologia.2005.07.017; Schippers MB, 2010, P NATL ACAD SCI USA, V107, P9388, DOI 10.1073/pnas.1001791107; Smith JD, 2011, J EXP PSYCHOL-ANIM B, V37, P20, DOI 10.1037/a0019497; Stanovich KE, 2000, BEHAV BRAIN SCI, V23, P645, DOI 10.1017/S0140525X00003435; Tognoli E, 2007, P NATL ACAD SCI USA, V104, P8190, DOI 10.1073/pnas.0611453104; Tomlin D, 2006, SCIENCE, V312, P1047, DOI 10.1126/science.1125596; Woolrich MW, 2004, NEUROIMAGE, V21, P1748, DOI 10.1016/j.neuroimage.2003.12.024; Worsley K., 2001, FUNCTIONAL MRI INTRO, V61	38	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0121791	10.1371/journal.pone.0121791	http://dx.doi.org/10.1371/journal.pone.0121791			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885446	Green Published, gold			2022-12-26	WOS:000353017000025
J	Singh, A; Jha, SK; Bagri, J; Pandey, GK				Singh, Amarjeet; Jha, Saroj K.; Bagri, Jayram; Pandey, Girdhar K.			ABA Inducible Rice Protein Phosphatase 2C Confers ABA Insensitivity and Abiotic Stress Tolerance in Arabidopsis	PLOS ONE			English	Article							REGULATES ABSCISIC-ACID; SIGNAL-TRANSDUCTION PATHWAY; COLD-ACCLIMATION; CALCIUM SENSOR; GENOME-WIDE; FRUIT-DEVELOPMENT; DROUGHT STRESS; GENE FAMILIES; CROSS-TALK; KINASE	Arabidopsis PP2C belonging to group A have been extensively worked out and known to negatively regulate ABA signaling. However, rice (Oryza sativa) orthologs of Arabidopsis group A PP2C are scarcely characterized functionally. We have identified a group A PP2C from rice (OsPP108), which is highly inducible under ABA, salt and drought stresses and localized predominantly in the nucleus. Genetic analysis revealed that Arabidopsis plants overexpressing OsPP108 are highly insensitive to ABA and tolerant to high salt and mannitol stresses during seed germination, root growth and overall seedling growth. At adult stage, OsPP108 overexpression leads to high tolerance to salt, mannitol and drought stresses with far better physiological parameters such as water loss, fresh weight, chlorophyll content and photosynthetic potential (Fv/Fm) in transgenic Arabidopsis plants. Expression profile of various stress marker genes in OsPP108 overexpressing plants revealed interplay of ABA dependent and independent pathway for abiotic stress tolerance. Overall, this study has identified a potential rice group A PP2C, which regulates ABA signaling negatively and abiotic stress signaling positively. Transgenic rice plants overexpressing this gene might provide an answer to the problem of low crop yield and productivity during adverse environmental conditions.	[Singh, Amarjeet; Jha, Saroj K.; Bagri, Jayram; Pandey, Girdhar K.] Univ Delhi, Dept Plant Mol Biol, New Delhi, India	University of Delhi	Pandey, GK (corresponding author), Univ Delhi, Dept Plant Mol Biol, South Campus,Benito Juarez Rd, New Delhi, India.	gkpandey@south.du.ac.in		PANDEY, GIRDHAR KUMAR/0000-0001-9180-0924	Council of Scientific and Industrial Research (CSIR), India	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	Support was provided by the Council of Scientific and Industrial Research (CSIR), India. The funder had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Antoni R, 2012, PLANT PHYSIOL, V158, P970, DOI 10.1104/pp.111.188623; Bhaskara GB, 2012, PLANT PHYSIOL, V160, P379, DOI 10.1104/pp.112.202408; Chae L, 2010, ABIOTIC STRESS ADAPTATION IN PLANTS: PHYSIOLOGICAL, MOLECULAR AND GENOMIC FOUNDATION, P123, DOI 10.1007/978-90-481-3112-9_7; Chaerle L, 2007, J EXP BOT, V58, P773, DOI 10.1093/jxb/erl257; Chakrabarty R, 2007, MOL PLANT MICROBE IN, V20, P740, DOI 10.1094/MPMI-20-7-0740; Chauhan H, 2012, PLANT CELL ENVIRON, V35, P1912, DOI 10.1111/j.1365-3040.2012.02525.x; Cheong YH, 2007, PLANT J, V52, P223, DOI 10.1111/j.1365-313X.2007.03236.x; Chinnusamy V, 2004, J EXP BOT, V55, P225, DOI 10.1093/jxb/erh005; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; D'Angelo C, 2006, PLANT J, V48, P857, DOI 10.1111/j.1365-313X.2006.02921.x; Ding ZJ, 2014, PLANT J, V79, P13, DOI 10.1111/tpj.12538; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Fujii H, 2009, P NATL ACAD SCI USA, V106, P8380, DOI 10.1073/pnas.0903144106; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Fujita Y, 2009, PLANT CELL PHYSIOL, V50, P2123, DOI 10.1093/pcp/pcp147; Guo Y, 2002, DEV CELL, V3, P233, DOI 10.1016/S1534-5807(02)00229-0; Himmelbach A, 2002, EMBO J, V21, P3029, DOI 10.1093/emboj/cdf316; Jain M, 2004, BBA-GENE STRUCT EXPR, V1676, P182, DOI 10.1016/j.bbaexp.2003.11.012; Jakab G, 2005, PLANT PHYSIOL, V139, P267, DOI 10.1104/pp.105.065698; Kim H, 2012, J EXP BOT, V63, P1013, DOI 10.1093/jxb/err338; Kim KN, 2003, PLANT CELL, V15, P411, DOI 10.1105/tpc.006858; Kim W, 2013, PLANT CELL PHYSIOL, V54, P555, DOI 10.1093/pcp/pct017; Komatsu K, 2009, PLANT MOL BIOL, V70, P327, DOI 10.1007/s11103-009-9476-z; KOORNNEEF M, 1982, THEOR APPL GENET, V61, P385, DOI 10.1007/BF00272861; Kuhn JM, 2006, PLANT PHYSIOL, V140, P127, DOI 10.1104/pp.105.070318; LANG V, 1992, PLANT MOL BIOL, V20, P951, DOI 10.1007/BF00027165; Leung J, 1997, PLANT CELL, V9, P759, DOI 10.1105/tpc.9.5.759; Leung J, 1998, ANNU REV PLANT PHYS, V49, P199, DOI 10.1146/annurev.arplant.49.1.199; Liu LX, 2009, J PLANT PHYSIOL, V166, P531, DOI 10.1016/j.jplph.2008.07.008; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Mao XG, 2010, J EXP BOT, V61, P683, DOI 10.1093/jxb/erp331; Merlot S, 2001, PLANT J, V25, P295, DOI 10.1046/j.1365-313x.2001.00965.x; Mishra M, 2013, OMICS, V17, P439, DOI 10.1089/omi.2012.0074; Mizoguchi M, 2010, PLANT CELL PHYSIOL, V51, P842, DOI 10.1093/pcp/pcq041; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Narusaka Y, 2003, PLANT J, V34, P137, DOI 10.1046/j.1365-313X.2003.01708.x; OKADA K, 1990, SCIENCE, V250, P274, DOI 10.1126/science.250.4978.274; Pandey GK, 2008, MOL PLANT, V1, P238, DOI 10.1093/mp/ssn003; Pandey GK, 2005, PLANT PHYSIOL, V139, P1185, DOI 10.1104/pp.105.066324; Pandey GK, 2004, PLANT CELL, V16, P1912, DOI 10.1105/tpc.021311; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Rubio S, 2009, PLANT PHYSIOL, V150, P1345, DOI 10.1104/pp.109.137174; Saez A, 2004, PLANT J, V37, P354, DOI 10.1046/j.1365-313X.2003.01966.x; Santiago J, 2009, NATURE, V462, P665, DOI 10.1038/nature08591; Sato A, 2009, BIOCHEM J, V424, P439, DOI 10.1042/BJ20091221; Seo M, 2002, TRENDS PLANT SCI, V7, P41, DOI 10.1016/S1360-1385(01)02187-2; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Singh A, 2012, J PLANT BIOCHEM BIOT, V21, pS100, DOI 10.1007/s13562-012-0150-1; Singh A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030947, 10.1371/journal.pone.0044728, 10.1371/journal.pone.0039812, 10.1371/journal.pone.0044931]; Singh A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-435; Sun L, 2011, J EXP BOT, V62, P5659, DOI 10.1093/jxb/err252; Tahtiharju S, 2001, PLANT J, V26, P461, DOI 10.1046/j.1365-313X.2001.01048.x; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Umezawa T, 2010, PLANT CELL PHYSIOL, V51, P1821, DOI 10.1093/pcp/pcq156; Umezawa T, 2009, P NATL ACAD SCI USA, V106, P17588, DOI 10.1073/pnas.0907095106; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; Wang YP, 2012, J PLANT PHYSIOL, V169, P1874, DOI 10.1016/j.jplph.2012.07.017; Xue TT, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-550; Yoshida R, 2002, PLANT CELL PHYSIOL, V43, P1473, DOI 10.1093/pcp/pcf188; Yoshida T, 2006, PLANT PHYSIOL, V140, P115, DOI 10.1104/pp.105.070128; You J, 2014, PLANT PHYSIOL, V166, P2100, DOI 10.1104/pp.114.251116; Zhang WH, 2004, P NATL ACAD SCI USA, V101, P9508, DOI 10.1073/pnas.0402112101	64	108	115	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0125168	10.1371/journal.pone.0125168	http://dx.doi.org/10.1371/journal.pone.0125168			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886365	Green Published, Green Submitted, gold			2022-12-26	WOS:000353017000152
J	Zhang, CC; Yu, HN; Ni, XF; Shen, SR; Das, UN				Zhang, Chengcheng; Yu, Haining; Ni, Xiaofeng; Shen, Shengrong; Das, Undurti N.			Growth Inhibitory Effect of Polyunsaturated Fatty Acids (PUFAs) on Colon Cancer Cells via Their Growth Inhibitory Metabolites and Fatty Acid Composition Changes	PLOS ONE			English	Article							LINOLEIC-ACID; LIPOXIN A(4); APOPTOSIS; CYCLOOXYGENASE-2; EXPRESSION; RESOLVINS; CARCINOMA; RADIATION; INVASION; SYNTHASE	Background Colorectal cancer is common. Polyunsaturated fatty acids (PUFAs) exert growth-inhibitory and pro-apoptotic effects on colon cancer cells. Metabolites of PUFAs such as prostaglandins (PGs), leukotrienes (LTs) and lipoxins (LXs) play a significant role in colon cancer. Methods Human colon cancer LoVo and RKO cells were cultured with different concentration of PUFAs and 5-fluorouracil (5-FU) in vitro. Cell morphological changes, fatty acid composition, formation of PGE2, LTB4 and LXA4 and expression of COX-2, ALOX5, PGD synthase (PGDS), microsomal prostaglandin E synthase (mPGES) were assessed in LoVo and RKO cells when supplemented with PUFAs and 5-FU. Results PUFAs and 5-FU inhibited growth of LoVo and RKO cells to the same extent at the doses used and produced significant alterations in their shape. As expected, higher concentrations of supplemented PUFAs were noted in the cells compared to control. LA, GLA, AA, ALA and EPA supplementation to LoVo cells suppressed production of PGE(2), LTB4, and ALOX5, mPGES expression, but enhanced that of LXA(4); whereas DHA enhanced PGE(2) and LXA(4) synthesis but decreased LTB4 formation and COX-2, ALOX5, mPGES expression. In contrast, 5-FU enhanced formation of PGE(2), LTB4 and mPGES expression, but suppressed LXA(4) synthesis and COX-2 expression. PGE(2), LTB4 synthesis and ALOX5 expression was suppressed by LA, GLA, ALA and DHA; whereas AA, EPA and 5-FU enhanced PGE(2) but paradoxically AA decreased and EPA and 5-FU enhanced LTB4 synthesis in RKO cells. All the PUFAs tested enhanced, while 5-FU decreased LXA(4) formation in RKO cells; whereas GLA, AA, and 5-FU augmented while LA, ALA, EPA and DHA enhanced COX-2 expression in RKO cells. Conclusions Tumoricidal action of PUFAs on colorectal LoVo and RKO cancer cells in vitro was associated with increased formation of LXA(4), decreased synthesis of PGE(2) and LTB4 and suppressed expression of COX-2, ALOX5, mPGES, whereas 5-FU produced contrasting actions on these indices.	[Zhang, Chengcheng; Ni, Xiaofeng; Shen, Shengrong] Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Yu, Haining] Zhejiang Univ Technol, Coll Pharmaceut Sci, Hangzhou 310032, Zhejiang, Peoples R China; [Das, Undurti N.] UND Life Sci, Federal Way, WA 98003 USA; [Das, Undurti N.] GVP Hosp, Dept Med, Visakhapatnam 530048, Andhra Pradesh, India; [Das, Undurti N.] GVP Hosp, BioSci Res Ctr, Visakhapatnam 530048, Andhra Pradesh, India	Zhejiang University; Zhejiang University of Technology	Shen, SR (corresponding author), Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou 310058, Zhejiang, Peoples R China.	shrshen@zju.edu.cn; Undurti@hotmail.com	Yu, Haining/HHC-0235-2022	Zhang, Chengcheng/0000-0002-0152-3001	Department of Biotechnology (DBT) [BT/PR11627/MED/30/157/2010]; Department of Science and Technology under Intensification of Research in High Priority Areas (IRPHA) [IR/SO/LU/03/2008/1]; Department of Biotechnology, New Delhi	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Department of Science and Technology under Intensification of Research in High Priority Areas (IRPHA); Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India)	UND is in receipt of Ramalingaswami fellowship of the Department of Biotechnology, New Delhi during the tenure of this study. This work was supported, in part, by grants from the Department of Biotechnology (DBT No. BT/PR11627/MED/30/157/2010), Department of Science and Technology (No. IR/SO/LU/03/2008/1) under Intensification of Research in High Priority Areas (IRPHA) to UND. Author UND is the President and CEO of UND Life Sciences without any financial compensation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai F, 2014, CLIN NUTR, V33, P164, DOI 10.1016/j.clnu.2013.04.005; Chae BS, 2008, ARCH PHARM RES, V31, P503, DOI 10.1007/s12272-001-1185-6; Chen EP, 2011, PROSTAG OTH LIPID M, V96, P14, DOI 10.1016/j.prostaglandins.2011.08.005; Chen ZY, 2000, PROSTAG LEUKOTR ESS, V63, P301, DOI 10.1054/plef.2000.0218; Cheng J, 2014, TOXICOL APPL PHARM, V274, P96, DOI 10.1016/j.taap.2013.10.021; Dai JF, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-71; Das UN, 2006, PROSTAG LEUKOTR ESS, V74, P165, DOI 10.1016/j.plefa.2006.01.002; Das UN, 2004, PROSTAGLANDINS LEUKO, V70, P419; Das UN, 2006, CURR PHARM BIOTECHNO, V7, P467, DOI 10.2174/138920106779116856; Das Undurti N., 2006, Biotechnology Journal, V1, P420, DOI 10.1002/biot.200600012; Das UN, 2012, PROSTAG LEUKOTR ESS, V86, P3, DOI 10.1016/j.plefa.2011.09.008; Das UN, 2011, CANCER METAST REV, V30, P311, DOI 10.1007/s10555-011-9316-x; Das UN, 2011, CLIN LIPIDOL, V6, P463, DOI 10.2217/CLP.11.34; Das UN, 2013, CLIN LIPIDOL, V8, P437, DOI 10.2217/CLP.13.31; Divangahi M, 2013, ADV EXP MED BIOL, V783, P103, DOI 10.1007/978-1-4614-6111-1_6; DUNBAR LM, 1975, J BIOL CHEM, V250, P1152; Fasano E, 2012, BBA-MOL BASIS DIS, V1822, P1762, DOI 10.1016/j.bbadis.2012.08.003; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Hao H, 2011, CANCER LETT, V309, P85, DOI 10.1016/j.canlet.2011.05.020; Hartwich J, 2001, Med Sci Monit, V7, P1171; Jachak SM, 2007, CURR OPIN INVEST DR, V8, P411; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kihara Y, 2009, P NATL ACAD SCI USA, V106, P21807, DOI 10.1073/pnas.0906891106; Koeberle A, 2009, MOL CANCER THER, V8, P2348, DOI 10.1158/1535-7163.MCT-09-0290; Kojima F, 2005, FUND CLIN PHARMACOL, V19, P255, DOI 10.1111/j.1472-8206.2005.00316.x; Kolar S, 2011, CANCER-AM CANCER SOC, V117, P5294, DOI 10.1002/cncr.26205; KORATKAR R, 1993, PROSTAG LEUKOTR ESS, V48, P175, DOI 10.1016/0952-3278(93)90107-8; Kummer NT, 2012, J CELL BIOCHEM, V113, P1998, DOI 10.1002/jcb.24069; Lu XF, 2010, J ZHEJIANG UNIV-SC B, V11, P923, DOI 10.1631/jzus.B1000125; Lu XF, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-106; Meng HZ, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-160; MORTON RE, 1979, BIOCHIM BIOPHYS ACTA, V573, P321, DOI 10.1016/0005-2760(79)90065-1; Pockaj BA, 2004, ANN SURG ONCOL, V11, P328, DOI 10.1245/ASO.2004.05.027; Polavarapu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114766; Qualtrough D, 2007, INT J CANCER, V121, P734, DOI 10.1002/ijc.22755; Ramesh G, 1996, CANCER LETT, V100, P199, DOI 10.1016/0304-3835(95)04095-1; RAMESH G, 1995, CANCER LETT, V95, P237, DOI 10.1016/0304-3835(95)03896-5; Ramesh G, 1998, CANCER LETT, V123, P207, DOI 10.1016/S0304-3835(97)00426-6; Roelofs HMJ, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-1; Samuelsson B, 2007, PHARMACOL REV, V59, P207, DOI 10.1124/pr.59.3.1; Seppanen-Laakso T, 2002, ANAL CHIM ACTA, V465, P39, DOI 10.1016/S0003-2670(02)00397-5; Serhan CN, 2004, LIPIDS, V39, P1125, DOI 10.1007/s11745-004-1339-7; Sinicrope FA, 2004, CANCER METAST REV, V23, P63, DOI 10.1023/A:1025863029529; SURYAPRABHA P, 1991, PROSTAG LEUKOTR ESS, V43, P251, DOI 10.1016/0952-3278(91)90038-7; Tateishi N, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-30; Urade Y, 2002, PROSTAG OTH LIPID M, V68-9, P375, DOI 10.1016/S0090-6980(02)00042-4; van Meeteren ME, 2005, EUR J CLIN NUTR, V59, P1347, DOI 10.1038/sj.ejcn.1602255; Yoshida T, 1998, SURG TODAY, V28, P740, DOI 10.1007/BF02484622	48	27	28	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123256	10.1371/journal.pone.0123256	http://dx.doi.org/10.1371/journal.pone.0123256			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886460	Green Submitted, Green Published, gold			2022-12-26	WOS:000353017000053
J	Petzold, C; Marceau, AH; Miller, KH; Marqusee, S; Keck, JL				Petzold, Christine; Marceau, Aimee H.; Miller, Katherine H.; Marqusee, Susan; Keck, James L.			Interaction with Single-stranded DNA-binding Protein Stimulates Escherichia coli Ribonuclease HI Enzymatic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							R-LOOP FORMATION; RNA-POLYMERASE BACKTRACKING; GENOME INSTABILITY; EXONUCLEASE-I; TRANSCRIPTION ELONGATION; FACILITATE REPLICATION; UNWINDING PROTEIN; TOPOISOMERASE-I; SSB; COMPLEXES	Single-stranded (ss) DNA-binding proteins (SSBs) bind and protect ssDNA intermediates formed during replication, recombination, and repair reactions. SSBs also directly interact with many different genome maintenance proteins to stimulate their enzymatic activities and/or mediate their proper cellular localization. We have identified an interaction formed between Escherichia coli SSB and ribonuclease HI (RNase HI), an enzyme that hydrolyzes RNA in RNA/DNA hybrids. The RNase HI center dot SSB complex forms by RNase HI binding the intrinsically disordered C terminus of SSB (SSB-Ct), a mode of interaction that is shared among all SSB interaction partners examined to date. Residues that comprise the SSB-Ct binding site are conserved among bacterial RNase HI enzymes, suggesting that RNase HI center dot SSB complexes are present in many bacterial species and that retaining the interaction is important for its cellular function. A steady-state kinetic analysis shows that interaction with SSB stimulates RNase HI activity by lowering the reaction K-m. SSB or RNase HI protein variants that disrupt complex formation nullify this effect. Collectively our findings identify a direct RNase HI/SSB interaction that could play a role in targeting RNase HI activity to RNA/DNA hybrid substrates within the genome.	[Petzold, Christine; Marceau, Aimee H.; Keck, James L.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, 1135 Biochem Sci Bldg,420 Henry Mall, Madison, WI 53706 USA; [Miller, Katherine H.; Marqusee, Susan] Univ Calif Berkeley, Calif Inst Quantitat Biosci, QB3, Berkeley, CA 94720 USA; [Miller, Katherine H.; Marqusee, Susan] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Keck, JL (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, 1135 Biochem Sci Bldg,420 Henry Mall, Madison, WI 53706 USA.	jlkeck@wisc.edu	Regan, Clinton/E-6250-2012	Keck, James/0000-0002-5961-0220	National Institutes of Health [GM098885, GM07215]; National Science Foundation Graduate Research Fellowship Program [DGE-1256259]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098885, T32GM008295, T32GM007215] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM098885 and GM07215 (a training grant in molecular biosciences to A. H. M.). This work was also supported by National Science Foundation Graduate Research Fellowship Program Grant DGE-1256259 (to C. P.). J. L. K. is cofounder of Replisoma, Inc.	Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Baharoglu Z, 2010, MOL MICROBIOL, V77, P324, DOI 10.1111/j.1365-2958.2010.07208.x; Bermejo R, 2012, MOL CELL, V45, P710, DOI 10.1016/j.molcel.2012.03.001; Bhattacharyya B, 2014, P NATL ACAD SCI USA, V111, P1373, DOI 10.1073/pnas.1318001111; Boubakri H, 2010, EMBO J, V29, P145, DOI 10.1038/emboj.2009.308; Broccoli S, 2004, MOL MICROBIOL, V52, P1769, DOI 10.1111/j.1365-2958.2004.04092.x; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Cadman CJ, 2004, NUCLEIC ACIDS RES, V32, P6378, DOI 10.1093/nar/gkh980; Camps M, 2005, FRONT BIOSCI-LANDMRK, V10, P689, DOI 10.2741/1564; Carlini L, 1998, FEBS LETT, V430, P197, DOI 10.1016/S0014-5793(98)00655-3; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Costes A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001238; CROUCH R J, 1990, New Biologist, V2, P771; Curth U, 1996, NUCLEIC ACIDS RES, V24, P2706, DOI 10.1093/nar/24.14.2706; Dabora JM, 1996, BIOCHEMISTRY-US, V35, P11951, DOI 10.1021/bi9611671; DASGUPTA S, 1987, CELL, V51, P1113, DOI 10.1016/0092-8674(87)90597-6; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DROLET M, 1995, P NATL ACAD SCI USA, V92, P3526, DOI 10.1073/pnas.92.8.3526; Duch A, 2013, J MOL BIOL, V425, P4745, DOI 10.1016/j.jmb.2013.08.019; Dutta D, 2011, CELL, V146, P533, DOI 10.1016/j.cell.2011.07.034; El Hage A, 2010, GENE DEV, V24, P1546, DOI 10.1101/gad.573310; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Epshtein V, 2014, NATURE, V505, P372, DOI 10.1038/nature12928; Genschel J, 2000, BIOL CHEM, V381, P183, DOI 10.1515/BC.2000.025; George NP, 2012, J BIOL CHEM, V287, P22123, DOI 10.1074/jbc.M112.367573; Ginno PA, 2012, MOL CELL, V45, P814, DOI 10.1016/j.molcel.2012.01.017; Glover BP, 1998, J BIOL CHEM, V273, P23476, DOI 10.1074/jbc.273.36.23476; Hamperl S, 2014, DNA REPAIR, V19, P84, DOI 10.1016/j.dnarep.2014.03.023; Handa P, 2001, J BIOL CHEM, V276, P16992, DOI 10.1074/jbc.M100393200; HAUSEN P, 1970, EUR J BIOCHEM, V14, P278, DOI 10.1111/j.1432-1033.1970.tb00287.x; Helmrich A, 2013, NAT STRUCT MOL BIOL, V20, P412, DOI 10.1038/nsmb.2543; Helmrich A, 2011, MOL CELL, V44, P966, DOI 10.1016/j.molcel.2011.10.013; Herrera-Moyano E, 2014, GENE DEV, V28, P735, DOI 10.1101/gad.234070.113; Hiller B, 2012, J EXP MED, V209, P1419, DOI 10.1084/jem.20120876; Hingorani Manju M., 2005, P193; Hobbs MD, 2007, J BIOL CHEM, V282, P11058, DOI 10.1074/jbc.M611007200; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; ITAYA M, 1990, P NATL ACAD SCI USA, V87, P8587, DOI 10.1073/pnas.87.21.8587; ITOH T, 1980, P NATL ACAD SCI-BIOL, V77, P2450, DOI 10.1073/pnas.77.5.2450; KATAYANAGI K, 1990, NATURE, V347, P306, DOI 10.1038/347306a0; Keck JL, 1997, TECH PROT CHEM, V8, P409, DOI 10.1016/S1080-8914(97)80041-5; Kelman Z, 1998, EMBO J, V17, P2436, DOI 10.1093/emboj/17.8.2436; KITANI T, 1985, J MOL BIOL, V184, P45, DOI 10.1016/0022-2836(85)90042-7; Kogoma T, 1997, MICROBIOL MOL BIOL R, V61, P212, DOI 10.1128/.61.2.212-238.1997; KORNBERG A, 1992, DNA REPLICATION, P275; Lazzaro F, 2012, MOL CELL, V45, P99, DOI 10.1016/j.molcel.2011.12.019; Lecointe F, 2007, EMBO J, V26, P4239, DOI 10.1038/sj.emboj.7601848; Leela JK, 2013, P NATL ACAD SCI USA, V110, P258, DOI 10.1073/pnas.1213123110; Lin YL, 2012, CURR GENOMICS, V13, P65, DOI 10.2174/138920212799034767; Lu D, 2008, P NATL ACAD SCI USA, V105, P9169, DOI 10.1073/pnas.0800741105; Lu D, 2011, NUCLEIC ACIDS RES, V39, P6536, DOI 10.1093/nar/gkr315; Maduike NZ, 2014, MOL MICROBIOL, V91, P39, DOI 10.1111/mmi.12440; Marceau AH, 2011, EMBO J, V30, P4236, DOI 10.1038/emboj.2011.305; Marechal A, 2014, MOL CELL, V53, P235, DOI 10.1016/j.molcel.2013.11.002; Masai H, 1996, BIOCHIMIE, V78, P1109, DOI 10.1016/S0300-9084(97)86737-5; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGlynn P, 2012, MOL MICROBIOL, V85, P12, DOI 10.1111/j.1365-2958.2012.08102.x; Merrikh H, 2012, NAT REV MICROBIOL, V10, P449, DOI 10.1038/nrmicro2800; MEYER RR, 1990, MICROBIOL REV, V54, P342, DOI 10.1128/MMBR.54.4.342-380.1990; MOLINEUX IJ, 1974, P NATL ACAD SCI USA, V71, P3858, DOI 10.1073/pnas.71.10.3858; MOLINEUX IJ, 1975, J MOL BIOL, V98, P811, DOI 10.1016/S0022-2836(75)80012-X; Nudler E, 2012, CELL, V149, P1438, DOI 10.1016/j.cell.2012.06.003; OGAWA T, 1984, MOL GEN GENET, V193, P231, DOI 10.1007/BF00330673; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Poveda AM, 2010, TRANSCR-AUSTIN, V1, P99, DOI 10.4161/trns.1.2.12665; Proshkin S, 2010, SCIENCE, V328, P504, DOI 10.1126/science.1184939; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rizzo J, 2002, MOL CELL PROBE, V16, P277, DOI 10.1006/mcpr.2002.0423; Ryzhikov M, 2011, NUCLEIC ACIDS RES, V39, P6305, DOI 10.1093/nar/gkr199; SAMBROOK J, 2001, MOL CLONING LAB MANU, V2; Sandigursky M, 1996, RADIAT RES, V145, P619, DOI 10.2307/3579281; Schweimer K, 2002, BIOCHEMISTRY-US, V41, P5120, DOI 10.1021/bi015986j; Shereda RD, 2007, J BIOL CHEM, V282, P19247, DOI 10.1074/jbc.M608011200; Shereda RD, 2009, J MOL BIOL, V386, P612, DOI 10.1016/j.jmb.2008.12.065; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Soultanas P, 2011, TRANSCR-AUSTIN, V2, P140, DOI 10.4161/trns.2.3.15908; Sparks JL, 2012, MOL CELL, V47, P980, DOI 10.1016/j.molcel.2012.06.035; Suski C, 2008, MOL CELL, V30, P779, DOI 10.1016/j.molcel.2008.04.020; Tehranchi AK, 2010, CELL, V141, P595, DOI 10.1016/j.cell.2010.03.036; von Hippel PH, 1998, SCIENCE, V281, P660, DOI 10.1126/science.281.5377.660; Wahba L, 2011, MOL CELL, V44, P978, DOI 10.1016/j.molcel.2011.10.017; Wessel SR, 2013, J BIOL CHEM, V288, P17569, DOI 10.1074/jbc.M113.478156; Wimberly H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3115; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; YANG W, 1990, SCIENCE, V249, P1398, DOI 10.1126/science.2169648; Yu K, 2006, METHOD ENZYMOL, V409, P316, DOI 10.1016/S0076-6879(05)09018-X; Yuzhakov A, 1999, CELL, V96, P153, DOI 10.1016/S0092-8674(00)80968-X	88	45	45	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14626	14636		10.1074/jbc.M115.655134	http://dx.doi.org/10.1074/jbc.M115.655134			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25903123	hybrid, Green Published			2022-12-26	WOS:000355754600033
J	Meulenbroeks, C; van der Lugt, JJ; van der Meide, NMA; Willemse, T; Rutten, VPMG; Zaiss, DMW				Meulenbroeks, Chantal; van der Lugt, Jaco J.; van der Meide, Nathalie M. A.; Willemse, Ton; Rutten, Victor P. M. G.; Zaiss, Dietmar M. W.			Allergen-Specific Cytokine Polarization Protects Shetland Ponies against Culicoides obsoletus-Induced Insect Bite Hypersensitivity	PLOS ONE			English	Article							E-BEARING CELLS; MAST-CELLS; BRITISH-COLUMBIA; FRIESIAN HORSES; SKIN BIOPSIES; SWEET ITCH; IGE; ANTIBODIES; TOLERANCE; IMMUNOTHERAPY	The immunological mechanisms explaining development of an allergy in some individuals and not in others remain incompletely understood. Insect bite hypersensitivity (IBH) is a common, seasonal, IgE-mediated, pruritic skin disorder that affects considerable proportions of horses of different breeds, which is caused by bites of the insect Culicoides obsoletus (C. obsoletus). We investigated the allergen-specific immune status of individual horses that had either been diagnosed to be healthy or to suffer of IBH. Following intradermal allergen injection, skin biopsies were taken of IBH-affected and healthy ponies and cytokine expression was determined by RT-PCR. In addition, allergen-specific antibody titers were measured and cytokine expression of in vitro stimulated, allergen-specific CD4 T-cells was determined. 24 hrs after allergen injection, a significant increase in mRNA expression of the type-2 cytokine IL-4 was observed in the skin of IBH-affected Shetland ponies. In the skin of healthy ponies, however, an increase in IFN gamma mRNA expression was found. Analysis of allergen-specific antibody titers revealed that all animals produced allergen-specific antibodies, and allergen-specific stimulation of CD4 T-cells revealed a significant higher percentage of IFN gamma-expressing CD4 T-cells in healthy ponies compared to IBH-affected ponies. These data indicate that horses not affected by IBH, in contrast to the so far established dogma, are not immunologically ignorant but have a Th1-skewed allergen-specific immune response that appears to protect against IBH-associated symptoms. To our knowledge this is the first demonstration of a natural situation, in which an allergen-specific immune skewing is protective in an allergic disorder.	[Meulenbroeks, Chantal; Willemse, Ton; Rutten, Victor P. M. G.; Zaiss, Dietmar M. W.] Univ Utrecht, Dept Infect Dis & Immunol, Fac Vet Med, Utrecht, Netherlands; [van der Lugt, Jaco J.] IDEXX Labs, Hoofddorp, Netherlands; [van der Meide, Nathalie M. A.] Wageningen Univ, Dept Cell Biol & Immunol, NL-6700 AP Wageningen, Netherlands; [Willemse, Ton] Univ Utrecht, Dept Clin Sci Compan Anim, Fac Vet Med, Utrecht, Netherlands; [Rutten, Victor P. M. G.] Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, ZA-0110 Onderstepoort, South Africa; [Zaiss, Dietmar M. W.] Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh EH9 3JT, Midlothian, Scotland	Utrecht University; Wageningen University & Research; Utrecht University; University of Pretoria; University of Edinburgh	Zaiss, DMW (corresponding author), Univ Utrecht, Dept Infect Dis & Immunol, Fac Vet Med, Utrecht, Netherlands.	Dietmar.Zaiss@ed.ac.uk	Rutten, Victor PMG/AAB-6833-2022	Rutten, Victor PMG/0000-0002-6171-1805; Zaiss, Dietmar M.W./0000-0003-3596-7062	Dutch Technology Foundation (STW-NOW); Dutch Federation of horse breeding and ALK-Abello/Artu Biologicals	Dutch Technology Foundation (STW-NOW); Dutch Federation of horse breeding and ALK-Abello/Artu Biologicals	This work was financially supported by the Dutch Technology Foundation (STW-NOW), the Dutch Federation of horse breeding and ALK-Abello/Artu Biologicals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author Jaco J. van der Lugt is employed by IDEXX Laboratories. IDEXX Laboratories provided support in the form of salary for author JJvdL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the author contributions section.	ANDERSON GS, 1988, CAN VET J, V29, P718; ANDERSON GS, 1991, J MED ENTOMOL, V28, P685, DOI 10.1093/jmedent/28.5.685; Burton OT, 2014, IMMUNITY, V41, P141, DOI 10.1016/j.immuni.2014.05.017; Byrne SN, 2008, J IMMUNOL, V180, P4648, DOI 10.4049/jimmunol.180.7.4648; Campbell JD, 2014, THORAX, V69, P565, DOI 10.1136/thoraxjnl-2013-204605; Creticos PS, 2006, NEW ENGL J MED, V355, P1445, DOI 10.1056/NEJMoa052916; de Vries VC, 2009, AM J TRANSPLANT, V9, P2270, DOI 10.1111/j.1600-6143.2009.02755.x; Forward NA, 2009, J IMMUNOL, V183, P3014, DOI 10.4049/jimmunol.0802509; Geroldinger-Simic M, 2011, J ALLERGY CLIN IMMUN, V127, P616, DOI 10.1016/j.jaci.2010.10.027; Hamza E, 2012, VET IMMUNOL IMMUNOP, V148, P139, DOI 10.1016/j.vetimm.2011.05.033; Heimann M, 2011, VET IMMUNOL IMMUNOP, V140, P63, DOI 10.1016/j.vetimm.2010.11.016; Hellberg W, 2006, VET IMMUNOL IMMUNOP, V113, P99, DOI 10.1016/j.vetimm.2006.04.009; Kline JN, 2002, AM J PHYSIOL-LUNG C, V283, pL170, DOI 10.1152/ajplung.00402.2001; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; Matsuoka T, 2013, ALLERGOL INT, V62, P403, DOI 10.2332/allergolint.13-RAI-0650; Meulenbroeks C, 2013, VET IMMUNOL IMMUNOP, V151, P147, DOI 10.1016/j.vetimm.2012.11.007; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Romagnani S, 2004, J ALLERGY CLIN IMMUN, V113, P395, DOI 10.1016/j.jaci.2003.11.025; Rufenacht S, 2005, VET DERMATOL, V16, P94, DOI 10.1111/j.1365-3164.2005.00440.x; Savilahti EM, 2010, J ALLERGY CLIN IMMUN, V125, P1315, DOI 10.1016/j.jaci.2010.03.025; Schaffartzik A, 2012, VET IMMUNOL IMMUNOP, V147, P113, DOI 10.1016/j.vetimm.2012.03.017; Schurink A, 2013, VET J, V195, P382, DOI 10.1016/j.tvjl.2012.06.037; van der Haegen A, 2001, EQUINE VET J, V33, P699, DOI 10.2746/042516401776249444; van der Meide NMA, 2012, VET IMMUNOL IMMUNOP, V149, P245, DOI 10.1016/j.vetimm.2012.07.007; van der Rijt R, 2008, VET J, V178, P91, DOI 10.1016/j.tvjl.2007.07.005; Van Grevenhof EM, 2007, EQUINE VET J, V39, P69, DOI 10.2746/042516407X153020; Varga EM, 2013, J ALLERGY CLIN IMMUN, V131, P1419, DOI 10.1016/j.jaci.2012.08.037; Wagner B, 2006, DEV COMP IMMUNOL, V30, P155, DOI 10.1016/j.dci.2005.06.008; Wagner B, 2006, VET RES, V37, P813, DOI 10.1051/vetres:2006039; Wilson AD, 2001, EQUINE VET J, V33, P707, DOI 10.2746/042516401776249363; Zaiss DMW, 2013, IMMUNITY, V38, P275, DOI 10.1016/j.immuni.2012.09.023	32	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0122090	10.1371/journal.pone.0122090	http://dx.doi.org/10.1371/journal.pone.0122090			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901733	Green Published, gold, Green Submitted			2022-12-26	WOS:000353331500014
J	Gilad, R; Meir, K; Stein, I; German, L; Pikarsky, E; Mabjeesh, NJ				Gilad, Roni; Meir, Karen; Stein, Ilan; German, Larissa; Pikarsky, Eli; Mabjeesh, Nicola J.			High SEPT9_i1 Protein Expression Is Associated with High-Grade Prostate Cancers	PLOS ONE			English	Article							ACTIVE SURVEILLANCE; VIRAL VACCINE; HYPOXIA; TUMORIGENESIS; ANGIOGENESIS; THERAPY; ANTIGEN; BREAST; CELLS; HIF-1	Septins are a family of GTP-binding cytoskeleton proteins expressed in many solid tumors. Septin 9 (SEPT9) in particular was found overexpressed in diverse carcinomas. Herein, we studied the expression of SEPT9 isoform 1 protein (SEPT9_i1) in human prostate cancer specimens. We utilized immunohistochemical staining to study the expression of SEPT9_i1 protein. Staining level was analyzed in association with clinical characteristics and the pathological Gleason grade and score. Fifty human prostate cancer specimens (42 primary tumors and 8 metastatic lesions) were stained by SEPT9_i1 antibody and analyzed. SEPT9_i1 protein was expressed in prostate cancer cells but absent in normal epithelial cells. The intensity of staining was correlated proportionally to pretreatment prostate-specific antigen (PSA) blood levels and Gleason score (P < 0.05). SEPT9_i1 was highly expressed in all metastatic lesions. A significant assocation between SEPT9_i1 expression and high Gleason score on multivariate linear regression analysis was found. We conclude that SEPT9_i1 is expressed in high-grade prostate tumors suggesting it has a significant role in prostate tumorigenesis and that it could serve as a molecular marker for prostate tumor progression.	[Gilad, Roni; German, Larissa; Mabjeesh, Nicola J.] Tel Aviv Univ, Sackler Fac Med, Tel Aviv Sourasky Med Ctr, Dept Urol, IL-69978 Tel Aviv, Israel; [Meir, Karen; Stein, Ilan; Pikarsky, Eli] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Pathol, IL-91010 Jerusalem, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Hebrew University of Jerusalem	Mabjeesh, NJ (corresponding author), Tel Aviv Univ, Sackler Fac Med, Tel Aviv Sourasky Med Ctr, Dept Urol, IL-69978 Tel Aviv, Israel.	nicolam@tlvmc.gov.il	pikarsky, eli/GXV-7099-2022	German, Larissa/0000-0003-3456-3509; pikarsky, eli/0000-0003-4186-7105	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF)	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF)	This work was supported by the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir S, 2006, CANCER RES, V66, P856, DOI 10.1158/0008-5472.CAN-05-2738; Amir S, 2010, MOL CANCER RES, V8, P643, DOI 10.1158/1541-7786.MCR-09-0497; Arnir S, 2007, CANCER BIOL THER, V6, P1926, DOI 10.4161/cbt.6.12.4971; Chacko AD, 2005, J PATHOL, V206, P458, DOI 10.1002/path.1794; Chacko AD, 2012, CELL ONCOL, V35, P85, DOI 10.1007/s13402-011-0066-0; Connolly D, 2011, BIOL CHEM, V392, P725, DOI 10.1515/BC.2011.073; Culig Z, 2009, J UROLOGY, V182, P1255, DOI 10.1016/j.juro.2009.07.073; Epstein JI, 2010, J UROLOGY, V183, P433, DOI 10.1016/j.juro.2009.10.046; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gonzalez ME, 2007, CANCER RES, V67, P8554, DOI 10.1158/0008-5472.CAN-07-1474; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; Kinoshita M, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-236; Lechleider RJ, 2008, CLIN CANCER RES, V14, P5284, DOI 10.1158/1078-0432.CCR-07-5162; Lindstrom S, 2012, CANCER EPIDEM BIOMAR, V21, P437, DOI 10.1158/1055-9965.EPI-11-1038; Mabjeesh NJ, 2007, HISTOL HISTOPATHOL, V22, P559, DOI 10.14670/HH-22.559; Mostowy S, 2014, BIOL CHEM, V395, P119, DOI 10.1515/hsz-2013-0291; Mullins JK, 2013, BJU INT, V111, P1037, DOI 10.1111/j.1464-410X.2012.11641.x; Nesslinger NJ, 2010, CLIN CANCER RES, V16, P4046, DOI 10.1158/1078-0432.CCR-10-0948; Oh Y, 2011, TRENDS CELL BIOL, V21, P141, DOI 10.1016/j.tcb.2010.11.006; Quintero M, 2004, EJSO-EUR J SURG ONC, V30, P465, DOI 10.1016/j.ejso.2004.03.008; Sandrock K, 2011, BIOL CHEM, V392, P751, DOI 10.1515/BC.2011.081; Santos J, 2010, LEUKEMIA RES, V34, P615, DOI 10.1016/j.leukres.2009.08.018; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Stanbery L, 2010, TRANSL ONCOL, V3, P239, DOI 10.1593/tlo.10109; van den Bergh RCN, 2014, EUR UROL, V65, P1023, DOI 10.1016/j.eururo.2014.01.027; Welty CJ, 2014, EUR UROL, V65, P1032, DOI 10.1016/j.eururo.2014.02.044; Yutkin V, 2007, J UROLOGY, V178, P2660, DOI 10.1016/j.juro.2007.07.118	28	15	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124251	10.1371/journal.pone.0124251	http://dx.doi.org/10.1371/journal.pone.0124251			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898316	gold, Green Published, Green Submitted			2022-12-26	WOS:000353212600057
J	Nagasawa, K; Meguro, M; Sato, K; Tanizaki, Y; Nogawa-Kosaka, N; Kato, T				Nagasawa, Kazumichi; Meguro, Mizue; Sato, Kei; Tanizaki, Yuta; Nogawa-Kosaka, Nami; Kato, Takashi			The Influence of Artificially Introduced N-Glycosylation Sites on the In Vitro Activity of Xenopus laevis Erythropoietin	PLOS ONE			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; BIOLOGICAL-ACTIVITY; VIVO POTENCY; EXPRESSION; CLONING; CDNA; SEQUENCE; GENE; IDENTIFICATION; CARBOHYDRATE	Erythropoietin (EPO), the primary regulator of erythropoiesis, is a heavily glycosylated protein found in humans and several other mammals. Intriguingly, we have previously found that EPO in Xenopus laevis (xlEPO) has no N-glycosylation sites, and cross-reacts with the human EPO (huEPO) receptor despite low homology with huEPO. In this study, we introduced N-glycosylation sites into wild-type xlEPO at the positions homologous to those in huEPO, and tested whether the glycosylated mutein retained its biological activity. Seven xlEPO muteins, containing 1-3 additional N-linked carbohydrates at positions 24, 38, and/or 83, were expressed in COS-1 cells. The muteins exhibited lower secretion efficiency, higher hydrophilicity, and stronger acidic properties than the wild type. All muteins stimulated the proliferation of both cell lines, xlEPO receptor-expressing xlEPOR-FDC/P2 cells and huEPO receptor-expressing UT-7/EPO cells, in a dose-dependent manner. Thus, the muteins retained their in vitro biological activities. The maximum effect on xlEPOR-FDC/P2 proliferation was decreased by the addition of N-linked carbohydrates, but that on UT-7/EPO proliferation was not changed, indicating that the muteins act as partial agonists to the xlEPO receptor, and near-full agonists to the huEPO receptor. Hence, the EPO-EPOR binding site in X. laevis locates the distal region of artificially introduced three N-glycosylation sites, demonstrating that the vital conformation to exert biological activity is conserved between humans and X. laevis, despite the low similarity in primary structures of EPO and EPOR.	[Nagasawa, Kazumichi; Meguro, Mizue; Sato, Kei; Tanizaki, Yuta; Nogawa-Kosaka, Nami; Kato, Takashi] Waseda Univ, Integrat Bioscience & Biomed Engn, Grad Sch Adv Sci & Engn, Ctr Adv Biomed Sci,Shinjuku Ku, Tokyo 1628480, Japan; [Tanizaki, Yuta; Kato, Takashi] Waseda Univ, Dept Biol, Sch Educ, Ctr Adv Biomed Sci,Shinjuku Ku, Tokyo 1628480, Japan	Waseda University; Waseda University	Kato, T (corresponding author), Waseda Univ, Integrat Bioscience & Biomed Engn, Grad Sch Adv Sci & Engn, Ctr Adv Biomed Sci,Shinjuku Ku, TWIns Bldg 2-2 Wakamatsu Cho, Tokyo 1628480, Japan.	tkato@waseda.jp	Kato, Takashi/AFO-2557-2022	Kato, Takashi/0000-0003-0384-7971; Sato, Kei/0000-0001-6923-5594	Japan Society for the Promotion of Science [20570063, 26440171]; Waseda University [2007B-061, 2011B-047, 2012B-045, 2013B-056]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [07H016]; MEXT	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Waseda University; Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Scientific Research (KAKENHI) from Japan Society for the Promotion of Science (No. 20570063 and 26440171), Grants for Special Research Project from Waseda University (No. 2007B-061, 2011B-047, 2012B-045 and 2013B-056) and by "High-Tech Research Center" Project for Private Universities: matching fund subsidy from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (No. 07H016). A part of this study was performed as MEXT-Supported Program for the Strategic Research Foundation at Private Universities.	Aizawa Y, 2005, J BIOCHEM, V138, P167, DOI 10.1093/jb/mvi113; Barrio Rendo Maria E., 1997, Acta Physiologica Pharmacologica et Therapeutica Latinoamericana, V47, P225; Bunn HF, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011619; Chou CF, 2004, BLOOD, V104, P1498, DOI 10.1182/blood-2003-10-3404; Chu CY, 2007, FEBS LETT, V581, P4265, DOI 10.1016/j.febslet.2007.07.073; Cowgill LD, 1998, J AM VET MED ASSOC, V212, P521; Darling RJ, 2002, BIOCHEMISTRY-US, V41, P14524, DOI 10.1021/bi0265022; David RB, 2001, DOMEST ANIM ENDOCRIN, V20, P137, DOI 10.1016/S0739-7240(01)00089-3; DELORME E, 1992, BIOCHEMISTRY-US, V31, P9871, DOI 10.1021/bi00156a003; Egrie JC, 2003, EXP HEMATOL, V31, P290, DOI 10.1016/S0301-472X(03)00006-7; Elliott S, 1997, BLOOD, V89, P493, DOI 10.1182/blood.V89.2.493; Elliott S, 2004, J BIOL CHEM, V279, P16854, DOI 10.1074/jbc.M311095200; Elliott S, 2003, NAT BIOTECHNOL, V21, P414, DOI 10.1038/nbt799; Elliott S, 2004, EXP HEMATOL, V32, P1146, DOI 10.1016/j.exphem.2004.08.004; FU P, 1993, MOL CELL ENDOCRINOL, V93, P107, DOI 10.1016/0303-7207(93)90113-X; FUKUDA MN, 1989, BLOOD, V73, P84; Gimenez E, 2007, ANAL BIOANAL CHEM, V388, P1531, DOI 10.1007/s00216-007-1334-8; GRODBERG J, 1993, EUR J BIOCHEM, V218, P597, DOI 10.1111/j.1432-1033.1993.tb18413.x; IMAI N, 1990, EUR J BIOCHEM, V194, P457, DOI 10.1111/j.1432-1033.1990.tb15639.x; JACOBS K, 1985, NATURE, V313, P806, DOI 10.1038/313806a0; Jelkmann W, 2013, TRANSFUS MED HEMOTH, V40, P302, DOI 10.1159/000356193; Katakura F, 2013, DEV COMP IMMUNOL, V40, P148, DOI 10.1016/j.dci.2013.02.007; KOMATSU N, 1993, BLOOD, V82, P456; Lasne F, 2000, NATURE, V405, P635, DOI 10.1038/35015164; LIN FK, 1985, P NATL ACAD SCI USA, V82, P7580, DOI 10.1073/pnas.82.22.7580; MacLeod JN, 1998, AM J VET RES, V59, P1144; Matthews DJ, 1996, P NATL ACAD SCI USA, V93, P9471, DOI 10.1073/pnas.93.18.9471; MCDONALD JD, 1986, MOL CELL BIOL, V6, P842, DOI 10.1128/MCB.6.3.842; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Nogawa-Kosaka N, 2011, J EXP BIOL, V214, P921, DOI 10.1242/jeb.050286; Nogawa-Kosaka N, 2010, EXP HEMATOL, V38, P363, DOI 10.1016/j.exphem.2010.02.009; Paffett-Lugassy N, 2007, BLOOD, V110, P2718, DOI 10.1182/blood-2006-04-016535; Pisal DS, 2010, J PHARM SCI-US, V99, P2557, DOI 10.1002/jps.22054; Randolph JF, 2004, AM J VET RES, V65, P1355, DOI 10.2460/ajvr.2004.65.1355; Sato F, 2004, AM J VET RES, V65, P15, DOI 10.2460/ajvr.2004.65.15; Sebaugh JL, 2011, PHARM STAT, V10, P128, DOI 10.1002/pst.426; Seyfang A, 2004, ANAL BIOCHEM, V324, P285, DOI 10.1016/j.ab.2003.10.012; SPIVAK JL, 1989, BLOOD, V73, P90; Suliman HB, 1996, GENE, V171, P275, DOI 10.1016/0378-1119(95)00895-0; Syed RS, 1998, NATURE, V395, P511, DOI 10.1038/26773; TSUDA E, 1990, EUR J BIOCHEM, V188, P405, DOI 10.1111/j.1432-1033.1990.tb15417.x; Vilalta A, 2001, BIOCHEM BIOPH RES CO, V284, P823, DOI 10.1006/bbrc.2001.5028; Wang YJ, 2010, J CONTROL RELEASE, V145, P306, DOI 10.1016/j.jconrel.2010.04.021; Wang ZL, 2012, CHINESE SCI BULL, V57, P997, DOI 10.1007/s11434-011-4911-3; WASLEY LC, 1991, BLOOD, V77, P2624; WEN D, 1993, BLOOD, V82, P1507; WEN DY, 1994, J BIOL CHEM, V269, P22839; Wilson S, 2011, J AM ASSOC LAB ANIM, V50, P635; YAMAGUCHI K, 1991, J BIOL CHEM, V266, P20434	49	3	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124676	10.1371/journal.pone.0124676	http://dx.doi.org/10.1371/journal.pone.0124676			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898205	Green Published, gold, Green Submitted			2022-12-26	WOS:000353212600079
J	Pak, HK; Gil, M; Lee, Y; Lee, H; Lee, AN; Roh, J; Park, CS				Pak, Hyo-Kyung; Gil, Minchan; Lee, Yoonkyung; Lee, Hyunji; Lee, A-Neum; Roh, Jin; Park, Chan-Sik			Regulator of G Protein Signaling 1 Suppresses CXCL12-Mediated Migration and AKT Activation in RPMI 8226 Human Plasmacytoma Cells and Plasmablasts	PLOS ONE			English	Article							EXPRESSION; RESPONSES; CXCR4; RESPONSIVENESS; PROLIFERATION; CHEMOKINES; SURVIVAL; LINE; RGS1	Migration of plasma cells to the bone marrow is critical factor to humoral immunity and controlled by chemokines. Regulator of G protein signaling 1 (RGS1) is a GTPase-activating protein that controls various crucial functions such as migration. Here, we show that RGS1 controls the chemotactic migration of RPMI 8226 human plasmacytoma cells and human plasmablasts. LPS strongly increased RGS1 expression and retarded the migration of RPMI 8226 cells by suppressing CXCL12-mediated AKT activation. RGS1 knockdown by siRNA abolished the retardation of migration and AKT suppression by LPS. RGS1-dependent regulation of migration via AKT is also observed in cultured plasmablasts. We propose novel functions of RGS1 that suppress AKT activation and the migration of RPMI 8226 cells and plasmablasts in CXCL12-mediated chemotaxis.	[Pak, Hyo-Kyung; Gil, Minchan; Lee, Yoonkyung; Lee, Hyunji; Lee, A-Neum; Park, Chan-Sik] Univ Ulsan, Coll Med, Cell Dysfunct Res Ctr, Seoul, South Korea; [Park, Chan-Sik] Univ Ulsan, Coll Med, Asan Med Ctr, Inst Life Sci, Seoul, South Korea; [Pak, Hyo-Kyung; Roh, Jin; Park, Chan-Sik] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea	University of Ulsan; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Park, CS (corresponding author), Univ Ulsan, Coll Med, Cell Dysfunct Res Ctr, Seoul, South Korea.	csikpark@amc.seoul.kr	Pak, Hyo-Kyung/A-1136-2014; Gil, Minchan/R-1280-2019	Pak, Hyo-Kyung/0000-0001-5897-4703	National Research Foundation of Korea [2008-0062286]; Asan Institute for Life Sciences [2011-0794]	National Research Foundation of Korea(National Research Foundation of Korea); Asan Institute for Life Sciences	This work was supported by the National Research Foundation of Korea, Grant No 2008-0062286, to C-SP (http://www.nrf.re.kr/) and the Asan Institute for Life Sciences, grant no. 2011-0794 to C-SP (http://en.ails.amc.seoul.kr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsayed Y, 2007, BLOOD, V109, P2708, DOI 10.1182/blood-2006-07-035857; Anger T, 2007, J BIOCHEM MOL BIOL, V40, P899; Azab AK, 2009, BLOOD, V113, P4341, DOI 10.1182/blood-2008-10-186668; Bansal G, 2008, J IMMUNOL, V181, P7882, DOI 10.4049/jimmunol.181.11.7882; Berthebaud M, 2005, BLOOD, V106, P2962, DOI 10.1182/blood-2005-02-0526; Fernandes JR, 2010, INT IMMUNOL, V22, P527, DOI 10.1093/intimm/dxq037; Fooksman DR, 2010, IMMUNITY, V33, P118, DOI 10.1016/j.immuni.2010.06.015; Gil M, 2010, IMMUNOLOGY, V130, P536, DOI 10.1111/j.1365-2567.2010.03252.x; Han JI, 2006, J LEUKOCYTE BIOL, V79, P1357, DOI 10.1189/jlb.1105693; Han SB, 2005, IMMUNITY, V22, P343, DOI 10.1016/j.immuni.2005.01.017; Hauser AE, 2002, J IMMUNOL, V169, P1277, DOI 10.4049/jimmunol.169.3.1277; Hideshima T, 2002, MOL CANCER THER, V1, P539; Kehrl JH, 1998, IMMUNITY, V8, P1, DOI 10.1016/S1074-7613(00)80453-7; KIM HS, 1995, J IMMUNOL, V155, P1101; Leleu X, 2007, BLOOD, V110, P4417, DOI 10.1182/blood-2007-05-092098; Lione AM, 2000, J NEUROCHEM, V75, P934, DOI 10.1046/j.1471-4159.2000.0750934.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mariani M, 2014, BLOOD TRANSFUS-ITALY, V12, P416, DOI 10.2450/2014.0198-13; Mellado M, 2001, ANNU REV IMMUNOL, V19, P397, DOI 10.1146/annurev.immunol.19.1.397; Moratz C, 2004, MOL CELL BIOL, V24, P5767, DOI 10.1128/MCB.24.13.5767-5775.2004; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; Muehlinghaus G, 2005, BLOOD, V105, P3965, DOI 10.1182/blood-2004-08-2992; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; Ryu CH, 2010, BIOCHEM BIOPH RES CO, V398, P105, DOI 10.1016/j.bbrc.2010.06.043; Shi CS, 2001, J BIOL CHEM, V276, P24293, DOI 10.1074/jbc.M100089200; Shi GX, 2004, J IMMUNOL, V172, P5175, DOI 10.4049/jimmunol.172.9.5175; Tangye SG, 2011, TRENDS IMMUNOL, V32, P595, DOI 10.1016/j.it.2011.09.001; Wieland T, 2003, PHARMACOL THERAPEUT, V97, P95, DOI 10.1016/S0163-7258(02)00326-1; Willimott S, 2007, BRIT J HAEMATOL, V138, P721, DOI 10.1111/j.1365-2141.2007.06717.x; Xue GD, 2013, JNCI-J NATL CANCER I, V105, P393, DOI 10.1093/jnci/djs648; Yoon SO, 2009, J LEUKOCYTE BIOL, V86, P1311, DOI 10.1189/jlb.0409268; Zamponi GW, 2001, CELL BIOCHEM BIOPHYS, V34, P79, DOI 10.1385/CBB:34:1:79	32	12	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124793	10.1371/journal.pone.0124793	http://dx.doi.org/10.1371/journal.pone.0124793			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897806	Green Submitted, Green Published, gold			2022-12-26	WOS:000353212600086
J	Euba, B; Moleres, J; Viadas, C; Mozos, IRD; Valle, J; Bengoechea, JA; Garmendia, J				Euba, Begona; Moleres, Javier; Viadas, Cristina; de Los Mozos, Igor Ruiz; Valle, Jaione; Antonio Bengoechea, Jose; Garmendia, Junkal			Relative Contribution of P5 and Hap Surface Proteins to Nontypable Haemophilus influenzae Interplay with the Host Upper and Lower Airways	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; RESPIRATORY EPITHELIAL-CELLS; MICROCOLONY FORMATION; SIALIC-ACID; CARCINOEMBRYONIC ANTIGENS; ICAM-1 EXPRESSION; SERINE-PROTEASE; N-GLYCOSYLATION; OTITIS-MEDIA; AUTOTRANSPORTER	Nontypable Haemophilus influenzae (NTHi) is a major cause of opportunistic respiratory tract disease, and initiates infection by colonizing the nasopharynx. Bacterial surface proteins play determining roles in the NTHi-airways interplay, but their specific and relative contribution to colonization and infection of the respiratory tract has not been addressed comprehensively. In this study, we focused on the ompP5 and hap genes, present in all H. influenzae genome sequenced isolates, and encoding the P5 and Hap surface proteins, respectively. We employed isogenic single and double mutants of the ompP5 and hap genes generated in the pathogenic strain NTHi375 to evaluate P5 and Hap contribution to biofilm growth under continuous flow, to NTHi adhesion, and invasion/phagocytosis on nasal, pharyngeal, bronchial, alveolar cultured epithelial cells and alveolar macrophages, and to NTHi murine pulmonary infection. We show that P5 is not required for bacterial biofilm growth, but it is involved in NTHi interplay with respiratory cells and in mouse lung infection. Mechanistically, P5(NTHi375) is not a ligand for CEACAM1 or alpha 5 integrin receptors. Hap involvement in NTHi375-host interaction was shown to be limited, despite promoting bacterial cell adhesion when expressed in H. influenzae RdKW20. We also show that Hap does not contribute to bacterial biofilm growth, and that its absence partially restores the deficiency in lung infection observed for the Delta ompP5 mutant. Altogether, this work frames the relative importance of the P5 and Hap surface proteins in NTHi virulence.	[Euba, Begona; Moleres, Javier; Viadas, Cristina; Antonio Bengoechea, Jose; Garmendia, Junkal] Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid, Spain; [Euba, Begona; Moleres, Javier; Viadas, Cristina; de Los Mozos, Igor Ruiz; Valle, Jaione; Garmendia, Junkal] Univ Publ Navarra Gobierno Navarra, CSIC, Inst Agrobiotecnol, Mutilva, Spain; [Viadas, Cristina; Antonio Bengoechea, Jose; Garmendia, Junkal] Govern Illes Balears, CSIC, FISIB, Lab Microbial Pathogenesis, Bunyola, Spain; [Antonio Bengoechea, Jose] Queens Univ Belfast, Ctr Infect & Immun, Belfast, Antrim, North Ireland	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-GN-UPNA - Instituto de Agrobiotecnologia (IDAB); Universidad Publica de Navarra; Consejo Superior de Investigaciones Cientificas (CSIC); Queens University Belfast	Garmendia, J (corresponding author), Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid, Spain.	juncal.garmendia@unavarra.es	jaione, valle/N-8005-2019; Moleres, Javier/AAR-4222-2020; Ruiz de los Mozos, Igor/C-3313-2013; Garmendia, Juncal/G-4360-2011; jaione, valle/G-6213-2011; de los Mozos, Igor Ruiz/Q-6269-2019	jaione, valle/0000-0003-3115-0207; Ruiz de los Mozos, Igor/0000-0003-4097-6422; Garmendia, Juncal/0000-0002-7440-2737; jaione, valle/0000-0003-3115-0207; de los Mozos, Igor Ruiz/0000-0003-4097-6422; Bengoechea, Jose/0000-0002-9677-8751; Moleres Apilluelo, Javier/0000-0002-2749-6988	ISCIII [PS09/00130]; Ministerio Economia y Competitividad-MINECO [SAF2012-31166]; Dpto. Salud Gobierno Navarra [359/2012]; CIBERES	ISCIII(Instituto de Salud Carlos III); Ministerio Economia y Competitividad-MINECO; Dpto. Salud Gobierno Navarra; CIBERES	This study was supported by ISCIII PS09/00130, Ministerio Economia y Competitividad-MINECO SAF2012-31166, Dpto. Salud Gobierno Navarra 359/2012, CIBERES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2011, J CLIN MICROBIOL, V49, P3728, DOI 10.1128/JCM.05476-11; Allen S, 2005, INFECT IMMUN, V73, P5291, DOI 10.1128/IAI.73.9.5291-5300.2005; Avadhanula V, 2006, INFECT IMMUN, V74, P830, DOI 10.1128/IAI.74.2.830-838.2006; Bookwalter JE, 2008, INFECT IMMUN, V76, P48, DOI 10.1128/IAI.00980-07; Bouchet V, 2003, P NATL ACAD SCI USA, V100, P8898, DOI 10.1073/pnas.1432026100; De Chiara M, 2014, P NATL ACAD SCI USA, V111, P5439, DOI 10.1073/pnas.1403353111; Duim B, 1997, INFECT IMMUN, V65, P1351, DOI 10.1128/IAI.65.4.1351-1356.1997; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Faustoferri RC, 1998, PLASMID, V40, P247, DOI 10.1006/plas.1998.1371; Fink DL, 2003, J BACTERIOL, V185, P1608, DOI 10.1128/JB.185.5.1608-1615.2003; Fink DL, 2001, J BIOL CHEM, V276, P39492, DOI 10.1074/jbc.M106913200; Fink DL, 2003, CELL MICROBIOL, V5, P175, DOI 10.1046/j.1462-5822.2003.00266.x; Fink DL, 2002, INFECT IMMUN, V70, P4902, DOI 10.1128/IAI.70.9.4902-4907.2002; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Frick AG, 2000, J IMMUNOL, V164, P4185, DOI 10.4049/jimmunol.164.8.4185; Garmendia J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097020; Garmendia J, 2012, INT MICROBIOL, V15, P158, DOI 10.2436/20.1501.01.169; GAUTHIER F, 1982, BIOCHIM BIOPHYS ACTA, V700, P178, DOI 10.1016/0167-4838(82)90095-4; GrayOwen SD, 1997, EMBO J, V16, P3435, DOI 10.1093/emboj/16.12.3435; Hendrixson DR, 1998, MOL CELL, V2, P841, DOI 10.1016/S1097-2765(00)80298-1; HERRIOTT RM, 1970, J BACTERIOL, V101, P513, DOI 10.1128/JB.101.2.513-516.1970; Hill DJ, 2001, MOL MICROBIOL, V39, P850, DOI 10.1046/j.1365-2958.2001.02233.x; Hood DW, 1999, MOL MICROBIOL, V33, P679, DOI 10.1046/j.1365-2958.1999.01509.x; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Jiang ZL, 1999, INFECT IMMUN, V67, P187, DOI 10.1128/IAI.67.1.187-192.1999; Kilian M, 2002, MOL MICROBIOL, V46, P1367, DOI 10.1046/j.1365-2958.2002.03254.x; Lopez-Gomez A, 2012, MICROBIOL-SGM, V158, P2384, DOI 10.1099/mic.0.059972-0; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Marti-Lliteras P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021133; Marti-Lliteras P, 2009, INFECT IMMUN, V77, P4232, DOI 10.1128/IAI.00305-09; Mell JC, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01245-14; Miyamoto N, 1996, MICROB PATHOGENESIS, V21, P343, DOI 10.1006/mpat.1996.0067; Morey P, 2013, INFECT IMMUN, V81, P4100, DOI 10.1128/IAI.00492-13; Morey P, 2011, MICROBIOL-SGM, V157, P234, DOI 10.1099/mic.0.040451-0; Mullins MA, 2009, J BACTERIOL, V191, P5988, DOI 10.1128/JB.00469-09; Murphy TF, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-7; Novotny LA, 2008, INFECT IMMUN, V76, P967, DOI 10.1128/IAI.01395-07; Otto VI, 2006, GLYCOBIOLOGY, V16, P1033, DOI 10.1093/glycob/cwl032; Reddy MS, 1996, INFECT IMMUN, V64, P1477, DOI 10.1128/IAI.64.4.1477-1479.1996; Rosadini CV, 2014, INFECT IMMUN, V82, P640, DOI 10.1128/IAI.01224-13; Rougeaux C, 2008, CELL MICROBIOL, V10, P632, DOI 10.1111/j.1462-5822.2007.01072.x; SIRAKOVA T, 1994, INFECT IMMUN, V62, P2002, DOI 10.1128/IAI.62.5.2002-2020.1994; Spahich NA, 2014, MICROBIOLOGY; Spahich NA, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00005; Spahich NA, 2012, J BACTERIOL, V194, P1815, DOI 10.1128/JB.06316-11; STGEME JW, 1994, MOL MICROBIOL, V14, P217, DOI 10.1111/j.1365-2958.1994.tb01283.x; STGEME JW, 1994, INFECT IMMUN, V62, P3881, DOI 10.1128/IAI.62.9.3881-3889.1994; Virji M, 2000, MOL MICROBIOL, V36, P784, DOI 10.1046/j.1365-2958.2000.01885.x; Webb DC, 1998, J MED MICROBIOL, V47, P1059, DOI 10.1099/00222615-47-12-1059; Webster P, 2006, J HISTOCHEM CYTOCHEM, V54, P829, DOI 10.1369/jhc.6A6922.2006; Wong SM, 2013, P NATL ACAD SCI USA, V110, P15413, DOI 10.1073/pnas.1311217110; ZHENG MZ, 1994, J BIOL CHEM, V269, P12325	52	17	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123154	10.1371/journal.pone.0123154	http://dx.doi.org/10.1371/journal.pone.0123154			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894755	Green Published, Green Submitted, gold			2022-12-26	WOS:000353211700024
J	Heinzmann, D; Bangert, A; Muller, AM; von Ungern-Sternberg, SNI; Emschermann, F; Schonberger, T; Chatterjee, M; Mack, AF; Klingel, K; Kandolf, R; Malesevic, M; Borst, O; Gawaz, M; Langer, HF; Katus, H; Fischer, G; May, AE; Kaya, Z; Seizer, P				Heinzmann, David; Bangert, Anna; Mueller, Anna-Maria; von Ungern-Sternberg, Saskia N. I.; Emschermann, Frederic; Schoenberger, Tanja; Chatterjee, Madhumita; Mack, Andreas F.; Klingel, Karin; Kandolf, Reinhard; Malesevic, Miroslav; Borst, Oliver; Gawaz, Meinrad; Langer, Harald F.; Katus, Hugo; Fischer, Gunter; May, Andreas E.; Kaya, Ziya; Seizer, Peter			The Novel Extracellular Cyclophilin A (CyPA) - Inhibitor MM284 Reduces Myocardial Inflammation and Remodeling in a Mouse Model of Troponin I - Induced Myocarditis	PLOS ONE			English	Article							OXIDATIVE STRESS; CYCLOSPORINE-A; HEART-FAILURE; EMMPRIN CD147; FIBROSIS; VIRUS; VITRO	Cyclophilins are a group of highly conserved cytosolic enzymes that have a peptidylprolyl cis/trans isomerase activity. Cyclophilin A (CyPA) can be secreted in the extracellular space by inflammatory cells and upon cell death. The presence of CyPA in patients with nonischemic cardiomyopathy is associated with poor clinical prognosis. Here, we investigated the inhibition of extracellular CyPA in a mouse model of troponin I-induced autoimmune myocarditis using the strictly extracellular CyPA-inhibitor MM284. Since A/J mice develop severe inflammation and fibrosis after immunization with murine cardiac troponin I (mcTn I), we used this model to analyze the effects of an extracellular CyPA inhibition. As extracellular CyPA-inhibitor we used the recently described CsA-derivate MM284. In vitro studies confirmed that MM284 inhibits CyPA-induced monocytic migration and adhesion. A/J mice immunized with mcTnI were treated with MM284 or vehicle every second day. After 28 days, we found a considerable reduction of myocardial injury and fibrosis. Further analysis revealed a reduced myocardial presence of T-cells and macrophages compared to control treated animals. Whereas MMP-9 expression was reduced significantly by MM284, we observed no significant reduction of inflammatory cytokines such as IL-6 or TNF alpha. Extracellular CyPA plays an important role in autoimmune myocarditis for myocardial damage and fibrosis. Our data suggest a new pharmacological approach for the treatment of myocardial inflammation and reduction of cardiac fibrosis by inhibition of extracellular CyPA.	[Heinzmann, David; von Ungern-Sternberg, Saskia N. I.; Emschermann, Frederic; Schoenberger, Tanja; Chatterjee, Madhumita; Borst, Oliver; Gawaz, Meinrad; Langer, Harald F.; May, Andreas E.; Seizer, Peter] Univ Tubingen, Kardiol & Kreislauferkrankungen, Med Klin 3, Tubingen, Germany; [Bangert, Anna; Mueller, Anna-Maria; Katus, Hugo; Kaya, Ziya] Heidelberg Univ, Dept Internal Med 3, Heidelberg, Germany; [Mack, Andreas F.] Univ Tubingen, Inst Anat, Tubingen, Germany; [Klingel, Karin; Kandolf, Reinhard] Univ Tubingen, Inst Pathol & Neuropathol, Dept Mol Pathol, Tubingen, Germany; [Malesevic, Miroslav] Univ Halle Wittenberg, Inst Biochem, Abt Enzymol, Projektgrp gFP5, D-06108 Halle, Saale, Germany; [Fischer, Gunter] Max Planck Inst Biophys Chem, BO Halle, D-37077 Gottingen, Germany	Eberhard Karls University of Tubingen; Ruprecht Karls University Heidelberg; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Martin Luther University Halle Wittenberg; Max Planck Society	Seizer, P (corresponding author), Univ Tubingen, Kardiol & Kreislauferkrankungen, Med Klin 3, Tubingen, Germany.	peter.seizer@med.uni-tuebingen.de	Malesevic, Miroslav/D-8128-2012; Chatterjee, Madhumita/AAJ-1802-2020	Malesevic, Miroslav/0000-0002-1484-3709; Chatterjee, Madhumita/0000-0002-3428-4107; Mack, Andreas/0000-0001-7591-4374; Borst, Oliver/0000-0003-4002-4085; Emschermann, Frederic/0000-0002-9564-2000	Deutsche Forschungsgemeinschaft [Transregio SFB19]; Klinische Forschergruppe [KFO274]; German Cardiac Society (DGK) [KA 1797/6-1]; Volkswagen Foundation (Lichtenberg program)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Klinische Forschergruppe; German Cardiac Society (DGK); Volkswagen Foundation (Lichtenberg program)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (Transregio SFB19, the Klinische Forschergruppe [KFO274] to HFL, MG, AEM, and PS. This work was furthermore supported by a research grant of the German Cardiac Society (DGK) to DH, [KA 1797/6-1] to ZK, and the Tuebingen Platelet Investigative Consortium (TuePIC). This work was furthermore supported by the Volkswagen Foundation (Lichtenberg program)	Balsley MA, 2010, J IMMUNOL, V185, P7663, DOI 10.4049/jimmunol.1001707; Calderon-Sanchez E, 2011, CURR MED CHEM, V18, P5408, DOI 10.2174/092986711798194379; Cooper LT, 2009, NEW ENGL J MED, V360, P1526, DOI 10.1056/NEJMra0800028; Elrod JW, 2010, J CLIN INVEST, V120, P3680, DOI 10.1172/JCI43171; Goser S, 2006, CIRCULATION, V114, P1693, DOI 10.1161/CIRCULATIONAHA.106.635664; Jin ZG, 2000, CIRC RES, V87, P789, DOI 10.1161/01.RES.87.9.789; Kaya Z, 2010, CLIN IMMUNOL, V134, P80, DOI 10.1016/j.clim.2009.04.008; Kindermann I, 2012, J AM COLL CARDIOL, V59, P779, DOI 10.1016/j.jacc.2011.09.074; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Ma S, 2006, ANTIMICROB AGENTS CH, V50, P2976, DOI 10.1128/AAC.00310-06; Malesevic M, 2013, J MED CHEM, V56, P7302, DOI 10.1021/jm4007577; Malesevic M, 2010, ANGEW CHEM INT EDIT, V49, P213, DOI 10.1002/anie.200904529; Nigro P, 2011, J EXP MED, V208, P53, DOI 10.1084/jem.20101174; Satoh K, 2009, NAT MED, V15, P649, DOI 10.1038/nm.1958; Seizer P, 2015, ARTERIOSCL THROM VAS, V35, P655, DOI 10.1161/ATVBAHA.114.305112; Seizer P, 2014, CARDIOVASC RES, V102, P17, DOI 10.1093/cvr/cvu035; Seizer P, 2013, INT J CARDIOL, V163, P299, DOI 10.1016/j.ijcard.2011.06.049; Seizer P, 2012, J MOL CELL CARDIOL, V53, P6, DOI 10.1016/j.yjmcc.2012.03.004; Seizer P, 2011, ARTERIOSCL THROM VAS, V31, P1377, DOI 10.1161/ATVBAHA.111.225771; SHERRY B, 1992, P NATL ACAD SCI USA, V89, P3511, DOI 10.1073/pnas.89.8.3511; Van Linthout S, 2014, CARDIOVASC RES, V102, P258, DOI 10.1093/cvr/cvu062; Wang H, 2011, J GASTROEN HEPATOL, V26, P558, DOI 10.1111/j.1440-1746.2010.06406.x; Zuern CS, 2013, EUR J HEART FAIL, V15, P176, DOI 10.1093/eurjhf/hfs185	23	34	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124606	10.1371/journal.pone.0124606	http://dx.doi.org/10.1371/journal.pone.0124606			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894208	Green Submitted, Green Published, gold			2022-12-26	WOS:000353211700109
J	Ish-Am, O; Kristensen, DM; Ruppin, E				Ish-Am, Oren; Kristensen, David M.; Ruppin, Eytan			Evolutionary Conservation of Bacterial Essential Metabolic Genes across All Bacterial Culture Media	PLOS ONE			English	Article							PROTEIN DISPENSABILITY; NONESSENTIAL GENES; GLOBAL-NETWORK; OPTIMIZATION; PROKARYOTES; DATABASE; GENOMES; MODELS	One of the basic postulates of molecular evolution is that functionally important genes should evolve slower than genes of lesser significance. Essential genes, whose knockout leads to a lethal phenotype are considered of high functional importance, yet whether they are truly more conserved than nonessential genes has been the topic of much debate, fuelled by a host of contradictory findings. Here we conduct the first large-scale study utilizing genome-scale metabolic modeling and spanning many bacterial species, which aims to answer this question. Using the novel Media Variation Analysis, we examine the range of conservation of essential vs. nonessential metabolic genes in a given species across all possible media. We are thus able to obtain for the first time, exact upper and lower bounds on the levels of differential conservation of essential genes for each of the species studied. The results show that bacteria do exhibit an overall tendency for differential conservation of their essential genes vs. their non-essential ones, yet this tendency is highly variable across species. We show that the model bacterium E. coli K12 may or may not exhibit differential conservation of essential genes depending on its growth medium, shedding light on previous experimental studies showing opposite trends.	[Ish-Am, Oren; Ruppin, Eytan] Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel; [Kristensen, David M.] NIH, Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20892 USA; [Ruppin, Eytan] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Ruppin, Eytan] Univ Maryland, Dept Comp Sci, College Pk, MD USA; [Ruppin, Eytan] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD USA	Tel Aviv University; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Tel Aviv University; Sackler Faculty of Medicine; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Ruppin, E (corresponding author), Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel.	ishamor@gmail.com; eyruppin@gmail.com	Ruppin, Eytan/R-9698-2017	Ruppin, Eytan/0000-0002-7862-3940	MICROME project; INFECT FP7 EU project; I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation [41/11]	MICROME project; INFECT FP7 EU project; I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation(Israel Science Foundation)	This work was supported by grants from the MICROME and the INFECT FP7 EU projects, the I-CORE Program of the Planning and Budgeting Committee and The Israel Science Foundation (grant No 41/11), supporting ER's research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barve A, 2012, P NATL ACAD SCI USA, V109, pE1121, DOI 10.1073/pnas.1113065109; Buescher JM, 2012, SCIENCE, V335, P1099, DOI 10.1126/science.1206871; Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803; Chaffron S, 2010, GENOME RES, V20, P947, DOI 10.1101/gr.104521.109; Chandrasekaran S, 2010, P NATL ACAD SCI USA, V107, P17845, DOI 10.1073/pnas.1005139107; Deutscher D, 2006, NAT GENET, V38, P993, DOI 10.1038/ng1856; Dotsch A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-234; Gong XD, 2008, MOL GENET GENOMICS, V279, P87, DOI 10.1007/s00438-007-0298-x; Heinemann M, 2010, SCIENCEDIRECT; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Hirsh AE, 2003, NATURE, V421, P497, DOI 10.1038/421497a; Hirsh AE, 2001, NATURE, V411, P1046, DOI 10.1038/35082561; Hurst LD, 1999, CURR BIOL, V9, P747, DOI 10.1016/S0960-9822(99)80334-0; Jordan IK, 2002, GENOME RES, V12, P962, DOI 10.1101/gr.87702; Mo ML, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-37; Nogales J, 2012, P NATL ACAD SCI USA, V109, P2678, DOI 10.1073/pnas.1117907109; Novichkov PS, 2009, NUCLEIC ACIDS RES, V37, pD448, DOI 10.1093/nar/gkn684; Novichkov PS, 2009, J BACTERIOL, V191, P65, DOI 10.1128/JB.01237-08; Pal C, 2003, NATURE, V421, P496, DOI 10.1038/421496b; Papp B, 2011, NAT REV GENET, V12, P591, DOI 10.1038/nrg3033; Parter M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-169; Plata G, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.60; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Rocha EPC, 2004, MOL BIOL EVOL, V21, P108, DOI 10.1093/molbev/msh004; Snitkin ES, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r140; Trawick JD, 2006, BIOCHEM PHARMACOL, V71, P1026, DOI 10.1016/j.bcp.2005.10.049; VARMA A, 1994, BIO-TECHNOL, V12, P994, DOI 10.1038/nbt1094-994; Wang Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000329; WILSON AC, 1977, ANNU REV BIOCHEM, V46, P573, DOI 10.1146/annurev.bi.46.070177.003041; Wolf YI, 2006, TRENDS GENET, V22, P354, DOI 10.1016/j.tig.2006.04.009; Zhang JZ, 2005, MOL BIOL EVOL, V22, P1147, DOI 10.1093/molbev/msi101; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858	32	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123785	10.1371/journal.pone.0123785	http://dx.doi.org/10.1371/journal.pone.0123785			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894004	Green Published, Green Submitted, gold			2022-12-26	WOS:000353211700057
J	Kawao, N; Tamura, Y; Horiuchi, Y; Okumoto, K; Yano, M; Okada, K; Matsuo, O; Kaji, H				Kawao, Naoyuki; Tamura, Yukinori; Horiuchi, Yoshitaka; Okumoto, Katsumi; Yano, Masato; Okada, Kiyotaka; Matsuo, Osamu; Kaji, Hiroshi			The Tissue Fibrinolytic System Contributes to the Induction of Macrophage Function and CCL3 during Bone Repair in Mice	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; ENDOTHELIAL GROWTH-FACTOR; INFLAMMATORY PROTEIN-1-ALPHA; OSTEOBLASTS; UROKINASE; RECEPTOR; CELLS; GENE; ANGIOGENESIS; OSTEOCLASTS	Macrophages play crucial roles in repair process of various tissues. However, the details in the role of macrophages during bone repair still remains unknown. Herein, we examined the contribution of the tissue fibrinolytic system to the macrophage functions in bone repair after femoral bone defect by using male mice deficient in plasminogen (Plg(-/-)), urokinase-type plasminogen activator (uPA(-/-)) or tissue-type plasminogen activator (tPA(-/-)) genes and their wild-type littermates. Bone repair of the femur was delayed in uPA(-/-) mice until day 6, compared with wild-type (uPA(+/+)) mice. Number of Osterix-positive cells and vessel formation were decreased in uPA(-/-) mice at the bone injury site on day 4, compared with those in uPA(+/+) mice. Number of macrophages and their phagocytosis at the bone injury site were reduced in uPA(-/-) and Plg(-/-), but not in tPA(-/-) mice on day 4. Although uPA or plasminogen deficiency did not affect the levels of cytokines, including TNF-alpha, IL-1 beta, IL-6, IL-4 and IFN-gamma mRNA in the damaged femur, the elevation in CCL3 mRNA levels was suppressed in uPA(-/-) and Plg(-/-), but not in tPA(-/-) mice. Neutralization of CCL3 antagonized macrophage recruitment to the site of bone injury and delayed bone repair in uPA(+/+), but not in uPA(-/-) mice. Our results provide novel evidence that the tissue fibrinolytic system contributes to the induction of macrophage recruitment and CCL3 at the bone injury site, thereby, leading to the enhancement of the repair process.	[Kawao, Naoyuki; Tamura, Yukinori; Yano, Masato; Okada, Kiyotaka; Matsuo, Osamu; Kaji, Hiroshi] Kinki Univ, Fac Med, Dept Physiol & Regenerat Med, Osakasayama, Japan; [Horiuchi, Yoshitaka; Okumoto, Katsumi] Kinki Univ, Life Sci Res Inst, Osaka, Japan	Kindai University (Kinki University); Kindai University (Kinki University)	Kaji, H (corresponding author), Kinki Univ, Fac Med, Dept Physiol & Regenerat Med, Osakasayama, Japan.	hkaji@med.kindai.ac.jp	Kaji, Hiroshi/AAI-5628-2020; MATSUO, OSAMU/AAM-9703-2020	Matsuo, Osamu/0000-0002-9806-2204; Kawao, Naoyuki/0000-0002-4148-5476	Kinki University Research; Ministry of Education, Culture, Sports, Science, and Technology of Japan [25460305, 24590289]	Kinki University Research; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was partly supported by a grant from a Kinki University Research and Grant-in-Aid for Scientific Research (C: 25460305) to N.K. and (C: 24590289) to H.K. from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander KA, 2011, J BONE MINER RES, V26, P1517, DOI 10.1002/jbmr.354; ALLAN EH, 1995, J CELL PHYSIOL, V165, P521, DOI 10.1002/jcp.1041650310; Berkman N, 1996, AM J RESP CELL MOL, V15, P382, DOI 10.1165/ajrcmb.15.3.8810643; Bezerra JA, 2001, AM J PATHOL, V158, P921, DOI 10.1016/S0002-9440(10)64039-4; Bostrom K, 2004, J BIOL CHEM, V279, P52904, DOI 10.1074/jbc.M406868200; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Bugge TH, 1996, P NATL ACAD SCI USA, V93, P5899, DOI 10.1073/pnas.93.12.5899; CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0; Carmeliet P, 1997, CIRC RES, V81, P829; Castellino FJ, 2005, THROMB HAEMOSTASIS, V93, P647, DOI 10.1160/TH04-12-0842; Claes L, 2012, NAT REV RHEUMATOL, V8, P133, DOI 10.1038/nrrheum.2012.1; Daci E, 2003, J BONE MINER RES, V18, P1167, DOI 10.1359/jbmr.2003.18.7.1167; Daci E, 2000, J BONE MINER RES, V15, P1510, DOI 10.1359/jbmr.2000.15.8.1510; Taddei SRD, 2013, BONE, V52, P259, DOI 10.1016/j.bone.2012.09.036; Deckers MML, 2002, ENDOCRINOLOGY, V143, P1545, DOI 10.1210/en.143.4.1545; FUKUMOTO S, 1992, J CELL PHYSIOL, V152, P346, DOI 10.1002/jcp.1041520216; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; HAMILTON JA, 1985, ENDOCRINOLOGY, V116, P2186, DOI 10.1210/endo-116-6-2186; Han JH, 2001, BLOOD, V97, P3349, DOI 10.1182/blood.V97.11.3349; HOUCK KA, 1992, J BIOL CHEM, V267, P26031; Kawao N, 2010, J THROMB HAEMOST, V8, P1555, DOI 10.1111/j.1538-7836.2010.03870.x; Kawao N, 2014, AM J PHYSIOL-ENDOC M, V307, pE278, DOI 10.1152/ajpendo.00129.2014; Kawao N, 2013, J BONE MINER RES, V28, P1561, DOI 10.1002/jbmr.1921; Kawao N, 2012, THROMB HAEMOSTASIS, V107, P749, DOI 10.1160/TH11-08-0567; Kawao N, 2011, THROMB HAEMOSTASIS, V105, P892, DOI 10.1160/TH10-08-0516; Kawao N, 2010, THROMB RES, V125, pE214, DOI 10.1016/j.thromres.2009.12.009; Lijnen HR, 2001, THROMB HAEMOSTASIS, V86, P324; Mao L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092686; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Ohta TM, 1998, INFLAMM RES, V47, P361, DOI 10.1007/s000110050345; PLOPLIS VA, 1995, CIRCULATION, V92, P2585, DOI 10.1161/01.CIR.92.9.2585; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schipani E, 2009, J BONE MINER RES, V24, P1347, DOI [10.1359/JBMR.090602, 10.1359/jbmr.090602]; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Sowa H, 2003, J BIOL CHEM, V278, P21058, DOI 10.1074/jbc.M302044200; Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342; Taichman RS, 2000, BRIT J HAEMATOL, V108, P275; Tamura Y, 2013, DIABETES, V62, P3170, DOI 10.2337/db12-1552; Tanaka K, 2012, J BIOL CHEM, V287, P11616, DOI 10.1074/jbc.M111.292193; Vallet S, 2011, LEUKEMIA, V25, P1174, DOI 10.1038/leu.2011.43; Xing ZQ, 2010, DIS MODEL MECH, V3, P451, DOI 10.1242/dmm.003186; Yang JN, 1997, J BONE MINER RES, V12, P761, DOI 10.1359/jbmr.1997.12.5.761; Yu XF, 2004, J BONE MINER RES, V19, P2065, DOI 10.1359/JBMR.040910	43	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123982	10.1371/journal.pone.0123982	http://dx.doi.org/10.1371/journal.pone.0123982			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893677	Green Published, gold, Green Submitted			2022-12-26	WOS:000353211700068
J	Liu, W; Li, W; He, QL; Daud, MK; Chen, JH; Zhu, SJ				Liu, Wei; Li, Wei; He, Qiuling; Daud, Muhammad Khan; Chen, Jinhong; Zhu, Shuijin			Characterization of 19 Genes Encoding Membrane-Bound Fatty Acid Desaturases and their Expression Profiles in Gossypium raimondii Under Low Temperature	PLOS ONE			English	Article							OMEGA-3-FATTY-ACID DESATURASE; DELTA(8)-SPHINGOLIPID DESATURASE; FUNCTIONAL-CHARACTERIZATION; OMEGA-3 DESATURASE; MOLECULAR-CLONING; TOLERANCE; EVOLUTION; GENOME; PLANTS; COLD	To produce unsaturated fatty acids, membrane-bound fatty acid desaturases (FADs) can be exploited to introduce double bonds into the acyl chains of fatty acids. In this study, 19 membrane-bound FAD genes were identified in Gossypium raimondii through database searches and were classified into four different subfamilies based on phylogenetic analysis. All 19 membrane-bound FAD proteins shared three highly conserved histidine boxes, except for GrFAD2.1, which lost the third histidine box in the C-terminal region. In the G. raimondii genome, tandem duplication might have led to the increasing size of the FAD2 cluster in the Omega Desaturase subfamily, whereas segmental duplication appeared to be the dominant mechanism for the expansion of the Sphingolipid and Front-end Desaturase subfamilies. Gene expression analysis showed that seven membrane-bound FAD genes were significantly up-regulated and that five genes were greatly suppressed in G. raimondii leaves exposed to low temperature conditions.	[Liu, Wei; Li, Wei; He, Qiuling; Daud, Muhammad Khan; Chen, Jinhong; Zhu, Shuijin] Zhejiang Univ, Dept Agron, Hangzhou 310058, Zhejiang, Peoples R China; [Daud, Muhammad Khan] Kohat Univ Sci & Technol, Dept Biotechnol & Genet Engn, Kohat 26000, Pakistan; [Chen, Jinhong; Zhu, Shuijin] Jiangsu Collaborat Innovat Ctr Modern Crop Prod, Nanjing 210095, Jiangsu, Peoples R China	Zhejiang University; Kohat University of Science & Technology	Chen, JH (corresponding author), Zhejiang Univ, Dept Agron, Hangzhou 310058, Zhejiang, Peoples R China.	jinhongchen@zju.edu.cn; shjzhu@zju.edu.cn	Khan, Muhammad Daud/AAF-1011-2021					Alonso DL, 2003, BIOCHEM SYST ECOL, V31, P1111, DOI 10.1016/S0305-1978(03)00041-3; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berberich T, 1998, PLANT MOL BIOL, V36, P297, DOI 10.1023/A:1005993408270; BROWSE J, 1993, J BIOL CHEM, V268, P16345; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Chapman KD, 2001, J AM OIL CHEM SOC, V78, P941, DOI 10.1007/s11746-001-0368-y; Chen M, 2012, PLANT J, V69, P769, DOI 10.1111/j.1365-313X.2011.04829.x; Chen MJ, 2013, PLANT CELL, V25, P1430, DOI 10.1105/tpc.113.111179; Chen ZJ, 2007, PLANT PHYSIOL, V145, P1303, DOI 10.1104/pp.107.107672; Chi XY, 2011, PLANT MOL BIOL REP, V29, P769, DOI 10.1007/s11105-010-0284-z; Clemente TE, 2009, PLANT PHYSIOL, V151, P1030, DOI 10.1104/pp.109.146282; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; FALCONE DL, 1994, PLANT PHYSIOL, V106, P1453, DOI 10.1104/pp.106.4.1453; Flores T, 2008, TRANSGENIC RES, V17, P839, DOI 10.1007/s11248-008-9167-6; GIBSON S, 1994, PLANT PHYSIOL, V106, P1615, DOI 10.1104/pp.106.4.1615; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Hashimoto K, 2008, J LIPID RES, V49, P183, DOI 10.1194/jlr.M700377-JLR200; Haun W, 2014, PLANT BIOTECHNOL J, V12, P934, DOI 10.1111/pbi.12201; Heilmann I, 2004, P NATL ACAD SCI USA, V101, P10266, DOI 10.1073/pnas.0402200101; IBA K, 1993, J BIOL CHEM, V268, P24099; Iba K, 2002, ANNU REV PLANT BIOL, V53, P225, DOI 10.1146/annurev.arplant.53.100201.160729; Im YJ, 2002, MOL CELLS, V13, P264; Kargiotidou A, 2008, J EXP BOT, V59, P2043, DOI 10.1093/jxb/ern065; Khodakovskaya M, 2006, PLANTA, V223, P1090, DOI 10.1007/s00425-005-0161-4; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li SF, 2012, J GENET GENOMICS, V39, P47, DOI 10.1016/j.jgg.2011.12.002; Li-Beisson Yonghua, 2010, Arabidopsis Book, V8, pe0133, DOI [10.1199/tab.0133, 10.1199/tab.0161]; Liu Q, 2002, PLANT PHYSIOL, V129, P1732, DOI 10.1104/pp.001933; Liu Q, 1999, AUST J PLANT PHYSIOL, V26, P101, DOI 10.1071/PP98118; Liu W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098189; Liu XY, 2006, J INTEGR PLANT BIOL, V48, P1096, DOI 10.1111/j.1744-7909.2006.00335.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Los DA, 1998, BBA-LIPID LIPID MET, V1394, P3, DOI 10.1016/S0005-2760(98)00091-5; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; McCartney AW, 2004, PLANT J, V37, P156, DOI 10.1111/j.1365-313X.2004.01949.x; MCCONN M, 1994, PLANT PHYSIOL, V106, P1609, DOI 10.1104/pp.106.4.1609; Michaelson LV, 2009, PLANT PHYSIOL, V149, P487, DOI 10.1104/pp.108.129411; Moreno-Perez AJ, 2011, J PLANT PHYSIOL, V168, P831, DOI 10.1016/j.jplph.2010.11.015; Nair PMG, 2009, PLANT CELL TISS ORG, V98, P87, DOI 10.1007/s11240-009-9541-y; Nishida I, 1996, ANNU REV PLANT PHYS, V47, P541, DOI 10.1146/annurev.arplant.47.1.541; OKULEY J, 1994, PLANT CELL, V6, P147, DOI 10.1105/tpc.6.1.147; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Pirtle IL, 2001, BBA-GENE STRUCT EXPR, V1522, P122, DOI 10.1016/S0167-4781(01)00312-8; Roman A, 2012, J EXP BOT, V63, P4973, DOI 10.1093/jxb/ers174; Sakamoto T, 2002, CURR OPIN MICROBIOL, V5, P206, DOI 10.1016/S1369-5274(02)00306-5; Shanklin J, 1998, ANNU REV PLANT PHYS, V49, P611, DOI 10.1146/annurev.arplant.49.1.611; Shi W, 2013, BMC GENOMICS, V14, DOI [10.1186/1471-2164-14-103, 10.1186/1471-2164-14-433]; SOMERVILLE C, 1991, SCIENCE, V252, P80, DOI 10.1126/science.252.5002.80; Sperling P, 2003, PROSTAG LEUKOTR ESS, V68, P73, DOI 10.1016/S0952-3278(02)00258-2; Sperling P, 2003, BBA-MOL CELL BIOL L, V1632, P1, DOI 10.1016/S1388-1981(03)00033-7; Sperling P, 2001, ARCH BIOCHEM BIOPHYS, V388, P293, DOI 10.1006/abbi.2001.2308; Sunilkumar G, 2005, PLANT BIOTECHNOL J, V3, P319, DOI 10.1111/j.1467-7652.2005.00126.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wagner N, 2011, PLANT BIOTECHNOL J, V9, P723, DOI 10.1111/j.1467-7652.2010.00573.x; Wang HS, 2014, PLANT CELL REP, V33, P131, DOI 10.1007/s00299-013-1517-z; Wang JW, 2006, BIOCHEM BIOPH RES CO, V340, P1209, DOI 10.1016/j.bbrc.2005.12.126; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wei Hengling, 2013, PLoS One, V8, pe68435, DOI 10.1371/journal.pone.0068435; Wu Q, 2009, AFR J BIOTECHNOL, V8, P1782; Yukawa Y, 1996, PLANT CELL PHYSIOL, V37, P201, DOI 10.1093/oxfordjournals.pcp.a028932; Yurchenko OP, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0312-5; Zhang DY, 2009, PLANT PHYSIOL BIOCH, V47, P462, DOI 10.1016/j.plaphy.2008.12.024; Zhang JT, 2009, BIOCHEM BIOPH RES CO, V390, P469, DOI 10.1016/j.bbrc.2009.09.095; Zhang JT, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030355, 10.1371/journal.pone.0041657]; Zhao Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028488	67	27	33	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123281	10.1371/journal.pone.0123281	http://dx.doi.org/10.1371/journal.pone.0123281			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894196	Green Submitted, Green Published, gold			2022-12-26	WOS:000353211700032
J	Mi, WD; Zhang, CS; Wang, H; Cao, JB; Li, CT; Yang, L; Guo, F; Wang, XW; Yang, T				Mi, Weidong; Zhang, Changsheng; Wang, Hong; Cao, Jiangbei; Li, Changtian; Yang, Li; Guo, Fang; Wang, Xianwang; Yang, Tie			Measurement and Analysis of the Tracheobronchial Tree in Chinese Population Using Computed Tomography	PLOS ONE			English	Article							DOUBLE-LUMEN TUBE; LEFT MAIN BRONCHUS; TRACHEAL WIDTH; SIZE; DIMENSIONS; SELECTION; DIAMETERS; PRESSURE; LENGTH; VOLUME	Objective To ascertain accurate measurements of, and the relationships between, the normative parameters of the tracheobronchial trees in the Chinese population using multi-slice spiral computed tomography (CT) and multi-planar reconstruction (MPR). Materials and Methods Measurements were performed on 2107 patients who underwent thoracic CT scans in the PLA General Hospital. The lengths of the trachea and the main stem bronchi, and the sizes of the subcarinal angle were obtained through CT or MPR imaging. Multi-variance analyses were performed to detect potential correlations between obtained parameters. Results The mean length of the trachea was 104.9 +/- 13.4 mm (107.8 +/- 13.2 mm for men and 101.4 +/- 12.8 mm for women). The mean lengths of the right and left main stem bronchi were 13.6 +/- 4.3 and 48.3 +/- 6.5 mm, respectively. The right bronchus angle and the left bronchus angle were 34.9 and 42.5 degrees, respectively. Significant gender differences were found in all the parameters measured except for the angle of the right upper lobe bronchus. There are no statistically significant correlations among these parameters. Conclusions The normal reference values and the likely ranges of distribution of the tracheobronchial trees in the Chinese population have been established. Significant gender differences exist in the dimensions of the trachea, with the exception of the Right upper bronchial angle (RUA).	[Mi, Weidong; Zhang, Changsheng; Wang, Hong; Cao, Jiangbei; Guo, Fang] Chinese Peoples Liberat Army Gen Hosp, Anesthesia & Operat Ctr, Beijing 100853, Peoples R China; [Li, Changtian] Chinese Peoples Liberat Army Gen Hosp, Southern Bldg, Dept Ultrasound, Beijing 100853, Peoples R China; [Yang, Li; Yang, Tie] Chinese Peoples Liberat Army Gen Hosp, Dept Radiol, Beijing 100853, Peoples R China; [Wang, Xianwang] Th Hosp Chinese PLA, Dept Anesthesia, Beijing 100096, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Mi, WD (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Anesthesia & Operat Ctr, Beijing 100853, Peoples R China.	plamzk@126.com	Cao, jiangbei/AFS-3772-2022; Cao, Jiangbei/ADE-0079-2022	Cao, Jiangbei/0000-0003-1218-4639				Munguia-Canales DA, 2011, CIR CIR, V79, P465; ATWELL SW, 1967, DIS CHEST, V52, P611, DOI 10.1378/chest.52.5.611; BENUMOF JL, 1987, ANESTHESIOLOGY, V67, P729, DOI 10.1097/00000542-198711000-00018; BREATNACH E, 1984, AM J ROENTGENOL, V142, P903, DOI 10.2214/ajr.142.5.903; Brodsky JB, 1996, ANESTH ANALG, V82, P861, DOI 10.1097/00000539-199604000-00032; Brodsky JB, 2005, J CLIN ANESTH, V17, P267, DOI 10.1016/j.jclinane.2004.07.008; Brodsky JB, 2001, J CARDIOTHOR VASC AN, V15, P216, DOI 10.1053/jcan.2001.21970; Cai BQ, 2011, PUMC RESPIROLOGY, P3; Chow MYH, 1999, ANESTH ANALG, V88, P302, DOI 10.1097/00000539-199902000-00014; Chunder R, 2010, Nepal Med Coll J, V12, P207; CROTEAU JR, 1961, J APPL PHYSIOL, V16, P170, DOI 10.1152/jappl.1961.16.1.170; Eberle B, 1999, J CARDIOTHOR VASC AN, V13, P532, DOI 10.1016/S1053-0770(99)90003-4; Ellis H, 2013, ANATOMY ANAESTHETIST, P42; FEARON B, 1967, ANN OTO RHINOL LARYN, V76, P964, DOI 10.1177/000348946707600507; GAMSU G, 1983, SEMIN ROENTGENOL, V18, P51, DOI 10.1016/S0037-198X(83)80009-1; Gatzoulis MA, 2008, GRAYS ANATOMY ANATOM, P989; GILES E, 1988, J FORENSIC SCI, V33, P1218; Grillo HC, 2004, SURG TRACHEA BRONCHI, P43; GRISCOM NT, 1982, RADIOLOGY, V145, P361, DOI 10.1148/radiology.145.2.7134436; GRISCOM NT, 1986, AM J ROENTGENOL, V146, P233, DOI 10.2214/ajr.146.2.233; GRISCOM NT, 1983, RADIOLOGY, V149, P27, DOI 10.1148/radiology.149.1.6611936; GRISCOM NT, 1985, AM REV RESPIR DIS, V131, P840; Hampton T, 2000, ANAESTH INTENS CARE, V28, P540, DOI 10.1177/0310057X0002800510; Hautmann H, 2000, ANESTH ANALG, V90, P1436, DOI 10.1097/00000539-200006000-00034; JESSEPH JE, 1957, SURG GYNECOL OBSTET, V105, P210; Kim D, 2014, J CARDIOTHOR VASC AN, V28, P890, DOI 10.1053/j.jvca.2013.05.029; Liu ZY, 2009, ENGLISH CHINESE TXB, P143; Olivier P, 2006, CHEST, V130, P101, DOI 10.1378/chest.130.1.101; S-R N, 2013, 5 MINUTE ANESTHESIA, P500; Seymour AH, 2003, J CARDIOTHOR VASC AN, V17, P299, DOI 10.1016/S1053-0770(03)00057-0; WITTENBORG MH, 1967, RADIOLOGY, V88, P653, DOI 10.1148/88.4.653; Yuceyar L, 2003, ACTA ANAESTH SCAND, V47, P622, DOI 10.1034/j.1399-6576.2003.00102.x; Zhevnov V N, 1969, Vestn Khir Im I I Grek, V103, P116	33	38	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123177	10.1371/journal.pone.0123177	http://dx.doi.org/10.1371/journal.pone.0123177			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894917	Green Published, Green Submitted, gold			2022-12-26	WOS:000353211700025
J	Rong, Y; Evans, J; Xu-Welliver, M; Pickett, C; Jia, G; Chen, Q; Zuo, L				Rong, Yi; Evans, Josh; Xu-Welliver, Meng; Pickett, Cadron; Jia, Guang; Chen, Quan; Zuo, Li			Dosimetric Evaluation of Intensity-Modulated Radiotherapy, Volumetric Modulated Arc Therapy, and Helical Tomotherapy for Hippocampal-Avoidance Whole Brain Radiotherapy	PLOS ONE			English	Article							ADULT NEUROGENESIS; RADIATION-THERAPY; IRRADIATION; METASTASES; IMRT; PROLIFERATION	Background Whole brain radiotherapy (WBRT) is a vital tool in radiation oncology and beyond, but it can result in adverse health effects such as neurocognitive decline. Hippocampal Avoidance WBRT (HA-WBRT) is a strategy that aims to mitigate the neuro-cognitive side effects of whole brain radiotherapy treatment by sparing the hippocampi while delivering the prescribed dose to the rest of the brain. Several competing modalities capable of delivering HA-WBRT, include: Philips Pinnacle step-and-shoot intensity modulated radiotherapy (IMRT), Varian RapidArc volumetric modulated arc therapy (RapidArc), and helical TomoTherapy (TomoTherapy). Methods In this study we compared these methods using 10 patient datasets. Anonymized planning CT (computerized tomography) scans and contour data based on fused MRI images were collected. Three independent planners generated treatment plans for the patients using three modalities, respectively. All treatment plans met the RTOG 0933 criteria for HA-WBRT treatment. Results In dosimetric comparisons between the three modalities, TomoTherapy has a significantly superior homogeneity index of 0.15 +/- 0.03 compared to the other two modalities (0.28 +/- .04, p < .005 for IMRT and 0.22 +/- 0.03, p < .005 for RapidArc). RapidArc has the fastest average delivery time of 2.5 min compared to the other modalities (15 min for IMRT and 18 min for TomoTherapy). Conclusion TomoTherapy is considered to be the preferred modality for HA-WBRT due to its superior dose distribution. When TomoTherapy is not available or treatment time is a concern, RapidArc can provide sufficient dose distribution meeting RTOG criteria and efficient treatment delivery.	[Rong, Yi; Xu-Welliver, Meng] Ohio State Univ, James Canc Hosp, Wexner Med Ctr, Dept Radiat Oncol, Columbus, OH 43210 USA; [Zuo, Li] Ohio State Univ, Wexner Med Ctr, Coll Med,Biophys Grad Program, Sch Hlth & Rehabil Sci,Radiol Sci & Resp Therapy, Columbus, OH 43210 USA; [Evans, Josh; Chen, Quan] Univ Virginia Hlth Syst, Dept Radiat Oncol, Charlottesville, VA 22903 USA; [Pickett, Cadron; Jia, Guang] Louisiana State Univ, Dept Phys & Astron, Baton Rouge, LA 70803 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Virginia; Louisiana State University System; Louisiana State University	Chen, Q (corresponding author), Univ Virginia Hlth Syst, Dept Radiat Oncol, Charlottesville, VA 22903 USA.	QC3K@hscmail.mcc.virginia.edu; zuo.4@osu.edu	Jia, Guang/A-1275-2016; Chen, Quan/E-5943-2012; Jia, Guang/E-3312-2011	Chen, Quan/0000-0001-5570-2462; Jia, Guang/0000-0001-5306-5607				Abayomi OK, 1996, ACTA ONCOL, V35, P659, DOI 10.3109/02841869609083995; Awad R, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-62; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Chang EL, 2009, LANCET ONCOL, V10, P1037, DOI 10.1016/S1470-2045(09)70263-3; Chen Q, 2012, MED PHYS, V39, P1877, DOI 10.1118/1.3693057; Chen QA, 2011, MED PHYS, V38, P1150, DOI 10.1118/1.3551996; DEANGELIS LM, 1989, NEUROLOGY, V39, P789, DOI 10.1212/WNL.39.6.789; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; FERRER I, 1993, J NEUROPATH EXP NEUR, V52, P370, DOI 10.1097/00005072-199307000-00004; Gondi V, 2010, RADIOTHER ONCOL, V97, P370, DOI 10.1016/j.radonc.2010.09.013; Gondi V, 2010, INT J RADIAT ONCOL, V78, P1244, DOI 10.1016/j.ijrobp.2010.01.039; Gondi V, 2010, RADIOTHER ONCOL, V95, P327, DOI 10.1016/j.radonc.2010.02.030; Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032; Li J, 2007, J CLIN ONCOL, V25, P1260, DOI 10.1200/JCO.2006.09.2536; Lu WG, 2010, PHYS MED BIOL, V55, P7175, DOI 10.1088/0031-9155/55/23/002; Lu WG, 2010, PHYS MED BIOL, V55, P7211, DOI 10.1088/0031-9155/55/23/003; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Marsh JC, 2013, J MED IMAG RADIAT ON, V57, P378, DOI 10.1111/1754-9485.12048; Meyers CA, 2006, J CLIN ONCOL, V24, P1305, DOI 10.1200/JCO.2005.04.6086; Meyers CA, 2004, J CLIN ONCOL, V22, P157, DOI 10.1200/JCO.2004.05.128; Mizumatsu S, 2003, CANCER RES, V63, P4021; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Nagai R, 2000, SURG NEUROL, V53, P503, DOI 10.1016/S0090-3019(00)00214-7; Nussbaum ES, 1996, CANCER-AM CANCER SOC, V78, P1781, DOI 10.1002/(SICI)1097-0142(19961015)78:8<1781::AID-CNCR19>3.3.CO;2-Z; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Regine WF, 2004, INT J RADIAT ONCOL, V58, P1346, DOI 10.1016/j.ijrobp.2003.09.023; ROMAN DD, 1995, INT J RADIAT ONCOL, V31, P983, DOI 10.1016/0360-3016(94)00550-8; Rong Y, 2014, MED PHYS, V41, DOI 10.1118/1.4870987; Siglin J, 2014, PRACT RADIAT ONCOL, V4, P378, DOI 10.1016/j.prro.2013.11.008; Tada E, 2000, NEUROSCIENCE, V99, P33, DOI 10.1016/S0306-4522(00)00151-2; Van Vulpen M, 2005, INT J RADIAT ONCOL, V62, P1535, DOI 10.1016/j.ijrobp.2005.04.011; Welzel G, 2008, INT J RADIAT ONCOL, V72, P1311, DOI 10.1016/j.ijrobp.2008.03.009	32	31	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0126222	10.1371/journal.pone.0126222	http://dx.doi.org/10.1371/journal.pone.0126222			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894615	Green Published, Green Submitted, gold			2022-12-26	WOS:000353211700141
J	Seo, K; Kitazawa, T; Yoshino, Y; Koga, I; Ota, Y				Seo, Kazunori; Kitazawa, Takatoshi; Yoshino, Yusuke; Koga, Ichiro; Ota, Yasuo			Characteristics of Serum Endocan Levels in Infection	PLOS ONE			English	Article							CELL-SPECIFIC MOLECULE-1; C-REACTIVE PROTEIN; PROCALCITONIN; BACTEREMIA; EXPRESSION; ESM-1; MARKER; IMPACT; LUNG	Objectives Endocan is a newly recognized biomarker of sepsis. However, there have been no studies of the trends in endocan levels during infection and their associations with other clinical factors. The aim of this study was to assess the time course of endocan levels and the associations of endocan with clinical factors during infection by comparison with other biomarkers. Methods Serum samples and blood cultures were obtained from patients who were diagnosed with infection from June 2013 to March 2014. Serum endocan, C-reactive protein (CRP), and procalcitonin (PCT) levels during four periods during infection were measured (day 0, day 12, day 3-5, and day 6-10). Results A total of 78 patients were enrolled in this study. The median endocan level decreased by only 23% during infection, whereas both serum CRP and PCT levels decreased by more than 80%. Endocan levels were correlated to neither CRP levels nor PCT levels in each period. Endocan levels at day 0 in patients with bacteremia were higher than those without bacteremia (1.09 ng/mL vs 0.82 ng/mL, P=0.002), but neither CRP levels nor PCT levels at day 0 were different between the two groups. Areas under the receiver operator characteristic (ROC) curves of endocan, CRP, and PCT at day 0 were 0.662, 0.343, and 0.563, respectively. Positive blood cultures tended to be related to high endocan levels, but not significantly (odds ratio: 4.24, 95% CI: 0.99-10.34, P=0.05). Conclusions In bacteremic cases, serum endocan levels in bacteremia tended to be higher than in non-bacteremic cases. Although endocan level was not identified as a prognostic factor of bacteremia, further prospective study concerning the relationship between serum endocan level and bacteremia would be needed.	[Seo, Kazunori; Kitazawa, Takatoshi; Yoshino, Yusuke; Koga, Ichiro; Ota, Yasuo] Teikyo Univ, Dept Internal Med, Tokyo 173, Japan	Teikyo University	Kitazawa, T (corresponding author), Teikyo Univ, Dept Internal Med, Tokyo 173, Japan.	tkitazaw@med.teikyo-u.ac.jp	Yoshino, Yusuke/V-9649-2019		Japan Society for the Promotion of Science KAKENHI [25462833]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant Number 25462833, http://www.jsps.go.jp/j-grantsinaid/, preparation of the manuscript.	Bates DW, 1997, J INFECT DIS, V176, P1538, DOI 10.1086/514153; Bechard D, 2000, J VASC RES, V37, P417, DOI 10.1159/000025758; Bechard D, 2001, J BIOL CHEM, V276, P48341, DOI 10.1074/jbc.M108395200; Chen LY, 2010, J INT MED RES, V38, P498, DOI 10.1177/147323001003800213; Dellinger RP, 2013, CRIT CARE MED, V41, P637, DOI [DOI 10.1097/CCM.0b013e31827e83af, DOI 10.1007/s00134-015-3827-9]; El Behery MM, 2013, ARCH GYNECOL OBSTET, V288, P1371, DOI 10.1007/s00404-013-2863-3; Grigoriu BD, 2006, CLIN CANCER RES, V12, P4575, DOI 10.1158/1078-0432.CCR-06-0185; Hatfield KJ, 2011, HEMATOLOGY, V16, P351, DOI 10.1179/102453311X13127324303434; Hoenigl M, 2014, INT J CLIN PRACT, V68, P1278, DOI 10.1111/ijcp.12474; Hohn A, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-158; HURLIMANN J, 1966, J EXP MED, V123, P365, DOI 10.1084/jem.123.2.365; Kim JH, 2012, ONCOL REP, V28, P1701, DOI 10.3892/or.2012.2012; Lassalle P, 1996, J BIOL CHEM, V271, P20458, DOI 10.1074/jbc.271.34.20458; Lee W, 2014, J CELL PHYSIOL, V229, P620, DOI 10.1002/jcp.24485; Leroy X, 2010, HISTOPATHOLOGY, V56, P180, DOI 10.1111/j.1365-2559.2009.03458.x; Liaudat S, 2001, EUR J CLIN MICROBIOL, V20, P524, DOI 10.1007/s100960100548; Luzzani A, 2003, CRIT CARE MED, V31, P1737, DOI 10.1097/01.CCM.0000063440.19188.ED; Mathevon T, 2002, SCAND J INFECT DIS, V34, P831, DOI 10.1080/0036554021000026934; Maurage CA, 2009, J NEUROPATH EXP NEUR, V68, P633, DOI 10.1097/NEN.0b013e3181a52a7f; Meisner M, 2002, CLIN CHIM ACTA, V323, P17, DOI 10.1016/S0009-8981(02)00101-8; Mikkelsen ME, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.07.077; Roudnicky F, 2013, CANCER RES, V73, P1097, DOI 10.1158/0008-5472.CAN-12-1855; Sarrazin S, 2006, BBA-REV CANCER, V1765, P25, DOI 10.1016/j.bbcan.2005.08.004; Scherpereel A, 2006, CRIT CARE MED, V34, P532, DOI 10.1097/01.CCM.0000198525.82124.74; Su YH, 2014, TRANSPL P, V46, P323, DOI 10.1016/j.transproceed.2013.10.057; Tang L, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/625180; TRINCHET JC, 1983, GASTROEN CLIN BIOL, V7, P518; Voiosu T, 2014, CLIN LAB, V60, P505, DOI 10.7754/Clin.Lab.2013.130333	28	30	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123358	10.1371/journal.pone.0123358	http://dx.doi.org/10.1371/journal.pone.0123358			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894539	Green Published, gold, Green Submitted			2022-12-26	WOS:000353211700035
J	Gardner, JK; Mamotte, CDS; Patel, P; Yeoh, TL; Jackaman, C; Nelson, DJ				Gardner, Joanne K.; Mamotte, Cyril D. S.; Patel, Priya; Yeoh, Teong Ling; Jackaman, Connie; Nelson, Delia J.			Mesothelioma Tumor Cells Modulate Dendritic Cell Lipid Content, Phenotype and Function	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; KAPPA-B ACTIVATION; T-CELLS; MALIGNANT MESOTHELIOMA; ANTITUMOR IMMUNITY; ALTERED MATURATION; CD1 MOLECULES; BREAST-CANCER; DIFFERENTIATION; INHIBITION	Dendritic cells (DCs) play an important role in the generation of anti-cancer immune responses, however there is evidence that DCs in cancer patients are dysfunctional. Lipid accumulation driven by tumor-derived factors has recently been shown to contribute to DC dysfunction in several human cancers, but has not yet been examined in mesothelioma. This study investigated if mesothelioma tumor cells and/ or their secreted factors promote increases in DC lipid content and modulate DC function. Human monocyte-derived DCs (MoDCs) were exposed to human mesothelioma tumor cells and tumor-derived factors in the presence or absence of lipoproteins. The data showed that immature MoDCs exposed to mesothelioma cells or factors contained increased lipid levels relative to control DCs. Lipid accumulation was associated with reduced antigen processing ability (measured using a DQ OVA assay), upregulation of the co-stimulatory molecule, CD86, and production of the tolerogenic cytokine, IL-10. Increases in DC lipid content were further enhanced by co-exposure to mesothelioma-derived factors and triglyceride-rich lipoproteins, but not low-density lipoproteins. In vivo studies using a murine mesothelioma model showed that the lipid content of tumor-infiltrating CD4+ CD8(alpha-)DCs, CD(4-)CD8(alpha-)DCs and plasmacytoid DCs increased with tumor progression. Moreover, increasing tumor burden was associated with reduced proliferation of tumor-antigen-specific CD8+ T cells in tumor-draining lymph nodes. This study shows that mesothelioma promotes DC lipid acquisition, which is associated with altered activation status and reduced capacity to process and present antigens, which may impair the ability of DCs to generate effective anti mesothelioma T cell responses.	[Gardner, Joanne K.; Patel, Priya; Yeoh, Teong Ling; Jackaman, Connie; Nelson, Delia J.] Curtin Univ, Immunol & Canc Grp, Sch Biomed Sci, Perth, WA 6845, Australia; [Gardner, Joanne K.; Mamotte, Cyril D. S.; Patel, Priya; Yeoh, Teong Ling; Jackaman, Connie; Nelson, Delia J.] Curtin Univ, CHIRI Biosci Res Precinct, Perth, WA 6845, Australia	Curtin University; Curtin University	Nelson, DJ (corresponding author), Curtin Univ, Immunol & Canc Grp, Sch Biomed Sci, Perth, WA 6845, Australia.	Delia.Nelson@curtin.edu.au	Mamotte, Cyril/AAF-9603-2020	Mamotte, Cyril/0000-0003-1831-3921; Nelson, Delia/0000-0002-8698-5300; Jackaman, Connie/0000-0002-4583-7029	Dust Disease Board of New South Wales, Australia	Dust Disease Board of New South Wales, Australia	This study was funded by a grant received by DJN from the Dust Disease Board of New South Wales, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allavena P, 1998, EUR J IMMUNOL, V28, P359, DOI 10.1002/(SICI)1521-4141(199801)28:01<359::AID-IMMU359>3.0.CO;2-4; Almand B, 2000, CLIN CANCER RES, V6, P1755; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Beckebaum S, 2004, CLIN CANCER RES, V10, P7260, DOI 10.1158/1078-0432.CCR-04-0872; Bellone G, 2006, J IMMUNOL, V177, P3448, DOI 10.4049/jimmunol.177.5.3448; Biswas S, 2007, J CLIN INVEST, V117, P1305, DOI 10.1172/JCI30740; Brown RD, 2001, BLOOD, V98, P2992, DOI 10.1182/blood.V98.10.2992; Caldwell S, 2003, J IMMUNOL, V171, P1676, DOI 10.4049/jimmunol.171.4.1676; Cao XC, 2002, J IMMUNOL, V169, P4770, DOI 10.4049/jimmunol.169.9.4770; Coventry B, 2004, TRENDS IMMUNOL, V25, P242, DOI 10.1016/j.it.2004.03.002; Coventry BJ, 2003, BRIT J CANCER, V89, P533, DOI 10.1038/sj.bjc.6601114; Della Bella S, 2003, BRIT J CANCER, V89, P1463, DOI 10.1038/sj.bjc.6601243; Diao J, 2011, J IMMUNOL, V186, P5058, DOI 10.4049/jimmunol.1004125; Furumoto K, 2004, J CLIN INVEST, V113, P774, DOI 10.1172/JCI200419762; Gabrilovich D, 2004, NAT REV IMMUNOL, V4, P941, DOI 10.1038/nri1498; Gabrilovich DI, 1996, NAT MED, V2, P1096, DOI 10.1038/nm1096-1096; Gabrilovich DI, 1999, CLIN CANCER RES, V5, P2963; Gerlini G, 2004, AM J PATHOL, V165, P1853, DOI 10.1016/S0002-9440(10)63238-5; Gerner MY, 2009, J IMMUNOL, V182, P2726, DOI 10.4049/jimmunol.0803479; Gogolak P, 2007, BLOOD, V109, P643, DOI 10.1182/blood-2006-04-016840; Goldman SA, 1998, ARCH OTOLARYNGOL, V124, P641, DOI 10.1001/archotol.124.6.641; Gottfried E, 2008, CYTOKINE GROWTH F R, V19, P65, DOI 10.1016/j.cytogfr.2007.10.008; Granucci F, 2001, EUR J IMMUNOL, V31, P2539, DOI 10.1002/1521-4141(200109)31:9<2539::AID-IMMU2539>3.0.CO;2-9; Hegmans JPJJ, 2006, EUR RESPIR J, V27, P1086, DOI 10.1183/09031936.06.00135305; Herber DL, 2010, NAT MED, V16, P880, DOI 10.1038/nm.2172; Hilkens CMU, 1997, BLOOD, V90, P1920, DOI 10.1182/blood.V90.5.1920; Inoshima N, 2002, CLIN CANCER RES, V8, P3480; Jackaman C, 2003, J IMMUNOL, V171, P5051, DOI 10.4049/jimmunol.171.10.5051; KE Y, 1989, AM J PATHOL, V134, P979; Kiertscher SM, 2000, J IMMUNOL, V164, P1269, DOI 10.4049/jimmunol.164.3.1269; Le Naour F, 2001, J BIOL CHEM, V276, P17920, DOI 10.1074/jbc.M100156200; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Mamotte CDS, 1996, ATHEROSCLEROSIS, V125, P103, DOI 10.1016/0021-9150(96)05867-4; MANNING LS, 1991, INT J CANCER, V47, P285, DOI 10.1002/ijc.2910470219; Moretto MM, 2010, INFECT IMMUN, V78, P2505, DOI 10.1128/IAI.00753-09; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; Oyama T, 1998, J IMMUNOL, V160, P1224; Parish CR, 1999, IMMUNOL CELL BIOL, V77, P499, DOI 10.1046/j.1440-1711.1999.00877.x; Peguet-Navarro J, 2003, J IMMUNOL, V170, P3488, DOI 10.4049/jimmunol.170.7.3488; Pooley JL, 2001, J IMMUNOL, V166, P5327, DOI 10.4049/jimmunol.166.9.5327; Robinson BWS, 2005, LANCET, V366, P397, DOI 10.1016/S0140-6736(05)67025-0; Saito T, 2008, CANCER SCI, V99, P2028, DOI 10.1111/j.1349-7006.2008.00907.x; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Sombroek CC, 2002, J IMMUNOL, V168, P4333, DOI 10.4049/jimmunol.168.9.4333; Torres-Aguilar H, 2010, J IMMUNOL, V184, P1765, DOI 10.4049/jimmunol.0902133; Villablanca EJ, 2010, NAT MED, V16, P98, DOI 10.1038/nm.2074; Yang AS, 2003, CANCER RES, V63, P2150; Zeyda M, 2005, J BIOL CHEM, V280, P14293, DOI 10.1074/jbc.M410000200	49	28	29	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123563	10.1371/journal.pone.0123563	http://dx.doi.org/10.1371/journal.pone.0123563			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886502	Green Published, Green Submitted, gold			2022-12-26	WOS:000353017000073
J	Kirchberger, J; Eisenhauer, N; Weisser, WW; Turke, M				Kirchberger, Johannes; Eisenhauer, Nico; Weisser, Wolfgang W.; Tuerke, Manfred			Experimental Evaluation of Herbivory on Live Plant Seedlings by the Earthworm Lumbricus terrestris L. in the Presence and Absence of Soil Surface Litter	PLOS ONE			English	Article							INVERTEBRATE HERBIVORY; GRASSLAND; PALATABILITY; COMMUNITIES; DIVERSITY; PATTERNS; SEEDS	Background Recent studies suggested that the earthworm Lumbricus terrestris might act as a seedling predator by ingesting emerging seedlings, and individuals were observed damaging fresh leaves of various plant species in the field. To evaluate the significance of herbivore behavior of L. terrestris for plant and earthworm performance we exposed 23-to 33-days-old seedlings of six plant species to earthworms in two microcosm experiments. Plants belonged to the three functional groups grasses, non-leguminous herbs, and legumes. Leaf damage, leaf mortality, the number of leaves as well as mortality and growth of seedlings were followed over a period of up to 26 days. In a subset of replicates 0.1 g of soil surface litter of each of the six plant species was provided and consumption was estimated regularly to determine potential feeding preferences of earthworms. Results There was no difference in seedling growth, the number of live seedlings and dead leaves between treatments with or without worms. Fresh leaves were damaged eight times during the experiment, most likely by L. terrestris, with two direct observations of earthworms tearing off leaf parts. Another nine leaves were partly pulled into earthworm burrows. Lumbricus terrestris preferred to consume legume litter over litter of the other plant functional groups. Earthworms that consumed litter lost less weight than individuals that were provided with soil and live plants only, indicating that live plants are not a suitable substitute for litter in earthworm nutrition. Conclusion Our results demonstrate that L. terrestris damages live plants; however, this behavior occurs only rarely. Pulling live plants into earthworm burrows might induce microbial decomposition of leaves to make them suitable for later consumption. Herbivory on plants beyond the initial seedling stage may only play a minor role in earthworm nutrition and has limited potential to influence plant growth.	[Kirchberger, Johannes; Weisser, Wolfgang W.; Tuerke, Manfred] Tech Univ Munich, Terr Ecol Res Grp, Dept Ecol & Ecosyst Management, D-85354 Freising Weihenstephan, Germany; [Eisenhauer, Nico; Tuerke, Manfred] German Ctr Integrat Biodivers Res iDiv, D-04103 Leipzig, Germany; [Eisenhauer, Nico; Tuerke, Manfred] Univ Leipzig, Inst Biol, D-04103 Leipzig, Germany	Technical University of Munich; Leipzig University	Turke, M (corresponding author), Tech Univ Munich, Terr Ecol Res Grp, Dept Ecol & Ecosyst Management, Hans Carl von Carlowitz Pl 2, D-85354 Freising Weihenstephan, Germany.	manfred.tuerke@gmx.net	Eisenhauer, Nico/I-5932-2012; Weisser, Wolfgang W/B-9718-2014; Eisenhauer, Nico/I-3191-2019; Türke, Manfred/AFE-8308-2022	Eisenhauer, Nico/0000-0002-0371-6720; Weisser, Wolfgang W/0000-0002-2757-8959; Eisenhauer, Nico/0000-0002-0371-6720; Türke, Manfred/0000-0002-8957-5454	German Ministry for Research and Education (BMBF) within the LEGATO-project [FKZ 01LL09 170]; German Centre for Integrative Biodiversity Research (iDiv) - German Science Foundation DFG [FZT 118]; DFG [FOR 1451]; Technische Universitat Munchen	German Ministry for Research and Education (BMBF) within the LEGATO-project(Federal Ministry of Education & Research (BMBF)); German Centre for Integrative Biodiversity Research (iDiv) - German Science Foundation DFG; DFG(German Research Foundation (DFG)); Technische Universitat Munchen	MT was funded by the German Ministry for Research and Education (BMBF funding measure 'Sustainable land management') within the LEGATO-project (FKZ 01LL09 170). NE was supported by the German Centre for Integrative Biodiversity Research (iDiv), funded by the German Science Foundation DFG (FZT 118). WWW was supported by the DFG (FOR 1451). This publication was financially supported by the DFG and the Technische Universitat Munchen in the framework of the program 'Open-Access-Publishing'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Barton KE, 2013, ANN BOT-LONDON, V112, P643, DOI 10.1093/aob/mct139; BELSKY AJ, 1986, AM NAT, V127, P870, DOI 10.1086/284531; Carson WP, 2000, ECOL MONOGR, V70, P73, DOI 10.1890/0012-9615(2000)070[0073:HAPSCC]2.0.CO;2; Cole L, 2006, APPL SOIL ECOL, V33, P186, DOI 10.1016/j.apsoil.2005.11.003; Curry J. P., 2007, PEDOBIOLOGIA, V50, P463, DOI DOI 10.1016/j.pedobi.2006.09.001; Daniel O, 1996, SOIL BIOL BIOCHEM, V28, P1235, DOI 10.1016/0038-0717(96)00121-6; Darwin C, 1882, FORMATION VEGETABLE; Doube BM, 1997, SOIL BIOL BIOCHEM, V29, P569, DOI 10.1016/S0038-0717(96)00032-6; Edwards CA, 1996, BIOL ECOLOGY EARTHWO, DOI DOI 10.1016/S0167-8809(97)88859-7; Eisenhauer N, 2012, OIKOS, V121, P1121, DOI 10.1111/j.1600-0706.2011.19807.x; Eisenhauer N, 2010, SOIL BIOL BIOCHEM, V42, P1245, DOI 10.1016/j.soilbio.2010.04.012; Eisenhauer N, 2009, PEDOBIOLOGIA, V52, P151, DOI 10.1016/j.pedobi.2008.07.002; Forey E, 2011, ACTA OECOL, V37, P594, DOI 10.1016/j.actao.2011.03.001; Frund HC, 2010, PEDOBIOLOGIA, V53, P119, DOI 10.1016/j.pedobi.2009.07.002; Griffith B, 2013, EUR J SOIL BIOL, V55, P62, DOI 10.1016/j.ejsobi.2012.12.002; Hulme PE, 1996, J ECOL, V84, P43, DOI 10.2307/2261698; Loranger H, 2014, OECOLOGIA, V174, P183, DOI 10.1007/s00442-013-2741-5; Prather CM, 2013, BIOL REV, V88, P327, DOI 10.1111/brv.12002; Scheu S, 2003, PEDOBIOLOGIA, V47, P846, DOI 10.1016/s0031-4056(04)70279-6; Schonholzer F, 1998, SOIL BIOL BIOCHEM, V30, P1805, DOI 10.1016/S0038-0717(98)00049-2; Shumway DL, 1994, APPL SOIL ECOL, V1, P11, DOI 10.1016/0929-1393(94)90019-1; Stein C, 2010, ECOLOGY, V91, P1639, DOI 10.1890/09-0600.1; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Weisser W.W., 2004, INSECTS ECOSYSTEM FU; Zaller JG, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-20	26	6	6	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123465	10.1371/journal.pone.0123465	http://dx.doi.org/10.1371/journal.pone.0123465			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885861	Green Published, gold, Green Submitted			2022-12-26	WOS:000353017000068
J	Levine, AP; Duchen, MR; de Villiers, S; Rich, PR; Segal, AW				Levine, Adam P.; Duchen, Michael R.; de Villiers, Simon; Rich, Peter R.; Segal, Anthony W.			Alkalinity of Neutrophil Phagocytic Vacuoles Is Modulated by HVCN1 and Has Consequences for Myeloperoxidase Activity	PLOS ONE			English	Article							NADPH OXIDASE; INTRACELLULAR PH; PROTON CHANNELS; SUPEROXIDE-PRODUCTION; PHAGOSOMAL PH; CATHEPSIN-G; VOLTAGE; CHLORINATION; TRANSPORT; SENSITIVITY	The NADPH oxidase of neutrophils, essential for innate immunity, passes electrons across the phagocytic membrane to form superoxide in the phagocytic vacuole. Activity of the oxidase requires that charge movements across the vacuolar membrane are balanced. Using the pH indicator SNARF, we measured changes in pH in the phagocytic vacuole and cytosol of neutrophils. In human cells, the vacuolar pH rose to similar to 9, and the cytosol acidified slightly. By contrast, in Hvcn1 knock out mouse neutrophils, the vacuolar pH rose above 11, vacuoles swelled, and the cytosol acidified excessively, demonstrating that ordinarily this channel plays an important role in charge compensation. Proton extrusion was not diminished in Hvcn1(-/-) mouse neutrophils arguing against its role in maintaining pH homeostasis across the plasma membrane. Conditions in the vacuole are optimal for bacterial killing by the neutral proteases, cathepsin G and elastase, and not by myeloperoxidase, activity of which was unphysiologically low at alkaline pH.	[Levine, Adam P.; Segal, Anthony W.] UCL, Div Med, London, England; [Duchen, Michael R.] UCL, Dept Cell & Dev Biol, London, England; [de Villiers, Simon; Rich, Peter R.] UCL, Glynn Lab Bioenerget, Dept Biol, London, England	University of London; University College London; University of London; University College London; University of London; University College London	Segal, AW (corresponding author), UCL, Div Med, London, England.	t.segal@ucl.ac.uk	duchen, michael/A-2116-2009	duchen, michael/0000-0003-2548-4294; Levine, Adam/0000-0003-1333-9938; Segal, Anthony/0000-0001-7602-9043	Wellcome Trust [WT081695]; Biotechnology and Biological Sciences Research Council; Irwin Joffe Memorial Fellowship; BBSRC [BB/K001094/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K001094/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Irwin Joffe Memorial Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Wellcome Trust Grant WT081695, the Biotechnology and Biological Sciences Research Council, and the Irwin Joffe Memorial Fellowship (APL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSNETT S, 1990, AM J PHYSIOL, V258, pC171, DOI 10.1152/ajpcell.1990.258.1.C171; BORREGAARD N, 1984, J CLIN INVEST, V74, P455, DOI 10.1172/JCI111442; Bourque CW, 2008, NAT REV NEUROSCI, V9, P519, DOI 10.1038/nrn2400; CECH P, 1984, BLOOD, V63, P88; Clanton TL, 2013, COMPR PHYSIOL, V3, P1135, DOI 10.1002/cphy.c120030; Cross AR, 2004, BBA-BIOENERGETICS, V1657, P1, DOI 10.1016/j.bbabio.2004.03.008; Czirjak G, 2006, MOL PHARMACOL, V69, P1024, DOI 10.1124/mol.105.018556; DALE WE, 1991, ANN NY ACAD SCI, V639, P616, DOI 10.1111/j.1749-6632.1991.tb17359.x; DeCoursey TE, 2003, NATURE, V422, P531, DOI 10.1038/nature01523; Dri P, 2002, CYTOMETRY, V48, P159, DOI 10.1002/cyto.10123; EGLINTON DG, 1982, BIOCHIM BIOPHYS ACTA, V703, P187, DOI 10.1016/0167-4838(82)90047-4; El Chemaly A, 2014, J LEUKOCYTE BIOL, V95, P827, DOI 10.1189/jlb.0513251; El Chemaly A, 2010, J EXP MED, V207, P129, DOI 10.1084/jem.20091837; Feldmesser M, 2006, INFECT IMMUN, V74, P6514, DOI 10.1128/IAI.01551-06; GRINSTEIN S, 1992, J EXP BIOL, V172, P179; GRINSTEIN S, 1986, AM J PHYSIOL, V251, pC55, DOI 10.1152/ajpcell.1986.251.1.C55; Grinstein S, AMJPHYSIOL, V250, pC283; Hahn I, 2011, INFECT IMMUN, V79, P4893, DOI 10.1128/IAI.05593-11; HENDERSON LM, 1987, BIOCHEM J, V246, P325, DOI 10.1042/bj2460325; HENDERSON LM, 1988, BIOCHEM J, V255, P285; HENDERSON LM, 1988, BIOCHEM J, V251, P563, DOI 10.1042/bj2510563; HILLAR A, 1995, ARCH BIOCHEM BIOPHYS, V323, P438, DOI 10.1006/abbi.1995.0065; HOLLAND PC, 1971, BIOCHEM J, V121, pP42; Holland SM, 2013, HEMATOL ONCOL CLIN N, V27, P89, DOI 10.1016/j.hoc.2012.11.002; HURST JK, 1984, J BIOL CHEM, V259, P4812; Ishida Y, 2013, J GEN PHYSIOL, V141, P705, DOI 10.1085/jgp.201210930; Jankowski A, 2002, J BIOL CHEM, V277, P6059, DOI 10.1074/jbc.M110059200; Jiang LL, 2012, J CELL SCI, V125, P5479, DOI 10.1242/jcs.110072; Jiang Q, 1997, CHEM RES TOXICOL, V10, P1080, DOI 10.1021/tx9700984; Johnson RP, 2004, AM J PHYSIOL-CELL PH, V286, pC391, DOI 10.1152/ajpcell.00401.2003; KETTLE AJ, 1995, BIOCHEM J, V308, P559, DOI 10.1042/bj3080559; KETTLE AJ, 1988, BIOCHEM J, V252, P529, DOI 10.1042/bj2520529; KETTLE AJ, 1988, BIOCHIM BIOPHYS ACTA, V957, P185, DOI 10.1016/0167-4838(88)90271-3; Klebanoff SJ, 2013, J LEUKOCYTE BIOL, V93, P185, DOI 10.1189/jlb.0712349; Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009; Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522; MAYER SJ, 1989, J LEUKOCYTE BIOL, V45, P239, DOI 10.1002/jlb.45.3.239; MCRIPLEY RJ, 1967, J BACTERIOL, V94, P1425, DOI 10.1128/JB.94.5.1425-1430.1967; Meech Robert, 2012, Wiley Interdiscip Rev Membr Transp Signal, V1, P533; MOLSKI TFP, 1980, BIOCHEM BIOPH RES CO, V94, P508, DOI 10.1016/0006-291X(80)91260-7; Moreland JG, 2006, J BIOL CHEM, V281, P12277, DOI 10.1074/jbc.M511030200; Morgan D, 2005, J PHYSIOL-LONDON, V569, P419, DOI 10.1113/jphysiol.2005.094748; Morgan D, 2009, P NATL ACAD SCI USA, V106, P18022, DOI 10.1073/pnas.0905565106; Murphy EJ, 2010, BIOCHEMISTRY-US, V49, P2150, DOI 10.1021/bi9021507; NAUSEEF WM, 1983, BLOOD, V61, P483; Okochi Y, 2009, BIOCHEM BIOPH RES CO, V382, P274, DOI 10.1016/j.bbrc.2009.03.036; Osteen JD, 2008, BIOPHYS J, V95, P4668, DOI 10.1529/biophysj.108.137158; OWEN CS, 1992, ANAL BIOCHEM, V204, P65, DOI 10.1016/0003-2697(92)90140-3; Painter RG, 2010, J LEUKOCYTE BIOL, V87, P933, DOI 10.1189/jlb.1009655; Pulli B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067976; Rada BK, 2004, BLOOD, V104, P2947, DOI 10.1182/blood-2004-03-1005; Ramsey IS, 2009, P NATL ACAD SCI USA, V106, P7642, DOI 10.1073/pnas.0902761106; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; Schrenzel J, 1998, NATURE, V392, P734, DOI 10.1038/33725; SEGAL AW, 1978, BIOCHEM BIOPH RES CO, V84, P611, DOI 10.1016/0006-291X(78)90749-0; SEGAL AW, 1981, NATURE, V290, P406, DOI 10.1038/290406a0; Sewell GW, 2012, INFLAMM BOWEL DIS, V18, P2120, DOI 10.1002/ibd.22952; Shi YJ, 2013, ADV EXP MED BIOL, V961, P411, DOI 10.1007/978-1-4614-4756-6_35; SIMCHOWITZ L, 1985, J GEN PHYSIOL, V85, P443, DOI 10.1085/jgp.85.3.443; Stauber T, 2013, ANNU REV PHYSIOL, V75, P453, DOI 10.1146/annurev-physiol-030212-183702; Sun HS, 2007, BIOPHYS J, V93, P1175, DOI 10.1529/biophysj.106.103333; Sun YT, 2012, J PHYSIOL-LONDON, V590, P3231, DOI 10.1113/jphysiol.2011.225300; TAKAHASHI T, 1985, CRYOBIOLOGY, V22, P215, DOI 10.1016/0011-2240(85)90143-9; TINGBEALL HP, 1993, BLOOD, V81, P2774; Tkalcevic J, 2000, IMMUNITY, V12, P201, DOI 10.1016/S1074-7613(00)80173-9	67	53	53	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0125906	10.1371/journal.pone.0125906	http://dx.doi.org/10.1371/journal.pone.0125906			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885273	gold, Green Published, Green Submitted			2022-12-26	WOS:000353017000164
J	Xiao, D; Peng, SP; Wang, EY				Xiao, Dong; Peng, Su-Ping; Wang, En-Yuan			Fermentation Enhancement of Methanogenic Archaea Consortia from an Illinois Basin Coalbed via DOL Emulsion Nutrition	PLOS ONE			English	Article							BIOGENIC METHANE; USA	Microbially enhanced coalbed methane technology must be used to increase the methane content in mining and generate secondary biogenic gas. In this technology, the metabolic processes of methanogenic consortia are the basis for the production of biomethane from some of the organic compounds in coal. Thus, culture nutrition plays an important role in re-mediating the nutritional deficiency of a coal seam. To enhance the methane production rates for microorganism consortia, different types of nutrition solutions were examined in this study. Emulsion nutrition solutions containing a novel nutritional supplement, called dystrophy optional modification latex, increased the methane yield for methanogenic consortia. This new nutritional supplement can help methanogenic consortia form an enhanced anaerobic environment, optimize the microbial balance in the consortia, and improve the methane biosynthesis rate.	[Xiao, Dong] China Univ Min & Technol, State Key Lab Coal Resources & Safe Min, Xuzhou, Jiang Su Provin, Peoples R China; [Peng, Su-Ping] China Univ Min & Technol, State Key Lab Coal Resources & Safe Min, Beijing, Peoples R China; [Wang, En-Yuan] China Univ Min & Technol, Fac Safety Engn, Xuzhou, Jiang Su Provin, Peoples R China	China University of Mining & Technology; China University of Mining & Technology; China University of Mining & Technology	Xiao, D (corresponding author), China Univ Min & Technol, State Key Lab Coal Resources & Safe Min, Xuzhou, Jiang Su Provin, Peoples R China.	dong.shaw@gmail.com		Wang, Enyuan/0000-0003-0239-3015; Xiao, Dong/0000-0001-9055-598X	Youth Science and Technology Found from Jiangsu Science and Technology Project [BK20140199]; Youth Science and Technology Found from CUMT Basic Scientific Research Project [2014QNB41]; State Key Laboratory of Coal Resources and Safe Mining, CUMT [SKLCRSM12X08]; Science and Technology Enterprise Innovation Fund from Jiangsu Science and Technology Department [BC2014066]; Development of Jiangsu Higher Education Institutions (PAPD) [SZBF2011-6-B35]	Youth Science and Technology Found from Jiangsu Science and Technology Project; Youth Science and Technology Found from CUMT Basic Scientific Research Project; State Key Laboratory of Coal Resources and Safe Mining, CUMT; Science and Technology Enterprise Innovation Fund from Jiangsu Science and Technology Department; Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by Youth Science and Technology Found BK20140199 from Jiangsu Science and Technology Project (http://www.jskjjh.gov.cn), by Youth Science and Technology Found 2014QNB41 from CUMT Basic Scientific Research Project, by State Key Laboratory of Coal Resources and Safe Mining, CUMT (SKLCRSM12X08) (http://skl.cumt.edu.cn/), and by Science and Technology Enterprise Innovation Fund (BC2014066) from Jiangsu Science and Technology Department (http://www.jskjjh.gov.cn), by Development of Jiangsu Higher Education Institutions (PAPD) SZBF2011-6-B35 (http://www.cumt.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCTECH Inc., 1993, TR101572 EPRI, P36; ARCTECH Inc., 1990, BIOL GAS COALS, P130; Barik S, 1998, PREPR PAP AM CHEM SO, V33, P548; Barik S, 1989, INVESTIGATION METABO, P193; Barik S, 1998, P 2 INT S BIOL PROC, P23; Faison B, MICROBIAL TRANSFORMA, P1; Gateway Mine, 2014, PEAB EN; Green MS, 2008, INT J COAL GEOL, V76, P34, DOI 10.1016/j.coal.2008.05.001; Jones EJP, 2008, INT J COAL GEOL, V76, P138, DOI 10.1016/j.coal.2008.05.011; Martini AM, 1998, GEOCHIM COSMOCHIM AC, V62, P1699, DOI 10.1016/S0016-7037(98)00090-8; MCINERNEY MJ, 1988, CAN J MICROBIOL, V34, P487, DOI 10.1139/m88-083; McIntosh J, 2008, INT J COAL GEOL, V76, P111, DOI 10.1016/j.coal.2008.03.004; Olson GJ, 1986, PROCESSING COAL MICR; Patrick CG, 2007, WORLD OIL, V228, P37; Scott AR, 1990, COALBED METHANE SCI, P89; TANNER RS, 2002, MANUAL ENV MICROBIOL, P62; THIELE JH, 1988, APPL ENVIRON MICROB, V54, P20, DOI 10.1128/AEM.54.1.20-29.1988; Winfrey M.R., 1984, PETROLEUM MICROBIOLO, P153	18	5	5	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124386	10.1371/journal.pone.0124386	http://dx.doi.org/10.1371/journal.pone.0124386			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884952	Green Published, gold, Green Submitted			2022-12-26	WOS:000353017000122
J	Barreto-Ortiz, SF; Fradkin, J; Eoh, J; Trivero, J; Davenport, M; Ginn, B; Mao, HQ; Gerecht, S				Barreto-Ortiz, Sebastian F.; Fradkin, Jamie; Eoh, Joon; Trivero, Jacqueline; Davenport, Matthew; Ginn, Brian; Hai-Quan Mao; Gerecht, Sharon			Fabrication of 3-dimensional multicellular microvascular structures	FASEB JOURNAL			English	Article						extracellular matrix; fibrin; microfiber; endothelial cell; perivascular cell	VASCULAR SMOOTH-MUSCLE; EXTRACELLULAR-MATRIX; BLOOD-VESSEL; IN-VITRO; TISSUE; FIBRIN; MORPHOGENESIS; MECHANISMS; ALIGNMENT; NETWORKS	Despite current advances in engineering blood vessels over 1 mm in diameter and the existing wealth of knowledge regarding capillary bed formation, studies for the development of microvasculature, the connecting bridge between them, have been extremely limited so far. Here, we evaluate the use of 3-dimensional (3D) microfibers fabricated by hydrogel electrospinning as templates for microvascular structure formation. We hypothesize that 3D microfibers improve extracellular matrix (ECM) deposition from vascular cells, enabling the formation of freestanding luminal multicellular microvasculature. Compared to 2-dimensional cultures, we demonstrate with confocal microscopy and RT-PCR that fibrin microfibers induce an increased ECM protein deposition by vascular cells, specifically endothelial colony-forming cells, pericytes, and vascular smooth muscle cells. These ECM proteins comprise different layers of the vascular wall including collagen types I, III, and IV, as well as elastin, fibronectin, and laminin. We further demonstrate the achievement of multicellular microvascular structures with an organized endothelium and a robust multicellular perivascular tunica media. This, along with the increased ECM deposition, allowed for the creation of self-supporting multilayered microvasculature with a distinct circular lumen following fibrin microfiber core removal. This approach presents an advancement toward the development of human microvasculature for basic and translational studies.	[Barreto-Ortiz, Sebastian F.; Fradkin, Jamie; Eoh, Joon; Trivero, Jacqueline; Davenport, Matthew; Gerecht, Sharon] Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Barreto-Ortiz, Sebastian F.; Fradkin, Jamie; Eoh, Joon; Trivero, Jacqueline; Davenport, Matthew; Gerecht, Sharon] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD 21218 USA; [Fradkin, Jamie; Eoh, Joon; Hai-Quan Mao] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Ginn, Brian; Hai-Quan Mao; Gerecht, Sharon] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA; [Ginn, Brian; Hai-Quan Mao] Johns Hopkins Sch Med, Translat Tissue Engn Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Gerecht, S (corresponding author), Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Dept Chem & Biomol Engn, 3400 N Charles St, Baltimore, MD 21218 USA.	gerecht@jhu.edu	Gerecht, Sharon/HCH-8629-2022	Gerecht, Sharon/0000-0002-8542-4835; Eoh, Joon/0000-0002-9890-4598; Mao, Hai-Quan/0000-0002-4262-9988	U.S. National Institutes of Health [R01HL107938, U54CA143868]; W.W. Smith Charitable Trust grant; NATIONAL CANCER INSTITUTE [U54CA143868] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107938] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W.W. Smith Charitable Trust grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Andrew Mao and Patrick Pena for assisting with cell culture and sample preparation. This research was partially funded by U.S. National Institutes of Health Grants R01HL107938 (National Heart, Lung, and Blood Institute) and U54CA143868 (National Cancer Institute); and a W.W. Smith Charitable Trust grant (to S.G.).	Abaci HE, 2014, SCI REP-UK, V4, DOI 10.1038/srep04951; Ahmann KA, 2010, TISSUE ENG PT A, V16, P3261, DOI [10.1089/ten.tea.2009.0708, 10.1089/ten.TEA.2009.0708]; ANONICK PK, 1992, ARTERIOSCLER THROMB, V12, P708, DOI 10.1161/01.ATV.12.6.708; Auger FA, 2013, ANNU REV BIOMED ENG, V15, P177, DOI 10.1146/annurev-bioeng-071812-152428; Baranski JD, 2013, P NATL ACAD SCI USA, V110, P7586, DOI 10.1073/pnas.1217796110; Barreto-Ortiz SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081061; Brooke BS, 2003, TRENDS CELL BIOL, V13, P51, DOI 10.1016/S0962-8924(02)00007-7; Chen XF, 2009, TISSUE ENG PT A, V15, P1363, DOI 10.1089/ten.tea.2008.0314; Clark RAF, 2003, J INVEST DERMATOL, V121, pXXI, DOI 10.1046/j.1523-1747.2003.12575.x; Dahl SLM, 2003, CELL TRANSPLANT, V12, P659, DOI 10.3727/000000003108747136; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Davis George E., 2007, Birth Defects Research, V81, P270, DOI 10.1002/bdrc.20107; Dickinson LE, 2010, SOFT MATTER, V6, P5109, DOI 10.1039/c0sm00233j; Gao J, 2008, J BIOMED MATER RES A, V85A, P1120, DOI 10.1002/jbm.a.32028; Grassl ED, 2002, J BIOMED MATER RES, V60, P607, DOI 10.1002/jbm.10107; Hanjaya-Putra D, 2011, BLOOD, V118, P804, DOI 10.1182/blood-2010-12-327338; Hanjaya-Putra D, 2010, J CELL MOL MED, V14, P2436, DOI 10.1111/j.1582-4934.2009.00981.x; He JK, 2013, ADV HEALTHC MATER, V2, P1108, DOI 10.1002/adhm.201200404; HIBBS RG, 1958, AM HEART J, V56, P662, DOI 10.1016/0002-8703(58)90209-6; Huang GY, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/1/012001; Hungerford JE, 1996, DEV BIOL, V178, P375, DOI 10.1006/dbio.1996.0225; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Kelm JM, 2010, J BIOTECHNOL, V148, P46, DOI 10.1016/j.jbiotec.2010.03.002; Kim BS, 1998, BIOTECHNOL BIOENG, V57, P46; Kim JA, 2006, J CEREBR BLOOD F MET, V26, P209, DOI 10.1038/sj.jcbfm.9600181; Kobayashi A, 2007, BIOCHEM BIOPH RES CO, V358, P692, DOI 10.1016/j.bbrc.2007.04.206; Kolesky DB, 2014, ADV MATER, V26, P3124, DOI 10.1002/adma.201305506; Kusuma S, 2012, FASEB J, V26, P4925, DOI 10.1096/fj.12-209296; L'Heureux N, 1998, FASEB J, V12, P47, DOI 10.1096/fasebj.12.1.47; LAURIE GW, 1982, J CELL BIOL, V95, P340, DOI 10.1083/jcb.95.1.340; Li YH, 2014, BIOTECHNOL ADV, V32, P347, DOI 10.1016/j.biotechadv.2013.11.007; Liu B, 2008, BIOPHYS J, V94, P1497, DOI 10.1529/biophysj.106.098574; Lodish H, 2000, MOL CELL BIOL; Long JL, 2003, MATRIX BIOL, V22, P339, DOI 10.1016/S0945-053X(03)00052-0; Marieb EN, 2007, HUMAN ANATOMY PHYSL; Mecham RP, 1997, J BIOL CHEM, V272, P18071, DOI 10.1074/jbc.272.29.18071; Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/NMAT3357, 10.1038/nmat3357]; Montano I, 2010, TISSUE ENG PT A, V16, P269, DOI [10.1089/ten.tea.2008.0550, 10.1089/ten.TEA.2008.0550]; Neumann T, 2003, MICROVASC RES, V66, P59, DOI 10.1016/S0026-2862(03)00040-2; Norotte C, 2009, BIOMATERIALS, V30, P5910, DOI 10.1016/j.biomaterials.2009.06.034; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Patel A, 2006, CARDIOVASC RES, V71, P40, DOI 10.1016/j.cardiores.2006.02.021; Pocock G, 2013, HUM PHYSIOL+; Quint C, 2011, P NATL ACAD SCI USA, V108, P9214, DOI 10.1073/pnas.1019506108; Rijken DC, 2009, J THROMB HAEMOST, V7, P4, DOI 10.1111/j.1538-7836.2008.03220.x; Roy S, 2010, CURR EYE RES, V35, P1045, DOI 10.3109/02713683.2010.514659; Standring A., 2008, ANATOMICAL BASIS CLI, V40th, p409?421; Tsamis A, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1004; Tsuda Y, 2007, BIOMATERIALS, V28, P4939, DOI 10.1016/j.biomaterials.2007.08.002; Vaz CM, 2005, ACTA BIOMATER, V1, P575, DOI 10.1016/j.actbio.2005.06.006; Verbridge SS, 2013, J BIOMED MATER RES A, V101, P2948, DOI 10.1002/jbm.a.34587; Wanjare M, 2014, STEM CELL REP, V2, P561, DOI 10.1016/j.stemcr.2014.03.004; Wanjare M, 2013, BIOTECHNOL J, V8, P434, DOI 10.1002/biot.201200199; WEBER K, 1973, ARCH DERMATOL FORSCH, V248, P29, DOI 10.1007/BF00594710; Wu W, 2011, ADV MATER, V23, pH178, DOI 10.1002/adma.201004625; YEN A, 1976, J INVEST DERMATOL, V66, P131, DOI 10.1111/1523-1747.ep12481678; Zhang SM, 2014, BIOMATERIALS, V35, P3243, DOI 10.1016/j.biomaterials.2013.12.081; Zheng Y, 2012, P NATL ACAD SCI USA, V109, P9342, DOI 10.1073/pnas.1201240109	58	22	23	0	57	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3302	3314		10.1096/fj.14-263343	http://dx.doi.org/10.1096/fj.14-263343			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25900808	Green Published			2022-12-26	WOS:000358796900018
J	Suo, YJ; Dong, C; Kang, XY				Suo, Yujing; Dong, Chunbo; Kang, Xiangyang			Inheritance and Variation of Cytosine Methylation in Three Populus Allotriploid Populations with Different Heterozygosity	PLOS ONE			English	Article							DNA-METHYLATION; WIDE HYBRIDIZATION; GENOME; POLYPLOIDY; ALLOPOLYPLOIDY; BRASSICA; PATTERNS; RICE	DNA methylation is an epigenetic mechanism with the potential to regulate gene expression and affect plant phenotypes. Both hybridization and genome doubling may affect the DNA methylation status of newly formed allopolyploid plants. Previous studies demonstrated that changes in cytosine methylation levels and patterns were different among individual hybrid plant, therefore, studies investigating the characteristics of variation in cytosine methylation status must be conducted at the population level to avoid sampling error. In the present study, an F1 hybrid diploid population and three allotriploid populations with different heterozygosity [originating from first-division restitution (FDR), second-division restitution (SDR), and post-meiotic restitution (PMR) 2n eggs of the same female parent] were used to investigate cytosine methylation inheritance and variation relative to their common parents using methylation-sensitive amplification polymorphism (MSAP). The variation in cytosine methylation in individuals in each population exhibited substantial differences, confirming the necessity of population epigenetics. The total methylation levels of the diploid population were significantly higher than in the parents, but those of the three allotriploid populations were significantly lower than in the parents, indicating that both hybridization and polyploidization contributed to cytosine methylation variation. The vast majority of methylated status could be inherited from the parents, and the average percentages of non-additive variation were 6.29, 3.27, 5.49 and 5.07% in the diploid, FDR, SDR and PMR progeny populations, respectively. This study lays a foundation for further research on population epigenetics in allopolyploids.	[Suo, Yujing; Dong, Chunbo; Kang, Xiangyang] Beijing Forestry Univ, Coll Biol Sci & Technol, Natl Engn Lab Tree Breeding, Beijing, Peoples R China; [Kang, Xiangyang] Beijing Forestry Univ, Coll Biol Sci & Technol, Key Lab Genet & Breeding Forest Trees & Ornamenta, Minist Educ, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University	Kang, XY (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol, Natl Engn Lab Tree Breeding, Beijing, Peoples R China.	kangxy@bjfu.edu.cn		Kang, Xiangyang/0000-0002-2557-4356	Special Fund for Forest Scientific Research in the Public Welfare [201404113]; 111 Project [B13007]; Program for Changjiang Scholars and Innovative Research Team in University [IRT13047]	Special Fund for Forest Scientific Research in the Public Welfare; 111 Project(Ministry of Education, China - 111 Project); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the Special Fund for Forest Scientific Research in the Public Welfare (201404113), the 111 Project (B13007) and the Program for Changjiang Scholars and Innovative Research Team in University (IRT13047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RJ, 2004, BIOL J LINN SOC, V82, P467, DOI 10.1111/j.1095-8312.2004.00333.x; Baumel A, 2002, MOL PHYLOGENET EVOL, V22, P303, DOI 10.1006/mpev.2001.1064; Chen CB, 2013, FOREST RES, P69; Chen LZ, 2008, GENOME, V51, P789, DOI 10.1139/G08-063; Dong CB, 2014, PLANT J, V80, P282, DOI 10.1111/tpj.12631; Dong CB, 2014, CAN J FOREST RES, V44, P692, DOI 10.1139/cjfr-2013-0360; Fulnecek J, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-2; Hegarty MJ, 2011, MOL ECOL, V20, P105, DOI 10.1111/j.1365-294X.2010.04926.x; Kang XiangYang, 1997, Acta Botanica Yunnanica, V19, P402; Kang XiangYang, 2010, Journal of Beijing Forestry University, V32, P149; Kashkush K, 2002, GENETICS, V160, P1651; KURATA N, 1978, JPN J GENET, V53, P251, DOI 10.1266/jjg.53.251; Leitch IJ, 1997, TRENDS PLANT SCI, V2, P470, DOI 10.1016/S1360-1385(97)01154-0; LEVIN DA, 1983, AM NAT, V122, P1, DOI 10.1086/284115; Li A, 2011, PLANT MOL BIOL REP, V29, P784, DOI 10.1007/s11105-010-0280-3; Li XL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-207; Lu YL, 2008, J GENET GENOMICS, V35, P41, DOI 10.1016/S1673-8527(08)60006-5; Lukens LN, 2006, PLANT PHYSIOL, V140, P336, DOI 10.1104/pp.105.066308; Madlung A, 2002, PLANT PHYSIOL, V129, P733, DOI 10.1104/pp.003095; MCCLELLAND M, 1994, NUCLEIC ACIDS RES, V22, P3640, DOI 10.1093/nar/22.17.3640; MENDIBURU AO, 1977, THEOR APPL GENET, V49, P53, DOI 10.1007/BF00275164; Parisod C, 2009, NEW PHYTOL, V184, P1003, DOI 10.1111/j.1469-8137.2009.03029.x; Peredo EL, 2006, J PLANT PHYSIOL, V163, P1071, DOI 10.1016/j.jplph.2005.09.010; Salmon A, 2005, MOL ECOL, V14, P1163, DOI 10.1111/j.1365-294X.2005.02488.x; Sha AH, 2005, MOL GENET GENOMICS, V273, P484, DOI 10.1007/s00438-005-1148-3; Shaked H, 2001, PLANT CELL, V13, P1749, DOI 10.1105/tpc.13.8.1749; SONG KM, 1995, P NATL ACAD SCI USA, V92, P7719, DOI 10.1073/pnas.92.17.7719; Verhoeven KJF, 2010, MOL ECOL, V19, P315, DOI 10.1111/j.1365-294X.2009.04460.x; Wang CG, 2009, BOT STUD, V50, P389; Wang J, 2012, SILVAE GENET, V61, P85, DOI 10.1515/sg-2012-0011; Wang J, 2012, ANN FOREST SCI, V69, P59, DOI 10.1007/s13595-011-0152-5; Xu ML, 2000, PLANT MOL BIOL REP, V18, P361, DOI 10.1007/BF02825064; Zhao XX, 2007, PLANT SCI, V172, P930, DOI 10.1016/j.plantsci.2007.01.002	33	6	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0126491	10.1371/journal.pone.0126491	http://dx.doi.org/10.1371/journal.pone.0126491			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901359	Green Published, Green Submitted, gold			2022-12-26	WOS:000353331500124
J	Tang, XL; Wang, HY; Shao, CY; Shao, HB				Tang, Xiaoli; Wang, Hongyan; Shao, Chuyang; Shao, Hongbo			Global Gene Expression of Kosteletzkya virginica Seedlings Responding to Salt Stress	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; BETULA-PLATYPHYLLA; SEASHORE MALLOW; SALINITY; DROUGHT; COLD; ACID; TOLERANCE; BIODIESEL; PROFILE	Soil salinization is becoming a serious threat to crop yield all over the world. Nowadays, acquainting the specific molecular mechanisms underlying various abiotic stresses especially to salt stress should be of great importance. While the development of the high-throughout sequencing technology promoted the progress powerfully. The intricate perception, transduction and regulation mechanisms underlying salt stress are being illustrated more and more clearly. As a perennial halophytic plant, Kosteletzkya virginica is able to help us to understand the mechanisms more directly and effectively. We carried out the whole transcriptome analysis on young seedlings with or without salt treatment through high-throughout sequencing technology. The results revealed that the numbers of different expressed transcripts between control and different treatments are 4145 and 9134, respectively. The ORF prediction suggested that there were 94308 ORF out of the 103489 (91.10%) total transcripts. We also carried out further differential expression analysis through gene ontology (GO) classification, cluster of orthologous groups (COG) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis. In a word, our transcriptome study on Kosteletzkya virginica would provide direct and effective references for researches on molecular mechanisms of salt-tolerance, extending our view of salt tolerance in plant further. Above all, the related report in this paper is the first about Kosteletzkya virginica.	[Tang, Xiaoli; Wang, Hongyan; Shao, Hongbo] Chinese Acad Sci, Yantai Inst Coastal Zone Res YIC, Key Lab Coastal Biol & Bioresources Utilizat, Yantai 264003, Peoples R China; [Shao, Hongbo] Jiangsu Acad Agr Sci, Inst Biotechnol, Nanjing 210014, Peoples R China; [Wang, Hongyan] China Agr Univ, Yantai Acad, Yantai 264670, Peoples R China; [Shao, Chuyang] Shandong Agr Univ, Tai An 271018, Shandong, Peoples R China; [Tang, Xiaoli; Wang, Hongyan] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS; Jiangsu Academy of Agricultural Sciences; China Agricultural University; Shandong Agricultural University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Shao, HB (corresponding author), Chinese Acad Sci, Yantai Inst Coastal Zone Res YIC, Key Lab Coastal Biol & Bioresources Utilizat, Yantai 264003, Peoples R China.	shaohongbochu@126.com			National Natural Science Foundation of China [41171216]; National Basic Research Program of China [2013CB430403]; CAS/SAFEA International Partnership Program for Creative Research Teams, Yantai Science & Technology Development Project [2011016]; Yantai Double-hundred Talent Plan [XY-003-02]; 135 Development Plan of YIC-CAS; Science & Technology Development Plan of Shandong Province [010GSF10208]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); CAS/SAFEA International Partnership Program for Creative Research Teams, Yantai Science & Technology Development Project; Yantai Double-hundred Talent Plan; 135 Development Plan of YIC-CAS(Chinese Academy of Sciences); Science & Technology Development Plan of Shandong Province	This research was partially supported by the National Natural Science Foundation of China (41171216), the National Basic Research Program of China (2013CB430403), the CAS/SAFEA International Partnership Program for Creative Research Teams, Yantai Science & Technology Development Project (No. 2011016), Yantai Double-hundred Talent Plan (XY-003-02), 135 Development Plan of YIC-CAS and the Science & Technology Development Plan of Shandong Province (010GSF10208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashraf M, 2009, BIOTECHNOL ADV, V27, P744, DOI 10.1016/j.biotechadv.2009.05.026; Bedell JA, 2005, PLOS BIOL, V3, P103, DOI 10.1371/journal.pbio.0030013; Chen WQ, 2002, PLANT CELL, V14, P559, DOI 10.1105/tpc.010410; Comai L, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001876; Cui MH, 2013, FEBS LETT, V587, P1773, DOI 10.1016/j.febslet.2013.04.028; deBruxelles GL, 1996, PLANT PHYSIOL, V111, P381, DOI 10.1104/pp.111.2.381; FAO, 2008, LAND PLANT NUTR MAN; Flowers TJ, 2008, NEW PHYTOL, V179, P945, DOI 10.1111/j.1469-8137.2008.02531.x; GALLAGHER JL, 1985, PLANT SOIL, V89, P323, DOI 10.1007/BF02182251; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Guo YQ, 2009, GENETICA, V137, P189, DOI 10.1007/s10709-009-9384-9; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Ibrahim MH, 2013, MOLECULES, V18, P7957, DOI 10.3390/molecules18077957; Jiang YQ, 2009, MOL GENET GENOMICS, V282, P503, DOI 10.1007/s00438-009-0481-3; Jiang YQ, 2009, PLANT MOL BIOL, V69, P91, DOI 10.1007/s11103-008-9408-3; Kalra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083336; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li HZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083530; Lv JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082155; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Matsui A, 2008, PLANT CELL PHYSIOL, V49, P1135, DOI 10.1093/pcp/pcn101; Menzel U, 1999, PROG BIOMET, V14, P127; Moser BR, 2013, RENEW ENERG, V50, P833, DOI 10.1016/j.renene.2012.08.016; Mu HZ, 2012, INT J MOL SCI, V13, P13012, DOI 10.3390/ijms131013012; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Pfeifer-Sancar K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-888; Pinto AC, 2011, GENET MOL RES, V10, P1707, DOI 10.4238/vol10-3gmr1554; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ruan CJ, 2008, ECOL ENG, V32, P320, DOI 10.1016/j.ecoleng.2007.12.010; Schroeder JI, 2013, NATURE, V497, P60, DOI 10.1038/nature11909; Tang X., 2014, CRIT REVI BIOTECH, P1; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Varshney RK, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001883; Villarino GH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094651; Voytas DF, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001877; Wang H, 2014, SCI WORLD J, V2014, P7; Wang YC, 2012, TREE GENET GENOMES, V8, P1031, DOI 10.1007/s11295-012-0483-x; Wang Zhangying FB, 2010, BMC GENOM, V11; Yan K, 2013, ACTA PHYSIOL PLANT, V35, P2867, DOI 10.1007/s11738-013-1325-7; Yang A, 2012, J EXP BOT, V63, P2541, DOI 10.1093/jxb/err431; Yang O, 2009, GENE, V436, P45, DOI 10.1016/j.gene.2009.02.010; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Ye NH, 2011, PLANT CELL PHYSIOL, V52, P689, DOI 10.1093/pcp/pcr028; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhou GS, 2010, AGRON J, V102, P395, DOI 10.2134/agronj2009.0274	49	18	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124421	10.1371/journal.pone.0124421	http://dx.doi.org/10.1371/journal.pone.0124421			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901608	Green Published, gold, Green Submitted			2022-12-26	WOS:000353331500085
J	Tran, MP; Phuong, NT; Scippo, ML; Dalsgaard, A				Tran Minh Phu; Phuong, Nguyen Thanh; Scippo, Marie-Louise; Dalsgaard, Anders			Quality of Antimicrobial Products Used in Striped Catfish (Pangasianodon hypophthalmus) Aquaculture in Vietnam	PLOS ONE			English	Article							EDWARDSIELLA-ICTALURI; ANTIBIOTICS; FEED	Antimicrobial usage is common in Asian aquaculture. This study aimed to determine the quality of antimicrobial products used by Vietnamese striped catfish (Pangasianodon hypophthalmus) farmers. Twenty one antimicrobial products (11 products contained a single antimicrobial and 10 products contained a mixture of two different antimicrobials) commonly used by catfish farmers were obtained from so-called chemical shops located in the Mekong Delta, Vietnam. Ultra High Performance Liquid Chromatography Mass Spectrometry was used to analyze concentration of sulfonamides, trimethoprim, amoxicillin, cefalexin and ciprofloxacin whereas concentrations of florfenicol and doxycycline were analyzed by High Performance Liquid Chromatography with UV detection. Results revealed that only 4/11 products with a single antimicrobial and 2/10 products with a mixture of antimicrobials contained active substances within +/- 10% of the concentration declared on the product label. Two products with antimicrobial mixtures did not contain any of the declared antimicrobials. Comparing two batches, analysis of 11 products revealed that only one product contained a concentration of active compound that varied with less than 10% in both batches. Several product labels provided inadequate information on how to calculate therapeutic dosage and further stated withdrawal time despite lack of pharmacokinetic data on the antimicrobials in catfish. There is an urgent need to strengthen approval procedures and in particular regularly to monitor the quality of antimicrobials used in Vietnamese aquaculture.	[Tran Minh Phu; Phuong, Nguyen Thanh] Can Tho Univ, Coll Aquaculture & Fisheries, Dept Aquat Nutr & Prod Proc, Can Tho, Vietnam; [Tran Minh Phu; Dalsgaard, Anders] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Microbiol, Copenhagen, Denmark; [Scippo, Marie-Louise] Univ Liege, Fac Vet Med, Dept Food Sci, Liege, Belgium	Can Tho University; University of Copenhagen; University of Liege	Tran, MP (corresponding author), Can Tho Univ, Coll Aquaculture & Fisheries, Dept Aquat Nutr & Prod Proc, Can Tho, Vietnam.	tmphu@ctu.edu.vn		Tran, Minh Phu/0000-0002-2521-0667	EU-funded FP7 project "Sustaining Ethical Aquaculture Trade" (SEAT) [222889]	EU-funded FP7 project "Sustaining Ethical Aquaculture Trade" (SEAT)	The work presented received financial and other support from the EU-funded FP7 project "Sustaining Ethical Aquaculture Trade" (SEAT project number 222889; www.seatglobal.eu). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulah R., 2012, PHARM REGUL AFF, V1, P2, DOI [10.4172/2167-7689.1000e106, DOI 10.4172/2167-7689.1000E106]; [Anonymous], 2017, 17025 ISOIEC; Bekoe SO, 2014, ANAL METHODS-UK, V6, P5847, DOI 10.1039/c4ay00748d; Cabello FC, 2006, ENVIRON MICROBIOL, V8, P1137, DOI 10.1111/j.1462-2920.2006.01054.x; Depaola Angelo, 1995, Journal of Aquatic Animal Health, V7, P155, DOI 10.1577/1548-8667(1995)007&lt;0155:TRBBIR&gt;2.3.CO;2; Dung TT, 2008, MICROB DRUG RESIST, V14, P311, DOI 10.1089/mdr.2008.0848; Gaunt PS, 2004, J WORLD AQUACULT SOC, V35, P257, DOI 10.1111/j.1749-7345.2004.tb01083.x; KAMAKURA K, 1994, J FOOD HYG SOC JPN, V35, P310; Mai Van Tai, 2012, FAO Fisheries and Aquaculture Technical Paper, V547, P91; Pearce JN, 2009, FOOD ADDIT CONTAM A, V26, P39, DOI 10.1080/02652030802189757; Phan LT, 2009, AQUACULTURE, V296, P227, DOI 10.1016/j.aquaculture.2009.08.017; Phuc NT, 2012, INT FISH S SHAR KNOW, P98; Prazuck T, 2002, SEX TRANSM DIS, V29, P624, DOI 10.1097/00007435-200211000-00002; Rico A, 2013, AQUACULTURE, V412, P231, DOI 10.1016/j.aquaculture.2013.07.028; Phu TM, 2015, AQUACULTURE, V438, P1, DOI 10.1016/j.aquaculture.2014.12.032; United States Department of Agriculture, 2010, CLG FLOR, V1. 04, P1; US Food and Drug Administration, 2011, US FISH WILDL SERV A; USDA, 2021, OILS WORLD MARK TRAD; Vietnamese Ministry of Agriculture and Rural Development, 2003, GUID 788 TY QLT REG; Zhao L, 2012, 201259905086EN AG, P5990	20	24	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124267	10.1371/journal.pone.0124267	http://dx.doi.org/10.1371/journal.pone.0124267			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897517	Green Published, Green Submitted, gold			2022-12-26	WOS:000353212600059
J	Henry, JD; Joeffry, S; Terrett, G; Ballhausen, N; Kliegel, M; Rendell, PG				Henry, Julie D.; Joeffry, Sebastian; Terrett, Gill; Ballhausen, Nicola; Kliegel, Matthias; Rendell, Peter G.			Prospective Memory Function in Late Adulthood: Affect at Encoding and Resource Allocation Costs	PLOS ONE			English	Article							AGE-DIFFERENCES; VALENCE; METAANALYSIS	Some studies have found that prospective memory (PM) cues which are emotionally valenced influence age effects in prospective remembering, but it remains unclear whether this effect reflects the operation of processes implemented at encoding or retrieval. In addition, none of the prior ageing studies of valence on PM function have examined potential costs of engaging in different valence conditions, or resource allocation trade-offs between the PM and the ongoing task. In the present study, younger, young-old and old-old adults completed a PM task in which the valence of the cues varied systematically (positive, negative or neutral) at encoding, but was kept constant (neutral) at retrieval. The results indicated that PM accuracy did not vary as a function of affect at encoding, and that this effect did not interact with age group. There was also no main or interaction effect of valence on PM reaction time in PM cue trials, indicating that valence costs across the three encoding conditions were equivalent. Old-old adults' PM accuracy was reduced relative to both young-old and younger adults. Prospective remembering incurred dual-task costs for all three groups. Analyses of reaction time data suggested that for both young-old and old-old, these costs were greater, implying differential resource allocation cost trade-offs. However, when reaction time data were expressed as a proportional change that adjusted for the general slowing of the older adults, costs did not differ as a function of group.	[Henry, Julie D.; Joeffry, Sebastian] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Terrett, Gill; Rendell, Peter G.] Australian Catholic Univ, Sch Psychol, Melbourne, Vic, Australia; [Ballhausen, Nicola; Kliegel, Matthias] Univ Geneva, Geneva, Switzerland	University of Queensland; Australian Catholic University; University of Geneva	Henry, JD (corresponding author), Univ Queensland, Sch Psychol, Brisbane, Qld, Australia.	Julie.henry@uq.edu.au	Ballhausen, Nicola/AAB-5781-2020; Terrett, Gill/D-7165-2019; Rendell, Peter/E-7539-2010	Ballhausen, Nicola/0000-0002-2268-3354; Terrett, Gill/0000-0003-2500-6428; Rendell, Peter/0000-0002-4829-4322; Kliegel, Matthias/0000-0002-2001-2522; Henry, Julie/0000-0002-2081-3717	Discovery Project Grant from the Australian Research Council [DP0984844]	Discovery Project Grant from the Australian Research Council(Australian Research Council)	This work was supported by a Discovery Project Grant from the Australian Research Council (DP0984844). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altgassen M, 2010, Q J EXP PSYCHOL, V63, P1057, DOI 10.1080/17470211003770920; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baltes PB, 2003, GERONTOLOGY, V49, P123, DOI 10.1159/000067946; BLANEY PH, 1986, PSYCHOL BULL, V99, P229, DOI 10.1037/0033-2909.99.2.229; Charles ST, 2003, J EXP PSYCHOL GEN, V132, P310, DOI 10.1037/0096-3445.132.2.310; Cohen J.E., 1988, STAT POWER ANAL BEHA; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; Gilbert SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059852; Gruhn D, 2008, BEHAV RES METHODS, V40, P512, DOI 10.3758/BRM.40.2.512; Guynn MJ, 2001, MEMORY ACTION DISTIN, P25; HASHER L, 1979, J EXP PSYCHOL GEN, V108, P356, DOI 10.1037/0096-3445.108.3.356; Henry JD, 2004, PSYCHOL AGING, V19, P27, DOI 10.1037/0882-7974.19.1.27; Kliegel M, 2008, PSYCHOL AGING, V23, P203, DOI 10.1037/0882-7974.23.1.203; Lang P.J., 2008, INT AFFECTIVE PICTUR; Levine TR, 2002, HUM COMMUN RES, V28, P612, DOI 10.1093/hcr/28.4.612; McDaniel M. A., 2008, PROSPECTIVE MEMORY C, P141; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; McDaniel MA, 2009, AGING NEUROPSYCHOL C, V16, P563, DOI 10.1080/13825580902866646; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; NEUGARTEN BL, 1974, ANN AM ACAD POLIT SS, V415, P187, DOI 10.1177/000271627441500114; Reed AE, 2014, PSYCHOL AGING, V29, P1, DOI 10.1037/a0035194; Rendell PG, 2011, COGNITION EMOTION, V25, P916, DOI 10.1080/02699931.2010.508610; SALTHOUSE TA, 1988, DEV REV, V8, P238, DOI 10.1016/0273-2297(88)90006-8; Schnitzspahn KM, 2012, PSYCHOL AGING, V27, P498, DOI 10.1037/a0025021; Schnitzspahn KM, 2011, INT PSYCHOGERIATR, V23, P583, DOI 10.1017/S1041610210001651; Smith RE, 2004, J EXP PSYCHOL LEARN, V30, P756, DOI 10.1037/0278-7393.30.4.756; Smith RE, 2007, J EXP PSYCHOL LEARN, V33, P734, DOI 10.1037/0278-7393.33.4.734; Wilson B, 1984, EVERYDAY MEMORY ACTI, P207	28	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0125124	10.1371/journal.pone.0125124	http://dx.doi.org/10.1371/journal.pone.0125124			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG3XA	25893540	gold, Green Published, Green Submitted			2022-12-26	WOS:000353211700132
J	Saeidi, A; Tien, VLT; Al-Batran, R; Al-Darraji, HA; Tan, HY; Yong, YK; Ponnampalavanar, S; Barathan, M; Rukumani, DV; Ansari, AW; Velu, V; Kamarulzaman, A; Larsson, M; Shankar, EM				Saeidi, Alireza; Tien, Vicky L. Tien; Al-Batran, Rami; Al-Darraji, Haider A.; Tan, Hong Y.; Yong, Yean K.; Ponnampalavanar, Sasheela; Barathan, Muttiah; Rukumani, Devi V.; Ansari, Abdul W.; Velu, Vijayakumar; Kamarulzaman, Adeeba; Larsson, Marie; Shankar, Esaki M.			Attrition of TCR Va7.2+CD161++ MAIT Cells in HIV-Tuberculosis Co-Infection Is Associated with Elevated Levels of PD-1 Expression	PLOS ONE			English	Article							INVARIANT T-CELLS; DISEASE PROGRESSION; INFECTION; LYMPHOCYTES; EXHAUSTION; RECEPTORS; SUBSETS; CD161	Mucosal-associated invariant T (MAIT) cells are evolutionarily conserved antimicrobial MR1-restricted CD8+ T cells co-expressing the semi-invariant TCR V alpha 7.2, and are numerous in the blood and mucosal tissues of humans. MAIT cells appear to undergo exhaustion in chronic viral infections. However, their role in human immunodeficiency virus type 1 (HIV1) mono-infection and HIV/tuberculosis (TB) co-infection have seldom been elaborately investigated. We conducted a cross-sectional study to investigate the frequencies and phenotypes of CD161++ CD8+ T cells among anti-retroviral therapy (ART)/anti-TB therapy (ATT) treatment-naive HIV/TB co-infected, ART/TB treated HIV/TB co-infected, ART naive HIV-infected, ART-treated HIV-infected patients, and HIV negative healthy controls (HCs) by flow cytometry. Our data revealed that the frequency of MAIT cells was severely depleted in HIV mono-and HIV/TB co-infections. Further, PD-1 expression on MAIT cells was significantly increased in HIV mono-and HIV-TB co-infected patients. The frequency of MAIT cells did not show any significant increase despite the initiation of ART and/or ATT. Majority of the MAIT cells in HCs showed a significant increase in CCR6 expression as compared to HIV/TB co-infections. No marked difference was seen with expressions of chemokine co-receptor CCR5 and CD103 among the study groups. Decrease of CCR6 expression appears to explain why HIV-infected patients display weakened mucosal immune responses.	[Saeidi, Alireza; Barathan, Muttiah; Rukumani, Devi V.; Shankar, Esaki M.] Univ Malaya, Fac Med, TIDREC, Dept Med Microbiol, Kuala Lumpur 50603, Malaysia; [Saeidi, Alireza; Al-Darraji, Haider A.; Tan, Hong Y.; Yong, Yean K.; Ponnampalavanar, Sasheela; Ansari, Abdul W.; Kamarulzaman, Adeeba; Shankar, Esaki M.] Univ Malaya, CERiA, Kuala Lumpur 50603, Malaysia; [Tien, Vicky L. Tien] Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur 50603, Malaysia; [Al-Batran, Rami] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur 50603, Malaysia; [Velu, Vijayakumar] Emory Vaccine Ctr, Dept Microbiol & Immunol, Atlanta, GA 30329 USA; [Larsson, Marie] Linkoping Univ, Inst Klin Expt Med, Mol Virol, S-58185 Linkoping, Sweden	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; Emory University; Linkoping University	Shankar, EM (corresponding author), Univ Malaya, Fac Med, TIDREC, Dept Med Microbiol, Kuala Lumpur 50603, Malaysia.	shankarem@um.edu.my	Muthu, Shankar Esaki/B-3132-2019; LA SRI PONNAMPALAVANAR, SASHEELA SRI/B-9703-2010; Al-Darraji, Haider Abdulrazzaq Abed/B-7978-2012; Yong, Yean Kong/Q-5318-2016; Velu, Vijayakumar/I-7585-2019; Yong, Yean/B-9202-2017; KAMARULZAMAN, ADEEBA/B-5216-2010; Muttiah, Barathan/M-8963-2016	Muthu, Shankar Esaki/0000-0002-7866-9818; Al-Darraji, Haider Abdulrazzaq Abed/0000-0003-2576-3218; Velu, Vijayakumar/0000-0003-4238-1924; Yong, Yean/0000-0002-8409-6251; sri la sri ponnampalavanar, sasheela/0000-0002-4506-1304; Larsson, Marie/0000-0002-4524-0177	High Impact Research [UM.C/625/1/HIR/MOHE/MED/014]; University of Malaya Research of the Health and Translational Medicine Research Cluster [RP021A-13HTM, RG448-12HTM]; Swedish Research Council [AI52731]; Swedish Physicians against AIDS Research Foundation; Swedish International Development Cooperation Agency; SIDA SARC; VINNMER for Vinnova; Linkoping University Hospital Research Fund; CALF; Swedish Society of Medicine	High Impact Research; University of Malaya Research of the Health and Translational Medicine Research Cluster; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Physicians against AIDS Research Foundation; Swedish International Development Cooperation Agency; SIDA SARC; VINNMER for Vinnova(Vinnova); Linkoping University Hospital Research Fund; CALF; Swedish Society of Medicine	The authors gratefully acknowledge funding support from High Impact Research project titled "Development of diagnostics to detect active and latent tuberculosis in humans using a novel peptide antigen derived from peptidoglycan layer of Mycobacterium tuberculosis" (UM.C/625/1/HIR/MOHE/MED/014) to Adeeba Kamarulzaman. The authors also acknowledge the funding support received from the University of Malaya Research Grants (UMRG) RP021A-13HTM and RG448-12HTM of the Health and Translational Medicine Research Cluster. Marie Larsson is supported by Grant No. AI52731 from the Swedish Research Council, the Swedish Physicians against AIDS Research Foundation, the Swedish International Development Cooperation Agency; SIDA SARC, VINNMER for Vinnova, Linkoping University Hospital Research Fund, CALF and the Swedish Society of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Billerbeck E, 2010, P NATL ACAD SCI USA, V107, P3006, DOI 10.1073/pnas.0914839107; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Carlyle JR, 2004, P NATL ACAD SCI USA, V101, P3527, DOI 10.1073/pnas.0308304101; Chung DR, 2003, J IMMUNOL, V170, P1958, DOI 10.4049/jimmunol.170.4.1958; Cosgrove C, 2013, BLOOD, V121, P951, DOI 10.1182/blood-2012-06-436436; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Fergusson JR, 2014, CELL REP, V9, P1075, DOI 10.1016/j.celrep.2014.09.045; Fergusson JR, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00036; Fernandez CS, 2015, IMMUNOL CELL BIOL, V93, P177, DOI 10.1038/icb.2014.91; Geldmacher C, 2008, J INFECT DIS, V198, P1590, DOI 10.1086/593017; Gold MC, 2011, MICROBES INFECT, V13, P742, DOI 10.1016/j.micinf.2011.03.007; Gold MC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000407; Greenspan D, 1996, LANCET, V348, P729, DOI 10.1016/S0140-6736(96)02308-2; Huang SX, 2009, P NATL ACAD SCI USA, V106, P8290, DOI 10.1073/pnas.0903196106; Jiang J, 2014, AM J RESP CRIT CARE, V190, P329, DOI 10.1164/rccm.201401-0106OC; Kurioka A, 2015, MUCOSAL IMMUNOL, V8, P429, DOI 10.1038/mi.2014.81; LANIER LL, 1994, J IMMUNOL, V153, P2417; Le Bourhis L, 2011, TRENDS IMMUNOL, V32, P212, DOI 10.1016/j.it.2011.02.005; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Lecureuil C, 2007, BLOOD, V109, P3649, DOI 10.1182/blood-2006-01-035717; Leeansyah E, 2013, BLOOD, V121, P1124, DOI 10.1182/blood-2012-07-445429; Maggi L, 2010, EUR J IMMUNOL, V40, P2174, DOI 10.1002/eji.200940257; Martin E, 2009, PLOS BIOL, V7, P525, DOI 10.1371/journal.pbio.1000054; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; Reantragoon R, 2013, J EXP MED, V210, P2305, DOI 10.1084/jem.20130958; Shankar EM, 2014, PATHOG DIS, V70, P110, DOI 10.1111/2049-632X.12108; Siawaya JFD, 2007, INT J INFECT DIS, V11, P289, DOI 10.1016/j.ijid.2007.02.001; Sonnenberg P, 2005, J INFECT DIS, V191, P150, DOI 10.1086/426827; Sutherland R, 2006, AIDS, V20, P821, DOI 10.1097/01.aids.0000218545.31716.a4; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Ussher JE, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00450; Walker LJ, 2012, BLOOD, V119, P422, DOI 10.1182/blood-2011-05-353789; Wong EB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083474	35	58	58	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124659	10.1371/journal.pone.0124659	http://dx.doi.org/10.1371/journal.pone.0124659			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894562	Green Submitted, Green Published, gold			2022-12-26	WOS:000353211700114
J	Sugyo, A; Tsuji, AB; Sudo, H; Okada, M; Koizumi, M; Satoh, H; Kurosawa, G; Kurosawa, Y; Saga, T				Sugyo, Aya; Tsuji, Atsushi B.; Sudo, Hitomi; Okada, Maki; Koizumi, Mitsuru; Satoh, Hirokazu; Kurosawa, Gene; Kurosawa, Yoshikazu; Saga, Tsuneo			Evaluation of Efficacy of Radioimmunotherapy with Y-90- Labeled Fully Human Anti-Transferrin Receptor Monoclonal Antibody in Pancreatic Cancer Mouse Models	PLOS ONE			English	Article							EXTERNAL-BEAM RADIOTHERAPY; TRANSFERRIN RECEPTOR; THERAPEUTIC AGENTS; TARGETED DELIVERY; CELL-GROWTH; GEMCITABINE; INHIBITION; CHEMOTHERAPY; METASTASES; BIOLOGY	Objective Pancreatic cancer is an aggressive tumor and the prognosis remains poor. Therefore, development of more effective therapy is needed. We previously reported that Zr-89-labeled TSP-A01, an antibody against transferrin receptor (TfR), is highly accumulated in a pancreatic cancer xenograft, but not in major normal organs. In the present study, we evaluated the efficacy of radioimmunotherapy (RIT) with Y-90-TSP-A01 in pancreatic cancer mouse models. Methods TfR expression in pancreatic cancer cell lines (AsPC-1, BxPC-3, MIAPaCa-2) was evaluated by immunofluorescence staining. In-111-labeled anti-TfR antibodies (TSP-A01, TSP-A02) were evaluated in vitro by cell binding assay with the three cell lines and by competitive inhibition assay with MIAPaCa-2. In vivo biodistribution was evaluated in mice bearing BxPC-3 and MIAPaCa-2 xenografts. Tumor volumes of BxPC-3 and MIAPaCa-2 were sequentially measured after Y-90-TSP-A01 injection and histological analysis of tumors was conducted. Results MIAPaCa-2 cells showed the highest TfR expression, followed by AsPC-1 and BxPC-3 cells. In-111-TSP-A01 and In-111-TSP-A02 bound specifically to the three cell lines according to TfR expression. The dissociation constants for TSP-A01, DOTA-TSP-A01, TSP-A02, and DOTA-TSP-A02 were 0.22, 0.28, 0.17, and 0.22 nM, respectively. In-111-TSP-A01 was highly accumulated in tumors, especially in MIAPaCa-2, but this was not true of In-111-TSP-A02. The absorbed dose for Y-90- TSP-A01 was estimated to be 8.3 Gy/MBq to BxPC-3 and 12.4 Gy/MBq to MIAPaCa-2. MIAPaCa-2 tumors treated with 3.7 MBq of Y-90-TSP-A01 had almost completely disappeared around 3 weeks after injection and regrowth was not observed. Growth of BxPC-3 tumors was inhibited by 3.7 MBq of Y-90-TSP-A01, but the tumor size was not reduced. Conclusion Y-90-TSP-A01 treatment achieved an almost complete response in MIAPaCa-2 tumors, whereas it merely inhibited the growth of BxPC-3 tumors. Y-90-TSP-A01 is a promising RIT agent for pancreatic cancer, although further investigation is necessary to improve the efficacy for the radioresistant types like BxPC-3.	[Sugyo, Aya; Tsuji, Atsushi B.; Sudo, Hitomi; Saga, Tsuneo] Natl Inst Radiol Sci, Mol Imaging Ctr, Diagnost Imaging Program, Inage Ku, Chiba 260, Japan; [Okada, Maki] Natl Inst Radiol Sci, Mol Imaging Ctr, Mol Probe Program, Inage Ku, Chiba 260, Japan; [Koizumi, Mitsuru] Canc Inst Hosp, Dept Nucl Med, Koto Ku, Tokyo, Japan; [Satoh, Hirokazu] Perseus Prote Inc, Reserch & Dev Div, Meguro Ku, Tokyo, Japan; [Kurosawa, Gene; Kurosawa, Yoshikazu] Fujita Hlth Univ, Sch Med, Innovat Ctr Adv Med, Toyoake, Aichi 47011, Japan	National Institutes for Quantum Science & Technology; National Institutes for Quantum Science & Technology; Fujita Health University	Tsuji, AB (corresponding author), Natl Inst Radiol Sci, Mol Imaging Ctr, Diagnost Imaging Program, Inage Ku, Chiba 260, Japan.	a_tsuji@nirs.go.jp	TSUJI, Atsushi B/I-9922-2019; Kurosawa, Gene/R-6508-2018	TSUJI, Atsushi B/0000-0003-2726-288X; Kurosawa, Gene/0000-0001-9477-7467; Satoh, Hirokazu/0000-0001-7629-3346	Ministry of Education, Culture, Sports, Science and Technology of Japan [KAKENHI 25861140]; National Institute of Radiological Sciences	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Radiological Sciences	This study was supported by the grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (KAKENHI 25861140 to AS) and the National Institute of Radiological Sciences (to TS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barendswaard EC, 1999, J NUCL MED, V40, P1764; Boyle P, 2008, WORLD CANC REPORT; BURAS RR, 1993, INT J RADIAT ONCOL, V25, P473, DOI 10.1016/0360-3016(93)90069-8; Cheson BD, 2003, BLOOD, V101, P391, DOI 10.1182/blood-2002-06-1793; Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010; Daniels TR, 2006, CLIN IMMUNOL, V121, P159, DOI 10.1016/j.clim.2006.06.006; Daniels TR, 2012, BBA-GEN SUBJECTS, V1820, P291, DOI 10.1016/j.bbagen.2011.07.016; Donohue E, 2013, J CANCER, V4, P585, DOI 10.7150/jca.7030; Eckerman KF, 2008, MIRD RADIONUCLIDE DA; Evans J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004215; GATTER KC, 1983, J CLIN PATHOL, V36, P539, DOI 10.1136/jcp.36.5.539; Graf F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088239; Halperin E C, 2008, PEREZ BRADYS PRINCIP; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Illidge TM, 2014, J CLIN ONCOL, V32, P212, DOI 10.1200/JCO.2013.50.3110; Kano MR, 2007, P NATL ACAD SCI USA, V104, P3460, DOI 10.1073/pnas.0611660104; Kassis AI, 2008, SEMIN NUCL MED, V38, P358, DOI 10.1053/j.semnuclmed.2008.05.002; Klee GG, 2000, ARCH PATHOL LAB MED, V124, P921; Knoop RF, 2014, NEOPLASIA, V16, P463, DOI 10.1016/j.neo.2014.05.010; Koppe MJ, 2006, CANCER BIOTHER RADIO, V21, P506, DOI 10.1089/cbr.2006.21.506; LESLEY JF, 1985, MOL CELL BIOL, V5, P1814, DOI 10.1128/MCB.5.8.1814; LINDMO T, 1984, J IMMUNOL METHODS, V72, P77, DOI 10.1016/0022-1759(84)90435-6; Matsumura Y, 2012, ADV DRUG DELIVER REV, V64, P710, DOI 10.1016/j.addr.2011.12.010; MEARES CF, 1990, BRIT J CANCER, V62, P21; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; NECKERS LM, 1986, CANCER INVEST, V4, P461, DOI 10.3109/07357908609017524; NIITSU Y, 1987, TOHOKU J EXP MED, V153, P239, DOI 10.1620/tjem.153.239; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; PANACCIO M, 1987, IMMUNOL CELL BIOL, V65, P461, DOI 10.1038/icb.1987.55; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Rucki AA, 2014, WORLD J GASTROENTERO, V20, P2237, DOI 10.3748/wjg.v20.i9.2237; Ryschich E, 2004, EUR J CANCER, V40, P1418, DOI 10.1016/j.ejca.2004.01.036; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sogawa C, 2010, NUCL MED BIOL, V37, P179, DOI 10.1016/j.nucmedbio.2009.10.008; Sudo H, 2012, CANCER SCI, V103, P203, DOI 10.1111/j.1349-7006.2011.02126.x; Sugyo A, 2015, NUCL MED COMMUN, V36, P286, DOI 10.1097/MNM.0000000000000245; TROWBRIDGE IS, 1982, P NATL ACAD SCI-BIOL, V79, P1175, DOI 10.1073/pnas.79.4.1175; van Bree C, 2008, BRIT J CANCER, V98, P1226, DOI 10.1038/sj.bjc.6604287; Vogel CA, 1997, CANCER RES, V57, P447; Yoshida C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059248	40	19	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123761	10.1371/journal.pone.0123761	http://dx.doi.org/10.1371/journal.pone.0123761			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893775	Green Submitted, Green Published, gold			2022-12-26	WOS:000353211700055
J	Thompson, LL; McManus, KJ				Thompson, Laura L.; McManus, Kirk J.			A Novel Multiplexed, Image-Based Approach to Detect Phenotypes That Underlie Chromosome Instability in Human Cells	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; GENOMIC INSTABILITY; NUCLEAR-ENVELOPE; GENE-EXPRESSION; CANCER; COHESIN; PLOIDY; MICRONUCLEUS; CHROMATIN; MITOSIS	Chromosome instability (CIN) is characterized by a progressive change in chromosome numbers. It is a characteristic common to virtually all tumor types, and is commonly observed in highly aggressive and drug resistant tumors. Despite this information, the majority of human CIN genes have yet to be elucidated. In this study, we developed and validated a multiplexed, image-based screen capable of detecting three different phenotypes associated with CIN. Large-scale chromosome content changes were detected by quantifying changes in nuclear volumes following RNAi-based gene silencing. Using a DsRED-LacI reporter system to fluorescently label chromosome 11 within a human fibrosarcoma cell line, we were able to detect deviations from the expected number of two foci per nucleus (one focus/labelled chromosome) that occurred following CIN gene silencing. Finally, micronucleus enumeration was performed, as an increase in micronucleus formation is a classic hallmark of CIN. To validate the ability of each assay to detect phenotypes that underlie CIN, we silenced the established CIN gene, SMC1A. Following SMC1A silencing we detected an increase in nuclear volumes, a decrease in the number of nuclei harboring two DsRED-LacI foci, and an increase in micronucleus formation relative to controls (untreated and siGAPDH). Similar results were obtained in an unrelated human fibroblast cell line. The results of this study indicate that each assay is capable of detecting CIN-associated phenotypes, and can be utilized in future experiments to uncover novel human CIN genes, which will provide novel insight into the pathogenesis of cancer.	[Thompson, Laura L.; McManus, Kirk J.] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada; [Thompson, Laura L.; McManus, Kirk J.] Manitoba Inst Cell Biol, Winnipeg, MB R3E 0V9, Canada	University of Manitoba	McManus, KJ (corresponding author), Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada.	Kirk.McManus@umanitoba.ca		McManus, Kirk/0000-0003-0081-8737	NSERC [RGPIN401851-2012]; Terry Fox Research Institute; Research Manitoba; CancerCare Manitoba Foundation; Manitoba Institute of Cell Biology	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Terry Fox Research Institute; Research Manitoba; CancerCare Manitoba Foundation; Manitoba Institute of Cell Biology	The authors acknowledge NSERC (http://www.nserc-crsng.gc.ca/index_eng.asp)(RGPIN 401851-2012) for operational funds (KJM), and the Terry Fox Research Institute (http://www.tfri.ca/en/), Research Manitoba (http://researchmanitoba.ca/) and CancerCare Manitoba Foundation (http://www.cancercarefdn.mb.ca/) for studentships (LLT). The authors also acknowledge the strong support of the Manitoba Institute of Cell Biology, which is funded in part by the CancerCare Manitoba Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakhoum SF, 2012, J CLIN INVEST, V122, P1138, DOI 10.1172/JCI59954; Barber TD, 2008, P NATL ACAD SCI USA, V105, P3443, DOI 10.1073/pnas.0712384105; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bauerschmidt C, 2011, EXP CELL RES, V317, P330, DOI 10.1016/j.yexcr.2010.10.021; Bauerschmidt C, 2010, NUCLEIC ACIDS RES, V38, P477, DOI 10.1093/nar/gkp976; Beheshti B, 2001, NEOPLASIA, V3, P62, DOI 10.1038/sj.neo.7900125; Bhatia A, 2013, APMIS, V121, P569, DOI 10.1111/apm.12033; Bozkurt S, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0443-1; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; Cogan N, 2010, MUTAT RES-FUND MOL M, V683, P1, DOI 10.1016/j.mrfmmm.2009.09.012; COX DM, 1973, CYTOGENET CELL GENET, V12, P165, DOI 10.1159/000130452; Dorsett D, 2012, CURR BIOL, V22, pR240, DOI 10.1016/j.cub.2012.02.046; Fenech M, 2002, DRUG DISCOV TODAY, V7, P1128, DOI 10.1016/S1359-6446(02)02502-3; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Ferlay J, 2013, IARC CANCERBASE; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Fischer AH, 2014, ADV EXP MED BIOL, V773, P49, DOI 10.1007/978-1-4899-8032-8_3; FLIEDNER TM, 1964, BLOOD, V23, P471, DOI 10.1182/blood.V23.4.471.471; Geigl JB, 2008, TRENDS GENET, V24, P64, DOI 10.1016/j.tig.2007.11.006; Heilig CE, 2010, J CELL MOL MED, V14, P895, DOI 10.1111/j.1582-4934.2009.00905.x; Iwaizumi M, 2009, GUT, V58, P249, DOI 10.1136/gut.2008.149468; Kong XD, 2009, MOL BIOL CELL, V20, P1289, DOI 10.1091/mbc.E08-04-0419; Lee AJX, 2011, CANCER RES, V71, P1858, DOI 10.1158/0008-5472.CAN-10-3604; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Leonard JM, 2008, J CELL BIOL, V183, P385, DOI 10.1083/jcb.200804042; Mannini L, 2010, HUM MUTAT, V31, P623, DOI 10.1002/humu.21252; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; McClelland SE, 2009, CELL CYCLE, V8, P3262, DOI 10.4161/cc.8.20.9690; NIELSEN K, 1989, APMIS, V97, P949, DOI 10.1111/j.1699-0463.1989.tb00503.x; Niu Y, 2013, PATHOL RES PRACT, V209, P221, DOI 10.1016/j.prp.2012.12.006; Nowak MA, 2002, P NATL ACAD SCI USA, V99, P16226, DOI 10.1073/pnas.202617399; Orr B, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00164; Pantazi E, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.535; Petersen I, 2009, LUNG CANCER, V65, P312, DOI 10.1016/j.lungcan.2008.12.013; Podgornova MN, 2009, B EXP BIOL MED+, V148, P643, DOI 10.1007/s10517-010-0785-7; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; RUDD NL, 1991, MUTAT RES, V261, P57, DOI 10.1016/0165-1218(91)90098-7; Sajesh BV, 2013, GENETICS, V195, P757, DOI 10.1534/genetics.113.156836; Sajesh BV, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-391; Solomon DA, 2014, BMB REP, V47, P299, DOI 10.5483/BMBRep.2014.47.6.092; Sotillo R, 2010, NATURE, V464, P436, DOI 10.1038/nature08803; Stirling PC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002057; Stopper H, 1997, TOXICOL IN VITRO, V11, P661, DOI 10.1016/S0887-2333(97)00084-2; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Thomson I, 2004, CURR BIOL, V14, P166, DOI 10.1016/j.cub.2003.12.024; van Pel DM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003254; Wang ZH, 2004, CANCER RES, V64, P2998, DOI 10.1158/0008-5472.CAN-04-0587; Webster M, 2009, J CELL SCI, V122, P1477, DOI 10.1242/jcs.037333; Wirth KG, 2006, J CELL BIOL, V172, P847, DOI 10.1083/jcb.200506119; Yuen KWY, 2007, P NATL ACAD SCI USA, V104, P3925, DOI 10.1073/pnas.0610642104; Zeimet AG, 2011, GYNECOL ONCOL, V121, P24, DOI 10.1016/j.ygyno.2010.12.332	52	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123200	10.1371/journal.pone.0123200	http://dx.doi.org/10.1371/journal.pone.0123200			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893404	Green Submitted, Green Published, gold			2022-12-26	WOS:000353211700027
J	Wang, L; Zhong, CG; Gao, PX; Xi, WM; Zhang, SX				Wang, Lai; Zhong, Chonggao; Gao, Pengxiang; Xi, Weimin; Zhang, Shuoxin			Soil Infiltration Characteristics in Agroforestry Systems and Their Relationships with the Temporal Distribution of Rainfall on the Loess Plateau in China	PLOS ONE			English	Article							DEFINING COMPETITION VECTORS; ALLEY CROPPING SYSTEM; INTERCROPPING SYSTEM; WATER INFILTRATION; MIDWESTERN USA; FINE-ROOT; VEGETATION; TILLAGE; RUNOFF; YIELD	Many previous studies have shown that land use patterns are the main factors influencing soil infiltration. Thus, increasing soil infiltration and reducing runoff are crucial for soil and water conservation, especially in semi-arid environments. To explore the effects of agroforestry systems on soil infiltration and associated properties in a semi-arid area of the Loess Plateau in China, we compared three plant systems: a walnut (Juglans regia) monoculture system (JRMS), a wheat (Triticum aestivum) monoculture system (TAMS), and a walnut-wheat alley cropping system (JTACS) over a period of 11 years. Our results showed that the JTACS facilitated infiltration, and its infiltration rate temporal distribution showed a stronger relationship coupled with the rainfall temporal distribution compared with the two monoculture systems during the growing season. However, the effect of JTACS on the infiltration capacity was only significant in shallow soil layer, i.e., the 0-40 cm soil depth. Within JTACS, the speed of the wetting front's downward movement was significantly faster than that in the two monoculture systems when the amount of rainfall and its intensity were higher. The soil infiltration rate was improved, and the two peaks of soil infiltration rate temporal distribution and the rainfall temporal distribution coupled in rainy season in the alley cropping system, which has an important significance in soil and water conservation. The results of this empirical study provide new insights into the sustainability of agroforestry, which may help farmers select rational planting patterns in this region, as well as other regions with similar climatic and environmental characteristics throughout the world.	[Wang, Lai; Zhong, Chonggao; Gao, Pengxiang; Zhang, Shuoxin] Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China; [Zhang, Shuoxin] Qingling Natl Forest Ecosyst Res Stn, Yangling, Shaanxi, Peoples R China; [Xi, Weimin] Texas A&M Univ, Dept Biol & Hlth Sci, Kingsville, TX USA	Northwest A&F University - China; Texas A&M University System; Texas A&M University Kingsville	Zhang, SX (corresponding author), Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China.	sxzhang@nwsuaf.edu.cn		Xi, Weimin/0000-0002-2827-8851	Chinese National Science and Technology Research Plan [2011BAD38B0202]; CFERN GENE	Chinese National Science and Technology Research Plan; CFERN GENE	This research was supported by the Chinese National Science and Technology Research Plan (2011BAD38B0202). This specific study was supported by CFERN & GENE Award Funds for Ecological Papers (http://www.cfern.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A., 1990, AMA, Agricultural Mechanization in Asia, Africa and Latin America, V21, P24; [Anonymous], 2011, 19522011 LYT; Armstrong AC, 1999, SOIL USE MANAGE, V15, P240, DOI 10.1111/j.1475-2743.1999.tb00096.x; Arnau-Rosalen E, 2008, GEOMORPHOLOGY, V101, P595, DOI 10.1016/j.geomorph.2008.03.001; Cao FL, 2012, AGROFOREST SYST, V84, P401, DOI 10.1007/s10457-012-9485-9; Cerda A, 1997, J HYDROL, V198, P209, DOI 10.1016/S0022-1694(96)03295-7; Cerda A, 1996, GEODERMA, V69, P217, DOI 10.1016/0016-7061(95)00062-3; Chartier MP, 2011, J ARID ENVIRON, V75, P656, DOI 10.1016/j.jaridenv.2011.02.007; Chen HS, 2008, GEODERMA, V143, P91, DOI 10.1016/j.geoderma.2007.10.013; Ding SS, 2010, AGROFOREST SYST, V80, P117, DOI 10.1007/s10457-010-9287-x; Fan Wei, 2000, Scientia Silvae Sinicae, V36, P16; Fang ZS, 1958, INVESTIGATION TERRAC, P53; Gao LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070739; Gillespie AR, 2000, AGROFOREST SYST, V48, P25, DOI 10.1023/A:1006285205553; Gomez JA, 1999, SOIL TILL RES, V52, P167, DOI 10.1016/S0167-1987(99)00078-1; Guo ZS, 2003, ACTA ECOLOGICA SINIC, V23, P1460; Hangen E, 2002, SOIL TILL RES, V63, P181, DOI 10.1016/S0167-1987(01)00234-3; [花伟东 HUA Weidong], 2008, [水土保持学报, Journal of Soil and Water Conservation], V22, P213; Jose S, 2000, AGROFOREST SYST, V48, P41, DOI 10.1023/A:1006289322392; Jouquet P, 2012, BIOL FERT SOILS, V48, P561, DOI 10.1007/s00374-011-0652-3; Khan S, 2009, AGR WATER MANAGE, V96, P349, DOI 10.1016/j.agwat.2008.09.022; Kostiakov AN, 1932, DYNAMICS COEFFICIE A, P15; Li FD, 2008, AGROFOREST SYST, V74, P163, DOI 10.1007/s10457-008-9122-9; Li W., 1994, AGROFORESTRY CHINA, P14; Livesley SJ, 2000, PLANT SOIL, V227, P149, DOI 10.1023/A:1026551616754; Ludwig JA, 2005, ECOLOGY, V86, P288, DOI 10.1890/03-0569; Marin CT, 2000, J HYDROL, V237, P40, DOI 10.1016/S0022-1694(00)00301-2; Matula S, 2003, PLANT SOIL ENVIRON, V49, P298, DOI 10.17221/4128-PSE; Meng Ping, 2002, Forest Research, V15, P369; Michaelides K, 2009, HYDROL PROCESS, V23, P1617, DOI 10.1002/hyp.7293; Mulumba LN, 2008, SOIL TILL RES, V98, P106, DOI 10.1016/j.still.2007.10.011; Neris J, 2012, CATENA, V98, P55, DOI 10.1016/j.catena.2012.06.006; Peng XB, 2009, AGROFOREST SYST, V76, P569, DOI 10.1007/s10457-009-9227-9; [任宗萍 Ren Zongping], 2012, [水土保持学报, Journal of Soil and Water Conservation], V26, P94; Rivest D, 2010, AGROFOREST SYST, V80, P33, DOI 10.1007/s10457-010-9342-7; Shi H, 2000, J ARID ENVIRON, V45, P9, DOI 10.1006/jare.1999.0618; Sun H, 2008, AGROFOREST SYST, V73, P65, DOI 10.1007/s10457-008-9113-x; van Schaik NLMB, 2009, CATENA, V78, P36, DOI 10.1016/j.catena.2009.02.017; Wu Q. X., 2005, SOIL WATER CONSERVAT, P118; Xu HS, 2013, INT J AGRIC BIOL, V15, P998; Zhang W, 2013, AGROFOREST SYST, V87, P929, DOI 10.1007/s10457-013-9609-x; [朱良君 Zhu Liangjun], 2012, [水土保持通报, Bulletin of Soil and Water Conservation], V32, P163; Zhu Q., 2003, SUSTAINABLE MANAGEME, P160; Zimmermann B, 2006, FOREST ECOL MANAG, V222, P29, DOI 10.1016/j.foreco.2005.10.070	44	7	7	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124767	10.1371/journal.pone.0124767	http://dx.doi.org/10.1371/journal.pone.0124767			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893832	Green Published, gold, Green Submitted			2022-12-26	WOS:000353211700120
J	Wu, ZZ; Che, ZW; Wang, YS; Dong, JD; Wu, ML				Wu, Zhen-Zhen; Che, Zhi-Wei; Wang, You-Shao; Dong, Jun-De; Wu, Mei-Lin			Identification of Surface Water Quality along the Coast of Sanya, South China Sea	PLOS ONE			English	Article							SELF-ORGANIZING MAP; DAYA BAY; PHYTOPLANKTON; RIVER; DYNAMICS; LIMITATION; ECOSYSTEMS; BASIN	Principal component analysis (PCA) and cluster analysis (CA) are utilized to identify the effects caused by human activities on water quality along the coast of Sanya, South China Sea. PCA and CA identify the seasonality of water quality (dry and wet seasons) and polluted status (polluted area). The seasonality of water quality is related to climate change and Southeast monsoons. Spatial pattern is mainly related to anthropogenic activities (especially land input of pollutions). PCA reveals the characteristics underlying the generation of coastal water quality. The temporal and spatial variation of the trophic status along the coast of Sanya is governed by hydrodynamics and human activities. The results provide a novel typological understanding of seasonal trophic status in a shallow, tropical, open marine bay.	[Wu, Zhen-Zhen; Wang, You-Shao; Dong, Jun-De; Wu, Mei-Lin] Chinese Acad Sci, State Key Lab Trop Oceanog, South China Sea Inst Oceanol, Guangzhou, Guangdong, Peoples R China; [Wu, Zhen-Zhen; Wang, You-Shao; Dong, Jun-De] Chinese Acad Sci, Key Lab Marine Bioresources Sustainable Utilizat, South China Sea Inst Oceanol, Guangzhou, Guangdong, Peoples R China; [Wu, Zhen-Zhen; Che, Zhi-Wei] State Ocean Adm, Haikou Marine Environm Monitoring Cent Stn, Haikou, Peoples R China; [Dong, Jun-De] Chinese Acad Sci, Trop Marine Biol Res Stn Hainan, Sanya, Peoples R China	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; State Oceanic Administration; Chinese Academy of Sciences	Wu, ML (corresponding author), Chinese Acad Sci, State Key Lab Trop Oceanog, South China Sea Inst Oceanol, Guangzhou, Guangdong, Peoples R China.	mlwu@scsio.ac.cn	Wu, Mei-Lin/G-4776-2011		Foundation of Key Laboratory of Yangtze River Water Environment, Ministry of Education (Tongji University), China [YRWEF201304]; State Key Laboratory of Tropical Oceanography (South China Sea Institute of Oceanology, Chinese Academy of Sciences) [LTO1304]; key laboratory for ecological environment in coastal areas, State Oceanic Administration [201211]; key laboratory of marine ecology and environmental science and engineering, State Oceanic Administration [MESE-2013-02]; National Natural Science Foundation of China [41206082]; Project of Key Laboratory of Sanya [L1301]; Special research fund of Sanya [2014KS20]	Foundation of Key Laboratory of Yangtze River Water Environment, Ministry of Education (Tongji University), China; State Key Laboratory of Tropical Oceanography (South China Sea Institute of Oceanology, Chinese Academy of Sciences); key laboratory for ecological environment in coastal areas, State Oceanic Administration; key laboratory of marine ecology and environmental science and engineering, State Oceanic Administration; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Key Laboratory of Sanya; Special research fund of Sanya	This research was supported by: 1. The Foundation of Key Laboratory of Yangtze River Water Environment, Ministry of Education (Tongji University), China (No. YRWEF201304), State Key Laboratory of Tropical Oceanography (South China Sea Institute of Oceanology, Chinese Academy of Sciences (No. LTO1304). These two foundations supported sampling and data collection and analysis. 2. The key laboratory for ecological environment in coastal areas, State Oceanic Administration (No. 201211), key laboratory of marine ecology and environmental science and engineering, State Oceanic Administration (MESE-2013-02), the National Natural Science Foundation of China (No. 41206082). These three foundations supported ecological environment research in tropical marine area. 3. Project of Key Laboratory of Sanya (L1301) and Special research fund of Sanya (2014KS20). These two foundations come from Sanya and had acquired some results about coastal area along Sanya City. The authors used previous results to design research programs, such as setting sampling stations.	[Anonymous], 2006, SAN STAT YB, P491; Boyacioglu H, 2008, ENVIRON GEOL, V54, P275, DOI 10.1007/s00254-007-0815-6; Cloern JE, 1996, REV GEOPHYS, V34, P127, DOI 10.1029/96RG00986; Dong JD, 2010, BRAZ J OCEANOGR, V58, P339, DOI 10.1590/S1679-87592010000400008; Dong JD, 2010, ENVIRON EARTH SCI, V60, P1673, DOI 10.1007/s12665-009-0301-4; Huang LM, 2003, MAR POLLUT BULL, V47, P180, DOI 10.1016/S0025-326X(03)00070-5; Jeong KS, 2008, LIMNOLOGY, V9, P231, DOI 10.1007/s10201-008-0243-7; Jickells TD, 1998, SCIENCE, V281, P217, DOI 10.1126/science.281.5374.217; Mendiguchia C, 2007, CHEMOSPHERE, V69, P1509, DOI 10.1016/j.chemosphere.2007.05.082; Nixon SW, 1993, INT S NUTR DYN COAST, P199; Paerl HW, 2002, ANTON LEEUW INT J G, V81, P487, DOI 10.1023/A:1020561422706; PENNOCK JR, 1985, ESTUAR COAST SHELF S, V21, P711, DOI 10.1016/0272-7714(85)90068-X; Shrestha S, 2007, ENVIRON MODELL SOFTW, V22, P464, DOI 10.1016/j.envsoft.2006.02.001; Simeonov V, 2003, WATER RES, V37, P4119, DOI 10.1016/S0043-1354(03)00398-1; Webster IT, 2005, MAR FRESHWATER RES, V56, P303, DOI 10.1071/MF04083; Wu ML, 2007, ESTUAR COAST SHELF S, V72, P732, DOI 10.1016/j.ecss.2006.11.032; Wu ML, 2012, OCEANOL HYDROBIOL ST, V41, P57, DOI 10.2478/s13545-012-0007-1; Wu ML, 2011, AQUAT ECOSYST HEALTH, V14, P291, DOI 10.1080/14634988.2011.604273; Wu ML, 2010, MAR POLLUT BULL, V60, P852, DOI 10.1016/j.marpolbul.2010.01.007; Wu ML, 2009, J ENVIRON MANAGE, V90, P3082, DOI 10.1016/j.jenvman.2009.04.017; Yin KD, 2001, MAR ECOL PROG SER, V221, P17, DOI 10.3354/meps221017; Zhou WH, 2009, J ENVIRON SCI-CHINA, V21, P595, DOI 10.1016/S1001-0742(08)62313-X	22	6	6	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123515	10.1371/journal.pone.0123515	http://dx.doi.org/10.1371/journal.pone.0123515			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894980	gold, Green Published, Green Submitted			2022-12-26	WOS:000353211700038
J	Yokogawa, N; Toribatake, Y; Murakami, H; Hayashi, H; Yoneyama, T; Watanabe, T; Tsuchiya, H				Yokogawa, Noriaki; Toribatake, Yasumitsu; Murakami, Hideki; Hayashi, Hiroyuki; Yoneyama, Takeshi; Watanabe, Tetsuyou; Tsuchiya, Hiroyuki			Differences in Gait Characteristics of Patients with Lumbar Spinal Canal Stenosis (L4 Radiculopathy) and Those with Osteoarthritis of the Hip	PLOS ONE			English	Article							WALKING PATTERNS; NORMAL MEN	It is important to differentially diagnose thigh pain from lumbar spinal stenosis (particularly lumbar fourth nerve root radiculopathy) and osteoarthritis of the hip. In this study, using a treadmill and a motion analysis method, gait characteristics were compared between these conditions. Patients with lumbar fourth nerve root radiculopathy had increased physiological knee flexion immediately after foot-ground contact, possibly owing to a slight decrease in the muscle strength of the quadriceps femoris muscle. Patients with osteoarthritis of the hip had decreased range of motion of the hip joint probably due to anatomically limited mobility as well as gait strategy to avoid pain resulting from increased internal pressure on the hip joint during its extension. Our facile and noninvasive method can be useful for the differential diagnosis of lumbar spinal canal stenosis from osteoarthritis of the hip.	[Yokogawa, Noriaki; Murakami, Hideki; Hayashi, Hiroyuki; Tsuchiya, Hiroyuki] Kanazawa Univ, Grad Sch Med Sci, Dept Orthoped Surg, Kanazawa, Ishikawa, Japan; [Toribatake, Yasumitsu] Kouseiren Takaoka Hosp, Dept Orthoped Surg, Takaoka, Toyama, Japan; [Yoneyama, Takeshi; Watanabe, Tetsuyou] Kanazawa Univ, Coll Sci & Engn, Sch Mech Engn, Kanazawa, Ishikawa, Japan	Kanazawa University; Kanazawa University	Yokogawa, N (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Orthoped Surg, Kanazawa, Ishikawa, Japan.	chakkun1981chakkun@yahoo.co.jp	Watanabe, Tetsuyou/L-3532-2015	Watanabe, Tetsuyou/0000-0003-2549-1435				KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Murray M P, 1970, Arch Phys Med Rehabil, V51, P637; MURRAY MP, 1971, J BONE JOINT SURG AM, VA 53, P259, DOI 10.2106/00004623-197153020-00006; MURRAY MP, 1964, J BONE JOINT SURG AM, V46, P335, DOI 10.2106/00004623-196446020-00009; MURRAY MP, 1969, J GERONTOL, V24, P169, DOI 10.1093/geronj/24.2.169; OFFIERSKI CM, 1983, SPINE, V8, P316, DOI 10.1097/00007632-198304000-00014; Pietraszewski B, 2012, ACTA BIOENG BIOMECH, V14, P9, DOI 10.5277/abb120302; Suda Y, 2002, SPINE, V27, P2509, DOI 10.1097/00007632-200211150-00016; White SC, 1998, MED SCI SPORT EXER, V30, P1537, DOI 10.1097/00005768-199810000-00011	9	11	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124745	10.1371/journal.pone.0124745	http://dx.doi.org/10.1371/journal.pone.0124745			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893667	gold, Green Published, Green Submitted			2022-12-26	WOS:000353211700119
J	Ellis, MK; Elliott, KS; Rautanen, A; Crook, DW; Hill, AVS; Chapman, SJ				Ellis, Magda K.; Elliott, Katherine S.; Rautanen, Anna; Crook, Derrick W.; Hill, Adrian V. S.; Chapman, Stephen J.			Rare Variants in MYD88, IRAK4 and IKBKG and Susceptibility to Invasive Pneumococcal Disease: A Population-Based Case-Control Study	PLOS ONE			English	Article							PYOGENIC BACTERIAL-INFECTIONS; GENOME-WIDE ASSOCIATION; HEALTHY-CHILDREN; GENOTYPE; POLYMORPHISMS; MUTATIONS; DATABASE; DEFECTS; HUMANS; TLR4	Although rare variants within the Toll-like receptor signalling pathway genes have been found to underlie human primary immunodeficiencies associated with selective predisposition to invasive pneumococcal disease (IPD), the contribution of variants in these genes to IPD susceptibility at the population level remains unknown. Complete re-sequencing of IRAK4, MYD88 and IKBKG genes was undertaken in 164 IPD cases from the UK and 164 geographically-matched population-based controls. 233 single-nucleotide variants (SNVs) were identified, of which ten were in coding regions. Four rare coding variants were predicted to be deleterious, two variants in MYD88 and two in IRAK4. The predicted deleterious variants in MYD88 were observed as two heterozygote cases but not seen in controls. Frequencies of predicted deleterious IRAK4 SNVs were the same in cases and controls. Our findings suggest that rare, functional variants in MYD88, IRAK4 or IKBKG do not significantly contribute to IPD susceptibility in adults at the population level.	[Ellis, Magda K.; Elliott, Katherine S.; Rautanen, Anna; Hill, Adrian V. S.; Chapman, Stephen J.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX1 2JD, England; [Ellis, Magda K.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Ellis, Magda K.] Univ Sydney, Centenary Inst, Sydney, NSW 2006, Australia; [Ellis, Magda K.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Crook, Derrick W.] John Radcliffe Hosp, Dept Microbiol, Oxford OX3 9DU, England; [Chapman, Stephen J.] Oxford Univ Hosp, Oxford Ctr Resp Med, Oxford, England	University of Oxford; Wellcome Centre for Human Genetics; QIMR Berghofer Medical Research Institute; University of Sydney; Centenary Institute; University of Sydney; University of Oxford	Ellis, MK (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX1 2JD, England.	m.ellis@centenary.org.au			Medical Research Council, UK; Wellcome Trust Centre for Human Genetics core grant [090532/Z/09/Z]; NIHR Biomedical Research Centre, Oxford; NHMRC Training Fellowship, Australia [GNT0552496]; Wellcome Trust [076113/C/04/Z]; Juvenile Diabetes Research Foundation [WT061858]; National Institute of Health Research of England; MRC [G1001712] Funding Source: UKRI; Medical Research Council [G1001712] Funding Source: researchfish; National Institute for Health Research [CL-2006-13-003, NF-SI-0512-10047] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Centre for Human Genetics core grant(Wellcome Trust); NIHR Biomedical Research Centre, Oxford(National Institute for Health Research (NIHR)); NHMRC Training Fellowship, Australia(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust(Wellcome TrustEuropean Commission); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institute of Health Research of England(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by the Medical Research Council, UK (www.mrc.ac.uk) and the Wellcome Trust Centre for Human Genetics core grant 090532/Z/09/Z (www.well.ox.ac.uk). SJC is supported by the NIHR Biomedical Research Centre, Oxford (oxcam.gpp.nih.gov). MKE is supported by an NHMRC Training Fellowship GNT0552496, Australia (www.nhmrc.gov.au). We acknowledge the use of DNA from The UK Blood Services collection of Common Controls (UKBS collection), funded by the Wellcome Trust grant 076113/C/04/Z, by the Juvenile Diabetes Research Foundation grant WT061858 (www.jdrf.org.uk), and by the National Institute of Health Research of England (www.nihr.ac.uk). The collection was established as part of the Wellcome Trust Case-Control Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Brouwer MC, 2009, LANCET INFECT DIS, V9, P31, DOI 10.1016/S1473-3099(08)70261-5; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chapman SJ, 2010, GENES IMMUN, V11, P319, DOI 10.1038/gene.2009.76; Chapman SJ, 2012, NAT REV GENET, V13, P175, DOI 10.1038/nrg3114; Chapman SJ, 2010, CRIT CARE, V14, DOI 10.1186/cc9377; Courtois G, 2006, CELL DEATH DIFFER, V13, P843, DOI 10.1038/sj.cdd.4401841; George J, 2011, J BIOL CHEM, V286, P1341, DOI 10.1074/jbc.M110.159996; Hanson EP, 2008, J ALLERGY CLIN IMMUN, V122, P1169, DOI 10.1016/j.jaci.2008.08.018; Hirschfeld AF, 2007, CLIN IMMUNOL, V122, P271, DOI 10.1016/j.clim.2006.10.012; Johansen CT, 2012, CIRC-CARDIOVASC GENE, V5, P66, DOI 10.1161/CIRCGENETICS.111.960864; Kiezun A, 2012, NAT GENET, V44, P623, DOI 10.1038/ng.2303; Ku CL, 2007, J EXP MED, V204, P2407, DOI 10.1084/jem.20070628; Ku CL, 2007, J MED GENET, V44, P16, DOI 10.1136/jmg.2006.044446; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Moens L, 2006, CLIN IMMUNOL, V118, P20, DOI 10.1016/j.clim.2005.08.002; Moens L, 2006, HUM IMMUNOL, V67, P605, DOI 10.1016/j.humimm.2006.04.014; Newport MJ, 2011, BRIEF FUNCT GENOMICS, V10, P98, DOI 10.1093/bfgp/elq037; Ohnishi H, 2009, P NATL ACAD SCI USA, V106, P10260, DOI 10.1073/pnas.0812956106; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Picard C, 2011, CLIN MICROBIOL REV, V24, P490, DOI 10.1128/CMR.00001-11; Picard C, 2010, MEDICINE, V89, P403, DOI 10.1097/MD.0b013e3181fd8ec3; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Roy S, 2002, LANCET, V359, P1569, DOI 10.1016/S0140-6736(02)08516-1; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Smirnova I, 2003, P NATL ACAD SCI USA, V100, P6075, DOI 10.1073/pnas.1031605100; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Uzel G, 2005, CURR OPIN ALLERGY CL, V5, P513, DOI 10.1097/01.all.0000191241.66373.74; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Yuan FF, 2008, IMMUNOL CELL BIOL, V86, P268, DOI 10.1038/sj.icb.7100155	38	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123532	10.1371/journal.pone.0123532	http://dx.doi.org/10.1371/journal.pone.0123532			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886387	Green Published, gold, Green Submitted			2022-12-26	WOS:000353017000072
J	Grutters, BMC; Pollux, BJA; Verberk, WCEP; Bakker, ES				Grutters, Bart M. C.; Pollux, Bart J. A.; Verberk, Wilco C. E. P.; Bakker, Elisabeth S.			Native and Non-Native Plants Provide Similar Refuge to Invertebrate Prey, but Less than Artificial Plants	PLOS ONE			English	Article							SUBMERGED AQUATIC VEGETATION; STRUCTURAL COMPLEXITY; HABITAT COMPLEXITY; FORAGING SUCCESS; INTRAGUILD PREDATION; LARGEMOUTH BASS; FISH; MACROPHYTE; DAPHNIA; SIZE	Non-native species introductions are widespread and can affect ecosystem functioning by altering the structure of food webs. Invading plants often modify habitat structure, which may affect the suitability of vegetation as refuge and could thus impact predator-prey dynamics. Yet little is known about how the replacement of native by non-native vegetation affects predator-prey dynamics. We hypothesize that plant refuge provisioning depends on (1) the plant's native status, (2) plant structural complexity and morphology, (3) predator identity, and (4) prey identity, as well as that (5) structurally similar living and artificial plants provide similar refuge. We used aquatic communities as a model system and compared the refuge provided by plants to macroinvertebrates (Daphnia pulex, Gammarus pulex and damselfly larvae) in three short-term laboratory predation experiments. Plant refuge provisioning differed between plant species, but was generally similar for native (Myriophyllum spicatum, Ceratophyllum demersum, Potamogeton perfoliatus) and non-native plants (Vallisneria spiralis, Myriophyllum heterophyllum, Cabomba caroliniana). However, plant refuge provisioning to macroinvertebrate prey depended primarily on predator (mirror carp: Cyprinus carpio carpio and dragonfly larvae: Anax imperator) and prey identity, while the effects of plant structural complexity were only minor. Contrary to living plants, artificial plant analogues did improve prey survival, particularly with increasing structural complexity and shoot density. As such, plant rigidity, which was high for artificial plants and one of the living plant species evaluated in this study (Ceratophyllum demersum), may interact with structural complexity to play a key role in refuge provisioning to specific prey (Gammarus pulex). Our results demonstrate that replacement of native by structurally similar non-native vegetation is unlikely to greatly affect predator-prey dynamics. We propose that modification of predator-prey interactions through plant invasions only occurs when invading plants radically differ in growth form, density and rigidity compared to native plants.	[Grutters, Bart M. C.; Bakker, Elisabeth S.] Netherlands Inst Ecol NIOO KNAW, Dept Aquat Ecol, Wageningen, Netherlands; [Pollux, Bart J. A.] Wageningen Univ, Dept Anim Sci, Expt Zool Grp, NL-6700 AP Wageningen, Netherlands; [Verberk, Wilco C. E. P.] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Anim Ecol & Ecophysiol, NL-6525 ED Nijmegen, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Wageningen University & Research; Radboud University Nijmegen	Grutters, BMC (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Aquat Ecol, Wageningen, Netherlands.	b.grutters@nioo.knaw.nl	Verberk, Wilco/E-6337-2011; Bakker, Elisabeth S/B-7185-2008; KNAW, NIOO-KNAW/A-4320-2012	Verberk, Wilco/0000-0002-0691-583X; Bakker, Elisabeth S/0000-0002-5900-9136; KNAW, NIOO-KNAW/0000-0002-3835-159X	Netherlands Organisation for Scientific Research [841.11.011, 821.02.024]; Marie Curie FP7-PEOPLE-IIF grant [299048]	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Marie Curie FP7-PEOPLE-IIF grant	BMCG and ESB were supported by the Netherlands Organisation for Scientific Research (Earth and Life Sciences - Research Program: Biodiversity works, grant 841.11.011, http://www.nwo.nl). BJAP was supported by Marie Curie FP7-PEOPLE-2011-IIF grant 299048 (http://ec.europa.eu/research/mariecurieactions) and by Netherlands Organisation for Scientific Research (Earth and Life Sciences - Open Programme, grant 821.02.024, http://www.nwo.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bal KD, 2011, FUNCT ECOL, V25, P1197, DOI 10.1111/j.1365-2435.2011.01909.x; Bartholomew A, 2000, MAR ECOL PROG SER, V206, P45, DOI 10.3354/meps206045; Bartholomew A, 2002, ESTUARIES, V25, P1045, DOI 10.1007/BF02691351; Boersma M, 1998, AM NAT, V152, P237, DOI 10.1086/286164; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bridgewater P, 2011, FRONT ECOL ENVIRON, V9, P423, DOI 10.1890/1540-9295-9.8.423; Burks RL, 2001, LIMNOL OCEANOGR, V46, P230, DOI 10.4319/lo.2001.46.2.0230; Burks RL, 2002, J CHEM ECOL, V28, P1901, DOI 10.1023/A:1020785525081; Calcagno V, 2011, AM NAT, V177, pE1, DOI 10.1086/657436; Cazzanelli M, 2008, HYDROBIOLOGIA, V605, P113, DOI 10.1007/s10750-008-9324-1; Chaplin GI, 2009, ESTUAR COAST, V32, P319, DOI 10.1007/s12237-008-9117-9; COBLE DW, 1985, CAN J FISH AQUAT SCI, V42, P791, DOI 10.1139/f85-101; Corbet P. S., 1999, DRAGONFLIES BEHAV EC; Crooks JA, 2002, OIKOS, V97, P153, DOI 10.1034/j.1600-0706.2002.970201.x; DIEHL S, 1988, OIKOS, V53, P207, DOI 10.2307/3566064; Dorner H, 2003, J FISH BIOL, V62, P1021, DOI 10.1046/j.1095-8649.2003.00092.x; Dutra HP, 2011, OECOLOGIA, V166, P649, DOI 10.1007/s00442-010-1895-7; EHLINGER TJ, 1989, ANIM BEHAV, V38, P643, DOI 10.1016/S0003-3472(89)80010-7; Figueiredo BRS, 2013, HYDROBIOLOGIA, V716, P21, DOI 10.1007/s10750-013-1540-7; Finke DL, 2006, OECOLOGIA, V149, P265, DOI 10.1007/s00442-006-0443-y; Flynn KE, 2011, HYDROBIOLOGIA, V675, P97, DOI 10.1007/s10750-011-0805-2; FOLSOM TC, 1984, OIKOS, V42, P105, DOI 10.2307/3544615; Fox J., 2019, R COMPANION APPL REG, V.; GOTCEITAS V, 1989, OECOLOGIA, V80, P158, DOI 10.1007/BF00380145; Grime JP, 1997, SCIENCE, V277, P1260, DOI 10.1126/science.277.5330.1260; Horinouchi M, 2009, MAR ECOL PROG SER, V377, P43, DOI 10.3354/meps07869; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hughes AR, 2006, OECOLOGIA, V149, P256, DOI 10.1007/s00442-006-0439-7; Hussner A, 2012, WEED RES, V52, P297, DOI 10.1111/j.1365-3180.2012.00926.x; Katayama M, 2014, HYDROBIOLOGIA, V732, P173, DOI 10.1007/s10750-014-1857-x; KEAST A, 1984, CAN J ZOOL, V62, P1289, DOI 10.1139/z84-186; Klecka J, 2014, OECOLOGIA, V176, P183, DOI 10.1007/s00442-014-3007-6; Klecka J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037741; Kouwen N., 1973, J HYDRAUL DIV, V99, P713, DOI DOI 10.1061/JYCEAJ.0003643; Lauridsen TL, 1996, LIMNOL OCEANOGR, V41, P794, DOI 10.4319/lo.1996.41.4.0794; Macneil C, 1999, BIOL REV, V74, P375, DOI 10.1017/S0006323199005368; Manatunge J, 2000, ENVIRON BIOL FISH, V58, P425, DOI 10.1023/A:1007691425268; Martin CW, 2011, ESTUAR COAST, V34, P364, DOI 10.1007/s12237-010-9274-5; Martin CW, 2010, OECOLOGIA, V162, P893, DOI 10.1007/s00442-010-1564-x; Mattos KJ, 2010, BEHAV ECOL, V21, P556, DOI 10.1093/beheco/arq020; McAbendroth L, 2005, OIKOS, V111, P279, DOI 10.1111/j.0030-1299.2005.13804.x; Michel MJ, 2009, BEHAV ECOL, V20, P313, DOI 10.1093/beheco/arp005; Orrock J.L., 2010, OPEN ECOL J, V3, P22, DOI [10.2174/1874213001003030022, DOI 10.2174/1874213001003030022]; Orrock JL, 2013, ECOLOGY, V94, P573, DOI 10.1890/12-0502.1; Padial AA, 2009, HYDROBIOLOGIA, V624, P161, DOI 10.1007/s10750-008-9690-8; PENNAK R W, 1973, Internationale Revue der Gesamten Hydrobiologie, V58, P569, DOI 10.1002/iroh.19730580406; R Core Team, 2021, R LANGUAGE ENV STAT; Rantala MJ, 2004, AQUAT ECOL, V38, P77; RYER CH, 1988, MAR ECOL PROG SER, V48, P37, DOI 10.3354/meps048037; Sagrario G, 2009, FRESHWATER BIOL, V54, P1042, DOI 10.1111/j.1365-2427.2008.02152.x; SAVINO JF, 1982, T AM FISH SOC, V111, P255, DOI 10.1577/1548-8659(1982)111&lt;255:PIBLBA&gt;2.0.CO;2; Scheinin M, 2012, OIKOS, V121, P1093, DOI 10.1111/j.1600-0706.2011.19941.x; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schultz R, 2012, HYDROBIOLOGIA, V684, P1, DOI 10.1007/s10750-011-0978-8; SHELDON RB, 1977, AM MIDL NAT, V97, P248, DOI 10.2307/2424706; Simberloff D, 2011, BIOL INVASIONS, V13, P1255, DOI 10.1007/s10530-011-9956-3; Stiers I, 2011, BIOL INVASIONS, V13, P2715, DOI 10.1007/s10530-011-9942-9; STONER AW, 1982, J EXP MAR BIOL ECOL, V58, P271, DOI 10.1016/0022-0981(82)90134-4; Strayer DL, 2003, FRESHWATER BIOL, V48, P1938, DOI 10.1046/j.1365-2427.2003.01142.x; Tavsanoglu UN, 2012, FRESHWATER BIOL, V57, P795, DOI 10.1111/j.1365-2427.2012.02745.x; Tokeshi M, 2012, HYDROBIOLOGIA, V685, P27, DOI 10.1007/s10750-011-0832-z; Valinoti CE, 2011, J EXP MAR BIOL ECOL, V409, P42, DOI 10.1016/j.jembe.2011.08.001; Valley RD, 2002, T AM FISH SOC, V131, P234, DOI 10.1577/1548-8659(2002)131&lt;0234:EOMBAO&gt;2.0.CO;2; Van de Meutter F, 2005, OECOLOGIA, V144, P327, DOI 10.1007/s00442-005-0050-3; Van de Meutter F, 2004, OIKOS, V107, P265, DOI 10.1111/j.0030-1299.2004.13221.x; van Kleunen M, 2014, BASIC APPL ECOL, V15, P1, DOI 10.1016/j.baae.2013.10.006; Venables WN., 2002, MODERN APPL STAT S 4; Verberk WCEP, 2013, FRESHW SCI, V32, P531, DOI 10.1899/12-092.1; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Warburton K, 2003, FISH FISH, V4, P203, DOI 10.1046/j.1467-2979.2003.00125.x; Warfe DM, 2006, OECOLOGIA, V150, P141, DOI 10.1007/s00442-006-0505-1; Warfe DM, 2004, OECOLOGIA, V141, P171, DOI 10.1007/s00442-004-1644-x; Wellborn GA, 1996, ANNU REV ECOL SYST, V27, P337, DOI 10.1146/annurev.ecolsys.27.1.337; WERNER EE, 1981, ECOLOGY, V62, P116, DOI 10.2307/1936675; Wimp GM, 2013, OECOLOGIA, V171, P505, DOI 10.1007/s00442-012-2435-4; WRIGHT D, 1990, FRESHWATER BIOL, V24, P43, DOI 10.1111/j.1365-2427.1990.tb00306.x	77	32	32	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124455	10.1371/journal.pone.0124455	http://dx.doi.org/10.1371/journal.pone.0124455			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885967	Green Submitted, Green Published, gold			2022-12-26	WOS:000353017000129
J	Gwak, JM; Jang, MH; Kim, DI; Seo, AN; Park, SY				Gwak, Jae Moon; Jang, Min Hye; Kim, Dong Il; Seo, An Na; Park, So Yeon			Prognostic Value of Tumor-Associated Macrophages According to Histologic Locations and Hormone Receptor Status in Breast Cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; PROGRESSION; CARCINOMA; THERAPY; ANGIOGENESIS; INFILTRATION; METASTASIS; CELLS	Tumor-associated macrophages (TAMs) are involved in tumor progression by promoting epithelial-mesenchymal transition (EMT), tumor cell invasion, migration and angiogenesis. However, in breast cancer, the clinical relevance of the TAM infiltration according to distinct histologic locations (intratumoral vs. stromal) and hormone receptor status is unclear. We investigated the significance of the levels of TAM infiltration in distinct histologic locations in invasive breast cancer. We also examined the relationship of the TAM levels with the clinicopathologic features of tumors, expression of EMT markers, and clinical outcomes. Finally, we analyzed the prognostic value of TAM levels according to hormone receptor status. High levels of infiltration of intratumoral, stromal and total TAMs were associated with high histologic grade, p53 overexpression, high Ki-67 proliferation index and negative hormone receptor status. Infiltration of TAMs was also correlated with overexpression of vimentin, smooth muscle actin and alteration of beta-catenin. Overall, a high level of infiltration of intratumoral TAMs was associated with poor disease-free survival, and was found to be an independent prognostic factor. In subgroup analyses by hormone receptor status, a high level of infiltration of intratumoral TAM was an independent prognostic factor in the hormone receptor-positive subgroup, but not in the hormone-receptor negative subgroup. Our findings suggest that intratumoral TAMs play an important role in tumor progression in breast cancer, especially in the hormone receptor-positive group, and the level of TAM infiltration may be used as a prognostic factor and even a therapeutic target in breast cancer.	[Gwak, Jae Moon; Park, So Yeon] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea; [Jang, Min Hye; Park, So Yeon] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Songnam, Gyeonggi, South Korea; [Kim, Dong Il] Green Cross Lab, Yongin, Gyeonggi, South Korea; [Seo, An Na] Kyungpook Natl Univ, Sch Med, Kyungpook Natl Univ Hosp, Dept Pathol, Daegu, South Korea	Seoul National University (SNU); Seoul National University (SNU); Kyungpook National University; Kyungpook National University Hospital	Park, SY (corresponding author), Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea.	sypmd@snu.ac.kr		Park, So Yeon/0000-0002-0299-7268	Green Cross Laboratory	Green Cross Laboratory	Green Cross Laboratory provided support in the form of salaries for author Dong Il Kim, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004; Bonde AK, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-35; Campbell MJ, 2011, BREAST CANCER RES TR, V128, P703, DOI 10.1007/s10549-010-1154-y; Ch'ng ES, 2013, VIRCHOWS ARCH, V462, P257, DOI 10.1007/s00428-012-1362-4; Choi Y, 2013, HUM PATHOL, V44, P2581, DOI 10.1016/j.humpath.2013.07.003; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Denkert C, 2010, J CLIN ONCOL, V28, P105, DOI 10.1200/JCO.2009.23.7370; Fan QM, 2014, CANCER LETT, V352, P160, DOI 10.1016/j.canlet.2014.05.008; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Jang MH, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3239; Krol M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083995; Leek RD, 1999, BRIT J CANCER, V79, P991, DOI 10.1038/sj.bjc.6690158; Leek RD, 1996, CANCER RES, V56, P4625; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Liu CY, 2013, LAB INVEST, V93, P844, DOI 10.1038/labinvest.2013.69; Mahmoud SMA, 2012, J CLIN PATHOL, V65, P159, DOI 10.1136/jclinpath-2011-200355; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Medrek C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-306; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Ohno S, 2002, ANTICANCER RES, V22, P4269; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Seo AN, 2013, BRIT J CANCER, V109, P2705, DOI 10.1038/bjc.2013.634; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Singh RP, 2014, BRIT J OPHTHALMOL, V98, P1, DOI 10.1136/bjophthalmol-2014-305502; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Su SC, 2014, CANCER CELL, V25, P605, DOI 10.1016/j.ccr.2014.03.021; Tang XQ, 2013, CANCER LETT, V332, P3, DOI 10.1016/j.canlet.2013.01.024; Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076147	31	85	91	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0125728	10.1371/journal.pone.0125728	http://dx.doi.org/10.1371/journal.pone.0125728			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884955	Green Published, gold, Green Submitted			2022-12-26	WOS:000353017000162
J	Nalbandian, A; Llewellyn, KJ; Nguyen, C; Yazdi, PG; Kimonis, VE				Nalbandian, Angele; Llewellyn, Katrina J.; Nguyen, Christopher; Yazdi, Puya G.; Kimonis, Virginia E.			Rapamycin and Chloroquine: The In Vitro and In Vivo Effects of Autophagy-Modifying Drugs Show Promising Results in Valosin Containing Protein Multisystem Proteinopathy	PLOS ONE			English	Article							INCLUSION-BODY MYOPATHY; PAGET-DISEASE; FRONTOTEMPORAL DEMENTIA; LIFE-SPAN; MUSCULAR-DYSTROPHY; VCP MUTATIONS; MOUSE MODEL; BONE; FAMILY; YEAST	Mutations in the valosin containing protein (VCP) gene cause hereditary Inclusion body myopathy (hIBM) associated with Paget disease of bone (PD B), frontotemporal dementia (FTD), more recently termed multisystem proteinopathy (MSP). Affected individuals exhibit scapular winging and die from progressive muscle weakness, and cardiac and respiratory failure, typically in their 40s to 50s. Histologically, patients show the presence of rimmed vacuoles and TAR DNA-binding protein 43 (TDP-43)-positive large ubiquitinated inclusion bodies in the muscles. We have generated a VCPR155H+ mouse model which recapitulates the disease phenotype and impaired autophagy typically observed in patients with VCP disease. Autophagy-modifying agents, such as rapamycin and chloroquine, at pharmacological doses have previously shown to alter the autophagic flux. Herein, we report results of administration of rapamycin, a specific inhibitor of the mechanistic target of rapamycin (mTOR) signaling pathway, and chloroquine, a lysosomal inhibitor which reverses autophagy by accumulating in lysosomes, responsible for blocking autophagy in 20-month old VCPR155H+- mice. Rapamycin-treated mice demonstrated significant improvement in muscle performance, quadriceps histological analysis, and rescue of ubiquitin, and TDP-43 pathology and defective autophagy as indicated by decreased protein expression levels of LC3-1/1I, p62/SQSTM1, optineurin and inhibiting the mTORC1 substrates. Conversely, chloroquine-treated VCPR155H+ mice revealed progressive muscle weakness, cytoplasmic accumulation of TDP-43, ubiquitin-positive inclusion bodies and increased LC3-1/1I, p62/SQSTM1, and optineurin expression levels. Our in vitro patient myoblasts studies treated with rapamycin demonstrated an overall improvement in the autophagy markers. Targeting the mTOR pathway ameliorates an increasing list of disorders, and these findings suggest that VCP disease and related neurodegenerative multisystem proteinopathies can now be included as disorders that can potentially be ameliorated by rapalogs.	[Nalbandian, Angele; Llewellyn, Katrina J.; Nguyen, Christopher; Kimonis, Virginia E.] Univ Calif Irvine, Dept Pediat, Div Genet & Metab, Irvine, CA 92717 USA; [Nalbandian, Angele; Llewellyn, Katrina J.; Yazdi, Puya G.; Kimonis, Virginia E.] Univ Calif Irvine, Sue & Bill Gross Stem Cell Ctr, Irvine, CA USA; [Yazdi, Puya G.] Syst Hlth LLC, Los Angeles, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Nalbandian, A (corresponding author), Univ Calif Irvine, Dept Pediat, Div Genet & Metab, Irvine, CA 92717 USA.	asialbandian@uci.edu; vkimonis@uci.edu		Yazdi, Puya/0000-0003-3456-8043	National Institutes of Health (NIH) [R21 AR063360]; Muscular Dystrophy Association (MDA) [175682]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR063360] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health (NIH) grant R21 AR063360 and Muscular Dystrophy Association (MDA) funding 175682 to VEK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badadani M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013183; Bays NW, 2002, CURR BIOL, V12, pR366, DOI 10.1016/S0960-9822(02)00862-X; Bersano A, 2007, NEUROBIOL AGING; Bibee KP, 2014, FASEB J, V28, P2047, DOI 10.1096/fj.13-237388; Bove J, 2011, NAT REV NEUROSCI, V12, P437, DOI 10.1038/nrn3068; Caccamo A, 2014, J NEUROSCI, V34, P7988, DOI 10.1523/JNEUROSCI.0777-14.2014; Ching JK, 2013, AUTOPHAGY, V9, P799, DOI 10.4161/auto.23958; Ching JK, 2013, HUM MOL GENET, V22, P1167, DOI 10.1093/hmg/dds524; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; De Palma C, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.159; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; Djamshidian A, 2009, MUSCLE NERVE, V39, P389, DOI 10.1002/mus.21225; Fanganiello RD, 2011, EXPT BRAIN RES UNPUB; FROHLICH KU, 1991, J CELL BIOL, V114, P443, DOI 10.1083/jcb.114.3.443; Fu XR, 2003, J CELL BIOL, V163, P21, DOI 10.1083/jcb.200307025; Ghosh I, 2014, INDIAN J MED PAEDIAT, V35, P99, DOI 10.4103/0971-5851.133733; Guyant-Marechal L, 2006, NEUROLOGY, V67, P644, DOI 10.1212/01.wnl.0000225184.14578.d3; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Haubenberger D, 2005, NEUROLOGY, V65, P1304, DOI 10.1212/01.wnl.0000180407.15369.92; Jiang D, 2014, ACTA PHARMACOL SIN, V35, P135, DOI 10.1038/aps.2013.144; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360; Ju JS, 2008, J BIOL CHEM, V283, P30289, DOI 10.1074/jbc.M805517200; Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115; Ju JS, AUTOPHAGY, V6; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kawai T, 1997, ORAL SURG ORAL MED O, V84, P449, DOI 10.1016/S1079-2104(97)90047-0; Kim EJ, 2011, ARCH NEUROL-CHICAGO, V68, P787, DOI 10.1001/archneurol.2010.376; Kimonis V, 2011, INCLUSION BODY MYOPA; Kimonis VE, 2005, ALZ DIS ASSOC DIS, V19, pS44, DOI 10.1097/01.wad.0000183081.76820.5a; Kimonis VE, 2000, GENET MED, V2, P232, DOI 10.1097/00125817-200007000-00006; Kimonis VE, 2008, AM J MED GENET A, V146A, P745, DOI 10.1002/ajmg.a.31862; Kimonis VE, 2008, BBA-MOL BASIS DIS, V1782, P744, DOI 10.1016/j.bbadis.2008.09.003; Komatsu J, 2013, MUSCLE NERVE, V48, P995, DOI 10.1002/mus.23960; Komatsu M, 2006, AUTOPHAGY, V2, P315, DOI 10.4161/auto.2974; Kovach MJ, 2001, MOL GENET METAB, V74, P458, DOI 10.1006/mgme.2001.3256; Kumar KR, 2010, NEUROMUSCULAR DISORD, V20, P330, DOI 10.1016/j.nmd.2010.03.002; Lamb JR, 2001, J BIOL CHEM, V276, P21512, DOI 10.1074/jbc.M100235200; Leon A, 1999, MOL BIOL CELL, V10, P3825, DOI 10.1091/mbc.10.11.3825; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li J, 2014, CELL METAB, V19, P373, DOI 10.1016/j.cmet.2014.01.001; Llewellyn K NA, 2013, HUM MOL GENET; Malicdan MCV, 2012, BRAIN PATHOL, V22, P82, DOI 10.1111/j.1750-3639.2011.00543.x; Miller TD, 2009, J NEUROL NEUROSUR PS, V80, P583, DOI 10.1136/jnnp.2008.148676; Muzic JG, 2014, JAMA DERMATOL, V150, P1024, DOI 10.1001/jamadermatol.2014.87; Nalbandian A, 2012, MUSCLE NERVE; Nalbandian A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046308; Nalbandian A, 2013, MUSCLE NERVE, V47, P260, DOI 10.1002/mus.23522; Peng ZF, 2014, J UROLOGY, V192, P1424, DOI 10.1016/j.juro.2014.04.096; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Rodriguez-Caruncho C, 2014, ACTAS DERMO-SIFILOGR, V105, P243, DOI [10.1016/j.ad.2012.10.005, 10.1016/j.adengl.2012.10.021]; Schroder R, 2005, ANN NEUROL, V57, P457, DOI 10.1002/ana.20407; Spina S, 2008, FASEB J, V22, P584; Tung YT, 2012, J BIOSCIENCES, V37, P157, DOI 10.1007/s12038-011-9176-0; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Vesa J, 2009, NEUROMUSCULAR DISORD, V19, P766, DOI 10.1016/j.nmd.2009.08.003; Viassolo V, 2008, CLIN GENET, V74, P54, DOI 10.1111/j.1399-0004.2008.00984.x; Watts GDJ, 2007, CLIN GENET, V72, P420, DOI 10.1111/j.1399-0004.2007.00887.x; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Watts GDJ, 2003, NEUROMUSCULAR DISORD, V13, P559, DOI 10.1016/S0960-8966(03)00070-1; Wojcik C, 2004, J CELL SCI, V117, P281, DOI 10.1242/jcs.00841; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yin HZ, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.115	65	55	56	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0122888	10.1371/journal.pone.0122888	http://dx.doi.org/10.1371/journal.pone.0122888			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884947	gold, Green Published			2022-12-26	WOS:000353017000042
J	Weme, RGJDO; Kovacs, AT; de Jong, SJG; Veening, JW; Siebring, J; Kuipers, OP				Weme, Ruud G. J. Detert Oude; Kovacs, Akos T.; de Jong, Sander J. G.; Veening, Jan-Willem; Siebring, Jeroen; Kuipers, Oscar P.			Single Cell FRET Analysis for the Identification of Optimal FRET-Pairs in Bacillus subtilis Using a Prototype MEM-FLIM System	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; RED FLUORESCENT PROTEIN; ESCHERICHIA-COLI; STREPTOCOCCUS-PNEUMONIAE; IMAGING MICROSCOPY; MONOMERIC RED; ACQUISITION; BACTERIA; LIFETIME; VARIANT	Protein-protein interactions can be studied in vitro, e.g. with bacterial or yeast two-hybrid systems or surface plasmon resonance. In contrast to in vitro techniques, in vivo studies of protein-protein interactions allow examination of spatial and temporal behavior of such interactions in their native environment. One approach to study protein-protein interactions in vivo is via Forster Resonance Energy Transfer (FRET). Here, FRET efficiency of selected FRET-pairs was studied at the single cell level using sensitized emission and Frequency Domain-Fluorescence Lifetime Imaging Microscopy (FD-FLIM). For FRET-FLIM, a prototype Modulated Electron-Multiplied FLIM system was used, which is, to the best of our knowledge, the first account of Frequency Domain FLIM to analyze FRET in single bacterial cells. To perform FRET-FLIM, we first determined and benchmarked the best fluorescent protein-pair for FRET in Bacillus subtilis using a novel BglBrick-compatible integration vector. We show that GFP-tagRFP is an excellent donor-acceptor pair for B. subtilis in vivo FRET studies. As a proof of concept, selected donor and acceptor fluorescent proteins were fused using a linker that contained a tobacco etch virus (TEV)-protease recognition sequence. Induction of TEV-protease results in loss of FRET efficiency and increase in fluorescence lifetime. The loss of FRET efficiency after TEV induction can be followed in time in single cells via time-lapse microscopy. This work will facilitate future studies of in vivo dynamics of protein complexes in single B. subtilis cells.	[Weme, Ruud G. J. Detert Oude; Kovacs, Akos T.; Veening, Jan-Willem; Siebring, Jeroen; Kuipers, Oscar P.] Univ Groningen, Mol Genet Grp, Groningen Biomol Sci & Biotechnol Inst, Ctr Synthet Biol, NL-9747 AG Groningen, Netherlands; [de Jong, Sander J. G.] Lambert Instruments BV, NL-9301 ZP Roden, Netherlands	University of Groningen	Kuipers, OP (corresponding author), Univ Groningen, Mol Genet Grp, Groningen Biomol Sci & Biotechnol Inst, Ctr Synthet Biol, NL-9747 AG Groningen, Netherlands.	o.p.kuipers@rug.nl	Kovács, Ákos T/A-9433-2015; Kuipers, Oscar/B-6752-2009	Kovács, Ákos T/0000-0002-4465-1636; Kuipers, Oscar/0000-0001-5596-7735; Veening, Jan-Willem/0000-0002-3162-6634	EMBO Young Investigator Programme; VIDI fellowship from the Netherlands Organisation for Scientific Research, Earth and Life Sciences (NWO-ALW) [864.12.001]; ERC [337399]; STW grants (NWO); EU; ALW-NWO; Lambert Instruments B.V.	EMBO Young Investigator Programme(European Molecular Biology Organization (EMBO)); VIDI fellowship from the Netherlands Organisation for Scientific Research, Earth and Life Sciences (NWO-ALW)(Netherlands Organization for Scientific Research (NWO)); ERC(European Research Council (ERC)European Commission); STW grants (NWO); EU(European Commission); ALW-NWO(Netherlands Organization for Scientific Research (NWO)); Lambert Instruments B.V.	J.W.V. is supported by the EMBO Young Investigator Programme, a VIDI fellowship (864.12.001) from the Netherlands Organisation for Scientific Research, Earth and Life Sciences (NWO-ALW) and ERC starting grant 337399-PneumoCell. O.P.K. was supported by several STW grants (NWO), two EU FW7 grants: SynPeptide and BachBerry and R.D.O.W. and O.P.K. by a specific SYSMO2 grant from ALW-NWO. Lambert Instruments B.V. provided support in the form of salary for author S.J., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alexeeva S, 2010, MOL MICROBIOL, V77, P384, DOI 10.1111/j.1365-2958.2010.07211.x; ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741, DOI 10.1128/JB.81.5.741-746.1961; Anderson J Christopher, 2010, J Biol Eng, V4, P1, DOI 10.1186/1754-1611-4-1; Crivat G, 2012, TRENDS BIOTECHNOL, V30, P8, DOI 10.1016/j.tibtech.2011.08.002; Day RN, 2009, CHEM SOC REV, V38, P2887, DOI 10.1039/b901966a; de Jong IG, 2011, JOVE-J VIS EXP, DOI 10.3791/3145; DOUGHERTY WG, 1989, VIROLOGY, V172, P302, DOI 10.1016/0042-6822(89)90132-3; Forster T., 1948, ANN PHYS, V2, P55; Goedhart J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001011; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Gruber S, 2014, CURR BIOL; GueroutFleury AM, 1996, GENE, V180, P57, DOI 10.1016/S0378-1119(96)00404-0; Harwood CR, 1990, MOL BIOL METHODS BAC; Kentner D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.77; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Knight T., 2003, IDEMPOTENT VECTOR DE; Kramer N, 2007, MOL MICROBIOL, V65, P454, DOI 10.1111/j.1365-2958.2007.05799.x; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lakowicz JR., 2006, ANONYMOUS PRINCIPLES, P157; Lakowicz JR., 2006, ANONYMOUS PRINCIPLES, P443; Marchadier E, 2011, PROTEOMICS, V11, P2981, DOI 10.1002/pmic.201000791; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Mika JT, 2010, MOL MICROBIOL, V77, P200, DOI 10.1111/j.1365-2958.2010.07201.x; Munster vEB, 2005, ADV BIOCHEM ENG BIOT, P143; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nagy P, 1998, EUR BIOPHYS J BIOPHY, V27, P377, DOI 10.1007/s002490050145; Overkamp W, 2013, APPL ENVIRON MICROB, V79, P6481, DOI 10.1128/AEM.02033-13; Padilla-Parra S, 2009, BIOPHYS J, V97, P2368, DOI 10.1016/j.bpj.2009.07.044; Poyales DA, 1994, FOCUS, V16, P1; Remington SJ, 2011, PROTEIN SCI, V20, P1509, DOI 10.1002/pro.684; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rudner DZ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000307; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Scheu PD, 2012, J BACTERIOL, V194, P636, DOI 10.1128/JB.06345-11; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shapiro L, 2009, SCIENCE, V326, P1225, DOI 10.1126/science.1175685; Shcherbo D, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-24; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; van der Krogt GNM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001916; Van Munster EB, 2004, J MICROSC-OXFORD, V213, P29, DOI 10.1111/j.1365-2818.2004.01249.x; van Rheenen J, 2004, BIOPHYS J, V86, P2517, DOI 10.1016/S0006-3495(04)74307-6; W. M. Keck Center for Cellular Imaging, 7 IM REQ FRET DAT PR; Wade JT, 2007, MOL MICROBIOL, V65, P21, DOI 10.1111/j.1365-2958.2007.05781.x; Zhao QL, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.12.126020	46	9	9	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123239	10.1371/journal.pone.0123239	http://dx.doi.org/10.1371/journal.pone.0123239			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886351	Green Submitted, gold, Green Published			2022-12-26	WOS:000353017000052
